ID,Label,Preferred label,Synonyms
C098107,CHEMICAL,flibanserin [Supplementary Concept],Flibanserin|Benzimidazoles|flibanserin
NEW00000,MENTAL_HEALTH,acquired generalized hypoactive sexual desire disorder,acquired generalized hypoactive sexual desire disorder
D020018,DISEASE,"Sexual Dysfunctions, Psychological","|Sexual Aversion Disorder|Sexual Aversion Disorders|Dysfunctions, Psychological Sexual|Psychosexual Dysfunctions|Hypoactive sexual desire disorder|Psychosexual Disorder|Orgasmic Disorder|Orgasmic Disorders|sexual dysfunctions|sexual arousal disorder|low sexual desire|Disorders, Psychosexual|frigidity|Disorders, Orgasmic|Disorders, Sexual Aversion|Sexual Arousal Disorder|Dysfunction, Psychosexual|HSDD|Disorder, Psychosexual|sexual disorders|hypoactive sexual desire disorder|desire|Arousal Disorders, Sexual|Frigidity|Psychological Sexual Dysfunction|Psychosexual Disorders|Sexual Arousal Disorders|Disorders, Sexual Arousal|Dysfunction, Psychological Sexual|Sexual Dysfunction, Psychological|dysfunctions|Psychosexual Dysfunction|Psychological Sexual Dysfunctions|Hypoactive Sexual Desire Disorder|Dysfunctions, Psychosexual|Aversion Disorders, Sexual|sexual desire"
NEW00001,CHEMICAL,multifunctional serotonin receptor agonist,multifunctional serotonin receptor agonist
D063766,DISEASE,Pediatric Obesity,"Overweight, Adolescent|Obesity, Infantile|Adolescent Obesity|Obesity in Adolescence|Child Obesity|Obesity, Childhood Onset|Obesity, Childhood|Obesity, Infant|Adolescent Overweight|Childhood Onset Obesity|Infant Overweight|Overweight, Infant|Infantile Obesity|Childhood Overweight|Obesity, Child|Obesity, Pediatric|Obesity, Adolescent|Childhood Obesity|Infant Obesity|obesity|Obesity in Childhood|Obesity|Overweight, Childhood"
NEW00002,CHEMICAL,reduced testosterone,reduced testosterone
NEW00003,DISEASE,erectile function,erectile function
C093875,CHEMICAL,montelukast [Supplementary Concept],Acetates|Montelukast|montelukast|Cyclopropanes|Sulfides|Quinolines|MTK
NEW00004,CHEBI,safe drug,safe drug
D015525,NUTRITION,"Fatty Acids, Omega-3","n-3 Polyunsaturated Fatty Acid|polyunsaturated fatty acid|Omega 3 Fatty Acids|Oil, n3|n3-PUFA|Omega-3 Fatty Acid|Acid, N-3 Fatty|omega-3 fatty acids|n-3 Fatty Acids|n-3 Oils|n3 Fatty Acid|n3 PUFA|omega-3|Omega-3 fatty acids|Fatty Acid, n3|PUFA, n3|Omega 3 Fatty Acid|n-3 fatty acids|n 3 PUFA|n3 Oils|n 3 Polyunsaturated Fatty Acid|n 3 Fatty Acids|Oil, n-3|Omega-3 Fatty Acids|PUFA|n3 Oil|N 3 Fatty Acid|n-3 Oil|PUFA, n-3|Acid, Omega-3 Fatty|N-3 Fatty Acid|n 3 Oils|n 3 Oil|n3 Polyunsaturated Fatty Acid|n-3 PUFA|Fatty Acid, N-3|Fatty Acid, Omega-3|N-3 fatty acids"
D015289,CHEMICAL,Leukotrienes,leukotrienes|Leukotriene
NEW00005,DISEASE,psychiatric adverse events,psychiatric adverse events
D015118,CHEMICAL,Eicosapentaenoic Acid,"omega-3-Eicosapentaenoic Acid|Eicosapentanoic Acid|Acid, Eicosapentanoic|5,8,11,14,17-Icosapentaenoic Acid|Eicosapentaenoic acid|5,8,11,14,17-Eicosapentaenoic Acid|omega 3 Eicosapentaenoic Acid|Timnodonic Acid|eicosapentaenoic|EPA|Icosapent|eicosapentaenoic acid"
NEW00006,DISEASE,cognitive functioning =,cognitive functioning =
D001206,CHEBI,Ascorbic Acid Deficiency,"Ascorbic acid|vitamin C|Vitamin C Deficiency|vitamin C deficiency|ascorbic acid|Vitamin C Deficiencies|Deficiency, Vitamin C|Vitamin C deficiency|Ascorbic Acid Deficiencies|Deficiency, Ascorbic Acid|Deficiencies, Ascorbic Acid|ascorbic acid deficiency|Deficiencies, Vitamin C"
D019636,DISEASE,Neurodegenerative Diseases,"Neurologic Degenerative Conditions|Neurologic Disorder, Degenerative|Neurologic Degenerative Condition|Neurodegenerative Disease|Neurologic Disease, Degenerative|Degenerative Diseases, Spinal Cord|neurodegenerative|neurologic diseases|Neurologic Diseases, Degenerative|Neurologic Degenerative Diseases|Degenerative Diseases, Nervous System|neurodegenerative diseases|neurodegenerative disorders|Degenerative Neurologic Disorders|Degenerative Condition, Neurologic|Neurologic Disorders, Degenerative|Neurodegenerative Disorder|Degenerative Conditions, Neurologic|Nervous System Degenerative Diseases|Degenerative Neurologic Disorder|Degenerative Neurologic Disease|degenerative diseases|Degenerative Diseases, Neurologic|Neurologic disorders|Degenerative Neurologic Diseases|Neurologic Degenerative Disease|neurologic disorders|Neurodegenerative Disorders|Degenerative Diseases, Central Nervous System"
D020529,DISEASE,"Multiple Sclerosis, Relapsing-Remitting","Acute Relapsing Multiple Sclerosis|Multiple Sclerosis, Remitting-Relapsing|Remitting Relapsing Multiple Sclerosis|Multiple Sclerosis, Acute Relapsing|Relapsing Remitting Multiple Sclerosis|Remitting-Relapsing Multiple Sclerosis|Relapsing-Remitting Multiple Sclerosis|Multiple Sclerosis, Relapsing Remitting|multiple sclerosis"
D000544,DISEASE,Alzheimer Disease,"|Alzheimer Dementia|ATD|Alzheimer's Disease, Focal Onset|Late Onset Alzheimer Disease|Early Onset Alzheimer Disease|Dementia, Primary Senile Degenerative|SDAT|disease dementia|Presenile Dementia|Senile Dementia, Alzheimer Type|Alzheimer type dementia|Familial Alzheimer Disease (FAD)|type dementia|Alzheimer Type Dementia|Alzheimer Diseases|Presenile Alzheimer Dementia|Alzheimer Sclerosis|senile dementia|Dementia, Senile|Primary Senile Degenerative Dementia|Alzheimer Type Dementia (ATD)|Dementia, Alzheimer|Alzheimer Type Senile Dementia|Dementia, Alzheimer-Type (ATD)|Alzheimer type|Senile Dementia|Alzheimer Disease, Early Onset|Alzheimer's Diseases|Dementia, Presenile|Senile Dementia, Acute Confusional|dementia Alzheimer type|Familial Alzheimer Diseases (FAD)|Alzheimer's disease|Acute Confusional Senile Dementia|Sclerosis, Alzheimer|Alzheimers Diseases|Alzheimer Dementias|Alzheimer dementia|Focal Onset Alzheimer's Disease|Dementia, Alzheimer Type|Alzheimer Disease, Familial (FAD)|Alzheimer disease|Alzheimer Disease|Alzheimer Syndrome|Alzheimer-Type Dementia (ATD)|Alzheimer's Disease|Alzheimer Disease, Late Onset"
D000690,DISEASE,Amyotrophic Lateral Sclerosis,"Guam Form of Amyotrophic Lateral Sclerosis|Guam Disease|ALS Amyotrophic Lateral Sclerosis|Amyotrophic Lateral Sclerosis|Disease, Guam|ALS|Gehrig Disease|Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam|ALS - Amyotrophic Lateral Sclerosis|Lou Gehrig Disease|Amyotrophic Lateral Sclerosis, Guam Form|Sclerosis, Amyotrophic Lateral|Lou-Gehrigs Disease|Gehrig's Disease|Amyotrophic Lateral Sclerosis With Dementia|Motor Neuron Disease, Amyotrophic Lateral Sclerosis|Lateral Sclerosis|amyotrophic lateral sclerosis|Charcot Disease|Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam|Lou Gehrig's Disease|Dementia With Amyotrophic Lateral Sclerosis|Gehrigs Disease|Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1|lateral sclerosis|Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1|Disease, Lou-Gehrigs"
NEW00007,DISEASE,schizophrenic patients,schizophrenic patients
D011736,CHEBI,Pyridoxine,Vitamin B6|Pyridoxine Hydrochloride|vitamin B6|pyridoxine|Pyridoxol|Rodex|Pyridoxine|Pyridoxin|Pyridoxol Hydrochloride
NEW00008,CHEMICAL,high plasma pentosidine levels,high plasma pentosidine levels
NEW00009,DISEASE,idiopathic carbonyl stress,idiopathic carbonyl stress
NEW00010,CHEMICAL,high pentosidine levels,high pentosidine levels
NEW00011,CHEBI,lowered vitamin B6 levels,lowered vitamin B6 levels
D018164,DISEASE,"Hemorrhagic Disease Virus, Epizootic",hemorrhagic disease|Epizootic hemorrhagic disease virus
D034161,DISEASE,Pelvic Infection,"infection|Infection|Infection, Pelvic|Infections, Pelvic|Pelvic Infections"
NEW00012,MENTAL_HEALTH,unlearned fear,unlearned fear|anxiety
D059787,DISEASE,Acute Pain,"Pain, Acute|acute pain|Pains, Acute|Pain|pain|arthritis model|Acute Pains"
D064417,CHEBI,Vitamin K Epoxide Reductases,"Vitamin K Epoxidase|Vitamin K 2,3 Epoxide Reductase|Vitamin KO Reductase|K Epoxidase, Vitamin|Epoxide Reductase, Menadione|phylloquinone|Vitamin K 2,3-Epoxide Reductase|Epoxide Reductase, Phylloquinone|vitamin K.|Epoxidase, Vitamin K|Vitamin K 1 Epoxidase|Vitamin K Epoxide Reductase|Vitamin K1 Oxide Reductase|Menadione Epoxide Reductase|vitamin K|Phylloquinone Epoxide Reductase|Reductase, Vitamin KO|Vitamin K|Reductase, Phylloquinone Epoxide|Reductase, Menadione Epoxide"
NEW00013,CHEBI,Riboflavin transporter deficiency,Riboflavin transporter deficiency
D064507,CHEBI,"Solute Carrier Family 12, Member 4","Erythroid K-Cl Cotransporter 1|carrier family|Protein, KCC1|Erythroid K Cl Cotransporter 1|Protein, SLC12A4|KCC1 Protein|Electroneutral Potassium-Chloride Cotransporter 1|SLC12A4 Protein|carrier|Solute Carrier Family 12 (Potassium Chloride Transporters), Member 4 Protein|Electroneutral Potassium Chloride Cotransporter 1"
NEW00014,CHEBI,folate deficiency,folate deficiency
NEW00015,DISEASE,psychiatric hospitalization,psychiatric hospitalization
NEW00016,DISEASE,psychiatric patients,psychiatric patients
NEW00017,CHEBI,low serum folate values,low serum folate values
NEW00018,DISEASE,B12 insufficiency,B12 insufficiency
D060825,DISEASE,Cognitive Dysfunction,"Impairments, Mild Cognitive|Disorders, Mild Neurocognitive|Deteriorations, Mental|Impairment, Mild Cognitive|Impairments, Cognitive|Disorder, Mild Neurocognitive|Mild Neurocognitive Disorders|Cognitive Impairments, Mild|Mild Cognitive Impairment|Neurocognitive Disorders, Mild|Declines, Cognitive|Cognitive Impairment, Mild|cognitive dysfunction|Mental Deterioration|Cognitive Impairments|Mild Cognitive Impairments|Cognitive Impairment|Decline, Cognitive|cognitive decline|MCI|Mild Neurocognitive Disorder|mild cognitive impairment|Cognitive Decline|Dysfunctions, Cognitive|Deterioration, Mental|Neurocognitive Disorder, Mild|Cognitive Dysfunctions|Cognitive Declines|Dysfunction, Cognitive|cognitive impairments|Impairment, Cognitive|Cognitive dysfunction|Mental Deteriorations"
NEW00019,CHEMICAL,Biotin-dependent carboxylases,Biotin-dependent carboxylases
D027982,CHEMICAL,Sodium-Bicarbonate Symporters,"Symport, Na-HCO3|Symporters, Sodium-Bicarbonate|Solute Carrier Family 4 Member 10|Electroneutral Sodium Bicarbonate Exchanger 1|Na-HCO3 Symport|Electrogenic Sodium Bicarbonate Cotransporter 4|NBCn2 Protein|Electrogenic Sodium Bicarbonate Cotransporter 1|Sodium driven chloride bicarbonate exchanger|NBCE1 Protein|Protein, SLC4A5|NBCe2 Protein|bicarbonate|Symport, Sodium Bicarbonate|Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 4|Protein, NBCn2|Protein, NBCe2|SLC4A10 Protein|Electroneutral Na(+)-Driven Cl-HCO3 Exchanger|Protein, NBC4|Sodium-driven chloride bicarbonate exchanger|Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 7|Protein, NBCE1|Protein, NBC1|Solute Carrier Family 4 Member 4|Bicarbonate Transporters, Sodium-Coupled|Sodium Bicarbonate Cotransporter 3|Cotransporter, Sodium-Bicarbonate|NCBE Protein|NBC1 Protein|Solute Carrier Family 4 Member 7|Protein, SLC4A7|NBC4 Protein|Sodium Bicarbonate Cotransporter 2|k-NBC3 Protein|SLC4A4 Protein|Protein, SLC4A8|Bicarbonate Symport, Sodium|Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 5|NBC3 Protein|Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 8|Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 10|k NBC3 Protein|Na HCO3 Symport|Sodium-Coupled Bicarbonate Transporters|Sodium-Bicarbonate Cotransporter|Protein, k-NBC3|Sodium Coupled Bicarbonate Transporters|SLC4A5 Protein|Sodium Bicarbonate Symport|Solute Carrier Family 4 Member 5|SLC4A7 Protein|Transporters, Sodium-Coupled Bicarbonate|Sodium Bicarbonate Cotransporter|Sodium Bicarbonate Symporters|Protein, NBC3|Solute Carrier Family 4 Member 8|SLC4A8 Protein|Protein, SLC4A4|Protein, SLC4A10"
D053831,MENTAL_HEALTH,Surgical Fixation Devices,"surgical fixation|Fixation Devices, Surgical|fixation|Devices, Surgical Fixation|Surgical Fastener|Device, Surgical Fixation|Fixation Device, Surgical|Surgical Fixation Device|Fasteners, Surgical|Surgical Fasteners|Fastener, Surgical"
D024361,CHEMICAL,"Amino Acids, Basic","amino acids|Amino Acid, Basic|Basic Amino Acids|Basic Amino Acid|Amino acids"
D044242,NUTRITION,Trans Fatty Acids,"Acids, Trans Fatty|Acid, Trans Fatty|Trans-Fatty Acids|fatty acids|Acids, Trans-Fatty|trans-fatty acids|trans fatty acids|Fatty acids|Fatty Acids, Trans|Fatty Acid, Trans|Trans Fatty Acid|TFA"
C531633,CHEBI,Biotin deficiency [Supplementary Concept],Biotinidase Deficiency|Biotin deficiency|biotin deficiency
D009123,DISEASE,Muscle Hypotonia,"Hypotonia|muscle flaccidity|Muscle, Floppy|Tone Atonic, Muscle|Flaccidity, Muscular|Muscular Flaccidities|hypotonia|Flaccid Muscle Tone|Hypotonia, Unilateral|Floppy Muscle|Neonatal Hypotonia|Hypomyotonia|Decreased Muscle Tone|Muscular Flaccidity|Hypotonia, Muscle|Muscles, Floppy|Muscle Tone Atonic|Muscular Hypotonia|flaccidity|Hypotonias, Neonatal|Hypotonia, Muscular|Hypotonia, Neonatal|Floppy Muscles|Hypotony, Muscle|Muscle Tone, Decreased|Unilateral Hypotonia|Muscle Tone, Flaccid|Tone Poor, Muscle|Flaccidity, Muscle|Hypotonias, Unilateral|Muscle Hypotony|Muscle Tone Atonics|Neonatal Hypotonias|Muscle Flaccidity|Muscle Tone Poor"
NEW00020,DISEASE,organic aciduria,organic aciduria
D058066,DISEASE,Digital Dermatitis,"Foot Wart, Bovine|Bovine Digital Dermatitis|Digital Dermatitis, Ovine|Papillomatosis, Digital|Digital Dermatitis, Papillomatous|Hairy Footwart, Bovine|Wart, Bovine Foot|Warts, Bovine Foot|Bovine Foot Warts|Digital Dermatitides, Bovine|Dermatitides, Bovine Digital|Bovine Foot Wart|Hairy Footwarts, Bovine|Dermatitides, Digital|Dermatitis, Digital|Footwart, Bovine Hairy|Digital Papillomatoses|Bovine Hairy Footwart|Papillomatous Digital Dermatitis|Papillomatous Digital Dermatitides|Digital Dermatitis, Bovine|Dermatitis, Bovine Digital|Digital Papillomatosis|Digital Dermatitides|Digital Dermatitides, Ovine|Bovine Digital Dermatitides|dermatitis|Foot Warts, Bovine|Ovine Digital Dermatitides|Digital Dermatitides, Papillomatous|Footwarts, Bovine Hairy|Papillomatoses, Digital|Ovine Digital Dermatitis|Bovine Hairy Footwarts"
D020270,DISEASE,Alcohol Withdrawal Seizures,"Seizures, Alcohol Withdrawal|Alcohol Withdrawal Induced Major Motor Seizure|Alcohol Withdrawal-Induced Status Epilepticus|Alcohol Withdrawal Induced Seizure|Seizure, Alcoholic|Seizures, Alcoholic|Alcohol-Related Seizure|Alcoholic Seizure|Seizures|Alcohol Withdrawal Seizure|Alcohol Withdrawal-Induced Seizures|Withdrawal-Induced Seizures, Alcohol|Seizure, Alcohol Withdrawal|Seizure, Alcohol-Related|Major Motor Seizure, Alcohol Withdrawal-Induced|Seizures, Alcohol Withdrawal-Induced|Alcohol Related Seizures|alcohol withdrawal|Alcohol-Related Seizures|Status Epilepticus, Alcohol Withdrawal Induced|Alcohol Withdrawal-Induced Major Motor Seizure|Status Epilepticus, Alcohol Withdrawal-Induced|Alcoholic Seizures|Withdrawal-Induced Seizure, Alcohol|Seizure, Alcohol Withdrawal-Induced|Seizures, Alcohol-Related|Alcohol Withdrawal Induced Status Epilepticus|Alcohol withdrawal|withdrawal seizures|Alcohol Withdrawal-Induced Seizure|seizures"
D064007,DISEASE,Ataxia Telangiectasia Mutated Proteins,"ATM Protein|ataxia|Ataxia|Mutated Protein, AT|A-T Protein|Protein, AT Mutated|Protein, A-T|A T Protein|AT Mutated Protein"
NEW00021,DISEASE,ketolactic acidosis,ketolactic acidosis
D000505,DISEASE,Alopecia,"hair loss||Androgenic Alopecia|Baldness, Pattern|Androgenic Alopecias|Hair Losses|Alopecia, Male Pattern|Pseudopelade|Alopecia|Pattern Baldness|Alopecia Cicatrisatas|Alopecias, Androgenic|Losses, Hair|Androgenetic Alopecia|Baldness, Female Pattern|androgenetic alopecia|Androgenetic alopecia|Male Pattern Baldness|Female Pattern Baldness|Alopecia Cicatrisata|Alopecia, Androgenic|Loss, Hair|Baldness, Male Pattern|Male Pattern Alopecia|Hair Loss|Alopecia, Androgenetic|Baldness"
D051860,MENTAL_HEALTH,Fragile X Mental Retardation Protein,Fragile X Mental Retardation 1 Protein|MR|Fragile X Mental Retardation-1 Protein|FMRP Protein|Mental retardation|Fragile X Mental Retardation Protein|mental retardation
NEW00022,CHEBI,folate levels,folate levels
NEW00023,MENTAL_HEALTH,ADHD patients,ADHD patients
NEW00024,CHEBI,vitamin abnormalities,vitamin abnormalities
D003324,DISEASE,Coronary Artery Disease,"coronary artery disease||Atherosclerosis, Coronary|Coronary Arteriosclerosis|Artery Diseases, Coronary|Artery Disease, Coronary|Left Main Diseases|Arterioscleroses, Coronary|Coronary Atheroscleroses|coronary atherosclerosis|Atheroscleroses, Coronary|Left Main Coronary Disease|CAD|Coronary Arterioscleroses|Left Main Coronary Artery Disease|Arteriosclerosis, Coronary|Left Main Disease|Coronary Atherosclerosis|Coronary Artery Diseases"
NEW00025,DISEASE,AD VaD patients,AD VaD patients
D008315,CHEMICAL,Malondialdehyde,"|Propanedial|Malonylaldehyde|Malonyldialdehyde|malondialdehyde|Malonaldehyde|Sodium Malondialdehyde|Malondialdehyde, Sodium|MDA"
NEW00026,CHEMICAL,serotonin 5-HT1A/1B receptor agonist eltoprazine,serotonin 5-HT1A/1B receptor agonist eltoprazine
NEW00027,DISEASE,Parkinson 's disease,Parkinson 's disease|early Parkinson 's disease|PD
NEW00028,DISEASE,dyskinetic-like behavior,dyskinetic-like behavior
D058917,CHEMICAL,Adenosine A2 Receptor Antagonists,Adenosine A2B Receptor Antagonists|Adenosine A2A receptor antagonists|Adenosine A2A Receptor Antagonists|adenosine A2A receptor antagonists|A2A receptor antagonists|adenosine A2A receptor
NEW00029,CHEMICAL,l-dopa efficacy,l-dopa efficacy
C539997,CHEMICAL,"2-(2-furanyl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)-1-piperazinyl)ethyl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidine-5-amine [Supplementary Concept]",preladenant|Triazoles|Pyrimidines
NEW00030,CHEMICAL,chronic subordinate colony housing,CSC|chronic subordinate colony housing
NEW00031,DISEASE,haloperidol-induced catalepsy,haloperidol-induced catalepsy
C108242,CHEMICAL,"1-aminocyclopentane-1,3,4-tricarboxylic acid [Supplementary Concept]",Tricarboxylic Acids|ACPT-I|Cyclopentanes
D002375,DISEASE,Catalepsy,"Catalepsies|Waxy Flexibilities||Flexibility, Waxy|parkinsonian catalepsy|Waxy Flexibility|Flexibilitas, Cerea|Anochlesia|Catalepsy|catalepsy|Flexibilities, Waxy|Cerea Flexibilitas|Anochlesias"
NEW00032,CHEMICAL,mGluR5 inverse agonist 2-methyl-6-(phenylethynyl)pyridine,mGluR5 inverse agonist 2-methyl-6-(phenylethynyl)pyridine|MPEP
NEW00033,DISEASE,parkinsonian rats,parkinsonian rats
D007980,CHEMICAL,Levodopa,"Larodopa||L-dopa|L-3,4-Dihydroxyphenylalanine|L-Dopa|L-3,4-dihydroxyphenylalanine|l-3,4-dihydroxyphenylalanine|Dopar|Levopa|L 3,4 Dihydroxyphenylalanine|L-DOPA|3 Hydroxy L tyrosine|Levodopa|Dopaflex|L Dopa|levodopa|3-Hydroxy-L-tyrosine|l-DOPA"
D018726,MENTAL_HEALTH,Anti-Dyskinesia Agents,"Agents, Movement Disorder|Dyskinesia|Movement Disorder Agents|dyskinesia|Agents, Anti-Dyskinesia|Anti Dyskinesia Agents|Disorder Agents, Movement"
D010300,DISEASE,Parkinson Disease,"|Idiopathic Parkinson's Disease|Parkinson's Disease, Idiopathic|Parkinson's Disease, Lewy Body|Idiopathic Parkinson Disease|Parkinson's Disease|Parkinson´s disease|Paralysis Agitans|idiopathic Parkinson's disease|Lewy Body Parkinson Disease|Lewy Body Parkinson's Disease|Primary Parkinsonism|Parkinsonism, Primary|Parkinson's disease|Parkinson Disease, Idiopathic"
NEW00034,CHEMICAL,"dopamine precursor L-3,4-dihydroxyphenylalanine","dopamine precursor L-3,4-dihydroxyphenylalanine|L-DOPA"
C111599,CHEMICAL,istradefylline [Supplementary Concept],istradefylline|KW-6002|Istradefylline|Purines
D002110,CHEMICAL,Caffeine,"No Doz||Dexitac|Durvitan|Percutaféine|Quick Pep|trimethylxanthine|Percoffedrinol N|Quick-Pep|Vivarin|Coffeinum N|caffeine|Caffedrine|1,3,7-Trimethylxanthine|Caffeine|Coffeinum Purrum|QuickPep"
D011619,CHEBI,Psychotropic Drugs,"Psychoactive Agents|Agent, Psychoactive|Psychoactive Agent|Psychopharmaceuticals|Psychoactive Drug|Psychotropic Drug|Drugs, Psychoactive|Drug, Psychotropic|Psychoactive Drugs|psychoactive drug|Psychopharmaceutical|Agents, Psychoactive|Drug, Psychoactive|Drugs, Psychotropic|psychotropic drug"
NEW00035,CHEMICAL,adenosine A2A antagonists,adenosine A2A antagonists
C087658,CHEMICAL,levodopa receptor [Supplementary Concept],"L-dopa|LDl|L-Dopa|L-DOPA|Receptors, Neurotransmitter|l-dopa"
NEW00036,CHEBI,agonist drugs,agonist drugs
NEW00037,MENTAL_HEALTH,subscale D,subscale D|depression|central alpha-2 receptors
NEW00038,CHEBI,drug class,drug class
NEW00039,CHEBI,A2A antagonists,A2A antagonists
NEW00040,DISEASE,neuronal loss,neuronal loss
D000077285,CHEMICAL,Rimonabant,"SR141716|SR141716A|Zimulti|SR-141716A|Rimonabant|rimonabant|SR 141716A|Rimonabant Hydrochloride|SR 141716|Acomplia|N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide hydrochloride"
D064829,CHEMICAL,Alcohol Abstinence,"Abstinence, Alcohol|alcohol|Abstinence, Ethanol|Abstinence from Ethanol|Ethanol Abstinence|Abstinence from Ethanols|alcohol abstinence|Alcohol"
NEW00041,CHEMICAL,acid/kainate receptor-type neurotoxicity,acid/kainate receptor-type neurotoxicity
NEW00042,CHEMICAL,voltage sensitive calcium channels,voltage sensitive calcium channels
NEW00043,CHEMICAL,oxotremorine treatment,oxotremorine treatment
NEW00044,DISEASE,chronic stress-induced cognitive deficits,chronic stress-induced cognitive deficits
D014147,CHEMICAL,Tramadol,|Tramadol-ratiopharm|TramaDorsch|Tramagit|Tramadol Bayvit|MTWTramadol|Tramex|Tramadolor|Tramadol Hameln|Tramadol|Tramabeta|Zumalgic|Trama-Dorsch|Biokanol|Zytram|Takadol|Tramadol Dolgit|Jutadol|Tradol|Tramadol-Dolgit|Tramadol AL|Tradonal|Ranitidin 1A Pharma|Tramadol Asta Medica|MTW Tramadol|Tramadol Cinfa|Tradol-Puren|Trama Dorsch|TradolPuren|Tramadolratiopharm|Tramal|Tralgiol|Tramake|Nobligan|Tramadol-Hameln|Trama 1A Pharma|Tramadol Edigen|Ultram|Tramadol Kern|Trasedal|Tramagetic|Biodalgic|Tramadol Mabo|Xymel 50|Tramundin|K-315|Adolonta|Tramadol Basics|Tramadol PB|Theradol|Tramadin|Contramal|Tramadol Lichtenstein|Zamudol|Topalgic|Tramadol Bexal|Zydol|Tramadol Ratiopharm|Tramadol Heumann|Amadol|TramadolHameln|Tramadoc|Tiral|K 315|Tradol Puren|tramadol|Tramadol Lindo|Trama AbZ|Tramadol acis|TramadolDolgit|Tramadura|K315|Tramadol Stada|Tramadol Hydrochloride|Prontofort|Trama KD|MTW-Tramadol|Tramadol 1A|Tramadol Normon
D018712,CHEBI,"Analgesics, Non-Narcotic","Analgesics, Non-Opioid|Analgesics, Non Narcotic|Opioid analgesics|Analgesics, Nonnarcotic|Analgesic, Non Opioid|Non Opioid Analgesics|Non-Opioid Analgesics|opioid analgesics|Opioid Analgesic, Non|opioid analgesic|Nonopioid Analgesics|Non Opioid Analgesic|Non-Narcotic Analgesics|Analgesic, Non-Opioid|Nonnarcotic Analgesics|Analgesics, Nonopioid|Non-Opioid Analgesic|Analgesic, Nonopioid|Nonopioid Analgesic"
NEW00045,CHEMICAL,tramadol administration,tramadol administration
NEW00046,DISEASE,neurodegeneration effect,neurodegeneration effect
D003024,CHEMICAL,Clozapine,|CLZ|Clozaril|clozapine|Clozapine|Leponex|clozapine-
D000090663,MENTAL_HEALTH,"Schizophrenia, Treatment-Resistant","Treatment Resistant Schizophrenia|Refractory Schizophrenia|refractory schizophrenia|Treatment-Resistant Schizophrenia|treatment-resistant schizophrenia|schizophrenia treatment|Schizophrenia, Treatment Resistant|Schizophrenia, Refractory|treatment resistant schizophrenia"
NEW00047,CHEMICAL,analgesic opioid prescription,analgesic opioid prescription|AOP
NEW00048,MENTAL_HEALTH,abuse disorder,abuse disorder
NEW00049,CHEMICAL,age ≤ old female gender,age ≤ old female gender
C087036,DISEASE,"NS-5 protein, hepatitis C virus [Supplementary Concept]",hepatitis C virus|Hepatitis C virus|Viral Nonstructural Proteins|HCV|RNA-Dependent RNA Polymerase
D009340,CHEMICAL,Nefopam,"Fenazoxine|Nefopam Hydrochloride|Hydrochloride, Nefopam|Nefopam hydrochloride|Silentan Nefopam|nefopam|Ajan|Nefopam, Silentan|Acupan"
NEW00050,DISEASE,electric seizure threshold,electric seizure threshold
D010098,CHEMICAL,Oxycodone,|Pancodine|Dihydrohydroxycodeinone|Oxiconum|Oxycodone|Eucodal|Oxycodeinon|Dihydrone|Oxycone|Oxycodone Hydrochloride|Oxycontin|Dinarkon|Theocodin|oxycodone
NEW00051,DISEASE,severe pain,severe pain
NEW00052,CHEMICAL,opioid-naive patients,opioid-naive patients
D018847,CHEMICAL,Opioid Peptides,"Opioid Peptide|Opiates, Endogenous|opioid|Opiate Peptides|Peptides, Opioid|Peptides, Opiate|Peptide, Opioid|morphine|Endogenous Opiates"
NEW00053,DISEASE,renal impairment due,renal impairment due
D000072716,DISEASE,Cancer Pain,"Pains, Cancer-Associated|Pains, Oncology|Neoplasm-Related Pain|Oncology Pains|Cancer Pains|Tumor Related Pain|Tumor Associated Pain|cancer pain|Cancer-Associated Pains|Pain, Oncological|Oncology Pain|Neoplasm-Related Pains|Oncological Pain|Cancer-Associated Pain|Neoplasm Related Pain|Pains, Neoplasm-Related|Tumor-Associated Pains|Cancer-Related Pain|Pain, Tumor-Associated|Pains, Cancer-Related|Neoplasm-Associated Pain|Oncological Pains|Pains, Oncological|Tumor-Related Pain|Pain, Tumor-Related|Cancer Related Pain|Neoplasm Associated Pain|Cancer-Related Pains|Pain, Cancer|Pain, Oncology|Neoplasm-Associated Pains|Pain, Neoplasm-Associated|Pains, Tumor-Associated|Tumor-Related Pains|Pain, Cancer-Related|Pain, Neoplasm-Related|Pains, Cancer|Pains, Tumor-Related|Pain, Cancer-Associated|Cancer Associated Pain|Pains, Neoplasm-Associated|Tumor-Associated Pain"
NEW00054,DISEASE,severe postoperative pain,severe postoperative pain
NEW00055,DISEASE,cerebral oedema,cerebral oedema
D007676,DISEASE,"Kidney Failure, Chronic","|uremic toxin|Chronic Kidney Failure|End Stage Renal Disease|End-Stage Renal Failure|renal disease|Disease, End-Stage Renal|Disease, End-Stage Kidney|renal failure|Renal Failure, End-Stage|ESRD|Kidney Disease, End-Stage|Chronic Renal Failure|End-Stage Renal Disease|Renal Failure, Chronic|end-stage renal disease|Renal Failure, End Stage|Renal Disease, End Stage|End Stage Kidney Disease|chronic renal failure|end-stage kidney disease|kidney failure|End-Stage Kidney Disease|Renal Disease, End-Stage|Kidney failure|End-stage renal disease"
NEW00056,DISEASE,cardiac conduction abnormalities,cardiac conduction abnormalities
D065632,DISEASE,Chikungunya Fever,"fever|Chikungunya Virus Infections|Fever, Chickungunya|Fever, Chikungunya|Chikungunya Fevers|Chickungunya Fevers|Chickungunya Fever|Chikungunya Virus Infection|Infection, Chikungunya Virus"
NEW00057,MENTAL_HEALTH,CNS respiratory depression,CNS respiratory depression
D015877,DISEASE,Miosis,"|Pupils, Constricted|Constricted Pupil|Pupillary Miosis|miosis|Pupillary Mioses|Persistent Miosis|Pupils, Small|Small Pupils|Miosis, Pupillary|Mioses, Pupillary|Miosis, Persistent|Mioses, Persistent|Mioses|Constricted Pupils|Persistent Mioses|Pupil, Small|Pupil, Constricted|Small Pupil"
D020230,DISEASE,Serotonin Syndrome,"|Syndromes, Serotonin|Serotonin syndrome|SS|toxicity|Serotonin Syndromes|Syndrome, Serotonin|serotonin syndrome"
NEW00058,DISEASE,deep coma,deep coma
NEW00059,DISEASE,recurrent seizures,recurrent seizures
D020182,DISEASE,"Sleep Apnea, Central","central apnoea||Hypoventilation, Central Alveolar|Alveolar Hypoventilation, Central|Primary Sleep Apneas of Newborn|Central Alveolar Hypoventilation Syndrome|Central Sleep Apnea, Primary|sleep apnea|Ondine Syndrome|Apneas, Central Sleep|Alveolar Hypoventilations, Central|Apnea, Sleep, Central|Newborn Primary Sleep Apneas|Sleep Apnea, Lethal Central|Secondary Central Sleep Apnea|Apneas, Central|Sleep-Disordered Breathings, Central|Central Apnea|Breathing, Central Sleep-Disordered|central sleep apnea|Central Sleep Disordered Breathing|Central Sleep Apneas|Sleep Apnea, Newborn, Primary|Central Alveolar Hypoventilation|Central Sleep-Disordered Breathing|CSA|Apnea, Central Sleep|sleep-disordered breathing|Central Sleep-Disordered Breathings|Hypoventilations, Central Alveolar|Central Sleep Apnea Syndrome|Sleep-disordered breathing|Primary Central Sleep Apnea|Central Sleep Apnea, Secondary|Sleep apnea|Apnea, Central|Sleep Apneas, Central|apnea|Central Apneas|Central Sleep Apnea|central apnea|Breathings, Central Sleep-Disordered|Sleep Disordered Breathing, Central|Sleep-Disordered Breathing, Central"
NEW00060,DISEASE,coma inadequate respirations,coma inadequate respirations
NEW00061,CHEMICAL,d)furan-5(6H)-one,d)furan-5(6H)-one|naloxone
NEW00062,MENTAL_HEALTH,new depression episodes,new depression episodes
D002047,CHEMICAL,Buprenorphine,"Buprex|Temgesic|6029 M|Prefin|BUP|6029M|Buprenex|RX6029M|RX 6029 M|Buprenorphine Hydrochloride|Hydrochloride, Buprenorphine|RX-6029-M|buprenorphine|Buprenorphine|Subutex|6029-M|Temgésic"
D009293,DISEASE,Opioid-Related Disorders,"Prescription Opioid Misuses|Opioid Abuse|OUD|Dependence, Opioid|Opioid Misuse|opioid abuse|Opioid Dependence|Opioid Addictions|Opiate Addiction|Misuse, Prescription Opioid|Opioid Dependences|opioid dependence|Abuse, Opioid|Abuse, Prescription Opioid|Opioid-Related Disorder|Opioid Abuse, Prescription|Opioid Use Disorder|Prescription Opioid Abuses|Opiate Dependence|Misuse, Opioid|Opioid Addiction|Opiate Abuse|Opioid Use Disorders|Prescription Opioid Misuse|Opioid Misuses|Opioid Abuses|opioid use disorder|Addiction, Opioid|opiate dependence|Disorder, Opioid Use|Addiction, Opiate|Opiate Abuses|Opioid Related Disorders|Abuse, Opiate|Dependence, Opiate|Prescription Opioid Abuse"
D013313,MENTAL_HEALTH,"Stress Disorders, Post-Traumatic","Post-Traumatic Stress Disorder|PTSD+|Stress Disorders, Posttraumatic|Acute Post-Traumatic Stress Disorder|Post-Traumatic Neuroses|traumatic stress|PTSD|Neuroses, Post-Traumatic|Moral Injury|Stress Disorder, Post-Traumatic|Chronic Post-Traumatic Stress Disorder|posttraumatic stress disorder|Post-traumatic stress disorder|Stress Disorder, Posttraumatic|Posttraumatic stress disorder|post-traumatic stress disorders|post traumatic stress disorder|Posttraumatic Neuroses|Post Traumatic Stress Disorder|Post Traumatic Stress Disorders|Acute Post Traumatic Stress Disorder|Posttraumatic Stress Disorders|post-traumatic stress disorder|acute post-traumatic stress disorder|Delayed Onset Post Traumatic Stress Disorder|Posttraumatic Stress Disorder|Chronic Post Traumatic Stress Disorder|Injury, Moral|Stress Disorder, Post Traumatic|Neuroses, Posttraumatic|Delayed Onset Post-Traumatic Stress Disorder|stress disorder|Post-Traumatic Stress Disorders|Neuroses, Post Traumatic|Moral Injuries"
NEW00063,DISEASE,co-occurring pain,co-occurring pain
D034062,MENTAL_HEALTH,"Insomnia, Fatal Familial","Familial Fatal Insomnia|insomnia|Insomnia|Insomnias, Fatal Familial|Fatal Insomnia, Familial|Familial Fatal, Insomnia|Insomnia Familial Fatals|Fatal, Insomnia Familial|Insomnia, Familial Fatal|Familial Fatals, Insomnia|Fatal Familial Insomnias|Insomnia Familial Fatal|Insomnias, Familial Fatal|Familial Fatal Insomnias|Fatal Familial Insomnia|Fatals, Insomnia Familial|Fatal Insomnias, Familial"
D000068876,CHEMICAL,Fingolimod Hydrochloride,"FTY 720|2-Amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol hydrochloride|Gilenya|Fingolimod|FTY-720|Gilenia|FTY720"
NEW00064,CHEMICAL,sphingosine-1-phosphate S1P receptor agonist,sphingosine-1-phosphate S1P receptor agonist
NEW00065,MENTAL_HEALTH,chronic stress,chronic stress
D001492,NUTRITION,Bass,"sea bass|Sea Basses|Basses, Temperate|Perch, White|Temperate Basses|Moronidae|Morone|Morone americana|Dicentrarchus|Bass, Sea|Micropterus|Sea Bass|Serranidae|White Perch|Basses, Sea"
NEW00066,CHEMICAL,antidepressant medications,antidepressant medications
NEW00067,CHEBI,sialidase inhibitor oseltamivir,sialidase inhibitor oseltamivir
D016553,DISEASE,"Purpura, Thrombocytopenic, Idiopathic","Purpuras, Idiopathic Thrombocytopenic|Autoimmune Thrombocytopenia|Thrombocytopenic Purpura, Immune|Thrombocytopenia, Autoimmune|Immune Thrombocytopenic Purpura|Purpuras, Autoimmune Thrombocytopenic|Purpuras, Immune Thrombocytopenic|immune thrombocytopenia|Idiopathic Thrombocytopenic Purpura|Thrombocytopenia, Immune|Thrombocytopenias, Autoimmune|Disease, Werlhof|Immune Thrombocytopenic Purpuras|Werlhof's Disease|Immune Thrombocytopenias|Purpura, Idiopathic Thrombocytopenic|Werlhof Disease|Thrombocytopenic Purpuras, Idiopathic|Autoimmune Thrombocytopenias|Autoimmune Thrombocytopenic Purpuras|Immune Thrombocytopenia|Thrombocytopenias, Immune|ITP|Thrombocytopenic Purpuras, Immune|Idiopathic Thrombocytopenic Purpuras|Thrombocytopenic Purpura, Autoimmune|Purpura, Thrombocytopenic, Autoimmune|Werlhofs Disease|Purpura, Autoimmune Thrombocytopenic|Disease, Werlhof's|Autoimmune Thrombocytopenic Purpura|Purpura, Immune Thrombocytopenic|Thrombocytopenic Purpura, Idiopathic"
NEW00068,DISEASE,A. glehni extract,A. glehni extract
NEW00069,CHEMICAL,kaempferol glycosides,kaempferol glycosides
NEW00070,NUTRITION,phenylpropanoid moieties,phenylpropanoid moieties
NEW00071,DISEASE,pentylenetetrazole-induced mice,pentylenetetrazole-induced mice
NEW00072,CHEMICAL,water-ethanol extract,water-ethanol extract
C522975,CHEMICAL,p-coumaric acid glucoside [Supplementary Concept],Glucosides|Coumaric Acids|p-coumaric acid
NEW00073,DISEASE,ulcer prophylaxis,ulcer prophylaxis
D011899,CHEMICAL,Ranitidine,"|Ranitidine|Zantac|Ranitidine Hydrochloride|Sostril|AH-19065|Hydrochloride, Ranitidine|N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine|Zantic|ranitidine|Biotidin|AH 19065|Ranisen|Ranitidin|AH19065"
NEW00074,CHEBI,histamine receptor blocker therapy,histamine receptor blocker therapy
D020820,DISEASE,Dyskinesias,"Dyskinesias, Linguofacial||Movement, Involuntary|Abnormal movements|Dyskinesia, Oral|Dyskinesia, Lingual-Facial-Buccal|ballismus|Linguofacial Dyskinesia|Dyskinesias, Orofacial|Oral Facial Dyskinesia|dyskinesias|Lingual-Facial-Buccal Dyskinesia|movement abnormalities|Hemiballismus|Ballismus|Dyskinesias, Oral|involuntary movements|Movements, Involuntary|Dyskinesia|Oral-Facial Dyskinesias|Movement, Abnormal|Hemiballism|Linguofacial Dyskinesias|Tardive Oral Dyskinesia|Abnormal Movements|Tardive Oral Dyskinesias|Involuntary Movements|abnormal movements|Dyskinesia, Linguofacial|Lingual Facial Buccal Dyskinesia|Dyskinesia, Orofacial|Asterixis|Oral-Facial Dyskinesia|Movements, Abnormal|Lingual-Facial-Buccal Dyskinesias|Involuntary Movement|Orofacial Dyskinesias|Oral Dyskinesias|Dyskinesias, Oral-Facial|Orofacial Dyskinesia|Oral Dyskinesia|Oral dyskinesia|Dyskinesia, Oral-Facial|Dyskinesias, Lingual-Facial-Buccal|Involuntary movements|Abnormal Movement"
NEW00075,CHEMICAL,% ethanol E. senticosus root extract,% ethanol E. senticosus root extract
NEW00076,DISEASE,nosemosis,nosemosis
C000713177,CHEMICAL,Siberian ginseng root [Supplementary Concept],Eleutherococcus senticosus|Plant Extracts|Eleutherococcus
D064547,MENTAL_HEALTH,Myxovirus Resistance Proteins,"RESISTANCE|resistance|Interferon-Induced Protein Mx|Protein Mx, Interferon Induced|Resistance|Protein Mx|Protein Mx, Interferon-Induced|Mx, Interferon-Induced Protein|Mx, Protein"
D018763,MENTAL_HEALTH,Muscle Fatigue,"Fatigue|Muscular Fatigue|fatigue|muscle fatigue|Fatigue, Muscular|Fatigue, Muscle"
D015673,MENTAL_HEALTH,"Fatigue Syndrome, Chronic","CFS|Postviral Fatigue Syndrome|Fatigue Disorders, Chronic|Postviral Fatigue Syndromes|Fatigue Disorder, Chronic|Chronic Fatigue Disorders|Infectious Mononucleosis-Like Syndrome, Chronic|Myalgic Encephalomyelitis|Encephalomyelitis, Myalgic|Chronic Fatigue Syndromes|Fatigue-Fibromyalgia Syndromes, Chronic|Chronic fatigue syndrome|Fatigue Syndromes, Chronic|Fatigue Syndromes, Postviral|Chronic Fatigue-Fibromyalgia Syndromes|Systemic Exertion Intolerance Disease|Chronic Fatigue-Fibromyalgia Syndrome|Chronic Fatigue and Immune Dysfunction Syndrome|Chronic Fatigue Disorder|immune dysfunction|Chronic Fatigue Fibromyalgia Syndrome|Chronic Fatigue Syndrome|chronic fatigue syndrome|Infectious Mononucleosis Like Syndrome, Chronic|Royal Free Disease|Fatigue-Fibromyalgia Syndrome, Chronic|Fatigue Syndrome, Postviral"
NEW00077,CHEBI,Serotonergic antagonists,Serotonergic antagonists
D019967,MENTAL_HEALTH,Schizophrenia Spectrum and Other Psychotic Disorders,SCZ|psychotic disorders|schizophrenia spectrum|schizophrenia|Schizophrenia|psychotic|schizophrenia-spectrum|psychotic features|Schizophrenia and Disorders with Psychotic Features|schizophrenia =|Scz|Psychotic disorders
NEW00078,CHEBI,alpha-adrenoceptor antagonists,alpha-adrenoceptor antagonists
NEW00079,CHEMICAL,Phosphodiesterase isoenzymes 5 inhibitors,PDE5-Is|Phosphodiesterase isoenzymes 5 inhibitors
D007172,MENTAL_HEALTH,Erectile Dysfunction,"|Sexual Impotence, Male|Male Sexual Impotence|Dysfunction, Erectile|Erectile dysfunction|erectile dysfunction|sexual impotence|Impotence, Male|Impotence, Male Sexual|Impotence|Male Impotence"
NEW00080,DISEASE,prostate cancer patients,prostate cancer patients
D000068581,CHEMICAL,Tadalafil,"IC351|Pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, 6-(1,3- benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)-|IC-351|IC 351|Cialis|tadalafil|Tadalafil"
NEW00081,DISEASE,urinary tract calculi,urinary tract calculi
D010411,DISEASE,Penile Induration,"Peyronie's disease|Fibrous Cavernitides|Peyronie's Disease|Cavernitis, Fibrous|Peyronies Disease|Fibrous Cavernitis|Penile Fibromatosis|Plastic Induration of the Penis|Peyronie Disease|Cavernitides, Fibrous|Fibromatosis, Penile"
D061686,MENTAL_HEALTH,Premature Ejaculation,"Ejaculations, Premature|Ejaculatio Praecoxs|Ejaculatio Praecox|Ejaculation, Premature|Premature ejaculation|Praecox, Ejaculatio|Praecoxs, Ejaculatio|premature ejaculation|Premature Ejaculations"
D011317,DISEASE,Priapism,|Priapism|priapism|Priapisms
NEW00082,MENTAL_HEALTH,female sexual dysfunction,female sexual dysfunction
NEW00083,DISEASE,urinary illnesses,urinary illnesses
NEW00084,CHEBI,alpha adrenoceptor antagonists,alpha adrenoceptor antagonists
NEW00085,DISEASE,benign prostatic hyperplasia sufferers,benign prostatic hyperplasia sufferers
NEW00086,CHEBI,α1-adrenoceptor antagonists,α1-adrenoceptor antagonists
NEW00087,DISEASE,prostate tumor growth,prostate tumor growth
NEW00088,DISEASE,crucial etiological contributor to post-traumatic stress disorder,crucial etiological contributor to post-traumatic stress disorder|PTSD
D065627,DISEASE,Familial Primary Pulmonary Hypertension,"Pulmonary Hypertension, Primary, Fenfluramine-Associated|Pph1 With Hht|Hypertension|Heritable Pulmonary Arterial Hypertension|Idiopathic Pulmonary Hypertension|Hypertension, Primary Pulmonary|Primary Pulmonary Hypertension|Pulmonary Hypertension, Primary, Dexfenfluramine-Associated|Pulmonary Hypertension, Idiopathic|Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia|Hypertension, Idiopathic Pulmonary|pulmonary hypertension|Pulmonary Hypertension, Primary, 1|Pulmonary Hypertension, Primary|Idiopathic Pulmonary Arterial Hypertension|hypertension"
NEW00089,CHEMICAL,quinazoline based compounds,quinazoline based compounds
NEW00090,DISEASE,prostate tumors,prostate tumors
D064751,CHEMICAL,Ammonium Compounds,doxazosin|Ammonium|compounds
NEW00091,CHEMICAL,α-blockade,α-blockade
C537243,DISEASE,"Prostate cancer, familial [Supplementary Concept]",prostate cancer|Prostatic Neoplasms
NEW00092,CHEBI,Muscarinic receptor antagonists,Muscarinic receptor antagonists
NEW00093,DISEASE,overactive bladder syndrome,overactive bladder syndrome
NEW00094,DISEASE,benign prostatic enlargement/benign prostatic obstruction,benign prostatic enlargement/benign prostatic obstruction
NEW00095,CHEBI,drug classes,drug classes
D003583,CHEMICAL,Cytokinins,Cytokinin|cytokinins
D013312,MENTAL_HEALTH,"Stress, Physiological","Metabolic Stress Response|Stress, Metabolic|Physiological Stress Reactions|Abiotic Stress Reaction|Abiotic Stress Responses|Biotic Stress|Stress Reaction, Physiological|Metabolic Stress|Abiotic Stress Reactions|Metabolic Stresses|Physiological Stresses|Stress Response, Metabolic|Biological Stresses|Physiological Stress Responses|Response, Metabolic Stress|Stress, Biotic|Physiological Stress|stress reactions|Stress Response, Physiological|Physiological Stress Reactivity|Reactions, Abiotic Stress|Physiological Stress Response|Biotic Stresses|Physiological Stress Reaction|Stress, Abiotic|Response, Abiotic Stress|Abiotic Stress Response|Abiotic Stress|Abiotic Stresses|Reaction, Abiotic Stress|Metabolic Stress Responses|Biological Stress|Stress, Biological"
D014968,CHEMICAL,Xanthine Dehydrogenase,"Oxidoreductase, Xanthine|Dehydrogenase, Xanthine|xanthine dehydrogenase|Xanthine Oxidoreductase|Purine Hydroxylase I"
NEW00096,CHEMICAL,purine catabolism,purine catabolism
D050876,CHEMICAL,Sulfite Oxidase,"Oxidase, Sulfite|sulphite oxidase|Sulphite Oxidase|Oxidase, Sulphite"
NEW00097,CHEMICAL,excess sulphite,excess sulphite
NEW00098,CHEMICAL,Activity-based anorexia,ABA|activity-based anorexia|Activity-based anorexia
NEW00099,CHEMICAL,second messenger cyclic ADP-ribose,second messenger cyclic ADP-ribose
NEW00100,DISEASE,tumor factor-alpha production,tumor factor-alpha production
D052139,CHEMICAL,Intracellular Calcium-Sensing Proteins,"Intracellular Calcium Sensing Peptides|Calcium Sensing Proteins, Intracellular|Calcium-Sensing Proteins, Intracellular|Peptides, Intracellular Calcium-Sensing|Intracellular Calcium Sensing Proteins|Calcium Sensing Peptides, Intracellular|Intracellular Calcium-Sensing Peptides|intracellular calcium|Calcium-Sensing Peptides, Intracellular"
D052250,CHEMICAL,Nitric Oxide Synthase Type III,"nitric oxide synthase|ECNOS Enzyme|Nitric oxide|Nitric Oxide Synthase, Type III|Endothelial Nitric Oxide Synthase|oxide synthase|nitric oxide|Endothelial Constitutive Nitric Oxide Synthase|NO|ENOS Enzyme"
NEW00101,NUTRITION,Trans Fatty Acid TFA intake,Trans Fatty Acid TFA intake
D003327,DISEASE,Coronary Disease,"Coronary Heart Disease|Diseases, Coronary|coronary heart disease|Coronary Diseases|Heart Diseases, Coronary|coronary disease|Disease, Coronary Heart|Coronary Heart Diseases|Heart Disease, Coronary|coronary heart diseases|Disease, Coronary|Diseases, Coronary Heart"
NEW00102,CHEMICAL,MSUD metabolites,MSUD metabolites
NEW00103,CHEMICAL,pyruvate dehydrogenase activity,pyruvate dehydrogenase activity
NEW00104,CHEMICAL,brain kynurenic acid levels,brain kynurenic acid levels
D064529,CHEMICAL,"Receptor, Metabotropic Glutamate 5","metabotropic glutamate receptor|Receptor 5, Metabotropic Glutamate|Glutamate|Protein, mGluR5b|glutamate|metabotropic glutamate|mGluR5b Protein|Metabotropic Glutamate Receptor 5a|Protein, mGluR5|Metabotropic Glutamate Receptor 5|Metabotropic Glutamate Receptor 5b|Protein, mGluR5a|mGluR5 Protein|mGluR5a Protein"
D065127,CHEMICAL,Dopamine D2 Receptor Antagonists,"Dopamine D2 Receptor Antagonist|dopamine D2 receptor|D2 Antagonists, Dopamine|bromocriptine|dopamine|Dopamine|dopamine D2 receptor antagonist|Receptor Antagonists, Dopamine D2|Antagonist, Dopamine D2|Dopamine D2 Antagonists|D2 Antagonist, Dopamine|quinpirole|Dopamine D2 Antagonist|D2|DA|D2 antagonist|D2 antagonists|Antagonists, Dopamine D2|dopamine D2 receptor antagonists"
D007736,CHEMICAL,Kynurenic Acid,"Kynurenic acid|Kynurenate|kynurenic acid|KYNA|kynurenic|KynA|Acid, Kynurenic"
NEW00105,CHEMICAL,kynurenic acid production,kynurenic acid production
D001928,DISEASE,"Brain Diseases, Metabolic","Metabolic Brain Syndromes|Metabolic Brain Syndromes, Acquired|Encephalopathy, Metabolic, Acquired|Metabolic Encephalopathies|Metabolic Brain Syndrome|Brain Disorders, Metabolic, Acquired|Metabolic Disorder, Central Nervous System, Acquired|Nervous System Acquired Metabolic Diseases|CNS Metabolic Disorders|Brain Syndrome, Metabolic, Acquired|Acquired Metabolic Diseases, Nervous System|Metabolic Disorder, CNS|Metabolic Disorder, Brain|Metabolic Disorders, CNS|Brain Metabolic Disorder|Metabolic Brain Diseases|Metabolic Brain Disease|Metabolic Diseases, Acquired, Nervous System|brain disorders|CNS Metabolic Disorder|CNS Metabolic Disorders, Acquired|Central Nervous System Metabolic Disorders|Encephalopathies, Acquired Metabolic|Metabolic Brain Syndrome, Acquired|Brain Disorders, Metabolic|Acquired Metabolic Encephalopathy|Metabolic Encephalopathy, Acquired|Acquired Metabolic Encephalopathies|Encephalopathy, Metabolic|Metabolic Disorders, Brain|Metabolic Disorders, Central Nervous System|Metabolic Encephalopathy|Metabolic Disorders, CNS, Acquired|Brain Disorder, Metabolic|Brain Diseases, Metabolic, Acquired|Metabolic Brain Disorders|Acquired Metabolic Diseases, Brain|Encephalopathies, Metabolic|Encephalopathy, Acquired Metabolic|Brain Metabolic Disorders|Metabolic Brain Disorder|Brain Syndrome, Metabolic|Brain Disease, Metabolic|Metabolic Encephalopathies, Acquired|Metabolic Brain Diseases, Acquired|metabolic disorder"
NEW00106,CHEMICAL,kynurenine pathway,kynurenine pathway
D000597,CHEMICAL,"Amino Acids, Branched-Chain","Branched-chain amino acids|Branched Chain Amino Acid|BCAAs|branched-chain amino acids|BCAA|Amino Acid, Branched-Chain|Branched-Chain Amino Acid|Amino Acids, Branched Chain|Acid, Branched-Chain Amino|Acids, Branched-Chain Amino|Branched-Chain Amino Acids"
D050495,CHEMICAL,Vesicular Inhibitory Amino Acid Transport Proteins,"Vesicular Inhibitory Amino Acid Transporter Proteins|Vesicular GABA-Glycine Transport Proteins|VGAT Transporter Proteins|Vesicular GABA Glycine Transporter Proteins|VIAAT Transporter Proteins|Vesicular GABA Glycine Transport Proteins|Vesicular GABA-Glycine Transporter Proteins|amino acid transport|Transporter Proteins, VIAAT|Transporter Proteins, VGAT"
NEW00107,DISEASE,neurological sequelae,neurological sequelae
NEW00108,CHEMICAL,BCAA metabolism,BCAA metabolism
D055825,DISEASE,National Institute of Neurological Disorders and Stroke (U.S.),neurological disorders|National Institute of Neurological Disorders and Stroke|NINDS
D008375,CHEMICAL,Maple Syrup Urine Disease,"Maple Syrup Urine Disease, Thiamine-Responsive|Intermittent Maple Syrup Urine Disease|Maple Syrup Urine Disease, Intermediate|BCKD Deficiency|MSUD (Maple Syrup Urine Disease)|Ketoacidurias, Branched-Chain|Ketoaciduria, Branched-Chain|Maple Syrup Urine Disease, Classic|Branched-Chain alpha-Keto Acid Dehydrogenase Deficiency|Branched Chain alpha Keto Acid Dehydrogenase Deficiency|Branched-Chain Ketoaciduria|Maple Syrup Urine Disease, Intermittent|Maple syrup urine disease|Branched Chain Ketoaciduria|Branched-Chain Ketoacidurias|Thiamine Responsive Maple Syrup Urine Disease|Keto Acid Decarboxylase Deficiency|Classic Maple Syrup Urine Disease|Classical Maple Syrup Urine Disease|Maple Syrup Urine Disease, Thiamine Responsive|Intermediate Maple Syrup Urine Disease|MSUD|Maple Syrup Urine Disease, Classical"
NEW00109,CHEMICAL,Objectives Valproic acid,VPA|Objectives Valproic acid
D000341,MENTAL_HEALTH,"Affective Disorders, Psychotic","Psychotic Mood Disorder|Mood Disorder, Psychotic|Affective Disorders|Affective Psychoses|Psychoses, Affective|Affective Disorder, Psychotic|Depression, Reactive, Psychotic|psychotic depression|Psychotic Mood Disorders|affective disorders|Psychotic Affective Disorders|Disorder, Psychotic Affective|Affective disorders|Mood Disorders, Psychotic|Psychotic Affective Disorder|affective psychoses|Disorders, Psychotic Affective|Affective psychoses"
NEW00110,CHEMICAL,essential amino acid tryptophan,essential amino acid tryptophan|TRP
D007405,MENTAL_HEALTH,Intervertebral Disc Displacement,"Intervertebral Disk Protrusion|Intervertebral Disc Herniation|Intervertebral Disc Herniations|Protruded Disc|Prolapsed Disc|Herniation, Intervertebral Disc|Disk, Protruded|Prolapses, Disk|Herniated Disc|Disc Protrusions|Displacement|Slipped Disk|Disk Protrusion|Prolapsed Discs|Prolapse, Disk|Protrusion, Disc|Slipped Disks|Intervertebral Disc Displacements|Disc, Herniated|Herniation, Disc|Herniation, Intervertebral Disk|Disc Herniation|Protruded Disk|Intervertebral Disk Protrusions|Disk Prolapses|Disc, Slipped|Disc Protrusion|Protruded Discs|Intervertebral Disc Protrusion|Disc Herniations|Protrusions, Intervertebral Disk|Intervertebral Disk Herniations|Disk Protrusions|Disk Protrusion, Intervertebral|Intervertebral Disk Displacements|Disk Displacement, Intervertebral|Slipped Disc|Protrusion, Intervertebral Disc|Protrusion, Intervertebral Disk|Intervertebral Disk Displacement|Herniated Disk|Disk, Prolapsed|Intervertebral Disk Herniation|Disk Herniation|Disk Prolapse|displacement|Protrusion, Disk|Disk Herniations|Disc Protrusion, Intervertebral|Disc, Protruded|Herniated Disks|Disk, Slipped|Discs, Protruded|Intervertebral Disc Protrusions|Slipped Discs|Disc Protrusions, Intervertebral|Herniated Discs|Disk, Herniated|Protruded Disks|Disc Displacement, Intervertebral|Prolapsed Disk|Disc, Prolapsed|% displacement|Prolapsed Disks|Herniation, Disk"
D016883,DISEASE,Diabetic Ketoacidosis,"Ketoacidosis, Diabetic|Diabetic Acidoses|Diabetic Acidosis|Acidoses, Diabetic|DKA|DKA Diabetic Ketoacidoses|diabetic ketoacidosis|Acidosis, Diabetic|DKA Diabetic Ketoacidosis|Ketosis, Diabetic|Diabetic Ketoacidoses|Diabetic ketoacidosis|Diabetic Ketoses|Ketoses, Diabetic|Diabetic Ketosis|Ketoacidoses, Diabetic|Diabetic Ketoacidosis, DKA|Ketoacidosis, DKA Diabetic|ketoacidosis"
D003922,DISEASE,"Diabetes Mellitus, Type 1","|Autoimmune Diabetes|Insulin-Dependent Diabetes Mellitus|Diabetes Mellitus, Brittle|Juvenile Onset Diabetes|Brittle Diabetes Mellitus|Diabetes, Autoimmune|Diabetes Mellitus, Juvenile-Onset|Juvenile-Onset Diabetes Mellitus|(insulin-dependent) diabetes mellitus|Diabetes, Type 1|Diabetes, Juvenile-Onset|Type 1 Diabetes|IDDM|Diabetes Mellitus, Sudden-Onset|Diabetes Mellitus, Sudden Onset|Diabetes Mellitus, Ketosis-Prone|Diabetes Mellitus, Ketosis Prone|Juvenile-Onset Diabetes|insulin-dependent diabetes mellitus|Type 1 Diabetes Mellitus|Insulin Dependent Diabetes Mellitus 1|Diabetes Mellitus, Insulin Dependent|Sudden-Onset Diabetes Mellitus|Insulin-Dependent Diabetes Mellitus 1|Diabetes Mellitus, Insulin-Dependent|Diabetes Mellitus, Insulin-Dependent, 1|Diabetes Mellitus, Type I|Ketosis-Prone Diabetes Mellitus|Diabetes Mellitus, Juvenile Onset"
NEW00111,DISEASE,severe metabolic disturbance,severe metabolic disturbance
NEW00112,NUTRITION,plasma tryptophan,plasma tryptophan
D010650,CHEMICAL,Phenylalanine Ammonia-Lyase,"Phenylalanine Ammonia Lyase|Phenylalanine Tyrosine Ammonia lyase|Ammonia|Ammonia-Lyase, Phenylalanine|Phenylalanine-Tyrosine Ammonia-lyase|ammonia|Ammonia-lyase, Phenylalanine-Tyrosine"
D056806,CHEMICAL,"Urea Cycle Disorders, Inborn","Disorder, Urea Cycle|urea cycle disorders|urea|Urea Cycle Disorders|urea cycle|Inborn Urea Cycle Disorder|Urea cycle disorders|Disorders, Urea Cycle|Urea Cycle Disorder"
NEW00113,DISEASE,rare inherited metabolic diseases,rare inherited metabolic diseases
D043202,DISEASE,"Steroid Metabolism, Inborn Errors","Inborn Errors of Steroid Metabolism|Congenital Errors of Steroid Metabolism|Steroid Metabolic Diseases, Inborn|inborn errors"
NEW00114,DISEASE,neurocognitive deficits,neurocognitive deficits
D020207,DISEASE,"Coma, Post-Head Injury","Coma, Post Trauma|Post-Head Injury Coma|Post-Trauma Coma|Coma, Post Concussive|Traumatic Coma|Coma, Traumatic|Post-Concussive Coma|Comas, Post-Concussive|coma|comas|Coma, Post Head Injury|Post-Head Injury Comas|Coma, Post-Traumatic|Coma, Post Traumatic|Coma, Post-Traumatic, Prolonged|Post-Trauma Comas|Comas, Post-Head Injury|Comas, Post-Trauma|Coma, Post-Trauma|Coma, Post-Concussive|Post-Traumatic Coma|Post Head Injury Coma|Post-Concussive Comas"
D066088,DISEASE,Infant Death,"Deaths, Infant|Infant Deaths|death|Death, Infant|Death"
D022124,DISEASE,Hyperammonemia,|Ammonia (1966-2000)|pregnenolone sulfate|hyperammonemia|Hyperammonemia
C075773,CHEMICAL,4-phenylbutyric acid [Supplementary Concept],NaPB|Phenylbutyrates|phenylbutyrate|Sodium 4-phenylbutyrate|Sodium phenylbutyrate
NEW00115,CHEMICAL,glutamine consumption,glutamine consumption
NEW00116,CHEMICAL,mg/kg/dose,mg/kg/dose
NEW00117,DISEASE,Huntington 's disease,Huntington 's disease|HD
NEW00118,CHEMICAL,BCAA/AAA molar ratio,BCAA/AAA molar ratio
NEW00119,MENTAL_HEALTH,transient hallucinations,transient hallucinations
D000592,CHEMICAL,"Amino Acid Metabolism, Inborn Errors","Inborn Amino Acidopathies|Amino Acidopathy, Congenital|Amino Acid Metabolism Disorders, Inborn|Inborn Amino Acidopathy|Amino Acidopathy, Inborn|Amino Acidopathies, Inborn|Amino Acidopathies, Congenital|Amino Acid Metabolism, Inborn Error|Amino Acid Metabolism, Inherited Disorders|Congenital Amino Acidopathies|amino acid metabolism|Inborn Errors, Amino Acid Metabolism|Inherited Errors of Amino Acid Metabolism|Congenital Amino Acidopathy"
NEW00120,CHEMICAL,alcohol withdrawal syndrome,alcohol withdrawal syndrome
D014635,CHEMICAL,Valproic Acid,"|divalproex sodium|Valproate Calcium|VPA|Semisodium Valproate|Vupral|Calcium Valproate|Valproic Acid, Sodium Salt (2:1)|Depakote|Sodium Valproate|Dipropyl Acetate|Propylisopropylacetic Acid|Ergenyl|valproate|Depakine|Valproate|Valproate Sodium|Sodium valproate|2-Propylpentanoic Acid|Depakene|2 Propylpentanoic Acid|Valproic acid|Divalproex|Divalproex Sodium|sodium valproate|divalproex|valproic acid|Divalproex sodium|Convulsofin|Magnesium Valproate"
NEW00121,DISEASE,dose-limited absorption,dose-limited absorption
NEW00122,MENTAL_HEALTH,decreased anxiety,decreased anxiety
NEW00123,CHEMICAL,"estrogen-mediated liver Trp 2,3-dioxygenase","estrogen-mediated liver Trp 2,3-dioxygenase"
NEW00124,CHEMICAL,serotonin function,serotonin function
NEW00125,CHEMICAL,albumin-bound Trp,albumin-bound Trp
NEW00126,CHEMICAL,cerebral serotonin synthesis,cerebral serotonin synthesis
NEW00127,CHEMICAL,serotonin synthesis,serotonin synthesis
D000374,DISEASE,Aggression,Aggressions|aggression|Aggression
NEW00128,CHEMICAL,anabolic-androgenic steroids,AAS|anabolic-androgenic steroids
D009752,DISEASE,Nutritional Status,"Status, Nutritional|nutritional status|Status, Nutrition|Nutrition Status"
NEW00129,DISEASE,neuropsychiatric abnormalities,neuropsychiatric abnormalities
NEW00130,CHEMICAL,plasma amino acid levels,plasma amino acid levels
D005222,MENTAL_HEALTH,Mental Fatigue,"Fatigue, Mental|mental fatigue"
D000755,DISEASE,"Anemia, Sickle Cell","Sickle Cell Anemia|Anemias, Sickle Cell|Cell Diseases, Sickle|Hemoglobin S Disease|Sickle Cell Disorders|Cell Disorders, Sickle|Sickle Cell Disease|Sickling Disorder Due to Hemoglobin S|sickle cell disease|s disease|Cell Disorder, Sickle|Sickle Cell Disorder|Disease, Hemoglobin S|HbS Disease|Sickle Cell Anemias|Sickle Cell Diseases|Cell Disease, Sickle|Hemoglobin S Diseases"
NEW00131,CHEMICAL,corticosterone concentrations,corticosterone concentrations
D000437,MENTAL_HEALTH,Alcoholism,"Intoxication, Chronic Alcoholic|Alcohol Use Disorders|AUDs|ethanol abuse|alcohol dependence|Alcohol use disorders|Alcohol Abuse|alcohol use disorders|Alcohol dependence|Alcohol Addiction|Ethanol Abuse|Abuse, Ethanol|Alcohol Dependence|Addiction, Alcohol|AUD|Dependence, Alcohol|Alcoholic Intoxication, Chronic|Chronic Alcoholic Intoxication|Alcohol Use Disorder|alcohol addiction|Abuse, Alcohol|Use Disorders, Alcohol|alcohol use disorder"
NEW00132,CHEMICAL,norepinephrine systems,norepinephrine systems
D050484,CHEMICAL,Norepinephrine Plasma Membrane Transport Proteins,"Norepinephrine Transporter|Norepinephrine Plasma Membrane Transporter Proteins|norepinephrine transporter|Transporters, Noradrenaline-Specific Neurotransmitter|Sodium-Dependent Noradrenaline Transporter|Transporter Protein, Norepinephrine|Noradrenaline Transporter|Neurotransmitter Transporters, Noradrenaline-Specific|Solute Carrier Family 6 Member 2|NET Protein, Neuronal|Noradrenaline Plasma Membrane Transport Proteins|Norepinephrine|SLC6A2 Protein|Transporter, Norepinephrine|Neurotransmitter Transporters, Noradrenaline Specific|Norepinephrine Plasma Membrane Transporters|Norepinephrine Transporter Protein|Noradrenaline Transporter, Sodium-Dependent|NE|Neuronal NET Protein|norepinephrine|Noradrenaline-Specific Neurotransmitter Transporters|Sodium Dependent Noradrenaline Transporter|Transporter, Noradrenaline"
D000319,CHEBI,Adrenergic beta-Antagonists,"|beta Adrenergic Antagonist|beta Adrenergic Blockers|beta-adrenoceptor antagonists|beta Adrenoceptor Antagonist|Blockader, beta-Adrenergic Receptor|Antagonists, beta-Adrenoceptor|beta-Adrenergic Antagonists|beta Adrenergic Blocker|Adrenergic beta-Antagonist|beta blockers|Blockaders, Adrenergic beta-Receptor|beta-Adrenergic Blocking Agents|beta-Adrenergic Receptor Blockaders|beta-Blockers, Adrenergic|beta-adrenergic blocker|beta-Antagonist, Adrenergic|beta Adrenergic Blocking Agent|Receptor Blockaders, beta-Adrenergic|β-adrenergic antagonists|beta-Adrenoceptor Antagonists|β-adrenoceptor antagonists|Blockers, beta-Adrenergic|Antagonists, beta-Adrenergic|beta-adrenergic blockers|beta Adrenergic Antagonists|•    β-Blockers|Beta-adrenoceptor antagonists|adrenoceptor antagonists|beta-Adrenergic Blockers|Adrenergic beta-Receptor Blockaders|Adrenergic beta Receptor Blockaders|beta Adrenergic Blocking Agents|beta-Adrenoceptor Antagonist|Beta-adrenergic blockers|beta-adrenergic blocking drugs|Blockader, Adrenergic beta-Receptor|Agents, beta-Adrenergic Blocking|beta-adrenergic antagonists|Adrenergic beta Receptor Blockader|beta Blockers, Adrenergic|beta-Adrenergic Blocking Agent|Adrenergic beta-Blockers|Blocker, beta-Adrenergic|beta-blockers|beta-Receptor Blockaders, Adrenergic|beta-adrenoceptor antagonist|Blocking Agent, beta-Adrenergic|Adrenergic beta-Receptor Blockader|Beta blockers|Antagonist, beta-Adrenergic|beta Adrenergic Receptor Blockaders|Adrenergic beta Antagonist|beta-Receptor Blockader, Adrenergic|beta Adrenergic Receptor Blockader|beta-Antagonists, Adrenergic|beta-Adrenergic Blocker|beta-Adrenergic Receptor Blockader|Blockaders, beta-Adrenergic Receptor|Antagonist, beta-Adrenoceptor|beta Adrenoceptor Antagonists|beta-Adrenergic Antagonist|Beta-adrenergic antagonists|Beta-blockers|Blocking Agents, beta-Adrenergic|Receptor Blockader, beta-Adrenergic|Agent, beta-Adrenergic Blocking|Adrenergic beta Antagonists"
NEW00133,MENTAL_HEALTH,acute stress reactions,acute stress reactions
D020329,DISEASE,Essential Tremor,"familial tremor|Essential Tremor, Benign|Essential Tremors, Benign|Tremor, Familial|Familial Tremor|Tremors, Familial|Benign Essential Tremors|Tremor|Benign Essential Tremor|Tremors, Benign Essential|Tremor, Benign Essential|Hereditary Essential Tremor|Tremor, Essential|Essential Tremors|Tremors, Essential|Familial Tremors|essential tremor|tremor"
D000073222,MENTAL_HEALTH,Patient Health Questionnaire,PHQ-2|generalized anxiety disorder|GAD-2|Generalized Anxiety Disorder Scale|PRIME-MD|generalised anxiety|Patient Health Questionnaire 9|PHQ-9|generalised anxiety disorder|Primary Care Evaluation of Mental Disorders|Patient Health Questionnaire Anxiety and Depression Scale|generalized anxiety|Patient Health Questionnaire 2|PHQ Patient Health Questionnaire|PHQ-ADS|GAD-7|Two-Item Generalised Anxiety Disorder Scale
D060486,DISEASE,Ophthalmoplegic Migraine,"Ophthalmoplegic Migraine Syndrome|Migraine Syndrome, Ophthalmoplegic|Migraine|Syndromes, Ophthalmoplegic Migraine|migraine|Ophthalmoplegic Migraines|Migraine Syndromes, Ophthalmoplegic|Ophthalmoplegic Migraine Syndromes|Syndrome, Ophthalmoplegic Migraine|Migraines, Ophthalmoplegic|Migraine, Ophthalmoplegic"
D008790,CHEMICAL,Metoprolol,|metoprolol|Toprol-XL|Metoprolol CR XL|Metoprolol Tartrate|Beloc-Duriles|CGP2175|Beloc Duriles|Seloken|Betaloc Astra|H 93 26|metoprolol tartrate|Metoprolol CR-XL|Betaloc-Astra|Betalok|Betaloc|Toprol|Metoprolol Succinate|H 93-26|CGP-2175|Spesicor|Metoprolol|H 9326|Lopressor|Spesikor|CGP 2175|Toprol XL
D009248,CHEMICAL,Nadolol,Corgard|SQ11725|SQ-11725|Solgol|nadolol|SQ 11725
D011433,CHEMICAL,Propranolol,"|AY-20694|propanolol|Propranolol|Dexpropranolol|Propranolol Hydrochloride|Rexigen|Betadren|Propanolol|AY 20694|Anaprilin|Inderal|Avlocardyl|AY20694|Obsidan|Obzidan|Hydrochloride, Propranolol|propranolol|Anapriline|Dociton"
D000788,DISEASE,"Angina Pectoris, Variant","|Prinzmetal's Angina|variant angina|Prinzmetal Angina|angina pectoris|Angina, Prinzmetal|Prinzmetals Angina|Variant Angina Pectoris|Angina, Prinzmetal's"
D001145,DISEASE,"Arrhythmias, Cardiac","|cardiac arrhythmias|Arrythmia|arrhythmias|Dysrhythmia, Cardiac|Cardiac Dysrhythmia|Arrhythmia|Cardiac Arrhythmia|Cardiac Arrhythmias|dysrhythmia|Arrhythmia, Cardiac|cardiac arrhythmia"
D065546,CHEBI,Drug Liberation,"drug|Drug Release|Liberation, Drug|drug release|Drug|Dissolution, Drug|Release, Drug|Drug Dissolution"
D001523,DISEASE,Mental Disorders,"psychiatric disorders||Illness, Mental|Psychiatric Disorders|Psychiatric Illness|Psychiatric disorders|severe mental disorder|behavioral impairment|Mental Disorder|Psychiatric Diseases|Mental Illness|Behavior Disorders|Psychiatric Diagnosis|mental illness|Psychiatric Disease|Severe Mental Disorders|psychiatric disease|psychiatric diseases|mental disorder|Mental Disorders, Severe|Severe Mental Disorder|Psychiatric Disorder|psychiatric illnesses|psychiatric disorder|psychiatric illness|Mental Illnesses|Mental Disorder, Severe|Diagnosis, Psychiatric|Psychiatric Illnesses"
D001289,MENTAL_HEALTH,Attention Deficit Disorder with Hyperactivity,"Disorders, Attention Deficit-Hyperactivity|Hyperactivity|attention-deficit disorder|attention deficit disorder|Deficit Disorder, Attention|Attention Deficit Disorders|brain dysfunction|Disorder, Attention Deficit-Hyperactivity|Hyperkinetic Syndrome|Deficit-Hyperactivity Disorders, Attention|attention deficit-hyperactivity disorder|Attention deficit hyperactivity disorder|Deficit Disorders, Attention|deficit hyperactivity disorder|Disorders, Attention Deficit|Brain Dysfunction, Minimal|ADDH|deficit disorder|Dysfunction, Minimal Brain|attention-deficit hyperactivity disorder|Disorder, Attention Deficit|Attention Deficit Hyperactivity Disorder|ADHD|Syndromes, Hyperkinetic|hyperactivity disorder|Deficit-Hyperactivity Disorder, Attention|Attention Deficit-Hyperactivity Disorders|Attention Deficit Disorders with Hyperactivity|Attention Deficit Disorder|attention deficit hyperactivity disorder|ADD-H|attention-deficit-hyperactivity disorder|hyperactivity|Minimal Brain Dysfunction|Attention-deficit hyperactivity disorder|Attention Deficit Hyperactivity Disorders|deficit hyperactivity disorders|Attention Deficit-Hyperactivity Disorder"
NEW00134,CHEMICAL,its's specific anti-hostility effect,its's specific anti-hostility effect
NEW00135,DISEASE,persistent aggressive behaviour,persistent aggressive behaviour
D010554,MENTAL_HEALTH,Personality Disorders,"|Inadequate Personality|Impulse Ridden Personality|Avoidant Personality Disorders|Personality Disorder|aggressive behavior|Impulse-Ridden Personality|Personality, Impulse-Ridden|Personality disorders|avoidant personality disorder|Personality, Inadequate|Avoidant Personality Disorder|Personality Disorder, Avoidant|personality disorders|Personality Disorder, Narcissistic|Narcissistic Personality Disorder|Personality Disorders, Avoidant|As If Personality|Personality, As If"
NEW00136,DISEASE,poor impulsivity,poor impulsivity
NEW00137,CHEBI,Mood stabilizers,Mood stabilizers
NEW00138,DISEASE,drug- withdrawal syndromes,drug- withdrawal syndromes
NEW00139,DISEASE,advanced pancreatic cancer,advanced pancreatic cancer
C056507,CHEMICAL,gemcitabine [Supplementary Concept],Gemcitabine||Deoxycytidine/analogs  and  derivatives|GEM|gemcitabine
D004833,DISEASE,"Epilepsy, Temporal Lobe","TLE|Lateral Temporal Epilepsy|Uncinate Epilepsies||Temporal Lobe Epilepsies|Temporal Lobe Epilepsy|Epilepsies, Uncinate|Epilepsy, Lateral Temporal|Benign Psychomotor Epilepsy, Childhood|Lateral Temporal Epilepsies|Epilepsies, Lateral Temporal|Uncinate Epilepsy|Childhood Benign Psychomotor Epilepsy|Epilepsies, Temporal Lobe|Epilepsy, Benign Psychomotor, Childhood|temporal lobe epilepsy|Epilepsy, Uncinate"
D001569,CHEMICAL,Benzodiazepines,|benzodiazepines|Benzodiazepine|BZDs|Benzodiazepines|Benzodiazepine Compounds
NEW00140,MENTAL_HEALTH,associated anxiety,associated anxiety
D020003,CHEMICAL,1-Octanol,"1-octanol|1 Octanol|n-Octyl Alcohol|n Octyl Alcohol|Alcohol, n-Octyl|n Octanol|n-Octanol"
NEW00141,CHEMICAL,dimethoxymethyl-diphenyl-barbituric acid,dimethoxymethyl-diphenyl-barbituric acid
D012978,CHEMICAL,Sodium Oxybate,"Xyrem|Oxybate, Sodium|Somsanit|Sodium oxybate|SXB|4 Hydroxybutyrate Sodium|GHB|Sodium gamma-Hydroxybutyrate|sodium oxybate|Oxybate Sodium|Oxybutyrate, Sodium|Gamma-hydroxybutyrate|4-Hydroxybutyrate Sodium|oxybate|gamma Hydroxybutyrate|gamma-Hydroxybutyrate|Sodium Oxybutyrate|Sodium gamma Hydroxybutyrate"
D013956,CHEBI,Antithyroid Agents,"Goitrogens||Antithyroid Effects|Agent, Antithyroid|Antithyroid Effect|Thyroid Antagonists|Effect, Antithyroid|Drug, Antithyroid|Agents, Antithyroid|Effects, Antithyroid|antithyroid drug|Antithyroid drugs|Antagonists, Thyroid|Antithyroid Agent|Drugs, Antithyroid|Antithyroid Drugs|Anti-thyroid drugs|Antithyroid Drug|antithyroid drugs|Goitrogen"
D006980,DISEASE,Hyperthyroidism,"Hyperthyroidism, Primary|Hyperthyroid|Hyperthyroids|Hyperthyroidism|Primary Hyperthyroidism|hyperthyroidism"
NEW00142,DISEASE,euthyroidism,euthyroidism
D059411,DISEASE,Lower Urinary Tract Symptoms,lower urinary tract symptoms|lower urinary tract|LUTS|Lower Urinary Tract Symptom
NEW00143,DISEASE,medication-induced sexual adverse effects,medication-induced sexual adverse effects
D000068577,CHEMICAL,Nebivolol,"R67555|Nebivolol|Silostar|Hydrochloride, Nebivolol|R 67555|nebivolol|R-67555|Bystolic|Alpha,Alpha'-(Iminobis(Methylene))bis(6-Fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol|Nebilet|67555, R|Lobivon|Nebivolol Hydrochloride"
NEW00144,CHEBI,long-term beta-adrenoceptor antagonist therapy,long-term beta-adrenoceptor antagonist therapy
NEW00145,DISEASE,male hypertensive patients,male hypertensive patients
NEW00146,CHEBI,cardioselective beta(1)-adrenoceptor antagonists,cardioselective beta(1)-adrenoceptor antagonists
NEW00147,CHEBI,antihypertensive drug treatment,antihypertensive drug treatment
D058669,CHEMICAL,Adrenergic alpha-2 Receptor Antagonists,"Adrenergic alpha-2 Receptor Blockers|Adrenergic alpha2 Antagonists|Antagonists, alpha2-Adrenergic|alpha2 Adrenergic Antagonists|Antagonists, Adrenergic alpha-2|Adrenergic alpha2-Antagonists|alpha 2 Adrenergic Blocking Agents|Adrenergic alpha 2 Receptor Blockers|alpha(2)-antagonists|alpha2-Antagonists, Adrenergic|alpha2-Adrenergic Antagonists|Adrenergic alpha 2 Receptor Antagonists|alpha-2 Adrenergic Blocking Agents|Adrenergic alpha 2 Antagonists|Adrenergic alpha-2 Antagonists|alpha-2 Antagonists, Adrenergic"
D054563,MENTAL_HEALTH,National Institute on Alcohol Abuse and Alcoholism (U.S.),Alcoholism|NIAAA|National Institute on Alcohol Abuse and Alcoholism|Alcohol Abuse|Alcohol abuse|alcoholism|alcohol abuse
NEW00148,CHEBI,effective pharmaceutical adjuncts,effective pharmaceutical adjuncts
NEW00149,CHEMICAL,Nocturnal urinary melatonin excretion,Nocturnal urinary melatonin excretion
D006212,MENTAL_HEALTH,Hallucinations,"|Hallucinations, Formed, of People|visual hallucination|Hallucinations, Visual|Hallucination, Tactile|Hypnagogic Hallucinations|hallucinations|Hallucinations, Elementary|Hallucinations, Reflex|Hallucination, Hypnagogic|Gustatory Hallucinations|Hallucination, Somatic|Hallucinations, Internal Body Sensation|Mood Congruent Hallucinations|Auditory Hallucination, Verbal|Hallucinations, Olfactory|Dissociative Hallucination|Organic Hallucination|hypnagogic hallucinations|Hallucination, Olfactory|Visual Hallucination|Hypnagogic Hallucination|Hallucinations|visual hallucinations|Reflex Hallucination|Hallucination, Kinesthetic|Dissociative Hallucinations|Somatic Hallucinations|Hallucination|Hallucinations, Organic|Auditory Hallucinations|Hallucinations, Kinesthetic|Hallucination, Verbal Auditory|Hallucination, Organic|Tactile Hallucinations|auditory hallucinations|Sensory Hallucinations|Hallucination, Visual|Mood Incongruent Hallucinations|Kinesthetic Hallucinations|Visual hallucinations|Hallucination, Reflex|Verbal Auditory Hallucinations|Sensory Hallucination|Body Sensation Hallucination|Mood Incongruent Hallucination|Auditory Hallucinations, Verbal|Hallucinations, Verbal Auditory|Organic Hallucinations|Hallucinations, Hypnagogic|Hallucination, Gustatory|Body Sensation Hallucinations|Hypnapompic Hallucinations|Hallucinations, Visual, Unformed|Hallucinations, Auditory|Hypnapompic Hallucination|Olfactory Hallucinations|Somatic Hallucination|Auditory Hallucination|VHs|Hallucinations, Gustatory|Hallucinations, Dissociative|Hallucination, Auditory|Hallucinations, Tactile|Kinesthetic Hallucination|hallucination|Hallucination, Dissociative|Hallucination, Sensory|Hallucination, Elementary|Hallucination, Hypnapompic|Hallucinations, Visual, Formed|Reflex Hallucinations|Hallucination of Body Sensation|Hallucination, Mood Incongruent|Mood Congruent Hallucination|Verbal Auditory Hallucination|Hallucinations, Mood Congruent|Hallucinations, Somatic|Tactile Hallucination|Hallucinations, Sensory|Hallucination, Mood Congruent|Gustatory Hallucination|Olfactory Hallucination|Elementary Hallucination|Hallucinations, Mood Incongruent|tactile hallucination|Elementary Hallucinations|Hallucinations, Hypnapompic|Visual Hallucinations"
NEW00150,CHEMICAL,Nightly melatonin excretion,Nightly melatonin excretion
NEW00151,DISEASE,nightly CNS-symptoms,nightly CNS-symptoms
NEW00152,CHEBI,alpha(2)-adrenoceptor agonists,alpha(2)-adrenoceptor agonists
C565201,DISEASE,"Prostate Cancer, Hereditary, 7 [Supplementary Concept]",Prostatic Neoplasms|aggressiveness
D007175,DISEASE,Impulsive Behavior,"Impulsive Behaviors|impulsivity|impulsive behaviors|impulsive behavior|Impulsivity|Behaviors, Impulsive|Impulsivities|Behavior, Impulsive"
D017367,CHEMICAL,Serotonin Uptake Inhibitors,"|5-Hydroxytryptamine Uptake Inhibitor|Uptake Inhibitors, 5 HT|5-hydroxytryptamine uptake|5 Hydroxytryptamine Uptake Inhibitors|Serotonin Reuptake Inhibitor|Inhibitors, Serotonin Reuptake|Inhibitors, 5-Hydroxytryptamine Uptake|Uptake Inhibitor, 5-Hydroxytryptamine|Selective Serotonin Reuptake Inhibitor|Inhibitor, Serotonin Uptake|-selective serotonin reuptake inhibitor|Uptake Inhibitor, 5-HT|Serotonin reuptake inhibitors|5-Hydroxytryptamine Uptake Inhibitors|reuptake inhibitor|serotonin reuptake inhibitor|Uptake Inhibitors, 5 Hydroxytryptamine|Inhibitor, Serotonin Reuptake|Reuptake Inhibitor, Serotonin|5-hydroxytryptamine|serotonin reuptake inhibitors|SRI|Uptake Inhibitors, 5-HT|serotonin uptake inhibitors|5-HT|Inhibitors, 5 Hydroxytryptamine Uptake|5-HT uptake|selective serotonin reuptake inhibitor|selective serotonin|serotonin reuptake|5-HT Uptake Inhibitors|5 HT Uptake Inhibitors|Uptake Inhibitors, 5-Hydroxytryptamine|Selective serotonin reuptake inhibitors|SRIs|Selective Serotonin Reuptake Inhibitors|selective-serotonin reuptake inhibitor|Uptake Inhibitors, Serotonin|SSRIs|Serotonin Uptake Inhibitor|Serotonin Reuptake Inhibitors|Inhibitors, 5 HT Uptake|Uptake Inhibitor, Serotonin|5-HT Uptake Inhibitor|SSRI|5 Hydroxytryptamine Uptake Inhibitor|Selective serotonin reuptake inhibitor|Serotonin uptake inhibitors|Reuptake Inhibitors, Serotonin|Inhibitors, Serotonin Uptake|Inhibitor, 5-HT Uptake|Inhibitor, 5-Hydroxytryptamine Uptake|selective serotonin reuptake inhibitors|5 HT Uptake Inhibitor|serotonin uptake inhibitor|Inhibitors, 5-HT Uptake|selective serotonin reuptake"
D016728,DISEASE,Self-Injurious Behavior,"self-harm|self-injurious|Harm, Self|self-injurious behaviors|deliberate self-harm|Behavior, Self-Destructive|Intentional Self Harm|Non-Suicidal Self Injuries|Nonsuicidal Self Injuries|Self Injury, Intentional|Self-Injurious Behaviors|Self Injury|Intentional Self Injury|Self-Harm, Deliberate|Self Harm, Intentional|Self-Destructive Behaviors|Nonsuicidal Self Injury|Behavior, Self-Injurious|Intentional Self Injuries|self-injuries|Self Destructive Behavior|Deliberate Self-Harm|Self-Injury|Deliberate Self Harm|Self Injurious Behavior|Non-Suicidal Self Injury|Non Suicidal Self Injury|Self-Destructive Behavior|Self Injury, Nonsuicidal|Self Harm|Self Injury, Non-Suicidal|self-injurious behavior"
D019167,CHEMICAL,Appetite Stimulants,"stimulants|appetite|appetite stimulants|Appetite-Stimulating Drugs|Stimulants|Stimulants, Appetite|Appetite Stimulating Drugs|Drugs, Appetite-Stimulating"
D008124,MENTAL_HEALTH,Locomotion,"Activities, Locomotor|Locomotor Activity|Locomotor Activities|hyperactivity|Activity, Locomotor|locomotor activity"
D003863,DISEASE,Depression,"Depressive Symptoms|Depressive symptoms|depressive symptoms|Emotional Depression|Depressive Symptom|Symptoms, Depressive|Depression, Emotional|Symptom, Depressive"
D019964,MENTAL_HEALTH,Mood Disorders,"mood disorder|Mood disorders||Disorder, Affective|Disorder, Mood|Mood Disorder|Disorders, Mood|mood disorders|Affective Disorder|Disorders, Affective|mood|Affective Disorders"
NEW00153,DISEASE,aggressive behaviour,aggressive behaviour
D001010,MENTAL_HEALTH,"Anxiety, Separation","Separation Anxiety Disorder|Separation Anxiety|Anxiety disorder|SAD|separation anxiety|anxiety disorder|separation anxiety disorder|Anxiety Disorder, Separation|GAD"
D008803,CHEMICAL,Mianserin,"Mianserin Hydrochloride|Lerivon|Mianserin Monohydrochloride|Hydrochloride, Mianserin|mianserin|Tolvon|Monohydrochloride, Mianserin|Org GB 94"
D002385,MENTAL_HEALTH,Cataplexy,"Status Cataplexicus|Syndromes, Tonelessness|Syndrome, Henneberg|Attacks, Cataleptic|Cataleptic Attack|Tonelessness Syndromes|cataplexy|Cataleptic Attacks|Tonelessness Syndrome|Syndrome, Tonelessness|Cataplexy|Attack, Cataleptic|Henneberg Syndrome"
NEW00154,CHEMICAL,atipemazole,atipemazole
D015016,CHEMICAL,Yohimbine,"yohimbine|Tartrate, Corynanthine||Rauwolscine|Yohimbine|Aphrodine Hydrochloride|Corynanthine|Hydrochloride, Yohimbine|YOH|yohimbine hydrochloride|Yohimbin Spiegel|alpha2-adrenergic antagonist|Hydrochloride, Aphrodine|Yohimex|Yocon|Yohimbine Houdé|Rauhimbine|Corynanthine Tartrate|Aphrodyne|Pluriviron|Yohimbine Hydrochloride"
NEW00155,CHEBI,selective alpha-2 adrenoceptor antagonists,selective alpha-2 adrenoceptor antagonists
D010883,CHEMICAL,Piperoxan,piperoxan|Forneau 933|Piperoxane|Benodain|Benodaine
D008774,CHEMICAL,Methylphenidate,"|Methylin|MPH|Hydrochloride, Methylphenidate|Equasym|methylphenidate hydrochloride|ritalin|Daytrana|methylphenidate|Ritaline|Concerta|Tsentedrin|Ritalin|Phenidylate|MP|Methylphenidate|Metadate|Ritalin SR|Centedrin|Ritalin-SR|Methylphenidate Hydrochloride"
NEW00156,DISEASE,attention-deficit/hyperactivity disorder,attention-deficit/hyperactivity disorder
D003913,CHEMICAL,Dextroamphetamine,"|d-Amphetamine|d-amphetamine|Dextroamphetamine Sulfate|D-amphetamine|Dexamphetamine|Dexamfetamine|Dextro Amphetamine Sulfate|dexamphetamine|dextro Amphetamine|Curban|Dextro-Amphetamine Sulfate|d-Amphetamine Sulfate|DextroStat|d Amphetamine|Oxydess|dextro-Amphetamine|d Amphetamine Sulfate|Sulfate, Dextroamphetamine|Dexedrine|dextroamphetamine"
NEW00157,DISEASE,orthostatic testing,orthostatic testing
D006852,CHEMICAL,Hydrochlorothiazide,|Sectrazide|Esidrix|Dichlothiazide|HydroDIURIL|HCTZ|Oretic|Hypothiazide|Dihydrochlorothiazide|hydrochlorothiazide|Esidrex
NEW00158,DISEASE,hypertensive patients,hypertensive patients
NEW00159,CHEMICAL,lower pyruvate kinase activity,lower pyruvate kinase activity
NEW00160,MENTAL_HEALTH,possible metabolic depression,possible metabolic depression
D058832,CHEMICAL,Serotonin 5-HT4 Receptor Antagonists,"5-HT4 Antagonists|Serotonin 5 HT4 Receptor Antagonists|Antagonists, 5-HT4|Antagonist, 5-HT4|5-HIAA|Serotonin|5-HT4 Antagonist|5 HT4 Antagonists|5-HT|5 HT4 Antagonist|5HT|serotonin"
C448763,NUTRITION,"calcification-associated peptide-1, crayfish [Supplementary Concept]",crayfish|Peptides|Crayfish
NEW00161,DISEASE,anxiety-like behavior,anxiety-like behavior
D018727,CHEBI,Muscarinic Antagonists,"Agents, Antimuscarinic|Antimuscarinic agents|Antimuscarinic|Muscarinic Antagonists, Cholinergic|Antagonist, Muscarinic|Antagonists, Muscarinic|Antagonists, Cholinergic Muscarinic|Cholinergic Muscarinic Antagonists|Antimuscarinic Agent|Antagonist, Cholinergic Muscarinic|muscarinic antagonist|muscarinic antagonists|Muscarinic Antagonist, Cholinergic|Agent, Antimuscarinic|Cholinergic Muscarinic Antagonist|Antimuscarinics|Muscarinic Antagonist|antimuscarinic agents|Antimuscarinic Agents"
NEW00162,DISEASE,extrapyramidal symptoms,extrapyramidal symptoms
NEW00163,DISEASE,neuroleptic-induced akathisia,neuroleptic-induced akathisia
D018491,CHEMICAL,Dopamine Agonists,"Receptor Agonist, Dopamine|dopaminergic agonist|DAs|dopamine agonists|Agonist, Dopaminergic|Agonists, Dopaminergic|Dopamine Agonist|Dopamine receptor|Agonists, Dopamine|dopamine receptor agonists|dopamine receptor agonist|dopaminergic agonists|Agonists, Dopamine Receptor|dopamine agonist|Dopaminergic agonists|Dopamine Receptor Agonist|Agonist, Dopamine|dopamine receptor|Dopamine agonists|Dopaminergic Agonist|Agonist, Dopamine Receptor|Dopaminergic Agonists|Dopamine Receptor Agonists|Receptor Agonists, Dopamine"
D012702,CHEBI,Serotonin Antagonists,"Serotonin Blockader|Antagonist, 5-Hydroxytryptamine|5-HT Antagonist|Receptor Antagonist, Serotonin|Serotonin Receptor Blockers|Antiserotonergic Agent|Antagonist, Serotonin|Receptor Blockers, Serotonin|serotonin receptor antagonist|5-Hydroxytryptamine Antagonists|Blockaders, Serotonin|Blockader, Serotonin|Antagonists, Serotonin Receptor|Antagonists, 5 Hydroxytryptamine|Antagonists, 5-Hydroxytryptamine|Agent, Antiserotonergic|Agents, Antiserotonergic|5 HT Antagonist|Antiserotonergic Agents|serotonin serotonin|serotonin antagonists|Antagonists, 5 HT|5 HT Antagonists|Serotonin Antagonist|5-Hydroxytryptamine Antagonist|5 Hydroxytryptamine Antagonists|Antagonist, Serotonin Receptor|Antagonist, 5-HT|Blocker, Serotonin Receptor|Receptor Blocker, Serotonin|Serotonin Receptor Antagonist|Antagonists, 5-HT|5-HT Antagonists|Serotonin Blockaders|5 Hydroxytryptamine Antagonist|Receptor Antagonists, Serotonin|serotonin antagonist|Antagonists, Serotonin|Blockers, Serotonin Receptor|Serotonin Receptor Blocker|Serotonin Receptor Antagonists"
NEW00164,DISEASE,acute akathisia,acute akathisia
NEW00165,CHEMICAL,mianserin mg/d,mianserin mg/d
NEW00166,CHEMICAL,vitamin mg/d,vitamin mg/d
NEW00167,DISEASE,schizoaffective inpatients,schizoaffective inpatients
NEW00168,DISEASE,neuroleptic-induced movement disorders,neuroleptic-induced movement disorders
NEW00169,MENTAL_HEALTH,anxiety symptoms,anxiety symptoms
NEW00170,CHEMICAL,heterocyclic antidepressants,heterocyclic antidepressants
D020250,DISEASE,Postoperative Nausea and Vomiting,"|Vomiting, Postoperative|CINV|Nausea, Postoperative|Emeses, Postoperative|Nausea|Postoperative Nausea|PONV|Postoperative Emeses|Emesis, Postoperative|vomiting|Postoperative Emesis|Nausea and Vomiting, Postoperative|Postoperative Vomiting|nausea|emesis|nausea, vomiting"
NEW00171,DISEASE,paraesthesias,paraesthesias
NEW00172,DISEASE,rhinorrhoea,rhinorrhoea
D011000,DISEASE,"Pleurodynia, Epidemic","Pleurodynias, Epidemic|Bornholm Disease|Epidemic Myalgia|Epidemic Pleurodynias|myalgias|Myalgia, Epidemic|Epidemic Myalgias|Epidemic Pleurodynia|Myalgias, Epidemic"
D000856,DISEASE,Anorexia Nervosa,"Nervosa, Anorexia|Anorexia Nervosa|anorexia|AN|Anorexia|Nervosas, Anorexia|anorexia nervosa|Anorexia Nervosas|Anorexia nervosa"
D011595,MENTAL_HEALTH,Psychomotor Agitation,"psychomotor agitation|Restlessness||Psychomotor Restlessness|agitation|Restlessness, Psychomotor|Psychomotor Hyperactivity|Agitation, Psychomotor|Hyperactivity, Psychomotor|allodynia|Psychomotor Excitement|Akathisia|Excitement, Psychomotor|restlessness"
NEW00173,DISEASE,diaphoresis,diaphoresis
C538206,DISEASE,Deal Barratt Dillon syndrome [Supplementary Concept],Jaundice|diarrhoea|Fanconi Syndrome|Ichthyosis|Congenital Abnormalities
D008996,CHEMICAL,Monoamine Oxidase Inhibitors,"monoamine oxidase MAO inhibitors|Inhibitors, MAO|MAO inhibitors|Inhibitor, MAO|Monoamine oxidase inhibitors|Reversible Inhibitor of Monoamine Oxidase|MAO Inhibitors|Monoamine Oxidase Inhibitor|MAO|Monoamine oxidase A|RIMA (Reversible Inhibitor of Monoamine Oxidase A)|MAO-A|Inhibitor, Monoamine Oxidase|Reversible Inhibitors of Monoamine Oxidase|MAO Inhibitor|Monoamine oxidase|Inhibitors, Monoamine Oxidase"
D000084202,DISEASE,Chemotherapy-Related Cognitive Impairment,"Cognitive Impairments, Chemotherapy-Induced|Chemotherapy-Induced Cognitive Impairment|Chemobrain|Chemotherapy Related Cognitive Impairment|Chemo Fog|Cognitive Dysfunction, Chemotherapy-Induced|Chemotherapy-Induced Cognitive Impairments|Cognitive impairment|Cognitive Impairments, Chemotherapy-Related|Chemotherapy-Related Cognitive Dysfunction|Chemotherapy-Related Cognitive Dysfunctions|Cognitive Impairment, Chemotherapy-Related|Chemotherapy-Related Cognitive Impairments|Chemo-Fog|Chemotherapy Induced Cognitive Dysfunction|Cognitive Dysfunction, Chemotherapy-Related|cognitive impairment|Chemotherapy Induced Cognitive Impairment|Chemotherapy-Induced Cognitive Dysfunction|Chemotherapy Induced Cognitive Impairments|Cognitive Impairment, Chemotherapy-Induced|Chemotherapy Related Cognitive Dysfunction"
NEW00174,DISEASE,persecution,persecution
D003702,MENTAL_HEALTH,Delusions,delusions|Delusion
NEW00175,MENTAL_HEALTH,severe anxiety,severe anxiety
D003693,MENTAL_HEALTH,Delirium,"|Subacute Deliriums|Deliriums, Subacute|Mixed Origin Delirium|Delirium, Subacute|delirium|Mixed Origin Deliriums|Delirium|Delirium of Mixed Origin|Subacute Delirium"
NEW00176,MENTAL_HEALTH,drowsiness,drowsiness
D007319,DISEASE,Sleep Initiation and Maintenance Disorders,"|Insomnia, Secondary|Dysfunctions, Sleep Initiation|Insomnia|Insomnias|Rebound Insomnia|Nonorganic Insomnia|Insomnia, Chronic|chronic insomnia|Insomnia, Nonorganic|inability to sleep|Sleep Initiation Dysfunctions|sleeplessness|Insomnia disorder|Chronic Insomnia|Dysfunction, Sleep Initiation|Insomnia, Primary|Psychophysiological Insomnia|primary insomnia|Disorders of Initiating and Maintaining Sleep|Transient Insomnia|Primary Insomnia|Secondary Insomnia|Sleeplessness|Awakening, Early|DIMS (Disorders of Initiating and Maintaining Sleep)|Insomnia, Transient|Insomnia, Psychophysiological|Sleep Initiation Dysfunction|Early Awakening|Insomnia Disorders|Insomnia Disorder|Insomnia, Rebound"
NEW00177,DISEASE,suicidality,suicidality
NEW00178,CHEBI,Antimuscarinic cholinergic drugs,Antimuscarinic cholinergic drugs
NEW00179,MENTAL_HEALTH,characteristic hyperactivity,characteristic hyperactivity
NEW00180,MENTAL_HEALTH,dream-like hallucinations,dream-like hallucinations
D001286,CHEMICAL,Atropine Derivatives,Atropines|atropine
D012602,CHEMICAL,Scopolamine Derivatives,"Derivatives, Scopolamine|scopolamine|Sco|Scopolamine|Scopolamines"
D004244,DISEASE,Dizziness,Dizziness||orthostasis|lightheadedness|Dizzyness|dizziness|Orthostasis|Lightheadedness|Light-Headedness|Light Headedness
NEW00181,CHEMICAL,tolterodine users,tolterodine users
C005419,CHEMICAL,oxybutynin [Supplementary Concept],Oxybutynin|oxybutynin|Mandelic Acids
C015586,CHEMICAL,propiverine [Supplementary Concept],Benzilates|propiverine
NEW00182,CHEBI,schizophrenia drug abuse,schizophrenia drug abuse
D055808,CHEBI,Drug Discovery,"Prospecting, Drug|Drug Prospecting|drug discovery|Discovery, Drug"
NEW00183,DISEASE,GI motility,GI motility
D065101,CHEBI,Chloride Channel Agonists,"Chloride Channel Activators|Agonists|agonists|Channel Agonists, Chloride|Activators, Chloride Channel|Chloride Channel Stimulators|Stimulators, Chloride Channel|Channel Stimulators, Chloride|Channel Activators, Chloride|Agonists, Chloride Channel"
NEW00184,CHEBI,potential analgesic agents,potential analgesic agents
NEW00185,CHEBI,selective mGlu2/3 receptor agonists,selective mGlu2/3 receptor agonists
C007076,CHEMICAL,citral [Supplementary Concept],Acyclic Monoterpenes|Citral
NEW00186,DISEASE,chronic regional pain syndrome,chronic regional pain syndrome
D006930,DISEASE,Hyperalgesia,"|hyperalgesia|Hyperalgia, Secondary|Allodynia, Thermal|Mechanical Hyperalgia|allodynia|Hyperalgesia, Secondary|Hyperalgesias, Thermal|Sensation, Hyperalgesic|Secondary Hyperalgia|Hyperalgesias|Allodynias|Hyperalgesia, Thermal|Hyperalgia|Hyperalgesic Sensations|Hyperalgesia, Primary|Allodynia, Tactile|Hyperalgesic Sensation|Mechanical allodynia|Thermal Allodynia|Secondary Hyperalgias|Thermal Hyperalgesia|Primary Hyperalgias|Hyperalgia, Primary|secondary hyperalgesia|Allodynia, Mechanical|Hyperalgia, Mechanical|Mechanical Hyperalgias|Primary Hyperalgia|Sensations, Hyperalgesic|Hyperalgesia, Tactile|Mechanical Hyperalgesia|tactile allodynia|mechanical hyperalgesia|Allodynia|Mechanical Allodynia|Hyperalgesia, Mechanical|thermal hyperalgesia|mechanical allodynia|hyperalgesic|Tactile Allodynia|Thermal hyperalgesia"
NEW00187,CHEBI,mGluR2 mGluR antagonists,mGluR2 mGluR antagonists
NEW00188,CHEMICAL,antidepressant properties,antidepressant properties
D065171,CHEBI,Estrogen Receptor Antagonists,"Estrogen|estrogen receptor antagonists|antagonists|Antagonists, Estrogen Receptor|Receptor Antagonist, Estrogen|Antagonists|Receptor Antagonists, Estrogen|Estrogen receptor|Antagonist, Estrogen Receptor|Estradiol Receptor Antagonist|Receptor Antagonist, Estradiol|estrogen receptor antagonist|estrogen receptor|Estrogen Receptor Antagonist|Antagonist, Estradiol Receptor|estrogen|receptor antagonists|Estradiol Receptor Antagonists|Receptor Antagonists, Estradiol|Antagonists, Estradiol Receptor"
NEW00189,CHEBI,group mGluR agonists,group mGluR agonists
D001008,MENTAL_HEALTH,Anxiety Disorders,"|anxiety|Anxiety Neuroses|anxiety states|Neurotic Anxiety States|Disorders, Anxiety|Anxiety disorders|Neurotic Anxiety State|anxiety disorders|anxiety state|Anxiety Disorder|Disorder, Anxiety|Anxiety States, Neurotic|Neuroses, Anxiety|States, Neurotic Anxiety|anxiety- disorders|State, Neurotic Anxiety|Anxiety State, Neurotic"
NEW00190,CHEMICAL,glutamate activity,glutamate activity
NEW00191,CHEMICAL,gamma-aminobutyric acid GABA system,gamma-aminobutyric acid GABA system
NEW00192,MENTAL_HEALTH,anxiety interventions,anxiety interventions
NEW00193,CHEBI,partial benzodiazepine-GABA receptor antagonists,partial benzodiazepine-GABA receptor antagonists
NEW00194,CHEMICAL,anticataplectic drugs,anticataplectic drugs|antidepressants
NEW00195,CHEBI,insulin-sensitizing agent,insulin-sensitizing agent
D003866,MENTAL_HEALTH,Depressive Disorder,"|Neurotic Depression|Depressive Neurosis|unipolar depression|endogenous depression|Syndromes, Depressive|Unipolar Depressions|Depression, Endogenous|Depression, Unipolar|Disorders, Depressive|Depressions, Neurotic|Neurosis, Depressive|Melancholia|Melancholias|Depressive Neuroses|Neuroses, Depressive|Depressions, Endogenous|Syndrome, Depressive|Endogenous Depressions|Depressions, Unipolar|Disorder, Depressive|depression|Depression, Neurotic|Depressive Syndrome|Neurotic Depressions|Endogenous Depression|melancholia|Unipolar Depression|Depressive Syndromes|Depressive Disorders"
NEW00196,CHEMICAL,Open-label rosiglitazone,Open-label rosiglitazone
D054990,CHEMICAL,Idiopathic Pulmonary Fibrosis,"Pneumonitides, Usual Interstitial|Pulmonary Dysplasia, Fibrocystic|Familial Idiopathic Pulmonary Fibrosis|TAU|Cryptogenic Fibrosing Alveolitides|Fibrocystic Pulmonary Dysplasia|Cryptogenic Fibrosing Alveolitis|Fibrosing Alveolitis, Cryptogenic|Fibrosing Alveolitides, Cryptogenic|pulmonary fibrosis|Usual Interstitial Pneumonitis|Pulmonary Fibrosis, Idiopathic|Usual Interstitial Pneumonitides|Fibrocystic Pulmonary Dysplasias|Pulmonary Fibroses, Idiopathic|Idiopathic Pulmonary Fibrosis, Familial|Interstitial Pneumonitis, Usual|Idiopathic Pulmonary Fibroses|Idiopathic Fibrosing Alveolitis, Chronic Form|Usual Interstitial Pneumonia|Interstitial Pneumonia, Usual|Usual Interstitial Pneumonias|Pneumonitis, Usual Interstitial|Dysplasia, Fibrocystic Pulmonary|idiopathic pulmonary fibrosis|usual"
C555357,CHEMICAL,3-((methylsulfonyl)amino)-2-phenyl-N-(1-phenylpropyl)quinolin-4-carboxamide [Supplementary Concept],Sulfonamides|Aminoquinolines|AZD2624
NEW00197,CHEBI,NK3 receptor antagonist,NK3 receptor antagonist
NEW00198,CHEMICAL,Pantothenate kinase deficiency,Pantothenate kinase deficiency
NEW00199,DISEASE,progressive extrapyramidal dysfunction,progressive extrapyramidal dysfunction
D057180,MENTAL_HEALTH,Frontotemporal Dementia,"Diseases, Wilhelmsen-Lynch|FTLD-17 GRN|Disinhibition Dementia Parkinsonism Amyotrophy Complex|Disease, Familial Pick's|Dementia, Frontotemporal, with Parkinsonism|Familial Pick Disease|Frontotemporal Lobe Dementias (FLDEM)|Dementia, Ubiquitin-Positive Frontotemporal|Frontotemporal Dementias|Disinhibition-Dementia-Parkinsonism-Amytrophy Complices|Disinhibition Dementia Parkinsonism Amytrophy Complex|Frontotemporal Lobar Degeneration With Ubiquitin Positive Inclusions|Pick's Diseases, Familial|FTLD with TDP-43 Pathology|Dementias, Ubiquitin-Positive Frontotemporal|Lobe Dementia, Frontotemporal|Ubiquitin-Positive Frontotemporal Dementias|Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions|FTDP-17|Familial Picks Disease|Frontotemporal Lobe Dementia (FLDEM)|Complex, Disinhibition-Dementia-Parkinsonism-Amyotrophy|FTD-PGRN|Dementia, Hereditary Dysphasic Disinhibition|Frontotemporal Dementia, Ubiquitin Positive|Complex, Disinhibition-Dementia-Parkinsonism-Amytrophy|Familial Pick's Disease|Ubiquitin-Positive Frontotemporal Dementia|Dementia|Dementias, Frontotemporal|Hereditary Dysphasic Disinhibition Dementia|HIVD|frontotemporal dementia|DDPAC|Frontotemporal Dementia, GRN-Related|FTLD with TDP 43 Pathology|Complices, Disinhibition-Dementia-Parkinsonism-Amyotrophy|Frontotemporal Dementias, Ubiquitin-Positive|Dementias, Frontotemporal Lobe (FLDEM)|HDDD2|Dementia, Semantic|Disinhibition-Dementia-Parkinsonism-Amyotrophy Complices|FTLD-TDP|Wilhelmsen Lynch Disease|Dementias, Frontotemporal Lobe|Disinhibition-Dementia-Parkinsonism-Amyotrophy Complex|Frontotemporal Dementia with Parkinsonism 17|Disinhibition-Dementia-Parkinsonism-Amytrophy Complex|Complices, Disinhibition-Dementia-Parkinsonism-Amytrophy|Frontotemporal Dementia, Ubiquitin-Positive|dementia|Wilhelmsen-Lynch Disease|Pick's Disease, Familial|BPSD|GRN Related Frontotemporal Dementia|GRN-Related Frontotemporal Dementias|Multiple System Tauopathy with Presenile Dementia|Dementia, Frontotemporal Lobe (FLDEM)|Frontotemporal Dementia with Parkinsonism-17|tauopathy|Dementias, Semantic|Dementias, GRN-Related Frontotemporal|Disease, Wilhelmsen-Lynch|Familial Pick's Diseases|Frontotemporal Lobe Dementia|HDDD1|Wilhelmsen-Lynch Diseases|Dementia, GRN-Related Frontotemporal|Dementia, Frontotemporal Lobe|Semantic Dementia|GRN-Related Frontotemporal Dementia|Diseases, Familial Pick's|Dementia, Frontotemporal|Frontotemporal Dementia with Parkinsonism|Semantic Dementias|Lobe Dementias, Frontotemporal|FTD-GRN|Frontotemporal Dementias, GRN-Related|Frontotemporal Lobe Dementias"
D009771,MENTAL_HEALTH,Obsessive-Compulsive Disorder,"|Obsessive compulsive disorder|obsessive-compulsive disorder|Obsessive-Compulsive Neuroses|Anankastic Personalities|Neurosis, Obsessive Compulsive|obsessive-compulsive|Obsessive-Compulsive Neurosis|Disorder, Obsessive-Compulsive|Personality, Anankastic|Neuroses, Obsessive-Compulsive|Obsessive-Compulsive Disorders|Obsessive-Compulsive|Disorders, Obsessive-Compulsive|Obsessive Compulsive disorder|Obsessive-compulsive disorder|compulsive disorder|Neurosis, Obsessive-Compulsive|Anankastic Personality|obsessive compulsive disorder|obsessive-compulsive disorders|OCD|Obsessive Compulsive Disorder|Personalities, Anankastic"
D006211,DISEASE,Pantothenate Kinase-Associated Neurodegeneration,"iron accumulation|Neurodegeneration with Brain Iron Accumulation Type 1|PKAN Neuroaxonal Dystrophy, Juvenile-Onset|Neurodegeneration With Brain Iron Accumulation 1|PKAN|Dystrophy, Juvenile-Onset Neuroaxonal|Pantothenate kinase|Hallervorden-Spatz Syndrome|Juvenile-Onset Neuroaxonal Dystrophy|Hallervorden-Spatz syndrome|brain iron accumulation|Degeneration, Pigmentary Pallidal|PKAN Neuroaxonal Dystrophy, Juvenile Onset|kinase-associated neurodegeneration|Pigmentary Pallidal Atrophy|Pantothenate Kinase Associated Neurodegeneration|Neuroaxonal Dystrophy, Juvenile-Onset|neurodegeneration|Iron accumulation|Neuroaxonal Dystrophies, Juvenile-Onset|Hallervorden-Spatz Disease|Kinase-Associated Neurodegeneration|Neurodegeneration|Neurodegeneration, Pantothenate Kinase-Associated|Pigmentary Pallidal Degeneration|Pallidal Atrophy, Pigmentary|Hallervorden Spatz Disease|Hallervorden Spatz Syndrome|Dystrophies, Juvenile-Onset Neuroaxonal|Neuroaxonal Dystrophy, Juvenile Onset|Juvenile-Onset Neuroaxonal Dystrophies"
NEW00200,DISEASE,McLeod's syndrome,McLeod's syndrome
D054546,DISEASE,Neuroacanthocytosis,"Choreoacanthocytosis|Chorea-Acanthocytosis|Levine Critchley Syndrome|Chorea Acanthocytoses|Acanthocytoses, Chorea|Chorea Acanthocytosis Syndromes|Chorea Acanthocytosis|Levine-Critchley Syndrome|Acanthocytosis with Neurologic Disorder|Choreoacanthocytoses|chorea-acanthocytosis|Acanthocytosis, Chorea|Chorea Acanthocytosis Syndrome|Chorea-Acanthocytoses"
NEW00201,MENTAL_HEALTH,dysexecutive syndromes,dysexecutive syndromes
NEW00202,CHEMICAL,brain iron accumulation diseases,brain iron accumulation diseases
NEW00203,DISEASE,Pantothenase kinase-associated neurodegeneration,Pantothenase kinase-associated neurodegeneration|PKAN
NEW00204,DISEASE,severe progressive dystonia,severe progressive dystonia
NEW00205,MENTAL_HEALTH,rare neuropsychiatric syndromes,rare neuropsychiatric syndromes
D020183,DISEASE,Nocturnal Paroxysmal Dystonia,"Paroxysmal Dystonias, Hypnogenic|Paroxysmal Dystonias, Nocturnal|Dystonias, Sleep-Related|Dystonia, Nocturnal Paroxysmal|Dystonia, Hypnogenic Paroxysmal|Dystonia, Nocturnal, Paroxysmal|Dystonia, Sleep-Related|Dystonias, Hypnogenic Paroxysmal|Hypnogenic Paroxysmal Dystonias|Nocturnal Paroxysmal Dystonias|dystonia|Paroxysmal Dystonia, Hypnogenic|Hypnogenic Paroxysmal Dystonia|Paroxysmal Dystonia, Nocturnal|Sleep-Related Dystonia|Sleep Related Dystonia|Dystonias, Nocturnal Paroxysmal|Sleep-Related Dystonias"
NEW00206,CHEMICAL,intrathecal baclofen infusion,intrathecal baclofen infusion
D000071516,CHEMICAL,Alpha-Ketoglutarate-Dependent Dioxygenase FTO,"Dioxygenase, Alpha-Ketoglutarate-Dependent|AlkB Homolog 9 Protein|FTO, Alpha-Ketoglutarate-Dependent Dioxygenase|Alpha-Ketoglutarate-Dependent Dioxygenase|Fat Mass and Obesity Associated (FTO) Protein|alpha-ketoglutarate|Fat Mass and Obesity Associated Protein|Alpha Ketoglutarate Dependent Dioxygenase FTO|Alpha Ketoglutarate Dependent Dioxygenase"
NEW00207,CHEMICAL,mmol L-carnitine/kg BW,mmol L-carnitine/kg BW
D051278,CHEMICAL,beta-Alanine-Pyruvate Transaminase,"alanine|beta-Alanine Pyruvate Aminotransferase|beta Alanine Pyruvate Transaminase|Aminotransferase, beta-Alanine Pyruvate|β-alanine|pyruvate|beta Alanine Pyruvate Aminotransferase|Pyruvate Aminotransferase, beta-Alanine|Transaminase, beta-Alanine-Pyruvate|beta-Alanine - Pyruvate Transaminase"
D045022,CHEMICAL,Lactate Dehydrogenases,"Dehydrogenases, Lactate|Lactate|lactate"
NEW00208,CHEMICAL,L-Carnitine treatment,L-Carnitine treatment
D000255,CHEMICAL,Adenosine Triphosphate,"|Magnesium Adenosine Triphosphate|Adenosine Triphosphate, Chromium Ammonium Salt|Manganese Adenosine Triphosphate|Adenosine Triphosphate, Magnesium Chloride|Adenosine Triphosphate, Manganese Salt|Adenosine Triphosphate, Chromium Salt|Cr(H2O)4 ATP|adenosine triphosphate|Chromium Adenosine Triphosphate|CaATP|Adenylpyrophosphate|Adenosine Triphosphate, Magnesium Salt|ATP|CrATP|ATP-MgCl2|Striadyne|MnATP|MgATP|ATP MgCl2|Adenosine Triphosphate, Calcium Salt|Atriphos"
D048828,CHEMICAL,beta-N-Acetyl-Galactosaminidase,beta N Acetyl Galactosaminidase|beta N Acetylgalactosaminidase|N Acetyl beta Galactosaminidase|beta-N-Acetylgalactosaminidase|N-Acetyl-beta-Galactosaminidase|acetyl
NEW00209,CHEMICAL,spf/Y mice,spf/Y mice
NEW00210,CHEMICAL,triphosphate CoA levels,triphosphate CoA levels
NEW00211,DISEASE,congenital chronic hyperammonemia,congenital chronic hyperammonemia
NEW00212,CHEMICAL,L-carnitine administration,L-carnitine administration
C548080,DISEASE,Neuroferritinopathy [Supplementary Concept],Neuroferritinopathy|Iron Metabolism Disorders|Neuroaxonal Dystrophies
NEW00213,DISEASE,autosomal dominant neurodegenerative disorder,autosomal dominant neurodegenerative disorder
NEW00214,DISEASE,rare disorder PKAN,rare disorder PKAN
NEW00215,DISEASE,common neurodegenerative diseases,common neurodegenerative diseases
D019189,CHEMICAL,Iron Metabolism Disorders,"iron metabolism|Disorders, Iron Metabolism|Metabolism Disorder, Iron|Metabolism Disorders, Iron|Iron Metabolism Disorder|Disorder, Iron Metabolism"
D000077205,CHEMICAL,Pioglitazone,"U72107A|U 72107A|Actos|5-(4-(2-(5-Ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione|PIO|AD4833|Pioglitazone|U72,107A|pioglitazone|AD-4833|U-72107A|AD 4833|Pioglitazone Hydrochloride"
NEW00216,DISEASE,neurobehavioral impairments,neurobehavioral impairments
NEW00217,DISEASE,LPS-induced dopaminergic neuronal loss,LPS-induced dopaminergic neuronal loss
NEW00218,CHEMICAL,PPARγ agonist pioglitazone,PPARγ agonist pioglitazone
NEW00219,MENTAL_HEALTH,Nrf2/ARE-dependent HO-1 pathway defense mechanism,Nrf2/ARE-dependent HO-1 pathway defense mechanism
NEW00220,CHEBI,PPARγ agonists,PPARγ agonists
NEW00221,DISEASE,experimental PD,experimental PD
D051023,CHEBI,BH3 Interacting Domain Death Agonist Protein,Bid Protein|agonist|tBid Protein|Truncated Bid Protein
NEW00222,DISEASE,progressive weight loss,progressive weight loss
NEW00223,CHEMICAL,PPARγ thiazolidinedione,PPARγ thiazolidinedione
C000716087,CHEBI,"8-(2-aminophenyl)-3-butyl-1,6,7-trimethyl-1H-imidazo(2,1-f)purine-2,4(3H,8H)-dione [Supplementary Concept]",rosiglitazone|Imidazoles|Purines|PPARγ agonist
NEW00224,DISEASE,mHTT-evoked energy deficiency,mHTT-evoked energy deficiency
NEW00225,CHEMICAL,GW1929 treatment,GW1929 treatment
NEW00226,DISEASE,IR induced neurological symptoms,IR induced neurological symptoms
NEW00227,DISEASE,hippocampal neuronal damage,hippocampal neuronal damage
NEW00228,DISEASE,cognitive deficits,cognitive deficits
NEW00229,DISEASE,hyperlocomotion,hyperlocomotion
NEW00230,DISEASE,IR injury,IR injury
NEW00231,MENTAL_HEALTH,apoptotic DNA fragmentation,apoptotic DNA fragmentation
NEW00232,CHEMICAL,thiazolidinedione PPARγ agonist,thiazolidinedione PPARγ agonist
NEW00233,DISEASE,global cerebral IR injury,global cerebral IR injury
NEW00234,CHEMICAL,N-(2-benzoylphenyl)-O-[2-(methyl-2-pyridinylamino)ethyl]-l-tyrosine,N-(2-benzoylphenyl)-O-[2-(methyl-2-pyridinylamino)ethyl]-l-tyrosine|GW1929
NEW00235,CHEBI,PPARγ agonist treatment,PPARγ agonist treatment
NEW00236,DISEASE,pain-related behaviors,pain-related behaviors
NEW00237,MENTAL_HEALTH,excessive anxiety,excessive anxiety
NEW00238,CHEMICAL,pioglitazone microinjection,pioglitazone microinjection
C487473,CHEMICAL,17beta-estradiol platinum(II) [Supplementary Concept],Organoplatinum Compounds|E2|17β-estradiol|Estradiol/analogs  and  derivatives
NEW00239,DISEASE,anxiety- behaviors,anxiety- behaviors
NEW00240,CHEBI,PPARγ agonist rosiglitazone,PPARγ agonist rosiglitazone
D003924,DISEASE,"Diabetes Mellitus, Type 2","Slow-Onset Diabetes Mellitus|Maturity-Onset Diabetes|T2 DM|Diabetes Mellitus, Maturity-Onset|Diabetes Mellitus, Maturity Onset|Maturity-Onset Diabetes Mellitus|T2DM|Diabetes Mellitus, Non-Insulin-Dependent|Type 2 Diabetes|T2D|Diabetes Mellitus, Non Insulin Dependent|DM|Diabetes Mellitus, Type II|Stable Diabetes Mellitus|Diabetes Mellitus, Stable|Diabetes Mellitus, Slow Onset|2 diabetes mellitus|Diabetes Mellitus, Noninsulin Dependent|Maturity Onset Diabetes Mellitus|Type 2 diabetes mellitus|Adult-Onset Diabetes Mellitus|Type 2 Diabetes Mellitus|Diabetes, Maturity-Onset|Diabetes Mellitus, Ketosis Resistant|Diabetes Mellitus, Adult-Onset|NIDDM|type 2 diabetes|Diabetes Mellitus, Noninsulin-Dependent|Diabetes Mellitus, Adult Onset|Maturity Onset Diabetes|Non-Insulin-Dependent Diabetes Mellitus|noninsulin-dependent diabetes|Ketosis-Resistant Diabetes Mellitus|Noninsulin Dependent Diabetes Mellitus|non-insulin-dependent diabetes mellitus|Diabetes, Type 2|Noninsulin-Dependent Diabetes Mellitus|diabetes mellitus|Diabetes Mellitus, Slow-Onset|type-2 diabetes|MODY|type 2 diabetes mellitus|Diabetes mellitus|Diabetes Mellitus, Ketosis-Resistant"
D000069499,CHEMICAL,"Ezetimibe, Simvastatin Drug Combination","Combination, Ezetimibe-Simvastatin Drug|Drug Combination, Ezetimibe-Simvastatin|Ezetimibe-Simvastatin Drug Combination|Inegy|Ezetimibe|Combination, Ezetimibe-Simvastatin|Ezetimibe Simvastatin Drug Combination|Vytorin|Ezetimibe-Simvastatin Combination|Ezetimibe Simvastatin Combination"
D065626,DISEASE,Non-alcoholic Fatty Liver Disease,"|alcoholic fatty liver disease|Alcoholic fatty liver disease|Fatty Liver, Nonalcoholic|Nonalcoholic fatty liver disease|Fatty Livers, Nonalcoholic|Fatty liver disease|fatty liver|Steatohepatitis, Nonalcoholic|Nonalcoholic Fatty Liver Disease|disease|nonalcoholic fatty liver disease|Nonalcoholic steatohepatitis|Nonalcoholic Fatty Livers|Liver, Nonalcoholic Fatty|steatohepatitis|Nonalcoholic Steatohepatitis|liver disease|nonalcoholic steatohepatitis|Nonalcoholic Fatty Liver|Non-alcoholic fatty liver disease|Livers, Nonalcoholic Fatty|Non alcoholic Fatty Liver Disease|NASH|AFLD|non-alcoholic fatty liver disease|Fatty liver|Nonalcoholic Steatohepatitides|NAFLD|Steatohepatitides, Nonalcoholic"
NEW00241,DISEASE,NAFLD/NASH patients,NAFLD/NASH patients
NEW00242,CHEMICAL,CCR(5 modulators,CCR(5 modulators
NEW00243,CHEBI,CXCR(4 antagonist development,CXCR(4 antagonist development
NEW00244,CHEMICAL,anesthetic premedication,anesthetic premedication
NEW00245,MENTAL_HEALTH,preoperative anxiety,preoperative anxiety
D064729,CHEBI,Neurokinin-1 Receptor Antagonists,"Blocker, Neurokinin-1 Receptor|Neuroleukin-1 Receptor Blockers|Receptor Antagonist, Neurokinin-1|Blockers, Neurokinin-1 Receptor|Receptor Blocker, Neurokinin-1|Neuroleukin 1 Receptor Blockers|Tachykinin Receptor 1 Antagonists|Receptor Blocker, Neuroleukin-1|Receptor Blockers, Neurokinin-1|blocker|Antagonist, Neurokinin-1 Receptor|Blocker, Neuroleukin-1 Receptor|Tachykinin Receptor 1 Blocker|Neurokinin-1 Receptor Blockers|Tachykinin Receptor 1 Blockers|Substance P Receptor Blocker|Tachykinin Receptor 1 Antagonist|Substance P Receptor Blockers|Blockers, Neuroleukin-1 Receptor|Neurokinin 1 Receptor Antagonist|Neuroleukin 1 Receptor Blocker|Receptor Blockers, Neuroleukin-1|Neurokinin 1 Receptor Antagonists|neurokinin-1-receptor antagonists|Substance P Receptor Antagonist|Neurokinin-1 Receptor Blocker|Antagonists, Neurokinin-1 Receptor|Neurokinin 1 Receptor Blockers|Neuroleukin-1 Receptor Blocker|Receptor Antagonists, Neurokinin-1|Neurokinin-1 Receptor Antagonist|Neurokinin 1 Receptor Blocker|Substance P Receptor Antagonists|substance P receptor antagonists"
NEW00246,DISEASE,depressed patients,depressed patients
NEW00247,CHEMICAL,antidepressant effects,antidepressant effects
NEW00248,CHEMICAL,Betaine Bet,Betaine Bet
D006712,DISEASE,Homocystinuria,"Cystathionine beta Synthase Deficiency Disease|cystathionine β-synthase deficiency|CBS Deficiency|Deficiencies, CBS|Cystathionine Beta Synthase Deficiency|CBS Deficiencies|Deficiency Disease, Cystathionine beta Synthase|Homocystinuria|Deficiency, CBS|Deficiency Disease, Cystathionine beta-Synthase|homocystinuria|Cystathionine beta-Synthase Deficiency Disease"
NEW00249,CHEMICAL,sachet,sachet
D053485,DISEASE,Porcine epidemic diarrhea virus,diarrhea|Coronavirus (1988-2006)|IBS-D
NEW00250,DISEASE,diarrhea prominent irritable bowel syndrome,diarrhea prominent irritable bowel syndrome
C021822,CHEMICAL,myo-inositol-1 (or 4)-monophosphatase [Supplementary Concept],Phosphoric Monoester Hydrolases|inositol monophosphatase|Inositol monophosphatase
NEW00251,DISEASE,human lumbar cerebrospinal fluid,human lumbar cerebrospinal fluid
NEW00252,CHEMICAL,phosphatidyl-inositol-4-kinase-catalytic-alpha,phosphatidyl-inositol-4-kinase-catalytic-alpha
NEW00253,DISEASE,22q11.2 region,22q11.2 region
NEW00254,CHEMICAL,Environmental tobacco smoke exposure,Environmental tobacco smoke exposure
D013398,DISEASE,Sudden Infant Death,"Cot Death|Death, Crib|Death, Cot|Crib Death|Death, Sudden Infant|Infant Death, Sudden|Sudden Infant Death Syndrome|Cot Deaths|sudden infant death syndrome|SID|SIDS"
D053496,CHEMICAL,"Inositol 1,4,5-Trisphosphate Receptors","Type 1 Inositol 1,4,5-trisphosphate Receptor|INSP3 Receptor Type 1|Type 3 Inositol 1,4,5-trisphosphate Receptor|INSP3 Receptor Type 3|Inositol Triphosphate Receptor|Receptor, IP3|Receptor, INSP3|1,4,5-INTP Receptor|Inositol 1,4,5-trisphosphate Receptor Type 3|Inositol 1,4,5-Trisphosphate Receptor|IP3 Receptor|Inositol 1,4,5-trisphosphate Receptor Type 2|Inositol 1,4,5-trisphosphate Receptor Type 1|Inositol 1,4,5-Triphosphate Receptors|INSP3 Receptor Type 2|Inositol-1,4,5-Triphosphate Receptor|Receptor, Inositol Triphosphate|inositol|Inositol|Receptor, Inositol-1,4,5-triphosphate|Inositol 1,4,5-Triphosphate Receptor|Inositol 1,4,5-trisphosphate Receptor Subtype 3|Triphosphate Receptor, Inositol|INSP3 Receptor"
D016584,DISEASE,Panic Disorder,"|panic disorders|panic disorder|Panic attacks|MDP|Panic Attacks|Panic Disorders|Disorders, Panic|Attacks, Panic|Panic Disorder|Attack, Panic|panic attacks|Disorder, Panic|panic attack|Panic Attack|panic"
D016666,CHEMICAL,Fluvoxamine,"|Fluvoxamin ratiopharm|DU 23000|Floxyfral|Fluvoxamin Stada|Fevarin|Nu-Fluvoxamine|Fluvoxamin AL|Dumirox|Nu Fluvoxamine|Fluvoxamine Maleate, (E)-Isomer|Novo-Fluvoxamine|Novo Fluvoxamine|Fluvoxamine|Fluvoxamine, (Z)-Isomer|Desiflu|fluvoxamine|DU23000|PMS-Fluvoxamine|Luvox|Fluvoxadura|Fluvoxamin neuraxpharm|Fluvoxamin-neuraxpharm|Faverin|PMS Fluvoxamine|Fluvoxamine Maleate|ratio Fluvoxamine|Fluvoxamin-ratiopharm|Fluvoxamina Geminis|Fluvoxamin beta|Geminis, Fluvoxamina|DU-23000|ratio-Fluvoxamine"
NEW00255,DISEASE,tiredness,tiredness
NEW00256,NUTRITION,poly-unsaturated fatty acids,poly-unsaturated fatty acids
NEW00257,DISEASE,related weight loss,related weight loss
C067772,CHEMICAL,IdB 1016 [Supplementary Concept],Phosphatidylcholines|Silymarin|Silipide
NEW00258,CHEMICAL,ethanol-derived radicals,ethanol-derived radicals
D003865,DISEASE,"Depressive Disorder, Major","Depressive Disorders, Major||Involutional Psychoses|Involutional Depression|major depressive disorders|Involutional Paraphrenias|Major depressive disorders|Major Depressive Disorders|Melancholia|Major depressive disorder|Major Depressive Disorder|major depressive disorder|Depression, Involutional|Involutional Paraphrenia|MDP|Paraphrenia, Involutional|Melancholia, Involutional|melancholia|MDD|Paraphrenias, Involutional|Involutional Melancholia|Involutional Psychosis|Psychoses, Involutional|Psychosis, Involutional"
NEW00259,NUTRITION,long-chain omega-3 polyunsaturated fatty acids,long-chain omega-3 polyunsaturated fatty acids
D005231,CHEMICAL,"Fatty Acids, Unsaturated","Polyunsaturated Fatty Acid|Acids, Polyunsaturated Fatty|Unsaturated Fatty Acid|Unsaturated Fatty Acids|Acid, Unsaturated Fatty|Fatty Acids, Polyunsaturated|Fatty Acid, Polyunsaturated|Fatty Acid, Unsaturated|Unsaturated fatty acids|Acids, Unsaturated Fatty|PUFAs|Polyunsaturated fatty acids|Polyunsaturated Fatty Acids|polyunsaturated fatty acids|unsaturated fatty acids|Acid, Polyunsaturated Fatty"
NEW00260,DISEASE,low-grade inflammation,low-grade inflammation
D000090862,DISEASE,Neuroinflammatory Diseases,"Neuroinflammatory Disease|Neuroinflammation|Disorder, Neuroinflammatory|neuroinflammatory diseases|Neuroinflammations|neuroinflammation|Disease, Neuroinflammatory|Neuroinflammatory Disorder|Neuroinflammatory Disorders"
D063388,CHEMICAL,Endocannabinoids,endocannabinoids|Endocannabinoids|Endocannabinoid
D051599,CHEMICAL,Glucose-1-Phosphate Adenylyltransferase,"Glucose|Pyrophosphorylase, Adenosine Diphosphoglucose|Diphosphoglucose Pyrophosphorylase, Adenosine|Adenosine Diphosphate Glucose Pyrophosphorylase|Pyrophosphorylase, ADPGlucose|Pyrophosphorylase, ADP-Glucose|Adenosine Diphosphoglucose Pyrophosphorylase|ADP-Glucose Synthase|Glucose 1 Phosphate Adenylyltransferase|ADP-Glucose Synthetase|ADP Glucose Synthase|ADP-Glucose Pyrophosphorylase|Synthetase, ADPG|Adenylyltransferase, Glucose-1-Phosphate|glucose|ADP Glucose Pyrophosphorylase|Synthetase, ADP-Glucose|ADP Glucose Synthetase|ADPG Synthetase|ADPGlucose Pyrophosphorylase|Synthase, ADP-Glucose"
NEW00261,DISEASE,compulsive disorders,compulsive disorders
D052018,MENTAL_HEALTH,Bulimia Nervosa,"bulimia nervosa|Nervosa, Bulimia|bulimia"
NEW00262,NUTRITION,n-3 long chain polyunsaturated fatty acids,n-3 long chain polyunsaturated fatty acids
D033363,CHEMICAL,Neutron Diffraction,"22:6n-3|n-3|6n3|neutron|22:6n3|22:5n-6|Diffractions, Neutron|Diffraction, Neutron|Neutron Diffractions|18:2n-6|20:3n-3"
NEW00263,DISEASE,desaturation,desaturation
NEW00264,CHEMICAL,n-3 long chain polyunsaturated fatty acids,n-3 long chain polyunsaturated fatty acids|n-3 LC-PUFA
D007333,MENTAL_HEALTH,Insulin Resistance,"|Insulin resistance|Sensitivity, Insulin|Resistance, Insulin|insulin resistance|insulin sensitivity|Insulin Sensitivity"
D005234,DISEASE,Fatty Liver,"|Steatoses, Liver|Steatoses, Visceral|steatosis|Steatosis, Visceral|Steatohepatitides|liver steatosis|Liver Steatoses|Liver Steatosis|Steatosis of Liver|Visceral Steatosis|Liver, Fatty|Visceral Steatoses|Steatosis, Liver|fatty change|Steatohepatitis"
NEW00265,DISEASE,seizure thresholds,seizure thresholds
D012640,DISEASE,Seizures,"Seizure, Visual||Seizure, Vertiginous|Vertiginous Seizures|Auditory Seizure|convulsive seizures|Myoclonic Seizures|Seizure, Non-Epileptic|Seizures, Vertiginous|Seizure, Absence|Petit Mal Convulsion|Seizures, Focal|Seizure, Single|Seizure, Somatosensory|Seizure, Jacksonian|Seizures, Tonic-Clonic|Absence Seizures|Tonic-Clonic Seizures|Single Seizure|Seizure, Tonic Clonic|Atonic Absence Seizures|Sensory Seizures|Convulsive Seizure|Generalized Tonic-Clonic Seizures|Seizure, Focal|Seizures, Epileptic|Generalized Seizures|Gustatory Seizure|Non Epileptic Seizure|Nonepileptic Seizures|Convulsion, Petit Mal|Olfactory Seizures|Olfactory Seizure|Partial Seizures|Tonic Clonic Seizures|Seizures, Vestibular|Visual Seizure|Non-Epileptic Seizures|Convulsive Seizures|Seizures, Motor|tonic-clonic seizures|Complex Partial Seizures|Seizure|Single Seizures|Nonepileptic Seizure|Tonic-Clonic Seizure, Generalized|Absence Seizure, Atonic|Absence Seizures, Generalized|Seizures, Gustatory|Seizure, Nonepileptic|Atonic Absence Seizure|Myoclonic Seizure|Partial Seizure, Complex|Convulsion, Non-Epileptic|Jacksonian Seizure|myoclonic seizures|Atonic Seizure|Non-Epileptic Seizure|Vertiginous Seizure|Seizure, Tonic|clonic seizures|Seizures, Nonepileptic|Seizures, Convulsive|Seizure, Atonic Absence|Seizure, Tonic-Clonic|Tonic-Clonic Seizures, Generalized|Seizure, Sensory|complex partial seizures|Seizures, Tonic|epileptic seizures|Generalized Seizure|Vestibular Seizure|Partial Seizures, Complex|Tonic Seizure|Seizure, Convulsive|Focal Seizures|Complex Partial Seizure|Motor Seizures|Vestibular Seizures|Seizure, Generalized|seizure|Auditory Seizures|Seizures, Olfactory|generalized seizures|Clonic Seizure, Tonic|Generalized Absence Seizures|Seizure, Clonic|Clonic Seizures, Tonic|Seizures, Generalized Tonic-Clonic|Seizure, Epileptic|Gustatory Seizures|Clonic Seizures|Convulsion|GTCS|Seizure, Motor|Seizure, Olfactory|Seizure, Vestibular|Non Epileptic Seizures|Seizure, Complex Partial|Convulsions|Seizure, Auditory|Seizures, Somatosensory|Generalized Tonic Clonic Seizures|Seizure, Partial|Seizures, Sensory|Seizure, Generalized Absence|Generalized Tonic-Clonic Seizure|Visual Seizures|Convulsions, Non-Epileptic|seizures|Sensory Seizure|atonic|Absence Seizure, Generalized|Convulsion, Non Epileptic|Motor Seizure|Seizure, Atonic|Absence Seizure|Clonic Seizure|Atonic Seizures|Epileptic Seizure|Epileptic Seizures|Seizures, Clonic|Seizure, Myoclonic|Somatosensory Seizure|Seizure, Generalized Tonic-Clonic|Seizures, Auditory|Focal Seizure|Tonic Clonic Seizure|Non-Epileptic Convulsion|Seizure, Gustatory|Tonic Seizures|Seizures, Visual|Absence Seizures, Atonic|Non-Epileptic Convulsions|Generalized Absence Seizure|Tonic-Clonic Seizure|Seizures, Generalized|Partial Seizure|Somatosensory Seizures"
NEW00266,CHEBI,FDA-approved PPAR-γ agonist drug,FDA-approved PPAR-γ agonist drug
C040048,CHEMICAL,caffeic acid [Supplementary Concept],caffeic acid|Caffeic acid|Caffeic Acids
NEW00267,DISEASE,chronic fatigue-like condition,chronic fatigue-like condition
NEW00268,CHEMICAL,weeks pioglitazone,weeks pioglitazone
NEW00269,MENTAL_HEALTH,fatigue animals,fatigue animals
D058607,CHEMICAL,Fibric Acids,"Acid Derivatives, Fibric|Methyl-2-Phenoxypropanoic Acid Derivatives|Fibrate|2 Phenoxy 2 Methylpropionic Acid Derivatives|fibrates|Isobutyric Acids, 2-Phenoxy|2-Phenoxy-2-Methylpropionic Acid Derivatives|Fibrates|2-Phenoxy Isobutyric Acids|Methyl 2 Phenoxypropanoic Acid Derivatives|2 Phenoxy Isobutyric Acids|Fibric Acid Derivatives"
NEW00270,CHEBI,synthetic PPAR agonists,synthetic PPAR agonists
D045162,CHEBI,Thiazolidinediones,Glitazones|Thiazolidinediones|TZDs|glitazones|thiazolidinediones
NEW00271,CHEBI,PPAR agonists,PPAR agonists
D019966,CHEBI,Substance-Related Disorders,"Drug Dependence|SUD|Substance Use|Drug Abuse|Dependence, Drug|Substance Abuse|Substance use disorder|Abuse, Drug|Related Disorder, Substance|Substance Dependence|Disorder, Substance Use|Chemical Dependences|Drug Use Disorders|Disorders, Substance Related|Abuse, Substance|Substance Abuses|Habituation, Drug|Use, Substance|Addiction, Substance|Substance Uses|Addiction, Drug|Prescription Drug Abuse|Disorder, Drug Use|Related Disorders, Substance|Dependence, Chemical|Substance|Substance Use Disorder|Substance Use Disorders|Organic Mental Disorders, Substance-Induced|Chemical Dependence|Dependence, Substance|Dependences, Chemical|Drug Use Disorder|Drug Addiction|Substance Related Disorder|organic mental disorders|Disorder, Substance Related|drug addiction|Abuse, Prescription Drug|Organic Mental Disorders, Substance Induced|drug dependence|substance-use disorders|Substance Addiction|substance dependence|Drug Habituation|Drug addiction|Drug Abuse, Prescription"
D020790,DISEASE,"Diabetes Insipidus, Neurogenic","Vasopressin Defective Diabetes Insipidus|Type Diabetes|diabetes insipidus|Central Diabetes Insipidus|Diabetes Insipidus, Cranial Type|Vasopressin Deficiency|type diabetes|Neurohypophyseal Diabetes Insipidus|Diabetes Insipidus, Primary Central|Diabetes Insipidus, Neurohypophyseal|Pituitary Diabetes Insipidus|Diabetes Insipidus, Central|Diabetes Insipidus Primary Central|Diabetes Insipidus Secondary To Vasopressin Deficiency|Diabetes Insipidus Cranial Type|Diabetes Insipidus, Pituitary|Type diabetes|Neurogenic Diabetes Insipidus|Diabetes Insipidus, Neurohypophyseal Type"
NEW00272,CHEMICAL,sulfonlyureas,sulfonlyureas
D008687,CHEMICAL,Metformin,"|metformin|Dimethylbiguanidine|Metformin HCl|Metformin Hydrochloride|Hydrochloride, Metformin|Glucophage|Dimethylguanylguanidine|Metformin|HCl, Metformin"
D050171,DISEASE,Dyslipidemias,|Dyslipoproteinemia|dyslipidemia|Dyslipidemia|Dyslipoproteinemias
NEW00273,CHEMICAL,serum alanine amino transferase concentrations,serum alanine amino transferase concentrations
D000077288,CHEMICAL,Troglitazone,"troglitazone|CS-045|Rezulin|5-(4-((6-Hydroxy-2,5,7,8-tetramethylchroman-2-yl-methoxy)benzyl)-2,4-thiazolidinedione) - T|Prelay|CS045|CS 045"
NEW00274,CHEMICAL,fasting plasma glucose,fasting plasma glucose
NEW00275,DISEASE,sustained chronic hyperglycemia,sustained chronic hyperglycemia
NEW00276,DISEASE,type diabetes mellitus,type diabetes mellitus
NEW00277,MENTAL_HEALTH,peripheral vascular resistance,peripheral vascular resistance
NEW00278,MENTAL_HEALTH,Improved insulin resistance,Improved insulin resistance
NEW00279,CHEMICAL,sulfonylurea use,sulfonylurea use
NEW00280,DISEASE,severe hypoglycemia,severe hypoglycemia
NEW00281,CHEBI,peroxiproliferator-activated receptor gamma agonist pioglitazone,peroxiproliferator-activated receptor gamma agonist pioglitazone
NEW00282,DISEASE,familial AD-linked PSEN1 mutants,familial AD-linked PSEN1 mutants
D008869,CHEMICAL,Microtubule-Associated Proteins,"MAP1 Microtubule-Associated Protein|Microtubule Associated Proteins|Microtubule-Associated Protein 2|Microtubule Associated Protein|Protein, Microtubule-Associated|Microtubule Associated Protein 1|Tau|MAP2 Microtubule Associated Protein|Microtubule-Associated Protein|MAP2 Microtubule-Associated Protein|microtubule-associated protein|Microtubule Associated Protein 2|MAP3 Microtubule Associated Protein|Microtubule-Associated Protein, MAP1|MAP1 Microtubule Associated Protein|Microtubule-Associated Protein, MAP3|Associated Protein, Microtubule|Microtubule-Associated Protein 3|Microtubule Associated Protein 3|Microtubule-Associated Protein 1|Protein, Microtubule Associated|Microtubule-Associated Protein, MAP2|MAP3 Microtubule-Associated Protein"
NEW00283,MENTAL_HEALTH,fragile X mental retardation FMR1 gene,fragile X mental retardation FMR1 gene
NEW00284,CHEMICAL,gonadotrophins,gonadotrophins
NEW00285,CHEBI,Endocrine changes,Endocrine changes
D051479,DISEASE,Plant Infertility,"Infertility, Plant|Reproductive Sterility, Plants|infertility|Sterility, Reproductive, Plants|Reproductive Sterility in Plants"
NEW00286,CHEBI,GnRH agonists,GnRH agonists
D004715,DISEASE,Endometriosis,Endometrioma|endometriomas|Endometriomas|Endometrioses|endometriosis
D003277,CHEMICAL,"Contraceptives, Oral, Combined","Contraceptive, Combined Oral||Combined Oral Contraceptive|Combined oral contraceptives|Oral Contraceptive, Combined|Contraceptive Agents, Female, Combined|combined oral contraceptives|Combined Oral Contraceptives|Contraceptives, Combined Oral|Oral Contraceptives, Combined"
NEW00287,DISEASE,endometriosis symptoms,endometriosis symptoms
D055744,CHEMICAL,Invasive Pulmonary Aspergillosis,"Allergic Bronchopulmonary Mycosis|Allergic Bronchopulmonary Mycoses|Mycosis, Allergic Bronchopulmonary|Aspergillosis, Invasive Pulmonary|Pulmonary Aspergillosis, Invasive|IPA|Bronchopulmonary Mycosis, Allergic|Bronchopulmonary Mycoses, Allergic|Pulmonary Aspergillosis - Invasive|Pulmonary Aspergilloses, Invasive|Mycoses, Allergic Bronchopulmonary|invasive pulmonary aspergillosis|Pulmonary Aspergillosis Invasive|Chronic Necrotizing Pulmonary Aspergillosis"
NEW00288,CHEBI,Toxic Substances Control,Toxic Substances Control
C051356,CHEMICAL,"isopropanol, phenol, salicylic acid drug combination [Supplementary Concept]",Drug Combinations|Salicylates|isopropanol
NEW00289,MENTAL_HEALTH,transient central nervous system depression,transient central nervous system depression
NEW00290,DISEASE,rodent toxicity endpoints,rodent toxicity endpoints
NEW00291,CHEMICAL,plasma corticosterone levels,plasma corticosterone levels
NEW00292,DISEASE,tumor growth enhancement,tumor growth enhancement
D050565,CHEMICAL,Benzoate 4-Monooxygenase,"4-Hydroxylase, Benzoate|4-Monooxygenase, Benzoate|Benzoate 4-Hydroxylase|Benzoate 4 Monooxygenase|Benzoate|Benzoate 4 Hydroxylase|Benzoate-Para-Hydroxylase|Benzoate Para Hydroxylase"
D057096,DISEASE,Shellfish Poisoning,"Shellfish Poisonings, Amnesic|Diarrhetic Shellfish Poisonings|Poisonings, Paralytic Shellfish|Poisonings, Shellfish|Neurotoxic Shellfish Poisoning|Poisonings, Diarrhetic Shellfish|Amnesic Shellfish Poisoning|Shellfish Poisonings, Paralytic|Paralytic Shellfish Poisoning|Paralytic Shellfish Poisonings|Poisonings, Amnesic Shellfish|Poisoning, Amnesic Shellfish|Poisonings, Neurotoxic Shellfish|Shellfish Poisoning, Paralytic|Amnesic Shellfish Poisonings|Shellfish Poisonings|neurotoxic|Shellfish Poisonings, Diarrhetic|Diarrhetic Shellfish Poisoning|Poisoning, Diarrhetic Shellfish|Shellfish Poisoning, Amnesic|Poisoning, Paralytic Shellfish|Poisoning, Neurotoxic Shellfish|Poisoning, Shellfish|Neurotoxic Shellfish Poisonings|Amnesic shellfish poisoning|Shellfish Poisoning, Diarrhetic|Shellfish Poisoning, Neurotoxic|ASP|Shellfish Poisonings, Neurotoxic"
D020160,CHEMICAL,Sodium Benzoate,"Sodium benzoate|Benzoate, Sodium|NaB|sodium benzoate"
NEW00293,MENTAL_HEALTH,Chronic stress,Chronic stress
D000068760,CHEMICAL,Serotonin and Noradrenaline Reuptake Inhibitors,norepinephrine reuptake|NRIs|Serotonin and Norepinephrine Reuptake Inhibitors|Norepinephrine reuptake inhibitors|SNRI|NRIs and SSRIs|SSRIs and NRIs|noradrenaline|reuptake inhibitors|Serotonin and Norepinephrine Uptake Inhibitors|norepinephrine|norepinephrine uptake inhibitors|SNRIs|norepinephrine reuptake inhibitors|Serotonin and Noradrenaline Uptake Inhibitors|Noradrenaline
C020611,CHEMICAL,cortisol 21-sulfate [Supplementary Concept],Cortisol|Hydrocortisone/analogs  and  derivatives|cortisol
NEW00294,CHEBI,stress hormones,stress hormones
NEW00295,DISEASE,oral carcinogenesis,oral carcinogenesis
NEW00296,CHEMICAL,"pro-carcinogen 1,2-dimethylhydrazine","pro-carcinogen 1,2-dimethylhydrazine|DMH"
NEW00297,DISEASE,colon inflammation,colon inflammation
NEW00298,CHEMICAL,plasmatic corticosterone,plasmatic corticosterone
NEW00299,DISEASE,colon carcinogenesis,colon carcinogenesis
NEW00300,CHEMICAL,Fetal alcohol exposure,Fetal alcohol exposure
NEW00301,DISEASE,carcinogen-induced mammary cancer progression,carcinogen-induced mammary cancer progression
D044123,CHEMICAL,"Receptor, Melatonin, MT2","melatonin|MLT|Melatonin 1b Receptor|Mel 1b Receptor|Receptor, Melatonin 1b|Receptor, MT2|Melatonin MT2 Receptor|MT2 Receptor, Melatonin|Melatonin|MT2 Receptor|Receptor, Melatonin MT2"
C024025,CHEMICAL,"7,12-dimethylbenz(a)anthracene-5,6-dihydrodiol [Supplementary Concept]","7,12-dimethylbenz(a)anthracene|9,10-Dimethyl-1,2-benzanthracene/analogs  and  derivatives"
D066066,DISEASE,Response Evaluation Criteria in Solid Tumors,RECIST|Tumors|solid tumors|tumors
D020849,CHEMICAL,Raloxifene Hydrochloride,|Keoxifene Hydrochloride|LY-139481|LY-156758|LY156758|LY 139481|raloxifene|Evista|Raloxifene hydrochloride|Raloxifene|RAL|Keoxifene|LY 156758|LY139481|Raloxifene HCl
D010903,DISEASE,"Pituitary Gland, Anterior","Anteriors, Lobus|pituitary glands|Pituitary Glands, Anterior|Anterior Lobe of Pituitary|Lobus Anterior|Adenohypophysis|Pituitary Pars Distalis|Adenohypophyses|Lobus Anteriors|Anterior Pituitary Gland|Anterior, Lobus|Pituitary Anterior Lobe|Anterior Pituitary Glands|Pars Distalis of Pituitary"
NEW00302,DISEASE,carcinogen-induced tumors,carcinogen-induced tumors
C057820,CHEMICAL,atrial natriuretic factor (7-23) [Supplementary Concept],Atrial Natriuretic Factor|Peptide Fragments|3.19|Alcohol
D061325,DISEASE,Hereditary Breast and Ovarian Cancer Syndrome,"Syndromes, HBOC|Syndrome, HBOC|Cancer|HBOC Syndromes|HBOC Syndrome|OC|Ovarian cancer|ovarian cancer|cancer"
NEW00303,CHEBI,Group carcinogen,Group carcinogen
NEW00304,CHEMICAL,excessive alcohol intake,excessive alcohol intake
C537258,DISEASE,Fibrolamellar hepatocellular carcinoma [Supplementary Concept],"Carcinoma, Hepatocellular|Hepatocellular Carcinoma|hepatocellular carcinoma|HCC"
D008106,DISEASE,"Liver Cirrhosis, Experimental","Experimental Hepatic Cirrhosis|Cirrhosis, Experimental Liver|Hepatic Cirrhosis, Experimental|Cirrhoses, Experimental Liver|liver cirrhosis|Experimental Liver Cirrhoses|cirrhosis|Experimental Liver Cirrhosis|Liver Cirrhoses, Experimental"
NEW00305,DISEASE,acute/chronic hepatitis,acute/chronic hepatitis
D015197,CHEBI,Carcinogenicity Tests,"Tests, Carcinogenesis|Tumorigenicity Test|Tests, Carcinogenic Potency|Tumorigenicity Tests|Carcinogen Test|carcinogen|Test, Carcinogenic Potency|Carcinogen Tests|Carcinogenesis Tests|Carcinogenicity Test|Test, Tumorigenicity|Tests, Carcinogenicity|Test, Carcinogenicity|Carcinogenesis Test|Carcinogenic Activity Tests|Potency Tests, Carcinogenic|Potency Test, Carcinogenic|Test, Carcinogen|Tests, Tumorigenicity|Tests, Carcinogenic Activity|Carcinogenic Potency Test|Test, Carcinogenesis|Carcinogenic Activity Test|Test, Carcinogenic Activity|Tests, Carcinogen|Carcinogenic Potency Tests"
NEW00306,DISEASE,studies tumors,studies tumors
NEW00307,MENTAL_HEALTH,binge alcohol abuse,binge alcohol abuse
NEW00308,CHEMICAL,TNF-alpha treatment,TNF-alpha treatment
D007538,CHEMICAL,Isoniazid,"|Acid Vanillylidenehydrazide, Isonicotinic|Vanillylidenehydrazide, Isonicotinic Acid|Isonex|Isoniazid|Phthivazid|Ftivazide|Tubazide|Hydrazide, Isonicotinic Acid|Isonicotinic Acid Hydrazide|Phthivazide|isoniazid-|isoniazid|INH|Isonicotinic Acid Vanillylidenehydrazide"
NEW00309,DISEASE,Club cell mitogenesis,Club cell mitogenesis
NEW00310,DISEASE,necrotic changes,necrotic changes
NEW00311,DISEASE,cancer risk factor,cancer risk factor
D065819,CHEMICAL,Voriconazole,"Voriconazole|UK109,496|UK 109,496|Vfend|UK-109,496|UK109496|voriconazole|UK 109496|UK-109496"
NEW00312,DISEASE,leukemia patients,leukemia patients
D000072742,DISEASE,Invasive Fungal Infections,"Infection, Disseminated Fungal|Fungal Infection, Disseminated|invasive fungal infections|Disseminated Fungal Infections|Fungal Infection, Invasive|Mycoses, Invasive|fungal infection|Invasive Mycoses|Disseminated Fungal Infection|Fungal infection|Invasive Fungal Infection|Infection, Invasive Fungal"
D020953,DISEASE,Neuroaspergillosis,"Neuroaspergilloses|Nervous System Invasive Aspergillosis|Aspergillosis, Nervous System Invasive|invasive aspergillosis"
NEW00313,CHEBI,primary antifungal agent,primary antifungal agent
D051271,CHEBI,"Headache Disorders, Secondary","Headache, Medication Overuse|Headaches, Analgesic Overuse|Headache Disorder, Secondary|Medication Overuse Headache|Medication overuse headache|Overuse Headache, Medication|Secondary Headache Disorders|Headaches, Analgesic Rebound|Analgesic Rebound Headaches|analgesic|Medication Overuse Headaches|Analgesic Overuse Headaches|Headache, Analgesic Overuse|Disorders, Secondary Headache|Secondary Headache Disorder|Headache, Analgesic Rebound|Analgesic Overuse Headache|Disorder, Secondary Headache|Headaches, Medication Overuse|Overuse Headaches, Medication|Analgesic Rebound Headache|headache disorders"
NEW00314,CHEBI,new antifungal agent effective,new antifungal agent effective
NEW00315,CHEMICAL,single oral 4-mg rosiglitazone dose,single oral 4-mg rosiglitazone dose
NEW00316,CHEMICAL,once-daily 750-mg SCY-078 dose,once-daily 750-mg SCY-078 dose
D002176,DISEASE,Candida albicans,Candida albicans var. stellatoidea|Candida stellatoidea|Dematium albicans|Syringospora albicans|Monilia albicans|Procandida stellatoidea|Candida albicans|Parasaccharomyces albicans|Myceloblastanon albicans|Saccharomyces albicans|Procandida albicans|Mycotorula albicans
NEW00317,CHEBI,higher toxin levels,higher toxin levels
NEW00318,NUTRITION,icefish hearts,icefish hearts
NEW00319,DISEASE,higher maximum stroke volume,higher maximum stroke volume
NEW00320,CHEMICAL,Increased urine porphobilinogen excretion,Increased urine porphobilinogen excretion
NEW00321,DISEASE,National Acute Porphyria Service,National Acute Porphyria Service
D057233,CHEMICAL,Radio Frequency Identification Device,•    Identification|RFID|Radio Frequency Identification
D011166,NUTRITION,Porphyrins,porphyrins|Porphyrin
D014914,CHEMICAL,Whole Blood Coagulation Time,"•    Whole blood|Blood Coagulation Time, Whole|Coagulation Time, Whole Blood|Activated Coagulation Time, Whole Blood"
D046351,DISEASE,"Protoporphyria, Erythropoietic","Erythropoietic Protoporphyrias|Heme Synthetase Deficiency|Heme Synthetase Deficiencies|Synthetase Deficiency, Heme|Deficiencies, Ferrochelatase|Erythropoietic Protoporphyria|Ferrochelatase Deficiency|protoporphyria|Protoporphyrias, Erythropoietic|Deficiency, Heme Synthetase|Deficiency, Ferrochelatase|Synthetase Deficiencies, Heme|Deficiencies, Heme Synthetase|Ferrochelatase Deficiencies|Erythrohepatic Protoporphyria"
NEW00322,CHEMICAL,chronic lead-exposure,chronic lead-exposure
D018373,DISEASE,Peripheral Nervous System Agents,Peripheral Nervous System Effects|Peripheral Nervous System Drugs|peripheral nervous system|Peripheral Nervous System Effect
NEW00323,MENTAL_HEALTH,Severe pain syndromes,Severe pain syndromes
D059345,DISEASE,Cerebral Small Vessel Diseases,"Cerebral Microangiopathies|Microangiopathy, Cerebral|Microangiopathies, Cerebral|diseases|Cerebral Small Vessel Disease|Cerebral Microangiopathy"
D005198,DISEASE,Fanconi Syndrome,"Syndrome, Fanconi Renotubular||Hepatic Glycogenosis with Fanconi Nephropathy|Pseudo Phlorizin Diabetes|Fanconi Syndrome, Adult|Syndromes, Fanconi-Bickel|Fanconi Syndrome with Intestinal Malabsorption and Galactose Intolerance|Primary Toni-Debre-Fanconi Syndrome|Toni-Debre-Fanconi Syndrome|Syndrome, Renal Fanconi|Proximal Renal Tubular Dysfunction|Hepatorenal Glycogenosis with Renal Fanconi Syndrome|Diabetes, Pseudo-Phlorizin|Fanconi Bickel Syndrome|Fanconi-Bickel Syndrome|Lignac Fanconi Syndrome|Diabete, Pseudo-Phlorizin|Fanconi-Bickel Syndromes|Fanconi Type Glycogenosis|tubular dysfunction|Renal Fanconi Syndrome|Syndrome, Lignac-Fanconi|Syndrome, Fanconi Bickel|Luder-Sheldon Syndrome|Syndrome, Adult Fanconi|Luder Sheldon Syndrome|Syndrome, Fanconi-Bickel|Fanconi Syndrome, Renal|Glycogenosis, Fanconi Type|Neonatal De Toni-Debre-Fanconi Syndrome|Idiopathic De Toni-Debre-Fanconi Syndrome|Pseudo-Phlorizin Diabetes|Fanconi's syndrome|Renotubular Syndrome, Fanconi|Adult Fanconi Syndrome|Glycogen Storage Disease XI|Bickel Syndrome, Fanconi|De Toni-Debre-Fanconi Syndrome|Syndrome, Fanconi|Fanconi Syndrome without Cystinosis|Syndrome, Luder-Sheldon|Lignac-Fanconi Syndrome|Hepatic Glycogenosis with Amino Aciduria and Glucosuria|Fanconi Renotubular Syndrome|Pseudo-Phlorizin Diabete|Fanconi-Bickel syndrome"
D054818,CHEMICAL,Hexosaminidase A,beta N Acetylhexosaminidase A|beta-N-Acetylhexosaminidase A|Hex A
NEW00324,NUTRITION,fractionated porphyrins,fractionated porphyrins
NEW00325,DISEASE,acute hepatic porphyrias,acute hepatic porphyrias
NEW00326,DISEASE,rare porphyria,rare porphyria
D046350,DISEASE,"Porphyria, Variegate","Porphyria, South African Type|Porphyria Variegata|Variegate Porphyria|Deficiency, Ppox|Protoporphyrinogen Oxidase Deficiency|variegate porphyria|Ppox Deficiency|Ppox Deficiencies|Variegate porphyria|Porphyria Variegate|porphyria"
D046349,DISEASE,"Coproporphyria, Hereditary","hereditary coproporphyria|Hereditary Coproporphyria|Deficiency, Coproporphyrinogen Oxidase|Coproporphyrinogen Oxidase Deficiency"
NEW00327,CHEMICAL,ALA dehydratase,ALA dehydratase|ADP
D017118,DISEASE,"Porphyria, Acute Intermittent","UPS Deficiency|PBGD Deficiency|Synthase Deficiencies, Uroporphyrinogen|Deficiency, Porphobilinogen Deaminase|Hydroxymethylbilane Synthase Deficiencies|Acute Intermittent Porphyrias|Type Porphyrias, Swedish|Porphyrias, Swedish Type|Uroporphyrinogen Synthase Deficiency|Porphyria, Swedish Type|Porphyrias, Acute|Synthase Deficiency, Hydroxymethylbilane|Deaminase Deficiencies, Porphobilinogen|acute intermittent porphyria|Acute Porphyrias|Deficiencies, UPS|Deaminase Deficiency, Porphobilinogen|AIP|Porphyria, Acute|Porphobilinogen Deaminase Deficiencies|Porphyrias, Acute Intermittent|UPS Deficiencies|Acute Intermittent Porphyria|Uroporphyrinogen Synthase Deficiencies|Deficiency, UPS|Intermittent Porphyria, Acute|Intermittent Porphyrias, Acute|Deficiencies, Uroporphyrinogen Synthase|Deficiencies, PBGD|Deficiencies, Hydroxymethylbilane Synthase|Type Porphyria, Swedish|Synthase Deficiency, Uroporphyrinogen|Porphobilinogen Deaminase Deficiency|Deficiency, PBGD|Deficiencies, Porphobilinogen Deaminase|Deficiency, Hydroxymethylbilane Synthase|Deficiency, Uroporphyrinogen Synthase|Swedish Type Porphyria|Synthase Deficiencies, Hydroxymethylbilane|PBGD Deficiencies|Hydroxymethylbilane Synthase Deficiency|Swedish Type Porphyrias|Acute Porphyria"
NEW00328,DISEASE,due autosomal dominant genetic abnormalities,due autosomal dominant genetic abnormalities
D010383,DISEASE,Pellagra,Pellagras|pellagra
C538178,CHEMICAL,Acrodermatitis enteropathica [Supplementary Concept],Acrodermatitis|Zinc/deficiency|acrodermatitis enteropathica|zinc deficiency|Zinc deficiency
NEW00329,DISEASE,Skin photosensitivity,Skin photosensitivity
NEW00330,CHEMICAL,Trp metabolite picolinic acid,Trp metabolite picolinic acid
NEW00331,CHEMICAL,haem precursor 5-aminolaevulinic acid,haem precursor 5-aminolaevulinic acid
C546511,CHEMICAL,5-aminolevulinic acid heptyl ester [Supplementary Concept],5-ALA|Aminolevulinic Acid/antagonists  and  inhibitors|5-aminolevulinic acid
NEW00332,NUTRITION,photo-reactive porphyrins,photo-reactive porphyrins
NEW00333,CHEMICAL,histidine metabolite urocanic acid,histidine metabolite urocanic acid
NEW00334,CHEMICAL,serotonin deficiency,serotonin deficiency
D036881,MENTAL_HEALTH,Long-Term Synaptic Depression,"long-term depression|Long-Term Depression, Physiologic|sucrose splash test|Neurophysiologic Long-Term Depression|long term|Long-Term Depressions, Neurophysiological|Depression|long term depression|Long Term Depression, Physiological|Long-Term Depression, Physiological|Homosynaptic Depression|depression|Depression, Physiological Long-Term|Long Term Synaptic Depression|Long Term Depression, Physiologic|Depressions, Physiological Long-Term|Neurophysiological Long-Term Depression|Synaptic Depression, Long-Term|Depression, Neurophysiological Long-Term|Long-Term Depression, Neurophysiological|Long Term Depression, Neurophysiological|Neurophysiological Long-Term Depressions|Physiological Long-Term Depressions|Long Term Depression, Neurophysiologic|CSD|Physiological Long-Term Depression|Long-Term Depression, Neurophysiologic|serotonin regulation|synaptic depression|Depressions, Neurophysiological Long-Term|Depression, Homosynaptic|Long-Term Depressions, Physiological|Depotentiation|Physiologic Long-Term Depression"
D060805,MENTAL_HEALTH,Performance Anxiety,"anxiety|performance anxiety|Anxieties, Performance|ANX|Performance Anxieties|Anxiety|Anxiety, Performance"
NEW00335,CHEMICAL,5-ALA Trp metabolite kynurenic acid,5-ALA Trp metabolite kynurenic acid
NEW00336,DISEASE,neurological disturbances,neurological disturbances
D009525,CHEBI,Niacin,"Niacin Cobalt (2+) Salt||Nicamin|Tartrate, Niacin|Wampocap|Potassium Salt, Niacin|Nicolar|Nicobid|Niacin Hydrochloride|Tosylate, Niacin|Lithium Nicotinate|Nicotinate|Niacin Calcium Salt|Niacin Lithium Salt|Sodium Salt, Niacin|niacin|Enduracin|Niacin Tartrate|Niacin Lithium Salt, Hemihydrate|Nicocap|Niacin Tosylate|Niacin Copper (2+) Salt|Niacin Magnesium Salt|Aluminum Salt, Niacin|Niacin Ammonium Salt|Niacin Zinc Salt|Induracin|Nico400|Nico-400|Niacin Iron (2+) Salt|Nicotinate, Lithium|Hydrochloride, Niacin|Nico 400|Niacin Potassium Salt|Niacin Aluminum Salt|Niacin Manganese (2+) Salt|3 Pyridinecarboxylic Acid|3-Pyridinecarboxylic Acid|Niacin Sodium Salt|Nicotinic Acid"
D051279,CHEMICAL,Tryptophan Transaminase,"Trp|Transaminase, Tryptophan|L-Tryptophan Aminotransferase|Aminotransferase, Tryptophan|Aminotransferase, L-Tryptophan|L Tryptophan Aminotransferase|tryptophan|TRP|Tryptophan|Tryptophan Aminotransferase"
NEW00337,DISEASE,Alcoholic pellagra encephalopathy,Alcoholic pellagra encephalopathy
D014803,CHEBI,Vitamin B Complex,"B Vitamins|B Vitamin|B vitamins|Vitamin, B|vitamin B complex|B-vitamins|Neurobion|vitamins B"
NEW00338,DISEASE,skin disturbances,skin disturbances
NEW00339,CHEMICAL,abnormal gamma-glutamyl transpeptidase,abnormal gamma-glutamyl transpeptidase
D054506,DISEASE,Chloracne,"Acnes, Chlorine|Chlorine Acnes|Chloracnes|Chlorine Acne|Acne, Chlorine|chloracne"
NEW00340,CHEMICAL,mean triglyceride values,mean triglyceride values
D017119,DISEASE,Porphyria Cutanea Tarda,Porphyria (1966-1992)|Porphyria cutanea tarda
D014575,CHEMICAL,Uroporphyrinogen Decarboxylase,"Decarboxylase, Uroporphyrinogen III|Carboxy-Lyase, Uroporphyrinogen|uroporphyrinogen decarboxylase|Decarboxylase, Uroporphyrinogen|Uroporphyrinogen III Decarboxylase|Uroporphyrinogen Carboxy Lyase|Uroporphyrinogen Carboxy-Lyase"
NEW00341,CHEMICAL,direct-acting antivirals,Direct-acting antivirals|direct-acting antivirals|DAA
D015828,DISEASE,"Eye Infections, Viral","Ocular Infection, Viral|Ocular Infections, Viral|Viral Ocular Infections|Eye Infection, Viral|Infections, Viral Eye|Viral Eye Infections|Viral Ocular Infection|Infection, Viral Ocular|Infections, Viral Ocular|Infection, Viral Eye|viral infection|Viral Eye Infection"
NEW00342,DISEASE,phototoxic skin reaction,phototoxic skin reaction
NEW00343,NUTRITION,poly-carboxylated porphyrins,poly-carboxylated porphyrins
D058085,CHEMICAL,Iron Compounds,"iron|Fe|Compounds, Iron|Iron"
NEW00344,DISEASE,chronic viral infection,chronic viral infection
NEW00345,CHEMICAL,polyhalogenated cyclic hydrocarbons,polyhalogenated cyclic hydrocarbons
NEW00346,DISEASE,chronic HCV infection,chronic HCV infection
NEW00347,CHEMICAL,fermentopathy,fermentopathy
NEW00348,DISEASE,relevant porphyria,relevant porphyria
NEW00349,DISEASE,motor neuropathy symptoms,motor neuropathy symptoms
D015746,DISEASE,Abdominal Pain,"|Abdominal Pains|Pain, Colicky|Colicky Pain|Pains, Abdominal|abdominal pain|Pain, Abdominal|Colicky Pains|Pains, Colicky"
NEW00350,NUTRITION,Urinary porphyrins,Urinary porphyrins
NEW00351,DISEASE,Sociability,Sociability
NEW00352,DISEASE,severe ASDs,severe ASDs
C513117,CHEMICAL,precoproporphyrin [Supplementary Concept],precoproporphyrin|Porphyrins
C034350,CHEMICAL,pentacarboxylic porphyrin [Supplementary Concept],pentacarboxyporphyrin|Porphyrins
NEW00353,NUTRITION,intoxication-associated urinary porphyrins,intoxication-associated urinary porphyrins
NEW00354,DISEASE,mild ASDs,mild ASDs
NEW00355,NUTRITION,mercury intoxication,mercury intoxication
NEW00356,DISEASE,autistic symptoms,autistic symptoms
C538258,DISEASE,ATR-X syndrome [Supplementary Concept],"alpha-Thalassemia|ATR-X syndrome|Mental Retardation, X-Linked"
NEW00357,DISEASE,ATR-X syndrome patient,ATR-X syndrome patient
NEW00358,DISEASE,ATR-X syndrome model,ATR-X syndrome model
D054577,CHEBI,National Institute on Drug Abuse (U.S.),NIDA (US)|National Institute on Drug Abuse|Drug Abuse|Drug abuse|drug abuse
D000082922,DISEASE,HIV Testing,"HIV Infection Diagnosis|HIV-AIDS Testing|Testing, AIDS|HIV-infection|HIV infection|AIDS Testing|Diagnosis, HIV Infection|Testing, HIV-AIDS|Testing, HIV|HIV AIDS Testing"
D019965,DISEASE,Neurocognitive Disorders,"organic brain syndrome||Organic Mental Disorders, Psychotic|cognitive disorders|Disorder, Neurocognitive|Organic Mental Disorders|Organic Mental Disorder|Traumatic Psychoses|Disorders, Organic Mental|Neurocognitive Disorder|Disorders, Neurocognitive|Clerambault Syndrome|Mental Disorders, Organic|organic mental disorder|Organic Brain Syndrome, Nonpsychotic|Mental Disorder, Organic|Psychoses, Traumatic|Nonpsychotic Organic Brain Syndrome|Delirium, Dementia, Amnestic, Cognitive Disorders|Kandinsky Syndrome|neurocognitive disorders"
NEW00359,CHEMICAL,CD14+CD16,CD14+CD16
NEW00360,DISEASE,HIV neuropathogenesis,HIV neuropathogenesis
NEW00361,DISEASE,HIV infected drug abusers,HIV infected drug abusers
NEW00362,CHEMICAL,dopamine rich brain regions,dopamine rich brain regions
NEW00363,CHEMICAL,elevated extracellular dopamine,elevated extracellular dopamine
NEW00364,DISEASE,PD-associated pain,PD-associated pain
NEW00365,CHEBI,D2 dopamine agonist,D2 dopamine agonist
C047508,CHEMICAL,rotigotine [Supplementary Concept],Tetrahydronaphthalenes|Rotigotine|Thiophenes
D001058,CHEMICAL,Apomorphine,"|Apomorphine Hydrochloride, Hemihydrate|Britaject|Apomorphine|Apo|Apomorphine hydrochloride|Apomorphine Hydrochloride Anhydrous|Apomorphin-Teclapharm|Apomorphine Chloride|Apokinon|Apomorphin Teclapharm|Apomorphine Hydrochloride|Apomorphine Hydrochloride, Anhydrous|apomorphine"
D000077487,CHEMICAL,Pramipexole,"Pramipexole Hydrochloride Monohydrate|2-Amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole|SND-919|Pramipexole Dihydrochloride|Pramipexol Dihydrochloride, (S)-isomer|Sifrol|2 Amino 6 propylaminotetrahydrobenzothiazole|SND-919CL2x|Pramipexole|Pramipexol, (+-)-isomer|Pramipexol Dihydrobromide, (+-)-isomer|KNS 760704|Pramipexole Dihydrochloride Anhydrous|6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate|SND 919|Mirapex|4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazole-diamine|KNS-760704|SND 919CL2x|2-Amino-6-propylaminotetrahydrobenzothiazole|pramipexole|Pramipexol, (R)-isomer|Dexpramipexole|SND919CL2x|Pramipexol|KNS760704"
D000077432,CHEMICAL,Tapentadol,"Tapentadol Hydrochloride|3-((1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl)phenol|Tapentadol|tapentadol|Nucynta"
C557247,CHEMICAL,oxycodone naloxone combination [Supplementary Concept],Naloxone|Targinact|Oxycodone|Drug Combinations
NEW00366,CHEBI,opioid agonist oxycodone,opioid agonist oxycodone
NEW00367,CHEBI,central-acting oral analgesic,central-acting oral analgesic
D000929,CHEMICAL,"Antidepressive Agents, Tricyclic","Tricyclic antidepressants|Drugs, Tricyclic Antidepressant|Tricyclic Antidepressive Agent|Agent, Tricyclic Antidepressive|antidepressant drugs|Tricyclic Antidepressive Agents|Tricyclic Antidepressant Drug|Tricyclic Antidepressants|Antidepressant Drug, Tricyclic|Antidepressants, Tricyclic|antidepressant drug|Antidepressant Drugs, Tricyclic|Drug, Tricyclic Antidepressant|TCAs|antidepressant|Antidepressant, Tricyclic|Antidepressive Agent, Tricyclic|Tricyclic Antidepressant Drugs|Agents, Tricyclic Antidepressive|Antidepressant drugs|tricyclic antidepressants|Tricyclic Antidepressant|tricyclic antidepressant"
NEW00368,CHEMICAL,native dopamine D(2)-like receptors,native dopamine D(2)-like receptors
D001971,CHEMICAL,Bromocriptine,"|Bromocriptin|Mesylate, 2-Bromoergocryptine|2 Bromo alpha ergocryptine|2-Bromoergocryptine Mesylate|2-Bromoergocryptine Methanesulfonate|2-Bromo-alpha-ergokryptine|Methanesulfonate, 2-Bromoergocryptine|2 Bromoergokryptine|bromocriptine|Mesylate, Bromocriptine|Parlodel|CB154|2 Bromo alpha ergokryptine|2 Bromoergocryptine Methanesulfonate|2-Bromoergocryptine|2 Bromoergocryptine|2-Bromo-alpha-ergocryptine|2-Bromoergokryptine|Bromocryptin|CB 154|Bromocriptine|CB-154|2 Bromoergocryptine Mesylate|Bromocriptine Mesylate"
NEW00369,CHEMICAL,nonergoline dopamine receptor agonist,nonergoline dopamine receptor agonist
C046649,CHEMICAL,ropinirole [Supplementary Concept],ropinirole|Indoles|Ropinirole
D020734,DISEASE,Parkinsonian Disorders,"Parkinsonism, Juvenile, Autosomal Dominant||Juvenile Parkinson Disease, Autosomal Recessive|Juvenile Parkinson Disease, Autosomal Dominant|Experimental Parkinsonism, MPTP Induced|Parkinson Disease, Juvenile, Autosomal Recessive|Parkinson Disease 2, Autosomal Recessive Juvenile|Parkinson Disease 2|Parkinson Disease, Experimental|Parkinsonism, Autosomal Recessive|Experimental Parkinsonism, MPTP-Induced|MPTP-Induced Experimental Parkinsonism|Autosomal Dominant Juvenile Parkinsonism|parkinsonian|MPTP-induced experimental parkinsonism|Experimental Parkinsonism|MPTP Induced Experimental Parkinsonism|Parkinsonism, Autosomal Dominant|Juvenile Parkinsonisms|Juvenile Parkinsonism|Parkinsonism, Experimental|Autosomal Dominant Parkinsonism|Parkinson Disease, Juvenile|experimental parkinsonism|Parkinsonism, Juvenile|Parkinson Diseases, Experimental|Parkinsonism, Early Onset, with Diurnal Fluctuation|Parkinsonian Diseases|Juvenile Parkinsonism, Autosomal Recessive|Chromosome 6-Linked Autosomal Recessive Parkinsonism|Parkinsonism, Juvenile, Autosomal Recessive|Parkinsonism, Familial Juvenile|Parkinsonian Syndromes|Familial Juvenile Parkinsonism|Familial Parkinson Disease, Autosomal Recessive|Parkinsonisms, Juvenile|Juvenile Parkinson Disease|parkinsonism|Parkinsonisms, Experimental|Parkinsonism|Parkinson Disease Autosomal Recessive, Early Onset|Parkinson Disease, Familial, Autosomal Recessive|Parkinsonian Syndrome|Juvenile Parkinsonism, Familial|Juvenile Parkinsonism, Autosomal Dominant|Autosomal Recessive Juvenile Parkinson Disease|Experimental Parkinson Diseases|Parkinson Disease, Autosomal Dominant. Juvenile|Ramsay Hunt Paralysis Syndrome|Dominant Parkinsonism, Autosomal|Experimental Parkinsonisms|Diseases, Experimental Parkinson|Autosomal Dominant Juvenile Parkinson Disease|Experimental Parkinson Disease|Parkinsonism, MPTP-Induced Experimental|Recessive Parkinsonism, Autosomal|Chromosome 6 Linked Autosomal Recessive Parkinsonism|Autosomal Recessive Juvenile Parkinsonism|Parkinsonism, Early-Onset, With Diurnal Fluctuation|Parkinson Disease, Juvenile, Autosomal Dominant|Autosomal Recessive Parkinsonism"
D017265,CHEMICAL,Procaterol,"CI 888||monohydrochloride|Procaterol, (R*,R*)-(+-)-Isomer|OPC2009|Pro Air|Procaterol Monohydrochloride, (R*,R*)-(-)-Isomer|Procaterol Monohydrochloride, (R*,R*)-(+)-Isomer|Procaterol Monohydrochloride, (R*,S*)-(+)-Isomer|Procaterol Monohydrochloride, (R*,R*)-(+-)-Isomer|CI-888|(R*,S*)-(+-)-8-Hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-2(1H)-quinolinone|Monohydrochloride, Procaterol|Procaterol Hydrochloride|Procaterol, (R*,S*)-(-)-Isomer|CI888|OPC 2009|Procaterol Monohydrochloride, (R*,S*)-(-)-Isomer|Pro-Air|Procaterol|Hydrochloride, Procaterol|Procaterol Monohydrochloride|ProAir|OPC-2009"
NEW00370,DISEASE,MPTP-treated marmosets,MPTP-treated marmosets
NEW00371,MENTAL_HEALTH,akinesia movement,akinesia movement
NEW00372,MENTAL_HEALTH,obvious dyskinesia,obvious dyskinesia
NEW00373,CHEMICAL,dopamine D(2)-like receptor agonistic drug,dopamine D(2)-like receptor agonistic drug
D050637,CHEMICAL,"Receptors, Dopamine D3","Dopamine D3 Receptor|dopamine D3 receptor|Dopamine Receptor D3|Dopamine D3 Receptors|Dopamine-D3 Receptor|dopamine D3 receptors|Receptor, Dopamine-D3"
NEW00374,DISEASE,L-DOPA-induced dyskinesia,L-DOPA-induced dyskinesia|LID
NEW00375,CHEMICAL,dopamine depletion,dopamine depletion
D007649,CHEMICAL,Ketamine,|ketamine|Calypsol|Calipsol|Ketaset|Ketamine Hydrochloride|Ketamine|Kalipsol|CI581|CI-581|CI 581|2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone|Ketalar|Ketanest|KET|125mg/kg
NEW00376,CHEBI,non-competitive NMDA receptor antagonist,non-competitive NMDA receptor antagonist
D016194,CHEMICAL,"Receptors, N-Methyl-D-Aspartate","NMDA|NMDA receptors|Receptor, NMDA|N Methylaspartate Receptors|Receptors, N-Methylaspartate|Receptors, N Methylaspartate|N-methyl-D-aspartate receptors|N-Methyl-D-Aspartate Receptors|Receptors, NMDA|NMDA Receptor-Ionophore Complex|N-methyl-d-aspartate NMDA receptor|N Methyl D Aspartate Receptors|N-methyl D-aspartate receptors|N-methyl-d-aspartate|N-Methyl-D-Aspartate Receptor|N-methyl-D-aspartate NMDA receptor|NMDA Receptor Ionophore Complex|Receptors, N Methyl D Aspartate|N-Methylaspartate Receptors|NMDARs|NMDA Receptor|N Methyl D Aspartate Receptor|NMDA Receptors|N-methyl-d-aspartate receptors|Receptor, N-Methyl-D-Aspartate"
NEW00377,DISEASE,tamoxifen-treated,tamoxifen-treated
NEW00378,DISEASE,receptor-mediated psychosis-like behaviours,receptor-mediated psychosis-like behaviours
NEW00379,CHEMICAL,17α-estradiol,17α-estradiol
D042724,CHEBI,"Estrogens, Esterified (USP)",Estrogens|estrogens|Esterified Estrogens (USP)
NEW00380,DISEASE,hyperprolactinemia movement disorders,hyperprolactinemia movement disorders
D000425,MENTAL_HEALTH,Alcohol Amnestic Disorder,"Alcohol-Induced Amnestic Psychosis|Alcohol-Induced Dysmnesic Psychosis|Alcohol-Induced Dysmnesic Psychoses|psychosis|Psychosis, Alcohol-Induced Amnestic|Alcohol Induced Dysmnesic Psychosis|Alcohol-Induced Dysmnesic Syndrome|amnestic|Psychoses, Alcohol-Induced Dysmnesic|Amnestic Syndrome, Alcohol-Induced|alcohol amnestic disorder|Amnestic Psychosis, Alcohol Induced|Dysmnesic Psychosis, Alcohol-Induced|Amnestic Syndromes, Alcohol-Induced|Alcohol Induced Persisting Amnestic Disorder|Psychosis, Alcohol-Induced Dysmnesic|Amnestic Psychoses, Alcohol-Induced|Alcohol-Induced Dysmnesic Syndromes|Dysmnesic Psychoses, Alcohol-Induced|Alcohol Amnestic Disorders|Alcohol-Induced Amnestic Syndromes|Alcohol-Induced Persisting Amnestic Disorder|Alcohol Amnestic Syndrome|Alcohol Induced Amnestic Psychosis|Amnestic Disorder, Alcohol|Psychoses, Alcohol-Induced Amnestic|Alcohol-Induced Amnestic Syndrome|Alcohol Induced Dysmnesic Syndrome|Amnestic Psychosis, Alcohol-Induced|Dysmnesic Syndromes, Alcohol-Induced|Alcohol-Induced Amnestic Psychoses|Alcohol Amnestic Syndromes|Alcohol Induced Amnestic Syndrome|Dysmnesic Syndrome, Alcohol-Induced|Psychosis|amnestic syndrome"
NEW00381,DISEASE,psychotic illnesses,psychotic illnesses
NEW00382,CHEMICAL,Low dopamine levels,Low dopamine levels
D012726,DISEASE,"Sexual Behavior, Animal","Animal Mating Behaviors|Sexual behavior|Sex Behavior, Animal|Animal Sexual Behaviors|Animal Sex Behavior|Sex Behaviors, Animal|Sexual Behaviors, Animal|Animal Sex Behaviors|Mating Behaviors, Animal|sexual behaviors|Animal Sexual Behavior|Mating Behavior, Animal|sexual behavior|Animal Mating Behavior"
NEW00383,MENTAL_HEALTH,moderate sexual dysfunction,moderate sexual dysfunction
D005473,CHEMICAL,Fluoxetine,|Fluoxetine hydrochloride|Fluoxetin|Sarafem|Lilly110140|Lilly-110140|Lilly 110140|Fluoxetine|N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|Fluoxetine Hydrochloride|FLX|fluoxetine|Prozac
NEW00384,DISEASE,depressive-like behavior,depressive-like behavior
NEW00385,CHEMICAL,rotigotine-loaded microspheres,RoMS|rotigotine-loaded microspheres
D015663,DISEASE,"Osteoporosis, Postmenopausal","Bone Losses, Perimenopausal|Perimenopausal Bone Loss|Perimenopausal Bone Losses|Post-Menopausal Osteoporoses|Postmenopausal Osteoporosis|Osteoporosis|Osteoporoses, Postmenopausal|Osteoporosis, Post Menopausal|Postmenopausal Bone Losses|Post-Menopausal Osteoporosis|Osteoporosis, Post-Menopausal|Bone Loss, Perimenopausal|Postmenopausal Bone Loss|Bone Loss, Postmenopausal|Osteoporoses, Post-Menopausal|Bone Losses, Postmenopausal|Postmenopausal Osteoporoses|osteoporosis"
NEW00386,DISEASE,Antipsychotic-induced hyperprolactinaemia,Antipsychotic-induced hyperprolactinaemia
D016320,CHEBI,Substance Abuse Treatment Centers,"Treatment Centers, Drug|Drug Treatment Center|Center, Drug Rehabilitation|Rehabilitation Center, Drug|Centers, Drug Treatment|Rehabilitation Centers, Drug|substance abuse|Substance abuse|Drug Rehabilitation Centers|Center, Drug Treatment|Drug Abuse Treatment Centers|abuse treatment|drug treatment|Drug Rehabilitation Center|Treatment Centers, Substance Abuse|Treatment Centers, Drug Abuse|Drug treatment|Treatment Center, Drug|Centers, Drug Rehabilitation|Drug Treatment Centers"
NEW00387,MENTAL_HEALTH,Severe impulse control disorders,Severe impulse control disorders
NEW00388,CHEBI,dopamine receptor agonist drugs,dopamine receptor agonist drugs
NEW00389,MENTAL_HEALTH,impulse control disorders secondary,impulse control disorders secondary
D012148,DISEASE,Restless Legs Syndrome,"|Wittmaack Ekbom Syndrome|Restless Leg Syndrome|Willis-Ekbom Disease|Disease, Willis Ekbom|Syndrome, Willis-Ekbom|Willis Ekbom Syndrome|Restless Legs|Disease, Willis-Ekbom|Syndrome, Willis Ekbom|Restless Legs Syndrome|Syndrome, Wittmaack Ekbom|Syndrome, Restless Leg|restless legs syndrome|restless leg syndrome|Syndrome, Wittmaack-Ekbom|Willis Ekbom Disease|Restless legs syndrome|Willis-Ekbom Syndrome|Wittmaack-Ekbom Syndrome"
D005715,MENTAL_HEALTH,Gambling,"Pathological Gambling|pathological gambling|Gamblings, Pathological|Gambling, Pathological|Gamblings|Gambling, Pathologic|Pathological Gamblings|Pathological gambling"
NEW00390,CHEMICAL,Pathologic gambling,PG|Pathologic gambling
NEW00391,CHEMICAL,Subcutaneous apomorphine,Subcutaneous apomorphine
NEW00392,CHEMICAL,levodopa therapy,levodopa therapy
C100146,CHEMICAL,trimethobenzamide [Supplementary Concept],trimethobenzamide|Benzamides
NEW00393,CHEMICAL,apomorphine treatment,apomorphine treatment
D004294,CHEMICAL,Domperidone,"|Nauzelin|domperidone|R33812|Gamir, Domperidona|DOM|Domperidon Hexal|Domperidon-TEVA|Novo Domperidone|Maleate, Domperidone|PMS Domperidone|Domidon|Motilium|Nu Domperidone|Monohydrochloride, Domperidone|Domperidone Maleate (1:1)|Domperidon AL|Domperidon|Hexal, Domperidon|Domperidone Maleate|Domperidona Gamir|Nu-Domperidone|R-33812|R-33,812|Ratio Domperidone|Apo Domperidone|Novo-Domperidone|Gastrocure|PMS-Domperidone|R33,812|Domperidone Monohydrochloride|Domperidon Stada|Domperidone|Domperidon TEVA|Apo-Domperidone|Ratio-Domperidone|Stada, Domperidon|Péridys"
NEW00394,DISEASE,advanced Parkinson disease,advanced Parkinson disease
NEW00395,DISEASE,nausea hypotension,nausea hypotension
NEW00396,CHEMICAL,apomorphine test,apomorphine test
NEW00397,CHEMICAL,apomorphine bolus,apomorphine bolus
D010301,DISEASE,"Parkinson Disease, Postencephalitic","Parkinsonism, Postencephalitic|Postencephalitic Economo Type Parkinsonism|Postencephalitic Economo-Type Parkinsonism|Parkinsonism, Postencephalitic Economo-Type|Postencephalitic Parkinsonism|von Economo Encephalitis Type Parkinsonism|Parkinsonian Syndrome, Postencephalitis|Post-Encephalitic Parkinson Disease|Post Encephalitic Parkinson Disease|parkinsonian syndrome|Parkinsonisms, Viral Meningoencephalitic|Encephalitis Lethargica Type Parkinsonism|Parkinson Disease, Post-Encephalitic|Parkinsonism, Viral Meningoencephalitic|Economo-Type Parkinsonism, Postencephalitic|Postencephalitic Parkinson Disease|Viral Meningoencephalitic Parkinsonism|Parkinson Disease, Post Encephalitic|Meningoencephalitic Parkinsonism, Viral|Postencephalitis Parkinsonian Syndrome"
NEW00398,MENTAL_HEALTH,atypical parkinsonian syndromes,atypical parkinsonian syndromes
NEW00399,CHEMICAL,profile apomorphine,profile apomorphine
NEW00400,DISEASE,off-phases dyskinesias,off-phases dyskinesias
D000069445,CHEMICAL,Atomoxetine Hydrochloride,"Atomoxetine|atomoxetine|Hydrochloride, Atomoxetine|Tomoxetine Hydrochloride, (+)-isomer - T351671|HCl, Atomoxetine|Tomoxetine|N-methyl-gamma-(2-methylphenoxy)benzenepropanamine hydrochloride|Strattera|LY 139603|139603, LY|Atomoxetine HCl|Tomoxetine Hydrochloride, (+-)-isomer|Tomoxetine Hydrochloride, (-)-isomer"
D052244,CHEBI,Endocrine Disruptors,"Endocrine Disruptor|endocrine disruptor|endocrine disruptors|Disrupting Chemical, Endocrine|Endocrine Disrupting Chemicals|Disruptor Effects, Endocrine|Chemical, Endocrine Disrupting|Disruptor Effect, Endocrine|endocrine-disrupting chemicals|Endocrine Disruptor Effects|Disruptors, Endocrine|endocrine disrupting chemicals|Chemicals, Endocrine Disrupting|Effect, Endocrine Disruptor|Endocrine Disrupting Chemical|Disruptor, Endocrine|endocrine effects|Effects, Endocrine Disruptor|Endocrine Disruptor Effect"
NEW00401,CHEMICAL,dopamine auto,dopamine auto
D000547,CHEMICAL,Amantadine,"|Juventus, Amantadina|GenAmantadine|Mantadix|tregor|Hydrochloride, Amantadine|Symmetrel|Adekin|1 Aminoadamantane|Amantadine Sulfate|Amantadin neuraxpharm|Amantadina Llorente|Llorente, Amantadina|Sulfate, Amantadine|Gen Amantadine|PMSAmantadine|Stada, Amantadin|Infex|Aman|Amixx|PMS-Amantadine|1-Aminoadamantane|Amanta|Symadine|Amantadinneuraxpharm|Infecto-Flu|Midantan|AZU, Amantadin|Amantadine Hydrochloride|Gen-Amantadine|AmantaSulfateAZU|Adamantylamine|Amantadin AZU|Amantadinratiopharm|Amantadina Juventus|Amanta HCI AZU|Amantadin Stada|Viregyt|Infecto Flu|Amantadin ratiopharm|AL, Amantadin|Cerebramed|Amantadin-neuraxpharm|AmantaHCIAZU|Amantadin-ratiopharm|Endantadine|PMS Amantadine|Amanta Sulfate AZU|Wiregyt|Amantadin AL|Amanta-Sulfate-AZU|InfectoFlu|Amantadine|Amanta-HCI-AZU|amantadine"
D000070642,DISEASE,"Brain Injuries, Traumatic","Traumas, Brain|Brain Trauma|traumatic brain|TBI (Traumatic Brain Injury)|Brain Traumas|traumatic brain injury|Traumatic Brain Injury|Traumatic Encephalopathy|Trauma, Brain|Encephalopathies, Traumatic|TBI (Traumatic Brain Injuries)|TBIs (Traumatic Brain Injuries)|Traumatic Encephalopathies|Traumatic Brain Injuries|Encephalopathy, Traumatic|Traumatic brain injury|Injury, Brain, Traumatic|Brain Injury, Traumatic"
NEW00402,DISEASE,total body iron,total-body irradiated|TBI|total body iron
NEW00403,CHEMICAL,Intracellular amyloid β-protein,Intracellular amyloid β-protein
D010302,DISEASE,"Parkinson Disease, Secondary","|Secondary Vascular Parkinson Disease|Parkinson Disease|Parkinsonism, Secondary|parkinsonism|Parkinson disease|Secondary Parkinson Disease|Atherosclerotic Parkinsonism|secondary parkinsonism|Symptomatic Parkinson Disease|Parkinsonism, Atherosclerotic|Parkinsonism, Symptomatic|Parkinson Disease, Symptomatic|Secondary Parkinsonism|Symptomatic Parkinsonism|Parkinson Disease, Secondary Vascular"
D000318,CHEBI,Adrenergic beta-Agonists,"beta-Adrenergic Agonist|Agonists, beta-Adrenergic Receptor|Receptor Agonists, beta Adrenergic|beta-Agonists, Adrenergic|Receptor Agonist, beta-Adrenergic|beta-Agonist, Adrenergic|Adrenergic beta-Receptor Agonists|receptors agonists|beta-Receptor Agonists, Adrenergic|Agonists, beta-Adrenergic|beta-Adrenergic Receptor Agonist|Adrenergic beta Receptor Agonist|Agonist, Adrenergic beta-Receptor|Adrenergic beta-Receptor Agonist|Adrenergic beta-Agonist|Agonist, beta-Adrenergic|Receptor Agonists, beta-Adrenergic|beta Adrenergic Receptor Agonist|Agonists, Adrenergic beta-Receptor|Receptors Agonists, Adrenergic beta|beta Adrenergic Receptor Agonists|Betamimetics|beta-Adrenergic Agonists|beta-adrenergic agonist|beta-Receptor Agonist, Adrenergic|Adrenergic beta Receptor Agonists|Beta-adrenergic agonists|beta-Adrenergic Receptor Agonists|Adrenergic beta Agonists|beta Adrenergic Agonists|Agonist, beta-Adrenergic Receptor|receptor agonist|beta-adrenergic agonists|beta Adrenergic Agonist|Adrenergic beta Agonist"
NEW00404,CHEMICAL,A147E,HbCLP2|A147E
C096258,DISEASE,"ALTA1 protein, Alternaria alternata [Supplementary Concept]",Allergens|Alternaria alternata|Fungal Proteins
NEW00405,CHEBI,antifungal activity,antifungal activity
NEW00406,CHEMICAL,α(2)-adrenergic agonist,clonidine|α(2)-adrenergic agonist
D009357,MENTAL_HEALTH,Neonatal Abstinence Syndrome,"Syndromes, Neonatal Withdrawal|Neonatal Substance Withdrawal|Neonatal Abstinence Syndromes|Substance Withdrawal, Neonatal|Neonatal Substance Withdrawals|Syndromes, Neonatal Abstinence|Withdrawal Syndrome, Neonatal|neonatal abstinence syndrome|Addictions, Neonatal Passive|abstinence syndrome|Addiction, Neonatal Passive|Syndrome, Neonatal Abstinence|Neonatal abstinence syndrome|Neonatal Withdrawal Syndromes|Neonatal Withdrawal Syndrome|Abstinence Syndromes, Neonatal|Neonatal Passive Addiction|Passive Addictions, Neonatal|Neonatal Passive Addictions|Substance Withdrawals, Neonatal|Abstinence Syndrome, Neonatal|Withdrawal, Neonatal Substance|Passive Addiction, Neonatal|Withdrawal Syndromes, Neonatal|Syndrome, Neonatal Withdrawal"
NEW00407,CHEMICAL,Stellate ganglion block,SGB|Stellate ganglion block
NEW00408,DISEASE,new psychiatric disorders,new psychiatric disorders
D019161,CHEMICAL,Hydroxymethylglutaryl-CoA Reductase Inhibitors,"Inhibitors, HMG CoA Reductase|HMG CoA Reductase Inhibitor|HMG-CoA Reductase Inhibitor|Reductase Inhibitors, Hydroxymethylglutaryl-CoA|HMG-CoA Reductase Inhibitors|Reductase Inhibitors, HMG-CoA|Hydroxymethylglutaryl CoA Reductase Inhibitors|Hydroxymethylglutaryl CoA Reductase Inhibitor|Reductase Inhibitor, Hydroxymethylglutaryl-CoA|Statins, HMG CoA|HMG-CoA Statins|Inhibitors, Hydroxymethylglutaryl-CoA|Statins|Inhibitors, Hydroxymethylglutaryl Coenzyme A|Hydroxymethylglutaryl-CoA Reductase Inhibitor|Statin|Hydroxymethylglutaryl-Coenzyme A Inhibitors|Inhibitors, Hydroxymethylglutaryl CoA|statins|Hydroxymethylglutaryl-CoA Inhibitors|Inhibitors, HMG-CoA Reductase|Inhibitors, Hydroxymethylglutaryl-CoA Reductase|Inhibitors, Hydroxymethylglutaryl-Coenzyme A|Statins, HMG-CoA|HMG CoA Reductase Inhibitors"
D000077550,CHEMICAL,Ivabradine,"S162602|S 16260 2|S 16257|ivabradine|S-16257-2|S 162572|S-16260-2|S-16257|7,8-Dimethoxy-3-(3-(((4,5-dimethoxybenzocyclobutan-1-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-2H-benzazepin-2-one|S 16260-2|Corlanor|S162572|S 16257-2|S 16257 2|S16257|S 162602"
NEW00409,CHEBI,acting sympatholytics,acting sympatholytics
D002121,CHEMICAL,Calcium Channel Blockers,"|Exogenous Calcium Blockader|calcium channel|Channel Blocker, Calcium|calcium-channel blockers|Exogenous Calcium Inhibitors|Calcium Inhibitor, Exogenous|Calcium Inhibitors, Exogenous|Blockader, Exogenous Calcium|Calcium Blockader, Exogenous|calcium antagonists|Exogenous Calcium Antagonists|Exogenous Calcium Blockaders|Calcium channel blockers|Calcium Channel Antagonists|Calcium Channel Blocker|MeHg|Calcium Channel Blocking Drug|Channel Blockers, Calcium|Calcium Antagonists, Exogenous|Calcium Blockaders, Exogenous|exogenous|Blocker, Calcium Channel|Calcium antagonists|calcium channel antagonists|Blockers, Calcium Channel|Antagonists, Calcium Channel|Inhibitor, Exogenous Calcium|Exogenous Calcium Inhibitor|Calcium Channel Antagonist|Antagonists, Exogenous Calcium|calcium channel blockers|Calcium Channel Blocking Drugs|Channel Antagonist, Calcium|Antagonist, Calcium Channel|Calcium channel"
NEW00410,NUTRITION,alpha 2-adrenoceptor,alpha 2-adrenoceptor
D012735,MENTAL_HEALTH,"Sexual Dysfunction, Physiological","Physiological Sexual Dysfunction|physiological sexual dysfunction|Sexual dysfunction|Sex Disorders|Sexual Disorders, Physiological|Physiological Sexual Dysfunctions|Physiological Sexual Disorder|Sexual Disorder, Physiological|SD|sexual dysfunction|Physiological Sexual Disorders|Sexual Dysfunctions, Physiological"
NEW00411,CHEBI,beta-blocker,beta-blocker
D000806,CHEMICAL,Angiotensin-Converting Enzyme Inhibitors,"|Inhibitors, Angiotensin-Converting Enzyme|Kininase II Antagonists|Enzyme Inhibitors, Angiotensin-Converting|Angiotensin I Converting Enzyme Inhibitors|Kininase II Inhibitors|Angiotensin I-Converting Enzyme Inhibitors|Enzyme Antagonists, Angiotensin-Converting|ACE Inhibitor|ACE inhibitor|Angiotensin Converting Enzyme Inhibitor|Angiotensin Converting Enzyme Antagonists|Inhibitor, Kininase II|Kininase II Inhibitor|Inhibitors, ACE|Angiotensin I-Converting Enzyme Inhibitor|Inhibitors, Kininase II|ACE inhibitors|ACE Inhibitors|Angiotensin I Converting Enzyme Inhibitor|Angiotensin Converting Enzyme Inhibitors|Antagonists, Kininase II|Angiotensin-Converting Enzyme Antagonists|Antagonists, Angiotensin-Converting Enzyme|Inhibitor, Angiotensin-Converting Enzyme|Angiotensin converting enzyme|II Inhibitor, Kininase|Inhibitor, ACE|angiotensin converting enzyme|Antagonists, Angiotensin Converting Enzyme|Inhibitors, Angiotensin Converting Enzyme|Angiotensin-Converting Enzyme Inhibitor|Enzyme Inhibitor, Angiotensin-Converting"
NEW00412,DISEASE,concomitant congestive heart failure,concomitant congestive heart failure
NEW00413,DISEASE,hypertensive patient,hypertensive patient
NEW00414,CHEBI,Antiarrhythmic drug therapy,Antiarrhythmic drug therapy
C067192,CHEMICAL,ibutilide [Supplementary Concept],Sulfonamides|ibutilide
D054141,DISEASE,Ventricular Flutter,Ventricular Flutters|flutter
D014693,DISEASE,Ventricular Fibrillation,"|ventricular fibrillation|Fibrillation, Ventricular|Fibrillations, Ventricular|Ventricular Fibrillations|fibrillation"
D000638,CHEMICAL,Amiodarone,"|Aratac|Ortacrone|L3428|Amiodarona|Braxan|Amiobeta|Amiodarone Hydrochloride|Amiodarex|Kordaron|Amiohexal|Cordarex|L-3428|Cordarone|SKF 33134 A|Corbionax|Hydrochloride, Amiodarone|Rytmarone|amiodarone|Tachydaron|SKF 33134A|Amiodarone|L 3428|SKF 33134-A|Trangorex"
D001919,DISEASE,Bradycardia,|bradyarrhythmias|tachy- or bradycardia|Bradycardia|Bradyarrhythmia|Bradyarrhythmias|Bradycardias|bradycardia
NEW00415,CHEMICAL,class III/IA agents,class III/IA agents
D065666,DISEASE,Mesenteric Ischemia,"Nonocclusive Mesenteric Ischemia|Ischemia, Mesenteric|Occlusive Mesenteric Arterial Ischemia|Ischemias, Nonocclusive Mesenteric|Mesenteric Vascular Insufficiency|Nonocclusive Mesenteric Ischemias|Acute Mesenteric Arterial Thrombosis|Mesenteric Venous Thrombosis|Mesenteric Ischemias|Vascular Insufficiencies, Mesenteric|Venous Thromboses, Mesenteric|Venous Thrombosis, Mesenteric|Mesenteric Ischemias, Nonocclusive|Mesenteric Vascular Insufficiencies|Thrombosis, Mesenteric Venous|Ischemia, Nonocclusive Mesenteric|Insufficiencies, Mesenteric Vascular|Ischemias, Mesenteric|Acute Mesenteric Arterial Embolus|Mesenteric Ischemia, Nonocclusive|Mesenteric Venous Thromboses|Thromboses, Mesenteric Venous|Insufficiency, Mesenteric Vascular|ischemia|Vascular Insufficiency, Mesenteric"
NEW00416,DISEASE,impaired cell contact,impaired cell contact
NEW00417,DISEASE,de pointes,de pointes
D016171,DISEASE,Torsades de Pointes,"Pointes, Torsades de||Torsades de pointes|de Pointes, Torsade|de Pointes, Torsades|pointes|Pointes, Torsade de|Torsade de Pointes|torsade"
NEW00418,CHEMICAL,ongoing NIMV,ongoing NIMV
D010698,MENTAL_HEALTH,Phobic Disorders,"School Phobia|Claustrophobias|Phobias, School|Disorders, Phobic|Claustrophobia|Neuroses, Phobic|claustrophobia|Phobia|phobic disorder|Disorder, Phobic|Phobia, School|Phobias|School Phobias|Phobic Disorder|school phobia|phobias|Phobic Neuroses"
NEW00419,CHEBI,analgesic effects,analgesic effects
NEW00420,MENTAL_HEALTH,high anxiety,high anxiety
NEW00421,MENTAL_HEALTH,deafferentation syndromes,deafferentation syndromes
D014313,DISEASE,Trismus,"|Lockjaw|Spasm, Masseter Muscle|Spasm, Masseter|Muscle Spasms, Masseter|Masseter Muscle Spasm|muscle spasm|Masseter Spasm|masseter spasm|Masseter Spasms|Masseter Muscle Spasms|Spasms, Masseter|Muscle Spasm, Masseter|Spasms, Masseter Muscle|muscle spasms|Lock Jaw"
NEW00422,MENTAL_HEALTH,Perioperative anxiety,Perioperative anxiety
D000071257,MENTAL_HEALTH,Emergence Delirium,"Excitement, Emergence|emergence delirium|Excitement, Postanesthetic|Emergence Delirium, Anesthesia|Emergence agitation|emergence agitation|Agitated Emergence|Emergence Excitement|Emergence, Agitated|Postanesthetic Excitement|Delirium, Anesthesia Emergence|Agitation, Emergence|Agitations, Emergence|Emergence Agitation|Emergence delirium|Delirium, Emergence|Anesthesia Emergence Delirium"
NEW00423,CHEMICAL,desflurane anesthesia,desflurane anesthesia
D004414,MENTAL_HEALTH,Dyspareunia,|dyspareunia|Vulvar Vestibulitis|Dyspareunia|penile pain
NEW00424,DISEASE,breast cancer survivors,breast cancer survivors
NEW00425,CHEBI,low estrogen,low estrogen
NEW00426,DISEASE,introital pain,introital pain
NEW00427,DISEASE,pain patients,pain patients
NEW00428,MENTAL_HEALTH,greater analgesia,greater analgesia
D002188,CHEMICAL,Cannabis,"Hashish|Marihuana|Cannabis|Plant, Hemp|Bhang|Marijuana|Cannabi|Cannabis indica|Hashishs|Bhangs|Ganjas|Plants, Hemp|Hemp Plant|Cannabis sativa|cannabis|Ganja|Hemps|Hemp Plants|Hemp"
NEW00429,CHEMICAL,low dose oxycodone,low dose oxycodone
NEW00430,CHEMICAL,cannabis smokers =,cannabis smokers =
NEW00431,CHEMICAL,smoked cannabis,smoked cannabis
C072823,CHEMICAL,delta9-tetrahydrocannabinol hemisuccinate [Supplementary Concept],% Δ9 tetrahydrocannabinol|delta9-tetrahydrocannabinol|Dronabinol/analogs  and  derivatives|Δ9-tetrahydrocannabinol|delta9-THC|Δ9-THC
D013759,CHEMICAL,Dronabinol,"|Tetrahydrocannabinol, (6a-trans)-Isomer|Δ(9)-THC|delta(1)-Tetrahydrocannabinol|THC|dronabinol|Tetrahydrocannabinol, (6aR-cis)-Isomer|9 ene Tetrahydrocannabinol|delta 9-tetrahydrocannabinol|tetrahydrocannabinol|9-ene-Tetrahydrocannabinol|delta-9-THC|Tetrahydrocannabinol, Trans Isomer|Tetrahydrocannabinol, Trans-Isomer|Tetrahydrocannabinol, (6aS-cis)-Isomer|Tetrahydrocannabinol|Marinol|Delta(9)-THC|delta(9)-Tetrahydrocannabinol|Tetrahydrocannabinol, Trans-(+-)-Isomer|delta(9)-THC|delta(1)-THC|delta-9-tetrahydrocannabinol"
NEW00432,CHEMICAL,Terminalia ivorensis A. Chev,Terminalia ivorensis A. Chev
C014215,CHEMICAL,tetrahydropalmatine [Supplementary Concept],THP|Tetrahydropalmatine|Berberine Alkaloids
D020258,DISEASE,Neurotoxicity Syndromes,"|Neurotoxin Disorders|Nervous System Poisoning|Encephalitis, Toxic|Neurotoxicity Syndrome|Nervous System Poisonings|Encephalopathies, Toxic|Neurotoxin Disease|Syndromes, Neurotoxicity|Toxic Encephalopathies|Neurotoxicity|Syndrome, Neurotoxicity|Encephalitides, Toxic|Poisonings, Nervous System|Neurotoxin Diseases|neurotoxicity|neurotoxic|Neurotoxic Disorders|Poisoning, Nervous System|Toxic Encephalopathy|Neurotoxin Disorder|Encephalopathy, Toxic|Toxic Encephalitis|Toxic Encephalitides|Neurotoxic Disorder"
NEW00433,CHEMICAL,tyrosine kinase receptor B (TrkB)/calmodulin,tyrosine kinase receptor B (TrkB)/calmodulin
NEW00434,DISEASE,MA-induced neurotoxicity,MA-induced neurotoxicity
NEW00435,DISEASE,neurotoxic diseases related,neurotoxic diseases related
NEW00436,CHEBI,potential therapeutic drug,potential therapeutic drug
D015667,CHEMICAL,Acupuncture Analgesia,"Analgesia, Acupuncture|Acupuncture Anesthesia|acupuncture anesthesia|AA|acupuncture analgesia|Anesthesia, Acupuncture"
NEW00437,CHEBI,better analgesic effect,better analgesic effect
D020927,CHEMICAL,Dexmedetomidine,"|MPV-1440|Dexmedetomidine|MPV1440|Dexmedetomidine Hydrochloride|Hydrochloride, Dexmedetomidine|Dex|Precedex|MPV 1440|dexmedetomidine"
D000068882,CHEMICAL,Paliperidone Palmitate,"3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one|9-Hydroxy-risperidone|R76477|R-76477|9-Hydroxyrisperidone|Paliperidone|Sustenna, Invega|PP|Invega|paliperidone palmitate|Palmitate|9-OH-risperidone|9 OH risperidone|paliperidone|Invega Sustenna|9 Hydroxy risperidone|9 Hydroxyrisperidone|palmitate|Palmitate, Paliperidone|R 76477"
D011618,MENTAL_HEALTH,Psychotic Disorders,"|Disorder, Schizophreniform|psychosis|Brief Reactive Psychosis|Disorders, Schizoaffective|Brief Reactive Psychoses|Schizoaffective Disorder|Reactive Psychoses, Brief|Disorders, Psychotic|reactive psychosis|Psychoses|Schizophreniform Disorder|Reactive Psychosis, Brief|Schizoaffective Disorders|Disorder, Schizoaffective|Psychosis, Brief Reactive|schizoaffective disorders|schizoaffective disorder|Schizophreniform Disorders|Disorders, Schizophreniform|brief reactive psychosis|Disorder, Psychotic|Psychotic Disorder|Psychoses, Brief Reactive|Psychosis|schizoaffective|schizophreniform disorder"
NEW00438,CHEBI,mood stabilizers,mood stabilizers
NEW00439,CHEBI,pain analgesic consumption,pain analgesic consumption
NEW00440,CHEMICAL,thiocyanoacetamide,thiocyanoacetamide
D000379,MENTAL_HEALTH,Agoraphobia,agoraphobia|Agoraphobias
NEW00441,CHEBI,Analgesic activity,Analgesic activity
NEW00442,DISEASE,rodent aphthous ulcer pain,rodent aphthous ulcer pain
C052509,CHEMICAL,bulleyaconitine A [Supplementary Concept],BAA|Aconitine/analogs  and  derivatives|Bulleyaconitine A
NEW00443,CHEMICAL,aconitine analog,aconitine analog
D009437,DISEASE,Neuralgia,"|Neuralgias, Supraorbital|Stump Neuralgia|Neurodynia|Pains, Nerve|Neuralgias, Ilioinguinal|Atypical Neuralgias|Iliohypogastric Nerve Neuralgia|Ilioinguinal Neuralgia|Nerve Pain|Neuralgia, Vidian|Pain, Neuropathic|Nerve Pains, Paroxysmal|Neurodynias|Supraorbital Neuralgia|Vidian Neuralgias|Supraorbital Neuralgias|Neuralgia, Perineal|Neuropathic pain|Neuralgias, Iliohypogastric Nerve|Paroxysmal Nerve Pain|Perineal Neuralgia|Neuralgia, Supraorbital|Stump Neuralgias|Nerve Neuralgias, Iliohypogastric|Neuropathic Pain|Neuralgias|Neuralgia, Iliohypogastric Nerve|Pains, Paroxysmal Nerve|Perineal Neuralgias|Nerve Neuralgia, Iliohypogastric|Neuropathic Pains|Neuralgias, Vidian|Neuralgias, Perineal|Atypical Neuralgia|Neuralgias, Atypical|Pain, Paroxysmal Nerve|Iliohypogastric Nerve Neuralgias|Neuralgia, Stump|Nerve Pains|Nerve Pain, Paroxysmal|Neuralgia, Atypical|Vidian Neuralgia|Ilioinguinal Neuralgias|Neuralgia, Ilioinguinal|Paroxysmal Nerve Pains|Pains, Neuropathic|Pain, Nerve|Neuralgias, Stump|neuropathic pain"
D059265,DISEASE,Visceral Pain,"Pain, Visceral|Pains, Visceral|visceral pain|Visceral Pains"
NEW00444,DISEASE,significant antivisceral pain effect,significant antivisceral pain effect
NEW00445,DISEASE,chronic visceral pain,chronic visceral pain
NEW00446,MENTAL_HEALTH,heterotypic intermittent chronic stress protocol,heterotypic intermittent chronic stress protocol
NEW00447,CHEMICAL,"2,4,6-trinitrobenzene sulfonic acid","2,4,6-trinitrobenzene sulfonic acid"
NEW00448,DISEASE,antivisceral pain mechanism,antivisceral pain mechanism
NEW00449,DISEASE,marked pain effects,marked pain effects
NEW00450,CHEBI,analgesic armamentarium,analgesic armamentarium
NEW00451,DISEASE,comorbid psychiatric condition,comorbid psychiatric condition
D020918,DISEASE,Complex Regional Pain Syndromes,"CRPS (Complex Regional Pain Syndromes)|Pain Syndromes, Regional Complex|Complex Regional Pain Syndrome|pain syndromes|regional pain syndromes"
NEW00452,CHEMICAL,natural diallyl disulfide,natural diallyl disulfide
NEW00453,DISEASE,chronic osteoarthritic pain,chronic osteoarthritic pain
NEW00454,DISEASE,associated strength deficits,associated strength deficits
C028009,CHEMICAL,diallyl disulfide [Supplementary Concept],Disulfides|Allyl Compounds|Diallyl disulfide|DADS|diallyl disulfide
NEW00455,CHEMICAL,GYY4137 slow-releasing H2S donors,GYY4137 slow-releasing H2S donors
NEW00456,CHEMICAL,slow-releasing H2S donors,slow-releasing H2S donors
C529376,CHEMICAL,GYY 4137 [Supplementary Concept],Organothiophosphorus Compounds|GYY4137|Morpholines
C412584,CHEMICAL,DADS-C12 [Supplementary Concept],diallyl disulfide|DADS|Benzenesulfonates
NEW00457,CHEMICAL,H2S donors,H2S donors
NEW00458,CHEMICAL,Kv7 potassium channels,Kv7 potassium channels
D020950,CHEMICAL,Vitex,"Vitex agnus castus|VAC|Chastetrees|Chasteberry Tree|Vitex agnus-castus|Chasteberry|Trees, Chasteberry|Tree, Chasteberry|Chaste Tree|Trees, Chaste|Chasteberries|Chasteberry Trees|Chaste Trees|chaste tree|Chastetree|Tree, Chaste|Vitex rotundifolia"
D020078,DISEASE,Neurogenic Inflammation,"inflammation|Inflammation|neurogenic inflammation|Neurogenic inflammation|Neurogenic Inflammations|Inflammation, Neurogenic|Inflammations, Neurogenic"
D059373,DISEASE,Mastodynia,"|mastalgia|Breast Pain|Pain, Breast|mastodynia|Pains, Breast|Mastalgias|Mammalgia|Mastalgia|Mastodynia|Mammalgias|Mastodynias|Breast Pains|breast pain"
NEW00459,CHEBI,analgesic efficacy,analgesic efficacy
NEW00460,DISEASE,acute pain conditions,acute pain conditions
D017116,DISEASE,Low Back Pain,"|back pain|Backaches, Low|Back Pain, Lower|Backache, Low|Pain, Lower Back|Back Ache, Low|Aches, Low Back|Low Back Pains|Low Backaches|Ache, Low Back|Low Back Aches|Pains, Lower Back|Low Back Pain, Posterior Compartment|Recurrent Low Back Pain|low back pain|Back Aches, Low|Pains, Low Back|Postural Low Back Pain|Back Pain, Low|Lumbago|Lower Back Pains|Low Back Pain, Recurrent|Back Pains, Lower|Lower Back Pain|Low Back Ache|Mechanical Low Back Pain|Back Pains, Low|Low Back Pain, Mechanical|Low Back Pain, Postural|Low Backache|Pain, Low Back"
D004361,CHEBI,Drug Tolerance,"drug tolerance|Drug Tolerances|Tolerance, Drug|Tolerances, Drug"
D026881,DISEASE,Acupuncture,Acupuncture|acupuncture|Pharmacopuncture
NEW00461,CHEBI,its's analgesic effect,its's analgesic effect
NEW00462,MENTAL_HEALTH,Anxiety conditions,Anxiety conditions
NEW00463,CHEMICAL,α2-AR modulation,α2-AR modulation
NEW00464,CHEMICAL,IDAZ,IDAZ
NEW00465,CHEMICAL,NA p    2C-AR antagonism,NA p    2C-AR antagonism
NEW00466,CHEBI,selective α2C-AR antagonists,selective α2C-AR antagonists
D000068099,DISEASE,Trauma and Stressor Related Disorders,stress-related disorders|Trauma and Stress Related Disorders
D002185,CHEMICAL,Cannabidiol,"Cannabidiol|CBD|1,3-Benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)-|cannabidiol|Epidiolex"
NEW00467,DISEASE,gastrointestinal damage,gastrointestinal damage
NEW00468,DISEASE,traumatic skeletal injuries,traumatic skeletal injuries
D006992,DISEASE,"Hypnosis, Dental","Hypnoses, Dental|Dental Hypnosis|Hypnosis|Dental Hypnoses"
NEW00469,DISEASE,needle-related procedural pain,needle-related procedural pain
D012128,DISEASE,Respiratory Distress Syndrome,"Acute Respiratory Distress Syndrome|ARDS, Human|Respiratory Distress Syndrome|respiratory distress syndrome|Human ARDS|ARDS|Distress Syndromes, Respiratory|Respiratory Distress Syndrome, Pediatric|Distress Syndrome, Respiratory|Respiratory Distress Syndromes|Respiratory Distress Syndrome, Adult|distress|Shock Lung|Syndrome, Respiratory Distress|Lung, Shock|Pediatric Respiratory Distress Syndrome|Adult Respiratory Distress Syndrome|acute respiratory distress syndrome|Respiratory Distress Syndrome, Acute"
D055770,MENTAL_HEALTH,Interpleural Analgesia,"analgesia|Analgesia, Intrapleural|Interpleural Analgesias|Analgesias, Interpleural|Intrapleural Analgesia|Analgesia|Analgesia, Interpleural"
NEW00470,CHEBI,adjunct analgesic therapies,adjunct analgesic therapies
NEW00471,MENTAL_HEALTH,Butorphanol's postoperative analgesia,Butorphanol's postoperative analgesia
NEW00472,DISEASE,postoperative respiratory depression,postoperative respiratory depression
NEW00473,MENTAL_HEALTH,postoperative intravenous analgesia,postoperative intravenous analgesia
D002077,CHEMICAL,Butorphanol,"BC 2627|Dolorex|Apo-Butorphanol|Stadol NS|butorphanol|17-(Cyclobutylmethyl)morphinan-3,14-diol|Beforal|Stadol|BC2627|Butorphanol Tartrate|Moradol|BC-2627|Torbugesic"
D048949,DISEASE,Labor Pain,"labor pain|Pain, Obstetric|Pain, Labor|labor|Obstetric Pain"
NEW00474,CHEMICAL,Medium concentration,Medium concentration
C068615,CHEMICAL,paracetamol sulfotransferase [Supplementary Concept],acetaminophen|Sulfotransferases|Paracetamol|paracetamol
NEW00475,CHEMICAL,N-acetyl-p-benzo-quinone-imine,N-acetyl-p-benzo-quinone-imine
NEW00476,DISEASE,hepatic toxicity threshold,hepatic toxicity threshold
D051549,CHEMICAL,Glutathione S-Transferase pi,"GST Class phi|Transferase P1-1, Glutathione|Glutathione S Transferase pi|GSTP1 Glutathione D Transferase|D-Transferase, GSTP1 Glutathione|GSTP1 Glutathione D-Transferase|Class-phi, GST|GSH|Glutathione Transferase P1 1|Glutathione D-Transferase, GSTP1|Glutathione|Glutathione Transferase P1-1|glutathione|GST Class-phi"
NEW00477,DISEASE,liver damage,liver damage
D010146,DISEASE,Pain,"|Crushing Pain|Physical Suffering|Suffering, Physical|pain|Sufferings, Physical|Pains, Migratory|Pain, Crushing|Pains, Radiating|Splitting Pains|Pain, Burning|Burning Pain|physical pain|Pains, Burning|Aches|Migratory Pain|Burning Pains|Physical Sufferings|Migratory Pains|Pain, Splitting|Splitting Pain|Pains, Splitting|Crushing Pains|Pains, Crushing|Ache|Radiating Pains|Pain, Migratory|Radiating Pain|Pain, Radiating"
NEW00478,CHEBI,non-medical analgesic use,non-medical analgesic use
D016739,DISEASE,"Behavior, Addictive","addictive behavior|Behaviors, Addictive|Addictive Behavior|Addictive Behaviors|addictive behaviors"
NEW00479,CHEBI,analgesic medication,analgesic medication
NEW00480,MENTAL_HEALTH,Anxiety scores,Anxiety scores
D014653,DISEASE,Vascular Headaches,"Vascular Headache|Cephalgias, Vascular|Headache, Vascular|Vascular Cephalgia|Headaches, Vascular|Vascular Cephalgias|headaches|Cephalgia, Vascular|Headaches"
NEW00481,DISEASE,overall functional impairment,overall functional impairment
NEW00482,MENTAL_HEALTH,headache frequency,headache frequency
NEW00483,DISEASE,CBTs,CBTs
C499681,CHEMICAL,Ralfinamide [Supplementary Concept],Ralfinamide|Fluorobenzenes
NEW00484,DISEASE,stimulus-evoked chronic pain,stimulus-evoked chronic pain
NEW00485,CHEBI,analgesic effect,analgesic effect
D012652,DISEASE,Self Mutilation,"Behavior, Self Mutilating|Autotomy Human|self-mutilation|autotomy|Self Mutilating Behavior|Self Mutilating Behaviors|Autotomy Humans|Mutilation, Self|Mutilating Behavior, Self"
NEW00486,DISEASE,pain-related behavior,pain-related behavior
NEW00487,DISEASE,Nav1.8,Nav1.8
NEW00488,CHEMICAL,NMDA receptor antagonism,NMDA receptor antagonism
NEW00489,CHEMICAL,Cav2.2 channels,Cav2.2 channels
D000071739,CHEMICAL,Calcium Release Activated Calcium Channels,"CRAC Channel|Calcium Release Activated Calcium Channel|calcium|Channel, CRAC|CRAC Channels|Calcium Release-Activated Channels|Calcium Release-Activated Calcium Channels|Calcium Release Activated Channels|Ca++|Ca|Calcium|Ca2"
NEW00490,CHEMICAL,male sex hormone,male sex hormone|testosterone
D012739,CHEMICAL,Gonadal Steroid Hormones,"Steroid Hormones, Sex|Hormones, Gonadal Steroid|Sex Hormones|Steroid Hormone, Sex|Hormone, Sex|Hormone, Gonadal Steroid|Steroid Hormone, Gonadal|steroid hormones|Sex steroid hormones|sex hormones|gonadal steroid hormone|Steroid Hormones, Gonadal|gonadal steroid hormones|Sex Hormone|gonadal steroid|steroid hormone|Sex Steroid Hormone|sex-steroid hormones|Sex Steroid Hormones|Hormone, Sex Steroid|sex steroid hormones|Gonadal Steroid Hormone|Sex hormones|Hormones, Sex Steroid"
D001520,DISEASE,Behavior and Behavior Mechanisms,BE|behavior|BLE|Behavior And Behavior Mechanism
D020222,DISEASE,Abducens Nerve Injury,"Sixth-Nerve Palsies, Traumatic|Sixth-Nerve Traumas|Traumatic Abducens Neuropathies|Traumatic Abducens Neuropathy|Nerve Injury, Abducens|Sixth-Nerve Palsy, Traumatic|Nerve Trauma, Abducens|Abducens Nerve Traumas|Trauma, Sixth-Nerve|Traumas, Abducens Nerve|Sixth Cranial Nerve Injury|Injury, Cranial Nerve VI|Sixth Nerve Trauma|Traumas, Sixth-Nerve|Nerve Injuries, Abducens|Traumatic Sixth-Nerve Palsy|Injuries, Abducens Nerve|Injury, Sixth Cranial Nerve|Abducens Nerve Trauma|Cranial Nerve VI Injury|Injury, Abducens Nerve|Traumatic Sixth Nerve Palsy|Abducens Neuropathy, Traumatic|Traumatic Sixth-Nerve Palsies|Abducens Nerve Injuries|Abducens Neuropathies, Traumatic|Sixth-Nerve Trauma|Trauma, Abducens Nerve|Nerve Traumas, Abducens|nerve injury|Sixth Cranial Nerve Injuries|Sixth Nerve Palsy, Traumatic"
D022603,CHEBI,Shiga Toxins,"Vero Cell Cytotoxins|Cytotoxin, Vero Cell|Toxins, Shiga|toxins|Cytotoxins, Vero Cell|Cytoxins, Vero|Toxin, Vero|Toxins, Vero|Vero Cell Cytotoxin|Verotoxins|Vero Cytotoxin|Vero Cytoxins|Shiga Like Toxins|Verotoxin|Toxins, Shiga-Like|Cytotoxin, Vero|Shiga-Like Toxins|Vero Toxins|Toxins|Shiga toxins|Vero Toxin|Cell Cytotoxins, Vero"
NEW00491,CHEMICAL,analgesic/antipyretic acetaminophen,analgesic/antipyretic acetaminophen
NEW00492,CHEBI,Stress-induced weak androgens,Stress-induced weak androgens
NEW00493,CHEMICAL,mature GABA,mature GABA
NEW00494,CHEBI,estrogen depletion,estrogen depletion
NEW00495,DISEASE,hyperexcitability,hyperexcitability
NEW00496,CHEMICAL,insufficient maternal oxytocin,insufficient maternal oxytocin
D000067877,MENTAL_HEALTH,Autism Spectrum Disorder,"autistic spectrum|Disorder, Autistic Spectrum|ASD|Autism|autism-spectrum disorder|ASDs|Autistic Spectrum Disorder|Autistic Spectrum Disorders|Autism spectrum disorder|Autism Spectrum Disorders|autism spectrum disorder|Autism Spectrum|Autism Spectrum Disorder|autism|autism spectrum disorders"
D000072861,MENTAL_HEALTH,"Phobia, Social","phobia|Social Anxiety Disorder|social anxiety|Social Phobia|gSAD|Social Anxiety Disorders|Social Phobias|Disorders, Social Anxiety|social anxiety disorder|Disorder, Social Anxiety|Phobia|Anxiety Disorders, Social|Phobias, Social|Anxiety Disorder, Social|social phobias|social phobia"
NEW00497,DISEASE,white matter asymmetry,white matter asymmetry
NEW00498,DISEASE,diabetic peripheral neuropathy,diabetic peripheral neuropathy
D051474,DISEASE,"Neuralgia, Postherpetic",Postherpetic Neuralgia|PHN|postherpetic neuralgia|Postherpetic neuralgia
NEW00499,CHEMICAL,pregabalin administration,pregabalin administration
NEW00500,DISEASE,chronic heart failure decompensation,chronic heart failure decompensation
NEW00501,CHEBI,analgesic properties,analgesic properties
NEW00502,DISEASE,intractable pruritus,intractable pruritus
NEW00503,CHEMICAL,certain antidepressants,certain antidepressants
NEW00504,CHEMICAL,methadone maintenance treatment,methadone maintenance treatment
D000082002,DISEASE,Sexual Trauma,"sexual abuse|Trauma, Sexual Abuse|Abuse Trauma, Sexual|Sexual Traumas|Traumas, Sexual Abuse|Traumas, Sexual|Abuse Traumas, Sexual|Sexual Abuse Trauma|Sexual Abuse Traumas|Trauma, Sexual"
NEW00505,DISEASE,pain indices,pain indices
D011963,CHEMICAL,"Receptors, GABA-A","GABA receptors|GABA-A Receptor delta Subunit|Muscimol Receptors|GABA-A Receptor beta Subunit|Benzodiazepine-GABA Receptor|GABA A Receptor alpha Subunit|GABA Benzodiazepine Receptors|GABA A Receptors|Receptors, GABA Benzodiazepine|gamma Aminobutyric Acid Subtype A Receptors|Receptors, Benzodiazepine|Receptors, Diazepam|GABA(A) Receptor|Muscimol Receptor|Receptors, GABA-Benzodiazepine|Receptor, Benzodiazepine|Receptor, GABA-A|GABA-A Receptor epsilon Subunit|GABA-A Receptor alpha Subunit|benzodiazepine receptors|benzodiazepine receptor|GABA-A Receptors|epsilon Subunit, GABA-A Receptor|delta Subunit, GABA A Receptor|GABA A Receptor beta Subunit|Benzodiazepine Receptors|Receptors, Benzodiazepine GABA|GABA-Benzodiazepine Receptors|GABA A Receptor|GABA-A Receptor|Receptors, Muscimol|Benzodiazepine-Gaba Receptors|delta Subunit, GABA-A Receptor|Benzodiazepine Receptor|GABA-A Receptor gamma Subunit|Receptors, GABA A|Diazepam Receptor|benzodiazepine|Receptor, Muscimol|Receptors, Benzodiazepine-GABA|Diazepam Receptors|epsilon Subunit, GABA A Receptor|Receptor, Benzodiazepine-GABA|GABA Benzodiazepine Receptor|Benzodiazepine Gaba Receptors|GABA-Benzodiazepine Receptor|GABA A Receptor epsilon Subunit|GABA A Receptor delta Subunit|GABA-A Receptor rho Subunit|GABA A Receptor gamma Subunit|gamma-Aminobutyric Acid Subtype A Receptors|Receptor, GABA-Benzodiazepine|Benzodiazepine GABA Receptor|Receptor, Diazepam|GABA A Receptor rho Subunit"
NEW00506,DISEASE,higher pain thresholds,higher pain thresholds
D000077274,DISEASE,Nasopharyngeal Carcinoma,"Carcinomas, Nasopharyngeal|Carcinoma, Nasopharyngeal|nasopharyngeal carcinoma|Nasopharyngeal Carcinomas"
D059248,CHEMICAL,Chemoradiotherapy,"Concurrent Radiochemotherapy|Concurrent Chemoradiotherapies|chemoradiotherapy|Radiochemotherapy, Concomitant|Chemoradiotherapies, Concurrent|Chemoradiotherapies|Concomitant Chemoradiotherapies|Concomitant Radiochemotherapy|Chemoradiotherapy, Concurrent|Concurrent Chemoradiotherapy|Radiochemotherapies|Chemoradiotherapy, Synchronous|Concomitant Chemoradiotherapy|Chemoradiotherapy, Concomitant|concurrent chemoradiotherapy|Radiochemotherapy|Concomitant Radiochemotherapies|Chemoradiotherapies, Concomitant|Radiochemotherapy, Concurrent|Concurrent Radiochemotherapies|Synchronous Chemoradiotherapy|Radiochemotherapies, Concurrent|Radiochemotherapies, Concomitant|Chemoradiotherapies, Synchronous|Synchronous Chemoradiotherapies"
NEW00507,CHEBI,central acting analgesic,central acting analgesic
NEW00508,CHEMICAL,paracetamol poisoning,paracetamol poisoning
NEW00509,DISEASE,subsequent psychiatric disorder,subsequent psychiatric disorder
D018021,NUTRITION,Lithium Chloride,"|Li+|Lithium|Chloride, Lithium|Lithium Chloride|Li|lithium|Lithium chloride|lithium chloride|LiCl"
NEW00510,DISEASE,classic bipolar disorders,classic bipolar disorders
D000077213,CHEMICAL,Lamotrigine,"Labileno|BW 430C|BW430C|BW-430C|Crisomet|Lamiktal|Lamotrigine|3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine|Lamictal|lamotrigine|3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine"
D001714,MENTAL_HEALTH,Bipolar Disorder,"|affective psychosis|Bipolar Disorder|Bipolar Disorders|Manic Depressive Psychosis|Manic Depression|Depression, Bipolar|bipolar mood disorder|manic depression|Psychoses, Bipolar Affective|Disorder, Manic|bipolar disorders|bipolar disorder|Disorder, Bipolar|Depressions, Manic|manic|Psychoses, Manic Depressive|Manic Disorder|Disorder, Bipolar Mood|mania|Bipolar Mood Disorder|BDs|Psychosis, Manic Depressive|bipolar mood disorders|BPD|Manic-Depressive Psychosis|Manic Disorders|bipolar depression|Depression, Manic|Bipolar Affective Psychosis|Affective Psychosis, Bipolar|Psychosis, Manic-Depressive|Psychosis, Bipolar Affective|Psychoses, Manic-Depressive|Bipolar Depression|Bipolar disorder|Bipolar Mood Disorders|Mood Disorder, Bipolar"
NEW00511,DISEASE,treatment-refractory rapid cycling,treatment-refractory rapid cycling
NEW00512,MENTAL_HEALTH,bipolar disorder patients,bipolar disorder patients
D000078305,CHEMICAL,Zonisamide,"zonisamide|3-Sulfamoylmethyl-1,2-benzisoxazole|CI912|3 Sulfamoylmethyl 1,2 benzisoxazole|AD-810|Zonegran|AD 810|CI 912|Zonisamide|CI-912|Zonisamide Monosodium|AD810"
D015431,DISEASE,Weight Loss,"|Reductions, Weight|Losses, Weight|weight loss|Weight Reductions|Weight loss|Weight Reduction|Loss, Weight|Reduction, Weight|Weight Losses|% weight loss"
D000077236,CHEMICAL,Topiramate,"Topamax|Topiramate|Epitomax|2,3-4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|McN-4853|USL255|McN4853|McN 4853|topiramate"
D066229,MENTAL_HEALTH,Speech Sound Disorder,"Disorder|GD|disorder|Disorder, Speech Sound|Speech Sound Disorders|Disorders, Phonological|Phonological Disorder|Disorder, Phonological|Phonological Disorders|Disorders, Speech Sound"
NEW00513,MENTAL_HEALTH,bulimia alcohol dependence,bulimia alcohol dependence
D000078330,CHEMICAL,Oxcarbazepine,"oxcarbazepine|Oxcarbazepine|Timox|10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide|Trileptal|GP 47680"
NEW00514,MENTAL_HEALTH,acute mania,acute mania
NEW00515,CHEMICAL,DA receptor blocker,haloperidol|DA receptor blocker
D010672,CHEMICAL,Phenytoin,"Phenhydan|Dihydan|Fenitoin|Hydantol||Dilantin|Diphenylhydantoinate, Sodium|Antisacer|5,5-Diphenylhydantoin|phenytoin|Phenytoin|Epamin|Sodium Diphenylhydantoinate|Diphenylhydantoin|Difenin|Phenytoin Sodium|diphenylhydantoin|Epanutin|5,5-diphenylimidazolidine-2,4-dione"
NEW00516,MENTAL_HEALTH,adjunctive mania efficacy,adjunctive mania efficacy
NEW00517,DISEASE,thermal pain threshold,thermal pain threshold
NEW00518,CHEBI,bee venom acupuncture,bee venom acupuncture
D013119,DISEASE,Spinal Cord Injuries,"Contusions, Spinal Cord|Spinal Cord Laceration|Cord Trauma, Spinal|Transection, Spinal Cord|Spinal Cord Injury|Spinal Cord Traumas|Cord Injuries, Spinal|Spinal Cord Transections|Cord Transections, Spinal|Contusion, Spinal Cord|Trauma, Spinal Cord|Cord Injury, Spinal|Cord Contusion, Spinal|Cord Traumas, Spinal|Transections, Spinal Cord|Myelopathies, Post-Traumatic|Spinal Cord Transection|Cord Contusions, Spinal|Spinal cord injury|Spinal Cord Lacerations|Injuries, Spinal Cord|Cord Lacerations, Spinal|Cord Transection, Spinal|Spinal Cord Contusion|Traumas, Spinal Cord|Traumatic Myelopathies|spinal cord injury|Spinal Cord Trauma|Injury, Spinal Cord|Post-Traumatic Myelopathy|Post-Traumatic Myelopathies|Post Traumatic Myelopathy|Myelopathies, Traumatic|Cord Laceration, Spinal|Myelopathy, Traumatic|Spinal Cord Contusions|spinal cord myelopathy|Myelopathy, Post-Traumatic|Traumatic Myelopathy|Laceration, Spinal Cord|Lacerations, Spinal Cord"
D054580,DISEASE,National Institute of Arthritis and Musculoskeletal and Skin Diseases (U.S.),arthritis|NIAMS|skin diseases|National Institute of Arthritis and Musculoskeletal and Skin Diseases
D008167,DISEASE,Lumpy skin disease virus,Neethling Virus|skin disease|lumpy skin disease
C535531,DISEASE,Intervertebral disc disease [Supplementary Concept],intervertebral disc disease|Intervertebral Disc Displacement|Intervertebral Disc Degeneration
D059352,DISEASE,Musculoskeletal Pain,"|Pain, Musculoskeletal|Musculoskeletal Pains|Pains, Musculoskeletal|musculoskeletal pain"
D020800,CHEMICAL,"Receptor, Nerve Growth Factor","Receptor, NGF|p75, Neurotrophin Receptor|GP80-LNGFR|p75 Neurotrophin Receptor|NGFR, gp75|NGFR Protein|p75, Neurotropin Receptor|gp75 NGFR|Neurotropin|GP80 LNGFR|Neurotropin Receptor p75|NGF Receptor|Neurotrophin Receptor p75|Receptor, p75 Neurotrophin|Nerve Growth Factor Receptor p75|Receptor p75, Neurotropin|Neurotrophin Receptor, p75|Nerve Growth Factor Receptor, Low Affinity|NTP|Receptor p75, Neurotrophin|Nerve Growth Factor Receptor, Low-Affinity"
NEW00519,CHEMICAL,cannabis plant,Cannabis sativa|cannabis plant
D017387,CHEBI,Investigational New Drug Application,new drug|Investigational New Drug Applications|Drug application
D060426,CHEMICAL,Anti-N-Methyl-D-Aspartate Receptor Encephalitis,"N-methyl-D-aspartate receptor|anti-N-methyl-D-aspartate receptor|Anti-NMDAR Encephalitis, Non-paraneoplastic|N-Methyl-D-aspartate receptor|Non-paraneoplastic Anti-NMDAR Encephalitides|Encephalitis, Non-paraneoplastic Anti-NMDAR|Anti-NMDA Receptor Encephalitides|Non-paraneoplastic Anti-NMDA Receptor Encephalitis|NMDA receptor|Encephalitides, Anti-NMDAR|anti-NMDAR encephalitis|N-methyl-d-aspartate receptor|Anti N Methyl D Aspartate Receptor Encephalitis|Encephalitis, Anti-NMDAR|Anti NMDA Receptor Encephalitis|Anti-NMDAR Encephalitis|Encephalitides, Paraneoplastic Anti-NMDAR|N -methyl- D -aspartate receptor|Non paraneoplastic Anti N Methyl D Aspartate Receptor Encephalitis|Paraneoplastic Anti NMDAR Encephalitis|Paraneoplastic Anti NMDA Receptor Encephalitis|Non paraneoplastic Anti NMDAR Encephalitis|Encephalitis, Paraneoplastic Anti-NMDAR|Paraneoplastic Anti-NMDAR Encephalitides|Non-paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis|aspartate|Anti-N-Methyl-D-Aspartate Receptor Encephalitides|Receptor Encephalitis, Anti-NMDA|Paraneoplastic Anti-NMDAR Encephalitis|Encephalitis, Anti-N-Methyl-D-Aspartate Receptor|Encephalitides, Anti-N-Methyl-D-Aspartate Receptor|Anti NMDAR Encephalitis|Anti-NMDAR Encephalitides|encephalitis|Anti-NMDA Receptor Encephalitis|anti-N-methyl-D-aspartate receptor encephalitis|Encephalitides, Non-paraneoplastic Anti-NMDAR|Encephalitides, Anti-NMDA Receptor|Paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis|Paraneoplastic Anti N Methyl D Aspartate Receptor Encephalitis|Non-paraneoplastic Anti-NMDAR Encephalitis|Anti-NMDAR Encephalitides, Non-paraneoplastic|Anti-NMDAR Encephalitis, Paraneoplastic|Receptor Encephalitides, Anti-NMDA|Non paraneoplastic Anti NMDA Receptor Encephalitis|Anti-NMDAR Encephalitides, Paraneoplastic|Encephalitis, Anti-NMDA Receptor|Paraneoplastic Anti-NMDA Receptor Encephalitis"
NEW00520,CHEMICAL,cannabinoid receptor type 1,cannabinoid receptor type 1|CB1Rs
NEW00521,DISEASE,psychotic symptoms,psychotic symptoms
D066246,CHEMICAL,ErbB Receptors,"Receptor, TGF alpha|Receptors, Epidermal Growth Factor Urogastrone|Epidermal Growth Factor Receptor Family Protein|c-ErbB-1 Protein, Proto-oncogene|Receptor, Urogastrone|erbB-1 Proto-Oncogene Protein|TGF-alpha Receptor|Receptor, ErbB|Receptor, Epidermal Growth Factor|Proto oncogene c ErbB 1 Protein|ErbB-1 Receptor|c erbB 1 Protein|Epidermal Growth Factor Receptor|Receptors, Epidermal Growth Factor-Urogastrone|erbB 1 Proto Oncogene Protein|Proto-oncogene c-ErbB-1 Protein|Receptor, ErbB 1|ErbB Receptor|Receptors, Epidermal Growth Factor|HER Family Receptors|Family Receptors, HER|NMDARs|Receptor, Transforming-Growth Factor alpha|Epidermal Growth Factor Receptor Kinase|Receptors, ErbB|Receptor, EGF|Epidermal Growth Factor Receptor Protein-Tyrosine Kinase|Receptor, TGF-alpha|Transforming Growth Factor alpha Receptor|Family Receptor, HER|EGF Receptor|EGF Receptors|Receptor, HER Family|HER Family Receptor|Urogastrone Receptor|c-erbB-1 Protein|Receptor Tyrosine protein Kinase erbB 1|Epidermal Growth Factor Receptor Family Proteins|Epidermal Growth Factor Receptor Protein Tyrosine Kinase|Receptor, ErbB-1|receptors|Receptors, EGF|Receptors, HER Family|Proto-Oncogene Protein, erbB-1|Receptor, Transforming Growth Factor alpha|Receptor Tyrosine-protein Kinase erbB-1"
NEW00522,CHEBI,Noncompetitive N-methyl-d-aspartate receptor antagonists,Noncompetitive N-methyl-d-aspartate receptor antagonists
NEW00523,CHEMICAL,NMDA receptor signaling,NMDA receptor signaling
D059350,DISEASE,Chronic Pain,"Pain, Widespread Chronic|Pains, Widespread Chronic|Widespread Chronic Pain|chronic pain|Chronic Pains, Widespread|Pain, Chronic|Widespread Chronic Pains|Chronic Pains|Pains, Chronic|Chronic pain|Chronic Pain, Widespread"
D052248,CHEMICAL,Nitric Oxide Synthase Type I,"NCNOS Enzyme|Nitric Oxide Synthase, Type I|neuronal nitric oxide synthase|Neuronal Nitric Oxide Synthase|neuronal nitric oxide|Neural Constitutive Nitric Oxide Synthase|NOS1 Protein|nNOS Enzyme"
C546030,CHEMICAL,"2-((1H-benzo(d)(1,2,3)triazol-5-ylamino)methyl)-4,6-dichlorophenol [Supplementary Concept]",IC87201|Triazoles|Chlorophenols
NEW00524,DISEASE,2A pain behavior,2A pain behavior
NEW00525,CHEMICAL,Elevated N-methyl-D-aspartate receptor activity,Elevated N-methyl-D-aspartate receptor activity
NEW00526,CHEBI,glycine site agonists,glycine site agonists
NEW00527,CHEMICAL,chronic high-dose glycine nutritional supplementation,chronic high-dose glycine nutritional supplementation
NEW00528,CHEMICAL,preliminary D-serine trial,preliminary D-serine trial
NEW00529,DISEASE,excitotoxic damage,excitotoxic damage
NEW00530,DISEASE,antipsychotic-induced parkinsonian symptoms,antipsychotic-induced parkinsonian symptoms
NEW00531,DISEASE,Anti-N-methyl-D-aspartate receptor NMDAR encephalitis patients,Anti-N-methyl-D-aspartate receptor NMDAR encephalitis patients
D009069,DISEASE,Movement Disorders,|Status Marmoratus|Movement Disorder|Parkinson disability|Movement Disorder Syndrome|Dyskinesia Syndromes|movement disorders|Dyskinesia Syndrome|Movement Disorder Syndromes|Etat Marbre
NEW00532,DISEASE,glutamate/NMDAR system dysfunction,glutamate/NMDAR system dysfunction
NEW00533,CHEBI,drug withdrawal syndrome,drug withdrawal syndrome
NEW00534,CHEBI,NMDAR antagonists,NMDAR antagonists
NEW00535,DISEASE,near-death experiences,near-death experiences
NEW00536,CHEBI,human carriers,human carriers
NEW00537,CHEMICAL,glutamate signals,glutamate signals
NEW00538,DISEASE,stress-induced depressive-like behavior,stress-induced depressive-like behavior
NEW00539,CHEBI,NMDAR1-AB carriers,NMDAR1-AB carriers
NEW00540,DISEASE,depression/anxiety,depression/anxiety
NEW00541,CHEMICAL,Intravenous ketamine,Intravenous ketamine
NEW00542,DISEASE,severe neuropathic pain,severe neuropathic pain
NEW00543,CHEBI,Oral N-methyl-D-aspartate receptor antagonists,Oral N-methyl-D-aspartate receptor antagonists
NEW00544,CHEMICAL,ketamine infusions,ketamine infusions
D018710,DISEASE,Pain Clinics,"Services, Acute Pain|Multidisciplinary Pain Centers|Acute Pain Service|Clinic, Pain|Pain Center, Multidisciplinary|Multidisciplinary Pain Center|Multidisciplinary Pain Clinics|Pain Clinics, Multidisciplinary|Clinics, Multidisciplinary Pain|Pain Services, Acute|Clinics, Pain|Centers, Pain|Units, Pain Relief|Clinic, Multidisciplinary Pain|Pain Centers|Service, Acute Pain|Centers, Multidisciplinary Pain|pain relief|Center, Multidisciplinary Pain|Multidisciplinary Pain Clinic|Pain Clinic, Multidisciplinary|Pain Service, Acute|Acute Pain Services|Pain Relief Unit|Pain Centers, Multidisciplinary|Unit, Pain Relief|Pain Clinic|Pain Center|Pain Relief Units|Center, Pain"
D008559,CHEMICAL,Memantine,"Memantine Hydrochloride|Namenda|Axura|memantine|D 145|Memantine|D-145|Ebixa|1-Amino-3,5-dimethyladamantane|D145|1,3-Dimethyl-5-aminoadamantane|Memantin"
NEW00545,CHEMICAL,intravenous ketamine,intravenous ketamine
NEW00546,CHEMICAL,oral dextromethorphan,oral dextromethorphan
NEW00547,CHEMICAL,psychotomimetic effects,psychotomimetic effects
NEW00548,DISEASE,functional heterogeneity,functional heterogeneity
NEW00549,DISEASE,cortical microcircuit,cortical microcircuit
NEW00550,CHEMICAL,D-serine effects,D-serine effects
NEW00551,MENTAL_HEALTH,established schizophrenia,established schizophrenia
NEW00552,CHEBI,N-methyl-D-aspartate NMDA receptor NMDAR antagonists,N-methyl-D-aspartate NMDA receptor NMDAR antagonists
D061218,MENTAL_HEALTH,"Depressive Disorder, Treatment-Resistant","treatment-resistant depression|therapy-resistant depressions|TRD|Refractory Depressions|Therapy-Resistant Depressions|Refractory Depression|Depression, Therapy-Resistant|Resistant Depressions, Treatment|Disorder, Treatment-Resistant Depressive|Disorders, Treatment-Resistant Depressive|Depressive Disorder, Treatment Resistant|Depressions, Treatment Resistant|Depressions, Therapy-Resistant|Therapy Resistant Depression|depression therapy|Depressive Disorders, Treatment-Resistant|Depressions, Refractory|depressions|resistant depression|Treatment Resistant Depressions|refractory depression|Treatment Resistant Depression|Resistant Depression, Treatment|Depression, Treatment Resistant|depressive disorder|Therapy-Resistant Depression|Treatment-Resistant Depressive Disorders|Depression, Refractory|depressive|Depressive disorders|depressive disorders|Treatment-Resistant Depressive Disorder"
NEW00553,DISEASE,such treatment-resistant depressed patients,TRD|such treatment-resistant depressed patients
D009609,CHEMICAL,Nitrous Oxide,"Gas, Laughing|Oxide, Nitrous|Nitrogen Protoxide|Laughing Gas|nitrous oxide|Nitrous oxide"
NEW00554,DISEASE,ill TRD patients,ill TRD patients
NEW00555,CHEMICAL,NRG2 KOs,NRG2 KOs
NEW00556,CHEMICAL,dopamine dysbalance,dopamine dysbalance
NEW00557,CHEMICAL,higher extracellular dopamine levels,higher extracellular dopamine levels
D019969,CHEMICAL,Amphetamine-Related Disorders,"Abuse, Amphetamine|amphetamine|Amphetamine Addiction|Disorders, Amphetamine-Related|AMPH|Addiction, Amphetamine|amphetamine dependence|Amphetamine Related Disorders|Disorder, Amphetamine-Related|Amphetamine Dependence|Dependence, Amphetamine|Amphetamine Abuse|amphetamine abuse|Amphetamine"
D063926,DISEASE,Drug Hypersensitivity Syndrome,"Syndrome, Drug Hypersensitivity|Syndromes, Drug Hypersensitivity|Hypersensitivity Syndromes, Drug|Drug Reaction with Eosinophilia and Systemic Symptoms|Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome|hypersensitivity|Drug Reaction With Eosinophilia And Systemic Symptom|DRESS Syndromes|Drug Hypersensitivity Syndromes|Hypersensitivity Syndrome, Drug|DRESS Syndrome"
NEW00558,CHEMICAL,GABA(A)-BZD receptor formation,GABA(A)-BZD receptor formation
NEW00559,DISEASE,cocaine-related behavioral disturbances,cocaine-related behavioral disturbances
NEW00560,CHEBI,Low serum vitamin D levels,Low serum vitamin D levels
NEW00561,MENTAL_HEALTH,schizophrenia studies,schizophrenia studies
NEW00562,DISEASE,ovarian cancer cells,ovarian cancer cells
NEW00563,DISEASE,ovarian tumor tissues,ovarian tumor tissues
NEW00564,DISEASE,tumor tissue arrays,tumor tissue arrays
NEW00565,DISEASE,serous EOC,serous EOC
NEW00566,DISEASE,abdominal tumor burden,abdominal tumor burden
D017114,DISEASE,"Liver Failure, Acute","|Fulminating Liver Failures|Hepatic Failure, Fulminant|Fulminant Liver Failures|Hepatic Failure, Acute|Acute liver failure|Failure, Acute Liver|Fulminating Liver Failure|Hepatic Failure, Fulminating|Acute Liver Failure|Fulminating Hepatic Failures|ALF|Fulminant Hepatic Failures|acute liver failure|Acute Hepatic Failure|Failure, Acute Hepatic|Fulminating Hepatic Failure|Fulminant Liver Failure|Liver Failure, Fulminating|Fulminant Hepatic Failure|Liver Failure, Fulminant"
NEW00567,CHEMICAL,high-energy phosphor-nucleotides,high-energy phosphor-nucleotides
NEW00568,CHEMICAL,glycolysis pentose phosphate pathways,glycolysis pentose phosphate pathways
C028921,CHEMICAL,hypotaurine aminotransferase [Supplementary Concept],Transaminases|hypotaurine
D019803,CHEMICAL,Glutathione Disulfide,"|glutathione disulfide|Disulfide, Glutathione|oxidized glutathione|disulfide|Oxidized glutathione|GSSG|Glutathione Disulfide, Ion(1-)|Oxidized Glutathione|Glutathione, Oxidized"
D013654,CHEMICAL,Taurine,"Tauphon|Taurine Hydrochloride|Taurine|Taufon|Taurine, Monopotassium Salt|taurine|Taurine Zinc Salt (2:1)"
C104722,CHEMICAL,"glutamate receptor ionotropic, AMPA 2 [Supplementary Concept]","GluA2|Receptors, AMPA"
NEW00569,CHEMICAL,TREML2 rs3747742,TREML2 rs3747742
NEW00570,CHEMICAL,CSF total-tau levels,CSF total-tau levels
NEW00571,CHEMICAL,memantine treatment group,memantine treatment group
NEW00572,DISEASE,Severe Impairment Battery,Severe Impairment Battery
D019695,CHEMICAL,Glycyrrhizic Acid,"Acid, Glycyrrhizic|Zinc Glycyrrhizate|glycyrrhizic acid|Glycyrrhizin|Diammonium Glycyrrhizinate|Glycyrrhizic Acid|Glycyrrhizate, Zinc|Glycyrrhizinic Acid|Acid, Glycyrrhizinic|Glycyrrhizinate, Diammonium|Glycyrrhizinate, Dipotassium|Dipotassium Glycyrrhizinate"
NEW00573,CHEMICAL,scopolamine-induced cognitive impairment,scopolamine-induced cognitive impairment
D029882,CHEMICAL,Glycyrrhiza uralensis,"zaos, Gan|Gan caos|Gan cao|Glycyrrhiza uralensis|Gan zaos|Glycyrrhiza uralenses|Licorice, Chinese|Gan zao|cao, Gan|Chinese Licorice|Chinese Licorices|uralenses, Glycyrrhiza|Licorices, Chinese"
NEW00574,CHEBI,AhR antagonist,AhR antagonist
NEW00575,DISEASE,AOAH-deficient depressive phenotype,AOAH-deficient depressive phenotype
D020845,CHEBI,Selective Estrogen Receptor Modulators,"Estrogen Receptor Modulators, Selective|selective estrogen receptor modulator|Selective Estrogen Receptor Modulator|Selective estrogen receptor modulators|Estrogen Receptor Modulator, Selective|Selective Estrogen Receptor|SERM|SERMs"
NEW00576,DISEASE,clinical psychiatric practice,clinical psychiatric practice
NEW00577,CHEBI,ongoing estrogen deficiency,ongoing estrogen deficiency
D012753,MENTAL_HEALTH,Shared Paranoid Disorder,"Disorders, Shared Psychotic|Disorders, Shared Paranoid|Paranoid Disorder, Shared|Disorder, Shared Paranoid|Folie a Trois|Shared Paranoid Disorders|Shared Psychotic Disorders|psychotic disorder|Disorder, Shared Psychotic|paranoid|Shared Psychotic Disorder|Folie a Deux|Paranoid Disorders, Shared|Psychotic Disorders, Shared|Psychotic Disorder, Shared"
NEW00578,MENTAL_HEALTH,substance-induced psychotic disorder secondary,substance-induced psychotic disorder secondary
NEW00579,CHEBI,cumulative estrogen exposure,cumulative estrogen exposure
NEW00580,MENTAL_HEALTH,new psychotic disorder,new psychotic disorder
D012110,CHEMICAL,Reserpine,|V-Serp|V Serp|reserpine|Raupasil|Serpasil|Rausedil|Reserpine|Raunervil|Serpivite|Rausedyl
NEW00581,DISEASE,involuntary oral movements,involuntary oral movements
NEW00582,DISEASE,progressive catalepsy,progressive catalepsy
NEW00583,CHEBI,Estrogen levels,Estrogen levels
NEW00584,DISEASE,catalepsy duration,catalepsy duration
NEW00585,CHEMICAL,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model","1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model"
NEW00586,CHEMICAL,"neurotoxins 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","neurotoxins 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|MPTP"
NEW00587,DISEASE,subtle sexually-dimorphic impairments,subtle sexually-dimorphic impairments
NEW00588,CHEMICAL,physiological estradiol,physiological estradiol
NEW00589,MENTAL_HEALTH,stress-related memory disorders,stress-related memory disorders
NEW00590,CHEMICAL,circulating estradiol,circulating estradiol
NEW00591,DISEASE,HTLV scores,HTLV scores
D002318,DISEASE,Cardiovascular Diseases,"|Cardiovascular diseases|sinuatrial disease|cardiovascular diseases|Diseases, Cardiovascular|Cardiovascular Disease|Disease, Cardiovascular"
NEW00592,CHEBI,hormone therapy,hormone therapy
D008569,MENTAL_HEALTH,Memory Disorders,"|memory deficit|Memory Disorders, Age-Related|age-related memory disorders|Memory Disorder, Semantic|Semantic Memory Disorder|memory disorders|Cognitive Retention Disorder|Age-Related Memory Disorders|Age-Related Memory Disorder|Cognitive Retention Disorders|Age Related Memory Disorders|Memory Disorders, Age Related|Memory Disorders, Spatial|impaired immediate free recall|Memory Disorder, Age-Related|Spatial Memory Disorders|Memory Losses|Retention Disorders, Cognitive|Spatial Memory Disorder|Retention Disorder, Cognitive|Memory Deficit|Memory Disorders, Semantic|Semantic Memory Disorders|Deficits, Memory|Memory Disorder, Spatial|Memory Disorder|memory deficits|Deficit, Memory|Memory Deficits|Memory Loss"
NEW00593,CHEBI,estrogen level,estrogen level
D010572,DISEASE,"Pest Control, Biological","Biological Pest Controls|Pest Controls, Biologic|Pest Control, Biologic|Pest Controls, Biological|controls|Biological Pest Control|TD|Biologic Pest Control|Biologic Pest Controls"
D000071057,MENTAL_HEALTH,Tardive Dyskinesia,"Dyskinesia, Tardive|tardive dyskinesia|tardive dystonia|Tardive dystonia|Dystonia, Tardive|Dystonias, Tardive|Tardive Dystonias|Dyskinesias, Tardive|Tardive Dystonia|Tardive Dyskinesias|Tardive dyskinesia"
NEW00594,DISEASE,extrapyramidal motor disorders,extrapyramidal motor disorders
D000067531,CHEMICAL,Alarmins,Danger Associated Molecular Pattern Molecules|Damage-Associated Molecular Pattern Molecules|Alarmin Proteins|Alarmin|Damage Associated Molecular Pattern Molecules|alarmins|Danger-Associated Molecular Pattern Molecules
NEW00595,DISEASE,sterile brain inflammation,sterile brain inflammation
NEW00596,CHEMICAL,gonadal steroids,gonadal steroids
NEW00597,CHEBI,estrogen research,estrogen research
NEW00598,CHEMICAL,melatonin concentrations related,melatonin concentrations related
NEW00599,DISEASE,mood vasomotor symptoms,mood vasomotor symptoms
D011372,CHEBI,Progestins,"Effect, Gestagen|Progestin Effects|progestogen|progestin|Agent, Gestagenic|Compound, Progestational|Agent, Progestational|Progestational Agent|Progestational Compounds|Progestin|Progestagenic Agent|Gestagenic Agent|Effects, Progestogen|Progestational Compound|gestagens|Effects, Progestin|Progestogen Effect|Gestagen Effect|Progestin Effect|Progestational Agents|Progestogens|Gestagenic Agents|Effect, Progestin|Progestagen|Progestins|Gestagen Effects|Progestagenic Agents|Effect, Gestagenic|Progestational Hormone|Effects, Gestagen|Progestogen Effects|Gestagen|Gestagenic Effects|Gestagens|Hormone, Progestational|Progestagens|Progestational Hormones|Progestogen|Effects, Gestagenic|Gestagenic Effect|Effect, Progestogen|Agent, Progestagenic"
NEW00600,DISEASE,vascular occlusion disturbances,stroke|vascular occlusion disturbances
D002309,DISEASE,Cardiology,"Cardiovascular Disease Specialty|Medicine, Vascular|Disease Specialty, Cardiovascular|cardiovascular disease|Angiology|CVD|Vascular Medicine|Specialty, Cardiovascular Disease|Cardiovascular disease"
NEW00601,DISEASE,cognitive improvements,cognitive improvements
NEW00602,CHEMICAL,adjunctive raloxifene treatment,adjunctive raloxifene treatment
NEW00603,CHEMICAL,thirteen-week,thirteen-week
NEW00604,CHEMICAL,oral adjunctive raloxifene treatment,oral adjunctive raloxifene treatment
D016574,MENTAL_HEALTH,Seasonal Affective Disorder,"SAD|Mood Disorder, Seasonal|Seasonal affective disorder|seasonal affective disorder|Depression, Winter|mood disorder|Seasonal Mood Disorders|Seasonal mood|winter depression|Affective Disorder, Seasonal|Disorder, Seasonal Affective|Seasonal Affective Disorders|Winter Depression|Seasonal Mood Disorder|affective disorder|Disorder, Seasonal Mood"
D000081227,CHEMICAL,Neurosteroids,"Neuro-Steroids|Neuro-Steroid|Neuro Steroid|Neuroactive steroids|Neuroactive Steroids|Steroid, Neuroactive|Neurosteroids|Neuro Steroids|Neuroactive Steroid|Neurosteroid"
NEW00605,CHEMICAL,hormones testosterone,hormones testosterone
NEW00606,MENTAL_HEALTH,major depression,major depression
NEW00607,DISEASE,MAO-A VT,MAO-A VT
NEW00608,CHEBI,ovariectomy-reduced hormones,ovariectomy-reduced hormones
NEW00609,MENTAL_HEALTH,depression symptom scores,depression symptom scores
D045166,CHEMICAL,Estradiol Congeners,"Synthetic Estrogens|Estrogen Analog|estradiol|Estrogens, Synthetic|Analogues, Estrogen|Estrogen Analogue|Synthetic Estrogen|Estradiol Congener|Analog, Estrogen|Analogue, Estrogen|Estrogen, Synthetic|Analogs, Estrogen|Estrogen Analogs|Estrogen Analogues|Estradiol|Congener, Estradiol"
NEW00610,MENTAL_HEALTH,Postmenopausal depression,Postmenopausal depression
NEW00611,CHEBI,ovarian hormones,ovarian hormones
NEW00612,DISEASE,depression-like behavior,depression-like behavior
C105482,CHEMICAL,allergen Bla g 1 [Supplementary Concept],G-1|Allergens
NEW00613,CHEBI,GPER agonist,GPER agonist
C549840,CHEMICAL,"gper1 protein, zebrafish [Supplementary Concept]","G protein-coupled estrogen receptor|Receptors, G-Protein-Coupled|GPER|Zebrafish Proteins"
NEW00614,MENTAL_HEALTH,estrogen deficiency-related affective disorders,estrogen deficiency-related affective disorders
D012004,DISEASE,Rectal Neoplasms,"Cancer, Rectum|Rectal Neoplasm|Rectum Neoplasm|Rectal Tumors|Rectum Cancer|rectal cancer|Rectum Cancers|Cancer of the Rectum|Neoplasm, Rectal|Rectal Tumor|Cancer, Rectal|Cancer of Rectum|Neoplasms, Rectal|Tumor, Rectal|Rectal Cancers|Rectum Neoplasms|Neoplasm, Rectum|Rectal Cancer"
NEW00615,MENTAL_HEALTH,postoperative sexual dysfunction,postoperative sexual dysfunction
NEW00616,CHEBI,Gender affirming hormone therapy,Gender affirming hormone therapy
D000068116,MENTAL_HEALTH,Gender Dysphoria,"Gender Identity Disorders|gender identity disorder|gender dysphoria|Gender Identity Disorder|Identity Disorder, Gender|Disorder, Gender Identity|dysphoria"
NEW00617,DISEASE,Cholestasis indices,Cholestasis indices
NEW00618,CHEBI,synthetic hormone therapy,synthetic hormone therapy
C489843,DISEASE,"Map3k8 protein, mouse [Supplementary Concept]",Tumor progression|MAP Kinase Kinase Kinases|Proto-Oncogene Proteins|tumor progression
D019337,DISEASE,Hematologic Neoplasms,"Malignancy, Hematological|Hematopoietic Malignancies|Hematopoietic Neoplasm|Neoplasm, Hematopoietic|Malignancies, Hematologic|malignancies|Hematologic Neoplasm|Malignancy, Hematologic|Neoplasm, Hematological|hematologic malignancies|Hematological Neoplasm|hematological malignancies|Neoplasms, Hematological|Malignancies, Hematological|malignancy|Neoplasms, Hematologic|Hematological Neoplasms|Hematological Malignancies|Neoplasm, Hematologic|Hematologic Malignancy|Hematopoietic Malignancy|Hematologic Malignancies|Hematological Malignancy|Malignancies, Hematopoietic|Neoplasms, Hematopoietic|Hematopoietic Neoplasms|Malignancy, Hematopoietic"
NEW00619,DISEASE,BPD symptom exacerbations,BPD symptom exacerbations
D001883,DISEASE,Borderline Personality Disorder,"Disorders, Borderline Personality|borderline personality disorder|BPD|Personality Disorder, Borderline|Personality Disorders, Borderline|borderline personality disorders|Disorder, Borderline Personality|Borderline Personality Disorders|Borderline Personality Disorder|Borderline personality disorder"
NEW00620,CHEMICAL,neuropeptide oxytocin,neuropeptide oxytocin
NEW00621,DISEASE,affiliative behaviors,affiliative behaviors
NEW00622,CHEMICAL,Oxytocin levels,Oxytocin levels
NEW00623,DISEASE,aggressive behavior,aggressive behavior
D041722,MENTAL_HEALTH,"Genes, Transgenic, Suicide","Apoptosis-Inducing Transgenes|suicide|Transgene, Suicide|Genes, Transduced Suicide|Transduced Suicide Genes|Suicide Gene, Transduced|Transgenic Suicide Gene|Suicide Transgene|Transgenic Apoptosis-Inducing Gene|Apoptosis-Inducing Genes, Transgenic|Genes, Transgenic Suicide|Transgenic Suicide Genes|Suicide Genes, Transgenic|Transgene, Apoptosis-Inducing|Transgenic Apoptosis-Inducing Genes|Gene, Transgenic Apoptosis-Inducing|Gene, Transgenic Suicide|Apoptosis-Inducing Transgene|Suicide Genes, Transduced|Suicide Transgenes|Transgenes, Suicide|Transduced Suicide Gene|Genes, Suicide, Metabolic, Transgenic|Genes, Transgenic Apoptosis Inducing|Transgenic Metabolic Suicide Genes|Apoptosis-Inducing Gene, Transgenic|Genes, Transgenic Apoptosis-Inducing|Transgenes, Apoptosis-Inducing|Apoptosis Inducing Transgenes|Suicide Gene, Transgenic|suicide gene|Gene, Transduced Suicide|Suicide"
NEW00624,CHEMICAL,oxytocin system,oxytocin system
NEW00625,CHEMICAL,oxytocin concentrations,oxytocin concentrations
NEW00626,DISEASE,childhood traumata,childhood traumata
NEW00627,CHEMICAL,plasma oxytocin,plasma oxytocin
D000076783,DISEASE,Adverse Childhood Experiences,"Stresses, Early-Life|traumatic experience|Trauma, Childhood|Stresses, Early Life|Childhood Experience, Traumatic|Childhood Trauma|Childhood Experiences, Adverse|Experiences, Traumatic Childhood|Adolescent Traumas|Early Life Stress|Stress, Early Life|Adverse Childhood Experience|Childhood Experience, Adverse|Trauma, Adolescent|childhood trauma|Life Stress, Early|Adolescent Trauma|Childhood Traumas|Early-Life Stresses|Early-Life Stress|Traumas, Adolescent|Experience, Traumatic Childhood|Traumatic Childhood Experiences|Life Stresses, Early|Traumatic Childhood Experience|Childhood Experiences, Traumatic|Early Life Stresses|Traumas, Childhood|Stress, Early-Life"
NEW00628,DISEASE,suicidal behaviors,suicidal behaviors
NEW00629,NUTRITION,estrogen receptor alpha gene variants,estrogen receptor alpha gene variants
NEW00630,DISEASE,anger- behaviors,anger- behaviors
NEW00631,CHEBI,estrogen levels,estrogen levels
NEW00632,CHEMICAL,θ-band,p<0.01|θ-band
NEW00633,DISEASE,BPD symptoms,BPD symptoms
NEW00634,DISEASE,residual psychotic symptoms,residual psychotic symptoms
NEW00635,CHEMICAL,saturated HFD,saturated HFD
NEW00636,CHEBI,plasma estrogen,plasma estrogen
NEW00637,CHEMICAL,HFDs,HFDs
NEW00638,DISEASE,metabolic impairments,metabolic impairments
NEW00639,CHEMICAL,Various antidepressants,Various antidepressants
D019314,CHEMICAL,Dehydroepiandrosterone Sulfate,"Sulfate, DHEA|DHEA Sulfate|DHEA-S|DHA Sulfate|Sulfate, Prasterone|DHEAS|Prasterone Sulfate|Dehydroisoandrosterone Sulfate|Dehydroepiandrosterone|Sulfate, Dehydroepiandrosterone|dehydroepiandrosterone|Sulfate, Dehydroisoandrosterone|DHEA|Sulfate, DHA|dehydroepiandrosterone sulfate"
NEW00640,DISEASE,depression-like behaviors,depression-like behaviors
NEW00641,CHEMICAL,sex steroids,sex steroids
D011085,DISEASE,Polycystic Ovary Syndrome,"Ovary, Sclerocystic|Syndrome, Stein-Leventhal|Sclerocystic Ovarian Degeneration|Polycystic Ovary Syndrome 1|Ovarian Degeneration, Sclerocystic|PCOS|Sclerocystic Ovaries|Polycystic Ovarian Syndrome|Syndrome, Polycystic Ovary|Sclerocystic Ovary|Sclerocystic Ovary Syndrome|polycystic ovarian syndrome|Ovarian Syndrome, Polycystic|Polycystic Ovary Syndrome|Stein-Leventhal Syndrome|polycystic ovary syndrome|Polycystic ovary syndrome|Ovary Syndrome, Polycystic|Stein Leventhal Syndrome"
NEW00642,CHEBI,abnormal hormone levels,abnormal hormone levels
NEW00643,CHEMICAL,melatonin regulation,melatonin regulation
NEW00644,CHEBI,androgen production,androgen production
NEW00645,DISEASE,antioxidative damage,antioxidative damage
NEW00646,CHEMICAL,peptides growth hormone-releasing hormone,peptides growth hormone-releasing hormone|GHRH
D000324,CHEBI,Adrenocorticotropic Hormone,"|Adrenocorticotropin|Corticotropin|adrenocorticotrophic hormone|1-39 ACTH|Hormone, Adrenocorticotrophic|ACTH (1-39)|adrenocorticotropic hormone|ACTH|Hormone, Adrenocorticotropic|Corticotropin (1-39)|Corticotrophin (1-39)|Adrenocorticotrophic Hormone|Corticotrophin|Adrenocorticotropic hormone"
D000172,CHEBI,Acromegaly,"|Somatotropin Hypersecretion Syndromes (Acromegaly)|Inappropriate GH Secretion Syndrome (Acromegaly)|Syndromes, Somatotropin Hypersecretion (Acromegaly)|Somatotropin Hypersecretion Syndrome (Acromegaly)|acromegaly|Hypersecretion Syndrome, Somatotropin (Acromegaly)|Growth hormone secretion|Syndrome, Somatotropin Hypersecretion (Acromegaly)|growth hormone secretion|Hypersecretion Syndromes, Somatotropin (Acromegaly)|Acromegaly|Inappropriate Growth Hormone Secretion Syndrome (Acromegaly)"
D042782,CHEMICAL,"Estrogenic Steroids, Alkylated",steroids|Steroids|Alkylated Estrogenic Steroids|Alkyl Estrogenic Steroids
D047748,DISEASE,Pituitary ACTH Hypersecretion,"ACTH Hypersecretion, Pituitary|Inappropriate Adrenocorticotropic Hormone Secretion|Pituitary Cushing Diseases|Cushing's disease|Cushing's Disease|hypercortisolism|Pituitary-Dependant Hypercortisolism Disorders|Pituitary Dependant Cushing Syndrome|Pituitary-Dependant Hypercortisolism Disorder|Cushing Diseases, Pituitary|Hypersecretion, Pituitary ACTH|Pituitary Cushing Syndrome|Pituitary Cushing Disease|Pituitary Dependant Hypercortisolism Disorder|Cushing Disease|Pituitary-Dependant Hypercortisolisms|Hypercortisolism Disorder, Pituitary-Dependant|Hypercortisolism, Pituitary-Dependant|Cushing Syndrome, Pituitary|Cushing Syndrome, Pituitary-Dependant|Cushing Disease, Pituitary|Disease, Cushing|Pituitary Dependant Hypercortisolism|Pituitary-Dependant Cushing Syndrome|Adrenocorticotropic Hormone, Inappropriate Secretion|Inappropriate ACTH Secretion Syndrome|Pituitary-Dependant Hypercortisolism|adrenocorticotropic hormone secretion"
D004393,DISEASE,"Dwarfism, Pituitary","Isolated Somatotropin Deficiency|Hypophysial Dwarf|Isolated Human Growth Hormone Deficiency|Pituitary Nanism|Nanism, Pituitary|Pituitary Dwarfism|Isolated Growth Hormone Deficiency|Pituitary Dwarf|GH deficiency|Isolated HGH Deficiency|Growth Hormone Deficiency Dwarfism|Hyposomatotrophic Dwarfism|Isolated GH Deficiency|Dwarfism, Growth Hormone Deficiency|Isolated Somatotropin Deficiency Disorder|dwarfism"
D020181,MENTAL_HEALTH,"Sleep Apnea, Obstructive","Sleep Apnea Hypopnea Syndrome||Obstructive sleep apnea syndrome|Apneas, Obstructive Sleep|Sleep Apnea Syndrome, Obstructive|Apnea, Obstructive Sleep|Obstructive Sleep Apnea|Syndrome, Sleep Apnea, Obstructive|Syndrome, Obstructive Sleep Apnea|Upper Airway Resistance Sleep Apnea Syndrome|Sleep Apneas, Obstructive|Obstructive sleep apnea|Obstructive Sleep Apneas|Obstructive Sleep Apnea Syndrome|OSAHS|obstructive sleep apnea syndrome|obstructive sleep apnea|OSA|OSAS|Syndrome, Upper Airway Resistance, Sleep Apnea|sleep apnea syndrome"
D020208,DISEASE,"Brain Injury, Chronic","Brain Injuries, Chronic|Chronic Brain Injuries|Chronic Brain Injury|brain injury"
NEW00647,DISEASE,drug-induced benign pituitary tumor,prolactinoma|drug-induced benign pituitary tumor
D016884,DISEASE,"Polyendocrinopathies, Autoimmune","Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy|APS Type 1|Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy, Autoimmune|Autoimmune Polyglandular Syndrome, Type 1|Autoimmune Polyglandular Syndrome Type III|Deficiency, AIRE|Autoimmune Polyglandular Syndrome, Type I|Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal-Dystrophy|Autoimmune Polyendocrinopathy with Candidiasis and Ectodermal Dystrophy|APECED|Polyglandular Type III Autoimmune Syndrome|AIRE Deficiency|Autoimmune Syndrome Type II, Polyglandular|Polyglandular Autoimmune Syndrome, Type I|Autoimmune Polyglandular Syndrome Type II|Autoimmune Polyendocrinopathy|Autoimmune Polyendocrine Syndrome, Type 2|Syndrome, Schmidt's|Polyendocrinopathy Candidiasis Ectodermal Dystrophy, Autoimmune|Addison's disease|Polyendocrine Autoimmune Syndrome, Type II|Polyglandular Type II Autoimmune Syndrome|Polyglandular Type I Autoimmune Syndrome|Autoimmune Polyglandular Syndrome Type I|Autoimmune Polyglandular Syndrome, Type 3|Autoimmune Polyendocrinopathy Syndrome Type 1|Polyendocrinopathy-Candidiasis-Ectodermal-Dystrophy, Autoimmune|Syndrome, Schmidt|Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy|Polyglandular Autoimmune Syndrome, Type 1|Polyendocrinopathy, Autoimmune|AIRE Deficiencies|Diabetes Mellitus, Addison Disease, Myxedema|autoimmune syndrome|Polyglandular Autoimmune Syndrome, Type 3|Polyglandular Autoimmune Syndrome, Type 2|Diabetes Mellitus, Addison's Disease, Myxedema|Autoimmune Syndrome Type I, Polyglandular|Multiple Endocrine Deficiency Syndrome, Type 2|Polyglandular Deficiency Syndrome, Type 2|Autoimmune Polyendocrine Syndrome, Type II|Schmidt Syndrome|Autoimmune Syndrome Type III, Polyglandular|Schmidt's Syndrome"
NEW00648,CHEBI,corticotropin-releasing hormone neurons,corticotropin-releasing hormone neurons
NEW00649,CHEMICAL,oxytocin neurons,oxytocin neurons
D011218,MENTAL_HEALTH,Prader-Willi Syndrome,"PWS|Labhart-Willi-Prader-Fanconi Syndrome|Syndrome, Willi-Prader|Labhart Willi Syndrome|Willi Prader Syndrome|Prader Labhart Willi Syndrome|Syndrome, Royer's|Syndrome, Prader-Willi|Willi-Prader Syndrome|Royer's Syndrome|Royers Syndrome|Prader Willi Syndrome|Syndrome, Royer|Labhart Willi Prader Fanconi Syndrome|Labhart-Willi Syndrome|Syndrome, Labhart-Willi|Syndrome, Labhart-Willi-Prader-Fanconi|Royer Syndrome|Prader-Labhart-Willi Syndrome|Prader-Willi Syndrome|Syndrome, Prader-Labhart-Willi|Prader-Willi syndrome"
D020641,CHEMICAL,"Polymorphism, Single Nucleotide","Single Nucleotide Polymorphisms|single nucleotide polymorphism|Single nucleotide polymorphism|SNPs|Nucleotide Polymorphisms, Single|Single Nucleotide Polymorphism|Polymorphisms, Single Nucleotide|Single nucleotide polymorphisms|Nucleotide Polymorphism, Single|single nucleotide polymorphisms|single-nucleotide polymorphism|SNP"
NEW00650,CHEMICAL,AGRP gene,AGRP gene
D055824,CHEBI,Formulary [Publication Type],"Essential Medicines List|Preferred Drug List|Formularies, Drug|Formularies|Drug Formularies|preferred drug"
NEW00651,CHEMICAL,serum GPER level,serum GPER level
NEW00652,DISEASE,ASD patients,ASD patients
NEW00653,CHEMICAL,decreased serum GPER levels,decreased serum GPER levels
D042341,CHEBI,Gonadal Hormones,"gonadal hormones|Hormone, Gonadal|Hormones, Gonadal|hormones|Gonadal Hormone|Gonadal hormones"
NEW00654,MENTAL_HEALTH,analgesia responses,analgesia responses
NEW00655,DISEASE,anxiety-related behaviors,anxiety-related behaviors
D018045,CHEMICAL,"Receptors, Oxytocin","oxytocin receptors|Oxytocin|oxytocin|oxytocin receptor|Oxytocin Receptors|Oxytocin Receptor|Receptor, Oxytocin"
NEW00656,DISEASE,Corticotrophin-releasing factor,CRF|Corticotrophin-releasing factor
NEW00657,DISEASE,CRF promoter,CRF promoter
NEW00658,CHEBI,estrogen response elements,estrogen response elements
NEW00659,CHEMICAL,low endogenous estradiol,low endogenous estradiol
NEW00660,CHEMICAL,high estradiol levels,high estradiol levels
NEW00661,CHEMICAL,ventromedial hypothalamus,ventromedial hypothalamus
D020177,DISEASE,Idiopathic Hypersomnia,"Idiopathic CNS Hypersomnolences|CNS Hypersomnolences, Idiopathic|Hypersomnolence, CNS, Idiopathic|Hypersomnias, Idiopathic|Hypersomnolences, Idiopathic|Hypersomnolences, Idiopathic CNS|Hypersomnolence, Idiopathic|Idiopathic Hypersomnolences|hypersomnia|Idiopathic CNS Hypersomnolence|Hypersomnia, Idiopathic|Idiopathic Central Nervous System Hypersomnolence|Hypersomnolence, Idiopathic CNS|Idiopathic Hypersomnias|idiopathic hypersomnia|CNS Hypersomnolence, Idiopathic|Idiopathic Hypersomnolence|Hypersomnia"
NEW00662,MENTAL_HEALTH,increased daytime sleepiness,increased daytime sleepiness
NEW00663,DISEASE,winter SAD,winter SAD
NEW00664,MENTAL_HEALTH,Hypoactive desire disorder,Hypoactive desire disorder
D039721,MENTAL_HEALTH,Diagnostic and Statistical Manual of Mental Disorders,mental disorders|DSM-IV|DSM-V|DSM-III|Mental Disorders|DSM-II
NEW00665,MENTAL_HEALTH,sexual fantasies,sexual fantasies
NEW00666,DISEASE,Text Revision,DSM-IV-TR|Text Revision
D045167,CHEMICAL,Progesterone Congeners,"Progestogens|Progestin Analogues|Progestins, Synthetic|Progestin Analogs|Progesterone|Progestational Hormones, Synthetic|Synthetic Progestin|Synthetic Progestogens|Synthetic Progestins|synthetic progestin|Progestational Hormone Analogues|Progestin, Synthetic|synthetic progestins|Synthetic progestogens|progestogens|Progestagens|Progestogens, Synthetic|Progestagens, Synthetic|PROG|progesterone|progestagens|Progestational Hormone Analogs|Synthetic Progestagens|Synthetic Progestational Hormones|progestins"
NEW00667,CHEBI,Endocrine therapy adherence,Endocrine therapy adherence
NEW00668,DISEASE,optimal estrogen receptor-positive breast cancer outcomes,optimal estrogen receptor-positive breast cancer outcomes
NEW00669,DISEASE,estrogen receptor positive ER+ breast cancer,estrogen receptor positive ER+ breast cancer
NEW00670,CHEBI,endocrine therapies,endocrine therapies
NEW00671,DISEASE,puerperal major depression,puerperal major depression
NEW00672,CHEMICAL,high-dose oral estrogen,high-dose oral estrogen
NEW00673,MENTAL_HEALTH,puerperal psychosis,puerperal psychosis
NEW00674,CHEBI,estrogen withdrawal,estrogen withdrawal
D011629,DISEASE,"Puberty, Precocious","Central Precocious Puberties|Pubertas Praecox|Precocity, Idiopathic Sexual|Sexual Precocities|Puberties, Male-Limited Precocious|Precocious Puberties, Central|Precocities, Sexual|Puberties, Precocious|Precocious Puberty, Male Limited|Familial Precocious Puberty|Precocious Puberties|Precocious Puberty, Central|Sexual Precocities, Idiopathic|Sexual Precocity, Idiopathic|Male-Limited Precocious Puberties|Precocious Puberties, Male-Limited|puberty|Familial Precocious Puberties|Puberties, Central Precocious|Puberties, Familial Precocious|Testotoxicosis|Praecox, Pubertas|Idiopathic Sexual Precocity|Precocious Puberty, Familial|Central Precocious Puberty|Puberty, Male-Limited Precocious|Precocious Puberties, Familial|Precocious Puberty|Idiopathic Sexual Precocities|Precocities, Idiopathic Sexual|Male-Limited Precocious Puberty|Precocity, Sexual|Puberty, Familial Precocious|Precocious Puberty, Male-Limited|Puberty, Central Precocious|Sexual Precocity"
D000081029,DISEASE,Pulmonary Arterial Hypertension,"Hypertension, Pulmonary Arterial|arterial hypertension|pulmonary arterial hypertension|Arterial Hypertension, Pulmonary|PAH|Pulmonary arterial hypertension"
NEW00675,CHEBI,sex hormone levels,sex hormone levels
D020938,DISEASE,"Epilepsy, Partial, Motor","Clonic Seizures, Focal|Seizure Disorder, Motor|Epilepsy, Hemimotor|Tonic Seizure, Focal|Seizure, Versive|Seizure Disorders, Hemimotor|Focal Tonic Seizures|Epilepsy, Motor Partial|Motor Seizure Disorder|Motor Partial Seizure Disorder|Partial Epilepsy, Motor|Versive Seizures|SUDEP|Focal Clonic Seizures|Partial Seizure Disorder, Motor|Focal Tonic Seizure|Seizure, Focal Clonic|Focal Clonic Seizure|Hemimotor Seizure Disorder|Seizure Disorder, Partial, Motor|Epilepsy, Focal Motor|Hemimotor Epilepsy|Focal Motor Epilepsy|seizure disorders|Hemimotor Epilepsies|Seizures, Versive|Motor Epilepsy, Focal|Versive Seizure|epilepsy|Motor Seizure Disorders|Seizure Disorder, Hemimotor|Epilepsy|Seizure Disorders, Motor|Hemimotor Seizure Disorders|Tonic Seizures, Focal"
NEW00676,MENTAL_HEALTH,Female sexual arousal disorder,Female sexual arousal disorder
D015914,CHEBI,Estrogen Replacement Therapy,"Estrogen Progestin Combination Therapy|Estrogen Replacement|Hormone Replacement Therapy, Post Menopausal|Replacement Therapy, Estrogen|Estrogen Progestin Replacement Therapy|estrogen-progestin combination|HRT|postmenopausal hormone replacement therapy|Hormone Replacement Therapy, Post-Menopausal|Therapy, Estrogen Replacement|Estrogen Replacement Therapies|estrogen replacement therapy|Replacements, Estrogen|Estrogen Replacements|Therapies, Estrogen Replacement|Replacement Therapies, Estrogen|Replacement, Estrogen|Postmenopausal Hormone Replacement Therapy"
NEW00677,DISEASE,vaginal lubricants,vaginal lubricants
NEW00678,CHEMICAL,Testosterone inhibitors,Testosterone inhibitors
NEW00679,DISEASE,cognitive functioning,cognitive functioning
NEW00680,DISEASE,cognitive circuits,cognitive circuits
D065446,MENTAL_HEALTH,Premenstrual Dysphoric Disorder,"Premenstrual Dysphoric Syndrome|premenstrual dysphoric disorder|Premenstrual Dysphoric Disorder|Disorder, Premenstrual Dysphoric|Dysphoric Disorder, Premenstrual|Premenstrual dysphoric disorder|Syndrome, Premenstrual Dysphoric"
NEW00681,MENTAL_HEALTH,sex-specific hormone-dependent mood disorder,sex-specific hormone-dependent mood disorder
NEW00682,CHEBI,Endocrine organizational influences,Endocrine organizational influences
NEW00683,CHEMICAL,aromatase inactivator exemestane,aromatase inactivator exemestane
NEW00684,DISEASE,metastatic breast cancer,metastatic breast cancer
D000077289,CHEMICAL,Letrozole,"CGS-20267|CGS 20267|letrozole|CGS20267|4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile)|Femara|Fémara"
D062950,MENTAL_HEALTH,rho Guanine Nucleotide Dissociation Inhibitor gamma,rhoGDI gamma|rhoGDI3|Dissociation|CAD|dissociation|rho GDP-Dissociation Inhibitor 3|rho Guanine Nucleotide Dissociation Inhibitor 3|rho GDI gamma|rho GDP Dissociation Inhibitor (GDI) gamma|rhoGDIgamma
NEW00685,DISEASE,social distress,social distress
NEW00686,CHEBI,sex hormone profile,sex hormone profile
D000735,CHEMICAL,Androstenedione,"4-Androstene-3,17-dione|delta-4-Androstenedione|Androstenedione|4 Androstene 3,17 dione|delta 4 Androstenedione|androstenedione"
D065086,CHEMICAL,Acetaldehyde Dehydrogenase Inhibitors,"Dehydrogenase Blockers, Aldehyde|Aldehyde Dehydrogenase Blockers|Acetaldehyde Dehydrogenase Antagonists|Dehydrogenase Inhibitors, Acetaldehyde|acetaldehyde|Dehydrogenase Antagonists, Acetaldehyde"
D000431,CHEMICAL,Ethanol,"|Grain Alcohol|Ethanol|alcohol|AN|Ethyl Alcohol|Alcohol, Grain|Alcohol, Ethyl|Alcohol, Absolute|ETOH|% ethanol|ethanol|Absolute Alcohol|EtOH"
NEW00687,MENTAL_HEALTH,chronic alcohol abuse,chronic alcohol abuse
D000087523,CHEMICAL,Endotoxin Tolerance,"Desensitization, Endotoxin|Tolerance, Endotoxin|endotoxin|Endotoxin Desensitization"
NEW00688,DISEASE,hepatotoxic,hepatotoxic
NEW00689,CHEMICAL,its's primary metabolite acetaldehyde,its's primary metabolite acetaldehyde
D008108,DISEASE,"Liver Diseases, Alcoholic","alcoholic liver disease|ALD|Alcoholic Liver Disease|Liver Disease, Alcoholic|Alcoholic liver disease|Alcoholic Liver Diseases"
NEW00690,CHEMICAL,ethanol metabolism,ethanol metabolism
NEW00691,MENTAL_HEALTH,chronic ethanol abuse,chronic ethanol abuse
D010788,CHEMICAL,Photosynthesis,"Photosynthesis Dark Reaction|Calvin Cycle|Reductive Pentose Phosphate Cycle|carbon fixation|Cycle, Calvin|Carbon Fixation, Photosynthetic|Photosynthesis Dark Reactions|Calvin Benson Bassham Cycle|Cycle, Calvin-Benson|Calvin-Benson Cycle|Dark Reactions of Photosynthesis|Cycle, Calvin-Benson-Bassham|Calvin-Benson-Bassham Cycle|Calvin Benson Cycle|Photosynthetic Carbon Fixation"
NEW00692,CHEMICAL,atmospheric carbon dioxide,atmospheric carbon dioxide
D002245,CHEMICAL,Carbon Dioxide,"Anhydride, Carbonic||% carbon dioxide|Dioxide, Carbon|Carbonic Anhydride|carbon dioxide|CO2"
NEW00693,CHEMICAL,Manganese toxicity,Manganese toxicity
NEW00694,DISEASE,levodopa-resistant akinetic-rigid syndrome,levodopa-resistant akinetic-rigid syndrome
NEW00695,DISEASE,autistic population,autistic population
NEW00696,CHEMICAL,sex- controls,sex- controls
D017633,CHEMICAL,Magnesium Silicates,"magnesium|Magnesium|Mg|Mg2|Silicates, Magnesium"
D017608,CHEMICAL,Chromium Compounds,"Chromium|chromium|Compounds, Chromium|Cr"
NEW00697,CHEMICAL,calcium higher levels,calcium higher levels
NEW00698,DISEASE,autistic features,autistic features
D019256,CHEMICAL,Cadmium Chloride,"Cd|CdCl2|Chloride, Cadmium|Cadmium Dichloride|cadmium|Dichloride, Cadmium|Cadmium"
D003037,CHEMICAL,Cobalt Radioisotopes,"Radioisotopes, Cobalt|cobalt"
NEW00699,CHEMICAL,Mn poisoning,Mn poisoning
NEW00700,MENTAL_HEALTH,early psychotic disorder,early psychotic disorder
NEW00701,CHEMICAL,Developmental manganese Mn exposure,Developmental manganese Mn exposure
C567628,DISEASE,"Spastic Paraplegia 18, Autosomal Recessive [Supplementary Concept]","Contracture|Intellectual Disability|motor dysfunction|Spastic Paraplegia, Hereditary"
NEW00702,CHEMICAL,chronic postnatal Mn exposure,chronic postnatal Mn exposure
NEW00703,DISEASE,fine motor dysfunction due,fine motor dysfunction due
NEW00704,CHEMICAL,Mn exposure,Mn exposure
NEW00705,CHEMICAL,brain extracellular dopamine,brain extracellular dopamine
NEW00706,CHEMICAL,MPH efficacy,MPH efficacy
D020149,CHEMICAL,Manganese Poisoning,"Neurotoxicity Syndrome, Manganese|Manganese Neurotoxicity Syndromes|Nervous System Diseases, Manganese Induced|Poisoning, Manganese|manganese|Mn|Neurotoxicity Syndromes, Manganese|Nervous System Poisoning, Manganese|Manganese Neurotoxicity Syndrome|Syndromes, Manganese Neurotoxicity|Syndrome, Manganese Neurotoxicity|Nervous System Diseases, Manganese-Induced"
NEW00707,DISEASE,neurotoxic effects,neurotoxic effects
NEW00708,CHEMICAL,bioavailable Mn,bioavailable Mn
D006816,DISEASE,Huntington Disease,"Juvenile-Onset Huntington Disease|Progressive Chorea, Chronic Hereditary (Huntington)|Huntington's Chorea|Chorea, Huntington|Huntington's Disease|Huntington Disease, Juvenile-Onset|Huntington Chorea|Chorea, Chronic Progressive Hereditary (Huntington)|Juvenile Onset Huntington Disease|Huntington Disease, Akinetic Rigid Variant|Chorea, Huntington's|Progressive Chorea, Hereditary, Chronic (Huntington)|Late-Onset Huntington Disease|Huntington disease|Huntington Disease, Juvenile|Akinetic-Rigid Variant of Huntington Disease|Juvenile Huntington Disease|Huntington Disease, Juvenile Onset|Chronic Progressive Hereditary Chorea (Huntington)|Huntington|Huntington Disease, Akinetic-Rigid Variant|Huntington Chronic Progressive Hereditary Chorea|Late Onset Huntington Disease|Huntington Disease, Late Onset|Huntington Disease, Late-Onset|Akinetic Rigid Variant of Huntington Disease|akinetic-rigid variant"
NEW00709,CHEMICAL,chronic Mn exposure paradigm,chronic Mn exposure paradigm
NEW00710,DISEASE,Neuromotor deficits,Neuromotor deficits
NEW00711,CHEMICAL,manganese Mn toxicity,manganese Mn toxicity
NEW00712,CHEMICAL,chronic Mn exposure,chronic Mn exposure
NEW00713,DISEASE,dopaminergic neuron loss,dopaminergic neuron loss
D017607,CHEMICAL,Aluminum Compounds,"aluminum|Al|Compounds, Aluminum|Aluminum"
D019345,CHEMICAL,Zinc Acetate,"Zinc Acetate Anhydrous|Anhydrous Zinc Acetate|Galzin|Zinc Acetate, Anhydrous|zinc|Zn|Zinc Acetate Dihydrate"
D019327,CHEMICAL,Copper Sulfate,"copper|copper sulfate|Sulfate, Cupric|Blue Vitriol|Sulfate, Copper|Copper|Vitriol, Blue|Cupric Sulfate|Cu|Cu++"
D001608,CHEMICAL,Beryllium,beryllium
D020262,NUTRITION,"Mercury Poisoning, Nervous System","mercury|Mad Hatters Disease|Mercurialism, Neurologic|Poisoning, Mercury, Neurologic|Mercurialism, Nervous System|Organic Mercury Poisoning|Syndrome, Mercury Neurotoxicity|Nervous System Diseases, Mercury-Induced|Poisoning, Inorganic Mercury|Poisoning, Mercury, Nervous System|mercury poisoning|System Mercurialism, Nervous|Mercury Poisoning, Neurologic|Encephalopathy, Mercury|Neurotoxicity Syndrome, Mercury|Mercury|Mad Hatter's Disease|Neurologic Mercury Poisoning|Mercurial Psychosis|Neuroanesthenia, Mercurial|Mad Hatter Disease|mercury mercury|Poisoning, Organic Mercury|Mercury Poisoning, Organic|Psychosis, Mercury|Psychosis, Mercurial|Nervous System Diseases, Mercury Induced|Mercury Encephalopathy|inorganic mercury|Mercury Induced Nervous System Diseases|Inorganic Mercury Poisoning|Hg0|organic mercury|Mercury Neurotoxicity Syndrome|Nervous System Mercurialism|Nervous System Poisoning, Mercury|Mercury-Induced Nervous System Diseases|Mercury Psychosis|Syndromes, Mercury Neurotoxicity|Mad Hatter Diseases|Minamata Disease|Mercury Poisoning, Inorganic|Mercurial Neuroanesthenia|Neurotoxicity Syndromes, Mercury|Poisoning, Neurologic Mercury|Mercury Neurotoxicity Syndromes|Neurologic Mercurialism"
D064588,CHEMICAL,Selenium Oxides,"Selenium Monoxide|selenium|Oxides, Selenium|Selenium Dioxide|Trioxide, Selenium|Selenium Trioxide|Selenium|Se|Monoxide, Selenium|Oxide, Selenium|Selenium Oxide|Dioxide, Selenium"
D009414,CHEMICAL,Nerve Growth Factors,"Factors, Neurite Outgrowth|Neuronal Growth-Associated Proteins|neurotrophins|Neuronal Growth Associated Protein|Factor, Neurotrophic|Neurotrophin|Factors, Neuronotrophic|Neurotrophins|Growth-Associated Proteins, Neuronal|Growth Associated Proteins, Neuronal|Neuronotrophic Factor|Protein, Neuronal Growth-Associated|Neurotrophic Factors|Neuronal Growth Associated Proteins|Neuronotrophic Factors|Neurotrophic Protein|Factors, Nerve Growth|Proteins, Neuronal Growth-Associated|Neurotrophic Factor|Outgrowth Factors, Neurite|Factor, Neurite Outgrowth|Neurotrophic Proteins|Growth-Associated Protein, Neuronal|Neurite Outgrowth Factors|Factors, Neurotrophic|Outgrowth Factor, Neurite|Neuronal Growth-Associated Protein|Neurite Outgrowth Factor|Factor, Neuronotrophic"
NEW00714,DISEASE,depression-related behaviors,depression-related behaviors
NEW00715,CHEMICAL,immobilization stress-1 group,immobilization stress-1 group
NEW00716,MENTAL_HEALTH,anxiety behaviors,anxiety behaviors
NEW00717,CHEMICAL,Mn overexposure,Mn overexposure
NEW00718,DISEASE,atypical parkinsonian syndrome,atypical parkinsonian syndrome|manganism
D014028,CHEMICAL,Tobacco Smoke Pollution,"Smokings, Passive|Smokes, Secondhand|Passive Smoking|Hand Smokes, Second|Second Hand Smokes|Environmental Smoke Pollution, Tobacco|Smokings, Involuntary|tobacco smoke|Air Pollution, Tobacco Smoke|Involuntary Smokings|Secondhand Smokings|Secondhand Smoke|Smokes, Second Hand|Tobacco Smoke Pollutions|Second Hand Smoke|Passive Smokings|Secondhand Smokes|Smokings, Secondhand|Smoke Pollutions, Tobacco|Smoke, Secondhand|Smoking, Secondhand|Pollution, Tobacco Smoke|Involuntary Smoking|Smoking, Passive|Environmental Tobacco Smoke Pollution|Smoke, Second Hand|Hand Smoke, Second|Pollutions, Tobacco Smoke|Environmental Pollution, Tobacco Smoke|Smoke Pollution, Tobacco|Smoking, Involuntary|Secondhand Smoking"
NEW00719,DISEASE,oesophageal carcinogenesis,oesophageal carcinogenesis
NEW00720,DISEASE,parkinsonian patients,parkinsonian patients
NEW00721,CHEMICAL,3 L-dopa,3 L-dopa
NEW00722,CHEBI,Dopamine agonist therapy,Dopamine agonist therapy
NEW00723,CHEMICAL,L-dopa therapy,L-dopa therapy
D006970,MENTAL_HEALTH,Disorders of Excessive Somnolence,"|Excessive Somnolence Disorders|daytime sleepiness|Excessive daytime sleepiness|drowsiness|Secondary Hypersomnolence Disorders|Daytime Sleepiness|Sleepiness, Daytime|Hypersomnolence Disorder, Secondary|Drowsiness|recurrent hypersomnia|Hypersomnia Disorder, Primary|Hypersomnolence Disorder, Primary|Sleepiness, Excessive Daytime|Hypersomnolence|Primary Hypersomnia Disorders|Hypersomnolence Disorder|Primary Hypersomnia Disorder|Daytime Somnolences|Primary Hypersomnolence Disorder|Excessive Daytime Sleepiness|Recurrent Hypersomnia|Secondary Hypersomnia Disorder|Somnolence|Hypersomnia, Recurrent|daytime somnolence|Hypersomnia|Somnolence Disorder, Excessive|Recurrent Hypersomnias|Secondary Hypersomnia Disorders|hypersomnolence|Somnolence, Daytime|Hypersomnolence Disorders|Excessive Somnolence Disorder|Primary Hypersomnolence Disorders|excessive daytime sleepiness|Hypersomnia Disorder, Secondary|DOES (Disorders of Excessive Somnolence)|excessive somnolence|Hypersomnolence Disorders, Secondary|Daytime Sleepiness, Excessive|Excessive Daytime Sleepinesses|Hypersomnias|Hypersomnolence Disorders, Primary|Secondary Hypersomnolence Disorder|somnolence|Daytime Somnolence|DOESs (Disorders of Excessive Somnolence)|Daytime Sleepinesses"
D020269,DISEASE,Alcoholic Neuropathy,"Peripheral Neuropathies, Alcohol-Induced|Alcohol-Induced Polyneuropathies|Peripheral neuropathy|Alcohol-Related Autonomic Polyneuropathies|Alcohol Related Polyneuropathy|Neuropathy, Alcoholic Axonal|Neuropathy, Alcohol-Induced Peripheral|Alcohol-Induced Peripheral Neuropathy|Polyneuropathy, Alcoholic|Alcoholic Polyneuropathy|Polyneuropathies, Alcoholic|Neuropathy, Alcoholic|Alcoholic Axonal Neuropathies|Polyneuropathy, Alcohol-Related Autonomic|Alcoholic Polyneuritides|Polyneuropathies, Alcohol-Related|Polyneuritis, Alcoholic|Polyneuropathy, Alcohol-Induced|Polyneuritides, Alcoholic|Alcoholic Polyneuritis|Autonomic Polyneuropathies, Alcohol-Related|Axonal Neuropathy, Alcoholic|Alcohol Induced Polyneuropathy|Polyneuropathies, Alcohol-Related Autonomic|Alcoholic Axonal Neuropathy|Axonal Neuropathies, Alcoholic|Peripheral Neuropathy, Alcohol Induced|Alcoholic Neuropathies|Alcohol-Induced Peripheral Neuropathies|alcoholic peripheral neuropathy|Alcohol-Induced Polyneuropathy|Alcohol-Related Polyneuropathy|Alcohol-Related Polyneuropathies|Alcoholic Polyneuropathies|Alcohol-Related Autonomic Polyneuropathy|Alcohol Related Autonomic Polyneuropathy|Neuropathies, Alcoholic Axonal|Autonomic Polyneuropathy, Alcohol-Related|Neuropathies, Alcoholic|Polyneuropathy, Alcohol-Related|Alcohol Induced Peripheral Neuropathy|Neuropathies, Alcohol-Induced Peripheral|Polyneuropathies, Alcohol-Induced|peripheral neuropathy|Alcoholic neuropathy|Peripheral Neuropathy, Alcohol-Induced"
D008742,CHEMICAL,Methyl n-Butyl Ketone,"2 Hexanone|Ketone, Methyl n-Butyl|2-Hexanone|Butylmethyl Ketone|Hexan-2-one|Ketone, Butylmethyl|Hexan 2 one|methyl n-butyl ketone|n-Butyl Ketone, Methyl|Methyl n Butyl Ketone"
D014241,CHEMICAL,Trichloroethylene,"TCE|Trichloroethylene|Trielina|Trilene|trichloroethylene|Trichloroethene|Trichloride, Ethinyl|Ethinyl Trichloride"
NEW00724,CHEMICAL,Dyshomeostasis,Dyshomeostasis
NEW00725,CHEMICAL,copper levels,copper levels
NEW00726,DISEASE,severe neuronal damage,severe neuronal damage
NEW00727,CHEMICAL,excessive Mn,excessive Mn
NEW00728,DISEASE,irreversible mild cognitive impairment,irreversible mild cognitive impairment
D065852,DISEASE,Spatial Memory,"Spatial Memories|Memories, Spatial|Memory, Spatial|memory"
NEW00729,DISEASE,MP density,MP density
NEW00730,CHEBI,brain lutein,brain lutein
D000068180,CHEMICAL,Aripiprazole,"OPC-14597|Aripiprazole|Aripiprazol|7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone|APZ|OPC 14597|Abilify|APPZ|ARI|aripiprazole"
NEW00731,CHEBI,vitamin E supplementation,vitamin E supplementation
NEW00732,MENTAL_HEALTH,anxiety increase,anxiety increase
D014811,CHEBI,Vitamin E Deficiency,"Vitamin E deficiency|Vitamin E Deficiencies|vitamin-E|Deficiencies, Vitamin E|vitamin E|Deficiency, Vitamin E|vitamin E deficiency|Vitamin E"
NEW00733,CHEMICAL,IU all-rac-alpha-tocopheryl acetate,IU all-rac-alpha-tocopheryl acetate
NEW00734,CHEBI,Antacids almagel,Antacids almagel
NEW00735,DISEASE,concomitant duodenitis,concomitant duodenitis
D064098,CHEMICAL,Esomeprazole,"Nexium|Esomeprazole Sodium|Strontium, Esomeprazole|Esomeprazole Potassium|Esomeprazole Magnesium|esomeprazole|Esomeprazole Strontium Anhydrous|Esomeprazole Strontium"
D006356,DISEASE,Heartburn,Pyroses|heartburn|Pyrosis
D064747,CHEMICAL,Lansoprazole,"AG 1749|Ogastro|Monolitum|AG1749|Lansoprazol|Lansoprazole Sodium|Lanzor|2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole|Sodium, Lansoprazole|Ogast|Lansol|Pro Ulco|Zoton|lansoprazole|Prevacid|Opiren|Ulpax|Takepron|Agopton|Bamalite|Promeco|Prezal|AG-1749|Lansoprazoles"
D009853,CHEMICAL,Omeprazole,"Prilosec||H 168-68|H 168 68|Omeprazole Magnesium|omeprazole|Sodium, Omeprazole|Magnesium, Omeprazole|Omeprazole Sodium|H 16868"
NEW00736,DISEASE,esophagitis higher healing rates,esophagitis higher healing rates
NEW00737,DISEASE,gastric mucosal injury,gastric mucosal injury
NEW00738,CHEBI,over-the-counter antacids,over-the-counter antacids
NEW00739,DISEASE,pregnancy-associated heartburn,pregnancy-associated heartburn
NEW00740,DISEASE,hypokalaemia,hypokalaemia
NEW00741,DISEASE,uterine irritability,uterine irritability
NEW00742,DISEASE,threatened preterm labour,threatened preterm labour
D000863,CHEBI,Antacids,"Agent, Alkalinizing|Agents, Alkalinizing|antacid|Alkalinizing Agent|Alkalinizing Agents|Antacid|antacids|Antacids"
NEW00743,CHEMICAL,fluoride application,fluoride application
NEW00744,CHEBI,traditional antihistamines,traditional antihistamines
NEW00745,DISEASE,functional impairment,functional impairment
NEW00746,CHEMICAL,CRF-related single nucleotide polymorphisms,CRF-related single nucleotide polymorphisms
NEW00747,MENTAL_HEALTH,anxiety depressive disorders,anxiety depressive disorders
NEW00748,DISEASE,hyperactive central corticotropin releasing factor CRF systems,hyperactive central corticotropin releasing factor CRF systems
NEW00749,DISEASE,neuronal hypersecretion,neuronal hypersecretion
NEW00750,DISEASE,excessive central CRF neurotransmission,excessive central CRF neurotransmission
NEW00751,DISEASE,synaptic CRF,synaptic CRF
NEW00752,CHEMICAL,N-methyl-D-aspartate NMDA receptor antagonists,N-methyl-D-aspartate NMDA receptor antagonists
NEW00753,CHEMICAL,R-ketamine,R-ketamine
NEW00754,CHEMICAL,rapid antidepressant effects,rapid antidepressant effects
NEW00755,CHEMICAL,MT-stabilizing compounds,MT-stabilizing compounds
NEW00756,DISEASE,related tauopathies,related tauopathies
C000620616,CHEMICAL,amyloid beta-peptide (1-30) [Supplementary Concept],amyloid-β peptide|amyloid beta-peptide|Peptide Fragments|Aβ|Amyloid beta-Peptides|amyloid β-peptide
NEW00757,DISEASE,neuronal injuries,neuronal injuries
NEW00758,CHEMICAL,methadone poisoning,methadone poisoning
NEW00759,DISEASE,poisoning referral wards,poisoning referral wards
D002189,MENTAL_HEALTH,Marijuana Abuse,"Dependence, Marijuana|Abuse, Marijuana|Dependence, Cannabis|Cannabis abuse|Cannabis Related Disorder|marijuana abuse|Marijuana Dependence|Abuse, Hashish|cannabis dependence|Hashish Abuse|Cannabis Abuse|Cannabis Dependence|Cannabis-Related Disorder|Abuse, Marihuana|Abuse, Cannabis|Marihuana Abuse|Marijuana abuse|Disorder, Cannabis-Related|cannabis abuse"
D009294,CHEBI,Narcotics,"Narcotic Analgesics|Narcotic analgesics|narcotics|Narcotic|Narcotic Effects|Narcotic Effect|Effect, Narcotic|narcotic analgesics|Analgesics, Narcotic|Effects, Narcotic"
NEW00760,DISEASE,truancy,truancy
D015819,CHEBI,"Substance Abuse, Intravenous","intravenous drug abuse|Intravenous Substance Abuse|Drug Abuse, Intravenous|Parenteral Drug Abuse|Intravenous Drug Abuse|Drug Abuse, Parenteral"
NEW00761,DISEASE,type achalasia A3 motor pattern,type achalasia A3 motor pattern
NEW00762,CHEMICAL,high-dose opioids,high-dose opioids
NEW00763,CHEMICAL,adolescent morphine,adolescent morphine
NEW00764,CHEMICAL,acute morphine analgesia,acute morphine analgesia
NEW00765,DISEASE,Many schizophrenic patients,Many schizophrenic patients
NEW00766,CHEBI,self-medication drug abuse,self-medication drug abuse
NEW00767,CHEBI,Narcotic withdrawal,Narcotic withdrawal
NEW00768,MENTAL_HEALTH,atypical depression,atypical depression
NEW00769,DISEASE,EPP communication,EPP communication
NEW00770,CHEBI,preoperative narcotic use,preoperative narcotic use
NEW00771,CHEBI,Narcotic-induced    androgen insufficiency,Narcotic-induced    androgen insufficiency
NEW00772,DISEASE,chronic C infection,chronic C infection
D019698,DISEASE,"Hepatitis C, Chronic",chronic hepatitis C.|CHC|chronic hepatitis C|hepatitis C.|hepatitis C|Chronic Hepatitis C
NEW00773,DISEASE,hepatitis C virus disease progression,hepatitis C virus disease progression
NEW00774,CHEBI,narcotic analgesic use,narcotic analgesic use
D054586,DISEASE,National Institute of Diabetes and Digestive and Kidney Diseases (U.S.),National Institute of Diabetes and Digestive and Kidney Diseases|NIDDK|diabetes|Diabetes
D015212,DISEASE,Inflammatory Bowel Diseases,"inflammatory bowel disease|IBD|Bowel Diseases, Inflammatory|inflammatory bowel diseases|Inflammatory Bowel Disease"
NEW00775,CHEBI,oral narcotics,oral narcotics
NEW00776,DISEASE,existing psychiatric comorbidity,existing psychiatric comorbidity
NEW00777,MENTAL_HEALTH,schizophrenia-like psychosis,schizophrenia-like psychosis
NEW00778,DISEASE,chronic alcoholism nosological differentiation,chronic alcoholism nosological differentiation
D011605,DISEASE,"Psychoses, Substance-Induced","|Psychoses, Drug|Drug Psychoses|Psychoses, Toxic|Substance Induced Psychoses|Psychoses, Substance Induced|Toxic Psychoses|Substance-Induced Psychoses|psychoses"
D054972,DISEASE,Postural Orthostatic Tachycardia Syndrome,"Postural Tachycardia Syndrome|Tachycardia|Syndrome, Postural Tachycardia|Postural tachycardia syndrome|POTS|Tachycardia Syndrome, Postural|orthostatic tachycardia syndrome|tachycardia"
D065809,DISEASE,Respiratory Sinus Arrhythmia,"Arrhythmia, Respiratory Sinus|Sinus Arrhythmia, Respiratory|respiratory|arrhythmia|respiratory sinus arrhythmia"
D003644,DISEASE,Death Certificates,"Record, Death|Death Records|Death Record|Records, Death|death certificate|Death Certificate|Certificates, Death|Certificate, Death"
NEW00779,CHEMICAL,SUD recovery,SUD recovery
NEW00780,DISEASE,serious physical injuries,serious physical injuries
NEW00781,DISEASE,trauma exposure,trauma exposure
NEW00782,DISEASE,co-occurring psychiatric disorders,co-occurring psychiatric disorders
NEW00783,CHEBI,Estrogen treatment,Estrogen treatment
NEW00784,CHEMICAL,present antidepressants,present antidepressants
NEW00785,DISEASE,Late-life depression,LLD|Late-life depression
NEW00786,CHEMICAL,NMDAR-glycine site treatments,NMDAR-glycine site treatments
NEW00787,DISEASE,specific psychiatric entities,specific psychiatric entities
NEW00788,CHEBI,Other drug groups,Other drug groups
NEW00789,CHEMICAL,NMDA antagonists,NMDA antagonists
NEW00790,DISEASE,young Parkinson patients,young Parkinson patients
D018663,CHEBI,Adrenergic Agents,"Drugs, Adrenergic Neuron|Adrenergic Neuron Agents|Adrenergics|Release Inhibitors, Adrenergic|Adrenergic Release Inhibitors|Inhibitors, Adrenergic Release|Neuron Agents, Adrenergic|Depleters, Adrenergic Neurohumor|Adrenergic Neuron Drugs|Adrenergic drugs|adrenergic agent|Adrenergic Drugs|Sympathetic Transmitter Releasers|Adrenergic Neurohumor Depleters|Adrenergic Effect|Adrenergic Synthesis Inhibitors|Adrenergic Drug|Transmitter Releasers, Sympathetic|Releasers, Sympathetic Transmitter|adrenergic agents|Inhibitors, Adrenergic Synthesis|Drugs, Adrenergic|Synthesis Inhibitors, Adrenergic|Adrenergic agents|Neuron Drugs, Adrenergic|Effects, Adrenergic|Agent, Adrenergic|Adrenergic Agent|Neurohumor Depleters, Adrenergic|Drug, Adrenergic|Effect, Adrenergic|Agents, Adrenergic Neuron|Adrenergic|adrenergic drugs|Adrenergic Effects|Agents, Adrenergic"
C566822,MENTAL_HEALTH,Perry Syndrome [Supplementary Concept],Depression|mental depression|Hypoventilation|Parkinsonian Disorders
NEW00791,CHEBI,beta-adrenergic drugs,beta-adrenergic drugs
D062686,CHEBI,Epithelial Sodium Channel Blockers,"Channel Blockers, ENaC|Renal Epithelial Sodium Channel Blockers|blockers|Epithelial Sodium Channel Inhibitors|ENaC Channel Blockers|Epithelial Sodium Ion Channel Blockers|Epithelial Sodium Channel Antagonists|Renal Epithelial Sodium Channel Inhibitors"
NEW00792,CHEMICAL,nicotine withdrawal,nicotine withdrawal
NEW00793,CHEMICAL,digitalis toxicity,digitalis toxicity
D000087122,MENTAL_HEALTH,Mania,"Mania|Hypomania|Hypomanic Episodes|Manias|Manic Episode|manic episodes|hypomanic episode|manic state|hypomania|manic episode|hypomanic episodes|Manic Episodes|Hypomanic Episode|Manic State|Manic episodes|Hypomanias|hypomanic|mania|Episode, Manic"
D014700,CHEMICAL,Verapamil,"|Iproveratril|Isoptine|Dexverapamil|Cordilox|verapamil|Lekoptin|Calan|Finoptin|Verapamil Hydrochloride|Isoptin|Falicard|Verapamil|Hydrochloride, Verapamil|Izoptin"
C537163,DISEASE,Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections [Supplementary Concept],Streptococcal Infections|Autoimmune Diseases|Obsessive-Compulsive Disorder|neuropsychiatric disorders
D005996,CHEMICAL,Nitroglycerin,"|Nitrospan|Susadrin|nitroglycerin|Trinitrin|Nitro-Dur|Nitrostat|Sustak|Nitroderm TTS|Nitro-Bid|Nitrocard|Trinitrate, Glyceryl|NitroDur|Dynamite|Perlinganit|Nitrong|Nitrangin|Nitroderm|NTG|Nitro Bid|Transderm Nitro|Nitroglycerin|Gilustenon|Nitro Dur|NitroBid|Glyceryl Trinitrate|Nitrolan|Sustac|Nitrol|Tridil|Anginine|glyceryl trinitrate|Nitroglyn|Trinitrolong|Sustonit"
D000075222,DISEASE,Essential Hypertension,"Hypertension, Essential|essential hypertension"
NEW00794,MENTAL_HEALTH,alcohol dependence syndrome,alcohol dependence syndrome
NEW00795,CHEMICAL,BclI-SNP,BclI-SNP
NEW00796,DISEASE,traumatic memories,traumatic memories
NEW00797,DISEASE,PTSD symptoms,PTSD symptoms
NEW00798,CHEMICAL,lower basal cortisol levels,lower basal cortisol levels
D006145,CHEMICAL,Guanethidine,"Sulfate, Guanethidine|Ismelin|Octadine|Guanethidine Sulfate|Monosulfate, Guanethidine|Guanethidine Sulfate (1:2)|Guanethidine|Guanethidine Sulfate (2:1), 14C-Labeled|((2-Hexahydro-1(2H)-azocinyl)ethyl)guanidine|guanethidine|Guanethidine Sulfate (1:1)|Guanethidine Monosulfate|Guanethidine Sulfate (2:1)|Isobarin|Oktadin"
NEW00799,CHEBI,methyldopa peripheral adrenergic drugs,methyldopa peripheral adrenergic drugs
NEW00800,DISEASE,psychiatric side effects,psychiatric side effects
D008750,CHEMICAL,Methyldopa,|methyldopa|Dopergit|alpha Methyl L Dopa|Sembrina|Apo-Methyldopa|Aldomet|Dopamet|Dopegyt|Meldopa|Nu-Medopa|Dopegit|alpha Methyldopa|alpha-Methyl-L-Dopa|Hydopa|Apo Methyldopa|Nu Medopa|Alphamethyldopa|alpha-methyldopa|Methyldopate|alpha-Methyldopa
NEW00801,DISEASE,neuronal impairments,neuronal impairments
D019970,CHEMICAL,Cocaine-Related Disorders,"cocaine dependence|Cocaine-Related Disorder|Addiction, Cocaine|Cocaine Addiction|cocaine addiction|Cocaine Related Disorders|Cocaine Dependence|Dependence, Cocaine|Dependences, Cocaine|Disorders, Cocaine-Related|cocaine|Cocaine|cocaine abuse|Cocaine Abuse|Cocaine abuse|Abuse, Cocaine|Disorder, Cocaine-Related"
D009498,CHEBI,Neurotoxins,"Alpha-Neurotoxins|Neurotoxin, Excitatory|Neurotoxin|Excitotoxin|Myotoxin|Myotoxins|Alpha-Neurotoxin|Alpha Neurotoxin|Excitatory Neurotoxins|Excitatory Neurotoxin|Excitotoxins|neurotoxins|Neurotoxins, Excitatory|Alpha Neurotoxins"
NEW00802,DISEASE,immune dysfunctions,immune dysfunctions
NEW00803,DISEASE,neurocognitive impairments,neurocognitive impairments
NEW00804,DISEASE,schizophrenic brains,schizophrenic brains
D047208,CHEBI,Eosinophil-Derived Neurotoxin,"Neurotoxin, RNS2|Eosinophil Protein X|RNS2 Neurotoxin|Serum Eosinophil Protein X|neurotoxin|Neurotoxin, Eosinophil-Derived|s-EPX|Eosinophil Derived Neurotoxin"
NEW00805,DISEASE,drug-naïve schizophrenic patients,drug-naïve schizophrenic patients
NEW00806,MENTAL_HEALTH,previous long-term cannabis abuse,previous long-term cannabis abuse
NEW00807,DISEASE,neurotoxic events,neurotoxic events
NEW00808,DISEASE,Drug-naive schizophrenic patients,Drug-naive schizophrenic patients
NEW00809,CHEMICAL,cannabis controls,cannabis controls
D008538,MENTAL_HEALTH,Meige Syndrome,"Orofacial Dyskinesias, Idiopathic|Blepharospasm-Oromandibular Dystonia Syndrome|Blepharospasm-Oromandibular Dystonia|orofacial dyskinesia|Idiopathic Blepharospasm-Oromandibular Dystonia Syndrome|Dyskinesia, Idiopathic Orofacial|Blepharospasm Oromandibular Dystonia|Blepharospasm-Oromandibular Dystonia Syndrome, Idiopathic|Idiopathic Orofacial Dyskinesias|Blepharospasm Oromandibular Dystonia Syndrome, Idiopathic|Blepharospasm-Oromandibular Dystonias|Orofacial Dyskinesia, Idiopathic|Dystonias, Blepharospasm-Oromandibular|Idiopathic Blepharospasm Oromandibular Dystonia Syndrome|Dyskinesias, Blepharospasm-Oromandibular|Dystonia Syndrome, Blepharospasm-Oromandibular|Dystonia Syndromes, Blepharospasm-Oromandibular|Dystonia, Blepharospasm-Oromandibular|Dyskinesias, Idiopathic Orofacial|Brueghel Syndrome|Blepharospasm Oromandibular Dyskinesia|Idiopathic Orofacial Dyskinesia|Blepharospasm-Oromandibular Dyskinesias|Syndrome, Blepharospasm-Oromandibular Dystonia|Blepharospasm-Oromandibular Dyskinesia|Blepharospasm-Oromandibular Dystonia Syndromes|Blepharospasm Oromandibular Dystonia Syndrome|Dyskinesia, Blepharospasm-Oromandibular"
NEW00810,CHEMICAL,second-line immunotherapy,second-line immunotherapy
NEW00811,CHEMICAL,Catecholamine neurons,Catecholamine neurons
D020267,CHEMICAL,MPTP Poisoning,"MPTP|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|MPTP Induced Degeneration of the Striatum|MPTP-Induced Degeneration of the Striatum|Neurotoxicity Syndromes, MPTP|MPTP-Induced Parkinsonism|Neurotoxicity Syndrome, MPTP|MPTP Induced Parkinsonism|N-methyl-4 phenyl-1,2,3,6 tetrahydropyridine|MPTP Neurotoxicity Syndromes|Poisoning, MPTP|Poisoning, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine|MPTP neurotoxicity|MPTP Neurotoxicity Syndrome|1-methyl 4-phenyl 1,2,3,6 tetrahydropyridine|Parkinsonism, MPTP-Induced"
NEW00812,CHEMICAL,MPTP intoxication,MPTP intoxication
NEW00813,DISEASE,comparable neuronal loss,comparable neuronal loss
NEW00814,CHEBI,Botulinum neurotoxin injections,Botulinum neurotoxin injections
NEW00815,DISEASE,focal spasticity,focal spasticity
C568481,DISEASE,"C19orf12 protein, human [Supplementary Concept]",human neurodegeneration|Mitochondrial Proteins
NEW00816,DISEASE,restraint-induced gastric mucosal lesions,restraint-induced gastric mucosal lesions
NEW00817,CHEMICAL,Bilateral micro-applications,Bilateral micro-applications
NEW00818,DISEASE,ulcer pathology,ulcer pathology
C012102,CHEMICAL,DSP 4 [Supplementary Concept],DSP-4|Benzylamines
NEW00819,CHEBI,NA neurotoxin,NA neurotoxin
NEW00820,CHEMICAL,MAM    mg/kg,MAM    mg/kg
NEW00821,DISEASE,schizophrenia-like phenotype,schizophrenia-like phenotype
NEW00822,MENTAL_HEALTH,schizophrenia symptoms,schizophrenia symptoms
NEW00823,CHEMICAL,neurotoxin methylazoxymethanol acetate,neurotoxin methylazoxymethanol acetate
NEW00824,CHEMICAL,central OXT,central OXT
NEW00825,CHEMICAL,MAM model,MAM model
NEW00826,CHEMICAL,VP systems,VP systems
NEW00827,DISEASE,Extrapyramidal side-effects,EPSE|Extrapyramidal side-effects
NEW00828,CHEMICAL,co-occurring methamphetamine,co-occurring methamphetamine
NEW00829,CHEMICAL,consumption DSP4 treatment,consumption DSP4 treatment
NEW00830,CHEMICAL,high sucrose consumption,high sucrose consumption
NEW00831,CHEMICAL,NO production,NO production
NEW00832,CHEMICAL,months,months
D028021,CHEMICAL,Sodium-Potassium-Chloride Symporters,"Solute Carrier Family 12|Sodium Potassium Chloride Cotransporter|Sodium-Potassium-Chloride Cotransporters|Symporters, Sodium-Potassium-Chloride|Cotransporter, NaCl-KCl|Na(+), K(+), Cl(-)-Cotransporter|Na-K-Cl-Symporter|Sodium Potassium Chloride Symporters|Na-K-Cl-Transporter|NaCl-KCl Cotransporter|NaK2Cl Symporter|Sodium Potassium Chloride Cotransporters|Cotransporters, Sodium-Potassium-Chloride|NaCl KCl Cotransporter|KCl|Sodium, Potassium, Chloride-Cotransporter|Cotransporter, Sodium-Potassium-Chloride|Symporter, NaK2Cl|Transporters, SLC12A|Na K Cl Transporter|NaCl|Na K Cl Symporter|Sodium-Potassium-Chloride Cotransporter|SLC12A Transporters"
NEW00833,CHEMICAL,BOTOX ®,BOTOX ®
NEW00834,MENTAL_HEALTH,anxiety oxidative stress,anxiety oxidative stress
NEW00835,CHEMICAL,Chronic inorganic arsenic iAs exposure,Chronic inorganic arsenic iAs exposure
D002220,CHEMICAL,Carbamazepine,|Carbamazepine Anhydrous|Carbamazepine Acetate|Carbamazepine L-Tartrate (4:1)|Carbamazepine Sulfate (2:1)|Carbamazepine Dihydrate|Tegretol|Carbazepin|Finlepsin|Epitol|Neurotol|carbamazepine|Amizepine|Carbamazepine Hydrochloride|Carbamazepine Phosphate|Carbamazepine|CZP
NEW00836,DISEASE,hypomanic switches,hypomanic switches
NEW00837,CHEMICAL,neuropeptide Y-like immunoreactivity NPY-LI concentrations,neuropeptide Y-like immunoreactivity NPY-LI concentrations
D003027,MENTAL_HEALTH,Cluster Headache,"Chronic Cluster Headache|Ciliary Neuralgia|Cluster Headache Syndromes|Syndrome, Horton|Cluster Headache, Episodic|Atypical Cluster Headaches|Neuralgia, Ciliary|Neuralgic Migraine|Cluster Headaches, Atypical|Cephalgias, Histamine|Cephalgia, Histamine|Headache, Cluster|Migraine, Neuralgic|Cluster Headaches|Cluster Headache, Chronic|Horton Syndrome|Ciliary Neuralgias|Syndrome, Horton's|Headache, Episodic Cluster|Headaches, Atypical Cluster|Headache, Chronic Cluster|Hortons Syndrome|Episodic Cluster Headaches|Neuralgias, Ciliary|Headaches, Episodic Cluster|Migraines, Neuralgic|Episodic Cluster Headache|Cluster Headache Syndrome|Cluster Headache, Atypical|Headache, Atypical Cluster|Histamine Cephalgias|Syndromes, Cluster Headache|Headaches, Chronic Cluster|Headache Syndromes, Cluster|Horton's Syndrome|Headache Syndrome, Cluster|Histamine Cephalgia|Headaches, Cluster|Syndrome, Cluster Headache|Chronic Cluster Headaches|cluster headache|Neuralgic Migraines|Cluster Headaches, Episodic|Cluster Headaches, Chronic|Atypical Cluster Headache"
NEW00838,CHEMICAL,SP+CGRP relaxation curves,SP+CGRP relaxation curves
NEW00839,NUTRITION,M lithium,M lithium
NEW00840,DISEASE,neurologic injury,neurologic injury
D015306,CHEMICAL,Biogenic Monoamines,"monoamines|Monoamines, Biogenic|Monoamines"
D006501,DISEASE,Hepatic Encephalopathy,"Encephalopathies, Hepatic|Encephalopathy, Hepatic|Hepatic Coma|Portosystemic Encephalopathies|Hepatocerebral Encephalopathy|Portal Systemic Encephalopathy|Hepatic Comas|hepatic encephalopathy|Hepatic Stupor|Encephalopathy, Hepatocerebral|Portal-Systemic Encephalopathy|Encephalopathies, Portal-Systemic|Portosystemic Encephalopathy|Encephalopathy, Portal-Systemic|Encephalopathies, Hepatocerebral|hepatic coma|Hepatic Stupors|Stupor, Hepatic|Hepatic Encephalopathies|Encephalopathy, Portosystemic|Stupors, Hepatic|Encephalopathies, Portosystemic|Hepatocerebral Encephalopathies|Encephalopathy, Portal Systemic|Fulminant Hepatic Failure with Cerebral Edema|Comas, Hepatic|Portal-Systemic Encephalopathies|Coma, Hepatic"
NEW00841,DISEASE,mitochondrial impairment,mitochondrial impairment
NEW00842,CHEMICAL,NH4 neurotoxicity,NH4 neurotoxicity
NEW00843,CHEMICAL,neurotoxin ammonia,neurotoxin ammonia
C000631768,DISEASE,Pediatric acute-onset neuropsychiatric syndrome [Supplementary Concept],Autoimmune Diseases|Obsessive-Compulsive Disorder|neuropsychiatric syndrome
NEW00844,CHEBI,well-recognized neurotoxin,well-recognized neurotoxin
NEW00845,DISEASE,neurotoxic properties,neurotoxic properties
D002549,DISEASE,Diffuse Cerebral Sclerosis of Schilder,"Alper's Disease|Poliodystrophia Cerebri|neuronal degeneration|Sclerosis, Diffuse Cerebral|Diffuse Sclerosis, Myelinoclastic|Syndrome, Alpers-Huttenlocher|Diffuse Scleroses, Myelinoclastic|Sclerosis, Myelinoclastic Diffuse|Scleroses, Myelinoclastic Diffuse|Encephalitis Periaxialis Concentrica|Encephalitis Periaxialis|Progressive Sclerosing Poliodystrophy|Diffuse Cerebral Scleroses|Scleroses, Balo's Concentric|Disease, Schilder|Balo Concentric Sclerosis|Alpers Syndrome|Balo's Concentric Sclerosis|Alpers Disease|Alper Syndrome|Progressive Sclerosing Poliodystrophies|Concentric Sclerosis, Balo's|Alper's Syndrome|Encephalitis Periaxialis Diffusa|Diffuse Cerebral Sclerosis|Progressive Neuronal Degeneration of Childhood with Liver Disease|Syndrome, Alpers|Alpers' Disease|Alpers' Syndrome|Schilders Disease|Cerebral Sclerosis, Diffuse|Alpers Diffuse Degeneration of Cerebral Gray Matter with Hepatic Cirrhosis|Alpers-Huttenlocher Syndrome|Disease, Alpers'|Myelinoclastic Diffuse Scleroses|Myelinoclastic Diffuse Sclerosis|Alper Disease|Schilder Disease|Schilder's Disease|Disease, Schilder's|Concentric Sclerosis, Balo|Sudanophilic Cerebral Sclerosis|Alpers Huttenlocher Syndrome|Neuronal Degeneration Of Childhood With Liver Disease, Progressive|Alpers Progressive Infantile Poliodystrophy"
D053380,DISEASE,Tumor Necrosis Factor Ligand Superfamily Member 15,"tumor necrosis factor|TL1 Ligand|Ligand, TL1A|VEGI (Vascular Endothelial Growth Inhibitor) Protein|TL1A Ligand|Tumor necrosis factor|Ligand, TL1|necrosis"
C012301,CHEMICAL,domoic acid [Supplementary Concept],Kainic Acid/analogs  and  derivatives|Domoic acid|domoic acid|domoate
D000080549,DISEASE,Autophagic Cell Death,"Deaths, Autophagy-Dependent Cell|Autophagy-Dependent Cell Deaths|Deaths, Autophagic Cell|Deaths|Programmed Cell Death, Type II|Autophagy-Dependent Cell Death|Autophagic Programmed Cell Death|Death, Autophagic Cell|Death, Autophagy-Dependent Cell|Cell Death, Autophagy-Dependent|Cell Deaths, Autophagic|Autophagy Dependent Cell Death|deaths|Cell Deaths, Autophagy-Dependent|Cell Death, Autophagic|Autophagic Cell Deaths"
NEW00846,CHEMICAL,dopamine levels,dopamine levels
NEW00847,DISEASE,PD mouse model,PD mouse model
NEW00848,CHEBI,mitochondrial neurotoxin,mitochondrial neurotoxin
NEW00849,CHEBI,MPTP-like toxin,MPTP-like toxin
NEW00850,DISEASE,idiopathic parkinsonism,idiopathic parkinsonism
C064498,CHEMICAL,mitochondrial processing peptidase [Supplementary Concept],Metalloendopeptidases|MPP(+|MPP+
D012642,CHEMICAL,Selegiline,"|E-250|Selegiline Hydrochloride, (R,S)-Isomer|Selegiline Hydrochloride, (R)-Isomer|Selegiline, (R,S)-Isomer|Selegiline, (R)-Isomer|Selegiline Hydrochloride, (S)-Isomer|selegiline|Zelapar|E250|(-)Deprenyl|Humex|(-)deprenyl|L-deprenyl|Selegiline|Deprenalin|Selegiline, (S)-Isomer|Emsam|Jumex|Selegyline|l-deprenyl|Yumex|E 250|Selegiline Hydrochloride|Eldepryl|L-Deprenyl|Deprenil|Deprenyl"
NEW00851,DISEASE,neuronal death,neuronal death
NEW00852,DISEASE,SC degeneration,SC degeneration
NEW00853,DISEASE,narcoleptic-like behavior,narcoleptic-like behavior
NEW00854,CHEMICAL,HCRT2/SAP-lesioned rats,HCRT2/SAP-lesioned rats
NEW00855,DISEASE,narcoleptic-like sleep behavior,narcoleptic-like sleep behavior
NEW00856,CHEBI,neurotoxin HCRT2-SAP,neurotoxin HCRT2-SAP
D012892,MENTAL_HEALTH,Sleep Deprivation,"Sleep Fragmentation|Sleep Deprivation, REM|Sleep, Inadequate|Sleep Insufficiency|Sleep fragmentation|Deprivation, Sleep|REM Sleep Deprivation|Sleep, Insufficient|Syndrome, Insufficient Sleep|Insufficient Sleep Syndromes|insufficient sleep syndrome|Inadequate Sleep|Insufficiency, Sleep|Insufficiencies, Sleep|Sleep Insufficiencies|Insufficient Sleep|sleep fragmentation|Deprivation, REM Sleep|Insufficient Sleep Syndrome|Sleep Debt|Fragmentation, Sleep"
NEW00857,CHEMICAL,hypocretin2-sap,hypocretin2-sap
D008767,CHEMICAL,Methylmercury Compounds,"Methyl mercury|Compounds, Methylmercury|Compounds, Methyl Mercury|Methyl Mercury Compounds|MeHg|Methylmercury|Mercury Compounds, Methyl"
NEW00858,CHEMICAL,neurotoxin methylmercury,neurotoxin methylmercury
NEW00859,CHEMICAL,selective noradrenaline reuptake inhibitor,selective noradrenaline reuptake inhibitor
NEW00860,CHEMICAL,noradrenaline reuptake inhibitor,noradrenaline reuptake inhibitor
D044183,CHEBI,"Receptor, Parathyroid Hormone, Type 2","Parathyroid Hormone Receptor 2|PTH2 Receptor|PTH 2 Receptor|PTH|Receptor, PTH2|PTH-2 Receptor|Receptor, PTH-2|parathyroid hormone"
D014511,DISEASE,Uremia,|Uremias|uremia
NEW00861,CHEBI,known neurotoxin,known neurotoxin
NEW00862,CHEBI,Neurotoxin dosage,Neurotoxin dosage
D020271,DISEASE,"Heredodegenerative Disorders, Nervous System","Hereditary Degenerative Disorders, Nervous System|Hereditary Disease, Neurodegenerative|neurodegenerative disease|Neurodegenerative Hereditary Diseases|Neurodegenerative Hereditary Disease|Hereditary-Degenerative Disorders, Nervous System|Neurodegenerative Disease, Hereditary|Hereditary Neurodegenerative Diseases|Disease, Neurodegenerative Hereditary|hereditary diseases|Diseases, Hereditary Neurodegenerative|Nervous System Hereditary Degenerative Diseases|Hereditary Diseases, Neurodegenerative|Disease, Hereditary Neurodegenerative|Nervous System Diseases, Degenerative, Hereditary|Nervous System Degenerative Hereditary Diseases|Hereditary Neurodegenerative Disease|Degenerative Hereditary Diseases, Nervous System|degenerative disease|Degenerative Disease, Nervous System, Hereditary|Neurodegenerative Diseases, Hereditary|Diseases, Neurodegenerative Hereditary|Degenerative Hereditary Disorders, Nervous System"
NEW00863,DISEASE,high-incidence ALS,high-incidence ALS
NEW00864,DISEASE,severe hypomagnesemia,severe hypomagnesemia
NEW00865,CHEMICAL,intravenous magnesium replacement,intravenous magnesium replacement
NEW00866,CHEMICAL,kynurenine ratio,kynurenine ratio
NEW00867,CHEMICAL,interferon-α treated patients,interferon-α treated patients
NEW00868,DISEASE,bipolar manic-depressive disorder,bipolar manic-depressive disorder
NEW00869,CHEMICAL,reduced kynurenic acid,reduced kynurenic acid
NEW00870,DISEASE,major psychiatric disorders,major psychiatric disorders
NEW00871,CHEMICAL,unbalanced kynurenine metabolism,unbalanced kynurenine metabolism
NEW00872,DISEASE,human brain diseases,human brain diseases
NEW00873,NUTRITION,tryptophan degradation,tryptophan degradation
NEW00874,DISEASE,Excitotoxic damage,Excitotoxic damage
NEW00875,DISEASE,hypoglycaemic brain damage,hypoglycaemic brain damage
D000083242,DISEASE,Ischemic Stroke,"Wake-up Stroke|Cryptogenic Embolism Stroke|Ischemic stroke|ischemic stroke|Stroke, Acute Ischemic|acute ischemic stroke|Stroke, Cryptogenic Embolism|Ischaemic Strokes|Cryptogenic Stroke|Embolism Stroke, Cryptogenic|Stroke, Wake-up|Cryptogenic Strokes|Stroke, Ischemic|Ischaemic Stroke|Acute Ischemic Stroke|Wake up Stroke|Ischemic Strokes|Stroke, Cryptogenic|Stroke, Ischaemic|Cryptogenic Ischemic Strokes|Ischemic Stroke, Cryptogenic|Acute Ischemic Strokes|Cryptogenic Ischemic Stroke|Cryptogenic Embolism Strokes|Stroke, Cryptogenic Ischemic|ischaemic stroke|Wake-up Strokes|Ischemic Stroke, Acute"
C580174,DISEASE,Huntington Disease-Like Syndrome [Supplementary Concept],"Huntington's disease|Heredodegenerative Disorders, Nervous System"
NEW00876,DISEASE,spontaneous daytime motor activity,spontaneous daytime motor activity
NEW00877,CHEMICAL,bilateral quinolinate+haloperidol rats,bilateral quinolinate+haloperidol rats
NEW00878,CHEMICAL,bilateral quinolinate group,bilateral quinolinate group
NEW00879,CHEMICAL,D-cycloserine,D-cycloserine
NEW00880,CHEBI,partial N-methyl-D-aspartate receptor agonist,partial N-methyl-D-aspartate receptor agonist
NEW00881,CHEMICAL,D-Cycloserine,D-Cycloserine
NEW00882,CHEBI,glutamatergic N-methyl-d-aspartate receptor agonist,glutamatergic N-methyl-d-aspartate receptor agonist
D050601,CHEMICAL,Kynurenine 3-Monooxygenase,"kynurenine|Kynurenine|L Kynurenine 3 Hydroxylase|Kynurenine 3 Monooxygenase|L-Kynurenine-3-Hydroxylase|Kynurenine 3-Hydroxylase|Hydroxylase, Kynurenine|3-Hydroxylase, Kynurenine|Kyn|3-Monooxygenase, Kynurenine|Kynurenine Hydroxylase|KYN|Kynurenine 3 Hydroxylase"
D017378,CHEMICAL,Quinolinic Acid,"Quinolinic Acid, Copper(2+) Salt|quinolinic acid|quinolinic|Quinolinic Acid, Strontium Salt|Quinolinate|Quinolinic acid|Quinolinic Acid, Disodium Salt|QUIN"
NEW00883,DISEASE,demonstrated neurotoxic effects,demonstrated neurotoxic effects
NEW00884,CHEBI,potent N-methyl-D-aspartate receptor agonist,potent N-methyl-D-aspartate receptor agonist
NEW00885,CHEBI,CCR5-coreceptor antagonists,CCR5-coreceptor antagonists
NEW00886,DISEASE,infected individuals,infected individuals
D006397,CHEBI,Hematinics,"erythropoiesis-stimulating agents|Hematopoietic Agents|Erythropoiesis Stimulating Agents|Erythropoiesis-stimulating agents|Hematinic|Stimulating Agent, Erythropoiesis|Agent, Erythropoiesis Stimulating|erythropoiesis-stimulating agent|Erythropoiesis Stimulating Agent"
NEW00887,DISEASE,HD patients,HD patients
NEW00888,CHEBI,Parathyroid hormone level,Parathyroid hormone level
NEW00889,CHEMICAL,chronic cortisol elevation,chronic cortisol elevation
NEW00890,NUTRITION,subordinate trout,subordinate trout
NEW00891,NUTRITION,trout O.    mykiss,trout O.    mykiss
D020739,DISEASE,"Brain Diseases, Metabolic, Inborn","Inherited Metabolic Disorders, Brain|Central Nervous System Inborn Metabolic Diseases|inborn metabolic diseases|Encephalopathies, Metabolic, Inborn|Inborn Metabolic Brain Disorders|Familial Metabolic Disorders, Brain|Inherited Metabolic Brain Diseases|metabolic disorders|Brain Diseases, Metabolic, Inherited|Metabolic Brain Syndrome, Inborn|CNS Metabolic Disorders, Inborn|Metabolic Diseases, Inborn, Brain|Metabolic Brain Diseases, Inborn|Metabolic Disorders, Familial, Brain|Brain diseases|Metabolic Disorders, Brain, Inherited|Metabolic Disorders, CNS, Inborn|Metabolic Brain Diseases, Inherited|Metabolic Brain Diseases, Familial|brain diseases|Central Nervous System Inborn Metabolic Disorders|brain metabolic disorders|Metabolic Diseases, Inborn, Central Nervous System|Inborn Errors of Metabolism, Brain|Inborn Metabolic Brain Diseases|Familial Metabolic Brain Diseases|Brain Diseases, Metabolic, Familial|Brain Syndrome, Metabolic, Inborn|Inborn Metabolic Disorders, Brain"
NEW00892,MENTAL_HEALTH,chronic stress status,chronic stress status
D015283,CHEMICAL,Citalopram,|Citalopram Hydrobromide|Lu10171|Cytalopram|Celexa|citalopram|Seropram|Lu-10-171
D015928,DISEASE,Cognitive Behavioral Therapy,"behaviour|Therapies, Cognitive Behaviour|Cognitive Psychotherapy|Cognitive Psychotherapies|Therapy, Cognitive Behavior|Cognitive Behaviour Therapy|Therapy, Cognition|Therapies, Cognition|Cognition Therapies|Therapy, Cognitive Behaviour|Behavioral Therapies, Cognitive|Therapy, Cognitive|Behavior Therapies, Cognitive|cognitive behavior|Therapies, Cognitive Behavior|Therapies, Cognitive|Cognitive Behavior Therapy|Psychotherapies, Cognitive|Cognitive Behavioral Therapies|Cognition Therapy|cognitive behaviour|Behavior Therapy, Cognitive|Cognitive Behaviour Therapies|Cognitive Behavior Therapies|Therapies, Cognitive Behavioral|cognitive behavior therapy|cognitive behavioral therapy|Behaviour Therapy, Cognitive|cognitive behaviour therapy|Cognitive Therapies|Cognitive Therapy|Psychotherapy, Cognitive|Therapy, Cognitive Behavioral|Behaviour Therapies, Cognitive|Behavioral Therapy, Cognitive"
NEW00893,CHEMICAL,stress hormone cortisol,stress hormone cortisol
NEW00894,DISEASE,memory retention,memory retention
NEW00895,NUTRITION,juvenile rainbow trout,Oncorhynchus mykiss|juvenile rainbow trout
C008757,CHEMICAL,palmitoleic acid [Supplementary Concept],"Fatty Acids, Monounsaturated|POA|palmitoleic acid|Palmitoleic acid"
NEW00896,DISEASE,CRF expression,CRF expression
C585684,CHEMICAL,TIC10 compound [Supplementary Concept],MGS0008|Pyridines|Pyrimidines|Compound (+)-7|Imidazoles
C453300,CHEMICAL,isocoumarin NM-3 [Supplementary Concept],Isocoumarins|nM
C102718,CHEMICAL,metabotropic glutamate receptor 3 [Supplementary Concept],"Receptors, Metabotropic Glutamate|mGluR3"
NEW00897,CHEBI,agonist activity,agonist activity
NEW00898,CHEMICAL,phencyclidine (PCP)-induced hyperactivity,phencyclidine (PCP)-induced hyperactivity
D005442,CHEMICAL,Flumazenil,|Ro 15 1788|Lanexat|Romazicon|Anexate|1788|Flumazepil|Ro 15-1788|Ro 151788|flumazenil|Flumazenil
D062787,DISEASE,Drug Overdose,"|Overdose|Drug overdose|overdose|Drug Overdoses|overdosage|drug overdose|Overdoses, Drug|Overdose, Drug"
D000380,DISEASE,Agranulocytosis,|Agranulocytoses|Granulocytopenias|agranulocytosis|Granulocytopenia|granulocytopenia
C498829,CHEMICAL,"Hrh4 protein, mouse [Supplementary Concept]","Histamine H4 receptor|Receptors, Histamine H4"
NEW00899,DISEASE,clozapine-induced hematopoietic toxicity,clozapine-induced hematopoietic toxicity
NEW00900,CHEBI,H4-receptor agonist,H4-receptor agonist
D000069348,CHEMICAL,Quetiapine Fumarate,"ICI 204636|ICI204636|Seroquel|ICI-204636|quetiapine =|Quetiapine|quetiapine|Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (E)-2-butenedioate (2:1) (salt)|2-(2-(4-dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol|ICI 204,636"
NEW00901,DISEASE,levodopa-induced motor complications,levodopa-induced motor complications
NEW00902,CHEMICAL,GLP-1 receptor stimulation,GLP-1 receptor stimulation
NEW00903,CHEMICAL,acute cocaine self-administration,acute cocaine self-administration
NEW00904,MENTAL_HEALTH,L-Dopa-induced dyskinesia,L-Dopa-induced dyskinesia
NEW00905,CHEMICAL,N-methyl-D-aspartate glutamate receptors,N-methyl-D-aspartate glutamate receptors
D053590,CHEBI,Interleukin 1 Receptor Antagonist Protein,"Kineret|interleukin-1 receptor antagonist|IL1 Febrile Inhibitor|IL1 Inhibitor, Urine-Derived|IL-1 Inhibitor, Urine|antagonist|Urine IL-1 Inhibitor|Urine-Derived IL1 Inhibitor|Antril|receptor antagonist|Urine Derived IL1 Inhibitor|Febrile Inhibitor, IL1|IL 1 Inhibitor, Urine|IL-1Ra|Anakinra|Interleukin 1 Inhibitor, Urine|AM251|CNQX"
NEW00906,CHEMICAL,antiepileptic drug topiramate,antiepileptic drug topiramate
NEW00907,DISEASE,parkinsonian disability,parkinsonian disability
NEW00908,CHEMICAL,low-dose amantadine,low-dose amantadine
NEW00909,CHEBI,D1R agonists,D1R agonists
NEW00910,CHEBI,novel D1R agonists,novel D1R agonists
C061532,CHEMICAL,dihydrexidine [Supplementary Concept],dihydrexidine|Phenanthridines|Dihydrexidine
NEW00911,CHEBI,first dopamine receptor agonist,first dopamine receptor agonist
NEW00912,DISEASE,central nervous disorders,central nervous disorders
D024741,DISEASE,"Cardiomyopathy, Hypertrophic, Familial","Familial Ventricular Hypertrophy|Familial Hypertrophic Cardiomyopathy|Hypertrophic Cardiomyopathy, Familial|Hypertrophy, Familial Ventricular|Familial Ventricular Hypertrophies|Ventricular Hypertrophy, Hereditary|ventricular hypertrophy|Hereditary Ventricular Hypertrophy|Hypertrophy, Hereditary Ventricular|Asymmetric Septal Hypertrophy, Familial|Cardiomyopathies, Familial Hypertrophic|Hypertrophic Cardiomyopathies, Familial|Ventricular Hypertrophies, Hereditary|Hereditary Ventricular Hypertrophies|Hypertrophic Subaortic Stenosis, Idiopathic|Obstructive Asymmetric Septal Hypertrophy|Ventricular Hypertrophy, Familial|Ventricular Hypertrophies, Familial|Hypertrophies, Hereditary Ventricular|Cardiomyopathy, Familial Hypertrophic|Familial Hypertrophic Cardiomyopathies"
D054549,DISEASE,Takotsubo Cardiomyopathy,"|Tako-tsubo Cardiomyopathy|Syndromes, Tako-tsubo|Tako tsubo Syndrome|Left Ventricular Apical Ballooning Syndrome|Syndromes, Broken Heart|Tako tsubo Cardiomyopathy|Cardiomyopathy, Stress|left ventricular apical ballooning syndrome|cardiomyopathy|Takotsubo syndrome|Stress Cardiomyopathy|Cardiomyopathy, Takotsubo|Apical Ballooning Syndrome|Transient Apical Ballooning Syndrome|Broken Heart Syndrome|Syndrome, Broken Heart|Takotsubo cardiomyopathy|Takotsubo Syndrome|Tako-tsubo Syndrome|stress cardiomyopathy|Cardiomyopathy, Tako-tsubo|Tako-tsubo Syndromes|Syndrome, Apical Ballooning|Syndrome, Tako-tsubo|Stress cardiomyopathy"
D056989,DISEASE,Inferior Wall Myocardial Infarction,"Myocardial Infarctions, Inferior|Diaphragmatic Myocardial Infarction|Acute Inferior Myocardial Infarction|myocardial infarction|Infarction, Diaphragmatic Myocardial|Diaphragmatic Myocardial Infarctions|Infarction, Inferior Myocardial|infarction|Myocardial Infarction, Inferior Wall|Infarctions, Diaphragmatic Myocardial|Inferior Myocardial Infarctions|Infarctions, Inferior Myocardial|Myocardial Infarction, Diaphragmatic|Myocardial Infarction, Inferior|Myocardial Infarctions, Diaphragmatic|Inferior Myocardial Infarction"
NEW00913,DISEASE,Acute myocardial ischemia,Acute myocardial ischemia
D003329,DISEASE,Coronary Vasospasm,"Coronary Artery Vasospasms||Artery Vasospasm, Coronary|Artery Vasospasms, Coronary|Vasospasms, Coronary Artery|Vasospasm, Coronary Artery|Coronary Vasospasms|Vasospasms, Coronary|coronary vasospasm|Coronary Artery Vasospasm|Vasospasm, Coronary|coronary spasm"
NEW00914,DISEASE,cocaine-induced myocardial infarction,cocaine-induced myocardial infarction
D009543,CHEMICAL,Nifedipine,"|Cordipin|Nifedipine-GTIS|Monohydrochloride, Nifedipine|Procardia XL|Nifedipine Monohydrochloride|Bay1040|Bay-1040|Procardia|Cordipine|Nifangin|Corinfar|Korinfar|Nifedipine GTIS|BAYa1040|Bay 1040|Vascard|BAY a 1040|Adalat|Fenigidin|BAY-a-1040|nifedipine"
D009566,CHEMICAL,Nitrates,nitrates|Nitrate
NEW00915,DISEASE,chronic assaultiveness,chronic assaultiveness
D058226,DISEASE,"Plaque, Atherosclerotic","Streak, Arterial Fatty|Fibroatheromatous Plaques|Atheromas|Atherosclerotic Plaques|Plaque, Atheromatous|Atheroma|Plaques, Atherosclerotic|atherosclerotic plaques|Atherosclerotic Plaque|Atheromatous Plaques|Fibroatheroma|Atheromatous Plaque|Fibroatheromas|Arterial Fatty Streak|Arterial Fatty Streaks|Plaque, Fibroatheromatous|atheromatous plaques|Fibroatheromatous Plaque|Plaques, Fibroatheromatous|Plaques, Atheromatous|Fatty Streaks, Arterial|Streaks, Arterial Fatty|Fatty Streak, Arterial"
D010323,DISEASE,Passive Cutaneous Anaphylaxis,"PCA|Anaphylaxis, Passive Cutaneous|anaphylaxis|Cutaneous Anaphylaxis, Passive"
NEW00916,DISEASE,syndrome medications,syndrome medications
NEW00917,DISEASE,autonomous cortisol secretion,ACS|autonomous cortisol secretion
D004837,CHEMICAL,Epinephrine,"|epinephrine|Adrenaline Bitartrate|Adrenaline Hydrochloride|Epinephrine Hydrochloride|Epinephrine Acetate|4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol|Epinephrine Bitartrate|Epinephrine Hydrogen Tartrate|Epinephrine|Epifrin|Adrenaline|Adrenaline Acid Tartrate|Epitrate|Acetate, Epinephrine|Lyophrin|Medihaler-Epi"
D007741,CHEMICAL,Labetalol,"|Labetalol|R,R-Labetalol|SCH19927|Normodyne|R,R Labetalol|Apo-Labetalol|Apo Labetalol|SCH 19927|AH5158|Trandate|Labetalol, (R,R)-Isomer|Albetol|Hydrochloride, Labetalol|Presolol|AH 5158|Labetalol Hydrochloride|AH-5158|Labetolol|SCH-19927|ApoLabetalol|labetalol|Dilevalol"
NEW00918,DISEASE,hypertensive emergencies,hypertensive emergencies
D008881,MENTAL_HEALTH,Migraine Disorders,"|Acute Confusional Migraines|Abdominal Migraines|Migraines, Hemicrania|Migraines, Acute Confusional|Cervical Migraine Syndrome|Sick Headache|Sick Headaches|Disorder, Migraine|Migraine Syndromes, Cervical|Headaches, Migraine|Headache, Sick|Disorders, Migraine|migraines|Hemicrania Migraines|Migraine Variant|Cervical Migraine Syndromes|Migraine, Acute Confusional|Migraine Syndrome, Cervical|Migraines|Migraine Headache|migraine headache|Migraines, Abdominal|Migraine Variants|Hemicrania Migraine|Variants, Migraine|Migraine Headaches|Acute Confusional Migraine|Migraine, Hemicrania|Status Migrainosus|Migraine|Headaches, Sick|migraine|Migraine Disorder|Migraine, Abdominal|Variant, Migraine|Headache, Migraine|migraine headaches|Abdominal Migraine"
NEW00919,DISEASE,palpitations,palpitations
NEW00920,MENTAL_HEALTH,sluggishness sexual dysfunction,sluggishness sexual dysfunction
D013565,CHEBI,Sympatholytics,"Sympatholytic Drugs|Sympatholytic Effects|sympatholytic agents|Sympathetic-Blocking Agents|Sympatholytic Agents|Sympatholytic Agent|Effect, Sympatholytic|Sympatholytic|Drug, Sympatholytic|Sympatholytic Effect|Sympathetic Blocking Agents|Agents, Sympathetic-Blocking|Effects, Sympatholytic|Sympatholytic drugs|Drugs, Sympatholytic|Agents, Sympatholytic|sympatholytic|Agent, Sympatholytic|Sympatholytic Drug"
D007008,DISEASE,Hypokalemia,|Hypokalemias|hypokalemia|Hypopotassemia|Hypopotassemias|Hypokalemia
NEW00921,CHEBI,nonselective beta-adrenergic blockers,nonselective beta-adrenergic blockers
D049993,CHEMICAL,Sodium Chloride Symporter Inhibitors,"Thiazide Diuretics|Sodium Chloride Symporter Inhibitor|Benzothiadiazine Diuretic|Thiazide diuretics|Diuretic, Benzothiadiazine|Thiazide Sensitive NaCl Cotransporter Inhibitor|sodium chloride|Diuretic, Potassium Depleting|Thiazide Diuretic|Diuretics, Thiazide|Diuretics, Benzothiadiazine|Sodium Chloride Cotransporter Inhibitors|Potassium Depleting Diuretics|Diuretic, Thiazide|Diuretics, Potassium Depleting|Thiazide Sensitive NaCl Cotransporter Inhibitors|Potassium Depleting Diuretic|Benzothiadiazine Diuretics|Depleting Diuretic, Potassium|Sodium Chloride Cotransporter Inhibitor"
D018783,MENTAL_HEALTH,"Impotence, Vasculogenic","Penile Venous Leakage|Arteriogenic Impotence|vasculogenic impotence|Impotence, Venogenic|Impotence, Arteriogenic|Venous Leakage, Penile|Leakage, Penile Venous|Venogenic Impotence|impotence|Vasculogenic Impotence"
NEW00922,MENTAL_HEALTH,craving levels,craving levels
NEW00923,CHEMICAL,beta blocker,atenolol|one peripheral|beta blocker
D066249,MENTAL_HEALTH,Craving,Craving|Cravings|craving
NEW00924,DISEASE,psychocardiac disorders,psychocardiac disorders
D015220,CHEMICAL,Calcium Channels,"Ion Channel, Calcium|Voltage Dependent Calcium Channel|Channels, Voltage-Dependent Calcium|Voltage-Dependent Calcium Channel|Calcium Ion Channel|VDCC|Calcium Channel Antagonist Receptor|Calcium Ion Channels|Voltage Dependent Calcium Channels|Receptors, Calcium Channel Antagonist|calcium-channel blocker|Calcium Channel|Calcium Channel Blocker Receptors|Receptors, Calcium Channel Blocker|Ion Channels, Calcium|Voltage-Dependent Calcium Channels|Calcium Channel, Voltage-Dependent|Calcium Channels, Voltage-Dependent|Calcium Channel Blocker Receptor|Calcium Channel Antagonist Receptors|Channel, Voltage-Dependent Calcium"
NEW00925,CHEMICAL,blocker verapamil,blocker verapamil
NEW00926,MENTAL_HEALTH,anxiety neurosis,anxiety neurosis
NEW00927,CHEMICAL,psychostimulants,psychostimulants
NEW00928,CHEMICAL,Bupropion antidepressants,Bupropion antidepressants
NEW00929,DISEASE,managing cognitive symptoms,managing cognitive symptoms
D000316,CHEBI,Adrenergic alpha-Agonists,"α-adrenergic agonists|Receptor Agonists, alpha-Adrenergic|alpha Adrenergic Receptor Agonists|Receptor Agonists, alpha Adrenergic|Agonists, Adrenergic alpha-Receptor|Adrenergic alpha Receptor Agonist|Agonists, alpha-Adrenergic|alpha-Adrenergic Receptor Agonist|Agonist, Adrenergic alpha-Receptor|Agonist, alpha-Adrenergic Receptor|Adrenergic alpha-Receptor Agonist|alpha Adrenergic Agonists|Alpha adrenergic agonists|Adrenergic alpha-Receptor Agonists|alpha Adrenergic Agonist|Agonist, alpha-Adrenergic|Alpha-adrenergic agonists|Adrenergic alpha Agonist|alpha-Adrenergic Agonists|Agonists, alpha-Adrenergic Receptor|Receptor Agonists, Adrenergic alpha|alpha-Adrenergic Agonist|alpha-agonists|α agonist|Adrenergic alpha-Agonist|Receptor Agonist, alpha-Adrenergic|alpha Adrenergic Receptor Agonist|Adrenergic alpha Agonists|alpha-Agonists, Adrenergic|Adrenergic alpha Receptor Agonists|alpha-Receptor Agonists, Adrenergic|alpha-Receptor Agonist, Adrenergic|alpha receptor|alpha-adrenergic agonist|alpha-Agonist, Adrenergic|alpha-Adrenergic Receptor Agonists"
D000077265,CHEMICAL,Donepezil,"Aricept|1-Benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine hydrochloride|donepezil|Eranz|E-2020|Donepezil|E2020|Donepezilium Oxalate Trihydrate|Donepezil Hydrochloride|E 2020"
NEW00930,MENTAL_HEALTH,core ADHD symptoms,core ADHD symptoms
NEW00931,CHEBI,ABSTRACT beta-Adrenergic blockers,ABSTRACT beta-Adrenergic blockers
NEW00932,DISEASE,verbal aggression,verbal aggression
NEW00933,DISEASE,physical aggression,physical aggression
NEW00934,DISEASE,peripheral blockade,peripheral blockade
NEW00935,CHEMICAL,5-(2-Chlorophenoxy)-3-methyl-1-phenyl-1H-pyrazole-4-carbaldehyde,5-(2-Chlorophenoxy)-3-methyl-1-phenyl-1H-pyrazole-4-carbaldehyde
NEW00936,CHEMICAL,carbaldehyde group,carbaldehyde group
C042788,CHEMICAL,fluoren-9-ol [Supplementary Concept],9-hydroxyfluorene|Fluorenes
C562130,CHEMICAL,2-hydroxynaphthalene(dodecylo)-6-sulfonamide [Supplementary Concept],Naphthalenes|2-hydroxynaphthalene|Sulfonamides
NEW00937,CHEMICAL,3-hydroxyphenanthrene,3-hydroxyphenanthrene
C093851,CHEMICAL,1-hydroxypyrene-glucuronide [Supplementary Concept],Glucuronates|1-hydroxypyrene|Pyrenes
NEW00938,CHEMICAL,urinary polyaromatic hydrocarbons,urinary polyaromatic hydrocarbons
C477779,CHEMICAL,2-hydroxyfluorene [Supplementary Concept],2-hydroxyfluorene|Fluorenes
NEW00939,CHEMICAL,1-hydroxynaphthalene 1-naphthol,1-hydroxynaphthalene 1-naphthol
NEW00940,CHEMICAL,polar phenolic extract,polar phenolic extract
NEW00941,DISEASE,human neuroblastoma SK-N-SH cells,human neuroblastoma SK-N-SH cells
NEW00942,CHEMICAL,Dietary flavonoids,Dietary flavonoids
NEW00943,DISEASE,various chronic diseases,various chronic diseases
D003000,CHEMICAL,Clonidine,"|Catapressan|Monohydrochloride, Clonidine|Clonidine Monohydrochloride|M5041T|Catapresan|ST155|Clonidine|Clonidine hydrochloride|Clonidine Monohydrobromide|ST-155|Klofenil|Gemiton|Clopheline|M-5041T|clonidine|Hemiton|Hydrochloride, Clonidine|Chlophazolin|Catapres|ST 155|Isoglaucon|Clofelin|Clonidine Dihydrochloride|Monohydrobromide, Clonidine|Dixarit|Clonidine Hydrochloride|Clofenil|Dihydrochloride, Clonidine|Klofelin|M 5041T"
NEW00944,CHEBI,acting alpha-2 selective adrenergic receptor agonist,acting alpha-2 selective adrenergic receptor agonist
NEW00945,DISEASE,Adult Separation Anxiety Disorder,Adult Separation Anxiety Disorder|ASAD
D000069503,CHEMICAL,Vilazodone Hydrochloride,"Vilazodone HCl|EMB-68843|Vilazodone|EMB68843|vilazodone|Viibryd|Hydrochloride, Vilazodone|2-benzofurancarboxamide, 5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)-1-piperazinyl)-, hydrochloride (1:1)|EMB 68843|5-(4-(4-(5-cyano-3-indolyl)butyl)-1-piperazinyl)benzofuran-2-carboxamide|68843, EMD|EMD 68843|HCl, Vilazodone"
NEW00946,MENTAL_HEALTH,Obsessive-compulsive disorder patients,Obsessive-compulsive disorder patients
D058825,CHEBI,Serotonin 5-HT1 Receptor Agonists,"Serotonin agonists|Agonist, 5-HT1B|Serotonin 5 HT1D Receptor Agonists|Serotonin 5-HT1A Receptor Agonists|Agonist, 5-HT1|5-HT1A receptor agonists|5-HT1 Agonists|5 HT1 Agonists|Serotonin 5-HT1B-D Agonists|Serotonin 5 HT1 Receptor Agonists|5-HT1B receptor agonists|Serotonin 5 HT1B Receptor Agonists|Agonist, 5-HT1A|Serotonin 5-HT1D Receptor Agonists|5-HT1B-D Agonists, Serotonin|5-HT1D Agonist|serotonin agonists|Serotonin 5 HT1B D Agonists|5 HT1B D Agonist|Serotonin 5-HT1B Receptor Agonists|Agonists, Serotonin 5-HT1B-D|5-HT1A Agonist|5-HT1a agonist|5-HT1A agonist|5-HT1B Agonist|5-HT1B-D Agonist|5 HT1A Agonist|5-HT1 Agonist|Agonist, 5-HT1B-D|Agonists, 5-HT1|5 HT1 Agonist|Agonist, 5-HT1D|Serotonin 5 HT1A Receptor Agonists|5 HT1D Agonist|5 HT1B Agonist"
D050486,CHEMICAL,Serotonin Plasma Membrane Transport Proteins,"Serotonin Transporter|Transporter, Sodium-Dependent Serotonin|Serotonin-Specific Neurotransmitter Transporters|Platelet Serotonin Transporter|Neurotransmitter Transporters, Serotonin-Specific|Sodium-Dependent Serotonin Transporter|Platelets Serotonin Transporter|platelet serotonin|5-Hydroxytryptamine Plasma Membrane Transport Protein|5 Hydroxytryptamine Plasma Membrane Transport Protein|Serotonin Transporter, Platelet|Neurotransmitter Transport Proteins, Serotonin-Specific|Neurotransmitter Transport Proteins, Serotonin Specific|Solute Carrier Family 6, Member 4 Protein|serotonin transporter SERT|Serotonin Plasma Membrane Transporter Proteins|Serotonectin|SERT Proteins|Serotonin Transporter, Platelets|specific serotonin|Serotonin Transporter, Sodium-Dependent|Sodium Dependent Serotonin Transporter|SLC6A4 Protein|serotonin transporter|5HT Transporter|Neurotransmitter Transporters, Serotonin Specific"
NEW00947,DISEASE,glia restricted progenitor GRP cells,glia restricted progenitor GRP cells
NEW00948,CHEMICAL,NSC production,NSC production
NEW00949,CHEMICAL,NR4A1 Nur77 subfamily,NR4A1 Nur77 subfamily
D001171,DISEASE,"Arthritis, Juvenile","Arthritis, Juvenile Idiopathic|Stills Disease, Juvenile-Onset|Rheumatoid Arthritis, Juvenile|Juvenile-Onset Stills Disease|Still Disease, Juvenile Onset|Still Disease, Juvenile-Onset|Juvenile Enthesitis-Related Arthritis|Juvenile Rheumatoid Arthritis|Arthritis, Juvenile Enthesitis-Related|Juvenile-Onset Still Disease|Juvenile-Onset Still's Disease|juvenile arthritis|rheumatoid arthritis|Systemic Arthritis, Juvenile|Oligoarthritis, Juvenile|Juvenile Idiopathic Arthritis|Chronic Arthritis, Juvenile|Juvenile Arthritis|Arthritis, Juvenile Chronic|Polyarthritis, Juvenile, Rheumatoid Factor Positive|Arthritis, Juvenile Systemic|Juvenile Oligoarthritis|Juvenile Chronic Arthritis|Arthritis, Juvenile Rheumatoid|Arthritis, Juvenile Psoriatic|JIA|Juvenile Systemic Arthritis|Psoriatic Arthritis, Juvenile|Still's Disease, Juvenile Onset|Enthesitis-Related Arthritis, Juvenile|Enthesitis Related Arthritis, Juvenile|Idiopathic Arthritis, Juvenile|Juvenile Onset Stills Disease|Juvenile idiopathic arthritis|Juvenile Onset Still Disease|Juvenile Psoriatic Arthritis|Still's Disease, Juvenile-Onset|Polyarthritis, Juvenile, Rheumatoid Factor Negative"
D050197,DISEASE,Atherosclerosis,|Atherosclerosis|atherosclerotic|Atherogenesis|atherogenesis|Atheroscleroses|atherosclerosis
D018160,CHEBI,"Receptors, Cytoplasmic and Nuclear","Membrane Receptors, Intracellular|Receptors, Nuclear Hormone|Hormone Receptors, Nuclear|Receptor, Nuclear Hormone|Nuclear Hormone Receptors|Hormone Receptors, Cytoplasmic|Nuclear Receptors|Receptors, Cytoplasmic|Receptor, Cytoplasmic|Cytoplasmic Receptors|Nuclear Receptor|Receptors, Cytosol and Nuclear|Nuclear and Cytoplasmic Receptors|Cytosolic and Nuclear Receptors|Receptors, Nuclear|Receptors, Intracellular Membrane|Receptor, Nuclear|Cytoplasmic and Nuclear Receptors|Hormone Receptor, Nuclear|Nuclear Hormone Receptor|nuclear hormone receptors|Intracellular Membrane Receptors|Cytosol and Nuclear Receptors|Receptors, Cytoplasmic Hormone|Receptors, Nuclear and Cytoplasmic|Receptors, Cytosolic and Nuclear|Cytoplasmic Receptor|Cytoplasmic Hormone Receptors"
NEW00950,CHEMICAL,mM Li+ concentration,mM Li+ concentration
NEW00951,CHEMICAL,"Ins(1,4,5)P3","Ins(1,4,5)P3"
NEW00952,CHEMICAL,"mass inositol 1,4,5-trisphosphate","mass inositol 1,4,5-trisphosphate"
NEW00953,CHEMICAL,intracellular free-Ca2,intracellular free-Ca2
NEW00954,DISEASE,manic-depressive disorder,manic-depressive disorder
NEW00955,NUTRITION,inositol phospholipid second-messenger generating system,inositol phospholipid second-messenger generating system
NEW00956,DISEASE,early THC abuse,early THC abuse
NEW00957,DISEASE,neuropsychological deficits,neuropsychological deficits
NEW00958,CHEMICAL,dopamine imbalances,dopamine imbalances
NEW00959,MENTAL_HEALTH,schizophrenia related,schizophrenia related
C510793,CHEMICAL,pimavanserin [Supplementary Concept],Piperidines|Urea/analogs  and  derivatives|Pimavanserin|pimavanserin
NEW00960,CHEBI,partial agonist,partial agonist
NEW00961,CHEBI,hormone dysregulation,hormone dysregulation
NEW00962,CHEMICAL,D-amino-acid-oxidase activator/G30 gene complex,D-amino-acid-oxidase activator/G30 gene complex
NEW00963,CHEMICAL,dopamine transporter gene,dopamine transporter gene
NEW00964,CHEMICAL,serotonin transporter gene,serotonin transporter gene
NEW00965,NUTRITION,tryptophan hydroxylase gene,tryptophan hydroxylase gene
NEW00966,CHEMICAL,new antidepressant agomelatine,new antidepressant agomelatine
NEW00967,CHEMICAL,first melatonergic antidepressant,first melatonergic antidepressant
NEW00968,CHEMICAL,agonists pramipexole,agonists pramipexole
NEW00969,CHEMICAL,dopamine modulator,dopamine modulator
NEW00970,CHEMICAL,modulator aripiprazole,modulator aripiprazole
C533287,CHEMICAL,cariprazine [Supplementary Concept],Cariprazine|cariprazine|Piperazines
NEW00971,CHEMICAL,potent dopamine D3    mg/d,potent dopamine D3    mg/d
NEW00972,CHEMICAL,K(+)-channel blocker 4-aminopyridine,K(+)-channel blocker 4-aminopyridine
NEW00973,CHEMICAL,glutamate release,glutamate release
NEW00974,CHEMICAL,AMPA infusion,AMPA infusion
D020514,DISEASE,Hypokalemic Periodic Paralysis,"Periodic Paralysis- Hypokalemics|Westphall Disease|Hypokalemic Periodic Paralysis, Familial|Paralysis, Hypokalemic Periodic|Primary Hypokalemic Periodic Paralysis|Periodic Paralysis- Hypokalemic|HYPOKPP|HYPOPP|paralysis|HOKPP|Familial Hypokalemic Periodic Paralysis|Periodic Paralysis, Hypokalemic|Periodic Paralysis Hypokalemic"
NEW00975,DISEASE,MN death,MN death
D001640,CHEMICAL,Bicuculline,"|6-(5,6,7,8-Tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)furo(3,4-e)1,3-benzodioxol-8(6H)one|bicuculline"
NEW00976,DISEASE,hyperexcitation,hyperexcitation
C000603040,CHEMICAL,gintonin [Supplementary Concept],Gintonin|Plant Extracts
NEW00977,DISEASE,neuroinflammation- neurodegeneration,neuroinflammation- neurodegeneration
D055495,DISEASE,Neurogenesis,Neurogeneses|neurogenesis
NEW00978,CHEBI,oestrogen depletion,oestrogen depletion
NEW00979,CHEMICAL,selective GPER agonist G1,selective GPER agonist G1
NEW00980,DISEASE,iron- impairments,iron- impairments
NEW00981,CHEBI,novel oestrogen agonists,novel oestrogen agonists
D007213,CHEMICAL,Indomethacin,|Indomethacin|Indocid|Osmosin|Indomet 140|Amuno|Indometacin|indomethacin|Metindol|Indomethacin Hydrochloride|Indocin
NEW00982,CHEMICAL,prostaglandins synthesis,prostaglandins synthesis
NEW00983,CHEMICAL,KCZ mg/kg,KCZ mg/kg
NEW00984,DISEASE,stress (CRS)-induced ulcer formation,stress (CRS)-induced ulcer formation
NEW00985,CHEMICAL,KCZ effects,KCZ effects
NEW00986,CHEMICAL,naltrexone mg/kg pretreatment,naltrexone mg/kg pretreatment
NEW00987,DISEASE,chronic restraint stress,type 1 cardiorenal syndrome|chronic restraint stress|CRS
D017294,CHEMICAL,Ondansetron,"|Ondansetron, (+,-)-Isomer|Ondansetron Monohydrochloride|Ondansetron, (R)-Isomer|SN307|Ondansetron, (S)-Isomer|Zofran|Ondansetron|ondansetron|Ondansetron Monohydrochloride Dihydrate|Hydrochloride, Ondansetron|4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-|SN 307|SN-307|GR38032F|Dihydrate, Ondansetron Monohydrochloride|Ondansetron Hydrochloride|Monohydrochloride, Ondansetron|Monohydrochloride Dihydrate, Ondansetron|GR-38032F|GR 38032F"
NEW00988,CHEBI,serotonin 5HT3 receptor antagonist,serotonin 5HT3 receptor antagonist
NEW00989,CHEBI,ondansetron 5HT3 antagonist,ondansetron 5HT3 antagonist
D000077526,CHEMICAL,Tropisetron,Navoban|Indole 3 carboxylic Acid Tropine Ester|tropisetron|ICS-205930|(3 alpha-Tropanyl)-1H-indole-3-carboxylic Acid Ester|ICS 205-930|Indole-3-carboxylic Acid Tropine Ester|ICS-205-930|ICS 205930|ICS 205 930|Tropisetron Hydrochloride
NEW00990,CHEMICAL,Liraglutide mg,Liraglutide mg
NEW00991,CHEBI,once daily GLP-1 receptor agonist,once daily GLP-1 receptor agonist
NEW00992,CHEBI,Selective agonists,Selective agonists
NEW00993,CHEMICAL,M4 muscarinic acetylcholine receptors,M4 muscarinic acetylcholine receptors
NEW00994,DISEASE,rheumathoid arthritis,rheumathoid arthritis
NEW00995,MENTAL_HEALTH,conditions sexual impotence,conditions sexual impotence
NEW00996,DISEASE,haemorrhagic shock,haemorrhagic shock
NEW00997,DISEASE,toxic neuropathies,toxic neuropathies
D002100,DISEASE,Cachexia,HIV Wasting Syndrome|Wasting Syndrome|cachexia
D058639,DISEASE,Cold-Shock Response,"Responses, Cold-Stress|Stresses, Cold Shock|Cold-Stress Response|Cold Shocks|Stress, Cold|Stress, Cold Shock|Cold Stress Reaction|Response, Cold-Stress|Cold Shock Response|Cold-Stress Responses|Cold Shock|Cold-Stress Reaction|Cold Stress|Cold Stress Response|Shock Stresses, Cold|Cold Shock Stress|Cold-Shock Responses|Cold-Stress Reactions|Shock Stress, Cold|Cold Shock Stresses|shock"
NEW00998,DISEASE,ischemia/reperfusion-induced brain damage,ischemia/reperfusion-induced brain damage
D003929,DISEASE,Diabetic Neuropathies,"|Diabetic Polyneuropathy|Simplex, Diabetic Mononeuropathy|Diabetic Neuropathy|Diabetic Mononeuropathies|Diabetic Autonomic Neuropathy|Mononeuropathy Simplices, Diabetic|Painful Diabetic Neuropathies|Polyneuropathies, Diabetic Asymmetric|Diabetic Amyotrophies|Diabetic Mononeuropathy Simplex|Autonomic Neuropathies, Diabetic|Mononeuropathy, Diabetic|Neuropathy, Diabetic Autonomic|painful diabetic neuropathy|Neuralgia, Diabetic|Polyneuropathies, Diabetic|Diabetic Neuropathies, Painful|Simplices, Diabetic Mononeuropathy|Diabetic Neuralgias|Diabetic Autonomic Neuropathies|Neuropathies, Diabetic|Neuropathies, Painful Diabetic|Amyotrophy, Diabetic|Asymmetric Diabetic Proximal Motor Neuropathy|Neuropathies, Diabetic Autonomic|Polyneuropathy, Diabetic|Polyneuropathy, Diabetic Asymmetric|Diabetic Mononeuropathy|Symmetric Diabetic Proximal Motor Neuropathy|Autonomic Neuropathy, Diabetic|Asymmetric Polyneuropathies, Diabetic|diabetic neuropathy|mononeuropathy|Diabetic Polyneuropathies|Neuropathy, Diabetic|Diabetic Asymmetric Polyneuropathy|Amyotrophies, Diabetic|Neuropathy, Painful Diabetic|Diabetic Asymmetric Polyneuropathies|Painful Diabetic Neuropathy|Mononeuropathy Simplex, Diabetic|Mononeuropathies, Diabetic|Neuralgias, Diabetic|Diabetic Amyotrophy|Diabetic Neuropathy, Painful|Diabetic Mononeuropathy Simplices|diabetic autonomic neuropathy|Diabetic Neuralgia|Asymmetric Polyneuropathy, Diabetic"
C084711,CHEMICAL,agomelatine [Supplementary Concept],Valdoxan|Acetamides|Naphthalenes|agomelatine|Agomelatine
NEW00999,DISEASE,novelty-induced hypophagia,novelty-induced hypophagia
NEW01000,CHEMICAL,KCl-evoked serotonin,KCl-evoked serotonin
NEW01001,CHEMICAL,KCl-evoked 5-HT release,KCl-evoked 5-HT release
NEW01002,CHEMICAL,5-HT release,5-HT release
NEW01003,CHEMICAL,antidepressant action,antidepressant action
NEW01004,MENTAL_HEALTH,type depression,type depression
NEW01005,CHEBI,dopamine-serotonin partial agonist,dopamine-serotonin partial agonist
NEW01006,CHEMICAL,increased cortisol levels,increased cortisol levels
NEW01007,DISEASE,epilepsy patients,epilepsy patients
NEW01008,CHEBI,behavior hormone levels,behavior hormone levels
C095476,CHEMICAL,"theophylline, salbutamol drug combination [Supplementary Concept]",salbutamol|Albuterol|Theophylline|Drug Combinations
D025521,DISEASE,Tumor Suppressor Proteins,"Metastasis Suppressor Proteins|Proteins, Growth Suppressor|Suppressor Protein, Metastasis|Protein, Metastasis Suppressor|Metastasis Suppressor Protein|Proteins, Metastasis Suppressor|Proteins, Tumor Suppressor|Suppressor Protein, Tumor|Tumor Suppressor Protein|Growth Suppressor Proteins|tumor growth|Protein, Tumor Suppressor"
NEW01009,DISEASE,transplanted tumor tissue,transplanted tumor tissue
NEW01010,MENTAL_HEALTH,conclusion chronic stress model,conclusion chronic stress model
NEW01011,CHEMICAL,miR-134 5p promoter,miR-134 5p promoter
C039979,CHEMICAL,gepirone [Supplementary Concept],gepirone|Pyrimidines|Gepirone
D019263,MENTAL_HEALTH,Dysthymic Disorder,"Disorder, Dysthymic|Dysthymia and Chronic Depression|dysthymia|chronic depression|Dysthymia|Dysthymic|neurotic depression|Neurotic Depression, Persistent Depressive Disorder|Persistent Depressive Disorder, Dysthymia|Dysthymic Disorders|dysthymic disorder"
NEW01012,CHEMICAL,novel antidepressant,novel antidepressant
NEW01013,CHEMICAL,serotonin 1A receptor partial agonist ipsapirone hydrochloride,serotonin 1A receptor partial agonist ipsapirone hydrochloride
NEW01014,CHEBI,master hormone,master hormone
D014527,CHEMICAL,Uric Acid,"Monosodium Urate|Potassium Urate|Monohydrate, Monosodium Urate|uric acid|Urate|Monosodium Urate Monohydrate|Acid Urate, Ammonium|Acid, Uric|Sodium Acid Urate Monohydrate|Urate, Sodium|Urate Monohydrate, Sodium|2,6,8-Trihydroxypurine|Trioxopurine|Urate, Potassium|Acid Urate, Sodium|Urate, Sodium Acid|Ammonium Acid Urate|Sodium Urate Monohydrate|Urate, Monosodium|Urate Monohydrate, Monosodium|Sodium Urate|Urate, Ammonium Acid|Sodium Acid Urate|Monohydrate, Sodium Urate"
D000493,CHEMICAL,Allopurinol,Embarin|Lysuron|Pan Quimica|Urosin|Milurit|Allural|Xanthomax|Urtias|Cellidrin|Xanturic|Allohexan|Jenapurinol|Uripurinol|Purinol|Capurate|Pureduct|Hamarin|Alloprin|Allorin|Apurin|Apulonga|Caplenal|Allopurin|Progout|Allohexal|Novopurol|Tipuric|Bleminol|Uribenz|Lopurin|Allpargin|Remid|Rimapurinol|Zygout|allopurinol|Zyloric|Roucol|Milurite|Uridocid|Atisuril|Suspendol|Foligan|Zyloprim
D006074,DISEASE,Gout Suppressants,"Antigout Agents|Agents, Antigout|Antihyperuricemics|Suppressants, Gout|Antihyperuricemic|gout"
NEW01015,CHEMICAL,nucleotide receptors,nucleotide receptors
NEW01016,CHEMICAL,adenosine P1 receptors,adenosine P1 receptors
D043705,CHEMICAL,"Receptor, Adenosine A2A","A2A Receptor, Adenosine|A(2A receptor|adenosine receptors|Adenosine A2A Receptors|Adenosine A2A Receptor|adenosine A(2A receptor|adenosine A2A|Adenosine A(2A) Receptor|Receptors, Adenosine A2A|Adenosine A(2A|adenosine A2A receptors|A2A Receptors, Adenosine|Adenosine receptors"
D064428,CHEMICAL,Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels,"Channels, Ih Cation|Channel, HCN2|Hyperpolarization Activated Cyclic Nucleotide-Gated Potassium Channel 2|HCN2 Potassium Channel|Potassium Channel, HCN2|Channel, HCN4|Hyperpolarization Cyclic-Nucleotide Gated Cation Channel 3|Channels, HCN Pacemaker|Hyperpolarization Cyclic-Nucleotide Gated Ion Channels|Pacemaker Channels, HCN|I(h) Channels|Hyperpolarization Cyclic-Nucleotide Gated Cation Channel 4|Channel, Hyperpolarization-Activated Cation|Potassium Sodium Hyperpolarization Activated Cyclic Nucleotide Gated Channel 2|Hyperpolarization Cyclic Nucleotide Gated Ion Channels|nucleotide|Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 2|Hyperpolarization Activated Cyclic Nucleotide Gated Channels|Cation Channel, Hyperpolarization-Activated|Hyperpolarization Cyclic Nucleotide Gated Cation Channel 3|Channel, HCN2 Potassium|Channel, HCN1|Hyperpolarization Activated Cation Channel|HCN1 Channel|Hyperpolarization-Activated Cation Channel|HCN Pacemaker Channels|I(h) Cation Channels|HCN3 Channel|Hyperpolarization Cyclic-Nucleotide Gated Cation Channel 1|Channel, HCN3|Ih Cation Channels|Cation Channels, Ih|Potassium-Sodium Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel 2|Hyperpolarization Cyclic Nucleotide Gated Cation Channel 4|Hyperpolarization Cyclic Nucleotide Gated Cation Channel 1|HCN2 Channel|HCN4 Channel"
NEW01017,CHEBI,KOR antagonist treatment,KOR antagonist treatment
NEW01018,DISEASE,anxiogenic affective-like behaviors,anxiogenic affective-like behaviors
D006966,DISEASE,Hyperprolactinemia,"Prolactin Hypersecretion Syndrome||Secretion Prolactin, Inappropriate|Hyperprolactinaemia|hyperprolactinaemia|hyperprolactinemia|Syndrome, Prolactin Hypersecretion|Secretion, Inappropriate Prolactin|Prolactin, Inappropriate Secretion|Inappropriate Secretion Prolactin|hyperprolactinemic|Hypersecretion Syndrome, Prolactin|Hyperprolactinemia|Inappropriate Prolactin Secretion Syndrome|Hyperprolactinemias|Prolactin Secretion, Inappropriate|Inappropriate Prolactin Secretion"
NEW01019,CHEMICAL,methadone maintenance therapy,methadone maintenance therapy
NEW01020,MENTAL_HEALTH,improved anxiety,improved anxiety
NEW01021,CHEMICAL,potent dopamine D3/D2 receptor partial agonist,potent dopamine D3/D2 receptor partial agonist
D053578,DISEASE,Opsoclonus-Myoclonus Syndrome,"Myoclonus, Opsoclonus|Dancing Eyes, Dancing Feet Syndrome|Dancing Eyes Dancing Feet Syndrome|myoclonus|Paraneoplastic Opsoclonus Myoclonus Ataxia|Myoclonus|Dancing Eyes-Dancing Feet Syndrome|Opsoclonus Myoclonus Ataxia|Paraneoplastic Opsoclonus-Myoclonus Ataxia|Kinsbourne Syndrome|Infants Myoclonic Encephalopathy|Opsoclonus Myoclonus|Myoclonic Encephalopathy of Infants|Infants Myoclonic Encephalopathies|Opsoclonus Myoclonus Syndrome"
D000077206,CHEMICAL,Gabapentin,Gabapentin-Ratiopharm|Novo Gabapentin|NovoGabapentin|Novo-Gabapentin|1-(Aminomethyl)cyclohexaneacetic Acid|gabapentin|Neurontin|PMS-Gabapentin|Convalis|Apo Gabapentin|Gabapentin Ratiopharm|ApoGabapentin|Gabapentin|Gabapentin Hexal|Gabapentin Stada|Apo-Gabapentin|GBP
NEW01022,DISEASE,diffuse brain damage,diffuse brain damage
NEW01023,DISEASE,preexisting myoclonus,preexisting myoclonus
NEW01024,MENTAL_HEALTH,chronic static encephalopathy,chronic static encephalopathy
NEW01025,DISEASE,myoclonic potential,myoclonic potential
NEW01026,CHEMICAL,GBP discontinuation,GBP discontinuation
D001418,CHEMICAL,Baclofen,"Clofen|Gen Baclofen|Nu Baclo||Baclofène Irex|NuBaclo|beta-(p-Chlorophenyl)-gamma-aminobutyric Acid|Genpharm|BaclofèneIrex|Nu-Baclo|Baclofène-Irex|Ba34,647|Ba-34647|Atrofen|PMS Baclofen|PCP-GABA|Lebic|GenBaclofen|AWD, Baclofen|Baclofen|Apo Baclofen|beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid|CIBA34,647BA|Baclophen|Ba-34,647|Liorésal|GABA, Chlorophenyl|Gen-Baclofen|Apo-Baclofen|PMS-Baclofen|Baclofen AWD|Baclospas|Lioresal|baclofen|Ba34647|CIBA-34,647-BA|Chlorophenyl GABA|ApoBaclofen|PMSBaclofen"
NEW01027,DISEASE,spastic muscle activity,spastic muscle activity
NEW01028,CHEBI,hepatic vitamin A,hepatic vitamin A
C507711,CHEMICAL,4-(4-(2-(n-butoxy)ethoxy)-5-methylthiazol-2-yl)-2-fluorobenzoic acid [Supplementary Concept],AC261066|Thiazoles|Benzoates
NEW01029,DISEASE,alcohol-driven hepatic retinoid losses,alcohol-driven hepatic retinoid losses
NEW01030,CHEMICAL,retinoic acid RA receptor β2,retinoic acid RA receptor β2
NEW01031,CHEMICAL,cytochrome P450 4A,cytochrome P450 4A|CYP4A
NEW01032,DISEASE,ALD pathogenesis,ALD pathogenesis
NEW01033,CHEBI,agonist SR9009,agonist SR9009
NEW01034,CHEMICAL,CYP4A antagonist,CYP4A antagonist
C000708209,CHEMICAL,HET0016 [Supplementary Concept],HET0016|Amidines
NEW01035,DISEASE,lithium-treated euthymic bipolar patients,lithium-treated euthymic bipolar patients
NEW01036,CHEBI,agonist activation,agonist activation
NEW01037,CHEBI,first drug,first drug
NEW01038,MENTAL_HEALTH,dysfunction hypoactive sexual desire disorder,dysfunction hypoactive sexual desire disorder
NEW01039,CHEMICAL,C-QUIP,C-QUIP
D000068105,CHEMICAL,Bipolar and Related Disorders,ICRDs|related disorders
NEW01040,CHEMICAL,dopamine receptor partial agonists,dopamine receptor partial agonists
D017109,DISEASE,"Akathisia, Drug-Induced","|Akathisia, Drug Induced|akathisia|Drug Induced Akathisia|Acathisia, Drug Induced|Drug-Induced Acathisia|Pseudoakathisia|Akathisia, Tardive|Drug-Induced Akathisia|Acathisia, Drug-Induced|Tardive Akathisia"
C000591922,CHEMICAL,brexpiprazole [Supplementary Concept],Brexpiprazole|Quinolones|Thiophenes|brexpiprazole
NEW01041,CHEMICAL,Partial dopamine agonism,Partial dopamine agonism
NEW01042,CHEBI,partial dopamine agonist activity,partial dopamine agonist activity
NEW01043,MENTAL_HEALTH,pathological gambling due,pathological gambling due
NEW01044,CHEMICAL,mg fludrocortisone,mg fludrocortisone
NEW01045,DISEASE,BPD patients,BPD patients
D005438,CHEMICAL,Fludrocortisone,"9 alpha-Fluoro-17-Hydroxycorticosterone|Astonin-H|Astonin H|9 Fluorohydrocortisone|9 alpha Fluorohydrocortisone|Astonin Merck|Astonin|fludrocortisone|Merck, Astonin|9 alpha-Fluorohydrocortisone|9 Fluorocortisol|9-Fluorocortisol|9 alpha Fludrohydrocortisone|9-Fluoro-17-Hydroxycortisone|FCOL|9 Fluoro 17 Hydroxycortisone|9 alpha Fluoro 17 Hydroxycorticosterone|9-Fluorohydrocortisone"
C056895,CHEMICAL,flesinoxan [Supplementary Concept],flesinoxan|Piperazines
C516975,CHEMICAL,pitolisant [Supplementary Concept],Piperidines|Pitolisant|pitolisant|tiprolisant
D009290,MENTAL_HEALTH,Narcolepsy,"Narcolepsy|Narcoleptic Syndrome|Narcolepsy-Cataplexy Syndromes|Narcolepsy Cataplexy Syndrome|Syndromes, Narcolepsy-Cataplexy|narcolepsy|Narcolepsy-Cataplexy Syndrome|Narcoleptic Syndromes|Sleep, Paroxysmal|Gelineau's Syndromes|Gelineau's Syndrome|Syndrome, Narcoleptic|narcoleptic|Gelineau Syndrome|Syndrome, Gelineau's|Syndromes, Gelineau's|Syndrome, Gelineau|Gelineaus Syndrome|Syndrome, Narcolepsy-Cataplexy|Paroxysmal Sleep|Syndromes, Narcoleptic|narcolepsy-cataplexy syndrome"
D011968,CHEMICAL,"Receptors, Histamine","Histamine Receptor|Histamine Binding Sites|histamine receptors|Sites, Histamine Binding|Receptor, Histamine|Histamine Receptors|Binding Sites, Histamine"
NEW01046,CHEBI,histamine receptor antagonist/inverse agonist,histamine receptor antagonist/inverse agonist
NEW01047,MENTAL_HEALTH,cataplexy rate,cataplexy rate
C000713090,CHEMICAL,MDMB-4en-PINACA [Supplementary Concept],MDMB-4en-PINACA|Cannabinoids
NEW01048,CHEBI,synthetic cannabinoid receptor agonist,synthetic cannabinoid receptor agonist
NEW01049,CHEMICAL,pimavanserin augmentation,pimavanserin augmentation
NEW01050,CHEBI,agonist muscles,agonist muscles
NEW01051,DISEASE,gait disturbance,gait disturbance
D016750,DISEASE,Stiff-Person Syndrome,"Congenital Stiff-Man Syndrome|Syndrome, Stiff-Person|Startle Syndrome|Hyperekplexias, Familial|Syndromes, Stiff-Trunk|Stiff-person syndrome|Stiff-Baby Syndrome|Stiff-Man Syndrome|Congenital Stiff-Person Syndrome|Syndrome, Stiff-Trunk|Syndromes, Startle|Syndromes, Congenital Stiff-Person|Congenital Stiff-Man Syndromes|Familial hyperekplexia|Hereditary Hyperekplexias|Stiff Man Syndrome|Hereditary Hyperekplexia|Moersch-Woltmann Syndrome|Stiff-Person Syndromes, Congenital|Stiff-Trunk Syndromes|Stiff Person Syndrome|Syndrome, Stiffman|Congenital Stiff-Person Syndromes|Syndrome, Moersch-Woltmann|Syndrome, Startle|Familial Hyperekplexia|Hyperekplexias, Hereditary|Syndrome, Congenital Stiff-Man|Stiffman Syndrome|Stiff-Person Syndrome, Congenital|Stiff-Baby Syndromes|Startle Syndromes|Moersch Woltmann Syndrome|Stiff Trunk Syndrome|Hyperekplexia, Hereditary|Syndrome, Stiff-Man|Syndromes, Stiff-Baby|Congenital Stiff Man Syndrome|Stiff-Trunk Syndrome|Familial Hyperekplexias|Syndrome, Stiff-Baby|Stiff-Man Syndromes, Congenital|Syndrome, Congenital Stiff-Person|Stiff-Man Syndrome, Congenital|Hyperekplexia, Familial|Syndromes, Congenital Stiff-Man"
NEW01052,CHEBI,full mu-receptor agonist opioid,full mu-receptor agonist opioid
NEW01053,CHEMICAL,mean morphine equivalent dose,mean morphine equivalent dose
D009270,CHEMICAL,Naloxone,"Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer|MRZ2593|Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer|Naloxone Abello|NLX|Naloxone Hydrochloride|MRZ 2593Br|naloxone hydrochloride|Naloxon Curamed|Hydrochloride Dihydride, Naloxone|Naloxone Hydrochloride Dihydride|Dihydride, Naloxone Hydrochloride|Hydrobromide, Naloxone|MRZ 2593-Br|Naloxone|MRZ-2593|Curamed, Naloxon|MRZ 2593|MRZ 2593 Br|Narcan|Narcanti|Abello, Naloxone|Hydrochloride, Naloxone|Naloxone Hydrobromide|(+)naloxone|naloxone|BuNa|Naloxon Ratiopharm|Naloxon-Ratiopharm|Nalone"
NEW01054,MENTAL_HEALTH,opioid craving,opioid craving
NEW01055,DISEASE,co-occurring psychiatric symptoms,co-occurring psychiatric symptoms
NEW01056,CHEBI,opioid agonist treatment,opioid agonist treatment
NEW01057,CHEBI,full μ-receptor agonist opioids,full μ-receptor agonist opioids
NEW01058,CHEBI,full μ-receptor agonists,full μ-receptor agonists
NEW01059,DISEASE,lower self-reported pain,lower self-reported pain
NEW01060,DISEASE,higher pain tolerance,higher pain tolerance
NEW01061,MENTAL_HEALTH,drug-induced psychosis,drug-induced psychosis
NEW01062,MENTAL_HEALTH,psychotic mania,psychotic mania
NEW01063,CHEBI,its's inverse agonist effect,its's inverse agonist effect
NEW01064,CHEMICAL,selective histamine receptor antagonist/inverse agonist,selective histamine receptor antagonist/inverse agonist
NEW01065,MENTAL_HEALTH,excessive sleepiness,excessive sleepiness
D014486,CHEMICAL,United States Food and Drug Administration,"Drug Administration|USFDA|Food and Drug Administration (U.S.)|Food and Drug Administration|United States Food, Drug Administration|FDA|drug administration"
NEW01066,CHEMICAL,serotonin-norepinephrine viloxazine,serotonin-norepinephrine viloxazine
NEW01067,CHEMICAL,non-stimulant,non-stimulant
NEW01068,CHEMICAL,extended-release capsule,extended-release capsule|viloxazine ER
C507283,CHEMICAL,GLYX-13 peptide [Supplementary Concept],GLYX-13|Oligopeptides
NEW01069,CHEMICAL,selective 5-HT2A antagonist M100907,selective 5-HT2A antagonist M100907
NEW01070,MENTAL_HEALTH,different psychosis models,different psychosis models
D006220,CHEMICAL,Haloperidol,|haloperidol|HAL|Haldol|haloperidol-|Haloperidol
NEW01071,CHEMICAL,NMDA antagonist-,NMDA antagonist-
NEW01072,MENTAL_HEALTH,antagonist- hyperactivity spontaneous locomotion,antagonist- hyperactivity spontaneous locomotion
D058830,CHEBI,Serotonin 5-HT2 Receptor Antagonists,"5-HT2 Antagonist|Serotonin 5 HT2B Receptor Antagonists|serotonin 5-HT2C receptor|5 HT2A Antagonist|Serotonin 5-HT2C Receptor Antagonists|5 HT2B Antagonist|Antagonist, 5-HT2B|Serotonin 5-HT2B Receptor Antagonists|Serotonin 5 HT2 Receptor Antagonists|Antagonist, 5-HT2|5 HT2 Antagonist|Serotonin 5 HT2C Receptor Antagonists|5-HT2A Antagonist|Serotonin 5-HT2A Receptor Antagonists|5-HT2C receptor antagonists|Antagonist, 5-HT2C|5-HT2B Antagonist|Antagonist, 5-HT2A|Serotonin 5 HT2A Receptor Antagonists|5-HT2C Antagonist|5-HT2A receptor antagonists|5 HT2C Antagonist"
NEW01073,DISEASE,behavioural anomalies,behavioural anomalies
NEW01074,CHEMICAL,dopamine agonist apomorphine,dopamine agonist apomorphine
NEW01075,MENTAL_HEALTH,defined melancholia,defined melancholia
D009483,DISEASE,Neuropsychological Tests,"Symbol Digit Modalities Test|Cognitive Test|AX-CPT|Memory for Designs Test|Paced Auditory Serial Addition Test|Tests, Neuropsychological|Neuropsychologic Test|Hooper Visual Organization Test|cognitive function|Clock Test|Testing, Cognitive|Neuropsychological Test|Cognitive Function Scanner|Tests, Cognitive|Delis-Kaplan Executive Function System|Continuous Performance Task|Cognitive Testing|NEPSY|Repeatable Battery for the Assessment of Neuropsychological Status|Controlled Oral Word Association Test|Test, Cognitive|Testing, Neuropsychological|Tower of London Test|Test of Everyday Attention|Behavioral Assessment of Dysexecutive Syndrome|Rey-Osterrieth Complex Figure|Cognitive Tests|Developmental Neuropsychological Assessment|Neuropsychological Testing|Aphasia Tests|CANTAB|Neuropsychologic Tests|Cambridge Neuropsychological Test Automated Battery|Test, Neuropsychological"
NEW01076,CHEBI,dopamine D2 receptor agonist,dopamine D2 receptor agonist
NEW01077,CHEMICAL,oral fenfluramine,oral fenfluramine
NEW01078,DISEASE,non-endogenous subjects,non-endogenous subjects
NEW01079,CHEMICAL,Antidepressant use,Antidepressant use
NEW01080,CHEMICAL,SUD treatment,SUD treatment
C090499,CHEMICAL,salvinorin A [Supplementary Concept],"Diterpenes, Clerodane|Salvinorin A|SalvA"
NEW01081,DISEASE,gastrointestinal disturbances,gastrointestinal disturbances
NEW01082,CHEMICAL,dextromethorphan dependence,dextromethorphan dependence
NEW01083,DISEASE,cough medicine,cough medicine
D003915,CHEMICAL,Dextromethorphan,"|Dextromethorphan Hydrobromide, (+-)-Isomer|Hydrobromide, Dextromethorphan|Racemethorphan|Dextromethorphan Hydrobromide, Monohydrate|Levomethorphan|l-Methorphan|Delsym|Dextromethorphan Hydrobromide|Dextromethorphan Hydrochloride|Dextromethorphan|Hydrochloride, Dextromethorphan|dextromethorphan|Dextromethorphan, (+-)-Isomer|d-Methorphan"
D007926,DISEASE,Lesch-Nyhan Syndrome,"complete HPRT deficiency|Deficiencies, HGPRT|Deficiency Disease, Hypoxanthine-Phosphoribosyl-Transferase|Self-Mutilation Syndrome, Choreoathetosis|Hyperuricemia Syndrome, Juvenile|choreoathetosis|HPRT Deficiencies, Total|Hyperuricemia Syndromes, Juvenile|Juvenile Hyperuricemia Syndrome|Deficiency Disease, Hypoxanthine Phosphoribosyl Transferase|Hyperuricemias, X-Linked Primary|Guanine Phosphoribosyltransferase Deficiency|Syndrome, Juvenile Hyperuricemia|Guanine Phosphoribosyltransferase Deficiencies|HPRT Deficiency, Total|HPRT Deficiency, Complete|HGPRT Deficiency|HGPRT Deficiencies|HPRT Deficiencies, Complete|Primary Hyperuricemia, X-Linked|Complete Hypoxanthine Guanine Phosphoribosyltransferase Deficiency|Total Hypoxanthine Guanine Phosphoribosyl Transferase Deficiency|Lesch Nyhan Syndrome|X-Linked Primary Hyperuricemia|Deficiency of Guanine Phosphoribosyltransferase|Hypoxanthine Guanine Phosphoribosyltransferase Deficiency|Phosphoribosyltransferase Deficiencies, Hypoxanthine|X-Linked Hyperuricemia|Hypoxanthine Phosphoribosyl Transferase Deficiency Disease|Deficiencies, Total HPRT|Hyperuricemia, X-Linked|Phosphoribosyltransferase Deficiency, Hypoxanthine|X Linked Primary Hyperuricemia|Lesch-Nyhan Disease|Hyperuricemia Syndrome, Primary|Lesch-Nyhan syndrome|Total HPRT Deficiency|Total Hypoxanthine-Guanine Phosphoribosyl Transferase Deficiency|Deficiency Diseases, Hypoxanthine-Phosphoribosyl-Transferase|Lesch Nyhan Disease|hypoxanthine guanine phosphoribosyl transferase|Deficiency, HGPRT|Hypoxanthine-Phosphoribosyl-Transferase Deficiency Diseases|hypoxanthine phosphoribosyl transferase|Total HPRT Deficiencies|Hyperuricemia Syndromes, Primary|HPRT|Hypoxanthine Phosphoribosyltransferase Deficiency|X-Linked Hyperuricemias|Choreoathetosis|Syndrome, Choreoathetosis Self-Mutilation|Self-Mutilation Syndromes, Choreoathetosis|Deficiency, Complete HPRT|Syndromes, Primary Hyperuricemia|Hypoxanthine Phosphoribosyltransferase Deficiencies|Hypoxanthine Guanine Phosphoribosyltransferase 1 Deficiency|Syndrome, Primary Hyperuricemia|Deficiency, Total HPRT|Choreoathetosis Self Mutilation Hyperuricemia Syndrome|Deficiency, Hypoxanthine Phosphoribosyltransferase|Complete Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency|Juvenile Hyperuricemia Syndromes|Juvenile Gout, Choreoathetosis, Mental Retardation Syndrome|HGPRT Deficiency Disease, Complete|Hypoxanthine-Phosphoribosyl-Transferase Deficiency Disease|Complete HPRT Deficiencies|Choreoathetosis Self-Mutilation Hyperuricemia Syndrome|Primary Hyperuricemias, X-Linked|Syndromes, Choreoathetosis Self-Mutilation|Syndromes, Juvenile Hyperuricemia|Complete HPRT Deficiency|X Linked Hyperuricemia|Hyperuricemias, X-Linked|X-Linked Primary Hyperuricemias|Choreoathetosis Self-Mutilation Syndromes|Hyperuricemia, X-Linked Primary|Deficiency of Hypoxanthine Phosphoribosyltransferase|Lesch-Nyhan disease|Phosphoribosyltransferase Deficiency, Guanine|Choreoathetosis Self-Mutilation Syndrome|Complete HGPRT Deficiency Disease|Primary Hyperuricemia Syndromes|Deficiencies, Hypoxanthine Phosphoribosyltransferase|Phosphoribosyltransferase Deficiencies, Guanine|hypoxanthine-guanine phosphoribosyltransferase|Deficiencies, Complete HPRT|Primary Hyperuricemia Syndrome|Choreoathetosis Self Mutilation Syndrome|Deficiency Disease, Complete HGPRT"
D007041,CHEMICAL,Hypoxanthine Phosphoribosyltransferase,"HPRTase|Phosphoribosyltransferase, Guanine|hypoxanthine phosphoribosyltransferase|Phosphoribosyltransferase, Hypoxanthine-Guanine|HGPRT|Hypoxanthine-Guanine Phosphoribosyltransferase|IMP Pyrophosphorylase|Guanine Phosphoribosyltransferase|Pyrophosphorylase, IMP|HPRT|Hypoxanthine Guanine Phosphoribosyltransferase|Phosphoribosyltransferase, Hypoxanthine"
D016244,CHEMICAL,Guanosine 5'-O-(3-Thiotriphosphate),"gamma-Thio-GTP|guanosine|Guanosine 5'-(gamma-S)Triphosphate|gamma Thio GTP|GTP gamma S|gamma S, GTP|Guanosine 5'-(3-O-Thio)Triphosphate|GTPgammaS"
NEW01084,DISEASE,possible excitotoxic damage,possible excitotoxic damage
D009118,CHEMICAL,Muscimol,|muscimol|Agarin|Pantherine|Muscimol
NEW01085,DISEASE,irritability,irritability
D058785,CHEBI,GABA-A Receptor Agonists,"Receptor Agonist, GABA-A|Agonists, GABA-A Receptor|Agonists, GABA-A|Receptor Agonists, GABA-A|Agonist, GABA-A Receptor|GABA-a receptor agonist|GABA A Agonists|GABA A Receptor Agonist|GABA-A Receptor Agonist|GABA A Receptor Agonists|GABA-A Agonists"
NEW01086,DISEASE,i.p.)-induced aggressive behaviors,i.p.)-induced aggressive behaviors
NEW01087,DISEASE,clonidine-induced aggressive behaviors,clonidine-induced aggressive behaviors
NEW01088,CHEMICAL,mg/kg,mg/kg
NEW01089,CHEMICAL,muscimol mg/kg,muscimol mg/kg
D010852,CHEMICAL,Picrotoxin,|GABA Antagonists|Antidotes|Central Nervous System Stimulants|Convulsants|picrotoxin|PTX|Picrotoxin
NEW01090,CHEMICAL,L-PIA mg/kg,L-PIA mg/kg
D007174,MENTAL_HEALTH,"Disruptive, Impulse Control, and Conduct Disorders","Impulse control disorders|Impulse Control Disorders|Impulse-Control Disorders|Intermittent Explosive Disorder|Explosive Disorder, Intermittent|Disorders, Impulse Control|kleptomania|explosive disorder|Disorders, Intermittent Explosive|Kleptomania|impulse-control disorders|Intermittent Explosive Disorders|impulse control disorders|control disorders|intermittent explosive disorder"
NEW01091,CHEMICAL,dopamine replacement therapy,dopamine replacement therapy
NEW01092,CHEBI,D2/D3 agonists,D2/D3 agonists
NEW01093,DISEASE,risk-taking behaviour,risk-taking behaviour
NEW01094,CHEMICAL,mesocorticolimbic dopamine system,mesocorticolimbic dopamine system
NEW01095,CHEBI,agonist therapy,agonist therapy
NEW01096,DISEASE,risk-taking behavior,risk-taking behavior
D059445,MENTAL_HEALTH,Anhedonia,"sucrose preference|Anhedonia, Social|Physical Anhedonias|Anhedonia, Physical|Anhedonia|social anhedonia|Anhedonias, Social|Social Anhedonias|anhedonia|Anhedonias|Anhedonias, Physical|Physical Anhedonia|Social Anhedonia"
NEW01097,DISEASE,potential hepatotoxicity,potential hepatotoxicity
NEW01098,CHEMICAL,Melatonin agonists,Melatonin agonists
D020919,MENTAL_HEALTH,"Sleep Disorders, Intrinsic","insomnia|Post-Traumatic Hypersomnias|Posttraumatic Hypersomnia|Sleep State Misperceptions|Hypersomnias, Post-Traumatic|Sleep disorders|Hypersomnia, Post Traumatic|Sleep Disorder, Intrinsic|Hypersomnias, Posttraumatic|Sleep State Misperception|Hypersomnia, Posttraumatic|Intrinsic Sleep Disorders|Posttraumatic Hypersomnias|sleep disorders|Post-Traumatic Hypersomnia|Intrinsic Sleep Disorder|Hypersomnia, Post-Traumatic|hypersomnias"
D018017,CHEBI,"Receptors, Pituitary Hormone-Regulating Hormone","Receptors, Hypothalamic Release-Inhibiting Hormones|Receptors, Pituitary Hormone Releasing Hormone|Receptors, Pituitary Hormone Release Inhibiting Hormones|Hypothalamic Releasing Hormone Receptors|Receptors, Pituitary Hormone-Releasing Hormone|Receptors, Pituitary Hormone Regulating Hormone|Pituitary Hormone Releasing Hormone Receptors|Pituitary Hormone-Regulating Hormone Receptors|Hypothalamic Release-Inhibiting Hormone Receptors|Pituitary Hormone Regulating Hormone Receptors|Hypothalamic Release Inhibiting Hormone Receptors|Pituitary Hormone-Releasing Hormone Receptors|hormone|Receptors, Hypothalamic Releasing Hormones|Receptors, Hypothalamic Release Inhibiting Hormones"
C476721,CHEMICAL,bremelanotide [Supplementary Concept],"alpha-MSH|Peptides, Cyclic|Bremelanotide|bremelanotide"
NEW01099,DISEASE,acquired generalized HSDD,acquired generalized HSDD
NEW01100,CHEBI,novel melanocortin receptor agonist,novel melanocortin receptor agonist
D000077334,CHEMICAL,Zolpidem,"Zolpidem Hemitartrate|SL 80.0750|Zoldem|Zolpi-Lich|Zolpidem|SL-800750-23-N|Zolirin|Imidazo(1,2-a)pyridine-3-acetamide, N,N,6-trimethyl-2-(4-methylphenyl)-|SL 800750 23 N|Stilnox|Bikalm|Zolpidem AbZ|Ambien|zolpidem|Zolpidem 1A Pharma|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2a)pyridine-3-acetamide hemitartrate|Stilnoct|Zolpimist|Zolpi Lich|Dalparan|Zodormdura|Zolpidem Tartrate|Zolpinox|Amsic"
NEW01101,CHEBI,nonbenzodiazepine indirect GABA A receptor agonist,nonbenzodiazepine indirect GABA A receptor agonist
NEW01102,CHEMICAL,chronic CORT treatment,chronic CORT treatment
NEW01103,DISEASE,behavioral deficits,behavioral deficits
NEW01104,CHEBI,Neurotensin receptor-1 agonist,Neurotensin receptor-1 agonist
NEW01105,CHEBI,atypical antipsychotic drug,atypical antipsychotic drug
NEW01106,CHEMICAL,3-hydroxykynurenine branch,3-hydroxykynurenine branch
C005045,CHEMICAL,3-hydroxykynurenine [Supplementary Concept],3HK|3-hydroxykynurenine|Kynurenine/analogs  and  derivatives
NEW01107,CHEBI,NMDA receptor antagonist,NMDA receptor antagonist
NEW01108,CHEMICAL,excess KynA production,excess KynA production
NEW01109,MENTAL_HEALTH,affective psychosis group relative,affective psychosis group relative
NEW01110,MENTAL_HEALTH,comorbid major depressive disorder,comorbid major depressive disorder
NEW01111,CHEMICAL,antidepressant medicines,antidepressant medicines
NEW01112,CHEMICAL,tablet baclofen,tablet baclofen
C574027,CHEMICAL,lorcaserin N-carbamoyl glucuronide [Supplementary Concept],Glucuronides|lorcaserin|Benzazepines
NEW01113,DISEASE,intake gain,intake gain
NEW01114,DISEASE,pain activity,pain activity
NEW01115,DISEASE,seizure-like,seizure-like
NEW01116,CHEBI,Drug classes,Drug classes
D019440,DISEASE,Anti-Obesity Agents,"Weight Loss Agents|Weight Loss Drugs|Drug, Antiobesity|Anti Obesity Agents|Agents, Weight-Loss|anti-obesity agent|Antiobesity Drugs|Agent, Anti-Obesity|Drug, Weight-Loss|Agent, Antiobesity|Anti Obesity Drugs|Drugs, Weight-Loss|anti-obesity drug|Weight-Loss Agents|Weight-Loss Drug|Drugs, Anti-Obesity|Anti-Obesity Drug|Anti-Obesity Drugs|Drugs, Antiobesity|Agents, Antiobesity|Anti-Obesity Agent|weight loss agents|Weight-Loss Drugs|Antiobesity Agents|Weight Loss Drug|Antiobesity Agent|Agents, Anti-Obesity|anti-obesity agents|Drug, Anti-Obesity|Antiobesity Drug|Anti Obesity Agent|Anti Obesity Drug"
D009292,CHEBI,Narcotic Antagonists,"opioid antagonist|opioid receptor antagonist|Reversal Agents, Opioid|Opioid Reversal Agent|Antagonists, Competitive Opioid|Antagonist, Narcotic|Antagonist, Opioid Receptor|Opioid Receptor Antagonist|Opioid Antagonists, Competitive|Opioid Antagonist, Competitive|narcotic antagonists|opioid antagonists|Opioid antagonists|Narcotic Antagonist|Competitive Opioid Antagonists|narcotic antagonist|Antagonists, Narcotic|Opioid Reversal Agents|Opioid Receptor Antagonists|Receptor Antagonist, Opioid|opioid receptor antagonists|Reversal Agent, Opioid|Antagonist, Opioid|Competitive Opioid Antagonist|Antagonist, Competitive Opioid|Opioid Antagonists|Agent, Opioid Reversal|Agents, Opioid Reversal|Antagonists, Opioid|Antagonists, Opioid Receptor|Opioid Antagonist|Receptor Antagonists, Opioid"
NEW01117,MENTAL_HEALTH,food intermittent binge eating model,food intermittent binge eating model
D000077465,CHEMICAL,Cabergoline,Dostinex|Cabergoline Diphosphate|FCE-21336|1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabaser|Cabergoline|cabergoline|Cabaseril|1-Ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate|Galastop|FCE 21336
NEW01118,CHEMICAL,"4-(3-(3-fluoro-5-(trifluoromethyl)benzyl)-5-methyl-1H-1,2,4-triazol-1-yl)-2-methylbenzamide","FTBMT|4-(3-(3-fluoro-5-(trifluoromethyl)benzyl)-5-methyl-1H-1,2,4-triazol-1-yl)-2-methylbenzamide"
NEW01119,MENTAL_HEALTH,acute psychosis,acute psychosis
NEW01120,MENTAL_HEALTH,MK-801-induced hyperactivity,MK-801-induced hyperactivity
D011293,MENTAL_HEALTH,Premenstrual Syndrome,"Premenstrual Tension|Premenstrual Syndrome|Syndrome, Premenstrual|Tension, Premenstrual|Premenstrual Tensions|Premenstrual Syndromes|premenstrual syndrome|Tensions, Premenstrual|PMS|Syndromes, Premenstrual"
NEW01121,CHEBI,various drug protocols,various drug protocols
D012044,MENTAL_HEALTH,Regression Analysis,"Regression analyses|Regression Analyses|Regression, Statistical|Analysis, Regression|Diagnostics, Regression|regression analyses|Statistical Regression|Regressions, Statistical|Statistical Regressions|Regression Diagnostics|regression analysis|Regression analysis|Analyses, Regression|regression"
NEW01122,NUTRITION,fecal cholesterol,fecal cholesterol
NEW01123,CHEBI,LXR agonists,LXR agonists
NEW01124,NUTRITION,body cholesterol,body cholesterol
NEW01125,NUTRITION,fecal cholesterol content,fecal cholesterol content
NEW01126,DISEASE,Atherosclerosis attenuation,Atherosclerosis attenuation
NEW01127,NUTRITION,increased fecal cholesterol,increased fecal cholesterol
NEW01128,NUTRITION,fecal cholesterol counts,fecal cholesterol counts
NEW01129,CHEMICAL,aortic cholesteryl ester content,aortic cholesteryl ester content
NEW01130,CHEBI,Ang-(1 agonists,Ang-(1 agonists
NEW01131,CHEMICAL,HF-saline treated mice,HF-saline treated mice
D000073879,CHEMICAL,Rice Bran Oil,"rice bran|Oil, Rice Bran|rice bran oil|RBO|Bran Oil, Rice"
D011597,DISEASE,Psychomotor Performance,"Sensory Motor Performances|Motor Coordinations, Visual|Visual Motor Coordination|Visual Motor Coordinations|Motor Performances, Sensory|Perceptual Motor Performances|Performance, Sensory Motor|Performance, Perceptual Motor|Psychomotor Performances|Performances, Psychomotor|motor coordination|Motor Coordination, Visual|Motor Performance, Perceptual|Performance, Psychomotor|Coordination, Visual Motor|Perceptual Motor Performance|Motor Performances, Perceptual|Coordinations, Visual Motor|Performances, Sensory Motor|motor performance|Motor Performance, Sensory|Performances, Perceptual Motor|Sensory Motor Performance"
NEW01132,CHEBI,D2 antagonist haloperidol,D2 antagonist haloperidol
NEW01133,DISEASE,neurological deficits,neurological deficits
NEW01134,CHEMICAL,grain Zn concentrations,grain Zn concentrations
NEW01135,CHEMICAL,Fe concentrations,Fe concentrations
C013172,CHEMICAL,gamma-oryzanol [Supplementary Concept],γ-oryzanol|Phenylpropionates
NEW01136,DISEASE,stress-induced hypoadiponectinemia,stress-induced hypoadiponectinemia
D005680,CHEMICAL,gamma-Aminobutyric Acid,"Acid, Hydrochloride gamma-Aminobutyric|Aminalone|gamma-Aminobutyric Acid, Calcium Salt (2:1)|gamma Aminobutyric Acid|gamma-Aminobutyric Acid, Hydrochloride|Hydrochloride gamma-Aminobutyric Acid|GABA|GABA+|4 Aminobutyric Acid|gamma Aminobutyric Acid, Monosodium Salt|Gammalon|gamma-Aminobutyric Acid, Monosodium Salt|gamma Aminobutyric Acid, Hydrochloride|gamma-Aminobutyric Acid, Zinc Salt (2:1)|gamma Aminobutyric Acid, Monolithium Salt|GABA, Lithium|4-Aminobutanoic Acid|Gamma-aminobutyric acid|4 Aminobutanoic Acid|4-Aminobutyric Acid|γ-aminobutyric acid|gamma-aminobutyric acid|Aminalon|Lithium GABA|gamma-Aminobutyric Acid, Monolithium Salt"
NEW01137,CHEMICAL,childhood separation anxiety,CSA|childhood separation anxiety
NEW01138,CHEMICAL,mild/moderate alcohol use,mild/moderate alcohol use
NEW01139,CHEMICAL,Zinc Zn deficiency,Zinc Zn deficiency
NEW01140,DISEASE,prevalent micronutrient disorder,prevalent micronutrient disorder
NEW01141,CHEMICAL,glutathione levels,glutathione levels
NEW01142,CHEMICAL,CRWP nutritional intervention,CRWP nutritional intervention
NEW01143,CHEMICAL,supersensitive D1 dopamine receptors located,supersensitive D1 dopamine receptors located
NEW01144,DISEASE,stable motor deficits,stable motor deficits
C095427,CHEMICAL,A 86929 [Supplementary Concept],A-86929|Quinolones|Thiophenes
NEW01145,DISEASE,dose-dependent dyskinesias,dose-dependent dyskinesias
NEW01146,CHEBI,long-acting D1 agonist A-77636,long-acting D1 agonist A-77636
NEW01147,CHEMICAL,twice-daily L-dopa dosing locomotion,twice-daily L-dopa dosing locomotion
C079415,CHEMICAL,A 77636 [Supplementary Concept],Adamantane/analogs  and  derivatives|A-77636|Benzopyrans
NEW01148,DISEASE,prominent dystonia,prominent dystonia
D020150,DISEASE,Chorea Gravidarum,"Gravidarum, Chorea|Choreoathetoses, Pregnancy-Associated|Chorea Gravidarums|Chorea, Pregnancy-Induced|Choreas, Pregnancy-Induced|chorea|Choreoathetosis, Pregnancy Associated|Chorea, Pregnancy Induced|Pregnancy-Associated Choreoathetoses|Choreoathetosis, Pregnancy-Associated|Pregnancy-Induced Choreas|Pregnancy-Associated Choreoathetosis|Pregnancy-Induced Chorea|Chorea"
NEW01149,CHEBI,known D1-selective agonists,known D1-selective agonists
D002908,DISEASE,Chronic Disease,"Disease, Chronic|Chronic Condition|Illness, Chronic|Chronic Conditions|Chronic Illnesses|chronic illness|Chronic Illness|Chronically Ill|Condition, Chronic|Chronic Diseases"
NEW01150,DISEASE,dlPFC pyramidal cell dendritic atrophy,dlPFC pyramidal cell dendritic atrophy
NEW01151,CHEMICAL,cortical dopamine,cortical dopamine
D012569,DISEASE,Schizotypal Personality Disorder,"Latent Schizophrenias|Schizophrenias, Pseudopsychopathic|Pseudopsychopathic Schizophrenia|schizotypal personality disorder|Schizophrenia, Latent|Borderline Schizophrenias|Disorders, Schizotypal Personality|Schizophrenia, Borderline|Pseudoneurotic Schizophrenias|personality disorder|Personality Disorders, Schizotypal|Schizophrenia, Pseudoneurotic|Disorder, Schizotypal Personality|Pseudoneurotic Schizophrenia|SPD|Schizophrenias, Latent|Schizophrenias, Incipient|Latent Schizophrenia|Personality Disorder, Schizotypal|Schizophrenias, Pseudoneurotic|Incipient Schizophrenias|Schizophrenia, Pseudopsychopathic|schizotypal disorder|Borderline Schizophrenia|Schizotypal personality disorder|Pseudopsychopathic Schizophrenias|Schizophrenia, Incipient|Schizophrenias, Borderline|Incipient Schizophrenia|Schizotypal Personality Disorders"
NEW01152,DISEASE,fear/anxiety,fear/anxiety
NEW01153,CHEBI,D1 agonists,D1 agonists
D017447,CHEMICAL,"Receptors, Dopamine D1","dopamine D1 receptor|D1 Receptors, Dopamine|Dopamine D1 Receptors|Dopamine D1 Receptor|Dopamine-D1 Receptor|Receptor, Dopamine-D1|dopamine D1 receptors|D1- receptors|Dopamine D1 receptors"
NEW01154,DISEASE,experimental gastroduodenal lesions,experimental gastroduodenal lesions
C534628,CHEMICAL,SCH 23390 [Supplementary Concept],|SCH 23390|SCH-23390|D1 dopamine receptor antagonist|SCH23390|Benzazepines
NEW01155,CHEBI,DA1/D1 agonists,DA1/D1 agonists
NEW01156,DISEASE,experimental gastric mucosal injury,experimental gastric mucosal injury
D015647,CHEMICAL,"2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine","SKF 38393-A|SK and F 38393|R-SK and F 38393|SK and F-38393|SK and F38393|SKF 38393|1H-3-Benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-|RSK and F 38393|SKF 38393 A|SKF|SKF38393|SKF 38393A|SKF-38393"
D010479,CHEMICAL,Pergolide,"Pergolide Mesylate|LY127,809|Mesylate, Pergolide||Parkotil|LY127809|Pharken|pergolide|LY-127809|Permax|Pergolide|Celance|LY-127,809"
NEW01157,CHEMICAL,term levodopa monotherapy,term levodopa monotherapy
NEW01158,CHEMICAL,levodopa dosage,levodopa dosage
NEW01159,DISEASE,advanced Parkinson's disease,advanced Parkinson's disease
NEW01160,CHEBI,potent drug,potent drug
D009127,DISEASE,Muscle Rigidity,"Muscular Rigidity||Rigidity, Muscle|Rigidity, Cogwheel|Rigidity, Catatonic|Cogwheel Rigidities|Extrapyramidal Rigidity|muscle rigidity|Extensor Rigidity|muscular rigidity|Rigidity, Extensor|Gegenhaltens|Cogwheel Rigidity|rigidity|Catatonic Rigidity|Nuchal Rigidity|Gegenhalten|Rigidity, Extrapyramidal|Rigidities, Cogwheel|Rigidity, Nuchal|Rigidity, Muscular"
C537921,MENTAL_HEALTH,"Fetal akinesia syndrome, X-linked [Supplementary Concept]","Limb Deformities, Congenital|akinesia|Fetal Growth Retardation|Genetic Diseases, X-Linked|Pterygium|Akinesia"
D006636,CHEMICAL,Histamine Release,histamine release|Histamine Releases|Histamine Liberation|Histamine Liberations
D017478,CHEMICAL,"Receptors, Phencyclidine","Phencylidine Receptor|Receptor, Phencylidine|Phencyclidine Receptors|Phencyclidine|PCP|phencyclidine|PCP Receptor|Receptors, PCP|Receptor, PCP|PCP receptor|PCP Receptors"
NEW01161,MENTAL_HEALTH,schizophrenia histamine release,schizophrenia histamine release
D018494,CHEBI,Histamine Agents,"Histaminergic Drugs|Drugs, Histamine|Drugs, Histaminergic|Effect, Histamine|Agents, Histamine|Agents, Histaminergic|Effects, Histamine|Histaminergic Effects|Histamine Effect|histamine agents|Histaminergic Agents|Effects, Histaminergic|Effect, Histaminergic|Histaminergic Effect|Histamine Drugs|Histamine Effects"
NEW01162,CHEMICAL,histamine neuron system,histamine neuron system
NEW01163,DISEASE,extradopaminergic brain dysfunction,extradopaminergic brain dysfunction
D054828,CHEMICAL,Histamine H3 Antagonists,"histamine H3 receptor|Antagonists, Histamine H3|H3 receptor antagonists|Histamine H3 receptor|Histamine H3 Blockers|Antihistaminics, H3|Histamine H3 Receptor Antagonists|H3 Antagonists, Histamine|histamine H3 antagonists|Blockers, Histamine H3|H3 Blockers, Histamine|H3 Antihistaminics|Histamine|Histamine H3 receptor antagonists|histamine|H3 antagonists"
NEW01164,CHEMICAL,H1 receptor antagonist pyrilamine,H1 receptor antagonist pyrilamine
NEW01165,CHEBI,H3 antagonist thioperamide,H3 antagonist thioperamide
D006635,CHEBI,Histamine H2 Antagonists,"H2 Receptor Blockader|H2-Receptor Antagonists|Histamine H2 Receptor Blockaders|Histamine H2 Antagonist|H2 receptor antagonists|Blockaders, H2 Receptor|Blockers, Histamine H2|H2-receptor antagonist|H2 Blocker, Histamine|Receptor Antagonists, Histamine H2|Histamine H2 Blocker|Receptor Blockader, H2|Receptor Blockaders, H2|Antagonists, Histamine H2|H2 receptor antagonist|H2 Receptor Blockaders|H2 Antagonist, Histamine|Histamine H2 Blockers|Histamine H2 Receptor Blockader|Histamine H2 Receptor Antagonist|histamine H2-receptor antagonist|H2 Blockers, Histamine|Blockader, H2 Receptor|Histamine H2 Receptor Antagonists|H2 Antagonists, Histamine|Antihistaminics, H2|H2-receptor antagonists|histamine H2 antagonist|Antagonist, Histamine H2|H2 Antihistaminics|Blocker, Histamine H2|Blockaders, Histamine H2 Receptor"
D017442,CHEBI,Histamine Agonists,"Histamine H2 Receptor Agonist|H1 Agonist|Histaminergic Agonists|H3 Agonists|Agonist, Histamine H2|Histamine H2 Receptor Agonists|Histamine Agonist|H2 Agonists|histaminergic agonist|H2 Agonists, Histamine|H1 Agonists|Agonists, Histaminergic|Agonist, H3|histamine H1 receptor agonists|Agonists, Histamine H3|Agonist, Histamine H3|Agonists, H3|Histamine H3 Agonist|H3 receptor agonists|Agonist, H2|Histamine H1 Agonists|histaminergic agonists|Histaminergic Agonist|Histamine H1 Receptor Agonists|Agonists, H1|Agonist, H1|Agonists, Histamine|Histamine H3 Receptor Agonists|H3 Agonist|Histamine H1 Agonist|H2 Agonist|Histamine H3 Agonists|Agonist, Histamine|H3 Agonist, Histamine|Agonists, Histamine H1|Histamine H2 Agonist|H1 Agonists, Histamine|Agonist, Histamine H1|H1 Agonist, Histamine|Agonists, Histamine H2|Agonist, Histaminergic|H2 Agonist, Histamine|Histamine H1 Receptor Agonist|H3 Agonists, Histamine|Histamine H2 Agonists|Agonists, H2"
D006634,CHEMICAL,Histamine H1 Antagonists,"H1 Antagonist, Histamine|Antagonists, Histamine H1 Receptor|Receptor Blockaders, H1|Antihistaminics, H1|Histamine H1 Antagonist|H1 Antagonists, Histamine|Histamine H1 Receptor Antagonists|antihistaminics|Histamine H1 Receptor Blockaders|Histamine H1 Blockers|H1 Antihistaminics|Antagonist, Histamine H1|Histamine H1 receptor antagonists|H1 Receptor Blockaders|First Generation H1 Antagonists|Blockaders, Histamine H1 Receptor|Antagonists, Histamine H1|Histamine H1 Receptor Antagonist|Antihistaminics, Classical|Classical Antihistamines|Antihistamines, Sedating|H1 receptor antagonists|Classical Antihistaminics|Sedating Antihistamines|Antihistamines, Classical"
NEW01166,CHEMICAL,histamine turnovers,histamine turnovers
D002524,DISEASE,Cerebellar Ataxia,"Cerebellar Incoordination||Hypermetrias|Ataxia, Cerebellar|Adiadochokinesis|Cerebellar Ataxias|Hemiataxias, Cerebellar|Incoordinations, Cerebellar|incoordination|Ataxias, Cerebellar|Dysmetrias|Hemiataxia, Cerebellar|Cerebellar Hemiataxia|Dysmetrias, Cerebellar|Hypermetria|hemiataxia|Adiadochokineses|Dysmetria, Cerebellar|cerebellar ataxia|Cerebellar Dysmetrias|Cerebellar Incoordinations|dysmetria|Incoordination, Cerebellar|Cerebellar Hemiataxias|Cerebellar Dysmetria|Cerebellar ataxia|Dysmetria"
NEW01167,CHEMICAL,MeHg levels,MeHg levels
NEW01168,DISEASE,Alois Alzheimer,Alois Alzheimer
C083889,CHEMICAL,hemoglobin Tubingen [Supplementary Concept],"Hemoglobins, Abnormal|Tübingen"
NEW01169,DISEASE,unusual brain disease,unusual brain disease
D019958,MENTAL_HEALTH,Attention Deficit and Disruptive Behavior Disorders,"|behavior disorders|Disruptive Behavior Disorder|disruptive behaviors|Disorder, Disruptive Behavioral|oppositional defiant disorder|behavioral disorders|disruptive behavior|behavioral disorder|attention deficit|disruptive behavioral disorders|Oppositional Defiant Disorder|Behavioral Disorder, Disruptive|disruptive behavior disorders|Disruptive Behavioral Disorders|Disruptive Behavioral Disorder|Attention Deficit and Disruptive Behavioral Disorders|Defiant Disorder, Oppositional|Behavior Disorder, Disruptive"
D018967,CHEMICAL,Risperidone,"|risperidone|R 64766|R64766|R-64766|Risperdal Consta|Consta, Risperdal|Risperidal|RSP|Risperidone|R-64,766|R64,766|R 64,766"
NEW01170,MENTAL_HEALTH,Multivariable logistic regression,Multivariable logistic regression
NEW01171,CHEBI,antimalarial drug categories,antimalarial drug categories
NEW01172,MENTAL_HEALTH,Common mental disorders,Common mental disorders
NEW01173,DISEASE,psychotic episodes,psychotic episodes
NEW01174,CHEMICAL,iron deposition,iron deposition
NEW01175,DISEASE,atherosclerotic plaque instability,atherosclerotic plaque instability
NEW01176,CHEMICAL,above-mentioned bioelements,above-mentioned bioelements
NEW01177,DISEASE,hyperactive children,hyperactive children
D009155,MENTAL_HEALTH,Mutism,"Mutisms, Elective|Kussmaul's Aphasia|Mutism, Voluntary|Organic Mutisms|Conversion Mutisms|Mutism, Conversion|Conversion Mutism|Kussmaul Aphasia|Voluntary Mutisms|Elective Mutism|Mutisms, Conversion|Selective Mutism|Aphasia, Kussmaul|Aphasia, Kussmaul's|Mutisms, Organic|Elective Mutisms|selective mutism|Organic Mutism|Mutism, Organic|Mutisms, Voluntary|Mutisms|Voluntary Mutism|Mutism, Elective|Kussmauls Aphasia|Mutism, Selective"
D013342,MENTAL_HEALTH,Stuttering,"Stuttering, Developmental|Stuttering, Childhood|Stuttering, Acquired|Stuttering|Developmental Stuttering|Stuttering, Adult|Acquired Stuttering|Childhood Stuttering|Adult Stuttering|Stammering|developmental stuttering|Stuttering, Familial Persistent 1|stuttering"
D020323,DISEASE,Tics,"Tic, Gestural|Tics, Motor|Motor Tic|Vocal Tic|Tics, Transient|Habit Choreas|Tics, Vocal|Transient Tic|Tics, Gestural|Spasm, Habituation|Habituation Spasm|Tic, Vocal|Habituation Spasms|Habit Spasms|Spasm, Habit|Habit Chorea|Motor Tics|Gestural Tics|Gestural Tic|Habit Spasm|Tic, Motor|Spasms, Habituation|Vocal Tics|Tic, Transient|Choreas, Habit|Tic|Spasms, Habit|Transient Tics|Chorea, Habit|tics"
D053207,MENTAL_HEALTH,Diurnal Enuresis,"Daytime Wetting|Daytime Urinary Incontinence|enuresis|Urinary Incontinence, Daytime|Wetting, Daytime|Enuresis, Diurnal|Incontinence, Daytime Urinary"
NEW01178,DISEASE,disruptive behaviour disorders,disruptive behaviour disorders
NEW01179,CHEMICAL,zinc content,zinc content
NEW01180,DISEASE,behaviour disorder,behaviour disorder
NEW01181,CHEMICAL,magnesium supplementation,magnesium supplementation
NEW01182,MENTAL_HEALTH,ADHD children,ADHD children
D006527,DISEASE,Hepatolenticular Degeneration,"Diseases, Hepato-Neurologic Wilson|Lenticular Degeneration, Progressive|Hepato Neurologic Wilson Disease|Kinnier-Wilson Disease|Wilson's disease|Progressive Lenticular Degeneration|Westphal-Strumpell Syndrome|Neurohepatic Degenerations|Hepatic Form of Wilson Disease|Wilson's Disease|Diseases, Kinnier-Wilson|Wilson Disease, Hepatic Form|Disease, Copper Storage|Kinnier-Wilson Diseases|Syndrome, Hepatolenticular Degeneration|Copper Storage Disease|Hepato-Neurologic Wilson Disease|hepatocerebral degeneration|Neurohepatic Degeneration|Degeneration, Progressive Lenticular|Pseudoscleroses, Cerebral|Degeneration, Hepatolenticular|Syndromes, Hepatolenticular Degeneration|Kinnier Wilson Disease|Wilson Diseases, Hepato-Neurologic|Wilson Disease|hepatolenticular degeneration|Degeneration, Neurohepatic|Degeneration, Hepatocerebral|Storage Disease, Copper|Degeneration Syndrome, Hepatolenticular|Wilsons Disease|Hepatolenticular Degeneration Syndromes|Westphal-Strumpell Syndromes|Diseases, Copper Storage|Hepatocerebral Degenerations|Degeneration Syndromes, Hepatolenticular|Pseudosclerosis, Cerebral|Hepato-Neurologic Wilson Diseases|Copper Storage Diseases|Hepatolenticular Degeneration Syndrome|Pseudosclerosis|Cerebral Pseudosclerosis|Wilson Disease, Hepato-Neurologic|Cerebral Pseudoscleroses|Degenerations, Neurohepatic|Westphal Strumpell Syndrome|Storage Diseases, Copper|Hepatocerebral Degeneration|Degenerations, Hepatocerebral"
C583283,CHEMICAL,"COMMD9 protein, rat [Supplementary Concept]","copper metabolism|Adaptor Proteins, Signal Transducing"
D053360,DISEASE,"Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive","Autosomal Recessive Anhydrotic Ectodermal Dysplasia|autosomal recessive|Anhidrotic Ectodermal Dysplasia, Autosomal Recessive|Autosomal Recessive Anhidrotic Ectodermal Dysplasia|Anhidridic Ectodermal Dysplasia, Autosomal Recessive|Anhydridic Ectodermal Dysplasia, Autosomal Recessive|Ectodermal Dysplasia, Hypohydrotic, Autosomal Recessive|Ectodermal Dysplasia, Anhidrotic, Autosomal Recessive"
NEW01183,DISEASE,inherited neurodegenerative disorder,inherited neurodegenerative disorder
D017301,CHEMICAL,Ca(2+) Mg(2+)-ATPase,"Mg2+-ATPase|Ca2+ Mg2+ ATPase|ATPase, Magnesium|Calcium Magnesium Adenosine Triphosphatase|Magnesium Adenosine Triphosphatase|Mg2+-Dependent ATPase|Adenosinetriphosphatase, Calcium, Magnesium|Calcium Magnesium Adenosinetriphosphatase|Magnesium ATPase|Adenosine Triphosphatase, Calcium, Magnesium|ATPase, Mg2+-Dependent|adenosine triphosphatase|Adenosinetriphosphatase, Calcium Magnesium|ATPase, Ca2+-Mg2+|Adenosinetriphosphatase, Magnesium|Ca Mg-ATPase|Calcium Magnesium ATPase|Mg2+ Dependent ATPase|Magnesium Adenosinetriphosphatase|ATPase, Calcium Magnesium|Ca2+-Mg2+ ATPase|Ca Mg ATPase|Mg2+ ATPase|Adenosine Triphosphatase, Magnesium"
NEW01184,DISEASE,ophthalmologic disorder,ophthalmologic disorder
D003315,DISEASE,Cornea,Corneas|cornea
NEW01185,CHEMICAL,excess zinc,excess zinc
NEW01186,DISEASE,concurrent anaemia,concurrent anaemia
NEW01187,DISEASE,dorsal column syndrome,dorsal column syndrome
D007706,DISEASE,Menkes Kinky Hair Syndrome,"Syndromes, Steely Hair|Copper Transport Disease|Menkes' Disease|Menkes Disease|Copper Deficiencies, X-Linked|Hair Diseases, Steely|Steely Hair Disease|Menkea Syndrome|Hypocupremias, Congenital|Copper Transport Diseases|Diseases, Copper Transport|Copper Deficiency, X-Linked|Congenital Hypocupremias|Syndromes, Menkea|X-Linked Copper Deficiency|X-Linked Copper Deficiencies|Menkes' Diseases|Menkes Syndrome|Steely Hair Syndrome|Congenital Hypocupremia|Steely Hair Syndromes|Kinky Hair Diseases|Kinky Hair Disease|Transport Disease, Copper|Kinky Hair Syndrome|Copper deficiency|Steely Hair Diseases|Diseases, Steely Hair|Disease, Steely Hair|Syndrome, Menkea|Deficiency, X-Linked Copper|Deficiencies, X-Linked Copper|Diseases, Menkes'|Syndrome, Steely Hair|Menkea Syndromes|Transport Diseases, Copper|Hair Diseases, Kinky|Disease, Copper Transport|X Linked Copper Deficiency|Hypocupremia, Congenital|Diseases, Kinky Hair"
NEW01188,DISEASE,pre-existing cognitive impairment,pre-existing cognitive impairment
D061027,DISEASE,Programmed Cell Death 1 Ligand 2 Protein,"Ligand, PD-L2|B7 DC Ligand|PD-L2 Ligand|Antigens, CD273|Antigen, CD273|CD273 Antigens|Cell death|PD L2 Ligand|CD273 Antigen|B7-DC Ligand|B7-DC Antigen|Ligand, B7-DC|Antigen, B7-DC|B7 DC Antigen|programmed cell death"
NEW01189,CHEMICAL,to hydrogen peroxide,to hydrogen peroxide|H2O2
D003474,CHEMICAL,Curcumin,"Turmeric Yellow|Mervia|curcumin|Curcumin|Diferuloylmethane|Phytosome, Curcumin|CUR|1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (E,E)-|Curcumin Phytosome|CURC|Yellow, Turmeric"
NEW01190,DISEASE,CNS toxicity,CNS toxicity
NEW01191,CHEMICAL,Curcumin co-treatment,Curcumin co-treatment
NEW01192,MENTAL_HEALTH,Cu-induced anxiety,Cu-induced anxiety
C021343,CHEMICAL,haematoside synthetase [Supplementary Concept],LacCer|lactosylceramide|Sialyltransferases
NEW01193,DISEASE,Neurobehavioral abnormality,Neurobehavioral abnormality
NEW01194,MENTAL_HEALTH,being agitation,being agitation
NEW01195,DISEASE,night abnormal behavior,night abnormal behavior
NEW01196,CHEMICAL,%,%
NEW01197,DISEASE,aberrant motor behavior,aberrant motor behavior
NEW01198,DISEASE,elation,elation
D057565,DISEASE,Apathy,apathy|Motivation (1966-2010)|Emotions (1966-2010)|Apathy
NEW01199,DISEASE,neurobehavioral abnormalities,neurobehavioral abnormalities
NEW01200,CHEMICAL,glutamate level,glutamate level
NEW01201,DISEASE,pandemic syndrome,pandemic syndrome
D000080445,DISEASE,Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome,"overlap syndromes|Asthma COPD Overlap Syndrome|Asthma Chronic Obstructive Pulmonary Disease Overlap Syndrome|Overlap Syndrome, Asthma-COPD|obstructive pulmonary disease|Asthma-COPD Overlap Syndrome|Asthma-COPD Overlap Syndromes"
NEW01202,CHEMICAL,chi2=171,chi2=171
NEW01203,DISEASE,reactive airway disease,reactive airway disease
NEW01204,MENTAL_HEALTH,pre-existing anxiety disorder,pre-existing anxiety disorder
NEW01205,CHEMICAL,high serum copper level,high serum copper level
D004221,CHEMICAL,Disulfiram,"Disulfiram||Antabuse|Dicupral|Alcophobin|Tetraethylthiuram Disulfide|Disulfide, Tetraethylthiuram|Bis(diethylthiocarbamoyl) Disulfide|Teturam|Tetraethylthioperoxydicarbonic Diamide, ((H2N)C(S))2S2|disulfiram|Antabus|Esperal|Anticol"
NEW01206,CHEBI,well-known drug,well-known drug
NEW01207,CHEMICAL,alcohol-abuse drug disulfiram,alcohol-abuse drug disulfiram|DSF
NEW01208,DISEASE,impaired biliary excretion,impaired biliary excretion
NEW01209,CHEMICAL,urea excretion,urea excretion|J urea
NEW01210,CHEMICAL,excessive cadmium burden,excessive cadmium burden
NEW01211,CHEMICAL,Zn supplementation,Zn supplementation
NEW01212,CHEMICAL,mean serum Zn levels,mean serum Zn levels
NEW01213,CHEMICAL,Zn/Cu ratio,Zn/Cu ratio
D053579,DISEASE,Gitelman Syndrome,"Potassium and Magnesium Depletion|Familial Hypokalemia Hypomagnesemia|hypocalciuria|Tubular Hypomagnesemia Hypokalemia with Hypocalcuria|Hypokalemia-Hypomagnesemia, Familial|Primary Renotubular, Hypomagnesemia-Hypokalemia with Hypocalciuria|hypomagnesemia|Gitelman syndrome|Primary Renotubular, Hypokalemia-Hypomagnesemia with Hypocalciuria|Syndrome, Gitelman's|Tubular Hypomagnesemia-Hypokalemia with Hypocalcuria|Hypomagnesemia-Hypokalemia, Primary Renotubular, with Hypocalciuria|Familial Hypokalemia-Hypomagnesemia|Hypokalemia-Hypomagnesemia, Primary Renotubular, with Hypocalciuria|Syndrome, Gitelman|Gitelman's Syndrome"
D062865,CHEMICAL,"Diuretics, Potassium Sparing",K+|Potassium Sparing Diuretics|potassium-sparing diuretics|potassium|K
NEW01214,DISEASE,autosomal recessive kidney disorder,autosomal recessive kidney disorder
D020886,DISEASE,Somatosensory Disorders,"Thermal Sensation Disorders|Pinprick Sensation Diminished|Somatic Sensation Disorder|Somatosensory Disorder|Pinprick Sensation Diminisheds|Sensation Disorders, Thermal|Proprioceptive Disorder|Proprioceptive Disorders|Light Touch Sensation Impairment|Pain Sensation Diminished|Sense Disorders, Position|Somatic Sensation Disorders|pain sensation|Diminished, Pinprick Sensation|Thermal Sensation Disorder|Sensation Disorders, Somatic|Sensation Diminished, Pinprick|Position Sense Disorders|Position Sense Disorder|Impairment, Light Touch Sensation|Diminisheds, Pinprick Sensation|Diminished, Pain Sensation|Sensation Disorder, Somatic|Sensation Diminished, Pain|Diminisheds, Pain Sensation|Pain Sensation Diminisheds|Sensation Disorder, Thermal|Sense Disorder, Position|Sensation Diminisheds, Pain|Sensation Diminisheds, Pinprick"
D009477,DISEASE,Hereditary Sensory and Autonomic Neuropathies,"CIPA|Hereditary Sensory Radicular Neuropathy, Recessive Form|Hereditary Sensory and Autonomic Neuropathy Type II|HSAN5|Insensitivity to Pain with Anhidrosis, Congenital|Hereditary Sensory Neuropathy|Neuropathy, Hereditary Sensory|HSAN2|Hereditary Sensory Autonomic Neuropathy, Type 2|Neuropathies, Hereditary Sensory|Hereditary Sensory and Autonomic Neuropathy Type 1|Hereditary Sensory and Autonomic Neuropathy Type V|Neuropathy, Hereditary Sensory And Autonomic, Type I|Hereditary Sensory and Autonomic Neuropathy Type IV|Acroosteolysis, Neurogenic|Type IV, HSAN|HSN Type II|HSANII|Hereditary Sensory Neuropathy Type 1|Neuropathy, Progressive Sensory, Of Children|Hereditary Sensory and Autonomic Neuropathy 4|Sensory Neuropathy, Hereditary|HSAN Type II|HSAN 1|HSANs (Hereditary Sensory Autonomic Neuropathy)|Neurogenic Acroosteolysis|autonomic neuropathy|Sensory Neuropathies, Hereditary|Acroosteolysis, Giaccai Type|Hereditary Sensory And Autonomic Neuropathy IV|Pain Insensitivity with Anhidrosis, Congenital|Hereditary Sensory and Autonomic Neuropathy, Type 4|Hereditary Sensory Neuropathies|Congenital Insensitivity to Pain with Anhidrosis|Sensory Neuropathies, Congenital|Neuropathy Hereditary Sensory and Autonomic Type 1|Neuropathy, Hereditary Sensory, Type I|Hereditary Sensory Autonomic Neuropathy, Type 1|HSAN I|HSAN|HSN Type IIs|Hereditary Sensory Radicular Neuropathy|Hereditary Sensory Autonomic Neuropathy, Type 5|Neuropathy, Hereditary Sensory Radicular, Autosomal Recessive|HSAN 5|Neuropathy, Hereditary Sensory Radicular, Autosomal Dominant|Acroosteolyses, Neurogenic|Congenital Sensory Neuropathies|HSAN IV|HSAN Type IV|Hereditary Sensory and Autonomic Neuropathy, Type 5|HSAN (Hereditary Sensory Autonomic Neuropathy)|Hereditary Sensory and Autonomic Neuropathy Type 2|Giaccai Type Acroosteolysis|Neuropathies, Hereditary Sensory and Autonomic|Sensory Neuropathy, Congenital|Hereditary Sensory Neuropathy Type Ia|Neuropathy, Hereditary Sensory And Autonomic, Type V|Hereditary Sensory and Autonomic Neuropathy Type I|Neuropathy, Congenital Sensory, with Anhidrosis|Familial Dysautonomia, Type 2|Insensitivity to Pain, Congenital, with Anhidrosis|HSAN V|Type I, HSAN|Familial Dysautonomia, Type II|Neuropathy, Congenital Sensory|Sensory and Autonomic Neuropathies, Hereditary|Type I, HSN|Congenital Sensory Neuropathy|Neurogenic Acroosteolyses|HSAN 4|HSN Type I|Hereditary Sensory Neuropathy Type I|anhidrosis|HSAN Type V|Neuropathies, Congenital Sensory|HSAN Type I|Neuropathy Hereditary Sensory Radicular, Autosomal Dominant|Hereditary Sensory Autonomic Neuropathy, Type 4"
D015430,DISEASE,Weight Gain,"Weight Gains|Gains, Weight||gain|WG|Weight gain|weight gain|Gain, Weight"
NEW01215,CHEMICAL,contraceptive depot medroxyprogesterone acetate,contraceptive depot medroxyprogesterone acetate|DMPA
NEW01216,CHEMICAL,depot medroxyprogesterone acetate,depot medroxyprogesterone acetate
NEW01217,CHEMICAL,polyP deficient strain,polyP deficient strain
NEW01218,CHEMICAL,copper resistance systems,copper resistance systems
NEW01219,DISEASE,low hypozincemia detection,low hypozincemia detection
NEW01220,CHEMICAL,acute cerebral amyloid angiopathy,CAA|acute cerebral amyloid angiopathy
D002561,DISEASE,Cerebrovascular Disorders,"|Vascular Disorders, Brain|Intracranial Vascular Disorder|Intracranial Vascular Diseases|Occlusions, Cerebrovascular|Disease, Cerebrovascular|Diseases, Cerebrovascular|Occlusion, Cerebrovascular|Brain Vascular Disorder|vascular disorder|Cerebrovascular Occlusion|Cerebrovascular Occlusions|Insufficiency, Cerebrovascular|vascular dysfunctions|Vascular Diseases, Intracranial|Vascular Disease, Intracranial|Cerebrovascular Insufficiencies|Vascular Disorder, Intracranial|Cerebrovascular Disorder|Vascular Disorders, Intracranial|Insufficiencies, Cerebrovascular|Brain Vascular Disorders|Cerebrovascular Insufficiency|cerebrovascular disorders|Vascular Disorder, Brain|Cerebrovascular Disease|Intracranial Vascular Disease|Cerebrovascular Diseases|Intracranial Vascular Disorders"
D028243,DISEASE,"Cerebral Amyloid Angiopathy, Familial","Cerebral Amyloid Angiopathy, Cst3 Related|Cerebral Hemorrhage, Hereditary, With Amyloidosis|Cerebral Amyloid Angiopathy, Hereditary|Amyloidosis VIs|Icelandic Type Amyloidosis|Icelandic Type Hereditary Cerebral Amyloid Angiopathy|CAA|Cerebral amyloid angiopathy|Cerebral Amyloid Angiopathy, Genetic|Cerebral Amyloid Angiopathy, Cst3-Related|Familial Cerebral Amyloid Angiopathy|Hereditary Cerebral Amyloid Angiopathy, Icelandic Type|Amyloidosis, Cerebroarterial, Icelandic Type|Autosomal Dominant Cerebrovascular Amyloidosis|Amyloidosis, Icelandic Type|amyloid angiopathy|Amyloidosis VI|Hereditary Cerebral Hemorrhage With Amyloidosis|HCHWA|Hereditary Cerebral Amyloid Angiopathy"
D000927,CHEBI,Anticonvulsants,"Antiepileptic Drugs|Agent, Anticonvulsive|Drug, Anticonvulsant|anticonvulsant drug|Drugs, Antiepileptic|Antiepileptic Agent|Antiepileptic Drug|Drug, Anticonvulsive|Anticonvulsant Drug|Anticonvulsive Agents|Agents, Anticonvulsive|antiepileptic drug|Drugs, Anticonvulsant|Anticonvulsive Agent|Antiepileptic Agents|Anticonvulsant Drugs|Anticonvulsant|Drug, Antiepileptic|Agent, Antiepileptic|Anticonvulsive Drug|Agents, Antiepileptic|Anticonvulsive Drugs|Antiepileptic|Antiepileptics|Drugs, Anticonvulsive"
D007010,DISEASE,Hyponatremia,Hyponatremias||hyponatremia|Hyponatremia
NEW01221,MENTAL_HEALTH,atypical autism,atypical autism
D000078306,CHEMICAL,Clobazam,"LM 2717|HR 376|clobazam|Urbanyl|1-Phenyl-5-methyl-8-chloro-1,2,4,5- tetrahydro-2,4-diketo-3H-1,5-benzodiazepine|Onfi|Frisium|LM-2717|LM2717"
NEW01222,DISEASE,nonbipolar patients,nonbipolar patients
NEW01223,DISEASE,aggressive behaviors,aggressive behaviors
NEW01224,MENTAL_HEALTH,treatment refractory schizophrenia,treatment refractory schizophrenia
NEW01225,DISEASE,severe cardiac adverse events,severe cardiac adverse events
D009205,DISEASE,Myocarditis,|Myocarditides|Carditis|hypersensitivity myocarditis|myocarditis
NEW01226,DISEASE,Cocaine-induced cardiotoxicity,Cocaine-induced cardiotoxicity
NEW01227,CHEMICAL,catecholamine uptake,catecholamine uptake
D062626,CHEMICAL,Degenerin Sodium Channels,"Sodium Channels, Degenerin|Ion Channels, Degenerin|Degenerin|Degenerins|Degenerin Sodium Ion Channels|Degenerin Ion Channels|sodium channels"
NEW01228,DISEASE,cocaine-associated chest pain,cocaine-associated chest pain
D053840,DISEASE,Brugada Syndrome,"Brugada Syndrome 1|Brugada Type ECG Pattern|Brugada syndrome|Sudden Unexplained Nocturnal Death Syndrome|Sudden Unexplained Death Syndrome|Right Bundle Branch Block, ST Segment Elevation, and Sudden Death Syndrome|Brugada ECG Pattern|Sudden Unexplained Nocturnal Death Syndrome (SUNDS)|ECG Pattern, Brugada|sudden death syndrome"
NEW01229,CHEMICAL,lactate infusion,lactate infusion
D007464,CHEMICAL,Clioquinol,Entero-Septol||Entero Septol|clioquinol|5-Chloro-7-iodo-8-quinolinol|Entero-Vioform|Iodochloroxyquinoline|Enteroquinol|Chloroiodoquine|Chinoform|EnteroVioform|Clioquinol|Entero Vioform|Vioform|CQ|Iodochlorhydroxyquin|5 Chloro 7 iodo 8 quinolinol|EnteroSeptol
NEW01230,MENTAL_HEALTH,Claustrophobia Questionnaire,Claustrophobia Questionnaire
NEW01231,MENTAL_HEALTH,childhood-onset Pervasive Developmental Disorders,childhood-onset Pervasive Developmental Disorders
NEW01232,CHEMICAL,inositol signaling,inositol signaling
D010042,CHEMICAL,Ouabain,ouabain||Ouabain|Acolongifloroside K|G Strophanthin|G-Strophanthin|Acocantherin
NEW01233,CHEMICAL,sodium-potassium adenosine triphosphatase,sodium-potassium adenosine triphosphatase
NEW01234,NUTRITION,lithium acid,lithium acid
NEW01235,DISEASE,ouabain-induced neurotoxicity,ouabain-induced neurotoxicity
D062708,CHEMICAL,Epithelial Sodium Channel Agonists,sodium-|Epithelial Sodium Channel Activators|sodium|Na|Epithelial Sodium Channel Stimulators
NEW01236,DISEASE,bipolar patients,bipolar patients
NEW01237,CHEMICAL,nimodipine herbs,nimodipine herbs
D014012,DISEASE,Tinnitus,"Tinnitus, Leudets|Objective Tinnitus|Clicking Tinnitus|Tinnitus, Objective|Leudet Tinnitus|Tinnitus, Leudet's|Induced Tinnitus, Noise|Tinnitus, Spontaneous Oto-Acoustic Emission|Tinnitus, Tensor Palatini Induced|Tinnitus, Clicking|Leudet's Tinnitus|Tinnitus, Leudet|tinnitus|Tinnitus, Vascular Origin|Vascular Origin Tinnitus|Ringing-Buzzing-Tinnitus|Tinnitus, Noise Induced|Tinnitus, Tensor Tympani Induced|Ringing Buzzing Tinnitus|Tinnitus of Vascular Origin|Noise Induced Tinnitus|Tensor Tympani Induced Tinnitus|Tensor Palatini Induced Tinnitus|Tinnitus, Pulsatile|Spontaneous Oto-Acoustic Emission Tinnitus|Subjective Tinnitus|Tinnitus, Subjective|Tinnitus, Spontaneous Oto Acoustic Emission|Pulsatile Tinnitus|Spontaneous Oto Acoustic Emission Tinnitus"
D004213,MENTAL_HEALTH,Dissociative Disorders,"Fugue|dissociative disorder|Dissociation|dissociative reaction|Dissociative Disorder|Reaction, Dissociative|Hysteria, Dissociative|Hysterias, Dissociative|Disorder, Dissociative|Dissociative Reaction|Dissociative Hysteria|Reactions, Dissociative|dissociative disorders|Disorders, Dissociative|Dissociative Reactions"
D004546,CHEBI,Elapid Venoms,"Elapidae Venom|Venom, Cobra|Venom, Elapid|Venom, Naja|Venom, King Cobra|Venom, Elapidae|Naja Venom|Cobra Venoms|Ophiophagus hannah Venom|Venoms, Sea Snake|Hydrophid Venom|Venoms, Elapidae|Venom, Ophiophagus hannah|Sea Snake Venoms|venom|Venom, Hydrophid|Venoms, Cobra|Venoms, Elapid|Venom, Sea Snake|Venoms, Hydrophid|Elapid Venom|Naja Venoms|cobra venom|Sea Snake Venom|Elapidae Venoms|Venoms, Naja|Cobra Venom|King Cobra Venom|Hydrophid Venoms"
NEW01238,DISEASE,ADP-induced platelet aggregation,ADP-induced platelet aggregation
D010975,DISEASE,Platelet Aggregation Inhibitors,"Platelet Antiaggregants|Platelet Antiaggregant|Drugs, Antiplatelet|Antiplatelet Agent|Platelet Antiaggregant, Blood|Antagonist, Blood Platelet|Drug, Antiplatelet|Aggregation Inhibitors, Platelet|Antiaggregant, Blood Platelet|Blood Platelet Antagonist|platelet aggregation|Blood Platelet Antiaggregants|Antiaggregants, Platelet|Inhibitors, Platelet|Blood Platelet Aggregation Inhibitors|Agent, Antiplatelet|Antiaggregants, Blood Platelet|Platelet Inhibitors|Platelet Antagonist|Blood Platelet Antagonists|Antiaggregant, Platelet|Antiplatelet Agents|Platelet Inhibitor|Platelet Antagonist, Blood|Antagonists, Platelet|Agents, Antiplatelet|Aggregation Inhibitor, Platelet|Platelet Antagonists|Antagonists, Blood Platelet|Inhibitors, Platelet Aggregation|Antagonist, Platelet|Blood Platelet Antiaggregant|Antiplatelet Drugs|Blood Platelet Aggregation Inhibitor|Inhibitor, Platelet Aggregation|Platelet Aggregation Inhibitor|platelet aggregation inhibitor|Inhibitor, Platelet|Antiplatelet Drug"
D020936,DISEASE,"Epilepsy, Benign Neonatal","Benign Neonatal Epilepsy, Nonfamilial|Epilepsy, Benign Neonatal Infantile|Benign Familial Neonatal Epilepsy|Benign Familial Neonatal Convulsions|Neonatal-Infantile Epilepsies, Benign|Non Familial Benign Neonatal Convulsions|Convulsions, Benign Neonatal, Non-Familial|Familial Benign Neonatal Convulsions|Epilepsy, Benign Neonatal-Infantile|Benign Familial Infantile Convulsions|Convulsions, Benign Neonatal|Seizures, Benign Familial Infantile, 3|Epilepsies, Benign Neonatal-Infantile|Benign Neonatal Nonfamilial Epilepsy|Benign Familial Neonatal Infantile Seizures|Non-Familial Benign Neonatal Epilepsy|Benign Neonatal Convulsions|Benign Neonatal Non-Familial Convulsions|Neonatal Epilepsies, Benign|Convulsion, Benign Neonatal|Epilepsy, Benign Neonatal, Familial|Benign Neonatal Epilepsies|Epilepsies, Benign Neonatal|Neonatal Convulsions, Benign|Benign Non-Familial Neonatal Convulsions|Convulsions, Benign Neonatal, Familial|Convulsions Benign Familial Neonatal|Benign Neonatal-Infantile Epilepsy|Neonatal Epilepsy, Benign|Convulsions, Benign Familial Infantile, 3|Benign Neonatal-Infantile Epilepsies|Neonatal-Infantile Epilepsy, Benign|Epilepsy, Benign Neonatal, Nonfamilial|Benign Familial Neonatal-Infantile Seizures|Non-Familial Benign Neonatal Convulsions|Benign Neonatal Non Familial Convulsions|Seizures, Benign Familial Infantile, 1|Benign Non Familial Neonatal Convulsions|Familial Benign Neonatal Epilepsy|Non Familial Benign Neonatal Epilepsy|Convulsions, Benign Familial Infantile, 1|convulsions|Benign Familial Infantile Convulsions Syndrome|Benign Infantile Familial Convulsions|Epilepsy, Benign Neonatal, Non-Familial|Seizures, Benign Familial Neonatal-Infantile|Benign Neonatal Convulsion|Seizures, Benign Familial Neonatal Infantile|Neonatal Convulsion, Benign|Benign Neonatal Epilepsy"
NEW01239,DISEASE,cardiac rhythm impairment,cardiac rhythm impairment
NEW01240,CHEMICAL,Phenytoin therapy,Phenytoin therapy
D000077287,CHEMICAL,Levetiracetam,"Etiracetam, R isomer|UCB-6474|alpha ethyl 2 oxo 1 Pyrrolidineacetamide|UCB 6474|Etiracetam, (R)-|Etiracetam, S isomer|R-isomer Etiracetam|Etiracetam|Ucb-L060|Ucb-L059|UCB6474|Keppra|alpha-ethyl-2-oxo-1-Pyrrolidineacetamide|levetiracetam|LEV|Etiracetam, S-isomer|ucb L059|Ucb L060|Etiracetam, R-isomer|Levetiracetam|S-isomer Etiracetam|Ucb L059|UcbL060"
NEW01241,DISEASE,extrapyramidal adverse effects,extrapyramidal adverse effects
C005569,CHEMICAL,pipamperone [Supplementary Concept],Butyrophenones|pipamperone|Pipamperone
D015662,CHEBI,"Trimethoprim, Sulfamethoxazole Drug Combination",|Sumetrolim|Biseptol 480|Co Trimoxazole|Eusaprim|Lescot|Trimethoprim-sulfamethoxazole|Trimethoprim Sulfamethoxazole Combination|Centrin|TMP-SMX|Insozalin|TMP/SMX|Drylin|Sulfamethoxazole Trimethoprim Combination|co-trimoxazole|Biseptol-480|Trimosulfa|TMP SMX|drug combination|Biseptol480|Trimezole|Kepinol|Kepinol Forte|Eslectin|Metomide|Abactrim|Septrin|Septra|Trimethoprimsulfa|sulfamethoxazole-trimethoprim|Sulfamethoxazole-Trimethoprim Combination|Trimethoprim-Sulfamethoxazole|Sulprim|Trimethoprim|Biseptol|Trimethoprim-Sulfamethoxazole Combination|Trimethoprim Sulfamethoxazole|Bactrim|Centran|Bactifor|Cotrimoxazole|Oriprim|Co-Trimoxazole|Trimedin
NEW01242,CHEBI,common food preservative,common food preservative
NEW01243,CHEMICAL,kinesin inhibition,kinesin inhibition
D050031,DISEASE,Hashimoto Disease,"Hashimoto Syndrome|Syndromes, Hashimoto's|Chronic Lymphocytic Thyroiditis|Hashimoto's Disease|Hashimoto's Struma|Chronic Lymphocytic Thyroiditides|Thyroiditis, Chronic Lymphocytic|Lymphocytic Thyroiditides, Chronic|Disease, Hashimoto's|Hashimoto's Syndromes|Hashimoto Thyroiditis|Hashimoto Thyroiditides|Hashimoto Struma|Hashimoto's Syndrome|Hashimoto thyroiditis|Thyroiditides, Chronic Lymphocytic|Syndrome, Hashimoto's|Thyroiditides, Hashimoto|Hashimotos Disease|Disease, Hashimoto|Lymphocytic Thyroiditis, Chronic|Thyroiditis, Hashimoto|Hashimotos Syndrome"
NEW01244,CHEMICAL,microg/day,microg/day
D013974,CHEMICAL,Thyroxine,"|Levothyroxin Delalande|L-Thyroxin Henning|Eltroxin|L Thyroxin beta|Tiroidine|L Thyroxine|Levothyroxine|sodium levothyroxine|Levo-T|L-Thyroxine|Levothyroxine Sodium|Levothroid|Levothyroxin Deladande|L-3,5,3',5'-Tetraiodothyronine|L Thyroxine Roche|Levoxine|Novothyral|levothyroxine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine|Lévothyrox|Dexnon|Synthrox|Sodium Levothyroxine|L Thyroxin Henning|L-Thyroxin beta|Thyrax|Eferox|Levothyroid|Euthyrox|Levo T|L Thyrox|Thyroxine|Thyroxin|Tiroxina Leo|L-Thyroxine Roche|Novothyrox|Levoxyl|Eltroxine|L-Thyrox|Thyroid Hormone, T4|Unithroid|Thevier|Eutirox|Oroxine|O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine|Synthroid|3,5,3',5'-Tetraiodothyronine|T4 Thyroid Hormone|Berlthyrox"
NEW01245,DISEASE,persistent hypothyroidism,persistent hypothyroidism
D007037,DISEASE,Hypothyroidism,"|Hypothyroidism, Secondary|Deficiency, TSH|TSH Deficiencies|Primary Hypothyroidism|Hypothyroidism, Central|Thyroid Stimulating Hormone Deficiency|thyroid stimulating hormone|Hypothyroidism|Central Hypothyroidisms|Hormone Deficiency, Thyroid-Stimulating|Secondary Hypothyroidism|Primary hypothyroidism|Hypothyroidisms|TSH Deficiency|thyroid-stimulating hormone|central hypothyroidism|Hypothyroidism, Primary|Primary Hypothyroidisms|Central Hypothyroidism|Thyroid-Stimulating Hormone Deficiencies|Secondary Hypothyroidisms|Deficiency, Thyroid-Stimulating Hormone|hypothyroidism|Thyroid-Stimulating Hormone Deficiency"
NEW01246,DISEASE,multinodular atoxic goiter,multinodular atoxic goiter
NEW01247,DISEASE,experimental colitis,experimental colitis
D016264,CHEMICAL,Dextran Sulfate,"Sulfate, Sodium Dextran|Sodium Dextran Sulfate|dextran sulfate sodium|Sulfate, Dextran|Dextran Sulfate Sodium|DSS|Dextran Sulfate, Sodium|Sulfate Sodium, Dextran"
NEW01248,DISEASE,DSS-induced experimental colitis,DSS-induced experimental colitis
NEW01249,CHEMICAL,continuous curcumin,continuous curcumin
D053655,CHEMICAL,"Receptors, Interleukin-21","Receptors, IL-21|IL 21 Receptor|Interleukin-21 Receptor|IL-21 Receptors|Interleukin 21 Receptor|Receptor, Interleukin 21|Interleukin-21 Receptors|IL-21 Receptor|IL-21|Receptor, Interleukin-21|Interleukin 21 Receptors|Receptor, IL-21|Receptors, Interleukin 21|IL21R|IL 21 Receptors"
NEW01250,DISEASE,colonic mucosal ulceration,colonic mucosal ulceration
D008516,DISEASE,"Medicine, Chinese Traditional","Tongue Diagnoses, Traditional|Tongue Diagnosis, Traditional|Traditional Tongue Assessment|Traditional Chinese medicine|Chinese Medicine, Traditional|Traditional Chinese Medicine|Hsueh, Chung I|Traditional Tongue Diagnoses|Traditional Tongue Assessments|Chinese Traditional Medicine|Tongue Assessment, Traditional|TCM|Zhong Yi Xue|Traditional Medicine, Chinese|Traditional Tongue Diagnosis|traditional Chinese medicine|Chung I Hsueh"
NEW01251,DISEASE,amnesic potential,amnesic potential
NEW01252,DISEASE,memory impairment,memory impairment
NEW01253,CHEMICAL,BDNF Arc promoter,BDNF Arc promoter
C095582,NUTRITION,"lebocin protein, Bombyx mori [Supplementary Concept]",Insect Proteins|Bombyx mori
NEW01254,DISEASE,induced reproductive toxicity,induced reproductive toxicity
D017382,CHEMICAL,Reactive Oxygen Species,"Oxygen, Active|Active Oxygen|oxygen species|Pro-Oxidants|Pro Oxidants|reactive oxygen species|Oxygen Species, Reactive|Oxygen Radical|Oxygen Radicals|Radical, Oxygen|Pro Oxidant|Reactive oxygen species|Pro-Oxidant|ROS"
NEW01255,MENTAL_HEALTH,oxidative stress reactions,oxidative stress reactions
NEW01256,DISEASE,Intestinal inflammation,Intestinal inflammation
NEW01257,DISEASE,common digestive tract disease,common digestive tract disease
D007052,CHEMICAL,Ibuprofen,"|Motrin|ibuprofen|Ibuprofen, Sodium Salt|Ibumetin|Ibuprofen, Calcium Salt|Trauma Dolgit Gel|Ibuprofen Zinc|Ibuprofen-Zinc|Ibuprofen, Zinc Salt|Rufen|Ibuprofen, Aluminum Salt|Salprofen|Ibuprofen, Potassium Salt|Nuprin|Ibuprofen, Copper (2+) Salt|Brufen|Ibuprofen, (+-)-Isomer|Ibuprofen, (S)-Isomer|Trauma-Dolgit Gel|Ibuprofen, (R)-Isomer|alpha-Methyl-4-(2-methylpropyl)benzeneacetic Acid|Ibuprofen, Magnesium Salt"
NEW01258,CHEMICAL,metallothioneins,metallothioneins
D055551,DISEASE,HSP27 Heat-Shock Proteins,"HSP27 Heat Shock Proteins|HSP27 Protein|HSP27 Proteins|Heat Shock Protein 27|heat shock proteins|Protein 27, Heat-Shock|Heat-Shock Protein 27|Heat Shock Protein beta 1|heat shock|Heat Shock Protein beta-1|Heat-Shock Proteins, HSP27|heat-shock proteins|Heat-Shock Proteins 27|Heat Shock Proteins 27|HSP27"
D000530,CHEBI,Alfaxalone Alfadolone Mixture,"Alfatesine|CT 1341|mixture|Saffan|CT1341|Alfadolone Mixture, Alfaxalone|Mixture|Althesin|Alfathesin|Alphadione|Alphathesin|CT-1341|Glaxovet"
NEW01259,CHEMICAL,Sodium Voltage-Gated Channel Beta Subunit,Sodium Voltage-Gated Channel Beta Subunit
NEW01260,CHEMICAL,dopamine hypothesis,dopamine hypothesis
NEW01261,CHEMICAL,DA receptor D2,DA receptor D2
NEW01262,MENTAL_HEALTH,schizophrenia patients,schizophrenia patients
NEW01263,DISEASE,valve collapse,valve collapse
D019354,CHEMICAL,Sodium Lactate,"sodium lactate|Sodium lactate|Lactate, Sodium"
NEW01264,CHEMICAL,BACKGROUND Empagliflozin,BACKGROUND Empagliflozin
NEW01265,DISEASE,diabetic management,diabetic management
NEW01266,CHEMICAL,glucose reabsorption,glucose reabsorption
NEW01267,CHEMICAL,sodium excretion,sodium excretion
D050608,CHEMICAL,Sodium-Phosphate Cotransporter Proteins,"Transporters, Sodium Phosphate|Phosphate Transporters, Sodium|Symporters, Sodium-Phosphate|Sodium-Phosphate Cotransporter|Sodium Phosphate Cotransporter|Cotransporter Proteins, Sodium-Phosphate|sodium transporters|Sodium Phosphate Cotransporter Proteins|Sodium Phosphate Transporters|Phosphate Transporter, Sodium|Sodium-Phosphate Symporters|Sodium Phosphate Symporters|Sodium Phosphate Transporter"
NEW01268,NUTRITION,therapeutic lithium levels,therapeutic lithium levels
NEW01269,CHEMICAL,inpatient blood glucose measurements,inpatient blood glucose measurements
NEW01270,CHEMICAL,Fused-in-Sarcoma gene,Fused-in-Sarcoma gene
NEW01271,DISEASE,juvenile-onset Amyotrophic Lateral Sclerosis,juvenile-onset Amyotrophic Lateral Sclerosis
NEW01272,MENTAL_HEALTH,CVS-induced anxiety level,CVS-induced anxiety level
NEW01273,CHEMICAL,lateral amygdala,lateral amygdala|LA|lupus anticoagulants
NEW01274,DISEASE,pain patient anxiety,pain patient anxiety
NEW01275,CHEMICAL,buffered lidocaine,buffered lidocaine
NEW01276,CHEMICAL,lidocaine injection,lidocaine injection
NEW01277,CHEMICAL,lidocaine solution,lidocaine solution|CTB
NEW01278,CHEMICAL,lower-sodium oxybate,lower-sodium oxybate
NEW01279,CHEMICAL,Fluoride exposure,Fluoride exposure
NEW01280,DISEASE,anxiety- behavior,anxiety- behavior
NEW01281,DISEASE,Cancer Research ICR,Cancer Research ICR
NEW01282,CHEMICAL,exercise fluoride group,exercise fluoride group
NEW01283,CHEMICAL,mg/kg NaF,mg/kg NaF
D012969,CHEMICAL,Sodium Fluoride,"Zymafluors|Fluorides, Sodium|Fluoride, Sodium|Fluoristats|Ossin|Fluoristat|Zymafluor|fluoride|NaF|Sodium Fluorides|sodium fluoride|Ossins"
NEW01284,CHEMICAL,fluoride group,fluoride group
NEW01285,CHEMICAL,mg/kg sodium fluoride,mg/kg sodium fluoride
NEW01286,MENTAL_HEALTH,bipolar affective disorders,bipolar affective disorders
NEW01287,DISEASE,sexual disturbances,sexual disturbances
NEW01288,DISEASE,narcoleptic patients,narcoleptic patients
D000078328,CHEMICAL,Felbamate,"W 554|ADD 03055|ADD-03055|W554|Felbamyl|Felbatol|2-Phenyl-1,3-propanediol dicarbamate|felbamate|ADD03055|(3-Carbamoyloxy-2-phenyl-propyl) carbamate|2 Phenyl 1,3 propanediol dicarbamate|W-554|Taloxa"
D010634,CHEMICAL,Phenobarbital,"|Sodium, Phenobarbital|Phenobarbitone|Phenobarbital, Monosodium Salt|Phenemal|Phenobarbital Sodium|luminal|Luminal|Monosodium Salt Phenobarbital|Gardenal|Acid, Phenylethylbarbituric|phenobarbitone|phenobarbital|Phenylethylbarbituric Acid|Phenylbarbital|Hysteps"
NEW01289,CHEMICAL,chronic alcohol consumption,chronic alcohol consumption
D055397,DISEASE,Ventilator-Induced Lung Injury,"Lung Injury, Ventilator Induced|lung injury|Lung Injury, Ventilator-Induced|Lung Injuries, Ventilator-Induced|Ventilator Induced Lung Injury|Ventilator-Induced Lung Injuries"
D011654,DISEASE,Pulmonary Edema,"|Lung, Wet|pulmonary edema|Edema, Pulmonary|Lungs, Wet|Edemas, Pulmonary|Wet Lung|Wet Lungs|Pulmonary Edemas"
NEW01290,DISEASE,LPS‑induced lung injury,LPS‑induced lung injury
NEW01291,CHEMICAL,A2AR‑mediated cAMP pathway,A2AR‑mediated cAMP pathway
D056487,DISEASE,"Chemical and Drug Induced Liver Injury, Chronic","liver injury|chronic liver injury|Hepatitis, Chronic, Drug-Induced|Liver Injury, Drug-Induced, Chronic|Drug Induced Liver Injury, Chronic|Chemical-Induced Liver Injury, Chronic|Chemically Induced Liver Injury, Chronic|Chronic Drug Induced Liver Injury|Chemical Induced Liver Injury, Chronic|Chemically-Induced Liver Injury, Chronic|Drug-Induced Liver Injury, Chronic|Hepatitis, Chronic, Drug-Related|Chronic Drug-Induced Liver Injury"
NEW01292,CHEMICAL,recent alcohol consumption,recent alcohol consumption
NEW01293,DISEASE,alcohol-associated hepatitis,alcohol-associated hepatitis
NEW01294,CHEMICAL,Elevated PAA,Elevated PAA
NEW01295,DISEASE,reversible neurological toxicity,reversible neurological toxicity
C538380,DISEASE,HHH syndrome [Supplementary Concept],"HHH syndrome|Ornithine/deficiency|ornithine translocase|Urea Cycle Disorders, Inborn|Hyperammonemia|hyperornithinemia-hyperammonemia-homocitrullinuria syndrome"
NEW01296,CHEMICAL,deficient mitochondrial ornithine transporter,deficient mitochondrial ornithine transporter
NEW01297,DISEASE,rare autosomal recessive disorder,rare autosomal recessive disorder
NEW01298,CHEMICAL,plasma amino acid profile,plasma amino acid profile
NEW01299,CHEMICAL,Amytal Sodium interviews,Amytal Sodium interviews
NEW01300,DISEASE,obsessive patients,obsessive patients
D015813,CHEBI,Substance Abuse Detection,"Illicit Drug Detections|Drug Abuse Testing|Testings, Illicit Drug|Drug Testings, Illicit|Detection, Substance Abuse|Testing, Street Drug|Detection, Street Drug|Detections, Substance Abuse|Drug Abuse Detection|Illicit Drug Detection|Detections, Drug Abuse|Drug Abuse Testings|Detections, Illicit Drug|Street Drug Detection|Street Drug Detections|Detection, Illicit Drug|Street Drug Testings|Testing, Drug Abuse|Drug Abuse Screening|Drug Abuse Screenings|Street Drug Testing|Detection, Drug Abuse|Substance Abuse Detections|Illicit Drug Testings|Substance Abuse Testings|Detections, Street Drug|street drug|Testings, Street Drug|Screening, Drug Abuse|illicit drug|Testing, Substance Abuse|Drug Testing, Illicit|Testings, Substance Abuse|Screenings, Drug Abuse|Substance Abuse Testing|Testings, Drug Abuse|Drug Abuse Detections|Illicit Drug Testing|Testing, Illicit Drug"
D002809,CHEMICAL,Chondroitin Sulfates,"|Chondroitin Sulfate, Potassium Salt|Sulfates, Chondroitin|Chondroitin Sulfate C|sodium salt|Chondroitin Sulfate, Iron (+3) Salt|Chondroitin Sulfate, Zinc Salt|Chondroitin 6 Sulfate|Chondroitin Sulfate 4-Sulfate, Sodium Salt|Chondroitin Sulfate, Calcium Salt|Chondroitin Sulfate, Iron Salt|Chondroitin 4-Sulfate|Sulfate, Chondroitin|Chondroitin Sulfate, Sodium Salt|Chondroitin Sulfate A|Chondroitin 4 Sulfate, Potassium Salt|Sulfate, Sodium Chondroitin|Chondroitin 6-Sulfate, Potassium Salt|Chondroitin Sulfate, Sodium|Chondroitin 6 Sulfate, Sodium Salt|Chondroitin 4 Sulfate|Sodium Chondroitin Sulfate|chondroitin sulfate|Chondroitin 6-Sulfate, Sodium Salt|Translagen|Chondroitin 4-Sulfate, Aluminum Salt|Chondroitin 4-Sulfate, Potassium Salt|Chonsurid|Blutal|Chondroitin Sulfate|Chondroitin 4 Sulfate, Aluminum Salt|Chondroitin Sulfate 4 Sulfate, Sodium Salt|Chondroitin 6-Sulfate|Chondroitin 6 Sulfate, Potassium Salt"
NEW01301,CHEMICAL,sodium oxybate Alcover,sodium oxybate Alcover
NEW01302,DISEASE,psychiatric co-morbidity,psychiatric co-morbidity
NEW01303,MENTAL_HEALTH,residual sleepiness,residual sleepiness
D017723,CHEBI,Drug Utilization Review,"Drug-Use Review|Utilization Reviews, Drug|Drug Utilization Evaluation|Evaluations, Drug Utilization|Reviews, Drug Utilization|Drug Use Review|Review, Drug-Use|Utilization Evaluations, Drug|Reviews, Drug-Use|Evaluation, Drug Utilization|Drug Utilization Evaluations|Utilization Review, Drug|Utilization Evaluation, Drug|Drug utilization|Drug Utilization Reviews|Drug-Use Reviews|Review, Drug Use|drug review|Review, Drug Utilization"
NEW01304,CHEBI,drug chemistry,drug chemistry
NEW01305,MENTAL_HEALTH,narcolepsy patients,narcolepsy patients
NEW01306,MENTAL_HEALTH,narcolepsy symptoms,narcolepsy symptoms
D020188,DISEASE,Sleep Paralysis,"Paralysis, Sleep|Sleep paralysis|sleep paralysis"
D020155,CHEMICAL,3-Hydroxybutyric Acid,beta Hydroxybutyric Acid|beta-Hydroxybutyrate|beta-Hydroxybutyric Acid|beta Hydroxybutyrate|3 Hydroxybutyric Acid|3 Hydroxybutyrate|3-Hydroxybutyrate|(+ -)-3-Hydroxybutyric Acid|hydroxybutyric acid|β-Hydroxybutyrate
NEW01307,CHEMICAL,second-line agents,second-line agents
NEW01308,CHEMICAL,Various antidepressant medications,Various antidepressant medications
NEW01309,CHEMICAL,norepinephrine serotonin reuptake inhibitors,norepinephrine serotonin reuptake inhibitors
NEW01310,CHEMICAL,JZP-386,JZP-386
NEW01311,CHEMICAL,FT extended-release formulation,FT extended-release formulation
D000077408,CHEMICAL,Modafinil,armodafinil|Benzhydrylsulfinylacetamide|2-((R)-(Diphenylmethyl)sulfinyl)acetamide|R-Modafinil|Modafinil|Modiodal|CRL 40476|Armodafinil|Alertec|2-((diphenylmethyl)sulfinyl)acetamide|modafinil|CRL-40476|Provigil|Nuvigil|2-((Diphenylmethyl)sulfinyl)acetamide|Sparlon|Vigil|R Modafinil
NEW01312,CHEMICAL,deuterated sodium oxybate oral suspension,deuterated sodium oxybate oral suspension
C000623308,CHEMICAL,solriamfetol [Supplementary Concept],Phenylalanine/analogs  and  derivatives|Solriamfetol|solriamfetol|Carbamates|JZP-110
D017291,CHEMICAL,Clarithromycin,A-56268|A56268||TE031|Biaxin|Clarithromycin|clarithromycin|TE-031|6-O-Methylerythromycin|TE 031|A 56268
NEW01313,CHEBI,GABAA receptor agonists,GABAA receptor agonists
NEW01314,CHEMICAL,γ-amino butyric acid GABA modulation,γ-amino butyric acid GABA modulation
NEW01315,CHEBI,Selective serotonin reuptake inhibitor antidepressants,Selective serotonin reuptake inhibitor antidepressants
D055013,DISEASE,"Osteoarthritis, Spine","Lumbar Osteoarthritis|Osteoarthritis of the Spine|Osteoarthritis of Spine|osteoarthritis|Osteoarthritis, Spinal|Spinal Osteoarthritis|Osteoarthritis, Lumbar|Spine Osteoarthritis"
NEW01316,CHEMICAL,Piperazine derivatives,Piperazine derivatives
NEW01317,MENTAL_HEALTH,various mental illness,various mental illness
NEW01318,CHEMICAL,piperazine derivative,piperazine derivative
D000086663,CHEMICAL,COVID-19 Vaccines,"coronavirus disease|Virus Vaccine, COVID-19|Vaccines, COVID-19|Vaccine, COVID-19|COVID19 Vaccines|COVID 19 Virus Vaccines|Vaccine, COVID 19|Coronavirus disease 2019|COVID 19 Vaccine|Virus Vaccines, COVID-19|Vaccines, SARS-CoV-2|Vaccines, SARS2|Virus Vaccines, COVID19|Coronavirus Disease-19 Vaccine|Virus Vaccine, COVID19|COVID19 Vaccine|2019 Novel Coronavirus Vaccine|Vaccines, COVID-19 Virus|COVID-19 Vaccine|2019 nCoV Vaccines|SARS CoV 2 Vaccines|Coronavirus Disease 2019 Vaccines|Coronavirus Disease 2019 Virus Vaccine|2019-nCoV Vaccines|Vaccines, COVID19 Virus|Vaccine, SARS-CoV-2|SARS-CoV-2 Vaccine|2019-nCoV Vaccine|COVID 19 Virus Vaccine|COVID 19 Vaccines|Vaccine, COVID-19 Virus|SARS2 Vaccines|Vaccine, Coronavirus Disease-19|COVID19 Virus Vaccines|Vaccine, SARS2|COVID-19 Virus Vaccine|SARS-CoV-2 Vaccines|Coronavirus Disease 2019 Virus Vaccines|2019 nCoV Vaccine|SARS2 Vaccine|Coronavirus Disease 2019 Vaccine|COVID19 Virus Vaccine|Coronavirus Disease 19 Vaccine|Vaccine, 2019-nCoV|Vaccines, 2019-nCoV|SARS Coronavirus 2 Vaccines|Vaccines, COVID19|coronavirus disease 2019|SARS CoV 2 Vaccine|COVID-19 Virus Vaccines|COVID-19|Coronavirus Disease 19 Vaccines|Vaccines, Coronavirus Disease-19|Coronavirus Disease-19 Vaccines|Vaccine, COVID19 Virus|Vaccine, COVID19|2019 Novel Coronavirus Vaccines|COVID-2019"
NEW01319,DISEASE,human behaviour,human behaviour
NEW01320,DISEASE,behavioural deficits,behavioural deficits
NEW01321,CHEMICAL,sodium salt valproate,sodium salt valproate
D000069470,CHEMICAL,Venlafaxine Hydrochloride,"Trevilor|VLX|Vandral|Hydrochloride, Venlafaxine|Wy 45030|Wy45,030|Sila Venlafaxine|Wy-45030|Wy45030|VEN|venlafaxine|Sila-Venlafaxine|Efexor|Venlafaxine|1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol HCl|Dobupal|Effexor|Wy 45,030|Wy-45,030|Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride"
D000078334,CHEMICAL,Lacosamide,Lacosamide|N-benzyl-2-acetamido-3-methoxypropionamide|N-benzyl-AcMeOPrNH2|lacosamide|Vimpat|N benzyl AcMeOPrNH2|N benzyl 2 acetamido 3 methoxypropionamide
D017029,DISEASE,"Epilepsy, Complex Partial","Epilepsy, Psychic Equivalent|Cryptogenic Partial Complex Epilepsy|epilepsy disorder|Partial Epilepsy, Complex|Partial Complex Epilepsy, Cryptogenic|Disorder, Complex Partial Seizures|Epilepsy, Symptomatic, Partial Complex|Epilepsy, Psychomotor|partial epilepsy|Seizure Disorder, Complex Partial|Complex Partial Seizure Disorder|Symptomatic Partial Complex Epilepsy|Psychic Equivalent Epilepsy|Psychomotor Epilepsy|Partial Complex Epilepsy, Symptomatic|Epilepsy, Cryptogenic, Partial Complex|Complex Partial Epilepsy"
D008376,CHEMICAL,Maprotiline,"Deprilept|Maprotilin|Mirpan|Novo Maprotiline|Maprotilin-ratiopharm|N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine|Hydrochloride, Maprotiline|Dibencycladine|Maprotilin-neuraxpharm|Mesylate, Maprotiline|Maprotilin-TEVA|maprotiline|Maprotiline Hydrochloride|Psymion|Maprotiline Mesylate|Maprolu|Maprotilin Holsten|Maprotilin neuraxpharm|maprotilin von ct|Maprotilin ratiopharm|Novo-Maprotiline|Maprotilin TEVA|Ludiomil|Ba34,276|Ba-34,276"
D000078785,CHEMICAL,Mirtazapine,Esmirtazapine|Remergil|ORG3770|(N-Methyl-11C)mirtazapine|ORG 3770|6 Azamianserin|Org 50081|ORG-3770|Zispin|Remeron|Mirtazapine|mirtazapine|6-Azamianserin|Rexer|(S)-Mirtazapine|Norset
NEW01322,CHEMICAL,sodium valprote,sodium valprote
C567827,DISEASE,"Generalized Epilepsy With Febrile Seizures Plus, 7 [Supplementary Concept]","febrile seizures|Epilepsy, Generalized|Seizures, Febrile"
NEW01323,CHEMICAL,cerebral sodium channels,cerebral sodium channels
D004829,DISEASE,"Epilepsy, Generalized","Convulsive Epilepsies, Generalized|Seizure Disorder, Generalized Nonconvulsive|Epilepsies, Generalized Convulsive|Generalized Seizure Disorders|Seizure Disorder, Convulsive, Generalized|Seizure Disorder, Nonconvulsive Generalized|Generalized Seizure Disorder, Nonconvulsive|Generalized Onset Seizure Disorder|Nonconvulsive Epilepsy, Generalized|Tonic Epilepsy|Generalized Seizure Disorder|Generalized Epilepsy|Seizure Disorders, Generalized|Epilepsy, Symptomatic Generalized|Generalized Epilepsy, Symptomatic|Epilepsy, Atonic|Akinetic Epilepsies|Convulsive Epilepsy, Generalized|Epilepsy, Akinetic|Generalized Convulsive Epilepsy|Atonic Epilepsy|Nonconvulsive Seizure Disorder, Generalized|Epilepsies, Atonic|Nonconvulsive Generalized Seizure Disorder|Epilepsy, Generalized Nonconvulsive|Epilepsies, Akinetic|Convulsive Seizure Disorder, Generalized|Convulsive Generalized Seizure Disorder|Atonic Epilepsies|Epilepsies, Generalized|Generalized Epilepsies|Akinetic Epilepsy|Seizure Disorder, Generalized|Generalized Convulsive Epilepsies|Tonic Epilepsies|Seizure Disorder, Generalized Onset|Epilepsy, Tonic|Generalized Seizure Disorder, Convulsive|Epilepsy, Generalized Convulsive|Seizure Disorder, Generalized, Convulsive|Generalized epilepsy|Generalized Nonconvulsive Seizure Disorder|Generalized Nonconvulsive Epilepsy|Epilepsies, Tonic|Symptomatic Generalized Epilepsy"
D020663,DISEASE,ras Guanine Nucleotide Exchange Factors,ras GEF|rasGEF|ras-GEFs|ras Guanine Nucleotide Exchange Factor|GEFS+|ras GEFs|ras-GEF|rasGEFs
NEW01324,CHEMICAL,DSS colitis,DSS colitis
NEW01325,CHEMICAL,immunosuppressant drug rapamycin,immunosuppressant drug rapamycin
NEW01326,DISEASE,aging disorders,aging disorders
NEW01327,CHEMICAL,neurotransmitter serotonin 5-hydroxytryptamine,neurotransmitter serotonin 5-hydroxytryptamine
NEW01328,CHEMICAL,TRP depletion,TRP depletion
NEW01329,DISEASE,transient depressive relapse,transient depressive relapse
NEW01330,DISEASE,short-term depressive relapse,short-term depressive relapse
NEW01331,DISEASE,paraphilic sexual disorders,paraphilic sexual disorders
D008694,CHEMICAL,Methamphetamine,"|methamphetamine|Deoxyephedrine|METH|Madrine|Desoxyn|Desoxyephedrine|Metamfetamine|Methylamphetamine|Hydrochloride, Methamphetamine|Methamphetamine Hydrochloride|N Methylamphetamine|N-Methylamphetamine|Methamphetamine"
NEW01332,MENTAL_HEALTH,sleepiness due,sleepiness due
NEW01333,CHEMICAL,acid-induced encephalopathy,acid-induced encephalopathy
NEW01334,DISEASE,hyperammonemia enzyme dysfunction,hyperammonemia enzyme dysfunction
NEW01335,CHEMICAL,urea cycle enzyme,urea cycle enzyme
NEW01336,CHEMICAL,L-carnitine deficiency,L-carnitine deficiency
NEW01337,DISEASE,acute encephalopathy,acute encephalopathy
NEW01338,CHEMICAL,plasma corticosterone,plasma corticosterone
NEW01339,DISEASE,chronic social defeat stress,CSDS|chronic social defeat stress
NEW01340,DISEASE,CSDS group,CSDS group
D000074261,DISEASE,"Receptors, Enterotoxin","Cyclase C, Guanylyl|Heat-Stable Enterotoxin Receptors|Receptor, GC-C|Guanyl Cyclase-C Receptors|Heat Stable Enterotoxin Receptors|Guanyl Cyclase-C Receptor|Receptor, Guanylin-Uroguanylin|Guanyl Cyclase C Receptors|Receptors, Heat-Stable Enterotoxin|Heat-Stable Enterotoxin Receptor|Receptor, Guanyl Cyclase C|Receptors, Enterotoxin-Guanylin|Guanylin Uroguanylin Receptor|GC-C Receptor|Enterotoxin Guanylin Receptors|Receptors, GC-C|Guanylin-Uroguanylin Receptors|Receptor, Guanyl Cyclase-C|Enterotoxin Guanylin Receptor|Enterotoxin Receptors|Receptor, Enterotoxin|GC C Receptor|Receptor, Heat-Stable Enterotoxin|guanylin|GC C Receptors|Receptors, Guanyl Cyclase C|Enterotoxin Receptor, Heat-Stable|Enterotoxin Receptor|Guanylin Uroguanylin Receptors|Receptors, Guanylin-Uroguanylin|Guanylin-Uroguanylin Receptor|Enterotoxin-Guanylin Receptor|Receptors, Guanyl Cyclase-C|Heat Stable Enterotoxin Receptor|Cyclase-C Receptors, Guanyl|Enterotoxin-Guanylin Receptors|Guanylyl Cyclase C|Receptor, Enterotoxin-Guanylin|Enterotoxin Receptors, Heat-Stable|GN|Guanyl Cyclase C Receptor|GC-C Receptors"
D003908,CHEMICAL,Dexamethasone Isonicotinate,"dexamethasone|Auxison|HE 111|HE111|Isonicotinate, Dexamethasone|HE-111"
NEW01341,MENTAL_HEALTH,pure mania,pure mania
NEW01342,NUTRITION,lithium therapy,lithium therapy
NEW01343,MENTAL_HEALTH,Mixed mania,Mixed mania
NEW01344,MENTAL_HEALTH,secondary mania,secondary mania
NEW01345,MENTAL_HEALTH,extreme psychosis,extreme psychosis
D000077152,CHEMICAL,Olanzapine,"LY-170052|2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine|OLZ|LY170052|olanzapine|Zyprexa|Olanzapine Pamoate|Olanzapine|zyprexa|LY 170053|LY 170052|Zolafren|OLA"
D017590,DISEASE,"Myelinolysis, Central Pontine","Myelinoclases, Extrapontine|Extrapontine Myelinoclasis|Central pontine myelinolysis|Myelinolysis, Extrapontine|Myelinoclasis, Central Pontine|CPM|Extrapontine Myelinolysis|Central Pontine Myelinoclasis|Extrapontine Myelinolyses|Extrapontine Myelinoclases|Myelinolyses, Extrapontine|Central Pontine Myelinolysis|Myelinoclasis, Extrapontine|Pontine Myelinolysis, Central"
NEW01346,DISEASE,acute demyelinating neurological disorder,acute demyelinating neurological disorder
D004401,DISEASE,Dysarthria,"|Guttural Dysarthria|Scanning Speech|Mixed Dysarthrias|Hyperkinetic Dysarthria|Scanning Speechs|Guttural Dysarthrias|Speechs, Scanning|Dysarthria, Hypokinetic|Flaccid Dysarthrias|Spastic Dysarthrias|Hypokinetic Dysarthria|Dysarthrias, Guttural|Hyperkinetic Dysarthrias|Dysarthria, Guttural|Scanning Dysarthria|Dysarthoses|Dysarthria, Flaccid|Dysarthrias, Flaccid|Dysarthrias, Scanning|dysarthria|Dysarthrias|Mixed Dysarthria|Dysarthrias, Spastic|Dysarthria, Mixed|Dysarthrias, Hyperkinetic|Dysarthria, Hyperkinetic|Hypokinetic Dysarthrias|Dysarthria, Spastic|Dysarthrias, Mixed|Dysarthosis|Dysarthrias, Hypokinetic|Dysarthria, Scanning|Spastic Dysarthria|Scanning Dysarthrias|Flaccid Dysarthria"
D020828,DISEASE,Pseudobulbar Palsy,"pseudobulbar palsy|Pseudobulbar Syndromes|Pseudobulbar Paralysis|Dysarthria, Pseudobulbar|Palsies, Spastic Bulbar|Paresis, Pseudobulbar|Pseudobulbar Dysarthria|Paralysis, Pseudobulbar|Palsy, Spastic Bulbar|Bulbar Palsies, Spastic|Pseudobulbar Dysarthrias|Pseudobulbar Syndrome|Pseudobulbar Paresis|Palsies, Pseudobulbar|Paralyses, Pseudobulbar|Pseudobulbar Mutism|Spastic Bulbar Palsy|Spastic Bulbar Palsies|Pareses, Pseudobulbar|Pseudobulbar Mutisms|Mutisms, Pseudobulbar|Dysarthrias, Pseudobulbar|Pseudobulbar Pareses|Mutism, Pseudobulbar|Syndromes, Pseudobulbar|Bulbar Palsy, Spastic|Syndrome, Pseudobulbar|Palsy, Pseudobulbar|Pseudobulbar Paralyses|Pseudobulbar Palsies"
D011782,DISEASE,Quadriplegia,"|Spastic Tetraplegia|Quadriplegias, Spastic|Flaccid Tetraplegia|spastic quadriparesis|Quadriplegia, Flaccid|Quadriplegia, Spastic|Quadriparesis|Tetraplegia|Quadriplegias, Flaccid|Paralysis, Spinal, Quadriplegic|Tetraplegias, Spastic|Tetraplegias, Flaccid|Flaccid Tetraplegias|Flaccid Quadriplegias|Quadriplegias|Spastic Tetraplegias|Flaccid Quadriplegia|Tetraplegias|Spastic Quadriplegias|Tetraplegia, Flaccid|flaccid paralysis|Tetraplegia, Spastic|Quadripareses|flaccid|quadriplegic|Spastic Quadriplegia"
NEW01347,DISEASE,various degrees coma,various degrees coma
D065166,DISEASE,Sepsis-Associated Encephalopathy,"Associated Delirium, Sepsis|encephalopathy|Sepsis Associated Delirium|Encephalopathies, Sepsis-Associated|Sepsis-Associated Delirium|Delirium, Sepsis-Associated|Deliriums, Sepsis Associated|Associated Encephalopathies, Sepsis|Sepsis Associated Encephalopathies|Encephalopathy, Sepsis-Associated|Sepsis-Associated Deliriums|sepsis|Sepsis Associated Deliriums|Encephalopathy, Sepsis Associated|Associated Deliriums, Sepsis|Encephalopathies, Sepsis Associated|Delirium, Sepsis Associated|Sepsis-Associated Encephalopathies|Deliriums, Sepsis-Associated|Sepsis Associated Encephalopathy|Associated Encephalopathy, Sepsis"
NEW01348,CHEBI,effective drug treatment,effective drug treatment
NEW01349,CHEMICAL,peripheral DAAO levels,peripheral DAAO levels
D054795,CHEMICAL,Incretins,"Incretin Effects|Effects, Incretin|Hormone, Glucose-Dependent Insulin-Releasing|Glucose-Dependent Insulin-Releasing Hormone|Glucose Dependent Insulin Releasing Hormone|Incretin Effect|Incretin|Effect, Incretin|Insulin-Releasing Hormone, Glucose-Dependent|incretins"
D005749,CHEMICAL,Gastric Inhibitory Polypeptide,"Glucose Dependent Insulin Releasing Peptide|glucose-dependent insulinotropic peptide|Inhibitory Polypeptide, Gastric|Glucose-Dependent Insulin-Releasing Peptide|Peptide, Glucose-Dependent Insulin-Releasing|Polypeptide, Gastric Inhibitory|Polypeptide, Gastric-Inhibitory|Peptide, Glucose-Dependent Insulinotropic|Insulin-Releasing Peptide, Glucose-Dependent|Gastric-Inhibitory Polypeptide|Insulinotropic Peptide, Glucose-Dependent|Glucose Dependent Insulinotropic Peptide|Glucose-Dependent Insulinotropic Peptide"
D005702,CHEMICAL,Galantamine,|Reminyl|galantamine|Galanthamine hydrobromide|Galantamine|Galanthamine Hydrobromide|Lycoremine|Nivaline|Galanthamine|Nivalin|Razadyne|Galantamin
C561589,CHEMICAL,mangiferin heptasulfate [Supplementary Concept],Xanthones|Mangiferin|Sulfuric Acid Esters|mangiferin
D001929,DISEASE,Brain Edema,"|Brain Swelling|Brain Edema, Cytotoxic|Brain Swellings|Edema, Intracranial|Cerebral Edema, Cytotoxic|Cerebral Edema|Edema, Vasogenic Brain|Swelling, Brain|Cerebral Edema, Vasogenic|Edema, Vasogenic Cerebral|Vasogenic Cerebral Edema|cerebral edema|Edema, Cytotoxic Brain|Cytotoxic Cerebral Edema|Cytotoxic Brain Edema|Edema, Cytotoxic Cerebral|Edema, Cerebral|Edema, Brain|Vasogenic Brain Edema|Brain Edema, Vasogenic|Intracranial Edema|brain edema|Cerebral Edemas, Vasogenic"
NEW01350,DISEASE,neuronal damage,neuronal damage
D002544,DISEASE,Cerebral Infarction,"|Right Hemisphere, Infarction, Cerebral|Infarction, Left Hemisphere, Cerebral|Anterior Choroidal Artery Infarction|Infarction, Subcortical|Infarctions, Cerebral|Left Hemisphere, Infarction, Cerebral|Infarcts, Cerebral|Subcortical Infarction|Subcortical Infarctions|Infarction, Cerebral, Left Hemisphere|Cerebral Infarctions|Cerebral Infarction, Right Hemisphere|Infarction, Cerebral, Right Hemisphere|Cerebral Infarcts|Cerebral, Left Hemisphere, Infarction|Infarction, Right Hemisphere, Cerebral|Infarct, Cerebral|cerebral infarction|Infarctions, Subcortical|Infarction, Cerebral|Cerebral Infarct|Infarcts in substantia nigra pars reticulata|Right Hemisphere, Cerebral Infarction|Left Hemisphere, Cerebral Infarction|Cerebral, Right Hemisphere, Infarction|Cerebral Infarction, Left Hemisphere|Posterior Choroidal Artery Infarction"
NEW01351,DISEASE,various neurological disorders,various neurological disorders
NEW01352,CHEMICAL,H. perforatum L.,H. perforatum L.
NEW01353,MENTAL_HEALTH,moderate mental depression,moderate mental depression
NEW01354,DISEASE,Tovophyllin A,Tovophyllin A
D044004,NUTRITION,Xanthones,"xanthones|Derivatives, Xanthone|Xanthone Derivatives"
NEW01355,DISEASE,proven duodenitis,proven duodenitis
NEW01356,CHEMICAL,solids,solids
C074385,CHEMICAL,caldecrin [Supplementary Concept],Serine Endopeptidases|serum calcium|Serum calcium
D017674,DISEASE,Hypophosphatemia,hypophosphatemia|Hypophosphatemias
NEW01357,CHEMICAL,Urinary phosphate excretion,Urinary phosphate excretion
NEW01358,CHEBI,antacid use,antacid use
D005767,DISEASE,Gastrointestinal Diseases,"Disease, Gastrointestinal|Diseases, Gastrointestinal|Gastrointestinal Disorder|Gastrointestinal Disorders, Functional|Cholera Infantum||Gastrointestinal Disease|gastrointestinal disorder|Gastrointestinal Disorder, Functional|Gastrointestinal Disorders|gastrointestinal disorders|gastrointestinal diseases|Functional Gastrointestinal Disorders|Functional Gastrointestinal Disorder"
D008286,DISEASE,Malabsorption Syndromes,"malabsorption|Syndrome, Malabsorption|Malabsorption Syndrome|Syndromes, Malabsorption"
NEW01359,CHEMICAL,serum phosphate level,serum phosphate level
NEW01360,CHEMICAL,urinary phosphate excretion,urinary phosphate excretion
NEW01361,CHEMICAL,normal serum calcium level,normal serum calcium level
NEW01362,CHEMICAL,severe phosphate diabetes,severe phosphate diabetes
NEW01363,DISEASE,spinal pain,spinal pain
NEW01364,MENTAL_HEALTH,chronic fatigue ascribable,chronic fatigue ascribable
D018771,DISEASE,Arthralgia,"|Joint Pain|Pain, Joint|arthralgia|Arthralgias|joint pain|Pains, Joint|Polyarthralgias|Joint Pains|Polyarthralgia|arthralgias|polyarthralgia"
NEW01365,CHEBI,inverse agonist activity,inverse agonist activity
NEW01366,DISEASE,psychotomimetic-like effects,psychotomimetic-like effects
NEW01367,CHEMICAL,full mGlu5 NAM chemotypes,full mGlu5 NAM chemotypes
C541428,CHEMICAL,"3-((2-methyl-1,3-thiazol-4-yl)ethynyl)piperidine [Supplementary Concept]",Piperidines|Thiazoles|MTEP
NEW01368,CHEBI,reported 5-HT2C selective agonists,reported 5-HT2C selective agonists
NEW01369,CHEBI,mixed-action serotonergic drugs,mixed-action serotonergic drugs
NEW01370,MENTAL_HEALTH,abuse pharmacotherapy,abuse pharmacotherapy
NEW01371,DISEASE,spasm activity,spasm activity
NEW01372,CHEBI,neutral antagonist,neutral antagonist
D058668,CHEBI,Adrenergic alpha-1 Receptor Antagonists,"α(1 antagonists|Adrenergic alpha1 Antagonists|Adrenergic alpha 1 Antagonists|Adrenergic alpha 1 Receptor Antagonists|Adrenergic alpha1-Antagonists|alpha1-Adrenoceptor Blocker|α1-adrenergic antagonists|Antagonists, alpha1-Adrenergic|alpha-1 Adrenergic Blocking Agents|alpha1-Antagonists, Adrenergic|alpha1 Adrenergic Antagonists|Adrenergic alpha-1 Receptor Blockers|alpha1 Adrenoceptor Blocker|Adrenergic alpha-1 Antagonists|alpha 1 Adrenergic Blocking Agents|alpha1-Adrenergic Antagonists|alpha-1 Antagonists, Adrenergic|Adrenergic alpha 1 Receptor Blockers"
NEW01373,CHEBI,inverse agonists,inverse agonists
D011224,CHEMICAL,Prazosin,"|Prazosin HCL|Prazosin Hydrochloride|Furazosin|HCL, Prazosin|Minipress|Pratsiol|Prazosin|Hydrochloride, Prazosin|prazosin"
D007859,MENTAL_HEALTH,Learning Disabilities,"|Adult Learning Disorder|Learning Disability, Adolescent|Adult Learning Disability|Learning Disabilities, Adult|Disabilities, Child Learning|Disorders, Learning|Learning Disorder, Adult|Child Learning Disability|Academic Disabilities, Developmental|Disabilities, Adult Learning|Disability, Adult Learning|Disabilities, Developmental Academic|Disability, Learning|impairment of learning|Disorders, Adult Learning|Learning Disability|Developmental Academic Disorders|Adolescent Learning Disability|learning disorders|Adult Learning Disorders|Academic Disability, Developmental|Disability, Adolescent Learning|Disturbances, Learning|Learning Disabilities, Child|Disabilities, Adolescent Learning|Developmental Disabilities of Scholastic Skills|Disability, Child Learning|Learning Disability, Child|Adolescent Learning Disabilities|learning disability|Scholastic Skills Development Disorders|Learning Disorders|Disabilities, Learning|Developmental Disorders of Scholastic Skills|Learning Disturbances|Disability, Developmental Academic|Learning Disorders, Adult|Learning Disability, Adult|Learning Disturbance|Developmental Academic Disability|Academic Disorder, Developmental|Disorder, Learning|Developmental Academic Disabilities|Learning Disorder|Developmental Academic Disorder|Learning Disabilities, Adolescent|Child Learning Disabilities|Academic Disorders, Developmental|Disturbance, Learning|Adult Learning Disabilities"
D026261,CHEMICAL,Diazepam Binding Inhibitor,"Protein, Acyl-CoA-Binding|Binding Inhibitor, Diazepam|Acyl CoA Binding Protein|Inhibitor, Diazepam Binding|Acyl-CoA-Binding Protein|diazepam|Peptide, DBI|EpDBI|Diazepam|DBI Peptide|Medium-Chain Acyl CoA-Binding Protein|Endozepine|Medium Chain Acyl CoA Binding Protein"
NEW01374,DISEASE,memory deficits similar,memory deficits similar
NEW01375,CHEMICAL,benzodiazepine agonist,benzodiazepine agonist
NEW01376,CHEMICAL,antimitotic agent methylazoxymethanol acetate,MAM|antimitotic agent methylazoxymethanol acetate
NEW01377,MENTAL_HEALTH,schizophrenia long-lasting behavioral alterations,schizophrenia long-lasting behavioral alterations
NEW01378,CHEMICAL,antimitotic agent methylazoxymethanol acetate,antimitotic agent methylazoxymethanol acetate
NEW01379,DISEASE,Schizophrenia-like deficits,Schizophrenia-like deficits
NEW01380,CHEBI,CB1 antagonist/inverse agonist AM251,CB1 antagonist/inverse agonist AM251
NEW01381,CHEBI,adenosine receptor antagonist caffeine,adenosine receptor antagonist caffeine
NEW01382,CHEBI,benzodiazepine receptor agonist N-methyl-beta-carboline-3-carboxamide,benzodiazepine receptor agonist N-methyl-beta-carboline-3-carboxamide
NEW01383,DISEASE,treatment resistant psychotic symptoms,treatment resistant psychotic symptoms
NEW01384,MENTAL_HEALTH,refractory hallucinations,refractory hallucinations
NEW01385,CHEMICAL,mono-amine reuptake,mono-amine reuptake
NEW01386,MENTAL_HEALTH,schizophrenia disorder,schizophrenia disorder
NEW01387,DISEASE,affective abnormalities,affective abnormalities
C092292,CHEMICAL,ziprasidone [Supplementary Concept],|Ziprasidone|Thiazoles|ziprasidone|Piperazines
NEW01388,CHEMICAL,long-term ziprasidone therapy,long-term ziprasidone therapy
NEW01389,DISEASE,cognitive benefits,cognitive benefits
NEW01390,DISEASE,repeated chronic intermittent ethanol,repeated chronic intermittent ethanol
NEW01391,CHEMICAL,male alcohol use,male alcohol use
NEW01392,CHEMICAL,glutamate transmission,glutamate transmission
NEW01393,DISEASE,Stress-induced psychiatric disorders,Stress-induced psychiatric disorders
NEW01394,CHEMICAL,major protein Homer1,major protein Homer1
NEW01395,DISEASE,psychopathologies,psychopathologies
NEW01396,CHEBI,selective mGluR5 inverse agonist,selective mGluR5 inverse agonist
NEW01397,DISEASE,behavioral alterations,behavioral alterations
NEW01398,CHEBI,benzodiazepine inverse agonist,benzodiazepine inverse agonist
NEW01399,DISEASE,seizure activity,seizure activity
NEW01400,CHEBI,CB1 antagonists,CB1 antagonists
NEW01401,CHEBI,partial inverse agonist,partial inverse agonist
D004314,MENTAL_HEALTH,Down Syndrome,"Down's Syndrome|47,XX,+21|Partial Trisomy 21 Down Syndrome|Mongolism|Trisomy G|Down Syndrome|Trisomy 21, Meiotic Nondisjunction|Down syndrome|Syndrome, Down|Downs Syndrome|Syndrome, Down's|Down Syndrome, Partial Trisomy 21|Trisomy 21, Mitotic Nondisjunction|47,XY,+21|Trisomy 21"
NEW01402,CHEMICAL,nonsedative anxiolytics,nonsedative anxiolytics
NEW01403,CHEBI,antidepressant drug development,antidepressant drug development
NEW01404,CHEMICAL,GABA hypothesis,GABA hypothesis
NEW01405,CHEBI,inverse agonist,inverse agonist
NEW01406,CHEMICAL,adjunctive pimavanserin,adjunctive pimavanserin
NEW01407,CHEMICAL,unconventional steroid signaling,unconventional steroid signaling
NEW01408,DISEASE,alcohol-induced behaviors,alcohol-induced behaviors
NEW01409,CHEMICAL,nongenomic G-protein-coupled steroid receptors,nongenomic G-protein-coupled steroid receptors
NEW01410,CHEBI,CB1R neutral antagonist,CB1R neutral antagonist
NEW01411,CHEMICAL,endomorphin analogs,endomorphin analogs
D009021,MENTAL_HEALTH,Morphine Dependence,"morphine addiction|Addiction, Morphine|Morphine dependence|Dependence, Morphine|dependence|Morphine Abuse|Morphine Addiction|morphine dependence|Abuse, Morphine"
NEW01412,CHEMICAL,naloxone- withdrawal syndromes,naloxone- withdrawal syndromes
NEW01413,CHEMICAL,naltrexone-elicited,naltrexone-elicited
NEW01414,MENTAL_HEALTH,psychosis related,psychosis related
NEW01415,CHEBI,oral 5-HT2A inverse agonist,oral 5-HT2A inverse agonist
NEW01416,MENTAL_HEALTH,acute anxiety,acute anxiety
C100419,CHEMICAL,ethyl octylphosphonofluoridate [Supplementary Concept],Organophosphorus Compounds|ethyl octylphosphonofluoridate|EOPF
NEW01417,DISEASE,ADHD-like behaviors,ADHD-like behaviors
D058437,DISEASE,Hypertensive Retinopathy,"hypertensive|retinopathy|Retinopathies, Hypertensive|Retinopathy, Hypertensive|Hypertensive Retinopathies"
NEW01418,DISEASE,EOPF-induced behaviors,EOPF-induced behaviors
NEW01419,CHEBI,agonist SLV-319,agonist SLV-319
NEW01420,DISEASE,H3 receptor inverse agonists,IAs|H3 receptor inverse agonists
NEW01421,CHEMICAL,ethanol addiction,ethanol addiction
NEW01422,CHEMICAL,SAR110894 mg/kg,SAR110894 mg/kg
NEW01423,CHEMICAL,SAR110894,SAR110894
NEW01424,DISEASE,selective attention deficit,selective attention deficit
D019954,DISEASE,Neurobehavioral Manifestations,"Symptoms, Cognitive|Neurobehavioral Manifestation|Manifestation, Neurobehavioral|Manifestation, Cognitive|Cognitive Symptoms|Cognitive Symptom|Manifestations, Neurobehavioral|Signs and Symptoms, Neurobehavioral|Cognitive Manifestations|Cognitive Manifestation|Manifestations, Cognitive|Neurobehavioral Signs and Symptoms|Symptom, Cognitive|cognitive symptoms"
C574738,CHEMICAL,MK-0249 [Supplementary Concept],MK-0249|Quinazolinones
NEW01425,CHEMICAL,histamine subtype receptor inverse agonists,histamine subtype receptor inverse agonists
NEW01426,CHEBI,MPEP GABA(B)R orthosteric agonist R-baclofen,MPEP GABA(B)R orthosteric agonist R-baclofen
NEW01427,CHEMICAL,R-baclofen,R-baclofen
NEW01428,CHEMICAL,Negative allosteric modulators,Selective negative allosteric modulators|NAMs|Negative allosteric modulators
D005600,MENTAL_HEALTH,Fragile X Syndrome,"FRAXA Syndromes|Marker X Syndromes|Fragile X syndrome|Martin-Bell syndrome|Fra(X) Syndrome|Syndromes, Marker X|FXS|Syndrome, Fragile X|fra(X syndrome|Syndrome, Marker X|Syndrome, FRAXE|Mental Retardation, X-Linked, Associated With Marxq28|fragile X syndrome|Martin-Bell Syndrome|Syndromes, FRAXE|X Linked Mental Retardation and Macroorchidism|FRAXE Syndrome|FRAXE Syndromes|Martin Bell Syndrome|Fragile X-F Mental Retardation Syndrome|X-Linked Mental Retardation and Macroorchidism|Mar (X) Syndrome|Fragile X Syndromes|Syndrome, Martin-Bell|Syndromes, FRAXA|Marker X Syndrome|Fragile X Mental Retardation Syndrome|FRAXA Syndrome|Syndromes, Fragile X|fra(X|X syndrome|Syndrome, FRAXA|Mental Retardation, X-Linked, Associated With Fragile Site Fraxe"
NEW01429,CHEMICAL,metabotropic glutamate receptor subtype,metabotropic glutamate receptor subtype
NEW01430,CHEMICAL,metabotropic glutamate receptor subtype 5,mGlu5|metabotropic glutamate receptor subtype 5
C040653,NUTRITION,"boric acid, nitrofurazone, procaine drug combination [Supplementary Concept]",boric acid|Boric Acids|Nitrofurazone|Procaine|Drug Combinations
NEW01431,DISEASE,experimental acute sciatic nerve injury,experimental acute sciatic nerve injury
D020833,DISEASE,Diffuse Axonal Injury,"Axonal Injuries, Diffuse|axonal injury|DAI (Diffuse Axonal Injury)|Injury, Diffuse Axonal|Diffuse Axonal Injuries|Injuries, Diffuse Axonal|DAIs (Diffuse Axonal Injury)|Axonal Injury, Diffuse"
NEW01432,DISEASE,injured sciatic nerve,injured sciatic nerve
NEW01433,DISEASE,borated zirconia,borated zirconia
NEW01434,CHEMICAL,phosphate ion competition,phosphate ion competition
D065098,NUTRITION,Catechol O-Methyltransferase Inhibitors,"Catechol O Methyltransferase Inhibitors|catechol|O-Methyltransferase Inhibitors, Catechol"
NEW01435,CHEMICAL,Dietary boron,Dietary boron
D003520,CHEMICAL,Cyclophosphamide,"|(+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate|Cyclophosphamide Monohydrate|Sendoxan|Cytoxan|NSC-26271|Cyclophosphamide, (S)-Isomer|CP|Cyclophosphane|NSC26271|Cyclophosphamide, (R)-Isomer|NSC 26271|B518|B-518|Cyclophosphamide|Procytox|Neosar|Endoxan|cyclophosphamide|B 518|Cytophosphane|Cytophosphan|Cyclophosphamide Anhydrous"
NEW01436,DISEASE,uncontrolled pain management,uncontrolled pain management
NEW01437,CHEMICAL,anti-depressants,anti-depressants
D059408,DISEASE,Pain Management,"Management, Pain|pain management|Pain Managements|Managements, Pain"
D000084783,CHEBI,Recreational Drug Use,"Drug Use, Recreational|Recreational Drug Uses|recreational drug|drug use|Drug Use"
NEW01438,CHEBI,month illicit drug users,month illicit drug users
D000063,DISEASE,"Accidents, Traffic","Traffic Crashes|accidents|Accident, Traffic|Traffic Accidents|Traffic Accident|Traffic Collision|crashes|Traffic Collisions|Collisions, Traffic|Collision, Traffic|Crashes, Traffic|traffic accidents"
NEW01439,DISEASE,more deaths,more deaths
NEW01440,DISEASE,Diverse behavioral disorders,Diverse behavioral disorders
D011396,CHEMICAL,Promedol,Dimethylmeperidine|promedol|Trimeperidine|Isopromedol
D011596,DISEASE,Psychomotor Disorders,"|Psychomotor impairment|Psychomotor Impairments|Impairments, Psychomotor|suppression of motility|Psychomotor Disorders, Developmental|Psychomotor Disorder, Developmental|Developmental Psychomotor Disorders|Psychomotor Impairment|Impairment, Psychomotor|Developmental Psychomotor Disorder"
NEW01441,DISEASE,schizophrenic-like psychoses,schizophrenic-like psychoses
D000662,CHEMICAL,Amphetamines,Amphetamine (1966-1975)|amphetamines
NEW01442,DISEASE,psychotic state,psychotic state
D058748,DISEASE,Pain Perception,"Perceptions, Pain|Pain Perceptions|Perception, Pain|pain perception|Pain perception"
D003221,DISEASE,Confusion,"Confusion, Post-Ictal||Confusional States|Confusional State|Confusion, Post Ictal|Disorientation|Post-Ictal Confusion|Confusion|Bewilderment|confusion|Confusion, Reactive|State, Confusional|States, Confusional|Reactive Confusion"
NEW01443,CHEBI,pre-existing drug abuse,pre-existing drug abuse
D000088942,DISEASE,Technology Addiction,"Addiction|Cell Phone Addictions|Addiction, Cell Phone|Game Addiction, Video|Video Game Addictions|addiction|Technology Addictions|Addictions, Mobile Phone|Addiction, Video Game|Cell Phone Addiction|Mobile Phone Addiction|Addiction, Mobile Phone|Phone Addiction, Mobile|Addictions, Video Game|Video Game Addiction|Mobile Phone Addictions"
D008140,CHEMICAL,Lorazepam,"|Medical, Lorazepam|Sinestron|Lorazepam Ratiopharm|Durazolam|Nu-Loraz|Idalprem|Nu Loraz|WY 4036|Donix|Laubeel|Sedicepan|Ativan|Tolid|WY-4036|WY4036|Wyeth, Orfidal|Somagerol|Temesta|Von Ct, Lorazep|Lorazep Von Ct|Orfidal Wyeth|Lorazepam-Ratiopharm|Lorazepam Medical|Lorazepam-Neuraxpharm|Apo-Lorazepam|Novo-Lorazem|Témesta|Lorazepam Neuraxpharm|lorazepam|Duralozam|Apo Lorazepam|Novo Lorazem"
NEW01444,DISEASE,bone pains,bone pains
NEW01445,CHEMICAL,Haloperidol treatment,Haloperidol treatment
NEW01446,DISEASE,orofacial dyskinetic movements,orofacial dyskinetic movements
NEW01447,CHEBI,Chronic treatment lycopene,Chronic treatment lycopene
NEW01448,CHEMICAL,colchicine treated rats,colchicine treated rats
NEW01449,DISEASE,mito-oxidative damage parameters,mito-oxidative damage parameters
D000077276,CHEBI,Lycopene,"Prolycopene|lycopene|Pro Lycopene|Pro-Lycopene|Lycopene, (cis)-isomer|All trans Lycopene|trans-lycopene|LYCOMATO|all-trans-lycopene|LYC O MATO|Lycopene, (13-cis)-isomer|Lycopene|LYC-O-MATO|All-trans-Lycopene|Lycopene, (7-cis,7'-cis,9-cis,9'-cis)-isomer -"
NEW01450,DISEASE,memory dysfunction,memory dysfunction
NEW01451,CHEMICAL,inhibitor SP600125,inhibitor SP600125
NEW01452,DISEASE,CRS-induced hippocampal mitochondrial dysfunction,CRS-induced hippocampal mitochondrial dysfunction
NEW01453,CHEBI,lycopene consumption,lycopene consumption
NEW01454,DISEASE,diseases prostate cancer,diseases prostate cancer
D018950,CHEMICAL,Lipopolysaccharide Receptors,"Lipopolysaccharide|sCD14|Antigens, CD14|CD14 Protein, Soluble|Soluble CD14 Antigen|CD14 Monocyte Differentiation Antigen|CD14 Antigen|Receptor, LPS|Receptor, Lipoglycan|Lipoglycan Receptor|Soluble CD14 Protein|Receptors, Lipopolysaccharide|lipopolysaccharide|Soluble CD14|CD14 Antigens|CD14, Soluble|CD14 Antigen, Soluble|LPS|LPS Receptor"
NEW01455,DISEASE,colitis mice,colitis mice
NEW01456,CHEBI,lycopene supplementation,lycopene supplementation
NEW01457,DISEASE,learning impairment,learning impairment
NEW01458,DISEASE,learning impairments,learning impairments
NEW01459,DISEASE,SMZ-induced brain injury,SMZ-induced brain injury
C004999,CHEMICAL,ferulic acid [Supplementary Concept],ferulic acid|Coumaric Acids|Ferulic acid
D065730,CHEMICAL,Limonene Hydroxylases,"(R)-Limonene 6-Monooxygenase|(S)-Limonene 6-Monooxygenase|Hydroxylases, Limonene|limonene|Monooxygenases, Limonene|(S)-Limonene 7-Monooxygenase|Limonene Monooxygenases"
C009091,CHEMICAL,protocatechuic acid [Supplementary Concept],Hydroxybenzoates|protocatechuic acid
D002392,NUTRITION,Catechin,"KB 53|Cyanidanol 3|KB-53|(+)-Cyanidanol-3|Catechuic Acid|KB53|Zyma|Catechinic Acid|Cianidanol|Epicatechin|Catechin|2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-cis)-|Cyanidanol-3|Catergen|3,3',4',5,7-Flavanpentol|catechin|(+)-Cyanidanol|Z 7300|(+)-Catechin|(-)-Epicatechin|(2R,3R)-2-(3,4-Dihydroxyphenyl)-3,5,7-chromanetriol"
D000077185,CHEMICAL,Resveratrol,"SRT-501|Resveratrol, (Z)-|SRT 501|RSV|trans-Resveratrol-3-O-sulfate|cis Resveratrol|Resveratrol 3 sulfate|Resveratrol-3-sulfate|resveratrol|cis-Resveratrol|trans-Resveratrol|Resveratrol|trans Resveratrol 3 O sulfate|trans Resveratrol|3,4',5-Trihydroxystilbene|3,4',5-Stilbenetriol|3,5,4'-Trihydroxystilbene|SRT501"
D002726,CHEMICAL,Chlorogenic Acid,"Acid, 3-Caffeoylquinic|3 Caffeoylquinic Acid|Acid, Chlorogenic|chlorogenic acid|3-Caffeoylquinic Acid|Chlorogenic acid"
C515382,CHEMICAL,esculetin-4-carboxylic acid ethyl ester [Supplementary Concept],esculetin|Umbelliferones
C501718,CHEMICAL,3'-O-beta-D-glucopyranosyl rosmarinic acid [Supplementary Concept],rosmarinic acid|Monosaccharides|Depsides|Cinnamates
D011794,CHEMICAL,Quercetin,"Quercetin|Dikvertin|3,3',4',5,7-Pentahydroxyflavone|quercetin"
D005707,CHEMICAL,Gallic Acid,"Acid, Gallic|gallic acid|3,4,5-Trihydroxybenzoic Acid"
D004610,CHEMICAL,Ellagic Acid,"Benzoaric Acid|Acid, Benzoaric|Acid, Ellagic|ellagic acid"
C005274,CHEMICAL,naringin [Supplementary Concept],naringin|Flavanones|Naringin|naringin dihydrochalcone
D002338,CHEBI,Carotenoids,"Tetraterpenes|Derivatives, Tetraterpene|Carotene|carotenoids|Carotenoids|Carotenes|Carotenoid|Tetraterpene Derivatives"
NEW01460,DISEASE,ischemic-induced injury,ischemic-induced injury
D005419,CHEMICAL,Flavonoids,2-Phenyl-Chromenes|2 Phenyl Chromenes|2 Phenyl Chromene||Flavonoid|2 Phenyl Benzopyran|2-Phenyl-Chromene|2 Phenyl Benzopyrans|Bioflavonoid|Bioflavonoids|bioflavonoid|flavonoids|2-Phenyl-Benzopyran|2-Phenyl-Benzopyrans
NEW01461,DISEASE,persistent hypercalcemia,persistent hypercalcemia
NEW01462,CHEBI,apparent extrarenal vitamin D synthesis,apparent extrarenal vitamin D synthesis
NEW01463,CHEMICAL,Associated aluminium intoxication,Associated aluminium intoxication
NEW01464,DISEASE,adynamic uremic osteodystrophy,adynamic uremic osteodystrophy
NEW01465,CHEMICAL,desferrioxamine challenge,desferrioxamine challenge
NEW01466,CHEMICAL,high plasma homocysteine concentration,high plasma homocysteine concentration
NEW01467,DISEASE,large vessel disease,large vessel disease
NEW01468,CHEBI,D status,D status
NEW01469,DISEASE,deficit symptoms,deficit symptoms
NEW01470,CHEMICAL,elevated homocysteine Hcy level,elevated homocysteine Hcy level
D050940,CHEMICAL,Betaine-Homocysteine S-Methyltransferase,"Betaine Homocysteine S Methyltransferase|Betaine Homocysteine Methyltransferase|Betaine-Homocysteine Methyltransferase-2|betaine|Methyltransferase, Betaine-Homocysteine|Homocysteine|Betaine-Homocysteine Methyltransferase|Bet-HCys MTase|MTase, Bet-HCys|HCys|Betaine Homocysteine Methyltransferase 2|Homocysteine Methyltransferase, Betaine|Methyltransferase, Betaine Homocysteine|Methyltransferase 2, Betaine-Homocysteine|Betaine-Homocysteine Methyltransferase 2|S-Methyltransferase, Betaine-Homocysteine|Bet HCys MTase|homocysteine|Hcy|Methyltransferase-2, Betaine-Homocysteine|Betaine"
NEW01471,CHEMICAL,Plasma Hcy,Plasma Hcy
NEW01472,MENTAL_HEALTH,untreated psychosis,untreated psychosis
D014899,DISEASE,Wernicke Encephalopathy,"Wernicke encephalopathy|Encephalopathy, Wernicke's||Gayet Wernicke Encephalopathy|Cerebral Beriberi|Wernicke's Polioencephalitis, Superior Hemorrhagic|Wernicke Superior Hemorrhagic Polioencephalitis|Wernicke's Disease|Wernicke's Syndrome|Gayet-Wernicke Encephalopathy|Beriberi, Cerebral|Wernicke's encephalopathy|Wernicke's Encephalopathy|Wernicke Syndrome|Encephalopathy, Wernickes|Encephalopathy, Wernicke|Wernicke Encephalopathies|Wernicke Disease|Wernicke's Superior Hemorrhagic Polioencephalitis|Encephalopathy, Gayet Wernicke|Encephalopathy, Gayet-Wernicke|Encephalopathies, Wernicke|Wernicke Polioencephalitis, Superior Hemorrhagic"
NEW01473,CHEBI,vitamin B1 deficiency,vitamin B1 deficiency
D014815,CHEBI,Vitamins,Vitamin|Vitamins|vitamins
NEW01474,CHEBI,folate metabolism,folate metabolism
NEW01475,DISEASE,severe hypertension,severe hypertension
D013971,DISEASE,Thyrotoxicosis,thyrotoxicosis||Thyrotoxicoses|Thyrotoxicosis
D064420,CHEBI,Drug-Related Side Effects and Adverse Reactions,"Adverse Drug Reaction|drug toxicity|Reactions, Adverse Drug|Drug Reactions, Adverse|Drug Side Effect|Adverse Drug Event|Toxicities, Drug|Drug Toxicities|Side Effects, Drug|Effects, Drug Side|Drug Side Effects|Drug Event, Adverse|Side Effect, Drug|Drug Events, Adverse|Drug Related Side Effects and Adverse Reaction|Adverse Drug Events|Toxicity, Drug|adverse drug reactions|Adverse Drug Reactions|Side Effects of Drugs|Drug-Related Side Effects and Adverse Reaction|Drug Reaction, Adverse|Drug Toxicity|Drug Related Side Effects and Adverse Reactions"
D014808,CHEBI,Vitamin D Deficiency,"vitamin D deficiency|Deficiency, Vitamin D|Vitamin D deficiency|Vitamin D Deficiencies|Deficiencies, Vitamin D"
D030181,CHEBI,Vitamin D Response Element,"vitamin D.|cholecalciferol|Vit D|Response Element, Vitamin D|vitamin-D|Vitamin D|vitamin D"
NEW01476,DISEASE,post-MVC pain outcomes,post-MVC pain outcomes
NEW01477,CHEBI,vitamin D insufficiency,vitamin D insufficiency
NEW01478,DISEASE,pain outcomes,pain outcomes
NEW01479,CHEMICAL,monoamines synthesis,monoamines synthesis
NEW01480,DISEASE,cognitive abilities,cognitive abilities
NEW01481,DISEASE,severe coagulopathy related,severe coagulopathy related
NEW01482,CHEBI,vitamin K antagonists,vitamin K antagonists
NEW01483,CHEBI,vitamin K deficient proteins,vitamin K deficient proteins
D000066608,CHEMICAL,Underage Drinking,"Underage Alcohol Use|Drinking, Underage|drinking alcohol|Adolescent Alcohol Intake|Drinking Age, Legal|Alcohol intake|Youth Alcohol Consumption|Adolescent Alcohol Consumption|Drinking Age, Minimum|Alcohol Consumption, Adolescent|Legal Drinking Ages|Underage Alcohol Consumption|Teenage Drinking|Alcohol Use, Adolescent|Adolescent Alcohol Drinking|Alcohol Drinking, Adolescent|Teen Drinking|Drinking Ages, Legal|Minimum Drinking Ages|alcohol consumption|Drinking, Youth|Drinking alcohol|Minimum Legal Drinking Age|Alcohol Use|Drinking Ages, Minimum|Alcohol Consumption, Youth|Adolescent Alcohol Use|Drinking, Teenage|Drinking, Teen|Drinking, Adolescent|Alcohol consumption|Alcohol Intake, Adolescent|Youth Drinking|Alcohol use|Alcohol Use, Underage|alcohol use|Alcohol Consumption, Underage|Legal Drinking Age|Adolescent Drinking|alcohol intake|Minimum Drinking Age"
NEW01484,DISEASE,persistent physical abnormalities,persistent physical abnormalities
NEW01485,CHEBI,vitamin E administration,vitamin E administration
NEW01486,CHEMICAL,hypovitaminosis D,hypovitaminosis D
NEW01487,DISEASE,stress-associated metabolic disorders,stress-associated metabolic disorders
NEW01488,CHEMICAL,Hypovitaminosis D,Hypovitaminosis D
NEW01489,DISEASE,bone injury,bone injury
NEW01490,CHEBI,vitamin B group,vitamin B group
NEW01491,DISEASE,Ang II-related cognitive impairment,Ang II-related cognitive impairment
D013838,CHEBI,Thiamine Triphosphate,"Triphosphate, Thiamin|Triphosphate, Thiamine|thiamine|Thiamin Triphosphate"
NEW01492,DISEASE,pathogenic Candida strains,pathogenic Candida strains
NEW01493,DISEASE,acute respiratory infection,acute respiratory infection
D012141,DISEASE,Respiratory Tract Infections,"Infections, Respiratory Tract|respiratory tract infection|Infection, Respiratory Tract|respiratory infections|Respiratory Infection, Upper|respiratory tract infections|Respiratory Infections|Infections, Respiratory|Upper Respiratory Infections|Infections, Upper Respiratory Tract|Upper Respiratory Tract Infection|Infections, Upper Respiratory|Upper Respiratory Tract Infections|Respiratory Tract Infection"
NEW01494,CHEBI,vitamin D levels,vitamin D levels
NEW01495,MENTAL_HEALTH,factors anxiety,factors anxiety
NEW01496,DISEASE,incident TRD,incident TRD
NEW01497,MENTAL_HEALTH,broad depression phenotypes,broad depression phenotypes
NEW01498,DISEASE,MDD subtypes,MDD subtypes
D007011,DISEASE,Hypoparathyroidism,"hypoparathyroidism|Hypoparathyroidism, Idiopathic|Idiopathic Hypoparathyroidism"
NEW01499,CHEMICAL,calcium medication,calcium medication
D064149,CHEMICAL,"Influenza Pandemic, 1918-1919","pandemic|Influenza Pandemic, 1918 1919|Spanish Flu Pandemic, 1918-1919|Spanish Flu Pandemic, 1918 1919|H1N1 Influenza Pandemic, 1918 1919|1918-1919 Influenza Pandemics|1918-1919 Influenza Pandemic|H1N1 Influenza Pandemic, 1918-1919|Pandemics, 1918-1919 Influenza|Influenza Pandemics, 1918-1919"
NEW01500,DISEASE,depressed individuals,depressed individuals
NEW01501,DISEASE,multistrain probiotic,multistrain probiotic
D001710,CHEBI,Biotin,"Vitamin H|Medebiotin|Gabunat|Biotin-Ratiopharm|Roche, Biotine|Biotine Roche|Deacura|Biotin Ratiopharm|Biodermatin|biotine|Biokur|Biotin Hermes|Hermes, Biotin|Medobiotin|Biotin Gelfert|biotin|vitamin B7|Rombellin|Gelfert, Biotin"
D007003,DISEASE,Hypoglycemia,"Hypoglycemia, Reactive|Postabsorptive Hypoglycemia|Hypoglycemia, Postprandial|Postprandial Hypoglycemia|Reactive Hypoglycemia|Hypoglycemia|Fasting Hypoglycemia|Hypoglycemia, Fasting|Hypoglycemia, Postabsorptive|hypoglycemia"
NEW01502,DISEASE,modest weight reduction,modest weight reduction
NEW01503,DISEASE,fasting hyperammonemia,fasting hyperammonemia
NEW01504,DISEASE,renal azotemia,renal azotemia
C536778,CHEMICAL,Systemic carnitine deficiency [Supplementary Concept],Carnitine/deficiency|Muscular Diseases|Carnitine deficiency|carnitine deficiency|Cardiomyopathies|Hyperammonemia
D034141,DISEASE,Hypoalbuminemia,|Serum Albumin (1965-2002)|hypoalbuminemia|Hypoproteinemia (1965-2002)
NEW01505,CHEMICAL,ammonia detoxification,ammonia detoxification
NEW01506,NUTRITION,fatty acid metabolism,fatty acid metabolism
D055948,DISEASE,Sarcopenia,Sarcopenias|sarcopenia
C567088,DISEASE,"Angiopathy, Hereditary, With Nephropathy, Aneurysms, And Muscle Cramps [Supplementary Concept]",Muscle Cramp|muscle cramps|Raynaud Disease
NEW01507,DISEASE,liver cirrhotic patients,liver cirrhotic patients
NEW01508,CHEMICAL,Carnitine supplementation,Carnitine supplementation
C546380,CHEMICAL,N-(2-((2-mercapto-2-methylpropyl)amino)ethyl)-1-methylimidazole-2-carboxamido nickel(II) [Supplementary Concept],MMA|Organometallic Compounds
NEW01509,DISEASE,chronic tubulointerstitial nephritis,chronic tubulointerstitial nephritis
NEW01510,MENTAL_HEALTH,alcoholic delirium,alcoholic delirium
NEW01511,CHEMICAL,Nitrous oxide abuse,Nitrous oxide abuse
NEW01512,DISEASE,psychiatric symptoms,psychiatric symptoms
D014806,CHEBI,Vitamin B 12 Deficiency,"vitamin B(12|vitamin B-12|Vitamin B12 Deficiency|Vitamin B12 Deficiencies|Deficiency, Vitamin B 12|Deficiencies, Vitamin B12|B12 deficiency|Vitamin B12 deficiency|vitamin B12 deficiency|Deficiency, Vitamin B12|vitamin B(12 deficiency"
NEW01513,CHEMICAL,nitrous oxide use,nitrous oxide use
NEW01514,DISEASE,Hypercoagulability workup,Hypercoagulability workup
NEW01515,CHEMICAL,elevated homocysteine level,elevated homocysteine level
D012614,DISEASE,Scurvy,scurvy|Hypoascorbemia|Hypoascorbemias|Scorbutus|Scurvies|Scurvy
NEW01516,CHEBI,D supplementation,D supplementation
NEW01517,MENTAL_HEALTH,withdrawal-induced anxiety,withdrawal-induced anxiety
D065668,CHEBI,Vitamin D3 24-Hydroxylase,"P-450 CYP24A1, Cytochrome|Calcitriol 24-Hydroxylase|24-Hydroxylase, Vitamin D3|Vitamin D3 24 Hydroxylase|vitamin|D3 24-Hydroxylase, 1,25-Dihydroxyvitamin|alpha,25-Dihydroxycholecalciferol-24-Hydroxylase, 1|vitamin D3|Vitamin D 24-Hydroxylase|Cytochrome P-450 CYP24A1|Cytochrome P 450 CYP24A1|1 alpha,25-Dihydroxyvitamin D(3)-24-Hydroxylase|1,25-Dihydroxyvitamin D3 24-Hydroxylase|CYP24A1|25 Hydroxycholecalciferol 24 Hydroxylase|1,25 Dihydroxyvitamin D3 24 Hydroxylase|Calcitriol 24 Hydroxylase|1 alpha,25-Dihydroxycholecalciferol-24-Hydroxylase|Vitamin D3|CYP24A1, Cytochrome P-450|1 alpha,25 Dihydroxycholecalciferol 24 Hydroxylase|25-Hydroxycholecalciferol-24-Hydroxylase|Vitamin D 24 Hydroxylase"
NEW01518,MENTAL_HEALTH,withdrawal-induced anxiety related,withdrawal-induced anxiety related
NEW01519,CHEBI,vitamin B12 levels,vitamin B12 levels
D003291,MENTAL_HEALTH,Conversion Disorder,"Disorder, Functional Movement|conversion disorder|Conversion Neuroses|Conversion Neurosis|neurological disorder|Movement Disorder, Functional|Movement Disorders, Functional|Neuroses, Conversion|Functional Neurological Disorders|Hysteria, Conversion|Functional Movement Disorders|Conversion Hysteria|Neurological Disorders, Functional|Disorder, Functional Neurological|Functional Neurological Disorder|Conversion Disorder|Astasia Abasia|Functional Movement Disorder|Conversion Disorders|Conversion Reaction|Astasia-Abasia|Neurological Disorder, Functional|Neurosis, Conversion"
NEW01520,CHEBI,intravenous vitamin D analogs,intravenous vitamin D analogs
D006962,DISEASE,"Hyperparathyroidism, Secondary","secondary hyperparathyroidism|Secondary Hyperparathyroidisms|Secondary Hyperparathyroidism|Hyperparathyroidisms, Secondary|SHPT"
NEW01521,CHEMICAL,chronic nitrous oxide abuse,chronic nitrous oxide abuse
D014804,CHEBI,Vitamin B Deficiency,"vitamin B deficiency|Deficiencies, Vitamin B|Vitamin B Deficiencies|B deficiencies|Deficiency, Vitamin B"
NEW01522,CHEBI,serum vitamin B12 levels,serum vitamin B12 levels
NEW01523,MENTAL_HEALTH,Narcolepsy type,Narcolepsy type
NEW01524,DISEASE,immune-mediated disease,immune-mediated disease
NEW01525,DISEASE,different etiologies,different etiologies
NEW01526,MENTAL_HEALTH,unexplained fatigue,unexplained fatigue
D014802,CHEBI,Vitamin A Deficiency,"vitamin A deficiency|A deficiency|Deficiency, Vitamin A|vitamin A|VAD|VA|Vitamin A Deficiencies|Deficiencies, Vitamin A|Vitamin A deficiency|Vitamin A"
NEW01527,DISEASE,sleep disturbances,sleep disturbances
NEW01528,CHEMICAL,VA levels,VA levels
NEW01529,DISEASE,ASD subjects,ASD subjects
NEW01530,CHEBI,vitamin B6 level,vitamin B6 level
NEW01531,CHEMICAL,TC-II functional abnormality,TC-II functional abnormality
NEW01532,CHEBI,tissue vitamin B12 deficiency,tissue vitamin B12 deficiency
NEW01533,DISEASE,Aggressive behavior,Aggressive behavior
NEW01534,CHEBI,Vitamin D/B12 supplementation,Vitamin D/B12 supplementation
C010549,CHEBI,allantoin - escin - esculoside - hamamelis - methol - vitamin B1 - vitamin E [Supplementary Concept],Escin|Vitamin E|vitamin B1|Rutin|Vitamin B1|Esculin|Drug Combinations
NEW01535,DISEASE,Wernicke-Korsakov syndrome,Wernicke-Korsakov syndrome
NEW01536,DISEASE,alcoholic complaints,alcoholic complaints
D000430,MENTAL_HEALTH,Alcohol Withdrawal Delirium,"Hallucinosis, Alcohol Withdrawal|Delirium Tremens, Alcohol Withdrawal Induced|Alcohol Withdrawal Induced Delirium Tremens|Alcohol Withdrawal Associated Autonomic Hyperactivity|Delirium, Alcohol Withdrawal|Delirium tremens|Alcohol Withdrawal Hallucinosis|hallucinosis|Delirium Tremens|delirium tremens|Alcohol Withdrawal-Induced Delirium Tremens|withdrawal delirium|autonomic hyperactivity|Autonomic Hyperactivity, Alcohol Withdrawal Associated"
NEW01537,CHEBI,vitamin B1 absorption,vitamin B1 absorption
D014155,CHEBI,Transcobalamins,"Holo-Transcobalamin II|vitamin B12|Transcobalamin III|Transcobalamin|cobalamin|Cobalamin Binding Proteins|Vitamin B12-Binding Protein|Vitamin B12 Binding Proteins|Transcobalamin II|Cobalophilin|Cobalamin-Binding Proteins|methylcobalamin|Vitamin B12-Binding Proteins|Proteins, Cobalamin-Binding|Vitamin B 12-Binding Protein|Transcobalamin (I)|R-Binder|Holo Transcobalamin II|Vitamin B 12-Binding Proteins|Vitamin B12|R Binder|Vitamin B12 Binding Protein|Haptocorrin|B12-Binding Protein, Vitamin|Transcobalamin I|Protein, Cobalamin-Binding|Vitamin B 12 Binder|Cobalamin-Binding Protein|Vitamin B 12 Binding Protein|Cobalamin Binding Protein|Proteins, Vitamin B12-Binding|Vitamin B 12 Binding Proteins|Protein, Vitamin B12-Binding"
NEW01538,CHEBI,narcotic drug,narcotic drug
NEW01539,DISEASE,psychiatric treatment,psychiatric treatment
D006934,DISEASE,Hypercalcemia,"|milk-alkali syndrome|Hypercalcemia|Milk-Alkali Syndrome|Hypercalcemias|Syndrome, Milk-Alkali|Milk Alkali Syndrome|hypercalcemia"
D011241,CHEMICAL,Prednisone,"|Prednidib|Encortone|Cortan|Sone|Pronisone|delta-Cortisone|Apo-Prednisone|Prednison Acsis|Meticorten|Prednison Hexal|Sterapred|Panasol|Acsis, Prednison|prednisone|Ultracorten|Decortin|Dehydrocortisone|Predniment|Cortancyl|Panafcort|Orasone|Enkortolon|Prednison Galen|Rectodelt|Predni Tablinen|Encorton|Winpred|Deltasone|Cutason|Decortisyl|Liquid Pred|Dacortin|Kortancyl"
D058286,CHEMICAL,Calcitonin Receptor-Like Protein,"Receptor-Like Receptor, Calcitonin|Calcitonin Receptor Like Receptor|calcitonin|Calcitonin|Calcitonin Receptor-Like Receptor|Calcitonin Receptor Like Protein|Receptor-Like Protein, Calcitonin"
D000077211,CHEMICAL,Zoledronic Acid,"CGP 42446|CGP42446|CGP-42446|2-(Imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid|Zometa|CGP 42446A|CGP 42'446|CGP42'446|Zoledronate|CGP-42'446|zoledronic acid|Zoledronic Acid Anhydrous"
NEW01540,DISEASE,adverse psychiatric effects,adverse psychiatric effects
NEW01541,CHEBI,vitamin D deficiency related,vitamin D deficiency related
NEW01542,DISEASE,bone damage related,bone damage related
NEW01543,DISEASE,avoidant/restrictive food intake disorder,ARFID|avoidant/restrictive food intake disorder
NEW01544,CHEBI,most vitamins,most vitamins
NEW01545,MENTAL_HEALTH,acute manic episode,acute manic episode
D015652,CHEMICAL,25-Hydroxyvitamin D 2,"25-Hydroxycalciferol|25 Hydroxyvitamin D 2|9,10-Secoergosta-5,7,10(19),22-tetraene-3 beta,25-diol|Ercalcidiol|25-Hydroxyergocalciferol|25 Hydroxycalciferol|25-Hydroxyvitamin D2|25 Hydroxyergocalciferol|25-hydroxyvitamin D|25-hydroxyvitamin D.|25 Hydroxyvitamin D2"
NEW01546,CHEBI,lower vitamin D status,lower vitamin D status
NEW01547,CHEBI,vitamin D status,vitamin D status
NEW01548,CHEBI,perinatal suboptimal vitamin D concentrations,perinatal suboptimal vitamin D concentrations
NEW01549,DISEASE,diabetic individuals,diabetic individuals
NEW01550,CHEBI,vitamin D supplementation,vitamin D supplementation
D008607,DISEASE,Intellectual Disability,"Development Disorder, Intellectual|Deficiency, Mental|Disabilities, Intellectual|Idiocy|intellectual disabilities|Psychosocial Mental Retardations|Mental Retardation, Psychosocial|Mental Retardations, Psychosocial|Mental Deficiencies|Mental Deficiency|Psychosocial Mental Retardation|Disorder, Intellectual Development|Development Disorders, Intellectual|intellectual disability|Mental Retardation|Retardation, Mental|Intellectual Development Disorders|Disorders, Intellectual Development|Retardation, Psychosocial Mental|Intellectual Disabilities|Intellectual Development Disorder|Deficiencies, Mental|Disability, Intellectual|Retardations, Psychosocial Mental"
NEW01551,CHEBI,vitamin D receptor VDR gene polymorphisms,vitamin D receptor VDR gene polymorphisms
NEW01552,CHEMICAL,triptoreline,triptoreline
NEW01553,DISEASE,aggressive hypersexual patients,aggressive hypersexual patients
NEW01554,DISEASE,placentitis,placentitis
D019761,CHEMICAL,Phosphorus-Oxygen Lyases,"Lyases, Phosphorus-Oxygen|Phosphorus|phosphorus|P<0.01|P2=0.200|P<0.001|P4|Phosphorus Oxygen Lyases"
NEW01555,DISEASE,hormesis phenomenon,hormesis phenomenon
NEW01556,CHEMICAL,female sexual steroids,female sexual steroids
NEW01557,CHEBI,sequential hormone therapy,sequential hormone therapy
NEW01558,DISEASE,adverse mood,adverse mood
NEW01559,DISEASE,Hormone therapy,HT|Hormone therapy
NEW01560,CHEMICAL,allopregnanolone increase,allopregnanolone increase
NEW01561,CHEBI,Exogenous oestrogens,Exogenous oestrogens
NEW01562,CHEBI,estrogen deficiency,estrogen deficiency
NEW01563,DISEASE,cognitive disturbances,cognitive disturbances
NEW01564,CHEBI,Estrogen administration,Estrogen administration
D002560,DISEASE,Cerebrovascular Circulation,"Cerebral Circulation|Blood Flow, Cerebral|Pressure, Cerebral Perfusion|Cerebral Blood Flow|Cerebral Blood Flows|Circulation, Cerebrovascular|Circulation, Cerebral|Cerebral Circulations|Flow, Brain Blood|Cerebral Perfusion Pressures|Cerebral Perfusion Pressure|Regional Cerebral Blood Flow|Brain Blood Flow|Blood Flow, Brain|Perfusion Pressure, Cerebral|Flow, Cerebral Blood|cerebral blood flow|Brain Blood Flows"
NEW01565,CHEMICAL,cerebral glucose administration,cerebral glucose administration
D059002,CHEBI,Androgen Receptor Antagonists,"Androgen receptor|Androgen Receptor Antagonist|Receptor Antagonists, Androgen|Receptor Antagonist, Androgen|Antagonist, Androgen Receptor|androgen|androgen receptor|Antagonists, Androgen Receptor"
NEW01566,DISEASE,neurological disease,neurological disease
NEW01567,DISEASE,Chronic fat malabsorption syndromes,Chronic fat malabsorption syndromes
C048016,CHEBI,"fatty acid, fat-soluble vitamin and phospholipid emulsion [Supplementary Concept]",fat-soluble vitamin|Phospholipids|Fatty Acids|Emulsions|Vitamin D|Vitamin A
NEW01568,CHEBI,vitamin E levels,vitamin E levels
NEW01569,DISEASE,spinal-cerebral diseases,spinal-cerebral diseases
NEW01570,DISEASE,digestive disorders,digestive disorders
D011602,DISEASE,Psychophysiologic Disorders,Psychophysiologic Disorder|Psychosomatic Disorder|psychophysiological disorders|Psychophysiological Disorders|Psychophysiological Disorder|Psychosomatic Disorders
D050500,DISEASE,"Pancreatitis, Chronic",Chronic Pancreatitis|chronic pancreatitis|Chronic pancreatitis
NEW01571,CHEMICAL,caudate putamen,caudate putamen|CP
D001851,DISEASE,"Bone Diseases, Metabolic","|Low Bone Mineral Density|Metabolic Bone Disease|bone disease|Osteopenias|osteopenia|Osteopenia|metabolic bone disease|Low Bone Density|Bone Density, Low|metabolic bone diseases|Metabolic Bone Diseases|Low Bone Densities|Bone Disease, Metabolic"
NEW01572,DISEASE,secondary osteoporosis,secondary osteoporosis
NEW01573,DISEASE,sitophobia,sitophobia
NEW01574,DISEASE,maldigestion due,maldigestion due
D010188,DISEASE,Exocrine Pancreatic Insufficiency,"Exocrine Pancreatic Insufficiencies|Insufficiency, Pancreatic|Pancreatic Insufficiency|Insufficiencies, Pancreatic|Insufficiency, Exocrine Pancreatic|Pancreatic Insufficiencies|exocrine pancreatic insufficiency|Pancreatic Insufficiency, Exocrine|Pancreatic Insufficiencies, Exocrine|Insufficiencies, Exocrine Pancreatic|Exocrine pancreatic insufficiency"
NEW01575,MENTAL_HEALTH,smoking abuse,smoking abuse
NEW01576,CHEBI,low vitamin D,low vitamin D
NEW01577,CHEBI,fat-soluble vitamins,fat-soluble vitamins
NEW01578,CHEMICAL,pancreatic enzyme replacement therapy,pancreatic enzyme replacement therapy|PERT
D049950,DISEASE,"Hyperparathyroidism, Primary","Primary Hyperparathyroidism|Primary hyperparathyroidism|Primary Hyperparathyroidisms|Hyperparathyroidisms, Primary|hyperparathyroidism|primary hyperparathyroidism"
D015228,DISEASE,Hypertriglyceridemia,|hypertriglyceridaemia|hypertriglyceridemia|Hypertriglyceridemias
D019005,DISEASE,Cystic Fibrosis Transmembrane Conductance Regulator,"Protein, CFTR|Chloride channels, ATP gated CFTR|Chloride channels, ATP-gated CFTR|CFTR Protein|cystic fibrosis"
NEW01579,DISEASE,pancreatic endocrine function,pancreatic endocrine function
NEW01580,DISEASE,hyperglycaemia overt diabetes mellitus,hyperglycaemia overt diabetes mellitus
D002780,DISEASE,"Cholestasis, Intrahepatic","|Intrahepatic Cholestasis|Biliary Stasis, Intrahepatic|Intrahepatic Biliary Stasis|Bile Duct Obstruction, Intrahepatic|Cholestases, Intrahepatic|intrahepatic cholestasis|Intrahepatic Biliary Stases|cholestasis|Biliary Stases, Intrahepatic|Intrahepatic Cholestases"
NEW01581,CHEBI,fat soluble vitamin deficiencies,fat soluble vitamin deficiencies
D011539,DISEASE,Pruritus Vulvae,Pruritus|pruritus
C537706,DISEASE,Kaler Garrity Stern syndrome [Supplementary Concept],"Hair Diseases|osteopenia|Intellectual Disability|Bone Diseases, Metabolic"
NEW01582,CHEBI,essential fat-soluble vitamin,essential fat-soluble vitamin
D063730,DISEASE,"Rickets, Hypophosphatemic","Hypophosphatemic Rickets|Rickets, Vitamin D-Resistant|Acquired Vitamin D-Resistant Rickets|Hypophosphatemic Vitamin D-Resistant Rickets|rickets|Rickets, Vitamin D Resistant|Hypophosphatemia, Vitamin D-Resistant Rickets|Vitamin D-Resistant Rickets|Ricket, Hypophosphatemic|Hypophosphatemic Vitamin D Resistant Rickets|Hypophosphatemic Ricket|Acquired Vitamin D Resistant Rickets"
C023336,CHEMICAL,trimethylamine [Supplementary Concept],Trimethylamine|TMA|trimethylamine|Methylamines
C536561,DISEASE,Trimethylaminuria [Supplementary Concept],"trimethylaminuria|Methylamines/urine|Metabolism, Inborn Errors"
NEW01583,DISEASE,volatile trimethyl arsenic acid,TMA|volatile trimethyl arsenic acid|volatile trimethylamine
D001321,MENTAL_HEALTH,Autistic Disorder,"Autism, Early Infantile||Kanner's Syndrome|autistic disorder|Disorder, Autistic|Kanner Syndrome|Kanners Syndrome|Autism|Infantile Autism, Early|Infantile Autism|Autism, Infantile|Disorders, Autistic|infantile autism|autism|Early Infantile Autism"
NEW01584,CHEMICAL,Omega-3 brain-food,Omega-3 brain-food
NEW01585,DISEASE,dietary deficit,dietary deficit
NEW01586,CHEMICAL,deficient brain-food,deficient brain-food|Omega-3
NEW01587,CHEBI,used antipsychotic drug,used antipsychotic drug
NEW01588,CHEMICAL,histidine supplementation,histidine supplementation
NEW01589,DISEASE,metabolic dysfunction,metabolic dysfunction
NEW01590,NUTRITION,native fish species,native fish species
NEW01591,CHEMICAL,SC09-Ysa,SC09-Ysa
NEW01592,DISEASE,Salmonella enterica pathogenicity island,Salmonella enterica pathogenicity island
NEW01593,DISEASE,various brain disorders,various brain disorders
NEW01594,MENTAL_HEALTH,Schizophrenia pathophysiology,Schizophrenia pathophysiology
NEW01595,MENTAL_HEALTH,dopaminergic hyperactivity,dopaminergic hyperactivity
NEW01596,CHEMICAL,NMDA receptor hypofunction,NMDA receptor hypofunction
D016291,CHEMICAL,Dizocilpine Maleate,|MK801|dizocilpine|MK-801|Dizocilpine|MK 801|dizocilpine maleate|(+)-MK-801
NEW01597,MENTAL_HEALTH,schizophrenia features,schizophrenia features
NEW01598,DISEASE,fear/anxiety behaviour,fear/anxiety behaviour
NEW01599,CHEMICAL,alarm pheromone,alarm pheromone
D004316,CHEMICAL,Doxepin,"Sinequan|Zonalon|Xepin|Apo-Doxepin|∼1 %|Hydrochloride, Doxepin|Doneurin|Prudoxin|Doxepin-RPh|Mareen|Doxepia|Deptran|Doxepin Hydrochloride, Cis-Trans Isomer Mixture (approximately 1:5)|Novo Doxepin|Sinquan|Quitaxon|Doxepin RPh|ApoDoxepin|Novo-Doxepin|Apo Doxepin|Doxepin Hydrochloride|Aponal|Desidox|Doxepin beta|Espadox"
NEW01600,DISEASE,severe psychiatric disorders,severe psychiatric disorders
D003345,CHEMICAL,Corticosterone,corticosterone|Anti-Inflammatory Agents
NEW01601,DISEASE,dendritic atrophy,dendritic atrophy
NEW01602,CHEMICAL,highest ketamine concentration,highest ketamine concentration
NEW01603,DISEASE,slight memory impairment,slight memory impairment
D013482,CHEMICAL,Superoxide Dismutase,"Erythrocuprein|Superoxide Dismutase, Ag-Zn|Hemocuprein|Cu-Superoxide Dismutase|superoxide dismutase|Dismutase, Fe-Superoxide|Fe-Superoxide Dismutase|Dismutase, Superoxide|Superoxide dismutase|Fe Zn Superoxide Dismutase|Cobalt Superoxide Dismutase|Superoxide Dismutase, Manganese|Mn Superoxide Dismutase|Fe-Zn Superoxide Dismutase|Dismutase, Cobalt Superoxide|Dismutase, Ag-Zn Superoxide|Dismutase, Cu-Superoxide|Dismutase, Mn-Superoxide|Mn-SOD|Iron Superoxide Dismutase|Fe Superoxide Dismutase|Manganese Superoxide Dismutase|Dismutase, Fe-Zn Superoxide|Dismutase, Manganese Superoxide|Mn SOD|Cu Superoxide Dismutase|Dismutase, Iron Superoxide|superoxide|Superoxide Dismutase, Fe-Zn|Superoxide Dismutase, Iron|Ag-Zn Superoxide Dismutase|Ag Zn Superoxide Dismutase|Superoxide Dismutase, Cobalt|Mn-Superoxide Dismutase"
D050886,DISEASE,HSP20 Heat-Shock Proteins,"HSP20 Heat-Shock Protein|Heat-Shock Proteins, HSP20|Heat-Shock Protein, HSP20|Heat-Shock Proteins 20|Heat-Shock Protein pp3|heat shock protein|Heat Shock Protein pp3|Heat Shock Proteins 20|HSP20 Heat Shock Protein|HSP20 Heat Shock Proteins|pp3, Heat-Shock Protein"
NEW01604,CHEMICAL,µM cyclophosphamide exposure,µM cyclophosphamide exposure
NEW01605,CHEMICAL,Antidepressant fluoxetine,FLX|Antidepressant fluoxetine
NEW01606,CHEBI,emerging endocrine disruptor,emerging endocrine disruptor
NEW01607,CHEMICAL,antidepressant fluoxetine,antidepressant fluoxetine
NEW01608,DISEASE,hypocortisol phenotype,hypocortisol phenotype
D062313,CHEBI,"Databases, Pharmaceutical","Pharmaceutical Databases|Drug Database|Drug Databases|pharmaceutical|Pharmaceutic Databases|Databases, Pharmaceutic|Database, Drug|Databases, Drug|Pharmaceutic Database|Database, Pharmaceutical|Pharmaceutical Database|Database, Pharmaceutic"
NEW01609,DISEASE,CRF type receptor selective antagonist antalarmin,CRF type receptor selective antagonist antalarmin
NEW01610,DISEASE,HEA-mediated neurogenic impairment,HEA-mediated neurogenic impairment
NEW01611,CHEMICAL,ammonia poisoning,ammonia poisoning
D005979,CHEMICAL,Glutathione Peroxidase,"Glutathione Peroxidase, Cytosolic|Cytosolic Glutathione Peroxidase|Peroxidase, Selenoglutathione|glutathione peroxidase|Lipoperoxidase, Glutathione|Peroxidase, Glutathione|Selenoglutathione Peroxidase|Glutathione Lipoperoxidase"
D056825,CHEMICAL,Thyroxine-Binding Globulin,Serpin A7|Thyropexin|thyroxine-binding globulin|thyroxine|globulin|TBG|Thyroxine Binding Globulin
NEW01612,CHEMICAL,DHA combinations,DHA combinations
NEW01613,DISEASE,attention deficit/hyperactivity disorder,attention deficit/hyperactivity disorder
D001072,MENTAL_HEALTH,Apraxias,"Dyspraxias, Verbal|Verbal Apraxias|Dyspraxia, Articulatory|Phonation Apraxias|Dyspraxias, Oral|Articulatory Dyspraxias|Apraxia, Oral|Motor Apraxias|Apraxias, Articulatory|Developmental Verbal Dyspraxia|Apraxia, Facial-Oral|Apraxias, Dressing|Disorder 1s, Speech-Language|Dyspraxia|Oral Dyspraxia|Speech And Language Disorder With Orofacial Dyspraxia|Oral Apraxias|Apraxias, Motor|Gestural Apraxias|Apraxia of Phonation|Articulatory Apraxia|Developmental Verbal Apraxias|Ideational Apraxias|Dressing Apraxia|Apraxia, Articulatory|Facial-Oral Apraxias|Motor Apraxia|Verbal Apraxia, Developmental|Dyspraxias|Ideational Apraxia|Developmental Verbal Apraxia|Apraxias, Gestural|Speech-Language Disorder 1s|1s, Speech-Language Disorder|Dyspraxias, Articulatory|Apraxia|Dyspraxias, Developmental Verbal|Apraxias, Oral|Verbal Dyspraxias|Verbal Dyspraxias, Developmental|Apraxias, Facial-Oral|Gestural Apraxia|Apraxias, Ideational|Facial-Oral Apraxia|Dyspraxia, Oral|Verbal Apraxia|Apraxia, Dressing|Apraxia, Gestural|Dyspraxia, Developmental Verbal|Phonation Apraxia|Disorder 1, Speech-Language|Apraxia, Developmental Verbal|Apraxia, Verbal|Verbal Apraxias, Developmental|Dressing Apraxias|Apraxias, Verbal|Oral Dyspraxias|Apraxia, Motor|Verbal Dyspraxia|Developmental Verbal Dyspraxias|Oral Apraxia|Articulatory Apraxias|Dyspraxia, Verbal|Apraxias, Developmental Verbal|Apraxia, Facial Oral|dyspraxia|Articulatory Dyspraxia|Speech Language Disorder 1|Speech-Language Disorder 1|Apraxia, Ideational|Verbal Dyspraxia, Developmental"
D004411,MENTAL_HEALTH,"Dyslexia, Acquired","Acquired Spelling Dyslexia|Reading Disabilities, Acquired|Acquired Word Blindnesses|Acquired Alexia|Word Blindnesses, Acquired|Reading Disability, Acquired|Acquired Dyslexia|Dyslexia, Acquired Spelling|Acquired Word Blindness|Global Dyslexia, Acquired|Word Blindness, Acquired|Disability, Acquired Reading|dyslexia|Acquired Reading Disabilities|Spelling Dyslexia, Acquired|Blindness, Acquired Word|Acquired Global Dyslexia|Alexia, Acquired|Disabilities, Acquired Reading|Dyslexia|Blindnesses, Acquired Word|Acquired Reading Disability|Dyslexia, Acquired Global"
NEW01614,NUTRITION,omega-3 fatty acid treatment,omega-3 fatty acid treatment
NEW01615,CHEMICAL,Antidepressant AD drugs,Antidepressant AD drugs
NEW01616,CHEMICAL,flax oil,flax oil
NEW01617,NUTRITION,Low omega-3 polyunsaturated fatty acid levels,Low omega-3 polyunsaturated fatty acid levels
D004281,CHEMICAL,Docosahexaenoic Acids,"Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Potassium Salt|Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer|Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer, Sodium Salt|Docosahexenoic Acids|Acids, Docosahexenoic|Docosahexaenoate|Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cesium Salt|docosahexaenoic acids|Acid, Docosahexaenoic|DHA|Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer)|Acids, Docosahexaenoic|Docosahexaenoic Acid, 3,6,9,12,15,18-Isomer|Docosahexaenoic acid|Docosahexaenoic Acid (All-Z Isomer)|Docosahexaenoic Acid|Docosahexaenoic Acid Dimer (All-Z Isomer)|docosahexaenoic acid|Docosahexaenoic Acid, 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer)|Docosahexaenoic Acid, Sodium Salt|Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cerium Salt"
NEW01618,CHEMICAL,selective dopamine,selective dopamine
NEW01619,CHEMICAL,low plasma DHA,low plasma DHA
D065886,DISEASE,Neurodevelopmental Disorders,"Disorder, Child Mental|Mental Disorders Diagnosed in Childhood|Mental Disorder, Child|Neurodevelopmental Disorder|neurodevelopmental disorders|Neurodevelopmental Disorders Usually Diagnosed in Infancy, Childhood or Adolescence|child mental disorders|Mental Disorders Usually Diagnosed in Infancy, Childhood or Adolescence|Child Mental Disorder|Mental Disorders, Child|neurodevelopmental disorder|disorders|Child Mental Disorders|Disorder, Neurodevelopmental"
NEW01620,NUTRITION,n-3 fatty acid supplementation,n-3 fatty acid supplementation
D000079262,DISEASE,"Obesity, Maternal",maternal obesity|Maternal Obesity|Obesity in Pregnancy
D002547,DISEASE,Cerebral Palsy,"Infantile Cerebral Palsy, Diplegic|Congenital Cerebral Palsy|Quadriplegic Infantile Cerebral Palsy|Mixed Cerebral Palsy|Rolandic Type Cerebral Palsy|Mixed Cerebral Palsies|Cerebral Palsies, Dystonic-Rigid|Cerebral Palsy, Spastic|Cerebral Palsy, Hypotonic|Cerebral Palsy, Atonic|Spastic Cerebral Palsy|Hypotonic Cerebral Palsies|Little Disease|Cerebral Palsy, Dyskinetic|Cerebral Palsy, Diplegic, Infantile|Cerebral Palsy, Rolandic Type|Spastic Diplegias|Athetoid Cerebral Palsy|Cerebral palsy|Diplegias, Spastic|Monoplegic Cerebral Palsy|Cerebral Palsies, Monoplegic|Diplegia, Spastic|Monoplegic Infantile Cerebral Palsy|Infantile Cerebral Palsy, Monoplegic|Atonic Cerebral Palsy|Hypotonic Cerebral Palsy|Cerebral Palsy, Dystonic-Rigid|Dystonic-Rigid Cerebral Palsies|Dystonic-Rigid Cerebral Palsy|Dyskinetic Cerebral Palsy|cerebral palsy|Cerebral Palsies, Dyskinetic|Diplegic Infantile Cerebral Palsy|Monoplegic Cerebral Palsies|Cerebral Palsy, Monoplegic, Infantile|Cerebral Palsy, Monoplegic|Cerebral Palsy, Athetoid|Spastic Diplegia|Cerebral Palsy, Congenital|Cerebral Palsy, Quadriplegic, Infantile|Infantile Cerebral Palsy, Quadriplegic|Little's Disease|Cerebral Palsies, Athetoid|Cerebral Palsy, Mixed|Cerebral Palsy, Dystonic Rigid|Spastic Cerebral Palsies|CP (Cerebral Palsy)"
NEW01621,CHEMICAL,SMOF group,SMOF group
D003963,DISEASE,Diaper Rash,"rash|Diaper Rashes|Rashes, Diaper|Rash, Diaper"
C093230,CHEMICAL,fexofenadine [Supplementary Concept],Terfenadine/analogs  and  derivatives|fexofenadine
D006854,CHEMICAL,Hydrocortisone,"Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-|Cortril|11-Epicortisol||Epicortisol|cortisol|Hydrocortisone|Hydrocortisone, (11 alpha)-Isomer|Cortisol|11 Epicortisol|Cortifair|Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer|hydrocortisone|Cortef"
D061906,DISEASE,Advanced Trauma Life Support Care,trauma|Advanced Trauma Life Support
NEW01622,CHEMICAL,slow acting antidepressant,slow acting antidepressant
D019052,MENTAL_HEALTH,"Depression, Postpartum","Postnatal Depression|Postnatal depression|Post-Partum Depression|Post-partum depression|Depression, Post-Natal|Postpartum Depression|postnatal depression|Post Partum Depression|Depression, Postnatal|Depression, Post-Partum|post-partum depression|Post Natal Depression|Post-Natal Depression|postpartum depression"
NEW01623,DISEASE,neurocranial deformity,neurocranial deformity
NEW01624,DISEASE,common external abnormality,common external abnormality
NEW01625,CHEMICAL,omega-3 supplementation,omega-3 supplementation
NEW01626,CHEMICAL,abnormal membrane prostaglandin production,abnormal membrane prostaglandin production
NEW01627,CHEMICAL,low omega-3 index,low omega-3 index
NEW01628,CHEBI,niacin test,niacin test
NEW01629,CHEMICAL,arachidonic acid levels,arachidonic acid levels
NEW01630,CHEMICAL,NMDA antagonist-induced impairment,NMDA antagonist-induced impairment
D000069077,DISEASE,Memory Consolidation,"memory consolidation|Memory Consolidations|Consolidations, Memory|Consolidation, Memory"
NEW01631,CHEMICAL,subeffective doses,subeffective doses
NEW01632,CHEBI,neurotoxin 1-methyl-4-phenyl-1,neurotoxin 1-methyl-4-phenyl-1
NEW01633,CHEMICAL,6-tetrahydropyridine,6-tetrahydropyridine
C585473,NUTRITION,"theaflavin-3,3'-digallate [Supplementary Concept]",theaflavin|Catechin/analogs  and  derivatives|Biflavonoids
D050483,CHEMICAL,Dopamine Plasma Membrane Transport Proteins,"Transporter, Dopamine|Neurotransmitter Transport Proteins, Dopamine-Specific|Dopamine Plasma Membrane Transporter Proteins|Carriers, Dopamine|Neurotransmitter Transport Proteins, Dopamine Specific|Dopamine-Specific Neurotransmitter Transporters|Transporters, Dopamine-Specific Neurotransmitter|dopamine transporter|Transporter Proteins, Dopamine|DAT Dopamine Transporter|Neurotransmitter Transporters, Dopamine-Specific|Solute Carrier Family 6 (Neurotransmitter Transporter), Member 3 Protein|Dopamine Transporter, DAT|SLC6A3 Protein|Dopamine Carriers|Dopamine Transporter|DAT Dopamine Transporter Proteins|Protein, SLC6A3|Dopamine Transporter Proteins|Dopamine Uptake Complex|Transporter, DAT Dopamine|Neurotransmitter Transporters, Dopamine Specific"
NEW01634,CHEMICAL,nigral tyrosine hydroxylase,nigral tyrosine hydroxylase
NEW01635,DISEASE,progressive neurodegenerative diseases,progressive neurodegenerative diseases
NEW01636,CHEMICAL,Theaflavins,Theaflavins
D013662,NUTRITION,Tea,"black tea|Green Tea|Green Teas|Tea, Green|Black Tea|Black Teas|Tea, Black|Teas, Black|Teas, Green"
NEW01637,CHEMICAL,pro-NMDA drugs,pro-NMDA drugs
NEW01638,DISEASE,schizophrenic people,schizophrenic people
NEW01639,CHEMICAL,NMDA receptor function,NMDA receptor function
NEW01640,CHEMICAL,NMDA receptor complex,NMDA receptor complex
NEW01641,CHEMICAL,N-methyl-D-aspartate NMDA receptors,N-methyl-D-aspartate NMDA receptors
NEW01642,DISEASE,pain pathways,pain pathways
NEW01643,CHEMICAL,N-methyl-D-aspartate NMDA receptor antagonist,N-methyl-D-aspartate NMDA receptor antagonist
NEW01644,CHEMICAL,Memantine treatment,Memantine treatment
NEW01645,CHEMICAL,corticosterone levels,corticosterone levels
NEW01646,CHEBI,NMDA receptor antagonists,NMDA receptor antagonists
NEW01647,DISEASE,schizophrenia-like symptoms,schizophrenia-like symptoms
NEW01648,CHEBI,Non-competitive N-methyl-D-aspartic acid NMDA receptor antagonists,Non-competitive N-methyl-D-aspartic acid NMDA receptor antagonists
NEW01649,CHEMICAL,endogenous NMDA receptor,endogenous NMDA receptor
NEW01650,DISEASE,anxiety-like behaviors,anxiety-like behaviors
NEW01651,DISEASE,stress-induced depression/anxiety,stress-induced depression/anxiety
NEW01652,MENTAL_HEALTH,neurogenic stress-induced depression,neurogenic stress-induced depression
NEW01653,DISEASE,behavioral despair,behavioral despair
NEW01654,CHEMICAL,melatonin pathway,melatonin pathway
NEW01655,CHEMICAL,NMDA pathway,NMDA pathway
NEW01656,DISEASE,neurogenic stress-induced depressive behaviors,neurogenic stress-induced depressive behaviors
NEW01657,CHEMICAL,GluN2A subunit-containing NMDA receptors,GluN2A subunit-containing NMDA receptors
C574512,CHEMICAL,TCN 201 [Supplementary Concept],TCN-201|Sulfonamides
NEW01658,MENTAL_HEALTH,parallel orientation,parallel orientation
C097015,CHEMICAL,oxazole yellow [Supplementary Concept],Benzoxazoles|oxazole|Quinolines
NEW01659,DISEASE,seizure burden,seizure burden
NEW01660,CHEMICAL,N-methyl-d-aspartate receptor-ionophore complex,N-methyl-d-aspartate receptor-ionophore complex
D050487,CHEMICAL,Glycine Plasma Membrane Transport Proteins,"Glycine Plasma Membrane Transporter Proteins|Glycine Transporter|Neurotransmitter Transporters, Glycine Specific|Transporters, Glycine-Specific Neurotransmitter|Glycine Transporter 1|GLYT Proteins|Neurotransmitter Transport Proteins, Glycine-Specific|Glycine Transporter 2|Neurotransmitter Transporters, Glycine-Specific|Neurotransmitter Transport Proteins, Glycine Specific|glycine transporter-1|Glycine-Specific Neurotransmitter Transporters"
C101950,CHEMICAL,D-serine dehydratase [Supplementary Concept],D-Serine|D-serine|Hydro-Lyases
D051263,CHEMICAL,D-Alanine Transaminase,"Aminotransferase, D-Alanine|Transaminase, D-Glutamate-D-Alanine|D Alanine Aminotransferase|D Alanine Transaminase|D-Alanine Aminotransferase|D-Glutamate-D-Alanine Transaminase|D Glutamate D Alanine Transaminase|D-alanine|alanine aminotransferase|Transaminase, D-Alanine"
NEW01661,CHEMICAL,D-amino acid oxidase inhibitors,D-amino acid oxidase inhibitors
D050892,CHEMICAL,Sarcosine Dehydrogenase,"Sarcosine|sarcosine|Dehydrogenase, Monomethylglycine|Sarcosine N Demethylase|Monomethylglycine Dehydrogenase|Dehydrogenase, Sarcosine|Sarcosine N-Demethylase|N-Demethylase, Sarcosine"
NEW01662,CHEMICAL,group metabotropic glutamate receptors,group metabotropic glutamate receptors
D051308,CHEMICAL,Glycine Transaminase,"glycine|Glycine-2-Oxoglutarate Aminotransferase|Glycine 2 Oxoglutarate Aminotransferase|Aminotransferase, Glycine|Aminotransferase, Glycine-2-Oxoglutarate|Transaminase, Glycine|strychnine|Glycine|Glycine Aminotransferase"
D000701,CHEBI,"Analgesics, Opioid","Agonists, Full Opioid|Agonists, Partial Opioid|Opioid Partial Agonists|partial agonists|Opioid agonists|Opioid|Opioid Mixed Agonist Antagonists|opioid agonists|Partial Agonists, Opioid|Opioid Analgesics|Opioids|Agonist-Antagonists, Opioid Mixed|Analgesic, Opioid|Agonists, Opioid Full|Opioid Analgesic|Opioid Agonists, Partial|Partial Opioid Agonists|Opioid Agonists, Full|Opioid Full Agonists|Agonists, Opioid Partial|mixed agonist|Full Opioid Agonists|full agonists|Opioid Mixed Agonist-Antagonists|Mixed Agonist-Antagonists, Opioid|Full Agonists, Opioid|Full opioid agonists"
C095106,CHEMICAL,traxoprodil mesylate [Supplementary Concept],"CP-101,606|Piperidines|traxoprodil|CP-101,606 %"
NEW01663,CHEBI,GluN2B subtype antagonists,GluN2B subtype antagonists
NEW01664,CHEMICAL,glycine site,glycine site
NEW01665,DISEASE,ischaemia,ischaemia
NEW01666,CHEMICAL,elevated ammonia concentrations,elevated ammonia concentrations
NEW01667,DISEASE,neuro-cognitive deficits,neuro-cognitive deficits
NEW01668,CHEMICAL,urea cycle defects,urea cycle defects
D065290,DISEASE,Acute-On-Chronic Liver Failure,"Failures, Acute-On-Chronic Liver (ACLF)|Acute On Chronic Liver Failure|Acute-On-Chronic Liver Failures (ACLF)|Acute On Chronic Liver Failure (ACLF)|Acute-On-Chronic Liver Failure (ACLF)|Liver Failures, Acute-On-Chronic (ACLF)|Acute-On-Chronic Liver Failures|Liver Failures, Acute-On-Chronic|Liver Failure, Acute On Chronic|Liver Failure, Acute-On-Chronic (ACLF)|Failure, Acute-On-Chronic Liver (ACLF)|failure|Failures, Acute-On-Chronic Liver|Failure, Acute-On-Chronic Liver|liver failure|Liver Failure, Acute-On-Chronic"
NEW01669,DISEASE,hyperammonemic fish,hyperammonemic fish
C020658,CHEMICAL,glutamine-synthetase adenylyltransferase [Supplementary Concept],Nucleotidyltransferases|Glutamine synthetase|glutamine synthetase
NEW01670,NUTRITION,synthetase inhibitor methionine sulfoximine MK-801,synthetase inhibitor methionine sulfoximine MK-801
NEW01671,CHEMICAL,urea cycle diseases,urea cycle diseases
NEW01672,CHEMICAL,ammonium elimination,ammonium elimination
NEW01673,CHEMICAL,urea cycle deficiencies,urea cycle deficiencies
NEW01674,DISEASE,organic acidemias,organic acidemias
NEW01675,CHEMICAL,ammonium exposure,ammonium exposure
NEW01676,CHEMICAL,amino acid pathways,amino acid pathways
NEW01677,CHEMICAL,nitric oxide synthesis,nitric oxide synthesis
NEW01678,CHEMICAL,ATP levels,ATP levels
NEW01679,DISEASE,addiction-like behaviors,addiction-like behaviors
NEW01680,DISEASE,hypersynchronization,hypersynchronization
NEW01681,CHEBI,psychotomimetic N-methyl-D-aspartic acid NMDA receptor antagonists,psychotomimetic N-methyl-D-aspartic acid NMDA receptor antagonists
NEW01682,CHEMICAL,NMDA antagonist-intake,NMDA antagonist-intake
NEW01683,CHEMICAL,increasing extrasynaptic glycine concentrations,increasing extrasynaptic glycine concentrations
C037078,CHEMICAL,MSH release inhibiting hormone receptor [Supplementary Concept],"glycinamide|Receptors, Pituitary Hormone-Regulating Hormone"
NEW01684,CHEMICAL,glutamate system,glutamate system
NEW01685,DISEASE,psychiatric pathology,psychiatric pathology
NEW01686,CHEMICAL,synapses/circuitry,synapses/circuitry
NEW01687,CHEMICAL,amygdala glutamate systems,amygdala glutamate systems
NEW01688,MENTAL_HEALTH,clinical anxiety disorders,clinical anxiety disorders
D018691,CHEBI,Excitatory Amino Acid Antagonists,"glutamate receptor antagonist|Glutamate Receptor Antagonist|Antagonists, Glutamate Receptor|excitatory amino acid antagonist|EAA Antagonists|Receptor Antagonist, Glutamate|glutamate antagonist|Glutamate Antagonists|Excitatory Amino Acid Antagonist|Antagonist, Glutamate|Antagonists, EAA|Antagonist, Glutamate Receptor|excitatory amino acid antagonists|Receptor Antagonists, Glutamate|Amino Acids, Excitatory, Antagonists|Glutamate Receptor Antagonists|Antagonists, Glutamate|glutamate antagonists|glutamate receptor antagonists|Glutamate Antagonist|Antagonists, Excitatory Amino Acid|Amino Acid Antagonists, Excitatory|Excitatory amino acid antagonists"
NEW01689,CHEMICAL,serotonin-enhancing agents,serotonin-enhancing agents
NEW01690,CHEMICAL,gamma-aminobutyric acid GABA analog,gamma-aminobutyric acid GABA analog
NEW01691,MENTAL_HEALTH,MK-801-induced amnesia,MK-801-induced amnesia
NEW01692,MENTAL_HEALTH,major mental disorders,major mental disorders
NEW01693,CHEMICAL,Boophone disticha,Boophone disticha
NEW01694,CHEBI,beta Aβ oligomers,beta Aβ oligomers
NEW01695,MENTAL_HEALTH,Alzheimer disease patients,Alzheimer disease patients
NEW01696,CHEMICAL,theta burst stimulation,TBS|theta burst stimulation
D054821,CHEBI,beta-Hexosaminidase beta Chain,"Hexosaminidase B, beta Chain|Hexosaminidase A, beta Chain|beta|beta Chain, beta-Hexosaminidase|beta    =|beta Chain, beta-N-Acetylhexosaminidase|beta Hexosaminidase beta Chain|beta-N-Acetylhexosaminidase beta Chain|beta N Acetylhexosaminidase beta Chain|β"
NEW01697,DISEASE,TBS-induced LTP,TBS-induced LTP
NEW01698,CHEBI,nucleoside reverse transcriptase inhibitors,nucleoside reverse transcriptase inhibitors
C050147,CHEMICAL,"3-(2,2,2-trimethylhydrazine)propionate [Supplementary Concept]",mildronate|Methylhydrazines
C052873,CHEMICAL,zidovudine triphosphate [Supplementary Concept],azidothymidine|Zidovudine/analogs  and  derivatives
D000068257,CHEMICAL,"Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination",efavirenz|Efavirenz|Atripla|EFV
NEW01699,CHEMICAL,EVG-based ART regimen,EVG-based ART regimen
NEW01700,DISEASE,improved PTSD symptoms,improved PTSD symptoms
D059147,CHEMICAL,HIV Serosorting,"YLPHIV|HIV|WWH|Serosorting, HIV"
NEW01701,CHEMICAL,antiretrovirals,antiretrovirals
NEW01702,DISEASE,HIV-associated neurocognitive disorder,HIV-associated neurocognitive disorder
NEW01703,CHEBI,first generation analogue reverse transcriptase inhibitor,first generation analogue reverse transcriptase inhibitor
NEW01704,CHEMICAL,non-nucleoside analogue,non-nucleoside analogue
NEW01705,DISEASE,mitochondrial dysfunction,mitochondrial dysfunction
D015215,CHEMICAL,Zidovudine,"3'-Azido-2',3'-Dideoxythymidine||BWA509U|AZT, Antiviral|Antiviral AZT|Azidothymidine|3' Azido 2',3' Dideoxythymidine|BWA-509U|BW A509U|3'-Azido-3'-deoxythymidine|ZDV|AZT|Zidovudine|3' Azido 3' deoxythymidine|BWA 509U|AZT Antiviral|zidovudine|AZT (Antiviral)|Retrovir"
NEW01706,CHEBI,non-nucleoside reverse transcriptase inhibitor NNRTI efavirenz,non-nucleoside reverse transcriptase inhibitor NNRTI efavirenz
NEW01707,CHEBI,GnRH agonist analogue,GnRH agonist analogue
NEW01708,DISEASE,ovarian suppression,ovarian suppression
NEW01709,CHEBI,oestrogen signalling,oestrogen signalling
NEW01710,CHEBI,peripartum sex-steroid hormone fluctuations,peripartum sex-steroid hormone fluctuations
NEW01711,DISEASE,neurodevelopmental toxicity,neurodevelopmental toxicity
NEW01712,DISEASE,developmental neurotoxicity,developmental neurotoxicity
D000068079,DISEASE,Motor Disorders,motor disorders|Motor Skills Disorders (1998-2015)
D002994,CHEMICAL,Clofibrate,"Miskleron|Clofibric Acid, Ethyl Ester|clofibrate|Atromid|Atromid S|Ethyl Chlorophenoxyisobutyrate|Miscleron|Athromidin|Chlorophenoxyisobutyrate, Ethyl"
NEW01713,DISEASE,neuronal inflammation,neuronal inflammation
D017706,CHEMICAL,Lisinopril,Lysinopril||Lisinopril Maleate (1:1)|Zestril|MK-521|Lisinopril Sulfate (1:2)|Prinivil|lisinopril
NEW01714,DISEASE,neurodegeneration motor disorders,neurodegeneration motor disorders
NEW01715,CHEBI,novel drug candidate,novel drug candidate
NEW01716,DISEASE,idiopathic PAH,idiopathic PAH
C106276,CHEMICAL,sitaxsentan [Supplementary Concept],sitaxsentan|Isoxazoles|Thiophenes
NEW01717,CHEMICAL,severe COVID-19,severe COVID-19
NEW01718,DISEASE,significant pulmonary fibrosis,significant pulmonary fibrosis
NEW01719,DISEASE,new HCV infections,new HCV infections
NEW01720,CHEBI,Direct Antiviral Agents,Direct Antiviral Agents
NEW01721,DISEASE,acute viral illness,acute viral illness
C462182,CHEMICAL,favipiravir [Supplementary Concept],Amides|Pyrazines|favipiravir|Favipiravir
C584156,DISEASE,"MIRN-H27 microRNA, herpes simplex virus 1 [Supplementary Concept]",HSV1|oral herpes|MicroRNAs
NEW01722,CHEMICAL,amyloid beta-protein Aβ aggregation,amyloid beta-protein Aβ aggregation
D000998,CHEBI,Antiviral Agents,"antiviral|Antiviral|Agents, Antiviral|Antiviral agents|Antiviral Agent|Antivirals|Drugs, Antiviral|Agent, Antiviral|Antiviral Drugs|antiviral agents|Antiviral Drug|Drug, Antiviral|antiviral drugs|antivirals|antiviral agent"
NEW01723,DISEASE,peripheral HSV infection,peripheral HSV infection
NEW01724,DISEASE,HSV infections,HSV infections
NEW01725,MENTAL_HEALTH,dementia risk,dementia risk
D021821,DISEASE,"Communicable Diseases, Emerging","Diseases, Re-Emerging Infectious|Disease, Reemerging Infectious|Disease, Emerging Communicable|Communicable Diseases, Re Emerging|Reemerging Infectious Disease|Re-Emerging Communicable Disease|Re-Emerging Communicable Diseases|Emerging Communicable Diseases|Communicable Disease, Emerging|Disease, Re-Emerging Infectious|Infectious Diseases, Re Emerging|Re-Emerging Infectious Disease|Communicable Disease, Reemerging|Diseases, Re-Emerging Communicable|Disease, Re-Emerging Communicable|Infectious Disease, Reemerging|Infectious Diseases, Re-Emerging|Diseases, Emerging Communicable|Disease, Emerging Infectious|Infectious Disease, Emerging|Diseases, Reemerging Communicable|Diseases, Reemerging Infectious|Infectious Diseases, Emerging|Communicable Disease, Re-Emerging|Emerging Communicable Disease|Communicable Diseases, Re-Emerging|Infectious Diseases, Reemerging|Communicable Diseases, Reemerging|Reemerging Communicable Diseases|Diseases, Emerging Infectious|Disease, Reemerging Communicable|emerging infectious disease|Emerging Infectious Diseases|Emerging Infectious Disease|Re-Emerging Infectious Diseases|Reemerging Infectious Diseases|Infectious Disease, Re-Emerging|Reemerging Communicable Disease"
NEW01726,CHEMICAL,self-administered female-sexual-function index FSFI questionnaire,self-administered female-sexual-function index FSFI questionnaire
D053139,CHEMICAL,Oseltamivir,GS-4071|GS4071|GS-4104|Tamiflu|GS4104|oseltamivir|GS 4071|Oseltamivir|GS 4104
NEW01727,CHEMICAL,haloperidol doses,haloperidol doses
NEW01728,MENTAL_HEALTH,longer delirium duration,longer delirium duration
NEW01729,DISEASE,Conclusions,Conclusions
NEW01730,CHEBI,anti-coronavirus drug development,anti-coronavirus drug development
D018352,DISEASE,Coronavirus Infections,"Infection, Coronavirus|coronavirus infections|Coronavirus Infection|Middle East Respiratory Syndrome|Infections, Coronavirus|MERS (Middle East Respiratory Syndrome)"
D060737,CHEMICAL,Reproductive Tract Infections,"Genital Tract Infections|Infection, Reproductive Tract|Infections|Reproductive Tract Infection|Infection, Genital Tract|Genital Tract Infection|infections|Infections, Genital Tract|Infections, Reproductive Tract"
NEW01731,DISEASE,Many psychiatric patients,Many psychiatric patients
D053480,NUTRITION,Cholesterol Ester Transfer Proteins,"% % cholesterol|Cholesteryl Ester Exchange Protein|Cholesterol|cholesteryl ester|cholesterol|Ch|Cholesteryl Ester Transfer Protein|Cholesterol Ester Transport Protein, CETP|Cholesterol Ester Transfer Protein"
D001218,CHEMICAL,Aspartame,"Canderel|SC-18862|SC 18862|Milisucre|Methyl Ester, Aspartylphenylalanine|Aspartylphenylalanine, Methyl|TriSweet|SC18862|Aspartylphenylalanine Methyl Ester|Aspartame|Gold, Hermesetas|Nozucar|Goldswite|aspartame|NutraSweet|Tri Sweet|Hermesetas Gold|Tri-Sweet|Methyl Aspartylphenylalanine"
C058272,CHEMICAL,norclozapine [Supplementary Concept],Clozapine/analogs  and  derivatives|N-Desmethylclozapine|N-desmethylclozapine
NEW01732,MENTAL_HEALTH,therapy-resistant schizophrenia,therapy-resistant schizophrenia
NEW01733,CHEMICAL,atypical antipsychotic drug clozapine,atypical antipsychotic drug clozapine
NEW01734,CHEMICAL,sEPSCs,spontaneous excitatory postsynaptic currents|sEPSCs
NEW01735,CHEMICAL,spontaneous glutamate release,spontaneous glutamate release
NEW01736,CHEMICAL,µ1,µ1
D050638,CHEMICAL,"Receptors, Dopamine D4","Dopamine D4 Receptors|D4 Receptors, Dopamine|D4 Receptor, Dopamine|Dopamine D4 Receptor|dopamine D4 receptor|Receptor, Dopamine D4"
NEW01737,CHEMICAL,Oxytocin Receptor G protein β3 subunit genes,Oxytocin Receptor G protein β3 subunit genes
NEW01738,CHEMICAL,β/γ dimer-mediated signaling,β/γ dimer-mediated signaling
NEW01739,MENTAL_HEALTH,adult separation anxiety,adult separation anxiety
NEW01740,CHEMICAL,glutamate signaling,glutamate signaling
NEW01741,CHEMICAL,Frrs1l-/- mice,Frrs1l-/- mice
NEW01742,DISEASE,hyperactive exhibited,hyperactive exhibited
NEW01743,CHEMICAL,Dopamine dysfunctions,Dopamine dysfunctions
NEW01744,CHEMICAL,K+ sheep,K+ sheep
NEW01745,CHEMICAL,volume-sensitive K+-Cl- COT,volume-sensitive K+-Cl- COT
NEW01746,MENTAL_HEALTH,profound dementia common,profound dementia common
NEW01747,CHEBI,overall beta-amyloid protein,beta AP|overall beta-amyloid protein
NEW01748,DISEASE,retina damage,retina damage
NEW01749,CHEMICAL,THC exposure,THC exposure
NEW01750,DISEASE,psychiatric manifestations,psychiatric manifestations
NEW01751,DISEASE,mutant DISC1,mutant DISC1
NEW01752,DISEASE,patient's movement disorders,patient's movement disorders
D001379,CHEMICAL,Azathioprine,"|Imurel|Azothioprine|Immuran|Sodium, Azathioprine|Azathioprine Sodium|Imuran|Azathioprine Sodium Salt|azathioprine|Azathioprine Sulfate"
NEW01753,CHEMICAL,novel Dlg2+/- rat,novel Dlg2+/- rat
NEW01754,CHEMICAL,N-Methyl-D-aspartic acid receptor antagonist phencyclidine,N-Methyl-D-aspartic acid receptor antagonist phencyclidine
NEW01755,DISEASE,psychiatric endophenotypes,psychiatric endophenotypes
NEW01756,DISEASE,p53-dependent neuron death,p53-dependent neuron death
NEW01757,DISEASE,SMA mice,SMA mice
D050417,CHEBI,Insulin-Secreting Cells,"Cell, Insulin-Secreting|Insulin-Secreting Cell|Pancreatic B Cells|Cells, Insulin-Secreting|Pancreatic beta Cell|beta Cells, Pancreatic|B Cell, Pancreatic|beta Cell, Pancreatic|Pancreatic beta Cells|B Cells, Pancreatic|Pancreatic B Cell|pancreatic beta cells|Insulin Secreting Cells"
NEW01758,CHEBI,date drug treatment,date drug treatment
NEW01759,CHEMICAL,verapamil treatment,verapamil treatment
D002540,CHEMICAL,Cerebral Cortex,"Paleocortices|Allocortices|Paleocortex|Archipallium|Archipalliums|cerebral cortex|Cortical Plate|Periallocortex|Allocortex|Cortex Cerebrus|Plate, Cortical|Cortical Plates|Cortex Cerebri|Cortex, Cerebral|Periallocortices|Cerebral Cortices|CC"
C019143,CHEMICAL,long-chain-fatty-acid-CoA ligase [Supplementary Concept],acyl-CoA synthetase long-chain family member|Coenzyme A Ligases
NEW01760,MENTAL_HEALTH,nonsyndromic X-linked mental retardation,nonsyndromic X-linked mental retardation
NEW01761,CHEMICAL,Higher CSF glucose,Higher CSF glucose
NEW01762,CHEBI,Standardized beta =,Standardized beta =
NEW01763,CHEMICAL,membrane phospholipids,MPL|membrane phospholipids
NEW01764,CHEMICAL,testosterone synthesis,testosterone synthesis
NEW01765,NUTRITION,N-3 polyunsaturated fatty acids,N-3 polyunsaturated fatty acids
NEW01766,MENTAL_HEALTH,CMS+MS-induced depression models,CMS+MS-induced depression models
NEW01767,DISEASE,CMS+MS-induced postmenopausal bone loss,CMS+MS-induced postmenopausal bone loss
D016301,DISEASE,Alveolar Bone Loss,"Alveolar Resorption|Alveolar Bone Losses|Resorption, Alveolar|Resorptions, Alveolar|Bone Atrophies, Alveolar|Bone Loss, Alveolar|Resorption, Periodontal|Alveolar Bone Atrophy|Periodontal Bone Losses|Alveolar Process Atrophy|bone loss|Alveolar Resorptions|Periodontal Resorptions|Alveolar Bone Atrophies|Bone Losses, Periodontal|Bone Loss, Periodontal|Alveolar Process Atrophies|Periodontal Bone Loss|Bone Atrophy, Alveolar|Periodontal Resorption"
D066300,CHEMICAL,Electronic Nicotine Delivery Systems,"Cigarettes, Electronic|E Cigs|Electronic Cigarettes|E Cig|Cigarette, Electronic|Nicotine|systems|Electronic Cigarette|E-Cigs|E Cigarette|E Cigarettes|E-Cigarette|Electronic Nicotine Delivery System|E-Cig|E-Cigarettes|nicotine"
NEW01768,CHEMICAL,brain serotonin secretion,brain serotonin secretion
NEW01769,DISEASE,SAD patients,SAD patients
D024941,NUTRITION,Starch Phosphorylase,"Phosphorylase a, Starch|Amylophosphorylase|Starch Phosphorylase a|Phosphorylase, Starch|Phosphorylase b, Starch|Starch Phosphorylase b|starch"
NEW01770,CHEBI,drug usage,drug usage
D005938,CHEMICAL,Glucocorticoids,"Glucocorticoid Effect|Effects, Glucorticoid|Effect, Glucocorticoid|Glucorticoid Effects|Glucocorticoid|glucocorticoids|GCs"
NEW01771,DISEASE,skeletal muscle atrophy,skeletal muscle atrophy
C024750,CHEMICAL,didrovaltrate [Supplementary Concept],Iridoids|Didrovaltrate
NEW01772,DISEASE,DEX-induced myotube atrophy,DEX-induced myotube atrophy
NEW01773,CHEMICAL,anterior corona radiata,ACR|anterior corona radiata
NEW01774,MENTAL_HEALTH,male sexual dysfunction,male sexual dysfunction
D020106,CHEMICAL,Acrylamide,Acrylamides (1982-1998)|Acrylamide
D000079403,CHEMICAL,Ferroptosis,Oxytosis|Ferroptosis
NEW01775,DISEASE,non-apoptotic oxidative death,non-apoptotic oxidative death
D019283,DISEASE,"Pancreatitis, Acute Necrotizing","Acute Necrotizing Pancreatitis|Pancreatitis Necrotizings|Pancreatitis, Hemorrhagic Necrotic|Pancreatic Necrosis|Necrosis, Pancreatic|Necrotic Pancreatitis, Hemorrhagic|acute pancreatitis|Hemorrhagic Necrotic Pancreatitis|Pancreatic Necroses|Pancreatitis Necrotisings|Pancreatitis Necrotising|Hemorrhagic Necrotic Pancreatitides|Pancreatitis Necrotizing|Necrotizing Pancreatitis, Acute"
D055589,DISEASE,"Pancreatitis, Graft",pancreatitis|Graft Pancreatitis
D017044,DISEASE,"Polycystic Kidney, Autosomal Recessive","Polycystic Kidney and Hepatic Disease 1|Polycystic Kidney Disease, Infantile, Type 1|Polycystic Kidney and Hepatic Disease 1 (Autosomal Recessive)|Polycystic Kidney Disease, Autosomal Recessive|Hepatic disease|ARPKD|Autosomal Recessive Polycystic Kidney Disease|Kidney, Polycystic, Autosomal Recessive|Autosomal Recessive Polycystic Kidney|Polycystic Kidney Disease, Infantile, Type I"
NEW01776,DISEASE,spike induced hepatitis,spike induced hepatitis
NEW01777,CHEMICAL,pre-existing AUD,pre-existing AUD
NEW01778,DISEASE,SARS-CoV2 infection,SARS-CoV2 infection
NEW01779,DISEASE,severe liver disease,severe liver disease
D000428,CHEMICAL,Alcohol Drinking,"Alcohol Intakes|Alcohol drinking|Intake, Alcohol|Alcohol Drinking Habits|Habit, Alcohol Drinking|Habits, Alcohol Drinking|Alcohol Consumption|Drinking Habit, Alcohol|Alcohol Intake|alcohol drinking|Drinking, Alcohol|Alcohol Drinking Habit|Consumption, Alcohol"
NEW01780,NUTRITION,Lithium acid treatments,Lithium acid treatments
NEW01781,DISEASE,stimulus-induced PKC translocations,stimulus-induced PKC translocations
NEW01782,DISEASE,BD manic patients,BD manic patients
NEW01783,CHEMICAL,lithium acid treatments,lithium acid treatments
NEW01784,NUTRITION,lithium treatment,lithium treatment
NEW01785,DISEASE,hyperinsulinism/hyperammonemia HI/HA syndrome,hyperinsulinism/hyperammonemia HI/HA syndrome
NEW01786,CHEMICAL,mitochondrial enzyme glutamate dehydrogenase,mitochondrial enzyme glutamate dehydrogenase
D044903,DISEASE,Congenital Hyperinsulinism,"Familial Hyperinsulinism|Neonatal Hyperinsulinism|Hypoglycemia, Hyperinsulinemic, of Infancy|Neonatal Hyperinsulinisms|Infancy Hyperinsulinemia Hypoglycemia|Hyperinsulinisms, Neonatal|Hypoglycemias, Persistent Hyperinsulinemic|Hyperinsulinism, Neonatal|Hyperinsulinemic Hypoglycemias, Persistent|congenital hyperinsulinism|Familial Hyperinsulinemic Hypoglycemia 1|Hypoglycemia, PHHI|PHHI Hypoglycemias|Hyperinsulinism, Congenital|Hyperinsulinism, Familial|Familial Hyperinsulinisms|Persistent Hyperinsulinemic Hypoglycemia|Hyperinsulinisms, Familial|Hyperinsulinemic Hypoglycemia, Familial, 1|hyperinsulinism|Infancy Hyperinsulinemia Hypoglycemias|hyperinsulinemia|Hyperinsulinisms, Congenital|Hypoglycemia, Persistent Hyperinsulinemic|Persistent Hyperinsulinemia Hypoglycemia of Infancy|Hyperinsulinemic Hypoglycemia, Familial, 2|Hyperinsulinemia Hypoglycemia of Infancy|Hypoglycemias, PHHI|Congenital Hyperinsulinisms|PHHI Hypoglycemia|Hyperinsulinemic Hypoglycemia Due to Focal Adenomatous Hyperplasia|Hyperinsulinemic Hypoglycemia, Persistent|Persistent Hyperinsulinemic Hypoglycemias"
NEW01787,CHEBI,drug reward,drug reward
D000076226,CHEMICAL,Rapamycin-Insensitive Companion of mTOR Protein,RICTOR Protein|Rapamycin|Rapamycin Insensitive Companion of mTOR Protein|rapamycin
NEW01788,CHEMICAL,PI3 K pathway,PI3 K pathway
NEW01789,MENTAL_HEALTH,excessive aberrant learning disorder,excessive aberrant learning disorder
NEW01790,DISEASE,maladaptive behavior,maladaptive behavior
D000077252,CHEMICAL,Dialectical Behavior Therapy,"Behavior Therapy, Dialectical|DBT|Dialectical Behavior Therapies|dialectical behavior therapy"
NEW01791,MENTAL_HEALTH,somnolence sleep attacks,somnolence sleep attacks
D057178,DISEASE,Primary Progressive Nonfluent Aphasia,"Progressive Nonfluent Aphasia|PPA|svPPA|Syndromes, PPA|Non fluent Primary Progressive Aphasia|Nonfluent Aphasias, Progressive|Aphasia, Progressive Nonfluent|Aphasias, Progressive Nonfluent|PPA Syndromes|PPA Syndrome|primary progressive aphasia|Progressive Nonfluent Aphasias|Primary progressive aphasia|Syndrome, PPA|Non-fluent Primary Progressive Aphasia|Nonfluent Aphasia, Progressive|aphasia"
NEW01792,MENTAL_HEALTH,progressive language disorder due,progressive language disorder due
D020961,MENTAL_HEALTH,Lewy Body Disease,"Lewy Body disease|Lewy Body Dementia|Lewy Body Type Senile Dementia|Lewy Body Disease, Diffuse|diffuse Lewy body disease|Lewy body dementia|Lewy body disease|Lewy Body Disease, Cortical|Diffuse Lewy Body Disease|Dementia, Lewy Body|DLB|Cortical Lewy Body Disease"
NEW01793,CHEBI,KOR agonists,KOR agonists
D007815,DISEASE,Larva Migrans,"Itchs, Ground|Larva Migrans, Cutaneous|Dew Itch|Eruptions, Creeping|Itchs, Dew|Creeping Eruption|Eruption, Creeping|Ground Itchs|Cutaneous Larva Migrans|Larva Migrans, Ocular|itch|Creeping Eruptions|Itch, Dew|Dew Itchs|Ground Itch|Ocular Larva Migrans|Itch, Ground"
NEW01794,CHEMICAL,glucuronate levels,glucuronate levels
D020723,CHEMICAL,Glucuronic Acid,"glucuronate|Glucuronic Acid, 6-(14)C-labeled, (D)-isomer|Glucuronate, Monopotassium|Glucuronic Acid, Monopotassium Salt|GlucA|Glucuronate, Monosodium|Glucuronic Acid, Monosodium Salt|Monosodium Glucuronate|Glucuronate|Monopotassium Glucuronate"
NEW01795,MENTAL_HEALTH,drug-resistant schizophrenia,drug-resistant schizophrenia
NEW01796,CHEMICAL,low-density HDLP lipoproteins,low-density HDLP lipoproteins
NEW01797,NUTRITION,HDLP cholesterol level,HDLP cholesterol level
NEW01798,MENTAL_HEALTH,Drug-induced psychosis,Drug-induced psychosis
NEW01799,CHEMICAL,mesolimbic-cortical dopamine receptors,mesolimbic-cortical dopamine receptors
D065087,CHEMICAL,Acetylcholine Release Inhibitors,"acetylcholine release|acetylcholine|Acetylcholine|ACh|Blockers, Acetylcholine Release|Acetylcholine Release Blockers|Acetylcholine Release Antagonists|Release Blockers, Acetylcholine|Antagonists, Acetylcholine Release|ACH|Inhibitors, Acetylcholine Release"
NEW01800,CHEMICAL,3-(2-chloro-10H-phenothiazin-10-yl)-N-methyl-N-(4-(3-(piperidin-1-yl)propoxy)benzyl)propan-1-amine,3-(2-chloro-10H-phenothiazin-10-yl)-N-methyl-N-(4-(3-(piperidin-1-yl)propoxy)benzyl)propan-1-amine
NEW01801,DISEASE,repetitive/compulsive behaviors,repetitive/compulsive behaviors
NEW01802,DISEASE,social deficits,social deficits
NEW01803,CHEMICAL,glucose control medication,glucose control medication
NEW01804,CHEBI,first-line drug,first-line drug
NEW01805,MENTAL_HEALTH,ADHD aged,ADHD aged
NEW01806,CHEBI,G allele carrier group,G allele carrier group
NEW01807,NUTRITION,Abnormal fatty acid metabolism,Abnormal fatty acid metabolism
NEW01808,DISEASE,increased depressive,increased depressive
NEW01809,CHEMICAL,aluminium chloride,aluminium chloride|AlCl3
NEW01810,CHEBI,nuclear factor- k beta,nuclear factor- k beta
NEW01811,CHEMICAL,Al activity,Al activity
NEW01812,CHEMICAL,ionized calcium binding adaptor molecule,ionized calcium binding adaptor molecule
NEW01813,CHEMICAL,acetyl cholinesterase,acetyl cholinesterase
D052247,CHEMICAL,Nitric Oxide Synthase Type II,"inducible nitric oxide synthase|Nitric Oxide Synthase, Type II|Inducible NOS Protein|Nitric Oxide Synthase II|INOS Enzyme|NOS II|NOS-II|Inducible Nitric Oxide Synthase"
D014409,NUTRITION,Tumor Necrosis Factor-alpha,"TNF-alpha|Cachectin-Tumor Necrosis Factor|Tumor Necrosis Factor Ligand Superfamily Member 2|Tumor Necrosis Factor alpha|tumor necrosis factor-α|Cachectin|Cachectin Tumor Necrosis Factor|TNF Superfamily, Member 2|tumor necrosis factor α|tumor necrosis factor-alpha|Tumor necrosis factor-alpha|Tumor Necrosis Factor|TNFalpha|TNFα|tumor necrosis factor alpha|TNF-α"
NEW01814,DISEASE,brain impairment,brain impairment
D048308,CHEBI,Mitogen-Activated Protein Kinase 14,"MAPK14|MAPK14 Mitogen-Activated Protein Kinase|CSAID Binding Protein|p38alpha MAP Kinase|CSAID-Binding Protein|MAP Kinase, p38alpha|p38alphaMAPK|Mitogen Activated Protein Kinase 14|anti-inflammatory drug|MAX-Interacting Protein 2|Stress-activated protein kinase 2a|CSBP, Kinase|Cytokine Suppressive Anti-inflammatory Drug Binding Protein|drug binding|MAX Interacting Protein 2|Kinase CSBP|Cytokine Suppressive Anti inflammatory Drug Binding Protein|SAPK2a|MAPK14 Mitogen Activated Protein Kinase|p38alpha Mitogen-Activated Protein Kinase|p38alpha Mitogen Activated Protein Kinase|Mxi2 Protein|Stress activated protein kinase 2a"
NEW01815,CHEMICAL,neurotrophic tyrosine kinase receptor type gene,neurotrophic tyrosine kinase receptor type gene
NEW01816,CHEMICAL,purine salvage enzyme,purine salvage enzyme
NEW01817,CHEMICAL,enzyme hypoxanthine phosphoribosyltransferase,enzyme hypoxanthine phosphoribosyltransferase
NEW01818,DISEASE,autistic traits,autistic traits
NEW01819,CHEMICAL,psychedelic drugs,psychedelic drugs
NEW01820,MENTAL_HEALTH,disorder anxiety disorder,disorder anxiety disorder
NEW01821,CHEMICAL,SB impairments,SB impairments
NEW01822,DISEASE,fear memory expression,fear memory expression
NEW01823,CHEBI,CGRP receptor antagonist BIBN4096,CGRP receptor antagonist BIBN4096
NEW01824,CHEMICAL,N-Acetylserotonin O-methyltransferase,N-Acetylserotonin O-methyltransferase|ASMT
D010871,DISEASE,Pinealoma,"Tumor, Pineal Gland|Pineal Tumors|Pineal Neoplasms|Mixed Pineocytoma-Pineoblastoma|Pineal Parenchymal Tumors|pineal parenchymal tumors|Pineal Gland Tumors|Neoplasm, Pineal|Pineocytomas|Neoplasms, Pineal|Pineocytoma|Pineal Neoplasm|Mixed Pineocytoma Pineoblastoma|Tumors, Pineal|Pineal Gland Tumor|Pinealocytoma|Tumor, Pineal|Pineocytoma-Pineoblastoma, Mixed|Tumor, Pineal Parenchymal|Mixed Pineocytoma-Pineoblastomas|Tumors, Pineal Gland|Pineal Tumor|Pinealomas|Pinealocytomas|Pineoblastoma|Pineoblastomas|Pineocytoma-Pineoblastomas, Mixed|Tumors, Pineal Parenchymal|Pineal Parenchymal Tumor"
D054648,DISEASE,Protein Phosphatase 2,"Serine-Threonine-Protein Phosphatase 2A Catalytic Subunit alpha Isoform|Protein Phosphatase 2A, Regulatory Subunit A, beta Isoform|Serine Threonine Protein Phosphatase 2A Catalytic Subunit beta Isoform|Protein Phosphatase 2A|Protein Phosphatase 2A, Catalytic Subunit, alpha Isoform|Protein Phosphatase 2, Regulatory Subunit|Protein Phosphatase 2, Regulatory Subunit B, alpha Isoform|Serine Threonine Protein Phosphatase 2A Catalytic Subunit alpha Isoform|Protein Phosphatase 2, Catalytic Subunit, beta Isoform|Protein Phosphatase 2, Regulatory Subunit B, beta Isoform|Protein Phosphatase 2, Regulatory Subunit A, alpha Isoform|Protein Phosphatase 2, Catalytic Subunit|Protein Phosphatase 2A, Regulatory Subunit B, alpha Isoform|Protein Phosphatase 2A, Regulatory Subunit A , alpha Isoform|Protein Phosphatase 2A, Regulatory Subunit B, gamma Isoform|Protein Phosphatase 2, Regulatory Subunit B, delta Isoform|RII|Protein Phosphatase 2A, Catalytic Subunit, beta Isoform|Protein Phosphatase 2, Regulatory Subunit A, beta Isoform|PPP2CA Phosphatase|Protein Phosphatase 2, Catalytic Subunit, alpha Isoform|regulatory subunit|PPP2CB Phosphatase|Protein Phosphatase-2A|Phosphatase, PPP2CA|Phosphatase, PPP2CB|Protein Phosphatase 2, Regulatory Subunit B, gamma Isoform|Protein Phosphatase 2A, Regulatory Subunit B, delta Isoform|alpha isoform|Protein Phosphatase 2A, Regulatory Subunit B, beta Isoform"
NEW01825,CHEMICAL,ethanol exposure,ethanol exposure
NEW01826,CHEMICAL,"CNS 3',5'-cyclic adenosine monophosphate","cyclic AMP|CNS 3',5'-cyclic adenosine monophosphate"
NEW01827,CHEMICAL,morpholino-induced pgrmc1 knockdown,morpholino-induced pgrmc1 knockdown
NEW01828,DISEASE,cataract formation,cataract formation
NEW01829,DISEASE,significant cataract formation,significant cataract formation
NEW01830,CHEMICAL,c.757C T,c.757C T
NEW01831,CHEMICAL,chronic ketamine use,chronic ketamine use
NEW01832,DISEASE,impairments years,impairments years
NEW01833,CHEMICAL,beta-lactam ceftriaxone,beta-lactam ceftriaxone
NEW01834,DISEASE,memory impairments,memory impairments
NEW01835,DISEASE,early brain injury,early brain injury
D020206,DISEASE,"Subarachnoid Hemorrhage, Traumatic","Post-Traumatic Subarachnoid Hemorrhage|Post Traumatic Subarachnoid Hemorrhage|Traumatic Subarachnoid Hemorrhages|Post-Traumatic Subarachnoid Hemorrhages|Subarachnoid Hemorrhages, Post-Traumatic|subarachnoid hemorrhage|Hemorrhages, Post-Traumatic Subarachnoid|Subarachnoid Hemorrhages, Traumatic|Hemorrhage, Traumatic Subarachnoid|Traumatic Subarachnoid Hemorrhage|Hemorrhage, Post-Traumatic Subarachnoid|Subarachnoid Hemorrhage, Post-Traumatic"
NEW01836,CHEBI,common environmental endocrine disrupters,common environmental endocrine disrupters
NEW01837,DISEASE,developmental toxicity,developmental toxicity
D017438,CHEMICAL,Bisphenol A-Glycidyl Methacrylate,"Concise Resin|Kerr Pit and Fissure Sealant|Nuva Seal|Epoxylite9075|Bis-GMA Polymer|Resin, Concise Composite|Epoxylite 9075|Composite Resins, Concise|Conclude Resin|Resin, Conclude|Bis(Phenol A-Glycidyl Methacrylate)|Resin, Bis-GMA|Bis-GMA|Bis GMA Resin|Bisphenol A-Glycidyl Methacrylate Homopolymer|Bis-GMA Resin|Resins, Bis-GMA|Polymer, Bis-GMA|BPA|Opaque, Panavia|Concise Enamel Bond System|Concise Composite Resins|Bisphenol A Glycidyl Methacrylate Polymer|Polymers, Bis-GMA|Resin, Concise|bisphenol A|Bis GMA|Bis(Phenol A-Glycydyl Methacrylate)|2-Propenoic acid, 2-methyl-, (1-methylethylidene)bis(4,1-phenyleneoxy(2-hydroxy-3,1-propanediyl)) ester, homopolymer|Silux|Epoxylite-9075|Bis(Phenol A-Glycidyl Methacrylate), Homopolymer|Concise Resins|Retroplast|Resin, Conclude Composite|Kerr Sealer|Adaptic|Bis-GMA Polymers|Bisphenol A Glycidyl Methacrylate|Concise White Sealant|Bis GMA Polymer|Methacrylate, Bisphenol A-Glycidyl|NuvaSeal|Resins, Concise Composite|Concise Enamel Bond|Panavia Opaque|Composite Resin, Concise|Bisphenol A Glycidyl Methacrylate Homopolymer|Enamel Bond, Concise|Nuva-Seal|Concise Composite Resin|Delton|Conclude Composite Resin|Bisphenol A-Glycidyl Methacrylate Polymer|Bisphenol A|Resins, Concise|Poly(Bis-GMA)|Bond, Concise Enamel|Composite Resin, Conclude|Bis-GMA Resins"
NEW01838,CHEMICAL,Ala147Thr SNP,Ala147Thr SNP
NEW01839,CHEMICAL,steroids present,steroids present
NEW01840,DISEASE,Parkinson's diseases,Parkinson's diseases
NEW01841,CHEBI,beta protein levels,beta protein levels
D020117,CHEMICAL,Cisapride,|R 51619|cisapride|Propulsid|R51619|Cisapride|R-51619
NEW01842,DISEASE,serious cardiac arrhythmias,serious cardiac arrhythmias
NEW01843,DISEASE,functional disability scores,functional disability scores
D019274,CHEMICAL,"Botulinum Toxins, Type A","botulinum toxin type A|Meditoxin|Neurotoxin A, Botulinum|Clostridium Botulinum Toxin Type A|Botox|botulinum toxin A|botulinum toxin|Toxin A, Botulinum|Botulinum Neurotoxin Type A|Neuronox|Botulinum Toxin Type A|BT|Botulinum Neurotoxin A|Botulinum neurotoxin|Botulinum A Toxin|OnabotulinumtoxinA|Vistabex|Vistabel|Onabotulinumtoxin A|Botulinum toxin A|Clostridium botulinum A Toxin|Botulinum toxin|Botulinum toxins|BTX|Oculinum|Toxin, Botulinum A|Botulinum Toxin A"
NEW01844,CHEMICAL,educational DVD,educational DVD
NEW01845,MENTAL_HEALTH,anxiety glycaemic control,anxiety glycaemic control
NEW01846,CHEMICAL,circulating cortisol,circulating cortisol
NEW01847,CHEMICAL,meal cortisol reactions,meal cortisol reactions
NEW01848,CHEMICAL,oxygen consumption rate,oxygen consumption rate
NEW01849,MENTAL_HEALTH,non-seasonal depression,non-seasonal depression
NEW01850,DISEASE,depressed women,depressed women
NEW01851,MENTAL_HEALTH,various affective disorders,various affective disorders
NEW01852,CHEMICAL,unique antidepressant,unique antidepressant
NEW01853,CHEMICAL,de arginine synthesis,de arginine synthesis
D015937,CHEMICAL,"Complement C5a, des-Arginine","des-Arginine C5 a|C5 a, des Arg|C5a des-Arginine|C5a, des Arg|C5 a, des Arginine|Complement 5a, des Arginine|des-Arg C5a|des-Arg, C5a|des-Arginine C5a|des-Arginine Complement 5a|Complement C5a, des Arginine|C5a, des-Arg|C5a des Arginine|C5a, des-Arginine Complement|Arginine|arginine|des-Arginine, C5a|C5 a, des-Arginine|C5a, des-Arginine|Complement 5a, des-Arginine|des-Arginine Complement C5a|de-Arginine Complement 5a|Complement 5a, de Arginine|C5 a, des-Arg|C5a, des Arginine|Complement 5a, de-Arginine|des-Arg C5 a|C5a des-Arg"
NEW01854,DISEASE,arterial hyperammonemia,arterial hyperammonemia
NEW01855,CHEBI,drug absorption,drug absorption
NEW01856,CHEMICAL,mumols/l,mumols/l
NEW01857,DISEASE,stuporous states,stuporous states
D000077260,MENTAL_HEALTH,Sleepiness,Sleepiness|Somnolence|sleepiness
NEW01858,MENTAL_HEALTH,subjective sleepiness,subjective sleepiness
NEW01859,MENTAL_HEALTH,Logistic regression analysis,Logistic regression analysis
NEW01860,CHEMICAL,parental smoking status,parental smoking status
NEW01861,MENTAL_HEALTH,Addiction score,Addiction score
NEW01862,CHEMICAL,Lower-brain glucose uptake,Lower-brain glucose uptake
NEW01863,DISEASE,cognitive deterioration,cognitive deterioration
NEW01864,CHEMICAL,MCTs,MCTs|MCT-Es
NEW01865,CHEMICAL,plasma medium-chain fatty acids,plasma medium-chain fatty acids
NEW01866,CHEMICAL,ketogenesis,ketogenesis
NEW01867,CHEBI,stress hormone,stress hormone
NEW01868,DISEASE,tumor types,tumor types
C088327,CHEMICAL,plerixafor [Supplementary Concept],Cyclams|plerixafor|Benzylamines|Plerixafor|AMD3100
NEW01869,CHEMICAL,anti-PD-1,αPD-1|anti-PD-1
D014411,DISEASE,Neoplastic Stem Cells,"Tumor Stem Cell|Initiating Cell, Tumor|Neoplastic Colony-Forming Unit|Cancer Stem Cell|Neoplastic Stem Cell|Tumor Stem Cells|Neoplastic Colony Forming Units|Cell, Cancer Stem|Cells, Cancer Stem|Colony-Forming Unit, Neoplastic|Cells, Tumor Initiating|Stem Cell, Cancer|Neoplastic Colony-Forming Units|Stem Cells, Neoplastic|Stem Cells, Cancer|Cell, Neoplastic Stem|Colony Forming Units, Neoplastic|Cell, Tumor Initiating|Stem Cells, Tumor|Stem Cell, Tumor|Cancer stem cells|Tumor Initiating Cells|Stem Cell, Neoplastic|Cells, Tumor Stem|Cell, Tumor Stem|Unit, Neoplastic Colony-Forming|Initiating Cells, Tumor|Cells, Neoplastic Stem|Cancer Stem Cells|Colony-Forming Units, Neoplastic|Tumor Initiating Cell|Units, Neoplastic Colony-Forming"
NEW01870,DISEASE,glioblastoma GBM development,glioblastoma GBM development
D062688,DISEASE,Buschke-Lowenstein Tumor,"Löwenstein Tumor, Buschke|Tumor, Buschke Lowenstein|Condyloma Acuminatum, Giant|Giant Condyloma of Buschke and Löwenstein|Giant Condyloma Acuminatum|Condyloma Acuminatums, Giant|Giant Condyloma of Buschke and Lowenstein|Buschke Lowenstein Tumor|Buschke-Löwenstein Tumor|Anogenital Type Verrucous Carcinoma|Tumor, Buschke-Löwenstein|Tumor, Buschke-Lowenstein|tumor|Lowenstein Tumor, Buschke|Tumor, Buschke Löwenstein|Buschke Löwenstein Tumor|Giant Condyloma Acuminatums"
NEW01871,DISEASE,agitation/allodynia,agitation/allodynia
C570280,CHEMICAL,"AP5B1 protein, human [Supplementary Concept]","Adaptor Proteins, Vesicular Transport|AP-5"
C104712,CHEMICAL,ACEA 1416 [Supplementary Concept],Quinoxalines|ACEA
NEW01872,CHEMICAL,NMDA antagonism,NMDA antagonism
NEW01873,DISEASE,tonic pain,tonic pain
D009271,CHEMICAL,Naltrexone,naltrexone|Antaxone|EN-1639A|Naltrexone|NTX|EN1639A|Naltrexone Hydrochloride|Nalorex|ReVia|Nemexin|NAL|EN 1639A|Trexan|Celupan
NEW01874,CHEMICAL,hypoanalgesic response,hypoanalgesic response
NEW01875,CHEBI,mu opioid antagonist,mu opioid antagonist
NEW01876,DISEASE,defeat-induced analgesia,defeat-induced analgesia
NEW01877,CHEBI,delta opioid antagonist,delta opioid antagonist
NEW01878,MENTAL_HEALTH,nondefeat-induced analgesia,nondefeat-induced analgesia
NEW01879,CHEMICAL,ICI-154,ICI-154
NEW01880,DISEASE,defeat-induced increases,defeat-induced increases
D007981,CHEMICAL,Levorphanol,"L-Dromoran|Levodroman|3 Hydroxy N methylmorphinan|LevoDromoran|Tartrate, Levorphanol|3-Hydroxy-N-methylmorphinan|L Dromoran|levorphanol|Levo-Dromoran|Levorphan|Levorphanol Tartrate|Levo Dromoran"
NEW01881,CHEBI,mu agonist,mu agonist
NEW01882,MENTAL_HEALTH,significant analgesia,significant analgesia
D008139,CHEMICAL,Loperamide,"Hydrochloride, Loperamide|Loperamide Monohydrochloride|Loperamide Hydrochloride|R 18553|Imodium|R18553|loperamide hydrochloride|R-18553|Monohydrochloride, Loperamide|loperamide"
NEW01883,MENTAL_HEALTH,animal anxiety,animal anxiety
C041269,CHEMICAL,N-methylnaloxone [Supplementary Concept],methylnaloxone|Naloxone/analogs  and  derivatives|Quaternary Ammonium Compounds
NEW01884,CHEMICAL,μ-opioid receptor antagonist methylnaloxone,μ-opioid receptor antagonist methylnaloxone
NEW01885,DISEASE,first submersion,first submersion
D004681,DISEASE,"Encephalomyelitis, Autoimmune, Experimental","Autoimmune Experimental Encephalomyelitis|Autoimmune Encephalomyelitis, Experimental|Encephalomyelitis, Experimental Autoimmune|Encephalomyelitis, Experimental Allergic|Experimental Allergic Encephalomyelitides|Encephalomyelitis, Allergic|Allergic Encephalomyelitis|Allergic Encephalomyelitis, Experimental|experimental allergic encephalomyelitis|Encephalomyelitis, Autoimmune Experimental|experimental autoimmune encephalomyelitis|Experimental Allergic Encephalomyelitis|EAE|Experimental Autoimmune Encephalomyelitis|Experimental Encephalomyelitis, Autoimmune"
NEW01886,DISEASE,experimental encephalomyelitis model,experimental encephalomyelitis model
C029167,CHEMICAL,ST 1435 [Supplementary Concept],Norprogesterones|Nestorone
NEW01887,DISEASE,hippocampus abnormalities,hippocampus abnormalities
NEW01888,CHEBI,hormone treatments,hormone treatments
NEW01889,CHEBI,selective oestrogen receptor modulators,selective oestrogen receptor modulators
NEW01890,CHEMICAL,Adjunctive MPA treatment,Adjunctive MPA treatment
NEW01891,MENTAL_HEALTH,mania symptoms,mania symptoms
D017258,CHEMICAL,Medroxyprogesterone Acetate,"|Curretab|Medroxyprogesterone acetate|medroxyprogesterone acetate|6-alpha-Methyl-17alpha-hydroxyprogesterone Acetate|Gestapuran|Cycrin|Depo Medroxyprogesterone Acetate|Medroxyprogesterone 17-Acetate, (6 alpha,17 alpha)-Isomer|Depo Provera|Farlutal|Perlutex|Depo-Provera|Medroxyprogesterone|MPA|Veramix|Medroxyprogesterone 17-Acetate, (6 beta)-Isomer|Medroxyprogesterone 17-Acetate|6 alpha Methyl 17alpha hydroxyprogesterone Acetate|medroxyprogesterone|DepoProvera|(6 alpha)-17-(Acetoxy)-6-methylpregn-4-ene-3,20-dione|Provera|Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6alpha)-|Medroxyprogesterone 17 Acetate|Medroxyprogesterone Acetate|Depo-Medroxyprogesterone Acetate"
NEW01892,MENTAL_HEALTH,persistent mania,persistent mania
NEW01893,MENTAL_HEALTH,severe depression,severe depression
NEW01894,CHEMICAL,Oral contraceptive use,Oral contraceptive use
NEW01895,MENTAL_HEALTH,suicidal behavior,suicidal behavior
NEW01896,NUTRITION,Lithium antidepressants,Lithium antidepressants
NEW01897,DISEASE,ovarian hormone-linked upsets,ovarian hormone-linked upsets
NEW01898,MENTAL_HEALTH,antidepressants hyperactivity,antidepressants hyperactivity
NEW01899,CHEMICAL,brain monoamines,brain monoamines
NEW01900,DISEASE,childhood attention-deficit/hyperactivity disorder,childhood attention-deficit/hyperactivity disorder
NEW01901,CHEMICAL,Long-acting MPA,Long-acting MPA
D005201,MENTAL_HEALTH,Fantasy,"Daydreams|Dream, Day|Fantasies|Daydream|Day Dream|fantasies|Dreams, Day|Day Dreams"
NEW01902,CHEMICAL,progestin-only preparations,progestin-only preparations
NEW01903,DISEASE,depressive patients,depressive patients
NEW01904,CHEMICAL,estrogen-containing contraceptives,estrogen-containing contraceptives
D054556,DISEASE,Venous Thromboembolism,"thromboembolism||Thromboembolism, Venous|venous thromboembolism"
D003276,CHEMICAL,"Contraceptives, Oral","|Oral Contraceptive, Low-Dose|Low-Dose Oral Contraceptive|Oral contraceptives|Oral Contraceptive|Low-Dose Oral Contraceptives|Contraceptive, Low-Dose Oral|Oral Contraceptives, Low Dose|Low Dose Oral Contraceptive|Contraceptives, Phasic Oral|Oral Contraceptives, Phasic|Oral Contraceptives, Low-Dose|Oral Contraceptives|Phasic Oral Contraceptives|oral contraceptives|Contraceptives, Low-Dose Oral|low-dose oral contraceptives|Contraceptive, Oral|low-dose"
D064129,DISEASE,"Prostatic Neoplasms, Castration-Resistant","Prostatic Neoplasms, Androgen Independent|Androgen Independent Prostatic Cancer|Castration-Resistant Prostatic Cancer|Cancer, Androgen-Resistant Prostatic|Prostatic Cancer, Androgen-Resistant|Neoplasm, Androgen-Insensitive Prostatic|cancers|Prostatic Neoplasm, Castration-Resistant|Prostatic Neoplasms, Androgen-Insensitive|Prostatic Neoplasms, Androgen-Independent|Prostatic Cancer, Androgen-Independent|Cancers, Androgen-Insensitive Prostatic|Hormone Refractory Prostatic Cancer|Prostatic Cancers, Castration-Resistant|Neoplasms, Androgen-Resistant Prostatic|Androgen-Resistant Prostatic Cancers|Androgen-Independent Prostatic Neoplasm|Prostatic Cancer, Androgen Independent|Androgen-Independent Prostatic Cancers|Prostatic Cancer, Androgen-Insensitive|Cancer, Androgen-Insensitive Prostatic|Castration-Resistant Prostatic Neoplasm|Neoplasms, Androgen-Insensitive Prostatic|Androgen-Resistant Prostatic Neoplasm|Prostatic Cancer, Castration Resistant|Neoplasms, Castration-Resistant Prostatic|Prostatic Cancer, Androgen Resistant|Cancers, Castration-Resistant Prostatic|Androgen-Resistant Prostatic Neoplasms|Prostatic Cancers, Androgen-Independent|Androgen Resistant Prostatic Cancer|Androgen-Independent Prostatic Cancer|Neoplasm, Androgen-Independent Prostatic|Hormone Refractory Prostatic Neoplasms|Prostatic Cancers, Androgen-Insensitive|Castration-Resistant Prostatic Neoplasms|Prostatic Neoplasm, Androgen-Insensitive|Prostatic Neoplasms, Hormone Refractory|Prostatic Cancers, Androgen-Resistant|Prostatic Cancer, Androgen Insensitive|Androgen Independent Prostatic Neoplasms|Prostatic Neoplasms, Castration Resistant|Prostatic Neoplasms, Androgen-Resistant|Androgen-Insensitive Prostatic Neoplasm|Castration-Resistant Prostatic Cancers|Prostatic Neoplasms, Androgen Insensitive|Cancer, Castration-Resistant Prostatic|Androgen Resistant Prostatic Neoplasms|Androgen Insensitive Prostatic Neoplasms|Androgen-Independent Prostatic Neoplasms|Androgen-Insensitive Prostatic Cancer|Neoplasms, Androgen-Independent Prostatic|Castration Resistant Prostatic Cancer|Androgen-Insensitive Prostatic Cancers|Prostatic Neoplasm, Androgen-Resistant|Androgen Insensitive Prostatic Cancer|Androgen-Insensitive Prostatic Neoplasms|Prostatic Neoplasms, Androgen Resistant|Neoplasm, Castration-Resistant Prostatic|Cancer, Androgen-Independent Prostatic|Prostatic Cancer, Castration-Resistant|Neoplasm, Androgen-Resistant Prostatic|Prostatic Neoplasm, Androgen-Independent|Cancers, Androgen-Resistant Prostatic|Androgen-Resistant Prostatic Cancer|Cancers, Androgen-Independent Prostatic|Castration Resistant Prostatic Neoplasms|Prostatic Cancer, Hormone Refractory"
NEW01905,DISEASE,menstruation-related symptoms,menstruation-related symptoms
NEW01906,DISEASE,favorable bleeding patterns,favorable bleeding patterns
D000153,DISEASE,Acne Keloid,"Nuchal Keloid Acnes|Dermatitis Papillaris Capillitius|acne|Lichen Keloidalis Nuchae|Keloidalis Nuchae, Lichen|Capillitius, Dermatitis Papillaris|Acne Keloidalis|Acne, Keloidal|Keloidalis Nuchae, Folliculitis|Keloidal Acnes|Acne|Nuchal Keloid Acne|Dermatitis Papillaris Capillitii|Folliculitis Keloidalis Nuchae|Keloid Acnes, Nuchal|Keloid, Acne|Keloid Acne, Nuchal|Capillitii, Dermatitis Papillaris|Acnes, Nuchal Keloid|Nuchae, Folliculitis Keloidalis|Nuchae, Lichen Keloidalis|Papillaris Capillitii, Dermatitis|Acne, Nuchal Keloid|Keloids, Acne|Acne Keloids|Folliculitis Keloidalis|Keloidal Acne|Papillaris Capillitius, Dermatitis"
NEW01907,CHEMICAL,levonorgestrel implants,levonorgestrel implants
NEW01908,DISEASE,prolactinoma size,prolactinoma size
D011954,CHEMICAL,"Receptors, Dopamine","Dopamine Receptor|Dopamine Receptors|Dopamine receptors|Receptor, Dopamine|dopamine receptors"
NEW01909,DISEASE,psychiatric benefits,psychiatric benefits
NEW01910,CHEMICAL,D2 dopamine receptors,D2 dopamine receptors
NEW01911,DISEASE,human CCF-STTG1 astrocytoma cells,human CCF-STTG1 astrocytoma cells
D008234,CHEMICAL,Lynestrenol,"Ethinylestrenol|Linesterol|lynestrenol|Linestrenol|Lynestrenol, (9 beta, 10 alpha,17 alpha)-Isomer|Lynoestrenol|Exluton|19-Norpregn-4-en-20-yn-17-ol, (17alpha)-"
NEW01912,DISEASE,CCF-STTG1 astrocytoma cells,CCF-STTG1 astrocytoma cells
NEW01913,NUTRITION,cholesterol transporter ABCA1,cholesterol transporter ABCA1
NEW01914,CHEMICAL,inhibitor RU486,inhibitor RU486
NEW01915,CHEMICAL,progesterone receptor inhibitor,progesterone receptor inhibitor
NEW01916,CHEBI,estrogen therapy,estrogen therapy
NEW01917,CHEBI,anti-TB drug,anti-TB drug
NEW01918,CHEMICAL,higher BMI zinc levels,higher BMI zinc levels
NEW01919,CHEBI,higher circulating vitamin D,higher circulating vitamin D
NEW01920,DISEASE,syndrome vitiligo,syndrome vitiligo
NEW01921,DISEASE,oxidative neuronal injury,oxidative neuronal injury
D050559,CHEBI,"beta-Carotene 15,15'-Monooxygenase","Cleaving Enzyme, beta-Carotene|15,15'-Dioxygenase, beta-Carotene|15,15'-Monooxygenase, beta-Carotene|Dioxygenase, Carotene|Carotene Dioxygenase|beta Carotene 15,15' Dioxygenase|beta-Carotene 15,15'-Dioxygenase|beta Carotene 15,15' Monooxygenase|beta-carotene|beta Carotene Cleaving Enzyme|beta-Carotene Cleaving Enzyme|carotene|beta, beta-Carotene-15,15'-Dioxygenase|beta, beta-Carotene-15,15'-Monooxygenase"
NEW01922,CHEBI,vitamins E,vitamins E
NEW01923,NUTRITION,membrane phospholipids,membrane phospholipids
NEW01924,CHEMICAL,EPUFAs,EPUFAs
C511402,CHEMICAL,Grape Seed Proanthocyanidins [Supplementary Concept],Proanthocyanidins|Grape Seed Extract|proanthocyanidin extract|GSP|grape seed proanthocyanidins
NEW01925,DISEASE,chemical-induced hepatotoxicity,chemical-induced hepatotoxicity
NEW01926,DISEASE,nephrotoxicity,nephrotoxicity
NEW01927,CHEBI,diverse drug,diverse drug
D066126,DISEASE,Cardiotoxicity,"|cardiotoxicity|Cardiotoxicities|Cardiac Toxicities|Toxicity, Cardiac|Cardiac Toxicity|cardiac toxicity"
NEW01928,DISEASE,selected human cancer cells,selected human cancer cells
NEW01929,DISEASE,DMN-induced liver carcinogenesis,DMN-induced liver carcinogenesis
NEW01930,CHEMICAL,mg/dl ethanol,mg/dl ethanol
D012838,CHEMICAL,Silymarin,Karsil|Carsil|silymarin|Legalon|Silimarin|Silymarin
NEW01931,DISEASE,hepatic damage,hepatic damage
D053700,CHEMICAL,"Receptors, Interleukin-8","Receptors, IL-8|IL 8 Receptors|Receptors, IL8|Receptors, Interleukin 8|Interleukin 8 Receptors|IL8 Receptors|IL-8 Receptors|IL-8|Interleukin-8 Receptors"
D017455,CHEMICAL,"Receptors, IgE","Fc Receptors, epsilon|IgE Receptors|Fc epsilon RII|Antigens, CD 23|IgE Receptor|epsilon Fc Receptors|Receptor, Immunoglobulin E|Receptor, epsilon Fc|epsilon RI, Fc|Fc epsilon Receptor|Fc Receptor, epsilon|Antigen, CD23|IgE|Fc epsilon Receptors|epsilon Fc Receptor|CD23 Antigens|epsilon RII, Fc|epsilon Receptors, Fc|Fc epsilon RI|Receptor, IgE|epsilon Receptor, Fc|Immunoglobulin E Receptor|CD23 Antigen|Receptors, Fc epsilon|Antigens, CD23|Receptors, epsilon Fc|CD 23 Antigens|Receptor, Fc epsilon"
NEW01932,CHEMICAL,urinary 8-hydroxy-2'deoxyguanosine,urinary 8-hydroxy-2'deoxyguanosine
D053649,CHEMICAL,"Receptors, Interleukin-5","IL-5|Receptors, Interleukin 5|Interleukin 5 Receptor|Receptors, IL-5|Il 5 Receptor|Receptor, IL5|IL5 Receptor|Receptor, Interleukin-5|Interleukin-5 Receptors|Receptor, Interleukin 5|Interleukin-5 Receptor|IL-5 Receptors|IL 5 Receptors|Il-5 Receptor|Receptor, Il-5|Interleukin 5 Receptors"
NEW01933,CHEMICAL,plasma malondialdehyde,plasma malondialdehyde
C545682,DISEASE,"M-sec protein, mouse [Supplementary Concept]",tumour necrosis factor|Tumor Necrosis Factors
NEW01934,CHEMICAL,Erythrocyte glutathione,Erythrocyte glutathione
NEW01935,CHEBI,antioxidants retinol,antioxidants retinol
NEW01936,DISEASE,hepatic injury,hepatic injury
D056912,MENTAL_HEALTH,Binge-Eating Disorder,"Disorders, Binge-Eating|Binge-Eating Disorders|Binge eating disorder|binge-eating disorder|eating|eating disorder|binge eating|Binge Eating Disorder|Disorder, Binge-Eating"
NEW01937,CHEBI,vitamin A poisoning secondary,vitamin A poisoning secondary
NEW01938,CHEBI,vitamin E components,vitamin E components
NEW01939,DISEASE,hepato-splenomegaly,hepato-splenomegaly
NEW01940,DISEASE,severe iron deficiency anemia,severe iron deficiency anemia
D007006,DISEASE,Hypogonadism,"Hypogonadism, Hypergonadotropic|Hypogonadism, Hypogonadotropic|Hypogonadism, Isolated Hypogonadotropic|Hypergonadotropic Hypogonadism|Hypogonadotropic Hypogonadism|Hypogonadism|hypogonadism"
D063465,DISEASE,Skin Cream,"Skin Lotion|Skin Lotions|Cream, Skin|Cream, Dermal|Creams, Skin|Lotions, Skin|skin|Skin Creams|Lotion, Skin|Creams, Dermal|Dermal Cream|Dermal Creams"
NEW01941,DISEASE,tuberculosis ward,tuberculosis ward
NEW01942,DISEASE,elevated mood,elevated mood
D000995,CHEBI,Antitubercular Agents,"Anti Tuberculosis Drug||Anti-Tuberculosis Agent|Anti Tuberculosis Agents|Antituberculosis|Agent, Antitubercular|Agent, Tuberculostatic|Drug, Anti-Tuberculosis|Anti-Tuberculosis Agents|Antitubercular Agent|Anti Tuberculosis Agent|Anti-Tuberculosis Drugs|Anti-Tuberculosis Drug|Anti Tuberculosis Drugs|Antitubercular Drugs|Agent, Anti-Tuberculosis|Tuberculostatic Agents|Drug, Antitubercular|Tuberculostatic Agent|antitubercular drugs|Antitubercular Drug"
D055985,DISEASE,Latent Tuberculosis,"Latent Tuberculosis Infections|latent tuberculosis|tuberculosis|Latent Tuberculoses|Tuberculosis Infections, Latent|Tuberculosis, Latent|Latent Tuberculosis Infection|Tuberculosis Infection, Latent|Infection, Latent Tuberculosis|Tuberculoses, Latent|Tuberculosis|Infections, Latent Tuberculosis"
NEW01943,CHEBI,medical drug,medical drug
D001037,DISEASE,Aphasia,"|Aphasia, Graphomotor|Progressive Aphasia|Aphasia, Global|Aphasia, Post Ictal|Post-Traumatic Aphasias|Aphasias, Commisural|Global Aphasia|Intellectual Aphasia|Alogias|Anepia|Phenomenon, Dejerine-Lichtheim|Deafness, Word|Ageusic Aphasias|Aphasia, Functional|Aphasia, Post-Ictal|Logamnesia|Mixed Aphasias|Syntactical Aphasia|Anepias|Lichtheim's Sign|Sign, Lichtheim's|alogia|Dysphasia|Ageusic Aphasia|Global Aphasias|Auditory Discriminatory Aphasias|Discriminatory Aphasia, Auditory|Functional Aphasias|Syntactical Aphasias|Logamnesias|Dysphasia, Global|Lichtheims Sign|Logagnosia|Graphomotor Aphasias|Progressive Aphasias|aphasia|Commisural Aphasias|Discriminatory Aphasias, Auditory|Logasthenias|Aphasia, Semantic|Word Deafness|Aphasia, Post Traumatic|Functional Aphasia|Post-Traumatic Aphasia|Global Dysphasias|Acquired Aphasia|Dejerine Lichtheim Phenomenon|Aphasia, Acquired|Graphomotor Aphasia|Aphasia, Intellectual|Aphasia, Progressive|Dejerine-Lichtheim Phenomenon|Logagnosias|Intellectual Aphasias|Aphasia, Commisural|Post-Ictal Aphasias|Auditory Discriminatory Aphasia|Aphasia, Ageusic|Lichtheim Sign|Mixed Aphasia|Aphasia, Syntactical|Semantic Aphasias|Logasthenia|Post-Ictal Aphasia|Global Dysphasia|Commisural Aphasia|Aphasia, Post-Traumatic|Aphasia, Mixed|Semantic Aphasia|Alogia|aphasias|Aphasia, Auditory Discriminatory"
D017483,CHEMICAL,"Receptors, Vasopressin","Hormone Receptors, Antidiuretic|Vascular-Hepatic Type Arginine Vasopressin Receptor|Antidiuretic Hormone Receptor 1b|Receptors, V1|V2 Receptors|V1a Vasopressin Receptor|vasopressin|Receptor, Vasopressin V1b|8-Arg-Vasopressin Receptor|8 Arg Vasopressin Receptor|Vasopressin V1a Receptor|Receptor, Arginine(8)-Vasopressin|Receptors, Argipressin|Vasopressin Receptor, V1b|Receptor, Argipressin|Vascular Hepatic Type Arginine Vasopressin Receptor|Antidiuretic Hormone Receptor 1a|Vasopressin Receptor 1|Argipressin Receptor|Renal-Type Arginine Vasopressin Receptor|Receptors, Antidiuretic Hormone|Arginine Vasopressin Receptor|Receptor, Vasopressin V3|Receptor, Antidiuretic Hormone|Receptor, Vasopressin|Vasopressin Type 1A Receptor|Vasopressin V1b Receptor|V1 Receptors|Antidiuretic Hormone Receptor|Hormone Receptor, Antidiuretic|Vasopressin V3 Receptor|Receptors, V2|Vasopressin|V1b Receptor, Vasopressin|Receptor, V1|Receptor, V2|Renal Type Arginine Vasopressin Receptor|Vasopressin Receptor|Vasopressin V2 Receptor|Vasopressin Receptors|V2 Receptor|Receptor, Arginine Vasopressin|V1b Vasopressin Receptor|Argipressin Receptors|V1 Receptor|Antidiuretic Hormone Receptors"
NEW01944,DISEASE,efferent motor aphasias,efferent motor aphasias
NEW01945,CHEMICAL,CA1 postsynaptic histamine H1,CA1 postsynaptic histamine H1
NEW01946,CHEMICAL,high-dose betahistine treatment,high-dose betahistine treatment
D001621,CHEMICAL,Betahistine,"Betahistine Methanesulphonate|Dihydrobromide, Betahistine|Mersilon|Lectil|Betavert|Betahistine Methanesulfonate|Mesylate, Betahistine|Methanesulphonate, Betahistine|Betahistine Dihydrochloride|By-Vertin|By Vertin|PT-9|Aequamen|Betahistine Mesylate|Extovyl|Betahistine Dihydrobromide|Betahistin-Ratiopharm|Methanesulfonate, Betahistine|Vertigon|PT 9|Betahistine|Betahistine Hydrochloride|Melopat|PT9|Hydrochloride, Betahistine|Betaserc|betahistine|Fidium|Betahistin AL|Ribrain|Betahistine Biphar|Vasomotal|Dihydrochloride, Betahistine|Serc|Betahistin Ratiopharm|Betahistin Stada"
NEW01947,CHEMICAL,classic histamine receptors,classic histamine receptors
D057985,DISEASE,"Multi-Ingredient Cold, Flu, and Allergy Medications","Multi-Ingredient Cold and Flu Medications|Multi-Ingredient Allergy Medications|Cold Remedies, Multi-Ingredient|Multi-Ingredient Cold Remedies|Flu Medications, Multi-Ingredient|Cold Medications, Multi-Ingredient|Medications, Multi-Ingredient Allergy|Multi Ingredient Cold Medications|Multi-Ingredient Cold Medications|allergy|Medications, Multi-Ingredient Cold|Medications, Multi-Ingredient Flu|Multi Ingredient Cold and Flu Medications|Cold, Flu, and Allergy Medications, Multi-Ingredient|Cold and Flu Medications, Multi Ingredient|Allergy Medications, Multi-Ingredient|Multi Ingredient Flu Medications|Cold and Flu Medications, Multi-Ingredient|Remedies, Multi-Ingredient Cold|Multi-Ingredient Flu Medications|Multi Ingredient Cold Remedies|Multi Ingredient Allergy Medications"
D013276,DISEASE,Stomach Ulcer,"Stomach Ulcers|Gastric Ulcers|Ulcer, Gastric|Ulcer, Stomach|Ulcers, Gastric|Ulcers, Stomach|Gastric Ulcer|gastric ulcer"
NEW01948,CHEBI,drug targets,drug targets
NEW01949,CHEBI,H3 receptor antagonist,H3 receptor antagonist
C115705,CHEMICAL,ciproxifan [Supplementary Concept],ciproxifan|Imidazoles
NEW01950,DISEASE,chronic restraint stress,chronic restraint stress
NEW01951,CHEMICAL,histamine neurons,histamine neurons
NEW01952,CHEMICAL,H(3)-type histamine receptors,H(3)-type histamine receptors
NEW01953,CHEBI,histamine H3 receptor antagonist,histamine H3 receptor antagonist
NEW01954,DISEASE,potential syndrome,potential syndrome
NEW01955,CHEBI,histamine (H3)-receptor antagonist/inverse agonist,histamine (H3)-receptor antagonist/inverse agonist
D018687,CHEMICAL,"Antidepressive Agents, Second-Generation","Antidepressive Drugs, Second-Generation|Antidepressive Agents, Second Generation|Second-Generation Antidepressive Drugs|Agents, Second-Generation Antidepressive|Antidepressants|Antidepressive Drugs, Second Generation|Second-Generation Antidepressive Agents|Atypical Antidepressants|Drugs, Second-Generation Antidepressive|Antidepressants, Atypical|Second Generation Antidepressive Agents|antidepressants"
NEW01956,CHEMICAL,methylphenidate preparations,methylphenidate preparations
D018100,CHEMICAL,"Receptors, Histamine H3","H3 Receptor, Histamine|Receptor, H3|H3 Receptor|Histamine H3 Receptors|H3 Receptors|H3 Receptors, Histamine|histamine receptor|Receptors, H3|histamine H3 receptors|Histamine H3 Receptor|Receptor, Histamine H3|Histamine H3 receptors"
NEW01957,CHEMICAL,non-histamine neurons,non-histamine neurons
C574166,CHEMICAL,bavisant [Supplementary Concept],JNJ-31001074|Benzamides|Piperazines|Bavisant
NEW01958,CHEBI,selective antagonist,selective antagonist
C052075,CHEMICAL,thioperamide [Supplementary Concept],|Piperidines|thioperamide
NEW01959,CHEBI,multifunctional drug able,multifunctional drug able
NEW01960,CHEMICAL,histaminergic H1 receptor,histaminergic H1 receptor
NEW01961,DISEASE,weight gain/obesity side-effects,weight gain/obesity side-effects
NEW01962,CHEBI,betahistine histaminergic H1R agonist,betahistine histaminergic H1R agonist
NEW01963,DISEASE,SGA-induced weight gain/obesity,SGA-induced weight gain/obesity
NEW01964,CHEMICAL,Betahistine co-treatment,Betahistine co-treatment
D051782,CHEMICAL,Sterol Regulatory Element Binding Protein 2,Sterol regulatory element binding protein|sterol regulatory element-binding protein|Sterol-Regulatory Element-Binding Protein 2|SREBP2 Protein|SRE-2 Binding Protein|SRE 2 Binding Protein
NEW01965,DISEASE,dizocilpine (DIZ)-induced memory deficits,dizocilpine (DIZ)-induced memory deficits
NEW01966,CHEMICAL,histamine H3 receptor antagonist E159,histamine H3 receptor antagonist E159
NEW01967,DISEASE,DIZ-induced amnesic model,DIZ-induced amnesic model
NEW01968,CHEMICAL,H2R antagonist zolantidine,H2R antagonist zolantidine
NEW01969,CHEMICAL,H1R antagonist pyrilamine,H1R antagonist pyrilamine
D020277,DISEASE,"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating","Polyradiculopathy, Chronic Inflammatory|Inflammatory Polyradiculoneuropathy, Chronic|Inflammatory Polyradiculoneuropathies, Chronic|Chronic Inflammatory Polyradiculoneuropathy|Chronic Inflammatory Polyradiculopathies|Polyradiculopathies, Chronic Inflammatory|CIDP|Chronic Inflammatory Polyradiculoneuropathies|Chronic Inflammatory Polyradiculopathy|Inflammatory Polyradiculopathies, Chronic|Polyradiculoneuropathy, Chronic Inflammatory|Polyneuropathy, Inflammatory Demyelinating, Chronic|Inflammatory Polyradiculopathy, Chronic|polyradiculoneuropathy|Polyradiculoneuropathies, Chronic Inflammatory|Chronic Inflammatory Demyelinating Polyradiculoneuropathy"
D006680,CHEBI,HLA Antigens,"Antigens, Human Leukocyte|HL A Antigens|Human Leukocyte Antigens|Antigens, Leukocyte|Antigens, HLA|Leukocyte Antigens, Human|Antigens, HL-A|Human Leukocyte Antigen|Leukocyte Antigen, Human|Leukocyte Antigens|human leukocyte antigens|HLA antigens|HL-A Antigens|Antigen, Human Leukocyte"
NEW01970,CHEBI,antithyroid drug treatment,antithyroid drug treatment
NEW01971,CHEMICAL,free calcium,free calcium
NEW01972,CHEBI,increased thyroid hormone levels,increased thyroid hormone levels
NEW01973,DISEASE,Graves's disease,Graves's disease
NEW01974,CHEBI,thyroid hormone values,thyroid hormone values
NEW01975,DISEASE,liver disease due,liver disease due
NEW01976,DISEASE,euthyroid neonate,euthyroid neonate
NEW01977,DISEASE,fetal goitrous hypothyroidisms,fetal goitrous hypothyroidisms
NEW01978,DISEASE,fetal dyshormonogenesis,fetal dyshormonogenesis
NEW01979,CHEMICAL,brain dopamine,brain dopamine
NEW01980,CHEMICAL,PET dopamine measurements,PET dopamine measurements
NEW01981,CHEBI,drugs levodopa,drugs levodopa
NEW01982,DISEASE,hypersexual behaviours,hypersexual behaviours
NEW01983,CHEMICAL,neuromodulator dopamine,neuromodulator dopamine
D002211,CHEMICAL,Capsaicin,|8-Methyl-N-Vanillyl-6-Nonenamide|Capsidol|Katrum|CAP|Capsaicine|NGX 4010|Capsin|Axsain|Antiphlogistine Rub A-535 Capsaicin|Zostrix|Capsicum Farmaya|Gelcen|NGX4010|Capzasin|8 Methyl N Vanillyl 6 Nonenamide|Zacin|Capsaicin|capsaicin|NGX-4010
D020278,DISEASE,"Demyelinating Autoimmune Diseases, CNS","Autoimmune Demyelinating Disorders, CNS|Demyelinating Autoimmune Diseases, Central Nervous System|Demyelinating Autoimmune Diseases, Spinal Cord|Autoimmune Demyelinating Diseases, Cerebral|Autoimmune Diseases, Demyelinating, Brain|autoimmune diseases|Brain Autoimmune Demyelinating Diseases|Demyelinating Autoimmune Diseases, Cerebral|Autoimmune Demyelinating Diseases, Spinal Cord|Demyelinating Autoimmune Disorders, CNS|Autoimmune Demyelinating Diseases, CNS|Demyelinating Autoimmune Diseases, Brain|Cerebral Demyelinating Diseases, Autoimmune|CNS Demyelinating Autoimmune Diseases|CNS Autoimmune Demyelinating Disorders|Autoimmune Demyelinating Diseases, Central Nervous System|Spinal Cord Demyelinating Autoimmune Diseases|Demyelinating Disease, Autoimmune, CNS"
NEW01984,CHEMICAL,LPS mg/kg 5-day,LPS mg/kg 5-day
NEW01985,CHEMICAL,dietary CAP,dietary CAP
NEW01986,CHEMICAL,behavior sucrose preference test,behavior sucrose preference test
NEW01987,CHEMICAL,Community-acquired pneumonia,Community-acquired pneumonia|CAP|compound action potential
NEW01988,DISEASE,depression-related microbiota,depression-related microbiota
C000638160,DISEASE,Sutterella parvirubra [Supplementary Concept],Sutterella|Burkholderiales
C000648698,DISEASE,Allobaculum stercoricanis [Supplementary Concept],Firmicutes|Allobaculum
D045243,DISEASE,Prevotella ruminicola,Prevotella (1992-2003)|Prevotella
C000643374,DISEASE,Oscillospira guilliermondii [Supplementary Concept],Clostridiales|Oscillospira
NEW01989,CHEBI,TRPV1 antagonists,TRPV1 antagonists
D008305,DISEASE,Malignant Hyperthermia,"Hyperthermia, Anesthesia Related|hyperthermia|Anesthesia Hyperthermia|Hyperthermia of Anesthesia|Malignant Hyperpyrexia|Hyperthermia, Malignant|Anesthesia Related Hyperthermia|Hyperpyrexia, Malignant|Malignant Hyperpyrexias"
NEW01990,MENTAL_HEALTH,Specific phobias,Specific phobias
NEW01991,CHEMICAL,higher alcohol consumption,higher alcohol consumption
NEW01992,DISEASE,cannabis-dependent group,cannabis-dependent group
D066235,CHEMICAL,Fluorine-19 Magnetic Resonance Imaging,"F[2,23 =|Fluorine 19 Magnetic Resonance Imaging|F10.4|fluorine|F10,141=0.4|19F MRI"
NEW01993,CHEMICAL,cocaine use,cocaine use
D004360,CHEBI,"Drug Therapy, Computer-Assisted","Drug therapy|Therapy, Computer Assisted Drug|Therapies, Computer-Assisted Drug|Protocol Drug Therapy, Computer Assisted|Computer-Assisted Drug Therapy|Drug Therapy, Computer Assisted|Drug Therapies, Computer-Assisted|Protocol Drug Therapy, Computer-Assisted|Computer Assisted Drug Therapy|Computer-Assisted Drug Therapies|Therapy, Computer-Assisted Drug|drug therapy"
NEW01994,CHEMICAL,Supplemental oxygen,Supplemental oxygen
NEW01995,MENTAL_HEALTH,specific mental disorders,specific mental disorders
NEW01996,DISEASE,phobias/separation anxiety/autism spectrum deficit hyperactivity disorder/social anxiety,phobias/separation anxiety/autism spectrum deficit hyperactivity disorder/social anxiety
NEW01997,MENTAL_HEALTH,anxiety problems,anxiety problems
D063647,CHEMICAL,Fetal Alcohol Spectrum Disorders,"Fetal Alcohol Spectrum Disorder|alcohol-related birth defects|Fetal alcohol syndrome|birth defects|Alcohol-Related Birth Defects|FAE (Fetal Alcohol Effects)|fetal alcohol spectrum disorder|Alcohol Related Birth Defects|Alcohol Related Neurodevelopmental Disorder|Fetal Alcohol Syndrome|fetal alcohol syndrome|Partial Fetal Alcohol Syndrome|Syndrome, Fetal Alcohol|Growth Retardation, Facial Abnormalities, and Central Nervous System Dysfunction|pFAS|Fetal alcohol spectrum disorder|Fetal alcohol spectrum disorders|alcohol-related neurodevelopmental disorder|fetal alcohol effects|FASD|FAEs (Fetal Alcohol Effects)|partial fetal alcohol syndrome|Birth Defects, Alcohol-Related|FAS|ARND|fetal alcohol spectrum disorders|FASDs|Fetal Alcohol Spectrum Disorders"
D000342,MENTAL_HEALTH,Affective Symptoms,"Alexithymia|alexithymia|Emotional Disturbance|Disturbance, Emotional|Emotional Disturbances|Symptom, Affective|Affective Symptom|Symptoms, Affective|Disturbances, Emotional|emotional disturbance|Alexithymias|emotional disturbances"
D019973,CHEMICAL,Alcohol-Related Disorders,"Alcohol Related Disorders|Alcohol Problem|Disorder, Alcohol-Related|Alcohol Problems|Alcohol-Related Disorder|alcohol problem"
NEW01998,DISEASE,Attention-Deficit/Hyperkinetic Disorder,Attention-Deficit/Hyperkinetic Disorder
NEW01999,CHEBI,hormone melatonin,hormone melatonin
NEW02000,MENTAL_HEALTH,hyperkinetic disorder,hyperkinetic disorder
D008903,DISEASE,Minerals,minerals|Mineral
D019287,CHEMICAL,Zinc Sulfate,"Sulfate, Zinc|Zinc Sulfate, Heptahydrate|Zinc sulfate|Zincteral|zinc sulfate"
NEW02001,MENTAL_HEALTH,ADHD therapy,ADHD therapy
NEW02002,CHEMICAL,zinc deficit,zinc deficit
NEW02003,CHEMICAL,zinc supplementation,zinc supplementation
NEW02004,MENTAL_HEALTH,ADHD treatment,ADHD treatment
NEW02005,CHEMICAL,Benzodiazepine dependence,Benzodiazepine dependence
NEW02006,CHEMICAL,Diazepam overdosage,Diazepam overdosage
NEW02007,CHEMICAL,barbiturate overdosage,barbiturate overdosage
D055963,CHEMICAL,"Asthma, Aspirin-Induced","Aspirin-Induced Asthmas|Asthmas, NSAID-induced|Asthma, NSAID induced|Aspirin Induced Asthma Syndrome|Asthma, NSAID-induced|NSAID-induced Asthma|Induced Asthma, Aspirin|NSAID-induced Asthmas|Aspirin Induced Asthma|Asthma Syndromes, Aspirin-Induced|Asthmas, Aspirin Induced|Asthmas, Aspirin-Induced|aspirin|Aspirin-Induced Asthma|Syndrome, Aspirin-Induced Asthma|Aspirin-Induced Asthma Syndromes|Aspirin-Induced Asthma Syndrome|Aspirin Induced Asthmas|Syndromes, Aspirin-Induced Asthma|Asthma Syndrome, Aspirin-Induced|Induced Asthmas, Aspirin|Asthma, Aspirin Induced"
NEW02008,DISEASE,overdose situations,overdose situations
NEW02009,CHEBI,common drug,common drug
NEW02010,MENTAL_HEALTH,character disorder,character disorder
NEW02011,DISEASE,European Cardiac Arrhythmia Society,ECAS|European Cardiac Arrhythmia Society
D058687,DISEASE,Out-of-Hospital Cardiac Arrest,"Out of Hospital Cardiac Arrest|Out of Hospital Heart Arrest|Cardiac Arrest, Out-of-Hospital|Cardiac Arrests, Out-of-Hospital|Heart Arrest, Out-of-Hospital|Out-of-Hospital Cardiac Arrests|Heart Arrests, Out-of-Hospital|Out-of-Hospital Heart Arrest|cardiac arrest|Out-of-Hospital Heart Arrests"
NEW02012,DISEASE,life-threatening arrhythmias,life-threatening arrhythmias
NEW02013,DISEASE,impaired driving,impaired driving
NEW02014,DISEASE,increased risk-taking behaviors,increased risk-taking behaviors
NEW02015,MENTAL_HEALTH,caffeine intoxication,caffeine intoxication
NEW02016,CHEMICAL,Inhaled loxapine,Inhaled loxapine
NEW02017,MENTAL_HEALTH,mild-to-moderate agitation,mild-to-moderate agitation
NEW02018,DISEASE,earlier sexual abuse,earlier sexual abuse
D063868,DISEASE,Patient Outcome Assessment,"Outcome Assessments, Patient|Patient Centered Outcomes Research|Assessments, Patient Outcome|Patient Outcome Assessments|Outcomes Assessments, Patient|Assessment, Patient Outcome|Patient Outcomes Assessment|Assessment, Patient Outcomes|Patient-Centered Outcomes Research|outcome|Outcome Assessment, Patient|Research, Patient-Centered Outcomes|polysubstance abuse"
NEW02019,MENTAL_HEALTH,pathological craving,pathological craving
NEW02020,CHEMICAL,alcohol drugs,alcohol drugs
NEW02021,CHEMICAL,cannabis preparations,cannabis preparations
NEW02022,CHEMICAL,increased tetrahydrocannabinol content,increased tetrahydrocannabinol content
NEW02023,CHEMICAL,cannabis indicators,cannabis indicators
NEW02024,DISEASE,self-reported psychotic disorders,self-reported psychotic disorders
NEW02025,CHEMICAL,Caine criteria,Caine criteria
NEW02026,DISEASE,dietary deficiency,dietary deficiency
NEW02027,DISEASE,low general cognitive functioning abnormalities,low general cognitive functioning abnormalities
D002526,DISEASE,Cerebellar Diseases,"|Dysfunction, Cerebellar|cerebellar dysfunction|Cerebellar Disease|Cerebellum Diseases|cerebellum diseases|Syndrome, Cerebellar|Cerebellum Disease|Cerebellar Syndromes|Disease, Cerebellum|Cerebellar Dysfunctions|Cerebellar Disorders|Cerebellar Syndrome|Disorder, Cerebellar|Cerebellar Dysfunction|Cerebellar Disorder|Disease, Cerebellar|cerebellum damage"
NEW02028,MENTAL_HEALTH,Multiple regression,Multiple regression
NEW02029,NUTRITION,low whole blood thiamine level consistent,low whole blood thiamine level consistent
NEW02030,DISEASE,violent offense,violent offense
NEW02031,DISEASE,sexual offenders,sexual offenders
D010410,DISEASE,Penile Erection,"Erection, Penile|penile tumescence|Penile Tumescence, Nocturnal|Nocturnal Penile Tumescence|Penile Tumescence|Tumescence, Nocturnal Penile|Tumescence, Penile|penile erection"
NEW02032,CHEMICAL,smoked cocaine users,smoked cocaine users
NEW02033,MENTAL_HEALTH,Canadian Pathological Gambling Index,Canadian Pathological Gambling Index
C532690,CHEMICAL,"piracetam, vinpocetine drug combination [Supplementary Concept]",vinpocetine|Piracetam|Vinpocetine|Drug Combinations|Vinca Alkaloids
NEW02034,CHEBI,semisynthetic drug,semisynthetic drug
NEW02035,CHEMICAL,Excessive alcohol intake,Excessive alcohol intake
NEW02036,CHEMICAL,melatonin suppression,melatonin suppression
NEW02037,DISEASE,Hypersexuality,Hypersexuality
NEW02038,DISEASE,hypersexuality,hypersexuality
NEW02039,DISEASE,resistant hypersexuality,resistant hypersexuality
D014029,DISEASE,Tobacco Use Disorder,"Dependence, Nicotine|Tobacco Dependence|Nicotine Addictions|Addiction, Nicotine|Nicotine Dependence|nicotine addiction|Nicotine dependence|nicotine dependence|Tobacco Use Disorders|Tobacco-Use Disorder|Nicotine Addiction|Nicotine Use Disorder|Disorder, Nicotine Use|Disorder, Tobacco-Use|tobacco dependence|Dependence, Tobacco|nicotine use|Nicotine Use Disorders|Nicotine use|Disorder, Tobacco Use|use disorder"
NEW02040,DISEASE,severe psychiatric diseases,severe psychiatric diseases
NEW02041,MENTAL_HEALTH,Major depression,Major depression
NEW02042,MENTAL_HEALTH,anxiety level,anxiety level
NEW02043,MENTAL_HEALTH,depression level,depression level
NEW02044,CHEMICAL,alcohol cues,alcohol cues
D008995,DISEASE,Monoamine Oxidase,"Oxidase, Monoamine|Tyramine Oxidase|Monoamine Oxidase A|Type B Monoamine Oxidase|MAO|Type A Monoamine Oxidase|MAO B|Amine Oxidase (Flavin-Containing)|MAO-A|MAO A|Monoamine Oxidase B|MAO-B|Oxidase, Tyramine"
NEW02045,DISEASE,implicit attentional bias,implicit attentional bias
NEW02046,MENTAL_HEALTH,Univariable regression models,Univariable regression models
D016015,MENTAL_HEALTH,Logistic Models,"Logistic Model|Logit Model|Logit Models|Regression, Logistic|Logistic Regression|Logistic regression|Models, Logistic|Logistic Regressions|Models, Logit|Model, Logit|Regressions, Logistic|logistic regression|Model, Logistic"
NEW02047,MENTAL_HEALTH,log-linear regression,log-linear regression
NEW02048,CHEMICAL,Sedative antidepressants,Sedative antidepressants
D014196,CHEMICAL,Trazodone,PMS Trazodone||Trazodon Neuraxpharm|Trazodone|Gen-Trazodone|AF 1161|Gen Trazodone|PMS-Trazodone|Tradozone|Trazodone Hydrochloride|Trazon|AF1161|Ratio-Trazodone|Ratio Trazodone|Desyrel|Nu Trazodone|trazodone|Trazodon Hexal|TrazodonNeuraxpharm|Novo-Trazodone|Novo Trazodone|Trz|Molipaxin|AF-1161|Apo-Trazodone|Apo Trazodone|Trittico|Nu-Trazodone|Deprax|RatioTrazodone|Trazodon-Neuraxpharm|Thombran
NEW02049,MENTAL_HEALTH,sleep onset insomnia,sleep onset insomnia
NEW02050,CHEMICAL,one LEP haplotype,AB2H8|one LEP haplotype
NEW02051,MENTAL_HEALTH,Dependence FTND scores,Dependence FTND scores
NEW02052,CHEMICAL,lower Fagerström Test,lower Fagerström Test
NEW02053,CHEMICAL,Chronic alcohol intake,Chronic alcohol intake
NEW02054,DISEASE,hepatotoxicity,hepatotoxicity
D020805,DISEASE,Central Nervous System Viral Diseases,"Viral Disease, CNS|CNS Infections, Viral|Infection, Viral CNS|Viral Diseases, Central Nervous System|Central Nervous System Viral Infections|CNS Viral Disease|CNS Viral Diseases|Viral Infections, Central Nervous System|Disease, CNS Viral|Diseases, CNS Viral|Infections, Viral CNS|Viral CNS Infection|Infections, CNS, Viral|Viral Diseases, CNS|CNS Infection, Viral|viral infections|Viral CNS Infections"
D059607,DISEASE,"Polydipsia, Psychogenic","psychogenic polydipsia|Primary Polydipsias|Psychogenic Polydipsias|polydipsia|Polydipsia, Primary|Polydipsia|Polydipsias, Psychogenic|Psychogenic Polydipsia|Primary Polydipsia|Polydipsias, Primary"
NEW02055,MENTAL_HEALTH,upcoming manic episode,upcoming manic episode
D007027,DISEASE,Hypothalamic Diseases,"Diencephalic Syndrome, Pituitary|Hypothalamic Pseudopuberties|Disorder, Hypothalamic-Adenohypophyseal|Syndromes, Hypothalamic Dysfunction|Syndromes, Pituitary Diencephalic|Diencephalic Syndromes, Pituitary|Hypothalamic Dysfunction Syndromes|Syndrome, Hypothalamic Dysfunction|Hypothalamic-Adenohypophyseal Disorders|Hypothalamic Neurohypophyseal Disorders|Disease, Hypothalamic|Froehlich Syndrome|Froehlich's Syndrome|Hypothalamic Dysfunction Syndrome|Syndrome, Hypothalamic Overactivity|Hypothalamic Overactivity Syndrome|Diseases, Hypothalamic|Pseudopuberties, Hypothalamic|Pituitary Diencephalic Syndrome|Dysinhibition Syndromes, Hypothalamic|Disorders, Hypothalamic-Neurohypophyseal|Dysfunction Syndromes, Hypothalamic|Dysfunction Syndrome, Hypothalamic|Hypothalamic-Adenohypophyseal Disorder|Hypothalamic-Neurohypophyseal Disorder|Hypothalamic Adenohypophyseal Disorders|Syndromes, Hypothalamic Dysinhibition|Pituitary Diencephalic Syndromes|Hypothalamic Disease|Froehlichs Syndrome|Overactivity Syndrome, Hypothalamic|Hypothalamic Dysinhibition Syndromes|Disorder, Hypothalamic-Neurohypophyseal|hypothalamic dysfunction|Syndromes, Hypothalamic Overactivity|Overactivity Syndromes, Hypothalamic|Hypothalamic Dysinhibition Syndrome|Disorders, Hypothalamic-Adenohypophyseal|Pseudopuberty, Hypothalamic|Syndrome, Froehlich's|Hypothalamic-Neurohypophyseal Disorders|Dysinhibition Syndrome, Hypothalamic|Hypothalamic Overactivity Syndromes|Syndrome, Hypothalamic Dysinhibition|Hypothalamic Pseudopuberty"
NEW02056,CHEMICAL,Antidepressant treatments,Antidepressant treatments
NEW02057,DISEASE,manic symptoms,manic symptoms
NEW02058,DISEASE,Antimanic treatments,Antimanic treatments
NEW02059,CHEBI,genuine mood stabiliser,genuine mood stabiliser
NEW02060,DISEASE,manic states,manic states
NEW02061,NUTRITION,lithium due,lithium due
C566501,DISEASE,Major Affective Disorder 3 [Supplementary Concept],manic-depression|Bipolar affective disorder|Bipolar Disorder|bipolar affective disorder
NEW02062,CHEMICAL,smoking intake,smoking intake
NEW02063,CHEMICAL,liver-gut axis,liver-gut axis
D011604,MENTAL_HEALTH,"Psychoses, Alcoholic",Alcoholic Psychoses|alcoholic psychoses
NEW02064,DISEASE,DSM-III sexual dysfunctions,DSM-III sexual dysfunctions
NEW02065,CHEMICAL,random forest-trees analysis,random forest-trees analysis
D000075384,DISEASE,Neuroticism,Neuroticism Trait|Neuroticism Traits|Neuroticism|neuroticism
NEW02066,DISEASE,low conscientiousness,low conscientiousness
NEW02067,DISEASE,MDD patients,MDD patients
NEW02068,DISEASE,overdose risk,overdose risk
NEW02069,CHEMICAL,Co-use,Co-use
NEW02070,DISEASE,Alcohol Use Disorder Interview Schedule,Alcohol Use Disorder Interview Schedule
NEW02071,DISEASE,fifth edition,fifth edition|DSM-5
NEW02072,MENTAL_HEALTH,suicide attempts,suicide attempts
NEW02073,CHEMICAL,major tranquillisers,major tranquillisers
NEW02074,MENTAL_HEALTH,psychosis determinants,psychosis determinants
NEW02075,CHEMICAL,COVID-19 era,COVID-19 era
NEW02076,DISEASE,paroxysmal neurological diseases,paroxysmal neurological diseases
NEW02077,CHEMICAL,lifetime cocaine use,lifetime cocaine use
NEW02078,MENTAL_HEALTH,narcolepsy withdrawal,narcolepsy withdrawal
C431546,CHEMICAL,hydroxybutyryl ethanolamide [Supplementary Concept],gamma-hydroxybutyric acid|Gamma hydroxybutyric acid|Gamma-hydroxybutyric acid|gamma-Aminobutyric Acid/analogs  and  derivatives
NEW02079,CHEMICAL,diclofenac NSAIDs,diclofenac NSAIDs
NEW02080,DISEASE,comatose state,comatose state
NEW02081,NUTRITION,short-chain fatty acid present,short-chain fatty acid present
NEW02082,CHEBI,date-rape drug,date-rape drug
D020324,MENTAL_HEALTH,"Amnesia, Anterograde","Amnesia, Post Ictal|Post Ictal Memory Loss|Post-Ictal Amnesias|amnesia|Anterograde Memory Losses|Post-Ictal Memory Loss|Amnesias, Post-Ictal|Memory Loss, Post-Ictal|Anterograde Amnesia|Post-Ictal Memory Losses|Amnesias, Anterograde|Memory Loss, Anterograde|Amnesia, Post-Ictal|Anterograde Memory Loss|Post-Ictal Amnesia|losses|memory loss|Anterograde Amnesias|Loss, Post-Ictal Memory|Losses, Post-Ictal Memory|Memory Losses, Post-Ictal|Memory Losses, Anterograde|anterograde amnesia"
D013406,MENTAL_HEALTH,"Suicide, Attempted","suicide attempt|Attempted Suicide|Suicide Attempt|Attempt, Suicide|Parasuicides|Parasuicide"
NEW02083,CHEMICAL,maternal alcohol consumption,maternal alcohol consumption
NEW02084,MENTAL_HEALTH,childhood autism spectrum disorders,childhood autism spectrum disorders
NEW02085,DISEASE,violent crimes,violent crimes
NEW02086,CHEMICAL,noradrenergic antidepressants,noradrenergic antidepressants
D003891,CHEMICAL,Desipramine,"|Novo Desipramine|Apo Desipramine|Norpramin|Hydrochloride, Desipramine|Demethylimipramine|Desipramine|Desipramine Hydrochloride|Novo-Desipramine|Apo-Desipramine|Pertrofran|Ratio Desipramine|desipramine|DMI|PMS Desipramine|Nu Desipramine|Ratio-Desipramine|Pertofrane|Petylyl|Pertofran|PMS-Desipramine|Nu-Desipramine|desmethylimipramine|Desmethylimipramine"
NEW02087,DISEASE,PTSD comorbid groups,PTSD comorbid groups
D017374,CHEMICAL,Paroxetine,"Paroxetine||Paroxetine, trans-(+)-Isomer|Paroxetine Acetate|FG7051|Paroxetine, cis-(+)-Isomer|Paroxetine Hydrochloride Anhydrous|Paroxetine hydrochloride|BRL-29060|FG 7051|Paroxetine Hydrochloride, Hemihydrate|BRL29060|Paroxetine Hydrochloride Hemihydrate|Paroxetine, cis-(-)-Isomer|paroxetine|Paroxetine Hydrochloride|FG-7051|Aropax|Paxil|Seroxat|BRL 29060|Paroxetine hydrochloride hemihydrate|Paroxetine Maleate"
NEW02088,MENTAL_HEALTH,depression group,depression group
D063726,MENTAL_HEALTH,Delusional Parasitosis,"|Delusion, Dermatozoic|Delusions, Dermatozoic|Dermatozoic Delusion, Ekbom|Ekbom Psychogenic Parasitosis|Dermatozoic Delusions|Parasitosis, Ekbom Delusory|Delusory Parasitoses|delusional parasitosis|Ekbom Dermatozoic Delusion|Ekbom Delusory Parasitoses|Parasitoses, Delusional|Delusory Parasitosis, Ekbom|Psychogenic Parasitoses, Ekbom|Delusional Parasitosis, Ekbom|delusion =|Parasitosis, Delusional|Ekbom Delusional Parasitosis|Parasitoses, Ekbom Delusional|delusion|Psychogenic Parasitosis|Ekbom Delusory Parasitosis|Delusion, Ekbom Dermatozoic|Parasitosis, Psychogenic|Delusional Parasitoses, Ekbom|Parasitosis, Delusory|Psychogenic Parasitoses|Ekbom Dermatozoic Delusions|Dermatozoic Delusions, Ekbom|Delusional Parasitoses|Delusory Parasitosis|Ekbom Delusional Parasitoses|Parasitoses, Ekbom Psychogenic|Psychogenic Parasitosis, Ekbom|Parasitoses, Ekbom Delusory|Parasitosis, Ekbom Delusional|Parasitoses, Psychogenic|Delusory Parasitoses, Ekbom|Dermatozoic Delusion|Parasitosis, Ekbom Psychogenic|Delusions, Ekbom Dermatozoic|Parasitoses, Delusory|Ekbom Psychogenic Parasitoses"
NEW02089,MENTAL_HEALTH,group manic-depressive psychosis,group manic-depressive psychosis
NEW02090,CHEBI,toxin exposure,toxin exposure
NEW02091,MENTAL_HEALTH,severe intellectual disability,severe intellectual disability
NEW02092,MENTAL_HEALTH,symptom sleepiness,symptom sleepiness
D016009,CHEMICAL,Chi-Square Distribution,"Chi Square Test|Chi-Square Tests|Test, Chi-Square|Chi-Square Test|χ|Tests, Chi-Square|Chi-Square Distributions|Chi Square Distribution|Distribution, Chi-Square|Distributions, Chi-Square"
D000987,MENTAL_HEALTH,Antisocial Personality Disorder,"|Personality, Antisocial|Personality Disorders, Antisocial|Personality, Sociopathic|Sociopathic Personality|Personalities, Psychopathic|Disorder, Antisocial Personality|Psychopathic Personalities|Antisocial Personality|Antisocial Behaviors|Dyssocial Behavior|Behaviors, Dyssocial|antisocial|Behavior, Antisocial|Psychopathic Personality|Personality, Psychopathic|Personalities, Antisocial|Personality Disorder, Antisocial|antisocial personality disorder|Disorders, Antisocial Personality|Behaviors, Antisocial|Antisocial Personality Disorder|antisocial personality|antisocial behavior|Antisocial Behavior|Sociopathic Personalities|Behavior, Dyssocial|Personalities, Sociopathic|Antisocial Personality Disorders|psychopathic personality|Dyssocial Behaviors|Antisocial Personalities"
NEW02093,CHEMICAL,problematic alcohol consumption,problematic alcohol consumption
NEW02094,CHEMICAL,psychopathy-focused Psychopathy Measure,psychopathy-focused Psychopathy Measure
NEW02095,CHEMICAL,self-control seeking,self-control seeking
NEW02096,CHEMICAL,intercellular dopamine,intercellular dopamine
NEW02097,CHEMICAL,norepinephrine levels,norepinephrine levels
NEW02098,CHEMICAL,Post-cocaine,Post-cocaine
NEW02099,MENTAL_HEALTH,depression craving,depression craving
NEW02100,CHEMICAL,Antidepressant pharmacotherapy,Antidepressant pharmacotherapy
NEW02101,CHEMICAL,cocaine abstinence,cocaine abstinence
NEW02102,CHEMICAL,general antidepressant action,general antidepressant action
D058545,MENTAL_HEALTH,Inhalant Abuse,"Glue Abuse|Abuse, Glue|Glue Sniffing|Abuses, Inhalant|abuse|Abuses, Glue|Inhalant Abuses|Glue Sniffings|Abuse, Inhalant|Glue Abuses"
NEW02103,MENTAL_HEALTH,debilitating mental illness,debilitating mental illness
D011239,CHEMICAL,Prednisolone,|PSL|Di-Adreson-F|Predate|Di Adreson F|DiAdresonF|Predonine|prednisolone
D054319,CHEMICAL,Marchiafava-Bignami Disease,Marchiafava-Bignami disease|Marchiafava-Bignami Syndrome|Marchiafava Bignami Syndrome|MBD|Marchiafava-Bignami syndrome|Marchiafava Bignami Disease
NEW02104,DISEASE,disordered eating,disordered eating
NEW02105,MENTAL_HEALTH,adolescent anxiety,adolescent anxiety
NEW02106,CHEMICAL,later alcohol use,later alcohol use
NEW02107,DISEASE,Externalizing disorders,Externalizing disorders
D054062,MENTAL_HEALTH,Deaf-Blind Disorders,"Deaf Mutism Blind Disorders|Deaf-Blindness Disorder|Deaf-Mutism-Blind Disorder|Deaf-Blindness Disorders|Deafness-Blindness, Prelingual|Deaf-Mutism-Blind Disorders|Blind-Deaf Disorders|Prelingual Deaf-Blind Disorders|Disorder, Deaf-Mutism-Blind|Prelingual Deafness-Blindnesses|Deaf-Blind Disorders, Prelingual|Disorder, Blind-Deaf|Disorders, Blind-Deaf|Deaf-Blind Disorder|Blindness Deafness|Disorder, Deaf-Blind|Prelingual Deafness-Blindness|Prelingual Deaf Blind Disorders|Vision and Hearing Loss|disorder disorder|Deaf-Blind Syndrome|Deaf-Blind Syndromes|Deaf Blind Syndromes|Blind Deaf Disorders|Disorders, Prelingual Deaf-Blind|Deafness-Blindness|Deaf-Blind Disorder, Prelingual|Deaf Blind Disorders|Prelingual Deaf-Blind Disorder|Disorders, Deaf-Blindness|Syndromes, Deaf-Blind|Deaf Blindness Disorders|Disorders, Deaf-Blind|Blind-Deaf Disorder|Disorders, Deaf-Mutism-Blind|Prelingual Deafness Blindness|Deafness Blindness|Hearing and Vision Loss|Syndrome, Deaf-Blind|Deafness-Blindnesses, Prelingual|Blindness-Deafness|Disorder, Deaf-Blindness|Disorder, Prelingual Deaf-Blind"
D015035,CHEMICAL,Zinc Oxide-Eugenol Cement,"Oxide-Eugenol Cement, Zinc|Caryosan|Zinc Oxide Eugenol Cement|Cement, Zinc Oxide-Eugenol|eugenol"
NEW02108,DISEASE,mume floral scent,mume floral scent
C046412,CHEMICAL,benzyl acetate [Supplementary Concept],Benzyl acetate|Benzyl Compounds
NEW02109,CHEMICAL,heavy alcohol intake,heavy alcohol intake
NEW02110,DISEASE,Systemic diseases,Systemic diseases
D054144,DISEASE,"Heart Failure, Diastolic","Heart Failure, Preserved Ejection Fraction|heart failure|Heart Failure, Normal Ejection Fraction|Diastolic Heart Failure|Diastolic Heart Failures|Heart failure"
NEW02111,CHEMICAL,low dose clozapine,low dose clozapine
D010259,MENTAL_HEALTH,Paranoid Disorders,"|Psychoses, Paranoid|Paranoia|paranoia|Disorder, Paranoid|Paranoid Psychoses|Disorders, Paranoid|Paranoias|Paranoid Disorder"
D001960,CHEMICAL,Bromazepam,"Bromazepam Ratiopharm|Durazanil|Lexotanil|Lexatin|Gen Bromazepam|Gen-Bromazepam|Beta, Bromazepam|Von Ct, Bromazep|Bromazepam Beta|Anxyrex|Ro 53350|Bromazepam Neuraxpharm|Bromazepam-Neuraxpharm|Apo-Bromazepam|Bromazanil|Bromazepam Heumann|Bromazepam AL|BromaLich|Lexotan|Bromaz 1A Pharma|Lexomil|Apo Bromazepam|Bromazep Von Ct|Bromazepam-Ratiopharm|Ro 5-3350|Bromazepam"
NEW02112,CHEBI,dopaminergic agent dose reduction,dopaminergic agent dose reduction
D010262,MENTAL_HEALTH,Paraphilic Disorders,"Sex Deviations|Disorders, Paraphilic|paraphilic disorders|Deviations, Sex|Deviation, Sex|paraphilia|Sex Deviation|Paraphilia|Disorder, Paraphilic|Paraphilias|Paraphilic Disorder|paraphilias"
D020214,DISEASE,Cerebrovascular Trauma,"Vascular Traumas, Brain|Injury, Vascular, Brain|Brain Vascular Injury|Vascular Brain Injuries|Brain Injury, Vascular|Vascular Injury, Brain|Trauma, Cerebrovascular|Injuries, Brain Vascular|Injury, Brain Vascular|Vascular Brain Injury|Vascular Trauma, Brain|Brain Vascular Trauma|vascular injury|Brain Injuries, Vascular"
D044062,CHEMICAL,Prostaglandins I,Prostacyclins|prostaglandins|Prostaglandins|Prostaglandin I
D000081025,CHEMICAL,Sphingosine-1-Phosphate Receptors,"Sphingosine-1-Phosphate Receptor|S1P2 Receptor|G Protein Coupled Receptor H218|Sphingosine 1 Phosphate Receptor|G-Protein Coupled Receptor H218|Sphingosine 1 Phosphate Receptor 3|Sphingosine 1 Phosphate Receptor 4|Sphingosine-1-Phosphate Receptor 3|sphingosine-1-phosphate|Sphingosine 1 Phosphate Receptor 2|Sphingosine-1-Phosphate Receptor 1|S1P1 Receptor|EDG5 Protein|S1P3 Receptor|Nrg-1 Receptor|S1P5 Receptor|Sphingosine-1-Phosphate Receptor 5|H218 Protein|AGR16 Protein|S1P|Edg-5 Receptor|Edg 5 Receptor|Receptor, Sphingosine-1-Phosphate|Sphingosine-1-Phosphate Receptor 4|sphingosine-1-phosphate receptors|Edg Receptors|Sphingosine 1-phosphate|Sphingosine-1-Phosphate Receptor 2|Sphingosine 1-Phosphate Receptor|Nrg 1 Receptor|Sphingosine 1 Phosphate Receptor 5|Sphingosine 1 Phosphate Receptor 1|Sphingosine 1 Phosphate Receptors|S1P Receptor|S1P d18:1|S1P4 Receptor"
NEW02113,CHEMICAL,gamma-Hydroxybutyrate sodium oxybate,gamma-Hydroxybutyrate sodium oxybate
D012131,MENTAL_HEALTH,Respiratory Insufficiency,"acute respiratory failure||Ventilatory Depression|Respiratory Depression|Depressions, Ventilatory|respiratory insufficiency|Hypoxemic Respiratory Failure|respiratory failure|Hypercapnic Respiratory Failures|Respiratory Failure, Hypoxemic|Hypercapnic Respiratory Failure|Failure, Respiratory|Failure, Hypercapnic Respiratory|Respiratory Failure|Hypercapnic Acute Respiratory Failure|Respiratory Failure, Hypercapnic|Respiratory Failures|Hypoxemic Acute Respiratory Failure|Acute Hypercapnic Respiratory Failure|Hypoxemic Respiratory Failures|Failure, Hypoxemic Respiratory|Respiratory depression|Acute Hypoxemic Respiratory Failure|respiratory depression"
C037481,CHEMICAL,4-butyrolactone receptor [Supplementary Concept],"gamma-butyrolactone|Receptors, GABA-A"
NEW02114,DISEASE,overdose treatment approaches,overdose treatment approaches
NEW02115,DISEASE,Psychiatric problems,Psychiatric problems
NEW02116,MENTAL_HEALTH,organic brain syndromes,organic brain syndromes
NEW02117,DISEASE,terminal illness,terminal illness
D016540,CHEMICAL,Smoking Cessation,"Smoking, Stopping|Giving Up Smoking|Smoking, Quitting|Smoking cessation|smoking|Up Smoking, Giving|Cessation, Smoking|Smokings, Giving Up|Smoking Cessations|Stopping Smoking|Smoking, Giving Up|Quitting Smoking"
NEW02118,CHEMICAL,Smoking cessation treatment,Smoking cessation treatment
NEW02119,MENTAL_HEALTH,profound depression,profound depression
NEW02120,CHEMICAL,Nicotine administration,Nicotine administration
NEW02121,DISEASE,sensory-processing deficits,sensory-processing deficits
NEW02122,DISEASE,schizophrenic families,schizophrenic families
C416186,NUTRITION,H-2O antigen [Supplementary Concept],Histocompatibility Antigens Class II|alpha locus
D063992,NUTRITION,"Mitochondrial Trifunctional Protein, alpha Subunit",alpha subunit|Multienzyme Complexes (1994-2013)
NEW02123,CHEMICAL,caffeine users,caffeine users
NEW02124,MENTAL_HEALTH,hunger craving postcessation,hunger craving postcessation
NEW02125,DISEASE,Cannabis use disorder,cocaine use disorder|CUD|Cannabis use disorder
NEW02126,MENTAL_HEALTH,Abuse Screening Test,Abuse Screening Test
NEW02127,CHEMICAL,±,±
NEW02128,CHEMICAL,mean ± interactions,mean ± interactions
NEW02129,CHEMICAL,passive tobacco smoke exposure,passive tobacco smoke exposure
NEW02130,DISEASE,neuromuscular junction degeneration consistent,neuromuscular junction degeneration consistent
NEW02131,DISEASE,cognitive function disorders,cognitive function disorders
D056128,DISEASE,"Obesity, Abdominal","Obesity, Visceral|visceral obesity|Obesities, Abdominal|Central Obesity|Obesities, Visceral|Obesity, Central|Abdominal Obesity|central obesity|Visceral Obesities|Abdominal Obesities|Visceral Obesity|Central Obesities|Obesities, Central"
NEW02132,CHEBI,multiple endocrine disturbances,multiple endocrine disturbances
C068282,CHEMICAL,"N-(2-O-(2-acetamido-1,2,3,5-tetradeoxy-1,5-iminoglucitol-3-yl)lactoyl)alanyl-isoglutamine [Supplementary Concept]",N(2)O|Acetylmuramyl-Alanyl-Isoglutamine/analogs  and  derivatives
NEW02133,DISEASE,alcohol tobacco withdrawal syndrome,alcohol tobacco withdrawal syndrome
NEW02134,CHEMICAL,d nicotine metabolite ratio,d nicotine metabolite ratio
D012907,DISEASE,Smoking,"Behaviors, Smoking|Habits, Smoking|smoking behavior|Smoking Behavior|Behavior, Smoking|Smoking Habit|Smoking Habits|Smoking Behaviors|Habit, Smoking"
NEW02135,CHEMICAL,nicotine metabolism,nicotine metabolism
NEW02136,DISEASE,Schedule DSM-5 Version,Schedule DSM-5 Version
NEW02137,DISEASE,psychiatric conditions,psychiatric conditions
NEW02138,DISEASE,Disorder Associated Disabilities,Disorder Associated Disabilities
NEW02139,CHEMICAL,Alcohol Use Disabilities Interview,Alcohol Use Disabilities Interview
D000067559,MENTAL_HEALTH,Specific Learning Disorder,"Learning Disorder, Specific|Learning Disorders, Specific|Specific Learning Disorders|Disorder, Specific Learning|specific learning disorders"
NEW02140,CHEBI,environmental toxins,environmental toxins
NEW02141,MENTAL_HEALTH,anxiety behavior,anxiety behavior
NEW02142,CHEMICAL,opioid substitution treatment programmes,OSP|opioid substitution treatment programmes
D055098,CHEBI,Endocrine Cells,"Cell, Endocrine|Endocrine|Endocrine Cell|endocrine|Cells, Endocrine"
NEW02143,DISEASE,cannabinoid hyperemesis,cannabinoid hyperemesis
NEW02144,DISEASE,Gastrointestinal complications,Gastrointestinal complications
NEW02145,DISEASE,schizophrenic crises,schizophrenic crises
D009105,DISEASE,Dissociative Identity Disorder,"Disorder, Multiple Personality|Multiple Identity Disorders|Disorder, Multiple Identity|Multiple Personality Disorders|Multiple Personality|Identity Disorder, Dissociative|Multiple Personalities|Personality, Dual|Personalities, Dual|Disorder, Dissociative Identity|Identity Disorder, Multiple|Personality Disorder, Multiple|dissociative|Personality Disorders, Multiple|Personalities, Multiple|Personality, Multiple|Multiple Personality Disorder|Dual Personality|Multiple Identity Disorder"
NEW02146,CHEMICAL,clinical high risk,clinical high risk|CHR
NEW02147,CHEMICAL,cannabis use,cannabis use
NEW02148,CHEMICAL,CHR sample,CHR sample
NEW02149,DISEASE,allergic diseases,allergic diseases
NEW02150,MENTAL_HEALTH,ADHD symptoms,ADHD symptoms
NEW02151,DISEASE,allergic participants,allergic participants
NEW02152,MENTAL_HEALTH,probable ADHD,probable ADHD
D005512,DISEASE,Food Hypersensitivity,"Allergy, Food|Hypersensitivity, Food|Allergies, Food|Food Allergy|Food allergies|Food hypersensitivity|Food Allergies|Hypersensitivities, Food|food allergy|food allergies|Food Hypersensitivities"
D016642,CHEMICAL,Bupropion,"|Bupropion, (+-)-Isomer|Bupropion Hydrochloride|Bupropion Hydrochloride, (+-)-Isomer|Zyntabac|Wellbutrin|Zyban (Bupropion)|Bupropion|Zyban (Anti-Smoking)|Amfebutamone|Quomen|(+-)-1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone|bupropion"
NEW02153,DISEASE,metabolic transformation,metabolic transformation
NEW02154,CHEBI,SSRI drugs,SSRI drugs
C567288,DISEASE,Specific Language Impairment 4 [Supplementary Concept],SLI|Specific Language Impairment|Language Development Disorders|specific language impairment
D000073869,CHEMICAL,Tobacco Smoking,"Smoking, Tobacco|tobacco smoking"
D001942,DISEASE,Breast Feeding,"Breast Fed|Wet Nursing|Breast Feeding, Exclusive|Milk Sharing|Exclusive Breast Feeding|Breastfeeding|Sharing, Milk|breast feeding|Exclusive Breastfeeding|Breastfed|Breastfeeding, Exclusive"
NEW02155,CHEMICAL,Smoking prevalence,Smoking prevalence
NEW02156,DISEASE,comorbid diabetes,comorbid diabetes
NEW02157,MENTAL_HEALTH,serious mental illness,serious mental illness
C000718127,CHEMICAL,COVID-19 breakthrough infections [Supplementary Concept],COVID-19 infection|COVID-19 Vaccines|COVID-19
NEW02158,CHEMICAL,smoking status,smoking status
NEW02159,MENTAL_HEALTH,non-affective psychosis,non-affective psychosis
NEW02160,CHEMICAL,nicotine consumption,nicotine consumption
D017831,DISEASE,"Diagnosis, Dual (Psychiatry)","Dual Psychiatric Diagnosis|Diagnosis, Psychiatric Dual|Diagnosis, Dual Psychiatric|Dual Diagnosis|Psychiatric Diagnosis, Dual|Diagnoses, Dual Psychiatric|Diagnoses, Dual (Psychiatry)|Dual Diagnoses (Psychiatry)|Dual Diagnoses, Psychiatric|Dual Psychiatric Diagnoses|Dual Diagnosis (Psychiatry)|Psychiatric Dual Diagnoses|Psychiatric Dual Diagnosis|psychiatric diagnosis|Dual Diagnoses|Psychiatric Diagnoses, Dual|psychiatric diagnoses|Diagnoses, Dual|Diagnoses, Psychiatric Dual|Diagnosis, Dual|Dual Diagnosis, Psychiatric"
C506324,CHEMICAL,"2R-(n-butyl)-16-methyl-3S,5S,7S,9R,11R,13R,15S,26S, 27R-nonahydroxyoctacosa-16,18,20,22,24-pentaenoic acid, 27-lactone [Supplementary Concept]",Macrolides|TPU
NEW02161,NUTRITION,e.g. gummy bear,e.g. gummy bear
NEW02162,DISEASE,hedonic flavors,hedonic flavors
NEW02163,CHEMICAL,suppressant effects,suppressant effects
NEW02164,CHEMICAL,cannabis rich,cannabis rich
D056829,DISEASE,Hereditary Angioedema Types I and II,"Hereditary Angioedema Type I|Angioedema, Hereditary, Type I|Hereditary Angioedema Type II|Angioedema|Angioedema, Hereditary, Types I and II|HAE|Angioedema, Hereditary, Type II|angioedema|Hereditary Angioedema Type 1|C1 INH|Hereditary angioedema|C1 Esterase Inhibitor, Deficiency Of|C1 esterase inhibitor|Deficiency of C1 Esterase Inhibitor"
D002746,CHEMICAL,Chlorpromazine,"Hydrochloride, Chlorpromazine||Contomin|Chlorpromazine|Aminazine|Chlorazine|Fenactil|Thorazine|Chlorpromazine Hydrochloride|chlorpromazine|Propaphenin|Chlordelazine|Largactil"
C081732,CHEMICAL,iloperidone [Supplementary Concept],Piperidines|Isoxazoles|iloperidone
NEW02165,DISEASE,increased smoking behavior,increased smoking behavior
D012878,DISEASE,Skin Neoplasms,"Neoplasms, Skin|skin cancer|Cancers, Skin|Neoplasm, Skin|skin neoplasms|Skin Neoplasm|Cancer of the Skin|Cancer of Skin|Cancer, Skin|Skin Cancers|Skin Cancer"
NEW02166,DISEASE,tumor size,tumor size
NEW02167,DISEASE,tumor stages,tumor stages
NEW02168,CHEMICAL,aberrant dopamine signaling,aberrant dopamine signaling
NEW02169,CHEMICAL,dopamine system function,dopamine system function
NEW02170,CHEBI,major female sex hormone 17β-estradiol,major female sex hormone 17β-estradiol
D014599,DISEASE,Uterus,"Wombs|Uteri, Fundus|Fundus, Uterine|Womb|Uterus Cornua|Cornua, Uterine|Uterine Fundus|uterus|Uterine Cornua|Fundus Uterus|Fundus Uteri|Uteri"
D005283,CHEMICAL,Fentanyl,|fentanyl|Fentanest|Sublimaze|Duragesic|Phentanyl|Fentanyl|Fentora|Fentanyl Citrate|R-4263|R4263|Transmucosal Oral Fentanyl Citrate|Durogesic|R 4263
NEW02171,DISEASE,AAS abuse,AAS abuse
NEW02172,CHEMICAL,Mu-opioids morphine,Mu-opioids morphine
C572396,CHEMICAL,morphine-6-O-sulfate [Supplementary Concept],morphine-6-O-sulfate|Morphine Derivatives
NEW02173,CHEMICAL,Ketamine treatments,Ketamine treatments
NEW02174,DISEASE,altered pain sensitivity,altered pain sensitivity
NEW02175,CHEBI,narcotic use,narcotic use
NEW02176,DISEASE,neuropsychiatric illness,neuropsychiatric illness
NEW02177,DISEASE,cold pressor pain models,cold pressor pain models
NEW02178,DISEASE,Pain sensitivity,Pain sensitivity
NEW02179,CHEBI,drug liking,drug liking
NEW02180,CHEMICAL,mg oxycodone,mg oxycodone
NEW02181,MENTAL_HEALTH,Anxiety ratings,Anxiety ratings
NEW02182,CHEMICAL,GAD group,GAD group
NEW02183,DISEASE,cell toxicity,cell toxicity
NEW02184,CHEBI,NeuN antigen,NeuN antigen
NEW02185,CHEMICAL,Sodium dimethyldithiocarbamate,Sodium dimethyldithiocarbamate
NEW02186,CHEMICAL,striatal TH staining,striatal TH staining
NEW02187,DISEASE,nigral cell loss,nigral cell loss
NEW02188,DISEASE,persistent motor deficits,persistent motor deficits
D015039,CHEMICAL,Ziram,"Cuman L|Dimethyldithiocarbamate, Zinc|Milbam|Fuklasin|Zinc Dimethyldithiocarbamate|Zerlate|ziram"
NEW02189,DISEASE,selective dopaminergic cell damage,selective dopaminergic cell damage
NEW02190,CHEMICAL,pesticide neurotoxicity,pesticide neurotoxicity
NEW02191,DISEASE,mild cognitive dysfunction,mild cognitive dysfunction
C012864,CHEMICAL,dazomet [Supplementary Concept],dazomet|Thiadiazines
D012436,CHEMICAL,S-Adenosylmethionine,Ademetionine|AdoMet|S-Adenosyl-L-Methionine|S Amet|S Adenosylmethionine Sulfate Tosylate|FO-1561|Samyr|S Adenosyl L Methionine|S-Adenosylmethionine Sulfate Tosylate|FO 1561|FO1561|S Adenosylmethionine|S-adenosylmethionine|S-Adenosylmethionine|SAM-e|Gumbaral
NEW02192,DISEASE,mouse liver microsomes,mouse liver microsomes
NEW02193,CHEMICAL,S-methyl metam,S-methyl metam
C008435,CHEMICAL,methyldithiocarbamate [Supplementary Concept],Thiocarbamates|Metam
NEW02194,MENTAL_HEALTH,known acute poisoning syndromes,known acute poisoning syndromes
NEW02195,DISEASE,depressed red blood cell cholinesterase levels,depressed red blood cell cholinesterase levels
D062025,CHEMICAL,Organophosphate Poisoning,"Organophosphate Poisonings|Poisoning, Organothiophosphate|Organophosphate poisoning|Poisonings, Organothiophosphonate|Poisoning, Organophosphate|poisoning|Organothiophosphate Poisonings|Organothiophosphonate Poisonings|Poisoning, Organothiophosphonate|Organothiophosphonate Poisoning|Organophosphorus Poisoning|Poisonings, Organothiophosphate|Poisonings, Organophosphate|Organothiophosphate Poisoning"
D000071248,CHEBI,Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha,Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 alpha|PGC 1 alpha Protein|PPARGC-1-alpha Protein|PPAR-γ|PPAR|peroxisome proliferator-activated receptor-gamma|PPARGC1a Protein|PPARGC 1 alpha Protein|peroxisome proliferator-activated receptor|PGC-1-alpha Protein|peroxisome proliferator-activated receptor gamma|PPAR gamma
NEW02196,CHEBI,receptor-γ agonists,receptor-γ agonists
NEW02197,DISEASE,Memory impairment,Memory impairment
NEW02198,CHEBI,PPAR-γ antagonist BADGE,PPAR-γ antagonist BADGE
NEW02199,DISEASE,β-amyloid-induced memory dysfunction due,β-amyloid-induced memory dysfunction due
NEW02200,CHEBI,PPAR gamma agonists,PPAR gamma agonists
NEW02201,DISEASE,learning deficits,learning deficits
NEW02202,DISEASE,clozapine-treated patients,clozapine-treated patients
D000077154,CHEMICAL,Rosiglitazone,"rosiglitazone|Avandia|5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate|Rosiglitazone Maleate|BRL-49653|RSG|BRL 49653|Rosiglitazone|BRL49653|4mg/day"
NEW02203,DISEASE,harmaline-induced locomotor,harmaline-induced locomotor
D019986,DISEASE,Persons With Hearing Impairments,"Hearing Impaired Persons|Hearing Impaired Person|Persons, Hearing Impaired|Hard of Hearing Persons|Persons, Deaf|impairments|Person, Hearing Disabled|Person, Deaf|Deaf Persons|Disabled Persons, Hearing|Hearing Disabled Persons|Persons, Hearing Disabled|Hearing Disabled Person|Deaf Person|Person, Hearing Impaired"
C035100,CHEMICAL,nilvadipine [Supplementary Concept],Nifedipine/analogs  and  derivatives|Nilvadipine
D000077333,CHEMICAL,Telmisartan,"telmisartan|Telmisartan|Micardis|BIBR 277|4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|Pritor|BIBR-277"
D016898,CHEMICAL,Interferon-alpha,"|Lymphoblastoid Interferon|Leif D|Interferon alpha-1|alpha Interferon|Interferon alpha 17|Interferon alpha 5|Interferon alpha-5|Interferon alpha J|Interferon, alpha|Interferon alpha 88|IFN-alpha|alpha interferon|Interferon, Lymphoblastoid|Interferon alpha-T|Interferon, Leukocyte|Interferon-alpha|Interferon alpha 7|interferon-alpha|Interferon alpha-17|Interferon alpha-7|Interferon Alfa|Interferon alpha4|Interferon, Lymphoblast|IFN alpha D|LeIF J|IFN-alpha D|Interferon alpha 4|Interferon alpha-4|Interferon alpha-88|Interferon alpha T|Leukocyte Interferon|Lymphoblast Interferon|Interferon α|Interferon alpha-J|LeIF I|Interferon alpha|alpha-Interferon|IFN-alpha5|IFN alpha5|Interferon alpha 1|Interferon alpha5"
NEW02204,DISEASE,depressive- behaviour,depressive- behaviour
NEW02205,CHEMICAL,oral erinaceus supplementation,oral erinaceus supplementation
NEW02206,CHEMICAL,erinaceus supplementation,erinaceus supplementation
NEW02207,DISEASE,depressive-anxious nature,depressive-anxious nature
C000679167,NUTRITION,Hericium erinaceus [Supplementary Concept],Hericium erinaceus|Hericium
C000607528,CHEMICAL,amycenone [Supplementary Concept],amycenone|Plant Extracts
NEW02208,DISEASE,LPS-induced inflammation model,LPS-induced inflammation model
NEW02209,CHEMICAL,H. erinaceus,H. erinaceus
D005106,DISEASE,Exploratory Behavior,"Behavior, Novelty-Seeking|Behavior, Exploratory|Curiosities|Behaviors, Novelty-Seeking|Exploratory Behaviors|Novelty-Seeking Behaviors|Novelty-Seeking Behavior|exploratory behaviors|novelty-seeking|Behaviors, Exploratory|Novelty Seeking Behavior|novelty-seeking behavior|Curiosity"
NEW02210,CHEMICAL,MGS0274 besylate,MGS0274 besylate
NEW02211,CHEBI,mGlu3 receptor agonist MGS0008,mGlu3 receptor agonist MGS0008
NEW02212,CHEMICAL,C-3's substituted carboxy cyclopropyl glycine,C-3's substituted carboxy cyclopropyl glycine
D019072,CHEBI,Antibiotic Prophylaxis,"Premedications, Antibiotic|Antibiotic Premedications|Antibiotic Premedication|Premedication, Antibiotic|antibiotic|Prophylaxis, Antibiotic"
NEW02213,CHEMICAL,d-cycloserine,d-cycloserine
D018492,CHEMICAL,Dopamine Antagonists,"Antagonists, Dopamine|dopamine antagonist|Antagonists, Dopamine Receptor|Dopamine Blocker|Dopaminergic Antagonists|Dopaminergic Antagonist|Dopamine Receptor Antagonists|Antagonist, Dopaminergic|dopamine receptor antagonist|dopamine antagonists|dopamine receptor antagonists|Antagonists, Dopaminergic|Dopamine Receptor Antagonist|Antagonist, Dopamine|Dopamine Antagonist|Antagonist, Dopamine Receptor|Dopamine Blockers|Blockers, Dopamine|Blocker, Dopamine|Receptor Antagonists, Dopamine|dopamine blocker|Receptor Antagonist, Dopamine|Dopamine blockers|dopaminergic antagonists"
D000928,CHEMICAL,Antidepressive Agents,"Agent, Antidepressive||Drug, Antidepressant|Thymoleptic|Antidepressant Drug|antidepressant medication|Thymoanaleptic|antidepressant|Antidepressant medication|Antidepressant Drugs|Antidepressant Medication|Antidepressants|Medication, Antidepressant|Thymoanaleptics|Antidepressant|Thymoleptics|Antidepressive Agent"
NEW02214,DISEASE,tetanic spasms,tetanic spasms
NEW02215,MENTAL_HEALTH,pediatric anxiety disorders,pediatric anxiety disorders
NEW02216,CHEMICAL,selective serotonin norepinephrine reuptake inhibitors,SSNRIs|selective serotonin norepinephrine reuptake inhibitors
NEW02217,CHEMICAL,VPA monotherapy,VPA monotherapy
NEW02218,MENTAL_HEALTH,comorbid generalized anxiety disorder,comorbid generalized anxiety disorder
NEW02219,CHEMICAL,VPA group,VPA group
D018490,CHEBI,Serotonin Agents,"Serotonin Effects||Serotonergic drugs|Effect, Serotoninergic|Effect, Serotonin|Serotonergic Drugs|Serotonergic Agents|Serotoninergic Effect|Serotonergic agents|Serotoninergic Effects|Agents, Serotonin|serotonergic drugs|serotonergic agents|Agents, Serotonergic|Drugs, Serotonin|Serotonin Effect|Drugs, Serotonergic|Effects, Serotoninergic|Effects, Serotonin|Serotonergic antidepressants|Serotonin Drugs"
D000639,CHEMICAL,Amitriptyline,"|Amitriptylin-Neuraxpharm|Apo-Amitriptyline|Tryptanol|Tryptizol|Lentizol|Amitriptylin Beta|Domical|Elavil|Amitriptyline|Amitriptyline Hydrochloride|Anapsique|Apo Amitriptyline|Endep|Amitriptylin RPh|Tryptine|Amitriptylin Neuraxpharm|Laroxyl|Syneudon|Amitrol|Novoprotect|Desitin, Amitriptylin|Amineurin|Damilen|Amitriptylin Desitin|Amitrip|amitriptyline|Sarotex|Saroten|Triptafen|RPh, Amitriptylin|Amitriptyline hydrochloride"
NEW02220,MENTAL_HEALTH,intrusive thoughts,intrusive thoughts
NEW02221,DISEASE,acute PTSD symptoms,acute PTSD symptoms
NEW02222,DISEASE,emotional numbing,emotional numbing
NEW02223,DISEASE,flashbacks,flashbacks
NEW02224,MENTAL_HEALTH,hyperarousal,hyperarousal
NEW02225,DISEASE,numbing symptoms,numbing symptoms
NEW02226,DISEASE,chronic PTSD symptoms,chronic PTSD symptoms
D006167,DISEASE,Guilt,Guilts|guilt
NEW02227,CHEMICAL,serotonin neurotransmission,serotonin neurotransmission
D013629,CHEMICAL,Tamoxifen,"|Novaldex|ICI-46,474|Tamoxifen Citrate|ICI46474|Zitazonium|ICI 47699|Tamoxifen|ICI 46474|ICI-47699|ICI47699|Nolvadex|Tomaxithen|Citrate, Tamoxifen|ICI 46,474|Soltamox|tamoxifen|ICI46,474|ICI-46474"
NEW02228,MENTAL_HEALTH,acute bipolar depression,acute bipolar depression
NEW02229,CHEMICAL,FEWP,FEWP
D011285,CHEMICAL,Pregnenolone Carbonitrile,"PCN|Pregnenolone|Carbonitrile, Pregnenolone|Pregnenolone Carbonitrile, (3 beta)-Isomer|Pregnenolone 16 alpha Carbonitrile|Pregnenolone Carbonitrile, (3 beta,16 beta)-Isomer|16 alpha-Carbonitrile, Pregnenolone|Pregnenolone 16 alpha-Carbonitrile|pregnenolone"
NEW02230,CHEMICAL,lamotrogine,lamotrogine
NEW02231,MENTAL_HEALTH,depression symptom improvement relative,depression symptom improvement relative
NEW02232,DISEASE,Schizotypal disorders,Schizotypal disorders
NEW02233,CHEMICAL,low-dose antipsychotic drugs,low-dose antipsychotic drugs
NEW02234,CHEBI,luteinizing hormone-releasing hormone agonists,luteinizing hormone-releasing hormone agonists
NEW02235,DISEASE,paraphilic patients,paraphilic patients
D048148,CHEMICAL,Casein Kinase Idelta,Casein Kinase I delta|Protein Kinase CK1delta|CK1δ|Casein Kinase 1 delta
NEW02236,MENTAL_HEALTH,familial advanced sleep phase syndrome,familial advanced sleep phase syndrome
NEW02237,CHEBI,Middle-aged carriers,Middle-aged carriers
NEW02238,DISEASE,fragile X-associated tremor/ataxia syndrome,fragile X-associated tremor/ataxia syndrome
C564105,DISEASE,Fragile X Tremor Ataxia Syndrome [Supplementary Concept],fragile X-associated tremor ataxia syndrome|FXTAS|Fragile X Syndrome|Ataxia|Tremor
D005879,MENTAL_HEALTH,Tourette Syndrome,"Gilles de la Tourette's syndrome|Gilles De La Tourette's Syndrome|Tourette syndrome|Tourette's syndrome|Tourette Disease|Combined Multiple Motor and Vocal Tic Disorder|Tourette's Disease|Multiple Motor and Vocal Tic Disorder, Combined|Tourette's Disorder|Tourettes Disease|Tourette Syndrome|Syndrome, Tourette|Combined Vocal and Multiple Motor Tic Disorder|Gilles de la Tourette's Disease|Tourettes Disorder|Gilles de la Tourette Disorder|Gilles de la Tourette Syndrome|Tourette Disorder|Chronic Motor and Vocal Tic Disorder|Tourette's disorder|Tourettes Syndrome|Tic Disorder, Combined Vocal and Multiple Motor|Tourette's Syndrome|GTS"
NEW02239,CHEMICAL,dopamine dysregulation syndrome,dopamine dysregulation syndrome
NEW02240,DISEASE,non-Parkinson's disease patients,non-Parkinson's disease patients
NEW02241,DISEASE,infarct rat brain regions,infarct rat brain regions
NEW02242,CHEMICAL,triphenyltetrazolium chloride staining technique,triphenyltetrazolium chloride staining technique
NEW02243,CHEMICAL,NO signaling pathway,NO signaling pathway
D009461,DISEASE,Neurologic Manifestations,"Neurologic Sign|Neurologic Deficit|Neurologic Symptom|Neurologic Signs|neurologic dysfunction|deficits|Deficit, Focal Neurologic|Deficits, Focal Neurologic|Focal Neurologic Deficit|Neurologic Deficit, Focal|Manifestations, Neurologic|Manifestation, Neurological|Neurologic Finding|Symptom, Neurologic|Manifestations, Neurological|Findings, Neurologic|Neurologic Deficits, Focal|Deficit, Neurologic|Signs, Neurologic|Neurologic Dysfunction|Symptoms, Neurologic|Deficits, Neurologic|Neurological Manifestations|Neurologic Manifestation|Neurologic Dysfunctions|Dysfunctions, Neurologic|Neurologic Deficits|Manifestation, Neurologic|Neurologic Findings|Focal Neurologic Deficits|Finding, Neurologic|Sign, Neurologic|Neurological Manifestation|Neurologic Symptoms|Dysfunction, Neurologic|Neurologic Signs and Symptoms"
D000068677,CHEMICAL,Sildenafil Citrate,"Sildenafil Nitrate|UK 92480-10|NCX 911|Sildenafil|Citrate, Sildenafil|UK 9248010|UK 92,480 10|UK 92480 10|NCX911|1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate|Homosildenafil|Lactate, Sildenafil|NCX-911|Revatio|Nitrate, Sildenafil|Desmethyl Sildenafil|Acetildenafil|Hydroxyhomosildenafil|Sildenafil, Desmethyl|sildenafil citrate|Viagra|UK-92,480-10|Desmethylsildenafil|sildenafil|Sildenafil Lactate"
NEW02244,DISEASE,arterial pulmonary hypertension,arterial pulmonary hypertension
NEW02245,MENTAL_HEALTH,erectile dysfunction due,erectile dysfunction due
NEW02246,CHEMICAL,nitric oxide-system,nitric oxide-system
NEW02247,CHEMICAL,vesicles depletion nitric oxide-system disturbances,vesicles depletion nitric oxide-system disturbances
NEW02248,CHEMICAL,receptors blockade,receptors blockade
NEW02249,CHEMICAL,non-responsive L-arginine responsive,non-responsive L-arginine responsive
NEW02250,DISEASE,nigrostriatal damage,nigrostriatal damage
NEW02251,CHEMICAL,L-arginine responsive,L-arginine responsive
NEW02252,CHEMICAL,L-NAME responsive,L-NAME responsive
NEW02253,CHEMICAL,dopamine disturbances,dopamine disturbances
NEW02254,DISEASE,alleviated vascular occlusion disturbances,alleviated vascular occlusion disturbances
NEW02255,CHEMICAL,eplerenone treatment,eplerenone treatment
D006177,DISEASE,Gynecomastia,"Enlargement, Male Breast|Male Breast Enlargement|gynecomastia|Gynecomastia, Infant|Breast Enlargement, Male|Adolescent Gynecomastia|Infant Gynecomastia|Gynecomastia, Adolescent|Newborn Gynecomastia|Gynecomastia, Newborn"
NEW02256,DISEASE,abnormal vaginal bleeding,abnormal vaginal bleeding
D000077545,CHEMICAL,Eplerenone,"Eplerenone|Eplerenon|Inspra|9,11-Epoxy-7-(methoxycarbonyl)-3-oxo-17-pregn-4-ene-21,17-carbolactone|eplerenone"
NEW02257,DISEASE,renal retention,renal retention
D013148,CHEMICAL,Spironolactone,"Verospiron||Veroshpiron|SC 9420|Spirolactone|Aldactone|Verospirone|SC-9420|spironolactone|Duraspiron|SC9420|Frumikal|Spironolactone|Ct, Spiro Von|Spirolang|Spirono Isis|Espironolactona Mundogen|Spiractin|Spirono-Isis|Spiro Von Ct|Von Ct, Spiro|Spirospare|Spirobeta|Novo Spiroton|Jenaspiron|Flumach|Aquareduct|Practon|Spironone|Aldactone A|Spirogamma|Novo-Spiroton|Espironolactona Alter|NovoSpiroton|Spiro L.U.T."
NEW02258,CHEMICAL,antikaliuretic,antikaliuretic
NEW02259,DISEASE,hypertension control,hypertension control
NEW02260,CHEMICAL,diuretic-based pharmacotherapy,diuretic-based pharmacotherapy
D006947,DISEASE,Hyperkalemia,|hyperkalemia|Hyperpotassemia|Hyperkalemias|Hyperpotassemias
C102018,NUTRITION,fatty-acid amide hydrolase [Supplementary Concept],anandamide|Amidohydrolases|N-arachidonoylethanolamine|fatty acid amide hydrolase|FAAH KO|Fatty-acid amide hydrolase|Fatty acid amide hydrolase|AEA|FAAH
NEW02261,CHEMICAL,carbon dioxide CO2 inhalation,carbon dioxide CO2 inhalation
NEW02262,MENTAL_HEALTH,distinct syndromes,distinct syndromes
C529311,CHEMICAL,CTAP octapeptide [Supplementary Concept],Peptide Fragments|TCA|Somatostatin
NEW02263,MENTAL_HEALTH,chronic anxiety state,chronic anxiety state
NEW02264,CHEMICAL,to monoamine oxidase inhibitor,MAOI|to monoamine oxidase inhibitor
NEW02265,MENTAL_HEALTH,disorder receptor theory,disorder receptor theory
NEW02266,CHEBI,action drug information,action drug information
NEW02267,NUTRITION,lithium intoxication,lithium intoxication
NEW02268,DISEASE,myxedema coma,myxedema coma
NEW02269,DISEASE,cumulative seizure risk,cumulative seizure risk
NEW02270,CHEMICAL,bupropion SR,bupropion SR
NEW02271,CHEMICAL,Second generation antipsychotics,SGAs|Second generation antipsychotics|second generation antipsychotics|second-generation antipsychotics
D051958,CHEMICAL,Nuclear Receptor Coactivator 2,Transcription Intermediary Factor 2|Glucocorticoid Receptor Interacting Protein 1|Steroid Receptor Coactivator-2|Glucocorticoid Receptor-Interacting Protein 1|GR|Steroid Receptor Coactivator 2|Glucocorticoid Receptor|Steroid Receptor Coactivator SRC2|glucocorticoid receptor
NEW02272,DISEASE,gastroesophageal reflux disease symptoms,gastroesophageal reflux disease symptoms
D010434,CHEMICAL,Pepsin A,Pepsin|pepsin|Pepsin 1|Pepsin 3
D020178,DISEASE,"Sleep Disorders, Circadian Rhythm","Shift Work Sleep Disorder|delayed sleep phase syndrome|Sleep Wake Cycle Disorder|Delayed Sleep Phase Syndrome|Nyctohemeral Rhythms, Disturbed|Circadian Rhythm Sleep Disorders|Disturbed Nyctohemeral Rhythm|Nonorganic Sleep Wake Cycle Disorder|Shift-Work Sleep Disorder|sleep phase syndrome|Disturbed Nyctohemeral Rhythms|Nonorganic Sleep Wake Cycle Disorders|Delayed Sleep-Phase Syndrome|Sleep Wake Cycle Disorders|Sleep Wake Schedule Disorder|DSPS|Nyctohemeral Rhythm, Disturbed|Sleep-Wake Schedule Disorder|circadian rhythm sleep disorders|Sleep Wake Disorder, Non 24 Hour|Sleep-Wake Schedule Disorders|Sleep Disorders, Shift-Work|Non 24 Hour Sleep Wake Disorder|Delayed Sleep-Phase Syndromes|Circadian Rhythm Sleep Disorder|Shift-Work Sleep Disorders|Sleep-Wake Cycle Disorders|Sleep Disorder, Shift Work|shift-work sleep disorders|Advanced Sleep Phase Syndrome|Sleep Disorder, Shift-Work|Sleep-Wake Cycle Disorder|Non-24 Hour Sleep-Wake Disorder|Sleep Wake Schedule Disorders|CRSD|Sleep-Wake Disorder, Non-24 Hour"
NEW02273,CHEMICAL,irreversible monoamine oxidase inhibitors,MAOIs|irreversible monoamine oxidase inhibitors
C058967,CHEMICAL,genipin 1-gentiobioside [Supplementary Concept],genipin|Iridoids
NEW02274,CHEBI,HIV antigen,HIV antigen
D000077582,CHEMICAL,Amisulpride,LIN 1418|Solian|LIN-1418|amisulpride|DAN 2163|DAN-2163|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Sultopride Hydrochloride|Sultopride|N-(Ethyl-1-pyrrolidinyl- 2-methyl)methoxy-2-ethylsulfonyl-5-benzamide|Barnetil
NEW02275,MENTAL_HEALTH,psychiatric syndromes,psychiatric syndromes
C564108,DISEASE,Major Affective Disorder 2 [Supplementary Concept],"Genetic Diseases, X-Linked|Bipolar Disorder|manic depressive illness|manic-depressive illness"
NEW02276,CHEMICAL,ethanol extraction process,ethanol extraction process
NEW02277,CHEMICAL,rutin agents,rutin agents
NEW02278,CHEBI,pharmaceutical companies,pharmaceutical companies
NEW02279,CHEMICAL,divalproex ER,divalproex ER
NEW02280,CHEMICAL,peak ammonia levels,peak ammonia levels
NEW02281,DISEASE,Ureaplasma colonization,Ureaplasma colonization
NEW02282,DISEASE,autosomal recessive diseases,autosomal recessive diseases
D020163,DISEASE,Ornithine Carbamoyltransferase Deficiency Disease,"Ornithine Transcarbamylase Deficiencies|Ornithine Transcarbamylase Deficiency, Hyperammonemia Due To|OTC Deficiencies|Deficiency, OTC|Ornithine Transcarbamylase Deficiency Disease|ornithine transcarbamylase deficiency|ornithine transcarbamylase|Deficiency Disease, Ornithine Carbamoyltransferase|Ornithine Transcarbamylase Deficiency|Ornithine Carbamoyltransferase Deficiency|Deficiency, Ornithine Transcarbamylase|Ornithine transcarbamylase deficiency|OTC Deficiency|Deficiencies, Ornithine Transcarbamylase|Deficiencies, OTC|Deficiency Disease, Ornithine Transcarbamylase"
NEW02283,CHEMICAL,Ammonia metabolism,Ammonia metabolism
NEW02284,CHEMICAL,acquired urea cycle dysfunction,acquired urea cycle dysfunction
NEW02285,DISEASE,adult-onset NCH,adult-onset NCH
C011941,CHEMICAL,nabilone [Supplementary Concept],Nabilone|nabilone|Dronabinol/analogs  and  derivatives
NEW02286,DISEASE,severe gastrointestinal toxicity,severe gastrointestinal toxicity
NEW02287,CHEMICAL,difficult therapeutic area-those patients,difficult therapeutic area-those patients
NEW02288,CHEBI,long-acting beta-adrenergic blocker,long-acting beta-adrenergic blocker
NEW02289,MENTAL_HEALTH,persistent anxiety,persistent anxiety
D015784,CHEMICAL,Betaxolol,"Betoptic|Betaxolol|Betaxolol Hydrochloride|SL-75212|ALO140102|SL 75212|Betaxolol Alcon|Alcon, Betaxolol|ALO 1401 02|Oxodal|Betoptima|ALO-1401-02|Hydrochloride, Betaxolol|Kerlon|SL75212|Kerlone"
NEW02290,CHEMICAL,smoking inactivity,smoking inactivity
NEW02291,DISEASE,psychotic naive patients,psychotic naive patients
D006943,DISEASE,Hyperglycemia,"Postprandial Hyperglycemia|hyperglycemia||Hyperglycemias|Hyperglycemias, Postprandial|Hyperglycemia, Postprandial|Postprandial Hyperglycemias"
NEW02292,CHEBI,dopamine agonist use,dopamine agonist use
NEW02293,CHEMICAL,n-3 polyunsaturated fatty acids,n-3 polyunsaturated fatty acids|n-3 PUFAs
NEW02294,CHEMICAL,Second-line choices,Second-line choices
D008454,CHEMICAL,Mazindol,Teronac||Diestet|AN-448|AN448|mazindol|Teronak|Mazindole|Sanjorex|Sanorex|Solucaps|Mazanor
NEW02295,CHEMICAL,selective serotonin reuptake inibitors,selective serotonin reuptake inibitors
D015259,CHEBI,Dopamine Agents,"Drugs, Dopamine|Dopamine Effect|Dopaminergic Effect|Agents, Dopamine|Dopamine Effects|Effect, Dopaminergic|Effects, Dopamine|dopamine drugs|Effect, Dopamine|Dopamine Drugs|Dopaminergic Agents|dopamine agents|Dopaminergic Drugs|Dopaminergic Effects|Drugs, Dopaminergic|Dopaminergic agents|Effects, Dopaminergic|dopaminergic agents|Agents, Dopaminergic"
NEW02296,DISEASE,postural abnormalities,postural abnormalities
NEW02297,CHEBI,multiple serotonergic agents,multiple serotonergic agents
NEW02298,CHEMICAL,COVID-19 patients,COVID-19 patients
NEW02299,MENTAL_HEALTH,fear-related anxiety disorders,fear-related anxiety disorders
NEW02300,MENTAL_HEALTH,#NAME?,-depression-related insomnia
NEW02301,DISEASE,disorders indication,disorders indication
NEW02302,DISEASE,hypersomnia due sleep apnea,hypersomnia due sleep apnea
NEW02303,DISEASE,parasomnia related,parasomnia related
D020184,DISEASE,Night Terrors,"Terror, Primary Night|Terrors, Primary Night|Adult Pavor Nocturnus|Terrors, Adult Night|Pavor Nocturnus, Childhood|Sleep Terrors|Secondary Night Terror|night terrors|Terrors, Sleep|Terrors, Childhood Night|Terror, Sleep|Childhood Night Terrors|Pavor Nocturnus|Terror, Childhood Night|Sleep Terror Disorder|Night Terrors, Secondary|Primary Night Terrors|Terror, Secondary Night|pavor nocturnus|Night Terror, Adult|Adult Night Terrors|Terrors, Secondary Night|Primary Night Terror|Sleep Terror|Night Terror, Primary|Secondary Night Terrors|Night Terrors, Childhood|Night Terror, Secondary|Childhood Pavor Nocturnus|Night Terrors, Primary|Night Terrors, Adult|Nocturnus, Childhood Pavor|Childhood Night Terror|Nocturnus, Adult Pavor|Terror, Adult Night|Adult Night Terror|Night Terror, Childhood|Pavor Nocturnus, Adult"
D005356,DISEASE,Fibromyalgia,"Syndrome, Fibromyalgia-Fibromyositis|Muscular Rheumatism|Fibromyalgia-Fibromyositis Syndromes|Fibrositis|Syndrome, Fibromyositis-Fibromyalgia|Fibromyositis-Fibromyalgia Syndromes|Fibromyalgia Fibromyositis Syndrome|Diffuse Myofascial Pain Syndrome|Fibromyalgias|Rheumatism, Muscular|Fibrositides|Secondary Fibromyalgias|Fibromyalgia, Secondary|Fibromyalgia, Primary|Fibromyositis-Fibromyalgia Syndrome|Myofascial Pain Syndrome, Diffuse|Primary Fibromyalgias|Syndromes, Fibromyositis-Fibromyalgia|Fibromyalgia-Fibromyositis Syndrome|Secondary Fibromyalgia|Syndromes, Fibromyalgia-Fibromyositis|Fibromyalgias, Primary|Fibromyositis Fibromyalgia Syndrome|Fibromyalgias, Secondary|fibromyalgia|Primary Fibromyalgia"
NEW02304,CHEMICAL,serotoninergic antidepressants,serotoninergic antidepressants
D005907,CHEMICAL,Gliclazide,gliclazide|S852|S1702|Glyade|S-1702|S 852|Diaglyk|Diamicron|Novo Gliclazide|Gen Gliclazide|S-852|Gliklazid|Novo-Gliclazide|Diabrezide|Diaikron|S 1702|Gen-Gliclazide|Glyclazide
NEW02305,DISEASE,hyperglycaemia,hyperglycaemia
NEW02306,DISEASE,hypoglycaemic seizures,hypoglycaemic seizures
NEW02307,CHEBI,human antimicrobial peptide,human antimicrobial peptide
D041981,DISEASE,Gastrointestinal Tract,GI Tracts|Gastrointestinal Tracts|Digestive Tract|gastrointestinal tract|Digestive Tracts|GI Tract
D059545,MENTAL_HEALTH,"Paraneoplastic Syndromes, Ocular","Syndrome, Ocular Paraneoplastic|Cancer-Associated Retinopathy|Ocular Paraneoplastic Disease|Ocular Paraneoplastic Diseases|Paraneoplastic Melanocytic Proliferation|Syndromes, Ocular Paraneoplastic|Ocular Paraneoplastic Syndromes|Retinopathies, Cancer-Associated|Syndromes|Melanocytic Proliferations, Paraneoplastic|Paraneoplastic Syndrome, Ocular|Retinopathy, Cancer-Associated|Paraneoplastic Melanocytic Proliferations|Melanoma-Associated Retinopathy|Retinopathies, Melanoma-Associated|Paraneoplastic Disease, Ocular|Retinopathy, Melanoma-Associated|Cancer Associated Retinopathy|Bilateral Diffuse Uveal Melanocytic Proliferation, Paraneoplastic|Paraneoplastic Diseases, Ocular|Melanoma-Associated Retinopathies|syndromes|paraneoplastic|Melanoma Associated Retinopathy|Melanocytic Proliferation, Paraneoplastic|Ocular Paraneoplastic Syndrome|Diseases, Ocular Paraneoplastic|Cancer-Associated Retinopathies|Disease, Ocular Paraneoplastic"
NEW02308,MENTAL_HEALTH,battle fatigue,battle fatigue
D009449,MENTAL_HEALTH,Neurocirculatory Asthenia,"asthenia|Heart Syndrome, Hyperkinetic|Neurosis, Cardiac|Cardiac Phobia|neurocirculatory asthenia|Effort Syndrome|cardiac neurosis|Asthenia, Neurocirculatory|Neurocirculatory Asthenias|Hyperkinetic Syndrome|Syndrome, Hyperkinetic Heart|Hyperkinetic Heart Syndrome|Phobia, Cardiac|Cardiac Neurosis|Cardiac Neuroses|Syndrome, Effort"
D003130,DISEASE,Combat Disorders,"Shocks, Shell|Stress Disorders, Combat|Neurosis, War|Disorder, Combat|Neuroses, War|Neuroses, Combat|neurosis|Shell Shocks|Combat Neuroses|Disorders, Combat Stress|Shell Shock|War Neurosis|Stress Disorder, Combat|Combat Neurosis|Disorders, Combat|Disorder, Combat Stress|Shock, Shell|Combat Stress Disorders|shell shock|Combat Disorder|Combat Stress Disorder|Neurosis, Combat|War Neuroses"
C531763,DISEASE,Irritable heart [Supplementary Concept],irritable heart|Orthostatic Intolerance
NEW02309,CHEMICAL,Da Costa,Da Costa
NEW02310,DISEASE,related hearing loss,related hearing loss
D055954,DISEASE,Corneal Endothelial Cell Loss,"Corneal Endothelial Cell Damage|Endothelial Cell Loss, Corneal|loss|cell loss"
NEW02311,MENTAL_HEALTH,drug-related psychosis,drug-related psychosis
NEW02312,CHEMICAL,amphetamine users,amphetamine users
NEW02313,MENTAL_HEALTH,narcolepsy Human Leukocyte Antigen HLA risk allele,narcolepsy Human Leukocyte Antigen HLA risk allele
NEW02314,CHEMICAL,antiseizure medications,antiseizure medications
NEW02315,DISEASE,obstructive sleep apnea/hypopnea syndrome,OSAS|obstructive sleep apnea/hypopnea syndrome
NEW02316,CHEMICAL,iron-dopamine hypothesis,iron-dopamine hypothesis
NEW02317,CHEBI,toxin injections,toxin injections
D010868,CHEMICAL,Pimozide,Orap|Orap forte|R6238|R-6238|pimozide|Antalon
D020111,CHEMICAL,Chlorodiphenyl (54% Chlorine),Aroclor 1254|chlorine|Chlorine|Aroclor-1254|Cl(-
NEW02318,CHEMICAL,inhibitory transmitter GABA,inhibitory transmitter GABA
NEW02319,DISEASE,infantile autistic syndrome,infantile autistic syndrome
NEW02320,DISEASE,Repetitive behaviors,Repetitive behaviors
NEW02321,CHEMICAL,selective serotonin-receptive inhibitor fluvoxamine,selective serotonin-receptive inhibitor fluvoxamine
NEW02322,DISEASE,repetitive behaviors,repetitive behaviors
NEW02323,CHEMICAL,liquid fluoxetine,liquid fluoxetine
NEW02324,CHEMICAL,Low-dose liquid fluoxetine,Low-dose liquid fluoxetine
NEW02325,MENTAL_HEALTH,CY-BOCS compulsion scale,CY-BOCS compulsion scale
NEW02326,CHEMICAL,Liquid fluoxetine,Liquid fluoxetine
NEW02327,MENTAL_HEALTH,childhood autism,childhood autism
NEW02328,DISEASE,REM sleep abnormalities,REM sleep abnormalities
NEW02329,CHEBI,cholinomimetic agents,cholinomimetic agents
NEW02330,MENTAL_HEALTH,melancholic depression,melancholic depression
NEW02331,CHEMICAL,LC n-3 PUFAs,LC n-3 PUFAs
NEW02332,DISEASE,aggressive behaviours,aggressive behaviours
NEW02333,CHEMICAL,LC n-6,LC n-6
NEW02334,DISEASE,psychiatric samples,psychiatric samples
D006791,DISEASE,Hostility,hostility|Hostilities
NEW02335,CHEMICAL,serotonin system,serotonin system
NEW02336,DISEASE,Psychotic symptoms,Psychotic symptoms
NEW02337,CHEMICAL,clozapine group,clozapine group
NEW02338,DISEASE,hereditary catalepsy,hereditary catalepsy
NEW02339,DISEASE,learning deficit,learning deficit
D007050,CHEMICAL,Ibogaine,NIH-10567|Endabuse|12 Methoxyibogamine|Ibogaine|NIH 10567|ibogaine|12-Methoxyibogamine|NIH10567
NEW02340,CHEMICAL,occurring psychoactive indole alkaloid,occurring psychoactive indole alkaloid
D003637,CHEMICAL,DEAE-Dextran,"Pulsar|Sephadex, DEAE|DEAE-Dextran|Diethylaminoethyldextran|DEAE Sephadex|DEAE Dextran"
NEW02341,CHEMICAL,OECD-407,OECD-407
NEW02342,DISEASE,dose day oral toxicity,dose day oral toxicity
NEW02343,DISEASE,sub-acute toxicity,sub-acute toxicity
NEW02344,CHEMICAL,used antidepressant drugs,used antidepressant drugs
D065104,CHEBI,Cystine Depleting Agents,"agents|Disulfide Reducers, Cystine|Cystine Disulfide Reducing Agents|Cystine Disulfide Reducers|Agents, Cystine Depleting|Reducers, Cystine Disulfide|Depleting Agents, Cystine"
NEW02345,CHEBI,sexual hormones,sexual hormones
NEW02346,CHEBI,antimuscarinic drug,antimuscarinic drug
NEW02347,DISEASE,Etiopathogenic hypothesis,Etiopathogenic hypothesis
NEW02348,DISEASE,hydroxychloroquine lethal illness,hydroxychloroquine lethal illness
NEW02349,CHEMICAL,glucocorticosteroids,glucocorticosteroids
D016207,CHEMICAL,Cytokines,Cytokine|cytokines|Cytokines
NEW02350,DISEASE,antiphospholipide,antiphospholipide
NEW02351,CHEMICAL,NMDAR-enhancing agents,NMDAR-enhancing agents
NEW02352,CHEBI,drug free/ drug naïve patients,drug free/ drug naïve patients
NEW02353,CHEBI,mGluR₂/₃ antagonists,mGluR₂/₃ antagonists
NEW02354,DISEASE,disease pneumonia,disease pneumonia
NEW02355,DISEASE,acute hypoxic respiratory failure secondary,acute hypoxic respiratory failure secondary
NEW02356,DISEASE,nonsuppressed BPE,nonsuppressed BPE
C086501,CHEMICAL,N-acetylcysteine lysinate [Supplementary Concept],N-acetylcysteine|n-acetylcysteine|Acetylcysteine/analogs  and  derivatives|NAC|Lysine/analogs  and  derivatives
NEW02357,DISEASE,BPE suppression,BPE suppression
NEW02358,DISEASE,HR-positive cohort,HR-positive cohort
D052656,NUTRITION,Ictalurivirus,"Viruses, Channel Catfish|Catfish|channel catfish|Ictalurid herpesvirus 1|Channel Catfish Virus|Virus, Channel Catfish|channel catfish virus|Channel Catfish Viruses|Ictaluriviruses"
D000904,CHEBI,"Antibiotics, Antitubercular",antibiotics|Antibiotics|Antitubercular Antibiotics
NEW02359,DISEASE,depressed HLP-1 levels,depressed HLP-1 levels
NEW02360,NUTRITION,channel catfish skin,channel catfish skin
NEW02361,CHEMICAL,ammonia group,ammonia group
NEW02362,CHEMICAL,bilirubin plasma concentrations,bilirubin plasma concentrations
D011566,DISEASE,Psychiatric Aides,"Ward Attendants, Psychiatric|Hospital Orderlies, Psychiatric|Hospital Orderly, Psychiatric|Aide, Psychiatric|Psychiatric Ward Attendants|Psychiatric Hospital Orderlies|Psychiatric Hospital Orderly|Psychiatric Hospital|Orderlies, Psychiatric Hospital|Ward Attendant, Psychiatric|Orderly, Psychiatric Hospital|Attendants, Psychiatric Ward|Psychiatric Ward|Psychiatric Aide|Psychiatric Ward Attendant|psychiatric hospital|Aides, Psychiatric|Attendant, Psychiatric Ward"
D051556,DISEASE,"Hyperbilirubinemia, Neonatal","Neonatal Indirect Hyperbilirubinemia|Indirect Hyperbilirubinemia, Neonatal|Direct Hyperbilirubinemia, Neonatal|During Infancies, Hyperbilirubinemia|Infancy, Hyperbilirubinemia During|Hyperbilirubinemia, Neonatal Indirect|Neonatal Hyperbilirubinemia|Neonatal Direct Hyperbilirubinemia|hyperbilirubinemia|Hyperbilirubinemia During Infancy|Hyperbilirubinemia, Neonatal Direct|neonatal hyperbilirubinemia"
NEW02363,MENTAL_HEALTH,schizophrenic psychosis,schizophrenic psychosis
NEW02364,CHEMICAL,chronic estradiol,chronic estradiol
NEW02365,CHEMICAL,sub-chronic PCP-induced cognitive deficits,sub-chronic PCP-induced cognitive deficits
NEW02366,DISEASE,PCP treatment,PCP treatment
NEW02367,NUTRITION,essential fatty acid,essential fatty acid
NEW02368,DISEASE,ALS pathogenesis,ALS pathogenesis
C508230,CHEMICAL,soy isoflavone aglycone [Supplementary Concept],Isoflavones|soy isoflavone|beta-Glucans
D020925,DISEASE,"Hypoxia-Ischemia, Brain","Hypoxia-Ischemia, Cerebral|Cerebral Anoxia-Ischemia|Anoxia-Ischemias, Cerebral|Cerebral Hypoxia-Ischemias|Anoxia-Ischemia, Brain|Ischemic-Hypoxic Encephalopathies|Encephalopathy, Hypoxic Ischemic|Brain Hypoxia Ischemia|Ischemia-Hypoxias, Cerebral|Hypoxic Ischemic Encephalopathy|Ischemia Anoxia, Brain|Cerebral Ischemia-Anoxias|Hypoxia-Ischemias, Brain|Hypoxia-Ischemias, Cerebral|Anoxia-Ischemia, Cerebral|Ischemia-Hypoxia, Brain|Brain Hypoxia-Ischemia|Ischemia-Anoxias, Cerebral|cerebral ischemia|Brain Anoxia-Ischemia|Ischemia Anoxia, Cerebral|Hypoxia Ischemia, Brain|Ischemia-Anoxia, Brain|Brain Ischemia-Anoxias|Cerebral Ischemia-Anoxia|Brain Ischemia-Anoxia|Cerebral Anoxia Ischemia|Encephalopathies, Anoxic-Ischemic|Encephalopathy, Hypoxic-Ischemic|Anoxia Ischemia, Brain|Brain Anoxia Ischemia|Ischemia-Anoxias, Brain|Brain Ischemia-Hypoxias|Cerebral Hypoxia Ischemia|Anoxic-Ischemic Encephalopathies|Encephalopathies, Hypoxic-Ischemic|Hypoxia Ischemia, Cerebral|Encephalopathy, Anoxic-Ischemic|Encephalopathy, Ischemic-Hypoxic|Ischemia-Anoxia, Cerebral|Cerebral Ischemia Hypoxia|Ischemia Hypoxia, Brain|Brain Ischemia-Hypoxia|Cerebral ischemia|Hypoxic-Ischemic Encephalopathies|Cerebral Ischemia-Hypoxia|Brain Ischemia Anoxia|Anoxia Ischemia, Cerebral|Cerebral Anoxia-Ischemias|stroke|Ischemic-Hypoxic Encephalopathy|Anoxic Ischemic Encephalopathy|Hypoxic-Ischemic Encephalopathy|Ischemia-Hypoxia, Cerebral|Brain Hypoxia-Ischemias|Anoxic-Ischemic Encephalopathy|Ischemic Hypoxic Encephalopathy|Cerebral Hypoxia-Ischemia|Brain Anoxia-Ischemias|Brain Ischemia Hypoxia|Cerebral Ischemia Anoxia|Encephalopathy, Anoxic Ischemic|Encephalopathies, Ischemic-Hypoxic|Cerebral Ischemia-Hypoxias|Ischemia Hypoxia, Cerebral|anoxia|Ischemia-Hypoxias, Brain|Anoxia-Ischemias, Brain"
D019833,CHEMICAL,Genistein,genistein|Genistein|Genestein|GEN
NEW02369,CHEMICAL,phytoestrogen genistein,phytoestrogen genistein|GEN
NEW02370,DISEASE,short-term hypogonadism,short-term hypogonadism
NEW02371,DISEASE,long-term hypogonadism,long-term hypogonadism
NEW02372,DISEASE,tissue loss,tissue loss
NEW02373,CHEMICAL,Excessive salt intake,Excessive salt intake
NEW02374,DISEASE,hypertension rats,hypertension rats
D000073296,DISEASE,Noncommunicable Diseases,"Non communicable Diseases|Non-infectious Disease|Non-communicable Diseases|Non infectious Diseases|Non-communicable Chronic Diseases|Chronic Disease, Non-communicable|Disease, Non-communicable|Noninfectious Diseases|Non communicable Chronic Diseases|Noninfectious Disease|chronic diseases|Non-infectious Diseases|Non-communicable Chronic Disease|Noncommunicable Disease|Non-communicable Disease"
NEW02375,CHEMICAL,typical increased sodium preference,typical increased sodium preference
NEW02376,CHEMICAL,Estradiol treatment,Estradiol treatment
NEW02377,MENTAL_HEALTH,trauma resistance,trauma resistance
NEW02378,DISEASE,body weight gain,body weight gain
NEW02379,CHEBI,peripheral sex hormones,peripheral sex hormones
NEW02380,CHEMICAL,Serotonin 1A receptors,Serotonin 1A receptors
NEW02381,DISEASE,various neuropsychiatric disorders,various neuropsychiatric disorders
D005070,CHEMICAL,Evans Blue,"Evans blue|Blue, Azovan|Azovan Blue|Blue, Evans|C.I. 23860|Evan Blue|EB|Blue, Evan's|Evan's Blue|C.I. Direct Blue 53"
NEW02382,CHEMICAL,Decreased serotonin function,Decreased serotonin function
C504569,NUTRITION,"tph2 protein, rat [Supplementary Concept]",TpH2|tryptophan hydroxylase-2|TPH2|Tryptophan Hydroxylase
NEW02383,DISEASE,cognitive behaviors,cognitive behaviors
NEW02384,CHEBI,potent circulating estrogen,potent circulating estrogen
NEW02385,CHEMICAL,oral hormonal contraceptives,oral hormonal contraceptives
NEW02386,CHEBI,psychiatric adverse drug reactions,psychiatric adverse drug reactions
NEW02387,DISEASE,hepatic deficiency,hepatic deficiency
NEW02388,DISEASE,common human porphyria due,common human porphyria due
NEW02389,CHEBI,new agents,new agents
NEW02390,DISEASE,HCV infection,HCV infection
NEW02391,CHEMICAL,low IGF1,low IGF1
NEW02392,DISEASE,brain masculinization due,brain masculinization due
D013034,CHEMICAL,Sparteine,"beta-Isosparteine|Genisteine Alkaloid|Sparteine, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer|Sparteine, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer|Sparteine Sulfate (1:1), (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer|Sparteine, (7S-(7alpha,7abeta,14alpha,14abeta))-Isomer|Sparteine, (+)-Isomer|Sparteine, (-)-Isomer|Sparteine Sulfate Anhydrous|Sparteine, (7R-(7alpha,7abeta,14alpha,14abeta))-Isomer|Sparteine Sulfate|alpha Isosparteine|Pachycarpine|Anhydrous, Sparteine Sulfate|Sparteine Hydroiodide, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer|Sparteine Hydrochloride, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer|D-sparteine|beta Isosparteine|Pachycarpine Sulfate (1:1), Pentahydrate, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer|Sparteine Hydrochloride, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer|Sparteine Monohydroiodide, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer|Sulfate Anhydrous, Sparteine|Sparteine Sulfate (1:1), (7S-(7alpha,7aalpha,14alpha,14aalpha))-Isomer|L-Sparteine|Sparteine Monohydrochloride, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer|Sparteine, (7S-(7alpha,7aalpha,14alpha,14aalpha))-Isomer|alpha-Isosparteine|Depasan Retard|7α-"
NEW02393,CHEMICAL,C19 Δ5 steroids,C19 Δ5 steroids
NEW02394,CHEMICAL,free isopregnanolone,free isopregnanolone
NEW02395,CHEMICAL,5α/β-reduced pregnane steroids,5α/β-reduced pregnane steroids
NEW02396,CHEMICAL,HSD17B3 genes,HSD17B3 genes
D046468,DISEASE,Sexual Development,"Sex Development|46,XY DSD|Development, Sex|Development, Sexual|sexual development"
NEW02397,DISEASE,low T production,low T production
C562567,DISEASE,Leydig Cell Hypoplasia [Supplementary Concept],"Disorder of Sex Development, 46,XY|46,XY disorder|Testis/abnormalities"
D045165,CHEMICAL,Testosterone Congeners,"anabolic steroids|Analogues, Androgen|Androgens, Synthetic|Androgen Analogues|Analogs, Androgen|Steroids, Anabolic|Androgen, Synthetic|Synthetic Androgen|Anabolic Steroids|Androgen Analogs|Testosterone|Steroid, Anabolic|Anabolic Steroid|Synthetic Androgens"
NEW02398,DISEASE,PCOS women,PCOS women
NEW02399,CHEBI,androgen excess markers,androgen excess markers
NEW02400,CHEBI,conventional hormone therapy,conventional hormone therapy
NEW02401,CHEBI,exogenous androgen,exogenous androgen
NEW02402,CHEMICAL,prolactin/oxytocin,prolactin/oxytocin
NEW02403,MENTAL_HEALTH,glucocorticoid hyperactivity,glucocorticoid hyperactivity
NEW02404,CHEBI,estrogen receptor ESR1 gene,estrogen receptor ESR1 gene
NEW02405,CHEMICAL,eight-SNP haplotype,eight-SNP haplotype
NEW02406,CHEBI,hormone medication,hormone medication
NEW02407,CHEBI,endocrine anomalies,endocrine anomalies
NEW02408,CHEBI,hormone axis,hormone axis
NEW02409,DISEASE,amenorrhea/oligomenorrhea delayed puberty,amenorrhea/oligomenorrhea delayed puberty
NEW02410,DISEASE,isolated hypogonadotropic hypogonadism,isolated hypogonadotropic hypogonadism
NEW02411,CHEBI,growth hormone axis,growth hormone axis
D004966,CHEBI,"Estrogens, Conjugated (USP)","Conjugated Equine Estrogen|Conjugated Estrogens||Estrogenic Hormones, Conjugated|Oestro Feminal|Estrogen, Conjugated|Estro Feminal|Climarest|Congest|Presomen|Estrogens, Conjugated|Progen|Estrogenic Substances, Conjugated|hormones estrogens|Estrogen, Conjugated Equine|Conjugated Estrogenic Hormones|Conjugated Equine Estrogens|Oestrofeminal|Carentil|Oestro-Feminal|Conjugated Estrogenic Substances|Climopax|Progens|conjugated estrogens|Transannon|Equine Estrogen, Conjugated|Conjugated Estrogen|Equine Estrogens, Conjugated|Prelestrin|Dagynil|Estro-Feminal|Premarin|Femavit"
NEW02412,DISEASE,pain sensitivity,pain sensitivity
NEW02413,DISEASE,female affective behaviors,female affective behaviors
NEW02414,CHEMICAL,estradiol levels,estradiol levels
NEW02415,MENTAL_HEALTH,female depression,female depression
NEW02416,CHEMICAL,saccharin preference test,saccharin preference test
NEW02417,CHEMICAL,anti-inflammatory agent minocycline,anti-inflammatory agent minocycline
NEW02418,CHEMICAL,clozapine refractory schizophrenia,clozapine refractory schizophrenia
NEW02419,CHEMICAL,long-acting risperidone,long-acting risperidone
NEW02420,CHEMICAL,long-acting injectable risperidone,long-acting injectable risperidone
NEW02421,CHEMICAL,Hair cortisol measurement,Hair cortisol measurement
NEW02422,CHEMICAL,hair cortisol,hair cortisol
D001924,DISEASE,Brain Concussion,"Severe Concussion|Concussion, Cerebral|Brain Concussions|Mild Concussion|Concussion, Brain|Cerebral Concussion|Mild Traumatic Brain Injury|Cerebral Concussions|Severe Concussions|Intermediate Concussion|Concussion, Mild|mild traumatic brain injury|Mild Concussions|Concussion, Severe|Intermediate Concussions|Commotio Cerebri|Concussion, Intermediate"
NEW02423,NUTRITION,well-known food additive,well-known food additive
D012970,CHEMICAL,Sodium Glutamate,"Glutamate, Sodium|Monosodium glutamate|Monosodium Glutamate|Vestin|monosodium glutamate|Accent|MSG"
NEW02424,CHEMICAL,Alcohol biomarkers,Alcohol biomarkers
NEW02425,CHEMICAL,Chronic alcohol consumption,Chronic alcohol consumption
NEW02426,DISEASE,cortical bone fractures,cortical bone fractures
D014552,DISEASE,Urinary Tract Infections,"urinary tract infection|Tract Infection, Urinary|Infection, Urinary Tract|Urinary tract infections|Infections, Urinary Tract|Tract Infections, Urinary|Urinary Tract Infection|urinary tract infections"
NEW02427,DISEASE,uropathy fistula,uropathy fistula
NEW02428,DISEASE,hyperammonemic encephalopathy,hyperammonemic encephalopathy
D056807,DISEASE,Argininosuccinic Aciduria,"ASA Deficiencies|Argininosuccinic Acidemia|Argininosuccinicacidurias|Argininosuccinate Lyase Deficiency|Argininosuccinate Acidemias|Deficiencies, Argininosuccinate Lyase|Acidemias, Argininosuccinate|Acidurias, Argininosuccinic|Urea Cycle Disorder, Arginino Succinase Type|Asauria|Arginino Succinase Deficiency|ASA Deficiency|Inborn Error of Urea Synthesis, Arginino Succinic Type|Deficiency, Arginino Succinase|Argininosuccinic aciduria|Argininosuccinic Acid Lyase Deficiency|Aciduria, Argininosuccinic|Deficiency, Argininosuccinate Lyase|Arginosuccinase Deficiency|urea synthesis|Deficiency, ASL|Deficiency, ASA|Arginino Succinase Deficiencies|Deficiencies, ASL|Deficiencies, ASA|Deficiencies, Arginino Succinase|Acidemia, Argininosuccinate|Argininosuccinate Acidemia|ASL Deficiency|Argininosuccinate Lyase Deficiencies|Argininosuccinyl-Coa Lyase Deficiency|Argininosuccinic Acidurias|Argininosuccinicaciduria|Argininosuccinase Deficiency|ASL Deficiencies"
C562342,CHEMICAL,"alanyl-phosphatidylglycerol synthase, Pseudomonas aeruginosa [Supplementary Concept]",PGs|Bacterial Proteins|Aminoacyltransferases
NEW02429,CHEMICAL,marble burying test,MBT|marble burying test
D000066511,CHEMICAL,Intimate Partner Violence,"Intimate Partner Abuse|Dating Violence|Abuse, Intimate Partner|IPV|Partner Violence, Intimate|Intimate partner violence|Violence, Dating|Violence, Intimate Partner|Partner Abuse, Intimate"
C476644,DISEASE,"mutacin III, Streptococcus mutans [Supplementary Concept]",Bacteriocins|S. mutans
NEW02430,DISEASE,caries prevention agents,caries prevention agents
NEW02431,CHEBI,carbapenem antibiotic,carbapenem antibiotic
NEW02432,DISEASE,complicated urinary tract infections,complicated urinary tract infections
NEW02433,DISEASE,complicated intra-abdominal infections,complicated intra-abdominal infections|cIAIs
NEW02434,CHEMICAL,Doripenem monohydrate,Doripenem monohydrate
NEW02435,NUTRITION,Melissa officinalis L.,Melissa officinalis L.
NEW02436,DISEASE,traditional medicine psychiatric conditions,traditional medicine psychiatric conditions
NEW02437,CHEBI,Antimicrobial drugs,Antimicrobial drugs
NEW02438,DISEASE,selective toxicity,selective toxicity
D005892,DISEASE,"Gingivitis, Necrotizing Ulcerative","Vincent's Stomatitis|Acute Membranous Gingivitis|Vincent Infection|Fusospirillosis|Vincent Angina|Phagedenic Gingivitis|Ulcerative Gingivitis|Fusospirillary Gingivitis|Trench Mouth|Stomatitis, Ulcerative|Vincent's Infection|Acute Necrotizing Ulcerative Gingivitis|Vincent's Gingivitis|NUG"
D000890,CHEBI,Anti-Infective Agents,"Anti Infective Agent|Agent, Antimicrobial|Antimicrobial Agents|Agents, Anti-Infective|Agents, Anti-Microbial|Anti-Microbial Agent|Anti Microbial Agent|Anti-Microbial Agents|Agent, Anti-Microbial|Antiinfective Agents|Anti Microbial Agents|Anti Infective Agents|Microbicide|Agent, Anti-Infective|Agents, Antiinfective|Agents, Antimicrobial|antimicrobial agents|antimicrobial agent|Microbicides|Anti-Infective Agent|Antimicrobial Agent"
NEW02439,DISEASE,dopaminergic toxicity,dopaminergic toxicity
NEW02440,MENTAL_HEALTH,L-DOPA-induced dyskinesia,L-DOPA-induced dyskinesia
NEW02441,CHEMICAL,cerebral glutathione deficit,cerebral glutathione deficit
NEW02442,CHEMICAL,low brain glutathione,low brain glutathione
NEW02443,CHEBI,ascorbic acid levels,ascorbic acid levels
NEW02444,CHEMICAL,R)-sulfoximine,BSO|R)-sulfoximine
C536868,DISEASE,"Spastic paraplegia 9, autosomal dominant [Supplementary Concept]","Cataract|Bone and Bones/abnormalities|cataracts|Growth Disorders|Spastic Paraplegia, Hereditary"
D018765,CHEMICAL,Dopamine Uptake Inhibitors,"dopamine uptake|Inhibitors, Dopamine Uptake|Uptake Inhibitors, Dopamine|dopamine uptake inhibitors|Reuptake Inhibitors, Dopamine|Dopamine Reuptake Inhibitors|Inhibitors, Dopamine Reuptake"
NEW02445,DISEASE,long-term cognitive deficits,long-term cognitive deficits
NEW02446,CHEMICAL,brain glutathione synthesis,brain glutathione synthesis
NEW02447,CHEMICAL,low glutathione levels,low glutathione levels
NEW02448,CHEBI,dopamine uptake inhibitor,dopamine uptake inhibitor
NEW02449,DISEASE,neurobehavioral disorders,neurobehavioral disorders
NEW02450,CHEMICAL,FUB181,FUB181
NEW02451,DISEASE,deficit hyperactive disorder,deficit hyperactive disorder
NEW02452,CHEMICAL,GT2016,GT2016
NEW02453,CHEBI,inverse histamine H3 receptor agonist pitolisant,inverse histamine H3 receptor agonist pitolisant
NEW02454,CHEMICAL,α2-adrenoceptor antagonist mirtazapine,α2-adrenoceptor antagonist mirtazapine
NEW02455,DISEASE,constipating,constipating
NEW02456,CHEMICAL,inhibitory α2-adrenoceptors,inhibitory α2-adrenoceptors
NEW02457,CHEMICAL,antihypertensive drug clonidine,antihypertensive drug clonidine
NEW02458,DISEASE,stress-related psychiatric disorders,stress-related psychiatric disorders
NEW02459,CHEBI,Non-competitive N-methyl-d-aspartate receptor antagonists,Non-competitive N-methyl-d-aspartate receptor antagonists
NEW02460,DISEASE,psychotomimetic-like behaviors,psychotomimetic-like behaviors
NEW02461,CHEMICAL,Fra-2 immunoreactivity,Fra-2 immunoreactivity|Fra-2-IR
NEW02462,DISEASE,ATN disinhibition,ATN disinhibition
D020643,DISEASE,Anterior Thalamic Nuclei,"Nucleus, Anteromedial Thalamic|Anterior Nuclear Group|Anteroventral Thalamic Nucleus|Thalamic Nuclei, Anterior|Nucleus, Anteroventral Thalamic|ATN|Nucleus, Anteromedial|Anterior Thalamic Nucleus|Anteroventral Nucleus|anterior thalamic nuclei|Anterodorsal Nucleus|Anteromedial Nucleus|Thalamic Nucleus, Anteromedial|Nucleus, Anterodorsal|Anterior Nucleus of Thalamus|Thalamic Nucleus, Anterodorsal|Anterodorsal Thalamic Nucleus|Nuclei, Anterior Thalamic|Anterior Thalamus|Thalamic Nucleus, Anteroventral|Thalamus, Anterior|Nucleus, Anterodorsal Thalamic|Nucleus, Anteroventral|Anteromedial Thalamic Nucleus|Thalamus Anterior Nucleus"
C567439,DISEASE,Chromosome 15q13.3 Microdeletion Syndrome [Supplementary Concept],"Chromosome Disorders|Intellectual Disability|Seizures|Chromosome Deletion|15q13.3 microdeletion syndrome|Chromosomes, Human, Pair 15"
NEW02463,CHEMICAL,Df[h15q13]/+,Df[h15q13]/+
NEW02464,MENTAL_HEALTH,postpartum anxiety,postpartum anxiety
C515179,CHEMICAL,caryophyllene oxide [Supplementary Concept],β-caryophyllene|Polycyclic Sesquiterpenes
D001927,DISEASE,Brain Diseases,"|encephalopathy|CNS Disorder, Intracranial|Encephalopathy|Central nervous system disorders|central nervous system disorders|Central Nervous System Intracranial Disorders|Brain Disease|Encephalopathies|CNS Disorders, Intracranial|Intracranial CNS Disorder|Encephalon Disease|Brain Disorder|Brain Disorders|Central Nervous System Disorders, Intracranial|Intracranial Central Nervous System Disorders|Intracranial CNS Disorders|Encephalon Diseases"
NEW02465,CHEMICAL,serotonergic systems ATPase activity,serotonergic systems ATPase activity
C051622,CHEMICAL,"9-amino-6-methyl-5,6,6a,7-tetrahydro-4H-benzo-(de)thiazolo(4,5-g)quinoline [Supplementary Concept]",quinoline|Quinolines|Thiazoles|4-PSQ
C499076,CHEMICAL,"ATP1A1 protein, human [Supplementary Concept]",K+ ATPase|Sodium-Potassium-Exchanging ATPase
C000589472,CHEMICAL,gardenin A [Supplementary Concept],Gardenin A|GA|Flavones
NEW02466,DISEASE,pentobarbital-induced sleep test,pentobarbital-induced sleep test
NEW02467,DISEASE,strychnine-induced seizure test,strychnine-induced seizure test
NEW02468,CHEMICAL,intravenous anesthetic propofol,intravenous anesthetic propofol
NEW02469,DISEASE,sexual disinhibition,sexual disinhibition
D032341,CHEMICAL,Withania,"somniferas, Withania|Withania somniferas|Withanias|Withania somnifera"
NEW02470,DISEASE,nervous exhaustion,nervous exhaustion
D000073496,DISEASE,Frailty,Frailty Syndrome|debility|Debilities|Debility|Frailties|Frailness|frailty syndrome
NEW02471,CHEMICAL,PS episodes,PS episodes
NEW02472,CHEBI,GABAA receptor antagonist,GABAA receptor antagonist
NEW02473,DISEASE,episodic memory impairments,episodic memory impairments
NEW02474,DISEASE,plasticity deficits,plasticity deficits
NEW02475,CHEBI,GABAA receptor antagonists,GABAA receptor antagonists
C537723,DISEASE,Lubs X-linked mental retardation syndrome [Supplementary Concept],"MECP2 duplication syndrome|Mental Retardation, X-Linked"
NEW02476,CHEMICAL,morphine-clonidine,morphine-clonidine
NEW02477,DISEASE,cross-sensitivity effect,cross-sensitivity effect
D058666,CHEMICAL,Adrenergic beta-2 Receptor Agonists,"Adrenergic beta-2 Receptor Agonist|Adrenergic beta-2 Agonists|Adrenergic beta 2 Receptor Agonist|Agonists, Adrenergic beta-2|Adrenergic beta2-Agonists|beta2-Agonists, Adrenergic|Adrenergic beta2 Agonists|β2-agonists|Adrenergic beta 2 Agonists|beta-2 Agonists, Adrenergic|Adrenergic beta 2 Receptor Agonists"
D016316,CHEMICAL,Guanfacine,"guanfacine|Guanfacine Hydrochloride|Monohydrochloride, Guanfacine|Guanfacine|Tenex|Guanfacine Monohydrochloride|BS 100 141|BS100141|Estulic|BS-100-141|Hydrochloride, Guanfacine|Lon798"
NEW02478,CHEBI,alpha-2 agonist,alpha-2 agonist
NEW02479,CHEMICAL,dopamine efflux,dopamine efflux
NEW02480,CHEBI,alpha-2A agonists,alpha-2A agonists
NEW02481,CHEBI,its's good analgesic action,its's good analgesic action
NEW02482,DISEASE,traumatic stress symptoms,traumatic stress symptoms
NEW02483,MENTAL_HEALTH,comorbid ADHD symptoms,comorbid ADHD symptoms
NEW02484,CHEMICAL,Extended-release guanfacine hydrochloride,GXR|Extended-release guanfacine hydrochloride
NEW02485,CHEMICAL,serotonergic 5-HT system,serotonergic 5-HT system
C071321,CHEMICAL,flerobuterol [Supplementary Concept],flerobuterol|Albuterol/analogs  and  derivatives
NEW02486,CHEMICAL,5-HT system,5-HT system
D004415,DISEASE,Dyspepsia,Indigestion|dyspepsia|Indigestions|Dyspepsias
NEW02487,DISEASE,abnormal endoscopy,abnormal endoscopy
NEW02488,CHEMICAL,serotonin/noradrenaline reuptake inhibitors,serotonin/noradrenaline reuptake inhibitors
D010433,CHEMICAL,Pentylenetetrazole,|pentylenetetrazol|Corazol|Leptazole|Corazole|Cardiazol|Pentamethylenetetrazole|Pentazol|Metrazole|Pentylenetetrazol|Pentylenetetrazole|pentylenetetrazole|pentylenetetrazol-|Metrazol|Pentetrazole|Korazole|PTZ|Corasol|Korazol
NEW02489,CHEBI,alpha-2-adrenoceptor agonists,alpha-2-adrenoceptor agonists
NEW02490,CHEBI,α₂-adrenoceptor agonists,α₂-adrenoceptor agonists
D058647,NUTRITION,Adrenergic alpha-2 Receptor Agonists,"α2 agonists|Agonists, Adrenergic alpha-2|alpha(2)-agonists|Adrenergic alpha 2 Receptor Agonists|Adrenergic alpha-2 Receptor Agonist|alpha-2 agonists|alpha 2-agonists|Adrenergic alpha 2 Agonists|Adrenergic alpha2 Agonists|alpha2-Agonists, Adrenergic|alpha-2 receptor agonist|Adrenergic alpha2-Agonists|Adrenergic alpha 2 Receptor Agonist|Adrenergic alpha-2 Agonists|alpha-2 Agonists, Adrenergic"
D036361,CHEBI,Peptide Hormones,"Polypeptide Hormones|Peptide hormones|Hormones, Peptide|Peptide Hormone|Polypeptide Hormone|Hormone, Polypeptide|Hormone, Peptide|Hormones, Polypeptide"
NEW02491,CHEBI,5-hydroxytryptamine-2A antagonists,5-hydroxytryptamine-2A antagonists
NEW02492,CHEBI,growth hormone agonists,growth hormone agonists
D006633,CHEBI,Histamine Antagonists,"Antagonists, Histamine|Antagonist, Histamine|histamine antagonists|Antihistamines|Antihistamine|Histamine Antagonist"
NEW02493,CHEBI,ghrelin agonists,ghrelin agonists
NEW02494,CHEBI,beta3-adrenoceptor agonists,beta3-adrenoceptor agonists
NEW02495,CHEBI,corticotropin-releasing factor receptor antagonists,corticotropin-releasing factor receptor antagonists
NEW02496,CHEBI,melanocortin receptor antagonists,melanocortin receptor antagonists
D000068796,CHEBI,Orexin Receptor Antagonists,"dual orexin receptor antagonists|dual orexin receptor antagonist|Dual Orexin Receptor Antagonists|Dual orexin receptor antagonists|Receptor Antagonist, Orexin|Orexin receptor antagonists|orexin receptor antagonists|Orexin Receptor Blockers|orexin receptor antagonist|Orexin Receptor Antagonist|Dual Orexin Receptor Antagonist|Antagonist, Orexin Receptor"
NEW02497,CHEMICAL,gas transfer,gas transfer
D029424,DISEASE,"Pulmonary Disease, Chronic Obstructive","COPD|airway disease|Chronic Airflow Obstructions|obstructive lung disease|chronic obstructive pulmonary diseases|chronic obstructive pulmonary disease|pulmonary disease|Chronic Obstructive Pulmonary Diseases|Chronic Airflow Obstruction|Chronic Obstructive Lung Disease|Chronic Obstructive Pulmonary Disease|Airflow Obstruction, Chronic|Airflow Obstructions, Chronic|COAD|Chronic Obstructive Airway Disease"
NEW02498,CHEBI,multiple endocrine abnormalities,multiple endocrine abnormalities
NEW02499,DISEASE,depots,depots
NEW02500,CHEBI,hormone secretions,hormone secretions
NEW02501,CHEMICAL,elevated cortisol,elevated cortisol
NEW02502,CHEBI,its's endocrine abnormalities,its's endocrine abnormalities
C567328,CHEBI,"Coloboma, Ocular, And Ichthyosis, Brain Malformations, And Endocrine Abnormalities [Supplementary Concept]",endocrine abnormalities|Congenital Disorders of Glycosylation
NEW02503,CHEBI,endocrine perturbations,endocrine perturbations
D000015,DISEASE,"Abnormalities, Multiple",Multiple Abnormalities|multiple abnormalities
NEW02504,DISEASE,Iatrogenic Creutzfeldt-Jakob disease,Iatrogenic Creutzfeldt-Jakob disease
NEW02505,CHEBI,human growth hormones,human growth hormones
NEW02506,DISEASE,insufficient pain sedating effect,insufficient pain sedating effect
NEW02507,CHEMICAL,Azaperon,Azaperon
NEW02508,DISEASE,Alcoholic encephalopathy,Alcoholic encephalopathy
D009536,CHEMICAL,Niacinamide,"B3, Vitamin|niacinamide|Vitamin PP|3 Pyridinecarboxamide|3-Pyridinecarboxamide|Nicotinamide|Nicotinsäureamid Jenapharm|Nicobion|Papulex|Vitamin B 3|Vitamin B3|Enduramide|B 3, Vitamin|Jenapharm, Nicotinsäureamid"
NEW02509,CHEMICAL,glutamate metabolism,glutamate metabolism
NEW02510,CHEMICAL,thiamin deficiency,thiamin deficiency
D064799,DISEASE,Hypoxia-Inducible Factor-Proline Dioxygenases,"Hypoxia-Inducible Factor Prolyl Hydroxylase 1|HIF Prolyl 4 Hydroxylases|Egl Nine Homolog 3 Protein|Hypoxia-Inducible Factor Prolyl Hydroxylase 2|Prolyl-4-Hydroxylase, HIF|Hypoxia-Inducible Factor-Proline Dioxygenase|Dioxygenase, Hypoxia-Inducible Factor-Proline|Factor-Proline Dioxygenases, Hypoxia-Inducible|Prolyl-4-Hydroxylases, HIF|HIF Prolyl-4-Hydroxylase|Hypoxia Inducible Factor Prolyl Hydroxylase 1|HIF Prolyl-4-Hydroxylases|HIF Prolyl 4 Hydroxylase|Dioxygenases, Hypoxia-Inducible Factor-Proline|Hypoxia|hypoxia|Egl Nine Homolog 2 Protein|proline|Hypoxia Inducible Factor Prolyl Hydroxylase 3|Hypoxia Inducible Factor Proline Dioxygenases|Hypoxia-Inducible Factor Prolyl Hydroxylase 3|Factor-Proline Dioxygenase, Hypoxia-Inducible|hypoxia inducible factor|Hypoxia Inducible Factor Proline Dioxygenase|Egl Nine Homolog 1 Protein|Hypoxia Inducible Factor Prolyl Hydroxylase 2"
NEW02511,CHEMICAL,DA release,DA release
NEW02512,CHEMICAL,ACh release,ACh release
D013832,CHEBI,Thiamine Deficiency,"Deficiencies, Thiamine|Thiamine deficiency|thiamine deficiency|Deficiency, Thiamine|Thiamine Deficiencies"
NEW02513,DISEASE,alcohol-related cortical neuronal loss,alcohol-related cortical neuronal loss
NEW02514,CHEBI,Vitamin abnormalities,Vitamin abnormalities
NEW02515,CHEMICAL,thiamin metabolism,thiamin metabolism
C501104,CHEMICAL,"17-cyclopropylmethyl-3-hydroxy-(5beta,7beta,3',5')-pyrrolidino-2'(S)-phenyl-7alpha-methyl-6,14-endoetheno morphinan [Supplementary Concept]",BU74|Bridged-Ring Compounds|Morphinans
NEW02516,CHEBI,delayed antagonist actions,delayed antagonist actions
D016183,DISEASE,Murine Acquired Immunodeficiency Syndrome,"AIDSs, Murine|Murine Acquired Immuno Deficiency Syndrome|AIDS|acquired immunodeficiency syndrome|immune deficiency syndrome|Murine Acquired Immuno-Deficiency Syndrome|Murine Acquired Immune Deficiency Syndrome|Murine AIDSs|MAIDS|AIDS, Murine|Murine AIDS"
NEW02517,CHEBI,common mu opioid receptor agonists,common mu opioid receptor agonists
NEW02518,MENTAL_HEALTH,increased anxiety,increased anxiety
NEW02519,DISEASE,cocaine-induced anxiety- behaviors,cocaine-induced anxiety- behaviors
NEW02520,CHEBI,delta opioid receptor agonist SNC80,delta opioid receptor agonist SNC80
NEW02521,CHEMICAL,selective cholecystokinin B antagonists,selective cholecystokinin B antagonists
C065599,CHEMICAL,PD 134308 [Supplementary Concept],Meglumine/analogs  and  derivatives|CI-988|Indoles
C067110,CHEMICAL,enadoline [Supplementary Concept],enadoline|Benzofurans|CI-977|Pyrrolidines
NEW02522,CHEMICAL,tricyclo[3.3.1.1.3.1]dec-2-yloxy)carbonyl]amino]propyl]ami no]-1-phenethyl]amino-4-oxobutanoic acid,tricyclo[3.3.1.1.3.1]dec-2-yloxy)carbonyl]amino]propyl]ami no]-1-phenethyl]amino-4-oxobutanoic acid
NEW02523,CHEMICAL,selective B antagonists,selective B antagonists
NEW02524,CHEBI,high efficacy kappa opioid-receptor agonists,high efficacy kappa opioid-receptor agonists
NEW02525,CHEBI,DOR agonists,DOR agonists
NEW02526,CHEMICAL,alcohol abstinence state,alcohol abstinence state
NEW02527,DISEASE,obsessive-compulsive behavior,obsessive-compulsive behavior
NEW02528,DISEASE,ethanol-withdrawal,ethanol-withdrawal
NEW02529,DISEASE,marble-burying behavior,marble-burying behavior
NEW02530,CHEBI,GnRH agonist,GnRH agonist
NEW02531,DISEASE,ethanol-withdrawal-induced changes,ethanol-withdrawal-induced changes
D016729,CHEMICAL,Leuprolide,"|A-43818|leuprorelin|TAP144|Acetate, Leuprolide|Leuprorelin|Leuprolide acetate|LEU|Monoacetate, Leuprolide|Leuprolide, (L-Leu)-Isomer|A43818|TAP-144|Leuprolide Monoacetate|A 43818|Lupron|Leuprolide, (DL-Leu)-Isomer|leuprolide acetate|leuprolide|Leuprolide Acetate|Enantone|TAP 144"
NEW02532,CHEMICAL,Clomipramine treatment,Clomipramine treatment
NEW02533,CHEMICAL,deslorelin treatment,deslorelin treatment
NEW02534,CHEBI,Gonadotropin-releasing hormone agonists,Gonadotropin-releasing hormone agonists
NEW02535,CHEMICAL,Androgen deprivation therapy,ADT|androgen deprivation therapy|Androgen deprivation therapy
NEW02536,DISEASE,cardiovascular events,cardiovascular events
NEW02537,DISEASE,clinical osteoporosis identification,clinical osteoporosis identification
NEW02538,DISEASE,fragility fractures,fragility fractures
NEW02539,CHEBI,hormone agonist exposure,hormone agonist exposure
NEW02540,CHEMICAL,ovarian steroids,ovarian steroids
NEW02541,DISEASE,Ovarian suppression,Ovarian suppression
NEW02542,CHEMICAL,gonadotropin-releasing hormone (GnRH)-agonist,Lupron|gonadotropin-releasing hormone (GnRH)-agonist
NEW02543,DISEASE,Ovarian cyclicity,Ovarian cyclicity
NEW02544,MENTAL_HEALTH,premenstrual dysphoria,premenstrual dysphoria
NEW02545,CHEMICAL,free testosterone levels,free testosterone levels
NEW02546,DISEASE,depressed mood,depressed mood
NEW02547,DISEASE,Puberty suppression,Puberty suppression
NEW02548,CHEBI,gonadotropin-releasing hormone agonists,gonadotropin-releasing hormone agonists
NEW02549,CHEBI,androgen deprivation therapy,androgen deprivation therapy
NEW02550,MENTAL_HEALTH,subsequent dementia risk,subsequent dementia risk
C555622,CHEMICAL,ulipristal acetate [Supplementary Concept],ulipristal acetate|Norpregnadienes
NEW02551,CHEBI,progesterone receptor antagonist,progesterone receptor antagonist
NEW02552,CHEBI,Gonadotropin Releasing Hormone (GnRH)-agonist,Gonadotropin Releasing Hormone (GnRH)-agonist
D008796,DISEASE,Metrorrhagia,"Bleeding, Breakthrough|Bleeding Between Periods|Uterine Bleeding, Dysfunctional|Dysfunctional Uterine Bleedings|Dysfunctional Uterine Bleeding|Breakthrough Bleeding|uterine bleeding|Spotting|metrorrhagia|Intermenstrual Bleeding"
NEW02553,CHEMICAL,"second-messenger inositol 1,4,5-trisphosphate","second-messenger inositol 1,4,5-trisphosphate"
D016564,CHEMICAL,Amyloid beta-Protein Precursor,"amyloid beta-protein|Amyloid-β|Nexin 2, Protease|Amyloid Protein Precursor|Amyloid beta Precursor Protein|amyloid- β|beta-Protein Precursor, Amyloid|Aβ|beta Amyloid Protein Precursor|amyloid-β|amyloid β|amyloid beta protein|Protease Nexin II|Amyloid beta Protein Precursor|beta-Amyloid Protein Precursor|Protease Nexin 2|amyloid beta|Nexin II, Protease|Amyloid A4 Protein Precursor"
NEW02554,MENTAL_HEALTH,disease attractive therapeutic strategy,disease attractive therapeutic strategy
D044402,CHEMICAL,"Receptor, Serotonin, 5-HT2A","5 HT2A Receptor|Receptors, Serotonin 2A|Serotonin 2A Receptors|5-HT(2A|5-HT(2A) Receptor|5-HT2A Receptor|Serotonin 2A Receptor|Receptor, Serotonin 2A|Receptor, 5-HT2A|5-HT(2A receptor"
NEW02555,CHEMICAL,typical APDs,typical APDs
D044263,CHEMICAL,"Receptors, Serotonin, 5-HT1","Receptors, Serotonin 5-HT1|Serotonin 5-HT1 Receptors|5-HT1 Receptor|Receptor, 5-HT1|5-HT1 Serotonin Receptors|5 HT1 Receptors|Serotonin, 5 HT1 Receptors|Serotonin Receptors, 5-HT1|5-HT1 Receptor, Serotonin|Serotonin 5 HT1 Receptor|Serotonin 5 HT1 Receptors|Serotonin receptors|5 HT1 Receptor|5-HT1 Receptors|Serotonin Receptors, 5 HT1|5-HT1 Receptors, Serotonin|Receptors, 5-HT1 Serotonin|Serotonin 5-HT1 Receptor|Receptors Serotonin, 5-HT1|5-HT1 Receptors Serotonin|Receptors, 5-HT1|Serotonin, 5-HT1 Receptors|Receptor, Serotonin 5-HT1|serotonin receptors"
D044405,CHEMICAL,"Receptor, Serotonin, 5-HT2C","Receptor, 5 Hydroxytryptamine Type 2C|Receptor, 5-HT2C|5 HT2C Receptor|5-Hydroxytryptamine Type 2C Receptor|5-HT(2C) Receptor|5 Hydroxytryptamine Type 2C Receptor|5-HT2C Receptor|5-Hydroxytryptamine Type 2C Receptors|Receptor, Serotonin 2C|Receptor, 5-Hydroxytryptamine Type 2C|Serotonin 2C Receptor|5 Hydroxytryptamine Type 2C Receptors|5-HT(2C"
C518685,CHEMICAL,"CP-809,101 [Supplementary Concept]","CP-809,101|Pyrazines|Piperazines"
NEW02556,MENTAL_HEALTH,PCP- hyperactivity,PCP- hyperactivity
NEW02557,CHEMICAL,5-HT(2C agonists,5-HT(2C agonists
NEW02558,DISEASE,taste aversions,taste aversions
NEW02559,CHEBI,antagonists cyproheptadine,antagonists cyproheptadine
C084642,CHEMICAL,2-bromolysergic acid diethylamide [Supplementary Concept],Lysergic Acid Diethylamide/analogs  and  derivatives|bromolysergic acid|bromo-LSD
D008784,CHEMICAL,Methysergide,"|methysergide|Désernil Sandoz|UML491|Desril|Maleate, Methysergide|Dimaleate, Methysergide|Dimethylergometrin|Deseril|UML-491|Désernil-Sandoz|Methysergide Maleate|Methylmethylergonovine|UML 491|Sansert|Methysergide Dimaleate"
D008711,CHEMICAL,Metergoline,metergoline|Methergoline|Liserdol
NEW02560,CHEMICAL,effective antidepressant therapies,effective antidepressant therapies
NEW02561,DISEASE,CRF hypersecretion,CRF hypersecretion
NEW02562,DISEASE,psychiatric groups,psychiatric groups
D016651,NUTRITION,Lithium Carbonate,"|CP15,46761|Quilinorm retard|Lithium Bicarbonate|Carbonate, Dilithium|Lithium carbonate|Priadel|Lithonate|CP-15,467-61|NSC 16895|Quilinormretard|NSC16895|Micalith|Eskalith|Lithotabs|Lithobid|Bicarbonate, Lithium|Dilithium Carbonate|CP 15,467 61|Quilinorm-retard|Carbonate, Lithium|lithium carbonate|Lithane|NSC-16895"
C017783,CHEMICAL,"somatostatin, Trp(8)- [Supplementary Concept]",SRIF|Somatostatin/analogs  and  derivatives
NEW02563,CHEBI,endocrine variables,endocrine variables
NEW02564,MENTAL_HEALTH,anxiety scores,anxiety scores
NEW02565,DISEASE,unipolar endogenous depressed,unipolar endogenous depressed
D010891,CHEMICAL,Piribedil,"ET-495|Piribedil Mono hydrochloride|Piribedil Mono-hydrochloride|piribedil|Piribedil Hydrochloride|Hydrochloride, Piribedil|Piribedil|Trivastal|EU4200|Piribedil Mesylate|ET 495|Piribendyl|ET495|EU 4200|Mesylate, Piribedil|EU-4200|Mono-hydrochloride, Piribedil"
NEW02566,DISEASE,depressed man,depressed man
NEW02567,MENTAL_HEALTH,alcoholic hallucinosis,alcoholic hallucinosis
D011986,CHEBI,"Receptors, Somatotropin","Growth Hormone Receptors|Somatomammotropin Receptor|Receptors, Somatomammotropin|somatotropin|Somatotropin Receptors|Receptor, Growth Hormone|Hormone Receptors, Growth|Growth Hormone Receptor|Receptors, Growth Hormone|Hormone Receptor, Growth|Somatomammotropin Receptors|Somatotropin Receptor"
NEW02568,MENTAL_HEALTH,Epidermal growth factor receptor EGFR tyrosine kinase inhibitor resistance,Epidermal growth factor receptor EGFR tyrosine kinase inhibitor resistance
D002289,DISEASE,"Carcinoma, Non-Small-Cell Lung","Lung Carcinomas, Non-Small-Cell|Non Small Cell Lung Carcinoma|Non-Small Cell Lung Carcinoma|non-small cell lung cancer|Non-Small-Cell Lung Carcinoma|Carcinoma, Non Small Cell Lung|Non-small cell lung cancer|Lung Carcinoma, Non-Small-Cell|Non-Small-Cell Lung Carcinomas|Nonsmall Cell Lung Cancer|Non-Small Cell Lung Cancer|Carcinomas, Non-Small-Cell Lung|Carcinoma, Non-Small Cell Lung|NSCLC"
NEW02569,DISEASE,advanced non-small cell lung cancer,advanced non-small cell lung cancer|NSCLC
NEW02570,DISEASE,NSCLC cells,NSCLC cells
NEW02571,MENTAL_HEALTH,chronic stress hormones,chronic stress hormones
NEW02572,CHEMICAL,EGFR TKI resistance,EGFR TKI resistance
NEW02573,CHEBI,5-HT₃ antagonist studies,5-HT₃ antagonist studies
NEW02574,MENTAL_HEALTH,stable schizophrenia patients,stable schizophrenia patients
D018722,CHEBI,Nicotinic Agonists,"nicotinic agonists|Nicotinic agonists|Nicotinic cholinergic agonists|Cholinergic Agonists, Nicotinic|Agonist, Nicotinic Cholinergic|Agonists, Nicotinic Cholinergic|Cholinergic Agonist, Nicotinic|Agonists, Nicotinic|Agonist, Nicotinic|Nicotinic Cholinergic Agonists|cholinergic agonist|Nicotinic Agonist|Nicotinic Cholinergic Agonist"
NEW02575,CHEMICAL,24-hour urinary beta-phenylethylamine,24-hour urinary beta-phenylethylamine|endocannabinoid congener N-palmitoylethanolamine|PEA
NEW02576,CHEBI,standard anxiolytic drug,standard anxiolytic drug
NEW02577,CHEBI,5-HT(3 receptor antagonists,5-HT(3 receptor antagonists
D043183,DISEASE,Irritable Bowel Syndrome,"Colon, Irritable|Colitis, Mucous|IBS|Irritable bowel syndrome|Colitides, Mucous|Mucous Colitides|Irritable Bowel Syndromes|Irritable Colon|Irritable Bowel Syndrome|Syndromes, Irritable Bowel|Syndrome, Irritable Bowel|irritable bowel syndrome|Mucous Colitis"
NEW02578,CHEBI,5-HT(1A agonists,5-HT(1A agonists
NEW02579,DISEASE,similar behavioral disturbances,similar behavioral disturbances
NEW02580,CHEMICAL,SIGNIFICANCE STATEMENT Ethanol consumption agents,SIGNIFICANCE STATEMENT Ethanol consumption agents
NEW02581,CHEBI,maternal CCR2 antagonist,maternal CCR2 antagonist
NEW02582,CHEMICAL,ethanol drinking,ethanol drinking
NEW02583,DISEASE,Cognitive deficits,Cognitive deficits
NEW02584,CHEBI,gonadotropins sex hormone biosynthesis,gonadotropins sex hormone biosynthesis
NEW02585,CHEBI,androgen receptor gene,androgen receptor gene
NEW02586,CHEMICAL,lower peripheral testosterone levels,lower peripheral testosterone levels
NEW02587,CHEMICAL,testosterone system,testosterone system
NEW02588,DISEASE,child sexual offenders,child sexual offenders
NEW02589,DISEASE,sexual offenses,sexual offenses
NEW02590,CHEBI,Antiandrogen therapy,Antiandrogen therapy
NEW02591,CHEMICAL,Chronic pharmacologic testosterone treatment,Chronic pharmacologic testosterone treatment
NEW02592,NUTRITION,acetyltransferase ChAT mRNA levels,acetyltransferase ChAT mRNA levels
D002795,NUTRITION,Choline O-Acetyltransferase,"Acetyltransferase, Choline|O-Acetyltransferase, Choline|Choline Acetyltransferase|Choline Acetylase|Acetylase, Choline|Choline O Acetyltransferase|choline acetyltransferase|ChAT"
NEW02593,CHEMICAL,testosterone levels,testosterone levels
NEW02594,DISEASE,sexual symptoms,sexual symptoms
NEW02595,CHEMICAL,pharmacologic testosterone treatment effects,pharmacologic testosterone treatment effects
NEW02596,DISEASE,testosterone-induced temporal fluctuations,testosterone-induced temporal fluctuations
NEW02597,DISEASE,chronic anovulation,chronic anovulation
NEW02598,CHEBI,androgen hypersecretion,androgen hypersecretion
D000506,DISEASE,Alopecia Areata,alopecia|alopecia areata|Alopecia areata|Alopecia Circumscripta
NEW02599,DISEASE,hirsuitism,hirsuitism
D008599,DISEASE,Menstruation Disturbances,"|Menstruation Disorder|menstrual irregularities|Menstruation Disorders|Polymenorrhea|Menstrual Irregularities|Menstrual Disorders|Menstrual Irregularity|Irregularity, Menstrual|Irregular Menses|Menstruation Disturbance|Disorder, Menstruation|Disorders, Menstruation|Disturbances, Menstruation|Hypomenorrhea|Disturbance, Menstruation|Retrograde Menstruation|Menstruation, Irregular|Irregular Menstruation|Menstrual irregularities|Menses, Irregular|Menstruation, Retrograde"
NEW02600,CHEBI,common endocrine disorder,common endocrine disorder
NEW02601,CHEMICAL,vasopresin,vasopresin
NEW02602,CHEMICAL,Prolactine,Prolactine
D012738,CHEMICAL,Sex Hormone-Binding Globulin,"estradiol binding|SHBG|sex hormone|Testosterone-Estradiol Binding Globulin|Steroid-Binding Protein, Sex|sex hormone binding globulin|Sex Steroid-Binding Protein|Sex Hormone Binding Globulin|sex-hormone-binding globulin|Testosterone Estradiol Binding Globulin|sex hormone-binding globulin|hormone binding|Globulin, Testosterone-Estradiol Binding|Sex Steroid Binding Protein|Binding Globulin, Testosterone-Estradiol|sex-hormone|Globulin, Sex Hormone-Binding|Hormone-Binding Globulin, Sex"
NEW02603,CHEBI,Androgen deprivation therapy,Androgen deprivation therapy
NEW02604,DISEASE,advanced prostate cancer,advanced prostate cancer
NEW02605,CHEBI,androgen deprivation,androgen deprivation
NEW02606,MENTAL_HEALTH,social impotence,social impotence
C488187,CHEMICAL,"FRS2alpha protein, mouse [Supplementary Concept]",tyrosine phosphorylated|Membrane Proteins
NEW02607,CHEBI,Androgen excess,Androgen excess
D057466,CHEBI,Nonsteroidal Anti-Androgens,"Androgens|AntiAndrogens, Nonsteroidal|Nonsteroidal Anti Androgens|anti-androgens|Anti-Androgens, Nonsteroidal|androgens|testosterone undecanoate|Nonsteroidal Antiandrogens"
NEW02608,DISEASE,obesity states,obesity states
NEW02609,CHEBI,androgen excess,androgen excess
D024821,DISEASE,Metabolic Syndrome,"Syndromes, Cardiometabolic|Syndrome X, Metabolic|Metabolic Syndromes|Syndrome, Metabolic Cardiovascular|Syndrome X, Insulin Resistance|Metabolic X Syndrome|Syndrome, Cardiometabolic|Dysmetabolic Syndrome X|Syndrome X, Dysmetabolic|Cardiovascular Syndrome, Metabolic|Cardiometabolic Syndromes|Metabolic syndrome|Syndrome X, Reaven|X Syndrome, Metabolic|Syndrome, Metabolic|Metabolic Cardiovascular Syndrome|metabolic syndrome|metabolic syndromes|Syndrome, Metabolic X|Reaven Syndrome X|insulin resistance syndrome|Cardiovascular Syndromes, Metabolic|Metabolic Syndrome|Metabolic Syndrome X|Cardiometabolic Syndrome|Syndromes, Metabolic|Insulin Resistance Syndrome X|MetS"
NEW02610,DISEASE,hyperandrogenic state,hyperandrogenic state
NEW02611,CHEBI,sex hormone balance,sex hormone balance
NEW02612,DISEASE,Depression-like behaviors,Depression-like behaviors
NEW02613,CHEMICAL,5-α reductase deficiency type,5-α reductase deficiency type
NEW02614,DISEASE,DSM-IV Axis I,DSM-IV Axis I
D001368,DISEASE,"Axis, Cervical Vertebra","Epistropheus|C2 Vertebras|Axis|C2 Vertebra|Os Odontoideum|Vertebra Axis, Cervical|Cervical Vertebra Axis"
D013734,CHEBI,Androgen-Insensitivity Syndrome,"Partial Androgen Insensitivity|Androgen-Insensitivity Syndromes, Complete|Deficiencies, AR|Androgen Insensitivity Syndrome, Partial|AR Deficiencies|Deficiencies, Dihydrotestosterone Receptor|Receptor Deficiencies, Dihydrotestosterone|Receptor Deficiencies, Androgen|Deficiency, AR|Partial Androgen Insensitivities|Male Pseudohermaphroditism Due to Androgen Insensitivity|Partial Androgen-Insensitivity Syndromes|Testicular Feminization Syndromes|Androgen insensitivity syndrome|Testicular Feminization Syndrome|Androgen Resistance Syndrome|Deficiency, Androgen Receptor|DHTR Deficiency|Feminization, Testicular|Insensitivity Syndromes, Androgen|Androgen Receptor Deficiencies|Androgen Insensitivity Syndromes|Androgen Insensitivities, Partial|Androgen-Insensitivity Syndromes, Partial|Deficiencies, Androgen Receptor|complete androgen insensitivity syndrome|DHTR Deficiencies|AR Deficiency|Androgen-Insensitivity Syndromes|Insensitivity Syndrome, Androgen|Deficiency, DHTR|Androgen Insensitivity Syndrome|Reifenstein's Syndrome|Androgen-Insensitivity Syndrome, Partial|Insensitivity, Partial Androgen|Testicular Feminizations|Dihydrotestosterone Receptor Deficiency|Reifenstein Syndrome|Insensitivities, Partial Androgen|Feminization Syndrome, Testicular|Feminization Syndromes, Testicular|Receptor Deficiency, Dihydrotestosterone|Androgen Receptor Deficiency|CAIS|Testicular Feminization|Resistance Syndrome, Androgen|Resistance Syndromes, Androgen|Reifensteins Syndrome|Complete Androgen-Insensitivity Syndrome|androgen insensitivity syndrome|Partial Androgen-Insensitivity Syndrome|Dihydrotestosterone Receptor Deficiencies|Androgen Insensitivity Syndrome, Complete|Receptor Deficiency, Androgen|Deficiencies, DHTR|Androgen-Insensitivity Syndrome, Complete|Complete Androgen-Insensitivity Syndromes|Deficiency, Dihydrotestosterone Receptor|Androgen Insensitivity, Partial|Androgen Resistance Syndromes|Feminizations, Testicular"
NEW02615,CHEBI,different sex hormone milieu,different sex hormone milieu
NEW02616,CHEBI,short-term sex hormone deficiency,short-term sex hormone deficiency
NEW02617,CHEBI,Long-term androgen deficiency,Long-term androgen deficiency
NEW02618,MENTAL_HEALTH,anxiety open field,anxiety open field
NEW02619,CHEBI,exogenous sex hormones,exogenous sex hormones
NEW02620,CHEMICAL,Reduced testosterone levels,Reduced testosterone levels
NEW02621,CHEMICAL,high DHEA doses,high DHEA doses
NEW02622,CHEMICAL,DHEA therapy,DHEA therapy
NEW02623,MENTAL_HEALTH,inhibited sexual desire,inhibited sexual desire
NEW02624,CHEMICAL,CC abnormalities,CC abnormalities
NEW02625,DISEASE,psychotic illness,psychotic illness
NEW02626,DISEASE,daily psychiatric evaluation,daily psychiatric evaluation
NEW02627,MENTAL_HEALTH,major depressive episode,major depressive episode
NEW02628,CHEBI,physiological androgen blood levels,physiological androgen blood levels
NEW02629,CHEBI,elevated maternal androgens,elevated maternal androgens
NEW02630,DISEASE,psychiatric morbidity,psychiatric morbidity
NEW02631,DISEASE,premature ovarian insufficiency,premature ovarian insufficiency|POI
NEW02632,DISEASE,17β-HSD3 deficiency,17β-HSD3 deficiency
D014770,DISEASE,Virilism,Virilization|Androgenization
NEW02633,MENTAL_HEALTH,purging type,purging type
D037101,CHEBI,"Luteinizing Hormone, beta Subunit","Luteinizing Hormone, beta Polypeptide Chain|Luteinizing Hormone, beta Chain|ICSH, beta Subunit|LH, beta Subunit|LH beta|Lutropin-beta|Lutropin, beta Subunit|luteinizing hormone|Lutropin beta|LH-beta"
NEW02634,DISEASE,ovarian morphology,ovarian morphology
NEW02635,CHEMICAL,5alpha-dihydrotestosterone,5alpha-dihydrotestosterone
NEW02636,CHEMICAL,deyhydroepiahndrosterone sulfate,deyhydroepiahndrosterone sulfate
NEW02637,CHEMICAL,serum testosterone,serum testosterone
NEW02638,DISEASE,Maternal polycystic ovary syndrome,Maternal polycystic ovary syndrome
NEW02639,CHEBI,prenatal androgen exposure,prenatal androgen exposure
D017588,DISEASE,Hyperandrogenism,Androgens (1966-1993)|hyperandrogenism
NEW02640,DISEASE,severe ASD,severe ASD
NEW02641,CHEMICAL,elevated prenatal testosterone exposure,elevated prenatal testosterone exposure
NEW02642,CHEMICAL,fetal testosterone,fetal testosterone
NEW02643,CHEMICAL,fT levels,fT levels
NEW02644,CHEBI,androgen deficiency,androgen deficiency
NEW02645,DISEASE,vibration disease patients,vibration disease patients
NEW02646,MENTAL_HEALTH,personal anxiety,personal anxiety
NEW02647,CHEBI,androgen signaling,androgen signaling
NEW02648,DISEASE,human aggressive behavior,human aggressive behavior
NEW02649,CHEMICAL,5alpha-dihydrotestosterone,non-aromatized androgene dihydrotestosterone|DHT|5alpha-dihydrotestosterone
D011944,CHEBI,"Receptors, Androgen","Dihydrotestosterone Receptors|Androgen Receptor|Testosterone Receptor|Receptor, Stanolone|Androgen Receptors|Receptors, Stanolone|Stanolone Receptors|5 alpha-Dihydrotestosterone Receptor|alpha-Dihydrotestosterone Receptor, 5|Stanolone Receptor|Androgens Receptors|5 alpha Dihydrotestosterone Receptor|Receptors, Androgens|androgen receptors|Receptor, Testosterone|Receptors, Dihydrotestosterone|Receptor, 5 alpha-Dihydrotestosterone|Receptor, Androgen"
D008914,CHEMICAL,Minoxidil,|Minoxidil|Regaine|Loniten|Rogaine|U 10858|minoxidil
D006628,DISEASE,Hirsutism,Hypertrichosis|hirsutism
NEW02650,DISEASE,systemic hypertension,systemic hypertension
C041226,CHEMICAL,Terazosin [Supplementary Concept],Prazosin/analogs  and  derivatives|terazosin
D006333,DISEASE,Heart Failure,"|Heart Failure, Left Sided|Myocardial Failure|Heart Decompensation|CHF|congestive heart failure|heart failure|Left Sided Heart Failure|Cardiac Failure|Cardiac failure|Right Sided Heart Failure|Heart Failure, Right-Sided|Heart Failure, Right Sided|Right-Sided Heart Failure|decompensation|Heart Failure, Congestive|Congestive Heart Failure|Left-Sided Heart Failure|Heart Failure, Left-Sided|Decompensation, Heart"
NEW02651,DISEASE,ureteric calculi,ureteric calculi
D049971,CHEMICAL,Thiazides,Thiazide|Thiazides
NEW02652,CHEMICAL,described anti-androgen side effects,described anti-androgen side effects
D000152,DISEASE,Acne Vulgaris,Acne|acne vulgaris
NEW02653,CHEBI,hormone influences,hormone influences
NEW02654,CHEMICAL,amine neurotransmitter systems,amine neurotransmitter systems
D050503,CHEMICAL,"Indoleamine-Pyrrole 2,3,-Dioxygenase","Indolamine-2,3-Dioxygenase|Indoleamine 2,3 Dioxygenase|Indoleamine-Oxygen 2,3-Oxidoreductase (Decyclizing)|indoleamine 2,3-dioxygenase|IDO Dioxygenase|Indoleamine 2,3-Dioxygenase|Dioxygenase, IDO|Indolamine 2,3 Dioxygenase|indolamine"
NEW02655,DISEASE,disorder due to partial,disorder due to partial|PAIS
D007343,CHEBI,Insurance Carriers,"Insurance Providers|Insurance Carrier|carriers|Insurance Provider|Carrier, Insurance|Insurer|Carriers, Insurance|Insurers|Carriers|Providers, Insurance|Provider, Insurance"
NEW02656,CHEBI,relative androgen deficiency,relative androgen deficiency
NEW02657,MENTAL_HEALTH,greater depression,greater depression
NEW02658,MENTAL_HEALTH,anxiety symptom severity,anxiety symptom severity
NEW02659,DISEASE,common psychiatric condition,common psychiatric condition
D020204,DISEASE,"Skull Fracture, Depressed","Depressed Skull Fracture|Compound Depressed Skull Fracture|Skull Fractures, Compound Depressed|depressed|Compound Depressed Skull Fractures|Depressed Skull Fractures|Skull Fractures, Depressed|Fracture, Depressed Skull|Skull Fracture, Compound Depressed|Fractures, Depressed Skull"
NEW02660,MENTAL_HEALTH,perimenopausal dysphoria,perimenopausal dysphoria
NEW02661,MENTAL_HEALTH,postpartum psychosis,postpartum psychosis
NEW02662,CHEMICAL,available oral contraceptives,available oral contraceptives
D004412,DISEASE,Dysmenorrhea,"Menstrual Pains|menstrual pain|Menstruations, Painful|Pain, Menstrual|Painful Menstruation|Menstrual Pain|Pains, Menstrual|Menstruation, Painful|dysmenorrhea|Painful Menstruations|Dysmenorrheas"
NEW02663,CHEBI,Androgen receptor AR splice variants,Androgen receptor AR splice variants
NEW02664,DISEASE,lethal castration-resistant prostate cancer,lethal castration-resistant prostate cancer
NEW02665,DISEASE,"other 46,XY","other 46,XY|DSD"
D007021,DISEASE,Hypospadias,Hypospadia|hypospadias
NEW02666,DISEASE,metastatic prostate cancer,metastatic prostate cancer
NEW02667,NUTRITION,Corylus avellana L.,Corylus avellana L.|high-quality hazelnuts
NEW02668,DISEASE,Neuroleptic-induced acute akathisia,NIA|Neuroleptic-induced acute akathisia
NEW02669,CHEMICAL,dopamine enhancers,dopamine enhancers
D018680,CHEBI,Cholinergic Antagonists,"Antagonist, Cholinergic|Cholinergic Blocking Agent|Anticholinergic|Acetylcholine Antagonists|Anticholinergics|Acetylcholine Antagonist|tropicamide|acetylcholine antagonists|anticholinergic agents|Cholinergic-Blocking Agent|Cholinergic Antagonist|Antagonists, Cholinergic|Anticholinergic agents|Antagonist, Cholinergic Receptor|Agent, Anticholinergic|cholinergic antagonist|Receptor Antagonist, Cholinergic|Anti Cholinergic|Cholinergic-Blocking Agents|Anti-Cholinergic|Cholinolytic|Antagonists, Acetylcholine|anticholinergics|Antagonist, Acetylcholine|Cholinergic Receptor Antagonist|Cholinergic Blocking Agents|Receptor Antagonists, Cholinergic|Cholinergic Receptor Antagonists|Agent, Cholinergic-Blocking|Cholinolytics|Anti Cholinergics|methylatropine nitrate|Antagonists, Cholinergic Receptor|Agents, Cholinergic-Blocking|Cholinergic antagonists|Anticholinergic Agents|Anticholinergic Agent|Agents, Anticholinergic|Anti-Cholinergics"
NEW02670,DISEASE,female schizophrenic patients,female schizophrenic patients
NEW02671,DISEASE,diabetic diabetic animals,diabetic diabetic animals
NEW02672,CHEMICAL,higher blood glucose levels,higher blood glucose levels
D011943,CHEBI,"Receptors, Adrenergic, beta","beta adrenergic receptors|Receptors, beta-Adrenergic|beta-Receptor, Adrenergic|beta Adrenergic Receptors|Receptor, beta-Adrenergic|beta-Adrenergic Receptors|Adrenergic Receptor, beta|Adrenergic beta Receptor|Receptor, beta Adrenergic|beta Adrenergic Receptor|Receptor, Adrenergic, beta|Adrenergic beta Receptors|Adrenergic beta-Receptor|Receptors, beta Adrenergic|beta-Adrenergic Receptor|Adrenergic beta-Receptors|beta-Receptors, Adrenergic"
NEW02673,DISEASE,traumatic memory,traumatic memory
D002395,CHEMICAL,Catecholamines,catecholamines|Catecholamine|Sympathins|Catecholamines|Sympathin
NEW02674,CHEBI,stress hormone effects,stress hormone effects
NEW02675,CHEBI,intrathecal AMPA receptor antagonists,intrathecal AMPA receptor antagonists
NEW02676,DISEASE,various pain states,various pain states
NEW02677,CHEMICAL,intrathecal perampanel,intrathecal perampanel
C551441,CHEMICAL,perampanel [Supplementary Concept],Nitriles|Perampanel|perampanel|Pyridones
NEW02678,DISEASE,neuropathic inflammatory pain,neuropathic inflammatory pain
NEW02679,DISEASE,pain conditions,pain conditions
D019782,CHEMICAL,Riluzole,riluzole|Rilutek|PK-26124|PK26124|PK 26124|Riluzole|RP-54274|RP54274|RP 54274|2 Amino 6 trifluoromethoxybenzothiazole|2-Amino-6-trifluoromethoxybenzothiazole
NEW02680,CHEBI,non-selective alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid AMPA receptor antagonists,non-selective alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid AMPA receptor antagonists
NEW02681,DISEASE,audiogenic seizures,audiogenic seizures
NEW02682,CHEMICAL,"2,3-benzodiazepine derivatives","2,3-benzodiazepine derivatives"
C119033,CHEMICAL,CFM 2 [Supplementary Concept],Benzodiazepinones|CFM-2
NEW02683,CHEMICAL,pentylentetrazole,pentylentetrazole
NEW02684,CHEMICAL,"novel 2,3-benzodiazepines","novel 2,3-benzodiazepines"
C110629,CHEMICAL,YM 872 [Supplementary Concept],Imidazoles|YM872|Quinoxalines
NEW02685,DISEASE,thermal pain,thermal pain
NEW02686,DISEASE,thermal nociceptions,thermal nociceptions
NEW02687,CHEBI,rats analgesic effects,rats analgesic effects
D018091,CHEMICAL,"Receptors, AMPA","AMPA|Receptor, Quisqualate|Quisqualate Receptors|Quisqualate Receptor|quisqualate|AMPA receptors|AMPA Receptors|Receptors, Quisqualate|AMPA Receptor|Receptor, AMPA"
NEW02688,DISEASE,psychiatric comorbidities,psychiatric comorbidities
NEW02689,CHEMICAL,AMPA-type glutamate receptors,AMPA-type glutamate receptors
NEW02690,CHEMICAL,GluR-A subunit-containing AMPA receptors,GluR-A subunit-containing AMPA receptors
D012920,DISEASE,Social Behavior Disorders,"Disorders, Social Behavior|social behavior|Behavior Disorders, Social"
NEW02691,CHEMICAL,"active antagonist 2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo(F)quinoxaline","NBQX|active antagonist 2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo(F)quinoxaline"
NEW02692,DISEASE,ambivalent aggression,ambivalent aggression
NEW02693,DISEASE,TNA mice,TNA mice
NEW02694,CHEBI,AMPA receptor antagonists,AMPA receptor antagonists
NEW02695,CHEBI,potent toxin,potent toxin
NEW02696,DISEASE,limbic seizures,limbic seizures
NEW02697,CHEMICAL,Endogenous glutamate,Endogenous glutamate
D001925,DISEASE,"Brain Damage, Chronic","|chronic brain damage|brain damage|Chronic Encephalopathy|Encephalopathy, Chronic|Chronic Brain Damage"
NEW02698,DISEASE,neurological diseases,neurological diseases
D014407,DISEASE,"Tumor Cells, Cultured","Tumor Cell, Cultured|tumor cells|Cells, Cultured Neoplastic|Cultured Neoplastic Cell|Cultured Tumor Cell|Cells, Cultured Tumor|Cell, Cultured Neoplastic|Neoplastic Cells, Cultured|Cell, Cultured Tumor|Cultured Neoplastic Cells|Cultured Tumor Cells|Neoplastic Cell, Cultured"
NEW02699,MENTAL_HEALTH,chronic stress conditions,chronic stress conditions
NEW02700,CHEMICAL,hypoxia‑inducible factor (HIF)‑1α,hypoxia‑inducible factor (HIF)‑1α
D045468,DISEASE,Fallopia japonica,"Polygonum cuspidatums|Knotweeds, Japanese|Knotweed, Japanese|japonicas, Fallopia|cuspidatum, Polygonum|Polygonum cuspidatum|Japanese Knotweeds|Japanese Knotweed|Fallopia japonicas|Japanese knotweed"
NEW02701,DISEASE,depressive behaviors,depressive behaviors
NEW02702,CHEMICAL,sucrose preference test,sucrose preference test
NEW02703,CHEMICAL,suitable ethanol markers,suitable ethanol markers
NEW02704,MENTAL_HEALTH,chronic abuse control,chronic abuse control
NEW02705,CHEMICAL,interesting aroma,interesting aroma
C119846,DISEASE,"HST7 protein, Candida albicans [Supplementary Concept]",Fungal Proteins|C. albicans|Mitogen-Activated Protein Kinase Kinases
D055624,DISEASE,Methicillin-Resistant Staphylococcus aureus,methicillin-resistant Staphylococcus aureus|MRSA|Methicillin-resistant Staphylococcus aureus|Methicillin Resistant Staphylococcus aureus|Staphylococcus aureus
NEW02706,CHEBI,antimicrobial activity,antimicrobial activity
C018961,CHEMICAL,hexamidine [Supplementary Concept],Hexamidine Diisethionate|Benzamidines|% Hexamidine Diisethionate
NEW02707,DISEASE,slight erythema,slight erythema
NEW02708,DISEASE,slight edema,slight edema
NEW02709,DISEASE,neurotoxicity brain damage,neurotoxicity brain damage
NEW02710,CHEBI,neurotoxic agents,neurotoxic agents
D005503,CHEBI,Food Additives,"food additives|polyols|Food Additive|additives|Food additives|Additives, Food|Additive, Food|food additive"
D015767,CHEMICAL,Mefloquine,"|Lariam|WR-142,490|Mefloquine Hydrochloride|WR-177,602|Ro 21 5998 001|Mefloquine|Mephloquine|WR177,602|WR 177,602|WR142,490|mefloquine|WR 142,490|Ro-21-5998-001|Ro215998001"
NEW02711,DISEASE,direct toxicity,direct toxicity
D044342,DISEASE,Malnutrition,malnutrition|Nutritional Deficiency|Nutritional deficiencies|nutritional deficiency|Nutritional Deficiencies|Undernutrition|Malnourishments|Malnourishment|Malnutrition|nutritional deficiencies
NEW02712,CHEBI,tocopherols supplementation,tocopherols supplementation
NEW02713,MENTAL_HEALTH,premenstrual depression,premenstrual depression
NEW02714,DISEASE,cerebral functions,cerebral functions
D018798,CHEMICAL,"Anemia, Iron-Deficiency","Iron Deficiency Anemias|Iron deficiency anemia|Iron Deficiency Anemia|Anemias, Iron Deficiency|Anemia, Iron Deficiency|Anemias, Iron-Deficiency|Iron-Deficiency Anemias|iron deficiency|Iron-Deficiency Anemia|iron deficiency anemia|Iron deficiency"
NEW02715,CHEMICAL,Iron deficiency anaemia,Iron deficiency anaemia
D020233,MENTAL_HEALTH,"Gait Disorders, Neurologic","Gait, Stumbling|Stumbling Gait|Gait, Scissors|Locomotion Disorders, Neurologic|Gait, Spastic|Gait, Athetotic|Festinating Gait|Frontal Gait|Marche a Petit Pas|Reeling Gait|Neurologic Gait Disorder|Charcot's Gait|Ambulation Disorder, Neurologic|Neurologic Locomotion Disorders|Scissors Gait|Gait Disorders, Sensorimotor|Foot Gait, Drop|Gait, Hysterical|Gait, Widebased|Locomotion Disorder, Neurologic|Gait, Festinating|Gait Dysfunctions, Neurologic|Gait, Duck|Gait Disorder, Neurologic|Gait, Shuffling|Gait, Unsteady|Charcot Gait|Gait, Rigid|Gait, Charcot|Neurologic Locomotion Disorder|Shuffling Gait|Unsteady Gait|Broadened Gait|Duck Gait|Neurologic Ambulation Disorder|Sensorimotor Gait Disorders|Gait Dysfunction, Neurologic|Neurologic Gait Disorders|Hysterical Gait|Gait, Charcot's|Gait, Broadened|Athetotic Gait|Gait, Hemiplegic|Rigid Gait|Gaits, Charcot|Ambulation Disorders, Neurologic|gait disorders|Neurologic Ambulation Disorders|Gait, Reeling|Drop Foot Gait|Neurologic Gait Dysfunctions|Charcot Gaits|Gait Disorder, Sensorimotor|Gait, Drop Foot|Widebased Gait|Charcots Gait|Gait, Frontal|Hemiplegic Gait|Rapid Fatigue of Gait|Sensorimotor Gait Disorder|Neurologic Gait Dysfunction|rapid fatigue|Spastic Gait|Shuffling Gaits"
D017613,CHEMICAL,Iodine Compounds,"Compounds, Iodine|iodine"
NEW02716,DISEASE,severe cerebral dysfunction,severe cerebral dysfunction
D003409,DISEASE,Congenital Hypothyroidism,"Cretinism, Endemic|cretinism|Fetal Iodine Deficiency Disorder|Cretinism|Myxedema, Congenital|Hypothyroidism, Congenital|Endemic Cretinism|congenital hypothyroidism"
NEW02717,DISEASE,dietary deficiencies,dietary deficiencies
D024505,CHEBI,Tocopherols,"Richtavit E|Tocopherol|E-Vicotrat|Tocolion|Tocopharm|Vitamin-E Dragees|EUNOVA Vitamin E|Sanavitan S|Antioxidans E-Hevert|Ecoro|Evion|Puncto E|Davitamon|Vitagutt Vitamin E|E Vitamin E|Dal E|Vitamin E Suspension|VitaminE EVIMIRALE|Vit. E Stada|Mowivit Vitamin E|Biosan|Vita Plus E|VitaE|Vitamin E AL|UnoVit|E-Vitamin-Ratiopharm|Equivit E|E-ferol|Eplonat|Vitamin E Dragees|tocopherols|E-Mulsin|Vita E|E Vicotrat|Vitamin E Natur|Lasar|Vitamin E mp|Vit E hydrosol|Auxina E|Vitamin E, Vitagutt|Dermorelle|Hydrovit E|Vitamin E-mp|Vitamine E GNR|Spondyvit|Vitamin Emp|Ephynal|VitaPlus E|Vitamin-E EVI-MIRALE|Vitamin E, Mowivit|E Mulsin|Vita-Plus E|Embial|Vitamin E EVI MIRALE|Detulin|Tocopa|Uno-Vit|Dal-E|Elex Verla|Bio E|Biopto-E|Vitamin E Sanum|Tocopherol Bayer|Unique E|Vitamin E, Togasan|Vibolex|Vita-E|Micorvit E|Snow-E Muscle, Energy  and  Feritility|Uno Vit|Tocovital|Malton E|Vitazell|Bioweyxin|Abortosan|Aquasol E|Eusovit|Togasan Vitamin E"
D063427,CHEBI,Food Quality,"Quality, Food|Food Qualities|Qualities, Food|food|tocopherol"
NEW02718,CHEBI,outpatient parenteral antimicrobial therapy,outpatient parenteral antimicrobial therapy
NEW02719,CHEBI,antibiotic treatment,antibiotic treatment
NEW02720,DISEASE,severe injection-related infections,severe injection-related infections
NEW02721,CHEMICAL,buprenorphine induction,buprenorphine induction
NEW02722,MENTAL_HEALTH,antimicrobial resistance,antimicrobial resistance
NEW02723,MENTAL_HEALTH,induced psychosis,induced psychosis
NEW02724,DISEASE,clinical syndrome,clinical syndrome
C000590837,CHEMICAL,"lumbricusin peptide, Lumbricus terrestris [Supplementary Concept]",Lumbricusin|Helminth Proteins
NEW02725,CHEMICAL,Lumbricusin Analogue,Lumbricusin Analogue
D053583,CHEMICAL,Interleukin-1beta,Interleukin-1 beta|Interleukin 1 beta|Catabolin|IL-1β|interleukin-1β|IL-1 beta|Interleukin 1beta|interleukin-1beta
C000713927,CHEMICAL,ginger extract [Supplementary Concept],ginger extract|Plant Extracts|Ginger
NEW02726,MENTAL_HEALTH,various memory disorders,various memory disorders
NEW02727,CHEBI,memory enhancing drug,memory enhancing drug
D023181,CHEMICAL,Antimicrobial Cationic Peptides,"Antimicrobial Peptides, Cationic|Peptide, Host Defense|Cationic Proteins, Microbicidal|Amphipathic Cationic Antimicrobial Peptides|Peptides, Host Defense|Peptides, Cationic Antimicrobial|Antimicrobial Peptide, Cationic|AMP|Defense Peptide, Host|Peptides, Antimicrobial Cationic|cationic antimicrobial peptides|Cationic Antimicrobial Peptides|Microbicidal Cationic Proteins|Host Defense Peptides|Cationic Host Defense Peptides|Defense Peptides, Host|Host Defense Peptide|Cationic antimicrobial peptides|Peptide, Cationic Antimicrobial|Proteins, Microbicidal Cationic|Cationic Peptides, Antimicrobial|Cationic Antimicrobial Peptide"
NEW02728,DISEASE,congenital immunity,congenital immunity
NEW02729,CHEBI,antimicrobial action,antimicrobial action
NEW02730,CHEMICAL,Nutmegs,Nutmegs
NEW02731,CHEMICAL,stimulant psychotomimetic agents,stimulant psychotomimetic agents
NEW02732,CHEMICAL,proline metabolism,proline metabolism
D056627,DISEASE,Peritoneal Fibrosis,"Fibrosing Syndrome, Peritoneal|Syndromes, Peritoneal Fibrosing|Fibrosis, Peritoneal|Peritoneal Fibroses|Sclerosis, Encapsulating Peritoneal|Scleroses, Encapsulating Peritoneal|Syndrome, Peritoneal Fibrosing|Peritoneal Fibrosing Syndromes|Peritoneal Scleroses|Fibroses, Peritoneal|Peritoneal Sclerosis|Peritoneal Fibrosing Syndrome|Peritoneal Sclerosis, Encapsulating|Peritoneal Scleroses, Encapsulating|Scleroses, Peritoneal|Encapsulating Peritoneal Sclerosis|Fibrosing Syndromes, Peritoneal|fibrosis|Sclerosis, Peritoneal|Encapsulating Peritoneal Scleroses|Fibrosis"
NEW02733,DISEASE,secondary bacterial infections,secondary bacterial infections
NEW02734,NUTRITION,Salvia sclarea,clary sage|Salvia sclarea
NEW02735,DISEASE,endothelial dysfunction,endothelial dysfunction
D000077723,CHEMICAL,Cefepime,BMY-28142|Quadrocef|Cefepime Hydrochloride|Cefepime|cefepime|BMY 28142|Axépim|BMY28142|Cefepim|Maxipime
NEW02736,DISEASE,severe infections,severe infections
NEW02737,CHEMICAL,Repeated cefepime treatment,Repeated cefepime treatment
D015643,CHEMICAL,Erythromycin Ethylsuccinate,"Pediamycin|Monomycin|Ethylsuccinate, Erythromycin|Succinate, Eyrthromycin Ethyl|Erythroped|E-Mycin E|EMycin E|EryPed|Eyrthromycin Ethyl Succinate|Erythromycin|Wyamycin E|erythromycin|Ethyl Succinate, Eyrthromycin"
D008795,CHEMICAL,Metronidazole,|Trichazol|Clont|Metronidazole Hydrochloride|metronidazole|MetroGel|MNZ|Metronidazole Monohydrochloride|2 Methyl 5 nitroimidazole 1 ethanol|Gineflavir|Metronidazole|2-Methyl-5-nitroimidazole-1-ethanol|Danizol|Metronidazole Phosphoester|Vagilen|Trivazol|Metrogyl|Satric|Metric|Metronidazole Phosphate|Metrodzhil|Flagyl|Trichopol|Bayer 5360
D002045,CHEMICAL,Bupivacaine,"Bupivacaine||Carbostesin|Svedocain Sin Vasoconstr|Bupivacaine Monohydrochloride, Monohydrate|Bupivacaina Braun|Bupivacaine Hydrochloride|Sensorcaine|Bupivacaine Anhydrous|Marcaine|Bupivacain-RPR|Marcain|Bupivacaine Carbonate|Bupivacain Janapharm|Dolanaest|Buvacaina|1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide|Bupivacain RPR|bupivacaine"
NEW02738,DISEASE,pain control,pain control
D045704,CHEMICAL,Mycoplasma genitalium,Mycoplasma (1981-2003)|Mycoplasma genitalium
D011472,DISEASE,Prostatitis,"|Bacterial Prostatitis, Chronic|Bacterial Prostatitides, Acute|Asymptomatic Inflammatory Prostatitides|Prostatitides|Chronic Bacterial Prostatitides|chronic bacterial prostatitis|Acute Bacterial Prostatitides|Bacterial Prostatitis, Acute|Chronic Bacterial Prostatitis|Chronic Prostatitis with Chronic Pelvic Pain Syndrome|Acute bacterial prostatitis|chronic prostatitis|prostatitis|Acute Bacterial Prostatitis|Inflammatory Prostatitis, Asymptomatic|Bacterial Prostatitides, Chronic|Prostatitides, Chronic Bacterial|Asymptomatic Inflammatory Prostatitis|bacterial prostatitis"
NEW02739,DISEASE,particular Chlamydia trachomatis,particular Chlamydia trachomatis
NEW02740,DISEASE,Infections agents,Infections agents
C000629385,CHEBI,ceragenins [Supplementary Concept],antimicrobials|Steroids|Antimicrobials
NEW02741,CHEBI,bactericidal antimicrobials,bactericidal antimicrobials
D019868,CHEMICAL,Kanamycin Kinase,"Phosphotransferase, Aminocyclitol|Aminoglycoside Phosphotransferase|Phosphotransferase, Neomycin|Kanamycin Neomycin Phosphate Transferase|Phosphate Transferase, Kanamycin-Neomycin|3'-Phosphotransferase, Amikacin|aphVII Gene Product|APH(3')-IIb|Amikacin 3' Phosphotransferase|Phosphotransferase II, Neomycin|APHVII|Aminoglycoside Phosphotransferase Type III|APH(3')-IIIa|Aminoglycoside 3'-Phosphotransferase Type VIII|aminoglycoside|Neomycin Phosphotransferase II|APT-3'-I and II|Neomycin Phosphotransferase|Phosphotransferase, Aminoglycoside|Aminoglycoside 3' Phosphotransferase Type VIII|APT 3' I and II|Amikacin 3'-Phosphotransferase|Aminoglycoside 3'-Phosphotransferases (I and II)|Kinase, Kanamycin|Aminocyclitol Phosphotransferase|Kanamycin-Neomycin Phosphate Transferase|Transferase, Kanamycin-Neomycin Phosphate"
NEW02742,CHEMICAL,broad-spectrum penicillins,broad-spectrum penicillins
NEW02743,DISEASE,urosepsis,urosepsis
NEW02744,DISEASE,serious infection,serious infection
D000077731,CHEMICAL,Meropenem,Ronem|Penem|3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|SM7338|SM 7338|Merrem|meropenem|SM-7338
NEW02745,DISEASE,multiresistant gramnegative pathogens,multiresistant gramnegative pathogens
D000077725,CHEMICAL,"Piperacillin, Tazobactam Drug Combination","Tazocin|Piperacillin-Tazobactam Combination Product|Pipercillin Sodium Tazobactam Sodium|Piperacillin - Tazobactam|Piperacillin Tazobactam|piperacillin-tazobactam|Tazobactam, Piperacillin -|Pipercillin Sodium - Tazobactam Sodium|Pipercillin Sodium, Tazobactam Sodium Drug Combination|Piperacillin Tazobactam Combination Product|Tazocel|Tazocillin|Zosyn"
D024841,CHEMICAL,Fluoroquinolones,fluoroquinolones|Fluoroquinolone|Fluoroquinolones
D018942,CHEMICAL,Macrolides,Macrolide|macrolides
D013754,CHEMICAL,Tetracyclines,tetracyclines
D000617,CHEMICAL,Aminoglycosides,|Aminoglycoside|Aminoglycosides|aminoglycosides
NEW02746,DISEASE,resistant prostatitis,resistant prostatitis
D005578,CHEMICAL,Fosfomycin,"Fosfomycin Trometamol Salt|Fosfomycin Tromethamine|Monuril|fosfomycin|Phosphomycin|Phosphonomycin|Tromethamine, Fosfomycin"
NEW02747,CHEMICAL,alphablockers,alphablockers
NEW02748,DISEASE,prostatitis symptoms,prostatitis symptoms
NEW02749,CHEBI,single drug treatment,single drug treatment
D005436,CHEMICAL,Floxacillin,Fluorochloroxacillin|Flucloxacillin|flucloxacillin
NEW02750,DISEASE,kerosene poisoning,kerosene poisoning
NEW02751,CHEMICAL,oxygen support,oxygen support
NEW02752,DISEASE,aspiration pneumonitis,aspiration pneumonitis
D019475,CHEMICAL,Camphor 5-Monooxygenase,Cytochrome P 450 101|Cytochrome P-450 101|Cytochrome P 450 cam|Cytochrome P-450-cam|P450cam|camphor|Cytochrome P-450(cam)|CYP101|Camphor-5-Monooxygenase|Cytochrome P450(cam)|Camphor 5 Monooxygenase
NEW02753,DISEASE,serious toxicity,serious toxicity
NEW02754,CHEMICAL,camphor toxicity,camphor toxicity
NEW02755,CHEMICAL,naphthalene toxicity,naphthalene toxicity
NEW02756,DISEASE,acute intravascular hemolysis,acute intravascular hemolysis
D006457,DISEASE,"Hemoglobinuria, Paroxysmal","Hemoglobinuria, Paroxysmal Cold|Paroxysmal Hemoglobinuria, Nocturnal|Paroxysmal Cold Hemoglobinuria|Paroxysmal Hemoglobinuria, Cold|Hemoglobinuria, Cold Paroxysmal|Paroxysmal Nocturnal Hemoglobinuria|Marchiafava Micheli Syndrome|Nocturnal Paroxysmal Hemoglobinuria|hemoglobinuria|Hemoglobinuria, Paroxysmal Nocturnal|Marchiafava-Micheli Syndrome|Paroxysmal Hemoglobinuria|Syndrome, Marchiafava-Micheli|Hemoglobinuria, Nocturnal Paroxysmal|Cold Paroxysmal Hemoglobinuria"
D000468,CHEMICAL,Alkalies,|Alkali|alkalis|Alkalis|alkali
NEW02757,CHEBI,antimicrobial therapy,antimicrobial therapy
D008585,DISEASE,"Meningitis, Meningococcal","Serogroup B Meningococcal Meningitis|Serogroup W-135, Meningococcal Meningitis|Serogroup C Meningococcal Meningitis|Meningococcal Meningitis, Serogroup W135|Meningitis, Meningococcal, Serogroup W135|Meningococcal Meningitis, Serogroup W-135|Meningococcal Meningitis, Serogroup Y|Serogroup W 135, Meningococcal Meningitis|Meningitis, Meningococcic|Meningococcal Meningitis, Serogroup B|Meningococcal Meningitis, Serogroup W 135|Meningitis, Meningococcal, Serogroup B|Meningitis, Meningococcal, Serogroup Y|meningococcal meningitis|Meningococcal Meningitis, Serogroup A|Serogroup W135, Meningococcal Meningitis|Meningitis, Meningococcal, Serogroup C|Meningitis, Meningococcal, Serogroup A|Serogroup Y, Meningococcal Meningitis|Meningococcal Meningitis, Serogroup C|Serogroup A Meningococcal Meningitis|Meningococcal Meningitis|Meningitis, Meningococcal, Serogroup W-135"
NEW02758,CHEMICAL,2-propyl valeric acid,2-propyl valeric acid
D000073358,CHEMICAL,Mycobacterium abscessus,Mycobacterium bolletii|Mycobacterium abscessus Complex|Mycobacteroides abscessus|Mycobacteroides abscessus subsp. abscessus|Mycobacterium abscessus complex|Mycobacterium abscessus abscessus|Mycobacterium abscessus subsp. bolletii|Mycobacterium abscessus subspecies abscessus|Mycobacterium abscessus bolletii|Mycobacterium abscessus|Mycobacterium massiliense|Mycobacterium abscessus subsp. abscessus|Mycobacteroides abscessus subsp. massiliense|Mycobacterium chelonae abscessus|Mycobacterium abscessus subspecies bolletii
NEW02759,DISEASE,pulmonary nontuberculous mycobacteria infections,pulmonary nontuberculous mycobacteria infections
D000069196,CHEMICAL,Gastrointestinal Microbiome,"Gut Microflora|Gut Microbiota|Gastric Microbiomes|Intestinal Microbiomes|Gastrointestinal Microbial Community|Gastrointestinal Microflora|Microflora, Intestinal|Gastrointestinal Microbiotas|Gastrointestinal Microbial Communities|Microbiota, Gut|Flora, Gut|Intestinal Microflora|gastrointestinal microbiome|Intestinal Microbiota|Gastrointestinal Microbiota|Intestinal Flora|Flora, Gastrointestinal|Gastric Microbiome|Microbiota, Intestinal|Microflora, Gastrointestinal|Intestinal Microbiotas|Microflora, Gut|Enteric Bacteria|Gastrointestinal Microbiomes|Gut Microbiotas|Gut Microbiomes|Flora, Intestinal|Gastrointestinal Flora|Microbiota, Gastrointestinal|Microbiome, Gastric|Microbial Community, Gastrointestinal|Gut Microbiome|Microbiome, Intestinal|Microbiome, Gastrointestinal|Gut Flora|gut microbiota|GM|Intestinal Microbiome|Microbiome, Gut|Bacteria, Enteric"
NEW02760,DISEASE,microbial dysbiosis,microbial dysbiosis
NEW02761,CHEMICAL,circulating catecholamines,circulating catecholamines
NEW02762,DISEASE,peripheral lipolysis,peripheral lipolysis
D000081207,DISEASE,Primary Immunodeficiency Diseases,"Primary Antibody Deficiency Disorder|Immunodeficiency Diseases, Primary|Primary Immunodeficiency Syndrome|Primary Antibody Deficiency Disorders|Primary Immune Deficiency|Immunodeficiency Disorder, Congenital|Immunodeficiency Syndromes, Inherited|Congenital Immunodeficiency Diseases|Deficiency, Primary Immune|Primary Immune Deficiency Diseases|Congenital Immunodeficiency Disease|Immunodeficiency Syndromes, Primary|Primary Immunodeficiency Disorder|Congenital Immunodeficiency Syndromes|Immunodeficiency Disease, Congenital|Immunodeficiency Syndrome, Congenital|Immunodeficiency Diseases, Congenital|Immunodeficiency Syndromes, Congenital|Immunodeficiency Syndrome, Primary|Primary Immunodeficiency Disease|Primary Immune Deficiencies|Immunodeficiency Disorders, Inherited|Immunodeficiency Disorders, Congenital|Inherited Immunodeficiency Disorder|Primary Immune Deficiency Disorder|Antibody Deficiency, Primary|Primary Immune Deficiency Disorders|Primary Immunodeficiency Syndromes|immune deficiency|Inherited Immunodeficiency Syndromes|Inherited Immunodeficiency Syndrome|Inherited Immunodeficiency Diseases|Primary Immune Deficiency Syndrome|Immunodeficiency Disorder, Primary|Immune Deficiency, Primary|Congenital Immunodeficiency Disorders|Immunodeficiency Disease, Primary|Congenital Immunodeficiency Syndrome|deficiency disorder|Immunodeficiency Disease, Inherited|Immunodeficiency Syndrome, Inherited|Immunodeficiency Diseases, Inherited|Immunodeficiency Disorder, Inherited|Primary Antibody Deficiency|Inherited Immunodeficiency Disease|Primary Immunodeficiency Disorders|Primary Antibody Deficiencies|Primary Immune Deficiency Disease|Congenital Immunodeficiency Disorder|Primary Antibody Deficiency Syndrome|Inherited Immunodeficiency Disorders|Primary Immune Deficiency Syndromes|Primary Antibody Deficiency Syndromes"
NEW02763,DISEASE,hypermetabolic response,hypermetabolic response
NEW02764,DISEASE,opportunistic nosocomial bacterial resistance,opportunistic nosocomial bacterial resistance
NEW02765,DISEASE,severe burns,severe burns
NEW02766,MENTAL_HEALTH,emerging resistance,emerging resistance
NEW02767,CHEBI,antibiotic armamentarium,antibiotic armamentarium
NEW02768,CHEBI,newer antibiotics,newer antibiotics
NEW02769,DISEASE,large burns,large burns
D008933,DISEASE,Mitochondrial Swelling,"mitochondrial swelling|Swelling, Mitochondrial|Mitochondrial Swellings|Swellings, Mitochondrial|swelling"
D006987,DISEASE,Hypesthesia,"Hypesthesias, Tactile|Sensations, Impaired|Hypesthesia, Tactile|Sensation, Reduced|Hypoesthesias|Thermal Hypesthesias|Hypoesthesia|Sensation, Impaired|Impaired Sensation|Sensations, Reduced|numbness|Impaired Sensations|Tactile Hypesthesia|Reduced Sensation|Numbness|Hypesthesia, Thermal|Hypesthesias, Thermal|Hypesthesias|Reduced Sensations|Tactile Hypesthesias|Thermal Hypesthesia"
NEW02770,CHEMICAL,sodium depletion,sodium depletion
NEW02771,DISEASE,severe vomiting,severe vomiting
D020852,DISEASE,Lyme Neuroborreliosis,"Lyme Polyradiculopathy|Lyme Polyradiculopathies|Peripheral Nervous System Lyme Disease|Mononeuritis Multiplex, Lyme Disease|Central Nervous System Lyme Disease|Borrelia burgdorferi Neuroborreliosis|Meningoradiculitis, Lyme|Neuroborrelioses, Borrelia burgdorferi|Nervous System Lyme Disease|Lyme Disease Mononeuritis Multiplex|Meningoencephalitis, Lyme|Polyradiculopathy, Lyme|Lyme Disease, Nervous System|Neuroborreliosis, Borrelia burgdorferi|Lyme Polyradiculitides|Polyradiculitides, Lyme|Lyme Disease, Central Nervous System|Lyme Meningoradiculitis|Lyme Disease Encephalopathies|Polyradiculopathies, Lyme|Lyme Disease Encephalopathy|Neuroborreliosis, Lyme|lyme borreliosis|Polyradiculitis, Lyme|Encephalopathy, Lyme Disease|Encephalopathies, Lyme Disease|Lyme Polyradiculitis|Nervous System Lyme Borreliosis|Lyme Meningoencephalitis|Lyme Borreliosis, Nervous System"
NEW02772,CHEBI,unnecessary antimicrobial treatments,unnecessary antimicrobial treatments
NEW02773,MENTAL_HEALTH,advanced dementia,advanced dementia
D005472,CHEMICAL,Fluorouracil,"5-Fluorouracil-Biosyn||Fluoroplex|5-FU Medac|Fluracedyl|5FU|5 FU Medac|Fluorouracil GRY|Haemato FU|5 FU Lederle|Fluorouracil Mononitrate|Onkofluor|Fluorouracilo Ferrer Far|Ribofluor|Fluorouracil Monosodium Salt|5 HU Hexal|Dakota, Fluorouracile|5-FU|Haemato-FU|5-Fu|Fluorouracil-GRY|Carac|5-fluorouracil|5 Fluorouracil Biosyn|Fluorouracil Potassium Salt|Fluoruracil|Adrucil|Fluoro Uracile ICN|5 Fluorouracil|Fluorouracil Monopotassium Salt|5-Fluorouracil|Fluoro-Uracile ICN|Fluorouracile Dakota|fluorouracil|Efudex|Neofluor|Efudix|Flurodex|5-HU Hexal|5-FU Lederle"
D003123,DISEASE,"Colorectal Neoplasms, Hereditary Nonpolyposis","Hereditary Nonpolyposis Colorectal Cancer|colon cancer|colorectal cancer|Colorectal Cancer Hereditary Nonpolyposis|Lynch Syndrome|Familial Nonpolyposis Colon Cancer Type 1|Colon Cancer, Familial Nonpolyposis|Hereditary Nonpolyposis Colorectal Cancer Type 1|Colon Cancer, Familial Nonpolyposis, Type 1|Hereditary Nonpolyposis Colorectal Neoplasms|Hereditary Nonpolyposis Colon Cancer|Lynch Syndrome I|Colorectal Cancer, Hereditary Nonpolyposis, Type 1|Syndrome, Lynch|Lynch Cancer Family Syndrome I|Familial Nonpolyposis Colon Cancer"
D002955,CHEBI,Leucovorin,"Leucovorin, Calcium (1:1) Salt, (DL)-Isomer||leucovorin|Calcium Folinate|Leucovorin, (D)-Isomer|Calcium Leucovorin|Leukovorum|Leucovorin, Calcium (1:1) Salt, Pentahydrate|Leucovorin, (R)-Isomer|Leucovorin, Calcium (1:1) Salt|5 Formyltetrahydropteroylglutamate|Folinate, Calcium|Citrovorum Factor|Factor, Citrovorum|Leukovorin|Wellcovorin|Folinic Acid|Leucovorin, Calcium|folinic acid|5 Formyltetrahydrofolate|5-Formyltetrahydropteroylglutamate|Leucovorin, (DL)-Isomer|Acid, Folinic|Leucovorin, Monosodium Salt|Monosodium Salt Leucovorin|5-Formyltetrahydrofolate|Folinic Acid-SF|Folinic Acid SF|N(5)-Formyltetrahydrofolate"
NEW02774,MENTAL_HEALTH,high fatigue,high fatigue
NEW02775,CHEBI,H1 antagonist drug doxepin hydrocholoride,H1 antagonist drug doxepin hydrocholoride
D054316,CHEBI,"Biomarkers, Pharmacological","Drug Dosing Biomarkers|Dosing Biomarkers, Drug|Biomarkers, Drug Response|Pharmacological Biological Markers|Biomarker, Drug Dosing|Response Biomarkers, Drug|Pharmacological Biomarkers|Drug Safety|Dosing Biomarker, Drug|Safety Biomarkers, Drug|drug response|Drug Response Biomarkers|Markers, Pharmacological Biological|Biomarkers, Drug Safety|Biomarkers, Drug Dosing|Drug Dosing Biomarker|Drug Safety Biomarkers|Biological Markers, Pharmacological"
NEW02776,CHEMICAL,Arecoline responses,Arecoline responses
NEW02777,DISEASE,well-state bipolar patients,well-state bipolar patients
NEW02778,CHEMICAL,nicotine therapy,nicotine therapy
NEW02779,DISEASE,acute post-stroke period,acute post-stroke period
D002217,CHEMICAL,Carbachol,"|Carbamylcholine|carbamylcholine|Carbachol, Isopto|Doryl|Carbocholine|Carbacholine|Carbachol|Miostat|Jestryl|Carboptic|Carbamann|Carbastat|Isopto Carbachol|Carbamoylcholine|carbachol"
D022681,DISEASE,Diphtheria-Tetanus-acellular Pertussis Vaccines,"Diphtheria Tetanus acellular Pertussis Vaccines|Pertussis Vaccines, Diphtheria-Tetanus-acellular|Tetanus|Diphtheria-Tetanus-acellular Pertussis Vaccine|ACEL IMUNE|Vaccines, DTaP|Pertussis Vaccine, Diphtheria-Tetanus-acellular|Diphtheria Tetanus acellular Pertussis Vaccine|Vaccine, Diphtheria-Tetanus-acellular Pertussis|DTaP Vaccine|ACEL-IMUNE|DTaP Vaccines|Vaccines, Diphtheria-Tetanus-acellular Pertussis|tetanus|Infanrix|Tripedia|Vaccine, DTaP|ACELIMUNE"
NEW02780,CHEBI,cholinergic agonist pilocarpine,cholinergic agonist pilocarpine
NEW02781,DISEASE,unfavorable lactation-induced malnutrition,unfavorable lactation-induced malnutrition
NEW02782,CHEMICAL,pilocarpine effects,pilocarpine effects
C498513,CHEMICAL,PNU-282987 [Supplementary Concept],Bridged Bicyclo Compounds|PNU|PNU-282987|Benzamides
C000716082,CHEBI,ICH3 alpha7 nicotinic acetylcholine receptor agonist [Supplementary Concept],nicotinic acetylcholine receptor agonist|Spiro Compounds|Fumarates|α7 nicotinic acetylcholine receptor agonist
NEW02783,DISEASE,TgR mice,TgR mice
NEW02784,MENTAL_HEALTH,severe mania,severe mania
D010862,CHEMICAL,Pilocarpine,"pilocarpine|Isoptocarpine|Pilocarpine Hydrochloride|Hydrochloride, Pilocarpine|Pilocarpine Nitrate||Salagen|Isopilocarpine|Ocusert|Pilocarpine, Monohydrochloride, (3S-cis)-Isomer|Nitrate, Pilocarpine|Pilocarpine Mononitrate, (3S-cis)-Isomer|Pilocarpine"
NEW02785,DISEASE,muscle atonia,muscle atonia
D000068797,CHEMICAL,Orexins,Hypocretin-2|Orexin B|Orexin|Hypocretin-1|ORX|Hypocretin|Hypocretin 2|Orexin-A|Orexin-B|Hypocretins|orexins|Orexin A|Hypocretin 1
NEW02786,DISEASE,narcolepsy/cataplexy,narcolepsy/cataplexy
C059240,CHEMICAL,cevimeline [Supplementary Concept],Quinuclidines|AF102B|Thiophenes|cevimeline
NEW02787,MENTAL_HEALTH,mild-to-moderate Alzheimer disease,mild-to-moderate Alzheimer disease
NEW02788,CHEMICAL,transdermal xanomeline,transdermal xanomeline
NEW02789,CHEBI,M1-selective cholinergic agonist,M1-selective cholinergic agonist
NEW02790,CHEMICAL,acetylcholine synthesis,acetylcholine synthesis
NEW02791,NUTRITION,cytosolic choline,cytosolic choline
NEW02792,CHEMICAL,mint aroma,mint aroma
NEW02793,DISEASE,S. divinorum,S. divinorum
NEW02794,CHEBI,potent agonist,potent agonist
NEW02795,CHEMICAL,Eredményeink azt mutatják,Eredményeink azt mutatják
NEW02796,CHEMICAL,károsodás negatív,károsodás negatív
D007184,DISEASE,Incontinentia Pigmenti,"Syndrome, Bloch-Sulzberger|Bloch-Sulzberger Syndrome|Bloch-Siemens-Sulzberger Syndrome|incontinentia|Bloch-Siemens Syndrome|Bloch Sulzberger Syndrome"
NEW02797,CHEMICAL,N-methyl-d-aspartate receptor hypofunction,N-methyl-d-aspartate receptor hypofunction
C496397,CHEMICAL,"benzonitrile, 4-(2-(2-((2r)-2-methyl-1-pyrrolidinyl)ethyl)-5-benzofuranyl)- [Supplementary Concept]",Benzofurans|Pyrrolidines|ABT-239
NEW02798,DISEASE,neurodevelopmental model,neurodevelopmental model
NEW02799,CHEMICAL,MAM rats,MAM rats
NEW02800,DISEASE,spontaneous alternation impairments,spontaneous alternation impairments
NEW02801,CHEBI,Several histamine H3 receptor antagonists,Several histamine H3 receptor antagonists
NEW02802,MENTAL_HEALTH,narcolepsy deficits,narcolepsy deficits
NEW02803,CHEMICAL,c-hydroxybutyrate,c-hydroxybutyrate
NEW02804,CHEBI,full antagonist,full antagonist
NEW02805,DISEASE,neonatal habenula lesion,non-Hodgkin 's lymphoma|NHL|neonatal habenula lesion
NEW02806,CHEBI,H3 antagonist administration,H3 antagonist administration
NEW02807,DISEASE,NHL-induced hyperlocomotion,NHL-induced hyperlocomotion
D015123,DISEASE,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide","7,8-Dihydroxy-9,10-Epoxy-7,8,9,10-Tetrahydrobenzo(a)pyrene|Anti BaPDE|7,8-BaP-9,10-Diol Epoxide|Benzo(a)pyrene 7,8-Dihydrodiol 9,10-Epoxide|Anti-BaPDE|BPDE|7|Benzo(a)pyrene-7,8-diol 9,10-Epoxide"
NEW02808,DISEASE,progressive neurodegenerative disease,progressive neurodegenerative disease
D002974,CHEMICAL,Clemastine,Tavist|Clemastine Fumarate|Tavegyl|HS592|Clemastine|HS 592|2-(2-(1-(4-Chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine|Meclastine|clemastine|HS-592|Mecloprodin
D016589,CHEMICAL,Astemizole,"Esmacen|Fustermizol|Urdrim|Astemina|Hismanal|Paralergin|Alonga, Astemizol|R43512|Laridal|Emdar|Romadin|Histaminos|R-43-512|Rifedot|Ratiopharm, Astemizol|Retolen|Rimbol|Astemizol Alonga|R 43 512|Hubermizol|Simprox|Astemizol Ratiopharm|Alermizol|Astesen|astemizole"
NEW02809,DISEASE,epileptic patients,epileptic patients
NEW02810,CHEMICAL,non-sedative histamine H1 receptor antagonist terfenadine mg/kg,non-sedative histamine H1 receptor antagonist terfenadine mg/kg
NEW02811,CHEMICAL,terfenadine treatment,terfenadine treatment
NEW02812,CHEMICAL,histamine H1 receptor antagonist terfenadine,histamine H1 receptor antagonist terfenadine
D016593,CHEMICAL,Terfenadine,"Terfenadin-Ratiopharm||RMI-9918|Terfedura|Terfemundin|Terfenadin Stada|Triludan|Rapidal|Terfenadin AL|Seldane|Cyater|Terfenadin Ratiopharm|Ternadin|Terfenadin Heumann|alpha-(4-(1,1-Dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-1-piperdinebutanol|Hisfedin|Terfenadin Von Ct|Terfenadine|Teldane|RMI 9918|Terfenidine|RMI9918|terfenadine|Balkis Saft Spezial"
NEW02813,CHEMICAL,selective histamine H1 receptor antagonist,selective histamine H1 receptor antagonist
NEW02814,CHEMICAL,h post-nicotine withdrawal time,h post-nicotine withdrawal time
NEW02815,DISEASE,somatic behavior,somatic behavior
NEW02816,CHEMICAL,μg/mouse,μg/mouse
D017332,CHEMICAL,Cetirizine,"Virlix|Cetirigamma|Zetir|Dihydrochloride, Cetirizine|Ceti-Puren|Cetirizine Dihydrochloride|Ceti TAD|Cetalerg|Ceterifug|P 071|Zyrtec|Cetirizin AL|P071|CetiLich|Cetirlan|Cetil von ct|Reactine|Cetidura|cetirizine|Voltric|Cetirizin Basics|P-071|Cetiderm|Zirtek|Cetirizin AZU|(2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic Acid|Alerlisin"
NEW02817,CHEMICAL,endogenous histamine,endogenous histamine
NEW02818,CHEMICAL,adenosine A1 receptor agonist N6-cyclopentyladenosine,CPA|adenosine A1 receptor agonist N6-cyclopentyladenosine
NEW02819,DISEASE,impaired emotional memory,impaired emotional memory
C021062,CHEMICAL,niaprazine [Supplementary Concept],Niacinamide/analogs  and  derivatives|niaprazine|Niaprazine
NEW02820,CHEMICAL,mg lorazepam,mg lorazepam
NEW02821,CHEMICAL,L-759274,L-759274
NEW02822,CHEMICAL,Substance P NK1 receptor antagonists,Substance P NK1 receptor antagonists
NEW02823,CHEMICAL,conventional antidepressants,conventional antidepressants
NEW02824,CHEBI,drug agreements,drug agreements
NEW02825,DISEASE,drug-induced impairments,drug-induced impairments
NEW02826,DISEASE,sleep deficits,sleep deficits
NEW02827,CHEBI,unintentional drug overdoses,unintentional drug overdoses
NEW02828,CHEBI,opioid agents,opioid agents
NEW02829,DISEASE,injury death,injury death
NEW02830,DISEASE,burn pain management,burn pain management
NEW02831,CHEBI,drug arm,drug arm
NEW02832,CHEBI,nonspecific GABAA receptor agonist muscimol,nonspecific GABAA receptor agonist muscimol
D016688,DISEASE,"Mice, Inbred NOD","NOD Mice, Inbred|Diabetic Mouse, Nonobese|Non-Obese Diabetic Mouse|Mice, Non-Obese Diabetic|Non Obese Diabetic Mouse|Mouse, Non-Obese Diabetic|Inbred NOD Mice|Mouse, Inbred NOD|Non Obese Diabetic Mice|Mice, NOD|Diabetic Mice, Non-Obese|Diabetic Mouse, Non-Obese|Mouse, NOD|Inbred NOD Mouse|NOD Mouse, Inbred|Mice, Nonobese Diabetic|Diabetic Mice, Nonobese|Nonobese Diabetic Mouse|NOD Mouse|diabetic mice|Mouse, Nonobese Diabetic|Nonobese Diabetic Mice|Non-Obese Diabetic Mice|NOD Mice"
NEW02833,MENTAL_HEALTH,various mental disorders,various mental disorders
C015542,CHEMICAL,gaboxadol [Supplementary Concept],Isoxazoles|OV101|Gaboxadol
NEW02834,CHEBI,δ-subunit-selective GABAA receptor agonist,δ-subunit-selective GABAA receptor agonist
NEW02835,DISEASE,FXS adolescents,FXS adolescents
NEW02836,CHEMICAL,OV101    mg QD,OV101    mg QD
NEW02837,CHEBI,GABAA receptor agonist,GABAA receptor agonist
NEW02838,DISEASE,behavioral abnormalities,behavioral abnormalities
D011280,CHEMICAL,Pregnanolone,"alpha-Hydroxy-5 beta-pregnan-20-one, 3|Pregnanolone, (3beta, 5beta)-isomer|3 alpha Hydroxy 5 beta pregnan 20 one|Pregnan 3alpha ol 20 one|3 alpha, 5 beta Tetrahydroprogesterone|Epipregnanolone|allopregnanolone|pregnanolone|3beta Hydroxy 5alpha pregnan 20 one|Sepranolone|3 alpha-Hydroxy-5 beta-pregnan-20-one|Pregnanolone, (3alpha)-isomer|3 alpha-Hydroxy-5 alpha-pregnan-20-one|Pregnanolone, (3alpha, 5beta, 17-alpha)-isomer|Pregnanolone, (3beta, 5alpha, 8alpha, 17beta)-isomer|beta-pregnan-20-one, 3 alpha-Hydroxy-5|Eltanolone|alpha-Hydroxy-5 alpha-pregnan-20-one, 3|Pregnanolone, (3beta, 5beta, 17alpha)-isomer|Pregnanolone, (5alpha)-isomer|Pregnanolone, (3beta, 5alpha)-isomer|Allopregnan-3 beta-ol-20-one|3 alpha, 5 beta-Tetrahydroprogesterone|Pregnanolone, (3beta, 5alpha, 17alpha)-isomer|Pregnanolone, (3beta)-isomer|3-Hydroxypregnan-20-one|3beta-Hydroxy-5alpha-pregnan-20-one|beta-ol-20-one, Allopregnan-3|Pregnanolone, (3beta, 5beta,14beta)-isomer|alpha-pregnan-20-one, 3 alpha-Hydroxy-5|Pregnanolone|3 alpha Hydroxy 5 alpha pregnan 20 one|Pregnanolone, (3alpha,5alpha)-isomer|3 Hydroxypregnan 20 one|Pregnan-3alpha-ol-20-one|Pregnanolone, (3alpha,5beta)-isomer|Allopregnanolone|100nM|Allopregnan 3 beta ol 20 one"
NEW02839,CHEMICAL,NMDA receptor activation enhancer,NMDA receptor activation enhancer
NEW02840,CHEMICAL,tetrahydrodeoxy-corticosterone,THDOC|tetrahydrodeoxy-corticosterone
D020941,CHEMICAL,"Myasthenia Gravis, Neonatal","MG|Myasthenia Gravis, Neonatal, Transient|Persistent Neonatal Myasthenia Gravis|Myasthenia gravis|Antenatal Myasthenia Gravis|Neonatal Myasthenia Gravis|Myasthenia Gravis, Transient, Neonatal|Neonatal Myasthenia Gravis, Persistent|Transient Neonatal Myasthenia Gravis|Myasthenia Gravis, Persistent, Neonatal|myasthenia gravis|Myasthenia Gravis, Antenatal|Neonatal Myasthenia Gravis, Transient|Myasthenia Gravis, Neonatal, Persistent"
C432169,CHEMICAL,"6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyrido(3,4-b)indol-1-one [Supplementary Concept]",Pyrroles|Indoles|SL651498
NEW02841,CHEBI,drug development candidate,drug development candidate
NEW02842,CHEMICAL,"6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyrido[3,4-b]indol-1-one","6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyrido[3,4-b]indol-1-one"
NEW02843,DISEASE,drugs muscle weakness,drugs muscle weakness
C584145,DISEASE,"SZT2 protein, human [Supplementary Concept]",Nerve Tissue Proteins|seizure threshold
C543979,CHEMICAL,artemisinin-naphthoquine combination [Supplementary Concept],artemisinin|Artemisinin|Artemisinins|Naphthoquinones
NEW02844,DISEASE,intestinal tract helminthosis,intestinal tract helminthosis
D017780,DISEASE,Malaria Vaccines,"Malaria Vaccine|Malarial Vaccine|Vaccine, Malarial|malaria|Vaccine, Malaria|Vaccines, Malaria|Vaccines, Malarial|Malarial Vaccines"
D003048,DISEASE,Coccidiosis,Besnoitiosis|Besnoitiasis|coccidiosis|Besnoitiases|Besnoitioses|Coccidioses
NEW02845,CHEBI,promising drug,promising drug
NEW02846,CHEMICAL,combined CO2-/O2-stunning,combined CO2-/O2-stunning
NEW02847,MENTAL_HEALTH,new stress reactions,new stress reactions
NEW02848,CHEMICAL,5-fluoro-uracil,5-fluoro-uracil
NEW02849,CHEBI,nutritional niacin deficiency,nutritional niacin deficiency
D006827,CHEMICAL,Hydantoins,"Hydantoin|hydantoins|Imidazolidine 2,4 Diones|Imidazolidine-2,4-Diones"
NEW02850,CHEMICAL,pyrazinamide ehtionamide,pyrazinamide ehtionamide
D015500,CHEMICAL,Chloramphenicol O-Acetyltransferase,"Transacetylase, Chloramphenicol|CAT Enzyme|chloramphenicol|Chloramphenicol O Acetyltransferase|Chloramphenicol Transacetylase|Chloramphenicol Acetyltransferase|Acetyltransferase, Chloramphenicol|O-Acetyltransferase, Chloramphenicol|Enzyme, CAT"
NEW02851,DISEASE,gastro-intestinal malabsorption,gastro-intestinal malabsorption
D015122,CHEMICAL,Mercaptopurine,"6-Thiopurine|1,7-Dihydro-6H-purine-6-thione|BW 57-323H|6-mercaptopurine|6-Mercaptopurine|6 Thiopurine|Mecaptopurine Anhydrous|Purinethol|Purimethol|6 Mercaptopurine Monohydrate|6 Mercaptopurine|6 Thiohypoxanthine|6-Thiohypoxanthine|Leupurin|6-Mercaptopurine Monohydrate|6H-Purine-6-thione, 1,7-dihydro-|BW 57323H|Mercaptopurina Wellcome|BW 57 323H|Puri-Nethol"
NEW02852,DISEASE,chronic alcoholism,chronic alcoholism
D054409,CHEBI,Nicotinamide Phosphoribosyltransferase,"Colony-Enhancing Factor, Pre-B-Cell|Pre-B-Cell Colony-Enhancing Factor|NAMPT Protein|Nicotinamide|nicotinamide|Visfatin|NAmPRTase|NMN Pyrophosphorylase|Phosphoribosyltransferase, Nicotinamide|Pre B Cell Colony Enhancing Factor"
NEW02853,CHEBI,niacin cures,niacin cures
NEW02854,CHEMICAL,Creatine supplementation,Creatine supplementation
NEW02855,DISEASE,muscular myopathies,muscular myopathies
NEW02856,NUTRITION,omega-6 polyunsaturated fatty acids,omega-6 polyunsaturated fatty acids
NEW02857,CHEMICAL,dietary omega-3,dietary omega-3
NEW02858,DISEASE,dopaminergic abnormalities,dopaminergic abnormalities
NEW02859,DISEASE,working memory impairments,working memory impairments
NEW02860,CHEMICAL,Selective D1 dopamine agonists,Selective D1 dopamine agonists
C095428,CHEMICAL,adrogolide hydrochloride [Supplementary Concept],Tetrahydronaphthalenes|Pyridines|ABT-431|Adrogolide
NEW02861,DISEASE,inpatient psychiatric unit,inpatient psychiatric unit
NEW02862,DISEASE,psychiatric history,psychiatric history
NEW02863,CHEMICAL,once-daily extended-release oral formulation,once-daily extended-release oral formulation
D064699,CHEMICAL,Dexmethylphenidate Hydrochloride,"dexmethylphenidate|Dexmethylphenidate|XR, Focalin|Focalin|Hydrochloride, Dexmethylphenidate|Focalin XR"
NEW02864,CHEMICAL,dexmethylphenidate XR,dexmethylphenidate XR
NEW02865,CHEBI,AVP receptor agonists,AVP receptor agonists
NEW02866,CHEMICAL,Hypothalamic oxytocin,Hypothalamic oxytocin|OXT
D003894,CHEMICAL,Deamino Arginine Vasopressin,"Octostim|Monoacetate, Desmopressin|Arginine vasopressin|1-Desamino-8-arginine Vasopressin|Apo-Desmopressin|Ferring, Desmopressine|Desmopressin Monoacetate|Desmopressin|Vasopressin, 1-Deamino-8-D-arginine|Desmotabs|arginine-vasopressin|Vasopressin, 1-Desamino-8-arginine|Minirin|Trihydrate Desmopressin Monoacetate|Desmogalen|DDAVP|Acetate, Desmopressin|Monoacetate, Trihydrate Desmopressin|Adiuretin SD|Desmopressin Acetate|arginine vasopressin|1-Deamino-8-D-arginine Vasopressin|Desmospray|AVP|Desmopressine Ferring|Nocutil|Octim|Minurin|Desmopressin Monoacetate, Trihydrate|Vasopressin, Deamino Arginine|Arginine Vasopressin, Deamino|Adiuretin"
NEW02867,DISEASE,stress-induced depressive behaviors,stress-induced depressive behaviors
NEW02868,CHEMICAL,OXT transcripts,OXT transcripts
NEW02869,DISEASE,Stress-induced depression-like behaviors,Stress-induced depression-like behaviors
NEW02870,CHEMICAL,OXT promoters,OXT promoters
NEW02871,CHEMICAL,β-adrenergic blocker propranolol,β-adrenergic blocker propranolol
NEW02872,DISEASE,subsequent traumatic imagery,subsequent traumatic imagery
NEW02873,CHEBI,glucocorticoid GR antagonist mifepristone,glucocorticoid GR antagonist mifepristone
NEW02874,DISEASE,Erythrocyte deformations,Erythrocyte deformations
D018019,CHEBI,"Receptors, Corticotropin-Releasing Hormone","CRF Receptor|CRH Receptors|Corticotropin Releasing Factor Receptors|Receptor, Corticotropin Releasing-Factor|CRF|Releasing-Hormone Receptors, Corticotropin|CRF Receptors|Receptors, Corticotropin Releasing Hormone|Corticotropin Releasing Hormone Receptor|Corticotropin Releasing Hormone Receptors|Receptors, Corticotropin Releasing-Factor|Corticotropin-releasing hormone|Receptors, CRH|Receptor, CRH|Corticotropin Releasing-Factor Receptors|Corticotropin Releasing-Hormone Receptors|corticotropin-releasing hormone|Hormone Receptors, Corticotropin-Releasing|Receptor, Corticotropin Releasing-Hormone|CRH Receptor|Corticotropin-releasing factor|Corticotropin Releasing Factor Receptor|Corticotropin-Releasing Hormone Receptors|CRF receptors|Corticotropin Releasing-Factor Receptor|Receptor, CRF|Releasing-Hormone Receptor, Corticotropin|Receptors, CRF|CRH|Corticotropin Releasing-Hormone Receptor|Releasing-Factor Receptors, Corticotropin|Receptors, Corticotropin Releasing-Hormone|Releasing-Factor Receptor, Corticotropin"
D000087527,CHEBI,Uremic Toxins,Uremia Toxins|uremic toxins|Uremic Retention Solutes|Uremic toxins
NEW02875,DISEASE,distal polyneuropathy,distal polyneuropathy
D020364,DISEASE,Paraneoplastic Polyneuropathy,"Neuropathies, Paraneoplastic Peripheral|Paraneoplastic Neuropathies|Polyneuropathies, Paraneoplastic|Peripheral Neuropathy, Paraneoplastic|Polyneuropathy, Paraneoplastic|Paraneoplastic Peripheral Neuropathy|polyneuropathy|Paraneoplastic Peripheral Neuropathies|Neuropathy, Paraneoplastic Peripheral|Neuropathies, Paraneoplastic|Neuropathy, Paraneoplastic|Paraneoplastic Neuropathy|Paraneoplastic Polyneuropathies|Peripheral Neuropathies, Paraneoplastic|peripheral neuropathies"
NEW02876,DISEASE,central nervous system toxicity,central nervous system toxicity
D058186,DISEASE,Acute Kidney Injury,"|Kidney Injuries, Acute|Acute Kidney Insufficiencies|Acute Kidney Injuries|Kidney Failures, Acute|Renal Failure, Acute|Acute Renal Injuries|Renal Insufficiencies, Acute|ARF|Renal Injuries, Acute|kidney injury|acute kidney injury|Acute Renal Injury|Renal Insufficiency, Acute|Acute Kidney Failure|acute renal failure|Kidney Injury, Acute|Acute Renal Failure|Acute Renal Insufficiency|Kidney Failure, Acute|Kidney Insufficiencies, Acute|Acute Renal Insufficiencies|Acute Kidney Failures|Acute Renal Failures|Kidney Insufficiency, Acute|Renal Injury, Acute|Renal Failures, Acute|AKI|Acute Kidney Insufficiency"
NEW02877,CHEBI,major uremic toxin,major uremic toxin
NEW02878,CHEMICAL,Baseline indoxyl sulfate abundance,Baseline indoxyl sulfate abundance
NEW02879,MENTAL_HEALTH,psychic anxiety,psychic anxiety
D007200,CHEMICAL,Indican,"Indoxyl Sulfate|Monosodium Salt, Indican|indoxyl sulfate|Indican Monopotassium Salt|Sulfate, Indoxyl|1H-Indol-3-ol Hydrogen Sulfate Ester|Indoxyl sulfate|Indican Monosodium Salt|Monopotassium Salt, Indican"
NEW02880,CHEMICAL,corticosterone element-1 silencing factor REST regulators,corticosterone element-1 silencing factor REST regulators
C408690,CHEMICAL,4-cresol sulfate [Supplementary Concept],p-Cresol|Cresols|P-cresol|p-cresol|p-cresol sulfate|Sulfuric Acid Esters
D052241,DISEASE,Fanconi Anemia Complementation Group G Protein,XRCC9 Protein|FANCG Protein|anemia|Fanconi Anemia Group G Protein|X Ray Repair Complementing Defective Repair In Chinese Hamster Cells 9 Protein|X-Ray Repair Complementing Defective Repair In Chinese Hamster Cells 9 Protein|Fanconi Anemia Group G Complementing Protein
NEW02881,CHEBI,accumulative uremic toxin,accumulative uremic toxin
NEW02882,CHEBI,aging toxins,aging toxins
D017366,CHEBI,Serotonin Receptor Agonists,"Agonist, 5-Hydroxytrytamine|Agonists, 5-Hydroxytryptamine|Serotonin Agonists|5-HT Agonist|Agonists, 5-HT|5-Hydroxytryptamine Agonists|Agonists, Serotonin Receptor|Agonist, Serotonin Receptor|5 Hydroxytryptamine Agonists|Agonists, Serotonin|serotonergic agonist|5 HT Agonists|serotonin receptor agonist|Receptor Agonist, Serotonin|5-HT agonists|serotonergic agonists|Serotonin Agonist|Serotonergic Agonist|serotonin receptor agonists|Agonist, 5-HT|5 Hydroxytrytamine Agonist|Agonist, Serotonergic|serotonin receptor|5 HT Agonist|Agonists, Serotonergic|Serotonergic Agonists|Receptor Agonists, Serotonin|5-Hydroxytrytamine Agonist|Agonist, Serotonin|5-HT Agonists|Serotonin Receptor Agonist"
C015068,CHEMICAL,1-(3-chlorophenyl)piperazine [Supplementary Concept],|m-chlorophenylpiperazine|meta-chlorophenylpiperazine|Piperazines
NEW02883,CHEMICAL,nigrostriatal DA neurons,nigrostriatal DA neurons
NEW02884,MENTAL_HEALTH,dyskinesia expression,dyskinesia expression
NEW02885,CHEMICAL,ionotropic N-methyl-D -aspartate receptors,ionotropic N-methyl-D -aspartate receptors
NEW02886,CHEBI,direct-acting postsynaptic serotonergic agonist,direct-acting postsynaptic serotonergic agonist
NEW02887,MENTAL_HEALTH,treatment-refractory chronic schizophrenia,treatment-refractory chronic schizophrenia
NEW02888,CHEMICAL,Oral metachlorophenylpiperazine,Oral metachlorophenylpiperazine
NEW02889,DISEASE,serotonergic dysfunction,serotonergic dysfunction
NEW02890,CHEMICAL,serotonin agonist meta-chlorophenylpiperazine,m-CPP|serotonin agonist meta-chlorophenylpiperazine|0.5mg/kg metachlorophenylpiperazine
NEW02891,DISEASE,DSM-III-R chronic schizophrenic patients,DSM-III-R chronic schizophrenic patients
NEW02892,CHEMICAL,oral m-CPP,oral m-CPP
NEW02893,DISEASE,hostility factor,hostility factor
NEW02894,CHEMICAL,m-CPP condition,m-CPP condition
NEW02895,CHEMICAL,smaller cortisol response,smaller cortisol response
NEW02896,CHEMICAL,Meta-chloro-phenyl-piperazine,Meta-chloro-phenyl-piperazine
C000628274,CHEMICAL,"HTR2C protein, human [Supplementary Concept]","Receptor, Serotonin, 5-HT2C|5HT2c|5HT2C"
NEW02897,CHEBI,nonspecific serotonergic agonist,nonspecific serotonergic agonist
NEW02898,DISEASE,OCD patients,OCD patients
NEW02899,CHEMICAL,5-HT agonist metachlorophenylpiperazine,mCPP|meta-chlorphenylpiprazine|5-HT agonist metachlorophenylpiperazine
NEW02900,CHEMICAL,cocaine withdrawal,cocaine withdrawal
NEW02901,CHEMICAL,cocaine administration,cocaine administration
NEW02902,MENTAL_HEALTH,cocaine-induced anxiety,cocaine-induced anxiety
NEW02903,DISEASE,OCD symptoms,OCD symptoms
NEW02904,CHEMICAL,intravenous mCPP,intravenous mCPP
NEW02905,CHEMICAL,oral mCPP,oral mCPP
NEW02906,CHEBI,potent serotonin antagonist,potent serotonin antagonist
D011562,CHEMICAL,Psilocybin,Psilocybine|Psilocibin|psilocybin|Psilocybin
NEW02907,DISEASE,sleep-related neuroplasticity,sleep-related neuroplasticity
NEW02908,DISEASE,GAS mice,GAS mice
NEW02909,CHEBI,agonist infiltrates,agonist infiltrates
NEW02910,CHEBI,safe CRF antagonists,safe CRF antagonists
NEW02911,DISEASE,human diseases,human diseases
NEW02912,CHEBI,important neuropeptide hormone,important neuropeptide hormone
NEW02913,DISEASE,CRF system,CRF system
D010437,DISEASE,Peptic Ulcer,"|Gastroduodenal Ulcer|Ulcers, Marginal|Ulcers, Gastroduodenal|Marginal Ulcers|Ulcer, Marginal|Gastroduodenal Ulcers|Ulcer, Gastroduodenal|peptic ulcer disease|Ulcers, Peptic|Marginal Ulcer|Peptic Ulcers|peptic ulcers|Ulcer, Peptic"
NEW02914,CHEMICAL,standard CRF antagonist drug antalarmin,standard CRF antagonist drug antalarmin
NEW02915,CHEMICAL,CRF/CRF1R unit,CRF/CRF1R unit
NEW02916,DISEASE,CRF peptide antagonists,CRF peptide antagonists
NEW02917,DISEASE,stress/anxiety,stress/anxiety
NEW02918,CHEBI,hormone mediator,hormone mediator
NEW02919,CHEBI,endocrine responses,endocrine responses
NEW02920,CHEBI,lipophilic CRF antagonists,lipophilic CRF antagonists
NEW02921,CHEMICAL,antidepressant activity,antidepressant activity
NEW02922,DISEASE,CRF neuronal hyperactivity,CRF neuronal hyperactivity
NEW02923,CHEBI,CRF(1 receptor antagonists,CRF(1 receptor antagonists
NEW02924,DISEASE,CRF release,CRF release
NEW02925,CHEBI,CRF antagonists,CRF antagonists
NEW02926,DISEASE,PFC cognitive dysfunction,PFC cognitive dysfunction
NEW02927,CHEBI,CRFR1 antagonists,CRFR1 antagonists
NEW02928,CHEBI,CRFR1 antagonist,CRFR1 antagonist
NEW02929,DISEASE,kindling seizure,kindling seizure
D011345,CHEMICAL,Fenofibrate,"Fenofibrat Stada|Fenofibrat Heumann|Micronized Procetofen, Antara|Nu-Fenofibrate|Fenofibrat AL|Livesan|Phenofibrate|Lipidil|Procetofen, Antara Micronized|fenofibrat von ct|Fénofibrate MSD|Secalip|durafenat|Gen Fenofibrate|Lipidil Ter|PMS-Fenofibrate Micro|Controlip|Lipantil|Tricor|Novo-Fenofibrate|Supralip|MTW Fenofibrat|Nu Fenofibrate|LF-178|Debat, Fénofibrate|CiL|Lipanthyl|Apo Fenofibrate|Fenofibrat FPh|fenofibrate|Fenofibrat ratiopharm|Liparison|PMS Fenofibrate Micro|Hexal, Fenofibrat|Lipidil-Ter|LF 178|Fénofibrate Debat|Apo-Fenofibrate|Procetofene|AZU, Fenofibrat|Apo Feno Micro|Fenofibrat Hexal|Stada, Fenofibrat|LF178|Procetofen|Fenofibrat AZU|Fenofanton|Lofibra|Novo Fenofibrate|Normalip|Fenofibrat-ratiopharm|Fenofibrat AbZ|Apo-Feno-Micro|Fenobeta|MTW-Fenofibrat|Antara Micronized Procetofen|Gen-Fenofibrate|Fenofibrate|Heumann, Fenofibrat"
NEW02930,DISEASE,seizure latency,seizure latency
NEW02931,DISEASE,latency behaviors,latency behaviors
NEW02932,DISEASE,PTZ-induced kindling seizure,PTZ-induced kindling seizure
NEW02933,CHEMICAL,2-ethyl-3-methylpyrazine,2-ethyl-3-methylpyrazine
D010424,CHEMICAL,Pentobarbital,"|Diabutal|pentobarbital|Pentobarbitone|Nembutal|Pentobarbital, Monosodium Salt|Monosodium Salt Pentobarbital|Ethaminal|Etaminal|Pentobarbital Sodium|Mebubarbital|Mebumal|Sagatal"
NEW02934,CHEMICAL,Aqueous katsuobushi,AK|Aqueous katsuobushi
NEW02935,CHEBI,Kappa-opioid receptor antagonists,Kappa-opioid receptor antagonists
NEW02936,MENTAL_HEALTH,abuse disorders,abuse disorders
NEW02937,CHEMICAL,KOP agonists,KOP agonists
NEW02938,CHEBI,strong analgesic effect,strong analgesic effect
D058999,DISEASE,Drug-Seeking Behavior,"drug-seeking behaviors|Drug-Seeking Behaviors|Drug Seeking Behavior|drug seeking|Behavior, Drug-Seeking|Behaviors, Drug-Seeking|Drug-seeking behavior|drug-seeking behavior"
NEW02939,CHEMICAL,"U50,488 mg/kg","U50,488 mg/kg"
NEW02940,CHEMICAL,systemic nicotine,systemic nicotine
NEW02941,CHEMICAL,κ-receptor antagonist norbinaltorphimine,norBNI|κ-receptor antagonist norbinaltorphimine
NEW02942,MENTAL_HEALTH,stress-induced anxiety responses,stress-induced anxiety responses
NEW02943,MENTAL_HEALTH,anxiety responses,anxiety responses
NEW02944,NUTRITION,Elemental mercury,Elemental mercury
NEW02945,CHEBI,well-recognized neurotoxicant,well-recognized neurotoxicant
C040533,CHEMICAL,trimethyltin chloride [Supplementary Concept],Trimethyltin Compounds|Trimethyltin chloride|TMT
NEW02946,MENTAL_HEALTH,related mental disorders,related mental disorders
NEW02947,CHEMICAL,Non-dioxin-like NDL polychlorinated biphenyls,Non-dioxin-like NDL polychlorinated biphenyls
NEW02948,DISEASE,neuropsychological dysfunction,neuropsychological dysfunction
NEW02949,CHEBI,potential neurotoxicant,potential neurotoxicant
NEW02950,CHEMICAL,Cd exposure,Cd exposure
NEW02951,CHEBI,widespread environmental neurotoxicant,widespread environmental neurotoxicant
NEW02952,CHEMICAL,acute carbon disulfide exposure,acute carbon disulfide exposure
NEW02953,DISEASE,psychiatric risk,psychiatric risk
NEW02954,CHEMICAL,polycyclic aromatic hydrocarbons common,polycyclic aromatic hydrocarbons common
NEW02955,CHEMICAL,dopamine neurotransmission,dopamine neurotransmission
NEW02956,CHEBI,neurotoxicant,neurotoxicant
NEW02957,DISEASE,its's neurotoxicity,its's neurotoxicity
NEW02958,CHEMICAL,elevated BHg levels,elevated BHg levels
NEW02959,NUTRITION,Omega-3 polyunsaturated fatty acids,Omega-3 polyunsaturated fatty acids
NEW02960,CHEBI,antifungal treatment,antifungal treatment
NEW02961,DISEASE,primary illness,primary illness
NEW02962,DISEASE,early infections,early infections
NEW02963,CHEMICAL,Sulfamate derivatives,Sulfamate derivatives
D057066,DISEASE,Low Tension Glaucoma,"Normal Tension Glaucoma|Glaucoma, Normal Tension|Low Tension Glaucomas|Glaucoma, Low Tension|Normal Tension Glaucomas|glaucoma"
NEW02964,DISEASE,hormone-dependent tumors,hormone-dependent tumors
D020728,DISEASE,Transurethral Resection of Prostate,"Transurethral Radiofrequency Thermal Ablation|Thermotherapy, Transurethral Microwave|Prostatectomy, Transurethral|Prostate Transurethral Vaporesection|Transurethral Electrovaporization of Prostate|Microwave Thermotherapy, Transurethral|Prostate Resections, Transurethral|Prostate Transurethral Electroresections|Resection, Transurethral Prostate|Contact Laser Ablation of Prostate|TURPs|Transurethral Needle Ablation of Prostate|TURP|Transurethral Prostate Resections|Prostate Transurethral Electrovaporizations|Transurethral Prostatectomy|Transurethral Visual Laser Ablation of Prostate|Prostate Transurethral Vaporesections|Transurethral Prostatectomies|Prostate Resection, Transurethral|Transurethral Vaporesection of Prostate|Transurethral Ultrasound-Guided Laser-Induced Prostatectomy|Transurethral Thermotherapy|Thermotherapies, Transurethral|Resections, Transurethral Prostate|Prostatectomies, Transurethral|Prostate Transurethral Resections|Prostate Transurethral Resection|prostate|Transurethral Electroresection of Prostate|VLAP|Transurethral Ultrasound Guided Laser Induced Prostatectomy|Prostate Transurethral Electrovaporization|TUVP|Transurethral Prostate Resection|Thermotherapy, Transurethral|Transurethral Thermotherapies|Transurethral Microwave Thermotherapy|Prostate Transurethral Electroresection"
D016889,DISEASE,Endometrial Neoplasms,"|Carcinoma of Endometrium|Cancers, Endometrium|Endometrium Carcinomas|Cancers, Endometrial|Carcinomas, Endometrial|Endometrium Cancer|Cancer of Endometrium|endometrial cancer|Endometrium Cancers|Endometrial Carcinomas|Neoplasm, Endometrial|Cancer of the Endometrium|endometrial cancers|Endometrial Carcinoma|Endometrial Neoplasm|Endometrial Cancers|Carcinoma, Endometrial|Endometrial Cancer|Cancer, Endometrium|Neoplasms, Endometrial|Endometrium Carcinoma|Cancer, Endometrial"
NEW02965,CHEMICAL,calcium sensing receptor agonists,calcium sensing receptor agonists
D042462,CHEMICAL,4-Quinolones,4-Quinolinones|4 Quinolinone|4-Oxoquinolines|4-Quinolinone|4 Quinolone|4 Quinolones|quinolones|Quinolones|4 Oxoquinolines|4 Quinolinones|4-Oxoquinoline|4-Quinolone|4 Oxoquinoline
D054579,DISEASE,National Institute of Allergy and Infectious Diseases (U.S.),infectious diseases|National Institute of Allergy and Infectious Diseases|NIAID
D000900,CHEBI,Anti-Bacterial Agents,"Anti-Mycobacterial Agent|Anti Mycobacterial Agents|Bacteriocide|Agent, Anti-Mycobacterial|Anti Bacterial Compounds|Compounds, Anti-Bacterial|Anti Bacterial Agents|antibacterial agents|Bacteriocidal Agents|Compound, Anti-Bacterial|Agent, Antimycobacterial|Antibacterial Agent|Anti-Mycobacterial Agents|Agents, Bacteriocidal|Anti-Bacterial Compound|Anti Bacterial Compound|Anti-Bacterial Compounds|Agent, Bacteriocidal|Antibacterial Agents|Bacteriocides|Agents, Anti-Bacterial|Anti Bacterial Agent|antibacterial agent|Agents, Antibacterial|Bacteriocidal Agent|Anti-Bacterial Agent|Agents, Anti-Mycobacterial|Anti Mycobacterial Agent|Agent, Anti-Bacterial|Agents, Antimycobacterial|Antibiotics|Agent, Antibacterial|Antimycobacterial Agents|Antibiotic|Antimycobacterial Agent"
D015242,CHEMICAL,Ofloxacin,|ORF 28489|Ru43280|ORF-28489|Hoe 280|Ofloxacin Hydrochloride|Hoe-280|DR 3355|Ru 43280|DL-8280|ORF28489|Ofloxacine|DL 8280|DR-3355|DR3355|ofloxacin|DL8280|Hoe280|Ru-43280|Tarivid
D013000,DISEASE,Psychiatric Somatic Therapies,"Therapy, Psychiatric Somatic|Therapies, Psychiatric Somatic|Psychiatric Somatic Therapy|Somatic Therapy, Psychiatric|Somatic Therapies, Psychiatric|psychiatric"
D002939,CHEMICAL,Ciprofloxacin,"|Cipro|Hydrochloride, Ciprofloxacin|Bay 09867|Ciprinol|Ciprofloxacin Monohydrochloride Monohydrate|Ciprofloxacin|Ciprofloxacin Hydrochloride Anhydrous|Bay-09867|Monohydrate, Ciprofloxacin Monohydrochloride|Bay09867|Anhydrous, Ciprofloxacin Hydrochloride|Hydrochloride Anhydrous, Ciprofloxacin|Ciprofloxacin Hydrochloride|Monohydrochloride Monohydrate, Ciprofloxacin|ciprofloxacin"
NEW02966,CHEMICAL,third-generation cephalosporin,third-generation cephalosporin
NEW02967,DISEASE,community-acquired brain abscess,community-acquired brain abscess
D026141,CHEBI,"Drug Resistance, Multiple, Fungal","Multiple Antifungal Drug Resistance|Multidrug Resistance, Fungal|drug resistance"
NEW02968,CHEBI,traditional antibiotic therapy,traditional antibiotic therapy
NEW02969,CHEBI,antibiotic treatments,antibiotic treatments
NEW02970,DISEASE,satiation weight loss,satiation weight loss
NEW02971,CHEMICAL,maternal supplemental iron,maternal supplemental iron
NEW02972,DISEASE,ASD prevention strategies,ASD prevention strategies
D002446,DISEASE,Celiac Disease,"Enteropathies, Gluten|Gluten-Sensitive Enteropathies|Celiac Sprue|Sprue|Nontropical Sprue|Enteropathies, Gluten-Sensitive|Gluten Sensitive Enteropathy|celiac disease|Celiac disease|Gluten-Sensitive Enteropathy|Sprue, Celiac|Gluten Enteropathies|Enteropathy, Gluten-Sensitive|Disease, Celiac|Enteropathy, Gluten|Sprue, Nontropical|Gluten Enteropathy|Celiac Disease"
NEW02973,DISEASE,unique autoimmune disorder,unique autoimmune disorder
D000074242,DISEASE,Sunflower Oil,"sunflower oil|Seed Oil, Sunflower|Oil, Sunflower|Sunflower Seed Oil|Oil, Sunflower Seed"
D019787,CHEMICAL,Linoleic Acid,"Linoleic Acid, Sodium Salt, (E,E)-Isomer|Linoleic acid|Linolelaidic Acid|9-trans,12-trans-Octadecadienoic Acid|9 trans,12 trans Octadecadienoic Acid|Linoleic Acid, (E,E)-Isomer|Linoleic Acid, Sodium Salt, (Z,Z)-Isomer|Linoleic Acid, Calcium Salt, (Z,Z)-Isomer|Linoleic Acid, (Z,Z)-Isomer, 14C-Labeled|trans,trans-9,12-Octadecadienoic Acid|linoleic acid|Linoleic Acid, (Z,Z)-Isomer|Acid, 9,12-Octadecadienoic|cis,cis-9,12-Octadecadienoic Acid|Linoleic Acid, Potassium Salt, (Z,Z)-Isomer|Linoelaidic Acid, (E,Z)-Isomer|9,12-Octadecadienoic Acid|Linoelaidic Acid|Linoleate|Linoleic Acid, (Z,E)-Isomer|Linoleic Acid, Ammonium Salt, (Z,Z)-Isomer|CLA|9,12 Octadecadienoic Acid"
NEW02974,NUTRITION,mercury heavy metal,mercury heavy metal
NEW02975,CHEBI,toxic agent,toxic agent
NEW02976,NUTRITION,possible mercury involvement,possible mercury involvement
C540355,CHEMICAL,fenamidone [Supplementary Concept],Fenamidone|Strobilurins
NEW02977,DISEASE,yolk sac edema,yolk sac edema
NEW02978,DISEASE,pericardial edema,pericardial edema
D013121,DISEASE,Spinal Curvatures,"spinal curvature|Curvature, Spinal|Spinal Curvature|Curvatures, Spinal"
NEW02979,CHEMICAL,μM. Fenamidone,μM. Fenamidone
NEW02980,CHEBI,mixture rabbits,mixture rabbits
D050033,DISEASE,Thyroid Dysgenesis,"Agenesis, Thyroid|Ectopic Thyroids|Thyroid, Ectopic|Thyroid Agenesis|Hypoplasia, Thyroid|Thyroids, Ectopic|Dysgenesis, Thyroid|Thyroid Hypoplasia|Ectopic Thyroid|dysgenesis"
D003634,CHEMICAL,DDT,"Chlorophenothane|Benzochloryl|p',p'-DDT|TbisC ethane|4,4'-DDT|4,4'-Dichlorodiphenyltrichloroethane|4,4' DDT|1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane|4,4' Dichlorodiphenyltrichloroethane|TbisC-ethane|DDT"
D003456,DISEASE,Cryptorchidism,"Cryptorchidism, Inguinal|Testis, Undescended|Undescended Testis|Inguinal Cryptorchidism|Unilateral Cryptorchidism|Cryptorchism|Cryptorchidism, Unilateral|Bilateral Cryptorchidism|Cryptorchidism, Unilateral Or Bilateral|Undescended Testes|Cryptorchidism, Bilateral|Abdominal Cryptorchidism|Cryptorchidism, Abdominal|Testes, Undescended|cryptorchidism"
NEW02981,CHEMICAL,cocaine mg/kg,cocaine mg/kg
C111212,CHEMICAL,TRK 820 [Supplementary Concept],nalfurafine hydrochloride|nalfurafine|Nalfurafine hydrochloride|TRK-820|Spiro Compounds|Nalfurafine|Morphinans
NEW02982,CHEMICAL,REMITCH CAPSULES microg,REMITCH CAPSULES microg
NEW02983,CHEBI,Torii Pharmaceutical Co.,Torii Pharmaceutical Co.
NEW02984,CHEBI,kappa-opioid receptor agonist,kappa-opioid receptor agonist
NEW02985,DISEASE,abnormal behaviors related,abnormal behaviors related
NEW02986,CHEMICAL,alpha-1 adrenoceptor antagonist prazosin,alpha-1 adrenoceptor antagonist prazosin
NEW02987,MENTAL_HEALTH,chronic stress disorders,chronic stress disorders
NEW02988,CHEMICAL,"agonist U50,488H","agonist U50,488H"
NEW02989,DISEASE,mechanical hypersensitivity,mechanical hypersensitivity
C038981,CHEMICAL,nalmefene [Supplementary Concept],nalmefene|Nalmefene|Naltrexone/analogs  and  derivatives
NEW02990,CHEBI,partial opioid receptor agonist,partial opioid receptor agonist
NEW02991,CHEBI,antipruritus drug,antipruritus drug
C583636,CHEMICAL,eluxadoline [Supplementary Concept],Phenylalanine/analogs  and  derivatives|eluxadoline|Imidazoles|Eluxadoline
D003248,DISEASE,Constipation,|Constipation|Colonic Inertia|Dyschezia|constipation
NEW02992,DISEASE,biliary duct obstruction,biliary duct obstruction
NEW02993,DISEASE,known mechanical gastrointestinal obstruction,known mechanical gastrointestinal obstruction
NEW02994,DISEASE,known pancreatic duct obstruction,known pancreatic duct obstruction
NEW02995,MENTAL_HEALTH,active alcohol abuse,active alcohol abuse
NEW02996,DISEASE,severe hepatic impairment,severe hepatic impairment
D046628,DISEASE,Sphincter of Oddi Dysfunction,|Sphincter of Oddi Stenosis|Sphincter of Oddi Dyskinesia|Oddi dysfunction|sphincter of Oddi dyskinesia
NEW02997,CHEMICAL,hallucinogen effects,hallucinogen effects
NEW02998,CHEMICAL,neoclerodane diterpene Salvinorin A,neoclerodane diterpene Salvinorin A
NEW02999,DISEASE,central pruritus,central pruritus
NEW03000,CHEBI,κ-opioid receptor agonist,κ-opioid receptor agonist
NEW03001,DISEASE,uremic pruritus,uremic pruritus
NEW03002,CHEMICAL,kappa-opioid-receptor agonist,kappa-opioid-receptor agonist
NEW03003,CHEMICAL,topical capsaicin cream,topical capsaicin cream
NEW03004,CHEMICAL,oral activated charcoal,oral activated charcoal
NEW03005,CHEMICAL,ultraviolet B phototherapy,ultraviolet B phototherapy
NEW03006,CHEBI,α₂-adrenoceptor agonist,α₂-adrenoceptor agonist
NEW03007,MENTAL_HEALTH,patients ADHD symptoms,patients ADHD symptoms
NEW03008,CHEBI,5-HT2 antagonist ritanserin,5-HT2 antagonist ritanserin
NEW03009,CHEMICAL,Alektorophobia,Alektorophobia
NEW03010,CHEMICAL,Feather corticosterone concentration,Feather corticosterone concentration
NEW03011,MENTAL_HEALTH,depression treatment,depression treatment
NEW03012,DISEASE,Acute pancreatitis pancreatic cancer,Acute pancreatitis pancreatic cancer
NEW03013,DISEASE,distinct pancreatic diseases,distinct pancreatic diseases
NEW03014,CHEMICAL,hereditary CP,hereditary CP
D010190,DISEASE,Pancreatic Neoplasms,"pancreatic cancer|Pancreatic Cancer|Cancer, Pancreatic|Pancreas Neoplasms|Neoplasm, Pancreatic|Cancer of the Pancreas|Neoplasms, Pancreatic|Pancreas Cancers|Pancreas Neoplasm|Cancer, Pancreas|Neoplasms, Pancreas|Cancers, Pancreas|Cancers, Pancreatic|Pancreas Cancer|Neoplasm, Pancreas|Pancreatic Neoplasm|Cancer of Pancreas|Pancreatic Cancers"
NEW03015,CHEMICAL,PRSS1-mediated CP,PRSS1-mediated CP
NEW03016,DISEASE,autosomal dominant hereditary CP,autosomal dominant hereditary CP
NEW03017,MENTAL_HEALTH,process schizophrenia,process schizophrenia
NEW03018,CHEMICAL,glyphosate-based herbicides,glyphosate-based herbicides
NEW03019,CHEBI,beta deposition,beta deposition
NEW03020,DISEASE,Alzheimer brains,Alzheimer brains
NEW03021,CHEBI,potent dual orexin receptor antagonists,potent dual orexin receptor antagonists
NEW03022,DISEASE,mouse formalin pain model,mouse formalin pain model
C000595055,CHEMICAL,dual orexin receptor antagonist 12 [Supplementary Concept],Azepines|DORA-12|Benzimidazoles
NEW03023,DISEASE,pain responses,pain responses
NEW03024,DISEASE,Mechanical hypersensitivity,Mechanical hypersensitivity
C581638,CHEMICAL,DORA-22 [Supplementary Concept],Piperidines|Triazoles|DORA-22
NEW03025,CHEMICAL,DORA-2,DORA-2
D013706,DISEASE,Temporomandibular Joint Dysfunction Syndrome,"Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint|pain dysfunction|Costen's Syndrome|Syndrome, Costen's|Costen Syndrome|Syndrome, TMJ|Syndrome, Temporomandibular Joint|Costens Syndrome|temporomandibular joint dysfunction|TMJ Syndrome|Temporomandibular Joint Syndrome|Joint Syndrome, Temporomandibular"
NEW03026,CHEMICAL,nitroglycerin rat model,nitroglycerin rat model
NEW03027,CHEMICAL,Cocaine users,Cocaine users
NEW03028,CHEBI,pharmaceutical strategies,pharmaceutical strategies
D013375,CHEBI,Substance Withdrawal Syndrome,"|Symptom, Drug Withdrawal|Withdrawal Symptom|Withdrawal Symptoms|Withdrawal Syndromes, Substance|Symptoms, Withdrawal|Drug Withdrawal Symptoms|Drug Withdrawal Symptom|Withdrawal Symptom, Drug|Syndromes, Substance Withdrawal|Substance Withdrawal Syndromes|Symptom, Withdrawal|drug withdrawal|Withdrawal Syndrome, Substance|Symptoms, Drug Withdrawal|withdrawal syndrome|Withdrawal syndromes|Drug withdrawal|withdrawal symptoms|withdrawal syndromes|Syndrome, Substance Withdrawal|Withdrawal Symptoms, Drug"
NEW03029,MENTAL_HEALTH,anxiety levels,anxiety levels
D006935,DISEASE,Hypercapnia,|hypercapnia
NEW03030,CHEBI,drug challenge,drug challenge
C551624,CHEMICAL,suvorexant [Supplementary Concept],Azepines|Suvorexant|Triazoles|suvorexant
NEW03031,DISEASE,Psychostimulants,Psychostimulants
NEW03032,MENTAL_HEALTH,human narcolepsy,human narcolepsy
NEW03033,CHEMICAL,5-HT-related compounds,5-HT-related compounds
NEW03034,CHEBI,orexin antagonist,orexin antagonist
D018908,DISEASE,Muscle Weakness,"|muscle weakness|Weakness, Muscular|Muscular Weaknesses|Weaknesses, Muscle|Muscular Weakness|weakness|Weakness, Muscle|Muscle Weaknesses|Weaknesses, Muscular"
NEW03035,MENTAL_HEALTH,cataplexy sudden episodes,cataplexy sudden episodes
NEW03036,CHEMICAL,lemborexant-treated WT mice,lemborexant-treated WT mice
NEW03037,CHEMICAL,non-benzodiazepine,non-benzodiazepine
NEW03038,CHEMICAL,selective OX2R antagonists,selective OX2R antagonists|SORA2s
NEW03039,CHEBI,additional pharmaceutical option,additional pharmaceutical option
NEW03040,CHEBI,poisonous substance,poisonous substance
NEW03041,DISEASE,factitious thyrotoxicosis,factitious thyrotoxicosis
NEW03042,CHEMICAL,thyroglobulin antibodies,thyroglobulin antibodies
D017903,DISEASE,Bacteriophage T3,"Enterobacteria phage T3|T3 Phage|Phage T3|Phages, T3|T3 Phages|T3|Coliphage T3|Phage, T3"
NEW03043,DISEASE,callous personality traits,callous personality traits
NEW03044,CHEMICAL,peripheral deiodination,peripheral deiodination
NEW03045,MENTAL_HEALTH,bipolar depressive disorder,bipolar depressive disorder
NEW03046,CHEMICAL,inositol phospholipid metabolism,inositol phospholipid metabolism
NEW03047,MENTAL_HEALTH,unit due delusions,unit due delusions
NEW03048,CHEBI,normal serum thyroid hormone levels,normal serum thyroid hormone levels
NEW03049,DISEASE,malignant neuroleptic syndrome,malignant neuroleptic syndrome
NEW03050,DISEASE,drug-induced hypothyroidism,drug-induced hypothyroidism
NEW03051,DISEASE,Febrile catatatony,Febrile catatatony
NEW03052,DISEASE,psychotic phenomena,psychotic phenomena
C487948,CHEMICAL,3-iodothyronamine [Supplementary Concept],3-Iodothyronamine|T1AM|Thyronines
D013963,CHEBI,Thyroid Hormones,"Hormone, Thyroid|Hormones, Thyroid|TH|thyroid hormones|Thyroid Hormone|Thyroid hormones"
NEW03053,CHEBI,thyroid hormone levels,thyroid hormone levels
NEW03054,CHEMICAL,free triiodothyronine,free triiodothyronine
NEW03055,DISEASE,non-attempters,non-attempters
NEW03056,MENTAL_HEALTH,suicide attempters,suicide attempters
NEW03057,CHEBI,existing drug regimen,existing drug regimen
NEW03058,DISEASE,Other carbamazepine-induced changes,Other carbamazepine-induced changes
NEW03059,NUTRITION,cholesterol concentrations,cholesterol concentrations
NEW03060,CHEBI,cortisol hormones,cortisol hormones
D050564,CHEMICAL,Trans-Cinnamate 4-Monooxygenase,"4-Hydroxylase, Cinnamate|Cinnamate 4-Hydroxylase|4-Monooxygenase CYP73, Trans-Cinnamate|Cinnamate 4 Hydroxylase|CYP73, Trans-Cinnamate 4-Monooxygenase|Trans Cinnamate 4 Monooxygenase|Trans Cinnamate 4 Monooxygenase CYP73|Trans-Cinnamic Acid 4-Hydroxylase|Acid 4-Hydroxylase, Trans-Cinnamic|Trans-Cinnamate 4-Monooxygenase CYP73|4-Monooxygenase, Trans-Cinnamate|Trans Cinnamic Acid 4 Hydroxylase|trans-|4-Hydroxylase, Trans-Cinnamic Acid"
NEW03061,DISEASE,thyroid dysfunction,thyroid dysfunction
NEW03062,CHEBI,low thyroid hormone secretion,low thyroid hormone secretion
NEW03063,CHEMICAL,FT3 levels,FT3 levels
NEW03064,DISEASE,somatoform factor score,somatoform factor score
NEW03065,CHEMICAL,free triiodothyronine,free T3|free triiodothyronine|FT3
D037042,CHEBI,Thyroid Hormone Receptors beta,"Gene Products, THRB|NR1A2 Gene Products|Receptors beta, Thyroid Hormone|ERBA2 Gene Products|c erbA beta|Thyroid Hormone Receptor beta-1|thyroid hormone receptor beta|thyroid hormone|thyroid hormone receptors|Gene Products, NR1A2|Thyroid Hormone Receptor beta-2|Thyroid Hormone Receptor beta 1|Thyroid Hormone Receptor beta|THRB Gene Products|Gene Products, ERBA2|TR beta|Thyroid Hormone Receptor beta 2|c-erbA beta"
C548078,DISEASE,Mungan Syndrome [Supplementary Concept],cardiac abnormalities|Barrett Esophagus|Cardiac abnormalities|Intestinal Pseudo-Obstruction
NEW03066,CHEBI,High dose thyroid hormone,High dose thyroid hormone
NEW03067,CHEBI,plasma thyroid hormone concentrations,plasma thyroid hormone concentrations
NEW03068,CHEMICAL,chronic daily ethanol consumption,chronic daily ethanol consumption
NEW03069,CHEMICAL,daily ethanol consumption,daily ethanol consumption
NEW03070,DISEASE,HPT axis,HPT axis
D018025,CHEBI,"Receptors, Thyrotropin-Releasing Hormone","Thyrotropin-releasing hormone|thyrotropin-releasing hormone|Protirelin Receptors|Receptor, Protirelin|Thyrotropin-Releasing Hormone Receptors|Protirelin Receptor|Receptors, TRH|TRH Receptors|Thyroliberin Receptors|thyrotropin releasing hormone|TRH Receptor|Receptors, Thyroliberin|Receptor, TRH|protirelin|Thyrotropin Releasing Hormone Receptor|Thyrotropin Releasing Hormone Receptors|Receptors, Protirelin|Receptors, Thyrotropin Releasing Hormone"
NEW03071,CHEMICAL,response to TSH releasing hormone,response to TSH releasing hormone|response to thyrotropin-releasing hormone|TRH
NEW03072,CHEBI,thyroid-stimulating hormone response,thyroid-stimulating hormone response
NEW03073,CHEMICAL,NRA groups,NRA groups
NEW03074,DISEASE,TRH-induced TSH,TRH-induced TSH
C106996,CHEMICAL,NRA 0045 [Supplementary Concept],NRA|Pyrrolidines|Thiazoles
NEW03075,CHEBI,Thyroid hormone replacement,Thyroid hormone replacement
NEW03076,DISEASE,hepatic decompensation,hepatic decompensation
NEW03077,CHEMICAL,elevated ammonia level,elevated ammonia level
NEW03078,DISEASE,consciousness disturbance,consciousness disturbance
NEW03079,DISEASE,hyperammonemia portal-systemic encephalopathy,hyperammonemia portal-systemic encephalopathy
D012742,DISEASE,Sex Offenses,"sexual violence|Sexual Assault|Sexual Abuse|Sexual Violences|Assault, Sexual|Sex Offense|Sexual Abuses|Abuse, Sexual|sexual assault|Violence, Sexual|Offense, Sex|Offenses, Sex|Assaults, Sexual|Sexual Violence|Violences, Sexual|Sexual Assaults|Abuses, Sexual"
NEW03080,CHEBI,thyroid hormone alterations,thyroid hormone alterations
NEW03081,DISEASE,severe hypothyroidism,severe hypothyroidism
NEW03082,MENTAL_HEALTH,patient's mania,patient's mania
NEW03083,CHEBI,thyroid hormone signalling,thyroid hormone signalling
C000622662,CHEMICAL,"thyroid hormone receptor alpha, human [Supplementary Concept]",Thyroid Hormone Receptors alpha|TRα|TRαAMI/Cre3 mice
NEW03084,MENTAL_HEALTH,heightened anxiety,heightened anxiety
NEW03085,CHEMICAL,Glucocorticoid reproductive steroid levels,Glucocorticoid reproductive steroid levels
NEW03086,CHEBI,sex hormone secretion disorders,sex hormone secretion disorders
NEW03087,CHEMICAL,triiodothyronine conversion,triiodothyronine conversion
NEW03088,CHEBI,classic thyroid hormone disruptor,classic thyroid hormone disruptor
NEW03089,CHEMICAL,polybrominated diphenyl ether,polybrominated diphenyl ether
NEW03090,CHEMICAL,Exposure to perfluoroalkyl substances,context to pollen-food allergy syndrome|PFAS|Exposure to perfluoroalkyl substances
NEW03091,DISEASE,maternal thyroid anomalies,maternal thyroid anomalies
NEW03092,CHEMICAL,levothyroxine treatment,levothyroxine treatment
NEW03093,DISEASE,neurodevelopmental impairments,neurodevelopmental impairments
NEW03094,CHEBI,thyroid hormone regulation,thyroid hormone regulation
NEW03095,CHEMICAL,(IRMA)-and free-thyroid-hormone levels,(IRMA)-and free-thyroid-hormone levels
NEW03096,DISEASE,depressed females,depressed females
NEW03097,CHEMICAL,Baseline thyroid-secreting-hormone,Baseline thyroid-secreting-hormone
NEW03098,CHEBI,thyroid hormone medication,thyroid hormone medication
NEW03099,DISEASE,goiter recurrence,goiter recurrence
NEW03100,CHEBI,suppressive thyroid hormone therapy,suppressive thyroid hormone therapy
NEW03101,CHEBI,thyroid hormone abuse,thyroid hormone abuse
D013954,DISEASE,Thyroglobulin,thyroglobulin
NEW03102,DISEASE,endogenous hyperthyroidism,endogenous hyperthyroidism
C537149,DISEASE,"Hypogammaglobulinemia and Isolated growth hormone deficiency, X-linked [Supplementary Concept]","Dwarfism, Pituitary|Agammaglobulinemia|growth hormone deficiency|GHD|Growth hormone deficiency|Genetic Diseases, X-Linked"
NEW03103,CHEBI,brain thyroid hormones,brain thyroid hormones
NEW03104,CHEBI,thyroid-stimulating hormone TSH secretion,thyroid-stimulating hormone TSH secretion
NEW03105,DISEASE,mild central hypothyroidism,mild central hypothyroidism
C575259,CHEBI,"TRIP13 protein, human [Supplementary Concept]",ATPases Associated with Diverse Cellular Activities|Cell Cycle Proteins|thyroid hormone receptor interactor
NEW03106,CHEBI,TRIP12 mutation carriers,TRIP12 mutation carriers
NEW03107,CHEBI,altered thyroid hormone levels,altered thyroid hormone levels
NEW03108,CHEMICAL,serotonin 5-hydroxytryptamine levels,serotonin 5-hydroxytryptamine levels
NEW03109,DISEASE,hypothyroid rats,hypothyroid rats
NEW03110,CHEMICAL,central serotonin system,central serotonin system
NEW03111,CHEMICAL,cretins,cretins
NEW03112,MENTAL_HEALTH,permanent mental retardation,permanent mental retardation
NEW03113,DISEASE,MMI-treated hypothyroid rats,MMI-treated hypothyroid rats
NEW03114,CHEMICAL,D(2)-like dopamine receptors,D(2)-like dopamine receptors
NEW03115,MENTAL_HEALTH,depression refractory,depression refractory
D000077273,DISEASE,"Thyroid Cancer, Papillary","Thyroid Carcinoma, Papillary|Nonmedullary Thyroid Carcinomas|Thyroid Carcinomas, Nonmedullary|papillary thyroid carcinoma|Cancer, Papillary Thyroid|Thyroid Cancers, Papillary|Papillary Carcinoma Of Thyroid|Carcinoma, Nonmedullary Thyroid|Carcinoma, Papillary Thyroid|Nonmedullary Thyroid Carcinoma|Carcinomas, Nonmedullary Thyroid|Carcinomas, Papillary Thyroid|Papillary Thyroid Cancers|Papillary Thyroid Carcinomas|Thyroid Carcinomas, Papillary|Papillary Thyroid Cancer|Papillary Thyroid Carcinoma|Thyroid Carcinoma, Nonmedullary|Familial Nonmedullary Thyroid Cancer|Cancers, Papillary Thyroid"
NEW03116,CHEMICAL,elective radioactive iodine treatment,elective radioactive iodine treatment
D038263,DISEASE,Auditory Brain Stem Implantation,"Auditory Brainstem Implantation|Brainstem Implantations, Auditory|auditory|Auditory Brainstem Implantations|Brainstem Implantation, Auditory|Implantation, Auditory Brainstem|brain stem"
NEW03117,MENTAL_HEALTH,paranoid delusion,paranoid delusion
NEW03118,MENTAL_HEALTH,flat affect,flat affect
NEW03119,DISEASE,euthyroid patients,euthyroid patients
NEW03120,CHEBI,insulin sensitizers,insulin sensitizers
D044882,CHEMICAL,Glucose Metabolism Disorders,"Metabolic Disorder, Glucose|glucose metabolism|Disorder, Glucose Metabolism|Glucose Metabolism Disorder|Metabolism Disorder, Glucose|Glucose Metabolic Disorders|Disorder, Glucose Metabolic|Metabolic Disorders, Glucose|Disorders, Glucose Metabolic|Glucose Metabolic Disorder|Disorders, Glucose Metabolism|Metabolism Disorders, Glucose"
NEW03121,CHEMICAL,metformin use,metformin use
NEW03122,DISEASE,diabetes risk,diabetes risk
NEW03123,DISEASE,Peripheral hyperinsulinemia,Peripheral hyperinsulinemia
NEW03124,DISEASE,tau hyperphosphorylation,tau hyperphosphorylation
NEW03125,CHEMICAL,sensitizers pioglitazone,sensitizers pioglitazone
NEW03126,MENTAL_HEALTH,mild Alzheimer disease,mild Alzheimer disease
NEW03127,CHEBI,ORL-1 agonists,ORL-1 agonists
NEW03128,CHEMICAL,mesolimbic dopamine release,mesolimbic dopamine release
NEW03129,CHEMICAL,Endomorphins,Endomorphins
NEW03130,CHEMICAL,low subanalgesic doses,low subanalgesic doses
NEW03131,DISEASE,traumatic event,traumatic event
NEW03132,CHEMICAL,morphine CPP,morphine CPP
NEW03133,CHEBI,Full μ-opioid agonists,Full μ-opioid agonists
NEW03134,DISEASE,various etiologies,various etiologies
D004418,DISEASE,"Dyspnea, Paroxysmal","Paroxysmal Dyspnea|Dyspnea, Paroxysmal Nocturnal|Asthma, Cardiac|dyspnea|Paroxysmal Dyspneas|nocturnal asthma|Dyspneas, Paroxysmal"
D014150,CHEBI,Antipsychotic Agents,"|Antipsychotics|Antipsychotic Drugs|Antipsychotic Drug|Antipsychotic Medication|Agent, Neuroleptic|antipsychotic drug|Tranquilizing Agents, Major|Antipsychotic Effect|Major Tranquilizer|neuroleptic drugs|Antipsychotic|Major Tranquillizing Agents|Tranquilizer, Major|Neuroleptics|Neuroleptic Drug|Neuroleptic Agents|Antipsychotic Effects|Medication, Antipsychotic|Drug, Antipsychotic|Neuroleptic Drugs|Agent, Antipsychotic|Tranquillizing Agents, Major|Antipsychotic Agent|Drug, Neuroleptic|Major Tranquilizing Agents|neuroleptic drug|Effect, Antipsychotic|Neuroleptic Agent|Major Tranquilizers|Neuroleptic"
NEW03135,CHEMICAL,available antidepressants,available antidepressants
D018723,CHEMICAL,Bethanechol,"PMS Bethanechol Chloride|Hermes, Myo|Bethanecol|Myo Hermes|Duvoid|Myocholine|Chloride, Bethanechol|Bethanechol Chloride|Myotonine|PMS-Bethanechol Chloride|Myotonachol|Urecholine|Bethanechol|Urocarb"
D018678,CHEBI,Cholinergic Agents,"cholinomimetic|Nicotinic Effect|Cholinergic Effect|Drug, Cholinergic|Cholinergic Drugs|Muscarinic Agent|Effects, Cholinergic|Cholinomimetic|Agent, Nicotinic|Effect, Muscarinic|Muscarinics|Acetylcholine Agent|cholinergic drug|Agent, Acetylcholine|Effect, Cholinergic|cholinomimetics|Agents, Muscarinic|Effects, Muscarinic|Cholinergic|Muscarinic|Effects, Nicotinic|Muscarinic Effects|Cholinergic Drug|cholinergic agent|Cholinergic Agent|Muscarinic Effect|Cholinergic Effects|cholinergic drugs|Cholinergic drugs|Nicotinic Agent|Acetylcholine Agents|Cholinomimetics|Agents, Nicotinic|cholinergic agents|Agent, Cholinergic|Drugs, Cholinergic|Cholinergics|Agents, Cholinergic|Agents, Acetylcholine|Nicotinic Effects|Effect, Nicotinic|Agent, Muscarinic|Nicotinic Agents|Muscarinic Agents"
C052450,CHEMICAL,physostigmine heptyl [Supplementary Concept],Heptylphysostigmine|Physostigmine/analogs  and  derivatives
NEW03136,CHEBI,new cholinergic drug,new cholinergic drug
NEW03137,DISEASE,TD antigen,TD antigen
NEW03138,DISEASE,addictive diseases,addictive diseases
NEW03139,DISEASE,multiple hepatic injuries,multiple hepatic injuries
C567531,DISEASE,Major Affective Disorder 9 [Supplementary Concept],major affective disorder|Bipolar Disorder
C052746,CHEMICAL,adriamycin-cardiolipin complex [Supplementary Concept],cardiolipin|Cardiolipins|Doxorubicin
NEW03140,CHEMICAL,HEp2-substrate,HEp2-substrate
NEW03141,CHEBI,intracellular antigens,intracellular antigens
D000069283,CHEMICAL,Rituximab,"CD20 Antibody, Rituximab|IDEC C2B8|IDEC-C2B8|IDEC C2B8 Antibody|rituximab|Rituximab CD20 Antibody|Rituximab|Mabthera|GP2013|IDEC-C2B8 Antibody|Rituxan"
D020363,DISEASE,Limbic Encephalitis,"limbic encephalitis|Paraneoplastic Limbic Encephalitis|Encephalitides, Paraneoplastic Limbic|Paraneoplastic limbic encephalitis|Encephalitis, Paraneoplastic Limbic|Encephalitis, Limbic|Limbic Encephalitis, Paraneoplastic"
D008228,CHEMICAL,"Lymphoma, Non-Hodgkin","|Lymphoma, Small Cleaved-Cell, Diffuse|Lymphoma, High Grade|Nonhodgkin's Lymphoma|Lymphoma, Intermediate Grade|Low-Grade Lymphomas|Lymphoma, Non Hodgkin|Lymphoma, Pleomorphic|Diffuse Undifferentiated Lymphomas|Lymphoma, Non-Hodgkins|Lymphocytic-Histiocytic Lymphoma, Mixed|Small Noncleaved-Cell Lymphomas|Undifferentiated Lymphomas|Mixed Lymphoma|Non-Cleaved-Cell Lymphoma, Small|Diffuse Mixed Cell Lymphoma|Lymphoma, Mixed Small and Large Cell, Diffuse|Lymphoma, Low Grade|Lymphoma, Mixed Cell, Diffuse|Low-Grade Lymphoma|Small Non-Cleaved-Cell Lymphoma|lymphoma|Nonhodgkins Lymphoma|Lymphosarcomas|Lymphoma, Diffuse Undifferentiated|Lymphoma, Diffuse|Undifferentiated Lymphoma, Diffuse|Pleomorphic Lymphomas|Lymphoma, Atypical Diffuse Small Lymphoid|Diffuse Small Cleaved-Cell Lymphoma|Reticulum Cell Sarcoma|Lymphoma, Non Hodgkins|Lymphoma, Small Noncleaved-Cell|Sarcoma, Reticulum Cell|Lymphoma, Non Hodgkin's|Mixed-Cell Lymphoma|Diffuse Mixed-Cell Lymphomas|Small Noncleaved Cell Lymphoma|Non-Hodgkin's Lymphoma|Diffuse Mixed Small and Large Cell Lymphoma|Sarcoma, Lymphatic|Intermediate-Grade Lymphomas|Diffuse Lymphomas|Lymphoma, Low-Grade|Lymphocytic-Histiocytic Lymphomas, Mixed|Mixed-Cell Lymphoma, Diffuse|High-Grade Lymphoma|Lymphoma, Intermediate-Grade|Reticulum-Cell Sarcoma|Lymphoma, Mixed|Non-Hodgkins Lymphoma|Non-Hodgkin Lymphoma|Diffuse Lymphoma|Diffuse Mixed-Cell Lymphoma|Lymphoma, Small Noncleaved Cell|non-Hodgkin lymphomas|Lymphoma, Mixed-Cell, Diffuse|Lymphoma, Small and Large Cleaved-Cell, Diffuse|Lymphoma, Small Non Cleaved Cell|Intermediate-Grade Lymphoma|Pleomorphic Lymphoma|Sarcoma, Reticulum-Cell|Lymphoma, Small Cleaved Cell, Diffuse|Reticulum Cell Sarcomas|Lymphoma, Mixed Lymphocytic Histiocytic|Reticulosarcomas|Mixed-Cell Lymphomas|Lymphatic Sarcomas|Noncleaved-Cell Lymphoma, Small|Mixed Lymphocytic-Histiocytic Lymphoma|Mixed Small and Large Cell Lymphoma, Diffuse|Lymphoma, Small Non-Cleaved-Cell|Mixed Cell Lymphoma|Lymphoma, Diffuse Mixed-Cell|Small Non-Cleaved-Cell Lymphomas|Small Cleaved Cell Lymphoma, Diffuse|Undifferentiated Lymphoma|Lymphoma, High-Grade|Lymphosarcoma|Lymphoma, Non-Hodgkin, Familial|Lymphatic Sarcoma|non-Hodgkin lymphoma|Non Hodgkin Lymphoma|Lymphoma, Mixed-Cell|Lymphoma, Nonhodgkin's|Non Hodgkin's Lymphoma|Lymphoma, Nonhodgkin|Lymphoma, Undifferentiated, Diffuse|Diffuse Small Cleaved Cell Lymphoma|Lymphoma, Mixed Lymphocytic-Histiocytic|Small Noncleaved-Cell Lymphoma|Reticulosarcoma|Mixed Cell Lymphoma, Diffuse|Small Cleaved-Cell Lymphoma, Diffuse|Mixed Lymphocytic-Histiocytic Lymphomas|Mixed Lymphomas|Reticulum-Cell Sarcomas|Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic|Lymphoma, Nonhodgkins|Lymphoma, Non-Hodgkin's|Small Non Cleaved Cell Lymphoma|High-Grade Lymphomas|Lymphoma, Undifferentiated|Diffuse Undifferentiated Lymphoma|Lymphoma, Mixed Cell"
D013945,DISEASE,Thymoma,"Thymomas|thymoma|Carcinoma, Thymic|Thymic Carcinomas|Thymic Carcinoma|Carcinomas, Thymic"
NEW03142,DISEASE,AntiMa2,testicular tumor|AntiMa2
NEW03143,DISEASE,ANNA3,ANNA3|bronchial small cell carcinoma
NEW03144,DISEASE,severe psychiatric illness,severe psychiatric illness
NEW03145,CHEMICAL,brain-gut-microbiota axis,brain-gut-microbiota axis
D020274,DISEASE,Autoimmune Diseases of the Nervous System,"Autoimmune Diseases, Neurologic|Diseases, Neurologic Autoimmune|Neurologic Autoimmune Diseases|Nervous System Immune Diseases|Immune Diseases, Nervous System|Nervous System Autoimmune Diseases|Disease, Neurologic Autoimmune|Nervous System Immune Disorders|autoimmune disorders|Immune Disorders, Nervous System|Autoimmune Disorders of the Nervous System|Autoimmune Diseases, Nervous System|Neurologic Autoimmune Disease|Autoimmune Disorders, Nervous System|Autoimmune Disease, Neurologic|Autoimmune Nervous System Diseases"
NEW03146,CHEBI,indiscriminate antibiotic use,indiscriminate antibiotic use
NEW03147,CHEMICAL,environmental chemicals,environmental chemicals
NEW03148,CHEBI,prostate antigens,prostate antigens
NEW03149,DISEASE,CP/CPPS patients,CP/CPPS patients
NEW03150,DISEASE,Japanese narcoleptic patients,Japanese narcoleptic patients
NEW03151,CHEMICAL,synapsin (Ig)G serum antibody positive patients,synapsin (Ig)G serum antibody positive patients
NEW03152,DISEASE,acute psychiatric care,acute psychiatric care
NEW03153,CHEMICAL,anti-synapsin positive patients,anti-synapsin positive patients
NEW03154,CHEMICAL,anti-synapsin negative patients,anti-synapsin negative patients
NEW03155,CHEMICAL,Anti-synapsin positive patients,Anti-synapsin positive patients
NEW03156,MENTAL_HEALTH,higher agitation scores,higher agitation scores
NEW03157,CHEBI,neuronal surface antigens,neuronal surface antigens
NEW03158,DISEASE,autoimmune encephalitis,autoimmune encephalitis
NEW03159,CHEMICAL,Monoclonal proteins,Monoclonal proteins|paraproteins
NEW03160,DISEASE,paraproteinemic multifocal motor neuropathy,paraproteinemic multifocal motor neuropathy
NEW03161,CHEMICAL,Yo antibodies,Yo antibodies
NEW03162,CHEMICAL,ANeA-positive,ANeA-positive
D007111,DISEASE,"Immunity, Cellular","Cell Mediated Immunity|Cellular Immunities|Cellular Immune Response|Immunity, Cell-Mediated|cell-mediated immunity|Cellular Immunity|Immunities, Cellular|Immune Responses, Cellular|Immunities, Cell-Mediated|Immune Response, Cellular|Cell-Mediated Immunity|Response, Cellular Immune|Cellular Immune Responses|Cell-Mediated Immunities"
NEW03163,DISEASE,hypersensitivity DTH skin responses,hypersensitivity DTH skin responses
D060887,CHEBI,B7 Antigens,"antigens|B 7 Antigen|Costimulatory Molecules, B7|B-7 Antigen|B7 Costimulatory Molecules|Molecules, B7|B7 Antigen|Antigens|B7 Molecules|Antigen, B7|Antigens, B7|Antigen, B-7"
NEW03164,CHEMICAL,increased circulating catecholamines,increased circulating catecholamines
NEW03165,DISEASE,severe depressive disorders,severe depressive disorders
NEW03166,DISEASE,Hypercortisolaemia,Hypercortisolaemia
C434825,DISEASE,"Desrt protein, mouse [Supplementary Concept]",DNA-Binding Proteins|immune abnormalities|Transcription Factors
NEW03167,DISEASE,impaired cell-mediated immunity,impaired cell-mediated immunity|CMI|Cornell Medical Index-Health questionnaire
NEW03168,DISEASE,T- dysfunction,T- dysfunction
NEW03169,CHEMICAL,dexamethasone suppression test,dexamethasone suppression test
NEW03170,DISEASE,immunologic impairment indicative,immunologic impairment indicative
NEW03171,CHEBI,neural antigens,neural antigens
NEW03172,CHEMICAL,ex-methamphetamine abusers,ex-methamphetamine abusers
D059425,CHEMICAL,Interferon-gamma Release Tests,"Test, Interferon-gamma Release|Interferon gamma Release Assay|Interferon-gamma Release Assays|Interferon gamma Release Tests|Tests, Interferon-gamma Release|interferon γ|Release Assays, Interferon-gamma|Interferon-gamma Release Assay|Release Assay, Interferon-gamma|Release Tests, Interferon-gamma|Interferon-gamma Release Test|Release Test, Interferon-gamma|Assay, Interferon-gamma Release|Interferon gamma Release Assays|Assays, Interferon-gamma Release|interferon-γ"
C037709,DISEASE,HLA-A9 antigen [Supplementary Concept],HLA-A Antigens|HLA-A9
NEW03173,DISEASE,partial noncicatricial hair loss,partial noncicatricial hair loss
NEW03174,DISEASE,immune-mediated encephalopathy/encephalitis,immune-mediated encephalopathy/encephalitis
NEW03175,DISEASE,prominent psychiatric symptoms,prominent psychiatric symptoms
D018334,DISEASE,Leishmania guyanensis,"guyanensis guyanensis, Leishmania|viannia guyanenses, Leishmania|panamenses, Leishmania viannia|guyanensis, Leishmania guyanensis|brasiliensis guyanensis, Leishmania|guyanenses, Leishmania|Leishmania guyanensis guyanensis|guyanenses, Leishmania brasiliensis|guyanenses, Leishmania braziliensis|guyanensis, Leishmania braziliensis|Leishmania brasiliensis guyanensis|Leishmania viannia panamenses|Leishmania viannia guyanenses|Leishmania viannia guyanensis|guyanensis, Leishmania viannia|guyanenses, Leishmania guyanensis|viannia panamenses, Leishmania|Leishmania brasiliensis guyanenses|Leishmania (Viannia) guyanensis|Leishmania =|Leishmania (Viannia) panamensis|Leishmania braziliensis guyanensis|Leishmania braziliensis guyanenses|Leishmania guyanensis guyanenses|Leishmania|Leishmania guyanenses|guyanensis, Leishmania brasiliensis|viannia panamensis, Leishmania|Leishmania viannia panamensis|viannia guyanensis, Leishmania|braziliensis guyanenses, Leishmania"
NEW03176,CHEBI,antigen formulation,antigen formulation
NEW03177,CHEMICAL,LACK Leishmania analogue,LACK Leishmania analogue
NEW03178,DISEASE,genus Leishmania,genus Leishmania
NEW03179,CHEMICAL,Antimuscarinic acetylcholine receptor-3 m3AChR autoantibodies,Antimuscarinic acetylcholine receptor-3 m3AChR autoantibodies
NEW03180,DISEASE,primary Sjögren 's syndrome,pSS|primary Sjögren 's syndrome
NEW03181,CHEBI,HERV-K env-su glycoprotein antigens,HERV-K env-su glycoprotein antigens
NEW03182,DISEASE,Alzheimer's disease patients,Alzheimer's disease patients
NEW03183,MENTAL_HEALTH,odor-induced anxiety,odor-induced anxiety
NEW03184,CHEBI,orexin receptor antagonist SB-334867,orexin receptor antagonist SB-334867
C073839,CHEMICAL,SR 48968 [Supplementary Concept],saredutant|Piperidines|Benzamides
C520475,CHEMICAL,"CHIC1 protein, human [Supplementary Concept]",DNA-Binding Proteins|hydrophobic domain|Transcription Factors
NEW03185,CHEBI,noncompetitive NMDA receptor antagonist,noncompetitive NMDA receptor antagonist
NEW03186,CHEBI,fact antagonist effect,fact antagonist effect
NEW03187,CHEMICAL,plausible surface-target elements,plausible surface-target elements
C541361,CHEMICAL,3-trans-feruloyl maslinic acid [Supplementary Concept],maslinic acid|Triterpenes
NEW03188,DISEASE,schizophrenia-like behaviors,schizophrenia-like behaviors
NEW03189,DISEASE,behavior deficits,behavior deficits
NEW03190,DISEASE,MK-801-induced memory impairments,MK-801-induced memory impairments
NEW03191,DISEASE,interaction deficits,interaction deficits
NEW03192,DISEASE,chronic pain states,chronic pain states
NEW03193,DISEASE,hypersensitivity attention,hypersensitivity attention
NEW03194,DISEASE,hemiparkinsonian,hemi-PD|hemiparkinsonian
NEW03195,DISEASE,akinetic motor deficit,akinetic motor deficit
NEW03196,CHEMICAL,N-methyl-d-aspartate NMDA receptor hyperactivity,N-methyl-d-aspartate NMDA receptor hyperactivity
NEW03197,DISEASE,epilepsy-related memory dysfunction,epilepsy-related memory dysfunction
NEW03198,DISEASE,Excitotoxic injury,Excitotoxic injury
C059294,CHEMICAL,"3,3',4',5,6,7,8-heptamethoxyflavone [Supplementary Concept]","HMF|3,5,6,7,8,3',4'-heptamethoxyflavone|Flavonoids"
NEW03199,CHEBI,NMDA receptor antagonist MK-801,NMDA receptor antagonist MK-801
NEW03200,MENTAL_HEALTH,experimental schizophrenia model,experimental schizophrenia model
NEW03201,CHEMICAL,NMDA receptor blockade,NMDA receptor blockade
NEW03202,CHEMICAL,Neonatal MK-801 exposure,Neonatal MK-801 exposure
NEW03203,CHEMICAL,sucrose preference,sucrose preference
NEW03204,MENTAL_HEALTH,profound motor hyperactivity,profound motor hyperactivity
C494553,CHEMICAL,"3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide [Supplementary Concept]",Pyrazoles|CDPPB|Benzamides
NEW03205,CHEMICAL,Ketamine-a noncompetitive glutamate N-methyl-d-aspartate NMDA receptor antagonist,Ketamine-a noncompetitive glutamate N-methyl-d-aspartate NMDA receptor antagonist
NEW03206,CHEMICAL,rapid-onset antidepressant effects,rapid-onset antidepressant effects
NEW03207,CHEMICAL,single-dose intravenous ketamine,single-dose intravenous ketamine
NEW03208,DISEASE,chronic PTSD,chronic PTSD
NEW03209,DISEASE,impaired neural connectivity,impaired neural connectivity
NEW03210,CHEMICAL,elevated corticosterone levels,elevated corticosterone levels
NEW03211,CHEMICAL,currents sEPSCs,currents sEPSCs
NEW03212,MENTAL_HEALTH,DRN projection cells,DRN projection cells
NEW03213,CHEMICAL,Repeated corticosterone administration,Repeated corticosterone administration
NEW03214,CHEMICAL,sIPSC frequency,sIPSC frequency
NEW03215,CHEMICAL,rapid antidepressant response,rapid antidepressant response
NEW03216,DISEASE,depressed-like anhedonic behavior,depressed-like anhedonic behavior
NEW03217,DISEASE,brief tail shock,brief tail shock
NEW03218,CHEMICAL,μg/side,μg/side
NEW03219,CHEMICAL,NMDA receptor agonism,NMDA receptor agonism
NEW03220,DISEASE,pain behaviors,pain behaviors
NEW03221,DISEASE,brief noxious tail shock,brief noxious tail shock
NEW03222,CHEMICAL,CNQX .5,CNQX .5
C109603,CHEMICAL,N-(1-(2-nitrophenyl)ethoxycarbonyl)-D-AP5 [Supplementary Concept],"AP5|Receptors, Serotonin|D-AP5"
NEW03223,CHEMICAL,NMDA receptor antagonist D-2-amino-5-phosphonovalerate,NMDA receptor antagonist D-2-amino-5-phosphonovalerate
NEW03224,CHEMICAL,"non-NMDA receptor antagonist 6-Cyano-7-nitroquinoxaline-2,3-dione disodium","non-NMDA receptor antagonist 6-Cyano-7-nitroquinoxaline-2,3-dione disodium"
NEW03225,DISEASE,unilaterality,unilaterality
C114144,CHEMICAL,neramexane [Supplementary Concept],neramexane|Cyclopentanes
NEW03226,DISEASE,ethanol dependence,ethanol dependence|withdrawal-associated audiogenic seizures
NEW03227,CHEBI,low-to-moderate affinity uncompetitive NMDA receptor antagonist,low-to-moderate affinity uncompetitive NMDA receptor antagonist
NEW03228,CHEMICAL,Furosemide agents,Furosemide agents
D053145,DISEASE,Cell Nucleus Size,"cell volume|Cell Nuclear Volumes|edema|Nuclear Size, Cell|Nucleus Sizes, Cell|Sizes, Cell Nuclear|Cell Nuclear Size|Volume, Cell Nuclear|Volumes, Cell Nuclear|Nucleus Size, Cell|Nucleus Volume, Cell|Cell Nuclear Volume|Cell Nucleus Volumes|Cell Nucleus Volume|Nucleus Volumes, Cell|Sizes, Cell Nucleus|Size, Cell Nuclear|Nuclear Sizes, Cell|Nuclear Volume, Cell|Cell Nucleus Sizes|Cell Nuclear Sizes|Nuclear Volumes, Cell|Volumes, Cell Nucleus|Size, Cell Nucleus|Volume, Cell Nucleus"
NEW03229,CHEMICAL,KP metabolite kynurenic acid,KP metabolite kynurenic acid|KYNA
NEW03230,CHEMICAL,its's glycine site,its's glycine site
NEW03231,CHEBI,endogenous NMDA receptor antagonist,endogenous NMDA receptor antagonist
NEW03232,CHEMICAL,GSH consumption,decreased GSH/GSSG ratio|GSH consumption
NEW03233,CHEMICAL,GSH synthesis,GSH synthesis
NEW03234,CHEMICAL,noncompetitive NMDA-receptor antagonist memantine intraperitoneal,noncompetitive NMDA-receptor antagonist memantine intraperitoneal
NEW03235,CHEMICAL,amino acid concentrations,amino acid concentrations
NEW03236,CHEMICAL,plasma ammonia concentrations,plasma ammonia concentrations
NEW03237,CHEMICAL,glutamate N-methyl-D-aspartate NMDA receptor antagonist ketamine,glutamate N-methyl-D-aspartate NMDA receptor antagonist ketamine
NEW03238,CHEMICAL,noncompetitive glutamatergic N-methyl-d-aspartate NMDA receptor antagonist,noncompetitive glutamatergic N-methyl-d-aspartate NMDA receptor antagonist
NEW03239,DISEASE,treatment-resistant major depressive disorder,treatment-resistant major depressive disorder
NEW03240,CHEMICAL,rapid antidepressant responses,rapid antidepressant responses
NEW03241,CHEBI,Several monoamine-based pharmacological drug classes,Several monoamine-based pharmacological drug classes
NEW03242,CHEBI,noncompetitive NMDA receptor antagonist ketamine,noncompetitive NMDA receptor antagonist ketamine
NEW03243,CHEMICAL,non-competitive NMDA receptor antagonist ketamine,non-competitive NMDA receptor antagonist ketamine
NEW03244,CHEMICAL,ketamine's rapid antidepressant activity,ketamine's rapid antidepressant activity
NEW03245,DISEASE,treatment-resistant MDD,treatment-resistant MDD
NEW03246,CHEMICAL,non-competitive N-methyl-d-aspartate NMDA receptor antagonist ketamine,non-competitive N-methyl-d-aspartate NMDA receptor antagonist ketamine
NEW03247,DISEASE,treatment-resistant patients,treatment-resistant patients
D058468,CHEMICAL,"Receptors, Ionotropic Glutamate","Glutamate Receptors, Ionotropic|Glutamate receptors|glutamate receptors|ionotropic glutamate receptors|Glutamate Receptor, Ionotropic|Ionotropic Glutamate Receptor|Ionotropic Glutamate Receptors|Receptor, Ionotropic Glutamate"
NEW03248,DISEASE,food-seeking behavior,food-seeking behavior
NEW03249,CHEMICAL,T-type channel antagonists/blockers,T-type channel antagonists/blockers
NEW03250,CHEMICAL,N-methyl-D-aspartate NMDA receptor antagonist memantine,N-methyl-D-aspartate NMDA receptor antagonist memantine
NEW03251,DISEASE,dependent memory deficits,dependent memory deficits
NEW03252,CHEBI,Current approved drug treatments,Current approved drug treatments
NEW03253,CHEBI,NMDA receptor antagonist memantine,NMDA receptor antagonist memantine
D000068836,CHEMICAL,Rivastigmine,"713, SDZ ENA|(S)-N-Ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate|Rivastigmine|713, ENA|rivastigmine|RivastigmineTartrate|SDZ ENA 713|ENA-713|Exelon|Hydrogen Tartrate, Rivastigmine|Tartrate, Rivastigmine Hydrogen|Rivastigmine Hydrogen Tartrate|ENA713|ENA 713|ENA 713, SDZ"
D016567,CHEMICAL,Nizatidine,"N-(2-(((2-((Dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine|LY 139037|Axid|LY139037|nizatidine|LY-139037"
NEW03254,DISEASE,reducing/limiting weight gain,reducing/limiting weight gain
D015738,CHEMICAL,Famotidine,|MK-208|Famotidine|Pepcid|YM-11170|MK208|YM11170|MK 208|YM 11170|Famotidine Hydrochloride|famotidine
NEW03255,DISEASE,our's treatment-resistant patients,our's treatment-resistant patients
NEW03256,DISEASE,Paranoid disturbances,Paranoid disturbances
NEW03257,CHEMICAL,famotidine augmentation,famotidine augmentation
D002927,CHEMICAL,Cimetidine,"HCl, Cimetidine||cimetidine|SK and F 92334|Hydrochloride, Cimetidine|Biomet|SK and F-92334|Cimetidine|Cimetidine Hydrochloride|N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine|Eureceptor|Altramet|SKF-92334|Tagamet|Biomet400|SK and F92334|Histodil|SKF 92334|Cimetidine HCl|SKF92334"
NEW03258,CHEMICAL,drug-drug interaction,drug-drug interaction|DDI
C576143,CHEMICAL,G6 stilbenoid tyrosine kinase inhibitor [Supplementary Concept],Stilbenes|TKI|tyrosine-kinase inhibitor
NEW03259,DISEASE,advanced non-small-cell cancer aNSCLC patients,advanced non-small-cell cancer aNSCLC patients
NEW03260,DISEASE,major DDIs,major DDIs
NEW03261,CHEMICAL,Lycopodium alkaloids,Lycopodium alkaloids|LAs
NEW03262,NUTRITION,fresh onion juice,fresh onion juice
NEW03263,CHEMICAL,serum testosterone levels,serum testosterone levels
NEW03264,MENTAL_HEALTH,paroxetine-induced sexual dysfunction,paroxetine-induced sexual dysfunction
NEW03265,DISEASE,A. cepa bulb ethyl acetate fraction,A. cepa bulb ethyl acetate fraction
NEW03266,CHEMICAL,paroxetine-induced male rats,paroxetine-induced male rats
D000857,DISEASE,Olfaction Disorders,"Impaired Olfaction||Impairment, Olfactory|Olfaction, Impaired|Olfactory Impairment|Phantosmia|Smell Disorders|Paraosmias|Impaired Olfactions|dysosmia|Olfactions, Impaired|Dysosmia|Dysosmias|Parosmia|Phantosmias|Paraosmia|phantosmia|Smell Disorder|Cacosmias|Olfaction Disorder|Dysfunction, Smell|Parosmias|Smell Dysfunction|Cacosmia"
NEW03267,DISEASE,postinfectious anosmia,postinfectious anosmia
NEW03268,DISEASE,age-related cognitive decline,age-related cognitive decline
NEW03269,NUTRITION,quercetin-rich onion,quercetin-rich onion
NEW03270,CHEBI,potent opioid receptor antagonists,potent opioid receptor antagonists
NEW03271,DISEASE,sexual overstimulation,sexual overstimulation
NEW03272,DISEASE,severe locomotor deficits,severe locomotor deficits
NEW03273,CHEMICAL,dopamine precursor,dopamine precursor
NEW03274,CHEMICAL,precursor L-DOPA,precursor L-DOPA
NEW03275,DISEASE,LID severity,LID severity
NEW03276,CHEBI,nonspecific antagonist,nonspecific antagonist
NEW03277,DISEASE,LIDs,LIDs|levodopa-induced dyskinesias
NEW03278,DISEASE,Parkinson's disease motor symptoms,Parkinson's disease motor symptoms
NEW03279,CHEBI,brain nucleus-targeted µ receptor agonists,brain nucleus-targeted µ receptor agonists
NEW03280,CHEMICAL,weeks morphine abstinence,weeks morphine abstinence
NEW03281,DISEASE,depressive-like behaviors,depressive-like behaviors
NEW03282,CHEMICAL,chronic escalating morphine regimen,chronic escalating morphine regimen
NEW03283,CHEMICAL,opioid receptor antagonist nor-Binaltorphimine,opioid receptor antagonist nor-Binaltorphimine
NEW03284,DISEASE,moderate-to-severe pain constipation,moderate-to-severe pain constipation
NEW03285,DISEASE,chronic constipation,chronic constipation
NEW03286,DISEASE,postoperative ileus,postoperative ileus
NEW03287,CHEMICAL,KOR/dynorphin system,KOR/dynorphin system
NEW03288,DISEASE,multiple neuropsychological disorders,multiple neuropsychological disorders
NEW03289,CHEBI,KOR antagonist nor-binaltorphimine,KOR antagonist nor-binaltorphimine
NEW03290,CHEBI,KOR antagonists,KOR antagonists
NEW03291,CHEMICAL,novel antidepressants,novel antidepressants
NEW03292,MENTAL_HEALTH,prevalent impulse control disorder,prevalent impulse control disorder
NEW03293,CHEBI,mixed μ-opioid antagonist,mixed μ-opioid antagonist
NEW03294,CHEBI,non-selective opioid receptor antagonists,non-selective opioid receptor antagonists
NEW03295,DISEASE,short-term weight loss,short-term weight loss
NEW03296,DISEASE,prurigo nodularis therapy,prurigo nodularis therapy
NEW03297,CHEBI,μ-opioid receptor antagonists,μ-opioid receptor antagonists
NEW03298,CHEMICAL,topical steroids,topical steroids
NEW03299,DISEASE,Breast milk carotenoids,Breast milk carotenoids
NEW03300,CHEMICAL,nitric oxide NO system,nitric oxide NO system
NEW03301,CHEMICAL,central histamine systems,central histamine systems
D008635,CHEMICAL,Mescaline,"mescaline|3,4,5-Trimethoxyphenethylamine|Mezcalin|Peyote|Trimethoxyphenethylamine"
D032302,CHEMICAL,Datura,Daturas
NEW03302,CHEMICAL,atropine content,atropine content
NEW03303,CHEMICAL,Mucuna pruriens,Mucuna pruriens
D013036,DISEASE,"Spasms, Infantile","Nodding Spasms|Cryptogenic Infantile Spasm|Spasm, Symptomatic Infantile|West Syndrome|Infantile Spasm, Cryptogenic|Attacks, Lightning|Jackknife Seizure|Spasm, Cryptogenic Infantile|Infantile Spasms|West Syndrome, Symptomatic|spasms|Seizure, Jackknife|Symptomatic Infantile Spasm|Symptomatic Infantile Spasms|Infantile Spasms, Cryptogenic|Infantile Spasm|Infantile Spasms, Symptomatic|Salaam Seizures|Infantile Spasm, Symptomatic|Syndrome, West|Lightning Attack|Cryptogenic West Syndrome|Spasm, Nodding|Symptomatic West Syndrome|Cryptogenic Infantile Spasms|Salaam Attacks|Nodding Spasm|Spasms, Nodding|Spasmus Nutans|Syndrome, Cryptogenic West|Seizures, Salaam|Spasms, Cryptogenic Infantile|Attacks, Salaam|West Syndrome, Cryptogenic|Syndrome, Symptomatic West|Seizures, Jackknife|Hypsarrhythmia|Jackknife Seizures|Lightning Attacks|infantile spasms|Hypsarrhythmias|Attack, Lightning|Spasms, Symptomatic Infantile"
NEW03304,DISEASE,diet-induced obesity,diet-induced obesity
NEW03305,CHEMICAL,ss-endorphins,ss-endorphins
C583676,CHEMICAL,"FNDC5 protein, rat [Supplementary Concept]",Fibronectins|Irisin|irisin
C535554,DISEASE,Abdominal obesity metabolic syndrome [Supplementary Concept],Metabolic Syndrome|abdominal obesity
NEW03306,MENTAL_HEALTH,antipsychotic drug-induced insulin resistance,antipsychotic drug-induced insulin resistance
NEW03307,CHEMICAL,pruriens seeds,pruriens seeds
D008012,CHEMICAL,Lidocaine,"|2-2EtN-2MePhAcN|Lidocaine Monohydrochloride, Monohydrate|lidocaine %|2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide|Xylocitin|Xyloneural|Lignocaine|Lidocaine Carbonate|lidocaine hydrochloride|Lidocaine Hydrocarbonate|lidocaine|Xylocaine|Xylesthesin|Dalcaine|Lidocaine Hydrochloride|Octocaine|Lidocaine Carbonate (2:1)|Lidocaine Sulfate (1:1)|Lidocaine Monohydrochloride|Lidocaine|Lidocaine Monoacetate"
NEW03308,DISEASE,withdrawal-induced hyperalgesia,withdrawal-induced hyperalgesia
C087260,CHEMICAL,YM 022 [Supplementary Concept],Benzodiazepines|YM022
NEW03309,CHEBI,5HT3 receptor antagonist,5HT3 receptor antagonist
NEW03310,CHEBI,neurokinin NK1 receptor antagonists,neurokinin NK1 receptor antagonists
NEW03311,CHEMICAL,serotonin neurons,serotonin neurons
NEW03312,DISEASE,hepatic dysfunction,hepatic dysfunction
NEW03313,CHEBI,common antibiotics,common antibiotics
NEW03314,CHEMICAL,dopamine regulation,dopamine regulation
NEW03315,CHEMICAL,severe aripiprazole hepatotoxicity,severe aripiprazole hepatotoxicity
D012258,CHEBI,Riboflavin Synthase,"Synthase, Riboflavin|riboflavin"
NEW03316,DISEASE,motor disability,motor disability
D054069,DISEASE,Multiple Acyl Coenzyme A Dehydrogenase Deficiency,"Multiple acyl-CoA dehydrogenase deficiency|Glutaric Aciduria Type II|Electron Transfer Flavoprotein Dehydrogenase Deficiency|ETFDH Deficiencies|Glutaric Aciduria II|Ethylmalonic-Adipic Aciduria|ETFA Deficiencies|Glutaric Aciduria, Type 2|Glutaric Aciduria IIC|Glutaric Aciduria Type 2|Glutaric Aciduria IIA|ETFA Deficiency|Multiple FAD Dehydrogenase Deficiency|ETFB Deficiency|MADD|Ethylmalonic Adipic Aciduria|MADD (Multiple Acyl-CoA Dehydrogenase Deficiency)|Aciduria, Ethylmalonic-Adipic|Ethylmalonic-Adipic Acidurias|ETFB Deficiencies|Electron Transfer Flavoprotein Alpha Subunit Deficiency|Glutaric Aciduria IIB|Ethylmalonic-Adipicaciduria|MADD (Multiple Acyl CoA Dehydrogenase Deficiency)|Glutaric aciduria type|Ethylmalonic Adipicaciduria|Multiple Acyl-CoA Dehydrogenase Deficiency|Multiple Acyl CoA Dehydrogenase Deficiency|Glutaric Acidemia Type II|ETFDH Deficiency|MADDs (Multiple Acyl-CoA Dehydrogenase Deficiency)|Multiple acyl-coA dehydrogenase deficiency|Electron Transfer Flavoprotein Beta Subunit Deficiency|Glutaric Acidemia, Type 2|Electron Transfer Flavoprotein Deficiency|Acidurias, Ethylmalonic-Adipic"
D002333,CHEMICAL,Carnitine Acyltransferases,"Acylcarnitine Translocase|Translocase, Carnitine|Carnitine Acylcarnitine Translocase|Carnitine-Acetylcarnitine Translocase|Carnitine Translocase|Translocase, Carnitine-Acetylcarnitine|Carnitine-Acylcarnitine Translocase|Translocase, Acylcarnitine|Carnitine Acetylcarnitine Translocase|Acyltransferases, Carnitine|Translocase, Carnitine-Acylcarnitine|acylcarnitine"
NEW03317,CHEBI,Higher nicotinamide level,Higher nicotinamide level
D026681,CHEBI,Vitamin B 6 Deficiency,"vitamin B6 deficiency|pyridoxine|B6 Deficiency, Vitamin|B6 Deficiencies, Vitamin|VB6|vitamin deficiencies|vitamin B|Deficiencies, Vitamin B6|Deficiency, Vitamin B 6|Vitamin Deficiencies, B6|Vitamin B|Vitamin Deficiency, B6|Vitamin B6|Deficiency, Vitamin B6|vitamin B6|vitamin B₁₂|Vitamin B6 Deficiency|B6 Vitamin Deficiency|Deficiency, B6 Vitamin|Vitamin B6 Deficiencies|B6 Vitamin Deficiencies|Deficiencies, B6 Vitamin|Pyridoxine Deficiency|Deficiency, Pyridoxine"
NEW03318,CHEMICAL,Hepatic ammonia levels,Hepatic ammonia levels
NEW03319,DISEASE,secondary hyperammonemia,secondary hyperammonemia
NEW03320,DISEASE,Higher anxiety-like behavior,Higher anxiety-like behavior
NEW03321,CHEMICAL,KCl-induced CSDs,KCl-induced CSDs
C535306,DISEASE,2-Hydroxyglutaricaciduria [Supplementary Concept],"L-2-hydroxyglutaric aciduria|L-2-HGA|Brain Diseases, Metabolic, Inborn|combined D-2-"
NEW03322,CHEMICAL,elevated L-2-hydroxyglutaric acid,elevated L-2-hydroxyglutaric acid|L-2-HG
NEW03323,DISEASE,striatal damage,striatal damage
C000603057,CHEMICAL,"L2HGDH protein, mouse [Supplementary Concept]",Alcohol Oxidoreductases|L-2-hydroxyglutarate dehydrogenase
NEW03324,CHEMICAL,fish-white meat,fish-white meat
NEW03325,CHEMICAL,blood zinc,blood zinc
NEW03326,CHEMICAL,kynurenines,kynurenines
NEW03327,CHEMICAL,kynurenine catabolism,kynurenine catabolism
NEW03328,MENTAL_HEALTH,Norwegian adult ADHD patients,Norwegian adult ADHD patients
NEW03329,DISEASE,rare neurological disorder,rare neurological disorder
NEW03330,CHEBI,defective riboflavin transporters,defective riboflavin transporters
C537111,DISEASE,Brown-Vialetto-Van Laere syndrome [Supplementary Concept],"Brown-Vialetto-Van Laere Syndrome|Bulbar Palsy, Progressive|Hearing Loss, Sensorineural"
NEW03331,CHEMICAL,Anabolic Androgenic Steroids,Anabolic Androgenic Steroids
NEW03332,CHEMICAL,oral contraceptive use,oral contraceptive use
C562465,MENTAL_HEALTH,"Phobia, Specific [Supplementary Concept]",Phobic Disorders|specific phobia
NEW03333,CHEMICAL,chronic all-trans retinoic acid administration,chronic all-trans retinoic acid administration
D014212,CHEMICAL,Tretinoin,"|trans-Retinoic Acid|Retin A|Retinoic Acid|Vitamin A Acid|trans Retinoic Acid|Salt, Tretinoin Zinc|Salt, Tretinoin Potassium|Acid, all-trans-Retinoic|All-trans retinoic acid|Salt, Tretinoin Sodium|Sodium Salt, Tretinoin|Acid, beta-all-trans-Retinoic|Acid, Retinoic|Tretinoin Zinc Salt|Acid, Vitamin A|Vesanoid|All- trans-retinoic acid|Tretinoin Sodium Salt|ATRA|all trans Retinoic Acid|beta-all-trans-Retinoic Acid|Potassium Salt, Tretinoin|all-trans-Retinoic Acid|Zinc Salt, Tretinoin|beta all trans Retinoic Acid|all-trans retinoic acid|Acid, trans-Retinoic|Retin-A|Tretinoin Potassium Salt|trans retinoic acid"
NEW03334,DISEASE,CRF neurons,CRF neurons
NEW03335,CHEBI,sex hormone receptors,sex hormone receptors
NEW03336,DISEASE,ATRA-induced CRF over-expression,ATRA-induced CRF over-expression
NEW03337,CHEMICAL,arginine-vasopressin up-regulation,arginine-vasopressin up-regulation
NEW03338,CHEMICAL,Chronic ATRA treatment,Chronic ATRA treatment
D046790,DISEASE,"Pancreas, Exocrine",pancreas|Exocrine Pancreas
NEW03339,CHEMICAL,sex-hormone production,sex-hormone production
NEW03340,CHEBI,oestrogen replacement therapy,oestrogen replacement therapy
NEW03341,DISEASE,comorbid schizophrenia spectrum disorders,SSD|comorbid schizophrenia spectrum disorders
NEW03342,CHEBI,oestrogens,oestrogens
NEW03343,DISEASE,SCZ patients,SCZ patients
NEW03344,DISEASE,first-episode SCZ patients,first-episode SCZ patients
NEW03345,CHEMICAL,serum progesterone levels,serum progesterone levels
NEW03346,CHEBI,blood hormone levels,blood hormone levels
NEW03347,DISEASE,multifactorial disease,multifactorial disease
D006931,CHEMICAL,Hyperbaric Oxygenation,"Oxygenation, Hyperbaric|Oxygenations, Hyperbaric|Hyperbaric Oxygenations|oxygen therapy|Oxygen Therapies, Hyperbaric|Hyperbaric Oxygen Therapies|Therapies, Hyperbaric Oxygen|Hyperbaric Oxygen Therapy|Therapy, Hyperbaric Oxygen|Oxygen Therapy, Hyperbaric"
NEW03348,MENTAL_HEALTH,secondary sexual impotence,secondary sexual impotence
NEW03349,CHEMICAL,microng LHRH,microng LHRH
NEW03350,CHEMICAL,2.39+/-0.4 mu/ml,2.39+/-0.4 mu/ml
NEW03351,MENTAL_HEALTH,schizophrenia relative,schizophrenia relative
NEW03352,CHEMICAL,oestrogen-based therapies,oestrogen-based therapies
NEW03353,CHEBI,selective oestrogen receptor modulator raloxifene,selective oestrogen receptor modulator raloxifene
NEW03354,CHEBI,sex hormone depletion,sex hormone depletion
NEW03355,CHEBI,adrenal hormones,adrenal hormones
NEW03356,CHEMICAL,elevated testosterone,elevated testosterone
NEW03357,MENTAL_HEALTH,elevated anxiety scores,elevated anxiety scores
NEW03358,CHEMICAL,elevated estradiol,elevated estradiol
NEW03359,MENTAL_HEALTH,elevated depression,elevated depression
NEW03360,CHEBI,difference/10 % hormone increase,difference/10 % hormone increase
NEW03361,CHEMICAL,β=0.42,β=0.42
D016014,MENTAL_HEALTH,Linear Models,"Log-Linear Models|Linear Model|Model, Linear|Log-Linear Model|linear regression|Regressions, Linear|Regression, Linear|Linear Regression|Models, Log-Linear|Linear Regressions|Log Linear Models|Models, Linear|Model, Log-Linear"
NEW03362,CHEMICAL,Higher cortisol levels,Higher cortisol levels
NEW03363,MENTAL_HEALTH,depression association,depression association
NEW03364,CHEBI,most hormones,most hormones
NEW03365,CHEMICAL,lower testosterone concentrations,lower testosterone concentrations
NEW03366,DISEASE,more fractures,more fractures
NEW03367,DISEASE,higher depressive symptomatology,higher depressive symptomatology
NEW03368,DISEASE,higher depressive,higher depressive
NEW03369,CHEBI,endogenous gonadal hormones,endogenous gonadal hormones
NEW03370,CHEMICAL,MPH treatment,MPH treatment
D010226,CHEMICAL,Parabens,4-Hydroxybenzoic Acids|para-Hydroxybenzoic Acids|Paraben|para-hydroxybenzoic acids|4 Hydroxybenzoic Acids|para Hydroxybenzoic Acids
NEW03371,CHEMICAL,phthalates,phthalates
D004703,CHEBI,Endocrine System,"Endocrine Systems|endocrine systems|Systems, Endocrine|endocrine system|Endocrine systems|System, Endocrine"
D043373,CHEBI,"Follicle Stimulating Hormone, Human","Human FSH|follicle-stimulating hormone|FSH, human (follicle stimulating hormone)|Human Follicle Stimulating Hormone|follicle stimulating hormone|hFSH|Anthrogon|FSH, Human"
NEW03372,CHEMICAL,free testosterone,free testosterone
C012313,CHEMICAL,ethyl-p-hydroxybenzoate [Supplementary Concept],EP|ethylparaben|Parabens
NEW03373,MENTAL_HEALTH,ADHD n,ADHD n
NEW03374,CHEMICAL,lower SHBG,lower SHBG
NEW03375,CHEMICAL,bioavailable testosterone,bioavailable testosterone
NEW03376,MENTAL_HEALTH,ADHD measures,ADHD measures
NEW03377,CHEMICAL,Osmotic-release oral system methylphenidate treatment,Osmotic-release oral system methylphenidate treatment
NEW03378,CHEBI,abnormal sex hormone levels,abnormal sex hormone levels
NEW03379,CHEMICAL,lower DHEA-S levels,lower DHEA-S levels
NEW03380,CHEMICAL,DHEA-S levels,DHEA-S levels
NEW03381,DISEASE,impulsivity performance,impulsivity performance
NEW03382,CHEMICAL,SHBG levels,SHBG levels
NEW03383,MENTAL_HEALTH,ADHD behavior symptoms,ADHD behavior symptoms
NEW03384,CHEMICAL,endogenous oxytocin concentrations,endogenous oxytocin concentrations
NEW03385,MENTAL_HEALTH,lower Liebowitz Anxiety Score,lower Liebowitz Anxiety Score
NEW03386,CHEMICAL,high oxytocin,high oxytocin
NEW03387,CHEBI,individual sex hormone levels,individual sex hormone levels
NEW03388,MENTAL_HEALTH,basal anxiety levels,basal anxiety levels
NEW03389,CHEBI,sex hormone differences,sex hormone differences
NEW03390,DISEASE,PTSD symptomology,PTSD symptomology
NEW03391,DISEASE,subsequent post-traumatic stress symptoms,subsequent post-traumatic stress symptoms
NEW03392,CHEBI,intrauterine sex hormone exposure,intrauterine sex hormone exposure
NEW03393,MENTAL_HEALTH,moderate intellectual disability,moderate intellectual disability
NEW03394,MENTAL_HEALTH,cycle-related mood disorders,cycle-related mood disorders
NEW03395,CHEBI,female sex hormones,female sex hormones
NEW03396,MENTAL_HEALTH,major depression disorder,major depression disorder
NEW03397,MENTAL_HEALTH,certain mental disorders,certain mental disorders
NEW03398,CHEMICAL,cross-sex hormone therapy,cross-sex hormone therapy
NEW03399,CHEBI,prenatal sex hormone exposure,prenatal sex hormone exposure
NEW03400,MENTAL_HEALTH,dementia diagnosis,dementia diagnosis
NEW03401,CHEBI,non-NMDA N-methyl-D-aspartic acid receptor antagonist CNQX,non-NMDA N-methyl-D-aspartic acid receptor antagonist CNQX
NEW03402,DISEASE,burying behavior,burying behavior
NEW03403,CHEMICAL,intra-septal infusions,intra-septal infusions
NEW03404,CHEBI,NMDA receptor antagonist AP-5,NMDA receptor antagonist AP-5
NEW03405,CHEMICAL,different EAA receptor types,different EAA receptor types
NEW03406,DISEASE,different anxiety-related behaviors,different anxiety-related behaviors
NEW03407,CHEMICAL,Certain D2 dopamine receptor Taq 1A genotypes,Certain D2 dopamine receptor Taq 1A genotypes
NEW03408,MENTAL_HEALTH,obesity substance abuse,obesity substance abuse
NEW03409,CHEMICAL,cortisol measures,cortisol measures
NEW03410,NUTRITION,blood cholesterol levels,blood cholesterol levels
NEW03411,CHEMICAL,increased cortisol secretion,increased cortisol secretion
D050528,CHEMICAL,"Diet, Carbohydrate-Restricted","Diet, Carbohydrate Restricted|low-carbohydrate diets|Carbohydrate Diet, Low|Diets, Low Carbohydrate|Low-Carbohydrate Diets|Diets, Carbohydrate-Restricted|Carbohydrate-Restricted Diet|Carbohydrate Diets, Low|Carbohydrate Restricted Diet|Low Carbohydrate Diets|Diet, Low-Carbohydrate|Diets, Low-Carbohydrate|Carbohydrate-Restricted Diets|Diet, Low Carbohydrate|Low-Carbohydrate Diet|Low Carbohydrate Diet"
NEW03412,DISEASE,diabetes management,diabetes management
C538646,NUTRITION,"High serum cholesterol, familial [Supplementary Concept]",serum cholesterol|High serum cholesterol|Hyperlipoproteinemia Type II
NEW03413,NUTRITION,long-chain polyunsaturated fatty acids,long-chain polyunsaturated fatty acids
NEW03414,MENTAL_HEALTH,ADHD group,ADHD group
NEW03415,NUTRITION,plasma phospholipids,plasma phospholipids
NEW03416,CHEMICAL,ascorbate concentrations,ascorbate concentrations
NEW03417,CHEBI,TAAR1 agonists,TAAR1 agonists
NEW03418,DISEASE,schedule-induced polydipsia,schedule-induced polydipsia
NEW03419,CHEBI,selective partial TAAR1 agonist,selective partial TAAR1 agonist
C000596180,CHEMICAL,"4-(3-fluoro-2-methylphenyl)-4,5-dihydrooxazol-2-ylamine [Supplementary Concept]",RO5263397|Oxazoles
NEW03420,CHEMICAL,Orx2 receptors,Orx2 receptors
NEW03421,DISEASE,anxious behavior,anxious behavior
NEW03422,CHEMICAL,azapirone anxiolytics,azapirone anxiolytics
NEW03423,DISEASE,experiments polydipsia,experiments polydipsia
C414463,DISEASE,"SIP protein, Streptococcus group B [Supplementary Concept]","SIP|Antigens, Bacterial"
D002065,CHEMICAL,Buspirone,"Ratio-Buspirone|Apo-Buspirone|Lin Buspirone|Buspirone|buspirone|Nu-Buspirone|Gen Buspirone|Gen-Buspirone|buspirone hydrochloride|Neurosine|Lin-Buspirone|Buspar|Anxut|Bespar|Hydrochloride, Buspirone|PMS-Buspirone|PMS Buspirone|Novo Buspirone|Apo Buspirone|Novo-Buspirone|Nu Buspirone|N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-1-cyclopentanediacetamide|Busp|Ratio Buspirone|MJ90221|Buspirone Hydrochloride|MJ-9022-1|MJ 9022 1"
C043077,CHEMICAL,ipsapirone [Supplementary Concept],ipsapirone|Pyrimidines
D017371,CHEMICAL,8-Hydroxy-2-(di-n-propylamino)tetralin,"8-Hydroxy-2-(di-n-propylamino)tetralin Hydrochloride, (S)-Isomer|8-Hydroxy-2-(di-n-propylamino)tetralin, (+-)-Isomer|8-Hydroxy-2-(di-n-propylamino)tetralin, (S)-Isomer|8-hydroxy-2-(di-n-propylamino)tetralin|8-Hydroxy-2-(di-n-propylamino)tetralin Hydrobromide|8-Hydroxy-2-(di-n-propylamino)tetralin Hydrobromide, (S)-Isomer,|8-Hydroxy-2-(di-n-propylamino)tetralin, (R)-Isomer|8-Hydroxy-2-(di-n-propylamino)tetralin Hydrobromide, (R)-Isomer,|8-OH-DPAT|8-Hydroxy-2-(di-n-propylamino)tetralin Hydrochloride, (R)-Isomer,|8-Hydroxy-2-(di-n-propylamino)tetralin Hydrobromide, (+-)-Isomer|tetralin"
NEW03424,CHEBI,nicotinic cholinergic drugs,nicotinic cholinergic drugs
NEW03425,CHEMICAL,alpha7-N-receptors,alpha7-N-receptors
NEW03426,DISEASE,cortical circuits,cortical circuits
NEW03427,DISEASE,motor habituation,motor habituation
D010830,CHEMICAL,Physostigmine,|Eserine|Physostigmine|PHYSO|physostigmine|PHY
D010095,CHEMICAL,Oxotremorine,Oxytremorine|oxotremorine
D000089502,DISEASE,Antiglaucoma Agents,"Anti Glaucoma Medications|Drug, Anti-Glaucoma|Medications, Anti-Glaucoma|Anti-Glaucoma Drug|Anti-Glaucoma Medications|glaucoma medications|Anti-Glaucoma Agent|Drugs, Anti-Glaucoma|Anti-Glaucoma Drugs|Medications, Antiglaucoma|Antiglaucoma Drugs|Antiglaucoma Medications|Anti-Glaucoma Agents|anti-glaucoma agents"
D003566,CHEMICAL,Cytidine Diphosphate Choline,"Choline, CDP|Cytidine 5'-Diphosphocholine|5'-Diphosphocholine, Cytidine|Cyticholine|citicholine|CDP Choline|Citicholine|Cidifos|citicoline|Citicoline|Diphosphate Choline, Cytidine|Cytidine 5' Diphosphocholine|Choline, Cytidine Diphosphate"
NEW03428,DISEASE,glaucomatous damages,glaucomatous damages
NEW03429,CHEMICAL,ACh signaling,ACh signaling
D012133,DISEASE,Respiratory Paralysis,"Muscle Paralyses, Respiratory||muscle paralysis|Paralysis, Diaphragmatic|Paralysis, Respiratory|Muscle Paralysis, Respiratory|Paralysis, Respiratory Muscle|Diaphragmatic Paralysis|respiratory paralysis|Respiratory Muscle Paralysis"
D000077924,DISEASE,Palonosetron,"Palonosetron, (R-(R*,R*))-isomer|Palonosetron, (R-(R*,S*))-isomer|RS 25259|RS 25259 197|RS 25233 198|RS-25259-197|RS 25259 198|RS-25233-198|RS 25233198|RS|RS 25233-197|RS-25259-198|RS25259|RS25233197|RS25233198|Palonosetron, (3R)-|RS25259197|RS 25233-198|2-QHBIQO|Aloxi|RS-25259|2-(1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one|RS25259198|Palonosetron, (S-(R*,S*))-isomer|RS 25259197|RS 25233197|RS 25233 197|RS 25259198|Palonosetron Hydrochloride|RS 25259-197|RS-25233-197|RS 25259-198"
NEW03430,CHEBI,direct cholinergic agonist,direct cholinergic agonist
D017202,DISEASE,Myocardial Ischemia,"Heart Disease, Ischemic||Ischemia, Myocardial|Ischemic Heart Diseases|Disease, Ischemic Heart|Diseases, Ischemic Heart|Myocardial Ischemias|Heart Diseases, Ischemic|myocardial ischemia|Ischemias, Myocardial|ischemic heart disease|Ischemic Heart Disease"
NEW03431,DISEASE,geriatric age,geriatric age
NEW03432,DISEASE,Hcrt-r2 mutation,Hcrt-r2 mutation
NEW03433,MENTAL_HEALTH,drug-induced cataplexy,drug-induced cataplexy
D018679,CHEBI,Cholinergic Agonists,"Acetylcholine Agonist|Agonists, Cholinergic|acetylcholine agonists|Acetylcholine Agonists|Cholinergic Agonist|Agonist, Cholinergic|Agonist, Acetylcholine|cholinergic agonists|Agonists, Acetylcholine|Cholinergic agonists"
NEW03434,DISEASE,narcoleptic canines,narcoleptic canines
NEW03435,MENTAL_HEALTH,common mental illness,common mental illness
NEW03436,MENTAL_HEALTH,schizophrenia research,schizophrenia research
D015140,DISEASE,"Dementia, Vascular","Binswanger's Encephalopathy|Arteriosclerotic Dementias|Subcortical Encephalopathy, Chronic Progressive|Subcortical Arteriosclerotic Encephalopathy|Disease, Binswanger|VaD|Arteriosclerotic Dementia|Arteriosclerotic Encephalopathy, Subcortical|Binswangers Disease|Binswanger Encephalopathy|Encephalopathy, Binswangers|Subcortical Vascular Dementia|Binswanger Disease|Encephalopathy, Binswanger's|Subcortical Leukoencephalopathy|Vascular Dementias, Subcortical|Vascular Dementia, Subcortical|Vascular Dementia, Acute Onset|Chronic Progressive Subcortical Encephalopathy|Encephalopathies, Subcortical Arteriosclerotic|Encephalopathy, Subcortical, Chronic Progressive|Dementia, Subcortical Vascular|Vascular dementia|Subcortical Leukoencephalopathies|Dementia, Arteriosclerotic|Subcortical Arteriosclerotic Encephalopathies|Encephalopathy, Chronic Progressive Subcortical|subcortical vascular dementia|Leukoencephalopathies, Subcortical|Acute Onset Vascular Dementia|Leukoencephalopathy, Subcortical|Vascular Dementias|vascular dementia|Arteriosclerotic Encephalopathies, Subcortical|Encephalopathy, Subcortical Arteriosclerotic|vascular dementias|Dementias, Subcortical Vascular|Dementias, Vascular|multi-infarct dementia|Dementias, Arteriosclerotic|Vascular Dementia|Subcortical Vascular Dementias|Encephalopathy, Binswanger|Disease, Binswanger's|Binswanger's Disease"
C032114,CHEMICAL,propentofylline [Supplementary Concept],Xanthines|propentofylline
C055448,CHEMICAL,posatirelin [Supplementary Concept],posatirelin|Thyrotropin-Releasing Hormone/analogs  and  derivatives
D009530,CHEMICAL,Nicergoline,"|Nicergolin Lindo|Nicergolin Atid|Ergobel|Nicotergoline|Nicergolin Ratiopharm|nicergoline|Nicergobeta|Nimergoline|Circo-Maren|Circo Maren|Von Ct, Nicergolin|Nicergoline|Fisifax|Nicergolin TEVA|Nicergolin Neuraxpharm|Nicergolin-Ratiopharm|Nicergolin Von Ct|Nicerium|F.I. 6714|Sermion|Nicergolin-Neuraxpharm|Nicergolin-TEVA"
D010431,CHEMICAL,Pentoxifylline,|Trental|Agapurin|Oxpentifylline|BL 191|BL191|pentoxifylline|Torental|BL-191|Pentoxifylline|Pentoxil
NEW03437,CHEBI,H(2)-receptor antagonists,H(2)-receptor antagonists
NEW03438,CHEMICAL,ranitidine exposure,ranitidine exposure
NEW03439,CHEMICAL,cimetidine exposure,cimetidine exposure
NEW03440,DISEASE,ulcer surgery,ulcer surgery
NEW03441,CHEBI,central adverse drug reactions,central adverse drug reactions
NEW03442,DISEASE,slurred speech,slurred speech
NEW03443,CHEMICAL,rare ADR,rare ADR
D056344,DISEASE,Executive Function,"Functions, Executive|Executive Controls|Function, Executive|Executive Control|function|executive functions|Executive Functions"
NEW03444,DISEASE,E-mediated anaphylaxis,E-mediated anaphylaxis
NEW03445,CHEMICAL,ternatea L.,ternatea L.
NEW03446,DISEASE,chronic thromboembolic pulmonary hypertension,CTEPH|chronic thromboembolic pulmonary hypertension
NEW03447,CHEMICAL,high energy phosphate,high energy phosphate
NEW03448,CHEMICAL,blood/urine samples,blood/urine samples
NEW03449,MENTAL_HEALTH,non-MD/SZ suicide group,non-MD/SZ suicide group
NEW03450,CHEMICAL,Chaiyuwendan decoction,Chaiyuwendan decoction
NEW03451,DISEASE,depressed rats,depressed rats
NEW03452,CHEMICAL,methadone withdrawal,methadone withdrawal
NEW03453,DISEASE,comparison TLR3-induced hyperthermia,comparison TLR3-induced hyperthermia
NEW03454,CHEMICAL,lipid-derived messenger oleoylethanolamide,OEA|lipid-derived messenger oleoylethanolamide
NEW03455,DISEASE,hyperthermia-related genes,hyperthermia-related genes
NEW03456,CHEBI,PPAR signalling system,PPAR signalling system
NEW03457,DISEASE,psychiatric population,psychiatric population
D064446,CHEMICAL,Orexin Receptors,"Hypocretin Receptors|Receptor 2, Hypocretin|Orexin-A Receptors|Receptors, Hypocretin|Receptor 2, Orexin|Hypocretin 1 Receptor|Receptor, Hypocretin|Receptors, Orexin-B|Receptor, Orexin A|Orexin Receptor Type 1|Hypocretin Receptor 2|Orexin A Receptor|Receptors, Orexin|Receptors 2, Hypocretin|Orexin B Receptor|Orexin Receptor Type 2|Protein, HCTR2|Hypocretin Receptor|Receptor, Orexin|Orexin-A Receptor|Orexin Receptor 2|Receptor, Hypocretin-2|Orexin A Receptors|Receptor, Orexin-B|Hypocretin Receptors 2|Hypocretin 2 Receptor|OX1 Receptor|Hypocretin-1 Receptor|OX1 Receptors|Receptors, OX1|HCTR2 Protein|OX2 Receptor|Receptor, OX2|Orexin B Receptors|Receptor 1, HCRT|Receptor, Orexin B|Hypocretin-2 Receptor|Receptor, OX1|Receptor 2, HCRT|Receptors, OX2|Receptor, Hypocretin-1|Orexin-B Receptor|Orexin-B Receptors|Receptor, Orexin-A|HCRT Receptor 2|Orexin Receptor|Orexin A|OX2 Receptors|Receptors, Orexin-A|HCRT Receptor 1"
NEW03458,DISEASE,cataplexies,cataplexies
C094503,CHEMICAL,glyceryl 2-arachidonate [Supplementary Concept],Arachidonic Acids|2-AG|2-arachidonoylglycerol|Endocannabinoids|Glycerides|2-arachidonoyl glycerol
NEW03459,MENTAL_HEALTH,comorbid ADHD,comorbid ADHD
C000596110,CHEMICAL,palmitoylethanolamide-succinamylgalactos-6'-yl ester [Supplementary Concept],Palmitates|Palmitoylethanolamide|Galactose/analogs  and  derivatives
C565342,MENTAL_HEALTH,Macrocephaly Autism Syndrome [Supplementary Concept],autism syndrome|Autistic Disorder|Facies|Megalencephaly
NEW03460,CHEBI,SSRI antidepressants,SSRI antidepressants
NEW03461,CHEMICAL,GABA action,GABA action
NEW03462,DISEASE,PTSD patients,PTSD patients
NEW03463,CHEMICAL,related N-acyl-ethanolamides,related N-acyl-ethanolamides
NEW03464,MENTAL_HEALTH,anxiety memories,anxiety memories
D051298,DISEASE,Post-Traumatic Headache,"traumatic|Post-Traumatic Headaches|Cervicogenic Headaches|Headaches, Post-Traumatic|Headache, Post-Traumatic|Cervicogenic Headache|Headaches, Cervicogenic|Post Traumatic Headache|Headache, Cervicogenic"
C441623,CHEMICAL,"3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide [Supplementary Concept]",Benzopyrans|NAE
NEW03465,DISEASE,traumatic stress exposure,traumatic stress exposure
NEW03466,CHEMICAL,hydrochloride sulfate,hydrochloride sulfate
NEW03467,CHEMICAL,indoleamines,indoleamines
C029261,CHEMICAL,phenethylamine [Supplementary Concept],Phenethylamines|2-phenylethylamine|phenylethylamine
NEW03468,CHEMICAL,MAO enzymatic activity,MAO enzymatic activity
NEW03469,DISEASE,severe depressive stress symptoms,severe depressive stress symptoms
NEW03470,CHEMICAL,2-AG concentrations,2-AG concentrations
C466089,CHEMICAL,stearoylethanolamide [Supplementary Concept],Stearic Acids|stearoylethanolamide|SEA
NEW03471,DISEASE,Reported traumatic stress,Reported traumatic stress
NEW03472,DISEASE,mg/kg behavioral impairments,mg/kg behavioral impairments
NEW03473,CHEMICAL,ribonuclease H inhibitors,ribonuclease H inhibitors
D015658,DISEASE,HIV Infections,"HIV infections|T-Lymphotropic Virus Type III Infections, Human|Infections, HIV|HTLV-III-LAV Infection|HTLV-III-LAV Infections|Infection, HTLV-III|Infections, HTLV-III-LAV|HIV Coinfections|HTLV III LAV Infections|HTLV III Infections|T Lymphotropic Virus Type III Infections, Human|Coinfection, HIV|HTLV-III Infection|Infection, HIV|HIV Infection|HTLV-III Infections|Infection, HTLV-III-LAV|HIV Coinfection|Infections, HTLV-III|Coinfections, HIV"
C477074,DISEASE,"MYCT1 protein, human [Supplementary Concept]",cancer cells|Nuclear Proteins|Cancer cells
NEW03474,CHEMICAL,polyphenol (-)-epigallocatechin-3-gallate,EGCg|polyphenol (-)-epigallocatechin-3-gallate
NEW03475,CHEMICAL,various quinone site inhibitors,various quinone site inhibitors
D015325,DISEASE,Pyruvate Dehydrogenase Complex Deficiency Disease,"PDHC Deficiency Disease|Lactic Acidosis with Ataxia, Type I|Ataxia, Intermittent, with Pyruvate Dehydrogenase, or Decarboxylase, Deficiency|lactic acidosis|Ataxia, Intermittent, with Abnormal Pyruvate Metabolism|Neonatal Pyruvate Dehydrogenase Complex Deficiency Disease|PDH Deficiency|Ataxia with Lactic Acidosis|Lactic acidosis|Pyruvate Dehydrogenase Complex Deficiency Disease, Neonatal|PDHC Deficiency|Deficiency, PDH|Type I Ataxia with Lactic Acidosis|pyruvate dehydrogenase complex|Deficiency, Pyruvate Dehydrogenase|Juvenile Pyruvate Dehydrogenase Complex Deficiency Disease|Deficiency, Pyruvate Decarboxylase|Pyruvate Dehydrogenase Complex|Pyruvate Dehydrogenase Complex Deficiency|Pyruvate Decarboxylase Deficiency|Ataxia with Lactic Acidosis I|Intermittent Ataxia with Pyruvate Dehydrogenase Deficiency|Deficiency, PDHC|Ataxia with Lactic Acidosis, Type I|Pyruvate Dehydrogenase Complex Deficiency Disease, Juvenile|Pyruvate Dehydrogenase Deficiency"
NEW03476,DISEASE,hepatosteatosis,hepatosteatosis
C451734,CHEMICAL,etravirine [Supplementary Concept],Nitriles|Pyrimidines|Etravirine
NEW03477,CHEMICAL,non-nucleoside reverse transcriptase inhibitors,non-nucleoside reverse transcriptase inhibitors
NEW03478,DISEASE,Extrapyramidal symptoms,Extrapyramidal symptoms|EPS|serious extrapyramidal side effects
NEW03479,CHEBI,rare adverse drug reactions,rare adverse drug reactions
NEW03480,CHEMICAL,selective serotonin re-uptake inhibitors,selective serotonin re-uptake inhibitors
NEW03481,MENTAL_HEALTH,serotonin-related mental disorders,serotonin-related mental disorders
NEW03482,DISEASE,chronic spinal cord injury,chronic spinal cord injury
NEW03483,CHEMICAL,indorenate 5-methoxytryptamine beta-methyl carboxylate hydrochloride,indorenate 5-methoxytryptamine beta-methyl carboxylate hydrochloride
NEW03484,CHEMICAL,Dysfunctional 5HT rhythms,Dysfunctional 5HT rhythms
NEW03485,CHEMICAL,5HT mechanisms,5HT mechanisms
NEW03486,CHEMICAL,5HT oscillations,5HT oscillations
C062720,CHEMICAL,mosapride [Supplementary Concept],Morpholines|Benzamides|mosapride
D015154,DISEASE,Esophageal Motility Disorders,"Esophageal Motility Disorder|Motility Disorder, Esophageal|Disorder, Esophageal Motility|Motility Disorders, Esophageal|Dysmotilities, Esophageal|Esophageal Dysmotilities|Disorders, Esophageal Motility|esophageal motility|Nutcracker Esophagus|Dysmotility, Esophageal|Esophageal Dysmotility|Esophagus, Nutcracker"
C406662,CHEMICAL,prucalopride [Supplementary Concept],Prucalopride|prucalopride|Benzofurans
NEW03487,CHEMICAL,1-[2-[(methyl sulfonyl)-amino]-ethyl]-4-piperidinyl-methyl-5-fluoro-2-methoxy-1H-indole-3-carboxylate i.p,1-[2-[(methyl sulfonyl)-amino]-ethyl]-4-piperidinyl-methyl-5-fluoro-2-methoxy-1H-indole-3-carboxylate i.p
NEW03488,CHEBI,selective 5-HT4 receptor antagonist GR,selective 5-HT4 receptor antagonist GR
NEW03489,CHEBI,GABA-ergic agents,GABA-ergic agents
NEW03490,CHEMICAL,NO donors,NO donors
NEW03491,CHEMICAL,progesterone mg/kg,progesterone mg/kg
NEW03492,DISEASE,significant hyperphagia,significant hyperphagia
NEW03493,CHEMICAL,direct quipazine mg/kg,direct quipazine mg/kg
NEW03494,CHEMICAL,indirect fluoxetine,indirect fluoxetine
NEW03495,DISEASE,significant hypophagia,significant hypophagia
NEW03496,CHEMICAL,fluoxetine mg/kg,fluoxetine mg/kg
NEW03497,DISEASE,progesterone-induced hyperphagia,progesterone-induced hyperphagia
C046301,CHEMICAL,seganserin [Supplementary Concept],Seganserin|Piperidines
NEW03498,CHEMICAL,quipazine-induced hypophagia,quipazine-induced hypophagia
D011814,CHEMICAL,Quipazine,|quipazine|Quipazine Maleate (1:1)|MA1291|2-(1-Piperazinyl)quinoline|MA-1291|MA 1291|Quipazine Hydrochloride|Quipazine Maleate
NEW03499,CHEMICAL,specific serotonin reuptake inhibitors,specific serotonin reuptake inhibitors
D020912,CHEMICAL,Moclobemide,"Healthsense Moclobemide|DBL Moclobemide|Moclodura|Moclobemide, GenRX|Rimoc|Moclobemide, DBL|Moclobemid von ct|Moclobamide|Nu-Moclobemide|Ro 11 1163|NuMoclobemide|Apo-Moclobemide|Novo-Moclobemide|Moclamine|PMS-Moclobemide|Moclobemid Puren|Moclix|Moclobemid-ratiopharm|NovoMoclobemide|Ro 11-1163|Chem mart Moclobemide|Arima|Aurorex|GenRX Moclobemide|Moclobemid 1A Pharma|Moclobemid ratiopharm|von ct, Moclobemid|AZU, Moclobemid|Moclobemide|Moclobeta|Aurorix|Deprenorm|Moclobemid Stada|Moclobemid-1A Pharma|Novo Moclobemide|Manerix|PMS Moclobemide|Moclobemid AZU|Terry White Chemists Moclobemide|Moclobemide, Healthsense|moclobemide|Moclobemid1A Pharma|Moclobemid-Puren|Apo Moclobemide|Nu Moclobemide|Moclobemide, Chem mart|Ro-11-1163|Feraken|Moclonorm|Stada, Moclobemid"
D002997,CHEMICAL,Clomipramine,"Chlorimipramine|Hydiphen|Clomipramine||clomipramine|Clomipramine Maleate (1:1)|Chlomipramine|Anafranil|Hydrochloride, Clomipramine|Clomipramine Monohydrochloride|Monohydrochloride, Clomipramine|Clomipramine Hydrochloride"
NEW03500,CHEBI,SSRI therapy,SSRI therapy
NEW03501,DISEASE,inappropriate antidiuretic hormone,inappropriate antidiuretic hormone|SIADH|inadequate antidiuretic hormone secretion
NEW03502,MENTAL_HEALTH,severe anxiety symptoms,severe anxiety symptoms
NEW03503,DISEASE,panic patients,panic patients
NEW03504,DISEASE,depressive problems,depressive problems
NEW03505,CHEMICAL,Karoussi,Karoussi
NEW03506,CHEMICAL,low-dose neuroleptics,low-dose neuroleptics
NEW03507,DISEASE,affective instability abnormalities,affective instability abnormalities
NEW03508,CHEMICAL,serotonin levels,serotonin levels
NEW03509,DISEASE,hippocampus-dependent behaviors,hippocampus-dependent behaviors
NEW03510,CHEMICAL,azapirones,azapirones
NEW03511,MENTAL_HEALTH,anxiety disorder pharmacotherapy,anxiety disorder pharmacotherapy
NEW03512,CHEBI,selective norepinephrine reuptake inhibitor,selective norepinephrine reuptake inhibitor
NEW03513,DISEASE,hyperactive mice,hyperactive mice
NEW03514,CHEMICAL,serotonin system genes,serotonin system genes
NEW03515,CHEMICAL,normal brain serotonin function,normal brain serotonin function
D000089983,CHEMICAL,Escitalopram,Escitalopram|escitalopram|Lexapro|Escitalopram Oxalate
NEW03516,MENTAL_HEALTH,generalized social phobia,generalized social phobia
D020280,CHEMICAL,Sertraline,"|Rhoxal-sertraline|Apo Sertraline|Rhoxal sertraline|Aremis|Zoloft|Hydrochloride, Sertraline|Novo Sertraline|Lustral|Altruline|sertraline|ratio Sertraline|Gladem|Sealdin|Apo-Sertraline|Gen-Sertraline|Besitran|ratio-Sertraline|Gen Sertraline|Novo-Sertraline|Sertraline|Sertraline Hydrochloride (1S-cis)-Isomer|Sertraline Hydrochloride"
C051752,CHEMICAL,nefazodone [Supplementary Concept],nefazodone|Triazoles|Piperazines
NEW03517,CHEMICAL,reduced serotonin transporter binding,reduced serotonin transporter binding
NEW03518,CHEMICAL,3-methoxy-4-hydrophenylglycol,3-methoxy-4-hydrophenylglycol
NEW03519,CHEMICAL,serotonin systems,serotonin systems
NEW03520,CHEMICAL,serotonin-noradrenaline reuptake inhibitors,serotonin-noradrenaline reuptake inhibitors
NEW03521,CHEMICAL,noradrenaline reuptake inhibitor,noradrenaline reuptake inhibitor|serotonin-norepinephrine reuptake inhibitor|SNRI
NEW03522,MENTAL_HEALTH,premenstrual dysphoric disorder efficacy,premenstrual dysphoric disorder efficacy
NEW03523,CHEMICAL,antidepressant response,antidepressant response
D020249,CHEBI,Hormone Replacement Therapy,"Therapies, Hormone Replacement|Hormone Replacement Therapies|Therapy, Hormone Replacement|Replacement Therapy, Hormone|Replacement Therapies, Hormone|hormone therapies|hormone replacement therapy"
NEW03524,CHEMICAL,intra-synaptic central nervous system serotonin,intra-synaptic central nervous system serotonin
NEW03525,CHEBI,adverse drug effects,adverse drug effects
NEW03526,CHEMICAL,serotonin toxicity,serotonin toxicity
NEW03527,CHEMICAL,moderate serotonin toxicity,moderate serotonin toxicity
NEW03528,CHEBI,novel KOP-r agonist MSB,novel KOP-r agonist MSB
NEW03529,DISEASE,alcoholism treatment models,alcoholism treatment models
NEW03530,DISEASE,tuberculous meningitis patients,tuberculous meningitis patients
D058918,CHEMICAL,Adenosine A3 Receptor Antagonists,"Receptor, Adenosine A3/antagonists and inhibitors (2004-2010)|adenosine|Adenosine"
NEW03531,DISEASE,tachy-brady arrhythmias,tachy-brady arrhythmias
NEW03532,DISEASE,SAN dysfunction,SAN dysfunction
NEW03533,CHEBI,empirical antitubercular therapy,empirical antitubercular therapy
D016921,DISEASE,"Meningitis, Fungal","Fungal Pachymeningitis|Pachymeningitides, Fungal|Fungal Meningitides|Fungal Pachymeningitides|Fungal Meningitis|Meningitides, Fungal|Pachymeningitis, Fungal|fungal meningitis"
C051038,CHEMICAL,"Inositol 1,4,5-trisphosphate 3-kinase [Supplementary Concept]",IP(3|Phosphotransferases (Alcohol Group Acceptor)
NEW03534,CHEMICAL,"(1,4,5)-trisphosphate signalling","(1,4,5)-trisphosphate signalling"
NEW03535,CHEBI,Lithium mood stabilisers,Lithium mood stabilisers
NEW03536,CHEMICAL,intracellular inositol,intracellular inositol
NEW03537,DISEASE,stimulation-related manic state,stimulation-related manic state
NEW03538,CHEBI,only mood stabiliser,only mood stabiliser
NEW03539,CHEBI,mood stabiliser,mood stabiliser
NEW03540,CHEBI,drug treatments,drug treatments
NEW03541,CHEBI,mood stabilisers,mood stabilisers
NEW03542,CHEBI,mood stabiliser treatment,mood stabiliser treatment
NEW03543,MENTAL_HEALTH,bipolar mania,bipolar mania
C522667,CHEMICAL,asenapine [Supplementary Concept],|Asenapine maleate|Dibenzocycloheptenes|Asenapine|asenapine
NEW03544,MENTAL_HEALTH,uncomplicated BD depression,uncomplicated BD depression
NEW03545,CHEMICAL,intravenous ascorbate,intravenous ascorbate|VitC
NEW03546,MENTAL_HEALTH,neuromuscular fatigue resistance,neuromuscular fatigue resistance
NEW03547,CHEBI,Acute vitamin C administration,Acute vitamin C administration
NEW03548,MENTAL_HEALTH,fatigue development,fatigue development
D058979,CHEBI,Proton-Coupled Folate Transporter,"folate|Folate|Folate Transporter, Proton Coupled|Solute Carrier Family 46, Member 1|Transporter, Proton-Coupled Folate|Folate Transporter, Proton-Coupled|Proton Coupled Folate Transporter"
NEW03549,CHEMICAL,higher E-DII scores,higher E-DII scores
NEW03550,CHEMICAL,energy-adjusted DII,energy-adjusted DII|E-DII
NEW03551,CHEBI,ascorbic acid supplementation,ascorbic acid supplementation
NEW03552,CHEMICAL,antidepressant effect,antidepressant effect
NEW03553,MENTAL_HEALTH,anxiety spectrum disorders,anxiety spectrum disorders
NEW03554,DISEASE,low toxicity,low toxicity
NEW03555,CHEMICAL,chronic stress-induced epinephrine,chronic stress-induced epinephrine
NEW03556,CHEMICAL,lactate metabolic rewiring,lactate metabolic rewiring
NEW03557,CHEBI,LDHA-lowering agent vitamin C,LDHA-lowering agent vitamin C
NEW03558,DISEASE,stress-associated breast cancer,stress-associated breast cancer
D040701,MENTAL_HEALTH,"Stress Disorders, Traumatic, Acute","Stress Disorder, Acute|Stress Disorders, Acute|Acute Stress Disorders|acute stress|acute stress disorder|Acute Stress Disorder"
NEW03559,CHEMICAL,abnormal early morning cortisol levels,abnormal early morning cortisol levels
NEW03560,NUTRITION,Low serum cholesterol levels,Low serum cholesterol levels
NEW03561,CHEMICAL,Prostaglandin (PG)E1,Prostaglandin (PG)E1
NEW03562,DISEASE,manic patients,manic patients
NEW03563,CHEMICAL,more PGE1,more PGE1
NEW03564,CHEMICAL,alcohol concentrations,alcohol concentrations
NEW03565,CHEMICAL,PGE1 concentrations,PGE1 concentrations
NEW03566,NUTRITION,Omega fatty acids,Omega fatty acids
NEW03567,MENTAL_HEALTH,chemotherapy resistance,chemotherapy resistance
NEW03568,CHEMICAL,Carbon dioxide laser technology,Carbon dioxide laser technology
NEW03569,CHEMICAL,Chronic ethanol exposure,Chronic ethanol exposure
NEW03570,CHEMICAL,Ethanol treatment,Ethanol treatment
D000872,NUTRITION,Anthocyanins,Anthocyanidin|Leucoanthocyanidins|Anthocyanidins|Anthocyanins|Anthocyanin|anthocyanins|ANT
NEW03571,DISEASE,ethanol-induced neuronal cell death,ethanol-induced neuronal cell death
NEW03572,CHEBI,oral vitamin C supplementation,oral vitamin C supplementation
NEW03573,MENTAL_HEALTH,modest anxiety disorders,modest anxiety disorders
D006713,CHEMICAL,Homogentisic Acid,"Acid, Homogentisic|Homogentisic acid"
D017042,DISEASE,"Phenylketonuria, Maternal","PKU|phenylketonuria|Maternal Phenylalanine Hydroxylase Deficiency Disease|Maternal Phenylketonuria|Phenylalanine-Hydroxylase Deficiency Disease, Maternal|Phenylketonuria|PKU, Maternal|Pregnancy in Phenylketonuria|Phenylalanine Hydroxylase Deficiency Disease, Maternal|Phenylketonuria, Pregnancy in"
D010652,CHEMICAL,Phenylalanine-tRNA Ligase,"Ligase, Phenylalanine-tRNA|Phenylalanyl-tRNA Synthetase|Phe-tRNA Ligase|Phenylalanine tRNA Ligase|Ligase, Phe-tRNA|Synthetase, Phenylalanyl-tRNA|Phenylalanyl T RNA Synthetase|Phe tRNA Ligase|Phenylalanyl tRNA Synthetase|Phe|phenylalanine|PHE"
D061626,CHEMICAL,Immunoreceptor Tyrosine-Based Inhibition Motif,Immuno-Receptor Tyrosine-Based Inhibition Motif|Tyrosine|Immuno Receptor Tyrosine Based Inhibition Motif|Immunoreceptor Tyrosine Based Inhibition Motif|Immune Receptor Tyrosine-Based Inhibition Motif|tyrosine|Immune Receptor Tyrosine Based Inhibition Motif
NEW03574,DISEASE,biomolecular damage,biomolecular damage
NEW03575,CHEBI,whose's vitamin C intake,whose's vitamin C intake
NEW03576,CHEMICAL,short-chain EFA supplementation,short-chain EFA supplementation
D002637,DISEASE,Chest Pain,"|Pains, Chest|Texidor's Twinge|Precordial Catch Syndrome|chest pain|Chest Pains|Pain, Chest|Texidor Twinge|Precordial Catch|Syndrome, Precordial Catch"
D057774,DISEASE,Post-Exercise Hypotension,"Post-Exercise Hypotensions|hypotension|Hypotension|Hypotension, Postexercise|Hypotensions, Post-Exercise|Hypotension, Post Exercise|Post Exercise Hypotension|Post Exercise Hypotensions|Hypotensions, Post Exercise|Hypotension, Post-Exercise|Hypotensions, Postexercise|Postexercise Hypotension|Postexercise Hypotensions"
D060347,CHEBI,Sodium-Coupled Vitamin C Transporters,"Sodium Dependent Vitamin C Transporter|Sodium-Dependent Vitamin C Transporter|Transporter, SLC23A1|vitamin C|Solute Carrier Family 23 (Nucleobase Transporters), Member 1|SLC23A2 Transporter|Sodium-Dependent Vitamin C Transporter 1|SVCT 1, Ascorbic Acid Transporter|vitamin-C|Sodium-Dependent Vitamin C Transporter 2|Sodium Dependent Vitamin C Transporter 2|SLC23A1 Transporter|Sodium Dependent Vitamin C Transporter 1|Solute Carrier Family 23 (Nucleobase Transporters), Member 2|vitamin C.|SVCT 2, Ascorbic Acid Transporter|Sodium Coupled Vitamin C Transporters|Transporter, SLC23A2"
NEW03577,CHEMICAL,respective RDAs/DRIs,respective RDAs/DRIs
NEW03578,CHEBI,B-complex vitamins,B-complex vitamins
NEW03579,CHEBI,vitamin C. athletes,vitamin C. athletes
NEW03580,CHEBI,higher vitamin C,higher vitamin C
NEW03581,DISEASE,greater confusion,greater confusion
NEW03582,CHEBI,vitamin levels,vitamin levels
NEW03583,DISEASE,Alzheimer group,Alzheimer group
NEW03584,NUTRITION,signifi thiamine =,signifi thiamine =
NEW03585,DISEASE,CONCLUSIONS Hyperhomocysteinemia,CONCLUSIONS Hyperhomocysteinemia
D006950,DISEASE,"Hyperlipidemia, Familial Combined","Combined Hyperlipidemia, Familial|Familial Combined Hyperlipidemias|Multiple Lipoprotein-Type Hyperlipidemia|Lipoprotein-Type Hyperlipidemia, Multiple|hyperlipidemia|Combined Hyperlipidemias, Familial|Hyperlipidemia, Multiple Lipoprotein Type|Multiple Lipoprotein-Type Hyperlipidemias|Hyperlipidemias, Multiple Lipoprotein-Type|Hyperlipidemia|Familial Combined Hyperlipidemia|Hyperlipidemia, Multiple Lipoprotein-Type|Lipoprotein-Type Hyperlipidemias, Multiple|Hyperlipidemias, Familial Combined"
C104273,CHEMICAL,hydroxyglimepiride [Supplementary Concept],glimepiride|Sulfonylurea Compounds
NEW03586,DISEASE,inflammatory disorder,inflammatory disorder
D020806,DISEASE,Central Nervous System Bacterial Infections,"Bacterial Infections, Central Nervous System|Infections, Bacterial, Central Nervous System|bacterial infections"
NEW03587,CHEMICAL,Freeman AA,Freeman AA
NEW03588,CHEMICAL,Rye DB,Rye DB
NEW03589,DISEASE,hypersomnia patients,hypersomnia patients
D021182,NUTRITION,Wheat Hypersensitivity,"wheat|Wheat Hypersensitivities|Wheat|Allergy, Wheat|Hypersensitivity, Wheat|Wheat Allergy|Allergies, Wheat|wheat allergy|Triticum aestivum L.|Wheat Allergies|Hypersensitivities, Wheat"
NEW03590,DISEASE,immune-mediated disease dependent,immune-mediated disease dependent
NEW03591,CHEBI,artificial non-nutritive sweeteners,artificial non-nutritive sweeteners
NEW03592,DISEASE,AN-B/P group,AN-B/P group
D013549,CHEBI,Sweetening Agents,"Agent, Sweetening|Sugar Substitute|Artificial Sweeteners|Sweetener|Agents, Sweetening|artificial sweetener|Sweeteners|Sweetening Agent|Artificial Sweetener|Sweeteners, Artificial|sweetener|Substitute, Sugar|Substitutes, Sugar|Sweetener, Artificial|Sugar Substitutes"
C016766,CHEMICAL,sulforaphane [Supplementary Concept],Sulfoxides|sulforaphane|Isothiocyanates|Sulforaphane
D000077157,CHEMICAL,Sorafenib,BAY 673472|BAY 439006|Nexavar|Sorafenib Tosylate|BAY 43 9006|BAY 545 9085|BAY-673472|BAY 545-9085|BAY 5459085|BAY 43-9006|4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxylic acid methyamide-4-methylbenzenesulfonate|sorafenib|Sorafenib N Oxide|BAY-545-9085|BAY5459085|Sorafenib N-Oxide|Sorafenib
C025457,CHEMICAL,2-ethylamino-1-(3-stearoylphenyl)ethanol [Supplementary Concept],Etilefrine/analogs  and  derivatives|stearic acid
NEW03593,DISEASE,body-weight gain,body-weight gain
D019301,CHEMICAL,Oleic Acid,oleic acid|9-Octadecenoic Acid|9 Octadecenoic Acid|cis 9 Octadecenoic Acid|Oleate|cis-9-Octadecenoic Acid
D019308,CHEMICAL,Palmitic Acid,"palmitic acid|Acid, Palmitic|Palmitate, Sodium|Acid, Hexadecanoic|Calcium Palmitate|Hexadecanoic Acid|Sodium Palmitate|Palmitate, Calcium"
NEW03594,NUTRITION,selenium-rich Brazil nut,selenium-rich Brazil nut|Bertholletia excelsa
NEW03595,DISEASE,MCI patients,MCI patients
D063309,CHEMICAL,"2',3'-Cyclic Nucleotide 3'-Phosphodiesterase","3-|3'-Phosphodiesterase, 2',3'-Cyclic Nucleotide|2',3' CNPase|2',3' Cyclic Nucleotide 3' Phosphodiesterases|2',3'-CNPase|2',3' Cyclic Nucleotide 3' Phosphodiesterase|2',3' CN Phosphodiesterase|2',3'-Cyclic Nucleotide 3'-Phosphodiesterases|Cyclic CMP Phosphodiesterase|2',3'-CN Phosphodiesterase"
NEW03596,CHEMICAL,pioglitazone mg/kg,pioglitazone mg/kg
NEW03597,CHEMICAL,mg/kg i.p doses,mg/kg i.p doses
NEW03598,DISEASE,chronic thermal hyperalgesia,chronic thermal hyperalgesia
NEW03599,CHEMICAL,pioglitazone group,pioglitazone group
NEW03600,DISEASE,neuroprotective heat shock proteins,neuroprotective heat shock proteins
NEW03601,CHEBI,Xenoestrogen endocrine disrupters,Xenoestrogen endocrine disrupters
NEW03602,CHEBI,street drug use,street drug use
NEW03603,CHEBI,reproductive hormones,reproductive hormones
D020528,DISEASE,"Multiple Sclerosis, Chronic Progressive","Progressive Relapsing Multiple Sclerosis|Multiple Sclerosis, Secondary Progressive|SPMS|Multiple Sclerosis, Remittent Progressive|Multiple Sclerosis, Primary Progressive|Secondary Progressive Multiple Sclerosis|Primary Progressive Multiple Sclerosis|Multiple Sclerosis, Progressive Relapsing|Remittent Progressive Multiple Sclerosis|secondary progressive multiple sclerosis|Chronic Progressive Multiple Sclerosis"
C051774,CHEMICAL,neurofilament protein H [Supplementary Concept],neurofilament-H+|Neurofilament Proteins
D003711,DISEASE,Demyelinating Diseases,"|Demyelinating Disorders|Demyelinating Disease|Demyelinating Disorder|demyelination|Clinically Isolated CNS Demyelinating Syndrome|Demyelination|Clinically Isolated Syndrome, CNS Demyelinating|Demyelinations|demyelinating disorder"
NEW03604,DISEASE,Ovarian dysfunction,Ovarian dysfunction
NEW03605,NUTRITION,abnormal follicle counts,abnormal follicle counts
C548904,CHEMICAL,"insulin-like growth factor-1, rat [Supplementary Concept]",Insulin-Like Growth Factor I|insulin-like growth factor 1|IGF1
NEW03606,CHEMICAL,increased serum corticosterone levels,increased serum corticosterone levels
NEW03607,MENTAL_HEALTH,chronic stress HFSC quiescence,chronic stress HFSC quiescence
NEW03608,CHEMICAL,melanopsin system responsible,melanopsin system responsible
NEW03609,DISEASE,photosensitive dermal melanophores,photosensitive dermal melanophores
D014820,DISEASE,Vitiligo,vitiligo
D001679,CHEMICAL,Biogenic Amines,"biogenic amines|Biogenic Amine|Amines, Biogenic|Amine, Biogenic"
D059565,CHEMICAL,G2 Phase Cell Cycle Checkpoints,"Checkpoint, G2 Phase|Antephase Checkpoint|Restriction Points, G2|G2 Phase Checkpoints|G2-M Cell Cycle Checkpoint|G2 Restriction Point|G2 Restriction Points|G2 Cell Cycle Checkpoints|Checkpoint, Antephase|Checkpoints, Antephase|Antephase Checkpoints|G2 Cell Cycle Control|Restriction Point, G2|Checkpoints, G2 Phase|G2 Phase Checkpoint|G2 phase|G2 Cell Cycle Arrest|G2 M Cell Cycle Checkpoint"
C454300,CHEMICAL,estradiol valerate-dienogest [Supplementary Concept],Dienogest|Estradiol/analogs  and  derivatives|Drug Combinations|Climodien|Nandrolone/analogs  and  derivatives|dienogest|estradiol valerate
NEW03610,CHEBI,serum sex hormone levels,serum sex hormone levels
NEW03611,MENTAL_HEALTH,primary affective disorders,primary affective disorders
NEW03612,DISEASE,depressive phase,depressive phase
NEW03613,DISEASE,Abnormal anterior pituitary responsiveness,Abnormal anterior pituitary responsiveness
NEW03614,DISEASE,schizoaffective patients,schizoaffective patients
NEW03615,DISEASE,schizoaffective subject,schizoaffective subject
NEW03616,CHEMICAL,high testosterone levels,high testosterone levels
NEW03617,DISEASE,hypoprolactinemia,hypoprolactinemia
NEW03618,DISEASE,abnormal FSH,abnormal FSH
NEW03619,DISEASE,alopecic lesions,alopecic lesions
NEW03620,NUTRITION,hair follicle structures,hair follicle structures
D057092,DISEASE,Geographic Atrophy,"Geographic Atrophies|Degenerations, Dry Macular|Macular Degenerations, Dry|Dry Macular Degeneration|Dry Macular Degenerations|atrophy|Macular Degeneration, Dry|Degeneration, Dry Macular|Atrophy, Geographic|Atrophies, Geographic"
NEW03621,DISEASE,severe inflammation,severe inflammation
NEW03622,DISEASE,severe hair loss,severe hair loss
NEW03623,CHEMICAL,high DHEA level,high DHEA level
NEW03624,CHEMICAL,excess dopamine,excess dopamine
NEW03625,CHEMICAL,dexamethasone administration,dexamethasone administration
NEW03626,CHEBI,hormone concentrations,hormone concentrations
NEW03627,MENTAL_HEALTH,DSM-III melancholia,DSM-III melancholia
NEW03628,CHEMICAL,post-LHRH,post-LHRH
NEW03629,DISEASE,psychiatric presentation,psychiatric presentation
D009839,DISEASE,Oligomenorrhea,|Oligomenorrheas|oligomenorrhea
NEW03630,DISEASE,cardiovascular fitness,cardiovascular fitness
NEW03631,CHEBI,lower estrogen levels,lower estrogen levels
NEW03632,CHEMICAL,D-amino acid oxidase inhibitor,D-amino acid oxidase inhibitor
NEW03633,MENTAL_HEALTH,early-phase Alzheimer disease,early-phase Alzheimer disease
NEW03634,CHEMICAL,cortical 5-HT(2A receptors,cortical 5-HT(2A receptors
NEW03635,DISEASE,Chronic restraint stress,Chronic restraint stress
NEW03636,CHEBI,hormones epinephrine,hormones epinephrine
NEW03637,DISEASE,tumour growth,tumour growth
NEW03638,CHEBI,selective ADRB1 antagonist atenolol,selective ADRB1 antagonist atenolol
NEW03639,DISEASE,tumour cell proliferation,tumour cell proliferation
NEW03640,CHEBI,ADRB2 antagonists,ADRB2 antagonists
D009362,DISEASE,Neoplasm Metastasis,"Metastases, Neoplasm|Metastase|Metastasis, Neoplasm|Metastases|metastasis|Metastasis|Neoplasm Metastases"
NEW03641,DISEASE,tumour tissue,tumour tissue
NEW03642,DISEASE,CRH hypersecretion,CRH hypersecretion
NEW03643,CHEMICAL,17beta-oestradiol,17beta-oestradiol
NEW03644,NUTRITION,alpha oestrogen receptors,alpha oestrogen receptors
NEW03645,DISEASE,age-related diseases,age-related diseases
NEW03646,DISEASE,AP-1 antagonist A-Fos,AP-1 antagonist A-Fos
NEW03647,DISEASE,neurotoxic effect,neurotoxic effect
D000077410,CHEMICAL,Aluminum Chloride,"aluminum chloride|Aluminum Chloride, Anhydrous|Aluminum Chloride Hexahydrate|AlCl3|Anhydrous Aluminum Chloride|Drysol|Aluminum chloride|Aluminum Trichloride"
C062088,CHEMICAL,ferric maltol [Supplementary Concept],Ferric Compounds|Pyrones|maltol
NEW03648,CHEMICAL,Al chloride,Al chloride
NEW03649,CHEBI,drug olanzapine,drug olanzapine
D051296,CHEMICAL,Glucose Transporter Type 5,GLUT5 Protein|SLC2A5 Protein|D-Fructose Transporter|GLUT-5 Protein|GLUT 5 Protein|glucose transporter
C495677,CHEMICAL,"SLC2A1 protein, human [Supplementary Concept]",Glucose Transporter Type 1|human glucose transporter
D013212,DISEASE,Staphylococcus epidermidis,Staphylococcus (1966-1983)|Staphylococcus epidermidis
NEW03650,CHEMICAL,compound melatonin,compound melatonin
NEW03651,DISEASE,CPZ-induced liver disease,CPZ-induced liver disease
NEW03652,CHEBI,stress hormone corticosterone,stress hormone corticosterone
NEW03653,DISEASE,colonic hyperalgesia,colonic hyperalgesia
NEW03654,CHEMICAL,short-term ATR exposure,short-term ATR exposure
NEW03655,DISEASE,motor cognitive functions,motor cognitive functions
NEW03656,DISEASE,behavioral abnormalities suggestive,behavioral abnormalities suggestive
NEW03657,DISEASE,human mental health,human mental health
NEW03658,CHEBI,stress hormone due,stress hormone due
NEW03659,CHEMICAL,Abeta42 levels,Abeta42 levels
NEW03660,MENTAL_HEALTH,disease mutations,disease mutations
D007665,CHEMICAL,Ketotifen,"Ketotifen Fumarate|Fumarate, Ketotifen|Ketotiphen|Ketotiphene|Zaditen|4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)-cyclohepta(1,2-b)thiophen-10-one|Ketotifene|ketotifen"
NEW03661,CHEMICAL,electroconvulsions,electroconvulsions
NEW03662,DISEASE,Sleep-wake behavior,Sleep-wake behavior
NEW03663,CHEMICAL,central histamine studies,central histamine studies
NEW03664,CHEMICAL,fluvoxamine treatment,fluvoxamine treatment
D027425,MENTAL_HEALTH,Multidrug Resistance-Associated Proteins,"Resistance-Associated Protein, Multidrug|multidrug resistance|Multidrug resistance|Multidrug Resistance Associated Proteins|Multispecific Organic Anion Transporter|Multidrug Resistance Associated Protein|Multidrug Resistance-Associated Protein|MOAT Protein|ATP Binding Cassette, Sub Family C Proteins|MDR|ATP-Binding Cassette, Sub-Family C Proteins|Multispecific Organic Anion Transport Proteins"
NEW03665,DISEASE,effective cancer chemotherapy,effective cancer chemotherapy
NEW03666,CHEMICAL,human doxorubicin,doxo|human doxorubicin
NEW03667,DISEASE,resistant cancer cells,resistant cancer cells
C021183,CHEMICAL,"1,7-dimethylxanthine [Supplementary Concept]","Theophylline|1,7-dimethylxanthine|Paraxanthine"
NEW03668,DISEASE,lower toxicity,lower toxicity
NEW03669,CHEMICAL,Chocolate intake,Chocolate intake
NEW03670,CHEMICAL,Piperaceae organic solvent-extract,Piperaceae organic solvent-extract
NEW03671,MENTAL_HEALTH,moderate anxiety,moderate anxiety
C452039,CHEMICAL,flavokawain B [Supplementary Concept],flavokawain B|Flavonoids|FKB
NEW03672,DISEASE,severe liver damage,severe liver damage
NEW03673,DISEASE,iron-overload disease,iron-overload disease
NEW03674,DISEASE,alcohol-induced liver damage,alcohol-induced liver damage
NEW03675,CHEMICAL,excess iron,excess iron
NEW03676,DISEASE,damage excess,damage excess
D008104,DISEASE,"Liver Cirrhosis, Alcoholic","Hepatic Cirrhosis, Alcoholic|Alcoholic Hepatic Cirrhosis|Alcoholic Cirrhosis|Alcoholic Liver Cirrhosis|alcoholic cirrhosis"
NEW03677,DISEASE,primary hepatic carcinoma,primary hepatic carcinoma
D019190,CHEMICAL,Iron Overload,"iron overload|Overload, Iron"
NEW03678,CHEMICAL,Hepatic ammonia detoxification,Hepatic ammonia detoxification
NEW03679,DISEASE,hyperammonemia neurological damage,hyperammonemia neurological damage
D064791,CHEMICAL,Desoxycorticosterone Acetate,"acetate|DOC|Acetate, Desoxycortone|Deoxycorticosterone 21 acetate|Desoxycorticosterone 21 acetate|DOCA|DOC-21-acetate|Syncortyl|DOC 21 acetate|Desoxycorticosterone-21-acetate|Deoxycorticosterone-21-acetate|Desoxycortone Acetate"
NEW03680,DISEASE,simple hyperammonemia,simple hyperammonemia
NEW03681,CHEMICAL,Tau content,Tau content
NEW03682,CHEBI,hepatotoxin,hepatotoxin
NEW03683,CHEMICAL,uracil moiety,uracil moiety
D037361,CHEBI,Adenylate Cyclase Toxin,"Toxin, cyaA|Pertussis Adenylate Cyclase Haemolysin Bifunctional Protein|Bordetella pertussis Adenylate Cyclase Toxin|Cyclolysin|Protein, Bordetella cyaA|AC Toxin, Bordetella|Bordetella AC Toxin|cyaA Toxin|Toxin, Adenylate Cyclase|Adenylate Cyclase-Hemolysin|Cyclase Toxin, Adenylate|Pertussis Adenylate Cyclase-Haemolysin Bifunctional Protein|Adenylate Cyclase Hemolysin|toxin|Ac-Hly, Bordetella|cyaA Protein, Bordetella|Adenylate Cyclase Haemolysin Bifunctional Protein, B. pertussis|Toxin, Bordetella AC|Adenylate Cyclase-Haemolysin Bifunctional Protein, B. pertussis|Ac Hly, Bordetella|Bordetella Adenylate Cyclase Toxin|Bordetella Ac-Hly|cyaA Gene Product, Bordetella|Cyclase-Hemolysin, Adenylate|Bordetella cyaA Protein"
NEW03684,CHEMICAL,catalytic site(s,catalytic site(s
NEW03685,CHEMICAL,CACNA1C voltage-gated calcium channel gene,CACNA1C voltage-gated calcium channel gene
NEW03686,CHEMICAL,voltage-gated calcium channels,voltage-gated calcium channels
NEW03687,DISEASE,Most phaeochromocytomas,Most phaeochromocytomas
NEW03688,CHEBI,alpha-adrenergic antagonist,alpha-adrenergic antagonist
NEW03689,CHEMICAL,Neuronal NO synthase,Neuronal NO synthase
NEW03690,MENTAL_HEALTH,resistance vasculature,resistance vasculature
NEW03691,CHEMICAL,SMTC 0.05,SMTC 0.05
NEW03692,CHEMICAL,selective nNOS inhibitor S-methyl-l-thiocitrulline,selective nNOS inhibitor S-methyl-l-thiocitrulline
NEW03693,DISEASE,Ovarian function suppression,Ovarian function suppression
NEW03694,DISEASE,metastasis breast cancer,metastasis breast cancer
NEW03695,CHEBI,Endocrine Society,Endocrine Society
NEW03696,DISEASE,puberty suppression,puberty suppression
NEW03697,DISEASE,hypogonadotropic hypogonadal state,hypogonadotropic hypogonadal state
NEW03698,CHEMICAL,pseudomenopause,pseudomenopause
NEW03699,CHEMICAL,estrogen/progesterone hormone replacement therapy,estrogen/progesterone hormone replacement therapy
NEW03700,CHEMICAL,benzodiazepine binding sites,benzodiazepine binding sites
NEW03701,MENTAL_HEALTH,anxiety due occupancy,anxiety due occupancy
NEW03702,CHEBI,selective receptor agonists,selective receptor agonists
NEW03703,CHEMICAL,i.c microinfusion,i.c microinfusion
NEW03704,DISEASE,confusion/disorientation,confusion/disorientation
NEW03705,CHEMICAL,cyclizine ingestions,cyclizine ingestions
D004155,CHEMICAL,Diphenhydramine,"2-Diphenylmethoxy-N,N-dimethylethylamine|Allerdryl|Diphenhydramine Hydrochloride|Benadryl|Hydrochloride, Diphenhydramine|Diphenhydramine Citrate|Benylin|Diphenhydramine hydrochloride|diphenhydramine|Dimedrol|Benzhydramine|Diphenhydramine|Diphenylhydramine|Citrate, Diphenhydramine|Diphenylhydramin|Diphenhydramine Citrate (1:1)|Dormin|Benhydramin"
D039563,CHEBI,"Histamine H1 Antagonists, Non-Sedating","Second Generation H1 Antagonist|Antihistamine, Second Generation|H1 Antihistamines, Non-Sedating|histamine H1 antagonists|Non-Sedating H1 Antihistamines|H1 Antihistamines, Non Sedating|Second Generation Antihistamine|Antihistamines|Second Generation Antihistamines|antihistamines|second generation antihistamines|Antihistamines, Second Generation|Third Generation H1 Antagonists|Generation Antihistamine, Second|Histamine H1 Antagonists, Non Sedating|Second Generation H1 Antagonists|Third Generation H1 Antagonist|antihistamine"
NEW03706,DISEASE,varicella-zoster lesions,varicella-zoster lesions
C010119,CHEMICAL,latrepirdine [Supplementary Concept],Dimebon|latrepirdine|Indoles|dimebon
NEW03707,DISEASE,concurrent angioedema due,concurrent angioedema due
NEW03708,CHEMICAL,risperidone BID,risperidone BID
NEW03709,DISEASE,hand tremor,hand tremor
NEW03710,CHEMICAL,voltage-gate Ca+2 channels,voltage-gate Ca+2 channels
D000080223,DISEASE,Chronic Urticaria,"Chronic Urticaria, Idiopathic|Urticaria, Chronic Inducible|Autoimmune Urticaria|Chronic Inducible Urticarias|Urticaria, Chronic Idiopathic|chronic spontaneous urticaria|Urticaria, Idiopathic Chronic|Urticaria, Chronic Spontaneous|Idiopathic Chronic Urticaria|Urticaria, Autoimmune|Chronic Idiopathic Urticarias|Chronic Urticarias|CIndU|Chronic Spontaneous Urticaria|Chronic Autoimmune Urticarias|Spontaneous Urticaria, Chronic|Chronic urticaria|Chronic Idiopathic Urticaria|Urticaria, Chronic|Idiopathic Chronic Urticarias|Chronic idiopathic urticaria|Chronic Spontaneous Urticarias|Chronic Inducible Urticaria|Autoimmune Urticaria, Chronic|Chronic Autoimmune Urticaria|Autoimmune Urticarias|Urticaria, Chronic Autoimmune|chronic inducible urticaria|CIU|Idiopathic Urticaria, Chronic|Inducible Urticaria, Chronic"
NEW03711,DISEASE,debilitating skin disease,debilitating skin disease
D006919,CHEMICAL,Hydroxyzine,"Vistaril|Atarax|Hydroxyzine Hydrochloride|Orgatrax|Hydroxyzine Pamoate|Durrax|Hydroxyzine|Pamoate, Hydroxyzine|Hydroxyzine Dihydrochloride|hydroxyzine|2-(2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)ethanol"
NEW03712,CHEMICAL,Pheniramine abuse,Pheniramine abuse
NEW03713,DISEASE,Severe pruritus,Severe pruritus
NEW03714,MENTAL_HEALTH,dysfunction limitations,dysfunction limitations
NEW03715,CHEMICAL,weals,weals
NEW03716,CHEMICAL,Zyprexatrade mark,Zyprexatrade mark
C121345,CHEMICAL,desloratadine [Supplementary Concept],Loratadine/analogs  and  derivatives|desloratadine
NEW03717,CHEMICAL,histamine central nervous system,histamine central nervous system
NEW03718,CHEMICAL,Pitolisant brand name,Pitolisant brand name
NEW03719,MENTAL_HEALTH,paradoxical hyperarousal,paradoxical hyperarousal
D010632,CHEMICAL,Pheniramine,"Prophenpyridamine|pheniramine|Pheniramine Bimaleate|Maleate, Pheniramine|Histapyridamine|Bimaleate, Pheniramine|Daneral|Avil|Propheniramine|Pheniramine Maleate"
NEW03720,MENTAL_HEALTH,disease patients,disease patients
NEW03721,DISEASE,Aβ toxicity,Aβ toxicity
D018755,CHEBI,GABA Agonists,"GABA Receptor Agonists|gamma-Aminobutyric Acid Agonists|gamma Aminobutyric Acid Agonists|Agonists, GABA Receptor|Agonists, GABA|Agonist, gamma-Aminobutyric Acid|Receptor Agonists, GABA|GABA receptor agonists|Acid Agonist, gamma-Aminobutyric|Agonist, GABA Receptor|Agonist, GABA|GABA agonist|gamma-Aminobutyric Acid Agonist|Agonists, gamma-Aminobutyric Acid|GABA agonists|GABA-receptor agonists|GABA Agonist|Acid Agonists, gamma-Aminobutyric|GABA Receptor Agonist|Receptor Agonist, GABA|gamma Aminobutyric Acid Agonist"
NEW03722,DISEASE,recognition memory impairment,recognition memory impairment
D058786,CHEBI,GABA-B Receptor Agonists,"Receptor Agonist, GABA-B|GABA B Agonists|Receptor Agonists, GABA-B|Agonists, GABA-B|GABA B Receptor Agonists|GABA-B receptor agonist|GABA(B receptor agonists|GABA-B Receptor Agonist|GABA-B Agonists|GABA B Receptor Agonist|Agonists, GABA-B Receptor|GABA(B receptor agonist|Agonist, GABA-B Receptor"
NEW03723,CHEBI,Non-competitive NMDA receptor antagonists,Non-competitive NMDA receptor antagonists
NEW03724,DISEASE,approach-avoidance behavior,approach-avoidance behavior
NEW03725,CHEMICAL,mesolimbic dopamine DA system,mesolimbic dopamine DA system
NEW03726,CHEBI,GABA receptor agonist progabide,GABA receptor agonist progabide
D007099,CHEMICAL,Imipramine,"|Imizin|Melipramine|imipramine|Tofranil|4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2)|Imipramine|Norchlorimipramine|Imipramine Monohydrochloride|Imipramine Hydrochloride|Janimine|Imipramine Pamoate|Imidobenzyle|Pryleugan"
NEW03727,MENTAL_HEALTH,major affective disorders,major affective disorders
NEW03728,CHEMICAL,dopamine release,dopamine release
NEW03729,DISEASE,neuroleptic-induced increase,neuroleptic-induced increase
NEW03730,CHEMICAL,dopamine turnover,dopamine turnover
C017985,CHEMICAL,progabide [Supplementary Concept],Progabide|gamma-Aminobutyric Acid/analogs  and  derivatives|progabide
NEW03731,DISEASE,neuroleptic-induced up-regulation,neuroleptic-induced up-regulation
NEW03732,CHEMICAL,adenine diet,adenine diet
NEW03733,DISEASE,colon motility,colon motility
NEW03734,CHEBI,Uraemic toxins,Uraemic toxins
NEW03735,DISEASE,CKD-associated symptom burden,CKD-associated symptom burden
D020521,DISEASE,Stroke,"|Cerebral Stroke|CVAs (Cerebrovascular Accident)|Cerebrovascular Accidents, Acute|Cerebrovascular Strokes|Acute Strokes|Strokes, Cerebral|Stroke, Acute|Strokes, Acute|Acute Stroke|Cerebrovascular Accident|Apoplexy, Cerebrovascular|Stroke, Cerebral|Acute Cerebrovascular Accident|Stroke, Cerebrovascular|Strokes|stroke|Brain Vascular Accident|Cerebrovascular Accident, Acute|CVA (Cerebrovascular Accident)|Cerebral Strokes|cerebral stroke|cerebrovascular accidents|Apoplexy|Cerebrovascular Accidents|acute stroke|strokes|Cerebrovascular Apoplexy|Vascular Accidents, Brain|Strokes, Cerebrovascular|Cerebrovascular Stroke|Acute Cerebrovascular Accidents|Vascular Accident, Brain|Brain Vascular Accidents"
NEW03736,DISEASE,chronic disease (CKD)-related complications,chronic disease (CKD)-related complications
NEW03737,DISEASE,renal anemia,renal anemia
NEW03738,DISEASE,Cerebral uremic solute accumulation,Cerebral uremic solute accumulation
NEW03739,DISEASE,uremic encephalopathy,uremic encephalopathy
NEW03740,DISEASE,End-stage renal disease patients,End-stage renal disease patients
D020144,DISEASE,Basal Ganglia Cerebrovascular Disease,"Vascular Lenticulostriate Diseases|Vascular Diseases, Basal Ganglia|Vascular Disease, Lenticulostriate|Lenticulostriate Vasculopathies|Lenticulostriate Diseases, Vascular|Lenticulostriate Vasculopathy|cerebrovascular disease|Vasculopathy, Lenticulostriate|Cerebrovascular Disease, Basal Ganglia|vascular disease|Lenticulostriate Vascular Disease|Vascular Disease, Basal Ganglia|Basal Ganglia Vascular Disease|Vasculopathies, Lenticulostriate|Lenticulostriate Vascular Diseases|Vascular Diseases, Lenticulostriate"
NEW03741,CHEMICAL,cerebral oxygen extraction fraction,cerebral oxygen extraction fraction
NEW03742,CHEBI,retinoid X receptor agonist,retinoid X receptor agonist
NEW03743,MENTAL_HEALTH,Alzheimer disease (AD)-transgenic mice,Alzheimer disease (AD)-transgenic mice
NEW03744,CHEMICAL,soluble amyloid-β,soluble amyloid-β
D000077610,CHEMICAL,Bexarotene,"LGD 1069|LGD-1069|LG69 compound|LGD1069|Targretin|Bexarotene|bexarotene|3-methyl-TTNEB|4-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethenyl)benzoic acid"
NEW03745,CHEMICAL,Methamphetamine neurotoxicity,Methamphetamine neurotoxicity
D008691,CHEMICAL,Methadone,"|Dolophine|Phenadone|Hydrochloride, Methadone|Physeptone|Methadone|Methadose|Amidone|Metasedin|methadone|Symoron|Pinadone|Methaddict|Metadol|Biodone|Methadone Hydrochloride|Methex|Phymet"
NEW03746,DISEASE,peripheral neuropathic pain,peripheral neuropathic pain
NEW03747,CHEMICAL,agonists morphine,agonists morphine
D003061,CHEMICAL,Codeine,"|N Methylmorphine|N-Methylmorphine|codeine|Isocodeine|Codeine|Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-|Ardinex|Codeine Phosphate"
NEW03748,CHEBI,D2-like receptor agonists,D2-like receptor agonists
NEW03749,CHEBI,μ-opioid receptor agonists,μ-opioid receptor agonists
NEW03750,CHEBI,analgesic targets,analgesic targets
D055953,DISEASE,Microscopic Polyangiitis,"Polyangiitides, Microscopic|polyangiitis|Polyangiitis, Microscopic|Microscopic Polyangiitides"
D056647,DISEASE,Systemic Vasculitis,"Vasculitis, Systemic|systemic vasculitis|Systemic Vasculitides|Vasculitides, Systemic"
NEW03751,CHEBI,Pharmacological therapy leukotriene antagonists,Pharmacological therapy leukotriene antagonists
NEW03752,DISEASE,associated allergic diseases,associated allergic diseases
NEW03753,DISEASE,haloperidol-induced locomotor hypoactivity,haloperidol-induced locomotor hypoactivity
NEW03754,CHEBI,H3-receptor antagonists/inverse agonists,H3-receptor antagonists/inverse agonists
NEW03755,CHEMICAL,striatal alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA glutamate receptors,striatal alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA glutamate receptors
NEW03756,CHEMICAL,Ca(2+)-permeable AMPA receptors,Ca(2+)-permeable AMPA receptors
C550098,CHEMICAL,"TRIOBP protein, mouse [Supplementary Concept]",TRIO|Microfilament Proteins
NEW03757,DISEASE,matter alterations,matter alterations
NEW03758,CHEMICAL,soy-derived phosphatidylserine,PS|soy-derived phosphatidylserine|bovine brain phosphatidylserine
NEW03759,CHEMICAL,PFOS exposure,PFOS exposure
C000719052,CHEMICAL,"GRM1 protein, human [Supplementary Concept]","glutamate metabotropic receptor|Receptors, Metabotropic Glutamate"
NEW03760,CHEMICAL,increased dorsal striatum dopamine release,increased dorsal striatum dopamine release
C410218,CHEMICAL,serogroup C meningococcal conjugate vaccine [Supplementary Concept],Meningococcal Vaccines|MNC
D017239,CHEMICAL,Paclitaxel,"|Taxol|Onxol|Taxol A|Paclitaxel|Taxol, Bris|Bris Taxol|NSC125973|paclitaxel|7-epi-Taxol|Paclitaxel, (4 alpha)-Isomer|Paxene|7 epi Taxol|Anzatax|Praxel|NSC 125973|NSC-125973"
NEW03761,DISEASE,breast ovarian cancer patients,breast ovarian cancer patients
D064706,DISEASE,Vocal Cord Dysfunction,"Exercise-Induced Vocal Cord Dysfunction|Dysfunction, Vocal Cord|Exercise Induced Vocal Cord Dysfunction|Paradoxical Vocal Fold Motion Disorder|Paradoxical Vocal Fold Motion|dysfunction|Dysfunctions, Vocal Cord|Vocal Cord Dysfunctions"
NEW03762,CHEBI,cancer chemotherapeutic drug,cancer chemotherapeutic drug
D016190,CHEMICAL,Carboplatin,|JM-8|NSC241240|Carbosin|Platinwas|Carboplat|Neocarbo|Ercar|NSC 241240|Paraplatine|Ribocarbo|CBDCA|carboplatin|Carbotec|Paraplatin|JM 8|JM8|cis-Diammine(cyclobutanedicarboxylato)platinum II|Nealorin|NSC-241240|Carboplatin|Blastocarb
NEW03763,CHEBI,Androgen deficiency,Androgen deficiency
NEW03764,DISEASE,genitourinary syndrome,genitourinary syndrome
NEW03765,DISEASE,vulvovaginal atrophy,vulvovaginal atrophy
NEW03766,DISEASE,Bladder dysfunction,Bladder dysfunction
NEW03767,CHEBI,mirabegron agonist,mirabegron agonist
D015103,CHEMICAL,Droxidopa,"droxidopa|DL threo 3,4 Dihydroxyphenylserine|3,4 threo DOPS|erythro-3,4-Dihydroxyphenylserine|Droxidopa|DL-threo-3,4-Dihydroxyphenylserine|3,4-Dihydroxyphenylserine|3,4-threo-DOPS|Droxidopa, (DL-Tyr)-Isomer|threo DOPS|erythro 3,4 Dihydroxyphenylserine|threo-DOPS|3,4 Dihydroxyphenylserine"
D012791,DISEASE,Shy-Drager Syndrome,"Autonomic Failures, Progressive|Hypotension Syndromes, Dysautonomia-Orthostatic|Progressive Autonomic Failures|Hypotensions, Dysautonomic Orthostatic|Orthostatic Hypotensions, Dysautonomic|Orthostatic Hypotension, Dysautonomic|Failure, Progressive Autonomic|Syndromes, Dysautonomia-Orthostatic Hypotension|Hypotension Syndrome, Dysautonomia-Orthostatic|Dysautonomia-Orthostatic Hypotension Syndrome|Syndrome, Dysautonomia Orthostatic Hypotension|Dysautonomic Orthostatic Hypotensions|Autonomic Failure, Progressive|Syndrome, Dysautonomia-Orthostatic Hypotension|Hypotension, Dysautonomic Orthostatic|Dysautonomia Orthostatic Hypotension Syndrome|Idiopathic Orthostatic Hypotension, Shy Drager Type|orthostatic hypotension|Shy Drager Syndrome|Orthostatic hypotension|Dysautonomia-Orthostatic Hypotension Syndromes|Dysautonomic Orthostatic Hypotension|Idiopathic Orthostatic Hypotension, Shy-Drager Type|Progressive Autonomic Failure|Syndrome, Shy-Drager|Failures, Progressive Autonomic"
D008879,CHEMICAL,Midodrine,"ST-1085|ST 1085|Monohydrochloride, Midodrine|Midodrine Hydrochloride|midodrine|Midodrine Monohydrochloride|ProAmatine|ST1085|Midodrin|Gutron|Midon|Amatine"
NEW03768,CHEMICAL,due alcohol toxicity,due alcohol toxicity
NEW03769,DISEASE,white-matter abnormalities,white-matter abnormalities
NEW03770,CHEMICAL,± old,± old
NEW03771,CHEMICAL,AL    ±,AL    ±
NEW03772,CHEMICAL,Ammonia-scavenging transmembrane pH-gradient poly(styrene)-b-poly(ethylene oxide polymersomes,Ammonia-scavenging transmembrane pH-gradient poly(styrene)-b-poly(ethylene oxide polymersomes
NEW03773,DISEASE,hyperammonemia condition,hyperammonemia condition
NEW03774,DISEASE,neurologic complications,neurologic complications
NEW03775,DISEASE,impaired cognitive flexibility,impaired cognitive flexibility
NEW03776,CHEMICAL,glutamatergic mossy cells,glutamatergic mossy cells|MCs
NEW03777,MENTAL_HEALTH,autism research,autism research
NEW03778,DISEASE,TD children,TD children
NEW03779,CHEMICAL,human DES gene,human DES gene
D058065,DISEASE,Diabetic Cardiomyopathies,"Diabetic Cardiomyopathy|cardiomyopathies|Cardiomyopathy, Diabetic|diabetic|Cardiomyopathies, Diabetic"
NEW03780,DISEASE,hereditary myopathies,hereditary myopathies
NEW03781,MENTAL_HEALTH,physical fatigue,physical fatigue
NEW03782,CHEMICAL,COVID-19 long-haulers,COVID-19 long-haulers
NEW03783,MENTAL_HEALTH,persistent hyperactivity,persistent hyperactivity
NEW03784,DISEASE,functional pituitary adenomas,functional pituitary adenomas
NEW03785,DISEASE,distinct psychotic symptom clusters,distinct psychotic symptom clusters
NEW03786,MENTAL_HEALTH,elevated thought disorder cluster scores,elevated thought disorder cluster scores
NEW03787,CHEMICAL,central DA receptor supersensitivity,central DA receptor supersensitivity
NEW03788,MENTAL_HEALTH,thought disorder,thought disorder
NEW03789,CHEMICAL,DA receptor blocker,DA receptor blocker
NEW03790,CHEMICAL,impaired iron metabolism,impaired iron metabolism
NEW03791,DISEASE,schizophrenic-like symptoms,schizophrenic-like symptoms
NEW03792,CHEMICAL,alpha(2)-adrenoreceptor agonist clonidine,alpha(2)-adrenoreceptor agonist clonidine|CLO
NEW03793,DISEASE,SAD n=16,SAD n=16
NEW03794,MENTAL_HEALTH,DSM-IV schizophrenia,DSM-IV schizophrenia
NEW03795,CHEBI,agonist clonidine,agonist clonidine
NEW03796,DISEASE,paranoid SCZ patients,paranoid SCZ patients
NEW03797,DISEASE,young male psychotic patients,young male psychotic patients
NEW03798,CHEBI,subsensitive neuroendocrine,growth hormone|subsensitive neuroendocrine
NEW03799,DISEASE,neuroleptic-free psychotic patients,neuroleptic-free psychotic patients
NEW03800,CHEBI,hormone GH response,hormone GH response
NEW03801,NUTRITION,alpha 2-adrenergic receptor sensitivity,alpha 2-adrenergic receptor sensitivity
NEW03802,CHEBI,dopamine agonist apomorphine APO hydrochloride,dopamine agonist apomorphine APO hydrochloride
NEW03803,MENTAL_HEALTH,DSM-III-R schizophrenia =,DSM-III-R schizophrenia =
NEW03804,CHEMICAL,extrahypothalamic corticotropin-releasing hormone,extrahypothalamic corticotropin-releasing hormone|CRH
NEW03805,CHEBI,CRH antagonists,CRH antagonists
NEW03806,MENTAL_HEALTH,chronic anxiety,chronic anxiety
D015671,CHEMICAL,Electroacupuncture,electroacupuncture|Electroacupuncture|Acupuncture (1966-1989)
NEW03807,DISEASE,SI mice,SI mice
C511689,CHEMICAL,(N)-methanocarba-2MeSADP [Supplementary Concept],MRS2365|Adenosine Diphosphate/analogs  and  derivatives
NEW03808,MENTAL_HEALTH,anxiety status,anxiety status
NEW03809,DISEASE,Depression-related phenotypes,Depression-related phenotypes
NEW03810,CHEBI,desipramine-induced hormone stimulation,desipramine-induced hormone stimulation
NEW03811,DISEASE,manic phase,manic phase
NEW03812,DISEASE,late-onset OTCD,late-onset OTCD
NEW03813,CHEMICAL,arginine treatment,arginine treatment
NEW03814,CHEMICAL,urea cycle function,urea cycle function
NEW03815,DISEASE,peripheral noradrenergic dysfunction,peripheral noradrenergic dysfunction
NEW03816,CHEMICAL,MG patients,MG patients
NEW03817,CHEBI,Several endocrine abnormalities,Several endocrine abnormalities
NEW03818,DISEASE,hypogonadotrophic hypogonadism,hypogonadotrophic hypogonadism
D007987,CHEBI,Gonadotropin-Releasing Hormone,"Kryptocur|LHRH|Releasing Hormone, LHFSH|LHFSHRH|Factrel|LH-FSH Releasing Hormone|Luliberin|Gonadorelin Acetate|Gn-RH|Luteinizing Hormone Releasing Hormone|Lh-Rh|Gonadorelin Hydrochloride|LH-RH|GnRH|gonadotropin-releasing hormone|Cystorelin|LH-Releasing Hormone|Dirigestran|LH FSH Releasing Hormone|Luteinizing Hormone-Releasing Hormone|Gonadotropin Releasing Hormone|LFRH|LHFSH Releasing Hormone|Gonadoliberin|FSH Releasing Hormone|Gonadorelin|LH Releasing Hormone|FSH-Releasing Hormone"
NEW03819,CHEMICAL,altered GHRH circadian rhythm,altered GHRH circadian rhythm
D000077310,DISEASE,"Sleep, Slow-Wave","N3 Sleep|Slow-Wave Sleep|Sleep, N3|Stage 3, NREM|Sleep, Slow Wave|Deep Sleep|Sleep, Deep|Slow Wave Sleep|Delta Sleep|SWS|Sleep, Delta|NREM Stage 3|slow wave sleep"
NEW03820,DISEASE,attention-deficit/hyperactivity disorder stimulant medication,attention-deficit/hyperactivity disorder stimulant medication
NEW03821,CHEBI,hormone treatment,hormone treatment
NEW03822,MENTAL_HEALTH,non-psychotic depression,non-psychotic depression
NEW03823,CHEMICAL,serotonin 5-HT reuptake inhibitor clomipramine,serotonin 5-HT reuptake inhibitor clomipramine
NEW03824,MENTAL_HEALTH,Major Depression,Major Depression
NEW03825,CHEMICAL,GHRH curve,GHRH curve
NEW03826,DISEASE,female psychiatric inpatients,female psychiatric inpatients
NEW03827,CHEMICAL,intravenous morphine,intravenous morphine
D009022,CHEMICAL,Morphine Derivatives,morphine|Morphines|Morphine
NEW03828,CHEMICAL,plasma cortisol,plasma cortisol
NEW03829,CHEMICAL,chronic sulpiride therapy,chronic sulpiride therapy
NEW03830,MENTAL_HEALTH,anxiety reactions,anxiety reactions
D007046,MENTAL_HEALTH,Hysteria,"Neuroses, Hysterical|Hysterical Neuroses|hysteria"
NEW03831,DISEASE,childhood psychoses,childhood psychoses
NEW03832,CHEBI,growth hormone GH secretion,growth hormone GH secretion
NEW03833,DISEASE,insulin-induced hypoglycemia,insulin-induced hypoglycemia
D013469,CHEMICAL,Sulpiride,|Sulpiride|Arminol|sulpiride|Sulperide|Synédil|dopamine D2 receptor antagonist|Digton|Vertigo Meresa|Ekilid|Vertigo-Meresa|Sulpitil|Lebopride|neogama|vertigo-neogama|Eglonyl|Sulp|Aiglonyl|vertigo neogama|Psicocen|Dolmatil|D2-like dopamine receptor antagonist|Dogmatil|Sulpivert|Sulpor|Guastil|Desisulpid|Pontiride|Deponerton|Tepavil|Meresa|(-)-sulpiride
NEW03834,CHEMICAL,GABAB receptor function,GABAB receptor function
NEW03835,CHEMICAL,baclofen administration,baclofen administration
NEW03836,DISEASE,SAD controls,SAD controls
NEW03837,DISEASE,experimental spinal cord injury,experimental spinal cord injury
NEW03838,DISEASE,shock states,shock states
NEW03839,CHEBI,Growth hormone responses,Growth hormone responses
NEW03840,CHEMICAL,clonidine stimulation,clonidine stimulation
NEW03841,CHEMICAL,presynaptic noradrenaline secretion,presynaptic noradrenaline secretion
D006556,DISEASE,Heroin Dependence,"heroin dependence|heroin|methadone|Addiction, Heroin|Dependence, Heroin|heroin abuse|Abuse, Heroin|Smoking, Heroin|Heroin Addiction|Heroin|Heroin Smoking|heroin addiction|Heroin Smokings|Heroin Abuse"
NEW03842,CHEMICAL,methylphenidate challenge,methylphenidate challenge
NEW03843,CHEMICAL,weeks MPH treatment,weeks MPH treatment
D001615,CHEMICAL,beta-Endorphin,"beta Endorphin|beta-endorphin|beta-Endorphin (1-31)|beta-EP|beta-END|β-Endorphin|Endorphin, beta|β-endorphin"
NEW03844,CHEMICAL,single acute MPH administration,single acute MPH administration
NEW03845,DISEASE,ADDH children,ADDH children
NEW03846,CHEMICAL,beta-EP release,beta-EP release
NEW03847,CHEBI,Growth hormone 3-methoxy-4-hydroxyphenelethylene glycol response,Growth hormone 3-methoxy-4-hydroxyphenelethylene glycol response
NEW03848,CHEBI,plasma growth hormone,plasma growth hormone
NEW03849,DISEASE,scallop flesh extract,SE|scallop flesh extract
NEW03850,DISEASE,ADD+H,ADD+H
NEW03851,CHEBI,somatotropic axis growth hormone,somatotropic axis growth hormone
NEW03852,CHEMICAL,metformin administration,metformin administration
D012080,DISEASE,Chronic Kidney Disease-Mineral and Bone Disorder,"Renal Osteodystrophy|kidney disease|Osteodystrophy, Renal|Chronic Kidney Disease Mineral and Bone Disorder|Rickets, Renal|Renal Rickets|Renal Osteodystrophies|CKD-MBD|CKD|chronic kidney disease|Osteodystrophies, Renal"
NEW03853,DISEASE,infectious agents,infectious agents
D000083123,DISEASE,Vancomycin-Resistant Staphylococcus aureus,Glycopeptide-Intermediate S. aureus|vancomycin-intermediate|Vancomycin-Intermediate Staphylococcus aureus|S.    aureus|S aureus|Glycopeptide-Intermediate Staphylococcus aureus|Vancomycin-Resistant S. aureus|vancomycin-resistant S. aureus|Vancomycin-Intermediate S. aureus|Glycopeptide-Resistant Staphylococcus aureus|Glycopeptide-Resistant S. aureus
C476155,DISEASE,"beta-lactamase SPM-1, Pseudomonas aeruginosa [Supplementary Concept]",P.    aeruginosa|beta-Lactamases
D017919,DISEASE,"Hepatitis B Virus, Woodchuck","hepatitis B virus|Viruses, Woodchuck Hepatitis|Hepatitis Virus, Woodchuck|Woodchuck Hepatitis Viruses|Woodchuck Hepatitis Virus|Hepatitis Viruses, Woodchuck|Woodchuck Hepatitis B Virus|Virus, Woodchuck Hepatitis"
NEW03854,DISEASE,multiple infectious diseases,multiple infectious diseases
NEW03855,DISEASE,CAG trinucleotide expansion,CAG trinucleotide expansion
NEW03856,DISEASE,mutant HTT-induced toxicity,mutant HTT-induced toxicity
NEW03857,CHEMICAL,PPAR-γ agonist,PPAR-γ agonist
NEW03858,DISEASE,HD mouse brain,HD mouse brain
NEW03859,CHEBI,Peroxiproliferator-activated receptor gamma agonist,Peroxiproliferator-activated receptor gamma agonist
NEW03860,DISEASE,metabolic disorder-related depression,metabolic disorder-related depression
NEW03861,DISEASE,astrocytic deficits,astrocytic deficits
NEW03862,DISEASE,HFD-induced glucose-metabolic dysfunctions,HFD-induced glucose-metabolic dysfunctions
NEW03863,DISEASE,depressive phenotypes,depressive phenotypes
NEW03864,MENTAL_HEALTH,associated depression,associated depression
NEW03865,CHEBI,insulin-sensitizing peroxiproliferator-activated receptor agonist,insulin-sensitizing peroxiproliferator-activated receptor agonist
NEW03866,MENTAL_HEALTH,bipolar depression symptom severity,bipolar depression symptom severity
NEW03867,DISEASE,Subacute myelo-optico-neuropathy,Subacute myelo-optico-neuropathy
NEW03868,DISEASE,fatal bacterial infections,fatal bacterial infections
NEW03869,CHEMICAL,cyclic depsipeptide teixobactin,cyclic depsipeptide teixobactin
NEW03870,CHEMICAL,antipsychotic-associated weight gain,antipsychotic-associated weight gain
NEW03871,CHEMICAL,betahistine group,betahistine group
NEW03872,DISEASE,less weight gain,less weight gain
NEW03873,DISEASE,osteoporotic hip fracture,osteoporotic hip fracture
NEW03874,CHEBI,Naranjo adverse drug reaction probability scale,Naranjo adverse drug reaction probability scale
NEW03875,DISEASE,acute hearing loss,acute hearing loss
D010111,CHEMICAL,Oxymorphone,Opana|Oxymorphone HCl|Oxymorphone Hydrochloride|oxymorphone|Numorphan
NEW03876,CHEMICAL,cocaine self-administration,cocaine self-administration
NEW03877,DISEASE,cocaine-induced behaviors,cocaine-induced behaviors
NEW03878,CHEBI,mu-opioid receptor agonist,mu-opioid receptor agonist
D059026,DISEASE,Diagnostic Self Evaluation,"Self-Evaluations|Subjective Health Complaint|Complaints, Subjective Health|Self-Appraisal|Self-Evaluation|Self-Appraisals|Self Evaluation|Complaint, Subjective Health|Complaints|Subjective Health|Self Evaluation, Diagnostic|Health, Subjective|Self Evaluations, Diagnostic|Subjective Healths|Health Complaints, Subjective|Self Appraisal|Evaluations, Diagnostic Self|Subjective Health Complaints|Health Complaint, Subjective|Diagnostic Self Evaluations"
D017974,CHEMICAL,Uranium Compounds,"Compounds, Uranium|uranium|U69,593|(-)-U-50,488|U-47700"
NEW03879,DISEASE,clinical neurotoxicity,clinical neurotoxicity
NEW03880,DISEASE,depressed adult outpatients,depressed adult outpatients
NEW03881,CHEMICAL,antidepressant treatment,antidepressant treatment
NEW03882,CHEMICAL,μ-opioid receptor agonist loperamide,μ-opioid receptor agonist loperamide
NEW03883,CHEBI,polymer patch delivery,polymer patch delivery
NEW03884,CHEBI,polymer delivery system,polymer delivery system
NEW03885,CHEBI,#NAME?,-adrenergic receptor agonist dexmedetomidine
NEW03886,DISEASE,heat pain,heat pain
NEW03887,CHEBI,"selective TRPV1 antagonist JTS-653 (3S)-3-(hydroxymethyl)-4-(5-methylpyridin-2-yl)-N-[6-(2,2,2-trifluoroethoxy)pyridin-3-yl]-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxamide","selective TRPV1 antagonist JTS-653 (3S)-3-(hydroxymethyl)-4-(5-methylpyridin-2-yl)-N-[6-(2,2,2-trifluoroethoxy)pyridin-3-yl]-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxamide"
NEW03888,DISEASE,formalin-induced pain,formalin-induced pain
NEW03889,DISEASE,NSAID-refractory chronic pain,NSAID-refractory chronic pain
D050051,CHEMICAL,Transient Receptor Potential Channels,"Channels, TRP Cation|Channel, TRP Cation|TRP Cation Channels|Transient Receptor Potential Channel|Transient Receptor Potential Cation Channel|TRP Cation Channel|Cation Channels, TRP|Membrane Proteins, TRP|TRP Membrane Proteins|Cation Channel, TRP|Proteins, TRP Membrane|TRP channels|Transient Receptor Potential Cation Channels"
NEW03890,CHEMICAL,Chronic alcohol use,Chronic alcohol use
NEW03891,DISEASE,increased pain perception,increased pain perception
NEW03892,CHEMICAL,adrenoreceptor antagonist prazosin,adrenoreceptor antagonist prazosin
NEW03893,CHEMICAL,noradrenaline effects,noradrenaline effects
NEW03894,CHEMICAL,Antidepressant medications,Antidepressant medications
NEW03895,CHEMICAL,5-hydroxytryptamine reuptake,5-hydroxytryptamine reuptake
NEW03896,CHEMICAL,5-HT transport,5-HT transport
NEW03897,CHEMICAL,low-dose dopamine DA antagonists,low-dose dopamine DA antagonists
NEW03898,MENTAL_HEALTH,comorbid chronic tic disorder,comorbid chronic tic disorder
NEW03899,CHEMICAL,5-HT systems,5-HT systems
NEW03900,CHEBI,toxin lesion,toxin lesion
NEW03901,CHEMICAL,serotonin tone,serotonin tone
NEW03902,DISEASE,LID therapeutic effect,LID therapeutic effect
NEW03903,CHEMICAL,serotonin precursor 5-hydroxy-tryptophan,serotonin precursor 5-hydroxy-tryptophan|5-HTP|serotonin precursor 5-hydroxytryptophan
NEW03904,CHEMICAL,5-HTP mg/kg,5-HTP mg/kg
NEW03905,DISEASE,L-DOPA-primed dyskinetic rats,L-DOPA-primed dyskinetic rats
NEW03906,DISEASE,behavioral disturbances,behavioral disturbances
NEW03907,CHEMICAL,prototypic antidepressant,prototypic antidepressant
NEW03908,CHEMICAL,adult antidepressant treatment,adult antidepressant treatment
NEW03909,CHEMICAL,neonatal citalopram exposure,neonatal citalopram exposure
NEW03910,DISEASE,male sexual behavior,male sexual behavior
NEW03911,DISEASE,lasting behavioral abnormalities,lasting behavioral abnormalities
NEW03912,CHEMICAL,relevant antidepressant treatments,relevant antidepressant treatments
NEW03913,CHEMICAL,atypical antipsychotic clozapine,atypical antipsychotic clozapine
NEW03914,CHEMICAL,melatonin agonist/5-HT(2C,melatonin agonist/5-HT(2C
NEW03915,CHEMICAL,cholinergic agents/SRIs,cholinergic agents/SRIs
NEW03916,CHEBI,concurrent drug therapy,concurrent drug therapy
NEW03917,CHEMICAL,newer cyclic antidepressants,newer cyclic antidepressants
NEW03918,DISEASE,nausea arrhythmias,nausea arrhythmias
NEW03919,DISEASE,relapsing disease,relapsing disease
NEW03920,CHEMICAL,maintenance antidepressant therapy,maintenance antidepressant therapy
NEW03921,MENTAL_HEALTH,recurrent depression,recurrent depression
NEW03922,CHEMICAL,effective antidepressants,effective antidepressants
C000712087,CHEMICAL,ACH-000029 [Supplementary Concept],ACH-000029|Quinazolines|Piperazines
NEW03923,CHEBI,cannabinoid CB(1 receptor antagonists,cannabinoid CB(1 receptor antagonists
NEW03924,DISEASE,pain regulation,pain regulation
NEW03925,CHEMICAL,newer antidepressants,newer antidepressants
NEW03926,DISEASE,Seizure risk,Seizure risk
D000317,NUTRITION,Adrenergic alpha-Antagonists,"Agents, alpha-Adrenergic Blocking|Adrenergic alpha-Blockers|Adrenergic alpha Blockers|alpha Adrenergic Receptor Blockaders|Blockaders, alpha-Adrenergic Receptor|Adrenergic alpha Receptor Blockaders|alpha-Blockers, Adrenergic|alpha-Antagonists, Adrenergic|alpha-adrenergic antagonists|alpha blockers|Antagonists, alpha-Adrenergic|Blockaders, Adrenergic alpha-Receptor|alpha-Adrenergic Blockers|Adrenergic alpha-Receptor Blockaders|alpha Adrenergic Blocking Agents|Blockers, alpha-Adrenergic|alpha-Adrenergic Antagonists|Adrenergic alpha Antagonists|Receptor Blockaders, alpha-Adrenergic|alpha-Adrenergic Blocking Agents|alpha-blockers|alpha Adrenergic Antagonists|alpha-adrenergic blockers|alpha-Adrenergic Receptor Blockaders|alpha Blockers, Adrenergic|Blocking Agents, alpha-Adrenergic|alpha Adrenergic Blockers|alpha-Receptor Blockaders, Adrenergic|Alpha-adrenergic antagonists"
D014550,DISEASE,"Urinary Incontinence, Stress","|stress incontinence|Incontinence, Urinary Stress|Stress Incontinence, Urinary|Urinary Stress Incontinence"
D053202,DISEASE,"Urinary Incontinence, Urge","Urge Incontinence|Urinary Urge Incontinence|Incontinence, Urinary Reflex|urinary incontinence|Urinary Reflex Incontinence|Incontinence, Urge|incontinence|urge incontinence"
D016055,DISEASE,Urinary Retention,"retention of urine||Retention, Urinary|urinary retention"
D007669,DISEASE,Kidney Calculi,"|Renal Calculi|Kidney Stone|Calculus, Kidney|Kidney Calculus|Renal Calculus|Nephrolith|Calculus, Renal|Calculi, Kidney|Stones, Kidney|Stone, Kidney|renal calculi|Kidney Stones|Calculi, Renal"
NEW03927,CHEMICAL,calcium supplementation,calcium supplementation
NEW03928,CHEMICAL,triamterene inhibitors,triamterene inhibitors
D019469,CHEMICAL,Indinavir,"|indinavir|Crixivan|Indinavir Sulfate|L735 524|Sulfate, Indinavir|L735,524|L 735,524|MK 639|MK639|L-735,524|Indinavir, Sulfate (1:1)|MK-639|L 735 524|L-735 524"
NEW03929,MENTAL_HEALTH,Drug-induced sexual dysfunction,Drug-induced sexual dysfunction
NEW03930,CHEBI,beta adrenoceptor blockers,beta adrenoceptor blockers
NEW03931,DISEASE,neuropsychiatric complications,neuropsychiatric complications
NEW03932,MENTAL_HEALTH,anxiety due,anxiety due
D000077593,CHEMICAL,Reboxetine,Reboxetine Mesylate|reboxetine|Vestra|Reboxetine|2-((2-Ethoxyphenoxy)benzyl)morpholine methanesulfonate
C536274,DISEASE,"Ichthyosis, mental retardation, dwarfism, and renal impairment [Supplementary Concept]",renal impairment|Intellectual Disability|Dwarfism|Kidney Diseases|Ichthyosis
NEW03933,DISEASE,impulsive behavioural dyscontrol symptoms,impulsive behavioural dyscontrol symptoms
NEW03934,CHEMICAL,SNRI duloxetine,SNRI duloxetine
NEW03935,DISEASE,somatic complaints,somatic complaints
NEW03936,DISEASE,DSM-IV-TR diagnosis,DSM-IV-TR diagnosis
NEW03937,CHEMICAL,open-label duloxetine,open-label duloxetine
D000068736,CHEMICAL,Duloxetine Hydrochloride,"LY 227942|Duloxetine hydrochloride|duloxetine|Cymbalta|Duloxetine HCl|LY-248686|N-methyl-3-(1-naphthalenyloxy)-2-thiophenepropanamine|LY-227942|HCl, Duloxetine|LY248686|Duloxetine, (+)-isomer|Hydrochloride, Duloxetine|LY 248686|Duloxetine|Duloxetine Ethanedioate (1:1), (+-)-isomer - T353987|N-methyl-3-(1-naphthalenyloxy)-3-(2-thiophene)propanamide|LY227942"
NEW03938,CHEBI,serotonin norepinephrine reuptake inhibitors,serotonin norepinephrine reuptake inhibitors
NEW03939,CHEMICAL,available serotonin reuptake inhibitors,available serotonin reuptake inhibitors
NEW03940,DISEASE,hallucinatory-paranoid state,hallucinatory-paranoid state
NEW03941,CHEMICAL,amphetamine-like stimulants,amphetamine-like stimulants
NEW03942,CHEMICAL,serotonin-norepinephrine reuptake inhibitors,serotonin-norepinephrine reuptake inhibitors
D020303,DISEASE,"Rats, Inbred Dahl","Dahl Rats|Salt-Sensitive Rat, Dahl|Dahl Hypertensive Rats|Salt-Sensitive Rats, Dahl|Dahl Rats, Inbred|Dahl Salt Sensitive Rat|SHRSP/Ezo|Dahl Salt Sensitive Rats|Rats, Dahl Salt-Sensitive|Rat, Dahl|hypertensive rats|Dahl Salt-Resistant Rats|Rats, Dahl Hypertensive|Rat, Dahl Salt-Sensitive|Salt-Resistant Rats, Dahl|Rats, Dahl Salt-Resistant|Dahl Salt-Sensitive Rat|Rats, Dahl|Inbred Dahl Rats|Dahl Salt-Sensitive Rats|Hypertensive Rats, Dahl|Dahl Rat|Dahl Salt Resistant Rats"
NEW03943,CHEMICAL,serotonin-norepinephrine antidepressant,serotonin-norepinephrine antidepressant
NEW03944,CHEMICAL,cholecystokinin/pentagastrin,cholecystokinin/pentagastrin
NEW03945,MENTAL_HEALTH,similar anxiety reactions,similar anxiety reactions
NEW03946,CHEMICAL,5HT1A serotonin receptor subtypes,5HT1A serotonin receptor subtypes
NEW03947,CHEMICAL,Platelet 5HT2 receptor density,Platelet 5HT2 receptor density
NEW03948,DISEASE,orthostatic challenge test,orthostatic challenge test
NEW03949,CHEMICAL,Norepinephrine response,Norepinephrine response
NEW03950,CHEMICAL,low dopamine transporter site density,low dopamine transporter site density
NEW03951,CHEMICAL,benzodiazepines clonazepam,benzodiazepines clonazepam
NEW03952,DISEASE,dry mouth,dry mouth
NEW03953,MENTAL_HEALTH,comorbid alcohol dependence,comorbid alcohol dependence
NEW03954,CHEMICAL,neurotransmitters serotonin,neurotransmitters serotonin
C113970,CHEMICAL,dexaminoglutethimide [Supplementary Concept],escitalopram|enantiomer|Glutethimide
NEW03955,MENTAL_HEALTH,seasonal depression,seasonal depression
NEW03956,MENTAL_HEALTH,antenatal depression,antenatal depression
NEW03957,CHEBI,selective norepinephrine reuptake inhibitors,selective norepinephrine reuptake inhibitors
NEW03958,MENTAL_HEALTH,purging episodes,purging episodes
NEW03959,MENTAL_HEALTH,severe premenstrual syndrome,severe premenstrual syndrome
NEW03960,DISEASE,premenstrual syndrome/premenstrual dysphoric disorder,premenstrual syndrome/premenstrual dysphoric disorder
NEW03961,DISEASE,cataract development,cataract development
NEW03962,DISEASE,abnormal uterine bleeding,abnormal uterine bleeding
NEW03963,CHEMICAL,low iron level,low iron level
D000073396,DISEASE,Metal-Organic Frameworks,"Porous Coordination Polymers|Metal-Organic Framework|Frameworks, Metal-Organic|Polymer, Porous Coordination|Coordination Polymers, Porous|Coordination Polymer, Porous|Framework, Metal Organic|Polymers, Porous Coordination|Porous Coordination Polymer|Coordination Networks, Porous|frameworks|Framework, Metal-Organic|Metal Organic Framework|Covalent Organic Framework|Organic Framework, Metal|Porous Coordination Networks|Framework, Covalent Organic|Organic Framework, Covalent|Networks, Porous Coordination|Metal Organic Frameworks"
NEW03964,CHEMICAL,multiple micronutrient supplementation,MMS|multiple micronutrient supplementation
NEW03965,DISEASE,anemia rates,anemia rates
NEW03966,CHEMICAL,oral iron therapy,oral iron therapy
NEW03967,CHEMICAL,combined iron supplementation,combined iron supplementation
C038178,CHEMICAL,ammonium ferrous sulfate [Supplementary Concept],ferrous sulfate|Ferrous Compounds|Quaternary Ammonium Compounds
D002971,DISEASE,Cleft Lip,"|cleft lip|Harelip|Cleft lip|Cleft Lips|Lips, Cleft|Harelips|Lip, Cleft"
NEW03968,DISEASE,maternal hypoxia,maternal hypoxia
D010547,DISEASE,Persistent Fetal Circulation Syndrome,"Persistent Pulmonary Hypertension of Newborn|ACD-MPV|Hypertension, Pulmonary, of Newborn, Persistent|congenital anomalies|Pulmonary Hypertension, Familial Persistent, of the Newborn|Persistent pulmonary hypertension|Alveolar Capillary Dysplasia With Misalignment Of Pulmonary Veins|Persistent Fetal Circulation|Alveolar Capillary Dysplasia With Misalignment Of Pulmonary Veins And Other Congenital Anomalies|ACD MPV|Circulation, Persistent Fetal|Familial Persistent Pulmonary Hypertension of the Newborn|ACDMPV|Misalignment of the Pulmonary Vessels|Fetal Circulation, Persistent"
NEW03969,CHEMICAL,ferrous citrate (FC)-infusion,ferrous citrate (FC)-infusion
NEW03970,CHEMICAL,female endogenous estradiol,female endogenous estradiol
NEW03971,DISEASE,Methaemoglobinaemia,Methaemoglobinaemia
D003622,CHEMICAL,Dapsone,"|Dapsone|DADPS|Sulfonyldianiline|Sulfona|Dapson-Fatol|4,4' Diaminophenyl Sulfone|dapsone|4,4'-Diaminophenyl Sulfone|Sulfone, 4,4'-Diaminophenyl|Disulone|Avlosulfone|Diaminodiphenylsulfone|Dapsoderm-X|Diaphenylsulfone"
NEW03972,DISEASE,methaemoglobinaemia,methaemoglobinaemia
NEW03973,MENTAL_HEALTH,HO-1 hyperactivity,HO-1 hyperactivity
NEW03974,CHEMICAL,pathological iron deposition,pathological iron deposition
NEW03975,DISEASE,bioenergetic failure,bioenergetic failure
NEW03976,CHEMICAL,non-transferrin iron,non-transferrin iron
NEW03977,MENTAL_HEALTH,Glial HO-1 hyperactivity,Glial HO-1 hyperactivity
NEW03978,DISEASE,fescue toxicosis,fescue toxicosis
NEW03979,CHEBI,related dopamine antagonist,related dopamine antagonist
NEW03980,DISEASE,depressed concentrations,depressed concentrations
NEW03981,MENTAL_HEALTH,weight Chronic stress,weight Chronic stress
NEW03982,CHEMICAL,mg/kg BW dexamethasone,mg/kg BW dexamethasone
NEW03983,CHEMICAL,Hair cortisol,Hair cortisol
NEW03984,CHEMICAL,± kg,± kg
NEW03985,DISEASE,beef cattle,beef cattle
NEW03986,DISEASE,obesity therapy,obesity therapy
D000071220,CHEBI,Pharmaceutical Research,"Research, Pharmaceutical|pharmaceutical research"
C491208,CHEMICAL,"MCHR1 protein, rat [Supplementary Concept]","Receptors, Somatostatin|MCH|Melanin concentrating hormone"
NEW03987,CHEMICAL,lower blood glucose levels,lower blood glucose levels
NEW03988,CHEMICAL,thiazolidinedione pioglitazone,thiazolidinedione pioglitazone
C526140,CHEBI,"GDF15 protein, human [Supplementary Concept]",Growth Differentiation Factor 15|non-steroidal anti-inflammatory drug
NEW03989,MENTAL_HEALTH,experimental anxiety,experimental anxiety
D011738,CHEMICAL,Pyrilamine,"Pyranisamine|Pyrilamine Maleate|Kriptin|Maleate, Pyrilamine|Maleate, Mepyramine|mepyramine|Mepyramine|Anthisan|Mepyramine Maleate|Boots Bite  and  Sting Relief"
C564560,DISEASE,"Mental Retardation, X-Linked, Syndromic 10 [Supplementary Concept]","Dyskinesias|abnormal behavior|Mental Retardation, X-Linked"
NEW03990,CHEBI,anticholinergic drug,anticholinergic drug
NEW03991,CHEMICAL,phenomenon conditioning-specific reflex modification,CRM|phenomenon conditioning-specific reflex modification
NEW03992,DISEASE,milder tics persons,milder tics persons
D000322,CHEBI,Adrenergic Agonists,"Adrenergic Receptor Agonists|adrenergic agonists|Agonists, Adrenergic|Receptor Agonists, Adrenergic|Adrenergic Receptor Agonist|Receptor Agonist, Adrenergic|adrenomimetics|Agonist, Adrenergic|Agonists, Adrenergic Receptor|Agonist, Adrenergic Receptor|Adrenergic Agonist|Adrenomimetics"
NEW03993,DISEASE,chronic spinal catheters,chronic spinal catheters
NEW03994,CHEMICAL,selective noradrenaline re-uptake inhibitor,selective noradrenaline re-uptake inhibitor
NEW03995,CHEBI,agonists clonidine,agonists clonidine
NEW03996,CHEMICAL,Regionally-specific stimulant-induced elevations,Regionally-specific stimulant-induced elevations
NEW03997,MENTAL_HEALTH,pediatric ADHD,pediatric ADHD
NEW03998,CHEMICAL,non-stimulant medications,non-stimulant medications
NEW03999,DISEASE,tic severity,tic severity
NEW04000,CHEMICAL,catecholamine pathway dysfunction,catecholamine pathway dysfunction
NEW04001,MENTAL_HEALTH,uncomplicated ADHD,uncomplicated ADHD
NEW04002,CHEBI,different drug therapies,different drug therapies
NEW04003,CHEMICAL,methadone use,methadone use
NEW04004,CHEMICAL,recent nonmedical buprenorphine use,recent nonmedical buprenorphine use
NEW04005,CHEMICAL,recent methadone maintenance treatment = =,recent methadone maintenance treatment = =
NEW04006,MENTAL_HEALTH,multivariate logistic regression analysis,multivariate logistic regression analysis
NEW04007,CHEMICAL,Testosterone values,Testosterone values
NEW04008,MENTAL_HEALTH,ASEX dysfunction scores,ASEX dysfunction scores
NEW04009,CHEBI,opioid agonist,opioid agonist
NEW04010,CHEMICAL,Glutamate toxicity,Glutamate toxicity
C402107,CHEMICAL,2-(phosphonomethyl)pentanedioic acid [Supplementary Concept],Organophosphorus Compounds|2-PMPA|2-(phosphonomethyl)-pentanedioic acid
NEW04011,DISEASE,chronic glutamate-mediated neuron degeneration,chronic glutamate-mediated neuron degeneration
NEW04012,NUTRITION,choline acetyltransferase activity,choline acetyltransferase activity
NEW04013,CHEMICAL,environmental enrichment,EE|environmental enrichment
NEW04014,CHEMICAL,olfactory neuronal precursors,olfactory neuronal precursors|ONP
NEW04015,CHEBI,high-throughput drug screening,high-throughput drug screening
D056572,CHEMICAL,Histone Deacetylase Inhibitors,"Inhibitor, HDAC|Inhibitors, Histone Deacetylase|HDAC inhibitors|HDAC Inhibitors|Deacetylase Inhibitor, Histone|Inhibitors, HDAC|Deacetylase Inhibitors, Histone|Histone Deacetylase Inhibitor|Inhibitor, Histone Deacetylase|HDAC Inhibitor"
NEW04016,CHEMICAL,repeated imipramine,repeated imipramine
NEW04017,CHEMICAL,phosphorylated form,p-Hdac5|phosphorylated form
NEW04018,MENTAL_HEALTH,Clock-induced repression,Clock-induced repression
NEW04019,CHEMICAL,reduced alcohol consumption,reduced alcohol consumption
NEW04020,CHEMICAL,alcohol administration,alcohol administration
NEW04021,DISEASE,permanent behavioral abnormality,permanent behavioral abnormality
D015740,CHEMICAL,Calcitonin Gene-Related Peptide,"beta-Calcitonin Gene-Related Peptide|Calcitonin Gene Related Peptide I|beta Calcitonin Gene Related Peptide|Calcitonin Gene-Related Peptide I|calcitonin gene-related peptide|Calcitonin Gene-Related Peptide II|CGRP|alpha-Calcitonin Gene-Related Peptide|Calcitonin Gene Related Peptide II|beta-CGRP|alpha-CGRP|alpha Calcitonin Gene Related Peptide|Calcitonin Gene Related Peptide|Gene-Related Peptide, Calcitonin"
NEW04022,DISEASE,traumatic fear,traumatic fear
NEW04023,CHEMICAL,stimulant methylphenidate,stimulant methylphenidate
NEW04024,CHEMICAL,hepatic metabolised amphetamine prodrug Lisdexamfetamin,hepatic metabolised amphetamine prodrug Lisdexamfetamin
NEW04025,CHEMICAL,α(2)A-adrenoceptor-agonist Guanfacine,α(2)A-adrenoceptor-agonist Guanfacine
NEW04026,CHEMICAL,Intuniv ®,Intuniv ®
NEW04027,CHEBI,MGlu5 receptor antagonists,MGlu5 receptor antagonists
NEW04028,CHEMICAL,mGlu5 receptor antagonists,mGlu5 receptor antagonists
NEW04029,DISEASE,chronic neurodegenerative disorders,chronic neurodegenerative disorders
NEW04030,CHEBI,mGlu4/7/8 receptor agonists,mGlu4/7/8 receptor agonists
NEW04031,CHEMICAL,type DM,type DM
D029747,CHEMICAL,Opuntia,"Cactus, Prickly-pear|Cholla Cactus|Prickly pear Cactus|Opuntia ficus-indica|Opuntia ficus|Prickly-pear Cactus|Cactus, Cholla"
NEW04032,CHEMICAL,Air exposure,Air exposure
NEW04033,CHEMICAL,alcohol binge,alcohol binge
NEW04034,DISEASE,intestinal dysbiosis,intestinal dysbiosis
D006944,DISEASE,Hyperglycemic Hyperosmolar Nonketotic Coma,"|Hyperosmolar Hyperglycemic Syndromes|Hyperglycemic Coma, Nonketotic|Hyperosmolar Hyperglycemic Nonketotic Coma|Comas, Hyperosmolar Nonketotic|Comas, Nonketotic Hyperosmolar|Nonketotic Comas, Hyperosmolar|Nonketotic Hyperglycemic Coma|Syndromes, Hyperosmolar Hyperglycemic|Nonketotic Hyperosmolar Comas|Coma, Nonketotic Hyperosmolar|Coma, Hyperglycemic Hyperosmolar Nonketotic|Hyperglycemic States, Hyperosmolar|Nonketotic Hyperosmolar Coma|Hyperosmolar Coma, Nonketotic|Hyperglycemic Syndrome, Hyperosmolar|Nonketotic Coma, Hyperosmolar|Syndrome, Hyperosmolar Hyperglycemic|Coma, Nonketotic Hyperglycemic|Hyperglycemic State, Hyperosmolar|Hyperosmolar Hyperglycemic Syndrome|Coma, Hyperosmolar Nonketotic|Hyperosmolar Comas, Nonketotic|Hyperosmolar Nonketotic Coma|Hyperosmolar Hyperglycemic States|Hyperosmolar Hyperglycemic State|Hyperglycemic Syndromes, Hyperosmolar|Hyperosmolar nonketotic coma|hyperosmolar coma|Hyperosmolar Nonketotic Comas"
NEW04035,CHEMICAL,oolong tea,oolong tea
NEW04036,DISEASE,severe hyponatremia,severe hyponatremia
D012206,DISEASE,Rhabdomyolysis,|rhabdomyolysis|Rhabdomyolyses
NEW04037,CHEMICAL,caffeine toxicity,caffeine toxicity
NEW04038,DISEASE,severe rhabdomyolysis,severe rhabdomyolysis
NEW04039,CHEMICAL,cannabis cessation,cannabis cessation
NEW04040,CHEMICAL,NAA concentration,NAA concentration
NEW04041,MENTAL_HEALTH,chronic psychosis patients,chronic psychosis patients
D018476,DISEASE,Hypokinesia,"bradykinesia||Bradykinesias|Hypokinesias, Antiorthostatic|akinetic|Bradykinesia|Antiorthostatic Hypokinesias|Hypodynamia|Antiorthostatic Hypokinesia|Hypokinesia, Antiorthostatic"
NEW04042,CHEMICAL,heavy ethanol exposure,heavy ethanol exposure
NEW04043,DISEASE,motor impairments,motor impairments
NEW04044,DISEASE,long-lasting cerebellar degeneration,long-lasting cerebellar degeneration
C036619,CHEMICAL,idebenone [Supplementary Concept],Ubiquinone/analogs  and  derivatives|idebenone|Idebenone
D016903,CHEBI,Drug Monitoring,"Therapeutic Drug Monitoring|therapeutic drug|Drug Monitoring, Therapeutic|drug monitoring|Monitoring, Therapeutic Drug|Monitoring, Drug|TDM|Therapeutic drug monitoring|therapeutic drug monitoring"
C000598329,CHEMICAL,hydroxy-alpha sanshool [Supplementary Concept],"Hydroxy-α-sanshool|Fatty Acids, Unsaturated|Polyunsaturated Alkamides"
NEW04045,CHEMICAL,radium poisoning,radium poisoning
NEW04046,CHEMICAL,serotonin neurotransmitter systems,serotonin neurotransmitter systems
NEW04047,MENTAL_HEALTH,disorder individuals,disorder individuals
NEW04048,NUTRITION,long-term lithium,long-term lithium
NEW04049,NUTRITION,short-term lithium,short-term lithium
NEW04050,MENTAL_HEALTH,suicide risk,suicide risk
D000086,CHEMICAL,Acetazolamide,"|acetazolamide|Acetazolamide, Monosodium Salt|Ak Zol|Diuramide|Huma-Zolamide|Apo-Acetazolamide|Diacarb|Glauconox|Edemox|Acetazolam|Acetadiazol|Apo Acetazolamide|Huma Zolamide|Ak-Zol|AkZol|Glaupax|Acetazolamide Sodium, (Sterile)|Diamox|Acetazolamide|ApoAcetazolamide|ACZ|Défiltran|HumaZolamide"
NEW04051,CHEBI,third-generation antipsychotic drug,third-generation antipsychotic drug
NEW04052,CHEBI,stress hormone system dysregulations,stress hormone system dysregulations
NEW04053,DISEASE,sleeping-related disorders,sleeping-related disorders
NEW04054,DISEASE,certain cancers,certain cancers
NEW04055,DISEASE,neurological conditions,neurological conditions
NEW04056,CHEMICAL,Rohypnol use,Rohypnol use
NEW04057,DISEASE,sexual behaviour,sexual behaviour
NEW04058,MENTAL_HEALTH,Rohypnol-induced sexual dysfunction,Rohypnol-induced sexual dysfunction
NEW04059,CHEBI,circulatory follicle-stimulating hormone,circulatory follicle-stimulating hormone
NEW04060,CHEBI,luteinising hormone,luteinising hormone
C570497,CHEBI,"MEDA-7 protein, mouse [Supplementary Concept]",Cytokines|oestrogen
D005445,CHEMICAL,Flunitrazepam,"|Narcozep|Fluni 1A Pharma|Flunizep Von Ct|Flunitrazepam-Teva|Flunitrazepam-Ratiopharm|Fluninoc|Flunibeta|flunitrazepam|Rohypnol|RO-5-4200|Rohipnol|Flunimerck|Flunitrazepam Neuraxpharm|Fluridrazepam|Flunitrazepam Teva|Von Ct, Flunizep|Flunitrazepam Ratiopharm|Flunitrazepam|RO54200|Flunitrazepam-Neuraxpharm"
NEW04061,DISEASE,BPD group,BPD group
D011803,CHEMICAL,Quinine,"|Quinamm|Legatrim|Quinine Hydrochloride|Strema|Bisulfate, Quinine|Quinine Sulfate|Quinson|Quinbisan|Surquina|Sulphate, Quinine|Quinoctal|Quinbisul|Quindan|Myoquin|Quinine Bisulfate|Quinine Lafran|Quinine-Odan|Quinsul|Hydrochloride, Quinine|quinine|Sulfate, Quinine|Biquinate|Quinine Sulphate|Quinimax"
NEW04062,CHEMICAL,mEq/liter,mEq/liter
C029311,CHEMICAL,serum sodium transport inhibitor [Supplementary Concept],serum sodium|serum sodium =|Peptides
D012919,DISEASE,Social Behavior,"Sociality|Behaviors, Social|Social Behaviors|social behaviors|Behavior, Social"
NEW04063,MENTAL_HEALTH,withdrawal excessive daytime sleepiness,withdrawal excessive daytime sleepiness
NEW04064,DISEASE,attention-deficit hyperactive disorder,attention-deficit hyperactive disorder
NEW04065,DISEASE,LD MP treatment,LD MP treatment
NEW04066,CHEMICAL,brain glucose metabolism,brain glucose metabolism|BGluM
NEW04067,CHEMICAL,Agmatine treatment,Agmatine treatment
NEW04068,DISEASE,olfactory impairments,olfactory impairments
D000376,CHEMICAL,Agmatine,4-(Aminobutyl)guanidine|1 Amino 4 guanidinobutane|1-Amino-4-guanidinobutane|agmatine
NEW04069,CHEMICAL,unique exposure to nickel chloride,unique exposure to nickel chloride|NiCl2
NEW04070,MENTAL_HEALTH,anxiety tests,anxiety tests
NEW04071,CHEMICAL,oxide lipid peroxidation,oxide lipid peroxidation
NEW04072,CHEMICAL,antidepressant therapy,antidepressant therapy
NEW04073,CHEMICAL,ASM-ceramide system,ASM-ceramide system
D015742,CHEMICAL,Propofol,"|Propofol Rovi|Diprivan|Propofol Fresenius|Propofol|ICI35,868|Ivofol|Aquafol|Propofol MCT|Propofol-Lipuro|Fresofol|2,6-Bis(1-methylethyl)phenol|ICI-35868|Recofol|ICI-35,868|propofol|ICI35868|2,6-Diisopropylphenol|Disoprivan|Propofol Abbott|ICI 35,868|ICI 35868|2,6 Diisopropylphenol|Disoprofol"
NEW04074,DISEASE,post-traumatic stress disease,post-traumatic stress disease
NEW04075,DISEASE,disease pandemic,disease pandemic
NEW04076,MENTAL_HEALTH,global mental illness,global mental illness
NEW04077,DISEASE,hypothyroidism group,hypothyroidism group
D011441,CHEMICAL,Propylthiouracil,|6-Propyl-2-Thiouracil|propylthiouracil|6 Propyl 2 Thiouracil|% propylthiouracil
NEW04078,CHEMICAL,exposure to 0.05 % propylthiouracil,PTU|exposure to 0.05 % propylthiouracil
NEW04079,NUTRITION,to substrate,choline|to substrate
D005910,DISEASE,Glioma,"Malignant Gliomas|Tumors, Glial Cell|Glioma, Mixed|Glial Cell Tumors|Tumor, Glial Cell|Gliomas, Mixed|Gliomas|Mixed Gliomas|malignant gliomas|Glioma, Malignant|gliomas =|Mixed Glioma|Glial Cell Tumor|Malignant Glioma|Gliomas, Malignant|gliomas"
NEW04080,NUTRITION,choline elevation,choline elevation
NEW04081,DISEASE,grade gliomas,grade gliomas
NEW04082,CHEMICAL,choline/creatine ratios,choline/creatine ratios
NEW04083,CHEMICAL,myoinositol/creatine ratio,myoinositol/creatine ratio
NEW04084,NUTRITION,elevated choline levels,elevated choline levels
NEW04085,CHEMICAL,choline/creatine elevation,choline/creatine elevation
C024894,CHEMICAL,tanshinone II A sodium sulfonate [Supplementary Concept],Phenanthrenes|tanshinone IIA|Sodium tanshinone IIA sulfonate
NEW04086,CHEMICAL,cocktail dopamine D2 receptor antagonist,cocktail dopamine D2 receptor antagonist
NEW04087,DISEASE,repetitive behavior,repetitive behavior
NEW04088,CHEBI,drug cocktail,drug cocktail
NEW04089,DISEASE,repetitive motor behavior,repetitive motor behavior
NEW04090,DISEASE,sciatic MNCV,sciatic MNCV
NEW04091,DISEASE,diabetic animals,diabetic animals
NEW04092,CHEMICAL,nerve blood flow,nerve blood flow|NBF
NEW04093,CHEMICAL,Adenosine mg/kg,Adenosine mg/kg
NEW04094,DISEASE,diabetic rats,diabetic rats
NEW04095,CHEMICAL,acute ethanol exposure,acute ethanol exposure
NEW04096,MENTAL_HEALTH,hangover-induced anxiety,hangover-induced anxiety
NEW04097,CHEMICAL,ethanol administration,ethanol administration
D017448,CHEMICAL,"Receptors, Dopamine D2","dopamine D2-receptors|Receptor, Dopamine-D2|sulpiride|Dopamine D2 Receptor|Dopamine D2 Receptors|D2 Receptors, Dopamine|Dopamine D2 receptors|dopamine D2 receptors|Dopamine-D2 Receptor"
NEW04098,DISEASE,human neuroblastoma cells,human neuroblastoma cells
NEW04099,CHEMICAL,"3,4-metyhlenedioxymethamphetamine","MDMA|3,4-metyhlenedioxymethamphetamine"
NEW04100,CHEMICAL,chronic gestational stress,chronic gestational stress|CGS
NEW04101,CHEBI,antagonist effects,antagonist effects
NEW04102,DISEASE,MDMA hippocampal neurotoxic effects,MDMA hippocampal neurotoxic effects
NEW04103,CHEMICAL,contrast to A2a antagonist,SCH|contrast to A2a antagonist
NEW04104,CHEBI,A2a agonist,A2a agonist
NEW04105,NUTRITION,yeast cells,yeast cells
D003681,DISEASE,Dehydration,"Water Stress|Stress, Water|dehydration"
D014439,CHEMICAL,Tyramine,4-(2-Aminoethyl)phenol|tyramine|p-Tyramine|4-Hydroxyphenethylamine|4 Hydroxyphenethylamine|para-Tyramine
C075222,CHEMICAL,amyloid beta-protein (1-42) [Supplementary Concept],Peptide Fragments|Aβ42|Amyloid beta-Peptides
NEW04106,DISEASE,coagulation abnormalities,coagulation abnormalities
D054098,DISEASE,"Thrombocytopenia, Neonatal Alloimmune","Neonatal Thrombocytopenias|Neonatal Thrombocytopenia|Alloimmune Thrombocytopenia, Neonatal|Thrombocytopenia, Neonatal|thrombocytopenia|Thrombocytopenias, Neonatal Alloimmune|Neonatal Alloimmune Thrombocytopenias|Thrombocytopenias, Neonatal|Alloimmune Thrombocytopenias, Neonatal|Neonatal Alloimmune Thrombocytopenia"
NEW04107,NUTRITION,yeast β-glucans,yeast β-glucans
NEW04108,DISEASE,intestinal inflammation,intestinal inflammation
NEW04109,MENTAL_HEALTH,human alcohol abuse,human alcohol abuse
NEW04110,CHEMICAL,cellular acetaldehyde pools,cellular acetaldehyde pools
NEW04111,CHEMICAL,inositol synthesis,inositol synthesis
NEW04112,CHEMICAL,NH4(+ toxicity,NH4(+ toxicity
NEW04113,CHEMICAL,specific essential amino acid,specific essential amino acid
C566555,DISEASE,Desmosterolosis [Supplementary Concept],"Lipid Metabolism, Inborn Errors|Abnormalities, Multiple|desmosterolosis"
NEW04114,CHEMICAL,cholesterol precursor desmosterol,cholesterol precursor desmosterol
NEW04115,DISEASE,gastrointestinal inflammation,gastrointestinal inflammation
NEW04116,CHEBI,food antigens,food antigens
NEW04117,CHEMICAL,gluten exorphins,gluten exorphins
NEW04118,CHEBI,Anti-food antigen antibodies,Anti-food antigen antibodies
NEW04119,CHEMICAL,intestinally-infectious pathogen,intestinally-infectious pathogen
C417762,DISEASE,"H4 protein, Toxoplasma gondii [Supplementary Concept]",Protozoan Proteins|Toxoplasma gondii|Immunodominant Epitopes
NEW04120,MENTAL_HEALTH,recent onset schizophrenia,recent onset schizophrenia
NEW04121,MENTAL_HEALTH,Familial Alzheimer disease mutations,Familial Alzheimer disease mutations
NEW04122,CHEMICAL,FAD mutations,FAD mutations
D055646,NUTRITION,"Killer Factors, Yeast","Yeast|Killer Toxin, Yeast|Killer Factor, Yeast|Factor, Yeast Killer|Yeast Killer Factors|Toxin, Yeast Killer|Factors, Yeast Killer|Yeast Killer Toxin|yeast|Saccharomyces cerevisiae|Yeast Killer Factor"
NEW04123,CHEMICAL,Ala substitution,Ala substitution
NEW04124,CHEBI,deadly poisons,deadly poisons
D011039,CHEBI,Poison Control Centers,"poison|Poison Control Center|Control Centers, Poison|Center, Poison Control|Centers, Poison Control"
NEW04125,MENTAL_HEALTH,widespread public anxiety,widespread public anxiety
NEW04126,CHEMICAL,≥12<17 years age group,≥12<17 years age group
NEW04127,NUTRITION,Fatty acid ethyl esters,Fatty acid ethyl esters
D011042,CHEBI,Poisons,Poison|poisons
NEW04128,DISEASE,factitial disease,factitial disease
NEW04129,CHEBI,metabolic poisons,metabolic poisons
C030290,CHEMICAL,malonic acid [Supplementary Concept],Malonates|malonic acid
C015392,CHEMICAL,3-nitropropionic acid [Supplementary Concept],3-NP|Nitro Compounds|3-Nitropropionic acid|Propionates|3-nitropropionic acid
NEW04130,CHEMICAL,systemic 3-NP,systemic 3-NP
NEW04131,DISEASE,malonate-induced neuronal damage,malonate-induced neuronal damage
D000077300,CHEMICAL,Bosentan,"Ro-47-0203|Bosentan Anhydrous|bosentan|Ro 47-0203|Ro 47 0203|Bosentan|Bosentan Monohydrate|Ro 470203|4-t-Butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide|Tracleer"
NEW04132,CHEBI,endothelin receptor antagonist combination,endothelin receptor antagonist combination
NEW04133,MENTAL_HEALTH,General Fatigue,General Fatigue
NEW04134,MENTAL_HEALTH,Physical Fatigue,Physical Fatigue
NEW04135,MENTAL_HEALTH,fatigue dimensions,fatigue dimensions
NEW04136,CHEBI,oral dual endothelin receptor antagonist,oral dual endothelin receptor antagonist
NEW04137,MENTAL_HEALTH,chronic pain disorder,chronic pain disorder
NEW04138,CHEMICAL,catecholamine neurotransmission,catecholamine neurotransmission
NEW04139,CHEMICAL,glutamate-glutamine shuttle mechanism,glutamate-glutamine shuttle mechanism
NEW04140,DISEASE,orofacial motor dysfunction,orofacial motor dysfunction
NEW04141,CHEMICAL,homocysteine levels,homocysteine levels
NEW04142,DISEASE,thyroid disorders,thyroid disorders
NEW04143,CHEMICAL,prolactin-serotonin-dopamine interactions,prolactin-serotonin-dopamine interactions
NEW04144,DISEASE,debilitating disorder,debilitating disorder
NEW04145,CHEBI,high-dose vitamin B6,high-dose vitamin B6
NEW04146,CHEMICAL,Hcy levels,Hcy levels
NEW04147,CHEBI,vitamin B6 levels,vitamin B6 levels
NEW04148,CHEMICAL,hepatic β-muricholic acid,hepatic β-muricholic acid|βMCA
NEW04149,DISEASE,NAFLD therapy,NAFLD therapy
NEW04150,NUTRITION,methionine Met levels,methionine Met levels
NEW04151,CHEMICAL,Methyl donor SAM,Methyl donor SAM
NEW04152,DISEASE,hypoactive Gln synthetase,hypoactive Gln synthetase|GS
D008717,NUTRITION,Methionine Sulfoximine,"methionine sulfoximine|Sulfoximine, Methionine"
NEW04153,CHEMICAL,Glu levels,Glu levels
D019733,CHEMICAL,Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor,glutamine|Carbon Nitrogen Ligases with Glutamine as Amide N Donor|Gln|Glx
NEW04154,CHEMICAL,Gln supplementation,Gln supplementation
NEW04155,MENTAL_HEALTH,mild-to-moderate depression,mild-to-moderate depression
C060234,CHEMICAL,magnesium-protoporphyrin methyltransferase [Supplementary Concept],Methyltransferases|S-adenosyl-L-methionine|SAMe|S-Adenosyl-L-methionine
NEW04156,CHEMICAL,Methyl donor micronutrient score,MDMS|Methyl donor micronutrient score
NEW04157,CHEMICAL,0·60,0·60
NEW04158,CHEMICAL,0·31,0·31
NEW04159,DISEASE,C677 T polymorphism,C677 T polymorphism
NEW04160,DISEASE,idiopathic male infertility,idiopathic male infertility
NEW04161,CHEMICAL,MTHFR gene,MTHFR gene
NEW04162,CHEMICAL,homocysteine plasma concentration,homocysteine plasma concentration
D066248,CHEMICAL,High Fructose Corn Syrup,"Maize Syrup, High-Fructose|fructose|Glucose-Fructose Syrup|high-fructose corn syrup|High fructose|Glucose Fructose Syrup|High Fructose Maize Syrup|Syrup, Maize|Syrup, Glucose-Fructose|Syrup, High-Fructose Maize|Corn Sugar|Isoglucose|High-Fructose Maize Syrup|Sugar, Corn|Maize Syrup"
NEW04163,NUTRITION,methionine Met polymorphism,methionine Met polymorphism
D050802,CHEMICAL,Valine Dehydrogenase (NADP+),"valine|Valine Dehydrogenase, NADP-Dependent|Dehydrogenase, NADP-Dependent Valine|NADP-Dependent Valine Dehydrogenase|Valine Dehydrogenase, NADP Dependent"
C007957,CHEMICAL,homocysteine thiolactone [Supplementary Concept],Homocysteine/analogs  and  derivatives|Homocysteine thiolactone|homocysteine thiolactone
NEW04164,MENTAL_HEALTH,increased alcohol abuse,increased alcohol abuse
D000082,CHEMICAL,Acetaminophen,|Anacin 3|N-Acetyl-p-aminophenol|Anacin3|APAP|paracetamol|Acetaco|Acamol|Acetominophen|Algotropyl|Tylenol|acetaminophen|Acetamidophenol|Anacin-3|Panadol|p-Acetamidophenol|Acetaminophen|p-Hydroxyacetanilide|N-(4-Hydroxyphenyl)acetanilide|Paracetamol|Datril|Acephen|Hydroxyacetanilide
NEW04165,MENTAL_HEALTH,significant schizophrenia,significant schizophrenia
NEW04166,CHEMICAL,common single nucleotide polymorphism,common single nucleotide polymorphism
NEW04167,NUTRITION,methionine substitution,methionine substitution
NEW04168,NUTRITION,methionine metabolism methionine adenosyltransferase MAT    A,methionine metabolism methionine adenosyltransferase MAT    A
NEW04169,DISEASE,fibrosis carcinoma,fibrosis carcinoma
NEW04170,NUTRITION,adequate methionine supplementation,adequate methionine supplementation
NEW04171,MENTAL_HEALTH,Increased narcolepsy incidence,Increased narcolepsy incidence
NEW04172,CHEMICAL,Pandemrix ®,Pandemrix ®
NEW04173,MENTAL_HEALTH,paired ADHD,paired ADHD
D010625,CHEMICAL,Phenylethanolamine N-Methyltransferase,"Noradrenalin N-Methyltransferase|Norepinephrine N Methyltransferase|Methyltransferase, Norepinephrine|Norepinephrine N-Methyltransferase|Noradrenaline N-Methyltransferase|noradrenalin|Noradrenaline N Methyltransferase|Norepinephrine Methyltransferase|Phenethanolamine N Methyltransferase|Noradrenalin N Methyltransferase|Phenylethanolamine N Methyltransferase|Phenethanolamine N-Methyltransferase"
NEW04174,CHEMICAL,perinatal acetaminophen exposure,perinatal acetaminophen exposure
NEW04175,MENTAL_HEALTH,childhood attention-deficit hyperactivity disorder,childhood attention-deficit hyperactivity disorder
NEW04176,CHEMICAL,umbilical cord plasma amino acids,umbilical cord plasma amino acids
NEW04177,CHEMICAL,antioxidant glutathione,antioxidant glutathione
NEW04178,CHEMICAL,biomarker 8-hydroxy-deoxyguanosine,biomarker 8-hydroxy-deoxyguanosine
NEW04179,CHEMICAL,cord plasma acetaminophen,cord plasma acetaminophen
NEW04180,CHEMICAL,Cord unmetabolized acetaminophen,Cord unmetabolized acetaminophen
D051150,NUTRITION,Methionine Sulfoxide Reductases,"Peptide-Methionine (S)-S-oxide Reductase|Selenoprotein R|Peptide-Methionine (R)-S-oxide Reductase|Methionine Sulfoxide Reductase B|SelR Protein|Methionine-R-sulfoxide Reductases|Methionine R sulfoxide Reductase|Methionine R sulfoxide Reductases|Reductase, Methionine-R-sulfoxide|Methionine Sulfoxide Reductase A|Reductases, Methionine-R-sulfoxide|methionine sulfoxide|Methionine-R-sulfoxide Reductase|methionine|Reductases, Methionine Sulfoxide|Sulfoxide Reductases, Methionine"
NEW04181,CHEMICAL,8-hydroxy-deoxyguanosine,8-hydroxy-deoxyguanosine
NEW04182,MENTAL_HEALTH,childhood ADHD,childhood ADHD
D058570,CHEMICAL,TOR Serine-Threonine Kinases,"FKBP12 Rapamycin Associated Protein|threonine|Serine-Threonine Kinase, mTOR|mTOR Serine-Threonine Kinase|mTOR Serine Threonine Kinases|TOR Kinases|Kinase, TOR Serine-Threonine|TOR Serine Threonine Kinases|FK506 Binding Protein 12 Rapamycin Associated Protein 1|Mechanistic Target of Rapamycin Protein|TOR Serine Threonine Kinase|Protein, mTOR|Mammalian Target of Rapamycin|Protein, RAFT-1|mTOR Serine-Threonine Kinases|RAFT 1 Protein|Target of Rapamycin Proteins|FKBP12 Rapamycin Complex Associated Protein|FKBP12-Rapamycin Associated Protein|Kinase, TOR|Kinases, mTOR Serine-Threonine|TOR Serine-Threonine Kinase|FKBP12-Rapamycin Complex-Associated Protein|serine|Target of Rapamycin Protein|TOR Kinase|Serine-Threonine Kinase, TOR|mTOR Serine Threonine Kinase|Serine-Threonine Kinases, mTOR|RAFT-1 Protein|Rapamycin Protein Target|Serine-Threonine Kinases, TOR|Protein Target, Rapamycin|Kinase, mTOR Serine-Threonine|FK506 Binding Protein 12-Rapamycin Associated Protein 1|Kinases, TOR Serine-Threonine|Rapamycin Target Protein|mTOR Protein"
NEW04183,NUTRITION,increasing cord methionine,increasing cord methionine
NEW04184,CHEMICAL,DA system,DA system
NEW04185,CHEMICAL,valine allele,valine allele
NEW04186,CHEMICAL,Val66Met amino acid polymorphism,Val66Met amino acid polymorphism
C023550,CHEMICAL,galactose-binding protein [Supplementary Concept],D-galactose|Calcium-Binding Proteins|Monosaccharide Transport Proteins|Periplasmic Binding Proteins
NEW04187,DISEASE,gut microbial dysbiosis,gut microbial dysbiosis
NEW04188,DISEASE,peripheral inflammation,peripheral inflammation
NEW04189,CHEMICAL,deserticola polysaccharides,deserticola polysaccharides
NEW04190,DISEASE,age-related decline cognitive function,age-related decline cognitive function
NEW04191,CHEMICAL,natural killer cell activity,NKCA|natural killer cell activity
NEW04192,CHEMICAL,taurochenodesoxycholic acid,taurochenodesoxycholic acid
D019271,CHEMICAL,Hypoxanthine,hypoxanthine|Hypoxanthines (1981-1996)
NEW04193,CHEMICAL,L-acetylcarnitine,L-acetylcarnitine
D012695,CHEMICAL,L-Serine Dehydratase,"Serine-Threonine Dehydratase|Ammonia-Lyase, L-Serine|L Serine Ammonia Lyase|Serine Deaminase|L-Serine Ammonia-Lyase|Deaminase, Serine|Dehydratase, L-Serine|Dehydratase, Serine-Threonine|Serine Threonine Dehydratase|L Serine Dehydratase|Serine Dehydratase|L-serine|Dehydratase, Serine"
D007296,CHEMICAL,Myo-Inositol-1-Phosphate Synthase,"Cycloaldolase|Myo Inositol 1 Phosphate Synthase|Inositol-1-Phosphate Synthase|Cyclase, Inositol|Synthase, Myo-Inositol-1-Phosphate|Inositol 1 Phosphate Synthase|Synthase, Inositol-1-Phosphate|Inositol Cyclase|myo-inositol"
D016603,CHEMICAL,Eosinophilia-Myalgia Syndrome,"L-Tryptophan-Related Eosinophilia-Myalgia Syndromes|Trp|eosinophilia|Syndrome, L-Tryptophan-Related Eosinophilia-Myalgia|Eosinophilia Myalgia Syndrome|L-Tryptophan-Related Eosinophilia-Myalgia Syndrome|Eosinophilia-Myalgia Syndromes|Syndromes, L-Tryptophan-Related Eosinophilia-Myalgia|Eosinophilia-Myalgia Syndrome, L-Tryptophan-Related|L-tryptophan|Eosinophilia-Myalgia Syndromes, L-Tryptophan-Related|Syndrome, Eosinophilia-Myalgia, L-Tryptophan-Related|Syndrome, Eosinophilia-Myalgia|Syndromes, Eosinophilia-Myalgia"
C018524,CHEMICAL,"N,N-dimethylarginine [Supplementary Concept]",asymmetric dimethylarginine|Arginine/analogs  and  derivatives
D001216,CHEMICAL,Asparagine,L-asparagine|L-Asparagine
D007862,CHEMICAL,Phosphatidylcholine-Sterol O-Acyltransferase,"Acyltransferase, Lecithin|Cholesterol Ester Lysolecithin Acyltransferase|Phosphatidylcholine Sterol O Acyltransferase|O-Acyltransferase, Phosphatidylcholine-Sterol|Acyltransferase, Phosophatidylcholine-Sterol|Phosophatidylcholine Sterol Acyltransferase|Lecithin Acyltransferase|Acyltransferase, Lecithin Cholesterol|Lecithin Cholesterol Acyltransferase|phosphatidylcholine|Phosophatidylcholine-Sterol Acyltransferase|Cholesterol Acyltransferase, Lecithin"
C031570,CHEMICAL,2-hydroxybutyric acid [Supplementary Concept],Hydroxybutyrates|2-hydroxybutyric acid
D003404,CHEMICAL,Creatinine,"Creatinine Sulfate Salt|Salt, Creatinine Sulfate|Krebiozen|Sulfate Salt, Creatinine|creatinine"
D019289,CHEMICAL,Pyruvic Acid,"Acid, Pyruvic|Pyruvate|pyruvic acid"
C471253,CHEMICAL,L-glutamine 2-deoxy-scyllo-inosose aminotransferase [Supplementary Concept],Transaminases|L-glutamine
C420324,CHEMICAL,nangibotide [Supplementary Concept],Rhodamines|Oligopeptides|dodecanoic acid|Lauric Acids
C094930,CHEMICAL,"arginine, L-methionine, zinc drug combination [Supplementary Concept]",Zinc|L-methionine|l-methionine|Methionine|Arginine|Drug Combinations
NEW04194,CHEMICAL,L-tryptophan acid,L-tryptophan acid
NEW04195,MENTAL_HEALTH,Depression rating scores,Depression rating scores
NEW04196,NUTRITION,methionine Met cycle,methionine Met cycle
NEW04197,CHEMICAL,homocysteine ratio,homocysteine ratio
NEW04198,MENTAL_HEALTH,incident dementia,incident dementia
NEW04199,CHEMICAL,reactive oxygen species synthesis,reactive oxygen species synthesis
NEW04200,DISEASE,consequent impairment,consequent impairment
NEW04201,CHEBI,nicotinamide adenine dinucleotide phosphate-oxidase,nicotinamide adenine dinucleotide phosphate-oxidase
NEW04202,CHEMICAL,oxide reactive oxygen species synthesis,oxide reactive oxygen species synthesis
D020138,DISEASE,Hyperhomocysteinemia,Hyperhomocysteinemia|Hyperhomocysteinemias|hyperhomocysteinemia
NEW04203,DISEASE,memory motor coordination,memory motor coordination
NEW04204,CHEMICAL,melatonin pretreatment,melatonin pretreatment
NEW04205,CHEBI,peripheral glucocorticoid receptor agonist,peripheral glucocorticoid receptor agonist
NEW04206,DISEASE,stress-related behavioral deficits,stress-related behavioral deficits
NEW04207,CHEMICAL,UCR patients,UCR patients
NEW04208,MENTAL_HEALTH,greater anxiety,greater anxiety
NEW04209,MENTAL_HEALTH,chronic stress levels,chronic stress levels
NEW04210,DISEASE,systemic low-grade inflammation,systemic low-grade inflammation
NEW04211,CHEMICAL,depression-like behavior,DAB|depression-like behavior
NEW04212,CHEMICAL,fludrocortisone test,fludrocortisone test
NEW04213,MENTAL_HEALTH,essential relative resistance,essential relative resistance
NEW04214,CHEMICAL,Sutherlandia frutescens,Sutherlandia frutescens
NEW04215,CHEMICAL,Dexamethaone,Dexamethaone
NEW04216,MENTAL_HEALTH,disorder rats,disorder rats
NEW04217,CHEMICAL,GR inhibitor group,RU486|GR inhibitor group
NEW04218,DISEASE,male hypertensive rats,male hypertensive rats
NEW04219,CHEBI,GR agonist group,GR agonist group
NEW04220,CHEMICAL,GR agonist,GR agonist
NEW04221,CHEMICAL,DA levels,DA levels
NEW04222,DISEASE,POF disease stress model group,POF disease stress model group
NEW04223,CHEMICAL,low-drug,low-drug
NEW04224,MENTAL_HEALTH,CIS-induced depression animal models,CIS-induced depression animal models
NEW04225,CHEMICAL,glutamate levels,glutamate levels
NEW04226,CHEMICAL,glutamate kinase activity,GKA|glutamate kinase activity
NEW04227,MENTAL_HEALTH,maximum resistance,maximum resistance
NEW04228,CHEMICAL,guanine stacks,guanine stacks
NEW04229,CHEMICAL,consecutive nucleotides,consecutive nucleotides
NEW04230,MENTAL_HEALTH,pain depression,pain depression
NEW04231,DISEASE,hyperactive symptoms,hyperactive symptoms
NEW04232,CHEMICAL,Cerebral spinal fluid CSF magnesium,Cerebral spinal fluid CSF magnesium
NEW04233,MENTAL_HEALTH,treatment-resistant suicidal depression,treatment-resistant suicidal depression
NEW04234,CHEMICAL,magnesium treatment,magnesium treatment
NEW04235,MENTAL_HEALTH,agitated depression,agitated depression
NEW04236,CHEMICAL,anti-depressant imipramine,anti-depressant imipramine
NEW04237,CHEMICAL,Intravenous magnesium,Intravenous magnesium
NEW04238,CHEBI,common food additives,common food additives
NEW04239,CHEMICAL,inadequate brain magnesium,inadequate brain magnesium
D008708,DISEASE,Methemoglobinemia,Methemoglobinemia|Methemoglobinemias
NEW04240,CHEMICAL,oxygen transfer,oxygen transfer
NEW04241,DISEASE,Acquired methemoglobinemia,Acquired methemoglobinemia
NEW04242,CHEMICAL,Wide-scope target,Wide-scope target
NEW04243,CHEMICAL,Corticosterone administration,Corticosterone administration
NEW04244,CHEMICAL,Chronic corticosterone treatment,Chronic corticosterone treatment
NEW04245,CHEMICAL,adenosine A2A receptor antagonist,adenosine A2A receptor antagonist
NEW04246,DISEASE,breast cells,breast cells
NEW04247,CHEMICAL,β2-AR,β2-AR
NEW04248,DISEASE,prostate cancer metastasis formation,prostate cancer metastasis formation
NEW04249,CHEMICAL,cAMP signaling,cAMP signaling
NEW04250,MENTAL_HEALTH,baseline anxiety,baseline anxiety
D013732,MENTAL_HEALTH,Test Anxiety Scale,"test anxiety|anxiety scale|anxiety test|Questionnaires, Test Anxiety|Questionnaire, Test Anxiety|Test Anxiety Questionnaires|Test Anxiety Questionnaire|Test Anxiety Scales|Scales, Test Anxiety|Scale, Test Anxiety"
NEW04251,MENTAL_HEALTH,context-specific anxiety,context-specific anxiety
D063487,CHEBI,Prescription Drug Misuse,"Prescription Medicine Misuse|Non-Medical Use of Prescription Drugs|Prescription Medicine Misuses|Misuse, Prescription Drug|Medicine Misuse, Prescription|drug misuse|Non Medical Use of Prescription Drugs|Misuse, Prescription Medicine|Drug Misuse, Prescription|NMUPD"
NEW04252,CHEBI,drug cues,drug cues
D000066553,DISEASE,Problem Behavior,"Problem Behaviors|disruptive behaviors|Disruptive Behavior|Behavior, Psychology Dysfunctional|Behaviors, Problem|Problem, Behavioral|Behavior, Disruptive|Disruptive Behaviors|Behaviors, Psychology Dysfunctional|Behaviors, Disruptive|Behavior, Problem|Dysfunctional Behaviors, Psychology|Dysfunctional Behavior, Psychology|Psychology Dysfunctional Behaviors|Psychology Dysfunctional Behavior|Problems, Behavioral|Behavioral Problems|Behavioral Problem"
NEW04253,CHEMICAL,central nervous system norepinephrine,central nervous system norepinephrine
NEW04254,DISEASE,neuronal injury,neuronal injury
NEW04255,MENTAL_HEALTH,Alzheimer disease neuropathology,Alzheimer disease neuropathology
NEW04256,CHEMICAL,medullary catecholamines,medullary catecholamines
NEW04257,CHEMICAL,Prolonged β-adrenergic blockade,Prolonged β-adrenergic blockade
NEW04258,CHEMICAL,β-blockade,β-blockade
NEW04259,CHEBI,used beta-adrenergic blocker,used beta-adrenergic blocker
NEW04260,CHEMICAL,specific serotonin uptake blocker fluoxetine,specific serotonin uptake blocker fluoxetine
NEW04261,MENTAL_HEALTH,extent cataplexy,extent cataplexy
NEW04262,MENTAL_HEALTH,experimental cataplexy,experimental cataplexy
NEW04263,CHEMICAL,alpha-adrenoreceptor blocker clonidine,alpha-adrenoreceptor blocker clonidine
NEW04264,CHEMICAL,dopamine receptor blocker pimozide,dopamine receptor blocker pimozide
NEW04265,CHEMICAL,anticholinesterase physostigmine,anticholinesterase physostigmine
NEW04266,CHEMICAL,melatonin secretion,melatonin secretion
NEW04267,CHEMICAL,its's antidepressant effects,its's antidepressant effects
D004071,CHEMICAL,Digitalis Glycosides,"|digitalis|digitalis glycosides|Glycosides, Digitalis"
D001281,DISEASE,Atrial Fibrillation,"|Fibrillations, Familial Atrial|Persistent Atrial Fibrillation|Atrial Fibrillations, Paroxysmal|Atrial Fibrillation, Paroxysmal|Familial Atrial Fibrillation|Atrial Fibrillations, Persistent|paroxysmal atrial fibrillation|Atrial Fibrillation, Persistent|Fibrillation, Atrial|atrial fibrillation|Fibrillation, Persistent Atrial|Persistent Atrial Fibrillations|Fibrillation, Familial Atrial|Fibrillations, Paroxysmal Atrial|Fibrillation, Paroxysmal Atrial|Auricular Fibrillations|Fibrillations, Atrial|Paroxysmal Atrial Fibrillation|Paroxysmal Atrial Fibrillations|Fibrillations, Persistent Atrial|Fibrillation, Auricular|Familial Atrial Fibrillations|AF|Auricular Fibrillation|Atrial Fibrillations|Fibrillations, Auricular|Atrial Fibrillations, Familial|Atrial Fibrillation, Familial"
D004110,CHEMICAL,Diltiazem,Tiazac|Dilzem|Aldizem|Cardizem||CRD 401|Cardil|Dilacor XR|Diltiazem Hydrochloride|Dilacor|Dilren|CRD-401|Diltiazem Malate|diltiazem|CRD401
D015764,CHEMICAL,Bepridil,"|Bepridil, alpha Isomer|Vascor|Bepridil, (-)-Isomer|1978-CERM|Bedapin|Bepridil, (+)-Isomer|1978 CERM|Bepridil, alpha-Isomer|1978CERM|Unicordium|CERM-1978|Bepridil Monohydrochloride, alpha Isomer|CERM 1978|Bepridil Monohydrochloride|Monohydrochloride, alpha-Isomer Bepridil|Bepridil, (+-)-Isomer|CERM1978|Bepridil Monohydrochloride, alpha-Isomer|bepridil|Cordium|Bepridil Monohydrochloride, Monohydrate|Monohydrochloride, Bepridil|Bepadin"
D026941,CHEMICAL,Sodium Channel Blockers,"Channel Blocker, Sodium|Channel Inhibitors, Sodium|sodium channel blocker|Channel Inhibitor, Sodium|Sodium Channel Blocker|Sodium Channel Inhibitors|Inhibitors, Sodium Channel|Inhibitor, Sodium Channel|Sodium Channel Inhibitor|Blocker, Sodium Channel|Channel Blockers, Sodium"
NEW04268,CHEMICAL,µatm CO2,µatm CO2
NEW04269,CHEMICAL,GABAA-receptor agonist muscimol,GABAA-receptor agonist muscimol
NEW04270,CHEMICAL,altered Cl(- flux,altered Cl(- flux
D004958,CHEMICAL,Estradiol,"|17 beta Estradiol|Estradiol, (+-)-Isomer|17beta-estradiol|17 beta-Oestradiol|Estradiol, Sodium Salt|Estradiol Valeriante|Estradiol 17 alpha|17 beta Oestradiol|Ovocyclin|Estradiol, Monosodium Salt|Estradiol Hemihydrate|Estradiol, (8 alpha,17 beta)-(+-)-Isomer|Estradiol-17beta|Estradiol 17beta|Estradiol-17 alpha|Estradiol Anhydrous|Estradiol, (9 beta,17 beta)-Isomer|oestradiol|17 beta-Estradiol|Estradiol, (9 beta,17 alpha)-Isomer|Estradiol Hemihydrate, (17 alpha)-Isomer|Progynon Depot|Estradiol, (17-alpha)-Isomer|Vivelle|Estrace|Estraderm TTS|Estradiol-17 beta|Estradiol Monohydrate|Estradiol, (16 alpha,17 beta)-Isomer|Delestrogen|Estradiol 17 beta|Progynon-Depot|Aerodiol|Estradiol, (8 alpha,17 beta)-Isomer|Oestradiol|Estradiol Valerate|Progynova|Estradiol, (-)-Isomer|Estradiol, (16 alpha,17 alpha)-Isomer"
NEW04271,CHEMICAL,hippocampal serotonergic system,hippocampal serotonergic system
NEW04272,CHEMICAL,oestradiol treatment,oestradiol treatment
NEW04273,DISEASE,comorbid depressive symptoms,comorbid depressive symptoms
NEW04274,MENTAL_HEALTH,comorbid depression,comorbid depression
NEW04275,CHEMICAL,adjunctive oestradiol treatment,adjunctive oestradiol treatment
NEW04276,CHEMICAL,brain sex steroid receptors,brain sex steroid receptors
NEW04277,CHEMICAL,circulating sex steroid levels,circulating sex steroid levels
NEW04278,CHEMICAL,testosterone relative,testosterone relative
NEW04279,CHEMICAL,lower testosterone levels,lower testosterone levels
NEW04280,DISEASE,impaired cognition,impaired cognition
C107914,CHEBI,estrogen receptor-related receptor beta [Supplementary Concept],"oestrogen receptor|Receptors, Estrogen"
D001111,CHEMICAL,Arcuate Nucleus of Hypothalamus,"Infundibular Nucleus|Arcuate Nucleus|Nucleus, Arcuate|arcuate nucleus|Hypothalamus Arcuate Nucleus|ARC|Nucleus, Infundibular"
NEW04281,MENTAL_HEALTH,Antenatal depression,Antenatal depression
NEW04282,CHEMICAL,reduced cortisol levels,reduced cortisol levels
NEW04283,CHEMICAL,cortisol withdrawal,cortisol withdrawal
NEW04284,CHEBI,reproductive hormone,reproductive hormone
NEW04285,DISEASE,various chronic liver diseases,various chronic liver diseases
NEW04286,DISEASE,DCI administration,DCI administration
NEW04287,DISEASE,DCI treatment,DCI treatment
NEW04288,CHEMICAL,mg dydrogesterone tablets,mg dydrogesterone tablets
NEW04289,CHEMICAL,dydrogesterone treatment,dydrogesterone treatment
D004394,CHEMICAL,Dydrogesterone,dydrogesterone|6 Dehydro 9 beta 10 alpha progesterone|Dehydrogesterone|Duphaston|Isopregnenone|6-Dehydro-9 beta-10 alpha-progesterone|Dydrogesterone
NEW04290,CHEBI,topical oestrogens,topical oestrogens
NEW04291,DISEASE,oestrogen/progesterone receptor positive breast cancer,oestrogen/progesterone receptor positive breast cancer
NEW04292,DISEASE,TG secretion,TG secretion
D064386,DISEASE,Ankle Fractures,"Malleolus Fractures, Posterior|Ankle Fracture, Bimalleolar|Ankle Fractures, Trimalleolar|Fractures, Bimalleolar Ankle|Fractures, Trimalleolar Ankle|Bimalleolar Fracture|Malleolus Fractures, Medial|Posterior Malleolus Fracture|Fracture, Bimalleolar Equivalent|Lateral Malleolus Fractures|Ankle Fracture|Bimalleolar Equivalent Ankle Fractures|Ankle Fractures, Bimalleolar|Malleolus Fracture, Posterior|Equivalent Fracture, Bimalleolar|Fracture, Bimalleolar|Fractures, Medial Malleolus|Fracture, Lateral Malleolus|Fracture, Ankle|Malleolus Fracture, Lateral|Trimalleolar Fractures|Fracture, Trimalleolar|Ankle Fracture, Trimalleolar|Posterior Malleolus Fractures|Equivalent Fractures, Bimalleolar|Fractures, Lateral Malleolus|Bimalleolar Ankle Fractures|Fracture, Bimalleolar Ankle|Fracture, Trimalleolar Ankle|Bimalleolar Fractures|Fractures, Bimalleolar|Medial Malleolus Fractures|Malleolus Fractures, Lateral|Bimalleolar Ankle Fracture|Fractures, Trimalleolar|Fracture, Medial Malleolus|Fracture, Posterior Malleolus|Trimalleolar Fracture|Fractures, Ankle|Bimalleolar Equivalent Fractures|Lateral Malleolus Fracture|Medial Malleolus Fracture|fractures|Trimalleolar Ankle Fracture|Trimalleolar Ankle Fractures|Malleolus Fracture, Medial|Fractures, Bimalleolar Equivalent|Fractures, Posterior Malleolus|Bimalleolar Equivalent Fracture"
D019386,CHEMICAL,Alendronate,"|MK217|Alendronate|Alendronate Monosodium Salt, Trihydrate|MK-217|4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate|alendronate|Alendronate Sodium|Aminohydroxybutane Bisphosphonate|MK 217|Fosamax"
NEW04293,DISEASE,wrist fractures,wrist fractures
D000068296,CHEMICAL,Risedronic Acid,"1-Hydroxy-2-(3-pyridyl)ethylidene diphosphonate|Risedronate|Risedronate Sodium|Atelvia|Bisphosphonate Risedronate Sodium|Actonel|Risedronic Acid, Monosodium Salt|Sodium, Bisphosphonate Risedronate|2-(3-pyridinyl)-1-hydroxyethylidenebisphosphonate|Risedronate Sodium, Bisphosphonate|2-(3-pyridinyl)-1-hydroxyethylidene-bisphosphonate"
NEW04294,DISEASE,spine fractures,spine fractures
NEW04295,NUTRITION,platelet alpha 2-adrenoceptors,platelet alpha 2-adrenoceptors
NEW04296,CHEBI,endogenous oestrogen,endogenous oestrogen
NEW04297,NUTRITION,platelet alpha capacity,platelet alpha capacity
NEW04298,MENTAL_HEALTH,maternity blues,maternity blues
NEW04299,CHEBI,rational drug development,rational drug development
NEW04300,CHEMICAL,GS/noMS mothers,GS/noMS mothers
NEW04301,CHEMICAL,noGS/noMS,noGS/noMS
NEW04302,CHEMICAL,lower serum 17-beta-oestradiol levels,lower serum 17-beta-oestradiol levels
NEW04303,CHEMICAL,Benzodiazepine dependency,Benzodiazepine dependency
NEW04304,DISEASE,sleep disturbance,sleep disturbance
NEW04305,DISEASE,Secondary PCOS,Secondary PCOS
C535979,DISEASE,Congenital adrenal hyperplasia due to 21 hydroxylase deficiency [Supplementary Concept],"congenital adrenal hyperplasia|Adrenal Hyperplasia, Congenital|Congenital adrenal hyperplasia|21-hydroxylase deficiency|CAH"
NEW04306,DISEASE,Primary PCOS,Primary PCOS
NEW04307,CHEBI,adrenal androgen status,adrenal androgen status
NEW04308,CHEBI,mild adrenal androgen,mild adrenal androgen
NEW04309,DISEASE,adrenal hyperresponsiveness,adrenal hyperresponsiveness
NEW04310,CHEMICAL,increased cortisol clearance,increased cortisol clearance
C535739,DISEASE,Congenital disorder of glycosylation type 1A [Supplementary Concept],congenital disorder|Phosphotransferases (Phosphomutases)/deficiency|carbohydrate-deficient glycoprotein syndrome|Congenital Disorders of Glycosylation
NEW04311,CHEMICAL,17-hydroxyprogesterone production,17-hydroxyprogesterone production
D000858,DISEASE,Anovulation,Anovulations|anovulation
NEW04312,CHEBI,oestrogen levels,oestrogen levels
NEW04313,CHEBI,mild adrenal androgen excess,mild adrenal androgen excess
NEW04314,CHEMICAL,PACAP-PAC1 receptor pathway,PACAP-PAC1 receptor pathway
NEW04315,DISEASE,human male sexual behaviour,human male sexual behaviour
NEW04316,MENTAL_HEALTH,psychosexual orientation,psychosexual orientation
NEW04317,CHEBI,global endocrine dysregulation,global endocrine dysregulation
NEW04318,DISEASE,loss comorbidities,loss comorbidities
NEW04319,DISEASE,premenstrual syndrome-type symptoms,premenstrual syndrome-type symptoms
NEW04320,CHEBI,Endocrine therapy,Endocrine therapy
NEW04321,DISEASE,oestrogen receptor positive ER+ breast cancer,oestrogen receptor positive ER+ breast cancer
D006065,CHEMICAL,"Gonadotropins, Pituitary",Pituitary Gonadotropins|pituitary gonadotropins|gonadotropins
NEW04322,CHEMICAL,microg ethinylestradiol/3 drospirenone,microg ethinylestradiol/3 drospirenone
NEW04323,CHEBI,Luteinising hormone-releasing hormone antagonists,Luteinising hormone-releasing hormone antagonists
NEW04324,CHEMICAL,rapid testosterone suppression,rapid testosterone suppression
NEW04325,CHEMICAL,radioiodine,radioiodine
NEW04326,CHEMICAL,thionamides,thionamides
D018149,CHEMICAL,Glucose Intolerance,"Impaired Glucose Tolerances|glucose tolerance curves||glucose intolerance|Intolerance, Glucose|Intolerances, Glucose|Impaired Glucose Tolerance|Glucose Tolerance, Impaired|Glucose Tolerances, Impaired|glucose tolerances|Glucose Intolerances|impaired glucose tolerance|Tolerances, Impaired Glucose|Tolerance, Impaired Glucose"
NEW04327,CHEBI,endocannabinoid CB1 receptor antagonist,endocannabinoid CB1 receptor antagonist
NEW04328,CHEBI,Selective antagonists,Selective antagonists
D007752,DISEASE,"Obstetric Labor, Premature","Labor, Preterm|preterm labor|premature labor|Labor, Premature|Premature Labor|Premature Obstetric Labor|Labor, Premature Obstetric|Preterm Labor"
NEW04329,DISEASE,inflammatory disorders,inflammatory disorders
NEW04330,CHEBI,Non-tissue selective antagonists,Non-tissue selective antagonists
NEW04331,DISEASE,deficiency revolve,deficiency revolve
NEW04332,CHEMICAL,Hypo/achloridia,Hypo/achloridia
D018358,DISEASE,Neuroendocrine Tumors,"Tumors, Neuroendocrine|Neuroendocrine Tumor|Tumor, Neuroendocrine|neuroendocrine tumors"
NEW04333,CHEMICAL,serum gastrin levels,serum gastrin levels
D000082742,DISEASE,Heart Disease Risk Factors,"heart disease risk factors|Cardiovascular Risk|Risk Factor, Cardiovascular|Cardiovascular Risk Scores|Cardiovascular Risks|Residual Cardiovascular Risks|cardiovascular risk|Cardiovascular Risk, Residual|Risk Factors for Heart Disease|Factor, Cardiovascular Risk|Risk, Cardiovascular|Residual Cardiovascular Risk|Cardiovascular Risk Factor|Cardiovascular Risk Score|Score, Cardiovascular Risk|Cardiovascular Risk Factors|Risk, Residual Cardiovascular|Risk Factors for Cardiovascular Disease|Risk Score, Cardiovascular"
NEW04334,DISEASE,spinal cord demyelination,spinal cord demyelination
NEW04335,DISEASE,sensory-motor abnormalities,sensory-motor abnormalities
NEW04336,CHEBI,Vitamin B12 assay,Vitamin B12 assay
NEW04337,CHEBI,MTHFR T allele carriers,MTHFR T allele carriers
NEW04338,CHEMICAL,677CC genotype,677CC genotype
D015243,NUTRITION,"Cholesterol, VLDL","low-density lipoprotein cholesterol|Cholesterol, Pre-beta-Lipoprotein|Cholesterol, Prebetalipoprotein|Very Low Density Lipoprotein Cholesterol|Prebetalipoprotein Cholesterol|Pre beta Lipoprotein Cholesterol|Pre-beta-Lipoprotein Cholesterol|% low density lipoprotein cholesterol|VLDL Cholesterol|VLDL-cholesterol|low density lipoprotein cholesterol"
NEW04339,DISEASE,MTHFR A1298C,MTHFR A1298C
NEW04340,NUTRITION,folate level,folate level
NEW04341,DISEASE,SCZ groups,SCZ groups
NEW04342,CHEMICAL,omega-3 treatments,omega-3 treatments
NEW04343,CHEBI,Vitamin B(12 cobalamin deficiency,Vitamin B(12 cobalamin deficiency
NEW04344,CHEMICAL,nocturnal melatonin secretion,nocturnal melatonin secretion
NEW04345,CHEMICAL,low melatonin secretion,low melatonin secretion
NEW04346,CHEMICAL,metformin therapy,metformin therapy
NEW04347,DISEASE,incident peripheral neuropathy,incident peripheral neuropathy
NEW04348,CHEBI,parenteral vitamin B12 supplementation,parenteral vitamin B12 supplementation
NEW04349,CHEMICAL,elevated serum homocysteine,elevated serum homocysteine
NEW04350,CHEBI,Serum vitamin B12,Serum vitamin B12
NEW04351,CHEMICAL,homocysteine concentrations,homocysteine concentrations
NEW04352,CHEMICAL,Homocysteine levels,Homocysteine levels
NEW04353,MENTAL_HEALTH,Yale-Brown compulsion,Yale-Brown compulsion
NEW04354,CHEMICAL,higher homocysteine levels,higher homocysteine levels
NEW04355,CHEMICAL,Cbl deficiency,Cbl deficiency
NEW04356,CHEMICAL,certain amino acids,certain amino acids
NEW04357,CHEMICAL,phenylalanine hydroxylase enzyme,phenylalanine hydroxylase enzyme
NEW04358,DISEASE,PKU patients,PKU patients
NEW04359,DISEASE,cardiovascular problems,cardiovascular problems
C023894,CHEMICAL,methylcobalamin-coenzyme M methyltransferase [Supplementary Concept],Methyltransferases|methyl-B12|Archaeal Proteins
NEW04360,CHEBI,Maternal Vitamin B12 deficiency,Maternal Vitamin B12 deficiency
NEW04361,DISEASE,offspring neuropsychiatric disorders,offspring neuropsychiatric disorders
NEW04362,MENTAL_HEALTH,offspring ADHD,offspring ADHD
NEW04363,NUTRITION,n-6/n-3 fatty acid ratio,n-6/n-3 fatty acid ratio
D005229,NUTRITION,"Fatty Acids, Monounsaturated","Acids, Monounsaturated Fatty|Monounsaturated Fatty Acids|Fatty Acid, Monounsaturated|MUFAs|Acid, Monounsaturated Fatty|Monounsaturated Fatty Acid|monounsaturated fatty acid|monounsaturated fatty acids"
NEW04364,NUTRITION,serum saturated fatty acids,serum saturated fatty acids
NEW04365,CHEMICAL,inorganic phosphorous concentration,inorganic phosphorous concentration
C046441,CHEBI,"cyanocobalamin, pyridoxine, thiamine drug combination [Supplementary Concept]",cyanocobalamin|Vitamin B 12|Thiamine|vitamin B12|Pyridoxine|Drug Combinations
NEW04366,MENTAL_HEALTH,winter seasonal affective disorder,winter seasonal affective disorder
NEW04367,CHEBI,vitamin B12 serum levels,vitamin B12 serum levels
NEW04368,DISEASE,impairment symptoms,impairment symptoms
NEW04369,CHEBI,addictive drug,addictive drug
NEW04370,MENTAL_HEALTH,diagnosed depression,diagnosed depression
D000752,DISEASE,"Anemia, Pernicious","Addisons Anemia|Anemia, Addison|Pernicious Anemia|Anemia, Addison's|pernicious anemia|Addison Anemia|Anemia, Addisons|Addison's Anemia"
NEW04371,CHEBI,high-dosage folic acid,high-dosage folic acid
D058972,CHEBI,Folic Acid Transporters,"Folate Transporters|Proteins, Folate Transport|Folate Transport Proteins|Transporters, Folate|folic acid|Acid Transporters, Folic|Folic Acid Transport Proteins|Transporters, Folic Acid|Transport Proteins, Folate|folate transport"
NEW04372,CHEBI,low vitamin B12 status,low vitamin B12 status
NEW04373,DISEASE,primary immune thrombocytopenia,chronic immune thrombocytopenia|ITP|primary immune thrombocytopenia
NEW04374,CHEMICAL,working life/studies,working life/studies
NEW04375,CHEMICAL,acetaminophen overdose,acetaminophen overdose
C558827,CHEMICAL,N-acetyl cysteine proline cysteine amide [Supplementary Concept],N- Acetyl Cysteine|Oligopeptides|Sulfhydryl Compounds
NEW04376,DISEASE,Serious toxicities,Serious toxicities
D006464,CHEMICAL,Hemoperfusion,Hemoperfusions|Hemoperfusion|Hemosorptions|Hemosorption
NEW04377,CHEMICAL,caffeine abuse,caffeine abuse
NEW04378,CHEMICAL,caffeine intake,caffeine intake
NEW04379,MENTAL_HEALTH,major depression patients,major depression patients
NEW04380,DISEASE,diagnostic groups,DSM-III-R criteria|diagnostic groups
NEW04381,MENTAL_HEALTH,anxiety patients,anxiety patients
NEW04382,CHEMICAL,high caffeine users,high caffeine users
NEW04383,MENTAL_HEALTH,factor depression,factor depression
NEW04384,CHEMICAL,caffeine consumption,caffeine consumption
NEW04385,CHEMICAL,excessive caffeine consumption,excessive caffeine consumption
NEW04386,MENTAL_HEALTH,reactions gene expression,reactions gene expression
NEW04387,DISEASE,combat-stress reaction,combat-stress reaction
NEW04388,CHEMICAL,caffeine withdrawal,caffeine withdrawal
NEW04389,DISEASE,humans caffeinism,humans caffeinism
NEW04390,MENTAL_HEALTH,refractory psychosis,refractory psychosis
NEW04391,CHEMICAL,concomitant alcohol intake,concomitant alcohol intake
NEW04392,CHEMICAL,CLZ adverse reactions,CLZ adverse reactions
NEW04393,MENTAL_HEALTH,short-lasting hyperactivity,short-lasting hyperactivity
NEW04394,DISEASE,depressive effects,depressive effects
NEW04395,MENTAL_HEALTH,anxiety breaks,anxiety breaks
NEW04396,MENTAL_HEALTH,anxiety attacks,anxiety attacks
D000069956,CHEMICAL,Chocolate,"Chocolates|Cocoa Powder|Cocoa Powders|chocolate|cocoa|Powders, Cocoa|Powder, Cocoa"
NEW04397,DISEASE,PD probands,PD probands
NEW04398,CHEMICAL,week alcohol problems,week alcohol problems
NEW04399,MENTAL_HEALTH,dependence risk,dependence risk
NEW04400,CHEMICAL,chronic caffeine exposure,chronic caffeine exposure
NEW04401,DISEASE,French psychiatric patients,French psychiatric patients
NEW04402,MENTAL_HEALTH,anxiety disturbance,anxiety disturbance
NEW04403,CHEMICAL,Synthetic caffeine,Synthetic caffeine
NEW04404,DISEASE,cardiovascular function,cardiovascular function
NEW04405,CHEMICAL,greater caffeine intake,greater caffeine intake
NEW04406,DISEASE,SGAP-induced weight gain,SGAP-induced weight gain
NEW04407,DISEASE,glucose dysregulation,glucose dysregulation
NEW04408,CHEBI,glucagon-like peptide-1 receptor agonists,glucagon-like peptide-1 receptor agonists
NEW04409,DISEASE,antipsychotic-associated body weight gain,antipsychotic-associated body weight gain
NEW04410,CHEMICAL,Glucagon-like peptide-1 receptor agonists,Glucagon-like peptide-1 receptor agonists|GLP-1RAs
NEW04411,DISEASE,effective weight reduction interventions,effective weight reduction interventions
NEW04412,CHEMICAL,aripiprazole augmentation,aripiprazole augmentation
NEW04413,CHEMICAL,d-fenfluramine,d-fenfluramine
NEW04414,CHEMICAL,glucose levels,glucose levels
NEW04415,CHEBI,Glucagon-like peptide-1 receptor agonists,Glucagon-like peptide-1 receptor agonists
NEW04416,DISEASE,diabetes studies,diabetes studies
NEW04417,DISEASE,obesity treatment,obesity treatment
NEW04418,CHEBI,Peptide-1 Receptor Agonists,Peptide-1 Receptor Agonists
NEW04419,DISEASE,NAFLD/NASH,NAFLD/NASH
NEW04420,DISEASE,Cardiovascular Disease CVD morbidity,Cardiovascular Disease CVD morbidity
D053767,CHEMICAL,Glucagon-Like Peptide 2,Glucagon|Glucagon-Like Peptide-2 (1-33)|Proglucagon (126-158)|glucagon|Glucagon Like Peptide 2|hyperglucagonemia
NEW04421,CHEMICAL,co- Transporter-2 inhibitors,co- Transporter-2 inhibitors
NEW04422,CHEBI,Glucagon-like peptide-1 GLP-1 receptor agonists,Glucagon-like peptide-1 GLP-1 receptor agonists
NEW04423,DISEASE,favorable psychiatric adverse event profiles,favorable psychiatric adverse event profiles
NEW04424,CHEMICAL,GLP-1 receptor agonists,GLP-1 receptor agonists
NEW04425,CHEMICAL,oral semaglutide,oral semaglutide
D000068900,CHEMICAL,Sitagliptin Phosphate,"4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine|Monophosphate Monohydrate, Sitagliptin|Sitagliptin Phosphate Monohydrate|Sitagliptin Phosphate Anhydrous|Anhydrous, Sitagliptin Phosphate|Januvia|Phosphate Anhydrous, Sitagliptin|0431, MK|Sitagliptin Monophosphate Monohydrate|Monohydrate, Sitagliptin Monophosphate|Monohydrate, Sitagliptin Phosphate|Phosphate, Sitagliptin|MK 0431|MK-0431|sitagliptin|MK0431|Phosphate Monohydrate, Sitagliptin|Sitagliptin"
C570240,CHEMICAL,empagliflozin [Supplementary Concept],Benzhydryl Compounds|empagliflozin|Glucosides
NEW04426,CHEBI,necessary drug intervention,necessary drug intervention
NEW04427,DISEASE,loss potential,loss potential
C534611,CHEMICAL,rGLP-1 protein [Supplementary Concept],Albiglutide|Glucagon-Like Peptide 1/analogs  and  derivatives
NEW04428,DISEASE,MACE infarction events,MACE infarction events
C479460,CHEMICAL,lixisenatide [Supplementary Concept],Peptides|Lixisenatide
NEW04429,CHEMICAL,once-weekly semaglutide,once-weekly semaglutide
NEW04430,DISEASE,stroke events,stroke events
NEW04431,DISEASE,cardiovascular deaths,cardiovascular deaths
NEW04432,CHEMICAL,glucagon-like peptide-1 receptor agonists,glucagon-like peptide-1 receptor agonists|GLP-1 RAs
NEW04433,DISEASE,T2DM patients,T2DM patients
NEW04434,CHEMICAL,metformin monotherapy,metformin monotherapy
NEW04435,CHEBI,different antidiabetic drug monotherapies,different antidiabetic drug monotherapies
NEW04436,CHEBI,glucagon-like peptide receptor agonists,glucagon-like peptide receptor agonists
NEW04437,CHEMICAL,Alcohol neurotoxicity,Alcohol neurotoxicity
NEW04438,DISEASE,Alcoholic organic brain disease,Alcoholic organic brain disease
NEW04439,CHEMICAL,ethanol neurotoxicity,ethanol neurotoxicity
NEW04440,CHEBI,nutritional thiamine deficiency,nutritional thiamine deficiency
NEW04441,DISEASE,alcoholism-associated dysfunction,alcoholism-associated dysfunction
NEW04442,CHEMICAL,alcohol dependents,alcohol dependents
NEW04443,DISEASE,Such cognitive disorders,Such cognitive disorders
NEW04444,CHEMICAL,controlled alcohol consumption,controlled alcohol consumption
NEW04445,DISEASE,alcohol-related cognitive deficits,alcohol-related cognitive deficits
NEW04446,DISEASE,profound anterograde memory deficit,profound anterograde memory deficit
D020915,DISEASE,Korsakoff Syndrome,"Korsakoff Psychoses|Korsakoff syndrome|Wernicke Korsakoff Syndrome|Korsakoff Psychosis|Wernicke-Korsakoff Syndromes|Psychoses, Korsakoff|Wernicke-Korsakoff Syndrome|Psychosis, Korsakoff"
D000076042,DISEASE,Alcoholic Korsakoff Syndrome,"Wernicke-Korsakoff syndrome|WKS|Korsakoff Syndrome, Alcoholic|Alcohol-Induced Korsakoff Syndrome|Wernicke-Korsakoff Syndrome, Alcoholic|Alcoholic Wernicke-Korsakoff Syndrome|Alcohol Induced Korsakoff Syndrome|Korsakoff Syndrome, Alcohol-Induced|Alcoholic Wernicke Korsakoff Syndrome|Wernicke-Korsakoff Syndrome"
NEW04447,MENTAL_HEALTH,unrecognized schizophrenia,unrecognized schizophrenia
NEW04448,MENTAL_HEALTH,malnourishment due poisoning delusions,malnourishment due poisoning delusions
D019947,CHEMICAL,"Receptors, Interleukin-6","Receptor, Interleukin-6|Receptors, IL 6|IL-6 Receptors|Interleukin 6 Receptors|IL 6 Receptors|Interleukin 6 Receptor|Receptors, Interleukin 6|IL6 Receptor|IL 6 Receptor|Receptor, Interleukin 6|Interleukin-6 Receptor|Interleukin-6 Receptors|Receptor, IL6|IL-6 Receptor|interleukin-6|Receptor, IL-6|IL6 Receptors|Receptors, IL6|Receptors, IL-6"
D005911,DISEASE,Gliosis,"Glial Scar|Astrogliosis|Astrocytoses|Glial Scars|gliosis|Astrocytosis|Scar, Glial|astrocytosis"
NEW04449,CHEMICAL,phosphate esters,phosphate esters
NEW04450,CHEBI,vitamin deficit,vitamin deficit
NEW04451,CHEMICAL,urea metabolism,urea metabolism
D012202,DISEASE,Reye Syndrome,"|Reye's Like Syndrome|Adult Reye Syndrome|Reye Johnson Syndrome|Reye's Syndrome, Adult|Reye|Reye-Johnson Syndrome|Reye's syndrome|Reye's-Like Syndrome|Reye Syndrome, Adult|Fatty Liver with Encephalopathy|Reye's Syndrome|Reye-Like Syndrome|Reye Like Syndrome|Adult Reye's Syndrome"
NEW04452,DISEASE,neonatal congenital lactic acidosis,neonatal congenital lactic acidosis
D015324,CHEMICAL,Pyruvate Carboxylase Deficiency Disease,"Ataxia with Lactic Acidosis 2|Ataxia with Lactic Acidosis II|Lactic Acidosis with Ataxia, Type II|Pyruvate Carboxylase Deficiency|Deficiency Disease, Pyruvate Carboxylase|Deficiency, Pyruvate Carboxylase|pyruvate carboxylase deficiency|Type II Ataxia with Lactic Acidosis|Ataxia with Lactic Acidosis, Type II"
NEW04453,DISEASE,Hyperlactacidemia,Hyperlactacidemia
NEW04454,CHEBI,decreased beta hydroxybutyrate/acetoacetate ratio,decreased beta hydroxybutyrate/acetoacetate ratio
NEW04455,CHEMICAL,lactate/pyruvate ratio,lactate/pyruvate ratio
NEW04456,CHEMICAL,pentose cycle,pentose cycle
NEW04457,DISEASE,send-out cerebrospinal fluid autoimmune encephalitis panel,send-out cerebrospinal fluid autoimmune encephalitis panel
NEW04458,CHEMICAL,neuronal inositol triphosphate receptor,neuronal inositol triphosphate receptor
D007069,CHEMICAL,Ifosfamide,"|NSC 109724|NSC 109,724|Isofosfamide|Iso-Endoxan|Isophosphamide|NSC109724|Ifosfamide|Iphosphamide|NSC109,724|NSC-109,724|Iso Endoxan|Asta Z 4942|Holoxan|ifosfamide|NSC-109724"
NEW04459,CHEBI,vitamin malnutrition,vitamin malnutrition
NEW04460,CHEBI,vitamin deficiency syndromes,vitamin deficiency syndromes
D046915,CHEMICAL,Penicillin-Binding Proteins,"Penicillin Binding Protein 5|Synthetase, Peptidoglycan|Penicillin|Penicillin Binding Protein 2a|Penicillin-Binding Protein 4|Penicillin-Binding Protein 2|Penicillin-Binding Protein 5|Penicillin-Binding Protein 1|Penicillin Binding Proteins|Penicillin-Binding Protein 1b|Penicillin-Binding Protein 2a|Penicillin-Binding Protein|Penicillin-Binding Protein 6|Protein 1A, Penicillin-Binding|Penicillin Binding Protein|Penicillin Binding Protein 1b|Penicillin Binding Protein 6|Penicillin Binding Protein 4|Penicillin Binding Protein 1|Penicillin Binding Protein 2b|Penicillin-Binding Protein 3|Penicillin-Binding Protein 2b|Penicillin Binding Protein 7|Penicillin Binding Protein 2|Penicillin Binding Protein 3|penicillin|Proteins, Penicillin-Binding|Penicillin Binding Protein 1A|Penicillin-Binding Protein 7|Penicillin-Binding Protein 1A|Peptidoglycan Synthetase|Penicillin-Binding Protein-2a|Protein 1b, Penicillin-Binding"
NEW04461,DISEASE,cerebral pellagra,cerebral pellagra
D006778,DISEASE,"Hospitals, Psychiatric","Psychiatric Hospital|Institutions, Mental|Hospital, Psychiatric|Mental Hospitals|Mental Institutions|Mental Institution|Hospital, Mental|Mental Hospital|Institution, Mental|Psychiatric Hospitals|psychiatric hospitals|Hospitals, Mental"
NEW04462,DISEASE,syphilitic general paralysis,syphilitic general paralysis
C021864,CHEBI,nicotinate phosphoribosyltransferase [Supplementary Concept],nicotinic acid|Pentosyltransferases
D055677,DISEASE,Refeeding Syndrome,"Syndrome, Refeeding|refeeding syndrome"
D006996,DISEASE,Hypocalcemia,|hypocalcemia|Hypocalcemias|Hypocalcemia
D000308,DISEASE,Adrenocortical Hyperfunction,"Hyperfunction, Adrenocortical|Hypercorticism|Hyperfunction, Adrenal Gland|Hyperadrenalism|Hyperadrenocorticism|hypercorticism|Adrenal Gland Hyperfunction"
NEW04463,CHEBI,hormone status,hormone status
NEW04464,DISEASE,self-neglect abuse,self-neglect abuse
NEW04465,CHEBI,immediate vitamin replacement,immediate vitamin replacement
NEW04466,DISEASE,impaired consciousness,impaired consciousness
NEW04467,CHEBI,thiamine pyrophosphate deficiency,thiamine pyrophosphate deficiency
D007655,CHEMICAL,Ketoglutarate Dehydrogenase Complex,"Oxoglutarate Dehydrogenase|Complex, alpha-Ketoglutarate Dehydrogenase|2-Keto-4-Hydroxyglutarate Dehydrogenase|Dehydrogenase, 2-Oxoglutarate|Dehydrogenase Complex, alpha-Ketoglutarate|Complex, 2-Oxoglutarate Dehydrogenase|Dehydrogenase, 2-Keto-4-Hydroxyglutarate|2-Oxoglutarate Dehydrogenase Complex|Dehydrogenase Complex, 2-Oxoglutarate|alpha Ketoglutarate Dehydrogenase|alpha Ketoglutarate Dehydrogenase Complex|alpha-Ketoglutarate Dehydrogenase Complex|Dehydrogenase, Oxoglutarate|2 Oxoglutarate Dehydrogenase|2-Oxoglutarate Dehydrogenase|Complex, Ketoglutarate Dehydrogenase|2 Keto 4 Hydroxyglutarate Dehydrogenase|ketoglutarate dehydrogenase|Dehydrogenase Complex, Ketoglutarate|alpha-Ketoglutarate Dehydrogenase|Dehydrogenase, alpha-Ketoglutarate|2 Oxoglutarate Dehydrogenase Complex"
D030481,CHEMICAL,Pyruvate Dehydrogenase (Lipoamide),Pyruvate Dehydrogenase-E1|Pyruvate Decarboxylase (Lipoamide)|Pyruvate Dehydrogenase Component E1|pyruvate dehydrogenase|Pyruvate Dehydrogenase E1
NEW04468,CHEMICAL,subclinical Zn excess,subclinical Zn excess
NEW04469,DISEASE,overt neuronal impairment,overt neuronal impairment
NEW04470,DISEASE,TD deficits,TD deficits
NEW04471,CHEMICAL,acetyl-CoA/acetylcholine metabolism,acetyl-CoA/acetylcholine metabolism
NEW04472,DISEASE,mild TD,mild TD
NEW04473,CHEMICAL,non-harmful border-line Zn excitotoxic signals,non-harmful border-line Zn excitotoxic signals
NEW04474,NUTRITION,Reduced thiamine,Reduced thiamine
NEW04475,CHEBI,"agonist (RS)-3,5-dihydroxyphenylglycine","agonist (RS)-3,5-dihydroxyphenylglycine"
NEW04476,DISEASE,NMDAR-dependent long-term depression,LTD|NMDAR-dependent long-term depression
NEW04477,MENTAL_HEALTH,mGluR-dependent long-term depression,mGluR-dependent long-term depression
NEW04478,DISEASE,specific deficiency syndrome,specific deficiency syndrome
D007383,DISEASE,Intermittent Claudication,"|Claudication, Intermittent|intermittent claudication"
D005348,DISEASE,Fibrocystic Breast Disease,"Adenoses, Microglandular|Breast Disease, Fibrocystic|Microglandular Adenoses|Microglandular Adenosis|Breast Cystic Diseases|Fibrocystic Disease of Breast|Breast Cystic Disease|Dysplasia, Mammary|Breast Fibrocystic Changes|Cystic Disease of Breast|Cystic Mastitis, Chronic|Fibrocystic Mastopathy|Chronic Cystic Mastitis|Dysplasia, Breast|fibrocystic breast disease|Mammary Dysplasia|Breast Dysplasia|Breast Adenosis|Breast Fibrocystic Disease|Breast Fibrocystic Change|Mastopathy, Fibrocystic|Adenosis, Microglandular|Disease, Fibrocystic Breast|Adenosis of Breast|Breast Disease, Cystic|Fibrocystic Changes of Breast|Disease, Cystic Breast|Cystic Breast Disease"
NEW04479,CHEMICAL,Sodium benzoate therapy,Sodium benzoate therapy
C016030,CHEMICAL,pantogab [Supplementary Concept],Calcium hopantenate|Pantothenic Acid/analogs  and  derivatives|gamma-Aminobutyric Acid/analogs  and  derivatives|calcium hopantenate
NEW04480,DISEASE,behavior abnormalities,behavior abnormalities
C536351,DISEASE,"Visceral Steatosis, Congenital [Supplementary Concept]",Fatty Liver|hepatic steatosis
NEW04481,NUTRITION,pantothenic acid antagonist,pantothenic acid antagonist
D010205,NUTRITION,Pantothenic Acid,"Vitamin B5|B5, Vitamin|Dexol|B 5, Vitamin|Pantothenate, Zinc|pantothenic acid|Zinc Pantothenate|Pantothenate, Calcium|Vitamin B 5|vitamin B5|Calcium Pantothenate"
C480564,CHEMICAL,coumaryl gamma-amino-butyric acid diazopyruvate [Supplementary Concept],γ-amino butyric acid|Pyruvates|Coumarins|Aminobutyrates|gamma-amino butyric acid
NEW04482,CHEMICAL,selective receptor agonist lorcaserin,selective receptor agonist lorcaserin
NEW04483,CHEMICAL,serotonin releasers,serotonin releasers
D058826,CHEBI,Serotonin 5-HT2 Receptor Agonists,"Serotonin 5 HT2 Receptor Agonists|5 HT2B Agonist|5 HT2A Agonist|5-HT2A Agonist|5 HT2 Agonists|Serotonin 5 HT2B Receptor Agonists|5-HT2C Agonist|Serotonin 5-HT2C Receptor Agonists|Agonists, 5-HT2|5-HT2 Agonists|5 HT2C Agonist|Serotonin 5 HT2A Receptor Agonists|Agonist, 5-HT2C|5-HT2 Agonist|Serotonin 5-HT2B Receptor Agonists|Agonist, 5-HT2A|Agonist, 5-HT2B|5-HT2C receptor agonists|Serotonin 5 HT2C Receptor Agonists|Serotonin 5-HT2A Receptor Agonists|5-HT2B Agonist|5 HT2 Agonist|Agonist, 5-HT2|5-HT2A agonist"
NEW04484,CHEMICAL,(dex)fenfluramine,(dex)fenfluramine
NEW04485,DISEASE,feeding weight gain,feeding weight gain
NEW04486,MENTAL_HEALTH,pediatric depression,pediatric depression
NEW04487,MENTAL_HEALTH,multiple different anxiety disorders,multiple different anxiety disorders
NEW04488,DISEASE,obsessive beliefs,obsessive beliefs
NEW04489,CHEMICAL,noradrenaline nervous system,noradrenaline nervous system
NEW04490,NUTRITION,alpha antagonist,alpha antagonist
D043887,CHEMICAL,"Receptor, Cholecystokinin B","Cholecystokinin|cholecystokinin|CCK-B Receptor|Receptors, Gastrin|CCK2 Receptor|Cholecystokinin-2 Receptor|B Receptor, Cholecystokinin|Receptor, CCK2|Receptors, CCK-B|Cholecystokinin 2 Receptor|Gastrin Receptors|Receptor, CCK B|Gastrin Receptor|Receptor, Cholecystokinin-2|Receptor, CKK-2|Receptor, CCK-B|Receptor, Gastrin|CCK-B Receptors|CKK-2 Receptor|CCK B Receptor|Cholecystokinin B Receptor|CKK 2 Receptor|CCK B Receptors"
NEW04491,CHEBI,psycho-stimulant drug,psycho-stimulant drug
NEW04492,DISEASE,vivid psychotic,vivid psychotic
NEW04493,MENTAL_HEALTH,cataplexy production,cataplexy production
NEW04494,DISEASE,neuropsychiatric diseases,neuropsychiatric diseases
NEW04495,CHEMICAL,GABA genes,GABA genes
NEW04496,CHEMICAL,surprising NMDA receptor downregulation,surprising NMDA receptor downregulation
NEW04497,CHEBI,SSRI treatment,SSRI treatment
NEW04498,DISEASE,cardiometabolic alterations,cardiometabolic alterations
NEW04499,CHEBI,Perinatal SSRI exposure,Perinatal SSRI exposure
NEW04500,DISEASE,perinatal SSRI-induced behavioral abnormalities,perinatal SSRI-induced behavioral abnormalities
NEW04501,DISEASE,complex psychiatric disorder,complex psychiatric disorder
NEW04502,MENTAL_HEALTH,seasonal winter depression,seasonal winter depression
NEW04503,CHEMICAL,escitalopram mg,escitalopram mg
NEW04504,CHEBI,SSRI paroxetine,SSRI paroxetine
NEW04505,CHEMICAL,circulating irisin levels,circulating irisin levels
NEW04506,CHEMICAL,Post-SSRI sexual-dysfunction,Post-SSRI sexual-dysfunction
NEW04507,DISEASE,iatrogenic syndrome,iatrogenic syndrome
NEW04508,MENTAL_HEALTH,instance sexual dysfunction,instance sexual dysfunction
NEW04509,CHEMICAL,Selective serotonin 5-hydroxytryptamine reuptake inhibitors,Selective serotonin 5-hydroxytryptamine reuptake inhibitors
D000083302,DISEASE,Hemorrhagic Stroke,"Hemorrhagic Stroke, Intracerebral|Subarachnoid Hemorrhagic Strokes|Stroke, Intracerebral Hemorrhagic|Subarachnoid Hemorrhagic Stroke|Intracerebral Hemorrhagic Stroke|Hemorrhagic Stroke, Subarachnoid|Hemorrhagic Strokes|Stroke, Intracerebral Hemorrhage|hemorrhagic stroke|Intracerebral Hemorrhage Stroke|intracerebral hemorrhage|Stroke, Hemorrhagic|Hemorrhage Stroke, Intracerebral|Intracerebral Hemorrhage Strokes|Intracerebral Hemorrhagic Strokes|Stroke, Subarachnoid Hemorrhagic"
D006475,DISEASE,Vitamin K Deficiency Bleeding,Newborn Hemorrhagic Disease|Newborn Hemorrhagic Diseases|bleeding|Hemorrhagic Disease of Newborn
NEW04510,DISEASE,UK CSM,UK CSM
NEW04511,CHEMICAL,Serotonin neurotransmission,Serotonin neurotransmission
NEW04512,DISEASE,Bipolar depressions,Bipolar depressions
NEW04513,CHEBI,mood stabilizer,mood stabilizer
NEW04514,CHEMICAL,carbamazapine,carbamazapine
NEW04515,CHEMICAL,dopamine function,dopamine function
NEW04516,DISEASE,Behavioral addictions,Behavioral addictions
NEW04517,CHEMICAL,SSRIs paroxetine,SSRIs paroxetine
NEW04518,DISEASE,OCD similar efficacy,OCD similar efficacy
NEW04519,CHEMICAL,Fluvoxamine weeks,Fluvoxamine weeks
D057215,MENTAL_HEALTH,Body Dysmorphic Disorders,"BDD|Body Image Disorders|Body Image Disfunctions|Body Image Disfunction|Disorder, Body Dysmorphic|Image Disfunction, Body|Image Disorders, Body|Dysmorphic Disorder, Body|body dysmorphic disorder|dysmorphic disorder|Disfunctions, Body Image|Disfunction, Body Image|Disorders, Body Dysmorphic|Disorders, Body Image|Body Image Disorder|Dysmorphic Disorders, Body|Image Disfunctions, Body|Body Dysmorphic Disorder"
D014256,MENTAL_HEALTH,Trichotillomania,Trichotillomanias|Trichotillomania|trichotillomania|TTM
NEW04520,CHEMICAL,central serotonin function,central serotonin function
NEW04521,CHEMICAL,acetylcholine systems,acetylcholine systems
NEW04522,MENTAL_HEALTH,pathological anxiety,pathological anxiety
NEW04523,CHEBI,SSRI fluvoxamine,SSRI fluvoxamine
NEW04524,DISEASE,unipolar major depression,unipolar major depression|DSM-III-R
NEW04525,DISEASE,status cataplecticus,status cataplecticus
NEW04526,MENTAL_HEALTH,cataplexy attacks due,cataplexy attacks due
NEW04527,CHEBI,dopamine reuptake inhibitor,dopamine reuptake inhibitor
NEW04528,CHEBI,SSRI concomitant therapies,SSRI concomitant therapies
NEW04529,DISEASE,MP misuse,MP misuse
NEW04530,DISEASE,male ASD cases,male ASD cases
NEW04531,CHEMICAL,higher platelet 5-HT content,higher platelet 5-HT content
NEW04532,CHEMICAL,serotonin 5-HT reuptake,serotonin 5-HT reuptake
NEW04533,DISEASE,behavioral impairments,behavioral impairments
NEW04534,DISEASE,behavioral dysfunctions,behavioral dysfunctions
NEW04535,CHEMICAL,serotonin transmission,serotonin transmission
NEW04536,DISEASE,multiple depressive phenotypes,multiple depressive phenotypes
NEW04537,CHEMICAL,antidepressant citalopram,CIT|antidepressant citalopram
NEW04538,MENTAL_HEALTH,various phobias,various phobias
NEW04539,MENTAL_HEALTH,central nervous system affective disorders,central nervous system affective disorders
NEW04540,CHEMICAL,gamma-aminobutyric acid pathways,gamma-aminobutyric acid pathways
D001007,DISEASE,Anxiety,"Social Anxieties|Hypervigilance|Angst|Anxieties, Social|Anxiety, Social|nervousness|Anxiousness|Social Anxiety|Nervousness|hypervigilance"
NEW04541,CHEMICAL,Haldol    Decanoate long-acting injectable,Haldol    Decanoate long-acting injectable
NEW04542,DISEASE,refractory PE,refractory PE
NEW04543,MENTAL_HEALTH,prevalent mental illness,prevalent mental illness
NEW04544,CHEMICAL,intranasal OXT,intranasal OXT
NEW04545,CHEMICAL,Oxytocin treatment,Oxytocin treatment
NEW04546,MENTAL_HEALTH,comorbid unipolar depression,comorbid unipolar depression
NEW04547,MENTAL_HEALTH,Acute anxiety,Acute anxiety
NEW04548,CHEMICAL,benzodiazepine treatment,benzodiazepine treatment
NEW04549,MENTAL_HEALTH,pediatric anxiety,pediatric anxiety
NEW04550,DISEASE,Premenstrual Disorders,Premenstrual Disorders
NEW04551,CHEMICAL,Syst Rev 2:CD001396,Syst Rev 2:CD001396
NEW04552,NUTRITION,cholesterol ATP-binding cassette transporter,cholesterol ATP-binding cassette transporter
C536595,MENTAL_HEALTH,Alzheimer disease type 2 [Supplementary Concept],late-onset Alzheimer disease|Alzheimer Disease
D053661,CHEMICAL,Interleukin-13 Receptor alpha1 Subunit,"Antigen, CD213a1|α1|Interleukin-13 Receptor alpha1 Chain|CD213a1 Antigens|Antigens, CD213a1|CD213a1 Antigen|Interleukin 13 Receptor alpha1 Chain|Interleukin-4, 13 Receptor Shared Subunit|Interleukin 4, 13 Receptor Shared Subunit|IL-13Ralpha1|Interleukin 13 Receptor alpha1 Subunit"
NEW04553,CHEMICAL,Alpha-1-adrenergic antagonist prazosin,Alpha-1-adrenergic antagonist prazosin
NEW04554,MENTAL_HEALTH,anxiety disorders related,anxiety disorders related
NEW04555,CHEMICAL,catecholamine secretion,catecholamine secretion
NEW04556,CHEBI,antagonist AM251,antagonist AM251
NEW04557,CHEMICAL,Chronic AM251,Chronic AM251
NEW04558,DISEASE,chronic PCP,chronic PCP
NEW04559,DISEASE,excessive weight gain,excessive weight gain
NEW04560,CHEMICAL,antidepressant effectiveness,antidepressant effectiveness
D002186,CHEMICAL,Cannabinoids,Cannabinoid|Cannabinoids
NEW04561,CHEMICAL,JZL184 MAGL inhibitor,JZL184 MAGL inhibitor
NEW04562,DISEASE,marble burying behavior,marble burying behavior
NEW04563,CHEMICAL,anandamide transport inhibitor N-(4-hydroxyphenyl)-arachidonamide,AM404|anandamide transport inhibitor N-(4-hydroxyphenyl)-arachidonamide
NEW04564,DISEASE,mild hypokinesia,mild hypokinesia
NEW04565,DISEASE,juvenile hypertensive rats,juvenile hypertensive rats
NEW04566,CHEBI,CB1 cannabinoid receptor antagonist,CB1 cannabinoid receptor antagonist
NEW04567,CHEMICAL,catecholamine determinations,catecholamine determinations
NEW04568,CHEBI,corelating hormone cortisol,corelating hormone cortisol
NEW04569,CHEMICAL,Low melatonin levels,Low melatonin levels
D060545,DISEASE,Pudendal Neuralgia,"Pudendal Neuropathy|Pudendal Canal Entrapment Syndrome|Pudendal Nerve Entrapment Syndrome|Entrapment, Pudendal Nerve|neuralgia|Pudendal Nerve Entrapments|Nerve Entrapment, Pudendal|Neuralgia, Pudendal|Neuropathy, Pudendal|Pudendal Neuralgias|Entrapments, Pudendal Nerve|Pudendal Neuropathies|Neuralgias, Pudendal|Neuropathies, Pudendal|Pudendal Nerve Entrapment|Nerve Entrapments, Pudendal"
NEW04570,CHEMICAL,Melatonin profiles,Melatonin profiles
NEW04571,MENTAL_HEALTH,autism spectrum disorder diagnosis,autism spectrum disorder diagnosis
NEW04572,DISEASE,autism-like traits,autism-like traits
NEW04573,CHEBI,normalized thyroid hormones,normalized thyroid hormones
NEW04574,CHEBI,thyroid hormone elevation,thyroid hormone elevation
NEW04575,CHEBI,exogenous thyroid hormones,exogenous thyroid hormones
NEW04576,DISEASE,depressive states,depressive states
NEW04577,CHEMICAL,Methadone maintenance therapy,Methadone maintenance therapy
NEW04578,CHEMICAL,Elevated T3 levels,Elevated T3 levels
NEW04579,CHEMICAL,T3 levels,T3 levels
NEW04580,DISEASE,violent/aggressive behavior,violent/aggressive behavior
NEW04581,NUTRITION,lithium controls,lithium controls
NEW04582,CHEMICAL,ammonia secondary,ammonia secondary
NEW04583,CHEMICAL,ammonia load,ammonia load
NEW04584,DISEASE,hypothyroid myopathy,hypothyroid myopathy
NEW04585,CHEMICAL,ammonia secondary to,ammonia secondary to
NEW04586,DISEASE,Decreased liver ureagenesis,Decreased liver ureagenesis
NEW04587,NUTRITION,Circulating cholesterol,Circulating cholesterol
NEW04588,MENTAL_HEALTH,Eating Disorder Inventory-2,Eating Disorder Inventory-2
NEW04589,DISEASE,subclinical hypothyroidism,subclinical hypothyroidism
NEW04590,DISEASE,subtle thyroid dysfunction,subtle thyroid dysfunction
NEW04591,CHEMICAL,low triiodothyronine syndrome,low triiodothyronine syndrome
NEW04592,DISEASE,hypothyroidism treatment,hypothyroidism treatment
NEW04593,CHEBI,synthetic T4 hormone,synthetic T4 hormone
NEW04594,CHEMICAL,hormones fT3 TSH serum levels,hormones fT3 TSH serum levels
NEW04595,DISEASE,thyroid gland disorder,thyroid gland disorder
D005067,DISEASE,Euthyroid Sick Syndromes,"Syndrome, Non-Thyroidal Illness|Non-Thyroidal Illness Syndrome|Low T3 syndrome|Syndromes, Non-Thyroidal Illness|Non Thyroidal Illness Syndrome|Low T3 High T4 Syndrome|Sick Euthyroid Syndrome|Low T3-High T4 Syndrome|Euthyroid Sick Syndrome|Syndrome, Sick Euthyroid|Low T3-Low T4 Syndrome|High T4 Syndromes|Low T3 Low T4 Syndrome|Low T3 Syndrome|Low T3 and Low T4 Syndrome|High T4 Syndrome"
NEW04596,CHEMICAL,inactive triiodothyronine,inactive triiodothyronine
NEW04597,DISEASE,Subacute thyreoiditis,Subacute thyreoiditis
NEW04598,DISEASE,hyperthyreosis,hyperthyreosis
NEW04599,CHEMICAL,normal anti-TPO,normal anti-TPO
NEW04600,DISEASE,medullar carcinoma,medullar carcinoma
D002291,DISEASE,"Carcinoma, Papillary","Papillary Carcinoma|Papillary Carcinomas|papillary carcinomas|Carcinomas, Papillary"
NEW04601,CHEBI,thyroid hormone beta,thyroid hormone beta
NEW04602,CHEMICAL,thyroid hormone-disrupting chemicals,thyroid hormone-disrupting chemicals
C101203,DISEASE,IQ motif containing GTPase activating protein 1 [Supplementary Concept],ras GTPase-Activating Proteins|IQ
NEW04603,CHEBI,fetal endocrine disruption,fetal endocrine disruption
NEW04604,DISEASE,neurobehavioral disabilities,neurobehavioral disabilities
NEW04605,DISEASE,manic phases,manic phases
NEW04606,CHEBI,thyroid hormones secretion,thyroid hormones secretion
NEW04607,CHEMICAL,TH supply,TH supply
NEW04608,DISEASE,various neurological dysfunctions,various neurological dysfunctions
NEW04609,CHEBI,glucagon-like peptide-1 receptor agonist liraglutide,glucagon-like peptide-1 receptor agonist liraglutide
D000077403,CHEMICAL,Orlistat,Alli|Ro-18-0647|orlistat|Tetrahydrolipastatin|Ro 18 0647|THLP|Xenical|1-((3-Hexyl-4-oxo-2-oxetanyl)methyl)dodecyl-2-formamido-4-methylvalerate|Tetrahydrolipstatin
NEW04610,DISEASE,antidiabetic weight glucagon-like peptide-1 receptor agonist liraglutide,antidiabetic weight glucagon-like peptide-1 receptor agonist liraglutide
D019987,DISEASE,Visually Impaired Persons,"Blind Person|Person, Blind|Person, Visually Impaired|Persons, Visually Impaired|Impaired Person, Visually|Persons, Blind|Visually Impaired Person|Impaired Persons, Visually|Blind Persons|impaired"
NEW04611,CHEMICAL,overweight glucose tolerance,overweight glucose tolerance
NEW04612,DISEASE,prediabetic overweight/obese schizophrenia-spectrum disorder patients,prediabetic overweight/obese schizophrenia-spectrum disorder patients
NEW04613,DISEASE,glucometabolic disturbances,glucometabolic disturbances
NEW04614,CHEMICAL,glucagon-like peptide-1 receptor agonist liraglutide treatment,glucagon-like peptide-1 receptor agonist liraglutide treatment
NEW04615,CHEBI,glucagon-like peptide-1 GLP-1 receptor agonist,glucagon-like peptide-1 GLP-1 receptor agonist
NEW04616,DISEASE,cardiovascular injury,cardiovascular injury
NEW04617,CHEMICAL,GLP-1 analogue exenatide,GLP-1 analogue exenatide
D052216,CHEMICAL,Glucagon-Like Peptide 1,Glucagon-like peptide 1|glucagon-like peptide-1|Glucagon-like peptide-1|GLP 1|Glucagon-Like Peptide-1|Glucagon Like Peptide 1|GLP-1
NEW04618,DISEASE,prevalent multi-factorial functional bowel disorder,prevalent multi-factorial functional bowel disorder
D005769,DISEASE,Gastrointestinal Motility,"Motilities, Intestinal|Intestinal Motility|intestinal motility|Gastrointestinal Motilities|gastrointestinal motility|Motility, Intestinal|Intestinal Motilities|Motilities, Gastrointestinal|Motility, Gastrointestinal"
D008152,CHEMICAL,Loxapine,"loxapine succinate|Loxitane|CL 71,563|Oxilapine|Loxipine Succinate|Loxapinsuccinate|loxapine hydrochloride|Loxapine Succinate|Loxipine Maleate|CL71,563|Cloxazepine|Maleate, Loxipine|Succinate, Loxapine|Loxapine Monohydrochloride|Loxapine Hydrochloride|Hydrochloride, Loxapine|Loxapine|CL-71,563|2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine"
NEW04619,CHEMICAL,plasma glucose levels,plasma glucose levels
NEW04620,MENTAL_HEALTH,increased insulin resistance index,increased insulin resistance index
C027576,CHEMICAL,4-hydroxy-2-nonenal [Supplementary Concept],4-HNE|Aldehydes
NEW04621,CHEMICAL,4-hydroxynonenal marker,4-hydroxynonenal marker
D000069450,CHEMICAL,Liraglutide,"NN2211|NN-2211|Victoza|Saxenda|2211, NN|liraglutide|NN 2211"
NEW04622,CHEBI,glucagon-like peptide-1 receptor agonist,glucagon-like peptide-1 receptor agonist
NEW04623,DISEASE,T2DM rats,T2DM rats
NEW04624,CHEMICAL,reboxetine-betahistine combination,reboxetine-betahistine combination
NEW04625,DISEASE,olanzapine-induced weight gain,olanzapine-induced weight gain
NEW04626,CHEMICAL,Histamine antagonism,Histamine antagonism
NEW04627,DISEASE,antipsychotic drug-induced weight gain,antipsychotic drug-induced weight gain
NEW04628,MENTAL_HEALTH,first-episode schizophrenia patients,first-episode schizophrenia patients
NEW04629,CHEMICAL,histamine enhancer,histamine enhancer
NEW04630,CHEMICAL,t.i.d,t.i.d
NEW04631,MENTAL_HEALTH,similar depression remission rates,similar depression remission rates
D058831,CHEMICAL,Serotonin 5-HT3 Receptor Antagonists,"5-HT3 Antagonist|Antagonists, 5-HT3|5-HT3 Antagonists|5 HT3 Antagonists|Antagonist, 5-HT3|5-HT3 receptor antagonists|Serotonin 5 HT3 Receptor Antagonists|5-HT3 receptor|5 HT3 Antagonist"
NEW04632,DISEASE,hepatitis C viral infection,hepatitis C viral infection
NEW04633,MENTAL_HEALTH,Depression Inventory,Depression Inventory
NEW04634,CHEMICAL,interferon-alpha IFN-alpha therapy,interferon-alpha IFN-alpha therapy
NEW04635,DISEASE,IFN-alpha-induced MDD,IFN-alpha-induced MDD
NEW04636,CHEMICAL,IFN-alpha therapy,IFN-alpha therapy
NEW04637,CHEBI,selective serotonin reuptake inhibitor agent,selective serotonin reuptake inhibitor agent
NEW04638,MENTAL_HEALTH,treatment resistance,treatment resistance
NEW04639,MENTAL_HEALTH,Depression Rating Scale,Depression Rating Scale
NEW04640,MENTAL_HEALTH,Depression Rating Scale response rate,Depression Rating Scale response rate
NEW04641,DISEASE,primary DSM-IV OCD diagnosis,primary DSM-IV OCD diagnosis
NEW04642,DISEASE,comorbid chronic tics,comorbid chronic tics
NEW04643,DISEASE,comorbid tics,comorbid tics
NEW04644,CHEMICAL,SRI treatment response,SRI treatment response
NEW04645,CHEMICAL,risperidone addition,risperidone addition
NEW04646,DISEASE,OCD refractory,OCD refractory
D012565,DISEASE,Schizophrenic Psychology,"Psychology, Schizophrenic|schizophrenic"
D011985,CHEMICAL,"Receptors, Serotonin","5-HT Receptors|Receptors, Tryptamine|Receptors, 5 HT|5 HT Receptor|5 HT Receptors|Receptors, 5 Hydroxytryptamine|5 Hydroxytryptamine Receptors|5-HT Receptor|Receptor, Tryptamine|Receptor, 5-HT|5 Hydroxytryptamine Receptor|Receptors, 5-HT|Receptor, 5-Hydroxytryptamine|Tryptamine Receptor|Tryptamine Receptors|Serotonin Receptor|Receptor, Serotonin|5-Hydroxytryptamine Receptors|Serotonin Receptors|Receptors, 5-Hydroxytryptamine|5-Hydroxytryptamine Receptor|5-HT receptors|serotonin 5-hydroxytryptamine"
NEW04647,CHEMICAL,inhibitor antidepressants,inhibitor antidepressants
NEW04648,DISEASE,early-life exposure,early-life exposure
NEW04649,DISEASE,early-life selective serotonin reuptake inhibitor exposure,early-life selective serotonin reuptake inhibitor exposure
NEW04650,CHEMICAL,threat-elicited negative emotions,threat-elicited negative emotions
NEW04651,CHEMICAL,amygdala serotonin transporter,amygdala serotonin transporter
NEW04652,CHEMICAL,amygdala serotonin reuptake,amygdala serotonin reuptake
NEW04653,MENTAL_HEALTH,maternal mental illness,maternal mental illness
NEW04654,MENTAL_HEALTH,numerous affective disorders,numerous affective disorders
NEW04655,CHEBI,selective serotonin reuptake inhibitor medications,selective serotonin reuptake inhibitor medications
D010292,DISEASE,Paresthesia,"|Paresthesias, Painful|Paresthesia, Distal|Dysesthesia|Distal Paresthesias|Formication|Dysesthesias|Paresthesia, Painful|Paresthesias|Painful Paresthesias|Paresthesias, Distal|Formications|Distal Paresthesia|paresthesia|Painful Paresthesia"
NEW04656,DISEASE,cerebellar symptoms,cerebellar symptoms
D019462,DISEASE,"Syncope, Vasovagal","|Malignant Neurocardiogenic Syncope|Syncopes, Supine|Neurocardiogenic Syncope|Cerebral Syncopes|Neurally Mediated Faints|Neurocardiogenic Syncope, Malignant|Malignant Neurocardiogenic Syncopes|Syncope, Malignant Neurocardiogenic|Syncope, Vasodepressor|Supine Syncopes|Syncope, Cerebral|Syncopes, Vasodepressor|Syncope, Vasovagal, Neurally-Mediated|Vasovagal Syncope|Vasodepressor Syncope|Syncopes, Cerebral|Vasovagal syncope|Neurogenic Syncope|Syncope, Supine|Neurally Mediated Faint|syncope|Faint, Neurally Mediated|Vasovagal Syncopes|Neurocardiogenic Syncopes, Malignant|Syncope, Neurogenic|Supine Syncope|Faints, Neurally Mediated|Syncopes, Malignant Neurocardiogenic|Syncopes, Neurogenic|Neurogenic Syncopes|Syncopes, Neurocardiogenic|Neurocardiogenic Syncopes|Vasodepressor Syncopes|Syncopes, Vasovagal|Syncope, Neurocardiogenic|Cerebral Syncope"
NEW04657,DISEASE,K´s manic symptoms,K´s manic symptoms
NEW04658,DISEASE,personality disordered patients,personality disordered patients
NEW04659,CHEMICAL,relative glucose metabolism,relative glucose metabolism
NEW04660,DISEASE,impulsive aggression,impulsive aggression
NEW04661,CHEBI,selective inhibitor SSRI treatment,selective inhibitor SSRI treatment
D001930,DISEASE,Brain Injuries,"|Lacerations, Brain|acute injury|Focal Brain Injuries|Injuries, Focal Brain|Injuries, Brain|Brain Injury|Brain Lacerations|Laceration, Brain|Injury, Brain|Injury, Acute Brain|Injury, Focal Brain|Acute Brain Injuries|hippocampal injury|Brain Laceration|Brain Injuries, Acute|Focal Brain Injury|brain injuries|Brain Injury, Focal|Brain Injuries, Focal|Brain Injury, Acute|Injuries, Acute Brain|Acute Brain Injury"
NEW04662,DISEASE,impulsive aggressive behavior,impulsive aggressive behavior
NEW04663,CHEBI,SSRI treatment duration,SSRI treatment duration
NEW04664,CHEMICAL,simultaneous BZD initiation,simultaneous BZD initiation
NEW04665,CHEMICAL,BZD treatment,BZD treatment
NEW04666,DISEASE,debilitating sleep disease,debilitating sleep disease
NEW04667,CHEMICAL,serotonin reuptake-inhibitor fluoxetine,serotonin reuptake-inhibitor fluoxetine
D003192,DISEASE,Compulsive Behavior,"Behaviors, Compulsive|compulsive behaviors|Compulsive Behaviors|Behavior, Compulsive"
NEW04668,CHEMICAL,serotonin precursor 5-hydroxytryptophan,serotonin precursor 5-hydroxytryptophan
NEW04669,CHEMICAL,extended-release methylphenidate,extended-release methylphenidate
D010869,CHEMICAL,Pindolol,LB46|pindolol|Prindolol|LB-46|LB 46|Visken
NEW04670,DISEASE,SSRI-refractory patients,SSRI-refractory patients
NEW04671,CHEMICAL,mg/day,mg/day
NEW04672,CHEMICAL,antidepressant responses,antidepressant responses
D011790,CHEMICAL,Quarantine,"quarantine|Self Quarantine|Stay at Home Orders|Cordon Sanitaire|Health Lockdowns|Lockdowns, Health|Lockdown, Health|Self-Quarantine|Quarantines|Health Lockdown"
NEW04673,DISEASE,traumatic events,traumatic events
NEW04674,CHEMICAL,GABA type A receptor,GABAAR|GABA type A receptor
NEW04675,CHEMICAL,neuroactive steroid allopregnanolone,neuroactive steroid allopregnanolone
NEW04676,CHEMICAL,GABA type A receptor,GABA type A receptor
NEW04677,CHEMICAL,neuroactive steroid allopregnanolone,ALLO|neuroactive steroid allopregnanolone
NEW04678,DISEASE,mediated depression/anxiety,mediated depression/anxiety
NEW04679,CHEMICAL,glutamate neurotransmission,glutamate neurotransmission
NEW04680,CHEBI,selective serotonin reuptake inhibitor sertraline,selective serotonin reuptake inhibitor sertraline
NEW04681,DISEASE,sublethal neuronal damage,sublethal neuronal damage
NEW04682,DISEASE,dexamethasone-induced neuronal damage,dexamethasone-induced neuronal damage
NEW04683,DISEASE,dexamethasone-associated neuronal damage,dexamethasone-associated neuronal damage
NEW04684,CHEMICAL,chronic antidepressant medication,chronic antidepressant medication
NEW04685,CHEMICAL,adjunctive quetiapine,adjunctive quetiapine
NEW04686,DISEASE,PMS/PMDD,PMS/PMDD
NEW04687,CHEMICAL,antidepressant use,antidepressant use
NEW04688,DISEASE,Alzheimer's Disease Study-2,Alzheimer's Disease Study-2
NEW04689,CHEMICAL,agent amantadine,agent amantadine
NEW04690,DISEASE,levodopa-induced dyskinesias,levodopa-induced dyskinesias
NEW04691,CHEMICAL,Amantadine toxicity,Amantadine toxicity
D051437,DISEASE,Renal Insufficiency,"|Failure, Renal|Kidney Failures|Kidney Insufficiency|Renal Failures|Failure, Kidney|Kidney Insufficiencies|Renal Failure|Renal Insufficiencies|Kidney Failure|renal failure|Insufficiency, Kidney|Failures, Kidney|Failures, Renal|renal insufficiency"
D000377,MENTAL_HEALTH,Agnosia,"Auditory Agnosia|Visual Disorientation Syndromes|Olfactory Agnosias|Agnosias, Visuospatial|Agnosia, Visual|Finger Agnosia|Agnosias, Somatosensory|Visual Agnosia|Agnosia for Temperature|Auditory Agnosias|Agnosias, Visual|Developmental Agnosia|Agnosias, Body-Image|Syndrome, Visual Disorientation|Auditory Agnosias, Congenital|Agnosia, Body-Image|Sensory Agnosia|Topographical Agnosia|Agnosia, Position|Agnosia, Auditory|Visual Disorientation Syndrome|Agnosias, Developmental|Congenital Auditory Agnosia|Agnosias, Auditory|Agnosias, Ideational|Anosognosia|Topographical Agnosias|Agnosia, Tactile|Ideational Agnosia|Visuospatial Agnosia|Tactile Agnosia|Tactile Agnosias|Body-Image Agnosias|Somatosensory Agnosia|Position Agnosias|Agnosias, Finger|Agnosia, Somatosensory|Agnosia, Gustatory|Agnosias, Tactile|Agnosia for Tastes|Gustatory Agnosia|Agnosia, Time|Body-Image Agnosia|Agnosia, Developmental|Somatosensory Agnosias|Agnosia, Sensory|Agnosias, Congenital Auditory|Agnosia for Smell|anosognosia|Agnosias, Topographical|disorientation|Auditory Agnosia, Congenital|Finger Agnosias|Syndromes, Visual Disorientation|Agnosias, Position|Developmental Agnosias|Visual Agnosia for Objects|Ideational Agnosias|Olfactory Agnosia|Time Agnosia|Agnosias, Sensory|Agnosias, Time|Position Agnosia|Agnosia, Congenital Auditory|Agnosia, Olfactory|Agnosias|Visuospatial Agnosias|Agnosia, Topographical|Agnosia for Pain|Agnosia, Ideational|Visual Agnosias|Time Agnosias|Agnosia, Finger|Body Image Agnosia|Sensory Agnosias|Agnosias, Olfactory|Agnosia, Visuospatial|Agnosia for Taste|Congenital Auditory Agnosias|Anosognosias"
NEW04692,DISEASE,Extrapyramidal symptoms,Extrapyramidal symptoms
NEW04693,CHEMICAL,anti-NMDA receptor antibodies,anti-NMDA receptor antibodies
NEW04694,DISEASE,BK virus encephalitis,BK virus encephalitis
NEW04695,CHEBI,direct antiviral therapy,direct antiviral therapy
D010269,CHEMICAL,Paraquat,"Gramoxone|PQ|Paragreen A|Viologen, Methyl|Methyl Viologen|paraquat"
NEW04696,CHEMICAL,Monoamine systems,Monoamine systems
NEW04697,CHEMICAL,current antidepressants,current antidepressants
NEW04698,CHEMICAL,systems serotonin,systems serotonin
NEW04699,DISEASE,KIV mice,KIV mice
NEW04700,CHEMICAL,serotonin synthesizing enzyme,serotonin synthesizing enzyme
D014365,NUTRITION,Tryptophan Hydroxylase,"Tryptophan Monooxygenase|tryptophan hydroxylase|Hydroxylase, Tryptophan|Monooxygenase, Tryptophan"
D018340,NUTRITION,"Receptors, Adrenergic, alpha-1","Receptor, alpha-1A Adrenergic|Adrenergic alpha 1D Receptors|Receptors, Adrenergic, alpha-1D|alpha-1A Receptors, Adrenergic|Adrenergic alpha 1 Receptors|alpha 1D Adrenergic Receptor|Adrenergic Receptor, alpha-1C|Adrenergic alpha-1B Receptors|Adrenergic alpha-1 Receptors|alpha 1A Adrenergic Receptor|Receptors, alpha-1 Adrenergic|alpha-1B Receptors, Adrenergic|alpha-1B Adrenergic Receptor|Adrenergic alpha-1D Receptors|Receptor, alpha-1C Adrenergic|alpha-1 Adrenergic Receptor|Receptor, alpha-1 Adrenergic|Adrenergic alpha-1A Receptors|Receptor, Adrenergic, alpha-1B|Adrenergic Receptor, alpha 1|alpha-1D Adrenergic Receptor|Receptors, Adrenergic, alpha-1A|alpha 1 Adrenergic Receptors|Receptor, Adrenergic, alpha-1A|Adrenergic Receptor, alpha-1B|Adrenergic Receptors, alpha-1|alpha 1B Adrenergic Receptor|Receptor, Adrenergic, alpha-1|Adrenergic Receptor, alpha-1D|Adrenergic Receptor, alpha-1A|alpha-1 Receptors, Adrenergic|Receptors, Adrenergic alpha-1|Receptor, alpha-1D Adrenergic|alpha-1 Adrenergic Receptors|Receptors, Adrenergic alpha-1B|Receptors, Adrenergic alpha-1D|alpha-1D Receptors, Adrenergic|alpha 1a|Adrenergic alpha 1B Receptors|alpha-1C Adrenergic Receptor|Receptor, alpha-1B Adrenergic|Receptors, alpha 1 Adrenergic|Receptors, Adrenergic alpha-1A|alpha 1C Adrenergic Receptor|Receptor, Adrenergic, alpha-1D|Adrenergic alpha 1A Receptors|alpha-1A Adrenergic Receptor|alpha 1 Adrenergic Receptor|Receptors, Adrenergic, alpha-1B|Adrenergic Receptor, alpha-1"
NEW04701,CHEMICAL,Ginkgo biloba supplement,Ginkgo biloba supplement|GB-S
NEW04702,CHEMICAL,chronic binge-pattern alcohol consumption,chronic binge-pattern alcohol consumption
NEW04703,CHEMICAL,uroporphyrin characteristic,uroporphyrin characteristic
NEW04704,DISEASE,uroporphyria,uroporphyria
D014576,CHEMICAL,Uroporphyrinogen III Synthetase,"Cosynthetase, Uroporphyrinogen III|Uroporphyrinogen III Cosynthetase|Uroporphyrinogen III Synthase|Synthetase, Uroporphyrinogen III|uroporphyrinogen|Uroporphyrinogen Isomerase|Cosynthase|Isomerase, Uroporphyrinogen|Uroporphyrinogen-III Synthase|Synthase, Uroporphyrinogen-III"
D004492,CHEMICAL,Edetic Acid,"|Versenate|Edetates|Edetate, Calcium Disodium|Acid, Ethylenediaminetetraacetic|Edetic Acid, Disodium, Magnesium Salt|Disodium Versenate, Calcium|Stannous EDTA|Tetracemate|Chelaton 3|Edetic Acid, Calcium, Sodium Salt|N,N'-1,2-Ethanediylbis(N-(carboxymethyl)glycine)|Edetic Acid, Disodium, Monopotassium Salt|Edetic Acid, Sodium Salt|Edetic Acid, Calcium Salt|Versenate, Calcium Disodium|Coprin|ethylenediaminetetraacetic acid|Calcitetracemate, Disodium|Edetic Acid, Disodium Salt, Dihydrate|Edetic Acid, Monosodium Salt|Edetic Acid, Chromium Salt|Chromium EDTA|Dinitrilotetraacetate, Disodium Ethylene|Ethylene Dinitrilotetraacetate|EDTA, Copper|Ethylene Dinitrilotetraacetate, Disodium|Gallium EDTA|EDTA, Potassium|Dicobalt EDTA|Tetacine, Calcium|Disodium Calcitetracemate|EDTA, Gallium|Versene|EDTA, Stannous|Ethylenedinitrilotetraacetic Acid|Dinitrilotetraacetate, Ethylene|Ethylenediaminetetraacetic Acid|Calcium Tetacine|disodium edetate|Edetate Disodium Calcium|Edetic Acid, Dipotassium Salt|Acid, Edetic|EDTA, Magnesium Disodium|Disodium Ethylene Dinitrilotetraacetate|Potassium EDTA|EDTA|Edetic Acid, Monopotassium Salt|Calcium Disodium Versenate|Calcium Disodium Edetate|Edetic Acid, Magnesium Salt|Edathamil|Edetic Acid, Disodium Salt|Distannous EDTA|Acid, Ethylenedinitrilotetraacetic|Magnesium Disodium EDTA|Edetic Acid, Potassium Salt|Copper EDTA|Disodium EDTA|EDTA, Chromium|EDTA, Distannous|EDTA, Dicobalt|EDTA, Disodium"
NEW04705,CHEMICAL,hydrogen peroxide-dependent oxidation,hydrogen peroxide-dependent oxidation
D007502,CHEMICAL,Iron Chelating Agents,"Agents, Iron Chelating|iron chelates|Chelates, Iron|Chelating Agents, Iron|Iron Chelates"
D008862,DISEASE,"Microsomes, Liver","Microsome, Liver|Liver Microsomes|Liver Microsome|liver microsomes"
NEW04706,CHEMICAL,iron stores,iron stores
NEW04707,CHEMICAL,DES treatment,DES treatment
NEW04708,CHEMICAL,restricted Rg1,restricted Rg1
D020264,DISEASE,"Lead Poisoning, Nervous System, Childhood","Lead Poisoning, Neurologic, Childhood|Encephalopathy, Childhood Saturine|Plumbism, Neurologic, Childhood|Lead Encephalopathy, Childhood|Saturnism, Childhood Neurologic|Lead encephalopathy|Nervous System Poisoning, Lead, Childhood|Neurotoxicity Syndrome, Lead, Childhood|Lead-Induced Nervous System Disease, Childhood|Neurologic Saturnism, Childhood|Childhood Saturine Encephalopathy|Encephalopathy, Childhood Lead|Nervous System Disease, Lead-Induced, Childhood|Poisoning, Lead, Nervous System, Childhood|Poisoning, Lead, Neurologic, Childhood|Lead Induced Nervous System Disease, Childhood|Saturine Encephalopathy, Childhood|Childhood Lead Encephalopathy|Childhood Neurologic Saturnism"
NEW04709,NUTRITION,calcium disodium ethylenediaminetetraacetic acid,calcium disodium ethylenediaminetetraacetic acid
D004112,CHEMICAL,Dimercaprol,"Anti-Lewisite Agent, British|Anti-Lewisite, British|2,3-Dimercaptopropanol, Cadmium|British Anti-Lewisite Agent|British Anti Lewisite|Dicaptol|2,3 Dimercaptopropanol|BAL in Oil|dimercaprol|British Anti-Lewisite|B.A.L.|Oil, BAL in|2,3 Dithiopropan 1 o1|Cadmium 2,3-Dimercaptopropanol|2,3-Dithiopropan-1-o1|British Anti Lewisite Agent|in Oil, BAL|2,3-Dimercaptopropanol|Cadmium 2,3 Dimercaptopropanol"
NEW04710,CHEMICAL,higher-dose ESA,higher-dose ESA
NEW04711,CHEMICAL,l-dopa therapy,l-dopa therapy
NEW04712,CHEMICAL,Hoffmann reflex H reflex,Hoffmann reflex H reflex
NEW04713,DISEASE,depressed type,depressed type
C493250,CHEMICAL,1-(((alpha-isobutanoyloxyethoxy)carbonyl)aminomethyl)-1-cyclohexaneacetic acid [Supplementary Concept],Carbamates|gabapentin enacarbil|gamma-Aminobutyric Acid/analogs  and  derivatives
NEW04714,DISEASE,severe RLS,severe RLS
NEW04715,CHEMICAL,first-line therapy,first-line therapy
NEW04716,DISEASE,impaired balance,impaired balance
NEW04717,CHEMICAL,Background Methylphenidate hydrochloride,Background Methylphenidate hydrochloride
NEW04718,CHEMICAL,dopamine similar,dopamine similar
NEW04719,CHEMICAL,myopic shifts,myopic shifts
D047728,DISEASE,"Myopia, Degenerative","Myopias, Progressive|Progressive Myopias|Progressive Myopia|Pathological Myopias|Myopias, Degenerative|Myopia, Progressive|Pathological Myopia|myopia|Degenerative Myopias|Myopias, Pathological|Myopia, Pathological|Degenerative Myopia"
NEW04720,DISEASE,unipolar depressed patients,unipolar depressed patients
NEW04721,MENTAL_HEALTH,double controlled bipolar depression treatment studies,double controlled bipolar depression treatment studies
NEW04722,DISEASE,DLB patients,DLB patients
NEW04723,CHEMICAL,adjunctive amantadine,adjunctive amantadine
D065768,DISEASE,Lennox Gastaut Syndrome,Lennox-Gastaut syndrome|Lennox-Gastaut Syndrome|Lennox Gastaut Syndromes
NEW04724,DISEASE,refractory absence seizures,refractory absence seizures
NEW04725,CHEMICAL,(R)-(-)-carvone,(R)-(-)-carvone
NEW04726,MENTAL_HEALTH,methylphenidate-induced hyperactivity,methylphenidate-induced hyperactivity
NEW04727,CHEMICAL,(S)-(+)-carvone,(S)-(+)-carvone
NEW04728,CHEMICAL,natural amino acid,natural amino acid
C000616255,CHEMICAL,ethyl 6-bromocoumarin-3-carboxylyl theanine [Supplementary Concept],L-theanine|Coumarins|l-Theanine|Glutamates|L-THE
NEW04729,NUTRITION,Proprietary spearmint extract,Proprietary spearmint extract
NEW04730,CHEBI,novel NMDAR glycine-site functional partial agonist,novel NMDAR glycine-site functional partial agonist
NEW04731,DISEASE,Porsolt hypophagia,Porsolt hypophagia
NEW04732,CHEBI,muscle relaxant effect,drug discrimination|muscle relaxant effect
NEW04733,CHEMICAL,ketamine plasticity enhancement,ketamine plasticity enhancement
NEW04734,CHEMICAL,non-competitive N-methyl-D-aspartate receptor antagonist ketamine,non-competitive N-methyl-D-aspartate receptor antagonist ketamine
NEW04735,DISEASE,substance abuse disorders,SUD|substance abuse disorders
C000629870,CHEMICAL,Esketamine [Supplementary Concept],Ketamine|Esketamine|esketamine|S-ketamine|S)-ketamine
NEW04736,CHEMICAL,D-serine levels,D-serine levels
NEW04737,DISEASE,sporadic ALS,sporadic ALS
NEW04738,DISEASE,auditory information processing,auditory information processing
NEW04739,CHEMICAL,N-methyl-d-aspartate receptor dysfunction,N-methyl-d-aspartate receptor dysfunction
NEW04740,MENTAL_HEALTH,hypothalamic-pituitary-adrenal axis hyperactivity,hypothalamic-pituitary-adrenal axis hyperactivity
NEW04741,CHEBI,corticotrophin-releasing hormone (CRH)-expressing neurons,corticotrophin-releasing hormone (CRH)-expressing neurons
NEW04742,DISEASE,cognitive flexibility,cognitive flexibility
NEW04743,CHEBI,noncompetitive antagonist,noncompetitive antagonist
NEW04744,CHEMICAL,ketamine 10mg/kg,ketamine 10mg/kg
NEW04745,DISEASE,stress-induced cognitive inflexibility,stress-induced cognitive inflexibility
NEW04746,DISEASE,ataxic effects,ataxic effects
NEW04747,CHEBI,prototypical NMDAR antagonist MK-801,prototypical NMDAR antagonist MK-801
NEW04748,DISEASE,sedation/hypnosis,sedation/hypnosis
NEW04749,DISEASE,ethanol-induced ataxia,ethanol-induced ataxia
NEW04750,DISEASE,ethanol-induced sedation/hypnosis,ethanol-induced sedation/hypnosis
NEW04751,MENTAL_HEALTH,chronic stress exposure,chronic stress exposure
NEW04752,DISEASE,excitotoxicity-induced neuronal loss,excitotoxicity-induced neuronal loss
NEW04753,CHEMICAL,ethanol withdrawal symptoms,ethanol withdrawal symptoms
NEW04754,CHEMICAL,increased glutamate indicative,increased glutamate indicative
NEW04755,CHEMICAL,calcium increase,calcium increase
NEW04756,DISEASE,GluN2B activation,GluN2B activation
NEW04757,DISEASE,NMDAR antagonist PCP,NMDAR antagonist PCP
NEW04758,CHEMICAL,endogenous estradiol,endogenous estradiol
NEW04759,CHEMICAL,NMDAr-dependent mechanisms,NMDAr-dependent mechanisms
NEW04760,CHEMICAL,glutamate N-methyl-D-aspartate receptor hypofunction,glutamate N-methyl-D-aspartate receptor hypofunction
NEW04761,CHEMICAL,glutamate burst,glutamate burst
NEW04762,CHEBI,noncompetitive NMDAR antagonist,noncompetitive NMDAR antagonist
NEW04763,CHEBI,first nonstimulant drug,first nonstimulant drug
NEW04764,CHEMICAL,norepinephrine transporter inhibitor atomoxetine,norepinephrine transporter inhibitor atomoxetine
NEW04765,CHEBI,NMDAR antagonist memantine,NMDAR antagonist memantine
NEW04766,DISEASE,stress-induced depression-like behaviors,stress-induced depression-like behaviors
NEW04767,CHEBI,non-competitive NMDA receptor NMDAR antagonist,non-competitive NMDA receptor NMDAR antagonist
NEW04768,DISEASE,pronounced neuroinflammation,pronounced neuroinflammation
NEW04769,DISEASE,peripheral infections,peripheral infections
NEW04770,MENTAL_HEALTH,e.g. delirium,e.g. delirium
NEW04771,DISEASE,NMDAR blockade,NMDAR blockade
C049058,CHEMICAL,amperozide [Supplementary Concept],Amperozide|Piperazines
NEW04772,DISEASE,DSM-III-defined major depression,DSM-III-defined major depression
NEW04773,CHEMICAL,sertraline group,sertraline group
NEW04774,DISEASE,gastrointestinal complaints,gastrointestinal complaints
NEW04775,CHEMICAL,amitriptyline group,amitriptyline group
NEW04776,CHEMICAL,TCA use,TCA use
NEW04777,DISEASE,fibrosis progression,fibrosis progression
D008103,DISEASE,Liver Cirrhosis,"|Fibrosis, Liver|cirrhosis of the liver|liver fibrosis|Liver Fibrosis|Cirrhosis, Liver|Cirrhosis, Hepatic|Liver fibrosis|Hepatic Cirrhosis"
NEW04778,CHEMICAL,Venlafaxine dosage,Venlafaxine dosage
NEW04779,CHEMICAL,Nefazodone clearance,Nefazodone clearance
NEW04780,DISEASE,hepatic impairment,hepatic impairment
NEW04781,CHEMICAL,reversible monoamine oxidase type A inhibitor brofaromine,reversible monoamine oxidase type A inhibitor brofaromine
NEW04782,MENTAL_HEALTH,Liebowitz Anxiety Scale,Liebowitz Anxiety Scale
C038213,CHEMICAL,brofaromine [Supplementary Concept],brofaromine|Piperidines
NEW04783,CHEMICAL,brofaromine group,brofaromine group
NEW04784,MENTAL_HEALTH,alcohol craving relative,alcohol craving relative
NEW04785,DISEASE,stereotyped repetitive behavior disorders,stereotyped repetitive behavior disorders
C565506,MENTAL_HEALTH,"Muscular Dystrophy, Congenital, associated with Calf Hypertrophy, Microcephaly, and Severe Mental Retardation [Supplementary Concept]","Muscular Dystrophies|Muscle, Skeletal/abnormalities|Intellectual Disability|Microcephaly|severe mental retardation"
NEW04786,CHEBI,serotonin uptake inhibitor clomipramine,serotonin uptake inhibitor clomipramine
NEW04787,CHEMICAL,Escitalopram treatment,Escitalopram treatment
NEW04788,DISEASE,autism-like neurobehavioral defects,autism-like neurobehavioral defects
NEW04789,CHEMICAL,acetylcholine esterase,acetylcholine esterase
NEW04790,CHEMICAL,novel dual-active ligand E100,novel dual-active ligand E100
NEW04791,CHEBI,high H3R antagonist affinity,high H3R antagonist affinity
C477020,CHEMICAL,Eudragit E100 [Supplementary Concept],Polymers|Acrylates|E100
NEW04792,DISEASE,repetitive compulsive behaviors,repetitive compulsive behaviors
NEW04793,CHEBI,Drug relapse,Drug relapse
NEW04794,DISEASE,anxiety depressive states,anxiety depressive states
C000626969,CHEMICAL,poly(diol sebacate) [Supplementary Concept],BTMPS|Decanoic Acids|sebacate|Dicarboxylic Acids|Polymers
NEW04795,DISEASE,cocaine-induced anxiety-like behaviors,cocaine-induced anxiety-like behaviors
D000700,CHEBI,Analgesics,"Anodynes|Analgesic Agents|Antinociceptive Agents|Analgesic Drugs|Drugs, Analgesic|Agents, Analgesic|Agents, Antinociceptive|Analgesic|analgesic drugs"
NEW04796,CHEMICAL,α9α10 nicotinic acetylcholine receptor,α9α10 nicotinic acetylcholine receptor
NEW04797,CHEBI,peptide antagonists,peptide antagonists
NEW04798,DISEASE,α9α10 subtype,α9α10 subtype
NEW04799,CHEMICAL,Dopamine signaling,Dopamine signaling
NEW04800,CHEMICAL,γ-aminobutyric acid GABA dysregulation,γ-aminobutyric acid GABA dysregulation
D058788,CHEMICAL,GABA-B Receptor Antagonists,"GABA B Receptor Antagonists|GABA-B Antagonists|GABA B Antagonists|GABA-B Receptor Antagonist|Receptor Antagonist, GABA-B|GABA-B|Receptor Antagonists, GABA-B|Antagonists, GABA-B Receptor|Antagonists, GABA-B|GABA B Receptor Antagonist|Antagonist, GABA-B Receptor"
NEW04801,CHEMICAL,kynurenine acid,kynurenine acid
D008464,CHEMICAL,Mecamylamine,Ganglionic Blockers|Nicotinic Antagonists|mecamylamine|Inversine|Antihypertensive Agents|Mecamylamine
NEW04802,CHEMICAL,psychotomimetic drug,psychotomimetic drug
NEW04803,MENTAL_HEALTH,mood disorder aetiology,mood disorder aetiology
NEW04804,CHEMICAL,neurotransmitter serotonin,neurotransmitter serotonin
NEW04805,CHEMICAL,nicotine withdrawal syndrome,nicotine withdrawal syndrome
NEW04806,CHEMICAL,relevant nicotine dosing regimens,relevant nicotine dosing regimens
NEW04807,CHEMICAL,Brain nicotinic acetylcholine receptors,Brain nicotinic acetylcholine receptors
NEW04808,DISEASE,adult neurogenesis,adult neurogenesis
NEW04809,DISEASE,impaired neurogenesis,impaired neurogenesis
NEW04810,DISEASE,attentional impairment,attentional impairment
NEW04811,CHEMICAL,α7 nicotinic acetylcholine receptor antagonist,α7 nicotinic acetylcholine receptor antagonist
NEW04812,CHEBI,dopamine D1 receptor antagonist,dopamine D1 receptor antagonist
C054634,CHEMICAL,methyllycaconitine [Supplementary Concept],methyllycaconitine|Aconitine/analogs  and  derivatives
NEW04813,DISEASE,Shati/Nat8l-/- attentional impairment,Shati/Nat8l-/- attentional impairment
D064569,CHEMICAL,alpha7 Nicotinic Acetylcholine Receptor,"α7 nicotinic acetylcholine receptor|α-bungarotoxin|α7|Receptor, alpha-Bungarotoxin|alpha-Bungarotoxin Receptors|alpha7 Subunit, nAChR|Receptor, alpha Bungarotoxin|alpha Bungarotoxin Receptors|Subunit, nAChR alpha7|nAChR alpha7 Subunit|Nicotinic Acetylcholine Receptor alpha7|Receptors, alpha-Bungarotoxin|alpha7nAChR|α7nAChR|alpha7-nicotinic acetylcholine receptor|alpha-Bungarotoxin Receptor"
NEW04814,CHEMICAL,5-HT(2C receptors,5-HT(2C receptors
NEW04815,CHEBI,preferential 5-HT(2C receptor agonist,preferential 5-HT(2C receptor agonist
NEW04816,CHEMICAL,5-HT receptor subtypes,5-HT receptor subtypes
NEW04817,CHEMICAL,serotonin receptor 2B agonist,serotonin receptor 2B agonist
D006963,DISEASE,Hyperphagia,Polyphagia|hyperphagia|Overeating|Polyphagias
C092430,CHEMICAL,1-(5-(2-thenyloxy)-1H-indol-3-yl)propan-2-amine [Supplementary Concept],Indoles|BW723C86|Thiophenes
NEW04818,CHEBI,serotonin agonist BW723C86,serotonin agonist BW723C86
NEW04819,DISEASE,skin hyperpigmentation disorders,skin hyperpigmentation disorders
NEW04820,CHEMICAL,postsynaptic 5-HT(1A CGS 12066B DOI receptors,postsynaptic 5-HT(1A CGS 12066B DOI receptors
C066304,CHEMICAL,sertindole [Supplementary Concept],Imidazoles|sertindole|Indoles
C060632,CHEMICAL,ICI 170809 [Supplementary Concept],"ICI-170,809|Quinolines"
D007650,CHEMICAL,Ketanserin,"ketanserin|R-41468|R-41,468|R41,468|3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione|R 41,468|R41468|R 41468"
NEW04821,CHEMICAL,antagonists ritanserin,antagonists ritanserin
NEW04822,MENTAL_HEALTH,chronic primary insomnia,chronic primary insomnia
D016713,CHEMICAL,Ritanserin,"ritanserin|Ritanserin Hydrochloride|Ritanserin|6-(2-(4-(Bis(4-fluorophenyl)methylene)-1-piperidinyl)ethyl)-7-methyl-5H-thiazolo(3,2-a)pyrimidin-5-one|R 55667|R55667|Ritanserin Tartrate|R-55667"
NEW04823,CHEMICAL,agonist APD-125,agonist APD-125
NEW04824,CHEMICAL,BZD hypnotics,BZD hypnotics
NEW04825,CHEMICAL,5-HT(2A antagonists,5-HT(2A antagonists
NEW04826,CHEMICAL,"2,5-Dimethoxy-4-ethylphenethylamine","2,5-Dimethoxy-4-ethylphenethylamine"
NEW04827,DISEASE,several new psychoactive substances,NPS|several new psychoactive substances|overall neuropsychiatric symptoms
NEW04828,CHEMICAL,psychedelic phenylethylamine,psychedelic phenylethylamine
NEW04829,CHEMICAL,5-HT2 receptor blockade,5-HT2 receptor blockade
NEW04830,CHEMICAL,dopamine D2 partial agonism,dopamine D2 partial agonism
NEW04831,CHEMICAL,serotonin 5-HT1A agonism,serotonin 5-HT1A agonism
NEW04832,CHEMICAL,serotonin 5-HT releasers (+/-)-fenfluramine,serotonin 5-HT releasers (+/-)-fenfluramine
D006349,DISEASE,Heart Valve Diseases,"valvular heart disease|Heart Valvular Diseases|Heart Disease, Valvular|Valve Disease, Heart|Heart Valvular Disease|Valvular Heart Diseases|Disease, Heart Valvular|Valvular Disease, Heart|Heart Valve Disease|Valvular Heart Disease"
D005277,CHEMICAL,Fenfluramine,"|fenfluramines|Fenfluramine Hydrochloride, R Isomer|Hydrochloride, Fenfluramine|(+)-fenfluramine|Fenfluramine Hydrochloride, R-Isomer|fenfluramine|Fenfluramine|Pondimin|Fintepla|Isomeride|Fenfluramine Hydrochloride|FEN|Fenfluramine, (+-)-Isomer|Fenfluramine, R Isomer|Fenfluramine Hydrochloride, (+-)-Isomer|Fenfluramine, R-Isomer"
NEW04833,CHEMICAL,H(2)-histamine antagonists,H(2)-histamine antagonists
NEW04834,DISEASE,system reactions,system reactions
NEW04835,DISEASE,patient's severe chronic intestinal pseudo-obstruction,patient's severe chronic intestinal pseudo-obstruction
NEW04836,DISEASE,brown bowel syndrome,brown bowel syndrome
NEW04837,DISEASE,significant weight loss,significant weight loss
NEW04838,CHEBI,certain fat-soluble vitamins A,certain fat-soluble vitamins A
NEW04839,CHEBI,mitochondrial solute carrier protein,mitochondrial solute carrier protein
D005943,CHEMICAL,Gluconeogenesis,gluconeogenesis
NEW04840,CHEMICAL,βα1 domain,βα1 domain
NEW04841,DISEASE,intestinal lipid malabsorption,intestinal lipid malabsorption
NEW04842,DISEASE,severe hypobetalipoproteinemia,severe hypobetalipoproteinemia
NEW04843,DISEASE,maldigestion fat,maldigestion fat
D045602,DISEASE,Steatorrhea,steatorrhea|Celiac Disease (1964-2003)
NEW04844,CHEBI,decreased vitamin D level,decreased vitamin D level
D015255,CHEMICAL,Idarubicin,"NSC256439|IMI30|NSC 256439|IMI|IMI-30|4 Demethoxydaunorubicin|4-Demethoxydaunorubicin|NSC-256439|4-Desmethoxydaunorubicin|Idarubicin Hydrochloride|4 Desmethoxydaunorubicin|Hydrochloride, Idarubicin|IMI 30"
NEW04845,CHEMICAL,dopamine DA agonists,dopamine DA agonists
NEW04846,DISEASE,TBI females,TBI females
NEW04847,CHEMICAL,DA metabolisms,DA metabolisms
NEW04848,MENTAL_HEALTH,first episode untreated schizophrenia,first episode untreated schizophrenia
NEW04849,CHEBI,drug naïve,drug naïve
NEW04850,CHEMICAL,Nitric oxide (NO)/cGMP,Nitric oxide (NO)/cGMP
NEW04851,MENTAL_HEALTH,anxiety modulation,anxiety modulation
NEW04852,CHEMICAL,NO system,NO system
NEW04853,CHEBI,ovarian sex hormones,ovarian sex hormones
C485949,DISEASE,"Mass1 protein, mouse [Supplementary Concept]","seizure susceptibility|Receptors, G-Protein-Coupled|audiogenic seizure"
NEW04854,DISEASE,sex-specific pain hypersensitivity,sex-specific pain hypersensitivity
D018500,DISEASE,"Diabetes Insipidus, Nephrogenic","|nephrogenic diabetes insipidus|Nephrogenic Diabetes Insipidus|Diabetes Insipidus, Nephrogenic, Autosomal|ADH-Resistant Diabetes Insipidus|Congenital nephrogenic diabetes insipidus|Diabetes Insipidus, Nephrogenic, Type 1|Nephrogenic Diabetes Insipidus, Type I|Nephrogenic Diabetes Insipidus, Type II|Acquired Nephrogenic Diabetes Insipidus|Diabetes Insipidus, Nephrogenic, X-Linked|Congenital Nephrogenic Diabetes Insipidus|Vasopressin-Resistant Diabetes Insipidus|Diabetes Insipidus Renalis|Diabetes Insipidus, Nephrogenic, Type I|Diabetes Insipidus, Nephrogenic, Type II"
NEW04855,DISEASE,long-term hyperglycemia,long-term hyperglycemia
NEW04856,DISEASE,diabetic vascular neuropathy,diabetic vascular neuropathy
D018384,DISEASE,Oxidative Stress,"Stress, Nitro-Oxidative|Oxidative Damage|Oxidative Cleavage|DNA Damage, Oxidative|Stress, Anti-oxidative|Oxidative DNA Damage|Oxidative Damage, DNA|oxidative stress injury|Damage, Oxidative|Damage, DNA Oxidative|Nitro Oxidative Stress|Stress, Oxidative Nitrative|Antioxidative Stress|DNA Oxidative Damages|Oxidative Stresses|Injury, Oxidative Stress|Nitro-Oxidative Stresses|Stress, Oxidative|Stress, Antioxidative|Oxidative Stress Injuries|Stresses, Nitro-Oxidative|Anti-oxidative Stresses|Antioxidative Stresses|Nitro-Oxidative Stress|Oxidative Nitrative Stresses|Oxidative Nitrative Stress|Stress Injury, Oxidative|DNA Oxidative Damage|Oxidative Cleavages|Oxidative Injury|Oxidative DNA Damages|Oxidative and Nitrosative Stress|Anti-oxidative Stress|Oxidative Injuries|Oxidative Damages|Injury, Oxidative|Nitrative Stress, Oxidative|Cleavage, Oxidative|Oxidative Stress Injury|Anti oxidative Stress|Damage, Oxidative DNA"
NEW04857,CHEMICAL,abnormal zinc metabolism,abnormal zinc metabolism
NEW04858,CHEMICAL,dopamine D4 receptor genotype/function,dopamine D4 receptor genotype/function
NEW04859,MENTAL_HEALTH,future alcohol abuse,future alcohol abuse
D015275,DISEASE,Tumor Lysis Syndrome,"Tumor Lysis Syndromes|Syndromes, Tumour Lysis|Syndromes, Tumor Lysis|tumour|Tumour Lysis Syndrome|Syndrome, Tumour Lysis|Tumour Lysis Syndromes|Syndrome, Tumor Lysis"
NEW04860,DISEASE,tumour burden,tumour burden
NEW04861,DISEASE,non-advanced tumours,non-advanced tumours
NEW04862,DISEASE,cirrhotic HCC,cirrhotic HCC
NEW04863,DISEASE,extinction recall,extinction recall
NEW04864,CHEMICAL,elevated oestradiol,elevated oestradiol
NEW04865,CHEMICAL,cortisol neurotrophic factor,cortisol neurotrophic factor
NEW04866,DISEASE,vaginal dryness,vaginal dryness
NEW04867,DISEASE,vaginal lubrication,vaginal lubrication
D017373,CHEMICAL,Cyproterone Acetate,"|Cyproterone Acetate, (17 alpha)-Isomer|CPA|Cyproterone acetate|Androcur|Cyproterone Acetate, (1 alpha,2 alpha)-Isomer|cyproterone acetate|Cyproterone Acetate, (1 alpha,2 alpha,9 beta,10 alpha)-Isomer"
NEW04868,DISEASE,paraphilic men,paraphilic men
NEW04869,DISEASE,sexual crimes,sexual crimes
NEW04870,CHEBI,active drug,active drug
NEW04871,NUTRITION,tart cherry extracts,tart cherry extracts
NEW04872,DISEASE,paw edema,paw edema
NEW04873,DISEASE,inflammation-induced thermal hyperalgesia,inflammation-induced thermal hyperalgesia
NEW04874,NUTRITION,tart cherry anthocyanins,tart cherry anthocyanins
NEW04875,DISEASE,inflammatory pain,inflammatory pain
NEW04876,NUTRITION,anthocyanin production pathway,anthocyanin production pathway
NEW04877,MENTAL_HEALTH,nitrogen chronic stress conditions,nitrogen chronic stress conditions
NEW04878,DISEASE,crispa W. Deane,crispa W. Deane
D055731,DISEASE,Carbohydrate Biochemistry,"carbohydrate|Biochemistry, Carbohydrate"
D019422,CHEMICAL,Dietary Sucrose,"sucrose|Table Sugar|Dietary Sucroses|Sucrose, Dietary|Sucroses, Dietary|Sugars, Table|% sucrose|Table Sugars"
NEW04879,CHEMICAL,HFHC-diet protein,HFHC-diet protein
NEW04880,CHEMICAL,sabdariffa Linne,sabdariffa Linne
NEW04881,CHEMICAL,sabdariffa aqueous extracts,sabdariffa aqueous extracts
NEW04882,CHEMICAL,H. sabdariffa L.,H. sabdariffa L.
NEW04883,DISEASE,aqueous extracts,aqueous extracts|HSE
NEW04884,DISEASE,atherosclerosis chemopreventive agents,atherosclerosis chemopreventive agents
D003921,CHEMICAL,"Diabetes Mellitus, Experimental","Experimental Diabetes Mellitus|Diabete, Streptozocin|Diabetes, Alloxan|streptozotocin|Diabetes, Streptozotocin|Alloxan Diabetes|Streptozotocin Diabetes|Streptozocin Diabetes|Diabetes, Streptozocin|Streptozocin Diabete|STZ"
NEW04885,DISEASE,polyphenol-rich extracts,HPE|polyphenol-rich extracts
NEW04886,DISEASE,STZ-induced SDAT,STZ-induced SDAT
NEW04887,CHEMICAL,caffeine poisoning,caffeine poisoning
NEW04888,CHEBI,peripheral muscarinic antagonist,peripheral muscarinic antagonist
NEW04889,DISEASE,DFP-induced bradycardia,DFP-induced bradycardia
D019832,CHEMICAL,N-Methylscopolamine,"N Methylscopolamine Iodide|N Methylscine Methylsulfate|Methylbromide, Scopolamine|N-Methylscopolamine Nitrate|N Methylscopolamine|N Methylscopolamine Methylsulfate|Hyoscine|Hyoscine Methobromide|N-Methylscopolamine Bromide|N Methylscopolamine Nitrate|N Methylscopolamine Bromide|Methylscopolamine Nitrate|Ulix|N-Methylscopolamine Methylsulfate|Methylsulfate, N-Methylscine|Methscopolamine|Iodide, N-Methylscopolamine|Scopolamine Methylbromide|Skopyl|Methylchloride, N-Methylscopolamine|N-Methylscopolamine Methylchloride|Methylscopolammonium Methylsulfate|DD-234|N-Methylscine Methylsulfate|Methylsulfate, N-Methylscopolamine|N Methylscopolamine Methylchloride|Methobromide, Hyoscine|N-Methylscopolamine Iodide|Nitrate, Methylscopolamine|Nitrate, N-Methylscopolamine|Bromide, N-Methylscopolamine|Methylscopolamine|Methiodide, Hyoscine|DD234|Hyoscine Methiodide|Methylsulfate, Methylscopolammonium|DD 234"
NEW04890,DISEASE,DFP-induced hypothermia,DFP-induced hypothermia
NEW04891,CHEMICAL,Chronic scopolamine,Chronic scopolamine
NEW04892,CHEMICAL,prostaglandin release,prostaglandin release
NEW04893,DISEASE,DFP-induced hyperthermia,DFP-induced hyperthermia
NEW04894,CHEMICAL,diisopropyl fluorophosphate,DFP|diisopropyl fluorophosphate
NEW04895,CHEBI,beta-blocker prophylaxis,beta-blocker prophylaxis
NEW04896,CHEMICAL,oxytocine,oxytocine
NEW04897,CHEBI,beta blocker,beta blocker
NEW04898,DISEASE,clozapine-induced tachycardia,clozapine-induced tachycardia
NEW04899,CHEMICAL,catecholamine dysfunction,catecholamine dysfunction
D047368,DISEASE,Tumor Burden,"Tumor Volume|Tumor Weights|tumor weights|Weight, Tumor|Load, Tumor|Volume, Tumor|Loads, Tumor|tumor burden|tumor weight|Tumor Load|Tumor Weight|Tumor Loads|Weights, Tumor|Burden, Tumor"
NEW04900,DISEASE,cancer therapies,cancer therapies
NEW04901,CHEBI,CNS beta receptors,CNS beta receptors
NEW04902,CHEBI,beta-blocker medication,beta-blocker medication
D053609,DISEASE,Lethargy,|lethargy|Sleep Stages (1977-2006)
NEW04903,DISEASE,Smoking abuse,Smoking abuse
NEW04904,CHEBI,generation non selective vasodilating beta adrenergic blocking agent,generation non selective vasodilating beta adrenergic blocking agent
NEW04905,NUTRITION,alpha adrenoceptor,alpha adrenoceptor
NEW04906,CHEMICAL,agent Carvedilol,agent Carvedilol
NEW04907,CHEMICAL,timolol drops,timolol drops
D001250,DISEASE,"Asthma, Exercise-Induced","Bronchospasm, Exercise-Induced|Bronchospasm, Exercise Induced|Exercise Induced Asthma|Exercise-Induced Asthma|Exercise-Induced Bronchospasms|Asthma, Exercise Induced|Exercise-Induced Bronchospasm|Bronchospasms, Exercise-Induced|Asthmas, Exercise-Induced|Exercise Induced Bronchospasm|bronchospasm|Exercise-Induced Asthmas"
D014331,CHEMICAL,Tropicamide,"|Tropicamide Minims|Mydriafair|Tropicamide Monofree|Tropicamide, (S)-Isomer|OcuTropic|Mydrum|Tropicamide, (+-)-Isomer|tropicamide|Ocu-Tropic|Tropicamide Monohydrochloride, (S)-Isomer|N-Ethyl-alpha-(hydroxymethyl)-N-(4-pyridinylmethyl)benzeneacetamide|Ocu Tropic|Tropicamide, (R)-Isomer|Mydriaticum|N-Ethyl-N-(4-pyridylmethyl)tropamide|Tropicamide Faure|Mydral|Tropicacyl|Tropicamide Monohydrochloride, (R)-Isomer|Tropicamide|Minims Tropicamide|Colircusi Tropicamida"
D065346,CHEMICAL,Lubricant Eye Drops,"Drops, Lubricant Eye|Lubricant Eye Drop|Eye Drop, Lubricant|Lubricating Eye Drops|Tears, Artificial|Drops, Lubricating Eye|eye-drops|Eye Drops, Lubricating|Lubricating Eye Drop|Artificial Tear|Eye Drops, Lubricant|Artificial Tears|Tear, Artificial|Drop, Lubricant Eye|Drop, Lubricating Eye|Eye Drop, Lubricating"
NEW04908,DISEASE,major anti-hypertensive AHT drug classes,major anti-hypertensive AHT drug classes
NEW04909,CHEMICAL,CCBs,CCBs
NEW04910,CHEMICAL,ACEIs,ACEIs
NEW04911,CHEMICAL,Adderall overdose,Adderall overdose
D014202,DISEASE,Tremor,"Intermittent Tremor||Massive Tremors|Tremor, Fine|Tremor, Continuous|Tremor, Intermittent|Tremors, Intermittent|Quiver, Involuntary|Rest Tremors|Tremors, Darkness|Pill Rolling Tremor|Perioral Tremors|Tremors, Fine|Tremor, Nerve|Darkness Tremors|Resting Tremor|Neonatal Tremor|Tremor, Static|Tremor, Perioral|Quivers, Involuntary|Limb Tremors|Tremor, Massive|Tremors, Coarse|Rolling Tremors, Pill|Fine Tremors|Saturnine Tremor|resting tremor|Nerve Tremor|Tremors, Intention|Tremors, Senile|Continuous Tremors|muscle tremors|Tremors, Limb|Tremors, Muscle|Tremors, Neonatal|Tremors, Passive|Tremors, Static|Tremor, Darkness|Coarse Tremors|Intention Tremor|Static Tremor|Tremors, Rest|Static Tremors|Continuous Tremor|Semirhythmic Tremors|Tremor, Limb|Fine Tremor|Intention Tremors|Rest Tremor|Passive Tremors|Tremor, Action|Action Tremors|Massive Tremor|Tremor, Rest|Tremor, Passive|Tremors, Pill Rolling|Persistent Tremor|Persistent Tremors|Tremors, Nerve|Nerve Tremors|Intermittent Tremors|Tremor, Persistent|Tremors, Continuous|Involuntary Quivers|Senile Tremors|Pill Rolling Tremors|muscle tremor|Tremor, Senile|rest tremor|Action Tremor|Tremor, Pill Rolling|Tremor, Neonatal|Tremors, Semirhythmic|Tremors, Perioral|Tremors, Massive|Senile Tremor|Neonatal Tremors|Tremors, Persistent|Tremors, Resting|Tremor, Semirhythmic|Coarse Tremor|Darkness Tremor|Tremor, Coarse|Involuntary Quiver|Resting Tremors|tremors|Tremor, Muscle|Tremors|Rolling Tremor, Pill|Tremor, Saturnine|Tremor, Intention|Muscle Tremors|Tremor, Resting|Saturnine Tremors|Tremors, Action|Passive Tremor|Limb Tremor|Semirhythmic Tremor|Perioral Tremor|Muscle Tremor|Tremors, Saturnine|tremor"
D059246,DISEASE,Tachypnea,Tachypneas|tachypnea
D015878,DISEASE,Mydriasis,|Pupil (1967-1989)|mydriasis
NEW04912,CHEMICAL,Adderall intoxication,Adderall intoxication
C566014,DISEASE,Undritz Anomaly [Supplementary Concept],hypersegmentation|Leukocyte Disorders
NEW04913,DISEASE,mild thrombocytopenia,mild thrombocytopenia
D010640,CHEMICAL,Phenothiazines,phenothiazines|Antipsychotic Agents
NEW04914,DISEASE,Cardiac tachyarrhythmias,Cardiac tachyarrhythmias
NEW04915,DISEASE,NA dysfunction,NA dysfunction
NEW04916,DISEASE,neuropsychiatric illnesses,neuropsychiatric illnesses
NEW04917,CHEBI,additional beta-blocker use,additional beta-blocker use
NEW04918,DISEASE,hypertensive response,hypertensive response
NEW04919,CHEBI,antiviral efficacy,antiviral efficacy
NEW04920,CHEBI,antibiotic azithromycin,antibiotic azithromycin
NEW04921,CHEMICAL,supra-infections,supra-infections
D006886,CHEMICAL,Hydroxychloroquine,Hydroxychloroquine||Oxychlorochin|Hydroxychloroquine Sulfate (1:1) Salt|Hydroxychlorochin|Hydroxychloroquine Sulfate|Plaquenil|HCQ|hydroxychloroquine|Oxychloroquine
D011655,DISEASE,Pulmonary Embolism,"|pulmonary obstruction|Embolism, Pulmonary|pulmonary embolism|Pulmonary Thromboembolism|Pulmonary Embolisms|Thromboembolism, Pulmonary|Embolisms, Pulmonary|Pulmonary Thromboembolisms|Thromboembolisms, Pulmonary"
D016757,DISEASE,"Death, Sudden, Cardiac","sudden cardiac death||sudden cardiac arrest|Cardiac Death, Sudden|Cardiac Arrests, Sudden|Arrest, Sudden Cardiac|Sudden Death, Cardiac|Sudden Cardiac Arrest|Cardiac Sudden Death|Death, Sudden Cardiac|Cardiac Arrest, Sudden|Sudden Cardiac Death|Death, Cardiac Sudden"
C580047,DISEASE,Dmd-Associated Dilated Cardiomyopathy [Supplementary Concept],"dilated cardiomyopathy|Cardiomyopathy, Dilated|Dilated cardiomyopathy|DCM"
NEW04922,CHEBI,ischemic toxins,ischemic toxins
NEW04923,DISEASE,Carnitine deficiency-induced cardiomyopathy,Carnitine deficiency-induced cardiomyopathy
NEW04924,CHEMICAL,Carnitine deficiency-induced myopathy,Carnitine deficiency-induced myopathy
NEW04925,CHEMICAL,Atenolol mg/day,Atenolol mg/day
NEW04926,CHEMICAL,propranolol therapy,propranolol therapy
NEW04927,CHEBI,heterozygous carriers,heterozygous carriers
NEW04928,DISEASE,hand movements,hand movements
NEW04929,DISEASE,clumsiness,clumsiness
C529843,CHEMICAL,3beta-OH-tibolone [Supplementary Concept],Norpregnanes|Tibolone
NEW04930,CHEBI,known carcinogens,known carcinogens
D007562,DISEASE,Creutzfeldt-Jakob Syndrome,"Familial Creutzfeldt-Jakob Disease|CJD (Creutzfeldt-Jakob Disease)|Creutzfeldt Jakob Disease, Familial|CJD (Creutzfeldt Jakob Disease)|Jakob Creutzfeldt Syndrome|Creutzfeldt Jakob Disease, Variant|Jakob Creutzfeldt Disease|Familial Creutzfeldt-Jakob Diseases|Creutzfeldt-Jakob disease|Variant Creutzfeldt Jakob Disease|Spongiform Encephalopathies, Subacute|New Variant Creutzfeldt-Jakob Disease|Creutzfeldt-Jakob syndrome|Creutzfeldt Jacob Disease|Disease, Creutzfeldt Jacob|Familial Creutzfeldt Jakob Disease|V-CJD (Variant-Creutzfeldt-Jakob Disease)|Syndrome, Jakob-Creutzfeldt|Creutzfeldt Jakob disease|Creutzfeldt-Jakob Disease, New Variant|Disease, Familial Creutzfeldt-Jakob|New Variant Creutzfeldt Jakob Disease|Subacute Spongiform Encephalopathies|Subacute Spongiform Encephalopathy|V CJD (Variant Creutzfeldt Jakob Disease)|Creutzfeldt-Jakob Disease|Creutzfeldt-Jakob Disease, Variant|Disease, Creutzfeldt-Jakob|Jacob Disease, Creutzfeldt|Creutzfeldt-Jakob Diseases, Familial|Encephalopathies, Subacute Spongiform|Creutzfeldt Jakob Disease, New Variant|Syndrome, Creutzfeldt-Jakob|Variant Creutzfeldt-Jakob Disease|Jakob-Creutzfeldt Disease|Jakob-Creutzfeldt Syndrome|Disease, Jakob-Creutzfeldt|Creutzfeldt Jakob Syndrome|Spongiform Encephalopathy, Subacute|Creutzfeldt Jakob Disease|Encephalopathy, Subacute Spongiform|Creutzfeldt-Jakob Disease, Familial|CJD"
D017096,DISEASE,Prion Diseases,"prion diseases|Dementia, Transmissible|Transmissible Dementia|Prion Protein Diseases|Prion Disease|Encephalopathies, Spongiform, Transmissible|Spongiform Encephalopathy, Transmissible|Transmissible Spongiform Encephalopathy|Disorders, Prion-Induced|Spongiform Encephalopathies, Transmissible|Prion-Associated Disorders|Dementias, Transmissible|Prion Protein Disease|Transmissible Spongiform Encephalopathies|transmissible spongiform encephalopathies|Inherited Human Transmissible Spongiform Encephalopathies|Prion-Induced Disorders|Encephalopathies, Transmissible Spongiform|Disorder, Prion-Induced|Encephalopathy, Transmissible Spongiform|Transmissible Dementias|Prion-Induced Disorder|Human Transmissible Spongiform Encephalopathies, Inherited|Prion Induced Disorder"
NEW04931,CHEMICAL,CJres,CJres
NEW04932,DISEASE,Chronic psycho-environmental stress,Chronic psycho-environmental stress
NEW04933,CHEMICAL,cortisol levels,cortisol levels
NEW04934,DISEASE,neurological dysfunction due,neurological dysfunction due
NEW04935,DISEASE,chronic psycho-environmental stress,chronic psycho-environmental stress
NEW04936,MENTAL_HEALTH,Psychological chronic stress,Psychological chronic stress
C536653,DISEASE,Penttinen-Aula syndrome [Supplementary Concept],"Limb Deformities, Congenital|premature aging|Progeria|Acro-Osteolysis"
NEW04937,CHEMICAL,psychiatric CNTDs,psychiatric CNTDs
NEW04938,CHEMICAL,inadequate omega-3 levels,inadequate omega-3 levels
D019587,NUTRITION,Dietary Supplements,"Neutraceutical|Neutraceuticals|Dietary Supplementations|food supplements|Supplementations, Dietary|Herbal Supplements|Supplements, Dietary|nutraceutical|Supplement, Food|Nutriceutical|Nutriceuticals|Nutraceutical|Food Supplementations|Supplements, Food|Nutraceuticals|Dietary Supplement|Supplements, Herbal|Herbal Supplement|Food Supplements|Supplement, Herbal|Food Supplement"
NEW04939,CHEMICAL,chronic cortisol exposure,chronic cortisol exposure
NEW04940,DISEASE,psychiatric drug investigators,psychiatric drug investigators
NEW04941,NUTRITION,our's sample lithium,our's sample lithium
D002707,CHEMICAL,Chlordiazepoxide,"Monohydrochloride, Chlordiazepoxide|Hydrochloride, Chlordiazepoxide|Librium|7-Chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepine-4-oxide|7 Chloro 2 methylamino 5 phenyl 3H 1,4 benzodiazepine 4 oxide|Chlordiazepoxide|Chlordiazepoxide Hydrochloride|Methaminodiazepoxide|Chlozepid|Chlordiazepoxide Perchlorate|chlordiazepoxide|Hydrobromide, Chlordiazepoxide|Chlordiazepoxide Monohydrochloride|Elenium|Chlordiazepoxide Hydrobromide|Perchlorate, Chlordiazepoxide|7 Chloro N methyl 5 phenyl 3H 1,4 benzodiazepin 2 amine 4 oxide|7-Chloro-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-amine 4-oxide"
NEW04942,MENTAL_HEALTH,associated organic brain syndromes,associated organic brain syndromes
D000069056,CHEMICAL,Lurasidone Hydrochloride,"Lurasidone HCl|HCl, Lurasidone|SM13496|SM13,496|SM 13,496|13496, SM|Lurasidone|SM-13,496|SM 13496|Hydrochloride, Lurasidone|SM-13496|N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide|lurasidone|Latuda"
NEW04943,NUTRITION,Lithium antipsychotics,Lithium antipsychotics
NEW04944,DISEASE,behavioral dyscontrol,behavioral dyscontrol
D006677,MENTAL_HEALTH,Histrionic Personality Disorder,"Hysterical Personality|Hysterical Personalities|Histrionic Personality Disorder|Disorders, Histrionic Personality|Histrionic Personality Disorders|Personality, Hysterical|Personalities, Hysterical|Personality Disorder, Histrionic|Personality Disorders, Histrionic|histrionic personality|Disorder, Histrionic Personality"
NEW04945,CHEMICAL,depot antipsychotic drug,depot antipsychotic drug
NEW04946,DISEASE,explosive behavior,explosive behavior
D010076,CHEMICAL,Oxazepam,oxazepam|Tazepam|Serax|Adumbran
NEW04947,DISEASE,severe PD,severe PD
NEW04948,DISEASE,Comorbid depression,Comorbid depression
NEW04949,MENTAL_HEALTH,Comorbid neurotic disorder,Comorbid neurotic disorder
D004308,CHEMICAL,Dothiepin,"dothiepin hydrochloride||Dothiepin Hydrochloride|Dosulepin|dothiepin|Hydrochloride, Dothiepin|Prothiaden"
NEW04950,MENTAL_HEALTH,Comorbid social phobia,Comorbid social phobia
D008148,CHEMICAL,Lovastatin,"|1 alpha-Isomer Lovastatin|Mevinolin|6 Methylcompactin|MK-803|MK 803|MK803|Lovastatin, 1 alpha Isomer|Lovastatin|Mevacor|6-Methylcompactin|lovastatin|Monacolin K|alpha-Isomer Lovastatin, 1|Lovastatin, 1 alpha-Isomer|Lovastatin, (1 alpha(S*))-Isomer"
NEW04951,DISEASE,bipolar disorder-manic phase,bipolar disorder-manic phase
NEW04952,CHEMICAL,lovastatin group,lovastatin group
NEW04953,CHEMICAL,melatonin metabolism,melatonin metabolism
C000632444,DISEASE,"Aniridia, Partial, with Unilateral Renal Agenesis and Psychomotor Retardation [Supplementary Concept]",Aniridia|psychomotor retardation|Psychomotor Disorders
NEW04954,DISEASE,concurrent psychotic spectrum disorders,concurrent psychotic spectrum disorders
NEW04955,DISEASE,SUI-resistant patients,SUI-resistant patients
NEW04956,NUTRITION,chronic lithium treatment,chronic lithium treatment
NEW04957,DISEASE,motor impulsivity,motor impulsivity
NEW04958,MENTAL_HEALTH,generalized anxiety patients,generalized anxiety patients
NEW04959,MENTAL_HEALTH,rebound anxiety state,rebound anxiety state
NEW04960,CHEMICAL,benzodiazepines alprazolam,benzodiazepines alprazolam
NEW04961,CHEMICAL,classical benzodiazepines,classical benzodiazepines
NEW04962,DISEASE,novel psychiatric indications,novel psychiatric indications
NEW04963,CHEMICAL,triazolobenzodiazepine,triazolobenzodiazepine
NEW04964,CHEMICAL,medium potency benzodiazepines,medium potency benzodiazepines
D000525,CHEMICAL,Alprazolam,"|Nu-Alpraz|Alprazolam|Nu Alpraz|Novo Alprazol|Alprazolan|Ralozam|Tafil|Apo Alpraz|Xanax|Cassadan|Alprox|Kalma|Apo-Alpraz|alprazolam|D65MT|Esparon|U-31,889|D-65MT|U31,889|Trankimazin|Novo-Alprazol"
D002998,CHEMICAL,Clonazepam,"|2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-|Ro 54023|Rivotril|Clonazepam|clonazepam|Ro 5-4023|Klonopin|Antelepsin"
NEW04965,CHEMICAL,new potent benzodiazepine,new potent benzodiazepine
NEW04966,CHEMICAL,Low-dose repeated lipopolysaccharide pre-challenge,Low-dose repeated lipopolysaccharide pre-challenge
NEW04967,DISEASE,general depressive symptoms,general depressive symptoms
NEW04968,MENTAL_HEALTH,Bipolar Disorder PGBD Study,Bipolar Disorder PGBD Study
NEW04969,NUTRITION,lithium response,lithium response
NEW04970,CHEMICAL,low-dose aspirin,low-dose aspirin
NEW04971,CHEMICAL,LLD-Li therapy,LLD-Li therapy
NEW04972,DISEASE,chronic social defeat stress,chronic social defeat stress
NEW04973,NUTRITION,Lithium therapy,Lithium therapy
NEW04974,CHEBI,lifesaving drug,lifesaving drug
NEW04975,DISEASE,hyperosmolar state,hyperosmolar state
NEW04976,DISEASE,psychiatric practice,psychiatric practice
D009404,DISEASE,Nephrotic Syndrome,"|Syndromes, Nephrotic|Nephrotic syndrome|Nephrotic Syndromes|nephrotic syndrome|Syndrome, Nephrotic"
NEW04977,NUTRITION,lithium serum level,lithium serum level
NEW04978,DISEASE,AKI development,AKI development
NEW04979,NUTRITION,lithium therapy duration,lithium therapy duration
D058924,CHEMICAL,Thienopyridines,"thienopyridine derivatives|Derivatives, Thienopyridine|Thienopyridine Derivatives"
D003374,CHEMICAL,Coumarins,"1,2 Benzopyrones|Benzopyran-2-ones|1,2-Benzopyrone Derivatives|1,2 Benzo Pyrones|Benzopyran 2 ones|Coumarin Derivative|1,2 Benzopyrone Derivatives|1,2-Benzo-Pyrones|Coumarine|Derivatives, Coumarin|1,2-Benzopyrones|Coumarines|Derivative, Coumarin|Coumarin|Coumarin Derivatives|Derivatives, 1,2-Benzopyrone"
NEW04980,DISEASE,vasculogenic priapism,vasculogenic priapism
NEW04981,CHEMICAL,Newer thienopyridine derivatives,Newer thienopyridine derivatives
D000077144,CHEMICAL,Clopidogrel,"SC 25990C|Clopidogrel Bisulfate|SC 25989C|Clopidogrel Hydrochloride|SR 25989|Clopidogrel, (+)(S)-isomer|Plavix|clopidogrel|Clopidogrel Sandoz|Iscover|Clopidogrel Mepha|Clopidogrel Napadisilate|Clopidogrel Besylate|Clopidogrel-Mepha|PCR-4099|Clopidogrel Besilate|PCR 4099"
D000068799,CHEMICAL,Prasugrel Hydrochloride,"CS747|Efient|747, CS|Effient|LY 640315|CS 747|Prasugrel|prasugrel|Prasugrel HCl|LY640315|LY-640315|Hydrochloride, Prasugrel|640315, LY|HCl, Prasugrel|CS-747"
D000077486,CHEMICAL,Ticagrelor,"Ticagrelor|ticagrelor|3-(7-((2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-(1-3)-triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol|AZD 6140|AZD-6140|Brilinta|AZD6140|Brilique"
D013009,DISEASE,Somnambulism,"Sleep Walking Disorder|Wandering, Nocturnal|Sleep Walking Disorders|Nocturnal Wandering|Sleepwalking|somnambulism|Sleep Walking"
NEW04982,MENTAL_HEALTH,childhood depression,childhood depression
D020315,DISEASE,Latex Hypersensitivity,"Latex Allergies|Rubber Latex Allergies|Allergy, Latex|Hypersensitivities, Latex|Hypersensitivity, Latex|Latex Allergy|allergies|Allergies, Rubber Latex|Allergy, Rubber Latex|Allergy, Rubber|Allergies, Rubber|Rubber Allergy|Allergies, Latex|Latex Hypersensitivities|Natural Rubber Latex Allergy|Rubber Allergies|Rubber Latex Allergy"
D020190,DISEASE,"Myoclonic Epilepsy, Juvenile","Impulsive Petit Mal Epilepsy|Juvenile Myoclonic Epilepsy of Janz|petit mal epilepsy|Epilepsy, Adolescent Myoclonic|Myoclonic Epilepsy, Juvenile, 1|Epilepsy, Juvenile Myoclonic|Myoclonic Epilepsy, Adolescent|Epilepsy, Myoclonic Juvenile|Epilepsy, Myoclonic, Juvenile|Janz Syndrome|Impulsive Petit Mal, Janz|Myoclonic Juvenile Epilepsy|myoclonic epilepsy|Janz Impulsive Petit Mal|Juvenile Epilepsy, Myoclonic|JMEs (Juvenile Myoclonic Epilepsy)|Janz Juvenile Myoclonic Epilepsy|Petit Mal, Impulsive|JME (Juvenile Myoclonic Epilepsy)|Adolescent Myoclonic Epilepsy|Petit Mal, Impulsive, Janz|Juvenile Myoclonic Epilepsy"
NEW04983,DISEASE,bipolar spectrum comorbidity,bipolar spectrum comorbidity
NEW04984,CHEMICAL,PG subjects,PG subjects
NEW04985,CHEMICAL,Vaccine administration,Vaccine administration
NEW04986,DISEASE,low mood,low mood
C003402,CHEMICAL,sapropterin [Supplementary Concept],tetrahydrobiopterin|BH4|Biopterin/analogs  and  derivatives
NEW04987,CHEMICAL,antidepressant treatments,antidepressant treatments
NEW04988,CHEMICAL,LPS-induced microglia/macrophage M1-polarization,LPS-induced microglia/macrophage M1-polarization
NEW04989,DISEASE,manic switch,manic switch
NEW04990,DISEASE,Hyperammonemic encephalopathy,Hyperammonemic encephalopathy
NEW04991,CHEMICAL,plasma ammonia,plasma ammonia
NEW04992,DISEASE,bacterial sepsis,bacterial sepsis
NEW04993,CHEMICAL,NCG,NCG
NEW04994,DISEASE,neonatal hyperammonemia,neonatal hyperammonemia
D007792,CHEMICAL,Lactulose,Duphalac|Amivalex|Lactulose|lactulose|Normase
NEW04995,DISEASE,neurological toxicity,neurological toxicity
NEW04996,DISEASE,skin disorders,skin disorders
D008107,DISEASE,Liver Diseases,"|Dysfunction, Liver|Liver Disease|Diseases, Liver|hepatic impairment|Liver Dysfunction|liver dysfunction|Liver Dysfunctions|Disease, Liver|Dysfunctions, Liver"
D013262,DISEASE,Stevens-Johnson Syndrome,"|Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum|Lyell's Syndrome|Lyell Syndrome|Syndrome, Mycoplasma-Induced Stevens-Johnson|Mycoplasma Induced Stevens Johnson Syndrome|Syndrome, Lyell's|Nonstaphylococcal Scalded Skin Syndrome|Toxic epidermal necrolysis|Stevens-Johnson Syndrome Toxic Epidermal Necrolysis|Toxic Epidermal Necrolysis Stevens Johnson Syndrome Spectrum|Stevens-Johnson Syndrome, Drug-Induced|Epidermal Necrolyses, Toxic|Epidermal Necrolysis, Toxic|Drug-Induced Stevens-Johnson Syndromes|Syndromes, Lyell's|Necrolysis, Toxic Epidermal|Toxic Epidermal Necrolyses|Mycoplasma-Induced Stevens-Johnson Syndrome|Necrolyses, Toxic Epidermal|Stevens Johnson Syndrome Toxic Epidermal Necrolysis|Stevens-Johnson Syndrome, Mycoplasma-Induced|Lyell's Syndromes|Toxic Epidermal Necrolysis Stevens-Johnson Syndrome Spectrum|Toxic Epidermal Necrolysis|Scalded Skin Syndrome, Nonstaphylococcal|Stevens-Johnson syndrome|Toxic Epidermal Necrolysis Stevens-Johnson Syndrome|Stevens-Johnson Syndromes, Drug-Induced|Drug Induced Stevens Johnson Syndrome|Stevens Johnson Syndrome|Stevens Johnson Syndrome Toxic Epidermal Necrolysis Spectrum|Mycoplasma-Induced Stevens Johnson Syndrome|Drug-Induced Stevens Johnson Syndrome|Drug-Induced Stevens-Johnson Syndrome|Toxic Epidermal Necrolysis Stevens Johnson Syndrome|Stevens-Johnson syndromes"
NEW04997,DISEASE,severe skin disorders,severe skin disorders
NEW04998,MENTAL_HEALTH,disorder behaviors,disorder behaviors
NEW04999,CHEMICAL,"genetic condition-""borderline","genetic condition-""borderline"
NEW05000,DISEASE,its's cognitive peculiarities ideas,its's cognitive peculiarities ideas
NEW05001,CHEMICAL,major condition schizophrenia-BPD,major condition schizophrenia-BPD
D011307,CHEBI,Drug Prescriptions,"Prescribing, Drug|Drug Prescription|Prescribings, Drug|Drug Prescribings|drug prescriptions|Drug Prescribing"
NEW05002,MENTAL_HEALTH,Steroid-induced psychosis,Steroid-induced psychosis
NEW05003,CHEMICAL,corticosteroid therapy,corticosteroid therapy
NEW05004,MENTAL_HEALTH,disorders comorbidity,disorders comorbidity
NEW05005,DISEASE,alcohol-substance use,alcohol-substance use
NEW05006,CHEBI,first line mood stabilizers,first line mood stabilizers
NEW05007,CHEMICAL,new antipsychotic quetiapine,new antipsychotic quetiapine
NEW05008,MENTAL_HEALTH,paranoid psychosis,paranoid psychosis
NEW05009,MENTAL_HEALTH,simple hallucinations,simple hallucinations
D008238,CHEMICAL,Lysergic Acid Diethylamide,"Lysergic acid diethylamide|Lysergic Acid Diethylamide Tartrate|LSD-25|Lysergide|LSD|Diethylamide, Lysergic Acid|lysergic acid diethylamide|Acid Diethylamide, Lysergic|LSD 25"
NEW05010,DISEASE,pseudohallucinations,pseudohallucinations
NEW05011,DISEASE,hallucinatory experience,hallucinatory experience
NEW05012,DISEASE,minimal neurocognitive impairments,minimal neurocognitive impairments
NEW05013,DISEASE,recurrent manic-depressive disorders,recurrent manic-depressive disorders
NEW05014,CHEBI,NOP agonists,NOP agonists
NEW05015,DISEASE,innovative psychiatric drugs,innovative psychiatric drugs
NEW05016,DISEASE,hypersomnia attacks,hypersomnia attacks
NEW05017,MENTAL_HEALTH,chronic mental illness,chronic mental illness
NEW05018,NUTRITION,lithium antipsychotics,lithium antipsychotics
NEW05019,CHEMICAL,atypical antipsychotics,atypical antipsychotics|AAPs
NEW05020,DISEASE,Total trauma scores,Total trauma scores
NEW05021,DISEASE,comorbid psychiatric disorders,comorbid psychiatric disorders
NEW05022,CHEMICAL,lifetime antidepressant use,lifetime antidepressant use
NEW05023,DISEASE,steroid-induced psychiatric symptoms,steroid-induced psychiatric symptoms
NEW05024,CHEMICAL,Extended-release venlafaxine,Extended-release venlafaxine
NEW05025,MENTAL_HEALTH,Sexual dysfunction related,Sexual dysfunction related
NEW05026,DISEASE,Tourette symptoms,Tourette symptoms
NEW05027,DISEASE,bipolar symptomatology,bipolar symptomatology
NEW05028,DISEASE,psychiatric medications,psychiatric medications
NEW05029,NUTRITION,lithium antagonists,lithium antagonists
C488250,CHEMICAL,oleoylethanolamide [Supplementary Concept],Oleic Acids|Endocannabinoids|oleoylethanolamide
NEW05030,DISEASE,MDMA-induced deficits,MDMA-induced deficits
NEW05031,CHEBI,endogenous peroxiproliferator-activated receptor-alpha PPAR-alpha agonist,endogenous peroxiproliferator-activated receptor-alpha PPAR-alpha agonist
NEW05032,CHEMICAL,OEA administration,OEA administration
NEW05033,CHEBI,PPAR-α agonist,PPAR-α agonist
NEW05034,DISEASE,stroke models,stroke models
NEW05035,CHEMICAL,octadecylpropyl sulfamide,octadecylpropyl sulfamide|SUL
NEW05036,DISEASE,lipid-related cardiovascular diseases,lipid-related cardiovascular diseases
D019821,CHEMICAL,Simvastatin,|MK733|MK 733|Zocor|simvastatin|statin|Synvinolin|MK-733
NEW05037,CHEMICAL,Lipophilic statins,Lipophilic statins
NEW05038,MENTAL_HEALTH,autism disorders,autism disorders
NEW05039,CHEMICAL,Dopamine RSS,Dopamine RSS
NEW05040,CHEMICAL,DA denervation,DA denervation
NEW05041,DISEASE,hand dexterity,hand dexterity
NEW05042,CHEMICAL,Basal dopamine levels,Basal dopamine levels
NEW05043,DISEASE,NQO1 deficiency,NQO1 deficiency
NEW05044,CHEBI,D1 agonist,D1 agonist
NEW05045,CHEMICAL,dopamine neurotransmitter,dopamine neurotransmitter
NEW05046,CHEMICAL,Dopamine system,Dopamine system
D016627,CHEMICAL,Oxidopamine,"|6-Hydroxydopamine|Oxidopamine Hydrochloride|Hydrochloride, Oxidopamine|6-OHDA|Hydrobromide, Oxidopamine|6-hydroxydopamine|6 Hydroxydopamine|Oxidopamine Hydrobromide"
NEW05047,CHEMICAL,dopamine content,dopamine content
NEW05048,CHEMICAL,tyrosine hydroxylase immunoreactivity,tyrosine hydroxylase immunoreactivity
NEW05049,DISEASE,impaired motor functions,impaired motor functions
NEW05050,CHEMICAL,DA depletion,DA depletion
NEW05051,CHEMICAL,D1- behaviors,D1- behaviors
NEW05052,DISEASE,Chronic abuse,Chronic abuse
NEW05053,DISEASE,long-lasting cognitive impairment,long-lasting cognitive impairment
NEW05054,DISEASE,drug-driven behavior,drug-driven behavior
NEW05055,CHEMICAL,different dopamine receptors,different dopamine receptors
NEW05056,DISEASE,heroin-induced cognitive impairment,heroin-induced cognitive impairment
NEW05057,CHEBI,botanical drug,botanical drug
NEW05058,CHEBI,ethical drug,ethical drug
NEW05059,CHEMICAL,GAD activities,GAD activities
NEW05060,CHEMICAL,Gamma-aminobutyric acid GABA receptors,Gamma-aminobutyric acid GABA receptors
D051245,DISEASE,Retinal Bipolar Cells,"retinal bipolar cells|Cell, Retinal Bipolar|Bipolar Cell, Retinal|Retinal Bipolar Cell|Cells, Retinal Bipolar|Bipolar Cells, Retinal"
NEW05061,CHEMICAL,acid 13-cis-RA,acid 13-cis-RA
NEW05062,DISEASE,severe acne,severe acne
NEW05063,DISEASE,RA catabolism,RA catabolism
NEW05064,CHEMICAL,at-RA levels,at-RA levels
NEW05065,CHEBI,vitamins A/D/E,vitamins A/D/E
NEW05066,MENTAL_HEALTH,schizophrenia vital neuroprotective roles,schizophrenia vital neuroprotective roles
NEW05067,CHEMICAL,hypovitaminosis,hypovitaminosis
NEW05068,DISEASE,RA signaling,RA signaling
NEW05069,DISEASE,acne patient,acne patient
D015474,CHEMICAL,Isotretinoin,"13-Cis-retinoic acid||Ro 4 3780|13-cis-Retinoic Acid|isotretinoin|Isotretinoin Zinc Salt, 13-cis-Isomer|13-cis-retinoic acid|Ro 4-3780|13-cis-RA|Ro 43780|Isotretinoin|Isotretinoin Zinc Salt, 13 cis Isomer|Roaccutane|13 cis Retinoic Acid|Accutane"
NEW05070,DISEASE,psychiatric effects,psychiatric effects
NEW05071,CHEMICAL,Isotretinoin use,Isotretinoin use
NEW05072,DISEASE,stress neuro inflammation,stress neuro inflammation
NEW05073,CHEMICAL,Ethanol exposure,Ethanol exposure
D013401,CHEMICAL,Sugar Alcohol Dehydrogenases,"Dehydrogenases, Sugar Alcohol|Oxidoreductases, Sugar Alcohol|alcohol dehydrogenases|Sugar Alcohol Oxidoreductases|Alcohol Dehydrogenases, Sugar|Alcohol Oxidoreductases, Sugar"
NEW05074,CHEBI,antiviral function,antiviral function
NEW05075,CHEMICAL,retinoic acid signaling pathway,retinoic acid signaling pathway
NEW05076,DISEASE,depression-related behavior,depression-related behavior
NEW05077,CHEMICAL,retinoic acid signaling,retinoic acid signaling
D051739,DISEASE,Microphthalmia-Associated Transcription Factor,"Transcription Factor, Microphthalmia-Associated|Microphthalmia Associated Transcription Factor|microphthalmia|Transcription Factor Microphthalmia|Microphthalmia, Transcription Factor|MITF Protein|MITF Transcription Factor"
D000074122,DISEASE,Short Stature Homeobox Protein,SHOXY Protein|GCFX Protein|SHOX Protein|short stature|PHOG Protein
NEW05078,DISEASE,microcephally dysmorphogenesis,microcephally dysmorphogenesis
D018168,CHEMICAL,"Receptors, Retinoic Acid","Retinoic Acid Receptors|Retinoic Acid-Binding Proteins|retinoic acid|Receptor, Retinoic Acid|Proteins, Retinoic Acid-Binding|Retinoic acid|Retinoic Acid Binding Proteins|RA|Retinoic Acid Receptor"
NEW05079,CHEBI,antagonistic to retinol,antagonistic to retinol|Vitamin A
D054840,CHEBI,"Retinol-Binding Proteins, Cellular","Retinol-Binding Protein 1, Cellular|Retinol Binding Protein 2|Retinol|Cellular Retinol Binding Protein|Cellular Retinol-Binding Protein I|Retinol-Binding Protein 2, Cellular|Retinol-Binding Protein 1|Retinol-Binding Protein (Type 2)|Cellular Retinol-Binding Proteins|Retinol Binding Protein 1|Cellular Retinol Binding Protein I|Retinol Binding Protein II, Cellular|Retinol Binding Protein 2, Cellular|Retinol Binding Protein 1, Cellular|retinol|retinol binding protein|Retinol binding protein|Retinol-Binding Protein II, Cellular|Retinol Binding Proteins, Cellular"
NEW05080,CHEMICAL,osmotic-release oral-system methylphenidate remission rate,osmotic-release oral-system methylphenidate remission rate
NEW05081,MENTAL_HEALTH,ADHD co-deficiency,ADHD co-deficiency
NEW05082,MENTAL_HEALTH,ADHD inattention subscale,ADHD inattention subscale
NEW05083,CHEBI,Vitamins A,Vitamins A
NEW05084,NUTRITION,Omega-3 fatty acid supplementation,Omega-3 fatty acid supplementation
NEW05085,DISEASE,autistic children,autistic children
NEW05086,CHEMICAL,more VA deficiencies,more VA deficiencies
C115632,CHEMICAL,"COG5 protein, human [Supplementary Concept]","% GTC|Adaptor Proteins, Vesicular Transport"
NEW05087,CHEMICAL,baso-kisei,baso-kisei
C024070,CHEMICAL,pycnogenols [Supplementary Concept],French maritime pine|Flavonoids|Pycnogenol|Plant Extracts
NEW05088,CHEMICAL,1-month Pycnogenol administration,1-month Pycnogenol administration
C516941,CHEMICAL,peracetylated epigallocatechin-3-gallate [Supplementary Concept],EGCG|Acetates|Catechin/analogs  and  derivatives|(-)-Epigallocatechin-3-gallate|(-)-epigallocatechin-3-gallate|epigallocatechin 3-gallate|epigallocatechin-3-gallate
NEW05089,CHEMICAL,important polyphenol,important polyphenol
NEW05090,CHEMICAL,Tetrapleura tetraptera,Tetrapleura tetraptera
NEW05091,CHEMICAL,High-temperature-processed green tea extract,HTP-GTE|High-temperature-processed green tea extract
NEW05092,CHEMICAL,HTP-GTE intake,HTP-GTE intake
NEW05093,CHEMICAL,cognitive-decline phenotypes,cognitive-decline phenotypes
NEW05094,CHEMICAL,HTP-GTE supplementation,HTP-GTE supplementation
NEW05095,NUTRITION,Catechins,Catechins
NEW05096,NUTRITION,catechins,catechins
NEW05097,CHEMICAL,Amyloid-β Aβ production,Amyloid-β Aβ production
NEW05098,CHEMICAL,G single nucleotide polymorphism,G single nucleotide polymorphism
NEW05099,CHEBI,important carriers,important carriers
NEW05100,DISEASE,neurological pathologies,neurological pathologies
NEW05101,CHEMICAL,serotonin transporter-linked polymorphic region,serotonin transporter-linked polymorphic region
NEW05102,MENTAL_HEALTH,Cannabis Abuse Screening Test,Cannabis Abuse Screening Test
NEW05103,CHEBI,hepatic virus carriers,hepatic virus carriers
C567511,DISEASE,"Chromosome 22q11.2 Deletion Syndrome, Distal [Supplementary Concept]","Abnormalities, Multiple|Chromosome Deletion|Chromosomes, Human, Pair 22|22q11.2 deletion syndrome|DiGeorge Syndrome"
NEW05104,DISEASE,neurogenetic disorder,neurogenetic disorder
NEW05105,CHEMICAL,Glutathione S-transferase A1*B polymorphism,Glutathione S-transferase A1*B polymorphism
NEW05106,MENTAL_HEALTH,schizophrenia diagnosis,schizophrenia diagnosis
NEW05107,CHEBI,non-B carriers,non-B carriers
NEW05108,CHEBI,Premutation carriers,Premutation carriers
NEW05109,CHEBI,premutation carriers,premutation carriers
NEW05110,CHEBI,FMR1 premutation carriers,FMR1 premutation carriers
NEW05111,CHEMICAL,common BDNF SNP,common BDNF SNP
NEW05112,DISEASE,stroke recovery,stroke recovery
NEW05113,DISEASE,DRD patients,DRD patients
NEW05114,CHEMICAL,single l-dopa dose,single l-dopa dose
NEW05115,CHEMICAL,complex tumor microenvironment,complex tumor microenvironment|Acute toxic-metabolic encephalopathy|TME
NEW05116,CHEBI,STin2.12 repeat carrier,STin2.12 repeat carrier
NEW05117,MENTAL_HEALTH,schizophrenia occurrence,schizophrenia occurrence
NEW05118,CHEBI,STin2.12 repeat carriers,STin2.12 repeat carriers
NEW05119,MENTAL_HEALTH,schizophrenia cases,schizophrenia cases
NEW05120,CHEMICAL,higher peripheral NO metabolite,higher peripheral NO metabolite
NEW05121,CHEMICAL,NOx- concentration,NOx- concentration
NEW05122,MENTAL_HEALTH,depression symptom severity,depression symptom severity
NEW05123,CHEBI,unmodified modified based carriers,unmodified modified based carriers
NEW05124,DISEASE,malignancies glioblastomas,malignancies glioblastomas
C547076,CHEMICAL,tafamidis [Supplementary Concept],Benzoxazoles|tafamidis
NEW05125,DISEASE,tetrameric TTR,tetrameric TTR
NEW05126,CHEBI,5-HTTLPR/rs25531 LALA genotype carriers,5-HTTLPR/rs25531 LALA genotype carriers
NEW05127,MENTAL_HEALTH,anxiety traits,anxiety traits
NEW05128,CHEBI,rs2146323 A- carriers,rs2146323 A- carriers
NEW05129,MENTAL_HEALTH,fewer hallucinations,fewer hallucinations
NEW05130,DISEASE,non-psychotic psychiatric disorder,non-psychotic psychiatric disorder
NEW05131,CHEBI,C-allele carriers,C-allele carriers
C000608144,CHEMICAL,"MCHR2-AS1 long non-coding RNA, human [Supplementary Concept]","MCHR2-AS1|RNA, Long Noncoding"
NEW05132,DISEASE,amyloid pathologies,amyloid pathologies
NEW05133,CHEBI,female premutation carriers,female premutation carriers
NEW05134,DISEASE,CGG-repeats stretch,CGG-repeats stretch
NEW05135,DISEASE,late-onset neurodegenerative disorder Fragile X-associated tremor-ataxia syndrome,late-onset neurodegenerative disorder Fragile X-associated tremor-ataxia syndrome
NEW05136,MENTAL_HEALTH,neurodevelopmental Fragile X syndrome,neurodevelopmental Fragile X syndrome
NEW05137,MENTAL_HEALTH,Fragile X Mental Retardation FMR1 gene,Fragile X Mental Retardation FMR1 gene
NEW05138,CHEMICAL,serotonin transporter gene's,serotonin transporter gene's
NEW05139,DISEASE,early-life adversity,early-life adversity
NEW05140,MENTAL_HEALTH,recurrent depressive disorder,recurrent depressive disorder
NEW05141,CHEMICAL,Urea Cycle Rare disorders,Urea Cycle Rare disorders
NEW05142,CHEBI,mitochondrial carrier mutations,mitochondrial carrier mutations
NEW05143,NUTRITION,fatty acid amide hydrolase FAAH C385A polymorphism,fatty acid amide hydrolase FAAH C385A polymorphism
NEW05144,CHEBI,often carriers,often carriers
NEW05145,CHEBI,duplication carriers,duplication carriers
NEW05146,CHEBI,older female FMR1 premutation carriers,older female FMR1 premutation carriers
NEW05147,CHEBI,Female carriers,Female carriers
D013959,DISEASE,Thyroid Diseases,"|Thyroid Disease|Disease, Thyroid|Diseases, Thyroid|thyroid disease|Thyroid disorders"
D016649,DISEASE,Primary Ovarian Insufficiency,"Ovarian Failure, Premature|Gonadotropin-Resistant Ovary Syndrome|X-Linked Hypergonadotropic Ovarian Failure|FMR1-Related Primary Ovarian Insufficiency|Hypergonadotropic Ovarian Failure, X-Linked|Premature Ovarian Failure 1|Gonadotropin Resistant Ovary Syndrome|Resistant Ovary Syndrome|FMR1 Related Primary Ovarian Insufficiency|Primary Ovarian Insufficiency, Fragile X-Associated|Fragile X Premature Ovarian Failure|Premature Ovarian Failure, X-Linked|Primary Ovarian Insufficiency, Fragile X Associated|fragile X-associated primary ovarian insufficiency|ovarian failure|Premature Ovarian Failure, X Linked|Fragile X-Associated Primary Ovarian Insufficiency|Hypergonadotropic Ovarian Failure, X Linked|Fragile X Associated Primary Ovarian Insufficiency|Premature Ovarian Failure|primary ovarian insufficiency|Ovarian Insufficiency, Primary|X Linked Hypergonadotropic Ovarian Failure"
NEW05148,DISEASE,neurotoxic metals,neurotoxic metals
NEW05149,CHEBI,human leukocyte antigen class DQB1 allele,human leukocyte antigen class DQB1 allele
NEW05150,CHEBI,external toxic agents,external toxic agents
NEW05151,CHEBI,human leukocyte antigen HLA class allele,human leukocyte antigen HLA class allele
NEW05152,MENTAL_HEALTH,narcolepsy onset,narcolepsy onset
NEW05153,CHEMICAL,CPT1B carnitine palmitoyltransferase,CPT1B carnitine palmitoyltransferase
NEW05154,CHEBI,human leukocyte antigen (HLA)-DRB1 15:01-DQB1 haplotype,human leukocyte antigen (HLA)-DRB1 15:01-DQB1 haplotype
NEW05155,CHEMICAL,CCR genes,CCR genes
NEW05156,DISEASE,Spanish DAS,Spanish DAS
NEW05157,NUTRITION,Spanish HIV/AIDS patients,Spanish HIV/AIDS patients
NEW05158,MENTAL_HEALTH,death anxiety,death anxiety
NEW05159,CHEMICAL,first-line medicine,first-line medicine
NEW05160,DISEASE,common childhood-onset neurodevelopmental disorder,common childhood-onset neurodevelopmental disorder
NEW05161,CHEMICAL,functional intronic CDH13 SNP rs2199430,functional intronic CDH13 SNP rs2199430
NEW05162,DISEASE,childhood ASD,childhood ASD
D058978,CHEMICAL,Reduced Folate Carrier Protein,"Protein, SLC19a1|carrier protein|Reduced Folate Carrier|Folate Transporter 1|Folate Carrier, Reduced|SLC19a1 Protein|Solute Carrier Family 19, Member 1|Transporter 1, Folate|SLC19A1|Transporter, SLC19a1|SLC19a1 Transporter|Carrier, Reduced Folate"
NEW05163,CHEMICAL,NOS-I,NOS-I
NEW05164,DISEASE,hyperactive/impulsive phenotypes,hyperactive/impulsive phenotypes
NEW05165,DISEASE,self-directed aggression relative,self-directed aggression relative
NEW05166,CHEMICAL,Oxytocin receptor gene polymorphisms,Oxytocin receptor gene polymorphisms
NEW05167,DISEASE,Fragile X Associated Tremor Ataxia Syndrome FXTAS syndrome,Fragile X Associated Tremor Ataxia Syndrome FXTAS syndrome
NEW05168,CHEBI,solute carrier transporters,solute carrier transporters
NEW05169,CHEBI,Female S carriers,Female S carriers
NEW05170,CHEMICAL,serotonergic discrepancies,serotonergic discrepancies
NEW05171,CHEMICAL,OXTR SNP rs2254298,OXTR SNP rs2254298
NEW05172,MENTAL_HEALTH,nervosa neural responses,nervosa neural responses
NEW05173,CHEMICAL,particular Ser704Cys SNP,particular Ser704Cys SNP
NEW05174,MENTAL_HEALTH,Phobic anxiety,Phobic anxiety
NEW05175,DISEASE,Paranoid ideation,Paranoid ideation
C030284,CHEMICAL,3-methoxy-4-hydroxyphenylglycol sulfate [Supplementary Concept],3-methoxy-4-hydroxyphenylglycol|Methoxyhydroxyphenylglycol/analogs  and  derivatives
NEW05176,DISEASE,drug-free psychiatric patients,drug-free psychiatric patients
NEW05177,DISEASE,Psychiatric conditions,Psychiatric conditions
NEW05178,CHEMICAL,peripheral melatonin levels,peripheral melatonin levels
NEW05179,DISEASE,venous ammonemia,venous ammonemia
NEW05180,CHEMICAL,arterio-venous ammonia difference,arterio-venous ammonia difference
NEW05181,CHEMICAL,oral glucose administration,oral glucose administration
NEW05182,DISEASE,peripheral muscular ammonia uptake,peripheral muscular ammonia uptake
C072188,CHEMICAL,"vasopressin, 1-(beta-mercapto-beta,beta-cyclopentamethylene propionic acid)-(O-ethyl)Tyr(2)-Val(4)-Lys(8)-N(6)-carboxytetramethylrhodamine- [Supplementary Concept]",propionic acid|Lypressin/analogs  and  derivatives|PPA|Propionic acid
NEW05183,CHEMICAL,propionic acid-treated,propionic acid-treated
NEW05184,CHEMICAL,thiobarbituric acid reactive species,thiobarbituric acid reactive species
D005978,CHEMICAL,Glutathione,"Reduced Glutathione|gamma L Glu L Cys Gly|Glutathione, Reduced|gamma L Glutamyl L Cysteinylglycine|reduced glutathione|gamma-L-Glutamyl-L-Cysteinylglycine|gamma-L-Glu-L-Cys-Gly"
D053701,CHEMICAL,"Receptors, Interleukin-10","IL 10 Receptor|Receptor, Interleukin 10|Interleukin-10 Receptor|interleukin-10|IL-10 Receptor|Receptors, IL 10|Receptor, IL-10|Interleukin 10 Receptors|Interleukin 10 Receptor|Receptor, Interleukin-10|Receptors, Interleukin 10|Receptors, IL-10|IL-10 Receptors|Interleukin-10 Receptors"
NEW05185,CHEMICAL,postnatal acid-induced social impairment,postnatal acid-induced social impairment
NEW05186,DISEASE,prenatal VPA-induced social impairment,prenatal VPA-induced social impairment
NEW05187,DISEASE,VPA-induced autistic phenotypes,VPA-induced autistic phenotypes
NEW05188,CHEMICAL,glutamate-modulating mood-stabilizing drugs,glutamate-modulating mood-stabilizing drugs
NEW05189,DISEASE,female manic patients,female manic patients
NEW05190,MENTAL_HEALTH,cycloid psychosis,cycloid psychosis
NEW05191,DISEASE,hypocortisolism,hypocortisolism
NEW05192,CHEMICAL,cortisol long-term stress,cortisol long-term stress
NEW05193,DISEASE,dendritic hypertrophy,dendritic hypertrophy
D017668,CHEMICAL,Age of Onset,Age at Onset|Age-at-onset|Age-at-Onset|Onset Age
NEW05194,MENTAL_HEALTH,anorgasmia,anorgasmia
NEW05195,CHEBI,drug mechanism,drug mechanism
D020908,CHEMICAL,"Calcium Channels, R-Type","Calcium Channel, R-Type|Calcium Channels, R Type|R-Type Calcium Channel|R Type Calcium Channels|R Type VDCC|R Type Voltage Dependent Calcium Channels|R-Type VDCC|calcium channels|R-Type Voltage-Dependent Calcium Channels|Channel, R-Type Calcium|R Type Calcium Channel|VDCC, R-Type|R-Type Calcium Channels"
NEW05196,CHEMICAL,quetiapine therapy,quetiapine therapy
NEW05197,DISEASE,comorbid alcoholism,comorbid alcoholism
NEW05198,CHEMICAL,offending drug,methotrexate|offending drug
NEW05199,CHEBI,cytotoxic drug,cytotoxic drug
NEW05200,CHEBI,opiate antagonist treatment,opiate antagonist treatment
NEW05201,CHEMICAL,acid turnover,acid turnover
NEW05202,NUTRITION,brain phospholipids,brain phospholipids
NEW05203,DISEASE,Nausea/vomiting,Nausea/vomiting
NEW05204,DISEASE,sedation gain,sedation gain
NEW05205,CHEMICAL,anti-ADHD medications,anti-ADHD medications
NEW05206,CHEMICAL,novel antipsychotic drug quetiapine,novel antipsychotic drug quetiapine
NEW05207,DISEASE,severe self-mutilation,severe self-mutilation
NEW05208,CHEMICAL,serotonin hypothesis,serotonin hypothesis
D007520,CHEMICAL,Isocarboxazid,Isocarboxazid|isocarboxazid|Monoamine Oxidase Inhibitors|Antidepressive Agents
NEW05209,MENTAL_HEALTH,pervasive developmental disorder,pervasive developmental disorder
D013981,DISEASE,Tic Disorders,"|Post Traumatic Tic Disorder|Tic Disorder, Childhood|Post-Traumatic Tic Disorders|Motor or Vocal Tic Disorder, Chronic|Tic Disorders, Childhood|Tic Disorders, Transient|Tic Disorder, Vocal|Childhood Tic Disorders|Motor Tic Disorder|Vocal Tic Disorders|Chronic Motor or Vocal Tic Disorder|Vocal Tic Disorder|Tic Disorder, Post-Traumatic|Transient Tic Disorder|tic disorders|Tic Disorders, Vocal|Transient Tic Disorders|Tic Disorder|Tic Disorder, Chronic Motor or Vocal|Motor Tic Disorders|Tic Disorder, Transient|tic-like symptoms|Tic Disorders, Post-Traumatic|tic disorder|Childhood Tic Disorder|Post-Traumatic Tic Disorder|Tic Disorder, Post Traumatic|Tic Disorder, Motor|motor tic|Tic Disorders, Motor"
NEW05210,MENTAL_HEALTH,adolescent onset schizophrenia,adolescent onset schizophrenia
NEW05211,CHEBI,useful drug,useful drug
NEW05212,MENTAL_HEALTH,resistant childhood schizophrenia,resistant childhood schizophrenia
NEW05213,DISEASE,adolescent onset schizophrenic patients,adolescent onset schizophrenic patients
D000275,MENTAL_HEALTH,Adjustment Disorders,"Reactive Disorder|Adjustment disorder =|Disturbance, Transient Situational|Reactive Depressions|Adjustment disorder|Reactive Disorders|Disorder, Reactive|Reaction, Anniversary|Situational Disturbance, Transient|Depression, Reactive|Disorders, Reactive|Reactions, Anniversary|Transient Situational Disturbance|Anniversary Reaction|Transient Situational Disturbances|Disorders, Adjustment|Depressions, Reactive|Disorder, Adjustment|Disturbances, Transient Situational|reactive depression|Situational Disturbances, Transient|Reactive Depression|Anniversary Reactions|Adjustment Disorder|adjustment disorder"
NEW05214,CHEMICAL,COVID-19 group,COVID-19 group
NEW05215,DISEASE,common psychiatric symptom,common psychiatric symptom
NEW05216,MENTAL_HEALTH,insomnia symptoms,insomnia symptoms
NEW05217,DISEASE,psychiatric inpatient settings,psychiatric inpatient settings
NEW05218,DISEASE,acute psychotic disorders,acute psychotic disorders
NEW05219,CHEBI,dissociative drug,dissociative drug
NEW05220,DISEASE,WMC errors,WMC errors
NEW05221,CHEMICAL,full D1 receptor agonist dihydrexidine,full D1 receptor agonist dihydrexidine|DHX
NEW05222,CHEMICAL,"(+/-)-trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine hydrochloride","(+/-)-trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine hydrochloride"
NEW05223,CHEMICAL,ethanol self-administration,ethanol self-administration
NEW05224,CHEMICAL,oleoylethanoloamide,oleoylethanoloamide
NEW05225,CHEBI,PPARα agonists,PPARα agonists
NEW05226,CHEMICAL,"3,6'-dithioPom","DP|3,6'-dithioPom"
D018887,MENTAL_HEALTH,Landau-Kleffner Syndrome,"Acquired Epileptiform Aphasia|LKS|Epileptic Aphasias, Acquired|Landau Kleffner Acquired Epileptiform Aphasia|Acquired Aphasia with Convulsive Disorder|Acquired Epileptic Aphasias|Epileptiform Aphasias, Acquired|Acquired Epileptic Aphasia|Aphasia, Acquired Epileptic|Landau-Kleffner Acquired Epileptiform Aphasia|Epileptiform Aphasia, Acquired|Landau Kleffner Syndrome|Acquired Epileptiform Aphasias|Aphasia, Acquired, With Convulsive Disorder|acquired aphasia|Aphasia, Epileptic, Acquired|Epileptic Aphasia, Acquired|Syndrome, Landau-Kleffner|Landau-Kleffner syndrome|Acquired Childhoood Aphasia with Convulsive Disorder"
NEW05227,CHEMICAL,intensive naming therapy,intensive naming therapy|INT
NEW05228,DISEASE,related cognitive posttraumatic deficits,related cognitive posttraumatic deficits
NEW05229,CHEMICAL,REM sleep-induction-test,REM sleep-induction-test
NEW05230,DISEASE,depressives,depressives
NEW05231,DISEASE,tremor features,tremor features
NEW05232,DISEASE,Demented PD patients =,Demented PD patients =
NEW05233,CHEMICAL,rivastigmine mean dose,rivastigmine mean dose
NEW05234,DISEASE,demented PD patients,demented PD patients
NEW05235,CHEBI,active cholinergic agent,active cholinergic agent
NEW05236,DISEASE,chloroquine-resistant areas,chloroquine-resistant areas
NEW05237,DISEASE,malaria prophylaxis,malaria prophylaxis
NEW05238,MENTAL_HEALTH,self-limiting psychosis,self-limiting psychosis
NEW05239,CHEBI,antimalarial mefloquine,antimalarial mefloquine
NEW05240,CHEMICAL,nitric oxide (NO)-cyclic guanosine monophosphate cGMP cascade,nitric oxide (NO)-cyclic guanosine monophosphate cGMP cascade
D000962,CHEBI,Antimalarials,"Anti Malarial|Antimalarial Drug|antimalarial drugs|Anti-Malarials|Antimalarial Drugs|Antimalarial|Anti-Malarial|antimalarial agents|Agents, Antimalarial|Antimalarial Agents|Anti Malarials|Antimalarial Agent|antimalarials|Drugs, Antimalarial|antimalarial|Drug, Antimalarial|antimalarial drug|Agent, Antimalarial"
D002229,CHEMICAL,Carbenoxolone,"Carbenoxalone|Glycyrrhetinic Acid 3-O-hemisuccinate|Biogastrone|18alpha Glycyrrhetinic Acid 3beta O Hemisuccinate|Carbosan|Sanodin|Bioral|Carbenoxolone Sodium|18alpha-Glycyrrhetinic Acid 3beta-O-Hemisuccinate|3-O-hemisuccinate, Glycyrrhetinic Acid|CBX|Pharmaxolon|carbenoxolone|Acid 3-O-hemisuccinate, Glycyrrhetinic|Glycyrrhetinic Acid 3 O hemisuccinate|Duogastrone|Carbeneoxolone|18alpha Carbenoxolone|3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic Acid|18alpha-Carbenoxolone|Acid 3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic|Carbenoxolone Disodium Salt"
D043564,CHEMICAL,Inorganic Pyrophosphatase,"Proton-Pumping Inorganic Pyrophosphatase|Inorganic Pyrophosphatase, Pyrophosphate-Energized|Proton-Translocating Pyrophosphatase|Proton Translocating Pyrophosphatase|Pyrophosphatase, Proton-Translocating|Pyrophosphatase, Inorganic|H+-Pyrophosphatase|Pyrophosphate-Energized Inorganic Pyrophosphatase|Pyrophosphatase, Proton-Pumping Inorganic|Proton Pumping Inorganic Pyrophosphatase|Inorganic pyrophosphate|Pyrophosphatase, Pyrophosphate-Energized Inorganic|Pyrophosphate Energized Inorganic Pyrophosphatase|H(+)-PPase|H+ Pyrophosphatase|Inorganic Pyrophosphatase, Proton-Pumping"
D008179,DISEASE,"Lupus Erythematosus, Discoid","Lupus Erythematosus, Chronic Cutaneous|discoid lupus|Lupus Erythematosus, Cutaneous, Chronic|Discoid Lupus Erythematosus"
D011796,CHEMICAL,Quinacrine,"|Quinacrine Dihydrochloride, Dihydrate|Quinacrine Dihyrochloride, (R)-Isomer|Quinacrine Hydrochloride|Quinacrine Monomesylate|Monohydrochloride, Quinacrine|Monomesylate, Quinacrine|Dihydrochloride, Quinacrine|Quinacrine, (S)-Isomer|Quinacrine Dihyrochloride, (S)-Isomer|Monoacetate, Quinacrine|Atebrin|Quinacrine, (R)-Isomer|Quinacrine, (+-)-Isomer|Hydrochloride, Quinacrine|Mepacrine|Quinacrine Monohydrochloride|Quinacrine Dimesylate|Quinacrine Dihydrochloride|Dimesylate, Quinacrine|Quinacrine Monoacetate|Atabrine|Acrichine|quinacrine hydrochloride"
D002738,CHEMICAL,Chloroquine,"|Khingamin|Sulphate, Chloroquine|Arechine|Chloroquine|Chloroquine Sulphate|Aralen|chloroquine|Nivaquine|Arequin|Chingamin|Chlorochin|Sulfate, Chloroquine|Chloroquine Sulfate"
NEW05241,DISEASE,chloroquine-resistant malaria,chloroquine-resistant malaria
NEW05242,CHEMICAL,camara,camara|LCEO
D064687,CHEMICAL,Diarylquinolines,"Derivatives, Diaryl Quinoline|Derivative, Diarylquinoline|Diarylquinoline Derivatives|Diarylquinoline|Quinoline Derivatives, Diaryl|Quinoline derivatives|Derivatives, Diarylquinoline|Quinoline Derivative, Diaryl|Derivative, Diaryl Quinoline|Diaryl Quinoline Derivatives|Diarylquinoline Derivative|Diaryl Quinoline Derivative"
D019575,DISEASE,"Blindness, Cortical","Anton's Syndrome|blindness|Blindnesses, Reversible Cortical|Cortical Blindnesses, Reversible|Blindness, Cortical, Post-Ictal|Reversible Cortical Blindness|Syndrome, Anton-Babinski|Cortical Blindness, Reversible|Reversible Cortical Blindnesses|Cortical Blindness|Anton Babinski Syndrome|Blindness, Cortical, Transient|Anton-Babinski Syndrome|Transient Antons Syndrome|Syndrome, Anton's|Anton's Syndrome, Transient|Transient Anton's Syndrome|Transient Anton Syndrome|Blindness|Antons Syndrome|Blindness, Reversible Cortical|Syndrome, Transient Anton's|Anton Syndrome|Syndrome, Anton|Psychic Denial of Blindness"
NEW05243,CHEMICAL,quinine overdose,quinine overdose
D000655,CHEMICAL,Amodiaquine,"Amodiachin|Hydrochloride, Amodiaquine|Amodiaquine|Camoquin|Flavoquine|Amodiaquin|Camoquine|Amodiaquine Hydrochloride"
NEW05244,DISEASE,gastrointestinal symptoms,gastrointestinal symptoms
D035923,DISEASE,Hepatitis delta Antigens,"delta Antigen, Hepatitis|Hepatitis delta Antigen|delta Antigen|HDAg|delta Antigens, Hepatitis|Antigen, delta|Antigens, Hepatitis delta|hepatitis|Antigen, Hepatitis delta|Hepatitis D Antigens|Antigens, Hepatitis D|Hepatitis D Antigen|Antigen, Hepatitis D"
NEW05245,CHEMICAL,primaquine overdose,primaquine overdose
D004830,DISEASE,"Epilepsy, Tonic-Clonic","|Cryptogenic Tonic-Clonic Epilepsy|Convulsions, Grand Mal|Tonic Clonic Convulsions|Seizure Disorder, Tonic-Clonic|Epilepsies, Cryptogenic Tonic-Clonic|Tonic-Clonic Convulsion Disorder|Convulsion, Tonic Clonic|Seizure Disorders, Tonic-Clonic|Convulsion Syndromes, Tonic-Clonic|Tonic-Clonic Convulsion Syndrome|Seizure Syndrome, Tonic-Clonic|Seizure Syndromes, Tonic-Clonic|Syndromes, Tonic-Clonic Seizure|Major Epilepsy|Tonic Clonic Convulsion Disorder|Epilepsies, Symptomatic Tonic-Clonic|Tonic Clonic Seizure Syndrome|Epilepsy, Tonic Clonic|Tonic-Clonic Epilepsy|Epilepsy, Major|Tonic-Clonic Convulsion Syndromes|Syndrome, Tonic-Clonic Convulsion|Tonic Clonic Convulsion Syndrome|Disorder, Tonic-Clonic Seizure|Seizure Disorder, Major Motor|Convulsion|Symptomatic Tonic-Clonic Epilepsies|Convulsions, Tonic Clonic|Tonic-Clonic Epilepsy, Symptomatic|Familial Tonic-Clonic Epilepsy|Tonic Clonic Convulsion|Tonic-Clonic Epilepsies, Familial|Epilepsy, Grand Mal|Tonic-Clonic Seizure Syndromes|Epilepsies, Tonic-Clonic|Tonic-Clonic Epilepsy, Familial|Epilepsy, Symptomatic Tonic-Clonic|Tonic-Clonic Seizure Syndrome|Convulsion Syndrome, Tonic-Clonic|Seizure Disorder, Tonic Clonic|Tonic-Clonic Epilepsy, Cryptogenic|Epilepsy, Familial Tonic-Clonic|Familial Tonic Clonic Epilepsy|Symptomatic Tonic Clonic Epilepsy|Epilepsy, Tonic-Clonic, Familial|Grand Mal Seizure Disorder|Epilepsy, Tonic-Clonic, Cryptogenic|Grand Mal Convulsions|convulsion|Syndrome, Tonic-Clonic Seizure|Tonic-Clonic Seizure Disorder|Syndromes, Tonic-Clonic Convulsion|Major Epilepsies|Tonic-Clonic Epilepsies|Tonic-Clonic Epilepsies, Cryptogenic|Cryptogenic Tonic-Clonic Epilepsies|Grand Mal Convulsion|Disorders, Tonic-Clonic Convulsion|Familial Tonic-Clonic Epilepsies|tonic-clonic seizures|Convulsion Disorders, Tonic-Clonic|Tonic-Clonic Epilepsies, Symptomatic|Epilepsy, Tonic-Clonic, Symptomatic|Disorders, Tonic-Clonic Seizure|Tonic-Clonic Convulsion Disorders|Convulsion, Grand Mal|Tonic Clonic Seizure Disorder|Seizure Disorder, Grand Mal|Epilepsies, Familial Tonic-Clonic|Major Motor Seizure Disorder|Disorder, Tonic-Clonic Convulsion|Cryptogenic Tonic Clonic Epilepsy|Grand Mal Epilepsy|Symptomatic Tonic-Clonic Epilepsy|Tonic-Clonic Seizure Disorders|tonic-clonic|Convulsion Disorder, Tonic-Clonic|Epilepsy, Cryptogenic Tonic-Clonic|clonic convulsions"
D011797,CHEMICAL,Quinacrine Mustard,"Yperite, Acrichine|Acrichine Yperite|quinacrine|Mustard, Quinacrine|Quinacrine"
NEW05246,CHEMICAL,acridine derivative,acridine derivative
NEW05247,CHEMICAL,pyrimethamine overdose,pyrimethamine overdose
D013413,CHEMICAL,Sulfadoxine,Sulphorthodimethoxine|Fanasil|Ro 4-4393|Ro 4 4393|Sulphormetoxin|Sulformethoxine|Ro 44393|Sulforthomidine|Sulformetoxine|Sulfadoxine
NEW05248,DISEASE,Lyell syndromes,Lyell syndromes
NEW05249,CHEMICAL,dapsone poisoning,dapsone poisoning
NEW05250,DISEASE,severe methaemoglobinaemia,severe methaemoglobinaemia
NEW05251,CHEMICAL,artemesinine,artemesinine
NEW05252,CHEBI,new antimalarial,new antimalarial
NEW05253,CHEBI,antimalarial overdose,antimalarial overdose
NEW05254,CHEMICAL,lavage treatment.(ABSTRACT,lavage treatment.(ABSTRACT
NEW05255,CHEBI,individual antimalarial drugs,individual antimalarial drugs
NEW05256,CHEMICAL,to 42.7 %,amodiaquine|to 42.7 %
NEW05257,DISEASE,acute malaria studies,acute malaria studies
C001205,CHEMICAL,"fanasil, pyrimethamine drug combination [Supplementary Concept]",sulphadoxine|Sulfadoxine|Drug Combinations|Pyrimethamine
NEW05258,MENTAL_HEALTH,anxiety mental distress,anxiety mental distress
D017963,CHEMICAL,Azithromycin,"Azithromycin||Zitromax|Azadose|Ultreon|Azithromycin Monohydrate|Zentavion|Zithromax|Goxal|Vinzam|azithromycin|Monohydrate, Azithromycin|CP62993|CP-62993|Sumamed|Azithromycin Dihydrate|Azitrocin|CP 62993|Dihydrate, Azithromycin|Azythromycin|Toraseptol"
D029862,DISEASE,Prosopis,Algarrobos|Algarrobo|Prosopi|Mesquites|Mesquite|Prosopis
D027961,CHEMICAL,Potassium-Hydrogen Antiporters,"H|Potassium-Hydrogen Exchanger|H1|Potassium Hydrogen Antiporter|K(+)-H(+)-Exchanger|hydrogen|Potassium Hydrogen Exchanger|Antiporter, Potassium-Hydrogen|Antiporters, Potassium-Hydrogen|Potassium Hydrogen Antiporters|H+|Potassium-Hydrogen Antiporter"
D012216,DISEASE,Rheumatic Diseases,"rheumatic diseases|Rheumatic Disease|Diseases, Rheumatic|Rheumatism|Disease, Rheumatic"
D003078,CHEMICAL,Colchicine,"colchicine|Colchicine, (R)-Isomer|Colchicine, (+-)-Isomer"
NEW05259,MENTAL_HEALTH,initial depression,initial depression
NEW05260,CHEMICAL,b.i.d,b.i.d
D004723,CHEMICAL,Endorphins,endorphins|Endorphin
NEW05261,CHEBI,opiate agonists,opiate agonists
NEW05262,CHEMICAL,L-alpha acetyl methadyl,L-alpha acetyl methadyl|LAAM
D011431,CHEMICAL,Dextropropoxyphene,"Propoxyphene Phosphate, (S-(R*,S*))-Isomer|Hydrochloride, Propoxyphene|D Propoxyphene|Propoxyphene Hydrochloride, (R-(R*,R*))-Isomer|Propoxyphene Hydrochloride, (R-(R*,S*))-Isomer|Propoxyphene|Propoxyphene Hydrochloride, (R*,R*)-(+-)-Isomer|Propoxyphene Sulfate, (S-(R*,S*))-Isomer|Darvon|Propoxyphene Hydrochloride|Propoxyphene Maleate, (+)-Isomer|Propoxyphene Hydrochloride, (S-(R*,R*))-Isomer|propoxyphene|D-Propoxyphene"
NEW05263,CHEBI,2-adrenergic agonists,2-adrenergic agonists
NEW05264,MENTAL_HEALTH,adrenergic hyperarousal,adrenergic hyperarousal
NEW05265,CHEMICAL,arylcyclohexylamine class,arylcyclohexylamine class
NEW05266,CHEBI,abused drug,abused drug
NEW05267,CHEBI,opiate antagonist,opiate antagonist
NEW05268,CHEMICAL,inhibitor tranylcypromine,TCP|inhibitor tranylcypromine
NEW05269,CHEMICAL,opiate agonist,etonitazene|opiate agonist
C096813,CHEMICAL,"Cep104 protein, rat [Supplementary Concept]",TCP binding|Membrane Glycoproteins|Nerve Tissue Proteins
NEW05270,CHEMICAL,SWA adenosine tone,SWA adenosine tone
NEW05271,DISEASE,sleep loss,sleep loss
NEW05272,CHEMICAL,chronic GUO treatment,chronic GUO treatment
NEW05273,DISEASE,mood dysfunction,mood dysfunction
NEW05274,DISEASE,our's previous study clonic/tonic seizures,our's previous study clonic/tonic seizures
NEW05275,CHEBI,adenosine A1 receptor antagonist,adenosine A1 receptor antagonist
NEW05276,DISEASE,NMDA-evoked seizures,NMDA-evoked seizures
NEW05277,CHEMICAL,metabotropic glutamate2/3 mGlu2/3 receptor agonists,metabotropic glutamate2/3 mGlu2/3 receptor agonists
NEW05278,DISEASE,diverse neuropsychiatric illness,diverse neuropsychiatric illness
NEW05279,CHEMICAL,"phenethylamine hallucinogen (+/-)-2,5-dimethoxy-4-iodoamphetamine hydrochloride","phenethylamine hallucinogen (+/-)-2,5-dimethoxy-4-iodoamphetamine hydrochloride"
D058915,CHEMICAL,Purinergic P1 Receptor Antagonists,"Receptor Antagonist, Adenosine|Antagonists, P1 Purinoceptor|adenosine receptor antagonists|Receptor Antagonists, Adenosine|Purinergic P1 Receptor Antagonist|P1 Purinoceptor Antagonist|Antagonists, Adenosine Receptor|Antagonist, P1 Purinoceptor|Adenosine Receptor Antagonist|Purinoceptor Antagonist, P1|adenosine receptor|Purinoceptor Antagonists, P1|P1 Purinoceptor Antagonists|Antagonist, Adenosine Receptor|adenosine receptor antagonist|Adenosine Receptor Antagonists"
C027513,CHEMICAL,N(6)-cyclohexyladenosine [Supplementary Concept],Adenosine/analogs  and  derivatives|N(6)-cyclohexyladenosine
NEW05280,CHEBI,adenosine receptor agonist,adenosine receptor agonist
NEW05281,DISEASE,DOI-induced head shakes,DOI-induced head shakes
C051360,CHEMICAL,"1,3-dipropyl-8-cyclopentylxanthine [Supplementary Concept]","8-cyclopentyl-1,3-dipropylxanthine|Xanthines"
NEW05282,CHEMICAL,adenosine receptor blockers,adenosine receptor blockers
NEW05283,MENTAL_HEALTH,anxiety task,anxiety task
NEW05284,CHEMICAL,novel adenosine A1 receptor antagonist,novel adenosine A1 receptor antagonist
NEW05285,MENTAL_HEALTH,dementia disorders,dementia disorders
NEW05286,CHEMICAL,alpha(1)-blockers,alpha(1)-blockers
D011470,DISEASE,Prostatic Hyperplasia,"Prostatic Adenoma|Prostatic Adenomas|Benign Prostatic Hyperplasias|Prostatic Hyperplasia, Benign|Benign Prostatic Hyperplasia|Hypertrophies, Prostatic|Hypertrophy, Prostatic|Prostatic Hyperplasias, Benign|Hyperplasia, Prostatic|benign prostatic hyperplasia|Hypertrophy, Benign Prostatic|Prostatic Hypertrophy|Prostatic Hypertrophies|Adenomas, Prostatic|Benign Prostatic Hypertrophy|Adenoma, Prostatic|Hyperplasias, Benign Prostatic|benign prostatic hypertrophy|Hyperplasia, Benign Prostatic|Prostatic Hypertrophy, Benign"
NEW05287,DISEASE,human prostate tissue,human prostate tissue
NEW05288,DISEASE,human detrusor muscle,human detrusor muscle
C047638,CHEMICAL,alfuzosin [Supplementary Concept],alfuzosin|Quinazolines|Alfuzosin
D017311,CHEMICAL,Amlodipine,"|Amlodipine Maleate (1:1)|Istin|amlodipine|Amlodipine, (+-)-Isomer|Amlodipine Maleate|Amlor|Amlodis|Norvasc|Amlodipine, (S)-Isomer, Maleate (1:1)|Astudal|Amlodipine Besylate|Amlodipine, (+-)-Isomer, Maleate (1:1)|Amlodipine, (R)-Isomer"
D014655,MENTAL_HEALTH,Vascular Resistance,"Pulmonary Vascular Resistance|peripheral resistance|Total Peripheral Resistance|Resistance, Vascular|Resistance, Peripheral|Systemic Vascular Resistance|Resistance, Systemic Vascular|Vascular Resistance, Pulmonary|Peripheral Resistance, Total|Resistance, Pulmonary Vascular|Peripheral Resistance|systemic vascular resistance|pulmonary vascular resistance|Vascular Resistance, Systemic|Resistance, Total Peripheral"
NEW05289,CHEMICAL,baseline norepinephrine levels,baseline norepinephrine levels
NEW05290,CHEMICAL,COVID-19 knowledge,COVID-19 knowledge
NEW05291,CHEMICAL,clonidine micrograms,clonidine micrograms
NEW05292,DISEASE,suprasacral spinal cord lesions,suprasacral spinal cord lesions
NEW05293,DISEASE,chronic spinal lesions,chronic spinal lesions
NEW05294,DISEASE,hyperactive micturition reflexes,hyperactive micturition reflexes
NEW05295,DISEASE,long-term paralysis,long-term paralysis
NEW05296,CHEBI,2-adrenergic receptor agonist,2-adrenergic receptor agonist
NEW05297,CHEMICAL,Clonidine pretreatment,Clonidine pretreatment
NEW05298,DISEASE,drug-induced deficits,drug-induced deficits
NEW05299,CHEMICAL,2-adrenergic receptor agonist clonidine,2-adrenergic receptor agonist clonidine
NEW05300,CHEMICAL,mafedine,mafedine
NEW05301,CHEMICAL,zebrafish-a sensitive vertebrate aquatic model,zebrafish-a sensitive vertebrate aquatic model
NEW05302,CHEMICAL,Baseline cortisol,Baseline cortisol
NEW05303,DISEASE,Depressed patients,Depressed patients
NEW05304,CHEMICAL,Guanfacine extended-release,Guanfacine extended-release
NEW05305,MENTAL_HEALTH,adult ADHD,adult ADHD
NEW05306,DISEASE,VTE laps,VTE laps
NEW05307,DISEASE,diverse etiologies,diverse etiologies
NEW05308,CHEMICAL,dobutamine stress magnetic resonance,dobutamine stress magnetic resonance
NEW05309,DISEASE,chronic migraine,chronic migraine|CM
D005444,CHEMICAL,Flunarizine,"Flunarizine Dihydrochloride|Dihydrochloride, Flunarizine|Hydrochloride, Flunarizine|flunarizine|Sibelium|R-14950|Flunarizin|R 14950|R14950|Flunarizine Hydrochloride"
NEW05310,CHEBI,unselective beta blocker,unselective beta blockers
NEW05311,CHEMICAL,profound catecholamine stimulation,profound catecholamine stimulation
NEW05312,CHEMICAL,discharge ciprofloxacin mg tablet,discharge ciprofloxacin mg tablet
NEW05313,DISEASE,barnes akathisia rating scale,Barnes akathisia rating scale
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Akathisia,DISEASE,akathisia,drug-drug-induced akathisia
D016907,CHEBI,Adverse Drug Reaction Reporting Systems,"Drug Reaction Reporting Systems, Adverse|adverse drug reaction|Adverse Drug Reaction Reporting System|drug reaction"
D017298,CHEMICAL,Bisoprolol,"Bisoprolol, Fumarate (1:1) Salt|CL297939|Bisoprolol Fumarate|Bisoprolol, (-)-Isomer|EMD-33512|Bisoprolol Fumarate (1:1) Salt, (+-)-Isomer|CL 297939|Bisoprolol Methanesulfonate Salt|Bisoprolol, (+-)-Isomer|Concor|Bisoprolol, Fumarate (2:1) Salt|CL-297939|Fumarate, Bisoprolol|Hydrochloride, Bisoprolol|bisoprolol|Bisoprolol Hydrochloride|EMD 33512|EMD33512|Bisoprolol Fumarate (2:1) Salt, (+-)-Isomer"
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Chronic_Stress,MENTAL_HEALTH,chronic stress,Chronic stress|chronic stress
NEW05314,CHEMICAL,β2-ar signaling,β2-AR signaling
NEW05315,MENTAL_HEALTH,apoptosis resistance,apoptosis resistance
NEW05316,DISEASE,lung cancer cell,lung cancer cells
NEW05317,CHEMICAL,endogenous catecholamine,Endogenous catecholamines
NEW05318,MENTAL_HEALTH,chronic stress norepinephrine,chronic stress norepinephrine
NEW05319,CHEMICAL,circulate epinephrine,circulating epinephrine
http://purl.obolibrary.org/obo/CHEBI_48407,CHEMICAL,antiparkinson drug,antiparkinson agent|anticataplectic drugs|antidepressants
NEW05320,CHEMICAL,OR:1.34,OR:1.34
http://purl.obolibrary.org/obo/CHEBI_51080,CHEMICAL,nitrate ester,nitrate esters|nitrate esters OR:1.93
NEW05321,DISEASE,or:0.85,OR:0.85
http://purl.obolibrary.org/obo/CHEBI_87631,CHEMICAL,statin,statins|statin OR:0.77
NEW05322,CHEMICAL,OR:1.58,OR:1.58
NEW05323,CHEMICAL,0.002,0.002
NEW05324,CHEMICAL,females/24.8 %,females/24.8 %
NEW05325,DISEASE,induce hyperammonemia,induced hyperammonemia
NEW05326,CHEMICAL,ammonia clearance,ammonia clearance
NEW05327,MENTAL_HEALTH,chronic subpanic anxiety,chronic subpanic anxiety
C025655,CHEMICAL,lofexidine [Supplementary Concept],Clonidine/analogs  and  derivatives|lofexidine
http://purl.obolibrary.org/obo/SYMP_0000260,DISEASE,dry mouth,dry mouth
NEW05328,CHEMICAL,sirolimus conversion,sirolimus conversion
D020123,CHEMICAL,Sirolimus,|AY 22-989|sirolimus|I 2190A|AY 22 989|Rapamune|Rapamycin|I-2190A|I2190A|AY 22989
NEW05329,CHEMICAL,non-amphetamine stimulant,non-amphetamine stimulant
NEW05330,CHEMICAL,its 's precursor gamma-butyrolactone,its's precursor gamma-butyrolactone
NEW05331,DISEASE,obsessive-compulsive dimension,obsessive-compulsive dimension
NEW05332,CHEBI,neuroleptic drug treatment,Neuroleptic drug treatments
NEW05333,MENTAL_HEALTH,severe agitation,severe agitation
NEW05334,DISEASE,severe extrapyramidal reaction,severe extrapyramidal reactions
NEW05335,DISEASE,severe axillary hyperhidrosis,severe axillary hyperhidrosis
NEW05336,MENTAL_HEALTH,anxiety hallmark,anxiety hallmarks
NEW05337,CHEBI,direct-acting antiviral,direct-acting antivirals
NEW05338,CHEMICAL,dasabuvir (obv/ptv/r+dsv)±ribavirin,dasabuvir (OBV/PTV/r+DSV)±ribavirin|RBV
NEW05339,CHEMICAL,gt1a infection,GT1a infection
NEW05340,CHEBI,direct-acting antiviral,Direct-acting antivirals
NEW05341,CHEBI,antibacterial,antibacterials
NEW05342,CHEBI,direct-acting antiviral medication,direct-acting antiviral medications
NEW05343,CHEBI,act antiviral,acting antivirals
NEW05344,DISEASE,extrahepatic hcv disease,extrahepatic HCV diseases
NEW05345,DISEASE,global pandemic,global pandemic
NEW05346,MENTAL_HEALTH,pandemic-related anxiety,pandemic-related anxiety
NEW05347,CHEBI,multiple drug use,multiple drug use
NEW05348,MENTAL_HEALTH,mental disorder secondary,mental disorders secondary
http://purl.obolibrary.org/obo/NCBITaxon_12721,DISEASE,human immunodeficiency virus,human immunodeficiency virus infection|human immunodeficiency virus C virus
NEW05349,CHEBI,antiviral treatment,antiviral treatment
NEW05350,CHEMICAL,successful daa treatment,successful DAA treatment
D010665,CHEMICAL,Phenylpropanolamine,"|phenylpropanolamine|Phenylpropanolamine|Dexatrim|Norephedrine|Triaminic DM|Phenylpropanolamine Hydrochloride|Prolamine|Hydrochloride, Phenylpropanolamine|Propagest"
NEW05351,CHEBI,sympathomimetic agent present,sympathomimetic agent present
http://purl.obolibrary.org/obo/DOID_1229,MENTAL_HEALTH,paranoid schizophrenia,chronic paranoid schizophrenia|paranoid psychosis|Paraphrenic schizophrenia|Paranoid type schizophrenia|Paraphrenia - late|paranoid type schizophrenia subchronic state
NEW05352,DISEASE,hypertensive crisis,hypertensive crises
NEW05353,DISEASE,hypertensive crisis,Hypertensive crises
D010646,CHEMICAL,Phentolamine,"Mesylate, Phentolamine||Phentolamine Mono-hydrochloride|Phentolamine Methanesulfonate|Fentolamin|Methanesulfonate, Phentolamine|Regitine|Mono-hydrochloride, Phentolamine|Mesilate, Phentolamine|Z-Max|Phentolamine Mono hydrochloride|Rogitine|Regityn|Phentolamine Mesylate|Phentolamine Mesilate|phentolamine"
NEW05354,DISEASE,psychiatric symptom,Psychiatric symptoms
NEW05355,MENTAL_HEALTH,marked anxiety,marked anxiety
http://purl.obolibrary.org/obo/SYMP_0000412,MENTAL_HEALTH,anxiety,VCD-induced anxiety|NTG-induced anxiety|Anxiety Disorders-7|CUMS-induced anxiety|ICH-induced anxiety
NEW05356,CHEMICAL,sb334867,SB334867
NEW05357,CHEMICAL,(rs)-2-chloro-5-hydroxyphenylglycine,(RS)-2-chloro-5-hydroxyphenylglycine|CHPG
D003888,CHEBI,"Desensitization, Immunologic","Shot, Allergy|Immunologic Desensitizations|Immunotherapy, Allergen|Hyposensitization Therapies|Venom Immunotherapy|Desensitizations, Immunologic|Venom Immunotherapies|Allergen immunotherapy|Immunologic Desensitization|Allergen Immunotherapies|Allergy Shots|Hyposensitization Therapy|Allergy Shot|Allergen Immunotherapy|Immunotherapy, Venom|Therapy, Hyposensitization"
NEW05358,DISEASE,mild-to-moderate allergic asthma,mild-to-moderate allergic asthma
D000069444,CHEMICAL,Omalizumab,Xolair|Omalizumab
D000067251,DISEASE,Symptom Flare Up,"Symptom Flareups|Symptom Flaring Up|Symptom Flare-up|Worsening, Symptom|Acute Symptom Flare|Magnification, Symptom|Exacerbation, Symptom|Flare Up, Symptom|Flare-up, Symptom|Exaggeration, Symptom|Symptom Increase|Symptom Magnifications|exacerbations|Symptom Worsening|Symptom Exaggerations|Flareup, Symptom|Symptom Flareup|Symptom Flare-ups|Increase, Symptom|Symptom Exacerbation|Symptom Magnification|Symptom Exaggeration|Symptom Flare, Acute|Symptom Exacerbations|Flareups, Symptom|Flare Ups, Symptom|Acute Symptom Flares|Symptom Flare Ups|Flaring Up, Symptom|Flare-ups, Symptom"
NEW05359,DISEASE,persistent moderate-to-severe allergic asthma,persistent moderate-to-severe allergic asthma
NEW05360,CHEMICAL,recombinant humanize monoclonal anti-ige antibody,recombinant humanized monoclonal anti-IgE antibody
NEW05361,CHEBI,allergen specific ige antibody,allergen specific IgE antibodies
NEW05362,CHEBI,allergen exposure,allergen exposure
D006255,DISEASE,"Rhinitis, Allergic, Seasonal","Allergic Rhinitis, Seasonal|Pollinosis|Hay Fever|Rhinitis, Seasonal Allergic|Allergic Rhinitides, Seasonal|Pollen Allergies|Allergy, Pollen|Rhinitides, Seasonal Allergic|Fever, Hay|Pollinoses|Allergies, Pollen|Seasonal Allergic Rhinitis|Pollen Allergy|Seasonal Allergic Rhinitides|Hayfever|allergic rhinitis"
NEW05363,DISEASE,Pediatr Allergy Immunol 25:236,Pediatr Allergy Immunol 25:236
NEW05364,CHEBI,long-term allergen exposure,long-term allergen exposure
http://purl.obolibrary.org/obo/GO_0007610,DISEASE,behavior,shock/reminders-induced PTSD- behaviors|sociability- behaviors|co-existing behaviors|OCD-like behavior|restless/tense behavior|PTSD-like behaviors|PTSD-like behavior|DA-dependent behaviors|AD/HD-like behaviors|ASD-like behavior
http://purl.obolibrary.org/obo/DOID_417,DISEASE,autoimmune disease,auto-immune diseases|hypersensitivity reaction type II disease|autoimmune hypersensitivity disease
NEW05365,DISEASE,so-called alcohol-induced disease,so-called alcohol-induced diseases
NEW05366,CHEMICAL,repeat alcohol withdrawal,repeated alcohol withdrawals
NEW05367,DISEASE,potential auto-immune disease,potential auto-immune diseases
NEW05368,DISEASE,neuroimmunologic disease,Neuroimmunologic diseases
D016269,DISEASE,Milk Hypersensitivity,"Cow's Milk Protein Allergy|Allergy, Milk|Hypersensitivity, Milk|milk allergy|Cows Milk Allergy|Milk Allergy, Cow's|Cow's Milk Allergies|Milk Allergies|Milk Allergy|Milk Hypersensitivities|Cow's Milk Allergy|Allergy, Cow's Milk|Cow Milk Allergy"
D001985,CHEBI,Bronchial Provocation Tests,"Test, Bronchial Challenge|Tests, Bronchial Challenge|Endobronchial Allergen Challenge|Test, Endobronchial Challenge|Provocation Tests, Bronchial|Challenge Test, Endobronchial|Inhalation Provocation Test|Allergen Challenge, Bronchial|Bronchial Allergen Challenges|Test, Bronchial Provocation|Bronchial Provocation Test|Test, Inhalation Provocation|Tests, Inhalation Provocation|Allergen Bronchial Provocation Tests|Allergen Challenge, Endobronchial|Challenge Tests, Endobronchial|Challenges, Endobronchial Allergen|Challenge, Endobronchial Allergen|allergen|Provocation Tests, Inhalation|Challenges, Bronchial Allergen|Provocation Test, Bronchial|Provocation Test, Inhalation|Inhalation Provocation Tests|Antigen Bronchial Provocation Tests|Endobronchial Challenge Tests|Bronchial Challenge Test|Endobronchial Allergen Challenges|Bronchial Challenge Tests|Challenge, Bronchial Allergen|Challenge Tests, Bronchial|Bronchial Allergen Challenge|Endobronchial Challenge Test|Allergen Challenges, Bronchial|Challenge Test, Bronchial|Tests, Bronchial Provocation|Tests, Endobronchial Challenge|Allergen Challenges, Endobronchial"
NEW05369,DISEASE,anxiety-like behavior level,anxiety-like behavior levels
NEW05370,DISEASE,allergic cohort,allergic cohorts
NEW05371,CHEMICAL,population(s,population(s
D004597,DISEASE,Electroshock,"electroconvulsive shock|Electroconvulsive Shock|Electroshocks|Shock, Electroconvulsive|Electroconvulsive Shocks|Shocks, Electroconvulsive"
NEW05372,MENTAL_HEALTH,post-ictal analgesia,post-ictal analgesia
NEW05373,CHEBI,opiate antagonist,opiate antagonists
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Catalepsy,DISEASE,catalepsy,hypolocomotion|post-ECS catalepsy|sedation/hypnosis|m-CPP-induced hypolocomotion
NEW05374,MENTAL_HEALTH,post-ecs analgesia,post-ECS analgesia
NEW05375,DISEASE,chronic right hemiplegia effective,chronic right hemiplegia effective
D007977,CHEMICAL,Levallorphan,Naloxiphan|levallorphan|Lorfan
NEW05376,CHEMICAL,endorphin unclear,endorphins unclear
NEW05377,MENTAL_HEALTH,schizophrenia syndrome,schizophrenia syndromes
NEW05378,CHEMICAL,endorphin system,endorphin systems
NEW05379,CHEBI,choose antiepileptic drug treatment,chosen antiepileptic drug treatment
NEW05380,DISEASE,lesional epilepsy,lesional epilepsy
NEW05381,DISEASE,frontal-cortical behavioral control,frontal-cortical behavioral control
NEW05382,CHEMICAL,negative affect-anxiety,negative affect-anxiety
NEW05383,DISEASE,primary alcoholism,primary alcoholism
NEW05384,CHEMICAL,serotonin 5-hydroxytryptamine reuptake inhibitor,serotonin 5-hydroxytryptamine reuptake inhibitors
NEW05385,CHEMICAL,naloxone injection,naloxone injection
NEW05386,DISEASE,pain response,pain response
NEW05387,CHEBI,oral opiate antagonist drug,oral opiate antagonist drugs
NEW05388,DISEASE,life-threatening disorder,life-threatening disorder
D004341,CHEBI,Drug Evaluation,"Drug Evaluation Studies|Studies, Drug Evaluation|Drug Evaluation Study|drug studies|Study, Drug Evaluation|Evaluation Studies, Drug|Evaluations, Drug|Drug Evaluations|Evaluation Study, Drug|Evaluation, Drug"
D016465,MENTAL_HEALTH,Bone Marrow Purging,"Hematopoietic Stem Cell Purging|Purging, Bone Marrow|purging"
NEW05389,MENTAL_HEALTH,retardation autism disorder,retardation autism disorders
NEW05390,CHEMICAL,atypical neuroleptic risperidone,atypical neuroleptic risperidone
NEW05391,CHEBI,serotonin 2a-dopamine d2 antagonist,serotonin 2A-dopamine D2 antagonist
NEW05392,DISEASE,recurrent maladaptive gambling behavior,recurrent maladaptive gambling behavior
NEW05393,DISEASE,postprandial fullness,Postprandial fullness
http://purl.org/sig/ont/fma/fma85813,CHEMICAL,solid,solids|MLSS
NEW05394,DISEASE,functional dyspepsia,functional dyspepsia
http://purl.obolibrary.org/obo/CHEBI_59282,CHEBI,kappa-opioid receptor agonist,selective kappa-opioid receptor agonist|kappa-opioid agonists|kappa-opioid agonist|kappa-opiate agonists|kappa-opioid receptor agonist|Kappa-opioid receptor agonists|kappa-opioid receptor agonists
NEW05395,MENTAL_HEALTH,functional digestive syndrome,functional digestive syndromes
http://purl.obolibrary.org/obo/CHEBI_60606,CHEBI,opioid receptor agonist,benzodiazepine receptor agonist|Benzodiazepine receptor agonists|opioid receptor agonists|selective opioid receptor agonist|opioid receptor agonist|novel opioid receptor agonist|potent opioid receptor agonist|mixed opioid receptor agonists|benzodiazepine receptor agonists|opioid agonist|opioid agonists|opiate agonist|sufentanil|opiate agonists|mu opioid receptor partial agonist receptor antagonist|Opioid receptor agonists
NEW05396,MENTAL_HEALTH,robust analgesia,robust analgesia
http://purl.org/sig/ont/fma/fma67224,CHEMICAL,muscarinic acetylcholine receptor,muscarinic acetylcholine receptor M1 agonism|muscarinic acetylcholine receptor antagonist|muscarinic-2 receptor|muscarinic acetylcholine receptor activation|M1 muscarinic acetylcholine receptor
NEW05397,CHEBI,strong anticholinergic,strong anticholinergics
NEW05398,DISEASE,common behavioral impairment,common behavioral impairment
http://purl.obolibrary.org/obo/OGMS_0000090,CHEMICAL,treatment,GnRH-agonist treatment|TCDD treatment|MPTP/p treatment|BZF treatment|MK-801 treatment|C(60)HyFn treatment|ENF treatment|ACEA treatment|ABT-418 treatment|addiction-based treatments|GW501516 treatment|DSP-4 treatment|BCAA treatments|GSPE treatment|N-AC treatment|MTX-LV treatment|GnRHa treatment|VLX treatment|MPP(+ treatment|Ro41 treatment|SSRIs treatment|5HPP-33 treatment|UVB treatment|YCHT treatment|T-588 treatment
NEW05399,CHEBI,pre-test drug,pre-test drug
D000086882,CHEMICAL,Coronavirus Papain-Like Proteases,"PLP 2 Protein, Coronavirus|PLP-3 Protein, Coronavirus|Papain-Like Proteinase 3, Coronavirus|Papain-Like Proteinase 2, Coronavirus|PLP|Papain-Like Proteinase 1, Coronavirus|Papain-Like Proteases, Coronavirus|Coronavirus PLP-2 Protein|Papain Like Proteinase 1, Coronavirus|Papain Like Protease, Coronavirus|PLP 3 Protein, Coronavirus|PLP-1 Protein, Coronavirus|Coronavirus Papain Like Proteases|Papain Like Proteinase 3, Coronavirus|PLP-2 Protein, Coronavirus|Coronavirus PLP-3 Protein|Coronavirus PLP-1 Protein|Papain-Like Protease, Coronavirus|Papain Like Proteinase 2, Coronavirus|PLP 1 Protein, Coronavirus"
NEW05400,CHEBI,classical estrogen receptor,classical estrogen receptors
NEW05401,DISEASE,long-term behavioral disorder,long-term behavioral disorders
C026777,CHEMICAL,ICI 118551 [Supplementary Concept],Propanolamines|ICI
C043090,CHEMICAL,estradiol-bovine serum albumin [Supplementary Concept],"Serum Albumin, Bovine|Estradiol|E2-BSA"
NEW05402,CHEMICAL,Evans blue eb content,Evans blue EB contents
NEW05403,DISEASE,cognitive deficiency,cognitive deficiency
NEW05404,CHEBI,endogenous ovarian hormone,endogenous ovarian hormones
D063087,CHEMICAL,Noninvasive Ventilation,"Noninvasive Ventilations|Ventilations, Non Invasive|Non-invasive ventilation|Ventilation, Non-Invasive|Non-Invasive Ventilation|Ventilation, Non Invasive|Non Invasive Ventilations|Ventilation, Noninvasive|Ventilations, Non-Invasive|Ventilations, Noninvasive|Noninvasive ventilation|Non Invasive Ventilation|Non-Invasive Ventilations|NIV"
NEW05405,DISEASE,niv failure,NIV failure
NEW05406,CHEMICAL,Shire,Shire
D013226,DISEASE,Status Epilepticus,"|Non-Convulsive Status Epilepticus|Status Epilepticus, Generalized|Non Convulsive Status Epilepticus|Petit Mal Status|Grand Mal Status Epilepticus|Complex Partial Status Epilepticus|Status epilepticus|Status, Petit Mal|Status Epilepticus, Grand Mal|Electrographic Status Epilepticus|Status Epilepticus, Subclinical|Status Epilepticus, Generalized Convulsive|status epilepticus|Generalized Status Epilepticus|Generalized Convulsive Status Epilepticus|Subclinical Status Epilepticus|Status, Absence|Status Epilepticus, Electrographic|Status Epilepticus, Non Convulsive|Status Epilepticus, Non-Convulsive|Status Epilepticus, Complex Partial|Simple Partial Status Epilepticus|Absence Status|Status Epilepticus, Simple Partial"
NEW05407,DISEASE,acute repetitive seizure,acute repetitive seizures
NEW05408,DISEASE,migraine prophylaxis,migraine prophylaxis
NEW05409,CHEMICAL,SPD-421,SPD-421
NEW05410,CHEMICAL,berserk,berserks
NEW05411,DISEASE,character trait,character traits
NEW05412,MENTAL_HEALTH,antiepileptic drug-induced psychotic disorder,Antiepileptic drug-induced psychotic disorder
NEW05413,CHEBI,iatrogenic drug reaction,iatrogenic drug reaction
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Acute_Psychosis,MENTAL_HEALTH,acute psychosis,acute psychosis
NEW05414,CHEMICAL,dopamine d2-receptor blockade,Dopamine D2-receptor blockade
D014747,CHEMICAL,Vinblastine,"Cellblastin|Vincaleukoblastine|Velbe|Vinblastinsulfat-Gry|Vinblastin Hexal|Vinblastina Lilly|Lemblastine|Sulfate, Vinblastine|Vinblastine|Vinblastine Sulfate|VBL|Velban"
NEW05415,CHEMICAL,agent ibuprofen,agent ibuprofen
NEW05416,DISEASE,acute intermittent hypoxia,AIH|Acute intermittent hypoxia
http://purl.obolibrary.org/obo/DOID_14330,DISEASE,parkinson's disease,paralysis agitans|Parkinson's disease patients|unilateral 6-hydroxydopamine lesioning|experimental Parkinson's disease|Parkinson's disease model|untreated Parkinson's disease|Parkinson's Alzheimer's diseases|early Parkinson 's disease|Parkinson disease|Parkinson 's disease|Parkinson's disease dementia|PD|advanced Parkinson's disease|Parkinson's diseases
C029036,CHEMICAL,crocin [Supplementary Concept],crocin|Carotenoids
NEW05417,CHEMICAL,strobilanthe crispus ethanol extract,Strobilanthes crispus ethanol extract
NEW05418,CHEMICAL,azoxymethane (aom)-induced colonic aberrant crypt focus,azoxymethane (AOM)-induced colonic aberrant crypt foci
D051844,CHEMICAL,alpha-Synuclein,Alpha-synuclein|Non-AB Component of AD Amyloid Protein|α-synuclein|alpha Synuclein|Non AB Component of AD Amyloid Protein|alpha-synuclein
NEW05419,DISEASE,abnormal aggregation,abnormal aggregation
D008777,CHEMICAL,Methyltestosterone,Mesterone|17-Epimethyltestosterone|17beta Hydroxy 17 methyl 4 androsten 3 one|Testred|Metandren|17alpha Methyltestosterone|17 alpha Methyltestosterone|Mesteron|Android-5|Methitest|17 Epimethyltestosterone|17 beta Methyltestosterone|17 beta-Hydroxy-17-methyl-4-androsten-3-one|Android-10|17alpha-Methyl-Testosterone|17-alpha-Methyltestosterone|17alpha-Methyltestosterone|Android (Methyltestoterone)|methyltestosterone|17beta-Methyltestosterone|17alpha Methyl Testosterone|Testoviron|17 beta-Methyltestosterone|17beta-Hydroxy-17-methyl-4-androsten-3-one|Android-25|Android 25|Virilon|Oreton|Android 10|17 beta Hydroxy 17 methyl 4 androsten 3 one|Android 5|17beta Methyltestosterone
NEW05420,DISEASE,low weight gain,low weight gain
http://purl.obolibrary.org/obo/DOID_1470,MENTAL_HEALTH,major depressive disorder,depression major depressive disorder|single major depressive episode|recurrent major depressive disorder|major depressive disorder subjects|major depressive disorder sample|major depressive disorder symptoms|unipolar major depressive disorder|recurrent major depression|adult major depressive disorders|treatment-resistant major depressive disorder|nonpsychotic major depressive disorder|major depression disorder
NEW05421,DISEASE,disorder population,disorder population
NEW05422,CHEMICAL,demonstrable antidepressant efficacy,Demonstrable antidepressant efficacy
NEW05423,CHEMICAL,aed lamotrigine,AED lamotrigine
NEW05424,CHEMICAL,lamotrigine monotherapy,lamotrigine monotherapy
NEW05425,CHEMICAL,lamotrigine adjunctive therapy,lamotrigine adjunctive therapy
NEW05426,CHEMICAL,valproate monotherapy,valproate monotherapy
NEW05427,CHEMICAL,serotonergic agent meta-chlorophenylpiperazine,serotonergic agent meta-chlorophenylpiperazine
D009665,CHEMICAL,Noscapine,"Prikkelhoest, Librochin|Noscapect|noscapine|Capval|Hydrogen Embonate, Noscapine|Librochin Prikkelhoest|Capval Tropfen|Tropfen, Capval|Noscapine|Hydrochloride, Noscapine|Tuscalman|Noscapine Hydrochloride|Embonate, Noscapine Hydrogen|Noscapine Hydrogen Embonate|Narcotine"
NEW05428,CHEMICAL,bradykinin histaminergic system,bradykinin histaminergic systems
NEW05429,DISEASE,Disease Lateral Sclerosis,Disease Lateral Sclerosis
NEW05430,DISEASE,ischemic brain damage,ischemic brain damage
http://purl.obolibrary.org/obo/CHEBI_2721,CHEMICAL,angoline,methyl-noscapine|Angoline
NEW05431,CHEMICAL,pb neurotoxicity,Pb neurotoxicity
NEW05432,CHEMICAL,vasopressin staining,vasopressin staining
NEW05433,CHEMICAL,avp release,AVP release
NEW05434,DISEASE,epithelial degeneration,epithelial degeneration
NEW05435,DISEASE,sustained dystonia,Sustained dystonia
NEW05436,CHEMICAL,choreoatheosis,choreoatheosis
D019956,DISEASE,Stereotypic Movement Disorder,"Movement Disorder, Stereotypic|Body Rocking|movement disorder|Head Banging|Stereotypic Movement Disorders"
NEW05437,CHEMICAL,to chlorpromazine,CPZ|to chlorpromazine
NEW05438,DISEASE,lactobacillus reuteri jbd400,Lactobacillus reuteri JBD400
NEW05439,CHEMICAL,intestinal ammonia,intestinal ammonia
NEW05440,DISEASE,prehospital pain control,prehospital pain control
NEW05441,CHEMICAL,glutamate n-methyl d-aspartate receptor antagonist,glutamate N-methyl D-aspartate receptor antagonist
C484876,CHEMICAL,scutellarin [Supplementary Concept],Scu|Glucuronates|Scutellarin|Apigenin
NEW05442,DISEASE,stress-related neuropsychological disorder,stress-related neuropsychological disorders
NEW05443,DISEASE,prepsychotic condition,prepsychotic condition
http://purl.obolibrary.org/obo/CHEBI_46634,CHEMICAL,carbapenemcarboxylic acid,"TeA|iso-diabolic acid|acid 13-cis-RA|3β-azido-6α-ethyl-7α-hydroxy-5β-cholan-24-oic acid|ACPD|DL-(E)-2-amino-4-methyl- 5-phosphono-3-pentenoic acid|(1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid|wheat-tenuazonic acid|acid (GABA)-mediated|azaleic acid|[3H]kainic acid"
http://purl.obolibrary.org/obo/CHEBI_22720,CHEMICAL,benzodiazepine,GABA-acting benzodiazepines|benzodiazepines
NEW05444,MENTAL_HEALTH,autism paradoxical effect,autism paradoxical effects
NEW05445,MENTAL_HEALTH,autism old,autism old
D002034,CHEMICAL,Bumetanide,Miccil|Bumedyl|bumetanide|PF-1593|Burinex|Bumethanide|PF 1593|Fordiuran|Bumex|Drenural|Bumetanide|PF1593
D020817,MENTAL_HEALTH,Asperger Syndrome,"Asperger syndrome|Diseases, Asperger's|Asperger's syndrome|Syndrome, Asperger|Asperger Disease|Disease, Asperger|Asperger's Disorder|Asperger's Diseases|Disorder, Asperger|Asperger׳s Syndrome|Asperger Disorders|Asperger Diseases|Disease, Asperger's|Disorders, Asperger|Asperger Disorder|Asperger's Disease|Aspergers Disease|Aspergers Syndrome|Disorder, Asperger's|Aspergers Disorder|Syndrome, Asperger's|Asperger's Syndrome|Diseases, Asperger"
NEW05446,MENTAL_HEALTH,Childhood autism rating scale,Childhood Autism Rating Scale
NEW05447,CHEMICAL,D90-D0,D90-D0
NEW05448,DISEASE,autistic symptomatology,autistic symptomatology
http://purl.obolibrary.org/obo/SYMP_0000666,DISEASE,abnormal behavior,abnormal behaviour|abnormal behaviors
http://purl.obolibrary.org/obo/CHEBI_4530,CHEMICAL,diethylpropion,alpha-diethylaminopropiophenone|2-(diethylamino)propiophenone|(+-)-diethylpropion|amfepramone|d-Fenfluramine|1-phenyl-2-diethylamino-1-propanone|Diethylpropion|2-(diethylamino)-1-phenylpropan-1-one|Amfepramone|amfepramonum|anfepramona|alpha-benzoyltriethylamine|2-(diethylamino)-1-phenyl-1-propanone
NEW05449,MENTAL_HEALTH,unipolar major depression,unipolar major depression
NEW05450,CHEMICAL,specific serotonin (5-ht)-releasing agent,specific serotonin (5-HT)-releasing agent
C050504,CHEMICAL,tianeptine [Supplementary Concept],Tianeptine|Thiazepines|tianeptine
NEW05451,DISEASE,stress-induced behavioural deficit,stress-induced behavioural deficits
NEW05452,CHEMICAL,antidepressant efficacy,antidepressant efficacy
NEW05453,MENTAL_HEALTH,major depression similar,major depression similar
http://purl.obolibrary.org/obo/DOID_3312,MENTAL_HEALTH,bipolar disorder,depressed bipolar disorder|manic depression|Manic Depressive disorder|Manic bipolar I disorder|manic-depressive bipolar disorder|Depressive-manic psych.|mixed bipolar disorder|Manic Bipolar Affective disorder|bipolar disorder manic phase|bipolar depression|bipolar affective disorders|known bipolar disorder|manic disorder|treatment-resistant bipolar disorder
NEW05454,CHEMICAL,tianeptine therapy,tianeptine therapy
NEW05455,CHEMICAL,post-alcohol-withdrawal,post-alcohol-withdrawal
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Major_Depression,MENTAL_HEALTH,major depression,Major Depression|DSM-III major depression|major depression
NEW05456,MENTAL_HEALTH,coexist depression,coexisting depression
NEW05457,MENTAL_HEALTH,primary anxiety,primary anxiety
http://purl.obolibrary.org/obo/SYMP_0000024,MENTAL_HEALTH,drowsiness,somnolence|drowsiness|drowsy
http://purl.obolibrary.org/obo/SYMP_0000530,DISEASE,palpitation,diaphoresis|dizziness/syncope|abnormal heart beats
NEW05458,CHEMICAL,amitriptyline recipient,amitriptyline recipients
NEW05459,CHEMICAL,more tianeptine,more tianeptine
NEW05460,CHEBI,first effective drug,first effective drug
NEW05461,MENTAL_HEALTH,treatment-resistant insomnia,treatment-resistant insomnia
NEW05462,CHEMICAL,atypical antipsychotic quetiapine,atypical antipsychotic quetiapine
http://purl.obolibrary.org/obo/DOID_12700,DISEASE,hyperprolactinemia,hypoprolactinemia|macroprolactinemia|Pregnancy-related A-G syndrome|hyper-prolactinemia|hyperestrogenism|hyperprolactinaemia|Chiari-Frommel syndrome|hyperprolactinemic
NEW05463,CHEMICAL,agomelatine augmentation,agomelatine augmentation
NEW05464,DISEASE,treatment-resistant ocd,treatment-resistant OCD
NEW05465,CHEMICAL,agomelatine augmentation,Agomelatine augmentation
NEW05466,MENTAL_HEALTH,its 's obsession,its's obsession
NEW05467,MENTAL_HEALTH,compulsion subscale,compulsion subscales
NEW05468,DISEASE,difficult-to-treat illness,difficult-to-treat illness
C082372,CHEMICAL,T 588 [Supplementary Concept],Diethylamines|T-588|Thiophenes
NEW05469,CHEMICAL,scopolamine-induced memory impairment,scopolamine-induced memory impairments
NEW05470,CHEBI,produce drug,produced drug
NEW05471,CHEMICAL,synthetic glucocorticoid dexamethasone,synthetic glucocorticoid dexamethasone|DXM
D000996,DISEASE,Antitussive Agents,"Antitussive Agent|cough suppressant|Cough Suppressant|Suppressant, Cough|Antitussive Drug|Agent, Antitussive|Drug, Antitussive|Antitussive Drugs|Agents, Antitussive|Suppressants, Cough|antitussives|Antitussive|Cough Suppressants|Drugs, Antitussive|Antitussives"
NEW05472,MENTAL_HEALTH,dextromethorphan-induced psychotic disorder,dextromethorphan-induced psychotic disorder
http://purl.obolibrary.org/obo/DOID_8646,MENTAL_HEALTH,substance-induced psychosis,substance-induced psychosis
NEW05473,CHEMICAL,hu211,HU211
NEW05474,DISEASE,severe autotomy,severe autotomy
C029892,CHEMICAL,cupric chloride [Supplementary Concept],Copper|cupric chloride|CuCl2
NEW05475,MENTAL_HEALTH,insomnia abnormality,insomnia abnormalities
NEW05476,CHEMICAL,oxytocin administration,oxytocin administration
NEW05477,MENTAL_HEALTH,so-called mask depression,so-called masked depression
http://purl.obolibrary.org/obo/DOID_11328,MENTAL_HEALTH,schizophreniform disorder,schizophreniform psychosis|schizo-affective psychosis
D003471,CHEMICAL,Cuprizone,"Cuprizone|Oxaldihydrazone, Biscyclohexanone|Biscyclohexanone Oxaldihydrazone"
NEW05478,CHEMICAL,substrain,substrains
NEW05479,DISEASE,similar weight loss,similar weight loss
NEW05480,CHEBI,antibiotic exposure,antibiotic exposure
NEW05481,CHEBI,tetracycline antibiotic minocycline,tetracycline antibiotic minocycline
D010406,CHEMICAL,Penicillins,"|Penicillin Antibiotics|Antibiotics, Penicillin|Penicillin|penicillins"
D002511,CHEMICAL,Cephalosporins,"Antibiotic, Cephalosporin|Cephalosporin Antibiotic|Acids, Cephalosporanic|Cephalosporin|Cephalosporanic Acid|Cephalosporin Antibiotics|Antibiotics, Cephalosporin|Cephalosporanic Acids|cephalosporins|Acid, Cephalosporanic"
D004318,CHEMICAL,Doxycycline,"Doxycycline Chinoin|Doxycycline Calcium|BMY28689|Vibramycin Novum|Vibra-Tabs|Doxycycline|Vibra Tabs|Doxycycline Hyclate|Alpha 6 Deoxyoxytetracycline|Vibravenos|BU 3839T|Doxycycline Monohydrochloride, 6-epimer|Periostat|Atridox|Alpha-6-Deoxyoxytetracycline|BU3839T|Doxycycline Monohydrochloride, 6 epimer|Doxycycline Monohydrochloride, Dihydrate|Oracea|Doxycycline Monohydrate|Doxycycline Phosphate (1:1)|Doxycycline-Chinoin|2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-|Hydramycin|Doxycycline Hemiethanolate|BMY 28689|BU-3839T|BMY-28689|doxycycline|Doxycycline Calcium Salt (1:2)|Vibramycin|Doryx"
D000069285,CHEMICAL,Infliximab,"Remicade|Infliximab-dyyb|Infliximab|Antibody cA2, Monoclonal|Infliximab-abda|Monoclonal Antibody cA2|cA2, Monoclonal Antibody|Infliximab dyyb|MAb cA2|Infliximab abda|Renflexis|Inflectra"
NEW05482,DISEASE,various autoimmune disorder,various autoimmune disorders
NEW05483,CHEMICAL,albendazole monotherapy,albendazole monotherapy
NEW05484,CHEMICAL,sertraline percent,sertraline percent
NEW05485,CHEMICAL,token-reward system,token-reward systems
NEW05486,CHEMICAL,short-term naloxone hydrochloride administration,short-term naloxone hydrochloride administration
NEW05487,DISEASE,schizophrenic population,schizophrenic population
NEW05488,CHEMICAL,naloxone-associated improvement,naloxone-associated improvement
NEW05489,CHEMICAL,endorphin involvement,endorphin involvement
NEW05490,CHEMICAL,cannabis risk,cannabis risks
NEW05491,CHEBI,gut microbial toxin,gut microbial toxins
D017615,DISEASE,Enteric Nervous System,"Systems, Enteric Nervous|Nervous Systems, Enteric|System, Enteric Nervous|Nervous System, Enteric|Enteric Nervous Systems|enteric nervous system|ENS"
http://purl.obolibrary.org/obo/CHEBI_51065,CHEBI,dopamine agonist,dopamine D3/D2 receptor-preferring agonist|D2/D3 dopamine agonist|Agonista dopaminergico|dopamine receptor agonist piribedil|dopamine receptor agonist apomorphine|D2/D3 dopamine agonist quinpirole|Dopaminergic agonist|Dopamine receptor agonist|direct dopamine agonists
D008090,CHEMICAL,Lisuride,"Maleate, Lisuride|Lisuride Hydrochloride|Lisuride|Arolac|Methylergol Carbamide|Dopergin|Lysenyl|Lysurid|Lisuride Mesylate|Carbamide, Methylergol|Mesylate, Lisuride|Dopergine|Lisuride Maleate, (8beta)-Isomer|Cuvalit|Hydrochloride, Lisuride|Lysuride Hydrogen Maleate|Hydrogen Maleate, Lysuride|Lisuride Maleate|Lisuride Maleate (1:1)|Lisuride, (8alpha)-(+-)-Isomer|Lisuride Phosphate (1:1)|Revanil"
NEW05492,DISEASE,akinetic crisis,akinetic crisis
NEW05493,MENTAL_HEALTH,intrusive thought,Intrusive thoughts
NEW05494,DISEASE,obsessive-compulsive symptom,obsessive-compulsive symptoms
D006259,DISEASE,Craniocerebral Trauma,"Region Traumas, Frontal|Head Injuries, Minor|Temporal Region Trauma|Region Trauma, Frontal|Head Injuries, Multiple|Occipital Region Traumas|Occipital Region Trauma|Trauma, Parietal Region|Head Injury, Superficial|Traumas, Occipital Region|Skull Injuries, Crushing|Injuries, Craniocerebral|Head Injuries|Injury, Craniocerebral|Head Injury|Region Trauma, Parietal|Traumas, Occipital|Occipital Traumas|Temporal Region Traumas|Traumas, Forehead|Injuries, Superficial Head|Superficial Head Injuries|Craniocerebral Injuries|Trauma, Frontal Region|Injury, Head|Injury, Superficial Head|Traumas, Head|Region Traumas, Occipital|Minor Head Injuries|Injury, Minor Head|Trauma, Temporal Region|Head Injuries, Superficial|Craniocerebral Injury|Head Injury, Open|Superficial Head Injury|Occipital Trauma|Region Traumas, Parietal|Injuries, Open Head|Traumas, Parietal Region|Region Trauma, Occipital|Head Traumas|Multiple Head Injury|Parietal Region Trauma|Trauma, Head|Open Head Injury|Crushing Skull Injuries|Skull Injury, Crushing|Injuries, Multiple Head|Forehead Traumas|Multiple Head Injuries|Minor Head Injury|Trauma, Occipital|Head Trauma|Head Injuries, Open|Head Injury, Multiple|Frontal Region Traumas|Traumas, Frontal Region|Injury, Open Head|Parietal Region Traumas|Injuries, Minor Head|Trauma, Occipital Region|Injury, Multiple Head|Crushing Skull Injury|Traumas, Temporal Region|Frontal Region Trauma|Traumas, Craniocerebral|Head Injury, Minor|head injury|Trauma, Craniocerebral|Trauma, Forehead|Injuries, Head|Open Head Injuries|Forehead Trauma|Craniocerebral Traumas"
D002389,DISEASE,Catatonia,"|Catatonic Disorders, Organic|Catatonias, Malignant|Schizophreniform Catatonias|Catatonias|Catatonia, Malignant|Malignant Catatonia|Malignant Catatonias|Organic Catatonia|Catatonia, Organic|Schizophreniform Catatonia|Catatonia, Schizophreniform|Organic Catatonias|catatonia|Catatonic Disorder, Organic|Organic Catatonic Disorders|Lethal Catatonias|Catatonia, Lethal|Catatonias, Lethal|Lethal Catatonia|Catatonias, Organic|Catatonia|Organic Catatonic Disorder|Catatonias, Schizophreniform"
NEW05495,DISEASE,stress-induced metabolic alteration,stress-induced metabolic alterations
NEW05496,CHEMICAL,glucose uptake,glucose uptake
NEW05497,DISEASE,skewed x-inactivation,Skewed X-inactivation
NEW05498,CHEBI,carrier mother,carrier mother
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Obsessive_Compulsive_Personality_Disorder,MENTAL_HEALTH,obsessive compulsive personality disorder,Obsessive personality disorder|OCPD|Obsessive compulsive personality disorder
D015897,DISEASE,Comorbidity,Diagnosis Related Groups (1986-1989)|specific disease/complications (1977-1989)|comorbidity|Length of Stay (1986-1989)
D055809,DISEASE,Illness Behavior,"Behavior, Sickness|Sickness Behaviors|Sickness Behavior|Behaviors, Illness|Behaviors, Sickness|illness|Illness Behaviors|Behavior, Illness"
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Obsessive_Compulsive_Disorder,DISEASE,obsessive compulsive disorder,obsessive compulsive-related disorders|treatment-resistant obsessive compulsive disorder|compulsive disorders|obsessive compulsive symptoms
NEW05499,MENTAL_HEALTH,anxiety spectrum disorder,anxiety spectrum disorder
NEW05500,DISEASE,most psychogenic nonepileptic seizure,most psychogenic nonepileptic seizures|PNESs
NEW05501,DISEASE,epilepsy great conscious awareness,epilepsy greater conscious awareness
D056805,DISEASE,Consciousness Monitors,"Index of Consciousness-View Monitor|consciousness|Bispectral Index Monitor|Cerebral State Index Monitor|Bispectral Index Monitors|Index of ConsciousnessView Monitor|Consciousness Monitor|Monitors, Consciousness|Monitor, Bispectral Index|Monitors, Bispectral Index|Index of Consciousness View Monitor|Monitor, Consciousness"
D000091323,DISEASE,Psychogenic Nonepileptic Seizures,"Psychogenic Pseudoseizure|Seizure, Psychogenic Nonepileptic|psychogenic nonepileptic seizures|Psychogenic Pseudoseizures|Nonepileptic Seizure, Psychogenic|Pseudoseizure, Psychogenic|Psychogenic Nonepileptic Seizure"
D000068356,CHEMICAL,Self-Control,"Regulation, Self|Self-Regulation|Self Control|self-control|Self Regulation|Control, Self"
NEW05502,DISEASE,accidental overdose,accidental overdose
NEW05503,NUTRITION,teddy bear,teddy bear
NEW05504,MENTAL_HEALTH,high baseline adhd severity,higher baseline ADHD severity
NEW05505,CHEMICAL,osmotic-release oral system methylphenidate,OROS-MPH|osmotic-release oral system methylphenidate
NEW05506,DISEASE,obsessional character,obsessional character
NEW05507,CHEMICAL,cx-516,CX-516
http://purl.obolibrary.org/obo/CHEBI_64159,CHEMICAL,2-methyl-6-(phenylethynyl)pyridine,AMPAkines|2-methyl-6-(phenylethynyl)pyridine|6-Methyl-2-(phenylethynyl)pyridine|AMPAkine LY451395|MPEP
D011558,DISEASE,"Herpesvirus 1, Suid","Swine Herpesvirus 1|Virus, Pseudorabies|Herpesvirus Suis|Viruses, Pseudorabies|Aujeszky Disease Virus|Herpesvirus 1, Swine|Suid Herpesvirus 1|Pseudorabies Viruses|Pseudorabies Virus|Aujeszkys Disease Virus|Aujeszky's disease|Aujeszky's Disease Virus|Herpesvirus 1 (alpha), Suid"
NEW05508,CHEMICAL,Val di non,Val di Non
NEW05509,DISEASE,raw pork,raw pork
NEW05510,DISEASE,new dsm-5 system,new DSM-5 system
NEW05511,DISEASE,gambling disorder,gambling disorder
NEW05512,DISEASE,post-traumatic stress symptom,post-traumatic stress symptoms
NEW05513,CHEMICAL,gd grubbs,GD Grubbs
NEW05514,MENTAL_HEALTH,brief disorder,brief disorder
NEW05515,DISEASE,severe neuropsychiatric reaction,severe neuropsychiatric reaction
http://purl.obolibrary.org/obo/CHEBI_9288,CHEMICAL,streptozocin,Streptozotocin|2-Deoxy-2-(((methylnitrosoamino)carbonyl)amino)-D-glucopyranose|N-D-Glucosyl-(2)-N&#39;-nitrosomethylharnstoff|Zanosar|Streptozocinium|N-D-Glucosyl-(2)-N'-nitrosomethylurea|streptozocinum|streptozocine|2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose|estreptozocina|Streptozotocin (STZ)-induced|2-deoxy-2-{[methyl(nitroso)carbamoyl]amino}-alpha-D-glucopyranose|streptozocin
http://purl.obolibrary.org/obo/SYMP_0000647,DISEASE,tache noire,(STZ)-induced diabetes
http://purl.obolibrary.org/obo/CHEBI_7009,CHEMICAL,moxonidine,clonidine withdrawal-contracture|L-baclofen|moxonidin|Moxonidine|normoxocin
http://purl.obolibrary.org/obo/CHEBI_68563,CHEMICAL,p2y12 receptor antagonist,"5-HT(2C receptor antagonists|5-HT(3A receptor antagonists|NK(1 receptor antagonists|5-HT(1A receptor agonist receptor antagonist|δ-opioid receptor antagonist|P2Y12 receptor antagonists|GABAA receptor antagonist|purinergic receptor subtype P2Y12 antagonist|μ-opioid receptor antagonists|purinergic receptor subtype P2Y12 antagonists|D1-like receptor antagonist|ADP receptor subtype P2Y12 antagonists|D2-dopamine receptor antagonist|ADP receptor subtype P2Y12 antagonist|5-HT2A receptor antagonist|D(2)-like receptor antagonist|EP4 receptor antagonist L161,982|5-HT3 receptor antagonist|new glycoprotein-IIb/IIIa receptor antagonists|CCKB receptor antagonist|μ-opioid receptor antagonist|μ-Opioid receptor antagonist"
D013373,CHEMICAL,Substance P,"SP|SP(1-11)|Euler-Gaddum Substance P|Substance P, Euler-Gaddum|Substance P, Hypothalamic|Hypothalamic Substance P|Substance P|Euler Gaddum Substance P|substance P"
NEW05516,DISEASE,pain transmission,pain transmission
NEW05517,DISEASE,vomit reflex,vomiting reflex
NEW05518,CHEBI,nk-1 antagonist,NK-1 antagonists
C518176,CHEMICAL,maropitant [Supplementary Concept],Quinuclidines|maropitant
NEW05519,DISEASE,opioid-induced vomiting,opioid-induced vomiting
D011292,CHEMICAL,Premedication,Premedications|premedication
C534550,CHEMICAL,vestipitant [Supplementary Concept],Piperidines|Fluorobenzenes|vestipitant
NEW05520,CHEBI,potent nk(1 receptor antagonist,potent NK(1 receptor antagonist
NEW05521,CHEMICAL,buffer stz,buffered STZ
NEW05522,CHEMICAL,human dopamine d2 receptor long isoform,human dopamine D2 receptor long isoform
NEW05523,NUTRITION,g wheat germ,g wheat germ
D018998,NUTRITION,Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate,Wheat Germ Agglutinin Horseradish Peroxidase Conjugate|WGA-HRP|wheat germ
NEW05524,CHEMICAL,competitive non-nmda ampa/kainate receptor antagonist,competitive non-NMDA AMPA/kainate receptor antagonist
http://purl.obolibrary.org/obo/CHEBI_24866,CHEMICAL,salt,NBQX-disodium salt
http://purl.obolibrary.org/obo/CHEBI_60643,CHEBI,nmda receptor antagonist,glutamate NMDA receptor antagonists|N-methyl-D-aspartate NMDA receptor antagonist drugs|NMDAR antagonist|NMDAR antagonists|competitive NMDA receptor antagonist|N-methyl-d-aspartate NMDA receptor antagonists|NMDA receptor antagonist dextromethorphan|competitive NMDA receptor antagonists|N-Methyl-D-aspartate NMDA receptor antagonists|N-methyl-D-aspartate receptor NMDA antagonist|NMDA receptor blockade|N-methyl-D-aspartate receptor antagonists|N-Methyl-D-aspartate NMDA receptor antagonist MK-801|NMDA receptor antagonists|NMDA antagonist|NMDA receptor antagonist memantine|N-methyl-D-aspartate receptor antagonist|NMDA receptor antagonist administration|glutamate NMDA receptor antagonist|non-competitive NMDA receptor NMDAr antagonist|non-competitive NMDA receptor antagonist|NMDA antagonists|N-methyl-d-aspartate NMDA receptor antagonist|promising NMDA receptor antagonist|nonselective N-methyl-D-aspartate NMDA receptor antagonist|N-methyl-D-aspartate NMDA receptor antagonists|NMDA receptor antagonist|N-methyl-D-aspartate NMDA receptor antagonism
NEW05525,DISEASE,thermal allodynia behavior,thermal allodynia behavior
NEW05526,CHEMICAL,systemic mk-801,Systemic MK-801
NEW05527,CHEBI,analgesic dose,analgesic doses
NEW05528,DISEASE,severe motor impairment,severe motor impairment
NEW05529,CHEMICAL,systemic nmda,systemic NMDA
NEW05530,DISEASE,chronic allodynia-like response,chronic allodynia-like response
C017069,CHEMICAL,bicuculline methiodide [Supplementary Concept],bicuculline methiodide|Bicuculline/analogs  and  derivatives
NEW05531,CHEMICAL,gamma-aminobutyric acid gabaa receptor,gamma-aminobutyric acid GABAA receptors
NEW05532,CHEMICAL,short-acting clonidine,Short-acting clonidine
NEW05533,DISEASE,rebound hypertension,rebound hypertension
NEW05534,CHEMICAL,past-year NMUPO,past-year NMUPO
NEW05535,DISEASE,physical pain relief,physical pain relief
NEW05536,CHEMICAL,commonly-endorsed reason,commonly-endorsed reasons
NEW05537,CHEMICAL,acetate mmol/kg,acetate mmol/kg
C018824,CHEMICAL,ammonium acetate [Supplementary Concept],|ammonium acetate|NH4Ac|Acetates
NEW05538,CHEBI,drug response,drug responses
NEW05539,CHEBI,impaired drug metabolism,impaired drug metabolism
NEW05540,CHEBI,drug action,drug action
NEW05541,CHEMICAL,acetylcholine-induced catecholamine release,acetylcholine-induced catecholamine release
NEW05542,CHEMICAL,mm nh4ac,mM NH4Ac
http://purl.obolibrary.org/obo/CHEBI_17303,CHEMICAL,morphine,"morfina|(5R,6S,9R,13S,14R)-4,5-epoxy-N-methyl-7-morphinen-3,6-diol|D-enkephalin morphine|(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL|(5alpha,6alpha)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol|Morphine|(5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphin|Morphia|morphinum|17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol|morphine analgesia-|morphium|(-)-morphine"
NEW05543,DISEASE,analgesia- muscular incoordination,analgesia- muscular incoordination
D010147,DISEASE,Pain Measurement,"Test, Analgesia|Pain Severity|Pain Measurements|Pain Questionnaire, McGill|Severity, Pain|Analog Pain Scale|Formalin Test|Pain Assessments|Pain Intensity|Tourniquet Pain Test|Test, Tourniquet Pain|Formalin Tests|McGill Pain Scale|Test, Nociception|Tests, Nociception|pain assessment|Analgesia Tests|Pain Intensities|Analogue Pain Scales|Pain Scale, McGill|Scale, Analog Pain|McGill Pain Questionnaire|Scale, McGill Pain|pain severity|Scale, Analogue Pain|Pain Severities|Test, Formalin|Nociception Tests|Tourniquet Pain Tests|Visual Analogue Pain Scale|pain intensity|Nociception Test|Visual Analog Pain Scale|Pain Scale, Analogue|Analgesia Test|Analogue Pain Scale|Measurement, Pain|Pain Test, Tourniquet|Pain Assessment|Pain Scale, Analog|Assessment, Pain|Analog Pain Scales|Intensity, Pain|Questionnaire, McGill Pain|pain tests"
NEW05544,DISEASE,nociceptive pain component,nociceptive pain component
http://purl.obolibrary.org/obo/SYMP_0000832,DISEASE,neuropathic pain,neuropathic pain due|new neuropathic pain|neuropathic pain models|neuropathic pain development|severe neuropathic pain
NEW05545,MENTAL_HEALTH,adequate analgesia,adequate analgesia
NEW05546,CHEMICAL,hydromorphone pca,hydromorphone PCA
NEW05547,DISEASE,pain treatment,pain treatment
NEW05548,DISEASE,end-stage cancer patient,end-stage cancer patients
D010101,CHEMICAL,Oxygen Consumption,"Oxygen Consumptions|Consumption, Oxygen|Consumptions, Oxygen|oxygen consumption"
NEW05549,NUTRITION,toadfish,toadfish
NEW05550,DISEASE,hyperammonemic condition,hyperammonemic conditions
NEW05551,DISEASE,fatty acid-binding protein fabp3 knockout mouse,fatty acid-binding protein FABP3 knockout mice
NEW05552,DISEASE,antagonist-induced catalepsy behavior,antagonist-induced catalepsy behaviors
NEW05553,DISEASE,abnormal dopamine-related behavior,abnormal dopamine-related behaviors
NEW05554,CHEMICAL,ramelteon     mg/kg,ramelteon    mg/kg
http://purl.obolibrary.org/obo/CHEBI_79046,CHEBI,melatonin receptor agonist,melatonin receptor agonists|melatonin receptor agonist
D027582,DISEASE,Humulus,Humulus lupulus|Hops
NEW05555,CHEBI,nk-1 receptor antagonist,NK-1 receptor antagonists
NEW05556,DISEASE,tumour cell,tumour cells
NEW05557,DISEASE,tumour cell death,tumour cell death
NEW05558,CHEMICAL,potassium-evoked release,potassium-evoked release
NEW05559,DISEASE,elevated pain threshold,elevated pain thresholds
NEW05560,CHEMICAL,naltrexone pretreatment,naltrexone pretreatment
C036286,CHEMICAL,vitamin D2 glucosiduronate [Supplementary Concept],Vit D2|vitamin D2|Ergocalciferols
NEW05561,MENTAL_HEALTH,anxiety evaluation,anxiety evaluation
NEW05562,DISEASE,behavioral dysfunction,behavioral dysfunction
NEW05563,CHEMICAL,peripheral-cns interaction,peripheral-CNS interactions
NEW05564,DISEASE,diet-induced function,diet-induced function
NEW05565,CHEMICAL,fructose intake,fructose intake
NEW05566,DISEASE,hepatocellular carcinoma incidence,hepatocellular carcinoma incidence
NEW05567,CHEMICAL,aflatoxin exposure,aflatoxin exposure
NEW05568,DISEASE,hepatocellular carcinoma risk factor,hepatocellular carcinoma risk factors
D016031,DISEASE,Liver Transplantation,"Liver Transplants|Transplant, Liver|Liver Transplant|liver liver|Hepatic Transplantation|Liver Grafting|Liver Transplantations|Grafting, Liver|Transplantation, Liver|Hepatic Transplantations|Transplantation, Hepatic"
NEW05569,CHEMICAL,increase acetaldehyde production,Increased acetaldehyde production
NEW05570,DISEASE,alcoholic liver injury,alcoholic liver injury
D059333,DISEASE,Central Nervous System Sensitization,"Central Sensitizations|Sensitizations, Central|central nervous system|Central Sensitization|Sensitization, Central"
NEW05571,NUTRITION,choline availability,choline availability
NEW05572,CHEMICAL,acetylchyoline synthesis,acetylchyoline synthesis
http://purl.obolibrary.org/obo/CHEBI_26208,CHEMICAL,polyunsaturated fatty acid,n-3 polyunsaturated fatty acids|altered polyunsaturated fatty acid|Polyunsaturated fatty acid supplementation|n-3 PUFAs|long-chain n-3 fatty acids|PUFA|chain polyunsaturated fatty acids|higher omega-6:omega-3 n-6:n-3 long-chain polyunsaturated fatty acid ratio|omega3 poly-unsaturated fatty acids|polyunsaturated fatty acid composition|Omega (ω)-3 polyunsaturated fatty acids|long-chain polyunsaturated fatty acids|major polyunsaturated fatty acids|poly-unsaturated fatty acid abnormalities|PUFAs|natural n-3 unsaturated fatty acid|n-3 LCPUFA|Omega-3 long-chain polyunsaturated fatty acid status|LCPUFA|long-chain ω-3 polyunsaturated fatty acids|important polyunsaturated fatty acids|ω6 polyunsaturated fatty acid|n-6 polyunsaturated fatty acids|certain polyunsaturated fatty acids|ω-3-PUFA|omega-3 polyunsaturated fatty acid metabolic pathways|ω-3 polyunsaturated fatty acids|polyunsaturated fatty acids|ω-3 PUFA
http://purl.obolibrary.org/obo/SYMP_0000681,DISEASE,aggressive behavior,aggressive behaviors|aggressive behaviour|aggressive behavior
NEW05573,CHEMICAL,omega-3 long     chain polyunsaturated fatty acid,omega-3 long    chain polyunsaturated fatty acids
D059551,DISEASE,"Toxicity Tests, Subacute","Toxicity|toxicity test|Tests, Subacute Toxicity|subacute toxicity|Toxicity Test, Subacute|toxicity|Subacute Toxicity Test|Test, Subacute Toxicity|Subacute Toxicity Tests"
NEW05574,CHEMICAL,mg ion,Mg ions
D013778,CHEMICAL,Tetrazolium Salts,"Salts, Tetrazolium|Tetrazolium Salt|Salt, Tetrazolium|salts"
NEW05575,MENTAL_HEALTH,alzheimer disease development,Alzheimer disease development
C568831,CHEMICAL,alpha-((5-fluoro-2-methoxyphenyl)methyl)-alpha-(tetrahydro-2H-pyran-4-yl)-2-morpholinemethanol [Supplementary Concept],Phenylethyl Alcohol/analogs  and  derivatives|edivoxetine|Morpholines
D009949,MENTAL_HEALTH,Orientation,"Mental Orientations|Cognitive Orientation|Orientations|Mental Orientation|Orientations, Cognitive|Psychological Orientation|orientation|Orientations, Psychological|Psychological Orientations|Orientation, Mental|Cognitive Orientations|Orientation, Psychological|Orientation, Cognitive|Orientations, Mental"
http://purl.obolibrary.org/obo/CHEBI_39243,CHEMICAL,kinoprene,"ng/bee|(E,E)-2-propynyl 3,7,11-trimethyl-2,4-dodecadienoate|Kinoprene|prop-2-yn-1-yl (2E,4E)-3,7,11-trimethyldodeca-2,4-dienoate|2-propynyl (E,E)-3,7,11-trimethyl-2,4-dodecadienoate|(E,E)-3,7,11-trimethyl-2,4-dodecadienoic acid 2-propynyl ester"
NEW05576,DISEASE,severe atypical parkinsonian syndrome,severe atypical parkinsonian syndrome
NEW05577,CHEMICAL,brain neurotrophin,brain neurotrophins
NEW05578,DISEASE,chronic unpredictable mild stress,chronic unexpected mild stress|chronic unpredictable mild stress|CUMS
NEW05579,DISEASE,depressive status,depressive status
NEW05580,CHEMICAL,non-protein thiol,NPSH|non-protein thiol
D004801,CHEMICAL,Eosine Yellowish-(YS),"Tetrabromofluorescein|C.I. Acid Red 87|Eosin|Eosin (yellowish) (free acid)|eosin|Eosine Yellowish|Acid Red 87|Eosine Yellowish-(YS), Potassium, Sodium Salt|Eosin Y|Eosine|Eosine Yellowish-(YS), Dipotassium Salt"
C588289,CHEMICAL,chrysin 6-C-rutinoside [Supplementary Concept],Disaccharides|Flavones|chrysin
NEW05581,DISEASE,Mad Honey Disease,Mad Honey Disease
C497274,CHEMICAL,grayanotoxin XXI [Supplementary Concept],Diterpenes|grayanotoxin
http://purl.obolibrary.org/obo/DOID_0050544,DISEASE,hypermethioninemia,Hyperammonaemia|over-ingestion
NEW05582,MENTAL_HEALTH,chronic pain syndrome,chronic pain syndromes
NEW05583,CHEMICAL,nonbromide counterpart,nonbromide counterparts
D021902,DISEASE,Enterobacter aerogenes,Klebsiella mobilus|Enterobacter %|Klebsiella mobilis|Aerobacter aerogenes|Klebsiella aerogenes
D011514,DISEASE,Proteus vulgaris,Proteus (1966-1971)|Proteus vulgaris
D011550,DISEASE,Pseudomonas aeruginosa,Bacterium aeruginosum|Pseudomonas aeruginosa|Pseudomonas polycolor|Bacillus aeruginosus|Pseudomonas pyocyanea|Bacillus pyocyaneus|Bacterium pyocyaneum|Micrococcus pyocyaneus
NEW05584,DISEASE,global pandemic lockdown,global pandemic lockdown
D017563,DISEASE,"Lung Diseases, Interstitial","Interstitial Lung Diseases|Pneumonitides, Interstitial|Lung Disease, Interstitial|lung disease|Pneumonias, Interstitial|Interstitial Pneumonia|Pneumonia, Interstitial|Pneumonitis, Interstitial|Diffuse Parenchymal Lung Disease|Interstitial Pneumonitides|Diffuse Parenchymal Lung Diseases|Interstitial Pneumonitis|lung diseases|Interstitial Pneumonias|Interstitial Lung Disease"
NEW05585,CHEBI,humidifier disinfectant,humidifier disinfectants
NEW05586,DISEASE,advanced cancer,advanced cancer
NEW05587,CHEMICAL,adjuvant chemoradiation therapy,adjuvant chemoradiation therapy
NEW05588,DISEASE,cancer health disparity,cancer health disparities
D002274,CHEBI,"Carcinogens, Environmental",environmental carcinogens|carcinogens|Environmental Carcinogens
D008672,CHEBI,"Metals, Alkali","human carcinogens|Alkali Metal|alkali metals|1 Element, Group|Metal, Alkali|Element, Group 1|Group 1 Elements|Group 1 Element|Elements, Group 1|Alkali Metals|Group 1|alkali metal"
C092153,CHEMICAL,microsomal ethanol-oxidizing system [Supplementary Concept],Cytochrome P-450 Enzyme System|microsomal ethanol oxidizing system|Alcohol Oxidoreductases
C420272,CHEMICAL,"ADH1C protein, human [Supplementary Concept]",human-alcohol dehydrogenase|Alcohol Dehydrogenase
NEW05589,CHEMICAL,chronic alcohol comsumption,Chronic alcohol comsumption
NEW05590,DISEASE,pancreas damage,pancreas damage
D049310,DISEASE,Distal Myopathies,"Udd Markesbery Muscular Dystrophy|Myopathy, Laing Distal|Tibial Muscular Dystrophy, Tardive|Finnish Markesbery Muscular Dystrophy|Myopathy, Distal, Early-Onset, Autosomal Dominant|Muscular Dystrophies, Tibial|Myopathy 1, Distal|Udd Myopathy|Muscular Dystrophy, Tibial|Distal 1 Myopathies|Udd-Markesbery Muscular Dystrophy|Distal 1 Myopathy|Myopathy 1s, Distal|Muscular Dystrophy, Distal, Late-Onset, Autosomal Dominant|Udd Distal Myopathy|Distal Myopathy Markesbery-Griggs Type|Myopathies, Distal 1|Myopathies, Distal|Myopathy, Udd Distal|Tibial Muscular Dystrophy|Laing Distal Myopathy|Muscular Dystrophies, Distal|Distal Muscular Dystrophy|Distal Myopathy 1s|Tardive Tibial Muscular Dystrophy|Distal Myopathy, Welander|Muscular Dystrophy, Distal|Myopathy, Late Distal Hereditary|Distal Myopathy|Muscular Dystrophy, Finnish-Markesbery|Laing Early-Onset Distal Myopathy|Distal Muscular Dystrophies|Finnish-Markesbery Muscular Dystrophy|Distal Myopathy Markesbery Griggs Type|Myopathy, Distal 1|Distal Myopathy, Laing|Muscular Dystrophy, Udd-Markesbery|myopathies|Myopathy, Udd|Distal Myopathy 1|Myopathy, Distal, Swedish|Myopathy, Distal|Laing Early Onset Distal Myopathy|Welander Distal Myopathy|Distal Myopathy, Udd"
NEW05591,DISEASE,lipid damage,lipid damage
C465628,DISEASE,"LTO1 protein, human [Supplementary Concept]",Neoplasm Proteins|oral cancer
NEW05592,DISEASE,different pain model,different pain models
D018733,CHEBI,Nicotinic Antagonists,"Nicotinic antagonists|Antagonists, Nicotinic|nicotinic antagonists"
C403531,CHEMICAL,nicotinic receptor alpha4beta2 [Supplementary Concept],"Receptors, Nicotinic|α4β2"
NEW05593,DISEASE,amnestic effect,amnestic effects
http://purl.obolibrary.org/obo/CHEBI_48878,CHEBI,nicotinic antagonist,selective nicotinic agonists|agents antinicotiniques|α7 nicotinic antagonists|agente antinicotinico|nicotinic acetylcholine receptor antagonist|nicotinic cholinergic antagonists|nicotinic cholinergic antagonist|agentes antinicotinicos|antinicotinicos|nicotinic acetylcholine receptor antagonists|nicotinic antagonists
NEW05594,CHEMICAL,α4β2 receptor expression,α4β2 receptor expression
NEW05595,CHEMICAL,nicotine receptor,Nicotine receptors
http://purl.obolibrary.org/obo/CHEBI_10302,CHEMICAL,alpha-methyl-m-tyramine,Gepefrine|norepinepherine|alpha-Methyl-m-tyramine|d-alpha-Methyl-m-tyramine|5-HT releasers
NEW05596,CHEMICAL,muscarinic ach,muscarinic ACh
NEW05597,CHEMICAL,transdermal nicotine,transdermal nicotine
NEW05598,DISEASE,e. hirta,E. hirta
NEW05599,CHEMICAL,flavonoid content,flavonoids contents
http://purl.obolibrary.org/obo/PR_Q58G47,CHEBI,protein tify 6a (arabidopsis thaliana),jasmonates|at1g48500|jasmonate zim domain-containing protein 4 (arabidopsis thaliana)|jaz4|t1n15.11|at-tify6a|tify6a|Jasmonates
NEW05600,MENTAL_HEALTH,development reaction,development reactions
C539351,CHEMICAL,elagolix [Supplementary Concept],"Elagolix|Hydrocarbons, Fluorinated|Pyrimidines"
D014103,DISEASE,Torticollis,"Intermittent Torticollis|Cervical Dystonias|Dystonias, Cervical|Dystonia, Cervical|Wryneck|torticollis|Torticollis, Spasmodic|Torticollis, Psychogenic|Psychogenic Torticollis|Torticollis, Intermittent|Spasmodic Torticollis|Cervical Dystonia"
NEW05601,CHEMICAL,catecholamine metabolism,catecholamine metabolism
D001480,MENTAL_HEALTH,Basal Ganglia Diseases,Lenticulostriate Disorder||extrapyramidal disorders|Basal Ganglia Disorders|Extrapyramidal Disorder|Lenticulostriate Disorders|Basal Ganglia Disorder|Basal Ganglia Disease|axonal damage|Extrapyramidal Disorders
C558368,CHEMICAL,argiotoxin-636 [Supplementary Concept],Indoleacetic Acids|Polyamines|AR636
NEW05602,DISEASE,human breast adenocarcinoma cell line,human breast adenocarcinoma cell line
NEW05603,CHEBI,antihypertensive antibiotic antitumor class,antihypertensive antibiotic antitumor classes
NEW05604,DISEASE,b. jararaca venom,B. jararaca venom
NEW05605,CHEMICAL,conotoxin cyclization,conotoxin cyclization
NEW05606,CHEMICAL,α- conotoxin class,α- conotoxin classes
http://purl.obolibrary.org/obo/CHEBI_16737,CHEMICAL,creatinine,"creatinine concentration-are|1-Methylhydantoin-2-imide|Creatinine|2-Amino-1-methylimidazolin-4-one|creatinina|2-amino-1,5-dihydro-1-methyl-4H-Imidazol-4-one|Creatine anhydride|1-methylglycocyamidine|1-Methylglycocyamidine|Kreatinin|2-imino-1-methylimidazolidin-4-one|creatinine"
NEW05607,MENTAL_HEALTH,focal fragmentation,focal fragmentation
D064666,NUTRITION,"Diapause, Insect",insect|Insect Diapause
D051299,MENTAL_HEALTH,Post-Dural Puncture Headache,"Postdural Puncture Headache|Headache, Post-Dural Puncture|headache|Headache, Postdural Puncture|Headaches, Postdural Puncture|Postdural Puncture Headaches|Post-Lumbar Puncture Headache|Headaches, Post-Dural Puncture|Post Dural Puncture Headache|Post-Dural Puncture Headaches"
D000744,DISEASE,"Anemia, Hemolytic, Autoimmune","|Autoimmune Haemolytic Anaemia|Cold Antibody Diseases|Idiopathic Autoimmune Hemolytic Anemia|Cold Agglutinin Disease|Haemolytic Anaemia, Autoimmune|Anaemia, Autoimmune Haemolytic|Agglutinin Disease, Cold|Autoimmune Haemolytic Anaemias|Autoimmune Hemolytic Anemia|anaemia|Acquired Autoimmune Hemolytic Anemia|autoimmune hemolytic anemia|Cold Antibody Hemolytic Anemia|Autoimmune Hemolytic Anemias|Cold Agglutinin Diseases|Anemia, Hemolytic, Cold Antibody|Hemolytic Anemia, Autoimmune|Anemia, Autoimmune Hemolytic|Cold Antibody Disease|Anemia, Hemolytic, Idiopathic Acquired"
http://purl.obolibrary.org/obo/SYMP_0000081,DISEASE,low grade fever,low grade fever
NEW05608,DISEASE,bloat,bloating
NEW05609,MENTAL_HEALTH,its 's effective projection,its's effective projection
NEW05610,NUTRITION,so-called toad vaccine,so-called toad vaccine
NEW05611,MENTAL_HEALTH,States abuse treatment,States abuse treatment
NEW05612,CHEMICAL,gamma-aminobutyric acid type b,gamma-aminobutyric acid type B
NEW05613,DISEASE,catatonic feature,catatonic features
NEW05614,DISEASE,spastic han-wistar rat,spastic Han-Wistar rat
NEW05615,CHEBI,acetylcholine agonist carbachol,acetylcholine agonist carbachol
C117902,CHEMICAL,vanadocene dithiocyanate [Supplementary Concept],Organometallic Compounds|VDS
NEW05616,CHEMICAL,methyl glyoxal,methyl glyoxal
C530255,CHEMICAL,fluorodeoxyglucose F18-maleimidehexyloxime [Supplementary Concept],Maleimides|FDG|Oximes
D025341,MENTAL_HEALTH,Principal Component Analysis,"Analysis, Principal Component|pICA|Principal Component Analyses|component analysis|Analyses, Principal Component"
NEW05617,CHEMICAL,moderate iodine deficiency,moderate iodine deficiency
NEW05618,DISEASE,transient maternal hypothyroidism,transient maternal hypothyroidism
NEW05619,DISEASE,impaired mental development,impaired mental development
NEW05620,NUTRITION,lithium receptor mglur antagonist,lithium receptor mGluR antagonists
D025542,DISEASE,Neurofibromin 1,Neurofibromin|Neurofibromatosis Type 1 Gene Product|NF1-GAP-Related Protein|NF1 Protein|NF 1 Protein|NF-1 Protein|NF1|NF1 GRP|Neurofibromatosis Type 1 Protein|NF1 GAP Related Protein
C097222,CHEMICAL,"glutamate receptor ionotropic, AMPA 1 [Supplementary Concept]","Receptors, AMPA|glutamate receptor"
NEW05621,CHEMICAL,hmg-coa reductase inhibitor lavastatin,HMG-CoA reductase inhibitor lavastatin
NEW05622,CHEBI,pharmaceutical treatment,Pharmaceutical treatments
NEW05623,CHEBI,mglur antagonist,mGluR antagonists
NEW05624,CHEMICAL,reduce gaba neurotransmission,Reduced GABA neurotransmission
NEW05625,CHEMICAL,positive allosteric gaba modulator,i.e benzodiazepines|positive allosteric GABA modulators
NEW05626,MENTAL_HEALTH,depression symptom,depression symptoms
NEW05627,CHEBI,unique drug,unique drug
NEW05628,DISEASE,tertiary epilepsy center,tertiary epilepsy centers
D000069279,CHEMICAL,Drug Resistant Epilepsy,"Epilepsies, Drug Resistant|Drug Refractory Epilepsy|Epilepsy, Intractable|DRE|Resistant Epilepsy, Medication|Refractory Epilepsies, Drug|refractory epilepsy|Medication Resistant Epilepsies|Epilepsies, Intractable|Drug Resistant Epilepsies|drug-resistant epilepsy|Epilepsies, Medication Resistant|Refractory Epilepsy|Epilepsy, Drug Resistant|Drug Refractory Epilepsies|Refractory Epilepsy, Drug|Medication Resistant Epilepsy|Epilepsies, Drug Refractory|Epilepsy, Drug Refractory|Epilepsy, Medication Resistant|Epilepsy, Refractory|Resistant Epilepsies, Medication|Intractable Epilepsy|Resistant Epilepsies, Drug|Intractable Epilepsies|drug resistant epilepsy|Epilepsies, Refractory|Refractory Epilepsies|Resistant Epilepsy, Drug"
NEW05629,NUTRITION,10-month-old Argentine Dogo,10-month-old Argentine Dogo
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Extrapyramidal_Symptoms,DISEASE,extrapyramidal symptoms,Extrapyramidal symptoms|EPS|extrapyramidal symptoms
NEW05630,CHEMICAL,striatal dopamine activity,striatal dopamine activity
NEW05631,MENTAL_HEALTH,specific phobia anxiolytic effect,specific phobia anxiolytic effect
NEW05632,CHEMICAL,descend serotonin,descending serotonin
NEW05633,CHEMICAL,chronic cannabis use,Chronic cannabis use
NEW05634,DISEASE,psychotic state,psychotic states
NEW05635,CHEMICAL,repeat ppx administration,repeated PPX administration
D000069583,CHEMICAL,Pregabalin,"(R-)-3-isobutyl GABA|3-isobutyl GABA|Pregabalin|CI-1008|PGB|(S+)-3-isobutyl GABA|3 isobutyl GABA|(S)-3-(aminomethyl)-5-methylhexanoic acid|3-(aminomethyl)-5-methylhexanoic acid|GABA, 3-isobutyl|pregabalin|Lyrica|CI1008|CI 1008|1008, CI"
NEW05636,DISEASE,type diabetic mouse,type diabetic mice
NEW05637,CHEMICAL,npy-npy y1 receptor system,NPY-NPY Y1 receptor system
NEW05638,MENTAL_HEALTH,troubledyskinesia,troubledyskinesia
NEW05639,MENTAL_HEALTH,forepaw akinesia,forepaw akinesia
NEW05640,CHEBI,hormone level,hormone levels
NEW05641,DISEASE,female sexual desire,female sexual desire
NEW05642,CHEMICAL,adenosine degradation product,adenosine degradation products
NEW05643,CHEMICAL,adenosine release,adenosine release
NEW05644,CHEMICAL,adenosine level,adenosine levels
NEW05645,DISEASE,experimental hyperammonemia,Experimental hyperammonemia
D018388,DISEASE,"Codon, Terminator","Opal Stop Codons|TAG Codon|Terminator Codon, Amber|UAA Codon|Terminator Codons|Stop Codon|Ochre Codon|Codon UGA, Stop|Codon, UAG|UGA, Stop Codon|Codon, UGA Stop|Codons, Amber Terminator|Stop Codon, Amber|Codon, Amber|Stop Signals, Translation|Codons, Stop|Termination Codons|Codon, UGA|Ochre Stop Codon|UAA Stop Codons|TAA|Codons, Opal Stop|Codon, Opal Stop|TAA Codons|Translation Stop Signals|UAA Stop Codon|Stop Codon, UAA|Codons, Amber|UAG Codon|Terminator Codons, Amber|Codons, UAA|Codons, Termination|Stop Signal, Translation|TGA Codon|Codon, UAG Stop|Codons, TAA|UGA Codons|Codon, Amber Stop|Stop Codon, Ochre|Stop Codons, Amber|Stop Codon UGAs|Stop Codons, UGA|Amber Codon|Ochre Codons|Codon UAG, Stop|Opal Stop Codon|Codon, Opal|Codon, Ochre|Stop Codon UAA|Codons, Amber Stop|Codon, TAA|Codons, Ochre|Stop Codons, UAA|Amber Terminator Codon|Stop Codons, Ochre|Codons, TGA|UAG Stop Codons|Stop Codon UAG|Codons, UAG Stop|Codon, Termination|Stop Codons, Opal|Translation Stop Signal|Codon, UAA Stop|Codons, TAG|UGA Codon|Codons, UAG|Codons, Ochre Stop|Amber Stop Codon|Terminator Codon|TAG Codons|Opal Codons|Codon, Amber Terminator|UAA Codons|Stop Codons|Stop Codon, UAG|UAG Stop Codon|UAA, Stop Codon|UGA Stop Codon|Opal Codon|Stop Codon, UGA|Ochre Stop Codons|TGA Codons|Stop Codons, UAG|Codons, UAA Stop|Codons, UGA Stop|UGA Stop Codons|Codon UAA, Stop|UAG Codons|Codons, UGA|Amber Stop Codons|Codon, Stop|Stop Codon UGA|Codon, Ochre Stop|Codon, TGA|Amber Terminator Codons|Codons, Opal|Codons, Terminator|UAG, Stop Codon|Codon, TAG|Stop Codon, Opal|Amber Codons|TAA Codon|Termination Codon|Codon, UAA"
C440500,CHEMICAL,N-methyl D-aspartate receptor subtype 2A [Supplementary Concept],"NMDA glutamate receptor|Receptors, N-Methyl-D-Aspartate|GluN2A"
http://purl.obolibrary.org/obo/DOID_10937,MENTAL_HEALTH,impulse control disorder,Impulse control disorder|impulse control disorder
NEW05646,CHEMICAL,dopamine replacement therapy,Dopamine replacement therapy
NEW05647,CHEBI,dopamine agonist action,dopamine agonist action
NEW05648,CHEBI,pineal gland hormone,pineal gland hormone
NEW05649,CHEMICAL,25i-nbome critical review,25I-NBOMe Critical Review
NEW05650,DISEASE,ars group,ARS group
NEW05651,DISEASE,ars-induced anxiety-like behavior,ARS-induced anxiety-like behavior
NEW05652,CHEBI,specific cb1 receptor agonist,specific CB1 receptor agonist
C090111,CHEMICAL,LEK 8829 [Supplementary Concept],LEK-8829|Lysergic Acid/analogs  and  derivatives
NEW05653,MENTAL_HEALTH,mutilation effect,mutilation effect
NEW05654,DISEASE,treatment-resistant psychiatric disorder,treatment-resistant psychiatric disorders
NEW05655,CHEBI,future drug development,future drug developments
NEW05656,DISEASE,se animal,SE animals
http://purl.obolibrary.org/obo/CHEBI_65254,CHEMICAL,lrh-1 agonist,"agonist CGS21680|Y1R agonists|sigma(1 agonists|mGlu2/3 agonist LY379268|RARγ agonists|liver receptor homologue-1 agonist|GPCR agonists|RARalpha agonists|β-adrenoceptor agonists|nAChR agonists|clonidine|PPARα agonists|PPAR-δ agonists|D3-preferential agonists|5HT1β agonists|agonist APD-125|PPARδ agonist|PPARδ agonists|KOPr agonists|LRH-1 agonists|liver receptor homologue-1 agonists|TrpV1-receptor agonist|5-HT(2A agonist|PPAR-γ agonists|agonist LY354740|β2-adrenergic agonists|PPARs agonists|mGluR2/3 agonist|PPARd agonists|5-HT(1A agonists|fenofibrate|nuclear receptor subfamily 5 group A member 2 agonists|nuclear receptor subfamily 5 group A member 2 agonist|α(2)-adrenergic agonist|5-HT-1B agonist|agonist CP809.101|α7 agonists|γ-aminobutyric (GABA)-related agonists|PPARD agonists|agonists dual agonists|PPAR-δ agonist|agonists TPO-RAs|NR5A2 agonist|PPARβ/δ agonists|PPARγ agonists|25I-NBOMe agonists|α7nAChR agonist|NR5A2 agonists|LXRβ agonists|PPAR-γ agonist|PPARβ/δ agonist|PPAR- α agonist|agonist AM251|GC-C agonists|agonist (S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)-pyridine|agonist U50,488H|5-HT(2A)R agonists|GTS-21|DA-1 agonists|β3-adrenoceptor agonists|G-protein-biased agonists"
NEW05657,DISEASE,shock exposure rat,shock exposure rats
NEW05658,CHEMICAL,endocannabinoid anandamide,endocannabinoid anandamide
NEW05659,CHEMICAL,"npy1 receptor agonist leu31,pro34-npy","NPY1 receptor agonist Leu31,Pro34-NPY"
NEW05660,CHEMICAL,intra-bla urb597,Intra-BLA URB597
NEW05661,CHEMICAL,depression-behavior,depression-behaviors
NEW05662,DISEASE,social impairment,social impairments
NEW05663,CHEMICAL,melatonin secretion rhythm,melatonin secretion rhythm
NEW05664,CHEMICAL,suitable antidepressant,suitable antidepressant
NEW05665,CHEBI,antipsychotic drug action,antipsychotic drug actions
NEW05666,MENTAL_HEALTH,schizophrenia pathophysiology,schizophrenia pathophysiology
NEW05667,CHEMICAL,specific 5-ht receptor subtype,specific 5-HT receptor subtypes
NEW05668,MENTAL_HEALTH,hormone-induced depression,hormone-induced depression
D043682,CHEMICAL,"Receptor, Adenosine A1","adenosine A1 receptors|Receptors, Adenosine A1|Adenosine A1 Receptor|Adenosine A1 Receptors"
NEW05669,DISEASE,spare nerve injury,spared nerve injury
NEW05670,CHEMICAL,standard analgesic pregabalin,standard analgesic pregabalin
NEW05671,DISEASE,pain behavior,pain behavior
NEW05672,CHEBI,partial a1r agonist,partial A1R agonists
http://purl.obolibrary.org/obo/MFOMD_0000004,MENTAL_HEALTH,mental disorder,various mental disorders|certain mental disorders
NEW05673,CHEMICAL,its 's metabotropic gabab receptor,its's metabotropic GABAB receptor
NEW05674,CHEMICAL,gabab receptor signaling,GABAB receptor signaling
NEW05675,DISEASE,fxs improvement,FXS improvement
NEW05676,DISEASE,frequent psychiatric comorbiditie,frequent psychiatric comorbidities
http://purl.obolibrary.org/obo/DOID_2030,MENTAL_HEALTH,anxiety disorder,anxiety|anxiety mood disorders|childhood anxiety disorders|refractory anxiety anxiety disorder|different anxiety disorders|certain anxiety disorders|anxiety state|development anxiety disorders
NEW05677,CHEMICAL,baclofen efficacy,baclofen efficacy
http://purl.obolibrary.org/obo/DOID_303,DISEASE,substance-related disorder,offspring psychiatric disorders|certain psychiatric disorders|related psychiatric disorders|various psychiatric disorders|major psychiatric disorders|psychiatric disorders related|comorbid psychiatric disorders|Many psychiatric disorders
NEW05678,CHEMICAL,aud patient,AUD patients
NEW05679,DISEASE,disorder vs.,disorders vs.
NEW05680,CHEBI,exogenic carcinogenic agent,exogenic carcinogenic agents
http://purl.obolibrary.org/obo/DOID_9854,DISEASE,lingual-facial-buccal dyskinesia,LID|Levodopa-induced dyskinesia|LDD|Levodopa-induced dyskinesias|L-DOPA-induced dyskinesias|l-dopa-induced dyskinesia|levodopa-induced dyskinesias|L-DOPA-induced dyskinesia|Oro-facial dyskinesia|L-dopa-induced dyskinesia|l-DOPA-induced dyskinesia
NEW05681,CHEMICAL,chronic dopamine agonism,chronic dopamine agonism
NEW05682,DISEASE,striatal dopamine-receptor hypersensitivity,striatal dopamine-receptor hypersensitivity
NEW05683,CHEBI,other pharmaceutical therapy,Other pharmaceutical therapies
http://purl.obolibrary.org/obo/CHEBI_167633,CHEMICAL,cpsf3 inhibitor,inhibitor GBR-12935|CPSF3 inhibitors|DMH1-an inhibitor|TNF-α inhibitors|CPSF-73 inhibitors|cleavage and polyadenylation specificity factor subunit 3 inhibitor|cleavage and polyadenylation specificity factor 73 KDa subunit inhibitor|MK-801 inhibitors|CPSF73 inhibitors|cleavage and polyadenylation specific factor 3 inhibitor|serotonin-recapture inhibitors|prostanoid-synthesis inhibitor|inhibitor Neu5Gc2en|DAAO inhibitor|cleavage and polyadenylation specific factor 3 inhibitors|GABA-transaminase inhibitors|cleavage and polyadenylation specificity factor 73 KDa subunit inhibitors|CPSF-73 inhibitor|oxidase-B inhibitors|cleavage and polyadenylation specificity factor subunit 3 inhibitors|factor-κB inhibitor|CPSF73 inhibitor
NEW05684,CHEMICAL,mesocorticolimbic dopamine receptor,mesocorticolimbic dopamine receptors
NEW05685,DISEASE,tardive parkinsonism,tardive parkinsonism
NEW05686,MENTAL_HEALTH,extrapyramidal syndrome,extrapyramidal syndromes
D009128,DISEASE,Muscle Spasticity,"Clasp Knife Spasticity|spasticity|Spastic|Spasticity, Muscle|muscle spasticity|Spasticity, Clasp-Knife|Clasp-Knife Spasticity"
http://purl.obolibrary.org/obo/DOID_3669,DISEASE,intermittent claudication,Charcot's syndrome|Intermittent claudication|intermittent self-catheterisation
NEW05687,DISEASE,bladder dysfunction,bladder dysfunction
NEW05688,CHEBI,low-dose antibiotic,low-dose antibiotics
NEW05689,CHEBI,Delirium Drug scale,Delirium Drug Scale
NEW05690,CHEBI,drug burden,drug burden
D053201,DISEASE,"Urinary Bladder, Overactive","|Overactive Detrusor Function|Overactive Detrusor|Detrusor, Overactive|Overactive Bladder|Bladder, Overactive|bladder hyperactivity|Detrusor Function, Overactive|Overactive Urinary Bladder|Overactive bladder|OAB"
NEW05691,CHEBI,intravesical botulinum toxin,intravesical botulinum toxin
D006024,CHEMICAL,Glycopyrrolate,"Glycopyrrolate||Bromide, Glycopyrronium|Glycopyrronium|Pyrrolidinium, 3-((cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-, bromide|glycopyrronium|glycopyrrolate|NVA 237|NVA237|NVA-237|Glycopyrronium Bromide"
NEW05692,DISEASE,compensatory hyperhidrosis,compensatory hyperhidrosis
NEW05693,DISEASE,affective disorder patient,affective disorder patients
NEW05694,CHEBI,act cholinomimetic drug,acting cholinomimetic drugs
http://purl.obolibrary.org/obo/MFOMD_0000131,MENTAL_HEALTH,anergia,anergia
NEW05695,DISEASE,pelvic organ autonomic dysfunction,pelvic organ autonomic dysfunctions
NEW05696,CHEMICAL,levodopa treatment,levodopa treatment
NEW05697,DISEASE,radiation dermatitis,Radiation dermatitis
http://purl.obolibrary.org/obo/CHEBI_38706,CHEMICAL,pediculicide,pediculicides|emollient creams
D017564,DISEASE,Radiation Pneumonitis,"Pneumonitis, Radiation|Radiation pneumonitis|Pneumonia, Radiation|Radiation Pneumonia"
NEW05698,CHEMICAL,oral prednisone,oral prednisone
NEW05699,DISEASE,radiation-induced emesis,Radiation-induced emesis
http://purl.obolibrary.org/obo/CHEBI_50137,CHEBI,mu-opioid receptor antagonist,acting mu-opioid receptor antagonists|mu-opioid antagonists|endothelin-A receptor antagonist BQ123|mu-opioid receptor antagonist|5-hydroxytryptamine3 receptor antagonists|selective NK(3 receptor antagonist osanetant|mu-opioid antagonist|Histamine-1 receptor antagonists|functional mu-opioid receptor antagonist|mu-opioid receptor antagonists|specific mu-opioid receptor antagonist
NEW05700,DISEASE,chronic radiation cystitis,chronic radiation cystitis
D010621,CHEMICAL,Phenazopyridine,"Prodium|Pyridiate|Re-Azo|Azo-Natural|AzoGesic|Azo-Gesic|Baridium|Phenazopyridine Hydrochloride|Azo-Dine|AzoDine|Re Azo|AzoStandard|phenazopyridine|Phenazo|Azo-Standard|Hydrochloride, Phenazopyridine|Pyridium|Azo Gesic|Azo Natural|ReAzo|Azo Dine|UTI Relief|AzoNatural|Urogesic|Azo Standard|Geridium"
NEW05701,DISEASE,genitourinary autonomic dysfunction,genitourinary autonomic dysfunctions
NEW05702,CHEBI,dopamine agonist useful,dopamine agonist useful
NEW05703,DISEASE,neurodevelopmental disability,neurodevelopmental disabilities
http://purl.obolibrary.org/obo/SYMP_0000581,MENTAL_HEALTH,sleep apnea,Mild sleep apnea|problematic sleep apnea
D020024,CHEBI,Leukotriene Antagonists,"leukotriene|Antagonist, Leukotriene|Receptor Antagonists, Leukotriene|Antagonists, Leukotriene Receptor|Leukotriene Receptor Antagonists|leukotriene receptor antagonist|leukotriene antagonist|Receptor Antagonist, Leukotriene|leukotriene receptor antagonists|Leukotriene receptor antagonists|Leukotriene Antagonist|Antagonist, Leukotriene Receptor|montelukast|Leukotriene Receptor Antagonist|Antagonists, Leukotriene"
http://purl.obolibrary.org/obo/MFOMD_0000105,CHEMICAL,enuresis,NME|nonmonosymptomatic enuresis
D020721,DISEASE,"Nervous System Autoimmune Disease, Experimental","Autoimmune Myositis, Experimental|Nervous System Autoimmune Disease Models|Autoimmune Disease Models, Nervous System|Experimental Myositis, Autoimmune|Experimental Autoimmune Myositis|Autoimmune Experimental Myositis|Myositis, Experimental Autoimmune|Disease Models, Autoimmune, Nervous System|autoimmune disease|Myositis, Autoimmune Experimental"
NEW05704,CHEBI,central anticholinergic drug,central anticholinergic drug
http://purl.obolibrary.org/obo/MFOMD_0000113,DISEASE,flashback,(PTSD)-related flashbacks|sleep-driving
NEW05705,CHEMICAL,serum corticosterone level,serum corticosterone levels
D014282,CHEMICAL,Trihexyphenidyl,Cyclodol|ApoTrihex||Parkopan|Trihexane|Trihexyphenidyl Hydrochloride|Apo Trihex|Trihexyphenidyl Hydrochloride Elixir|Artane|trihexyphenidyl|Benzhexol|Trihexidyl Hydrochloride|Apo-Trihex|Parkinane|Hipokinon
NEW05706,DISEASE,trauma associated-behavioral change,trauma associated-behavioral changes
NEW05707,CHEMICAL,arginine vasopressin avp system,arginine vasopressin AVP system
NEW05708,CHEMICAL,selective vasopressin type 1a receptor agonist selepressin,selective vasopressin type 1a receptor agonist selepressin
NEW05709,CHEMICAL,mixed vasopressin type 1a receptor/vasopressin v2 receptor agonist vasopressor hormone arginine vasopressin,mixed vasopressin type 1a receptor/vasopressin V2 receptor agonist vasopressor hormone arginine vasopressin
NEW05710,DISEASE,pseudomonas aeruginosa pneumonia-induced severe sepsis,Pseudomonas aeruginosa pneumonia-induced severe sepsis
NEW05711,CHEMICAL,"cyclic adenosine 3',5'-phosphate","cyclic adenosine 3',5'-phosphate"
D016891,DISEASE,"Polycystic Kidney, Autosomal Dominant","Polycystic Kidney Disease, Adult, Type II|Polycystic Kidney Disease, Type 2|Adult Polycystic Kidney Disease Type 2|Kidney, Polycystic, Autosomal Dominant|Autosomal Dominant Polycystic Kidney|Polycystic Kidney Disease, Autosomal Dominant|ADPKD|Polycystic Kidney Disease 2|Adult Polycystic Kidney Disease Type 1|Polycystic Kidney, Type 2 Autosomal Dominant Disease|Polycystic Kidney Disease, Adult|Polycystic Kidney Disease, Adult Type 2|autosomal dominant polycystic kidney disease|Polycystic Kidney, Type 1 Autosomal Dominant Disease|Adult Polycystic Kidney Disease|polycystic kidney disease"
NEW05712,CHEMICAL,intracellular calcium homeostasis,intracellular calcium homeostasis
NEW05713,CHEMICAL,arginine vasopressin v2 receptor antagonist,arginine vasopressin V2 receptor antagonists
http://purl.obolibrary.org/obo/DOID_0110861,DISEASE,autosomal recessive polycystic kidney disease,"human autosomal recessive polycystic kidney disease|Arpkd|Polycystic Kidney and Hepatic Disease 1|Pkhd1|Polycystic Kidney Disease, Infantile, Type I"
http://purl.obolibrary.org/obo/CHEBI_37955,CHEBI,h1-receptor antagonist,antagonist SCH23390|NMDA-receptor antagonist|5-HT3R antagonists|MCH1 antagonists|antagonists MK-801|H1 receptor blockaders|RXFP3 antagonist|OX2R antagonist|Ca-channel antagonists|antagonist BMS-193884|CRF-receptor antagonist alpha-h-CRF|classical antihistamines|CRFR1 antagonist|H1-receptor antagonists|H1 antihistaminics|CB1r antagonist|AMPA-receptor antagonist|CCK-B antagonists|NMDA-R antagonists|antagonists OPC-31260|GABAA antagonist|α(1 antagonist|KOPr antagonists|GHRH antagonists|classical antihistaminics|CRFR1 antagonists|5-HT2 antagonists|non-NMDA antagonist NBQX|GPIIb/IIIa antagonists|pan-RAR antagonist|antagonist MK-869|GpIIb/IIIa antagonists|α-adrenoceptor antagonists|A(2A antagonists|σ1 antagonists|CCK(1 antagonists|pan-CHRM antagonist|σ1 antagonist|CCK(B antagonists|H1-receptor blocker|serotonin1A antagonist|NMDAR antagonists|antagonist LY686017|5-HT(2A antagonists|H1-receptor blockers|PPARγ antagonist GW9662|mGluR5 antagonists|A2AR antagonists|mGluR1 antagonist|NK(3 antagonists|α1-adrenoceptor antagonists|antagonist NitroSynapsin|H1 receptor antagonists|CCK(2 antagonists|mGluR5 antagonist|antagonist PT150|D2-selective antagonist
NEW05714,CHEBI,v2 receptor antagonist,V2 receptor antagonists
NEW05715,DISEASE,hypertension chronic kidney disease progression,hypertension chronic kidney disease progression
D000077602,CHEMICAL,Tolvaptan,"OPC-41061|tolvaptan|OPC 41061|Samsca|OPC41061|Tolvaptan|7-Chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine"
C537699,DISEASE,"Nephronophthisis, familial juvenile [Supplementary Concept]","Kidney Diseases, Cystic/congenital|nephronophthisis"
NEW05716,CHEMICAL,arachis hypogaea l. peanut leaf,Arachis hypogaea L. peanut leaf
NEW05717,CHEBI,endocrine dysfunction,endocrine dysfunction
NEW05718,DISEASE,high frequency stimulation,HFS|high frequency stimulation
NEW05719,CHEMICAL,drug dysport,abobotulotoxin|drug dysport
NEW05720,CHEMICAL,guanosine triphosphate (gtp)-binding protein,guanosine triphosphate (GTP)-binding protein
NEW05721,CHEMICAL,mal quality,MAL quality
NEW05722,MENTAL_HEALTH,severe memory disorder,severe memory disorders
NEW05723,CHEMICAL,n-cadherin/β-catenin,N-cadherin/β-catenin
NEW05724,CHEMICAL,ziprasidone treatment,ziprasidone treatment
NEW05725,CHEMICAL,l-α-aminoadipate,l-α-aminoadipate
NEW05726,CHEMICAL,reserpine model,reserpine model
NEW05727,DISEASE,current pd treatment,current PD treatments
C023754,CHEMICAL,tizanidine [Supplementary Concept],|Tizanidine|Clonidine/analogs  and  derivatives|TZD|tizanidine
NEW05728,CHEBI,adjuvant botulinum toxin a.,adjuvant botulinum toxin A.
NEW05729,DISEASE,genetic defect,genetic defects
NEW05730,CHEMICAL,aliphatic halogenated hydrocarbon,aliphatic halogenated hydrocarbons
NEW05731,DISEASE,life-threatening liver injury,life-threatening liver injury
NEW05732,CHEMICAL,signal-transducing guanine nucleotide-binding g protein,signal-transducing guanine nucleotide-binding G proteins
C095470,CHEMICAL,"Grp protein, Zymomonas mobilis [Supplementary Concept]",Bacterial Proteins|DNA-Binding Proteins|glutamate uptake|Transcription Factors
NEW05733,CHEMICAL,reduce glutamate uptake activity,reduced glutamate uptake activity
NEW05734,DISEASE,neuropsychiatric alteration,neuropsychiatric alterations
NEW05735,CHEBI,botulinum toxin therapy,botulinum toxin therapy
NEW05736,CHEMICAL,≤,≤
NEW05737,DISEASE,motoric symptom,motoric symptoms
NEW05738,DISEASE,juvenile hd onset,juvenile HD onset
NEW05739,DISEASE,spider envenoming,spider envenoming
NEW05740,CHEMICAL,ketamine     mg,ketamine    mg
NEW05741,CHEMICAL,mg intravenous ketamine,mg intravenous ketamine
NEW05742,MENTAL_HEALTH,standard analgesia,standard analgesia
NEW05743,DISEASE,additional pain relief,additional pain relief
NEW05744,CHEBI,botulinum toxin injection,botulinum toxin injections
NEW05745,CHEBI,potent eugeroic wakefulness-promoting drug,potent eugeroic wakefulness-promoting drug
http://purl.obolibrary.org/obo/CL_0000540,CHEMICAL,neuron,hypo-cretin neurons|glycine/GABA neurons
D020923,DISEASE,REM Sleep Parasomnias,"Rapid Eye Movement Sleep Parasomnias|Sleep, REM, Parasomnias|Parasomnias, REM Sleep|Sinus Arrest, REM Sleep Related|sleep-related|Painful Erections, Sleep-Related|REM Sleep-Related Sinus Arrest|Parasomnia, REM Sleep|Painful Erection, Sleep-Related|REM Sleep Parasomnia|Sleep-Related Painful Erection|REM Sleep Related Sinus Arrest|REM-atonia|Sleep-Related Painful Erections|Painful Erections, Sleep Related|parasomnias|Erection, Sleep-Related Painful|Sleep Related Painful Erections|Erections, Sleep-Related Painful|Sinus Arrest, REM Sleep-Related|REM sleep"
NEW05746,CHEMICAL,enzyme hypoxanthine-guanine phosphoribosyltransferase,enzyme hypoxanthine-guanine phosphoribosyltransferase
NEW05747,CHEMICAL,purine metabolism due,purine metabolism due
NEW05748,CHEMICAL,enzyme hypozanthine-guanine phosphoribosyltransferase,enzyme hypozanthine-guanine phosphoribosyltransferase
NEW05749,CHEMICAL,score ±,score ±
NEW05750,MENTAL_HEALTH,anxiety lsa score,anxiety LSA score
D012019,DISEASE,Reflex Sympathetic Dystrophy,"CRPS|Sympathetic Dystrophies, Reflex|Type I Complex Regional Pain Syndrome|Algodystrophic Syndrome|Shoulder-Hand Syndrome|Cervical Sympathetic Dystrophy|Reflex Sympathetic Dystrophy Syndrome|Complex regional pain syndrome|Syndrome, Shoulder-Hand|Dystrophies, Reflex Sympathetic|Syndromes, Shoulder-Hand|CRPS Type I|Dystrophies, Cervical Sympathetic|Cervical Sympathetic Dystrophies|Sympathetic Dystrophies, Cervical|Algodystrophies|Reflex Dystrophia, Sympathetic|Sympathetic Reflex Dystrophias|Sympathetic Dystrophy, Reflex|Algodystrophy|Type I, CRPS|Dystrophy, Cervical Sympathetic|Shoulder Hand Syndrome|RSDs (Reflex Sympathetic Dystrophy)|Pain Syndrome Type I, Regional, Complex|Syndrome, Reflex Sympathetic Dystrophy|Syndrome, Algodystrophic|Sudeks Atrophy|Sympathetic Reflex Dystrophia|Atrophies, Sudek's|Pain Syndrome Type I, Complex Regional|Shoulder-Hand Syndromes|Atrophy, Sudek|Sudek's Atrophy|Complex Regional Pain Syndrome, Type I|regional pain syndrome|Sudek's Atrophies|Atrophy, Sudek's|CRPS Type Is|Sudek Atrophy|Dystrophy, Reflex Sympathetic|Sympathetic Dystrophy, Cervical|Reflex Sympathetic Dystrophies|RSD (Reflex Sympathetic Dystrophy)"
NEW05751,DISEASE,crps-i,CRPS-I
NEW05752,CHEMICAL,crps-ii,CRPS-II
NEW05753,CHEMICAL,ge;30,ge;30
NEW05754,DISEASE,probable ptsd symptom,probable PTSD symptoms
NEW05755,MENTAL_HEALTH,toxin-dependent sleepiness,toxin-dependent sleepiness
NEW05756,MENTAL_HEALTH,hypersomnic syndrome,hypersomnic syndromes
D013747,CHEMICAL,Tetrabenazine,Xenazine||tetrabenazine|Nitoman|Tetrabenazine|TBZ
C566398,DISEASE,Huntington Disease-Like 1 [Supplementary Concept],neurodegenerative disorder|Huntington Disease
NEW05757,CHEBI,active bacterial toxin tcdb,active bacterial toxin TcdB
NEW05758,DISEASE,major clostridioide difficile virulence factor,major Clostridioides difficile virulence factor
NEW05759,DISEASE,initial infection,initial infection
NEW05760,DISEASE,axillary hyperhidrosis,axillary hyperhidrosis
NEW05761,CHEMICAL,topical aluminum salt,topical aluminum salts
D000072656,DISEASE,Breast Cancer Lymphedema,"Lymphedema, Post-mastectomy|Breast Cancer Treatment-Related Lymphedema|Post mastectomy Lymphedema|Post-mastectomy Lymphedema|breast cancer treatment|Breast Cancer Treatment Related Lymphedema|breast cancer|Lymphedema, Postmastectomy|Lymphedemas, Postmastectomy|Lymphedema, Breast Cancer|Breast Cancer Related Arm Lymphedema|Breast Cancer Lymphedemas|Breast Cancer-Related Arm Lymphedema|Breast Cancer Related Lymphedema|Postmastectomy Lymphedema|Post-mastectomy Lymphedemas|Postmastectomy Lymphedemas"
NEW05762,DISEASE,moderate hypertension,moderate hypertension
NEW05763,CHEMICAL,± 3(sd,± 3(SD
NEW05764,CHEMICAL,artificial food coloring,AFCs|artificial food colorings
NEW05765,CHEBI,artificial food coloring,artificial food colorings
NEW05766,MENTAL_HEALTH,hyperactive syndrome,hyperactive syndromes
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Hypersexuality,DISEASE,hypersexuality,hypersexuality
NEW05767,DISEASE,more punde patient,more punding patients
NEW05768,CHEMICAL,high da agonist,higher DA agonists
NEW05769,CHEMICAL,levodopa equivalent daily dose,levodopa equivalent daily dose
NEW05770,CHEMICAL,da agonist,DA agonists
http://purl.obolibrary.org/obo/CHEBI_37886,CHEBI,adrenergic agonist,adrenergic agonists|adrenergic receptor agonist|alpha-2 adrenergic agonist|adrenomimetic|Alpha-2 adrenergic agonists|adrenomimetics|adrenoceptor agonists|alpha-2 adrenergic agonists
NEW05771,CHEMICAL,antidepressant substance,antidepressant substances
D063386,CHEBI,Cannabinoid Receptor Agonists,"Receptor Agonists, Cannabinoid|Agonist, Cannabinoid Receptor|Cannabinoid agonists|Receptor Agonist, Cannabinoid|Cannabinoid Agonists|Agonist, Cannabinoid|cannabinoid receptor agonists|Activators, Cannabinoid Receptor|Cannabinoid Agonist|Receptor Activators, Cannabinoid|cannabinoid agonist|cannabinoid receptor agonist|Cannabinoid Receptor Activators|Agonists, Cannabinoid|Cannabinoid Receptor Agonist|Agonists, Cannabinoid Receptor|cannabinoid agonists"
NEW05772,CHEMICAL,cannabis exposure,cannabis exposure
NEW05773,MENTAL_HEALTH,psychosis onset,psychosis onset
NEW05774,MENTAL_HEALTH,full schizophrenia,full schizophrenia
NEW05775,CHEMICAL,cannabis user,cannabis users
NEW05776,CHEMICAL,heptahelical serotonin 2a receptor,heptahelical serotonin 2A receptors
NEW05777,MENTAL_HEALTH,drug-induced hallucination,drug-induced hallucinations
NEW05778,MENTAL_HEALTH,depression rating score,depression rating scores
NEW05779,CHEBI,agonist infusion,agonists infusion
NEW05780,CHEMICAL,chronic bicuculline infusion,chronic bicuculline infusion
NEW05781,DISEASE,ipsilateral gait alteration,ipsilateral gait alterations
NEW05782,DISEASE,significant neuron loss,significant neuron loss
NEW05783,DISEASE,phalange flaccidity,phalange flaccidity
C564593,DISEASE,"Gaze Palsy, Familial Horizontal, with Progressive Scoliosis [Supplementary Concept]","Scoliosis|Ophthalmoplegia, Chronic Progressive External|bilateral paralysis"
NEW05784,CHEMICAL,phytocannabinoid devoid,phytocannabinoid devoid
NEW05785,CHEMICAL,levodopa therapy,Levodopa therapy
NEW05786,CHEBI,effective drug,effective drug
NEW05787,DISEASE,hypocretin-ligand deficiency,hypocretin-ligand deficiency
NEW05788,CHEMICAL,dysregulate gabab receptor signaling,dysregulated GABAB receptor signaling
NEW05789,CHEMICAL,gabab receptor,GABAB receptor
NEW05790,CHEBI,numerous agonist,Numerous agonists
NEW05791,CHEMICAL,endocannabinoid cannabinoid,endocannabinoids cannabinoids
NEW05792,CHEMICAL,aea signaling,AEA signaling
NEW05793,CHEBI,chronic antipsychotic drug treatment,Chronic antipsychotic drug treatment
NEW05794,CHEMICAL,gamma-aminobutyric acid gaba agonist drug,Gamma-aminobutyric acid GABA agonist drugs
NEW05795,CHEMICAL,5-ht neuron,5-HT neurons
NEW05796,CHEMICAL,gabab receptor-based drug,GABAB receptor-based drugs
NEW05797,CHEMICAL,traditional antidepressant,traditional antidepressants
NEW05798,CHEMICAL,glucagon-like peptide functional agonist,glucagon-like peptide functional agonists
NEW05799,CHEMICAL,potential antidepressant,potential antidepressants
NEW05800,DISEASE,new hypoglycemic drug,New hypoglycemic drugs
NEW05801,CHEMICAL,glp-1 functional agonist,GLP-1 functional agonists
NEW05802,MENTAL_HEALTH,depression rating scale,depression rating scales
NEW05803,CHEMICAL,glutamate receptor expression,glutamate receptor expression
NEW05804,DISEASE,steroid-independent sexual behavior,steroid-independent sexual behavior
NEW05805,DISEASE,neuroinflammation decrease,neuroinflammation decrease
NEW05806,CHEBI,synthetic agonist,synthetic agonists
NEW05807,CHEMICAL,voluntary alcohol consumption,voluntary alcohol consumption
NEW05808,CHEMICAL,α-msh mc4r signaling,α-MSH MC4R signaling
NEW05809,MENTAL_HEALTH,bipolar depression imaging study,bipolar depression imaging studies
NEW05810,CHEMICAL,dopamine transporter level,dopamine transporter levels
NEW05811,DISEASE,bipolar depressive symptom,bipolar depressive symptoms
NEW05812,CHEMICAL,increase striatal dopamine transporter level,increased striatal dopamine transporter levels
NEW05813,MENTAL_HEALTH,mania dat blockade,mania DAT blockade
http://purl.obolibrary.org/obo/DOID_14761,DISEASE,greig cephalopolysyndactyly syndrome,polysyndactyly with peculiars skull shape|hyperinsulinism/hyperammonemia HI/HA syndrome
D018086,CHEMICAL,Glutamate Dehydrogenase (NADP+),"NADP+-Dependent Glutamate Dehydrogenase|NADP-Specific Glutamate Dehydrogenase|Glutamate dehydrogenase|Glutamate Dehydrogenase, NADP-Dependent|NADP-Dependent Glutamate Dehydrogenase|GDH|Dehydrogenase, NADP-Dependent Glutamate|NADP Specific Glutamate Dehydrogenase|NADP Dependent Glutamate Dehydrogenase|Glutamate Dehydrogenase, NADP+-Dependent|Glutamate Dehydrogenase, NADP-Specific|NADPH-Dependent Glutamate Dehydrogenase|NADPH Dependent Glutamate Dehydrogenase|NADP+ Dependent Glutamate Dehydrogenase|Dehydrogenase, NADP-Specific Glutamate|glutamate dehydrogenase|Dehydrogenase, NADP+-Dependent Glutamate|Glutamate Dehydrogenase, NADPH-Dependent|Dehydrogenase, NADPH-Dependent Glutamate"
NEW05814,CHEMICAL,da therapy,DA therapy
C010169,CHEMICAL,glucose utilization inhibitor [Supplementary Concept],glucose utilization|Peptides
NEW05815,DISEASE,impulsive aggression,Impulsive aggression
D006897,CHEMICAL,Hydroxyindoleacetic Acid,"Acetic Acid, 5-Hydroxyindolamine|5-HIAA|5-Hydroxyindolamine Acetic Acid|Acid, 5-Hydroxy-3-Indoleacetic|Acid, Hydroxyindoleacetic|Acid, 5-Hydroxyindolamine Acetic|5 Hydroxyindolamine Acetic Acid|5 Hydroxy 3 Indoleacetic Acid|5-Hydroxy-3-Indoleacetic Acid"
NEW05816,CHEMICAL,l fenfluramine,l fenfluramine
D049268,CHEMICAL,Positron-Emission Tomography,"positron-emission tomography|Imaging, PET|Positron Emission Tomography Imaging|Tomography Imaging, Positron-Emission|PET Scan|Scan, PET|PET Imaging|Positron-Emission Tomography Imaging|Tomography, Positron Emission|Positron-Emission Tomography Imagings|Imaging, Positron-Emission Tomography|Tomography, Positron-Emission|PET Imagings|PET Scans|Positron Emission Tomography"
NEW05817,DISEASE,irresistible sleep episode,irresistible sleep episodes
http://purl.obolibrary.org/obo/DOID_3109,DISEASE,idiopathic cd4-positive t-lymphocytopenia,idiopathic SRED
NEW05818,DISEASE,rls-related sred,RLS-related SRED
NEW05819,CHEBI,thyromimetic,thyromimetics
D000090542,DISEASE,Homozygous Familial Hypercholesterolemia,"HoFH|Recessive Hypercholesterolemia, Autosomal|Recessive Hypercholesterolemias, Autosomal|Autosomal Recessive Hypercholesterolemias|Hypercholesterolemias, Autosomal Recessive|familial hypercholesterolemia|homozygous familial hypercholesterolemia|Hypercholesterolemias, Homozygous Familial|Autosomal Recessive Hypercholesterolemia|FH"
C526273,CHEMICAL,"3-((3,5-dibromo-4-(4-hydroxy-3-(1-methylethyl)phenoxy)phenyl)amino)-3-oxopropanoic acid [Supplementary Concept]",Anilides|KB2115
NEW05820,DISEASE,parkinsonian side effect,parkinsonian side effects
NEW05821,CHEBI,only drug,only drug
NEW05822,DISEASE,pd motor function,PD motor function
NEW05823,CHEBI,orexin agonist,orexin agonists
NEW05824,CHEMICAL,5-ht receptor-mediated signal transduction system,5-HT receptor-mediated signal transduction systems
NEW05825,CHEMICAL,purine metabolism,purine metabolism
NEW05826,CHEMICAL,dopamine deficiency,dopamine deficiency
http://purl.obolibrary.org/obo/CHEBI_140535,CHEMICAL,trpv1 agonist,CCK antagonists|TRPV1 agonists|transient receptor potential cation channel subfamily V member 1 agonist|transient receptor potential vanilloid 1 agonist|CCK antagonist|transient receptor potential vanilloid 1 agonists|capsaicin receptor agonists|transient receptor potential cation channel subfamily V member 1 agonists|vanilloid receptor 1 agonists|CCK agonists|AVP agonists|capsaicin receptor agonist|vanilloid receptor 1 agonist
NEW05827,DISEASE,ptsd-like manner,PTSD-like manner
NEW05828,DISEASE,rodent behavior,rodents behavior
NEW05829,CHEMICAL,avp signaling,AVP signaling
NEW05830,CHEBI,v1a receptor antagonist,V1a receptor antagonists
NEW05831,CHEMICAL,y2r agonist npy,Y2R agonist NPY
http://purl.obolibrary.org/obo/DOID_535,DISEASE,sleep disorder,Non-organic sleep disorder|RBD|shift-work disorder|sleep behaviour disorder|sleep muscle-tone-related disorder
D020372,CHEMICAL,Dexfenfluramine,"Dexfenfluramine Hydrochloride|Redux|Dexfenfluramine|Hydrochloride, Dexfenfluramine"
NEW05832,CHEMICAL,dextrorotatory isomer,dextrorotatory isomer
NEW05833,CHEBI,interventional drug trial,interventional drug trials
NEW05834,DISEASE,effective weight loss,effective weight loss
NEW05835,CHEMICAL,conclusion Cabergoline,Conclusions Cabergoline
D015175,DISEASE,Prolactinoma,"|Pituitary Adenoma, Prolactin-Producing|Prolactin-Producing Pituitary Adenomas|Adenoma, Prolactin-Secreting, Pituitary|Prolactin-Producing Pituitary Adenoma|Pituitary Adenomas, Prolactin-Secreting|Macroprolactinomas|Lactotroph Adenomas|Pituitary Adenoma, Prolactin-Secreting|prolactinomas|Microprolactinoma|Microprolactinomas|Prolactinomas|PRL-Secreting Pituitary Adenoma|Pituitary Adenoma, PRL-Secreting|Pituitary Adenomas, PRL-Secreting|Lactotroph Adenoma|Macroprolactinoma|Prolactin Producing Pituitary Adenoma|Pituitary Adenoma, Prolactin Secreting|prolactinoma|microprolactinomas|Prolactin-Secreting Pituitary Adenoma|Adenomas, Lactotroph|PRL-Secreting Pituitary Adenomas|Prolactinoma, Familial|Adenoma, Lactotroph|Prolactin-Secreting Pituitary Adenomas|Prolactin Secreting Pituitary Adenoma|PRL Secreting Pituitary Adenoma|Pituitary Adenomas, Prolactin-Producing"
NEW05836,DISEASE,tumour mass,tumour mass
NEW05837,CHEBI,gut release hormone,gut released hormone
NEW05838,DISEASE,metabolic impairment,metabolic impairment
http://purl.obolibrary.org/obo/CHEBI_71196,CHEMICAL,glucagon-like peptide-1 receptor agonist,GLP-1 receptor agonists|Glucagon-like peptide-1 GLP-1 receptor agonists|GLP-1 receptor agonist|GLP-1RAs|glucagon-like peptide-1 receptor agonists|glucagon-like peptide-1 GLP-1 receptor agonists|Glucagon-like peptide-1 receptor agonists
NEW05839,DISEASE,cerebral infarct area,cerebral infarct area
NEW05840,DISEASE,neurological deficit,neurological deficit
D002545,DISEASE,Brain Ischemia,"|Cerebral Ischemia|Encephalopathy, Ischemic|Ischemic Encephalopathy|Ischemia, Brain|Ischemias, Cerebral|Ischemia, Cerebral|brain ischemia|cerebral ischaemia|Cerebral Ischemias|Brain Ischemias|Ischemic Encephalopathies"
D000077270,CHEMICAL,Exenatide,"exendin-4|Bydureon|Exendin 4|Exenatide|AC 2993 LAR|Byetta|exenatide|Ex4 Peptide|Peptide, Ex4|AC 2993|ITCA 650|Exendin-4"
NEW05841,DISEASE,great weight loss,greater weight loss
NEW05842,CHEMICAL,once-weekly extended-release subcutaneous exenatide n,once-weekly extended-release subcutaneous exenatide n
NEW05843,CHEBI,glucagon peptide glp-1 receptor agonist,Glucagon peptide GLP-1 receptor agonists
NEW05844,CHEMICAL,exenatide group,exenatide group
NEW05845,DISEASE,great mean weight loss,greater mean weight loss
NEW05846,CHEMICAL,fast glucose,fasting glucose
NEW05847,CHEBI,glucagon-like peptide glp-1 receptor agonist,Glucagon-like peptide GLP-1 receptor agonists
http://purl.obolibrary.org/obo/DOID_9352,DISEASE,type 2 diabetes mellitus,type diabetes mellitus|type 2 diabetes|non-insulin-dependent diabetes mellitus|insulin resistance|Type diabetes mellitus|NIDDM|type II diabetes mellitus
NEW05848,CHEMICAL,its 's antidepressant effect,its's antidepressant effect
NEW05849,CHEBI,glp-1 agonist,GLP-1 agonists
NEW05850,CHEMICAL,gsh concentration,GSH concentrations
NEW05851,DISEASE,reduce genotoxic damage,reduced genotoxic damage
C116241,DISEASE,"MICU1 protein, human [Supplementary Concept]",atopy|Calcium-Binding Proteins|Cation Transport Proteins|Mitochondrial Membrane Transport Proteins
NEW05852,DISEASE,throat tighten,throat tightening
NEW05853,CHEMICAL,pyrrolidine group,pyrrolidine groups
NEW05854,CHEBI,dop agonist,DOP agonists
NEW05855,DISEASE,convulsive-like behavior,convulsive-like behaviors
C088464,CHEMICAL,"4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide [Supplementary Concept]",Benzamides|Piperazines|SNC80
NEW05856,CHEBI,α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (ampa)/kainite receptor antagonist cnqx,α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainite receptor antagonist CNQX
NEW05857,DISEASE,tremor-like behavior,tremor-like behaviors
C000610195,CHEMICAL,"17-cyclopropylmethyl-3-hydroxy-4,5-epoxy-7,8-en-6-((3'-iodo)benzamido)morphinan [Supplementary Concept]",MP1104|Morphinans
NEW05858,CHEMICAL,pyridomorphinan,pyridomorphinans
NEW05859,CHEBI,non-selective potent antagonist,non-selective potent antagonists
NEW05860,DISEASE,normal pain state,normal pain state
NEW05861,CHEBI,dor agonist,DOR agonist
http://purl.org/sig/ont/fma/fma276189,CHEMICAL,dorsolateral prefrontal cortex,PL-PFC|DL-PFC|prelimbic medial prefrontal cortex|DLPFC
D000077182,CHEMICAL,Polylactic Acid-Polyglycolic Acid Copolymer,"Polylactic Acid Polyglycolic Acid Copolymer|Polylactic-co-glycolic Acid Copolymer|Poly (Lactic-co-glycolic Acid) -|PLG Polymers|PLGA Compounds|Acids, PLGA|Poly-L-lactic-polyglycolic Acids|LactoSorb|PLGA Acid|TFB-TBOA|PLGA Compound|Poly(L-lactide)-co-glycolide|Poly (D,L-lactic-co-glycolic Acid)|PLG Polymer|Copolymer, PL-PG|Polymers, PLG|Poly(Lactic-co-glycolic Acid)|PLGA Acids|PL-PG Copolymers|Poly(Glycolide-co-lactide)|PL-PG Copolymer|acid|Poly-L-lactic-polyglycolic Acid|Polylactic co glycolic Acid Copolymer|Poly L lactic polyglycolic Acid|Copolymers, PL-PG|Copolymer, Polylactic-co-glycolic Acid|PL PG Copolymer|Polylactic-co-glycolic Acid Copolymers|Polymer, PLG|RG 502|Acid, PLGA|Poly(D,L-lactide-co-glycolide)|Copolymers, Polylactic-co-glycolic Acid|Poly(DL-lactide-co-glycolic Acid)"
C555233,CHEMICAL,KNT 127 [Supplementary Concept],KNT-127|Morphinans
http://purl.obolibrary.org/obo/CHEBI_53115,CHEMICAL,8-(3-chlorostyryl)caffeine,"CSC|8-[(E)-2-(3-chlorophenyl)ethenyl]-1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione|co-perfusion"
C008922,CHEMICAL,piperine [Supplementary Concept],Polyunsaturated Alkamides|Benzodioxoles|piperine|Alkaloids|Piperidines
NEW05862,DISEASE,schizophrenia-like behavioural abnormality,schizophrenia-like behavioural abnormalities
C473195,CHEMICAL,(-)-alpha-pinene synthase [Supplementary Concept],Carbon-Oxygen Lyases|pinene|α-pinene
NEW05863,DISEASE,behavioural abnormality,behavioural abnormalities
D004923,CHEMICAL,Erythrosine,"Erythrosine B|2',4',5',7'-Tetraiodofluorescein|F D  and  C #3|Erythrosin|erythrosine|FD  and  C Red No. 3|Erythrosin B|FDC Red No. 3"
D013645,CHEMICAL,Tartrazine,"FD  and  C Yellow No. 5|Barium, Tartrazine|FD and C Yellow No. 5|Tartrazine|tartrazine|Tartrazine Barium (2:3)|Tartrazine Barium"
NEW05864,DISEASE,hd mouse,HD mice
NEW05865,CHEBI,nutraceutical coffee,nutraceutical coffee
NEW05866,DISEASE,anti-inflammatory type-2 diabetes mellitus,anti-inflammatory type-2 diabetes mellitus
NEW05867,CHEBI,gut-derived uremic toxin,gut-derived uremic toxins
NEW05868,DISEASE,systemic inflammation,systemic inflammation
NEW05869,CHEBI,biased cb1r inverse agonist,biased CB1R inverse agonists
NEW05870,DISEASE,related cardiometabolic complication,related cardiometabolic complications
NEW05871,CHEBI,putative cb1r neutral antagonist,putative CB1R neutral antagonists
D000076722,CHEBI,Drug Development,"pharmaceutical development|Drug Target Predictions|Development, Pharmaceutical|Medication Development|Computational Prediction of Drug-Target Interactions|Target Prediction, Drug|Development, Medication|Development, Drug|Drug Target Prediction|drug development|Pharmaceutical Development|Prediction, Drug Target"
C515162,CHEMICAL,"5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole [Supplementary Concept]",Triazoles|LH-21
NEW05872,DISEASE,convulsive behavior,convulsive behavior
NEW05873,CHEBI,hybrid cb1r/inos antagonist,hybrid CB1R/iNOS antagonist
NEW05874,CHEMICAL,cb1r antagonist rimonabant,CB1R antagonist rimonabant
NEW05875,CHEBI,dual-target peripheral cb1r/inos antagonist,dual-target peripheral CB1R/iNOS antagonists
NEW05876,CHEBI,generation cb1r antagonists/inverse agonist,generation CB1R antagonists/inverse agonists
C521311,CHEMICAL,N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide [Supplementary Concept],Amides|Pyridines|taranabant
http://purl.obolibrary.org/obo/CHEBI_90847,CHEBI,inverse agonist,inverse agonist|inverse agonists|CB1R inverse agonists|5-HT2A inverse agonists|5-HT2A inverse agonist
NEW05877,CHEBI,neutral cb1r antagonist,neutral CB1R antagonists
NEW05878,CHEBI,novel selective cb1 receptor antagonist,novel selective CB1 receptor antagonists
NEW05879,CHEMICAL,Combretum zeyheri,Combretum zeyheri
D061387,DISEASE,Chlamydial Pneumonia,"Pneumonia, Chlamydial|Pneumonia, Chlamydophila|Chlamydophila Pneumonia|Pneumonias, Chlamydial|Pneumonias, Chlamydophila|Chlamydial Pneumonias|Chlamydophila Pneumonias|pneumonia"
NEW05880,CHEMICAL,th target gene,TH target genes
NEW05881,DISEASE,thyrotoxic state,thyrotoxic state
NEW05882,CHEBI,thyroid hormone transporter monocarboxylate transporter,thyroid hormone transporter monocarboxylate transporter
http://purl.obolibrary.org/obo/CHEBI_47958,CHEBI,nicotinic acetylcholine receptor agonist,α7-nicotinic acetylcholine receptor agonists|novel selective α7 nicotinic acetylcholine receptor agonist|nicotinic agonists|alpha7-nicotinic acetylcholine receptor agonist interventions|Nicotinic acetylcholine receptor agonists|novel α4β2 nicotinic acetylcholine nAChR antagonist|muscarinic agonists|selective alpha4beta2 nicotinic receptor antagonist|novel α7 nicotinic acetylcholine receptor agonist ABT-126|alpha7 nicotinic acetylcholine receptor agonists|Alpha7 nicotinic acetylcholine receptor agonists|nicotinic agonist|nicotinic acetylcholine receptor antagonists|nicotinic acetylcholine receptor agonists
C506289,CHEMICAL,"8-(4-(3-(5-fluoro-1H-indol-3-yl)propyl)piperazin-1-yl)-4H-benzo(1,4)oxazin-2-methyl-3-one [Supplementary Concept]",SLV314|Indoles|Benzoxazines
NEW05883,CHEBI,inhibition ssri functionality,inhibition SSRI functionality
NEW05884,CHEMICAL,selective serotonin reuptake inhibition,selective serotonin reuptake inhibition
http://purl.obolibrary.org/obo/CHEBI_131787,CHEMICAL,dopamine receptor d2 antagonist,selective D4 dopamine receptor antagonist|dopamine D2 receptor agonist quinpirole|dopamine D2 receptor antagonism|D2 receptor antagonist|QNP|selective dopamine D2 receptor antagonist|dopamine D2 receptor agonists|dopamine D4 receptor antagonist|dopamine receptor D2 antagonism|D2R antagonist
NEW05885,DISEASE,motor deficit,motor deficits
NEW05886,CHEMICAL,l-dopa agonist,l-dopa agonists
http://purl.obolibrary.org/obo/SYMP_0000594,DISEASE,abnormal involuntary movement,Abnormal involuntary movements|abnormal involuntary movements
NEW05887,DISEASE,l-dopa-induced enhancement,l-dopa-induced enhancement
NEW05888,CHEBI,d2r antagonist eticlopride,D2R antagonist eticlopride
NEW05889,CHEBI,d2 agonist quinpirole,D2 agonist quinpirole
NEW05890,DISEASE,levodopa-treated animal,levodopa-treated animals
NEW05891,CHEMICAL,dopamine producing cell,dopamine producing cells
NEW05892,DISEASE,abnormal degeneration,abnormal degeneration
NEW05893,DISEASE,chinese pd patient,Chinese PD patients
D011569,MENTAL_HEALTH,Psychiatric Status Rating Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale|depression scale|Mini International Neuropsychiatric Interview|Wittenborn Scales|Factor Construct Rating Scales (FCRS)|Edinburgh Postnatal Depression Scale|Katz Adjustment Scales|Depression Scale
NEW05894,CHEMICAL,levodopa equivalent daily dose,levodopa equivalent daily doses
NEW05895,DISEASE,associate periodic leg movement,associated periodic leg movements
NEW05896,DISEASE,postnatal forebrain,postnatal forebrain
NEW05897,CHEBI,stimulant agonist drug,stimulant agonist drugs
NEW05898,MENTAL_HEALTH,transcriptional repression,Transcriptional repression
NEW05899,CHEMICAL,dopamine replacement,dopamine replacement
NEW05900,DISEASE,ten normoprolactinemic,ten normoprolactinemic
NEW05901,CHEMICAL,plasma testosterone,plasma testosterone
NEW05902,DISEASE,hyperprolactinemic patient,hyperprolactinemic patients
NEW05903,DISEASE,normoprolactinemic,normoprolactinemic
NEW05904,DISEASE,hyperprolactinemic group,hyperprolactinemic group
D035842,CHEMICAL,Research Subjects,"subjects|Subjects, Research|Subject, Human|ASPD|MDMA users|Human Subjects|Subjects, Human|Research Subject|Subject, Research|Human Subject"
NEW05905,DISEASE,Buss Hostility Inventory,Buss Hostility Inventory
NEW05906,MENTAL_HEALTH,Hamilton Depression rating scale,Hamilton Depression Rating Scale
NEW05907,CHEMICAL,adjunctive rotigotine,adjunctive rotigotine
NEW05908,DISEASE,advanced pd,advanced PD
NEW05909,CHEBI,non-ergotic d2/d3 dopaminergic agonist,non-ergotic D2/D3 dopaminergic agonist
D000082882,DISEASE,Bicuspid Aortic Valve Disease,"valve disease|Aortic Valve, Bicuspid|Bicuspid Aortic Valve|Valve, Bicuspid Aortic|Aortic Valve Disease 1|Bicuspid Aortic Valves"
NEW05910,MENTAL_HEALTH,dopaminergic-induced hallucination,dopaminergic-induced hallucinations
NEW05911,DISEASE,pd patient,PD patients
http://purl.obolibrary.org/obo/MFOMD_0000179,MENTAL_HEALTH,suicidal behavior,suicidal behaviors|Suicidal behaviors|suicidal behavior
NEW05912,CHEMICAL,dl-mph,dl-MPH
NEW05913,DISEASE,depressive dose,depressive dose
NEW05914,CHEMICAL,dl-mph stimulation,dl-MPH stimulation
NEW05915,CHEMICAL,urinary d-mph,urinary d-MPH
http://purl.obolibrary.org/obo/CHEBI_82181,CHEMICAL,perfluidone,l-EPH
NEW05916,CHEMICAL,mph-ethanol interaction,MPH-ethanol interactions
NEW05917,MENTAL_HEALTH,adhd personalized medicine,ADHD personalized medicine
NEW05918,DISEASE,eph preclinical neuropharmacology,EPH preclinical neuropharmacology
NEW05919,CHEMICAL,dopamine system,dopamine system
NEW05920,CHEMICAL,dopamine d3 receptor gene,dopamine D3 receptor gene
NEW05921,CHEBI,d3 antagonist,D3 antagonists
NEW05922,CHEMICAL,Camfetamine,Camfetamine
NEW05923,CHEMICAL,(phenylisopropyl)n-phenylcarbamoylsydnonimine,(phenylisopropyl)N-phenylcarbamoylsydnonimine
NEW05924,CHEBI,psychostimulant drug,psychostimulant drug
C083949,CHEMICAL,sydnogluton [Supplementary Concept],Glutamates|Sydnones|Sydnocarb|Drug Combinations
http://purl.obolibrary.org/obo/CHEBI_35499,DISEASE,hallucinogen,hallucinogenic drugs|hallucinogenic agents|psychostimulants|psychedelics|psychedelic agents|Psychostimulants|hallucinogens
D017392,CHEMICAL,Thiobarbituric Acid Reactive Substances,Thiobarbituric Acid Reactive Substances|thiobarbituric acid reactive substances|TBARs|
NEW05925,CHEMICAL,oxide generation,oxide generation
NEW05926,DISEASE,acute neurotoxicity,acute neurotoxicity
NEW05927,CHEBI,alpha-tocopherol level,alpha-tocopherol level
C490598,DISEASE,"SYD-2 protein, C elegans [Supplementary Concept]",SYD|Intercellular Signaling Peptides and Proteins|Caenorhabditis elegans Proteins
NEW05928,DISEASE,few neurotoxic property,fewer neurotoxic properties
NEW05929,DISEASE,selective neuronal damage,selective neuronal damage
C082097,CHEBI,"tocotrienol, delta [Supplementary Concept]",tocotrienol|Tocotrienol|Vitamin E/analogs  and  derivatives
D010024,DISEASE,Osteoporosis,"|Bone Losses, Age-Related|Osteoporosis, Age Related|Osteoporoses, Senile|age-related|Age-Related Bone Loss|Age-Related Osteoporoses|Osteoporoses, Age-Related|Osteoporosis, Age-Related|Age-Related Osteoporosis|Osteoporosis, Involutional|Osteoporosis, Post-Traumatic|Post-Traumatic Osteoporosis|Senile Osteoporoses|Age-Related Bone Losses|Osteoporoses|Osteoporosis, Senile|Bone Loss, Age Related|Bone Loss, Age-Related|Senile Osteoporosis|Age Related Osteoporosis|osteoporosis|Osteoporosis, Post Traumatic|Post-Traumatic Osteoporoses"
NEW05930,MENTAL_HEALTH,cerebrovascular memory disorder,cerebrovascular memory disorders
NEW05931,CHEMICAL,acid l-tryptophan,acid L-tryptophan
NEW05932,CHEMICAL,nootropic agent piracetam,nootropic agent piracetam
D018038,CHEMICAL,Sodium Selenite,"Sodium Selenite Pentahydrate|Selenite, Disodium|Pentahydrate, Sodium Selenite|Selenite Pentahydrate, Sodium|Selenite, Monosodium|sodium selenite|Na2SeO3|Selenite, Sodium|Monosodium Selenite|Biselenite, Sodium|selenite|Selenous Acid Disodium Salt|Disodium Selenite|Selenous Acid, Disodium Salt|Sodium Biselenite"
NEW05933,NUTRITION,antioxidant alpha-tocopherol,antioxidants alpha-tocopherol
NEW05934,CHEMICAL,oral clozapine administration,oral clozapine administration
NEW05935,CHEBI,less drug transfer,less drug transfer
NEW05936,CHEMICAL,α2-adrenoblocker,α2-adrenoblockers
NEW05937,CHEMICAL,high caffeine intake,high caffeine intake
NEW05938,CHEMICAL,ethanol toxicity,ethanol toxicity
NEW05939,DISEASE,hepatic siderosis,hepatic siderosis
NEW05940,DISEASE,hyperornithinemia-hyperammonemia-homocitrullinuria hhh syndrome,Hyperornithinemia-hyperammonemia-homocitrullinuria HHH syndrome
D065108,CHEMICAL,Ornithine Decarboxylase Inhibitors,"ornithine|Ornithine|Decarboxylase Inhibitors, Ornithine|Inhibitors, Ornithine Decarboxylase|ornithine decarboxylase"
C488998,CHEMICAL,"SLC25A2 protein, human [Supplementary Concept]","Amino Acid Transport Systems, Basic|mitochondrial ornithine transporter"
C001352,CHEMICAL,homocitrulline [Supplementary Concept],Citrulline/analogs  and  derivatives|homocitrulline
NEW05941,CHEBI,tocopherol binder,tocopherol binders
NEW05942,CHEBI,natural vitamin e metabolite,natural vitamin E metabolite
C473370,CHEMICAL,garcinoic acid [Supplementary Concept],Garcinoic acid|Benzopyrans
NEW05943,CHEBI,low-serum vitamin e,low-serum vitamin E
NEW05944,MENTAL_HEALTH,severe alzheimer disease,severe Alzheimer disease
NEW05945,DISEASE,severe paraphilia,severe paraphilia
NEW05946,CHEMICAL,long-acting gonadotrophin hormone releasing hormone analogue,long-acting gonadotrophin hormone releasing hormone analogue
NEW05947,CHEBI,antiandrogen treatment,antiandrogen treatment
NEW05948,DISEASE,secondary amenorrhea,secondary amenorrhea
NEW05949,CHEBI,gnrh-a program,GnRH-a program
NEW05950,DISEASE,cardiovascular disorder,cardiovascular disorders
NEW05951,CHEMICAL,extracellular serotonin,extracellular serotonin
NEW05952,CHEMICAL,central 5-ht,central 5-HT
NEW05953,CHEBI,5-ht agonist metachlorophenylpiperazine,5-HT agonist metachlorophenylpiperazine
NEW05954,DISEASE,various addiction disorder,various addiction disorders
NEW05955,CHEMICAL,partial serotonin agonist meta-chlorophenylpiperazine,partial serotonin agonist meta-chlorophenylpiperazine
NEW05956,CHEMICAL,serotonin pathway,Serotonin pathways
NEW05957,DISEASE,cranial nerve neuralgias,cranial nerve neuralgias
NEW05958,CHEMICAL,serotonin 5-ht 2a receptor,serotonin 5-HT 2A receptor
NEW05959,CHEMICAL,5-ht tone,5-HT tone
NEW05960,DISEASE,behavioral impulsiveness,behavioral impulsiveness
NEW05961,MENTAL_HEALTH,headache response,headache responses
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Migraine_Headache,DISEASE,migraine headache,severe migraine-like headaches
NEW05962,CHEMICAL,high peak m-cpp level,higher peak m-CPP levels
NEW05963,CHEMICAL,5-ht pathway,5-HT pathways
NEW05964,DISEASE,hi insult,HI insult
NEW05965,DISEASE,Plinia trunciflora fruit extract,Plinia trunciflora fruit extract|PTE
NEW05966,DISEASE,spatial memory impairment,spatial memory impairment
NEW05967,NUTRITION,lithium clinic,lithium clinics
NEW05968,NUTRITION,today 's lithium therapy,today's lithium therapy
NEW05969,DISEASE,climacterium,Climacterium
NEW05970,DISEASE,diabetic group,diabetic group
NEW05971,CHEMICAL,Vitex fruit extract,Vitex fruit extract
NEW05972,DISEASE,stz-induced diabete,STZ-induced diabetes
http://purl.obolibrary.org/obo/CHEBI_35477,CHEMICAL,antimanic drug,antimanics|antimanic drugs|antimanic agent|anti-depressant drugs
NEW05973,CHEBI,well-known neurotoxin,well-known neurotoxin
NEW05974,CHEMICAL,excessive ammonia content,Excessive ammonia content
D000643,CHEMICAL,Ammonium Chloride,"|ammonium chloride|NH4CL|Chloride, Ammonium|Sal Ammoniac|Ammoniac, Sal|NH4Cl"
D018094,CHEMICAL,"Receptors, Metabotropic Glutamate","Receptor, Metabotropic Glutamate|Metabotropic glutamate receptors|Receptors, Glutamate, Metabotropic|Glutamate Receptor, Metabotropic|Metabotropic Glutamate Receptors|metabotropic glutamate receptors|Glutamate Receptors, Metabotropic|Metabotropic Glutamate Receptor"
D020165,CHEMICAL,Carbamoyl-Phosphate Synthase I Deficiency Disease,"carbamoyl phosphate synthase|Carbamoyl-Phosphate Synthetase I Deficiency Disease|Carbamoyl Phosphate Synthase (Ammonia) Deficiency Disease|Carbamoyl-Phosphate Synthase I Deficiency Disease (Ornithine Carbamoyl Phosphate Deficiency)|Carbamyl Phosphate Synthetase 1 Deficiency Disease|Carbamoyl Phosphate Synthase 1 Deficiency Disease (Ornithine Carbamoyl Phosphate Deficiency)|Carbamoylphosphate Synthetase 1 Deficiency Disease|CPS I Deficiency|Carbamoylphosphate Synthetase 1 Deficiency Disease -|Carbamyl-Phosphate Synthetase I Deficiency Disease|CPS I Deficiencies|Carbamyl Phosphate Synthetase (CPS) Deficiency|CPS 1 Deficiency|Carbamoyl Phosphate Synthetase I Deficiency|Carbamoyl Phosphate Synthetase I Deficiency Disease|Carbamoylphosphate Synthetase I Deficiency Disease|Carbamoyl Phosphate Synthetase I Deficiency, Hyperammonemia Due To|Carbamoyl-Phosphate Synthase 1 Deficiency Disease|Carbamyl Phosphate Synthetase Deficiency Disease|Carbamyl Phosphate Synthetase I Deficiency Disease|Carbamoyl Phosphate Synthase 1 Deficiency Disease|Carbamyl-Phosphate Synthetase 1 Deficiency Disease|Carbamoyl-Phosphate Synthase 1 Deficiency Disease (Ornithine Carbamoyl Phosphate Deficiency)|CPS 1 Deficiencies|Hyperammonemia Due to Carbamoyl Phosphate Synthetase 1 Deficiency|Carbamoyl Phosphate Synthase 1 Deficiency"
NEW05975,CHEMICAL,urea cycle enzyme,urea cycle enzymes
NEW05976,CHEMICAL,black/dark blue belladonna fruit berry,black/dark blue belladonna fruit berries
NEW05977,DISEASE,possible confusion,possible confusion
NEW05978,CHEMICAL,bergamot essential oil,Bergamot essential oil
NEW05979,MENTAL_HEALTH,stress-induced anxiety,stress-induced anxiety
http://purl.obolibrary.org/obo/DOID_14755,CHEMICAL,argininosuccinic aciduria,deficiency of argininosuccinate lyase|glutaric aciduria type I. Glutaric acid|argininosuccinic acidemia|arginosuccinase deficiency|Argininosuccinate lyase deficiency
D008401,CHEMICAL,Gas Chromatography-Mass Spectrometry,"Spectrometry-Gas Chromatography, Mass|Spectrometry, Gas Chromatography-Mass|Gas Chromatography Mass Spectrometry|Gas-Liquid Chromatography-Mass Spectrometry|Spectrometry, Mass Gas Chromatography|Spectrum Analysis, Mass Gas Chromatography|Gas Liquid Chromatography Mass Spectrometry|Chromatography-Mass Spectrometry, Gas-Liquid|Mass Spectrometry-Gas Chromatography|GCMS|Spectrum Analysis, Mass-Gas Chromatography|Chromatography, Mass Spectrometry-Gas|Spectrometry, Gas-Liquid Chromatography-Mass|gas chromatography-mass spectrometry|Chromatography-Mass Spectrometry, Gas|Chromatography, Gas Liquid Mass Spectrometry|Chromatography, Gas Mass Spectrometry|Mass Spectrometry Gas Chromatography|Spectrometries, Mass-Gas Chromatography|gas chromatography|Spectrometry, Mass-Gas Chromatography|Chromatography, Gas-Liquid-Mass Spectrometry|Chromatography, Gas-Mass Spectrometry"
NEW05980,CHEMICAL,gte fruit,GTE fruit
D056486,DISEASE,Chemical and Drug Induced Liver Injury,"|Toxicity, Chemically-Induced Liver|Injuries, Drug-Induced Liver|Liver Toxicities, Chemically-Induced|Liver Toxicity, Chemically-Induced|Drug-Induced Liver Diseases|Liver Injury, Drug-Induced|Diseases, Drug-Induced Liver|Injury, Drug-Induced Liver|Hepatitis, Drug Induced|Drug-Induced Liver Disease|Acute Liver Injury, Drug-Induced|Liver Injuries, Drug-Induced|Drug-Induced Hepatitides|Liver Injury, Drug Induced|ALI|Hepatitis, Toxic|Chemically Induced Liver Toxicity|Liver Diseases, Drug-Induced|Drug Induced Liver Injury|hepatitis|Hepatitis, Drug-Induced|Liver Disease, Drug-Induced|Drug-Induced Liver Injuries|Drug-Induced Hepatitis|Drug-Induced Liver Injury|Drug Induced Acute Liver Injury|Drug Induced Liver Disease|Disease, Drug-Induced Liver|Toxic Hepatitis|Toxicities, Chemically-Induced Liver|Hepatitides, Drug-Induced|Toxic Hepatitides|liver toxicity|acute liver injury|Chemically-Induced Liver Toxicities|Liver Injury, Drug-Induced, Acute|Acute liver injury|Acute Liver Injury, Drug Induced|Hepatitides, Toxic|Chemically-Induced Liver Toxicity|Drug-Induced Acute Liver Injury"
NEW05981,CHEMICAL,ethanol extract,ethanol extract
D002252,CHEMICAL,Carbon Tetrachloride Poisoning,"Poisoning, Carbon Tetrachloride|CCl4 Poisoning|carbon tetrachloride|CCl4 Poisonings|Carbon Tetrachloride Poisonings|Poisonings, Carbon Tetrachloride|Poisoning, CCl4|Carbon tetrachloride"
NEW05982,CHEMICAL,Grewia tenax,Grewia tenax
NEW05983,CHEMICAL,several Cecropiaceae specie,Several Cecropiaceae species
D029481,DISEASE,"Bronchitis, Chronic",Chronic Bronchitis|bronchitis
NEW05984,DISEASE,p. alata,P. alata
http://purl.obolibrary.org/obo/NCBITaxon_72171,DISEASE,ziziphus,Convolvulus pluricaulis Choisy|Atractylodes macrocephala Koidz|incarnata fluidextract|μg/mL gallnut|ringens Vahl|Vo-80ME|Ziziphus mucronata|tenuifolia Willd|pudica Linn|Vitex agnus-castus L.|Houttuynia cordata Thunb|Cinnamomum zeylanicum bark|Ficus thonningii|Verbena officinalis|Ferula assa-foetida|Mentha arvensis
C000179,CHEMICAL,N-acetylaspartate [Supplementary Concept],N-acetyl aspartate|N-acetylaspartate|Aspartic Acid/analogs  and  derivatives|NAA
D010725,CHEMICAL,Phosphocreatine,"phosphocreatine|Neoton|Phosphocreatine, Disodium Salt|Phosphate, Creatine|Phosphorylcreatine|Disodium Salt Phosphocreatine|Creatine Phosphate|PCr"
http://purl.obolibrary.org/obo/DOID_890,DISEASE,mitochondrial encephalomyopathy,Mitochondrial neurogastrointestinal encephalomyopathy
D013939,CHEMICAL,Thymidine Phosphorylase,thymidine|PD-ECGF|Gliostatin|Platelet-Derived Endothelial Cell Growth Factor|Platelet Derived Endothelial Cell Growth Factor|thymidine phosphorylase
D011741,CHEMICAL,Pyrimidine Nucleosides,"Nucleosides, Pyrimidine|nucleosides"
NEW05985,CHEMICAL,mitochondrial dna mtdna deoxyribonucleoside triphosphate,mitochondrial DNA mtDNA deoxyribonucleoside triphosphates
http://purl.obolibrary.org/obo/CHEBI_17972,CHEMICAL,ribonucleoside triphosphate,deoxyribonucleoside triphosphates|dNTPs|Ribonucleoside triphosphate|ribonucleoside triphosphates
NEW05986,CHEMICAL,purine salvage pathway,purine salvage pathway
NEW05987,DISEASE,preexist psychiatric disorder,preexisting psychiatric disorders
NEW05988,CHEMICAL,covid-19 outbreak,COVID-19 outbreak
http://purl.obolibrary.org/obo/CHEBI_75253,CHEMICAL,phenylarsine oxide,oxo(phenyl)arsine|Oxophenylarsine|nitric oxide (NO)-dependent|nitric oxide system|Phenylarsenoxide|Phenyl arsine oxide|PhAsO|nitric oxide-induced|endogenous nitric oxide|Arsenosobenzene
NEW05989,CHEMICAL,peroxynitrite- apoptosis,peroxynitrite- apoptosis
NEW05990,CHEMICAL,striatal superoxide dismutase,striatal superoxide dismutase
C485766,DISEASE,"Ero1a protein, rat [Supplementary Concept]",Membrane Glycoproteins|global ischemia
http://purl.obolibrary.org/obo/DOID_11119,MENTAL_HEALTH,gilles de la tourette syndrome,Gille de la Tourette syndrome|Psychogenic tics|Tourette syndrome|motor-verbal tic disorder|Guinon's disease
NEW05991,CHEMICAL,aqueous virgin olive oil,VOO|aqueous virgin olive oil
NEW05992,DISEASE,chronic degenerative disease,chronic degenerative diseases
NEW05993,CHEMICAL,its 's phenolic compound,its's phenolic compound
NEW05994,DISEASE,chronic unpredictable stressor,Chronic unpredictable stressors
NEW05995,MENTAL_HEALTH,clinical depression,clinical depression
NEW05996,CHEMICAL,mesb     mg/kg,MESB    mg/kg
NEW05997,CHEMICAL,mesb-treated mouse,MESB-treated mice
NEW05998,CHEMICAL,capsaicin test,capsaicin test
NEW05999,CHEMICAL,bilgeriana,bilgeriana|MESB
NEW06000,DISEASE,unregulated inflammation,unregulated inflammation
NEW06001,CHEMICAL,phenolic glycoside,phenolic glycoside
http://purl.obolibrary.org/obo/CHEBI_7714,DISEASE,obamegine,Rhizoma Gastrodiae|Ziziphi Spinosae Semen|Epimedii Folium|Obamegine|(+)-Obamegine
C583105,CHEMICAL,4-(4'-hydroxybenzyl)phenyl glucoside [Supplementary Concept],Phenyl Ethers|Gastrodin|Glucosides
C555358,CHEMICAL,PF 592379 [Supplementary Concept],Aminopyridines|Morpholines|PF-592379
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Female_Sexual_Dysfunction,MENTAL_HEALTH,female sexual dysfunction,male sexual dysfunction|Female sexual dysfunction|female sexual dysfunction
NEW06002,MENTAL_HEALTH,male erectile dysfunction,male erectile dysfunction
D013729,CHEMICAL,Terpenes,Terpene|Isoprenoids|Terpenoid|Isoprenoid|Terpenoids|terpenes
http://purl.obolibrary.org/obo/CHEBI_166890,CHEMICAL,phenolic acid,phenolic acids|phenolic acid constituent|phenolcarboxylic acids
NEW06003,DISEASE,micro-element,micro-elements
D035264,CHEMICAL,Flowers,"Plant Styles|Plant Stamens|Bloom, Plant|Anther, Plant|Plant Ovary|Stamens, Plant|Plant Corolla|Blooms, Plant|Petals, Plant|Plant Stigma|Plant Blooms|Blossoms|Plant Sepal|Petal, Plant|Styles, Plant|Plant Style|Plant Carpals|Plant Carpal|Plant Calyxs|Pistil|Flower|Plant Petals|Plant Anthers|Calyx, Plant|Plant Anther|Carpals, Plant|Calyxs, Plant|Filament, Flower|Plant Sepals|Pistils|Style, Plant|Corollas, Plant|Plant Bloom|Plant Stigmas|Stigma, Plant|Flower Filament|Corolla, Plant|Ovary, Plant|Plant Ovaries|flowers|Flower Filaments|Anthers, Plant|Plant Stamen|Cannabis extracts|Ovaries, Plant|Stamen, Plant|Filaments, Flower|Plant Petal|Sepals, Plant|Plant Calyx|Blossom|Plant Corollas|Stigmas, Plant|Sepal, Plant|Carpal, Plant"
NEW06004,CHEMICAL,second-choice approach,second-choice approach
NEW06005,CHEBI,hormone due,hormones due
NEW06006,CHEMICAL,sertindole effect,sertindole effect
NEW06007,DISEASE,schizophrenic patient intolerant,schizophrenic patients intolerant
NEW06008,CHEMICAL,conclusion second-line choice,conclusion second-line choice
NEW06009,DISEASE,intractable vomiting,intractable vomiting
NEW06010,DISEASE,refractory vomiting,refractory vomiting
NEW06011,DISEASE,cancer patient,cancer patients
NEW06012,CHEMICAL,brain histamine,brain histamine
NEW06013,CHEMICAL,histidine decarboxylase null,histidine decarboxylase null
NEW06014,DISEASE,csds initiation,CSDS initiation
NEW06015,DISEASE,behavior impairment,behavior impairments
NEW06016,CHEMICAL,serotonin neuronal activity,serotonin neuronal activity
NEW06017,CHEBI,potential spinal analgesic action,potential spinal analgesic action
NEW06018,CHEBI,alpha-2-adrenergic drug,alpha-2-adrenergic drug
NEW06019,CHEMICAL,serotonine agonist,serotonine agonist
NEW06020,DISEASE,sleep confusion,sleeping confusions
NEW06021,CHEMICAL,pro-inflammatory cytokine,pro-inflammatory cytokines
C497736,CHEBI,phytoalexin spirobrassinin [Supplementary Concept],phytoalexin|Spiro Compounds|Thiazoles
C044615,CHEMICAL,urodiolenone [Supplementary Concept],urodiolenone|Urodiolenone|Sesquiterpenes
NEW06022,DISEASE,labile hypertension,labile hypertension
NEW06023,DISEASE,hypertensive subject,hypertensive subjects
NEW06024,DISEASE,cocaine-induced increase,cocaine-induced increases
NEW06025,CHEMICAL,2-ag signaling,2-AG signaling
NEW06026,CHEBI,cb1 receptor antagonists/inverse agonist,CB1 receptor antagonists/inverse agonists
NEW06027,CHEBI,cb1 receptor-neutral antagonist,CB1 receptor-neutral antagonists
NEW06028,CHEBI,prototype cb1 receptor antagonists/inverse agonist,prototype CB1 receptor antagonists/inverse agonists
NEW06029,CHEMICAL,β-neurexin,β-neurexins
NEW06030,DISEASE,psychotic reaction,psychotic reactions
NEW06031,CHEMICAL,delta(9)-tetrahydrocannabinol characteristic psychomotor effect,Delta(9)-Tetrahydrocannabinol characteristic psychomotor effects
NEW06032,CHEMICAL,central cannabinoid cb(1 receptor,central cannabinoid CB(1 receptor
http://purl.obolibrary.org/obo/CHEBI_73416,CHEBI,cb1 receptor antagonist,CB1 receptor agonists|type 1 cannabinoid receptor antagonist|CB1 receptor antagonist AM-251|CB1R antagonists|cannabinoid receptor type 1 antagonist|type 1 cannabinoid receptor antagonists|CB1 receptor antagonists|CB1R antagonist|cannabinoid receptor type 1 antagonists|CB1 receptor antagonist
D001249,DISEASE,Asthma,"bronchial asthma|Asthma, Bronchial|Bronchial Asthma|Asthmas"
D001067,CHEMICAL,Appetite Depressants,"|Appetite Suppressant Drug|Appetite-Suppressant Drug|Drug, Appetite-Suppressant|Depressants, Appetite|Anorexic Drug|Anorectic|Appetite Suppressant|Drug, Anorexic|Appetite Suppressants|Drugs, Anorexigenic|Agents, Anorectic|Anorectic Agents|Drug, Anorexigenic|Appetite Depressant|appetite suppressants|Anorectic Agent|Appetite-Depressing Drugs|Anorectics|Depressant, Appetite|Appetite Depressing Drug|Anorexic Drugs|Appetite Suppressant Drugs|Drugs, Appetite-Depressing|Drugs, Anorexic|Anorexigenic Drug|Drugs, Appetite-Suppressant|Appetite Depressing Drugs|Suppressant, Appetite|Appetite-Depressing Drug|Suppressants, Appetite|Appetite-Suppressant Drugs|Drug, Appetite-Depressing|Agent, Anorectic|Anorexigenic Drugs"
NEW06033,CHEBI,act antagonist,acting antagonists
NEW06034,DISEASE,serious psychiatric side effect,serious psychiatric side effects
NEW06035,CHEBI,first-in-class cb1r antagonist/inverse agonist,first-in-class CB1R antagonist/inverse agonist
NEW06036,MENTAL_HEALTH,stress-induced analgesia,stress-induced analgesia
NEW06037,CHEBI,endogenous cb1 receptor agonist,endogenous CB1 receptor agonists
NEW06038,CHEBI,drug intake,drug intake
C531600,CHEBI,Growth hormone excess [Supplementary Concept],Acromegaly|hormone excess
D006763,DISEASE,"Hospitals, Chronic Disease","Hospital, Chronic Disease|Tuberculosis Hospital|Tuberculosis Hospitals|Tuberculosis Sanitarias|chronic disease|Sanitoria, Tuberculosis|Tuberculosis Sanitorias|Hospital, Tuberculosis|Tuberculosis Sanitoria|Tuberculosis Sanitaria|Hospitals, Tuberculosis|Chronic Disease Hospitals|Sanitorias, Tuberculosis|Sanitaria, Tuberculosis|Sanitarias, Tuberculosis|Chronic Disease Hospital"
NEW06039,CHEMICAL,universal somatostatin receptor agonist pasireotide,universal somatostatin receptor agonist pasireotide
NEW06040,DISEASE,behavioural syndrome,behavioural syndrome
http://purl.obolibrary.org/obo/CHEBI_135470,CHEMICAL,indoramin,indoramine|dl-Propranolol|dl-propranolol|Wy-21901|Wy 21901|Wy21901
NEW06041,CHEMICAL,5meodmt,5MEODMT
NEW06042,DISEASE,myoclonic jerking movement,myoclonic jerking movements
NEW06043,MENTAL_HEALTH,chronic schizophrenia,chronic schizophrenia
http://purl.obolibrary.org/obo/CHEBI_184908,CHEMICAL,"2-methyl-3-(2-methylphenyl)-3,4-dihydroquinazolin-4-one [2-(diphenylmethoxy)ethyl]dimethylamine hydrochloride","LY2216684|ITI-007 tosylate|Edivoxetine hydrochloride|Naldemedine tosylate|ethoxy]ethanol hydrochloride|2-benzhydryloxy-N,N-dimethylethanamine;2-methyl-3-(2-methylphenyl)quinazolin-4-one;hydrochloride|R(-)-1-(benzo[b]thiophen-5-yl)-2-[2-(N N-diethylamino ethoxy]ethanol hydrochloride|T-588|LY3038404 HCl|N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride|(±)-N-methyl-γ-[4-(trifluoromethyl)phenoxy]benzenepropanamine hydrochloride"
NEW06044,CHEBI,first-in-class investigational drug,first-in-class investigational drug
C000705749,CHEMICAL,lumateperone [Supplementary Concept],"ITI-007|Heterocyclic Compounds, 4 or More Rings|lumateperone|Lumateperone tosylate|Lumateperone"
NEW06045,CHEBI,novel drug,novel drug
NEW06046,DISEASE,obsessive-compulsive symptom,obsessive-compulsive symptoms|OCS
NEW06047,DISEASE,distinct schizophrenic subgroup,distinct schizophrenic subgroup
NEW06048,MENTAL_HEALTH,oc schizophrenia,OC schizophrenia
NEW06049,CHEBI,specific agonist,specific agonists
NEW06050,DISEASE,human narcoleptic patient,human narcoleptic patients
NEW06051,MENTAL_HEALTH,worldwide abuse problem,worldwide abuse problem
http://purl.obolibrary.org/obo/CHEBI_50786,CHEMICAL,anabolic androgenic steroid,Anabolic steriod|Androgenic-anabolic steroids|anabolic-androgenic steroids|AAS|Anabolic-androgenic steroids
NEW06052,CHEMICAL,testosterone dysregulation,testosterone dysregulation
NEW06053,CHEMICAL,chronic intermittent hypoxia,CIH|chronic intermittent hypoxia|Chronic intermittent hypoxia
NEW06054,DISEASE,significant spatial memory impairment,significant spatial memory impairment
D047072,CHEMICAL,Aromatase Inhibitors,"Inhibitors, Aromatase|aromatase inhibitors|Aromatase Inhibitor|Inhibitor, Aromatase|AI"
NEW06055,CHEMICAL,ai treatment,AI treatment
NEW06056,CHEMICAL,low testosterone level,Low testosterone levels
NEW06057,DISEASE,iatrogenic adrenal insufficiency secondary,Iatrogenic adrenal insufficiency secondary
NEW06058,DISEASE,systematic rheumatic disease,systematic rheumatic diseases
D017380,DISEASE,"Hypertrophy, Right Ventricular","hypertrophy|Ventricular Hypertrophies, Right|Right Ventricular Hypertrophy|right ventricular hypertrophy|Hypertrophies, Right Ventricular|Right Ventricular Hypertrophies|Ventricular Hypertrophy, Right"
NEW06059,DISEASE,astrocytic atrophy,astrocytic atrophy
NEW06060,DISEASE,female depressed patient,female depressed patients
NEW06061,DISEASE,female bipolar patient,female bipolar patients
NEW06062,DISEASE,mdd group,MDD group
NEW06063,DISEASE,bipolar woman,bipolar women
NEW06064,MENTAL_HEALTH,stress-mediated affective disorder,stress-mediated affective disorders
NEW06065,CHEMICAL,serotonin circuit,serotonin circuits
NEW06066,CHEBI,gonadal hormone influence,gonadal hormone influence
C101530,CHEBI,CRF receptor type 1 [Supplementary Concept],"Receptors, Corticotropin-Releasing Hormone|Corticotropin-releasing hormone receptor"
NEW06067,DISEASE,anxiety-type behavior,anxiety-type behaviors
NEW06068,DISEASE,mood behavior,mood behaviors
NEW06069,CHEBI,increase androgen,increased androgens
C537436,DISEASE,Aromatase deficiency [Supplementary Concept],"Aromatase/deficiency|Infertility, Male|Gynecomastia|46, XX Disorders of Sex Development|Metabolism, Inborn Errors|placental aromatase deficiency"
NEW06070,CHEMICAL,novel d-amphetamine prodrug lisdexamfetamine,novel d-amphetamine prodrug lisdexamfetamine
http://purl.obolibrary.org/obo/DOID_11612,DISEASE,polycystic ovary syndrome,polycystic ovary|concomitant polycystic ovary syndrome|Stein-Leventhal syndrome|Multicystic ovaries|polycystic ovary syndrome adults|Background Polycystic ovary syndrome|Polycystic ovaries|PCOS|Polycystic Ovarian disease|Polycystic ovary syndrome|Stein-Leventhal synd.|Maternal polycystic ovary syndrome
NEW06071,DISEASE,common metabolic disorder,common metabolic disorder
NEW06072,CHEBI,androgen androgen sensitivity,androgens androgen sensitivity
NEW06073,DISEASE,psychiatric characteristic,psychiatric characteristics
NEW06074,DISEASE,idiopathic hirsutism,Idiopathic hirsutism
NEW06075,CHEBI,circulate androgen,circulating androgens
http://purl.obolibrary.org/obo/DOID_1414,DISEASE,ovarian dysfunction,ovarian dysfunctions
NEW06076,CHEBI,diagnose endocrine disorder,diagnosed endocrine disorder
D024282,CHEMICAL,"Genes, sry","Sex-Determining Region Gene On Y|Gene, Sex Determining Region Y|sry Genes|Sex-Related Y Genes|Y Genes, Sex-Related|Genes, Sex Related Y|Gene, Sex-Determining Region Y|Sex-Related Y Gene|Y Gene, Sex-Related|Sex Determining Region Gene On Y|Sex-Related Gene On Y|sry Gene|Sex Related Gene On Y|Gene, Sex-Related Y|Gene, sry|Sry|Genes, Sex-Related Y"
http://purl.org/sig/ont/fma/fma54319,CHEMICAL,pubic hair,pubic hair
C567552,DISEASE,Spondylodysplasia And Premature Pubarche [Supplementary Concept],"Osteochondrodysplasias|premature pubarche|Puberty, Precocious|Spine/abnormalities"
NEW06077,MENTAL_HEALTH,insulin resistance index,Insulin resistance index
NEW06078,CHEMICAL,2.09±1.42,2.09±1.42
D005247,MENTAL_HEALTH,Feeding Behavior,"Dietary Habits|Feeding Behaviors|Behavior, Feeding|Eating Behaviors|Food Habits|Behavior, Feeding-Related|Eating Habits|Pattern, Feeding|Eating Habit|Habits, Diet|Diet Habit|Habit, Eating|eating behaviors|Habit, Food|Feeding-Related Behavior|Feeding Pattern|Feeding Related Behavior|Feeding Patterns|Eating Behavior|Feeding-Related Behaviors|Dietary Habit|Habit, Dietary|Habit, Diet|Food Habit|Diet Habits|Behavior, Eating"
NEW06079,DISEASE,insulin instability,insulin instability
http://www.semanticweb.org/ontologies/2015/0/disorderscluster.owl#Symptomology,DISEASE,symptomology,PCOS symptomatology
D000077339,CHEMICAL,Leflunomide,Arava|HWA 486|HWA-486|N-(4-Trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide|Leflunomide|SU101|HWA486|leflunomide
NEW06080,DISEASE,ra patient,RA patients
http://purl.obolibrary.org/obo/CHEBI_50114,CHEBI,estrogen,Oestrogen|oestrogenes|estrogen (GPER)-mediated|Oestrogens|estrogenos|estrogene|oestrogene|Oestrogene|estrogenes|oestrogen|estrogens|Estrogene|estrogeno|oestrogens|estrogenes Hormon
NEW06081,CHEMICAL,long-term adt,Long-term ADT
NEW06082,CHEMICAL,dose- adt,dose- ADT
NEW06083,CHEBI,hormone sex chromosome,hormones sex chromosomes
NEW06084,CHEBI,complete androgen resistance,complete androgen resistance
NEW06085,CHEBI,androgen therapy,androgen therapy
NEW06086,CHEBI,androgen administration,androgen administration
NEW06087,DISEASE,als motoneuron recovery,ALS motoneuron recovery
NEW06088,DISEASE,anticonvulsant reversible hepatic dysfunction,anticonvulsant reversible hepatic dysfunction
NEW06089,DISEASE,irreversible hepatic failure,irreversible hepatic failure
NEW06090,CHEMICAL,vpa hepatotoxicity,VPA hepatotoxicity
NEW06091,DISEASE,additional neurological disease,additional neurological disease
NEW06092,CHEMICAL,enzyme-inducing drug,enzyme-inducing drugs
NEW06093,DISEASE,direct neurotoxic effect,direct neurotoxic effect
NEW06094,CHEBI,water-soluble vitamin,water-soluble vitamins
C022172,CHEMICAL,zotepine [Supplementary Concept],Dibenzothiepins|Zotepine
NEW06095,DISEASE,rs lps animal group,RS LPS animal groups
NEW06096,CHEMICAL,atp level,ATP level
D064430,CHEMICAL,NAD (+) and NADP (+) Dependent Alcohol Oxidoreductases,"Alchohol Oxidoreductases, NAD (+) and NADP (+) Dependent|NAD+|NAD"
NEW06097,CHEMICAL,deplete monoamine,depleted monoamines
NEW06098,DISEASE,alcohol-related illness,alcohol-related illness
NEW06099,CHEBI,leucocyte ascorbic acid level,leucocyte ascorbic acid level
C016470,CHEBI,"ascorbic acid, B2, B6, bendazol, caffeine, citric acid, distilled H2O, ethanol, gelatin, glutamic acid, KCl, MgCl2, NaCl, sorbitol, sucrose, vitamins B1 drug combination [Supplementary Concept]",Hexoses|Glutamates|vitamins B1|Drug Combinations
NEW06100,CHEMICAL,gamma-glutamyl transferase,gamma-glutamyl transferase
NEW06101,DISEASE,alcohol-induced damage,alcohol-induced damage
NEW06102,DISEASE,group 3-without extensive liver cell damage,group 3-without extensive liver cell damage
NEW06103,DISEASE,group cirrhosis,group cirrhosis
NEW06104,DISEASE,group 2-with extensive liver cell damage,group 2-with extensive liver cell damage
C524644,CHEMICAL,Yi-Gan San [Supplementary Concept],"Yi-gan san|YKS|Drugs, Chinese Herbal|Yokukansan"
http://purl.obolibrary.org/obo/SYMP_0000654,DISEASE,irritability,irritability|Inconsolability
NEW06105,DISEASE,head-dipping behavior,head-dipping behaviors
NEW06106,CHEMICAL,benzodiazepine receptor antagonist flumazenil,benzodiazepine receptor antagonist flumazenil
NEW06107,CHEMICAL,1mg/kg,1mg/kg
http://purl.obolibrary.org/obo/CHEBI_64600,CHEBI,c21-steroid hormone,corticoctropin-releasing hormone|GH-releasing hormone|C21-steroid hormones|GHRH
NEW06108,CHEBI,its 's endocrine mode,its's endocrine mode
NEW06109,CHEMICAL,stress-hormone system,stress-hormone system
NEW06110,CHEBI,approve drug,approved drug
NEW06111,CHEMICAL,network 's dopamine system,network's dopamine system
NEW06112,MENTAL_HEALTH,disorder patient,disorder patients
NEW06113,CHEMICAL,water-soluble extract,HX106|water-soluble extracts
D002437,CHEMICAL,Cefazolin,"Cephazolin Sodium|Sodium Cephazolin|cefazolin|Totacef|Cefazolin Sodium|Kefzol|Gramaxin|Ancef|Cefamezine|Cefamedin|Sodium, Cefazolin|Cephamezine|Cephazolin|Sodium, Cephazolin|Cephazolin, Sodium"
NEW06114,CHEBI,excessive antibiotic,Excessive antibiotics
C031815,DISEASE,"toxB protein, Clostridium difficile [Supplementary Concept]",Bacterial Proteins|Bacterial Toxins|Clostridium difficile toxin B|Clostridium difficile
C074968,CHEMICAL,pentaacetyl geniposide [Supplementary Concept],Iridoid Glucosides|geniposide
NEW06115,DISEASE,stz-induced learning deficit,STZ-induced learning deficit
NEW06116,DISEASE,non-celiac gluten sensitivity,Non-celiac gluten sensitivity
NEW06117,NUTRITION,wheat protein,wheat proteins
NEW06118,CHEBI,food antigen,Food antigens
NEW06119,CHEMICAL,food(s,food(s
NEW06120,DISEASE,intestinal symptom,intestinal symptoms
NEW06121,DISEASE,magnesium ion neuronal deficit,magnesium ion neuronal deficits
NEW06122,CHEMICAL,excessive dietary calcium,excessive dietary calcium
NEW06123,DISEASE,dietary deficiency,Dietary deficiencies
D008275,CHEMICAL,Magnesium Deficiency,"Magnesium Deficiencies|magnesium deficiency|Deficiency, Magnesium|Deficiencies, Magnesium"
NEW06124,DISEASE,non-celiac gluten sensitivity,non-celiac gluten sensitivity
NEW06125,MENTAL_HEALTH,disease-related fatigue,disease-related fatigue
D008043,CHEMICAL,Linseed Oil,"Oil, Linseed|Oil, Flaxseed|flaxseed|Flaxseed Oil"
NEW06126,MENTAL_HEALTH,conclusion mental fatigue,conclusion mental fatigue
NEW06127,CHEMICAL,neuroprotective steroid,neuroprotective steroid
NEW06128,DISEASE,tat-related behavioral impairment,Tat-related behavioral impairments
NEW06129,CHEMICAL,5α-reduced pregnane steroid,5α-reduced pregnane steroids
NEW06130,CHEBI,pharmaceutical therapeutic,pharmaceutical therapeutic
NEW06131,DISEASE,female sexual disorder,female sexual disorders
NEW06132,CHEBI,pharmaceutical pathway,pharmaceutical pathways
NEW06133,CHEMICAL,drospirenone/ethinylestradiol 3mg/20microg,Drospirenone/ethinylestradiol 3mg/20microg
NEW06134,DISEASE,moderate acne vulgaris,moderate acne vulgaris
D011980,CHEMICAL,"Receptors, Progesterone","Receptor, Progesterone|Progesterone Receptor|progesterone receptors|Receptors, Progestin|Progestin Receptors|Receptor, Progestin|Progestin Receptor|Progesterone Receptors"
NEW06135,DISEASE,psychosomatic health,psychosomatic health
NEW06136,DISEASE,heavy bleeding,heavy bleeding
NEW06137,CHEBI,different progestogen,different progestogens
NEW06138,CHEMICAL,term hrt,term HRT
NEW06139,DISEASE,low fracture incidence,lower fracture incidence
NEW06140,CHEMICAL,hrt hrt,HRT HRT
NEW06141,DISEASE,fracture prevention,fracture prevention
NEW06142,DISEASE,cardiovascular disease prevention,cardiovascular disease prevention
http://purl.obolibrary.org/obo/DOID_1612,DISEASE,breast cancer,primary breast cancer|malignant tumor of the breast|ERα+ breast cancer|malignant neoplasm of breast|breast cancer tumors|hormone-dependent breast cancer|cancer breasts|mammary cancer|metastatic breast cancer|HR+/HER2- breast cancer|breast tumor|mammary neoplasm|mammary tumor
NEW06143,CHEMICAL,in ral,In RAL
NEW06144,DISEASE,estrogen-dependent breast adenocarcinoma cell,estrogen-dependent breast adenocarcinoma cells
D000535,CHEMICAL,Aluminum,Aluminum-27|Aluminium 27|aluminium|Aluminium-27|Aluminum 27|Aluminium
D006967,DISEASE,Hypersensitivity,"Allergic Reaction|Allergy|allergic reactions|Allergic Reactions|Allergies|Reaction, Allergic|Hypersensitivities|Reactions, Allergic"
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Respiratory_Tract_Disorders,DISEASE,respiratory tract disorders,respiratory tract disorders
NEW06145,CHEBI,potential toxic agent,potential toxic agent
NEW06146,CHEMICAL,aluminium powder,aluminium powder
NEW06147,CHEMICAL,aluminium fume,aluminium fumes
NEW06148,DISEASE,severe neuron damage,severe neuron damage
NEW06149,DISEASE,early pd,early PD
NEW06150,CHEMICAL,midbrain dopamine neuron,midbrain dopamine neurons
NEW06151,DISEASE,profound neurodegeneration,profound neurodegeneration
NEW06152,CHEMICAL,unregulated cytosolic dopamine,unregulated cytosolic dopamine
NEW06153,CHEMICAL,thallium poisoning,thallium poisoning
NEW06154,DISEASE,digestive complaint,digestive complaints
NEW06155,CHEMICAL,report-ed adverse effect,report-ed adverse effects
NEW06156,DISEASE,mental slowness,mental slowness
NEW06157,DISEASE,depressive thought,depressive thoughts
NEW06158,CHEMICAL,self-reported cannabis use,self-reported cannabis use
NEW06159,DISEASE,acute psychotic decompensation,acute psychotic decompensation
NEW06160,CHEBI,main toxic agent,main toxic agent
NEW06161,DISEASE,chemical poisoning,chemical poisoning
C034024,CHEMICAL,iodized salt [Supplementary Concept],"Sodium Chloride, Dietary|Iodine|iodized salt"
NEW06162,CHEMICAL,ethanol consumption,ethanol consumption
NEW06163,DISEASE,chronic cerebral hypoperfusion,chronic cerebral hypoperfusion
NEW06164,NUTRITION,angelica injection,angelica injection
NEW06165,DISEASE,sciatic crush,sciatic crush
NEW06166,DISEASE,several nervous system injury model,Several nervous system injury models
D029971,NUTRITION,Angelica sinensis,"angelica|Angelica sinenses|angelica sinensis|sinenses, Angelica"
NEW06167,NUTRITION,Angelica dahurica,Angelica dahurica
D065631,DISEASE,"Rhinitis, Allergic","Allergic Rhinitis|Allergic Rhinitides|rhinitis|Rhinitides, Allergic"
http://purl.obolibrary.org/obo/NCBITaxon_400053,CHEMICAL,sylvaemus group,coremium groups|UVB group|ADHD-C group|HVF group|PWS group|blueberry-treated group|PPAV groups|Control-AH groups|NASH group|-SH groups|LTRA group|DMPA-SC group|sulfamidoalkyl groups|PCOS group|CUMS group|EstroG-100 group
D065635,DISEASE,Benign Paroxysmal Positional Vertigo,"Benign Recurrent Vertigo|Familial Vestibulopathy|Vestibulopathies, Familial|Recurrent Vertigos, Benign|Familial Benign Recurrent Vertigo|benign paroxysmal positional vertigo|Vertigo, Benign Recurrent|Vertigo, Benign Paroxysmal Positional|vertigo|Familial Vestibulopathies|Vestibulopathy, Familial|Benign Recurrent Vertigos|Recurrent Vertigo, Benign"
C574038,CHEMICAL,EstroG-100 [Supplementary Concept],EstroG-100|Plant Extracts
NEW06168,DISEASE,pre- peri- woman,pre- peri- women
C532268,CHEMICAL,xiaoyaosan [Supplementary Concept],"Xiaoyaosan|XYS|Drugs, Chinese Herbal"
NEW06169,CHEMICAL,corticosterone cort model,corticosterone CORT model
NEW06170,CHEMICAL,medicine Jangwonhwan,medicine Jangwonhwan
NEW06171,DISEASE,neurogenic pulmonary edema,neurogenic pulmonary edema
D015190,CHEMICAL,Blood Glucose Self-Monitoring,"Glucose Self-Monitoring, Blood|Self-Monitorings, Blood Glucose|Monitoring, Home Blood Glucose|Glucose Self-Monitorings, Blood|Blood Sugar Self-Monitorings|Self-Monitoring, Blood Glucose|Sugar Self-Monitorings, Blood|blood sugar|Glucose, Blood, Self Monitoring|Blood Glucose Self-Monitorings|Self-Monitoring, Blood Sugar|Blood Sugar Self Monitoring|Blood Glucose Self Monitoring|Self-Monitorings, Blood Sugar|FBS|Sugar Self-Monitoring, Blood|Self Monitoring, Blood Glucose|Blood Sugar Self-Monitoring|Glucose, Blood, Self-Monitoring|glucose monitoring|blood glucose|Home Blood Glucose Monitoring"
NEW06172,DISEASE,diabete animal model,diabetes animal model
NEW06173,CHEMICAL,mg/dl fasting blood glucose,mg/dl fasting blood glucose
NEW06174,NUTRITION,combination     lithium,Combination    lithium
C000713787,DISEASE,rehmannia root [Supplementary Concept],Rehmannia|Plant Extracts|Radix Rehmanniae
NEW06175,CHEMICAL,rehmannia glutionsa Libosch,Rehmannia glutionsa Libosch
NEW06176,DISEASE,inflammatory injury,inflammatory injury
C430864,DISEASE,"DLC-1 (deleted in liver cancer) protein, mouse [Supplementary Concept]",Tumor Suppressor Proteins|liver cancer|GTPase-Activating Proteins
NEW06177,DISEASE,hyperammonemia generation,hyperammonemia generation
NEW06178,CHEMICAL,lactulose pretreatment,lactulose pretreatment
NEW06179,DISEASE,decrease blood ammonia,decreased blood ammonia
NEW06180,DISEASE,meth-induced neurotoxicity,METH-induced neurotoxicity
C521955,CHEMICAL,"N,N-(2-methylnaphthylbenzyl)-2-aminoacetonitrile [Supplementary Concept]",Aminoacetonitrile/analogs  and  derivatives|Naphthalenes|LPI
NEW06181,DISEASE,protein malnutrition,protein malnutrition
http://purl.obolibrary.org/obo/DOID_12399,CHEMICAL,pathological gambling,PG|Pathologic gambling|at-risk/probable pathological gambling|Compulsive gambling|Pathological gambling
NEW06182,DISEASE,persistent maladaptive gambling behavior,persistent maladaptive gambling behavior
NEW06183,CHEMICAL,representation-mediated taste aversion,Representation-mediated taste aversion
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Distractibility,DISEASE,distractibility,hyperactivity/impulsivity|inattentiveness
NEW06184,CHEMICAL,high-sugar/unhealthy food intake,high-sugar/unhealthy food intake
NEW06185,CHEMICAL,prenatal alcohol exposure,Prenatal alcohol exposure
NEW06186,DISEASE,adhd-like hyperactive behavior,ADHD-like hyperactive behavior
NEW06187,CHEMICAL,prenatal alcohol exposure,PAE|prenatal alcohol exposure|Prenatal alcohol exposure
NEW06188,DISEASE,metabolic disturbance,metabolic disturbance
NEW06189,MENTAL_HEALTH,adhd neuropathology,ADHD neuropathology
NEW06190,CHEMICAL,hx106-treated OPAE,HX106-treated OPAE
NEW06191,DISEASE,hyperactive behavior,hyperactive behavior
NEW06192,CHEMICAL,vehicle-treated OPAE,vehicle-treated OPAE
NEW06193,CHEMICAL,ligasure,LigaSure
NEW06194,CHEMICAL,acetaminophen group,acetaminophen group
NEW06195,MENTAL_HEALTH,low social anxiety,lower social anxiety
NEW06196,DISEASE,social pain,social pain
NEW06197,DISEASE,metabolic derangement,metabolic derangements
NEW06198,DISEASE,binge-like eat behavior,Binge-like eating behavior
NEW06199,CHEMICAL,low-calorie food,low-calorie foods
C026285,CHEMICAL,trichlorosucrose [Supplementary Concept],Sucrose/analogs  and  derivatives|sucralose
NEW06200,DISEASE,animal cancer bioassay,animal cancer bioassays
NEW06201,CHEMICAL,novel synthetic glycolipids-disaccharide-based lipid a mimetic,novel synthetic glycolipids-disaccharide-based lipid A mimetics|DLAMs
NEW06202,DISEASE,exceptional conformational rigidity,exceptional conformational rigidity
C044283,DISEASE,lipid X [Supplementary Concept],E. coli lipid A.|Glycolipids
NEW06203,CHEMICAL,sugar scaffold,sugar scaffold
NEW06204,CHEMICAL,disaccharide skeleton,disaccharide skeleton
NEW06205,MENTAL_HEALTH,bind orientation,binding orientation
NEW06206,DISEASE,ad patient,AD patients
NEW06207,MENTAL_HEALTH,resistance homa-ir index,Resistance HOMA-IR index
NEW06208,DISEASE,due disc degeneration,due disc degeneration
NEW06209,DISEASE,parkinsonian phenotype,parkinsonian phenotype
NEW06210,DISEASE,reserpine-induced hypothermia,reserpine-induced hypothermia
D002976,CHEMICAL,Clenbuterol,NAB365|clenbuterol|NAB-365|Planipart|NAB 365
NEW06211,DISEASE,hypotensive property,hypotensive properties
C024763,CHEMICAL,talipexole [Supplementary Concept],Azepines|B-HT920
NEW06212,CHEMICAL,clonidine = b-ht920 great,clonidine = B-HT920 greater
NEW06213,CHEMICAL,b-ht920 great,B-HT920 greater
http://purl.obolibrary.org/obo/SYMP_0000719,DISEASE,memory impairment,MK-801-induced memory impairment|short-term memory impairment|episodic memory impairments|ECT-induced memory impairment|memory impairment|IL-1beta-induced memory impairment|memory impairments
NEW06214,CHEMICAL,nmda receptor hypofunction state,NMDA receptor hypofunction state
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Neurotoxicity,DISEASE,neurotoxicity,NRHypo neurotoxicity|Aβ-induced neurotoxicity|CORT-induced neurotoxicity|CisPt-induced neurotoxicity|(MPTP)-induced neurotoxicity|neuroapoptosis
NEW06215,CHEMICAL,non-nmda glutamate antagonist,non-NMDA glutamate antagonists
http://purl.obolibrary.org/obo/CHEBI_48876,CHEMICAL,muscarinic antagonist,muscarinic acetylcholine receptor antagonist|muscarinic antagonists|agente antimuscarinico|muscarinic antagonist atropine|antimuscarinic agents|Antimuskarinikum|muscarinic antagonist scopolamine|antimuscarinicos|Antimuskarinika|agents antimuscariniques|nonselective muscarinic acetylcholine receptor antagonist|agentes antimuscarinicos
NEW06216,CHEMICAL,muscarinic glu agonist,muscarinic Glu agonists
NEW06217,DISEASE,neurotoxic reaction,neurotoxic reaction
C101562,CHEMICAL,"XenU1 protein, Xenopus [Supplementary Concept]","Xenopus Proteins|Receptors, Glutamate|non-NMDA"
NEW06218,CHEMICAL,5-ht releasing agent,5-HT releasing agents
D010133,CHEMICAL,p-Chloroamphetamine,Parachloroamphetamine|p-Chloramphetamine|Ly 123362|para-Chloroamphetamine|para Chloroamphetamine|Ly123362|Ly-123362|LY-121860|LY 121860|p Chloramphetamine|p Chloroamphetamine|p-chloroamphetamine|LY121860
NEW06219,DISEASE,auditory prepulse inhibition,auditory prepulse inhibition
NEW06220,CHEMICAL,cortical 5-ht,cortical 5-HT
NEW06221,DISEASE,neurotoxic dose,neurotoxic dose
NEW06222,DISEASE,hospitalize schizophrenic patient,hospitalized schizophrenic patients
NEW06223,DISEASE,stress-induced lung metastasis,stress-induced lung metastasis
NEW06224,CHEMICAL,stress-related catecholamine,stress-related catecholamine
C097869,CHEMICAL,"3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate [Supplementary Concept]",SR59230A|Propanolamines
NEW06225,DISEASE,swim-induced hyperalgesia,swim-induced hyperalgesia
NEW06226,CHEMICAL,peripheral 2-adrenergic agonist reproterol,peripheral 2-adrenergic agonist reproterol
NEW06227,CHEMICAL,ring-a-reduced progesterone derivative 5 alpha-pregnan-3 alpha-ol-20-one,ring-A-reduced progesterone derivative 5 alpha-pregnan-3 alpha-ol-20-one|tetrahydroprogesterone
NEW06228,MENTAL_HEALTH,corticotropin-releasing hormone-induced anxiety,corticotropin-releasing hormone-induced anxiety
D004809,CHEMICAL,Ephedrine,"|Ephedrine Erythro Isomer|Ephedrine Renaudin|SalPhedrine|Sulfate, Ephedrine|Erythro Isomer of Ephedrine|Sal-Phedrine|Renaudin, Ephedrine|Ephedrine Hydrochloride|Hydrochloride, Ephedrine|Ephedrine Sulfate|ephedrine|Sal Phedrine"
http://purl.obolibrary.org/obo/MFOMD_0000191,CHEMICAL,anorgasmia,anorgasmia|orgasm intensity/pleasure
D005039,CHEMICAL,Etilefrine,"Effortil|Efortil|Eti-Puren|Adrenam|Etilefrin-ratiopharm|Ethyladrianol|Ethyl Adrianol|Hydrochloride, Etilefrine|Phetanol|Bioflutin|Etilefrine Pivalate Hydrochloride|Etilefrine Hydrochloride|etil von ct|Etilefrin ratiopharm|Ethylnorphenylephrine|Hydrochloride, Etilefrine Pivalate|Etilefrin AL|Fetanol|Ethylphenylephrine|Adrianol, Ethyl|Eti Puren|etilefrine|Etilefrin|Circupon|Thomasin|Pivalate Hydrochloride, Etilefrine|Cardanat"
NEW06229,DISEASE,month hypertension,months hypertension
NEW06230,DISEASE,ventricular arrhythmia,ventricular arrhythmia
NEW06231,CHEBI,alpha-2-adrenergic agonist,alpha-2-adrenergic agonist
NEW06232,DISEASE,stress-induced cardiomyopathy,stress-induced cardiomyopathy
NEW06233,CHEMICAL,excessive extracellular dopamine,excessive extracellular dopamine
NEW06234,CHEMICAL,second-line therapy,second-line therapies
NEW06235,CHEBI,central alpha-adrenoreceptor agonist,central alpha-adrenoreceptor agonists
NEW06236,DISEASE,report ingestion,reported ingestions
NEW06237,CHEMICAL,modafinil overdose,modafinil overdose
NEW06238,CHEMICAL,atomoxetine overdose,atomoxetine overdose
NEW06239,DISEASE,paradoxical hypertension,paradoxical hypertension
NEW06240,CHEMICAL,past alcohol use,past alcohol use
NEW06241,CHEMICAL,lofexidine recipient,lofexidine recipient
NEW06242,MENTAL_HEALTH,due transient hallucination,due transient hallucinations
NEW06243,CHEBI,alpha(2 adrenergic agonist clonidine,alpha(2 adrenergic agonist clonidine
NEW06244,CHEBI,growth hormone gh response,growth hormone GH response
NEW06245,DISEASE,high crf concentration,high CRF concentrations
NEW06246,DISEASE,serial csf crf concentration,serial CSF CRF concentrations
NEW06247,DISEASE,high csf crf,high CSF CRF
NEW06248,DISEASE,system crf activity,system CRF activity
NEW06249,CHEBI,neonatal narcotic addiction,neonatal narcotic addiction
NEW06250,CHEMICAL,alcohol detoxification,alcohol detoxification
NEW06251,CHEBI,novel psychostimulant drug,novel psychostimulant drug
NEW06252,CHEMICAL,(diphenyl-methyl)sulphinyl-2-acetamide,(diphenyl-methyl)sulphinyl-2-acetamide
NEW06253,CHEBI,α2-adrenergic agonist medication,α2-adrenergic agonist medications
NEW06254,CHEMICAL,enteral guanfacine therapy,Enteral guanfacine therapy
D000074022,DISEASE,"Anesthesia, Cardiac Procedures","Anesthesias, Cardiac Procedures|Cardiac Anaesthesias|Anesthesia, Cardiovascular|Cardiothoracic Anaesthesia|Anesthesia, Cardiothoracic|Cardiac Anesthesia|Cardiac Procedures Anesthesias|Cardiothoracic Anesthesia|Anesthesia, Cardiac|Cardiac Procedures Anesthesia|cardiac procedures|Anaesthesia, Cardiothoracic|Cardiac Anaesthesia|Cardiovascular Anesthesia"
NEW06255,DISEASE,maladaptive behavior,maladaptive behaviors
NEW06256,CHEMICAL,double-blind randomised-withdrawal study,double-blind randomised-withdrawal study
NEW06257,CHEMICAL,gxr efficacy,GXR efficacy
NEW06258,CHEMICAL,α2a-adrenergic agonist guanfacine,α2A-adrenergic agonist guanfacine
NEW06259,DISEASE,chf patient,CHF patients
NEW06260,CHEBI,its 's adrenergic agonist property,Its's adrenergic agonist properties
NEW06261,CHEMICAL,imidazoline derivative antihypertensive medication,imidazoline derivative antihypertensive medication
C060897,CHEMICAL,ractopamine [Supplementary Concept],Phenethylamines|ractopamine
http://purl.obolibrary.org/obo/DOID_3389,DISEASE,papillon-lefevre disease,malfunction-induced disease|HIV-related diseases|Usutu disease|Papillon Lefevre syndrome|Papillon-Lefvre syndrome|PKAN disease|Alzheimer&rsquo;s disease|Shuni disease|Alz-heimer disease|Kasba disease|Schmallenberg disease|disease COVID-19 disease|Pseudo-rust disease|Wesselsbron disease
NEW06262,DISEASE,article neurodegeneration,article neurodegeneration
D004390,CHEMICAL,Chlorpyrifos,Lorsban|Dursban|CPF|Chlorpyrifos|chlorpyrifos
NEW06263,CHEMICAL,reduce acetylcholine esterase,reduced acetylcholine esterase
NEW06264,CHEMICAL,grape seed proanthocyanidin extract,GSPE|grape seed proanthocyanidins extracts
NEW06265,CHEMICAL,subacute cpf,subacute CPF
http://purl.obolibrary.org/obo/CHEBI_136044,CHEMICAL,fimasartan,fimasartan potassium|fimasartan potassium trihydrate|kanarb|clinidipine|BR-A-657|fimasartan potassium hydrate
D020108,CHEMICAL,Nicorandil,"2-Nicotinamidethyl Nitrate|SG-75|Nitrate, 2-Nicotinamidoethyl|SG75|2-Nicotinamidoethyl Nitrate|Dancor|Ikorel|Adancor|2 Nicotinamidethyl Nitrate|nicorandil|Nitrate, 2-Nicotinamidethyl|2 Nicotinamidoethyl Nitrate|SG 75"
C473739,NUTRITION,proanthocyanidin A1 [Supplementary Concept],Proanthocyanidins|proanthocyanidin
NEW06266,DISEASE,lps-induced depressive-like behavior,LPS-induced depressive-like behaviors
NEW06267,CHEMICAL,mixed dopamine da d1/d2 receptor agonist apomorphine,mixed dopamine DA D1/D2 receptor agonist apomorphine
NEW06268,CHEBI,dopamine d1/d2 receptor agonist,dopamine D1/D2 receptor agonist
NEW06269,CHEMICAL,dopamine releaser,dopamine releaser
NEW06270,DISEASE,pcp-induced cognitive deficit,PCP-induced cognitive deficits
NEW06271,CHEBI,selective sigma-1 receptor antagonist ne-100,selective sigma-1 receptor antagonist NE-100
NEW06272,CHEMICAL,neurosteroid dehydroepiandrosterone 3-sulfate,neurosteroid dehydroepiandrosterone 3-sulfate
NEW06273,CHEMICAL,selective sigma-1 receptor agonist sa4503,selective sigma-1 receptor agonist SA4503
NEW06274,CHEMICAL,dhea-s mg/kg/day,DHEA-S mg/kg/day
http://purl.obolibrary.org/obo/CHEBI_55322,CHEBI,mu-opioid receptor agonist,sigma-1 receptor agonists|mu-opioid agonists|mu-opioid agonist D-Ala2 DAMGO|synthetic melatonergic receptor agonist|serotonin-1A receptor agonist|cholecystokinin2 CCK2 receptor agonist|micro-opioid receptor agonists|mu-opioid receptor agonists|sigma-1 receptor σ1R agonist|mu opioid agonist|Mu-opioid receptor agonists|partial mu-opioid receptor agonist
NEW06275,MENTAL_HEALTH,contrary high anxiety,contrary higher anxiety
NEW06276,MENTAL_HEALTH,caffeine-induced anxiety,caffeine-induced anxiety
NEW06277,CHEMICAL,"neurosteroid 3alpha,5alpha-thp","neurosteroid 3alpha,5alpha-THP"
NEW06278,DISEASE,depressive animal model,depressive animal model
NEW06279,CHEBI,phenytoin-sensitive sigma1-receptor agonist,phenytoin-sensitive sigma1-receptor agonists
NEW06280,CHEMICAL,"(+)-skf-10,047","(+)-SKF-10,047"
NEW06281,DISEASE,decrease sexual motivation,decreased sexual motivation
NEW06282,DISEASE,orgasm difficulty,orgasm difficulties
http://purl.obolibrary.org/obo/DOID_1876,DISEASE,sexual dysfunction,SSRI-induced sexual dysfunction
NEW06283,CHEMICAL,5-ht1a receptor agonist buspirone,5-HT1A receptor agonist buspirone
http://purl.obolibrary.org/obo/CHEBI_9139,CHEMICAL,sildenafil,"sildenafil|1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine|5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one|sildenafil Viagra ®|PDE5-i sildenafil"
NEW06284,CHEBI,selective serotonin type 5-ht4 receptor agonist,selective serotonin type 5-HT4 receptor agonist
NEW06285,CHEBI,endocrine tissue,endocrine tissues
NEW06286,DISEASE,increase neoplasia incidence,increased neoplasia incidence
NEW06287,CHEBI,prolactin receptor-expressing endocrine tissue,prolactin receptor-expressing endocrine tissues
C537716,DISEASE,Macrocephaly mesodermal hamartoma spectrum [Supplementary Concept],macrocephaly|Proteus Syndrome
NEW06288,DISEASE,axonal remodeling,axonal remodeling
C491521,CHEMICAL,"CPI-17 protein, Oryctolagus cuniculus [Supplementary Concept]",Phosphoproteins|CPI-17|Muscle Proteins
NEW06289,CHEMICAL,3xtg‑ad mouse,3xTg‑AD mice
NEW06290,DISEASE,cognitive competence,cognitive competence
NEW06291,CHEBI,efficient drug,efficient drug
NEW06292,MENTAL_HEALTH,schizophrenia antipsychotic,schizophrenia antipsychotics
NEW06293,CHEMICAL,dopamine receptor subtype,dopamine receptor subtypes
NEW06294,CHEMICAL,monoamine deficiency,monoamines deficiency
NEW06295,CHEMICAL,ag nm,Ag NM
NEW06296,DISEASE,its 's toxicity,its's toxicity
D011507,DISEASE,Proteinuria,|proteinuria|Proteinurias
D011141,DISEASE,Polyuria,polyuria||Polyurias
NEW06297,NUTRITION,chronic lithium nephrotoxicity,chronic lithium nephrotoxicity
D005923,DISEASE,"Glomerulosclerosis, Focal Segmental","|Focal Sclerosing Glomerulonephritis|Focal Sclerosing Glomerulonephritides|Glomerular Hyalinosis, Segmental|Focal Glomerulosclerosis|Glomerulonephritis, Focal Sclerosing|Focal Segmental Glomerulosclerosis|Sclerosing Glomerulonephritis, Focal|Glomerulonephritides, Focal Sclerosing|Segmental Hyalinosis|Segmental Glomerular Hyalinosis|glomerulosclerosis|focal segmental glomerulosclerosis|Glomerulosclerosis, Focal|Sclerosing Glomerulonephritides, Focal|Hyalinosis, Segmental Glomerular|Hyalinosis, Segmental|Segmental Glomerulosclerosis, Focal|focal glomerulosclerosis"
D009395,DISEASE,"Nephritis, Interstitial","|Interstitial Nephritides|Interstitial Nephritis|Tubulointerstitial Nephritides|Tubulointerstitial Nephritis|Nephritides, Tubulointerstitial|Nephritides, Interstitial|interstitial nephritis|Nephritis, Tubulointerstitial"
NEW06298,NUTRITION,lithium time,lithium time
NEW06299,DISEASE,glomerular disease,glomerular disease
NEW06300,DISEASE,nephrotoxic short-term,nephrotoxic short-term
NEW06301,DISEASE,high psychiatric dose,higher psychiatric doses
NEW06302,NUTRITION,low-dose lithium,low-dose lithium
NEW06303,DISEASE,acute kidney disease,acute kidney disease
NEW06304,CHEMICAL,binge ethanol exposure,Binge ethanol exposure
NEW06305,DISEASE,pleomorphic congenital hyperammonemia,pleomorphic congenital hyperammonemia
C511993,CHEMICAL,kaempferol-3-O-(6-trans-caffeoyl)-beta-D-glucopyranosyl-(1- 2)-beta-D-glucopyranoside-7-O-beta-D-glucopyranoside [Supplementary Concept],Kaempferols|Glycosides|Kaempferol|KPF
NEW06306,CHEMICAL,beta-amyloid protein inhibition,beta-amyloid protein inhibition
NEW06307,CHEMICAL,csf t-tau level,CSF t-tau levels
NEW06308,CHEMICAL,nucleotide position,nucleotide position
http://purl.obolibrary.org/obo/DOID_705,DISEASE,leber hereditary optic neuropathy,Leber's hereditary optic neuropathy|Leber 's hereditary optic neuropathy|Leber's optic atrophy|LHON
D050768,CHEMICAL,Protoporphyrinogen Oxidase,"Oxidase, Protoporphyrinogen|Protoporphyrinogen Dehydrogenase|Dehydrogenase, Protoporphyrinogen|Protox|Protoporphyrinogen IX Oxidase|protoporphyrinogen oxidase|Protoporphyrinogenase|Oxidase, Protoporphyrinogen IX"
D051778,CHEMICAL,Basic Helix-Loop-Helix Leucine Zipper Transcription Factors,"BHLH-Zip Transcription Factors|Transcription Factors, BHLH-Zip|Basic Helix Loop Helix Leucine Zipper Transcription Factors|leucine|BHLH Zip Transcription Factors|Transcription Factors, BHLHLZ|BHLHLZ Transcription Factors"
C551435,DISEASE,"CDKL5 protein, rat [Supplementary Concept]",CDKL5|Protein Serine-Threonine Kinases|Cyclin-dependent kinase-like 5
NEW06309,CHEMICAL,extracellular dopamine,extracellular dopamine
NEW06310,CHEMICAL,phosphorylate dopamine transporter,phosphorylated dopamine transporter
D017102,DISEASE,Fracture Healing,"Healings, Fracture|Fracture Healings|fracture healing|Healing, Fracture"
NEW06311,CHEMICAL,low‑dose injection,low‑dose injections
NEW06312,CHEMICAL,key amino acid essential,key amino acid essential
C487773,CHEMICAL,trans-sodium crocetinate [Supplementary Concept],Vitamin A/analogs  and  derivatives|crocetin|Crocetin|Carotenoids
D000666,CHEMICAL,Amphotericin B,Amphotericin||Amphotericin B|Amphotericin B.|Amphotericin B Colloidal Dispersion|amphotericin|Fungizone|Amphotericin B Cholesterol Dispersion|amphotericin B|Amphocil|AmB
NEW06313,DISEASE,obvious depression-like behavior,obvious depression-like behaviors
NEW06314,CHEMICAL,interleukin-6 level,interleukin-6 levels
NEW06315,CHEMICAL,amphotericin b liposome,amphotericin B liposome
D008911,CHEMICAL,Minocycline,"|Lederderm|Cyclomin|Aknin-Mino|Minocin|Mynocine|Akamin|Dynacin|Minomycin|Monohydrochloride, Minocycline|Blemix|Hydrochloride, Minocycline|Apo-Minocycline|Akne Puren|Aknemin|Aknin Mino|Mino Wolff|Minakne|Minocycline|Minolis|Minoplus|Cyclops|Minoclir|Minocycline, (4R-(4 alpha,4a beta,5a beta,12a beta))-Isomer|Minocycline Monohydrochloride|Minotab|Dentomycin|Minocin MR|Klinomycin|Minox 50|Aknosan|Icht Oral|Mino-Wolff|Akne-Puren|Mestacine|Minocycline Hydrochloride|Icht-Oral|Arestin|Apo Minocycline|minocycline"
NEW06316,NUTRITION,Whortleberry extract,Whortleberry extract
NEW06317,CHEMICAL,dopamine homeostasis,dopamine homeostasis
NEW06318,DISEASE,neurogenetic change,neurogenetic changes
NEW06319,CHEMICAL,dopamine transmodulational signaling,dopamine transmodulational signaling
NEW06320,CHEBI,dopamine agonist treatment,dopamine agonist treatment
NEW06321,DISEASE,emotional deficit,emotional deficits
NEW06322,CHEBI,exaggerated beta,exaggerated beta
NEW06323,CHEBI,twice-daily chronic dopamine antagonist treatment,Twice-daily chronic dopamine antagonist treatment
NEW06324,CHEMICAL,hz power/coherence,Hz power/coherence
NEW06325,CHEMICAL,long-term aripiprazole therapy,Long-term aripiprazole therapy
D009459,DISEASE,Neuroleptic Malignant Syndrome,"Neuroleptic malignant syndrome||Syndromes, Neuroleptic Malignant|Neuroleptic-Malignant Syndrome, Neuroleptic Induced|Neuroleptic Induced Neuroleptic Malignant Syndrome|Syndrome, Neuroleptic Malignant|NMS (Neuroleptic Malignant Syndrome)|neuroleptic malignant syndrome|Neuroleptic-Induced Neuroleptic Malignant Syndrome|neuroleptic|NMSs (Neuroleptic Malignant Syndrome)|Neuroleptic Malignant Syndrome, Neuroleptic Induced|Neuroleptic Malignant Syndromes|malignant syndrome|Leponex"
NEW06326,DISEASE,drug-induced extrapyramidal reaction,drug-induced extrapyramidal reactions
NEW06327,CHEBI,antiviral medication,antiviral medication
NEW06328,CHEMICAL,amantadine dosage,amantadine dosage
NEW06329,DISEASE,severe withdrawal syndrome,severe withdrawal syndrome
NEW06330,DISEASE,75-year-old depressed patient,75-year-old depressed patient
NEW06331,MENTAL_HEALTH,case catatonic delirium,case catatonic delirium
NEW06332,CHEMICAL,outpatient amantadine,outpatient amantadine
C536742,DISEASE,Woodhouse Sakati syndrome [Supplementary Concept],"Intellectual Disability|extrapyramidal syndrome|Alopecia|Basal Ganglia Diseases|Arrhythmias, Cardiac|Woodhouse-Sakati syndrome|Diabetes Mellitus|Hypogonadism"
NEW06333,CHEBI,administer synthetic dopamine agonist,administered synthetic dopamine agonist
D065606,DISEASE,Metabolic Side Effects of Drugs and Substances,drugs|Substance Effects on Metabolism|effects|Metabolic Side Effects of Substances|Drug Effects on Metabolism|Metabolic Side Effects of Drugs
NEW06334,DISEASE,cardinal motor parkinsonian symptom,cardinal motor parkinsonian symptoms
NEW06335,DISEASE,conditioned-avoidance respond behavior,conditioned-avoidance responding behaviors
D018721,CHEBI,Muscarinic Agonists,"Agonists, Muscarinic|Agonists, Muscarinic Cholinergic|muscarinic agonists|Muscarinic Agonist|Agonist, Muscarinic Cholinergic|Muscarinic Cholinergic Agonists|Cholinergic Muscarinic Agonists|Agonist, Muscarinic|Muscarinic Cholinergic Agonist|muscarinic agonist|Cholinergic Agonists, Muscarinic|Muscarinic Agonists, Cholinergic|Agonists, Cholinergic Muscarinic|Muscarinic agonists|Cholinergic Agonist, Muscarinic|muscarinic cholinergic agonists"
C075257,CHEMICAL,xanomeline [Supplementary Concept],xanomeline|Thiadiazoles|Pyridines
NEW06336,CHEBI,combined agonist,combined agonist
NEW06337,CHEBI,dopamine agonist apomorphine hydrochloride,dopamine agonist apomorphine hydrochloride
NEW06338,DISEASE,functional psychosis,functional psychoses
NEW06339,CHEMICAL,risperidone classical antipsychotic,risperidone classical antipsychotics
NEW06340,CHEMICAL,postsynaptic dopamine antagonism,Postsynaptic dopamine antagonism
NEW06341,MENTAL_HEALTH,antipsychotic-induced sexual dysfunction,antipsychotic-induced sexual dysfunction
NEW06342,CHEBI,potent dopamine agonist,potent dopamine agonist
NEW06343,DISEASE,invasive giant prolactinoma,invasive giant prolactinoma
NEW06344,MENTAL_HEALTH,abuse tobacco,abuse tobacco
NEW06345,CHEMICAL,nicotine replacement therapy,nicotine replacement therapy|smoking addiction
NEW06346,DISEASE,reward dependence,reward dependence
http://purl.obolibrary.org/obo/DOID_10936,DISEASE,schizoid personality disorder,schizotypal borderline personality disorders
NEW06347,CHEMICAL,amphetamine administration,amphetamine administration
http://purl.obolibrary.org/obo/CHEBI_131795,CHEBI,dopamine receptor d1 agonist,D1 agonist|D1 agonists|dopamine D1 receptor agonist|D1-like D1 dopamine receptor antagonist|dopamine receptor D1 agonists|D1 dopamine receptors|dopamine D1 receptor agonists|dopamine D-2 receptor antagonists|D1-D2 dopamine agonist
NEW06348,CHEBI,old drug,oldest drug
NEW06349,MENTAL_HEALTH,parkinson disease psychosis,Parkinson disease psychosis
NEW06350,CHEMICAL,adjunctive clozapine,adjunctive clozapine
NEW06351,CHEBI,dopamine agonist discontinuation,Dopamine agonist discontinuation
NEW06352,CHEMICAL,hypothalamic dopamine d2 receptor,hypothalamic dopamine D2 receptors
NEW06353,DISEASE,sleep attack,Sleep attacks
D056508,DISEASE,Sleep Medicine Specialty,"PLMS|sleep|Medicine Specialties, Sleep|catalepsy|Specialty, Sleep Medicine|Specialties, Sleep Medicine|Sleep Medicine Specialties|Medicine Specialty, Sleep"
C002474,CHEMICAL,tyrosine-4-azophenyltrimethylammonium chloride [Supplementary Concept],l-tyrosine|Tyrosine/analogs  and  derivatives
NEW06354,DISEASE,dependent depression,dependent depressions
NEW06355,CHEMICAL,glutamate pathology,Glutamate pathology
NEW06356,CHEMICAL,ng muscimol,ng muscimol
NEW06357,DISEASE,self-mutilation behavior,self-mutilation behavior
NEW06358,CHEMICAL,serotonergic antidepressant,Serotonergic antidepressants
NEW06359,DISEASE,dsm-iv sand,DSM-IV SAnD
NEW06360,CHEMICAL,pramipexole mg,pramipexole mg
NEW06361,DISEASE,untreated sand subject,Untreated SAnD subjects
C027125,CHEMICAL,3-n-butylphthalide [Supplementary Concept],NBP|Benzofurans|3-N-butylphthalide
NEW06362,DISEASE,plasmodium falciparum proliferation,Plasmodium falciparum proliferation
NEW06363,CHEMICAL,purine salvage,purine salvage
NEW06364,MENTAL_HEALTH,dissociative reaction coordinate path,dissociative reaction coordinate path
NEW06365,CHEMICAL,immobile purine base,immobile purine base
D020945,DISEASE,"Lupus Vasculitis, Central Nervous System","systemic lupus erythematosus|Central Nervous System Systemic Lupus Erythematosis|Lupus Meningoencephalitides|Neuropsychiatric Systemic Lupus Erythematosus|Central Nervous System Lupus Vasculitis|Meningoencephalitides, Lupus|Systemic Lupus Erythematosis, Central Nervous System|Lupus Meningoencephalitis|Central Nervous System Lupus|Meningoencephalitis, Lupus"
NEW06366,DISEASE,lupus patient,lupus patients
NEW06367,CHEMICAL,mefloquine neurotoxicity,mefloquine neurotoxicity
http://purl.obolibrary.org/obo/SYMP_0000566,DISEASE,sleep disturbance,sleep disturbance|Sleep disturbance|sleep disturbances|Sleep disturbances
NEW06368,DISEASE,adverse neuropsychiatric event,adverse neuropsychiatric events
NEW06369,MENTAL_HEALTH,bipolar disorder relapse,bipolar disorder relapse
NEW06370,CHEMICAL,intravenous cyclophosphamide,intravenous cyclophosphamide
NEW06371,DISEASE,lupus nephritis class,lupus nephritis classes
D009173,CHEMICAL,Mycophenolic Acid,"Mycophenolate Mofetil|Mycophenolate Sodium|Mycophenolate, Sodium|RS-61443|mycophenolic acid|Mofetil, Mycophenolate|RS 61443|mycophenolate|Mycophenolic Acid Morpholinoethyl Ester|RS61443|Mycophenolate Mofetil Hydrochloride|Mycophenolate mofetil|Mofetil Hydrochloride, Mycophenolate|Cellcept|Myfortic|Sodium Mycophenolate"
NEW06372,CHEMICAL,inhibitor cyclosporine,inhibitors cyclosporine
D008181,DISEASE,Lupus Nephritis,"Nephritis, Lupus|Glomerulonephritides, Lupus|Glomerulonephritis, Lupus|Lupus Glomerulonephritides|Lupus Glomerulonephritis|lupus nephritis|Nephritides, Lupus|Lupus Nephritides"
C511911,CHEMICAL,belimumab [Supplementary Concept],"Antibodies, Monoclonal, Humanized|belimumab"
NEW06373,DISEASE,refractory lupus nephritis patient,refractory lupus nephritis patients
NEW06374,CHEMICAL,inhibitor use,inhibitor use
NEW06375,CHEMICAL,vasopressin 1a receptor,vasopressin 1A receptor
NEW06376,CHEMICAL,srx251,SRX251
NEW06377,CHEBI,v1a antagonist,V1a antagonists
NEW06378,DISEASE,stable chronic hyponatremia,Stable chronic hyponatremia
NEW06379,CHEMICAL,continuous vasopressin v(2 receptor stimulation,continuous vasopressin V(2 receptor stimulation
NEW06380,CHEMICAL,plasma sodium concentration,plasma sodium concentrations
NEW06381,DISEASE,hyponatremic rat,hyponatremic rats
NEW06382,CHEMICAL,avp receptor modulator,AVP receptor modulators
NEW06383,CHEBI,vasopressin v1b receptor antagonist,Vasopressin V1B receptor antagonists
NEW06384,CHEMICAL,arginine vasopressin (avp)-receptor antagonist,arginine vasopressin (AVP)-receptor antagonists
NEW06385,CHEMICAL,avp infusion,AVP infusion
NEW06386,DISEASE,renal glomerular endotheliosis,renal glomerular endotheliosis
NEW06387,DISEASE,placental hypoxia,placental hypoxia
NEW06388,CHEMICAL,placental fms-like tyrosine kinase-1,placental fms-like tyrosine kinase-1
NEW06389,CHEBI,avp receptor antagonist,AVP receptor antagonists
NEW06390,DISEASE,renal pathology,renal pathologies
NEW06391,CHEBI,arginine vasopressin hormone responsible,arginine vasopressin hormone responsible
C564491,DISEASE,Nephrogenic Syndrome of Inappropriate Antidiuresis [Supplementary Concept],"SIAD|inappropriate antidiuresis|NSIAD|Genetic Diseases, X-Linked|Inappropriate ADH Syndrome|nephrogenic syndrome"
NEW06392,CHEMICAL,low plasma arginine vasopressin hormone level,low plasma arginine vasopressin hormone levels
NEW06393,CHEMICAL,v(2)-receptor due,V(2)-receptor due
NEW06394,CHEBI,indirect-acting muscarinic cholinergic agonist,indirect-acting muscarinic cholinergic agonists
NEW06395,CHEBI,direct-acting muscarinic receptor agonist,direct-acting muscarinic receptor agonists
NEW06396,CHEMICAL,cyclosporine eye,cyclosporine eye
NEW06397,DISEASE,ocular symptom,ocular symptoms
NEW06398,DISEASE,depressive symptomatology,depressive symptomatology
NEW06399,DISEASE,lithium/pilocarpine-induced status epilepticus,Lithium/pilocarpine-induced status epilepticus
NEW06400,CHEMICAL,h. kainic acid,h. Kainic acid
NEW06401,CHEMICAL,kainate administration,kainate administration
NEW06402,MENTAL_HEALTH,food-elicite Cataplexy Test,Food-Elicited Cataplexy Test
D065821,CHEMICAL,Pontine Tegmentum,"Protuberancials, Tegmentum|Acoustic Strias, Dorsal|Acoustic Stria, Dorsal|Pons Tegmentum|Pons Tegmentums|Tegmentum Pontis|Tracts, Central Tegmental|Nucleus, Accessory Abducens|Dorsal Acoustic Stria|Tegmentum Protuberancials|Pontine Reticular Formation|Tegmentum of Pons|Reticular Formation, Pontine|Tegmentum Ponti|Tegmentums, Pontine|Reticular Formations, Pontine|Tegmental Tract, Central|Central Tegmental Tracts|Ponti, Tegmentum|Tegmentum, Pontine|Accessory Abducens Nucleus|Subceruleus, Nucleus|Tegmentum Protuberancial|Protuberancial, Tegmentum|Pons Dorsal Parts|Tegmental Tracts, Central|Nuclei of the Lateral Lemniscus|Formations, Pontine Reticular|Pons Reticular Formations|Dorsal Part of Pons|Pontis, Tegmentum|Pars Dorsalis Pontis|Pons Reticular Formation|Paralemniscal Nucleus|Pons Dorsal Part|pontine reticular formation|Dorsal Acoustic Strias|Nucleus, Paralemniscal|Reticular Formation of Pons|Pontine Tegmentums|Nucleus Subceruleus|Central Tegmental Tract|Pontine Reticular Formations|Stria, Dorsal Acoustic|Tract, Central Tegmental|Abducens Nucleus, Accessory|Strias, Dorsal Acoustic|Formation, Pontine Reticular"
C042375,CHEMICAL,"4-diphenylacetoxy-1,1-dimethylpiperidinium [Supplementary Concept]",4-DAMP|Piperidines
D005703,CHEMICAL,Gallamine Triethiodide,"Flaxedil|Gallamine Triethochloride|Gallamonium Iodide|Triethochloride, Gallamine|Gallamine Triethyl Iodide|Iodide, Gallamonium|Iodide, Gallamine Triethyl|Triethyl Iodide, Gallamine|Gallamine|gallamine|Triethiodide, Gallamine"
D010890,CHEMICAL,Pirenzepine,"pirenzepine|Pirenzepin|Pirenzepin Ratiopharm|Piren-Basan|Pirenzepine Dihydrochloride|LS-519|Von Ct, Pirenzepin|Pirenzepin Von Ct|LS519|Ulcoprotect|Pirenzepin-Ratiopharm|Ulgescum|L-S 519|LS 519|Dihydrochloride, Pirenzepine|Gastrozepin|Gastrotsepin|Pyrenzepine|Piren Basan"
NEW06403,CHEBI,inhibitory gabaergic receptor agonist muscimol,inhibitory GABAergic receptor agonist muscimol
D014236,CHEMICAL,Trichlorfon,Dylox|Foschlor|Chlorophos|Metrifonate|Trichlorphon|Metriphonate|Dipterex|Neguvon|Ricifon|Chlorofos|Bilarcil
NEW06404,DISEASE,related neurodegenerative dementia,related neurodegenerative dementias
C500712,DISEASE,"NOP53 protein, human [Supplementary Concept]",Tumor Suppressor Proteins|human glioma
NEW06405,DISEASE,neuroblastoma cell,neuroblastoma cells
NEW06406,MENTAL_HEALTH,schizophrenia subject,schizophrenia subjects
NEW06407,NUTRITION,free cholesterol,free cholesterol
http://purl.obolibrary.org/obo/CHEBI_132501,NUTRITION,fatty acid 17:2,polyunsaturates fatty acids|free fatty acid 17:2|FA 17:2
NEW06408,NUTRITION,severe mercury intoxication,Severe mercury intoxication
NEW06409,MENTAL_HEALTH,volatile substance abuse,volatile substance abuse
NEW06410,DISEASE,glutamatergic neurochemical dysfunction,glutamatergic neurochemical dysfunction
NEW06411,CHEMICAL,long-term chronic hgcl2 intoxication,long-term chronic HgCl2 intoxication
NEW06412,DISEASE,functional damage,functional damage
NEW06413,DISEASE,overall brain damage,overall brain damage
NEW06414,DISEASE,motor damage,motor damage
NEW06415,NUTRITION,egg White Hydrolysate,Egg White Hydrolysate
NEW06416,MENTAL_HEALTH,recognition memory disorder,recognition memory disorders
NEW06417,CHEBI,toxin level,toxin levels
NEW06418,DISEASE,early-life exposure,Early-life exposures
NEW06419,NUTRITION,mercury study,MERCURY study
http://purl.obolibrary.org/obo/DOID_9191,CHEMICAL,diabetic macular edema,DME|diabetic macular oedema|diabetic macular edema
NEW06420,DISEASE,impaired visual acuity,impaired visual acuity
NEW06421,NUTRITION,mercury exposure,mercury exposure
NEW06422,DISEASE,impaired memory,impaired memory
NEW06423,MENTAL_HEALTH,increase anxiety,Increasing anxiety
NEW06424,NUTRITION,inorganic mercury compound,inorganic mercury compounds
NEW06425,DISEASE,neurotoxic heavy metal,neurotoxic heavy metal
NEW06426,CHEMICAL,methylmercury exposure,methylmercury exposure
NEW06427,CHEMICAL,mehg exposure,MeHg exposure
NEW06428,CHEMICAL,triglyceride level,triglyceride levels
NEW06429,CHEMICAL,decrease triglyceride level,decreased triglyceride levels
NEW06430,MENTAL_HEALTH,suicide gesture,suicide gesture
http://purl.obolibrary.org/obo/CHEBI_35113,NUTRITION,elemental mercury,elemental mercury
NEW06431,NUTRITION,mercury concentration,mercury concentrations
NEW06432,MENTAL_HEALTH,multiple regression model,multiple regression models
NEW06433,MENTAL_HEALTH,chronic alcohol abuse,Chronic alcohol abuse
NEW06434,DISEASE,cardiovascular system hypertension,cardiovascular system hypertension
NEW06435,NUTRITION,chronic mercury intoxication,chronic mercury intoxication
D010842,MENTAL_HEALTH,Pica,pica|Allotriophagy|Pica|Geophagia|picA
NEW06436,CHEMICAL,often-potassium zinc deficiency,often-potassium zinc deficiency
D000077215,DISEASE,Clay,Halloysite|clay|Clays|Halloysites
NEW06437,DISEASE,gastrointestinal obstruction,gastrointestinal obstructions
NEW06438,NUTRITION,starch ingestion,starch ingestion
NEW06439,MENTAL_HEALTH,toluene-induced partial insomnia,toluene-induced partial insomnia
NEW06440,CHEMICAL,high urinary pea excretion,high urinary PEA excretion
C025136,NUTRITION,phenylacetic acid [Supplementary Concept],phenylacetic acid|Phenylacetates
NEW06441,CHEMICAL,post-synaptic dopamine receptor,post-synaptic dopamine receptor
NEW06442,CHEMICAL,neuromodulator phenylethylamine,neuromodulator phenylethylamine
NEW06443,DISEASE,drug-free psychiatric inpatient,drug-free psychiatric inpatients
NEW06444,CHEMICAL,5-ht turnover,5-HT turnover
NEW06445,CHEMICAL,various antidepressant,various antidepressants
NEW06446,CHEMICAL,hange-koboku-to-mediated reduction,Hange-koboku-to-mediated reduction
NEW06447,DISEASE,offence history/institutional behavior,offence history/institutional behavior
D000786,DISEASE,Anger,Angers|anger
NEW06448,CHEMICAL,neonatal urea cycle disorder,Neonatal Urea cycle disorders
NEW06449,DISEASE,severe hyperammonemia,severe hyperammonemia
NEW06450,CHEMICAL,phenylacetylglutamine rare genetic disorder,phenylacetylglutamine rare genetic disorders
NEW06451,CHEMICAL,urinary phenylacetylglutamine,PAGN|urinary phenylacetylglutamine
C570223,CHEMICAL,glycerol phenylbutyrate [Supplementary Concept],Phenylbutyrates|Glycerol/analogs  and  derivatives|glycerol phenylbutyrate
NEW06452,CHEMICAL,psychostimulant methylphenidate,psychostimulant methylphenidate
NEW06453,MENTAL_HEALTH,adhd subject,ADHD subjects
D019805,CHEMICAL,alpha-Methyltyrosine,"alpha-methyl- DL-Tyrosine|alpha-Methyltyrosine Hydrochloride|alpha Methyltyrosine|alpha-Methyltyrosine, (L)-Isomer|DL-Tyrosine, alpha-methyl-|alpha-Methyltyrosine, (+,-)-Isomer|alpha Methyl p tyrosine|Metyrosine|Demser|Hydrochloride, alpha-Methyltyrosine|alpha Methyl para tyrosine|alpha Methyltyrosine Hydrochloride|alpha-MPT|alpha-Methyltyrosine, (D,L)-Isomer|alpha MPT|Metirosine|alpha-Methyl-para-tyrosine|alpha-Methyl-p-tyrosine|Racemetirosine|p-tyrosine|Tyr"
NEW06454,CHEMICAL,aas abuser,AAS abusers
D013197,CHEMICAL,Stanozolol,Stanazolol|Stromba|Winstrol|Methylstanazol|Androstanazol|stanozolol
D001115,CHEMICAL,Arecoline,Arecolin|Methylarecaidin|Arecholin|Arecaline|Arecholine|arecoline
D050792,DISEASE,"Circulatory Arrest, Deep Hypothermia Induced",Deep Hypothermic Circulatory Arrest|hypothermia
D013619,CHEMICAL,Tacrine,"1,2,3,4-Tetrahydroaminoacridine||9-Amino-1,2,3,4-tetrahydroacridine|1,2,3,4-Tetrahydro-9-acridinamine|Cognex|tetrahydroaminoacridine|9-Amino-1,2,3,4-Tetrahydroacridine|Tacrine|tacrine|Romotal|Tetrahydroaminoacridine|Tacrine Hydrochloride|Tenakrin|THA"
http://purl.obolibrary.org/obo/CHEBI_68992,CHEMICAL,nantenine,"AF102B FSK-508 cis-2-methylspiro|Domestine|(6aS)-1,2-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-benzo[de][1,3]benzodioxolo[5,6-g]quinoline|o-Methyldomesticine|6a-alpha-Aporphine, 1,2-dimethoxy-9,10-(methylenedioxy)-"
NEW06455,CHEBI,m1-type novel m1 agonist,M1-type novel M1 agonist
http://purl.obolibrary.org/obo/CHEBI_38325,CHEBI,muscarinic agonist,specific muscarinic agonist|muscarinic cholinergic agonists|muscarinic cholinergic agonist|muscarinic agonists|muscarinic acetylcholine receptor agonist|muscarinic receptor agonists|Muscarinic receptor agonists|Cholinergic muscarinic receptor agonists|muscarinic receptor agonist|muscarinic agonist carbachol|Selective muscarinic agonists|muscarinic M1/M2/M4-preferring receptor agonists
NEW06456,MENTAL_HEALTH,experimental amnesia,experimental amnesia
NEW06457,DISEASE,stress-induced cognitive impairment,stress-induced cognitive impairment
http://purl.obolibrary.org/obo/CHEBI_38324,CHEBI,cholinergic agonist,cholinomimetic|acetylcholine receptor agonist|acetylcholine agonists|muscarinic cholinergic agonist pilocarpine|acetylcholine agonist|cholinergic agonists|cholinergic muscarinic agonist|cholinomimetics
NEW06458,CHEBI,subtype selective muscarinic receptor agonist,subtype selective muscarinic receptor agonist
NEW06459,CHEMICAL,patient xanomeline,patients xanomeline
http://cbmi.med.harvard.edu/asdphenotype#Class_218,DISEASE,impatience,suspiciousness
NEW06460,DISEASE,behavioral disturbance,behavioral disturbance
NEW06461,DISEASE,vocal outburst,vocal outbursts
NEW06462,CHEMICAL,various dopamine model,various dopamine models
NEW06463,CHEMICAL,formulation xanomeline adverse effect,formulation xanomeline adverse effects
NEW06464,CHEBI,muscarinic agonist pilocarpine,muscarinic agonist pilocarpine
C088566,CHEMICAL,carboxyebselen [Supplementary Concept],Ebselen|Organoselenium Compounds|ebselen
NEW06465,DISEASE,pilocarpine-induced seizure,pilocarpine-induced seizures
NEW06466,DISEASE,pilocarpine-induced tremor,pilocarpine-induced tremor
D017255,CHEMICAL,Acitretin,"|Ro-13-7652|13-cis-Acitretin|Etretin|Neotigason|Ro 13-7652|Ro-10-1670|Ro 137652|Ro 10-1670|Isoacitretin|acitretin|Isoetretin|Ro137652|Ro101670|Acitretin, (Z,E,E,E)-Isomer|Ro 101670|Soriatane"
NEW06467,CHEMICAL,fyn kinase,Fyn kinase
http://purl.obolibrary.org/obo/DOID_0060018,DISEASE,cd3gamma deficiency,GRK5 deficiency|FATP4 deficiency|LC-PUFA deficiencies|VB6 deficiency|25(OH)D3 deficiency|CblC deficiency
NEW06468,CHEMICAL,hippocampal ach release,hippocampal ACh release
NEW06469,CHEMICAL,af267b administration,AF267B administration
D020551,CHEBI,"Pulse Therapy, Drug","drug therapies|Therapies, Pulse Drug|Drug Therapy, Pulse|Pulse Therapies, Drug|Therapy, Drug Pulse|Therapies, Drug Pulse|Drug Pulse Therapy|Therapy, Pulse Drug|Pulse Drug Therapies|Drug Therapies, Pulse|Drug Pulse Therapies|Pulse Drug Therapy"
NEW06470,DISEASE,various neuropathic pain syndrome,various neuropathic pain syndromes
NEW06471,CHEMICAL,sligrl-amide,SLIGRL-amide
NEW06472,DISEASE,a infection,A infection
NEW06473,CHEMICAL,glu(k5 kainate receptor subunit,GLU(K5 kainate receptor subunits
NEW06474,CHEMICAL,glu(k5 kainate receptor subtype,GLU(K5 kainate receptor subtype
NEW06475,DISEASE,persistent pain,persistent pain
http://purl.obolibrary.org/obo/CHEBI_83821,CHEMICAL,amino acid derivative,amino acid compounds
NEW06476,CHEMICAL,non-peptide kinin receptor antagonist,non-peptide kinin receptor antagonists
NEW06477,DISEASE,cutaneous inflammation model,cutaneous inflammation models
NEW06478,CHEMICAL,capsaicin microinjection,capsaicin microinjections
NEW06479,DISEASE,persistent tachypnoea,persistent tachypnoea
NEW06480,CHEMICAL,5-ht serum level,5-HT serum levels
D020382,CHEMICAL,Interleukin-18,"IFN gamma Inducing Factor|Interleukin 18|Interferon-gamma-Inducing Factor|IFN-gamma-Inducing Factor|Interferon gamma Inducing Factor|Inducing Factor, IFN-gamma|IL18|IFN-|Interferon-gamma Inducing Factor|IFN-gamma Inducing Factor|IL-18|Inducing Factor, Interferon-gamma|IFN-γ"
NEW06481,CHEMICAL,perforin b,perforin B
NEW06482,CHEMICAL,intracortical iron injection,intracortical iron injection
NEW06483,CHEMICAL,mm fecl3,mM FeCl3
NEW06484,NUTRITION,buckthorn seed oil,buckthorn seed oil
NEW06485,MENTAL_HEALTH,depression management,depression management
NEW06486,CHEMICAL,low high testosterone level,Low high testosterone levels
NEW06487,CHEBI,high androgen level,high androgen levels
NEW06488,DISEASE,hypoandrogenic postmenopausal woman,hypoandrogenic postmenopausal women
NEW06489,CHEMICAL,testosterone replacement therapy,Testosterone replacement therapy
NEW06490,CHEBI,long-acting agonist analogue,long-acting agonist analogue
NEW06491,CHEMICAL,testosterone secretion,testosterone secretion
NEW06492,DISEASE,deviant sexual behavior,deviant sexual behavior
NEW06493,DISEASE,numerous psychiatric disorder,Numerous psychiatric disorders
NEW06494,CHEMICAL,mesocortical dopamine pathway,mesocortical dopamine pathway
NEW06495,DISEASE,due vaginal dryness,due vaginal dryness
NEW06496,CHEMICAL,responsive to estrogen replacement therapy,responsive to estrogen replacement therapy|ERT
NEW06497,DISEASE,whose 's sexual difficulty,whose's sexual difficulties
NEW06498,DISEASE,preexist psychiatric illness,preexisting psychiatric illness
NEW06499,CHEBI,new progestin,new progestins
NEW06500,CHEMICAL,combination contraceptive,combination contraceptives
NEW06501,CHEMICAL,excess serotonin,Excess serotonin
NEW06502,CHEMICAL,toxicity-serotonin toxicity,toxicity-serotonin toxicity
NEW06503,CHEMICAL,serotonin toxicity,Serotonin toxicity
D020211,DISEASE,Autonomic Dysreflexia,"Autonomic Dysreflexias|Autonomic Hyperreflexia|Dysreflexias, Autonomic|Dysreflexia, Spinal Autonomic|Autonomic Dysreflexia, Spinal|Hyperreflexias, Autonomic|hyperreflexia|Hyperreflexia, Autonomic|Spinal Autonomic Dysreflexia|Spinal Autonomic Dysreflexias|Dysreflexias, Spinal Autonomic|Dysreflexia, Autonomic|Autonomic Dysreflexias, Spinal|Autonomic Hyperreflexias"
NEW06504,DISEASE,hyperthermia flush,hyperthermia flushing
NEW06505,DISEASE,moderate toxicity,moderate toxicity
NEW06506,DISEASE,dramatic gross brain abnormality,dramatic gross brain abnormalities
NEW06507,CHEMICAL,late gestational mam injection,late gestational MAM injection
NEW06508,CHEBI,mitotic inhibitor methylazoxymethanol,mitotic inhibitor methylazoxymethanol
NEW06509,MENTAL_HEALTH,female postpartum anxiety,females postpartum anxiety
D008425,DISEASE,Maternal Behavior,"Maternal Behaviors|Maternal Care Pattern|maternal behavior|Maternal Care Patterns|Patterns, Maternal Care|Behaviors, Maternal|Pattern, Maternal Care|Behavior, Maternal|Care Patterns, Maternal|Care Pattern, Maternal|Maternal Patterns of Care"
NEW06510,DISEASE,platinum-refractory ovarian cancer,platinum-refractory ovarian cancer
C072383,CHEMICAL,canertinib dihydrochloride [Supplementary Concept],Carbamates|CI-980|Pyrazines|Pyridines
NEW06511,CHEBI,stress hormone,Stress hormones
NEW06512,MENTAL_HEALTH,depression model,depression model
NEW06513,DISEASE,depressive behaviour,depressive behaviours
D019208,CHEMICAL,Brain-Derived Neurotrophic Factor,"brain-derived neurotrophic factor|Neurotrophic Factor, Brain-Derived|Factor, Brain-Derived Neurotrophic|proBDNF|Brain Derived Neurotrophic Factor|BDNF"
NEW06514,CHEMICAL,nasal cannabidiol inclusion complex temperature-sensitive hydrogel,nasal cannabidiol inclusion complex temperature-sensitive hydrogels|CBD TSGs
NEW06515,NUTRITION,chronic cholesterol depletion,chronic cholesterol depletion
NEW06516,MENTAL_HEALTH,radial displacement,radial displacement
C056599,CHEMICAL,icariin [Supplementary Concept],Icariin|icariin|ICA|Flavonoids
http://purl.obolibrary.org/obo/CHEBI_6628,CHEMICAL,macrozamin,Herba epimedii|Puerariae Lobatae Radix(YHG|raw Polygalae Radix|Macrozamin|Radix Morindae Officinalis
D060789,CHEMICAL,Prostatein,"steroid binding|Steroid-Binding Protein, Prostatic|Prostatic Steroid-Binding Protein|Prostatic Steroid Binding Protein"
NEW06517,CHEMICAL,allopregnanolone action,allopregnanolone action
C038369,CHEMICAL,hirsutine [Supplementary Concept],Hirsutine|Alkaloids
C087631,CHEMICAL,gou-teng [Supplementary Concept],"Uncaria rhynchophylla|Drugs, Chinese Herbal"
NEW06518,CHEMICAL,hp-cd microsphere,HP-CD microspheres
D053938,MENTAL_HEALTH,DNA Fragmentation,"fragmentation|Fragmentation, DNA|Apoptotic DNA Degradation|DNA Degradation, Apoptotic|Fragmentation|DNA fragmentation"
NEW06519,NUTRITION,neuron-derived cholesterol content similar,neuron-derived cholesterol content similar
NEW06520,MENTAL_HEALTH,comorbid substance abuse,comorbid substance abuse
NEW06521,MENTAL_HEALTH,comorbid chronic pain syndrome,comorbid chronic pain syndromes
NEW06522,CHEMICAL,chronic 071031b treatment,Chronic 071031B treatment
NEW06523,CHEMICAL,reduce sucrose preference,reduced sucrose preference
D016754,CHEMICAL,Boron Neutron Capture Therapy,"Therapy, Boron Neutron Capture|boron|B12|071031B|Neutron Capture Therapy, Boron|Boron-Neutron Capture Therapy|Therapy, Boron-Neutron Capture"
NEW06524,CHEMICAL,potent antidepressant effect,potent antidepressant effects
NEW06525,CHEMICAL,novel serotonin,novel serotonin
NEW06526,DISEASE,low hepatotoxicity,lower hepatotoxicity
NEW06527,DISEASE,mood spectrum disorder,mood spectrum disorders
NEW06528,CHEMICAL,Levomilnacipran LVM,Levomilnacipran LVM
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Atypical_Depression,MENTAL_HEALTH,atypical depression,atypical depression|Atypical depression
NEW06529,CHEMICAL,tyramine-restricted diet,tyramine-restricted diets
NEW06530,CHEMICAL,mao substrate,MAO substrates
NEW06531,CHEMICAL,new maoi,newer MAOI
NEW06532,CHEMICAL,old maoi,older MAOIs
NEW06533,DISEASE,mau inhibition,MAU inhibition
NEW06534,CHEMICAL,reserpine reversal,reserpine reversal
NEW06535,DISEASE,vocal impairment,vocal impairment
C536334,DISEASE,Polymorphic catecholergic ventricular tachycardia [Supplementary Concept],"Tachycardia, Ventricular|ventricular tachycardia"
NEW06536,DISEASE,depressed 48-year-old woman,depressed 48-year-old woman
NEW06537,MENTAL_HEALTH,less sexual dysfunction,less sexual dysfunction
NEW06538,CHEBI,multifunctional serotonin agonist,multifunctional serotonin agonist
NEW06539,CHEMICAL,non-fda,Non-FDA
NEW06540,CHEMICAL,benzodiazepine hypnotic,benzodiazepine hypnotics
NEW06541,CHEMICAL,lc ne neuron,LC NE neurons
NEW06542,DISEASE,narcolepsy/cataplexy symptom,narcolepsy/cataplexy symptoms
NEW06543,CHEMICAL,lc ne dysregulation,LC NE dysregulation
http://purl.obolibrary.org/obo/SYMP_0000408,MENTAL_HEALTH,cataplexy,narcolepsy hypersomnia
NEW06544,CHEMICAL,dextroamphetamine preparation,dextroamphetamine preparations
NEW06545,CHEMICAL,modafinil/armodafinil,modafinil/armodafinil
NEW06546,MENTAL_HEALTH,cataplexy treatment,Cataplexy treatment
NEW06547,DISEASE,newborn heart defect,newborn heart defects
NEW06548,CHEBI,individualized drug management,individualized drug management
NEW06549,DISEASE,main psychosomatic treatment,main psychosomatic treatment
NEW06550,CHEMICAL,serotonin-norepinephrine reuptake,serotonin-norepinephrine reuptake
NEW06551,CHEMICAL,inhibitors(SNRIs,inhibitors(SNRIs
NEW06552,CHEMICAL,covid-19 community,COVID-19 community
NEW06553,DISEASE,subthreshold psychotic symptom,subthreshold psychotic symptoms
NEW06554,CHEMICAL,plant Cannabis sativa,plant Cannabis sativa
NEW06555,DISEASE,chronic brain inflammation,chronic brain inflammation
NEW06556,DISEASE,brain infection,brain infections
D013385,CHEMICAL,Succinate Dehydrogenase,"Dehydrogenase, Succinate|Reductase, Fumarate|Succinic Dehydrogenase|succinate dehydrogenase|Fumarate Reductase|Succinic Oxidase|Dehydrogenase, Succinic|Oxidase, Succinic"
http://purl.obolibrary.org/obo/DOID_12858,DISEASE,huntington's disease,Huntington 's disease|Huntington's disease therapy|HD|Huntington's chorea|Huntington disease
D000108,CHEMICAL,Acetylcarnitine,"ALCAR|Acetyl L Carnitine|Alcar|Levocarnitine Acetyl|Acetyl-L-Carnitine|acetyl-L-carnitine|Medosan|Acetylcarnitine, (R)-Isomer|Carnitine, Acetyl|Acetyl Carnitine|Branigen"
C539260,CHEMICAL,"alpha-lipoic acid, 4-aminobenzoic acid, aniline, benfotiamine, thioctic Acid, vitamin E drug combination [Supplementary Concept]",benfotiamine|Drug Combinations|Thiamine/analogs  and  derivatives|Thioctic Acid|4-Aminobenzoic Acid|ALA|Alpha lipoic acid|Alpha-lipoic acid|Folic Acid|Vitamin E
D016718,CHEMICAL,Arachidonic Acid,"arachidonic acid|Arachidonic Acid, Potassium Salt, (all-Z)-Isomer|Vitamin F|Arachidonic acid|Arachidonic Acid, Cerium Salt, (all-Z)-Isomer|(all-Z)-5,8,11,14-Eicosatetraenoic acid|Arachidonic Acid, (all-Z)-isomer, 3H-Labeled|Arachidonic Acid, Ammonium Salt, (all-Z)-Isomer|Arachidonic Acid, Sodium Salt|Arachidonic Acid, Cesium Salt, (all-Z)-Isomer|Arachidonic Acid, Sodium Salt, (all-Z)-Isomer|Arachidonate, Sodium|Arachidonic Acid, (all-Z)-Isomer, 1-(14)C-Labeled|AA|Sodium Arachidonate|Arachidonic Acid, Lithium Salt, (all-Z)-Isomer|Arachidonic Acid, Zinc Salt, (all-Z)-Isomer"
NEW06557,DISEASE,brain hypoperfusion,brain hypoperfusion
NEW06558,DISEASE,psychotic episode,psychotic episode
NEW06559,MENTAL_HEALTH,chronic stress response,chronic stress response
NEW06560,CHEMICAL,omega-3 ps,omega-3 PS
NEW06561,MENTAL_HEALTH,chronic stress level,chronic stress level
NEW06562,DISEASE,anxiety-related disorder,anxiety-related disorders
http://purl.obolibrary.org/obo/DOID_0080779,DISEASE,plasmablastic lymphoma,Burkitt lymphoma cells|common Burkitt lymphoma
NEW06563,CHEMICAL,calcium flux,calcium flux
C099490,CHEMICAL,Dyrk kinase [Supplementary Concept],Protein Serine-Threonine Kinases|Protein-Tyrosine Kinases|tyrosine phosphorylation
NEW06564,DISEASE,resultant ssri-induced apoptosis,Resultant SSRI-induced apoptosis
D053078,DISEASE,"Membrane Potential, Mitochondrial","Mitochondrial Membrane Potentials|DeltaPsi M|mitochondrial membrane potential|Mitochondrial Transmembrane Potential|Transmembrane Potential, Mitochondrial|Delta Psi M|Mitochondrial Transmembrane Potentials|M, DeltaPsi|Membrane Potentials, Mitochondrial|DeltapsiM|Transmembrane Potentials, Mitochondrial|Mitochondrial Membrane Potential"
http://purl.obolibrary.org/obo/CHEBI_48593,CHEBI,benzocycloheptapyridine,benzocycloheptapyridines|SSRI class
NEW06565,CHEBI,charge drug molecule,charged drug molecules
NEW06566,NUTRITION,phosphatidylserine membrane,phosphatidylserine membranes
D010717,NUTRITION,CDPdiacylglycerol-Serine O-Phosphatidyltransferase,"Synthase, CDP-DG|CDP-DG Synthase|Synthase, Phosphatidylserine|CDPdiacylglycerol Serine O Phosphatidyltransferase|CDP Diacylglycerol Serine O Phosphatidyltransferase|Diacylglycerol-Serine O-Phosphatidyltransferase, CDP|Phosphatidylserine Synthetase|O-Phosphatidyltransferase, CDP Diacylglycerol-Serine|CDP Diglyceride Serine O Phosphatidyltransferase|CDP Diacylglycerol-Serine O-Phosphatidyltransferase|Phosphatidylserine Synthase|CDP Diglyceride Serine O-Phosphatidyltransferase|phosphatidylserine|O-Phosphatidyltransferase, CDPdiacylglycerol-Serine|Synthetase, Phosphatidylserine|CDP DG Synthase"
NEW06567,NUTRITION,soy-derived phosphatidylserine,soy-derived phosphatidylserine
D049294,NUTRITION,Phospholipid Transfer Proteins,"Phosphatidylinositol Transfer Protein beta|Aminophospholipid Transfer Proteins|Phospholipid Translocating Protein|Phosphatidylinositol Transfer Protein|Nonspecific Phospholipid Transfer proteins|Aminophospholipid Flippase|Phosphatidylinositol Transfer Protein alpha|Transfer Proteins, Phospholipid|phospholipid|Phospholipid Exchange Protein|Phosphatidylinositol Transfer Proteins|Aminophospholipid Transporter|Lecithin Transfer Protein|Phospholipid Scramblase|Translocator, Aminophospholipid|Phosphatidyl Transfer Protein|Phosphatidylcholine Transfer Protein|Phosphatidylcholine Exchange Protein|Translocase, Aminophospholipid|Phosphatidylinositol Exchange Protein|Aminophospholipid Translocase|Transporter, Aminophospholipid|Phosphatidylcholine Transfer Proteins|Phospholipid Transfer Protein|Phospholipid Exchange Proteins|Phosphatidylserine Translocase|Scramblase, Phospholipid|Aminophospholipid Translocator|Translocase, Phosphatidylserine"
C498493,DISEASE,"Cln8 protein, mouse [Supplementary Concept]",CLN8|Membrane Proteins
NEW06568,DISEASE,cln8 domain,CLN8 domain
NEW06569,DISEASE,cognitive impairment due,cognitive impairment due
NEW06570,CHEMICAL,tea polyphenol,tea polyphenols
NEW06571,DISEASE,excitotoxicity,excitotoxicity
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Tourette_Syndrome,MENTAL_HEALTH,tourette syndrome,Tourette syndrome symptoms
NEW06572,CHEMICAL,partial agonist-like aripiprazole,partial agonist-like aripiprazole
NEW06573,DISEASE,odd behavior,odd behavior
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Magical_Thinking,MENTAL_HEALTH,magical thinking,magical thinking
NEW06574,MENTAL_HEALTH,japanese schizophrenia patient,Japanese schizophrenia patients
NEW06575,DISEASE,treatment-resistant td,treatment-resistant TD
NEW06576,DISEASE,young treatment-resistant schizophrenic patient,young treatment-resistant schizophrenic patients
NEW06577,CHEMICAL,caffeine mg/kg,caffeine mg/kg
NEW06578,DISEASE,si-induced latent learning deficit,SI-induced latent learning deficit
NEW06579,DISEASE,si-induced attention deficit,SI-induced attention deficit
NEW06580,CHEMICAL,da transmission,DA transmission
NEW06581,CHEMICAL,premenstrual tension syndrome,premenstrual tension syndrome|PMS
NEW06582,CHEMICAL,vac extract,VAC extract
http://purl.obolibrary.org/obo/SYMP_0000462,DISEASE,symptom,SRS-induced PTSD-like symptoms|PCOS symptoms|RLS/WED symptoms|ASD-like symptoms|PMS/PMDD symptoms|ADHD/ODD symptoms|8-OH-DPAT-mediated symptoms
NEW06583,CHEMICAL,abeta42 production,Abeta42 production
NEW06584,CHEMICAL,Healthy Foods North,Healthy Foods North|HFN
NEW06585,DISEASE,chronic disease risk factor,chronic disease risk factors
NEW06586,DISEASE,classroom deficit/hyperactivity disorder,classroom deficit/hyperactivity disorder
NEW06587,MENTAL_HEALTH,cam dissociation,CaM dissociation
NEW06588,CHEMICAL,tau phosphorylation,TAU phosphorylation
NEW06589,CHEMICAL,appnl-g-f mouse,AppNL-G-F mice
NEW06590,DISEASE,neuronal cell loss,neuronal cell loss
http://purl.obolibrary.org/obo/CHEBI_171887,CHEMICAL,acrimarine n,"N N-trimethylglycine|1-hydroxy-3,5,6-trimethoxy-2-[1-(7-methoxy-2-oxochromen-6-yl)-3-methylbut-2-enyl]-10-methylacridin-9-one"
NEW06591,DISEASE,diabetic symptom,diabetic symptoms
NEW06592,MENTAL_HEALTH,disease animal,disease animals
NEW06593,CHEMICAL,aldosterone level,aldosterone levels
D000451,CHEMICAL,Mineralocorticoid Receptor Antagonists,"aldosterone antagonists|Aldosterone Antagonists|mineralocorticoid receptor antagonists|Aldosterone Receptor Antagonist|Receptor Antagonists, Aldosterone|Antagonists, Aldosterone Receptor|Antagonist, Mineralocorticoid|Antagonists, Mineralocorticoid Receptor|Antagonist, Aldosterone Receptor|Mineralocorticoid Receptor Antagonist|Aldosterone Antagonist|Receptor Antagonist, Aldosterone|Antagonist, Aldosterone|Mineralocorticoid Antagonist|Antagonists, Aldosterone|Antagonists, Mineralocorticoid|Aldosterone Receptor Antagonists|Receptor Antagonists, Mineralocorticoid|Antagonist, Mineralocorticoid Receptor|Aldosterone antagonists|Mineralocorticoid Antagonists|Receptor Antagonist, Mineralocorticoid"
NEW06594,DISEASE,mild-to-moderate hypertension,mild-to-moderate hypertension
NEW06595,DISEASE,resistant hypertension,resistant hypertension
NEW06596,CHEBI,androgen adverse event,androgen adverse events
http://purl.obolibrary.org/obo/CHEBI_50844,CHEBI,aldosterone antagonist,selective aldosterone antagonist
NEW06597,DISEASE,mild-to-moderate hypertension similar,mild-to-moderate hypertension similar
NEW06598,DISEASE,hypertensive population,hypertensive population
NEW06599,CHEBI,mineral corticoid antagonist,mineral corticoid antagonist
NEW06600,MENTAL_HEALTH,nervosa symptom,nervosa symptoms
NEW06601,CHEMICAL,sr58611a,SR58611A
NEW06602,MENTAL_HEALTH,primary depression,primary depression
NEW06603,CHEMICAL,secondary aud,secondary AUD
NEW06604,DISEASE,pain state,pain states
C462679,CHEMICAL,SMP 500 [Supplementary Concept],Naphthyridines|Urea/analogs  and  derivatives|SMP
NEW06605,CHEMICAL,clonidine intervention,clonidine interventions
NEW06606,CHEBI,primary analgesic,primary analgesic
NEW06607,DISEASE,aberrant behavior,aberrant behavior
D009102,DISEASE,Multiple Organ Failure,"Multiple Organ Failures|Organ Failure, Multiple|Multiple Organ Dysfunction Syndrome|MODS|organ failure|Failure, Multiple Organ|Organ Dysfunction Syndrome, Multiple"
D000077769,CHEMICAL,Rilmenidine,Rilmenidine Phosphate|Hyperium|rilmenidine|S 3341|S-3341|2-(N-(Dicyclopropylmethyl)amino)oxazoline Phosphate Salt|S3341|S-3341-3|2-(N-(Dicyclopropylmethyl)amino)oxazoline|S33413|S 3341 3|Oxaminozoline
NEW06608,CHEBI,particular sympatholytic property,particular sympatholytic properties
D020361,DISEASE,"Paraneoplastic Syndromes, Nervous System","Paraneoplastic Autonomic Dysfunctions|Encephalomyelitis, Paraneoplastic|autonomic dysfunction|Syndromes, Paraneoplastic Neurologic|Autonomic Dysfunction, Paraneoplastic|Paraneoplastic Neurologic Syndromes|Paraneoplastic Autonomic Dysfunction|Neurologic Syndromes, Paraneoplastic|Autonomic Dysfunctions, Paraneoplastic|Paraneoplastic Neurologic Syndrome|Syndrome, Paraneoplastic Neurologic|Nervous System Paraneoplastic Syndromes|Paraneoplastic Encephalomyelitis|Neurologic Syndrome, Paraneoplastic|Paraneoplastic Encephalomyelitides"
NEW06609,DISEASE,neurogenic disorder,neurogenic disorders
NEW06610,DISEASE,neurological symptom,neurological symptoms
NEW06611,CHEMICAL,act moxonidine metoprolol sympatholytic agent,acting moxonidine metoprolol sympatholytic agents
NEW06612,DISEASE,hypertensive man,hypertensive men
NEW06613,CHEMICAL,moxonidine monotherapy,moxonidine monotherapy
http://purl.obolibrary.org/obo/CHEBI_167165,CHEBI,kappa-opioid receptor antagonist,kappa-opioid receptor antagonist nor-binaltorphimine|kappa-opioid receptor antagonist actions|kappa-opioid receptor antagonist|kappa-opioid antagonist|kappa-opioid antagonists|kappa-opioid receptor antagonists
NEW06614,CHEBI,aberrant glycosylate muc1 neoantigen,aberrant glycosylated MUC1 neoantigen
NEW06615,DISEASE,various cancer,various cancers
C545823,CHEMICAL,"soybean oil, phospholipid emulsion [Supplementary Concept]",Emulsions|Phospholipids|Soybean Oil|Intralipid
NEW06616,CHEMICAL,caffeine concentration,caffeine concentration
NEW06617,DISEASE,depressed heart,depressed heart
NEW06618,CHEMICAL,high ca/mg ratio,high Ca/Mg ratio
D025861,DISEASE,"Blood Coagulation Disorders, Inherited","Hereditary Coagulation Disorders|Inherited Coagulation Disorders|Inherited Blood Coagulation Disorders|blood coagulation|Hereditary Blood Coagulation Disorders|Coagulation Disorder, Hereditary|Inherited Coagulation Disorder|Hereditary Coagulation Disorder|Coagulation Disorders, Hereditary|Coagulation Disorders, Inherited|Coagulation Disorder, Inherited"
NEW06619,DISEASE,acth-evoked cardiac fibrosis,ACTH-evoked cardiac fibrosis
NEW06620,CHEMICAL,mg supplementation,Mg supplementation
NEW06621,DISEASE,acth-induced hpa axis hyperactivity,ACTH-induced HPA axis hyperactivity
NEW06622,CHEMICAL,psychostimulant caffeine,psychostimulant caffeine
NEW06623,CHEMICAL,magnesium status,Magnesium status
NEW06624,MENTAL_HEALTH,subjective anxiety,subjective anxiety
NEW06625,CHEMICAL,magnesium level,magnesium levels
NEW06626,CHEMICAL,serum zinc,Serum zinc
NEW06627,DISEASE,middle aged hypertensive man,middle aged hypertensive men
NEW06628,CHEMICAL,low serum zinc level,low serum zinc levels
NEW06629,DISEASE,severe rapid cycling manic-depressive patient,severe rapid cycling manic-depressive patients
NEW06630,CHEMICAL,magnesium preparation,magnesium preparation
NEW06631,CHEMICAL,magnesiocard meq/day,Magnesiocard mEq/day
D001224,CHEMICAL,Aspartic Acid,"Mg-5-Longoral|(+-)-Aspartic Acid|L Aspartate|Calcium Aspartate|Aspartate Magnesium Hydrochloride|Sodium Aspartate|Monosodium Aspartate|Aspartic Acid, Magnesium (2:1) Salt|Aspartate, Calcium|Aspartic Acid, Ammonium Salt|L Aspartic Acid|Ammonium Aspartate|L-Aspartate|Magnesium Aspartate|Aspartic Acid, Hydrochloride|Aspartic Acid, Magnesium (1:1) Salt, Hydrochloride, Trihydrate|Dipotassium Aspartate|(R,S)-Aspartic Acid|Aspartic Acid, Monopotassium Salt|Aspartic Acid, Hydrobromide|Aspartate, Magnesium|L-Aspartic Acid|Aspartic Acid, Dipotassium Salt|Aspartate, Sodium|Aspartic Acid, Disodium Salt|Potassium Aspartate|Aspartate|Aspartic Acid, Sodium Salt|Aspartate, Ammonium|Disodium Aspartate|Aspartic Acid, Calcium Salt|Aspartate, Potassium|Aspartate, Monopotassium|Magnesiocard|Aspartate, Dipotassium|Aspartate, Disodium|Monopotassium Aspartate|Aspartic Acid, Potassium Salt|Aspartate, Monosodium|Aspartic Acid, Monosodium Salt|Aspartic Acid, Magnesium-Potassium (2:1:2) Salt"
D008278,CHEMICAL,Magnesium Sulfate,"|magnesium sulfate|Sulfate, Magnesium|Heptahydrate Magnesium Sulfate|Magnesium Sulfate, Heptahydrate"
NEW06632,DISEASE,eclampsia edema,eclampsia edema
D011225,DISEASE,Pre-Eclampsia,"Proteinuria-Edema-Hypertension Gestosis|EPH Toxemias|Gestosis, Proteinuria-Edema-Hypertension|1, Preeclampsia Eclampsia|preeclampsia|Gestosis, Hypertension-Edema-Proteinuria|eclampsia|Of Pregnancies, Toxemia|Of Pregnancy, Toxemia|Toxemias, Pregnancy|Hypertension-Edema-Proteinuria Gestosis|PE|Toxemia, Pregnancy|Pre Eclampsia|EPH Gestosis|Preeclampsia|pre-eclampsia|Gestosis, Edema-Proteinuria-Hypertension|Preeclampsia Eclampsia 1s|Toxemia, EPH|Toxemia Of Pregnancies|Edema Proteinuria Hypertension Gestosis|Edema-Proteinuria-Hypertension Gestosis|Pregnancies, Toxemia Of|EPH Toxemia|Hypertension Edema Proteinuria Gestosis|EPH Complex|1s, Preeclampsia Eclampsia|Pregnancy, Toxemia Of|Gestosis, EPH|Eclampsia 1, Preeclampsia|Proteinuria Edema Hypertension Gestosis|Preeclampsia Eclampsia 1|Pre-eclampsia|Toxemia Of Pregnancy|Eclampsia 1s, Preeclampsia|Toxemias, EPH|Pregnancy Toxemias|Pregnancy Toxemia"
NEW06633,DISEASE,hypermagnesemia,hypermagnesemia
NEW06634,CHEMICAL,glutamate aquaporin-4 expression,glutamate aquaporin-4 expression
NEW06635,MENTAL_HEALTH,well control hallucination,better control hallucinations
NEW06636,CHEMICAL,over-the-counter magnesium chloride,over-the-counter magnesium chloride
D015636,CHEMICAL,Magnesium Chloride,"Chloride, Magnesium|magnesium chloride|MgCl2"
C004454,CHEBI,"dicyclomine, doxylamine, pyridoxine drug combination [Supplementary Concept]",Dicyclomine|Pyridoxine|Pyridoxine hydrochloride|Doxylamine|Drug Combinations
D055030,CHEBI,Drug Users,"Addict, Drug|Intravenous Drug Users|Drug User, Intravenous|Drug Addicts|Drug Abuser|User, Drug|Abuser, Drug|IV Drug Users|Users, Drug|User, Intravenous Drug|People Who Inject Drugs|Drug Addict|Addicts, Drug|Drug Abusers|drug abusers|Users, Intravenous Drug|drug addicts|IV Drug User|Intravenous Drug User|Drug User|Users, IV Drug|Drug User, IV|Drug Users, IV|Abusers, Drug|Drug Users, Intravenous|User, IV Drug"
NEW06637,DISEASE,psychiatric comorbidity,psychiatric comorbidity
NEW06638,CHEMICAL,serum mg++ level,serum Mg++ levels
NEW06639,CHEMICAL,clozapine user,clozapine users
C574608,DISEASE,"Sab protein, E coli [Supplementary Concept]",Escherichia coli Proteins|Membrane Transport Proteins|biofilm formation
NEW06640,DISEASE,genomovar isolate,genomovar isolates
NEW06641,CHEMICAL,≥,≥
NEW06642,CHEMICAL,serum magnesium level,serum magnesium levels
NEW06643,MENTAL_HEALTH,all-cause dementia,all-cause dementia
NEW06644,CHEMICAL,endocrine-disrupting chemical bisphenol a,endocrine-disrupting chemicals bisphenol A
NEW06645,DISEASE,childhood neurodevelopmental disorder,childhood neurodevelopmental disorders
C543008,CHEMICAL,bis(4-hydroxyphenyl)sulfone [Supplementary Concept],Phenols|Bisphenol S|Sulfones|bisphenol S|BPS
NEW06646,CHEMICAL,contaminant bpa,contaminants BPA
http://purl.obolibrary.org/obo/CHEBI_50792,CHEBI,estrogen receptor antagonist,"nonselective estrogen receptor antagonist|estrogen receptor antagonist ICI182,780|estrogen receptor antagonists"
NEW06647,MENTAL_HEALTH,anxiety time,anxiety time
NEW06648,DISEASE,human neuroblastoma cell line sk-n-be,human neuroblastoma cell line SK-N-BE
NEW06649,CHEMICAL,brain high-energy phosphate metabolism,brain high-energy phosphate metabolism
http://purl.obolibrary.org/obo/DOID_0060481,DISEASE,goldberg-shprintzen syndrome,pollen-food-latex syndromes|hyperinsulinemia/hyperammonemia syndrome|Morvan syndrome|Ehler-Danlos syndrome|OA-related syndromes|Fahr syndrome|Goldberg-Shprintzen megacolon syndrome|antiphospholipide|syndrome comorbidities
http://purl.org/sig/ont/fma/fma83374,CHEBI,parathyroid hormone,excess parathyroid hormone|intact parathyroid hormone
NEW06650,DISEASE,motor nerve conduction velocity,motor nerve conduction velocity
NEW06651,DISEASE,preexist chronic renal failure,preexisting chronic renal failure
NEW06652,CHEMICAL,mncv calcium content,MNCV calcium content
NEW06653,NUTRITION,phosphorus spectroscopy,phosphorus spectroscopy
NEW06654,MENTAL_HEALTH,schizophrenia altered metabolism,schizophrenia altered metabolism
NEW06655,DISEASE,premorbid neurodevelopmental abnormality,premorbid neurodevelopmental abnormality
NEW06656,DISEASE,bipolar subject,bipolar subjects
NEW06657,CHEMICAL,high-energy phosphate metabolite,high-energy phosphate metabolites
NEW06658,DISEASE,depressive state,depressive state
NEW06659,CHEMICAL,high mpl precursor level,higher MPL precursor levels
NEW06660,CHEMICAL,high-energy phosphate neuropsychological performance,high-energy phosphate neuropsychological performance
D013702,DISEASE,Temporal Lobe,"Gyrus, Inferior Temporal|Temporal Cortices|Temporal Gyrus, Inferior|Cortex, Temporal|Temporal Horn of the Lateral Ventricle|Lateral Occipitotemporal Gyrus|Temporal Gyrus, Middle|Area 21, Brodmann|Inferior Temporal Gyrus|Brodmanns Area 20|Temporal Horns|Brodmann Area 37|Lateral Occipito Temporal Gyrus|Area 22, Brodmann|Gyrus, Temporal|Middle Temporal Gyrus|Brodmann's Area 21|Superior Temporal Gyrus|Area, Parainsular|Brodmann Area 20|Inferior Horn of Lateral Ventricle|Temporal Region|Brodmann Area 22|Region, Temporal|Area 37, Brodmann's|Gyrus Temporalis Superior|Areas, Parainsular|Temporal Lobes, Anterior|Brodmann's Area 20|Brodmann Area 21|Gyrus, Lateral Occipitotemporal|Brodmanns Area 21|Brodmann's Area 52|Brodmann Area 38|Temporal Sulcus|Temporal Cortex|Horn, Temporal|Occipitotemporal Gyrus|Area 37, Brodmann|Brodmanns Area 22|Brodmann's Area 22|Area 20, Brodmann's|Fusiform Gyrus|Lobe, Temporal|Gyrus, Middle Temporal|Lateral Occipito-Temporal Gyrus|Gyrus, Fusiform|Area 20, Brodmann|Anterior Temporal Lobe|Area 52, Brodmann|Occipitotemporal Gyrus, Lateral|Temporal Operculum|Brodmanns Area 38|Inferior Horn of the Lateral Ventricle|Temporal Gyrus|Operculum, Temporal|Temporal Regions|Temporal Horn|Area 38, Brodmann|Anterior Temporal Lobes|Sulcus, Temporal|Occipito-Temporal Gyrus, Lateral|Area 22, Brodmann's|Area 21, Brodmann's|Temporal Lobes|Parainsular Areas|Brodmann's Area 37|Parainsular Area|Gyrus Fusiformis|Brodmann Area 52|Planum Polare|Temporal Gyrus, Superior|Brodmanns Area 37|Temporal Lobe, Anterior|Brodmanns Area 52|Brodmann's Area 38|temporal regions|Gyrus, Occipitotemporal|Gyrus, Superior Temporal|Gyrus, Lateral Occipito-Temporal|Area 38, Brodmann's|Lobe, Anterior Temporal|Area 52, Brodmann's"
D017241,DISEASE,MELAS Syndrome,"Mitochondrial Myopathy, Lactic Acidosis, Stroke-Like Episode|Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes|Myopathy, Mitochondrial-Encephalopathy-Lactic Acidosis-Stroke|mitochondrial encephalopathy|MELAS|Syndrome, MELAS|Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes"
D051436,DISEASE,"Renal Insufficiency, Chronic","Kidney Insufficiency, Chronic|Chronic Kidney Insufficiencies|Kidney Diseases, Chronic|Chronic Renal Disease|Diseases, Chronic Renal|Chronic Kidney Disease|Renal Insufficiencies, Chronic|Chronic Kidney Diseases|Renal Disease, Chronic|Chronic Kidney Insufficiency|Kidney Insufficiencies, Chronic|Chronic Renal Insufficiencies|Disease, Chronic Renal|Chronic Renal Diseases|Disease, Chronic Kidney|Diseases, Chronic Kidney|chronic renal diseases|Kidney Disease, Chronic|Chronic Renal Insufficiency|Renal Diseases, Chronic"
NEW06661,CHEBI,kidney estrogen,kidneys estrogens
D010281,CHEMICAL,Parathyroid Hormone,"Natpara|Parathyroid Hormone Peptide (1-34)|parathormone|Parathyroid Hormone (1-84)|Parathyrin|PTH (1-84)|PTH|Parathormone|Parathyroid Hormone (1-34)|Hormone, Parathyroid|PTH(1-34)"
NEW06662,CHEBI,vitamin d fibroblast growth factor,vitamin D fibroblast growth factor
NEW06663,DISEASE,chronic alcohol-abuse,chronic alcohol-abuse
NEW06664,CHEMICAL,"1,25-dihydroxyvitamin D. symptom","1,25-dihydroxyvitamin D. Symptoms"
NEW06665,DISEASE,bone pain,bone pain
D018167,CHEMICAL,"Receptors, Calcitriol","1,25-dihydroxyvitamin D3|Vitamin D3 Receptor|D3 Receptors, Vitamin|D Receptor, Vitamin|Vitamin D 3 Receptors|1,25 Dihydroxycholecalciferol Receptor|Receptors, Cholecalciferol|D3 Receptor, Vitamin|Receptor, 1,25-Dihydroxycholecalciferol|D3 Receptors, 1,25-Dihydroxyvitamin|1,25-Dihydroxycholecalciferol Receptors|Receptors, Vitamin D3|calcitriol|1,25-Dihydroxyvitamin D3 Receptors|Receptors, 1,25-Dihydroxyvitamin D3|1,25-dihydroxycholecalciferol|1,25-Dihydroxyvitamin D 3 Receptor|Receptor, Vitamin D|Receptors, 1,25-Dihydroxyvitamin D 3|Receptor, Vitamin D3|D Receptors, Vitamin|Receptors, 1,25-Dihydroxycholecalciferol|1,25-Dihydroxyvitamin D3 Receptor|Receptors, Vitamin D|1,25 Dihydroxycholecalciferol Receptors|Calcitriol Receptors|Receptors, Vitamin D 3|1,25 Dihydroxyvitamin D 3 Receptor|Vitamin D 3 Receptor|1,25 Dihydroxyvitamin D3 Receptor|D3 Receptor, 1,25-Dihydroxyvitamin|1,25-Dihydroxycholecalciferol Receptor|Vitamin D Receptors|Calcitriol Receptor|Vitamin D3 Receptors|Calcitriol|Vitamin D Receptor|Receptor, 1,25-Dihydroxyvitamin D3|1,25 Dihydroxyvitamin D3 Receptors|Receptor, Calcitriol|Cholecalciferol Receptors"
D054559,DISEASE,Hyperphosphatemia,|hyperphosphatemia|Hyperphosphatemias
NEW06666,CHEBI,vitamin d compound,vitamin D compounds
NEW06667,CHEBI,new vitamin d analogue,new vitamin D analogue
NEW06668,CHEMICAL,calcium level,calcium levels
NEW06669,CHEMICAL,paricalcitol therapy,paricalcitol therapy
NEW06670,CHEMICAL,crp μg/ml age,CRP μg/ml age
NEW06671,DISEASE,substantial hyponatremia,substantial hyponatremia
http://purl.obolibrary.org/obo/CHEBI_35471,CHEBI,psychotropic drug,psychoactive agent|well-known psychotropic drug|psychotropic drugs|psychopharmaceuticals|psychoactive drugs
NEW06672,CHEMICAL,elevated glucose,elevated glucose
D003444,DISEASE,Crush Syndrome,"Syndromes, Crush|crush syndrome|Syndrome, Crush|Crush Syndromes"
NEW06673,DISEASE,acute arterial occlusion,acute arterial occlusion
NEW06674,DISEASE,diabetic nonketotic coma,diabetic nonketotic coma
NEW06675,DISEASE,psychotic patient,psychotic patients
C028815,CHEMICAL,salmon calcitonin [Supplementary Concept],synthetic salmon calcitonin|Calcitonin
C535858,DISEASE,HEM dysplasia [Supplementary Concept],Osteochondrodysplasias|ectopic calcification
http://purl.obolibrary.org/obo/CHEBI_166857,CHEMICAL,3-acetylpyridine adenine dinucleotide,"(3-acetylpyridine)AD|3-acetylpyridine-NAD|3-acetylpyridine-DPN|acetylpyridine-adenine dinucleotide|3-acetyl NAD|nicotinamide adenine dinucleotide phosphate oxidases|3-acetylpyridineadenine dinucleotide|3-acetyl-1-[(2R,3R,4S,5R)-5-{[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphorylphosphonato)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-1lambda(5)-pyridin-1-ylium|3-acetylpyridine NAD|nicotinamide adenine dinucleotide NAD+ precursors|nicotinamide adenine dinucleotide NAD+ deficiency"
NEW06676,DISEASE,myocardial infarction-induced inflammatory response,myocardial infarction-induced inflammatory response
NEW06677,CHEBI,vitamin d receptor mutant,vitamin D receptor mutants
NEW06678,CHEBI,vitamin d signalling,vitamin D signalling
NEW06679,CHEBI,normocalcaemic vitamin d receptor mutant,normocalcaemic vitamin D receptor mutants
http://purl.obolibrary.org/obo/DOID_5844,DISEASE,myocardial infarction,Myocardial infarct|heart attack|function post-myocardial infarction
D065386,CHEMICAL,Historically Controlled Study,"Studies, Historical Controlled|Historical Control Studies|Study, Historically Controlled|Study, Historical Control|Studies, Historical Control|Historically Controlled Studies|• study|Historical Controlled Study|Historical Controlled Studies|Studies, Historically Controlled|Study, Historical Controlled|Historical Control Study"
NEW06680,CHEMICAL,insecticide synergist pbo,insecticide synergist PBO
NEW06681,CHEMICAL,top chemical,top chemicals
D018846,CHEMICAL,Excitatory Amino Acids,"Excitatory amino acids|excitatory amino acids|Amino Acid, Excitatory|Amino Acids, Excitatory|Acid, Excitatory Amino|Acids, Excitatory Amino|Excitatory Amino Acid|EAA"
NEW06682,DISEASE,neurotoxic substance,neurotoxic substances
NEW06683,DISEASE,postischemic damage,postischemic damage
http://purl.obolibrary.org/obo/CHEBI_71014,CHEBI,ampa receptor antagonist,"N-Methyl-D-Aspartate    receptor antagonists|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist|N-methyl-D-aspartate receptor antagonist MK-801|NMDA AMPA receptor antagonists|N-methyl-D-aspartate NMDA receptor antagonist memantine|selective N-methyl-D-aspartate NMDA receptor antagonist D-2-amino-5-phosphonovalerate|Noncompetitive N-methyl-D-aspartate NMDA receptor antagonists|N-methyl-d-aspartate glutamate receptor antagonist|glutamate AMPA receptor antagonists|noncompetitive N-methyl-D-aspartic acid NMDA receptor antagonist|N-methyl-D-aspartate receptor antagonists|AMPA receptor antagonists|glutamate N-methyl-d-aspartate receptor antagonist|AMPA receptor antagonist|N-methyl-d-aspartate receptor antagonists|AMPA receptor antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzoquinoxaline-2,3-dione|AMPA antagonist|NBQX|NR2B selective N-methyl-D-aspartate receptor antagonist MK-0657|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonists|noncompetitive N-methyl-D-aspartate NMDA receptor antagonists"
NEW06684,CHEMICAL,electrical activity felbamate,electrical activity felbamate
D018009,CHEMICAL,"Receptors, Glycine","Receptors, GlyB|Receptor, SIG|Strychnine-Insensitive Glycine Receptor|Inhibitory Glycine Receptor|Glycine Receptor alpha1|Receptor, Inhibitory Glycine|Strychnine Insensitive Glycine Receptor|GlyB Receptors|glycine receptor|Glycine A Receptors|Excitatory Glycine Receptors|Glycine Receptors|Glycine Receptor, Strychnine-Sensitive|Receptor, Strychnine-Insensitive Glycine|Receptor, Glycine|strychnine sensitive|Receptor, Strychnine-Sensitive Glycine|Glycine B Receptors|GlyA Receptors|Glycine Receptor, Strychnine-Insensitive|glycine receptors|Glycine Receptor, Inhibitory|Strychnine-Sensitive Glycine Receptor|SIG Receptor|Glycine Receptor|Strychnine Sensitive Glycine Receptor"
NEW06685,DISEASE,several neurodegenerative disorder,Several neurodegenerative disorders
NEW06686,CHEMICAL,glutamate pathway,glutamate pathways
NEW06687,CHEMICAL,extracellular atp,Extracellular ATP
NEW06688,CHEBI,muscarinic receptor partial agonist,muscarinic receptor partial agonists
NEW06689,DISEASE,great exploratory behavior,greater exploratory behaviors
NEW06690,MENTAL_HEALTH,input resistance,input resistance
NEW06691,CHEMICAL,tetrodotoxin ttx tmn neuron,tetrodotoxin TTX TMN neurons
NEW06692,CHEMICAL,brain histamine system,brain histamine system
http://purl.obolibrary.org/obo/MF_0000012,DISEASE,arousal,TRH-induced arousal
NEW06693,CHEBI,antimitotic compound methylazoxymethanol,antimitotic compound methylazoxymethanol
NEW06694,DISEASE,dose-dependent atrophy,dose-dependent atrophy
http://purl.obolibrary.org/obo/CHEBI_73413,CHEMICAL,cannabinoid receptor antagonist,CB1-selective cannabinoid receptor antagonist|cannabinoid CB(1 receptor antagonists|cannabinoid CB1 receptor antagonist/inverse agonist|cannabinoid CB1 receptor antagonist/inverse agonist AM251|cannabinoid receptor antagonists|cannabinoid receptor antagonist SR
NEW06695,CHEMICAL,non-psychotropic phytocannabinoid cannabidiol,non-psychotropic phytocannabinoid cannabidiol
NEW06696,CHEMICAL,mg/kg/day,mg/kg/day
NEW06697,CHEMICAL,peripubertal cannabidiol treatment,peripubertal cannabidiol treatment
NEW06698,CHEMICAL,mam insult,MAM insult
NEW06699,DISEASE,schizophrenia-like deficit,schizophrenia-like deficits
D050256,CHEBI,Antimitotic Agents,"Agent, Antimitotic|Agents, Antimitotic|Antimitotic|Antimitotic Drug|Drugs, Antimitotic|Antimitotic Drugs|antimitotic agent|Antimitotics|Antimitotic Agent|Drug, Antimitotic"
NEW06700,DISEASE,schizophrenic symptome,schizophrenic symptomes
NEW06701,DISEASE,advanced pretraite relapsed soft tissue sarcoma,advanced pretraited relapsed soft tissue sarcoma
http://purl.obolibrary.org/obo/CHEBI_31824,CHEMICAL,mesna,g/m2/cycle ifosfamide|Mesna
NEW06702,DISEASE,global brain injury,Global brain injury
NEW06703,MENTAL_HEALTH,childhood hyperactivity,childhood hyperactivity
NEW06704,CHEMICAL,antimitotic drug temozolomide,antimitotic drug temozolomide|TMZ
D001932,DISEASE,Brain Neoplasms,"Primary Brain Neoplasm|Brain Tumor, Primary|Cancer of the Brain|Brain Tumors, Recurrent|Brain Neoplasms, Malignant, Primary|Primary Malignant Brain Neoplasms|Neoplasm, Brain|Neoplasms, Brain, Primary|Tumor, Brain|Intracranial Neoplasms|Brain Cancers|Neoplasms, Intracranial|brain metastases|Malignant Brain Neoplasm|Brain Metastases|Neoplasms, Brain, Benign|Brain Cancer|Malignant Neoplasm, Brain|Primary Brain Tumors|Brain Neoplasms, Malignant|Brain Neoplasm, Benign|Brain Neoplasms, Primary Malignant|Malignant Neoplasms, Brain|Primary Malignant Brain Tumors|Brain Metastase|Primary Brain Tumor|Cancer, Brain|Brain Neoplasms, Primary|Brain Neoplasm, Malignant|Benign Neoplasms, Brain|Primary Brain Neoplasms|Brain Benign Neoplasm|Neoplasms, Brain, Malignant|brain cancer|Brain Benign Neoplasms|Recurrent Brain Tumor|Malignant Primary Brain Tumors|Benign Brain Neoplasms|Malignant Brain Neoplasms|Neoplasms, Brain|Cancer of Brain|Benign Brain Neoplasm|Intracranial Neoplasm|Malignant Primary Brain Neoplasms|Brain Tumor, Recurrent|Brain Neoplasm, Primary|Brain Neoplasms, Benign|Brain Malignant Neoplasm|Neoplasm, Intracranial|brain tumors|Brain Malignant Neoplasms|Brain Tumors|Brain Neoplasm|Brain Tumor|Recurrent Brain Tumors|Benign Neoplasm, Brain"
NEW06705,CHEBI,dopaminergic neurotoxin,dopaminergic neurotoxin
http://purl.obolibrary.org/obo/CHEBI_3396,CHEMICAL,carbidopa-levodopa,Carbidopa-levodopa|levodopa-carbidopa|levodopa/carbidopa|levodopa/benserazide
NEW06706,CHEMICAL,levodopa dose necessary,levodopa dose necessary
C088383,CHEMICAL,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole [Supplementary Concept],ABT-418|Isoxazoles|Pyrrolidines
NEW06707,CHEMICAL,ns9775,NS9775
NEW06708,DISEASE,y-maze learning deficit,Y-maze learning deficits
http://purl.org/sig/ont/fma/fma61796,CHEMICAL,nicotinic acetylcholine receptor,α7 nicotinic acetylcholine receptor expression|α4β2 nicotinic acetylcholine receptor desensitization|alpha7-nicotinic acetylcholine receptor-deficiency|nicotinic acetylcholine receptor levels|α7-nAChR|nicotinic receptor α7|α7 nicotinic acetylcholine receptors|nicotinic acetylcholine receptor nAChR subtype|Brain nicotinic acetylcholine receptors|alpha-7 nicotinic acetylcholine receptors|neuronal nicotinic acetylcholine receptors
NEW06709,MENTAL_HEALTH,mild-to-moderate alzheimer 's dementia,mild-to-moderate Alzheimer's dementia
NEW06710,CHEMICAL,cholinomimetic galantamine,cholinomimetics galantamine
NEW06711,CHEMICAL,Betel nut alkaloid,Betel nut alkaloids
NEW06712,CHEBI,potent muscarinic cholinomimetic,potent muscarinic cholinomimetics
NEW06713,DISEASE,tbi patient,TBI patients
NEW06714,DISEASE,severe traumatic brain injury patient,severe traumatic brain injury patients
NEW06715,DISEASE,noncognitive behavior,noncognitive behaviors
C420685,CHEMICAL,CS 932 [Supplementary Concept],CS-932|Quinuclidines|Isoxazoles
NEW06716,DISEASE,severe gad,severe GAD
NEW06717,DISEASE,subsyndromal depressive symptom,subsyndromal depressive symptoms
NEW06718,DISEASE,p. flavus isolate,P. flavus isolates
NEW06719,CHEMICAL,hydrocarbon substrate,hydrocarbons substrates
D002957,CHEMICAL,Citrus,"Trees, Seville Orange|bergamia, Citrus|Citrus maxima|Trees, Citron|Tree, Seville Orange|Tree, Bitter Orange|Trees, Bitter Orange|Tangerine Trees|Pomelo Trees|Citrus bergamia|Trees, Tangerine|medicas, Citrus|Bitter Orange Tree|aurantium, Citrus|Orange Tree, Seville|Citrus hystrix|Citrus medica|Bitter Orange Trees|Orange Tree, Bitter|Tree, Pummelo|Pomelo Tree|Citrus aurantium|Tree, Pomelo|Trees, Lemon|Lime, Kaffir|Sour Orange Tree|Pummelo Tree|maxima, Citrus|Citrus medicas|Trees, Pummelo|Orange Trees, Mandarin|Tangerine Tree|Fruit, Citrus|Citrus grandis|Tree, Citron|Seville Orange Tree|Lemon Tree|Trees, Sour Orange|reticulata, Citrus|Tree, Lemon|Citrus bergamias|Lemon Trees|Orange Tree, Mandarin|Pummelo Trees|Trees, Mandarin Orange|Citron Trees|Citrus reticulatas|Citrus limon|Mandarin Orange Tree|Seville Orange Trees|Citrus Fruit|Mandarin Orange Trees|Orange Trees, Seville|Orange Trees, Bitter|Citron Tree|Citrus reticulata|hystrices, Citrus|Tree, Mandarin Orange|Citrus aurantiums|Orange Tree, Sour|Trees, Pomelo|Orange Trees, Sour|Tree, Sour Orange|Kaffir Lime|Citrus grandi|Tree, Tangerine|Sour Orange Trees|Citrus hystrices"
D031162,NUTRITION,Achillea,"Achillea millefoliums|Achillea millefolium|Yarrow|Yarrows|millefolium, Achillea|Achilleas"
http://purl.obolibrary.org/obo/CHEBI_166595,CHEBI,yessotoxin,"cyanotoxin β-N-methylamino-l-alanine|cyanotoxin|BMAA|[(1R,3S,5R,7S,9R,11S,13R,14S,16R,18S,20R,22S,25R,27S,30S,31R,33S,34R,35R,37S,40S,42R,44S,46R,48S)-34-hydroxy-40-[(2R,3E)-2-hydroxy-5-methylideneocta-3,7-dien-2-yl]-13,25,27,30,35-pentamethyl-39-methylidene-13-(2-sulooxyethyl)-4,8,12,17,21,26,32,36,41,45,49-undecaoxaundecacyclo[25.22.0.03,25.05,22.07,20.09,18.011,16.031,48.033,46.035,44.037,42]nonatetracontan-14-yl] hydrogen sulate"
NEW06720,DISEASE,sporadic neurodegenerative disease,sporadic neurodegenerative diseases
NEW06721,MENTAL_HEALTH,Kernel Machine regression,Kernel Machine Regression
NEW06722,CHEBI,high quartile mixture level,higher quartile mixture levels
NEW06723,CHEMICAL,ccr5 inhibitor maraviroc,CCR5 inhibitor Maraviroc
D000077261,CHEMICAL,Carvedilol,"Carvedilol, (S)-isomer|Carvedilol, (+)|Carvedilol, (-)-isomer|carvedilol|Kredex|Eucardic|Carvedilol, 14C-labeled|Coropres|BM14190|Carvedilol Hydrochloride|Dilatrend|BM 14190|Carvedilol, 14C labeled|Carvedilol, (+-)-isomer|Carvedilol, (R)-isomer|14C-labeled Carvedilol|BM-14190|Coreg|Carvedilol, (+)-isomer|Carvedilol, (-)|Querto"
NEW06724,MENTAL_HEALTH,neuroleptic-induced orofacial dyskinesia,neuroleptic-induced orofacial dyskinesia
NEW06725,CHEMICAL,basal phosphate accumulation,basal phosphate accumulations
NEW06726,CHEBI,stimulant drug,stimulant drug
D052556,DISEASE,"Niemann-Pick Disease, Type C","Niemann Pick Disease, Type C1|Niemann Pick Disease Type C|Niemann Pick disease, Subacute Juvenile Form|Nova Scotia Niemann-Pick Disease (Type D)|Niemann-Pick Disease, Type D|Nova Scotia Niemann Pick Disease (Type D)|Niemann Pick Disease, Nova Scotian|Niemann Pick Disease, Chronic Neuronopathic Form|Niemann Pick's Disease Type D|Niemann-Pick Disease Type D|Niemann Pick Disease with Cholesterol Esterification Block|Niemann-Pick Type D Disease|Niemann-Pick Disease with Cholesterol Esterification Block|Niemann-Pick's Disease Type D|Niemann-Pick Disease without Sphingomyelinase Deficiency|Niemann Pick Disease Type D|Niemann Pick Disease without Sphingomyelinase Deficiency|Niemann Pick Disease, Type C|Niemann Pick Type D Disease|Nova Scotia (Type D) Form of Niemann-Pick Disease|Niemann-Pick's Disease Type C|Niemann-Pick Disease Type C|Niemann Pick Disease, Type D|Niemann-Pick Disease, Nova Scotian|Niemann-Pick Type C Disease|Niemann-Pick disease type C|Neurovisceral Storage Disease with Vertical Supranuclear Ophthalmoplegia|Niemann Pick's Disease Type C|Niemann-Pick Disease, Type C1|Niemann-Pick disease, Subacute Juvenile Form|Niemann Pick Type C Disease|Niemann-Pick Disease, Chronic Neuronopathic Form"
NEW06727,DISEASE,severe neurovisceral lipid storage disease,severe neurovisceral lipid storage disease
NEW06728,DISEASE,mesial temporal sclerosis,mesial temporal sclerosis
NEW06729,DISEASE,pure TLE,pure TLE
NEW06730,DISEASE,seizure frequency,Seizure frequency
NEW06731,CHEMICAL,increase mda,increased MDA
NEW06732,CHEMICAL,increase mda,Increased MDA
NEW06733,CHEMICAL,low mda level,lower MDA levels
NEW06734,CHEMICAL,mda level,MDA levels
NEW06735,DISEASE,oxidative stress toxicity protein oxidation,oxidative stress toxicity protein oxidation
NEW06736,CHEMICAL,tle/mts,TLE/MTS
NEW06737,NUTRITION,dietary omega-3 fatty acid supplementation,dietary omega-3 fatty acid supplementation
NEW06738,CHEBI,safe analgesic,safe analgesic
C527126,CHEMICAL,green tea extract polyphenone E [Supplementary Concept],Catechin/analogs  and  derivatives|green tea
NEW06739,DISEASE,long-term nervous system damage,long-term nervous system damage
NEW06740,CHEMICAL,chronic ethanol intoxication,Chronic ethanol intoxication
NEW06741,DISEASE,significant motor deficit,significant motor deficits
NEW06742,CHEMICAL,nitrite peroxidation,nitrite peroxidation
NEW06743,CHEMICAL,continuous ethanol intoxication,continuous ethanol intoxication
NEW06744,DISEASE,neurobehavioral damage,neurobehavioral damage
D000069059,CHEMICAL,Atorvastatin,"atorvastatin|Atorvastatin Calcium Anhydrous|(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid|Liptonorm|Lipitor|CI 981|Atorvastatin, Calcium Salt|CI-981|Atorvastatin Calcium Trihydrate|CI981|Atorvastatin Calcium Hydrate|Atorvastatin Calcium"
http://purl.obolibrary.org/obo/DOID_9971,CHEMICAL,hypervitaminosis d,Hypovitaminosis D|hypovitaminosis D|Hypervitaminosis D|Vitamins D
NEW06745,CHEBI,d adequacy,D adequacy
D000077962,DISEASE,Body-Weight Trajectory,"Trajectory, Body-Weight|Trajectories, Weight|Weight Loss Trajectories|Trajectories, Weight Change|Weight Change Trajectory|Weight Change Trajectories|Loss Trajectory, Weight|Body-Weight Trajectories|Trajectory, Weight Change|Gain Trajectories, Weight|Trajectory, Weight|Weight Trajectories|Change Trajectory, Weight|Trajectory, Weight Gain|weight change|Weight Trajectory|Trajectories, Body-Weight|Change Trajectories, Weight|Weight Loss Trajectory|Weight Gain Trajectory|Trajectories, Weight Gain|Body Weight Trajectory|Weight Gain Trajectories|Trajectories, Weight Loss|Loss Trajectories, Weight|Gain Trajectory, Weight|Trajectory, Weight Loss"
NEW06746,DISEASE,acute dyslipidemia independent,acute dyslipidemia independent
NEW06747,CHEMICAL,antidepressant anti-stress effect,antidepressant anti-stress effects
NEW06748,NUTRITION,low cholesterol,Low cholesterol
http://purl.obolibrary.org/obo/MFOMD_0000178,DISEASE,assaultive behavior,violent behaviour|violent behaviors
NEW06749,CHEMICAL,clozapine titration,clozapine titration
NEW06750,DISEASE,psychiatric exacerbation,psychiatric exacerbation
NEW06751,NUTRITION,low high-density lipid cholesterol,lower high-density lipid cholesterol
http://purl.obolibrary.org/obo/CHEBI_25681,NUTRITION,omega-3 fatty acid,n-3 fatty acid|omega-3 fatty acid intake|n-3 essential fatty acid eicosapentaenoic acid|Omega-3 fatty acids rich|omega-3 fatty acid docosahexaenoic acid|Omega-3 polyunsaturated fatty acid supplements|omega-3 fatty acids|omega-3 PUFAs|n-3 omega-3 fatty acids|Omega-3 polyunsaturated fatty acids|omega-6/omega-3 fatty acids|Dietary omega-3 fatty acids|omega-3 fatty acid|omega-3 polyunsaturated fatty acids|omega-3 fatty acid supplementation|omega-3 polyunsaturated fatty acid supplementation|long-chain omega-3 fatty acid docosahexaenoic acid|principle brain omega-3 fatty acid|n-3 fatty acids|omega-3 fatty acid deficiency|n-3 PUFA|long-chain omega-3 LCn-3 fatty acids|n-3 fatty acid consumption
NEW06752,CHEMICAL,myristoleic acid concentration,myristoleic acid concentration
NEW06753,CHEMICAL,triacylglycerol alpha-linolenic acid concentration,Triacylglycerol alpha-linolenic acid concentration
NEW06754,DISEASE,summer-fall euthymia,summer-fall euthymia
NEW06755,CHEMICAL,1-stearyl-2-docosahexaenoyl-sn-glycero-3-phosphoethanolamine,1-stearyl-2-docosahexaenoyl-sn-glycero-3-phosphoethanolamine
NEW06756,CHEMICAL,cholesteryl ester oleic acid,cholesteryl ester oleic acid
NEW06757,CHEMICAL,il-1β related,IL-1β related
C060504,CHEMICAL,dihydrosphingosine 1-phosphate [Supplementary Concept],Sphingosine/analogs  and  derivatives|sphinganine-1-phosphate
NEW06758,MENTAL_HEALTH,comorbid affective disorder,comorbid affective disorders
NEW06759,CHEMICAL,cer22:0,Cer22:0
NEW06760,MENTAL_HEALTH,multivariable regression model,multivariable regression models
NEW06761,CHEMICAL,neurolipidome,neurolipidome
NEW06762,DISEASE,eighty-three manic patient,Eighty-three manic patients
NEW06763,NUTRITION,regular lithium carbonate,regular lithium carbonate
NEW06764,DISEASE,hyperammonemia cramp,hyperammonemia cramps
NEW06765,DISEASE,cirrhotic liver,cirrhotic liver
NEW06766,DISEASE,conclusion hepatocellular damage,conclusion hepatocellular damage
NEW06767,DISEASE,human chronic liver disease,human chronic liver diseases
D002331,CHEMICAL,Carnitine,levocarnitine|Vitamin BT|L-Carnitine|l-carnitine|L -carnitine|Levocarnitine|Bicarnesine|L Carnitine|L-carnitine
NEW06768,CHEMICAL,mets prevalence,MetS prevalence
NEW06769,CHEMICAL,individual mets criterion,individual MetS criteria
NEW06770,CHEMICAL,benzodiazepine dependency,benzodiazepine dependency
D063425,CHEMICAL,Binge Drinking,"Binge Alcohol Consumption|Drinking, Binge|Alcohol Consumption, Binge|Binge alcohol consumption"
NEW06771,CHEMICAL,eicosapentaenoic acid supplementation,Eicosapentaenoic acid supplementation
NEW06772,CHEMICAL,epa metabolite,EPA metabolites
NEW06773,DISEASE,memory-related disorder,memory-related disorders
D000072376,CHEMICAL,Oxysterols,oxysterols|Oxysterols|Oxysterol
D020765,DISEASE,Intracranial Arterial Diseases,"Intracranial Arterial Disorder|Intracranial Arterial Disorders|Arterial Brain Diseases|Arterial Disease, Brain|Brain Diseases, Arterial|Intracranial Arterial Disease|Arterial Brain Disorder|Arterial Disorders, Intracranial|brain disorder|Arterial Disorder, Intracranial|Brain Arterial Disease|Arterial Diseases, Brain|Arterial Brain Disease|Arterial Disease, Intracranial|Arterial Brain Disorders|Brain Disorders, Arterial|Brain Arterial Diseases|Arterial Diseases, Intracranial|Brain Disorder, Arterial"
NEW06774,CHEMICAL,altered oxysterol level,Altered oxysterol levels
NEW06775,DISEASE,alzheimer 's disease amyotrophic,Alzheimer's disease Amyotrophic
NEW06776,DISEASE,numerous neuropsychiatric disorder,numerous neuropsychiatric disorders
NEW06777,NUTRITION,cholesterol metabolism,cholesterol metabolism
C044563,CHEMICAL,24-hydroxycholesterol [Supplementary Concept],24-hydroxycholesterol|Hydroxycholesterols
NEW06778,CHEMICAL,circulate oxysterol,circulating oxysterols
C041324,CHEMICAL,prostaglandin E2 methyl ester [Supplementary Concept],Dinoprostone/analogs  and  derivatives|PGE2|prostaglandin E2|Prostaglandin E2
NEW06779,CHEMICAL,pge2 pathway,PGE2 pathway
NEW06780,CHEMICAL,monoamine catabolism,monoamines catabolism
NEW06781,NUTRITION,low cholesterol level,lower cholesterol levels
NEW06782,CHEMICAL,hematoxylin-eosin,hematoxylin-eosin
NEW06783,NUTRITION,total cholesterol,Total cholesterol
NEW06784,DISEASE,3-month post-discharge violent behaviour,3-month post-discharge violent behaviour
NEW06785,DISEASE,inpatient violent behaviour,inpatient violent behaviour
NEW06786,CHEMICAL,enzyme superoxide dismutase activity level,enzymes superoxide dismutase activity levels
NEW06787,CHEMICAL,malondialdehyde level,malondialdehyde levels
D006937,NUTRITION,Hypercholesterolemia,"|Elevated Cholesterol|Cholesterol Level, High|Elevated Cholesterols|high cholesterol|cholesterol level|cholesterol levels|Cholesterol Levels, High|Level, High Cholesterol|Cholesterols, Elevated|High Cholesterol Level|High Cholesterol Levels|hypercholesteremia|Hypercholesteremia|high cholesterol levels|Hypercholesterolemias|hypercholesterolemia|High cholesterol|Cholesterol, Elevated|Levels, High Cholesterol|Hypercholesteremias"
NEW06788,DISEASE,SAD group,SAD group
NEW06789,NUTRITION,low cholesterol level,low cholesterol levels
NEW06790,NUTRITION,abnormal membrane phospholipid metabolism,abnormal membrane phospholipid metabolism
NEW06791,CHEMICAL,reduce n-3 content,Reduced n-3 content
NEW06792,CHEMICAL,antidepressant potential,antidepressant potentials
NEW06793,DISEASE,high syndrome prevalence,high syndrome prevalence
NEW06794,DISEASE,serious mental illness,SMI|serious mental illness
NEW06795,CHEMICAL,comorbidities.7 mental health training,comorbidities.7 Mental health training
NEW06796,NUTRITION,phospholipid deficit,phospholipid deficits
NEW06797,CHEMICAL,cannabis consumption,cannabis consumption
NEW06798,DISEASE,related metabolic alteration,related metabolic alterations
D008385,CHEMICAL,Marijuana Smoking,"Hashish Smoking|Blunt, Smoking|Blunts Smokings|Smoking Blunt|Blunts Smoking|Smokings, Blunts|Smoking, Marijuana|Blunts, Smoking|Cannabis smoking|Smoking, Marihuana|Smoking, Cannabis|Smoking, Hashish|Marihuana Smoking|Smoking, Blunts|Cannabis Smoking|Smoking Blunts"
NEW06799,DISEASE,mean weight loss,Mean weight loss
NEW06800,DISEASE,corticotropin-releasing factor crf mrna level,corticotropin-releasing factor CRF mRNA levels
NEW06801,DISEASE,binge-like eat behavior,binge-like eating behavior
NEW06802,DISEASE,adult attention-deficit hyperactivity disorder,A-ADHD|adult attention-deficit hyperactivity disorder
NEW06803,CHEMICAL,adipoko mouse,adipoKO mice
D000419,DISEASE,Albuminuria,|Albuminurias|albuminuria
D017270,CHEMICAL,Lipoprotein(a),Lipoprotein(a|Lipoprotein Lp(a)|Lipoprotein (a-)|Lipoprotein a|Lipoprotein (a)|lipoprotein(a
NEW06804,DISEASE,premature coronary heart disease,premature coronary heart disease
http://purl.obolibrary.org/obo/CHEBI_62754,CHEBI,glycine receptor antagonist,Glycine receptor antagonists|glycine receptor antagonists|topiramate-a glutamate receptor antagonist
C111401,CHEMICAL,hemoglobin Strasbourg [Supplementary Concept],"Hemoglobins, Abnormal|GAERS|Strasbourg"
NEW06805,CHEBI,specific antagonist,specific antagonists
C473669,CHEMICAL,"dynorphin A-(1-11)amide, cyclo(N,5)(Trp(3)-Trp(4)-Glu(5))-- [Supplementary Concept]","Dynorphins|Peptides, Cyclic|A(1"
NEW06806,DISEASE,spike-and-wave discharge,SWDs|spike-and-wave discharges
NEW06807,CHEBI,agonist r-n6(phenylisopropyl)adenosine mg/kg,agonist R-N6(phenylisopropyl)adenosine mg/kg
NEW06808,DISEASE,withdrawal diarrhea,withdrawal diarrhea
NEW06809,DISEASE,dog shake,dog shakes
NEW06810,CHEMICAL,"adenosine a1 antagonist 1,3-dipropyl-8-cyclopentylxanthine mg/kg","adenosine A1 antagonist 1,3-dipropyl-8-cyclopentylxanthine mg/kg"
NEW06811,CHEBI,a2 antagonist,A2 antagonist
NEW06812,CHEMICAL,endogenous modulator adenosine,endogenous modulator adenosine
NEW06813,MENTAL_HEALTH,anergia lack,anergia lack
NEW06814,CHEMICAL,non-selective adenosine antagonist,non-selective adenosine antagonist
NEW06815,CHEMICAL,caffeine adenosine antagonist,caffeine adenosine antagonists
http://purl.obolibrary.org/obo/CHEBI_71232,CHEMICAL,adenosine receptor antagonist,adenosine A(2A receptor antagonists|adenosine receptor antagonists|caffeine adenosine receptor antagonists|potent adenosine receptor antagonist|methylxanthine adenosine receptor antagonists|non-selective adenosine receptor antagonist|adenosine antagonists
NEW06816,DISEASE,motivational dysfunction,motivational dysfunction
NEW06817,DISEASE,minor psychostimulant,minor psychostimulants
D013806,CHEMICAL,Theophylline,"|Sodium Glycinate, Theophylline|Theo Dur|Glycine Theophyllinate|Theo Von Ct|Constant-T|3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione|Theodur|SloPhyllin|Theocin|Glycinate, Theophylline Sodium|Lodrane|1,3-Dimethylxanthine|Theophyllinate, Glycine|Theostat|Theon|Theo24|Theoconfin Continuous|Anhydrous, Theophylline|Theo-Dur|Euphylong|Slo Phyllin|Theopek|Nuelin|Elixophyllin|Theobid|Theo-24|Uniphyllin|Uniphyl|Monospan|Constant T|Von Ct, Theo|Quibron TSR|Accurbron|Aerobin|Somophyllin-T|Somophyllin T|Theolair|Nuelin S.A.|Sustaire|Theophylline Anhydrous|Theonite|Slo-Phyllin|Aerolate|1,3 Dimethylxanthine|Quibron T SR|Theo 24|Theospan|Ct, Theo Von|Bronchoparat|Synophylate|Aquaphyllin|theophylline|Uniphylline|Afonilum Retard|SomophyllinT|Quibron T-SR|Armophylline|Theovent|ConstantT|Bronkodyl|Theolix|Theophylline Sodium Glycinate"
http://purl.obolibrary.org/obo/CHEBI_28946,CHEMICAL,theobromine,"3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione|3,7-dimethylxanthine|Methylxanthines|3,7-dimethylpurine-2,6-dione|Theobromine|3,7-Dimethylxanthine|theobromine|3,7-dihydro-3,7-dimethyl-1H-purine-2,6-dione|factors:1 caffeine|methylxanthines|Theobromin|THEOBROMINE"
NEW06818,CHEMICAL,a1 a2a adenosine receptor,A1 A2A adenosine receptors
http://purl.obolibrary.org/obo/CHEBI_48279,CHEBI,serotonergic antagonist,noradrenergic antagonists|serotonergic antagonist|5-HT antagonists|serotonin antagonists|5-hydroxytryptamine antagonists|serotonin blockaders|antiserotonergic agents|adenosinergic antagonists
NEW06819,CHEBI,broad-spectrum antifungal,broad-spectrum antifungal
NEW06820,CHEBI,azole antifungal,azole antifungal
NEW06821,CHEMICAL,toxic voriconazole blood level,toxic voriconazole blood levels
NEW06822,MENTAL_HEALTH,patient 's auditory hallucination,patient's auditory hallucinations
NEW06823,CHEMICAL,voriconazole treatment,voriconazole treatment
NEW06824,CHEMICAL,high voriconazole level,high voriconazole levels
NEW06825,CHEMICAL,1 voriconazole,Vfend|1 Voriconazole
NEW06826,DISEASE,reversible visual disturbance,reversible visual disturbances
NEW06827,CHEBI,pfizer drug safety datum,Pfizer drug safety data
NEW06828,DISEASE,monogenic disease autoimmune polyendocrine syndrome type,monogenic disease autoimmune polyendocrine syndrome type
NEW06829,CHEBI,multiple endocrine organ,multiple endocrine organs
D002178,CHEMICAL,"Candidiasis, Chronic Mucocutaneous","chronic mucocutaneous candidiasis|Mucocutaneous Candidiasis, Chronic|Chronic Mucocutaneous Candidiases|Chronic Mucocutaneous Candidiasis|CMC|Candidiases, Chronic Mucocutaneous|Mucocutaneous Candidiases, Chronic"
NEW06830,CHEBI,topical antifungal treatment,Topical antifungal treatments
NEW06831,DISEASE,c. japonicum,C. japonicum
D000935,CHEBI,Antifungal Agents,"antifungal agents|Agent, Antifungal|Therapeutic Fungicides|Fungicides, Therapeutic|Agents, Antifungal|antifungal|Antifungal Agent|Antibiotics, Antifungal|Antifungal Antibiotics|antifungal agent"
NEW06832,CHEMICAL,sertraline therapy,sertraline therapy
NEW06833,CHEMICAL,Tresleen,Tresleen
http://purl.obolibrary.org/obo/DOID_2272,DISEASE,vulvovaginal candidiasis,Candidiasis of vulva and vagina|Monilial vulvovaginitis|Vulvovaginal Candidiasis|Candidal vulvovaginitis|RVVC|recurrent vulvovaginal candidiasis|Candidal: cervix
NEW06834,CHEBI,antifungal activity,Antifungal activity
NEW06835,DISEASE,candida specie,Candida species
C059765,CHEMICAL,"amphotericin B, deoxycholate drug combination [Supplementary Concept]",Deoxycholic Acid||amphotericin B-sodium deoxycholate|Amphotericin B|amphotericin B deoxycholate|Drug Combinations
D054714,CHEMICAL,Echinocandins,Pneumocandin|Echinocandins|Aculeacins|Pneumocandins|Mulundocandins|echinocandins|Echinocandin|Aculeacin
NEW06836,DISEASE,biofilm-associated infection,biofilm-associated infections
NEW06837,DISEASE,fungi aspergillus niger,fungi Aspergillus niger
NEW06838,CHEBI,antifungal assay,antifungal assay
NEW06839,CHEMICAL,galanthus nivalis L.,Galanthus nivalis L.
NEW06840,CHEMICAL,galanthamine content,galanthamine content
NEW06841,CHEMICAL,"1-methyl-4-phenyl-1,2,3,6-tetrahydropypridine MPTP mouse model","1-methyl-4-phenyl-1,2,3,6-tetrahydropypridine MPTP mouse model"
NEW06842,DISEASE,kainate-induced epilepsy,kainate-induced epilepsy
NEW06843,DISEASE,behavioural alteration,behavioural alterations
Q000187,CHEBI,drug effects [Subheading],effect of drugs|pharmacologic effects|Drug effects|drug effects
NEW06844,CHEMICAL,weight gain/hyperglycaemia side-effect,weight gain/hyperglycaemia side-effects
NEW06845,CHEMICAL,glp-1 receptor agonist,GLP-1 receptor agonist
NEW06846,DISEASE,genetic absence epileptic glaxo/rijswijk rat,genetic absence epileptic Glaxo/Rijswijk rats
NEW06847,DISEASE,metabolic disturbance,metabolic disturbances
NEW06848,CHEMICAL,glp-1 analog,GLP-1 analogs
C089946,CHEMICAL,"2,4-thiazolidinedione [Supplementary Concept]",Thiazolidinediones|thiazolidinedione
NEW06849,CHEMICAL,nucleos(t)ide analogue,nucleos(t)ide analogues|NUCs
NEW06850,DISEASE,fibrosis advanced fibrosis,fibrosis advanced fibrosis
C000720465,CHEMICAL,PEGylated ifngamma [Supplementary Concept],pegylated IFN|Interferon-gamma|PEG-IFN|Polyethylene Glycols
NEW06851,CHEMICAL,new nuc,newer NUCs
NEW06852,DISEASE,behavior symptom,behavior symptoms
http://purl.obolibrary.org/obo/CHEBI_91016,CHEMICAL,gabaa receptor agonist,5-HT(2C receptor agonist|5-HT(1A receptor agonist|non-NMDA receptor agonists|CB(2 receptor agonists|GABAA receptor agonists|μ- Κ-opioid receptor agonists|5-HT2C receptor agonist|GABAA receptor agonist|Non-N-methyl-D-aspartate receptor agonists|μ-opioid receptor agonists|κ-opioid receptor agonists|μ-opioid receptor agonist|endogenous GHB/GABAB receptor agonist|µ-opioid receptor agonist|GABAB receptor agonist|GABAB receptor agonists|galcanezumab receptor agonists|selective 5-HT4 receptor agonist|mGlu2/3 receptor agonists|receptor agonist (S)-AMPA
NEW06853,CHEMICAL,omega-3 deficiency,omega-3 deficiency
NEW06854,CHEMICAL,adenosine monophosphate-activated protein kinase,adenosine monophosphate-activated protein kinase
NEW06855,DISEASE,tbi animal,TBI animals
NEW06856,CHEBI,trkb receptor agonist,TrkB receptor agonist
C485383,CHEMICAL,"6,7-dihydroxyflavone [Supplementary Concept]","7,8-Dihydroxyflavone|Flavones|7,8-dihydroxyflavone"
NEW06857,CHEMICAL,omega-3 deficiency,Omega-3 deficiency
NEW06858,CHEBI,"agonist 7,8-dihydroxyflavone dhf h","agonist 7,8-dihydroxyflavone DHF h"
NEW06859,DISEASE,ptsd-like effect,PTSD-like effect
NEW06860,CHEBI,selective nk3 antagonist,selective NK3 antagonists
NEW06861,MENTAL_HEALTH,slow dissociation kinetic,slower dissociation kinetics
C106716,CHEMICAL,SB 223412 [Supplementary Concept],Talnetant|Quinolines
NEW06862,CHEMICAL,potent nk(3 receptor antagonist able,potent NK(3 receptor antagonist able
C091554,CHEMICAL,SR 142801 [Supplementary Concept],Osanetant|Piperidines
NEW06863,CHEBI,neurokinin nk3 receptor antagonist,neurokinin NK3 receptor antagonist
NEW06864,DISEASE,diabetic patient,diabetic patients
NEW06865,DISEASE,mild hypertension,mild hypertension
http://purl.obolibrary.org/obo/CHEBI_35469,CHEMICAL,antidepressant,mood-stabilizers|SSRI antidepressant|thymoanaleptics|thymoleptics|antidepressant drugs|thymoleptic drugs|anti-depressants|SSRI antidepressants|nonstimulant|non-SSRI antidepressants|antidepressants
NEW06866,DISEASE,trauma symptom,trauma symptoms
NEW06867,CHEMICAL,stimulant methylphenidate,stimulants methylphenidate
NEW06868,CHEMICAL,nonstimulant entity,nonstimulant entities
NEW06869,CHEMICAL,dopamine neuron loss,dopamine neuron loss
http://purl.obolibrary.org/obo/SYMP_0019183,MENTAL_HEALTH,hyperactivity,MK-801-induced hyperactivity|CaMKII hyperactivity|AMPH-induced hyperactivity|6-hydroxydopamine-lesion-induced hyperactivity|CRH-induced hyperactivity
C586534,CHEMICAL,(1-(5-hydropentyl)indol-3-yl)-(1-naphthyl)methanone [Supplementary Concept],Indoles|JWH-018|Naphthalenes|JWH
NEW06870,DISEASE,ethanol-induced motor impairment,ethanol-induced motor impairments
C000606289,CHEMICAL,N-(1-(aminocarbonyl)-2-methylpropyl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide [Supplementary Concept],Indazoles|AB-CHMINACA|Valine/analogs  and  derivatives
NEW06871,DISEASE,ethanol-induced motor impairment,ethanol-induced motor impairment
NEW06872,CHEMICAL,extracellular glutamate level,extracellular glutamate levels
http://purl.obolibrary.org/obo/CHEBI_140971,CHEMICAL,lysophosphatidylcholine 22:5-omega-3,phosphatidylinosites|LPC 22:5-w3|LPC(22:5-w3)
NEW06873,DISEASE,neurocirculatory dystonia,neurocirculatory dystonia
NEW06874,DISEASE,che tg class,ChE TG classes
NEW06875,CHEMICAL,ChE-PICALM,ChE-PICALM
http://purl.obolibrary.org/obo/DOID_10652,DISEASE,alzheimer's disease,Alzheimer's disease markers|severe Alzheimer's disease|Alzheimer 's disease pathology|Alzheimer's disease patients|Alzheimer's disease treatment|Alzheimer disease|impairment Alzheimer's disease|Alzheimer 's disease|AD|CBS-AD|Alzheimers dementia|AD-MD|presenile dementia
C569957,CHEMICAL,"Slc24a4 protein, mouse [Supplementary Concept]",SLC24A4|Antiporters
NEW06876,CHEMICAL,acid level,acid levels
D024882,CHEBI,"Drug Resistance, Viral","Antiviral Drug Resistance|Drug Resistances, Viral|antiviral drug|Antiviral Drug Resistances"
NEW06877,DISEASE,motor impairment,motor impairment
NEW06878,CHEMICAL,drug valproic acid,drugs valproic acid
C564004,DISEASE,"Macrocytosis, Familial [Supplementary Concept]","Erythrocytes, Abnormal|Hematologic Diseases|macrocytosis"
NEW06879,DISEASE,nhale patient,NHALE patients
NEW06880,CHEMICAL,ovarian-teratoma-related anti-n-methyl-d-aspartate receptor,ovarian-teratoma-related anti-N-methyl-D-aspartate receptor
NEW06881,CHEMICAL,oseltamivir intake,oseltamivir intake
NEW06882,DISEASE,adverse behavior,adverse behaviors
NEW06883,DISEASE,behavioural disorder,behavioural disorders
D022261,DISEASE,Respiratory Syncytial Virus Vaccines,"RSV Vaccine|respiratory syncytial virus|Vaccines, RSV|Respiratory Syncytial Virus Vaccine|RSV Vaccines|Vaccine, RSV"
C076799,CHEMICAL,interferon-alpha 8 [Supplementary Concept],IFN alpha|Interferon-alpha|IFN α
D001990,DISEASE,"Bronchiolitis, Viral","Bronchiolitides, Viral|Viral Bronchiolitis|bronchiolitis|Viral Bronchiolitides"
NEW06884,CHEBI,commercial antiviral drug,commercial antiviral drug
NEW06885,CHEBI,vr1 antagonist capsazepine,VR1 antagonist capsazepine
NEW06886,DISEASE,persistent pain state,persistent pain states
NEW06887,CHEMICAL,inject capsaicin,injected capsaicin
NEW06888,CHEMICAL,latent inhibition,latent inhibition|LI
NEW06889,DISEASE,attentional deficit,attentional deficit
NEW06890,DISEASE,paradoxical pain,paradoxical pain
NEW06891,DISEASE,thermal hypersensitivity,thermal hypersensitivity
NEW06892,CHEBI,direct act antiviral agent,direct acting antiviral agents
NEW06893,CHEMICAL,hippocampal NSC,hippocampal NSC
D004671,DISEASE,"Encephalitis, Arbovirus","Encephalitides, Arthropod-Borne|Encephalitis, Arthropod Borne|Arbovirus Encephalitis|Encephalitides, Epidemic|Encephalitis, Arthropod-Borne|Mosquito-Borne Encephalitides|Arthropod-Borne Viral Encephalitis|Encephalitis, Arthropod-Borne Viral|Mosquito Borne Encephalitis|Arthropod-Borne Encephalitis|Arthropod-Borne Viral Encephalitides|Encephalitis, Mosquito Borne|Arbovirus Encephalitides|Encephalitis, Arboviral|Arthropod Borne Viral Encephalitis|Arthropod-Borne Encephalitides|Viral Encephalitis, Arthropod Borne|Encephalitides, Arboviral|Encephalitides, Arthropod-Borne Viral|Arboviral Encephalitis|Encephalitis, Epidemic|Viral Encephalitides, Arthropod-Borne|Epidemic Encephalitides|Arboviral Encephalitides|Viral Encephalitis, Arthropod-Borne|viral encephalitis|Encephalitides, Mosquito-Borne|Encephalitides, Arbovirus|Epidemic Encephalitis|Mosquito-Borne Encephalitis|Encephalitis, Mosquito-Borne|Arthropod Borne Encephalitis"
NEW06894,CHEMICAL,NSC progeny,NSC progeny
NEW06895,DISEASE,learn defect,learning defects
NEW06896,CHEBI,antiviral cytokine,antiviral cytokine
NEW06897,CHEBI,former intravenous drug abuse,former intravenous drug abuse
D053633,CHEMICAL,"Receptor, Interferon alpha-beta","Interferon alpha beta Receptor 1|Interferon alpha Receptors|Interferon alpha beta Receptor IFNAR2 Subunit|IFNAR1 Subunit, Interferon alpha beta Receptor|alpha beta|Interferon alpha-beta Receptor|Receptors, Interferon alphabeta|Receptors, Interferon alpha|Interferon alpha-beta Receptor IFNAR1 Subunit|IFNAR2.1 Subunit, Interferon alpha beta Receptor|IFN-alphaR|Interferon alpha-beta Receptor-1|IFNAR2.2 Subunit, Interferon alpha beta Receptor|IFN alphabetaR|Interferon alpha beta Receptor Chain 2|Interferon alpha beta Receptor Chain 1|IFNAR1 Subunit, Interferon alpha-beta Receptor|Interferon alpha-beta Receptor Chain 2|IFN-alphabetaR|Receptor-2, Interferon alpha-beta|IFNAR2.2 Subunit, Interferon alpha-beta Receptor|Interferon alpha-beta Receptor IFNAR2 Subunit|Receptor, Interferon alpha beta|Type I Interferon Receptor|alpha Receptor, Interferon|IFNAR2 Subunit, Interferon alpha-beta Receptor|Interferon alpha beta Receptor IFNAR1 Subunit|Interferon alpha beta Receptor|alpha-beta Receptor-1, Interferon|Interferon alpha-beta Receptor Chain 1|Receptor, Interferon alpha|alpha Receptors, Interferon|Interferon alpha beta Receptor 2|alpha-beta Receptor-2, Interferon|Receptor-1, Interferon alpha-beta|Interferon alpha-beta Receptor-2|interferon-alpha receptor|Interferon alphabeta Receptors|IFNAR2.1 Subunit, Interferon alpha-beta Receptor|Interferon alpha Receptor|IFNAR2 Subunit, Interferon alpha beta Receptor"
D011484,CHEMICAL,Protein-Arginine N-Methyltransferases,"Type I Protein Arginine N-Methyltransferase|Type I Protein Arginine N Methyltransferase|Type II Protein Arginine Methyltransferase|Protein Arginine Methyltransferase|Arginine Methylase|(Myelin Basic Protein)-Arginine N-Methyltransferase|Protein Methylase I|arginine methyltransferase|Arginine Methyltransferase, Protein|Protein Arginine N Methyltransferase|Type I Protein Arginine Methyltransferase|Protein Methyltransferase I|Myelin Basic Protein (Arginine) Methyltransferase|Protein-Arginine N-Methyltransferase|Methyltransferase, Protein Arginine|Protein Arginine N Methyltransferases"
NEW06898,CHEBI,antiviral effect,Antiviral effects
NEW06899,CHEMICAL,daa therapy,DAA therapy
NEW06900,DISEASE,hcv infection sexual function,HCV infection sexual function
C535382,DISEASE,Arthrogryposis renal dysfunction cholestasis syndrome [Supplementary Concept],Cholestasis|renal dysfunction|Arthrogryposis|Renal Insufficiency
D006521,DISEASE,"Hepatitis, Chronic","|Cryptogenic Chronic Hepatitis|Chronic Active Hepatitis|Chronic Persistent Hepatitides|Chronic Persistent Hepatitis|Hepatitis, Chronic, Cryptogenic|Hepatitis, Cryptogenic Chronic|Hepatitis, Chronic Active|Chronic Hepatitis, Cryptogenic|Hepatitis, Chronic Persistent|Chronic active hepatitis|chronic hepatitis|Chronic Hepatitis"
D012254,CHEMICAL,Ribavirin,Tribavirin||Ribamidyl|Ribovirin|Virazide|ribavirin|ICN1229|Virazole|ICN-1229|Rebetol|Ribamidil|Vilona|ICN 1229|Viramide|Ribasphere|Ribamide
NEW06901,DISEASE,hepatitis c virus chronic liver disease,hepatitis C virus chronic liver disease
NEW06902,MENTAL_HEALTH,global anxiety,global anxiety
NEW06903,DISEASE,pandemic outbreak,pandemic outbreak
D012903,DISEASE,Smell,Olfaction|smell|Smell Sense|Sense of Smell
http://purl.obolibrary.org/obo/SYMP_0000480,DISEASE,nervous system symptom,central nervous system symptoms
http://purl.obolibrary.org/obo/NCBITaxon_10407,DISEASE,hepatitis b virus,hepatitis C virus infection|Hepatitis C virus infection
NEW06904,CHEMICAL,psychiatric-risk patient,psychiatric-risk patients
NEW06905,CHEMICAL,pegylated interferon alpha,pegylated interferon alpha
NEW06906,CHEMICAL,pegylated interferon alpha,pegylated interferon alpha|pegIFN-alpha
NEW06907,DISEASE,acute lung damage,acute lung damage
NEW06908,DISEASE,chronic impairment,chronic impairment
D000082424,DISEASE,Internet Addiction Disorder,"Addictions, Internet|Internet Gaming Disorder|Internet Addiction Disorders|internet addiction|Addiction Disorder, Internet|Disorder, Internet Addiction|Smartphone Addictions|Disorders, Internet Addiction|Gaming Disorders, Internet|Internet Gaming Disorders|Addiction, Internet|addiction disorders|Addiction, Smartphone|Addictions, Smartphone|Addictions, Social Media|Social Media Addiction|Social Media Addictions|Smartphone Addiction|Media Addiction, Social|Gaming Disorder, Internet|Addiction Disorders, Internet|Disorder, Internet Gaming|Internet Addiction|Disorders, Internet Gaming|Addiction, Social Media|Media Addictions, Social|Internet Addictions"
NEW06909,CHEMICAL,buprenorphine maintenance,buprenorphine maintenance
NEW06910,CHEMICAL,methadone maintenance,methadone maintenance
NEW06911,CHEMICAL,intramuscular im naltrexone,intramuscular IM naltrexone
NEW06912,CHEMICAL,tc-5214,TC-5214
D058365,DISEASE,"Candidiasis, Invasive","Invasive Candidiases|Invasive Candidiasis|invasive candidiasis|Candidiases, Invasive|candidiasis"
NEW06913,CHEMICAL,mg deficit,Mg deficit
NEW06914,CHEBI,prolonged antibiotic exposure,prolonged antibiotic exposure
NEW06915,CHEBI,oral antifungal therapy,oral antifungal therapy
NEW06916,DISEASE,candida desensitization,candida desensitization
D009617,DISEASE,Nocardia Infections,"Cutaneous Nocardiosis, Primary|Cutaneous Nocardioses, Primary|Infection, Nocardia|Nocardia asteroides Infections|Nocardioses, Pulmonary|Pulmonary Nocardiosis|Cerebral Nocardioses|Cerebral Nocardiosis|Infections, Nocardia asteroides|Nocardiosis, Pulmonary|Pulmonary Nocardioses|Primary Cutaneous Nocardioses|Primary Cutaneous Nocardiosis|Nocardioses, Cerebral|Infection, Nocardia asteroides|Nocardia asteroides Infection|Nocardiosis, Cerebral|Infections, Nocardia|Nocardia Infection|Nocardioses, Primary Cutaneous|Nocardioses|Nocardiosis|Nocardiosis, Primary Cutaneous"
NEW06917,CHEMICAL,oral co-trimoxazole treatment,oral co-trimoxazole treatment
C433236,CHEMICAL,N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide [Supplementary Concept],JTC-801|Aminoquinolines|Benzamides
NEW06918,CHEBI,novel gpcr antagonist,novel GPCR antagonist
NEW06919,DISEASE,human osteosarcoma cell,human osteosarcoma cells
NEW06920,DISEASE,cancer-associated death,cancer-associated death
NEW06921,CHEMICAL,monoamine dopamine,monoamines dopamine
NEW06922,DISEASE,different acute stressor,different acute stressors
NEW06923,DISEASE,skin damage,Skin damage
NEW06924,CHEMICAL,hdwgut12     h fish,HDWgut12    h fish
D005880,DISEASE,Gills,gills|Gill
http://purl.obolibrary.org/obo/CHEBI_60974,CHEMICAL,cyanoamino acid,acids catabolism|cyanoamino acids
C402565,CHEMICAL,glutamate decarboxylase 1 [Supplementary Concept],Glutamic acid decarboxylase|glutamic acid decarboxylase|Glutamate Decarboxylase
NEW06925,DISEASE,maternal inflammation,maternal inflammation
NEW06926,CHEMICAL,gad67 expression,GAD67 expression
NEW06927,CHEMICAL,tau intermediate aggregate aggregate,Tau intermediate aggregate aggregates
NEW06928,DISEASE,neurodegeneration impairment,neurodegeneration impairment
NEW06929,CHEMICAL,full-length abeta,full-length Abeta
NEW06930,CHEMICAL,cerebral abeta level,cerebral Abeta levels
NEW06931,CHEMICAL,mutant superoxide dismutase,mutant superoxide dismutase
C531617,DISEASE,Amyotrophic lateral sclerosis 1 [Supplementary Concept],Amyotrophic Lateral Sclerosis|familial amyotrophic lateral sclerosis
NEW06932,DISEASE,acetaminophen poison,acetaminophen poisoning
NEW06933,CHEMICAL,endogenous amino acid l-cysteine,endogenous amino acid L-cysteine
D065227,DISEASE,Transfusion Reaction,"Purpura, Post-Transfusion|Transfusion Reactions, Hypotensive|Acute Hemolytic Transfusion Reaction|Reaction, Hypotensive Transfusion|Allergic Reaction, Transfusion-Associated|Blood Transfusion Associated Adverse Reactions|Transfusion-Associated Allergic Reaction|Transfusion-Transmitted Infections|Transfusion Reactions|Purpura, Posttransfusion|Transfusion Associated Circulatory Overload|Reaction, Hemolytic Transfusion|Transfusion-Associated Circulatory Overload|Hemolytic Transfusion Reaction|Transfusion-Associated Dyspnea|Circulatory Overloads, Transfusion-Associated|Delayed Hemolytic Transfusion Reaction|Dyspnea, Transfusion-Associated|Reactions, Hemolytic Transfusion|Transfusion Transmitted Infection|Transfusion Associated Allergic Reaction|Transfusion Reaction, Hemolytic|Febrile Non Hemolytic Transfusion Reaction|Transfusion-Associated Graft Vs. Host Disease|Hypotensive Transfusion Reaction|Transfusion Associated Dyspnea|Transfusion-Transmitted Infection|Infection, Transfusion-Transmitted|Post Transfusion Purpura|Transfusion Associated Graft Vs. Host Disease|TAGHD|Delayed Serologic Transfusion Reaction|Febrile Non-Hemolytic Transfusion Reaction|Posttransfusion Purpuras|Transfusion Reaction, Hypotensive|Hemolytic Transfusion Reactions|allergic reaction|Transfusion-Associated Circulatory Overloads|Blood Transfusion-Associated Adverse Reactions|Posttransfusion Purpura|Transfusion Reactions, Hemolytic|Post-Transfusion Purpura|Circulatory Overload, Transfusion-Associated"
D004164,CHEMICAL,Diphosphonates,Bisphosphonates|Bisphosphonate|bisphosphonates
NEW06934,DISEASE,intermittent parathyroid hormone,intermittent parathyroid hormone
D000077557,CHEMICAL,Ibandronic Acid,"1-Hydroxy-3-(methylpentylamino)propylidenebisphosphonate|Ibandronate Sodium Anhydrous|Boniva|RPR102289A|Ibandronate Sodium|BM21.0955|RPR 102289A|BM210955|Bondronat|(1-Hydroxy-3-(methylpentylamino)propylidene)bisphosphonate|RPR-102289A|Ibandronate|BM 210955|BM-210955|BM-21.0955|BM 21.0955|Bonviva|Ibandronic Acid, Sodium Salt, Monohydrate|ibandronate"
NEW06935,CHEMICAL,microg ibandronate,microg ibandronate
NEW06936,DISEASE,alcohol-induced bone loss,alcohol-induced bone loss
NEW06937,DISEASE,alcohol-induced tibial bone loss,alcohol-induced tibial bone loss
NEW06938,DISEASE,narcolepsy disorder,narcolepsy disorders
NEW06939,DISEASE,high turnover bone loss,high turnover bone loss
NEW06940,CHEMICAL,serum type 1 pro-collagen n-terminal protein,serum type 1 pro-collagen N-terminal protein|P1NP
NEW06941,CHEMICAL,collagen type 1 cross-linked c-telopeptide,collagen type 1 cross-linked C-telopeptide|CTX-1
NEW06942,DISEASE,infertility treatment,infertility treatment
NEW06943,CHEBI,endocrine disturbance,endocrine disturbances
NEW06944,NUTRITION,alpha syn pathology,alpha Syn pathology
NEW06945,CHEMICAL,transitional/limbic,transitional/limbic
NEW06946,CHEMICAL,neurology 65:1863,Neurology 65:1863
NEW06947,DISEASE,untreated mild essential hypertension,untreated mild essential hypertension
NEW06948,CHEMICAL,nitrendipine mg,nitrendipine mg
NEW06949,CHEMICAL,alcohol/high fat ahf diet,alcohol/high fat AHF diet
NEW06950,CHEBI,novel selective cb2 receptor agonist,novel selective CB2 receptor agonist
NEW06951,DISEASE,chronic pancreatitis pain model,chronic pancreatitis pain model
NEW06952,CHEMICAL,nigrostriatal dopamine neuron,nigrostriatal dopamine neurons
http://purl.obolibrary.org/obo/CHEBI_67072,CHEMICAL,cannabinoid receptor agonist,"type cannabinoid receptor agonists|cannabinoid CB1/CB2 receptor agonist|non-selective cannabinoid receptor agonist WIN55,212|cannabinoid receptor inverse agonist|nonselective cannabinoid receptor agonists|cannabinoid receptor agonists"
NEW06953,CHEMICAL,win mg/kg,WIN mg/kg
NEW06954,CHEMICAL,tyrosine hydroxylase-positive neuron,tyrosine hydroxylase-positive neurons
NEW06955,DISEASE,mptp-induced loss,MPTP-induced loss
NEW06956,CHEMICAL,mptp administration,MPTP administration
NEW06957,CHEBI,gp 1a,selective CB2 receptor agonist|GP 1a
NEW06958,CHEMICAL,5-ht(2a receptor mrna,5-HT(2A receptor mRNA
NEW06959,DISEASE,stress-induced memory formation impairment,stress-induced memory formation impairment
NEW06960,CHEMICAL,intra-vh microinjection,intra-VH microinjection
C103505,CHEMICAL,AM 251 [Supplementary Concept],Pyrazoles|Piperidines|AM251|AM-251
NEW06961,CHEMICAL,morphine administration,morphine administration
NEW06962,DISEASE,stress-induced memory impairment,stress-induced memory impairment
NEW06963,CHEMICAL,gr level,GR levels
http://purl.obolibrary.org/obo/MFOMD_0000170,MENTAL_HEALTH,projection,collateral-CA1 projection
NEW06964,CHEMICAL,"win55,212 mg/kg","WIN55,212 mg/kg"
NEW06965,CHEMICAL,subchronic apomorphine treatment,subchronic apomorphine treatment
NEW06966,CHEMICAL,dopamine d2 receptor sensitization,dopamine D2 receptor sensitization
NEW06967,CHEMICAL,dri score,DRI scores
NEW06968,DISEASE,pain group,pain groups
NEW06969,CHEMICAL,dynamic risk indicator,DRI|Dynamic Risk Indicators
http://purl.obolibrary.org/obo/DOID_302,MENTAL_HEALTH,substance abuse,DSM-IV substance abuse
NEW06970,DISEASE,measurement violent patient,measurements violent patients
NEW06971,CHEBI,histaminergic h3 receptor antagonist,histaminergic H3 receptor antagonists
NEW06972,CHEBI,betahistine histaminergic h1 receptor agonist,betahistine histaminergic H1 receptor agonist
NEW06973,DISEASE,olanzapine-induced weight gain/obesity,olanzapine-induced weight gain/obesity
NEW06974,CHEMICAL,low-dose risperidone,low-dose risperidone
NEW06975,CHEMICAL,oral chronic exposure to ovalbumin,OVA|oral chronic exposure to ovalbumin
http://purl.obolibrary.org/obo/SYMP_0000311,DISEASE,intestinal hypermotility,intestinal hypermotility
http://purl.org/sig/ont/fma/fma23873,CHEBI,stabilizer,3ε stabilizer FC-A
NEW06976,DISEASE,depressed mouse,depressed mice
NEW06977,DISEASE,subdiagnostic transition,subdiagnostic transitions
NEW06978,CHEBI,mood stabilizer treatment,mood stabilizer treatment
NEW06979,CHEMICAL,best-known gsk3β inhibitor,best-known GSK3β inhibitor
NEW06980,CHEBI,approve mood stabilizer,approved mood stabilizer
NEW06981,NUTRITION,term low dose lithium,term low dose lithium
NEW06982,DISEASE,cardiac surgery associated acute kidney injury,CSA-AKI|Cardiac surgery associated acute kidney injury
NEW06983,CHEMICAL,dopamine stabilizer antipsychotic,dopamine stabilizer antipsychotic
NEW06984,MENTAL_HEALTH,acute bipolar mania,acute bipolar mania
NEW06985,DISEASE,clinical hypothyroidism,Clinical hypothyroidism
NEW06986,CHEMICAL,thyroxine replacement,thyroxine replacement
NEW06987,CHEBI,hormone value,hormone values
D063387,CHEBI,Cannabinoid Receptor Antagonists,"Blockers, Cannabinoid|Blocker, Cannabinoid Receptor|Receptor Antagonists, Cannabinoid|Antagonists, Cannabinoid Receptor|cannabinoid receptor antagonists|Blocker, Cannabinoid|Cannabinoid Antagonists|Receptor Blockers, Cannabinoid|Blockers, Cannabinoid Receptor|Cannabinoid Receptor Blockers|Receptor Antagonist, Cannabinoid|Antagonist, Cannabinoid Receptor|Antagonists, Cannabinoid|Antagonist, Cannabinoid|Cannabinoid Blockers|Cannabinoid Receptor Antagonist|Cannabinoid Receptor Blocker|Cannabinoid Antagonist|Cannabinoid Blocker|Receptor Blocker, Cannabinoid"
NEW06988,CHEMICAL,monoamine transport inhibitor,monoamine transport inhibitors
NEW06989,CHEMICAL,long-term vpa therapy,Long-term VPA therapy
NEW06990,DISEASE,psychiatric adult patient,psychiatric adult patients
NEW06991,CHEMICAL,serum vpa level,serum VPA level
D002334,CHEMICAL,Carnitine O-Palmitoyltransferase,"Palmitoyltransferase, Carnitine|Acyltransferase, Palmitylcarnitine|O-Palmitoyltransferase, Carnitine|Carnitine O Palmitoyltransferase|Carnitine Palmitoyltransferase|Palmitylcarnitine Acyltransferase|Palmitoyltransferase I, Carnitine|Acyltransferase I, Carnitine|Carnitine Acyltransferase I|carnitine|Palmitoylcarnitine Transferase|Transferase, Palmitoylcarnitine|Palmitoyltransferase II, Carnitine|CPT II|Carnitine Palmitoyltransferase II|II, Carnitine Palmitoyltransferase|Carnitine Palmitoyltransferase I"
NEW06992,CHEMICAL,ammonia level,ammonia levels
NEW06993,DISEASE,anti-nmda receptor nmdar encephalitis,Anti-NMDA receptor NMDAR encephalitis
NEW06994,CHEMICAL,serotonergic antidepressant medication,Serotonergic antidepressant medications
NEW06995,CHEBI,mood stabilizer therapy,Mood stabilizer therapy
NEW06996,MENTAL_HEALTH,comorbid bd disorder,comorbid BD disorder
NEW06997,CHEMICAL,benzodiazepine medication,benzodiazepine medications
NEW06998,DISEASE,canmat task force,CANMAT task force
NEW06999,CHEMICAL,third-line therapy,third-line therapy
NEW07000,CHEMICAL,megadose,Megadose
NEW07001,CHEMICAL,adjunctive modafinil,adjunctive modafinil
NEW07002,DISEASE,comorbid disorder,comorbid disorders
NEW07003,CHEBI,antidepressant stabilizer treatment,antidepressant stabilizer treatments
NEW07004,MENTAL_HEALTH,mood disorder patient,mood disorder patients
http://purl.obolibrary.org/obo/CHEBI_65191,CHEMICAL,second generation antipsychotic,SGAs|Second generation antipsychotics|atypical antipsychotic agent|atypical antipsychotic|second generation antipsychotic agent|second generation antipsychotic drug|second generation antipsychotics|atypical antipsychotic agents|atypical antipsychotics|atypical antipsychotic drugs|second generation antipsychotic agents|atypical antipsychotic drug|second generation antipsychotic drugs
NEW07005,CHEBI,safe monoamine stabilizer,safe monoamine stabilizer
NEW07006,DISEASE,dopaminergic dysfunction,dopaminergic dysfunction
NEW07007,CHEMICAL,anticonvulsant oxcarbazepine,anticonvulsant oxcarbazepine
NEW07008,CHEMICAL,substituted amphetamine,Substituted amphetamines
NEW07009,CHEMICAL,calcium signaling protein,calcium signaling proteins
http://purl.obolibrary.org/obo/DOID_9651,DISEASE,systolic heart failure,chronic systolic heart failure
NEW07010,DISEASE,episodic ataxia type lethargic,episodic ataxia type lethargic
C000589038,CHEMICAL,"PMCA4 protein, mouse [Supplementary Concept]",plasma-membrane Ca2|Calcium-Transporting ATPases
D020754,CHEMICAL,Spinocerebellar Ataxias,"SCA1s|Spinocerebellar Ataxia|Spinocerebellar Ataxia Type 5|Syndrome, Wadia-Swami|Atrophies, Spinocerebellar|Atrophy I, Spinocerebellar|Menzel Type OPCA|Spinocerebellar Ataxia-5|Olivopontocerebellar Atrophy II|OPCA with Retinal Degeneration|Olivopontocerebellar Atrophy IIIs|Spinocerebellar Ataxia 5|Syndrome, Wadia Swami|Spinocerebellar Ataxia 1|spinocerebellar ataxia type|SCA1|Spinocerebellar Ataxia-1|Spinocerebellar Atrophy Is|Atrophy III, Olivopontocerebellar|Spinocerebellar Ataxia 1s|Dominantly-Inherited Spinocerebellar Ataxias|Atrophy IVs, Olivopontocerebellar|Atrophy IV, Olivopontocerebellar|Spinocerebellar Ataxias, Dominantly-Inherited|Dominantly Inherited Spinocerebellar Ataxias|Atrophy 2, Olivopontocerebellar|OPCA with Macular Degeneration and External Ophthalmoplegia|Swami Syndrome, Wadia|Olivopontocerebellar Atrophy, Holguin Type|Olivopontocerebellar Atrophy IIs|Olivopontocerebellar Atrophy IVs|Spinocerebellar Ataxia 7s|Schut-Haymaker Type OPCA|Olivopontocerebellar Atrophy Is|Spinocerebellar Atrophies|Dominantly-Inherited Spinocerebellar Ataxia|Olivopontocerebellar Atrophy III|spinocerebellar ataxia|Spinocerebellar Ataxia Type 2|Type 7 Spinocerebellar Ataxia|Spinocerebellar Ataxia 2s|Spinocerebellar Atrophy 2s|Spinocerebellar Ataxia-7|Olivopontocerebellar Atrophy 2s|Ataxia, Dominantly-Inherited Spinocerebellar|Type 6 Spinocerebellar Ataxia|Spinocerebellar Atrophy IIs|Atrophy IIs, Spinocerebellar|Spinocerebellar Ataxia, Dominantly-Inherited|Spinocerebellar Ataxia Type 1|Spinocerebellar Ataxia-6|Autosomal Dominant Cerebellar Ataxia, Type II|Spinocerebellar Ataxia Type 6|Ataxia 5, Spinocerebellar|Olivopontocerebellar Atrophy IV|Schut Haymaker Type OPCA|Spinocerebellar Atrophy 2|Spinocerebellar Ataxia Type 7|Spinocerebellar Ataxia, Autosomal Dominant, with Sensory Axonal Neuropathy|Spinocerebellar Atrophy|Wadia-Swami Syndrome|Spinocerebellar Ataxia 5s|OPCA, Menzel Type|Ataxia 6, Spinocerebellar|Olivopontocerebellar Atrophy I|Spinocerebellar Ataxia 6s|Ataxias, Spinocerebellar|Spinocerebellar Atrophy I|Spinocerebellar Ataxia 4|Atrophy 2s, Olivopontocerebellar|Atrophy I, Olivopontocerebellar|Ataxia 4, Spinocerebellar|Cerebelloparenchymal Disorder I|Spinocerebellar Atrophy II|Atrophy, Spinocerebellar|Type 2 Spinocerebellar Ataxia|Spinocerebellar Ataxia Type 4|Spinocerebellar Ataxias, Dominantly Inherited|Spinocerebellar Ataxia-4|Spinocerebellar Ataxia with Slow Eye Movements|Ataxia 2, Spinocerebellar|Spinocerebellar Ataxia 7|Olivopontocerebellar Atrophy 2|Spinocerebellar Degeneration with Slow Eye Movements|Cerebellar Degeneration with Slow Eye Movements|Spinocerebellar Ataxia 4s|Ataxia 7, Spinocerebellar|Ataxia, Spinocerebellar|Ataxias, Dominantly-Inherited Spinocerebellar|Type 4 Spinocerebellar Ataxia|Spinocerebellar Ataxia, Cuban Type|Spinocerebellar Ataxia 2|Atrophy II, Olivopontocerebellar|Spinocerebellar Ataxia-2|Type 1 Spinocerebellar Ataxia|Atrophy 2s, Spinocerebellar|Ataxia 1, Spinocerebellar|Cerebelloparenchymal Disorder Is|Wadia Swami Syndrome|OPCA, Schut-Haymaker Type|Spinocerebellar Ataxia 6|Atrophy 2, Spinocerebellar|Type 5 Spinocerebellar Ataxia"
D020325,DISEASE,Migraine with Aura,"Basilar Type Migraine|Migraine with Typical Aura|Familial Hemiplegic Migraine|Basilar-Type Migraine|Basilar Migraines|Migraine with Acute Onset Aura|Migraine, Basilar|Migraine with Auras|Classical Migraine|Migraine, Basilar Artery|Typical Aura without Headache|familial hemiplegic migraine|Classic Migraine|Migraine with Prolonged Aura|Acute Onset Aura Migraine|Migraine Aura without Headache|Migraine, Classic|Hemiplegic Migraine, Familial|Familial Hemiplegic Migraines|Migraine, Prolonged Aura|Migraine, Complicated|Complicated Migraine|Basilar Migraine|Hemiplegic-Ophthalmoplegic Migraine|Prolonged Aura Migraine|Migraine, Basilar-Type|Basilar Artery Migraine|Migraine, Classical"
NEW07011,CHEMICAL,glutamate excitotoxicity,glutamate excitotoxicity
NEW07012,DISEASE,lithium-induced hyperparathyroidism,lithium-induced hyperparathyroidism
D053040,DISEASE,Nephrolithiasis,|nephrolithiasis|Kidney Calculi (1965-2006)
NEW07013,CHEMICAL,normal urinary cyclic adenosine monophosphate excretion,normal urinary cyclic adenosine monophosphate excretion
NEW07014,CHEMICAL,normal plasma inorganic phosphate,normal plasma inorganic phosphate
NEW07015,CHEMICAL,low urinary calcium excretion,low urinary calcium excretion
NEW07016,CHEBI,increase drug accessibility,increased drug accessibility
C536275,DISEASE,Fahr's disease [Supplementary Concept],Calcinosis|Basal ganglia calcification|Neurodegenerative Diseases|Fahr's syndrome|Basal Ganglia Diseases
NEW07017,CHEMICAL,bilateral intracranial calcium deposition,bilateral intracranial calcium deposition
NEW07018,CHEMICAL,other bisphosphonate,Other bisphosphonates
D066208,DISEASE,Olfactory Tubercle,"Olfactorium, Tuberculum|Tubercle, Olfactory|Tuberculum Olfactorium|Anterior Perforated Substances|Anterior Perforated Space|Olfactoriums, Tuberculum|Substance, Anterior Perforated|olfactory|Olfactory Tubercles|Tubercles, Olfactory|Tuberculum Olfactoriums|Substances, Anterior Perforated|Anterior Perforated Substance|Perforated Substance, Anterior|Perforated Substances, Anterior"
D012968,CHEMICAL,Etidronic Acid,"1-Hydroxyethylidene-1,1-Bisphosphonate|Phosphonic acid, (1-hydroxyethylidene)bis-, disodium salt|(1-hydroxyethylene)diphosphonic acid, Tetrapotassium Salt|etidronate|EHDP, Dicalcium|1,1 hydroxyethylenediphosphonate|Xydiphone|Ethanehydroxydiphosphonate|Etidronate|1 Hydroxyethylidene 1,1 Bisphosphonate|Disodium Etidronate|Tetrapotassium Salt Etidronate|Ethanehydroxyphosphate|HEDSPA|Etidronate, Sodium|Didronel|1,1-hydroxyethylenediphosphonate|Etidronate, Disodium|(1-hydroxyethylene)diphosphonic acid|Diphosphonic Acid, Hydroxyethylidene|Etidronate, Tetrapotassium Salt|Hydroxyethylidene Diphosphonic Acid|Xidifon|Xidiphon|Dicalcium EHDP|Salt Etidronate, Tetrapotassium|Diphosphonate, Disodium 1-Hydroxyethylene|1-Hydroxyethane-1,1-Diphosphonate|Hydroxyethanediphosphonate|Etidronate, Dicalcium|Sodium Etidronate|Etidronate Disodium|Dicalcium Etidronate|EHDP|1 Hydroxyethane 1,1 Diphosphonate|HEDP|Disodium 1 Hydroxyethylene Diphosphonate|Disodium 1-Hydroxyethylene Diphosphonate|1-Hydroxyethylene Diphosphonate, Disodium"
D000077268,CHEMICAL,Pamidronate,"Pamidronate Monosodium|1-Hydroxy-3-aminopropane-1,1-diphosphonic acid|Amino 1 hydroxypropane 1,1 diphosphonate|AHPrBP|pamidronate|(3-Amino-1-hydroxypropylidene)-1,1-biphosphonate|Aredia|Amino-1-hydroxypropane-1,1-diphosphonate|Pamidronic Acid|Aminopropanehydroxydiphosphonate|Pamidronate Disodium|Aminohydroxypropylidene Diphosphonate|Pamidronate Calcium|1 Hydroxy 3 aminopropane 1,1 diphosphonic acid|Amidronate"
NEW07019,CHEMICAL,only benzodiazepine,only benzodiazepines
NEW07020,MENTAL_HEALTH,anxiety immediate anxiolytic effect,anxiety immediate anxiolytic effect
C000719193,DISEASE,Arachnophobia [Supplementary Concept],Phobic Disorders|arachnophobia
NEW07021,CHEMICAL,quetiapine xr,quetiapine XR
NEW07022,DISEASE,chronic spinal cord injury,Chronic spinal cord injury|CSCI
NEW07023,CHEMICAL,neurological severity score,neurological severity scores|NSS
D000069448,CHEMICAL,Denosumab,Xgeva|AMG 162|Prolia|Denosumab|denosumab
D064594,DISEASE,Bone-Patellar Tendon-Bone Grafts,GCTB|Bone Patellar Tendon Bone Grafts|bone|Bone-Patellar Tendon-Bone Graft
D018212,DISEASE,Giant Cell Tumor of Bone,Giant Cell Tumors (1966-1993)|giant cell tumor|Bone Neoplasms (1966-1993)
NEW07024,DISEASE,lactate-induced panic-like response,lactate-induced panic-like response
NEW07025,CHEMICAL,angiotensin-ii mediated activation,angiotensin-II mediated activation
NEW07026,CHEMICAL,gamma aminobutyric acid gaba neuron-related marker,gamma aminobutyric acid GABA neuron-related markers
NEW07027,CHEMICAL,gaba-synthesizing enzyme gad67,GABA-synthesizing enzyme GAD67
NEW07028,CHEMICAL,calcium-binding protein parvalbumin,calcium-binding protein parvalbumin
NEW07029,CHEMICAL,cus mouse,CUS mice
NEW07030,CHEMICAL,calcium-phosphate balance,calcium-phosphate balance
D004062,DISEASE,DiGeorge Syndrome,"Familial Third and Fourth Pharyngeal Pouch Syndrome|Deletion 22q11.2 Syndrome|Velo Cardio Facial Syndrome|Thymic Aplasia Syndrome|Hypoplasia of Thymus and Parathyroids|Syndrome, DiGeorge|Sedlackova Syndrome|Pharyngeal Pouch Syndrome|Third and Fourth Pharyngeal Pouch Syndrome|Conotruncal Anomaly Face Syndrome|Velocardiofacial Syndrome|Syndrome, VCF|Syndrome, Velo-Cardio-Facial|22q11.2 Deletion Syndrome|Deletion Syndrome, 22q11.2|Autosomal Dominant Opitz G Bbb Syndrome|Autosomal Dominant Opitz G-Bbb Syndrome|Syndrome, Shprintzen|DiGeorge syndrome|VCF Syndrome|Syndrome, Sedlackova|Conotruncal Anomaly Face Syndrome (CTAF)|DiGeorge Anomaly|Shprintzen VCF Syndrome|DiGeorge Sequence|Velo-Cardio-Facial Syndrome|Shprintzen Syndrome|Syndrome, Velocardiofacial|22q11.2DS|Catch22"
NEW07031,CHEMICAL,elevated free intracellular calcium ion concentration,elevated free intracellular calcium ion concentrations
D007970,DISEASE,Leukopenia,Leukocytopenia||Leukocytopenias|Leukopenias|leukopenia
NEW07032,NUTRITION,mm lithium,mM lithium
NEW07033,DISEASE,hyperammonemic stress response,hyperammonemic stress response
NEW07034,CHEMICAL,dysregulate ammonia metabolism,Dysregulated ammonia metabolism
NEW07035,CHEMICAL,BabaoDan,BabaoDan
NEW07036,DISEASE,tcm clinic,TCM clinics
NEW07037,CHEMICAL,calcium pth level,calcium PTH levels
NEW07038,CHEMICAL,(5-ht)-stimulated platelet intracellular calcium ca mobilization,(5-HT)-stimulated platelet intracellular calcium Ca mobilization
NEW07039,DISEASE,unmedicated depressive patient,unmedicated depressive patients
NEW07040,CHEMICAL,intra-vmpfc administration prior,Intra-vmPFC administration prior
C000601471,CHEMICAL,"1,1,1,3,3,3-hexafluoropropan-2-yl 4-(bis(benzo(d)(1,3)dioxol-5-yl)(hydroxy)methyl)piperidine-1-carboxylate [Supplementary Concept]",Benzodioxoles|Piperidines|KML29
http://purl.obolibrary.org/obo/CHEBI_185741,CHEMICAL,brosimacutin h,"h. Fent-SR|H. contortus|1-[3-(2,3-dihydroxy-3-methylbutyl)-2,4-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one|H 8-hydroxy-N|KML29    h"
NEW07041,DISEASE,generalize disorder,generalized disorder
NEW07042,CHEBI,vitamin d insufficiency,Vitamin D insufficiency
NEW07043,DISEASE,cardiovascular cv disease,cardiovascular CV disease
http://purl.obolibrary.org/obo/CHEBI_30351,CHEMICAL,"2,2'-bipyridine","2,2'-bipyridyl|2,2'-Bipyridin|2,2'-bipyridine|alpha,alpha'-dipyridyl|5-HT-induced Ca2|2-(2-pyridyl)pyridine|alpha,alpha'-bipyridine|alpha,alpha'-bipyridyl|bpy|2,2'-dipyridine|alpha,alpha'-dipyridine|2,2'-dipyridyl"
NEW07044,MENTAL_HEALTH,cns hyperactivity,CNS hyperactivity
NEW07045,DISEASE,psychotic sign,psychotic signs
NEW07046,DISEASE,convulsive component,convulsive component
NEW07047,CHEMICAL,glucose consumption,glucose consumption
NEW07048,NUTRITION,acidic phospholipid,acidic phospholipids
NEW07049,DISEASE,cns hyperexcitability,CNS hyperexcitability
D051360,CHEMICAL,Cyclin-Dependent Kinase 5,"Cyclin Dependent Kinase 5|PSSALRE Protein|Neuronal Cdc2 Like Protein Kinase|CDK5|PSSALRE, Cdc2-Related Kinase|Neuronal Cdc2-Like Protein Kinase|Cdk5 Protein Kinase|Cdc2-Related Kinase PSSALRE|Protein Kinase, Cdk5|Cdk5 Protein|Cdc2 Related Kinase PSSALRE|Cyclin-dependent kinase 5"
NEW07050,CHEMICAL,high calcium level,High calcium levels
NEW07051,DISEASE,common neurodegenerative movement disorder,common neurodegenerative movement disorder
NEW07052,CHEMICAL,dopaminergic da neuron,dopaminergic DA neurons
NEW07053,CHEMICAL,α-synuclein (α-syn)-containing neuronal protein aggregate,α-synuclein (α-syn)-containing neuronal protein aggregates
NEW07054,CHEMICAL,Aqueously,Aqueously
NEW07055,DISEASE,principal neurotoxic form,principal neurotoxic forms
NEW07056,CHEMICAL,extraneuronal amyloid plaque,extraneuronal amyloid plaques
NEW07057,CHEMICAL,covid-19 situation,COVID-19 situation
D000067073,DISEASE,Psychological Trauma,"psychological trauma|Trauma, Psychological"
NEW07058,CHEMICAL,pure kavalactone,pure kavalactones
NEW07059,DISEASE,l5178y mouse lymphoma cell,L5178Y mouse lymphoma cells
NEW07060,CHEMICAL,d-kawain,D-kawain
D020901,CHEMICAL,Kava,"Kawa, Kawa|Piper methysticum|Kavas, Kava|Kava Kavas|Kavas|Kava, Kava|Kawa|Kawa Kawa|Kava Kava|Kawas|Kawa Kawas|Piper methysticums|Kawas, Kawa|kava|methysticums, Piper"
NEW07061,DISEASE,toxic ingestion,Toxic ingestions
NEW07062,DISEASE,peculiar tissue-specific microwave oven burn,peculiar tissue-specific microwave oven burns
NEW07063,MENTAL_HEALTH,chronic fatigue group,Chronic fatigue group
NEW07064,CHEMICAL,tnf-α level,TNF-α level
NEW07065,DISEASE,significant behavioral alteration,significant behavioral alterations
NEW07066,CHEMICAL,egcg administration,EGCG administration
NEW07067,DISEASE,neurodegenerative disease animal model,neurodegenerative disease animal models
D010264,DISEASE,Paraplegia,"|Paraplegias, Spastic|Paraplegia, Cerebral|Paraplegias, Cerebral|Paraplegia|Cerebral Paraplegias|Paraplegias|Paraplegias, Ataxic|Cerebral Paraplegia|ataxic|Paralysis, Lower Extremities|Paraplegias, Flaccid|Flaccid Paraplegias|Spinal Paraplegias|Flaccid Paraplegia|Paraplegias, Spinal|Spastic Paraplegias|Paraplegia, Flaccid|Paraplegia, Spastic|Ataxic Paraplegias|Spinal Paraplegia|Ataxic Paraplegia|Paraplegia, Ataxic|Paralysis, Legs|Spastic Paraplegia|Paralysis, Lower Limbs|Paraplegia, Spinal"
C062817,CHEMICAL,N-hydroxy-N'-aminoguanidine [Supplementary Concept],AG|Guanidines|aminoguanidine
NEW07068,DISEASE,nmda antagonist-stimulated motoric behavior,NMDA antagonist-stimulated motoric behavior
NEW07069,CHEMICAL,cortical glutamate eﬄux,cortical glutamate eﬄux
D002490,DISEASE,Central Nervous System,"Systems, Central Nervous|Cerebrospinal Axis|Central Nervous Systems|Axis, Cerebrospinal|Cerebrospinal Axi|central systems|Nervous Systems, Central|Axi, Cerebrospinal|Nervous System, Central"
http://purl.obolibrary.org/obo/DOID_6680,DISEASE,capgras syndrome,hyperinsulinism/hyperammonemia syndrome|HHS|Capgras delusion theory
NEW07070,CHEMICAL,glutamine catabolism,glutamine catabolism
NEW07071,DISEASE,various tumor,various tumors
NEW07072,CHEMICAL,gdh inhibitor,GDH inhibitors
D051960,CHEMICAL,"GTP-Binding Protein alpha Subunit, Gi2","GTP Binding Protein alpha Subunit, Gi2|Gi2 alpha Protein|G Protein Subunit alpha I2|GTP|Galpha(i2) Protein|Gi2-alpha Protein|Galphai2 Protein"
D004352,CHEBI,"Drug Resistance, Microbial","antibiotic resistance|Antibiotic Resistance|Antimicrobial Drug Resistance|Antibiotic Resistance, Microbial|Antibiotic resistance|Drug Resistances, Microbial|Antimicrobial Drug Resistances|Resistance, Antibiotic|antimicrobial drug resistance"
NEW07073,MENTAL_HEALTH,resistance mutation,resistance mutations
NEW07074,DISEASE,human tumor,human tumors
NEW07075,DISEASE,ra resistance,RA resistance
NEW07076,DISEASE,ra-regulated tumor suppressor gene,RA-regulated tumor suppressor gene
NEW07077,CHEMICAL,retinoic acid receptor beta2 gene,retinoic acid receptor beta2 gene
NEW07078,CHEBI,ha filler,HA fillers
NEW07079,CHEBI,non-hyalouronic filler,non-hyalouronic filler
NEW07080,CHEMICAL,silicon agents-in case,silicon agents-in cases
D000067548,CHEBI,Dermal Fillers,"Skin Filler|Dermal Filler|Filler, Dermal|Fillers, Dermal|filler|Skin Fillers|Fillers, Skin|Filler, Skin"
NEW07081,DISEASE,typical Language Development,TLD|Typical Language Development
http://purl.org/sig/ont/fma/fma86578,CHEMICAL,interleukin,Interleukins (IL)-8
NEW07082,DISEASE,vaginal inflammation,vaginal inflammation
NEW07083,CHEBI,il-1 receptor antagonist,IL-1 receptor antagonist
NEW07084,DISEASE,pain addiction management,pain addiction management
NEW07085,DISEASE,synergistic neurotoxicity,synergistic neurotoxicity
NEW07086,CHEMICAL,analogue lurasidone,analogue lurasidone
NEW07087,CHEMICAL,ziprasidone analogue,ziprasidone analogue
NEW07088,DISEASE,autoimmune encephalitis,Autoimmune encephalitis
NEW07089,DISEASE,neuronal atrophy,neuronal atrophy
NEW07090,CHEMICAL,plasma glutamate level,plasma glutamate levels
NEW07091,CHEMICAL,heparan fragment,heparan fragments
NEW07092,DISEASE,endothelial injury,endothelial injury
NEW07093,CHEMICAL,excessive alcohol consumption,excessive alcohol consumption
D061213,DISEASE,"Mortality, Premature","Deaths, Premature|Premature Mortalities|premature death|Premature Deaths|Premature Mortality|Premature Death|Mortalities, Premature|Death, Premature"
http://purl.obolibrary.org/obo/DOID_12930,DISEASE,dilated cardiomyopathy,nonischemic dilated cardiomyopathy|Familial dilated cardiomyopathy|primary dilated cardiomyopathy|Idiopathic dilation cardiomyopathy|Congestive cardiomyopathy
NEW07094,DISEASE,hypertension account,hypertension accounts
NEW07095,DISEASE,unintentional ingestion,unintentional ingestions
NEW07096,DISEASE,acute overdose,acute overdose
NEW07097,CHEMICAL,atp concentration,ATP concentrations
NEW07098,DISEASE,human neuroblastoma sh-sy5y cell,human neuroblastoma SH-SY5Y cells
NEW07099,NUTRITION,omega fatty acid,omega fatty acids
NEW07100,DISEASE,ad-like deficit,AD-like deficits
NEW07101,NUTRITION,tart cherry extract,tart cherry extract
NEW07102,NUTRITION,Cherry concentrate,Cherry concentrate
NEW07103,CHEMICAL,serum urate,SU|serum urate
NEW07104,CHEMICAL,urate flare,urate flares
NEW07105,CHEMICAL,natalizumab therapy,Natalizumab therapy
D005761,DISEASE,"Gastroenteritis, Transmissible, of Swine","Porcine Transmissible Gastroenteritides|Transmissible Gastroenteritides, Swine|Transmissible Porcine Gastroenteritis|Transmissible Gastroenteritis, Porcine|Transmissible Porcine Gastroenteritides|Gastroenteritis, Swine Transmissible|Porcine Transmissible Gastroenteritis|Porcine Gastroenteritis, Transmissible|Transmissible Gastroenteritis of Swine|Swine Transmissible Gastroenteritis|Gastroenteritides, Swine Transmissible|gastroenteritis|Gastroenteritis, Transmissible Porcine|Swine Transmissible Gastroenteritides|Gastroenteritis, Porcine Transmissible|Transmissible Gastroenteritis, Swine|Gastroenteritides, Transmissible Porcine|Gastroenteritis, Transmissible, Porcine|Porcine Gastroenteritides, Transmissible|Gastroenteritides, Porcine Transmissible|Transmissible Gastroenteritides, Porcine"
D007968,DISEASE,"Leukoencephalopathy, Progressive Multifocal","JC Polyomavirus Encephalopathy|Progressive Multifocal Leukoencephalopathy|Encephalopathy, JC Polyomavirus|Encephalopathies, JC Polyomavirus|Multifocal Leukoencephalopathies, Progressive|JC Polyomavirus Encephalitis|Progressive Multifocal Leukoencephalopathies|progressive multifocal leukoencephalopathy|Multifocal Leukoencephalopathy, Progressive|Encephalitis, JC Polyomavirus|Leukoencephalopathies, Progressive Multifocal"
D020773,DISEASE,Headache Disorders,"Syndrome, Headache|Chronic Daily Headaches|Headaches, Chronic Daily|Cephalgia Syndromes|Headache Disorder|Daily Headache, Chronic|Headache, Intractable|Headache Syndromes|Chronic Headaches|Headaches, Chronic|Chronic Headache|cephalgia|Headaches, Intractable|Intractable Headaches|Headache, Chronic Daily|Cephalgia Syndrome|intractable headaches|Headache Syndrome|Headache, Chronic|Intractable Headache|Daily Headaches, Chronic|Chronic Daily Headache"
D009304,DISEASE,Nasopharyngitis,Nasopharyngitides|nasopharyngitis
D014582,DISEASE,Urticaria Pigmentosa,"Cutaneous Mastocytosis, Maculopapular|Maculopapular Cutaneous Mastocytoses|Cutaneous Mastocytoses, Maculopapular|urticaria|Maculopapular Cutaneous Mastocytosis"
NEW07106,DISEASE,recurrent/chronic dermatophytosis,recurrent/chronic dermatophytosis
http://purl.obolibrary.org/obo/CHEBI_35718,CHEBI,antifungal agent,newer antifungal agents|antifungal agents|antifungal|antifungal drugs|antifungals|antifungal drug
NEW07107,DISEASE,haematological disease,haematological diseases
NEW07108,CHEMICAL,intravenous voriconazole,Intravenous voriconazole
NEW07109,DISEASE,visual disturbance,visual disturbances
D003480,DISEASE,Cushing Syndrome,"Cushing's syndrome|Syndrome, Cushing's|Hypercortisolism|Syndrome, Cushing|Cushing's Syndrome"
NEW07110,CHEMICAL,excessive cortisol,excessive cortisol
NEW07111,DISEASE,hypercortisolemia,hypercortisolemia
D017088,DISEASE,AIDS-Related Opportunistic Infections,"AIDS Related Opportunistic Infections|AIDS-Related Opportunistic Infection|Opportunistic Infections, HIV Related|HIV Related Opportunistic Infections|Opportunistic Infections, HIV-Related|Opportunistic Infections, AIDS-Related|Opportunistic Infection, AIDS-Related|Infection, HIV-Related Opportunistic|Opportunistic Infections, AIDS Related|Infections, HIV-Related Opportunistic|opportunistic infections|Opportunistic Infection, HIV-Related|HIV-Related Opportunistic Infection|HIV-Related Opportunistic Infections"
NEW07112,CHEMICAL,tau proteolysis,Tau proteolysis
NEW07113,DISEASE,neurodegenerative damage,neurodegenerative damage
NEW07114,CHEMICAL,lmw ≤10 k proteolytic peptide,LMW ≤10 K proteolytic peptides
http://purl.obolibrary.org/obo/CHEBI_132554,CHEMICAL,oligomer,oligomers|Amyloid-β Aβ oligomers
NEW07115,CHEBI,major neurotoxic agent,major neurotoxic agents
D009249,CHEBI,NADP,"Nicotinamide adenine dinucleotide|Nicotinamide Adenine Dinucleotide Phosphate|Triphosphopyridine Nucleotide|nicotinamide adenine dinucleotide|Nucleotide, Triphosphopyridine|Dinucleotide Phosphate, Nicotinamide-Adenine|Coenzyme II|Phosphate, Nicotinamide-Adenine Dinucleotide|Nicotinamide-Adenine Dinucleotide Phosphate|NADPH"
D009537,CHEMICAL,Nicotinamide Mononucleotide,"NMN|Mononucleotide, Nicotinamide|Nicotinamide mononucleotide"
http://purl.obolibrary.org/obo/CHEBI_37694,CHEMICAL,o-phospho peptide,colecystokinin-4 peptide|amyloid-β Aβ peptide|Aβ peptides|O-phospho peptides|peptide (GLP)-1
NEW07116,CHEBI,toxic agent,toxic agents
NEW07117,DISEASE,widespread amyloid deposition,widespread amyloid deposition
NEW07118,DISEASE,ari group,ARI group
NEW07119,CHEMICAL,± μg/l,± μg/L
D036102,DISEASE,Peripheral Blood Stem Cell Transplantation,"Transplantation, Peripheral Stem Cell|Peripheral Stem Cell Transplantation|Stem Cell Transplantation, Peripheral|peripheral blood"
NEW07120,CHEBI,vitamin b6 therapy,vitamin B6 therapy
NEW07121,DISEASE,stress-induced gastritis,stress-induced gastritis
NEW07122,CHEMICAL,vb6 supplementation,VB6 supplementation
NEW07123,DISEASE,low magnesemia,low magnesemia
NEW07124,DISEASE,ringed sideroblastic anemia,ringed sideroblastic anemia
NEW07125,CHEMICAL,alcohol abuser,alcohol abusers
D005494,CHEBI,Folic Acid Deficiency,"Acid Deficiencies, Folic|folic acid deficiency|Acid Deficiency, Folic|Deficiency, Folic Acid|Folic Acid Deficiencies|Deficiencies, Folic Acid"
C536510,DISEASE,Thiamine responsive megaloblastic anemia syndrome [Supplementary Concept],"Thiamine Deficiency/congenital|Megaloblastic anemia|Diabetes Mellitus|Anemia, Megaloblastic|Hearing Loss, Sensorineural"
http://purl.obolibrary.org/obo/DOID_13382,DISEASE,megaloblastic anemia,MGA1 Norwegian type|Imerslund-Grasbeck syndrome|erythropoietin-resistant microcytic hypochromic anemia|megaloblastic anaemia|recessive hereditary megaloblastic anemia 1|Grasbeck-Imerslund syndrome|hypochromic anaemia|recessive hereditary megaloblastic anaemia 1|IGS|RH-MGA1|microcytic anemia
C535323,DISEASE,Chromosome 5q Deletion Syndrome [Supplementary Concept],"macrocytic anemia|Chromosomes, Human, Pair 5|Chromosome Deletion|Anemia, Macrocytic"
http://purl.obolibrary.org/obo/SYMP_0000634,DISEASE,leukocytosis,anisocytosis
NEW07126,DISEASE,hyperammonemic patient,hyperammonemic patients
http://purl.obolibrary.org/obo/SYMP_0000272,DISEASE,myoclonic seizure,Pyridoxine-dependent seizure
D002129,CHEMICAL,Calcium Oxalate,"Calcium Oxalate Monohydrate (1:1)|Calcium Oxalate Dihydrate (1:1)|Monohydrate, Calcium Oxalate|Calcium Oxalate Monohydrate|Oxalate, Calcium|Calcium Oxalate (1:1)|Calcium Oxalate Trihydrate|Calcium Oxalate Dihydrate|oxalate|Dihydrate, Calcium Oxalate|Trihydrate, Calcium Oxalate"
C019635,CHEMICAL,Alanine-glyoxylate transaminase [Supplementary Concept],Transaminases|glyoxylate
D006960,DISEASE,"Hyperoxaluria, Primary","hyperoxalurias|Primary Oxalurias|Oxalosis, Primary|Primary Hyperoxaluria|Oxalurias, Primary|Primary Oxaluria|Primary Hyperoxalurias|Hyperoxalurias, Primary|Primary Oxalosis|Oxaloses, Primary|Primary Oxaloses|Oxaluria, Primary"
NEW07127,DISEASE,idiopathic hyperoxaluria,idiopathic hyperoxaluria
NEW07128,DISEASE,mild hyperhomocysteimenia,mild hyperhomocysteimenia
NEW07129,CHEBI,folate system genetic variant,folate system genetic variants
NEW07130,MENTAL_HEALTH,isoniazid-related psychosis,isoniazid-related psychosis
NEW07131,CHEMICAL,powerful imao,powerful IMAO
D007490,CHEMICAL,Iproniazid,Iprazid|iproniazid
NEW07132,CHEMICAL,author pyridoxin deficiency isoniazid toxicity,authors pyridoxin deficiency isoniazid toxicity
NEW07133,CHEMICAL,antituberculosis,antituberculosis
NEW07134,CHEMICAL,serum homocysteine,serum homocysteine
NEW07135,CHEBI,vitamin b supplementation,vitamin B supplementation
NEW07136,CHEBI,b vitamin supplementation,B vitamin supplementation
NEW07137,DISEASE,cognitive decline secondary,cognitive decline secondary
NEW07138,CHEMICAL,serum pyridoxal level,serum pyridoxal levels
http://purl.obolibrary.org/obo/CHEBI_176842,CHEBI,vitamin b9,vitamins B6|folate vitamers|folate vitamer|vitamins B9|vitamin B9 vitamers|vitamin B9 vitamer|vitamin B9|vitamin B-9
NEW07139,CHEMICAL,vasopressin v(1b receptor,vasopressin V(1b receptor
NEW07140,CHEMICAL,excessive vasopressin function,excessive vasopressin function
C456029,CHEMICAL,"1-(5-chloro-1-((2,4-dimethoxyphenyl)sulfonyl)-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl)-4-hydroxy-N,N-dimethyl-2-pyrrolidinecarboxamide [Supplementary Concept]",SSR149415|Indoles|Pyrrolidines
D011928,DISEASE,Raynaud Disease,"Raynaud's Disease||Raynaud's disease|Raynaud's phenomenon|Cold Fingers, Hereditary|Raynaud Phenomenon|Raynauds Disease"
D012964,CHEMICAL,Sodium,"Sodium-23|Sodium Ion Level|Ion Level, Sodium|Sodium 23|Level, Sodium Ion|sodium level"
NEW07141,DISEASE,due hyperproteinemia,due hyperproteinemia
NEW07142,NUTRITION,cholesterol catabolism,cholesterol catabolism
NEW07143,MENTAL_HEALTH,dementia pathogenesis,dementia pathogenesis
NEW07144,DISEASE,primary bile acid,primary bile acids
NEW07145,CHEMICAL,abu-genes,abu-genes
D010612,DISEASE,Pharyngitis,"|pharyngitis|Pharyngitides|Throat, Sore|Sore Throat|throat|Sore Throats"
NEW07146,MENTAL_HEALTH,virus tobacco abuse,virus tobacco abuse
D005750,DISEASE,Gastric Juice,"Gastric Juices|gastric juices|Juice, Gastric|Juices, Gastric"
NEW07147,CHEMICAL,tsen54 gene,Tsen54 gene
NEW07148,DISEASE,mental deficit,mental deficits
NEW07149,DISEASE,severe neurodegenerative disorder,severe neurodegenerative disorders
C548069,DISEASE,Pontocerebellar Hypoplasia Type 1 [Supplementary Concept],pontocerebellar hypoplasia|Olivopontocerebellar Atrophies
NEW07150,CHEBI,nk1 receptor antagonist,NK1 receptor antagonists
NEW07151,CHEBI,non-peptide nk1 receptor antagonist,non-peptide NK1 receptor antagonists
NEW07152,DISEASE,clinical pain condition,clinical pain conditions
NEW07153,CHEBI,nk3 receptor antagonist,NK3 receptor antagonists
NEW07154,CHEMICAL,substance p-neurokinin-1 nk1 receptor pathway,Substance P-neurokinin-1 NK1 receptor pathways
NEW07155,CHEBI,selective nk1 receptor antagonist,selective NK1 receptor antagonist
http://purl.obolibrary.org/obo/MFOMD_0000197,MENTAL_HEALTH,substance-induced anxiety disorder,anxiety depressive disorders
NEW07156,CHEBI,neuraminidase inhibitor,neuraminidase inhibitor
NEW07157,CHEMICAL,neuraminidase inhibitor 3r 5s]-4-acetamide-5-amino-3-(1-ethylpropyl)-1-cyclohexene-1-carboxylate phosphate,neuraminidase inhibitor 3R 5S]-4-Acetamide-5-amino-3-(1-ethylpropyl)-1-cyclohexene-1-carboxylate phosphate
NEW07158,DISEASE,influenza infection,influenza infections
NEW07159,DISEASE,hepatic ultra-structural damage,hepatic ultra-structural damage
NEW07160,CHEMICAL,conyza canadensis,Conyza canadensis
C026166,CHEMICAL,theanine [Supplementary Concept],Glutamates|theanine
NEW07161,CHEMICAL,caffeine catechin,caffeine catechins
NEW07162,CHEMICAL,tea consumption,tea consumption
NEW07163,CHEMICAL,mg/kg nicotine,mg/kg nicotine
NEW07164,MENTAL_HEALTH,significant locomotor depression,significant locomotor depression
NEW07165,MENTAL_HEALTH,significant hyperactivity,significant hyperactivity
NEW07166,CHEMICAL,mdma pretreated group,MDMA pretreated groups
D018817,CHEMICAL,"N-Methyl-3,4-methylenedioxyamphetamine","|Hydrochloride, N-Methyl-3,4-methylenedioxyamphetamine|Methylenedioxymethamphetamine|N Methyl 3,4 methylenedioxyamphetamine Hydrochloride|N Methyl 3,4 methylenedioxyamphetamine|MDMA|Ecstasy (Drug)|ecstasy|N-Methyl-3,4-methylenedioxyamphetamine Hydrochloride|MDMA-"
NEW07167,MENTAL_HEALTH,clear dissociation,clear dissociation
D020644,DISEASE,Midline Thalamic Nuclei,"Nucleus, Reuniens|Thalamus, Nucleus Reuniens|Nucleus, Reuniens Thalamic|Reuniens Nucleus|paraventricular thalamic nucleus|Thalamus Midline Nuclei|Thalamic Nuclei, Midline|Nucleus, Subfascular Thalamic|Thalamic Nucleus, Rhomboid|Thalamus Midline Nucleus|Periventricular Nuclei of Thalamus|Midline Nuclei of Thalamus|Reunien, Nucleus|Thalamus Periventricular Nuclei|Paratenial Nucleus|Thalami, Nucleus Reuniens|Rhomboidal Nucleus|Nucleus, Paratenial|Nucleus, Subfascular|Nucleus, Rhomboidal|Nucleus, Midline Thalamic|Nucleus, Rhomboid|Rhomboid Thalamic Nucleus|Thalamic Nucleus, Paraventricular|Midline Thalamic Nucleus|Paratenial Thalamic Nucleus|Nucleus, Parataenial|Nucleus, Paraventricular Thalamic|Thalamic Nucleus, Midline|Parataenial Nucleus|Reuniens, Nucleus|Paraventricular Nucleus of Thalamus|Paraventricular Thalamic Nucleus|Subfascular Thalamic Nucleus|Nucleus Reuniens Thalamus|Subfascular Nucleus|Reuniens Thalami, Nucleus|Reuniens Thalamus, Nucleus|Nuclei, Midline Thalamic|Nucleus Reuniens|Nucleus, Rhomboid Thalamic|Nucleus, Paratenial Thalamic|Nuclear Group, Midline|Thalamus Paraventricular Nucleus|Rhomboid Nucleus|Thalamic Nucleus, Subfascular|Nucleus Reuniens Thalami|PVT|Thalamic Nucleus, Reuniens|Reuniens Thalamic Nucleus|Nucleus Reunien|Midline Nuclear Group|Thalamic Nucleus, Paratenial"
NEW07168,CHEMICAL,ibogaine pretreatment,Ibogaine pretreatment
NEW07169,MENTAL_HEALTH,morphine-induced locomotor hyperactivity,morphine-induced locomotor hyperactivity
NEW07170,CHEMICAL,morphine-induced dopamine release,morphine-induced dopamine release
NEW07171,CHEBI,nmda antagonist action,NMDA antagonist actions
NEW07172,CHEBI,kappa agonist,kappa agonist
NEW07173,CHEMICAL,morphine self-administration,morphine self-administration
NEW07174,DISEASE,its 's developmental neurotoxicity,its's developmental neurotoxicity
NEW07175,MENTAL_HEALTH,initial locomotor hyperactivity,initial locomotor hyperactivity
NEW07176,DISEASE,tissue damage,tissue damage
NEW07177,DISEASE,locomotor dysfunction,locomotor dysfunction
D058908,CHEBI,Adenosine A2 Receptor Agonists,Adenosine A2A Receptor Agonists|Adenosine A2B Receptor Agonists|A2A receptor agonists|adenosine A2A receptor agonists
NEW07178,CHEMICAL,rotenone treated animal,rotenone treated animals
C021053,NUTRITION,mangostin [Supplementary Concept],Xanthones|alpha mangostin
NEW07179,CHEBI,cariprazine d2 receptor partial agonist,Cariprazine D2 receptor partial agonist
NEW07180,CHEMICAL,night-time levodopa,night-time levodopa
NEW07181,CHEMICAL,metabotropic eaa receptor,metabotropic EAA receptors
NEW07182,CHEMICAL,nmda receptor-ion channel complex,NMDA receptor-ion channel complexes
NEW07183,DISEASE,cardiovascular disease related,cardiovascular disease related
D015386,CHEBI,Hazardous Substances,"Substance, Toxic Environmental|Biohazards|Hazardous Materials|Toxic Environmental Substance|Environmental Substances, Toxic|Substances, Environmental Toxic|Chemical, Hazardous|Hazardous Substance|Material, Hazardous|Hazardous Chemicals|Environmental Toxic Substances|Toxic substances|Chemicals, Hazardous|Environmental Substance, Toxic|Substances, Toxic Environmental|toxic substance|toxic substances|Hazardous Material|Toxic Substances, Environmental|Biohazard|Substance, Hazardous|Toxic Environmental Substances|Materials, Hazardous|Substances, Hazardous|Hazardous Chemical"
NEW07184,CHEBI,toxic substance mixture,toxic substance mixtures
D011611,CHEMICAL,Psychosomatic Medicine,"APM|Medicine, Psychosomatic|Psychosomatic Medicine"
NEW07185,DISEASE,comorbid psychiatric medical condition,comorbid psychiatric medical conditions
NEW07186,DISEASE,remarkable cell apoptosis tumor elimination,remarkable cell apoptosis tumor elimination
NEW07187,CHEBI,alpha 1/alpha agonist clonidine,alpha 1/alpha agonist clonidine
NEW07188,MENTAL_HEALTH,reserpine akinesia,reserpine akinesia
NEW07189,CHEMICAL,clozapine non-clozapine group,clozapine non-clozapine groups
NEW07190,CHEMICAL,catecholamine agent,catecholamine agents
NEW07191,MENTAL_HEALTH,stress-induced craving,stress-induced craving
NEW07192,CHEMICAL,prazosin effect,prazosin effects
NEW07193,CHEMICAL,combined oral contraceptive use,Combined oral contraceptive use
NEW07194,CHEMICAL,coc user,COC users
NEW07195,CHEMICAL,add-back hormone replacement therapy,add-back hormone replacement therapy
http://purl.obolibrary.org/obo/CHEBI_41922,CHEMICAL,diethylstilbestrol,"trans-Diethylstilbestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|trans-Diethylstilbesterol|diethylstilbestrol|4,4'-dihydroxy-alpha,beta-diethylstilbene|DES|trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|Diethylstilbestrol|diethylstilboestrol|alpha,alpha'-diethyl-(E)-4,4'-stilbenediol|Distilbene|trans-Diethylstilboesterol|diethylstilbestrolum|4,4'-(3E)-hex-3-ene-3,4-diyldiphenol|dietilestilbestrol|(E)-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol"
NEW07196,CHEMICAL,prenatal exposure to diethylstilboestrol,DES|first generation drug-eluting stents|Prenatal exposure to diethylstilboestrol|biodegradable drug-eluting stent
NEW07197,CHEMICAL,selective nicotinic partial agonist varenicline,selective nicotinic partial agonist varenicline
D062706,DISEASE,Prodromal Symptoms,"Prodromal Characteristics|PTSS|Prodromal Sign|Symptom, Prodromal|Prodromal Period|Prodromal Stage|Periods, Prodromal|Prodromal States|Stages, Prodromal|Signs, Prodromal|symptoms|Prodromal Signs|Syndromes, Prodromal|State, Prodromal|Prodromal State|Prodromal Syndrome|Characteristic, Prodromal|Prodromal Symptom|Sign, Prodromal|Prodromal Syndromes|Syndrome, Prodromal|Period, Prodromal|Stage, Prodromal|Symptoms, Prodromal|States, Prodromal|Prodromal Stages|Prodromal Characteristic|Characteristics, Prodromal|Prodromal Periods"
C490152,CHEMICAL,ispronicline [Supplementary Concept],Pyridines|TC-1734
NEW07198,DISEASE,acute oral toxicity study,acute oral toxicity studies
D011978,CHEMICAL,"Receptors, Nicotinic","Nicotinic Acetylcholine Receptors|Nicotinic Receptors|Nicotinic Acetylcholine Receptor|Receptors, Nicotinic Acetylcholine|Nicotinic Receptor|Receptor, Nicotinic|Receptor, Nicotinic Acetylcholine|Acetylcholine Receptors, Nicotinic|Acetylcholine Receptor, Nicotinic|acetylcholine receptors|Nicotinic acetylcholine receptors|nicotinic acetylcholine receptors"
NEW07199,DISEASE,adult attention-deficit/hyperactivity disorder,adult attention-deficit/hyperactivity disorder
D000073865,DISEASE,Cigarette Smoking,"cigarette smoking|Smoking, Cigarette"
NEW07200,CHEMICAL,dopamine b significant risk factor,dopamine b significant risk factor
NEW07201,NUTRITION,nicotinic acetylcholine alpha receptor gene,nicotinic acetylcholine alpha receptor gene
NEW07202,MENTAL_HEALTH,adhd criterion,ADHD criteria
NEW07203,MENTAL_HEALTH,adhd parent-proband,ADHD parent-proband
NEW07204,DISEASE,invasive infection,invasive infections
NEW07205,DISEASE,cidp refractory,CIDP refractory
D016878,DISEASE,POEMS Syndrome,"Crow Fukase Syndrome|Takatsuki Syndrome|Polyneuropathy, Organomegaly, Endocrinopathy, M Protein, and Skin Changes Syndrome|Takatsuki's Syndrome|Organomegalies, Polyneuropathy|Crow-Fukase syndrome|Organomegaly, Polyneuropathy|Polyneuropathy Organomegaly|Crow-Fukase Syndrome|Syndrome, Crow-Fukase|Polyneuropathy Organomegalies|Syndrome, Takatsuki's|endocrinopathy|Syndrome, POEMS"
D013792,CHEMICAL,Thalidomide,|Thalidomide|thalidomide|Thalomid|Sedoval
NEW07206,MENTAL_HEALTH,canine cataplexy,canine cataplexy
NEW07207,DISEASE,tumor necrosis factor-alpha production,tumor necrosis factor-alpha production
http://purl.obolibrary.org/obo/CHEBI_187805,CHEMICAL,"(25r)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-27-oyl taurine","μg hypotaurine|2-[[(2R,6R)-2-methyl-6-[(3R,5S,7R,10S,12S,13R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoyl]amino]ethanesulonic acid"
NEW07208,DISEASE,spinal pain processing receptor,spinal pain processing receptors
NEW07209,CHEMICAL,intrathecal hypotaurine,intrathecal hypotaurine
C094635,CHEMICAL,L 701324 [Supplementary Concept],"L-701,324|Quinolones"
C058083,CHEMICAL,eliprodil [Supplementary Concept],Piperidines|eliprodil
NEW07210,CHEMICAL,nmdar1 subunit,NMDAR1 subunits
NEW07211,CHEMICAL,certain nmda receptor subunit,certain NMDA receptor subunits
NEW07212,CHEMICAL,chronic ethanol exposure,chronic ethanol exposure
NEW07213,CHEMICAL,third trimester ethanol exposure,third trimester ethanol exposure
NEW07214,CHEMICAL,oxaliplatin treatment,oxaliplatin treatment
D012021,DISEASE,"Reflex, Abnormal","|Reflex, Ankle, Decreased|Reflex, Triceps, Decreased|Reflex, Palmo-Mental|Reflex, Absent|Abnormal Reflex|Decreased Bulbocavernosus Reflex|Reflex Absent, Bulbocavernousus|Reflex, Triceps, Abnormal|Reflex, Anal, Decreased|Hyporeflexia|Reflex, Knee, Decreased|Reflex, Moro, Asymmetric|Reflex, Ankle, Abnormal|Hyperreflexia|Bulbocavernousus Reflex Absent|Reflex, Gag, Decreased|Reflex, Biceps, Decreased|Reflexes, Abnormal|Abnormal Reflexes|Reflex, Decreased|Reflex, Decreased Bulbocavernosus|Absent Reflex|Abnormal Deep Tendon Reflex|Reflex, Hoffman's|Reflex, Biceps, Abnormal|startle|Reflex, Anal, Absent|Reflex, Biceps, Absent|Hoffman's Reflex|Reflex, Corneal, Decreased|Reflex, Knee, Abnormal|Palmo Mental Reflex|Reflex, Acoustic, Abnormal|Reflex, Deep Tendon, Absent|Pendular Reflex|Reflex, Deep Tendon, Abnormal|Reflex, Corneal, Absent|Bulbocavernosus Reflex, Decreased|Reflex, Triceps, Absent|Decreased Reflex|Palmo-Mental Reflex|Reflex, Pendular|Reflex, Gag, Absent|hyporeflexia|Reflex, Ankle, Absent"
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Mental_Confusion,MENTAL_HEALTH,mental confusion,mental confusion
NEW07215,CHEBI,selective pparγ agonist,selective PPARγ agonists
NEW07216,CHEBI,synthetic agonist,synthetic agonist
C541917,CHEMICAL,INT 131 [Supplementary Concept],INT-131|Quinolines|Sulfonamides
NEW07217,CHEBI,act m1 muscarinic agonist,acting m1 muscarinic agonists
D012859,DISEASE,Sjogren's Syndrome,"Syndrome, Sjogren's|Syndrome, Sicca|Sjogren Syndrome|Sicca Syndrome|Sjogrens Syndrome|Sjögren's syndrome"
NEW07218,CHEMICAL,antisense oligonucleotide technology,antisense oligonucleotide technology
NEW07219,DISEASE,neuroregeneration,neuroregeneration
NEW07220,DISEASE,gene-related brain damage,gene-related brain damage
NEW07221,DISEASE,b. cereus SW7,B. cereus SW7
NEW07222,CHEBI,virulence factor gene,virulence factor genes
NEW07223,CHEMICAL,pneumococcal cap,pneumococcal CAP
NEW07224,DISEASE,p. aeruginosa tat mutant,P. aeruginosa tat mutants
NEW07225,CHEMICAL,2-alkyl-4-quinolone production,2-alkyl-4-quinolone production
NEW07226,CHEMICAL,cytotoxin-associated gene a,cytotoxin-associated gene A|CagA
NEW07227,CHEMICAL,selenium supplementation,selenium supplementation
NEW07228,CHEMICAL,copenhagen prospective study,COpenhagen Prospective Study
NEW07229,MENTAL_HEALTH,Neuropsychiatric Schizophrenia,Neuropsychiatric Schizophrenia
NEW07230,DISEASE,ASD symptom,ASD symptoms
NEW07231,CHEBI,d concentration,D concentrations
NEW07232,MENTAL_HEALTH,autism behavior checklist,Autism Behavior Checklist
NEW07233,MENTAL_HEALTH,Autism Diagnostic Observation Schedule-Second Edition,Autism Diagnostic Observation Schedule-Second Edition
NEW07234,MENTAL_HEALTH,multiple linear regression model,multiple linear regression model
NEW07235,CHEBI,vitamin d concentration,vitamin D concentration
NEW07236,DISEASE,metabolic dysfunction,Metabolic dysfunction
NEW07237,CHEMICAL,alcohol reward,alcohol reward
NEW07238,MENTAL_HEALTH,preclinical anxiety model,preclinical anxiety models
C527551,CHEMICAL,LY686017 [Supplementary Concept],Triazoles|LY686017|Pyridines
http://purl.obolibrary.org/obo/CHEBI_7936,CHEMICAL,paroxetine,"Paroxetine|20mg/d paroxetine|(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine|(3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|paroxetinum|(-)-(3S,4R)-4-(p-fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|paroxetina|DTG paroxetine"
http://purl.obolibrary.org/obo/CHEBI_4315,CHEMICAL,danazol,"danazolum|Cyclomen|50mg/d LY686017|[1,2]oxazolo[4',5':2,3]-17alpha-pregn-4-en-20-yn-17-ol|Danocrine|danazol"
NEW07239,CHEMICAL,with/without estradiol replacement,with/without estradiol replacement
NEW07240,CHEMICAL,amphetamine treatment,amphetamine treatment
NEW07241,DISEASE,attentional set-shifting,attentional set-shifting
NEW07242,CHEMICAL,intranasal oxytocin,intranasal oxytocin
NEW07243,MENTAL_HEALTH,canine separation anxiety,canine separation anxiety
NEW07244,DISEASE,emotional disorder,emotional disorders
NEW07245,CHEBI,corticotropin releasing hormone arginine vasopressin avp concentration,Corticotropin releasing hormone arginine vasopressin AVP concentrations
NEW07246,CHEMICAL,dopamine transporter inhibitor,Dopamine transporter inhibitors
NEW07247,DISEASE,chronic hyperammonemia,Chronic hyperammonemia
NEW07248,CHEMICAL,cortisol present,cortisol present
http://purl.obolibrary.org/obo/CHEBI_36699,CHEBI,corticosteroid hormone,corticosteroid hormones|adrenal cortex hormones
NEW07249,DISEASE,chronic hyperammonemia similar,chronic hyperammonemia similar
NEW07250,MENTAL_HEALTH,heterotypic chronic stress,heterotypic chronic stress
NEW07251,DISEASE,impairment disability,impairment disability
NEW07252,CHEBI,synthetic hormone,synthetic hormone
NEW07253,DISEASE,new-onset hypothyroidism,new-onset hypothyroidism
NEW07254,CHEMICAL,leuprorelin administration,Leuprorelin administration
NEW07255,CHEMICAL,leuprorelin injection,leuprorelin injection
NEW07256,CHEBI,gonadotrophin-releasing hormone analog,Gonadotrophin-Releasing Hormone analogs
NEW07257,CHEMICAL,central glutamate,central glutamate
NEW07258,CHEBI,plasma hpa axis hormone,Plasma HPA axis hormones
NEW07259,DISEASE,cancer cell line culture,cancer cell line cultures
NEW07260,CHEBI,long-term hormone replacement therapy,long-term hormone replacement therapy
C000719212,MENTAL_HEALTH,Pathophobia [Supplementary Concept],cancer phobia|Phobic Disorders
D020888,CHEMICAL,Vigabatrin,|gamma-Vinyl-GABA|vigabatrin|Sabrilex|gamma Vinyl gamma Aminobutyric Acid|gamma Vinyl GABA|Vigabatrin|VGB|gamma-Vinyl-gamma-Aminobutyric Acid|gamma-vinyl GABA|Sabril
NEW07261,MENTAL_HEALTH,static encephalopathy,static encephalopathy
NEW07262,CHEBI,tsh releasing hormone,TSH releasing hormone
NEW07263,CHEBI,hormone response,hormone response
NEW07264,CHEMICAL,trh stimulation,TRH stimulation
NEW07265,DISEASE,mood symptom,mood symptoms
NEW07266,DISEASE,substance-related addictive disorder,substance-related addictive disorders
NEW07267,CHEMICAL,cortisol plasma level,cortisol plasma levels
NEW07268,DISEASE,dopamine-related gene,dopamine-related genes
NEW07269,CHEMICAL,gonadal hormone testosterone,gonadal hormone testosterone
NEW07270,CHEMICAL,basal testosterone metabolism,basal testosterone metabolism
NEW07271,MENTAL_HEALTH,stress associate mental disorder,stress associated mental disorders
NEW07272,DISEASE,abnormal rem sleep manifestation,abnormal REM sleep manifestations
NEW07273,DISEASE,major orexin impairment,major orexin impairment
D020187,MENTAL_HEALTH,REM Sleep Behavior Disorder,"Behavior Disorder, REM|REM Behavior Disorder|REM behavior disorder|Rapid Eye Movement Sleep Behavior Disorder|REM sleep behavior disorder|Behavior Disorders, REM|RBD|REM Behavior Disorders|Behavior Disorder, Rapid Eye Movement Sleep|rapid eye movement sleep behavior disorder"
NEW07274,CHEMICAL,nesfatin-1-hormone,nesfatin-1-hormone
NEW07275,DISEASE,bpd symptomatology,BPD symptomatology
NEW07276,CHEMICAL,serum oxt,serum OXT
NEW07277,DISEASE,drug-facilitated sexual assault,drug-facilitated sexual assault
NEW07278,DISEASE,sexual predator,sexual predators
NEW07279,DISEASE,x-linked neurological disorder,X-linked neurological disorder
NEW07280,CHEMICAL,phosphorylate fty720,Phosphorylated FTY720
NEW07281,CHEMICAL,to sphingosine-1-phosphate receptor,to sphingosine-1-phosphate receptors|S1PRs
C542743,CHEMICAL,((E)-3-amino-5-(4-heptylphenyl)-3-(hydroxymethyl)pent-1-enyl)phosphonic acid [Supplementary Concept],FTY720-P|Organophosphonates|FTY720
D066253,DISEASE,Vascular Remodeling,"Remodelings, Pulmonary Arterial|Remodeling, Pulmonary Arterial|Pulmonary Arterial Remodeling|Arterial Remodelings, Pulmonary|Arterial Remodeling, Pulmonary|Remodeling, Vascular|Vascular Remodelings|Remodelings, Vascular|Pulmonary Arterial Remodelings|vascular remodeling"
NEW07282,CHEMICAL,down-regulating gr expression,down-regulating GR expression
NEW07283,DISEASE,adolescent stress-induced ptsd-like behavior,adolescent stress-induced PTSD-like behaviors
NEW07284,CHEBI,major metabolism-regulating hormone,major metabolism-regulating hormone
NEW07285,CHEMICAL,exogenous melatonin,Exogenous melatonin
NEW07286,MENTAL_HEALTH,peri-surgical anxiety,peri-surgical anxiety
NEW07287,DISEASE,functional dyspeptic syndrome,functional dyspeptic syndrome
D013001,DISEASE,Somatoform Disorders,"Medically Unexplained Syndromes|somatoform disorders|Unexplained Syndrome, Medically|Pain Disorder|Disorder, Somatoform|Briquet Syndrome|Somatization Disorder|somatoform disorder|pain disorder|Syndrome, Medically Unexplained|Somatoform Disorder|Medically Unexplained Syndrome|Syndrome, Briquet|Somatization Disorders"
NEW07288,CHEBI,hormone fluctuation,hormone fluctuation
NEW07289,DISEASE,thyroid autoimmunity,thyroid autoimmunity
NEW07290,MENTAL_HEALTH,early psychosis,early psychosis
NEW07291,CHEBI,hypothalamic-pituitary-thyroid axis hormone,hypothalamic-pituitary-thyroid axis hormones
NEW07292,MENTAL_HEALTH,postnatal psychosis,postnatal psychosis
NEW07293,MENTAL_HEALTH,imminent psychosis,imminent psychosis
NEW07294,CHEBI,preventive drug therapy,preventive drug therapy
NEW07295,CHEBI,mood stabiliser,Mood stabilisers
NEW07296,DISEASE,postnatal psychotic episode,postnatal psychotic episodes
http://purl.obolibrary.org/obo/MF_0000203,MENTAL_HEALTH,personality trait,psychopathic personality traits|personality traits
NEW07297,CHEMICAL,cortisol reactivity,cortisol reactivity
http://purl.obolibrary.org/obo/DOID_13351,DISEASE,pedophilia,psychopathy|Paedophilia
NEW07298,CHEMICAL,cortisol blunting,cortisol blunting
NEW07299,DISEASE,psychopathic trait,psychopathic traits
NEW07300,CHEMICAL,low cortisol secretion,lower cortisol secretion
NEW07301,CHEMICAL,low progesterone,low progesterone
NEW07302,DISEASE,psychopathy group,psychopathy group
NEW07303,CHEMICAL,deficient cortisol production,deficient cortisol production
NEW07304,MENTAL_HEALTH,myxedema psychosis,Myxedema psychosis
NEW07305,CHEBI,hypothyroidism-a common endocrine disorder,hypothyroidism-a common endocrine disorder
NEW07306,DISEASE,depressive symptomology,Depressive symptomology
NEW07307,CHEMICAL,glutamate glu level,glutamate Glu levels
NEW07308,CHEMICAL,cdk4/6 inhibitor,CDK4/6 inhibitor
NEW07309,DISEASE,her2-negative her2- metastatic breast cancer,HER2-negative HER2- metastatic breast cancer
NEW07310,CHEMICAL,er+ metastatic breast cancer,ER+ metastatic breast cancer|MBC
D021541,NUTRITION,Sea Bream,"Sparus auratus|Sparus aurata|Sea Breams|Gilthead Bream|Gilthead Breams|Seabream|Seabreams, Gilthead|Gilthead Seabreams|Gilthead Sea Breams|Gilthead Seabream|Seabreams|Gilthead Sea Bream|Seabream, Gilthead|gilthead sea bream|Sea Breams, Gilthead|Sea Bream, Gilthead"
NEW07311,CHEMICAL,brain renin-angiotensin system,brain renin-angiotensin system
NEW07312,CHEMICAL,angiotensin receptor ligand,angiotensin receptor ligands
NEW07313,NUTRITION,egg white hydrolysate,egg white hydrolysate
NEW07314,DISEASE,neuropathic disorder,neuropathic disorders
NEW07315,DISEASE,associate corrosive gastritis,associated corrosive gastritis
NEW07316,CHEMICAL,hydrogen sulfide poisoning,hydrogen sulfide poisoning
NEW07317,DISEASE,dispar larva,dispar larvae
NEW07318,CHEMICAL,dietary cadmium,dietary cadmium
http://purl.obolibrary.org/obo/DOID_3044,DISEASE,food allergy,perceived/self-reported food allergies|food hypersensitivity|IgE-mediated food allergy
NEW07319,CHEMICAL,specific ige-antibodie,specific IgE-antibodies
NEW07320,CHEMICAL,oral immunotherapy,Oral immunotherapy|OIT
D021181,DISEASE,Egg Hypersensitivity,"Egg Allergy|Egg Allergies|Allergies, Egg|Hypersensitivities, Egg|egg allergy|Hypersensitivity, Egg|Egg Hypersensitivities|Allergy, Egg"
D002096,CHEMICAL,C-Peptide,"C-peptide|C Peptide, Proinsulin|Connecting Peptide|C-Peptide, Proinsulin|Proinsulin C-Peptide|C Peptide|Proinsulin C Peptide"
NEW07321,DISEASE,devastate heart damage,devastating heart damage
D019727,MENTAL_HEALTH,Proxy,"Agent, Patient|Proxies|Agents, Patient|proxy|Patient Agent"
C028052,CHEMICAL,phenothiazine receptor [Supplementary Concept],"Receptors, Dopamine|phenothiazine"
http://purl.obolibrary.org/obo/CHEBI_63963,CHEMICAL,metabotropic glutamate receptor antagonist,mGluR antagonist|Metabotropic glutamate receptor antagonists|group metabotropic mGlu2/3 receptor antagonists|mGluR antagonists|metabotropic glutamate subtype mGlu5 receptor|metabotropic glutamate receptor subtype|metabotropic glutamate receptor antagonists
NEW07322,CHEMICAL,metabotropic glutamate subtype activity,metabotropic glutamate subtype activity
NEW07323,DISEASE,corticotropin-releasing factor crf receptor,corticotropin-releasing factor CRF receptors
NEW07324,CHEBI,potential drug target,potential drug targets
NEW07325,DISEASE,effective crf receptor antagonist,effective CRF receptor antagonists
NEW07326,CHEBI,different agonist,different agonists
NEW07327,CHEMICAL,ip1,IP1
NEW07328,CHEMICAL,camp accumulation,cAMP accumulation
NEW07329,MENTAL_HEALTH,dysfunctional family situation,dysfunctional family situation
NEW07330,DISEASE,migraine onset,migraine onset
NEW07331,CHEMICAL,caffeine consumption,Caffeine consumption
NEW07332,CHEMICAL,zolpidem concentration,Zolpidem concentrations
D014822,DISEASE,Vitreous Body,"Humor, Vitreous|Vitreous Humors|vitreous humor|Body, Vitreous|Bodies, Vitreous|Humors, Vitreous|Vitreous Humor|Vitreous Bodies"
NEW07333,CHEMICAL,acute zolpidem overdose,acute zolpidem overdose
NEW07334,CHEMICAL,high-dose caffeine ingestion,high-dose caffeine ingestions
NEW07335,CHEMICAL,pretreatment hva level,pretreatment HVA levels
NEW07336,CHEMICAL,acute arecoline treatment,acute arecoline treatments
NEW07337,DISEASE,overt anxiolytic-like behavior,overt anxiolytic-like behavior
NEW07338,CHEMICAL,adenosine a2a receptor function,adenosine A2A receptor function
NEW07339,DISEASE,induce neurotoxicity,induced neurotoxicity
NEW07340,DISEASE,dose panic state,dose panic states
NEW07341,NUTRITION,alpha frequency,alpha frequency
NEW07342,CHEBI,beta power,beta power
NEW07343,CHEMICAL,clozapine level,clozapine levels
NEW07344,CHEMICAL,heavy caffeine consumption,heavy caffeine consumption
NEW07345,CHEMICAL,caffeine use,caffeine use
C077059,CHEMICAL,"1,3,7,9-tetramethyluric acid [Supplementary Concept]",theacrine|Uric Acid/analogs  and  derivatives
NEW07346,CHEMICAL,abnormal 5-hydroxytryptamine metabolism,abnormal 5-hydroxytryptamine metabolism
NEW07347,DISEASE,chronic stress-induced depression-like disorder,chronic stress-induced depression-like disorders
NEW07348,CHEMICAL,neuronal adenosine a2a receptor,neuronal adenosine A2A receptors
NEW07349,DISEASE,stress-induced mood dysfunction,stress-induced mood dysfunction
NEW07350,DISEASE,memory deterioration,memory deterioration
NEW07351,DISEASE,sensory contact model,SCM|sensory contact model
NEW07352,CHEMICAL,green rooibo,green rooibos
http://purl.obolibrary.org/obo/CHEBI_176783,CHEBI,vitamin c,vitaminum C|vitamin C vitamer|vitamina C|vitamine C|vitamins C|vitamin C vitamers|Vitamin C
http://purl.obolibrary.org/obo/CHEBI_140133,CHEMICAL,demethoxyisogemichalcone c,C rooibos
NEW07353,CHEMICAL,low omega-3 index,low Omega-3 Index
NEW07354,CHEMICAL,Omega-3 index,Omega-3 Index
NEW07355,CHEMICAL,acute caffeine intake,acute caffeine intake
D010469,DISEASE,Perceptual Distortion,"Perceptual Distortions|Distortion, Perceptual|perceptual distortions|Distortions, Perceptual"
http://purl.obolibrary.org/obo/MF_0000003,DISEASE,alertness,alertness
NEW07356,CHEMICAL,caffeine response,caffeine response
NEW07357,MENTAL_HEALTH,idiopathic rem sleep behavior disorder,idiopathic REM sleep behavior disorder
D016631,MENTAL_HEALTH,Lewy Bodies,"Lewy bodies|Neurite, Lewy|Lewy Neurites|Lewy Body|DLB|Lewy Bodies|Lewy Neurite"
D051876,CHEMICAL,Sex-Determining Region Y Protein,Sex Determining Region Y Protein|y|Testis-Determining Factor|SRY Sex Determining Region Protein|SRY Sex-Determining Region Protein|Testis Determining Factor
D051760,DISEASE,Xeroderma Pigmentosum Group A Protein,Xeroderma Pigmentosum A Protein|XPA Nucleotide Excision Repair Protein|XPA Repair Protein|xeroderma pigmentosum|Xeroderma Pigmentosum Group A Complementing Protein|Xeroderma Pigmentosum-A Protein
NEW07358,MENTAL_HEALTH,drowsiness time,drowsiness time
NEW07359,DISEASE,pd trait,PD traits
NEW07360,CHEMICAL,caffeine variable,caffeine variable
NEW07361,MENTAL_HEALTH,mild dependence benefit,mild dependence benefits
NEW07362,CHEMICAL,moderate caffeine intake,moderate caffeine intake
NEW07363,DISEASE,cognitive failure,cognitive failures
NEW07364,MENTAL_HEALTH,symptom anxiety,symptoms anxiety
NEW07365,DISEASE,rare case psychotic,rare cases psychotic
NEW07366,MENTAL_HEALTH,performance anxiety disorder,performance anxiety disorder
NEW07367,DISEASE,neurotransmitter abnormality,neurotransmitter abnormality
NEW07368,CHEMICAL,postsynaptic serotonin receptor,postsynaptic serotonin receptors
NEW07369,CHEMICAL,striatal presynaptic dopamine transporter,striatal presynaptic dopamine transporter
NEW07370,DISEASE,female pd patient,female PD patients
NEW07371,DISEASE,oxidative/nitrative damage,oxidative/nitrative damage
NEW07372,CHEBI,putative cck receptor antagonist,putative CCK receptor antagonist
D011377,CHEMICAL,Proglumide,proglumide|Milid|Xylamide|Proglumide|Xilamide
NEW07373,CHEMICAL,cck relative,CCK relative
NEW07374,CHEMICAL,dopamine hyperactivity hypothesis,dopamine hyperactivity hypothesis
NEW07375,DISEASE,pain increase,pain increase
http://purl.obolibrary.org/obo/SYMP_0000209,DISEASE,ischemia,ischaemia
C572578,CHEMICAL,"SARAF protein, human [Supplementary Concept]",Intracellular Calcium-Sensing Proteins|calcium entry|Membrane Proteins
NEW07376,CHEBI,various nephrotoxin,various nephrotoxins
NEW07377,DISEASE,renal insufficiency due,renal insufficiency due
NEW07378,DISEASE,renal reperfusion,renal reperfusion
NEW07379,DISEASE,subarachnoid haemorrhage,subarachnoid haemorrhage
NEW07380,CHEMICAL,particular nimodipine,particular nimodipine
D020301,DISEASE,"Vasospasm, Intracranial","|Intracranial Vasospasms|Cerebral Vasospasm|Intracranial Vascular Spasm|Vasospasms, Intracranial|Angiospasms, Intracranial|Cerebral Angiospasm|Angiospasm, Cerebral|Angiospasm, Intracranial|Cerebral Artery Spasm|Intracranial Vascular Spasms|Vascular Spasm, Intracranial|vasospasm|Intracranial Angiospasm|Intracranial Angiospasms|Vasospasms, Cerebral|Vasospasm, Cerebral|Spasms, Cerebral Artery|Cerebral Angiospasms|Cerebral Vasospasms|Cerebrovascular Spasms|Spasms, Cerebrovascular|Angiospasms, Cerebral|Spasm, Cerebrovascular|Cerebrovascular Spasm|Cerebral Artery Spasms|Spasm, Intracranial Vascular|Spasms, Intracranial Vascular|Artery Spasms, Cerebral|Spasm, Cerebral Artery|Vascular Spasms, Intracranial|Intracranial Vasospasm|Artery Spasm, Cerebral"
http://purl.obolibrary.org/obo/DOID_3526,DISEASE,cerebral infarction,acute cerebral infarction|Cerebral infarction|Cerebral infarct|CVA - Cerebral infarction
NEW07381,CHEMICAL,sofosbuvir/velpatasvir combination regiman,sofosbuvir/velpatasvir combination regimen
NEW07382,DISEASE,hcv genotype,HCV genotypes
C571889,CHEMICAL,asunaprevir [Supplementary Concept],asunaprevir|Isoquinolines|Sulfonamides|Asunaprevir
NEW07383,CHEMICAL,interferon-free combination,interferon-free combinations
NEW07384,CHEMICAL,dopamine compromise,dopamine compromise
NEW07385,CHEMICAL,alcohol dependent patient,alcohol dependent patients
NEW07386,MENTAL_HEALTH,depression power,depression power
NEW07387,CHEMICAL,plasma amino acid level,Plasma amino acid levels
NEW07388,MENTAL_HEALTH,carbohydrate craving,carbohydrate craving
NEW07389,MENTAL_HEALTH,increase fatigue,increased fatigue
NEW07390,CHEMICAL,low serotonin level,low serotonin levels
D005505,CHEBI,Food Coloring Agents,"Coloring Agents, Food|Colorants, Food|Food Colorants|food coloring|Agents, Food Coloring"
NEW07391,CHEMICAL,α7 isoform,α7 isoform
NEW07392,CHEMICAL,pam pnu120596,PAM PNU120596
C502443,DISEASE,"Trib3 protein, rat [Supplementary Concept]",Protein Serine-Threonine Kinases/antagonists  and  inhibitors|neuronal cell death
D011220,DISEASE,Pralidoxime Compounds,"2-PAM Compounds|Pyridine Aldoxime Methyl Compounds|Compounds, 2-PAM|PAM|Compounds, Pralidoxime|2 PAM Compounds"
NEW07393,CHEMICAL,calcium current,calcium current
C527835,CHEMICAL,"N-(6-Chloropyridin-3-yl)-3,4-difluorobenzamide [Supplementary Concept]",ICa|Benzamides|Pyridines
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Anhedonia,DISEASE,anhedonia,fear/anxiety|avolition|CUMS-induced anhedonia
NEW07394,MENTAL_HEALTH,anxiety abuse,anxiety abuse
D000521,CHEMICAL,alpha-MSH,"Hormone, Desacetyl alpha-Melanocyte-Stimulating|ACTH(1-13)|alpha MSH|Adrenocorticotropin (1-13)NH2|MSH, (Desacetyl)alpha-|alpha-Melanotropin|Des-Acetyl MSH|Desacetyl alpha Melanocyte Stimulating Hormone|Hormone, alpha-Melanocyte-Stimulating|alpha-MSH, Desacetyl|alpha Melanocyte Stimulating Hormone|alphaMSH|MSH, Des-Acetyl|alpha-melanocyte stimulating hormone|Intermedin, alpha|(Des-Acetyl)-alpha-MSH|ACTH (1-13)NH2|Desacetyl alpha-Melanocyte-Stimulating Hormone|Desacetyl alpha MSH|(Desacetyl)alpha-MSH|alpha Intermedin|alpha Melanotropin|MSH, alpha|ACTH (1-13)|alpha-Melanocyte-Stimulating Hormone, Desacetyl|Desacetyl alpha-MSH|Acetylated ACTH (1-13)NH2|DE-alpha-MSH|alpha-Melanocyte-Stimulating Hormone"
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Nicotine_Withdrawal,CHEMICAL,nicotine withdrawal,nicotine withdrawal
NEW07395,CHEMICAL,erythromycin dopamine antagonist,erythromycin dopamine antagonists
NEW07396,DISEASE,acute severe exacerbation,acute severe exacerbations
D011949,CHEMICAL,"Receptors, Cholecystokinin","CCK-8 Receptors|Receptors, Sincalide|Sincalide Receptors|CCK|Cholecystokinin Receptor|Receptors, Caerulein|Octapeptide Receptors, Cholecystokinin|Cholecystokinin Receptors|Receptors, CCK-4|Receptors, CCK-8|CCK 8 Receptors|Caerulein Receptors|Receptors, Cholecystokinin Octapeptide|Receptors, CCK 8|CCK Receptor|Pancreozymin Receptors|Receptors, CCK 4|CCK-4 Receptors|Cholecystokinin Octapeptide Receptors|Receptors, Pancreozymin|CCK Receptors|Receptors, CCK|Receptor, Cholecystokinin|CCK 4 Receptors|Receptor, CCK"
NEW07397,CHEMICAL,cck level,CCK levels
NEW07398,MENTAL_HEALTH,saccadic distractibility,Saccadic distractibility
NEW07399,CHEMICAL,mg muscimol,mg muscimol
C055334,CHEMICAL,iso THIP [Supplementary Concept],Pyridines|Isoxazoles|THIP
NEW07400,CHEBI,active drug treatment,active drug treatment
NEW07401,DISEASE,shr impulsivity,SHR impulsivity
NEW07402,CHEBI,da antagonist,DA antagonist
C477966,CHEMICAL,baicalein-6-O-glucopyranuronoside [Supplementary Concept],Flavonoids|Glucuronates|baicalein
NEW07403,DISEASE,experimental myopia,experimental myopia
NEW07404,CHEMICAL,gaba biology,GABA biology
NEW07405,CHEBI,gaba agonist drug action,GABA agonist drug action
NEW07406,CHEMICAL,glutamate receptor biology,glutamate receptor biology
NEW07407,CHEMICAL,corticolimbic circuitry,Corticolimbic circuitry
D000078308,CHEMICAL,Tiagabine,"NO-329|tiagabine|TGB|NO-328|Tiagabine, (S)-isomer|Tiagabine hydrochloride|(R)-(4,4-bis(3-Methyl-2-thienyl)-3-butenyl)-3-piperidinecarboxylic acid, Hydrochloride|Gabitril|NO 328|Tiagabine|N-(4,4-di(3-Methylthien-2-yl)but-3-enyl)nipecotic acid|NO 329|Tiagabine Hydrochloride"
NEW07408,CHEBI,selective gamma-aminobutyric acid gaba reuptake inhibitor,selective gamma-aminobutyric acid GABA reuptake inhibitor
NEW07409,CHEMICAL,open-label tiagabine,open-label tiagabine
http://purl.obolibrary.org/obo/CHEBI_85384,CHEBI,gaba reuptake inhibitor,dopamine-norepinephrine reuptake inhibitor|GABA re-uptake inhibitor|gamma-aminobutyric acid reuptake inhibitor|GABA re-uptake inhibitors|selective GABA reuptake inhibitor|serotonin 5-HT reuptake inhibitor|serotonin re-uptake inhibitors|dopamine reuptake inhibitor|presynaptic GABA reuptake inhibitor|GABA reuptake inhibitors|serotonin-norepinephrine-dopamine reuptake inhibitor|selective serotonin reuptake inhibitors Administration-indicated|gamma-aminobutyric acid reuptake inhibitors|Serotonin Selective Reuptake Inhibitors|selective serotonin 5-HT reuptake inhibitors|serotonin re-uptake inhibitor|dopamine/norepinephrine reuptake inhibitor|gamma-aminobutyric acid re-uptake inhibitors|gamma-aminobutyric acid re-uptake inhibitor
http://purl.obolibrary.org/obo/DOID_9362,DISEASE,status asthmaticus,Severe asthma attack|nonconvulsive status epilepticus|Asthma with status asthmaticus|NCSE
NEW07410,DISEASE,generalize onset seizure,generalized onset seizures
NEW07411,CHEBI,novel gaba reuptake inhibitor antiepileptic drug,novel GABA reuptake inhibitor antiepileptic drug
http://purl.obolibrary.org/obo/CHEBI_131800,CHEMICAL,(r)-skf 38393,"(1R)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol|D2-agonist quinpirole|R-(+)-SKF-38393|(R)-SKF-38393|(1R)-2,3,4,5-tetrahydro-1-phenyl-1H-3-benzazepine-7,8-diol"
NEW07412,DISEASE,impaired retention,impaired retention
C441128,CHEMICAL,"3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate [Supplementary Concept]",trodusquemine|Cholestanes|Spermine/analogs  and  derivatives
NEW07413,CHEMICAL,vdm-11,VDM-11
http://purl.obolibrary.org/obo/CHEBI_188730,CHEMICAL,ifetroban,"co-infusion|3-[2-[[(1S,2R,3S,4R)-3-[4-(pentylcarbamoyl)-1,3-oxazol-2-yl]-7-oxabicyclo[2.2.1]heptan-2-yl]methyl]phenyl]propanoic acid"
NEW07414,CHEMICAL,carbachol-evoked ipsc,carbachol-evoked IPSCs
C062018,CHEMICAL,HU 211 [Supplementary Concept],HU-210|HU210|Dronabinol/analogs  and  derivatives
C067515,CHEMICAL,eicosapentaenoic omega 3-epoxygenase [Supplementary Concept],Cytochrome P-450 Enzyme System|ω3
NEW07415,CHEBI,cb1 receptor antagonist sr,CB1 receptor antagonist SR
NEW07416,CHEBI,psychostimulant drug amphetamine,psychostimulant drug amphetamine
NEW07417,DISEASE,attention-deficit/hyperactivity Disorder,Attention-Deficit/Hyperactivity Disorder
NEW07418,CHEBI,cb1 receptor antagonist radiotracer,CB1 receptor antagonist radiotracer
NEW07419,DISEASE,trauma history,trauma histories
NEW07420,CHEMICAL,cortisol level,Cortisol levels
NEW07421,DISEASE,trauma-exposed control,trauma-exposed controls|TC|total cholesterol
NEW07422,DISEASE,ptsd group relative,PTSD groups relative
NEW07423,CHEMICAL,area vta dopamine neuron,area VTA dopamine neurons
NEW07424,MENTAL_HEALTH,dependent long-term depression,dependent long-term depression
NEW07425,DISEASE,cognitive deficit,cognitive deficit
NEW07426,CHEBI,cb1 receptor neutral antagonist,CB1 receptor neutral antagonist
NEW07427,DISEASE,novel object-recognition memory deficit,novel object-recognition memory deficit
D065146,CHEBI,Zeaxanthins,"zeaxanthin|Zeaxanthin|Beta Carotene 3,3' Diol|3R,3'R Zeaxanthin|Beta-Carotene-3,3'-Diol|3R,3'R-Zeaxanthin|macular xanthophylls"
D013311,CHEMICAL,Streptozocin,|Streptozotocin|Zanosar|Streptozotocine|streptozocin|2-Deoxy-2-((methylnitrosoamino)carbonyl)amino-D-glucose|streptozotocin
C116653,CHEMICAL,"HGRG-14 protein, human [Supplementary Concept]",Phosphoproteins|Carrier Proteins|high glucose
NEW07428,NUTRITION,long-term zeaxanthin treatment,long-term zeaxanthin treatment
NEW07429,MENTAL_HEALTH,diabetes-associated anxiety,diabetes-associated anxiety
NEW07430,CHEBI,zeaxanthin equivalent,Zeaxanthin equivalents
NEW07431,CHEMICAL,isocitric acid level,isocitric acid levels
NEW07432,MENTAL_HEALTH,multivariate logistic regression,multivariate logistic regression
C034219,CHEMICAL,isocitric acid [Supplementary Concept],Isocitrates|isocitric acid|isocitrate
NEW07433,DISEASE,mitochondrial dysfunction hypothesis,mitochondrial dysfunction hypothesis
C010661,CHEMICAL,surfagon [Supplementary Concept],Gonadotropin-Releasing Hormone/analogs  and  derivatives|surfagon
NEW07434,CHEBI,gonadotropin-releasing hormone agonist treatment,gonadotropin-releasing hormone agonist treatment
NEW07435,CHEMICAL,progesterone treatment,progesterone treatments
NEW07436,CHEBI,hormone transition,hormone transition
NEW07437,DISEASE,severe depressive episode,severe depressive episodes
NEW07438,CHEBI,estrogen signaling,estrogen signaling
NEW07439,NUTRITION,sex steroid hormone fluctuation,sex steroid hormone fluctuations
NEW07440,CHEMICAL,gnrha model work,GnRHa model work
NEW07441,NUTRITION,sex steroid hormone milieu,sex steroid hormone milieu
NEW07442,CHEBI,abolish luteinizing hormone,abolishing luteinizing hormone
NEW07443,CHEMICAL,potent gonadotropin-lowering gonadotropin-releasing hormone agonist,potent gonadotropin-lowering gonadotropin-releasing hormone agonist
NEW07444,MENTAL_HEALTH,depression score,depression scores
NEW07445,DISEASE,cold- pain,cold- pain
NEW07446,DISEASE,depressed group,depressed group
NEW07447,DISEASE,organophosphate-induced delay neuropathy,Organophosphate-induced delayed neuropathy
NEW07448,CHEMICAL,op compound capable,OP compounds capable
D002122,CHEMICAL,Calcium Chloride,"|Calcium Chloride Dihydrate|calcium chloride|Calcium Chloride, Anhydrous"
NEW07449,DISEASE,cardiac inflammation,Cardiac inflammation
D000080044,CHEMICAL,Ado-Trastuzumab Emtansine,huN901DM1|Trastuzumab-DM1 Conjugate|Trastuzumab-DM1|huN901-DM1|trastuzumab|Trastuzumab Emtansine|Trastuzumab DM1 Conjugate|Kadcyla|Trastuzumab DM1|huN901 DM1|Ado Trastuzumab Emtansine
NEW07450,CHEMICAL,to trastuzumab,herceptin|to trastuzumab
NEW07451,CHEMICAL,c56bl/6n mouse,C56BL/6N mice
http://purl.obolibrary.org/obo/CHEBI_134834,CHEMICAL,pivagabine,pivagabin|tonerg|dl-3-n-butylphthalide|electroconvulsion|3-hydropxypyridine emoxipine
NEW07452,DISEASE,lumbal disc hen,lumbal disc hen
C009820,CHEMICAL,6-methyl-2-ethyl-3-hydroxypyridine [Supplementary Concept],Picolines|emoxipine
http://purl.obolibrary.org/obo/SYMP_0000006,DISEASE,backache,back pain|dorsalgia
C549374,CHEMICAL,Reamberin [Supplementary Concept],reamberin|Meglumine/analogs  and  derivatives|Succinates
D059226,DISEASE,Nociceptive Pain,"Tissue Pain|nociceptive pain|Nociceptive Pains|Somatic Pains|Pain, Tissue|Pain, Somatic|Pains, Somatic|Pain, Nociceptive|Tissue Pains|Somatic Pain|Pains, Tissue|Pains, Nociceptive"
NEW07453,DISEASE,pathic pain,pathic pain
C070020,CHEMICAL,emoxypine succinate [Supplementary Concept],Picolines|Mexidol|mexidol
NEW07454,CHEMICAL,most pron antidepressant effect,most pron antidepressant effect
NEW07455,NUTRITION,tryptophan breakdown,tryptophan breakdown
NEW07456,MENTAL_HEALTH,certain human disorder,certain human disorders
D005909,DISEASE,Glioblastoma,"Giant Cell Glioblastoma|Astrocytoma, Grade IV|Grade IV Astrocytoma|Grade IV Astrocytomas|Glioblastoma Multiforme|Glioblastomas, Giant Cell|Glioblastoma, Giant Cell|Glioblastomas|Astrocytomas, Grade IV|glioblastoma|glioblastomas|Giant Cell Glioblastomas"
http://purl.obolibrary.org/obo/CHEBI_90199,CHEMICAL,c-met tyrosine kinase inhibitor,"c-Met inhibitors|c-Met inhibitor|EGFR tyrosine kinase inhibitors|MET inhibitors|MET inhibitor|MET proto-oncogene, receptor tyrosine kinase inhibitor|MET proto-oncogene, receptor tyrosine kinase inhibitors|c-Met tyrosine kinase inhibitors"
NEW07457,DISEASE,notable toxicity,notable toxicity
D003542,CHEMICAL,Cystathionine gamma-Lyase,"gamma Cystathionase|Cystathionase|gamma-Lyase, Cystathionine|Desulfhydrase, Cystine|Deaminase, Homoserine|Cystine Desulfhydrase|gamma-Cystathionase|Homoserine Dehydratase|cystathionine γ-lyase|Cysteine Desulfhydrase|Cystathionine gamma Lyase|Dehydratase, Homoserine|Homoserine Deaminase|Desulfohydrolase, Cystine|cystathionine|Cystathionine|Desulfhydrase, Cysteine|Cystine Desulfohydrolase|CGL"
C418782,CHEMICAL,alpha-ketobutyrate oxidase [Supplementary Concept],Ketone Oxidoreductases|α-ketobutyrate
D058466,CHEMICAL,Cysteine Loop Ligand-Gated Ion Channel Receptors,"Cysteine Loop Ligand Gated Ion Channel Receptors|Cys-Loop Receptor|Receptors, Cys-Loop|Receptor Superfamily, Cys-Loop|Cysteine Loop Ligand-Gated Ion Channel Receptor|Cysteine Loop Ligand Gated Ion Channel Receptor|cysteine|Cys Loop Receptor Superfamily|Superfamily, Cys-Loop Receptor|Receptor, Cys-Loop|Cys Loop Receptors|Cys-Loop Receptors|Cys Loop Receptor|Cys-Loop Receptor Superfamily"
NEW07458,DISEASE,acute tubular necrosis,acute tubular necrosis
NEW07459,DISEASE,mild central nervous stimulant,mild central nervous stimulant
NEW07460,CHEMICAL,over-the-counter supplement,Over-the-counter supplements
NEW07461,CHEBI,prescription drug mixture,prescription drug mixtures
NEW07462,CHEMICAL,fatal caffeine overdose,Fatal caffeine overdoses
NEW07463,CHEMICAL,mg/l caffeine,mg/L caffeine
NEW07464,CHEMICAL,uranium toxicity threshold,uranium toxicity threshold
C061510,DISEASE,"alpha-amylase inhibitor, Phaseolus vulgaris [Supplementary Concept]",Plant Lectins|P. vulgaris
D013542,DISEASE,Sweat,Sweats|sweats
NEW07465,CHEMICAL,intake ≥0.25 kg,intake ≥0.25 kg
D005955,CHEMICAL,Glucosephosphate Dehydrogenase Deficiency,"Glucose 6 Phosphate Dehydrogenase Deficiency|Glucose-6-phosphate dehydrogenase deficiency|Deficiencies, Glucose-6-Phosphate Dehydrogenase|Deficiency, GPD|GPD Deficiency|G6PD Deficiency|Deficiency of Glucose-6-Phosphate Dehydrogenase|Hemolytic Anemia Due to G6PD Deficiency|Deficiency, G6PD|Deficiency, Glucose-6-Phosphate Dehydrogenase|Deficiencies, G6PD|G6PD Deficiencies|Glucosephosphate Dehydrogenase Deficiencies|Dehydrogenase Deficiencies, Glucosephosphate|Deficiencies, GPD|Deficiency, Glucosephosphate Dehydrogenase|Dehydrogenase Deficiencies, Glucose-6-Phosphate|Dehydrogenase Deficiency, Glucose-6-Phosphate|Dehydrogenase Deficiency, Glucosephosphate|GPD Deficiencies|Glucose-6-Phosphate Dehydrogenase Deficiency|Deficiencies, Glucosephosphate Dehydrogenase|Deficiency of Glucose 6 Phosphate Dehydrogenase|Glucose-6-Phosphate Dehydrogenase Deficiencies"
NEW07466,DISEASE,acute hemolysis,acute hemolysis
NEW07467,CHEBI,oxidative drug,oxidative drug
D031307,CHEMICAL,Vicia faba,"Horsebeans|Faba Bean|Horsebean|Bean, Horse|Bean, Fava|Fava Bean|Beans, Fava|Faba Beans|Horse Bean|fabas, Vicia|Fava Beans|Beans, Faba|Bean, Faba|fava beans|Beans, Horse|Horse Beans|Vicia fabas"
NEW07468,CHEMICAL,food iodization program,food iodization programs
NEW07469,DISEASE,id disorder,ID disorders
C000588741,CHEMICAL,saroglitazar [Supplementary Concept],Pyrroles|Phenylpropionates|Saroglitazar
NEW07470,DISEASE,diabetic dyslipidemia,diabetic dyslipidemia
NEW07471,CHEBI,approve pparα/γ dual agonist,approved PPARα/γ dual agonist
C493232,CHEMICAL,"Slc6a4 protein, rat [Supplementary Concept]",serotonin reuptake transporter|Serotonin Plasma Membrane Transport Proteins
NEW07472,DISEASE,male pattern hair loss,male pattern hair loss
NEW07473,DISEASE,female pattern hair loss,female pattern hair loss
NEW07474,CHEBI,rise serum prostate-specific antigen psa level,rising serum prostate-specific antigen PSA level
NEW07475,CHEBI,nonsteroidal antiandrogen,nonsteroidal antiandrogen
NEW07476,CHEBI,androgen suppression therapy,androgen suppression therapy
NEW07477,CHEMICAL,bicalutamide mg,Bicalutamide mg
http://purl.obolibrary.org/obo/DOID_12698,DISEASE,gynecomastia,gynaecomastia
NEW07478,CHEBI,antiandrogen monotherapy,antiandrogen monotherapy
NEW07479,CHEMICAL,bicalutamide monotherapy,Bicalutamide monotherapy
http://purl.obolibrary.org/obo/DOID_10283,DISEASE,prostate cancer,"NGP - new growth of prostate|tumor of the prostate|prostate neoplasm|malignant tumor of the prostate|advanced prostate cancer|prostatic cancer|hereditary prostate cancer|metastatic prostate cancer|prostatic neoplasm|prostate cancer, familial"
NEW07480,DISEASE,ovarian follicular atresia,Ovarian follicular atresia
NEW07481,CHEMICAL,high serum estradiol concentration,higher serum estradiol concentrations
NEW07482,DISEASE,breast development,breast development
NEW07483,CHEMICAL,suppress testosterone,suppressed testosterone
NEW07484,CHEMICAL,adt treatment,ADT treatment
NEW07485,DISEASE,neurocognitive dysfunction,neurocognitive dysfunction
NEW07486,DISEASE,induce toxicity,induced toxicity
NEW07487,CHEMICAL,sb exposure,SB exposure
D020265,DISEASE,"Lead Poisoning, Nervous System, Adult","Lead-Induced Polyneuropathies|Lead Polyneuropathy|Saturnism, Adult Neurologic|Neurologic Saturnism, Adult|Neurotoxicity Syndrome, Lead, Adult|Nervous System Poisoning, Lead, Adult|Nervous System Toxicity, Lead, Adult|Polyneuropathy, Lead|nervous system toxicity|Lead Induced Polyneuropathy|Lead Poisoning, Neurologic, Adult|Polyneuropathies, Lead-Induced|Polyneuropathy, Lead Induced|Poisoning, Lead, Nervous System, Adult|Polyneuropathy, Lead-Induced|lead|Lead Induced Nervous System Diseases, Adult|Adult Neurologic Saturnism|Lead-Induced Polyneuropathy|Plumbism, Neurologic, Adult|Poisoning, Lead, Neurologic, Adult|Pb|Nervous System Diseases, Lead Induced, Adult"
NEW07488,MENTAL_HEALTH,sulfite-induced anxiety,sulfite-induced anxiety
NEW07489,CHEMICAL,sulfite consumption,sulfite consumption
D050902,CHEMICAL,Sulfite Dehydrogenase,"sulphite|sulfite|Sulphite Dehydrogenase|Dehydrogenase, Sulfite|Dehydrogenase, Sulphite|Sulphite Cytochrome C Reductase|Sulfite Cytochrome C Reductase"
NEW07490,DISEASE,stimulant-induced hypertensive reaction,stimulant-induced hypertensive reactions
http://purl.obolibrary.org/obo/CHEBI_8188,CHEMICAL,physovenine,µM galanthamine|Physovenine
NEW07491,CHEMICAL,endogenous ach,endogenous Ach
C046131,CHEMICAL,"auxin receptor, plant [Supplementary Concept]","Plant Proteins|Receptors, Cell Surface|auxin|IAA"
NEW07492,DISEASE,4d toxicity,4D toxicity
C058254,CHEMICAL,sibutramine [Supplementary Concept],sibutramine|Sibutramine|Cyclobutanes
D010645,CHEMICAL,Phentermine,"|AdipexP|Duromine|Adipex P|Hydrochloride, Phentermine|Adipex-P|Phentermine Hydrochloride|Ionamine|phentermine"
NEW07493,CHEMICAL,depression-inducing effect,depression-inducing effect
NEW07494,DISEASE,obesity trial,obesity trials
NEW07495,CHEBI,partial 5ht agonist meta-chlorophenylpiperazine,partial 5HT agonist meta-chlorophenylpiperazine
NEW07496,DISEASE,trait hostility,trait hostility
NEW07497,CHEMICAL,partial 5ht agonist meta-chlorophenylpiperazine,partial 5HT agonist meta-chlorophenylpiperazine|MCPP
NEW07498,CHEBI,novel serotonin agonist,novel serotonin agonists
C105050,CHEMICAL,tegaserod [Supplementary Concept],tegaserod|Indoles
NEW07499,DISEASE,constipated ibs patient,constipated IBS patients
D004157,CHEMICAL,Diphenoxylate,"Diphenoxylate Hydrochloride|Diphenoxylate Monohydrochloride|Monohydrochloride, Diphenoxylate|diphenoxylate|Hydrochloride, Diphenoxylate"
NEW07500,DISEASE,diarrhea-predominant ibs,diarrhea-predominant IBS
NEW07501,DISEASE,negative symptom,negative symptoms
D012559,DISEASE,Schizophrenia,"|Schizophrenias|schizophrenic disorders|Disorder, Schizophrenic|Schizophrenic Disorders|Disorders, Schizophrenic|schizophrenic|Schizophrenic Disorder|Dementia Praecox"
NEW07502,CHEMICAL,antipsychotic/ssri combination,antipsychotic/SSRI combination
C022197,CHEMICAL,N-acetyl-5-hydroxytryptophyl-5-hydroxytryptophanamide [Supplementary Concept],(-)5HTP|5-Hydroxytryptophan/analogs  and  derivatives
NEW07503,CHEMICAL,non-competitive n-methyl-d-aspartate nmda antagonist dizocilpine,non-competitive N-methyl-D-aspartate NMDA antagonist dizocilpine
NEW07504,CHEMICAL,5ht precursor,5HT precursor
NEW07505,DISEASE,head shake,head shakes
NEW07506,CHEBI,non-competitive antagonist,non-competitive antagonists
NEW07507,CHEBI,competitive antagonist expression,competitive antagonists expression
NEW07508,CHEMICAL,glutamate deficiency,glutamate deficiency
NEW07509,CHEMICAL,pindolol group,pindolol group
C400939,CHEMICAL,methylone [Supplementary Concept],Methamphetamine/analogs  and  derivatives|methylone
NEW07510,CHEBI,mixed indirect dopamine-serotonin agonist,mixed indirect dopamine-serotonin agonists
NEW07511,CHEMICAL,"3,4-metyhlenedioxymethamphetamine","3,4-metyhlenedioxymethamphetamine"
NEW07512,CHEBI,psychedelic serotonin agonist,psychedelic serotonin agonists
NEW07513,CHEMICAL,different antidepressant,Different antidepressants
NEW07514,DISEASE,pain modulator,pain modulators
NEW07515,DISEASE,aforementioned esophageal disorder,aforementioned esophageal disorders
NEW07516,DISEASE,esophageal disorder,esophageal disorders
NEW07517,CHEBI,visceral analgesic effect,visceral analgesic effect
D004087,CHEMICAL,Dihydroergotamine,"Clavigrenin|DHE45|Von Ct, Ergotam|Dihydergot|Erganton|Tamik|Dihydroergotamine Mesylate|Agit|Dihydroergotamin AL|D Tamin Retard L.U.T.|D-Tamin Retard L.U.T.|DHE-45|DHE-Ratiopharm|DHE Ratiopharm|Dihydroergotamine-Sandoz|Mesylate, Dihydroergotamine|Orstanorm|Ergomimet|Ergotam Von Ct|Migranal|Verladyn|Methanesulfonate, Dihydroergotamine|Dihydroergotamine Methanesulfonate|Ergont|DHE Puren|Dihydroergotamine Sandoz|DHE-Puren|DET MS|D.H.E. 45|DHE 45|Dihytamin|Seglor|Ikaran|Dihydroergotamine|Angionorm"
http://purl.obolibrary.org/obo/CHEBI_4821,CHEMICAL,ergocristine,"ergots|5'alpha-benzyl-12'-hydroxy-3',6',18-trioxo-2'-(propan-2-yl)ergotaman|ergocrystine|Ergocristine|ergocristine"
NEW07518,DISEASE,convulsive ergotism,convulsive ergotism
NEW07519,CHEMICAL,benzodiazepine receptor sensitivity,benzodiazepine receptor sensitivity
NEW07520,DISEASE,prescribe psychiatric treatment,prescribed psychiatric treatments
NEW07521,DISEASE,postinfectious olfactory dysfunction,Postinfectious olfactory dysfunction
NEW07522,DISEASE,olfactory dysfunction,olfactory dysfunction
NEW07523,CHEMICAL,postinfectious olfactory dysfunction,Postinfectious olfactory dysfunction|PIOD
NEW07524,CHEMICAL,neurokinin nk1 receptor,Neurokinin NK1 receptors
C408447,CHEMICAL,"neurokinin A (4-10), Trp(7)-beta-Ala(8)- [Supplementary Concept]",Neurokinin A/analogs  and  derivatives|Peptide Fragments|NKA
http://purl.obolibrary.org/obo/CHEBI_80311,CHEMICAL,neurokinin a,Substance K|neurokinins A|Neuromedin L
NEW07525,DISEASE,fundamental psychiatric research,fundamental psychiatric research
D000077608,CHEMICAL,Aprepitant,"MK-0869|Emend|(1-(3,5-bis(Trifluoromethyl)phenyl)ethoxy)-3-(fluoro)phenyl-4-(3-oxo-1,2,4-triazol-5-yl)methylmorpholine|MK 0517|L-754,030|(2R)-(1R)-3,5-bis(Trifluoromethylphenyl)ethoxy)-(3S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazole)methyl-morpholine|MK0517|MK 869|MK-0517|L 754,030|MK0869|MK869|L-754030|MK 0869|MK-869|L754030|L 754030|L754,030"
NEW07526,CHEBI,oral vitamin k antagonist,Oral vitamin K antagonists
NEW07527,DISEASE,thromboembolic disease,thromboembolic disease
NEW07528,DISEASE,ttr measurement,TTR measurement
NEW07529,CHEMICAL,warfarin exposure,warfarin exposure
NEW07530,CHEMICAL,non-vitamin k antagonist oral anticoagulation agent,non-vitamin K antagonist oral anticoagulation agents
D065427,CHEMICAL,Factor Xa Inhibitors,"Direct-Acting Oral Anticoagulants|Direct-Acting Oral Anticoagulant|OAC|Oral Anticoagulants, Direct-Acting|Anticoagulants, Direct-Acting Oral|Anticoagulant, Direct-Acting Oral|Inhibitor, Factor Xa|Direct Factor Xa Inhibitors|oral anticoagulants|Factor Xa Inhibitor|Xa Inhibitor, Factor|Oral Anticoagulant, Direct-Acting|Direct Factor Xa Inhibitor|Direct Acting Oral Anticoagulant|Direct Acting Oral Anticoagulants"
http://purl.obolibrary.org/obo/SYMP_0000226,DISEASE,atrial fibrillation,auricular fibrillation|non-valvular atrial fibrillation|AF|a-fib
NEW07531,DISEASE,thrombo-embolic prophylaxis,thrombo-embolic prophylaxis
NEW07532,CHEMICAL,oral anticoagulation agent,NOAC|oral anticoagulation agents
http://purl.obolibrary.org/obo/CHEBI_55347,CHEBI,vitamin k antagonist,to vitamin K antagonists|VKA|vitamin K antagonist|vitamin K antagonists
NEW07533,CHEBI,multiple drug interaction,multiple drug interactions
NEW07534,DISEASE,bleed risk,bleeding risk
D014859,CHEMICAL,Warfarin,"|Apo-Warfarin|Tedicumar|Aldocumar|warfarin|Warfarin Sodium|Coumadin|Gen-Warfarin|Warfarin Potassium|4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one|Potassium, Warfarin|Marevan|Sodium, Warfarin|Warfant|Warfarin|Coumadine"
D014813,CHEBI,Vitamin K Deficiency,"Deficiencies, Vitamin K|Deficiency, Vitamin K|Vitamin K deficiency|Vitamin K Deficiencies"
D020299,DISEASE,"Intracranial Hemorrhage, Hypertensive","Hemorrhages, Hypertensive Intracranial|Hypertensive Cerebral Hemorrhages|Intracranial Hypertensive Hemorrhage|Cerebral Hemorrhage, Hypertensive|Hemorrhage, Hypertensive Intracranial|Hypertensive Cerebral Hemorrhage|Hypertensive Intracranial Hemorrhage|Intracerebral Hemorrhage, Hypertensive|Cerebral Hypertensive Hemorrhages|Cerebral Hemorrhages, Hypertensive|Hemorrhage, Cerebral Hypertensive|Intracranial Hypertensive Hemorrhages|Hypertensive Intracerebral Hemorrhages|Hypertensive Hemorrhage, Intracranial|Hemorrhages, Intracranial Hypertensive|Hypertensive Hemorrhages, Cerebral|Hypertensive Intracerebral Hemorrhage|Hypertensive Hemorrhage, Cerebral|Hemorrhage, Intracranial Hypertensive|Hemorrhages, Hypertensive Intracerebral|intracranial hemorrhage|Hemorrhage, Hypertensive Cerebral|Hypertensive Intracranial Hemorrhages|Hemorrhage, Hypertensive Intracerebral|Intracranial Hemorrhages, Hypertensive|Hemorrhages, Hypertensive Cerebral|Intracerebral Hemorrhages, Hypertensive|Cerebral Hypertensive Hemorrhage|Hypertensive Hemorrhages, Intracranial|Hemorrhages, Cerebral Hypertensive"
NEW07535,DISEASE,systemic embolism,systemic embolism
NEW07536,DISEASE,high thromboembolic risk factor,high thromboembolic risk factor
NEW07537,DISEASE,intestinal tract,intestinal tract
NEW07538,CHEMICAL,ammonium glycyrrhizate,Ammonium Glycyrrhizate
D000472,DISEASE,"Alkalosis, Respiratory","Respiratory Alkalosis|Alkaloses, Respiratory|alkalosis|Respiratory Alkaloses"
NEW07539,CHEMICAL,potassium excretion,potassium excretion
NEW07540,CHEMICAL,renin-angiotensis-aldosterone system,renin-angiotensis-aldosterone system
NEW07541,CHEMICAL,sodium retention,sodium retention
http://purl.obolibrary.org/obo/SYMP_0000403,DISEASE,weight gain,body weight gain
NEW07542,DISEASE,muscular paralysis,muscular paralysis
NEW07543,DISEASE,little short-term toxicity,Little short-term toxicity
D064753,CHEMICAL,Ammonium Hydroxide,"ammonium|Hydroxide, Ammonium"
D003009,CHEMICAL,Clorazepate Dipotassium,Chlorazepate|dipotassium|4306-CB|Clorazepic Acid|Clorazepate|Dipotassium Chlorazepate|Clorazepate Monopotassium|Tranxilium|Tranxene
C104670,CHEMICAL,disodium cocoamphodipropionate [Supplementary Concept],disodium salts|beta-Alanine/analogs  and  derivatives|Propionates
D006034,CHEMICAL,Glycyrrhetinic Acid,"Glycyrrhetinic Acid|Acid, Rhetinic|Enoxolone|Rhetinic Acid|Acid, Glycyrrhetic|Glycyram|Uralenic Acid|Acid, Uralenic|Po 12|12, Po|Glycyrrhetic Acid|Jintan|Glyciram|Acid, Glycyrrhetinic|Arthrodont"
NEW07544,DISEASE,phototoxic agent,phototoxic agents
NEW07545,CHEMICAL,Dipotassium glycyrrhizate,Dipotassium Glycyrrhizate
D018674,CHEBI,Adrenergic Antagonists,"Adrenergic-Blocking Agents|Adrenergic Receptor Blockaders|adrenergic receptor antagonists|Anti Adrenergics|Adrenergic Blockers|adrenergic antagonists|Agents, Adrenolytic|Blockers, Adrenergic|Adrenolytics|Adrenolytic Drugs|Adrenergic Antagonist|Receptor Antagonists, Adrenergic|Receptor Blockaders, Adrenergic|Agents, Adrenergic-Blocking|Blocker, Adrenergic|adrenergic blockers|Blockaders, Adrenergic|Adrenergic Blocker|Antagonist, Adrenergic|Antiadrenergic Agents|Adrenolytic Agents|Antiadrenergics|Antagonists, Adrenergic|Adrenergic Receptor Antagonists|Adrenergic Blocking Agents|Anti-Adrenergics|Adrenergic Blockaders|Drugs, Adrenolytic|Antagonists, Adrenergic Receptor|Agents, Antiadrenergic|Blockaders, Adrenergic Receptor"
NEW07546,CHEBI,serotoninergic-dopaminergic antagonist,serotoninergic-dopaminergic antagonist
NEW07547,DISEASE,similar cognitive impairment,Similar cognitive impairments
NEW07548,CHEBI,dopaminergic antagonist drug,dopaminergic antagonist drugs
NEW07549,CHEBI,dopaminergic antagonist antipsychotic,dopaminergic antagonist antipsychotics
NEW07550,CHEMICAL,domperidone treatment,Domperidone treatment
NEW07551,DISEASE,lps-induced tumor necrosis factor,LPS-induced tumor necrosis factor
NEW07552,DISEASE,inflammation subsequent inflammatory injury,inflammation subsequent inflammatory injury
NEW07553,MENTAL_HEALTH,severe mood disorder,severe mood disorder
NEW07554,CHEBI,abnormal endocrine,abnormal endocrine
NEW07555,MENTAL_HEALTH,endogenomorphic depression,endogenomorphic depression
NEW07556,DISEASE,obesity resistance,obesity resistance
NEW07557,CHEMICAL,culture hydrocortisone,cultures hydrocortisone
http://purl.org/sig/ont/fma/fma70549,CHEMICAL,epithelial cell of choroid plexus,CPEC|choroid plexus epithelial cells
NEW07558,DISEASE,folliculotropic lymphoma,Folliculotropic lymphoma
http://purl.obolibrary.org/obo/DOID_8691,CHEMICAL,mycosis fungoides,mycosis fungoides lymphoma|Mycosis fungoides|fungoid mycosis
D057112,DISEASE,Corneal Perforation,"Corneal Perforations|Perforations, Corneal|corneal perforation|Perforation, Corneal"
D020909,CHEMICAL,Acarbose,Glucobay|Bay g 5421|Prandase|Glucor|acarbose|Precose|Glumida
http://purl.obolibrary.org/obo/DOID_9351,DISEASE,diabetes mellitus,overt diabetes mellitus
http://purl.obolibrary.org/obo/DOID_784,DISEASE,chronic kidney disease,CRF|chronic renal failure syndrome|chronic kidney failure|chronic renal disease|renal failure - chronic|CKD|chronic liver diseases
NEW07559,CHEMICAL,acarbose treatment due,acarbose treatment due
D001219,CHEMICAL,Aspartate Aminotransferases,"Glutamic-Oxaloacetic Transaminase, Serum|Transaminase, Glutamic-Oxaloacetic|aspartate aminotransferases|Serum Glutamic-Oxaloacetic Transaminase|L-Aspartate-2-Oxoglutarate Aminotransferase|Serum Glutamic Oxaloacetic Transaminase|Apoaminotransferase, Aspartate|Glutamic Oxaloacetic Transaminase|Transaminase, Serum Glutamic-Oxaloacetic|Aspartate Transaminase|Transaminase, Glutamate-Aspartate|Glutamate-Aspartate Transaminase|Aminotransferase, Aspartate|Aminotransferases, Aspartate|Glutamate Aspartate Transaminase|Aspartate Aminotransferase|SGOT|L Aspartate 2 Oxoglutarate Aminotransferase|Glutamic-Oxaloacetic Transaminase|Aminotransferase, L-Aspartate-2-Oxoglutarate|Transaminase, Aspartate|Aspartate Apoaminotransferase"
NEW07560,CHEMICAL,serum sex-hormone-binding globulin ceruloplasmin concentration,Serum sex-hormone-binding globulin ceruloplasmin concentrations
NEW07561,CHEMICAL,serum shbg concentration,serum SHBG concentrations
NEW07562,CHEBI,multiple antibiotic,multiple antibiotics
D017714,DISEASE,Community-Acquired Infections,"Community Acquired Infection|Acquired Infections, Community|Infection, Community-Acquired|Infections, Community Acquired|Infection, Community Acquired|Infections, Community-Acquired|Community-Acquired Infection|community-acquired|Acquired Infection, Community|community-acquired infection|Community Acquired Infections"
http://purl.obolibrary.org/obo/IDO:0000630,DISEASE,hospital-acquired infection,hospital-acquired infection
NEW07563,CHEMICAL,chlorisondamine pretreatment,chlorisondamine pretreatment
NEW07564,DISEASE,acute pain model,acute pain models
NEW07565,CHEBI,nicotinic partial agonist,nicotinic partial agonists
NEW07566,DISEASE,chronic pain disorder,chronic pain disorders
NEW07567,DISEASE,rodent tonic pain model,rodent tonic pain model
NEW07568,MENTAL_HEALTH,schizophrenia self-administer nicotine,schizophrenia self-administer nicotine
NEW07569,DISEASE,synergistic hypolocomotion,synergistic hypolocomotion
NEW07570,CHEBI,nicotine nicotinic agonist,nicotine nicotinic agonists
NEW07571,CHEBI,effective nachr agonist,effective nAChR agonists
NEW07572,CHEMICAL,neuronal nicotinic acetylcholine receptor nnr system,neuronal nicotinic acetylcholine receptor NNR system
NEW07573,CHEMICAL,α7 receptor,α7 receptors
NEW07574,DISEASE,cognitive dysfunction relevant,cognitive dysfunction relevant
NEW07575,CHEBI,drug development target,drug development target
NEW07576,CHEBI,recreational drug abuse,recreational drug abuse
NEW07577,DISEASE,early endothelial dysfunction,early endothelial dysfunction
NEW07578,DISEASE,early endothelial damage,early endothelial damage
NEW07579,CHEMICAL,chronic cannabis use,chronic cannabis use
NEW07580,DISEASE,motor complete SCI,motor complete SCI
NEW07581,CHEMICAL,BMI     ±,BMI    ±
NEW07582,CHEMICAL,index bmi     ±,index BMI    ±
NEW07583,CHEMICAL,loi c4-t11,LOI C4-T11
NEW07584,CHEMICAL,va patient,VA patients
NEW07585,MENTAL_HEALTH,depression characteristic,Depression characteristics
NEW07586,DISEASE,depressed person,Depressed persons
NEW07587,CHEMICAL,low glucose level,lower glucose levels
NEW07588,CHEMICAL,high triglyceride level,higher triglyceride levels
NEW07589,CHEBI,solute carrier slc6 family member,solute carrier SLC6 family members
NEW07590,CHEBI,important drug target,important drug target
NEW07591,CHEMICAL,dm zebrafish,DM zebrafish
D019948,CHEMICAL,"Receptors, Interleukin-4","Receptor, Interleukin 4|Receptor, IL-4|Receptor, Interleukin-4|IL-4 Receptor|IL4 Receptor|IL-4 Receptors|Interleukin 4 Receptors|Interleukin-4 Receptor|IL 4 Receptor|Receptors, IL 4|Receptor, IL4|Receptors, IL-4|IL4 Receptors|Interleukin 4 Receptor|Receptors, IL4|Interleukin-4 Receptors|IL-4|IL 4 Receptors|Receptors, Interleukin 4"
NEW07592,CHEMICAL,elevated whole-body cortisol,elevated whole-body cortisol
NEW07593,NUTRITION,serum cholesterol level,serum cholesterol levels
NEW07594,CHEMICAL,abnormal sphingolipid metabolism,abnormal sphingolipid metabolism
C579867,DISEASE,3-Methylglutaconic Aciduria [Supplementary Concept],"3-methylglutaconic aciduria|Metabolism, Inborn Errors"
NEW07595,DISEASE,ketogenesis disorder,ketogenesis disorders
NEW07596,CHEMICAL,leucine oxidation,leucine oxidation
NEW07597,CHEMICAL,high-cholesterol diet,high-cholesterol diet
D005232,NUTRITION,"Fatty Acids, Volatile","Fatty Acid, Volatile|Short Chain Fatty Acid|Short-Chain Fatty Acids|Fatty Acids, Short Chain|short-chain fatty acids|short chain fatty acids|Acid, Volatile Fatty|Volatile Fatty Acid|Fatty Acids, Short-Chain|Fatty Acid, Short-Chain|SCFA|Short-Chain Fatty Acid|Acid, Short-Chain Fatty|Short-chain fatty acids|short-chain fatty acid|Volatile Fatty Acids"
NEW07598,DISEASE,cbz-induced increase,CBZ-induced increases
NEW07599,NUTRITION,baseline cholesterol,baseline cholesterol
NEW07600,CHEMICAL,cbz level,CBZ levels
NEW07601,NUTRITION,National Cholesterol Education Adult,National Cholesterol Education Adult
NEW07602,DISEASE,different psychiatric diagnosis,different psychiatric diagnoses
NEW07603,DISEASE,male non-suicidal patient,male non-suicidal patients
NEW07604,CHEMICAL,nbp treatment,NBPs treatment
C537769,DISEASE,Anophthalmos with limb anomalies [Supplementary Concept],Waardenburg Syndrome|limb anomalies
NEW07605,NUTRITION,cholesterol biosynthesis defect,cholesterol biosynthesis defect
D019082,DISEASE,Smith-Lemli-Opitz Syndrome,"Lethal Acrodysgenital Syndrome|Acrodysgenital Syndrome, Lethal|SLO Syndrome|Hyperotosis Corticalis Generalisata Familiaris|Smith-Lemli-Opitz Syndrome, Type 1|Smith Lemli Opitz syndrome, type 1|Deficiency, 7-Dehydrocholesterol Reductase|Acrodysgenital Syndromes, Lethal|RSH SLO Syndrome|Smith Lemli Opitz Syndrome|Reductase Deficiency, 7-Dehydrocholesterol|Smith-Lemli-Opitz Syndrome, Type 2|Smith-Lemli-Opitz Syndrome, Type I|Syndrome, Lethal Acrodysgenital|Rutledge Lethal Multiple Congenital Anomaly Syndrome|Reductase Deficiencies, 7-Dehydrocholesterol|Syndrome, RSH|7-Dehydrocholesterol Reductase Deficiencies|Rutledge Friedman Harrod Syndrome|Smith Lemli Opitz Syndrome, Type I|RSH-SLO Syndrome|RSH-SLO Syndromes|Syndromes, SLO|Lethal Acrodysgenital Syndromes|Polydactyly, Sex Reversal, Renal Hypoplasia, And Unilobar Lung|Syndrome, SLO|Syndromes, RSH|RSH Syndrome|RSH Syndromes|7-Dehydrocholesterol Reductase Deficiency|Smith-Lemli-Opitz syndrome|Smith Lemli Opitz Syndrome, Type 2|SLO Syndromes|Smith-Lemli-Opitz Syndrome, Type II|Smith Lemli Opitz Syndrome, Type II|Deficiencies, 7-Dehydrocholesterol Reductase"
http://purl.obolibrary.org/obo/DOID_0060764,DISEASE,autosomal recessive robinow syndrome,costovertebral segmentation defect-mesomelia syndrome|COVESDEM syndrome|RRS|autosomal recessive disorder
NEW07606,CHEMICAL,pregnanolone-neurosteroid,pregnanolone-neurosteroids
NEW07607,DISEASE,neurotrauma,neurotrauma
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Premenstrual_Dysphoric_Disorder,DISEASE,premenstrual dysphoric disorder,depression premenstrual dysphoric disorder|premenstrual dysphoric disorder effectiveness|pre-menstrual dysphoric disorder
NEW07608,CHEBI,non stimulant drug,non stimulant drug
NEW07609,DISEASE,attentional impulsivity,attentional impulsivity
D013186,CHEMICAL,Farnesyl-Diphosphate Farnesyltransferase,"Synthase, Presqualene-Diphosphate|Farnesyl Transferase, FPP-FPP|Squalene Synthase|Farnesyl Diphosphate Farnesyltransferase|Farnesyltransferase, Farnesyl-Diphosphate|Farnesyltransferase, Farnesyldiphosphate-Farnesyldiphosphate|squalene synthase|Presqualene Diphosphate Synthase|Synthetase, Squalene|FPP FPP Farnesyl Transferase|Presqualene-Diphosphate Synthase|Farnesyldiphosphate Farnesyldiphosphate Farnesyltransferase|Squalene Synthetase|Synthase, Squalene|Farnesyldiphosphate-Farnesyldiphosphate Farnesyltransferase|FPP-FPP Farnesyl Transferase|Transferase, FPP-FPP Farnesyl"
NEW07610,DISEASE,impaired dendritic development similar,impaired dendritic development similar
C075117,CHEMICAL,squalestatin 1 [Supplementary Concept],"Tricarboxylic Acids|Bridged Bicyclo Compounds, Heterocyclic|zaragozic acid"
NEW07611,DISEASE,tg hdl ratio,TG HDL ratio
NEW07612,DISEASE,psychiatric inpatient sample,psychiatric inpatient sample
NEW07613,CHEMICAL,blood glucose F=12•89,blood glucose F=12•89
NEW07614,MENTAL_HEALTH,depression scale,depression scales
NEW07615,MENTAL_HEALTH,relapse due depression,relapse due depression
C495910,CHEMICAL,ramelteon [Supplementary Concept],ramelteon|Ramelteon|Indenes
NEW07616,CHEMICAL,prenatal valproic acid,prenatal valproic acid|Pre-VPA
D000073039,CHEMICAL,Nitrosative Stress,"Nitrosative Stresses|Stress, Nitrosative|nitrosative stress|nitrite/nitrate|Stresses, Nitrosative"
NEW07617,CHEMICAL,brain calcium level,brain calcium levels
NEW07618,DISEASE,exploratory activity intestinal motility,exploratory activity intestinal motility
NEW07619,CHEMICAL,low nocturnal melatonin production,Low nocturnal melatonin production
NEW07620,DISEASE,elderly insomniac,elderly insomniacs
NEW07621,CHEBI,novel melatonergic drug,novel melatonergic drug
NEW07622,CHEMICAL,use antidepressant,used antidepressants
NEW07623,CHEMICAL,exogenous melatonin,exogenous melatonin
NEW07624,DISEASE,comorbid neurological,comorbid neurological
D010096,CHEMICAL,Oxprenolol,"Coretal|Trasicor, Slow|Koretal|Trasicor|Oxprenolol Hydrochloride|Slow Trasicor|Hydrochloride, Oxprenolol|Tevacor|oxprenolol"
D000526,CHEMICAL,Alprenolol,H-56-28|Alfeprol|Aptin|Aptin-Duriles|H5628|alprenolol|Aptin Duriles|Aptine|AptinDuriles|Aptina|H 56 28|Alprenolol Hydrochloride|1-(o-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alpheprol
NEW07625,DISEASE,airway beta2-adrenoceptor blockade,airway beta2-adrenoceptor blockade
NEW07626,CHEMICAL,endogenous catecholamine response,endogenous catecholamine responses
NEW07627,CHEBI,beta2-adrenoceptor agonist,beta2-adrenoceptor agonists
D013726,CHEMICAL,Terbutaline,|Monovent|KWD 2019|Terbutalin Stada|terbutalin von ct|Terbutalin AL|Terbutalin ratiopharm|Terbul|Brethine|Bricanyl|terbutaline|Terbuturmant|Terbutaline Sulfate|Butaliret|Taziken|Arubendol|Bricanyl SA|Terbutalin-ratiopharm|KWD-2019|Asthmoprotect|Butalitab|Tedipulmo|Terbasmin|Brethaire|Contimit|KWD2019
D000068299,CHEMICAL,Salmeterol Xinafoate,"Salmeterol|salmeterol|Xinafoate, Salmeterol|Serevent"
NEW07628,CHEMICAL,chlortalidone diuretic,chlortalidone diuretics
NEW07629,DISEASE,erectile problem,erectile problems
NEW07630,DISEASE,memory function,memory function
NEW07631,CHEBI,nonselective lipophilic beta-adrenoceptor antagonist,Nonselective lipophilic beta-adrenoceptor antagonists
NEW07632,CHEBI,hair androgen concentration,hair androgen concentrations
NEW07633,DISEASE,chronic blockade,chronic blockade
NEW07634,CHEBI,non-competitive nnr antagonist,non-competitive NNR antagonists
NEW07635,CHEBI,non-selective nnr antagonist,non-selective NNR antagonist
NEW07636,CHEMICAL,chronic fluoxetine,Chronic fluoxetine
NEW07637,CHEMICAL,impaired glutathione gsh synthesis,Impaired glutathione GSH synthesis
NEW07638,DISEASE,stress-induced anxiety/depression-like behavior,stress-induced anxiety/depression-like behaviors
NEW07639,CHEMICAL,corticosterone treatment,Corticosterone treatment
NEW07640,DISEASE,marked adrenal atrophy,marked adrenal atrophy
NEW07641,CHEMICAL,bupropion sr treatment,bupropion SR treatment
NEW07642,MENTAL_HEALTH,emergent sexual dysfunction,emergent sexual dysfunction
NEW07643,CHEMICAL,bupropion xr,bupropion XR
NEW07644,CHEMICAL,bath salt,bath salts
NEW07645,DISEASE,dopamine-induced vasoconstriction,dopamine-induced vasoconstriction|renal ischemia
NEW07646,DISEASE,volume contraction,volume contraction
NEW07647,CHEBI,direct drug effect,direct drug effects
NEW07648,DISEASE,coronary spasm,Coronary spasm
D000284,CHEBI,"Administration, Oral","oral drug|Administrations, Oral|Oral Drug Administrations|Oral Administrations|Administrations, Oral Drug|Administration, Oral Drug|Drug Administration, Oral|Oral Administration|Oral Drug Administration|Drug Administrations, Oral"
NEW07649,CHEMICAL,norepinephrine-dopamine reuptake inhibitor,norepinephrine-dopamine reuptake inhibitor
NEW07650,CHEMICAL,norepinephrine dopamine-reuptake inhibitor,norepinephrine dopamine-reuptake inhibitor
NEW07651,DISEASE,drug-induced altered mental status,drug-induced altered mental status
NEW07652,DISEASE,whose 's hand tremor,whose's hand tremors
NEW07653,CHEMICAL,bupropion use,bupropion use
NEW07654,CHEMICAL,bupropion mg,bupropion mg
NEW07655,CHEMICAL,norepinephrine-dopamine reuptake inhibitor bupropion,norepinephrine-dopamine reuptake inhibitor bupropion
NEW07656,CHEMICAL,chronic nicotine,chronic nicotine
NEW07657,DISEASE,d2r-antagonist-induced aberrant motor learning,D2R-antagonist-induced aberrant motor learning
D059290,CHEMICAL,Dopaminergic Neurons,"Dopamine Neurons|Dopaminergic Neuron|dopamine neurons|Dopamine Neuron|Neurons, Dopamine|Neuron, Dopamine|Neuron, Dopaminergic|Neurons, Dopaminergic"
NEW07658,DISEASE,d2r-mediated aberrant motor learning,D2R-mediated aberrant motor learning
NEW07659,DISEASE,chronic decrease,chronic decrease
NEW07660,DISEASE,aberrant motor learning,aberrant motor learning
NEW07661,CHEBI,d2r antagonist,D2R antagonist
NEW07662,CHEMICAL,dvl-gsk3β-β-catenin signalling,Dvl-GSK3β-β-catenin signalling
D015260,CHEMICAL,Neprilysin,"Enzyme, YGG-Forming|Endopeptidase, Neutral|Thermolysin Like Metalloendopeptidase|Antigen, CD10|Enkephalin Dipeptidyl Carboxypeptidase|Metalloendopeptidase, Thermolysin-Like|Antigens, CD10|Metallo-Endopeptidase, Membrane|Neutral Endopeptidase 24.11|Thermolysin-Like Metalloendopeptidase|Carboxypeptidase, Enkephalin Dipeptidyl|Endopeptidase-24.11|Enkephalinase|CD10 Antigens|Atriopeptidase|Membrane Metallo Endopeptidase|Antigens, Leukemia, Common Acute Lymphoblastic|CD10 Antigen|Membrane Metallo-Endopeptidase|Enkephalinase 24.11|Neutral Endopeptidase|YGG-Forming Enzyme|Common Acute Lymphoblastic Leukemia Antigens|neprilysin|Endopeptidase 24.11, Neutral|NEP|Kidney-Brush-Border Neutral Proteinase|Kidney Brush Border Neutral Proteinase|Neutral Proteinase, Kidney-Brush-Border|Dipeptidyl Carboxypeptidase, Enkephalin|YGG Forming Enzyme|Endopeptidase 24.11|CALLA Antigen|Enkephalinase-24.11"
http://purl.obolibrary.org/obo/CHEBI_81568,DISEASE,luteinizing hormone,hypothalamic luteinizing hormone releasing hormone|Interstitial cell stimulating hormone|LH|LHRH|ICSH|luteinizing hormone/follicle-stimulating hormone
NEW07663,CHEMICAL,ethanol dependence,ethanol dependence
NEW07664,CHEMICAL,ethanol liquid diet,ethanol liquid diet
NEW07665,CHEMICAL,ethanol withdrawal state,ethanol withdrawal state
NEW07666,CHEMICAL,ethanol withdrawal,ethanol withdrawal
NEW07667,CHEBI,depot gonadotrophin luteinizing releasing hormone analogue,depot gonadotrophin luteinizing releasing hormone analogue
NEW07668,CHEMICAL,triptorelin intramuscularly,triptorelin intramuscularly
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Antisocial_Behavior,DISEASE,antisocial behavior,paraphilic behavior
NEW07669,DISEASE,human SCI,human SCI
NEW07670,CHEMICAL,cortical gabab neuronal pathway,cortical GABAB neuronal pathways
NEW07671,DISEASE,reflexive behavior,reflexive behavior
NEW07672,CHEMICAL,central gamma-aminobutyric acid gaba system,central gamma-aminobutyric acid GABA system
NEW07673,DISEASE,schizophrenia-like behavioral deficit,schizophrenia-like behavioral deficits
NEW07674,DISEASE,chronic cerebral hypoperfusion model,chronic cerebral hypoperfusion model
NEW07675,CHEMICAL,2vo,2VO
NEW07676,DISEASE,two-vessel occlusion,two-vessel occlusion
D020191,DISEASE,"Myoclonic Epilepsies, Progressive","Action Myoclonus Renal Failure Syndrome|Encephalopathy, Biotin-Responsive|Atrophy, Dentatorubral-Pallidoluysian|Inclusion-Body Diseases, Atypical|Biotin Responsive Encephalopathy|Progressive Myoclonus Epilepsy|Haw River Syndromes|Dentatorubral Pallidoluysian Atrophy|Epilepsy, Progressive Myoclonic|Progressive Myoclonic Epilepsies|Epilepsy, Progressive Myoclonus|Progressive Myoclonic Epilepsy|Familial Progressive Myoclonic Epilepsy|Encephalopathies, Biotin-Responsive|Dentatorubral-Pallidoluysian Atrophies|River Syndromes, Haw|Syndromes, Myoclonus-Nephropathy|Myoclonus Nephropathy Syndrome|Myoclonus-Nephropathy Syndromes|Action Myoclonus-Renal Failure Syndrome|Inclusion-Body Disease, Atypical|Epilepsies, Progressive Myoclonic|Myoclonic Epilepsy, Progressive|Dentatorubral-Pallidoluysian Atrophy|Myoclonus Epilepsies, Progressive|Atrophies, Dentatorubral-Pallidoluysian|Ataxia, Chorea, Seizures, And Dementia|Biotin-Responsive Encephalopathy|Naito Oyanagi Disease|epilepsies|Haw River Syndrome|Atypical Inclusion-Body Diseases|Naito-Oyanagi Disease|Epilepsies, Progressive Myoclonus|Atypical Inclusion Body Disease|May-White Syndrome|Progressive Myoclonus Epilepsies|Biotin-Responsive Encephalopathies|Naito-Oyanagi Diseases|Atypical Inclusion-Body Disease|May White Syndrome|Myoclonus-Nephropathy Syndrome"
NEW07677,CHEMICAL,sedating antidepressant,sedating antidepressants
NEW07678,CHEBI,agonist baclofen/muscimol,agonists baclofen/muscimol
NEW07679,DISEASE,rat delay-independent deficit,rats delay-independent deficits
NEW07680,CHEMICAL,pfc nmda receptor,PFC NMDA receptors
NEW07681,CHEMICAL,prefrontal cortex gaba transmission,prefrontal cortex GABA transmission
NEW07682,CHEMICAL,n-methyl-d-aspartate (nmdar)-mediated glutamatergic pathway,N-methyl-d-aspartate (NMDAR)-mediated glutamatergic pathways
NEW07683,CHEMICAL,protract alcohol withdrawal,Protracted alcohol withdrawal
NEW07684,MENTAL_HEALTH,anxiety common,anxiety common
NEW07685,DISEASE,mood instability,mood instability
NEW07686,CHEMICAL,zopiclone dose,Zopiclone doses
C085665,CHEMICAL,zaleplon [Supplementary Concept],Acetamides|Pyrimidines|zaleplon
NEW07687,CHEBI,various subtype selective partial gaba-a agonist,Various subtype selective partial GABA-A agonists
C105051,CHEMICAL,ganaxolone [Supplementary Concept],Pregnanolone/analogs  and  derivatives|ganaxolone
D016572,CHEMICAL,Cyclosporine,CsA||Cyclosporin A|Cyclosporine-A|cyclosporine-A|cyclosporine A|OL 27-400|Neoral|Cyclosporine A|Sandimmun Neoral|Sandimmune|CyA-NOF|Ciclosporin|CsA Neoral|CyA NOF|CsA-Neoral|CsANeoral|OL 27400|Cyclosporin|cyclosporin|Sandimmun|OL 27 400
NEW07688,CHEMICAL,csa dosing regimen,CsA dosing regimens
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Traumatic_Brain_Injury,DISEASE,traumatic brain injury,traumatic injury
NEW07689,CHEMICAL,blood alcohol level,blood alcohol levels
NEW07690,CHEBI,estrogen deprivation,estrogen deprivation
NEW07691,CHEBI,long-term endocrine treatment,Long-term endocrine treatment
C000614027,DISEASE,huangqi decoction [Supplementary Concept],"SHD|Decoction|Drugs, Chinese Herbal"
NEW07692,DISEASE,breast cancer patient,breast cancer patients
D055423,CHEMICAL,"Diet, Ketogenic","Ketogenic diets|Ketogenic Diet|Diets, Ketogenic|Ketogenic Diets"
C030614,CHEMICAL,picolinic acid [Supplementary Concept],chromium picolinate|picolinic acid|Picolinic Acids
C536398,CHEMICAL,Neonatal-onset citrullinemia type 2 [Supplementary Concept],Citrullinemia|Citrin deficiency|NICCD|citrin deficiency|neonatal intrahepatic cholestasis
http://purl.obolibrary.org/obo/DOID_0070342,DISEASE,adult-onset type ii citrullinemia,Adult-onset type II citrullinemia|adult-onset type citrullinemia|citrin deficiency|Adult-onset type citrullinemia|adult-onset type II citrullinemia|CTLN2
C537398,DISEASE,Pili torti developmental delay neurological abnormalities [Supplementary Concept],Hair Diseases|Growth Disorders|neurological abnormalities
NEW07693,CHEMICAL,simultaneous glycine-plus-sucrose,simultaneous glycine-plus-sucrose
NEW07694,DISEASE,severe hyperammonemic state,severe hyperammonemic state
NEW07695,CHEMICAL,gly       suc administration,Gly      Suc administration
NEW07696,DISEASE,conclusion severe hyperammonemic state,conclusion severe hyperammonemic state
C538260,DISEASE,Atresia of small intestine [Supplementary Concept],"Intestinal Atresia|Intestine, Small/abnormalities|small intestine"
NEW07697,CHEMICAL,aspartate-to-alanine conversion,Aspartate-to-alanine conversion
NEW07698,CHEMICAL,inter-organ aspartate metabolism,inter-organ aspartate metabolism
http://purl.obolibrary.org/obo/DOID_0080543,DISEASE,hyperprolinemia type 2,hyperprolinemia type II|Hyperprolinemia type
D011394,CHEMICAL,Proline Oxidase,"Oxidase, Proline|Proline Dehydrogenase|proline oxidase|Dehydrogenase, Proline"
NEW07699,CHEMICAL,harman level,harman levels
D002243,CHEMICAL,Carbolines,"Pyrido(4,3-b)Indole|beta-carbolines|Beta Carbolines|Carboline|Beta-Carbolines|Pyrido(4,3-b)Indoles"
NEW07700,CHEMICAL,norharman level,norharman levels
C010262,CHEMICAL,norharman [Supplementary Concept],Carbolines|norharman|Norharmane
NEW07701,CHEMICAL,low-carbohydrate high-fat diet,Low-carbohydrate high-fat diets
NEW07702,CHEMICAL,glycolysis pathway,glycolysis pathway
D014531,CHEMICAL,Uridine Diphosphate Galactose,"galactose|Uridine Diphosphogalactose|Diphosphate Galactose, Uridine|Galactose, Uridine Diphosphate|Diphosphogalactose, Uridine|Galactose, UDP|Uridine Pyrophosphogalactose|UDP Galactose|Pyrophosphogalactose, Uridine|UDPGal"
D058619,CHEMICAL,Maltose-Binding Proteins,Maltose-Binding Protein|Maltose Binding Protein|maltose|Maltose Binding Proteins
D007789,CHEMICAL,Lactose Tolerance Test,"lactose %|Tolerance Test, Lactose|Tolerance Tests, Lactose|Tests, Lactose Tolerance|Lactose Tolerance Tests|Test, Lactose Tolerance"
NEW07703,DISEASE,hospitalize psychiatric patient,hospitalized psychiatric patients
NEW07704,NUTRITION,protein-source tryptophan,Protein-source tryptophan
D012528,DISEASE,Satiety Response,"satiety|Response, Satiety|Responses, Satiety|Satiety Responses"
NEW07705,DISEASE,mood alleviation,mood alleviation
NEW07706,DISEASE,pentetrazole convulsion,pentetrazole convulsions
NEW07707,CHEMICAL,tranquilizer treatment,tranquilizer treatment
NEW07708,CHEMICAL,atropine coma,atropine coma
NEW07709,CHEMICAL,pyruvate level,pyruvate levels
D018981,DISEASE,Congenital Disorders of Glycosylation,"Glycoprotein Syndrome, Carbohydrate-Deficient|glycosylation|Syndrome, Carbohydrate-Deficient Glycoprotein|CDGs|Carbohydrate-Deficient Glycoprotein Syndromes|Carbohydrate-Deficient Glycoprotein Syndrome|congenital disorders|Carbohydrate Deficient Glycoprotein Syndrome|Syndromes, Carbohydrate-Deficient Glycoprotein"
NEW07710,DISEASE,early onset severe seizure disorder,early onset severe seizure disorders
NEW07711,DISEASE,anchor-related congenital disorder,anchor-related congenital disorders
C536594,CHEMICAL,Alzheimer disease type 1 [Supplementary Concept],early-onset familial form|FAD|Alzheimer Disease
NEW07712,DISEASE,chronic ketosis,chronic ketosis
NEW07713,DISEASE,neurodegenerative condition,neurodegenerative conditions
NEW07714,CHEMICAL,blood glucose achievable,blood glucose achievable
D005764,DISEASE,Gastroesophageal Reflux,"Gastroesophageal Reflux Disease|Gastro oesophageal Reflux|Reflux Disease, Gastro-Esophageal|Gastro Esophageal Reflux Disease|Reflux, Gastro-oesophageal|Gastro-Esophageal Reflux Disease|gastroesophageal reflux disease|Gastro Esophageal Reflux|Gastro-oesophageal Reflux|GERD|Gastric Acid Reflux|Gastric Acid Reflux Disease|Gastro-Esophageal Reflux Diseases|gastro-esophageal reflux|Reflux, Gastroesophageal|Esophageal Reflux|Reflux, Gastro-Esophageal|Acid Reflux, Gastric|Reflux, Gastric Acid|Gastro-Esophageal Reflux"
http://purl.obolibrary.org/obo/DOID_0050456,DISEASE,buruli ulcer disease,peptic ulcer disease|Searle's ulcer|Daintree ulcer|Searl ulcer|Mossman ulcer|Bairnsdale ulcer
NEW07715,DISEASE,drug-induced parkinsonism,drug-induced parkinsonism
NEW07716,CHEMICAL,fo group,FO group
NEW07717,CHEMICAL,n-3 polyunsaturated-fa,n-3 polyunsaturated-FA
NEW07718,CHEMICAL,tfa incorporation,TFA incorporation
NEW07719,CHEMICAL,gr expression,GR expression
NEW07720,CHEMICAL,high pufa ratio,high PUFA ratio
NEW07721,CHEMICAL,significant antidepressant property,significant antidepressant properties
NEW07722,CHEMICAL,salivary cortisol,salivary cortisol
NEW07723,CHEMICAL,curcumin treatment,curcumin treatment
NEW07724,MENTAL_HEALTH,17-item Hamilton Depression rating scale,17-item Hamilton Depression Rating Scale
NEW07725,CHEMICAL,significant antidepressant behavioral response,significant antidepressant behavioral response
NEW07726,CHEMICAL,salivary cortisol concentration,salivary cortisol concentrations
NEW07727,DISEASE,a. glycine,A. glycines
D062559,CHEMICAL,NAV1.8 Voltage-Gated Sodium Channel,"Peripheral Nerve Sodium Channel 3|voltage-gated sodium channel|Type 10 Voltage-Gated Sodium Channel|Voltage Gated Sodium Channel Type 10 Subunit alpha|NAV1.8 Voltage Gated Sodium Channel|Sodium Channel Protein Type 10 Subunit alpha|Voltage-Gated Sodium Channel Type 10 Subunit alpha|SCN10A Sodium Channel alpha Subunit|Type 10 Voltage Gated Sodium Channel|Sodium Channel, PN3|Voltage-Gated Sodium Channel Type 10|Sodium Channel Protein Type X|Voltage Gated Sodium Channel Type 10|PN3 Sodium Channel"
http://purl.obolibrary.org/obo/PR_P10997,DISEASE,islet amyloid polypeptide (human),amylin (human)|hiapp|diabetes-associated peptide (human)|insulinoma amyloid peptide (human)|hIAPP|dap (human)|iapp
D000682,CHEMICAL,Amyloid,"Fibril, Amyloid|Amyloid Substance|Fibrils, Amyloid|Amyloid Fibrils|Amyloid Fibril|amyloid fibrils|Substance, Amyloid"
NEW07728,CHEMICAL,different amyloid peptide,different amyloid peptides
http://purl.obolibrary.org/obo/CHEBI_65057,CHEMICAL,adenosine a1 receptor agonist,CPA|A1 adenosine receptors|adenosine A1 receptor agonists|adenosine A1 receptor agonist N6-cyclopentyladenosine
NEW07729,DISEASE,chronic inflammatory pain,chronic inflammatory pain
NEW07730,CHEMICAL,medicine yokukansan,medicine yokukansan
NEW07731,MENTAL_HEALTH,disorder combat veteran,disorder combat veterans
NEW07732,CHEMICAL,high nalmefene dosage,higher nalmefene dosages
NEW07733,CHEBI,opiate antagonist naltrexone,opiate antagonist naltrexone
NEW07734,CHEMICAL,naltrexone mg/kg s.c,naltrexone mg/kg s.c
NEW07735,DISEASE,frequent hyperserotonemia,frequent hyperserotonemia
NEW07736,DISEASE,epilepsy disorder,epilepsy disorders
NEW07737,DISEASE,useful psychiatric disorder,useful psychiatric disorders
NEW07738,CHEMICAL,saccharin solution,saccharin solutions
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Alcohol_Abuse,MENTAL_HEALTH,alcohol abuse,abuse alcohol|long-term alcohol abuse
C563835,CHEBI,"Drug Metabolism, Poor, CYP2D6-Related [Supplementary Concept]","drug metabolism|Cytochrome P-450 CYP2D6/deficiency|Metabolism, Inborn Errors"
NEW07739,MENTAL_HEALTH,disorder alcohol abuse,disorder alcohol abuse
NEW07740,CHEMICAL,Pizotifene,Pizotifene
NEW07741,DISEASE,trh-induced tsh response,TRH-induced TSH response
NEW07742,CHEMICAL,opiate antagonist naloxone,opiate antagonist naloxone
NEW07743,DISEASE,male chronic schizophrenic patient,male chronic schizophrenic patients
NEW07744,CHEMICAL,naloxone administration,naloxone administration
NEW07745,CHEMICAL,"12-allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-(4ah)-(8,9-c)-iminoethanophenanthro(4,5-b","12-allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-(4aH)-(8,9-c)-iminoethanophenanthro(4,5-b"
NEW07746,CHEBI,specific opiate antagonist,specific opiate antagonist
NEW07747,DISEASE,catatonic state,catatonic states
NEW07748,DISEASE,psychotic symptomatology,psychotic symptomatology
NEW07749,DISEASE,narcoleptic subject,narcoleptic subjects
NEW07750,CHEMICAL,naloxone-related miosis,naloxone-related miosis
http://purl.obolibrary.org/obo/DOID_8986,DISEASE,narcolepsy,"Narcolepsy, without cataplexy|paroxysmal sleep|narcoleptics"
NEW07751,CHEBI,optimal vitamin d status,optimal vitamin D status
NEW07752,DISEASE,few depressive symptom,fewer depressive symptoms
D019694,DISEASE,"Hepatitis B, Chronic","|Chronic Hepatitis B|Chronic Hepatitis B Virus Infection|chronic hepatitis B virus infection|Hepatitis B Virus Infection, Chronic|chronic hepatitis B|CHB|Chronic hepatitis B virus infection"
NEW07753,CHEMICAL,contraceptive steroid,contraceptive steroids
D003278,CHEMICAL,"Contraceptives, Oral, Hormonal","Hormonal Oral Contraceptive Agent|Contraceptive Agents, Oral, Hormonal|Contraceptives, Hormonal Oral|Oral Contraceptive, Hormonal|Hormonal Oral Contraceptives|Estrogen Contraceptive Agents|Oral Contraceptives, Hormonal|Contraceptive Agents, Estrogen|Hormonal Oral Contraceptive Agents|Hormonal Oral Contraceptive|Oral Contraceptive Agents, Hormonal|oral contraceptive|Contraceptive, Hormonal Oral|hormonal contraceptives"
C020681,CHEMICAL,glycine amidinotransferase [Supplementary Concept],L-arginine|Amidinotransferases
NEW07754,DISEASE,ischemia-induced neural cell damage,ischemia-induced neural cell damage
C099630,CHEMICAL,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine [Supplementary Concept]","Pyrroles|Pyridines|L-745,870"
NEW07755,DISEASE,severe parkinsonian motor oscillation,severe Parkinsonian motor oscillations
NEW07756,CHEMICAL,dopamine receptor antagonist domperidone,dopamine receptor antagonist domperidone
NEW07757,CHEMICAL,intramuscular diphenhydramine,intramuscular diphenhydramine
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Premorbidity,DISEASE,premorbidity,treatment-resistance|suicidality
NEW07758,DISEASE,morphine-induced dopamine-related action,morphine-induced dopamine-related actions
NEW07759,CHEMICAL,stabilizer aripiprazole,stabilizer aripiprazole
NEW07760,DISEASE,morphine-induced hyperlocomotion,Morphine-induced hyperlocomotion
NEW07761,CHEMICAL,dopamine receptor antagonist prochlorperazine,dopamine receptor antagonist prochlorperazine
D011346,CHEMICAL,Prochlorperazine,"Prochlorperazine Maleate||Salt, Prochlorperazine Edisylate|Edisylate, Prochlorperazine|Prochlorperazine Edisylate|Maleate, Prochlorperazine|Edisylate Salt, Prochlorperazine|Compazine|prochlorperazine|Prochlorperazine Edisylate Salt"
NEW07762,CHEBI,dopamine receptor antagonist fluphenazine,dopamine receptor antagonist fluphenazine
NEW07763,CHEBI,indirect agonist,indirect agonists
D029771,CHEMICAL,Rhodiola,Rhodiola rosea|Roseroot|Rhodiola crenulata|Roseroots
NEW07764,DISEASE,fetal irritability,fetal irritability
NEW07765,DISEASE,gastrointestinal dysfunction,gastrointestinal dysfunction
C532132,CHEMICAL,cinnamomi cortex [Supplementary Concept],"Drugs, Chinese Herbal|cinnamon bark|Cinnamomum zeylanicum"
NEW07766,DISEASE,chinese hamster ovarian cho cell,Chinese hamster ovarian CHO cells
NEW07767,CHEMICAL,aβ40 production,Aβ40 production
NEW07768,CHEMICAL,acheis,AChEIs
NEW07769,CHEMICAL,apoeɛ4,ApoEɛ4
NEW07770,DISEASE,dysthymic patient,Dysthymic patients
http://purl.obolibrary.org/obo/MFOMD_0000143,MENTAL_HEALTH,major depressive episode,major depressive episodes|depressive episodes|major depressive episode|CGI-MDE|depressive episode
NEW07771,CHEMICAL,old mao inhibitor,Older MAO inhibitors
NEW07772,CHEBI,nonselective ff1/ff2 agonist,nonselective FF1/FF2 agonist
NEW07773,DISEASE,neuropathic rat,neuropathic rats
NEW07774,CHEBI,ff1 antagonist,FF1 antagonists
NEW07775,DISEASE,establish mechanical allodynia,established mechanical allodynia
D003071,DISEASE,Cognition,"cognitive functions|Cognitive Functions|Cognitions|Functions, Cognitive|Function, Cognitive|Cognitive Function"
NEW07776,CHEMICAL,thalamic gaba level,thalamic GABA levels
NEW07777,CHEMICAL,mn deposition,Mn deposition
NEW07778,DISEASE,past-12-month exposure level,past-12-months exposure levels
NEW07779,CHEMICAL,NLX-112 administration,NLX-112 administration
NEW07780,DISEASE,l-dopa-induced surge,l-DOPA-induced surge
C473959,CHEMICAL,befiradol [Supplementary Concept],NLX-112|Piperidines|Pyridines
NEW07781,CHEMICAL,specific gamma-aminobutyric acid(A,specific gamma-aminobutyric acid(A
C443680,CHEMICAL,"N-(3-furylmethyl)eicosa-5,8,11,14-tetraenamide [Supplementary Concept]",UCM707|Polyunsaturated Alkamides|Furans|Arachidonic Acids
NEW07782,CHEMICAL,parvalbumin (pv)-positive γ-aminobutyric acid gaba interneuron,parvalbumin (PV)-positive γ-aminobutyric acid GABA interneurons
D059330,CHEMICAL,GABAergic Neurons,"Neurons, GABAergic|GABA neurons|Cells, GABA|GABAergic Neuron|Cell, GABA|Neuron, GABAergic|GABA Neurons|GABA Cells|Neurons, GABA|GABA Neuron|Neuron, GABA|GABA Cell"
http://purl.obolibrary.org/obo/CHEBI_142184,CHEBI,5-hydroxytryptamine 2b receptor agonist,5-hydroxytryptamine receptor 2B agonist|5-HT2B receptor agonist|serotonin receptor 2B agonists|5-HT2B agonist|5-HT2B agonists|serotonin receptor 2B agonist|5-hydroxytryptamine receptor 2B agonists|serotonin 5-HT 1A receptor agonist|5-HT2B receptor agonists|5-hydroxytryptamine 2B receptor agonists
NEW07783,MENTAL_HEALTH,schizophrenia consistent,schizophrenia consistent
C503102,CHEMICAL,1-(3-(2-(1-benzothiophen-5-yl) ethoxy) propyl)-3-azetidinol maleate [Supplementary Concept],Maleates|T-817MA|Thiophenes
NEW07784,CHEMICAL,pv-positive gaba neuron,PV-positive GABA neurons
NEW07785,CHEMICAL,t-817ma 1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl azetidin-3-ol maleate,T-817MA 1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl azetidin-3-ol maleate
NEW07786,CHEMICAL,gaba neurotransmitter system,GABA neurotransmitter system
NEW07787,CHEBI,candidate drug,candidate drug
NEW07788,CHEMICAL,pregnenolone administration,pregnenolone administration
NEW07789,CHEMICAL,pregnenolone level,pregnenolone levels
NEW07790,CHEMICAL,adjunctive pregnenolone,adjunctive pregnenolone
NEW07791,DISEASE,bipolar type,bipolar type
NEW07792,CHEMICAL,novel gaba uptake inhibitor anticonvulsant,novel GABA uptake inhibitor anticonvulsant
NEW07793,CHEMICAL,gamma-amino butyric acid gaba type a gaba(a receptor,gamma-amino butyric acid GABA type A GABA(A receptor
http://purl.org/sig/ont/fma/fma83354,DISEASE,corticotropin-releasing factor,CRF|Corticotrophin-releasing factor
NEW07794,CHEBI,major adrenocorticotropic hormone acth secretagogue,major adrenocorticotropic hormone ACTH secretagogue
NEW07795,CHEMICAL,antiepileptic drug valproic acid,antiepileptic drug valproic acid
NEW07796,DISEASE,crf production,CRF production
NEW07797,CHEMICAL,valproate active moiety,Valproate active moiety
NEW07798,CHEMICAL,severe alcohol withdrawal,Severe alcohol withdrawal
NEW07799,CHEMICAL,adjunctive pregabalin,Adjunctive pregabalin
NEW07800,CHEMICAL,adjunctive pregabalin,adjunctive pregabalin
NEW07801,DISEASE,drug-resistant ocd,drug-resistant OCD
NEW07802,DISEASE,narcoleptic teenager,narcoleptic teenagers
NEW07803,MENTAL_HEALTH,epworth Sleepiness scale,Epworth Sleepiness Scale
NEW07804,DISEASE,Pediatric Daytime Sleepiness scale,Pediatric Daytime Sleepiness Scale
NEW07805,CHEMICAL,ghb use,GHB use
NEW07806,MENTAL_HEALTH,narcolepsy-associated cataplexy,narcolepsy-associated cataplexy
NEW07807,DISEASE,obesity mild weight loss,obesity mild weight loss
NEW07808,CHEMICAL,glucose regulation,glucose regulation
NEW07809,CHEMICAL,stimulant prodrug lisdexamfetamine,stimulant prodrug lisdexamfetamine
NEW07810,MENTAL_HEALTH,eat episode,eating episodes
D056768,DISEASE,Giant Axonal Neuropathy,"Neuropathy, Giant Axonal (GAN)|Giant Axonal Neuropathy 1|neuropathy|Axonal Neuropathy, Giant (GAN)|Giant Axonal Neuropathy (GAN)|Neuropathy, Giant Axonal, Autosomal Recessive|Axonal Neuropathy, Giant|Neuropathy, Giant Axonal|Giant Axonal Neuropathy 1 (GAN1)"
NEW07811,DISEASE,chemotherapy-induced neuropathic pain,chemotherapy-induced neuropathic pain
NEW07812,CHEBI,analgesic agent,analgesic agent
NEW07813,CHEBI,opioid dependence potential drug interaction,opioid dependence potential drug interactions
NEW07814,MENTAL_HEALTH,effective analgesia,effective analgesia
NEW07815,CHEMICAL,slow dose up-titration,slow dose up-titration
C548016,DISEASE,Hypermanganesemia with Dystonia Polycythemia and Cirrhosis [Supplementary Concept],Metabolic Diseases|CLD|Chronic liver disease|chronic liver disease
http://purl.obolibrary.org/obo/CHEBI_35623,CHEMICAL,anticonvulsant,anti-convulsive agents|anti-convulsants|anti-convulsive agent|antiepileptics|anticonvulsants|antiepileptiques|anticonvulsive agents|Antiepileptika|antiepileptique|Antikonvulsivum|anticonvulsive agent|Antikonvulsiva|antiepileptic|Antiepileptikum|anti-convulsant
NEW07816,DISEASE,epilepsy post-herpetic neuralgia,epilepsy post-herpetic neuralgia
NEW07817,CHEMICAL,gabapentin dependence,gabapentin dependence
NEW07818,MENTAL_HEALTH,toxic delirium,toxic delirium
NEW07819,DISEASE,prolonged post-withdrawal confusional state reminiscent,prolonged post-withdrawal confusional state reminiscent
NEW07820,CHEMICAL,benzodiazepine withdrawal,benzodiazepine withdrawal
NEW07821,CHEMICAL,csf glu level,CSF Glu levels
NEW07822,DISEASE,pain processing,pain processing
NEW07823,CHEBI,h3 receptor inverse agonist,H3 receptor inverse agonists
NEW07824,CHEBI,selective agonist activity,selective agonist activity
NEW07825,CHEMICAL,common anesthetic isoflurane,common anesthetic isoflurane
NEW07826,CHEBI,disease-associated amyloid beta protein,disease-associated amyloid beta protein
NEW07827,MENTAL_HEALTH,opioid-induced analgesia,opioid-induced analgesia
D012893,DISEASE,Sleep Wake Disorders,"Short Sleep Phenotype|Wake Disorders, Sleep|Tachypneas, Sleep-Related Neurogenic||Neurogenic Tachypnea, Sleep-Related|Sleep Related Neurogenic Tachypnea|Sleep Wake Disorder|Syndromes, Long Sleeper|Long Sleeper Syndrome|Sleeper Syndromes, Long|Short Sleep Phenotypes|Disorders, Sleep Wake|Disorder, Sleep Wake|Neurogenic Tachypneas, Sleep-Related|Sleep Disorders|Sleeper Syndromes, Short|Wake Disorder, Sleep|Subwakefullness Syndrome|Sleeper Syndrome, Short|Sleep-Related Neurogenic Tachypneas|Sleep-Related Neurogenic Tachypnea|Short Sleeper Syndrome|Tachypnea, Sleep-Related Neurogenic|Disorders, Sleep|Syndrome, Short Sleeper|sleep disturbance|Sleep Disorder|Sleeper Syndrome, Long|Phenotype, Short Sleep|Syndrome, Subwakefullness|Subwakefullness Syndromes|Syndromes, Short Sleeper|Disorder, Sleep|Short Sleeper Syndromes|sleep-wake disorders|Sleep Phenotypes, Short|Syndromes, Subwakefullness|Syndrome, Long Sleeper|Phenotypes, Short Sleep|Long Sleeper Syndromes"
NEW07828,CHEMICAL,high histamine concentration,high histamine concentrations
NEW07829,DISEASE,disease schizophrenic patient,disease schizophrenic patients
NEW07830,CHEMICAL,low histamine level,Low histamine levels
NEW07831,CHEMICAL,neuronal histamine,Neuronal histamine
D050492,CHEMICAL,Vesicular Biogenic Amine Transport Proteins,"Vesicular Amine Transport Proteins|Biogenic Amine Transporters, Vesicular|Amine Transporter, Vesicular|amine|Vesicular Amine Transporter|Vesicular Biogenic Amine Transporters|Vesicular Amine Transporter Proteins"
NEW07832,DISEASE,endogenous pain system,endogenous pain system
NEW07833,CHEBI,other analgesic drug,Other analgesic drugs
NEW07834,DISEASE,pain inhibition,pain inhibition
NEW07835,CHEMICAL,endothelial cell atp diphosphohydrolase,Endothelial cell ATP diphosphohydrolases
NEW07836,DISEASE,platelet thrombi,platelet thrombi
NEW07837,CHEMICAL,Hoeeum,Hoeeum
NEW07838,CHEMICAL,sbv pharmacopuncture,SBV pharmacopuncture
NEW07839,CHEMICAL,ammonium sensitivity,ammonium sensitivity
NEW07840,DISEASE,neuronal disorder,neuronal disorders
NEW07841,CHEBI,cobra venom ngf,cobra venom NGF
C029899,CHEMICAL,imidazole [Supplementary Concept],imidazole|Imidazoles
NEW07842,MENTAL_HEALTH,potential irreversible sexual dysfunction,potential irreversible sexual dysfunction
D018120,CHEMICAL,Finasteride,Chibro Proscar|Chibro-Proscar|Propecia|Eucoprost|Proscar|finasteride|MK 906|Propeshia|MK-906|MK906
NEW07843,CHEMICAL,da transporter,DA transporter
NEW07844,CHEMICAL,two-single-nucleotide-polymorphism haplotype,two-single-nucleotide-polymorphism haplotype
NEW07845,CHEBI,gene carrier,gene carriers
NEW07846,MENTAL_HEALTH,unwanted intrusive thought,unwanted intrusive thoughts
NEW07847,DISEASE,viral hepatitis c. patient,viral hepatitis C. patient
NEW07848,DISEASE,psychiatric clinical,Psychiatric Clinical
NEW07849,DISEASE,cognitive alteration,cognitive alterations
NEW07850,CHEMICAL,commercial motor vehicle driver,commercial motor vehicle drivers|CMVDs
NEW07851,DISEASE,respiratory dysfunction,respiratory dysfunction
NEW07852,CHEMICAL,5-ht transporter gene-linked polymorphic region,5-HT transporter gene-linked polymorphic region
http://purl.obolibrary.org/obo/DOID_12883,DISEASE,hypochondriasis,hypochondriacal neurosis|depressivity|obsessionality|Hypochondriacal disorder|Hypochondria
NEW07853,CHEMICAL,human serotonin transporter sert gene polymorphism,human serotonin transporter SERT gene polymorphism
NEW07854,DISEASE,multiple psychiatric disorder,multiple psychiatric disorders
NEW07855,CHEMICAL,tca cycle dysfunction,TCA cycle dysfunction
NEW07856,CHEMICAL,elevated pyruvate level,elevated pyruvate levels
NEW07857,DISEASE,[hypo]manic mood state,[hypo]manic mood state
NEW07858,DISEASE,depressed state,depressed state
C498532,CHEMICAL,"Atp1a2 protein, rat [Supplementary Concept]",Na K-ATPase|Sodium-Potassium-Exchanging ATPase
C542800,CHEBI,"Slc25a47 protein, rat [Supplementary Concept]",Mitochondrial Carrier Protein|Mitochondrial Membrane Transport Proteins
NEW07859,CHEMICAL,atp generation,ATP generation
NEW07860,DISEASE,mobility loss,mobility losses
NEW07861,CHEBI,carrier concentration,carrier concentration
D006719,CHEMICAL,Homovanillic Acid,"3-Methoxy-4-Hydroxyphenylacetic Acid|Acid, 3-Methoxy-4-Hydroxyphenylacetic|4-Hydroxy-3-Methoxyphenylacetic Acid|3 Methoxy 4 Hydroxyphenylacetic Acid|Acid, 4-Hydroxy-3-Methoxyphenylacetic|4 Hydroxy 3 Methoxyphenylacetic Acid|homovanillic acid|Acid, Homovanillic"
D008734,CHEMICAL,Methoxyhydroxyphenylglycol,"4 Hydroxy 3 methoxyphenylethylene Glycol|4-Hydroxy-3-methoxyphenylglycol|Methoxyhydroxyphenylglycol, (-)-Isomer|Hydroxymethoxyphenylglycol|4 Hydroxy 3 methoxyphenylglycol|4-hydroxy-3-methoxyphenylglycol|MHPG|MOPEG|Vanylglycol|4-Hydroxy-3-methoxyphenylethylene Glycol|4 Hydroxy 3 methoxyphenylethyleneglycol|4-Hydroxy-3-methoxyphenylethyleneglycol|Methoxyhydroxyphenylglycol, (+)-Isomer|Methoxyhydroxyphenylglycol, (+-)-Isomer"
NEW07862,CHEMICAL,platelet serotonin uptake,platelet serotonin uptake
NEW07863,CHEMICAL,5-hydroxyindoleacetic acid,5-hydroxyindoleacetic acid
NEW07864,DISEASE,axis disorder,Axis disorders
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Patient_Abuse,MENTAL_HEALTH,patient abuse,abuse patients
NEW07865,CHEBI,Carrier Foundation,Carrier Foundation
NEW07866,DISEASE,axis psychiatric comorbidity,Axis psychiatric comorbidity
NEW07867,DISEASE,axis diagnosis,Axis diagnoses
NEW07868,CHEMICAL,enzyme hypoxanthin-guanine phosphorribosyl transferase,enzyme hypoxanthin-guanine phosphorribosyl transferase
NEW07869,CHEMICAL,acid disorder,acid disorder
NEW07870,CHEMICAL,seasonal serotonin transporter fluctuation,seasonal serotonin transporter fluctuations
NEW07871,CHEMICAL,winter high serotonin transporter,winter higher serotonin transporter
NEW07872,CHEMICAL,serotonin transporter binding,serotonin transporter binding
NEW07873,DISEASE,depressive symptom severity,depressive symptom severity
NEW07874,CHEMICAL,affective disorders.media-1vid110.1093/brain/aww043_video_abstractaww043_video_abstract,affective disorders.media-1vid110.1093/brain/aww043_video_abstractaww043_video_abstract
NEW07875,CHEMICAL,antidepressant drug amitriptyline hydrochloride,antidepressant drug amitriptyline hydrochloride|AMT
NEW07876,CHEBI,c9orf72 mutation carrier,C9orf72 mutation carriers
NEW07877,MENTAL_HEALTH,diverse clinical syndrome,diverse clinical syndromes
NEW07878,DISEASE,binge-eating behavior,binge-eating behavior
NEW07879,CHEBI,obese carrier,obese carriers
NEW07880,MENTAL_HEALTH,mixed-effects regression model,Mixed-effects regression models
NEW07881,DISEASE,cognitive diagnosis,cognitive diagnosis
NEW07882,CHEMICAL,hypoglycemic treatment,Hypoglycemic treatments
NEW07883,DISEASE,hepatitis component,hepatitis component
http://purl.obolibrary.org/obo/CHEBI_9907,CHEMICAL,ursodeoxycholic acid,"Ursodeoxycholic acid|3alpha,7beta-dihydroxy-5beta-cholan-24-oic acid|Ursodeoxycholate|urodeoxycholic acid|(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid|3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid|Ursodiol|Actigall"
NEW07884,DISEASE,depressive illness,depressive illness
C417086,CHEMICAL,"5-(4-N,N-dimethylaminophenylmethylene)-4-hydroxy-2-(1-methylimidazol-2-ylthio)-4-(4-phenylbutyl)-2-cyclopentenone [Supplementary Concept]",cyclopentenone|Prostaglandins A
NEW07885,DISEASE,retinoblastoma protein phosphorylation,retinoblastoma protein phosphorylation
NEW07886,DISEASE,cancer heart disease,cancer heart disease
D017965,CHEMICAL,gamma-Linolenic Acid,"Gamolenic Acid|Acid, Gamolenic|gamma-Linolenic Acid, Zinc Salt|gamma-Linolenic Acid, Cerium Salt|gamma-Linolenic Acid, Potassium Salt|Acid, gamma-Linolenic|gamma Linolenic Acid|gamma-Linolenic Acid, Lithium Salt|gamma Linolenic Acid, Ammonium Salt|gamma Linolenic Acid, Sodium Salt|gamma Linolenic Acid, Zinc Salt|gamma-Linolenic Acid, Ammonium Salt|gamma Linolenic Acid, Potassium Salt|gamma Linolenic Acid, Indium Salt|gamma-Linolenic Acid, Sodium Salt|gamma Linolenic Acid, Cerium Salt|gamma-Linolenic Acid, Indium Salt|gamma-Linolenic acid|gamma Linolenic Acid, Lithium Salt"
D043371,NUTRITION,"Fatty Acids, Omega-6","Omega-6 Fatty Acids|Ω|Acid, N-6 Fatty|N-6 Fatty Acid|Acids, N-6 Fatty|N 6 Fatty Acid|Omega 6 Fatty Acid|Fatty Acids, Omega 6|Fatty Acids, N-6|Omega 6 Fatty Acids|Fatty Acid, Omega-6|n-6 fatty acids|Acids, Omega-6 Fatty|Omega-6 Fatty Acid|Fatty Acid, N-6|N-6 Fatty Acids|omega-6 fatty acids|Acid, Omega-6 Fatty|N 6 Fatty Acids"
D009288,CHEMICAL,Naproxen,"|Proxen|naproxen|Naprosyn|Sodium, Naproxen|Aleve|Sodium Naproxenate|Naproxen Sodium|Naproxenate, Sodium|Methoxypropiocin|Naprosin|Synflex|Anaprox"
D024502,CHEBI,alpha-Tocopherol,"Acetate, Tocopherol|Tocopherol Succinate|3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol|Tocopheryl Acetate|alpha Tocopherol Acetate|d-alpha-Tocopheryl Acetate|d alpha Tocopheryl Acetate|alpha Tocopherol Succinate|Tocopherol Acetate|alpha-Tocopherol Succinate|Tocopherol, d-alpha|alpha Tocopherol Hemisuccinate|alpha Tocopherol|alpha-Tocopheryl Calcium Succinate|Vitamin E Succinate|R,R,R-alpha-Tocopherol|alpha Tocopheryl Calcium Succinate|d alpha Tocopherol|alphaT|alpha-tocopherol|α-tocopherol|d-alpha Tocopherol|alpha-Tocopherol Hemisuccinate|alpha-Tocopherol Acetate"
D024504,NUTRITION,gamma-Tocopherol,"3,4-Dihydro-2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol|gamma-tocopherol|GTF|gamma-Tocopherol"
NEW07887,MENTAL_HEALTH,nicotine-induced long-lasting depression,nicotine-induced long-lasting depression
NEW07888,CHEMICAL,neuroadaptation,neuroadaptations
NEW07889,CHEMICAL,vesicular da content,vesicular DA content
NEW07890,CHEMICAL,neuroleptic flupenthixol,neuroleptic flupenthixol
NEW07891,CHEBI,possible anti-craving drug,possible anti-craving drug
NEW07892,CHEMICAL,cocaine addict,cocaine addicts
http://purl.obolibrary.org/obo/DOID_10600,MENTAL_HEALTH,chronic tic disorder,chronic motor tic disorder|chronic motor or vocal tic disorder|chronic tic disorder|chronic tic disorders|CMT
NEW07893,CHEMICAL,potent combined serotonin,potent combined serotonin
NEW07894,CHEMICAL,dopamine system dysfunction,Dopamine system dysfunction
NEW07895,CHEBI,potent dopamine da d2 receptor antagonist,potent dopamine DA D2 receptor antagonists
NEW07896,CHEBI,potent d2 antagonist,potent D2 antagonists
NEW07897,CHEMICAL,reward-enhancing effect,reward-enhancing effects
NEW07898,CHEMICAL,preserved 5-ht transmission,Preserved 5-HT transmissions
NEW07899,DISEASE,p. edulis,P. edulis
NEW07900,CHEMICAL,dopamine antagonism,dopamine antagonism
NEW07901,MENTAL_HEALTH,schizophrenia aged,schizophrenia aged
NEW07902,CHEMICAL,dopamine transmission abnormality,dopamine transmission abnormalities
NEW07903,CHEMICAL,particular dopamine d2-receptor deficiency,particular dopamine D2-receptor deficiency
NEW07904,DISEASE,cognitive distortion,cognitive distortions
NEW07905,CHEMICAL,dopamine excess,dopamine excess
NEW07906,DISEASE,positive psychotic symptom,positive psychotic symptoms
D003006,CHEMICAL,Clopenthixol,alpha Clopenthixol|zuclopenthixol|Cisordinol|Zuclopenthixol|alpha-Clopenthixol
NEW07907,CHEMICAL,atypical antipsychotic lek-8829,atypical antipsychotic LEK-8829
NEW07908,DISEASE,activity-based anorexia,Activity-based anorexia
NEW07909,DISEASE,loss restricted food access,loss restricted food access
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Aphagia,DISEASE,aphagia,hypophagia|hyperghrelinaemia|hypercorticosteronemia|1-NE-induced hypophagia
NEW07910,MENTAL_HEALTH,paradoxical hyperactivity,paradoxical hyperactivity
NEW07911,CHEBI,antagonist eticlopride,antagonists eticlopride
NEW07912,DISEASE,retinal alteration,retinal alterations
NEW07913,DISEASE,gastrointestinal injury,gastrointestinal injury
D000087522,CHEBI,Cyanobacteria Toxins,"Cyanobacterial Neurotoxin|Cyanotoxins|Cyanobacterial Toxins|cyanotoxins|Cyanobacterial Neurotoxins|Neurotoxin, Cyanobacterial"
NEW07914,CHEMICAL,mdrtb patient,MDRTB patients
D018501,CHEMICAL,Antirheumatic Agents,"Anti-Rheumatic Drugs|Antirheumatic Disease Modifying Second Line Drugs|Anti Rheumatic Drug|Disease Modifying Antirheumatic Drug|second-line drug|Anti-Rheumatic Agent|DMARD|Agent, Anti-Rheumatic|Drug, Disease-Modifying Antirheumatic|Anti Rheumatic Agents, Non Steroidal|Drug, Antirheumatic|Antirheumatic Drugs|Antirheumatic Drugs, Disease Modifying|Disease-Modifying Antirheumatic Drugs|Antirheumatic Disease-Modifying Second-Line Drug|Antirheumatic Agent|Non-Steroidal Anti-Rheumatic Agents|Anti Rheumatic Agent|Anti-Rheumatic Drug|Anti Rheumatic Agents|Disease-Modifying Antirheumatic Drug|Agent, Antirheumatic|Antirheumatic Drug, Disease-Modifying|Antirheumatic Drug|Disease Modifying, Antirheumatic Second Line Drugs|Drug, Anti-Rheumatic|Disease-Modifying, Antirheumatic Second-Line Drugs|Anti-Rheumatic Agents|Anti-Rheumatic Agents, Non-Steroidal|Antirheumatic Disease Modifying Second Line Drug|Antirheumatic Drugs, Disease-Modifying|Anti Rheumatic Drugs|Disease Modifying Antirheumatic Drugs|Antirheumatic Disease-Modifying Second-Line Drugs|second-line drugs"
NEW07915,CHEMICAL,MDRTB,MDRTB
NEW07916,MENTAL_HEALTH,additional resistance,additional resistance
NEW07917,CHEMICAL,pre-xdrtb,pre-XDRTB
NEW07918,CHEMICAL,second-line injectable,second-line injectable
NEW07919,CHEMICAL,MDRTB acquisition,MDRTB acquisition
NEW07920,DISEASE,most Parkinson 's disease patient,most Parkinson's disease patients
NEW07921,CHEMICAL,protein-gated inwardly rectify k+ girk channel,protein-gated inwardly rectifying K+ GIRK channels
NEW07922,CHEBI,act mor agonist,acting MOR agonist
NEW07923,DISEASE,heat hypersensitivity,heat hypersensitivity
C000606131,CHEMICAL,3-carboxamido-4-hydroxynaltrexone [Supplementary Concept],SAM|Samidorphan|Naltrexone/analogs  and  derivatives|samidorphan
NEW07924,CHEMICAL,antipsychotic olanzapine,antipsychotic olanzapine
http://purl.obolibrary.org/obo/CHEBI_60605,CHEMICAL,opioid receptor antagonist,Non-selective opioid receptor antagonists|opioid antagonist|nonselective opioid receptor antagonist|classical opioid receptor antagonist|opioid receptor antagonist medications|opiate antagonists|benzodiazepine receptor antagonists|selective opioid receptor antagonist|opioid receptor antagonist samidorphan|opiate antagonist|naloxone|opioid antagonists|opioid receptor antagonist naloxone|opioid receptor antagonists
NEW07925,DISEASE,metabolic dysregulation,metabolic dysregulation
NEW07926,CHEBI,second antipsychotic drug,second antipsychotic drug
NEW07927,DISEASE,olz-induced mass gain,OLZ-induced mass gain
http://purl.obolibrary.org/obo/CHEBI_64356,CHEMICAL,pregabalin,(3S)-3-(aminomethyl)-5-methylhexanoic acid|dextromethorphan/quinidine|oxycodone/naloxone|pregabaline|DM/Q|3-Isobutyl GABA|pregabalin|Lyrica|(S)-3-Isobutyl GABA
NEW07928,CHEMICAL,alcohol ethanol consumption,alcohol ethanol consumption
NEW07929,CHEMICAL,5ht2,5HT2
NEW07930,MENTAL_HEALTH,somnolence effect,Somnolence effects
NEW07931,DISEASE,alcoholism dependence,alcoholism dependence
D015551,DISEASE,Autoimmunity,Autoimmune Responses|Autoimmune Response|Autoimmunities|autoimmunity
NEW07932,NUTRITION,tree damage,tree damage
NEW07933,DISEASE,premature senescence,premature senescence
NEW07934,CHEMICAL,paopa-loaded snp-cmch hydrogel,PAOPA-loaded SNP-CMCh hydrogels
NEW07935,CHEMICAL,conventional paopa administration,conventional PAOPA administration
NEW07936,CHEMICAL,paopa dose,PAOPA dose
D000084922,NUTRITION,Resistant Starch,Starch (1984-2020)|Dietary Fiber (1984-2020)|resistant starch
NEW07937,DISEASE,obesity regulation,obesity regulation
NEW07938,CHEMICAL,prolonged benzodiazepine administration,prolonged benzodiazepine administration
D005951,CHEMICAL,Glucose Tolerance Test,"oral glucose tolerance test|Oral Glucose Tolerance|Glucose Tolerance, Oral|OGTT|Intravenous Glucose Tolerance|% oral glucose tolerance test|glucose tolerance|Oral Glucose Tolerance Test|Intravenous Glucose Tolerance Test|Glucose Tolerance Tests"
NEW07939,CHEMICAL,normal glucose tolerance,normal glucose tolerance
NEW07940,DISEASE,glucose-induced insulin release,glucose-induced insulin release
C000713387,CHEMICAL,peony root extract [Supplementary Concept],"Drugs, Chinese Herbal|Paeonia|root extract|Plant Extracts"
NEW07941,DISEASE,type hyperammonemia,type hyperammonemia
NEW07942,CHEMICAL,plasma citrulline,plasma citrulline
NEW07943,CHEMICAL,main intestinal fructose transporter protein,main intestinal fructose transporter proteins
NEW07944,DISEASE,fructose malabsorption,fructose malabsorption
D000072056,CHEMICAL,Transcription Factor HES-1,"HES-1, Transcription Factor|Hairy Like Transcription Factor|Transcription Factor, Hairy-Like|Hairy-Like Transcription Factor|HES|Hairy and Enhancer of Split 1 Protein|Transcription Factor HES 1"
NEW07945,DISEASE,cerebral hypoperfusion,cerebral hypoperfusion
D006895,NUTRITION,Hydroxyethyl Starch Derivatives,"Starches, 2 Hydroxyethyl|Plasmasteril|Hespan|Hydroxyethyl Starch 130 0.4|Elohes|Hydroxyethyl Starch (130 KD-0.4 Substitution)|Hydroxyethyl Starch 130-0.4|2-Hydroxyethyl Starches|Pentastarch|Hemohes|HAES-steril|Starch Derivatives, Hydroxyethyl|Pentaspan|Hydroxyethyl starch|Hetastarch|Pentafraction|Starches, Hydroxyethylated|Derivatives, Hydroxyethyl Starch|Hydroxyethylated Starches|Starches, 2-Hydroxyethyl"
NEW07946,CHEMICAL,phenolic compound myricetin,Myr|phenolic compounds myricetin
NEW07947,DISEASE,cellular toxicity,cellular toxicity
NEW07948,DISEASE,hepatic abnormality,hepatic abnormalities
NEW07949,CHEMICAL,glp-1 receptor,GLP-1 receptors
D000067758,CHEMICAL,Glucagon-Like Peptide-2 Receptor,"Glucagon-Like Peptide 2 Receptor|GLP-2R Receptor|GLP-2 Receptor|GLP 2R Receptor|Receptor, GLP-2R|Peptide-2 Receptor, Glucagon-Like|GLP 2 Receptor|GLP2R Protein|Receptor, Glucagon-Like Peptide-2|Receptor, GLP-2|GLP-2|Protein, GLP2R|Glucagon Like Peptide 2 Receptor"
NEW07950,CHEBI,gut hormone,gut hormones
NEW07951,CHEMICAL,glp-1 analogue,GLP-1 analogues
D008659,DISEASE,Metabolic Diseases,"Disease, Metabolic|Thesaurismosis|Diseases, Metabolic|Metabolic Disease|Thesaurismoses|metabolic disease"
C502483,DISEASE,"Ana o 3 protein, Anacardium occidentale [Supplementary Concept]","Plant Proteins|Antigens, Plant|ANA"
NEW07952,NUTRITION,serum folate,serum folate
NEW07953,CHEMICAL,twohour,twohour
NEW07954,CHEMICAL,post prandial blood sugar,post prandial blood sugar
NEW07955,DISEASE,anti- tuberculosis medication,anti- tuberculosis medication
NEW07956,CHEMICAL,medication rifampicin,medication rifampicin
NEW07957,CHEMICAL,thalidomide embryopathy,thalidomide embryopathy
C565618,DISEASE,DK Phocomelia Syndrome [Supplementary Concept],"phocomelia|Urogenital Abnormalities|Encephalocele|Ectromelia|Abnormalities, Multiple|Thrombocytopenia"
C536498,DISEASE,Tetra-amelia autosomal recessive [Supplementary Concept],Ectromelia|amelia
NEW07958,DISEASE,reversible memory loss,reversible memory loss
D009101,DISEASE,Multiple Myeloma,"Myelomas, Multiple|Myelomatoses|Disease, Kahler|MM|Plasma Cell Myelomas|Plasma-Cell Myelomas|Myelomatosis|Myeloma, Plasma Cell|Cell Myeloma, Plasma|Plasma-Cell Myeloma|Kahler Disease|Myeloma, Plasma-Cell|Myeloma, Multiple|Myelomas, Plasma-Cell|Plasma Cell Myeloma|multiple myeloma|Multiple Myelomas|Cell Myelomas, Plasma|Myeloma-Multiple|Myeloma Multiple|Myelomas, Plasma Cell|Myeloma-Multiples"
NEW07959,CHEBI,prescribe immunomodulatory drug,prescribed immunomodulatory drug
NEW07960,DISEASE,thalidomide-induced cognitive dysfunction,thalidomide-induced cognitive dysfunctions
NEW07961,CHEMICAL,paxilline treatment,paxilline treatment
NEW07962,CHEMICAL,10mg/kg,10mg/kg
NEW07963,CHEBI,anti-tubercular drug pharmacokinetic,anti-tubercular drug pharmacokinetics
NEW07964,CHEMICAL,sedative/hypnotic thalidomide,sedative/hypnotic thalidomide
http://purl.obolibrary.org/obo/DOID_0080750,DISEASE,erythema nodosum,ENL|erythema nodosum leprosum
NEW07965,DISEASE,severe birth defect,severe birth defects
D000069286,CHEMICAL,Bortezomib,"LDP 341|LDP-341|PS341|Velcade|PS 341|LDP341|341, PS|bortezomib|PS-341"
NEW07966,CHEMICAL,second-line therapy,second-line therapy
NEW07967,DISEASE,severe aggressive behavior,severe aggressive behavior
NEW07968,CHEBI,endocrine response,endocrine response
NEW07969,CHEMICAL,nicotine administration,nicotine administration
NEW07970,DISEASE,formalin-induced pain response,formalin-induced pain response
NEW07971,DISEASE,non-adhd subject,non-ADHD subjects
C537658,DISEASE,"Basal ganglia disease, biotin-responsive [Supplementary Concept]",basal ganglia disease|Basal Ganglia Diseases
NEW07972,DISEASE,psychotic condition,psychotic conditions
NEW07973,CHEBI,antiparkinsonian dopaminergic agent,antiparkinsonian dopaminergic agents
http://purl.obolibrary.org/obo/DOID_0090123,CHEMICAL,aromatic l-amino acid decarboxylase deficiency,enzyme aromatic L-amino acid decarboxylase|AADC|AADC deficiency|Aromatic l-amino acid decarboxylase AADC deficiency
NEW07974,DISEASE,parkinsonian rat striata,parkinsonian rat striata
NEW07975,CHEMICAL,dopamine storage,dopamine storage
NEW07976,CHEMICAL,l-dopa therapy,L-DOPA therapy
NEW07977,CHEMICAL,active dopamine,active dopamine
NEW07978,CHEMICAL,glutamate homeostasis,glutamate homeostasis
NEW07979,DISEASE,numerous neurological disorder,numerous neurological disorders
NEW07980,CHEMICAL,levodopa preparation,Levodopa preparations
http://purl.org/sig/ont/fma/fma70958,CHEMICAL,erythromelanin granule,Zishenpingchan granules
NEW07981,DISEASE,affective level disorder patient,affective level disorder patients
NEW07982,CHEBI,dopaminergic agent l-dopa,dopaminergic agents L-dopa
NEW07983,DISEASE,antidepressant-induced sexual dysfunction,antidepressant-induced sexual dysfunction
NEW07984,DISEASE,many behavioural abnormality,Many behavioural abnormalities
NEW07985,CHEMICAL,dopamine da producing cell,dopamine DA producing cells
NEW07986,DISEASE,specific cortico-subcortical extrapyramidal circuit,specific cortico-subcortical extrapyramidal circuits
NEW07987,MENTAL_HEALTH,dopaminergic projection area,dopaminergic projection areas
NEW07988,CHEMICAL,nigrostriatal dopamine,nigrostriatal dopamine
NEW07989,DISEASE,subtle cognitive disturbance,subtle cognitive disturbances
NEW07990,DISEASE,progressive motor dysfunction,progressive motor dysfunction
NEW07991,MENTAL_HEALTH,movement REM sleep behaviour disorder,movement REM sleep behaviour disorder
NEW07992,CHEMICAL,clonazepam agent,clonazepam agents
NEW07993,CHEBI,levodopa-carbidopa new dopamine agonist,levodopa-carbidopa newer dopamine agonists
NEW07994,DISEASE,periodic leg-movement disorder,periodic leg-movement disorder
NEW07995,DISEASE,rbd symptom,RBD symptoms
NEW07996,DISEASE,different neuropathologie,different neuropathologies
NEW07997,DISEASE,stress/anxiety rating,stress/anxiety ratings
NEW07998,CHEMICAL,cortisol basal level,cortisol basal levels
NEW07999,DISEASE,severe hypertriglyceridaemia,severe hypertriglyceridaemia
NEW08000,DISEASE,acute non-biliary pancreatitis,acute non-biliary pancreatitis
http://purl.obolibrary.org/obo/DOID_1387,DISEASE,hypolipoproteinemia,Lipoprotein deficiencies|Hypolipoproteinaemia|hypertriglyceridaemia
NEW08001,CHEMICAL,intravenous heparin,Intravenous heparin
http://purl.obolibrary.org/obo/DOID_4989,DISEASE,pancreatitis,hypertriglyceridaemia-induced pancreatitis
NEW08002,CHEMICAL,dha level,DHA levels
NEW08003,NUTRITION,lcn-3 fatty acid deficiency,LCn-3 fatty acid deficiency
NEW08004,DISEASE,neuroinflammation decline,neuroinflammation decline
NEW08005,CHEMICAL,marble-burying behavior,marble-burying behavior|MBB
C044894,CHEMICAL,ethylcholine aziridinium [Supplementary Concept],"2,4,6-trinitrobenzenesulfonic acid|Aziridines|Choline/analogs  and  derivatives"
NEW08006,DISEASE,model chronic post-inflammatory colonic hypersensitivity,model chronic post-inflammatory colonic hypersensitivity
NEW08007,CHEMICAL,trinitrobenzene sulfonic acid,trinitrobenzene sulfonic acid|TNBS
D019342,CHEMICAL,Acetic Acid,"Glacial Acetic Acid|Vinegar|Acetic Acid Glacial|Acetic Acid, Glacial|Glacial, Acetic Acid|acetic acid"
NEW08008,DISEASE,increase vmr,increased VMR
NEW08009,DISEASE,hypersensitive visceral motor response,VMR|hypersensitive visceral motor response|visceromotor reflex
C500065,CHEMICAL,4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide [Supplementary Concept],Aminopyridines|JNJ-17203212|Piperazines
NEW08010,DISEASE,colonic hypersensitivity,colonic hypersensitivity
NEW08011,CHEMICAL,luminal distension,luminal distension
NEW08012,CHEBI,selective trpv1 antagonist,selective TRPV1 antagonist
NEW08013,DISEASE,functional bowel disorder,functional bowel disorders
C500530,CHEMICAL,"3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide [Supplementary Concept]","Acrylamides|Bridged Bicyclo Compounds, Heterocyclic|AMG9810"
NEW08014,CHEBI,trpv1 antagonist drug,TRPV1 antagonist drug
NEW08015,DISEASE,alcohol-induced pancreatitis,alcohol-induced pancreatitis
http://purl.obolibrary.org/obo/CHEBI_82891,CHEBI,glucocorticoid receptor antagonist,glucocorticoid receptor GR antagonist RU486 antagonist|Glucocorticoid antagonists|glucocorticoid receptor antagonist RU38486|selective glucocorticoid receptor antagonist|glucocorticoid receptor antagonist|glucocorticoid receptor antagonists|glucocorticoid antagonists
NEW08016,DISEASE,prolonged sensitization pain,prolonged sensitization pain
C071423,CHEMICAL,capsazepine [Supplementary Concept],capsazepine|Capsaicin/analogs  and  derivatives
NEW08017,CHEMICAL,cox2 inhibitor ns-398,COX2 inhibitor NS-398
D009599,CHEMICAL,Nitroprusside,"Nipruton||Disodium Salt Nitroprusside|Nitropress|sodium nitroprusside|Nitroprusside, Disodium Salt, Dihydrate|Cyanonitrosylferrate|Naniprus|Nitroprusside, Sodium|Nipride|Nitroferricyanide|Sodium Nitroprusside|Nitroprusside, Disodium Salt|Nitriate|Ketostix|nitroprusside|Nitroprussiat Fides"
NEW08018,CHEMICAL,acid-induced gastric ulcer,acid-induced gastric ulcer
NEW08019,DISEASE,inflammatory cell infiltration,inflammatory cell infiltration
NEW08020,DISEASE,ulcer area,ulcer area
D026423,CHEMICAL,S-Nitroso-N-Acetylpenicillamine,"S-NONAP|SNAP (NO donor)|N2-Acetyl-S-Nitroso-D,L-Penicillinaminamide|N-Acetyl-S-Nitrosopenicillamine|NO donor|S-Nitrosylacetylpenicillamine"
NEW08021,DISEASE,chronic colitis,chronic colitis
C053402,CHEMICAL,"(N-(4-amino-4-deoxy-N(10)-methylpteroyl)amino)-3-chloro-4,5-dihydro-5-isoxazoleacetic acid [Supplementary Concept]",Acivicin|Methotrexate/analogs  and  derivatives|Isoxazoles|acivicin|AT-125
NEW08022,DISEASE,refractory advanced solid tumor,refractory advanced solid tumors
NEW08023,CHEMICAL,l-glutamine antagonist,L-glutamine antagonist
NEW08024,CHEMICAL,plasma acivicin level,plasma acivicin levels
NEW08025,DISEASE,advanced malignancy,advanced malignancies
D051046,CHEMICAL,Amino-Acid N-Acetyltransferase,"Synthase, N-Acetylglutamate|Acetyl CoA Glutamate N Acetyltransferase|Amino-Acid Acetyltransferase|Amino Acid Acetyltransferase|amino acid|N Acetylglutamate Synthase|Synthetase, N-Acetyl-L-Glutamate|Acid Acetyltransferase, Amino|N-Acetyl-L-Glutamate Synthetase|Acetyltransferase, Amino-Acid|Acetyltransferase, Amino Acid|Acetyl Coenzyme A Glutamate N-Acetyltransferase|N-Acetylglutamate Synthase|N Acetylglutamate Synthetase|Synthetase, N-Acetylglutamate|Amino Acid N Acetyltransferase|N-Acetylglutamate Synthetase|Acetyl CoA Glutamate N-Acetyltransferase|N Acetyl L Glutamate Synthetase|N-Acetyltransferase, Amino-Acid|Acetyl Coenzyme A Glutamate N Acetyltransferase"
NEW08026,DISEASE,acivicin-induced cns toxicity,acivicin-induced CNS toxicity
NEW08027,CHEMICAL,miltiorrhiza Bge,miltiorrhiza Bge
NEW08028,DISEASE,stroke treatment,stroke treatment
C571351,CHEMICAL,danshensu bingpian zhi [Supplementary Concept],Danshensu|Phenylpropionates|Camphanes
NEW08029,MENTAL_HEALTH,pro-inflammatory reaction,pro-inflammatory reactions
C085278,CHEMICAL,hydroxysafflor yellow A [Supplementary Concept],Hydroxysafflor yellow A|Chalcone/analogs  and  derivatives|hydroxysafflor yellow A|HSYA|Quinones
NEW08030,DISEASE,neurological defect,neurological defects
C513882,CHEMICAL,nicotiflorin [Supplementary Concept],Flavonoids|nicotiflorin|Nicotiflorin|Phenols
NEW08031,NUTRITION,Carthamus tinctorius L.,Carthamus tinctorius L.
NEW08032,DISEASE,cerebral i/r injury,cerebral I/R injury
NEW08033,NUTRITION,defective fatty acid oxidation,Defective fatty acid oxidation
NEW08034,DISEASE,neurodegeneration deficit,neurodegeneration deficits
C565304,DISEASE,Multiple Mitochondrial Dysfunctions Syndrome [Supplementary Concept],mitochondrial dysfunctions|Mitochondrial dysfunctions|Mitochondrial Diseases
NEW08035,CHEMICAL,dopamine da neuron system relevant,dopamine DA neuron system relevant
NEW08036,CHEMICAL,da hypothesis,DA hypotheses
NEW08037,CHEMICAL,d2-n-methyl-d-aspartate mglu5 heteroreceptor complex,D2-N-methyl-d-aspartate mGlu5 heteroreceptor complexes
NEW08038,CHEMICAL,a2a-d2-metabotropic glutamate receptor,A2A-D2-metabotropic glutamate receptor
NEW08039,CHEBI,biased agonist action,biased agonist action
NEW08040,DISEASE,psychotic action,psychotic actions
NEW08041,CHEMICAL,schizophrenic and-due,schizophrenics and-due
NEW08042,CHEMICAL,antidepressant fluoxetine,Antidepressant fluoxetine
NEW08043,CHEMICAL,FLX administration,FLX administration
NEW08044,CHEMICAL,5-ht increment,5-HT increment
NEW08045,CHEMICAL,fluoxetine administration,Fluoxetine administration
C520797,DISEASE,GB-115 [Supplementary Concept],GB-115|Dipeptides
NEW08046,NUTRITION,neuroactive tryptophane,neuroactive tryptophane
NEW08047,CHEMICAL,kynurenine metabolite,kynurenine metabolite
NEW08048,CHEMICAL,low phenylalanine phe diet,low phenylalanine Phe diet
NEW08049,CHEMICAL,defective phenylalanine metabolism,defective phenylalanine metabolism
NEW08050,CHEMICAL,tetrahydrobiopterin bh4 cofactor,tetrahydrobiopterin BH4 cofactor
D010661,DISEASE,Phenylketonurias,"Hyperphenylalaninemia, BH4-Deficient, C|Deficiency Disease, Dihydropteridine Reductase|Folling Disease|BH4 Deficiency|DHPR Deficiency|Atypical Phenylketonuria|Non-Phenylketonuric Hyperphenylalaninemia|Deficiency, BH4|Deficiency, PAH|Hyperphenylalaninemia, Non-Phenylketonuric|Deficiency, Tetrahydrobiopterin|Folling's Disease|Quinoid Dihydropteridine Reductase Deficiency|Classical Phenylketonuria|Deficiency Disease, Phenylalanine Hydroxylase|Disease, Folling|Phenylketonuria I|Phenylalanine Hydroxylase Deficiency Disease, Severe|Deficiency, Phenylalanine Hydroxylase|Atypical PKU|Oligophrenia Phenylpyruvica|PAH Deficiency|QDPR Deficiency|Dihydropteridine Reductase Deficiency|Hyperphenylalaninemia Caused by a Defect in Biopterin Metabolism|Phenylketonuria|Hyperphenylalaninaemia|HPABH4C|Non Phenylketonuric Hyperphenylalaninemia|Phenylketonuria II|Phenylketonuria, Atypical|Hyperphenylalaninemia, Non Phenylketonuric|Deficiency, QDPR|Phenylketonuria Type 2|Disease, Folling's|Deficiency Disease, Phenylalanine Hydroxylase, Severe|Phenylketonuria, Classical|Hyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To DHPR Deficiency|hyperphenylalaninemia|Deficiency, DHPR|Non-Phenylketonuric Hyperphenylalaninemias|Dihydropteridine Reductase Deficiency Disease|Phenylalanine Hydroxylase Deficiency Disease|Tetrahydrobiopterin Deficiency|Deficiency, Dihydropteridine Reductase|Phenylalanine Hydroxylase Deficiency|PKU, Atypical"
NEW08051,CHEMICAL,tetrahydrobiopterin deficiency,tetrahydrobiopterin deficiencies
NEW08052,CHEMICAL,quinoline derive substance,quinoline derived substances
NEW08053,NUTRITION,tryptophane hydroxylase gene polymorphism,tryptophane hydroxylase gene polymorphism
NEW08054,CHEMICAL,serotonin transporter promoter gene,serotonin transporter promoter gene
D020268,DISEASE,"Alcohol-Induced Disorders, Nervous System","Alcohol Abuse, Nervous System|Ethanol-Induced Disorders, Nervous System|Alcohol Induced Disorders, Nervous System|Ethyl Alcohol Abuse Neurologic Syndromes|Ethanol Induced Nervous System Disorders|Ethanol Induced Disorders, Nervous System|Nervous System Disorders, Ethanol-Induced|nervous system disorders|Ethanol-Induced Nervous System Disorders|Nervous System Disorders, Ethanol Induced"
NEW08055,CHEMICAL,human metabotropic glutamate receptor subtype,human metabotropic glutamate receptor subtype
NEW08056,CHEMICAL,aromatic alcohol phenol,aromatic alcohol phenol
NEW08057,CHEMICAL,n-alcohols methanol,n-alcohols methanol
D002722,CHEMICAL,Chlorobenzenes,chlorobenzenes
NEW08058,CHEMICAL,several antidepressant,Several antidepressants
NEW08059,NUTRITION,lithium prophylaxis,lithium prophylaxis
NEW08060,CHEBI,first-line antiepileptic drug,first-line antiepileptic drug
NEW08061,DISEASE,precancerous lesion,precancerous lesions
NEW08062,CHEMICAL,smoke consumption,smoking consumption
NEW08063,MENTAL_HEALTH,pathological gambling similar,pathological gambling similar
NEW08064,DISEASE,abnormal regional grey matter volume,abnormal regional grey matter volumes
NEW08065,DISEASE,severe neurological disorder,severe neurological disorder
NEW08066,DISEASE,whose be neurotoxic effect,whose's neurotoxic effects
NEW08067,DISEASE,cognitive development,cognitive development
http://purl.org/sig/ont/fma/fma71132,DISEASE,gastrointestinal tract,Gastrointestinal system|Gastro-intestinal system|human gastrointestinal tract
NEW08068,DISEASE,chronic mental stress,chronic mental stresses
D016480,DISEASE,Helicobacter pylori,Campylobacter pyloridis|Helicobacter nemestrinae|Helicobacter pylori|Campylobacter pylori|Campylobacter pylori subsp. pylori
NEW08069,CHEMICAL,lfao oligomeric strain,LFAO oligomeric strain
http://purl.obolibrary.org/obo/DOID_0070027,CHEMICAL,cst3-related cerebral amyloid angiopathy,"CAA|Cerebral Hemorrhage, Hereditary, with Amyloidosis, Icelandic Variant|Amyloidosis, Cerebroarterial, Icelandic Type|Hereditary Cerebral Hemorrhage with Amyloidosis, Icelandic Variant|Amyloidosis VI|HCHWA|acute cerebral amyloid angiopathy"
D008076,NUTRITION,"Cholesterol, HDL","HDL2 Cholesterol|high-density lipoprotein cholesterol|High Density Lipoprotein Cholesterol|high density lipoprotein-cholesterol|Cholesterol, HDL3|high-density-lipoprotein cholesterol|Cholesterol, alpha-Lipoprotein|alpha Lipoprotein Cholesterol|HDL Cholesterol|HDL3 Cholesterol|high-density lipoprotein-cholesterol|High Density Lipoprotein cholesterol|HDL(3) Cholesterol|alpha-Lipoprotein Cholesterol|Cholesterol, HDL2|HDL(2) Cholesterol"
NEW08070,DISEASE,atherosclerotic heart disease,atherosclerotic heart disease
D007863,CHEBI,Lecithin Cholesterol Acyltransferase Deficiency,"alpha-Lecithin-Cholesterol Acyltransferase Deficiency|alpha-LCAT Deficiency|Deficiency, alpha-LCAT|LCATA Deficiencies|Acyltransferase Deficiency, Lecithin:Cholesterol|cholesterol acyltransferase deficiency|lecithin|FLD|LCAT Deficiency|Fish Eye Disease|Fish-Eye Disease|Lecithin:Cholesterol Acyltransferase Deficiency|Norum Disease|Deficiency, LCAT|Corneal Dystrophy, Dyslipoproteinemic|LCATA Deficiency|alpha LCAT Deficiency|phosphatidyl-choline|alpha-Lecithin:Cholesterol Acyltransferase Deficiency|Dyslipoproteinemic Corneal Dystrophy|Lecithin"
NEW08071,DISEASE,levodopa-induced abnormal movement,levodopa-induced abnormal movements
NEW08072,DISEASE,liver fibrogenesis,liver fibrogenesis
NEW08073,DISEASE,viral liver disease,viral liver disease
NEW08074,CHEMICAL,platelet mao,platelet MAO
NEW08075,CHEMICAL,brain mao,brain MAO
D056732,CHEMICAL,Prolidase Deficiency,"Imidodipeptidase Deficiencies|Prolidase Deficiencies|Deficiency, Imidodipeptidase|Hyperimidodipeptiduria|Deficiency, Prolidase|Deficiencies, Imidodipeptidase|Deficiencies, Prolidase|FLD|Hyperimidodipeptidurias|Imidodipeptidase Deficiency|deficiency"
C563921,DISEASE,"Congenital Corneal Opacities, Cornea Guttata, and Corectopia [Supplementary Concept]","Corneal Dystrophies, Hereditary|Pupil Disorders|corneal opacities"
NEW08076,NUTRITION,familial lecithin cholesterol acyltransferase lcat deficiency,familial lecithin cholesterol acyltransferase LCAT deficiency
NEW08077,DISEASE,several inborn error,Several inborn errors
C536835,CHEMICAL,Glutathione synthetase deficiency [Supplementary Concept],"Glutathione Synthase/deficiency|pyroglutamic aciduria|Amino Acid Metabolism, Inborn Errors"
C537359,DISEASE,Methylmalonic acidemia with homocystinuria [Supplementary Concept],methylmalonic acidemia|Vitamin B 12 Deficiency/congenital|Homocystinuria
NEW08078,DISEASE,n-acetyl aspartic aciduria,N-acetyl aspartic aciduria
NEW08079,DISEASE,norway familial lecithin-cholesterol acyltransferase deficiency,Norway familial lecithin-cholesterol acyltransferase deficiency
D015211,DISEASE,Zellweger Syndrome,"Zellweger Spectrum|PBD, ZSS|Cerebro-Hepato-Renal Syndrome|Zellweger Syndrome Spectrum|Cerebrohepatorenal Syndrome|Zellweger Disease|Spectrum, Zellweger|Zellweger Like Syndrome|Zellweger's Syndrome|Zellweger-Like Syndrome|Peroxisome Biogenesis Disorders, Zellweger Syndrome Spectrum|Zellweger's syndrome|Cerebro Hepato Renal Syndrome"
D019294,DISEASE,"Xanthomatosis, Cerebrotendinous","Cerebral Cholesterinoses|Cerebrotendinous Xanthomatosis|Cerebral Cholesterinosis|Disease, Van Bogaert-Scherer-Epstein|Xanthomatoses, Cerebrotendinous|Cerebrotendinous Xanthomatoses|Van Bogaert Scherer Epstein Disease|Van Bogaert-Scherer-Epstein Disease|cerebrotendinous xanthomatosis|Bogaert-Scherer-Epstein Disease, Van"
D010743,NUTRITION,Phospholipids,Phospholipid|Phospholipids|Phosphatides|phospholipids
NEW08080,NUTRITION,soy lecithin,soy lecithin
NEW08081,MENTAL_HEALTH,early alzheimer disease,early Alzheimer disease
NEW08082,CHEBI,supplemental lecithin,supplemental lecithin
NEW08083,CHEMICAL,oral physostigmine,oral physostigmine
NEW08084,CHEMICAL,hepatic transaminase enzyme activity,hepatic transaminase enzyme activity|TEA|total elbow arthroplasty
http://purl.obolibrary.org/obo/CHEBI_65311,CHEMICAL,corticotropin-releasing hormone,extrahypothalamic corticotropin-releasing hormone|directed corticotropin-releasing hormones|CRH|corticotrophin-releasing hormone|corticotropin-releasing factor
NEW08085,CHEMICAL,elevated crh concentration,elevated CRH concentrations
NEW08086,CHEMICAL,gaba(a)-receptor alpha-reduced neuroactive steroid,GABA(A)-receptor alpha-reduced neuroactive steroids
NEW08087,CHEMICAL,glucocorticoid receptor gr antagonist ru38486,glucocorticoid receptor GR antagonist RU38486
NEW08088,CHEMICAL,specific mineralocorticoid receptor mr antagonist ru28318,specific mineralocorticoid receptor MR antagonist RU28318
D018028,CHEMICAL,"Receptors, Neurotensin","neurotensin|Receptor, Neurotensin|Neurotensin Receptor|Neurotensin Receptors"
NEW08089,CHEMICAL,gaba release,GABA release
NEW08090,CHEMICAL,neurotensin agonist neurotensin peptide fragment,neurotensin agonist neurotensin peptide fragment
C114036,CHEMICAL,neurotensin type 1 receptor [Supplementary Concept],"Receptors, Neurotensin|neurotensin receptor"
C513736,CHEMICAL,"(Trp3, Arg5)-ghrelin(1-5) [Supplementary Concept]",Arg5|Ghrelin
NEW08091,CHEMICAL,antioxidant defense system glutathione,antioxidant defense system glutathione
NEW08092,CHEMICAL,acetylcholine activity,acetylcholine activity
C016837,CHEMICAL,zinc chloride [Supplementary Concept],ZnCl₂|Zinc Compounds|zinc chloride|Chlorides
NEW08093,DISEASE,zncl₂. neurotoxic effect,ZnCl₂. Neurotoxic effects
NEW08094,CHEMICAL,high dietary zinc,high dietary zinc
NEW08095,CHEMICAL,zinc concentration enzyme activity,zinc concentration enzyme activity
http://purl.obolibrary.org/obo/DOID_9279,DISEASE,hyperhomocysteinemia,hyperzincuria
D000086582,DISEASE,Anosmia,Loss of Smell|anosmia|Hyposmia|Smell Loss|hyposmia
D000370,DISEASE,Ageusia,"Hysterical Ageusias|Ageusia, Hysterical|Taste-Blindness|Hypogeusia|hypogeusia|Loss of Taste|Taste Blindness|Hysterical Ageusia|Ageusias, Hysterical|Taste Loss|Hypogeusias"
NEW08096,DISEASE,mechanical pain,mechanical pain
NEW08097,CHEMICAL,zinc sulfate nasal irrigation,zinc sulfate nasal irrigation
NEW08098,DISEASE,mouse conditioned avoidance response,CAR|mouse conditioned avoidance response
NEW08099,CHEMICAL,factor nuclear factor-κb,factor nuclear factor-κB
http://purl.obolibrary.org/obo/CHEBI_16240,CHEMICAL,hydrogen peroxide,Oxydol|bis(hydridooxygen)(O--O)|HYDROGEN PEROXIDE|dioxidane|[OH(OH)]|H2O2|Hydrogen peroxide|HOOH|dihydrogen dioxide|hydrogen peroxide|perhydrol|hydrogen peroxide production|dihydrogen(peroxide)|to hydrogen peroxide|dihydrogen peroxide
NEW08100,CHEMICAL,low serum zinc,low serum zinc
NEW08101,CHEMICAL,high aspartate aminotransferase/alanine aminotransferase ratio,higher aspartate aminotransferase/alanine aminotransferase ratio
NEW08102,DISEASE,skeletal muscle mass,skeletal muscle mass
NEW08103,CHEMICAL,bcaa zinc preparation,BCAA zinc preparation
NEW08104,CHEMICAL,potent selective gdh inhibitor,potent selective GDH inhibitor
NEW08105,CHEMICAL,antidepressant agent,antidepressant agents
NEW08106,DISEASE,chronic bulimic symptom,chronic bulimic symptoms
NEW08107,CHEMICAL,zinc supplementation,Zinc supplementation
D005742,CHEMICAL,Gasoline,"Gasolines|Fuel, Diesel|Fuels, Diesel|Diesel Fuels|Diesel Fuel|gasoline"
http://cbmi.med.harvard.edu/asdphenotype#Class_58,DISEASE,self-injurious behavior,delinquent behavior
NEW08108,DISEASE,physio-somatic symptom,physio-somatic symptoms
NEW08109,DISEASE,postnatal depressive symptom,Postnatal depressive symptoms
NEW08110,MENTAL_HEALTH,prenatal depression,prenatal depression
NEW08111,DISEASE,prenatal depressive symptom,prenatal depressive symptoms
NEW08112,CHEMICAL,dietary zinc,dietary zinc
NEW08113,CHEMICAL,hair copper level,hair copper levels
NEW08114,CHEMICAL,spot urine creatinine,spot urine creatinine
NEW08115,CHEMICAL,zinc ratio,zinc ratio
D000090463,CHEMICAL,Iron Deficiencies,"iron deficiencies|Sideropenia|Sideropenias|Latent Iron Deficiency|Deficiency, Latent Iron|Hypoferritinemias|Latent Iron Deficiencies|Iron Deficiency|Deficiencies, Latent Iron|Iron Deficiencies, Latent|Iron Deficiency, Latent|Hypoferritinemia|Deficiency, Iron|Deficiencies, Iron"
NEW08116,DISEASE,common nutritional deficit,common nutritional deficits
NEW08117,DISEASE,major depressed subject,Major depressed subjects
NEW08118,CHEMICAL,low serum Fe,lower serum Fe
D033901,CHEMICAL,Bacterial Transferrin Receptor Complex,"Transferrin Binding Protein Complex, Bacterial|transferrin|Tf|Transferrin-Binding Protein Complex, Bacterial"
NEW08119,CHEMICAL,chronic high-level alcohol consumption,chronic high-level alcohol consumption
NEW08120,DISEASE,increase inflammation,increased inflammation
NEW08121,CHEMICAL,cortisol pathway dysregulation,cortisol pathway dysregulation
NEW08122,CHEMICAL,dietary zinc intake,Dietary zinc intake
NEW08123,DISEASE,daytime dysfunction,daytime dysfunction
NEW08124,CHEMICAL,dietary zinc intake,dietary zinc intake
D003533,CHEMICAL,Cyproheptadine,Viternum|Cyproheptadine|Antergan|Periactin|cyproheptadine|Dihexazin|Peritol
D012563,DISEASE,"Schizophrenia, Paranoid","delusional disorder|Delusional Disorder|delusional disorders|Paranoid Schizophrenias|Paranoid Schizophrenia|Delusional Disorders|Disorders, Delusional|paranoid schizophrenia|Schizophrenias, Paranoid|Disorder, Delusional"
NEW08125,MENTAL_HEALTH,refractory obsessive-compulsive disorder,refractory obsessive-compulsive disorder
NEW08126,CHEMICAL,bl-3912,BL-3912
NEW08127,CHEMICAL,lsd-trained rat,LSD-trained rats
NEW08128,CHEBI,potent postsynaptic serotonergic antagonist,potent postsynaptic serotonergic antagonist
NEW08129,CHEBI,daily prenatal vitamin,daily prenatal vitamin
NEW08130,DISEASE,neurologic fetal development,neurologic fetal development
http://purl.obolibrary.org/obo/CHEBI_82663,CHEMICAL,elemental iron,elemental iron
D009767,DISEASE,"Obesity, Morbid","Obesities, Severe|Severe Obesity|Morbid Obesity|Obesity, Severe|morbid obesity|Morbid Obesities|Severe Obesities|Obesities, Morbid"
D064306,CHEBI,Non-Nutritive Sweeteners,"Sweeteners, High-Intensity|Artificial Sweeteners, Non Nutritive|Artificial Sweeteners, Non-Nutritive|Non-Nutritive Artificial Sweeteners|High-Intensity Sweeteners|Sweeteners, Non-Nutritive|artificial sweeteners|High Intensity Sweeteners|Non Nutritive Sweeteners|Non-Nutritive Sweeteners"
NEW08131,CHEMICAL,kava hepatotoxicity,kava hepatotoxicity
http://purl.obolibrary.org/obo/DOID_3985,DISEASE,ostertagiasis,Salmonella-caused pullorosis|aflatoxicosis
D014761,DISEASE,Viral Hepatitis Vaccines,"Hepatitis, Viral, Vaccines|Viral hepatitis|Hepatitis Vaccines, Viral|viral hepatitis|Vaccines, Viral Hepatitis"
NEW08132,CHEMICAL,hepatic iron transporter,hepatic iron transporters
NEW08133,CHEMICAL,hereditary iron overload disease,hereditary iron overload diseases
D006432,DISEASE,Hemochromatosis,"Diabetes, Bronze|Hemochromatoses, Genetic|Bronze Diabetes|Bronzed Cirrhosis|Pigmentary Cirrhosis|Hemochromatosis, Familial|Cirrhosis, Pigmentary|Cirrhoses, Bronzed|Syndromes, Troisier-Hanot-Chauffard|Troisier-Hanot-Chauffard Syndromes|Syndrome, Troisier-Hanot-Chauffard|Hemochromatoses|Hemochromatosis, Genetic|Storage Disorder, Iron|Disease, Von Recklenhausen-Applebaum|Cirrhoses, Pigmentary|Hemochromatose|Iron Storage Disorders|Diseases, Von Recklenhausen-Applebaum|Troisier Hanot Chauffard Syndrome|Genetic Hemochromatosis|Cirrhosis, Bronzed|Pigmentary Cirrhoses|Familial Hemochromatosis|Disorder, Iron Storage|Hemochromatoses, Familial|Recklenhausen-Applebaum Diseases, Von|Primary Hemochromatosis|Familial Hemochromatoses|Von Recklenhausen Applebaum Disease|Von Recklenhausen-Applebaum Diseases|Haemochromatoses|iron storage|Disorders, Iron Storage|Recklenhausen-Applebaum Disease, Von|Haemochromatosis|Troisier-Hanot-Chauffard Syndrome|Von Recklenhausen-Applebaum Disease|Bronzed Cirrhoses|Iron Storage Disorder|Storage Disorders, Iron|Genetic Hemochromatoses|hemochromatosis"
NEW08134,CHEMICAL,iron toxicity,Iron toxicity
NEW08135,DISEASE,trigger organelle dysfunction,triggering organelle dysfunction
NEW08136,DISEASE,hepatotoxic potential,hepatotoxic potential
D004211,DISEASE,Disseminated Intravascular Coagulation,"|Disseminated Intravascular Coagulations|Coagulation, Intravascular Disseminated|DIC|Intravascular Disseminated Coagulations|Coagulation, Disseminated Intravascular|Coagulations, Intravascular Disseminated|Intravascular Coagulation, Disseminated|Coagulations, Disseminated Intravascular|Coagulopathy, Consumption|Consumption Coagulopathy|Consumption Coagulopathies|Disseminated Coagulations, Intravascular|intravascular coagulation|Disseminated Coagulation, Intravascular|Intravascular Coagulations, Disseminated|disseminated intravascular coagulation|Coagulopathies, Consumption|coagulopathy|Intravascular Disseminated Coagulation"
NEW08137,DISEASE,difficult-to-treat subtype,difficult-to-treat subtypes
NEW08138,DISEASE,bipolar illness,bipolar illness
NEW08139,DISEASE,depressed people,depressed people
NEW08140,CHEMICAL,adenosine 2a a2a receptor hyperactivation,adenosine 2A A2A receptor hyperactivation
NEW08141,CHEMICAL,acetylcholine depletion,acetylcholine depletion
NEW08142,CHEBI,microtubule stabiliser,microtubule stabilisers
NEW08143,NUTRITION,lithium relapse prevention effect,lithium relapse prevention effects
NEW08144,DISEASE,manic relapse,manic relapses
NEW08145,CHEMICAL,antidepressant prescription,antidepressant prescriptions
D056785,DISEASE,"Medicine, Mongolian Traditional","Medicine, Mongolian|Medicines, Mongolian|Folk Medicine, Mongolian|Mongolian Medicines|Medicines|Folk Medicines, Mongolian|Medicines, Mongolian Folk|Traditional Medicine, Mongolian|Mongolian Traditional Medicine|Mongolian Medicine|Medicine, Mongolian Folk|Mongolian Folk Medicines|Medicines, Mongolian Traditional|CSM|Mongolian Traditional Medicines|Mongolian Folk Medicine|Traditional Medicines, Mongolian"
NEW08146,CHEBI,low carotenoid status,Low carotenoid status
D014975,CHEBI,Lutein,"beta,epsilon-Carotene-3, 3'-Diol, (3R,3'R,6'S)-|gamma Lutein|beta,epsilon-Carotene-3,3'-diol, (3S,3'R,6'S)-|Lutein G|Lutein F|Lutein, gamma|lutein"
NEW08147,CHEMICAL,methamphetamine use,methamphetamine use
NEW08148,DISEASE,granulocytosis,granulocytosis
D008231,DISEASE,Lymphopenia,|Lymphopenias|lymphopenia|Lymphocytopenias|Lymphocytopenia
D066187,DISEASE,Basal Forebrain,"Telencephali, Pars Basalis|Basalis Telencephalus, Pars|Forebrains, Basal|Ventral Pallidum|Basalis Telencephali, Pars|Forebrain, Basal|Area, Basal Forebrain|Areas, Basal Forebrain|Basal Forebrain Areas|Basal Forebrain Area|Pallidum, Ventral|Pars Basalis Telencephali|Basal Forebrains|Forebrain Areas, Basal|Forebrain Area, Basal|Ventral Pallidums|Pars Basalis Telencephalus|Telencephalus, Pars Basalis|forebrain|Pallidums, Ventral"
D058953,DISEASE,Neural Stem Cells,"Cell, Neural Stem|Neural Stem Cell|Stem Cell, Neural|Cells, Neural Stem|Stem Cells, Neural|neural stem cells"
NEW08149,CHEMICAL,glutamate due,glutamate due
NEW08150,NUTRITION,prolonged lithium intoxication,Prolonged lithium intoxication
NEW08151,DISEASE,permanent brain damage,permanent brain damage
D012402,CHEMICAL,Rotenone,rotenone|Insecticides|Rotenone|Uncoupling Agents
D004178,CHEMICAL,Diquat,"Dibromide, Diquat|Diquat Dibromide|diquat"
NEW08152,DISEASE,impairment swimming score,impairment swimming score
NEW08153,DISEASE,mild nigrostriatal neurodegeneration,mild nigrostriatal neurodegeneration
NEW08154,CHEBI,multiple toxin,multiple toxins
http://purl.obolibrary.org/obo/DOID_4675,DISEASE,uremic neuropathy,uraemic neuropathy
NEW08155,CHEBI,clostridial neurotoxin,Clostridial neurotoxins
http://purl.obolibrary.org/obo/NCBITaxon_1491,DISEASE,clostridium botulinum,bacterium Clostridium botulinum|bacteria Clostridium botulinum
NEW08156,CHEBI,botulinum neurotoxin bont family,botulinum neurotoxin BoNT family
D009209,DISEASE,Myofascial Pain Syndromes,"Pain Syndromes, Myofascial|Trigger Point Pain, Myofascial|myofascial pain|Syndrome, Myofascial Pain|Pain Syndrome, Myofascial|Myofascial Pain Syndrome|Myofascial Trigger Point Pain|Syndromes, Myofascial Pain"
NEW08157,CHEMICAL,soluble amyloid oligomer,Soluble amyloid oligomers
NEW08158,MENTAL_HEALTH,damage disorder,damage disorders
NEW08159,NUTRITION,prenatal choline supplementation,prenatal choline supplementation
D000069338,DISEASE,Neuropathology,Neuropathologies|neuropathologies|neuropathology|Neuropathologists|Neuropathologist
NEW08160,CHEMICAL,high-dose mk-801 rat,high-dose MK-801 rats
NEW08161,CHEMICAL,plasma corticosterone,Plasma corticosterone
D059865,CHEMICAL,Endoplasmic Reticulum Stress,"Endoplasmic Reticulum Stresses|Stress, Endoplasmic Reticulum|stress|Reticulum Stresses, Endoplasmic|Stresses, Endoplasmic Reticulum|Reticulum Stress, Endoplasmic"
NEW08162,CHEMICAL,its 's oxidize product 1-methyl-4-phenylpyridinium,its's oxidized product 1-methyl-4-phenylpyridinium
NEW08163,DISEASE,parkinsonian symptom,parkinsonian symptoms
C549047,CHEMICAL,amyloid beta-peptide (9-42) [Supplementary Concept],beta-amyloid peptide|Peptide Fragments|Amyloid beta-Peptides
NEW08164,DISEASE,which be infectious disease,which's infectious disease
NEW08165,CHEBI,environmental neurotoxin,environmental neurotoxins
NEW08166,CHEBI,uraemic neurotoxin,uraemic neurotoxins
NEW08167,DISEASE,mci pathogenesis,MCI pathogenesis
NEW08168,DISEASE,oligomer-induced cognitive impairment,oligomer-induced cognitive impairment
NEW08169,DISEASE,only infection,only infections
NEW08170,DISEASE,amyloid-β-induce toxicity,amyloid-β-induced toxicity
NEW08171,DISEASE,neonatal infection,neonatal infections
NEW08172,DISEASE,death toll,death toll
NEW08173,CHEMICAL,resistant mycobacterium tuberculosis,resistant Mycobacterium tuberculosis
NEW08174,MENTAL_HEALTH,insomnia treatment,Insomnia treatment
D004347,CHEBI,Drug Interactions,"drug interactions|Interaction, Drug|Interactions, Drug|Drug Interaction"
NEW08175,CHEBI,new dual orexin receptor antagonist,new dual orexin receptor antagonist
NEW08176,MENTAL_HEALTH,Karolinska Sleepiness scale,Karolinska Sleepiness Scale
NEW08177,CHEMICAL,nonselective orexin receptor antagonist suvorexant,nonselective orexin receptor antagonist suvorexant
NEW08178,CHEBI,ox1 receptor antagonist,OX1 receptor antagonist
NEW08179,MENTAL_HEALTH,Binge eat Anxiety Disorders,Binge Eating Anxiety Disorders
NEW08180,CHEBI,orexin receptor oxr antagonist,orexin receptor OXR antagonists
http://purl.obolibrary.org/obo/CHEBI_83296,CHEMICAL,orexin receptor antagonist,orexin receptor antagonist similar|orexin receptor agonists|dual orexin receptor antagonist daridorexant|orexin receptor antagonists|potent orexin receptor antagonist|orexin receptor antagonist suvorexant
NEW08181,CHEBI,oxr antagonist,OXR antagonists
NEW08182,DISEASE,cocaine-evoked impulsivity,cocaine-evoked impulsivity
NEW08183,DISEASE,psychostimulant-induced motor impulsivity,psychostimulant-induced motor impulsivity
NEW08184,DISEASE,advanced pd stage,advanced PD stages
NEW08185,CHEMICAL,serotonin alteration,serotonin alterations
NEW08186,CHEMICAL,psychotogenic effect,psychotogenic effects
NEW08187,CHEBI,drug dopaminergic agonist,drugs dopaminergic agonists
NEW08188,CHEMICAL,psychotomimetic state,psychotomimetic states
http://purl.obolibrary.org/obo/DOID_10939,MENTAL_HEALTH,antisocial personality disorder,Psychopath.personality|Psychopathic personality disorder|sociopathic personality|Dissocial personality disorder|impulsive personality disorders|Asocial personality|Psychopathic personality
http://purl.obolibrary.org/obo/SYMP_0000607,MENTAL_HEALTH,hallucination,Medicationrelated hallucinations|LSD-like hallucinations
NEW08189,CHEBI,circulate oestrogen,circulating oestrogens
NEW08190,CHEBI,oestrogen therapy,Oestrogen therapy
NEW08191,DISEASE,peri- woman,peri- women
http://purl.obolibrary.org/obo/CHEBI_52550,CHEBI,theopalauamide,"(1S,7S,10R,14S,17S,20S,23R,26S,30S,33S,36S,39S)-17-[(1R)-2-amino-1-hydroxy-2-oxoethyl]-20-(2-amino-2-oxoethyl)-33-benzyl-14-[(1S)-1-(4-bromophenyl)ethyl]-44-(beta-D-galactopyranosyl)-10-hydroxy-39-[(1S)-1-hydroxyethyl]-26,36-bis(hydroxymethyl)-30-[(1S,2E,4E)-1-hydroxy-3-methyl-5-phenylpenta-2,4-dien-1-yl]-3,9,13,16,19,22,25,28,32,35,38,41-dodecaoxo-2,8,12,15,18,21,24,27,31,34,37,40,44-tridecaaza-46-azoniatricyclo[21.18.6.1(43,46)]octatetraconta-43(48),45-diene-7-carboxylate|antifungals|C(3.1),C(3.7)-[3-(beta-D-galactopyranosyl)-1H-imidazolium-4,1-diyl]-1,12-anhydro[L-alanyl-L-allothreonyl-L-seryl-L-phenylalanyl-(3S,4S,5E,7E)-3-amino-4-hydroxy-6-methyl-8-phenylocta-5,7-dienoyl-L-seryl-D-alanyl-L-asparaginyl-(3R)-3-hydroxy-L-asparaginyl-(betaS)-4-bromo-beta-methyl-L-phenylalanyl-(2R)-2-hydroxy-beta-alanyl-(5S)-5-amino-5-carboxylatopentanoyl]"
http://purl.obolibrary.org/obo/CHEBI_80841,CHEBI,kakuol,antimycobacterials|Kakoul
http://purl.org/sig/ont/fma/fma67440,CHEMICAL,claustrum,caudate putamen|Dorsal portion of claustrum|CP|Dorsal claustrum
NEW08192,CHEBI,lipophilic anticholinergic,Lipophilic anticholinergics
NEW08193,DISEASE,mnesic,mnesic
NEW08194,MENTAL_HEALTH,Disease Psychosis,Disease Psychosis
NEW08195,DISEASE,sinus arrhythmia measurement,Sinus arrhythmia measurements
NEW08196,CHEMICAL,mirabegron use,mirabegron use
NEW08197,DISEASE,uui,UUI
NEW08198,DISEASE,acute dystonia,Acute dystonia
NEW08199,CHEMICAL,strychnine poison,strychnine poisoning
NEW08200,DISEASE,localized tetanus,localized tetanus
D020937,DISEASE,"Epilepsy, Partial, Sensory","Sensory Seizure, Partial|Sensory Seizures, Partial|Seizure, Vertiginous Partial|Sensory Focal Seizure Disorder|Vertiginous Partial Seizure|Gustatory Partial Seizure|Sensory Partial Epilepsy|Seizure Disorder, Sensory|Sensory Partial Seizure Disorder|Partial Seizure, Gustatory|Partial Seizures, Gustatory|Seizure, Olfactory Partial|Seizure, Visual Partial|Seizures, Olfactory Partial|Olfactory Partial Seizure|Partial Seizures, Olfactory|Partial Seizure, Vertiginous|Seizures, Vertiginous Partial|Seizure, Gustatory Partial|Sensory Seizure, Focal|Partial Sensory Seizure|Epilepsy, Sensory|Seizure Disorders, Sensory|Partial Epilepsy, Sensory|Partial Seizure, Visual|Partial Sensory Seizures|Partial Seizures, Visual|Seizure Disorder, Partial, Sensory|Focal Seizure Disorder, Sensory|partial seizures|Seizures, Partial Sensory|Epilepsy, Sensory Partial|Sensory Seizure Disorder|Focal Sensory Seizure|Olfactory Partial Seizures|Seizure, Partial Sensory|Seizures, Focal Sensory|Visual Partial Seizure|Simple Partial Seizures, Special Sensory Symptoms|Partial Seizure, Olfactory|Seizure, Focal Sensory|Sensory Seizure Disorders|Visual Partial Seizures|Partial Seizures, Vertiginous|Vertiginous Partial Seizures|Sensory Epilepsy|Seizure Disorder, Sensory, Focal|Seizures, Simple Partial, Special Sensory Symptoms|Sensory Seizures, Focal|Gustatory Partial Seizures|Focal Sensory Seizures"
D008306,MENTAL_HEALTH,Malingering,malingering
D020814,DISEASE,"Meningitis, Escherichia coli","meningitis|Escherichia coli Meningitides|Escherichia coli Meningitis|Meningitides, Escherichia coli"
NEW08201,DISEASE,attention-deficit/hyperactivity disorder medication,attention-deficit/hyperactivity disorder medications
NEW08202,MENTAL_HEALTH,pediatric nocturnal enuresis,pediatric nocturnal enuresis
NEW08203,CHEBI,antidiuretic hormone analog,antidiuretic hormone analogs
NEW08204,MENTAL_HEALTH,enuresis alarm,enuresis alarms
NEW08205,MENTAL_HEALTH,toxic delirium,Toxic delirium
C026718,CHEMICAL,physostigmine salicylate [Supplementary Concept],physostigmine salicylate|Physostigmine/analogs  and  derivatives
NEW08206,CHEBI,neuroleptic anticholinergic,neuroleptics anticholinergics
C073145,CHEMICAL,S-adenosylmethionine-dependent phosphate methyltransferase [Supplementary Concept],Methyltransferases|AdoMet
C558116,CHEMICAL,"8-ethynyl-6-(2'-pyridine)-4H-2,5,10b-triazabenzo(e)azulene-3-carboxylic acid ethyl ester [Supplementary Concept]",Benzodiazepines|Imidazoles|HZ166
NEW08207,DISEASE,sedation motor impairment,sedation motor impairment
NEW08208,MENTAL_HEALTH,chronic stress aqp5 expressing cell,chronic stress AQP5 expressing cells
C500889,CHEMICAL,"Ara h 1 protein, Arachis hypogaea [Supplementary Concept]","Plant Proteins|Membrane Proteins|ARA|Antigens, Plant"
NEW08209,DISEASE,active disease,active disease
NEW08210,MENTAL_HEALTH,static encephalopathy,Static encephalopathy
NEW08211,CHEMICAL,amyloid evolvability,amyloid evolvability
D018244,NUTRITION,"Chromosomes, Artificial, Yeast","Chromosomes, Yeast Artificial|Yeast Artificial Chromosome|YAC (Chromosome)|Artificial Chromosomes, Yeast|Chromosome, Yeast Artificial|Artificial Chromosome, Yeast|YACs (Chromosomes)|yeast artificial chromosome|Yeast Artificial Chromosomes"
http://purl.obolibrary.org/obo/CHEBI_53121,CHEMICAL,adenosine a2a receptor antagonist,A2A adenosine receptor antagonism|adenosine A2A receptor antagonist|adenosine A2A receptor antagonists|A2A adenosine receptor antagonists|Adenosine A2A receptor blockade|potent adenosine A2a receptor antagonist
NEW08212,DISEASE,parkinsonian motor symptom,parkinsonian motor symptoms
NEW08213,CHEMICAL,"gold-standard 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","gold-standard 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"
NEW08214,DISEASE,postural deficit,postural deficits
NEW08215,CHEMICAL,istradefylline increase on-time,istradefylline increased on-time
NEW08216,CHEMICAL,optimal l-dopa treatment dose,optimal l-DOPA treatment dose
NEW08217,CHEMICAL,istradefylline administration,istradefylline administration
NEW08218,DISEASE,rare x-recessive disorder,rare X-recessive disorder
NEW08219,CHEMICAL,uric acid neurological problem,uric acid neurological problems
NEW08220,DISEASE,compulsive self-mutilation,compulsive self-mutilation
NEW08221,CHEMICAL,aicaribosid,AICAribosid|AICAR breakdown product
NEW08222,CHEMICAL,metabolite 5'-methylthioadenosine,metabolite 5'-methylthioadenosine|MTA
NEW08223,DISEASE,melanoma cell,melanoma cells
NEW08224,CHEBI,anthrax lethal toxin,anthrax lethal toxin
NEW08225,CHEMICAL,non-vitamin k antagonist oral anticoagulant,Non-vitamin K antagonist oral anticoagulants
NEW08226,DISEASE,non-valvular Atrial Fibrillation,non-valvular Atrial Fibrillation
NEW08227,DISEASE,stroke prevention,stroke prevention
NEW08228,CHEMICAL,Hypericum perforatum L.,Hypericum perforatum L.
NEW08229,CHEMICAL,clear antidepressant action,clear antidepressant action
NEW08230,CHEMICAL,kg(-1,kg(-1
NEW08231,DISEASE,non-spatial memory impairment due,non-spatial memory impairments due
NEW08232,CHEMICAL,hypericin content,hypericin content
NEW08233,CHEMICAL,zinc (zn)-deficiency,zinc (Zn)-deficiency
NEW08234,CHEMICAL,h. triquetrifolium,H. triquetrifolium
NEW08235,CHEMICAL,rat to chronic unpredictable stress,chronic unpredictable stress|rats to chronic unpredictable stress|CUS
NEW08236,DISEASE,associative memory impairment,associative memory impairment
NEW08237,DISEASE,body weight loss,body weight loss
D011490,CHEMICAL,Protein Disulfide Reductase (Glutathione),"Thiol Protein Disulfide Oxidoreductase|Transhydrogenase, Glutathione Insulin|Thiol-Disulfide Oxidoreductase|Insulin Transhydrogenase, Glutathione|Disulfide Oxidoreductase, Thiol-Protein|Oxidoreductase, Thiol-Protein Disulfide|Oxidoreductase, Thiol-Disulfide|Thiol-Protein Disulfide Oxidoreductase|thiol|Glutathione Insulin Transhydrogenase|Thiol Disulfide Oxidoreductase|Glutathione Protein Disulfide Oxidoreductase"
NEW08238,CHEMICAL,ud extract,UD extract
NEW08239,DISEASE,mediate neurological disorder,mediated neurological disorders
NEW08240,DISEASE,hypersomnia item,hypersomnia items
C422326,CHEMICAL,Hypericum extract LI 160 [Supplementary Concept],LI160|Hypericum|Plant Extracts
NEW08241,DISEASE,structural cardiac abnormality,structural cardiac abnormality
NEW08242,CHEMICAL,non-fda-approved over-the-counter OTC herbal supplement,non-FDA-approved over-the-counter OTC herbal supplement
C559745,CHEMICAL,hyperforin dicyclohexylammonium [Supplementary Concept],Terpenes|Hyperforin
D020244,DISEASE,"Infarction, Middle Cerebral Artery","Infarct, MCA|Thrombotic Infarction, Middle Cerebral Artery|cerebral artery occlusion|Middle Cerebral Artery Circulation Infarction|Right Middle Cerebral Artery Infarction|Middle Cerebral Artery Embolus|Stroke, Middle Cerebral Artery|Middle Cerebral Artery Embolic Infarction|middle cerebral artery occlusion|MCA Infarct|MCA Infarction|Left Middle Cerebral Artery Infarction|Middle Cerebral Artery Stroke|Occlusion, Middle Cerebral Artery|Middle Cerebral Artery Thrombosis|Cerebral Infarction, Middle Cerebral Artery|Middle Cerebral Artery Thrombotic Infarction|Embolus, Middle Cerebral Artery|Middle Cerebral Artery Occlusion|Middle Cerebral Artery Infarction|Middle Cerebral Artery Syndrome|Infarcts, MCA|MCA Infarcts|Embolic Infarction, Middle Cerebral Artery|Thrombosis, Middle Cerebral Artery"
NEW08243,DISEASE,edema formation,edema formation
NEW08244,DISEASE,neuronal cell injury,neuronal cell injury
NEW08245,CHEMICAL,hypericum extract,hypericum extracts|HpE
NEW08246,MENTAL_HEALTH,classical adhd drug,classical ADHD drugs
NEW08247,CHEBI,nutraceutical treatment,nutraceutical treatments
NEW08248,DISEASE,menstruous dysfunction,menstruous dysfunction
NEW08249,DISEASE,5-htp-induced dog shake behavior,5-HTP-induced dog shake behavior
NEW08250,CHEMICAL,2a-selective agonist guanfacine,2a-selective agonist guanfacine
http://purl.org/sig/ont/fma/fma67255,NUTRITION,alpha adrenergic receptor,post-junctional alpha receptors
NEW08251,CHEMICAL,"drug dopamine da precursor l-3,4-dihydroxy phenylamine","drugs dopamine DA precursor L-3,4-dihydroxy phenylamine"
NEW08252,DISEASE,induce catalepsy,induced catalepsy
NEW08253,CHEMICAL,da releaser amantadine,DA releaser amantadine
NEW08254,CHEMICAL,serum ni concentration,serum Ni concentrations
http://purl.obolibrary.org/obo/DOID_0060042,MENTAL_HEALTH,atypical autism,atypical autism|PDD
NEW08255,CHEMICAL,serum Al,serum Al
NEW08256,CHEMICAL,al concentration,Al concentration
NEW08257,MENTAL_HEALTH,childhood autism patient,childhood autism patients
NEW08258,CHEMICAL,serum selenium concentration,serum selenium concentrations
NEW08259,DISEASE,chronic neurodegeneration,chronic neurodegeneration
NEW08260,CHEMICAL,brain oxidize glutathione level,brain oxidized glutathione levels
NEW08261,CHEMICAL,selenium metabolism,selenium metabolism
C506812,DISEASE,"Htt protein, mouse [Supplementary Concept]",mouse HD|Huntingtin Protein
NEW08262,DISEASE,d-gal-induced anxiety- symptom,D-gal-induced anxiety- symptoms
NEW08263,DISEASE,d-gal-induced dysfunction,D-gal-induced dysfunction
Q000150,DISEASE,complications [Subheading],sequelae|concomitant conditions|sequels|associated conditions|associated disease|concomitant disease|coexistent conditions|coexistent disease
NEW08264,CHEBI,specific vitamin b-12,specific vitamins B-12
NEW08265,CHEMICAL,mineral calcium,minerals calcium
NEW08266,CHEMICAL,vitamin-like nutrient,vitamin-like nutrients
D051137,CHEMICAL,Selenium-Binding Proteins,"Protein, Selenium Binding|Protein, Se-Binding|Se Binding Proteins|Selenium Binding Protein|Se-Binding Proteins|Se Binding Protein|Selenium-Binding Protein|Protein, Selenium-Binding|Binding Protein, Selenium|Selenium Binding Proteins|Selenium binding protein|Se-Binding Protein"
C459607,CHEMICAL,"Zhf1 protein, S pombe [Supplementary Concept]",Membrane Transport Proteins|Schizosaccharomyces pombe Proteins|zinc homeostasis
NEW08267,DISEASE,secondary hypogonadism,secondary hypogonadism
NEW08268,CHEMICAL,selenium exposure,Selenium exposure
NEW08269,MENTAL_HEALTH,liver insulin resistance,liver insulin resistance
NEW08270,CHEMICAL,elevated plasma selenium level,elevated plasma selenium levels
NEW08271,CHEMICAL,increase plasma selenium level,increased plasma selenium level
NEW08272,CHEMICAL,blood plasma selenium,blood plasma selenium
D000072657,DISEASE,ST Elevation Myocardial Infarction,ST-elevation|ST Elevated Myocardial Infarction|STEMI|ST Segment Elevation Myocardial Infarction
D054058,DISEASE,Acute Coronary Syndrome,"ACS|Coronary Syndromes, Acute|ACSs|acute syndrome|acute coronary syndrome|acute coronary syndromes|Acute Coronary Syndromes|Syndrome, Acute Coronary|Coronary Syndrome, Acute|Syndromes, Acute Coronary"
NEW08273,DISEASE,myocardial infarction deficiency,myocardial infarction deficiency
C008493,CHEMICAL,methylselenic acid [Supplementary Concept],Methylseleninic acid|Organoselenium Compounds
NEW08274,DISEASE,induce methemoglobinemia,induced methemoglobinemia
NEW08275,DISEASE,hematological disorder,hematological disorder
NEW08276,CHEMICAL,selenium nanoparticle,Selenium nanoparticles
NEW08277,CHEBI,chronic disease long-term drug therapy,chronic disease long-term drug therapy
NEW08278,DISEASE,hyperlipidaemia,hyperlipidaemia
NEW08279,CHEMICAL,low-dose senps aggravated atherosclerotic lesion,low-dose SeNPs aggravated atherosclerotic lesions
NEW08280,CHEMICAL,maternal rbc se level,maternal RBC Se levels
NEW08281,CHEMICAL,maternal se,maternal Se
NEW08282,DISEASE,autistic subject,autistic subjects
NEW08283,DISEASE,diabetic people,diabetic people
NEW08284,CHEMICAL,desipramine mg/kg,desipramine mg/kg
NEW08285,DISEASE,picrotoxin-induced locomotor stimulation,picrotoxin-induced locomotor stimulation
D018756,CHEBI,GABA Antagonists,"Antagonists, gamma-Aminobutyric Acid|Acid Antagonists, gamma-Aminobutyric|Receptor Antagonists, GABA|Antagonist, GABA|GABA Receptor Antagonists|GABA antagonists|Antagonists, GABA|gamma-Aminobutyric Acid Antagonists|Antagonists, GABA Receptor|GABA Antagonist|GABA antagonist|gamma Aminobutyric Acid Antagonists|GABA antagonist-"
NEW08286,CHEBI,gaba antagonist drug,GABA antagonist drugs
NEW08287,DISEASE,motor incoordination,motor incoordination
D007222,DISEASE,Inert Gas Narcosis,"Nitrogen Narcosis|Nitrogen Narcoses|Narcoses, Inert Gas|narcosis|Narcosis, Nitrogen|Depth Intoxication|Inert Gas Narcoses|Intoxication, Depth|Intoxications, Depth|Narcosis, Inert Gas|Depth Intoxications|Narcoses, Nitrogen"
C513601,CHEMICAL,"gabP protein, E coli [Supplementary Concept]",Organic Anion Transporters|Escherichia coli Proteins|γ-aminobutyrate|GABA Plasma Membrane Transport Proteins
NEW08288,CHEBI,convulsant drug,convulsant drug
NEW08289,CHEMICAL,kainate-type glutamate receptor,kainate-type glutamate receptors
http://purl.obolibrary.org/obo/DOID_11723,DISEASE,duchenne muscular dystrophy,"Muscular dystrophy, Duchenne|Duchenne muscular dystrophy patients"
NEW08290,CHEMICAL,glucosamine hydrochloride,Glucosamine hydrochloride
NEW08291,DISEASE,antagonist- behavioral alteration,antagonist- behavioral alterations
NEW08292,CHEMICAL,la classification,LA classification
NEW08293,DISEASE,esophageal damage,esophageal damage
NEW08294,DISEASE,hepatotoxic effect,hepatotoxic effect
NEW08295,DISEASE,register gerd,registered GERD
NEW08296,DISEASE,due facial palsy,due facial palsy
NEW08297,DISEASE,eyelid swelling,eyelid swelling
D058568,DISEASE,Necrolytic Migratory Erythema,"Syndromes, Pseudoglucagonoma|Erythema, Necrolytic Migratory|erythema|Migratory Erythemas, Necrolytic|Migratory Erythema, Necrolytic|Erythemas, Necrolytic Migratory|Pseudoglucagonoma Syndrome|Syndrome, Pseudoglucagonoma|Pseudoglucagonoma Syndromes|Necrolytic Migratory Erythemas"
NEW08298,CHEMICAL,ros neutralize antioxidative defense mechanism,ROS neutralizing antioxidative defense mechanisms
NEW08299,DISEASE,neurotoxic adverse event,neurotoxic adverse events
NEW08300,MENTAL_HEALTH,schizophrenia behavior,schizophrenia behavior
D064147,DISEASE,Febrile Neutropenia,"Febrile Neutropenias|Neutropenias, Febrile|Neutropenia|Neutropenia, Febrile|febrile neutropenia|neutropenia"
NEW08301,MENTAL_HEALTH,persistent psychosis,persistent psychosis
NEW08302,CHEBI,antibiotic exposure,Antibiotics exposure
NEW08303,DISEASE,gut microbiota dysbiosis,gut microbiota dysbiosis
NEW08304,CHEBI,antibiotic exposure,antibiotics exposure
NEW08305,DISEASE,gut microbiome disturbance,gut microbiome disturbance
NEW08306,CHEMICAL,long-term azi treatment,Long-term AZI treatment
NEW08307,DISEASE,anxious behavior,anxious behaviors
http://purl.obolibrary.org/obo/CHEBI_34974,CHEMICAL,sennoside,"5,5'-bis(beta-D-glucopyranosyloxy)-4,4'-dihydroxy-10,10'-dioxo-9,9',10,10'-tetrahydro-9,9'-bianthracene-2,2'-dicarboxylic acid|Liuwei Dihuang Pills/Yougui|Yinchenhao Decoction|Senna-lax|Qianlie Shutong Capsules|YD|Fuzi decoction|sennaglucosides|QLSTC"
NEW08308,DISEASE,chronic prostatitis/chronic pelvic pain syndrome,chronic prostatitis/chronic pelvic pain syndrome|Chronic prostatitis/chronic pelvic pain syndrome|CP/CPPS
NEW08309,CHEMICAL,Qianlie Beixi Capsules,Qianlie Beixi Capsules
D057919,CHEMICAL,Biological Oxygen Demand Analysis,"Oxygen|Oxygen Demand, Biological|Biological Oxygen Demand Analyses|% O2|Demand, Chemical Oxygen|Chemical Oxygen Demand Analysis|Biological Oxygen Demand|Chemical Oxygen Demand Analyses|Chemical Oxygen Demand|oxygen|Oxygen Demand, Chemical|O2"
NEW08310,DISEASE,infection failure,infection failure
D001993,CHEMICAL,Bronchodilator Agents,"Broncholytic Effects|Bronchodilator Effect|Agent, Broncholytic|Agent, Bronchodilator|Bronchial-Dilating Agents|Agents, Broncholytic|Bronchial Dilating Agents|Bronchodilator|Effects, Bronchodilator|Bronchodilator Effects|Broncholytic Agent|bronchodilators|Effect, Broncholytic|Bronchodilators|Agents, Bronchodilator|Effect, Bronchodilator|Broncholytic Agents|Broncholytic Effect|Effects, Broncholytic|Agents, Bronchial-Dilating|Bronchodilator Agent"
http://purl.obolibrary.org/obo/SYMP_0000413,DISEASE,catatonia,Antibiomania
NEW08311,CHEBI,new antibiotic,new antibiotics
D015780,DISEASE,Carbapenems,"Carbapenem|Carbapenem Antibiotics|Antibiotics, Carbapenem|Carbapenems"
NEW08312,CHEMICAL,cephalosporin family,cephalosporin family
D015378,CHEMICAL,Imipenem,"N-Formimidoylthienamycin|Imipenem|N Formimidoylthienamycin|Imipemide|Imipenem Anhydrous|Anhydrous Imipenem|MK-0787|Imipenem, Anhydrous|Anhydrous, Imipenem|MK0787|imipenem|MK 0787"
NEW08313,DISEASE,suspect aspiration pneumonia,suspected aspiration pneumonia
NEW08314,MENTAL_HEALTH,addition antibiotic resistance,addition antibiotic resistance
D004405,DISEASE,"Dysentery, Bacillary","Dysentery, Shigella dysenteriae|Shigella Dysenteries|Shigellosis|Dysenteries, Shigella boydii|Shigella flexneri Dysenteries|Infections, Shigella|Dysentery, Shigella boydii|Dysentery, Shigella|Dysenteries, Shigella sonnei|Shigella dysenteriae Dysenteries|Shiga bacillus Dysentery|dysentery|Shigella sonnei Dysentery|Dysenteries, Shigella flexneri|Shigella boydii Dysenteries|Dysentery, Shiga bacillus|Shigella sonnei Dysenteries|Shigella boydii Dysentery|Dysentery, Shigella dysenteriae type 1|Shigella Infection|shigellosis|Shigella Dysentery|Dysentery, Shigella flexneri|Shigella Infections|Bacillary Dysentery|Infection, Shigella|Dysenteries, Shigella dysenteriae|Shigella flexneri Dysentery|Shigella dysenteriae Dysentery|Dysenteries, Shigella|Dysentery, Shigella sonnei"
NEW08315,MENTAL_HEALTH,long-term adhd rate,long-term ADHD rates
NEW08316,CHEBI,late antibiotic treatment,Late antibiotic treatment
NEW08317,DISEASE,early childhood shigellosis,early childhood shigellosis
NEW08318,CHEBI,late antibiotic treatment,late antibiotic treatment
D014647,DISEASE,Varicose Ulcer,"Ulcers, Venous Stasis|Ulcers, Varicose|ulcers|Ulcers, Venous|Venous Hypertension Ulcer|Hypertension Ulcers, Venous|Ulcer, Varicose|Ulcer, Venous Hypertension|Venous Stasis Ulcer|Venous Hypertension Ulcers|Stasis Ulcers, Venous|Venous Stasis Ulcers|Stasis Ulcer|Ulcer, Venous Stasis|Varicose Ulcers|Ulcers, Venous Hypertension|Venous Ulcer|Venous Ulcers|Hypertension Ulcer, Venous|Stasis Ulcers|Ulcer, Venous|Ulcer, Stasis|Ulcers, Stasis|Stasis Ulcer, Venous"
NEW08319,CHEBI,appropriate antibiotic,appropriate antibiotics
NEW08320,MENTAL_HEALTH,severe mental illness,severe mental illness
C536215,DISEASE,Pediatric Crohn's disease [Supplementary Concept],Crohn's disease|Crohn Disease
NEW08321,DISEASE,gut microbiome dysbiosis,gut microbiome dysbiosis
NEW08322,CHEMICAL,isotretinoin user,isotretinoin users
NEW08323,DISEASE,moderate acne,moderate acne
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Suicidal_Ideation,MENTAL_HEALTH,suicidal ideation,pre-existing suicidal ideations|active suicidal ideations|suicide ideation
NEW08324,DISEASE,community-acquired pneumonia,Community-acquired pneumonia
D002945,CHEMICAL,Cisplatin,"Diamminodichloride, Platinum||Platidiam|Cisplatin|cisplatin|cisplatin-|cis Diamminedichloroplatinum|cis-Diamminedichloroplatinum(II)|cis-Diamminedichloroplatinum|cis-Platinum|Biocisplatinum|cis Platinum|cis-Dichlorodiammineplatinum(II)|Platino|NSC-119875|Dichlorodiammineplatinum|Platinum Diamminodichloride|Platinol"
NEW08325,DISEASE,chemotherapy-induced peripheral neuropathy,chemotherapy-induced peripheral neuropathy|CIPN|pain due to chemotherapy-induced peripheral neuropathy
D018946,DISEASE,Chemokine CCL5,"CCL5 Chemokine|RANTES|CCL5, Chemokine|RANTES Protein, T Cell|RANTES Protein, T-Cell|Chemokine, CCL5|T-Cell RANTES Protein"
NEW08326,CHEMICAL,aspirin activity,Aspirin activity
NEW08327,DISEASE,platelet aggregation platelet release,platelet aggregation platelet release
D007529,CHEMICAL,Isoflavones,"3-Benzylidene-4-Chromanone|3 Benzylchroman 4 One|3-Benzylchroman-4-Ones|Isoflavone|Isoflavone Derivatives|isoflavones|Derivative, Isoflavone|3 Benzylidene 4 Chromanone|3-Benzylchroman-4-One|3 Benzylidene 4 Chromanones|isoflavone|Isoflavone Derivative|Homoisoflavone|3 Benzylchroman 4 Ones|3-Benzylidene-4-Chromanones|Homoisoflavones|Derivatives, Isoflavone"
D013025,NUTRITION,Soybeans,"Soybean|Bean, Soy|soybeans|Soy Bean|Glycine max|Soybeans|Soy Beans|Beans, Soy"
NEW08328,NUTRITION,soybean consumption,soybeans consumption
NEW08329,DISEASE,alcoholic organic brain syndrome,alcoholic organic brain syndrome
NEW08330,DISEASE,idiopathic hypersomniac,idiopathic hypersomniacs
NEW08331,DISEASE,noradrenergic deficit,noradrenergic deficits
NEW08332,DISEASE,tic-related neurophysiologic dysfunction,tic-related neurophysiologic dysfunction
NEW08333,CHEBI,blood pressure-enhancing alpha-adrenergic agonist,blood pressure-enhancing alpha-adrenergic agonist
NEW08334,DISEASE,hypotensive person,hypotensive persons
http://purl.obolibrary.org/obo/CHEBI_73966,CHEMICAL,nitric oxide synthase activator,nitric oxide synthase gene|nitric oxide synthase activators|NOS activator|NOS activators
http://purl.obolibrary.org/obo/UBERON_0001621,DISEASE,coronary artery,coronary artery spasm
NEW08335,DISEASE,enzyme myocardial infarction,enzyme myocardial infarction
NEW08336,CHEMICAL,nitric oxide-mediated,nitric oxide-mediated
NEW08337,MENTAL_HEALTH,resistance vessel,resistance vessels
NEW08338,CHEMICAL,antisense nucleotide,antisense nucleotides
NEW08339,CHEBI,selective agonist,selective agonists
D028227,DISEASE,"Amyloid Neuropathies, Familial","Amyloidoses, Portuguese Polyneuritic|Type VI Familial Amyloid Polyneuropathy|Amyloidoses, Hereditary Neuropathic|Familial Amyloid Polyneuropathy, Appalachian Type|Hereditary Neuropathic Amyloidosis|Iowa Type Amyloid Polyneuropathy|Polyneuritic Amyloidosis, Portuguese|Familial Amyloid Polyneuropathy, Type VI|Amyloid Polyneuropathy, British Type|Cerebral Amyloid Angiopathy, British Type|Type III Familial Amyloid Polyneuropathy|Neuropathy, Familial Amyloid|Type IV Familial Amyloid Polyneuropathy|Polyneuropathies, Familial Amyloid|Neuropathic Amyloid Syndromes|Amyloid Polyneuropathy, Swiss Type|Wohlwill-Corino Andrade Syndrome|Appalachian Type Familial Amyloid Polyneuropathy|Amyloid Neuropathy, Familial|Familial Amyloid Polyneuropathy|Amyloid Syndromes, Neuropathic|Finnish Type Familial Amyloid Neuropathy|Amyloidosis, Hereditary Neuropathic|Jewish Type Familial Amyloid Polyneuropathy|Familial Amyloid Polyneuropathies|Hereditary Neuropathic Amyloidoses|Neuropathies, Familial Amyloid|Familial Amyloid Polyneuropathy, Type II|Amyloid Polyneuropathy, Iowa Type|Familial Amyloid Polyneuropathy, Jewish Type|Portuguese Type Familial Amyloid Neuropathy|Familial Amyloid Neuropathy|Familial Amyloid Polyneuropathy, Type III|Familial Amyloid Neuropathy, Andrade Type|British Type Amyloid Polyneuropathy|Wohlwill Andrade Syndrome|Neuropathic Amyloidosis, Hereditary|Wohlwill Corino Andrade Syndrome|Amyloid Neuropathy Type 1|Portuguese Polyneuritic Amyloidosis|Portuguese Polyneuritic Amyloidoses|neuropathic|Familial Amyloid Polyneuropathy, Type IV|Familial Amyloid Neuropathies|Amyloid Polyneuropathies, Familial|Type V Familial Amyloid Polyneuropathy|Amyloid Polyneuropathy, Familial|Type I Familial Amyloid Polyneuropathy|Neuropathic Amyloidoses, Hereditary|Familial Amyloid Polyneuropathy, Type I|Polyneuropathy, Familial Amyloid|Swiss Type Amyloid Polyneuropathy|Type II Familial Amyloid Polyneuropathy|Neuropathic Amyloid Syndrome|Polyneuritic Amyloidoses, Portuguese|Wohlwill-Andrade Syndrome|Amyloidosis, Portuguese Polyneuritic|Amyloid Syndrome, Neuropathic|Familial Portuguese Polyneuritic Amyloidosis|Familial Amyloid Neuropathy, Portuguese Type|Familial Amyloid Neuropathy, Finnish Type|Familial Amyloid Polyneuropathy, Type V"
NEW08340,DISEASE,inflammatory bone cancer pain,inflammatory bone cancer pain
NEW08341,CHEMICAL,cannabinoid cb(2 receptor activation,Cannabinoid CB(2 receptor activation
C445383,CHEMICAL,"4,4'-bis-methyl-5,5'-((1-methyltrimethylene)di)methylnicotinate [Supplementary Concept]",Niacin/analogs  and  derivatives|methylnicotinate
NEW08342,DISEASE,effective durable pain relief,effective durable pain relief
NEW08343,CHEMICAL,trpv1 antagonist 5'-iodoresiniferatoxin,TRPV1 antagonist 5'-Iodoresiniferatoxin
NEW08344,DISEASE,formalin-evoked nociceptive behaviour,formalin-evoked nociceptive behaviour
NEW08345,CHEBI,trpv1 agonist capsaicin,TRPV1 agonist capsaicin
NEW08346,CHEMICAL,intra-vlpag administration,Intra-VLPAG administration
NEW08347,DISEASE,nociceptive behaviour,nociceptive behaviour
NEW08348,CHEMICAL,intra-lpag administration,Intra-LPAG administration
NEW08349,CHEBI,selective inverse agonist,selective inverse agonist
NEW08350,DISEASE,nerve injury model,nerve injury model
NEW08351,CHEMICAL,structural different receptor inverse agonist ciproxifan,structural different receptor inverse agonists ciproxifan
NEW08352,DISEASE,common neurological disorder,common neurological disorder
NEW08353,CHEMICAL,trigeminal cgrp release,trigeminal CGRP release
NEW08354,DISEASE,preclinical pain model,preclinical pain models
NEW08355,CHEBI,channel v1 agonist capsaicin,channel V1 agonist capsaicin
NEW08356,CHEBI,photoswitchable trpa1 agonist,photoswitchable TRPA1 agonists
NEW08357,DISEASE,pain signaling,pain signaling
NEW08358,CHEMICAL,local capsaicin,local capsaicin
NEW08359,DISEASE,early axon loss,early axon loss
NEW08360,CHEMICAL,capsaicin potentiation,Capsaicin potentiation
NEW08361,CHEBI,drug permeation,drug permeation
NEW08362,MENTAL_HEALTH,gbp depression,GBP depression
NEW08363,DISEASE,pain mediator,pain mediators
NEW08364,DISEASE,damage impairment,damage impairment
NEW08365,CHEMICAL,central apelin,Central apelin
http://purl.obolibrary.org/obo/CHEBI_88295,CHEBI,g-protein-coupled receptor antagonist,GPCR antagonists|GPCR antagonist|APJ receptor antagonist F13A|G-protein-coupled receptor antagonists
NEW08366,DISEASE,chronic homotypic stress,chronic homotypic stress
NEW08367,DISEASE,central corticotrophin releasing-factor crf signalling pathway,Central corticotrophin releasing-factor CRF signalling pathways
NEW08368,CHEBI,endocrine behavioural response,endocrine behavioural responses
NEW08369,DISEASE,early trauma,early trauma
NEW08370,DISEASE,intestinal mucosal dysfunction,intestinal mucosal dysfunction
NEW08371,CHEBI,its 's endocrine function,its's endocrine functions
NEW08372,DISEASE,crf transgenic animal,CRF transgenic animals
NEW08373,CHEMICAL,nociceptin/orphanin fq,Nociceptin/orphanin FQ
NEW08374,CHEBI,functional antagonist,functional antagonist
NEW08375,CHEMICAL,5-hiaa content,5-HIAA content
NEW08376,CHEMICAL,5-ht level,5-HT levels
NEW08377,CHEBI,crf antagonist r121919,CRF antagonist R121919
NEW08378,CHEBI,gaba(a)α1-preferring benzodiazepine-site agonist,GABA(A)α1-preferring benzodiazepine-site agonist
NEW08379,CHEMICAL,crf-gaba(a)α1 ko,CRF-GABA(A)α1 KO
NEW08380,DISEASE,endogenous crf,endogenous CRF
http://purl.org/sig/ont/fma/fma72478,CHEMICAL,locus ceruleus,locus coeruleus (LC)-norepinephrine system|Nucleus of locus caeruleus|Locus coeruleus|Caerulean nucleus
NEW08381,DISEASE,defense behavior,defense behaviors
NEW08382,DISEASE,crf receptor antagonist d-phe crf,CRF receptor antagonist d-Phe CRF
NEW08383,CHEMICAL,alcohol seek,alcohol seeking
NEW08384,CHEMICAL,yohimbine toxicity,yohimbine toxicity
NEW08385,CHEMICAL,isoproterenol treatment,isoproterenol treatment
NEW08386,DISEASE,high-fructose rat,high-fructose rats
D008070,CHEMICAL,Lipopolysaccharides,lipopolysaccharides|Lipopolysaccharide|Lipoglycans
NEW08387,DISEASE,depressive- behavior,depressive- behaviors
NEW08388,CHEMICAL,repeat lps administration,repeated LPS administration
NEW08389,CHEBI,repeat nmdar agonist administration,repeated NMDAR agonist administration
NEW08390,DISEASE,nmdar dysfunction,NMDAR dysfunction
NEW08391,CHEMICAL,tryptophan catabolite,TRYCATs|Tryptophan catabolites
NEW08392,DISEASE,neuro-inflammatory disease,neuro-inflammatory disease
NEW08393,CHEMICAL,other trycats,Other TRYCATS
NEW08394,CHEMICAL,synaptic d-aspartate nmda receptor,synaptic D-Aspartate NMDA receptors
NEW08395,CHEMICAL,d-aspartate level,D-aspartate levels
D050804,CHEMICAL,D-Aspartate Oxidase,"Oxidase, Aspartic|D-aspartate oxidase|Oxidase, D-Aspartate|D aspartic Oxidase|D-aspartic Oxidase|Aspartic Oxidase|Oxidase, D-aspartic|D Aspartate Oxidase"
NEW08396,DISEASE,temporal reduction,Temporal reduction
NEW08397,CHEMICAL,increase d-aspartate level,increased D-aspartate levels
D065767,DISEASE,"Activation, Metabolic","Drug Activation|Metabolic Activation|activation|Activation, Drug"
NEW08398,CHEMICAL,d-aspartate content,D-aspartate content
D003605,CHEMICAL,D-Amino-Acid Oxidase,"D Amino Acid Dehydrogenase|Acid Dehydrogenase, D-Amino|Oxidase, dextro-Amino Acid|Dehydrogenase, D-Amino Acid|dextro-Amino Acid Oxidase|dextro Amino Acid Oxidase|D-amino acid|Oxidase, D-Amino-Acid|Acid Oxidase, dextro-Amino|D Amino Acid Oxidase|D-Amino Acid Dehydrogenase"
NEW08399,CHEMICAL,elevated quinolinic acid concentration,elevated quinolinic acid concentrations
http://purl.obolibrary.org/obo/CHEBI_135649,CHEMICAL,alpidem,6beta-naltrexol|D-cycloserine|ananxyl
NEW08400,CHEBI,partial nmda-receptor agonist,partial NMDA-receptor agonist
NEW08401,CHEMICAL,selective crf1 corticotropin releasing factor type receptor antagonist ssr125543,selective CRF1 corticotropin releasing factor type receptor antagonist SSR125543
NEW08402,DISEASE,long-term cognitive deficit,long-term cognitive deficit
NEW08403,NUTRITION,tryptophan metabolite,tryptophan metabolites
NEW08404,CHEMICAL,kynurenine metabolite,kynurenine metabolites
NEW08405,MENTAL_HEALTH,unipolar treatment-resistant depression,unipolar treatment-resistant depression
http://purl.obolibrary.org/obo/CHEBI_16946,CHEMICAL,l-kynurenine,KYNURENINE|L-Kynurenine|3-Anthraniloyl-L-alanine|kynurenines|3-(2-aminobenzoyl)-L-alanine|(2S)-2-amino-4-(2-aminophenyl)-4-oxobutanoic acid
NEW08406,CHEMICAL,nmda modulator,NMDA modulators
NEW08407,DISEASE,morphine-induced memory impairment,morphine-induced memory impairment
NEW08408,CHEMICAL,dl-ap5,DL-AP5
D010208,CHEMICAL,Papaverine,"|Cerespan|Pavabid|Papaverine|Papaverine Hydrochloride|Hydrochloride, Papaverine|Pavatym|papaverine"
NEW08409,CHEMICAL,"its 's intracellular signal inositol 1,4,5 trisphosphate concentration","its's intracellular signal inositol 1,4,5 trisphosphate concentrations"
NEW08410,CHEBI,standardized antipsychotic drug treatment,standardized antipsychotic drug treatment
NEW08411,CHEBI,long-term pertussis toxin treatment,Long-term pertussis toxin treatment
D020339,DISEASE,Optic Nerve Glioma,"Glioma, Optic|Optic Gliomas|Optic Nerve, Malignant Astrocytoma|Astrocytoma, Malignant, Optic Nerve|Glioma, Optic Nerve|Glioma, Optic Nerve, Childhood|Malignant Astrocytoma, Optic Nerve|Gliomas, Optic Nerve|Malignant Optic Nerve Astrocytoma|Glioma, Optic Nerve, Adult|Gliomas, Optic|Childhood Optic Nerve Glioma|glioma|Optic Nerve Gliomas|Optic Nerve Glioma, Childhood|Adult Optic Nerve Glioma|Optic Nerve Glioma, Adult|Optic Glioma"
NEW08412,CHEBI,mitochondrial poison,mitochondrial poisons
http://purl.obolibrary.org/obo/CHEBI_22587,CHEBI,antiviral agent,antiviral|anti-viral agents|Anti-viral agents|anti-viral agent|antiviral agents|antivirals
NEW08413,CHEMICAL,microglial structural reorganization,Iba-1|microglial structural reorganization
NEW08414,CHEMICAL,iba-1 positive cell,Iba-1 positive cells
NEW08415,CHEMICAL,secondary thalamic neurodegeneration,STND|secondary thalamic neurodegeneration
C114781,CHEBI,"endothelial barrier antigen, rat [Supplementary Concept]","endothelial barrier antigen|Antigens, Surface"
NEW08416,DISEASE,blood-brain barrier damage,blood-brain barrier damage
C039123,CHEMICAL,fucosyl GM1 ganglioside [Supplementary Concept],G(M1) Ganglioside/analogs  and  derivatives|GM1 ganglioside
NEW08417,DISEASE,chronic acquire motor neuropathy,chronic acquired motor neuropathies
NEW08418,CHEMICAL,serum igm binding to gm1 ganglioside,Serum IgM binding to GM1 ganglioside|GM1
D006918,CHEMICAL,Hydroxyurea,Hydroxycarbamid|hydroxyurea|Oncocarbide|Hydrea
NEW08419,DISEASE,vascular damage,vascular damage
D006461,DISEASE,Hemolysis,"|Hemolysis, Extravascular|Extravascular Hemolyses|Extravascular Hemolysis|Haemolysis|Intravascular Hemolyses|Hemolyses, Extravascular|Intravascular Hemolysis|Hemolyses, Intravascular|Hemolysis, Intravascular|hemolysis|Haemolyses"
NEW08420,DISEASE,prostate volume median mean,prostate volume Median mean
NEW08421,MENTAL_HEALTH,low sexual dysfunction,lower sexual dysfunction
D018809,CHEBI,Proliferating Cell Nuclear Antigen,"PCNA|proliferating cell nuclear antigen|Antigen, Proliferating Cell Nuclear"
NEW08422,CHEMICAL,tnf-α system,TNF-α system
NEW08423,CHEMICAL,cd19 chimeric antigen receptor car t cell,CD19 chimeric antigen receptor CAR T cells
NEW08424,DISEASE,relapsed/refractory diffuse large b cell lymphoma,relapsed/refractory diffuse large B cell lymphoma
http://purl.obolibrary.org/obo/DOID_9952,DISEASE,acute lymphoblastic leukemia,acute lymphoblastic leukaemia|childhood acute lymphoblastic leukemia|acute lymphocytic leukaemia|ALL|precursor lymphoblastic lymphoma/leukemia|Down syndrome-associated acute lymphoblastic leukemia|DS-ALL|acute lymphoblastic leukemia|pediatric acute lymphoblastic leukemia management|B-lineage acute lymphoblastic leukemia
NEW08425,CHEMICAL,high-dose treatment,high-dose treatment
NEW08426,DISEASE,acute graft-versus-host disease,acute graft-versus-host disease
D003975,CHEMICAL,Diazepam,"7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one||Apaurin|Relanium|Sibazon|diazepam|Seduxen|Faustan|Diazemuls|Stesolid|Valium"
C558166,DISEASE,"Shh protein, Xenopus [Supplementary Concept]",Xenopus Proteins|Hedgehog Proteins|Shh
D004931,DISEASE,Esophageal Achalasia,"Cardiospasm|Achalasia, Esophageal|Achalasias, Esophageal|Cardiospasms|Achalasia|Achalasias|Megaesophagus|Esophageal Achalasias|megaesophagus"
NEW08427,DISEASE,muscle development disorder,muscle development disorder
NEW08428,DISEASE,Zhu S.,Zhu S.
NEW08429,DISEASE,sonic hedgehog gene,sonic hedgehog gene
NEW08430,CHEMICAL,mice.-Jia X.,mice.-Jia X.
NEW08431,DISEASE,autoimmune thyroid disorder,autoimmune thyroid disorder
NEW08432,CHEBI,thyroid-stimulating hormone receptor antibody,thyroid-stimulating hormone receptor antibody
D024483,CHEMICAL,Vitamin K 3,"Sodium bisulfite|Menadione Sodium Bisulfite|Sodium Bisulfite, Menadione|Menadione Sodium Bisulfite, Trihydrate|2-Methylnaphthoquinone|Bisulfite, Menadione Sodium|Vikasol|Vitamin K3|2-Methyl-1,4-naphthalenedione|2-Methyl-1,4-naphthoquinone|Menadione|Vicasol|Bisulfite, Menadione|Menadione Bisulfite|Vitamin K3 Sodium Bisulfite"
NEW08433,DISEASE,bipolar disease patient,bipolar disease patients
NEW08434,DISEASE,antigen positive asd,antigen positive ASD
NEW08435,DISEASE,td maternal sample,TD maternal samples
NEW08436,DISEASE,bipolar affective illness,bipolar affective illness
NEW08437,NUTRITION,high lithium ratio,high lithium ratio
NEW08438,DISEASE,severe gbv,Severe GBV
http://purl.obolibrary.org/obo/DOID_1574,CHEMICAL,alcohol use disorder,disordered alcohol use|Ethanol abuse|alcohol disorder|alcohol abuse
NEW08439,DISEASE,sexual GBV,Sexual GBV
NEW08440,CHEBI,human leukocyte antigen hla locus,Human leukocyte antigen HLA loci
D017593,MENTAL_HEALTH,Kleine-Levin Syndrome,"Familial Kleine Levin Syndrome|Kleine Levin Critchley Syndrome|Syndrome, Kleine-Levin Hibernation|Periodic Hypersomnias|Hypersomnia, Periodic|Syndrome, Kleine-Levin-Critchley|Kleine Levin syndrome|Kleine Levin Hibernation Syndrome|Hibernation Syndrome, Kleine-Levin|Periodic Hypersomnia|Kleine Levin Syndrome|Kleine-Levin-Critchley Syndrome|Kleine-Levin syndrome|Syndrome, Kleine-Levin|Familial Kleine-Levin Syndrome|Kleine-Levin Hibernation Syndrome|Syndrome, Familial Kleine-Levin|Familial Hibernation (Kleine-Levin) Syndrome|Kleine-Levin Syndrome, Familial"
C536209,DISEASE,Congenital central hypoventilation syndrome [Supplementary Concept],"Sleep Apnea, Central|central hypoventilation|Hypoventilation/congenital"
D064532,CHEBI,Histocompatibility Antigen H-2D,"Histocompatibility Antigen H 2D|antigen|H-2D(d) Antigen|H-2D(d)-Q10(b) Histocompatibility Antigen|H-2D(b) Antigen|H-2L(d)s Self Peptide Complex|Antigen H-2D, Histocompatibility|H-2D(p) Antigen|H-2D(b) Glycoprotein|H-2D(q) Histocompatibility Antigen|H-2L(d) Antigen|Histocompatibility Antigen H-2D(b)|H-2D(k) Antigen|H-2D, Histocompatibility Antigen|H-2D(q)"
NEW08441,DISEASE,ovarian teratoma,ovarian teratomas
NEW08442,DISEASE,encephalitis decrease,encephalitis decrease
NEW08443,CHEMICAL,anti-n-methyl-d-aspartate nmda receptor encephalitis,anti-N-methyl-d-aspartate NMDA receptor encephalitis
D008731,CHEMICAL,Methoxychlor,"DMDT|Dianisyl Trichloroethane|Metox|Trichloroethane, Dianisyl|Methoxychlor"
NEW08444,DISEASE,dimorphic behavioral alteration,dimorphic behavioral alterations
http://purl.obolibrary.org/obo/CHEBI_76988,CHEBI,xenoestrogen,xenoestrogens
NEW08445,DISEASE,fertility behavior,fertility behaviors
http://purl.obolibrary.org/obo/CHEBI_38657,CHEMICAL,organochlorine acaricide,organochloride acaricide|organochlorine acaricides|chlororganische Akarizide|organochloride acaricides|organochlorine insecticide Methoxychlor|MXC
NEW08446,DISEASE,emotional behavior,emotional behaviors
NEW08447,CHEMICAL,prenatal nicotine exposure,prenatal nicotine exposure
NEW08448,CHEMICAL,selective nri,selective NRIs
NEW08449,CHEMICAL,serotonin reuptake inhibiting property,serotonin reuptake inhibiting properties
NEW08450,DISEASE,depressive pd,depressive PD
NEW08451,CHEMICAL,dopaminergic anti-depressant,dopaminergic anti-depressant
NEW08452,CHEMICAL,noradrenergic ne system,noradrenergic NE system
NEW08453,CHEMICAL,exogenous norepinephrine administration,exogenous Norepinephrine administration
D014745,CHEMICAL,Viloxazine,"Vivalan|Viloxazine, (R)-Isomer|Emovit|viloxazine|ICI58,834|Viloxazine Hydrochloride, (R)-Isomer|Viloxazine Hydrochloride, (S)-Isomer|Viloxazine, (+-)-Isomer|Viloxazine Hydrochloride|Viloxazine, (S)-Isomer|ICI-58,834|Viloxazine|Viloxazine Oxalate (1:1)"
NEW08454,MENTAL_HEALTH,adhd medication,ADHD medications
NEW08455,DISEASE,seizure-induced respiratory arrest,seizure-induced respiratory arrest
NEW08456,DISEASE,sudep case,SUDEP cases
NEW08457,CHEBI,norepinephrine reuptake inhibitor,norepinephrine reuptake inhibitor
D012129,DISEASE,Respiratory Function Tests,"Function Test, Lung|Function Test, Pulmonary|Test, Lung Function|Function Tests, Lung|Tests, Lung Function|Tests, Respiratory Function|Function Tests, Respiratory|Function Test, Respiratory|Lung Function Test|Test, Pulmonary Function|respiratory function|Pulmonary Function Test|Lung Function Tests|Test, Respiratory Function|Function Tests, Pulmonary|Respiratory Function Test|Tests, Pulmonary Function|Pulmonary Function Tests"
http://purl.obolibrary.org/obo/MFOMD_0000214,MENTAL_HEALTH,perseveration,perseveration
NEW08458,CHEMICAL,clinical relevant nri,clinical relevant NRIs
NEW08459,DISEASE,traumatic brain damage,traumatic brain damage
D014911,DISEASE,Whiplash Injuries,"whiplash|Injuries, Whiplash|Whiplash Injury|Injury, Whiplash"
NEW08460,CHEMICAL,noradrenaline norepinephrine reuptake inhibitor,noradrenaline norepinephrine reuptake inhibitor
NEW08461,DISEASE,seizure phenomenon,seizure phenomena
NEW08462,CHEMICAL,alcohol preference,alcohol preference
NEW08463,CHEMICAL,chronic alcohol intake,chronic alcohol intake
NEW08464,CHEMICAL,paliperidone combination,paliperidone combination
NEW08465,CHEMICAL,pparα blockade,PPARα blockade
NEW08466,CHEMICAL,venlafaxine treatment,venlafaxine treatment
NEW08467,CHEMICAL,serotonin reuptake blockade,Serotonin reuptake blockade
NEW08468,CHEMICAL,chronic milnacipran treatment,chronic milnacipran treatment
NEW08469,DISEASE,cognitive set-shifting,cognitive set-shifting
D000078764,CHEMICAL,Milnacipran,milnacipran|Milnacipran Hydrochloride|1-Phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane HCl|1 Phenyl 1 diethylaminocarbonyl 2 aminomethylcyclopropane HCl|F 2207|Midalcipran|Ixel|F-2207|F2207|Milnacipran|Savella
NEW08470,CHEMICAL,cortisol response,cortisol response
NEW08471,CHEMICAL,impaired norepinephrine system,impaired norepinephrine system
NEW08472,CHEMICAL,brand antidepressant,branded antidepressants
NEW08473,DISEASE,placebo depressive symptom,placebo depressive symptoms
D000078784,CHEMICAL,Vortioxetine,"Vortioxetine|Vortioxetine Hydrobromide|LuAA21004|1-(2-(2,4-Dimethylphenylsulfanyl)phenyl)piperazine|Lu AA21004|Brintellix|Lu-AA21004|vortioxetine"
NEW08474,CHEMICAL,levomilnacipran er,Levomilnacipran ER
NEW08475,CHEMICAL,serotonin norepinephrine reuptake inhibitor,serotonin norepinephrine reuptake inhibitor
NEW08476,CHEMICAL,first-line treatment levomilnacipran due,first-line treatment levomilnacipran due
NEW08477,CHEMICAL,second-line treatment,second-line treatments
NEW08478,MENTAL_HEALTH,sleep-related hallucination,sleep-related hallucinations
NEW08479,MENTAL_HEALTH,cataplexy attack,cataplexy attacks
NEW08480,CHEMICAL,γ-aminobutyric acid b gabab receptor,γ-aminobutyric acid B GABAB receptors
NEW08481,CHEBI,selective serotonin reuptake inhibitor ssri medication,selective serotonin reuptake inhibitor SSRI medication
NEW08482,CHEMICAL,desipramine treatment,desipramine treatment
NEW08483,CHEMICAL,urinary catecholamine,urinary catecholamines
http://purl.obolibrary.org/obo/CHEBI_135925,CHEMICAL,lisdexamfetamine,non-stimulant|lisdexamfetamine dimesylate|vyvanse|lisdexamphetamine
NEW08484,CHEMICAL,Supernus Pharmaceuticals,Supernus Pharmaceuticals
http://purl.obolibrary.org/obo/DOID_3324,MENTAL_HEALTH,mood disorder,comorbid mood disorder|psychosis-related disorders|episodic mood disorder
NEW08485,CHEMICAL,extended-release form,extended-release form
NEW08486,CHEMICAL,immediate-release formulation,immediate-release formulation
NEW08487,CHEMICAL,e.g. tricyclic antidepressant,e.g. tricyclic antidepressants
NEW08488,CHEMICAL,first-generation antidepressant,first-generation antidepressants
NEW08489,CHEMICAL,serotonin release,serotonin release
NEW08490,NUTRITION,lithium exposure,Lithium exposure
NEW08491,DISEASE,fetal cardiac malformation,fetal cardiac malformations
NEW08492,CHEMICAL,suprathreshold duloxetine,suprathreshold duloxetine
NEW08493,MENTAL_HEALTH,co-morbid anorexia nervosa binge-purging type,co-morbid anorexia nervosa binge-purging type
NEW08494,CHEMICAL,5-ht reuptake,5-HT reuptake
NEW08495,CHEMICAL,levomilnacipran extended-release,Levomilnacipran extended-release
NEW08496,CHEMICAL,fda-approved serotonin norepinephrine reuptake inhibitor,FDA-approved serotonin norepinephrine reuptake inhibitor
NEW08497,CHEMICAL,dopamine d2 receptor partial agonist,dopamine D2 receptor partial agonist
C509981,CHEMICAL,bifeprunox [Supplementary Concept],Benzoxazoles|DU-127090|Piperazines
NEW08498,CHEMICAL,mixed dopamine antagonist/serotonin agonist,mixed dopamine antagonist/serotonin agonist
NEW08499,CHEBI,act 5-ht1c/5-ht2 agonist,acting 5-HT1C/5-HT2 agonist
NEW08500,CHEMICAL,6-chloro-2-(1-piperaziny)pyrazine,6-chloro-2-(1-piperaziny)pyrazine|MK-212
NEW08501,DISEASE,autistic patient,autistic patients
NEW08502,DISEASE,poisoning due,poisoning due
C006737,CHEMICAL,1-benzylpiperazine [Supplementary Concept],BZP|Piperazines|Benzylpiperazine
NEW08503,DISEASE,loudness dependence,loudness dependence
NEW08504,NUTRITION,prophylactic lithium treatment,prophylactic lithium treatment
NEW08505,CHEMICAL,overactive serotonin activity,overactive serotonin activity
NEW08506,CHEMICAL,phosphodiesterase-5 inhibitor drug,phosphodiesterase-5 inhibitor drugs
NEW08507,MENTAL_HEALTH,dysfunction account,dysfunction accounts
D003861,MENTAL_HEALTH,Depersonalization,"derealization|Derealizations|Disorders, Depersonalization|Depersonalization Disorders|Disorder, Depersonalization|Depersonalization Disorder|Depersonalizations|Derealization|depersonalization"
NEW08508,MENTAL_HEALTH,panic anxiety,panic anxiety
NEW08509,DISEASE,agoraphobic patient,agoraphobic patients
NEW08510,DISEASE,baseline depressive symptom rating,baseline depressive symptom rating
NEW08511,CHEMICAL,whole-blood serotonin content,whole-blood serotonin content
NEW08512,DISEASE,eating-disorder patient,eating-disorder patients
NEW08513,CHEMICAL,fenfluramine challenge,fenfluramine challenge
D018589,DISEASE,Gastroparesis,"Stasis, Gastric|Gastric Stasis|Gastropareses|Stases, Gastric|gastroparesis|Gastric Stases"
NEW08514,DISEASE,bowel disorder,bowel disorders
NEW08515,DISEASE,pancreatic disorder,pancreatic disorders
http://purl.obolibrary.org/obo/CHEBI_73296,CHEBI,cholecystokinin antagonist,cholecystokinin antagonists|CCK antagonists|Cholecystokinin antagonists|CCK antagonist
NEW08516,MENTAL_HEALTH,human anxiety,human anxiety
NEW08517,CHEMICAL,cck receptor system,CCK receptor systems
D010418,CHEMICAL,Pentagastrin,"Pentapeptide, Gastrin|Gastrin Pentapeptide|Peptavlon|Acignost|Pentagastrin"
D013758,CHEMICAL,Tetragastrin,"CCK-4|Gastrin Tetrapeptide|AOC Tetrapeptide|CCK (30-33)|Cholecystokinin-Tetrapeptide|Cholecystokinin (30-33)|AOC-Tetrapeptide|AOC-Tetragastrin|Tetrapeptide, Gastrin|Cholecystokinin Tetrapeptide|AOC Tetragastrin|Cholecystokinin-tetrapeptide|cholecystokinin-tetrapeptide|Cholecystokinin 4|CKK-4"
NEW08518,DISEASE,spontaneous panic attack,spontaneous panic attacks
D006569,NUTRITION,Hesperidin,"Hesperetin 7 Rhamnoglucoside|Hesperidin 2S|4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-|7-Rhamnoglucoside, Hesperetin|2S, Hesperidin|Hst|HT|Hesperetin 7-Rhamnoglucoside|Hesperetin 7 Rutinoside|Hesperetin|hesperetin|Hesperetin-7-Rutinoside"
C565557,CHEMICAL,"Gamma-Glutamylcysteine Synthetase Deficiency, Hemolytic Anemia due to [Supplementary Concept]","Anemia, Hemolytic|Glutamate-Cysteine Ligase/deficiency|γ-glutamylcysteine synthetase"
NEW08519,DISEASE,glucose-induced neuronal damage,glucose-induced neuronal damages
NEW08520,MENTAL_HEALTH,summary diabetes-associated anxiety,summary diabetes-associated anxiety
NEW08521,CHEMICAL,gsh level,GSH level
NEW08522,CHEMICAL,prenatal valproic acid-exposed rat,Prenatal valproic acid-exposed rat
NEW08523,NUTRITION,hesperetin treatment,Hesperetin treatment
NEW08524,NUTRITION,its 's aglycone hesperetin,its's aglycone hesperetin
NEW08525,CHEMICAL,constituent hesperidin,constituents hesperidin
NEW08526,DISEASE,stz-induced oxidative stress,STZ-induced oxidative stress
NEW08527,CHEMICAL,moderate ethanol feeding,moderate ethanol feeding
NEW08528,DISEASE,ccl₄-induced liver injury,CCl₄-induced liver injury
NEW08529,DISEASE,frank fibrosis,frank fibrosis
NEW08530,CHEMICAL,ethanol feeding,ethanol feeding
NEW08531,CHEMICAL,adolescent cee,adolescent CEE
NEW08532,CHEMICAL,ss activity,SS activity
NEW08533,DISEASE,seizure phase,seizure phases
NEW08534,DISEASE,epilepsy prone rat,epilepsy prone rats
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Audiogenic_Seizures,DISEASE,audiogenic seizures,audiogenic seizures|pentylenetetrazole-induced seizures
NEW08535,DISEASE,lidocaine-induced,lidocaine-induced
NEW08536,DISEASE,chronic stress-induced depression-like behavior,chronic stress-induced depression-like behavior
NEW08537,CHEMICAL,ketamine metabolite,ketamine metabolite
C000592340,DISEASE,yuan zhi [Supplementary Concept],"Polygalae extract|Drugs, Chinese Herbal"
NEW08538,CHEMICAL,possible antidepressant action,possible antidepressant action
NEW08539,CHEMICAL,n-methyl d-aspartate nmda neurotoxicity,N-methyl D-aspartate NMDA neurotoxicity
NEW08540,CHEMICAL,l-lactate level,l-lactate levels
NEW08541,DISEASE,stz-induced diabetic mouse,STZ-induced diabetic mice
NEW08542,CHEMICAL,mct inhibitor 4-cin,MCT inhibitor 4-CIN
NEW08543,CHEMICAL,long-term alcohol exposure,Long-term alcohol exposure
C056723,CHEMICAL,FG 9041 [Supplementary Concept],DNQX|Quinoxalines
NEW08544,DISEASE,withdrawal-related anxiety-like behavior,withdrawal-related anxiety-like behavior
NEW08545,CHEBI,possible drug target,possible drug targets
NEW08546,DISEASE,post-natal dietary deficit,Post-natal dietary deficits
NEW08547,DISEASE,neuropsychiatric disorder,neuropsychiatric disorder
NEW08548,CHEMICAL,gsh depletion,GSH depletion
NEW08549,CHEMICAL,beta-casein a1,beta-casein A1
NEW08550,DISEASE,ischaemic heart disease,ischaemic heart disease
http://purl.obolibrary.org/obo/CHEBI_134765,CHEMICAL,isometheptene,octinum|gabapentinoids|isometeptene|isometheptene mucate|6-Methylamino-2-methylheptene|isomethepten
NEW08551,DISEASE,various psychiatric condition,various psychiatric conditions
NEW08552,CHEBI,drug discrimination procedure,drug discrimination procedures
NEW08553,DISEASE,paw tremor,paw tremors
D000071896,DISEASE,Medically Unexplained Symptoms,"Unexplained Symptom, Medically|Medically Unexplained Symptom|Somatic Symptoms|Symptom, Somatic|Symptom, Medically Unexplained|Symptoms, Medically Unexplained|Symptoms, Somatic|Unexplained Symptoms, Medically|Somatic Symptom|somatic symptoms"
NEW08554,CHEMICAL,5 mg intravenous delta-9-tetrahydrocannabinol,5 mg intravenous delta-9-tetrahydrocannabinol|Delta-9-THC
NEW08555,DISEASE,increase nervous system stress-reactivity,increased nervous system stress-reactivity
NEW08556,CHEBI,potential endocrine,potential endocrine
NEW08557,CHEMICAL,high evening cortisol,high evening cortisol
NEW08558,CHEMICAL,morning dhea,morning DHEA
NEW08559,CHEBI,endocrine abnormality,endocrine abnormality
NEW08560,CHEBI,specific endocrine disturbance,specific endocrine disturbances
NEW08561,MENTAL_HEALTH,strong posttraumatic stress reaction,stronger posttraumatic stress reactions
NEW08562,CHEMICAL,within-individual cortisol dysregulation,within-individual cortisol dysregulation
NEW08563,CHEBI,adjuvant endocrine therapy,adjuvant endocrine therapy
NEW08564,DISEASE,chinese young breast cancer patient old,Chinese young breast cancer patients old
NEW08565,CHEMICAL,ovarian function suppression,ovarian function suppression|OFS
NEW08566,CHEBI,antipsychotic drug therapy,Antipsychotic drug therapy
NEW08567,DISEASE,drug-induced benign pituitary tumor,drug-induced benign pituitary tumor
NEW08568,CHEMICAL,tailor phospholipid-enriched buttermilk,tailored phospholipid-enriched buttermilk
NEW08569,CHEMICAL,preferential responsiveness to monoamine oxidase inhibitor,preferential responsiveness to monoamine oxidase inhibitors|MAO-I
C565974,DISEASE,Familial Glucocorticoid Deficiency 1 [Supplementary Concept],"Adrenal Insufficiency|glucocorticoid deficiency|Steroid Metabolism, Inborn Errors"
NEW08570,CHEBI,endocrine stress signaling pathway,endocrine stress signaling pathways
D011565,DISEASE,Psoriasis,Pustulosis of Palms and Soles|psoriasis|Pustulosis Palmaris et Plantaris|Pustular Psoriasis of Palms and Soles|Palmoplantaris Pustulosis|Psoriases
C537365,DISEASE,Ichthyosis and male hypogonadism [Supplementary Concept],"Cryptorchidism|Male hypogonadism|Intellectual Disability|Hypogonadism|Ichthyosis, X-Linked|male hypogonadism"
D002310,DISEASE,"Cardiomyopathy, Alcoholic",Alcoholic Cardiomyopathy|alcoholic cardiomyopathy
NEW08571,DISEASE,alcoholic hypertension,alcoholic hypertension
C536575,CHEBI,Borjeson-Forssman-Lehmann syndrome [Supplementary Concept],"Fingers/abnormalities|endocrine disorders|Growth Disorders|Mental Retardation, X-Linked|Epilepsy|Obesity|Face/abnormalities|Hypogonadism"
D019512,DISEASE,"Pancreatitis, Alcoholic",alcoholic pancreatitis|Alcoholic Pancreatitis
NEW08572,DISEASE,vascular lesion,vascular lesions
NEW08573,DISEASE,consequent metabolic disease,consequent metabolic diseases
NEW08574,DISEASE,alcohol injury,alcohol injury
NEW08575,DISEASE,cancer risk,cancer risk
NEW08576,DISEASE,promise hepato- due,promising hepato- due
NEW08577,CHEBI,endocrine system insulin resistance,endocrine system insulin resistance
NEW08578,DISEASE,muscle mass,muscle mass
C538167,CHEMICAL,"Acidemia, isovaleric [Supplementary Concept]","isovaleric acidemia|Isovaleryl-CoA Dehydrogenase/deficiency|Amino Acid Metabolism, Inborn Errors"
NEW08579,DISEASE,non-anion metabolic acidosis,non-anion metabolic acidosis
NEW08580,DISEASE,glucose disturbance,glucose disturbances
NEW08581,CHEBI,endocrine screening,endocrine screening
D058533,CHEMICAL,Sex Chromosome Disorders of Sex Development,"Chromosome DSD, Sex|Sex Chromosome DSD|Sex Chromosome DSDs|Chromosome DSDs, Sex|DSD, Sex Chromosome|DSDs, Sex Chromosome|sex-"
NEW08582,CHEBI,endocrine alteration,endocrine alterations
NEW08583,CHEBI,hypothalamus-regulated endocrine axis hypothalamic pituitary-gonadal,hypothalamus-regulated endocrine axes hypothalamic pituitary-gonadal
NEW08584,CHEMICAL,new antidepressant,new antidepressants
http://purl.obolibrary.org/obo/CHEBI_135889,CHEMICAL,sorbinicate,glucitol hexanicotinate|gammahydroxybutyrate
NEW08585,CHEMICAL,serotonin key neurotransmitter,serotonin key neurotransmitters
NEW08586,DISEASE,maladaptive bodily behavior,maladaptive bodily behavior
NEW08587,CHEBI,abnormal growth hormone,Abnormal growth hormones
NEW08588,CHEMICAL,high mehp level,higher MEHP levels
NEW08589,CHEBI,endocrine marker,endocrine markers
NEW08590,CHEBI,endocrine change,endocrine changes
NEW08591,DISEASE,first-time trauma,first-time trauma
NEW08592,CHEBI,low serum calcidiol concentration,Low serum calcidiol concentrations
NEW08593,CHEBI,vitamin insufficiency,vitamin insufficiency
NEW08594,CHEMICAL,calcipherol system,calcipherol system
http://purl.obolibrary.org/obo/GO_0061744,DISEASE,motor behavior,motor behavior
NEW08595,CHEBI,endocrine regulation,endocrine regulation
NEW08596,CHEMICAL,5-ht function,5-HT functions
NEW08597,NUTRITION,dietary tryptophan supplementation,dietary tryptophan supplementation
NEW08598,NUTRITION,tryptophan supplementation,tryptophan supplementation
NEW08599,MENTAL_HEALTH,depression unrelated,depression unrelated
NEW08600,CHEMICAL,low dehydroepiandrosterone sulfate level,lower dehydroepiandrosterone sulfate levels
NEW08601,CHEMICAL,reproductive steroid level,reproductive steroid levels
NEW08602,MENTAL_HEALTH,reproductive mood disorder,reproductive mood disorders
D007340,DISEASE,Insulinoma,"beta Cell Tumor|Tumors, beta-Cell|Adenomas, beta-Cell|beta-Cell Adenomas|beta-Cell Tumor|Tumor, beta-Cell|beta-Cell Adenoma|Insulinomas|Insulinoma|beta-Cell Tumors|Insuloma|Adenoma, beta-Cell|Insulomas|Adenoma, beta Cell"
NEW08603,CHEBI,deceptive endocrine tumour,deceptive endocrine tumour
NEW08604,CHEBI,common endocrine disorder,common endocrine disorders
NEW08605,DISEASE,small ovarian cyst,small ovarian cysts
http://purl.obolibrary.org/obo/CHEBI_139503,CHEBI,vitamin d receptor agonist,Vitamin D receptor VDR agonists|vitamin D nuclear receptor agonist|VDRA|vitamin D nuclear receptor agonists|calcitriol receptor agonists|calcitriol receptor agonist|VDR agonists|VDR agonist|vitamin D receptor agonists
NEW08606,DISEASE,hyperparathyroidism secondary to chronic kidney disease,CKD|hyperparathyroidism secondary to chronic kidney disease
NEW08607,DISEASE,established uremia,established uremia
NEW08608,CHEBI,elevated serum parathyroid hormone,elevated serum parathyroid hormone
NEW08609,DISEASE,abnormal cardiac function,abnormal cardiac function
C570781,CHEMICAL,"5-(2-(1-(1-(3-hydroxy-2,3-dimethylbutoxy)ethyl)-7alpha-methyldihydro-1H-inden-4(2H,5H,6H,7H,7alphaH)-ylidene)ethylidene)-2-methylenecyclohexane-1,3-diol [Supplementary Concept]",Calcitriol/analogs  and  derivatives|VS-105
NEW08610,DISEASE,cardiac fibrosis,cardiac fibrosis
NEW08611,DISEASE,induce hypoparathyroidism,induced hypoparathyroidism
NEW08612,CHEMICAL,phosphate wasting,phosphate wasting
D043782,CHEMICAL,"Receptor, Bradykinin B2","Bradykinin B2 Receptor|B2 Receptor, Bradykinin|Bradykinin Type 2 Receptor|Bradykinin receptors|Receptor, Bradykinin Type 2|Bradykinin B2 Receptors|Receptors, Bradykinin B2|B2 Receptors, Bradykinin"
NEW08613,CHEMICAL,kinin receptor deficiency,kinin receptor deficiency
NEW08614,DISEASE,endotoxin-induced hypotension,endotoxin-induced hypotension
http://purl.obolibrary.org/obo/CHEBI_50888,CHEMICAL,fluoroarene,ASP8477|aryl fluoride|3-Pyridyl 4-(phenylcarbamoyl)piperidine-1-carboxylate|fluoroarenes|aryl fluorides
NEW08615,CHEMICAL,potent faah inhibitor,potent FAAH inhibitor
NEW08616,DISEASE,chronic constriction nerve injury rat,chronic constriction nerve injury rats
NEW08617,DISEASE,cold allodynia,cold allodynia
NEW08618,CHEBI,analgesic activity,analgesic activity
NEW08619,CHEMICAL,faah inhibitor urb597,FAAH inhibitor URB597
NEW08620,DISEASE,inflammatory pain state,inflammatory pain states
NEW08621,MENTAL_HEALTH,receptor-mediated analgesia,receptor-mediated analgesia
NEW08622,CHEMICAL,cannabidiol combination,cannabidiol combination
NEW08623,DISEASE,spasticity due,spasticity due
C587251,CHEMICAL,nabiximols [Supplementary Concept],Cannabidiol|Sativex|Nabiximols|Dronabinol|Drug Combinations
http://purl.obolibrary.org/obo/CHEBI_23888,CHEBI,drug,one-milligram drug|drug ZJ43|drug Epidiolex
NEW08624,DISEASE,childhood seizure,childhood seizures
NEW08625,CHEMICAL,cannabis use,Cannabis use
NEW08626,CHEMICAL,cannabis variant,cannabis variants
NEW08627,DISEASE,few psychotic experience,fewer psychotic experiences
NEW08628,MENTAL_HEALTH,psychosis condition,Psychosis conditions
NEW08629,CHEMICAL,5-ht(2a receptor,5-HT(2A receptors
NEW08630,MENTAL_HEALTH,nps toxicity syndrome,NPS toxicity syndromes
NEW08631,DISEASE,psychiatric inpatient,psychiatric inpatient
NEW08632,CHEMICAL,d-amphetamine nmda receptor blocker,d-amphetamine NMDA receptor blockers
D043425,CHEMICAL,Glutamate Carboxypeptidase II,"Dipeptidase, N-Acetylated-alpha-Linked Acidic|N Acetylated alpha Linked Acidic Dipeptidase|Hydrolase I, Folate|N Acetylaspartylglutamate Peptidase|Acidic Dipeptidase, N-Acetylated-alpha-Linked|NAAG Peptidase|Peptidase, N-Acetylaspartylglutamate|NAALADase II|glutamate carboxypeptidase|NAALADase L|N-Acetylaspartylglutamate Peptidase|NAALADase|N-Acetylated-alpha-Linked Acidic Dipeptidase|Carboxypeptidase II, Glutamate|Folate Hydrolase I|FOLH1 Protein"
NEW08633,CHEMICAL,different naag peptidase inhibitor,different NAAG peptidase inhibitors
NEW08634,CHEMICAL,dopamine model,dopamine models
http://purl.obolibrary.org/obo/CHEBI_61966,CHEMICAL,metabotropic glutamate receptor agonist,group metabotropic glutamate receptor agonist|group metabotropic glutamate receptors|mGluRs agonist|Group metabotropic glutamate receptors|metabotropic glutamate receptor agonists|mGlu5 metabotropic glutamate receptors|metabotropic glutamate receptor mGluR3 gene|metabotropic glutamate receptor type receptor agonists
NEW08635,CHEBI,group mglu receptor agonist,group mGlu receptor agonists
NEW08636,DISEASE,toxic leukoencephalopathy,Toxic leukoencephalopathy
D056784,DISEASE,Leukoencephalopathies,"Myelinosis Centralis Diffusas||Cree Leukoencephalopathies|Diffusas, Myelinosis Centralis|White Matter Diseases|white matter disease|Myelinosis Centralis Diffusa|Leukoencephalopathy|Leukoencephalopathy with Vanishing White Matter|Syndrome, CACH VWM|Vanishing White Matter Disease|CACH VWM Syndromes|Diffusa, Myelinosis Centralis|Childhood Ataxia with Central Nervous System Hypomyelination|Childhood Ataxia with Central Nervous System Hypomyelinization|Vanishing White Matter Leukodystrophy|CACH Syndromes|Cree Leukoencephalopathy|CACH VWM Syndrome|Childhood Ataxia with Diffuse Central Nervous System Hypomyelination|Leukoencephalopathy, Cree|White Matter Disease|VWM Syndrome, CACH|CACH Syndrome|Centralis Diffusa, Myelinosis|leukoencephalopathy"
NEW08637,CHEBI,neurotoxic agent,neurotoxic agent
NEW08638,DISEASE,neuronal dysfunction,neuronal dysfunctions
C026385,CHEMICAL,n-hexane [Supplementary Concept],hexane|Hexane|Hexanes|n-hexane
NEW08639,DISEASE,central system,central system
NEW08640,DISEASE,obvious demyelination,Obvious demyelination
D066271,DISEASE,External Capsule,"external capsule|Capsule, External|Capsula Externas|External Capsules|Capsules, External|Externas, Capsula|Capsula Externa|Externa, Capsula"
NEW08641,DISEASE,behavioral disturbance,Behavioral disturbance
D054561,DISEASE,National Institute on Aging (U.S.),NIA (US)|National Institute on Aging|aging
NEW08642,DISEASE,inborn deficiency,Inborn deficiencies
NEW08643,CHEMICAL,intestinal ammonia production,intestinal ammonia production
NEW08644,CHEMICAL,ammonia generation,ammonia generation
NEW08645,CHEMICAL,ammoniagenic amino acid,ammoniagenic amino acids
NEW08646,DISEASE,acute toxicity,acute toxicities
NEW08647,DISEASE,anion-gap metabolic,anion-gap metabolic
NEW08648,CHEMICAL,cellular differentiate agent hexamethylene bisacetamide,cellular differentiating agent hexamethylene bisacetamide
NEW08649,CHEMICAL,mao inhibitor isocarboxazid,MAO inhibitor isocarboxazid
NEW08650,CHEMICAL,high blood ua level,High blood UA level
NEW08651,CHEMICAL,sulphur amino acid metabolism,sulphur amino acid metabolism
NEW08652,CHEMICAL,endogenous sulphite,Endogenous sulphite
http://purl.obolibrary.org/obo/CHEBI_26834,CHEMICAL,sulfur-containing amino acid,sulfur-containing amino acids|sulphur-containing amino acids
http://purl.obolibrary.org/obo/DOID_0111270,CHEMICAL,isolated sulfite oxidase deficiency,sulphite oxidase deficiency|sulfocysteinuria
C567856,DISEASE,"Growth Retardation, Developmental Delay, Coarse Facies, And Early Death [Supplementary Concept]","Developmental Disabilities|early death|Abnormalities, Multiple|Facies|Failure to Thrive|Dwarfism"
NEW08653,CHEMICAL,sulphite radical,Sulphite radicals
http://purl.obolibrary.org/obo/CHEBI_60798,CHEBI,excitatory amino acid antagonist,EAA receptor antagonists|excitatory amino acid receptor antagonists|selective excitatory amino acid antagonists|EAA receptor antagonist|excitatory amino acid receptor antagonist|excitatory amino acid antagonists
D000069446,CHEMICAL,Atazanavir Sulfate,"CGP-75355|3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester|CGP73547|BMS 232632 05|BMS23263205|232632, BMS|CGP-73547|CGP 73547|CGP|BMS 232632|Reyataz|BMS-232632|CGP 75355|CGP 75136|CGP-75136|CGP75136|CGP75176|CGP 75176|BMS232632|Atazanavir|CGP75355|CGP-75176|BMS-232632-05"
C031231,CHEMICAL,2-amino-7-phosphonoheptanoic acid [Supplementary Concept],2-Amino-5-phosphonovalerate/analogs  and  derivatives|AP7|APH|2-amino-7-phosphonoheptanoic acid
C106106,CHEMICAL,sigma-1 receptor [Supplementary Concept],"sigma-1 receptor|Receptors, sigma"
NEW08654,CHEMICAL,dopamine blocking property,dopamine blocking properties
NEW08655,CHEMICAL,d2 dopamine receptor,D2 dopamine receptor
C042709,CHEMICAL,tiospirone [Supplementary Concept],Spiro Compounds|tiaspirone
NEW08656,DISEASE,Kingdom National OCD Inpatient Service,Kingdom National OCD Inpatient Service
NEW08657,CHEMICAL,functional snp located,functional SNP located
NEW08658,CHEMICAL,bradykinin receptor b2 gene,bradykinin receptor B2 gene
NEW08659,CHEMICAL,dexamethasone suppression,dexamethasone suppression
http://purl.obolibrary.org/obo/DOID_2468,MENTAL_HEALTH,psychotic disorder,neuroleptic-responsive psychotic disorder|mental or behavioural disorder
NEW08660,CHEBI,growth hormone response,growth hormone response
NEW08661,MENTAL_HEALTH,drug-responsive psychotic disorder,drug-responsive psychotic disorder
NEW08662,CHEBI,excessive growth hormone response,excessive growth hormone response
D000745,DISEASE,"Anemia, Hemolytic, Congenital","Hereditary Hemolytic Anemias|Hemolytic Anemias, Congenital|Anemia, Hemolytic, Hereditary|Anemias, Hereditary Hemolytic|Hemolytic Anemias, Hereditary|Anemia, Hereditary Hemolytic|Hereditary Hemolytic Anemia|Hemolytic Anemia, Hereditary|Hemolytic Anemia, Congenital|Anemia, Congenital Hemolytic|Anemias, Congenital Hemolytic|anemias|Congenital Hemolytic Anemias|Congenital Hemolytic Anemia"
http://purl.obolibrary.org/obo/CHEBI_37845,CHEBI,growth hormone,GH|growth hormones|Wachstumshormon|growth hormone (GH)-insulin|Somatotropin
NEW08663,MENTAL_HEALTH,verbal memory disorder,verbal memory disorders
C567209,DISEASE,"Mental Retardation, Joint Hypermobility, And Skin Laxity, With Or Without Metabolic Abnormalities [Supplementary Concept]",Skin Diseases|metabolic abnormalities|Intellectual Disability|Joint Instability/congenital
D010900,DISEASE,Pituitary Diseases,"Adenohypophyseal Disease|Hypophyseal Disorders|Pituitary Disease, Anterior|Disease, Pituitary Gland|Diseases, Pituitary Gland|Pituitary Gland Diseases|Anterior Pituitary Diseases|Disease, Adenohypophyseal|Posterior Pituitary Diseases|Pituitary Disease|Disorder, Hypophyseal|Pituitary Gland Disease|Disease, Posterior Pituitary|Hypophyseal Disorder|Pituitary Disorder|Diseases, Anterior Pituitary|Diseases, Adenohypophyseal|Pituitary Disorders|Disease, Anterior Pituitary|Diseases, Posterior Pituitary|Disease, Neurohypophyseal|Pituitary Diseases, Posterior|Disorder, Pituitary|Adenohypophyseal Diseases|Diseases, Pituitary|Neurohypophyseal Disease|Disorders, Pituitary|Anterior Pituitary Disease|Disease, Pituitary|Neurohypophyseal Diseases|Posterior Pituitary Disease|Pituitary Diseases, Anterior|Disorders, Hypophyseal|Diseases, Neurohypophyseal|Pituitary Disease, Posterior|pituitary disease"
NEW08664,DISEASE,secondary adrenal failure,secondary adrenal failure
NEW08665,CHEMICAL,crh administration,CRH administration
http://purl.obolibrary.org/obo/DOID_656,DISEASE,adrenal adenoma,adenoma of the Adrenal gland|adrenal adenoma|adrenal adenomas
NEW08666,NUTRITION,ovarian follicle maturation,ovarian follicle maturation
NEW08667,CHEBI,human growth hormone hgh response,human growth hormone HGH response
NEW08668,CHEMICAL,dextroamphetamine sulfate dose,dextroamphetamine sulfate doses
NEW08669,CHEMICAL,ghrh analog,GHRH analogs
NEW08670,CHEMICAL,stress-related hormone cortisol,stress-related hormone cortisol
NEW08671,DISEASE,issnhl patient,ISSNHL patients
NEW08672,DISEASE,body compositionand hypotony,body compositionand hypotony
D063305,DISEASE,Organ Dysfunction Scores,"SOFAS Score|Score, SOFAS|Scores, Organ Failure|Organ Dysfunction Score|Organ Failure Score|organ dysfunction|Scores, SOFAS|Sequential Organ Failure Assessment Scores|Score, Organ Failure|Score, MODS|Organ Failure Scores|Score, Organ Dysfunction|MODS Scores|Sequential Organ Failure Assessment Score|Scores, Organ Dysfunction|Scores, MODS|MODS Score|SOFAS Scores|Multiple Organ Dysfunction Score"
NEW08673,DISEASE,muscle loss,muscle loss
D019382,CHEBI,Human Growth Hormone,"Umatrope|HGH|Somatotropin (Human)|rhGH|recombinant human growth hormone|Cryo-Tropin|Cryo Tropin|Maxomat|r-hGH-M|CryoTropin|Somatropin|Serostim|Zomacton|Humatrope|Norditropin|Nutropin|r-hGH(m)|Norditropin Simplexx|Norditropine|hGH (Human Growth Hormone)|Genotropin|Genotonorm|Growth Hormone, Human|human growth hormone|Saizen|Omnitrope|Recombinant Human Growth Hormone (Mammalian)|Somatropin (Human)"
NEW08674,CHEBI,early treatment growth hormone,Early treatment growth hormone
NEW08675,DISEASE,extensive burn,extensive burns
D020881,CHEMICAL,"Enkephalin, D-Penicillamine (2,5)-","DPLPE|L-Pen5-Enkephalin D-Pen2|Bis-Penicillamine-Enkephalin|Bis Pen Enkephalin|Enkephalin, Penicillamine (2,5)-|DPDPE(SH)2|Bis Penicillamine Enkephalin|DPDPE|Enkephalin, Pen(2,5)-|D Pen2, D Pen5 Enkephalin|D-Pen5-Enkephalin D-Pen2|D Pen2, L Pen5 Enkephalin|Bis-Pen-Enkephalin|D-Pen2, D-Pen5-Enkephalin|penicillamine|d-Penicillamine|D-Pen2, L-Pen5-Enkephalin|D-Penicillamine (2,5)-Enkephalin"
NEW08676,DISEASE,chronic debilitating disorder,chronic debilitating disorders
NEW08677,CHEMICAL,severe zinc deficiency,severe zinc deficiency
NEW08678,DISEASE,emotional disorder,emotional disorder
http://purl.obolibrary.org/obo/DOID_2723,DISEASE,dermatitis,eczema|skin inflammation|bullous-pustular dermatitis
NEW08679,DISEASE,intercurrent infection,intercurrent infections
NEW08680,MENTAL_HEALTH,personality disorder patient,personality disorder patients
NEW08681,CHEMICAL,physostigmine challenge,physostigmine challenge
NEW08682,DISEASE,non-borderline,non-borderline
NEW08683,MENTAL_HEALTH,States depression,States depression
NEW08684,DISEASE,depressive response,depressive response
NEW08685,DISEASE,acute depressive response,acute depressive responses
NEW08686,DISEASE,upd group,UPD group
D024182,DISEASE,Uniparental Disomy,"UPD|Uniparental Isodisomies|Disomy, Uniparental|uniparental disomy|Uniparental Heterodisomy|Isodisomies, Uniparental|Heterodisomy, Uniparental|Uniparental Disomies|Heterodisomies, Uniparental|Uniparental Isodisomy|Disomies, Uniparental|Uniparental Heterodisomies"
NEW08687,DISEASE,psychiatric behavior,psychiatric behaviors
C536560,NUTRITION,Chanarin-Dorfman Syndrome [Supplementary Concept],"Lipid Metabolism, Inborn Errors|Ichthyosiform Erythroderma, Congenital|Muscular Diseases|long-chain fatty acid oxidation|fatty acid oxidation"
NEW08688,CHEMICAL,mitochondrial acylcarnitine transport,mitochondrial acylcarnitine transport
NEW08689,DISEASE,hepatic glucose production secondary,hepatic glucose production secondary
NEW08690,CHEMICAL,glucose consumption secondary,glucose consumption secondary
NEW08691,CHEMICAL,drug.1 sodium salt,drug.1 Sodium salt
NEW08692,CHEBI,growth hormone release,growth hormone release
D058247,DISEASE,Loose Anagen Hair Syndrome,"Loose Anagen Syndrome|loose anagen hair|Loose Anagen Syndromes|Syndrome, Loose Anagen|Syndromes, Loose Anagen|Anagen Syndromes, Loose|Anagen Syndrome, Loose"
D011146,DISEASE,"Eczema, Dyshidrotic","Dyshydrotic Eczemas|Eczema, Vesicular Palmoplantar|Palmoplantar Eczema, Vesicular|Vesicular Palmoplantar Eczema|Eczemas, Vesicular Palmoplantar|Dyshydrotic Eczema|Palmoplantar Eczemas, Vesicular|Eczemas, Dyshydrotic|Vesicular Palmoplantar Eczemas|Pompholyx|Eczema, Dyshydrotic|eczema|Eczemas, Dyshidrotic|Dyshidrotic Eczemas|Dyshidrotic Eczema"
NEW08693,DISEASE,mild psychomotor delay,mild psychomotor delays
D053560,DISEASE,Ichthyosis Bullosa of Siemens,"ichthyosis|Ichthyosis, Bullous Type of Siemens|Siemens Ichthyosis Bullosa|Ichthyosis, Bullous Type|Bullous Type Ichthyosis|Bullous Type of Ichthyosis|Bullous Type Ichthyoses|Ichthyosis Bullous Type|Ichthyoses, Bullous Type"
D009634,DISEASE,Noonan Syndrome,"Female Pseudo Turner Syndrome|Noonan-Ehmke Syndrome|Noonan Syndrome 1|Female Pseudo-Turner Syndrome|Ullrich Noonan Syndrome|Pseudo-Ullrich-Turner Syndrome|Pseudo-Turner Syndrome, Female|Noonan syndrome|Familial Turner Syndrome|Turner Phenotype with Normal Karyotype|Turner-Like Syndrome|Male Turner Syndrome|Turner Syndrome, Male|Turner Syndrome, Familial|Male Turner's Syndrome|Turner's Phenotype, Karyotype Normal|Ullrich-Noonan Syndrome|Pseudo Ullrich Turner Syndrome|Turner Like Syndrome|Noonan Ehmke Syndrome|Turner's Syndrome, Male"
NEW08694,DISEASE,bipolar patient,Bipolar patients
NEW08695,CHEBI,numerous endocrine abnormality,Numerous endocrine abnormalities
NEW08696,DISEASE,depressive illness prediction,depressive illness prediction
NEW08697,DISEASE,unipolar affective disorder,unipolar affective disorder
NEW08698,CHEMICAL,serum cortisol,serum cortisol
C000610980,CHEMICAL,paeoniflorin-6'-O-benzenesulfonate [Supplementary Concept],Glucosides|paeoniflorin|Monoterpenes
NEW08699,DISEASE,twenty-four-hour hypersecretion,Twenty-four-hour hypersecretion
NEW08700,DISEASE,enzyme ghrelin o-acyltransferase,enzyme ghrelin O-acyltransferase|GOAT
NEW08701,MENTAL_HEALTH,bingeing-related eat disorder,bingeing-related eating disorders
C581708,CHEMICAL,cyclic des-acyl ghrelin (6-13) [Supplementary Concept],"DAG|des-acyl-ghrelin|Ghrelin|Peptide Fragments|Peptides, Cyclic"
D000073599,DISEASE,Health Risk Behaviors,"behaviors|Risk Behaviors, Health|Risky Health Behaviors|Behavior, Health Risk|Behaviors, Risky Health|Behavior, Risky Health|Risk Behavior, Health|Risky Health Behavior|Behaviors, Health Risk|health-risk behaviors|Health Behavior, Risky|Health Risk Behavior|Health Behaviors, Risky"
NEW08702,CHEBI,estrogen exposure,estrogen exposure
NEW08703,CHEMICAL,iron metabolism due,iron metabolism due
NEW08704,DISEASE,impaired fertility due,impaired fertility due
NEW08705,CHEMICAL,mk-0677-treated 5xfad mouse,MK-0677-treated 5XFAD mice
C094817,CHEMICAL,ibutamoren mesylate [Supplementary Concept],Indoles|Spiro Compounds|MK-0677
NEW08706,DISEASE,human motivational dysfunction,humans motivational dysfunction
NEW08707,NUTRITION,strawberry plant,strawberry plants
NEW08708,CHEMICAL,c-amp dependent protein kinase protein kinase a,c-AMP dependent protein kinase protein kinase A
C532492,CHEMICAL,"apelin-13, Ala(13)- [Supplementary Concept]",apelin-13|Intercellular Signaling Peptides and Proteins
NEW08709,CHEMICAL,gr dysfunction,GR dysfunctions
NEW08710,DISEASE,chronic stress-induced depression-like phenotype,chronic stress-induced depression-like phenotypes
NEW08711,CHEMICAL,ana-12 injection,ANA-12 injection
NEW08712,CHEMICAL,morphine withdrawal,morphine withdrawal
NEW08713,CHEMICAL,trkb receptor antagonist,ANA-12|TrkB receptor antagonist
NEW08714,CHEMICAL,morphine-dependent rat,morphine-dependent rats
NEW08715,DISEASE,anxiety/depressive-like behavior,anxiety/depressive-like behaviors
D020539,CHEMICAL,"Sequence Analysis, Protein","Protein Sequence Determination|Protein Sequence Analysis|Amino Acid Sequencing|Analyses, Peptide Sequence|Sequence Determinations, Amino Acid|Sequence Determination, Peptide|Sequence Analyses, Peptide|Amino Acid Sequence Determinations|Amino Acid Sequence Analyses|Sequence Analysis, Amino Acid|Sequence Determination, Amino Acid|Peptide Sequence Analyses|Sequence Determinations, Protein|Sequence Determinations, Peptide|Amino Acid Sequence Determination|Protein Sequence Determinations|Analyses, Protein Sequence|Acid Sequencing, Amino|Sequence Analysis, Peptide|Protein Sequencing|Protein Sequence Analyses|Sequence Determination, Protein|Peptide Sequence Analysis|Sequence Analyses, Protein|Amino Acid Sequence Analysis|Peptide Sequence Determinations|amino acid peptide|Sequencing, Amino Acid|Sequencing, Protein|Analysis, Protein Sequence|Sequence Analyses, Amino Acid|Peptide Sequence Determination|Analysis, Peptide Sequence"
NEW08716,MENTAL_HEALTH,anxiety regulation,anxiety regulation
NEW08717,DISEASE,dpag-evoked panic-like behaviour,DPAG-evoked panic-like behaviours
D010378,MENTAL_HEALTH,Pedophilia,Pederasty|pedophilia|Pederasties|Pedophilias
NEW08718,MENTAL_HEALTH,heterosexual pedophilia,heterosexual pedophilia
NEW08719,DISEASE,recent-onset psychotic patient,recent-onset psychotic patients
NEW08720,CHEMICAL,cortisol processing speed,cortisol processing speed
NEW08721,DISEASE,se female,SE females
NEW08722,CHEBI,drug injection,drug injection
NEW08723,CHEMICAL,at1 receptor blocker,AT1 receptor blocker|ARB
NEW08724,CHEMICAL,corticosterone response,corticosterone response
NEW08725,DISEASE,second rs period,second RS period
http://purl.obolibrary.org/obo/SYMP_0000835,DISEASE,hypoalgesia,ICS-induced hyperalgesia|hypernociception
NEW08726,MENTAL_HEALTH,schizophrenia inpatient,schizophrenia inpatients
NEW08727,CHEMICAL,prescribe clozapine dosage,prescribed clozapine dosage
NEW08728,CHEMICAL,plasma clozapine concentration,plasma clozapine concentrations
NEW08729,MENTAL_HEALTH,repeat chronic stress,Repeated chronic stress
D004700,CHEBI,Endocrine System Diseases,"Endocrine Diseases|System Disease, Endocrine|Disease, Endocrine|Diseases of Endocrine System|Endocrine System Disease|endocrine disease|System Diseases, Endocrine|Endocrine Disease|Disease, Endocrine System|Diseases, Endocrine System|Diseases, Endocrine"
C487045,MENTAL_HEALTH,"XRRA1 protein, human [Supplementary Concept]",radiation resistance|Proteins
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Psychiatric_Symptoms,DISEASE,psychiatric symptoms,psychiatric symptomatology
NEW08730,CHEBI,hormone supplement,hormone supplements
D047508,DISEASE,Massive Hepatic Necrosis,"|fulminant hepatitis|Yellow Atrophy, Acute|Drug-induced Hepatic Necrosis|Acute Yellow Atrophy|Necrosis, Submassive Hepatic|Hepatitis, Fulminant|Drug induced Hepatic Necrosis|Necrosis, Drug-induced Hepatic|Acute Yellow Atrophy of Liver|Fulminant Hepatitis|Hepatic Necrosis, Submassive|extensive hepatocellular necrosis|Hepatic Necrosis, Drug-induced|Drug-induced Hepatic Necroses|Fulminant Hepatitides|Acute Yellow Atrophies|Submassive Hepatic Necrosis|Hepatic Necrosis, Massive|Submassive Hepatic Necroses"
NEW08731,DISEASE,exacerbate hypercatabolism,exacerbated hypercatabolism
NEW08732,CHEBI,hypothalamic peptide hormone,hypothalamic peptide hormones
NEW08733,CHEMICAL,alcohol abstinence syndrome,alcohol abstinence syndrome
NEW08734,MENTAL_HEALTH,acute alcoholic psychosis,acute alcoholic psychoses
NEW08735,CHEBI,glucocorticoid hormone,Glucocorticoid hormones
NEW08736,CHEBI,glucocorticoid hormone,glucocorticoid hormones
NEW08737,DISEASE,behavioral addiction,behavioral addiction
NEW08738,DISEASE,neuropsychiatric impairment,neuropsychiatric impairments
D051247,CHEMICAL,Sodium-Glucose Transport Proteins,"Sodium-Glucose Transport Protein|Sodium Glucose Transport System|Glucose Cotransporters, Sodium|Transporter, Sodium Glucose|Glucose Transporter, Sodium|Cotransporter, Sodium Glucose|Sodium Glucose Transporter|SGLT Protein|Protein, Sodium-Glucose Transport|Protein, SGLT|Transporter, Sodium-Sugar|Sodium Glucose Transport Proteins|Sodium Glucose Transport Protein|glucose transporters|Sodium-Sugar Transporter|Sodium Glucose Cotransporters|Sodium Glucose Transporters|Glucose Sodium Transport System|Sodium Sugar Transporter|Glucose-Sodium Transport System|Sodium Glucose Cotransporter|SGLT Proteins|Sodium-Glucose Transport System|Glucose Transporters, Sodium|Glucose Cotransporter, Sodium|Transport Protein, Sodium-Glucose"
NEW08739,DISEASE,cluster b,cluster B
NEW08740,CHEMICAL,diameter low salivary cortisol level,diameter lower salivary cortisol levels
NEW08741,DISEASE,pd s,PD s
NEW08742,CHEBI,different endocrine profile,different endocrine profiles
NEW08743,MENTAL_HEALTH,stress resistance,stress resistance
NEW08744,MENTAL_HEALTH,seasonal affective disorder scale,seasonal affective disorder scale
NEW08745,CHEMICAL,low relative cortisol amplitude,lower relative cortisol amplitude
NEW08746,CHEBI,target hormone,target hormones
NEW08747,MENTAL_HEALTH,objective binge eat,objective binge eating
NEW08748,CHEMICAL,neuroactive steroid hormone,neuroactive steroid hormones
NEW08749,CHEMICAL,derive biogenic amine,derived biogenic amines
NEW08750,DISEASE,acute mental stress test,acute mental stress test
NEW08751,DISEASE,chronic mental stress,chronic mental stress
NEW08752,CHEMICAL,neurotransmitter precursor amino acid level,neurotransmitter precursor amino acid levels
NEW08753,CHEMICAL,kynurenine/tryptophan,Kynurenine/tryptophan
NEW08754,DISEASE,factor acute mental stress,factor acute mental stress
http://purl.obolibrary.org/obo/CHEBI_25500,CHEMICAL,neopterins,KYN/TRP
NEW08755,MENTAL_HEALTH,anxiety value,anxiety values
http://purl.obolibrary.org/obo/CHEBI_18257,CHEMICAL,ornithine,"PHE/TYR|ornithine|Ornithine|2,5-diaminopentanoic acid|DL-Ornithine|Orn|phenylalanine/tyrosine|2,5-Diaminopentanoic acid|2,5-Diaminovaleric acid"
NEW08756,MENTAL_HEALTH,chronic stress parameter,chronic stress parameters
NEW08757,DISEASE,chronic mental stress condition,chronic mental stress condition
NEW08758,CHEMICAL,acute acid,acute acid
NEW08759,DISEASE,acute mental stress,acute mental stress
NEW08760,MENTAL_HEALTH,great physical fatigue,greater physical fatigue
NEW08761,CHEMICAL,serotonergic receptor activity,serotonergic receptor activity
http://purl.obolibrary.org/obo/CHEBI_177381,CHEBI,naxagolide hydrochloride,"(4aR-trans)-3,4,4a,5,6,10b-hexahydro-4-propyl-2H-naphth[1,2-b]-1,4-oxazin-9-ol hydrochloride|(4aR,10bR)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol hydrochloride|MK 458|L-647,339|(+)-PHNO hydrochloride|agonist (±)-8-Hydroxy-2-dipropylaminotetralin hydrobromide|L 647339|MK-458|L 647,339|naxagolide monohydrochloride|(4aR,10bR)-9-hydroxy-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-4-ium chloride|naxagolide HCl"
NEW08762,CHEMICAL,95%ci=-0.128,95%CI=-0.128
NEW08763,CHEMICAL,pool logor=0.208,pooled logOR=0.208
NEW08764,CHEMICAL,pool logor=-0.366,pooled logOR=-0.366
NEW08765,CHEMICAL,placebo antidepressant combination,placebo antidepressant combination
NEW08766,CHEMICAL,tcp treatment,TCP treatment
NEW08767,DISEASE,mandatory tyramine-restricted diet,mandatory tyramine-restricted diet
NEW08768,DISEASE,hypertensive crisis,hypertensive crisis
NEW08769,CHEBI,indirect sympathomimetic drug,indirect sympathomimetic drugs
NEW08770,CHEMICAL,severe serotonin toxicity,severe serotonin toxicity
NEW08771,MENTAL_HEALTH,co-occurre eat disorder,co-occurring eating disorders
NEW08772,DISEASE,binge episode,binge episodes
NEW08773,CHEMICAL,serotonin dysregulation,serotonin dysregulation
NEW08774,CHEMICAL,available antidepressant medication,available antidepressant medications
NEW08775,CHEMICAL,5-ht(1a)-r full agonist (r)-(+)-8-hydroxy-2-(di-n-propylamino)tetralin,5-HT(1A)-R full agonist (R)-(+)-8-hydroxy-2-(di-n-propylamino)tetralin
NEW08776,CHEMICAL,neonatal flx effect,neonatal FLX effect
NEW08777,CHEMICAL,5-ht neurotransmission,5-HT neurotransmission
NEW08778,DISEASE,aberrant emotional behavior,aberrant emotional behaviors
NEW08779,DISEASE,hyperactivity deficit,hyperactivity deficits
NEW08780,CHEBI,toxin stereotactic surgery,toxin stereotactic surgery
NEW08781,CHEMICAL,dopamine depletor,dopamine depletors
NEW08782,CHEMICAL,dopamine receptor blocker,dopamine receptor blockers
http://purl.obolibrary.org/obo/DOID_11257,MENTAL_HEALTH,social phobia,specific social phobias
NEW08783,CHEMICAL,conventional irreversible maoi,conventional irreversible MAOIs
NEW08784,CHEMICAL,dietary tyramine,dietary tyramine
NEW08785,CHEMICAL,selective mao-a inhibitor,selective MAO-A inhibitors
NEW08786,CHEMICAL,conventional irreversible maoi,conventional irreversible MAOI
NEW08787,CHEMICAL,selective maoi-a inhibitor,selective MAOI-A inhibitors
NEW08788,DISEASE,nps intake,NPS intake
NEW08789,DISEASE,ss occurrence,SS occurrence
NEW08790,CHEBI,synthetic cannabinoid agonist win,synthetic cannabinoid agonist WIN
NEW08791,CHEMICAL,chronic morphine treatment,chronic morphine treatment
NEW08792,CHEMICAL,mesolimbic tract,mesolimbic tract
http://purl.obolibrary.org/obo/SYMP_0000422,DISEASE,dyspepsia,dysmotility-like functional dyspepsia|indigestion
NEW08793,DISEASE,double eyelid spasm,double eyelid spasm
NEW08794,CHEMICAL,benzodiazepine class,benzodiazepine class
NEW08795,CHEMICAL,clonazepam tablet,clonazepam tablets
NEW08796,CHEMICAL,coadministrate 5-ht1a agonistic psychotropic,coadministrating 5-HT1A agonistic psychotropics
NEW08797,CHEMICAL,severe serotonin excess,severe serotonin excess
NEW08798,CHEMICAL,dopamine receptor located,dopamine receptors located
http://purl.obolibrary.org/obo/CHEBI_81580,CHEMICAL,prolactin,PRL|prolactine
NEW08799,CHEMICAL,dopamine reward substrate,dopamine reward substrate
NEW08800,CHEBI,dopamine antagonist treatment,dopamine antagonist treatment
NEW08801,DISEASE,avh,AVHs
NEW08802,CHEBI,serotonin-dopamine antagonist,serotonin-dopamine antagonist
NEW08803,MENTAL_HEALTH,deficit hyperactivity disorder patient,deficit hyperactivity disorder patients
NEW08804,MENTAL_HEALTH,hyperactivity behavior,hyperactivity behavior
NEW08805,CHEBI,potent dopamine d2-like receptor antagonist,potent dopamine D2-like receptor antagonist
NEW08806,MENTAL_HEALTH,ppi hyperactivity,PPI hyperactivity
NEW08807,CHEMICAL,dopamine impairment,Dopamine impairments
NEW08808,DISEASE,schizophrenia-related ios,schizophrenia-related IOS
D000078262,CHEMICAL,Rifaximin,"Redactiv|L105|Xifaxan|L-105|L 105|rifaximin|Rifaximin|4-Deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4C)rifamycin"
NEW08809,DISEASE,hyperammonemia cognitive function,hyperammonemia cognitive function
NEW08810,CHEBI,nondopaminergic drug,nondopaminergic drug
http://purl.obolibrary.org/obo/CHEBI_134742,CHEMICAL,delamanid,40-mg|deltyba|OPC-67683|noninferior
NEW08811,DISEASE,motor fluctuation,motor fluctuations
D000348,CHEMICAL,Aflatoxins,Aflatoxin|aflatoxins
D012137,DISEASE,Respiratory System,"Tract, Respiratory|Respiratory Tract|Respiratory Tracts|Tracts, Respiratory|Respiratory Systems|System, Respiratory|Systems, Respiratory|respiratory systems"
C555344,CHEMICAL,deoxynivalenol sulfonate [Supplementary Concept],DON|Deoxynivalenol|Trichothecenes
NEW08812,CHEMICAL,low don exposure,lower DON exposure
D009183,CHEBI,Mycotoxins,"Fungal Toxins|mycotoxins|fungal toxins|Mycotoxin|Toxins, Fungal"
NEW08813,DISEASE,neuropsychological impairment,neuropsychological impairment
NEW08814,DISEASE,robust lordosis behavior,robust lordosis behavior
NEW08815,MENTAL_HEALTH,anxiety motor activity,anxiety motor activity
D016308,CHEMICAL,"Enkephalin, Leucine-2-Alanine","5-Leucine-2-Alanine Enkephalin|Enkephalin, Leucine 2 Alanine|D-Ala(2)-D-Leu(5)-Enkephalin|BW180C|Enkephalin, 5-Leucine-2-Alanine|Enkephalin-Leu,Ala(2)|2-Alanyl-Leucine Enkephalin|Leu Enkephalin 2 Ala|Leu-Enkephalin-2-Ala|Leucine Enkephalin-2-Alanine|BW-180C|Leucine Enkephalin 2 Alanine|BW 180C|Leucine-2-Alanine Enkephalin|Enkephalin-2-Alanine, Leucine|DADLE|Enkephalin, 2-Alanyl-Leucine|5 Leucine 2 Alanine Enkephalin|2 Alanyl Leucine Enkephalin"
NEW08816,CHEMICAL,oseltamivir treatment,oseltamivir treatment
NEW08817,DISEASE,childhood bpd,Childhood BPD
D010389,CHEMICAL,Pemoline,"|Compounds, Pemoline|Magnesium, Pemoline|pemoline|Pemoline Compounds|Pemoline|Phenylisohydantoin|Cylert|Phenoxazole|PemADD|Pemoline Magnesium|Tradon"
NEW08818,CHEMICAL,adenosine reuptake inhibitor,adenosine reuptake inhibitors
NEW08819,DISEASE,induce td,induced TD
D004176,CHEMICAL,Dipyridamole,|Persantine|Cerebrovase|Kurantil|Curantil|Dipyramidole|Cléridium|Apo-Dipyridamole|Antistenocardin|Dipyridamole|Novo Dipiradol|Persantin|Miosen|Novo-Dipiradol|dipyridamole|Curantyl|Apo Dipyridamole
NEW08820,CHEBI,anticonvulsant drug pregabalin,anticonvulsant drug pregabalin
NEW08821,DISEASE,drug-induced dependency,drug-induced dependency
NEW08822,CHEMICAL,selective bzd compound,selective BZD compounds
NEW08823,CHEBI,5-ht moduline antagonist,5-HT moduline antagonists
http://purl.obolibrary.org/obo/MFOMD_0000188,DISEASE,dysphoria,paruresis|hair-pulling|trichotillomania
http://purl.obolibrary.org/obo/DOID_10933,DISEASE,obsessive-compulsive disorder,Overanxious disorder|obsessive compulsive disorder|Anancastic neurosis
NEW08824,MENTAL_HEALTH,daytime drowsiness,daytime drowsiness
NEW08825,CHEMICAL,clozapine therapy,clozapine therapy
D009365,MENTAL_HEALTH,"Neoplasm Regression, Spontaneous","Spontaneous Neoplasm Regression|spontaneous regression|Neoplasm Remission, Spontaneous|Remission, Spontaneous Neoplasm|Spontaneous Neoplasm Remission|Regression, Spontaneous Neoplasm"
NEW08826,CHEMICAL,mild aa,mild AA
NEW08827,DISEASE,nonresponsive psychosis,nonresponsive psychoses
NEW08828,MENTAL_HEALTH,pupillary fatigue,pupillary fatigue
NEW08829,CHEMICAL,sucrose consumption,sucrose consumption
C527076,CHEMICAL,Avlimil [Supplementary Concept],Avlimil|Plant Extracts
NEW08830,CHEMICAL,estrogen receptor positive human cancer mcf-7 cell,estrogen receptor positive human cancer MCF-7 cells
C524675,NUTRITION,formic acid 4-(3-oxobutyl)phenyl ester [Supplementary Concept],Raspberry ketone|Formates
NEW08831,CHEMICAL,striatal dopamine innervation,striatal dopamine innervation
NEW08832,DISEASE,selective hyposmia,selective hyposmia
NEW08833,CHEMICAL,mesolimbic dopamine innervation,mesolimbic dopamine innervation
NEW08834,CHEBI,muscarinic cholinergic antagonist quinuclidinyl benzilate,muscarinic cholinergic antagonist quinuclidinyl benzilate
NEW08835,CHEMICAL,age-matched ethanol abuser,age-matched ethanol abusers
C515421,CHEMICAL,SB-699551-A [Supplementary Concept],SB-699551|Biphenyl Compounds
NEW08836,CHEMICAL,mecamylamine nachrs antagonist,mecamylamine nAChRs antagonists
NEW08837,DISEASE,bicuculline-induced seizure-like activity,bicuculline-induced seizure-like activity
C029617,CHEMICAL,ethyl loflazepate [Supplementary Concept],Benzodiazepines|Loflazepate
NEW08838,MENTAL_HEALTH,state anxiety,state anxiety
C004858,CHEMICAL,diphenidol [Supplementary Concept],Piperidines|Diphenidol
NEW08839,DISEASE,alzheimers s disease patient,Alzheimers s disease patients
D044945,NUTRITION,Proanthocyanidins,"Procyanidins|Tannins, Condensed|Proanthocyanidins|Condensed Tannins|Polymers, Anthocyanidin|Tannin, Condensed|Condensed Tannin|proanthocyanidins|Anthocyanidin Polymers"
D056604,CHEMICAL,Grape Seed Extract,"extract|seed extract|Seed Extract, Grape|exp.2|Extract, Grape Seed"
D059808,CHEMICAL,Polyphenols,Polyphenol|polyphenols|Provinols
NEW08840,DISEASE,classical nutritional deficiency model,classical nutritional deficiency models
NEW08841,CHEBI,isoflavonoid phytoestrogen,isoflavonoid phytoestrogen
NEW08842,CHEBI,standard drug fluoxetine,standard drug fluoxetine
NEW08843,CHEMICAL,genistein supplementation,Genistein supplementation
NEW08844,DISEASE,diabetes-associated ocd symptomatology,diabetes-associated OCD symptomatology
NEW08845,CHEMICAL,glucose parameter,glucose parameters
NEW08846,CHEMICAL,bps-exposed NODEF mouse,BPS-exposed NODEF mice
NEW08847,DISEASE,various hormone-dependent disorder,various hormone-dependent disorders
D048789,CHEBI,Phytoestrogens,"Estrogens, Plant|Estrogen-Like Plant Extracts|Phyto Estrogen|Plant Estrogen|Plant Estrogens|Phyto-Estrogen|Estrogen, Plant|Phytoestrogen|Plant Extracts, Estrogen-Like|phytoestrogen|Extracts, Estrogen-Like Plant|phytoestrogens|Phytoestrogens|Estrogen Like Plant Extracts"
C576978,CHEMICAL,7-(O)-carboxymethyl daidzein N-t-Boc-hexylenediamine conjugate [Supplementary Concept],daidzein|Isoflavones
NEW08848,DISEASE,diet-induced obese male mouse,diet-induced obese male mice
NEW08849,DISEASE,metabolic neurobehavioral disorder,metabolic neurobehavioral disorders
NEW08850,CHEMICAL,s-equol,S-equol
NEW08851,CHEMICAL,s-equol individual,S-equol individuals
NEW08852,CHEMICAL,sutaehwan,Sutaehwan
NEW08853,MENTAL_HEALTH,fetal restlessness,fetal restlessness
NEW08854,CHEMICAL,sth_kp17001,STH_KP17001
D006332,DISEASE,Cardiomegaly,"Heart, Enlarged||Cardiac Hypertrophies|Enlargement, Heart|cardiomegaly|Heart Hypertrophy|Heart Hypertrophies|Enlarged Heart|Hypertrophy, Heart|Heart Enlargement|heart hypertrophy|Cardiac Hypertrophy|Hypertrophy, Cardiac|Hypertrophies, Heart|Hypertrophies, Cardiac"
NEW08855,MENTAL_HEALTH,menopause-induced anxiety,menopause-induced anxiety
D062485,DISEASE,Breath Holding,"Holding, Breath|breath|Breath Holdings|Holdings, Breath"
NEW08856,CHEMICAL,selective serotonin reuptake inhibitor/serotonin,selective serotonin reuptake inhibitor/serotonin
NEW08857,CHEMICAL,hrt norepinephrine reuptake inhibitor antidepressant therapy,HRT norepinephrine reuptake inhibitor antidepressant therapy
NEW08858,CHEMICAL,Flax seed,Flax seed
C090142,CHEMICAL,secoisolariciresinol diglucoside [Supplementary Concept],secoisolariciresinol diglucoside|Butylene Glycols|Glucosides
D017962,CHEMICAL,alpha-Linolenic Acid,"alpha-Linolenic Acid, Zinc Salt|alpha Linolenic Acid, Calcium Salt|alpha-Linolenic Acid, Lithium Salt|alpha-Linolenic Acid, Ammonium Salt|alpha-Linolenic Acid, (E,E,E)-Isomer|Linolenic Acid|alpha Linolenic Acid, Magnesium Salt|alpha-Linolenic Acid, (Z,Z,E)-Isomer|alpha Linolenic Acid, Potassium Salt|alpha-Linolenic Acid, Sodium Salt|alpha-linolenic acid|alpha-Linolenic Acid, Calcium Salt|alpha-Linolenic Acid, (E,Z,E)-Isomer|alpha Linolenic Acid, Ammonium Salt|alpha-Linolenic Acid, (Z,E,E)-Isomer|alpha-Linolenic Acid, Magnesium Salt|alpha-Linolenic Acid, Potassium Salt|alpha Linolenic Acid, Sodium Salt|alpha-Linolenic Acid, (E,E,Z)-Isomer|alpha-Linolenic Acid, Tin(2+) Salt|Linolenate|alpha-Linolenic Acid, (Z,E,Z)-Isomer|alpha-Linolenic Acid, (E,Z,Z)-Isomer|alpha Linolenic Acid, Zinc Salt|alpha Linolenic Acid, Lithium Salt|alpha Linolenic Acid"
NEW08859,CHEBI,phytoestrogen precursor,phytoestrogen precursor
NEW08860,DISEASE,mature oligodendrocyte,mature oligodendrocytes
NEW08861,DISEASE,cholinergic-related alteration,cholinergic-related alterations
NEW08862,DISEASE,schizophrenia-like syndrome,schizophrenia-like syndrome
NEW08863,CHEBI,high affinity muscarinic antagonist,high affinity muscarinic antagonist
NEW08864,CHEMICAL,"l655,708","L655,708"
NEW08865,DISEASE,stroke-induced,stroke-induced
C082469,CHEMICAL,sodium-influx-stimulating peptide [Supplementary Concept],Neuropeptides|sodium influx
NEW08866,DISEASE,chronic stroke,chronic stroke
NEW08867,CHEBI,common endocrine disease,common endocrine disease
NEW08868,DISEASE,profound hypogonadism,profound hypogonadism
NEW08869,CHEMICAL,isoflavone intake,isoflavone intake
http://purl.obolibrary.org/obo/CHEBI_36005,CHEMICAL,docosahexaenoic acid,docosahexaenoic acid|DHA|docosahexaenoic acid content|acids docosahexaenoic acid|docosahexaenoic acids
NEW08870,CHEBI,suboptimal vitamin d,suboptimal vitamin D
NEW08871,DISEASE,advanced aids abuse,advanced AIDS abuse
D019829,CHEMICAL,Nevirapine,"|BI-RG-587|nevirapine|Hemihydrate, Nevirapine|BI RG 587|BIRG587|Nevirapine Hemihydrate|nevirapine-|Viramune"
http://purl.obolibrary.org/obo/CHEBI_31781,CHEMICAL,lopinavir,"(2S)-N-[(2S,4S,5S)-5-{[(2,6-dimethylphenoxy)acetyl]amino}-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide|ritonavir-boosted lopinavir|Lopinavir"
D000069545,CHEMICAL,"Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination","Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Disoproxil Fumarate Drug Combination|Stribild|TDF|Genvoya|Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate|Pill, Quad|Elvitegravir Cobicistat Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine|FTC|elvitegravir|Quad Pill|tenofovir disoproxil fumarate|Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate Drug Combination"
http://purl.obolibrary.org/obo/CHEBI_37924,CHEMICAL,atazanavir,"ATZ|atazanavirum|dimethyl (3S,8S,9S,12S)-9-benzyl-3,12-di-tert-butyl-8-hydroxy-4,11-dioxo-6-[4-(2-pyridyl)benzyl]-2,5,6,10,13-pentaazatetradecanedioate|atazanavir|ritonavir-boosted HIV-PI|ritonavir-boosted atazanavir"
NEW08872,DISEASE,its 's mitochondrial toxicity,its's mitochondrial toxicity
NEW08873,DISEASE,human immunodeficiency virus/acquired immunodeficiency syndrome chemotherapy,human immunodeficiency virus/acquired immunodeficiency syndrome chemotherapies
NEW08874,DISEASE,mitochondrial-dependent painful neuropathy,mitochondrial-dependent painful neuropathy
NEW08875,DISEASE,hiv/aids therapy neuropathy,HIV/AIDS therapy neuropathy
NEW08876,DISEASE,hiv-1 infection,HIV-1 infection
NEW08877,CHEMICAL,co-formulated bictegravir,Co-formulated bictegravir
C000654125,CHEMICAL,"bictegravir, emtricitabine, tenofovir alafenamide, drug combination [Supplementary Concept]",Emtricitabine|Tenofovir alafenamide|Alanine|Piperazines|Tenofovir|Pyridones|tenofovir alafenamide|Drug Combinations
C042080,CHEMICAL,diisodecyl phthalate [Supplementary Concept],DIDP|Diisodecyl phthalate|Phthalic Acids
D005557,CHEMICAL,Formaldehyde,Methanal|formaldehyde|Oxomethane|Formalin|Formol
D059409,DISEASE,"Stroke, Lacunar","Syndrome, Lacunar|Lacunar Infarction|Lacunar Infarcts|Infarct, Lacunar|Syndromes, Lacunar|Lacunar Strokes|Lacunar Syndrome|Lacunar Stroke|Infarctions, Lacunar|Infarcts, Lacunar|Lacunar Syndromes|Lacunar Infarct|Stroke|Strokes, Lacunar|Infarction, Lacunar|Lacunar Infarctions"
NEW08878,MENTAL_HEALTH,probable alzheimer disease,probable Alzheimer disease
NEW08879,DISEASE,Disease Disorders Association,Disease Disorders Association
NEW08880,CHEBI,adjunctive vitamin,adjunctive vitamin
NEW08881,MENTAL_HEALTH,long-term schizophrenia,long-term schizophrenia
NEW08882,CHEBI,antioxidant vitamin,antioxidant vitamins
NEW08883,DISEASE,k. anthotheca,K. anthotheca
D017968,CHEMICAL,Vanadium Compounds,"Compounds, Vanadium|V₂|vanadium|V1182.63|V1"
NEW08884,MENTAL_HEALTH,treatment-resistant recurrent depression,treatment-resistant recurrent depression
C034554,CHEMICAL,16 alpha-bromo-17 beta-estradiol [Supplementary Concept],beta-estradiol|Estradiol/analogs  and  derivatives
NEW08885,DISEASE,hp toxicity,HP toxicity
NEW08886,CHEMICAL,intracellular gsh,intracellular GSH
NEW08887,DISEASE,cytotoxic brain edema due,Cytotoxic brain edema due
NEW08888,DISEASE,astrocyte swelling,astrocyte swelling
NEW08889,CHEMICAL,astrocytic glutamate uptake,astrocytic glutamate uptake
NEW08890,NUTRITION,abnormal cholesterol synthesis,abnormal cholesterol synthesis
NEW08891,CHEBI,vitamin e family,vitamin E family
NEW08892,DISEASE,chronic neurological disease,chronic neurological diseases
NEW08893,DISEASE,severe respiratory infection,severe respiratory infections
NEW08894,DISEASE,vaccine-preventable infection,vaccine-preventable infections
NEW08895,CHEMICAL,• Health authority,• Health authorities
NEW08896,CHEMICAL,Objectives urea cycle disorder,Objectives Urea cycle disorders
NEW08897,DISEASE,rare hereditary disease,rare hereditary diseases
D011087,DISEASE,Polycythemia Vera,"Polycythemia Ruba Veras|Veras, Polycythemia Ruba|Erythremias|Vera, Polycythemia Ruba|Ruba Veras, Polycythemia|Erythremia|Polycythemia Ruba Vera|Vera, Polycythemia Rubra|Primary Polycythemia|Polycythemia Rubra Vera|Polycythemia Rubra Veras|Primary Polycythemias|Polycythemia, Primary|Veras, Polycythemia Rubra|Osler Vaquez Disease|Disease, Osler-Vaquez|Ruba Vera, Polycythemia|Polycythemias, Primary|polycythemia|Osler-Vaquez Disease"
NEW08898,CHEMICAL,background citrin deficiency,Background Citrin deficiency
NEW08899,CHEMICAL,mitochondrial aspartate/glutamate antiporter,mitochondrial aspartate/glutamate antiporter
D029761,DISEASE,Garcinia cambogia,"Garcinia cambogias|Mangostana cambogias|Citrin Fruit|Mangostana cambogia|Citrin Fruits|Fruits, Citrin|cambogia, Mangostana|Fruit, Citrin|citrin|cambogia, Garcinia"
NEW08900,DISEASE,pandemic professional,pandemic professionals
NEW08901,MENTAL_HEALTH,pneumonia-related anxiety,pneumonia-related anxiety
NEW08902,CHEMICAL,gad sample,GAD sample
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Death_Anxiety,MENTAL_HEALTH,death anxiety,death anxiety
D053722,DISEASE,"Receptors, Interleukin-17","CDw217 Antigen|IL 17 Receptors|Interleukin 17 Receptor A|Interleukin-17 Receptor C|Antigen, CDw217|Interleukin 17 Receptor D|Il 17 Receptor|Interleukin-17 Receptor A|Receptors, Interleukin 17|Receptor, Interleukin-17|Interleukin 17 Receptor C|Interleukin 17 Receptor E|Interleukin-17 Receptor|Receptor, Il-17|Interleukin 17 Receptors|Interleukin-17 Receptor E|Il-17 Receptor|Receptors, IL-17|Interleukin-17 Receptor D|Interleukin-17 Receptors|Cdw217 Antigens|Interleukin 17 Receptor B|Interleukin 17 Receptor|Interleukin-17 Receptor B|IL-17 Receptors|IL-17|Antigens, CDw217"
NEW08903,MENTAL_HEALTH,stress depression,stress depression
D013592,DISEASE,"Syphilis, Latent","syphilis|Latent Stage Syphilis|Syphilis, Latent Stage"
D009494,DISEASE,Neurosyphilis,"Neurosyphilis, Gummatous|Neurosyphilis, Secondary|Paralysis, General|General Paresis of the Insane|Neurosyphilis, Asymptomatic|Central Nervous System Syphilis|General Paresis|General Paralysis of the Insane|Syphilis, Central Nervous System|Juvenile Paresis|Neurosyphilis, Symptomatic|Paretic Neurosyphilis|Secondary Neurosyphilis|general paralysis|General Paralysis|Neurosyphilis, Juvenile|neurosyphilis|Syphilis, CNS"
NEW08904,CHEBI,supplementary vitamin =,supplementary vitamins =
NEW08905,DISEASE,ivig-dependent cidp patient,IVIg-dependent CIDP patients
NEW08906,CHEMICAL,elevated hcy level,Elevated Hcy levels
NEW08907,CHEMICAL,hcy metabolism,Hcy metabolism
NEW08908,CHEMICAL,chloride     mg/kg b.w,chloride    mg/kg b.w
D009963,CHEMICAL,Orotic Acid,"Orotate, Potassium|Potassium Orotate|Acid, Orotic|Zinc Orotate|Orotic acid|Orotate, Sodium|Sodium Orotate|Orotate, Zinc"
C027157,CHEMICAL,uridine 5'-monophosphate synthase [Supplementary Concept],Orotate Phosphoribosyltransferase|Orotidine-5'-Phosphate Decarboxylase|Multienzyme Complexes|uridine-5'-monophosphate
http://purl.obolibrary.org/obo/DOID_0080361,DISEASE,trimethylaminuria,HCys-related disorders|CblD disorder|ASD-like disorders|psicovegetative disorders|fish-odor syndrome|stimulant-spectrum disorders|co-occurring disorders
NEW08909,CHEMICAL,mmadhc gene mutation,MMADHC gene mutations
NEW08910,DISEASE,common psychiatric disorder,common psychiatric disorders
D053608,MENTAL_HEALTH,Stupor,Narcosis||stuporous|stupor
D003244,DISEASE,Consciousness Disorders,"|consciousness disorders|Depressed Level of Consciousness|Consciousness Disorder|impaired consciousness|Altered Level of Consciousness|Consciousness, Level Depressed|Semiconsciousness|Consciousness, Level Altered"
NEW08911,MENTAL_HEALTH,attention-deficit/hyperactivity Disorder adhd category,Attention-Deficit/Hyperactivity Disorder ADHD category
NEW08912,CHEMICAL,multinutrient formula,multinutrient formulas
NEW08913,DISEASE,multiple rare abnormality discovery,multiple rare abnormalities discovery
NEW08914,NUTRITION,physiologic folate transfer,physiologic folate transfer
NEW08915,CHEMICAL,serotonin depletion,serotonin depletion
NEW08916,DISEASE,premenstrual irritability,premenstrual irritability
NEW08917,CHEMICAL,gut-microbiota-brain axis dysfunction,gut-microbiota-brain axis dysfunction
NEW08918,CHEMICAL,b-vitamin intervention,B-vitamin intervention
NEW08919,CHEBI,niacin skin flush test,niacin skin flush test
NEW08920,DISEASE,ultra-high-risk stage,ultra-high-risk stage
NEW08921,CHEBI,niacin deficiency,niacin deficiency
NEW08922,CHEMICAL,dietary na supplementation,dietary NA supplementation
NEW08923,DISEASE,alcohol-induced fatty liver,alcohol-induced fatty liver
NEW08924,DISEASE,fetal morphological abnormality,fetal morphological abnormalities
NEW08925,CHEBI,vitamin metabolism,vitamin metabolism
NEW08926,CHEMICAL,glutamate equilibrium,glutamate equilibrium
NEW08927,CHEBI,vitamin action,vitamin action
NEW08928,CHEMICAL,abnormal calcium influx,abnormal calcium influx
NEW08929,DISEASE,serum tg,serum TG
NEW08930,DISEASE,undiagnosed encephalopathy,undiagnosed encephalopathies
NEW08931,CHEBI,multiple vitamin therapy,multiple vitamin therapy
NEW08932,DISEASE,chronic alcoholic patient,chronic alcoholic patients
NEW08933,DISEASE,severe encephalopathy,severe encephalopathy
NEW08934,NUTRITION,parenteral thiamine,parenteral thiamine
NEW08935,CHEBI,drug condition,drug conditions
NEW08936,CHEBI,vasodilator niacin,vasodilator niacin
NEW08937,CHEMICAL,topical methylnicotinate,topical methylnicotinate
NEW08938,DISEASE,result erythema,resulting erythema
NEW08939,DISEASE,factor due malnutrition,factor due malnutrition
NEW08940,CHEBI,beta (aβ)-injected mouse,beta (Aβ)-injected mice
NEW08941,MENTAL_HEALTH,alzheimer disease (ad)-related gene expression,Alzheimer disease (AD)-related gene expression
NEW08942,CHEMICAL,statin treatment,statin treatment
http://purl.org/sig/ont/fma/fma67372,CHEMICAL,serotonin receptor,serotonin 5-HT3 receptor antagonist|serotonin (5-HT)1A receptor agonist|serotonin 5-HT(2A receptor
NEW08943,CHEMICAL,lysergic acid diethylamine,lysergic acid diethylamine
NEW08944,CHEMICAL,psychedelic hallucinogen,psychedelic hallucinogens
NEW08945,CHEMICAL,glutamate mglu2 receptor,glutamate mGlu2 receptors
NEW08946,CHEBI,antipsychotic drug development,antipsychotic drug development
http://purl.obolibrary.org/obo/CHEBI_28790,CHEMICAL,serotonin,3-(2-Aminoethyl)-1H-indol-5-ol|Enteramine|5-Hydroxytryptamine|thrombocytin|serotonine|Serotonin|thrombotonin|3-(2-aminoethyl)-1H-indol-5-ol|SEROTONIN|5-HT|serotonin 5-HT(2A
NEW08947,CHEMICAL,"1r,4r,5s,6r-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate","1R,4R,5S,6R-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate"
C113896,CHEMICAL,dimethoxy-4-indophenyl-2-aminopropane [Supplementary Concept],"Indophenol/analogs  and  derivatives|1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane"
NEW08948,CHEMICAL,doi mouse,DOI mice
NEW08949,CHEBI,agonist doi,agonist DOI
NEW08950,NUTRITION,dietary thiamine deficiency,dietary thiamine deficiency
NEW08951,CHEMICAL,presynaptic 5-ht synthesis,presynaptic 5-HT synthesis
NEW08952,CHEMICAL,nmda n-methyl-d-aspartate receptor antagonist ketamine,NMDA N-methyl-D-aspartate receptor antagonist ketamine
NEW08953,DISEASE,context-dependent,context-dependent
NEW08954,CHEMICAL,its 's 5-ht(2a,its's 5-HT(2A
NEW08955,CHEBI,i.v 's antibiotic therapy,i.v's antibiotic therapy
http://purl.obolibrary.org/obo/DOID_10507,DISEASE,dressler's syndrome,Wernicke-Korsakoff 's syndrome|Wernicke-Korsakoff's syndrome|WKS|Dressler syndrome|fish-odor's syndrome|Postmyocardial infarction syndrome|Hoigne's syndrome
NEW08956,CHEMICAL,intramuscular procaine penicillin administration,intramuscular procaine penicillin administration
NEW08957,DISEASE,tbi-induced impulsivity,TBI-induced impulsivity
NEW08958,CHEBI,minocycline antibiotic,minocycline antibiotic
D000741,DISEASE,"Anemia, Aplastic","Anemia, Hypoplastic||Aplastic Anemias|Hypoplastic Anemias|Aplastic Anemia|Anaemia, Aplastic|Aplastic Anaemia|Hypoplastic Anemia|Aplastic Anaemias|aplastic anemia"
D007412,DISEASE,Intestinal Fistula,"Colovesical Fistula|Cholecystoduodenal Fistula|Fistula, Colovesical|Fistula, Intestinal|Enterocutaneous Fistula|Fistula, Cholecystoduodenal|Fistula, Enterocutaneous|enterocutaneous fistula"
NEW08959,CHEBI,antibiotic coverage,antibiotic coverage
C030880,CHEMICAL,gentamicin A [Supplementary Concept],Gentamicins|gentamicin
NEW08960,DISEASE,nephrotoxic effect,nephrotoxic effects
NEW08961,CHEBI,injection drug,injection drug
D018461,DISEASE,Soft Tissue Infections,"soft tissue infections|Soft Tissue Infection|Infections, Soft Tissue|Infection, Soft Tissue"
NEW08962,CHEMICAL,low-dose methotrexate,low-dose methotrexate
NEW08963,MENTAL_HEALTH,early schizophrenia,early schizophrenia
NEW08964,DISEASE,stress-induced inflammation,stress-induced inflammation
NEW08965,CHEMICAL,rifaximin treatment,Rifaximin treatment
NEW08966,CHEMICAL,lps plasma concentration,LPS plasma concentration
NEW08967,DISEASE,clostridium concentration,Clostridium concentration
NEW08968,DISEASE,lesion pituitary abscess,lesion pituitary abscess
D065507,CHEMICAL,Vancomycin-Resistant Enterococci,vancomycin|Vancomycin Resistant Enterococci|vancomycin-resistant enterococci
D002443,CHEMICAL,Ceftriaxone,"Ceftriaxone, Disodium Salt, Hemiheptahydrate||Ceftriaxon|Ceftriaxone, Disodium Salt|Ceftriaxona LDP Torlan|Rocephin|Ro13-9904|ceftriaxone|Ro 13-9904|Ceftriaxone Sodium|Rocephine|Benaxona|Tacex|Ro139904|Anhydrous Ceftriaxone Sodium|Rocefalin|Lendacin|Ro 13 9904|Terbac|Longaceph|Cefaxona|Cefatriaxone|Ceftriaxon Hexal|Ceftriaxone Irex|Ro-13-9904|Longacef|Ro 139904|Ceftriaxon Curamed|Ceftrex|Ceftriaxone Sodium, Anhydrous|Rocefin|Ro13 9904|Ceftriaxona Andreu"
NEW08969,CHEBI,broad spectrum antibiotic therapy,broad spectrum antibiotic therapy
D019755,CHEMICAL,Carbon-Carbon Lyases,"Lyases, Carbon-Carbon|Carbon Carbon Lyases|carbon|C18:1|° C"
http://purl.obolibrary.org/obo/SYMP_0000602,DISEASE,orthopnea,dyspnoea
NEW08970,CHEBI,antibiotic therapy,Antibiotic therapy
NEW08971,DISEASE,persistent frontal lobe syndrome,persistent frontal lobe syndrome
NEW08972,DISEASE,intentional overdose,intentional overdose
NEW08973,CHEBI,offend drug,offending drug
NEW08974,CHEBI,broad spectrum carbapenem antibiotic,broad spectrum carbapenem antibiotic
NEW08975,DISEASE,resistant infection,resistant infections
NEW08976,CHEMICAL,context ertapenem,Context Ertapenem
D010878,CHEMICAL,Piperacillin,"|Cl 227193|Pipera-Hameln|Monosodium Salt, Piperacillin|Pipcil|T1220|Piperacillin Ratiopharm|Curasan, Piperacillin|Pipril|Piperacillin Monosodium Salt|Piperacillin-Ratiopharm|Piperacillin Fresenius|AB Piperacillin|Pipera Hameln|Pipercillin|Salt, Piperacillin Monosodium|T-1220|Piperacillin Sodium|AB-Piperacillin|Cl-227193|piperacillin|T 1220|Piperacillin Hexal|Piperacillin Curasan|Cl227193|Pipracil|Sodium, Piperacillin|piperacillin sodium"
D000077727,CHEMICAL,Ertapenem,Invanoz|Ertapenem Sodium|Invanz|ertapenem
NEW08977,CHEBI,antibiotic treatment,Antibiotic treatment
NEW08978,DISEASE,brain abnormality,brain abnormalities
NEW08979,CHEBI,neurological adverse drug reaction,neurological adverse drug reactions
NEW08980,MENTAL_HEALTH,few hallucination,few hallucinations
D002442,CHEMICAL,Ceftazidime,"Fortaz|Ceftazidime Pentahydrate|GR-20263|Tazidime|LY139381|ceftazidime|GR 20263|Fortum|LY-139381|Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-|LY 139381|GR20263|Ceftazidime Anhydrous"
NEW08981,CHEBI,antibiotic drug exposure,antibiotic drug exposure
NEW08982,DISEASE,activation-mediated endogenous inflammation,activation-mediated endogenous inflammation
NEW08983,MENTAL_HEALTH,stress-induced anxiety disorder,stress-induced anxiety disorders
NEW08984,CHEMICAL,chronic minocycline treatment,chronic minocycline treatment
NEW08985,CHEMICAL,gaba signaling,GABA signaling
NEW08986,DISEASE,central nervous system hypersomnia,central nervous system hypersomnias
NEW08987,DISEASE,disruptive mood dysregulation disorder,disruptive mood dysregulation disorder
C431671,CHEMICAL,tertiary amine N-oxide reductase [Supplementary Concept],trimethylamine-N-oxide reductase|trimethylamine-N-oxide|trimethylamine N-oxide|Cytochrome P-450 Enzyme System
NEW08988,CHEBI,broad-spectrum antibiotic,broad-spectrum antibiotic
NEW08989,DISEASE,human gut bacterial na(+)-transporting nadh ubiquinone reductase nqr sequence,Human gut bacterial Na(+)-transporting NADH ubiquinone reductase NQR sequence
D046948,CHEMICAL,Secologanin Tryptamine Alkaloids,"Rauvolfia Alkaloids|Indole Alkaloids, Terpenoid|tryptamine|Yohimbans|Terpenoid Indole Alkaloids|Indole Alkaloids, Secologanin|Alkaloids, Terpenoid Indole|Alkaloids, Monoterpenoid Indole|Rauwolfia Alkaloids|Alseroxylon|Tryptamine|Alkaloids, Secologanin Indole|Secologanin Indole Alkaloids|Indole Alkaloids, Monoterpenoid|Strictosidine Derivatives|Alkaloids, Rauvolfia|Alkaloids, Secologanin Tryptamine|Tryptamine Alkaloids, Secologanin|Monoterpenoid Indole Alkaloids|Derivatives, Strictosidine|Alkaloids, Rauwolfia"
NEW08990,DISEASE,consequent neurodegeneration,consequent neurodegeneration
NEW08991,CHEMICAL,tryptamine treatment,tryptamine treatment
http://purl.obolibrary.org/obo/DOID_9993,DISEASE,hypoglycemia,prediabetes-related hypoglycemia|Hypoglycaemia
NEW08992,DISEASE,myoclonic status epilepticus,Myoclonic status epilepticus
NEW08993,DISEASE,acute symptomatic etiology,acute symptomatic etiologies
http://purl.obolibrary.org/obo/CHEBI_35481,CHEBI,non-narcotic analgesic,synthetic narcotic analgesic|new non-narcotic analgesic tilidine|narcotic analgesic use|Narcotic analgesic pethidine
NEW08994,DISEASE,severe pain secondary,severe pain secondary
D010423,CHEMICAL,Pentazocine,"|Pentazocine Hydrochloride|Hydrochloride, Pentazocine|Talwin|Lactate, Pentazocine|Pentazocine|pentazocine|Fortral|Pentazocine Lactate|Lexir"
D058986,CHEMICAL,Phosphodiesterase 5 Inhibitors,"Phosphodiesterase 5 Inhibitor|PDE-5 Inhibitors|PDE-5 Inhibitor|phosphodiesterase-5 inhibitor|Inhibitor, Phosphodiesterase 5|PDE5 Inhibitors|Phosphodiesterase Type 5 Inhibitor|Phosphodiesterase-5 inhibitors|Inhibitors, Phosphodiesterase 5|PDE 5 Inhibitor|Phosphodiesterase Type 5 Inhibitors|Inhibitors, PDE-5|Inhibitor, PDE5|phosphodiesterase-5|Inhibitors, PDE5|PDE5 Inhibitor|Inhibitor, PDE-5|PDE 5 Inhibitors|5 Inhibitor, Phosphodiesterase"
NEW08995,CHEMICAL,analgesic tramadol,analgesic tramadol
NEW08996,CHEMICAL,fentanyl overdose,Fentanyl overdose
D010889,CHEMICAL,Piracetam,Pirazetam|Cerepar N|Piracetam-RPh|piracetam|Dinagen|Gabacet|Pyracetam|Axonyl|Cerebroforte|2-Pyrrolidone-N-Acetamide|Avigilen|Pyramem|Geram|Cuxabrain|UCB 6215|Nootropil|Sinapsan|Piracetam RPh|UCB-6215|Nootrop|Piracebral|Memo-Puren|UCB6215|Piracetam AbZ|Piracetrop|Normabraïn|nootropil|Ciclofalina|Memo Puren|Nootropyl
NEW08997,MENTAL_HEALTH,period minimize hallucination,period minimizing hallucinations
D009020,CHEMICAL,Morphine,"|SDZ 202-250|SDZ202250|MS Contin|SDZ 202250|Duramorph|morphine sulfate|Morphine Chloride|Chloride, Morphine|Oramorph SR|SDZ202-250|Morphine Sulfate|Sulfate, Morphine|Morphine Sulfate (2:1), Pentahydrate|SDZ202 250|morphine|Contin, MS|SDZ 202 250|Morphia|Morphine Sulfate (2:1), Anhydrous"
NEW08998,CHEMICAL,standard lidocaine spinal anesthetic,standard lidocaine spinal anesthetic
D010149,DISEASE,"Pain, Postoperative","Acute Post-operative Pain||Post-operative Pain, Acute|Pain, Acute Postoperative|Post-surgical Pain|chronic postoperative pain|CPSP|Postsurgical Pain|Chronic Postsurgical Pain|Post operative Pain, Chronic|Chronic Postoperative Pain|Pain, Post operative|Chronic Post surgical Pain|Pain, Post-operative|Pain, Post-surgical|Postoperative Pain, Acute|Postoperative Pain|Postoperative Pain, Chronic|Pain, Chronic Postsurgical|Chronic Post operative Pain|Pain, Chronic Post-surgical|Postsurgical Pain, Chronic|Pain, Chronic Postoperative|Pain, Postsurgical|Post operative Pain|postoperative pain|Acute Post operative Pain|Post-operative Pain|Chronic Post-operative Pain|Pain, Persistent Postsurgical|Post-surgical Pain, Chronic|Persistent Postsurgical Pain|Pain, Acute Post-operative|Chronic Post-surgical Pain|Post-operative Pain, Chronic|Pain, Chronic Post-operative|Postsurgical Pain, Persistent|Post surgical Pain|post-surgical pain|Acute Postoperative Pain|Post-operative Pains|Chronic Postsurgical Pains|Post operative Pain, Acute"
NEW08999,CHEMICAL,central avp,Central AVP
NEW09000,DISEASE,ches-induced gastric motor maladaptation,CHeS-induced gastric motor maladaptation
NEW09001,CHEMICAL,term central avp antagonism,term central AVP antagonism
NEW09002,DISEASE,stress-related gastric motility disorder,stress-related gastric motility disorders
NEW09003,CHEBI,n-methyl-d-aspartate nmda antagonist,N-methyl-D-aspartate NMDA antagonists
NEW09004,CHEMICAL,vasopressin v1a receptor,vasopressin V1a receptors
NEW09005,DISEASE,stress-induced visceral hyperalgesia,stress-induced visceral hyperalgesia
http://purl.org/sig/ont/fma/fma275560,CHEMICAL,corticospinal-corticobulbar pathway,CRF/CRF(1 pathway|IL6/GP130/STAT3 pathway|AVP/V(3 pathway
NEW09006,DISEASE,chronic stress-related gastrointestinal disorder,chronic stress-related gastrointestinal disorders
NEW09007,CHEMICAL,corticotrophin releasing factor,corticotrophin releasing factor
NEW09008,CHEMICAL,vasopressin antagonism,vasopressin antagonism
NEW09009,DISEASE,stress-induced tachycardia,stress-induced tachycardia
NEW09010,CHEMICAL,central arginine vasopressin,central arginine vasopressin
NEW09011,CHEMICAL,vasopressin system,vasopressin system
NEW09012,CHEMICAL,ssr149415 mg/kg,SSR149415 mg/kg
NEW09013,CHEMICAL,tyr-avp,Tyr-AVP
NEW09014,CHEMICAL,arginine vasopressin avp receptor,arginine vasopressin AVP receptors
NEW09015,DISEASE,focal cerebral ischemia,focal cerebral ischemia
NEW09016,DISEASE,secondary brain damage,secondary brain damage
NEW09017,DISEASE,cortex specific gravity,cortex edema|cortex specific gravity
NEW09018,CHEMICAL,intranasal avp receptor antagonist-d(ch2)5tyr(et)davp,intranasal AVP receptor antagonist-D(CH2)5Tyr(ET)DAVP
NEW09019,CHEMICAL,avp level,AVP levels
NEW09020,DISEASE,focal cortex edema,focal cortex edema
NEW09021,CHEMICAL,intranasal avp,intranasal AVP
NEW09022,CHEMICAL,cerebral avp receptor,cerebral AVP receptor
NEW09023,DISEASE,ischemia-evoked cortex edema,ischemia-evoked cortex edema
NEW09024,DISEASE,lumbar sympathetic nerve activity,lumbar sympathetic nerve activity
NEW09025,CHEMICAL,ppads pre-treatment,PPADS pre-treatment
NEW09026,CHEBI,neuraminidase inhibitor,neuraminidase inhibitors
NEW09027,DISEASE,complicated influenza infection,complicated influenza infections
C518601,CHEMICAL,polysialic acid DP5 [Supplementary Concept],polysialic acid|Oligosaccharides|Sialic Acids
NEW09028,DISEASE,similar adverse neuropsychiatric reaction,similar adverse neuropsychiatric reactions
NEW09029,CHEMICAL,chronic corticosterone,Chronic corticosterone
NEW09030,CHEMICAL,elevated corticosterone concentration,elevated corticosterone concentrations
NEW09031,DISEASE,ischemic injury,ischemic injury
NEW09032,DISEASE,mood function,mood function
NEW09033,CHEMICAL,elevated corticosterone,elevated corticosterone
NEW09034,DISEASE,pyramidal neuron atrophy,pyramidal neuron atrophy
NEW09035,CHEMICAL,cus exposure,CUS exposure
NEW09036,DISEASE,adrenal hypertrophy,adrenal hypertrophy
NEW09037,CHEMICAL,elevated plasma corticosterone level,elevated plasma corticosterone levels
NEW09038,CHEMICAL,net mrna level,NET mRNA levels
NEW09039,CHEBI,glucocorticoid receptor antagonist mifepristone,glucocorticoid receptor antagonist mifepristone
http://purl.obolibrary.org/obo/DOID_0050782,DISEASE,zollinger-ellison syndrome,overt Cushing syndrome
D015735,CHEMICAL,Mifepristone,RU486|RU 38486|Mifepristone|R-38486|ZK98296|Mifeprex|RU38486|ZK 98296|RU-38486|mifepristone|ZK-98296|R38486|RU-486|Mifegyne|RU 486|Mifégyne|R 38486
NEW09040,CHEMICAL,glucose insulin resistance,glucose insulin resistance
NEW09041,CHEMICAL,mifepristone treatment,mifepristone treatment
NEW09042,CHEMICAL,concomitant abnormal glucose parameter,concomitant abnormal glucose parameters
NEW09043,CHEMICAL,mifepristone treatment,Mifepristone treatment
NEW09044,CHEMICAL,acs due,ACS due
NEW09045,DISEASE,single stress-induced hyperalgesia,single stress-induced hyperalgesia
NEW09046,MENTAL_HEALTH,elevated anxiety,elevated anxiety
NEW09047,DISEASE,rac1-gtp fear memory,Rac1-GTP fear memory
NEW09048,CHEMICAL,blunted cortisol response,Blunted cortisol responses
http://purl.obolibrary.org/obo/GO_0008542,DISEASE,visual learning,visual learning
NEW09049,CHEBI,bdnf bdnf receptor agonist,BDNF BDNF receptor agonist
http://purl.obolibrary.org/obo/CL_0002309,DISEASE,corticotroph,corticotroph pituitary tumor
NEW09050,CHEMICAL,adrenal-directed drug ketoconazole,adrenal-directed drug ketoconazole
NEW09051,CHEBI,use drug,used drug
NEW09052,DISEASE,acute organic schizophreniform disorder,acute organic schizophreniform disorder
NEW09053,NUTRITION,long-term lithium therapy,Long-term lithium therapy
C562732,DISEASE,Euthyroid Goiter [Supplementary Concept],"euthyroid goiter|Goiter, Nodular"
http://purl.obolibrary.org/obo/CHEBI_135441,CHEBI,metipamide,metipamid|betablockers|beta-blocker|hypotylin
NEW09054,DISEASE,tachy- cardia,tachy- cardia
NEW09055,CHEBI,thyroid hormone insufficiency,thyroid hormone insufficiency
NEW09056,CHEBI,thyroid-stimulating hormone level,thyroid-stimulating hormone level
NEW09057,DISEASE,thyroiditis iodine deficiency,thyroiditis iodine deficiency
NEW09058,CHEBI,thyroid hormone excess,thyroid hormone excess
NEW09059,CHEMICAL,free thyroxine,free thyroxine
NEW09060,DISEASE,high rate hypothyroidism,higher rated hypothyroidism
NEW09061,DISEASE,extra-pyramidal side-effect,extra-pyramidal side-effects
NEW09062,DISEASE,antipsychotic-induced constipation,antipsychotic-induced constipation
NEW09063,DISEASE,bacterial septicaemia,bacterial septicaemia
D011015,DISEASE,"Pneumonia, Aspiration","Syndrome, Acid Aspiration|Mendelson's Syndrome|Syndrome, Mendelson's|Pneumonias, Aspiration|Aspiration Pneumonia|Syndromes, Acid Aspiration|Syndrome, Mendelson|Mendelsons Syndrome|Acid Aspiration Syndrome|Gastric Acid Aspiration Syndrome|Acid Aspiration Syndromes|Aspiration Pneumonias|aspiration pneumonia|Mendelson Syndrome"
NEW09064,DISEASE,ischaemic bowel disease,ischaemic bowel disease
D045823,DISEASE,Ileus,Intestinal Obstruction (1968-2003)|ileus
NEW09065,DISEASE,colon perforation,colon perforation
D054715,DISEASE,Cardiotoxins,"Cardiotoxin|cardiotoxic|Cardiotoxic Agents|Agent, Cardiotoxic|Cardiotoxic Agent|Agents, Cardiotoxic"
NEW09066,MENTAL_HEALTH,comorbid anxiety,comorbid anxiety
NEW09067,CHEMICAL,bupropion therapy,Bupropion therapy
NEW09068,CHEMICAL,available antidepressant,available antidepressant
NEW09069,MENTAL_HEALTH,daily sleepiness,daily sleepiness
NEW09070,CHEMICAL,first selective serotonin,first selective serotonin
NEW09071,CHEMICAL,first selective serotonin 5-hydroxytryptamine reuptake inhibitor,first selective serotonin 5-hydroxytryptamine reuptake inhibitor
NEW09072,CHEMICAL,oral paroxetine,Oral paroxetine
NEW09073,DISEASE,nausea sexual dysfunction,nausea sexual dysfunction
NEW09074,MENTAL_HEALTH,geriatric dementia population,geriatric dementia population
NEW09075,CHEMICAL,profile buspirone,profile buspirone
NEW09076,DISEASE,cognitive problem,cognitive problems
NEW09077,MENTAL_HEALTH,excessive daytime sleepiness due,excessive daytime sleepiness due
NEW09078,CHEBI,selective histamine receptor agonist,selective histamine receptor agonists
NEW09079,DISEASE,brain pathology,brain pathologies
NEW09080,CHEMICAL,histamine neuron,Histamine neurons
NEW09081,CHEMICAL,brain histamine,Brain histamine
NEW09082,DISEASE,allergic patient,allergic patients
C545612,CHEMICAL,LASSBio-873 [Supplementary Concept],Pyrroles|Pyridines|Pyrazoles|LASSBio-873
NEW09083,CHEMICAL,due biperiden,due biperiden
NEW09084,CHEBI,parasympatholytic scopolamine similar,parasympatholytic scopolamine similar
D064692,CHEMICAL,Hyoscyamine,"Atropine Sulfate, 3(S)-endo-Isomer|Hyoscyamine Hydrobromide|Atropine, 3(S)-endo-Isomer|Hyoscyamine Sulfate Anhydrous|Anaspaz|hyoscyamine|Hyoscyamine Hydrochloride|Cytospaz|Hyoscyamine Sulfate"
NEW09085,CHEMICAL,atropine racemate,atropine racemate
NEW09086,CHEMICAL,post-weaning social isolation,ISO|post-weaning social isolation
NEW09087,CHEMICAL,iso mouse,ISO mice
NEW09088,MENTAL_HEALTH,adhd autism spectrum disorder symptom,ADHD autism spectrum disorder symptoms
NEW09089,DISEASE,comorbid developmental disorder,comorbid developmental disorder
http://purl.obolibrary.org/obo/CHEBI_33598,CHEMICAL,carbocyclic compound,tetracyclic piperazinoazepine compound
http://purl.obolibrary.org/obo/MFOMD_0000145,DISEASE,hypomanic episode,manic/hypomanic episodes
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Hypomania,DISEASE,hypomania,mania/hypomania
NEW09090,DISEASE,postprandial distress syndrome,Postprandial Distress Syndrome|PDS
NEW09091,DISEASE,postprandial syndrome symptom,Postprandial Syndrome symptoms
NEW09092,CHEMICAL,actiamide,actiamide
NEW09093,CHEBI,non-selective muscarinic antagonist scopolamine,non-selective muscarinic antagonist scopolamine
NEW09094,DISEASE,scopolamine-induced memory deficit,scopolamine-induced memory deficit
NEW09095,NUTRITION,choline esterase inhibitor,choline esterase inhibitor
NEW09096,CHEMICAL,inhibitor donepezil,inhibitor donepezil
NEW09097,CHEMICAL,direct oral anticoagulant,DOACs|Direct oral anticoagulants
NEW09098,DISEASE,pediatric antiphospholipid syndrome,Pediatric antiphospholipid syndrome|APS
NEW09099,CHEMICAL,contraceptive strategy,contraceptive strategies
NEW09100,DISEASE,acute dependence model,acute dependence model
NEW09101,CHEMICAL,naloxone minimal withdrawal,naloxone minimal withdrawal
NEW09102,DISEASE,chronic dependence model,chronic dependence model
NEW09103,NUTRITION,plasma phospholipid fatty acid,plasma phospholipid fatty acids
NEW09104,CHEMICAL,dysfunctional serotonergic turnover,dysfunctional serotonergic turnover
C556353,CHEMICAL,3-carba cyclic-phosphatidic acid [Supplementary Concept],cPA|Phosphatidic Acids|Cyclic phosphatidic acid
NEW09105,DISEASE,ischemia-induced delay neuronal death,ischemia-induced delayed neuronal death
NEW09106,DISEASE,cuprizone-induced demyelination,cuprizone-induced demyelination
NEW09107,CHEMICAL,bioavailable atx inhibitor pf-8380,bioavailable ATX inhibitor PF-8380
NEW09108,DISEASE,als mouse,ALS mice
NEW09109,DISEASE,mn loss,MN loss
D056889,DISEASE,Barth Syndrome,"Syndrome, Barth|3-Methylglutaconic Aciduria, Type II|MGA Type 2s|3-Methylglutaconicaciduria Type IIs|MGA Type IIs|Type 2s, MGA|MGA Type II|Type 2, MGA|3-Methylglutaconicaciduria Type 2|Type 2, 3-Methylglutaconicaciduria|3 Methylglutaconic Aciduria, Type II|Type IIs, MGA|Barth syndrome|MGA Type 2|3-Methylglutaconicaciduria Type 2s|Cardioskeletal Myopathy with Neutropenia and Abnormal Mitochondria|3 Methylglutaconicaciduria Type 2|Type II, MGA|3-Methylglutaconicaciduria Type II"
NEW09110,NUTRITION,phospholipid side chain,phospholipid side chains
NEW09111,NUTRITION,essential fatty acid aberration,essential fatty acid aberrations
http://purl.obolibrary.org/obo/CHEBI_171868,CHEMICAL,"11,12-epoxyeicosatrienoic acid","(5E,8E)-10-[3-[(E)-oct-2-enyl]oxiran-2-yl]deca-5,8-dienoic acid|14C-AA|14C-labeled arachidonic acid"
NEW09112,DISEASE,untreated psychiatric patient,untreated psychiatric patients
http://purl.obolibrary.org/obo/DOID_0060164,DISEASE,pain disorder,pain disorders
NEW09113,DISEASE,stress-induced pain prolongation,stress-induced pain prolongation
NEW09114,NUTRITION,g-protein coupled-receptor fatty acid receptor,G-protein coupled-receptor fatty acid receptor
NEW09115,DISEASE,stress-evoked pain chronicity,stress-evoked pain chronicity
NEW09116,CHEMICAL,n-3 fatty acid deficient mouse,n-3 fatty acid deficient mice
NEW09117,DISEASE,stress-induced persistent mechanical allodynia,stress-induced persistent mechanical allodynia
NEW09118,CHEMICAL,oral dha supplementation,oral DHA supplementation
NEW09119,DISEASE,stress-evoked chronic pain,stress-evoked chronic pain
D003930,DISEASE,Diabetic Retinopathy,"Diabetic Retinopathies|Retinopathy, Diabetic|diabetic retinopathy|Retinopathies, Diabetic"
NEW09120,CHEMICAL,right pwm mi/cr ratio,right PWM mI/Cr ratios
NEW09121,CHEMICAL,right mi/cr ratio,right mI/Cr ratios
NEW09122,CHEMICAL,inositol metabolism,inositol metabolism
NEW09123,DISEASE,depressed subject,depressed subjects
http://purl.obolibrary.org/obo/DOID_9271,CHEMICAL,ornithine carbamoyltransferase deficiency,X-linked ornithine transcarbamylase deficiency|ornithine transcarbamylase deficiency|deficiency of citrulline phosphorylase
NEW09124,DISEASE,congenital hyperammonemia,congenital hyperammonemia
NEW09125,CHEMICAL,hepatic triglyceride concentration,Hepatic triglyceride concentrations
NEW09126,DISEASE,hyperammonemic encephalopathy,hyperammonemic encephalopathies
D000067489,DISEASE,Metacognition,"Meta-cognitive Control|Metaemotions|Monitoring, Metacognitive|Metacognitive Awareness|Metacognitive Awarenesses|Metacognitive Monitoring|Meta-cognitive Awarenesses|Meta-cognitive Awareness|Meta-cognitive Controls|Awareness, Meta-cognitive|Meta cognitive Monitoring|Meta-cognition|Metacognitive Controls|Metacognitive Control|Metacognitive Knowledges|Metamemories|Meta-memory|Meta emotion|Meta-emotion|Meta-memories|Meta cognitive Awareness|Meta-cognitive Monitorings|Knowledge, Metacognitive|cognitive control|Meta cognition|Metaemotion|Meta cognitive Control|Metamemory|Metacognitive Knowledge|Meta memory|Awareness, Metacognitive|Meta-cognitive Monitoring"
NEW09127,CHEMICAL,epa/dha supplementation,EPA/DHA supplementation
NEW09128,CHEMICAL,brain tcr,brain tCr
NEW09129,MENTAL_HEALTH,great hyperactivity,greater hyperactivity
NEW09130,NUTRITION,phospholipid hypothesis,phospholipid hypothesis
C473373,NUTRITION,"RFC3 protein, Arabidopsis [Supplementary Concept]",fatty acid composition|acid composition|Ribosomal Proteins|Arabidopsis Proteins|Fatty acid composition
NEW09131,CHEMICAL,low erythrocyte n-3 pufa concentration,low erythrocyte n-3 PUFA concentrations
NEW09132,CHEMICAL,n-3 pufa supplementation,n-3 PUFA supplementation
C532623,DISEASE,"Mirn155 microRNA, mouse [Supplementary Concept]",MicroRNAs|microRNA-155
NEW09133,DISEASE,hpa-axis abnormality,HPA-axis abnormalities
NEW09134,NUTRITION,plasma fatty acid composition,plasma fatty acid composition
NEW09135,DISEASE,certain neurological disorder,certain neurological disorders
NEW09136,NUTRITION,plasma fatty acid level,plasma fatty acid levels
NEW09137,CHEMICAL,sigmaomega-6/ sigmaomega-3 ratio,Sigmaomega-6/ Sigmaomega-3 ratio
NEW09138,MENTAL_HEALTH,retardation plasma hdl concentration,retardation plasma HDL concentrations
http://purl.obolibrary.org/obo/CHEBI_85778,CHEMICAL,4beta-hydroxycholesterol,"4beta-hydroxycholesterol|cholest-5-ene-3beta,4beta-diol|plasma Sigmaomega-3|cholest-5-en-3beta,4beta-diol|(3beta,4beta)-cholest-5-ene-3,4-diol"
NEW09139,CHEMICAL,plasma dha,plasma DHA
NEW09140,NUTRITION,plasma sigmaomega-3 fatty acid,plasma Sigmaomega-3 fatty acids
NEW09141,CHEMICAL,epa supplementation,EPA supplementation
NEW09142,DISEASE,cardiometabolic disorder,cardiometabolic disorders
NEW09143,CHEBI,fluctuate estrogen level,fluctuating estrogen levels
NEW09144,DISEASE,depressed peri-menopausal woman,depressed peri-menopausal women
NEW09145,CHEBI,estrogen-containing hormone treatment,estrogen-containing hormone treatment
D011960,CHEBI,"Receptors, Estrogen","Estrogen Receptor|estrogen receptors|Receptors, Estrogen, Type I|Estrogen Nuclear Receptor|Estrogen Receptor Type I|Receptors, Estrogen, Type II|Nuclear Receptor, Estrogen|Estrogen Receptors Type I|Receptor, Estrogen|Estrogen Receptors|Receptor, Estrogen Nuclear|Estrogen Receptor Type II|Estrogen Receptors Type II"
NEW09146,CHEBI,estrogen signalling,estrogen signalling
NEW09147,CHEBI,estrogen receptor polymorphism,estrogen receptor polymorphisms
NEW09148,MENTAL_HEALTH,depression-related mood disorder,depression-related mood disorders
NEW09149,CHEBI,specific estrogen receptor polymorphism,specific estrogen receptor polymorphisms
C536227,DISEASE,Cyclic neutropenia [Supplementary Concept],Leucopenia|Neutropenia|leucopenia
D010198,DISEASE,Pancytopenia,Pancytopenia|pancytopenia|Pancytopenias
NEW09150,CHEMICAL,clozapine review,clozapine review
D054517,DISEASE,Orbital Cellulitis,"Cellulitis, Orbital|cellulitis|Orbital Cellulitides|Cellulitides, Orbital"
NEW09151,DISEASE,childhood bacterial skin infection,childhood bacterial skin infections
D046290,DISEASE,"Liver Abscess, Pyogenic","Abscess, Pyogenic Hepatic|Abscesses, Pyogenic Liver|Liver Abscesses, Pyogenic|abscess|Pyogenic Hepatic Abscess|Abscesses, Pyogenic Hepatic|Hepatic Abscesses, Pyogenic|Abscess, Pyogenic Liver|Pyogenic Liver Abscesses|Pyogenic Hepatic Abscesses|Pyogenic Liver Abscess|Hepatic Abscess, Pyogenic"
NEW09152,CHEBI,topical antibiotic,topical antibiotics
D012532,DISEASE,Scabies,"Sarcoptic Mange|Scabies|Mange, Sarcoptic"
NEW09153,CHEMICAL,topical permethrin,topical permethrin
NEW09154,DISEASE,common parasitic skin infection,common parasitic skin infection
NEW09155,CHEBI,various antibiotic,Various antibiotics
NEW09156,DISEASE,pcp effect,PCP effects
NEW09157,CHEMICAL,p<0.01 alone,p<0.01 alone
NEW09158,CHEMICAL,concurrent glycine treatment,concurrent glycine treatment
NEW09159,CHEMICAL,n-methyl-d-aspartate receptor function,N-methyl-D-aspartate receptor function
NEW09160,DISEASE,glun2b protein level,GluN2B protein levels
NEW09161,DISEASE,ltd sensitivity,LTD sensitivity
NEW09162,CHEMICAL,grin2b+/c456y mouse,Grin2b+/C456Y mice
NEW09163,DISEASE,abnormal anxiolytic-like behavior,abnormal anxiolytic-like behavior
NEW09164,CHEMICAL,glun2b-c456y haploinsufficiency,GluN2B-C456Y haploinsufficiency
NEW09165,DISEASE,nmdar-dependent ltd,NMDAR-dependent LTD
NEW09166,CHEBI,postpartum estrogen withdrawal,Postpartum estrogen withdrawal
http://purl.obolibrary.org/obo/CHEBI_64571,CHEBI,nmda receptor agonist,NMDA receptor agonist d-cycloserine|NMDAR agonists|NMDAR agonist|NMDA receptor agonist interventions|NMDA receptor agonists|NMDA receptor agonist activity|N-methyl-D-aspartate receptor agonists|GluN2A-containing NMDA receptors|N-methyl-D-aspartate receptor agonist|NMDAr agonist NMDA
NEW09167,DISEASE,depression- behavior,depression- behaviors
NEW09168,CHEMICAL,ro25 inhibitor dasatinib,Ro25 inhibitor dasatinib
NEW09169,DISEASE,hormone-simulated pregnancy,hormone-simulated pregnancy|HSP mice
NEW09170,CHEMICAL,trkb receptor inhibitor k252a,TrkB receptor inhibitor K252a
http://purl.obolibrary.org/obo/CHEBI_64102,CHEBI,ampa receptor agonist,endogenous N-methyl-d-aspartate receptor agonist|quisqualate receptor agonist|AMPA receptor desensitization|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor agonist|AMPAR agonist|AMPA receptor agonists
NEW09171,CHEMICAL,microglial quin content,microglial QUIN content
NEW09172,CHEMICAL,nmda depression,NMDA depression
NEW09173,CHEMICAL,metabotropic glutamate receptor located,metabotropic glutamate receptors located
NEW09174,CHEMICAL,accumbal dopamine release,accumbal dopamine release
NEW09175,CHEMICAL,blocker phencyclidine,blockers phencyclidine
NEW09176,CHEMICAL,n-methyl-d-aspartate nmda receptor open channel blocker,N-methyl-D-aspartate NMDA receptor open channel blockers
NEW09177,DISEASE,ptsd-related behavioral trait,PTSD-related behavioral traits
C000629763,CHEMICAL,BCI-838 [Supplementary Concept],BCI-838|Bridged Bicyclo Compounds
D000071518,CHEMICAL,Liver X Receptors,"Liver X Receptor-Alpha|Nuclear Oxysterol Receptors|Nuclear Orphan Receptor LXR-Alpha|LXR-Beta, Oxysterols Receptor|NR1H2 Protein|LXRbeta Protein|Nuclear Orphan Receptor LXR Alpha|Oxysterols Receptor LXR Alpha|Oxysterols Receptor LXR Beta|Nuclear Receptor Subfamily 1, Group H, Member 3|Liver X Receptor-Beta|LXRalpha Protein|LXR-Alpha Protein|NR1H3 Protein|Oxysterols Receptor LXR-Alpha|Liver X Receptor Alpha|Liver X Receptor Beta|Oxysterol Receptors, Nuclear|LXR-Alpha, Oxysterols Receptor|Liver X Receptor|LXRβ|Nuclear Receptor Subfamily 1, Group H, Member 2|Oxysterols Receptor LXR-Beta|LXR Alpha Protein"
NEW09178,CHEMICAL,serotonin 5-ht system,serotonin 5-HT system
NEW09179,CHEMICAL,brain serotonin,brain serotonin
NEW09180,MENTAL_HEALTH,amphetamine-induced hyperactivity,amphetamine-induced hyperactivity
NEW09181,CHEMICAL,striatal na release,striatal NA release
NEW09182,CHEMICAL,endogenous 5-ht,endogenous 5-HT
NEW09183,CHEMICAL,kyna exposure,KYNA exposure
NEW09184,DISEASE,birth variation,birth variations
D051306,CHEMICAL,L-Lysine 6-Transaminase,"L Lysine 6 Transaminase|lysine|Aminotransferase, Lysine-epsilon|Lysine 6-Aminotransferase|Lysine 2-Oxoglutarate 6-Aminotransferase|epsilon-Transaminase, Lysine|Lysine-6-Aminotransferase|2-Oxoglutarate 6-Aminotransferase, Lysine|Lysine epsilon Aminotransferase|6-Transaminase, L-Lysine|6-Aminotransferase, Lysine 2-Oxoglutarate|Lysine 2 Oxoglutarate 6 Aminotransferase|Lysine-epsilon Aminotransferase|Lysine epsilon Transaminase|6-Aminotransferase, Lysine|Lysine epsilon-Transaminase|Lysine 6 Aminotransferase"
D006901,CHEMICAL,Hydroxylysine,"(2S,5R)-2,6-Diamino-5-hydroxyhexanoic Acid|5-Hydroxylysine|2,6 Diamino 5 hydroxyhexanoic Acid|Lysine, 5-Hydroxy-|hydroxylysine|5 Hydroxylysine|Lysine, 5 Hydroxy|2,6-Diamino-5-hydroxyhexanoic Acid"
D003680,DISEASE,Deglutition Disorders,"|Oropharyngeal Dysphagia|Esophageal Dysphagia|dysphagia|Dysphagia, Esophageal|Swallowing Disorders|Disorders, Deglutition|Swallowing Disorder|Dysphagia, Oropharyngeal|Dysphagia|Deglutition Disorder"
NEW09185,DISEASE,severe dystonia,severe dystonia
NEW09186,CHEMICAL,kynurenine pathway metabolite,kynurenine pathway metabolites
NEW09187,NUTRITION,plasma tryptophan,Plasma tryptophan
NEW09188,CHEMICAL,serotonin biosynthesis,serotonin biosynthesis
NEW09189,CHEMICAL,inhale oxygen,inhaled oxygen
NEW09190,CHEMICAL,monoamine receptor,monoamine receptors
NEW09191,CHEMICAL,elevated neurotoxic kynurenine,elevated neurotoxic kynurenines
NEW09192,DISEASE,axonal degeneration,axonal degeneration
NEW09193,DISEASE,neuromuscular dysfunction,neuromuscular dysfunction
D016013,DISEASE,Likelihood Functions,"Maximum Likelihood Estimates|Likelihood Function|Estimates, Maximum Likelihood|Estimate, Maximum Likelihood|Function, Likelihood|Test, Likelihood Ratio|Functions, Likelihood|functions|Maximum Likelihood Estimate|Likelihood Ratio Test"
NEW09194,DISEASE,chronic enteropathy,chronic enteropathies
NEW09195,DISEASE,chronic enteropathy,chronic enteropathy
C497467,CHEMICAL,"TPH1 protein, human [Supplementary Concept]",TPH-1|tryptophan hydroxylase-1|Tryptophan Hydroxylase
NEW09196,MENTAL_HEALTH,neuro-cognitive psychosis,Neuro-Cognitive psychosis
NEW09197,CHEMICAL,major neuro-cognitive psychosis,MNP|Major Neuro-Cognitive psychosis
C041756,CHEMICAL,"alpha,beta-diacryloxypropionic acid [Supplementary Concept]",Acrylates|DAPS
NEW09198,CHEMICAL,ginseng saponin,ginseng saponins
NEW09199,DISEASE,chronic pain therapy,chronic pain therapy
NEW09200,CHEMICAL,kynurenine aminotransferase activity,kynurenine aminotransferase activity
NEW09201,NUTRITION,lowered plasma tryptophan,Lowered plasma tryptophan
NEW09202,DISEASE,enhance autonomic nervous system response,enhanced autonomic nervous system responses
NEW09203,CHEMICAL,ky/ka ratio,KY/KA ratio
NEW09204,CHEMICAL,ky ka acid,KY KA acid
NEW09205,CHEBI,new drug target,new drug targets
NEW09206,CHEMICAL,tryptophan-kynurenine pathway,tryptophan-kynurenine pathway
NEW09207,CHEMICAL,low prenatal kyn level,lower prenatal Kyn levels
NEW09208,DISEASE,high depressive symptom,higher depressive symptoms
NEW09209,CHEMICAL,kyn biomarker,Kyn biomarkers
NEW09210,MENTAL_HEALTH,chronic stress-induced depression,chronic stress-induced depression
NEW09211,CHEMICAL,subsequent prolonged elevated cortisol concentration,subsequent prolonged elevated cortisol concentrations
NEW09212,CHEMICAL,pic/quin,PIC/QUIN
NEW09213,CHEMICAL,kp metabolite,KP metabolites
NEW09214,CHEMICAL,l-tryptophan loading,L-tryptophan loading
NEW09215,MENTAL_HEALTH,minor depression,minor depression
NEW09216,DISEASE,depressive mood,depressive mood
NEW09217,CHEMICAL,xanthurenic acid xa flow,xanthurenic acid XA flow
NEW09218,CHEMICAL,efficacious antidepressant,efficacious antidepressants
NEW09219,CHEMICAL,efficacious antidepressant action,efficacious antidepressant action
NEW09220,CHEMICAL,brain serotonin system,Brain serotonin systems
NEW09221,NUTRITION,tryptophan depletion,tryptophan depletion
NEW09222,CHEMICAL,brain serotonin function,brain serotonin function
NEW09223,NUTRITION,tryptophan (trp)-kynurenine kyn pathway,tryptophan (Trp)-kynurenine Kyn pathway
NEW09224,MENTAL_HEALTH,age-related mood disorder,age-related mood disorders
NEW09225,CHEMICAL,fear-cascade modulation,fear-cascade modulation
D014364,NUTRITION,Tryptophan,Optimax|tryptophan metabolism|Naturruhe|Levotryptophan|Trofan|Tryptophan Metabolism Alterations|L Tryptophan|PMS Tryptophan|Tryptan|ratio-Tryptophan|Ardeytropin|Tryptacin|Lyphan|PMS-Tryptophan|L Tryptophan ratiopharm|ratio Tryptophan|L-Tryptophan-ratiopharm|Ardeydorm|L-Tryptophan
D051817,CHEMICAL,Butyrate Response Factor 1,Early Response Factor Berg36|butyrate
NEW09226,DISEASE,affective disorder model,affective disorder models
http://purl.obolibrary.org/obo/SYMP_0000022,MENTAL_HEALTH,depression,IFN-α-induced depression|42)-evoked depression
NEW09227,NUTRITION,tryptophan hydroxylase gene allele variant,Tryptophan hydroxylase gene allele variants
NEW09228,CHEMICAL,serotonin transporter promoter allele,serotonin transporter promoter allele
NEW09229,CHEMICAL,responsible serotonin,responsible serotonin
D002956,CHEMICAL,Citrulline,citrulline
NEW09230,DISEASE,excess hyperammonemia,excess hyperammonemia
NEW09231,DISEASE,chronic schizophrenic patient,chronic schizophrenic patients
NEW09232,NUTRITION,high tryptophan uptake,high tryptophan uptake
NEW09233,NUTRITION,tryptophan hydroxylase tph1 gene,tryptophan hydroxylase TPH1 gene
D054325,DISEASE,"vpr Gene Products, Human Immunodeficiency Virus","Viral Protein R, HIV|vpr Protein, Human Immunodeficiency Virus|HIV vpr Gene Product|human immunodeficiency virus"
http://purl.obolibrary.org/obo/DOID_0111146,DISEASE,acquired von willebrand syndrome,AVWS|von Willebrand syndrome
NEW09234,DISEASE,example eosinophilia-myalgia syndrome,examples eosinophilia-myalgia syndrome
NEW09235,CHEMICAL,basal cortisol level,basal cortisol levels
NEW09236,CHEMICAL,neuronal serotonin transporter,neuronal serotonin transporters
NEW09237,DISEASE,neurotoxic release,neurotoxic release
NEW09238,DISEASE,tumor necrosis factor-alpha system,tumor necrosis factor-alpha system
NEW09239,NUTRITION,serotonin-synthesizing tryptophan hydroxylase-2 tph2-/- gene,serotonin-synthesizing tryptophan hydroxylase-2 Tph2-/- gene
NEW09240,CHEMICAL,tryptophan metabolic pathway,TMP|tryptophan metabolic pathway
NEW09241,CHEMICAL,serum 3-hydroxykynurenine level,serum 3-hydroxykynurenine levels
NEW09242,DISEASE,adhd combined presentation,ADHD combined presentation|ADHD-C
NEW09243,CHEMICAL,serum kynurenine level,serum kynurenine levels
NEW09244,CHEMICAL,serum 3-hydroxykynurenine/kynurenine ratio,serum 3-hydroxykynurenine/kynurenine ratio
NEW09245,CHEMICAL,serum kynurenic acid/kynurenine ratio,serum kynurenic acid/kynurenine ratio
NEW09246,CHEMICAL,5-ht receptor mrna,5-HT receptor mRNA
NEW09247,CHEMICAL,dl-fenfluramine mg/kg,dl-fenfluramine mg/kg
NEW09248,CHEMICAL,baseline cortisol,baseline cortisol
NEW09249,DISEASE,dsm-iii-r melancholic subtype,DSM-III-R melancholic subtype
NEW09250,CHEMICAL,fenfluramine cortisol level,fenfluramine cortisol levels
NEW09251,CHEMICAL,baseline cortisol level,baseline cortisol levels
NEW09252,CHEMICAL,high postdexamethasone cortisol,higher postdexamethasone cortisol
NEW09253,CHEMICAL,low l-trp level,lower L-TRP levels
NEW09254,DISEASE,scid-ii interview,SCID-II interview
NEW09255,NUTRITION,tryptophan hydroxylase-2 gene,tryptophan hydroxylase-2 gene
NEW09256,DISEASE,self-aggressive behavior,self-aggressive behavior
NEW09257,CHEMICAL,synaptic serotonin availability,synaptic serotonin availability
NEW09258,CHEBI,selective serotonin reuptake inhibitor efficacy,selective serotonin reuptake inhibitor efficacy
NEW09259,NUTRITION,acute tryptophan depletion,acute tryptophan depletion
NEW09260,CHEMICAL,selective serotonin reuptake inhibitor-remitted obsessive-compulsive disorder patient,selective serotonin reuptake inhibitor-remitted obsessive-compulsive disorder patients
NEW09261,CHEMICAL,central serotonin transmission,central serotonin transmission
NEW09262,CHEMICAL,serotonin over-,serotonin over-
NEW09263,NUTRITION,tryptophan hydroxylase-2 tph2 g-703 t polymorphism,tryptophan hydroxylase-2 TPH2 G-703 T polymorphism
NEW09264,CHEMICAL,elevated neural serotonin synthesis rate,elevated neural serotonin synthesis rate
NEW09265,CHEMICAL,kynurenine-tryptophan ratio,kynurenine-tryptophan ratios
NEW09266,CHEMICAL,increase plasma kynurenine level,Increased plasma kynurenine levels
NEW09267,DISEASE,age-related disease,age-related disease
NEW09268,CHEMICAL,brain neurotransmitter serotonin,brain neurotransmitter serotonin
NEW09269,DISEASE,sad treatment,SAD treatment
NEW09270,CHEMICAL,exogenous l-tryptophan,exogenous l-tryptophan
NEW09271,CHEMICAL,5-ht synthesis,5-HT synthesis
NEW09272,CHEMICAL,matter GM volume,matter GM volumes
NEW09273,CHEMICAL,kyn pathway,Kyn pathway
NEW09274,CHEMICAL,to kynurenine,Kyn|to kynurenine
NEW09275,NUTRITION,tryptophan breakdown,Tryptophan breakdown
NEW09276,NUTRITION,serum tryptophan,Serum tryptophan
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Affective_Psychosis,MENTAL_HEALTH,affective psychosis,functional affective psychosis
D009473,DISEASE,Neuronal Plasticity,"Prunings, Axon|Axonal Pruning|Arborization, Neuronal|Neuronal Pruning|Synaptic Plasticity|Neuronal Arborizations|Neuronal Arborization|Neuroplasticities|Remodelings, Dendritic|Pruning, Synaptic|Network Remodeling, Neuronal|Network Remodelings, Neuronal|Plasticity, Brain|Neuronal Remodelings|Plasticities, Brain|Pruning, Axonal|Dendritic Arborizations|Prunings, Dendritic|Dendrite Prunings|Arborization, Dendritic|Dendritic Remodeling|Synaptic Plasticities|Prunings, Synaptic|Pruning, Axon|Neuronal Remodeling|Remodelings, Neuronal|Neuroplasticity|Neuronal Network Remodeling|Remodeling, Neuronal|Synaptic Prunings|Prunings, Dendrite|Prunings, Neurite|Pruning, Dendritic|Pruning, Neurite|Arborizations, Dendritic|Neurite Pruning|Dendrite Arborizations|Remodelings, Neuronal Network|Remodeling, Dendritic|Neuronal Network Remodelings|Dendritic Remodelings|Dendrite Pruning|Axonal Prunings|Brain Plasticity|neuronal plasticity|Neural Plasticity|Neurite Prunings|Axon Pruning|Plasticity, Synaptic|Remodeling, Neuronal Network|Axon Prunings|Synaptic Pruning|Pruning, Dendrite|Prunings, Axonal|Plasticities, Neural|Dendritic Pruning|Plasticity, Neural|Plasticities, Neuronal|Dendritic Arborization|Neural Plasticities|Brain Plasticities|Neuronal Plasticities|Pruning, Neuronal|Neuronal Prunings|Plasticity, Neuronal|Arborizations, Dendrite|Dendrite Arborization|Prunings, Neuronal|Arborization, Dendrite|Arborizations, Neuronal|Plasticities, Synaptic|Dendritic Prunings"
NEW09277,DISEASE,glun2b containing receptor,GluN2B containing receptors
NEW09278,CHEMICAL,wild-type nmdar,wild-type NMDARs
NEW09279,CHEMICAL,glun2a subunit,GluN2A subunits
NEW09280,CHEMICAL,5-ht neuronal modulation,5-HT neuronal modulation
NEW09281,CHEMICAL,lowered brain serotonin neurotransmission,lowered brain serotonin neurotransmission
NEW09282,DISEASE,dietary-induced impairment,dietary-induced impairment
NEW09283,CHEMICAL,serotonin activity,serotonin activity
NEW09284,CHEMICAL,5-ht signaling,5-HT signaling
NEW09285,DISEASE,chronic physical disease =,chronic physical disease =
NEW09286,CHEMICAL,kyn/trp index,KYN/TRP index
NEW09287,MENTAL_HEALTH,depression value,depression values
http://purl.obolibrary.org/obo/CHEBI_18053,CHEMICAL,1-aminocyclopropanecarboxylic acid,Kynurenic acid levels|1-aminocyclopropane-1-carboxylic acid|1-Aminocyclopropane-1-carboxylic acid|kynurenic acid levels|ACC|1-AMINOCYCLOPROPANECARBOXYLIC ACID
NEW09288,CHEMICAL,peripheral lipopolysaccharide injection,peripheral lipopolysaccharide injection
NEW09289,NUTRITION,phospholipid acid metabolism,phospholipid acid metabolism
NEW09290,NUTRITION,phospholipid metabolism,Phospholipid metabolism
NEW09291,CHEMICAL,atypical antipsychotic drug,Atypical antipsychotic drugs|AAPDs
D052283,CHEMICAL,"Creatine Kinase, MM Form","Creatine Kinase, M|M Creatine Kinase|Creatine Kinase, MM|Kinase, M Creatine|creatine|Kinase, MM Creatine|Kinase, Muscle Creatine|creatine kinase|Creatine Kinase, Muscle|Muscle Creatine Kinase|MM Creatine Kinase"
NEW09292,DISEASE,receptor-mediated neurotoxicity,receptor-mediated neurotoxicity
NEW09293,CHEMICAL,ampa administration,AMPA administration
NEW09294,DISEASE,long-term stressor,long-term stressors
NEW09295,CHEMICAL,citalopram administration,Citalopram administration
NEW09296,MENTAL_HEALTH,behavioral anxiety,behavioral anxiety
NEW09297,DISEASE,hashimoto's-related hypothyroidism stable,Hashimoto's-related hypothyroidism stable
NEW09298,DISEASE,pv loss,PV loss
NEW09299,CHEMICAL,th insufficiency,TH insufficiency
D010320,CHEMICAL,Parvalbumins,parvalbumin|Parvalbumin B|Parvalbumin
D002231,CHEMICAL,Carbimazole,|Carbimazole Henning|Carbimazole|Neo-Mercazole|Neo-Thyreostat|Neo Tomizol|carbimazole|Neomercazole
D006111,DISEASE,Graves Disease,"Disease, Graves'|Exophthalmic Goiters|Graves disease|Graves' Disease|Basedows Disease|Basedow Disease|Disease, Basedow|Basedow's Disease|Hyperthyroidism, Autoimmune|Disease, Basedow's|Disease, Graves|Goiters, Exophthalmic|Goiter, Exophthalmic|Exophthalmic Goiter"
NEW09300,DISEASE,abuse potential,abuse potential
NEW09301,NUTRITION,herbal food supplement,Herbal food supplements
NEW09302,DISEASE,different psychiatric disorder,different psychiatric disorders
D020441,CHEMICAL,Ginkgo biloba,"Ginkos|Gingko|bilobas, Gingko|gingko biloba|bilobas, Ginkgo|Maidenhair Tree|Ginkgophyta|Trees, Maidenhair|Gingko biloba|Ginkgophytas|Ginko|Ginkgo|Gingkos|Ginkgo bilobas|Maidenhair Trees|Tree, Maidenhair|Gingko bilobas|Ginkgos"
C000712971,CHEBI,N-methyl-d-aspartate receptor antagonist MN-08 [Supplementary Concept],N-methyl-D aspartate receptor antagonist|N -methyl-D-aspartate receptor antagonist|Adamantane/analogs  and  derivatives|N-methyl-D-aspartate receptor antagonist|N-methyl-D -aspartate receptor antagonist|NMDAR antagonist|N-methyl-d-aspartate receptor antagonist
NEW09303,CHEMICAL,nonselective n-methyl-d-aspartate receptor antagonist ketamine,nonselective N-methyl-D-aspartate receptor antagonist ketamine
NEW09304,MENTAL_HEALTH,low dose potent analgesia,low dose potent analgesia
NEW09305,CHEMICAL,chronic l-dopa administration,chronic l-DOPA administration
NEW09306,MENTAL_HEALTH,stn-hfs-evoked forelimb dyskinesia,STN-HFS-evoked forelimb dyskinesia
NEW09307,CHEMICAL,nr2b-containing n-methyl-d-aspartate receptor,NR2B-containing N-methyl-D-aspartate receptors
NEW09308,MENTAL_HEALTH,stn-hfs-induced forelimb dyskinesia,STN-HFS-induced forelimb dyskinesia
NEW09309,CHEMICAL,"cp-101,606 selective blocker","CP-101,606 selective blocker"
NEW09310,CHEBI,non-competitive modern-affinity strong voltage-dependent n-methyl-d-aspartate receptor antagonist,non-competitive modern-affinity strong voltage-dependent N-methyl-D-aspartate receptor antagonist
NEW09311,CHEMICAL,excessive glutamate transmission,Excessive glutamate transmission
NEW09312,CHEMICAL,enlarged calcium ion current,enlarged calcium ion current
NEW09313,MENTAL_HEALTH,schizophrenia subgroup,schizophrenia subgroup
NEW09314,CHEMICAL,plasma elevated kyn/trp ratio,plasma elevated KYN/TRP ratio
NEW09315,CHEMICAL,potent antidepressant,potent antidepressant
NEW09316,CHEMICAL,hyperphosphorylate tau protein,hyperphosphorylated Tau protein
C000626862,CHEMICAL,D-methadone [Supplementary Concept],d-methadone|D-methadone|Methadone
NEW09317,CHEMICAL,sucrose preference deficit,sucrose preference deficit
NEW09318,DISEASE,structural brain abnormality,structural brain abnormalities
NEW09319,DISEASE,hippocampal atrophy,hippocampal atrophy
NEW09320,CHEMICAL,monoaminergic neurotransmitter serotonin mechanism,Monoaminergic neurotransmitter serotonin mechanisms
NEW09321,CHEMICAL,n-methyl-d-aspartate receptor antagonist ketamine,N-methyl-D-aspartate receptor antagonist ketamine
NEW09322,DISEASE,treatment-resistant mdd patient,treatment-resistant MDD patients
NEW09323,CHEMICAL,translational ketamine model,translational ketamine models
NEW09324,MENTAL_HEALTH,first-episode psychosis,first-episode psychosis
NEW09325,MENTAL_HEALTH,prodromal schizophrenia,prodromal schizophrenia
D020235,DISEASE,Gait Apraxia,"Apraxia, Gait|Bruns Apraxia, Gait|Gait Apraxias, Frontal|Bruns' Gait Apraxias|Gait Dyspraxias|Bruns' Apraxia, Gait|Apraxia, Bruns' Gait|Apraxias, Gait|Gait Dyspraxia|Frontal Gait Apraxias|Frontal Gait Apraxia|Gait Apraxias|gait apraxia|Bruns' Gait Apraxia|Gait Apraxias, Bruns'|Apraxia, Frontal Gait|Bruns' Apraxia of Gait|Apraxias, Frontal Gait|gait|Gait Apraxia, Bruns'|Bruns Gait Apraxia|Apraxias, Bruns' Gait|FOG|Gait Apraxia, Frontal|Apraxia of Gait|Dyspraxia of Gait"
NEW09326,CHEMICAL,h. cumulative morphine consumption,h. Cumulative morphine consumption
NEW09327,DISEASE,postoperative pain intensity,postoperative pain intensity
NEW09328,CHEMICAL,cumulative morphine consumption,Cumulative morphine consumption
NEW09329,CHEBI,potent n-methyl-d-aspartate receptor antagonist,potent N-methyl-D-aspartate receptor antagonist
NEW09330,MENTAL_HEALTH,anxiety relative,anxiety relative
NEW09331,MENTAL_HEALTH,refractory anxiety disorder,refractory anxiety disorders
NEW09332,DISEASE,various psychiatric illness,various psychiatric illnesses
NEW09333,CHEMICAL,commercial isoflavone,commercial isoflavones
NEW09334,CHEMICAL,isoflavone treatment,isoflavones treatment
NEW09335,DISEASE,age-related cognitive impairment,age-related cognitive impairment
C561945,CHEMICAL,"2'', 3'', 4'', 6''-tetraacetyl puerarin [Supplementary Concept]",Isoflavones|puerarin|Puerarin
NEW09336,CHEBI,investigational drug status,investigational drug status
NEW09337,DISEASE,rsv group,RSV group
NEW09338,CHEMICAL,mg/kg i.p,mg/kg i.p
NEW09339,CHEMICAL,lps group,LPS group
NEW09340,CHEMICAL,estradiol level,estradiol level
NEW09341,CHEBI,mitochondrial a beta toxicity,mitochondrial A beta toxicity
D004960,CHEMICAL,Estradiol Dehydrogenases,"Estradiol 17 beta Dehydrogenase|Dehydrogenase, Estradiol|17 alpha-Dehydrogenase, Estradiol|17-beta Estradiol|17 beta Estradiol Dehydrogenase|Dehydrogenases, Estradiol|17 beta-Dehydrogenase, Estradiol|Estradiol 17 alpha Dehydrogenase|Dehydrogenase, 17 beta-Estradiol|17 beta-Estradiol Dehydrogenase|Estradiol Dehydrogenase|Estradiol 17 beta-Dehydrogenase|Estradiol 17 alpha-Dehydrogenase"
http://purl.obolibrary.org/obo/CHEBI_3160,CHEBI,botulinum toxin type a,Botulinum toxin type A|Botulinum toxin type A BoNT-A injection|Botulin A
NEW09342,CHEMICAL,oxygen production,oxygen production
NEW09343,MENTAL_HEALTH,typical stress reaction,typical stress reactions
NEW09344,CHEMICAL,dopamine neuron glutamate cotransmission,dopamine neuron glutamate cotransmission
NEW09345,CHEMICAL,cortisol content,cortisol contents
NEW09346,DISEASE,chronic pain patient,chronic pain patients
NEW09347,CHEMICAL,hair cortisol content,hair cortisol contents
NEW09348,MENTAL_HEALTH,major chronic stress,major chronic stress
D056650,DISEASE,Vulvodynia,"Generalized Vulvodynias|Generalized Vulvodynia|Vulvodynias, Generalized|Vulvodynias|vulvodynia|Vulvodynia, Generalized|Vestibulodynia|Vestibulodynias"
NEW09349,DISEASE,chronic injury,chronic injuries
NEW09350,CHEMICAL,immoderate alcohol consumption,immoderate alcohol consumption
NEW09351,DISEASE,metabolic failure,metabolic failure
NEW09352,DISEASE,progressive degenerative dementia,progressive degenerative dementias
NEW09353,DISEASE,prion disorder,prion disorders
NEW09354,CHEBI,environmental toxin,environmental toxin
NEW09355,CHEBI,antigen hla dqb1(*)0602,antigen HLA DQB1(*)0602
NEW09356,MENTAL_HEALTH,hyperactivity disorder model,hyperactivity disorder model
NEW09357,DISEASE,ptsd diagnosis,PTSD diagnosis
NEW09358,CHEBI,certain environmental toxin,certain environmental toxins
D001427,CHEBI,Bacterial Toxins,"bacterial toxins|Bacterial Toxin|Toxin, Bacterial|Toxins, Bacterial"
NEW09359,DISEASE,thalamic infarction,thalamic infarction
NEW09360,DISEASE,deep cerebral venous thrombosis,deep cerebral venous thrombosis
D020526,DISEASE,Brain Stem Infarctions,"Weber Syndrome|Infarcts, Brain Stem|basilar syndrome|Claude Syndrome|Brainstem Infarction|Stem Infarct, Brain|Brainstem Infarctions|Benedict Syndrome|Millard Gublar Syndrome|Stem Infarcts, Brain|Brainstem Stroke|Infarction, Brain Stem|Brain Stem Infarcts|Infarction, Brainstem|Foville Syndrome|Infarctions, Brainstem|Brain Stem Infarction|Millard-Gublar Syndrome|Top of the Basilar Syndrome|Infarctions, Brain Stem|Infarct, Brain Stem|Stroke, Brainstem|Syndrome, Millard-Gublar|Brain Stem Infarct"
D064726,DISEASE,Triple Negative Breast Neoplasms,"Triple Negative Breast Neoplasm|Triple-Negative Breast Cancers|Breast Cancers, Triple-Negative|Triple-Negative Breast Cancer|neoplasms|ER Negative PR Negative HER2 Negative Breast Cancer|Triple-Negative Breast Neoplasm|Breast Cancer, Triple-Negative|ER-Negative PR-Negative HER2-Negative Breast Cancer|ER-Negative PR-Negative HER2-Negative Breast Neoplasms|Breast Neoplasm, Triple-Negative|ER Negative PR Negative HER2 Negative Breast Neoplasms|Triple-Negative Breast Neoplasms|Triple Negative Breast Cancer|Breast Neoplasms, Triple-Negative"
NEW09361,CHEMICAL,elevated taurine level,elevated taurine level
NEW09362,DISEASE,cognition retardation,cognition retardations
NEW09363,CHEMICAL,taurine level,taurine levels
C076604,CHEBI,MT81 mycotoxin [Supplementary Concept],Anthraquinones|mycotoxin
NEW09364,CHEMICAL,quercetin mg/kg,quercetin mg/kg
NEW09365,CHEMICAL,afb1-mediated toxicity,AFB1-mediated toxicity
NEW09366,CHEMICAL,afb1-intoxicated mouse,AFB1-intoxicated mice
C075477,CHEMICAL,ochratoxin A hydroxylase [Supplementary Concept],Cytochrome P-450 Enzyme System|ochratoxin A|Ochratoxin A
NEW09367,CHEBI,ota mycotoxin,OTA mycotoxin
NEW09368,DISEASE,multifocal lymphoplasmacellular hepatitis,multifocal lymphoplasmacellular hepatitis
NEW09369,DISEASE,periportal fibrosis,periportal fibrosis
http://purl.obolibrary.org/obo/DOID_0060040,MENTAL_HEALTH,pervasive developmental disorder,pervasive developmental disorders|pervasive development disorder|Pervasive Child Development Disorders
http://purl.obolibrary.org/obo/CHEBI_35569,CHEBI,alpha-adrenergic agonist,alpha2-adrenergic agonist|alpha-adrenoceptor agonists|alpha-adrenergic receptor agonist|parenterally-administered alpha2-adrenergic receptor agonist|partial alpha-adrenergic agonist|alpha-adrenergic agonists|Alpha2-adrenergic agonists
NEW09370,CHEMICAL,its 's major extraneuronal metabolite,its's major extraneuronal metabolite
D009647,CHEMICAL,Normetanephrine,3-Methoxynoradrenaline|normetanephrine|Normetadrenaline|3 Methoxynoradrenaline
NEW09371,NUTRITION,nerve terminal alpha autoreceptor,nerve terminal alpha autoreceptors
NEW09372,CHEMICAL,exaggerated plasma ne,exaggerated plasma NE
NEW09373,DISEASE,subsensitivity,subsensitivity
NEW09374,CHEBI,chlorthalidone agonist,chlorthalidone agonists
NEW09375,CHEBI,non-cardioselective beta blocker,non-cardioselective beta blockers
NEW09376,CHEMICAL,propranolol thiazide diuretic,propranolol thiazide diuretics
NEW09377,CHEMICAL,clonidine ceruleus lesion,Clonidine ceruleus lesions
NEW09378,DISEASE,alcohol dependency,alcohol dependency
NEW09379,CHEMICAL,nonpsychostimulant medication,nonpsychostimulant medications
NEW09380,CHEMICAL,opioid antagonist naltrexone,opioid antagonist naltrexone|XR-NTX
NEW09381,DISEASE,serious illness,serious illness
NEW09382,MENTAL_HEALTH,placebo analgesia,placebo analgesia
D009245,CHEMICAL,NADH Dehydrogenase,"NADH dehydrogenase|NADH Cytochrome c Reductase|Diaphorase (NADH Dehydrogenase)|NADH (Acceptor) Oxidoreductase|Dehydrogenase, NADH|NADH Cytochrome c Oxidoreductase"
D051047,CHEMICAL,Dihydrolipoyllysine-Residue Acetyltransferase,"Pyruvate Dehydrogenase Complex E2|S-Acetyltransferase, Acetyl-CoA-Dihydrolipoamide|Transacetylase, Dihydrolipoyl|Acetyltransferase, Dihydrolipoyllysine-Residue|Acetyl CoA Dihydrolipoamide S Acetyltransferase|Acetyltransferase, Dihydrolipoamide|Lipoate Acetyltransferase|Dihydrolipoamide S-Acetyltransferase|Dihydrolipoyl Acetyltransferase|Acetyltransferase, Lipoate|S-Acetyltransferase, Dihydrolipoamide|Acetyltransferase, Dihydrolipoyl|Dihydrolipoamide Acetyltransferase|Dihydrolipoamide S Acetyltransferase|Dihydrolipoyllysine Residue Acetyltransferase|Dihydrolipoyl Transacetylase|Acetyl-CoA-Dihydrolipoamide S-Acetyltransferase|dihydrolipoamide acetyltransferase"
D007772,CHEMICAL,Lactate dehydrogenase-elevating virus,Lactate dehydrogenase-elevating viruses|Lactic Dehydrogenase Viruses|Lactic Dehydrogenase Virus|Lactate dehydrogenase elevating virus|lactate dehydrogenase|Lactate Dehydrogenase Viruses|Riley Virus|lactic dehydrogenase|Lactate Dehydrogenase Virus
C494878,CHEMICAL,"Dlat protein, mouse [Supplementary Concept]",E2 component|Mitochondrial Proteins|Dihydrolipoyllysine-Residue Acetyltransferase
NEW09383,DISEASE,jump impairment,jumping impairment
NEW09384,DISEASE,significant memory impairment,significant memory impairment
C113902,CHEMICAL,"D-glucose, O-D-glucopyranosyl-(1-4)-O-D-mannopyranosyl-(1-4) [Supplementary Concept]",d-glucose|D-glucose|Trisaccharides
NEW09385,CHEMICAL,morphine withdrawal jump,morphine withdrawal jumping
NEW09386,DISEASE,severe renal impairment,Severe renal impairment
NEW09387,CHEMICAL,olanzapine exposure,olanzapine exposure
NEW09388,DISEASE,moderate hepatic impairment,moderate hepatic impairment
NEW09389,DISEASE,olanzapine-associated weight gain,olanzapine-associated weight gain
D028642,DISEASE,Mentally Ill Persons,"Mentally Ill|Mental Patients|Persons, Mentally Ill|Ill, Mentally|Mentally Ill Person|Person, Mentally Ill|ill"
NEW09390,DISEASE,human psychogenic drinking behavior,human psychogenic drinking behavior
NEW09391,CHEMICAL,crh secretion,CRH secretions
http://purl.obolibrary.org/obo/CHEBI_80307,CHEMICAL,kisspeptin-10,PitVen ACTH
NEW09392,DISEASE,hypocortisolemia,hypocortisolemia
NEW09393,CHEBI,delta subtype-selective agonist,delta subtype-selective agonists
NEW09394,CHEMICAL,naltrexone therapy,Naltrexone therapy
NEW09395,MENTAL_HEALTH,context-related analgesia,context-related analgesia
NEW09396,CHEMICAL,context/expectation,context/expectation
NEW09397,MENTAL_HEALTH,context/expectation-driven relative relief-related analgesia,Context/expectation-driven relative relief-related analgesia
NEW09398,DISEASE,dry ejaculate,aspermia|dry ejaculate
D013566,CHEBI,Sympathomimetics,"Sympathomimetic Agent|Drugs, Sympathomimetic|Sympathomimetic Drug|sympathomimetic|sympathomimetics|Sympathomimetic Effects|Sympathomimetic Agents|Sympathomimetic|Effects, Sympathomimetic|Effect, Sympathomimetic|Sympathomimetic Amines|Agent, Sympathomimetic|Amines, Sympathomimetic|sympathomimetic amines|Sympathomimetics|Sympathomimetic Drugs|Agents, Sympathomimetic|Drug, Sympathomimetic|Sympathomimetic Effect"
NEW09399,CHEBI,indirect sympathomimetic,indirect sympathomimetics
NEW09400,MENTAL_HEALTH,self-reported delusion,self-reported delusions
D064086,CHEMICAL,Medical Marijuana,"Marijuana Dispensaries|Medicinal cannabis|marijuana|medical cannabis|Marijuana Treatment|Medicinal Cannabis|Medicinal Marijuana|Treatment, Marijuana|Dispensaries, Marijuana|Cannabis, Medical|medicinal cannabis|Marijuana, Medicinal|Medical Cannabis|Marijuana, Medical|Cannabis, Medicinal"
NEW09401,CHEMICAL,daily cocaine use,daily cocaine use
NEW09402,DISEASE,psychotic experience,psychotic experiences
NEW09403,CHEMICAL,ephedrine racemic amphetamine,ephedrine racemic amphetamine
D000309,DISEASE,Adrenal Insufficiency,"Adrenal insufficiency|Adrenal Insufficiencies|Hypoadrenalism|Hypofunction, Adrenal Gland|Adrenal Gland Hypofunction|adrenal insufficiency"
NEW09404,DISEASE,hyperkalaemia,hyperkalaemia
D064549,DISEASE,Myeloid Cell Leukemia Sequence 1 Protein,"Factor-1, Myeloid Cell|Cell Factor-1, Myeloid|Myeloid Cell Factor 1|Myeloid Cell Leukemia Sequence 1|Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1|Myeloid Cell Factor-1|Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1|leukemia"
NEW09405,DISEASE,chronic graft-versus-host disease,chronic graft-versus-host disease
D015320,CHEMICAL,Tachykinins,tachykinins|Tachykinin
NEW09406,MENTAL_HEALTH,schizophrenia field,schizophrenia field
NEW09407,CHEBI,nk2 receptor antagonist,NK2 receptor antagonists
D009561,CHEMICAL,Nisin,nisin|Antibiotics (1966-1972)|Nisin
D017347,DISEASE,Brucella melitensis,Brucella melitensis|Brucella (1966-1992)
NEW09408,DISEASE,non-24-hr sleep-wake disorder,non-24-hr sleep-wake disorder
NEW09409,DISEASE,seizure frequency,seizure frequency
NEW09410,CHEMICAL,mt2 receptor agonist,MT2 receptor agonist
NEW09411,DISEASE,ka-induced hyperlocomotion,KA-induced hyperlocomotion
NEW09412,CHEMICAL,ω3 lcpufa supplementation,ω3 LCPUFA supplementation
NEW09413,DISEASE,vehicle accident,vehicle accidents
NEW09414,CHEMICAL,fabp3－/－ mouse,Fabp3－/－ mice
NEW09415,DISEASE,neurotoxic protein,neurotoxic proteins
NEW09416,DISEASE,gc-induced deterioration,GC-induced deterioration
NEW09417,CHEMICAL,glucose homeostasis,glucose homeostasis
C581609,CHEMICAL,N-(2-(5-methoxy-indol-3-yl)-ethyl)-4-oxo-4H-pyran-2-carboxamide [Supplementary Concept],piromelatine|Indoles|Pyrans
http://purl.obolibrary.org/obo/DOID_4195,DISEASE,hyperglycemia,CF-induced hyperglycemia
http://purl.obolibrary.org/obo/CHEBI_131790,CHEMICAL,melatonin receptor antagonist,mixed melatonin receptor agonist/5-HT(2C receptor antagonist|melatonin receptor antagonists
NEW09418,CHEMICAL,gr mrna down-regulation,GR mRNA down-regulation
NEW09419,DISEASE,gr-i mouse,GR-i mice
NEW09420,CHEMICAL,acute fluoxetine,acute fluoxetine
NEW09421,CHEBI,neuroleptic drug sensitivity,neuroleptic drug sensitivity
NEW09422,DISEASE,dlb guideline,DLB guidelines
NEW09423,CHEBI,newly-developed orexin antagonist,newly-developed orexin antagonists
NEW09424,MENTAL_HEALTH,insomnia treatment,insomnia treatment
NEW09425,DISEASE,ham/tsp patient,HAM/TSP patients
D000212,CHEMICAL,Acyclovir,"Laciken|Virherpes|Acivir|Activir|Aciclobeta|Alonga, Aciclovir|Sodium, Acyclovir|Aciclovir|Acyclovir|aciclovir von ct|Virax-Puren|ViraxPuren|Herpoviric|Cicloferon|Genvir|Avirax|Herpofug|Acycloguanosine|Cusiviral|Virolex|Zyclir|acyclovir|Wellcome248U|Wellcome 248U|Acyclovir Sodium|Virax Puren|Isavir|Maynar|Aci Sanorania|Zovirax|Solutab, Acipen|Wellcome-248U|Virzin|Viclovir|Acifur|Clonorax|Acipen Solutab|Herpotern|Acic|9-((2-Hydroxyethoxy)methyl)guanine|Virmen|Opthavir|Zoliparin|Aciclovir Alonga|Acyclo-V|Milavir|Mapox|Supraviran|Vipral|Aciclovir-Sanorania|Aciclostad|Virupos|Antiherpes Creme|Aci-Sanorania|Herpetad|Aciclovir Sanorania|Acyclo V"
D000073618,DISEASE,Varicella Zoster Virus Infection,Congenital Varicella Syndrome|varicella zoster virus|virus infection
NEW09426,CHEBI,possible antiviral activity,possible antiviral activity
NEW09427,CHEMICAL,interferon-based treatment,interferon-based treatments
NEW09428,DISEASE,c patient toxicity,C patients toxicity
NEW09429,DISEASE,chc patient,CHC patients
NEW09430,CHEMICAL,"dopamine precursor l-3,4-dihydroxyphenylalanine","dopamine precursor L-3,4-dihydroxyphenylalanine"
C070417,CHEMICAL,"(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone [Supplementary Concept]","Morpholines|WIN-55,212|WIN|Benzoxazines|WIN55212|Naphthalenes"
NEW09431,DISEASE,l-dopa-induced alteration,L-DOPA-induced alteration
NEW09432,CHEMICAL,young-adult cannabis use,young-adult cannabis use
NEW09433,DISEASE,early neurodevelopmental disruption,early neurodevelopmental disruptions
C118149,NUTRITION,UDP-glucose anthocyanin 5-O-glucosyltransferase [Supplementary Concept],anthocyanin|Glucosyltransferases
NEW09434,DISEASE,experimental SDAT,experimental SDAT
NEW09435,CHEMICAL,5&#8242;-chloro-5&#8242;-deoxy-(&#177;)-enba mg/kg,5&#8242;-chloro-5&#8242;-deoxy-(&#177;)-ENBA mg/kg
NEW09436,DISEASE,hp-induced cataleptic symptom,HP-induced cataleptic symptoms
NEW09437,CHEMICAL,non-nmda glutamatergic receptor,non-NMDA glutamatergic receptors
NEW09438,CHEBI,depression antagonist,depression antagonists
NEW09439,CHEMICAL,adenosine neuromodulation,adenosine neuromodulation
NEW09440,DISEASE,respiratory disease,respiratory diseases
NEW09441,MENTAL_HEALTH,different mental disorder,different mental disorders
http://purl.obolibrary.org/obo/CHEBI_52214,CHEMICAL,ligand,ligands|A2-receptor ligands
NEW09442,CHEBI,selective a1-receptor antagonist,Selective A1-receptor antagonists
NEW09443,CHEMICAL,endogenous adenosine,endogenous adenosine
NEW09444,DISEASE,focal ischemia,focal ischemia
NEW09445,DISEASE,cerebral ischemic damage,cerebral ischemic damage
C571818,CHEMICAL,4-hydroxyospemifene [Supplementary Concept],ospemifene|Ospemifene|Tamoxifen/analogs  and  derivatives
NEW09446,MENTAL_HEALTH,dyspareunia due menopause,dyspareunia due menopause
NEW09447,MENTAL_HEALTH,moderate-to-severe dyspareunia,moderate-to-severe dyspareunia
NEW09448,DISEASE,breast cancer drug,breast cancer drugs
D017312,CHEMICAL,Toremifene,"FC-1157a|FC 1157a|Citrate, Toremifene|Toremifene Citrate|Toremifene Citrate (1:1)|Fareston|FC1157a|Toremifene, (E)-Isomer|toremifene"
NEW09449,CHEBI,selective estrogen receptor modulator strong,selective estrogen receptor modulators strong
NEW09450,CHEBI,full estrogen agonist effect,full estrogen agonist effect
NEW09451,CHEBI,post-menopausal estrogen therapy,Post-menopausal estrogen therapy
NEW09452,DISEASE,intrauterine infection,intrauterine infection
D051603,CHEBI,Recoverin,S-Modulin|antigen sensitivity|Cancer Associated Retinopathy Antigen|Sensitivity Modulating Protein|Sensitivity-Modulating Protein|S Modulin|Cancer-Associated Retinopathy Antigen
NEW09453,CHEMICAL,Cannabis sativa L.,Cannabis sativa L.
D003733,DISEASE,Dental Caries Susceptibility,"Caries Resistance, Dental|dental caries|Susceptibility, Dental Caries|Dental Caries Resistance|Caries Susceptibility, Dental|Resistance, Dental Caries"
NEW09454,CHEMICAL,tooth-pain management prevention,tooth-pain management prevention
NEW09455,CHEMICAL,urinary urea,urinary urea
NEW09456,DISEASE,bacterial diarrhea,bacterial diarrhea
NEW09457,CHEBI,use antimicrobial,used antimicrobials
D064704,CHEMICAL,Levofloxacin,"|Ofloxacin, (S)-Isomer|Levofloxacin Anhydrous|Anhydrous, Levofloxacin|Quixin|Levaquin|levofloxacin"
D020947,CHEMICAL,Tea Tree Oil,"tree|Melaleuca alternifolia Oil|Oil, Melaleuca alternifolia|Aetheroleum Melaleucae alternifoliae|Melaleucae alternifoliae, Aetheroleum|tea|Oil, Tea Tree"
NEW09458,CHEMICAL,average postmortem caffeine concentration,average postmortem caffeine concentration
NEW09459,MENTAL_HEALTH,lethal caffeine intoxication,lethal caffeine intoxication
NEW09460,DISEASE,consequent reduction,consequent reduction
NEW09461,CHEMICAL,agonist naïve patient,agonist naïve patients
NEW09462,DISEASE,non-motor symptom slow,non-motor symptoms slowing
NEW09463,DISEASE,pd treatment,PD treatment
NEW09464,CHEMICAL,different antidepressant,different antidepressants
NEW09465,MENTAL_HEALTH,chronic anxiety disorder,chronic anxiety disorders
NEW09466,CHEMICAL,antipsychotic aripiprazole,antipsychotics aripiprazole
D050493,CHEMICAL,Vesicular Monoamine Transport Proteins,"VMAT-1 Vesicular Monoamine Transporter|Monoamine Vesicular Transport Proteins|VMAT2 Vesicular Monoamine Transporter|Vesicular monoamine transporter 2|Vesicular Monoamine Transporter|Vesicular Monoamine Transporter 1|Monoamine transporters|VMAT 1 Vesicular Monoamine Transporter|Monoamine Vesicular Transporter|Monoamine Transporter, Vesicular|Vesicular Monoamine Transporter Proteins|VMAT2|Monoamine Transporters, Vesicular|Vesicular Monoamine Transporters|Vesicular Transporter, Monoamine|Vesicular Monoamine Transporter 2|Chromaffin Granule Amine Transporter"
NEW09467,DISEASE,various central nervous disorder,various central nervous disorders
NEW09468,CHEBI,central d2 antagonist,central D2 antagonists
C026539,CHEMICAL,preclamol [Supplementary Concept],Piperidines|3-PPP
NEW09469,CHEBI,d2 agonist,D2 agonist
NEW09470,CHEMICAL,norepinephrine-dopamine reuptake inhibitor,norepinephrine-dopamine reuptake inhibitors
NEW09471,CHEMICAL,dl-threo-Methylphenidate,dl-threo-Methylphenidate
NEW09472,CHEBI,efficacious drug,efficacious drug
http://purl.obolibrary.org/obo/CHEBI_44814,CHEMICAL,4-phenylbutylamine,4-phenylbutan-1-amine|4-amino-1-phenylbutane|1-amino-4-phenylbutane|l-threo-methylphenidate|benzenebutanamine|d-threo-methylphenidate
D045202,DISEASE,Porphyromonas endodontalis,Porphyromonas (1993-2003)|Porphyromonas
D037521,CHEBI,Virulence Factors,"Pathogenicity Factors|Factors, Virulence|Pathogenicity Factor|Factor, Pathogenicity|Factor, Virulence|virulence factors|Factors, Pathogenicity|Virulence Factor"
D000252,CHEMICAL,Calcium-Transporting ATPases,"ATPases, Calcium-Transporting|Calcium Adenosinetriphosphatase|ATPase, Ca2+|Calcium ATPase|Triphosphatase, Calcium Adenosine|calcium Ca(2|Calcium-ATPase|ATPase, Calcium|Adenosinetriphosphatase, Calcium|Adenosine Triphosphatase, Calcium|Ca2+ ATPase|Ca(2+)-Transporting ATPase|Calcium Transporting ATPases|Calcium Adenosine Triphosphatase"
NEW09473,DISEASE,p. aeruginosa biofilm formation,P. aeruginosa biofilm formation
D018410,DISEASE,"Pneumonia, Bacterial","Bacterial Pneumonias|Pneumonias, Bacterial|bacterial pneumonia|Bacterial Pneumonia"
NEW09474,DISEASE,bacterial cns infection,bacterial CNS infections
NEW09475,CHEBI,bacterial virulence factor,bacterial virulence factors
NEW09476,CHEMICAL,serotonin neuronal system,serotonin neuronal systems
NEW09477,MENTAL_HEALTH,drn projection region,DRN projection regions
NEW09478,CHEBI,5-ht(2a/2c agonist doi,5-HT(2A/2C agonist DOI
NEW09479,DISEASE,bobs receptor,bobs receptors
NEW09480,CHEBI,peripheral 5-ht(2a/2c antagonist xylamidine,peripheral 5-HT(2A/2C antagonist xylamidine
NEW09481,DISEASE,head bob,head bobs
NEW09482,DISEASE,body shake,body shakes
NEW09483,CHEMICAL,5-ht(2a receptor antagonist ketanserin,5-HT(2A receptor antagonist ketanserin
NEW09484,CHEMICAL,doi-elicited head bob,DOI-elicited head bobs
C550631,CHEMICAL,"(4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl)(5-methanesulfonyl-2-(2,2,2-trifluoro-1-methylethoxy)phenyl)methanone [Supplementary Concept]",bitopertin|Piperazines|Sulfones
NEW09485,CHEMICAL,early antiandrogen,Earlier antiandrogens
NEW09486,CHEMICAL,testosterone therapy,testosterone therapy
NEW09487,DISEASE,emotional instability,emotional instability
NEW09488,DISEASE,crf crf antagonist,CRF CRF antagonist
NEW09489,DISEASE,crf nmol/mouse,CRF nmol/mouse
NEW09490,CHEMICAL,atypical neuroleptic clozapine,atypical neuroleptic clozapine
NEW09491,CHEMICAL,n-acetyl aspartate/choline,N-acetyl aspartate/choline
NEW09492,CHEMICAL,naa/cr significant reduction,NAA/Cr significant reduction
NEW09493,NUTRITION,cortical choline acetyltransferase activity,cortical choline acetyltransferase activity
NEW09494,CHEMICAL,[(3)h]epibatidine binding,[(3)H]epibatidine binding
NEW09495,CHEMICAL,low [(125)i]alpha bungarotoxin binding,lower [(125)I]alpha bungarotoxin binding
NEW09496,DISEASE,delusional misidentification,delusional misidentification
NEW09497,NUTRITION,cortical alpha nicotinic receptor,cortical alpha nicotinic receptors
NEW09498,NUTRITION,choline administration,choline administration
NEW09499,DISEASE,cognitive performance,cognitive performance
D002798,CHEMICAL,Diacylglycerol Cholinephosphotransferase,"CDP-choline|CDP Choline 1,2 Diglyceride Choline Phosphotransferase|Phosphocholinetransferase|CDP-Diacylglycerol Synthase|Phosphorylcholine-Glyceride Transferase|Phosphorylcholineglyceride Transferase|Phosphocholinetransferase, PAF|CDP-Choline Cholinephosphotransferase|Cholinephosphotransferase, Diacylglycerol|Synthase, CDP-Diacylglycerol|Diacylglycerol CDP Choline Phosphotransferase|1-alkyl-2-Acetylglycerol Cholinephosphotransferase|Transferase, Phosphorylcholineglyceride|CDP Diacylglycerol Synthase|Phosphorylcholine Glyceride Transferase|Cholinephosphotransferase, CDP-Choline|Phosphotransferase, Diacylglycerol-CDP Choline|Diacylglycerol-CDP Choline Phosphotransferase|Transferase, Phosphorylcholine-Glyceride|Cholinephosphotransferase|Choline Phosphotransferase, Diacylglycerol-CDP|CDP-Choline 1,2-Diglyceride Choline Phosphotransferase|Cholinephosphotransferase, 1-alkyl-2-Acetylglycerol|CDP Choline Cholinephosphotransferase|PAF Phosphocholinetransferase"
NEW09500,DISEASE,ischaemic cell damage,ischaemic cell damage
D005230,NUTRITION,"Fatty Acids, Nonesterified","Free Fatty Acids|Fatty Acids, Free|Nonesterified Fatty Acids|Acid, Free Fatty|free fatty acids|Fatty Acid, Free|Acids, Free Fatty|NEFA|Acids, Nonesterified Fatty|Free Fatty Acid"
NEW09501,CHEBI,prescribe drug,prescribed drug
NEW09502,DISEASE,neuronal dysfunction,neuronal dysfunction
NEW09503,CHEMICAL,decrease naa concentration,Decreased NAA concentrations
NEW09504,CHEMICAL,choline-containing compound,Cho|choline-containing compounds
NEW09505,CHEMICAL,methyl donor choline,methyl donor choline|Ch
NEW09506,DISEASE,ms-induced cognitive deficit,MS-induced cognitive deficits
NEW09507,NUTRITION,altered brain choline level,altered brain choline levels
NEW09508,CHEMICAL,serum testosterone level,serum testosterone level
NEW09509,CHEMICAL,whose 's risperidone treatment,whose's risperidone treatment
NEW09510,DISEASE,unilateral galactorrhea,unilateral galactorrhea
NEW09511,NUTRITION,choline concentration,Choline concentration
NEW09512,DISEASE,fas/pfas relative,FAS/PFAS relative
NEW09513,NUTRITION,low choline concentration,low choline concentrations
NEW09514,DISEASE,fas/pfas,FAS/PFAS
NEW09515,DISEASE,matter deficit,matter deficits
C016583,CHEMICAL,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone [Supplementary Concept],4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone|butanone|Nitrosamines|NNK
NEW09516,NUTRITION,rbc choline uptake system,RBC choline uptake system
NEW09517,DISEASE,lithium-free bipolar patient,lithium-free bipolar patients
D008109,DISEASE,"Liver Diseases, Parasitic","Liver Disease, Parasitic|liver diseases|Disease, Parasitic Liver|Parasitic Liver Diseases|Parasitic Liver Disease|Diseases, Parasitic Liver"
NEW09518,CHEMICAL,blood ammonium,blood ammonium
NEW09519,CHEMICAL,increase glutamate/glutamine,increased Glutamate/glutamine
NEW09520,DISEASE,function deficit,functioning deficits
NEW09521,DISEASE,schizophrenia scz patient,schizophrenia SCZ patients
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Emotional_Abuse,DISEASE,emotional abuse,childhood emotional abuse
NEW09522,CHEMICAL,neurometabolite concentration,neurometabolite concentrations
D000080103,DISEASE,Emotional Regulation,"Self-Regulations, Emotion|Emotion Self-Regulations|Regulation, Emotional|Emotional Self-Regulation|Emotion Regulation|Emotional Self-Regulations|Emotion Self Regulation|Regulations, Emotional|Emotional Regulations|Self-Regulation, Emotion|Regulation, Emotion|Emotion Self-Regulation|Emotional Self Regulation|Self-Regulations, Emotional|Self-Regulation, Emotional|emotional regulation"
NEW09523,CHEMICAL,snp located,SNP located
C542592,CHEMICAL,"CHKB protein, human [Supplementary Concept]",CHKB|Choline Kinase
NEW09524,DISEASE,rem- neurotransmitter acetylcholine,REM- neurotransmitter acetylcholine
NEW09525,MENTAL_HEALTH,idiopathic narcolepsy,idiopathic narcolepsy
NEW09526,CHEMICAL,adhd-pae prenatal alcohol exposure,ADHD-PAE prenatal alcohol exposure
NEW09527,CHEMICAL,adhd+pae,ADHD+PAE
http://purl.obolibrary.org/obo/DOID_0090019,CHEMICAL,sitosterolemia,phytosterolemia|familial ADHD-PAE
NEW09528,DISEASE,familial etiology,familial etiologies
NEW09529,DISEASE,behavior memory formation,behavior memory formation
NEW09530,MENTAL_HEALTH,ASD hyperactivity disorder,ASD hyperactivity disorder
NEW09531,DISEASE,dose-dependent social deficit,dose-dependent social deficits
NEW09532,DISEASE,asd-like feature,ASD-like features
NEW09533,MENTAL_HEALTH,adult adhd study,Adult ADHD Study
NEW09534,CHEMICAL,glucose value,glucose value
NEW09535,CHEMICAL,on-line game addiction,PGA|on-line game addiction
NEW09536,MENTAL_HEALTH,internet Addiction scale,Internet Addiction Scale
NEW09537,CHEMICAL,PGA cohort,PGA cohort
http://purl.org/sig/ont/fma/fma72971,DISEASE,right temporal lobe,right temporal lobe
NEW09538,DISEASE,depressive Inventory score,Depressive Inventory scores
NEW09539,CHEMICAL,cho level,Cho levels
NEW09540,DISEASE,ptsd comorbidity,PTSD comorbidity
NEW09541,CHEMICAL,altered mpl metabolism,altered MPL metabolism
NEW09542,CHEMICAL,prenatal micronutrient,Prenatal micronutrients
D012178,DISEASE,Retinopathy of Prematurity,"Prematurity Retinopathy|prematurity|Prematurity|Fibroplasia, Retrolental|Prematurity Retinopathies|Retrolental Fibroplasia|Fibroplasias, Retrolental|ROP|Retrolental Fibroplasias"
NEW09543,DISEASE,neonatal wheezing prevention,neonatal wheezing prevention
NEW09544,NUTRITION,choline supplementation,Choline supplementation
NEW09545,NUTRITION,maternal choline,maternal choline
C031906,CHEMICAL,bifemelane [Supplementary Concept],Benzhydryl Compounds|MCI-2016
NEW09546,CHEMICAL,spontaneous alternation behavior,spontaneous alternation behavior|scopolamine-SA
D010767,NUTRITION,Phosphorylcholine,"Chloride, Phosphorylcholine|Choline Phosphate|Choline Phosphate Chloride|choline chloride|Phosphate Chloride, Choline|Phosphocholine|Phosphorylcholine Chloride|Phosphate, Choline|Choline Chloride Dihydrogen Phosphate|Chloride, Choline Phosphate|Choline chloride"
NEW09547,CHEBI,cholinomimetic drug,cholinomimetic drugs
NEW09548,CHEBI,cholinomimetic convulsant pilocarpine,cholinomimetic convulsant pilocarpine
NEW09549,DISEASE,neuronal damage,Neuronal damage
http://purl.obolibrary.org/obo/DOID_3328,DISEASE,temporal lobe epilepsy,"epilepsy, temporal lobe|mesial temporal lobe epilepsy"
NEW09550,DISEASE,hippocampal sclerosis,hippocampal sclerosis
NEW09551,CHEBI,cholinomimetic drug physostigmine,cholinomimetic drug physostigmine
NEW09552,CHEMICAL,serum norepinephrine level,serum norepinephrine levels
NEW09553,CHEMICAL,serum epinephrine level,serum epinephrine levels
NEW09554,DISEASE,catecholamine receptor hypersensitivity,catecholamine receptor hypersensitivity
NEW09555,CHEBI,growth hormone response,growth hormone responses
NEW09556,DISEASE,ethanol-induced behavioral deficit,ethanol-induced behavioral deficits
NEW09557,CHEMICAL,levodopa drug,levodopa drugs
NEW09558,CHEBI,cholinomimetic therapy,Cholinomimetic therapy
NEW09559,DISEASE,psychotic manifestation,psychotic manifestations
D011729,CHEMICAL,Pyridostigmine Bromide,"Pyridostigmine|pyridostigmine|Bromide, Pyridostigmine|Mestinon|PYR"
D000073943,CHEMICAL,Neonicotinoids,neonicotinoids|Neonicotinoid
NEW09560,CHEBI,cholinomimetic drug responsiveness,cholinomimetic drug responsiveness
NEW09561,CHEMICAL,ntx mg/d,NTX mg/d
NEW09562,CHEMICAL,ntx group,NTX group
C000609675,CHEMICAL,curzerene [Supplementary Concept],Curzerene|Sesquiterpenes
NEW09563,DISEASE,recurrent gambling behavior,recurrent gambling behaviors
D000448,DISEASE,Aldicarb,"ENT 27,093|ENT27,093|UC-21,149|UC 21,149|UC-21149|UC21149|Temik|ENT-27,093|UC|UC 21149|UC21,149"
C057287,CHEMICAL,3'-azido-3'-deoxythymidine 5'phosphate [Supplementary Concept],Dideoxynucleotides|Zidovudine/analogs  and  derivatives|3'-azido-3'-deoxythymidine|Thymine Nucleotides
NEW09564,DISEASE,anger out-hidden aggression,anger out-hidden aggression
NEW09565,CHEMICAL,low hdl-cholesterin,lower HDL-cholesterin
NEW09566,MENTAL_HEALTH,stepwise regression analysis,stepwise regression analysis
NEW09567,CHEMICAL,low uric acid,lower uric acid
NEW09568,NUTRITION,phospholipid metabolism,phospholipids metabolism
NEW09569,MENTAL_HEALTH,hallucination score,Hallucinations scores
http://purl.obolibrary.org/obo/CHEBI_28355,CHEMICAL,"adenosine 2',5'-bisphosphate",adenosine tri-phosphate
NEW09570,CHEMICAL,energy inorganic phosphate,energy inorganic phosphate
http://purl.obolibrary.org/obo/PR_000010963,CHEMICAL,n-acetylglucosamine-1-phosphodiester alpha-n-acetylglucosaminidase,phosphodiesters|nagpa|phosphodiester alpha-glcnacase|mannose 6-phosphate-uncovering enzyme
http://purl.obolibrary.org/obo/CHEBI_138101,CHEMICAL,"2-[(9s,11r)-epidioxy-(15s)-hydroxy-(5z,13e)-prostadienoyl]-sn-glycero-3- phosphocholine","phosphomonoesters|(2R)-3-hydroxy-2-{[(5Z)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl}hept-5-enoyl]oxy}propyl 2-(trimethylazaniumyl)ethyl phosphate|2-[(9S,11R)-epidioxy-15(S)-hydroxy-(5Z,13E)-prostadienoyl]-sn-glycero-3-phosphocholine|2-(prostaglandin H2)-sn-glycero-3-phosphocholine"
D053442,CHEMICAL,"High-Density Lipoproteins, Pre-beta","Pre-beta High-Density Lipoproteins|HDL, Pre-beta1|lipoproteins|PreBeta-HDL|Pre-beta HDL|Pre-beta1 HDL|HDL, Pre-beta|Pre beta HDL|high-density lipoprotein|Pre beta1 High Density Lipoprotein|Lipoprotein, Pre beta HDL|HDL Lipoprotein, Pre-beta|Pre beta High Density Lipoprotein|High Density Lipoproteins, Pre beta|PreBeta HDL|High-Density Lipoprotein, Pre-beta1|Pre-beta High-Density Lipoprotein|High Density Lipoprotein, Pre beta1|Pre beta1 HDL|Pre-beta1 High-Density Lipoprotein|Lipoprotein, Pre-beta HDL|Pre-beta HDL Lipoprotein|Nascent HDL|High-Density Lipoprotein, Pre-beta|HDL, Nascent|Lipoproteins, Pre-beta High-Density"
NEW09571,MENTAL_HEALTH,specific up-front fragmentation,specific up-front fragmentation
NEW09572,CHEMICAL,sphingomyelin sm molecular specie,sphingomyelin SM molecular species
NEW09573,CHEBI,niacin skin flush response,niacin skin flush response
NEW09574,NUTRITION,cell membrane phospholipid,cell membrane phospholipids
NEW09575,CHEBI,niacin flush,niacin flush
D002855,CHEMICAL,"Chromatography, Thin Layer","Chromatographies, Thin-Layer|Thin Layer Chromatographies|Thin Layer Chromatography|Chromatographies, Thin Layer|Thin-Layer Chromatographies|Thin layer chromatography|Chromatography, Thin-Layer|Thin-Layer Chromatography"
NEW09576,NUTRITION,erythrocyte membrane phospholipid composition,erythrocyte membrane phospholipid composition
NEW09577,NUTRITION,membrane phospholipid,Membrane phospholipids
NEW09578,CHEMICAL,"platelet membrane phosphatidylinositol-4,5-bisphosphate","platelet membrane phosphatidylinositol-4,5-bisphosphate"
NEW09579,CHEMICAL,liposome-supported peritoneal dialysis,Liposome-supported peritoneal dialysis
NEW09580,DISEASE,hyperammonemic crises-associated disorder,hyperammonemic crises-associated disorders
NEW09581,CHEMICAL,ammonia removal,ammonia removal
NEW09582,CHEMICAL,mg different lipoprotein concentration,Mg different lipoprotein concentration
NEW09583,MENTAL_HEALTH,depression disease,depression disease
NEW09584,CHEMICAL,polyunsaturated lipid,polyunsaturated lipids
NEW09585,CHEMICAL,dha-enriched membrane phospholipid,DHA-enriched membrane phospholipids
NEW09586,MENTAL_HEALTH,neuronal resistance,neuronal resistance
http://purl.obolibrary.org/obo/CL_0000127,CHEMICAL,astrocyte,DHA-enriched astrocytes
NEW09587,DISEASE,pain therapy,pain therapy
NEW09588,DISEASE,inflammatory pain test,inflammatory pain test
NEW09589,DISEASE,human pain therapy,human pain therapy
NEW09590,CHEBI,non-competitive nmdar n-methyl-d-aspartate receptor antagonist,Non-competitive NMDAR N-Methyl-d-aspartate receptor antagonists
NEW09591,DISEASE,negative deficit,negative deficits
NEW09592,CHEMICAL,presurgery memantine,presurgery memantine
NEW09593,DISEASE,cognition dysfunction,cognition dysfunction
NEW09594,DISEASE,pain n-methyl-d-aspartate receptor antagonist,pain N-methyl-D-aspartate receptor antagonists
NEW09595,DISEASE,opioid-induced hyperalgesia,opioid-induced hyperalgesia
NEW09596,CHEMICAL,single subanesthetic dose,Single subanesthetic doses
NEW09597,DISEASE,focal ischemia model,focal ischemia model
NEW09598,DISEASE,stroke patient,stroke patients
NEW09599,DISEASE,gastrointestinal tract no,gastrointestinal tract NO
NEW09600,DISEASE,intestinal peristaltism,intestinal peristaltism
NEW09601,DISEASE,bacterial gastroenteritis,bacterial gastroenteritis
D005770,DISEASE,Gastrointestinal Neoplasms,"Gastrointestinal Tract Cancer|Neoplasms, Gastrointestinal|Cancer, Gastrointestinal|Cancer of Gastrointestinal Tract|Gastrointestinal Neoplasm|Neoplasm, Gastrointestinal|Gastrointestinal Cancer|Cancers, Gastrointestinal|Cancer of the Gastrointestinal Tract|Gastrointestinal Cancers|Gastrointestinal Tract Cancers|gastrointestinal cancer"
NEW09602,DISEASE,chronic gastritis,chronic gastritis
NEW09603,CHEMICAL,numerous no-donor drug,Numerous NO-donor drugs
NEW09604,DISEASE,cardiovascular disease due,cardiovascular diseases due
NEW09605,CHEMICAL,nitrate derivative,nitrate derivatives
NEW09606,CHEMICAL,extracellular noradrenaline level,extracellular noradrenaline level
NEW09607,CHEMICAL,ne neuron,NE neurons
NEW09608,CHEMICAL,large na system,largest NA system
NEW09609,MENTAL_HEALTH,anxiety reaction,anxiety reaction
NEW09610,CHEMICAL,6-hydroxydopamine lesion,6-hydroxydopamine lesions
NEW09611,CHEMICAL,forebrain dopamine system,forebrain dopamine system
D006948,MENTAL_HEALTH,Hyperkinesis,"Hyperkinetic Movement|Hyperkinesia|Movement, Hyperkinetic|Motor Hyperactivity||Hyperkinetic Movements|Hyperkinesia, Generalized|motor hyperactivity|Hyperkinesias, Generalized|Movements, Hyperkinetic|hyper- or dyskinetic|Hyperactivity, Motor|hyperkinesia|Generalized Hyperkinesias|Generalized Hyperkinesia"
NEW09612,CHEMICAL,neonatal 6-hydroxydopamine,neonatal 6-hydroxydopamine
NEW09613,CHEMICAL,d-Methylphenidate,d-Methylphenidate
NEW09614,CHEMICAL,catecholamine dysregulation,catecholamine dysregulation
NEW09615,CHEMICAL,iy yohimbine,IY yohimbine
NEW09616,DISEASE,visual reminder,visual reminders
NEW09617,CHEMICAL,24-hour urine catecholamine excretion,24-hour urine catecholamine excretion
NEW09618,CHEMICAL,platelet paroxetine,platelet paroxetine
NEW09619,CHEMICAL,alphabetameatp,alphabetaMeATP
NEW09620,CHEMICAL,l-dopa administration,L-DOPA administration
NEW09621,DISEASE,post-transplantation abnormal movement,post-transplantation abnormal movements
NEW09622,CHEMICAL,amphetamine challenge,amphetamine challenge
NEW09623,CHEMICAL,cp94253,CP94253
D020891,CHEMICAL,Raclopride,"FLA870|FLB 472|FLA-870|FLA 870|raclopride|Raclopride C11|FLB-472|C11, Raclopride|FLB472"
NEW09624,MENTAL_HEALTH,amphetamine-induced dyskinesia,amphetamine-induced dyskinesia
C544831,CHEMICAL,GSK 1363089 [Supplementary Concept],Anilides|Quinolines|Foretinib
NEW09625,DISEASE,chemotherapy-induced axonal degeneration,chemotherapy-induced axonal degeneration
D018341,CHEMICAL,"Receptors, Adrenergic, alpha-2","alpha-2B Adrenergic Receptor|alpha-2A Receptors, Adrenergic|Adrenergic alpha-2D Receptors|Receptors, alpha-2 Adrenergic|Receptor, alpha-2D Adrenergic|Adrenergic alpha-2C Receptors|Receptor, Adrenergic, alpha-2B|Receptors, Adrenergic alpha-2B|Adrenergic Receptor alpha 2C|Receptors, Adrenergic alpha-2D|alpha 2B Adrenergic Receptor|alpha-2 Receptors, Adrenergic|Adrenergic Receptor alpha-2b|alpha 2A Adrenergic Receptor|alpha-2C Adrenergic Receptor|alpha 2C Adrenergic Receptor|alpha-2 Adrenergic Receptors|Receptor, Adrenergic, alpha-2D|Receptor alpha-2C, Adrenergic|Adrenergic Receptor, alpha-2C|alpha-2C, Adrenergic Receptor|alpha-2 Adrenergic Receptor|Receptors, alpha 2 Adrenergic|Receptor, Adrenergic, alpha-2C|Receptor, Adrenergic, alpha-2A|α-2 adrenergic receptors|alpha 2D Adrenergic Receptor|Adrenergic alpha 2C Receptors|alpha-2b, Adrenergic Receptor|Receptor, alpha-2C Adrenergic|Receptor, alpha-2B Adrenergic|Receptor, Adrenergic, alpha-2|Receptors, Adrenergic, alpha-2D|alpha-2C Receptors, Adrenergic|Adrenergic Receptor alpha 2b|alpha 2 Adrenergic Receptors|alpha-2D Adrenergic Receptor|Adrenergic Receptors, alpha-2|Receptors, Adrenergic, alpha-2B|Receptors, Adrenergic alpha-2A|Adrenergic Receptor, alpha-2|Adrenergic Receptor, alpha 2|Adrenergic Receptor alpha(2C)|Adrenergic alpha 2B Receptors|Adrenergic alpha 2D Receptors|Adrenergic Receptor alpha(2d)|Receptor, alpha-2A Adrenergic|Receptor alpha-2b, Adrenergic|alpha-2D Receptors, Adrenergic|Adrenergic Receptor, alpha-2D|alpha-2B Receptors, Adrenergic|Receptors, Adrenergic alpha-2C|Adrenergic alpha-2B Receptors|Adrenergic alpha-2A Receptors|Receptor, alpha-2 Adrenergic|Adrenergic Receptor alpha-2C|Adrenergic alpha-2 Receptors|Receptors, Adrenergic, alpha-2A|Adrenergic alpha 2 Receptors|Adrenergic Receptor, alpha-2A|alpha-2A Adrenergic Receptor|Adrenergic Receptor, alpha-2B|Receptors, Adrenergic alpha-2|Adrenergic alpha 2A Receptors"
NEW09626,DISEASE,neuropathic control,neuropathic controls
NEW09627,CHEMICAL,functional dopamine antagonism,functional dopamine antagonism
NEW09628,CHEMICAL,"muscarinic ligand (5r,6r)-6-(3-butylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane","BuTAC|muscarinic ligand (5R,6R)-6-(3-butylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane"
NEW09629,DISEASE,antipsychotic-induced side effect,antipsychotic-induced side effects
NEW09630,CHEMICAL,butac mouse,BuTAC mice
NEW09631,CHEMICAL,m2/m4(-/- double-knockout mouse,M2/M4(-/- double-knockout mice
NEW09632,CHEBI,natural anticholinergic drug,natural anticholinergic drug
NEW09633,CHEMICAL,abnormal iron metabolism,Abnormal iron metabolism
NEW09634,CHEMICAL,fenton reaction,Fenton reaction
NEW09635,CHEMICAL,hydroxyl radical,hydroxyl radicals
NEW09636,CHEMICAL,iron homeostasis,iron homeostasis
NEW09637,CHEMICAL,increase iron,Increased iron
http://purl.obolibrary.org/obo/DOID_13269,DISEASE,hereditary coproporphyria,Hereditary coproporphyria|hereditary coproporphyria porphyria|hereditary hemochromatosis|Coproporphyrinogen oxidase deficiency
NEW09638,DISEASE,common liver disease,common liver diseases
NEW09639,CHEMICAL,hepatitis c virus iron accumulation,hepatitis C virus iron accumulation
NEW09640,CHEMICAL,psychosis-its hallmark characteristic-can,psychosis-its hallmark characteristic-can
NEW09641,MENTAL_HEALTH,computationally-defined psychosis biotype,computationally-defined psychosis biotypes
NEW09642,CHEMICAL,rs3811655 polymorphism,rs3811655 polymorphism
NEW09643,CHEMICAL,low serum iron level,low serum iron levels
NEW09644,DISEASE,persistent iron dysfunction,persistent iron dysfunction
NEW09645,CHEMICAL,ask1 inhibitor gs-4997,ASK1 inhibitor GS-4997
NEW09646,DISEASE,hippocampal neuronal ferroptosis,hippocampal neuronal ferroptosis
NEW09647,DISEASE,common nutritional deficiency,common nutritional deficiency
NEW09648,DISEASE,stimulant-naive attention-deficit/hyperactivity disorder,stimulant-naive attention-deficit/hyperactivity disorder
D054038,DISEASE,Posterior Leukoencephalopathy Syndrome,"|Reversible Posterior Leukoencephalopathy Syndrome|Leukoencephalopathy Syndromes, Posterior|Syndromes, Posterior Leukoencephalopathy|Posterior Reversible Encephalopathy Syndrome|Syndrome, Posterior Leukoencephalopathy|Leukoencephalopathy Syndrome, Posterior|leukoencephalopathy|posterior reversible encephalopathy syndrome"
NEW09649,CHEMICAL,iron signal,iron signal
NEW09650,DISEASE,inherit neurologic disorder,inherited neurologic disorders
NEW09651,DISEASE,disease with/without metastasis weight loss,disease with/without metastases weight loss
NEW09652,DISEASE,acute diabete complication,acute diabetes complications
NEW09653,DISEASE,coagulopathy alcohol abuse,coagulopathy alcohol abuse
D058729,DISEASE,Peripheral Arterial Disease,"Arterial Diseases, Peripheral|Peripheral Artery Disease|Artery Disease, Peripheral|Peripheral Artery Diseases|Disease, Peripheral Arterial|Disease, Peripheral Artery|PAD|Diseases, Peripheral Artery|Diseases, Peripheral Arterial|peripheral artery disease|Peripheral Arterial Diseases|peripheral arterial disease|Arterial Disease, Peripheral|Artery Diseases, Peripheral"
NEW09654,CHEMICAL,baseline alcohol consumption,baseline alcohol consumption
D019943,CHEMICAL,Amino Acid Substitution,"Amino Acid Substitutions|Amino acid substitutions|Substitutions, Amino Acid|Substitution, Amino Acid|amino acid substitutions"
NEW09655,DISEASE,channel structural disorder,channel structural disorder
NEW09656,MENTAL_HEALTH,narcolepsy prs,Narcolepsy PRS
NEW09657,MENTAL_HEALTH,hyperactivity domain,hyperactivity domain
NEW09658,MENTAL_HEALTH,adhd trait,ADHD traits
NEW09659,CHEMICAL,serum iron level,serum iron levels
NEW09660,MENTAL_HEALTH,adhd symptom severity,ADHD symptom severity
NEW09661,CHEMICAL,low serum iron ferritin level,Low serum iron ferritin levels
NEW09662,MENTAL_HEALTH,adhd pathophysiology,ADHD pathophysiology
NEW09663,CHEMICAL,short-term oxygen storage,short-term oxygen storage
NEW09664,CHEMICAL,body iron,body iron
NEW09665,CHEMICAL,oxygen transport,oxygen transport
NEW09666,CHEMICAL,iron absorption,iron absorption
NEW09667,MENTAL_HEALTH,cognitive learning disorder,cognitive learning disorders
D059907,DISEASE,Functional Neuroimaging,"Brain Imagings, Functional|Neuroimaging, Functional|functional|Functional Brain Imaging|Imaging, Functional Brain|Brain Imaging, Functional|Imagings, Functional Brain|Functional Brain Imagings"
NEW09668,DISEASE,hfe gene,HFE gene
NEW09669,CHEMICAL,typical antipsychotic haloperidol,typical antipsychotic haloperidol
NEW09670,CHEBI,opioid agonist maintenance treatment,opioid agonist maintenance treatment
NEW09671,DISEASE,aggressive/hostile behaviour,aggressive/hostile behaviour
NEW09672,DISEASE,panic state,panic states
NEW09673,CHEMICAL,methadone maintenance,Methadone maintenance
NEW09674,DISEASE,psychiatric phenomenon,psychiatric phenomenon
NEW09675,DISEASE,previous psychiatric hospitalization,Previous psychiatric hospitalization
NEW09676,DISEASE,schizophrenic illness,schizophrenic illness
C482678,CHEMICAL,7-hydroxymitragynine [Supplementary Concept],7OH|Secologanin Tryptamine Alkaloids|7-Hydroxymitragynine
NEW09677,MENTAL_HEALTH,mouse analgesia test,mouse analgesia tests
NEW09678,CHEBI,low efficacy agonist,lower efficacy agonist
NEW09679,CHEMICAL,fluorine substituent,fluorine substituent
NEW09680,CHEMICAL,tramadol label,tramadol label
NEW09681,CHEBI,synthetic kappa-opioid agonist,synthetic kappa-opioid agonists
NEW09682,DISEASE,cocaine-induced surge,cocaine-induced surges
NEW09683,DISEASE,nocturnal eating behavior,nocturnal eating behaviors
NEW09684,DISEASE,slc16a2 gene mutation,SLC16A2 gene mutations
NEW09685,CHEMICAL,impaired th uptake,impaired TH uptake
NEW09686,MENTAL_HEALTH,intellectual disability due,intellectual disability due
NEW09687,CHEMICAL,levamisole toxicosis,levamisole toxicosis
NEW09688,DISEASE,hepatic degeneration,hepatic degeneration
D006359,DISEASE,Heat Exhaustion,"Heat Collapse|prostration|Prostration, Heat|Collapse, Heat|Exhaustion, Heat|Heat Prostration"
NEW09689,DISEASE,splenic congestion,splenic congestion
D020300,DISEASE,Intracranial Hemorrhages,"|Brain Hemorrhages|Hemorrhages, Posterior Fossa|Intracranial Hemorrhage|Hemorrhage, Brain|intracranial hemorrhage|Hemorrhage, Posterior Fossa|Brain Hemorrhage|Hemorrhage, Intracranial|Posterior Fossa Hemorrhage|Posterior Fossa Hemorrhages|Hemorrhages, Intracranial|Hemorrhages, Brain|hemorrhages"
NEW09690,CHEMICAL,subepicardium,subepicardium
D006941,DISEASE,Hyperesthesia,"Oxyesthesias|Hyperesthesia, Thermal|Hyperesthesias||Hyperesthesias, Thermal|Thermal Hyperesthesia|Tactile Hyperesthesia|Sensations, Hyperesthetic|Hyperesthetic Sensation|Sensation, Hyperesthetic|Hyperesthetic Sensations|Oxyesthesia|Hyperesthesias, Tactile|hyperesthesia|Hyperesthesia, Tactile|Tactile Hyperesthesias|Thermal Hyperesthesias"
D056844,DISEASE,Renal Colic,"Colics, Renal|Acute Renal Colic|Colic, Acute Renal|Renal Colics|Ureteral Colic|Ureteral Colics|Colic, Renal|Renal Colic, Acute|Colics, Acute Renal|renal colic|Colics, Ureteral|colic|Renal Colics, Acute|Colic, Ureteral|Acute Renal Colics"
D053490,DISEASE,Mink enteritis virus,"enteritis viruses, Mink|Mink enteritis viruses|enteritis|Infectious Enteritis Virus of Mink"
C496352,CHEMICAL,"7-(N,N-dimethylpiperazinium)-7-oxo-8,8-dicyanoquinodimethane [Supplementary Concept]",dimethylpiperazinium|Piperazines
NEW09691,DISEASE,levamisole-induced tachyphylaxis,levamisole-induced tachyphylaxis
NEW09692,DISEASE,depletion-induced cognitive deficit,depletion-induced cognitive deficits
NEW09693,CHEMICAL,dopamine transmission,dopamine transmission
NEW09694,DISEASE,selective cognitive impairment,Selective cognitive impairments
NEW09695,CHEMICAL,mitogen-activated protein kinase/extracellular signal-related kinase kinase inhibitor pd-0325901,mitogen-activated protein kinase/extracellular signal-related kinase kinase inhibitor PD-0325901
NEW09696,DISEASE,advanced non-small cell lung cancer patient,advanced non-small cell lung cancer patients
NEW09697,CHEMICAL,selective norepinephrine ne α2a-adrenoceptor α2a-ar agonist,selective norepinephrine NE α2A-adrenoceptor α2A-AR agonist
NEW09698,MENTAL_HEALTH,additional mental disorder,additional mental disorders
NEW09699,CHEMICAL,potassium-activated adenosine triphosphatase,potassium-activated adenosine triphosphatase
NEW09700,CHEMICAL,na membrane pump,Na membrane pump
NEW09701,CHEMICAL,ouabain administration,ouabain administration
NEW09702,CHEMICAL,potassium supplementation,potassium supplementation
NEW09703,NUTRITION,lithium efflux,lithium efflux
NEW09704,DISEASE,massive overdose,massive overdose
NEW09705,CHEMICAL,serum potassium,serum potassium
http://purl.obolibrary.org/obo/CHEBI_38999,CHEMICAL,gaba-gated chloride channel antagonist,GABA-gated chloride channel antagonists|potassium channel antagonist
NEW09706,DISEASE,chronic thoracolumbar spinal cord injury,chronic thoracolumbar spinal cord injury
D015761,CHEMICAL,4-Aminopyridine,"VMI103|4-Aminopyridine Sustained Release|4AP|Fampridine-SR|4-aminopyridine|VMI-103|Dalfampridine|Pymadine|Sustained Release, 4-Aminopyridine|4 Aminopyridine|Fampridine SR|4 Aminopyridine Sustained Release|4-Aminopyridine|VMI 103"
C548134,CHEMICAL,4-aminopyridine-3-methanol [Supplementary Concept],Aminopyridines|4-AP
NEW09707,DISEASE,chronic SCI,chronic SCI
NEW09708,CHEMICAL,oxygen evolution,oxygen evolution
NEW09709,CHEMICAL,glucose metabolism impairment,glucose metabolism impairment
NEW09710,DISEASE,severe shock,severe shock
NEW09711,CHEMICAL,non-competitive nmda receptor antagonist ketamine,KET|non-competitive NMDA receptor antagonist ketamine
D020013,CHEMICAL,Calcium Signaling,"Calcium Oscillations|Calcium Waves|Calcium Puff|Oscillations, Calcium|Puffs, Calcium|Calcium Oscillation|Signaling, Calcium|Calcium Puffs|Oscillation, Calcium|Spike, Calcium|Calcium Spike|Puff, Calcium|Calcium Spark|Wave, Calcium|Spark, Calcium|Calcium Wave|Calcium Signalings|Signalings, Calcium|Calcium Spikes|Waves, Calcium|Spikes, Calcium|Calcium Sparks|calcium signaling|Sparks, Calcium"
D051676,CHEMICAL,G Protein-Coupled Inwardly-Rectifying Potassium Channels,"Potassium Channel, GIRK2|G Protein-Coupled Inwardly-Rectifying Potassium Channel 1|Potassium Channel, Kir3.4|potassium channels|GIRK3 Potassium Channel|Potassium Channels, GIRK|G Protein-Activated Potassium Channels|Potassium Channel, Kir3.3|GIRK2 Potassium Channel|Potassium Channel, Kir3.1|G Protein-Coupled Inwardly-Rectifying Potassium Channel 4|G Protein-Coupled Inwardly-Rectifying Potassium Channel 3|Potassium Channel, Kir3.2|GIRK1 Potassium Channel|Kir3.3 Potassium Channel|G Protein Coupled Inwardly Rectifying Potassium Channel 4|G Protein Coupled Inwardly Rectifying Potassium Channel 3|G Protein Coupled Inwardly Rectifying Potassium Channel 2|GIRK4 Potassium Channel|G Protein-Coupled Inwardly-Rectifying Potassium Channel 2|Potassium Channel, GIRK1|GIRK Potassium Channels|Potassium Channel, GIRK3|Kir3.4 Potassium Channel|Kir3.1 Potassium Channel|Potassium Channel, GIRK4|Kir3.2 Potassium Channel|G Protein Coupled Inwardly Rectifying Potassium Channels|Kir3 Potassium Channels|G Protein Activated Potassium Channels|G Protein Coupled Inwardly Rectifying Potassium Channel 1|Potassium Channels, Kir3"
NEW09712,CHEMICAL,cyclic adenosine monophosphate response element binding protein,cyclic adenosine monophosphate response element binding protein
C067662,CHEMICAL,glibenclamide receptor [Supplementary Concept],"Receptors, Drug|Glibenclamide|Potassium Channels|glibenclamide"
NEW09713,DISEASE,type Diabetes Mellitus,Type Diabetes Mellitus
NEW09714,CHEMICAL,glibenclamide mg/kg,glibenclamide mg/kg
NEW09715,DISEASE,despair cognitive dysfunction,despair cognitive dysfunction
D013224,DISEASE,Status Asthmaticus,"Crises, Asthmatic|Crisis, Asthmatic|Asthmatic Shocks|Asthmatic Crises|Shock, Asthmatic|Shocks, Asthmatic|Asthmatic Shock|Asthmatic Crisis|Status asthmaticus|Asthmaticus, Status"
NEW09716,CHEMICAL,continuous albuterol,continuous albuterol
NEW09717,CHEMICAL,serial potassium monitoring,serial potassium monitoring
NEW09718,DISEASE,comorbidity migraine-epilepsy,comorbidity migraine-epilepsy
D013181,MENTAL_HEALTH,Cortical Spreading Depression,"Depression, Cortical Spreading|Depressions, Cortical Spreading|Spreading Cortical Depression|Spreading Depression, Cortical|Spreading Depressions, Cortical|Cortical Depression, Spreading|Cortical Spreading Depressions|Depressions, Spreading Cortical|Cortical Spreading Depression|Spreading Depression of Leao|Leao Spreading Depression|Depression, Spreading Cortical|Spreading Cortical Depressions|Cortical Depressions, Spreading"
NEW09719,CHEMICAL,extracellular glutamate,extracellular glutamate
NEW09720,DISEASE,neuronal hyperexcitability,neuronal hyperexcitability
NEW09721,MENTAL_HEALTH,common male sexual dysfunction,common male sexual dysfunction
NEW09722,CHEMICAL,noradrenaline- contraction,noradrenaline- contractions
http://purl.obolibrary.org/obo/DOID_3650,DISEASE,lactic acidosis,D-lactic acidosis|MALA|severe lactic acidosis|Metformin-associated lactic acidosis
NEW09723,CHEMICAL,urinary cortisol level,urinary cortisol level
NEW09724,DISEASE,corticotropin-dependent hypercortisolemia,corticotropin-dependent hypercortisolemia
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Dexamethasone_Suppression_Test,CHEMICAL,dexamethasone suppression test,dexamethasone suppression test
NEW09725,CHEMICAL,individual sex- control,individual sex- controls
NEW09726,DISEASE,lithium-free bipolar affective disorder patient,lithium-free bipolar affective disorder patients
NEW09727,DISEASE,manic group,manic group
NEW09728,CHEMICAL,ouabain-sensitive potassium ion uptake,Ouabain-sensitive potassium ion uptake
NEW09729,CHEMICAL,cell ouabain binding,Cell ouabain binding
NEW09730,NUTRITION,mood stabilizer lithium,mood stabilizer lithium
NEW09731,MENTAL_HEALTH,rebound mania,rebound mania
NEW09732,CHEMICAL,urea cycle pathway,urea cycle pathway
C000719301,CHEMICAL,anti-Kv1.4 autoantibody [Supplementary Concept],Autoantibodies|Anti-voltage-gated potassium channel
NEW09733,DISEASE,channel anti-vgkc antibody encephalitis,channel anti-VGKC antibody encephalitis
NEW09734,CHEMICAL,kir6.1+/- mouse,Kir6.1+/- mice
NEW09735,DISEASE,congenital disorder secondary,congenital disorders secondary
NEW09736,MENTAL_HEALTH,proxy syndrome,proxy syndrome
NEW09737,DISEASE,factitious hypoglycaemia,factitious hypoglycaemia
NEW09738,NUTRITION,fatty acid oxidation deficiency,fatty acid oxidation deficiency
NEW09739,DISEASE,srs score,SRS score
NEW09740,CHEMICAL,oral potassium supplement,oral potassium supplements
NEW09741,CHEMICAL,nucleotide change,nucleotide change
D019305,DISEASE,"Epilepsy, Rolandic","Centralopathic Epilepsy|Temporal-Central Focal Epilepsies|Epilepsy, Centrotemporal|Temporal Central Focal Epilepsy|Focal Epilepsies, Temporal-Central|Epilepsy, Rolands|Temporal-Central Focal Epilepsy|Rolandic Epilepsies|Benign Rolandic Epilepsy of Childhood|Epilepsies, Centrotemporal|Benign Rolandic Epilepsy|Centrotemporal Epilepsies|BECTS|Benign Childhood Epilepsy With Centro Temporal Spikes|Epilepsy, Sylvian|Epilepsies, Rolandic|rolandic epilepsy|Focal Epilepsy, Temporal-Central|Rolands Epilepsy|Sylvian Epilepsy|Benign Epilepsy Of Childhood With Centrotemporal Spikes|Centralopathic Epilepsies|childhood epilepsy|BCECTS|Benign Epilepsy With Centrotemporal Spikes|Rolandic Epilepsy|Epilepsy, Benign Rolandic|Epilepsies, Centralopathic|focal epilepsy|Epilepsy, Centralopathic|Benign Childhood Epilepsy With Centro-Temporal Spikes|Centrotemporal Epilepsy|Rolandic Epilepsy, Benign|Epilepsy, Temporal-Central Focal|Epilepsies, Temporal-Central Focal"
C562694,DISEASE,"Epilepsy, Idiopathic Generalized [Supplementary Concept]","Epilepsy, Generalized|IGE|idiopathic generalized epilepsy"
NEW09742,CHEMICAL,rare snp,rare SNP
D001030,CHEMICAL,Apamin,apamin|Bees (1966-1977)|Venoms (1966-1977)
NEW09743,DISEASE,mitochondrial dysfunction,Mitochondrial dysfunction
NEW09744,CHEMICAL,altered potassium homeostasis,altered potassium homeostasis
NEW09745,CHEBI,elevated s100 beta,elevated S100 beta
NEW09746,CHEMICAL,na level,NA levels
http://purl.obolibrary.org/obo/CHEBI_63129,CHEMICAL,ile-alapsi[(e)-ch=ch]gly-phe-lys(5-galo)-gly-glu-gln-gly-pro-lys-gly-glu-thr,"± =|L-isoleucyl-(3E,5S)-5-aminohex-3-enoyl-L-phenylalanyl-(5R)-5-(beta-D-galactopyranosyloxy)-L-lysylglycyl-L-alpha-glutamyl-L-glutaminylglycyl-L-prolyl-L-lysylglycyl-L-alpha-glutamyl-L-threonine|IleAlaPsi[(E)-CH=CH]GlyPheLys(5-GalO)GlyGluGlnGlyProLysGlyGluThr"
NEW09747,CHEMICAL,5-hydroxytryptamine 5-ht type 2a receptor,5-hydroxytryptamine 5-HT type 2A receptors
NEW09748,DISEASE,chronic constriction injury,chronic constriction injury
C514172,CHEMICAL,"(4-bromo-3,6-dimethoxybenzocyclobuten-1-yl)methylamine [Supplementary Concept]",Bridged Bicyclo Compounds|TCB-2|Methylamines
NEW09749,CHEMICAL,tcb-2 administration,TCB-2 administration
NEW09750,DISEASE,acute leukemia cell,acute leukemia cells
NEW09751,MENTAL_HEALTH,subsequent primary disorder,subsequent primary disorder
NEW09752,DISEASE,matter abnormality,matter abnormalities
NEW09753,DISEASE,myelinogenesis,myelinogenesis
NEW09754,CHEMICAL,carbon source,carbon source
NEW09755,MENTAL_HEALTH,profound stress reaction,profound stress reactions
NEW09756,NUTRITION,catechol o-methyltransferase comt gene,catechol O-methyltransferase COMT gene
NEW09757,MENTAL_HEALTH,antipsychotic-induced supersensitivity psychosis,antipsychotic-induced supersensitivity psychosis
NEW09758,CHEMICAL,dopamine tone,dopamine tone
NEW09759,DISEASE,severe ptsd,severe PTSD
NEW09760,CHEMICAL,liberally-biased respond,liberally-biased responding
D000077867,CHEMICAL,Tolcapone,"Ro 407592|Ro-40-7592|SOM0226|Ro407592|Ro 40 7592|Tasmar|3,4 Dihydroxy 5' methyl 5 nitrobenzophenone|Ro 40-7592|3,4-Dihydroxy-5'-methyl-5-nitrobenzophenone|tolcapone"
NEW09761,DISEASE,low severity ptsd subject,lower severity PTSD subjects
NEW09762,DISEASE,high severity ptsd subject,higher severity PTSD subjects
NEW09763,DISEASE,experimental sad model,experimental SAD model
NEW09764,CHEMICAL,5-ht brain system,5-HT brain systems
NEW09765,CHEMICAL,ObjectiveaaWe,ObjectiveaaWe
NEW09766,DISEASE,treatment-resistant case,treatment-resistant cases
NEW09767,CHEMICAL,early life stress serotonin transporter promoter variant,early life stress serotonin transporter promoter variant
NEW09768,CHEMICAL,sex-genotype interaction,Sex-genotype interactions
D000066891,DISEASE,Critical Care Outcomes,"Care Outcome, Critical|Care Outcomes, Critical|Outcome, Critical Care|Outcomes, Critical Care|Critical Care Outcome|outcomes"
NEW09769,CHEMICAL,puberty e2 replacement,puberty E2 replacement
NEW09770,CHEMICAL,inhibitory serotonin-1a receptor,inhibitory serotonin-1A receptor
NEW09771,MENTAL_HEALTH,idiopathic adhd,idiopathic ADHD
NEW09772,CHEMICAL,striatal dopamine level,striatal dopamine levels
NEW09773,DISEASE,orexin/hypocretin deficiency,orexin/hypocretin deficiency
NEW09774,DISEASE,woman narcoleptic,women narcoleptics
NEW09775,CHEMICAL,impaired dopamine activity,Impaired dopamine activity
NEW09776,CHEMICAL,mesolimbic dopamine sensitization,Mesolimbic dopamine sensitization
NEW09777,MENTAL_HEALTH,schizophrenia risk,schizophrenia risk
NEW09778,MENTAL_HEALTH,untreated psychosis,Untreated Psychosis
NEW09779,MENTAL_HEALTH,first-episode schizophrenia spectrum disorder,first-episode schizophrenia spectrum disorder
NEW09780,DISEASE,dup duration,DUP Duration
NEW09781,CHEMICAL,cannabis-comt interaction,cannabis-COMT interaction
D019808,DISEASE,Losartan,"Losartan||Monopotassium Salt, Losartan|2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol|MK-954|Potassium, Losartan|DuP 753|Cozaar|MK 954|DUP|Losartan Monopotassium Salt|Losartan Potassium|Dup 753|DuP-753|MK954|Salt, Losartan Monopotassium|DuP753"
NEW09782,CHEMICAL,neurotransmitter dopamine,neurotransmitter dopamine
NEW09783,DISEASE,impulsivity personality,impulsivity personality
NEW09784,MENTAL_HEALTH,food craving,food craving
NEW09785,MENTAL_HEALTH,heritable mood disorder,heritable mood disorder
NEW09786,CHEBI,met allele carrier,Met allele carriers
NEW09787,MENTAL_HEALTH,Dementia questionnaire,Dementia Questionnaire
NEW09788,CHEMICAL,42-residue amyloid β-protein,42-residue amyloid β-protein
NEW09789,CHEMICAL,numerous flavonoid,Numerous flavonoids
NEW09790,DISEASE,aβ42 aggregation,Aβ42 aggregation
C009288,CHEMICAL,metaperiodate [Supplementary Concept],sodium periodate|Periodic Acid
C067156,CHEMICAL,taxifolin-3-glucopyranoside [Supplementary Concept],(+)-taxifolin|Quercetin/analogs  and  derivatives|Glucosides
http://purl.obolibrary.org/obo/CHEBI_81173,DISEASE,akeboside stf,PD PD|PD synucleinopathies
D000292,DISEASE,Pelvic Inflammatory Disease,"Inflammatory Diseases, Pelvic|Pelvic Inflammatory Diseases|Inflammatory Pelvic Disease|Adnexitis|inflammatory diseases|Disease, Inflammatory Pelvic|Disease, Pelvic Inflammatory|Diseases, Pelvic Inflammatory|Pelvic Diseases, Inflammatory|Pelvic Disease, Inflammatory|Diseases, Inflammatory Pelvic|Inflammatory Pelvic Diseases|Inflammatory Disease, Pelvic|pelvic inflammatory disease"
NEW09791,DISEASE,infectious micro-organism,infectious micro-organisms
NEW09792,CHEMICAL,μg/dl. commonest symptom,μg/dL. commonest symptom
D009497,MENTAL_HEALTH,Neurotic Disorders,"Neuroses|Psychoneuroses|Disorder, Neurotic|Disorders, Neurotic|Neurotic Disorder|neurotic disorders"
NEW09793,DISEASE,significant toxicity,significant toxicity
NEW09794,CHEMICAL,new nontricyclic antidepressant,newer nontricyclic antidepressants
C093267,CHEMICAL,"tau protein (389-402), synthetic [Supplementary Concept]","Genes, Synthetic|tau Proteins|Peptide Fragments|Tau Protein"
NEW09795,MENTAL_HEALTH,autism patient,Autism patients
NEW09796,DISEASE,coexist infection,coexisting infections
C060564,CHEMICAL,"titanium dioxide, zinc peroxide, zinc oxide drug combination [Supplementary Concept]",Peroxides|TiO2|Titanium|Titanium Dioxide|Zinc Oxide|Drug Combinations
D017639,CHEMICAL,"Asbestos, Amosite",Amosite Asbestos|Cummingtonite-Grunerite|Cummingtonite Grunerite|Asbestos|Amosite
NEW09797,CHEMICAL,acetylcholine level,Acetylcholine levels
NEW09798,DISEASE,disease disturbance,Disease disturbances
C538385,DISEASE,Hyperprolinemia type 2 [Supplementary Concept],"1-Pyrroline-5-Carboxylate Dehydrogenase/deficiency|Amino Acid Metabolism, Inborn Errors|hyperprolinemia"
NEW09799,MENTAL_HEALTH,dsm iiir schizoaffective disorder,DSM IIIR schizoaffective disorder
NEW09800,CHEMICAL,valproate treatment,valproate treatment
NEW09801,CHEBI,new direct-acting antiviral,New direct-acting antivirals
NEW09802,DISEASE,chronic virus infection,chronic virus infection
D000142,DISEASE,"Acidosis, Respiratory","Respiratory Acidosis|Respiratory Acidoses|acidosis|Acidoses, Respiratory|respiratory acidosis|Respiratory acidosis"
C041364,CHEBI,nitrox [Supplementary Concept],gas mixture|Oxygen|Nitrogen
NEW09803,DISEASE,hypercarbia %,hypercarbia %
NEW09804,DISEASE,acute hyperammonemia,Acute hyperammonemia
NEW09805,CHEMICAL,mm ammonium acetate,mM ammonium acetate
NEW09806,CHEMICAL,intravenous atropine,intravenous atropine
NEW09807,MENTAL_HEALTH,patient 's hallucination,patient's hallucinations
D013255,CHEMICAL,Steroid 21-Hydroxylase,"Cytochrome P 450 CYP21|Cytochrome P-450 c21|Steroid 21-Monooxygenase|Steroid 21 Hydroxylase|Cytochrome P450c21|Steroid 21 Monooxygenase|Cytochrome P-450 CYP21|Cytochrome P-450 21-Hydroxylase|Cytochrome P-450(c-21)|21-Hydroxylase|Cytochrome P 450 c21|P-450 c21, Cytochrome|Cytochrome P 450 21 Hydroxylase|21 Hydroxylase|Steroid-21-Hydroxylase|Progesterone 21 Hydroxylase|Progesterone 21-Hydroxylase|steroid 21-hydroxylase"
NEW09808,CHEMICAL,cortisol biosynthesis,cortisol biosynthesis
NEW09809,DISEASE,common autosomal recessive disorder,common autosomal recessive disorder
D048550,DISEASE,Hepatic Insufficiency,"Insufficiency, Hepatic|hepatic insufficiency|Liver Insufficiency|Insufficiency, Liver"
NEW09810,CHEMICAL,atomoxetine exposure,atomoxetine exposure
NEW09811,CHEMICAL,once- atomoxetine,Once- atomoxetine
NEW09812,DISEASE,stimulant-naive patient,Stimulant-naive patients
NEW09813,CHEMICAL,atomoxetine treatment,atomoxetine treatment
NEW09814,CHEMICAL,atomoxetine recipient,atomoxetine recipients
D059020,DISEASE,Suicidal Ideation,"suicidal ideations|Ideations, Suicidal|suicidal ideation|Suicidal Ideations|Ideation, Suicidal"
NEW09815,DISEASE,serious liver injury,serious liver injury
NEW09816,CHEMICAL,oral atomoxetine,oral atomoxetine
NEW09817,MENTAL_HEALTH,adhd symptom score,ADHD symptom score
NEW09818,MENTAL_HEALTH,Conners 's adult adhd rating scale,Conners's Adult ADHD Rating Scale
NEW09819,MENTAL_HEALTH,Wender-Reimherr Adult Attention Deficit Disorder scale,Wender-Reimherr Adult Attention Deficit Disorder Scale
NEW09820,DISEASE,chronic stroke patient,chronic stroke patients
NEW09821,CHEMICAL,mesolimbic dopamine,mesolimbic dopamine
NEW09822,CHEMICAL,share antidepressant action,shared antidepressant action
NEW09823,DISEASE,consequent cognitive dysfunction,consequent cognitive dysfunctions
NEW09824,CHEMICAL,serotonergic antidepressant,serotonergic antidepressants
NEW09825,CHEMICAL,reboxetine group,reboxetine group
NEW09826,CHEMICAL,5-hydroxytryptamine mechanism,5-hydroxytryptamine mechanism
NEW09827,MENTAL_HEALTH,hyperarousal depression,hyperarousal depression
NEW09828,MENTAL_HEALTH,classic melancholic depression,classic melancholic depression
NEW09829,CHEMICAL,β-adrenergic receptor antagonist pindolol,β-adrenergic receptor antagonist pindolol
NEW09830,DISEASE,toxicity episode,toxicity episodes
NEW09831,CHEMICAL,mdma metabolism,MDMA metabolism
NEW09832,DISEASE,progressive neurodegeneration,progressive neurodegeneration
NEW09833,DISEASE,long-term neurotoxic effect,long-term neurotoxic effects
NEW09834,CHEMICAL,active selective dopamine,active selective dopamine
NEW09835,CHEMICAL,human serotonin 5-ht transporter,human serotonin 5-HT transporter
C493227,CHEMICAL,"SLC6A2 protein, human [Supplementary Concept]",human norepinephrine transporter|Norepinephrine Plasma Membrane Transport Proteins
NEW09836,CHEMICAL,noradrenaline reuptake inhibitor reboxetine,noradrenaline reuptake inhibitor reboxetine
NEW09837,CHEBI,serotonin-selective reuptake inhibitor ssri agent,serotonin-selective reuptake inhibitor SSRI agents
NEW09838,CHEMICAL,endogenous ne signaling,endogenous NE signaling
NEW09839,DISEASE,contrast pain hypersensitivity,contrast pain hypersensitivity
NEW09840,DISEASE,affective pain dimension,affective pain dimension
NEW09841,DISEASE,unipolar disorder,unipolar disorders
NEW09842,CHEMICAL,ne transmission,NE transmission
NEW09843,CHEMICAL,its 's antidepressant action,its's antidepressant action
NEW09844,CHEMICAL,prenatal op exposure,prenatal OP exposure
NEW09845,DISEASE,risk-taking behavior,risk-taking behaviors
NEW09846,DISEASE,psychotic symptom similar,psychotic symptoms similar
NEW09847,CHEBI,stress hormone concentration,stress hormone concentrations
NEW09848,DISEASE,related stay-at-home sah order,related stay-at-home SAH orders
NEW09849,DISEASE,drug/alcohol abuse,drug/alcohol abuse
NEW09850,DISEASE,economic stressor,economic stressors
NEW09851,CHEBI,drug prevention,Drug prevention
NEW09852,DISEASE,islet autoimmunity,islet autoimmunity
NEW09853,CHEBI,immunoregulatory human leukocyte antigen hla complex,immunoregulatory human leukocyte antigen HLA complex
NEW09854,CHEMICAL,high gestational dap concentration,Higher gestational DAP concentrations
NEW09855,CHEMICAL,maternal tdap vaccination,maternal Tdap vaccination
NEW09856,CHEBI,maternal folic acid,Maternal folic acid
NEW09857,DISEASE,adult psychiatric admission,adult psychiatric admissions
NEW09858,DISEASE,county psychiatric emergency service,county psychiatric emergency service
NEW09859,CHEMICAL,extrahypothalamic oxytocin neuron,extrahypothalamic oxytocin neurons
NEW09860,MENTAL_HEALTH,stress-induced anxiety behavior,stress-induced anxiety behaviors
NEW09861,CHEMICAL,"inositol 1,4,5-trisphosphate receptor gene","inositol 1,4,5-trisphosphate receptor gene"
NEW09862,DISEASE,sporadic als patient,sporadic ALS patients
NEW09863,CHEMICAL,gsk3β signaling,GSK3β signaling
NEW09864,CHEMICAL,aberrant nmda receptor function,Aberrant NMDA receptor functions
NEW09865,CHEMICAL,non-synonymous single nucleotide polymorphism,non-synonymous single nucleotide polymorphisms
NEW09866,DISEASE,threat-induced reduction,threat-induced reduction
NEW09867,CHEBI,anxiolytic drug diazepam,anxiolytic drug diazepam
NEW09868,CHEMICAL,clonidine treatment,clonidine treatment
NEW09869,DISEASE,threat-induced increase,threat-induced increase
NEW09870,DISEASE,massive destruction,massive destruction
NEW09871,DISEASE,central function,central functions
NEW09872,CHEBI,selective inhibitor ssri fluoxetine,selective inhibitor SSRI fluoxetine
NEW09873,CHEBI,high affinity selective agonist,high affinity selective agonists
C032412,CHEMICAL,Ro 22-1319 [Supplementary Concept],Ro|Isoquinolines
C080864,CHEMICAL,N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea [Supplementary Concept],Indoles|Urea/analogs  and  derivatives|SB-200646A
NEW09874,MENTAL_HEALTH,condition anxiety,conditioned anxiety
NEW09875,DISEASE,neuropsychological disease,neuropsychological diseases
NEW09876,CHEBI,new 5-ht2a receptor acting drug,new 5-HT2A receptor acting drug
http://purl.obolibrary.org/obo/CHEBI_73319,CHEMICAL,adenosine a3 receptor agonist,adenosine A3 receptor agonists|A3 agonist|A3 adenosine receptor|A3 receptor agonists|A3 receptor agonist|A3 agonists
NEW09877,CHEMICAL,a3 adenosine receptor expression/function,A3 adenosine receptor expression/function
http://purl.obolibrary.org/obo/CHEBI_36204,CHEMICAL,12-hydroxylaurate,12-OH dodecanoate|omega-hydroxy laurate|omega-OH dodecanoate|omega-hydroxydodecanoate|12-hydroxydodecanoate|nmol AP5|12-OH laurate|nmol DNQX|R-PIA nmol
http://purl.obolibrary.org/obo/CHEBI_17985,CHEMICAL,"adenosine 3',5'-bismonophosphate","adenosine 3',5'-bis(dihydrogen phosphate)|R-PIA|R-phenylisopropyl adenosine|3'-Phosphoadenylate|3'-phosphoadenylate|Phosphoadenosine phosphate|PAP|Adenosine 3',5'-bisphosphate"
NEW09878,CHEMICAL,adenosine receptor stimulation,adenosine receptor stimulation
NEW09879,DISEASE,conclusion tactile hypersensitivity,conclusion tactile hypersensitivity
NEW09880,DISEASE,immunosuppressed patient,immunosuppressed patients
NEW09881,CHEBI,antiviral resistance,antiviral resistance
NEW09882,DISEASE,primary nociceptor,Primary nociceptors
D001048,DISEASE,Aplysia,Aplysias|Aplysia
C050426,CHEMICAL,huperzine A [Supplementary Concept],huperzine A|Sesquiterpenes|Alkaloids|Huperzine A|HupA
NEW09883,MENTAL_HEALTH,alzheimer disease therapy,Alzheimer disease therapy
NEW09884,CHEMICAL,ys-13 fermentation broth,YS-13 fermentation broth
NEW09885,DISEASE,colon cancer cell,colon cancer cells
NEW09886,DISEASE,various toxicity marker,various toxicity markers
NEW09887,CHEMICAL,l. clavatum extract,L. clavatum extract
NEW09888,CHEMICAL,result quercetin,Results Quercetin
C478032,CHEMICAL,"8,15-dehydro-5,6-dihydrolycopodine [Supplementary Concept]",Quinolizines|Lycopodine|Alkaloids
NEW09889,MENTAL_HEALTH,inter-nucleosomal dna fragmentation,inter-nucleosomal DNA fragmentation
NEW09890,DISEASE,various liver ailment,various liver ailments
NEW09891,DISEASE,sperm head abnormality,sperm head abnormality
NEW09892,DISEASE,toxicity biomarker,toxicity biomarkers
NEW09893,CHEMICAL,aspartate amino transferase,aspartate amino transferases
http://purl.obolibrary.org/obo/NCBITaxon_51030,CHEMICAL,necator,Sisymbrium austriacum|Lyocopodium clavatum
NEW09894,CHEBI,potentize homeopathic drug,potentized homeopathic drug
NEW09895,CHEMICAL,Lycopodium-30,Lycopodium-30
NEW09896,CHEMICAL,potent acetylcholinesterase inhibitory,potent acetylcholinesterase inhibitory|AChEI
NEW09897,DISEASE,H. dichotoma,H. dichotoma
D012909,DISEASE,Snake Bites,"Snakebite|Bite, Snake|Snakebite Envenomations|Snakebite Envenomation|Envenoming, Snake|Envenomings, Snake|snakebite|Snakebites|Envenomation, Snakebite|Snake Envenoming|Snake Envenomings|Snake Bite"
NEW09898,CHEMICAL,Qiancengta,Qiancengta
D003288,DISEASE,Contusions,bruising||contusions|Bruise|Contusion|Bruises
http://purl.obolibrary.org/obo/CHEBI_44785,CHEMICAL,peroxide,dioxidanediide|PEROXIDE ION|dioxide(2-)|peroxide|O2(2-)|Superoxide-hydrogen peroxide|[O2](2-)
NEW09899,DISEASE,fetida earthworm,fetida earthworms
NEW09900,CHEMICAL,nm rotenone,nM rotenone
NEW09901,CHEMICAL,effective antiseizure medicine,effective antiseizure medicine
D001705,CHEMICAL,Bioprosthesis,"Porcine Xenograft Bioprosthesis|Bioprostheses, Porcine Xenograft|Glutaraldehyde-Stabilized Grafts|Heterograft Bioprostheses|glutaraldehyde|Grafts, Glutaraldehyde-Stabilized|Bioprosthesis, Heterograft|Bioprosthesis, Xenograft|Graft, Glutaraldehyde-Stabilized|Bioprostheses, Heterograft|Xenograft Bioprosthesis|Bioprostheses|Porcine Xenograft Bioprostheses|Glutaraldehyde-Stabilized Graft|Glutaraldehyde Stabilized Grafts|Bioprostheses, Xenograft|Xenograft Bioprostheses|Xenograft Bioprostheses, Porcine|Bioprosthesis, Porcine Xenograft|Heterograft Bioprosthesis|Xenograft Bioprosthesis, Porcine"
NEW09902,MENTAL_HEALTH,addition dissociation,addition dissociation
NEW09903,CHEMICAL,cd % up,Cd % up
NEW09904,CHEMICAL,cd up,Cd up
NEW09905,MENTAL_HEALTH,significant depression,significant depression
NEW09906,NUTRITION,earthworm Eisenia fetida,earthworm Eisenia fetida
D000086402,DISEASE,SARS-CoV-2,"2019 Novel Coronavirus|2019 Novel Coronaviruses|Virus, SARS-CoV-2|Coronavirus 2, SARS|Coronavirus Disease 2019 Virus|SARS CoV 2 Virus|SARS Coronavirus 2|Virus, COVID19|COVID-19 Virus|Novel Coronavirus, 2019|COVID 19 Virus|Severe Acute Respiratory Syndrome Coronavirus 2|SARS-CoV-2 Viruses|Wuhan Coronavirus|SARS CoV-2|COVID-19 Viruses|Virus, COVID-19|Coronavirus, Wuhan|Viruses, COVID19|Wuhan Seafood Market Pneumonia Virus|Coronavirus, 2019 Novel|2019-nCoV|COVID19 Virus|COVID19 Viruses|SARS-CoV-2|SARS-CoV-2 Virus"
NEW09907,NUTRITION,earthworm Eisenia andrei,earthworm Eisenia andrei
NEW09908,CHEMICAL,μg g(-1,μg g(-1
NEW09909,DISEASE,pollutant-induced stress syndrome,pollutant-induced stress syndrome
NEW09910,DISEASE,paper contact toxicity test,paper contact toxicity test
NEW09911,CHEMICAL,castor methyl ester,castor methyl ester
NEW09912,CHEMICAL,castor ethyl ester,Oral conjugated equine estrogens|CEE|castor ethyl ester
NEW09913,CHEMICAL,plant-based biodiesels-safflower methyl ester,plant-based biodiesels-safflower methyl ester
NEW09914,DISEASE,soil toxicity test,soil toxicity test
NEW09915,CHEMICAL,fusarium plant,Fusarium plant
NEW09916,NUTRITION,wheat straw,wheat straw
NEW09917,CHEMICAL,fusarium biomass,Fusarium biomass
NEW09918,DISEASE,a. caliginosa,A. caliginosa
NEW09919,CHEMICAL,don concentration,DON concentration
NEW09920,NUTRITION,earthworm P. excavate,earthworm P. excavates
NEW09921,DISEASE,s. feltiae,S. feltiae
NEW09922,NUTRITION,earthworm activity,earthworm activity
NEW09923,CHEMICAL,total ag measurement,Total Ag measurements
NEW09924,MENTAL_HEALTH,more displacement,more displacement
NEW09925,CHEMICAL,Mylabris phalerata Pallas,Mylabris phalerata Pallas
C475247,NUTRITION,"immotilin, earthworm [Supplementary Concept]",earthworm|Proteins
http://purl.obolibrary.org/obo/CHEBI_67452,CHEMICAL,isogomisin o,o p'-DDT
NEW09926,CHEMICAL,p'-dde,p'-DDE
http://purl.obolibrary.org/obo/CHEBI_175971,CHEMICAL,pteroside p,"p p'-DDT|p ≤|(2S)-5-(hydroxymethyl)-2,7-dimethyl-6-[2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]-2,3-dihydroinden-1-one"
D064227,CHEMICAL,"Chlorofluorocarbons, Ethane",Chlorofluoroethanes|Ethane Chlorofluorocarbons|ethane
http://purl.obolibrary.org/obo/CHEBI_42266,CHEMICAL,ethane,"dimethyl|1,1,1-trichloro-2-(p-chlorophenyl)-2-(o-chlorophenyl ethane|C2H6|ethyl hydride|Aethan|methylmethane|R-170|Ethan|bimethyl|ETHANE|CH3-CH3|ethane"
NEW09927,CHEMICAL,ethylene ethane,ethylene ethane
NEW09928,NUTRITION,phosphatidylserine externalization,phosphatidylserine externalization
NEW09929,MENTAL_HEALTH,chromosomal dna fragmentation,chromosomal DNA fragmentation
NEW09930,DISEASE,neurotoxic pollutant,neurotoxic pollutant
C423572,MENTAL_HEALTH,"Oxr1 protein, mouse [Supplementary Concept]",Mitochondrial Proteins|oxidation resistance
D000072257,CHEMICAL,Oxygen Radical Absorbance Capacity,"ORAC Method|ORAC Assays|Methods, ORAC|ORAC Assay|Method, ORAC|TEAC Assay|Trolox Equivalence Antioxidant Capacity Assay|Assays, ORAC|ORAC Methods|oxygen radical absorbance capacity|Assay, ORAC|TEAC"
NEW09931,CHEMICAL,PPO enzyme,PPO enzyme
NEW09932,DISEASE,emblica extract,emblica extract
NEW09933,CHEBI,effective alternative anticoccidial agent,effective alternative anticoccidial agent
NEW09934,DISEASE,serotonergic hyperstimulation,serotonergic hyperstimulation
NEW09935,NUTRITION,Platichthys stellatu,Platichthys stellatus
NEW09936,CHEMICAL,fin-feet,fin-feet
NEW09937,MENTAL_HEALTH,near displacement rotation,near displacement rotation
D012772,DISEASE,"Shock, Septic","Shock Syndrome, Toxic|Toxic Shock Syndromes|Endotoxin Shock|Shock, Toxic|toxic-shock syndrome|Toxic Shock Syndrome|septic shock|Shock, Endotoxin|Shock, Endotoxic|Shocks, Endotoxin|Toxic Shock|Endotoxin Shocks|Septic Shock"
NEW09938,MENTAL_HEALTH,depression severity,Depression severity
NEW09939,CHEMICAL,low ft3,low FT3
NEW09940,MENTAL_HEALTH,clinical insomnia,clinical insomnia
NEW09941,CHEMICAL,ft3 reduction,FT3 reduction
NEW09942,CHEMICAL,Carbon monoxide-oximetry,Carbon monoxide-oximetry
NEW09943,DISEASE,neurodegenerative disorder patient,neurodegenerative disorders patients
NEW09944,NUTRITION,systemic folate deficiency,systemic folate deficiency
NEW09945,DISEASE,neuropsychiatric phenotype,neuropsychiatric phenotypes
NEW09946,CHEBI,cerebral folate deficiency,cerebral folate deficiency
NEW09947,MENTAL_HEALTH,so-called deficiency cfd syndrome,so-called deficiency CFD syndromes
NEW09948,NUTRITION,folate receptor alpha autoimmunity,Folate receptor alpha autoimmunity
NEW09949,MENTAL_HEALTH,most cfd syndrome,most CFD syndromes
NEW09950,CHEMICAL,low csf N(5)-methyl-tetrahydrofolate,low CSF N(5)-methyl-tetrahydrofolate
NEW09951,CHEMICAL,bind propidium,bound propidium
NEW09952,MENTAL_HEALTH,dissociation rate,dissociation rate
D044149,DISEASE,Vibrio alginolyticus,Pseudomonas creosotensis|Beneckea alginolytica|Oceanomonas alginolytica|Vibrio alginolyticus
NEW09953,NUTRITION,pacific white shrimp,Pacific white shrimp
NEW09954,CHEBI,cis carotenoid isomer,cis carotenoid isomers
NEW09955,MENTAL_HEALTH,fragmentation pattern,fragmentation patterns
NEW09956,DISEASE,m. wisconsensis,M. wisconsensis
NEW09957,NUTRITION,common pheasant,common pheasant
NEW09958,MENTAL_HEALTH,two eurasian magpie,Pica pica|two Eurasian magpies
NEW09959,DISEASE,esbl isolate,ESBL isolates
NEW09960,CHEMICAL,trimethoprim/sulfamethoxazole,trimethoprim/sulfamethoxazole
D013753,CHEMICAL,Tetracycline Resistance,"Tetracycline|Drug Resistance, Microbial (1966-1987)|Tetracycline (1966-1987)|tetracycline"
D010403,CHEMICAL,Penicillin Resistance,"Resistances, Penicillin|penicillin resistance|Resistance, Penicillin|Penicillin Resistances"
NEW09961,MENTAL_HEALTH,tetracycline resistance,tetracyclines resistance
http://purl.obolibrary.org/obo/CHEBI_48539,CHEBI,alpha-adrenergic drug,alpha-adrenergic drugs
NEW09962,CHEBI,topical estrogen therapy,topical estrogen therapy
NEW09963,DISEASE,moderate hirsutism,moderate hirsutism
NEW09964,DISEASE,large paraovarian cyst due,large paraovarian cyst due
http://purl.obolibrary.org/obo/CHEBI_35530,CHEMICAL,beta-adrenergic antagonist,alpha(1)-adrenergic receptor antagonist prazosin|BBs|beta-adrenergic receptor antagonist|beta-adrenergic blocker|beta-blocker|beta-adrenergic blockers|beta-blockers|Beta1-receptor antagonists|beta-adrenoceptor antagonists|beta-adrenergic receptor blockaders|beta-adrenergic antagonists|beta-adrenergic receptor antagonist propranolol
NEW09965,CHEBI,endocrine disorder,endocrine disorder
http://purl.obolibrary.org/obo/CHEBI_26666,CHEMICAL,short-chain fatty acid,short-chain fatty acids|SCFAs|microbe-derived short-chain fatty acids|SCFA
NEW09966,CHEMICAL,d-amino acid,D-amino acids
D005693,DISEASE,Galactosemias,"Classic Galactosemias|Galactokinase Deficiency Diseases|Galactose-1-Phosphate Uridylyltransferase Deficiency|Galactosemias, Epimerase Deficiency|Deficiency, UDP-Galactose-4-Epimerase|Deficiency Disease, UDPglucose 4-Epimerase|Galactosemia|Galactose-1-Phosphate Uridylyltransferase Deficiencies|Hereditary Galactokinase Deficiency|Galactosemias, Classic|Deficiencies, Galactose-1-Phosphate Uridyltransferase|Deficiency Galactosemia, Epimerase|Epimerase Deficiency Galactosemias|Deficiency Diseases, UDP-Galactose-4-Epimerase|Deficiency Disease, Galactose 1 Phosphate Uridyl Transferase|UDP-Galactose-4-Epimerase Deficiencies|Galactosemia IIIs|Epimerase Deficiency Galactosemia|Galactosemia, Epimerase Deficiency|Hereditary Galactokinase Deficiencies|Galactokinase Deficiencies, Hereditary|Deficiency Disease, UDPglucose 4 Epimerase|Deficiencies, Galactokinase|GALK Deficiencies|UTP Hexose 1 Phosphate Uridylyltransferase Deficiency|Deficiency, GALK|Galactose-1-Phosphate Uridyltransferase Deficiency|Deficiency Disease, UDP Galactose 4 Epimerase|Deficiency Disease, Galactose-1-Phosphate Uridyl-Transferase|UDP Galactose 4 Epimerase Deficiency|Galactose-1-Phosphate Uridyltransferase Deficiencies|GALT Deficiencies|Galactosemia III|Galactosemia 3|Galactose-1-Phosphate Uridyl-Transferase Deficiency Disease|Deficiency, Galactose-1-Phosphate Uridyltransferase|Deficiency Disease, Galactokinase|Galactose Epimerase Deficiency|GALE Deficiencies|Classic galactosemia|Deficiencies, Galactose-1-Phosphate Uridylyltransferase|Deficiency, Hereditary Galactokinase|Deficiencies, GALE|Deficiencies, Hereditary Galactokinase|UTP-Hexose-1-Phosphate Uridylyltransferase Deficiency Disease|Deficiency Galactosemias, Epimerase|UDPGlucose Hexose-1-Phosphate Uridylyltransferase Deficiency|UDPglucose 4-Epimerase Deficiency Disease|Galactose 1 Phosphate Uridyltransferase Deficiency|Uridyltransferase Deficiency, Galactose-1-Phosphate|Galactosemia 3s|Deficiencies, Galactose Epimerase|Deficiency, Galactose-1-Phosphate Uridylyltransferase|GALK Deficiency|Galactokinase Deficiency|GALT Deficiency|Galactokinase Deficiency Disease|UDP Galactose 4 Epimerase Deficiency Disease|Deficiency, Galactokinase|Galactosemia, Classic|Uridylyltransferase Deficiencies, Galactose-1-Phosphate|UDPGlucose Hexose 1 Phosphate Uridylyltransferase Deficiency|Uridylyltransferase Deficiency, Galactose-1-Phosphate|UDP-Galactose-4-Epimerase Deficiency Diseases|Deficiencies, GALT|GALE Deficiency|Deficiency Disease, UDP-Galactose-4-Epimerase|Classic Galactosemia|UDPglucose 4 Epimerase Deficiency Disease|Deficiencies, GALK|UDP-Galactose-4-Epimerase Deficiency|Galactose 1 Phosphate Uridylyltransferase Deficiency|Deficiency, Galactose Epimerase|Deficiency, GALE|Galactose 1 Phosphate Uridyl Transferase Deficiency Disease|Galactose Epimerase Deficiencies|UTP Hexose 1 Phosphate Uridylyltransferase Deficiency Disease|Deficiency, GALT|Galactokinase Deficiency, Hereditary|UTP Hexose-1-Phosphate Uridylyltransferase Deficiency|Galactosemia 2s|Galactosemia 2|Deficiencies, UDP-Galactose-4-Epimerase|Galactokinase Deficiencies|UDP-Galactose-4-Epimerase Deficiency Disease|Uridyltransferase Deficiencies, Galactose-1-Phosphate"
NEW09967,CHEMICAL,galactose-1-phosphate uridyltransferase galt deficiency,galactose-1-phosphate uridyltransferase GALT deficiency
NEW09968,DISEASE,autosomal recessive disorder due,autosomal recessive disorder due
NEW09969,CHEMICAL,biogenic amine hypothesis,biogenic amine hypothesis
NEW09970,CHEMICAL,adenosine system,Adenosine systems
NEW09971,CHEMICAL,dopamine signaling,dopamine signaling
NEW09972,DISEASE,spontaneous hypertensive rat,Spontaneous Hypertensive Rats
NEW09973,DISEASE,adolescent hypertensive rat,adolescent hypertensive rats
NEW09974,MENTAL_HEALTH,validate adhd animal model,validated ADHD animal model
NEW09975,DISEASE,alcoholic organic brain syndrome patient,alcoholic organic brain syndrome patients
NEW09976,MENTAL_HEALTH,alcohol syndrome patient,Alcohol syndrome patients
NEW09977,CHEMICAL,csf 5hiaa,CSF 5HIAA
D004305,CHEBI,"Dose-Response Relationship, Drug","Dose Response Relationship, Drug|Drug Dose-Response Relationships|Relationship, Drug Dose-Response|Drug Dose-Response Relationship|Dose-Response Relationships, Drug|Relationships, Drug Dose-Response|drug dose"
NEW09978,DISEASE,rat clonal pheochromocytoma cell line,rat clonal pheochromocytoma cell line
NEW09979,DISEASE,hyperoxic,hyperoxic
NEW09980,CHEMICAL,exogenous alphat,exogenous alphaT
NEW09981,CHEMICAL,lactate dehydrogenase ldh leakage,lactate dehydrogenase LDH leakage
NEW09982,CHEBI,vitamin e homolog,vitamin E homologs
NEW09983,DISEASE,hyperoxic apoptosis,hyperoxic apoptosis
NEW09984,DISEASE,m crf 10(-8 m,M CRF 10(-8 M
NEW09985,DISEASE,crf effect,CRF effects
NEW09986,CHEBI,specific crf antagonist alpha-h-crf,specific CRF antagonist alpha-h-CRF
NEW09987,DISEASE,crf receptor concentration,CRF receptor concentration
NEW09988,CHEBI,crf antagonist,CRF antagonist
NEW09989,CHEMICAL,cbd-rich medical cannabis,CBD-rich medical cannabis
NEW09990,CHEMICAL,cannabis treatment,cannabis treatment
D008078,NUTRITION,"Cholesterol, LDL","Low Density Lipoprotein Cholesterol|beta Lipoprotein Cholesterol|LDL Cholesteryl Linoleate|Cholesterol, beta-Lipoprotein|Cholesteryl Linoleate, LDL|beta-Lipoprotein Cholesterol|LDL-cholesterol|LDL Cholesterol|LDL cholesterol"
NEW09991,DISEASE,estrogen receptor-positive er+ metastatic tumor,Estrogen receptor-positive ER+ metastatic tumors
NEW09992,DISEASE,breast cancer-related death,breast cancer-related deaths
NEW09993,CHEMICAL,estrogen receptor antagonist fulvestrant,estrogen receptor antagonist fulvestrant|Fulv
NEW09994,DISEASE,er+ metastatic liver tumor,ER+ metastatic liver tumors
NEW09995,CHEMICAL,glucose metabolism enzyme,glucose metabolism enzymes
NEW09996,CHEMICAL,mbc cell,MBC cells
NEW09997,CHEMICAL,increase glucose metabolism,increased glucose metabolism
NEW09998,DISEASE,liver metastatic tumor,liver metastatic tumors
NEW09999,MENTAL_HEALTH,anthelmintic resistance,anthelmintic resistance
NEW10000,CHEBI,drug efflux,drug efflux
NEW10001,DISEASE,nematode parasite infection,nematode parasite infections
D007978,CHEMICAL,Levamisole,"Dekaris|levamisole|Levotetramisole|Solaskil|Levamisole Hydrochloride|Hydrochloride, Levamisole|Decaris|L-Tetramisole"
D011717,CHEMICAL,Pyrantel Tartrate,"Banminth|Tartrate, Pyrantel|pyrantel"
NEW10002,CHEBI,drug target site,drug target site
NEW10003,DISEASE,psychiatric side-effect,psychiatric side-effects
NEW10004,DISEASE,dopaminergic deficit,dopaminergic deficits
NEW10005,CHEMICAL,l-dopa administration,L-dopa administration
http://purl.obolibrary.org/obo/SYMP_0000099,DISEASE,pain,lancinating pain|SCI-induced pain|PD-related pain|chronic/neuropathic pain|SCD-related pain
NEW10006,CHEMICAL,50 mg/kg berberine,BBR|50 mg/kg berberine
NEW10007,DISEASE,diet (hfd)-induced metabolic disorder,diet (HFD)-induced metabolic disorder
NEW10008,DISEASE,hepatic lipoprotein lipase,hepatic lipoprotein lipase
D054872,NUTRITION,Fatty Acid Synthesis Inhibitors,fatty acid synthesis|Fatty Acid Synthetase Complex (1971-2007)
NEW10009,NUTRITION,fatty acid uptake,fatty acid uptake
NEW10010,CHEMICAL,atp citrate lyase acly mrna expression,ATP citrate lyase ACLY mRNA expression
NEW10011,CHEBI,vitamin     d level,vitamin    D levels
NEW10012,DISEASE,autoimmune rheumatic disease,autoimmune rheumatic diseases
NEW10013,CHEBI,serum calcidiol,serum calcidiol
NEW10014,CHEBI,low serum calcidiol,low serum calcidiol
NEW10015,DISEASE,systolic hypertension,systolic hypertension
NEW10016,DISEASE,impulse behavior,impulse behavior
NEW10017,DISEASE,impulsive pd patient,impulsive PD patients
NEW10018,CHEMICAL,dopamine therapy,dopamine therapy
NEW10019,CHEMICAL,dopamine treatment,dopamine treatment
NEW10020,CHEMICAL,thalamic gaba concentration,thalamic GABA concentrations
NEW10021,DISEASE,diet deficiency,diet deficiency
http://purl.obolibrary.org/obo/DOID_9063,DISEASE,ritter's disease,"Staphylococcal scalded skin syndrome|Biermers's disease|Scalded skin syndrome|Ritter disease|Pemphigus neonatorum|Toxic epidermal necrolysis, subcorneal type|Dermatitis exfoliativa neonatorum"
NEW10022,CHEMICAL,Conclusion-We,Conclusion-We
NEW10023,DISEASE,atypical psychiatric symptom,atypical psychiatric symptoms
NEW10024,CHEBI,nicotine agonist,nicotine agonists
NEW10025,DISEASE,parkinson 's disease-like neurodegenerative disorder,Parkinson's disease-like neurodegenerative disorders
NEW10026,MENTAL_HEALTH,neonatal abstinence syndrome refractory,neonatal abstinence syndrome refractory
NEW10027,CHEBI,potent dopamine blocker,potent dopamine blocker
NEW10028,DISEASE,various psychiatric symptom,various psychiatric symptoms
NEW10029,MENTAL_HEALTH,high suicide risk,higher suicide risk
http://purl.obolibrary.org/obo/CHEBI_70565,CHEMICAL,"(-)-(4s,5s,10r,20r)-12,18-dihydroxy-7-oxo-abieta-8,11,13-trien-20-aldehyde 18,20-ethyl acetal","(20R)-20-ethoxy-12-hydroxy-19,20-epoxyabieta-8,11,13-trien-7-one|diallyl thiosulfinate"
C008692,CHEMICAL,nuciferine [Supplementary Concept],Aporphines|nuciferine
NEW10030,CHEBI,hormone change,hormone changes
NEW10031,NUTRITION,low antral follicle count,lower antral follicle count
NEW10032,CHEBI,fetal sex hormone,fetal sex hormones
NEW10033,CHEMICAL,reduce oestrodiol,reduced oestrodiol
NEW10034,MENTAL_HEALTH,autism pathophysiology,autism pathophysiology
NEW10035,CHEBI,postnatal sex hormone level,postnatal sex hormone levels
NEW10036,CHEBI,measure hormone,measured hormones
NEW10037,MENTAL_HEALTH,same autism group,same autism group
NEW10038,CHEMICAL,cyproterone acetate agonist,cyproterone acetate agonist
C053541,CHEMICAL,bicalutamide [Supplementary Concept],Nitriles|Anilides|bicalutamide|Tosyl Compounds
NEW10039,DISEASE,neonatal pulmonary hypertension,Neonatal pulmonary hypertension
NEW10040,CHEMICAL,prostanoid tp receptor,prostanoid TP receptor
D065091,CHEBI,Amylin Receptor Agonists,"Mimetics, Amylin|Amylin Receptor Agonist|receptor agonists|Receptor Agonists, Amylin|Amylin Agonists|Agonists, Amylin Receptor|Agonist, Amylin Receptor|Receptor Agonist, Amylin|Agonists, Amylin|Amylin Mimetics"
http://purl.obolibrary.org/obo/CHEBI_5854,CHEMICAL,ibotenic acid,excitotoxin quinolinic acid|Ibotenic acid
D015526,DISEASE,AIDS Dementia Complex,"ADRD|AIDS Encephalopathies|related dementia|HIV-Associated Cognitive Motor Complex|Encephalopathies, HIV|HIV-1-Associated Cognitive Motor Complex|Encephalopathies, AIDS|syndrome dementia complex|AIDS Related Dementia Complex|HIV Associated Cognitive Motor Complex|Complex, AIDS Dementia|HIV Encephalopathies|HIV-1 Cognitive and Motor Complex|Dementia Complex, AIDS Related|AIDS dementia complex|HIV 1 Associated Cognitive Motor Complex|AIDS-Related Dementia Complex|Dementia, HIV|Dementia Complex, AIDS-Related|AIDS Encephalopathy|HIV Dementias|HIV Dementia|Encephalopathy, HIV|Dementia Complex, AIDS|Dementia Complex, Acquired Immune Deficiency Syndrome|Encephalopathy, AIDS|HIV Encephalopathy|HIV 1 Cognitive and Motor Complex|Dementias, HIV|Acquired-Immune Deficiency Syndrome Dementia Complex|Complex, AIDS-Related Dementia"
NEW10041,DISEASE,d/1/california,D/1/California
NEW10042,CHEMICAL,serum quinolinic acid concentration,serum quinolinic acid concentrations
http://purl.obolibrary.org/obo/NCBITaxon_10379,DISEASE,rhadinovirus,SAIDS macaques
D017470,CHEMICAL,"Receptors, Glutamate","Excitatory Amino Acid Receptors|excitatory amino acid receptors|Receptor, Glutamate|Glutamate Receptor|Receptors, Excitatory Amino Acid|Excitatory Amino Acid Receptor|Glutamate Receptors"
http://purl.obolibrary.org/obo/IDO:0000586,DISEASE,infection,Noco2 infection|D/1/California infection|DHAV-1 infection|ISKNV infection|BmNPV infection|SRV-4 infection|SIVmac239 infection|Triggering'-when infection
NEW10043,CHEMICAL,normal csf quinolinic acid,normal CSF quinolinic acid
NEW10044,CHEMICAL,kynurenic acid concentration,kynurenic acid concentrations
NEW10045,CHEMICAL,serum l-kynurenine concentration,serum L-kynurenine concentrations
NEW10046,CHEMICAL,reduce serum l-tryptophan,reduced serum L-tryptophan
NEW10047,CHEBI,pharmacological drug treatment,pharmacological drug treatments
D001602,DISEASE,Beriberi,beriberi
NEW10048,DISEASE,deficiency explanation,deficiency explanation
NEW10049,CHEMICAL,Grijns dietary deficiency,Grijns dietary deficiency
http://purl.obolibrary.org/obo/CHEBI_15890,CHEMICAL,"5,6-dimethylbenzimidazole","Dimezol|Thiamin Thiamin|5,6-dimethyl-1H-benzimidazole|Dimesol|Dimedazole|5,6-Dimethylbenzimidazole|Dimedazol|5,6-DIMETHYLBENZIMIDAZOLE|5,6-dimethylbenzimidazole|Dimethylbenzimidazole"
C538618,DISEASE,Donath-Landsteiner hemolytic anemia [Supplementary Concept],"Anemia, Hemolytic, Autoimmune|Donath"
D012441,NUTRITION,Saccharomyces cerevisiae,"brewer's yeast|Baker Yeast|Baker's Yeasts|S cerevisiae|Yeast, Baker|Brewer's Yeast|Saccharomyces uvarum var. melibiosus|Baker's Yeast|Yeast, Baker's|Saccharomyces oviformis|Yeast, Brewer's|Candida robusta|Saccharomyces capensis|S. cerevisiae|Saccharomyces italicus"
NEW10050,CHEBI,vitamin fortification,Vitamin fortification
NEW10051,DISEASE,endemic pellagra,endemic pellagra
NEW10052,CHEBI,inadequate niacin,inadequate niacin
NEW10053,NUTRITION,precursor tryptophan,precursor tryptophan
NEW10054,CHEMICAL,its 's amino acid precursor,its's amino acid precursor
NEW10055,DISEASE,deficiency disease due,deficiency disease due
D009436,DISEASE,Neural Tube Defects,"Dysraphisms, Occult Spinal|Occult Spinal Dysraphisms|Spinal Dysraphisms, Occult|Spinal Cord Myelodysplasia|Myelodysplasias, Spinal Cord|Exencephalies|Diastematomyelia|Neuroenteric Cyst|Occult Spinal Dysraphism Sequence|Craniorachischisis|Tethered Cord Syndrome|Myelodysplasia, Spinal Cord|Cyst, Neurenteric|Acranias|Neural Tube Developmental Defects|Iniencephaly|Exencephaly|Cysts, Neurenteric|Iniencephalies|tube defects|Neurenteric Cysts|Craniorachischises|Cyst, Neuroenteric|Developmental Defects, Neural Tube|Acrania|Spinal Dysraphism, Occult|Spinal Cord Myelodysplasias|Tethered Cord Syndromes|Cysts, Neuroenteric|Tethered Spinal Cord Syndrome|Defect, Neural Tube|Diastematomyelias|Developmental Neural Tube Defects|Neuroenteric Cysts|Dysraphism, Occult Spinal|Defects, Neural Tube|Neurenteric Cyst|Neural Tube Defect|Occult Spinal Dysraphism"
NEW10056,CHEBI,folate deficiency,Folate deficiency
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Wernicke's_Syndrome,DISEASE,wernicke's syndrome,Wernicke's encephalopathy-Korsakoff syndrome
D013788,CHEMICAL,Thalamus,Thalamencephalon|PVT|Thalamencephalons|thalamus|THAL
D000079689,DISEASE,Opioid-Induced Constipation,"opioid-induced bowel dysfunction|OIC|Opioid-Induced Constipations|Opiate Induced Constipation|opioid-induced constipation|Opioid-Induced Bowel Dysfunction|Opioid Induced Bowel Dysfunction|Opioid Induced Constipation|Opioid-Induced Bowel Dysfunctions|Opiate-Induced Constipations|Constipation, Opiate-Induced|Bowel Syndrome, Narcotic|Opiate-Induced Constipation|Constipation, Opioid-Induced|Dysfunction, Opioid-Induced Bowel|Opioid-induced-constipation|Bowel Dysfunction, Opioid-Induced|Narcotic Bowel Syndromes|Narcotic Bowel Syndrome"
C000620491,CHEMICAL,naldemedine [Supplementary Concept],Naltrexone/analogs  and  derivatives|naldemedine
D051572,CHEMICAL,Proto-Oncogene Proteins c-hck,"Proto Oncogene Protein hck|hck Proto Oncogene Proteins|c-hck, Proto-Oncogene Protein|hck Proto-Oncogene Proteins|c-hck Proto-Oncogene Proteins|Proto-Oncogene Protein c-hck|c hck Proteins|Tyrosine-Protein Kinase HCK|Hck|Tyrosine Protein Kinase HCK|Proto Oncogene Protein c hck|Proto-Oncogene Protein hck|Hematopoietic Cell Kinase|Proto-Oncogene Proteins, hck|Proto Oncogene Proteins c hck|c-hck Proteins|c hck Proto Oncogene Proteins|Proto-Oncogene Proteins, c-hck"
NEW10057,MENTAL_HEALTH,dissociation constant,dissociation constants
D051076,CHEMICAL,Proto-Oncogene Proteins c-fyn,"Proto-Oncogene Protein p72(fyn)|p72 c fyn Protein|c-fyn, Proto-Oncogene Protein|Proteins c-fyn, Proto-Oncogene|c-fyn Protein, p59|c-fyn Protein|p59(fyn) Protein|fyn Proto-Oncogene Proteins|Protein-Tyrosine Kinase p59(fyn)|p59 c-fyn Protein|Proto-Oncogene Proteins, fyn|Fyn|Proto-Oncogene Protein p59(fyn)|p60(fyn) Protein|Tyrosine Kinase, Fyn|Proto-Oncogene Protein c-fyn|p60 c fyn Protein|c-fyn Proto-Oncogene Proteins|p60 c-fyn Protein|Proto Oncogene Proteins c fyn|Proto Oncogene Protein c fyn|fyn Proto Oncogene Proteins|p72 c-fyn Protein|Proto-Oncogene Protein c-syn|Proto-Oncogene Proteins, c-fyn|c-fyn Protein, p60|c-syn, Proto-Oncogene Protein|p72(fyn) Protein|c fyn Proto Oncogene Proteins|c-fyn, Proto-Oncogene Proteins|p59 c fyn Protein|Proto Oncogene Protein c syn|Proto-Oncogene Protein p60(fyn)|Fyn Tyrosine Kinase"
http://purl.obolibrary.org/obo/CHEBI_60004,CHEBI,mixture,xanthine-catechin mixture|XC mixture|ethanol-gelatin mixture
NEW10058,DISEASE,li-induced anti-inflammatory effect,Li-induced anti-inflammatory effects
NEW10059,CHEBI,selective alpha adrenal receptor α2-ar agonist,selective alpha adrenal receptor α2-AR agonist
NEW10060,DISEASE,ich-induced anxiety-like behavior,ICH-induced anxiety-like behaviors
NEW10061,NUTRITION,increase cholesterol level,increased cholesterol levels
NEW10062,DISEASE,alzheimer patient,Alzheimer patients
D004410,MENTAL_HEALTH,Dyslexia,"Developmental Reading Disorder|Word Blindness|Reading disorder|Reading Disorders|Disabilities, Developmental Reading|Disability, Developmental Reading|Reading Disability, Developmental|Disorder, Reading|Developmental Reading Disabilities|Reading Disorder, Developmental|Alexia|Blindnesses, Word|Word Blindnesses|Disorders, Developmental Reading|Developmental Dyslexia|Developmental Dyslexias|Disorders, Reading|developmental dyslexia|Reading Disorder|Alexias|Dyslexia, Developmental|Developmental Reading Disorders|Disorder, Developmental Reading|Dyslexias, Developmental|Reading Disabilities, Developmental|Reading Disorders, Developmental|Dyslexias|Blindness, Word|Developmental Reading Disability"
NEW10063,MENTAL_HEALTH,surface dyslexia,Surface dyslexia
NEW10064,CHEMICAL,methadone program,methadone program
NEW10065,DISEASE,hcv infection,HCV infections
NEW10066,CHEMICAL,norepinephrine precursor,norepinephrine precursor
NEW10067,DISEASE,moderate dlb,moderate DLB
http://purl.org/sig/ont/fma/fma271967,CHEMICAL,radlex term,nonperjorative term symbiophobia
C061277,CHEBI,"Cor a I protein, hazel [Supplementary Concept]",Plant Proteins|major allergen
NEW10068,DISEASE,in peptic digestion,in peptic digestion
NEW10069,CHEMICAL,n-dipropylaminotetralin,N-dipropylaminotetralin
NEW10070,MENTAL_HEALTH,dissociation constant =,dissociation constant =
NEW10071,CHEMICAL,± lower,± lower
NEW10072,CHEMICAL,∼1000 nm,∼1000 nm
C054649,CHEMICAL,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol [Supplementary Concept]","CP-55,940|Cyclohexanols"
NEW10073,CHEMICAL,[(3)h]btx-b,[(3)H]BTX-B
NEW10074,CHEMICAL,ipsc,IPSCs
C042403,CHEMICAL,vita K+B 93 [Supplementary Concept],Acrylic Resins|K(B
NEW10075,MENTAL_HEALTH,apparent dissociation constant,apparent dissociation constant
D032065,CHEMICAL,Mitragyna,Mitragyna speciosas|Mitragyna speciosa|Mitragynas|Kratoms|Kratom
NEW10076,DISEASE,pain suppression,pain suppression
NEW10077,MENTAL_HEALTH,cue-induced craving,cue-induced craving
NEW10078,DISEASE,drug-induced hyponatremia,drug-induced hyponatremia
NEW10079,CHEMICAL,serum sodium concentration,serum sodium concentration
NEW10080,CHEBI,inappropriate antidiuretic hormone,inappropriate antidiuretic hormone
D065092,CHEBI,Antidiuretic Hormone Receptor Antagonists,"Antidiuretic Hormone Antagonists|Vasopressin Receptor Antagonists|Hormone Antagonists, Antidiuretic|Hormone Antagonist, Antidiuretic|Antagonists, Vasopressin|vasopressin antagonists|Receptor Antagonists, Vasopressin|Antagonists, Vasopressin Receptor|Vasopressin Receptor Antagonist|hormone receptor|Antidiuretic Hormone Receptor Antagonist|Antagonist, Vasopressin Receptor|Vasopressin Antagonist|Antagonist, Vasopressin|Antagonist, Antidiuretic Hormone|vasopressin receptor antagonists|vasopressin receptor antagonist|antidiuretic hormone|vasopressin-receptor antagonists|Receptor Antagonist, Vasopressin|Antidiuretic Hormone Antagonist|Antagonists, Antidiuretic Hormone|Vasopressin Antagonists"
NEW10081,DISEASE,t2dm-related complication,T2DM-related complications
NEW10082,CHEMICAL,p-ir,p-IR
http://purl.obolibrary.org/obo/CHEBI_80875,CHEMICAL,nigakilactone k,p-PI3 K
C105254,CHEMICAL,pramlintide [Supplementary Concept],Islet Amyloid Polypeptide|Pramlintide
NEW10083,DISEASE,treatment-resistant depressed patient,treatment-resistant depressed patients
NEW10084,DISEASE,aspergillus flavus infection,Aspergillus flavus infection
NEW10085,MENTAL_HEALTH,kernel resistance,kernel resistance
NEW10086,CHEBI,antifungal protein,antifungal proteins
NEW10087,DISEASE,MLD group,MLD group
NEW10088,CHEMICAL,la group,LA group
NEW10089,DISEASE,specimen toxicity,specimen toxicity
NEW10090,CHEMICAL,tetrodotoxin bioassay,tetrodotoxin bioassay
D013779,CHEMICAL,Tetrodotoxin,"tetrodotoxin|Tarichatoxin|Tetradotoxin|Tetrodotoxin|Fugu Toxin|TTX|Toxin, Fugu"
NEW10091,CHEMICAL,ttx microg g(-1,TTX microg g(-1
NEW10092,CHEMICAL,intracellular atp content,intracellular ATP content
NEW10093,CHEMICAL,plasma phosphate level,Plasma phosphate levels
NEW10094,CHEMICAL,red cell organic phosphate ester fraction,red cell organic phosphate ester fractions
NEW10095,CHEMICAL,membrane atp pool,membrane ATP pool
NEW10096,DISEASE,primary depressive group,primary depressive group
D028061,CHEMICAL,Phosphate Transport Proteins,"inorganic phosphate|Transporter, Phosphate|Phosphate Transporters, Inorganic|Transporters, Phosphate|Phosphate Carriers|Inorganic Phosphate Transporter|Phosphate Transporters|Phosphate Transporter|Carriers, Phosphate|Transporters, Inorganic Phosphate|Inorganic Phosphate Transporters"
NEW10097,CHEMICAL,passive phosphate transport,passive phosphate transport
NEW10098,CHEMICAL,plasma cell inorganic phosphate level,Plasma cell inorganic phosphate levels
NEW10099,CHEMICAL,serum-free fatty acid level,serum-free fatty acid levels|FFA
NEW10100,NUTRITION,fast serum-free fatty acid level,Fasting serum-free fatty acid levels
NEW10101,CHEMICAL,ffa responsiveness,FFA responsiveness
NEW10102,DISEASE,general depressive syndrome,general depressive syndrome
NEW10103,CHEMICAL,increase ffa,increased FFA
D017970,DISEASE,Thorium Compounds,"thorium|Compounds, Thorium|Th-2"
NEW10104,DISEASE,th-1 neurotoxicity profile,Th-1 neurotoxicity profiles
NEW10105,CHEMICAL,increase pha th-1,increased PHA Th-1
http://purl.obolibrary.org/obo/CHEBI_156001,CHEMICAL,scb2,double-mutant A20T/A212S|CBD µg/mL|SCB2|CBD Epidiolex ®
NEW10106,DISEASE,th-1 neurotoxicity profile,Th-1 neurotoxicity profile
NEW10107,CHEMICAL,sacubitril/valsartan,Sacubitril/valsartan
D000082142,CHEBI,Mast Cell Stabilizers,"Mast Cells Stabilizers|Mast Cells Degranulation Stabilizers|Mast Cell Stabilizing Compound|Mast Cells Degranulation Stabilizer|Stabilizers, Mast Cell|Mast Cell Degranulation Stabilizer|Mast Cells Stabilizer|Mast Cell Stabilizing Compounds|Stabilizer, Mast Cell|Cell Stabilizer, Mast|Stabilizer, Mast Cells|Stabilizers, Mast Cells|stabilizer|Cells Stabilizer, Mast|Mast Cell Degranulation Stabilizers|Mast Cell Stabilizer|stabilizers"
D005421,CHEBI,Flavoring Agents,"Flavor Additives|Agents, Flavoring|Flavor Additive|Flavor Enhancer|Flavor Enhancers|Enhancer, Flavor|Agent, Flavoring|Flavoring Agent|Enhancers, Flavor|Additives, Flavor|flavoring agents|Additive, Flavor"
NEW10108,DISEASE,ouabain-induced bipolar disease model,ouabain-induced bipolar disease model
NEW10109,CHEMICAL,sucrose preference test,sucrose preference tests
NEW10110,DISEASE,drug-taking behavior,drug-taking behavior
C529765,CHEMICAL,AM4113 [Supplementary Concept],Pyrazoles|AM4113
http://purl.obolibrary.org/obo/CHEBI_17780,CHEMICAL,5-hydroxy-l-tryptophan,Cincofarm|L-5-hydroxytryptophan|5-Hydroxy-L-tryptophan|oxitriptan|4-dihydroxyphenylalanine|Tript-OH|5-hydroxytryptophan L-form|(2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid|Levothym|5-hydroxy-L-tryptophan|Oxitriptan
D050545,NUTRITION,Choline Dehydrogenase,"choline|Choline|Dehydrogenase, Choline"
NEW10111,DISEASE,comorbid physical disease,comorbid physical disease
NEW10112,CHEMICAL,hippocampal glutamate,hippocampal glutamate
NEW10113,MENTAL_HEALTH,depression treatment effect,depression treatment effects
NEW10114,DISEASE,dopaminergic deficiency,Dopaminergic deficiency
http://purl.obolibrary.org/obo/MFOMD_0000141,DISEASE,rem sleep behaviour disorder,REM sleep behaviour disorder
NEW10115,DISEASE,idiopathic rbd,idiopathic RBD
D008268,DISEASE,Macular Degeneration,"Macular Dystrophies|age-related macular degeneration|Age-Related Maculopathy|Macular Degeneration, Age-Related|Age Related Maculopathy|Age-Related Maculopathies|Dystrophy, Macular|Maculopathy, Age Related|Degeneration, Macular|Age Related Macular Degeneration|Maculopathy, Age-Related|Age-Related Macular Degenerations|Macular Degeneration, Age Related|Macular Dystrophy|Maculopathies, Age-Related|Macular Degenerations|Maculopathies|Age-Related Macular Degeneration|Age Related Maculopathies|Maculopathy"
NEW10116,CHEBI,dietary carotenoid,dietary carotenoids
NEW10117,MENTAL_HEALTH,preferential transmembrane orientation,preferential transmembrane orientation
D000069467,DISEASE,Fecal Microbiota Transplantation,"Intestinal Microbiome Transplantation|Intestinal Microbiota Transfers|Fecal Microbiome Transplantations|Transplantation, Fecal|Intestinal Microbiota Transfer|Donor Feces Infusion|Transplantation, Fecal Microbiota|Intestinal Microbiome Transfers|Microbiota Transplantation, Fecal|Fecal Microbiota Transfer|Microbiota Transfers, Fecal|Microbiota Transplant, Fecal|Microbiome Transplantation, Fecal|Transplants, Intestinal Microbiota|Transfer, Intestinal Microbiome|Donor Feces Infusions|Transplants, Fecal|Intestinal Microbiota Transplants|Fecal Microbiota Transplantations|Intestinal Microbiome Transplant|Transplantation, Intestinal Microbiota|Transplant, Intestinal Microbiota|Microbiome Transplantations, Intestinal|Fecal Transplants|Intestinal Microbiota Transplant|Microbiota Transfer, Intestinal|Transplants, Fecal Microbiota|Feces Infusion, Donor|Transfers, Intestinal Microbiota|Transfers, Fecal Microbiota|Transfers, Intestinal Microbiome|Fecal Microbiota Transplant|Transplantations, Fecal Microbiota|Intestinal Microbiome Transplantations|Microbiota Transfer, Fecal|Microbiota Transplant, Intestinal|Feces Infusions, Donor|Fecal Transplantations|Intestinal Microbiome Transplants|Microbiome Transfer, Intestinal|intestinal microbiome|Transplantations, Intestinal Microbiome|Fecal Transplantation|Microbiome Transplant, Intestinal|Transplant, Fecal Microbiota|Microbiota Transplantations, Intestinal|Fecal Microbiota Transfers|Transplantations, Fecal|Fecal Microbiome Transplantation|Infusions, Donor Feces|Transplant, Fecal|Infusion, Donor Feces|Transplantation, Fecal Microbiome|Microbiota Transplants, Intestinal|Fecal Microbiota Transplants|Microbiome Transplantations, Fecal|Transplantation, Intestinal Microbiome|Microbiome Transplants, Intestinal|Microbiota Transplantations, Fecal|Transplant, Intestinal Microbiome|Intestinal Microbiota Transplantation|Fecal Transplant|Microbiota Transfers, Intestinal|Transfer, Intestinal Microbiota|Transfer, Fecal Microbiota|Transplants, Intestinal Microbiome|Transplantations, Intestinal Microbiota|Microbiota Transplants, Fecal|Microbiome Transfers, Intestinal|Transplantations, Fecal Microbiome|Microbiome Transplantation, Intestinal|Intestinal Microbiome Transfer|Intestinal Microbiota Transplantations|Microbiota Transplantation, Intestinal"
NEW10118,NUTRITION,short fatty acid,short fatty acids
NEW10119,DISEASE,human liver microsome,human liver microsomes
C094644,CHEMICAL,L 754394 [Supplementary Concept],"Indans|Piperazines|L-754,394"
NEW10120,MENTAL_HEALTH,potent suicide inhibitor,potent suicide inhibitor
D031786,NUTRITION,Saccharum,Sugarcanes|Saccharum officinarum|sugarcane|Saccharum spontaneum|Sugarcane|Saccharum officinarum L.
NEW10121,MENTAL_HEALTH,external resistance,external resistance
http://purl.obolibrary.org/obo/SO_0000704,CHEMICAL,gene,gdhR gene|gdhR6|clavesin gene|7OMT gene|chrna7 gene|CEMB-GTGene genes|mGluR3 gene|ARHGAP26 gene|PANK2 gene
NEW10122,MENTAL_HEALTH,efficient resistance,efficient resistance
D001656,DISEASE,Biliary Atresia,"Intrahepatic Biliary Atresia|Biliary Atresia, Extrahepatic|Biliary Atresia, Intrahepatic|Atresia, Biliary|Atresia, Extrahepatic Biliary|Idiopathic Extrahepatic Biliary Atresia|biliary atresia|Familial Extrahepatic Biliary Atresia|Atresia, Intrahepatic Biliary|Extrahepatic Biliary Atresia"
D007154,DISEASE,Immune System Diseases,"Immunological Disease|Immunologic Diseases|Disease, Immunological|Immunologic Disease|Diseases of Immune System|Disease, Immunologic|Immune Disorder|Immunological Diseases|Immune System Disorders|Immune System Disease|Immune System Disorder|Immune Disorders|Immune Diseases|immune disorder|Disorder, Immune System|Disease, Immune System|Immune Disease|Disease, Immune"
NEW10123,DISEASE,heightened distress,heightened distress
NEW10124,CHEMICAL,altered calcium release,altered calcium release
NEW10125,DISEASE,adult type diabete,adult type diabetes
NEW10126,MENTAL_HEALTH,ntf dissociation,NTF dissociation
NEW10127,CHEMICAL,7tm n-terminal stalk,7TM N-terminal stalk
NEW10128,NUTRITION,alpha power,alpha power
NEW10129,CHEMICAL,cpt-3 task,CPT-3 tasks
D053501,CHEMICAL,Arsenite Transporting ATPases,"Arsenite-Transporting ATPase|ATPases, Arsenite Transporting|ATPase, Arsenite-Translocating|Arsenite Transporting ATPase|ATPase, Arsenite-Transporting|Arsenite-Translocating ATPase|Arsenite|Arsenite Translocating ATPase|Transporting ATPases, Arsenite"
NEW10130,CHEMICAL,periconceptional folic acid,periconceptional folic acid
NEW10131,DISEASE,congenital cardiovascular malformation,congenital cardiovascular malformations
NEW10132,DISEASE,congenital limb deficiency,congenital limb deficiencies
NEW10133,DISEASE,tract 's defect,tract's defects
http://purl.obolibrary.org/obo/CHEBI_176839,CHEBI,vitamin b3,vitamin B-3|vitamins B3|vitamin B3 vitamers|vitamin B3|vitamin B3 vitamer|vitamin B11
D017823,DISEASE,Furcation Defects,"defects|Furcation Defect|Defects, Furcation|Defect, Furcation"
D000013,DISEASE,Congenital Abnormalities,"Deformities|Birth Defect|Defect, Congenital|Abnormality, Congenital|Malformation, Fetal|Congenital Abnormality|Fetal Anomaly|Fetal Malformations|Congenital Defect|Abnormalities, Congenital|Fetal Anomalies|congenital abnormalities|Anomaly, Fetal|Fetal Malformation|Congenital Defects|Defect, Birth|Deformity|Birth Defects|Defects, Congenital"
NEW10134,CHEBI,water-soluble vitamin b,water-soluble vitamins B
NEW10135,DISEASE,hyperhomocysteinemia-related disorder,hyperhomocysteinemia-related disorders
NEW10136,DISEASE,bipolar family,bipolar family
NEW10137,DISEASE,suppose unipolar illness,supposed unipolar illness
NEW10138,DISEASE,manic mood swing,manic mood swings
C553458,CHEMICAL,apatinib [Supplementary Concept],apatinib|Pyridines
NEW10139,MENTAL_HEALTH,multidrug resistance reversal,multidrug resistance reversal
NEW10140,DISEASE,tumor regression,tumor regression
NEW10141,MENTAL_HEALTH,severe respiratory depression,severe respiratory depression
NEW10142,DISEASE,epileptic manifestation,epileptic manifestation
http://purl.obolibrary.org/obo/CHEBI_22586,CHEMICAL,antioxidant,antoxidant|nonsedating antioxidant|antioxidants|antioxydant
NEW10143,CHEMICAL,t. goniospermum extract,T. goniospermum extracts
NEW10144,NUTRITION,clinical yeast,clinical yeast
D019688,DISEASE,Gram-Negative Oxygenic Photosynthetic Bacteria,Gram Negative Oxygenic Photosynthetic Bacteria|Gram+
NEW10145,DISEASE,numerous brain abnormality,numerous brain abnormalities
NEW10146,CHEMICAL,amyloid pathway,amyloid pathways
NEW10147,DISEASE,acquire molybdenum deficiency,acquired molybdenum deficiency
NEW10148,CHEMICAL,low inorganic sulfate level,low inorganic sulfate levels
NEW10149,CHEMICAL,acetate complex,acetate complex
NEW10150,CHEMICAL,polyamine coproduct,polyamine coproduct
NEW10151,CHEMICAL,monomeric Al material,monomeric Al materials
NEW10152,DISEASE,gastrointestinal bioavailability,gastrointestinal bioavailability
NEW10153,CHEMICAL,oral Al hydroxide,Oral Al hydroxide
http://purl.obolibrary.org/obo/CHEBI_37853,CHEMICAL,phosphate salt,phosphate salt|Phosphatsalz|phosphate salts|Phosphatsalze
NEW10154,CHEMICAL,chronic al toxicity,chronic Al toxicity
NEW10155,CHEBI,vitamin d-resistant osteomalacia,vitamin D-resistant osteomalacia
D009141,DISEASE,Musculoskeletal System,"Musculoskeletal Systems|musculoskeletal system|System, Musculoskeletal|Systems, Musculoskeletal"
NEW10156,CHEMICAL,chronic Al toxicity,Chronic Al toxicity
NEW10157,CHEMICAL,al toxicity,Al toxicity
NEW10158,CHEMICAL,al accumulation,Al accumulation
C021080,CHEMICAL,pyrogastrone [Supplementary Concept],Carbenoxolone|Silicates|Bicarbonates|Al(OH)(3|Aluminum Hydroxide|Drug Combinations|Alginates
NEW10159,CHEMICAL,bone Al,bone Al
NEW10160,CHEMICAL,mg/kg-day Al,mg/kg-day Al
NEW10161,DISEASE,current cancer therapy,Current cancer therapy
NEW10162,CHEMICAL,site-selective camp analog,site-selective cAMP analogs
C526732,CHEMICAL,SALLRSIPA [Supplementary Concept],Nerve Tissue Proteins|SAL|Peptide Fragments|SALLRSIPA
NEW10163,DISEASE,ventricular enlargement,ventricular enlargement
http://purl.obolibrary.org/obo/DOID_0050453,DISEASE,lissencephaly,microencephaly
NEW10164,CHEBI,second compound,second compound|antagonist
http://purl.obolibrary.org/obo/NCBITaxon_7509,CHEMICAL,siphonaptera,KOH
NEW10165,MENTAL_HEALTH,agitation time,agitation time
NEW10166,CHEMICAL,airway-centric pattern,Airway-centric pattern
D018804,DISEASE,Hantavirus Pulmonary Syndrome,Hantavirus pulmonary syndrome|Hantavirus Pulmonary Syndromes|Hantavirus Associated Respiratory Distress Syndrome|HARDS|Hantavirus-Associated Respiratory Distress Syndrome
NEW10167,DISEASE,rare acquire infection,rare acquired infection
NEW10168,DISEASE,pediatric stroke case,pediatric stroke cases
NEW10169,DISEASE,focal cerebral arteriopathy,focal cerebral arteriopathy
NEW10170,DISEASE,cardioembolic mechanism,cardioembolic mechanism
D016908,DISEASE,Gram-Positive Bacterial Infections,"Gram-Positive Bacterial Infection|Bacterial Infections, Gram Positive|Infection, Gram-Positive Bacterial|Infections, Gram Positive Bacterial|Bacterial Infections, Gram-Positive|Staphylococcus aureus|Infections, Gram-Positive Bacterial|Gram-positive|Bacterial Infection, Gram-Positive|Gram Positive Bacterial Infections|bacterial infection"
NEW10171,CHEMICAL,covid-19 patient,Covid-19 patients
NEW10172,DISEASE,underreported cerebrovascular injury mechanism,underreported cerebrovascular injury mechanism
NEW10173,CHEBI,drug regiman,drug regimen
NEW10174,CHEBI,antimicrobial impact,antimicrobial impact
NEW10175,CHEMICAL,initial regimen isoniazid,initial regimen isoniazid
NEW10176,DISEASE,physiological impairment,physiological impairment
NEW10177,CHEBI,common environmental xenoestrogen,common environmental xenoestrogen
NEW10178,MENTAL_HEALTH,orientation selectivity,orientation selectivity
NEW10179,CHEMICAL,intravenous bpa administration,intravenous BPA administration
NEW10180,CHEMICAL,acute bpa exposure,acute BPA exposure
NEW10181,MENTAL_HEALTH,lgn projection,LGN projection
D017436,DISEASE,Kallmann Syndrome,"Hypogonadotropic Hypogonadism and Anosmia|Kallmanns Syndrome|Kallmann's Syndrome|Syndrome, Kallmann's|Syndrome, Kallmann|Hypogonadotropic Hypogonadism-Anosmia Syndrome|Anosmic Hypogonadism|Anosmic Hypogonadisms|Autosomal Dominant Form of Kallmann Syndrome|Dysplasia Olfactogenitalis of De Morsier|Kallmann Syndrome, Type 1, X-linked|Kallmann Syndrome 1|Hypogonadisms, Anosmic|Hypogonadotropic Hypogonadism, Anosmia, and Midline Cranial Anomalies (Cleft Lip, Cleft Palate and Imperfect Fusion)|Autosomal Recessive Form of Kallmann Syndrome|Hypogonadism, Anosmic|Kallmann Syndrome, Type 3, Recessive|Anosmic Idiopathic Hypogonadotropic Hypogonadism|Kallmann Syndrome 3|hypogonadotropic hypogonadism|Kallmann Syndrome 2"
C562492,DISEASE,Robinow Syndrome [Supplementary Concept],"Limb Deformities, Congenital|Urogenital Abnormalities|Dwarfism|Craniofacial Abnormalities|genital abnormalities"
NEW10182,DISEASE,precocious pubertal development,precocious pubertal development
NEW10183,CHEMICAL,gonadotropin-releasing hormone analog,gonadotropin-releasing hormone analog|GnRHa
C011896,CHEMICAL,lephetamine [Supplementary Concept],Phenethylamines|lefetamine
C585977,CHEMICAL,AZD6765 [Supplementary Concept],Phenethylamines|lanicemine|Pyridines
C067553,CHEMICAL,remacemide [Supplementary Concept],Acetamides|remacemide
NEW10184,CHEMICAL,dissociative agent diphenidine,dissociative agents diphenidine|DPH
NEW10185,DISEASE,testosterone deficiency,testosterone deficiency
D002064,CHEMICAL,Buserelin,"Profact|Suprefact|Buserelin|Bigonist|HOE-766|Acetate, Buserelin|HOE766|HOE 766|Tiloryth|Suprecur|Buserelin Acetate|Receptal"
C009093,CHEMICAL,protopine [Supplementary Concept],protopine|Benzophenanthridines|Berberine Alkaloids
NEW10186,CHEMICAL,sc mg.kg-1,sc mg.kg-1
NEW10187,CHEMICAL,mg.kg-1,mg.kg-1
D020555,MENTAL_HEALTH,GTP-Binding Protein Regulators,"GTP Binding Protein Regulators|Regulating Factors, G-Protein|Regulators, G-Protein Signaling|Regulating Factors, GTP-Binding Protein|Regulating Factors, GTP Binding Protein|Regulators, G Protein Signaling|analgesia|G-Protein Signaling Regulators|G Protein Signaling Regulators|G-Protein Regulating Factors|G Protein Regulating Factors|G-protein signaling|Signaling Regulators, G-Protein|Regulators, GTP-Binding Protein"
NEW10188,CHEMICAL,methotrexate mg.kg-1,methotrexate mg.kg-1
NEW10189,CHEMICAL,reserpine mg.kg-1,reserpine mg.kg-1
NEW10190,MENTAL_HEALTH,pro analgesia,Pro analgesia
NEW10191,DISEASE,clinical pain situation,clinical pain situation
NEW10192,MENTAL_HEALTH,dose-related analgesia,dose-related analgesia
NEW10193,DISEASE,epileptic seizure discharge,Epileptic seizure discharges
NEW10194,CHEMICAL,pyridaoxine,pyridaoxine
NEW10195,CHEMICAL,syringyl unit,syringyl units
http://purl.obolibrary.org/obo/MFOMD_0000167,MENTAL_HEALTH,defense mechanism,defense mechanism|host defense mechanism
NEW10196,CHEBI,interferon-based virus antiviral therapy,interferon-based virus antiviral therapy
NEW10197,DISEASE,hepatitis c. common side effect,hepatitis C. common side effect
http://purl.obolibrary.org/obo/DOID_9970,DISEASE,obesity,(HED)-induced obesity|high-fat-diet-induced obesity|HFD-induced obesity
NEW10198,MENTAL_HEALTH,leptin resistance,leptin resistance
NEW10199,CHEMICAL,neuroactive progesterone metabolite allopregnanolone effect,neuroactive progesterone metabolite allopregnanolone effect
NEW10200,CHEMICAL,serotonergic agent,fluoxetine|serotonergic agent
NEW10201,CHEMICAL,effective antidepressant,effective antidepressant
NEW10202,CHEMICAL,serotonin 1a receptor,serotonin 1A receptors
NEW10203,MENTAL_HEALTH,fluoxetine-induced sexual dysfunction,fluoxetine-induced sexual dysfunction
NEW10204,DISEASE,lordosis behavior,lordosis behavior
NEW10205,CHEBI,combined histamine antagonist activity,combined histamine antagonist activities
NEW10206,CHEMICAL,nitroethenediamine series,nitroethenediamine series
NEW10207,CHEMICAL,glutamic acid decarboxylase gad65 autoantibody,glutamic acid decarboxylase GAD65 autoantibodies
NEW10208,DISEASE,akinetic catatonia,akinetic catatonia
D058975,NUTRITION,Folate Receptor 1,"Ovarian Tumor-Associated Antigen MOv18|Ovarian Tumor Associated Antigen MOv18|folate receptor alpha|Receptor alpha, Folate|Receptor 1, Folate|Folate Receptor alpha"
D012560,MENTAL_HEALTH,"Schizophrenia, Catatonic","Schizophrenias, Catatonic|Catatonic Schizophrenias|Catatonic Schizophrenia|catatonic schizophrenia"
NEW10209,MENTAL_HEALTH,acoustic hallucination,Acoustic hallucinations
http://purl.obolibrary.org/obo/CHEBI_9598,CHEBI,tiludronic acid,folinic acid supplementation folinic acid|Tiludronic acid|Tiludronate|tiludronate disodium|folinic acid administration|folinic acid treatment
NEW10210,CHEBI,low serum folate level,low serum folate levels
NEW10211,CHEMICAL,different alkali metal,different alkali metals
NEW10212,MENTAL_HEALTH,fragmentation pathway,fragmentation pathways
D002588,CHEMICAL,Cesium Radioisotopes,"Cs+|Radioisotopes, Cesium|cesium"
NEW10213,MENTAL_HEALTH,hock fragmentation,Hock fragmentation
D049994,CHEMICAL,Sodium Potassium Chloride Symporter Inhibitors,"Na K CL Symporter Inhibitors|potassium chloride|Loop Diuretics|Symporter Inhibitors, Na-K-CL|Diuretics, Loop|Inhibitors, Na-K-CL Symporter|Na+ K+|Na-K-CL Symporter Inhibitors|Diuretic, Loop|High Ceiling Diuretics|Loop Diuretic|Bumetanide Sensitive Na K Cl Transporter Inhibitors|Ceiling Diuretics, High|Bumetanide Sensitive Na-K-Cl-Transporter Inhibitors|Diuretics, High Ceiling|Sodium Potassium Chloride Cotransporter Inhibitors"
D012414,CHEMICAL,Rubidium Radioisotopes,"Rb1|Radioisotopes, Rubidium|Rb+|rubidium"
http://purl.obolibrary.org/obo/CHEBI_73730,CHEBI,pparbeta/delta agonist,"PPAR-beta/delta agonists|PPARD receptor agonist|PPAR(beta/delta) agonist|PPARbeta/delta agonist|nuclear receptor subfamily 1, group C, member 2 agonists|PPARdelta agonists|PPARD agonists|PPARdelta agonist|NR1C2 agonists|PPARbeta agonists|PPAR-delta agonists|PPAR(beta/delta) agonists|5-HT1A agonists|PPAR-delta agonist|PPARD receptor agonists|PPAR-beta/delta agonist|PPARbeta agonist|PPARD agonist|peroxisome proliferator-activated receptor-delta agonist|peroxisome proliferator-activated receptor-delta agonists|PPAR-beta agonist|peroxisome proliferator-activated receptor-beta agonist|peroxisome proliferator-activated receptor-beta agonists|PPAR-beta agonists|NR1C2 agonist|PPARbeta/delta agonists|nuclear receptor subfamily 1, group C, member 2 agonist"
NEW10214,CHEMICAL,noradrenergic re-uptake inhibitor methylphenidate,noradrenergic re-uptake inhibitor methylphenidate
NEW10215,DISEASE,advanced pd subject,advanced PD subjects
NEW10216,CHEBI,muscarinic m4 cholinergic antagonist,muscarinic M4 cholinergic antagonists
NEW10217,CHEBI,to muscarinic m4 cholinergic antagonist,anticholinergics|to muscarinic M4 cholinergic antagonists
D000088282,CHEMICAL,Corticobasal Degeneration,Cortico-basal Degeneration|Corticobasal Syndrome|corticobasal degeneration|CBD|Cortico basal Degeneration|Cortico-basal Ganglionic Degeneration|Cortico basal Ganglionic Degeneration
NEW10218,CHEMICAL,cannabis consumption,Cannabis consumption
NEW10219,DISEASE,wild-type p. furiosus,wild-type P. furiosus
NEW10220,CHEMICAL,3hp titer,3HP titers
NEW10221,CHEMICAL,high co2 sparging rate,higher CO2 sparging rates
NEW10222,MENTAL_HEALTH,increase agitation,increased agitation
NEW10223,CHEMICAL,copro-porphyrin,copro-porphyrins
D028441,CHEMICAL,F2-Isoprostanes,F2-isoprostanes|F2 Isoprostane|F2 Isoprostanes|F2-Isoprostane|isoprostanes
NEW10224,CHEMICAL,transfer-purge chamber,transfer-purge chamber
NEW10225,CHEMICAL,count k cells/µL,count K cells/µL
NEW10226,DISEASE,cytopenia hemoglobin,cytopenia hemoglobin
NEW10227,CHEMICAL,copper nanoparticle,copper nanoparticles
D005781,CHEBI,"Gelatin Sponge, Absorbable","Gelfoam|Absorbable Gelatin Sponge|Sponges, Absorbable Gelatin|Absorbable Gelatin Sponges|Gelaspon|Gelatin Sponges, Absorbable|gelatin|Sponge, Absorbable Gelatin"
NEW10228,CHEMICAL,copper nanoparticle,copper nanoparticles|Cu-NPs
NEW10229,DISEASE,gram-positive bacillus subtilis,Gram-positive Bacillus subtilis
NEW10230,CHEBI,lipophilic beta-blocker propranolol,lipophilic beta-blocker propranolol
NEW10231,DISEASE,p. kudriavzevii,P. kudriavzevii
NEW10232,CHEMICAL,ca ascorbate,Ca ascorbate
NEW10233,CHEMICAL,cacl2,CaCl2
NEW10234,DISEASE,severe adrenal insufficiency,severe adrenal insufficiency
NEW10235,CHEMICAL,b (-)deprenyl,b (-)Deprenyl
NEW10236,CHEBI,act sympathomimetic,acting sympathomimetics
NEW10237,DISEASE,convulsive activity,convulsive activity
NEW10238,DISEASE,neuromuscular disorder,neuromuscular disorders
D006945,DISEASE,Hyperhidrosis,|hyperhidrosis|Hyperidrosis
http://purl.obolibrary.org/obo/SYMP_0000369,DISEASE,ptosis,droopiness|hyperlacrimation
NEW10239,DISEASE,excessive drooling,excessive drooling
NEW10240,DISEASE,nasal hypersecretion,nasal hypersecretion
NEW10241,CHEMICAL,btx treatment,BTX treatment
NEW10242,MENTAL_HEALTH,refractory tension headache,refractory tension headache
NEW10243,CHEBI,mr antagonist treatment,MR antagonist treatment
NEW10244,DISEASE,significant rv dysfunction,significant RV dysfunction
NEW10245,CHEMICAL,suhx pah model,SuHx PAH model
NEW10246,DISEASE,interventricular dependence,interventricular dependence
NEW10247,CHEBI,androgen receptor ar antagonist,Androgen receptor AR antagonists
NEW10248,CHEMICAL,ethanol extract,Ethanol extracts
NEW10249,DISEASE,% less polymicrobial biofilm formation,% less polymicrobial biofilm formation
NEW10250,CHEMICAL,prinoide ethanol extract,prinoides ethanol extracts
NEW10251,DISEASE,dual-specie biofilm formation,dual-species biofilm formation
NEW10252,CHEMICAL,long chain omega-3 polyunsaturated fatty acid,long chain omega-3 polyunsaturated fatty acids|LC omega-3 PUFA
D047928,DISEASE,Premature Birth,"preterm birth|premature births|Preterm Births|Premature Births|Birth, Preterm|PTB|Birth, Premature|Births, Preterm|Preterm Birth|Births, Premature"
NEW10253,CHEMICAL,low omega-3 intake,low Omega-3 intake
NEW10254,DISEASE,high mdd,higher MDD
NEW10255,DISEASE,mdd rate,MDD rates
NEW10256,CHEMICAL,cellular nad+ level,cellular NAD+ levels
NEW10257,DISEASE,aging disease,aging diseases
NEW10258,CHEMICAL,orally-administered antipsychotic,Orally-administered antipsychotics
NEW10259,CHEMICAL,administer 3h-morphine,administered 3H-morphine
NEW10260,CHEMICAL,silver grain localization,silver grain localization
NEW10261,MENTAL_HEALTH,significant dependent analgesia,significant dependent analgesia
NEW10262,CHEMICAL,spinal cord grain density,spinal cord grain density
NEW10263,CHEBI,impaired circulate estrogen level,Impaired circulating estrogen levels
NEW10264,CHEBI,folate supplementation,folate supplementation
NEW10265,CHEBI,folate supplement,folate supplement
NEW10266,DISEASE,amenable,psychiatric disorders|amenable
C005984,CHEMICAL,5-methyltetrahydrofolate [Supplementary Concept],Tetrahydrofolates|l-methylfolate
NEW10267,DISEASE,mthfr c677 t mutation,MTHFR C677 T mutation
NEW10268,DISEASE,complex psychiatric phenomenon,complex psychiatric phenomenon
NEW10269,CHEMICAL,vka therapy,VKA therapy
http://purl.obolibrary.org/obo/MFOMD_0000212,MENTAL_HEALTH,derailment,derailment
D019565,CHEMICAL,"Metals, Light",metals|Light Metals
NEW10270,DISEASE,organelle degeneration,organelle degeneration
C099831,CHEMICAL,tetracosahexaenoic acid [Supplementary Concept],Tetracosahexaenoic acid|Docosahexaenoic Acids
NEW10271,CHEMICAL,tha 24:6n-3,THA 24:6n-3
http://purl.obolibrary.org/obo/PR_Q9V4P1,DISEASE,anillin (fruit fly),protein scraps (fruit fly)|scra|abp8 (fruit fly)|fly-scra|SCRA|actin-binding protein 8 (fruit fly)|cg2092|ani
C000620621,CHEMICAL,1-pentyfluoro-1H-indole-3-carboxylic acid 8-quinolinyl ester [Supplementary Concept],Indoles|5F-PB-22|Quinolines
C000625623,CHEMICAL,1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide [Supplementary Concept],Cumyl-4CN-BINACA|Indazoles
NEW10272,CHEMICAL,adh aldh alcohol metabolizing gene,ADH ALDH alcohol metabolizing genes
NEW10273,DISEASE,ald role,ALD role
NEW10274,DISEASE,dyspeptic patient,dyspeptic patients
C090840,CHEMICAL,alosetron [Supplementary Concept],Alosetron|Carbolines
NEW10275,CHEMICAL,low-level pfoa,low-level PFOA
D063185,MENTAL_HEALTH,Epigenetic Repression,"repression|Repression, Epigenetic|Repression"
C553090,CHEMICAL,Vitex agnus castus extract [Supplementary Concept],"Drugs, Chinese Herbal|Agnus Castus Fruit|Vitex"
NEW10276,DISEASE,v. agnus-castus L.,V. agnus-castus L.
NEW10277,CHEMICAL,food-grade titanium dioxide,Food-grade titanium dioxide
NEW10278,MENTAL_HEALTH,pro-oxidant non-no-dependent cell defense mechanism,pro-oxidant non-NO-dependent cell defense mechanism
D000068258,CHEMICAL,Bevacizumab,Bevacizumab-awwb|Bevacizumab|Bevacizumab awwb|Avastin|Mvasi|bevacizumab
http://purl.obolibrary.org/obo/DOID_5585,DISEASE,ferguson-smith tumor,RAS-WT tumors|Multiple self-healing epithelioma of Ferguson-Smith|NNK-induced tumors|sex-steroid-related tumors
http://purl.obolibrary.org/obo/DOID_3498,DISEASE,pancreatic ductal adenocarcinoma,ductal adenocarcinoma of the pancreas|metastatic pancreatic ductal adenocarcinoma
NEW10279,CHEMICAL,gemcitabine-based chemotherapy,gemcitabine-based chemotherapy
D000068437,CHEMICAL,Pemetrexed,"231514, LY|N-(4-(2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid|LY 231,514|pemetrexed|231,514, LY|LY-231514|LY 231514|Pemetrexed|LY231514|Alimta|Disodium, Pemetrexed|MTA|Pemetrexed Disodium|LY-231,514"
NEW10280,CHEBI,cytostatic antifolate drug,cytostatic antifolate drug
NEW10281,CHEMICAL,pemetrexed pharmacokinetic,pemetrexed pharmacokinetics
NEW10282,CHEBI,high-dose folinic acid,high-dose folinic acid
NEW10283,DISEASE,pemetrexed-induced toxicity,pemetrexed-induced toxicity
D013092,DISEASE,Spermatogenesis-Blocking Agents,"Agents, Spermatogenesis-Blocking|Spermatogenesis Blocking Agents|Agents, Spermatogenesis Blocking|spermatogenesis"
NEW10284,DISEASE,fear-like behavior,fear-like behavior
NEW10285,CHEMICAL,traditional herbal medicine yokukansan,traditional herbal medicines yokukansan|YKS
D014277,DISEASE,Trigeminal Neuralgia,"Trifacial Neuralgias|Tic Doloureux|Trifacial Neuralgia|Neuralgia, Secondary Trigeminal|Epileptiform Neuralgia|Idiopathic Trigeminal Neuralgias|Trigeminal Neuralgias|trigeminal neuralgia|Trigeminal Neuralgia, Idiopathic|Epileptiform Neuralgias|Tic Douloureux|Neuralgia, Trifacial|Secondary Trigeminal Neuralgia|Idiopathic Trigeminal Neuralgia|Fothergill Disease|Neuralgia, Trigeminal|Neuralgia, Epileptiform|Disease, Fothergill|Trigeminal Neuralgia, Secondary|Secondary Trigeminal Neuralgias|Neuralgia, Idiopathic Trigeminal"
NEW10286,MENTAL_HEALTH,perioral dyskinesia,perioral dyskinesia
NEW10287,CHEMICAL,38393 0.1,38393 0.1
NEW10288,CHEBI,subsequent toxin production,subsequent toxin production
NEW10289,CHEMICAL,tianeptine treatment,tianeptine treatment
NEW10290,CHEMICAL,dopamine d₃-preferring d₃/d₂ receptor partial agonist,dopamine D₃-preferring D₃/D₂ receptor partial agonist
NEW10291,CHEBI,serotonin 5-ht1a receptor partial agonist,serotonin 5-HT1A receptor partial agonist
NEW10292,DISEASE,matter lesion,matter lesions
NEW10293,CHEMICAL,alcohol exposure,alcohol exposure
D054890,CHEMICAL,"Fatty Acid Synthase, Type I","Fatty Acid Synthase, Animal Form|fatty acid synthase|Fatty Acid Synthase, Mammalian|FAS"
D020920,MENTAL_HEALTH,Dyssomnias,"|Limit-Setting Sleep Disorders|Sleep Disorders, Extrinsic|Nocturnal Eating-Drinking Syndromes|sleep disturbance|Sleep Disorder, Extrinsic|Syndromes, Nocturnal Eating-Drinking|Eating-Drinking Syndromes, Nocturnal|Adjustment Sleep Disorder|Sleep Disorder, Limit Setting|Nocturnal Eating Drinking Syndrome|Adjustment Sleep Disorders|Sleep Disorder, Adjustment|Limit Setting Sleep Disorder|Sleep Disorders, Adjustment|Sleep Disorder, Environmental|Dyssomnia|Limit-Setting Sleep Disorder|Eating-Drinking Syndrome, Nocturnal|Sleep Disorder, Limit-Setting|Environmental Sleep Disorder|Environmental Sleep Disorders|Extrinsic Sleep Disorders|Nocturnal Eating-Drinking Syndrome|Syndrome, Nocturnal Eating-Drinking|Extrinsic Sleep Disorder|Sleep Disorders, Limit-Setting|Sleep Disorders, Environmental|sleep disorder"
NEW10294,MENTAL_HEALTH,dissociation constant kd,dissociation constant KD
NEW10295,CHEMICAL,antibody-antigen,antibody-antigen
NEW10296,CHEMICAL,anti-aβ40,anti-aβ40
D013539,CHEMICAL,Simian virus 40,SV 40 Viruses|40|Polyomavirus macacae|SV40 Viruses|SV 40 Virus|Vacuolating Agents|Vacuolating Agent|SV40 Virus|aβ40
http://purl.obolibrary.org/obo/DOID_9408,DISEASE,acute myocardial infarction,AMI|acute myocardial infarction
D000069347,CHEMICAL,Erlotinib Hydrochloride,"Tarceva|11C-erlotinib|CP358,774|Erlotinib|OSI774|erlotinib|358774, CP|CP358774|OSI 774|OSI-774|CP-358774|CP-358,774|HCl, Erlotinib|Hydrochloride, Erlotinib|358,774, CP|N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine|11C erlotinib|CP 358,774|CP 358774|Erlotinib HCl"
D005499,DISEASE,Folliculitis,Folliculitides|Sycoses|Sycosis|folliculitis
D003236,DISEASE,"Conjunctivitis, Viral","conjunctivitis|Viral Conjunctivitis|Viral Conjunctivitides|Conjunctivitides, Viral"
D007766,DISEASE,Lacrimal Apparatus Diseases,"Apparatus Diseases, Lacrimal|Lacrimal Apparatus Disease|Disease, Lacrimal Apparatus|epiphora|Apparatus Disease, Lacrimal|Diseases, Lacrimal Apparatus|Epiphora|Epiphoras"
NEW10297,DISEASE,inferior ventricular nerve,inferior ventricular nerve
NEW10298,CHEMICAL,thuja occidentalis l.,Thuja occidentalis L.
D029780,DISEASE,Chamaecyparis,"lawsonianas, Chamaecyparis|Cedar, Atlantic White|White Cedar, Atlantic|Cypress, Lawsons False|Yellow Cypresses|Cedar, Yellow|Lawsons False Cypress|white cedar|Yellow Cedar|Chamaecyparis nootkatenses|Chamaecyparis thyoides|Cedars, Yellow|Cedars, Atlantic White|Cypress, Hinoki|Yellow Cypress|thyoides, Chamaecyparis|False Cypress, Lawson's|Cypress, Lawson False|obtusas, Chamaecyparis|Chamaecypari|Cypress, Yellow|White Cedars, Atlantic|Cypress, Lawson's False|nootkatenses, Chamaecyparis|Chamaecyparis obtusas|Chamaecyparis lawsoniana|Atlantic White Cedars|Chamaecyparis lawsonianas|Chamaecyparis thyoide|Lawson's False Cypress|Lawson False Cypress|Hinoki Cypress|Cypresses, Yellow|Chamaecyparis nootkatensis|Lawson's False Cypresses|Yellow Cedars|Cypresses, Lawson's False|False Cypresses, Lawson's|Chamaecyparis obtusa|Atlantic White Cedar"
NEW10299,NUTRITION,ornamental tree,ornamental tree
http://purl.obolibrary.org/obo/CHEBI_9512,CHEMICAL,thalidasine,Xanthoceras sorbifolia Bunge|Salvia miltiorrhiza Bunge|Thalidasine
NEW10300,NUTRITION,edible tree specie peculiar,edible tree species peculiar
NEW10301,CHEBI,low csf amyloid beta,low CSF amyloid beta
NEW10302,DISEASE,pd long-term cognitive decline,PD long-term cognitive decline
NEW10303,MENTAL_HEALTH,juvenile paraphilia,juvenile paraphilias
D005084,MENTAL_HEALTH,Exhibitionism,exhibitionism|Exhibitionism|Exhibitionisms
C478603,CHEMICAL,N-palmitoylethanolamine-selective acid amidase [Supplementary Concept],Amidohydrolases|PEA|N-palmitoylethanolamine
NEW10304,DISEASE,obesity-related neuropsychiatric comorbiditie,obesity-related neuropsychiatric comorbidities
NEW10305,CHEBI,adjunct drug,adjunct drug
NEW10306,DISEASE,behavioral deficit,behavioral deficit
NEW10307,CHEMICAL,d1 dopamine receptor expression,D1 dopamine receptor expression
NEW10308,CHEMICAL,skin methylnicotinate stimulation,Skin methylnicotinate stimulation
NEW10309,CHEMICAL,omega-3 pufa,omega-3 PUFA
NEW10310,CHEMICAL,decrease pufa level,Decreased PUFA levels
NEW10311,CHEBI,niacin skin,niacin skin
NEW10312,MENTAL_HEALTH,depression severity,depression severity
NEW10313,CHEMICAL,n-3 pufa level,n-3 PUFA levels
NEW10314,CHEMICAL,low dha level,lower DHA levels
NEW10315,CHEMICAL,low dha level,low DHA levels
NEW10316,DISEASE,acs patient,ACS patients
NEW10317,MENTAL_HEALTH,depression variable,depression variables
NEW10318,CHEBI,selective serotonin reuptake inhibitor class,selective serotonin reuptake inhibitor class
NEW10319,MENTAL_HEALTH,Epizelus 's psychogenic mutism,Epizelus's psychogenic mutism
NEW10320,CHEBI,carrier Epizelus 's,carrier Epizelus's
NEW10321,DISEASE,myxedema coma,Myxedema coma
NEW10322,CHEBI,life-threatening endocrine emergency,life-threatening endocrine emergency
NEW10323,CHEMICAL,intravenous levothyroxine replacement,Intravenous levothyroxine replacement
NEW10324,MENTAL_HEALTH,serious mood disorder,serious mood disorder
NEW10325,DISEASE,nephrotoxic effect,nephrotoxic effect
NEW10326,CHEMICAL,oxalate deposition,oxalate deposition
NEW10327,DISEASE,uraemic encephalopathy secondary,uraemic encephalopathy secondary
NEW10328,CHEMICAL,caramboxin,caramboxin
NEW10329,CHEBI,folate receptor fr1,folate receptor FR1
NEW10330,DISEASE,primary cerebral folate deficiency,primary cerebral folate deficiency
NEW10331,CHEBI,to topical tocopherol,to topical tocopherol|vitamin E
NEW10332,CHEBI,q10 ubiquinol vitamin,Q10 ubiquinol vitamins
D029181,DISEASE,Spirituality,Spiritualities|spirituality
NEW10333,DISEASE,severe self-injury,severe self-injury
NEW10334,CHEMICAL,methadone treatment,methadone treatment
NEW10335,CHEMICAL,dexmedetomidine infusion,dexmedetomidine infusions
NEW10336,CHEMICAL,slow dissociation kinetic,slow dissociation kinetics|buprenorphine
NEW10337,DISEASE,malformation risk,malformation risk
http://purl.obolibrary.org/obo/CHEBI_35475,CHEBI,non-steroidal anti-inflammatory drug,NSAIDs|NSAID|non-steroid anti-inflammatory drug|non-steroidal anti-inflammatory agent|non-steroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drug ketoprofen
C028938,CHEMICAL,methyl acetylsalicylic acid [Supplementary Concept],acetylsalicylic acid|Aspirin/analogs  and  derivatives
D004374,DISEASE,"Ductus Arteriosus, Patent",ductus arteriosus|Patent Ductus Arteriosus Familial|Patency of the Ductus Arteriosus|Patent Ductus Arteriosus
http://purl.obolibrary.org/obo/GENO_0000149,DISEASE,x-linked recessive inheritance,X-linked recessive inheritance|X-linked semidominant inheritance|recessive X-linked
NEW10338,CHEBI,numerous virulence factor,numerous virulence factors
NEW10339,MENTAL_HEALTH,biofilm-mediated multidrug resistance,biofilm-mediated multidrug resistance
NEW10340,CHEBI,novel putative virulence factor,novel putative virulence factor
NEW10341,NUTRITION,phospholipid degrade enzyme,phospholipid degrading enzymes
NEW10342,DISEASE,p. aeruginosa biofilm,P. aeruginosa biofilms
D016360,DISEASE,Clostridioides difficile,Clostridium difficile|difficile
D002772,DISEASE,Cholera Toxin,"Cholera Toxin Protomer B|Cholera Toxin A|Choleragenoid|Cholera Toxin B Subunit|Exotoxin, Cholera|Cholera Exotoxin|Cholera Toxin B|Cholera Toxin A Subunit|Toxin B|Toxin, Cholera|Enterotoxin CT, Cholera|TcdB|Choleragen|Toxin B, Cholera|Cholera Toxin Subunit A|cholera toxin|Cholera Toxin Protomer A|Toxin A, Cholera|Cholera Toxin Subunit B|Procholeragenoid|Cholera Enterotoxin CT"
NEW10343,CHEBI,major virulence factor,major virulence factors
D048373,DISEASE,Treponema denticola,Treponema microdentium|Spirochaeta ambigua|Spirochaete dentium|Treponema denticola|Spironema dentium|Treponema comandonii|Spirochaeta dentium|Treponema dentium|Spirochaeta comandonii|Treponema orthodontum|Treponema dentium-stenogyratum|Spirochaeta microdentium|Spirochaeta orthodonta|Spirillum dentium|Spirochaete denticola|Treponema ambiguum
NEW10344,CHEMICAL,abnormal dopamine signalling,abnormal dopamine signalling
NEW10345,CHEMICAL,cannabis oil,cannabis oil
http://purl.obolibrary.org/obo/CHEBI_149711,CHEBI,chemokine receptor 2 antagonist,CCR2 antagonists|C-C chemokine receptor type 2 antagonist|chemokine receptor antagonists|CD192 antagonists|CKR-2B antagonist|C-C chemokine receptor type 2 antagonists|CCR-2 antagonist|chemokine receptor 2 antagonists|CCR-2 antagonists|CD192 antagonist|CKR-2B antagonists|CCR2 antagonist
NEW10346,DISEASE,test formalin pain assay,test formalin pain assay
NEW10347,CHEMICAL,sub-analgesic dose,sub-analgesic doses
NEW10348,MENTAL_HEALTH,maximal analgesia,maximal analgesia
NEW10349,CHEMICAL,serum homovanillic acid,HVA|serum homovanillic acid
NEW10350,CHEMICAL,high csf hva concentration,higher CSF HVA concentrations
NEW10351,CHEMICAL,plasma hva concentration,plasma HVA concentration
NEW10352,DISEASE,psychotic-like schizotypal symptom,psychotic-like schizotypal symptoms
C565393,DISEASE,3-Methylglutaconic Aciduria Type IV [Supplementary Concept],"Abnormalities, Multiple|3-Methylglutaconic aciduria type|Metabolism, Inborn Errors"
NEW10353,CHEMICAL,leucine degradation pathway,leucine degradation pathway
NEW10354,CHEMICAL,single nucleotide polymorphism array analysis,single nucleotide polymorphism array analysis
C536297,DISEASE,Male sterility due to Y-chromosome deletions [Supplementary Concept],"Infertility, Male|Sex Chromosome Aberrations|Chromosome Deletion|microdeletions|Chromosomes, Human, Y|Sex Chromosome Disorders of Sex Development"
NEW10355,CHEBI,female fmr1 premutation carrier,Female FMR1 premutation carriers
NEW10356,CHEMICAL,tca cycle,TCA cycle
NEW10357,CHEMICAL,nadh generation,NADH generation
NEW10358,CHEMICAL,multivitamin intake,multivitamins intake
NEW10359,CHEMICAL,arachidonic acid metabolite,arachidonic acid metabolites
NEW10360,DISEASE,violent antisocial personality,violent antisocial personality
NEW10361,CHEMICAL,pge1/dgla ratio,PGE1/DGLA ratio
NEW10362,DISEASE,violent suicidal,violent suicidal
NEW10363,NUTRITION,high phospholipid dgla value,high phospholipid DGLA values
NEW10364,NUTRITION,serum cholesterol fasting concentration,Serum cholesterol fasting concentrations
NEW10365,DISEASE,male homicidal offender,male homicidal offenders
NEW10366,DISEASE,habitually violent tendency,habitually violent tendency
C024524,CHEMICAL,beta-funaltrexamine [Supplementary Concept],Beta-funaltrexamine|Naltrexone/analogs  and  derivatives|beta-FNA
D057136,CHEMICAL,"Nuclear Receptor Subfamily 6, Group A, Member 1",naltrexone|group A|Retinoid Receptor Related Testis Specific Receptor|Retinoid Receptor-Related Testis-Associated Receptor|Nuclear Receptor NR6A1|Neuronal Cell Nuclear Factor|Retinoid Receptor Related Testis Associated Receptor|Germ Cell Nuclear Factor
NEW10367,NUTRITION,phenylacetic acid concentration,phenylacetic acid concentrations
NEW10368,MENTAL_HEALTH,0.001).multiple linear regression analysis,0.001).Multiple linear regression analysis
NEW10369,CHEMICAL,peak oxygen consumption,VO2|peak oxygen consumption
NEW10370,CHEMICAL,impaired glucose utilization,impaired glucose utilization
NEW10371,DISEASE,central anomaly,central anomalies
NEW10372,CHEMICAL,solanum torvum Sw,Solanum torvum Sw
NEW10373,DISEASE,m. arenaria,M. arenaria
NEW10374,CHEMICAL,12 day post infection,DPI|12 day post infection
NEW10375,CHEBI,established drug,established drug
C552171,CHEMICAL,edoxaban [Supplementary Concept],Pyridines|edoxaban|Thiazoles
NEW10376,DISEASE,anosmia/ageusia due ischemia,anosmia/ageusia due ischemia
D020275,DISEASE,Guillain-Barre Syndrome,"Familial Guillain-Barre Syndrome|Syndrome, Guillain-Barré|Syndromes, Familial Guillain-Barre|Polyneuropathy Acute, Inflammatory|Infectious Polyneuritis, Acute|Polyneuropathy, Acute Inflammatory|Autoimmune Neuropathy, Acute|Polyradiculoneuropathy, Acute Inflammatory Demyelinating|Guillain Barre Syndrome, Familial|Inflammatory Polyneuropathy, Acute|Inflammatory Demyelinating Polyradiculoneuropathy, Acute|Acute Autoimmune Neuropathies|Familial Guillain-Barre Syndromes|Guillaine-Barre Syndrome|Inflammatory Polyradiculoneuropathies, Acute|Acute Inflammatory Polyradiculoneuropathies|Syndrome, Familial Guillain-Barre|Syndrome, Guillain-Barre|Demyelinating Polyradiculoneuropathy, Acute Inflammatory|Polyneuritis, Acute Infectious|Acute Inflammatory Polyneuropathy|Acute Inflammatory Polyneuropathies|Guillain Barre Syndrome|Guillain-Barré Syndromes|Guillaine Barre Syndrome|Guillain-Barré Syndrome|Guillain-Barre Syndromes, Familial|GBS|Autoimmune Neuropathies, Acute|Polyneuropathies, Acute Inflammatory|Acute Autoimmune Neuropathy|Polyradiculoneuropathies, Acute Inflammatory|Inflammatory Polyneuropathies, Acute|Syndrome, Landry-Guillain-Barre|Acute Infectious Polyneuritis|Polyneuropathy, Inflammatory Demyelinating, Acute|Landry-Guillain-Barre Syndrome|Acute Inflammatory Polyradiculoneuropathy|Neuropathies, Acute Autoimmune|Inflammatory Polyneuropathy Acute|Syndrome, Guillaine-Barre|Neuropathy, Acute Autoimmune|Acute Inflammatory Demyelinating Polyradiculoneuropathy|Landry Guillain Barre Syndrome|Polyradiculoneuropathy, Acute Inflammatory|Guillain Barré Syndrome|Guillain-Barré syndrome|Guillain-Barre Syndrome, Familial|Acute Inflammatory Demyelinating Polyneuropathy|Syndromes, Guillain-Barré"
NEW10377,MENTAL_HEALTH,resistance reduction,resistance reduction
NEW10378,CHEMICAL,chronic l-dopa treatment,chronic L-DOPA treatment
NEW10379,DISEASE,intense axial dyskinetic symptom,intense axial dyskinetic symptoms
C033595,CHEMICAL,N-oleoylethanolamine [Supplementary Concept],Oleic Acids|N-oleoylethanolamine|Endocannabinoids|OEA|Ethanolamines
NEW10380,DISEASE,local prostate cancer recurrence,local prostate cancer recurrence
NEW10381,CHEBI,palliative androgen deprivation therapy,palliative androgen deprivation therapy
NEW10382,DISEASE,mood disturbance,mood disturbances
NEW10383,DISEASE,ejaculation disorder,ejaculation disorder
http://purl.obolibrary.org/obo/MFOMD_0000083,DISEASE,orgasmic disorder,orgasm disorders
D001052,CHEMICAL,Apoferritins,"ferritin heavy chain|L Subunit, Ferritin|Ferritin Light Chain|Light Chain, Ferritin|H Subunit, Ferritin|Ferritin, H|H Ferritin|Ferritin H Subunit|Heavy Chain, Ferritin|L Ferritin|L-Ferritin|Apoferritin|Ferritin Heavy Chain|H-Ferritin|Ferritin L Subunit|FTH"
NEW10384,DISEASE,combined tbi,combined TBI
NEW10385,DISEASE,hemorrhage shock,hemorrhage shock
NEW10386,MENTAL_HEALTH,asperger 's autism study,Asperger's autism study
NEW10387,DISEASE,syndrome/high function autism,syndrome/high functioning autism
D010840,CHEMICAL,Phytosterols,"Steroid, Plant|Phytosterol|Sterol, Plant|phytosterols|Steroids, Plant|Plant Steroid|Plant Steroids|Plant Sterols|Plant Sterol|Phytosteroid|Phytosteroids|plant sterols|Sterols, Plant"
D013024,NUTRITION,Soybean Oil,"Oil, Soybean|Oils, Soya|Oils, Soy Bean|Oil, Soya|Soya Oil|Soy Bean Oils|Soybean Oils|Soya Oils|Soy Bean Oil|Oils, Soybean|Oil, Soy Bean|soybean oil"
D000069463,DISEASE,Olive Oil,"Olive Oils|Oil, Olive|Oils, Olive|ROO|olive oil"
NEW10388,CHEMICAL,high oleic- sunflower oil,high oleic- sunflower oil
D012715,CHEMICAL,Sesame Oil,"sesame oil|Oil, Sesame|Sesame Oils|Oils, Sesame"
D064429,NUTRITION,Fatty Acid Synthases,"Synthase, Fatty Acid|Acid Synthases, Fatty|Synthetases, Fatty Acid|Fatty Acid Synthetases|Fatty Acid Synthase|Acid Synthase, Fatty|fatty acid"
D050603,CHEMICAL,Squalene Monooxygenase,"squalene|Squalene Epoxidase|Epoxidase, Squalene|Squalene Monooxygenase (2,3-Epoxidizing)|Monooxygenase, Squalene"
NEW10389,CHEBI,first-generation histamine antagonist,first-generation histamine antagonist
NEW10390,DISEASE,seasonal allergy,seasonal allergies
NEW10391,MENTAL_HEALTH,hyperactivity inducing property,hyperactivity inducing properties
NEW10392,MENTAL_HEALTH,haloperidol-induced orofacial dyskinesia,haloperidol-induced orofacial dyskinesia
NEW10393,CHEMICAL,3-hydroxy-3methyl glutaryl coenzyme a reductase,3-hydroxy-3methyl glutaryl Coenzyme A reductase
NEW10394,DISEASE,rtt patient,RTT patients
D051779,CHEMICAL,Sterol Regulatory Element Binding Proteins,"sterol regulatory element binding proteins|Sterol Regulatory Element Binding Protein|Protein, SREBP|SREBP Protein|SREBP Proteins"
D060492,NUTRITION,Low Density Lipoprotein Receptor-Related Protein-5,Low Density Lipoprotein Receptor Related Protein 5|Low Density Lipoprotein Receptor-Related Protein 5|low density lipoprotein|Lipoprotein Receptor Related Protein 5|low-density lipoprotein|LDLc|Lipoprotein Receptor-Related Protein 5|low density lipoprotein receptor
NEW10395,DISEASE,rtt pathology,RTT pathology
NEW10396,CHEBI,trkb agonist,TrkB agonist
NEW10397,DISEASE,experimental glaucoma model,experimental glaucoma models
C571746,CHEBI,alpha-tocotrienol quinone [Supplementary Concept],α-tocotrienol|Ubiquinone/analogs  and  derivatives|alpha- tocotrienol|alpha-tocotrienol
C082089,CHEBI,"tocotrienol, beta [Supplementary Concept]",beta-tocotrienol|Vitamin E/analogs  and  derivatives
NEW10398,DISEASE,volume overload,Volume overload
D058625,DISEASE,End Stage Liver Disease,"Chronic Liver Failure|Failure, Chronic Liver|Liver Failures, Chronic|end-stage liver disease|Failures, Chronic Liver|Liver Failure, Chronic|Chronic Liver Failures"
NEW10399,CHEMICAL,arginine vasopressin production,arginine vasopressin production
NEW10400,DISEASE,euvolemic hyponatremia due,euvolemic hyponatremia due
NEW10401,CHEMICAL,800-mg dose,800-mg dose
NEW10402,CHEMICAL,ooeo administration,OOEO administration
NEW10403,MENTAL_HEALTH,salvage resistance,salvage resistance
D009169,CHEMICAL,Mycobacterium tuberculosis,M. tuberculosis|Mycobacterium tuberculosis|Mycobacterium tuberculosis H37Rv
NEW10404,DISEASE,drug-resistant mycobacterium tuberculosis isolate,drug-resistant Mycobacterium tuberculosis isolates
NEW10405,CHEMICAL,err2510337-err2510445,ERR2510337-ERR2510445
NEW10406,CHEMICAL,BioSample prjeb32684,BioSample PRJEB32684
NEW10407,CHEMICAL,nicotinic acid derivative bgp-15,nicotinic acid derivative BGP-15
http://purl.obolibrary.org/obo/CHEBI_35875,CHEMICAL,imidazopyrimidine,(3-piperidine-2-hydroxy-1-propyl)-nicotinic amidoxime
NEW10408,CHEMICAL,intravenous lorazepam,intravenous lorazepam
NEW10409,DISEASE,relative deficiency,relative deficiency
NEW10410,CHEMICAL,inhibitory neurotransmitter γ-aminobutyric acid,inhibitory neurotransmitter γ-aminobutyric acid|GABA
D008787,CHEMICAL,Metoclopramide,"|Cerucal|Metaclopramide|Metoclopramide Monohydrochloride|Dihydrochloride, Metoclopramide|Maxolon|Metoclopramide Monohydrochloride, Monohydrate|Reglan|Metoclopramide Hydrochloride|Hydrochloride, Metoclopramide|Monohydrochloride, Metoclopramide|Primperan|Metoclopramide Dihydrochloride|4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide|Metoclopramide|metoclopramide|Rimetin"
C047182,CHEMICAL,3-hydroxynortropane-8-spiro-1'-pyrrolidinium [Supplementary Concept],trospium|Nortropanes
NEW10411,MENTAL_HEALTH,background anxiety,background anxiety
NEW10412,CHEMICAL,gabaergic benzodiazepine,clonazepam|GABAergic benzodiazepines
D017292,CHEMICAL,Doxazosin,"Carduran Neo|Apo-Doxazosin|Doxazosin beta|Progandol Neo|Doxazosin Wolff|DoxaUro|Cardular|Carduran|Doxatensa|UK-33274|Doxazosina Ratiopharm|ratio-Doxazosin|Mesylate, Doxazosin|Doxazosina Geminis|Doxazosin-Wolff|doxazosin|Doxazosin|Doxagamma|Neo, Carduran|Diblocin|Doxacor|ratio Doxazosin|Doxazosin Mesylate|Doxazosin Klast|MTW-Doxazosin|Von Ct, Doxazosin|Doxa-Puren|Cardura|Doxazosina Pharmagenus|MTW Doxazosin|UK33274|Doxazosina Alter|Doxa Puren|Doxazosin Stada|Novo Doxazosin|Doxazosin Apogepha|Doxazosin-ratiopharm|Ratiopharm, Doxazosina|Novo-Doxazosin|Jutalar|Monohydrochloride, Doxazosin|Doxazosina Cinfa|Gen-Doxazosin|Apo Doxazosin|Doxazomerck|Uriduct|Doxazosin Von Ct|1 (4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)piperazine|Doxazosin findusFit|Doxazosin Heumann|Zoxan|Doxazosina Normon|Doxazosin Monohydrochloride|Doxazosina Combino Pharm|UK 33274|Alfamedin|Doxazosin ratiopharm|Ct, Doxazosin Von|Doxazosina Ur|Doxazosin AL|Gen Doxazosin|Doxazosin AZU|Doxamax"
D000077409,CHEMICAL,Tamsulosin,YM-617|LY 253352|Flomax|Tamsulosin hydrochloride|YM 617|Tamsulosin Hydrochloride|5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|tamsulosin|LY-253352
D019815,CHEMICAL,Oxalic Acid,"Ammonium Oxalate|Iron Oxalate|Oxalate, Monosodium|Oxalate, Chromium|Chromium Oxalate|Chromium (3+) Oxalate (3:2)|Monopotassium Oxalate|Oxalate, Ferric|Ferric Oxalate|Monosodium Oxalate|Oxalate, Aluminum|Disodium Oxalate|Oxalate, Diammonium|Oxalate, Disodium|Monohydrogen Monopotassium Oxalate|Potassium Oxalate|Oxalate, Dilithium|Oxalate, Monoammonium|Chromium (2+) Oxalate|Oxalic acid|Iron (2+) Oxalate (1:1)|Oxalate, Monohydrogen Monopotassium|Oxalate, Sodium|Diammonium Oxalate|Magnesium Oxalate|Oxalate, Monopotassium|Oxalate, Dipotassium|Monoammonium Oxalate|Manganese (2+) Oxalate (1:1)|Potassium Oxalate (2:1)|Oxalate, Potassium|Magnesium Oxalate (1:1)|Dipotassium Oxalate|Aluminum Oxalate|Oxalate, Iron|Dilithium Oxalate|Oxalate, Magnesium|Sodium Oxalate|Potassium Chromium Oxalate|Oxalate, Potassium Chromium|Iron (3+) Oxalate|Acid, Oxalic"
C407905,CHEBI,"virulence factor p28, Ectromelia virus [Supplementary Concept]",virulence factor|Viral Proteins
NEW10413,CHEMICAL,photosensitizer hypericin,photosensitizers hypericin
NEW10414,MENTAL_HEALTH,photoactivate defense mechanism,photoactivated defense mechanism
D002928,CHEMICAL,Cinanserin,"cinanserin|Hydrochloride, Cinanserin|SQ-16,167|SQ16,167|SQ 10,643|SQ 16,167|SQ-10,643|SQ10,643|Monohydrochloride, Cinanserin|Cinanserin Hydrochloride|Cinanserin Monohydrochloride"
NEW10415,CHEMICAL,serotonin synthesis inhibition,serotonin synthesis inhibition|PCPA
NEW10416,CHEMICAL,serotonin nerve terminal damage,"serotonin nerve terminal damage|5,6-dihydroxytryptamine"
C029752,NUTRITION,branched-chain amino acid-binding proteins [Supplementary Concept],Carrier Proteins|branched chain amino acid
D057645,DISEASE,Deltoid Muscle,"Muscle, Deltoid|Muscles, Deltoid|Deltoid Muscles|muscle"
D020159,DISEASE,Citrullinemia,"Late-Onset Citrullinemias|Citrullinurias|Type I Citrullinemia|Deficiency, Argininosuccinate Synthetase|Citrullinuria|Argininosuccinic Acid Synthetase Deficiency, Complete|Citrullinemia, Classical|Classic Citrullinemias|Deficiency Disease, Argininosuccinate Synthase|Argininosuccinate Synthase Deficiency Disease|Citrullinemias|Classical Citrullinemias|Citrullinemia Type 1|Citrullinemia, Late Onset|ASS Deficiencies|Partial Argininosuccinic Acid Synthetase Deficiency Disease|Deficiency, Argininosuccinic Acid Synthetase, Partial|Deficiency Disease, Argininosuccinic Acid Synthase|Argininosuccinic Acid Synthase Deficiency Disease|ASS Deficiency|Citrullinemia 1|Classical Citrullinemia|Citrullinemias, Classic|Deficiencies, Argininosuccinate Synthetase|Citrullinemia, Type I|citrullinemia|Neonatal Citrullinemia|Deficiency, Argininosuccinic Acid Synthetase, Complete|Argininosuccinic Acid Synthetase Deficiency|Type I Citrullinemias|Argininosuccinate Synthetase Deficiencies|Citrullinemia, Classic|Classic Citrullinemia|Argininosuccinic Acid Synthetase Deficiency Disease|Argininosuccinate Synthetase Deficiency|Complete Argininosuccinic Acid Synthetase Deficiency Disease|Neonatal Citrullinemias|Late-Onset Citrullinemia|Argininosuccinic Acid Synthetase Deficiency Disease, Partial|Deficiency, ASS|Citrullinemia, Neonatal|Citrullinemia, Late-Onset"
NEW10417,CHEMICAL,urea cycle balance,urea cycle balance
NEW10418,CHEBI,alpha-adrenergic blocker,alpha-adrenergic blocker
NEW10419,DISEASE,related leg movement,related leg movements
D010643,CHEMICAL,Phenoxybenzamine,"Dibenziran|Dibenyline|phenoxybenzamine|Dibenzyline|Hydrochloride, Phenoxybenzamine|Dibenylene|Phenoxybenzamine Hydrochloride|Dibenzylin|Dibenzyran|Phenoxybenzamine"
NEW10420,DISEASE,mild sleep improvement,mild sleep improvements
NEW10421,DISEASE,neurogenic bladder dysfunction,neurogenic bladder dysfunction
http://purl.obolibrary.org/obo/CHEBI_37890,CHEBI,alpha-adrenergic antagonist,alpha-adrenergic receptor antagonist|alpha-adrenergic blocker|alpha-adrenergic antagonist|alpha-adrenoceptor antagonists|alpha-adrenergic blockers|alpha-adrenergic antagonists|alpha2-adrenergic receptor antagonist|alpha-adrenergic receptor blockaders
NEW10422,CHEBI,alpha-adrenoceptor agonist phenylpropanolamine,alpha-adrenoceptor agonist phenylpropanolamine
NEW10423,CHEBI,alpha 1-adrenoceptor antagonist,Alpha 1-Adrenoceptor antagonists
D010656,CHEMICAL,Phenylephrine,"|Neo-Synephrine|Phenylephrine Tannate|Neosynephrine|Phenylephrine Hydrochloride|Metasympatol|Phenylephrine|Neo Synephrine|Tannate, Phenylephrine|phenylephrine|Metaoxedrin|(R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol|Mezaton"
NEW10424,DISEASE,mcd reaction,MCD reactions
D004280,CHEMICAL,Dobutamine,"Dobutamine Tartrate||Dobutamin Solvay|Dobutamin ratiopharm|dobutamine|Dobuject|Hydrochloride, Dobutamine|Lilly 81929|Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer|Dobutamine (+)-Isomer|Lactobionate, Dobutamine|Oxiken|Posiject|Dobucor|Dobutamine Lactobionate|Dobutamine, (-)-Isomer|Dobutamina Inibsa|Dobutamine Hydrobromide|Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer|Dobutamine, Phosphate (1:1) Salt (+)-Isomer|Dobutamina Rovi|Hydrobromide, Dobutamine|Dobutamine Hydrochloride|Dobutamin Hexal|Dobutamin-ratiopharm|Dobutamin Fresenius|Tartrate, Dobutamine|Dobutrex|Dobutamine Phosphate (1:1) Salt, (-)-Isomer"
D007545,CHEMICAL,Isoproterenol,"|isoproterenol|Isadrin|Isopropylnoradrenaline|Izadrin|4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol|Isuprel|Isoproterenol Hydrochloride|Noradrenaline, Isopropyl|Isadrine|Euspiran|Isoprenaline|Novodrin|isadrine|Isopropylnorepinephrine|Norisodrine|Isopropylarterenol|isoprenaline|Sulfate, Isoproterenol|Hydrochloride, Isoproterenol|Isoproterenol Sulfate|Isopropyl Noradrenaline"
NEW10425,DISEASE,coronary vasodilation,MCD|coronary vasodilation
NEW10426,CHEMICAL,withdrawal phentolamine,Withdrawal phentolamine
NEW10427,CHEMICAL,elevated systemic bilirubin concentration,elevated systemic bilirubin concentrations
NEW10428,DISEASE,various stress-mediated disease,various stress-mediated diseases
D005878,DISEASE,Gilbert Disease,"Gilbert syndrome|Constitutional Liver Dysfunction|Hyperbilirubinemia, Arias Type|Syndrome, Gilbert|Gilbert's Disease|Hyperbilirubinemia 1s|Gilberts Disease|Familial Nonhemolytic Jaundice|Unconjugated Benign Bilirubinemia|Gilberts Syndrome|Hyperbilirubinemia 1|Disease, Gilbert|Syndrome, Gilbert's|Arias Type Hyperbilirubinemias|Meulengracht Syndrome|Gilbert-Lereboullet Syndrome|Disease, Gilbert's|Gilbert's Syndrome|Hyperbilirubinemia I|Gilbert Syndrome|Hyperbilirubinemias, Arias Type|Arias Type Hyperbilirubinemia"
NEW10429,CHEMICAL,high lactate level,high lactate levels
NEW10430,CHEMICAL,excessive lactate formation,excessive lactate formation
NEW10431,NUTRITION,possible thiamine deficiency,possible thiamine deficiency
NEW10432,CHEMICAL,ethanol ingestion,ethanol ingestion
D019343,CHEMICAL,Citric Acid,"citric acid|Uralyt U|Citric Acid Monohydrate|Anhydrous Citric Acid|Citric Acid, Anhydrous|Citrate"
NEW10433,CHEMICAL,high benzene concentration,high benzene concentrations
NEW10434,MENTAL_HEALTH,adhd development,ADHD development
NEW10435,DISEASE,parkinsonian feature,parkinsonian features
http://purl.obolibrary.org/obo/DOID_12361,CHEMICAL,graves' disease,Basedow's disease|Graves disease|GD|Graves ' Disease|Grave's disease|exophthalmic goiter
NEW10436,DISEASE,hypocalcemia secondary,hypocalcemia secondary
NEW10437,MENTAL_HEALTH,supplement non-compliance precipitated psychosis,supplement non-compliance precipitated psychosis
NEW10438,CHEMICAL,calcium supplement,calcium supplement
NEW10439,DISEASE,postsurgical hypoparathyroidism,postsurgical hypoparathyroidism
NEW10440,NUTRITION,functional folate deficiency,functional folate deficiency
NEW10441,NUTRITION,low folate,low folate
NEW10442,CHEMICAL,poor antidepressant response,poor antidepressant response
NEW10443,CHEBI,low-activity comt met158 variant carrier,low-activity COMT Met158 variant carriers
NEW10444,DISEASE,adverse cutaneous drug reaction,adverse cutaneous drug reactions
NEW10445,DISEASE,cholestatic liver insult,cholestatic liver insults
NEW10446,CHEMICAL,high cingulate myo-inositol/creatine-phosphocreatine measurement,higher cingulate myo-inositol/creatine-phosphocreatine measurements
D008614,CHEMICAL,Meperidine,pethidine|Meperidine Hydrochloride||Dolin|Dolantin|Operidine EPJ I|Dolargan|Lidol|Lydol|Dolcontral|Dolsin|Isonipecain|Operidine EPJ-I|Demerol|meperidine|Dolosal|Pethidine
C002752,CHEMICAL,normeperidine [Supplementary Concept],norpethidine||Normeperidine|Meperidine/analogs  and  derivatives
NEW10447,CHEMICAL,Carphedon,Carphedon
NEW10448,MENTAL_HEALTH,amnesia treatment,amnesia treatment
NEW10449,MENTAL_HEALTH,dimer inos dissociation,dimer iNOS dissociation
NEW10450,CHEMICAL,no synthesis activity,NO synthesis activity
NEW10451,CHEMICAL,μm hocl,μM HOCl
NEW10452,CHEMICAL,melatonin supplementation,Melatonin supplementation
NEW10453,CHEMICAL,physiological no function,physiological NO functions
NEW10454,MENTAL_HEALTH,brain insulin resistance,brain insulin resistance
NEW10455,CHEMICAL,increase renal glucose reabsorption,increased renal glucose reabsorption
NEW10456,CHEMICAL,glucagon secretion,glucagon secretion
NEW10457,CHEMICAL,gsh redox ratio,GSH redox ratio
NEW10458,CHEMICAL,play-leisure,play-leisure
NEW10459,DISEASE,associate asd symptom,associated ASD symptoms
NEW10460,CHEMICAL,acid metabolic pathway,acids metabolic pathways
http://purl.obolibrary.org/obo/NCBITaxon_8030,NUTRITION,salmo salar,trout Salmo trutta
NEW10461,NUTRITION,displace native white-spotted charr salvelinus leucomaeni,displaced native white-spotted charr Salvelinus leucomaenis
NEW10462,CHEMICAL,erosion-control dam,erosion-control dam
NEW10463,MENTAL_HEALTH,habitat fragmentation,habitat fragmentation
NEW10464,NUTRITION,winter cherry plant,winter cherry plant
NEW10465,CHEMICAL,a steroidal lactone,A steroidal lactone
NEW10466,DISEASE,autosomal dominant elovl4 mutation,autosomal dominant ELOVL4 mutations
http://purl.obolibrary.org/obo/DOID_1289,DISEASE,neurodegenerative disease,late-onset neurodegenerative disease|multiple neurodegenerative diseases|Neurodegenerative disease|degenerative disease|certain neurodegenerative diseases|diseases neurodegenerative diseases
NEW10467,MENTAL_HEALTH,cerebral resistance arteriole,cerebral resistance arterioles
NEW10468,DISEASE,cardiovascular-related disease,cardiovascular-related diseases
NEW10469,CHEMICAL,synthetic thc dronabinol,synthetic THC dronabinol
NEW10470,DISEASE,loop gain,loop gain
D006410,DISEASE,Hematopoiesis,"Medullary Hematopoiesis|Hematopoiesis, Medullary|haematopoiesis|Haematopoiesis"
D012084,CHEMICAL,Renin-Angiotensin System,"Renin Angiotensin System|System, Renin-Angiotensin-Aldosterone|Renin-Angiotensin-Aldosterone System|Renin Angiotensin Aldosterone System|renin-angiotensin aldosterone system|System, Renin-Angiotensin"
NEW10471,MENTAL_HEALTH,alzheimer 's dementia,Alzheimer's dementia
D012509,DISEASE,Sarcoma,"Sarcoma, Soft Tissue|Spindle Cell Sarcoma|Sarcomas, Spindle Cell|Sarcomas, Soft Tissue|Soft Tissue Sarcomas|soft tissue sarcomas|Epithelioid Sarcomas|Sarcoma, Epithelioid|Epithelioid Sarcoma|Soft Tissue Sarcoma|Sarcoma, Spindle Cell|sarcomas|Sarcomas, Epithelioid|Spindle Cell Sarcomas|Sarcomas"
D007252,CHEMICAL,Influenza Vaccines,"Influenza Virus Vaccines|Vaccine, Influenzavirus|high-dose|Influenza Vaccines, Monovalent|Universal Influenza Vaccine|Trivalent Live Attenuated Influenza Vaccine|Flu Vaccine|Monovalent Influenza Vaccine|Influenza Vaccine, Monovalent|LAIV Vaccine|Monovalent Influenza Vaccines|Influenza Vaccine, Trivalent|Vaccine, Universal Influenza|Vaccine, Flu|Influenzavirus Vaccine|Vaccine, Influenza Virus|Vaccine, Influenza|Influenzavirus Vaccines|Quadrivalent Influenza Vaccine|Vaccines, Monovalent Influenza|High-Dose Trivalent Influenza Vaccine|Universal Flu Vaccines|Vaccine, Universal Flu|Influenza Vaccine, Universal|High Dose Trivalent Influenza Vaccine|Universal Influenza Vaccines|Influenza Vaccine, Quadrivalent|Vaccine, Quadrivalent Influenza|Intranasal Live Attenuated Influenza Vaccine|Vaccine, Trivalent Influenza|Vaccine, Monovalent Influenza|Trivalent Influenza Vaccine|Flu Vaccines|Influenza Vaccine|Flu Vaccine, Universal|Virus Vaccine, Influenza|Intranasal Live-Attenuated Influenza Vaccine|Influenza Virus Vaccine|Universal Flu Vaccine|Vaccine, LAIV"
NEW10472,CHEMICAL,methotrexate mtx chemotherapy,methotrexate MTX chemotherapy
NEW10473,CHEBI,leucovorin lv rescue,leucovorin LV rescue
D008727,CHEMICAL,Methotrexate,"|MTX|Methotrexate, Sodium Salt|Amethopterin|Methotrexate, Dicesium Salt|Methotrexate|Methotrexate, (DL)-Isomer|Hydrate, Methotrexate|Dicesium Salt Methotrexate|Methotrexate, (D)-Isomer|Mexate|Methotrexate Hydrate|Methotrexate, Disodium Salt|Sodium, Methotrexate|Methotrexate Sodium|methotrexate"
NEW10474,CHEBI,somatotrophic hormone,somatotrophic hormone
http://purl.obolibrary.org/obo/DOID_10608,DISEASE,celiac disease,celiac sprue|idiopathic steatorrhea|coeliac disease
NEW10475,MENTAL_HEALTH,intestinal infantilism syndrome,intestinal infantilism syndrome
NEW10476,CHEMICAL,contextual fear conditioning,CFC|contextual fear conditioning
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Amnesia,MENTAL_HEALTH,amnesia,42-induced amnesia|Abeta-induced amnesia|SCO-induced amnesia|Cyt-4-induced amnesia
NEW10477,CHEBI,n-methyl-d-aspartate receptor antagonist magnesium sulfate,N-methyl-D-aspartate receptor antagonist magnesium sulfate
NEW10478,CHEMICAL,antidepressant effect subsequent,antidepressant effects subsequent
NEW10479,MENTAL_HEALTH,narcolepsy type incidence,Narcolepsy type incidence
NEW10480,CHEMICAL,GlaxoSmithKline,GlaxoSmithKline
NEW10481,DISEASE,h1n1 vaccine manufactured,H1N1 vaccine manufactured
NEW10482,CHEMICAL,l-dopa treatment,L-DOPA treatment
NEW10483,CHEMICAL,"brain d2 3,4-dihydroxyphenylethylamine","brain D2 3,4-dihydroxyphenylethylamine|dopamine"
NEW10484,CHEBI,d1 receptor agonist,D1 receptor agonists
NEW10485,DISEASE,mptp-induced parkinsonian monkey,MPTP-induced parkinsonian monkeys
NEW10486,DISEASE,initial dose p. odocoilei,initial dose P. odocoilei
C000719955,NUTRITION,Odocoileus virginianus [Supplementary Concept],Deer|white-tailed deer
NEW10487,CHEMICAL,angiotensin converting enzyme ace inhibitor,angiotensin converting enzyme ACE inhibitors
NEW10488,DISEASE,lv mass,LV mass
NEW10489,CHEBI,non-vitamin k antagonist oral anticoagulant noac drug,Non-vitamin K antagonist oral anticoagulant NOAC drugs
NEW10490,DISEASE,ischemic stroke prevention,ischemic stroke prevention
NEW10491,CHEMICAL,poly(I c challenge,poly(I C challenge
NEW10492,NUTRITION,large yellow croaker,large yellow croaker
NEW10493,CHEBI,antiviral defense mechanism,antiviral defense mechanism
NEW10494,MENTAL_HEALTH,frog retinotectal projection role,frog retinotectal projection role
NEW10495,CHEMICAL,nmda receptor activation,NMDA receptor activation
NEW10496,DISEASE,retinal arbor,retinal arbors
NEW10497,CHEBI,important spinal drug,important spinal drug
NEW10498,DISEASE,minimal toxicity,minimal toxicity
NEW10499,DISEASE,psychosis-like behaviour,psychosis-like behaviour
NEW10500,CHEMICAL,prolonged etoh exposure,Prolonged EtOH exposure
NEW10501,CHEMICAL,gas homeostatic change,gas homeostatic changes
NEW10502,MENTAL_HEALTH,acute alcoholic psychosis,acute alcoholic psychosis
http://purl.obolibrary.org/obo/CHEBI_26349,CHEMICAL,proteochondroitin sulfate,p-CS|p-Cresyl sulfate|p-cresyl sulfate
C030737,CHEMICAL,indoleacetic acid [Supplementary Concept],indole acetic acid|1H-indole-3-acetic acid|Indoleacetic Acids
D000072458,MENTAL_HEALTH,"Orientation, Spatial","Orientations, Spatial|spatial orientation|Spatial Orientations|Spatial Orientation"
NEW10503,CHEMICAL,lower-sodium oxybate,Lower-sodium oxybate
NEW10504,CHEMICAL,oxybate medication,oxybate medication
NEW10505,DISEASE,cardiovascular comorbiditie,cardiovascular comorbidities
NEW10506,CHEMICAL,active oxybate moiety,active oxybate moiety
NEW10507,CHEMICAL,alternative to sodium oxybate,alternative to sodium oxybate|SXB
NEW10508,CHEBI,dysfunctional beta fatty acid oxidation pathway,dysfunctional beta fatty acid oxidation pathway
NEW10509,CHEBI,flexible dopamine reuptake inhibitor,flexible dopamine reuptake inhibitor
NEW10510,CHEMICAL,hf/6 31g(d level,HF/6 31G(d levels
NEW10511,CHEMICAL,°,°
NEW10512,DISEASE,molecular orbital calculation,Molecular orbital calculations
NEW10513,CHEBI,indirect agonist therapy,indirect agonist therapy
NEW10514,DISEASE,cholestatic pruritus,cholestatic pruritus
NEW10515,DISEASE,bile acid resin,bile acid resins
NEW10516,DISEASE,itch pathophysiology,itch pathophysiology
C000711707,CHEBI,kappa-opioid agonist JT09 [Supplementary Concept],Peptides|kappa-opioid agonist
NEW10517,DISEASE,cholestatic itch,cholestatic itch
NEW10518,MENTAL_HEALTH,collision-induced dissociation,Collision-induced dissociation
NEW10519,CHEMICAL,pyrrolidine ring,pyrrolidine ring
NEW10520,CHEMICAL,human adenosine receptor,human adenosine receptors
NEW10521,CHEBI,agonist radioligand,agonist radioligand
NEW10522,CHEMICAL,[(125)I]N(6)-(4-amino-3-iodobenzyl)-5'-N-methylcarboxamidoadenosine,[(125)I]N(6)-(4-amino-3-iodobenzyl)-5'-N-methylcarboxamidoadenosine
NEW10523,CHEMICAL,3-(2-pyridinyl)isoquinoline derivative,3-(2-pyridinyl)isoquinoline derivatives
D000584,CHEMICAL,Amiloride,"amiloride|Hydrochloride, Anhydrous Amiloride|Amiloride Hydrochloride, Anhydrous|Hydrochloride, Amiloride|Amiloberag|Midoride|Amiduret Trom|Amiloride Hydrochloride|Amidal|Midamor|Anhydrous Amiloride Hydrochloride|Trom, Amiduret|Modamide|Kaluril"
NEW10524,CHEMICAL,biphosphonate,biphosphonates
NEW10525,CHEMICAL,one central,moxonidine|one central
NEW10526,DISEASE,hypertensive postmenopausal woman,hypertensive postmenopausal women
http://purl.obolibrary.org/obo/CHEBI_66991,CHEBI,sympatholytic agent,sympatholytic drugs|sympatholytic|sympatholytic agents|sympatholytic drug|Centrally-acting sympatholytic agents|sympatholytics
NEW10527,CHEMICAL,levodopa medication,levodopa medications
NEW10528,DISEASE,nocturnal pd model,nocturnal PD models
NEW10529,CHEMICAL,modafinil co-administration,modafinil co-administration
C008842,CHEMICAL,4-amino-3-phenylbutyric acid [Supplementary Concept],Phenibut|gamma-Aminobutyric Acid/analogs  and  derivatives
NEW10530,CHEMICAL,phenibut consumption,phenibut consumption
NEW10531,DISEASE,oligomeric αsyn-induced damage,oligomeric αSyn-induced damage
NEW10532,DISEASE,pd/lbd,PD/LBD
NEW10533,DISEASE,αsyn-induced synaptic spine loss,αSyn-induced synaptic spine loss
NEW10534,CHEBI,fda-approved drug memantine,FDA-approved drug memantine
D002800,CHEMICAL,Cholinesterase Inhibitors,"Anti Cholinesterase|Anticholinesterase Agents|Cholinesterase Inhibitor|cholinesterase inhibitors|Anti-Cholinesterases|Anticholinesterase Agent|Acetylcholinesterase inhibitors|Inhibitors, Irreversible Cholinesterase|Drugs, Anticholinesterase|Inhibitors, Acetylcholinesterase|Anti Cholinesterases|Acetylcholinesterase Inhibitor|Drug, Anticholinesterase|Inhibitor, Acetylcholinesterase|Anticholinesterase|Cholinesterase Inhibitors, Irreversible|Anticholinesterases|Anticholinesterase Drug|Irreversible Cholinesterase Inhibitors|Cholinesterase Inhibitors, Reversible|ChEIs|Inhibitors, Reversible Cholinesterase|AChEIs|Acetylcholinesterase Inhibitors|Inhibitors, Cholinesterase|Reversible Cholinesterase Inhibitors|Agent, Anticholinesterase|Anticholinesterase Drugs|Inhibitor, Cholinesterase|Agents, Anticholinesterase|Anti-Cholinesterase"
D000077443,CHEMICAL,Acamprosate,"Acetylhomotaurine, Sodium|Acetyl Homotaurinate, Calcium|N-Acetylhomotaurine|N Acetylhomotaurine, Monolithium Salt|N-Acetylhomotaurine, Magnesium (2:1) Salt|N-Acetylhomotaurine, Monolithium Salt|Acamprosate Calcium|acamprosate|N-Acetylhomotaurine, Monosodium Salt|Calcium Acetylhomotaurine|N-Acetylhomotaurine, Zinc (2:1) Salt|Acetylhomotaurinate, Calcium|Regtect|Acamprostate|N Acetylhomotaurine, Monopotassium Salt|Acetylhomotaurine, Calcium|Calcium Acetyl Homotaurinate|Campral EC|Aotal|Sodium Acetylhomotaurine|Acamprosate|N Acetylhomotaurine|N-Acetylhomotaurine, Monopotassium Salt|Calcium Acetylhomotaurinate|N-Acetylhomotaurine, Calcium (2:1) Salt|Campral|Zulex|N Acetylhomotaurine, Monosodium Salt"
NEW10535,MENTAL_HEALTH,chronic alcohol dependence,chronic alcohol dependence
NEW10536,DISEASE,adjuvant stroke treatment,adjuvant stroke treatment
NEW10537,DISEASE,rat ptsd model,rat PTSD model
NEW10538,CHEMICAL,propofol anesthesia,propofol anesthesia
NEW10539,DISEASE,48h memory retention,48h memory retention
NEW10540,DISEASE,traumatic memory enhancement,traumatic memory enhancement
NEW10541,CHEBI,phase drug,Phase drug
NEW10542,CHEBI,neoantigen neoag peptide,Neoantigen NeoAg peptides
C053387,DISEASE,endoplasmin [Supplementary Concept],Membrane Glycoproteins|tumor rejection
NEW10543,DISEASE,exquisite tumor specificity,exquisite tumor specificity
NEW10544,CHEMICAL,atp production,ATP production
NEW10545,DISEASE,mitochondrial damage,mitochondrial damage
NEW10546,CHEMICAL,lowered atp production,lowered ATP production
NEW10547,DISEASE,post exertional malaise,post exertional malaise
C103490,CHEMICAL,dexloxiglumide [Supplementary Concept],dexloxiglumide|Pentanoic Acids
C053737,CHEMICAL,loxiglumide [Supplementary Concept],loxiglumide|Proglumide/analogs  and  derivatives
C088990,CHEMICAL,"N-(1,3-dimethyl-2-butenyl)adenosine [Supplementary Concept]",S-enantiomer|Isopentenyladenosine/analogs  and  derivatives|esketamine
NEW10548,CHEMICAL,antiphospholipid,Antiphospholipids|aPLAs
D003072,DISEASE,Cognition Disorders,"|cognition|Overinclusion|Disorder, Cognition|Disorders, Cognition|impaired social and emotional judgement processes"
NEW10549,DISEASE,acute gastrointestinal distress,acute gastrointestinal distress
D064133,DISEASE,Sports Nutritional Physiological Phenomena,"Sports Nutritional Physiology Phenomena|Nutrition Physiology, Sports|anorexia|Sports Nutritional Physiological Phenomenon|Physiology, Exercise Nutrition|Nutrition Physiology, Exercise|Exercise Nutritional Physiology Phenomena|Sports Nutritional Physiology|Sports Nutritional Physiology Phenomenon|Physiology, Sports Nutrition|Nutritional Physiology, Sports|Exercise Nutritional Physiology|Sports Nutrition Physiology|Exercise Nutritional Physiology Phenomenon|Exercise Nutritional Physiological Phenomenon|Nutritional Physiology, Exercise|Exercise Nutritional Physiological Phenomena|Exercise Nutrition Physiology|Physiology, Exercise Nutritional|nutritional|Physiology, Sports Nutritional"
NEW10550,CHEMICAL,cholinergic-dopaminergic-serotinergic balance,cholinergic-dopaminergic-serotinergic balance
C442200,CHEMICAL,"9,10-dehydroepothilone D [Supplementary Concept]",Epothilones|Epothilone D
NEW10551,DISEASE,autism-like behavior,autism-like behaviors
D019344,CHEMICAL,Lactic Acid,"Propanoic Acid, 2-Hydroxy-, (2S)-|2 Hydroxypropionic Acid|2-Hydroxypropanoic Acid|lactic acid|Sarcolactic Acid|Lactate, Ammonium|Propanoic Acid, 2-Hydroxy-, (2R)-|D-Lactic Acid|Lactate|LA|Ammonium Lactate|L Lactic Acid|2-Hydroxypropionic Acid|2 Hydroxypropanoic Acid|L-Lactic Acid|D Lactic Acid"
http://purl.obolibrary.org/obo/CHEBI_59229,CHEBI,gnrh antagonist,GnRH antagonist|GnRH antagonists|gonadotrophin-releasing hormone antagonist|gonadotrophin-releasing hormone antagonists
NEW10552,CHEBI,estrogen withdrawal,Estrogen withdrawal
NEW10553,DISEASE,rapid bone loss,rapid bone loss
NEW10554,DISEASE,net bone loss,net bone loss
NEW10555,CHEMICAL,natural glucocorticoid hydrocortisone,Natural glucocorticoid hydrocortisone
D001997,DISEASE,Bronchopulmonary Dysplasia,"Dysplasia, Bronchopulmonary|bronchopulmonary dysplasia"
NEW10556,CHEBI,hormone treatment,Hormone treatment
NEW10557,MENTAL_HEALTH,dna fragmentation intensity,DNA fragmentation intensity
NEW10558,DISEASE,epilepsy bipolar disorder,epilepsy bipolar disorder
NEW10559,DISEASE,atherosclerosis model,atherosclerosis model
NEW10560,DISEASE,atherosclerosis in-stent restenosis,atherosclerosis in-stent restenosis
NEW10561,CHEBI,dietary folic acid augmentation,Dietary folic acid augmentation
NEW10562,DISEASE,disorder risk,disorder risk
NEW10563,CHEBI,excess maternal folic acid fortification,Excess maternal folic acid fortification
NEW10564,DISEASE,stroke-prone hypertensive rat,stroke-prone hypertensive rats
NEW10565,DISEASE,functional abnormality,functional abnormalities
NEW10566,DISEASE,ad/hd animal model,AD/HD animal model
NEW10567,CHEMICAL,d-serine/d-serine,D-serine/D-serine
D006624,CHEMICAL,Hippocampus,"Schaffer Collaterals|hippocampus|Collaterals, Schaffer|Schaffer Collateral|Ammons Horn|Formation, Hippocampal|Propers, Hippocampus|Collateral, Schaffer|Hippocampal Formation|Formations, Hippocampal|Subiculum|Ammon's Horn|Subiculums|HIP|Hippocampus Propers|Ammon Horn|Proper, Hippocampus|Hippocampal Formations|Cornu Ammonis|Hippocampus Proper|Horn, Ammon's|Horn, Ammon"
NEW10568,CHEMICAL,abnormal d-serine metabolism,abnormal D-serine metabolism
NEW10569,CHEMICAL,major pl class,major PL classes
NEW10570,CHEMICAL,monounsaturated fatty acid-containing phosphatidylcholine,monounsaturated fatty acid-containing phosphatidylcholine
NEW10571,CHEMICAL,tbi+ptsd,TBI+PTSD
NEW10572,DISEASE,tbi group,TBI groups
NEW10573,MENTAL_HEALTH,equilibrium dissociation constant,Equilibrium dissociation constants
NEW10574,CHEMICAL,protein-pfas pair,protein-PFAS pairs
NEW10575,CHEBI,synthetic inverse agonist,synthetic inverse agonists
NEW10576,MENTAL_HEALTH,basal repression,basal repression
NEW10577,CHEBI,ppar target gene,PPAR target genes
NEW10578,NUTRITION,California bobwhite quail lysozyme,California bobwhite quail lysozymes
NEW10579,MENTAL_HEALTH,quantitative microcomplement fixation test,quantitative microcomplement fixation tests
NEW10580,CHEMICAL,deficient acmsd activity,deficient ACMSD activity
NEW10581,MENTAL_HEALTH,suicide attempter,Suicide attempters
NEW10582,CHEMICAL,pic/quin ratio,PIC/QUIN ratio
NEW10583,CHEMICAL,SNP rs2121337,SNP rs2121337
NEW10584,CHEMICAL,increase csf quin,increased CSF QUIN
http://purl.obolibrary.org/obo/CHEBI_10211,CHEMICAL,alpha-aminoadipoyl-s-acyl enzyme,Aminoadip.-S|enzyme amino-β-carboxymuconate-semialdehyde-decarboxylase|ACMSD|alpha-Aminoadipoyl-S-acyl enzyme
http://purl.obolibrary.org/obo/CHEBI_176811,CHEMICAL,8-methyl nonanoic acid,8-methylnonanoic acid|5-trimethoxy cinnamic acid|TMCA
NEW10585,DISEASE,tooth chatter,teeth chattering
NEW10586,DISEASE,penis lick,penis licking
NEW10587,DISEASE,major disturbance,major disturbance
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Acute_Schizophrenia,MENTAL_HEALTH,acute schizophrenia,acute schizophrenia
D062145,CHEMICAL,Maternal Serum Screening Tests,serum|testosterone|Maternal Serum Triple Test
D005475,CHEMICAL,Flupenthixol,Emergil|Fluanxol|cis-Flupenthixol|alpha-Flupenthixol|Flupentixol|flupenthixol
NEW10588,DISEASE,acute schizophrenic illness,acute schizophrenic illnesses
NEW10589,DISEASE,neurotoxic metabolite quinolinic acid,neurotoxic metabolite quinolinic acid
NEW10590,MENTAL_HEALTH,crave time,craving time
NEW10591,CHEMICAL,alcohol craving,alcohol craving
NEW10592,CHEMICAL,naringin supplementation,naringin supplementation
NEW10593,DISEASE,hyperammonemic rat,hyperammonemic rats
NEW10594,MENTAL_HEALTH,cancer-related fatigue,cancer-related fatigue
NEW10595,CHEBI,lycopene treatment,lycopene treatment
D050900,CHEMICAL,Ferredoxin-Nitrite Reductase,"nitrite|Reductase, Ferredoxin-Nitrite|Ferredoxin Nitrite Reductase"
NEW10596,CHEBI,specific drug treatment,specific drug treatment
NEW10597,MENTAL_HEALTH,temporary organic mental disorder,temporary organic mental disorder
NEW10598,MENTAL_HEALTH,alcohol dependence treatment,alcohol dependence treatment
NEW10599,CHEMICAL,extended-release naltrexone,Extended-release naltrexone
NEW10600,CHEMICAL,daily oral naltrexone tablet,daily oral naltrexone tablets
NEW10601,CHEMICAL,alcohol relapse,Alcohol relapse
NEW10602,MENTAL_HEALTH,dementia-related psychosis,dementia-related psychosis
NEW10603,DISEASE,ethanol developmental neurotoxicity,ethanol developmental neurotoxicity
NEW10604,NUTRITION,mitochondrial phospholipid cardiolipin,mitochondrial phospholipid cardiolipin
NEW10605,CHEMICAL,alginate coat,Alginate coating
NEW10606,DISEASE,significant hypoglycemic effect,significant hypoglycemic effect
NEW10607,NUTRITION,alginate coat insulin-loaded yeast microcapsule,alginate coated insulin-loaded yeast microcapsule
NEW10608,NUTRITION,yeast saccharomyces cerevisiae,yeast Saccharomyces cerevisiae
NEW10609,DISEASE,overdose death,overdose death
NEW10610,DISEASE,criminal justice sample,criminal justice sample
D061986,CHEMICAL,MCF-7 Cells,"Michigan Cancer Foundation 7 Cells|Cell, MCF7|MCF7 Cells|Cell, MCF-7|Cells, MCF-7|MCF 7 Cells|Cells, MCF7|MCF7 Cell|MCF|MCF-7 Cell|MCF-7 cells|aMCF"
NEW10611,CHEMICAL,reduce intracellular glutathione level,reduced intracellular glutathione levels
NEW10612,DISEASE,autistic behaviour,autistic behaviour
NEW10613,CHEMICAL,glutamate decarboxylase,glutamate decarboxylases
NEW10614,CHEMICAL,abnormal gaba production,abnormal GABA production
NEW10615,DISEASE,autistic cerebellum,autistic cerebellum
NEW10616,DISEASE,excessive sleep disorder,excessive sleep disorders
http://purl.obolibrary.org/obo/CHEBI_188583,CHEMICAL,indiplon,"N-methyl-N-[3-[3-(thiophene-2-carbonyl)pyrazolo[1,5-a]pyrimidin-7-yl]phenyl]acetamide|Ramelteon Z-drugs"
NEW10617,MENTAL_HEALTH,sleep-onset insomnia,sleep-onset insomnia
NEW10618,DISEASE,self-limiting edema,self-limiting edema
NEW10619,DISEASE,allergic angioedema,Allergic angioedema
NEW10620,DISEASE,lorazepam-dependent rat,lorazepam-dependent rats
NEW10621,DISEASE,hyperaggression,hyperaggression
C096997,CHEMICAL,histidine N-acetyltransferase [Supplementary Concept],L-Histidine|Acetyltransferases
NEW10622,CHEMICAL,serotonin-norepinephrine reuptake inhibitor,Serotonin-norepinephrine reuptake inhibitors
C485926,DISEASE,"COMMD5 protein, human [Supplementary Concept]","hypertension related|Nuclear Proteins|Adaptor Proteins, Signal Transducing"
NEW10623,CHEMICAL,dopamine-norepinephrine reuptake inhibitor bupropion,dopamine-norepinephrine reuptake inhibitor bupropion
NEW10624,CHEMICAL,norepinephrine-serotonin modulator,norepinephrine-serotonin modulators
NEW10625,DISEASE,jaw-opening dystonia,jaw-opening dystonia
D013494,DISEASE,"Supranuclear Palsy, Progressive","Steele-Richardson-Olszewski Disease|Progressive Supranuclear Palsy|Progressive Supranuclear Palsies|Steele Richardson Olszewski Syndrome|Ophthalmoplegia, Progressive Supranuclear|Supranuclear Palsies, Progressive|Progressive Supranuclear Palsy 1|Progressive Supranuclear Ophthalmoplegia|PSP|Richardson's Syndrome|Palsy, Progressive Supranuclear|Supranuclear Palsy, Progressive, 1|Supranuclear Ophthalmoplegia, Progressive|Steele-Richardson-Olszewski Syndrome|progressive supranuclear palsy|Richardson Syndrome|Steele Richardson Olszewski Disease"
D000073942,DISEASE,T-Cell Acute Lymphocytic Leukemia Protein 1,"Transcription Factor, TAL1|acute lymphocytic leukemia|TAL-1 Protein|TAL1 Transcription Factor|TAL 1 Protein|T Cell Acute Lymphocytic Leukemia Protein 1"
NEW10626,CHEMICAL,persistent high methotrexate plasmatic level,persistent high methotrexate plasmatic levels
NEW10627,CHEMICAL,AcMYB123,AcMYB123
NEW10628,NUTRITION,anthocyanin biosynthesis,anthocyanin biosynthesis
NEW10629,MENTAL_HEALTH,rna interference repression,RNA interference repression
NEW10630,CHEMICAL,ghb uptake,GHB uptake
NEW10631,MENTAL_HEALTH,amnesia short detection,amnesia short detection
C082748,CHEMICAL,epibatidine [Supplementary Concept],"epibatidine|Bridged Bicyclo Compounds, Heterocyclic|Pyridines"
NEW10632,CHEMICAL,5-iodo-a-85380,A-85380|5-iodo-A-85380
C484549,CHEMICAL,"SLC33A1 protein, human [Supplementary Concept]",AT(1|Membrane Transport Proteins
NEW10633,CHEMICAL,intravenous cocaine,intravenous cocaine
NEW10634,CHEMICAL,ester nitric oxide synthase inhibitor,ester nitric oxide synthase inhibitor
NEW10635,CHEMICAL,"6-anilino-5,8-quinolinedione guanylate cyclase inhibitor","6-anilino-5,8-quinolinedione guanylate cyclase inhibitor"
NEW10636,CHEMICAL,thiopental/miconazole,thiopental/miconazole
NEW10637,CHEMICAL,indomethacin cyclo-oxygenase inhibitor,indomethacin cyclo-oxygenase inhibitor
D045462,CHEMICAL,Endothelium-Dependent Relaxing Factors,"Vasodilators, Endothelium-Dependent|Endothelium Dependent Relaxing Factors|Endothelium Derived Relaxant Factor|Endothelium-Derived Relaxing Factor|Endothelium-Derived Relaxant Factor|endothelium-dependent|Factor, Neutrophil-Derived Relaxant|Neutrophil-Derived Relaxant Factor|Endothelium-Dependent Vasodilators|Endothelium Dependent Relaxing Factor|Relaxing Factors, Endothelium-Dependent|Relaxant Factor, Neutrophil-Derived|Relaxing Factor, Endothelium-Derived|Endothelium Dependent Vasodilators|Relaxing Factor, Endothelium-Dependent|Neutrophil Derived Relaxant Factor|Endothelium-Dependent Relaxing Factor|Relaxant Factor, Endothelium-Derived|Endothelium Derived Relaxing Factor"
NEW10638,CHEMICAL,high n-6:n-3 fa ratio,higher n-6:n-3 FA ratios
NEW10639,CHEMICAL,low n-3 fa level,lower n-3 FA levels
NEW10640,CHEMICAL,sex steroid deficiency,sex steroid deficiency
NEW10641,DISEASE,secondary adrenal insufficiency,secondary adrenal insufficiency
NEW10642,DISEASE,cerebral insult,cerebral insults
NEW10643,CHEMICAL,adenosine receptor ligand,adenosine receptor ligands
C012509,CHEMICAL,propineb [Supplementary Concept],Zineb/analogs  and  derivatives|propineb
D008724,CHEMICAL,Methomyl,Lannate 20|Lannate|methomyl
D007559,CHEMICAL,Ivermectin,MK 933|Stromectol|MK-933|MK933|Eqvalan|Ivomec|ivermectin|Mectizan
NEW10644,CHEMICAL,ivermectin-diethylcarbamazine,ivermectin-diethylcarbamazine
D002235,CHEMICAL,Carbofuran,NIA 10242|Bayer 70143|Furadan|NIA10242|carbofuran|NIA-10242
D000072316,CHEMICAL,Dioxins and Dioxin-like Compounds,dioxin|Dioxins and Dioxin like Compounds
NEW10645,CHEBI,fungicide combination,fungicide combination
NEW10646,CHEBI,fungicide maneb,fungicide maneb
NEW10647,MENTAL_HEALTH,bacterial resistance,bacterial resistance
NEW10648,CHEBI,oral antibiotic,oral antibiotics
NEW10649,DISEASE,acute bacterial sinusitis,acute bacterial sinusitis
NEW10650,MENTAL_HEALTH,catecholaminergic hyperactivity,catecholaminergic hyperactivity
NEW10651,CHEMICAL,alcohol withdrawal reaction,alcohol withdrawal reaction
NEW10652,CHEBI,serum antioxidant vitamin,Serum antioxidant vitamins
NEW10653,CHEMICAL,heavy alcohol,heavy alcohol
NEW10654,DISEASE,disorder-related behavior,disorder-related behaviors
D013011,CHEMICAL,Sorbic Acid,"Acid, Sorbic|Potassium Sorbate|Sorbate, Potassium|Sorbate, Sodium|Acid, Hexadienoic|Propenylacrylic Acid|Sodium Sorbate|Hexadienoic Acid|Acid, Propenylacrylic|sorbic acid"
NEW10655,CHEMICAL,3.0 7.4,3.0 7.4
NEW10656,CHEMICAL,dmpc acyl chain,DMPC acyl chains
NEW10657,MENTAL_HEALTH,orientation order,orientation order
NEW10658,NUTRITION,phospholipid bilayer,phospholipid bilayer
NEW10659,CHEBI,androgen level,androgen levels
C117359,CHEMICAL,P-glycoprotein 2 [Supplementary Concept],"P-glycoprotein|ATP Binding Cassette Transporter, Subfamily B"
NEW10660,CHEMICAL,two-year fluoxetine administration,Two-year fluoxetine administration
D003642,DISEASE,Deanol,"Bisorcate, Deanol|N,N Dimethyl 2 hydroxyethylamine|N,N-Dimethyl-2-hydroxyethylamine|Dimethylaminoethanol|Demanol|Tonibral|Dimethylethanolamine|Demanyl|Deanol Bisorcate|N,N-Dimethylethanolamine|Astyl|Deanol"
NEW10661,CHEBI,putative cholinergic agonist,putative cholinergic agonist
C101425,CHEMICAL,posaconazole [Supplementary Concept],Triazoles|posaconazole
NEW10662,CHEBI,antifungal medicine,antifungal medicine
NEW10663,CHEMICAL,dopamine d1 receptor agent,dopamine D1 receptor agents
D008874,CHEMICAL,Midazolam,"|Midazolam Maleate|Ro 213981|Midazolam|Hydrochloride, Midazolam|Versed|Ro 21-3981|Midazolam Hydrochloride|Dormicum|midazolam|Maleate, Midazolam|Ro 21 3981"
NEW10664,CHEBI,micromolar canthaxanthin,micromolar canthaxanthin
NEW10665,CHEMICAL,increase lactate dehydrogenase,increased lactate dehydrogenase
NEW10666,DISEASE,tumor necrosis factor (tnf)-alpha,tumor necrosis factor (TNF)-alpha
D053475,CHEMICAL,Receptor-Interacting Protein Serine-Threonine Kinase 2,RIPK2 Protein|interleukin (IL)-1|RICK Protein|Receptor-Interacting Serine-Threonine Kinase 2|Receptor Interacting Protein Serine Threonine Kinase 2|CARDIAK|Receptor Interacting Serine Threonine Kinase 2|CARD-containing Interleukin (IL)-1 beta Converting Enzyme
NEW10667,CHEBI,epsilon carrier status,epsilon carrier status
NEW10668,CHEMICAL,dopamine hypofunction,dopamine hypofunction
NEW10669,CHEBI,drug craving,drug craving
NEW10670,CHEBI,promising drug candidate,promising drug candidates
C501919,DISEASE,"alpha-amylase, Bacillus licheniformis [Supplementary Concept]",B. licheniformis|alpha-Amylases
NEW10671,DISEASE,lactobacillus spp,Lactobacillus spp
NEW10672,CHEMICAL,cgj,CGJ
NEW10673,CHEMICAL,animal tissue-derived gelatin,animal tissue-derived gelatins
NEW10674,CHEMICAL,mu mutagenesis,Mu mutagenesis
NEW10675,CHEMICAL,pica::lacz fusion,picA::lacZ fusion
NEW10676,MENTAL_HEALTH,pica promoter,picA promoter
NEW10677,NUTRITION,cholesterol absorption inhibitor,cholesterol absorption inhibitors
NEW10678,CHEBI,peroxiproliferator-activated receptor-delta agonist,peroxiproliferator-activated receptor-delta agonists
NEW10679,DISEASE,lipid abnormality,lipid abnormalities
NEW10680,MENTAL_HEALTH,erectile dysfunction drug,erectile dysfunction drugs
D004345,CHEBI,Drug Industry,"Drug Industries|Pharmaceutical Industry|Industry, Drug|Industries, Drug|Pharmaceutic Industries|Pharmaceutical Industries|Industries, Pharmaceutical|Industry, Pharmaceutic|Industries, Pharmaceutic|Industry, Pharmaceutical|Pharmaceutic Industry|pharmaceutical industry"
NEW10681,CHEBI,orexigenic hormone ghrelin,orexigenic hormone ghrelin
NEW10682,CHEMICAL,byetta synthetic Exendin-4,Byetta synthetic Exendin-4
D018376,DISEASE,Cardiovascular Abnormalities,"|Abnormalities, Cardiovascular|Cardiovascular Abnormality|Abnormality, Cardiovascular|Cardiovascular alterations|cardiovascular abnormalities"
NEW10683,MENTAL_HEALTH,opiate abstinence syndrome,opiates abstinence syndrome
http://purl.obolibrary.org/obo/CHEBI_86029,CHEBI,liver x receptor agonist,Liver X receptor agonists|LXR agonists|Selective liver X receptor agonists|LXR agonist|liver X receptor agonists
NEW10684,NUTRITION,phospholipid efflux,phospholipid efflux
NEW10685,DISEASE,pathologic defect,pathologic defects
NEW10686,CHEBI,specific lxr agonist,specific LXR agonist
NEW10687,CHEMICAL,transient outward potassium current,transient outward potassium current
D011802,CHEMICAL,Quinidine,"|Apo Quinidine|Chinidin|Apo-Quinidine|quinidine|Sulfate, Quinidine|Quinora|Quinidine Sulfate|Quinidex|Quincardine|Quinidine|Adaquin"
NEW10688,DISEASE,malignant ventricular arrhythmia,malignant ventricular arrhythmias
NEW10689,CHEBI,alternative drug,alternative drug
D047868,DISEASE,Pulmonary Sclerosing Hemangioma,"Sclerosing Hemangioma, Pulmonary|Lung Sclerosing Hemangiomas|Hemangioma, Sclerosing, Pulmonary|Sclerosing Hemangioma, Lung|Pulmonary Sclerosing Hemangiomas|Sclerosing Hemangiomas, Pulmonary|hemangioma|Sclerosing Hemangioma of the Lung|Lung Sclerosing Hemangioma|Sclerosing Hemangiomas, Lung"
NEW10690,CHEMICAL,propranolol treatment,propranolol treatment
NEW10691,DISEASE,corneal neo-vascularisation phenotype,corneal neo-vascularisation phenotype
NEW10692,DISEASE,multi-factorial neurodegenerative disorder,multi-factorial neurodegenerative disorder
NEW10693,CHEBI,dietary sweetener,dietary sweetener
NEW10694,DISEASE,transgenic ad mouse,transgenic AD mice
NEW10695,CHEMICAL,non-invasive l. plant,non-invasive L. plants
NEW10696,CHEMICAL,° c condition,° C conditions
NEW10697,DISEASE,studied-the invasive lupinus polyphyllus Lindl,studied-the invasive Lupinus polyphyllus Lindl
NEW10698,CHEMICAL,prolactin/prlr antibody,prolactin/PRLR antibodies
NEW10699,DISEASE,migraine preventive,migraine preventives
NEW10700,CHEMICAL,agent atropine,agents atropine
D000550,DISEASE,Amblyopia,"|Amblyopia, Stimulus Deprivation-Induced|Amblyopias, Suppression|Lazy Eye|Amblyopias, Stimulus Deprivation-Induced|Anisometropic Amblyopia|Developmental Amblyopias|Stimulus Deprivation-Induced Amblyopias|Eye, Lazy|Amblyopia, Developmental|Deprivation-Induced Amblyopia, Stimulus|Eyes, Lazy|Stimulus Deprivation-Induced Amblyopia|Amblyopias, Developmental|Amblyopias|Deprivation-Induced Amblyopias, Stimulus|Amblyopias, Anisometropic|Lazy Eyes|Suppression Amblyopias|Suppression Amblyopia|Amblyopia, Suppression|Anisometropic Amblyopias|amblyopia|Developmental Amblyopia|Stimulus Deprivation Induced Amblyopia|Amblyopia, Stimulus Deprivation Induced|Amblyopia, Anisometropic"
NEW10701,DISEASE,control paralysis,controlled paralysis
D008916,CHEBI,Miotics,"Effects, Miotic|Miotic Effect|Miotic Effects|Effect, Miotic|miotics|miotic effects"
NEW10702,DISEASE,common strabismus syndrome,common strabismus syndromes
NEW10703,CHEMICAL,mg/d oral imipramine,mg/d oral Imipramine
NEW10704,MENTAL_HEALTH,21-item Hamilton Depression rating scale,21-item Hamilton Depression Rating Scale
NEW10705,CHEMICAL,150 mg/d oral imipramine,IMI|150 mg/d oral Imipramine
NEW10706,DISEASE,chronic viral Illness Service,Chronic Viral Illness Service
NEW10707,CHEBI,use illicit drug,used illicit drug
D018547,DISEASE,Plant Stems,"stems|Stems, Plant|Stem, Plant|Plant Stem"
NEW10708,DISEASE,fatal overdose,fatal overdose
NEW10709,DISEASE,hypercytokinaemia,hypercytokinaemia
NEW10710,MENTAL_HEALTH,severe acquire respiratory syndrome,severe acquired respiratory syndromes
http://purl.org/sig/ont/fma/fma74643,CHEBI,melanocyte-stimulating hormone,adrenocorticotropin hormone|MSH
NEW10711,CHEMICAL,plasma cortisol rise,plasma cortisol rise
NEW10712,CHEMICAL,supraphysiological steroid treatment,supraphysiological steroid treatment
NEW10713,DISEASE,emotional abnormality,emotional abnormality
NEW10714,DISEASE,human-like bile acid composition,human-like bile acid composition
NEW10715,DISEASE,cholangiopathy fibrosis,cholangiopathy fibrosis
NEW10716,CHEBI,steroidal ba-like fxr agonist,steroidal BA-like FXR agonist
D008105,DISEASE,"Liver Cirrhosis, Biliary","Biliary Cholangitides, Primary|Primary Biliary Cirrhosis|Biliary Cirrhosis, Primary|Obstructive Liver Cirrhosis|Primary Biliary Cholangitides|Liver Cirrhosis, Obstructive|Cholangitis, Secondary Biliary|Secondary Biliary Cholangitides|Biliary Cholangitis, Primary|primary biliary cholangitis|Biliary Cirrhosis, Secondary|Biliary Cirrhosis, Primary, 1|Biliary Cholangitis, Secondary|Cholangitis, Chronic Nonsuppurative Destructive|Secondary Biliary Cirrhosis|Liver Cirrhoses, Biliary|Primary Biliary Cholangitis|Cholangitis, Primary Biliary|Biliary Cirrhosis|Secondary Biliary Cholangitis|Cholangitides, Primary Biliary|Cirrhosis, Secondary Biliary|Cirrhosis, Biliary"
C464660,CHEMICAL,obeticholic acid [Supplementary Concept],Obeticholic acid|Chenodeoxycholic Acid/analogs  and  derivatives
D014580,CHEMICAL,Ursodeoxycholic Acid,"Cholit-Ursan|Ursacholic Acid|Deoxyursocholic Acid|Delursan|Ursodeoxycholate, Sodium|Sodium Ursodeoxycholate|Acid, Ursacholic|ursodeoxycholic acid|3 alpha,7 beta Dihydroxy 5 beta cholan 24 oic Acid|Ursogal|UDCA|Ursodiol|Ursofalk|Ursolvan|Ursochol|Destolit|Cholofalk|Acid, Deoxyursocholic|Urso|3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid|Urso Heumann|Urdox|Ursolite|Ursobilane|Acid, Ursodeoxycholic"
NEW10717,CHEMICAL,second-line treatment,second-line treatment
D007024,DISEASE,"Hypotension, Orthostatic","|postural hypotension|orthostatic hypotension|Postural Hypotension|Hypotension, Postural|Orthostatic Hypotension"
NEW10718,CHEMICAL,oral norepinephrine precursor droxidopa,oral norepinephrine precursor droxidopa
NEW10719,CHEMICAL,mm.,mM.
NEW10720,CHEBI,dietary vitamin b12,dietary vitamin B12
http://purl.obolibrary.org/obo/SYMP_0000030,DISEASE,paralysis,Aβ-induced paralysis
NEW10721,DISEASE,bioenergetic defect,bioenergetic defects
NEW10722,MENTAL_HEALTH,mitochondrial fragmentation,mitochondrial fragmentation
NEW10723,CHEBI,vitamin b12 supplementation,Vitamin B12 supplementation
NEW10724,MENTAL_HEALTH,ms fragmentation spectrum,MS fragmentation spectra
NEW10725,CHEMICAL,gsh marker,GSH markers
NEW10726,DISEASE,target mitochondria dysfunction,targets mitochondria dysfunction
D005739,DISEASE,Gas Poisoning,"gas poisoning|Poisoning, Gas|Poisonings, Gas|Gas Poisonings"
NEW10727,DISEASE,androgen-mediated cutaneous disorder,androgen-mediated cutaneous disorders
D014227,CHEMICAL,Triazines,triazines|Benzotriazines|Triazine
NEW10728,CHEMICAL,optimum anticoccidial activity,optimum anticoccidial activity|POAA
D014366,NUTRITION,Tryptophan Oxygenase,"Pyrrolase, Tryptophan|2,3-Dioxygenase, Tryptophan|Tryptophan 2,3-Dioxygenase|Tryptophan 2,3 Dioxygenase|Tryptophan Pyrrolase|TDO Dioxygenase|Dioxygenase, TDO|tryptophan 2,3-dioxygenase|Oxygenase, Tryptophan"
D011908,MENTAL_HEALTH,Rationalization,rationalization
NEW10729,CHEMICAL,his(55,His(55
NEW10730,CHEMICAL,thr(254,Thr(254
NEW10731,MENTAL_HEALTH,opiate abstinence syndrome,opiate abstinence syndrome
NEW10732,DISEASE,physical dependence,physical dependence
D019900,CHEMICAL,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer","U50488|trans-3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide|U 50488H|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monomethanesulfonate, (trans)-Isomer|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Mesylate, (trans)-(+)-Isomer|U50488H|U50,488H|U-50488|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Mesylate, (trans)-(+-)-Isomer|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monohydrochloride, (trans)-(+-)-Isomer,|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(+-)-Isomer|U 50,488H|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monomethanesulfonate, (trans)-(+)-Isomer|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monomethanesulfonate, (trans)-(+-)-Isomer|Benzeneacetamide, 3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, (trans)-Isomer|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(-)-Isomer|U-50,488H|trans-3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide Hydrochloride|U 50488|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (1S-cis)-Isomer|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (1R-cis)-Isomer|U-50488H"
D050499,DISEASE,Adrenarche,"Adrenarche|Puberty, Precocious (1966-2005)|Adrenal Glands (1973-2005)"
NEW10733,CHEBI,adrenal androgen production,adrenal androgen production
NEW10734,CHEMICAL,zr development,ZR development
NEW10735,CHEBI,adrenarchal androgen,Adrenarchal androgens
NEW10736,DISEASE,sexual pubic hair,sexual pubic hair|pubarche
NEW10737,DISEASE,premature adrenarche,Premature adrenarche
NEW10738,DISEASE,associate behavioral disorder,associated behavioral disorders
D033022,CHEMICAL,Vicia sativa,"sativa, Vicia|Vetch, Common|Common Vetch|sativa|Vetchs, Common|Vicia sativas|Common Vetchs"
NEW10739,CHEBI,several psychotropic drug class,Several psychotropic drug classes
NEW10740,DISEASE,lv infection,LV infection
NEW10741,NUTRITION,fish cell line,fish cell line
D004295,CHEMICAL,Dihydroxyphenylalanine,"L-dopa|3,4 Dihydroxyphenylalanine|beta Hydroxytyrosine|3,4-Dihydroxyphenylalanine|3 Hydroxy DL tyrosine|Dopa|beta-Hydroxytyrosine|Dihydroxyphenylalanine Hydrochloride, (2:1)|3-Hydroxy-DL-tyrosine|3,4-dihydroxyphenylalanine"
NEW10742,CHEMICAL,low ly303870,low LY303870
NEW10743,CHEMICAL,low sp receptor antagonist,low SP receptor antagonists
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Dyskinesia,DISEASE,dyskinesia,etc).Tardive dyskinesia|-dopa-induced dyskinesia|MA-elicited dyskinesias|LID
C096759,CHEMICAL,1-(N-(2-methoxybenzyl)acetylamino)-3-(1H-indol-3-yl)-2-(N-(2-(4-(piperidin-1-yl)piperidin-1-yl)acetyl)amino)propane [Supplementary Concept],LY303870|Indoles|Piperidines
NEW10744,CHEMICAL,ryr2(p/s,RyR2(p/s
NEW10745,DISEASE,lung edema clearance,lung edema clearance
NEW10746,DISEASE,edema clearance,edema clearance
NEW10747,CHEMICAL,alveolar epithelial na,alveolar epithelial Na
NEW10748,DISEASE,neuropathic pain syndrome,neuropathic pain syndromes
http://purl.obolibrary.org/obo/DOID_7148,DISEASE,rheumatoid arthritis,"atrophic Arthritis|Arthritis or polyarthritis, rheumatic|Rheumatoid arthritis patients|rheumatoid arthritis subjects"
NEW10749,MENTAL_HEALTH,stabilize psychosomatic disorder,stabilized psychosomatic disorder
NEW10750,DISEASE,neurotoxic process,Neurotoxic processes
NEW10751,CHEMICAL,n-methyl-d-aspartate nmda receptor activation,N-methyl-D-aspartate NMDA receptor activation
NEW10752,CHEMICAL,high-dose multivitamin,high-dose multivitamins
NEW10753,DISEASE,patient 's seizure,patient's seizures
NEW10754,MENTAL_HEALTH,severe treatment-resistant depression,severe treatment-resistant depression
C004651,CHEMICAL,dipropylacetamide [Supplementary Concept],Valpromide|Valproic Acid/analogs  and  derivatives|Depamide|VPD
NEW10755,CHEMICAL,valproate blood concentration,Valproate blood concentration
NEW10756,NUTRITION,integument enriched fatty acid elongase gene,integument enriched fatty acid elongase gene
NEW10757,MENTAL_HEALTH,desiccation resistance,desiccation resistance
D010937,CHEBI,Plant Growth Regulators,"Plant Hormone|Growth Regulators, Plant|Phytohormone|Regulators, Plant Growth|Phytohormones|Regulator, Plant Growth|Growth Regulator, Plant|Hormones, Plant|Plant hormones|Plant Growth Regulator|Hormone, Plant|phytohormones|Plant Hormones"
NEW10758,DISEASE,oral allergy syndrome,Oral allergy syndrome
NEW10759,CHEMICAL,d2-like receptor antagonist sulpiride,D2-like receptor antagonist sulpiride
C000603053,CHEMICAL,AVCRI104P4 [Supplementary Concept],"AVCRI104P4|Heterocyclic Compounds, 4 or More Rings"
NEW10760,CHEMICAL,multitarget donepezil-huprine hybrid,multitarget donepezil-huprine hybrid
NEW10761,CHEBI,dopamine receptor agonist drug,Dopamine receptor agonist drugs
NEW10762,CHEMICAL,edema dopamine agonist,edema dopamine agonists
D008939,CHEMICAL,Mitotane,"ortho,para DDD|Mitotane|Khloditan|ortho,para-DDD|Mytotan|o,p-DDD|Chlodithane|Chloditan|Lysodren"
NEW10763,DISEASE,high toxicity,high toxicity
D005045,CHEMICAL,Etomidate,etomidate||Radenarkon|R-26490|Etomidate|Hypnomidate|Ethomidate|R 26490|R26490
NEW10764,DISEASE,severe hypercortisolism,severe hypercortisolism
NEW10765,CHEMICAL,intracellular hydrogen peroxide,intracellular hydrogen peroxide
NEW10766,CHEMICAL,intracellular zn2,intracellular Zn2
D006861,CHEMICAL,Hydrogen Peroxide,"Hydrogen Peroxide (H2O2)|Hydroperoxide|Oxydol|hydrogen peroxide|Peroxide, Hydrogen|Superoxol|H2O2|Perhydrol"
NEW10767,CHEMICAL,HLAB*15:02,HLAB*15:02
NEW10768,DISEASE,lamotrigine sjs,lamotrigine SJS
NEW10769,CHEMICAL,phenyltriazine class,phenyltriazine class
D049912,CHEBI,Growth Hormone-Secreting Pituitary Adenoma,"Pituitary Adenoma, GH-Secreting|Adenoma, Somatotroph|GH Secreting Pituitary Adenoma|Somatotroph Adenomas|Adenomas, Somatotroph|growth hormone|Pituitary Growth Hormone-Secreting Adenoma|Acromegaly Due To Pituitary Adenoma|Pituitary Adenoma, Growth Hormone Secreting|Pituitary Adenoma, Growth Hormone-Secreting|Somatotropinoma, Familial Isolated|Pituitary Adenoma, GH Secreting|Pituitary Growth Hormone Secreting Adenoma|GH-Secreting Pituitary Adenomas|Somatotroph Adenoma|Pituitary Adenomas, GH-Secreting|Isolated Familial Somatotropinoma|GH-Secreting Pituitary Adenoma|Somatotrophinoma, Familial"
D000067401,CHEMICAL,Blood Alcohol Content,"Alcohol Content, Blood|Blood Alcohol Level|Content, Blood Alcohol|% blood alcohol concentration|Blood Alcohol Concentration|Alcohol Level, Blood|Level, Blood Alcohol|Alcohol Concentration, Blood|Concentration, Blood Alcohol"
NEW10770,CHEMICAL,ethanol intoxication,ethanol intoxication
D000077209,CHEMICAL,Decitabine,"5 Deoxyazacytidine|5-Azadeoxycytidine|5-Deoxyazacytidine|NSC127716|5 Azadeoxycytidine|5-AzadC|DAC|Dacogen|AzadC Compound|5 Aza 2' deoxycytidine|NSC-127716|2'-Deoxy-5-azacytidine|Decitabine|5-Aza-2'-deoxycytidine|5AzadC|2' Deoxy 5 azacytidine|NSC 127716|Mesylate, Decitabine|Compound, AzadC|Decitabine Mesylate"
D007521,CHEMICAL,Isocitrate Dehydrogenase,"Isocitrate Dehydrogenase I|NAD Isocitrate Dehydrogenase|Isocitrate Dehydrogenase-I|Isocitrate Dehydrogenase (NAD+)|isocitrate dehydrogenase|Dehydrogenase, NAD Isocitrate|Dehydrogenase, Isocitrate|Isocitrate Dehydrogenase, NAD"
NEW10771,DISEASE,idh-mutant glioma,IDH-mutant gliomas
NEW10772,CHEMICAL,gaba synthesis,GABA synthesis
NEW10773,CHEMICAL,l-allyglycine,l-allyglycine
NEW10774,CHEMICAL,nalac response,NaLac response
NEW10775,CHEMICAL,glutamate mechanism,glutamate mechanism
NEW10776,DISEASE,panic-like state,panic-like state
NEW10777,CHEMICAL,nalac-induced panic-like behavior,NaLac-induced panic-like behaviors
NEW10778,CHEMICAL,nalac challenge,NaLac challenge
NEW10779,DISEASE,cardiovascular tachycardia response,cardiovascular tachycardia responses
NEW10780,CHEMICAL,nalac-induced panic-like cardiovascular,NaLac-induced panic-like cardiovascular
NEW10781,CHEMICAL,nalac dose,NaLac dose
NEW10782,CHEMICAL,cbipes,CBiPES
NEW10783,CHEMICAL,chronic l-methionine administration,Chronic L-methionine administration
NEW10784,CHEMICAL,serum nitrite level,serum nitrite levels
NEW10785,DISEASE,l-methionine-induced endothelial dysfunction,L-methionine-induced endothelial dysfunction
C034364,CHEMICAL,ozagrel [Supplementary Concept],ozagrel|Methacrylates
C117600,CHEMICAL,enterostatin receptor [Supplementary Concept],"VPDPR|Enterostatin|Receptors, Cell Surface"
NEW10786,CHEMICAL,intracavernosal injection,Intracavernosal injections|ICI|intracavernous injections
NEW10787,CHEBI,female premutation carrier,Female premutation carriers
NEW10788,DISEASE,immune-mediated disorder,immune-mediated disorders
D031337,NUTRITION,Mentha spicata,"Mentha spicata|Spearmint|Spearmints|Mentha spicatas|spicata, Mentha"
NEW10789,DISEASE,primary hypoparathyroidism,Primary hypoparathyroidism
NEW10790,CHEBI,parathyroid hormone deficiency,parathyroid hormone deficiency
D004329,CHEMICAL,Droperidol,droperidol||Dehidrobenzperidol|Inapsine|Droperidol|Droleptan|Dehydrobenzperidol
NEW10791,DISEASE,primary organic disorder,Primary organic disorders
NEW10792,DISEASE,affective disease,affective disease
NEW10793,CHEMICAL,thyrotropin (tsh)-releasing hormone test,thyrotropin (TSH)-releasing hormone test
NEW10794,CHEBI,powerful stimulant drug,powerful stimulant drug
NEW10795,CHEBI,water-soluble vitamin e,water-soluble vitamin E
C550427,CHEMICAL,trolox-L-carnosine [Supplementary Concept],Trolox|Carnosine/analogs  and  derivatives
NEW10796,CHEMICAL,vilazodone poisoning,Vilazodone poisoning
C001864,CHEMICAL,aluminum phosphide [Supplementary Concept],Aluminum phosphide|Phosphines|Aluminum Compounds
NEW10797,MENTAL_HEALTH,common suicide agent,common suicide agent
D016267,MENTAL_HEALTH,External Fixators,"Fixation Device, External|Devices, External Fixation|External Fixator|Fixation Devices, External|External Fixation Devices|External Fixation Device|Device, External Fixation|Fixator, External|external fixation|Fixators, External"
NEW10798,CHEBI,narcotic analgesic support,narcotic analgesic support
D006620,DISEASE,Hip Fractures,"Fractures, Hip|Trochanteric Fractures|Fractures, Intertrochanteric|Subtrochanteric Fractures|intertrochanteric fractures|Fractures, Subtrochanteric|Fractures, Trochanteric|Intertrochanteric Fractures"
NEW10799,CHEMICAL,thyroxine level,thyroxine levels
NEW10800,DISEASE,muscle mass breakdown,muscle mass breakdown
NEW10801,DISEASE,depressed ambulatory outpatient,depressed ambulatory outpatients
D006502,DISEASE,Budd-Chiari Syndrome,"Chiari's Syndrome|Hepatic Vein Thrombosis|Thrombosis, Hepatic Vein|Budd Chiari Syndrome|Hepatic Venous Outflow Obstruction|Vein Thromboses, Hepatic|Budd-Chiari Syndrome|Thromboses, Hepatic Vein|Chiari Syndrome|Hepatic Vein Thromboses|Chiaris Syndrome|Vein Thrombosis, Hepatic"
C000599677,CHEMICAL,diphenidine [Supplementary Concept],Piperidines|Diphenidine
NEW10802,DISEASE,formalin-induced nociceptive behavior,formalin-induced nociceptive behavior
NEW10803,CHEBI,s carrier,s carriers
NEW10804,DISEASE,vacc dysfunction,vACC dysfunction
NEW10805,CHEMICAL,gaba activity,GABA activity
NEW10806,CHEBI,antipanic drug efficacy,antipanic drug efficacy
http://purl.obolibrary.org/obo/CHEBI_51373,CHEBI,gaba agonist,GABA receptor agonists|gamma-aminobutyric acid receptor agonist|GABA agonists|GABA receptor agonist|gamma-aminobutyric acid receptor agonists|selective GABA agonist
NEW10807,CHEBI,human drug use,human drug use
NEW10808,CHEMICAL,allopregnanalone,allopregnanalone
NEW10809,CHEBI,antimicrobial efficacy,antimicrobial efficacy
NEW10810,DISEASE,fungal strain,Candida albicans|fungal strain
NEW10811,CHEBI,synergistic antimicrobial effect,synergistic antimicrobial effect
NEW10812,CHEMICAL,specific oxygen uptake rate,specific oxygen uptake rates
NEW10813,CHEMICAL,calcium precipitation,calcium precipitation
NEW10814,DISEASE,eps content,EPS contents
NEW10815,CHEMICAL,specific ammonium oxidation rate,specific ammonium oxidation rates
NEW10816,DISEASE,high osa risk,high OSA risk
NEW10817,DISEASE,vdbt patient,VDBT patients
NEW10818,DISEASE,binswanger type vascular dementia,Binswanger type vascular dementia|VDBT
NEW10819,CHEMICAL,serotonin pathway,serotonin pathways
NEW10820,CHEMICAL,quaternary tetramethylammonium tetrafluoroborate tma bf4 salt,quaternary tetramethylammonium tetrafluoroborate TMA BF4 salt
NEW10821,DISEASE,high-modulus property,high-modulus properties
NEW10822,CHEMICAL,polyamide molecule,polyamide molecules
NEW10823,CHEMICAL,aliphatic polyamide nylon fibre,aliphatic polyamide nylon fibres
D000078789,CHEBI,Polyacetylene Polymer,"polymer|Polymers, Polyacetylene|Polyacetylene|Polymer, Polyacetylene|Polyacetylene Polymers"
http://purl.obolibrary.org/obo/CHEBI_61950,CHEBI,microtubule-stabilising agent,microtubule stabilising agent|microtubule-stabilizing agent|microtubule stabilizing role|microtubule stabilising role|microtubule stabilizing agents|microtubule-stabilising agents|microtubule stabilizing agent
NEW10824,CHEMICAL,natural epothilone b,natural epothilone B
C430592,CHEMICAL,ixabepilone [Supplementary Concept],Ixabepilone|Epothilones|ixabepilone
NEW10825,DISEASE,similar neurotoxicity profile,similar neurotoxicity profile
D043823,CHEMICAL,Taxoids,taxanes|Taxoid|Taxanes
NEW10826,CHEBI,microtubule stabilize agent,microtubule stabilizing agent
NEW10827,DISEASE,androgen-independent prostate cancer,androgen-independent prostate cancer
NEW10828,CHEMICAL,potent non-taxane microtubule,potent non-taxane microtubule
C093788,CHEMICAL,epothilone B [Supplementary Concept],epothilone B|Patupilone|Epothilones
D000072482,CHEMICAL,Retinoic Acid Receptor alpha,"RAR alpha 2|Retinoic Acid Receptor alpha 2|Retinoic acid receptor|Retinoic Acid Receptor alpha 1|alpha 1, RAR|alpha 2, RAR|RAR alpha 1"
NEW10829,DISEASE,cums rat,CUMS rats
NEW10830,MENTAL_HEALTH,hpa axis hyperactivity,HPA axis hyperactivity
NEW10831,CHEBI,corticotrophin-releasing hormone protein level,corticotrophin-releasing hormone protein level
NEW10832,CHEMICAL,reduce serum corticosterone level,reduced serum corticosterone level
C071721,CHEMICAL,Ro 41-0960 [Supplementary Concept],Ro41|Benzophenones
NEW10833,DISEASE,hippocampal neuronal deficit,hippocampal neuronal deficits
NEW10834,DISEASE,dyskinesia-like abnormal involuntary movement,dyskinesia-like abnormal involuntary movements
NEW10835,DISEASE,parkinson 's disease-model rat,Parkinson's disease-model rats
NEW10836,CHEMICAL,l-dopa injection,L-DOPA injection
NEW10837,DISEASE,l-dopa-induced dyskinesia-model rat,L-DOPA-induced dyskinesia-model rats
NEW10838,CHEMICAL,l-dopa dosing,L-DOPA dosing
NEW10839,CHEMICAL,excessive gaba storage,excessive GABA storage
D000068580,CHEMICAL,Varenicline,"Varenicline Tartrate|6,7,8,9-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)benzazepine|Varenicline|Champix|varenicline|Chantix"
NEW10840,CHEBI,partial nicotinic agonist,partial nicotinic agonist
NEW10841,MENTAL_HEALTH,late-life depression,Late-life depression
NEW10842,CHEBI,nicotinic agonist drug,nicotinic agonist drugs
NEW10843,CHEBI,androgen receptor (ar)-regulated gene,androgen receptor (AR)-regulated genes
NEW10844,DISEASE,ar-positive prostate cancer cell line,AR-positive prostate cancer cell lines
http://purl.obolibrary.org/obo/CHEBI_28121,CHEMICAL,harmine,"Harmine|Leucoharmine|7-methoxy-1-methyl-9H-beta-carboline|Banisterine|Yageine|Telepathine|6-Methoxyharman|Yajeine|7-methoxy-1-methyl-9H-pyrido[3,4-b]indole|CGA|astragalosides"
NEW10845,CHEMICAL,atp content,ATP content
D061566,CHEMICAL,Voltage-Gated Sodium Channels,"Voltage-Gated Sodium Channel|Voltage Gated Sodium Channel|Channels, Voltage-Gated Sodium|Sodium Channels, Voltage Gated|Sodium Channels, Voltage-Gated|Channel, Voltage-Gated Sodium|Sodium Channel, Voltage-Gated|Voltage-gated sodium channels|voltage-gated sodium channels|Voltage Gated Sodium Channels"
NEW10846,DISEASE,toxin-induced excruciate pain,toxin-induced excruciating pain
NEW10847,CHEMICAL,extraneous carbon,extraneous carbon
NEW10848,CHEMICAL,production profile,production profiles
NEW10849,CHEMICAL,pin2/terf1 interacting telomerase inhibitor,PIN2/TERF1 interacting telomerase inhibitor
NEW10850,CHEBI,telomerase inhibitor located,telomerase inhibitor located
D065851,DISEASE,Ovarian Reserve,"ovarian|Reserves, Ovarian|Ovarian Reserves|Reserve, Ovarian"
D001749,DISEASE,Urinary Bladder Neoplasms,"|Tumor, Bladder|Bladder Neoplasms|Urinary Bladder Cancer|Malignant Tumor of Urinary Bladder|Bladder Neoplasm|Bladder Cancers|Bladder Cancer|Neoplasm, Bladder|Cancer of the Bladder|bladder cancer|Bladder Tumors|bladder carcinomas|Neoplasm, Urinary Bladder|Bladder Tumor|Tumors, Bladder|Cancer of Bladder|Cancer, Urinary Bladder|Urinary Bladder Neoplasm|Neoplasms, Bladder|Cancer, Bladder"
D051794,DISEASE,Von Hippel-Lindau Tumor Suppressor Protein,Von Hippel Lindau Tumor Suppressor Protein|tumor suppressor|VHL Tumor Suppressor Protein
D019389,CHEMICAL,Cytochrome P-450 CYP2D6,"Debrisoquine 4-Hydroxylase|Debrisoquine Hydroxylase|P-450 CYP2D6, Cytochrome|Cytochrome P450 2D6|Monooxygenase, Sparteine|debrisoquine|Imipramine 2 Hydroxylase|2-Hydroxylase, Imipramine|CYP2D6, Cytochrome P-450|Sparteine Monooxygenase|Debrisoquine 4-Monooxygenase|Debrisoquine 4 Monooxygenase|Hydroxylase, Debrisoquine|Debrisoquine 4 Hydroxylase|4-Hydroxylase, Debrisoquine|CYP 2D6|Cytochrome P 450 CYP2D6|4-Monooxygenase, Debrisoquine|P450 2D6, Cytochrome|Imipramine 2-Hydroxylase|CYP2D6"
NEW10851,CHEBI,genetic probe drug,genetic probe drug
C028653,CHEMICAL,2-hydroxydesipramine [Supplementary Concept],2-hydroxydesipramine|Desipramine/analogs  and  derivatives
D000077208,CHEMICAL,Remifentanil,remifentanil|Remifentanil Hydrochloride|Ultiva|3-(4-Methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic Acid Methyl Ester|GI-87084B|Remifentanil Monohydrochloride|Remifentanil|GI 87084B|GI87084B
NEW10852,DISEASE,sphincter spasm,sphincter spasm
NEW10853,CHEBI,"nonselective cb1/cb2 receptor agonist win55,212","nonselective CB1/CB2 receptor agonist WIN55,212"
D015082,CHEMICAL,"2,2'-Dipyridyl","WIN|2,2-Dipyridyl|alpha,alpha-Dipyridyl|WIN-2|2,2'-Bipyridine|Dipyridyl, 2,2'|2,2 Dipyridyl|alpha,alpha Dipyridyl|2,2' Bipyridine|2,2 Bipyridine|2,2-Bipyridyl|2,2' Dipyridyl|2,2 Bipyridyl|inulins|Bipyridyl|2|Dipyridyl, 2,2|2,2-Bipyridine"
NEW10854,MENTAL_HEALTH,hand amnesia,hand amnesia
NEW10855,CHEMICAL,nmda μg/rat,NMDA μg/rat
http://purl.obolibrary.org/obo/CHEBI_144132,CHEMICAL,caperatic acid,docosahexaenoic acid C22:6 n-3|acids eicosapentaenoic acid|particular eicosapentaenoic acid
NEW10856,DISEASE,dietary deficiency,Dietary deficiency
http://purl.obolibrary.org/obo/CHEBI_26523,CHEMICAL,reactive oxygen species,reactive oxygen species capable|reactive oxygen species production|ROS
NEW10857,DISEASE,anger level,anger levels
NEW10858,DISEASE,aggressive tendency,aggressive tendencies
NEW10859,CHEBI,sympatholytic medication,sympatholytic medications
D020186,MENTAL_HEALTH,Sleep Bruxism,"Bruxisms, Nocturnal|Sleep Bruxism, Childhood|Sleep bruxism|Sleep Bruxisms, Adult|Sleep-Related Bruxisms|Adult Sleep Bruxisms|Adult Sleep Bruxism|Bruxism, Sleep|sleep bruxism|Childhood Sleep Bruxism|Sleep Related Bruxism|Nocturnal Bruxisms|bruxism|Bruxisms, Sleep|Nocturnal Bruxism|Childhood Sleep Bruxisms|Sleep-Related Bruxism|Sleep Bruxism, Adult|Sleep Bruxisms|Bruxism, Sleep-Related|Bruxisms, Sleep-Related|Nocturnal Teeth Grinding Disorder|Sleep Bruxisms, Childhood|Bruxism, Nocturnal|Teeth Grinding Disorder, Nocturnal"
NEW10860,DISEASE,episodes/Leigh overlap syndrome,episodes/Leigh overlap syndrome
NEW10861,DISEASE,mitochondrial disorder subtype,mitochondrial disorder subtype
NEW10862,DISEASE,silent pandemic,silent pandemic
NEW10863,CHEMICAL,preoperative gabapentin,Preoperative gabapentin
NEW10864,MENTAL_HEALTH,somnolence risk,somnolence risk
NEW10865,CHEBI,dopaminergic agonist group,dopaminergic agonist group
NEW10866,CHEMICAL,peripheral a1 adenosine receptor signaling,Peripheral A1 adenosine receptor signaling
NEW10867,CHEMICAL,camp signaling cascade,cAMP signaling cascades
NEW10868,MENTAL_HEALTH,local acupuncture analgesia,local acupuncture analgesia
NEW10869,DISEASE,acute animal pain model,acute animal pain models
NEW10870,CHEMICAL,adenosine a1 receptor activation,adenosine A1 receptor activation
NEW10871,CHEBI,combination antibacterial,Combination antibacterials
NEW10872,CHEBI,antiandrogen cyproterone acetate,antiandrogen cyproterone acetate
D002613,DISEASE,Cheilitis,Cheilitis|Cheilitides
NEW10873,NUTRITION,topical tocopherol,topical tocopherol
NEW10874,DISEASE,angular stomatitis,angular stomatitis
D002710,CHEMICAL,Chlorhexidine,"Sebidin A|MK412A|Chlorhexidine|Hydrochloride, Chlorhexidine|Chlorhexidine Acetate|Novalsan|chlorhexidine|Chlorhexidine Hydrochloride|Tubulicid|Acetate, Chlorhexidine|MK 412A|MK-412A"
D064548,CHEBI,Hand Sanitizers,"Antiseptic, Hand|disinfectant|Hand Disinfectant|Disinfectant, Hand|Hand Disinfectants|Hand Antiseptic|Sanitizer, Hand|Hand Antiseptics|Hand Sanitizer"
NEW10875,CHEBI,antibiotic policy,Antibiotic policies
NEW10876,CHEMICAL,elevated mao-a level,elevated MAO-A levels
NEW10877,DISEASE,depressive process,depressive process
NEW10878,CHEMICAL,1l-1β,1L-1β
NEW10879,MENTAL_HEALTH,systemic resistance,Systemic resistance
NEW10880,NUTRITION,insect pest,insect pests
NEW10881,DISEASE,impaired recognition memory,impaired recognition memory
NEW10882,CHEBI,asymptomatic gene carrier,asymptomatic gene carriers
NEW10883,DISEASE,early cognitive deficit,early cognitive deficits
NEW10884,CHEMICAL,baseline vasopressin release,baseline vasopressin release
NEW10885,CHEMICAL,crown rot,crown rot
NEW10886,DISEASE,major disease,major disease
C045246,DISEASE,"PAEP protein, human [Supplementary Concept]",Glycodelin|human pregnancy
D019465,DISEASE,Craniofacial Abnormalities,"Abnormalities, Craniofacial|Abnormality, Craniofacial|Craniofacial Abnormality|craniofacial abnormalities"
D000444,CHEMICAL,Aldehyde Dehydrogenase,"Aldehyde NAD Oxidoreductase|Aldehyde-NAD Oxidoreductase|Aldehyde Dehydrogenase E2|D Glucuronolactone Dehydrogenase|D-Glucuronolactone Dehydrogenase|Aldehyde Dehydrogenase E1|Dehydrogenase, D-Glucuronolactone|Dehydrogenase, Aldehyde|aldehyde dehydrogenase|Aldehyde Dehydrogenase (NAD(+))"
NEW10887,MENTAL_HEALTH,excitation dissociation,excitation dissociation
NEW10888,MENTAL_HEALTH,capture dissociation,capture dissociation
NEW10889,MENTAL_HEALTH,collision-induced dissociation,collision-induced dissociation
NEW10890,MENTAL_HEALTH,dissociation method,dissociation methods
NEW10891,CHEMICAL,ssri/snri,SSRI/SNRI
NEW10892,CHEBI,c. jejuni drug resistance,C. jejuni drug resistance
NEW10893,CHEBI,standard antibiotic,standard antibiotics
C005790,CHEMICAL,beta-thujone [Supplementary Concept],Bicyclic Monoterpenes|thujone
NEW10894,CHEMICAL,gaba type a receptor modulation,GABA type A receptor modulation
D014500,CHEMICAL,Uracil Nucleotides,"Phosphates, Uridine|Nucleotides, Uridine|Nucleotides, Uracil|Nucleotides|Uridine Phosphates|Uridine Nucleotides|nucleotides"
NEW10895,CHEMICAL,gtp gamma s great,GTP gamma S greater
D006165,CHEMICAL,Guanylyl Imidodiphosphate,"Guanosine 5'-(Beta,Gamma-Imido)Triphosphate|Guanyl 5' Imidodiphosphate|Guanyl-5'-Imidodiphosphate|Gpp(NH)p|GPP(NH)P|GMP-P(NH)P|P(NH)PPG|GMP-PNP|Imidodiphosphate, Guanylyl"
NEW10896,CHEMICAL,[3h]rauwolscine,[3H]rauwolscine
NEW10897,CHEMICAL,portunus trituberculatus,Portunus trituberculatus|Pt-egg oil
NEW10898,DISEASE,atoxigenic aspergillus flavus isolate,atoxigenic Aspergillus flavus isolates
NEW10899,CHEMICAL,aflatoxin contamination,aflatoxin contamination
D016607,CHEMICAL,Aflatoxin M1,"4-Hydroxyaflatoxin B1|4 Hydroxyaflatoxin B1|Aflatoxin|Aflatoxin M|Aflatoxin M1, cis(+-)-Isomer|aflatoxin|Aflatoxin M(1)"
NEW10900,DISEASE,atoxigenic a. flavus genotype,atoxigenic A. flavus genotypes
D016604,CHEMICAL,Aflatoxin B1,"Aflatoxin B1, (6aR-cis)-Isomer, 2H-Labeled|NSC 529592|Aflatoxin B1, cis(+,-)-Isomer|HSDB 3453|Aflatoxin B(1)|HSDB3453|Aflatoxin B|Aflatoxin B1 Dihydrochloride, (6aR-cis)-Isomer|Aflatoxin B1, (6aR-cis)-Isomer, 14C-Labeled|NSC529592|HSDB-3453|NSC-529592|aflatoxin B1|Aflatoxin B1, (6aR-cis)-Isomer, 3H-Labeled"
NEW10901,DISEASE,atoxigenic a. flavus,atoxigenic A. flavus
NEW10902,CHEMICAL,afb1 degradation,AFB1 degradation
NEW10903,MENTAL_HEALTH,competitive displacement,competitive displacement
NEW10904,CHEMICAL,crop aflatoxin contamination,crop aflatoxin contamination
NEW10905,CHEMICAL,schisandra chinensis extract,Schisandra chinensis extract
NEW10906,DISEASE,peripheral nerve ending,peripheral nerve endings
NEW10907,DISEASE,erectile body,erectile bodies
NEW10908,CHEBI,low vitamin d level,low vitamin D levels
NEW10909,CHEBI,hormone therapy,Hormone therapy
NEW10910,MENTAL_HEALTH,persistent gender dysphoria,persistent gender dysphoria
NEW10911,DISEASE,decrease sexual desire,Decreased sexual desire
NEW10912,CHEMICAL,testosterone concentration,testosterone concentrations
NEW10913,CHEBI,h2 antagonist activity,H2 antagonist activity
NEW10914,MENTAL_HEALTH,moment orientation,moment orientation
NEW10915,CHEMICAL,traditional antidepressant,serotonin re-uptake inhibitors|traditional antidepressants
NEW10916,CHEMICAL,bind ferulic acid,bound ferulic acid
NEW10917,CHEMICAL,carbamazepine treatment,Carbamazepine treatment
NEW10918,DISEASE,facial tic,facial tics
NEW10919,CHEMICAL,amyloid positron emission tomography,amyloid positron emission tomography
NEW10920,CHEBI,amyloid beta accumulation,amyloid beta accumulation
NEW10921,CHEMICAL,glyphosate-grown culture,glyphosate-grown cultures
NEW10922,CHEMICAL,co2 fixation,CO2 fixation
NEW10923,CHEMICAL,nitrate transport,nitrate transport
NEW10924,CHEMICAL,citrate cycle,citrate cycle
http://purl.obolibrary.org/obo/DOID_2575,MENTAL_HEALTH,barbiturate dependence,Barbiturate dependence
NEW10925,DISEASE,cerebrovascular inflammation,cerebrovascular inflammation
NEW10926,CHEMICAL,intraoperative adenosine,Intraoperative adenosine
NEW10927,DISEASE,aneurysm dome,aneurysm dome
NEW10928,DISEASE,great stress/anxiety,greater stress/anxiety
C562325,CHEMICAL,dolutegravir [Supplementary Concept],"Oxazines|Pyridones|Heterocyclic Compounds, 3-Ring|Piperazines|dolutegravir"
D000068898,CHEMICAL,Raltegravir Potassium,"MK-0518|Raltegravir|Potassium, Raltegravir|0518, MK|MK0518|Isentress|MK 0518"
NEW10929,MENTAL_HEALTH,less hyperarousal,less hyperarousal
NEW10930,CHEMICAL,wwh,WWH
NEW10931,CHEMICAL,peritraumatic ketamine,peritraumatic ketamine
D031581,CHEMICAL,Banisteriopsis,ayahuasca|Ayahuascas|Banisteriopses|Ayahuasca
NEW10932,MENTAL_HEALTH,crack cocaine dependence treatment,crack cocaine dependence treatment
NEW10933,CHEMICAL,high arachidonic acid level,high arachidonic acid levels
NEW10934,CHEMICAL,low sphingomyelin level,low sphingomyelin levels
NEW10935,DISEASE,sporadic ad patient,sporadic AD patients
NEW10936,DISEASE,obesity risk factor,obesity risk factors
NEW10937,CHEBI,noncompetitive n-methyl-d-aspartate/glutamate receptor antagonist,Noncompetitive N-methyl-D-aspartate/glutamate receptor antagonists
NEW10938,MENTAL_HEALTH,monoaminergic antidepressant-resistant mood disorder,monoaminergic antidepressant-resistant mood disorder
NEW10939,DISEASE,abdominal obesity lipid disorder,abdominal obesity lipids disorders
NEW10940,DISEASE,carbohydrate disorder,carbohydrates disorders
NEW10941,CHEMICAL,transdermal testosterone,transdermal testosterone
NEW10942,MENTAL_HEALTH,generalize acquire hypoactive sexual desire disorder,generalized acquired hypoactive sexual desire disorder
C035514,CHEMICAL,"N-2-diazo-3,3,3-trifluoropropionyl-3,5,3'-triiodothyronine [Supplementary Concept]",Diazonium Compounds|Triiodothyronine/analogs  and  derivatives|L-T3
NEW10943,CHEMICAL,rbc l-t3 uptake,RBC L-T3 uptake
NEW10944,CHEBI,translocation carrier,translocation carriers
NEW10945,CHEMICAL,persistent alcohol imbibing,persistent alcohol imbibing
NEW10946,DISEASE,nerve damage,nerve damage
D003620,CHEMICAL,Dantrolene,"Dantrolene Sodium|Sodium, Dantrolene|Dantrolene|Dantrium"
http://purl.obolibrary.org/obo/SYMP_0000187,DISEASE,tiredness,tiredness|forgetfulness
NEW10947,DISEASE,prolonged non-convulsive status epilepticus,prolonged non-convulsive status epilepticus|NCSE
D013874,CHEMICAL,Thiopental,|Pentothal Sodico|Bomathal|Thiomebumal|thiopental|Thiopentobarbital|Pentothal|Thiopental Sodium|sodium pentothal|Thionembutal|Trapanal|Tiobarbital Braun|Penthiobarbital|Sodipental|Nesdonal|Thiopental Nycomed|Thiopentone
NEW10948,CHEMICAL,intravenous oxycodone analgesia,Intravenous oxycodone analgesia
NEW10949,MENTAL_HEALTH,patient-controlled analgesia device,patient-controlled analgesia device
NEW10950,CHEBI,new oral gonadotropin-releasing hormone antagonist,new oral gonadotropin-releasing hormone antagonist
D062788,DISEASE,Adenomyosis,|adenomyosis|Adenomyoses
NEW10951,CHEBI,endometrial estrogen agonist,endometrial estrogen agonist
NEW10952,CHEMICAL,modulator bazedoxifene,modulators bazedoxifene
D000568,DISEASE,Amenorrhea,"|Amenorrhea, Postpartum|amenorrhea|Postpartum Amenorrhea|Postpartum Amenorrheas"
NEW10953,DISEASE,hormone-sensitive diseaseand,hormone-sensitive diseaseand
NEW10954,CHEMICAL,persistent testosterone,Persistent testosterone
NEW10955,CHEMICAL,impaired glucose metabolism,impaired glucose metabolism
NEW10956,CHEMICAL,neuronal histamine,neuronal histamine
NEW10957,MENTAL_HEALTH,meth-induced locomotor hyperactivity,METH-induced locomotor hyperactivity
D011969,CHEMICAL,"Receptors, Histamine H1","H1 Receptors|H1 receptors|Histamine H1 Receptors|Receptors, H1|H1 Receptors, Histamine|H1 Receptor, Histamine|histamine H1-receptors|H1 Receptor|Receptor, H1|Histamine H1 Receptor|Receptor, Histamine H1"
NEW10958,DISEASE,meth-induced abnormal behavior,METH-induced abnormal behaviors
http://cbmi.med.harvard.edu/asdphenotype#Class_386,CHEMICAL,perinatal exposures,perinatal SSRI exposure|perinatal DEHP exposure
NEW10959,DISEASE,asd-like behavioral change,ASD-like behavioral changes
NEW10960,CHEMICAL,plasma ne value,plasma NE values
NEW10961,CHEBI,appetite hormone,appetite hormones
http://purl.obolibrary.org/obo/DOID_8670,MENTAL_HEALTH,eating disorder,bulimic-spectrum eating disorders
NEW10962,CHEMICAL,steroidogenic inhibitor finasteride,steroidogenic inhibitor finasteride
NEW10963,MENTAL_HEALTH,pathological gambling severity,pathological gambling severity
NEW10964,CHEMICAL,RES     mg/kg/day,RES    mg/kg/day
NEW10965,DISEASE,key impulsivity function,key impulsivity function
NEW10966,CHEMICAL,dopamine d3 receptor-preferential agonist pramipexole,PPX|dopamine D3 receptor-preferential agonist pramipexole
NEW10967,CHEMICAL,monoamine-depleting agent reserpine,monoamine-depleting agent reserpine
NEW10968,DISEASE,botrytis sp.,Botrytis sp.
NEW10969,NUTRITION,black raspberry,black raspberry
NEW10970,NUTRITION,red raspberry,red raspberry
D031985,NUTRITION,Fragaria,"Strawberries, Woodland|Strawberries|Alpine Strawberries|Woodland Strawberry|Fragaria vesca|Strawberry|strawberry|Woodland Strawberries|Strawberry, Alpine|Strawberries, Alpine|Strawberry, Woodland|Alpine Strawberry"
NEW10971,MENTAL_HEALTH,resistance conferring mutation,Resistance conferring mutations
NEW10972,CHEMICAL,p225f,P225F
NEW10973,CHEMICAL,galantamine treatment,galantamine treatment
NEW10974,MENTAL_HEALTH,addition resistance,addition resistance
NEW10975,DISEASE,murine endotoxemia,murine endotoxemia
NEW10976,CHEMICAL,centrally-acting cholinergic drug galantamine,centrally-acting cholinergic drug galantamine
NEW10977,CHEMICAL,positive allosteric modulator benzyl quinolone carboxylic acid,positive allosteric modulator benzyl quinolone carboxylic acid
NEW10978,CHEMICAL,acetylcholine action,acetylcholine action
D023382,DISEASE,"Toxicity Tests, Acute","acute toxicity|Acute Toxicity Tests|Acute Toxicity Test|Tests, Acute Toxicity|Toxicity Test, Acute|Test, Acute Toxicity"
NEW10979,MENTAL_HEALTH,apparent drowsiness,apparent drowsiness
NEW10980,DISEASE,neck hyperextension,neck hyperextension
NEW10981,CHEBI,a dose equivalent,A doses equivalent
NEW10982,CHEMICAL,elevated triiodothyronine,T3|elevated triiodothyronine
D014284,CHEMICAL,Triiodothyronine,"T3 Thyroid Hormone|Liothyronine|triiodothyronine|Thyroid Hormone, T3|Liothyronine Sodium|Cytomel|3,3',5-Triiodothyronine|liothyronine"
D016640,DISEASE,"Diabetes, Gestational","Diabetes, Pregnancy-Induced|GDM|Diabetes, Pregnancy Induced|Gestational Diabetes Mellitus|gestational diabetes mellitus|Diabetes Mellitus, Gestational|Pregnancy-Induced Diabetes|Gestational Diabetes"
D019578,DISEASE,Multiple System Atrophy,"multiple system atrophy|Atrophies, Multisystemic|Atrophy, Multisystemic|Multiple System Atrophy Syndrome|multisystem atrophy|Multiple system atrophy|Multisystemic Atrophies|Multisystem Atrophy|Multisystem Atrophies|MSA|Multiple System Atrophies|Atrophy, Multiple System|Multisystemic Atrophy|Atrophies, Multisystem|Atrophy, Multisystem"
NEW10983,MENTAL_HEALTH,related erectile dysfunction,related erectile dysfunction
NEW10984,DISEASE,select neurological disorder,selected neurological disorders
NEW10985,CHEMICAL,sativa plant,sativa plant
NEW10986,DISEASE,psychotic symptom due,psychotic symptoms due
NEW10987,CHEMICAL,nad precursor,NAD precursors
D046730,DISEASE,"Colitis, Lymphocytic",Lymphocytic Colitis|colitis
http://purl.obolibrary.org/obo/CHEBI_89871,CHEMICAL,"2,2,4-trimethyl-1,3-pentadienol diisobutyrate","R-enantiomer|racemic N-propargylamine-2-aminotetralin|2,2,4-trimethyl-1-[(2-methylpropanoyl)oxy]pentan-3-yl 2-methylpropanoate|2-PAT"
NEW10988,CHEBI,serotonin agonist medication,serotonin agonist medications
NEW10989,CHEBI,life-threatening adverse drug reaction,life-threatening adverse drug reaction
NEW10990,MENTAL_HEALTH,second resistance mechanism,second resistance mechanism
C000602893,CHEMICAL,ribocil [Supplementary Concept],ribocil|Pyrimidines
NEW10991,CHEMICAL,natural riboswitch regulatory ligand flavin mononucleotide,natural riboswitch regulatory ligand flavin mononucleotide
NEW10992,CHEMICAL,ribocil binding,ribocil binding
NEW10993,CHEBI,riboflavin biosynthesis,riboflavin biosynthesis
NEW10994,MENTAL_HEALTH,efficient repression,efficient repression
NEW10995,CHEMICAL,low dopamine level,lower dopamine levels
NEW10996,CHEMICAL,norepinephrine stimulation,norepinephrine stimulation
NEW10997,CHEMICAL,α1 -adrenergic antagonist,α1 -adrenergic antagonist
NEW10998,DISEASE,cud patient,CUD patients
NEW10999,DISEASE,cjd patient,CJD patient
NEW11000,CHEBI,possible drug,possible drug
http://purl.obolibrary.org/obo/DOID_1510,MENTAL_HEALTH,personality disorder,character disorder|DSM-III-R personality disorders
NEW11001,CHEMICAL,serial plasma cortisol,serial plasma cortisol
NEW11002,CHEMICAL,cortisol response,cortisol responses
NEW11003,DISEASE,intermittent explosive disorder-revised,intermittent explosive disorder-revised
NEW11004,CHEMICAL,altered cortisol response,altered cortisol responses
NEW11005,DISEASE,intermittent explosive disorder-revised,IED-R|intermittent explosive disorder-revised
NEW11006,CHEMICAL,cortisol temperature response,cortisol temperature responses
NEW11007,CHEMICAL,menopausal transition,mechanical thrombectomy|MT|menopausal transition
NEW11008,DISEASE,osteolytic disease,Osteolytic disease
NEW11009,CHEMICAL,to oseltamivir carboxylate,to oseltamivir carboxylate|OC
NEW11010,MENTAL_HEALTH,orthogonal projection,orthogonal projection
NEW11011,CHEMICAL,d-palmitylcarnitine,D-Palmitylcarnitine
C008472,CHEMICAL,N-methylnicotinamide [Supplementary Concept],Niacinamide/analogs  and  derivatives|N-methylnicotinamide
C034516,CHEMICAL,dimethylamine [Supplementary Concept],Dimethylamines|dimethylamine
D006643,CHEMICAL,Histidine-tRNA Ligase,"Antigen, Jo-1|Synthetase, Histidyl-tRNA|Histidyl T RNA Synthetase|Ligase, Histidine-tRNA|His tRNA Ligase|Ligase, His-tRNA|Histidine tRNA Ligase|His-tRNA Ligase|Jo-1 Antigen|Jo 1 Antigen|Histidyl tRNA Synthetase|histidine|Histidyl-tRNA Synthetase"
C001505,CHEMICAL,alpha-ketoisovalerate [Supplementary Concept],alpha-ketoisovaleric acid|Keto Acids|Hemiterpenes
C475599,CHEMICAL,"3,7-dimethyl-1,6-octadien-3-yl isobutyrate [Supplementary Concept]",Butyrates|Monoterpenes|isobutyrate
C024840,CHEMICAL,ethyl acetoacetate [Supplementary Concept],acetoacetate|Acetoacetates
NEW11012,NUTRITION,branched-chain amino acid degradation pathway,branched-chain amino acid degradation pathways
NEW11013,DISEASE,massive proteinuria,massive proteinuria
NEW11014,MENTAL_HEALTH,depression medication,depression medication
http://purl.obolibrary.org/obo/CHEBI_70707,CHEMICAL,vilazodone,duloxetine milnacipran|5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxamide|vilazodonum|vilazodona|vilazodone
NEW11015,CHEMICAL,atypical antidepressant group,atypical antidepressants group
http://purl.obolibrary.org/obo/CHEBI_3219,CHEMICAL,bupropion,Bupropion|2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one|bupropion nefazodone
http://purl.obolibrary.org/obo/CHEBI_50940,CHEMICAL,tetracyclic antidepressant,piperazinoazepine antidepressant|antidepresivo tetraciclico|antidepresivos tetraciclicos|tetracyclic antidepressants
D000657,CHEMICAL,Amoxapine,"Demolox|2-Chloro-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepine|amoxapine|CL67,772|CL 67,772|Asendis|Défanyl|Asendin|CL-67,772|Desmethylloxapine"
NEW11016,CHEMICAL,significant drug-appropriate,significant drug-appropriate
NEW11017,MENTAL_HEALTH,chronic opioid abuse,Chronic opioid abuse
C052714,CHEMICAL,rhyncophylline [Supplementary Concept],Oxindoles|isorhynchophylline
NEW11018,DISEASE,writhe,writhes
NEW11019,CHEMICAL,apomorphine mg/kg,apomorphine mg/kg
NEW11020,CHEMICAL,mg/kg s.c,mg/kg s.c
NEW11021,MENTAL_HEALTH,pain analgesia,pain analgesia
NEW11022,MENTAL_HEALTH,significant analgesia,Significant analgesia
D001285,CHEMICAL,Atropine,"Atropin Augenöl|Anhydrous, Atropine Sulfate|Sulfate, Atropine|Augenöl, Atropin|Atropine Sulfate Anhydrous|AtroPen|atropine sulfate|Atropine Sulfate|Sulfate Anhydrous, Atropine|Atropinol|atropine"
NEW11023,CHEMICAL,one parenteral dopamine agonist,one parenteral dopamine agonist|apomorphine
NEW11024,DISEASE,depressive behavior,depressive behavior
NEW11025,CHEMICAL,cannabis toxicity,Cannabis toxicity
NEW11026,MENTAL_HEALTH,acute neurological symptom,acute neurological symptoms|stupor
NEW11027,CHEMICAL,cannabis law,cannabis laws
NEW11028,DISEASE,lung disease cardiovascular disease,lung disease cardiovascular disease
NEW11029,DISEASE,hyperemesis syndrome,hyperemesis syndrome
NEW11030,CHEMICAL,ergot alkaloid bromocriptine,ergot alkaloid bromocriptine
NEW11031,MENTAL_HEALTH,end-of-dose akinesia,end-of-dose akinesia
NEW11032,DISEASE,significant cad,significant CAD
http://purl.obolibrary.org/obo/CHEBI_91184,CHEMICAL,dehydrodiconiferyl alcohol,"lignin cw compound-2004|G(8-5)G|dehydrodiconiferol|DA-metabolite homovanillyl alcohol|4-{3-(hydroxymethyl)-5-[(1E)-3-hydroxyprop-1-en-1-yl]-7-methoxy-2,3-dihydro-1-benzofuran-2-yl}-2-methoxyphenol"
D002742,CHEMICAL,Chlorphenamidine,Chlordimeform|chlordimeform
NEW11033,CHEMICAL,oar-antagonist,OAR-antagonist
NEW11034,CHEMICAL,se nanoparticle,Se nanoparticles
NEW11035,DISEASE,aeromonas hydrophila infection,Aeromonas hydrophila infection
NEW11036,NUTRITION,striped catfish,striped catfish
NEW11037,CHEBI,drug label,drug label
NEW11038,CHEMICAL,peginterferon/ribavirin therapy,Peginterferon/Ribavirin therapy
http://purl.obolibrary.org/obo/DOID_0060060,DISEASE,non-hodgkin lymphoma,non-Hodgkin lymphomas
NEW11039,CHEBI,folinic acid supplementation,folinic acid supplementation
D012435,DISEASE,S-Adenosylhomocysteine,"Adenosylhomocysteine, S|S-adenosylhomocysteine|SAH|S Adenosylhomocysteine"
NEW11040,DISEASE,female rett patient,female Rett patients
NEW11041,CHEMICAL,sam level,SAM levels
NEW11042,CHEMICAL,PtDIR11,PtDIR11
NEW11043,CHEMICAL,acute cannabis exposure,Acute cannabis exposure
NEW11044,MENTAL_HEALTH,self-reported hallucination,self-reported hallucinations
NEW11045,MENTAL_HEALTH,reversible amnesia,reversible amnesia
NEW11046,MENTAL_HEALTH,amnesia development,amnesia development
NEW11047,CHEBI,thiamine repressible promoter,thiamine repressible promoter
NEW11048,MENTAL_HEALTH,repression condition,repression conditions
NEW11049,CHEMICAL,protein synthesis inhibitor cycloheximide,protein synthesis inhibitor cycloheximide
NEW11050,CHEBI,same drug,same drug
http://purl.obolibrary.org/obo/CHEBI_75228,CHEMICAL,sodium lactate,"sodium hydroxybutyrate|Monosodium lactate|Sodium alpha-hydroxypropionate|E325|Mediject L|Lactic acid, monosodium salt|2-Hydroxypropanoic acid, monosodium salt|sodium 2-hydroxypropanoate|Lactic acid sodium salt|Monosodium 2-hydroxypropanoate"
NEW11051,DISEASE,tumor cavity,tumor cavity
NEW11052,NUTRITION,liquid tissue marker sucrose acetate isobutyrate,liquid tissue marker sucrose acetate isobutyrate
NEW11053,CHEMICAL,radiopaque electron dense saib analogue,radiopaque electron dense SAIB analogue
NEW11054,CHEBI,prenatal progestin exposure,prenatal progestin exposure
NEW11055,DISEASE,autism-like behavior,autism-like behavior
D000033,DISEASE,"Abortion, Threatened","Miscarriage, Threatened|Threatened Miscarriages|Threatened Miscarriage|Threatened Abortions|Threatened Abortion|threatened abortion"
NEW11056,DISEASE,ASD development,ASD development
NEW11057,DISEASE,acute dystonia,acute dystonia
NEW11058,NUTRITION,tree cart analysis,tree CART analysis
NEW11059,DISEASE,core ptsd symptom cluster,core PTSD symptom clusters
NEW11060,NUTRITION,daily food intake,Daily food intake
NEW11061,DISEASE,arthritis development,arthritis development
NEW11062,CHEBI,daily vitamin b1,daily vitamin B1
NEW11063,DISEASE,metabolic imbalance,metabolic imbalances
NEW11064,DISEASE,increase talkativeness,Increased talkativeness
NEW11065,DISEASE,untreated toxicity,untreated toxicity
NEW11066,CHEBI,various carotenoid present,various carotenoids present
C467741,DISEASE,"STEAP2 protein, human [Supplementary Concept]",Oxidoreductases|human prostate cancer
NEW11067,DISEASE,prostate cancer cell,prostate cancer cells
D061146,CHEMICAL,Chlorophyll Binding Proteins,"Fucoxanthin Chlorophyll a c Binding Proteins|chlorophyll|Fucoxanthin|Proteins, Fucoxanthin Chlorophyll|Fucoxanthin Chlorophyll a-c Binding Proteins|Chlorophyll a Binding Proteins|Chlorophyll a-Proteins|fucoxanthin|Chlorophyll ac Proteins|Fucoxanthin Chlorophyll Proteins|Chlorophyll Protein Complexes|Chlorophyll ab Proteins|Chlorophyll a-c Binding Proteins|Fucoxanthin Chlorophyll Binding Proteins|Chlorophyll a-b Binding Proteins|Chlorophyll Proteins, Fucoxanthin|Chlorophyll a c Binding Proteins|Chlorophyll a Proteins|Chlorophyll ab-Proteins|Chlorophyll ac-Proteins|Chlorophyll a b Binding Proteins"
http://purl.obolibrary.org/obo/CHEBI_23044,CHEBI,carotenoid,"carotenoid|carotenes and carotenoids|xanthophyll carotenoid|carotenoids|5,6-monoepoxy carotenoids"
C011947,NUTRITION,neoxanthin [Supplementary Concept],Neoxanthin|neoxanthin|Xanthophylls
NEW11068,DISEASE,human prostate cancer cell,human prostate cancer cells
NEW11069,MENTAL_HEALTH,fiber orientation,fiber orientation
NEW11070,CHEMICAL,h dqf nmr spectroscopy,H DQF NMR spectroscopy
NEW11071,CHEMICAL,spermine synthase gene,spermine synthase gene
NEW11072,MENTAL_HEALTH,robinson mental retardation syndrome,Robinson mental retardation syndrome
NEW11073,CHEMICAL,excessive aspartame ingestion,excessive aspartame ingestion
NEW11074,DISEASE,emotional function,emotional functioning
NEW11075,DISEASE,rhabdovirus viral hemorrhagic septicemia virus vhsv genogroup iva,rhabdovirus Viral hemorrhagic septicemia virus VHSV genogroup IVa
NEW11076,NUTRITION,pacific herring,Pacific herring
C103308,DISEASE,"VAH1 protein, Listonella anguillarum [Supplementary Concept]",Bacterial Proteins|Listonella anguillarum|Hemolysin Proteins
NEW11077,DISEASE,floor muscle spasm,floor muscle spasm
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Postpartum_Psychosis,CHEMICAL,postpartum psychosis,Postpartum psychosis|postpartum psychosis|PPP
NEW11078,DISEASE,genus Clostridium,genus Clostridium
D018692,CHEMICAL,Antimanic Agents,"Effect, Antimanic|Effects, Antimanic|Antimanic Effects|antimanic effects|Antimanics|Antimanic Effect|Drugs, Antimanic|Agents, Antimanic|Antimanic Drugs"
NEW11079,CHEMICAL,amygdala faah density,amygdala FAAH density
D008406,DISEASE,Masseter Muscle,"Muscle, Masseter|Muscles, Masseter|masseter muscle|Masseter Muscles"
D013705,DISEASE,Temporomandibular Joint Disorders,"Temporomandibular Disorders|Disorders, Temporomandibular Joint|Disorders, TMJ|TMD|Temporomandibular Joint Disorder|Temporomandibular Joint Diseases|Disorders, Temporomandibular|Joint Disease, Temporomandibular|TMJ Disease|TMJ Disorder|temporomandibular disorders|Temporomandibular disorder|TMJ Diseases|Disorder, Temporomandibular|Diseases, TMJ|Diseases, Temporomandibular Joint|Joint Disorder, Temporomandibular|Disorder, Temporomandibular Joint|Disorder, TMJ|TMJ Disorders|Temporomandibular Joint Disease|Disease, TMJ|Disease, Temporomandibular Joint|Temporomandibular Disorder|Joint Diseases, Temporomandibular|Joint Disorders, Temporomandibular"
C536106,DISEASE,Myostatin-related muscle hypertrophy [Supplementary Concept],Muscular Diseases|muscle hypertrophy|Hypertrophy
NEW11080,DISEASE,temporary paralysis,Temporary paralysis
NEW11081,DISEASE,digestive gland-associated microbiota,digestive gland-associated microbiota
NEW11082,NUTRITION,red abalone,red abalone
NEW11083,NUTRITION,healthy red abalone,healthy red abalone
NEW11084,CHEMICAL,problematic methylphenidate,problematic methylphenidate
NEW11085,DISEASE,hepatic disorder,hepatic disorders
NEW11086,DISEASE,arterial hypotension,arterial hypotension
NEW11087,NUTRITION,spanish version,Spanish version
NEW11088,NUTRITION,spanish patient,Spanish patients
NEW11089,NUTRITION,spanish outpatient,Spanish outpatients
NEW11090,DISEASE,cobra naja melanoleuca venom,cobra Naja melanoleuca venom
http://purl.obolibrary.org/obo/CHEBI_137376,CHEMICAL,long-chain fatty acyl-amp,long-chain fatty acyl-adenylate|long-chain fatty acyl-adenosine-5-monophosphate|long-chain α-neurotoxins
NEW11091,MENTAL_HEALTH,slow dissociation,slower dissociation
NEW11092,CHEBI,modifier toxin,modifier toxins
NEW11093,MENTAL_HEALTH,channelopathie pain syndrome,channelopathies pain syndromes
D001180,CHEBI,Arthropod Venoms,"Venom, Hymenoptera|Arachnid Venoms|Arachnid Toxins|Venom, Arthropod|Venoms, Arachnid|Venoms, Insect|Venom, Insect|Venoms, Hymenoptera|arthropod venoms|Toxins, Arachnid|Arthropod Venom|Arachnid Toxin|Arachnid Venom|Toxin, Arachnid|Insect Venoms|Venom, Arachnid|Venoms, Arthropod|Hymenoptera Venom|Hymenoptera Venoms|Insect Venom"
C026013,CHEMICAL,fenproporex [Supplementary Concept],Amphetamines|fenproporex
NEW11094,CHEBI,drug concentration,drug concentrations
NEW11095,DISEASE,0.084 mg/L,0.084 mg/L|inferior vena cava blood
NEW11096,CHEMICAL,oxygen scavenging,oxygen scavenging
C501162,CHEMICAL,"FLT1 protein, human [Supplementary Concept]",sFlt-1|Vascular Endothelial Growth Factor Receptor-1
D017359,DISEASE,HELLP Syndrome,"Syndrome, HELLP|Hemolysis, Elevated Liver Enzymes, Lowered Platelets|HELLP syndrome"
C075750,CHEMICAL,8-epi-prostaglandin F2alpha [Supplementary Concept],|15-F(2t)-isoprostane|Dinoprost/analogs  and  derivatives|isoprostane
NEW11097,DISEASE,hellp rat,HELLP rats
NEW11098,DISEASE,alport mouse,Alport mice
http://purl.obolibrary.org/obo/CHEBI_135810,CHEMICAL,atrasentan,sitaxentan|atrasentan HCl|atrasentan hydrochloride
NEW11099,NUTRITION,receptor-related orphan receptor alpha,receptor-related orphan receptor alpha
NEW11100,DISEASE,learn motor deficit,learned motor deficits
NEW11101,NUTRITION,dysregulate phospholipid metabolism,Dysregulated phospholipid metabolism
NEW11102,NUTRITION,phospholipid metabolism,phospholipid metabolism
NEW11103,NUTRITION,phospholipid dysregulation,phospholipid dysregulation
NEW11104,DISEASE,lucidum stimulation,lucidum stimulation
NEW11105,CHEMICAL,"3'r)-2-(2,3-dicarboxyl-cyclopropyl)-glycine","3'R)-2-(2,3-dicarboxyl-cyclopropyl)-glycine"
C082313,CHEMICAL,"2-(2,3-dicarboxycyclopropyl)glycine [Supplementary Concept]",DCG-IV|Cyclopropanes|Glycine/analogs  and  derivatives
NEW11106,CHEMICAL,neuroimmunological kynurenine pathway,neuroimmunological kynurenine pathway
NEW11107,DISEASE,depressed adolescent,depressed adolescents
D065766,DISEASE,Atypical Hemolytic Uremic Syndrome,"Non-Shiga-Like Toxin-Associated HUS|Non Shiga Like Toxin Associated HUS|Syndromes, Atypical Hemolytic-Uremic|Nonenteropathic HUS|Atypical Hemolytic-Uremic Syndrome|Atypical Hemolytic-Uremic Syndromes|HUS, Nonenteropathic|HUSs, Non-Shiga-Like Toxin-Associated|Non-Stx-Hus|Non-Shiga-Like Toxin-Associated HUSs|Hemolytic-Uremic Syndromes, Atypical|Uremic syndrome|Nonenteropathic HUSs|Hemolytic-Uremic Syndrome, Atypical|HUS, Non-Shiga-Like Toxin-Associated|Syndrome, Atypical Hemolytic-Uremic|Non Stx Hus|Toxin-Associated HUS, Non-Shiga-Like|Toxin-Associated HUSs, Non-Shiga-Like|HUSs, Nonenteropathic|Hemolytic Uremic Syndrome, Atypical|atypical hemolytic uremic syndrome"
D017242,CHEMICAL,Complement Factor H,"Factor H, Complement|complement factor H|Factor H"
NEW11108,DISEASE,unsubstantiated parkinson disease diagnosis,unsubstantiated Parkinson disease diagnosis
D044348,CHEMICAL,"Receptors, Serotonin, 5-HT2","Receptors, 5-HT-2|5-HT2 Serotonin Receptors|Serotonin 2 Receptors|5-HT2 receptors|Receptors, Serotonin-2|Receptors, 5-HT2 Serotonin|Serotonin 5-HT2 Receptors|Serotonin S2 Receptors|Receptors, Serotonin S2|Receptors, Serotonin 5-HT2|5-HT-2 Receptors|Serotonin-2 Receptors|5 HT 2 Receptors|S2 Receptors, Serotonin|Serotonin Receptors, 5 HT2|5-HT2 Receptors, Serotonin|Serotonin Receptors, 5-HT2|Serotonin 5 HT2 Receptors|Receptors, 5 HT 2|Receptors, Serotonin 2"
NEW11109,MENTAL_HEALTH,pd psychosis,PD psychosis
NEW11110,CHEBI,high-dose folic acid supplement use,high-dose folic acid supplement use
NEW11111,DISEASE,acute thymic atrophy,acute thymic atrophy
NEW11112,CHEMICAL,leuprolide pretreatment,Leuprolide pretreatment
NEW11113,DISEASE,thymic atrophy,thymic atrophy
NEW11114,CHEMICAL,noradrenergic antidepressant,noradrenergic antidepressant
NEW11115,MENTAL_HEALTH,undifferentiated somatoform disorder,undifferentiated somatoform disorder
NEW11116,DISEASE,psychiatric indication,psychiatric indications
NEW11117,CHEMICAL,omega-3 hufa,omega-3 HUFAs
NEW11118,DISEASE,aggressive violent behavior,aggressive violent behavior
NEW11119,DISEASE,neonatal hypoxia-ischemia,Neonatal hypoxia-ischemia
NEW11120,CHEMICAL,oxygen deprivation,oxygen deprivation
NEW11121,DISEASE,system inflammation,system inflammation
NEW11122,DISEASE,cardiometabolic factor,cardiometabolic factors
http://purl.obolibrary.org/obo/CHEBI_178076,CHEMICAL,caffeic acid-13c9,"dinophysistoxins|(E)-3-(3,4-dihydroxy(1,2,3,4,5,6-13C6)cyclohexa-1,3,5-trien-1-yl)(1,2,3-13C3)prop-2-enoic acid"
NEW11123,CHEBI,diarrhetic shellfish-poisoning toxin,Diarrhetic shellfish-poisoning toxins
D019319,CHEMICAL,Okadaic Acid,Ocadaic Acid|okadaic acid
NEW11124,CHEMICAL,quinolone action,quinolone action
NEW11125,MENTAL_HEALTH,drug orientation,drug orientation
NEW11126,DISEASE,multiple mass spectrometry experiment,multiple mass spectrometry experiments
NEW11127,MENTAL_HEALTH,fragmentation scheme,fragmentation schemes
NEW11128,CHEMICAL,serotonin 5-ht1a receptor agonist,serotonin 5-HT1A receptor agonist
NEW11129,CHEMICAL,gepirone er,gepirone ER
NEW11130,MENTAL_HEALTH,recurrent major depression,recurrent major depression
NEW11131,CHEMICAL,pi3 k pathway activation,PI3 K pathway activation
NEW11132,DISEASE,erbb family tumor,ERBB family tumors
http://purl.obolibrary.org/obo/MFOMD_0000133,MENTAL_HEALTH,resistance,ABCG2/BCRP-mediated resistance|β-Lactamase-mediated resistance|M2-mediated DTA-1 resistance|WFT resistance
D011763,CHEMICAL,Pyrrolizidine Alkaloids,"Pyrrolizidine Alkaloid|pyrrolizidine alkaloid|Alkaloid, Senecio|Senecio Alkaloids|Senecio Alkaloid|Alkaloid, Pyrrolizidine|Alkaloids, Pyrrolizidine|Alkaloids, Senecio"
NEW11133,MENTAL_HEALTH,displacement reaction,displacement reaction
NEW11134,NUTRITION,pyrene boric acid,pyrene boric acid
NEW11135,CHEMICAL,deposit ag nanoparticle,deposit Ag nanoparticles|AgNPs
NEW11136,CHEMICAL,dopamine nanoparticle,dopamine nanoparticles
NEW11137,MENTAL_HEALTH,same compressive displacement,same compressive displacement
D011142,CHEMICAL,Polyvinyl Alcohol,"Polyviol|polyvinyl alcohol|Polyvinyl alcohol|PVA|Liquifilm Tears|Alcohol, Polyvinyl|Tears, Liquifilm"
NEW11138,CHEMICAL,15wt% PVA boric acid,15wt% PVA boric acid
NEW11139,MENTAL_HEALTH,same displacement test,same displacement test
NEW11140,MENTAL_HEALTH,lateral head displacement,lateral head displacement
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Perceptual_Disturbances,DISEASE,perceptual disturbances,perceptual disturbances
NEW11141,CHEMICAL,specific n-methyl-d-aspartic acid nmda glutamatergic blockade,specific N-methyl-D-aspartic acid NMDA glutamatergic blockade
NEW11142,DISEASE,c-treated dn-disc1 mouse,C-treated DN-DISC1 mice
NEW11143,DISEASE,atopic child,atopic children
NEW11144,DISEASE,repeat urticaria,repeated urticaria
http://purl.obolibrary.org/obo/CHEBI_77182,CHEBI,food colouring,food colorings|food colourings|food coloring
NEW11145,CHEBI,gradual antipsychotic drug discontinuation,gradual antipsychotic drug discontinuation
NEW11146,CHEMICAL,olanzapine initiation,olanzapine initiation
http://purl.obolibrary.org/obo/CHEBI_3360,CHEMICAL,cannabinol,Cannabinol|delta9-tetrahydrocannabinol (delta9-THC)-induced|CBDV|phytocannabinoid cannabidivarin
NEW11147,DISEASE,short-term memory deficit,short-term memory deficits
http://purl.obolibrary.org/obo/SYMP_0019187,DISEASE,repetitive behavior,THC-induced repetitive behavior|stimming|repetitive behaviors
NEW11148,CHEMICAL,symptomatic cbdv,symptomatic CBDV
NEW11149,CHEMICAL,prenatal vpa exposure,prenatal VPA exposure
D000073116,DISEASE,Cancer Survivors,"Cancer Survivor|Survivors of Childhood Cancer|Cancer Survivor, Long-Term|Survivors, Cancer|Survivorship, Cancer|Cancer Survivors, Childhood|Long-Term Cancer Survivors|Cancer Survivors, Long-Term|Cancer Survivor, Childhood|Survivor, Long-Term Cancer|Long-Term Cancer Survivor|Survivors, Long-Term Cancer|Cancer Survivorship|Childhood Cancer Survivors|Long Term Cancer Survivors|Childhood Cancer Survivor|cancer survivors"
NEW11150,CHEMICAL,serum omega-3 concentration,serum omega-3 concentration
NEW11151,MENTAL_HEALTH,multidimensional Fatigue Symptom Inventory,Multidimensional Fatigue Symptom Inventory
NEW11152,CHEMICAL,anti-convulsive property,anti-convulsive properties
NEW11153,CHEMICAL,dapsone treatment,dapsone treatment
NEW11154,DISEASE,mild methemoglobinemia,mild methemoglobinemia
http://purl.obolibrary.org/obo/SYMP_0000510,DISEASE,pallor,paleness
NEW11155,CHEBI,old drug,old drug
NEW11156,CHEBI,prevalent endocrine disorder,prevalent endocrine disorder
http://purl.obolibrary.org/obo/CHEBI_165543,CHEMICAL,n-oleoyl gaba,acidergic|gamma-vanylic GABA|4-[[(Z)-octadec-9-enoyl]amino]butanoic acid
C533284,CHEMICAL,"Ffar4 protein, rat [Supplementary Concept]","FFAR1/GPR40|fatty acid receptor 1|Receptors, G-Protein-Coupled"
NEW11157,DISEASE,glucose-induced insulin secretion,glucose-induced insulin secretion
C519853,NUTRITION,"FFAR4 protein, human [Supplementary Concept]","fatty acid receptor|Receptors, G-Protein-Coupled"
NEW11158,CHEMICAL,zly032,ZLY032
NEW11159,NUTRITION,methionine choline-deficient db/db mouse,methionine choline-deficient db/db mice
D063991,NUTRITION,Mitochondrial Trifunctional Protein,"FA beta-OMC|Mitochondrial Long Chain Enoyl CoA Hydratase 3 Hydroxyacyl CoA Dehydrogenase 3 Ketoacyl CoA Thiolase Trifunctional Protein|Mitochondrial Fatty Acid beta-Oxidation Trifunctional Protein|fatty acid β-oxidation|Mitochondrial Fatty Acid beta Oxidation Trifunctional Protein|Trifunctional Protein, Mitochondrial"
NEW11160,CHEMICAL,triglyceride metabolism,triglyceride metabolism
NEW11161,CHEMICAL,treatment glucolipid metabolism,treatment glucolipid metabolism
NEW11162,DISEASE,ccl4-induced liver fibrosis,CCl4-induced liver fibrosis
NEW11163,CHEBI,dual ffa1/pparδ agonist,dual FFA1/PPARδ agonists
NEW11164,NUTRITION,methionine intoxication,methionine intoxication
C513081,DISEASE,"Myo5a protein, rat [Supplementary Concept]",Myosin Type V|opisthotonus|Myosin Heavy Chains
NEW11165,DISEASE,neck torticollis alon,neck torticollis alons
C015816,CHEMICAL,dihydroguaiaretic acid [Supplementary Concept],Guaiacol/analogs  and  derivatives|meso-dihydroguaiaretic acid|Lignans
D050859,CHEMICAL,Betacyanins,Betanins|Betacyanin|Betanidins|betacyanins|Betanidin
C535516,DISEASE,Hereditary leiomyomatosis and renal cell cancer [Supplementary Concept],"renal cell cancer|Neoplastic Syndromes, Hereditary|Skin Neoplasms|Uterine Neoplasms|Leiomyomatosis"
http://purl.obolibrary.org/obo/CHEBI_22888,CHEMICAL,biphenyls,dioxin-like polychlorinated biphenyls|dl-PCBs
NEW11166,DISEASE,toxicity equivalent,toxicity equivalents
C067940,CHEMICAL,"2,3,3',4,4'-pentachlorobiphenyl [Supplementary Concept]",PCB|Polychlorinated Biphenyls
NEW11167,DISEASE,teq value,TEQ values
NEW11168,CHEBI,vitamin b. vitamin b,vitamin B. Vitamin B
NEW11169,CHEMICAL,33-kda cysteine protease,33-kDa cysteine protease
NEW11170,MENTAL_HEALTH,unusual host-plant resistance mechanism,unusual host-plant resistance mechanism
http://purl.obolibrary.org/obo/MFOMD_0000082,MENTAL_HEALTH,sexual arousal disorder,female sexual arousal disorder|FSAD|Female sexual arousal disorder
NEW11171,DISEASE,male sexual disorder,male sexual disorders
NEW11172,CHEMICAL,b-vitamin status,B-vitamin status
NEW11173,DISEASE,direct neurotoxicity,direct neurotoxicity
NEW11174,CHEMICAL,induce vad. l-methionone,induced VaD. l-methionone
NEW11175,DISEASE,VaD. Morris water-maze,VaD. Morris water-maze
NEW11176,CHEMICAL,l-methionine treated animal,L-methionine treated animals
NEW11177,CHEMICAL,serum nitrite/nitrate level,serum nitrite/nitrate levels
NEW11178,CHEMICAL,brain glutathione,brain glutathione
NEW11179,CHEMICAL,brain thiobarbituric acid reactive specie,brain thiobarbituric acid reactive species
NEW11180,CHEMICAL,hhcy-hl,HHcy-HL
D011623,CHEMICAL,gamma-Glutamyl Hydrolase,Folacin Conjugase|Carboxypeptidase G1|Carboxypeptidase G|Folate Conjugase|Folyl Polyglutamate Cleavage Enzyme|Conjugase|Folyl Poly-gamma-Glutamate Carboxypeptidase|gamma Glutamyl Hydrolase|Carboxypeptidase G2|Folylpolyglutamate Hydrolase|Folate Hydrolyzing Enzyme|Folyl Conjugate Synthetase|Pteroyl Polyglutamate Hydrolase|folacin
http://purl.obolibrary.org/obo/CHEBI_73085,CHEMICAL,colterol,"colterol|(+-)-N-t-butylnoradrenaline|(+/-)-N-tert-butylarterenol|colterolum|(+-)-N-tert-butylarterenol|D4Ch|4-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,2-diol"
NEW11181,CHEMICAL,cr ratio,Cr ratios
NEW11182,MENTAL_HEALTH,orientation bias,orientation bias
NEW11183,CHEMICAL,brain 5-ht functional activity,brain 5-HT functional activity
NEW11184,MENTAL_HEALTH,hyperactivity syndrome,hyperactivity syndrome
http://purl.obolibrary.org/obo/DOID_4543,MENTAL_HEALTH,retrograde amnesia,TGCI-induced retrograde amnesia|ECS-induced retrograde amnesia
NEW11185,CHEMICAL,mrn-lesioned rat,MRN-lesioned rats
NEW11186,DISEASE,choreiform limb,choreiform limb
NEW11187,CHEMICAL,globus pallidus par interna,GPi|globus pallidus pars interna
NEW11188,DISEASE,limb dyskinesia,limb dyskinesias
NEW11189,DISEASE,choreiform dyskinesia,choreiform dyskinesias
NEW11190,CHEBI,essential vitamin,essential vitamin
NEW11191,DISEASE,metabolism deficit,metabolism deficit
C483078,DISEASE,"BREVIS RADIX protein, Arabidopsis [Supplementary Concept]",Arabidopsis Proteins|brevis radix
NEW11192,NUTRITION,impaired primary root protophloem differentiation,impaired primary root protophloem differentiation
D000450,CHEMICAL,Aldosterone,"Aldosterone, (+-)-Isomer|aldosterone|Aldosterone, (11 beta,17 alpha)-Isomer|Aldosterone"
NEW11193,DISEASE,cardiac damage,cardiac damage
NEW11194,DISEASE,cardiovascular damage,cardiovascular damage
NEW11195,CHEBI,selective mineralocorticoid receptor antagonist,selective mineralocorticoid receptor antagonist
NEW11196,DISEASE,dry tissue,dry tissue
NEW11197,MENTAL_HEALTH,dissociation constant,dissociation constant
NEW11198,MENTAL_HEALTH,high dissociation rate,high dissociation rate
NEW11199,CHEBI,natural aldosterone antagonist,natural aldosterone antagonist
NEW11200,MENTAL_HEALTH,rapid dissociation,rapid dissociation
NEW11201,CHEMICAL,insufficient brain dha,Insufficient brain DHA
NEW11202,CHEMICAL,optimal brain dha status,optimal brain DHA status
NEW11203,DISEASE,age-related brain damage,age-related brain damage
D057265,CHEMICAL,Site-Specific DNA-Methyltransferase (Cytosine-N4-Specific),cytosine|N(4)-Cytosine-Specific DNA Methylase|Site-Specific DNA-Methyltransferase (Cytosine-N(4)-Specific)
NEW11204,CHEMICAL,thromboxane synthetase inhibitor,sodium ozagrel|thromboxane synthetase inhibitor
C519817,CHEMICAL,"1-(1-methylethyl)-4-((1-(6-(trifluoromethyl)-3-pyridinyl)-4-piperidinyl)carbonyl)hexahydro-1H-1,4-diazepine [Supplementary Concept]",GSK334429|Azepines|Pyridines
NEW11205,CHEBI,novel receptor antagonist,Novel receptor antagonists
C519816,CHEMICAL,"5-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-2-pyrazinecarboxamide [Supplementary Concept]",Pyrazines|GSK207040|Benzazepines
NEW11206,DISEASE,peripheral pain,peripheral pain
NEW11207,CHEMICAL,ca2 entry,Ca2 entry
NEW11208,DISEASE,neuronal disease,neuronal diseases
NEW11209,DISEASE,scop-induced oxidative toxicity,SCOP-induced oxidative toxicity
D012048,DISEASE,Correction of Hearing Impairment,"Hearing Impairment Habilitations|Aural Habilitations|Audiologic Habilitations|Impaired Habilitation, Hearing|Habilitations, Aural|Hearing Impaired Habilitation|Audiologic Habilitation|Hearing Impairment Corrections|Perception Correction, Auditory|impairment|Hearing Impairment Correction|Rehabilitation, Audiologic|Hearing Loss Correction|Impairment Corrections, Hearing|Habilitation, Audiologic|Hearing Impaired Rehabilitation|Rehabilitations, Audiologic|Aural Habilitation|Audiologic Rehabilitation|Hearing Impairment Habilitation|Hearing Impairment Rehabilitations|Hearing Loss Corrections|Auditory Perception Corrections|Audiologic Rehabilitations|Correction of Hearing Loss|Habilitation of Hearing Impaired|Aural Rehabilitations|Hearing Impaired Habilitations|Rehabilitations, Aural|Rehabilitation of Hearing Impairment|Rehabilitation of Hearing Impaired|Perception Corrections, Auditory|Impairment Correction, Hearing|Aural Rehabilitation|Loss Corrections, Hearing|Habilitations, Audiologic|Correction of Auditory Perception|Habilitation, Aural|Impairment Rehabilitation, Hearing|Auditory Perception Correction|Habilitation of Hearing Impairment|Impairment Habilitation, Hearing|Impairment Rehabilitations, Hearing|Rehabilitation, Aural|Impairment Habilitations, Hearing|Hearing Impairment Rehabilitation|Loss Correction, Hearing|Rehabilitation, Hearing Impaired|Impaired Habilitations, Hearing"
NEW11210,CHEMICAL,large spine abductor,large spine abductor
NEW11211,CHEMICAL,oral propranolol,oral propranolol
NEW11212,DISEASE,pre-threshold stage,pre-threshold stage
NEW11213,DISEASE,pre-threshold,pre-threshold
NEW11214,CHEMICAL,low-frequency electroacupuncture,Low-frequency electroacupuncture
NEW11215,CHEMICAL,sex steroid synthesis,sex steroid synthesis
NEW11216,CHEMICAL,low-frequency electroacupuncture,low-frequency electroacupuncture
NEW11217,CHEMICAL,elevated homocysteine level,Elevated homocysteine levels
NEW11218,DISEASE,non-cardiac vascular disease,non-cardiac vascular diseases
C100406,CHEMICAL,albocycline K3 [Supplementary Concept],Lactones|Albocycline
NEW11219,CHEMICAL,macrolactone natural product,macrolactone natural product
NEW11220,MENTAL_HEALTH,work-related fatigue,work-related fatigue
NEW11221,CHEMICAL,high alcohol intake,higher alcohol intake
D013805,NUTRITION,Theobromine,Bronchodilator Agents|Vasodilator Agents|theobromine
NEW11222,CHEMICAL,omega (n)-3,Omega (n)-3
NEW11223,CHEBI,obsessive compulsive Drug Use scale,Obsessive Compulsive Drug Use Scale
NEW11224,MENTAL_HEALTH,overall craving level,overall craving level
NEW11225,CHEMICAL,5-hydroxytryptamine receptor 3b,5-hydroxytryptamine receptor 3B
NEW11226,CHEMICAL,d2 dopamine receptor gene -141c ins/del polymorphism,D2 dopamine receptor gene -141C Ins/Del polymorphism
NEW11227,MENTAL_HEALTH,binding affinity dissociation constant kd,binding affinity dissociation constant KD
NEW11228,CHEMICAL,±       pg/ml.,±      pg/mL.
NEW11229,MENTAL_HEALTH,activate defense mechanism,Activated defense mechanism
NEW11230,CHEMICAL,extent casein glycomacropeptide,CGMP|extent casein glycomacropeptide
NEW11231,CHEMICAL,background diphenhydramine,Background Diphenhydramine
NEW11232,CHEMICAL,first-generation h1 receptor antihistamine,first-generation H1 receptor antihistamine
NEW11233,CHEMICAL,effective antidepressant agent,effective antidepressant agent
NEW11234,DISEASE,microscopic esophagitis,microscopic esophagitis
NEW11235,DISEASE,non-erosive reflux disease,NERD|non-erosive reflux disease
NEW11236,DISEASE,functional esophagus,functional esophagus
NEW11237,DISEASE,inflammatory bowel syndrome,inflammatory bowel syndrome
NEW11238,DISEASE,panic symptom,panic symptoms
NEW11239,CHEMICAL,5-ht availability,5-HT availability
D029588,CHEMICAL,Moringa oleifera,"Moringa oleifera|Moringa oleiferas|oleifera, Moringa|Drumsticktree|Drumsticktrees"
C037144,CHEMICAL,mifamurtide [Supplementary Concept],Phosphatidylethanolamines|Mifamurtide|Acetylmuramyl-Alanyl-Isoglutamine/analogs  and  derivatives|mifamurtide
NEW11240,DISEASE,high-grade osteosarcoma,high-grade osteosarcoma
NEW11241,CHEMICAL,combination chemotherapy doxorubicin,combination chemotherapy doxorubicin
NEW11242,DISEASE,diagnose osteosarcoma,diagnosed osteosarcoma
D054778,DISEASE,NM23 Nucleoside Diphosphate Kinases,NM23B Nucleoside Diphosphate Kinase|Nucleoside Diphosphate Kinase A|non-metastatic|NME1 Nucleoside Diphosphate Kinase|Granzyme A activated DNase|Granzyme A-activated DNase|Nucleoside Diphosphate Kinase B|Expressed in Non-Metastatic Cells 2 Protein|Expressed in Non Metastatic Cells 2 Protein|Tumor Metastatic Process Associated Protein|NM23-H3 Nucleoside Diphosphate Kinase|Non-Metastatic Cells 1 Protein|Nucleoside Diphosphate Kinase 3|NDP Kinase A|Nm23 H1 Nucleoside Diphosphate Kinase|NM23-H2 Nucleoside Diphosphate Kinase|DR-NM23 Nucleoside Diphosphate Kinase|NM23A Nucleoside Diphosphate Kinases|DR NM23 Nucleoside Diphosphate Kinase|Tumor Metastatic Process-Associated Protein|NM23 H3 Nucleoside Diphosphate Kinase|Nm23-H1 Nucleoside Diphosphate Kinase|NM23 H2 Nucleoside Diphosphate Kinase|Nucleoside Diphosphate Kinase C|Non Metastatic Cells 1 Protein
NEW11243,CHEMICAL,adjuvant postoperative mifamurtide,adjuvant postoperative mifamurtide
http://purl.obolibrary.org/obo/DOID_3356,DISEASE,localized osteosarcoma,localised Osteogenic sarcoma|localised osteosarcoma|localized Osteogenic sarcoma|localized osteosarcoma
D018217,DISEASE,"Osteosarcoma, Juxtacortical","Juxtacortical Osteosarcoma|Osteosarcomas, Juxtacortical|Juxtacortical Osteosarcomas|osteosarcoma"
NEW11244,CHEMICAL,mifamurtide administration,Mifamurtide administration
NEW11245,DISEASE,rare sarcoma,rare sarcoma
NEW11246,CHEMICAL,four-layered microgyria,Four-layered microgyria
http://purl.obolibrary.org/obo/DOID_0060041,MENTAL_HEALTH,autism spectrum disorder,PPA-induced- Autism spectrum disorder cases|schizophrenia spectrum disorders|child autism spectrum disorder
NEW11247,DISEASE,autistic spectrum disorder aged,autistic spectrum disorders aged
NEW11248,CHEBI,carotenoid beta-carotene,carotenoids beta-carotene
NEW11249,DISEASE,old autistic subject,Older autistic subjects
NEW11250,CHEBI,c beta-carotene plasma value,C beta-carotene plasma values
NEW11251,CHEBI,high plasma vitamin concentration,high plasma vitamin concentrations
NEW11252,DISEASE,old autistic group,older autistic group
NEW11253,DISEASE,epilepsy psychiatric disease,epilepsy psychiatric diseases
NEW11254,CHEMICAL,donor sodium nitroprusside,SNP|donor Sodium Nitroprusside
NEW11255,CHEMICAL,sucrose concentration,sucrose concentration
NEW11256,NUTRITION,vacuolar acid invertase activity,vacuolar acid invertase activity
C022699,CHEMICAL,sucrose synthase [Supplementary Concept],sucrose synthase|Glucosyltransferases
NEW11257,NUTRITION,elevated cytoplasmic trehalose level,elevated cytoplasmic trehalose levels
NEW11258,DISEASE,host infection,host infection
D014199,NUTRITION,Trehalose,Trehalose|trehalose
NEW11259,CHEBI,progestogen contraception,progestogen contraception
C494367,CHEMICAL,estroprogestin [Supplementary Concept],Ethinyl Estradiol|estroprogestin|Norpregnenes|Drug Combinations
NEW11260,CHEBI,exogenous oestrogen,exogenous oestrogens
NEW11261,DISEASE,pediatric mdd,pediatric MDDs
http://purl.obolibrary.org/obo/CHEBI_86324,CHEBI,quinolone antibiotic,quinolone antibiotics
NEW11262,DISEASE,convulsive stimulus,convulsive stimuli
NEW11263,MENTAL_HEALTH,medication-induced psychotic disorder,Medication-induced psychotic disorder
NEW11264,MENTAL_HEALTH,hallucination related,hallucinations related
NEW11265,DISEASE,obese osahs patient,obese OSAHS patients
NEW11266,CHEMICAL,n-6 family,n-6 families
NEW11267,MENTAL_HEALTH,multiple linear regression analysis,multiple linear regression analysis
NEW11268,CHEMICAL,n-6/n-3,n-6/n-3
NEW11269,MENTAL_HEALTH,depression development,depression development
NEW11270,DISEASE,obstructive Sleep Apnea Hypopnea Syndrome,Obstructive Sleep Apnea Hypopnea Syndrome|OSAHS
NEW11271,NUTRITION,particular fatty acid ratio,particular fatty acid ratio
NEW11272,CHEMICAL,prostaglandin family,prostaglandins family
NEW11273,CHEBI,conventional mood stabiliser,conventional mood stabilisers
NEW11274,CHEMICAL,rapid-acting antidepressant effect,rapid-acting antidepressant effects
NEW11275,CHEMICAL,dhbetae,DHbetaE
D014796,DISEASE,Visual Perception,"Visual Processing|Processing, Visual|visual processing|Perception, Visual"
NEW11276,DISEASE,mild hypothyroidism,mild hypothyroidism
NEW11277,MENTAL_HEALTH,fluorescence displacement assay,fluorescence displacement assay
NEW11278,CHEMICAL,major th transport protein,major TH transport proteins
NEW11279,CHEMICAL,sulfonate acid group,sulfonate acid group
NEW11280,DISEASE,ttr binding,TTR binding
NEW11281,CHEMICAL,remimazolam tosilate,Remimazolam tosilate
NEW11282,CHEMICAL,use benzodiazepine,used benzodiazepines
NEW11283,CHEBI,short-acting gabaa receptor agonist,short-acting GABAA receptor agonist
NEW11284,CHEMICAL,non-competitive n-methyl-d-aspartic acid nmda receptor inhibitor,non-competitive N-methyl-D-aspartic acid NMDA receptor inhibitor
NEW11285,DISEASE,hemorrhage risk,hemorrhage risk
NEW11286,DISEASE,ich guideline,ICH guideline
NEW11287,CHEMICAL,non-nucleoside reverse-transcriptase inhibitor,non-nucleoside reverse-transcriptase inhibitor
D045169,DISEASE,Severe Acute Respiratory Syndrome,"Respiratory Syndrome, Acute, Severe|severe acute respiratory syndrome|Respiratory Syndrome, Severe Acute|SARS (Severe Acute Respiratory Syndrome)"
http://purl.obolibrary.org/obo/DOID_0081013,CHEMICAL,severe covid-19,severe CKD|severe COVID-19
NEW11288,DISEASE,hepatitis b infection,hepatitis B infection
C047057,CHEMICAL,isoniazid acetyltransferase [Supplementary Concept],Arylamine N-Acetyltransferase|isoniazide
NEW11289,MENTAL_HEALTH,heavy ethanol abuse,heavy ethanol abuse
NEW11290,CHEBI,known hepatotoxic agent,known hepatotoxic agents
NEW11291,CHEMICAL,agent busulfan,agents busulfan
http://purl.obolibrary.org/obo/CHEBI_50908,CHEBI,hepatotoxic agent,hepatotoxicant|hepatoxic agent|hepatotoxins|agente hepatotoxico|hepatoxicant|hepatotoxicants|hepatotoxic agents|hepatotoxin
NEW11292,DISEASE,cums exposure,CUMS exposure
NEW11293,CHEBI,vitamin e. a deficiency,vitamin E. A deficiency
NEW11294,DISEASE,neuromuscular deficit,neuromuscular deficit
http://purl.obolibrary.org/obo/SYMP_0000336,DISEASE,neurological dysfunction,neurological dysfunction|Neurological dysfunction
NEW11295,CHEBI,prolonged vitamin e deficiency,prolonged vitamin E deficiency
NEW11296,CHEBI,serum vitamin e,serum vitamin E
D008728,CHEMICAL,Methotrimeprazine,|Tizercine|Tizertsin|levomepromazine|Levomepromazine|Levopromazine|Tisercin|Levomeprazin
NEW11297,DISEASE,cancer cell growth,cancer cell growth
NEW11298,DISEASE,severe exhibitionist,severe exhibitionist
http://purl.obolibrary.org/obo/CHEBI_7573,CHEBI,nilutamide,"antiandrogen flutamide|nilutamide|5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione|Nilandron|nilutamida|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamide|nilutamidum"
NEW11299,CHEBI,lhrh agonist,LHRH agonist
NEW11300,DISEASE,severe deviant behaviour,severe deviant behaviour
NEW11301,CHEBI,androgen blocking,androgen blocking
NEW11302,CHEBI,androgen blockade,androgen blockade
NEW11303,CHEBI,anti-androgenic hormone,anti-androgenic hormone
NEW11304,CHEMICAL,pilocarpine administration,pilocarpine administration
NEW11305,DISEASE,ics-induced thermal hyperalgesia,ICS-induced thermal hyperalgesia
NEW11306,CHEMICAL,repeat donepezil treatment,repeated donepezil treatments
NEW11307,MENTAL_HEALTH,morphine i.c.v analgesia,morphine i.c.v analgesia
NEW11308,CHEMICAL,ics model mouse,ICS model mice
NEW11309,DISEASE,sleep abnormality,sleep abnormalities
NEW11310,CHEMICAL,agent 5-aza-2'-deoxycytidine,agent 5-aza-2'-deoxycytidine
NEW11311,MENTAL_HEALTH,dnmt hyperactivity,DNMT hyperactivity
C479058,CHEMICAL,"oxoguanine glycosylase 1, human [Supplementary Concept]",DNA Glycosylases|hOGG1
C497172,DISEASE,"MSH2 protein, human [Supplementary Concept]",MutS Homolog 2 Protein|hMSH2
NEW11312,DISEASE,hyperoxia-induced pulmonary fibrosis,hyperoxia-induced pulmonary fibrosis
NEW11313,DISEASE,human sclc,human SCLC
NEW11314,DISEASE,neuroendocrine lung carcinoma similar,neuroendocrine lung carcinomas similar
NEW11315,MENTAL_HEALTH,nicotine-induced hyperactivity,nicotine-induced hyperactivity
D055752,DISEASE,Small Cell Lung Carcinoma,"Oat Cell Carcinoma of Lung|Carcinoma, Small Cell Lung|SCLC|Oat Cell Lung Cancer|small cell lung carcinoma|Small Cell Cancer Of The Lung|Small Cell Lung Cancer"
C096097,CHEMICAL,4-((hydroxymethyl)nitrosamino)-1-(3-pyridyl)-1-butanone [Supplementary Concept],Nitrosamines|NNK
http://purl.obolibrary.org/obo/CHEBI_39026,DISEASE,low-density lipoprotein,LDL|beta-lipoproteins|Elevated low-density lipoproteins|low-density lipoproteins
NEW11316,NUTRITION,acid ratio,acids ratio
NEW11317,NUTRITION,fatty acid unsaturation,fatty acid unsaturation
http://purl.obolibrary.org/obo/CHEBI_39025,DISEASE,high-density lipoprotein,HDL|high-density lipoproteins|alpha-lipoproteins|elevated high-density lipoproteins
NEW11318,CHEMICAL,elevated linoleic acid,Elevated linoleic acid
NEW11319,NUTRITION,n-6 fatty acid ratio,n-6 fatty acid ratios
NEW11320,NUTRITION,elevated saturated fatty acid ratio,elevated saturated fatty acid ratio
NEW11321,MENTAL_HEALTH,hierarchical multiple regression,Hierarchical multiple regression
NEW11322,DISEASE,p. infestan,P. infestans
http://purl.obolibrary.org/obo/CHEBI_81841,CHEBI,cyazofamid,"fungicides pyraclostrobin|oomycete-targeted fungicides|4-chloro-2-cyano-N,N-dimethyl-5-(4-methylphenyl)-1H-imidazole-1-sulfonamide|4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide"
http://purl.obolibrary.org/obo/CHEBI_1391,CHEMICAL,"3,4-methylenedioxymethamphetamine","DL-(3,4-Methylenedioxy)methamphetamine|1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine|1-(1,3-Benzodioxol-5-yl)-N-methyl-2-propanamine|3,4-Methylenedioxymethamphetamine|± 3,4-Methylenedioxymethamphetamine|(RS)-3,4-(methylenedioxy)methamphetamine|3,4-methylenedioxymethamphetamine|MDMA|N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine|ecstasy|N-Methyl-3,4-methylenedioxyamphetamine"
NEW11323,CHEBI,carrier youth,carrier youth
C106812,CHEMICAL,adefovir dipivoxil [Supplementary Concept],adefovir|Adenine/analogs  and  derivatives|Organophosphonates|ADV
NEW11324,DISEASE,renal interstitial fibrosis,renal interstitial fibrosis
D008407,CHEMICAL,Mast Cells,"Basophil, Tissue|Cells, Mast|Tissue Basophils|Mast cells|Cell, Mast|Basophils, Tissue|Mast Cell|MCs|Tissue Basophil"
D057911,CHEMICAL,Angiotensin Receptor Antagonists,"angiotensin receptor antagonists|Receptor Antagonist, Angiotensin|Receptor Blocker, Angiotensin|Angiotensin II Receptor Blocker|Angiotensin II Receptor Blockers|Angiotensin II Receptor Antagonists|Antagonist, Angiotensin Receptor|angiotensin receptor|Receptor Antagonists, Angiotensin|Angiotensin Receptor Antagonist|Blocker, Angiotensin Receptor|Receptor Blockers, Angiotensin|Angiotensin Receptor Blockers|Angiotensin Receptor Blocker|Angiotensin II Receptor Antagonist|Antagonists, Angiotensin Receptor"
D011339,CHEMICAL,Probenecid,probenecid|Benemid|Probecid|Benuryl|Pro-Cid|Probenecid Weimer|Benecid
NEW11325,DISEASE,adv-induced nephrotoxicity,ADV-induced nephrotoxicity
NEW11326,CHEBI,membrane stabilizer sodium cromoglycate,membrane stabilizer sodium cromoglycate
http://purl.obolibrary.org/obo/CHEBI_61016,CHEMICAL,angiotensin receptor antagonist,angiotensin receptor antagonist Valsartan|angiotensin receptor antagonists|VAL
NEW11327,CHEMICAL,mc membrane stabilizer sodium cromoglycate,MCs membrane stabilizer sodium cromoglycate|SCG
NEW11328,CHEMICAL,adv accumulation,ADV accumulation
http://purl.obolibrary.org/obo/DOID_0050855,DISEASE,renal fibrosis,renal fibrosis
NEW11329,CHEMICAL,interstitial mc,interstitial MCs
NEW11330,DISEASE,adv-associated fibrosis,ADV-associated fibrosis
NEW11331,DISEASE,lung cancer treatment,lung cancer treatments
NEW11332,DISEASE,cancer present,Cancer present
NEW11333,DISEASE,cancer relapse,cancer relapse
D059630,CHEMICAL,Mesenchymal Stem Cells,"Whartons Jelly Cells|Mesenchymal Stem Cell|Bone Marrow Stromal Cells|Stromal Cell, Mesenchymal|Bone Marrow Stromal Cells, Multipotent|Stem Cell, Mesenchymal|Bone Marrow Stromal Cell|Adipose Tissue Derived Mesenchymal Stem Cell|Mesenchymal Progenitor Cells|Mesenchymal Stem Cells, Adipose-Derived|Bone Marrow Mesenchymal Stem Cells|Adipose Tissue Derived Mesenchymal Stem Cells|Mesenchymal Stromal Cells, Multipotent|Adipose-Derived Mesenchymal Stem Cell|CSCs|Adipose Tissue-Derived Mesenchymal Stromal Cells|Mesenchymal Stromal Cell|Adipose-Derived Mesenchymal Stem Cells|Multipotent Bone Marrow Stromal Cell|Mesenchymal Stem Cells, Adipose Derived|Adipose Derived Mesenchymal Stem Cell|Wharton Jelly Cells|Adipose Tissue-Derived Mesenchymal Stem Cell|Mesenchymal Stromal Cells|Adipose Derived Mesenchymal Stromal Cells|Adipose Derived Mesenchymal Stem Cells|Mesenchymal Progenitor Cell|Adipose Tissue Derived Mesenchymal Stromal Cell|stem cells|Progenitor Cell, Mesenchymal|Multipotent Bone Marrow Stromal Cells|Multipotent Mesenchymal Stromal Cells|Adipose-Derived Mesenchymal Stromal Cells|Wharton's Jelly Cell|Multipotent Mesenchymal Stromal Cell|Stromal Cells, Mesenchymal|Progenitor Cells, Mesenchymal|Adipose Tissue Derived Mesenchymal Stromal Cells|Bone Marrow Mesenchymal Stem Cell|Adipose Tissue-Derived Mesenchymal Stem Cells|Stem Cells, Mesenchymal|Bone Marrow Stromal Stem Cells|Adipose Tissue-Derived Mesenchymal Stromal Cell|Wharton's Jelly Cells"
D001600,CHEMICAL,Berberine Alkaloids,"berberine|BBR|Berbines|Alkaloids, Berberine"
NEW11334,DISEASE,self-assembled thermosensitive in-situ hydrogel,self-assembled thermosensitive in-situ hydrogel
C533735,CHEMICAL,liposomal honokiol [Supplementary Concept],Biphenyl Compounds|Honokiol|Lignans
http://purl.obolibrary.org/obo/CHEBI_50268,CHEBI,gaba modulator,GABA modulator|GABA modulators
NEW11335,CHEMICAL,different add-back regimen,different add-back regimens
NEW11336,CHEBI,primary carotenoid,primary carotenoids
NEW11337,CHEMICAL,hiv-1 rt dna polymerase/rnase h activity,HIV-1 RT DNA polymerase/RNase H activities
NEW11338,MENTAL_HEALTH,potent strand displacement inhibitor,potent strand displacement inhibitors
http://purl.obolibrary.org/obo/CHEBI_31919,NUTRITION,norgalanthamine,Litchi chinensis fraction|Norgalanthamine|N-Demethylgalanthamine|aegyptiaca L. Delile
NEW11339,DISEASE,neuronal brain damage,neuronal brain damage
NEW11340,MENTAL_HEALTH,combined fatigue,combined fatigue
NEW11341,CHEBI,endogenous nmda receptor agonist other,endogenous NMDA receptor agonist other
NEW11342,CHEMICAL,chf3381,CHF3381
NEW11343,DISEASE,heat-capsaicin human pain model,heat-capsaicin human pain model
NEW11344,CHEMICAL,anti-synaptophysin reactivity,anti-synaptophysin reactivity
NEW11345,MENTAL_HEALTH,dlb dementia,DLB dementia
NEW11346,MENTAL_HEALTH,equilibrium dissociation constant,equilibrium dissociation constant
C028697,CHEMICAL,dexamethasone receptor [Supplementary Concept],"Receptors, Glucocorticoid|dexamethasone binding site"
NEW11347,CHEMICAL,receptor content,Ro|receptor content
NEW11348,CHEMICAL,m. suaveolen,M. suaveolens
NEW11349,MENTAL_HEALTH,response resistance,response resistance
NEW11350,CHEBI,conventional antimicrobial therapy,conventional antimicrobial therapy
NEW11351,MENTAL_HEALTH,mixed dementia,mixed dementia
C536300,DISEASE,Partington X-linked mental retardation syndrome [Supplementary Concept],"Seizures|Mental Retardation, X-Linked|Ataxia|dystonia|dystonic movements"
NEW11352,CHEMICAL,reduce gamma-aminobutyric acid gaba concentration,Reduced gamma-aminobutyric acid GABA concentrations
NEW11353,CHEMICAL,cortical gaba concentration,cortical GABA concentrations
NEW11354,CHEBI,usage inhibitor/angiotensin ⅱ receptor antagonist,usage inhibitor/Angiotensin Ⅱ receptor antagonist
NEW11355,CHEMICAL,bicarbonate OR=0.89,bicarbonate OR=0.89
NEW11356,CHEMICAL,acei/arb,ACEI/ARB
NEW11357,CHEMICAL,serum bicarbonate,serum bicarbonate
D027521,CHEMICAL,Nepeta,"Nepeta catarias|Catnip|Nepetas|Nepeta cataria|Catnips|cataria, Nepeta"
C000670042,CHEMICAL,Fusarium poae [Supplementary Concept],Fusarium|Fusarium poae
C409825,DISEASE,"PGX4 protein, Fusarium oxysporum [Supplementary Concept]",Fusarium oxysporum|Glycoside Hydrolases|Fungal Proteins
NEW11358,CHEMICAL,wheat- alternaria alternata,wheat- Alternaria alternata
C479959,DISEASE,"Bcchs1 protein, Botrytis cinerea [Supplementary Concept]",Botrytis cinerea|Chitin Synthase|Fungal Proteins
NEW11359,CHEBI,antifungal activity,antifungal activities
NEW11360,CHEMICAL,Crataegus sp.,Crataegus sp.
D031205,CHEMICAL,Taraxacum,Dandelions|Taraxacum officinale|Dandelion
D031168,CHEMICAL,Matricaria,"Chamomilla recutita|Matricaria matricarioide|German Chamomile|Matricaria matricarioides|Crown Mayweeds|Chamomilla recutitas|Pineapple Weed|German Camomile|Pineapple Weeds|Matricaria recutita|Camomile, German|Chamomile, German|Matricaria recutitas|Matricaria chamomillas|Mayweed, Crown|recutitas, Matricaria|Matricarias|Crown Mayweed|Mayweeds, Crown|chamomilla, Matricaria|German chamomile|Weeds, Pineapple|recutitas, Chamomilla|matricarioide, Matricaria|Weed, Pineapple|Matricaria chamomilla"
http://purl.obolibrary.org/obo/NCBITaxon_523089,NUTRITION,haemaphysalis concinna,Helichrysum arenarium|Trapa bispinosa
NEW11361,CHEBI,Fat-Soluble vitamin,Fat-Soluble Vitamins
NEW11362,CHEBI,vitamin d Endocrine system,Vitamin D Endocrine System
NEW11363,DISEASE,breast cancer cell,breast cancer cells
NEW11364,DISEASE,P. Quinn,P. Quinn
NEW11365,CHEMICAL,sex-hormone level,sex-hormone levels
NEW11366,CHEMICAL,cerebral serotonin transporter,cerebral serotonin transporter
NEW11367,CHEMICAL,serotonin signaling,serotonin signaling
NEW11368,DISEASE,tuberculosis control,tuberculosis control
NEW11369,DISEASE,intestinal protozoa,intestinal protozoa
NEW11370,CHEMICAL,srif receptor,SRIF receptors
NEW11371,DISEASE,human endometrial cancer cell line,human endometrial cancer cell line
NEW11372,CHEMICAL,mt2 melatonin receptor subtype,MT2 melatonin receptor subtype
NEW11373,DISEASE,endometrial cancer therapy,endometrial cancer therapy
NEW11374,CHEMICAL,melatonin treatment,Melatonin treatment
C084656,CHEMICAL,paricalcitol [Supplementary Concept],Pari|Paricalcitol|Ergocalciferols
NEW11375,CHEBI,vitamin d2 analogue,vitamin D2 analogue
NEW11376,CHEMICAL,pari administration,Pari administration
D014917,DISEASE,Whooping Cough,"Cough, Whooping|cough|Pertusses|Pertussis|Bordetella pertussis Infection, Respiratory|whooping cough"
D023341,DISEASE,Chills,chills|Shivering (1977-2000)
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Restlessness,DISEASE,restlessness,tiredness/fatigue
NEW11377,DISEASE,cold sore throat,cold sore throat
C008450,CHEMICAL,7-methylguanine [Supplementary Concept],7-methylguanine|Guanine/analogs  and  derivatives
C030514,CHEMICAL,hippuric acid [Supplementary Concept],Hippurates|hippuric acid
NEW11378,CHEBI,ovarian hormone signal,ovarian hormone signals
NEW11379,MENTAL_HEALTH,projection site,projection sites
http://purl.org/sig/ont/fma/fma77609,CHEMICAL,sublenticular extended amygdala,CMA|centromedial amygdala
NEW11380,NUTRITION,manner steroid hormone information,manner steroid hormone information
D006964,CHEBI,Hyperpituitarism,"Inappropriate Thyroid Stimulating Hormone Secretion|FSH Hypersecretion, Pituitary|Inappropriate FSH Secretion Syndrome|Pituitary LH Hypersecretion|Inappropriate LH Secretion Syndrome|Thyroid Stimulating Hormone, Inappropriate Secretion|Inappropriate Follicle Stimulating Hormone Secretion|Pituitary FSH Hypersecretion|hormone secretion|Inappropriate Luteinizing Hormone Secretion|Hypersecretion, Pituitary LH|LH Hypersecretion, Pituitary|Luteinizing Hormone, Inappropriate Secretion|Pituitary TSH Hypersecretion|TSH Hypersecretion, Pituitary|Hypersecretion, Pituitary TSH|Inappropriate TSH Secretion Syndrome|Hypersecretion, Pituitary FSH|Follicle Stimulating Hormone, Inappropriate Secretion"
D011133,CHEMICAL,Polysaccharide-Lyases,"Polysaccharide Lyases|polysaccharide|Lyase, Polysaccharide|Polysaccharide Lyase|Polysaccharide-Lyase|ASP"
D023681,CHEMICAL,Cichlids,"Cichlidae|Cichlid|Fish, Cichlid|Nile Tilapia|Oreochromis niloticus|Cichlid Fish|Oreochromis nilotica|Tilapia nilotica|Nile tilapia"
NEW11381,DISEASE,sub-lethal tl toxicity effect,sub-lethal Tl toxicity effects
C571043,CHEMICAL,exposed proliferation antigen 210 [Supplementary Concept],exposed|Peptide Fragments|Thymidine Kinase
D004289,NUTRITION,Dolphins,"Lagenorhynchus albirostris|Ganges River Dolphin|Atlantic White Sided Dolphins|Risso Dolphin|Dolphin|Yangtze River Dolphin|Right Whale Dolphins|Right Whale Dolphin|Inia geoffrensis|Pygmy Killer Whales|Frasers Dolphin|Gray Grampus|False Killer Whale|Feresa attenuata|White-Beaked Dolphins|Melon-Headed Whale|Whale, False Killer|Tucuxi Dolphin|White-Beaked Dolphin|Many-Toothed Blackfish|Pontoporia blainvilleus|Lagenorhynchus|Sotalia fluviatili|Langenorhynchus obliquidens|Atlantic White-Sided Dolphins|Humpback Dolphins|Delphinidae|Franciscanas|Lissodelphi|Melon Headed Whale|Franciscana|Pseudorca crassiden|Amazon River Dolphins|Ocean Dolphin|Marine Dolphin|Lagenodelphis hoseus|Rissos Dolphin|Pseudorca crassidens|Baijus|Pygmy Killer Whale|Many Toothed Blackfish|Pacific White Sided Dolphins|Orcaella brevirostris|Pacific White-Sided Dolphin|Tucuxi Dolphins|Lagenorhynchus albirostri|Marine Dolphins|blackfish|Fraser Dolphin|Melon-Headed Whales|Dolphin, Fraser's|Sousa|Humpback Dolphin|Baiji|Whale, Melon-Headed|Planista gangeticas|La Plata Dolphin|False Killer Whales|Lagenorhynchus acutus|Ocean Dolphins|Platanistas|Fraser's Dolphin|Platanista|Sotalia fluviatilis|Orcaella brevirostri|Pontoporia blainvillei|Grampus griseus|Rough-Toothed Dolphin|Peponocephala electra|Ganges Dolphin|Rough-Toothed Dolphins|Lagenodelphis hosei|Lissodelphis|Langenorhynchus obliquiden|Pacific White-Sided Dolphins|Steno bredanensis|Risso's Dolphin|Irrawaddy River Dolphin|Susus|Lipotes vexillifer|Whale, Pygmy Killer|Piebald Dolphin|White Beaked Dolphins|Planista gangetica|Rough Toothed Dolphin|Cephalorhynchus|Chinese River Dolphin|Atlantic White-Sided Dolphin|Piebald Dolphins|Amazon Dolphins"
D009586,MENTAL_HEALTH,Nitrogen Fixation,"Diazotrophic Activity|Activities, Diazotrophic|nitrogen fixation|Fixation, Nitrogen|N2 Fixation|Dinitrogen Fixation|Fixation, N2|Fixation, Dinitrogen|Activity, Diazotrophic|Diazotrophic Activities|Diazotrophy"
D029921,NUTRITION,Trifolium,"Trifoliums|pratenses, Trifolium|Trifolium pratense|Red Clover|Clover, Red|Trifolium pratenses|repen, Trifolium|Trifolium repen|red clover|Trifolium repens"
http://cbmi.med.harvard.edu/asdphenotype#Class_471,DISEASE,depressive disorder,manic depressive disorder|syndromal depression|bipolar depressive disorders
NEW11382,CHEMICAL,monoamine transporter-inhibiting antidepressant,monoamine transporter-inhibiting antidepressants
NEW11383,CHEMICAL,melatonin treatment,melatonin treatment
NEW11384,CHEBI,estrogen pathway,estrogen pathways
C000646209,CHEMICAL,Komagataeibacter hansenii [Supplementary Concept],Komagataeibacter|Acetobacteraceae
NEW11385,DISEASE,surgical Infection Society 's,Surgical Infection Society's
NEW11386,DISEASE,traumatic rib,traumatic rib
NEW11387,DISEASE,rib sternal fracture,rib sternal fractures
NEW11388,CHEBI,antibiotic use,antibiotic use
C062878,CHEMICAL,L-rhamnose isomerase [Supplementary Concept],L-rhamnose|Aldose-Ketose Isomerases
NEW11389,NUTRITION,trout egg l-rhamnose-binding lectin,trout egg L-rhamnose-binding lectins
D056730,CHEMICAL,Silver-Russell Syndrome,"Dwarfism, Silver Russell|Russell Silver Syndrome|Silver-Russell Dwarfism|silver|Silver Russell Dwarfism|Silver Russell Syndrome|Russell-Silver Syndrome|Dwarfism, Silver-Russell|Syndrome, Silver-Russell|Syndrome, Russell Silver"
C099881,NUTRITION,"egg jelly ligand receptors, Strongylocentrotus purpuratus [Supplementary Concept]","sea urchin|Receptors, Cell Surface"
NEW11390,DISEASE,lacunar stroke patient,lacunar stroke patients
NEW11391,CHEBI,brain antigen,brain antigens
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Dementia_with_Lewy_Bodies,DISEASE,dementia with lewy bodies,Lewy body-associated dementias
NEW11392,MENTAL_HEALTH,dementia type,dementia types
NEW11393,CHEBI,neuronal- antigen,neuronal- antigens
D016643,CHEMICAL,"Encephalopathy, Bovine Spongiform","BSE|Spongiform Encephalopathy, Bovine|Bovine Spongiform Encephalitis|Bovine Spongiform Encephalopathy|Mad Cow Disease|BSE (Bovine Spongiform Encephalopathy)|Encephalitis, Bovine Spongiform|Mad Cow Diseases|BSEs (Bovine Spongiform Encephalopathy)|Bovine spongiform encephalopathy"
NEW11394,CHEMICAL,certain amino acid residue,certain amino acid residues
C108475,CHEMICAL,pitavastatin [Supplementary Concept],Quinolines|Pitavastatin
C107067,NUTRITION,"2,4,6-trihydroxyacetophenone [Supplementary Concept]",Acetophenones|acetophenone
NEW11395,CHEMICAL,bond dissociation,bond dissociation
NEW11396,MENTAL_HEALTH,phenolic dissociation energy,phenolic dissociation energies
NEW11397,CHEBI,vitamin b6 supplementation,vitamin B6 supplementation
NEW11398,CHEBI,female hormone,female hormone
NEW11399,CHEBI,environmental oestrogen,Environmental oestrogens
NEW11400,DISEASE,reproductive disorder,reproductive disorders
NEW11401,CHEBI,sympathomimetic symptom,sympathomimetic symptoms
D020511,DISEASE,Neuromuscular Junction Diseases,"Neuromuscular Transmission Disorders|neuromuscular junction|Neuromuscular Transmission Disorder|Neuromuscular Junction Disorder|Neuromuscular Junction Disorders|Toxic Disorders, Neuromuscular Junction|Neuromuscular Junction Disease|Neuromuscular Junction Toxic Disorders"
NEW11402,CHEMICAL,da receptor,DA receptors
NEW11403,CHEMICAL,postsynaptic da receptor,postsynaptic DA receptors
NEW11404,DISEASE,aspd subject,ASPD subjects
NEW11405,CHEMICAL,dope ZnO,doped ZnO
NEW11406,DISEASE,aureus bacteria,aureus bacteria
NEW11407,CHEMICAL,chronic aicar administration,Chronic AICAR administration
D020388,DISEASE,"Muscular Dystrophy, Duchenne","Duchenne Muscular Dystrophy|Progressive Muscular Dystrophy, Duchenne Type|Pseudohypertrophic Muscular Dystrophy, Childhood|Pseudohypertrophic Muscular Dystrophy|Childhood Pseudohypertrophic Muscular Dystrophy|Duchenne Becker Muscular Dystrophy|Muscular Dystrophy Pseudohypertrophic Progressive, Becker Type|Muscular Dystrophy, Duchenne and Becker Types|Duchenne-Type Progressive Muscular Dystrophy|Muscular Dystrophy, Duchenne-Becker|Muscular Dystrophy, Becker|Childhood Muscular Dystrophy, Pseudohypertrophic|Pseudohypertrophic Childhood Muscular Dystrophy|Duchenne and Becker Muscular Dystrophy|Muscular Dystrophy, Duchenne Type|Cardiomyopathy, Dilated, 3B|Muscular Dystrophy, Pseudohypertrophic|Muscular Dystrophy, Pseudohypertrophic Progressive, Becker Type|Muscular Dystrophy, Becker's|Duchenne muscular dystrophy|Duchenne-Becker Muscular Dystrophy|Muscular Dystrophy, Becker Type|Muscular Dystrophy, Pseudohypertrophic, Childhood|Becker's Muscular Dystrophy|Muscular Dystrophy, Childhood, Pseudohypertrophic|Duchenne Type Progressive Muscular Dystrophy|Becker Muscular Dystrophy|Cardiomyopathy, Dilated, X-Linked|Muscular Dystrophy, Pseudohypertrophic Progressive, Duchenne Type"
NEW11408,CHEMICAL,chronic aicar treatment,chronic AICAR treatment
NEW11409,DISEASE,severe sma,severe SMA
NEW11410,CHEMICAL,adenosine monophosphate-activated protein kinase agonist 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside,adenosine monophosphate-activated protein kinase agonist 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside|AICAR
http://purl.obolibrary.org/obo/HP_0003202,DISEASE,skeletal muscle atrophy,skeletal muscle atrophy
NEW11411,CHEBI,endocrine disrute chemical,endocrine disruting chemicals
NEW11412,CHEMICAL,plasma bpa level,Plasma BPA levels
NEW11413,DISEASE,classic autistic child,classic autistic children
NEW11414,DISEASE,rigid-compulsive behavior,rigid-compulsive behavior
NEW11415,CHEBI,new female androgen patch,new female androgen patch
NEW11416,CHEMICAL,l. fruit,L. fruits
NEW11417,CHEMICAL,nicotine craving,nicotine craving
NEW11418,CHEMICAL,da agonist,DA agonist|lisuride
NEW11419,CHEMICAL,dopaminergic da response,dopaminergic DA response
NEW11420,DISEASE,behavioral aggression,Behavioral aggression
NEW11421,DISEASE,high dis,high DIS
NEW11422,CHEBI,da agonist lisuride,DA agonist lisuride
NEW11423,CHEBI,neurotoxic derivative antimalarial drug,neurotoxic derivative antimalarial drug
D061329,CHEMICAL,Oil and Gas Fields,"Reservoir, Gas|Gas Well|Gas Reservoir|Reservoirs, Gas|Gas Fields|Oil Reservoirs|Reservoir, Oil|Wells, Oil|ODSO|Field, Gas|Oil Reservoir|GAs|Field, Oil|Oil Fields|Oil Well|Fields, Oil|Oil and Gas Reservoirs|Gas Wells|Gas Reservoirs|oil|Well, Oil|Wells, Gas|Gas Field|Reservoirs, Oil|Fields, Gas|Oil and Gas Wells|Oil Wells|Oil Field|Well, Gas|gas"
NEW11424,CHEBI,safest drug,safest drug
NEW11425,DISEASE,co-morbiditie,co-morbidities
D016491,DISEASE,Peripheral Vascular Diseases,"peripheral vascular disease|Angiopathies, Peripheral|Disease, Peripheral Vascular|Peripheral Vascular Disease|Peripheral Angiopathy|Angiopathy, Peripheral|Diseases, Peripheral Vascular|Vascular Disease, Peripheral|Vascular Diseases, Peripheral|Peripheral Angiopathies"
D054537,DISEASE,Atrioventricular Block,"|AV Blocks|atrioventricular block|Block, AV|AV block|Atrioventricular Conduction Block|Atrioventricular Blocks|Atrioventricular Conduction Blocks|Conduction Blocks, Atrioventricular|Blocks, AV|Conduction Block, Atrioventricular|AV Block"
D062646,CHEBI,Acid Sensing Ion Channel Blockers,"ASIC Inhibitors|Proton Gated Sodium Channel Blockers|ASIC Channel Blockers|Proton-Gated Sodium Channel Blockers|Acid Sensing Ion Channel Inhibitors|ASIC Blockers|Channel Antagonists, ASIC|Antagonists, ASIC Channel|ASIC Channel Antagonists|Channel Blockers, ASIC|Blockers, ASIC Channel|channel antagonists"
NEW11426,DISEASE,elderly migraine patient,elderly migraine patients
D014363,CHEMICAL,Tryptamines,Triptan|triptan|Triptans|Indolylethylamines
NEW11427,DISEASE,migraine attack,migraine attacks
NEW11428,CHEBI,prophylactic treatment beta-adrenoceptor antagonist,prophylactic treatment beta-adrenoceptor antagonists
NEW11429,DISEASE,rodent td model,rodent TD models
NEW11430,DISEASE,tremor dominant,Tremor Dominant|TD
NEW11431,DISEASE,oral allergy syndrome,oral allergy syndrome
NEW11432,DISEASE,coloboma mouse,coloboma mice
NEW11433,CHEBI,alpha(2)-adrenergic receptor antagonist yohimbine,alpha(2)-adrenergic receptor antagonist yohimbine
NEW11434,CHEMICAL,serotonin 5-ht system activity,serotonin 5-HT system activity
NEW11435,DISEASE,personality-disordered individual,personality-disordered individuals
NEW11436,DISEASE,assaultiveness Buss-Durkee Assault,assaultiveness Buss-Durkee Assault
NEW11437,CHEMICAL,5-ht index,5-HT indices
NEW11438,CHEMICAL,pre-synaptic 5-ht function,pre-synaptic 5-HT function
D014754,MENTAL_HEALTH,Violence,"Structural Violence|Assaultive Behavior|assaultive behavior|Violence, Structural|Atrocities|Behavior, Assaultive"
NEW11439,MENTAL_HEALTH,depression symptomatology,depression symptomatology
NEW11440,DISEASE,adulthood psychiatric condition,adulthood psychiatric conditions
D016137,CHEMICAL,Spina Bifida Cystica,"Spina Bifida Aperta|Spina Bifida, Open|Spina Bifida Manifesta|spina bifida|SB|Open Spina Bifida|Spina bifida"
D052878,DISEASE,Urolithiasis,"urolithiasis|Lithiasis, Urinary|Urinary Lithiasis"
NEW11441,MENTAL_HEALTH,hyperactivity score,hyperactivity scores
NEW11442,CHEMICAL,polyene-loaded ergosterol-immobilized slab,polyene-loaded ergosterol-immobilized slabs
NEW11443,CHEBI,buffer medium drug,buffer medium drug
NEW11444,CHEMICAL,phytophagia due facility,phytophagia due facility
NEW11445,CHEMICAL,mir-330 3p target site snp,miR-330 3p target site SNP
NEW11446,CHEMICAL,Rs41305272,Rs41305272
NEW11447,CHEBI,rs41305272*t carrier frequency,Rs41305272*T carrier frequency
NEW11448,CHEMICAL,predict mir-330 3p target gene,Predicted miR-330 3p target genes
NEW11449,DISEASE,treatment-emergent nausea,treatment-emergent nausea
NEW11450,NUTRITION,cerebral folate deficiency,Cerebral folate deficiency
C548696,CHEMICAL,"FOLR1 protein, human [Supplementary Concept]",FOLR1|Folate Receptor 1
C077509,DISEASE,"mim-1 protein, Gallus gallus [Supplementary Concept]",OMIM # gene codes|Acetyltransferases
NEW11451,CHEBI,specific cns folate transporter,specific CNS folate transporter
NEW11452,NUTRITION,folr1-related folate deficiency present,FOLR1-related folate deficiency present
NEW11453,DISEASE,early childhood.(2 Seizures,early childhood.(2 Seizures
D006610,DISEASE,High Pressure Neurological Syndrome,"High Pressure Nervous Syndrome|neurological syndrome|HPNS|Experimental High Pressure Neurological Syndrome|High Pressure Neurological Syndrome, Experimental|High Pressure Neural Syndrome|high pressure nervous syndrome|HPNSs"
NEW11454,DISEASE,csf 5mthf deficiency,CSF 5MTHF deficiency
NEW11455,NUTRITION,normal folate metabolism,normal folate metabolism
NEW11456,CHEBI,platelet glycoprotein gp iib/iiia receptor antagonist,Platelet glycoprotein Gp IIb/IIIa receptor antagonists
NEW11457,MENTAL_HEALTH,non-st-segment elevation acute coronary syndrome,non-ST-segment elevation acute coronary syndromes
NEW11458,CHEMICAL,anticonvulsive agent gabapentin,anticonvulsive agent gabapentin
NEW11459,DISEASE,diabetic neuropathic patient,diabetic neuropathic patients
D000071442,MENTAL_HEALTH,Taxis Response,"Avoidance, Thermal|Thermal Avoidance|Orientation, Compass|Responses, Taxis|Galvanotaxis|Taxis Responses|Tropotaxis|Thermotaxis|Avoidance, Heat|Compass orientation|Compass Orientation|Response, Taxis|Heat Avoidance"
NEW11460,CHEMICAL,serum ua elevation,serum UA elevation
NEW11461,CHEMICAL,serum creatinine,serum creatinine
D011686,CHEMICAL,"Purine-Pyrimidine Metabolism, Inborn Errors","purine|Purine Pyrimidine Metabolism, Inborn Errors"
NEW11462,CHEMICAL,calcium concentration,calcium concentration
http://purl.obolibrary.org/obo/MFOMD_0000174,MENTAL_HEALTH,regression,mixed-logit regression|Passing-Bablok regression|Schild regression|Regression algorithms-that
D003663,NUTRITION,Decision Trees,"decision tree|Trees, Decision|Tree, Decision|Decision Tree"
NEW11463,NUTRITION,control crayfish,control crayfish
NEW11464,MENTAL_HEALTH,associate cardiac depression,associated cardiac depression
NEW11465,DISEASE,respiratory effect,respiratory effects
NEW11466,CHEBI,potent paf antagonist,potent PAF antagonist
http://purl.obolibrary.org/obo/DOID_2913,DISEASE,acute pancreatitis,acute necrotizing pancreatitis|severe acute pancreatitis|PANCREATITIS NECROTIZING
C103289,CHEMICAL,lexipafant [Supplementary Concept],Leucine/analogs  and  derivatives|Imidazoles|lexipafant
D018746,DISEASE,Systemic Inflammatory Response Syndrome,"Sepsis Syndrome|Syndrome, Sepsis|Inflammatory Response Syndrome, Systemic|Sepsis Syndromes|Syndromes, Sepsis|systemic inflammatory response syndrome|SIRS"
NEW11467,DISEASE,"5,10-methylenetetrahydrofolate reductase mthfr deficiency","5,10-methylenetetrahydrofolate reductase MTHFR deficiency"
NEW11468,DISEASE,various snps/mutation,various SNPs/mutations
C565512,DISEASE,"Mthfr Deficiency, Thermolabile Type [Supplementary Concept]",Methylenetetrahydrofolate Reductase (NADPH2)/deficiency|MTHFR deficiency|Homocystinuria
NEW11469,MENTAL_HEALTH,common sexual dysfunction,common sexual dysfunction
NEW11470,DISEASE,x-linked gene sts,X-linked gene STS
NEW11471,CHEMICAL,steroid hormone-modulating enzyme,steroid hormone-modulating enzyme
NEW11472,CHEMICAL,enzyme steroid sulfatase,enzyme steroid sulfatase
NEW11473,DISEASE,alternaria toxin reduction,Alternaria toxins reduction
NEW11474,MENTAL_HEALTH,regression function,Regression function
C018206,CHEMICAL,alternariol monomethyl ether [Supplementary Concept],Lactones|alternariol|AOH
http://purl.obolibrary.org/obo/DOID_0060436,DISEASE,chromosome 22q11.2 microduplication syndrome,22q11.2 microduplication syndrome|duplication 22q11.2|trisomy 22q11.2|22q11.2 microdeletion
NEW11475,CHEMICAL,clozapine treatment,clozapine treatment
NEW11476,NUTRITION,bobwhite quail,bobwhite quail
NEW11477,DISEASE,loose dropping,loose droppings
C035598,DISEASE,"enterotoxin, Clostridium [Supplementary Concept]",Enterotoxins|Clostridium perfringens type A
NEW11478,NUTRITION,10-to-16-wk-old bobwhite quail,10-to-16-wk-old bobwhite quail
NEW11479,DISEASE,ulcerative enteritis-like disease,Ulcerative enteritis-like disease
http://purl.obolibrary.org/obo/NCBITaxon_10278,DISEASE,molluscipoxvirus,A/chicken/Hong Kong/220/97 HK/220 HPAI virus
D003370,NUTRITION,Coturnix,"Japanese quail|Japanese Quail|Quail, Japanese|Japanese Quails|Quails, Japanese|Coturnix japonica"
NEW11480,CHEBI,b-cell maturation antigen bcma,B-cell maturation antigen BCMA
D016219,DISEASE,"Immunotherapy, Adoptive","Therapies, CAR T-Cell|Immunotherapies, Adoptive Cellular|CAR T-Cell Therapies|Cellular Immunotherapy, Adoptive|CAR T Cell Therapy|Adoptive Cellular Immunotherapies|CAR T-Cell Therapy|Chimeric Antigen Receptor Therapy|CAR T-cell therapy|T-Cell Therapies, CAR|Adoptive Immunotherapies|Cellular Immunotherapies, Adoptive|Immunotherapies, Adoptive|Immunotherapy, Adoptive Cellular|Adoptive Cellular Immunotherapy|T-Cell Therapy, CAR|Adoptive Immunotherapy|Therapy, CAR T-Cell"
NEW11481,CHEBI,antigen expression,antigen expression
NEW11482,DISEASE,tumour cell surface,tumour cell surface
NEW11483,DISEASE,Coratina,Coratina
D001555,CHEMICAL,Benzene Derivatives,"Derivatives, Benzene|Benzene"
NEW11484,MENTAL_HEALTH,projection score,projection scores
D020926,CHEMICAL,Medetomidine,"Levomedetomidine|MPV-785|MPV 785|MPV785|Medetomidine Hydrochloride|Hydrochloride, Medetomidine|medetomidine"
NEW11485,DISEASE,clinical pain management,clinical pain management
NEW11486,CHEMICAL,transmucosal route,transmucosal routes
NEW11487,DISEASE,obesity-related chronic pain,Obesity-related chronic pain
D000079524,CHEBI,Narcotic-Related Disorders,"Abuse, Narcotic|Addiction, Narcotic|Abuses, Narcotic|narcotic abuse|Narcotic Dependence|Disorder, Narcotic-Related|Dependence, Narcotic|Narcotic Addiction|Narcotic Abuse|narcotic dependence|Narcotic Related Disorders|Narcotic Abuses|Narcotic Addictions|Narcotic-Related Disorder"
NEW11488,CHEMICAL,conjugate bilirubin,conjugated bilirubin
D001663,CHEMICAL,Bilirubin,"Bilirubinate, Calcium|Bilirubin, Monosodium Salt|Bilirubin, (4E)-Isomer|Calcium Salt Bilirubin|Bilirubin, Calcium Salt|Monosodium Salt Bilirubin|Hematoidin|delta Bilirubin|Bilirubin, (15E)-Isomer|Calcium Bilirubinate|Bilirubin, (4E,15E)-Isomer|bilirubin|Disodium Salt Bilirubin|Bilirubin, Disodium Salt|Bilirubin IX alpha|delta-Bilirubin|Salt Bilirubin, Calcium"
NEW11489,MENTAL_HEALTH,final logistic regression model,final logistic regression model
D060467,MENTAL_HEALTH,Disease Resistance,"disease resistance|Resistance, Disease|Disease Resistances|Resistances, Disease"
NEW11490,CHEMICAL,low dissolve oxygen,low dissolved oxygen
D000089882,CHEMICAL,Antimicrobial Peptides,"AMP|Antimicrobial peptides|Antimicrobial Peptide|antimicrobial peptides|Peptide, Antimicrobial"
NEW11491,CHEBI,antibiotic development,antibiotic development
D000068579,CHEMICAL,Celecoxib,SC58635|Celebrex|SC-58635|SC 58635|4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide|Celecoxib|celecoxib
NEW11492,CHEMICAL,selective serotonin inhibitor-resistant ocd,selective serotonin inhibitor-resistant OCD
D000080702,DISEASE,Edible Insects,"As Foods, Insects|Insects As Food|insects|As Food, Insects|Food, Insects As|Foods, Insects As|Insects As Foods|Edible Insect|Insect, Edible|Insects, Edible"
NEW11493,CHEMICAL,fast-acting antidepressant therapy,fast-acting antidepressant therapy
D007023,DISEASE,"Hypotension, Controlled","Induced Hypotension|Hypotension, Induced|Controlled Hypotension|controlled hypotension"
NEW11494,DISEASE,ideal hypotensive agent,ideal hypotensive agent
NEW11495,CHEBI,anaesthetic drug,anaesthetic drug
NEW11496,DISEASE,hypotensive effect,hypotensive effect
NEW11497,CHEMICAL,agent isoflurane,agents isoflurane
NEW11498,DISEASE,reward-related eat behavior,reward-related eating behavior
http://purl.obolibrary.org/obo/CHEBI_74518,CHEBI,anti-obesity agent,therapeutic anti-obesity agents|anti-obestic agents|anti-obestic agent|anti-obesity agents
NEW11499,DISEASE,craving-related eat behavior,craving-related eating behavior
C453360,CHEMICAL,"6-O-(2'', 4''-diacetyl-3'' -O-p-methoxycinnamoyl)-rhamnopyranosyl catalpol [Supplementary Concept]",Iridoid Glycosides|catalpol|Cinnamates
NEW11500,CHEMICAL,lonchocarpus cyanescen,Lonchocarpus cyanescens
NEW11501,CHEMICAL,pb exposure,Pb exposure
NEW11502,CHEBI,endocrine hormone,endocrine hormones
NEW11503,NUTRITION,pacific oyster mortality syndrome,Pacific oyster mortality syndrome
NEW11504,DISEASE,ostreid herpesvirus type,Ostreid herpesvirus type
NEW11505,CHEBI,mollusc-derived antiviral,Mollusc-derived antivirals
NEW11506,DISEASE,human virus,human viruses
NEW11507,NUTRITION,pacific oyster,Pacific oyster
NEW11508,CHEBI,in antiviral activity,in antiviral activity
D022301,DISEASE,Herpes Simplex Virus Vaccines,"HSV Vaccines|Herpes Simplex Virus|Vaccines, HSV|herpes simplex virus|Vaccines, Simplexvirus|Simplexvirus Vaccines"
C000623855,DISEASE,Human mastadenovirus F [Supplementary Concept],"Adenoviruses, Human|human adenovirus"
http://purl.obolibrary.org/obo/NCBITaxon_11250,DISEASE,human orthopneumovirus,human coronaviruses
NEW11509,NUTRITION,Pacific Oyster Mortality Syndrome,Pacific Oyster Mortality Syndrome
C531821,DISEASE,Stenotrophomonas maltophilia bacteremia [Supplementary Concept],Gram-Negative Bacterial Infections|bacteraemia|Stenotrophomonas maltophilia/immunology
D006566,DISEASE,Herpesviridae Infections,"B Virus Infection|Infections, B Virus|Herpesviridae Infection|Herpesvirus Infection|B Virus Infections|Infection, Herpesviridae|Herpesvirus infection|Infections, Herpesvirus|Infection, Herpesvirus|herpesvirus infections|Infection, B Virus|Herpesvirus Infections|Infections, Herpesviridae"
C006624,CHEMICAL,arcaine [Supplementary Concept],Biguanides|arcaine
NEW11510,CHEMICAL,γ-aminobutyric acid gaba analogue,γ-aminobutyric acid GABA analogues
NEW11511,MENTAL_HEALTH,perioperative analgesia,perioperative analgesia
http://purl.obolibrary.org/obo/SYMP_0000686,DISEASE,chronic cough,chronic cough
NEW11512,NUTRITION,plasma alpha-tocopherol,Plasma alpha-tocopherol
http://purl.obolibrary.org/obo/HP_0003198,DISEASE,myopathy,myodegeneration
http://purl.obolibrary.org/obo/CHEBI_80945,CHEMICAL,octan-3-ol,N-methyl-N-propyl isomer|amyl ethyl carbinol|octan-3-ol|LAMPA|1-ethylhexanol|ethyl amyl carbinol|ethylhexyl alcohol|3-octanol
NEW11513,NUTRITION,novel wheat adp-ribosylation factor-like protein 6-interacting protein gene,novel wheat ADP-ribosylation factor-like protein 6-interacting protein gene
NEW11514,DISEASE,suppression subtractive hybridization,suppression subtractive hybridization|SSH
NEW11515,NUTRITION,don-treated wheat suspension cell,DON-treated wheat suspension cells
NEW11516,CHEMICAL,taarl6ip4,TaArl6ip4
NEW11517,CHEMICAL,taarl6ip4 expression,TaArl6ip4 expression
NEW11518,NUTRITION,fusarium intermediate susceptible wheat cultivar,Fusarium intermediate susceptible wheat cultivar
NEW11519,DISEASE,cultivar zhengmai9023 resistant cultivar sumai3,cultivar Zhengmai9023 resistant cultivar Sumai3
D005670,CHEMICAL,Fusarium,Fusariums|Fusarium
http://purl.obolibrary.org/obo/CHEBI_22527,CHEMICAL,aminopurine,DON|6-diazo-5-oxo-norleucine
NEW11520,CHEMICAL,taarl6ip4,TaARL6IP4
C000626918,CHEMICAL,"Vam7 protein, Fusarium graminearum [Supplementary Concept]",Synaptosomal-Associated Protein 25|Fungal Proteins|Fusarium graminearum
NEW11521,DISEASE,graminearum alternaria alternata,graminearum Alternaria alternata
NEW11522,CHEMICAL,± µm,± µM
http://purl.obolibrary.org/obo/CHEBI_168087,CHEMICAL,"11-acetoxy-3beta,6alpha-dihydroxy-24-methyl-27-nor-9,11-seco-5alpha-cholesta-7,22e-dien-9-one.","μg/mL.|2-[(1R,2R,5R)-2-[(4S,4aS,6S,8aS)-4,6-dihydroxy-8a-methyl-1-oxo-4,4a,5,6,7,8-hexahydronaphthalen-2-yl]-1-methyl-5-[(E,2R)-5-methylhept-3-en-2-yl]cyclopentyl]ethyl acetate|± µM."
NEW11523,CHEMICAL,don affinity,DON affinity
NEW11524,CHEMICAL,67HXXXG71,67HXXXG71
NEW11525,CHEMICAL,don binding motif,DON binding motif
NEW11526,CHEMICAL,fusarium resistance,Fusarium resistance
NEW11527,CHEMICAL,great don tolerance,greater DON tolerance
http://purl.obolibrary.org/obo/CHEBI_65423,CHEMICAL,ardimerin digallate,"ardimerin 6,6'-digallate|theaflavins|Theaflavins|catechins"
NEW11528,MENTAL_HEALTH,low dissociation constant,lower dissociation constants
C063843,CHEMICAL,insulin gene enhancer binding protein Isl-1 [Supplementary Concept],Transcription Factors|ISL|LIM-Homeodomain Proteins
NEW11529,CHEMICAL,unique nucleoside reverse transcriptase translocation inhibitor,unique nucleoside reverse transcriptase translocation inhibitor
NEW11530,CHEMICAL,morphine plasma concentration,morphine plasma concentration
NEW11531,MENTAL_HEALTH,perpendicular least-square regression,perpendicular least-square regression
NEW11532,CHEMICAL,morphine treatment period,morphine treatment periods
NEW11533,CHEMICAL,detectable prenatal urinary bpa,detectable prenatal urinary BPA
NEW11534,DISEASE,increase internalizing behavior,increased internalizing behaviors
NEW11535,DISEASE,withdrawn/depressed behavior,withdrawn/depressed behavior
NEW11536,DISEASE,disorder trait,Disorder traits
NEW11537,CHEMICAL,conventional monoaminergic antidepressant,conventional monoaminergic antidepressants
NEW11538,CHEMICAL,modulator ketamine,modulator ketamine
NEW11539,CHEMICAL,fast-acting sustained antidepressant,fast-acting sustained antidepressant
http://purl.obolibrary.org/obo/DOID_602,MENTAL_HEALTH,cancerophobia,cancer phobia|compulsion|Fear of getting cancer
NEW11540,CHEMICAL,sulphur-4'-thionucleosides,sulphur-4'-thionucleosides
NEW11541,CHEMICAL,methylene group-carbocyclic nucleoside,methylene group-carbocyclic nucleosides
NEW11542,CHEMICAL,ng tube,NG tube
http://purl.obolibrary.org/obo/SYMP_0000002,DISEASE,abdominal distention,abdominal distension
NEW11543,DISEASE,functional intestinal obstruction,functional intestinal obstruction
NEW11544,CHEBI,alpha-2 agonist use,alpha-2 agonist use
NEW11545,CHEMICAL,dexmedetomidine use,dexmedetomidine use
C018152,CHEMICAL,sucrose monolaurate [Supplementary Concept],Sucrose/analogs  and  derivatives|sucrose laurate
NEW11546,MENTAL_HEALTH,mild agitation,mild agitation
NEW11547,CHEBI,superb stabilizer,superb stabilizer
http://purl.obolibrary.org/obo/CHEBI_140431,CHEMICAL,cis-phytol,FXO|FO/flaxseed oil
NEW11548,DISEASE,arg-induced nephrotoxicity,ARG-induced nephrotoxicity
D001806,CHEMICAL,Blood Urea Nitrogen,"Urea Nitrogen, Blood|BUN|Nitrogen, Blood Urea|blood urea nitrogen"
NEW11549,CHEMICAL,increase serum creatinine,increased serum creatinine
NEW11550,MENTAL_HEALTH,antioxidant defense mechanism,antioxidant defense mechanism
C119572,CHEMICAL,"bearberry, bladderwrack, borage oil, centella, fatty acid, fish oil, ginkgo biloba, melilotus, soya lecithin drug combination [Supplementary Concept]",fish oil|FO|Plant Extracts|Drug Combinations
http://purl.obolibrary.org/obo/CHEBI_135892,CHEMICAL,acetyldigoxin,beta acetyldigoxin|novodigal|beta-Acetyldigoxin|PUFA-enriched FO
C028521,CHEMICAL,lanthanum chloride [Supplementary Concept],Lanthanum|lanthanum chloride
NEW11551,CHEMICAL,lanthanum tracer distribution similar,lanthanum tracer distribution similar
http://purl.obolibrary.org/obo/CHEBI_35524,CHEBI,sympathomimetic agent,sympathomimetic|cholinomimetic agents|sympathomimetics
C000705477,CHEMICAL,pemigatinib [Supplementary Concept],Pyrroles|Morpholines|pemigatinib|Pyrimidines
C000713257,CHEMICAL,futibatinib [Supplementary Concept],Pyrroles|Pyrimidines|futibatinib|Pyrazoles
C000604580,CHEMICAL,erdafitinib [Supplementary Concept],Pyrazoles|erdafitinib|Quinoxalines
C568950,CHEMICAL,infigratinib [Supplementary Concept],infigratinib|Pyrimidines|Phenylurea Compounds
C000621805,CHEMICAL,derazantinib [Supplementary Concept],derazantinib|Quinazolines|Aniline Compounds
D018281,DISEASE,Cholangiocarcinoma,"Cholangiocellular Carcinomas|Carcinoma, Cholangiocellular|intrahepatic cholangiocarcinoma|Carcinomas, Cholangiocellular|Intrahepatic Cholangiocarcinoma|Cholangiocarcinoma, Intrahepatic|Cholangiocarcinomas, Extrahepatic|Cholangiocellular Carcinoma|Cholangiocarcinomas, Intrahepatic|Cholangiocarcinoma, Extrahepatic|Intrahepatic Cholangiocarcinomas|cholangiocarcinoma|Extrahepatic Cholangiocarcinomas|Extrahepatic Cholangiocarcinoma|Cholangiocarcinomas"
NEW11552,CHEBI,selective fgfr inhibitor,selective FGFR inhibitors
NEW11553,DISEASE,chronic heart failure,chronic heart failure
D011249,DISEASE,"Pregnancy Complications, Cardiovascular","Cardiovascular Pregnancy Complications|Complication, Cardiovascular Pregnancy|Complications, Cardiovascular Pregnancy|Pregnancies, Cardiovascular Complications|Pregnancy, Cardiovascular Complications|Pregnancy Complication, Cardiovascular|cardiovascular complications|Cardiovascular Pregnancy Complication"
NEW11554,DISEASE,pulmonary hypertensive crisis,pulmonary hypertensive crises
C000648425,DISEASE,Flavobacterium columnare [Supplementary Concept],Flavobacterium|Flavobacterium columnare
NEW11555,NUTRITION,freshwater fish,freshwater fish
NEW11556,CHEMICAL,lyase-deficient δcsla δcslb mutant,lyase-deficient ΔcslA ΔcslB mutant
NEW11557,DISEASE,single-strain infection,single-strain infections
D018170,CHEMICAL,Sumatriptan,"|Imigran|Sumatriptan|Sumatriptan Succinate|Succinate, Sumatriptan|3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide|GR43175|sumatriptan|GR 43175|GR-43175"
NEW11558,CHEBI,potent 5-ht1 receptor agonist,potent 5-HT1 receptor agonist
NEW11559,CHEBI,selective α-adrenergic agonist,selective α-adrenergic agonist
NEW11560,DISEASE,hypotensive action,hypotensive action
NEW11561,CHEBI,relevant analgesic action,relevant analgesic action
NEW11562,CHEMICAL,6-hydroxydopamine mouse model,6-hydroxydopamine mouse model
NEW11563,CHEMICAL,levodopa off,levodopa OFF
C431071,DISEASE,"cml protein, Xenopus [Supplementary Concept]",Acetyltransferases|Xenopus Proteins|CML
http://purl.obolibrary.org/obo/CHEBI_38215,CHEMICAL,calcium channel blocker,calcium channel antagonist|calcium channels blocker|calcium channel antagonists|calcium channel blockers
NEW11564,DISEASE,hypersensibility,hypersensibility
NEW11565,CHEMICAL,glutamate complex receptor,glutamate complex receptor
NEW11566,CHEMICAL,morphine development,morphine development
NEW11567,CHEMICAL,morphine tolerance,morphine tolerance
NEW11568,CHEMICAL,sex steroid,Sex steroids
D050582,CHEMICAL,Excitatory Amino Acid Transporter 5,"EAAT-5 Excitatory Amino Acid Transporter|EAAT 5 Excitatory Amino Acid Transporter|excitatory amino acid|Transporter, SLC1A7|SLC1A7 Transporter|EAA"
NEW11569,CHEBI,coeruleus antagonist precipitate opioid withdrawal,coeruleus antagonist precipitated opioid withdrawal
NEW11570,CHEMICAL,excitatory amino acid pathway,excitatory amino acid pathways
NEW11571,MENTAL_HEALTH,lc hyperactivity,LC hyperactivity
NEW11572,CHEMICAL,eaa receptor,EAA receptors
NEW11573,DISEASE,social phobic patient,social phobic patients
NEW11574,CHEBI,cardioselective drug atenolol,cardioselective drug atenolol
C586085,CHEMICAL,perfluoroundecanoic acid [Supplementary Concept],Fatty Acids|Fluorocarbons|PFA
NEW11575,DISEASE,severe pfj oa refractory,severe PFJ OA refractory
C043874,DISEASE,tumor migration inhibition factor [Supplementary Concept],Lymphokines|tumor migration
NEW11576,MENTAL_HEALTH,cell cycle apprehension,cell cycle apprehension
NEW11577,CHEMICAL,"environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin","environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin|TCDD"
D051786,CHEMICAL,Cyclic AMP Response Element Modulator,"cyclic AMP response|ICERIIgamma|CREM Protein, alpha Isoform|ICERIgamma|CREM Protein, gamma Isoform|CREM Protein, epsilon Isoform|cAMP-Responsive Element Modulator|Inducible cAMP Early Regulator|CREM Protein, tau Isoform|cAMP Responsive Element Modulator"
http://purl.obolibrary.org/obo/CHEBI_48540,CHEBI,beta-adrenergic drug,Beta-adrenergic drugs|beta-adrenergic drugs
D015269,CHEMICAL,Mycobacterium avium Complex,Mycobacterium avium complex|Mycobacterium intracellulare|Battey Bacillus|Mycobacterium avium-intracellulare|Nocardia intracellularis|MAIC|Mycobacterium avium-intracellulare Complex
D008590,DISEASE,Meningoencephalitis,Cerebromeningitides|meningoencephalitis|Cerebromeningitis|Meningoencephalitides|Encephalomeningitides|Encephalomeningitis
NEW11578,CHEMICAL,endogenous κ-opioid receptor agonist dynorphin a,endogenous κ-opioid receptor agonist dynorphin A|Dyn A
NEW11579,DISEASE,erector spinae plane block,Erector spinae plane block|ESPB
C007287,CHEBI,"dexon (fungicide), sodium salt [Supplementary Concept]",fungicide|Benzenesulfonates
NEW11580,CHEMICAL,english grain aphid,English grain aphid
NEW11581,CHEBI,common antagonist,common antagonists
NEW11582,NUTRITION,wheat host plant,wheat host plants
NEW11583,DISEASE,aggravate b. graminis infection,aggravated B. graminis infection
D000601,CHEMICAL,"Amino Acids, Essential","essential amino acids|Essential Amino Acid|Acids, Essential Amino|Essential Amino Acids|Acid, Essential Amino|Amino Acid, Essential"
NEW11584,DISEASE,b. graminis infection,B. graminis infection
NEW11585,NUTRITION,wheat increase,wheat increase
NEW11586,DISEASE,disruptive behaviour,disruptive behaviour
NEW11587,CHEMICAL,pms common,PMS common
NEW11588,DISEASE,breast tenderness,breast tenderness
http://purl.obolibrary.org/obo/MFOMD_0000209,DISEASE,mood swing,mood swing|mood swings
NEW11589,DISEASE,abdominal bloating,abdominal bloating
NEW11590,DISEASE,nocturnal hypoxemia,nocturnal hypoxemia
NEW11591,CHEMICAL,morphine analgesic potency,morphine analgesic potency
NEW11592,DISEASE,neuronal excitotoxicity,neuronal excitotoxicity
NEW11593,DISEASE,perinatal hypoxia-ischemia,perinatal hypoxia-ischemia
NEW11594,MENTAL_HEALTH,detrusor hyperactivity,detrusor hyperactivity
NEW11595,CHEMICAL,dab staining,DAB staining
NEW11596,DISEASE,powdery mildew infection,powdery mildew infection
NEW11597,DISEASE,mildew infection,mildew infection
D019800,CHEMICAL,Phenol,"Phenol, Sodium Salt|Phenolate, Sodium|Hydroxybenzene|Phenolate Sodium|Sodium Phenolate|Carbol|Carbolic Acid|phenol"
NEW11598,CHEMICAL,mda content,MDA content
C523462,CHEMICAL,benzyloxycarbonyl-leucyl-leucyl-norleucinal [Supplementary Concept],TLnp/D&G|Oligopeptides|GSI
NEW11599,DISEASE,biosafety gastrointestinal toxicity,biosafety gastrointestinal toxicity
NEW11600,DISEASE,derive hdl,derived HDL
NEW11601,CHEMICAL,lecithin-cholesterol acyltransferase activity,lecithin-cholesterol acyltransferase activity
NEW11602,NUTRITION,cholesterol efflux capacity,cholesterol efflux capacity
NEW11603,CHEMICAL,iv amphotericin b,IV Amphotericin B
NEW11604,CHEBI,antifungal therapy,Antifungal therapy
NEW11605,DISEASE,extensive intracerebral calcification,extensive intracerebral calcifications
NEW11606,DISEASE,therapy-resistant parkinsonism,therapy-resistant parkinsonism
NEW11607,CHEMICAL,Acetaminophen misuse,Acetaminophen misuse
NEW11608,MENTAL_HEALTH,structure-activity rationalization,structure-activity rationalization
NEW11609,CHEBI,fxr agonist,FXR agonists
NEW11610,CHEBI,potent fxr agonist,potent FXR agonist
NEW11611,CHEMICAL,inherited amino acid substitution,Inherited amino acid substitutions
D000080662,NUTRITION,Phospholipid Hydroperoxide Glutathione Peroxidase,"PH-GPeroxidase|Glutathione Peroxidase 4|PH GPeroxidase|phospholipid hydroperoxide|GPX4 Phospholipid Hydroperoxide Glutathione Peroxidase|PHGPx Enzyme|Phospholipid-Hydroperoxide Glutathione Peroxidase|Selenium Dependent Glutathione Peroxidase Type 4|Glutathione Peroxidase, Phospholipid-Hydroperoxide|Phospholipid Hydroperoxide Glutathione Peroxidase GPX4|Selenium-Dependent Glutathione Peroxidase Type-4"
D000080874,CHEMICAL,Synucleinopathies,α-synucleinopathy|alpha-Synucleinopathies|a-Synucleinopathy|alpha-synucleinopathies|alpha Synuclein Pathology|alpha Synucleinopathies|Synucleinopathy|alpha Synuclein Pathologies|a-Synucleinopathies|alpha-Synucleinopathy
NEW11612,CHEBI,toad toxin,toad toxins
NEW11613,DISEASE,neuropsychiatric disease secondary,neuropsychiatric diseases secondary
NEW11614,DISEASE,schizophrenia-like syndrome,schizophrenia-like syndromes
NEW11615,MENTAL_HEALTH,organic psychosis,organic psychosis
D015493,DISEASE,"Paraparesis, Tropical Spastic","Paraplegias, Tropical Spastic|Myelopathies, Htlv-1-Associated|Familial Spastic Paraparesis, Htlv-1-Associated|Human T-Lymphotropic Virus Type 1 Associated Myelopathy|HTLV-I-Associated Myelopathy-Tropical Spastic Paraparesis|Spastic Paraplegia, Tropical|Spastic Paraplegias, Tropical|HTLV-I-Associated Myelopathy|Tropical Spastic Paraparesis|HTLV-I-Associated Myelopathies|Tropical Spastic Paraplegia|HTLV I Associated Myelopathy Tropical Spastic Paraparesis|Myelopathy, Human T-Lymphotropic Virus Type 1 Associated|Myelopathy, Htlv 1 Associated|Human T Lymphotropic Virus Type 1 Associated Myelopathy|Tropical Spastic Parapareses|spastic paraparesis|Spastic Parapareses, Tropical|myelopathy|Myelopathies, HTLV I Associated|Familial Spastic Paraparesis, Htlv 1 Associated|Spastic Paraparesis, Tropical|Tropical Spastic Paraplegias|Parapareses, Tropical Spastic|Htlv-1-Associated Myelopathies|Paraplegia, Tropical Spastic|Myelopathy, HTLV-I-Associated|HTLV I Associated Myelopathy|Myelopathies, HTLV-I-Associated|Myelopathy, Htlv-1-Associated|HTLV I Associated Myelopathies|Htlv-1-Associated Myelopathy|Myelopathy, Human T Lymphotropic Virus Type 1 Associated"
C487049,CHEMICAL,BXL628 [Supplementary Concept],Calcitriol/analogs  and  derivatives|BXL-628|Elocalcitol
NEW11616,DISEASE,chronic prostatitis/chronic pelvic pain syndrome patient,chronic prostatitis/chronic pelvic pain syndrome patients
NEW11617,DISEASE,bph-related low urinary tract symptom,BPH-related lower urinary tract symptoms
NEW11618,DISEASE,wide-spread neuroapoptosis,wide-spread neuroapoptosis
NEW11619,CHEMICAL,sim-9 microglia cell,SIM-9 microglia cells
NEW11620,DISEASE,alcohol-induced neuronal death,alcohol-induced neuronal death
NEW11621,DISEASE,ethanol-induced neuronal death,ethanol-induced neuronal death
NEW11622,CHEMICAL,β(1)ar,β(1)AR
NEW11623,DISEASE,body-focused repetitive behavior disorder,Body-focused repetitive behavior disorders
NEW11624,DISEASE,skin pick disorder,Skin Picking Disorder
NEW11625,DISEASE,oxidative stress damage,oxidative stress damage
NEW11626,CHEBI,vitamin toxicity,vitamin toxicity
D005076,DISEASE,Exanthema,"|Rash, Skin|Rash|Exanthem|skin rash|rash|Skin Rash"
NEW11627,DISEASE,non-union,non-union
NEW11628,CHEMICAL,simple fixation anol compression,simple fixation anol compression
NEW11629,DISEASE,chronic prostatitis/chronic pelvic pain syndrome,chronic prostatitis/chronic pelvic pain syndrome
NEW11630,CHEBI,serum sex hormone,serum sex hormones
NEW11631,DISEASE,severe psychiatric condition,severe psychiatric conditions
NEW11632,DISEASE,dysfunctional behaviour,dysfunctional behaviours
NEW11633,CHEMICAL,hypovitaminosis D.,hypovitaminosis D.
NEW11634,DISEASE,high-functioning adult male subject,high-functioning adult male subjects
NEW11635,MENTAL_HEALTH,dsm-iv Autistic Disorder,DSM-IV Autistic Disorder
C000598571,CHEMICAL,"(6-chloro-1-(2-(dimethylamino)ethyl)indol-3-yl)-spiro(1H-isobenzofuran-3,4'-piperidine)-1'-yl-methanone [Supplementary Concept]",Indoles|RO5028442|Spiro Compounds
NEW11636,DISEASE,adult male high-functioning Autistic patient,Adult Male High-Functioning Autistic Patients
NEW11637,DISEASE,ptsd-like sequela,PTSD-like sequelae
NEW11638,DISEASE,chronic psychosocial stress model,chronic psychosocial stress model
NEW11639,CHEBI,US Drug Administration,US Drug Administration
NEW11640,CHEBI,low level carcinogen,low level carcinogens
NEW11641,DISEASE,vaccine toxicity,vaccine toxicities
NEW11642,CHEMICAL,primary hepatic angiosarcoma,Primary hepatic angiosarcoma|PHA
D054440,CHEBI,"Receptors, Ghrelin","Receptor, Ghrelin|GHSR Protein|GHS R Type 1A|Growth Hormone Secretagogue Receptors|GHS Receptor Type 1|Ghrelin Receptors|Growth Hormone Secretogogue Receptor 1B|Ghrelin Receptor|Growth Hormone Secretagogue Receptor Type 1B|GHS-R1A|Growth Hormone Secretagogue Receptor|Receptor, Growth Hormone Secretagogue 1A|Growth Hormone Secretagogue Receptor Type 1|Growth Hormone Secretagogue Receptor Type 1A|growth hormone secretagogue receptor|GHS-R1B|GHS-R Type 1A"
D011966,CHEBI,"Receptors, LHRH","Luteinizing Hormone Releasing-Hormone Receptor|GnRH Receptors|Receptors, Gonadoliberin|Gonadotropin-Releasing Hormone Receptor|Gonadoliberin Receptors|Receptors, Luliberin|LHRH Receptor|Luliberin Receptors|GnRH Receptor|LHFSHRH Receptors|LHRH Receptors|Receptors, Gonadorelin|Releasing-Hormone Receptors, Gonadotropin|Hormone Receptor, Gonadotropin-Releasing|Gonadotropin Releasing Hormone Receptors|Receptor, LHRH|Receptor, GnRH|Follicle Stimulating Hormone Releasing Hormone Receptors|Receptor, Gonadotropin-Releasing Hormone|Receptors, Gonadotropin Releasing Hormone|Receptor, Gonadorelin|Receptors, GnRH|Gonadotropin Releasing Hormone Receptor|Receptors, LHFSHRH|hormone-releasing hormone receptor|Gonadotropin Releasing-Hormone Receptors|Luteinizing Hormone Releasing Hormone Receptor|Gonadorelin Receptor|Follicle Stimulating Hormone-Releasing Hormone Receptors|Gonadorelin Receptors|Receptors, Gonadotropin Releasing-Hormone|Luteinizing Hormone Releasing Hormone Receptors"
C099641,NUTRITION,"PRS3S protein, Papaver rhoeas [Supplementary Concept]",Plant Proteins|Papaver rhoeas
NEW11643,NUTRITION,winter wheat field,winter wheat fields
D064233,CHEMICAL,Sulfonylurea Receptors,"Receptor, Sulfonylurea|sulfonylurea|Sulfonylurea Receptor|Receptors, Sulfonylurea"
NEW11644,DISEASE,in als catalytic activity assay,in ALS catalytic activity assays
NEW11645,CHEMICAL,tribenuron resistant,R|tribenuron resistant
NEW11646,CHEMICAL,non-sulfonylurea als-inhibiting herbicide,non-sulfonylurea ALS-inhibiting herbicides
C471341,DISEASE,"29-kDa outer membrane protein, Acinetobacter baumannii [Supplementary Concept]",Bacterial Proteins|A. baumannii
NEW11647,DISEASE,galleria mellonella infection model,Galleria mellonella infection model
NEW11648,CHEMICAL,importance rifabutin,IMPORTANCE Rifabutin
NEW11649,DISEASE,antibiotic-resistant a. baumannii infection due,antibiotic-resistant A. baumannii infections due
NEW11650,NUTRITION,lipogenic enzyme fatty acid synthase,lipogenic enzyme fatty acid synthase
D058922,DISEASE,Inflammatory Breast Neoplasms,"Breast Cancer, Inflammatory|Inflammatory Breast Carcinomas|Inflammatory Breast Carcinoma|Cancer, Inflammatory Breast|Inflammatory Breast Cancer (IBC)|Inflammatory Breast Neoplasm|Breast Cancers, Inflammatory|Breast Neoplasm, Inflammatory|Cancers, Inflammatory Breast|Neoplasm, Inflammatory Breast|breast carcinomas|Breast Carcinoma, Inflammatory|Breast Carcinomas, Inflammatory|Neoplasms, Inflammatory Breast|Breast Neoplasms, Inflammatory|Inflammatory Breast Cancers|Carcinomas, Inflammatory Breast|Inflammatory Breast Cancer|Carcinoma, Inflammatory Breast"
NEW11651,MENTAL_HEALTH,fas hyperactivity,FAS hyperactivity
NEW11652,DISEASE,progestin-regulated breast cancer cell proliferation,progestin-regulated breast cancer cell proliferation
NEW11653,CHEMICAL,slow-binding fas inhibitor,slow-binding FAS inhibitor
NEW11654,DISEASE,nor-induced breast cancer cell proliferation,NOR-induced breast cancer cell proliferation
NEW11655,CHEMICAL,pr- fas up-regulation,PR- FAS up-regulation
NEW11656,DISEASE,nor-stimulated breast cancer cell,NOR-stimulated breast cancer cells
NEW11657,CHEMICAL,nor-induced fas activation,NOR-induced FAS activation
NEW11658,CHEMICAL,anti-estrogen ici,anti-estrogen ICI
NEW11659,CHEMICAL,fas activity,FAS activity
NEW11660,DISEASE,hormone-dependent breast cancer cell,hormone-dependent breast cancer cells
NEW11661,CHEMICAL,intrathecal baclofen,intrathecal baclofen
NEW11662,CHEBI,botulinum toxin injection,botulinum toxin injection
D020821,DISEASE,Dystonic Disorders,"Pseudodystonia|Dystonia, Sporadic|Adult-Onset Dystonia|Dystonic Disorder|Dystonia, Secondary|Dystonia, Psychogenic|Dystonias, Adult-Onset|Dystonia, Childhood Onset|Writer's Cramp|Pseudodystonias|Autosomal Dominant Familial Dystonia|Secondary Dystonia|Psychogenic Dystonias|Adult-Onset Dystonias|Adult Onset Idiopathic Focal Dystonias|Dystonia, Idiopathic Familial|Idiopathic Familial Dystonia|Dystonias, Hereditary|Autosomal Recessive Familial Dystonia|Dystonia Disorder|Familial Dystonia, Idiopathic|Dystonias, Secondary|Focal Dystonia|Dystonias, Sporadic|Familial Dystonias, Idiopathic|Secondary Dystonias|Dystonia, Adult-Onset|Childhood Onset Dystonia|Hereditary Dystonia|Primary Dystonias|Adult-Onset Idiopathic Focal Dystonias|Adult Onset Idiopathic Torsion Dystonias|Dystonias, Primary|Familial Dystonias|Dystonias, Psychogenic|Idiopathic Familial Dystonias|Writers Cramp|hereditary dystonia|Adult-Onset Idiopathic Torsion Dystonias|Dystonia, Hereditary|Familial Dystonia, Autosomal Recessive|Focal Dystonias|Familial Dystonia, Autosomal Dominant|Hereditary Dystonias|Dystonias, Idiopathic Familial|Dystonias, Childhood Onset|Sporadic Dystonias|Dystonia, Focal|Psychogenic Dystonia|Dystonias, Familial|Dystonia, Primary|focal dystonia|Primary Dystonia|Dystonia Disorders|Writer Cramp|Childhood Onset Dystonias|Dystonias, Focal|Dystonia, Familial|Adult Onset Dystonias|Familial Dystonia|Sporadic Dystonia"
NEW11663,CHEBI,neurobiological hormone sensitivity,neurobiological hormone sensitivities
NEW11664,CHEMICAL,enzymatic hydrolysate,enzymatic hydrolysate|glucose
NEW11665,DISEASE,HAMD psychotic symptom,HAMD psychotic symptoms
NEW11666,CHEBI,high thyroid stimulating hormone tsh serum level,higher thyroid stimulating hormone TSH serum levels
NEW11667,DISEASE,rat trigeminal ganglia,rat trigeminal ganglia|TG
NEW11668,MENTAL_HEALTH,suicide prevention,suicide prevention
NEW11669,MENTAL_HEALTH,suicide intervention,suicide intervention
NEW11670,DISEASE,impaired thyroid function,impaired thyroid function
NEW11671,CHEMICAL,blood glucose level,blood glucose level
C006606,CHEMICAL,anti-thyroglobulin [Supplementary Concept],Autoantibodies|anti-thyroglobulin|A-TG
D051667,CHEMICAL,Kv1.6 Potassium Channel,"Potassium Channel, RCK2|Potassium channel|Potassium Channel, Kv1.6|RCK2 Potassium Channel|Potassium Channel, HBK2|Potassium Channel, KCNA6|KCNA6 Potassium Channel|HBK2 Potassium Channel"
NEW11672,MENTAL_HEALTH,lamina projection neuron,lamina projection neurons
NEW11673,DISEASE,gly-sipsc,gly-sIPSC
NEW11674,DISEASE,sni-induced dynamic,SNI-induced dynamic
C546026,CHEMICAL,"2-(2-methyl-1H-indol-3-yl)-1H-imidazol(4,5-f)(1,10)phenanthroline [Supplementary Concept]",Imidazoles|ML133|Phenanthrolines
NEW11675,CHEMICAL,levodopa administration,levodopa administration
C505239,CHEMICAL,amyloid beta-protein (1-6) [Supplementary Concept],Peptide Fragments|Aβ1|Amyloid beta-Peptides
NEW11676,NUTRITION,fatty acid metabolic disorder,fatty acid metabolic disorders
NEW11677,NUTRITION,brain fatty acid metabolism,brain fatty acid metabolism
NEW11678,DISEASE,downstream impairment,downstream impairments
NEW11679,CHEBI,high carotenoid,High carotenoid
D016687,DISEASE,Polydioxanone,Polydioxanones|Absoloks|Absolok|PDS II (Ethicon)|PDS
NEW11680,DISEASE,bone calcification,bone calcification
D000072743,CHEMICAL,Beta-Cryptoxanthin,β-cryptoxanthin|β-Cryptoxanthin|Beta Cryptoxanthin
NEW11681,NUTRITION,platelet alpha 2-receptor,platelet alpha 2-receptors
http://purl.obolibrary.org/obo/CHEBI_36413,CHEBI,anabolic agent,anabolic agent
http://purl.obolibrary.org/obo/DOID_4337,DISEASE,tinea capitis,dermatophytosis of scalp or beard|Molds-induced Tinea capitis|tinea capitis due to Trichophyton rubrum|Scalp ringworm|Trichophyton rubrum tinea capitis|Dermatophytosis of scalp
NEW11682,CHEBI,antifungal susceptibility,antifungal susceptibility
NEW11683,DISEASE,behavioral damage,behavioral damage
NEW11684,CHEMICAL,high thc content,high THC content
NEW11685,DISEASE,subsequent hypodopaminergia,subsequent hypodopaminergia
NEW11686,DISEASE,non-substance behavioral addiction,non-substance behavioral addictions
NEW11687,CHEMICAL,pro dopamine regulation,pro dopamine regulation
NEW11688,MENTAL_HEALTH,induce anhedonia,induced anhedonia
D000069447,CHEMICAL,Tiotropium Bromide,"679 BR, BA|BA-679 BR|Spiriva|Bromide, Tiotropium|tiotropium|Tiotropium|7-((hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide|BA679 BR|BR, BA 679|BA 679 BR"
NEW11689,CHEBI,long-acting beta-2 agonist,long-acting beta-2 agonists
D000069502,CHEMICAL,"Budesonide, Formoterol Fumarate Drug Combination","Budesonide Formoterol Drug Combination|Symbicort|Drug Combination, Budesonide-Formoterol|formoterol|Combination, Budesonide-Formoterol Drug|Budesonide Formoterol Fumarate Drug Combination|Budesonide-Formoterol Fumarate Drug Combination|Budesonide-Formoterol Drug Combination"
C554862,CHEMICAL,indacaterol-glycopyrronium combination [Supplementary Concept],Indans|indacaterol|Glycopyrrolate/analogs  and  derivatives|Quinolones|Drug Combinations
NEW11690,CHEBI,long-acting muscarinic antagonist,Long-acting muscarinic antagonists
NEW11691,CHEMICAL,® device,® device
NEW11692,CHEMICAL,single-dose dry-powder inhaler,single-dose dry-powder inhaler
NEW11693,CHEBI,postmenopausal estrogen replacement therapy,postmenopausal estrogen replacement therapy
NEW11694,CHEBI,menopausal hormone treatment,menopausal hormone treatment
NEW11695,CHEMICAL,dopamine receptor blocking agent,dopamine receptor blocking agents
http://purl.obolibrary.org/obo/PR_Q9QXS6,CHEMICAL,drebrin (mouse),DRBA|mdbn1|developmentally-regulated brain protein (mouse)|dbn1|drba
NEW11696,DISEASE,movement phenomenology,movement phenomenology
NEW11697,CHEMICAL,drba exposure,DRBA exposure
NEW11698,CHEMICAL,vaccine-induced immune thrombotic thrombocytopenia,VITT|Vaccine-induced immune thrombotic thrombocytopenia
NEW11699,DISEASE,heparin-induced thrombocytopenia,heparin-induced thrombocytopenia
NEW11700,CHEMICAL,apixaban immunoglobulin ivig infusion,apixaban immunoglobulin IVIG infusion
NEW11701,CHEMICAL,platelet mao activity,platelet MAO activity
NEW11702,CHEMICAL,haloperidol administration,haloperidol administrations
NEW11703,DISEASE,similar motor disorder,similar motor disorders
NEW11704,CHEMICAL,acute reserpine,acute reserpine
NEW11705,CHEMICAL,approve antiseizure medication,approved antiseizure medications
http://purl.obolibrary.org/obo/DOID_2842,DISEASE,jervell-lange nielsen syndrome,Jervell and Lange-Nielson syndrome|SCN1A-related Dravet syndrome
C084582,CHEMICAL,clemizole [Supplementary Concept],Benzimidazoles|clemizole
NEW11706,CHEMICAL,sex steroid receptor,sex steroid receptors
D014189,MENTAL_HEALTH,Transsexualism,Transgenderism|transsexualism
NEW11707,CHEMICAL,fibrate medication,Fibrate medications
NEW11708,DISEASE,dyslipidaemia,dyslipidaemia
NEW11709,CHEMICAL,ppar-α ly518674,PPAR-α LY518674
D016632,DISEASE,Apolipoprotein A-I,Apo A-I Isoproteins|ApoA-1|Pro Apolipoprotein A I|apoA-I|Apo A I Isoproteins|Apolipoprotein A I Isoprotein 2|Apolipoprotein A-I|ApoA-I|Apolipoprotein A I Isoproteins|Pro-Apo A-I|Apolipoprotein A1|Apo AI|Apo A-I|Apo A-1|Apolipoprotein A-I Isoprotein-2|Apolipoprotein AI|Apolipoprotein A I|Apolipoprotein A-1|Apolipoprotein AI Propeptide|Apolipoprotein A 1|Apo A1|Apolipoprotein A-I Isoprotein-4|Apolipoprotein A-I Isoproteins|Apolipoprotein A I Isoprotein 4|Pro Apo A I|Proapolipoprotein AI|Pro-Apolipoprotein A-I
NEW11710,CHEMICAL,a derivative retinoic acid,A derivative retinoic acid
NEW11711,DISEASE,ra receptor,RA receptor
NEW11712,DISEASE,bladder inflammation,bladder inflammation
NEW11713,CHEMICAL,inhibitory system(s,inhibitory system(s
NEW11714,DISEASE,chronic bladder pain,chronic bladder pain
NEW11715,MENTAL_HEALTH,painful bladder syndrome,painful bladder syndromes
NEW11716,DISEASE,bladder hypersensitivity,bladder hypersensitivity
NEW11717,CHEMICAL,mid-dose range,mid-dose range
NEW11718,CHEMICAL,lipopolysaccharide administration,lipopolysaccharide administration
NEW11719,CHEMICAL,established systemic antidepressant,established systemic antidepressant
NEW11720,CHEMICAL,endogenous catecholamine,endogenous catecholamines
NEW11721,DISEASE,cerebral disease,cerebral diseases
NEW11722,CHEBI,rt inhibitor,RT inhibitor
D012365,CHEMICAL,"RNA, Transfer, Tyr","tRNATyr|Tyrosine Specific tRNA|RNA, Tyr Transfer|tRNA(Tyr)|Tyr Transfer RNA|Transfer RNA, Tyr|Tyrosine-Specific tRNA|tRNA, Tyrosine-Specific|Tyr"
NEW11723,CHEMICAL,n348i mutation,N348I mutation
NEW11724,CHEMICAL,rnase h-competent complex,RNase H-competent complexes
NEW11725,MENTAL_HEALTH,selective dissociation,selective dissociation
NEW11726,CHEMICAL,n348i,N348I
NEW11727,CHEMICAL,non-nucleoside rt inhibitor,NNRTI|non-nucleoside RT inhibitor
NEW11728,CHEMICAL,rnase h activity,RNase H activity
NEW11729,CHEMICAL,nnrti susceptibility,NNRTI susceptibility
NEW11730,DISEASE,chronic relapsing disorder,chronic relapsing disorder
NEW11731,CHEMICAL,paracetamol dose,Paracetamol dose
NEW11732,MENTAL_HEALTH,depression comorbid patient,depression comorbid patients
NEW11733,CHEMICAL,histamine system,histamine system
NEW11734,DISEASE,chronic disorder,chronic disorder
NEW11735,CHEMICAL,gamma-aminobutyric acid gaba pathway,gamma-aminobutyric acid GABA pathways
NEW11736,CHEMICAL,prepare clonidine admixture,prepared clonidine admixture
NEW11737,NUTRITION,fatty acid supplementation,Fatty acid supplementation
NEW11738,CHEBI,adequate folate intake,adequate folate intake
NEW11739,MENTAL_HEALTH,logistic regression analysis,logistic regression analysis
http://purl.obolibrary.org/obo/CHEBI_282234,CHEMICAL,dihydrodigitoxin,"20,22-Dihydrodigitoxin|(3beta,5beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-14-hydroxycardanolide|dihydrodigitoxin|10(-6)M"
D056824,DISEASE,Upper Extremity Deep Vein Thrombosis,"Effort-Related Upper Extremity Deep Vein Thrombosis|Paget-Schroetter Syndrome|Idiopathic Upper Extremity Deep Vein Thrombosis|Upper Extremity Deep Vein Thrombosis, Primary|Upper Extremity Deep Vein Thrombosis, Secondary|Effort Related Upper Extremity Deep Vein Thrombosis|Exercise-Induced Upper Extremity Deep Vein Thrombosis|Syndrome, Paget-Schroetter|Central Venous Catheter Thrombosis|Exercise Induced Upper Extremity Deep Vein Thrombosis|Effort-Induced Upper Extremity Deep Vein Thrombosis|deep vein thrombosis|Paget Schroetter Syndrome|thrombosis|Effort Induced Upper Extremity Deep Vein Thrombosis"
NEW11740,DISEASE,pregnancy-specific disorder,Pregnancy-specific disorders
D006939,DISEASE,Hyperemesis Gravidarum,Pernicious Vomiting of Pregnancy|hyperemesis gravidarum|Pregnancy Pernicious Vomiting
NEW11741,CHEMICAL,tumor necrosis factor-alpha inhibitor thalidomide,tumor necrosis factor-alpha inhibitor thalidomide
NEW11742,CHEMICAL,abnormal myo-inositol metabolism,Abnormal myo-inositol metabolism
NEW11743,MENTAL_HEALTH,radial arm maze amnesia,radial arm maze amnesia
NEW11744,CHEMICAL,lepidagathis hyalina Nees,Lepidagathis hyalina Nees
D003371,DISEASE,Cough,coughs||Coughs|cough
NEW11745,CHEMICAL,ghb administration,GHB administration
NEW11746,DISEASE,cardio-cerebrovascular disease,cardio-cerebrovascular diseases|CCVDs
NEW11747,CHEBI,selective serotonergic agonist fluoxetine,selective serotonergic agonist fluoxetine
NEW11748,MENTAL_HEALTH,major depressive disorder alcohol dependence,major depressive disorder alcohol dependence
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Diagnosis,DISEASE,diagnosis,DSM-III-R diagnoses
http://purl.obolibrary.org/obo/DOID_224,DISEASE,transient cerebral ischemia,Transient cerebral ischemia|global transient cerebral ischemia|TRANSIENT ISCHEMIC ATTACK|transient ischemic attack|Transient cerebral ischaemia|TIA|TIA - Transient ischaemic attack|Transient ischemic attacks
NEW11749,DISEASE,important cerebral lesion,important cerebral lesions
NEW11750,CHEMICAL,atropine toxicity,atropine toxicity
NEW11751,MENTAL_HEALTH,analytical projection model,analytical projection model
NEW11752,NUTRITION,reduce insect herbivory,reduced insect herbivory
NEW11753,NUTRITION,benthic-oriented brown bullhead,Benthic-oriented brown bullhead
NEW11754,NUTRITION,white sucker,white sucker
http://purl.obolibrary.org/obo/NCBITaxon_27458,NUTRITION,chrysops,smallmouth bass|largemouth bass|pelagic-oriented largemouth bass
NEW11755,NUTRITION,brown bullhead,brown bullhead
NEW11756,CHEBI,plasma hormone,plasma hormones
NEW11757,CHEBI,pcb mixture,PCB mixture
NEW11758,CHEMICAL,acute antidepressant efficacy,acute antidepressant efficacy
NEW11759,MENTAL_HEALTH,first-episode major depressive disorder,first-episode Major Depressive Disorder
D006820,CHEMICAL,Hyaluronic Acid,"Hyvisc|Healon|Amo Vitrax|Biolon|Acid, Hyaluronic|Hyaluronan|Vitrax, Amo|hyaluronic acid|Luronit|Sodium Hyaluronate|Hyaluronate, Sodium|Etamucine|Hyaluronate Sodium|Amvisc"
NEW11760,CHEMICAL,plant hormone gibberellin,GA|plant hormone gibberellin
http://purl.obolibrary.org/obo/SYMP_0000758,DISEASE,neurological alteration,neurological alterations
D015799,DISEASE,Gyrate Atrophy,"Ornithine-Delta-Aminotransferase Deficiency|Deficiency, Ornithine Aminotransferase|Hyperornithinemia with Gyrate Atrophy of Choroid and Retina|Ornithine Aminotransferase Deficiency|Atrophy, Gyrate|OKT Deficiency|gyrate atrophy|Ornithine Ketoacid Aminotransferase Deficiency|Ornithinemia with Gyrate Atrophy|Ornithine Keto Acid Aminotransferase Deficiency|Deficiency, OAT|Gyrate Atrophy of the Choroid and Retina|Deficiency, OKT|Deficiency, Ornithine-Delta-Aminotransferase|Ornithine Delta Aminotransferase Deficiency|OAT Deficiency|Gyrate Atrophy of Choroid and Retina"
NEW11761,CHEMICAL,normal ornithine level,normal ornithine level
NEW11762,DISEASE,k suicidal death,K suicidal deaths
NEW11763,CHEMICAL,k people,K people
NEW11764,CHEBI,partial opioid agonist,partial opioid agonist
NEW11765,CHEBI,kappa opioid antagonist property,kappa opioid antagonist properties
C576986,CHEMICAL,morin-5'-sulfonic acid [Supplementary Concept],Flavonoids|morin|Sulfonic Acids
NEW11766,DISEASE,social-defeat stress,social-defeat stress
NEW11767,DISEASE,behavioral deficit,Behavioral deficits
NEW11768,CHEMICAL,gad67 pathway,GAD67 pathways
NEW11769,DISEASE,sds-induced neurobehavioral deficit,SDS-induced neurobehavioral deficits
NEW11770,DISEASE,profound motor impairment,profound motor impairment
NEW11771,CHEMICAL,polyinosinic polycytidylic acid poly(i,polyinosinic polycytidylic acid poly(I
NEW11772,CHEMICAL,novel antidepressant (r)-ketamine,novel antidepressant (R)-ketamine
NEW11773,DISEASE,psychosis-like phenotype,psychosis-like phenotypes
NEW11774,CHEMICAL,(r)-ketamine,(R)-ketamine
D017397,CHEMICAL,Prefrontal Cortex,"Area, Subcallosal|Straight Gyrus|Area 11, Brodmann|Inferior Frontal Gyrus|Brodmanns Area 12|Convolution, Superior Frontal|mPFC|Anterior Prefrontal Cortices|Orbital Areas|Orbital Cortices|Gyrus, Orbital|Area 11, Brodmann's|Frontal Sulcus|Orbital Area|Gyrus, Inferior Frontal|Orbitofrontal Gyrus|Orbitofrontal Region|Gyrus Rectus|Area 10, Brodmann's|Gyrus Orbitalis|Orbitofrontal Cortex, Lateral|Gyrus Frontalis Inferior|Orbital Gyrus|Prefrontal Cortex, Ventromedial|Cortex, Prefrontal|Lateral Orbitofrontal Cortex|Convolutions, Superior Frontal|Cortex, Lateral Orbitofrontal|medial prefrontal cortex|Orbital Cortex|Orbitalis, Pars|Sulcus, Frontal|Area 47, Brodmann's|Ventral Medial Prefrontal Cortex|Brodmann's Area 12|Orbital Gyri|Area 10, Brodmann|Marginal Gyrus|Superior Frontal Convolutions|Cortex, Ventromedial Prefrontal|Gyrus, Rectus|Prefrontal Cortex, Anterior|Ventromedial Prefrontal Cortices|Subcallosal Areas|Orbitofrontal Cortices, Lateral|Medial Frontal Gyrus|Subcallosal Area|Brodmanns Area 10|Superior, Gyrus Frontalis|Orbitofrontal Regions|Pars Orbitalis|Cortices, Ventromedial Prefrontal|Gyrus, Superior Frontal|Gyrus, Straight|Anterior Prefrontal Cortex|Inferior, Gyrus Frontalis|Superior Frontal Convolution|Area 12, Brodmann's|Frontal Convolution, Superior|Frontal Gyrus, Medial|Prefrontal Cortices, Anterior|Olfactory Sulcus|Frontalis Superior, Gyrus|Area 12, Brodmann|Brodmanns Area 47|Brodmann's Area 10|Olfactory Sulci|Gyrus, Orbitofrontal|Superior Frontal Gyrus|Orbitofrontal Cortex|Ventromedial Prefrontal Cortex|Frontal Gyrus, Inferior|Brodmann Area 47|Orbitofrontal Gyri|Brodmann Area 11|Brodmann Area 12|Brodmann's Area 11|Cortex, Anterior Prefrontal|Area, Orbital|Brodmanns Area 11|Cortex, Orbitofrontal|Cortex, Orbital|Gyrus, Rectal|Gyrus Frontalis Superior|Frontal Gyrus, Superior|Brodmann Area 10|Gyrus, Medial Frontal|Orbitofrontal Cortices|Rectus Gyrus|Region, Orbitofrontal|Brodmann's Area 47|Gyrus, Marginal|Lateral Orbitofrontal Cortices|Area 47, Brodmann|Rectal Gyrus"
NEW11775,CHEMICAL,prenatal poly(i c exposure,prenatal poly(I C exposure
NEW11776,CHEBI,trkb antagonist weekly,TrkB antagonist weekly
C559317,CHEMICAL,ANA 12 compound [Supplementary Concept],Azepines|ANA-12|Benzamides
NEW11777,CHEBI,potential prophylactic drug,potential prophylactic drug
NEW11778,MENTAL_HEALTH,early onset psychosis,early onset psychosis
NEW11779,MENTAL_HEALTH,ramble accumulation pattern,rambling accumulation pattern
NEW11780,DISEASE,trace element toxicity,trace element toxicity
NEW11781,CHEBI,novel antiepileptic drug,novel antiepileptic drug
NEW11782,CHEMICAL,oral antidepressant,oral antidepressants|ADs
NEW11783,CHEMICAL,esketamine nasal spray,Esketamine nasal spray
NEW11784,CHEMICAL,esketamine nasal spray,esketamine nasal spray
NEW11785,CHEMICAL,intravenous ketamine augmentation,intravenous ketamine augmentation
NEW11786,MENTAL_HEALTH,treatment-resistant depression patient,treatment-resistant depression patients
NEW11787,CHEMICAL,dopamine receptor agonist apomorphine hydrochloride)-stimulate growth hormone release,dopamine receptor agonist apomorphine hydrochloride)-stimulated growth hormone release
NEW11788,DISEASE,schizophrenic inpatient,schizophrenic inpatients
D044095,DISEASE,Proteus penneri,Proteus (1982-2003)|Proteus
D044082,DISEASE,Citrobacter rodentium,Citrobacter|Citrobacter freundii Biotype 4280
NEW11789,CHEMICAL,selective gamma-amino-butyric acid type b gabab receptor agonist,selective gamma-amino-butyric acid type B GABAB receptor agonist
D013693,CHEMICAL,Temazepam,"Ro 5 5345|Novo Temazepam|Apo Temazepam|Tenox|Novo-Temazepam|Dasuen|3 Hydroxydiazepam|Temazep Von Ct|Temaze|Oxydiazepam|Remestan|Gen-Temazepam|temazepam|Levanxol|PMS Temazepam|WY-3917|Normitab|Ro-5-5345|3-Hydroxydiazepam|Ro55345|Restoril|Nocturne|Nortem|Norkotral Tema|Gen Temazepam|WY3917|Nu Temazepam|WY 3917|Von Ct, Temazep|Normison|SaH 47-603|Temtabs|PMS-Temazepam|Euhypnos|Planum|Pronervon T|Apo-Temazepam|SaH 47603|Nu-Temazepam|Hydroxydiazepam|Methyloxazepam|Signopam|SaH 47 603|Tema, Norkotral"
C014481,CHEBI,dihydrocodeine [Supplementary Concept],dihydrocodeine|Codeine/analogs  and  derivatives|opioid analgesic
NEW11790,CHEMICAL,inpatient surgery tramadol,inpatient surgery tramadol
NEW11791,CHEMICAL,premedicant,premedicant
D017321,CHEMICAL,"Clinical Trials, Phase I as Topic","Phase 1 Clinical Trial|Phase I Clinical Trials|Phase I Clinical Trial|Clinical Trials, Phase 1|Human Microdosing Trial|Trial, Human Microdosing|Drug Evaluation, FDA Phase 1|Phase 1 Clinical Trials|Evaluation Studies, FDA Phase I|Clinical Trials, Phase I|Drug Evaluation, FDA Phase I|Evaluation Studies, FDA Phase 1|Trials, Human Microdosing|Human Microdosing Trials|Microdosing Trials, Human|FDA|Microdosing Trial, Human|Drug Evaluation, FDA Phase I as Topic"
NEW11792,DISEASE,severe parkinsonism,severe parkinsonism
NEW11793,CHEMICAL,glutamate concentration,glutamate concentration
C003466,CHEMICAL,thymoquinone [Supplementary Concept],Benzoquinones|thymoquinone
NEW11794,DISEASE,cerebrovascular insufficiency state,cerebrovascular insufficiency states
NEW11795,CHEMICAL,N. sativa,N. sativa
NEW11796,CHEBI,antidiuretic hormone secretion,antidiuretic hormone secretion
NEW11797,DISEASE,intracranial mass,intracranial mass
NEW11798,DISEASE,cerebral edema due,cerebral edema due
NEW11799,MENTAL_HEALTH,crave risk,craving risk
NEW11800,CHEBI,opioid agonist therapy,Opioid agonist therapies
NEW11801,DISEASE,phobic symptom,phobic symptoms
NEW11802,CHEMICAL,ant-man,Ant-Man
NEW11803,CHEMICAL,acetylcholine level,acetylcholine levels
NEW11804,CHEMICAL,m(1)-selective positive allosteric modulator,M(1)-selective positive allosteric modulator
D004734,CHEMICAL,Energy Metabolism,"energy expenditure|Expenditures, Energy|Energy Expenditure|EE|Bioenergetic|Energy Metabolisms|Energy Expenditures|Metabolism, Energy|Bioenergetics|Metabolisms, Energy|Expenditure, Energy"
NEW11805,CHEMICAL,brand name elavil,brand name Elavil
NEW11806,CHEMICAL,anti-convulsant drug,anti-convulsant drugs
NEW11807,CHEMICAL,ethanol neurotoxicity,Ethanol neurotoxicity
D020197,DISEASE,"Head Injuries, Penetrating","Head Traumas, Penetrating|Head Injuries, Penetrating, Missile|Traumas, Penetrating Craniocerebral|Injuries, Penetrating Head|Penetrating Head Injury|Penetrating Head Traumas|Penetrating Head Injuries|Traumas, Penetrating Head|Cranial Trauma, Penetrating|Penetrating Brain Injuries|Penetrating Cranial Trauma|Head Injury, Penetrating|Penetrating Craniocerebral Trauma|Trauma, Penetrating Craniocerebral|Cranial Traumas, Penetrating|Missile Injuries, Penetrating, Head|Head Trauma, Penetrating|Penetrating Brain Injury|Brain Injuries, Penetrating|Injury, Penetrating Head|Penetrating Head Trauma|head trauma|Craniocerebral Traumas, Penetrating|Trauma, Penetrating Head|Penetrating Missile Injuries, Head|Brain Injury, Penetrating|Trauma, Penetrating Cranial|Craniocerebral Trauma, Penetrating|Traumas, Penetrating Cranial|Penetrating Cranial Traumas|Penetrating Craniocerebral Traumas"
NEW11808,MENTAL_HEALTH,global dementia,global dementia
NEW11809,MENTAL_HEALTH,maintenance insomnia,maintenance insomnia
NEW11810,CHEBI,kor agonist,KOR agonist
NEW11811,DISEASE,robust dependence behavior,robust dependence behaviors
D009026,DISEASE,Mortality,"Case Fatality Rates|Age-Specific Death Rate|CFR Case Fatality Rate|Case Fatality Rate|Rate, Mortality|Rate, Case Fatality|Age-Specific Death Rates|Rate, Death|Determinant, Mortality|Crude Mortality Rates|Rate, Age-Specific Death|Death Rate, Age-Specific|Mortality Determinant|Crude Death Rates|Excess Mortalities|Mortality Declines|Rate, Crude Mortality|Mortalities|death rate|Mortality Rate, Crude|Excess Mortality|Determinants, Mortality|Death Rate|Crude Death Rate|Decline, Mortality|Mortality Determinants|Mortality, Differential|Differential Mortalities|Mortality Decline|Mortality Rate|Differential Mortality|Rate, Crude Death|Death Rate, Crude|Death Rates|Mortality, Excess|Crude Mortality Rate|Rates, Case Fatality|Age Specific Death Rate|Mortality Rates"
NEW11812,MENTAL_HEALTH,narcotic craving,narcotic craving
NEW11813,CHEBI,opioid antagonist treatment,opioid antagonists treatment
NEW11814,CHEBI,selective antagonist sb-242084,selective antagonist SB-242084
NEW11815,DISEASE,impulsive behaviour,impulsive behaviours
NEW11816,CHEMICAL,carbon side chain,carbon side chain
http://purl.obolibrary.org/obo/CHEBI_27594,CHEMICAL,carbon atom,C|carbon|carbon atoms|Kohlenstoff|carbono|carbone|carbonium|Carbon|6C
NEW11817,CHEMICAL,ω-(furan-2-yl)alkane-1-thiol,ω-(furan-2-yl)alkane-1-thiols
http://purl.obolibrary.org/obo/CHEBI_52846,CHEMICAL,cycloalkane ring,thiophene ring|cycloalkane rings
http://purl.obolibrary.org/obo/CHEBI_52939,CHEMICAL,gamma-lactone ring,gamma-lactone|gamma-lactone ring|gamma-lactone rings|furan ring
C000611824,DISEASE,"EPS long non-coding RNA, mouse [Supplementary Concept]","extrapyramidal symptoms|EPS|RNA, Long Noncoding"
NEW11818,CHEMICAL,antiparkinson medication,antiparkinson medication
NEW11819,DISEASE,hyperlipidemia alteration,hyperlipidemia alterations
http://purl.obolibrary.org/obo/CHEBI_85834,CHEMICAL,triacylglycerol 51:4,triacylglycerol (TG)-|TG(51:4)|TAG(51:4)
NEW11820,DISEASE,epileptic episode,epileptic episodes
http://purl.obolibrary.org/obo/CHEBI_77391,CHEBI,trimyristin,"Tracylglycerol(14:0/14:0/14:0)|propane-1,2,3-triyl tritetradecanoate|Myristic acid triglyceride|lecithin (PC)-enriched|TAG(42:0)|1,2,3-trimyristoylglycerol|TAG(14:0/14:0/14:0)|1,2,3-Propanetriol tritetradecanoate|1,2,3-tritetradecanoylglycerol|Tracylglycerol(42:0)|Glyceryl trimyristate|Glycerol trimyristate|TG(14:0/14:0/14:0)|TG 14:0/14:0/14:0|Tetradecanoic acid, 1,2,3-propanetriyl ester|tritetradecanoylglycerol|TG(42:0)|Myristic triglyceride|Glyceryl tritetradecanoate|trimyristoylglycerol|Myristin"
NEW11821,NUTRITION,brain cholesterol,brain cholesterol
NEW11822,DISEASE,tg diet,TG diets
D051152,CHEMICAL,Clusterin,"Complement Associated Protein SP 40,40|Ionizing Radiation Induced Protein 8|X-Ray-Inducible Protein 8|ApoJ Protein|Ionizing Radiation-Induced Protein-8|TRPM-2 Protein|Sulfated Glycoprotein 2|Complement Lysis Inhibitor|MAC393 Antigen|X Ray Inducible Protein 8|Testosterone Repressed Prostate Message 2 Protein|Apolipoprotein J|SP-40,40, Complement-Associated Protein|TRPM 2 Protein|SGP 2 Protein|SP 40,40 Protein|XIP8 Protein|Radiation-Induced Protein-8, Ionizing|SGP-2 Protein|Testosterone-Repressed Prostate Message-2 Protein|Sulfated Glycoprotein-2|Complement-Associated Protein SP-40,40|apoJ"
NEW11823,DISEASE,encephalopathic mechanism,encephalopathic mechanisms
D015518,DISEASE,Rett Syndrome,"Syndrome, Rett|Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome|Rett syndrome|Cerebroatrophic Hyperammonemia|Hyperammonemias, Cerebroatrophic|RTT|RS|Autism, Dementia, Ataxia, and Loss of Purposeful Hand Use|Rett's Disorder|Hyperammonemia, Cerebroatrophic|Syndrome, Rett's|Retts Syndrome|Rett's Syndrome|Autism Dementia Ataxia Loss of Purposeful Hand Use Syndrome|Rett Disorder|Cerebroatrophic Hyperammonemias"
NEW11824,MENTAL_HEALTH,freeze point depression,freezing point depression
http://purl.obolibrary.org/obo/CHEBI_33978,CHEMICAL,alkali metal hydroxide,alkali metal bases|alkali metal base|alkali metal hydroxides|metal hydroxide
NEW11825,MENTAL_HEALTH,mla12 resistance pathway,Mla12 resistance pathways
NEW11826,CHEMICAL,carbon production,carbon production
NEW11827,CHEMICAL,barley leave,barley leaves
D000076107,DISEASE,"Diet, High-Protein Low-Carbohydrate","Carbohydrate Restricted High Protein Diet|Low-Carbohydrate Diet, High-Protein|Diet, High-Protein Carbohydrate-Restricted|High Protein Carbohydrate Restricted Diets|High-Protein Diets, Low-Carbohydrate|High-Protein Diets, Carbohydrate-Restricted|Carbohydrate Restricted High Protein Diets|High Protein Low Carbohydrate Diets|Carbohydrate-Restricted High-Protein Diets|South Beach Diet|Diet, Carbohydrate-Restricted High-Protein|Low Carbohydrate High Protein Diets|Diet, Low-Carbohydrate High-Protein|High-Protein Diet, Low-Carbohydrate|Carbohydrate-Restricted Diets, High-Protein|High-Protein Carbohydrate-Restricted Diets|High Protein Low Carbohydrate Diet|Low Carbohydrate High Protein Diet|Low-Carbohydrate Diets, High-Protein|Carbohydrate-Restricted High-Protein Diet|Low-Carbohydrate High-Protein Diets|Diets, Low-Carbohydrate High-Protein|Diets, High-Protein Carbohydrate-Restricted|High-Protein Carbohydrate-Restricted Diet|Diet, Atkins|High Protein Carbohydrate Restricted Diet|High-Protein Low-Carbohydrate Diets|Diet, South Beach|High-Protein Low-Carbohydrate Diet|Diets high|Low-Carbohydrate High-Protein Diet|Diet, High Protein Low Carbohydrate|Atkins Diet|Carbohydrate-Restricted Diet, High-Protein|High-Protein Diet, Carbohydrate-Restricted|Diets, High-Protein Low-Carbohydrate|Diets, Carbohydrate-Restricted High-Protein"
NEW11828,NUTRITION,ldl cholesterol level,LDL cholesterol levels
D005227,NUTRITION,Fatty Acids,"Fatty Acid|Fatty Acids, Esterified|Esterified Fatty Acids|Esterified Fatty Acid|Acid, Aliphatic|Fatty Acid, Esterified|saturated fatty acids|Saturated Fatty Acid|Acid, Esterified Fatty|Saturated Fatty Acids|Fatty Acid, Saturated|Acid, Saturated Fatty|Fatty Acids, Saturated|Aliphatic Acid|Saturated fatty acid|Aliphatic Acids"
NEW11829,NUTRITION,plasma cholesterol level,plasma cholesterol levels
NEW11830,CHEMICAL,sphingomyelin sm specie,sphingomyelin SM species
NEW11831,DISEASE,severe respiratory impairment,Severe respiratory impairment
NEW11832,CHEMICAL,lipid-lowering fluvastatin,lipid-lowering fluvastatin
NEW11833,DISEASE,respiratory anomaly,respiratory anomalies
http://purl.obolibrary.org/obo/CHEBI_61670,CHEMICAL,oroxylin a 7-o-beta-d-glucuronide,"5-hydroxy-6-methoxy-4-oxo-2-phenyl-4H-chromen-7-yl beta-D-glucopyranosiduronic acid|Tanshinone A|5-hydroxy-6-methoxy-flavone-7-yl beta-D-glucopyranosiduronic acid|5,7-dihydroxy-6-methoxyflavone 7-O-beta-D-glucuronide|oroxylin 7-O-beta-D-glucuronide"
NEW11834,CHEMICAL,tanshinoneⅱa,TanshinoneⅡA
NEW11835,CHEMICAL,porcine brain enzyme hydrolysate,porcine brain enzyme hydrolysate|PBEH
NEW11836,CHEBI,non-nucleoside reverse transcriptase inhibitor,non-nucleoside reverse transcriptase inhibitor
NEW11837,DISEASE,endocrine-responsive breast cancer cell,endocrine-responsive breast cancer cells
NEW11838,CHEMICAL,akt/mapk-related constitutive hyperactivation,AKT/MAPK-related constitutive hyperactivation
NEW11839,DISEASE,non-endocrine er+/her2 breast cancer cell,non-endocrine ER+/HER2 breast cancer cells
NEW11840,MENTAL_HEALTH,her2-driven endocrine resistance,HER2-driven endocrine resistance
NEW11841,DISEASE,er+ breast cancer,ER+ breast cancer
NEW11842,CHEMICAL,substance p sp level,Substance P SP levels
http://purl.obolibrary.org/obo/CHEBI_55351,CHEBI,substance p receptor antagonist,substance P receptor antagonists|substance P receptor antagonist MK-869
NEW11843,DISEASE,depressed outpatient,depressed outpatients
NEW11844,CHEMICAL,rs28836840 SNP,rs28836840 SNP
NEW11845,CHEMICAL,rs28386840 snp,rs28386840 SNP
NEW11846,MENTAL_HEALTH,bipolar disorder diagnosis,bipolar disorder diagnosis
NEW11847,DISEASE,weight gain useful,weight gain useful
NEW11848,CHEMICAL,cd to 5-fluorouracil,5FU|CD to 5-fluorouracil
NEW11849,DISEASE,human oral cancer cell,human oral cancer cells
C532843,CHEMICAL,coronarin D [Supplementary Concept],coronarin D|Diterpenes
NEW11850,MENTAL_HEALTH,non-alcohol related delirium,non-alcohol related delirium
C538346,DISEASE,Naxos disease [Supplementary Concept],"Keratoderma, Palmoplantar|Hair Diseases|Arrhythmogenic cardiomyopathy|Arrhythmogenic Right Ventricular Dysplasia"
NEW11851,DISEASE,desmosomal dysfunction,desmosomal dysfunction
NEW11852,CHEMICAL,acm heart,ACM heart
NEW11853,CHEMICAL,forebrain dopamine activity,forebrain dopamine activity
NEW11854,CHEBI,uremic toxin accumulation,uremic toxin accumulation
NEW11855,DISEASE,gut microbiota dysbiosis,gut microbiota dysbiosis|gut dysbiosis
D051784,CHEMICAL,Aryl Hydrocarbon Receptor Nuclear Translocator,"Hypoxia-Inducible Factor 1, beta Subunit|Nuclear Translocator, AhR|Dioxin Receptor, Nuclear Translocator|Ah Receptor Nuclear Translocator Protein|Aryl Hydrocarbon Nuclear Translocator|Hypoxia Inducible Factor 1, beta Subunit|AhR Nuclear Translocator|aryl hydrocarbon receptor"
NEW11856,MENTAL_HEALTH,transepithelial electrical resistance,transepithelial electrical resistance
NEW11857,DISEASE,online hemodiafiltration,Online hemodiafiltration|HDF
NEW11858,DISEASE,blood pressure management,blood pressure management
NEW11859,CHEMICAL,nucleus accumbens/anterior limb,nucleus accumbens/anterior limb
NEW11860,CHEBI,partial dopamine agonist,partial dopamine agonists
NEW11861,CHEBI,b group vitamin,B group vitamins
NEW11862,NUTRITION,steroid hormone level,steroid hormone levels
NEW11863,CHEMICAL,testosterone precursor,testosterone precursors
NEW11864,CHEMICAL,precursor dehydroepiandrosterone,precursors dehydroepiandrosterone
NEW11865,CHEBI,high androgen activity,higher androgen activity
NEW11866,CHEMICAL,many p450-derived lipid,Many p450-derived lipids
NEW11867,CHEMICAL,soluble epoxide hydrolase(seh)-derived oxylipin breakdown product,soluble epoxide hydrolase(sEH)-derived oxylipin breakdown products
http://purl.obolibrary.org/obo/CHEBI_156386,CHEMICAL,asperlactone,"(5R)-5-[(1S)-1-hydroxyethyl]-3-[(2S,3S)-3-methyloxiran-2-yl]furan-2(5H)-one|p450- oxylipins|phenylpropanoids|5R-[(1S)-1-hydroxyethyl]-3-[(2S,3S)-3-methyl-2-oxiranyl]-2(5H)-furanone"
NEW11868,DISEASE,morphine psychic dependence,morphine psychic dependence
NEW11869,CHEBI,narcotic addict,Narcotic addicts
NEW11870,CHEBI,popular drug,popular drug
NEW11871,DISEASE,cannabinoid hyperemesis syndrome,Cannabinoid Hyperemesis Syndrome
NEW11872,DISEASE,nausea hot bathing,nausea hot bathing
NEW11873,DISEASE,emesis response,emesis response
NEW11874,CHEMICAL,cannabis plant,cannabis plant
C037036,CHEMICAL,cannabigerol [Supplementary Concept],cannabigerol|Cannabinoids
C536228,DISEASE,Familial cyclic vomiting syndrome [Supplementary Concept],Cyclic Vomiting Syndrome|Vomiting
NEW11875,CHEMICAL,cannabinoid hyperemesis syndrome,Cannabinoid Hyperemesis Syndrome|CHS
NEW11876,MENTAL_HEALTH,perceive fatigue,perceived fatigue
http://purl.org/sig/ont/fma/fma61811,CHEBI,dopamine receptor,mesolimbic-cortical dopamine receptors|D2/D3 dopamine receptor agonist
NEW11877,CHEMICAL,naloxone challenge,Naloxone challenge
NEW11878,CHEMICAL,cgrp substance p immunoreactivity,CGRP substance P immunoreactivity
NEW11879,DISEASE,robust withdrawal syndrome,robust withdrawal syndrome
NEW11880,CHEBI,dopamine agonist therapy,dopamine agonist therapy
NEW11881,CHEMICAL,17α-ethinylestradiol,17α-ethinylestradiol|EE2
D018785,DISEASE,Tricuspid Atresia,"Tricuspid Valve Atresia|Tricuspid Atresias|Atresia, Tricuspid|Tricuspid Valve Atresias|Valve Atresia, Tricuspid|Atresia, Tricuspid Valve|Atresias, Tricuspid Valve|Atresias, Tricuspid|Valve Atresias, Tricuspid|atresia|Absent Right Atrioventricular Connection"
NEW11882,MENTAL_HEALTH,gonadal regression,gonadal regression
C000605449,CHEMICAL,Kai-Xin-San [Supplementary Concept],"KXS|Drugs, Chinese Herbal|Kai-Xin-San"
NEW11883,DISEASE,tcm doctor,TCM doctors
NEW11884,DISEASE,over-consolidated traumatic memory,over-consolidated traumatic memories
NEW11885,DISEASE,low parasitemia,lower parasitemia
D000091246,DISEASE,Memory T Cells,"T Lymphocyte, Memory|Lymphocytes, Memory T|Effector Memory T Cells|Memory T Cell|Memory T Lymphocytes|Virtual Memory T Cells|T Lymphocytes, Memory|effector memory T cells|Memory T Lymphocyte|Central Memory T Cells|Tissue Resident Memory T Cells|Lymphocyte, Memory T|T Cell, Memory"
NEW11886,DISEASE,late acute disease,late acute disease
NEW11887,DISEASE,mood behavior,mood behavior
NEW11888,CHEMICAL,ghb-/gabab-receptor,GHB-/GABAB-receptors
NEW11889,DISEASE,preexist pancreatic damage,preexisting pancreatic damage
NEW11890,CHEMICAL,background benzodiazepine,Background Benzodiazepines
NEW11891,DISEASE,disorder ptsd symptom,disorder PTSD symptoms
NEW11892,DISEASE,trauma other,trauma other
NEW11893,DISEASE,clinician-administered ptsd scale,Clinician-Administered PTSD Scale
NEW11894,CHEMICAL,benzodiazepine use,benzodiazepine use
NEW11895,DISEASE,ptsd scale,PTSD Scale
D054448,DISEASE,"Precursor Cells, B-Lymphoid","B-Lymphocytes, Progenitor|Progenitor B Lymphocytes|Precursor B Lymphocyte|Precursor B-Lymphocytes|Pro-B Cells|Immature B Lymphocyte|Transitional B Cell|Pro-B-Cells|B-Lymphocyte, Progenitor|Precursor Cell, B-Lymphoid|B-Lymphocyte, Precursor|B-Cell, Transitional|Pre B Lymphocyte|B-Cells, Immature|Lymphocyte, Pro-B|Cell, Pro-B|Pre-B-Cell|B-Cells, Progenitor|B-Cell, Immature|Progenitor B-Cell|Pre-B Cell|Precursor B-Cell|Cell, Immature B|Pro-B Lymphocytes|Pre-B Lymphocytes|B-Cell, Progenitor|B-Cells, Transitional|Immature B Cell|Pre-B Cells|B Cells, Immature|Cells, Immature B|Lymphocyte, Pre-B|B-Cells, Precursor|Immature B-Lymphocyte|Immature B-Lymphocytes|Immature B-Cells|Lymphocytes, Pre-B|Immature B Lymphocytes|Progenitor B-Lymphocyte|B-Cell, Precursor|Transitional B Lymphocyte|Immature B-Cell|B-Lymphoid Precursor Cells|B-Lymphocytes, Immature|Transitional B Cells|Cell, B-Lymphoid Precursor|Pro B Lymphocyte|Precursor B Cell|Cells, Pre-B|Transitional B-Lymphocytes|Cells, Pro-B|Precursor B-Cells|B-Lymphocyte, Transitional|Lymphocytes, Pro-B|B Lymphoid Precursor Cells|Transitional B-Cell|B Cell, Immature|Pro B Cells|Transitional B-Lymphocyte|Pre B Cells|Pro B Cell|B-Lymphocytes, Transitional|B-Lymphocytes, Precursor|B Lymphoid Precursor Cell|Pro-B Lymphocyte|Progenitor B-Lymphocytes|Cells, B-Lymphoid Precursor|Immature B Cells|SE|Precursor B Cells|Progenitor B Cells|Pre B Cell|Pro-B-Cell|Progenitor B Cell|Pre-B-Cells|Precursor B Lymphocytes|Pro-B Cell|Transitional B Lymphocytes|Precursor B-Lymphocyte|Transitional B-Cells|Pro B Lymphocytes|B|Progenitor B Lymphocyte|Precursor Cells, B Lymphoid|B-Lymphoid Precursor Cell|B-Lymphocyte, Immature|Cell, Pre-B|Pre B Lymphocytes|Pre-B Lymphocyte|Progenitor B-Cells"
NEW11896,DISEASE,acs-induced ptss,ACS-induced PTSS
NEW11897,MENTAL_HEALTH,drought resistance,drought resistance
NEW11898,CHEMICAL,phytopigment,phytopigments
NEW11899,CHEMICAL,hexagonal mgo nanoparticle,hexagonal MgO nanoparticles
NEW11900,DISEASE,diabetic cell,diabetic cells
NEW11901,DISEASE,least toxicity,least toxicity
NEW11902,CHEMICAL,mgo nanoparticle,MgO nanoparticles
NEW11903,MENTAL_HEALTH,resistance reversal capability,resistance reversal capability
NEW11904,CHEBI,group allergen,Group allergen
NEW11905,CHEBI,principal antigen,principal antigen
NEW11906,CHEBI,antigen a. method,Antigen A. methods
D014280,CHEMICAL,Triglycerides,TGs|Triglyceride|Triacylglycerol|triacylglycerols|Triacylglycerols|triglycerides
http://purl.obolibrary.org/obo/CHEBI_68565,CHEMICAL,tuberculostearic acid,10-methylstearic acid|10-methyloctadecanoic acid|docosatrienoic acid
C026219,CHEMICAL,docosapentaenoic acid [Supplementary Concept],"Fatty Acids, Unsaturated|docosapentaenoic acid"
NEW11907,CHEMICAL,pl lipid,PL lipids
NEW11908,DISEASE,3-year-old boy,3-year-old boy
NEW11909,DISEASE,alexithymic subject,Alexithymic subjects
NEW11910,CHEMICAL,hypothalamus-pituitary-adrenal (hpa)-axis,hypothalamus-pituitary-adrenal (HPA)-axis
NEW11911,NUTRITION,functionalize calcium phosphate,functionalized calcium phosphates
http://purl.obolibrary.org/obo/CHEBI_60247,CHEMICAL,silver ion,silver ions
NEW11912,MENTAL_HEALTH,OCPd,OCPd
NEW11913,CHEMICAL,nitrate solution,nitrate solution
NEW11914,CHEMICAL,l. rhamnosus,L. rhamnosus
NEW11915,CHEMICAL,3'-deoxy-hanasanagin,3'-deoxy-hanasanagin
NEW11916,NUTRITION,insect portion,insect portions
NEW11917,DISEASE,invasive mucormycosis,Invasive mucormycosis
NEW11918,CHEMICAL,severe covid-19 survivor,severe COVID-19 survivors
NEW11919,CHEBI,steroid drug administration,steroid drug administration
D009091,DISEASE,Mucormycosis,"Infection, Mucorales|Mucormycoses|mucormycosis|Mucorales Infections|Mucorales Infection|Mucormycose"
NEW11920,CHEMICAL,covid-19 sequela,COVID-19 sequela
NEW11921,DISEASE,slight hyperprolactinemia,slight hyperprolactinemia
NEW11922,DISEASE,check behavior,checking behavior
D019257,CHEMICAL,Quinpirole,|quinpirole|Quinpirole Monohydrochloride|Quinpirole Hydrochloride
NEW11923,DISEASE,progressive multisystem disorder,progressive multisystem disorder
NEW11924,DISEASE,pain research,pain research
NEW11925,DISEASE,so-called death,so-called deaths
NEW11926,DISEASE,punde,punding
NEW11927,DISEASE,further behavioral disorder,Further behavioral disorders
NEW11928,CHEBI,primary drug,primary drug
D016202,CHEMICAL,N-Methylaspartate,"N Methyl D aspartic Acid|N-Methyl-D-aspartic Acid|NMDA|N-Methyl-D-aspartate|N Methyl D aspartate|N Methylaspartate|Acid, N-Methyl-D-aspartic|N-methyl-d-aspartic acid"
NEW11929,DISEASE,lithium-induced spatial learning impairment,lithium-induced spatial learning impairment
NEW11930,DISEASE,non-dementia psychiatric disorder,non-dementia psychiatric disorders
NEW11931,CHEMICAL,add-on memantine,add-on memantine
NEW11932,NUTRITION,trifolium pratense L.,Trifolium pratense L.|Red Clover
NEW11933,DISEASE,menopause disorder,menopause disorders
http://purl.obolibrary.org/obo/CHEBI_37667,CHEMICAL,sesquiterpene lactone,new sesquiterpene lactones
NEW11934,DISEASE,s. castanea,S. castanea
NEW11935,NUTRITION,whole plant,whole plant
D055051,CHEMICAL,Salt-Tolerant Plants,"Plant, Halophilic|Saline-Resistant Plant|Halophytic Plant|Plant, Salt-Resistant|Salt-Adapted Plant|Halophilic Plant|Saline-Resistant Plants|Plant, Saline-Tolerant|Plants, Halophilic|Salt-Resistant Plant|Salt Resistant Plants|Salt-Tolerant Plant|Plant, Salt-Tolerant|Saline-Tolerant Plants|Plants, Saline-Tolerant|Saline Resistant Plants|Plants, Saline-Resistant|Plant, Halophytic|Plant, Saline-Resistant|Halophytes|Plants, Salt Tolerant|Halophilic Plants|Plants, Salt-Resistant|Saline Tolerant Plants|Salt Adapted Plants|Halophytic Plants|Salt Tolerant Plants|Plant, Salt-Adapted|Plants, Salt-Adapted|Salt-Adapted Plants|Plants, Salt-Tolerant|salt|Plants, Halophytic|Salt-Resistant Plants|Saline-Tolerant Plant|Halophyte"
NEW11936,CHEMICAL,acetyl zingerone,AZ|acetyl zingerone
D000077407,CHEMICAL,Cilostazol,"Pletal|OPC 13013|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone|OPC-13013|cilostazol"
NEW11937,DISEASE,pregnancy-associated mammary gland ductal side-branching,pregnancy-associated mammary gland ductal side-branching
D010693,CHEMICAL,Phloretin,Phloretin|phloretin|PHL
NEW11938,CHEMICAL,subacute scopolamine,subacute scopolamine
NEW11939,CHEMICAL,gli3 zinc finger transcription factor,GLI3 zinc finger transcription factor
D054975,DISEASE,Pallister-Hall Syndrome,"Hamartoblastoma Syndromes, Hypothalamic|Hall Pallister Syndrome|Hypothalamic Hamartoblastoma Syndrome|Syndrome, Hypothalamic Hamartoblastoma|Cerebroacrovisceral Early Lethality Complex|Syndrome, Pallister-Hall|CAVE Complices|CAVE Complex|Complex, CAVE|Syndromes, Hypothalamic Hamartoblastoma|Syndrome, Hall-Pallister|Hamartoblastoma Syndrome, Hypothalamic|Hypothalamic Hamartoblastoma, Hypopituitarism, Imperforate Anus, and Postaxial Polydactyly|Hypothalamic Hamartoblastoma Syndromes|Hall-Pallister Syndrome|Complices, CAVE|Pallister-Hall syndrome|Pallister Hall Syndrome"
http://purl.obolibrary.org/obo/DOID_0110978,DISEASE,brachydactyly type a1d,BDA1D|postaxial polydactyly type A
C537300,DISEASE,Greig cephalopolysyndactyly syndrome [Supplementary Concept],Greig cephalopolysyndactyly syndrome|Acrocephalosyndactylia
NEW11940,CHEMICAL,selective norepinephrine,selective norepinephrine
NEW11941,MENTAL_HEALTH,severe bipolar depression,severe bipolar depression
NEW11942,CHEMICAL,first-line antidepressant,first-line antidepressant
NEW11943,CHEMICAL,covid-19 case,COVID-19 cases
NEW11944,MENTAL_HEALTH,high nicotine dependence,higher nicotine dependence
NEW11945,CHEBI,bone morphogenic protein bmp antagonist,bone morphogenic protein BMP antagonist
NEW11946,MENTAL_HEALTH,retinotectal projection,retinotectal projection
NEW11947,DISEASE,pseudomonas putida kt2440,Pseudomonas putida KT2440
C001945,NUTRITION,syringic acid [Supplementary Concept],Gallic Acid/analogs  and  derivatives|SA|Syringic acid
NEW11948,NUTRITION,abundant phenolic acid compound,abundant phenolic acid compound
http://purl.obolibrary.org/obo/DOID_3083,DISEASE,chronic obstructive pulmonary disease,COPD|stable chronic obstructive pulmonary disease|chronic obstructive lung disease|COLD|chronic obstructive airway disease
NEW11949,CHEBI,short-acting beta-2-adrenoceptor agonist,short-acting beta-2-adrenoceptor agonists
NEW11950,CHEMICAL,inhaled corticosteroid,ICS|Inhaled corticosteroids
NEW11951,DISEASE,copd recurrent exacerbation,COPD recurrent exacerbations
NEW11952,CHEBI,long-acting beta-2-adrenoceptor agonist,long-acting beta-2-adrenoceptor agonists
http://purl.obolibrary.org/obo/CHEBI_35522,CHEBI,beta-adrenergic agonist,beta-adrenergic receptor agonist|beta-adrenergic agonists|beta-adrenoceptor agonists|beta-agonists|beta-Adrenoceptor agonists|beta-2-adrenoceptor agonists
NEW11953,CHEMICAL,don exposure,DON exposure
NEW11954,DISEASE,intestinal flora disorder,intestinal flora disorders
http://purl.obolibrary.org/obo/CHEBI_187010,CHEMICAL,19-phenyl nonadecanoic acid,excess palmitic acid|19-phenylnonadecanoic acid
NEW11955,DISEASE,enhance inflammation,enhanced inflammation
NEW11956,DISEASE,tumor necrosis factor-α     expression consistent,tumor necrosis factor-α    expression consistent
C091910,CHEMICAL,acridine mustard [Supplementary Concept],ICR-170|Aminoacridines|Nitrogen Mustard Compounds
NEW11957,CHEBI,beta conformation,beta conformation
NEW11958,DISEASE,chronic intermittent hypoxia,Chronic intermittent hypoxia
NEW11959,DISEASE,disease experience weight gain,disease experience weight gain
NEW11960,CHEMICAL,cih animal,CIH animals
http://purl.obolibrary.org/obo/DOID_0050848,DISEASE,obstructive sleep apnea,obstructive sleep apnea syndrome|obstructive sleep apnea hypopnea syndrome|moderate obstructive sleep apnea|Obstructive sleep apnea hypopnea syndrome|OSA|OSAHS
NEW11961,CHEBI,Federal Carrier Safety Administration,Federal Carrier Safety Administration
NEW11962,CHEMICAL,Lewy body Dementia Association,LBDA|Lewy Body Dementia Association
NEW11963,CHEBI,long-acting muscarinic antagonist,long-acting muscarinic antagonist
NEW11964,CHEMICAL,triple fixed-dose combination inhaler therapy,triple fixed-dose combination inhaler therapy
NEW11965,DISEASE,catalepsy intensity,catalepsy intensity
NEW11966,DISEASE,catalepsy onset,catalepsy onset
C084820,CHEMICAL,profenamine [Supplementary Concept],ethopropazine|Phenothiazines
D001590,CHEMICAL,Benztropine,"|Benzatropine Methanesulfonate, Hydrobromide|Cogentin|benztropine|Mesylate, Benzatropine|Apo-Benztropine|Cogentinol|Benzatropine Methanesulfonate, Hydrobromide, (endo)-Isomer|Benzatropine Mesylate|Benztropine Mesylate|Methanesulfonate, Benzatropine|Bensylate|N-Methylbenztropine|Benzatropine|Hydrobromide Benzatropine Methanesulfonate|Apo Benztropine|PMS-Benztropine|N Methylbenztropine|Benzatropine Methanesulfonate|Mesylate, Benztropine|PMS Benztropine|Methanesulfonate, Hydrobromide Benzatropine|Benzatropine Methanesulfonate, Hydrochloride, (endo)-Isomer"
NEW11967,DISEASE,catalepsy time,catalepsy time
NEW11968,CHEBI,selective a(2a)r antagonist zm,selective A(2A)R antagonist ZM
NEW11969,DISEASE,neuroleptic-induced eps,neuroleptic-induced EPS
NEW11970,CHEMICAL,inhalational anesthetic,Desflurane|inhalational anesthetic
NEW11971,CHEMICAL,maternal FLX,Maternal FLX
NEW11972,CHEMICAL,acerf2 induce transcript accumulation,AcERF2 induced transcript accumulation
NEW11973,DISEASE,bacterial pathogen pseudomonas syringae pv,bacterial pathogen Pseudomonas syringae pv
C514341,MENTAL_HEALTH,"RFO1 protein, Arabidopsis [Supplementary Concept]",Protein Kinases|Arabidopsis Proteins|Arabidopsis resistance
NEW11974,CHEMICAL,aberrant potassium regulation,aberrant potassium regulation
D015124,CHEMICAL,8-Bromo Cyclic Adenosine Monophosphate,"8 Bromo Cyclic Adenosine Monophosphate|AMP, Br Cycl|8-Bromo Cyclic Adenosine Monophosphate, Monosodium Salt||8 Br Cyclic AMP|8 Bromo Cyclic Adenosine Monophosphate, Sodium Salt|8 Bromoadenosine 3',5' Cyclic Monophosphate|monophosphate|8-Bromo Cyclic AMP|Cyclic AMP, 8-Bromo|adenosine monophosphate|Br Cycl AMP|cyclic adenosine monophosphate|8-bromo cyclic adenosine monophosphate|8 Bromo cAMP|8-Br Cyclic AMP|8-Bromo Cyclic Adenosine Monophosphate, Sodium Salt|8-Bromo-cAMP|8 Bromo Cyclic AMP|cAMP|Cyclic AMP, 8-Br|8-Bromoadenosine 3',5'-Cyclic Monophosphate|8 Bromo Cyclic Adenosine Monophosphate, Monosodium Salt"
NEW11975,CHEMICAL,camp inducing agent,cAMP inducing agents
NEW11976,CHEBI,agonist clenbuterol,agonist clenbuterol
NEW11977,CHEMICAL,clenbuterol muscle hypertrophy,clenbuterol muscle hypertrophy
NEW11978,CHEMICAL,cmrtf2h,CmRTF2h
NEW11979,CHEMICAL,various flavonoid,various flavonoids
NEW11980,CHEMICAL,rhodamine accumulation,Rhodamine accumulation
NEW11981,DISEASE,idiopathic calcinosis cutis,Idiopathic calcinosis cutis
C494366,NUTRITION,"calcium phosphate, dibasic, dihydrate [Supplementary Concept]",Calcium Phosphates|calcium phosphate
NEW11982,DISEASE,calcinosis cutis,Calcinosis cutis
NEW11983,CHEBI,novel norepinephrine reuptake inhibitor,novel norepinephrine reuptake inhibitor
D047494,CHEBI,PPAR delta,PPARdelta|Peroxisome Proliferator Activated Receptor delta|PPARD protein|Peroxisome Proliferator-Activated Receptor delta|PPARδ|PPAR δ
NEW11984,DISEASE,lps-induced lipidosis,LPS-induced lipidosis
NEW11985,DISEASE,inflammation pathway,inflammation pathway
NEW11986,DISEASE,hepatic fatty acid,hepatic fatty acids|steatosis
NEW11987,DISEASE,lps-related nafld damage,LPS-related NAFLD damage
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Pathology,DISEASE,pathology,CJD pathology|NASH pathology|Alzheimer-type pathology|CVD-driven pathologies
C000713688,CHEMICAL,seladelpar [Supplementary Concept],MBX-8025|Acetates|Seladelpar
NEW11988,DISEASE,glucose disposal,glucose disposal
NEW11989,DISEASE,nonalcoholic fatty liver disease activity score,nonalcoholic fatty liver disease activity score
NEW11990,CHEBI,selective ppar-δ agonist,Selective PPAR-δ agonists
NEW11991,MENTAL_HEALTH,deep depression,deep depression
NEW11992,MENTAL_HEALTH,nervous bulimia,nervous bulimia
NEW11993,DISEASE,a. cepa meristem cell,A. cepa meristem cells
NEW11994,CHEMICAL,fluoxetine cytotoxicity,fluoxetine cytotoxicity
NEW11995,CHEMICAL,17β-oestradiol,17β-oestradiol|E2
NEW11996,CHEMICAL,ovx+cums mouse,OVX+CUMS mice
D055118,DISEASE,Medication Adherence,"Non-Adherence, Medication|Medication Non-Compliance|Compliance, Drug|Medication Persistence|Medication Nonadherence|Medication Noncompliance|Medication Non Adherence|Persistence, Medication|Nonadherence, Medication|Medication Non Compliance|Non-Compliance, Medication|Medication Compliance|Noncompliance, Medication|Compliance, Medication|nonadherence|Nonadherence|Drug Adherence|Drug Compliance|Adherence, Drug|Adherence, Medication|Medication Non-Adherence"
NEW11997,CHEMICAL,~20%-60 %,~20%-60 %
NEW11998,CHEMICAL,comedication,comedication
NEW11999,CHEMICAL,oxidase mao-a,oxidases MAO-A
NEW12000,DISEASE,autosomal dominant calpainopathy,Autosomal dominant calpainopathy
NEW12001,CHEMICAL,normal creatine kinase level,normal creatine kinase levels
NEW12002,DISEASE,unexplained paravertebral myopathy,unexplained paravertebral myopathies
NEW12003,DISEASE,late onset camptocormia,late onset camptocormia
NEW12004,CHEBI,neoantigen processing,neoantigen processing
C014896,CHEMICAL,6-chloro-2-(1-piperazinyl)pyrazine [Supplementary Concept],Pyrazines|MK-212
NEW12005,CHEMICAL,damage brain serotonin neuron,damaged brain serotonin neurons
NEW12006,MENTAL_HEALTH,emergent impulse control disorder,emergent impulse control disorders
NEW12007,CHEMICAL,benzodiazepine agonist,benzodiazepine agonists
NEW12008,CHEMICAL,benzodiazepine derivative,Benzodiazepine derivatives
NEW12009,CHEBI,gaba-a receptor agonist hypnotic,GABA-A receptor agonist hypnotics
D017576,CHEMICAL,Daptomycin,"LY146032|Daptomycin, 9-L beta-Aspartic Acid|LY-146032|Daptomycin|Daptomycin, 9 L beta Aspartic Acid|LY 146032|Deptomycin|Cubicin"
D013203,DISEASE,Staphylococcal Infections,"Staphylococcus aureus Infections|Infections, Staphylococcal|Staphylococcus aureus Infection|Staphylococcal Infection|aureus infections"
NEW12010,CHEBI,cyclic lipopeptide antibiotic active,cyclic lipopeptide antibiotic active
NEW12011,CHEMICAL,zinc cluster transcription factor,zinc cluster transcription factors
NEW12012,DISEASE,oropharyngeal candidiasis,oropharyngeal candidiasis
NEW12013,CHEMICAL,antifungal drug fluconazole,antifungal drug fluconazole
C570512,MENTAL_HEALTH,"SARD1 protein, Arabidopsis [Supplementary Concept]",Arabidopsis Proteins|acquired resistance
D003882,DISEASE,Dermatomyositis,"Juvenile Dermatomyositis|Dermatomyositis, Childhood Type|dermatomyositis|Dermatopolymyositis|Dermatomyositis, Adult Type|Dermatomyositis, Juvenile|Adult Type Dermatomyositis|Polymyositis-Dermatomyositis|Childhood Type Dermatomyositis|Polymyositis Dermatomyositis|Myositis, Juvenile|Juvenile Myositis"
C448722,DISEASE,"DISC2 gene product, human [Supplementary Concept]","RNA, Long Noncoding|Disrupted-In-Schizophrenia"
NEW12014,DISEASE,simple constipation,simple constipation
NEW12015,NUTRITION,increase dietary fibre,increased dietary fibre
NEW12016,DISEASE,low incisor,lower incisors
C587462,CHEMICAL,sodium polyethylene glycol monododecyl ether sulfate [Supplementary Concept],ether sulfate|Polyethylene Glycols
NEW12017,CHEMICAL,naocl,NaOCl
NEW12018,CHEMICAL,hydroxyethylidene bisphosphonate,hydroxyethylidene bisphosphonate
NEW12019,NUTRITION,xp-endo Finisher instrument,XP-Endo Finisher instrument
NEW12020,CHEMICAL,central 5ht receptor sensitivity,central 5HT receptor sensitivity
NEW12021,CHEMICAL,serotonin 5ht agonist,serotonin 5HT agonist
NEW12022,MENTAL_HEALTH,animal anhedonia,animals anhedonia
NEW12023,CHEBI,antitubercular therapy,antitubercular therapy
NEW12024,NUTRITION,whale polar bear,whale polar bear
NEW12025,CHEBI,excessive vitamin a intake,excessive vitamin A intake
D009166,DISEASE,Mycobacterium leprae,Mycobacterium leprae|Leprostatic Agents
NEW12026,DISEASE,leprosy transmission,leprosy transmission
D058345,DISEASE,Asymptomatic Infections,"Colonization, Asymptomatic|Subclinical Infections|Infection, Presymptomatic|Subclinical infection|Infection, Asymptomatic|Infection, Inapparent|Inapparent Infections|Presymptomatic Infection|Asymptomatic Colonization|Asymptomatic Infection|Asymptomatic Colonizations|Subclinical Infection|Infection, Subclinical|Inapparent Infection|Presymptomatic Infections"
NEW12027,CHEBI,androgen secretion,androgen secretion
NEW12028,DISEASE,male-to-female transsexual,male-to-female transsexuals
NEW12029,CHEBI,estrogen supplementation ± suppression,estrogen supplementation ± suppression
NEW12030,MENTAL_HEALTH,slow dissociation,slow dissociation
NEW12031,CHEMICAL,glycine response kinetic,glycine response kinetics
http://purl.org/sig/ont/fma/fma67906,CHEMICAL,protein complex,Bmi1/Ring1 protein complex
NEW12032,MENTAL_HEALTH,transcriptional repression,transcriptional repression
http://purl.obolibrary.org/obo/DOID_0060014,DISEASE,cd45 deficiency,Bmi1 deficiency
D011371,DISEASE,Progeria,"Hutchinson-Gilford Syndrome|Hutchinson-Gilford Progeria Syndrome|progeria|Progeria Syndromes, Hutchinson-Gilford|Hutchinson Gilford Syndrome|Hutchinson-Gilford Progeria Syndromes|Hutchinson Gilford Progeria Syndrome|Progeria Syndrome, Hutchinson-Gilford"
NEW12033,MENTAL_HEALTH,autism group,autism group
NEW12034,CHEBI,pre- androgen level,pre- androgen levels
NEW12035,CHEBI,elevated androgen,elevated androgens
NEW12036,CHEMICAL,choline/creatine ratio,Choline/Creatine ratios
NEW12037,DISEASE,parietal c white matter,parietal C white matter
http://purl.obolibrary.org/obo/UBERON_0004720,DISEASE,cerebellar vermis,cerebellar vermian
NEW12038,CHEMICAL,ficus deltoidea L.,Ficus deltoidea L.
D011552,DISEASE,Pseudomonas Infections,"|Pseudomonas Infection|aeruginosa infections|Pseudomonas aeruginosa Infection|Pseudomonas infections|Pseudomonas aeruginosa Infections|Infections, Pseudomonas|Infection, Pseudomonas"
NEW12039,MENTAL_HEALTH,high intrinsic resistance,high intrinsic resistance
D019779,DISEASE,Salmonella enterica,Salmonella enterica|Salmonella (1980-1997)
http://purl.obolibrary.org/obo/CHEBI_478164,CHEMICAL,cefepime,"7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-[(1-methylpyrrolidinium-1-yl)methyl]-3,4-didehydrocepham-4-carboxylate|CFPM|(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|Cefepime|cefepime|cefepima|cefepimum|piperacillin/tazobactam"
http://purl.obolibrary.org/obo/CHEBI_29013,CHEMICAL,fusidic acid,"fucidic acid|Fusidine|(2Z)-2-[(17Z)-16beta-acetoxy-3alpha,11alpha-dihydroxy-4alpha,8alpha,10,14beta-tetramethyl-5alpha,9beta,13alpha-gonan-17-ylidene]-6-methylhept-5-enoic acid|amoxicillin/clavulanic acid|Fucidin acid|Ramycin|Fusidic acid"
NEW12040,NUTRITION,ounce,ounce
NEW12041,CHEMICAL,average daily ethanol intake,average daily ethanol intake
http://purl.obolibrary.org/obo/DOID_0050741,MENTAL_HEALTH,alcohol dependence,alcohol dependence||DSM-III-R alcohol dependence|DSM-IV alcohol dependence|alcoholism
D017828,CHEMICAL,Rifabutin,rifabutin|LM427|Ansatipin|Ansamycin|Ansatipine|LM-427|Mycobutin|Rifabutine|LM 427|Alfacid|Rifabutin
NEW12042,DISEASE,acquire immunodeficiency syndrome patient,acquired immunodeficiency syndrome patients
D015867,DISEASE,"Uveitis, Intermediate","Intermediate Uveitis|Chronic Cyclitis|Uveitis|Cyclitis, Chronic"
NEW12043,CHEMICAL,disseminated mycobacterium avium infection,Disseminated Mycobacterium avium infection
D016470,DISEASE,Bacteremia,bacteremia|Bacteremias
http://purl.obolibrary.org/obo/CHEBI_65751,CHEMICAL,"3,5-di-o-caffeoyl quinic acid","3,5-Dicaffeoylquinic acid|(1S,3R,4S,5R)-1,3,4,5-tetrahydroxy-1-carboxycyclohexane3,5-di-3-(3,4-dihydroxyphenyl)propenoate|3,5-DCQA|Isochlorogenic acid a|(3R,5R)-3,5-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,4-dihydroxycyclohexanecarboxylic acid|Quinic acid 3,5-di-O-caffeate|Sinapic acid treatment"
NEW12044,DISEASE,perirenal fat mass,perirenal fat mass
C073734,CHEMICAL,sinapinic acid [Supplementary Concept],Coumaric Acids|Sinapic acid|sinapic acid
NEW12045,DISEASE,dyslipidemia level,dyslipidemia levels
D051127,NUTRITION,"Scavenger Receptors, Class E","Oxidized Low-Density Lipoprotein Receptor 1|SR-E Proteins|Lectin Like Oxidized Low Density Lipoprotein Receptor 1|Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1|OLR1 Protein|Oxidized Low Density Lipoprotein Receptor 1|SR EI Proteins|SR-EI Proteins|lectin-like oxidized low-density lipoprotein receptor-1|Scavenger Receptors, Class E, Type I"
NEW12046,CHEMICAL,selective noradrenaline reuptake blocker atomoxetine,selective noradrenaline reuptake blocker atomoxetine
NEW12047,CHEMICAL,β1-β2 loop,β1-β2 loop
NEW12048,CHEMICAL,excessive ethanol consumption,Excessive ethanol consumption
C025910,CHEMICAL,dimethyl sulfone [Supplementary Concept],Methylsulfonylmethane|MSM|Dimethyl Sulfoxide|Sulfones
NEW12049,DISEASE,ethanol-induced brain injury,ethanol-induced brain injury
NEW12050,DISEASE,ethanol-mediated inflammation,ethanol-mediated inflammation
NEW12051,MENTAL_HEALTH,anti-oxidant defense mechanism,anti-oxidant defense mechanism
D020421,DISEASE,Vagus Nerve Diseases,"Vagus Nerve Sensory Disorder|Motor Disorder, Vagus Nerve|Pneumogastric Nerve Disorder|Vagus Neuropathy|Pneumogastric Nerve Disorders|Neuropathies, Vagus|Disorder, Pneumogastric Nerve|Disorders, Pneumogastric Nerve|Vagus Nerve Motor Disorder|Neuropathy, Vagus|Vagus Neuropathies|motor disorder|Sensory Disorder, Vagus Nerve|Vagus Nerve Disease|Vagus Nerve Disorder|Tenth Cranial Nerve Diseases|Cranial Nerve X Diseases|Vagus Nerve Disorders"
NEW12052,CHEBI,drug disorder,drug disorders
D002349,DISEASE,Carpal Tunnel Syndrome,"Carpal Tunnel Syndromes|Compression Neuropathy, Carpal Tunnel|Syndromes, Carpal Tunnel|Amyotrophy, Thenar, Of Carpal Origin|Syndrome, Carpal Tunnel|Median Neuropathy, Carpal Tunnel|CTS|Entrapment Neuropathy, Carpal Tunnel|carpal tunnel syndrome"
NEW12053,CHEBI,serum vitamin d level,serum vitamin D levels
NEW12054,CHEBI,serum vitamin d level,Serum vitamin D levels
NEW12055,DISEASE,sleep-disordered respiration,sleep-disordered respiration
NEW12056,DISEASE,upper airway muscle respiratory burst,upper airway muscle respiratory bursts
NEW12057,DISEASE,chocolate reformulation,chocolate reformulation
NEW12058,CHEBI,sugar sweetener,sugar sweeteners
NEW12059,DISEASE,plantarum 299v,plantarum 299v
NEW12060,DISEASE,lactobacillus acidophilus la3,Lactobacillus acidophilus La3
NEW12061,CHEMICAL,Morus alba L.,Morus alba L.
NEW12062,DISEASE,apnea/hypopnea index,apnea/hypopnea index
NEW12063,CHEBI,rapid-acting pure μ-opioid receptor agonist,rapid-acting pure μ-opioid receptor agonist
http://purl.obolibrary.org/obo/CHEBI_66568,DISEASE,lespeflorin g8,"G-protein-biased KOR|(6aR,11aR)-3,9-dimethoxy-10-(3-methylbut-2-en-1-yl)-6a,11a-dihydro-6H-[1]benzofuro[3,2-c]chromen-8-ol"
C586842,CHEMICAL,((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine [Supplementary Concept],Spiro Compounds|Oliceridine|Thiophenes
NEW12064,DISEASE,rodent head-shake,Rodent head-shakes
NEW12065,DISEASE,multiorgan syndrome,multiorgan syndrome
D012450,NUTRITION,Safflower Oil,"Safflower Oils|Oils, Safflower|Carthamus tinctorius L.|Safflower|Oil, Safflower"
NEW12066,DISEASE,dm disorder,DM disorders
D004652,DISEASE,Empty Sella Syndrome,"Empty sella syndrome|Empty Sella Syndrome, Primary|Empty Sella Syndrome, Secondary|Empty Sella Turcicas|Empty Sella Syndromes|Secondary Empty Sella Syndrome|Primary Empty Sella Syndrome|Sella Turcicas, Empty|Sella Turcica, Empty|Empty Sella Turcica|Empty Sella Turcica Syndrome"
NEW12067,CHEBI,endocrine presentation,endocrine presentations
NEW12068,NUTRITION,quantitative fatty acid composition,Quantitative fatty acid compositions
D002554,CHEMICAL,Cerebrosides,cerebrosides
NEW12069,NUTRITION,ganglioside fatty acid,ganglioside fatty acids
http://purl.obolibrary.org/obo/CHEBI_166968,CHEMICAL,trans-fatty acid,monounsaturated acids|high trans-fatty acids
NEW12070,CHEMICAL,serotonin reuptake blocker,serotonin reuptake blocker
D004875,CHEMICAL,Ergosterol,"D2, Pro-Vitamin|Pro-Vitamin D2|ergosterol|Pro Vitamin D2|Provitamin D 2|Lumisterol"
NEW12071,CHEMICAL,c1-thf synthase activity,C1-THF synthase activity
D033781,CHEMICAL,Adenine Nucleotide Translocator 3,"adenine|ADP, ATP Carrier Protein, Liver Isoform T2|ANT3 Transport Protein|Transport Protein, ANT-3|ADP ATP Carrier Protein, Liver Isoform T2|SLC25A6 Protein|Transport Protein, ANT3|ADP-ATP Carrier Protein, Liver Isoform T2|ANT-3 Transport Protein|Solute Carrier Family 25 Member 6|Solute Carrier Family 25, Member 6|Solute Carrier Family 25 (Mitochondrial Carrier - Adenine Nucleotide Translocator), Member 6|ANT 3 Transport Protein"
NEW12072,CHEMICAL,fumigation test,fumigation tests
D004331,DISEASE,Drosophila melanogaster,"D. melanogaster|Drosophila melanogasters|melanogaster, Drosophila|Drosophila melanogaster"
NEW12073,CHEMICAL,hdmse-ms/ms,HDMSE-MS/MS
NEW12074,MENTAL_HEALTH,collision-induced dissociation ms2 datum,collision-induced dissociation MS2 data
NEW12075,CHEBI,specific serotonin reuptake inhibitor,specific serotonin reuptake inhibitor
NEW12076,DISEASE,gts patient,GTS patients
D005659,CHEBI,"Fungicides, Industrial",Fungicides|Industrial Fungicides|fungicides
NEW12077,CHEBI,fungicide resistance,fungicide resistance
NEW12078,CHEMICAL,cytochrome p450-dependent sterol 14α-demethylase cyp51 gene,cytochrome P450-dependent sterol 14α-demethylase Cyp51 gene
NEW12079,CHEMICAL,drug-induced stuttering,DIS|Drug-induced stuttering
NEW12080,CHEBI,d-2 receptor antagonist,D-2 receptor antagonist
NEW12081,CHEBI,partial agonist agent,partial agonist agents
C000609690,CHEMICAL,deutetrabenazine [Supplementary Concept],Deutetrabenazine|Tetrabenazine/analogs  and  derivatives
NEW12082,CHEMICAL,increase dopamine level,increased dopamine levels
NEW12083,MENTAL_HEALTH,drug-induced stuttering,drug-induced stuttering
NEW12084,CHEMICAL,moderate prenatal alcohol exposure,Moderate prenatal alcohol exposure
NEW12085,DISEASE,opioid-related seizure,opioid-related seizure
NEW12086,DISEASE,schizophrenic proband,schizophrenic probands
NEW12087,CHEMICAL,low pge2 metabolite level,lower PGE2 metabolite levels
NEW12088,CHEBI,prophylactic beta-blocker therapy,prophylactic beta-blocker therapy
NEW12089,DISEASE,postoperative mi,postoperative MI
NEW12090,CHEMICAL,severe intractable ne,severe intractable NE
NEW12091,CHEMICAL,aemab,AEMAb
NEW12092,CHEMICAL,excessive fructose intake,Excessive fructose intake
C506936,DISEASE,"levoglucosan kinase, Aspergillus niger [Supplementary Concept]",Phosphotransferases|A. niger
NEW12093,CHEMICAL,sucrose- medium,sucrose- media
NEW12094,CHEBI,pubertal hormone,pubertal hormones
NEW12095,DISEASE,anxious psychopathology,anxious psychopathology
D043266,CHEMICAL,Steryl-Sulfatase,"Sulfate Sulfatase, Dehydroepiandrosterone|Sulfatase, DHEA|Sulfate Sulfohydrolase, Estrone|3 Beta-Hydroxysteroid Sulfate Sulfatase|Sulfatase, Dehydroepiandrosterone Sulfate|Sulfohydrolase, Estrone Sulfate|Steroid Sulfatase|Steroid Sulfohydrolase|Sulfate Sulfatase, Cholesterol|Estrone Sulfate Sulfohydrolase|Sulfatase, Cholesterol|Sulphatase, Steroid|Arylsulfatase C|Dehydroepiandrosterone Sulfate Sulfatase|Cholesterol Sulfatase|Sulfatase, Sterol|Sulfohydrolase, Steroid|Sulfatase, Steroid|3 Beta Hydroxysteroid Sulfate Sulfatase|Sulfate Sulfatase, Estrone|Steryl Sulfatase|Sulfatase, Estrone Sulfate|Sterylsulfatase|Sterol Sulfatase|Arylsulphatase C|Estrone Sulfate Sulfatase|Steroid Sulphatase|Cholesterol Sulfate Sulfatase|DHEA|DHEA Sulfatase|Sulfatase, Cholesterol Sulfate"
NEW12096,CHEMICAL,increase salivary dhea concentration,Increased salivary DHEA concentrations
NEW12097,MENTAL_HEALTH,self-reported anxiety symptom,self-reported anxiety symptoms
NEW12098,MENTAL_HEALTH,increase anxiety symptom count,increased anxiety symptom counts
NEW12099,MENTAL_HEALTH,generalize disorder symptom,generalized disorder symptoms
NEW12100,CHEMICAL,salivary dhea concentration,salivary DHEA concentrations
NEW12101,CHEMICAL,dhea concentration,DHEA concentrations
D060053,CHEMICAL,Transplant Donor Site,"Site, Transplant Donor|Donor Site, Transplant|Sites, Transplant Donor|DETA NONOate|Transplant Donor Sites|Donor Sites, Transplant|donor"
NEW12102,CHEMICAL,homovanillic acid hva,homovanillic acid HVA
NEW12103,DISEASE,aeromonas infection,Aeromonas infection
NEW12104,CHEMICAL,cortisol concentration,cortisol concentrations
D001764,DISEASE,Blepharospasm,Blepharospasms|blepharospasm
NEW12105,DISEASE,spinal cord ischaemia-reperfusion injury,spinal cord ischaemia-reperfusion injury
NEW12106,DISEASE,temporary ischaemia,temporary ischaemia
NEW12107,NUTRITION,microbiota-derived tryptophan metabolite,microbiota-derived tryptophan metabolites
NEW12108,DISEASE,intestinal mucosal immunity,intestinal mucosal immunity
NEW12109,CHEBI,gabapentin agonist,gabapentin agonists
C425043,CHEMICAL,jasmonic acid carboxyl methyltransferase [Supplementary Concept],Methyltransferases|JA|jasmonic acid|Jasmonic acid
NEW12110,MENTAL_HEALTH,plant defense mechanism,plant defense mechanism
NEW12111,CHEMICAL,exogenous meja,exogenous MeJA
C503359,DISEASE,"hang protein, Drosophila [Supplementary Concept]",Hangover|Drosophila Proteins
NEW12112,CHEMICAL,alcohol metabolism,alcohol metabolism
NEW12113,CHEMICAL,anti-hangover aho product,anti-hangover AHO product
NEW12114,CHEMICAL,sweet lime,sweet lime
NEW12115,DISEASE,incident exocrine pancreatic cancer case,incident exocrine pancreatic cancer cases
NEW12116,CHEBI,hormone use,hormone use
NEW12117,DISEASE,pancreatic cancer risk,pancreatic cancer risk
NEW12118,CHEMICAL,smoking duration,smoking duration
NEW12119,DISEASE,diabete status,diabetes status
NEW12120,MENTAL_HEALTH,conditional logistic regression analysis,conditional logistic regression analysis
NEW12121,CHEMICAL,cotinine level,cotinine levels
http://purl.obolibrary.org/obo/DOID_9972,CHEBI,hypervitaminosis a,vitamins A
NEW12122,DISEASE,colorectal cancer risk,colorectal cancer risk
NEW12123,DISEASE,rectal cancer case,rectal cancer cases
NEW12124,DISEASE,colon cancer case,colon cancer cases
D020803,DISEASE,"Encephalitis, Herpes Simplex","Meningoencephalitides, Herpetic|Encephalitis, Herpes|Meningoencephalitis, Herpetic|Herpetic Meningoencephalitis|Meningoencephalitides, Herpes Simplex|herpes simplex encephalitis|Herpes Encephalitis|Herpetic Meningoencephalitides|Herpetic Acute Necrotizing Encephalitis|Herpes Simplex Meningoencephalitides|Encephalitides, Herpes Simplex|Meningoencephalitis, Herpes Simplex Virus|Herpetic Encephalitis|Acute Necrotizing Encephalitis, Herpetic|Encephalitis, Herpetic|Meningoencephalitis, Herpes Simplex|Encephalitides, Herpetic|Herpes Simplex Meningoencephalitis|Herpetic Encephalitides|Herpes Simplex Encephalitides|Herpes Simplex Encephalitis"
NEW12125,CHEBI,effective antiviral therapy,effective antiviral therapies
NEW12126,DISEASE,psychiatric ramification,psychiatric ramifications
http://purl.obolibrary.org/obo/SYMP_0000018,DISEASE,darkening of skin,skin discoloration
NEW12127,CHEMICAL,zlt,ZLT
NEW12128,CHEMICAL,sterol profile,sterol profiles
NEW12129,DISEASE,alzheimer 's type,Alzheimer 's type|SDAT
D016633,CHEMICAL,Apolipoprotein A-II,Pro Apo A II|Apo A2|Apo A II Isoproteins|Apolipoprotein AII|Apo A-II Isoproteins|Apolipoprotein A II Isoproteins|Apolipoprotein A II|Proapolipoprotein A II|ApoA-2|apolipoprotein AII|Apo A-II|Apolipoprotein A-II Isoproteins|Pro-Apo A-II|ApoA-II|Pro Apolipoprotein A II|Apolipoprotein A-2|Pro-Apolipoprotein A-II|Apolipoprotein A 2|Apo AII|Apo A-2|Proapolipoprotein A-II|Apolipoprotein A2
NEW12130,DISEASE,human SDAT unclear,human SDAT unclear
D054312,DISEASE,Buruli Ulcer,"Buruli Ulcer Disease|Mycobacterium ulcerans Infections|Infections, Mycobacterium ulcerans|Mycobacterium ulcerans Infection|Ulcer Disease, Buruli|ulcer|Ulcer, Buruli|Buruli Ulcer Diseases|Diseases, Buruli Ulcer|Ulcer Diseases, Buruli|Disease, Buruli Ulcer|Infection, Mycobacterium ulcerans"
NEW12131,MENTAL_HEALTH,supraspinal descending projection fiber,supraspinal descending projection fibers
NEW12132,CHEMICAL,low serum testosterone concentration,lower serum testosterone concentration
NEW12133,CHEBI,niacin test oral administration,niacin test oral administration
NEW12134,DISEASE,endogenous depressed drug-free patient,endogenous depressed drug-free patients
NEW12135,CHEMICAL,nicotine acid,nicotine acid
NEW12136,MENTAL_HEALTH,beer craving,beer craving
NEW12137,CHEMICAL,sr receptor antagonist naltrexone,SR receptor antagonist naltrexone
NEW12138,MENTAL_HEALTH,drug resistance mutation,drug resistance mutations
NEW12139,CHEBI,suboptimal drug level,suboptimal drug levels
D018253,DISEASE,"Adenoma, Villous","Villous Adenomas|Adenomas, Villous|Villous Adenoma|villous adenomas"
NEW12140,CHEMICAL,y. pseudotuberculosis lipopolysaccharide,Y. pseudotuberculosis lipopolysaccharide
NEW12141,DISEASE,endotoxinemia,endotoxinemia
C042744,CHEMICAL,N-methylacetamide-oxotremorine M [Supplementary Concept],Oxotremorine/analogs  and  derivatives|oxotremorine-M
NEW12142,CHEMICAL,(3)h-pirenzepine binding,(3)H-pirenzepine binding
NEW12143,NUTRITION,cortical chat activity,cortical ChAT activity
D058225,CHEMICAL,"Plaque, Amyloid","Senile Plaque|Plaques, Neuritic|amyloid plaques|Amyloid Deposits|Amyloid Plaques|Amyloid Plaque|Plaque, Neuritic|Neuritic Plaques|Deposit, Amyloid|Amyloid Deposit|Senile Plaques|Plaques, Senile|Plaque, Senile|Neuritic Plaque|Deposits, Amyloid|Plaques, Amyloid"
NEW12144,CHEMICAL,large-scale isoniazid exposure,large-scale isoniazid exposure
NEW12145,CHEMICAL,pi transport,Pi transport
NEW12146,MENTAL_HEALTH,nonlinear regression,nonlinear regression
NEW12147,DISEASE,stroke breast cancer,stroke breast cancer
http://purl.obolibrary.org/obo/CHEBI_176350,CHEMICAL,sinapoyl glucose,"(E,5R,6S,7R,8R)-5,6,7,8,9-pentahydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)non-1-ene-3,4-dione|PGG|pentagalloyl glucose"
NEW12148,DISEASE,carbapenem-resistant acinetobacter baumannii,carbapenem-resistant Acinetobacter baumannii|CRAB
NEW12149,CHEBI,conclusion antimicrobial activity,conclusion antimicrobial activity
NEW12150,CHEBI,third-generation beta-adrenoceptor antagonist,third-generation beta-adrenoceptor antagonist
NEW12151,DISEASE,hypertension heart failure,hypertension heart failure
http://purl.obolibrary.org/obo/CHEBI_70868,CHEBI,antileishmanial agent,antileishmanial drug|antitrypanosomal agents|antileishmanial agents|antileishmanial drugs
NEW12152,DISEASE,rapid hydrophilic interaction liquid chromatography-tandem spectrometry method,rapid hydrophilic interaction liquid chromatography-tandem spectrometry method
NEW12153,CHEMICAL,mecp2 protein-either,MeCP2 protein-either
NEW12154,DISEASE,severe motor dysfunction,severe motor dysfunction
NEW12155,DISEASE,autistic behavior,autistic behavior
NEW12156,DISEASE,symptom vaginal dryness,symptoms vaginal dryness
NEW12157,MENTAL_HEALTH,management mood disorder,management mood disorders
NEW12158,CHEMICAL,ne level,NE levels
NEW12159,CHEBI,beta2-adrenergic agonist medication,Beta2-adrenergic agonist medications
D000420,CHEMICAL,Albuterol,|Albuterol Sulfate|salbutamol|Proventil|Ventolin|albuterol|Sultanol|2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol|Salbutamol
NEW12160,CHEBI,beta2-adrenergic agonist,beta2-adrenergic agonists
NEW12161,CHEMICAL,selenium deficiency,Selenium deficiency
D000072817,DISEASE,Eryptosis,"Apoptoses, Erythrocyte|Erythrocyte Death, Suicidal|Death, Suicidal Erythrocyte|Suicidal Erythrocyte Deaths|Suicidal Erythrocyte Death|Erythrocyte Deaths, Suicidal|Deaths, Suicidal Erythrocyte|Erythrocyte Apoptosis|Erythrocyte Apoptoses|suicidal erythrocyte death|Apoptosis, Erythrocyte"
NEW12162,NUTRITION,phosphatidylserine exposure,phosphatidylserine exposure
NEW12163,MENTAL_HEALTH,mania mood-stabilising agent,mania mood-stabilising agents
NEW12164,DISEASE,concurrent hypomanic symptom,concurrent hypomanic symptoms
NEW12165,MENTAL_HEALTH,depression recurrence,depression recurrences
NEW12166,CHEMICAL,glutamate system,glutamate systems
NEW12167,CHEMICAL,methanolic Blighia sapida leaf extract,methanolic Blighia sapida leaf extract
NEW12168,CHEMICAL,vpa toxicity,VPA toxicity
NEW12169,DISEASE,related hyperammonemia,related hyperammonemia
NEW12170,MENTAL_HEALTH,system depression,system depression
NEW12171,CHEMICAL,medicine yokukansan,medicines yokukansan
NEW12172,DISEASE,aggression test,aggression tests
D000087124,DISEASE,COVID-19 Serological Testing,"COVID-19 Serodiagnosis|SARS CoV 2 Infection Antibody Testing|Testing, SARS-COV-2 Antigen|SARS COV 2 Antigen Testing|COVID19 Serodiagnosis|SARS-COV-2 Antigen Testings|COVID-19 Serodiagnoses|COVID19 Serodiagnoses|COVID-19 Antibody Testing|COVID19 Serological Testing|Antibody Testing, COVID-19|Serological Testing, COVID-19|Serology Testing for COVID-19|SARS-CoV-2 Infection Antibody Testing|COVID19 Antibody Testing|Serology Testing for COVID 19|SARS CoV 2 Infection Serological Testing|COVID 19 Antibody Testing|Serodiagnosis, COVID19|SARS-COV-2 Antigen Testing|COVID-19 Serological Testings|Serological Testing, COVID19|Serodiagnosis, COVID-19|Antibody Testing, COVID19|Testing, COVID-19 Serological|COVID-19 Antibody Testings|COVID 19 Serodiagnosis|Testing, COVID19 Antibody|Testing, COVID19 Serological|SARS-CoV-2 infection|COVID19 Serological Testings|Testing, COVID-19 Antibody|Antigen Testings, SARS-COV-2|SARS-CoV-2 Infection Serological Testing|COVID19 Antibody Testings|COVID 19 Serological Testing"
http://purl.obolibrary.org/obo/MFOMD_0000102,MENTAL_HEALTH,apprehension,apprehension
NEW12173,DISEASE,host inflammation,host inflammation
NEW12174,CHEMICAL,vf gene,VF genes
NEW12175,CHEMICAL,low-fat whole-food vegan diet,low-fat whole-food vegan diet
C080710,CHEMICAL,policosanol [Supplementary Concept],Fatty Alcohols|policosanol
NEW12176,DISEASE,pre-existing coronary disease,pre-existing coronary disease
NEW12177,NUTRITION,fatty acid class,fatty acid class
NEW12178,NUTRITION,manage chat,managing chat
D004325,MENTAL_HEALTH,Dreams,nightmare|Nightmare|Nightmares|Dream
C097824,CHEMICAL,23-(O-ribofuranosyl)rifampicin [Supplementary Concept],rifampicin-|Rifampicin|rifampicin|RIF|Rifampin/analogs  and  derivatives
NEW12179,DISEASE,serious infectious disease,serious infectious diseases
NEW12180,DISEASE,mycobacterial infection,mycobacterial infections
NEW12181,CHEBI,critical first-line antibiotic,critical first-line antibiotic
NEW12182,CHEBI,riboflavin biosynthetic pathway,riboflavin biosynthetic pathway
NEW12183,CHEBI,novel antimycobacterial drug,novel antimycobacterial drugs
C581655,CHEBI,"SLC52A3 protein, rat [Supplementary Concept]","riboflavin transporter|Membrane Transport Proteins|Receptors, G-Protein-Coupled"
NEW12184,CHEBI,riboflavin analog,riboflavin analogs
NEW12185,MENTAL_HEALTH,riboswitch-mediated repression,riboswitch-mediated repression
NEW12186,DISEASE,hexa)-inactivate poliomyelitis-absorbe conjugate haemophilus influenzae type b vaccine,hexa)-inactivated poliomyelitis-absorbed conjugated Haemophilus influenzae type b vaccine
NEW12187,CHEMICAL,infanrix hexa trade mark,Infanrix hexa trade mark
NEW12188,DISEASE,diphtheria-tetanus-acellular pertussis-hepatitis b recombinant poliomyelitis-adsorbed conjugate haemophilus influenzae type b vaccine,diphtheria-tetanus-acellular pertussis-hepatitis B recombinant poliomyelitis-adsorbed conjugated Haemophilus influenzae type b vaccine
NEW12189,CHEMICAL,positive allosteric nicotinic acetylcholine receptor nachr modulator,positive allosteric nicotinic acetylcholine receptor nAChR modulators
NEW12190,CHEMICAL,approve nucleos(t)ide analog,approved nucleos(t)ide analogs
NEW12191,CHEBI,potential drug resistance,potential drug resistance
NEW12192,CHEMICAL,carbamate moiety,carbamate moiety
C031967,CHEMICAL,rasagiline [Supplementary Concept],Rasagiline|rasagiline|Indans
NEW12193,MENTAL_HEALTH,open-field hyperactivity,open-field hyperactivity
NEW12194,DISEASE,sixty-five psychotic proband,Sixty-five psychotic probands
NEW12195,DISEASE,apple replant disease,Apple replant disease
NEW12196,NUTRITION,tree nursery,tree nurseries
NEW12197,DISEASE,spontaneous seizure,Spontaneous seizures
NEW12198,CHEMICAL,pilocarpine model,pilocarpine model
NEW12199,CHEBI,antifungal probiotic saccharomyces boulardii,antifungal probiotic Saccharomyces boulardii
http://purl.obolibrary.org/obo/CHEBI_50825,CHEMICAL,gold nanoparticle,AuNP|gold nanoparticles
NEW12200,MENTAL_HEALTH,dose fixation study,dose fixation studies
NEW12201,MENTAL_HEALTH,excessive day-time sleepiness,excessive day-time sleepiness
NEW12202,CHEBI,novel nonstimulant wakefulness-promoting drug,novel nonstimulant wakefulness-promoting drug
http://purl.obolibrary.org/obo/CHEBI_47105,CHEBI,1-bromopropane,neurotoxicant|n-propyl bromide|1-bromopropane
NEW12203,CHEMICAL,l-kainate,L-kainate
NEW12204,CHEMICAL,mm nmda,mM NMDA
NEW12205,MENTAL_HEALTH,maximum depression,maximum depression
NEW12206,CHEBI,vitamin d administration,vitamin D administration
http://purl.obolibrary.org/obo/CHEBI_33237,CHEMICAL,vitamin d4,"24S-methylcalciol|1α,25(OH)2 Vitamin D3|Vitamin D4|22,23-dihydroercalciol|vitamin D4|(3S,5Z,7E)-9,10-secoergosta-5,7,10(19)-trien-3-ol|(5Z,7E)-(3S)-9,10-Seco-5,7,10(19)-ergostatrien-3-ol|(5Z,7E)-(3S)-9,10-secoergosta-5,7,10(19)-trien-3-ol|22-Dihydroergocalciferol|(3S)-9,10-seco-5Z,7E,10(19)-ergostatrien-3-ol|(24S)-methylcalciol|(3beta,5Z,7E)-9,10-secoergosta-5,7,10(19)-trien-3-ol|1,25-D3|22,23-dihydroergocalciferol"
D066257,CHEMICAL,Heparin-binding EGF-like Growth Factor,"Heparin binding Epidermal Growth Factor like Growth Factor Precursor Protein|Toxin Receptor, Diphtheria|SF HB EGF|Heparin binding EGF like Growth Factor|Diphtheria Toxin Receptor|HB EGF|Diphtheria Toxin Receptors|Heparin-binding Epidermal Growth Factor-like Growth Factor Precursor Protein|Heparin-binding EGF-like Growth-Factor|HB-EGF, Short Form|Short Form HB-EGF|Receptors, Diphtheria Toxin|Toxin Receptors, Diphtheria|HB-EGF Precursor|Receptor, Diphtheria Toxin|heparin|SF HB-EGF|Short Form HB EGF|HB-EGF|HB EGF Precursor"
NEW12207,DISEASE,human obesity,human obesity
http://purl.obolibrary.org/obo/CHEBI_48278,CHEBI,serotonergic drug,serotonergic drugs|serotonin drugs|serotonergic drug|serotonergic agents
NEW12208,CHEMICAL,dipalmitate astaxanthin,dipalmitate astaxanthin
NEW12209,CHEMICAL,palmitate esterification,palmitate esterification
NEW12210,MENTAL_HEALTH,distinctive mass spectrometry fragmentation pattern,distinctive mass spectrometry fragmentation pattern
http://purl.obolibrary.org/obo/CHEBI_10362,CHEBI,beta-cryptoxanthin,"lutein 3'-O-palmitate-3-O-linoleate|lutein 3'-O-linoleate|lutein 3-O-linoleate|lutein 3'-O-linoleate-3-O-palmitate|lutein 3'-O-palmitate|beta-Cryptoxanthin|(3R)-beta,beta-caroten-3-ol|cryptoxanthin|beta-cryptoxanthin"
NEW12211,CHEBI,lutein 3-O-palmitate,lutein 3-O-palmitate
NEW12212,CHEBI,lutein dilinoleate,lutein dilinoleate
NEW12213,CHEBI,lutein dipalmitate,lutein dipalmitate
NEW12214,DISEASE,full-length g glycoprotein,RABV-G|full-length G glycoprotein
NEW12215,CHEMICAL,pure pms group,Pure PMS group
NEW12216,DISEASE,early psychiatric history,earlier psychiatric history
NEW12217,MENTAL_HEALTH,less neurosis,less neurosis
NEW12218,DISEASE,polyketide lasiodiplodin,polyketides lasiodiplodin
NEW12219,CHEMICAL,prostaglandin biosynthesis,prostaglandin biosynthesis
NEW12220,DISEASE,human blood coagulation factor xiiia,human blood coagulation factor XIIIa
NEW12221,CHEMICAL,14-membered ral homologue,14-membered RAL homologues
NEW12222,DISEASE,fungal ipks,fungal iPKSs
http://purl.obolibrary.org/obo/CHEBI_25212,CHEMICAL,metabolite,metabolites|primary metabolites|metabolite|metabolite MPP+|secondary metabolites|RAL12 metabolites
NEW12223,DISEASE,pancreatic cancer tumorigenesis,pancreatic cancer tumorigenesis
C447119,CHEMICAL,bazedoxifene [Supplementary Concept],Bazedoxifene|bazedoxifene|Indoles
NEW12224,CHEMICAL,effective gp130/stat3 signaling inhibitor,effective GP130/STAT3 signaling inhibitor
NEW12225,CHEBI,selective estrogene receptor modulator available,selective estrogene receptor modulator available
NEW12226,DISEASE,pancreatic cancer therapy safe,pancreatic cancer therapy safe
D018567,DISEASE,"Breast Neoplasms, Male","Tumor, Male Breast|Breast Tumor, Male|Breast Tumors, Male|male breast cancer|Cancer, Male Breast|Male Breast Neoplasm|Tumors, Breast, Male|Carcinoma, Male Breast|Breast Neoplasm, Male|Male Breast Cancer|Neoplasm, Male Breast|Neoplasms, Breast, Male|Neoplasms, Male Breast|Tumors, Male Breast|Breast Carcinoma, Male|breast tumors|Breast Cancer, Male|Male Breast Tumor|Male Breast Carcinoma|Male Breast Neoplasms|Male Breast Tumors"
NEW12227,CHEMICAL,non-small/small cell bronchogenic/pulmonary type,non-small/small cell bronchogenic/pulmonary types
NEW12228,DISEASE,heritable peroxisomal disorder,heritable peroxisomal disorders
NEW12229,CHEMICAL,dha deficit,DHA deficits
NEW12230,DISEASE,peroxisomal impairment,peroxisomal impairment
NEW12231,CHEMICAL,erythrocyte plasmalogen,erythrocyte plasmalogen
http://purl.obolibrary.org/obo/CHEBI_35819,NUTRITION,branched-chain fatty acid,Branched chain fatty acid|BCFA|BCFAs|branched-chain fatty acids|branched fatty acids|branched fatty acid
C031345,CHEMICAL,pipecolic acid [Supplementary Concept],pipecolic acid|Pipecolic Acids
C000630968,CHEMICAL,"Elovl6 protein, mouse [Supplementary Concept]",Fatty Acid Elongases|VLCFA|long-chain fatty acids
NEW12232,DISEASE,significant erythrocyte dha deficit,significant erythrocyte DHA deficits
NEW12233,DISEASE,first-episode bipolar group,first-episode bipolar groups
NEW12234,CHEMICAL,low dha,lower DHA
NEW12235,CHEBI,cannabinoid cb1 receptor antagonist rimonabant,cannabinoid CB1 receptor antagonist rimonabant
NEW12236,CHEBI,competitive n-methyl-d-aspartate antagonist -3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonate,competitive N-methyl-D-aspartate antagonist -3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonate
http://purl.obolibrary.org/obo/CHEBI_139155,CHEBI,melanin-concentrating hormone receptor antagonist,MCHR agonist|melanin-concentrating hormone receptor antagonists|MCHR agonists|corticotrophin-releasing hormone receptors
NEW12237,CHEMICAL,n-methyl-d-aspartate receptor activity,N-methyl-D-aspartate receptor activity
NEW12238,DISEASE,mets complication,MetS complications
D002725,CHEMICAL,Chloroform,|Chloroform|Trichloromethane|chloroform
NEW12239,CHEBI,forget poison,forgotten poison
NEW12240,MENTAL_HEALTH,unexplained global amnesia great,unexplained global amnesia greater
NEW12241,DISEASE,severe apicomplexan infection,severe apicomplexan infection
NEW12242,NUTRITION,Chlamys islandica,Chlamys islandica
NEW12243,CHEMICAL,h(2)s,H(2)S
NEW12244,MENTAL_HEALTH,down syndrome patient,Down syndrome patients
NEW12245,CHEMICAL,perturb h(2)s synthesis,perturbed H(2)S synthesis
NEW12246,CHEMICAL,microm glutamate,microM glutamate
NEW12247,CHEBI,pharmacological glutamate receptor antagonist,pharmacological glutamate receptor antagonists
NEW12248,CHEMICAL,selective noradrenaline reuptake inhibitor atomoxetine,selective noradrenaline reuptake inhibitor atomoxetine
NEW12249,DISEASE,reflection impulsivity,reflection impulsivity
NEW12250,CHEBI,drug plasma level,drug plasma level
NEW12251,CHEMICAL,cannabis compound,cannabis compounds
NEW12252,DISEASE,cognitive impairment relevant,cognitive impairment relevant
D031171,NUTRITION,Artemisia absinthium,"Artemisia absinthium|Artemisia absinthiums|absinthiums, Artemisia"
NEW12253,CHEMICAL,Congo red staining,Congo red staining
NEW12254,CHEMICAL,murine amino terminal peptide sequence,murine amino terminal peptide sequence
D014816,DISEASE,Vitelline Duct,"Duct, Omphalomesenteric|Ducts, Omphalomesenteric|Ducts, Vitelline|Omphalomesenteric Ducts|duct|Duct, Vitelline|Vitelline Ducts|Omphalomesenteric Duct"
NEW12255,CHEMICAL,serum alanine aminotransferase level,serum alanine aminotransferase levels
D000326,DISEASE,Adrenoleukodystrophy,"X ALD (X Linked Adrenoleukodystrophy)|X-ALD|adrenoleukodystrophy|Siemerling-Creutzfeldt Disease|Schilder-Addison Complex|Leukodystrophy, Melanodermic|X Linked Adrenoleukodystrophy|Adrenomyeloneuropathy|Leukodystrophies, Melanodermic|Melanodermic Leukodystrophy|Adrenoleukodystrophy, X-Linked|Schilder Addison Complex|X-Linked Adrenoleukodystrophy|ALD (Adrenoleukodystrophy)|X-ALD (X-Linked Adrenoleukodystrophy)|Addison Disease and Cerebral Sclerosis|ALD|X ALD|Bronze Schilder Disease|Siemerling Creutzfeldt Disease"
NEW12256,DISEASE,ald group,ALD group
C501876,DISEASE,"Mps1 protein, Drosophila [Supplementary Concept]",Cell Cycle Proteins|ALD protein|Drosophila Proteins|Protein Serine-Threonine Kinases
C013147,CHEMICAL,nervonic acid [Supplementary Concept],"Fatty Acids, Monounsaturated|nervonic acid"
C049811,CHEMICAL,erucic acid [Supplementary Concept],erucic acid|Erucic Acids
NEW12257,CHEMICAL,vlcfa accumulation similar,VLCFA accumulation similar
NEW12258,DISEASE,ald fibroblast,ALD fibroblasts
NEW12259,CHEMICAL,intracellular atp production,intracellular ATP production
NEW12260,DISEASE,male xald mouse,male XALD mice
D000077405,CHEMICAL,Irbesartan,"SR 47436|irbesartan|BMS 186295|BMS-186295|SR47436|Avapro|2-N-Butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one|Aprovel|SR-47436|Karvea"
NEW12261,DISEASE,x-linked hypophosphataemia,X-linked hypophosphataemia
NEW12262,CHEBI,phosphaturic hormone fibroblast growth factor,phosphaturic hormone fibroblast growth factor
http://purl.obolibrary.org/obo/DOID_0080655,CHEMICAL,hypophosphatemic nephrolithiasis/osteoporosis,hypophosphataemia-associated rickets
NEW12263,CHEBI,active vitamin d metabolite,active vitamin D metabolites
NEW12264,DISEASE,leg deformity,leg deformities
NEW12265,CHEMICAL,phosphate supplement,phosphate supplements
D008737,CHEMICAL,Methyl Chloride,"methyl chloride|Chloromethane|Chloride, Methyl"
NEW12266,DISEASE,describe hereditary alpha-synucleinopathie,described hereditary alpha-synucleinopathies
NEW12267,CHEBI,m1 receptor agonist,M1 receptor agonists
NEW12268,DISEASE,low toxicity effect profile,low toxicity effect profile
NEW12269,CHEMICAL,n-arylthiourea,N-arylthioureas
NEW12270,CHEMICAL,continue effort 3-morpholino arecoline derivative,continuing effort 3-morpholino arecoline derivatives
NEW12271,MENTAL_HEALTH,neurological syndrome,neurological syndromes
NEW12272,DISEASE,eg nystagmus,eg nystagmus
D013837,CHEMICAL,Thiamin-Triphosphatase,thiamin|Thiamin Triphosphatase|Thiamin|Thiamine Triphosphatase
NEW12273,DISEASE,hypoglutamatergic disorder,hypoglutamatergic disorder
NEW12274,CHEMICAL,glutamate 5-ht 2a receptor,glutamate 5-HT 2A receptor
NEW12275,CHEBI,potent opiate antagonist,potent opiate antagonist
NEW12276,DISEASE,immunological abnormality,immunological abnormalities
NEW12277,MENTAL_HEALTH,adhd phenotype,ADHD phenotype
NEW12278,CHEBI,gnrh-a therapy,GnRH-a therapy
NEW12279,NUTRITION,mushroom Hericium erinaceus,mushroom Hericium erinaceus
D010523,DISEASE,Peripheral Nervous System Diseases,"|nervous system diseases|Diseases of peripheral nerves|Peripheral Nervous System Disease|Peripheral Nerve Diseases|Peripheral Neuropathy|Peripheral Neuropathies|Nerve Diseases, Peripheral|Peripheral Nervous System Disorders|PNS Diseases|PNS Disease|Peripheral Nerve Disease|PNS (Peripheral Nervous System) Diseases|Nerve Disease, Peripheral|Neuropathy, Peripheral"
NEW12280,DISEASE,ulcer effect,ulcer effects
D018697,CHEMICAL,Nootropic Agents,"Anti-Dementia Agent|Agents, Procognitive|Cognitive Enhancer|Nootropic Drug|Anti-Dementia Agents|Procognitive Agents|Agent, Procognitive|Procognitive Agent|Nootropic Drugs|Enhancer, Cognitive|Antidementia Agents|Cognitive Enhancers|Drugs, Nootropic|Agent, Antidementia|Enhancers, Cognitive|Agents, Antidementia|Agents, Nootropic|Agent, Nootropic|Agent, Anti-Dementia|Nootropics|Drug, Nootropic|Nootropic Agent|Anti Dementia Agents|anti-dementia|Agents, Anti-Dementia|Antidementia Agent|Anti Dementia Agent|Nootropic"
NEW12281,DISEASE,anti-gastric ulcer activity,anti-gastric ulcer activity
http://purl.obolibrary.org/obo/CHEBI_53233,CHEMICAL,"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide","3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay|Methylthiazoletetrazolium|3-(4,5-Dimethylthiazolyl)-2,5-diphenyltetrazolium bromide|Thiazolyl Blue Monotetrazolium|Thiazolyl blue|MTT|3-(4,5-dimethyl-1,3-thiazol-2-yl)-2,5-diphenyl-2H-tetrazol-3-ium bromide|3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide|TMCHB|2-(4,5-dimethyl-1,3-thiazol-2-yl)-3,5-diphenyl-2H-tetrazol-3-ium bromide|3-(4,5-Dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide|MMT Tetrazolium|Thiazolyl blue tetrazolium bromide"
NEW12282,DISEASE,ethanol-induced ulcer model,ethanol-induced ulcer model
NEW12283,MENTAL_HEALTH,metal-complex dissociation constant,metal-complex dissociation constants
D015222,CHEMICAL,Sodium Channels,"Channel, Sodium|Channels, Sodium Ion|Channels, Sodium|Ion Channels, Sodium|sodium ion|Sodium Ion Channels|Sodium Channel|Ion Channel, Sodium|Sodium Ion Channel|Channel, Sodium Ion"
NEW12284,MENTAL_HEALTH,grazer resistance,grazer resistance
NEW12285,CHEMICAL,dietary sterol,dietary sterol
NEW12286,DISEASE,toxicity availability,toxicity availability
http://purl.obolibrary.org/obo/CHEBI_140954,NUTRITION,fatty acid 20:3-omega-3omega-6,wt% fatty acids|Fatty acid profile|fatty acid metabolism|fatty acid content|major fatty acid|same fatty acids|Altered fatty acid|FA 20:3-w3w6|FA(20:3-w3w6)|Fatty acid metabolism
NEW12287,CHEBI,estrogen deficit,Estrogen deficit
NEW12288,DISEASE,modest hypotensive effect,modest hypotensive effect
NEW12289,DISEASE,drug-induced tremor,Drug-induced tremor
NEW12290,DISEASE,drug-induced tremor,drug-induced tremor
NEW12291,CHEMICAL,immediate-release preparation,immediate-release preparations
D000077291,CHEMICAL,Terbinafine,"Terbinafine, (Z)-isomer|Lamisil|Terbinafine Hydrochloride|(E)-N-(6,6-Dimethyl-2-heptenynyl)-N-methyl-1-naphthalenementhamin hydrochloride|SF 86327|DA 5505|SF86327|TDT-067|SF-86-327|Terbinafine, (Z)-|TDT 067|TDT067|Terbinafine|SF 86 327|SF 86-327"
NEW12292,DISEASE,more sfa,more SFAs
D050918,NUTRITION,Phosphatidylethanolamine N-Methyltransferase,"Phosphatidylethanolamine-Methyltransferase II|Cephalin N-Methyltransferase|N-Methyltransferase, Phosphatidylethanolamine|Methyltransferase, Phosphatidylethanolamine|Phosphatidylethanolamine N-Methyltransferase, S-Adenosylmethionine|N-Methyltransferase, Cephalin|Phosphatidylethanolamine Phosphatidylcholine N Methyltransferase|Phosphatidylethanolamine N Methyltransferase 2|S-Adenosylmethionine Phosphatidylethanolamine N-Methyltransferase|Methyltransferase II, PHET|Phosphatidylethanolamine Methyltransferase|S Adenosylmethionine Phosphatidylethanolamine N Methyltransferase|N-Methyltransferase-2, Phosphatidylethanolamine|PHET Methyltransferase II|Methyltransferase II, Phospholipid|Phospholipid Methyltransferase II|phosphatidylethanolamine|Phosphatidylethanolamine N Methyltransferase|Cephalin N Methyltransferase|N-Methyltransferase, Phosphatidylethanolamine-Phosphatidylcholine|Phosphatidylethanolamine-Phosphatidylcholine N-Methyltransferase|N-Methyltransferase, S-Adenosylmethionine Phosphatidylethanolamine|Phosphatidylethanolamine N-Methyltransferase-2|Phosphatidylethanolamine Methyltransferase II"
NEW12293,CHEMICAL,as-needed use,as-needed use
NEW12294,DISEASE,infection risk,infection risk
NEW12295,CHEMICAL,Koch- Institute,Koch- Institute
NEW12296,DISEASE,infection prevention,Infection Prevention
NEW12297,DISEASE,allergic risk,allergic risk
NEW12298,CHEMICAL,glucagon-like peptide receptor agonist,Glucagon-like peptide receptor agonists
NEW12299,MENTAL_HEALTH,elevated conditioned response level,Elevated conditioned response levels
D019796,NUTRITION,"15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid","9,11-Dideoxy-11 alpha,9-alpha-epoxymethano-PGF2 alpha|alpha|9,11 epoxymethano PGH2|(15S)-Hydroxy-11 alpha, 9 alpha-(epoxymethano)prosta-5Z, 13E-dienoic Acid|U 44619|11 alpha,9 alpha Epoxymethano PGH2|U46619|9,11-epoxymethano-PGH2|U44619|U-46619|9,11-Dideoxy-11 alpha,9 alpha-epoxymethanoprostaglandin F2 alpha|11 alpha,9 alpha-Epoxymethano PGH2|U-44619|(15S)hydroxy-9alpha,11alpha-(epoxymethano)prosta-5,13-dienoic acid|U 46619"
NEW12300,CHEMICAL,​0.81,​0.81
NEW12301,CHEBI,low vitamin e,Lower vitamin E
NEW12302,CHEBI,low a level,Lower A levels
NEW12303,CHEMICAL,bupropion overdose,bupropion overdose
D013616,DISEASE,"Tachycardia, Sinus","Tachycardias, Sinus||sinus tachycardia|Sinus Tachycardias|Sinus Tachycardia|sinus tachycardias"
NEW12304,DISEASE,amygdala cea long-lasting hyperexcitability,amygdala CeA long-lasting hyperexcitability
NEW12305,MENTAL_HEALTH,noradrenaline-induced depression,noradrenaline-induced depression
http://purl.obolibrary.org/obo/CHEBI_37887,CHEBI,adrenergic antagonist,adrenergic blockaders|adrenergic blockers|adrenergic antagonists propranolol|adrenergic antagonists|adrenoceptor antagonists|alpha-2 adrenergic receptor antagonist|adrenergic receptor blockaders|adrenergic blocker|adrenergic antagonist propranolol
NEW12306,CHEBI,alpha-1 adrenergic receptor antagonist,alpha-1 adrenergic receptor antagonist
D000068438,CHEMICAL,Brimonidine Tartrate,"Sanrosa|Brimonidine|Ratio Brimonidine|UK 14304|AGN-190342|Brimonidine Purite|Ratio-Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate|UK-14,304-18|Mirvaso|Brimonidine Tartrate (1:1), (S-(R*,R*))-Isomer|UK14,308|UK 14,30418|Alphagan|5-bromo-6-(imidazolidinylideneamino)quinoxaline|UK-14304|UK 14,304|UK14304|Alphagan P|UK-14,308|Bromoxidine|AGN 190342|AGN190342|UK 14,304 18|Brimonidine Tartrate, (R-(R*,R*))-Isomer|UK 14,308|UK 14,304-18|UK14,30418|UK 14308|Brimonidine Tartrate (1:1)|5-bromo-6-(imidazolin-2-ylamino)quinoxaline"
NEW12307,CHEBI,alpha-2 adrenergic receptor agonist,alpha-2 adrenergic receptor agonist
D008304,DISEASE,Malignant Catarrh,"Fevers, Malignant Catarrhal|Catarrh, Malignant|Catarrhal Fever, Malignant|Malignant Catarrhs|Malignant Catarrhal Fever|Malignant catarrhal fever|Malignant Catarrhal Fevers|Catarrhal Fevers, Malignant|Catarrhs, Malignant|Fever, Malignant Catarrhal"
NEW12308,NUTRITION,ranch american bison,ranched American bison
NEW12309,CHEBI,phytoestrogen exposure,phytoestrogen exposure
NEW12310,DISEASE,disease status epilepticus,disease status epilepticus
NEW12311,CHEBI,m-chlorophenylbiguanide 5-ht3 receptor agonist,m-chlorophenylbiguanide 5-HT3 receptor agonist
http://purl.obolibrary.org/obo/CHEBI_81507,CHEMICAL,"1,2,3,7,8-pentachlorodibenzofuran","A1254|PCDF 94|Aroclor1254|1,2,3,7,8-PeCDF"
NEW12312,CHEBI,hla class-1 antigen,HLA class-1 antigens
NEW12313,DISEASE,glial abnormality,glial abnormalities
D005458,CHEMICAL,Fluoride Poisoning,"Fluoride Poisonings|Poisoning, Fluoride|Poisonings, Fluoride|fluoride poisoning"
NEW12314,MENTAL_HEALTH,low n fixation,low N fixation
NEW12315,CHEMICAL,anabolic-androgenic steroid use,Anabolic-androgenic steroid use
NEW12316,DISEASE,various psychotic symptom,Various psychotic symptoms
NEW12317,CHEBI,anxiolytic analgesic property,anxiolytic analgesic properties
NEW12318,CHEBI,selective α-2 agonist,selective α-2 agonist
NEW12319,CHEMICAL,appz exposure,APPZ exposure
NEW12320,DISEASE,stress-induced social impairment,stress-induced social impairment
NEW12321,CHEBI,promising drug candidate,promising drug candidate
NEW12322,DISEASE,viral infection coronavirus disease,viral infection coronavirus disease
http://purl.obolibrary.org/obo/CHEBI_32460,CHEMICAL,cysteine residue,cysteine residue|cysteinyl|cysteine acid residue|cysteine residues
NEW12323,DISEASE,topical vaginal lubricant,topical vaginal lubricants
NEW12324,DISEASE,vaginal atrophy,Vaginal atrophy
NEW12325,CHEBI,vaginal oestrogen,vaginal oestrogen
NEW12326,NUTRITION,bombyx mori silk,Bombyx mori silk
NEW12327,CHEMICAL,pentachlorophenol dechlorinating anaerobic microbial culture,pentachlorophenol dechlorinating anaerobic microbial culture
NEW12328,CHEMICAL,co2 reduction,CO2 reduction
C520571,CHEMICAL,tideglusib [Supplementary Concept],Thiadiazoles|Tideglusib
NEW12329,CHEMICAL,hippocampus ca1 region,hippocampus CA1 region
NEW12330,CHEMICAL,dapt duration,DAPT duration
NEW12331,DISEASE,ischemic coronary disease,ischemic coronary disease
NEW12332,CHEMICAL,enzyme phenylalanine hydroxylase,enzyme phenylalanine hydroxylase
NEW12333,DISEASE,inherit deficiency,inherited deficiency
NEW12334,CHEMICAL,mild-to-moderate covid-19 symptom,Mild-to-moderate COVID-19 symptoms
D063806,DISEASE,Myalgia,"|tenderness|Pain, Muscle|Muscle Pain|Pains, Muscle|Muscle Tenderness|muscle pain|Tenderness, Muscle|myalgia|Muscle Soreness|Muscle Sorenesses|Soreness, Muscle"
NEW12335,DISEASE,acute inflammatory lung injury,acute inflammatory lung injury
NEW12336,CHEMICAL,circulate cytokine,circulating cytokines
NEW12337,DISEASE,ards/inflammatory lung injury,ARDS/inflammatory lung injury
C000605814,CHEMICAL,N-(7-chloro-N-quinuclidin-3-yl)benzo(b)thiophene-2-carboxamide [Supplementary Concept],Quinuclidines|Encenicline|encenicline|Thiophenes
NEW12338,MENTAL_HEALTH,pd dementia,PD dementia
NEW12339,DISEASE,fhp nonalcoholic man,FHP nonalcoholic men
D019205,NUTRITION,"GTP-Binding Protein alpha Subunits, Gs","G-Protein Gs, Stimulatory|G Protein, Gs alpha Family|Gs Stimulatory G-Proteins|Gs Stimulatory G Proteins|Stimulatory GTP Binding Protein, alpha Subunit|G Protein, Stimulatory Gs|Ns Protein, Regulatory|Stimulatory G-Protein Gs|Stimulatory G-Proteins, Gs|Gs, Stimulatory G-Protein|G-Proteins, Gs Stimulatory|Regulatory Ns Protein|G-Protein, Stimulatory Gs|Gs alpha GTP-Binding Protein Subunits|GTP Binding Protein alpha Subunits, Gs|Gs G-Protein, Stimulatory|alpha Gs|G-Protein, Gs alpha Family|Stimulatory GTP-Binding Protein, alpha Subunit|Gs alpha|Gs alpha GTP Binding Protein Subunits|G(s)alpha|Stimulatory Gs G-Protein|alpha-Gs|G(s), alpha Subunit|Gs, Stimulatory G Protein"
NEW12340,DISEASE,periodontal pathogen porphyromonas gingivalis,periodontal pathogen Porphyromonas gingivalis
D057056,CHEMICAL,Cysteine Proteases,"Proteinases, Cysteine|Cysteine Proteinase|Cysteine Proteinases|Cysteine Protease|cysteine proteases|Proteases, Cysteine|Protease, Cysteine|Proteinase, Cysteine"
NEW12341,CHEMICAL,omega-3 enriched dietary supplement,omega-3 enriched dietary supplements
NEW12342,CHEMICAL,high shbg level,higher SHBG levels
NEW12343,CHEBI,ngf stimulator,NGF stimulators
NEW12344,CHEMICAL,linc00511,LINC00511
NEW12345,CHEMICAL,er-negative-associated linc00511,ER-negative-associated LINC00511
D050760,CHEMICAL,Cyclin-Dependent Kinase Inhibitor p27,"CDKN4 Protein|CDKN1B|Cyclin Dependent Kinase Inhibitor p27|p27, CDK Inhibitor|CDK Inhibitor, p27|p27Kip1 Protein|p27 CDK Inhibitor|Kip1 Protein, p27|CDKN1B Protein|p27 Kip1 Protein|Cyclin-Dependent Kinase Inhibitor 1B|CDK Inhibitor p27|Cyclin Dependent Kinase Inhibitor 1B"
NEW12346,DISEASE,high-risk human papillomavirus hr‑hpv infection,high-risk human papillomavirus HR‑HPV infection
D064695,CHEMICAL,Enclomiphene,"Androxal|Enclomifene|trans-Clomiphene Citrate|(E)-2-(p-(2-Chloro-1,2-Diphenylvinyl)phenoxy)triethylamine Citrate|trans-Clomiphene|Enclomiphen|trans Clomiphene|clomiphene citrate|trans Clomiphene Citrate|En-Clomiphene|Citrate, Enclomiphene|Citrate, trans-Clomiphene|(E)-2-(p-(2-Chloro-1,2-Diphenylvinyl)phenoxy)triethylamine|CC|Enclomiphene Citrate"
NEW12347,CHEBI,successful analgesic,successful analgesic
NEW12348,CHEMICAL,hsp-inducing compound geranylgeranylacetone,HSP-inducing compound geranylgeranylacetone
NEW12349,MENTAL_HEALTH,proteostasis derailment,proteostasis derailment
NEW12350,DISEASE,neurodegenerative disorder due,neurodegenerative disorder due
http://purl.obolibrary.org/obo/CHEBI_52647,DISEASE,organoiridium compound,organoiridium compounds|TCM compounds
NEW12351,DISEASE,TCM database@taiwan,TCM Database@Taiwan
http://purl.obolibrary.org/obo/CHEBI_16494,CHEMICAL,lipoic acid,"5-(1,2-dithiolan-3-yl)pentanoic acid|Thioctsaeure|6-thioctic acid|6-thiotic acid|5-(dithiolan-3-yl)valeric acid|6,8-thiotic acid|Biletan|Acetate-replacing factor|1,2-dithiolane-3-valeric acid|liponic acid|6,8-thioctic acid|alpha-Lipoic acid|Thioctansaeure|β -lipoic acid|Lipoic acid|alpha-lipoic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioktsaeure|alpha-Liponsaeure|Thioctic acid|5-(1,2-dithiolan-3-yl)valeric acid|1,2-dithiolane-3-pentanoic acid"
http://purl.obolibrary.org/obo/CHEBI_177286,CHEMICAL,o-fatty acyl-l-serine residue,O-fatty acyl-L-serine residue|residue Ala327
C000469,CHEMICAL,diazobenzenesulfonic acid [Supplementary Concept],Sulfanilic Acids|sulfanilic acid|Diazonium Compounds
NEW12352,CHEMICAL,α2a-ar activation,α2A-AR activation
NEW12353,MENTAL_HEALTH,chronic cocaine abuse,chronic cocaine abuse
NEW12354,CHEMICAL,ng expression,Ng expression
NEW12355,CHEBI,male gonadal hormone,male gonadal hormones
NEW12356,DISEASE,lung infection,lung infection
http://purl.obolibrary.org/obo/DOID_1307,MENTAL_HEALTH,dementia,HIV-associated dementia|(HIV)-associated dementia
NEW12357,MENTAL_HEALTH,Cocaine dependence Disorder,Cocaine Dependence Disorder
NEW12358,DISEASE,major depressive illness,major depressive illness
NEW12359,CHEMICAL,slow-growing ntm specie mycobacterium chimaera,slow-growing NTM species Mycobacterium chimaera
NEW12360,DISEASE,multiple invasive infection,multiple invasive infections
NEW12361,NUTRITION,cholesterol serum level,cholesterol serum levels
C000591640,CHEMICAL,omadacycline [Supplementary Concept],Tetracyclines|Omadacycline
NEW12362,CHEMICAL,core tetracycline ring,core tetracycline rings
NEW12363,CHEMICAL,cannabis aor,cannabis AOR
C029738,CHEMICAL,tertiapin [Supplementary Concept],Bee Venoms|tertiapin
NEW12364,MENTAL_HEALTH,methamphetamine-induced hyperactivity,methamphetamine-induced hyperactivity
NEW12365,CHEMICAL,drug cloperastine,drugs cloperastine
NEW12366,MENTAL_HEALTH,drug-induced hyperactivity,drug-induced hyperactivity
NEW12367,CHEBI,important standardized beta,important standardized beta
NEW12368,DISEASE,high trait hostility male volunteer,high trait hostility male volunteers
NEW12369,CHEMICAL,acid drink,acid drink
NEW12370,DISEASE,autistic boy,autistic boys
NEW12371,CHEBI,inadequate vitamin e,inadequate vitamin E
D012605,DISEASE,Scorpions,scorpions|Scorpion
D009306,DISEASE,Natal Teeth,"Teeth Present At Birth|Tooth, Natal|Teeth, Natal|Natal Tooth|teeth"
NEW12372,NUTRITION,pecten,pectines
NEW12373,CHEMICAL,non-ergot dopamine agonist,Non-ergot dopamine agonist|NEDA
NEW12374,CHEMICAL,long-acting dopamine agonist,Long-acting dopamine agonists
NEW12375,CHEMICAL,cabergoline co-treatment,Cabergoline co-treatment
NEW12376,DISEASE,intense vomiting,intense vomiting
NEW12377,CHEMICAL,mg/kg nab,mg/kg NaB
http://purl.obolibrary.org/obo/CHEBI_50836,CHEMICAL,zinc oxide nanoparticle,Zinc oxide nanoparticles|ZnO-NPs
NEW12378,DISEASE,human gingival squamous cell carcinoma,human gingival squamous cell carcinoma
NEW12379,MENTAL_HEALTH,depression-related anxiety,depression-related anxiety
C109513,CHEMICAL,OSU 6162 [Supplementary Concept],Piperidines|OSU-6162
D040921,DISEASE,"Stress Disorders, Traumatic","Traumatic Stress Disorders|Traumatic Stress Disorder|Stress Disorder, Traumatic|stress disorders"
NEW12380,NUTRITION,blue honeysuckle,blue honeysuckle
NEW12381,MENTAL_HEALTH,particular bipolar depression,particular bipolar depression
NEW12382,DISEASE,fop mouse model,FOP mouse models
C516138,CHEMICAL,dorsomorphin [Supplementary Concept],Pyrazoles|Pyrimidines|dorsomorphin
NEW12383,CHEMICAL,"pyrazolo[1,5-a]pyrimidine scaffold","pyrazolo[1,5-a]pyrimidine scaffold"
NEW12384,CHEMICAL,l741626,L741626
NEW12385,DISEASE,wearing-off responder,wearing-off responders
NEW12386,CHEMICAL,acute levodopa challenge,acute levodopa challenge
NEW12387,MENTAL_HEALTH,glutamate hyperactivity,glutamate hyperactivity
NEW12388,DISEASE,hfpef patient,HFpEF patients
http://purl.obolibrary.org/obo/CHEBI_51060,CHEBI,hormone agonist,hormone agonists
NEW12389,DISEASE,flaccid state,flaccid state
D019332,CHEMICAL,Endothelin-1,"Precursor, Proendothelin-1|Endothelin-1, Big|Proendothelin 1 Precursor|Big Endothelin 1|Endothelin 1|Proendothelin (1-38)|Big Endothelin-1|Proendothelin-1 Precursor|Endothelin, Big|Preproendothelin|Endothelin Type 1|Big Endothelin|endothelin-1|Preproendothelin-1|Preproendothelin 1"
D014663,CHEMICAL,Nasal Decongestants,"decongestants|Agents, Nasal Vasoconstrictor|Decongestant, Nasal|Decongestants|Nasal Vasoconstrictor Agents|vasoconstrictors|Nasal Decongestant|Decongestant|Vasoconstrictor Agents, Nasal|Vasoconstrictors, Nasal|Nasal Vasoconstrictors|Decongestants, Nasal"
NEW12390,NUTRITION,alpha adrenergic neuroeffector,alpha adrenergic neuroeffector
NEW12391,CHEMICAL,relaxant yohimbine activity,relaxant yohimbine activity
NEW12392,CHEBI,androgen supplementation,androgen supplementation
NEW12393,DISEASE,pheochromocytoma cell,pheochromocytoma cells
NEW12394,CHEMICAL,beta-peptide-induced apoptosis,beta-peptide-induced apoptosis
C018919,CHEMICAL,"3,3'-diethyloxadicarbocyanine [Supplementary Concept]","Carbocyanines|3,3'-diethyloxadicarbocyanine"
NEW12395,CHEMICAL,oligodeoxynucleotide ttaggg,oligodeoxynucleotide TTAGGG
NEW12396,CHEMICAL,long term lom therapy,long term LOM therapy
NEW12397,DISEASE,primary generalize tonic-clonic seizure,primary generalized tonic-clonic seizures
http://purl.obolibrary.org/obo/SYMP_0000268,DISEASE,tonic-clonic seizure,grand mal seizure|partial-onset seizures|tonic-clonic pentylenetetrazol-induced seizures
NEW12398,NUTRITION,charr Salvelinus fontinalis,charr Salvelinus fontinalis
NEW12399,CHEMICAL,severe hypovitaminosis d3,severe hypovitaminosis D3
NEW12400,MENTAL_HEALTH,long-term eat disorder,long-term eating disorders
D052439,DISEASE,Lipid Metabolism Disorders,"Metabolism Disorders, Lipid|Metabolism Disorder, Lipid|Lipid Metabolism Disorder|lipid metabolism disorder"
D020939,CHEMICAL,Ginger,"Zingiber officinales|Zingiber officinale|Gingers|ginger|officinales, Zingiber"
D055552,DISEASE,Infectious Disease Medicine,"Disease Medicine, Infectious|Specialty, Infectious Diseases|Infectious Disease Specialties|Infectious Diseases Specialty|Specialties, Infectious Disease|Specialty, Infectious Disease|Medicine, Infectious Disease|infectious|Infectious Disease Specialty|Diseases Specialty, Infectious|Specialties, Infectious Diseases|Infectious Diseases Specialties"
NEW12401,CHEBI,allied nutraceutical constituent,allied nutraceutical constituents
D036381,CHEMICAL,Diarylheptanoids,"Diaryl Heptanoids|Linear Diarylheptanoids|Diarylheptanoids, Cyclic|Diarylheptanoid Derivatives|Cyclic Diarylheptanoids|Diarylheptanoid, Cyclic|Diarylheptanones|Diarylheptanoid|Heptanoids, Diaryl|Diarylheptanoids, Linear|curcuminoids|Acyclic Diarylheptanoids|Curcuminoids|Diarylheptanoids, Acyclic|Curcuminoid|Cyclic Diarylheptanoid|Derivative, Diarylheptanoid|Diarylheptanoid Derivative"
NEW12402,CHEBI,systemic drug therapy,Systemic drug therapies
NEW12403,MENTAL_HEALTH,other syndrome,Other syndromes
NEW12404,DISEASE,m74,M74
NEW12405,DISEASE,rbd patient,RBD patients
NEW12406,CHEMICAL,patients-there,patients-there
NEW12407,DISEASE,resistant arterial hypertension,HTN|resistant arterial hypertension
NEW12408,DISEASE,severe osa,severe OSA
NEW12409,DISEASE,s. terebinthifolius,S. terebinthifolius
NEW12410,NUTRITION,insect C. maculatus,insect C. maculatus
C049449,CHEMICAL,mepiquat [Supplementary Concept],Piperidines|Mepiquat chloride
NEW12411,NUTRITION,anthocyanidin cyanidin,anthocyanidins cyanidin
http://purl.obolibrary.org/obo/CHEBI_71507,NUTRITION,anthocyanidin 5-o-beta-d-glucoside 3-o-beta-d-sambubioside,anthocyanidin 5-O-beta-D-glucoside 3-O-[beta-D-xylosyl-(1->2)-beta-D-glucoside]s|anthocyanidin 5-O-beta-D-glucoside 3-O-beta-D-sambubiosides|anthocyanidin 5-O-beta-D-glucoside 3-O-[beta-D-xylosyl-(1->2)-beta-D-glucoside]|bilberry-derived anthocyanidins
NEW12412,CHEMICAL,tnbc paclitaxel (pac)-resistant tnbc cell,TNBC paclitaxel (PAC)-resistant TNBC cells
NEW12413,DISEASE,significant depressive symptom,significant depressive symptoms
NEW12414,MENTAL_HEALTH,depression independent,depression independent
NEW12415,NUTRITION,alpha diversity,Alpha diversity
NEW12416,DISEASE,age-related olfactory deficit,age-related olfactory deficits
NEW12417,CHEMICAL,peripheral sstr,peripheral SSTRs
NEW12418,MENTAL_HEALTH,chaotic orientation,chaotic orientation
NEW12419,DISEASE,monoamine neurotransmitter disorder,monoamine neurotransmitter disorders
NEW12420,CHEBI,dopamine agonist therapy intrinsic,dopamine agonist therapy intrinsic
NEW12421,CHEMICAL,ischaemic heart disease,ischaemic heart disease|IHD
NEW12422,DISEASE,contractile dysfunction,Contractile dysfunction
NEW12423,CHEMICAL,classic ischaemic preconditioning,classic ischaemic preconditioning|IPC
NEW12424,DISEASE,obesity-induced endothelial dysfunction,Obesity-induced endothelial dysfunction
NEW12425,CHEMICAL,decrease nitric oxide no production,decreased nitric oxide NO production
NEW12426,CHEMICAL,impaired endothelial no synthase activity,impaired endothelial NO synthase activity
NEW12427,CHEMICAL,renal cysteine conjugate beta-lyase,renal cysteine conjugate beta-lyase
NEW12428,CHEMICAL,pyridoxal phosphate (plp)-dependent enzyme,pyridoxal phosphate (PLP)-dependent enzyme
NEW12429,CHEMICAL,"model conjugate s-(1,2-dichlorovinyl)-l-cysteine","model conjugate S-(1,2-dichlorovinyl)-L-cysteine"
D000625,CHEMICAL,Aminooxyacetic Acid,"Acid, Aminooxyacetic|Aminooxyacetate|aminooxyacetic acid|Carboxymethoxyamine"
NEW12430,CHEMICAL,"model conjugate s-(1,2-dichlorovinyl)-l-cysteine","model conjugate S-(1,2-dichlorovinyl)-L-cysteine|DCVC"
NEW12431,CHEMICAL,"s-(1,2-dichlorovinyl)-l-homocysteine","S-(1,2-dichlorovinyl)-L-homocysteine"
NEW12432,CHEMICAL,"s-(1,2-dichlorovinyl)-l-homocysteine","DCVHC|S-(1,2-dichlorovinyl)-L-homocysteine"
NEW12433,CHEMICAL,"s-(1,2-dichlorovinyl)-dl-alpha-methylhomocysteine toxic","S-(1,2-dichlorovinyl)-DL-alpha-methylhomocysteine toxic"
NEW12434,CHEMICAL,alpha-methyl analogue,alpha-methyl analogue
NEW12435,CHEBI,potent nephrotoxin similar,potent nephrotoxin similar
NEW12436,MENTAL_HEALTH,suicide substrate,suicide substrate
C009055,CHEMICAL,propargylglycine [Supplementary Concept],Alkynes|propargylglycine|Glycine/analogs  and  derivatives
NEW12437,CHEMICAL,cb2r,CB2r
NEW12438,CHEMICAL,gen male,GEN males
http://purl.obolibrary.org/obo/NCBITaxon_136,DISEASE,spirochaetales,Flexispira spp
NEW12439,NUTRITION,oral choline supplementation,oral choline supplementation
http://purl.obolibrary.org/obo/DOID_8689,DISEASE,anorexia nervosa,diseases anorexia nervosa|restrictive-type anorexia nervosa|AN-R|anorexia nervosa patients|anorexia nervosa symptoms
NEW12440,CHEMICAL,purging behavior,purging behaviors|BPB
D013900,DISEASE,Thoracic Nerves,"Pectoral Nerves|Nerve, Pectoral|Pectoral Nerve|Thoracic Nerve|nerves|Nerves, Pectoral|Nerve, Thoracic|Nerves, Thoracic"
NEW12441,DISEASE,endothelial damage,endothelial damage
NEW12442,CHEMICAL,zykr1,ZYKR1
NEW12443,CHEMICAL,ed50     mg/kg,ED50    mg/kg
NEW12444,CHEBI,potent analgesic efficacy,potent analgesic efficacy
NEW12445,DISEASE,pain mouse,pain mouse
NEW12446,DISEASE,superimpose hyponatraemic dehydration,superimposed hyponatraemic dehydration
NEW12447,DISEASE,intramyelinic edema,intramyelinic edema
C546258,CHEMICAL,"Gabra3 protein, mouse [Supplementary Concept]","gamma-aminobutyric acid A receptor|Receptors, GABA-A|GABAAR|gamma-aminobutyric acid-A receptor"
NEW12448,DISEASE,peripheral age-related hearing loss,peripheral age-related hearing loss
NEW12449,CHEBI,effective mood stabilizer,effective mood stabilizer
D005157,DISEASE,Facial Pain,"Neuralgic Facial Pain|Facial Pain, Neuralgic|Pain, Facial|Pain, Face|Face Pain|Myofacial Pain|Craniofacial Pain|orofacial pain|Pain, Craniofacial|Orofacial Pain|Pain, Neuralgic Facial|Pain, Myofacial|Pain, Orofacial"
NEW12450,CHEMICAL,arsenic exposure,Arsenic exposure
NEW12451,CHEMICAL,arsenic exposure,arsenic exposure
NEW12452,CHEBI,opioid agonist treatment patient,opioid agonist treatment patients
NEW12453,DISEASE,ten-week-old male diabetic gk rat,Ten-week-old male diabetic GK rats
NEW12454,CHEMICAL,sham-it,Sham-IT
NEW12455,DISEASE,neurodegenerative disease model,neurodegenerative disease models
NEW12456,MENTAL_HEALTH,dementia disease,dementia diseases
NEW12457,CHEMICAL,various standard antidepressant drug,various standard antidepressant drugs
D003807,DISEASE,Dentin Sensitivity,"Sensitivity, Dentine|Dentin Hypersensitivities|Sensitivities, Dentine|Dentin Hypersensitivity|Dentine Hypersensitivity|Hypersensitivity, Dentine|dentine|Sensitivity, Dentin|Hypersensitivity, Dentin|Tooth Sensitivities|Sensitivities, Tooth|Tooth Sensitivity|Dentine Hypersensitivities|Hypersensitivities, Dentin|Dentine Sensitivities|Sensitivity, Tooth|Hypersensitivities, Dentine|Sensitivities, Dentin|Dentine Sensitivity|Dentin Sensitivities"
NEW12458,CHEMICAL,dentine to ca(oh)2,pH12.6|dentine to Ca(OH)2
NEW12459,MENTAL_HEALTH,fatigue failure,fatigue failure
C013572,CHEMICAL,"acetic acid, calcium hydroxide (Ca(OH)2), calcium salt (2:1), mercapto-, strontium hydroxide (Sr(OH)2) drug combination [Supplementary Concept]",Ca(OH)2|Calcium Hydroxide|Drug Combinations|Strontium|Thioglycolates
NEW12460,NUTRITION,yellow corn meal-based diet,yellow corn meal-based diet
NEW12461,DISEASE,eimeria acervulina oocyst,Eimeria acervulina oocysts
http://purl.obolibrary.org/obo/DOID_14323,DISEASE,marfan syndrome,Marfan's syndrome|pale-bird syndrome
NEW12462,CHEBI,absorb carotenoid,absorbed carotenoids
NEW12463,NUTRITION,brain choline acetyltransferase activity,Brain choline acetyltransferase activity
NEW12464,MENTAL_HEALTH,combined dementia,combined dementia
NEW12465,MENTAL_HEALTH,dementia due,dementia due
NEW12466,DISEASE,late-onset mthfr deficiency,late-onset MTHFR deficiency
NEW12467,CHEBI,secondary cerebral folate deficiency,secondary cerebral folate deficiency
NEW12468,CHEBI,synaptic antigen,synaptic antigens
NEW12469,CHEBI,intracellular neuronal antigen,intracellular neuronal antigens
NEW12470,DISEASE,classic paraneoplastic limbic encephalitis,classic paraneoplastic limbic encephalitis
NEW12471,MENTAL_HEALTH,neck resistance,neck resistance
NEW12472,CHEMICAL,≤ old group,≤ old group
http://purl.obolibrary.org/obo/CHEBI_33232,CHEMICAL,application,Kocide applications
NEW12473,DISEASE,different mineral fertilization level,different mineral fertilization levels
NEW12474,MENTAL_HEALTH,neuroleptic-induced dyskinesia,neuroleptic-induced dyskinesia
NEW12475,CHEMICAL,excessive alcohol consumption,Excessive alcohol consumption
NEW12476,DISEASE,schizophrenia-spectrum memory impairment,schizophrenia-spectrum memory impairments
NEW12477,NUTRITION,host fatty acid,host fatty acids
NEW12478,CHEBI,fasii antibiotic adaptation,FASII antibiotic adaptation
NEW12479,NUTRITION,fatty acid biosynthesis fasii enzyme,Fatty acid biosynthesis FASII enzymes
NEW12480,DISEASE,human pathogen staphylococcus aureus,human pathogen Staphylococcus aureus
NEW12481,CHEBI,antimicrobial drug development,antimicrobial drug development
NEW12482,CHEBI,selective serotonin reuptake inhibitor ssri fluoxetine,selective serotonin reuptake inhibitor SSRI fluoxetine
NEW12483,MENTAL_HEALTH,juvenile depression,juvenile depression
D065008,DISEASE,Scorpion Stings,"Sting, Scorpion|Scorpionisms|Scorpion Envenomings|Scorpion Envenomations|Scorpion stings|Scorpion Sting|Scorpionism|envenoming|Scorpion Envenoming|Envenoming, Scorpion|Scorpion Envenomation|Stings, Scorpion|Envenomation, Scorpion|Envenomings, Scorpion"
C541254,DISEASE,"hellerase, Crotalus oreganus helleri [Supplementary Concept]",Metalloproteases|Crotalus oreganus helleri|Crotalid Venoms
NEW12484,CHEBI,various adrenergic agent,various adrenergic agents
NEW12485,CHEMICAL,[3h]bunazosin binding,[3H]bunazosin binding
NEW12486,MENTAL_HEALTH,human depression ability,human depression ability
C413685,CHEMICAL,entecavir [Supplementary Concept],Entecavir|Guanine/analogs  and  derivatives
NEW12487,CHEBI,use anti-hepatitis virus hbv drug,used anti-hepatitis virus HBV drug
NEW12488,CHEMICAL,f115 bulge f88,F115 bulge F88
C100722,CHEMICAL,4-(N-(4-azidobenzoyl)-2-aminoethyl)-deoxycytidine triphosphate [Supplementary Concept],dCTP|Deoxycytosine Nucleotides
NEW12489,CHEBI,preoperative endocrine stress test,preoperative endocrine stress tests
NEW12490,CHEBI,receptor ppar family,receptor PPAR family
NEW12491,DISEASE,osteoporosis disorder,osteoporosis disorder
NEW12492,MENTAL_HEALTH,first-episode depression,first-episode depression
NEW12493,CHEMICAL,glucose delivery,glucose delivery
C528449,CHEMICAL,carglumic acid [Supplementary Concept],Glutamates|carglumic acid
NEW12494,CHEMICAL,ammonia scavenger treatment,ammonia scavenger treatment
NEW12495,CHEMICAL,anaplerosis,Anaplerosis
NEW12496,DISEASE,chronic hyperammonemia,chronic hyperammonemia
NEW12497,DISEASE,severe cardiac dysfunction,severe cardiac dysfunction
NEW12498,NUTRITION,typical phospholipid lamella structure,Typical phospholipid lamella structures
D010713,CHEMICAL,Phosphatidylcholines,"phosphatidylcholines|Phosphatidylcholine|Choline Phosphoglycerides|Choline Glycerophospholipids|Glycerophospholipids, Choline|Phosphoglycerides, Choline|Choline, Phosphatidyl|Phosphatidyl Choline|Cholines, Phosphatidyl|Phosphatidyl Cholines"
NEW12499,DISEASE,devastating pandemic,devastating pandemic
NEW12500,DISEASE,wheat embryo albumin,wheat embryo albumin|WEA
D024322,CHEMICAL,"Amino Acids, Aromatic","Aromatic Amino Acids|aromatic amino acids|Amino Acid, Aromatic|Aromatic Amino Acid"
http://purl.obolibrary.org/obo/CHEBI_25588,CHEMICAL,nonpolar amino acid,hydrophobic amino acids
NEW12501,MENTAL_HEALTH,lentiviral vector-based suicide gene therapy,lentiviral vector-based suicide gene therapy
NEW12502,CHEBI,toxin gene,toxin genes
NEW12503,CHEBI,natural drug extract,natural drug extracts
NEW12504,CHEMICAL,scopolamine-induced spatial memory impairment,scopolamine-induced spatial memory impairment
NEW12505,CHEMICAL,gb energy,GB energy
NEW12506,CHEMICAL,heterogeneous gb inclination,heterogeneous GB inclination
NEW12507,MENTAL_HEALTH,disorientation misorientation,disorientation misorientation
NEW12508,MENTAL_HEALTH,airway hyperactivity,airway hyperactivity
D013750,CHEMICAL,Tetrachloroethylene,Tetrachlorethylene|Perchloroethylene|Perchlorethylene|PERC|perchloroethylene|Tetrachloroethene
D009119,DISEASE,Muscle Contraction,"Contraction, Muscle|Inotropisms|Inotropism|muscle contraction|muscle contractions|Muscular Contractions|Contractions, Muscle|Muscle Contractions|Contraction, Muscular|Muscular Contraction|Contractions, Muscular"
NEW12509,CHEMICAL,Comorbidty,Comorbidty
NEW12510,CHEMICAL,ay001,AY001
C586769,CHEMICAL,"IAA29 protein, Arabidopsis [Supplementary Concept]",indole-3-acetic acid|Arabidopsis Proteins|Transcription Factors|IAA
NEW12511,CHEMICAL,phosphate solubilization,phosphate solubilization
NEW12512,CHEBI,know renal toxin,known renal toxins
NEW12513,DISEASE,excess death,excess deaths
D012997,CHEMICAL,Solvents,solvents|Solvent
C517734,CHEMICAL,roflumilast N-oxide [Supplementary Concept],Aminopyridines|roflumilast|Cyclopropanes|Benzamides|Roflumilast
http://purl.obolibrary.org/obo/CHEBI_35472,CHEBI,anti-inflammatory drug,antiinflammatory agent|anti-inflammatory drugs|antiinflammatory drugs|antiinflammatory drug
NEW12514,DISEASE,exacerbation lung function,exacerbations lung function
NEW12515,DISEASE,copd history,COPD history
NEW12516,MENTAL_HEALTH,undifferentiated agitated delirium,undifferentiated agitated delirium
D028361,DISEASE,Mitochondrial Diseases,"|Oxidative Phosphorylation Deficiencies|Deficiencies, Oxidative Phosphorylation|Disorder, Mitochondrial|Deficiency, Oxidative Phosphorylation|mitochondrial dysfunction|Electron Transport Chain Deficiencies, Mitochondrial|Mitochondrial Respiratory Chain Deficiencies|mitochondrial disorders|Mitochondrial Disorders|Mitochondrial Electron Transport Chain Deficiencies|Mitochondrial Disease|Phosphorylation Deficiency, Oxidative|Deficiency, Respiratory Chain|Disease, Mitochondrial|Disorders, Mitochondrial|Oxidative Phosphorylation Deficiency|Respiratory Chain Deficiency|Mitochondrial Disorder|Respiratory Chain Deficiencies, Mitochondrial|Phosphorylation Deficiencies, Oxidative|Deficiencies, Respiratory Chain"
NEW12517,DISEASE,prove mitochondrial disease,proven mitochondrial disease
NEW12518,CHEMICAL,most gas,most GAs
NEW12519,MENTAL_HEALTH,st segment depression,ST segment depression
D000138,DISEASE,Acidosis,"|Metabolic Acidosis|Acidosis, Metabolic|Acidoses|Acidoses, Metabolic|Metabolic Acidoses|metabolic acidosis"
NEW12520,MENTAL_HEALTH,numerous human syndrome,numerous human syndromes
C042496,CHEBI,ARK 62-62 [Supplementary Concept],L-ascorbic acid|Organoplatinum Compounds
D015470,DISEASE,"Leukemia, Myeloid, Acute","|Nonlymphocytic Leukemias, Acute|Acute Myelocytic Leukemia|Leukemias, Acute Myelogenous|Leukemia, Acute Myelogenous|Acute Nonlymphoblastic Leukemia|acute myeloid leukemia|Acute Myeloid Leukemias|Myeloid Leukemia, Acute, M1|Leukemia, Acute Myeloid|Leukemia, Myeloblastic, Acute|Nonlymphocytic Leukemia, Acute|Myelocytic Leukemias, Acute|Acute Nonlymphocytic Leukemia|Myeloid Leukemia, Acute, M2|Acute Myeloblastic Leukemia|Acute Myeloid Leukemia with Maturation|Leukemias, Acute Myeloid|Leukemia, Myeloid, Acute, M1|Myeloid Leukemia, Acute|Acute Myelogenous Leukemia|Leukemia, Myeloid, Acute, M2|Acute Myelocytic Leukemias|Myelocytic Leukemia, Acute|acute leukemia|Myeloblastic Leukemias, Acute|Myeloid Leukemias, Acute|Leukemia, Acute Myelocytic|Nonlymphoblastic Leukemia, Acute|Leukemias, Acute Nonlymphocytic|Nonlymphoblastic Leukemias, Acute|Myelogenous Leukemias, Acute|Myeloblastic Leukemia, Acute|Leukemias, Acute Nonlymphoblastic|Leukemias, Acute Myelocytic|Leukemia, Myelogenous, Acute|Leukemia, Nonlymphoblastic, Acute|Myelogenous Leukemia, Acute|Leukemia, Acute Myeloblastic|Acute Nonlymphocytic Leukemias|Leukemias, Acute Myeloblastic|Acute Myelogenous Leukemias|Acute Myeloid Leukemia|Leukemia, Myelocytic, Acute|Leukemia, Acute Nonlymphoblastic|Acute Myeloid Leukemia without Maturation|Acute Myeloblastic Leukemias|Leukemia, Nonlymphocytic, Acute|Leukemia, Acute Nonlymphocytic|ANLL|Acute Nonlymphoblastic Leukemias"
D009190,MENTAL_HEALTH,Myelodysplastic Syndromes,"Hematopoetic Myelodysplasias|Syndrome, Dysmyelopoietic||Dysmyelopoietic Syndrome|Syndrome, Myelodysplastic|Dysmyelopoietic Syndromes|myelodysplastic syndromes|Syndromes, Dysmyelopoietic|myelodysplastic syndrome|Myelodysplastic Syndrome|Myelodysplasias, Hematopoetic|Hematopoetic Myelodysplasia|Myelodysplastic syndrome|Myelodysplasia, Hematopoetic|Syndromes, Myelodysplastic"
NEW12521,MENTAL_HEALTH,synaptic fatigue,synaptic fatigue
NEW12522,CHEMICAL,young crayfish.(abstract,young crayfish.(ABSTRACT
NEW12523,DISEASE,hydropic vacuolation,hydropic vacuolation|HYDVAC
NEW12524,CHEMICAL,cellular alteration,FCA|cellular alteration
NEW12525,NUTRITION,white croaker,white croaker
NEW12526,NUTRITION,wheat gluten,wheat glutens
NEW12527,DISEASE,gastrointestinal gi tract,gastrointestinal GI tract
D006860,CHEMICAL,Hydrogen Bonding,"Bond, Hydrogen|Hydrogen Bonds|hydrogen bond|Hydrogen Bond|hydrogen bonds"
D012604,CHEMICAL,Scorpion Venoms,"alpha-Scorpion Toxin|alpha Scorpion Toxin|Tityus serrulatus Venom|beta-Scorpion Toxin|Scorpion Venom|Scorpion Toxin|gamma-Scorpion Toxin|Scorpion Toxins|venom peptide|Peptide, Scorpion Venom|beta Scorpion Toxin|gamma Scorpion Toxin|Toxin, Scorpion|Venom Peptide, Scorpion|Venom, Tityus serrulatus|Venom, Scorpion|scorpion venom|PESV|Toxin, alpha-Scorpion|Scorpion Venom Peptide|Toxin, beta-Scorpion"
NEW12528,DISEASE,nsclc process,NSCLC process
NEW12529,CHEMICAL,polypeptide extract,Polypeptide extract
NEW12530,DISEASE,nsclc progression,NSCLC progression
NEW12531,CHEBI,venom arsenal,venom arsenal
NEW12532,CHEMICAL,pelamitoxin a-encoding mrna,pelamitoxin a-encoding mRNAs
NEW12533,CHEMICAL,trocarin d,Trocarin D|TroD
NEW12534,DISEASE,blood coagulation factor xa,blood coagulation factor Xa
NEW12535,CHEBI,venom prothrombin activator,venom prothrombin activator
NEW12536,DISEASE,tropidechis carinatu,Tropidechis carinatus
NEW12537,CHEBI,low maternal vitamin d level,low maternal vitamin D levels
NEW12538,CHEMICAL,Dimu Ningshen,Dimu Ningshen
NEW12539,DISEASE,stiff-person spectrum disorder,stiff-person spectrum disorder
C566113,DISEASE,Progressive Encephalomyelitis with Rigidity [Supplementary Concept],Progressive encephalomyelitis|Muscle Rigidity|Encephalomyelitis
NEW12540,DISEASE,leishmania major ptr1,Leishmania major PTR1
NEW12541,CHEMICAL,biopterin derivative,biopterin derivatives
NEW12542,MENTAL_HEALTH,crave drug-seeking,craving drug-seeking
NEW12543,CHEBI,drug experience,drug experience
NEW12544,DISEASE,neuronal alteration,neuronal alterations
D019446,DISEASE,Endotoxemia,Endotoxemias|endotoxemia
NEW12545,CHEBI,traditional antihistamine chlorpheniramine,traditional antihistamine chlorpheniramine
NEW12546,CHEMICAL,hamlet human alpha-lactalbumin,HAMLET human alpha-lactalbumin
D050556,NUTRITION,Fatty Acid-Binding Proteins,"Myocardial Fatty Acid Binding Protein|Intestinal Fatty Acid-Binding Protein|Cytosolic Lipid Binding Proteins|Liver Fatty Acid Binding Protein|Brain-Type Fatty Acid-Binding Protein|Plasma Membrane Fatty Acid-Binding Protein|Intestinal Fatty Acid Binding Protein|Fatty Acid-Binding Proteins, Intestinal-Specific|Fatty Acid Binding Protein, Myocardial|Adipocyte-Specific Fatty Acid-Binding Protein|Adipocyte Specific Fatty Acid Binding Protein|Fatty Acid Binding Proteins, Myocardial Specific|Fatty Acid-Binding Proteins, Cytosolic-Specific|Lipid-Binding Proteins, Cytosolic|Plasma Membrane Fatty Acid Binding Protein|Fatty Acid Binding Protein|Liver Fatty Acid-Binding Protein|Fatty Acid-Binding Proteins, Brain-Specific|Brain Type Fatty Acid Binding Protein|Fatty Acid-Binding Proteins, Adipocyte-Specific|Adipocyte Lipid Binding Protein|Fatty Acid-Binding Proteins, Plasma-Membrane Specific|Myocardial Fatty Acid-Binding Protein|specific fatty acid|Acid-Binding Protein, Fatty|Fatty Acid Binding Proteins|Fatty Acid Binding Proteins, Liver Specific|Fatty Acid Binding Proteins, Intestinal Specific|Fatty Acid-Binding Protein, Myocardial|Fatty Acid Binding Protein, Cardiac Myocyte|Cytosolic Lipid-Binding Proteins|Fatty Acid-Binding Protein|Fatty Acid Binding Proteins, Plasma Membrane Specific|Fatty Acid Binding Proteins, Brain Specific|Protein, Fatty Acid-Binding|Fatty Acid-Binding Protein, Cardiac Myocyte|Fatty Acid Binding Proteins, Cytosolic Specific|Fatty Acid-Binding Proteins, Myocardial-Specific|Fatty Acid-Binding Proteins, Liver-Specific|Fatty Acid Binding Proteins, Adipocyte Specific"
NEW12547,CHEMICAL,agent ticagrelor,agent ticagrelor
NEW12548,MENTAL_HEALTH,central sleep apnea hypopnea syndrome,central sleep apnea hypopnea syndrome
NEW12549,DISEASE,heart failure patient,heart failure patient
D002639,DISEASE,Cheyne-Stokes Respiration,"Cheyne-Stokes respiration|Cheyne Stokes Respiration|Respiration, Cheyne-Stokes"
NEW12550,CHEMICAL,blood gas value,blood gas values
NEW12551,DISEASE,(neuro)muscular level,(neuro)muscular level
NEW12552,DISEASE,hypercapnic copd patient,hypercapnic COPD patients
NEW12553,CHEMICAL,clenbuterol overdosing,clenbuterol overdosing
D050615,NUTRITION,"Sodium-Phosphate Cotransporter Proteins, Type IIc","Type IIc Sodium-Phosphate Symporter Proteins|sodium phosphate|Type IIc Sodium-Phosphate Cotransporter Proteins|Type IIc Sodium Phosphate Symporter Proteins|Transporter Proteins, NPTIIc|Sodium-Phosphate Symporter Proteins, Type IIc|Sodium Phosphate Cotransporter Proteins, Type IIc|Type IIc Sodium Phosphate Cotransporter Proteins|NPTIIc Transporter Proteins|Sodium Phosphate Symporter Proteins, Type IIc"
NEW12554,CHEMICAL,intravenous calcium,intravenous calcium
D010319,DISEASE,Parturient Paresis,"Parturient Pareses|Animal Milk Fever|Paresis, Parturient|Milk Fever, Animal|parturient paresis|Pareses, Parturient|Fever, Animal Milk"
D008776,CHEMICAL,Methylprednisolone Hemisuccinate,"Solu-Medrol|Methylprednisolone Sodium Succinate|methylprednisolone|Methylprednisolone Sodium Hemisuccinate|UrbasonSoluble|Methylprednisolone Hemisuccinate Monosodium Salt|Methylprednisolone Succinate|A-MethaPred|6 alpha-Methylprednisolone Sodium Hemisuccinate|Solumedrol|Urbason-Soluble|Hemisuccinate, Methylprednisolone|Sodium Hemisuccinate, Methylprednisolone|Sodium Succinate, Methylprednisolone|Succinate, Methylprednisolone"
NEW12555,DISEASE,similar cardiovascular dysfunction,Similar cardiovascular dysfunctions
NEW12556,CHEBI,paf antagonist,PAF antagonists
NEW12557,MENTAL_HEALTH,myocardial depression,myocardial depression
D000542,DISEASE,"Alveolitis, Extrinsic Allergic","Extrinsic Allergic Alveolitis|Extrinsic Allergic Alveolitides|Allergic Alveolitides, Extrinsic|allergic alveolitis|Pneumonitis, Hypersensitivity|Pneumonitides, Hypersensitivity|Alveolitides, Extrinsic Allergic|Hypersensitivity Pneumonitides|Allergic Alveolitis, Extrinsic|Hypersensitivity Pneumonitis"
C543531,CHEMICAL,arbaclofen placarbil [Supplementary Concept],Baclofen/analogs  and  derivatives|Arbaclofen
NEW12558,CHEMICAL,gaba agonist muscimol,GABA agonist muscimol
NEW12559,CHEMICAL,antagonist bicucculline,antagonist bicucculline
NEW12560,MENTAL_HEALTH,violent hyperactivity,violent hyperactivity
NEW12561,DISEASE,abnormal limb movement,Abnormal limb movements|contralateral ballism
NEW12562,CHEMICAL,muscimol injection,muscimol injections
NEW12563,CHEMICAL,"n(1),n(5)-(z)-n(10)-(e)-tri-p-coumaroylspermidine","N(1),N(5)-(Z)-N(10)-(E)-tri-p-coumaroylspermidine"
NEW12564,CHEMICAL,novel serotonin transporter inhibitor,novel serotonin transporter inhibitor
NEW12565,DISEASE,neuropsychological disorder,neuropsychological disorders
D050644,CHEMICAL,Succinate-Semialdehyde Dehydrogenase,"Dehydrogenase, Succinate Semialdehyde|NAD(+)-Dependent Succinic Semialdehyde Dehydrogenase|Succinic Semialdehyde Dehydrogenase|Succinate Semialdehyde Dehydrogenase|Semialdehyde Dehydrogenase, Succinic|Dehydrogenase, Succinate-Semialdehyde|Dehydrogenase, Succinic Semialdehyde|Semialdehyde Dehydrogenase, Succinate|succinate"
NEW12566,CHEBI,backbone endocrine therapy,backbone endocrine therapy
NEW12567,CHEBI,advanced hormone receptor-positive,advanced hormone receptor-positive
NEW12568,CHEBI,endocrine therapy,endocrine therapy
NEW12569,CHEBI,endocrine side effect,Endocrine side effect
NEW12570,DISEASE,myocardial fibrosis,myocardial fibrosis
NEW12571,CHEMICAL,non potassium-sparing diuretic,Non potassium-sparing diuretics
NEW12572,DISEASE,allergy score,allergy scores
NEW12573,CHEMICAL,paliperidone er,paliperidone ER
NEW12574,MENTAL_HEALTH,associate synaptic depression,associated synaptic depression
NEW12575,CHEMICAL,ii/iii antagonist (rs)-alpha-cyclopropyl-4-phosphonophenylglycine,II/III antagonist (RS)-alpha-cyclopropyl-4-phosphonophenylglycine|CPPG
NEW12576,CHEMICAL,[14c]leucine,[14C]leucine
NEW12577,CHEMICAL,[14c]iodoantipyrine,[14C]iodoantipyrine
NEW12578,CHEMICAL,[3h]naloxone binding,[3H]naloxone binding
NEW12579,CHEMICAL,v-ki-ras protein p21,v-Ki-ras protein p21
NEW12580,MENTAL_HEALTH,agonist displacement,agonist displacement
http://purl.obolibrary.org/obo/CHEBI_43000,CHEMICAL,guanosine 5'-[gamma-thio]triphosphate,gamma-Thio-GTP|guanosine 5'-[gamma-thio]triphosphate|5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE|GTP-gamma-S|GTP gamma S|Guanosine 5'-O-(3-thiotriphosphate)|guanosine 5'-(tetrahydrogen 5-thiotriphosphate)|Guanosine 5'-(gamma-S)triphosphate
C535800,MENTAL_HEALTH,"Amyloidosis, Cerebral, with Spongiform Encephalopathy [Supplementary Concept]",Progressive dementia|Prion Diseases|Dementia
NEW12581,CHEBI,female x-ald carrier,female X-ALD carriers
D002336,CHEMICAL,Carnosine,"Carnosine|Carnosine Hydrochloride|Carnosine, (D-His)-Isomer|L-Carnosine|L Carnosine|carnosine|beta-Alanylhistidine|Hydrochloride, Carnosine|beta Alanylhistidine"
NEW12582,CHEMICAL,serotonin receptor gene polymorphism,Serotonin receptor gene polymorphism
NEW12583,DISEASE,diabetes patient,diabetes patients
NEW12584,CHEMICAL,bromocriptine-qr,bromocriptine-QR
NEW12585,CHEBI,sympatholytic dopamine agonist,sympatholytic dopamine agonist
NEW12586,CHEMICAL,ZT bromocriptine treatment,ZT bromocriptine treatment
NEW12587,CHEMICAL,circadian-timed bromocriptine treatment,circadian-timed bromocriptine treatment
NEW12588,CHEMICAL,circadian-timed bromocriptine-qr therapy,circadian-timed bromocriptine-QR therapy
D011236,DISEASE,Prediabetic State,"Prediabetic States|Prediabetes|States, Prediabetic|State, Prediabetic|prediabetes"
NEW12589,DISEASE,type diabete subject,type diabetes subjects
NEW12590,CHEMICAL,first-in-class angiotensin receptor neprilysin inhibitor,first-in-class angiotensin receptor neprilysin inhibitor
NEW12591,CHEMICAL,glucose uptake,Glucose uptake
NEW12592,CHEMICAL,3h-serotonin uptake,3H-serotonin uptake
NEW12593,CHEMICAL,l-carnitine ketogenic diet,L-carnitine ketogenic diet
NEW12594,CHEBI,widespread fungicide use,widespread fungicide use
NEW12595,CHEMICAL,noncompetitive n-methyl-d-aspartate receptor nmdar antagonist,noncompetitive N-methyl-D-aspartate receptor NMDAr antagonist
NEW12596,CHEMICAL,levodopa response,levodopa response
NEW12597,DISEASE,progressive micrographia,progressive micrographia
NEW12598,DISEASE,fhb resistance type,FHB resistance types
NEW12599,DISEASE,related hyponatremia,related hyponatremia
NEW12600,CHEMICAL,avp-induced water retention,AVP-induced water retention
NEW12601,DISEASE,non-endocrine disorder,non-endocrine disorders
NEW12602,DISEASE,dilutional hyponatremia,dilutional hyponatremia
NEW12603,CHEBI,accessory endocrine disorder,accessory endocrine disorder
D048668,DISEASE,Lactobacillus delbrueckii,Lactobacillus delbrueckii subsp. bulgaricus|Lactobacillus delbrueckii subspecies bulgaricus|Lactobacillus bulgaricus
NEW12604,CHEMICAL,gaba production,GABA production
NEW12605,CHEMICAL,μg/ml,μg/mL
NEW12606,DISEASE,small pulmonary artery vascular smooth muscle cell,small pulmonary artery vascular smooth muscle cells
NEW12607,CHEMICAL,berberine treatment,berberine treatment
NEW12608,DISEASE,monocrotaline-induced pulmonary hypertension,monocrotaline-induced pulmonary hypertension
NEW12609,MENTAL_HEALTH,therapy resistance,therapy resistance
NEW12610,CHEMICAL,pre-administration,Pre-administration
NEW12611,CHEMICAL,colitis dextran sodium sulfate-,colitis dextran sodium sulfate-
NEW12612,CHEMICAL,"2,4,6-trinitrobenzene sulfonic acid-induced","2,4,6-trinitrobenzene sulfonic acid-induced"
http://purl.org/sig/ont/fma/fma14984,DISEASE,mucosa of colon,Colonic mucous membrane|Colonic mucosa|colon mucosa|Colon mucosa
NEW12613,CHEMICAL,inducible no synthase,inducible NO synthase
NEW12614,CHEMICAL,pregnane x receptor expression,Pregnane X receptor expression
NEW12615,CHEMICAL,overprotection-overcontrol,overprotection-overcontrol
NEW12616,DISEASE,ambivalence,ambivalence
NEW12617,CHEBI,ir-like state high beta cell activity index,IR-like state high beta cell activity indices
NEW12618,DISEASE,aspd subject 's,ASPD subjects's
NEW12619,CHEMICAL,low testosterone level,low testosterone levels
NEW12620,CHEMICAL,reduce hr-qol.,reduced HR-QoL.
NEW12621,DISEASE,dystonia patient,dystonia patients
NEW12622,CHEMICAL,optimize bt treatment,optimized BT treatment
NEW12623,DISEASE,experimental autoimmune prostatitis persistent inflammatory immune response,Experimental autoimmune prostatitis persistent inflammatory immune response
NEW12624,CHEMICAL,acid nmda receptor,acid NMDA receptors
NEW12625,CHEMICAL,injectable paliperidone palmitate,injectable paliperidone palmitate
NEW12626,MENTAL_HEALTH,acute depression,acute depression
C106092,CHEMICAL,microsomal triglyceride transfer protein [Supplementary Concept],triglyceride|Carrier Proteins
NEW12627,NUTRITION,state-dependent low cholesterol relative,state-dependent lower cholesterol relative
NEW12628,DISEASE,severe anemia,severe anemia
NEW12629,CHEMICAL,plasma bhac level,plasma BHAC level
http://purl.obolibrary.org/obo/CHEBI_6954,CHEMICAL,mitotane,lysodren|Mitotane|mitotan|BHAC chemotherapy|Lysodren (TN)|chloditan|chlodithane|opeprim
NEW12630,CHEMICAL,5-fu metabolism,5-FU metabolism
NEW12631,DISEASE,tumor cell specie,tumor cell species
NEW12632,DISEASE,lethargy hyperactivity symptom,lethargy hyperactivity symptoms
NEW12633,CHEMICAL,n-3 index,n-3 index
http://purl.obolibrary.org/obo/DOID_10581,DISEASE,metachromatic leukodystrophy,deficiency of cerebroside-sulfatase|arylsulfatase A deficiency|MLD|sulfatide lipoidosis|Scholz cerebral sclerosis|Metachromatic leucodystrophy
D013433,CHEMICAL,Sulfoglycosphingolipids,Sulfatoglycosphingolipids|sulfatides|Sulfatides|Sulfatide
NEW12634,DISEASE,trichomoniasis case,trichomoniasis cases
NEW12635,CHEBI,nitroimidazole drug,nitroimidazole drug
D002181,DISEASE,"Candidiasis, Vulvovaginal","Vaginal Yeast Infections|Vaginal Yeast Infection|Vulvovaginal Candidiasis|Yeast Infection, Vaginal|Moniliasis, Vulvovaginal|Vulvovaginal Candidiasis, Genital|Vaginitis, Monilial|Vulvovaginal Moniliasis|vulvovaginal candidiasis|Genital Candidiasis|Candidiasis, Genital Vulvovaginal|Monilial Vaginitis|Infection, Vaginal Yeast|Vulvovaginal candidiasis|Infections, Vaginal Yeast|Candidiasis, Genital|Genital Vulvovaginal Candidiasis|Yeast Infections, Vaginal"
NEW12636,CHEMICAL,percent hydroxide solution,percent hydroxide solution
D059268,DISEASE,Atrophic Vaginitis,"Vaginitides, Atrophic|vaginitis|Atrophic Vaginitides|Atrophic vaginitis|Vaginitis, Atrophic"
NEW12637,DISEASE,irritation,irritation
D011537,DISEASE,Pruritus,|Pruritis|Itching|pruritis|itching|pruritus
NEW12638,NUTRITION,altered steroid hormone homeostasis,altered steroid hormone homeostasis
D002191,CHEMICAL,Canrenoic Acid,"Canrenoate, Potassium|potassium canrenoate|Soldactone|SC14266|17 Hydroxy 3 Oxo 17alpha Pregna 4,6 Diene 21 Carboxylic Acid|Soludactone|Potassium Canrenoate|Canrenoate Potassium|SC 14266|SC-14266|Kalium-Can.-Ratiopharm|17-Hydroxy-3-Oxo-17alpha-Pregna-4,6-Diene-21-Carboxylic Acid|Spiroctan|Kalium Can. Ratiopharm|Acid, Canrenoic|Acid, 17-Hydroxy-3-Oxo-17alpha-Pregna-4,6-Diene-21-Carboxylic"
NEW12639,MENTAL_HEALTH,male rat resistance,male rat resistance
NEW12640,MENTAL_HEALTH,habitual alcohol dependence,habitual alcohol dependence
NEW12641,CHEMICAL,testosterone effect,Testosterone effect
NEW12642,CHEMICAL,Muntingia calabura,Elaecoparceae|Muntingia calabura
NEW12643,DISEASE,gland swelling,gland swelling
NEW12644,CHEMICAL,ketamine compound,ketamine compound
NEW12645,CHEBI,available antitubercular drug,available antitubercular drugs
NEW12646,CHEMICAL,caffeine metabolite,caffeine metabolites
NEW12647,CHEMICAL,caffeine caffeine metabolite,caffeine caffeine metabolites
http://purl.obolibrary.org/obo/CL_0002077,CHEMICAL,ecto-epithelial cell,"Leu2a+ Leu15- cells,% Leu3a+ Leu8- cells|PDAC cells|OGD/R-stimulated BV-2 cells|DCT2/CNT cells|B-13 cell|TNBC cells"
NEW12648,MENTAL_HEALTH,gemcitabine resistance,gemcitabine resistance
NEW12649,CHEMICAL,thiazolidinedione class,thiazolidinedione class
NEW12650,DISEASE,transient forebrain ischemia,transient forebrain ischemia
NEW12651,CHEMICAL,pioglitazone treatment,pioglitazone treatment
NEW12652,DISEASE,neuronal ischemic injury,neuronal ischemic injury
NEW12653,DISEASE,abeta-induced cell death,Abeta-induced cell death
C000618847,CHEMICAL,amyloid beta-protein (5-16) [Supplementary Concept],Abeta|Peptide Fragments|Amyloid beta-Peptides
D000077466,CHEMICAL,Tirofiban,"Agrastat|L 700462|tirofiban|L-700462|Aggrastat|MK 383|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|L 700,462|L700,462|Tirofiban Hydrochloride|L-700,462|MK-383|Tirofiban Hydrochloride Monohydrate"
NEW12654,CHEMICAL,tyrosine analogue,tyrosine analogue
D000077284,CHEMICAL,Abciximab,"ReoPro|Fab, Chimeric 7E3|CentoRx|Abciximab|Chimeric 7E3 Fab|Clotinab|c7E3 Fab"
NEW12655,DISEASE,synthetic low-molecular-weight compound,synthetic low-molecular-weight compound
NEW12656,DISEASE,ischaemic adverse cardiovascular event,ischaemic adverse cardiovascular events
NEW12657,DISEASE,traumatic event exposure,traumatic event exposure
NEW12658,CHEBI,long-acting β2-adrenergic receptor agonist,long-acting β2-adrenergic receptor agonist
NEW12659,CHEBI,long-acting anticholinergic agent,long-acting anticholinergic agents
NEW12660,DISEASE,copd patient,COPD patients
NEW12661,CHEMICAL,laac,LAAC
NEW12662,CHEMICAL,long-acting β2-adrenergic receptor agonist,long-acting beta2-agonists|LABA|long-acting β2-adrenergic receptor agonist
D000069584,DISEASE,Unilateral Breast Neoplasms,"Breast Cancer, Left-Sided|Right-Sided Breast Neoplasm|Left Sided Breast Neoplasms|Right-Sided Breast Cancer|Left Sided Breast Neoplasm|Breast cancers|Breast Neoplasms, Unilateral|Right Sided Breast Cancer|Right-Sided Breast Neoplasms|Breast Cancers, Left-Sided|Breast Neoplasms, Left-Sided|Breast Neoplasm, Left-Sided|Breast Cancer, Right-Sided|Breast Neoplasm, Unilateral|Breast Cancers, Right-Sided|Left-Sided Breast Neoplasms|Breast Neoplasm, Right-Sided|Left-Sided Breast Cancers|Right-Sided Breast Cancers|Breast Cancers, Unilateral|Right Sided Breast Neoplasms|Unilateral Breast Cancers|Right Sided Breast Neoplasm|Left-Sided Breast Cancer|Left-Sided Breast Neoplasm|Unilateral Breast Cancer|Breast Neoplasms, Right-Sided|Left Sided Breast Cancer|breast cancers|Breast Cancer, Unilateral"
NEW12663,CHEBI,traditional menopausal hormone therapy,Traditional menopausal hormone therapy
NEW12664,CHEMICAL,selective estrogen receptor degrader fulvestrant,selective estrogen receptor degrader fulvestrant
NEW12665,DISEASE,repetitive interest,repetitive interests
NEW12666,DISEASE,abnormal motor movement,abnormal motor movements
NEW12667,CHEMICAL,nile tilapia skin,Nile tilapia skin
NEW12668,DISEASE,vaginal stenosis,vaginal stenosis
C537371,DISEASE,Mullerian aplasia [Supplementary Concept],"Mullerian Ducts/abnormalities|Mayer-Rokitansky-Küster-Hauser syndrome|46, XX Disorders of Sex Development|Congenital Abnormalities"
NEW12669,CHEMICAL,dha intake,DHA intake
NEW12670,CHEMICAL,high dha intake,high DHA intake
http://purl.obolibrary.org/obo/DOID_12849,MENTAL_HEALTH,autistic disorder,Kanner's syndrome|autistic disorder of childhood onset|childhood autism|autism disorder|infantile autism|autism
NEW12671,CHEMICAL,dietary dha,dietary DHA
NEW12672,DISEASE,autistic pup,Autistic pups
NEW12673,CHEMICAL,risperidone mg/kg ip,risperidone mg/kg ip
D000077149,CHEMICAL,Sevoflurane,"Sevoflurane|Ultane|Fluoromethyl Hexafluoroisopropyl Ether|Sevorane|Fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl Ether|BAX 3084|sevoflurane"
NEW12674,DISEASE,sevoflurane-induced cognitive impairment,sevoflurane-induced cognitive impairment
NEW12675,DISEASE,anesthetic-induced cognitive impairment,anesthetic-induced cognitive impairment
NEW12676,CHEMICAL,corylifolia l.,corylifolia L.
NEW12677,DISEASE,calvitie,calvities
NEW12678,DISEASE,mechanical trauma,mechanical trauma
NEW12679,DISEASE,most breast cancer,most breast cancers
D005688,CHEMICAL,Galactosamine,galactosamine||Hexosamines (1966-1970)
D001089,CHEMICAL,Arabinose,L-Arabinose|L Arabinose|arabinose
NEW12680,DISEASE,Prunus fermentation extract,Prunus fermentation extract
NEW12681,DISEASE,murine b16 melanoma cell,murine B16 melanoma cells
NEW12682,NUTRITION,skin whiting,skin whiting
NEW12683,DISEASE,hyperprolactinaemic state,hyperprolactinaemic states
NEW12684,CHEBI,long-acting dopamine agonist,long-acting dopamine agonist
C084809,CHEMICAL,lergotrile mesylate [Supplementary Concept],Ergolines|lergotrile mesylate
NEW12685,DISEASE,idiopathic hyperprolactinemia,idiopathic hyperprolactinemia
NEW12686,MENTAL_HEALTH,additional non-organic mental disorder,additional non-organic mental disorder
NEW12687,DISEASE,disorder due intake,disorders due intake
NEW12688,NUTRITION,wheat diet,wheat diets
D055272,CHEMICAL,Mucin-6,mucin|Mucin 6
NEW12689,DISEASE,dysplasia marker,dysplasia markers
NEW12690,DISEASE,factitious lesion,factitious lesion
NEW12691,MENTAL_HEALTH,severe premenstrual depression,severe premenstrual depression
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Premenstrual_Syndrome,MENTAL_HEALTH,premenstrual syndrome,severe premenstrual syndrome
NEW12692,CHEBI,transdermal estrogen,transdermal estrogens
NEW12693,DISEASE,chronic crf release,chronic CRF release
NEW12694,CHEMICAL,norepinephrine release,norepinephrine release
NEW12695,CHEBI,ketamine ionotropic glutamatergic nmdar n-methyl-d-aspartate receptor antagonist,ketamine ionotropic glutamatergic NMDAR N-methyl-D-aspartate receptor antagonist
NEW12696,CHEMICAL,fast-acting antidepressant response,fast-acting antidepressant responses
NEW12697,CHEMICAL,single low-dose intravenous infusion,single low-dose intravenous infusion
NEW12698,CHEMICAL,non-starch polysaccharide,Non-starch polysaccharides|NSPs
NEW12699,CHEMICAL,amyloid β Aβ deposition,amyloid β Aβ deposition
NEW12700,DISEASE,p-tau aggregation,p-Tau aggregation
NEW12701,CHEMICAL,brain iron overload,brain iron overload
C027492,DISEASE,Huang Qi [Supplementary Concept],"Drugs, Chinese Herbal|Astragali Radix|Astragalus propinquus|AMB|Bunge"
NEW12702,CHEMICAL,oral contraceptive user,oral contraceptive users
NEW12703,MENTAL_HEALTH,moderate depression syndrome,moderate depression syndromes
C006952,CHEMICAL,cerebrolysin [Supplementary Concept],Cerebrolysin|Amino Acids
NEW12704,DISEASE,advanced ad patient,advanced AD patients
NEW12705,DISEASE,new neurodevelopmental syndrome responsive,new neurodevelopmental syndrome responsive
NEW12706,CHEMICAL,serotonin production due,serotonin production due
D006916,CHEMICAL,5-Hydroxytryptophan,"Oxytryptophan|5-Hydroxy- Tryptophan|5-hydroxytryptophan|5 Hydroxytryptophan|5-HTP|Hydroxytryptophan|Oxitriptan|Tryptophan, 5-Hydroxy-|Tryptophan, 5 Hydroxy"
http://purl.obolibrary.org/obo/CHEBI_37622,CHEMICAL,carboxamide,"N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide"
C083501,CHEMICAL,Elacridar [Supplementary Concept],Acridines|GF120918|Tetrahydroisoquinolines
NEW12707,CHEMICAL,morphine slow-release pellet,morphine slow-release pellets
NEW12708,CHEMICAL,excitatory amino acid system,excitatory amino acid systems
NEW12709,CHEMICAL,high bcaa supplementation,high BCAA supplementation
http://purl.obolibrary.org/obo/PR_Q54N47,CHEMICAL,branched-chain-amino-acid aminotransferase (dictyostelium discoideum),BCAAs|dicty-ilve|bcaa|ddb_g0285509
NEW12710,DISEASE,diet-induced obese mouse,diet-induced obese mice
D012049,MENTAL_HEALTH,Rehabilitation of Speech and Language Disorders,speech disorder|Speech and Language Disorder Rehabilitation|language disorders|Language and Speech Disorder Rehabilitation
NEW12711,DISEASE,ptai lighting,PTAI lighting
NEW12712,CHEMICAL,air spora,Air spora
NEW12713,MENTAL_HEALTH,univariate regression model,univariate regression models
NEW12714,CHEMICAL,pinene emission,Pinene emissions
NEW12715,DISEASE,respiratory inflammation,respiratory inflammation
NEW12716,MENTAL_HEALTH,internucleosomal dna fragmentation,internucleosomal DNA fragmentation
NEW12717,CHEMICAL,shsvct2,shSVCT2
NEW12718,DISEASE,glu261-luneo xenograft tumor model,Glu261-LuNeo xenograft tumor model
NEW12719,CHEMICAL,atrx-dependent svct2 signal,ATRX-dependent SVCT2 signal
NEW12720,DISEASE,tumor cell proliferation,tumor cell proliferation
NEW12721,MENTAL_HEALTH,adhd trial,ADHD trial
NEW12722,MENTAL_HEALTH,adhd pharmacotherapy,ADHD pharmacotherapy
NEW12723,CHEMICAL,Azstarys ®,Azstarys ®
D000069478,CHEMICAL,Lisdexamfetamine Dimesylate,"LDX|Lisdexamfetamine|Dimesylate, Lis-dexamfetamine|Elvanse|Vyvanse|NRP-104|Dimesylate, Lisdexamfetamine|NRP104|NRP 104|Lis dexamfetamine Dimesylate|Lisdexamfetamine dimesylate|lisdexamfetamine|Lis-dexamfetamine Dimesylate"
NEW12724,DISEASE,psychophysiological stress-induced chronic sleep disorder,CSD|psychophysiological stress-induced chronic sleep disorder
NEW12725,CHEMICAL,% kcl solution,% KCl solution
NEW12726,CHEMICAL,ipsilateral/left hemisphere,ipsilateral/left hemisphere
NEW12727,CHEMICAL,raise plasma homocysteine,Raised plasma homocysteine
NEW12728,CHEMICAL,hp/g-bw film,HP/G-BW film
NEW12729,MENTAL_HEALTH,strong water resistance,strongest water resistance
NEW12730,DISEASE,aggressive disorder,aggressive disorders
NEW12731,CHEBI,preferable dopamine receptor antagonist,preferable dopamine receptor antagonist
NEW12732,CHEMICAL,haloperidol mg/kg,haloperidol mg/kg
NEW12733,NUTRITION,raw starch,raw starch
NEW12734,CHEMICAL,count iron study,count iron studies
NEW12735,CHEMICAL,gaba(a)-benzodiazepine receptor,GABA(A)-benzodiazepine receptor
NEW12736,CHEBI,endogenous inverse agonist,endogenous inverse agonist
NEW12737,CHEMICAL,gamma-aminobutyric acid type a gabaa receptor subunit gene,gamma-Aminobutyric acid type A GABAA receptor subunit genes
NEW12738,CHEMICAL,benzodiazepine agonist,Benzodiazepine agonists
NEW12739,NUTRITION,probe-sonicated achiote extract,probe-sonicated achiote extract
NEW12740,MENTAL_HEALTH,elegan resistance,elegans resistance
NEW12741,CHEMICAL,high δ-tocotrienol content,highest δ-tocotrienol content
NEW12742,NUTRITION,achiote lipophilic extract,Achiote lipophilic extract
C004588,CHEBI,bixin [Supplementary Concept],bixin|Carotenoids
NEW12743,NUTRITION,achiote seed extract,achiote seed extract
NEW12744,CHEBI,antioxidant vitamin level,antioxidant vitamin levels
C011991,CHEBI,phytoalexins [Supplementary Concept],phytoalexins|Sesquiterpenes
NEW12745,CHEMICAL,acute lsd administration,acute LSD administration
NEW12746,CHEMICAL,repeat lsd,repeated LSD
NEW12747,CHEMICAL,glutathione depletion,glutathione depletion
NEW12748,CHEMICAL,clinical-stage therapeutic vatiquinone,clinical-stage therapeutic vatiquinone
NEW12749,DISEASE,disorder pontocerebellar hypoplasia type,disorder pontocerebellar hypoplasia type
NEW12750,DISEASE,lithium neurotoxicity,Lithium neurotoxicity
NEW12751,DISEASE,creutzfeldt-jakob disease differential diagnosis,Creutzfeldt-Jakob disease differential diagnosis
NEW12752,CHEMICAL,dopamine d2 antagonism,dopamine D2 antagonism
NEW12753,DISEASE,s. trifoliatus,S. trifoliatus
D058976,CHEBI,Folate Receptor 2,"Placental Folate Receptor|Placental Folate-Binding Protein|Receptor, Fetal Folate|Placental Folate Binding Protein|beta, Folate Receptor|Folic Acid Receptor beta|Receptor, Placental Folate|folate receptor-β|Folate Receptor, Fetal|Folate-Binding Protein, Placental|Fetal Folate Receptor|Folate Receptor beta|Protein, Placental Folate-Binding|Receptor 2, Folate|Receptor beta, Folate|Folate Receptor, Placental"
NEW12754,MENTAL_HEALTH,concomitant metabolic syndrome,concomitant metabolic syndromes
NEW12755,CHEMICAL,developmental ethanol exposure,Developmental ethanol exposure
NEW12756,DISEASE,lifelong cognitive deficit,lifelong cognitive deficits
NEW12757,CHEMICAL,developmental etoh,developmental EtOH
NEW12758,MENTAL_HEALTH,adult behavioral hyperactivity,adult behavioral hyperactivity
NEW12759,DISEASE,neuroteratogen alcohol spectrum disorder,neuroteratogen alcohol spectrum disorders
NEW12760,CHEMICAL,maternal ethanol exposure,maternal ethanol exposure
NEW12761,DISEASE,ethanol-induced neuroapoptosis,ethanol-induced neuroapoptosis
NEW12762,CHEMICAL,high dose methotrexate infusion,High dose methotrexate infusion
D053626,CHEMICAL,Atovaquone,"566C|Wellvone|566C80 hydroxynaphthoquinone|atovaquone|compound 566|hydroxynaphthoquinone, 566C80|2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|hydroxynaphthoquinone 566C80|566C80|Mepron|2-(4-(4'-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone"
http://purl.obolibrary.org/obo/CHEBI_6719,CHEMICAL,mefloquine hydrochloride,proguanil HCl|Mefloquine hydrochloride|Lariam
NEW12763,CHEMICAL,papaverine prostaglandin e1,papaverine prostaglandin E1
NEW12764,MENTAL_HEALTH,erectile impotence,erectile impotence
NEW12765,DISEASE,traumatic paraplegic,traumatic paraplegics
NEW12766,CHEMICAL,oral terbutaline therapy,oral terbutaline therapy
http://purl.obolibrary.org/obo/DOID_3393,DISEASE,coronary artery disease,significant coronary artery disease|Coronary disease|coronary heart disease|CHD|coronary arteriosclerosis
NEW12767,CHEMICAL,sodium nitrite toxicity,Sodium nitrite toxicity
NEW12768,DISEASE,severe methemoglobinemia,severe methemoglobinemia
C000603935,CHEMICAL,aripiprazole lauroxil [Supplementary Concept],Aripiprazole lauroxil|Aripiprazole
D017330,CHEMICAL,Remoxipride,"|(S)-3-Bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamide|Remoxipride, (R)-Isomer|Hydrochloride Anhydrous, Remoxipride|FLA-731|FLA731|Remoxipride Monohydrochloride, (R)-Isomer|Anhydrous, Remoxipride Hydrochloride|Remoxipride Hydrochloride Anhydrous|Remoxipride Monohydrochloride Monohydrate|Monohydrochloride Monohydrate, Remoxipride|Monohydrochloride, Remoxipride|Remoxipride Hydrochloride|Remoxipride Monohydrochloride|remoxipride|Hydrochloride, Remoxipride"
NEW12769,NUTRITION,seal oil,seal oil
NEW12770,CHEMICAL,venlafaxine dosage,venlafaxine dosage
NEW12771,CHEMICAL,inhibit dopamine reuptake,inhibited dopamine reuptake
NEW12772,CHEMICAL,CAT-MH computerize adaptive test,CAT-MH computerized adaptive test
NEW12773,MENTAL_HEALTH,positive anxiety,positive anxiety
NEW12774,CHEMICAL,nitrous oxide sedation,nitrous oxide sedation
http://purl.obolibrary.org/obo/DOID_0050589,DISEASE,inflammatory bowel disease,concurrent inflammatory bowel disease
NEW12775,DISEASE,hippocampal neuronal injury,hippocampal neuronal injury
D010381,DISEASE,Pelger-Huet Anomaly,"Pelger-Huet Nuclear Anomaly|Anomaly, Pseudo Pelger-Huët|Pseudo Pelger-Huët Anomaly|Anomaly, Pelger-Huët|Pseudo Pelger Huët Anomaly|Pseudo Pelger Huet Anomaly|Pelger Huet Nuclear Anomaly|Pelger-Huët Nuclear Anomaly|Pelger-Huët Anomaly|Pseudo Pelger-Huet Nuclear Anomaly|Ovoid Neutrophil Nuclei, Developmental Delay, Epilepsy, and Skeletal Abnormalities|Pelger Huët Anomaly|Ovoid Neutrophil Nuclei, Developmental Delay, Epilepsy and Skeletal Abnormalities|anomaly|Anomaly, Pelger-Huët Nuclear|Anomaly, Pelger-Huet Nuclear|Anomaly, Pelger-Huet|Anomaly, Pseudo Pelger-Huet|Pelger-Huët Anomaly, Pseudo|Nuclear Anomaly, Pelger-Huet|Pseudo Pelger-Huet Anomaly|Pelger Huët Nuclear Anomaly|Nuclear Anomaly, Pelger-Huët|Pelger-Huet Anomaly, Pseudo|Pelger Huet Anomaly|Pseudo Pelger Huet Nuclear Anomaly"
NEW12776,CHEMICAL,non-menthol cooling agent,non-menthol cooling agents
NEW12777,CHEMICAL,menthol-only product,menthol-only products
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Attention_Deficit_Disorder,DISEASE,attention deficit disorder,attention deficit-hyperkinetic disorder|ADD|AD-HKD|attention deficit hybperactivity disorder (ADHD)/attention deficit disorder
NEW12778,DISEASE,attention Deficit Hyperactivity/Hyperkinetic Disorder,Attention Deficit Hyperactivity/Hyperkinetic Disorder
NEW12779,DISEASE,mdd treatment,MDD treatment
NEW12780,CHEBI,polymer chain reaction,Polymer Chain Reaction
NEW12781,CHEMICAL,mske,MSKE
NEW12782,CHEMICAL,4-hydoxytamoxifen,4-hydoxytamoxifen
NEW12783,DISEASE,global brain ischemia,global brain ischemia
NEW12784,DISEASE,posthypoxic myoclonus,posthypoxic myoclonus
NEW12785,CHEMICAL,lipopolysaccharide structure,lipopolysaccharide structures
NEW12786,CHEMICAL,nanoparticle/bacterium interaction,nanoparticle/bacterium interaction
NEW12787,MENTAL_HEALTH,partial dissociation,partial dissociation
C081954,CHEMICAL,lipoteichoic acid receptor [Supplementary Concept],"lipoteichoic acid|Receptors, Cell Surface"
NEW12788,CHEMICAL,c = o ester carbonyl stretch,C = O ester carbonyl stretch
NEW12789,CHEMICAL,hap nanoparticle,HAp nanoparticles
NEW12790,DISEASE,methicillin-resistant s. aureus,methicillin-resistant S. aureus
NEW12791,DISEASE,druginduced diabete,druginduced diabetes
NEW12792,CHEMICAL,olanzapine interruption,olanzapine interruption
NEW12793,DISEASE,sequential proton loss electron transfer,sequential proton loss electron transfer
NEW12794,DISEASE,severe depressive symptom,severe depressive symptoms
NEW12795,NUTRITION,total cholesterol,Total Cholesterol
NEW12796,CHEMICAL,intracavernosal alpha-adrenergic agent,intracavernosal alpha-adrenergic agents
NEW12797,DISEASE,cavernosal damage,cavernosal damage
NEW12798,CHEMICAL,GLOBIOM-Brazil scenario,GLOBIOM-Brazil scenarios
NEW12799,MENTAL_HEALTH,southward displacement,southward displacement
NEW12800,MENTAL_HEALTH,low displacement,low displacement
NEW12801,CHEMICAL,supra-therapeutic dose,supra-therapeutic doses
C538521,MENTAL_HEALTH,Bilateral temporal lobe disorder [Supplementary Concept],Kluver-Bucy Syndrome|distractibility
NEW12802,DISEASE,human behavior,human behavior
NEW12803,CHEMICAL,rho-kinase 2,ROCK-II|Rho-kinase 2
NEW12804,DISEASE,facial cellulitis,Facial cellulitis
NEW12805,CHEBI,ttr tetramer stabilizer,TTR tetramer stabilizers
NEW12806,CHEMICAL,attr amyloidosis,ATTR amyloidosis
NEW12807,CHEBI,stabilizer concentration,stabilizer concentration
NEW12808,CHEMICAL,hydrate dissociation,hydrate dissociation
NEW12809,DISEASE,associate arrhythmia,associated arrhythmias
NEW12810,DISEASE,copd exacerbation,COPD exacerbations
NEW12811,MENTAL_HEALTH,fragmentation mechanism,fragmentation mechanisms
NEW12812,CHEMICAL,isotope labeling experiment,isotope labeling experiments
http://purl.obolibrary.org/obo/CHEBI_22861,NUTRITION,betalain,nonglycosylated anthocyanins|betalains|anthocyanidins
NEW12813,MENTAL_HEALTH,general fragmentation mechanism,general fragmentation mechanism
NEW12814,CHEMICAL,hydroxyl proton,hydroxyl protons
NEW12815,CHEMICAL,h/d exchange,H/D exchange
NEW12816,CHEMICAL,procyanidin oligomer,procyanidin oligomers
NEW12817,CHEMICAL,apple fruitlet,apple fruitlets
D051304,CHEMICAL,Profilins,Profilin 4|Profilin-1|Profilin 3|Profilin 1|Profilin|profilin|Profilin-2|profilins|Profilin Proteins|Profilin-4|Profilin-3|Profilin 2|Profilin I
NEW12818,DISEASE,allergic symptom,allergic symptoms
NEW12819,MENTAL_HEALTH,various pollen-food syndrome,various pollen-food syndromes
NEW12820,DISEASE,behavioural deficit,Behavioural deficits
NEW12821,CHEMICAL,avpr1a antagonist relcovaptan,AVPR1a antagonist Relcovaptan|SR49059
NEW12822,DISEASE,bpd participant,BPD participants
NEW12823,CHEMICAL,nmda receptor-mediated glutamate transmission,NMDA receptor-mediated glutamate transmission
NEW12824,DISEASE,amygdala dysfunction,amygdala dysfunction
NEW12825,MENTAL_HEALTH,bipolar disorder patient,Bipolar disorder patients
NEW12826,DISEASE,cerebrovascular function,cerebrovascular functions
NEW12827,CHEMICAL,low-dose resveratrol,low-dose resveratrol
NEW12828,MENTAL_HEALTH,insulin resistance index,insulin resistance index
NEW12829,DISEASE,cvr hypercapnia,CVR hypercapnia
NEW12830,NUTRITION,dietary raspberry,dietary raspberry
NEW12831,DISEASE,neutropenic patient,neutropenic patients
NEW12832,DISEASE,spastic pain,spastic pain
D054631,DISEASE,"Receptor-Like Protein Tyrosine Phosphatases, Class 3","PTPRJ Phosphatase|Stomach Cancer-Associated Protein-Tyrosine Phosphatase|Phosphatase, GLEPP1|PTPRV Phosphatase|PTPRO Phosphatase|GLEPP1 Phosphatase|PTPRH Phosphatase|PTPRB Phosphatase|VE PTP Phosphatase|Receptor-Like Protein Tyrosine Phosphatases, Class III|Protein Tyrosine Phosphatase, Receptor Type Q|SAP-1 Phosphatase|SAP 1 Phosphatase|Protein Tyrosine Phosphatase, Receptor Type O|Receptor Like Protein Tyrosine Phosphatases, Class III|Protein Tyrosine Phosphatase, Receptor Type J|stomach cancer|DEP1 Phosphatase|Vascular Endothelial Protein Tyrosine Phosphatase|Stomach Cancer Associated Protein Tyrosine Phosphatase|Protein-Tyrosine Phosphatase eta|VE-PTP Phosphatase|Density-Enhanced Phosphatase 1|Phosphatase, SAP-1|Protein Tyrosine Phosphatase Receptor omicron|Glomerular Epithelial Protein 1|Phosphatase, PTPRB|Protein Tyrosine Phosphatase eta|Phosphatase, PTPRH|Phosphatase eta, Protein-Tyrosine|Protein Tyrosine Phosphatase, Receptor Type B|Phosphatase, PTPRV|Receptor Like Protein Tyrosine Phosphatases, Class 3|Protein Tyrosine Phosphatase, Receptor Type H|Phosphatase, PTPRQ|PTPRQ Phosphatase|Phosphatase, PTPRO|Phosphatase, PTPRJ|Protein Tyrosine Phosphatase, Receptor Type V|Density Enhanced Phosphatase 1"
D018698,CHEMICAL,Glutamic Acid,"D Glutamate|Glutamate|Glu|D-Glutamate|L-glutamate|L-Glutamate|Potassium Glutamate|L Glutamic Acid|L-Glutamic Acid|glutamic acid|Glutamate, Potassium|Glutamic Acid, (D)-Isomer|Aluminum L-Glutamate|Aluminum L Glutamate|L Glutamate|L-Glutamate, Aluminum|Glutamic acid"
NEW12833,CHEMICAL,phenylalanine value,phenylalanine values
NEW12834,NUTRITION,maximum likelihood tree,maximum likelihood tree
NEW12835,NUTRITION,multi-gene backbone constraint tree,multi-gene backbone constraint tree
C121465,CHEMICAL,6-methyl-2-(phenylethynyl)pyridine [Supplementary Concept],Pyridines|MPEP
NEW12836,DISEASE,il-1beta-induced mechanical allodynia,IL-1beta-induced mechanical allodynia
NEW12837,DISEASE,mirror-image mechanical allodynia,mirror-image mechanical allodynia
C117789,CHEMICAL,7-(hydroxyimino)cyclopropan(b)chromen-1a-carbxoylic acid ethyl ester [Supplementary Concept],Chromones|CPCCOEt
NEW12838,CHEBI,group mglur agonist,group mGluR agonist
C114785,CHEMICAL,2-amino-4-phosphono-propinate [Supplementary Concept],L-AP4|Propionates
C120942,CHEMICAL,"1,4-diaminopyrrolidine-2,4-dicarboxylic acid [Supplementary Concept]",APDC|Proline
NEW12839,DISEASE,irritability related,irritability related
NEW12840,CHEMICAL,opioid antagonist naltrexone,opioid antagonist naltrexone
NEW12841,MENTAL_HEALTH,hyperactivity hyperactivity disorder-like symptom,hyperactivity hyperactivity disorder-like symptoms
NEW12842,MENTAL_HEALTH,hyperactivity disorder-like symptom,hyperactivity disorder-like symptoms
http://purl.obolibrary.org/obo/CHEBI_67194,CHEMICAL,cannabinoid,cannabinoids Δ9-tetrahydrocannabinol|cannabinoids
D008173,DISEASE,"Lung Diseases, Obstructive","Obstructive Lung Disease|Obstructive Pulmonary Diseases|Lung Disease, Obstructive|Pulmonary Disease, Obstructive|pulmonary diseases|Obstructive Lung Diseases|Pulmonary Diseases, Obstructive|Obstructive Pulmonary Disease"
NEW12843,CHEMICAL,adenosine a1 a2a receptor,Adenosine A1 A2A receptors
NEW12844,DISEASE,complex neurological disease,complex neurological diseases
NEW12845,CHEMICAL,reduce testosterone level,reduced testosterone levels
C079215,CHEMICAL,"3,5-dihydroxyphenylglycine [Supplementary Concept]",Resorcinols|DHPG|Glycine/analogs  and  derivatives
NEW12846,CHEMICAL,mt chloride,MT chloride
NEW12847,DISEASE,mild-to-moderate ad patient,mild-to-moderate AD patients
NEW12848,MENTAL_HEALTH,suicide tendency,suicide tendencies
NEW12849,CHEMICAL,monoamine oxidase b inhibitor,Monoamine oxidase B inhibitors
NEW12850,DISEASE,reversible mao-a inhibitor,reversible MAO-A inhibitor
NEW12851,DISEASE,reversible mao-a inhibitor,reversible MAO-A inhibitors
http://purl.obolibrary.org/obo/CHEBI_146212,DISEASE,ilicicolin,ilicicolins|MAO-A inactivators
NEW12852,CHEBI,pharmaceutical class,pharmaceutical class
NEW12853,DISEASE,treatment-resistant depressive patient,treatment-resistant depressive patients
NEW12854,CHEMICAL,first successful ketamine application,first successful ketamine application
NEW12855,CHEMICAL,rapid-acting antidepressant,rapid-acting antidepressants
NEW12856,CHEMICAL,inappropriate metalaxyl usage,inappropriate metalaxyl usage
NEW12857,DISEASE,environmental toxicity,environmental toxicity
NEW12858,DISEASE,reduce abuse potential,reduced abuse potential
D057910,DISEASE,Implant Capsular Contracture,"Contracture, Implant Capsular|Capsular Contracture, Implant|contracture"
C010616,CHEMICAL,normorphine [Supplementary Concept],normorphine|Morphine Derivatives
NEW12859,DISEASE,fpra14-induced toxicity,FPRa14-induced toxicity
NEW12860,CHEMICAL,glutamatergic nmda,glutamatergic NMDA
NEW12861,DISEASE,unmedicate depressed patient,unmedicated depressed patients
NEW12862,NUTRITION,steroid hormone system,steroid hormone systems
NEW12863,CHEMICAL,da function,DA function
NEW12864,MENTAL_HEALTH,idiopathic impotence,idiopathic impotence
NEW12865,CHEBI,asymptomatic carrier,asymptomatic carriers
NEW12866,CHEMICAL,selective serotonin-norepinephrine reuptake inhibitor,selective serotonin-norepinephrine reuptake inhibitors
NEW12867,CHEMICAL,vpa model mouse,VPA model mice
NEW12868,DISEASE,robust autism-like behavior,robust autism-like behaviors
NEW12869,DISEASE,autism-like behavioral phenotype,autism-like behavioral phenotypes
NEW12870,MENTAL_HEALTH,autism symptom,autism symptoms
NEW12871,CHEBI,gabab receptor agonist administration,GABAB receptor agonist administration
NEW12872,CHEMICAL,γ-aminobutyric acid gaba receptor function,γ-aminobutyric acid GABA receptor function
NEW12873,DISEASE,metabolic impairment,Metabolic impairments
NEW12874,DISEASE,tissue hypoxia,tissue hypoxia
NEW12875,DISEASE,mild hypoxia,mild hypoxia
C472864,NUTRITION,"free fatty acid receptor R10, human [Supplementary Concept]","free fatty acid|Receptors, Cell Surface"
NEW12876,CHEMICAL,ffa uptake,FFA uptake
NEW12877,CHEMICAL,metformin treatment,metformin treatment
NEW12878,DISEASE,severe hypoxia,severe hypoxia
NEW12879,NUTRITION,scl27a4 solute family fatty acid transporter,SCL27A4 solute family fatty acid transporter
http://purl.org/sig/ont/fma/fma20335,CHEMICAL,l5 level,O2 levels
NEW12880,CHEMICAL,palmitate oxidation,palmitate oxidation
NEW12881,CHEMICAL,non-mitochondrial o2 consumption,non-mitochondrial O2 consumption
NEW12882,DISEASE,platelet aggregation,Platelet aggregations
D011064,CHEMICAL,Poly Adenosine Diphosphate Ribose,"ADP|Poly(ADP-Ribose)|adenosine diphosphate|Poly-Adenosine Diphosphate-Ribose|Poly ADP Ribose|Poly-ADPR|Diphosphate-Ribose, Poly-Adenosine|Poly ADPR|Ribose, Poly ADP|ADP Ribose, Poly"
NEW12883,CHEBI,selective antagonist available,selective antagonist available
NEW12884,DISEASE,pure menstrual migraine,Pure menstrual migraine
NEW12885,CHEMICAL,medium fertilizer-medium water treatment,medium fertilizer-medium water treatment
NEW12886,MENTAL_HEALTH,leaf resistance,leaf resistance
NEW12887,CHEMICAL,f2w3,F2W3
NEW12888,CHEMICAL,chlorophyll content,chlorophyll contents
NEW12889,CHEMICAL,malondialdehyde content,malondialdehyde content
http://purl.obolibrary.org/obo/DOID_10127,DISEASE,cerebral artery occlusion,acute cerebral artery occlusion
NEW12890,CHEMICAL,mt treatment,MT treatment
NEW12891,CHEBI,combination antimicrobial therapy,Combination antimicrobial therapy
NEW12892,DISEASE,multidrug-resistant a. baumannii infection due,multidrug-resistant A. baumannii infections due
D000583,CHEMICAL,Amikacin,"|Amukin|BBK 8|Amikafur|A.M.K|Amikin|BBK8|BB K8|BB-K 8|BB-K8|Yectamid|Amikayect|Kanbine|Sulfate, Amikacin|Gamikal|Amikason's|BB K 8|Amikalem|Amikacina Medical|Medical, Amikacina|Amikacin Sulfate|amikacin|Normon, Amikacina|Biklin|Amikacina Normon|Oprad|Amiklin|Biclin"
NEW12893,DISEASE,a. baumannii isolate,A. baumannii isolates
http://purl.obolibrary.org/obo/CHEBI_5138,CHEBI,fluvoxamine,(1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-(2-aminoethyl)oxime|O-(2-aminoethyl)-N-{(1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}hydroxylamine|Fluvoxamine|SSRI fluvoxamine|2-{[(E)-{5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino]oxy}ethan-1-amine|fluvoxamine|fluvoxamina|fluvoxaminum
NEW12894,CHEMICAL,cortical glucose metabolism,cortical glucose metabolism
NEW12895,DISEASE,ibs patient,IBS patients
D016210,CHEMICAL,Methacholine Chloride,"Methacholine|Acetyl-beta-methacholine Chloride|Mecholyl|methacholine|Provocholine|Acetyl-beta-methylcholine|Acetyl 2 methylcholine Chloride|Acetyl beta methacholine Chloride|Mecholine|Provokit|Acetyl-2-methylcholine Chloride|Acetyl beta methylcholine|2-(Acetyloxy)-N,N,N-trimethyl-1-propanaminium Chloride|Chloride, Methacholine"
NEW12896,DISEASE,atopic disease,atopic disease
NEW12897,CHEMICAL,cellular glutathione,cellular glutathione
NEW12898,CHEBI,apoe ε4 genotype carrier,APOE ε4 genotype carriers
NEW12899,DISEASE,amnestic variant,amnestic variants
NEW12900,DISEASE,aphasic,aphasic
NEW12901,MENTAL_HEALTH,regression model,regression models
NEW12902,CHEMICAL,non-tea flavonoid,non-tea flavonoids
NEW12903,CHEMICAL,2-hour post load plasma glucose,2-hour post load plasma glucose
NEW12904,CHEMICAL,restricted cubic spline,Restricted cubic splines
NEW12905,CHEMICAL,Langmuir equation model,Langmuir equation model
NEW12906,CHEMICAL,dm patient,DM patients
NEW12907,NUTRITION,cholesterol saturation,cholesterol saturation
D002769,DISEASE,Cholelithiasis,cholelithiasis|Gallstone Disease|Gallstone Diseases|Cholelithiases
NEW12908,DISEASE,liver portion,liver portions
NEW12909,DISEASE,disease morbidity,diseases morbidity
NEW12910,MENTAL_HEALTH,transient hallucination,transient hallucination
NEW12911,DISEASE,withdrawal convulsion,withdrawal convulsion
NEW12912,CHEMICAL,valproic acid vpa intake,Valproic acid VPA intake
NEW12913,MENTAL_HEALTH,autism risk,autism risk
NEW12914,CHEMICAL,vpa-induced embriotoxicity,VPA-induced embriotoxicity
NEW12915,DISEASE,human asd,human ASD
NEW12916,CHEMICAL,nac treatment,NAC treatment
http://purl.obolibrary.org/obo/MFOMD_0000199,MENTAL_HEALTH,social dysfunction,social dysfunction
NEW12917,CHEBI,nonsteroidal estrogenic mycotoxin,nonsteroidal estrogenic mycotoxin
NEW12918,MENTAL_HEALTH,hyperestrogenic syndrome,hyperestrogenic syndromes
D015025,CHEMICAL,Zearalenone,"Toxin, F-2|Zearalenone|F 2 Toxin|F2 Toxin|F-2 Toxin|Toxin, F2|ZEN"
NEW12919,CHEMICAL,fusarium specie,Fusarium species
NEW12920,DISEASE,b. amyloliquefacien ln,B. amyloliquefaciens LN
NEW12921,CHEMICAL,zen concentration,ZEN concentration
NEW12922,DISEASE,zen-contaminated meal medium,ZEN-contaminated meal medium
NEW12923,DISEASE,saline zen concentration,saline ZEN concentration
NEW12924,CHEMICAL,bile salt tolerance,bile salt tolerance
NEW12925,CHEBI,hormone neuron,Hormone neurons
NEW12926,CHEMICAL,blunt corticosterone secretion,blunted corticosterone secretion
NEW12927,CHEMICAL,dopamine dysregulation,dopamine dysregulation
NEW12928,MENTAL_HEALTH,resistance trait,resistance traits
D000861,CHEMICAL,Anserine,anserine|Beta-Alanyl-3-Methylhistidine|Balanine|Ophidine|Beta Alanyl 3 Methylhistidine
NEW12929,CHEMICAL,imidazole dipeptide,imidazole dipeptides
NEW12930,DISEASE,poststroke mood,poststroke mood
NEW12931,MENTAL_HEALTH,displacement rate,Displacement rate
NEW12932,CHEMICAL,2-alkylcylcyclobutanone,2-alkylcylcyclobutanones
D014151,CHEMICAL,Anti-Anxiety Agents,"Anti-Anxiety Effects|Anti Anxiety Agents|Agent, Anti-Anxiety|buspirone|Minor Tranquilizing Agents|Anti-Anxiety Drugs|Tranquillizing Agents, Minor|Drugs, Anti-Anxiety|Minor Tranquillizing Agents|Antianxiety Effects|Anxiolytic|Anxiolytics|Agents, Minor Tranquilizing|Agents, Minor Tranquillizing|Anti-Anxiety Drug|Effects, Antianxiety|anxiolytics|Effect, Antianxiety|Anxiolytic Agents|Agent, Anxiolytic|Drug, Anti-Anxiety|Anti Anxiety Agent|Anti Anxiety Effect|Anti Anxiety Effects|Tranquilizing Agents, Minor|Agents, Anti-Anxiety|Anti-Anxiety Effect|Anxiolytic Effect|Effects, Anxiolytic|Antianxiety Effect|Anti-Anxiety Agent|Effect, Anti-Anxiety|Anxiolytic Agent|Anti Anxiety Drug|Anti Anxiety Drugs|Anxiolytic Effects|Effects, Anti-Anxiety|Agents, Anxiolytic|Effect, Anxiolytic"
NEW12933,NUTRITION,whose 's yeast homolog,whose's yeast homolog
C079750,CHEMICAL,"VP23 protein, Human herpesvirus 1 [Supplementary Concept]",Capsid Proteins|uL18
NEW12934,DISEASE,pain reduction,pain reduction
http://purl.obolibrary.org/obo/CHEBI_183050,CHEBI,neoantigen,neoantigens|Neoantigens
NEW12935,DISEASE,major congenital anomaly,major congenital anomalies
NEW12936,CHEBI,maternal ltra use,maternal LTRA use
NEW12937,DISEASE,insomniac,insomniacs
NEW12938,CHEMICAL,treatment ° C/24 h,treatments ° C/24 h
NEW12939,NUTRITION,amorphous calcium phosphate nanoplatform,amorphous calcium phosphate nanoplatform
NEW12940,DISEASE,resistant tumor cell,resistant tumor cells
NEW12941,CHEMICAL,target combinational ferroptosis/apoptosis therapy,targeted combinational ferroptosis/apoptosis therapy
NEW12942,DISEASE,tumor intracellular environment,tumor intracellular environment
NEW12943,CHEMICAL,atp supply,ATP supply
NEW12944,CHEMICAL,ros level,ROS levels
NEW12945,CHEMICAL,nicotinamide adenine dinucleotide phosphate nadph oxidase,Nicotinamide adenine dinucleotide phosphate NADPH oxidase
NEW12946,CHEMICAL,chronic pentylenetetrazole treatment,chronic pentylenetetrazole treatment
C056165,CHEMICAL,acetovanillone [Supplementary Concept],apocynin|Acetophenones
NEW12947,DISEASE,seizure severity,seizure severity
NEW12948,DISEASE,stress-induced damage,stress-induced damage
NEW12949,CHEBI,dietary nicotinamide,dietary nicotinamide
NEW12950,CHEMICAL,tissue nad+ level,tissue NAD+ levels
NEW12951,MENTAL_HEALTH,hierarchical linear regression model,hierarchical linear regression model
NEW12952,CHEBI,nicotinamide intake,nicotinamide intake
NEW12953,CHEMICAL,nad+ level,NAD+ levels
NEW12954,CHEBI,daily dietary nicotinamide intake,Daily dietary nicotinamide intake
NEW12955,CHEMICAL,-29.7,-28.14 -1.56
NEW12956,CHEBI,drug exposure,drug exposure
NEW12957,DISEASE,disorder scale,Disorders scales
NEW12958,DISEASE,axis Disorders,Axis Disorders
NEW12959,DISEASE,tropane hydrochloride,tropane hydrochloride|DUI
NEW12960,CHEMICAL,membrane arachidonic acid level,membrane arachidonic acid levels
C543485,CHEMICAL,"EPHX1 protein, mouse [Supplementary Concept]",microsomal epoxide hydrolase|Epoxide Hydrolases
NEW12961,DISEASE,severe ss,Severe SS
NEW12962,DISEASE,severe ss,severe SS
NEW12963,CHEMICAL,serotonergic toxicity,serotonergic toxicity
NEW12964,DISEASE,g361 malignant human melanoma cell line,G361 malignant human melanoma cell lines
http://purl.obolibrary.org/obo/CHEBI_34324,CHEBI,"3,4-dihydro-3-hydroxy-4-s-glutathionyl bromobenzene","hepatotoxicants|3,4-Dihydro-3-hydroxy-4-S-glutathionyl bromobenzene"
NEW12965,NUTRITION,essential fatty acid status,essential fatty acid status
NEW12966,DISEASE,future suicidal behavior,future suicidal behaviors
NEW12967,CHEMICAL,vitamin-k-antagonist,Vitamin-K-antagonists
NEW12968,DISEASE,af vascular disease,AF vascular disease
NEW12969,CHEMICAL,direct oral anticoagulant,direct oral anticoagulants|DOAC
NEW12970,DISEASE,familial lcat deficiency,familial LCAT deficiency
NEW12971,DISEASE,early corneal opacity,early corneal opacity
NEW12972,NUTRITION,circulate esterify cholesterol,circulating esterified cholesterol
NEW12973,NUTRITION,unesterified cholesterol,unesterified cholesterol
NEW12974,NUTRITION,tryptophan addition,Tryptophan addition
NEW12975,MENTAL_HEALTH,rapid tat2 dissociation,rapid Tat2 dissociation
NEW12976,MENTAL_HEALTH,persecutory delusion,persecutory delusions
NEW12977,CHEMICAL,low pufa patient,low PUFA patients
C523360,CHEMICAL,astaxanthin-lysine conjugate Asly [Supplementary Concept],Astaxanthin|astaxanthin|AX|Carotenoids|Lysine/analogs  and  derivatives
NEW12978,DISEASE,pathological disorder,Pathological disorder
D016503,CHEBI,Drug Delivery Systems,"Delivery Systems, Drug|Delivery System, Drug|Drug Targetings|drug delivery|Targetings, Drug|Targeting, Drug|System, Drug Delivery|Systems, Drug Delivery|Drug Delivery System|Drug Targeting"
NEW12979,CHEMICAL,fast antidepressant effect,fast antidepressant effect
NEW12980,CHEMICAL,n-methyl-d-aspartate receptor antagonist ketamine,N-methyl-d-aspartate receptor antagonist ketamine
NEW12981,CHEBI,antimicrobial treatment,antimicrobial treatment
NEW12982,CHEBI,antibiotic-guided systemic antibiotic,antibiotic-guided systemic antibiotics
D013530,DISEASE,Surgical Wound Infection,"site infections|Postoperative Wound Infection|Wound Infections, Postoperative|Postoperative Wound Infections|Wound Infection, Surgical|Surgical Site Infection|Infections, Surgical Site|Surgical Site Infections|Infections, Postoperative Wound|Wound Infection, Postoperative|Infections, Surgical Wound|Surgical Wound Infections|Infection, Surgical Wound|surgical infection|Wound Infections, Surgical|Infection, Surgical Site|Infection, Postoperative Wound"
NEW12983,CHEBI,surgical antimicrobial prophylaxis,surgical antimicrobial prophylaxis
NEW12984,CHEMICAL,la infiltration,LA infiltration
NEW12985,MENTAL_HEALTH,postoperative analgesia,postoperative analgesia
NEW12986,CHEMICAL,mg/ml lidocaine,mg/mL Lidocaine
D064705,CHEMICAL,Racepinephrine,"racemic mixture|Adrenaline Hydrochloride, Racemic Mixture|Adrenaline, Racemic Mixture|Adrenaline, Racemic|Racepinephrine Hydrochloride|Vaponefrin|Epinephrine, Racemic Mixture|adrenaline|Micronefrin|Racemic Mixture Adrenaline|Racemic Adrenaline|Micronephrine|Racemic Mixture Epinephrine|Epinephrine Hydrochloride, Racemic Mixture|Racemic Epinephrine|Epinephrine, Racemic"
NEW12987,DISEASE,pseudomonas aeruginosa atcc,Pseudomonas aeruginosa ATCC
NEW12988,CHEMICAL,Group LA,Group LA
D034761,CHEMICAL,Heterogeneous-Nuclear Ribonucleoprotein Group M,"Mupirocine|Heterogeneous Nuclear Ribonucleoprotein Group M|Heterogeneous-Nuclear Ribonucleoprotein M|Ribonucleoprotein M, Heterogeneous-Nuclear|hnRNP M|Group M|Heterogeneous Nuclear Ribonucleoprotein M"
NEW12989,DISEASE,staphylococcus aureus american type culture collection,Staphylococcus aureus American type culture collection
D052240,CHEMICAL,Fanconi Anemia Complementation Group L Protein,PHD Finger Protein 9|Fanconi Anemia Group L Protein|Group L|Ubiquitin Ligase Protein PHF9|Lidocaine|Fanconi Anemia Group L Complementing Protein|FANCL Protein
NEW12990,CHEBI,in antimicrobial effect,in antimicrobial effects
NEW12991,CHEMICAL,mg/ml mupirocine,mg/mL mupirocine
C520851,CHEMICAL,"4'-(2-furyl)-N-pyridin-3-yl-4,5'-bipyrimidin-2'-amine [Supplementary Concept]",Furans|Pyrimidines|LAs
NEW12992,CHEBI,antimicrobial effect,antimicrobial effects
NEW12993,NUTRITION,local brown rice,Local brown rice
NEW12994,NUTRITION,brown rice,brown rice
D000085002,CHEMICAL,Glycemic Control,"Control, Blood Glucose|glucose control|Glucose Control, Blood|Control, Glycemic|Blood Glucose Control"
NEW12995,CHEMICAL,utilize nalfurafine,utilized nalfurafine
NEW12996,CHEBI,classic kop-r full agonist,classic KOP-r full agonists
NEW12997,CHEMICAL,pericyte-mediated capillary constriction,Pericyte-mediated capillary constriction
http://purl.org/sig/ont/fma/fma22315,CHEMICAL,gluteus medius,Gluteus medius muscle|GM|Gluteus medius|gluteus medius muscle
http://purl.obolibrary.org/obo/CHEBI_80661,CHEMICAL,"dna 2,6-diamino-5-formamido-3,4-dihydro-4-oxopyrimidine",DNA fragmentation/integrity
http://purl.obolibrary.org/obo/CHEBI_51246,CHEMICAL,propidium,"3,8-diamino-5-{3-[diethyl(methyl)ammonio]propyl}-6-phenylphenanthridinium|propidium iodide/""5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolyl|3,8-diamino-5-(3-(diethylmethylammonio)propyl)-6-phenylphenanthridinium|3,8-DIAMINO-5[3-(DIETHYLMETHYLAMMONIO)PROPYL]-6-PHENYLPHENANTHRIDINIUM"
NEW12998,CHEMICAL,"iodide/""5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolyl carbocyanine iodide","iodide/""5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolyl carbocyanine iodide"
NEW12999,CHEMICAL,neutral comet assay/acridine orange assay,neutral comet assay/acridine orange assay
NEW13000,DISEASE,sperm visual motility,sperm visual motility
NEW13001,DISEASE,chronic inflammatory disease,chronic inflammatory disease
D016388,DISEASE,Tooth Loss,"tooth loss|Loss, Tooth"
D010510,DISEASE,Periodontal Diseases,"Pyorrhea Alveolaris|Periodontal Disease|periodontal disease|Disease, Periodontal|Parodontoses|Parodontosis|Periodontal disease|Diseases, Periodontal"
NEW13002,CHEBI,hepatotoxin,hepatotoxins
C057816,DISEASE,"gene 5 protein, Enterobacteria phage M13 [Supplementary Concept]",DNA-Binding Proteins|Viral Proteins|enterobacteria
NEW13003,CHEBI,known hepatotoxin,known hepatotoxins
NEW13004,DISEASE,cholestatic dili,cholestatic DILI
NEW13005,CHEMICAL,omega-3 pufa supplement,omega-3 PUFA supplements
NEW13006,CHEBI,sex-steroid hormone level,sex-steroid hormone levels
NEW13007,CHEMICAL,gnrha intervention,GnRHa intervention
NEW13008,CHEMICAL,ovarian sex steroid,ovarian sex steroids
NEW13009,CHEMICAL,depot form,depot form
NEW13010,CHEBI,gonadotropin-releasing hormone agonist,Gonadotropin-releasing hormone agonist
NEW13011,DISEASE,chronic migraine,chronic migraine
NEW13012,CHEMICAL,nitroglycerin model,nitroglycerin model
NEW13013,CHEMICAL,n-diethyl-benzamide,N-diethyl-benzamide|SNC80
NEW13014,CHEMICAL,moh/oih,MOH/OIH
NEW13015,MENTAL_HEALTH,relative resistance,relative resistance
NEW13016,CHEBI,thyroid hormone inhibition,thyroid hormone inhibition
NEW13017,DISEASE,wolman 's disease fibroblast,Wolman's disease fibroblasts
D015217,CHEMICAL,Cholesterol Ester Storage Disease,cholesteryl ester storage|Cholesteryl Ester Storage Disease
D015312,DISEASE,Hemodialysis Solutions,"Hemodialyzates|Solutions, Hemodialysis Dialysis|HD|Hemodialysis Dialysis Solutions|Dialysis Solutions, Hemodialysis|Hemodialysates|hemodialysis|Solutions, Hemodialysis"
NEW13018,CHEBI,cerebral vitamin b5 deficiency,cerebral vitamin B5 deficiency
NEW13019,MENTAL_HEALTH,disorder research,disorder research
NEW13020,CHEMICAL,robust antidepressant action,robust antidepressant actions
NEW13021,CHEMICAL,ketamine-like antidepressant action,ketamine-like antidepressant actions
http://purl.org/sig/ont/fma/fma12520,CHEMICAL,axis,Axis (CII)|Second cervical vertebra|brain-spleen axis|C2 vertebra
NEW13022,CHEMICAL,non-competitive n-methyl-d-aspartate/glutamate receptor antagonism,Non-competitive N-methyl-D-aspartate/glutamate receptor antagonism
NEW13023,CHEMICAL,repeat ketamine intake,repeated ketamine intake
NEW13024,DISEASE,long-lasting memory-associated deficit,long-lasting memory-associated deficits
D015343,CHEBI,"DNA Probes, HLA","DNA Probes, HLA-Dw|DNA Probes, Histocompatibility Antigen|HLA-Dw DNA Probes|Probes, HLA-A DNA|HLA C DNA Probes|HLA DR DNA Probes|Probes, HLA DNA|Human Leukocyte Antigen DNA Probes|DNA Probes, HLA-C|DNA Probes, HLA-B|Probes, HLA-Dw DNA|HLA D DNA Probes|HLA DNA Probes|HLA-D DNA Probes|HLA-A DNA Probes|DNA Probes, HLA-D|HLA-B DNA Probes|Probes, HLA-D DNA|Probes, HLA-DR DNA|human leukocyte antigen|DNA Probes, HLA-A|HLA-C DNA Probes|HLA B DNA Probes|Probes, HLA-C DNA|HLA-DR DNA Probes|HLA Dw DNA Probes|HLA A DNA Probes|Histocompatibility Antigen DNA Probes|DNA Probes, HLA-DR|Probes, HLA-B DNA"
NEW13025,DISEASE,antiepileptic drug-induced skin rash,antiepileptic drug-induced skin rash
D006463,DISEASE,Hemolytic-Uremic Syndrome,"|Hemolytic Uremic Syndrome|HUS|Gasser Syndrome|Syndrome, Hemolytic-Uremic|Gasser's Syndrome|Gassers Syndrome|hemolytic uremic syndrome"
D022641,CHEBI,Shiga Toxin 2,"Cytotoxin, VT2|Shiga-Like Toxin II|SLTII|Stx2 protein|Shiga Like Toxin II|Vero Cytotoxin VT2|Shiga toxin|VT2 Cytotoxin|Shiga Toxin 2, Escherichia coli|SLT II|Verotoxin 2|SLT-II"
NEW13026,DISEASE,hus pathophysiology,HUS pathophysiology
NEW13027,CHEMICAL,urinary potassium,urinary potassium
NEW13028,DISEASE,distal nephron disorder,distal nephron disorders
NEW13029,DISEASE,lps/stx2-induced kidney injury model,LPS/Stx2-induced kidney injury model
NEW13030,CHEBI,5ht2a inverse agonist,5HT2A inverse agonist
D010636,NUTRITION,Phenols,phenols
NEW13031,CHEBI,polar narcotic,polar narcotics
NEW13032,CHEMICAL,n-buoh extract,n-BuOH extract
NEW13033,CHEMICAL,µg/ml,µg/mL
D016833,DISEASE,Trypanosoma brucei rhodesiense,"Trypanosoma rhodesiense|Trypanosoma rhodesienses|rhodesienses, Trypanosoma|brucei rhodesiense, Trypanosoma|rhodesienses, Trypanosoma brucei|Trypanosoma brucei|Trypanosoma brucei rhodesienses|brucei rhodesienses, Trypanosoma"
NEW13034,DISEASE,human breast cancer tissue,human breast cancer tissue
D047628,CHEMICAL,Estrogen Receptor alpha,"alpha, Estradiol Receptor|Receptor alpha, Estrogen|ERalpha|Estrogen Receptors alpha|ERα|Estrogen Receptor 1|Receptor alpha, Estradiol|Estradiol Receptor alpha|estrogen receptor-α"
NEW13035,CHEMICAL,hallucination-psychosis spectrum,hallucination-psychosis spectrum
NEW13036,MENTAL_HEALTH,music hallucination,Music hallucinations
NEW13037,NUTRITION,alpha band activity,alpha band activity
NEW13038,CHEBI,beta-selective antagonist,beta-selective antagonist
NEW13039,CHEMICAL,[3h]prazosin binding,[3H]prazosin binding
NEW13040,DISEASE,rat ventricular muscle membrane,rat ventricular muscle membranes
NEW13041,MENTAL_HEALTH,displacement potency,displacement potencies
NEW13042,CHEMICAL,microm phenoxybenzamine,microM phenoxybenzamine
NEW13043,CHEBI,1-adrenergic antagonist,1-adrenergic antagonists
NEW13044,NUTRITION,alpha site,alpha sites
NEW13045,DISEASE,adolescent mdd,adolescent MDD
http://purl.obolibrary.org/obo/CHEBI_34910,CHEMICAL,pentetrazol,"Corazol|Corazole|Diovascole|Deumacard|Cardosan|Cardosal|pentamethylene-1,5-tetrazole|6,7,8,9-tetrahydro-5H-tetrazolo[1,5-a]azepine|Pentetrazol|Corvasol|Phrenazol|Pentylenetetrazole|Metrazol|Cenazol|Korazol|Cenalene-M|pentetrazol|Coratoline|6,7,8,9-tetrahydro-5-azepotetrazole|pentylenetetrazol|Kardiazol|Cardiazol|Coryvet|Gewazol|pentetrazolum|alpha,beta-cyclopentamethylenetetrazole|Coranormol|1-kynurenine|7,8,9,10-tetrazabicyclo[5.3.0]-8,10-decadiene|Cardiotonicum|Cardiazole|1,5-pentamethylenetetrazole|KYN|Cardifortan|Ventrazol"
NEW13046,DISEASE,cognitive damage,cognitive damage
NEW13047,DISEASE,learn deficiency,learning deficiencies
NEW13048,CHEMICAL,amyloid-beta aβ protein expression,amyloid-beta Aβ protein expression
NEW13049,NUTRITION,american chestnut,American chestnut
NEW13050,MENTAL_HEALTH,blight resistance,blight resistance
NEW13051,CHEMICAL,bc3f2 tree 's,BC3F2 trees's
D010838,DISEASE,Phytophthora,"Phytophthora cinnamomus|Phytophthora parasitica|Phytophthora sojae|Phytophthora cinnamomi|Phytophthora ramorum|Phytophthora ramorums|Phytophthoras|parasitica, Phytophthora|Phytophthora parasiticas|cinnamomi, Phytophthora|ramorums, Phytophthora"
NEW13052,NUTRITION,chestnut backcross,chestnut backcross
D049970,DISEASE,Graves Ophthalmopathy,"Ophthalmopathy, Congestive|Edematous Ophthalmopathies|Myopathic Ophthalmopathy|Congestive Ophthalmopathies|Ophthalmopathy, Edematous|Eye Disease, Graves|Ophthalmopathy, Graves|Myopathic Ophthalmopathies|Thyroid Eye Diseases|Thyroid-Associated Ophthalmopathies|Ophthalmopathies, Thyroid-Associated|Ophthalmopathy, Thyroid Associated|Disease, Graves Eye|Infiltrative Ophthalmopathies|Ophthalmopathy, Myopathic|Ophthalmopathy, Infiltrative|Infiltrative Ophthalmopathy|Dysthyroid Ophthalmopathies|Orbitopathy, Graves|Graves Eye Disease|Thyroid Associated Ophthalmopathy|Disease, Thyroid Eye|Eye Disease, Thyroid|Congestive Ophthalmopathy|Graves Orbitopathy|Dysthyroid Ophthalmopathy|Ophthalmopathy, Dysthyroid|Ophthalmopathy, Thyroid-Associated|Thyroid Associated Ophthalmopathies|Thyroid Eye Disease|Thyroid-Associated Ophthalmopathy|Edematous Ophthalmopathy|Graves"
NEW13053,DISEASE,p. cinnamomi,P. cinnamomi
NEW13054,DISEASE,grave BC3F3,Graves BC3F3
NEW13055,DISEASE,p. cinnamomi infection,P. cinnamomi infection
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Spinal_Cord_Injuries,DISEASE,spinal cord injuries,e.g. spinal cord trauma
NEW13056,DISEASE,acute tissue injury state,acute tissue injury states
http://purl.obolibrary.org/obo/CHEBI_64344,CHEMICAL,"2',4',6'-trihydroxyacetophenone","2',4',6'-trihydroxyacetophenone|2,4,6-trihydroxyacetophenone|phloracetophenone|monoacetylphloroglucinol|THAP|1-(2,4,6-trihydroxyphenyl)ethanone|2-acetylphloroglucinol|acetylphloroglucinol|acetophloroglucine|phloroacetophenone"
C583588,CHEMICAL,2-acetylcyclopentanone [Supplementary Concept],Ketones|2-acetylcyclopentanone
NEW13057,CHEMICAL,intravenous magnesium loading,intravenous magnesium loading
NEW13058,DISEASE,functional hypoparathyroidism,functional hypoparathyroidism
NEW13059,CHEBI,"1,25-(oh)2 vitamin d consistent","1,25-(OH)2 vitamin D consistent"
NEW13060,CHEMICAL,intracellular magnesium deficiency,Intracellular magnesium deficiency
C025451,CHEMICAL,sodium bisulfide [Supplementary Concept],Sulfides|NaHS
http://purl.org/sig/ont/fma/fma321004,DISEASE,corpus cavernosum,human corpus cavernosum|HCC
C068637,CHEMICAL,"calcium D-pantothenate, L-cysteine drug combination [Supplementary Concept]",Pantothenic Acid|CYS|L-cysteine|Cysteine|Drug Combinations
NEW13061,CHEMICAL,no synthase inhibitor,NO synthase inhibitor
D019331,CHEMICAL,NG-Nitroarginine Methyl Ester,"Methyl Ester, NG-Nitroarginine|NG Nitro L Arginine Methyl Ester|NG Nitroarginine Methyl Ester, D Orn Isomer|N(G)-Nitroarginine Methyl Ester|L-NAME|N omega-Nitro-L-arginine Methyl Ester|Methyl Ester, NG-Nitro-L-Arginine|N omega Nitro L arginine Methyl Ester|NG-Nitro-L-Arginine Methyl Ester|N(omega)-Nitro-L-arginine Methyl Ester|N(G)-Nitro-L-arginine Methyl Ester|NG Nitroarginine Methyl Ester|NG-Nitroarginine Methyl Ester, D-Orn-Isomer|NG-Nitroarginine Methyl Ester, L-Orn-Isomer, Monohydrochloride"
C095284,CHEMICAL,"1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one [Supplementary Concept]",Oxadiazoles|ODQ|Quinoxalines
D019789,CHEMICAL,Tetraethylammonium,"Chloride, Tetraethylammonium|Tetraethylammonium Hydroxide|Tetraethylammonium Bromide|Bromide, Tetraethylammonium|Tetraethylammonium Chloride|Tetraethylammonium Iodide|Tetraethylammonium Ion|Iodide, Tetraethylammonium|tetraethylammonium|Ion, Tetraethylammonium|Hydroxide, Tetraethylammonium"
NEW13062,CHEMICAL,cgmp increase,cGMP increase
NEW13063,CHEMICAL,h2s synthesizing enzyme,H2S synthesizing enzymes
D003541,CHEMICAL,Cystathionine beta-Synthase,"Cystathionine Synthetase|cystathionine β-synthase|beta-Synthase, Cystathionine|Synthetase, Cystathionine|beta Thionase|Cystathionine beta Synthase|Serine Sulfhydrase|Sulfhydrase, Serine|beta-Thionase"
D006157,CHEMICAL,Guanosine Monophosphate,"Guanosine 5' Monophosphate|5'-Monophosphate, Guanosine|cGMP|Guanosine 5'-Monophosphate|5'-Guanylic Acid|guanosine monophosphate|Monophosphate, Guanosine|5' Guanylic Acid|Acid, Guanylic|Acid, 5'-Guanylic|Guanylic Acid|5'-GMP"
NEW13064,CHEMICAL,exogenous h2s,Exogenous H2S
NEW13065,CHEMICAL,cgmp accumulation,cGMP accumulation
NEW13066,CHEMICAL,meq/l bicarbonate,mEq/L bicarbonate
NEW13067,CHEMICAL,plasma bicarbonate,plasma bicarbonate
NEW13068,MENTAL_HEALTH,define syndrome,defined syndromes
D011084,CHEMICAL,Polycyclic Aromatic Hydrocarbons,"Hydrocarbons, Polycyclic Aromatic|Hydrocarbons, Aromatic Polycyclic|Polynuclear Aromatic Hydrocarbon|Aromatic Polycyclic Hydrocarbons|Aromatic Hydrocarbons, Polycyclic|Hydrocarbon, Polycyclic Aromatic|Aromatic Hydrocarbon, Polynuclear|polycyclic aromatic hydrocarbons|Aromatic Hydrocarbon, Polycyclic|Hydrocarbon, Polynuclear Aromatic|Aromatic Hydrocarbons, Polynuclear|Polynuclear Aromatic Hydrocarbons|Polycyclic Aromatic Hydrocarbon|Hydrocarbons, Polynuclear Aromatic|Polycyclic Hydrocarbons, Aromatic"
NEW13069,MENTAL_HEALTH,addition anterograde amnesia,addition anterograde amnesia
NEW13070,CHEBI,α7 nicotinic receptor partial agonist,α7 nicotinic receptor partial agonist
C543642,CHEMICAL,"spiro(1-azabicyclo(2.2.2)octane-3,2'(3H)-furo(2,3-b)pyridine) [Supplementary Concept]",AZD0328|Furans|Quinuclidines
NEW13071,CHEMICAL,chronic nicotine treatment,Chronic nicotine treatment
NEW13072,CHEMICAL,striatal presynaptic α6β2 receptor,striatal presynaptic α6β2 receptors
NEW13073,DISEASE,antidyskinetic effect,antidyskinetic effect
D000067399,DISEASE,Abnormal Involuntary Movement Scale,abnormal involuntary movement
NEW13074,DISEASE,parkinsonian monkey,parkinsonian monkeys
NEW13075,DISEASE,l-dopa-induced aim,L-dopa-induced AIMs
NEW13076,CHEMICAL,partial striatal dopamine lesion,partial striatal dopamine lesion
NEW13077,CHEBI,limited vitamin c intake,limited vitamin C intake
NEW13078,NUTRITION,european sea bass specimen,European sea bass specimens
NEW13079,DISEASE,experimental anemia,experimental anemia
C014758,CHEMICAL,plumbagin [Supplementary Concept],plumbagin|Naphthoquinones
NEW13080,DISEASE,bacillus subtilis cell,Bacillus subtilis cells
NEW13081,DISEASE,colic gastrointestinal disorder,colic gastrointestinal disorders
NEW13082,CHEMICAL,amiglumide,amiglumide
C048181,CHEMICAL,lorglumide [Supplementary Concept],lorglumide|Proglumide/analogs  and  derivatives
NEW13083,CHEMICAL,complex chromosome rearrangement,CCR|complex chromosome rearrangement
NEW13084,CHEMICAL,1-aminoanthraquinone-2-sulfonate,1-aminoanthraquinone-2-sulfonate
NEW13085,CHEMICAL,model anthraquinone compound,model anthraquinone compound
NEW13086,CHEBI,selective dopamine receptor agonist,selective dopamine receptor agonist
NEW13087,CHEMICAL,low hexcer,low HexCer
NEW13088,MENTAL_HEALTH,non-goal-directed nighttime hyperactivity,non-goal-directed nighttime hyperactivity
NEW13089,DISEASE,high tg,High TG
NEW13090,NUTRITION,photodynamic therapy porphyrin,Photodynamic therapy porphyrins
NEW13091,DISEASE,amyloid aggregation,amyloid aggregation
NEW13092,DISEASE,dsm-iii-r diagnostic criterion,DSM-III-R diagnostic criteria
D016163,CHEMICAL,"Genes, DCC","DCC Gene|Gene, DCC|DCC Genes|DCC"
NEW13093,CHEMICAL,glutamatergic n-methyl-d-aspartate nmda receptor,glutamatergic N-methyl-D-aspartate NMDA receptor
NEW13094,DISEASE,particular impairment,particular impairments
D000073218,CHEMICAL,Wisconsin Card Sorting Test,M-WCST|Modified Wisconsin Card Sorting Test|Wisconsin Card Sorting Test|Wisconsin Card Sorting test
NEW13095,MENTAL_HEALTH,increase distractibility,increased distractibility
NEW13096,DISEASE,endogenous psychosis,endogenous psychoses
NEW13097,CHEMICAL,ketamine effect,ketamine effects
C100708,CHEMICAL,oritavancin [Supplementary Concept],Oritavancin|Lipoglycopeptides|oritavancin
NEW13098,CHEMICAL,skin structure infection,skin structure infections|ABSSSI
NEW13099,CHEMICAL,common fq-related adverse effect,common FQ-related adverse effects
NEW13100,MENTAL_HEALTH,chelate agent picolinic acid,chelating agent picolinic acid|PICA
NEW13101,DISEASE,mp degradation,MP degradation
C521977,CHEMICAL,"poly-2,6-pyridinedicarboxylic acid [Supplementary Concept]","2,6-pyridinedicarboxylic acid|Pyridines|Carboxylic Acids"
C086107,CHEMICAL,"6-(4-hydroxybutyl)-2,3,5-trimethyl-1,4-benzoquinone [Supplementary Concept]","TMQ|6-(4-hydroxybutyl)-2,3,5-trimethyl-1,4- benzoquinone|Benzoquinones"
http://purl.obolibrary.org/obo/CHEBI_72294,CHEBI,nerve growth factor stimulator,nerve growth factor stimulators|NGF stimulator|NGF stimulators
NEW13102,DISEASE,different toxicity target,different toxicity targets
NEW13103,MENTAL_HEALTH,decrease forearm vascular resistance,decreased forearm vascular resistance
C511776,CHEMICAL,2'-((4'-trifluoromethanesulfonyloxy)phenyl)-N-methanesulfonylpropionamide [Supplementary Concept],Df|Sulfonamides
NEW13104,CHEMICAL,naoxintong capsule,NXTC|Naoxintong capsule
NEW13105,NUTRITION,insect herb,insect herbs
NEW13106,NUTRITION,adipocyte-derived saturated fatty acid,adipocyte-derived saturated fatty acids
NEW13107,DISEASE,grave abnormality,grave abnormalities
NEW13108,DISEASE,long-lasting neurobehavioral dysfunction,long-lasting neurobehavioral dysfunction
NEW13109,CHEMICAL,serum uric acid,serum uric acid
NEW13110,CHEBI,vitamin b3 nicotinic acid niacin deficiency,Vitamin B3 nicotinic acid niacin deficiency
NEW13111,DISEASE,systemic disease pellagra,systemic disease pellagra
D017495,DISEASE,Hyperpigmentation,Hypermelanosis|hyperpigmentation|Hypermelanoses
NEW13112,CHEMICAL,nad+ pool,NAD+ pool
NEW13113,DISEASE,reduce due stressor,reduced due stressors
NEW13114,CHEBI,vitamin b3 deficiency,Vitamin B3 deficiency
NEW13115,CHEMICAL,ethanol consumption,Ethanol consumption
NEW13116,DISEASE,fetal alcohol disorder,fetal alcohol disorders
NEW13117,DISEASE,structural damage,structural damage
D012410,MENTAL_HEALTH,"Rubella Syndrome, Congenital","Rubella Syndromes, Congenital|Syndromes, Congenital Rubella|congenital syndromes|Congenital Rubella Syndrome|Congenital Rubella Syndromes|Syndrome, Congenital Rubella"
D008831,DISEASE,Microcephaly,"Microlissencephaly|Microcephalies, Severe Congenital|Severe Congenital Microcephaly|Severe Congenital Microcephalies|Congenital Microcephalies, Severe|microcephaly|Microlissencephalies|Microcephalies|Congenital Microcephaly, Severe|Microcephaly, Severe Congenital"
NEW13118,DISEASE,speech difficulty,speech difficulties
D061085,DISEASE,Agenesis of Corpus Callosum,"Dysgenesis, Corpus Callosum|Corpus Callosum, Agenesis Of|Agenesis, Corpus Callosum|Corpus Callosum Agenesis|Hypogenesis, Corpus Callosum|Corpus Callosum Malformation|corpus callosum|Corpus Callosum Absences|Ageneses, Corpus Callosum|Corpus Callosum Hypogenesis|Absence of Corpus Callosum|Corpus Callosum Dysgeneses|Hypogeneses, Corpus Callosum|Corpus Callosum Ageneses|Corpus Callosum Dysgenesis|Corpus Callosum Hypogeneses|Dysgeneses, Corpus Callosum|Corpus Callosum Absence"
NEW13119,CHEMICAL,gold nanorod,AuNRs|gold nanorods
NEW13120,CHEMICAL,pendant ciprofloxacin,Cip|pendant ciprofloxacin
NEW13121,CHEBI,synergistic chemo-photothermal integrate antimicrobial platform,synergistic chemo-photothermal integrated antimicrobial platform
NEW13122,CHEBI,promise antibacterial agent,promising antibacterial agent
NEW13123,CHEMICAL,nucleotide metabolic pathway,nucleotide metabolic pathways
NEW13124,CHEMICAL,nucleotide pool,nucleotide pool
NEW13125,CHEMICAL,de purine biosynthesis,de purine biosynthesis
NEW13126,CHEMICAL,gdhr,gdhR
NEW13127,DISEASE,low tract infection,lower tract infection
NEW13128,CHEMICAL,gdhr,GdhR
NEW13129,CHEBI,virulence factor gene,virulence factor gene
http://purl.obolibrary.org/obo/SYMP_0000571,DISEASE,insomnia,agrypnia|sleep-disturbing
NEW13130,CHEMICAL,selective serotonin receptor inhibitor,selective serotonin receptor inhibitors
NEW13131,CHEMICAL,new serotonin 5-ht2-receptor antagonist,newer serotonin 5-HT2-receptor antagonists
NEW13132,CHEMICAL,effective antidepressant treatment,effective antidepressant treatment
NEW13133,DISEASE,hyperreactivity lung mechanic,hyperreactivity lung mechanics
D008355,CHEMICAL,Mannitol Phosphates,"mannitol|Phosphates, Mannitol"
NEW13134,CHEMICAL,h1 r expression,H1 R expression
NEW13135,CHEMICAL,m. genitalium,M. genitalium
D002575,DISEASE,Uterine Cervicitis,"Cervicitides, Uterine|Cervicitis|Uterine Cervicitides|Cervicitis, Uterine|cervicitis|Cervicitides"
D008594,DISEASE,"Menopause, Premature",menopause|Premature Menopause
NEW13136,CHEBI,vaginal estrogen,vaginal estrogen
NEW13137,CHEBI,vaginal vitamin e,vaginal vitamin E
NEW13138,CHEBI,old antimalarial drug,older antimalarial drug
NEW13139,CHEMICAL,daily glucose rhythm,daily glucose rhythm
NEW13140,CHEMICAL,elevated glutamate,Elevated glutamate
NEW13141,MENTAL_HEALTH,unipolar depression support model,unipolar depression support models
NEW13142,CHEMICAL,elevated lactate response,elevated lactate responses
NEW13143,CHEMICAL,increase glutamine/glutamate ratio,increased glutamine/glutamate ratio
NEW13144,CHEMICAL,low naa/cr,lower NAA/Cr
NEW13145,CHEMICAL,hippocampal naa/cr,hippocampal NAA/Cr
NEW13146,DISEASE,neuronal metabolic dysfunction,neuronal metabolic dysfunction
NEW13147,DISEASE,severe behavioural disorder,severe behavioural disorders
NEW13148,CHEBI,vitamin vitamin,vitamins vitamins
NEW13149,DISEASE,sensory deficit,sensory deficit
NEW13150,MENTAL_HEALTH,pregnancy depression,pregnancy depression
NEW13151,CHEBI,bixin aldehyde,bixin aldehyde
NEW13152,MENTAL_HEALTH,ion fragmentation pattern,ion fragmentation pattern
NEW13153,CHEMICAL,spirodiclofen administration,Spirodiclofen administration
NEW13154,CHEBI,lycopene application,Lycopene application
C508135,CHEMICAL,spirodiclofen [Supplementary Concept],spirodiclofen|4-Butyrolactone/analogs  and  derivatives|Spiro Compounds
NEW13155,CHEMICAL,sodium balance,sodium balance
NEW13156,DISEASE,osmoregulatory dysfunction,osmoregulatory dysfunction
NEW13157,CHEBI,serum carotenoid,Serum carotenoids
NEW13158,DISEASE,lean mass,lean mass
NEW13159,CHEBI,major serum carotenoid,major serum carotenoids
NEW13160,CHEMICAL,serum α-carotene,Serum α-carotene
NEW13161,DISEASE,chronic disease risk,chronic disease risk
NEW13162,DISEASE,seizure risk,seizure risk
NEW13163,CHEBI,analgesic action,analgesic action
D050482,CHEMICAL,Catecholamine Plasma Membrane Transport Proteins,"Catecholamine Transport Protein|Catecholamine Carrier|Neurotransmitter Transport Proteins, Catecholamine-Specific|Catecholamine Plasma Membrane Transporters|Catecholamine Plasma Membrane Transporter Proteins|Neurotransmitter Transport Proteins, Catecholamine Specific|catecholamine|Transporters, Catecholamine-Specific Neurotransmitter|Transport Protein, Catecholamine|Catecholamine-Specific Neurotransmitter Transporters|Neurotransmitter Transporters, Catecholamine-Specific|Neurotransmitter Transporters, Catecholamine Specific"
NEW13164,DISEASE,central centrifugal descend pain facilitatory system,central centrifugal descending pain facilitatory system
NEW13165,CHEMICAL,cortisol release,cortisol release
NEW13166,DISEASE,infantile-onset pompe disease,IOPD|infantile-onset Pompe disease
D006009,NUTRITION,Glycogen Storage Disease Type II,"Pompe Disease|Alpha-Glucosidase Deficiencies, Acid|Pompe's Disease|Juvenile Glycogen Storage Disease Type II|Type II, Glycogenosis|Deficiency of Alpha Glucosidase|Glycogenosis 2|GSD2s|Adult Glycogen Storage Disease Type II|Disease, Pompe's|Glycogen Storage Disease Type II, Infantile|GAA Deficiency|Deficiency Disease, Acid Maltase|Alpha-Glucosidase Deficiency, Acid|Deficiency, Acid Maltase|Alpha-1,4-Glucosidase Deficiencies|Alpha 1,4 Glucosidase Deficiency|Generalized Glycogenosis|Glycogen Storage Disease II|GSD II|Disease, Pompe|Deficiencies, Alpha-1,4-Glucosidase|Maltase Deficiencies, Acid|Glycogen Storage Disease Type 2|Lysosomal alpha-1,4-Glucosidase Deficiency Disease|GAA Deficiencies|Pompes Disease|Alpha-Glucosidase Deficiency|Deficiency of Alpha-Glucosidase|GSD2|Deficiency, Acid Alpha-Glucosidase|Acid Alpha-Glucosidase Deficiency|Deficiencies, Acid Alpha-Glucosidase|Deficiencies, Acid Maltase|Type IIs, Glycogenosis|Acid Alpha Glucosidase Deficiency|Glycogen Storage Disease Type II, Adult|Deficiency, GAA|Acid Alpha-Glucosidase Deficiencies|alpha glucosidase|Alpha-1,4-Glucosidase Deficiency|Alpha-Glucosidase Deficiencies|Glycogen Storage Disease Type II, Juvenile|Acid Maltase Deficiency|Generalized Glycogenoses|Lysosomal alpha 1,4 Glucosidase Deficiency Disease|Glycogenosis, Generalized|Acid Maltase Deficiency Disease|Glycogenoses, Generalized|Glycogenosis Type II|Infantile Glycogen Storage Disease Type II|Deficiencies, GAA|Deficiency, Alpha-1,4-Glucosidase|Deficiency Disease, Lysosomal alpha-1,4-Glucosidase|Acid Maltase Deficiencies"
C509951,CHEMICAL,"GAA protein, human [Supplementary Concept]",rhGAA|recombinant human acid alpha glucosidase|alpha-Glucosidases
D014003,NUTRITION,Tin Polyphosphates,"Polyphosphates, Stannous|Pyrophosphates, Stannous|Stannous Polyphosphates|Tin Pyrophosphates|Pyrophosphates, Tin|Polyphosphates, Tin|Stannous Pyrophosphates|Polyphosphates"
NEW13167,CHEMICAL,platelet-released polyp. p. gingivalis,platelet-released polyP. P. gingivalis
NEW13168,DISEASE,tumour necrosis factor-alpha suppressive property,tumour necrosis factor-alpha suppressive properties
D017676,CHEMICAL,"Lichen Planus, Oral",Oral Lichen Planus|Lichen planus
NEW13169,DISEASE,inflammatory autoimmune disorder,inflammatory autoimmune disorder
NEW13170,CHEMICAL,ai therapy,AIs therapy
http://purl.obolibrary.org/obo/CHEBI_22315,CHEMICAL,alkaloid,Rhoeadine alkaloids
NEW13171,DISEASE,p. somniferum,P. somniferum
NEW13172,DISEASE,p. rhoea,P. rhoeas
NEW13173,CHEMICAL,oral amantadine,oral amantadine
C583037,CHEMICAL,URMC-099 [Supplementary Concept],Pyrroles|Pyridines|URMC-099
NEW13174,DISEASE,synapse loss,synapse loss
NEW13175,DISEASE,dsd model,DSD model
NEW13176,CHEBI,brain-penetrant anti-inflammatory neuroprotective drug,brain-penetrant anti-inflammatory neuroprotective drug
NEW13177,CHEBI,hormone neurotrasnmitter molecule,hormone neurotrasnmitter molecule
NEW13178,CHEMICAL,fungi metarhizium robertsii dopamine,fungi Metarhizium robertsii dopamine
NEW13179,NUTRITION,great wax moth,greater wax moth
NEW13180,CHEMICAL,relative da concentration,relative DA concentrations
NEW13181,DISEASE,post infection time,post infection time
NEW13182,CHEMICAL,l-dopa preparation,L-dopa preparations
NEW13183,CHEBI,selective β3 adrenoceptor agonist,selective β3 adrenoceptor agonists
NEW13184,DISEASE,regional glucose hypometabolism,regional glucose hypometabolism
NEW13185,DISEASE,cispt-induced pharyngeal injury,CisPt-induced pharyngeal injury
NEW13186,CHEMICAL,approve serotonin re-uptake inhibitory drug duloxetine,approved serotonin re-uptake inhibitory drug duloxetine
NEW13187,CHEMICAL,approve antidepressant duloxetine,approved antidepressant duloxetine
NEW13188,DISEASE,gynecological condition,gynecological condition
NEW13189,CHEMICAL,female oxytocin system,female oxytocin system
NEW13190,DISEASE,bipolar spectrum,bipolar spectrum
NEW13191,DISEASE,seizure control,seizure control
NEW13192,CHEMICAL,clonazepam improvement,Clonazepam improvement
NEW13193,CHEBI,antiviral immunity,antiviral immunity
NEW13194,CHEMICAL,azt resistance,AZT resistance
NEW13195,CHEMICAL,chain-terminating nucleotide,chain-terminating nucleotide
NEW13196,CHEMICAL,engineer active tmpk,engineered active TMPK
NEW13197,CHEMICAL,azt activation,AZT activation
http://purl.obolibrary.org/obo/MFOMD_0000168,DISEASE,repression,CiFL1 repression|TNFα-mediated repression|CRISPR-mediated repression|SERCA2a repression|AZT-induced repression|CRISPRi-mediated repression|clove-mediated repression
NEW13198,DISEASE,hiv-infected t cell,HIV-infected T cells
NEW13199,CHEBI,sugar additive,sugar additives
NEW13200,DISEASE,social difficulty,social difficulties
NEW13201,CHEMICAL,low-quality friendship,low-quality friendships
NEW13202,NUTRITION,alpha 1-adrenoceptor,alpha 1-adrenoceptors
NEW13203,DISEASE,hypotensive activity,hypotensive activity
NEW13204,DISEASE,inherit metabolic disorder,inherited metabolic disorder
NEW13205,CHEMICAL,low-calorie ketogenic diet,Low-calorie ketogenic diets|LCKDs
http://purl.obolibrary.org/obo/SYMP_0000178,DISEASE,weight loss,pre-BS weight loss|Epigallocathechin-3-gallate-induced weight loss
NEW13206,CHEMICAL,pre-bs lckd,pre-BS LCKD
NEW13207,DISEASE,osas more,OSAS more
NEW13208,CHEMICAL,LCKD,LCKD
NEW13209,CHEMICAL,CPAP+LCKD,CPAP+LCKD
NEW13210,NUTRITION,low folate level,low folate level
NEW13211,CHEBI,folate increase,folate increase
NEW13212,DISEASE,cobalamin cbl c deficiency,cobalamin cbl C deficiency
NEW13213,CHEBI,vitamin b12 metabolism,vitamin B12 metabolism
D050683,CHEMICAL,R-SNARE Proteins,"RACT|R SNARES|R SNARE Proteins|Vesicle Associated Membrane Protein|R-SNARES|Membrane Proteins, Vesicle-Associated|Vesicle Associated Membrane Proteins|R|Synaptobrevins|Membrane Protein, Vesicle-Associated|Synaptobrevin|Proteins, R-SNARE|Vesicle-Associated Membrane Protein|Vesicle-Associated Membrane Proteins"
http://purl.obolibrary.org/obo/DOID_1094,DISEASE,attention deficit hyperactivity disorder,attention deficit disorder|ADHD|deficit hyperactivity disorder/attention deficit disorder|hyperkinetic disorder
NEW13214,DISEASE,unfavorable neuronal illness,unfavorable neuronal illnesses
NEW13215,DISEASE,deficit disorder deficit disorder,deficit disorder deficit disorder
NEW13216,CHEMICAL,mir-132 expression,miR-132 expression
NEW13217,DISEASE,gram-negative bacterium vibrio harveyi,Gram-negative bacterium Vibrio harveyi
NEW13218,CHEMICAL,available serotonin,available serotonin
C011626,CHEMICAL,adenosine 5'-triphosphate 3'-diphosphate [Supplementary Concept],adenosine 5'-triphosphate|Adenine Nucleotides|ATP
NEW13219,CHEMICAL,excitotoxic glutamate,excitotoxic glutamate
NEW13220,CHEBI,pharmacological antagonist,pharmacological antagonists
NEW13221,DISEASE,deleterious psychiatric condition,deleterious psychiatric conditions
NEW13222,CHEBI,brain penetrant p2x7r antagonist,brain penetrant P2X7R antagonists
NEW13223,CHEMICAL,rapid kinetic,rapid kinetics|fentanyl
NEW13224,MENTAL_HEALTH,cardiovascular depression,cardiovascular depression
NEW13225,CHEBI,narcotic anesthetic,narcotic anesthetic
NEW13226,MENTAL_HEALTH,prodromal psychosis,prodromal psychosis
NEW13227,CHEMICAL,spd screening questionnaire,SPD screening questionnaire
NEW13228,NUTRITION,dietary fibre intake,dietary fibre intake
D008797,CHEMICAL,Metyrapone,Methbipyranone|Metopiron|SU 4885|Methopyrapone|Métopirone|Metopirone|metyrapone
NEW13229,DISEASE,sps-induced anxiety-like behavior,SPS-induced anxiety-like behaviors
NEW13230,DISEASE,impaired fear extinction,impaired fear extinction
NEW13231,CHEMICAL,morphine effect,morphine effects
NEW13232,DISEASE,autoimmune thyroid disease,Autoimmune thyroid disease
NEW13233,CHEBI,common endocrine co-morbidity,common endocrine co-morbidity
NEW13234,DISEASE,tissue fibrosis,tissue fibrosis
D001546,CHEBI,Bentonite,Montmorillonite|Montmorrillonite|bentonite
NEW13235,CHEMICAL,small molecular aflatoxin b1,small molecular aflatoxin B1|AFB1
NEW13236,DISEASE,colorectal motility,colorectal motility
NEW13237,CHEMICAL,intracolonic administration,intracolonic administration
NEW13238,DISEASE,descend pain inhibitory pathway,descending pain inhibitory pathways
NEW13239,DISEASE,spinal defecation center,spinal defecation center
NEW13240,DISEASE,thoracic spinal transection,thoracic spinal transection
NEW13241,CHEMICAL,oxygen barrier,oxygen barrier
NEW13242,MENTAL_HEALTH,square displacement,square displacement
NEW13243,MENTAL_HEALTH,bond dissociation enthalpy,bond dissociation enthalpy
NEW13244,MENTAL_HEALTH,self-reported Athens insomnia scale,self-reported Athens insomnia scale
NEW13245,CHEMICAL,AIS score ≥,AIS score ≥
NEW13246,MENTAL_HEALTH,moderate insomnia,moderate insomnia
NEW13247,CHEMICAL,magnesium- melatonin-vitamin b complex supplementation,Magnesium- melatonin-vitamin B complex supplementation
NEW13248,CHEMICAL,tca overdose,TCA overdoses
NEW13249,CHEMICAL,physostigmine administration,physostigmine administration
NEW13250,CHEBI,dietary vitamin intake,dietary vitamin intakes
NEW13251,CHEBI,b2 vitamin E. Tobacco smoking,B2 vitamin E. Tobacco smoking
NEW13252,DISEASE,euglycemic hyperinsulinemia,euglycemic hyperinsulinemia
NEW13253,CHEBI,anterior pituitary trophic hormone,anterior pituitary trophic hormones
D055191,DISEASE,Delayed Emergence from Anesthesia,"Post-Anesthesia Delayed Awakenings|Residual Paralysis, Post Anesthesia|Neuromuscular Blockade, Residual|Residual Curarizations, Postoperative|neuromuscular block|Post-Anesthesia Residual Paralysis|Delayed Awakening, Post Anesthesia|Curarizations, Postoperative Residual|Residual Curarisations, Postoperative|Delayed Awakenings, Post-Procedural|Weaknesses, Postoperative Residual|Blockades, Residual Neuromuscular|Residual Neuromuscular Blockade|Delayed Awakening from Anesthesia|Post-Anesthesia Residual Paralyses|Weakness, Postoperative Residual|Residual Curarisation, Postoperative|Delayed Awakening, Post Procedural|Blockade, Residual Neuromuscular|Delayed Awakenings, Post-Anesthesia|Residual Curarization, Postoperative|Neuromuscular Block, Residual|Residual Neuromuscular Blocks|Residual Weaknesses, Postoperative|Residual Neuromuscular Block|Neuromuscular Blocks, Residual|Delayed Return of Consciousness|Postoperative Residual Curarizations|Block, Residual|Postoperative Residual Curarisation|Delayed Awakening, Post-Anesthesia|Block, Residual Neuromuscular|Residual Weakness, Postoperative|Delayed Recovery from Anesthesia|Neuromuscular Blockades, Residual|Curarization, Postoperative Residual|Delayed Regaining of Consciousness|Delayed Awakening, Post-Procedural|Paralyses, Post-Anesthesia Residual|Blocks, Residual Neuromuscular|Awakenings, Post-Anesthesia Delayed|Residual Neuromuscular Blockades|Postoperative Residual Weakness|Residual Block|Postoperative Residual Weaknesses|Residual Paralysis, Post-Anesthesia|Paralysis, Post-Anesthesia Residual|Blocks, Residual|Postoperative Residual Curarisations|Residual Paralyses, Post-Anesthesia|Post-Anesthesia Delayed Awakening|Postoperative Residual Curarization|Post-Procedural Delayed Awakening|Post-Procedural Delayed Awakenings|Residual Blocks|Awakening, Post-Anesthesia Delayed"
NEW13254,DISEASE,tetanic tension,tetanic tension
NEW13255,CHEMICAL,inject hexamethonium,injected hexamethonium
D010197,CHEMICAL,Pancuronium,"Pancuronium Bromide|Pancuronium Curamed|Pavulon|Bromide, Pancuronium|Pancuronium Organon|pancuronium"
NEW13256,CHEMICAL,partial tetanic fade,partial tetanic fade
D018696,CHEBI,Neuroprotective Agents,"neuroprotective drug|Neuroprotective Effects|Drugs, Neuroprotective|Neuroprotective Effect|Neuroprotective Drugs|Effect, Neuroprotective|Neuroprotective Drug|Agents, Neuroprotective|Drug, Neuroprotective|Neuroprotective Agent|Effects, Neuroprotective|Agent, Neuroprotective|Neuroprotectants|Neuroprotectant"
NEW13257,CHEMICAL,clinically-tolerated mechanism,clinically-tolerated mechanism
NEW13258,DISEASE,excitotoxic neuronal cell damage,Excitotoxic neuronal cell damage
NEW13259,CHEMICAL,n-methyl-d-aspartate (nmda)-type glutamate receptor,N-methyl-D-aspartate (NMDA)-type glutamate receptors
NEW13260,DISEASE,additional neurological disorder,additional neurological disorders
NEW13261,DISEASE,excitotoxic neuronal cell death,Excitotoxic neuronal cell death
NEW13262,CHEMICAL,n-methyl-d-aspartate (nmda)-type glutamate receptor,N-methyl-d-aspartate (NMDA)-type glutamate receptors
NEW13263,NUTRITION,main oil 's monounsaturated fatty acid,main oil's monounsaturated fatty acid
NEW13264,DISEASE,human cancer,human cancers
NEW13265,CHEMICAL,oleic acid oa,oleic acid OA
NEW13266,NUTRITION,steroid hormone signaling,steroid hormone signaling
NEW13267,CHEBI,serum sexual hormone level,serum sexual hormone levels
NEW13268,CHEBI,serum sexual hormone measurement,serum sexual hormone measurements
NEW13269,DISEASE,simple snore group,simple snoring group
NEW13270,DISEASE,severe osa patient,Severe OSA patients
NEW13271,CHEMICAL,low testosterone concentration,low testosterone concentration
NEW13272,CHEMICAL,anti-pd-1/anti-ctla-4 antibody,anti-PD-1/anti-CTLA-4 antibodies
NEW13273,DISEASE,tumor tissue,tumor tissues
NEW13274,DISEASE,t-cell infiltration,T-cell infiltration
http://purl.obolibrary.org/obo/CHEBI_65207,CHEBI,vascular endothelial growth factor receptor antagonist,VEGF receptor inhibitors|vascular endothelial growth factor receptor inhibitor|VEGF receptor inhibitor|vascular endothelial growth factor receptor inhibitors|vascular endothelial growth factor receptor antagonists|VEGFR inhibitor|VEGFR inhibitors
D000077784,CHEMICAL,Axitinib,AG-013736|AG013736|Inlyta|AG 013736|axitinib
NEW13275,CHEMICAL,human carbonic anhydrase 9,human carbonic anhydrase 9|hCA9
NEW13276,CHEBI,useful model neoantigen,useful model neoantigen
NEW13277,MENTAL_HEALTH,multivariable linear regression model,multivariable linear regression model
http://purl.obolibrary.org/obo/CHEBI_90620,CHEMICAL,vatalanib,PTK 787|CGP79787|N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine|PTK/ZK|PTK787|N-(p-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine|ZK-232934|axitinib AUCSS|CGP 79787|vatalanib|N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine|PTK-787|CGP-79787
NEW13278,DISEASE,mdd onset,MDD onset
NEW13279,MENTAL_HEALTH,nutrition mood disorder,nutrition mood disorders
NEW13280,CHEMICAL,endocannabinoid 2-arachidonylglycerol degradation,endocannabinoid 2-arachidonylglycerol degradation
NEW13281,CHEMICAL,serotonin gene-linked polymorphic region polymorphism,serotonin gene-linked polymorphic region polymorphisms
NEW13282,CHEMICAL,dapoxetine treatment,dapoxetine treatment
http://purl.obolibrary.org/obo/SYMP_0000061,DISEASE,inflammation,DHAV-1-induced inflammation|(LPS)-induced inflammation
NEW13283,MENTAL_HEALTH,phosphorylation modification,phosphorylation modification|pICA
NEW13284,CHEMICAL,dietary NA supplementation,Dietary NA supplementation
NEW13285,DISEASE,breast muscle,breast muscle
NEW13286,CHEMICAL,optimal dietary na supplementation,optimal dietary NA supplementation
NEW13287,CHEMICAL,tibial ca,tibial Ca
NEW13288,MENTAL_HEALTH,tamoxifen resistance,Tamoxifen resistance
NEW13289,DISEASE,estrogen receptor (er)‑positive breast cancer,estrogen receptor (ER)‑positive breast cancer
C000720887,CHEBI,EGFR inhibitor SP101 [Supplementary Concept],Quinazolines|EGFR inhibitor|Piperazines
NEW13290,CHEMICAL,tamoxifen resistance,tamoxifen resistance
D000077156,CHEMICAL,Gefitinib,N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide|gefitinib|ZD1839|Iressa|ZD 1839
NEW13291,CHEBI,fgfr inhibitor,FGFR inhibitors
NEW13292,DISEASE,advanced cholangiocarcinoma harboring fgfr2 fusion,advanced cholangiocarcinoma harboring FGFR2 fusions
NEW13293,CHEMICAL,lactate dehydrogenase efflux,lactate dehydrogenase efflux
NEW13294,CHEMICAL,mm nac,mM NAC
NEW13295,DISEASE,oxidative astrocyte death,oxidative astrocyte death
NEW13296,CHEMICAL,z-vad-fmk caspase inhibitor,z-VAD-FMK caspase inhibitor
NEW13297,CHEMICAL,cycloheximide protein synthesis inhibitor,Cycloheximide protein synthesis inhibitor
NEW13298,MENTAL_HEALTH,nuclear fragmentation,nuclear fragmentation
NEW13299,CHEBI,mm ascorbic acid,mM ascorbic acid
http://purl.obolibrary.org/obo/CHEBI_82625,CHEMICAL,trolox,"6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid|3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromene-2-carboxylic acid|Trolox C|6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|µM Trolox|Trolox"
NEW13300,DISEASE,oxidative neuronal death,oxidative neuronal death
NEW13301,DISEASE,bmaa-induced death,BMAA-induced death
NEW13302,DISEASE,tumor immunocombination therapy,tumor immunocombination therapy
NEW13303,DISEASE,tumor recurrence,tumor recurrence
NEW13304,DISEASE,immunogenic cell death effect,immunogenic cell death effect
NEW13305,CHEBI,antagonist (don)-loaded nanocarrier,antagonist (DON)-loaded nanocarrier
NEW13306,DISEASE,tumor immunocombination therapy due,tumor immunocombination therapy due
NEW13307,DISEASE,mx-1 human mammary tumor xenograft,MX-1 human mammary tumor xenograft
NEW13308,MENTAL_HEALTH,complete regression,complete regression
D008546,DISEASE,"Melanoma, Experimental","Experimental Melanoma|Harding-Passey Melanoma|Cloudman S91 Melanoma|Melanoma, Harding Passey|Melanomas, B16|S91 Melanoma, Cloudman|Melanoma, Cloudman S91|B16 melanoma|Melanomas, Experimental|Harding Passey Melanoma|Melanoma, Harding-Passey|B16 Melanoma|B16 Melanomas|Experimental Melanomas|Melanoma, B16"
NEW13309,DISEASE,cd8f1 mammary carcinoma,CD8F1 mammary carcinomas
NEW13310,DISEASE,hepatoma 3924a cell,hepatoma 3924A cells
NEW13311,CHEMICAL,purine nucleotide biosynthesis,purine nucleotide biosynthesis
C020828,CHEMICAL,GMP synthase (glutamine-hydrolyzing) [Supplementary Concept],Carbon-Nitrogen Ligases|GMP synthase
NEW13312,CHEBI,drug injection,Drug injection
http://purl.obolibrary.org/obo/PR_P23897,CHEMICAL,heat-stable enterotoxin receptor (rat),gc-c (rat)|intestinal guanylate cyclase (rat)|guanylyl cyclase c (rat)|gucy2c|guanylates|guc2c|sta receptor (rat)|rgucy2c
http://purl.obolibrary.org/obo/CHEBI_137396,CHEMICAL,5-carboxy-1-(5-o-phosphono-beta-d-ribofuranosyl)pyridinium-3-carbonyl adenylate,"adenylates|pyridinium-3,5-biscarboxylate mononucleotide adenylate|P2CMN-adenylate"
http://purl.obolibrary.org/obo/PR_P56702,CHEMICAL,diazepam-binding inhibitor-like 5 (rat),endozepines|dbil5|elp (rat)|rdbil5|endozepine-like peptide (rat)
D012214,DISEASE,Rheumatic Heart Disease,"Heart disease|Diseases, Rheumatic Heart|Heart Disease, Rheumatic|Bouillauds Disease|Rheumatic Heart Diseases|Bouillaud Disease|Disease, Bouillaud|Disease, Rheumatic Heart|Bouillaud's Disease|Heart Diseases, Rheumatic|heart disease|rheumatic heart disease|Disease, Bouillaud's"
NEW13313,CHEBI,secondary antibiotic prophylaxis,secondary antibiotic prophylaxis
NEW13314,CHEBI,antibiotic therapy,antibiotic therapy
NEW13315,CHEMICAL,oxytocin receptor gene allele,oxytocin receptor gene alleles
NEW13316,MENTAL_HEALTH,anxiety symptomology,anxiety symptomology
NEW13317,MENTAL_HEALTH,fatigue group,fatigue group
NEW13318,NUTRITION,sucker rod,sucker rods
NEW13319,MENTAL_HEALTH,experimental fatigue test,experimental fatigue tests
NEW13320,MENTAL_HEALTH,fatigue datum,fatigue data
NEW13321,CHEMICAL,ultra-high-strength hl,ultra-high-strength HL
NEW13322,MENTAL_HEALTH,fitting result fatigue test value,fitting result fatigue test value
NEW13323,NUTRITION,hl- ultra-high strength sucker rod,HL- ultra-high strength sucker rods
NEW13324,CHEMICAL,untreated mets rat,untreated MetS rats
NEW13325,DISEASE,behavioral abnormality,behavioral abnormality
NEW13326,CHEMICAL,win55,WIN55
NEW13327,CHEBI,antibiotic combination,Antibiotic combinations
NEW13328,CHEBI,available antibiotic,available antibiotics
NEW13329,MENTAL_HEALTH,fos resistance,FOS resistance
D011770,CHEMICAL,Pyruvate Kinase,"Pyruvate Kinase, M1-Type|M-Type Pyruvate Kinase|M1 Type Pyruvate Kinase|M2-Type Pyruvate Kinase|pyruvate kinase|L Type Pyruvate Kinase|Pyruvate Kinase, R-Type|Pyruvate Kinase, M-Type|M1-Type Pyruvate Kinase|M2 Type Pyruvate Kinase|Pyruvate Kinase, M2-Type|Pyruvate Kinase, L-Type|M Type Pyruvate Kinase|R-Type Pyruvate Kinase|Pyruvate Kinase L|R Type Pyruvate Kinase|L-Type Pyruvate Kinase"
NEW13330,CHEMICAL,phosphoenolpyruvate pep flux,phosphoenolpyruvate PEP flux
NEW13331,CHEMICAL,pep flux,PEP flux
C499823,CHEMICAL,"5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid [Supplementary Concept]",RvE1|Eicosapentaenoic Acid/analogs  and  derivatives|Resolvin E1
NEW13332,CHEMICAL,PSL     mg/kg,PSL    mg/kg
NEW13333,MENTAL_HEALTH,depression mouse model,depression mouse model
NEW13334,DISEASE,repeat psl-induced increase,repeated PSL-induced increase
NEW13335,CHEMICAL,intra-mpfc infusion,intra-mPFC infusions
NEW13336,DISEASE,psl-induced depression-like behavior,PSL-induced depression-like behavior
NEW13337,CHEMICAL,dha content,DHA content
NEW13338,CHEMICAL,lcpufa content,LCPUFA content
NEW13339,CHEMICAL,omega-3 pufa,Omega-3 PUFAs
NEW13340,CHEMICAL,glucocorticoid cortisol concentration,glucocorticoid cortisol concentrations
NEW13341,CHEMICAL,glycine antagonist,glycine antagonist
C066192,CHEMICAL,"5,7-dichlorokynurenic acid [Supplementary Concept]","DCKA|5,7-dichlorokynurenic acid|Kynurenic Acid/analogs  and  derivatives"
C105319,CHEMICAL,"3-(2-((phenylamino)carbonyl)ethenyl)-4,6-dichloroindole-2-carboxylic acid [Supplementary Concept]",Indoles|GV150526A
NEW13342,CHEBI,antimicrobial intervention,antimicrobial interventions
NEW13343,DISEASE,campylobacter population,Campylobacter populations
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Cerebral_Ischemia,DISEASE,cerebral ischemia,cerebral ischemia injury
NEW13344,DISEASE,infarct volume,Infarct volume
NEW13345,CHEMICAL,5-triphenyltetrazolium chloride staining,5-Triphenyltetrazolium chloride staining
NEW13346,CHEBI,glutamate n-methyl-d-aspartate nmda receptor antagonist ketamine,glutamate N-methyl-d-aspartate NMDA receptor antagonist ketamine
NEW13347,DISEASE,comorbid ptsd,comorbid PTSD
NEW13348,CHEMICAL,preferential d2 dopamine antagonist haloperidol,preferential D2 dopamine antagonist haloperidol
D013786,CHEMICAL,Thalamic Diseases,"Dejerine-Roussy Syndrome|Syndrome, Dejerine-Roussy|Syndrome, Thalamic|Syndromes, Thalamic|Thalamic Disease|Disease, Thalamic|Déjerine-Roussy syndrome|Thalamic Syndromes|Diseases, Thalamic|Dejerine Roussy Syndrome|thalamic syndrome|Thalamic Syndrome"
NEW13349,DISEASE,transient mild hemiparesis,transient mild hemiparesis
http://purl.obolibrary.org/obo/SYMP_0000293,DISEASE,hemiparesis,hemichoreoathetosis|hemichorea|hemihypoesthesia
http://purl.obolibrary.org/obo/SYMP_0000414,MENTAL_HEALTH,dysarthria,astereognosia
NEW13350,CHEMICAL,cd treatment,Cd treatment
NEW13351,DISEASE,juvenile P. trituberculatus,juvenile P. trituberculatus
NEW13352,DISEASE,juvenile f. chinensis,juvenile F. chinensis
NEW13353,DISEASE,immunotoxicity disorder,immunotoxicity disorder
NEW13354,CHEBI,maternal vitamin b12 status,maternal vitamin B12 status
NEW13355,MENTAL_HEALTH,adiposity resistance,adiposity resistance
NEW13356,DISEASE,ammonia-induced neurotoxicity,ammonia-induced neurotoxicity
NEW13357,DISEASE,bipolar patient,bipolar patient
NEW13358,CHEMICAL,carbidopa intestinal gel,carbidopa intestinal gel|Duodopa
NEW13359,MENTAL_HEALTH,sufficient analgesia,sufficient analgesia
NEW13360,DISEASE,surgical trauma,surgical trauma
D010908,CHEBI,"Pituitary Hormones, Anterior","Adenohypophyseal Hormones|Anterior Pituitary Hormones|anterior pituitary hormones|Hormones, Anterior Pituitary|Hormones, Adenohypophyseal"
NEW13361,CHEBI,infant carrier,Infant carriers
NEW13362,CHEMICAL,prenatal ethanol exposure,Prenatal ethanol exposure
C435731,CHEMICAL,fluoro jade [Supplementary Concept],Fluoro-jade-B|Fluoresceins
NEW13363,DISEASE,possible neurodegeneration,possible neurodegeneration
http://purl.obolibrary.org/obo/CHEBI_51240,CHEMICAL,propidium iodide,"propidium diiodide|3,8-diamino-5-(3-(diethylmethylammonio)propyl)-6-phenylphenanthridinium diiodide|3,8-diamino-5-{3-[diethyl(methyl)ammonio]propyl}-6-phenylphenanthridinium diiodide|propidium iodide staining"
NEW13364,CHEMICAL,gaba(b)r,GABA(B)R
NEW13365,CHEMICAL,nicotine neurodevelopmental defect,nicotine neurodevelopmental defects
NEW13366,MENTAL_HEALTH,regression slope,regression slopes
NEW13367,MENTAL_HEALTH,resistance class,resistance classes
NEW13368,CHEMICAL,grain weight,grain weight
NEW13369,DISEASE,% ger severity,% GER severity
NEW13370,CHEBI,multiple mycotoxin,multiple mycotoxins
D002953,CHEMICAL,Citrinin,Benzopyrans (1969-1974)|CIT|citrinin
NEW13371,CHEMICAL,aunp dimers/mxene,AuNP dimers/MXenes
C009166,CHEMICAL,retinol acetate [Supplementary Concept],9-cis-retinyl acetate|retinyl acetate|QLT091001|Retinyl Esters|Diterpenes|all-trans-retinyl acetate|RAc
http://purl.obolibrary.org/obo/DOID_10584,DISEASE,retinitis pigmentosa,LRAT-related retinitis pigmentosa|pericentral pigmentary retinopathy
http://purl.obolibrary.org/obo/CHEBI_47775,NUTRITION,high-density lipoprotein cholesterol,high-density lipoprotein HDL cholesterol efflux capacity|HDL cholesterol|HDL-C|alpha-lipoprotein cholesterol|low high-density lipoprotein cholesterol levels|lower high-density lipoprotein cholesterol
NEW13372,DISEASE,neuropsychological impairment,neuropsychological impairments
NEW13373,MENTAL_HEALTH,organic amnesia,organic amnesia
NEW13374,CHEMICAL,psl injury,PSL injury
NEW13375,DISEASE,reduce heat allodynia,reduced heat allodynia
NEW13376,DISEASE,concentration neuropathic pain,concentrations neuropathic pain
NEW13377,CHEMICAL,cholecystokinin cck receptor,Cholecystokinin CCK receptors
NEW13378,CHEMICAL,da activity,DA activity
NEW13379,CHEMICAL,1mm,1mM
NEW13380,DISEASE,rare inborn disease,rare inborn disease
NEW13381,CHEMICAL,fatty acid oxidation defect,Fatty acid oxidation defects|FAOD
NEW13382,DISEASE,common metabolic liver disease,common metabolic liver diseases
NEW13383,CHEMICAL,marked hprl,marked HPRL
D049913,DISEASE,ACTH-Secreting Pituitary Adenoma,"ACTH-Secreting Pituitary Adenomas|Corticotropin-Secreting Adenomas, Pituitary|Pituitary Adenomas, ACTH-Producing|Pituitary Adenomas, ACTH-Secreting|Adenoma, Corticotroph|ACTH-Producing Pituitary Adenoma|Pituitary Corticotropin-Secreting Adenomas|Corticotropin-Secreting Adenoma, Pituitary|Pituitary Corticotropin-Secreting Adenoma|pituitary adenoma|ACTH-Producing Pituitary Adenomas|Pituitary Adenoma, ACTH Secreting|Pituitary Corticotropin Secreting Adenoma|Corticotroph Adenomas|Pituitary Adenoma, ACTH-Secreting|Corticotroph Adenoma|Adenomas, Corticotroph|ACTH Secreting Pituitary Adenoma|Pituitary Adenoma, ACTH-Producing|ACTH Producing Pituitary Adenoma"
D029863,NUTRITION,Cicer,"Garbanzos|Cicer arietinum|Cicer arietinums|chickpea|Garbanzo|Chickpeas|Chickpea|arietinum, Cicer|Cicers"
NEW13384,NUTRITION,insect midgut,insect midgut
NEW13385,CHEMICAL,protoxin-toxin conversion,protoxin-toxin conversion
NEW13386,CHEMICAL,fosfomycin removal,Fosfomycin removal
NEW13387,MENTAL_HEALTH,orbital agitation speed,orbital agitation speed
NEW13388,CHEMICAL,non-synergistic strain,AB250|non-synergistic strain
NEW13389,DISEASE,heteroresistance subpopulation,heteroresistance subpopulation
NEW13390,DISEASE,maternal infection,maternal infections
NEW13391,CHEMICAL,vta dopamine neuron,VTA dopamine neurons
NEW13392,CHEMICAL,nicotine cocaine administration,nicotine cocaine administration
NEW13393,DISEASE,several hypertension guideline,Several hypertension guidelines
NEW13394,NUTRITION,european sea bass,European sea bass
NEW13395,CHEMICAL,antagonist ketamine,antagonists ketamine
NEW13396,CHEMICAL,naloxone-induced morphine abstinence syndrome,naloxone-induced morphine abstinence syndrome
NEW13397,CHEMICAL,naloxone-elicited morphine abstinence syndrome,naloxone-elicited morphine abstinence syndrome
C057884,CHEMICAL,diclazuril [Supplementary Concept],Triazines|Nitriles|diclazuril
NEW13398,CHEMICAL,amine template,amine templates
NEW13399,MENTAL_HEALTH,ionic dissociation,ionic dissociation
NEW13400,CHEBI,pre-polymerization mixture,pre-polymerization mixture
NEW13401,CHEMICAL,sucrose inhibition,Sucrose inhibition
NEW13402,CHEMICAL,guajava Linnaeus,guajava Linnaeus
NEW13403,DISEASE,gastroenteritis diarrhea,gastroenteritis diarrhea
NEW13404,CHEMICAL,guava leaf-made medicine,guava leaf-made medicines
NEW13405,DISEASE,diarrhea case,diarrhea cases
D002719,CHEMICAL,Chlormethiazole,|Clomethiazole|chlormethiazole|Distraneurin|clomethiazole
NEW13406,MENTAL_HEALTH,alcohol dependence long-lasting benzodiazepine,alcohol dependence long-lasting benzodiazepines
NEW13407,CHEBI,beta diversity,beta diversity
NEW13408,MENTAL_HEALTH,antimicrobial resistance,Antimicrobial resistance
NEW13409,CHEMICAL,myocellular h+ accumulation,Myocellular H+ accumulation
NEW13410,CHEMICAL,skeletal muscle atp-sensitive k+ katp channel,skeletal muscle ATP-sensitive K+ KATP channel
NEW13411,CHEMICAL,damage atp depletion,damaging ATP depletion
NEW13412,DISEASE,damage dysfunction,damage dysfunction
http://purl.obolibrary.org/obo/CHEBI_62215,CHEMICAL,allelochemical,fluazinam-treated plants|allelochemicals
NEW13413,MENTAL_HEALTH,early defense mechanism,early defense mechanism
NEW13414,CHEMICAL,resistance activator benzothiadiazole,resistance activator benzothiadiazole|BTH
NEW13415,MENTAL_HEALTH,pathogen resistance,pathogen resistance
NEW13416,CHEMICAL,systemic acquire resistance activator benzothiadiazole,systemic acquired resistance activator benzothiadiazole
NEW13417,CHEMICAL,hepatic cytosolic glutathione s-transferase,hepatic cytosolic glutathione S-transferases
NEW13418,CHEMICAL,overall gst-cdnb activity,overall GST-CDNB activity
D005015,CHEMICAL,Ethoxyquin,"ethoxyquin|1,2-Dihydro-6-Ethoxy-2,2,4-Trimethylquinoline|6-ethoxy-2,2,4-trimethyl-1,2-dihydroquinoline|Santoquin|6-ETMDQ"
NEW13419,NUTRITION,hepatic bullhead gst isoform,hepatic bullhead GST isoforms
NEW13420,NUTRITION,bullhead gst isoform,bullhead GST isoforms
NEW13421,DISEASE,pollutant-associated neoplasia,pollutant-associated neoplasia
NEW13422,MENTAL_HEALTH,potential repression,potential repression
NEW13423,CHEMICAL,fructose administration,fructose administration
NEW13424,CHEMICAL,increase lactate production,increased lactate production
NEW13425,NUTRITION,hair follicle stem/progenitor cell differentiation,hair follicle stem/progenitor cell differentiation
NEW13426,DISEASE,tumor initiation,tumor initiation
http://purl.obolibrary.org/obo/PR_000004112,CHEMICAL,ap-4 complex subunit epsilon-1,adapter-related protein complex 4 subunit epsilon-1|epsilon subunit of ap-4|ap-4 adapter complex subunit epsilon|epsilon-adaptin|ap4e1|AP4E1|ap-4 adaptor complex subunit epsilon|adaptor-related protein complex 4 subunit epsilon-1
NEW13427,MENTAL_HEALTH,persistent stuttering,persistent stuttering
C476123,CHEMICAL,"HEXIM1 protein, human [Supplementary Concept]",Transcription Factors|hexamethylene bisacetamide|RNA-Binding Proteins
NEW13428,CHEMICAL,deltapml-raralpha formation,deltaPML-RARalpha formation
NEW13429,DISEASE,nb4-ci arsenic-resistant nb4/as cell,NB4-CI arsenic-resistant NB4/As cells
NEW13430,CHEMICAL,activated-hydrochar,Activated-hydrochar
C018279,NUTRITION,sodium phosphate [Supplementary Concept],Phosphates|phosphoric acid
D012972,CHEMICAL,Sodium Hydroxide,"sodium hydroxide|Hydroxide, Sodium|Caustic Soda|Soda, Caustic"
NEW13431,DISEASE,activated-hydrochar,AHC|Activated-hydrochar
C071567,CHEMICAL,"general secretion pathway protein, Xanthomonas campestris [Supplementary Concept]",XPS|Bacterial Proteins|Membrane Transport Proteins
D015900,MENTAL_HEALTH,"Radiography, Dual-Energy Scanned Projection","Digital Scan Projection Radiography, Dual-Energy|Dual Energy Scanned Projection Radiography|Digital Scan Projection Radiography, Dual Energy|projection|Digital Scanned Projection Radiography, Dual Energy|Dual-Energy Scanned Projection Radiography|Radiography, Dual Energy Scanned Projection|Digital Scanned Projection Radiography, Dual-Energy"
D002482,CHEMICAL,Cellulose,"alpha-Cellulose|Rayophane|Avicel|Sulfite Cellulose|alpha Cellulose|Heweten|Polyanhydroglucuronic Acid|Acid, Polyanhydroglucuronic|Alphacel|alpha-cellulose"
C488493,CHEMICAL,"galactan-galactan galactosyltransferase, Ajuga reptans [Supplementary Concept]",Galactosyltransferases|galactan
NEW13432,NUTRITION,first whale,first whale
NEW13433,DISEASE,numerous skin lesion,numerous skin lesions
NEW13434,NUTRITION,second whale,second whale
NEW13435,CHEMICAL,aa/epa,AA/EPA
NEW13436,CHEMICAL,tissue pufa change,tissue PUFA change
NEW13437,CHEMICAL,binding affinity,ΔG|binding affinities
D047310,CHEMICAL,Apigenin,Apigenin|apigenin|Flavonoids (1967-2004)
NEW13438,DISEASE,human endometriosis,human endometriosis
NEW13439,DISEASE,endometriosis cell line,endometriosis cell lines
NEW13440,CHEMICAL,selective serotonin re-uptake inhibitor,selective serotonin re-uptake inhibitor
NEW13441,CHEMICAL,Zoloft trade mark,Zoloft trade mark
NEW13442,CHEMICAL,hexacarboxyporphyrin,hexacarboxyporphyrin
C026971,CHEMICAL,coproporphyrin III [Supplementary Concept],Zincphyrin|coproporphyrin|Coproporphyrins
http://purl.obolibrary.org/obo/CHEBI_52188,NUTRITION,meso-substituted porphyrin,meso-substituted porphyrins|porphyrins pentacarboxyporphyrin
D014578,CHEMICAL,Uroporphyrins,Porphyrins (1968-1974)|uroporphyrins
NEW13443,CHEMICAL,precoproporhyrin,precoproporhyrin
NEW13444,MENTAL_HEALTH,autism severity,autism severity
NEW13445,DISEASE,concomitant alcoholism,concomitant alcoholism
NEW13446,DISEASE,acute deficiency,acute deficiency
D000052,DISEASE,Acanthosis Nigricans,"acanthosis nigricans|Nigrican, Acanthosis|Acanthosis Nigrican|Nigricans, Acanthosis"
NEW13447,CHEMICAL,tianeptine selective serotonin reuptake enhancer,Tianeptine selective serotonin reuptake enhancer
NEW13448,CHEMICAL,aripiprazole adjunctive therapy,aripiprazole adjunctive therapy
NEW13449,DISEASE,complex post-stroke emotional disorder,complex post-stroke emotional disorders
NEW13450,CHEMICAL,gamma aminobutyric acid gaba receptor agonist,Gamma aminobutyric acid GABA receptor agonists
NEW13451,DISEASE,infarct size,infarct size
NEW13452,DISEASE,acute stroke patient due,acute stroke patients due
NEW13453,MENTAL_HEALTH,fragmentation regularity,fragmentation regularity
http://purl.obolibrary.org/obo/CHEBI_87100,CHEBI,triazole fungicide,triazole fungicides
NEW13454,NUTRITION,stg fatty acid composition,STG fatty acid composition
NEW13455,DISEASE,multiple sclerosis patient,multiple sclerosis patients
NEW13456,DISEASE,certain ejaculatory disorder,certain ejaculatory disorders
C090413,CHEMICAL,N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide [Supplementary Concept],"WAY-100,635|Pyridines|Piperazines"
NEW13457,CHEMICAL,specific serotonin receptor antagonist,specific serotonin receptor antagonists
http://purl.obolibrary.org/obo/CHEBI_24870,CHEMICAL,ion,Ag+ ion
C419664,CHEMICAL,udenafil [Supplementary Concept],Udenafil|Pyrimidines|Sulfonamides|udenafil
NEW13458,DISEASE,pulmonary vascular resistance index,pulmonary vascular resistance index
NEW13459,CHEMICAL,50-mg baseline dose,50-mg baseline dose
NEW13460,CHEMICAL,tadalafil cialis ®,tadalafil Cialis ®
NEW13461,DISEASE,severe hypotension,severe hypotension
NEW13462,CHEMICAL,natural antioxidant sulforaphane,natural antioxidant sulforaphane
NEW13463,CHEMICAL,parvalbumin immunoreactivity,parvalbumin immunoreactivity
http://purl.org/sig/ont/fma/fma74639,CHEMICAL,adrenocorticotropin,ACTH|adrenocorticotrophin
NEW13464,DISEASE,liver tumor,liver tumors
NEW13465,DISEASE,steatosis-related early-stage hepatocarcinogenesis,steatosis-related early-stage hepatocarcinogenesis
NEW13466,DISEASE,steatosis-related hepatocarcinogenesis,steatosis-related hepatocarcinogenesis
NEW13467,MENTAL_HEALTH,obvious due drug resistance,obvious Due drug resistance
NEW13468,DISEASE,p. aeruginosa colony formation,P. aeruginosa colony formation
C046641,CHEMICAL,juglone hydroxylase [Supplementary Concept],juglone|Oxidoreductases
NEW13469,CHEMICAL,impaired brain glucose metabolism,impaired brain glucose metabolism
NEW13470,DISEASE,cerebral hypoperfusion,Cerebral hypoperfusion
NEW13471,DISEASE,impaired bioavailability,impaired bioavailability
NEW13472,CHEMICAL,succinate dehydrogenase inhibitor,succinate dehydrogenase inhibitors|SDHIs
NEW13473,MENTAL_HEALTH,double resistance due,double resistance due
NEW13474,MENTAL_HEALTH,double resistance,double resistance
NEW13475,CHEMICAL,serotonin 5-hydroxytryptamine system,serotonin 5-hydroxytryptamine system
NEW13476,DISEASE,in gastrointestinal digestion,in gastrointestinal digestion
NEW13477,CHEBI,multiple stabilizer,multiple stabilizers
C085734,CHEMICAL,rhamnopyranosyl-3-hydroxydecanoyl-3-hydroxydecanoate [Supplementary Concept],rhamnolipid|Decanoates|Rhamnose/analogs  and  derivatives|Rha
C036604,CHEMICAL,esmolol [Supplementary Concept],Propanolamines|esmolol
NEW13478,CHEBI,selective beta antagonist,Selective beta antagonists
NEW13479,DISEASE,significant tachycardia,significant tachycardia
NEW13480,CHEBI,alpha adrenergic antagonist,alpha adrenergic antagonist
D011942,NUTRITION,"Receptors, Adrenergic, alpha","alpha Adrenergic Receptors|alpha receptors|Receptor, Adrenergic, alpha|Adrenergic alpha-Receptor|Receptor, alpha-Adrenergic|Receptors, alpha-Adrenergic|alpha-Receptors, Adrenergic|Adrenergic alpha Receptor|alpha-Receptor, Adrenergic|alpha-Adrenergic Receptors|Adrenergic alpha Receptors|alpha Adrenergic Receptor|Receptors, alpha Adrenergic|alpha-Adrenergic Receptor|Adrenergic alpha-Receptors"
NEW13481,CHEMICAL,excess catecholamine,excess catecholamines
D006323,DISEASE,Heart Arrest,"|Asystole|Arrest, Cardiopulmonary|asystole|Arrest, Cardiac|Asystoles|cardiac asystole|Cardiopulmonary Arrest|Arrest, Heart|Cardiac Arrest"
NEW13482,DISEASE,coronary spasm,coronary spasm
D019569,DISEASE,Hemifacial Spasm,"Unilateral Facial Spasm|Spasm, Unilateral Facial|Unilateral Facial Spasms|Myokymia, Hemifacial|Spasm, Hemifacial|Spasms, Hemifacial|Facial Spasm, Unilateral|Facial Spasms, Unilateral|Spasm|Spasms, Unilateral Facial|Hemifacial Myokymia|Hemifacial Spasms"
NEW13483,CHEMICAL,calcium blocker nitrendipine,calcium blocker nitrendipine
NEW13484,MENTAL_HEALTH,adhd comorbidity,ADHD comorbidity
NEW13485,DISEASE,various pediatric psychiatric disorder,various pediatric psychiatric disorders
NEW13486,CHEBI,drug profile,drug profile
NEW13487,CHEBI,human growth hormone intron,human growth hormone intron
C029795,CHEBI,diphtheria toxin fragment A [Supplementary Concept],Diphtheria Toxin|Peptide Fragments|diphtheria toxin fragment A
D048909,DISEASE,Diabetes Complications,Complications of Diabetes Mellitus|Diabetes Mellitus Complications|diabetes complications|diabetic complications|Diabetic Complications|Diabetes Complication|Diabetes-Related Complications|Diabetes Related Complications|Diabetes Mellitus Complication|Diabetes-Related Complication|Diabetic Complication
NEW13488,DISEASE,cardiomyopathy dcm protection,cardiomyopathy DCM protection
NEW13489,CHEMICAL,alpha- lipoic acid supplementation,alpha- lipoic acid supplementation
NEW13490,CHEMICAL,metabolite 3-methoxy-4-hydroxyphenylglycol,MHPG|metabolite 3-methoxy-4-hydroxyphenylglycol
NEW13491,DISEASE,melancholic patient,melancholic patients
NEW13492,DISEASE,microvesicular lipidosis,microvesicular lipidosis
NEW13493,CHEMICAL,long-acting β(2)-adrenoceptor agonist,long-acting β(2)-adrenoceptor agonists|LABAs
C564221,MENTAL_HEALTH,Glucocorticoid Receptor Deficiency [Supplementary Concept],"glucocorticoid resistance|Metabolism, Inborn Errors|Receptors, Glucocorticoid/deficiency"
C092797,CHEMICAL,safinamide [Supplementary Concept],Safinamide|Benzylamines|safinamide|Alanine/analogs  and  derivatives
D004079,CHEMICAL,Dihydro-beta-Erythroidine,"Dihydro beta Erythroidine|Erythroidine, Dihydro beta|beta Erythroidine, Dihydro|dihydro-beta-erythroidine"
NEW13494,DISEASE,chronic facial musculoskeletal pain,chronic facial musculoskeletal pain
NEW13495,CHEMICAL,za therapy,ZA therapy
D020913,CHEMICAL,Perindopril,"S 9490|Perstarium|S 9490-3|S-9490|S 9490 3|perindopril|S 94903|S9490|Perindopril Erbumine|Pirindopril|Erbumine, Perindopril"
NEW13496,DISEASE,mouse tumor growth,mice tumor growth
NEW13497,CHEMICAL,succinate deyhydrogenase 0.05,succinate deyhydrogenase 0.05
NEW13498,CHEMICAL,bpa exposure,BPA exposure
NEW13499,DISEASE,neurodevelopmental difficulty,neurodevelopmental difficulties
NEW13500,DISEASE,bdnf-induced platelet aggregation,BDNF-induced platelet aggregation
D020830,CHEBI,rac1 GTP-Binding Protein,"GTP-Binding Protein, TC-25|rac1 Protein|TC 25 GTP Binding Protein|GTP-Binding Protein, rac1|TC-25 GTP-Binding Protein|Ras-related C3 botulinum toxin substrate|ras Related C3 Botulinum Toxin Substrate 1|ras-Related C3 Botulinum Toxin Substrate 1|rac1 GTP Binding Protein"
NEW13501,MENTAL_HEALTH,worldwide antimicrobial resistance,Worldwide antimicrobial resistance
NEW13502,DISEASE,hiv rt mutation,HIV RT mutations
NEW13503,CHEMICAL,aztmp excision,AZTMP excision
NEW13504,CHEMICAL,zidovudine resistance,zidovudine resistance
NEW13505,CHEMICAL,cysteinyl leukotriene receptor antagonist,Cysteinyl leukotrienes receptor antagonists
D011014,DISEASE,Pneumonia,"lung inflammation||Inflammations, Lung|Inflammation, Pulmonary|Lung Inflammation|Inflammation, Experimental Lung|Pneumonias|Pneumonias, Lobar|Experimental Lung Inflammations|Lung Inflammation, Experimental|Lung Inflammations, Experimental|Pneumonitides|Lobar Pneumonia|pulmonary inflammation|Inflammation, Lung|Pneumonia, Lobar|Pulmonary Inflammations|Experimental Lung Inflammation|Pulmonary Inflammation|pneumonitis|Pneumonitis|Lung Inflammations|Lobar Pneumonias|Inflammations, Pulmonary"
NEW13506,CHEMICAL,iron-chelated aspartate,iron-chelated aspartate|Fe-Asp
C510105,CHEMICAL,halotrichite [Supplementary Concept],Alum Compounds|Ferrous Compounds|FeSO4
NEW13507,DISEASE,sunflower plant,sunflower plants
NEW13508,CHEMICAL,eef2 k,eEF2 K
NEW13509,DISEASE,aging-related cognitive deficit,aging-related cognitive deficits
NEW13510,CHEMICAL,eef2 k inhibitor,eEF2 K inhibitors
NEW13511,MENTAL_HEALTH,ad syndrome,AD syndromes
NEW13512,DISEASE,animal parkinsonism,animal parkinsonism
NEW13513,DISEASE,extensive wml,extensive WMLs
NEW13514,DISEASE,ovarian cancer patient,ovarian cancer patients
NEW13515,MENTAL_HEALTH,side-chain orientation,side-chain orientation
NEW13516,CHEMICAL,triglycerol pocket,triglycerol pocket
NEW13517,CHEBI,prototypical kor agonist,prototypical KOR agonists
NEW13518,CHEBI,dopamine agonist withdrawal syndrome,dopamine agonist withdrawal syndrome
NEW13519,DISEASE,dopamine agonist withdrawal syndrome,dopamine agonist withdrawal syndrome|DAWS
NEW13520,DISEASE,generalize pain craving,generalized pain cravings
NEW13521,CHEMICAL,hebt,HEBT
NEW13522,NUTRITION,brown rice extract,brown rice extracts
NEW13523,CHEBI,nutraceutical role,nutraceutical role
NEW13524,DISEASE,leave frontal lobe lesion,left frontal lobe lesion
NEW13525,CHEMICAL,urea cycle metabolism,urea cycle metabolism
NEW13526,DISEASE,melas phenotype,MELAS phenotype
NEW13527,MENTAL_HEALTH,psychomental regression,psychomental regression
NEW13528,CHEMICAL,creatine monohydrate,creatine monohydrate
NEW13529,DISEASE,renal function,renal function
NEW13530,CHEMICAL,urea retention,urea retention
NEW13531,CHEMICAL,creatine supplementation,creatine supplementation
NEW13532,DISEASE,acute mental deterioration,acute mental deterioration
NEW13533,DISEASE,preexist nephropathy,preexisting nephropathy
NEW13534,DISEASE,acute confusional state,acute confusional state
NEW13535,MENTAL_HEALTH,alpha-induced depression,alpha-induced depression
NEW13536,MENTAL_HEALTH,overlap syndrome,overlapping syndromes
NEW13537,DISEASE,depressive mood state,depressive mood states
NEW13538,CHEMICAL,two-step acid pickling,Two-step acid pickling
NEW13539,MENTAL_HEALTH,small equivalent series resistance lower,small equivalent series resistance lower
NEW13540,CHEMICAL,venlafaxine mg/day,venlafaxine mg/day
NEW13541,DISEASE,pds dosage,PDS dosage
NEW13542,CHEMICAL,bpa degradation pathway,BPA degradation pathway
C536830,DISEASE,Glut1 Deficiency Syndrome [Supplementary Concept],"Monosaccharide Transport Proteins/deficiency|GLUT1-DS|GLUT1 Deficiency Syndrome|Carbohydrate Metabolism, Inborn Errors"
C567924,DISEASE,Infantile Epileptic-Dyskinetic Encephalopathy [Supplementary Concept],"epileptic encephalopathy|Spasms, Infantile|early-infantile epileptic encephalopathy"
D051246,CHEMICAL,"Glucose Transport Proteins, Facilitative",GLUT Proteins|glucose transport|Glucose Transporter|SLC2A Proteins|Glucose Transport Protein|Glucose Transport Facilitators
NEW13543,CHEMICAL,very-long-chain acyl-coa dehydrogenase vlcad deficiency,Very-long-chain acyl-CoA dehydrogenase VLCAD deficiency
NEW13544,NUTRITION,mitochondrial long-chain fatty acid oxidation,mitochondrial long-chain fatty acid oxidation
NEW13545,CHEMICAL,n-methyl-d-aspartate nmda antagonist drug model,N-methyl-d-aspartate NMDA antagonist drug models
NEW13546,CHEMICAL,acute nicotine exposure,acute nicotine exposure
NEW13547,DISEASE,neurobiological deficiency,neurobiological deficiencies
NEW13548,DISEASE,increase depression-related behavior,increased depression-related behaviors
NEW13549,DISEASE,digital ulceration,digital ulceration
D065128,CHEBI,Endothelin Receptor Antagonists,"Endothelin Antagonist|Antagonist, Endothelin Receptor|Endothelin Antagonists|Endothelin Receptor Antagonist|Receptor Antagonist, Endothelin|Antagonists, Endothelin Receptor|endothelin receptor antagonists|Antagonist, Endothelin|Antagonists, Endothelin"
D000068877,CHEMICAL,Imatinib Mesylate,"Glivec|Imatinib mesylate|CGP57148B|Gleevec|ST 1571|Methanesulfonate, Imatinib|Alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide|Mesylate, Imatinib|CGP57148|STI 571|STI-571|imatinib|ST1571|Imatinib Methanesulfonate|CGP 57148|Imatinib|CGP-57148|STI571"
D000090122,DISEASE,Livedoid Vasculopathy,"Vasculopathy, Livedoid|Vasculitis, Livedoid|Livedoid Vasculopathies|vasculopathy|Livedo Reticularis with Summer Ulceration|Livedoid Vasculitis"
D017545,DISEASE,"Aortic Aneurysm, Thoracic","|Aortic Aneurysms, Thoracic|Thoracic Aortic Aneurysm|Aneurysms, Thoracoabdominal Aortic|Thoracoabdominal Aortic Aneurysm|Aortic Aneurysm, Thoracoabdominal|Aortic aneurysms|Aortic Aneurysms, Thoracoabdominal|thoracic aortic aneurysm|Aneurysm, Thoracic Aortic|Aneurysm, Thoracoabdominal Aortic|Thoracic Aortic Aneurysms|Thoracoabdominal Aortic Aneurysms"
NEW13550,CHEBI,type at1 receptor antagonist losartan,type AT1 receptor antagonist losartan
NEW13551,CHEMICAL,co-occurre ad,co-occurring ADs
NEW13552,DISEASE,anger attack,anger attack
NEW13553,CHEMICAL,protirelin test,protirelin test
NEW13554,CHEMICAL,assess thyroid status,assessing thyroid status
NEW13555,DISEASE,psychiatric medication,psychiatric medication
NEW13556,MENTAL_HEALTH,projection cortex,projection cortex
NEW13557,CHEMICAL,5ht system perturbation,5HT system perturbation
NEW13558,CHEMICAL,saccharin preference,saccharin preference
NEW13559,CHEMICAL,serotonin transporter expression,serotonin transporter expression
NEW13560,MENTAL_HEALTH,drn projection field,DRN projection fields
NEW13561,DISEASE,functional hypersensitivity,functional hypersensitivity
NEW13562,CHEMICAL,postsynaptic dopamine d2-receptor,postsynaptic dopamine D2-receptors
D013893,CHEMICAL,Thiram,"Bacteriostat|TMTD|TMT Disulfide|Disulfide, TMT|Nobecutan|Sadoplon 75|Disulfide, Tetramethylthiuram|Thiuram|Thiuram D|Tetramethylthiuram Disulfide|thiram"
NEW13563,CHEMICAL,thiram poisoning,thiram poisoning
C092282,CHEBI,"PSMC5 protein, human [Supplementary Concept]",thyroid hormone receptor|ATPases Associated with Diverse Cellular Activities|Proteasome Endopeptidase Complex
http://purl.obolibrary.org/obo/CHEBI_60311,CHEBI,thyroid hormone,thyroid hormone α|thyroid hormones
http://purl.obolibrary.org/obo/DOID_0080909,DISEASE,castration-resistant prostate carcinoma,CRPC|castration-resistant prostate cancer
NEW13564,CHEBI,novel antiandrogen treatment,novel antiandrogen treatments
NEW13565,DISEASE,renal insufficiency confusion,renal insufficiency confusion
NEW13566,CHEBI,non-selective muscarinic receptor agonist pilocarpine,non-selective muscarinic receptor agonist pilocarpine
NEW13567,DISEASE,age-related learning impairment,age-related learning impairments
NEW13568,DISEASE,manner age-related deficit,manner age-related deficits
NEW13569,MENTAL_HEALTH,clinical depression,Clinical depression
NEW13570,CHEMICAL,dopamine d2/3 receptor agonist,dopamine D2/3 receptor agonist
C028458,CHEMICAL,tipepidine [Supplementary Concept],Piperidines|tipepidine
NEW13571,DISEASE,sp. rm,sp. RM
C033955,CHEMICAL,glucose dehydrogenase (pyrroloquinoline-quinone) [Supplementary Concept],Glucose Dehydrogenases|quinoprotein glucose dehydrogenase
D044169,CHEMICAL,"Receptors, Calcium-Sensing","Calcium-Sensing Receptors|Calcium Sensing Receptor|Calcium Receptors|Receptor, Ca2+-Sensing|Ca-Sensing Receptors|Receptors, Calcium|Ca Sensing Receptors|CASR Protein|Calcium ion|Ca2+ Sensing Receptor|Receptor, Parathyroid Calcium-Sensing|Parathyroid Calcium-Sensing Receptor|Receptors, Ca-Sensing|Extracellular Calcium-Ion Sensing Receptor|Calcium-Sensing Receptor, Parathyroid|Receptor, Ca-Sensing|Receptor, Ca Sensing|calcium ion|Calcium-Sensing Receptor|Parathyroid Calcium Sensing Receptor|Ca-Sensing Receptor|Receptor Protein, Calcium-Sensing|Calcium-Sensing Receptor Protein|Ca2+-Sensing Receptor|Extracellular Calcium Ion Sensing Receptor|Receptor, Calcium-Sensing|Calcium Sensing Receptors|Receptors, Calcium Sensing|Calcium Sensing Receptor Protein"
NEW13572,CHEMICAL,oxphosci-linked,OXPHOSCI-LINKED
NEW13573,CHEMICAL,α-tocophenol,α-tocophenol
NEW13574,DISEASE,age-related cognitive deficit,age-related cognitive deficits
NEW13575,CHEMICAL,low α-tocopherol level,lower α-tocopherol levels
NEW13576,CHEMICAL,prenatal flutamide,Prenatal flutamide
NEW13577,CHEMICAL,hfn2,HFn2
http://purl.obolibrary.org/obo/CHEBI_82784,CHEMICAL,pvp38-ag np,HFn+ NPs|polyvinylpyrrolidone (38 nm) coated-Ag nanoparticle|polyvinylpyrrolidone (38 nm) coated-Ag nanoparticles|PVP38-Ag NPs|Cu2-x S@Ru NPs
NEW13578,CHEMICAL,excess alcohol consumption,excess alcohol consumption
NEW13579,DISEASE,hippocampal dysfunction,Hippocampal dysfunction
NEW13580,CHEMICAL,oral transmucosal fentanyl citrate,Oral transmucosal fentanyl citrate
NEW13581,MENTAL_HEALTH,rapid analgesia,rapid analgesia
NEW13582,CHEMICAL,pentagastrin pressor test,pentagastrin pressor test
NEW13583,DISEASE,comorbid medical illness,comorbid medical illnesses
NEW13584,CHEBI,prame tumour antigen,PRAME tumour antigen
NEW13585,DISEASE,tumour type,tumour types
NEW13586,DISEASE,splanchnic vein thrombosis,splanchnic vein thrombosis
D000069552,CHEMICAL,Rivaroxaban,"5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide|Rivaroxaban|BAY 597939|BAY 59 7939|Xarelto|BAY 59-7939"
NEW13587,DISEASE,non-cirrhotic patient,non-cirrhotic patients
NEW13588,DISEASE,thrombotic antiphospholipid syndrome,thrombotic antiphospholipid syndrome
NEW13589,CHEMICAL,thrombotic antiphospholipid syndrome,TAPS|Thrombotic antiphospholipid syndrome
NEW13590,DISEASE,autoimmune disorder,autoimmune disorder
NEW13591,CHEMICAL,non-triple positive taps,non-triple positive TAPS
C565018,DISEASE,Dysfibrinogenemia Causing Recurrent Thrombosis [Supplementary Concept],Thrombosis|recurrent thrombosis|Coagulation Protein Disorders/congenital
http://purl.obolibrary.org/obo/CHEBI_28675,NUTRITION,dextrin,retrograded starch|starch/chemically-modified starch|compatibilized starch
NEW13592,NUTRITION,rs resistant starch,RS resistant starch
NEW13593,CHEMICAL,acral soft tissue overgrowth,acral soft tissue overgrowth
NEW13594,MENTAL_HEALTH,associate clinical syndrome,associated clinical syndromes
NEW13595,MENTAL_HEALTH,non-specific neurological syndrome,non-specific neurological syndromes
NEW13596,CHEMICAL,elevated co2,Elevated CO2
NEW13597,DISEASE,wilt disease,wilt disease
NEW13598,DISEASE,trauma patient,Trauma patients
NEW13599,DISEASE,early post- traumatic stress reaction,early post- traumatic stress reaction
NEW13600,DISEASE,trauma phase,trauma phase
NEW13601,DISEASE,metabolic product,metabolic product
NEW13602,CHEBI,antiviral innate immune peptide characteristic,antiviral innate immune peptide characteristics
http://purl.obolibrary.org/obo/DOID_1561,DISEASE,cognitive disorder,cognitive disease|HAND|cognitive disorder|SEV-induced cognitive disorder|Organic Mental disorder|HIV-associated neurocognitive disorder
C000664111,DISEASE,Botrytis pseudocinerea [Supplementary Concept],Botrytis|Botrytis pseudocinerea
NEW13603,NUTRITION,strawberry field,strawberry fields
D065692,CHEBI,Cytochrome P-450 CYP3A Inhibitors,"Inhibitors, CYP3A5|Cytochrome P 450 CYP3A4 Inhibitor|Cytochrome P 450 CYP3A Inhibitor|Cytochrome P 450 CYP3A Inhibitors|Cytochrome P 450 CYP3A4 Inhibitors|Inhibitors, CYP3A4|Inhibitor, P450 CYP3A|P450 CYP3A7 Inhibitor|Inhibitor, CYP3A5|CYP3A7 Inhibitor, P450|CYP3A5 Inhibitor|inhibitors|CYP3A5 Inhibitor, P450|P450 CYP3A Inhibitor|Inhibitor, Cyp3A4|CYP3A5 Inhibitors, P450|Cyp3A4 Inhibitor|Cytochrome P-450 CYP3A7 Inhibitor|Inhibitor, P450 CYP3A5|Cytochrome P 450 CYP3A5 Inhibitor|P450 CYP3A4 Inhibitors|Inhibitors, P450 CYP3A4|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P 450 CYP3A7 Inhibitor|Cytochrome P-450 CYP3A Inhibitor|Inhibitor, CYP3A|CYP3A4 Inhibitor, P450|Inhibitors, P450 CYP3A|Inhibitors, CYP3A|Cytochrome P-450 CYP3A4 Inhibitor|Cytochrome P-450 CYP3A7 Inhibitors|CYP3A7 Inhibitors|CYP3A7 Inhibitor|CYP3A Inhibitors|P450 CYP3A4 Inhibitor|P450 CYP3A Inhibitors|P450 CYP3A7 Inhibitors|Cytochrome P 450 CYP3A7 Inhibitors|CYP3A Inhibitor, P450|CYP3A Inhibitor|Cytochrome P 450 CYP3A5 Inhibitors|CYP3A5 Inhibitors|CYP3A4 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitor|Inhibitor, CYP3A7|Inhibitor, P450 CYP3A4|Inhibitors, CYP3A7|P450 CYP3A5 Inhibitors|Inhibitor, P450 CYP3A7|CYP3A7 Inhibitors, P450|Inhibitors, P450 CYP3A7|P450 CYP3A5 Inhibitor"
NEW13604,MENTAL_HEALTH,major g143a resistance mutation,major G143A resistance mutation
NEW13605,CHEMICAL,mirtazapine use,mirtazapine use
NEW13606,DISEASE,hypothyroxinaemia,hypothyroxinaemia
NEW13607,CHEMICAL,a1 a2a adenosine receptor,A1 A2a adenosine receptors
NEW13608,DISEASE,mitochondrial function,mitochondrial function
NEW13609,NUTRITION,yeast prion,Yeast prions
NEW13610,CHEMICAL,memantine pretreatment,Memantine pretreatment
NEW13611,CHEMICAL,memantine effect,memantine effects
NEW13612,MENTAL_HEALTH,elderly bipolar disorder,elderly bipolar disorder
NEW13613,MENTAL_HEALTH,acute psychotic mania,acute psychotic mania
NEW13614,CHEMICAL,morphine dose,morphine dose
NEW13615,NUTRITION,american pokeweed plant,American pokeweed plant
NEW13616,CHEMICAL,broad-spectrum resistance,broad-spectrum resistance
NEW13617,CHEBI,pure opiate antagonist,pure opiate antagonist
NEW13618,CHEMICAL,methylnaloxonium administration,methylnaloxonium administration
C518846,CHEBI,N'-aminooxymethylcarbonylhydrazino D-biotin [Supplementary Concept],Hydrazines|Biotin/analogs  and  derivatives|d-biotin|D-biotin
NEW13619,CHEBI,serum biotin level,serum biotin level
NEW13620,CHEMICAL,nitric oxide/asymmetric dimethylarginine/dimethylarginine dimethylaminohydrolase no/adma/ddah pathway,nitric oxide/asymmetric dimethylarginine/dimethylarginine dimethylaminohydrolase NO/ADMA/DDAH pathway
NEW13621,CHEMICAL,wu-ling-shen,Wu-Ling-Shen
NEW13622,CHEMICAL,polymorphism arg16,polymorphism Arg16
NEW13623,CHEMICAL,conventional antidepressant,Conventional antidepressants
NEW13624,CHEMICAL,biogenic amine neurotransmitter,biogenic amine neurotransmitters
NEW13625,DISEASE,bone gain,bone gain
NEW13626,CHEMICAL,high h2-value,high h2-values
NEW13627,CHEMICAL,standard antidepressant,standard antidepressants
NEW13628,CHEMICAL,subanesthetic dose,subanesthetic doses
NEW13629,CHEMICAL,several glutamate receptor-modulating agent,Several glutamate receptor-modulating agents
NEW13630,CHEMICAL,intranasal esketamine,intranasal esketamine
C445659,CHEMICAL,bilastine [Supplementary Concept],Piperidines|Benzimidazoles|bilastine
NEW13631,CHEBI,non-carboxylated carboxylate antihistamine doxepin,non-carboxylated carboxylated antihistamines doxepin
NEW13632,DISEASE,rtt subject,RTT subjects
NEW13633,CHEMICAL,sub-inflammatory status,sub-inflammatory status
C538724,CHEMICAL,HhAntag691 [Supplementary Concept],Anilides|Pyridines|vismodegib
http://purl.obolibrary.org/obo/CHEBI_66908,CHEBI,smo receptor antagonist,smoothened receptor antagonists|smoothened receptor antagonist|smoothened antagonist|SMO receptor antagonists|smoothened antagonists|SMO antagonists
NEW13634,CHEBI,smoothen antagonist,Smoothened antagonist
D008527,DISEASE,Medulloblastoma,"Melanocytic Medulloblastoma|Medullomyoblastomas|Adult Medulloblastoma|Medulloblastomas, Childhood|Arachnoidal Cerebellar Sarcoma, Circumscribed|Medullomyoblastoma|medulloblastoma|Melanocytic Medulloblastomas|Medulloblastoma, Melanocytic|Medulloblastomas|Medulloblastomas, Desmoplastic|Sarcoma, Cerebellar, Circumscribed Arachnoidal|Childhood Medulloblastomas|Desmoplastic Medulloblastoma|Medulloblastomas, Melanocytic|Medulloblastoma, Desmoplastic|Medulloblastoma, Childhood|Desmoplastic Medulloblastomas|Childhood Medulloblastoma|Medulloblastomas, Adult|Adult Medulloblastomas|Medulloblastoma, Adult"
http://purl.obolibrary.org/obo/DOID_2513,DISEASE,basal cell carcinoma,malignant basal cell tumor|Basal cell carcinoma of skin|malignant Basal cell neoplasm|Basal cell cancer|Basal cell neoplasm|Basal cell tumor|Rodent ulcer|Epithelioma basal cell|human basal cell carcinoma
NEW13635,CHEMICAL,shh pathway inhibitor,Vismodegib|SHH pathway inhibitor
NEW13636,CHEMICAL,social deficit score,SOCDEF|Social deficit scores
NEW13637,MENTAL_HEALTH,pervasive developmental Disorder behavior Inventory-Screening Version,Pervasive Developmental Disorder Behavior Inventory-Screening Version
C435779,CHEMICAL,A-DP2 doxorubicin albumin conjugate [Supplementary Concept],Oligopeptides|DP2|Doxorubicin/analogs  and  derivatives
NEW13638,DISEASE,Clostridiaceae Clostridium,Clostridiaceae Clostridium
NEW13639,CHEMICAL,scfa concentration,SCFA concentrations
NEW13640,DISEASE,skin pain,skin pain
NEW13641,CHEMICAL,antimalarial chloroquine,CQ|antimalarials chloroquine
NEW13642,DISEASE,profound hypotension,profound hypotension
http://purl.obolibrary.org/obo/CHEBI_33288,CHEMICAL,rodenticide,HCQ poisoning|CQ/HCQ poisoning|rodenticides
NEW13643,CHEMICAL,sodium channel blockade,sodium channel blockade
NEW13644,DISEASE,impaired myocardial automaticity,impaired myocardial automaticity
NEW13645,DISEASE,seizure refractory,seizures refractory
NEW13646,CHEMICAL,high-dose intravenous diazepam,high-dose intravenous diazepam
NEW13647,DISEASE,severe hypokalemia,severe hypokalemia
NEW13648,DISEASE,unstable hypotension,unstable hypotension
NEW13649,CHEMICAL,oxytocin neuron,Oxytocin neurons
NEW13650,MENTAL_HEALTH,cellular opiate dependence,cellular opiate dependence
NEW13651,DISEASE,withdrawal hyperexcitation,withdrawal hyperexcitation
NEW13652,CHEMICAL,oc individual,OC individuals
NEW13653,DISEASE,ocd pathology,OCD pathology
NEW13654,DISEASE,multiple autoimmune disease,multiple autoimmune diseases
NEW13655,DISEASE,non-autoimmune eye disease,non-autoimmune eye disease
NEW13656,CHEMICAL,CA192-CsA,CA192-CsA
http://purl.obolibrary.org/obo/DOID_7188,DISEASE,autoimmune thyroiditis,Hashimoto's thyroiditis|autoimmune oophoritis secondary|Hashimoto's syndrome|Chronic Lymphocytic Thyroiditis|Hashimoto's Disease|Hashimoto thyroiditis|Lymphocytic Thyroiditis|autoimmune dacryoadenitis
NEW13657,CHEMICAL,il-2 expression model,IL-2 expression model
NEW13658,CHEMICAL,intravitreal bevacizumab,intravitreal bevacizumab
NEW13659,DISEASE,diabetic neuropathic pain,diabetic neuropathic pain
NEW13660,CHEMICAL,systemic win,Systemic WIN
NEW13661,DISEASE,severe tbi,severe TBI
NEW13662,MENTAL_HEALTH,catatonic posture,catatonic posturing
NEW13663,MENTAL_HEALTH,neurotic depressive state,neurotic depressive state
C101470,CHEMICAL,25-hydroxyvitamin D3-bromoacetate [Supplementary Concept],Calcifediol/analogs  and  derivatives|25(OH)D3
NEW13664,MENTAL_HEALTH,depression symptom,depression symptom
NEW13665,CHEBI,vitamin d metabolite,vitamin D metabolites
NEW13666,MENTAL_HEALTH,human premature ejaculation,human premature ejaculation
NEW13667,CHEMICAL,selective serotonin reuptake inhibitory,selective serotonin reuptake inhibitory
NEW13668,CHEBI,ssri property,SSRI properties
NEW13669,CHEMICAL,antagonist rimonabant,antagonist rimonabant
NEW13670,DISEASE,aids patient,AIDS patients
NEW13671,CHEMICAL,Hipoadiponectynemia,Hipoadiponectynemia
D052497,DISEASE,"Lipodystrophy, Congenital Generalized","Lipodystrophy, Berardinelli-Seip Congenital, Type 1|Brunzell Syndrome|Brunzell Syndrome (with Bone Cysts)|Syndrome, Berardinelli|lipodystrophy|Brunzell Syndrome, AGPAT2 Related|Syndrome, BSCL2-Related Brunzell|Berardinelli Syndrome|Lipodystrophies, Congenital Generalized|Lipodystrophy, Generalized|Berardinelli Seip Syndrome|Seip Syndrome|Lipodystrophy, Berardinelli-Seip Congenital, Type 2|Berardinelli Seip Congenital Lipodystrophy, Type 2|Diabete, Congenital Lipoatrophic|AGPAT2-Related Brunzell Syndrome|Lipodystrophy, Total|Congenital Lipoatrophic Diabete|Generalized Lipodystrophy, Congenital|Syndrome, Berardinelli-Seip|Congenital Lipoatrophic Diabetes|Lipodystrophies, Generalized|Lipodystrophies, Total|Berardinelli Seip Congenital Lipodystrophy|Congenital Generalized Lipodystrophies|Lipodystrophy, Congenital Generalized, Type 1|Berardinelli-Seip Congenital Lipodystrophy Type 2|Syndrome, AGPAT2-Related Brunzell|Syndrome, Seip|Total Lipodystrophies|Lipoatrophic Diabetes, Congenital|Lipodystrophy, Congenital Generalized, Type 2|Brunzell Syndrome, BSCL2 Related|Congenital Lipodystrophy, Berardinelli-Seip|Congenital Generalized Lipodystrophy|Generalized Lipodystrophies, Congenital|Syndrome, Brunzell|Lipoatrophic Diabete, Congenital|Berardinelli-Seip Congenital Lipodystrophy Type 1|Diabetes, Congenital Lipoatrophic|Total Lipodystrophy|Berardinelli-Seip Congenital Lipodystrophy|Generalized Lipodystrophies|Syndrome, Brunzell (with Bone Cysts)|Congenital Generalized Lipodystrophy Type 2|Berardinelli-Seip Congenital Lipodystrophy, Type 1|Berardinelli Seip Congenital Lipodystrophy, Type 1|Brunzell Syndrome, BSCL2-Related|Lipodystrophy, Berardinelli-Seip Congenital|Brunzell Syndrome, AGPAT2-Related|Berardinelli-Seip Syndrome|Congenital Generalized Lipodystrophy Type 1|Berardinelli Seip Congenital Lipodystrophy Type 1|Berardinelli-Seip Congenital Lipodystrophy, Type 2|Berardinelli Seip Congenital Lipodystrophy Type 2|Generalized Lipodystrophy|BSCL2-Related Brunzell Syndrome|Total Lipodystrophy and Acromegaloid Gigantism|Lipodystrophy, Total, And Acromegaloid Gigantism"
D053307,DISEASE,"Hyper-IgM Immunodeficiency Syndrome, Type 1","immunodeficiency syndrome|Immunodeficiency with Hyper-IgM, Type 1|HIGM1|AIDS|Immunodeficiencies, X-Linked Hyper-IgM|X-Linked Hyper-IgM Immunodeficiency|HIGM1 Syndrome|Hyper IgM Syndrome 1|Immunodeficiency, X-Linked Hyper-IgM|X Linked Hyper IgM Syndrome|Hyper IgM Immunodeficiency, X Linked|Hyper IgM Immunodeficiency Syndrome, Type 1|HIGM1 Syndromes|Hyper-IgM Immunodeficiencies, X-Linked|X-Linked Hyper-IgM Immunodeficiencies|Hyper-IgM Syndrome 1|X-Linked Hyper IgM Syndrome|Immunodeficiency with Hyper IgM, Type 1|Hyper-IgM Immunodeficiency, X-Linked"
NEW13672,MENTAL_HEALTH,pulmonary vessel resistance,pulmonary vessel resistance
NEW13673,CHEMICAL,bilirubin removal,bilirubin removal
NEW13674,MENTAL_HEALTH,free fatty acid ffa displacement,free fatty acid FFA displacement
NEW13675,NUTRITION,fatty acid mixture infusion prefilter,fatty acid mixtures infusion prefilter
NEW13676,CHEMICAL,bilirubin acid,bilirubin acids
NEW13677,CHEMICAL,biloba l.,biloba L.
NEW13678,MENTAL_HEALTH,moderate dementia,moderate dementia
NEW13679,CHEMICAL,abnormal brain serotonin turnover,abnormal brain serotonin turnover
NEW13680,CHEBI,folate receptor alpha FRα autoimmunity,folate receptor alpha FRα autoimmunity
NEW13681,CHEBI,maternal vitamin d deficiency,maternal vitamin D deficiency
NEW13682,MENTAL_HEALTH,infantile autism disease,infantile autism disease
NEW13683,MENTAL_HEALTH,agitation response,agitation response
NEW13684,CHEMICAL,skf10047,SKF10047
http://purl.obolibrary.org/obo/CHEBI_28973,CHEMICAL,strychnine,strychnine MK-801|Strychnine|Strychnin|strychnidin-10-one
NEW13685,MENTAL_HEALTH,dose-dependent depression,dose-dependent depression
NEW13686,CHEMICAL,strychnine hyperesthesia,strychnine hyperesthesia
http://purl.obolibrary.org/obo/CHEBI_176799,CHEMICAL,glytoucan g03183mg,Ritaline mg|≥40 mg
NEW13687,CHEBI,narcotic list,narcotic list
NEW13688,CHEMICAL,third-line agent,third-line agents
NEW13689,MENTAL_HEALTH,organic mania,organic mania
D002216,CHEMICAL,Captopril,"|SQ 14534|SQ14,225|SQ14,534|SQ-14,534|SQ-14534|SQ 14225|(S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline|SQ-14225|Lopirin|Capoten|SQ14534|SQ 14,534|SQ14225|SQ 14,225|SQ-14,225|captopril|Captopril"
NEW13690,CHEMICAL,baclofen withdrawal,baclofen withdrawal
NEW13691,CHEMICAL,tts malignancies:- patient,TTS malignancies:- patients
NEW13692,DISEASE,antecedent cancer,antecedent cancer
NEW13693,CHEBI,next drug target,next drug targets
NEW13694,DISEASE,legionella co-infection,Legionella co-infection
http://purl.obolibrary.org/obo/CHEBI_59662,CHEMICAL,colistimethate,meropenam|Meropenam
D059413,DISEASE,Intraabdominal Infections,"Infection, Intra-Abdominal|Infections, Intraabdominal|Intra Abdominal Infections|Intra-Abdominal Infections|Infection, Intraabdominal|intra- abdominal infections|Intraabdominal Infection|Intra-Abdominal Infection|Infections, Intra-Abdominal"
http://purl.obolibrary.org/obo/CHEBI_27933,CHEBI,beta-lactam antibiotic,beta-lactam antibiotic
C038366,CHEMICAL,ibudilast [Supplementary Concept],ibudilast|Pyridines
NEW13695,MENTAL_HEALTH,opioid overuse headache,opioid overuse headache
NEW13696,CHEBI,burden analgesic requirement,burden analgesic requirements
NEW13697,MENTAL_HEALTH,headache burden,headache burden
NEW13698,CHEBI,opioid analgesic requirement,opioid analgesic requirements
D000111,CHEMICAL,Acetylcysteine,"N-Acetyl-L-cysteine|Alveolex|Acetyst|Acetylin|Broncho Fips|Genac|Sanigen, Muco|durabronchal|Cystamucil|Fluimucil|acebraus|Mucomyst|Acetylcystein, mentopin|Monoammonium Salt Acetylcysteine|Broncho-Fips|Azubronchin|Acetylcysteine, Monoammonium Salt|Dampo Mucopect|Ilube|Acetylcystein Atid|Acetabs|Acetylcysteine Zinc|Muciteran|N-Acetylcysteine|Acetylcysteine Hydrochloride|Mucosolvin|BronchoFips|Hydrochloride, Acetylcysteine|mentopin Acetylcystein|M-Pectil|Mercapturic Acid|Acetylcysteine, (DL)-Isomer|Mucosil|Acid, Mercapturic|M Pectil|Lindocetyl|Broncholysin|NAC, Bisolvon|Broncoclar|Siran|Acetylcystein Heumann|Codotussyl|NAC Zambon|Optipect Hustengetränk|Jenacystein|Zambon, NAC|Muco Sanigen|Acemuc|Fluprowit|N Acetyl L cysteine|Acetylcysteine, Monosodium Salt|Mucopect, Dampo|Lantamed|MPectil|Hustengetränk, Optipect|Fabrol|Acetylcysteine, (D)-Isomer|Bromuc|Hoestil|Zinc, Acetylcysteine|Mucosol|Monosodium Salt Acetylcysteine|Eurespiran|Bisolvon NAC|Sodium, Acetylcysteine|Exomuc|Acétylcystéine GNR|Acetylcysteine Sodium|Frekatuss|Solmucol|NAC AL|Larylin NAC|N-acetyl-L-cysteine|Jenapharm|N Acetylcysteine|Acetylcystein Trom|Acetylcystein AL|Siccoral|Airbron"
NEW13699,DISEASE,bipolar-related disorder,bipolar-related disorders
NEW13700,CHEMICAL,angiotensin-ii receptor blocker losartan,angiotensin-II receptor blocker losartan
D020257,DISEASE,Ventricular Remodeling,"|Cardiac Remodeling, Ventricular|Remodelings, Ventricular Cardiac|Myocardial Remodeling, Ventricular|Remodeling, Ventricular Cardiac|Ventricle Remodelings|Ventricle Remodelings, Left|Ventricle Remodeling|Left Ventricle Remodelings|Ventricular Myocardial Remodeling|Ventricular Remodeling, Left|cardiac remodelling|Remodelings, Ventricular Myocardial|Ventricular Remodelings|Remodeling, Ventricle|Remodelings, Left Ventricular|Left Ventricle Remodeling|Remodelings, Ventricular|Remodeling, Left Ventricle|Myocardial Remodelings, Ventricular|cardiac remodeling|Remodelings, Ventricle|Remodeling, Ventricular|Ventricular Cardiac Remodelings|Ventricular Cardiac Remodeling|Cardiac Remodelings, Ventricular|Remodeling, Ventricular Myocardial|Left Ventricular Remodelings|Remodeling, Left Ventricular|Ventricular Myocardial Remodelings|Left Ventricular Remodeling|Remodelings, Left Ventricle|Ventricle Remodeling, Left|Ventricular Remodelings, Left"
NEW13701,CHEBI,beta-3 adrenergic receptor agonist mirabegron,beta-3 adrenergic receptor agonist mirabegron
NEW13702,DISEASE,doxo-induced cardiotoxicity model,DOXO-induced cardiotoxicity model
C520025,CHEMICAL,mirabegron [Supplementary Concept],Mirabegron|Thiazoles|Acetanilides|mirabegron
NEW13703,DISEASE,doxo-induced cardiac fibrosis,DOXO-induced cardiac fibrosis
C492923,CHEMICAL,"Cacnb1 protein, mouse [Supplementary Concept]","Calcium Channels, L-Type|L-type calcium channel"
NEW13704,DISEASE,af-associated ionic remodeling,AF-associated ionic remodeling
NEW13705,DISEASE,partial bladder outlet obstruction,BOO|Partial bladder outlet obstruction
NEW13706,CHEMICAL,ethanol reward,ethanol reward
NEW13707,CHEMICAL,cytochrome p450 ethanol metabolism,Cytochrome P450 ethanol metabolism
NEW13708,CHEMICAL,due to familial ad,FAD|due to familial AD
NEW13709,DISEASE,sad pathogenesis,SAD pathogenesis
NEW13710,DISEASE,gp120-induced neurotoxicity,gp120-induced neurotoxicity
NEW13711,DISEASE,tau-mediated impairment,tau-mediated impairments
C045855,CHEMICAL,"3-N-butyl-4,5-dihydrophthalide [Supplementary Concept]",Benzofurans|senkyunolide A
NEW13712,DISEASE,vital energy deficiency,vital energy deficiency
NEW13713,DISEASE,elevated blood glucose level,elevated blood glucose levels
NEW13714,CHEBI,peroxiproliferator-activated receptor gamma agonist,Peroxiproliferator-activated receptor gamma agonists
NEW13715,DISEASE,peripheral edema,peripheral edema
NEW13716,DISEASE,cardiometabolic abnormality,cardiometabolic abnormalities
C044361,CHEMICAL,M-VAC protocol [Supplementary Concept],VAC|Antineoplastic Combined Chemotherapy Protocols|Vinblastine|Methotrexate|Cisplatin|Doxorubicin
NEW13717,DISEASE,lps-induced acute lung damage,LPS-induced acute lung damage
NEW13718,DISEASE,rheumatic pain,rheumatic pains
NEW13719,NUTRITION,VAC food supplement,VAC food supplements
NEW13720,DISEASE,psychic premenstrual symptom,psychic premenstrual symptoms
NEW13721,CHEMICAL,whi-studie,WHI-studies
NEW13722,DISEASE,high-turnover osteoporosis,high-turnover osteoporosis
NEW13723,DISEASE,antagonist phencyclidine (pcp)-induced cognitive deficit,antagonist phencyclidine (PCP)-induced cognitive deficits
NEW13724,CHEMICAL,n-methyl-d-aspartate antagonist,N-methyl-D-aspartate antagonist
C010739,CHEMICAL,ifenprodil [Supplementary Concept],ifenprodil tartrate|Piperidines|ifenprodil
NEW13725,CHEBI,alpha7 nachr antagonist,alpha7 nAChR antagonist
NEW13726,CHEBI,inversion carrier,inversion carriers
NEW13727,MENTAL_HEALTH,severe learning disability,severe learning disability
C480551,CHEMICAL,benzylaminopurine [Supplementary Concept],Purines|6-benzylaminopurine|Benzyl Compounds|6-BA
NEW13728,DISEASE,hyperactive locomotion,hyperactive locomotion
NEW13729,CHEMICAL,nonpigmented epithelia,NPE|nonpigmented epithelia
D001082,DISEASE,Aqueous Humor,"Aqueous Flares|Humor, Aqueous|Aqueous Flare|Humors, Aqueous|Intraocular Fluid|Fluids, Intraocular|Fluid, Intraocular|Flare, Aqueous|Intraocular Fluids|Aqueous Humors|aqueous humor"
NEW13730,CHEBI,androgen therapy,Androgen therapy
NEW13731,CHEBI,gender-affirming hormone therapy,Gender-Affirming Hormone Therapy
NEW13732,CHEMICAL,pip2 signaling,PIP2 signaling
NEW13733,DISEASE,hypoxic hypoxidosis,hypoxic hypoxidosis
NEW13734,CHEMICAL,% oxygen equivalent,% oxygen equivalent
NEW13735,CHEMICAL,fix gas combination,fixed gas combination
D001784,CHEMICAL,Blood Gas Analysis,"Gas Analyses, Blood|Analysis, Blood Gas|Blood gas analysis|Blood Gas Analyses|Gas Analysis, Blood|Analyses, Blood Gas"
C423682,CHEMICAL,RXP03 [Supplementary Concept],PO2|Oligopeptides
NEW13736,CHEMICAL,Adult Anxiety Related disorder,SCAARED|Adult Anxiety Related Disorders
NEW13737,CHEMICAL,original SCAARED,original SCAARED
NEW13738,DISEASE,male autistic child,male autistic children
NEW13739,DISEASE,psychotic child aged,psychotic children aged
NEW13740,CHEMICAL,folic-acid deficient medium,folic-acid deficient medium
NEW13741,MENTAL_HEALTH,various amnesia model,various amnesia models
NEW13742,DISEASE,motoneuron disease,motoneuron disease
NEW13743,CHEMICAL,t-588 administration,T-588 administration
NEW13744,DISEASE,forelimb contracture,forelimb contracture
D015725,CHEMICAL,Fluconazole,|Fluconazol AL|Flunazul|FlucoLich|Fluconazol ratiopharm|Fluconazole|Solacap|Fluconazol Stada|Neofomiral|Loitin|Apo-Fluconazole|Fluconazol AbZ|fluconazole|Zonal|UK49858|Oxifungol|Diflucan|Fungata|Fluconazol von ct|Triflucan|Fluc Hexal|UK-49858|UK 49858|Flucobeta|Fluconazol-Isis|Lavisa|Béagyne|Apo Fluconazole|Fluconazol-ratiopharm|Fluconazol Isis
NEW13745,CHEMICAL,oral protexin,oral protexin
NEW13746,DISEASE,itch cheesy vaginal discharge,itching cheesy vaginal discharge
NEW13747,CHEMICAL,substitutive therapy,substitutive therapy
NEW13748,DISEASE,amyloid-β toxicity,amyloid-β toxicity
NEW13749,DISEASE,undifferentiated nb,undifferentiated NB
NEW13750,DISEASE,neuroleptic-induced purposeless,Neuroleptic-induced purposeless
C577430,CHEMICAL,"CDNF protein, rat [Supplementary Concept]",Nerve Growth Factors|cerebral dopamine
NEW13751,CHEMICAL,acetylcholine function,acetylcholine function
NEW13752,DISEASE,neuroleptic-induced dyskinesia,neuroleptic-induced dyskinesias
NEW13753,DISEASE,acute dyskinetic syndrome,acute dyskinetic syndrome
NEW13754,DISEASE,da deficiency,DA deficiency
NEW13755,DISEASE,haloperidol-induced acute dyskinesia,haloperidol-induced acute dyskinesias
http://purl.obolibrary.org/obo/CHEBI_32789,CHEMICAL,tyrosine residue,tyrosyl|tyrosine acid residue|residue tyrosine|tyrosine residues|tyrosine residue
NEW13756,CHEMICAL,functional cysteine,functional cysteine
C000706809,CHEMICAL,"CALHM2 protein, human [Supplementary Concept]",Calcium Channels|calcium homeostasis
NEW13757,CHEMICAL,aea level,AEA levels
NEW13758,CHEMICAL,cannabidiol fumarate,cannabidiol fumarate
NEW13759,DISEASE,human gastric cancer cell line,human gastric cancer cell line
NEW13760,DISEASE,prominent tumor inhibition effect,prominent tumor inhibition effects
NEW13761,CHEMICAL,risperidone user,risperidone users
D013274,DISEASE,Stomach Neoplasms,"|Cancer, Gastric|forestomach tumors|Gastric Cancers|Neoplasm, Stomach|Stomach Cancer|Gastric Cancer, Familial Diffuse|Neoplasms, Gastric|Gastric Neoplasm|Cancers, Gastric|Cancer of the Stomach|Cancers, Stomach|Gastric Neoplasms|Neoplasm, Gastric|Gastric Cancer|gastric cancer|Stomach Neoplasm|Cancer of Stomach|Neoplasms, Stomach|Cancer, Stomach|Stomach Cancers"
NEW13762,DISEASE,mucus hypersecretion,mucus hypersecretion
NEW13763,CHEBI,agonist bronchodilator,agonist bronchodilators
NEW13764,NUTRITION,rockfish,rockfish
NEW13765,DISEASE,advanced prostate cancer treatment,advanced prostate cancer treatment
NEW13766,CHEBI,estrogen inactivating sulfotransferase,estrogen inactivating sulfotransferase
NEW13767,DISEASE,diabetic woman,diabetic women
NEW13768,CHEBI,estrogen inactivation,estrogen inactivation
D000081015,DISEASE,Ototoxicity,"Drug Induced Vestibulotoxicity|Cochleotoxicities, Drug-Related|Drug-Related Cochlear Toxicity|Vestibulotoxicity, Drug-Induced|Otological Toxicity, Drug-Induced|Cochlear Toxicity, Drug-Related|Cochlear Toxicity, Drug-Induced|Drug-Induced Ototoxicity|Drug-Induced Otological Toxicities|Otological Toxicity, Drug-Related|Drug Induced Otological Toxicity|Drug-Induced Cochleotoxicity|Drug Related Otological Toxicity|Drug Induced Cochlear Toxicity|Drug-Related Otological Toxicities|Drug Related Cochleotoxicity|Drug-Induced Vestibulotoxicity|Ototoxicities, Drug-Related|Drug-Related Ototoxicities|Drug Related Ototoxicity|Drug-Induced Otological Toxicity|Drug Induced Vestibular Toxicity|Ototoxicity, Drug-Related|Drug-Related Ototoxicity|Drug Induced Cochleotoxicity|Drug-Related Otological Toxicity|Cochleotoxicity, Drug-Related|Drug-Induced Vestibular Toxicity|Drug Induced Ototoxicity|Cochlear Toxicities, Drug-Related|toxicities|Vestibular Toxicity, Drug-Induced|Cochleotoxicity, Drug-Induced|Drug-Induced Cochlear Toxicity|Drug Related Cochlear Toxicity|Ototoxicities|Drug-Induced Cochlear Toxicities|Drug-Related Cochlear Toxicities|Drug-Related Cochleotoxicity|Ototoxicity, Drug-Induced"
NEW13769,CHEMICAL,syndrome alcohol,syndromes alcohol
NEW13770,MENTAL_HEALTH,dementia-related agitation,dementia-related agitation
NEW13771,CHEMICAL,dopamine     d3 receptor-preferring d3/d2 partial agonist antipsychotic,dopamine    D3 receptor-preferring D3/D2 partial agonist antipsychotic
NEW13772,CHEBI,unique d3-preferring partial agonist pharmacology,unique D3-preferring partial agonist pharmacology
NEW13773,CHEMICAL,active comparator risperidone,active comparator risperidone
NEW13774,DISEASE,difficult-to-treat symptom,difficult-to-treat symptoms
NEW13775,DISEASE,mixed mania/depression,mixed mania/depression
NEW13776,CHEMICAL,antipsychotic aripiprazole due,antipsychotics aripiprazole due
NEW13777,CHEBI,partial agonist antipsychotic,partial agonist antipsychotics
D000071698,CHEMICAL,Latent Autoimmune Diabetes in Adults,"Diabetes, Type 1.5|LADA, Latent Autoimmune Diabetes in Adults|Type 1.5 Diabetes Mellitus|MIS-A|Latent Autoimmune Diabetes of Adults|Type 1.5 Diabetes|Diabetes Mellitus Type 1.5|adults"
C000705967,DISEASE,"pediatric multisystem inflammatory disease, COVID-19 related [Supplementary Concept]",COVID-19/complications|Multisystem inflammatory syndrome|Systemic Inflammatory Response Syndrome
NEW13778,DISEASE,ASD complexity,ASD complexity
NEW13779,CHEMICAL,gaba imbalance,GABA imbalance
NEW13780,DISEASE,autistic individual,autistic individuals
NEW13781,CHEMICAL,ppa treatment,PPA treatment
NEW13782,DISEASE,increase astrogliosis,increased astrogliosis
NEW13783,DISEASE,scorpion Androctonus australi,scorpion Androctonus australis
NEW13784,CHEBI,own venom,own venom
NEW13785,NUTRITION,crayfish Procambarus clarkii,crayfish Procambarus clarkii
NEW13786,CHEBI,purify toxin,purified toxins
NEW13787,CHEMICAL,ca2 k+ channel,Ca2 K+ channels
NEW13788,CHEBI,a. australis venom,A. australis venom
NEW13789,NUTRITION,crayfish giant axon,crayfish giant axon
D024681,CHEMICAL,"Potassium Channels, Calcium-Activated","Potassium Channel, Calcium Activated|Channels, Calcium-Dependent Potassium|Ca2+-Activated K+ Channels|Calcium-Activated K+ Channels|K+ Channels, Ca2+-Activated|Ca2+ Activated K+ Channels|Potassium Channels, Calcium Activated|Potassium Channel, Calcium-Activated|K+ Channels, Calcium Activated|K+ Channels, Calcium-Activated|Calcium-Dependent Potassium Channels|Calcium Activated Potassium Channels|Potassium Channels, Calcium-Dependent|Calcium-Activated Potassium Channel|Calcium Activated Potassium Channel|K+ Channels, Ca2+ Activated|Calcium Dependent Potassium Channels|Potassium Channels, Calcium Dependent|Calcium-Activated Potassium Channels|K+ channels"
NEW13790,DISEASE,a. australis,A. australis
NEW13791,CHEBI,present mixture,present mixture
D001412,DISEASE,Bacillus subtilis,Bacillus subtilis (natto)|Bacillus subtilis|Natto Bacteria|Bacillus subtilis var. natto
C027619,DISEASE,"uracil-DNA glycosylase inhibitor protein, B. subtilis bacteriophage [Supplementary Concept]",Viral Proteins|B. subtilis
NEW13792,DISEASE,p. viteana,P. viteana
NEW13793,CHEBI,overall mixture,overall mixture
NEW13794,DISEASE,human ovarian carcinoma cell line,human ovarian carcinoma cell lines
NEW13795,CHEBI,carrier status,carrier status
NEW13796,DISEASE,complex systemic autoimmune disease,complex systemic autoimmune disease
NEW13797,DISEASE,higher-order human behaviour,higher-order human behaviour
http://purl.obolibrary.org/obo/DOID_2848,DISEASE,melancholia,non-melancholic
NEW13798,MENTAL_HEALTH,sub-typing depression,sub-typing depression
NEW13799,CHEBI,erbeta selective agonist,ERbeta selective agonists
NEW13800,DISEASE,elasticum (pxe)-like syndrome,elasticum (PXE)-like syndrome
D003483,DISEASE,Cutis Laxa,Dermatomegaly|cutis laxa|Dermatolysis|Dermatolyses
NEW13801,DISEASE,pxe feature,PXE features
C564741,CHEBI,"Vitamin K-Dependent Clotting Factors, Combined Deficiency Of, 1 [Supplementary Concept]","Blood Coagulation Disorders, Inherited|vitamin K-dependent clotting factors"
NEW13802,CHEMICAL,phenolic antioxidant resveratrol,Phenolic antioxidant resveratrol
C109473,CHEMICAL,"orange carotenoid protein, Synechocystis [Supplementary Concept]",orange carotenoid protein|Bacterial Proteins|OCP
NEW13803,MENTAL_HEALTH,quench defense mechanism,quenching defense mechanism
C553237,CHEMICAL,paeonol oxime [Supplementary Concept],paeonol|Oximes
NEW13804,DISEASE,rat pd model,rat PD model
NEW13805,CHEBI,novel ppar agonist,Novel PPAR agonists
D009750,DISEASE,Nutritional and Metabolic Diseases,metabolic diseases
NEW13806,MENTAL_HEALTH,rgc hyperactivity,RGC hyperactivity
http://purl.obolibrary.org/obo/CHEBI_35941,CHEBI,serotonergic agonist,serotonergic agonists|5-hydroxytryptamine agonist|serotonin agonists|5-HT agonist|serotonin agonist|noradrenergic agonists
NEW13807,DISEASE,naloxone-precipitated withdrawal behavior,naloxone-precipitated withdrawal behaviors
NEW13808,CHEBI,glutamatergic antagonist,glutamatergic antagonists
NEW13809,CHEMICAL,clonidine microl,clonidine microl
C011266,CHEMICAL,ST 91 [Supplementary Concept],ST-91|Clonidine/analogs  and  derivatives
NEW13810,CHEMICAL,melatonin level,melatonin levels
NEW13811,MENTAL_HEALTH,moderate depression,moderate depression
NEW13812,CHEMICAL,adjunctive trazodone,adjunctive trazodone
NEW13813,DISEASE,bipolar spindle,bipolar spindle
NEW13814,CHEMICAL,gaba system gene,GABA system genes
NEW13815,MENTAL_HEALTH,amphetamine-induced psychotic disorder,amphetamine-induced psychotic disorder
NEW13816,MENTAL_HEALTH,amphetamine-induced psychotic disorder patient,amphetamine-induced psychotic disorder patients
NEW13817,MENTAL_HEALTH,% amphetamine-induced psychotic disorder patient,% amphetamine-induced psychotic disorder patients
NEW13818,DISEASE,osa comorbiditie,OSA comorbidities
D007989,DISEASE,Libido,"Libido, Increased|Increased Libido|libido|Libido, Decreased|Decreased Libido"
NEW13819,CHEMICAL,low-cost generic prozac,low-cost generic prozac
NEW13820,CHEBI,effective estrogen therapy,effective estrogen therapy
NEW13821,MENTAL_HEALTH,noniatrogenic nocturnal bruxism,noniatrogenic nocturnal bruxism
NEW13822,DISEASE,sugar addiction,sugar addiction
NEW13823,DISEASE,hypothalamic hyperphagia,hypothalamic hyperphagia
NEW13824,MENTAL_HEALTH,regression coefficient,regression coefficients
NEW13825,DISEASE,death Caps,Death Caps
NEW13826,NUTRITION,horse mushroom,Horse mushroom
NEW13827,DISEASE,high-energy diet,HED|high-energy diet
http://purl.obolibrary.org/obo/CHEBI_66854,CHEMICAL,phosphatidylcholine 34:5,phosphotidylcholine 3-octadecanoate|PC(34:5)|phosphatidylcholine(34:5)|PC 34:5|GPCho(34:5)
C064904,CHEMICAL,"poly(dG-dC)-benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide [Supplementary Concept]","DG|7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide|Polydeoxyribonucleotides"
C543520,CHEMICAL,nemonoxacin [Supplementary Concept],Quinolones|18:0/16:0/18:3|TG
D054800,CHEMICAL,Glycosylphosphatidylinositol Diacylglycerol-Lyase,"Glycosylphosphatidylinositol Diacylglycerol Lyase|Phospholipase C, PtdIns-Glycan|Phosphatidylinositol Glycan Specific Phospholipase C|PtdIns-Glycan Phospholipase C|Phospholipase C, Phosphatidylinositol-Glycan-Specific|Phospholipase C, Glycosylphosphatidylinositol-Specific|GPI-PLC|Glycosylphosphatidylinositol Specific Phospholipase C|diacylglycerol|PtdIns Glycan Phospholipase C|Diacylglycerol-Lyase, Glycosylphosphatidylinositol|Glycosylphosphatidylinositol-Specific Phospholipase C|Phosphatidylinositol-Glycan-Specific Phospholipase C"
NEW13828,CHEMICAL,ce 20:5,CE 20:5
D031324,CHEMICAL,Juglans,"English Walnut|Juglans regia|Juglans nigra|Walnuts, English|Walnut|English Walnuts|Walnut, English|Walnut, Black|Black Walnut|Walnuts, Black|Black Walnuts|Walnuts"
NEW13829,NUTRITION,tree nut consumption,tree nut consumption
NEW13830,MENTAL_HEALTH,square regression,squares regression
NEW13831,MENTAL_HEALTH,vectorial displacement,vectorial displacement
C074428,CHEMICAL,"atpB protein, E coli [Supplementary Concept]",Bacterial Proton-Translocating ATPases|Escherichia coli Proteins|ATP synthase
NEW13832,CHEMICAL,anti-akinetic effect,anti-akinetic effects
NEW13833,DISEASE,"(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced neuronal cell death","(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced neuronal cell death"
NEW13834,DISEASE,akinetic parkinsonian crisis,akinetic parkinsonian crisis
NEW13835,CHEMICAL,mao isoform,MAO isoforms
NEW13836,CHEMICAL,gamma-aminobutyric acid gaba neurotransmitter system,gamma-aminobutyric acid GABA neurotransmitter system
http://purl.obolibrary.org/obo/DOID_0050587,DISEASE,trichotillomania,cothymia
NEW13837,DISEASE,general neurotic syndrome,general neurotic syndrome
NEW13838,CHEBI,most drug treatment,most drug treatments
NEW13839,MENTAL_HEALTH,baseline personality disorder,baseline personality disorder
NEW13840,MENTAL_HEALTH,equilibrium dissociation constant,equilibrium dissociation constants
NEW13841,DISEASE,secondary fracture,secondary fractures
NEW13842,CHEBI,androgen hormone,androgen hormones
NEW13843,DISEASE,adolescent ptsd patient,adolescent PTSD patients
NEW13844,CHEBI,nk1 antagonist activity,NK1 antagonist activities
NEW13845,DISEASE,motor skill impairment,motor skill impairment
NEW13846,CHEBI,promising analgesic potency,promising analgesic potency
NEW13847,DISEASE,primary familial brain calcification,Primary familial brain calcification
NEW13848,CHEMICAL,ne region,NE region
NEW13849,CHEMICAL,vitamin b1 thiamin deficiency,vitamin B1 thiamin deficiency
NEW13850,DISEASE,stress urinary incontinence,stress urinary incontinence
NEW13851,DISEASE,α-syn fibrillation,α-syn fibrillation
NEW13852,CHEMICAL,hydroxyl moiety,hydroxyl moieties
NEW13853,MENTAL_HEALTH,anxiety group,anxiety group
NEW13854,CHEBI,specific neurotoxin,specific neurotoxin
NEW13855,CHEMICAL,oxygen contain medium,oxygen containing medium
http://purl.obolibrary.org/obo/DOID_12402,MENTAL_HEALTH,pyromania,firesetting behavior|MMPI-2 hysteria|Pathological firesetting
NEW13856,DISEASE,cynical personality,cynical personality
D002117,CHEMICAL,Calcitriol,"|Decostriol|Soltriol|1 alpha, 25-dihydroxy-20-epi-Vitamin D3|1,25 Dihydroxycholecalciferol|1,25-(OH)2D3|Bocatriol|D3, 1 alpha,25-Dihydroxyvitamin|1 alpha,25 Dihydroxyvitamin D3|Rocaltrol|1,25-dihydroxy-20-epi-Vitamin D3|1 alpha,25-Dihydroxycholecalciferol|Osteotriol|MC1288|D3, 1,25-Dihydroxyvitamin|1,25 Dihydroxyvitamin D3|1, 25-(OH)2D3|D3, 1,25-dihydroxy-20-epi-Vitamin|Calcitriol Nefro|25-(OH)2D3|Calcitriol KyraMed|1,25(OH)2-20epi-D3|Calcitriol-Nefro|Tirocal|1 alpha,25-Dihydroxyvitamin D3|KyraMed, Calcitriol|MC 1288|20-epi-1alpha,25-dihydroxycholecaliferol|Sitriol|1,25-Dihydroxycholecalciferol|1,25-Dihydroxyvitamin D3|Calcijex|Calcitriol|Silkis|1,25 dihydroxy 20 epi Vitamin D3|MC-1288|Renatriol"
NEW13857,CHEMICAL,serum nitrogen,serum nitrogen
NEW13858,CHEBI,charge micro-hydrated pantothenate [ca(panto-h)(h2o)]+ adduct,charged micro-hydrated pantothenate [Ca(panto-H)(H2O)]+ adduct
NEW13859,CHEMICAL,gas phase,gas phase
C066444,CHEMICAL,cocaethylene [Supplementary Concept],|Cocaethylene|Cocaine/analogs  and  derivatives|cocaethylene
NEW13860,CHEBI,agonist substitution therapy,agonist substitution therapy
NEW13861,CHEMICAL,occur cocaine derivative,occurring cocaine derivative
D012765,NUTRITION,Shikimic Acid,"shikimic acid|Acid, Shikimic|Shikimic acid"
NEW13862,MENTAL_HEALTH,high variable importance projection value,high variable importance projection values
C030691,CHEBI,gluconic acid [Supplementary Concept],Gluconates|gluconic acid
D043524,CHEMICAL,Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase,"PNGase F|N Glycosidase A|Peptide N-Glycanase|Peptide N glycohydrolase F|Glycopeptide N glycosidase|Glycopeptidase F|N-glycohydrolase F, Peptide|N-glycosidase, Glycopeptide|N Glycanase|N-Glycosidase, Peptide|N-Glycanase, Peptide|Glycopeptidase A|Glycopeptide N-glycosidase|N-Glycosidase F|Peptide N-Glycosidase|N-Glycanase|N Oligosaccharide Glycopeptidase|Peptide N Glycosidase|Glycopeptidase, N-Oligosaccharide|Peptide N Glycanase|asparagine|PNGase A|N-Glycosidase A|Peptide-N(4)-(acetyl-beta-glucosaminyl)Asparagine Amidase|N-Oligosaccharide Glycopeptidase|Peptide N-glycohydrolase F|Peptide-N-Glycanase|N Glycosidase F|Glycopeptidase"
NEW13863,CHEMICAL,gabbr2 gamma-aminobutyric acid type b receptor subunit gene,GABBR2 Gamma-Aminobutyric acid Type B Receptor Subunit gene
NEW13864,MENTAL_HEALTH,syndrome disorder,syndrome disorder
NEW13865,DISEASE,mecp2-mediated mitochondrial dysfunction,MeCP2-mediated mitochondrial dysfunction
NEW13866,DISEASE,rtt disease,RTT disease
NEW13867,CHEMICAL,arterioradionecrosis,arterioradionecrosis
D055513,DISEASE,Connective Tissue Growth Factor,connective tissue|CCN2 Protein|Insulin Like Growth Factor Binding Protein 8|IGF-Binding Protein-Related Protein-2|Insulin-Like Growth Factor Binding Protein 8|Hypertrophic Chondrocyte Specific Protein 24|IGFBP-8|Hypertrophic Chondrocyte-Specific Protein 24|IGF Binding Protein Related Protein 2|IGFBP-rP2
NEW13868,DISEASE,late toxicity,late toxicities
http://purl.obolibrary.org/obo/CHEBI_116931,CHEMICAL,nipecotic acid,3-piperidinecarboxylic acid|hexahydronicotinic acid|gamma-aminobutyric acid γ-aminobutyric acid|piperidine-3-carboxylic acid|Piperidine-3-carboxylic acid
NEW13869,CHEMICAL,menthol cigarette,menthol cigarettes
NEW13870,CHEMICAL,regular smoking dependence,regular smoking dependence
http://purl.obolibrary.org/obo/PR_Q63563,CHEMICAL,atp-binding cassette sub-family c member 9 (rat),Sulfonylureas|abcc9|sur2|rabcc9|sulfonylurea receptor 2 (rat)
NEW13871,DISEASE,diabetes treatment,diabetes treatment
D014044,CHEMICAL,Tolbutamide,Dolipol|tolbutamide|Diaval|Apo-Tolbutamide|Rastinon|Orabet|Orinase|Tolbutamid R.A.N.|Diabetol|Artosin
NEW13872,DISEASE,ucms-induced decrease,UCMS-induced decrease
NEW13873,DISEASE,admit psychiatric patient,admitted psychiatric patients
NEW13874,CHEMICAL,increase plasma cortisol concentration,increased plasma cortisol concentrations
NEW13875,MENTAL_HEALTH,schizoaffective mania,schizoaffective mania
NEW13876,CHEMICAL,plasma cortisol,Plasma cortisol
NEW13877,DISEASE,psychotic subgroup,psychotic subgroups
D009481,CHEMICAL,Neurophysins,"Neurophysin II|Neurophysin, Vasopressin-Associated|Vasopressin Associated Neurophysin|Neurophysin|Neurophysin, Oxytocin-Associated|Neurophysin I|Neurophysin III|neurophysins|Oxytocin Associated Neurophysin|Oxytocin-Associated Neurophysin|Vasopressin-Associated Neurophysin"
NEW13878,DISEASE,vascular damage,Vascular damage
NEW13879,CHEMICAL,cathepsin b. hfd aortae,cathepsin B. HFD aortae
D002402,CHEMICAL,Cathepsin D,Cathepsins (1966-1984)|cathepsin D
NEW13880,DISEASE,pain disease,pain diseases
NEW13881,DISEASE,refractory partial epilepsy,refractory partial epilepsy
NEW13882,CHEBI,class antiarrhythmic drug,class antiarrhythmic drug
NEW13883,DISEASE,inflammatory disorder,Inflammatory disorder
NEW13884,CHEMICAL,tnf-α expression,TNF-α expression
NEW13885,DISEASE,stz-induced rat model,STZ-induced rat model
NEW13886,CHEBI,selective agonist,selective agonist
NEW13887,CHEMICAL,intrathecal neostigmine,Intrathecal neostigmine
NEW13888,DISEASE,spinal pain transmission,spinal pain transmission
NEW13889,CHEMICAL,transdermal nitroglycerine,transdermal nitroglycerine
NEW13890,CHEMICAL,intrathecal neostigmine,intrathecal neostigmine
NEW13891,CHEMICAL,cocaine use,Cocaine use
NEW13892,DISEASE,cntnap2 ko mouse,Cntnap2 KO mice
NEW13893,CHEMICAL,vpa mouse,VPA mice
C074369,CHEMICAL,thiocyanate hydrolase [Supplementary Concept],Hydrolases|thiocyanate
C069599,DISEASE,"trypsin inhibitor protein, Brassica napus [Supplementary Concept]",Plant Proteins|kohlrabi
NEW13894,CHEMICAL,sweet potato,sweet potatoes
NEW13895,DISEASE,transient maternal hypothyroxinemia,transient maternal hypothyroxinemia
NEW13896,CHEMICAL,antenatal omega-3 supplementation,antenatal omega-3 supplementation
NEW13897,DISEASE,maternal depressive symptom,maternal depressive symptoms
NEW13898,CHEMICAL,omega-6/omega-3 ratio,omega-6/omega-3 ratio
NEW13899,NUTRITION,excessive fatty acid intake,excessive fatty acid intake
NEW13900,CHEMICAL,well-known olive polyphenol,well-known olive polyphenol
NEW13901,CHEBI,gabaa receptor antagonist picrotoxin,GABAA receptor antagonist picrotoxin
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Pathophysiology,DISEASE,pathophysiology,ASD-like pathophysiology
NEW13902,CHEBI,nonsymmetric a carotenoid α-carotene,nonsymmetric A carotenoid α-carotene
NEW13903,CHEBI,retinal vitamin a,retinal vitamin A
NEW13904,CHEBI,true vitamin a.,true vitamin A.
D012176,CHEBI,Retinoids,Retinoid|vitamin A|Retinoids
http://purl.obolibrary.org/obo/CHEBI_35701,CHEMICAL,ester,α-retinyl esters
C022521,DISEASE,retinol-palmitate esterase [Supplementary Concept],Retinyl palmitate|RP|retinyl palmitate|Carboxylic Ester Hydrolases
NEW13905,CHEMICAL,diacetate assay,diacetate assay
NEW13906,DISEASE,human skin jurkat t-cell,human skin Jurkat T-cells
NEW13907,CHEBI,n-methyl-d-aspartate receptor agonist quinolinate,N-methyl-d-aspartate receptor agonist quinolinate
http://purl.obolibrary.org/obo/PR_000015412,CHEMICAL,sortilin,gp95|nt3|neurotensin receptor 3|NT3|ntr3|sort1|glycoprotein 95|100 kda nt receptor
NEW13908,DISEASE,excitotoxic injury,excitotoxic injury
NEW13909,CHEMICAL,endogenous neurotrophin,endogenous neurotrophins
http://purl.obolibrary.org/obo/CHEBI_1547,CHEMICAL,3-hydroxykynurenine,3-(3-hydroxyanthraniloyl)alanine|quinolinic (QUIN)-induced|3-(2-amino-3-hydroxybenzoyl)alanine|3-Hydroxy-DL-kynurenine|2-amino-4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid|3-Hydroxykynurenine
NEW13910,MENTAL_HEALTH,medium-sized spiny projection neuron,medium-sized spiny projection neurons
NEW13911,DISEASE,adult hypertrichosis,Adult hypertrichosis
D003981,CHEMICAL,Diazoxide,Proglycem|Hyperstat|diazoxide
NEW13912,DISEASE,metabolic origin,porphyria|metabolic origin
http://purl.obolibrary.org/obo/CHEBI_31858,CHEMICAL,mizoribine,ciclosporine|beta-Bredinin|Mizoribine|bredinin
NEW13913,CHEBI,first-line drug therapy,first-line drug therapy
NEW13914,DISEASE,tmd patient,TMD patients
D002012,DISEASE,Bruxism,"Bruxomania|Disorder, Teeth Grinding|teeth-grinding|Teeth Grinding Disorders|Grinding Disorder, Teeth|Teeth Grinding Disorder"
NEW13915,CHEMICAL,guanylate cyclase-c agonist linaclotide,guanylate cyclase-C agonist linaclotide
NEW13916,DISEASE,post-inflammatory visceral hypersensitivity,post-inflammatory visceral hypersensitivity
NEW13917,DISEASE,ibs-c,IBS-C
NEW13918,DISEASE,fibromyalgia symptom,fibromyalgia symptoms
NEW13919,CHEMICAL,serotonin-norepinephrine noradrenaline reuptake inhibitor,serotonin-norepinephrine noradrenaline reuptake inhibitors
D061567,CHEBI,Voltage-Gated Sodium Channel Blockers,"Voltage-Gated Sodium Channel Antagonists|Channel Blockers, Voltage-Gated Sodium|Voltage-Gated Sodium Channel Inhibitors|Channel Blockers, Voltage Gated Sodium|Voltage Gated Sodium Channel Antagonists|Voltage Gated Sodium Channel Blockers|sodium channel antagonists|Voltage Gated Sodium Channel Inhibitors"
D008558,CHEMICAL,Melphalan,"|Merphalan|L-PAM|melphalan|Mustard, Phenylalanine|Medphalan|Phenylalanine Mustard|Sarkolysin|Sarcolysine|Alkeran|4-(Bis(2-chloroethyl)amino)phenylalanine"
D018880,DISEASE,Atrial Premature Complexes,"Atrial Ectopic Beats|Premature Atrial Complices|Atrial Extrasystole|Extrasystoles, Atrial|Atrial Premature Complex|Atrial Extrasystoles|Atrial Premature Complices|extrasystole|Premature Complices, Atrial|Atrial Complices, Premature|Atrial Ectopic Beat|Ectopic Beats, Atrial|Atrial Beat, Premature|Atrial Contractions, Premature|Supraventricular Beat, Premature|Atrial Complex, Premature|Premature Complex, Atrial|Atrial Beats, Premature|Premature Atrial Beat|Premature Atrial Beats|Atrial Contraction, Premature|Premature Atrial Contraction|Supraventricular Beats, Premature|Premature Supraventricular Beats|Premature Supraventricular Beat|Premature Atrial Complex|Premature Complexes, Atrial|Ectopic Beat, Atrial|Extrasystole, Atrial|Premature Atrial Contractions"
NEW13920,CHEMICAL,bicarbonate dialysis,bicarbonate dialysis
C552597,CHEMICAL,1-pentyl-3-(1-naphthoyl)indole [Supplementary Concept],Indoles|Naphthalen-1-yl-(1-pentylindol-3-yl)methanone|JWH-018|Naphthalenes
http://purl.obolibrary.org/obo/SYMP_0000302,DISEASE,hypothermia,Δ9-tetrahydrocannabinol hypothermia
http://purl.obolibrary.org/obo/CHEBI_59119,CHEMICAL,thiopropazate,2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethyl acetate|2-Chloro-10-(3-(1-(2-acetoxyethyl)-4-piperazinyl)propyl)phenothiazine|Thiopropazat|2-(4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethyl acetate|thiopropazatum|Dronabinol ®|thiopropazate|4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol acetate|N-(beta-Acetoxyethyl)-N'-(gamma-(2'-chloro-10'-phenothiazinyl)propyl)piperazine|tiopropazato|10-(3-(1-(2-Acetoxyethyl)-4-piperazinyl)propyl)-2-chlorophenothiazine|1-(2-Acetoxyethyl)-4-(3-(2-chloro-10-phenothiazinyl)propyl)piperazine
NEW13921,CHEMICAL,jwh-018 administration,JWH-018 administration
http://purl.obolibrary.org/obo/HP_0001336,DISEASE,myoclonus,myoclonia
NEW13922,CHEBI,"selective cb1 receptor antagonist/inverse agonist 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-n-(piperidin-1-yl)-1h-pyrazole-3-carboxamide","selective CB1 receptor antagonist/inverse agonist 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide"
http://purl.obolibrary.org/obo/CHEBI_9424,CHEMICAL,tecomine,bauchiense|Tecomine|methanolic extract
NEW13923,CHEMICAL,selective na reuptake inhibitor,selective NA reuptake inhibitors
NEW13924,CHEBI,study drug,study drug
NEW13925,MENTAL_HEALTH,attack severity,attack severity
NEW13926,CHEMICAL,continuous antidepressant therapy,continuous antidepressant therapy
C564809,DISEASE,"Spastic Paresis, Glaucoma, and Mental Retardation [Supplementary Concept]","Glaucoma|spastic paresis|Intellectual Disability|Paraparesis, Spastic"
NEW13927,DISEASE,spontaneous spasm,spontaneous spasms
NEW13928,CHEMICAL,cyproheptadine therapy,cyproheptadine therapy
NEW13929,MENTAL_HEALTH,joint angular displacement,joint angular displacement
NEW13930,MENTAL_HEALTH,suicide victim,suicide victims
NEW13931,MENTAL_HEALTH,adolescent suicide victim,adolescent suicide victims
NEW13932,CHEMICAL,arachidonic acid aa dha ratio,arachidonic acid AA DHA ratio
D009532,CHEMICAL,Nickel,Ni(2|nickel|Ni|Trace Elements
NEW13933,CHEMICAL,0.5mm,0.5mM
D000072283,CHEMICAL,A549 Cells,"A549 Cell Lines|A549 Cell Line|Cell, A549|Cells, A549|Cell Line, A549|Cell Lines, A549|A549 Cell|A549 cells"
NEW13934,CHEBI,organotropic carcinogen,Organotropic carcinogens
NEW13935,CHEBI,chemical carcinogen,chemical carcinogens
C045718,CHEMICAL,lavender oil [Supplementary Concept],"Silexan|Plant Oils|Lavandula|Oils, Volatile"
NEW13936,CHEMICAL,glutamate nmda-receptor antagonist,glutamate NMDA-receptor antagonist
NEW13937,DISEASE,snail disorder,snails disorders
NEW13938,CHEBI,indirect serotonergic agonist,indirect serotonergic agonist
NEW13939,CHEMICAL,fenfluramine administration,fenfluramine administration
D015715,DISEASE,Corneal Edema,"edema|Edema, Corneal|Corneal Edemas|Edemas, Corneal"
http://purl.obolibrary.org/obo/SYMP_0000867,DISEASE,gastrointestinal bleeding,gastrointestinal bleeding
D002915,DISEASE,Chylous Ascites,"Ascites, Chylous|Chyloperitoneum|ascites|Peritonitis, Chylous|Chylous Peritonitis"
NEW13940,DISEASE,coagulation disturbance,coagulation disturbances
NEW13941,DISEASE,spontaneous bacterial peritonitis,spontaneous bacterial peritonitis
D006530,DISEASE,Hepatorenal Syndrome,"Syndrome, Hepatorenal|hepatorenal syndrome"
NEW13942,DISEASE,alpha(1)-antitrypsin alpha(1)-at deficiency,alpha(1)-antitrypsin alpha(1)-AT deficiency
NEW13943,CHEBI,drug intervention,Drug intervention
NEW13944,DISEASE,severe hyperhomocysteinemia,HHcy|severe hyperhomocysteinemia
NEW13945,CHEMICAL,excessive hcy level,excessive Hcy level
NEW13946,CHEMICAL,hydrogen sulfide h2s deficiency,Hydrogen sulfide H2S deficiency
NEW13947,CHEBI,vitamin a. β-cryptoxanthin,vitamin A. β-Cryptoxanthin
NEW13948,CHEBI,antioxidative carotenoid,antioxidative carotenoid
NEW13949,MENTAL_HEALTH,improve insulin resistance,improved insulin resistance
NEW13950,CHEBI,peroxiproliferator-activated receptor ppar family activation,peroxiproliferator-activated receptor PPAR family activation
NEW13951,CHEMICAL,elevated corticosteroid level,elevated corticosteroid levels
NEW13952,DISEASE,dysphoric property,dysphoric properties
NEW13953,CHEBI,cyanocobalamin vitamin b12 deficiency,Cyanocobalamin vitamin B12 deficiency
NEW13954,CHEMICAL,caspr2-igg,Caspr2-IgG
NEW13955,DISEASE,anti-caspr2 antibody-associated autoimmune encephalitis,anti-Caspr2 antibody-associated autoimmune encephalitis
NEW13956,CHEMICAL,meoh h2o extract,MeOH H2O extracts
NEW13957,CHEMICAL,cuprac,CUPRAC
NEW13958,NUTRITION,proanthocyanidin tpa content,proanthocyanidin TPA content
C049960,CHEMICAL,1-salicylate glucuronide [Supplementary Concept],Glucuronates|phenolic|Salicylates
D050154,DISEASE,Adiposity,adiposity|Obesity (1965-2005)
NEW13959,DISEASE,plasmolysis,plasmolysis
C000611893,CHEMICAL,"2-(3,5-dimethyl-1H-pyrazol-1-yl)-5-methylphenol [Supplementary Concept]",Phenols|Pyrazoles|ME1111
NEW13960,DISEASE,fungal cell death,fungal cell death
NEW13961,CHEBI,effective antifungal agent,effective antifungal agent
NEW13962,CHEBI,sufficient drug concentration,sufficient drug concentrations
C431707,CHEMICAL,efinaconazole [Supplementary Concept],Triazoles|efinaconazole
D014009,DISEASE,Onychomycosis,"Onychomycoses|Tinea Unguium|onychomycosis|Fungus, Nail|Nail Fungus"
C512998,CHEMICAL,tavaborole [Supplementary Concept],"Bridged Bicyclo Compounds, Heterocyclic|Boron Compounds|Tavaborole"
NEW13963,CHEMICAL,concurrent thc treatment,concurrent THC treatment
NEW13964,DISEASE,transient global uterine ischemia,transient global uterine ischemia
NEW13965,CHEMICAL,PVA group,PVA group
NEW13966,CHEMICAL,polyvinyl alcohol particle,polyvinyl alcohol particles
NEW13967,CHEMICAL,fentanyl dose,fentanyl dose
NEW13968,DISEASE,similar pain score,similar pain scores
C496735,CHEBI,trisacryl gelatin microspheres [Supplementary Concept],Gelatin|Acrylic Resins|tris-acryl gelatin microspheres
NEW13969,DISEASE,frequent transient global uterine ischemia,frequent transient global uterine ischemia
NEW13970,CHEBI,rescue analgesic use,rescue analgesic use
D013922,DISEASE,Thrombocytosis,Thrombocytosis|Thrombocythemia|Thrombocytoses|Thrombocythemias
NEW13971,DISEASE,mct-induced liver injury,MCT-induced liver injury
NEW13972,CHEBI,plasmapheresis agonist,plasmapheresis agonist
NEW13973,DISEASE,siod,SIOD
NEW13974,DISEASE,seizure model,seizure model
NEW13975,CHEMICAL,N. fruit extract,N. fruit extract
NEW13976,DISEASE,persistent babesiosis,Persistent babesiosis
NEW13977,DISEASE,community-associated disease,community-associated diseases
NEW13978,DISEASE,chronic infectious disease,chronic infectious disease
NEW13979,DISEASE,severe disfiguring skin sore,severe disfiguring skin sores
D056006,DISEASE,"Leprosy, Multibacillary","Midborderline Lepromatous|Lepromatous, Borderline|Multibacillary Leprosy|Multibacillary Leprosies|Borderline Lepromatous|Leprosies, Multibacillary|leprosy|Lepromatous, Midborderline"
NEW13980,CHEMICAL,multidrug therapy,MDT|multidrug therapy
NEW13981,MENTAL_HEALTH,single- resistance,single- resistance
NEW13982,CHEBI,t allele carrier,T allele carriers
NEW13983,CHEMICAL,combination olanzapine,Combination olanzapine
C107773,CHEMICAL,pterostilbene [Supplementary Concept],Stilbenes|pterostilbene
NEW13984,CHEMICAL,bccao mouse,BCCAO mice
NEW13985,CHEMICAL,pterostilbene treatment,pterostilbene treatment
NEW13986,DISEASE,hippocampal neuronal death,hippocampal neuronal death
NEW13987,DISEASE,vascular cognitive impairment,vascular cognitive impairment
NEW13988,CHEBI,antimalarial drug available,antimalarial drug available
NEW13989,MENTAL_HEALTH,depression subtype,depression subtypes
NEW13990,CHEMICAL,ep2 receptor,EP2 receptor
NEW13991,DISEASE,salt-sensitive hypertension,salt-sensitive hypertension
NEW13992,CHEMICAL,self-supplying oxygen nanotherapeutic,Self-supplying oxygen nanotherapeutics
NEW13993,DISEASE,drug-resistant microbial keratitis,drug-resistant microbial keratitis
D000069479,CHEMICAL,"Buprenorphine, Naloxone Drug Combination","Combination, Buprenorphine-Naloxone|Buprenorphine Naloxone|Buprenorphine-Naloxone Drug Combination|buprenorphine-naloxone combination|Drug Combination, Buprenorphine-Naloxone|Buprenorphine-Naloxone|Buprenorphine Naloxone Drug Combination|Naloxone, Buprenorphine|Buprenorphine-Naloxone Combination|Buprenorphine Naloxone Combination|Suboxone|buprenorphine-naloxone|Combination, Buprenorphine-Naloxone Drug"
NEW13994,MENTAL_HEALTH,opioid abuse relapse,opioid abuse relapse
D002249,CHEMICAL,Carbon Monoxide Poisoning,"Carbon Monoxide Poisonings|Poisonings, Illuminating Gas|carbon monoxide|Monoxide Poisoning, Carbon|Gas Poisoning, Illuminating|Illuminating Gas Poisonings|Poisoning, Illuminating Gas|Gas Poisonings, Illuminating|Monoxide Poisonings, Carbon|Poisonings, Carbon Monoxide|Illuminating Gas Poisoning|Poisoning, Carbon Monoxide"
D008752,CHEMICAL,Methylene Chloride,"methylene chloride|Bichloride, Methylene|Dichloride, Methylene|Methylene Dichloride|Solaesthin|Chloride, Methylene|Methylene Bichloride|Dichloromethane"
NEW13995,DISEASE,non-inflammatory condition,non-inflammatory condition
http://purl.obolibrary.org/obo/SYMP_0000358,DISEASE,premature labor,premature labour
D016585,DISEASE,"Vaginosis, Bacterial","Bacterial Vaginitides|Vaginitis, Bacterial|Vaginitis, Nonspecific|Bacterial Vaginoses|Vaginoses, Bacterial|bacterial vaginosis|Vaginitides, Bacterial|Bacterial Vaginosis|Nonspecific Vaginitis|Bacterial vaginosis|Bacterial Vaginitis"
NEW13996,CHEBI,gut microbiota-derived vitamin,gut microbiota-derived vitamins
NEW13997,CHEMICAL,elevated homocysteine,Elevated homocysteine
NEW13998,DISEASE,diet (hfd)-induced obesity,diet (HFD)-induced obesity
C057215,NUTRITION,"8.2K CTP protein, Bos taurus [Supplementary Concept]",Membrane Transport Proteins|Cholesterol Transport
NEW13999,NUTRITION,reverse Cholesterol Transport,Reverse Cholesterol Transport
NEW14000,CHEMICAL,increase plasma malondialdehyde level,increased plasma malondialdehyde level
NEW14001,CHEMICAL,plasma histidine,plasma histidine
NEW14002,CHEBI,wild-type oprm1-aa genotype carrier,Wild-type OPRM1-AA genotype carriers
NEW14003,CHEMICAL,oprm1-ag/gg,OPRM1-AG/GG
http://purl.obolibrary.org/obo/DOID_14756,DISEASE,vascular type ehlers-danlos syndrome,autosomal dominant type IV Ehlers-Danlos syndrome|vascular Ehlers-Danlos syndrome
NEW14004,DISEASE,recurrent hemoptysis,recurrent hemoptysis
NEW14005,CHEMICAL,perennial ryegrass toxicosis,PRGT|perennial ryegrass toxicosis
NEW14006,MENTAL_HEALTH,elevated social anxiety,elevated social anxiety
http://purl.obolibrary.org/obo/MF_0000040,CHEMICAL,communication,digital/online communication
NEW14007,CHEBI,robust analgesic activity,robust analgesic activity
http://purl.obolibrary.org/obo/DOID_845,DISEASE,cyclothymic disorder,Cyclothymia|Cycloid personality|Cyclothymic personality|non-depressive psychiatric disorders|Affective personality disorder
NEW14008,NUTRITION,plasma choline phosphoglyceride,plasma choline phosphoglycerides
NEW14009,CHEMICAL,erythrocyte ethanolamine phosphoglyceride,erythrocyte ethanolamine phosphoglycerides
NEW14010,NUTRITION,long chain polyunsaturated fatty acid,long chain polyunsaturated fatty acids
NEW14011,CHEBI,gamma aminobutyric acid gaba receptor agonist,gamma aminobutyric acid GABA receptor agonist
NEW14012,DISEASE,hypertonia episode,hypertonia episodes
C507134,CHEMICAL,ON 01910 [Supplementary Concept],Rigosertib|Sulfones|Glycine/analogs  and  derivatives
NEW14013,CHEBI,novel anticancer drug,novel anticancer drug
NEW14014,CHEMICAL,low dose naltrexone,low dose naltrexone
NEW14015,CHEMICAL,statin therapy,statin therapy
NEW14016,CHEMICAL,statin therapy,Statin therapy
NEW14017,NUTRITION,fatty acid signalling,fatty acid signalling
NEW14018,CHEBI,islet beta cell compensation,islet beta cell compensation
http://purl.obolibrary.org/obo/CHEBI_76977,CHEBI,corticotropin-releasing factor receptor antagonist,corticotropin-releasing factor receptor antagonists|CRF antagonist|Corticotrophin-releasing factor antagonists|CRF antagonists
NEW14019,DISEASE,severe ocd,severe OCD
NEW14020,DISEASE,moderate-to-severe ocd,moderate-to-severe OCD
NEW14021,DISEASE,ocd treatment,OCD treatment
NEW14022,CHEMICAL,glutamate-modulating agent,glutamate-modulating agents
NEW14023,DISEASE,colonic motility,colonic motility
NEW14024,DISEASE,colonic dysmotility,colonic dysmotility
NEW14025,DISEASE,chronic constipation refractory,chronic constipation refractory
NEW14026,CHEBI,thyroid hormone therapy,thyroid hormone therapy
NEW14027,DISEASE,group constipation,Group constipation
NEW14028,DISEASE,failure-induced accumulation,failure-induced accumulation
NEW14029,DISEASE,renal failure patient,renal failure patients
http://purl.obolibrary.org/obo/CHEBI_61015,CHEBI,nephrotoxin,nephrotoxin|nephrotoxins
NEW14030,CHEMICAL,acacia drepanolobium,Acacia drepanolobium
NEW14031,CHEMICAL,morphine consumption,Morphine consumption
NEW14032,CHEMICAL,opioid antagonist naloxone,opioid antagonist naloxone
NEW14033,CHEBI,partial dopamine agonist,partial dopamine agonist
NEW14034,CHEMICAL,chronic ethanol feeding,chronic ethanol feeding
NEW14035,DISEASE,hepatotoxicity,Hepatotoxicity
NEW14036,CHEMICAL,dehydrogenase-mediated excessive hepatic generation,dehydrogenase-mediated excessive hepatic generation
NEW14037,DISEASE,nutritional deficit,nutritional deficits
NEW14038,CHEMICAL,gem/clf co-loaded liposome,GEM/CLF co-loaded liposomes
NEW14039,DISEASE,osteosarcoma cell line,osteosarcoma cell line
NEW14040,CHEMICAL,gem/clf co-loaded liposomal delivery system,GEM/CLF co-loaded liposomal delivery system
C085058,CHEMICAL,"alpha-cobratoxin cyclic peptide Cys-23,40 (23-40) [Supplementary Concept]","Cobra Neurotoxin Proteins|Peptides, Cyclic|Peptide Fragments|α-cobratoxin"
NEW14041,DISEASE,cancer-induced bone pain,CIBP|Cancer-induced bone pain
NEW14042,DISEASE,mechanical allodynia test,mechanical allodynia test
NEW14043,CHEMICAL,intracellular calcium measurement,intracellular calcium measurement
NEW14044,DISEASE,primary lumber sdh neuron,primary lumber SDH neurons
NEW14045,CHEMICAL,intracellular calcium concentration,intracellular calcium concentration
D001950,CHEMICAL,Bretylium Tosylate,Bretylol|Bretylium Tosilate|Bretylate|Ornid|tosylate
NEW14046,MENTAL_HEALTH,hydride displacement,hydride displacement
NEW14047,DISEASE,high heat coma threshold,highest heat coma threshold
NEW14048,CHEMICAL,well heat tolerance ctmax1,better heat tolerance CTmax1
NEW14049,MENTAL_HEALTH,high heat stupor threshold,highest heat stupor threshold
NEW14050,MENTAL_HEALTH,heat stress resistance,heat stress resistance
NEW14051,CHEMICAL,boreo-alpine specie,Boreo-Alpine species
NEW14052,MENTAL_HEALTH,heat resistance,heat resistance
NEW14053,CHEBI,ln retinol binding protein,ln retinol binding protein
NEW14054,DISEASE,reduce anaemia odd,reduced anaemia odds
D000077323,DISEASE,Salt Stress,"Response, Salt Stress|Stress, Salt|Stress, Salinity|Stress Reaction, Salt|Stress Reponse, Salinity|salt stress|Salinity Stresses|Salt Stress Reaction|Reponse, Salinity Stress|Salt Stresses|Stress Reaction, Salinity|Salinity Stress Reaction|Salinity Stress|Salinity Stress Reponses|Reaction, Salt Stress|Salinity Stress Reponse|Salt Stress Response|Salt Stress Reactions|Stress Response, Salt|Reaction, Salinity Stress|Salinity Stress Reactions|Salt Stress Responses"
NEW14055,CHEMICAL,cs treatment,Cs treatment
D005971,CHEMICAL,Glutamates,Glutamic Acids|glutamic acids|Glutamic Acid Derivatives|Glutaminic Acids
D013853,DISEASE,Thioacetamide,TAA|Thiacetamid|thioacetamide|Thioacetamid
D003980,CHEMICAL,Diazooxonorleucine,6 Diazo 5 oxo L norleucine|6-Diazo-5-oxo-L-norleucine
D062967,CHEMICAL,Cyclic GMP-Dependent Protein Kinase Type II,cGMP Dependent Protein Kinase 2|cGK II|cGMP-Dependent Protein Kinase 2|Cyclic GMP Dependent Protein Kinase Type II|cGMP Dependent Protein Kinase II|GMP|cGMP-Dependent Protein Kinase II
NEW14056,CHEMICAL,reversible defunctionalisation,Reversible defunctionalisation
NEW14057,CHEMICAL,trpv1 receptor agonist olvanil,TRPV1 receptor agonist olvanil
C564871,MENTAL_HEALTH,Progesterone Resistance [Supplementary Concept],progesterone resistance|Uterine Diseases|Endometrium/abnormalities
NEW14058,CHEMICAL,rapid carbon dioxide retention,rapid carbon dioxide retention
NEW14059,MENTAL_HEALTH,symptoms-like anxiety,symptoms-like anxiety
NEW14060,CHEMICAL,lidocaine ±     min,lidocaine ±    min
NEW14061,CHEMICAL,± min,± min
NEW14062,CHEMICAL,tramadol-lidocaine ±     min,tramadol-lidocaine ±    min
http://purl.obolibrary.org/obo/CHEBI_119915,CHEMICAL,fentanyl,N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide|N-(1-phenethyl-4-piperidyl)propionanilide|1-phenethyl-4-(N-phenylpropionamido)piperidine|N-phenethyl-4-(N-propionylanilino)piperidine|N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide|fentanyl|Duragesic|N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide|fentanilo|fentanylum|phentanyl|N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|1-phenethyl-4-N-propionylanilinopiperidine|tramadol-lidocaine|N-(1-phenethyl-piperidin-4-yl)-N-phenyl-propionamide
NEW14063,CHEMICAL,phosphate binder,Phosphate binders
NEW14064,CHEMICAL,calcium accumulation,calcium accumulation
NEW14065,DISEASE,aluminum-related bone disease,aluminum-related bone disease
NEW14066,MENTAL_HEALTH,alcohol-related brain disease,ARBD|alcohol-related brain disease
NEW14067,DISEASE,hypercalcaemia,hypercalcaemia
NEW14068,CHEMICAL,Dcycloserine,Dcycloserine
NEW14069,DISEASE,neurobehavioral function,neurobehavioral functions
NEW14070,CHEMICAL,glycine modulatory site,glycine modulatory site
NEW14071,MENTAL_HEALTH,withdrawal dysphoria,withdrawal dysphoria
NEW14072,MENTAL_HEALTH,increase craving,increasing craving
NEW14073,CHEMICAL,rna nanoparticle,RNA nanoparticles
NEW14074,CHEMICAL,hydrophobic drug,hydrophobic drugs
NEW14075,CHEMICAL,covid-19 vaccination campaign,COVID-19 vaccination campaign
NEW14076,DISEASE,un-resolve,un-resolving
C478745,CHEMICAL,tasimelteon [Supplementary Concept],Benzofurans|Cyclopropanes|tasimelteon
http://purl.obolibrary.org/obo/CHEBI_70782,CHEBI,pparalpha agonist,PPAR-alpha agonist|peroxisome proliferator-activated receptor-alpha agonist|PPARalpha agonists|FDA-approved PPARgamma agonist|PPAR agonists|PPARalpha agonist|peroxisome proliferator-activated receptor-alpha agonists|PPARgamma agonists|PPAR-alpha agonists
NEW14077,CHEMICAL,label fructan oligomer,labeled fructan oligomers
NEW14078,MENTAL_HEALTH,order ms fragmentation pattern,order MS fragmentation patterns
C044118,CHEMICAL,fructan beta-fructosidase [Supplementary Concept],Glycoside Hydrolases|fructan
NEW14079,DISEASE,severe motor deficit,severe motor deficits
NEW14080,CHEMICAL,dorsomedial striatal dopamine depletion,dorsomedial striatal dopamine depletion
NEW14081,MENTAL_HEALTH,initial perseveration,initial perseveration
NEW14082,CHEMICAL,intranasal corticoid,Intranasal corticoids
NEW14083,DISEASE,nose block,nose block
NEW14084,CHEMICAL,Myricitrin     mg/kg,Myricitrin    mg/kg
NEW14085,CHEBI,blood carotenoid,blood carotenoids
NEW14086,DISEASE,heightened mood intensification,heightened mood intensification
NEW14087,DISEASE,hyperactive bladder refractory,hyperactive bladder refractory
NEW14088,NUTRITION,many chromone,Many chromones
NEW14089,DISEASE,human leukaemia cell,human leukaemia cells
D013384,CHEMICAL,Succinate Cytochrome c Oxidoreductase,succinate cytochrome c reductase|Succinate Cytochrome c Reductase
NEW14090,DISEASE,object detection memory deficit,object detection memory deficit
http://purl.obolibrary.org/obo/CHEBI_135580,CHEMICAL,theodrenaline,0.04mg/kg|(+/-)-Theodrenaline
NEW14091,CHEBI,d1 receptor antagonist,D1 receptor antagonists
NEW14092,DISEASE,dmba-induced oral precancerous lesion,DMBA-induced oral precancerous lesions
D050998,CHEMICAL,bcl-2 Homologous Antagonist-Killer Protein,% BAK|bcl2 Homologous Antagonist-Killer Protein|Bak Protein|bcl2 Homologous Antagonist Killer Protein|N-Bak Protein|bcl 2 Homologous Antagonist Killer Protein
D013849,CHEMICAL,Thimerosal,"Merthiolate|Sodium Ethylmercurithiosalicylate|Mercurothiolate|Thimerosal|Thiomersalate|Thiomersal|Vitaseptol|Ethylmercurithiosalicylate, Sodium"
NEW14093,CHEBI,vaccine antimicrobial preservative,vaccine antimicrobial preservative
NEW14094,CHEMICAL,vaccine thimerosal exposure,vaccine thimerosal exposure
NEW14095,DISEASE,ocd pathophysiology,OCD pathophysiology
D003042,CHEMICAL,Cocaine,"|Hydrochloride, Cocaine|Cocaine Hydrochloride|cocaine|Cocaine HCl|Cocaine hydrochloride|HCl, Cocaine"
NEW14096,MENTAL_HEALTH,potentiate opiate analgesia,Potentiated opiate analgesia
NEW14097,MENTAL_HEALTH,opiate analgesia,opiate analgesia
NEW14098,CHEMICAL,systemic clonidine,Systemic clonidine
NEW14099,DISEASE,neuropathic pain refractory,neuropathic pain refractory
NEW14100,DISEASE,major cardiovascular dysfunction,major cardiovascular dysfunction
http://purl.obolibrary.org/obo/DOID_11634,DISEASE,myxedema,Amiodarone-induced thyrotoxicosis
NEW14101,CHEBI,suggestive drug history,suggestive drug history
NEW14102,DISEASE,metastatic pancreatic cancer,metastatic pancreatic cancer
D000077150,CHEMICAL,Oxaliplatin,"Oxaliplatin, (SP-4-3-(cis))-isomer|Platinum(II)-1,2-cyclohexanediamine Oxalate|Oxalato-(1,2-cyclohexanediamine)platinum II|ACT 078|Eloxatine|Cis-oxalato-(trans-l)-1,2-diaminocyclohexane-platinum(II)|ACT-078|Eloxatin|oxaliplatin|Oxaliplatin, (SP-4-2-(1R-trans))-isomer|ACT078|L-OHP Cpd|1,2-Diaminocyclohexane Platinum Oxalate|1,2-Diamminocyclohexane(trans-1)oxolatoplatinum(II)|Oxaliplatin, (SP-4-2-(1S-trans))-isomer|1,2 Diaminocyclohexane Platinum Oxalate|Oxaliplatine|Platinum(2+) ethanedioate (1R,2R)-1,2-cyclohexanediamine (1:1:1)"
C520255,CHEMICAL,130-nm albumin-bound paclitaxel [Supplementary Concept],Nab-paclitaxel|Albumins|Paclitaxel
D000077146,CHEMICAL,Irinotecan,SN-38-11|Camptothecin-11|Irrinotecan|CPT11|Camptosar|SN 38 11|7-Ethyl-10-hydroxycamptothecin|SN-38|SN 38|Camptothecin 11|SN3811|NK012 Compound|CPT 11|CPT-11|Irinotecan hydrochloride|7 Ethyl 10 hydroxycamptothecin|Irinotecan Hydrochloride|irinotecan
NEW14103,CHEBI,folate depletion,Folate depletion
D001973,CHEMICAL,Bromodeoxyuridine,"BrdU|NSC-38297|BUdR|bromodeoxyuridine|5-Bromodeoxyuridine|Deoxyriboside, Bromouracil|5-Bromo-2'-deoxyuridine|5 Bromodeoxyuridine|5 Bromo 2' deoxyuridine|Broxuridine|Bromouracil Deoxyriboside"
NEW14104,CHEMICAL,ropi treatment,ROPI treatment
NEW14105,CHEMICAL,agonist ropinirole,ROPI|agonist Ropinirole
D001463,CHEMICAL,Barbiturates,"Thiopental|Anesthetics, Intravenous|Anticonvulsants|barbiturates|Hypnotics and Sedatives"
NEW14106,DISEASE,respiratory motor output,respiratory motor output
NEW14107,CHEMICAL,classic antidepressant antidepressant role,classic antidepressant antidepressant role
C111960,CHEMICAL,baicalin 6-O-sulfate [Supplementary Concept],Flavonoids|baicalin
NEW14108,CHEMICAL,cyclin d1-cyclin dependent kinase,Cyclin D1-cyclin dependent kinase
NEW14109,DISEASE,various sleep disorder,various sleep disorders
NEW14110,DISEASE,atherosclerosis mouse model,atherosclerosis mouse model
http://purl.obolibrary.org/obo/CHEBI_87211,CHEMICAL,fluoroquinolone antibiotic,Macrolid antibiotics|fluoroquinolone antibiotics|Fluoroquinolone antibiotics
NEW14111,CHEMICAL,fluoroquinolone use,fluoroquinolone use
NEW14112,MENTAL_HEALTH,vasomotor syndrome,vasomotor syndromes
NEW14113,DISEASE,intestinal immunity,intestinal immunity
NEW14114,MENTAL_HEALTH,cluster crc syndrome,clustering CRC syndromes
D062556,DISEASE,NAV1.7 Voltage-Gated Sodium Channel,NAV1.7 Voltage Gated Sodium Channel|SCN9A Sodium Channel alpha Subunit|Type 9 Voltage-Gated Sodium Channel|Voltage-Gated Sodium Channel Type 9|Voltage Gated Sodium Channel Type 9|Voltage Gated Sodium Channel Type 9 Subunit alpha|Type 9 Voltage Gated Sodium Channel|Voltage-Gated Sodium Channel Type 9 Subunit alpha|Peripheral Sodium Channel 1|SCN9A
NEW14115,DISEASE,profound pain insensitivity,profound pain insensitivity
NEW14116,DISEASE,effective pain therapeutic,effective pain therapeutics
NEW14117,MENTAL_HEALTH,opioid analgesia,opioid analgesia
NEW14118,CHEMICAL,sterol metabolism,sterol metabolism
NEW14119,CHEMICAL,ketone ketogenic medium-chain triglyceride,ketones ketogenic medium-chain triglyceride
NEW14120,DISEASE,arterial damage,arterial damage
NEW14121,CHEMICAL,high homocysteine level,High homocysteine levels
C516256,CHEMICAL,"(2,4-bis(2-pyridylmethylimino)pentane)bis(acetonitrile)iron(II) [Supplementary Concept]",pentane|Ferrous Compounds
NEW14122,MENTAL_HEALTH,vitamin e-deficiency syndrome,vitamin E-deficiency syndromes
D003494,CHEMICAL,Cyclamates,"Cyclamic Acid|Potassium Cyclamate|Cyclamate, Potassium|Sodium cyclamate|Cyclamate, Calcium|Cyclamate, Sodium Salt|Calcium Cyclamate|Cyclamate Calcium (2:1) Salt|Cyclamate|Cyclamate, Calcium (2:1) Salt, Dihydrate|Cyclamate, Sodium|Sodium Cyclamate"
C006068,CHEMICAL,propylparaben [Supplementary Concept],propylparaben|Parabens
D010892,CHEMICAL,Pirinitramide,Dipydolor|Dipidolor|Piritramide|piritramide|Piritramid
NEW14123,MENTAL_HEALTH,intravenous analgesia,intravenous analgesia
NEW14124,DISEASE,inappropriate antidiuretic hormone release secondary,inappropriate antidiuretic hormone release secondary
NEW14125,CHEMICAL,readmission troponin,readmission troponins
D008551,DISEASE,Melena,melena|Melenas
D009705,CHEMICAL,Nucleosides,"Nucleoside Analog|Analog, Nucleoside|Nucleoside|nucleoside analogs|Analogs, Nucleoside|Nucleoside Analogs"
NEW14126,CHEBI,potential drug candidate,potential drug candidates
D054332,DISEASE,Leishmaniasis Vaccines,"Leishmania Vaccines|Vaccine, Leishmania|Leishmania Vaccine|Vaccines, Leishmania|Leishmaniasis Vaccine|Vaccine, Leishmaniasis|Vaccines, Leishmaniasis|leishmaniasis"
NEW14127,CHEMICAL,benzodiazepine group,benzodiazepine group
NEW14128,DISEASE,clozapine-induced allergic vasculitis,clozapine-induced allergic vasculitis
NEW14129,CHEBI,endocrine basis,endocrine basis
NEW14130,DISEASE,osa subject,OSA subjects
NEW14131,DISEASE,poor prognosis tumor,poor prognosis tumors
NEW14132,DISEASE,core basal phenotype tumor,core basal phenotype tumors
C444427,NUTRITION,"RSAD2 protein, human [Supplementary Concept]",S-Adenosyl methionine|Oxidoreductases Acting on CH-CH Group Donors
NEW14133,CHEMICAL,synthetic methionine enkephaline analogue fk,synthetic methionine enkephaline analogue FK
D018754,DISEASE,Ventricular Dysfunction,"Dysfunctions, Ventricular||impairment of ventricular function|ventricular dysfunction|Ventricular Dysfunctions|Dysfunction, Ventricular"
D000432,CHEMICAL,Methanol,"Carbinol|Wood Alcohol|Alcohol, Wood|Methanol|Sodium Methoxide|Methyl Alcohol|Methoxide, Sodium|Alcohol, Methyl"
NEW14134,CHEMICAL,k1 multiresistant,K1 multiresistant
NEW14135,DISEASE,p. falciparum nf54 sensitive,P. falciparum NF54 sensitive
NEW14136,CHEMICAL,ethyl acetate leaf extract,ethyl acetate leaf extracts
NEW14137,DISEASE,second-onset ocs,second-onset OCS
http://purl.org/sig/ont/fma/fma67310,MENTAL_HEALTH,projection neuron,projection neurons
NEW14138,CHEMICAL,methyl-esterified pectin,methyl-esterified pectins
NEW14139,CHEMICAL,cannabis withdrawal,cannabis withdrawal
NEW14140,CHEMICAL,dorsal anterior cingulate cortex dacc glutamate,Dorsal anterior cingulate cortex dACC glutamate
NEW14141,CHEBI,ovarian hormone,Ovarian hormones
NEW14142,CHEMICAL,cocaine craving,cocaine craving
NEW14143,CHEMICAL,heroin crosse,Heroin crosses
D007746,DISEASE,Labor Presentation,"Presentation, Labor|Malpresentation, Fetal|Fetal Malpresentations|Presentation, Fetal|malpresentation|Fetal Presentation|Fetal Malpresentation"
NEW14144,DISEASE,third trimester bleed,third trimester bleeding
D008471,DISEASE,Meconium Aspiration Syndrome,"Aspiration Syndrome, Meconium|meconium aspiration|Meconium Inhalation|Aspiration, Meconium|Meconium Aspiration|Syndrome, Meconium Aspiration"
http://purl.obolibrary.org/obo/SYMP_0019149,DISEASE,toxemia,toxaemia
NEW14145,DISEASE,reversible hepatitis,reversible hepatitis
NEW14146,CHEMICAL,mirtazapine augmentation,Mirtazapine augmentation
NEW14147,MENTAL_HEALTH,mixed depression,Mixed depression
NEW14148,CHEMICAL,antidepressant monotherapy,antidepressant monotherapy
NEW14149,DISEASE,mixed depressive state,mixed depressive states
NEW14150,DISEASE,fulminant alpha-synucleinopathy,fulminant alpha-synucleinopathy
NEW14151,DISEASE,gba mutation,GBA mutations
NEW14152,DISEASE,parkinson disease functional score,Parkinson disease functional scores
NEW14153,CHEMICAL,striatal dopamine synthesis,striatal dopamine synthesis
D002421,DISEASE,Caudate Nucleus,"caudate|Caudatus|Nucleus, Caudate|Caudatus, Nucleus|Nucleus Caudatus"
D005776,DISEASE,Gaucher Disease,"Gaucher Disease, Juvenile and Adult, Cerebral|Type 1 Gaucher Disease|Juvenile Gaucher Disease|Disease, Glucocerebrosidase Deficiency|Glucosylceramide Beta-Glucosidase Deficiency|Cerebroside Lipidosis Syndromes|Gaucher's Disease|Disease, Infantile Gaucher|Gaucher Disease, Type 3|Gauchers Diseases|Glucocerebrosidase Deficiencies|Disease, Juvenile Gaucher|Gaucher Disease, Acute Neuronopathic|Disease, Gaucher's|Splenomegaly, Gaucher|Histiocytosis, Kerasin|Lipidoses, Glucosylceramide|GBA Deficiency|Lipidoses, Glucosyl Cerebroside|Deficiency Disease, Glucocerebrosidase|Gaucher Disease, Neuronopathic|Gaucher Disease, Non Neuronopathic Form|Type 2 Gaucher Disease|Deficiencies, Glucocerebrosidase|Deficiencies, GBA|Disease, Gaucher|Gaucher Disease, Type 1|Diseases, Gauchers|Gaucher Disease, Type III|Syndrome, Cerebroside Lipidosis|Lipidosis Syndrome, Cerebroside|Gaucher Disease, Chronic|Glucocerebrosidoses|Glucocerebrosidosis|Lipoidosis, Kerasin|Type 3 Gaucher Disease|Gauchers Disease|Infantile Gaucher Disease|Glucosylceramidase Deficiency|Acid beta-Glucosidase Deficiency|Gaucher Disease, Chronic Neuronopathic Type|Gaucher Disease, Subacute Neuronopathic Form|Non Neuronopathic Gaucher Disease|Gaucher Disease, Juvenile|Gaucher Disease Type 2|Lipoidoses, Kerasin|Gaucher Disease, Type 2|Glucosylceramide Beta-Glucosidase Deficiency Disease|Gaucher Disease, Non-Neuronopathic Form|Disease, Non-Neuronopathic Gaucher|Gaucher Disease, Infantile Cerebral|Cerebroside Lipidosis Syndrome|Cerebroside Lipidoses, Glucosyl|GBA Deficiencies|Glucosylceramide Lipidoses|Gaucher Disease Type 3|Gaucher Disease, Acute Neuronopathic Type|Gaucher Disease, Noncerebral Juvenile|Kerasin Histiocytoses|thesaurismosis, Kerasin|Diseases, Glucocerebrosidase Deficiency|Gaucher Disease, Non-Neuronopathic|Glucosyl Cerebroside Lipidoses|Histiocytoses, Kerasin|Disease, Gauchers|thesaurismoses, Kerasin|Histiocytosis, Lipoid (Kerasin Type)|Gaucher Syndrome|Deficiency Diseases, Glucocerebrosidase|Gaucher Disease, Infantile|Glucocerebrosidase Deficiency|Acute Neuronopathic Gaucher Disease|Lipoid Histiocytoses (Kerasin Type)|Neuronopathic Gaucher Disease|Syndromes, Cerebroside Lipidosis|Kerasin Lipoidoses|Subacute Neuronopathic Gaucher Disease|Gaucher Disease, Type II|Histiocytoses, Lipoid (Kerasin Type)|Kerasin thesaurismosis|Disease, Neuronopathic Gaucher|Deficiency, Glucocerebrosidase|Syndrome, Gaucher|Gaucher Splenomegaly|Gaucher Disease Type 1|Chronic Gaucher Disease|Kerasin Lipoidosis|Glucocerebrosidase Deficiency Diseases|Lipidosis, Glucosylceramide|Lipidosis Syndromes, Cerebroside|Non-Neuronopathic Gaucher Disease|Lipidosis, Glucosyl Cerebroside|Cerebroside Lipidosis, Glucosyl|Acid beta-Glucosidase Deficiency Disease|Glucosylceramide Lipidosis|Gaucher disease|Lipoid Histiocytosis (Kerasin Type)|Kerasin Histiocytosis|Gaucher Disease, Type I|Disease, Chronic Gaucher|Gaucher Disease, Subacute Neuronopathic Type|Glucosyl Cerebroside Lipidosis|Glucocerebrosidase Deficiency Disease|Kerasin thesaurismoses|Deficiency, GBA"
NEW14154,CHEMICAL,striatal dopamine,striatal dopamine
NEW14155,CHEBI,phytohormone Abscisic Acid,phytohormone Abscisic Acid
NEW14156,DISEASE,impairment marker,impairment markers
D058486,CHEMICAL,"Receptors, Purinergic P2X7","Purinergic P2X7 Receptors|Purinergic Receptor P2X, Ligand-Gated Ion Channel, 7|P2X7 Receptors, Purinergic|Purinoceptors, P2X7|P2Z Receptor|P2X7 receptor|Purinergic P2X7 Receptor|P2X7 Receptor, Purinergic|P2X7 Purinoceptors|Purinoceptor, P2X7|P2X7 Receptor|Purinoceptor P2Z|P2X7 Purinoceptor|P2Z, Purinoceptor|Receptor, Purinergic P2X7"
D001729,NUTRITION,Bismuth,Bismuth|Antacids|bismuth
NEW14157,MENTAL_HEALTH,headache prophylaxis,headache prophylaxis
D051270,MENTAL_HEALTH,"Headache Disorders, Primary","Headache Disorder, Primary|Cough Headache|Clock Headache, Alarm|Headache, Thunderclap|Headache, Alarm Clock|Headaches, Alarm Clock|Headache, Primary Stabbing|Primary Thunderclap Headache|Headaches, Benign Cough|Primary headache|Cough Headaches, Benign|Headache Syndromes, Hypnic|Headache, Stabbing|Hypnic Headache Syndromes|Exertional Headache, Benign|Ice Pick Headache|Headache, Primary Thunderclap|Thunderclap Headache|Headache, Benign Exertional|Alarm Clock Headaches|Headache, Hypnic|Benign Exertional Headache|Disorder, Primary Headache|Hypnic Headache|Primary Cough Headache|Cough Headache, Benign|Headache, Primary Exertional|Headache, Primary Cough|Primary Stabbing Headache|Headache, Benign Cough|Headaches, Ice-Pick|Alarm Clock Headache|Headache Syndrome, Hypnic|Clock Headaches, Alarm|Stabbing Headache|Ice-Pick Headaches|Benign Cough Headaches|Headache, Ice-Pick|Ice-Pick Headache|Disorders, Primary Headache|primary headache|Benign Cough Headache|Primary Headache Disorders|Primary Headache Disorder|Headaches, Benign Exertional|Hypnic Headache Syndrome|Headache, Cough|Benign Exertional Headaches|Exertional Headaches, Benign|Primary Exertional Headache"
NEW14158,CHEBI,nutraceutical ingredient,nutraceutical ingredients
C575860,NUTRITION,"fatty acid 2-hydroxylase 2, Arabidopsis [Supplementary Concept]",Mixed Function Oxygenases|fatty acid 2-hydroxylase|Arabidopsis Proteins
NEW14159,DISEASE,complicated spastic paraplegia,complicated spastic paraplegia|SPG35
http://purl.obolibrary.org/obo/DOID_13282,DISEASE,intestinal tuberculosis,intestinal tuberculosis|tuberculosis of intestine
NEW14160,CHEBI,mycobacterial antigen,mycobacterial antigens
C517803,CHEMICAL,"4-aminho-2-thiabicyclo(3.1.0)hexane-4,6-dicarboxylic acid [Supplementary Concept]","LY2140023|LY404039|Bridged Bicyclo Compounds, Heterocyclic|Cyclic S-Oxides"
NEW14161,NUTRITION,geometry witch,geometry witch
NEW14162,MENTAL_HEALTH,solid fixation,solid fixation
NEW14163,CHEMICAL,ethanol-exposed ncc,ethanol-exposed NCCs
NEW14164,DISEASE,ncc viability,NCC viability
NEW14165,CHEMICAL,dca specimen,DCA specimens
NEW14166,DISEASE,hyalinize fibrosis,hyalinized fibrosis
NEW14167,CHEMICAL,smoking group,smoking group
NEW14168,DISEASE,chronic hypoxia,chronic hypoxia
NEW14169,NUTRITION,cane toad,cane toad
NEW14170,MENTAL_HEALTH,synthetic auxin herbicide resistance,synthetic auxin herbicide resistance
NEW14171,CHEBI,synthetic auxin binding kinetic,synthetic auxin binding kinetics
NEW14172,CHEMICAL,ja signal,JA signal
NEW14173,NUTRITION,circadian hyper amplitude tension,CHAT|Circadian Hyper Amplitude Tension
NEW14174,MENTAL_HEALTH,psychosomatic disorder related,psychosomatic disorder related
NEW14175,DISEASE,chronic intermittent hypoxia,chronic intermittent hypoxia
NEW14176,CHEBI,ppar‑γ agonist pioglitazone,PPAR‑γ agonist pioglitazone
NEW14177,CHEMICAL,cih condition,CIH conditions
NEW14178,DISEASE,sev‑induced cognitive decline,SEV‑induced cognitive decline
NEW14179,DISEASE,migraine pathophysiology,migraine pathophysiology
NEW14180,CHEMICAL,ape treatment,APE treatment
NEW14181,DISEASE,low disease activity index score,lower disease activity index score
NEW14182,DISEASE,less body weight loss,less body weight loss
NEW14183,DISEASE,hepatic centrilobular hypertrophy,Hepatic centrilobular hypertrophy
NEW14184,CHEMICAL,vd(o,VD(O
NEW14185,MENTAL_HEALTH,obstructive syndrome,obstructive syndromes
NEW14186,CHEBI,bind agonist,bound agonist
NEW14187,CHEMICAL,glutaraldehyde fixation,glutaraldehyde fixation
NEW14188,CHEMICAL,anticonvulsant topiramate,anticonvulsant topiramate
NEW14189,MENTAL_HEALTH,displacement study,Displacement studies
NEW14190,CHEMICAL,unlabeled avp,unlabeled AVP
NEW14191,CHEMICAL,glun2a_k879r knock-in mouse,GluN2A_K879R knock-in mice
NEW14192,DISEASE,anxiety/dysphoria,anxiety/dysphoria
NEW14193,MENTAL_HEALTH,high resistance,high resistance
http://purl.obolibrary.org/obo/CHEBI_84030,NUTRITION,reynoutria sachalinensis extract,giant knotweed extract|cowberry extract
D010131,CHEMICAL,Aminosalicylic Acid,"para Aminosalicylic Acid|p-Aminosalicylic Acid, Aluminum (2:1) Salt|p Aminosalicylic Acid|Rezipas|4 Aminosalicylic Acid|p-Aminosalicylic Acid Monolithium Salt|p-Aminosalicylic Acid Monopotassium Salt|4-Aminosalicylic Acid|para-Aminosalicylic Acid|p-aminosalicylic acid|p Aminosalicylic Acid Monolithium Salt|Alumino-4-Aminosalicylic Acid|p-Aminosalicylic Acid Monosodium Salt|Pamisyl|p-Aminosalicylic Acid|p Aminosalicylic Acid Monosodium Salt|p-Aminosalicylic Acid, Monosodium Salt, Dihydrate|Acid, Aminosalicylic|p Aminosalicylic Acid Monopotassium Salt|Alumino 4 Aminosalicylic Acid|p-Aminosalicylic Acid, Calcium (2:1) Salt"
NEW14194,DISEASE,manganism,Manganism
NEW14195,CHEMICAL,tropomyosin receptor kinase b,tropomyosin receptor kinase B
NEW14196,DISEASE,scz patient,Scz patients
NEW14197,CHEMICAL,5-hydroxytryptamine 5-ht receptor 1a,5-hydroxytryptamine 5-HT receptor 1A
D014446,CHEMICAL,Tyrosine 3-Monooxygenase,"Tyrosine 3 Monooxygenase|tyrosine hydroxylase|Tyrosine Hydroxylase|Hydroxylase, Tyrosine|3-Monooxygenase, Tyrosine"
http://purl.obolibrary.org/obo/CHEBI_187455,CHEMICAL,dihomo-gamma-linolenoyl dopamine,"dopamine 5-HTR1A|(8Z,11Z,14Z)-N-[2-(3,4-dihydroxyphenyl)ethyl]icosa-8,11,14-trienamide"
C006923,CHEMICAL,carvone [Supplementary Concept],carvone|Cyclohexane Monoterpenes
C117855,DISEASE,"MEP1 protein, Haemonchus contortus [Supplementary Concept]",Microsporum canis|Metalloendopeptidases|Fungal Proteins
C569516,DISEASE,Trichophyton infection [Supplementary Concept],Trichophyton rubrum|Tinea
C000686285,DISEASE,Epidermophyton floccosum [Supplementary Concept],Epidermophyton floccosum|Epidermophyton
NEW14198,DISEASE,day-case cataract surgery,day-case cataract surgery
NEW14199,CHEMICAL,alkalinized bupivacaine,Alkalinized bupivacaine
NEW14200,MENTAL_HEALTH,globe akinesia,globe akinesia
NEW14201,CHEMICAL,bupivacaine-lidocaine mixture,bupivacaine-lidocaine mixture
NEW14202,CHEMICAL,alkalinized bupivacaine group,alkalinized bupivacaine group
NEW14203,DISEASE,intraoperative pain,intraoperative pain
NEW14204,CHEMICAL,bupivacaine-lidocaine group,bupivacaine-lidocaine group
NEW14205,CHEMICAL,lidocaine-bupivacaine group,lidocaine-bupivacaine group
D004172,DISEASE,Diplopia,"Diplopia, Horizontal|Horizontal Diplopia|Diplopia, Intermittent|diplopia|Diplopia, Unilateral|Vertical Diplopias|Diplopia, Vertical|Unilateral Diplopias|Double Vision|Vertical Diplopia|Diplopias, Refractive|Diplopias, Intermittent|Unilateral Diplopia|Diplopia, Refractive|Cortical Diplopias|Vision, Double|Monocular Diplopias|Refractive Diplopias|Cortical Diplopia|Diplopias|Polyopsias|Diplopia, Monocular|Refractive Diplopia|Diplopias, Unilateral|Diplopias, Monocular|Intermittent Diplopias|Intermittent Diplopia|Monocular Diplopia|Polyopsia|Horizontal Diplopias|Diplopias, Horizontal|Diplopias, Vertical|Diplopia, Cortical|Diplopias, Cortical"
NEW14206,CHEMICAL,ph-adjusted bupivacaine group,pH-adjusted bupivacaine group
NEW14207,DISEASE,acromegaly patient due,acromegaly patients due
NEW14208,CHEBI,growth hormone (gh)-secreting tumor,growth hormone (GH)-secreting tumor
NEW14209,DISEASE,common comorbidity,common comorbidity
http://purl.obolibrary.org/obo/CHEBI_16113,NUTRITION,cholesterol,"Cholesterol|Cholest-5-en-3beta-ol|(3beta,14beta,17alpha)-cholest-5-en-3-ol|cholesterol cholesterol levels|cholesterol|cholest-5-en-3beta-ol|CHOLESTEROL|Cholesterin"
NEW14210,DISEASE,non-suicide attempter,non-suicide attempters
NEW14211,CHEBI,important antigen,important antigen
NEW14212,MENTAL_HEALTH,pain-related depression,Pain-related depression
NEW14213,CHEBI,receptor agonist morphine,receptor agonist morphine
NEW14214,MENTAL_HEALTH,pain-related depression,pain-related depression
NEW14215,CHEMICAL,ketoprofen effect,ketoprofen effects
NEW14216,CHEBI,kappa opioid receptor antagonist jdtic,kappa opioid receptor antagonist JDTic
NEW14217,CHEBI,semi-parametric group-based mixture model,semi-parametric group-based mixture model
NEW14218,CHEMICAL,low-dose combination,low-dose combination
NEW14219,CHEBI,antiandrogen drug,antiandrogen drug
NEW14220,CHEBI,antimineralocorticoid activity,antimineralocorticoid activity
NEW14221,CHEBI,antimineralocorticoid effect,antimineralocorticoid effects
http://purl.obolibrary.org/obo/NCBITaxon_151340,CHEMICAL,papillomaviridae,SNRIs family|family Akkermansiaceae
D011743,CHEMICAL,Pyrimidines,pyrimidines
D011687,CHEMICAL,Purines,Purines
NEW14222,CHEMICAL,amino acid level,amino acid level
NEW14223,CHEMICAL,nucleotide metabolite,nucleotides metabolite
NEW14224,CHEMICAL,metabolite amino acid pattern,metabolite amino acid pattern
NEW14225,MENTAL_HEALTH,depression patient,depression patients
NEW14226,CHEMICAL,nucleotide metabolite,nucleotide metabolite
NEW14227,CHEMICAL,itc measurement,ITC measurements
NEW14228,CHEBI,sulpiride d-2 antagonist,sulpiride D-2 antagonist
NEW14229,MENTAL_HEALTH,morphine analgesia,morphine analgesia
NEW14230,CHEMICAL,morphine-dependent mouse,morphine-dependent mice
NEW14231,CHEMICAL,aba model,ABA model
NEW14232,DISEASE,severe body weight loss,severe body weight loss
NEW14233,CHEMICAL,aba rat,ABA rats
NEW14234,CHEMICAL,treat aba rat,Treated ABA rats
NEW14235,CHEBI,gonadotropin-releasing hormone pulse,gonadotropin-releasing hormone pulses
NEW14236,CHEMICAL,increase dopamine activity,increased dopamine activity
NEW14237,DISEASE,responsive psychogenic amenorrhea patient,Responsive psychogenic amenorrhea patients
NEW14238,DISEASE,non-responsive psychogenic amenorrhea group,non-responsive psychogenic amenorrhea group
NEW14239,DISEASE,amenorrhea patient,amenorrhea patients
NEW14240,CHEMICAL,elevated cortisol level,elevated cortisol levels
NEW14241,MENTAL_HEALTH,severe akinesia,Severe akinesia
NEW14242,CHEMICAL,mptp injection,MPTP injections
NEW14243,CHEMICAL,deoxyglucose study,Deoxyglucose studies
NEW14244,MENTAL_HEALTH,thalamic projection territory,thalamic projection territory
NEW14245,CHEBI,new identify trkb receptor agonist,new identified TrkB receptor agonist
C557292,DISEASE,DHF 18 [Supplementary Concept],Flavones|Piperazines|DHF
NEW14246,CHEMICAL,cocaine reinforcement,cocaine reinforcement
NEW14247,DISEASE,peripheral ulcerative keratitis,peripheral ulcerative keratitis|PUK
NEW14248,CHEBI,infective antigen,infective antigens
NEW14249,CHEBI,intravenous drug abuser,Intravenous drug abusers
NEW14250,MENTAL_HEALTH,plant immune mechanism,plant immune mechanism
http://purl.obolibrary.org/obo/CHEBI_121846,CHEMICAL,3-benzamido-3-oxopropanethioic acid s-methyl ester,"benzo-1,2,3-thiadiazole-7-car ioic acid S-methyl ester"
NEW14251,DISEASE,a. besseyi,A. besseyi
NEW14252,MENTAL_HEALTH,rice resistance,rice resistance
C005073,CHEMICAL,ethephon [Supplementary Concept],Organophosphorus Compounds|ethephon
C072239,CHEMICAL,methyl jasmonate [Supplementary Concept],Cyclopentanes|Oxylipins|Acetates|methyl jasmonate
NEW14253,CHEMICAL,type pufa,type PUFAs
NEW14254,DISEASE,premature ageing,premature ageing
NEW14255,CHEMICAL,omega-3 type,omega-3 type
NEW14256,CHEMICAL,dietary dha uptake,dietary DHA uptake
NEW14257,DISEASE,ampa-mediated toxicity,AMPA-mediated toxicity
C566573,DISEASE,"Nephropathy, Progressive Tubulointerstitial, with Cholestatic Liver Disease [Supplementary Concept]","Nephritis, Interstitial|cholestatic liver disease|Cholestasis, Intrahepatic"
NEW14258,DISEASE,major extra-hepatic manifestation,major extra-hepatic manifestations
NEW14259,DISEASE,seizure generation,seizure generation
NEW14260,CHEMICAL,pilocarpine treatment,Pilocarpine treatment
NEW14261,CHEBI,muscarinic cholinergic agonist carbachol,muscarinic cholinergic agonist carbachol
NEW14262,CHEMICAL,calcium ionophore a23187,Calcium ionophore A23187
http://purl.obolibrary.org/obo/CHEBI_31410,CHEMICAL,clenbuterol hydrochloride,"clenbuterol clorhidrato|4-amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol monohydrochloride|clenbuterol HCl|zilpaterol hydrochloride|1-(4-amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol hydrochloride|4-amino-3,5-dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol monohydrochloride|4-amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol hydrochloride|(+-)-clenbuterol monohydrochloride|4-amino-3,5-dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol hydrochloride|clenbuterol monohydrochloride|(+-)-clenbuterol hydrochloride"
NEW14263,CHEBI,development due pharmaceutical innovation,development due pharmaceutical innovations
NEW14264,DISEASE,apparent bruise,apparent bruises
NEW14265,NUTRITION,hemorrhagic insect bite,hemorrhagic insect bites
NEW14266,NUTRITION,innumerable insect sting,innumerable insect stings
NEW14267,DISEASE,orthostatic tolerance,orthostatic tolerance
NEW14268,DISEASE,postprandial hypotension,postprandial hypotension
D015282,CHEMICAL,Octreotide,Sandostatin||SAN 201 995|SM 201 995|Sandoz 201 995|Compound 201-995|SMS 201-995|SAN 201-995|Sandoz 201995|Sandoz 201-995|Sandostatine|octreotide|Compound 201 995|SMS 201 995|SM 201-995|Compound 201995|Octreotide Acetate|SMS 201995|Octreotide Acetate Salt|SAN 201995|SM 201995
D016861,CHEMICAL,Cyclooxygenase Inhibitors,"|Inhibitor, Cyclooxygenase|Prostaglandin Synthase Inhibitor|Cyclooxygenase Inhibitor|Antagonists, Prostaglandin Synthesis|Cyclo Oxygenase Inhibitor|Prostaglandin Synthesis Antagonists|Inhibitors, Prostaglandin Synthase|Synthesis Antagonist, Prostaglandin|Prostaglandin Endoperoxide Synthase Inhibitor|Cyclo-Oxygenase Inhibitor|Synthase Inhibitor, Prostaglandin|Inhibitors, Cyclo-Oxygenase|Cyclo-Oxygenase Inhibitors|Inhibitors, Cyclo Oxygenase|Prostaglandin Synthase Inhibitors|Inhibitors, Prostaglandin-Endoperoxide Synthase|Prostaglandin Synthesis Antagonist|Inhibitor, Prostaglandin Synthase|Inhibitors, Cyclooxygenase|Inhibitor, Cyclo-Oxygenase|Prostaglandin Endoperoxide Synthase Inhibitors|prostaglandin inhibitors|Inhibitors, Prostaglandin Endoperoxide Synthase|Antagonist, Prostaglandin Synthesis|cyclooxygenase inhibitors|Cyclo Oxygenase Inhibitors"
NEW14269,DISEASE,nephrotoxicity,Nephrotoxicity
D011192,CHEMICAL,Potassium Dichromate,"Bichromate, Potassium|K2Cr2O7|Potassium Bichromate|Potassium dichromate|Dichromate, Potassium"
NEW14270,MENTAL_HEALTH,marked depression,marked depression
C534676,CHEMICAL,"S-(1,2-dichlorovinyl)-L-cysteine sulfoxide [Supplementary Concept]","S-(1,2- dichlorovinyl l-cysteine|Cysteine/analogs  and  derivatives"
NEW14271,DISEASE,depressed o(2 consumption rate,depressed O(2 consumption rates
C026729,CHEMICAL,4-aminophenol [Supplementary Concept],|p-aminophenol|Aminophenols
NEW14272,MENTAL_HEALTH,alp depression,ALP depression
NEW14273,DISEASE,androgen-dependent prostate cancer cell line,androgen-dependent prostate cancer cell line
NEW14274,DISEASE,dyspnea attack,Dyspnea attack
NEW14275,CHEMICAL,midazolam injection,midazolam injection
C092435,NUTRITION,"ventricular natriuretic factor, rainbow trout [Supplementary Concept]",Atrial Natriuretic Factor|rainbow trout|Rainbow trout|Oncorhynchus mykiss
http://purl.obolibrary.org/obo/MFOMD_0000134,MENTAL_HEALTH,conditioned response,conditioned response
NEW14276,DISEASE,psychosis-like behavior,psychosis-like behavior
NEW14277,CHEMICAL,aberrant dopamine system function,aberrant dopamine system function
NEW14278,DISEASE,paedophilic disorder,PeD|paedophilic disorder
C431566,CHEMICAL,acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide [Supplementary Concept],Oligopeptides|degarelix
NEW14279,DISEASE,severe cutaneous lupus,severe cutaneous lupus
NEW14280,CHEMICAL,prophylactic ketamine administration,prophylactic ketamine administration
NEW14281,CHEMICAL,ketamine group,ketamine group
NEW14282,CHEMICAL,ketamine administration,ketamine administration
NEW14283,DISEASE,antenatal depressive symptom,antenatal depressive symptom
NEW14284,CHEMICAL,prophylactic ketamine,prophylactic ketamine
NEW14285,CHEBI,specific δ-receptor antagonist,specific δ-receptor antagonist
NEW14286,MENTAL_HEALTH,head displacement,head displacement
C469346,CHEMICAL,N1'-fluoroethyl-(14-formylamino)naltrindole [Supplementary Concept],naltrindole|Naltrexone/analogs  and  derivatives
NEW14287,CHEMICAL,rice husk powder,rice husk powder
NEW14288,CHEMICAL,cu/zn ratio,Cu/Zn ratio
NEW14289,CHEBI,antioxidant vitamin e,antioxidant vitamin E
NEW14290,NUTRITION,impaired tryptophan catabolite pathway,impaired tryptophan catabolites pathway
NEW14291,CHEMICAL,glutathione peroxidise,glutathione peroxidise
NEW14292,CHEMICAL,abnormal nitric oxidative production,Abnormal nitric oxidative production
NEW14293,NUTRITION,tryptophan catabolite pathway,tryptophan catabolites pathway
D017984,CHEMICAL,Enoxaparin,"Clexane|PK-10,169|EMT966|EMT967|EMT 966|PK 10,169|EMT-966|Lovenox|Enoxaparin|PK10169|EMT 967|PK10,169|EMT-967|PK 10169|PK-10169|Enoxaparine"
NEW14294,DISEASE,recurrent ischemia,recurrent ischemia
NEW14295,DISEASE,frequent major adverse cardiac evenment,frequent major adverse cardiac evenment
NEW14296,CHEBI,Most narcotic,Most narcotics
NEW14297,DISEASE,intestinal illness,intestinal illnesses
NEW14298,DISEASE,Key pointscyberchondria,Key pointsCyberchondria
NEW14299,CHEMICAL,health anxiety/hypochondriasis,Health anxiety/hypochondriasis
NEW14300,CHEMICAL,cyb.patient,CYB.Patients
NEW14301,CHEMICAL,new oral anti-xa anticoagulant darexaban,new oral anti-Xa anticoagulant darexaban
NEW14302,CHEMICAL,non-vitamin k antagonist oral anticoagulant,non-vitamin K antagonist oral anticoagulants
C061050,CHEMICAL,bimakalim [Supplementary Concept],Benzopyrans|bimakalim|Dihydropyridines
NEW14303,CHEBI,atp-sensitive k+ channel opener,ATP-sensitive K+ channel openers
NEW14304,CHEMICAL,single oral dose bimakalim,single oral dose bimakalim
C059921,CHEMICAL,tedisamil [Supplementary Concept],"tedisamil|Tedisamil|Bridged Bicyclo Compounds, Heterocyclic|Cyclopropanes"
NEW14305,CHEMICAL,bimakalim antiischemic effect,bimakalim antiischemic effects
NEW14306,CHEMICAL,myocardial oxygen consumption,myocardial oxygen consumption
NEW14307,CHEMICAL,lactate concentration,lactate concentrations
D005711,CHEMICAL,Gallopamil,"Hydrochloride, Gallopamil|D 600|Elgiprona|gallopamil von ct|gallopamil|Procorum|Gallopamil Hydrochloride|Gallobeta|D-600|Methoxyverapamil|D600|Prebet"
NEW14308,MENTAL_HEALTH,segment depression,segment depression
NEW14309,CHEMICAL,iron chelation drug,Iron chelation drugs
NEW14310,CHEBI,botulinum toxin injection,Botulinum toxin injection
NEW14311,DISEASE,most sd patient,most SD patients
NEW14312,DISEASE,intestinal dysbacteriosis due,intestinal dysbacteriosis due
NEW14313,CHEBI,vitamin b5 deficiency,vitamin B5 deficiency
NEW14314,CHEMICAL,sodium (na+):multivitamin transporter,sodium (Na+):multivitamin transporter
NEW14315,CHEMICAL,sodium solute symporter family,sodium solute symporter family
D012974,CHEMICAL,Sodium Iodide,iodide|Sodium (1966-1978)|Iodides (1966-1978)
NEW14316,CHEMICAL,vitamin-like substance α-lipoic acid,vitamin-like substance α-lipoic acid
C119981,DISEASE,biotin transporter [Supplementary Concept],multivitamin transporter|Symporters|human SMVT
C520789,CHEMICAL,"TSPAN16 protein, human [Supplementary Concept]",Tetraspanins|TM4
NEW14317,DISEASE,describe multivitamin-responsive inherit metabolic disorder,described multivitamin-responsive inherited metabolic disorder
NEW14318,DISEASE,sodium-dependent transporter smvt deficiency,Sodium-dependent transporter SMVT deficiency
NEW14319,MENTAL_HEALTH,similar projection pattern,similar projection patterns
NEW14320,DISEASE,consumption gain,consumption gain
NEW14321,CHEMICAL,saccharin group,saccharin group
NEW14322,CHEMICAL,sucrose seek,sucrose seeking
NEW14323,CHEMICAL,sucrose self-administration,sucrose self-administration
NEW14324,CHEMICAL,sucrose craving,sucrose craving
NEW14325,MENTAL_HEALTH,crave incubate,craving incubates
NEW14326,MENTAL_HEALTH,craving generalize,craving generalizes
NEW14327,CHEMICAL,reagent 2-keto-3-butynoic acid,reagent 2-keto-3-butynoic acid
D044927,CHEMICAL,Electron-Transferring Flavoproteins,"Flavoprotein, Electron Transfer|Electron Transferring Flavoproteins|Flavoproteins, Electron-Transferring|ET Flavoprotein|flavoproteins|Electron-Transferring Flavoprotein|Flavoprotein, Electron-Transferring|Electron Transferring Flavoprotein|Electron Transfer Flavoprotein|Transfer Flavoprotein, Electron|Flavoprotein, ET"
NEW14328,MENTAL_HEALTH,suicide reagent,suicide reagent
C002479,CHEMICAL,2-hydroxy-3-butynoic acid [Supplementary Concept],Hydroxybutyrates|2-hydroxy-3-butynoate
NEW14329,CHEMICAL,pcb congener,PCB congeners
D005432,NUTRITION,Flounder,Halibut|Flounders|Pleuronectes platessa|Plaice|Pseudopleuronectes|Pleuronectes|Platichthys|flounders|Platichthys flesus
NEW14330,CHEMICAL,high pcb concentration,higher PCB concentrations
NEW14331,CHEMICAL,ng g(-1,ng g(-1
C105260,CHEMICAL,4-tert-octylphenol [Supplementary Concept],Phenols|OP|4-tert-octylphenol
NEW14332,DISEASE,liver tissue,liver tissues
http://purl.obolibrary.org/obo/CHEBI_34444,CHEMICAL,4-tert-butylphenol,|4-tert-octylphenol kg(-1|4-tert-butylphenol
NEW14333,CHEMICAL,4-tert-octylphenol kg(-1 bw,4-tert-octylphenol kg(-1 BW
D013737,DISEASE,Testis,Testicle|Testicles|testis|Testes
NEW14334,CHEMICAL,carbonic anhydrase inhibitor dorzolamide,carbonic anhydrase inhibitor dorzolamide
D009798,DISEASE,Ocular Hypertension,"|Hypertension, Ocular|Hypertensions, Ocular|Suspect Glaucomas|elevated intraocular pressure|ocular hypertension|Glaucoma, Suspect|Glaucomas, Suspect|Ocular Hypertensions|Suspect Glaucoma"
NEW14335,CHEBI,alpha-adrenergic agonist brimonidine,alpha-adrenergic agonist brimonidine
NEW14336,DISEASE,profound cognitive impairment,profound cognitive impairment
NEW14337,MENTAL_HEALTH,abuse problem,abuse problems
D010624,CHEMICAL,Phenelzine,"2-Phenethylhydrazine|Phenelzine Sulfate|2 Phenethylhydrazine|beta-Phenylethylhydrazine|Fenelzin|beta Phenylethylhydrazine|phenelzine|Sulfate, Phenelzine|Phenethylhydrazine|Nardil|Nardelzine|Phenelzine"
C000606999,CHEBI,"EGOT lncRNA, human [Supplementary Concept]","RNA, Long Noncoding|EGOT|vitamin B6"
NEW14338,CHEMICAL,pyridoxal phosphate level,pyridoxal phosphate levels
NEW14339,DISEASE,hypotensive action,hypotensive actions
D058906,CHEBI,Purinergic P1 Receptor Agonists,"Agonists, P1 Purinoceptor|Receptor Agonists, Adenosine|Purinoceptor Agonists, P1|Agonists, Adenosine Receptor|Adenosine Receptor Agonists|P1 Purinoceptor Agonists|adenosine receptor agonists"
NEW14340,DISEASE,several etiology,Several etiologies
NEW14341,CHEMICAL,cocaine abuser,cocaine abusers
NEW14342,DISEASE,non-cocaine-abusing depressed alcoholic,non-cocaine-abusing depressed alcoholics
NEW14343,DISEASE,cocaine-abuse depressed alcoholic,cocaine-abusing depressed alcoholics
NEW14344,MENTAL_HEALTH,bdi depression scale,BDI depression scales
NEW14345,CHEMICAL,non-cocaine abusing depressed alcoholic,non-cocaine abusing depressed alcoholics
NEW14346,MENTAL_HEALTH,common mental disorder,common mental disorders
NEW14347,CHEMICAL,calcium-dependent ne release,calcium-dependent NE release
NEW14348,CHEMICAL,brain ne concentration,brain NE concentrations
NEW14349,CHEBI,specific noradrenergic neurotoxin dsp-4,specific noradrenergic neurotoxin DSP-4
NEW14350,CHEMICAL,ne regulation,NE regulation
NEW14351,CHEMICAL,specific quencher,specific quencher
NEW14352,CHEMICAL,us/chlorine system,US/chlorine system
C005915,CHEMICAL,Allura Red AC Dye [Supplementary Concept],Allura Red AC|ARAC|Azo Compounds
NEW14353,CHEMICAL,generate hydroxyl radical,generated hydroxyl radical
D018092,CHEMICAL,"Receptors, Kainic Acid","Kainic Acid Receptors|Kainate Receptors|Receptors, Kainate|Kainic acid|KA|Receptor, Kainic Acid|Receptor, Kainate|kainic acid|Kainic Acid Receptor|Kainate Receptor"
NEW14354,DISEASE,nmdar glun2b,NMDAR GluN2B
NEW14355,CHEMICAL,increase plasma catecholamine level,increased plasma catecholamine levels
NEW14356,CHEMICAL,low plasma catecholamine level,lower plasma catecholamine levels
NEW14357,CHEBI,blunted plasma growth hormone response,Blunted plasma growth hormone responses
NEW14358,MENTAL_HEALTH,abnormal hypomania scale,abnormal hypomania scale
NEW14359,MENTAL_HEALTH,abnormal hysteria,abnormal hysteria
NEW14360,MENTAL_HEALTH,schizophrenia scale,schizophrenia scales
NEW14361,MENTAL_HEALTH,paranoia trait,Paranoia traits
NEW14362,CHEMICAL,blood cortisol level,blood cortisol levels
NEW14363,DISEASE,know DOA,known DOA
http://purl.obolibrary.org/obo/CHEBI_7799,CHEMICAL,oseltamivir phosphate,"Oseltamivir phosphate|Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (1:1)|ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate phosphate|Tamiflu|oseltamivir phosphate|(3R-(3alpha,4beta,5alpha))-Ethyl 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (1:1)"
NEW14364,DISEASE,potential liver toxicity,potential liver toxicity
NEW14365,MENTAL_HEALTH,elastin fragmentation,elastin fragmentation
D002341,DISEASE,Carotid Artery Thrombosis,"|Thrombosis, Carotid|Carotid Thrombosis|internal carotid artery thrombosis|Thrombosis, Carotid Artery|Internal Carotid Artery Thrombosis|Thrombosis, External Carotid Artery|External Carotid Artery Thrombosis|Thrombosis, Internal Carotid Artery|Common Carotid Artery Thrombosis|Carotid Artery Thromboses|Thrombosis, Common Carotid Artery|carotid thrombosis"
NEW14366,DISEASE,α-toxin-mediated platelet injury,α-toxin-mediated platelet injury
NEW14367,DISEASE,lethal sa infection,lethal SA infection
NEW14368,CHEMICAL,crh neuron,CRH neurons
NEW14369,DISEASE,depressed man,depressed men
NEW14370,MENTAL_HEALTH,depression important role,depression important role
NEW14371,CHEMICAL,gaba concentration,GABA concentrations
D000087623,DISEASE,Insular Cortex,"Gyrus, Insular|Visceral Cortices|Area 43, Brodmann's|Brodmann Area 14|Brodmann Area 13|Area 14, Brodmann's|Insular Cortices|Brodmanns Area 43|Brodmann's Area 13|Insular Regions|Gustatory Cortex, Primary|Lobus Insularis|Area 13, Brodmann|Primary Gustatory Cortex|Primary Gustatory Cortices|Visceral Cortex|Area 15, Brodmann's|Brodmanns Area 15|Brodmann's Area 14|Brodmann Area 16|Insula of Reil|Insular Gyrus|Cortex, Visceral|Area 16, Brodmann|Cortex, Opercular|Lobe, Central|Area 15, Brodmann|Brodmann's Area 16|Region, Insular|Central Lobe|Area 13, Brodmann's|Brodmann's Area 15|insula|Area 43, Brodmann|Brodmann Area 43|Central Lobes|Insular Region|Cortex, Insular|Brodmanns Area 13|Opercular Cortex|Cortex, Primary Gustatory|Brodmann Area 15|Gustatory Cortex|Cortex, Gustatory|Area 16, Brodmann's|Area 14, Brodmann|Brodmanns Area 14|Brodmann's Area 43|Brodmanns Area 16"
NEW14372,CHEMICAL,16:1(9z,16:1(9Z
NEW14373,NUTRITION,major skin-produced antimicrobial fatty acid,major skin-produced antimicrobial fatty acid
C519673,CHEMICAL,"cholest-11-en-3beta, 6beta, 7alpha, 22beta-tetraol-24-one-3beta-palmitoleate [Supplementary Concept]","Palmitoleate|Cholestadienols|Fatty Acids, Monounsaturated"
NEW14374,CHEMICAL,saohya,SaOhyA
http://purl.obolibrary.org/obo/CHEBI_78954,NUTRITION,(omega-1)-hydroxy fatty acid,unsaturated fatty acid level|antimicrobial unsaturated fatty acid|(omega-1)-hydroxy fatty acids|straight-chain fatty acids|essential unsaturated fatty acid
NEW14375,NUTRITION,fingerle rainbow trout =,Fingerling rainbow trout =
NEW14376,DISEASE,brief electric shock,brief electric shock
D015812,DISEASE,"Glaucoma, Angle-Closure","Glaucomas, Uncompensative|Angle-Closure Glaucoma|Glaucomas, Uncompensated|Glaucoma, Closed-Angle|Uncompensative Glaucomas|Glaucomas, Angle Closure|Closed-Angle Glaucoma|angle-closure glaucoma|Angle-Closure Glaucomas|Uncompensative Glaucoma|Closed-Angle Glaucomas|Uncompensated Glaucomas|Glaucoma, Narrow Angle|Glaucomas, Narrow-Angle|Glaucoma, Uncompensative|Narrow-Angle Glaucomas|Narrow-Angle Glaucoma|Angle Closure Glaucomas|Glaucoma, Angle Closure|Glaucoma, Closed Angle|Glaucomas, Closed-Angle|Angle Closure Glaucoma|Glaucoma, Uncompensated|Glaucoma, Narrow-Angle|Glaucomas, Angle-Closure|Uncompensated Glaucoma"
NEW14377,MENTAL_HEALTH,important displacement,important displacement
NEW14378,CHEMICAL,14c-choline,14C-choline
NEW14379,CHEMICAL,3h-m binding,3H-M binding
NEW14380,CHEMICAL,morphine min,morphine min
NEW14381,CHEMICAL,3h-morphine binding,3H-morphine binding
NEW14382,NUTRITION,fatty acid level,fatty acid levels
NEW14383,NUTRITION,dietary fatty acid level,dietary fatty acid levels
NEW14384,DISEASE,cognition dysfunction,cognition dysfunctions
NEW14385,CHEMICAL,min diethyl ether exposure,min diethyl ether exposure
C560532,DISEASE,"Omg protein, rat [Supplementary Concept]",GPI-Linked Proteins|OMG|Myelin Proteins
NEW14386,NUTRITION,omega-3 polyunsaturated fatty acid (pufa)/100 g body,omega-3 polyunsaturated fatty acid (PUFA)/100 g body
NEW14387,CHEMICAL,body weight/day,body weight/day
NEW14388,DISEASE,ibs-d therapeutic option,IBS-D therapeutic options
http://purl.obolibrary.org/obo/DOID_7907,CHEMICAL,mixed astrocytoma-ependymoma,mixed μ-
NEW14389,CHEBI,over-the-counter μ-opioid receptor agonist,over-the-counter μ-opioid receptor agonist
NEW14390,CHEMICAL,eluxadoline treatment,eluxadoline treatment
C574694,CHEMICAL,"CIC-DUX4 fusion protein, human [Supplementary Concept]","DUX4|Oncogene Proteins, Fusion"
D020391,DISEASE,"Muscular Dystrophy, Facioscapulohumeral","Facioscapulohumeral Type Progressive Muscular Dystrophy|Dystrophy, Landouzy-Dejerine|Facioscapulohumeral Atrophies|Dystrophy, Facioscapulohumeral Muscular|Atrophy, Facioscapulohumeral|Facioscapulohumeral Muscular Dystrophies|Atrophies, Facioscapulohumeral|Muscular Dystrophies, Facioscapulohumeral|FSH Muscular Dystrophy|facioscapulohumeral muscular dystrophy|Dystrophies, Landouzy-Dejerine|Progressive Muscular Dystrophy, Facioscapulohumeral Type|Facioscapuloperoneal Muscular Dystrophy|Dystrophies, Facioscapulohumeral Muscular|Facioscapulohumeral Muscular Dystrophy|Facioscapulohumeral Atrophy|Landouzy Dejerine Dystrophy|Muscular Dystrophy, Landouzy Dejerine|Landouzy-Dejerine Dystrophies|Landouzy-Dejerine Dystrophy|Facio-Scapulo-Humeral Dystrophy"
NEW14391,CHEBI,non-peptidic δ-opioid receptor agonist,non-peptidic δ-opioid receptor agonist
NEW14392,CHEMICAL,β-secretase activity,β-secretase activity
NEW14393,CHEMICAL,n-methyl-d -aspartate nmda glutamate receptor,N-methyl-D -aspartate NMDA glutamate receptor
NEW14394,MENTAL_HEALTH,chronic opiate dependence,chronic opiate dependence
NEW14395,CHEMICAL,nmda receptor site,NMDA receptor site
C535803,CHEMICAL,succinic semialdehyde dehydrogenase deficiency [Supplementary Concept],"Succinate-Semialdehyde Dehydrogenase/deficiency|Succinic semialdehyde dehydrogenase deficiency|Amino Acid Metabolism, Inborn Errors|Developmental Disabilities"
NEW14396,CHEMICAL,impaired gamma-aminobutyric acid metabolism,impaired gamma-aminobutyric acid metabolism
NEW14397,CHEMICAL,nes-wdr45(fl/y mouse,Nes-Wdr45(fl/Y mice
NEW14398,DISEASE,elevated apnea-hypopnea index,elevated apnea-hypopnea index
NEW14399,DISEASE,nocturnal hypoxemia,Nocturnal hypoxemia
NEW14400,DISEASE,narcotic pain management,Narcotic pain management
NEW14401,CHEBI,parenteral dopamine agonist,parenteral dopamine agonist
NEW14402,CHEMICAL,comt-inhibitor,COMT-inhibitors
C026710,CHEMICAL,budipine [Supplementary Concept],budipine|Piperidines
NEW14403,CHEMICAL,odd sum carbon number,odd summed carbon number
NEW14404,CHEMICAL,large-conductance k⁺ channel kca1.1,large-conductance K⁺ channel KCa1.1
NEW14405,DISEASE,high grade tumor,high grade tumors
NEW14406,CHEBI,vdr agonist,VDR agonists
NEW14407,DISEASE,tumor immune surveillance,tumor immune surveillance
NEW14408,MENTAL_HEALTH,stuttering severity,stuttering severity
NEW14409,MENTAL_HEALTH,pakistani stuttering individual,Pakistani stuttering individuals
NEW14410,CHEBI,new antiepileptic drug,new antiepileptic drug
NEW14411,CHEMICAL,acute perampanel overdose,acute perampanel overdose
NEW14412,CHEMICAL,perampanel overdose,perampanel overdose
NEW14413,MENTAL_HEALTH,prolonged stupor,prolonged stupor
D002698,CHEMICAL,Chloralose,beta-Chloralose|alpha-Chloralose|Glucochloral|beta Chloralose|Alpha-chloralose|alpha Chloralose|Anhydroglucochloral|Glucochloralose
D012378,DISEASE,Rodenticides,Rodenticide|rodenticide
NEW14414,DISEASE,hypoxia intoxication,Hypoxia intoxications
NEW14415,DISEASE,spindle coma,spindle coma
NEW14416,NUTRITION,alpha coma,alpha coma
NEW14417,MENTAL_HEALTH,late suicide attempt,later suicide attempt
NEW14418,DISEASE,depressed future attempter,depressed future attempters
http://purl.obolibrary.org/obo/CHEBI_36051,CHEMICAL,antisyphilitic drug,antisyphilitic drugs|antisyphilitics|antisyphilitic agent|antituberculosis drug|antisyphilitic agents
NEW14419,CHEMICAL,garlic chive-derived vln,GC-VLNs|garlic chive-derived VLNs
NEW14420,DISEASE,chemical-induced acute liver injury,chemical-induced acute liver injury
NEW14421,DISEASE,inflammasome-mediated inflammation,inflammasome-mediated inflammation
NEW14422,DISEASE,chronic inflammation,chronic inflammation
NEW14423,CHEMICAL,alcohol intoxication,alcohol intoxication
D000083682,DISEASE,Opiate Overdose,"Opioid Overdoses|Opiate Overdoses|Opioid Overdose|Overdose, Opiate|Opioid overdose|Overdose, Opioid|opioid overdose"
NEW14424,CHEBI,restricted kor agonist,restricted KOR agonists
NEW14425,CHEMICAL,combined gem,combined Gem
NEW14426,MENTAL_HEALTH,resistance gemr biomarker,resistance GemR biomarker
NEW14427,CHEMICAL,fibroblast growth factor receptor inhibitor (fgfri)/gemcitabine,Gem|fibroblast growth factor receptor inhibitor (FGFRi)/gemcitabine
NEW14428,CHEBI,non-specific fgfr inhibitor,non-specific FGFR inhibitors
C531958,CHEMICAL,lenvatinib [Supplementary Concept],Phenylurea Compounds|Quinolines|lenvatinib
C500007,CHEMICAL,4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one [Supplementary Concept],dovitinib|Quinolones|Benzimidazoles
D009582,CHEMICAL,Nitrofurantoin,"Furadonine||Nitrofurantoin Sodium Salt|Furadantine|Nitrofurantoins|Furantoin|Nitrofurantoin|Nitrofurantoin, Monohydrate|Furadantin|Furadoine|Macrodantin"
http://purl.obolibrary.org/obo/DOID_0080784,DISEASE,urinary tract infection,bacterial urinary tract infections|UTI
D052978,CHEBI,Disk Diffusion Antimicrobial Tests,"Etest|Test, Epsilometer|Epsilometer Test|Kirby-Bauer Disk-Diffusion Method|Kirby Bauer Disk Diffusion Method|Bauer Kirby Disk Diffusion Method|Disk-Diffusion Method, Kirby-Bauer|Epsilometer Tests|Tests, Epsilometer|Bauer-Kirby Disk-Diffusion Method|Etests|Disk-Diffusion Method, Bauer-Kirby|antimicrobial"
D009547,CHEMICAL,Nifurtimox,nifurtimox|Lampit|Bayer 2502
NEW14429,DISEASE,chronic human african trypanosomiasis,chronic human African trypanosomiasis
D014355,DISEASE,Chagas Disease,"Trypanosomiasis, American|Trypanosomiasis, South American|Trypanosoma cruzi Infections|Chagas disease|American Trypanosomiasis|Trypanosoma cruzi Infection|Infections, Trypanosoma cruzi|Chagas' Disease|South American Trypanosomiasis|Infection, Trypanosoma cruzi"
NEW14430,CHEMICAL,nitrofurantoin analog,nitrofurantoin analog
D014354,DISEASE,"Trypanosomiasis, Bovine","Bovine Trypanosomiases|Trypanosomiasis|Bovine Trypanosomiasis|Trypanosomiases, Bovine"
NEW14431,CHEMICAL,single-celle flagellate haemo-protozoan parasite,single-celled flagellated haemo-protozoan parasites
NEW14432,DISEASE,toxic tobacco alkaloid,toxic tobacco alkaloid
NEW14433,CHEBI,antimicrobial peptide hepcidin,antimicrobial peptide hepcidin
D002762,CHEBI,Cholecalciferol,"|cholecalciferol|Vitamin D 3|Calciol|Vitamin D3|Cholecalciferols|(3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol"
NEW14434,CHEMICAL,mao activity,MAO activity
NEW14435,DISEASE,high weight gain,highest weight gain
NEW14436,MENTAL_HEALTH,second-order polynomial regression model,second-order polynomial regression model
NEW14437,CHEMICAL,iu/kg dietary vd3,IU/Kg dietary VD3
NEW14438,NUTRITION,total fish intake,Total fish intake
NEW14439,NUTRITION,black carp,black carp
D002347,CHEMICAL,Carps,"Carp, Silver|Carp, Grass|Cyprinus|Crucian Carps|Grass Carp|Carp, Crucian|Crucian Carp|Carp, Koi|Silver Carps|Carassius carassius|Ctenopharyngodon idellus|silver carp|Koi Carp|Hypophthalmichthys molitrix|Carps, Crucian|Grass Carps|Carp|Carps, Grass|Carps, Silver|Silver Carp|Cyprinus carpio"
NEW14440,DISEASE,breast cancer risk,breast cancer risk
NEW14441,NUTRITION,fish intake,fish intake
NEW14442,CHEMICAL,antidepressant treatment,Antidepressant treatment
NEW14443,DISEASE,first depressive episode,first depressive episode
C031140,CHEMICAL,antheraxanthin [Supplementary Concept],antheraxanthin|Xanthophylls
NEW14444,MENTAL_HEALTH,oxygen evolution depression,Oxygen evolution depression
http://purl.obolibrary.org/obo/CHEBI_27547,CHEMICAL,zeaxanthin,"all-trans-beta-carotene-3,3'-diol|anchovyxanthin|(3R,3'R)-dihydroxy-beta,beta-carotene|beta,beta-carotene-3,3'-diol|all-trans-zeaxanthin|loroxanthin|Zeaxanthin|(3R,3'R)-beta,beta-carotene-3,3'-diol|lutein zeaxanthin"
D011700,CHEMICAL,Putrescine,"1,4-Butanediamine|1,4 Butanediamine|Tetramethylenediamine|1,4-Diaminobutane|1,4 Diaminobutane|putrescine"
C023290,CHEBI,violaxanthin de-epoxidase [Supplementary Concept],Oxidoreductases|violaxanthin
D013095,CHEMICAL,Spermidine,Amines (1966-1970)|spermidine
D013097,CHEMICAL,Spermine Synthase,"spermine|Synthetase, Spermine|Spermine Synthetase|Aminopropyltransferase, Spermidine|Spermidine Aminopropyltransferase|Synthase, Spermine"
NEW14445,DISEASE,progressive neurodegenerative disorder,progressive neurodegenerative disorder
NEW14446,NUTRITION,aged brown bear,aged brown bear
D007382,CHEMICAL,Intermediate Filaments,"Neurofilament|neurofilaments|Tonofilaments|Filaments, Intermediate|Tonofilament|Filament, Intermediate|Neurofilaments|Intermediate Filament"
D055956,DISEASE,Diffuse Neurofibrillary Tangles with Calcification,"NFT|Disease, Kosaka-Shibayama|Kosaka-Shibayama Disease|neurofibrillary tangles|Kosaka Shibayama Disease"
NEW14447,NUTRITION,aged polar bear,aged polar bear
NEW14448,DISEASE,numerous sp,numerous SP
NEW14449,CHEMICAL,calcium (ca2+)-permeable ampa receptor,Calcium (Ca2+)-permeable AMPA receptors
NEW14450,CHEMICAL,nmda receptor-independent seizure,NMDA receptor-independent seizures
NEW14451,CHEBI,ca2 -permeable ampa receptor antagonist,Ca2 -permeable AMPA receptor antagonist
C110702,CHEMICAL,IEM 1460 [Supplementary Concept],Adamantane/analogs  and  derivatives|IEM-1460
D001254,DISEASE,Astrocytoma,"Astrocytomas, Grade III|Anaplastic Astrocytomas|Astrocytomas, Protoplasmic|Mixed Oligoastrocytomas|Gliomas, Astrocytic|Cerebral Astrocytomas|Cerebral Astrocytomas, Childhood|Pilocytic Astrocytomas|Pilocytic Astrocytoma, Juvenile|Astrocytoma, Subependymal Giant Cell|Astrocytomas, Grade II|Astrocytoma, Gemistocytic|Astrocytomas, Grade I|Astrocytic Glioma|Gemistocytic Astrocytomas|Mixed Oligoastrocytoma|Oligoastrocytomas, Mixed|Astrocytoma, Protoplasmic|Pilocytic Astrocytoma|Juvenile Pilocytic Astrocytoma|Grade III Astrocytoma|Pilocytic Astrocytomas, Juvenile|Anaplastic Astrocytoma|Astrocytomas, Childhood Cerebral|astrocytoma|Glioma, Astrocytic|Grade III Astrocytomas|Grade I Astrocytoma|Astrocytoma, Fibrillary|Gemistocytic Astrocytoma|Oligoastrocytoma, Mixed|Grade II Astrocytomas|Astrocytoma, Anaplastic|Astrocytoma, Juvenile Pilocytic|Astrocytomas, Intracranial|Fibrillary Astrocytomas|Astrocytoma, Childhood Cerebral|Juvenile Pilocytic Astrocytomas|Astroglioma|Astrocytoma, Grade I|Grade II Astrocytoma|Astrocytoma, Cerebral|Intracranial Astrocytomas|Astrocytoma, Grade III|Astrocytomas, Pilocytic|Protoplasmic Astrocytomas|Childhood Cerebral Astrocytomas|Astrocytomas, Fibrillary|Astrocytomas, Gemistocytic|Childhood Cerebral Astrocytoma|Protoplasmic Astrocytoma|Astrocytoma, Intracranial|Astrocytomas, Juvenile Pilocytic|Astrocytoma, Grade II|Astrocytomas, Cerebral|Astrocytic Gliomas|Astrocytoma, Pilocytic|Intracranial Astrocytoma|Cerebral Astrocytoma, Childhood|Cerebral Astrocytoma|Grade I Astrocytomas|Astrocytomas, Anaplastic|Fibrillary Astrocytoma|Astrocytomas|Astrogliomas|Subependymal Giant Cell Astrocytoma"
NEW14452,DISEASE,behavioural impairment,behavioural impairments
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Senile_Dementia,MENTAL_HEALTH,senile dementia,disease senile dementia
D018382,DISEASE,Thyroid Hormone Resistance Syndrome,"RTH|Refetoff DeWind DeGroot Syndrome|Resistance, Thyroid Hormone|Syndrome, Refetoff|Thyroid Hormone Resistance|Generalized Thyroid Hormone Resistance|Syndrome, Refetoff-DeWind-DeGroot|Generalized Resistance to Thyroid Hormone|Refetoff-DeWind-DeGroot Syndrome|resistance to thyroid hormone|Hormone Resistance, Thyroid|thyroid hormone resistance|Refetoff Syndrome|hormone resistance"
D009266,CHEMICAL,Nalbuphine,EN 2234A|EN2234A|Nubain|Nalbuphine Serb|Nalbuphine|nalbuphine|EN-2234A|Nalbuphine Hydrochloride
NEW14453,MENTAL_HEALTH,limited respiratory depression,limited respiratory depression
NEW14454,CHEBI,strong antagonist activity withdrawal syndrome,strong antagonist activity withdrawal syndrome
NEW14455,CHEMICAL,due nalbuphine,due nalbuphine
NEW14456,CHEMICAL,ingest fk,ingested FK
D020109,CHEMICAL,Devazepide,"MK-329|L 364,718|L364,718|L-364,718|MK 329|MK329|devazepide"
D002078,CHEMICAL,Butoxamine,"Butoxamine Hydrochloride|Butaxamine|Butoxamine|Hydrochloride, Butoxamine"
NEW14457,DISEASE,ih-induced mandibular growth retardation,IH-induced mandibular growth retardation
NEW14458,DISEASE,intermittent hypercapnia,intermittent hypercapnia
NEW14459,MENTAL_HEALTH,depression min,depression min
NEW14460,CHEMICAL,5-ht receptor activation,5-HT receptor activation
NEW14461,DISEASE,intermittent hypercapnia exposure,intermittent hypercapnia exposure
C490101,DISEASE,"FTSJ1 protein, human [Supplementary Concept]",Methyltransferases|FTSJ1|Nuclear Proteins
NEW14462,MENTAL_HEALTH,retardation gene,retardation genes
NEW14463,CHEMICAL,escherichia coli methyltransferase ftsj/rrmj gene,Escherichia coli methyltransferase FtsJ/RrmJ gene
NEW14464,CHEMICAL,non-ache-inhibiting dose,non-AChE-inhibiting dose
NEW14465,DISEASE,sex-biased cognitive deficit,sex-biased cognitive deficits
NEW14466,CHEBI,adequate vitamin d status,Adequate vitamin D status
NEW14467,DISEASE,risk bacterial infection,risks bacterial infections
NEW14468,CHEBI,inadequate vitamin d status,inadequate vitamin D status
NEW14469,CHEBI,excess dietary vitamin a due,excess dietary vitamin A due
NEW14470,DISEASE,adverse psychiatric event,adverse psychiatric events
NEW14471,DISEASE,acne treatment,acne treatment
C535670,CHEMICAL,Accutane embryopathy [Supplementary Concept],"|Abnormalities, Drug-Induced|isotretinoin embryopathy|Isotretinoin/adverse effects|Accutane"
NEW14472,CHEMICAL,accutane use,Accutane use
NEW14473,CHEMICAL,gsh amount,GSH amount
NEW14474,CHEMICAL,iso rat,ISO rats
NEW14475,DISEASE,hepatic cat,hepatic CAT
NEW14476,CHEMICAL,csf alpha-synuclein assay,CSF Alpha-synuclein assay
NEW14477,DISEASE,manic recurrence,manic recurrences
NEW14478,DISEASE,second important psychiatric use,second important psychiatric use
NEW14479,DISEASE,herpes virus,herpes viruses
NEW14480,DISEASE,antipsychotic-induced hyperprolactinemia,hyperPRL|antipsychotic-induced hyperprolactinemia
NEW14481,MENTAL_HEALTH,prl hyperactivity,PRL hyperactivity
NEW14482,CHEBI,synthetic auxin resistance,synthetic auxin resistance
NEW14483,CHEMICAL,resistance-endowing iaa16 mutation,resistance-endowing IAA16 mutation
NEW14484,MENTAL_HEALTH,resistance allele,resistance alleles
NEW14485,CHEBI,hormone system,hormone systems
NEW14486,DISEASE,p. alata P. foetida,P. alata P. foetida
C082315,DISEASE,"GAG-BP protein, Streptococcus pyogenes [Supplementary Concept]",Bacterial Proteins|S. pyogenes|Carrier Proteins
C102405,CHEMICAL,camalexin [Supplementary Concept],Indoles|Camalexin|Thiazoles
NEW14487,CHEMICAL,indole phytoalexin family,indole phytoalexin family
NEW14488,DISEASE,microbial infection,microbial infection
NEW14489,CHEBI,phytoalexin deficient4,PHYTOALEXIN DEFICIENT4
NEW14490,CHEMICAL,loh1 inhibitor fumonisin b1,LOH1 inhibitor fumonisin B1
NEW14491,MENTAL_HEALTH,EDS1/PAD4-independent lcb accumulation resistance,EDS1/PAD4-independent LCB accumulation resistance
NEW14492,CHEMICAL,oxide (NO)/cyclic guanosine pathway,oxide (NO)/cyclic guanosine pathway
NEW14493,CHEBI,agonist damgo microg,agonist DAMGO microg
NEW14494,CHEMICAL,n-iminoethyl-l-ornithine,N-Iminoethyl-L-ornithine
D008751,CHEMICAL,Methylene Blue,"Blue, Swiss|methylene blue|Blue 9, Basic|Swiss Blue|Blue, Methylene|Chromosmon|Methylene Blue N|Blue N, Methylene|Blue, Urolene|Urolene Blue|Methylthioninium Chloride|Basic Blue 9|Methylthionine Chloride"
NEW14495,CHEMICAL,cgmp activation,cGMP activation
NEW14496,CHEMICAL,nadh fluorescence,NADH fluorescence
NEW14497,CHEMICAL,bh4 defect,BH4 defects
NEW14498,DISEASE,neuropsychiatric comorbiditie,neuropsychiatric comorbidities
NEW14499,CHEMICAL,gge subgroup,GGE subgroups
NEW14500,DISEASE,cinnamomi cassiae,Cinnamomi cassiae
D002292,DISEASE,"Carcinoma, Renal Cell","Clear Cell Renal Cell Carcinoma||Renal Adenocarcinoma|Collecting Duct Carcinomas (Kidney)|Nephroid Carcinomas|Renal Carcinoma|Renal Carcinomas|Kidney, Adenocarcinoma Of|Adenocarcinoma Of Kidneys|Adenocarcinoma, Renal|Renal Cell Carcinoma, Papillary|Collecting Duct Carcinoma of the Kidney|Hypernephroma|renal cell carcinoma|Carcinomas, Collecting Duct|Adenocarcinoma, Renal Cell|Renal Cell Cancers|Cancer, Renal Cell|Hypernephroid Carcinomas|Collecting Duct Carcinoma|Renal Cell Carcinoma|Carcinomas, Collecting Duct (Kidney)|Renal Cell Adenocarcinoma|Chromophil Renal Cell Carcinoma|renal cell carcinomas|Carcinoma, Collecting Duct|Sarcomatoid Renal Cell Carcinoma|Renal Cell Cancer|Renal Cell Adenocarcinomas|renal cell carsinom|Carcinoma, Hypernephroid|Chromophobe Renal Cell Carcinoma|Renal Adenocarcinomas|Carcinoma, Collecting Duct (Kidney)|Renal Collecting Duct Carcinoma|Carcinoma, Renal|Clear Cell Renal Carcinoma|Adenocarcinoma Of Kidney|Adenocarcinomas, Renal Cell|Papillary Renal Cell Carcinoma|Hypernephroid Carcinoma|Tumor, Grawitz|Collecting Duct Carcinomas|Nephroid Carcinoma|Clear cell renal cell carcinoma|Hypernephromas|Renal Cell Carcinomas|Collecting Duct Carcinoma (Kidney)|Carcinoma, Nephroid|Carcinomas, Renal Cell|Grawitz Tumor"
NEW14501,DISEASE,diet-induced obesity,Diet-induced obesity
NEW14502,CHEBI,vitamin d receptor agonist doxercalciferol,vitamin D receptor agonist doxercalciferol
NEW14503,CHEBI,vdr agonist,VDR agonist
NEW14504,DISEASE,diet-induced obese animal,diet-induced obese animals
NEW14505,DISEASE,diet-induce obesity,diet-induce obesity
NEW14506,DISEASE,thyroid disorder,Thyroid disorders
NEW14507,DISEASE,fms patient,FMS patients
NEW14508,DISEASE,fms control,FMS controls
NEW14509,CHEBI,unopposed estrogen,unopposed estrogens
NEW14510,CHEBI,add progestogen,Added progestogen
NEW14511,CHEMICAL,estrogen-progestogen user,estrogen-progestogen users
http://purl.obolibrary.org/obo/DOID_2870,DISEASE,endometrial adenocarcinoma,endometrial endometrioid adenocarcinoma with squamous differentiation|endometrioid adenomas and carcinomas|adenocarcinoma of the Endometrium|endometrial adenoacanthoma|endometrioid carcinoma of Endometrium|adenocarcinoma of endometrium|adenocarcinoma of uterus|endometrial endometrioid adenocarcinoma|endometrioid adenoma or carcinoma|endometrial adenocarcinoma
NEW14512,CHEMICAL,estrogen-progestogen user less,estrogen-progestogen users less
C505096,DISEASE,"PCA-1 antigen, human [Supplementary Concept]","prostate carcinoma|Antigens, Neoplasm"
NEW14513,CHEBI,novelty drug candidate,novelty drug candidate
http://purl.obolibrary.org/obo/CHEBI_36044,CHEBI,antiviral drug,anti-viral drug|new antiviral drugs|anti-virus drug|chemical-synthesized antiviral drugs|antiviral drugs
NEW14514,CHEBI,effective antiviral drug,effective antiviral drugs
NEW14515,CHEMICAL,key amino acid residue present,key amino acid residues present
NEW14516,MENTAL_HEALTH,downward orientation,downward orientation
NEW14517,CHEBI,dual agonist activity,dual agonist activity
C537271,DISEASE,Fowler Christmas Chapple syndrome [Supplementary Concept],Polycystic Ovary Syndrome|polycystic ovaries|voiding dysfunction|Urination Disorders
D002996,CHEMICAL,Clomiphene,"Klostilbegit|Gravosan||Clomifene|Clomid|Clomide|Serophene|clomiphene|Hydrochloride, Clomiphene|Dyneric|Clomiphene Citrate|Clomifen|Chloramiphene|Clostilbegit|Clomiphene Hydrochloride|Citrate, Clomiphene"
NEW14518,DISEASE,metabolic complication,metabolic complications
NEW14519,CHEMICAL,glutamate excitatory amino acid,glutamate excitatory amino acids
NEW14520,DISEASE,acute degeneration organ,acute degeneration organs
NEW14521,DISEASE,man acute syndrome,man acute syndrome
NEW14522,MENTAL_HEALTH,similar syndrome,similar syndromes
C104517,CHEMICAL,Gluk1 kainate receptor [Supplementary Concept],"Receptors, Kainic Acid|Kainate"
NEW14523,CHEMICAL,calcium radical,calcium radicals
NEW14524,DISEASE,human neurodegenerative disorder,human neurodegenerative disorders
NEW14525,CHEMICAL,Allium fistulosum,Allium fistulosum
D003139,DISEASE,Common Cold,"Colds, Common|Catarrh|Common Colds|Coryza, Acute|colds|Cold, Common|Acute Coryza|Catarrhs"
NEW14526,DISEASE,ptsd rat model,PTSD rat model
NEW14527,DISEASE,sps-induced memory deficit,SPS-induced memory deficits
NEW14528,CHEMICAL,new antidepressant class,newer antidepressant classes
NEW14529,CHEMICAL,glutamate neural transmission,glutamate neural transmission
NEW14530,MENTAL_HEALTH,methamphetamine-induced psychosis,methamphetamine-induced psychosis
NEW14531,DISEASE,schizophrenia-like behavioral abnormality,schizophrenia-like behavioral abnormalities
NEW14532,CHEMICAL,baicalensis Georgi,baicalensis Georgi
NEW14533,CHEMICAL,catecholamine deficiency hypothesis,catecholamine deficiency hypothesis
http://purl.obolibrary.org/obo/CHEBI_134870,CHEMICAL,toloxatone,"(5RS)-5-(hydroxymethyl)-3-(3-methylphenyl)-1,3-oxazolidin-2-one|Perenum|rac-5-(hydroxymethyl)-3-(3-methylphenyl)-1,3-oxazolidin-2-one|toloxatonum|toloxatone|Humoryl|MD-69276|MD69276|MD 69276|(RS)-toloxatone|toloxatona|racemic toloxatone|rac-toloxatone|Delalande 69276|iproniazide|rac-5-hydroxymethyl-3-(m-tolyl)-2-oxazolidinone|rac-5-(hydroxymethyl)-3-(3-methylphenyl)-2-oxazolidinone"
NEW14534,DISEASE,non-alcoholic wernicke Encephalopathy,Non-alcoholic Wernicke Encephalopathy
NEW14535,CHEBI,inadequate vitamine intake,inadequate vitamine intake
D056653,DISEASE,Rheumatoid Vasculitis,"Vasculitides, Rheumatoid|Rheumatoid Vasculitides|Vasculitis, Rheumatoid|vasculitis"
http://purl.obolibrary.org/obo/CHEBI_186644,CHEMICAL,zk 159222,"VKs|butyl 1-[(E,1R,4R)-4-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(3S,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-1-hydroxypent-2-enyl]cyclopropane-1-carboxylate"
NEW14536,CHEMICAL,whole body cortisol,Whole body cortisol
NEW14537,DISEASE,hypoxia stress,hypoxia stress
NEW14538,NUTRITION,whitefish embryo,whitefish embryos
NEW14539,CHEBI,t-type calcium channel antagonist mk-8998,T-type calcium channel antagonist MK-8998
http://purl.obolibrary.org/obo/DOID_0040088,DISEASE,autoimmune uveitis,autoimmune uveitis
NEW14540,CHEBI,exclusive pharmaceutical approach,exclusive pharmaceutical approaches
D064092,CHEMICAL,Calbindin 1,Calbindin D28K|calbindin|Calbindin D(28)K|Calbindin-D28K
NEW14541,CHEMICAL,phthalate concentration,phthalate concentrations
NEW14542,CHEMICAL,short-term phthalate exposure,short-term phthalate exposure
NEW14543,CHEMICAL,protein tyrosine phosphorylation,protein tyrosine phosphorylation
NEW14544,MENTAL_HEALTH,extract analgesia,extract analgesia
NEW14545,CHEMICAL,ng-nitro-l-arginine-methylester,NG-nitro-L-arginine-methylester
NEW14546,CHEMICAL,fortify juice,fortified juice
NEW14547,MENTAL_HEALTH,fatigue questionnaire,fatigue questionnaires
NEW14548,CHEMICAL,riboflavin-fortified cloudy apple juice,riboflavin-fortified cloudy apple juice
NEW14549,DISEASE,body muscle mass,body muscle mass
NEW14550,MENTAL_HEALTH,cis fatigue score,CIS fatigue score
NEW14551,CHEMICAL,serum malondialdehyde level,serum malondialdehyde level
NEW14552,MENTAL_HEALTH,subjective fatigue subscale,subjective fatigue subscale
NEW14553,CHEBI,vitamin b2 fortified-cloudy apple juice,vitamin B2 fortified-cloudy apple juice
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Restless_Leg_Syndrome,DISEASE,restless leg syndrome,idiopathic restless legs syndrome
NEW14554,CHEMICAL,serum calcium level,serum calcium level
NEW14555,CHEMICAL,mg/dl. intravenous zoledronic acid,mg/dL. Intravenous zoledronic acid
NEW14556,CHEMICAL,triiodothyronine level,triiodothyronine levels
http://purl.obolibrary.org/obo/DOID_0080832,DISEASE,mild cognitive impairment,mild cognitive impairment patients
NEW14557,CHEBI,circulate maternal thyroid hormone,circulating maternal thyroid hormones
NEW14558,DISEASE,irreversible cognitive deficit,irreversible cognitive deficits
NEW14559,CHEBI,subtle thyroid hormone insufficiency,subtle thyroid hormone insufficiency
NEW14560,DISEASE,significant liver disease,significant liver disease
NEW14561,CHEMICAL,long-acting benzodiazepine,long-acting benzodiazepines
NEW14562,CHEMICAL,nitrogen to ammonia,NH3|nitrogen to ammonia
NEW14563,CHEBI,photo-generated carrier,photo-generated carriers
NEW14564,MENTAL_HEALTH,photocatalytic fixation,Photocatalytic fixation
NEW14565,CHEMICAL,oxygen vacancie,oxygen vacancies
NEW14566,CHEBI,low endogenous androgen production,low endogenous androgen production
NEW14567,MENTAL_HEALTH,anxiety severity,anxiety severity
C526145,CHEMICAL,Phellinus linteus extract [Supplementary Concept],Phellinus linteus|Phellinus|Plant Extracts
NEW14568,CHEMICAL,pethidine addiction,pethidine addiction
NEW14569,MENTAL_HEALTH,abstinent syndrome,abstinent syndromes
C111857,CHEMICAL,flunixin glucuronide [Supplementary Concept],flunixin|Clonixin/analogs  and  derivatives|flunixin meglumine
NEW14570,CHEBI,parenterally analgesic,parenterally analgesic
NEW14571,CHEBI,auxin cytokinin response,auxin cytokinin response
C538274,DISEASE,Autoimmune oophoritis [Supplementary Concept],"Polyendocrinopathies, Autoimmune|Oophoritis|autoimmune oophoritis"
NEW14572,MENTAL_HEALTH,dna fragmentation gel,DNA fragmentation gel
NEW14573,CHEMICAL,propoli ethanolic extract,PEE|propolis ethanolic extract
NEW14574,CHEBI,propoli extract,propolis extract
NEW14575,DISEASE,lung tissue,lung tissues
NEW14576,DISEASE,inflammation group,inflammation group
NEW14577,CHEMICAL,no level,NO levels
NEW14578,CHEMICAL,amino-acid sequence identity,amino-acid sequence identity
C082925,CHEMICAL,retinoic acid receptor beta [Supplementary Concept],"retinoic acid receptor beta|Receptors, Retinoic Acid"
NEW14579,CHEMICAL,striatopallidal medium spiny neuron,striatopallidal medium spiny neurons|spMSNs
NEW14580,CHEMICAL,rarβ-/- spmsns,Rarβ-/- spMSNs
NEW14581,CHEMICAL,mitochondrial toxin 3-nitropropionic acid,3NP|mitochondrial toxin 3-nitropropionic acid
NEW14582,CHEMICAL,plasma glucose,plasma glucose
NEW14583,CHEMICAL,serum triglyceride,serum triglyceride
NEW14584,CHEMICAL,dntp metabolism,dNTP metabolism
D054306,CHEMICAL,Dideoxynucleotides,"Triphosphates, Dideoxynucleotide|Dideoxynucleotide Triphosphates|ddNTPs|dNTPs|triphosphates"
NEW14585,MENTAL_HEALTH,in-source fragmentation,in-source fragmentation
NEW14586,CHEMICAL,charge anion,charged anions
NEW14587,MENTAL_HEALTH,different dominant fragmentation channel,different dominant fragmentation channels
NEW14588,CHEMICAL,clomipramine treatment,clomipramine treatment
NEW14589,DISEASE,mineral disorder,mineral disorders
NEW14590,CHEBI,pharmaceutical standpoint,pharmaceutical standpoint
NEW14591,CHEBI,lowered pharmaceutical response,lowered pharmaceutical response
NEW14592,CHEBI,unusual filler usage,unusual filler usage
NEW14593,CHEMICAL,salt loading,salt loading
http://purl.obolibrary.org/obo/HP_0002157,DISEASE,azotemia,prerenal azotemia
C080234,DISEASE,ATN 10 [Supplementary Concept],ATN|Deuteroporphyrins
NEW14594,DISEASE,cerebrovascular dysfunction,cerebrovascular dysfunction
D047311,CHEMICAL,Luteolin,"3',4',5,7-Tetrahydroxy-Flavone|Luteoline|luteolin|3',4',5,7-Tetrahydroxyflavone"
NEW14595,DISEASE,abeta(25 35)-induced amnesic mouse,Abeta(25 35)-induced amnesic mice
NEW14596,MENTAL_HEALTH,35)-induced amnesia modulation,35)-induced amnesia modulation
NEW14597,DISEASE,depressive polarity,Depressive polarity
NEW14598,CHEMICAL,AimsThis study,AimsThis study
NEW14599,CHEMICAL,characterise scl32 gene,characterised SCL32 gene
NEW14600,MENTAL_HEALTH,increase resistance,increased resistance
NEW14601,CHEBI,antihistamine clemastine,antihistamine clemastine
http://purl.obolibrary.org/obo/NCBITaxon_5820,DISEASE,plasmodium,Plasmodium parasite
D056404,CHEMICAL,Chaperonin Containing TCP-1,"chaperonin|Chaperonin CCT, epsilon Subunit|Chaperonin CCT, eta Subunit|Chaperonin Containing TCP1, Subunit 6A|t Complex Protein 1|Chaperonin Containing TCP1, Subunit 3|Chaperonin CCT, delta Subunit|Chaperonin Containing t-Complex Polypeptide|Chaperonin CCT, gamma Subunit|Chaperonin CCT, zeta1 Subunit|Chaperonin Containing TCP1, Subunit 4|Chaperonin Containing TCP1, Subunit 1|t-Complex Protein 1|Chaperonin Containing TCP1, Subunit 5|Chaperonin Containing TCP1, Subunit 2|Cytosolic Chaperonin|Chaperonin Containing TCP1, Subunit 6B|Chaperonin Containing t Complex Polypeptide|Chaperonin CCT, beta Subunit|Chaperonin Containing TCP 1|t Complex Polypeptide 1|Chaperonin CCT, zeta2 Subunit|t-Complex Polypeptide 1|Chaperonin Containing TCP1, Subunit 7|Cytosolic Molecular Chaperone CCT|Chaperonin CCT, theta Subunit|Chaperonin CCT|Chaperonin, Cytosolic|CCT delta Subunit|Chaperonin Containing T Complex Polypeptide 1|Testis Complex Polypeptide 1|Chaperonin Containing TCP1, Subunit 8|Chaperonin CCT, alpha Subunit|Chaperonin-Containing T-Complex Polypeptide 1"
NEW14602,DISEASE,plasmodium falciparum tcp-1 ring complex,Plasmodium falciparum TCP-1 ring complex
NEW14603,DISEASE,p. falciparum tric subunit,P. falciparum TRiC subunits
NEW14604,DISEASE,p. falciparum parasite,P. falciparum parasites
NEW14605,CHEMICAL,major tric substrate tubulin,major TRiC substrate tubulin
NEW14606,CHEBI,first-generation antihistamine usage,first-generation antihistamine usage
NEW14607,DISEASE,vestibular illusion,vestibular illusions
D061565,NUTRITION,Cycloaddition Reaction,"Cycloaddition Reaction Techniques|Diels|Cycloaddition Reaction Technique|Diels Alder Reaction|Angelica sinensis|Cycloaddition|Reaction Technique, Cycloaddition|Reaction, Cycloaddition|Reaction, Diels-Alder|Techniques, Cycloaddition Reaction|Cycloaddition Reactions|Diels-Alder Reaction|Reaction Techniques, Cycloaddition|Reactions, Cycloaddition|Technique, Cycloaddition Reaction"
NEW14608,DISEASE,menstrual disease,menstrual diseases
NEW14609,CHEMICAL,graveolen L.,graveolens L.
NEW14610,CHEMICAL,Zingiber officinale Roscoe,Zingiber officinale Roscoe
NEW14611,DISEASE,poisoning case,poisoning case
NEW14612,CHEBI,hydrophilic cyanotoxin,hydrophilic cyanotoxins
NEW14613,DISEASE,parkinson syndrome,Parkinson syndrome
NEW14614,DISEASE,severe cognitive pathology,severe cognitive pathologies
NEW14615,DISEASE,endocrine aberration,endocrine aberrations
http://purl.obolibrary.org/obo/DOID_0050737,DISEASE,autosomal recessive disease,rare autosomal recessive disease
http://purl.obolibrary.org/obo/CHEBI_38637,CHEMICAL,tyrosine kinase inhibitor,protein tyrosine kinase inhibitor|TKI inhibitors|TKI inhibitor|tyrphostins|tyrphostin|protein tyrosine kinase inhibitors|tyrosine kinase inhibitors
NEW14616,DISEASE,high tumour burden,high tumour burden
NEW14617,DISEASE,advanced medullary thyroid carcinoma,advanced medullary thyroid carcinoma
NEW14618,CHEMICAL,inhibitor vandetanib,inhibitors vandetanib
C558660,CHEMICAL,cabozantinib [Supplementary Concept],Anilides|Pyridines|cabozantinib
NEW14619,CHEMICAL,mtc patient,MTC patients
NEW14620,CHEMICAL,vandetanib treatment,vandetanib treatment
NEW14621,DISEASE,apnea-hypopnea index,apnea-hypopnea index
NEW14622,CHEMICAL,type 5-ht3 serotonin receptor,type 5-HT3 serotonin receptors
NEW14623,DISEASE,sleep-related breathing disorder,sleep-related breathing disorder
http://purl.obolibrary.org/obo/CHEBI_7916,CHEBI,pantothenic acid,"Synthetic folic acid|Pantothenic acid|N-(2,4-dihydroxy-3,3-dimethylbutanoyl)-beta-alanine|3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoic acid"
NEW14624,DISEASE,endogenous infection,endogenous infection
NEW14625,CHEBI,"vitamin M""-deficient monkey","vitamin M""-deficient monkeys"
NEW14626,CHEMICAL,neutral methyl stearate,neutral methyl stearate
NEW14627,NUTRITION,fatty acid ester ion,fatty acid ester ions
NEW14628,MENTAL_HEALTH,activate dissociation,activated dissociation
D002414,CHEMICAL,"Cations, Monovalent","Cation, Monovalent|Monovalent Cation|Monovalent Cations|cations"
NEW14629,MENTAL_HEALTH,main dissociation channel,main dissociation channels
NEW14630,CHEMICAL,methyl stearate molecule,methyl stearate molecule
NEW14631,NUTRITION,fatty acid group,fatty acid group
http://purl.obolibrary.org/obo/CHEBI_69188,CHEMICAL,methyl stearate,"methyl octadecanoate|Methyl N-octadecanoate|Metholene 2218|Methyl ester of octadecanoic acid|Kemester 4516|N-Octadecanoic acid, methyl ester|Kemester 9018|Octadecanoic acid,methyl ester|n-Octadecanoic acid methyl ester|Methyl octadecanoate|methyl stearate|Kemester 9718|Octadecanoic acid, methyl ester|Stearic acid methyl ester|Stearic acid, methyl ester|Methyl (Z)-9-octadecenoate"
NEW14632,MENTAL_HEALTH,dissociation mechanism,dissociation mechanism
NEW14633,MENTAL_HEALTH,limb apraxia,Limb apraxia
NEW14634,DISEASE,disorder movement,disordered movements
C029878,CHEMICAL,"hlb protein, Staphylococcus aureus [Supplementary Concept]",HLB|Sphingomyelin Phosphodiesterase|Bacterial Toxins|Hemolysin Proteins
NEW14635,NUTRITION,excessive starch accumulation,excessive starch accumulation
NEW14636,MENTAL_HEALTH,opioid abuse disorder,opioid abuse disorder
NEW14637,NUTRITION,plant anthocyanin synthesis,plant anthocyanin synthesis
C506691,CHEMICAL,"FoxO1 protein, Xenopus [Supplementary Concept]",Xenopus Proteins|Forkhead Box Protein O1|• FOXO1
D064209,CHEMICAL,Phytochemicals,"Plant Biologically Active Compound|Plant-Derived Chemical|Plant Bioactive Coumpounds|Plant Derived Chemical|Phytonutrients|Plant Derived Compounds|Phytonutrient|Plant-Derived Compounds|Plant Bioactive Compounds|Coumpounds, Plant Bioactive|Plant Bioactive Compound|Bioactive Compound, Plant|Plant Derived Compound|Compounds, Plant-Derived|Phytochemicals, Dietary|Compound, Plant-Derived|Dietary Phytochemical|Bioactive Compounds, Plant|• Phytochemicals|Plant Derived Chemicals|Compounds, Plant Bioactive|Phytochemical, Dietary|Bioactive Coumpounds, Plant|Chemicals, Plant-Derived|Phytochemical|Plant-Derived Chemicals|Chemical, Plant-Derived|Biologically Active Coumpounds, Plant|Plant Biologically Active Compounds|Plant-Derived Compound|Compound, Plant Bioactive|Dietary Phytochemicals"
C012552,CHEMICAL,alpha-tocopherol phosphate [Supplementary Concept],α-tocopheryl phosphate|alpha-Tocopherol/analogs  and  derivatives
NEW14638,DISEASE,cb1r agonist-mediated hypothermia,CB1R agonist-mediated hypothermia
NEW14639,DISEASE,metabolic remodelling,metabolic remodelling
NEW14640,CHEMICAL,myocardial nad level,myocardial NAD levels
D005047,CHEMICAL,Etoposide,"|Etoposide, (5a alpha)-Isomer|Lastet|VP 16|Demethyl Epipodophyllotoxin Ethylidine Glucoside|Etoposide, alpha D Glucopyranosyl Isomer|Riboposid|VP-16|NSC-141540|Toposar|Vépéside Sandoz|etoposide|Eposide|Eposin|Etoposide Pierre Fabre|Etoposide Teva|Vépéside-Sandoz|Exitop|Etoposide, (5S)-Isomer|NSC 141540|VP 16-213|Etomedac|NSC141540|Etoposido Ferrer Farma|Etoposide, alpha-D-Glucopyranosyl Isomer|VP 16 213|alpha-D-Glucopyranosyl Isomer Etoposide|VP 16213|Celltop|Etoposide, (5a alpha,9 alpha)-Isomer|Eto GRY|Eto-GRY|Teva, Etoposide|Vepesid|Etoposide|Onkoposid|VP16|Etopos"
D006317,DISEASE,"Hearing Loss, Noise-Induced","Noise-Induced Hearing Loss|noise-induced hearing loss|Acoustic Trauma|Hearing Loss, Noise Induced"
NEW14641,CHEMICAL,p-tau181,p-tau181|threonine 181
NEW14642,DISEASE,neuro-axonal degeneration,neuro-axonal degeneration
D002991,CHEMICAL,Clofazimine,"clofazimine|Lamprene|B-663|G30,320|Clofazimine|B 663|G-30,320|G 30,320|N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-2-phenazinamine|B663"
NEW14643,DISEASE,severe abdominal pain,severe abdominal pain
NEW14644,DISEASE,skin gastrointestinal disorder,skin gastrointestinal disorder
NEW14645,CHEMICAL,clofazimine crystal,Clofazimine crystals
NEW14646,DISEASE,bright-red birefringence,bright-red birefringence
NEW14647,CHEMICAL,phloroglucinol treatment,phloroglucinol treatment
C506115,DISEASE,"bacteriocin-like inhibitory substance, Vibrio harveyi [Supplementary Concept]",V. harveyi|Bacteriocins
NEW14648,DISEASE,lethal heat shock,lethal heat shock
NEW14649,MENTAL_HEALTH,mouse-specific anxiety continuum,mouse-specific anxiety continuum
NEW14650,CHEMICAL,corticosterone secretion,corticosterone secretion
NEW14651,CHEMICAL,egfr-directed inhibitor cetuximab,EGFR-directed inhibitor cetuximab
D000077195,DISEASE,Squamous Cell Carcinoma of Head and Neck,"Squamous Cell Carcinoma of the Head and Neck|HNSCC|Laryngeal Squamous Cell Carcinoma|oral squamous cell carcinoma|Squamous Cell Carcinoma of the Larynx|Squamous Cell Carcinoma of the Mouth|Oral Tongue Squamous Cell Carcinoma|Squamous Cell Carcinoma, Head And Neck|Hypopharyngeal Squamous Cell Carcinoma|Oral Cavity Squamous Cell Carcinoma|Oral Squamous Cell Carcinomas|Head And Neck Squamous Cell Carcinomas|Squamous Cell Carcinoma of Larynx|Oral Squamous Cell Carcinoma|Head and Neck Squamous Cell Carcinoma|Squamous Cell Carcinoma of the Nasal Cavity|Carcinoma, Squamous Cell of Head and Neck|OSCC|Oropharyngeal Squamous Cell Carcinoma"
NEW14652,CHEMICAL,cetuximab sensitivity,cetuximab sensitivity
NEW14653,DISEASE,invasive human oscc line,invasive human OSCC line
NEW14654,CHEMICAL,cetuximab treatment,cetuximab treatment
NEW14655,DISEASE,tumor invasiveness,tumor invasiveness
NEW14656,CHEMICAL,human mesencephalic da neuron,human mesencephalic DA neurons
NEW14657,CHEMICAL,ketamine effective antidepressant,ketamine effective antidepressant
NEW14658,DISEASE,cirrhosis impairment,cirrhosis impairments
NEW14659,DISEASE,chronic toxicity,chronic toxicities
NEW14660,CHEMICAL,persistent methotrexate concentration,persistent methotrexate concentrations
NEW14661,NUTRITION,associate folate deficiency,associated folate deficiency
NEW14662,CHEBI,drug donepezil,drug donepezil
http://purl.obolibrary.org/obo/CHEBI_59059,CHEMICAL,methyl isocyanate,methyl isocyanate||methyl mercaptan
NEW14663,DISEASE,chronic respiratory disorder,chronic respiratory disorder
C033479,CHEMICAL,sodium sulfide [Supplementary Concept],Sulfides|sodium sulfide
NEW14664,CHEMICAL,pollutant hydrogen sulfide,pollutants hydrogen sulfides
NEW14665,NUTRITION,fish rainbow trout,fish rainbow trout
http://purl.obolibrary.org/obo/HP_0100543,DISEASE,cognitive impairment,cognition impairment|T2DM-induced cognitive impairment
NEW14666,CHEBI,selective ppar-δ agonist,selective PPAR-δ agonist
NEW14667,DISEASE,severe illness,severe illness
NEW14668,DISEASE,breast cancer cell proliferation,breast cancer cell proliferation
NEW14669,DISEASE,breast cancer cell line,breast cancer cell lines
C407042,CHEMICAL,plant stanol ester [Supplementary Concept],stanol|Sitosterols
NEW14670,MENTAL_HEALTH,treatment refractory depression,treatment refractory depression
NEW14671,MENTAL_HEALTH,recent suicide attempt,recent suicide attempt
NEW14672,CHEMICAL,ketamine treatment,Ketamine treatment
C522201,CHEMICAL,remimazolam [Supplementary Concept],Benzodiazepines|remimazolam
NEW14673,DISEASE,major bleeding,major bleeding
NEW14674,CHEMICAL,voltage-gated potassium channel vgkc complex,voltage-gated potassium channel VGKC complex
NEW14675,DISEASE,gad autoantibody,GAD autoantibodies
NEW14676,DISEASE,argyrophilic grain disease,Argyrophilic grain disease
NEW14677,DISEASE,common four-repeat tauopathy,common four-repeat tauopathy
NEW14678,CHEMICAL,argyrophilic grain disease,Argyrophilic grain disease|AGD
NEW14679,MENTAL_HEALTH,late-onset psychosis,late-onset psychosis
NEW14680,DISEASE,psp case,PSP cases
NEW14681,CHEMICAL,agd case,AGD cases
NEW14682,DISEASE,psp pathology,PSP pathologies
NEW14683,CHEMICAL,coexist agd,coexisting AGD
NEW14684,CHEMICAL,soluble egcg/hst5 complex,Soluble EGCG/Hst5 complexes
NEW14685,CHEMICAL,antiarrhythmic amiodarone,antiarrhythmic amiodarone
NEW14686,DISEASE,am-induced pulmonary toxicity,AM-induced pulmonary toxicity
NEW14687,CHEMICAL,metabolite desethylamiodarone,metabolite desethylamiodarone
D011419,CHEMICAL,Propidium,"Diiodide, Propidium|Propidium Diiodide|Propidium Iodide|propidium iodide|Iodide, Propidium"
NEW14688,CHEMICAL,metabolite desethylamiodarone,Des|metabolite desethylamiodarone
NEW14689,DISEASE,dose-dependent necrosis,dose-dependent necrosis
NEW14690,CHEBI,deficit hyperactivity disorder drug,deficit hyperactivity disorder drug
D000086102,DISEASE,Akkermansia,Akkermansia|Verrucomicrobia (2004-2020)
D001644,CHEMICAL,Bifidobacterium,Bifidobacterium|Actinomycetaceae (1975-1983)|Actinomycetales (1967-1974)
NEW14691,NUTRITION,alpha diversity,alpha diversity
NEW14692,CHEMICAL,acute cocaine toxicity,acute cocaine toxicity
NEW14693,CHEMICAL,noradrenaline release,noradrenaline release
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Erectile_Dysfunction,MENTAL_HEALTH,erectile dysfunction,concomitant erectile dysfunction
NEW14694,CHEMICAL,uroselective alpha1-adrenoceptor antagonist sanofi-aventis,uroselective alpha1-adrenoceptor antagonist Sanofi-Aventis
NEW14695,MENTAL_HEALTH,patient 's transvestism,patient's transvestism
NEW14696,CHEMICAL,dopamine potentiation,dopamine potentiation
NEW14697,CHEMICAL,high histamine concentration,high histamine concentration
NEW14698,CHEMICAL,brain t-meha level,brain t-MeHA levels
NEW14699,DISEASE,i disorder,I disorder
NEW14700,CHEMICAL,exogenous T1AM,exogenous T1AM
D017288,DISEASE,Pain Threshold,"Thresholds, Pain|Threshold, Pain|Pain Thresholds|pain threshold"
NEW14701,CHEMICAL,serotonin (5-ht)(1a)-receptor ligand,serotonin (5-HT)(1A)-receptor ligands
http://purl.obolibrary.org/obo/CHEBI_52210,CHEBI,pharmacological role,pharmacological role
NEW14702,CHEMICAL,l-acetyl-carnitine,LAC|L-acetyl-carnitine
NEW14703,DISEASE,shock resistance,shock resistance
NEW14704,CHEMICAL,cadmium resistance,cadmium resistance
NEW14705,CHEBI,diverse antiviral,diverse antivirals
NEW14706,MENTAL_HEALTH,inevitable viral resistance,inevitable viral resistance
C088115,CHEMICAL,anacardic acid [Supplementary Concept],Anacardic Acids|anacardic acid
NEW14707,CHEBI,fat-soluble vitamin deficiency,fat-soluble vitamin deficiencies
D000090124,DISEASE,Intestinal Failure,"Failure, Intestinal|intestinal failure"
NEW14708,CHEBI,fat soluble vitamin deficiency,fat soluble vitamin deficiency
NEW14709,CHEBI,sex hormone imbalance,sex hormone imbalances
NEW14710,DISEASE,parasympathetic dysfunction,parasympathetic dysfunction
NEW14711,DISEASE,c. chinensis,C. chinensis
NEW14712,CHEMICAL,µl/ml,µL/mL
NEW14713,DISEASE,classical program cell death,classical programmed cell death
NEW14714,DISEASE,abnormal aggregation,Abnormal aggregation
NEW14715,DISEASE,caspase mediated cell death,caspase mediated cell death
NEW14716,DISEASE,necrotic cell death,necrotic cell death
NEW14717,DISEASE,post-traumatic cell death,post-traumatic cell death
NEW14718,CHEMICAL,panicogenic agent cholecystokinin-tetrapeptide,panicogenic agent cholecystokinin-tetrapeptide
NEW14719,CHEMICAL,acylcarnitine level,acylcarnitine levels
NEW14720,CHEMICAL,oral l-carnitine,oral L-carnitine
NEW14721,CHEBI,aforementioned toxin,aforementioned toxins
D007004,DISEASE,Hypoglycemic Agents,"Drug, Hypoglycemic|Agent, Hypoglycemic|Antihyperglycemics|Agent, Antidiabetic|Antihyperglycemic Agents|Hypoglycemic Agent|Antidiabetic|Drug, Antidiabetic|hypoglycemic|Hypoglycemic Effects|Effects, Hypoglycemic|Antidiabetic Agents|Drugs, Hypoglycemic|Agents, Antihyperglycemic|Agent, Antihyperglycemic|Antidiabetic Drugs|Hypoglycemic Effect|Drugs, Antidiabetic|Effect, Hypoglycemic|Agents, Hypoglycemic|Hypoglycemic|Hypoglycemic Drug|hypoglycemic effect|Antidiabetic Drug|Hypoglycemics|Hypoglycemic Drugs|Antihyperglycemic|antidiabetic drug|Antidiabetics|Antihyperglycemic Agent|Antidiabetic Agent|Agents, Antidiabetic"
D000078304,CHEMICAL,Tigecycline,tigecycline|Tygacil|9-(tert-Butylglycylamido)minocycline|GAR-936|TBG-MINO|GAR 936|GAR936
NEW14722,DISEASE,tumor treatment,tumor treatment
NEW14723,MENTAL_HEALTH,associate vascular dementia,associated vascular dementia
NEW14724,MENTAL_HEALTH,hyperhomocysteinemia-induced vascular dementia,hyperhomocysteinemia-induced vascular dementia
NEW14725,CHEMICAL,testosterone therapy,Testosterone therapy
NEW14726,CHEMICAL,n-methyl-d-aspartate nmda glutamate receptor,N-methyl-d-aspartate NMDA glutamate receptor
NEW14727,CHEMICAL,serotonin na reuptake,serotonin NA reuptake
NEW14728,DISEASE,stress urinary incontinence,SUI|stress urinary incontinence
D053206,MENTAL_HEALTH,Nocturnal Enuresis,"Incontinence, Nighttime Urinary|Nighttime Urinary Incontinence|Urinary Incontinence, Nighttime|nocturnal enuresis|Bedwetting|Enuresis, Nocturnal"
NEW14729,DISEASE,ejaculatory disorder,ejaculatory disorders
NEW14730,CHEMICAL,5-ht na reuptake inhibitor snri duloxetine,5-HT NA reuptake inhibitor SNRI duloxetine
D000688,CHEMICAL,Amylose,amylose
NEW14731,CHEMICAL,surround crystalline region,surrounding crystalline regions
NEW14732,CHEMICAL,waxy-gene dosage,Waxy-gene dosage
NEW14733,CHEBI,specific sialidase inhibitor,Specific sialidase inhibitors
D006330,DISEASE,"Heart Defects, Congenital","Congenital Heart Defect|Heart Abnormality|Malformation Of Heart|Heart Defect, Congenital|heart defects|Congenital Heart Defects|Disease, Congenital Heart|Congenital Heart Disease|Heart Abnormalities|Defects, Congenital Heart|Malformation Of Hearts|Defect, Congenital Heart|Heart Disease, Congenital|Abnormality, Heart|Congenital Heart Diseases|Heart, Malformation Of"
NEW14734,DISEASE,anesthesia-induced cognitive dysfunction,anesthesia-induced cognitive dysfunction
NEW14735,DISEASE,isoflurane-induced cognitive impairment,isoflurane-induced cognitive impairment
D000086382,CHEMICAL,COVID-19,"COVID-19 Virus Infection|Coronavirus Disease-19|Virus Disease, COVID-19|SARS CoV 2 Infection|2019-nCoV Infections|COVID 19 Pandemic|2019-nCoV Diseases|Coronavirus Disease 19|COVID-19 Virus Diseases|COVID-19 Pandemic|SARS-CoV-2 Infections|Infection, 2019-nCoV|COVID 19 Virus Infection|Coronavirus Disease 2019|2019-nCoV Disease|Disease, COVID-19 Virus|SARS-CoV-2 Infection|COVID-19 Virus Infections|2019 Novel Coronavirus Disease|SARS Coronavirus 2 Infection|Infection, COVID-19 Virus|COVID 19 Virus Disease|2019-nCoV Infection|COVID-19 Pandemics|Disease, 2019-nCoV|2019 Novel Coronavirus Infection|Pandemic, COVID-19|Virus Infection, COVID-19|COVID-19 virus|Disease 2019, Coronavirus|COVID 19|COVID19|Infection, SARS-CoV-2|COVID-19 Virus Disease|Severe Acute Respiratory Syndrome Coronavirus 2 Infection|2019 nCoV Infection|2019 nCoV Disease"
NEW14736,CHEMICAL,l-alphahydrazinomethyldopa,MK-486|L-alphahydrazinomethyldopa
NEW14737,CHEMICAL,l-dopa effect,L-dopa effect
NEW14738,CHEMICAL,plasma dopa level,Plasma dopa levels
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Recurrent_Depression,MENTAL_HEALTH,recurrent depression,recurrent depression
NEW14739,CHEBI,various endocrine abnormality,various endocrine abnormalities
NEW14740,NUTRITION,chronic lithium therapy,chronic lithium therapy
NEW14741,DISEASE,multiglandular hyperparathyroidism,multiglandular hyperparathyroidism
NEW14742,DISEASE,subclinical parathyroid adenoma,subclinical parathyroid adenoma
NEW14743,CHEMICAL,preserve oxygen extraction fraction,preserved oxygen extraction fraction
NEW14744,CHEMICAL,acetylcholine precursor,acetylcholine precursors
NEW14745,DISEASE,avoidant personality trait,Avoidant personality traits
C005466,CHEMICAL,ursolic acid [Supplementary Concept],ursolic acid|UA|Triterpenes
C000711527,DISEASE,hikikomori [Supplementary Concept],"Shame|Phobia, Social|hikikomori"
NEW14746,CHEMICAL,low serum ua level,lower serum UA levels
NEW14747,CHEMICAL,% v/v aqueous acetic acid,% v/v aqueous acetic acid
NEW14748,CHEMICAL,% ethanol extract,% ethanol extract
D009072,DISEASE,Moyamoya Disease,"Progressive Intracranial Occlusive Arteropathy (Moyamoya)|Primary Moyamoya Diseases|Moyamoya Disease, Classic|Disease, Moya-Moya|moyamoya disease|Moyamoya Diseases, Primary|Moya Moya Disease|Disease, Primary Moyamoya|Classic Moyamoya Disease|Moya-Moya Disease|Disease, Classic Moyamoya|Secondary Moyamoya Disease|Primary Moyamoya Disease|Moyamoya Disease, Primary|Moyamoya Disease, Secondary|Moyamoya Syndrome|Cerebrovascular Moyamoya Disease"
NEW14749,DISEASE,perioperative hypertension,perioperative hypertension
NEW14750,CHEMICAL,rapamycin inhibitor,rapamycin inhibitor
D054066,DISEASE,"Leukemia, Large Granular Lymphocytic","NK-LGL Leukemia|Lymphoproliferative Disease of Granular Lymphocytes|Leukemia, T Cell Large Granular Lymphocytic|Large Granular Lymphocytosis|Natural Killer Cell Large Granular Lymphocytic Leukemia|Aggressive Natural Killer Cell Leukemia|T-LGL Leukemias|Large Granular Lymphocytoses|NK LGL Leukemia|T-Cell Large Granular Lymphocyte Leukemia|Leukemia, T-LGL|LGL Leukemias|Granular Lymphocytoses, Large|Leukemia, T-Cell Large Granular Lymphocytic|Lymphocytosis, Large Granular|Leukemia, LGL|T LGL Leukemia|NK Cell Large Granular Lymphocytic Leukemia|Granular Lymphocytosis, Large|Leukemia, NK-LGL|Leukemia, NK LGL|NK-LGL Leukemias|Large Granular Lymphocyte Leukemia|Leukemia, Lymphocytic, Large Granular|Leukemias, T-LGL|T Cell Large Granular Lymphocytic Leukemia|T Cell Large Granular Lymphocyte Leukemia|LGL Leukemia|NK-Cell Large Granular Lymphocytic Leukemia|T-Cell Large Granular Lymphocytic Leukemia|Lymphocytoses, Large Granular|Leukemias, NK-LGL|Leukemia, Natural Killer Cell Large Granular Lymphocytic|Leukemia, T LGL|T-LGL leukemia|Aggressive NK Cell Leukemia|Leukemias, LGL|T-LGL Leukemia|Lymphoproliferative Disease of Large Granular Lymphocytes"
NEW14751,MENTAL_HEALTH,nucleophilic displacement,nucleophilic displacement
NEW14752,CHEMICAL,malondialdehyde level,malondialdehyde level
NEW14753,CHEMICAL,interleukin-1β expression,interleukin-1β expression
NEW14754,MENTAL_HEALTH,transient dementia,transient dementia
NEW14755,DISEASE,arrhythmia vulnerability,arrhythmia vulnerability
NEW14756,CHEBI,drug modafinil,drug modafinil
D000070379,DISEASE,Attentional Bias,"Bias, Attentional|attentional bias|Attentional Biases|Biases, Attentional|Biased Attention|Attention, Biased"
NEW14757,DISEASE,uhr individual,UHR individuals
NEW14758,CHEMICAL,perturb glutamate,perturbed glutamate
NEW14759,DISEASE,subdural haematoma,subdural haematomas
NEW14760,MENTAL_HEALTH,resistance level,resistance levels
NEW14761,DISEASE,inflammatory lesion,inflammatory lesions
D019159,CHEMICAL,Nonheme Iron Proteins,"Non Heme Iron Proteins|Iron Proteins, Nonheme|Non-Heme Iron Proteins|Proteins, Non-Heme Iron|heme iron|Iron Proteins, Non-Heme|Iron Proteins, Non Heme|Proteins, Nonheme Iron"
NEW14762,DISEASE,chronic leg ulcer fluid,chronic leg ulcer fluids
NEW14763,DISEASE,chronic ulcer,chronic ulcers
NEW14764,CHEMICAL,amino acid homocysteine,amino acid homocysteine
D009165,DISEASE,"Mycobacterium Infections, Nontuberculous","Nontuberculous Mycobacterium Infection|Infections, Atypical Mycobacterium|Atypical Mycobacterial Infection, Disseminated|Familial Atypical Mycobacteriosis|Mycobacterium abscessus Infections|Nontuberculous Mycobacterium Infections|Atypical Mycobacteriosis, Familial Disseminated|Atypical Mycobacterium Infection|nontuberculous mycobacterium|Atypical Mycobacterial Infection, Familial Disseminated|Mycobacterium Infection, Nontuberculous|Infection, Mycobacterium abscessus|Mycobacteriosis, Familial Atypical|Mycobacterioses, Familial Atypical|Mycobacterium Infection, Atypical|Familial Atypical Mycobacterioses|Mycobacterium abscessus Infection|Infections, Mycobacterium abscessus|Mycobacterium Infections, Atypical|Atypical Mycobacterium Infections|Atypical Mycobacteriosis, Familial"
NEW14765,DISEASE,advanced melanoma patient,advanced melanoma patients
NEW14766,CHEMICAL,inhibitor rivaroxaban,inhibitor rivaroxaban
NEW14767,DISEASE,cteph patient,CTEPH patients
NEW14768,CHEMICAL,sex-microbiota-brain interaction,sex-microbiota-brain interactions
NEW14769,DISEASE,s. acmella,S. acmella
D020001,CHEMICAL,1-Butanol,"Alcohol, n-Butyl|n Butanol|n Butyl Alcohol|1 Butanol|n-Butanol|Alcohol, Butyl|butanol|Butyl Alcohol|n-Butyl Alcohol"
C027873,CHEMICAL,"2-butanone, ethyl acetate cavity cleaner [Supplementary Concept]",ethyl acetate|Butanones|Acetates
NEW14770,CHEMICAL,selective group i mglur antagonist (s)4-carboxyphenylglycine,4-CPG|selective group I mGluR antagonist (S)4-carboxyphenylglycine
NEW14771,MENTAL_HEALTH,task complete amnesia,task complete amnesia
C117595,CHEMICAL,methyl-CpG DNA demethylase [Supplementary Concept],"MCPG|Oxidoreductases, O-Demethylating"
C561247,CHEMICAL,"5alpha,10beta,13beta-triacetoxy-2 alpha,7beta-dihydroxy-2(3-20) abeotaxa-4(20),11-dien-9-one [Supplementary Concept]",Taxoids|tADA
NEW14772,CHEBI,Farsi,Farsi|Dari
NEW14773,MENTAL_HEALTH,suicide inhibitor alpha-difluoromethyl-lysine,suicide inhibitor alpha-difluoromethyl-lysine
C021520,CHEMICAL,lysine decarboxylase [Supplementary Concept],lysine decarboxylase|Carboxy-Lyases
D029681,DISEASE,Arabidopsis Proteins,"Proteins, Arabidopsis thaliana|thaliana Proteins, Arabidopsis|Thale Cress Proteins|Arabidopsis thaliana Proteins|Arabidopsis"
NEW14774,CHEMICAL,increase indole-3-butyric acid,increased indole-3-butyric acid
NEW14775,CHEBI,auxin glycosyltransferase ugt84a2,auxin glycosyltransferase UGT84A2
NEW14776,DISEASE,flowering-related,flowering-related
NEW14777,CHEMICAL,synthetic benzodiazepine,Synthetic benzodiazepines
NEW14778,CHEMICAL,bac-containing eye drop,BAC-containing eye drops
NEW14779,DISEASE,future glaucoma surgery,future glaucoma surgery
NEW14780,CHEMICAL,mitochondria-targeted antioxidant skq1,mitochondria-targeted antioxidant SkQ1
C532038,CHEMICAL,10-(6'-plastoquinonyl)decyltriphenylphosphonium [Supplementary Concept],SkQ1|Plastoquinone/analogs  and  derivatives
NEW14781,CHEMICAL,second-generation antidepressant,second-generation antidepressants
NEW14782,MENTAL_HEALTH,multivariate regression analysis,multivariate regression analysis
NEW14783,DISEASE,tbev replication,TBEV replication
NEW14784,CHEBI,antiviral role,antiviral role
D053060,CHEMICAL,West Nile Virus Vaccines,WNV|Nile virus|West Nile virus|Viral Vaccines (2000-2006)
NEW14785,DISEASE,serious mosquito-borne zoonotic disease,serious mosquito-borne zoonotic disease
NEW14786,MENTAL_HEALTH,chronic ethanol abuse,Chronic ethanol abuse
NEW14787,CHEBI,c vitamin status,C vitamins status
NEW14788,CHEMICAL,green-synthesized ag np,green-synthesized Ag NPs
D007898,DISEASE,"Leishmaniasis, Visceral","visceral leishmaniasis|Fever, Black|Kala Azar|Visceral Leishmaniasis|Black Fever|Kala-Azar"
NEW14789,DISEASE,acne arthritis,acne arthritis
NEW14790,CHEBI,establish broad-spectrum antibiotic,established broad-spectrum antibiotic
NEW14791,CHEMICAL,second-generation tetracycline,second-generation tetracycline
NEW14792,DISEASE,lupus b cell,Lupus B cells
D019309,CHEBI,Epstein-Barr Virus Nuclear Antigens,"Antigen, EBV Nuclear|Epstein-Barr Virus Nuclear Antigen|EBV Nuclear Antigen|Nuclear Antigens, EBV|Nuclear Antigen, EBV|Epstein Barr Virus Nuclear Antigens|Epstein Barr Virus Nuclear Antigen|Nuclear Antigens, Herpesvirus 4, Human|Herpesvirus 4, Human Nuclear Antigens|EBV Nuclear Antigens|nuclear antigens"
NEW14793,CHEBI,growth hormone secretagogue receptor type a,growth hormone secretagogue receptor type A
NEW14794,DISEASE,novel alcohol addiction treatment strategy,novel alcohol addiction treatment strategy
NEW14795,DISEASE,non-autoimmune hyperthyroidism,non-autoimmune hyperthyroidism
NEW14796,CHEMICAL,crh receptor 1,CRH receptor 1|CRHR1
NEW14797,CHEMICAL,inhibitory crhcea→vta input,inhibitory CRHCeA→VTA inputs
NEW14798,CHEMICAL,cortisol secretion,cortisol secretion
D007034,DISEASE,"Hypothalamus, Posterior","Nucleus, Supramammillary|Posterior, Area Hypothalamica|Commissure, Supramammillary|Posterior Hypothalamic Regions|Posterior Periventricular Nucleus|Premammillary Nucleus|Area Hypothalamica Posteriors|Posterior Hypothalamus|Region, Mammillary|Hypothalamic Regions, Posterior|Hypothalamic Region, Posterior|Mammillary Regions|Posterior Hypothalamic Region|Area Hypothalamica Posterior|Regions, Mammillary|Supramammillary Nucleus|Region, Posterior Hypothalamic|hypothalamus|Posteriors, Hypothalamus|HYPO|Nucleus, Premammillary|Posteriors, Area Hypothalamica|Mammillary Region|Hypothalamica Posteriors, Area|Supramammillary Commissures|Supramammillary Commissure|Nucleus, Posterior Periventricular|Hypothalamus Posterior|Periventricular Nucleus, Posterior|Posterior, Hypothalamus|Commissures, Supramammillary|Hypothalamus Posteriors|Regions, Posterior Hypothalamic|Hypothalamica Posterior, Area"
NEW14799,DISEASE,hypercortisolemia post-stress challenge,hypercortisolemia post-stress challenge
NEW14800,MENTAL_HEALTH,male hyperactivity,Male hyperactivity
NEW14801,CHEMICAL,comprehensive two-dimensional gas chromatography,comprehensive two-dimensional gas chromatography
C535466,DISEASE,Convulsions benign familial neonatal dominant form [Supplementary Concept],"Epilepsy, Benign Neonatal|neonatal seizures"
NEW14802,DISEASE,seizure-induced behavioral deficit,seizure-induced behavioral deficits
NEW14803,CHEMICAL,n-6/n-3 pufa,n-6/n-3 PUFA
NEW14804,DISEASE,somatic symptom disturbance,somatic symptom disturbance
C032257,CHEMICAL,methylnaltrexone [Supplementary Concept],methylnaltrexone|methylnaltrexone bromide|Quaternary Ammonium Compounds|Naltrexone/analogs  and  derivatives
NEW14805,DISEASE,crf signaling,CRF signaling
C499434,CHEMICAL,"corticotropin-releasing factor receptor type 2a, rat [Supplementary Concept]","Receptors, Corticotropin-Releasing Hormone|CRF(2"
NEW14806,DISEASE,tremor shake,tremor shake
NEW14807,CHEMICAL,last morphine injection,last morphine injection
NEW14808,CHEBI,gabaa agonist muscimol,GABAA agonist muscimol
NEW14809,CHEMICAL,gabab agonist baclofen bac,GABAB agonist baclofen BAC
NEW14810,DISEASE,excessive irritability,excessive irritability
NEW14811,DISEASE,anger outburst,anger outbursts
NEW14812,DISEASE,pathologic aggression,pathologic aggression
NEW14813,DISEASE,aggressive population,aggressive populations
NEW14814,CHEMICAL,pparγ thiazolidinedione tzd drug,PPARγ thiazolidinedione TZD drugs
C016299,CHEMICAL,chelerythrine [Supplementary Concept],chelerythrine|Benzophenanthridines
http://purl.org/sig/ont/fma/fma60992,CHEMICAL,helix,Helix of ear|Helix of pinna|Helix (Auricula)|Helical part of pinna|Helix of auricle of ear|TZDs helix
http://purl.obolibrary.org/obo/CHEBI_70781,CHEBI,ppar modulator,selective PPAR modulator|peroxisome proliferator-activated receptor modulators|peroxisome proliferator-activated receptor modulator
NEW14815,CHEMICAL,glucose lipid metabolism,glucose lipid metabolism
NEW14816,CHEMICAL,telmisartan treatment,Telmisartan treatment
NEW14817,MENTAL_HEALTH,5ht fixation,5HT fixation
D024508,CHEBI,Tocotrienols,tocotrienols|Tocotrienol
NEW14818,CHEMICAL,l-dihydroxyphenylalanine,l-dihydroxyphenylalanine
NEW14819,CHEBI,a2-adrenergic receptor agonist clonidine,a2-adrenergic receptor agonist clonidine
NEW14820,DISEASE,tardive dyskinetic symptomatology,tardive dyskinetic symptomatology
NEW14821,CHEMICAL,tardive dyskinetic symptomatology,TDS|tardive dyskinetic symptomatology
D061186,DISEASE,Breast Milk Expression,"Breast Milk Collection|Collections, Breastmilk|Pumping, Breast|milk|Milk Collection, Breast|Pumpings, Breast|Expressions, Breast Milk|Milk Collections, Breast|Expression, Breastmilk|Breastmilk Expression|Breast Milk Expressions|Breastmilk Expressions|Breast Milk Collections|Milk Expression, Breast|Breast Pumpings|Expression, Breast Milk|breast milk|Collection, Breastmilk|Breastmilk Collections|Milk Expressions, Breast|Breastmilk Collection|Breast Pumping|Collections, Breast Milk|Collection, Breast Milk|Expressions, Breastmilk"
NEW14822,CHEBI,drug effect,drug effect
NEW14823,MENTAL_HEALTH,psychogenic amnesia,psychogenic amnesia
C536350,DISEASE,Visceral myopathy familial external ophthalmoplegia [Supplementary Concept],"encephalopathy syndrome|Ophthalmoplegia/congenital|Intestinal Pseudo-Obstruction|Muscular Dystrophy, Oculopharyngeal"
NEW14824,CHEMICAL,aluminum balance,aluminum balance
NEW14825,CHEBI,parathyroid hormone withdrawal,parathyroid hormone withdrawal
NEW14826,DISEASE,uremia serum aluminum binding,uremia serum aluminum binding
NEW14827,CHEBI,many antibacterial drug,Many antibacterial drugs
NEW14828,NUTRITION,BlackThorn Therapeutics,BlackThorn Therapeutics
NEW14829,DISEASE,chronic paracoccidioidomycosis,chronic paracoccidioidomycosis
D009182,DISEASE,Mycosis Fungoides,mycosis
NEW14830,DISEASE,chronic paracoccidioidomycosis group,chronic paracoccidioidomycosis group
NEW14831,CHEMICAL,preferred carbon source,preferred carbon sources
D057465,MENTAL_HEALTH,Catabolite Repression,"Repression, Catabolite|Catabolite Repression, Carbon|Carbon Catabolite Repressions|Catabolite repression|Catabolite Repressions|catabolite repression|Carbon Catabolite Repression|Catabolite Repressions, Carbon|Repressions, Catabolite|Repression, Carbon Catabolite|Repressions, Carbon Catabolite"
NEW14832,CHEBI,amyloid beta abeta protein,Amyloid beta Abeta protein
NEW14833,CHEMICAL,(rs)-alpha-methyl-4-carboxyphenyglycine,(RS)-alpha-methyl-4-carboxyphenyglycine
NEW14834,CHEBI,nonselective group i/ii metabotropic glutamate receptor antagonist,nonselective group I/II metabotropic glutamate receptor antagonist
NEW14835,DISEASE,life-threatening invasive fungal infection,Life-threatening invasive fungal infections
http://purl.obolibrary.org/obo/CHEBI_35816,CHEBI,leprostatic drug,antifungal drugs|leprostatic agent|Antifungal drugs|leprostatic drugs|leprostatic
NEW14836,CHEMICAL,mycobacterium tuberculosis h37rv genome,Mycobacterium tuberculosis H37Rv genome
D007654,CHEMICAL,Ketoconazole,"|R41400|ketoconazole|R 41400|R41,400|R-41400|Nizoral"
NEW14837,CHEMICAL,novel nlr-like gene,novel NLR-like gene|LvNLRPL2
D046848,DISEASE,White spot syndrome virus 1,White Spot Syndrome Virus|WSSV|White spot syndrome virus|spot syndrome virus
NEW14838,DISEASE,parahaemolyticus infection,parahaemolyticus infection
D014735,DISEASE,Vibrio Infections,"Vibrio infection|Vibrio Illness|Vibriosis|Infection, Vibrio|Infections, Vibrio|Vibrioses|Vibrio Infection|Vibrio Illnesses"
D004878,CHEMICAL,Ergotamine,"Ergo Kranit|Ergo Sanol|Ergotaminine|Ergodryl Mono|Lingraine|Gynergen|Ergotamine Tartrate (2:1)|Tartrate, Ergotamine|Ergostat|Cornutamine|ergotamine|Ergotamine Tartrate|Ergo-Kranit|Ergomar|Mono, Ergodryl"
NEW14839,CHEMICAL,pro-serotonin effect,pro-serotonin effect
NEW14840,CHEMICAL,psbma-gelatin-mxene-glycerol pgmg organohydrogel,PSBMA-gelatin-MXene-glycerol PGMG organohydrogel
NEW14841,MENTAL_HEALTH,good fatigue resistance,good fatigue resistance
NEW14842,CHEBI,monoaminergic stabilizer,monoaminergic stabilizer
NEW14843,MENTAL_HEALTH,myalgic encephalomyelitis/chronic fatigue syndrome,myalgic encephalomyelitis/chronic fatigue syndrome
NEW14844,CHEMICAL,d-trp6-pro9-n-ethylamide-lhrh,D-Trp6-Pro9-N-ethylamide-LHRH|LHRHA
D062550,CHEMICAL,NAV1.1 Voltage-Gated Sodium Channel,"Sodium Channel, Voltage-Gated, Type I, alpha Protein|Type 1 Voltage Gated Sodium Channel|Voltage-Gated Sodium Channel Type 1 Subunit alpha|Voltage Gated Sodium Channel Type 1 Subunit alpha|alpha Subunit, NAV1.1|Voltage Gated Sodium Channel Type 1 alpha Subunit|Voltage-Gated Sodium Channel Type 1|Voltage-Gated Sodium Channel Type 1 alpha Subunit|NAV1.1 alpha Subunit|NAV1.1 Voltage Gated Sodium Channel|SCN1A Sodium Channel alpha Subunit|Voltage Gated Sodium Channel Type 1|Type 1 Voltage-Gated Sodium Channel|Nav1.1"
NEW14845,DISEASE,dravet syndrome mouse,Dravet syndrome mice
D004831,DISEASE,"Epilepsies, Myoclonic","|Severe Myoclonic Epilepsy, Infantile|Epilepsies, Infantile Myoclonic|Cryptogenic Myoclonic Epilepsies|Epilepsy, Myoclonic Astatic|Infantile Myoclonic Epilepsy|Epilepsies, Symptomatic Myoclonic|Epilepsy, Cryptogenic Myoclonic|Myoclonic seizures|Myoclonic Encephalopathy|Myoclonic Epilepsy, Symptomatic|Doose Syndrome|Early Childhood Epilepsy, Myoclonic|Epilepsy, Myoclonic Absence|Epilepsies, Cryptogenic Myoclonic|Myoclonic Astatic Epilepsies|Epilepsy, Myoclonic, Infantile|Myoclonic Epilepsy|Infantile Myoclonic Epilepsies|Myoclonic Epilepsy, Early Childhood|Epilepsy, Myoclonus|Myoclonic Astatic Epilepsy|Myoclonic Epilepsy, Infantile, Benign|Epilepsy, Myoclonic, Early Childhood|Myoclonic Epilepsy, Cryptogenic|Idiopathic Myoclonic Epilepsies|Astatic Epilepsy, Myoclonic|Epilepsy, Myoclonic, Infantile, Severe|Myoclonic Epilepsies|Benign Infantile Myoclonic Epilepsy|Myoclonus Epilepsies|Myoclonic Absence Epilepsies|Myoclonic Epilepsy, Benign Infantile|Myoclonic Encephalopathies|Epilepsies, Myoclonic Absence|Early Childhood, Myoclonic Epilepsy|Myoclonic Epilepsy, Severe, Of Infancy|Symptomatic Myoclonic Epilepsies|Infantile Severe Myoclonic Epilepsy|Myoclonic Absence Epilepsy|Epilepsy, Myoclonic, Infantile, Benign|Symptomatic Myoclonic Epilepsy|Astatic Epilepsies, Myoclonic|Myoclonic Epilepsy, Infantile|Myoclonic Epilepsies, Idiopathic|Epilepsy, Early Childhood, Myoclonic|Idiopathic Myoclonic Epilepsy|Severe Infantile Myoclonic Epilepsy|Dravet Syndromes|Cryptogenic Myoclonic Epilepsy|Epilepsy, Symptomatic Myoclonic|Myoclonic Epilepsy, Severe Infantile|Epilepsy, Myoclonic|Encephalopathies, Myoclonic|Myoclonic Epilepsies, Infantile|Myoclonic Epilepsy, Idiopathic|Myoclonic Epilepsies, Symptomatic|Myoclonic Epilepsies, Cryptogenic|Seizure Disorders, Myoclonic|Dravet syndrome|Epilepsy, Infantile Myoclonic|Epilepsies, Myoclonic Astatic|Epilepsies, Idiopathic Myoclonic|Myoclonic Epilepsy, Infantile, Severe|Epilepsy, Idiopathic Myoclonic|Myoclonic Seizure Disorders|Myoclonus Epilepsy|Severe Myoclonic Epilepsy Of Infancy|Encephalopathy, Myoclonic|Dravet Syndrome|Seizure Disorder, Myoclonic|Myoclonic Seizure Disorder"
NEW14846,DISEASE,severe childhood-onset epilepsy due,severe childhood-onset epilepsy due
NEW14847,CHEMICAL,Celery Seed extract,Celery Seed Extract|CSE
NEW14848,DISEASE,gastric irritation,gastric irritation
NEW14849,CHEMICAL,low-dose ketamine,Low-dose ketamine
NEW14850,DISEASE,refractory scd-related pain,refractory SCD-related pain
NEW14851,CHEMICAL,low-dose ketamine continuous infusion,low-dose ketamine continuous infusion
NEW14852,DISEASE,pain management safe,pain management safe
NEW14853,CHEMICAL,adjuvant ketamine use,adjuvant ketamine use
NEW14854,CHEMICAL,low-dose ketamine infusion,low-dose ketamine infusion
D003295,DISEASE,Convulsive Therapy,"Shock Therapy|Therapy, Convulsive|Therapy, Insulin Shock|Therapies, Convulsive|Therapies, Insulin Coma|Therapy, Shock|convulsive|Coma Therapies, Insulin|Coma Therapy, Insulin|Insulin Shock Therapy|Shock Therapies|Convulsive Therapies|Insulin Coma Therapies|Therapy, Insulin Coma|Insulin Coma Therapy|Therapies, Shock|Shock Therapy, Insulin"
NEW14855,MENTAL_HEALTH,anxiety manifestation,anxiety manifestations
NEW14856,CHEMICAL,selective norepinephrine reuptake inhibitor reboxetine,selective norepinephrine reuptake inhibitor reboxetine
NEW14857,CHEMICAL,dose-dependent cortisol release,dose-dependent cortisol release
http://purl.obolibrary.org/obo/DOID_3717,DISEASE,gastric adenocarcinoma,gastric adenocarcinoma|adenocarcinoma of stomach|stomach adenocarcinoma
NEW14858,CHEMICAL,lactulose mannitol test,lactulose mannitol test
http://purl.obolibrary.org/obo/MFOMD_0000012,DISEASE,hypomanic mood episode,mood episodes
NEW14859,DISEASE,manic/hypomanic patient,manic/hypomanic patients
NEW14860,MENTAL_HEALTH,event headache,events headache
NEW14861,CHEMICAL,lamotrigine treatment,lamotrigine treatment
http://purl.obolibrary.org/obo/DOID_0050426,DISEASE,stevens-johnson syndrome,mild Stevens-Johnson syndrome
NEW14862,DISEASE,serious rash,serious rash
NEW14863,DISEASE,symptomatic endometriosis,symptomatic endometriosis
NEW14864,CHEMICAL,subanalgesic dose,subanalgesic dose
C494581,CHEMICAL,"nac protein, Drosophila [Supplementary Concept]",Monosaccharide Transport Proteins|GDP-fucose|Drosophila Proteins
NEW14865,DISEASE,staphylococcal enterocolitis,staphylococcal enterocolitis
NEW14866,DISEASE,occasional anaphylactic reaction,occasional anaphylactic reactions
NEW14867,DISEASE,blood dyscrasia,blood dyscrasias
NEW14868,CHEMICAL,potassium depletion,potassium depletion
NEW14869,DISEASE,ventricular premature beat,ventricular premature beats
D006830,CHEMICAL,Hydralazine,"|Hydralazine mono Hydrochloride|hydralazine|Hydrochloride, Hydralazine|Hydralazine mono-Hydrochloride|mono-Hydrochloride, Hydralazine|Hydrazinophthalazine|Hydrallazin|Nepresol|Hydralazine Hydrochloride|Apressin|Apresoline|Apressoline|Hydralazine"
NEW14870,DISEASE,jaundice blood dyscrasia,jaundice blood dyscrasias
NEW14871,DISEASE,parkinsonian state,parkinsonian states
NEW14872,DISEASE,hepatic dna damage,hepatic DNA damage
NEW14873,CHEMICAL,cp extract,CP extract
NEW14874,CHEBI,addition endocrine disruption,addition endocrine disruption
NEW14875,NUTRITION,female african catfish,female African catfish
NEW14876,CHEMICAL,subchronic cpf toxicity,subchronic CPF toxicity
NEW14877,CHEBI,increase growth hormone response,increased growth hormone response
NEW14878,NUTRITION,lithium antagonist,lithium antagonist
NEW14879,CHEMICAL,calcium antagonist,calcium antagonist
NEW14880,MENTAL_HEALTH,folate level,enuresis group
NEW14881,CHEBI,mean vitamin B(12,mean vitamin B(12
NEW14882,CHEMICAL,mean vitamin B(12,kavalactones
NEW14883,CHEMICAL,mean vitamin B(12,kava group
NEW14884,CHEMICAL,gas chromatography- mass spectroscopy,gas chromatography- mass spectroscopy
C035736,CHEMICAL,glutaric acid [Supplementary Concept],Glutarates|glutaric acid
NEW14885,DISEASE,urinary organic acid analysis,Urinary organic acid analysis
NEW14886,CHEBI,urinary organic acid analysis,D1 agonist features
NEW14887,CHEMICAL,chronic ethanol,chronic ethanol
NEW14888,CHEMICAL,histidine ligand,histidine ligands
NEW14889,DISEASE,histidine ligand,dose-limiting schedule-dependent CNS toxicity
NEW14890,CHEBI,histidine ligand,glutamine antagonist
NEW14891,DISEASE,recurrent malignant astrocytoma,recurrent malignant astrocytomas
NEW14892,DISEASE,recurrent malignant astrocytoma,malignant astrocytomas
C083585,CHEMICAL,"cholesteryl ester transfer protein inhibitor, baboon [Supplementary Concept]",Peptide Fragments|Apolipoproteins C|cholesteryl ester transfer protein inhibitor
NEW14893,NUTRITION,recurrent malignant astrocytoma,high-density lipoprotein HDL cholesterol
NEW14894,MENTAL_HEALTH,phase agitation,phase agitation
NEW14895,CHEMICAL,phase agitation,undecenoic acid
NEW14896,CHEMICAL,combined monophasic contraceptive,combined monophasic contraceptives
NEW14897,DISEASE,combined monophasic contraceptive,functional ovarian cysts
NEW14898,CHEMICAL,ovocept-ld,Ovocept-LD
NEW14899,CHEBI,gamma-aminobutyric acid-a gabaa receptor agonist alprazolam,gamma-aminobutyric acid-A GABAA receptor agonist alprazolam
NEW14900,DISEASE,gamma-aminobutyric acid-a gabaa receptor agonist alprazolam,greatest weight gain
NEW14901,DISEASE,gamma-aminobutyric acid-a gabaa receptor agonist alprazolam,fatal poisoning
NEW14902,CHEBI,tlr5 agonist,TLR5 agonist
NEW14903,DISEASE,nonadjuvante Tetanus Toxoid,nonadjuvanting Tetanus Toxoid
D004299,CHEMICAL,Dopamine beta-Hydroxylase,"Dopamine beta-Monooxygenase|beta-Monooxygenase, Dopamine|Dopamine beta Monooxygenase|dopamine β-hydroxylase|beta-Hydroxylase, Dopamine|Dopamine beta Hydroxylase"
NEW14904,DISEASE,cannabinoid hyperemesis syndrome,cyclic nausea
NEW14905,DISEASE,cannabinoid hyperemesis syndrome,Cannabinoid hyperemesis syndrome
NEW14906,CHEMICAL,cannabinoid hyperemesis syndrome,Tau oligomers
http://purl.obolibrary.org/obo/DOID_9976,CHEMICAL,heroin dependence,Crack-cocaine dependence
NEW14907,DISEASE,psychiatric problem,psychiatric problems
NEW14908,CHEMICAL,Nat Rev Drug Discov,Nat Rev Drug Discov
D013124,DISEASE,Spinal Injuries,"Injury, Spinal|spinal injury|Spinal Injury|Injuries, Spinal"
NEW14909,MENTAL_HEALTH,resistance bacteria,resistance bacteria
NEW14910,CHEMICAL,grow chloramphenicol,growing chloramphenicol
C533194,CHEMICAL,SiO2-CaO-P2O5-Ag2O [Supplementary Concept],Ag2O|Ceramics
NEW14911,CHEMICAL,mibg imaging,MIBG imaging
NEW14912,DISEASE,mibg imaging,various cardiac diseases
NEW14913,DISEASE,postoperative hypoventilation,postoperative hypoventilation
NEW14914,CHEMICAL,rvmat2,rVMAT2
NEW14915,NUTRITION,rvmat2,yeast vacuole
NEW14916,CHEMICAL,rvmat2,parkinsonian toxin 1-methyl-4-phenylpyridinium
D000167,CHEMICAL,Acriflavine,"2,8-Diamino-10-Methylacridinium Chloride Mixture With 2,8-Diaminoacridine|acriflavine|Xanthacridinum"
NEW14917,CHEMICAL,amino acid replacement,amino acid replacements
D000071421,DISEASE,Life History Traits,"Life History Characteristics|Strategy, Life History|Life History Strategy|Life History Variation|Life History Characteristic|Life History Strategies|Life History Trait|Strategies, Life History|traits|Life History Theory|Life History Variations"
D064106,MENTAL_HEALTH,Human Coprophagia,"Cecotrophy, Human|Coprophagy, Human|Human Cecotrophy|Human Coprophagy|Coprophagia, Human|coprophagia"
NEW14918,MENTAL_HEALTH,bipolar disorder effect,Bipolar disorder effects
NEW14919,DISEASE,bipolar disorder effect,leg abduction
NEW14920,DISEASE,bipolar disorder effect,spontaneous pain
NEW14921,CHEBI,primary stabilizer,primary stabilizer
NEW14922,DISEASE,mitochondrial lesion,mitochondrial lesions
NEW14923,CHEMICAL,dilinoleoyl specie,dilinoleoyl species|DLPC
NEW14924,DISEASE,dilinoleoyl specie,ethanol-induced septal fibrosis
NEW14925,DISEASE,significant depression,excretory calcinosis
NEW14926,CHEMICAL,significant depression,calcium storage disease
NEW14927,CHEMICAL,high-mg2,high-Mg2
NEW14928,MENTAL_HEALTH,high-mg2,gm9 synaptic depression
NEW14929,CHEMICAL,inhibitor phenelzine,inhibitors phenelzine
NEW14930,CHEMICAL,antidepressant maprotiline,antidepressants maprotiline
NEW14931,NUTRITION,lithium agent,lithium agents
NEW14932,CHEBI,serum drug concentration,serum drug concentrations
NEW14933,CHEBI,serum drug concentration,prophylactic drug therapy
NEW14934,MENTAL_HEALTH,machine regression,machine regression
NEW14935,NUTRITION,machine regression,urinary phenols
NEW14936,CHEMICAL,regression model,tertile(T2-T3)medium/high
NEW14937,CHEMICAL,lopinavir/ritonavir-based combination,lopinavir/ritonavir-based combination
NEW14938,DISEASE,lopinavir/ritonavir-based combination,transaminitis
NEW14939,DISEASE,lopinavir/ritonavir-based combination,more bradycardia
NEW14940,DISEASE,agitation-assisted extraction,AAE|Agitation-assisted extraction|Annurca Apple Polyphenolic Extract
NEW14941,CHEBI,tumor necrosis factor tnf antagonist infliximab,tumor necrosis factor TNF antagonist infliximab
NEW14942,MENTAL_HEALTH,tumor necrosis factor tnf antagonist infliximab,treatment-resistant major depression
NEW14943,DISEASE,high inflammation,high inflammation
NEW14944,CHEMICAL,high inflammation,ethanol abstinence syndrome
NEW14945,CHEMICAL,ethanol dependence phase,ethanol dependence phase
NEW14946,MENTAL_HEALTH,ethanol dependence phase,progressive severity hyperactivity
NEW14947,DISEASE,ethanol dependence phase,spastic rigidity
NEW14948,CHEMICAL,acetyl-l-carnitine treatment,Acetyl-L-carnitine treatment
NEW14949,CHEMICAL,acetyl-l-carnitine treatment,ethanol withdrawal syndrome
NEW14950,CHEMICAL,acetyl-l-carnitine treatment,ethanol intake
NEW14951,DISEASE,amenable,psychiatric inpatients
NEW14952,DISEASE,schizophrenia/schizoaffective disorder,schizophrenia/schizoaffective disorders
NEW14953,CHEMICAL,standardized coefficient=0.385 p=0.007,standardized coefficient=0.385 p=0.007
http://purl.obolibrary.org/obo/CHEBI_131587,CHEMICAL,12-ethyl-8-propyl-3-vinylbacteriochlorophyllide d,"{3-[(3S,4S)-9-ethenyl-18-ethyl-4,8,13-trimethyl-20-oxo-14-propylphorbin-3-yl-kappa(4)N(23),N(24),N(25),N(26)]propanoato(2-)}magnesium|prevalent-hypovitaminosis D"
D015090,CHEBI,25-Hydroxyvitamin D3 1-alpha-Hydroxylase,"Calcidiol 1 Monooxygenase|25-Hydroxyergocalciferol 1-alpha-Hydroxylase|Cytochrome P 450 CYP27B1|25 Hydroxyvitamin D3 1 alpha Hydroxylase|25-Hydroxyvitamin D(3) 1 alpha-Hydroxylase|CYP27B1|25-Hydroxyvitamin D2|25-Hydroxyvitamin D 1-alpha-Hydroxylase|Calcidiol 1-Monooxygenase|25OHD2|25-Hydroxycholecalciferol-1-Hydroxylase|calcidiol|25-Hydroxycholecalciferol 1-Hydroxylase|25-Hydroxyvitamin D2 1-hydroxylase|25 Hydroxyvitamin D2 1 hydroxylase|25 Hydroxycholecalciferol 1 Hydroxylase|1-hydroxylase, 25-Hydroxyvitamin D2|25 Hydroxyvitamin D 1 alpha Hydroxylase|1-alpha-Hydroxylase, 25-Hydroxyergocalciferol|25 Hydroxyergocalciferol 1 alpha Hydroxylase|1-alpha-Hydroxylase, 25-Hydroxyvitamin D|Cytochrome P-450 CYP27B1"
NEW14954,DISEASE,depressive patient,depressive men
NEW14955,DISEASE,direct oral anticoagulant,gas significant pulmonary irritant
NEW14956,CHEBI,acute ssri treatment,Acute SSRI treatment
NEW14957,DISEASE,death scene,death scene
NEW14958,CHEBI,death scene,multiple drug ingestion
NEW14959,DISEASE,death scene,Alzheimer's type
NEW14960,CHEMICAL,msa case,MSA cases
NEW14961,DISEASE,msa case,sleep-wake rhythm disorders
NEW14962,CHEBI,thorough endocrine evaluation,thorough endocrine evaluation
C412383,CHEMICAL,R 121919 [Supplementary Concept],R121919|Pyrimidines
NEW14963,CHEMICAL,ssri-tca combination,SSRI-TCA combination
NEW14964,DISEASE,ssri-tca combination,disturbed schizophrenic patients
NEW14965,CHEMICAL,ssri-tca combination,K variants
NEW14966,CHEMICAL,alpha-linolenic acid pathway,alpha-linolenic acid pathway
D003428,DISEASE,Cross Infection,"Hospital Infections|Health Care Associated Infection|Infections, Healthcare Associated|Hospital Infection|Infection, Cross|Infection, Nosocomial|Health Care Associated Infections|Infection, Healthcare Associated|nosocomial infections|Healthcare Associated Infections|Infections, Cross|Infections, Hospital|Nosocomial Infections|Infection, Hospital|Infections, Nosocomial|Nosocomial Infection|Cross Infections|Healthcare Associated Infection"
NEW14967,CHEBI,alpha-linolenic acid pathway,antibiotic overuse
NEW14968,DISEASE,alpha-linolenic acid pathway,multidrug-resistant P. aeruginosa
NEW14969,DISEASE,alpha-linolenic acid pathway,ESBL+ Enterobacteriaceae
D003091,CHEMICAL,Colistin,"|colistin|Sulfate, Colistin|Coly-Mycin|Colistin|Totazina|Colisticin|Colistin Sulfate|Colimycin|Polymyxin E"
NEW14970,CHEMICAL,methylprednisolone therapy,methylprednisolone therapies
NEW14971,DISEASE,methylprednisolone therapy,dysarthria urinary incontinence
NEW14972,DISEASE,thromboembolic event,thromboembolic event
D006850,DISEASE,"Hydrocephalus, Normal Pressure","normal pressure hydrocephalus|Hakim Syndrome|Syndromes, Hakim's|Hakim's Syndrome|Normal Pressure Hydrocephalus|Syndrome, Hakim|Syndrome, Hakim's|Hakim's Syndromes|hydrocephalus|Hakim Syndromes|Syndromes, Hakim|Hydrocephalus, Normal-Pressure|Hakims Syndrome|NPH (Normal Pressure Hydrocephalus)|NPHs (Normal Pressure Hydrocephalus)"
NEW14973,NUTRITION,phospholipid antibody,phospholipid antibodies
C034504,CHEMICAL,digoxin-like factors [Supplementary Concept],Saponins|Cardenolides|endogenous digoxin
D004286,CHEMICAL,Dolichols,"6,10,14,18,22,26,30,34,38,42,46,50,54,58,62,66,70,74,78-Octacontanonadecaen-1-ol, 3,7,11,15,19,23,27,31,35,39,43,47,51,55,59,63,67,71,75,79-eicosamethyl-|Dolichol|Eicosamethyl Octacontanonadecasen-1-ol|dolichols|Eicosamethyl Octacontanonadecasen 1 ol|Octacontanonadecasen-1-ol, Eicosamethyl"
C013785,CHEMICAL,4-amino-5-hexynoic acid [Supplementary Concept],Alkynes|Aminocaproates|gamma-acetylenic GABA
D009207,DISEASE,Myoclonus,"|Extremity Myoclonus, Upper|Simplex, Myoclonus|Upper Extremity Myoclonus|Myoclonus, Intention|Myoclonus, Oculopalatal|Myoclonus Simplex|Myoclonus, Eyelid|Intention Myoclonus|Myoclonus, Action|Myoclonus, Palatal|Extremity Myoclonus, Lower|Nocturnal Myoclonus|Myoclonic Jerks|Eyelid Myoclonus|Myoclonus, Segmental|Jerks, Myoclonic|Lower Extremity Myoclonus|Oculopalatal Myoclonus|myoclonus|myoclonic jerks|Myoclonus, Nocturnal|Sleep Myoclonus|Myoclonus, Lower Extremity|Jerk, Myoclonic|Myoclonic Jerking|Polymyoclonus|Jerking, Myoclonic|Myoclonus, Sleep|Myoclonus, Upper Extremity|Myoclonic Jerk|Segmental Myoclonus|Action Myoclonus|Palatal Myoclonus"
NEW14974,CHEMICAL,inhibitory neurotransmitter γ-aminobutyric acid,GABAuria
C535407,CHEMICAL,Gamma aminobutyric acid transaminase deficiency [Supplementary Concept],"GABA transaminase|Amino Acid Metabolism, Inborn Errors|4-Aminobutyrate Transaminase/deficiency"
NEW14975,CHEMICAL,sucrose tolerance,sucrose tolerance
NEW14976,MENTAL_HEALTH,sucrose tolerance,food compulsion related
NEW14977,CHEBI,d3 agonist therapy,D3 agonist therapy
NEW14978,MENTAL_HEALTH,d3 agonist therapy,behavioral syndromes
NEW14979,MENTAL_HEALTH,reversible somnolence,Reversible somnolence
NEW14980,CHEMICAL,reversible somnolence,arginine butyrate doses
NEW14981,DISEASE,folate b12 insufficiency,Folate B12 insufficiencies
NEW14982,CHEMICAL,tamarillo pvy isolate,tamarillo PVY isolates
NEW14983,DISEASE,tamarillo pvy isolate,naranjilla
NEW14984,CHEMICAL,tam17,Tam17
NEW14985,DISEASE,tam17,systemic infection
NEW14986,MENTAL_HEALTH,tam17,mild mood disorders
NEW14987,CHEMICAL,low oxygen consumption,Lower oxygen consumption
NEW14988,DISEASE,lactobacillus level,Lactobacillus levels
NEW14989,CHEMICAL,lactobacillus level,HCY levels
NEW14990,CHEBI,classical androgen,classical androgens
NEW14991,DISEASE,classical androgen,differentiated Simpson-Golabi-Behmel Syndrome
NEW14992,CHEBI,11-oxygenated androgen,11-oxygenated androgens
NEW14993,DISEASE,11-oxygenated androgen,hyperandrogenic profile
NEW14994,DISEASE,11-oxygenated androgen,long-term diet-induced obesity
NEW14995,DISEASE,11-oxygenated androgen,short-term diet-induced weight gain
NEW14996,MENTAL_HEALTH,11-oxygenated androgen,conclusion resistance
NEW14997,CHEMICAL,pcstat isoform,PcSTAT isoforms
NEW14998,DISEASE,pcstat isoform,WSSV infection
NEW14999,NUTRITION,crayfish group,crayfish groups
D012276,CHEMICAL,Ricin,"Ricin|Ricinus Lectin|Ricin D|Lectin, Castor Bean|Ricin Toxin|Toxin, Ricinus|Ricin B Chain|A Chain, Ricin|Castor Bean Lectin|Ricinus Toxin|RCA 60|B Chain, Ricin|Toxin, Ricin|RCA60|Ricin I|Ricin A Chain|Lectin, Ricinus"
NEW15000,MENTAL_HEALTH,crayfish group,significant heat resistance
NEW15001,MENTAL_HEALTH,crayfish group,inherited intellectual disability
NEW15002,DISEASE,pathological pain,pathological pain
NEW15003,DISEASE,pathological pain state,pathological pain states
NEW15004,CHEMICAL,delta9-thc antinociception,delta9-THC antinociception
NEW15005,CHEBI,cannabinoid analgesic system,cannabinoid analgesic system
NEW15006,DISEASE,cannabinoid analgesic system,intractable pathological pain syndromes
NEW15007,CHEBI,c(50 beta-cyclic carotenoid synthesis gene cluster,C(50 beta-cyclic carotenoid synthesis gene cluster
NEW15008,CHEMICAL,c(50 beta-cyclic carotenoid synthesis gene cluster,C(50 epsilon-cyclic carotenoids
C011431,CHEMICAL,decaprenoxanthin [Supplementary Concept],decaprenoxanthin|Xanthophylls
C000647321,DISEASE,Agromyces mediolanus [Supplementary Concept],Actinobacteria|Agromyces mediolanus
D048230,DISEASE,Corynebacterium glutamicum,Corynebacterium (1969-2004)|Corynebacterium glutamicum|Corynebacterium
D026082,CHEMICAL,Singlet Oxygen,"singlet oxygen|Dioxygen, Singlet|Oxygen, Singlet|Singlet Dioxygen"
D017261,NUTRITION,Glycosylphosphatidylinositols,"phospholipid membrane|Linkage, Glycosylphosphatidylinositol|Anchors, Glycosylphosphatidylinositol|Glycosyl-Phosphatidylinositol Membrane Protein Anchors|PI Glycan|Phosphatidylinositols, Glycosylated|Gly-PtdIns|Glycosyl Phosphatidylinositol|Phosphatidylinositol Glycan|Membrane Anchors, GPI|PI-Glycan|Membrane Anchor, GPI|Glycan, Phosphatidylinositol|GPI Membrane Anchor|Glycosylphosphatidylinositol Linkage|Glycosyl Phosphatidylinositol Membrane Protein Anchor|Glycosyl Phosphatidylinositol Membrane Protein Anchors|Anchor, Glycosylphosphatidylinositol|Glycosylphosphatidylinositol Anchors|Glycosylphosphatidylinositol|Glycosylated Phosphatidylinositol|Anchors, GPI Membrane|Glycosyl-Phosphatidylinositol|Phosphatidylinositol, Glycosylated|Glycoinositol Phospholipid Membrane Anchor|GPI Membrane Anchors|Glycosylated Phosphatidylinositols|Glycosylphosphatidylinositol Anchor|Glycosyl-Phosphatidylinositol Membrane Protein Anchor|Anchor, GPI Membrane"
NEW15009,DISEASE,otological vertigo,Otological vertigo
NEW15010,DISEASE,otological vertigo,bilateral vestibular paresis
D020338,DISEASE,Vestibular Neuronitis,"Epidemic Neurolabyrinthitis|Vestibular Nerve Neuritides|Recurrent Vestibulopathy|Epidemic Neurolabyrinthitides|Vertigos, Episodic Recurrent|Vestibular Neuritides|Neuronitis, Vestibular|Vestibulopathy, Acute Peripheral|Nerve Inflammation, Vestibular|Vestibulopathies, Acute Peripheral|Vestibular Neuropathy|Neuropathies, Vestibular|Subacute Vestibular Neuritis|Peripheral Vestibulopathies, Acute|Vestibular Nerve Inflammations|Neuritis, Acute Vestibular|Vestibular Neuritides, Subacute|Vestibular Neuritides, Acute|Vestibular Nerve Inflammation|Recurrent Vestibular Neuritis|Recurrent Vestibular Neuritides|Vestibulopathy, Recurrent|Episodic Recurrent Vertigo|Neuritis, Vestibular Nerve|Vestibular Neuritides, Recurrent|Vestibular Nerve Neuritis|Acute Vestibular Neuritides|Vestibular Neuronitides|Recurrent Vestibulopathies|Recurrent Vertigos, Episodic|Neuronitides, Vestibular|Neuritis, Vestibular|Subacute Vestibular Neuritides|Peripheral Vestibulopathy, Acute|Vestibulopathies, Recurrent|Episodic Recurrent Vertigos|Neuropathy, Vestibular|Neuritides, Vestibular Nerve|Acute Peripheral Vestibulopathy|Neurolabyrinthitis, Epidemic|Vestibular Neuritis, Acute|Inflammation, Vestibular Nerve|Neurolabyrinthitides, Epidemic|Acute Peripheral Vestibulopathies|Nerve Neuritides, Vestibular|Nerve Neuritis, Vestibular|Recurrent Vertigo, Episodic|Vestibular Neuritis|Vestibular Neuropathies|Neuritis, Subacute Vestibular|Acute Vestibular Neuritis|Nerve Inflammations, Vestibular|vestibular neuritis|Neuritides, Vestibular|Neuritis, Recurrent Vestibular|Neuritides, Acute Vestibular|Neuritides, Subacute Vestibular|Vestibular Neuritis, Recurrent|Neuritides, Recurrent Vestibular|Inflammations, Vestibular Nerve|Vestibular Neuritis, Subacute|Vertigo, Episodic Recurrent"
NEW15011,CHEMICAL,vestibular suppressant,vestibular suppressants
NEW15012,DISEASE,vestibular suppressant,migraine-associated vertigo
NEW15013,CHEBI,agent l-channel channel antagonist,agents L-channel channel antagonists
NEW15014,DISEASE,parkinsonian patient,parkinsonian patient
NEW15015,CHEMICAL,"3,4-dihydroxyphenylacetic acid/l-dopa","3,4-dihydroxyphenylacetic acid/L-dopa"
NEW15016,CHEMICAL,5-hydroxyindoleacetic acid,alpha-methyldopa hydrazine
NEW15017,DISEASE,5-hydroxyindoleacetic acid,Parkinsonian patients
NEW15018,DISEASE,subsequent death,subsequent death
NEW15019,CHEBI,subsequent death,composite MARTX toxin
NEW15020,CHEBI,primary vv virulence factor,primary Vv virulence factor
NEW15021,DISEASE,primary vv virulence factor,permanent neurologic impairment
NEW15022,CHEMICAL,oral benzodiazepine,Oral benzodiazepines
NEW15023,CHEMICAL,oral benzodiazepine,best-assessed drugs
NEW15024,CHEMICAL,oral benzodiazepine,oral benzodiazepine
NEW15025,DISEASE,tumor vasculature,tumor vasculature
NEW15026,DISEASE,tumor vasculature,tumor accumulation
NEW15027,CHEMICAL,hydroxide anion,hydroxide anion
NEW15028,CHEMICAL,hydroxide anion,pyridinium group
NEW15029,DISEASE,unintentional traumatic injury,unintentional traumatic injury
NEW15030,CHEBI,vitamin k2 deficiency,vitamin K2 deficiency
NEW15031,DISEASE,vitamin k2 deficiency,developmental malformations
NEW15032,DISEASE,vitamin k2 deficiency,neurobehavioral anomalies
D009466,CHEMICAL,Neuromuscular Blocking Agents,"Blocking Agents, Neuromuscular|Agent, Neuromuscular Blocking|Blocking Agent, Neuromuscular|Neuromuscular Blockers|Neuromuscular Blocking Agent|Neuromuscular Blocker|NMBs|Agents, Neuromuscular Blocking|Blockers, Neuromuscular|Blocker, Neuromuscular|Neuromuscular blockers"
D000077122,CHEMICAL,Sugammadex,Sugammadex|Bridion|6-Perdeoxy-6-per(2-carboxyethyl)thio-gamma-cyclodextrin sodium salt|Sugammadex Sodium|Org 25969
NEW15033,CHEMICAL,er hydrocodone,ER hydrocodone
NEW15034,DISEASE,er hydrocodone,non-cancer non-neuropathic chronic pain
NEW15035,DISEASE,coital dysfunction,Coital dysfunction
NEW15036,CHEMICAL,coital dysfunction,endocrine/neuro-endocrine
NEW15037,DISEASE,coital dysfunction,ejaculatory dysfunction
NEW15038,DISEASE,intracorporeal fibrosis,intracorporeal fibrosis
NEW15039,MENTAL_HEALTH,intracorporeal fibrosis,permanent post-RRP erectile dysfunction
NEW15040,CHEBI,intracorporeal fibrosis,primary sex hormone
NEW15041,CHEMICAL,gonadal steroid,Gonadal steroids
NEW15042,MENTAL_HEALTH,free testosterone,schizophrenia groups
NEW15043,MENTAL_HEALTH,mania group,mania group
NEW15044,MENTAL_HEALTH,mania group,schizophrenia group
NEW15045,CHEMICAL,free testosterone level,free testosterone level
NEW15046,MENTAL_HEALTH,input resistance peak,input resistance peak
NEW15047,NUTRITION,spanish acronym,Spanish acronym
NEW15048,CHEMICAL,spanish acronym,fortification
D009421,DISEASE,Nervous System Malformations,"Abnormalities, Nervous System|Malformation, Nervous System|Abnormality, Nervous System|Nervous System Abnormality|Nervous System Anomaly|Congenital Abnormalities, Nervous System|Nervous System Abnormalities|Nervous System Congenital Malformations|Congenital Malformations, Nervous System|Anomaly, Nervous System|Nervous System Anomalies|Congenital Malformations|Congenital Anomalies, Nervous System|Nervous System Congenital Abnormalities|Cranioschises|Nervous System Malformations, Congenital|Malformations, Nervous System|Malformations, Nervous System, Congenital|Nervous System Malformation|Anomalies, Nervous System|Abnormalities, Congenital, Nervous System|Cranioschisis"
NEW15049,CHEBI,folic acid supplementation,folic acid supplementation
NEW15050,CHEBI,early folic acid supplementation,early folic acid supplementation
NEW15051,DISEASE,serotonergic dysfunction,Serotonergic dysfunction
NEW15052,CHEMICAL,21-gene expression assay,21-gene expression assay
NEW15053,CHEBI,21-gene expression assay,oestrogen receptor (ER)-positive
NEW15054,CHEBI,active environmental friendly antimicrobial alternative,active environmental friendly antimicrobial alternatives
http://purl.obolibrary.org/obo/CHEBI_50853,CHEMICAL,quantum dot,point quantique|ZnO quantum dots|Quantenpunkt|punto cuantico|ZnO QDs|QD
NEW15055,CHEMICAL,ofin vitrotest,ofin vitrotests
NEW15056,NUTRITION,ofin vitrotest,higher median cholesterol
NEW15057,CHEMICAL,cask gene,CASK gene
NEW15058,CHEMICAL,cask gene,ethyl acetate fraction|EAF
NEW15059,MENTAL_HEALTH,oxidative stress dna fragmentation,oxidative stress DNA fragmentation
D007593,DISEASE,Joint Instability,"Laxity, Joint|Instabilities, Joint|Joint Instabilities|Joint Laxities|Laxities, Joint|Joint Laxity|Joint Hypermobilities|Joint Hypermobility|hypermobility|Instability, Joint|Hypermobility, Joint|Hypermobilities, Joint"
D019224,DISEASE,Temporomandibular Joint Disc,"Disc, Temporomandibular Articular|Articular Disk, Temporomandibular|Discs, Temporomandibular Joint|Disk, Temporomandibular Joint|Discs, Temporomandibular Articular|Articular Disc, Temporomandibular|TMJ|Disk, Temporomandibular Articular|Joint Discs, Temporomandibular|Temporomandibular Articular Disk|Temporomandibular Joint Disk|Articular Discs, Temporomandibular|temporomandibular joint|Disks, Temporomandibular Articular|Temporomandibular Joint Disks|Disks, Temporomandibular Joint|Temporomandibular Articular Discs|Temporomandibular Articular Disc|Joint Disk, Temporomandibular|Disc, Temporomandibular Joint|Joint Disks, Temporomandibular|Joint Disc, Temporomandibular|Temporomandibular Articular Disks|Articular Disks, Temporomandibular|Temporomandibular Joint Discs"
NEW15060,CHEMICAL,LIGER,LIGER
NEW15061,DISEASE,Genus Akkermansia,Genus Akkermansia
http://purl.obolibrary.org/obo/CHEBI_64584,CHEBI,uremic toxin,uremic toxin|uremic toxins
NEW15062,CHEBI,protein-bound uremic toxin,protein-bound uremic toxin
D040941,DISEASE,Heredity,Heredity
NEW15063,CHEMICAL,serotonin-norepinephrine reuptake inhibitor,serotonin-norepinephrine reuptake inhibitor
NEW15064,MENTAL_HEALTH,dose fatigue,dosing fatigue
http://purl.obolibrary.org/obo/DOID_13328,DISEASE,diabetic cataract,diabetic cataract|Cataract - diabetic
NEW15065,CHEMICAL,polyol pathway,polyol pathway
D013012,CHEMICAL,Sorbitol,sorbitol|Sorbilax|Medevac|Glucitol|Yal|klysma Sorbit
NEW15066,CHEMICAL,selenium vitamin e,selenium vitamin E
NEW15067,CHEMICAL,selenium vitamin e,SAM homeostasis
NEW15068,CHEBI,vitamin e status,vitamin E status
NEW15069,MENTAL_HEALTH,disorder intervention,disorder interventions
NEW15070,CHEMICAL,intermediate etoh concentration,Intermediate EtOH concentrations
D019706,CHEMICAL,Excitatory Postsynaptic Potentials,"Current, Excitatory Postsynaptic|EPSP|Postsynaptic Potential, Excitatory|End Plate Potentials|Excitatory Postsynaptic Potential|Plate Potential, End|excitatory postsynaptic currents|Potential, End Plate|Potentials, End Plate|Potentials, Excitatory Postsynaptic|Postsynaptic Currents, Excitatory|Plate Potentials, End|EPSCs|Excitatory Postsynaptic Current|Potential, Excitatory Postsynaptic|Excitatory Postsynaptic Currents|Postsynaptic Potentials, Excitatory|Currents, Excitatory Postsynaptic|Postsynaptic Current, Excitatory|End Plate Potential"
NEW15071,MENTAL_HEALTH,intermediate etoh concentration,membrane resistance
NEW15072,CHEMICAL,high etoh concentration,High EtOH concentrations
NEW15073,DISEASE,high etoh concentration,greater depressive effects
NEW15074,MENTAL_HEALTH,crayfish hyperactivity,crayfish hyperactivity
NEW15075,MENTAL_HEALTH,elevated cortisol level,psychosis subsequent onset
NEW15076,CHEMICAL,cortisol alteration,cortisol alterations
NEW15077,MENTAL_HEALTH,cortisol alteration,psychosis expression
NEW15078,CHEMICAL,cortisol stress measure,cortisol stress measures
D017152,CHEMICAL,"Antibodies, Antiphospholipid","Antibody, Antiphospholipid|Antiphospholipid Antibody|APLA|Antiphospholipid Antibodies|antiphospholipid antibodies"
NEW15079,DISEASE,cortisol stress measure,Attention Deficit/Hyperactive Disorder
NEW15080,DISEASE,cortisol stress measure,ureteral calculi expulsion
NEW15081,CHEMICAL,chr mrna,CHR mRNA
NEW15082,DISEASE,chr mrna,primary hypertension
NEW15083,MENTAL_HEALTH,chr mrna,PVN-RVLM projection neurons
NEW15084,NUTRITION,spanish preschool child,Spanish preschool children
NEW15085,MENTAL_HEALTH,tea consumption,anxiety biomarkers
NEW15086,CHEMICAL,amino-acid analogue tracer,amino-acid analogue tracers
NEW15087,DISEASE,amino-acid analogue tracer,brain gliomas
NEW15088,CHEMICAL,adult fluoxetine combination therapy,adults fluoxetine combination therapy
NEW15089,CHEMICAL,fixed-dose formulation,fixed-dose formulation
NEW15090,DISEASE,fixed-dose formulation,difficult-to-treat patient group
NEW15091,MENTAL_HEALTH,serotonergic agent,long-standing bulimia nervosa
http://purl.obolibrary.org/obo/CHEBI_9123,CHEMICAL,sertraline,"(+)-sertraline|(1S,4S)-sertraline|(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine|(1S-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|SSRIs sertaline|Sertraline|sertraline|cis-(+)-sertraline|sertralinum|CP 51974|sertralina"
NEW15092,DISEASE,psychiatric comorbid condition,psychiatric comorbid conditions
NEW15093,CHEMICAL,plasma amino acid,plasma amino acid
NEW15094,DISEASE,urinary organic acid profile,urinary organic acid profile
NEW15095,CHEBI,urinary organic acid profile,B1 thiamine deficiency
NEW15096,DISEASE,urinary organic acid profile,different neurological diseases
NEW15097,NUTRITION,anthocyanin-rich wheat,anthocyanin-rich wheat
D052684,DISEASE,Thyrotrophs,"TSH-Producing Cell, Pituitary|Cell, TSH|Pituitary TSH-Producing Cells|Thyrotroph|TSH|TSH-Secreting Cell, Pituitary|TSH Cells|Pituitary TSH-Secreting Cells|Pituitary TSH-Producing Cell|IST|TSH Cell|Pituitary TSH Producing Cells|Pituitary TSH-Secreting Cell|TSH-Secreting Cells, Pituitary|Pituitary TSH Secreting Cells|TSH-Producing Cells, Pituitary"
NEW15098,DISEASE,accidental poisoning,accidental poisoning
NEW15099,CHEBI,accidental poisoning,Paris Poison Centre
NEW15100,CHEBI,ec inverse agonist,EC inverse agonists
NEW15101,CHEMICAL,ec inverse agonist,CB1/2 receptors
C031927,CHEMICAL,hydroquinone [Supplementary Concept],hydroquinone|Hydroquinones|MBEH
NEW15102,DISEASE,ec inverse agonist,necrotic melanocyte death
http://purl.obolibrary.org/obo/CHEBI_77161,CHEBI,toll-like receptor 2 agonist,TLR 2 agonist|Toll-like receptor 2 agonists|Toll-like receptor agonist|TLR-2 agonists|TLR-2 agonist|Toll-like receptor-2 agonist|Toll-like receptor-2 agonists|TLR 2 agonists|Toll-like Receptor agonists
NEW15103,DISEASE,vitiligo patient,vitiligo patients
D000077271,CHEMICAL,Imiquimod,"S-26308|1-Isobutyl-1H-imidazo(4,5-c)quinolin-4-amine|R-837|Aldara|S 26308|imiquimod|R837|Zyclara|R 837"
NEW15104,CHEBI,endocrine factor,endocrine factors
NEW15105,MENTAL_HEALTH,endocrine factor,female sexual arousal disorder
NEW15106,NUTRITION,ω-6 fish oil fatty acid,ω-6 fish oil fatty acids
NEW15107,NUTRITION,acid consumption,acids consumption
NEW15108,NUTRITION,ficus sycomorus stem bark,Ficus sycomorus stem bark
NEW15109,CHEBI,tnf-α antagonist therapy,TNF-α antagonist therapy
NEW15110,DISEASE,tnf-α antagonist therapy,severe disseminated tuberculosis
NEW15111,DISEASE,tnf-α antagonist therapy,medical co-morbidities
NEW15112,CHEMICAL,ethanol metabolism,Ethanol metabolism
NEW15113,CHEMICAL,ethanol metabolism,antioxidant molecule glutathione
NEW15114,CHEBI,ethanol metabolism,antioxidant folic acid
NEW15115,NUTRITION,ethanol metabolism,poor folate
NEW15116,DISEASE,ethanol metabolism,preventable birth defects
D005563,CHEMICAL,Formic Acid Esters,"formic acid|Formate Esters|Esters, Formic Acid|Acid Esters, Formic|Esters, Formate"
NEW15117,DISEASE,ethanol metabolism,craniofacial defects
NEW15118,CHEMICAL,ethanol metabolism,prenatal alcohol exposure
NEW15119,DISEASE,ethanol exposure,retinal defects
NEW15120,DISEASE,ethanol exposure,nerve differentiation defects
NEW15121,DISEASE,ethanol exposure,ethanol-induced retinal defects
NEW15122,CHEMICAL,ethanol exposure,GABA system
NEW15123,DISEASE,mtf population,MtF populations
NEW15124,DISEASE,cerebral masculinization,cerebral masculinization
NEW15125,DISEASE,pattern daughter loss method,pattern Daughter Loss methods
NEW15126,CHEMICAL,pattern daughter loss method,"cyanidin-3-O-(3″,6″-dimalonyl-glucoside"
NEW15127,MENTAL_HEALTH,ms/ms fragmentation pattern,MS/MS fragmentation pattern
NEW15128,DISEASE,ect-induced acute hypercortisolemia,ECT-induced acute hypercortisolemia
D000073932,DISEASE,Food Addiction,"Compulsive Eating|Food Addictions|compulsive eating|Eating, Compulsive"
NEW15129,CHEBI,dopamine agonist withdrawal syndrome,drug cravings
NEW15130,DISEASE,dopamine agonist withdrawal syndrome,generalized pain
NEW15131,MENTAL_HEALTH,visceral analgesia,visceral analgesia
NEW15132,CHEMICAL,guanylate cyclase-c guanosine monophosphate agonist,Guanylate cyclase-C guanosine monophosphate agonists
NEW15133,DISEASE,guanylate cyclase-c guanosine monophosphate agonist,CIC|chronic idiopathic constipation
NEW15134,CHEBI,synthetic gc-c agonist,synthetic GC-C agonist
C584575,CHEMICAL,plecanatide [Supplementary Concept],Natriuretic Peptides|Plecanatide
D010528,DISEASE,Peristalsis,Peristalses|peristalsis
NEW15135,CHEBI,oral poison,oral poisons
NEW15136,DISEASE,oral poison,nauseas
D003085,DISEASE,Colic,"Abdominal Cramp|Colic, Infantile|Abdominal Cramps|abdominal cramps|Infantile Colic|Cramps, Abdominal|Cramp, Abdominal"
NEW15137,DISEASE,oral poison,painful spasms
NEW15138,DISEASE,oral poison,hormone-sensitive breast cancer
NEW15139,MENTAL_HEALTH,breast cancer patient,undiagnosed bipolar disorder
NEW15140,CHEMICAL,breast cancer patient,p<0.009
NEW15141,DISEASE,breast cancer patient,dopaminergic/opioidergic dysregulation
NEW15142,MENTAL_HEALTH,reward crave,reward craving
NEW15143,MENTAL_HEALTH,relief craving,relief craving
NEW15144,CHEMICAL,relief craving,gamma-aminobutyric acid (GABA)ergic/glutamatergic dysregulation
http://purl.obolibrary.org/obo/CHEBI_15939,CHEMICAL,glycyrrhizinic acid,"glycyrrhizic acid|Glycyrrhizic acid|30-hydroxy-11,30-dioxoolean-12-en-3beta-yl (2-O-beta-D-glucopyranosyluronic acid)-alpha-D-glucopyranosiduronic acid|Glycyrrhizin|Protocatechuic acids|(3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl-2-O-beta-D-glucopyranuronosyl-alpha-D-glucopyranosiduronic acid"
NEW15145,CHEMICAL,glp-1 system,GLP-1 system
NEW15146,DISEASE,glp-1 system,cognitive processing
NEW15147,CHEMICAL,glp-1r agonist liraglutide,GLP-1R agonist liraglutide|LIRA
NEW15148,DISEASE,glp-1r agonist liraglutide,working impairments
NEW15149,CHEMICAL,fo metabolite,FO metabolites
NEW15150,CHEMICAL,fo treatment,FO treatment
NEW15151,CHEMICAL,fo treatment,NAD exhaustion
NEW15152,CHEMICAL,fo treatment,glutamate accumulation
D051997,CHEMICAL,ADP-ribosyl Cyclase 1,"Cyclase 1, ADP-ribosyl|ADPR Cyclase T10|Cyclase CD38, ADPR|Lymphocyte Differentiation Antigen CD38|CD38 Antigen|1, ADP-ribosyl Cyclase|ADPR|Acute Lymphoblastic Leukemia Cells Antigen CD38|Antigen, T10|CD38, ADPR Cyclase|ADP ribosyl Cyclase 1|T10 Antigen|Cyclase T10, ADPR|ADPR Cyclase CD38|Antigens, CD38|CD38 Antigens|NIM-R5 Antigen|NIM R5 Antigen"
NEW15153,CHEBI,specific antibiotic group,specific antibiotic groups
C012589,CHEMICAL,trichostatin A [Supplementary Concept],Hydroxamic Acids|trichostatin A
NEW15154,CHEBI,specific antibiotic group,pure agonist
D018528,CHEMICAL,ATP-Binding Cassette Transporters,"ABC Transporters|Transporter, ABC|ATP Binding Cassette Transporter|Cassette Transporter, ATP-Binding|ABC Transporter|ATP Binding Cassette Transporters|Transporter, ATP-Binding Cassette|Transporters, ABC|ATP binding|ATP-Binding Cassette Transporter|Transporters, ATP-Binding Cassette"
NEW15155,CHEBI,specific antibiotic group,values antagonist [3H]glibenclamide
NEW15156,MENTAL_HEALTH,specific antibiotic group,low dissociation constant
NEW15157,DISEASE,arthritis symptom,arthritis symptoms
D008713,CHEMICAL,Methimazole,"Methymazol|Mercazol||Thiamazol Hexal|Thyrozol|Thiamazol Henning|1-Methyl-2-mercaptoimidazole|Tirodril|Mercazole|Merkazolil|Metisol|Thiamazole|Henning, Thiamazol|Thimazol|Tapazole|Methylmercaptoimidazole|Hexal, Thiamazol|Strumazol|Favistan|Mercasolyl|Tiamazol|Metizol|thiamazole|methimazole|Mercazolyl|Methizol|Methimazole|1 Methyl 2 mercaptoimidazole"
NEW15158,CHEBI,vitamin alternation,Vitamin alternations
NEW15159,MENTAL_HEALTH,vitamin level,persistent mental illness
NEW15160,CHEMICAL,potent dopamine receptor antagonistic antipsychotic,potent dopamine receptor antagonistic antipsychotics
NEW15161,CHEBI,partial receptor agonist,partial receptor agonist
NEW15162,CHEMICAL,single amino acid mutation,single amino acid mutation
NEW15163,DISEASE,single amino acid mutation,early-onset autosomal recessive Parkinson disease
NEW15164,CHEMICAL,histone deacetylase inhibitor phenylbutyrate,histone deacetylase inhibitor phenylbutyrate
NEW15165,CHEMICAL,histone deacetylase inhibitor phenylbutyrate,N27 dopamine cell line
NEW15166,CHEMICAL,phenylbutyrate treatment,phenylbutyrate treatment
NEW15167,CHEMICAL,phenylbutyrate treatment,"4-phenyl 1,2,3,6-tetrahydropyridine MPTP toxicity"
NEW15168,MENTAL_HEALTH,phenylbutyrate treatment,diffuse Lewy body disease α-synuclein aggregation
NEW15169,DISEASE,idiopathic overactive bladder,Idiopathic overactive bladder|OAB
C087371,CHEMICAL,"11beta,17alpha,21-trihydroxypregn-4-ene-20-one-3-(O-(N-propargyl)carbamoylmethyl)oxime hexacarbonyldicobalt [Supplementary Concept]",Organometallic Compounds|Hydrocortisone/analogs  and  derivatives|cort
NEW15170,DISEASE,vmpfc brain dysfunction,VmPFC brain dysfunction
C071482,CHEMICAL,calpeptin [Supplementary Concept],calpeptin|Dipeptides
NEW15171,DISEASE,axonal protein,axonal proteins
NEW15172,CHEMICAL,EtOH vapor inhalation,EtOH vapor inhalation
NEW15173,CHEMICAL,penicillin injection,penicillin injections
C003603,CHEMICAL,tiglylglycine [Supplementary Concept],tiglylglycine|Glycine/analogs  and  derivatives
NEW15174,DISEASE,penicillin injection,positive aminoacidemia
D000608,DISEASE,Renal Aminoacidurias,"Renal Aminoaciduria|Aminoacidurias, Renal|Aminoaciduria, Renal|aminoaciduria"
C064989,CHEMICAL,"2,3-di-O-acetylglyceroaldehyde-2,4-dinitrophenylhydrazone [Supplementary Concept]",Hydrazones|Diglycerides|dinitrophenylhydrazone
NEW15175,DISEASE,penicillin injection,pain system
NEW15176,DISEASE,chronic alcohol consumption,certain rheumatic diseases
NEW15177,DISEASE,analgesic property,fibromyalgia pain
NEW15178,CHEBI,lycopene concentration,lycopene concentration
NEW15179,CHEBI,maternal serum lycopene concentration,Maternal serum lycopene concentrations
NEW15180,NUTRITION,maternal serum lycopene concentration,p cis-lycopene
NEW15181,MENTAL_HEALTH,maternal serum lycopene concentration,morphine- analgesia
NEW15182,DISEASE,pallido-nigro-luysian atrophy,Pallido-nigro-luysian atrophy
NEW15183,DISEASE,pallido-nigro-luysian atrophy,rare neurodegenerative disorder
NEW15184,CHEBI,opiate agonist therapy,opiate agonist therapy
NEW15185,CHEBI,opiate agonist therapy,opiate agonist
D000083083,DISEASE,Laminopathies,"Disease, LMNA-Associated|Laminopathy|LMNA-Associated Disease|LMNA-Linked Diseases|Disease, LMNA-Linked|LMNA Linked Diseases|LMNA-Linked Disease|LMNA Associated Diseases|LMNA|LMNA-Associated Diseases"
D014898,DISEASE,Werner Syndrome,"Syndrome, Werner's|Syndrome, Werners|Progeria, Adult|Werner's Syndrome|Werners Syndrome|Adult Progeria|Adult Premature Aging Syndrome|Syndrome, Werner|Werner Syndrome"
NEW15186,DISEASE,opiate agonist therapy,familial lipodystrophy FPLD type
C507159,CHEMICAL,"WRN protein, Xenopus [Supplementary Concept]",Xenopus Proteins|Werner Syndrome Helicase|WRN
NEW15187,DISEASE,nucleoside reverse transcriptase inhibitor,HAART-associated lipodystrophy syndrome
NEW15188,DISEASE,nucleoside reverse transcriptase inhibitor,lipodystrophies lipodystrophy
NEW15189,CHEMICAL,cannabis constituent,Cannabis constituent
NEW15190,CHEMICAL,co-administration,co-administrations
NEW15191,MENTAL_HEALTH,suicide substrate,suicide substrates
NEW15192,CHEMICAL,suicide substrate,"7,8,4'-trihydroxyisoflavone"
NEW15193,CHEMICAL,suicide substrate,"5,7,8,4'-tetrahydroxyisoflavone"
NEW15194,MENTAL_HEALTH,suicide substrate,potent suicide substrates
NEW15195,NUTRITION,sonchus asper,Sonchus asper
NEW15196,DISEASE,chronic social defeat exposure,Chronic social defeat exposure
NEW15197,CHEMICAL,chronic social defeat exposure,VTA putative dopamine neurons
NEW15198,CHEMICAL,nonstimulant atomoxetine formulation,nonstimulants atomoxetine formulations
http://purl.obolibrary.org/obo/CHEBI_48295,CHEMICAL,alpha-methylserotonin,3-(2-aminopropyl)-1H-indol-5-ol|alpha-methyl-5-hydroxytryptamine|(+/-)-cyclazocine|m-chlorophenylpiperazine m-CPP|alpha-methyl-5-HT
NEW15199,DISEASE,reversible ph,reversible PH
NEW15200,DISEASE,stress-related psychiatric disorder,Stress-related psychiatric disorders
NEW15201,CHEMICAL,nonacetylated salicylate,nonacetylated salicylate
NEW15202,CHEMICAL,salsalate treatment,salsalate treatment
NEW15203,CHEMICAL,nuclear inhibitor salsalate,nuclear inhibitor salsalate
D020512,DISEASE,"Myopathy, Central Core","Central Core Disease of Muscle|Syndrome, Shy-Magee|Central Core Myopathy|Shy Magee Syndrome|Shy-Magee Syndrome|myopathy|Central Core Myopathies|Myopathies, Central Core|Central Core Diseases|Central Core Disease"
NEW15204,CHEMICAL,mifepristone treatment,oral potassium replacement
NEW15205,CHEMICAL,phenolic glycoside,phenolic glycosides
NEW15206,MENTAL_HEALTH,phenolic glycoside,unique fragmentation pattern
NEW15207,DISEASE,phenolic glycoside,chemo-therapeutics chronic disease
NEW15208,CHEMICAL,5-hydroxytryptamine 5-ht2 receptor antagonist,5-hydroxytryptamine 5-HT2 receptor antagonists
NEW15209,CHEMICAL,serum homocysteine level,Serum homocysteine level
NEW15210,CHEMICAL,hh signaling,Hh signaling
NEW15211,DISEASE,hh signaling,pancreatic neoplasia
C585734,CHEMICAL,SAHA-PIP-delta [Supplementary Concept],Pyrroles|Nylons|SAHA
NEW15212,CHEMICAL,hh signaling,Hh pathway activity
NEW15213,CHEMICAL,hh signaling,Ptc-1 mRNA expression
NEW15214,MENTAL_HEALTH,hh signaling,preoperative apprehension
C413749,CHEMICAL,"CRT-1 protein, Carybdea rastoni [Supplementary Concept]",Cnidarian Venoms|Proteins|CrTX-B
NEW15215,DISEASE,suspect acute coronary syndrome,suspected acute coronary syndrome
NEW15216,MENTAL_HEALTH,suspect acute coronary syndrome,disorder symptoms
NEW15217,CHEBI,beta blocker administration,beta blocker administration
C519562,CHEMICAL,imetelstat [Supplementary Concept],Oligonucleotides|GRN163L|imetelstat|Imetelstat
D013920,DISEASE,"Thrombocythemia, Essential","Thrombocytoses, Autosomal Dominant|Hemorrhagic Thrombocythemias|Thrombocythemias, Primary|Thrombocythemia, Primary|Autosomal Dominant Thrombocytoses|Thrombocythemias, Idiopathic|Dominant Thrombocytoses, Autosomal|Thrombocytoses, Primary|Essential Thrombocythemia|Idiopathic Thrombocythemia|Thrombocythemias, Hemorrhagic|Thrombocythemia, Hemorrhagic|Thrombocythemias, Essential|Hemorrhagic Thrombocythemia|Essential Thrombocythemias|Autosomal Dominant Thrombocytosis|Primary Thrombocythemias|Primary Thrombocytosis|Primary Thrombocythemia|Primary Thrombocytoses|Idiopathic Thrombocythemias|Dominant Thrombocytosis, Autosomal|essential thrombocythemia|Thrombocythemia, Idiopathic|Thrombocytosis, Primary|Thrombocytosis, Autosomal Dominant"
NEW15218,DISEASE,mood stabilizer,urgency incontinence
NEW15219,NUTRITION,pear Opuntia ficus-indica,pear Opuntia ficus-indica
NEW15220,DISEASE,brown alga Padina pavonica,brown alga Padina pavonica|EPP
NEW15221,NUTRITION,brown alga Padina pavonica,yeast mutant
D015060,CHEMICAL,"1,2-Dipalmitoylphosphatidylcholine","1,2 Dipalmitoyl Glycerophosphocholine|glycerophosphocholine|1,2-Dihexadecyl-sn-Glycerophosphocholine|Dipalmitoylglycerophosphocholine|1,2-Dipalmitoyl-Glycerophosphocholine|Dipalmitoyl Phosphatidylcholine|Dipalmitoyllecithin|1,2 Dipalmitoylphosphatidylcholine|Phosphatidylcholine, Dipalmitoyl|1,2 Dihexadecyl sn Glycerophosphocholine|Dipalmitoylphosphatidylcholine"
NEW15222,MENTAL_HEALTH,brown alga Padina pavonica,collision-induced dissociation ion
NEW15223,DISEASE,brown alga Padina pavonica,PTSD Symptom
NEW15224,CHEMICAL,often-potassium zinc deficiency,sevoflurane-anesthesia
NEW15225,NUTRITION,maternal folate intake,Maternal folate intake
NEW15226,DISEASE,maternal folate intake,childhood low prosocial behavior
NEW15227,CHEBI,maternal vitamin b6 intake,Maternal vitamin B6 intake
NEW15228,MENTAL_HEALTH,maternal vitamin b6 intake,childhood hyperactivity problems
NEW15229,DISEASE,maternal vitamin b6 intake,low prosocial behavior
D051765,CHEBI,Early Growth Response Transcription Factors,"EGR Transcription Factors|Transcription Factors, EGR|EGR|vitamin B2"
NEW15230,DISEASE,maternal vitamin b6 intake,gonorrheal infections
NEW15231,DISEASE,a. alata,A. alata
D034421,NUTRITION,Sus scrofa,"Domestic Pigs|Pig, Domestic|Wild Boars|Boars, Wild|wild boar|Domestic Pig|Boar, Wild|Wild Boar|Pigs, Domestic|Sus scrofa domestica"
NEW15232,CHEMICAL,catecholamine mobilization,catecholamine mobilization
NEW15233,DISEASE,catecholamine mobilization,significant haemoconcentration
D043583,CHEMICAL,Nucleoside-Triphosphatase,"Nucleoside Triphosphate Phosphohydrolase II|Nucleosidetriphosphatase|Nucleoside Triphosphate Phosphohydrolase|NTPase|nucleoside triphosphate|Nucleoside Triphosphatase|Nucleoside Triphosphate Phosphohydrolase I|Triphosphate Phosphohydrolase, Nucleoside|Triphosphatase, Nucleoside|Phosphohydrolase, Nucleoside Triphosphate"
NEW15234,CHEMICAL,catecholamine mobilization,NTP|RBC
NEW15235,MENTAL_HEALTH,catecholamine mobilization,flu-like syndromes
NEW15236,CHEMICAL,catecholamine mobilization,oseltamivir group
NEW15237,DISEASE,catecholamine mobilization,type A/H7N7 virus
D053243,CHEMICAL,Zanamivir,"Relenza|4 Guanidino Neu5Ac2en|4-Guanidino-2,4-Dideoxy-2,3-Didehydro-N-Acetylneuraminic Acid|4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic Acid|2,3-Didehydro-2,4-Dideoxy-4-Guanidino-N-Acetyl-D-Neuraminic Acid|4 Guanidino 2 Deoxy 2,3 Didehydro N Acetylneuraminic Acid|GG 167|GG167|GG-167|Zanamivir|5-Acetylamino-2,6-Anhydro-4-Guanidino-3,4,5-Trideoxy-D-Galacto-Non-Enoic Acid|Acid, 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic|4-Guanidino-Neu5Ac2en|2,3-Didehydro-2,4-Dideoxy-4-Guanidinyl-N-Acetylneuraminic Acid"
NEW15238,DISEASE,catecholamine mobilization,life-threatening bronchospasm
NEW15239,DISEASE,document infection,documented infections
C004262,CHEMICAL,pleuromutilin [Supplementary Concept],pleuromutilin|Diterpenes|Polycyclic Compounds
NEW15240,CHEMICAL,document infection,S-nucleophiles
NEW15241,CHEMICAL,background     pregabalin,Background    Pregabalin
NEW15242,CHEMICAL,piperazine h1-receptor antagonist,piperazine H1-receptor antagonist
NEW15243,CHEBI,insect hormone balance,insect hormone balance
C034808,CHEMICAL,ecdysteroid receptor [Supplementary Concept],"Receptors, Steroid|20-hydroxyecdysone"
NEW15244,DISEASE,hyperactive stage,hyperactive stage
NEW15245,CHEMICAL,dopamine da titer,dopamine DA titer
NEW15246,DISEASE,dopamine da titer,mock infection
NEW15247,CHEBI,akh hormone,AKH hormone
NEW15248,MENTAL_HEALTH,akh hormone,starvation-induced hyperactivity
C023166,CHEMICAL,pyroglutamyl-peptidase II [Supplementary Concept],Pyrrolidonecarboxylic Acid/analogs  and  derivatives|thyroliberin|Aminopeptidases
NEW15249,CHEBI,pituitary hormone secretion,pituitary hormone secretion
NEW15250,CHEBI,somatotropin secretion,somatotropin secretion
NEW15251,DISEASE,somatotropin secretion,reactive depressive patients
NEW15252,DISEASE,somatotropin secretion,endogenous depressive patients
NEW15253,CHEBI,somatotropin stimulation maximum,Somatotropin stimulation maxima
NEW15254,MENTAL_HEALTH,somatotropin stimulation maximum,endogenous depression reactive form
C070499,CHEMICAL,1-(1-phenyl-2-methylcyclohexyl)piperidine [Supplementary Concept],piperidine|TCP|Phencyclidine/analogs  and  derivatives
D014191,CHEMICAL,Tranylcypromine,"|tranylcypromine|trans-2-Phenylcyclopropylamine|Tranylcypromine|Jatrosom|trans 2 Phenylcyclopropylamine|Parnate|Transamine|Sulfate, Tranylcypromine|Tranylcypromine Sulfate"
NEW15255,DISEASE,hypertensive crisis,Hypertensive crisis
NEW15256,CHEMICAL,hypertensive crisis,dual serotonin
NEW15257,CHEMICAL,cyp1a2-ko mouse,Cyp1a2-KO mice
NEW15258,DISEASE,cyp1a2-ko mouse,DLX hepatoxicity
NEW15259,CHEMICAL,cyp1a2-ko mouse,Cyp1a2-mediated metabolism
NEW15260,NUTRITION,Delicious 's winter squash c. maximum,Delicious's winter squash C. maxima
NEW15261,MENTAL_HEALTH,Delicious 's winter squash c. maximum,age-related resistance
NEW15262,CHEMICAL,hand-pollinated fruit,Hand-pollinated fruit
NEW15263,DISEASE,hand-pollinated fruit,P. capsici
NEW15264,DISEASE,hand-pollinated fruit,physical abnormalities
NEW15265,DISEASE,fasd spectrum,FASD spectrum
NEW15266,CHEBI,fasd spectrum,nutraceutical treatment
NEW15267,CHEBI,current antifungal drug,Current antifungal drugs
NEW15268,CHEBI,current antifungal drug,new antifungal therapeutics
NEW15269,CHEBI,fungicide use,fungicide use
NEW15270,CHEMICAL,fungicide use,triazole resistance development
NEW15271,CHEBI,fungicide use,potent antifungal agents
http://purl.obolibrary.org/obo/CHEBI_32483,CHEMICAL,glutamic acid residue,glutamic acid residues|glutamyl|glutamic acid residue|glutamic residue
NEW15272,CHEBI,optimal peptide polymer,optimal peptide polymer
NEW15273,CHEMICAL,partial zwitterion,partial zwitterions
NEW15274,CHEMICAL,microm cch,microM CCh
NEW15275,MENTAL_HEALTH,microm cch,reversible depression
NEW15276,CHEBI,cholinergic antagonist scopolamine,cholinergic antagonist scopolamine
NEW15277,DISEASE,cholinergic antagonist scopolamine,oxotremorine-induced tremor
NEW15278,CHEMICAL,active cholinergic antagonist methscopolamine,active cholinergic antagonist methscopolamine
NEW15279,CHEMICAL,active cholinergic antagonist methscopolamine,chromocacryorrhea
NEW15280,CHEBI,folate-related b vitamin,folate-related B vitamins
NEW15281,DISEASE,vascular dysfunction,vascular dysfunction
NEW15282,CHEBI,vascular dysfunction,normal sex hormone profiles
NEW15283,DISEASE,vascular dysfunction,female HD mice relative
NEW15284,DISEASE,vascular dysfunction,female HD mice
NEW15285,CHEMICAL,ERβ agonist diarylpropionitrile,ERβ agonist diarylpropionitrile|DPN
NEW15286,DISEASE,ERβ agonist diarylpropionitrile,direct neurotoxic effects
NEW15287,CHEMICAL,dilute pilocarpine test,dilute pilocarpine test
NEW15288,DISEASE,dilute pilocarpine test,anhidrosis denervation hypersensitivity
NEW15289,CHEMICAL,neuroprotective steroid,neuroprotective steroids
NEW15290,DISEASE,neuroprotective steroid,mood pain modulation
NEW15291,CHEMICAL,intratracheal i.t hydrochloric acid 0.1n hcl instillation,intratracheal i.t hydrochloric acid 0.1N HCl instillation
NEW15292,CHEMICAL,intratracheal i.t hydrochloric acid 0.1n hcl instillation,mg/kg i.t
NEW15293,CHEMICAL,intratracheal i.t hydrochloric acid 0.1n hcl instillation,selective serotonin reuptake blockers
NEW15294,CHEMICAL,intratracheal i.t hydrochloric acid 0.1n hcl instillation,β-catenin-activated HCA
NEW15295,MENTAL_HEALTH,intratracheal i.t hydrochloric acid 0.1n hcl instillation,frequent sleep disorder
NEW15296,MENTAL_HEALTH,intratracheal i.t hydrochloric acid 0.1n hcl instillation,anxious apprehension R(2 =
NEW15297,CHEMICAL,grin2-variant patient alteration,GRIN2-variant patients alterations
NEW15298,DISEASE,nmdar-dependent audiogenic seizure due,NMDAR-dependent audiogenic seizures due
NEW15299,DISEASE,glun2b disease-causing mutation,GluN2B disease-causing mutations
NEW15300,CHEBI,broccoli c,broccoli C
NEW15301,DISEASE,brain infarct area,Brain infarct area
NEW15302,CHEMICAL,brain infarct area,TNF-α mRNA
D015853,CHEMICAL,Cysteine Proteinase Inhibitors,"alpha-Cysteine Protease Inhibitor|Inhibitor, Cysteine Proteinase|Protease Inhibitor, Cysteine|Inhibitors, Cysteine Protease|Acid Cysteine Proteinase Inhibitor|Inhibitors, alpha-Cysteine Protease|Protease Inhibitor, alpha-Cysteine|Acid Cysteine Proteinase Inhibitors|Cysteine Protease Inhibitors|Proteinase Inhibitor, Cysteine|Cysteine Proteinase Antagonist|Cysteine Proteinase Inhibitor|Inhibitor, Cysteine Protease|alpha Cysteine Protease Inhibitor|Proteinase Antagonist, Cysteine|Cysteine Proteinase Inhibitors, Endogenous|Cysteine Proteinase Inhibitors, Exogenous|Inhibitors, Cysteine Proteinase|alpha-Cysteine Protease Inhibitors|Protease Inhibitors, Cysteine|Inhibitor, alpha-Cysteine Protease|alpha Cysteine Protease Inhibitors|Proteinase Inhibitors, Cysteine|Proteinase Antagonists, Cysteine|Cysteine Proteinase Antagonists|Antagonists, Cysteine Proteinase|Protease Inhibitors, alpha-Cysteine|Cysteine Protease Inhibitor|Antagonist, Cysteine Proteinase|cysteine Proteinase"
D023582,DISEASE,Alzheimer Vaccines,"Vaccines, Alzheimer|Alzheimer"
NEW15303,CHEBI,brain infarct area,fewer drug interactions
D029686,CHEMICAL,Lepidium,"meyenii, Lepidium|Macas|Lepidium meyenius|maca|Lepidium meyenii|WFWRM|Lepidiums|Maca"
NEW15304,MENTAL_HEALTH,brain infarct area,fatigue model
D000084882,DISEASE,Developmental Disability Nursing,"Developmental Disability Nursings|Disability Nursing, Developmental|developmental disability|Nursing, Developmental Disability"
NEW15305,CHEMICAL,dietary nitrate,dietary nitrate
NEW15306,DISEASE,dietary nitrate,severe cardiac diseases
NEW15307,CHEBI,dietary nitrate,opioid drug
NEW15308,DISEASE,dietary nitrate,mixed-mechanism opioid
NEW15309,DISEASE,dietary nitrate,postoperative pain management
NEW15310,MENTAL_HEALTH,epidural local analgesia,epidural local analgesia
NEW15311,DISEASE,epidural local analgesia,perioperative pain management
NEW15312,MENTAL_HEALTH,traditional antidepressant,hyperactivity symptomatology
NEW15313,DISEASE,traditional antidepressant,(ECT)-induced memory impairment
C068830,DISEASE,antithrombin III Hamilton [Supplementary Concept],Hamilton|Antithrombin III
NEW15314,NUTRITION,traditional antidepressant,important freshwater fish
NEW15315,DISEASE,clupisoma garua,Clupisoma garua
NEW15316,CHEMICAL,clupisoma garua,sufentanil group
NEW15317,CHEMICAL,clupisoma garua,fentanyl group
NEW15318,CHEMICAL,toxin gene,ST CC isolates
NEW15319,CHEMICAL,toxin gene,human adapted ST CC
NEW15320,DISEASE,toxin gene,S. aureus lineages
C573540,CHEMICAL,N-(N-benzoyl-O-(2-dimethylaminoethyl)tyrosyl)phenylalaninol [Supplementary Concept],Dipeptides|Benzamides|Bentysrepinine
NEW15321,DISEASE,toxin gene,hepatitis B virus (HBV)-infected hepatitis
NEW15322,CHEMICAL,repensine,repensine
NEW15323,DISEASE,c. australi,C. australis
NEW15324,CHEMICAL,c. australi,similar leaf gas exchange
NEW15325,CHEBI,β-adrenoreceptor blocking drug β-blocker prescription,β-adrenoreceptor blocking drug β-blocker prescription
NEW15326,DISEASE,β-adrenoreceptor blocking drug β-blocker prescription,knee hip osteoarthritis
NEW15327,DISEASE,central pain pathway,central pain pathways
NEW15328,DISEASE,central pain pathway,human mechanistic pain biomarkers
NEW15329,DISEASE,central pain pathway,chronic pain conditions
NEW15330,DISEASE,cuff pressure pain stimulation,Cuff pressure pain stimulation
NEW15331,DISEASE,cuff pressure pain stimulation,pain detection
NEW15332,DISEASE,cuff pressure pain stimulation,pain tolerance
NEW15333,CHEBI,implication analgesic effect,Implications Analgesic effects
NEW15334,DISEASE,implication analgesic effect,clinical pain populations
C502407,CHEMICAL,SSR125543 [Supplementary Concept],"SSR125543|Thiazines|Hydrocarbons, Halogenated"
NEW15335,CHEMICAL,abnormal fatty acid metabolism,FADS1 C/C
NEW15336,MENTAL_HEALTH,thermal resistance,thermal resistance
NEW15337,NUTRITION,thermal resistance,seal neonates
NEW15338,CHEBI,intraseptal muscarinic agonist,Intraseptal muscarinic agonists
C538669,DISEASE,Alcohol induced encephalopathy [Supplementary Concept],amnesic syndrome|Alcohol Amnestic Disorder
D032383,DISEASE,"Myocytes, Cardiac","Cell, Cardiac Muscle|Myocyte, Cardiac|Cardiomyocyte|Cardiac Myocyte|cardiac muscle|Cells, Heart Muscle|Heart Muscle Cells|Heart Muscle Cell|Muscle Cell, Cardiac|Cardiac Muscle Cell|Cardiac Myocytes|Muscle Cell, Heart|Muscle Cells, Heart|Cell, Heart Muscle|Cells, Cardiac Muscle|Cardiac Muscle Cells|Muscle Cells, Cardiac|Cardiomyocytes"
D019001,CHEMICAL,Nitric Oxide Synthase,"NO synthase|Synthase, Nitric Oxide|Nitric-Oxide Synthase|Oxide Synthase, Nitric|NO Synthase|Nitric-Oxide Synthetase|Nitric Oxide Synthetase"
NEW15339,DISEASE,intraseptal muscarinic agonist,contractile dysfunction characteristic
NEW15340,CHEMICAL,hip fracture,Hip fracture
NEW15341,DISEASE,hip fracture,hip fracture
C560743,CHEMICAL,menatetrenone epoxide [Supplementary Concept],MK-4|Epoxy Compounds|Vitamin K 2/analogs  and  derivatives
NEW15342,DISEASE,hip fracture,nonvertebral fractures
NEW15343,CHEMICAL,calcium supplement,calcium supplements
NEW15344,DISEASE,calcium supplement,high baseline fracture risk
NEW15345,DISEASE,calcium supplement,advanced colorectal cancer
NEW15346,CHEMICAL,calcium supplement,deoxyuridine triphosphatase
NEW15347,DISEASE,calcium supplement,p53-proficient colorectal cancer cell line HCT116 expression
C019396,CHEMICAL,formyltetrahydrofolate dehydrogenase [Supplementary Concept],10-Formyltetrahydrofolate dehydrogenase|10-formyltetrahydrofolate|Oxidoreductases Acting on CH-NH Group Donors
NEW15348,CHEMICAL,children-between year,children-between years
NEW15349,CHEMICAL,children-between year,P-5'-P
C587667,DISEASE,"GHET1 transcript, human [Supplementary Concept]","gastric carcinoma|RNA, Long Noncoding"
NEW15350,CHEMICAL,eserine sulfate,Eserine sulfate
NEW15351,CHEMICAL,ginger constituent,Ginger constituents
NEW15352,DISEASE,ginger constituent,cell cycle/DNA damage
NEW15353,CHEMICAL,estrogenic terpene,estrogenic terpenes
NEW15354,MENTAL_HEALTH,estrogenic terpene,menopausal syndromes
NEW15355,CHEBI,estrogenic terpene,endocrine toxicity/reproductive dysfunction
NEW15356,DISEASE,depressive state state,depressive state state
NEW15357,DISEASE,manic mood neuronal excitability,manic mood neuronal excitability
C420132,CHEMICAL,potassium channel subfamily K member 3 [Supplementary Concept],"K+ channel|Nerve Tissue Proteins|Potassium Channels, Tandem Pore Domain"
NEW15358,DISEASE,cancer patient,Cancer patients
D060831,DISEASE,Hand-Foot Syndrome,"|Chemotherapy Induced Acral Erythema|Chemotherapy-Induced Acral Erythemas|Chemotherapy Induced Palmoplantar Erythrodysesthesia|hand-foot syndrome|Palmoplantar Erythrodysesthesia, Chemotherapy-Induced|Syndromes, Hand-Foot|Syndrome, Hand-Foot|Acral Erythema, Chemotherapy-Induced|Hand Foot Syndrome|HFS|Chemotherapy-Induced Palmoplantar Erythrodysesthesia|Hand-Foot Syndromes|Chemotherapy-Induced Acral Erythema|Chemotherapy-Induced Palmoplantar Erythrodysesthesias|Acral Erythemas, Chemotherapy-Induced|Palmoplantar Erythrodysesthesias, Chemotherapy-Induced"
NEW15359,DISEASE,cancer patient,palmar-plantar erythrodysesthesia
NEW15360,CHEMICAL,background cisplatin/5-fluorouracil therapy,BACKGROUND Cisplatin/5-fluorouracil therapy
NEW15361,DISEASE,background cisplatin/5-fluorouracil therapy,unresectable esophageal cancer
NEW15362,CHEMICAL,cisplatin-based chemotherapy,Cisplatin-based chemotherapy
NEW15363,DISEASE,advanced esophageal cancer,advanced esophageal cancer
NEW15364,CHEMICAL,advanced esophageal cancer,cisplatin/5-fluorouracil therapy
C536164,DISEASE,Keratosis palmoplantaris with esophageal cancer [Supplementary Concept],"Keratoderma, Palmoplantar|esophageal cancer|Esophageal Neoplasms"
NEW15365,CHEMICAL,inadequate antidiuretic hormone secretion,colchicine exposure
NEW15366,CHEBI,lycopene administration,lycopene administration
NEW15367,MENTAL_HEALTH,lycopene administration,haloperidol-induced orofacial dyskinesia special therapeutic effects
D004834,DISEASE,"Epilepsy, Post-Traumatic","Late Post Traumatic Seizures|Seizure, Early Post-Traumatic|Seizure Disorder, Post Traumatic|Disorder, Post-Traumatic Seizure|Post-Traumatic Seizure, Late|Convulsion, Concussive|Epilepsies, Traumatic|Late Post-Traumatic Seizures|Late Post-Traumatic Seizure|Post Traumatic Seizure Disorder|Epilepsy, Traumatic|Early Post-Traumatic Seizures|Post-Traumatic Seizures, Late|Impact Seizure|Seizure Disorder, Post-Traumatic|Early Post Traumatic Seizures|Post-Traumatic Seizure Disorder|Post-traumatic seizures|Post-Traumatic Epilepsies|Convulsions, Concussive|Seizure, Late Post-Traumatic|Seizures, Late Post-Traumatic|Disorders, Post-Traumatic Seizure|Concussive Convulsion|Traumatic Epilepsies|Post-Traumatic Seizure, Early|Impact Seizures|Traumatic Epilepsy|Post-Traumatic Seizures, Early|Seizure Disorders, Post-Traumatic|Post-Traumatic Seizure Disorders|Epilepsies, Post-Traumatic|Concussive Convulsions|Post-Traumatic Epilepsy|Epilepsy, Post Traumatic|Early Post-Traumatic Seizure|Seizures, Early Post-Traumatic"
NEW15368,DISEASE,lycopene administration,TBI individuals
NEW15369,CHEMICAL,purmorphamine treatment,purmorphamine treatment
C470893,CHEMICAL,purmorphamine [Supplementary Concept],purmorphamine|Morpholines|Purines
NEW15370,DISEASE,purmorphamine treatment,TBI fish
NEW15371,DISEASE,tbi phenotype,TBI phenotypes
C542465,CHEMICAL,3-keto-N-aminoethylaminoethylcaproyldihydrocinnamoyl cyclopamine [Supplementary Concept],Veratrum Alkaloids|cyclopamine|Cinnamates
NEW15372,CHEMICAL,water-soluble diacyl arsenosugar phospholipid,Water-soluble diacyl arsenosugar phospholipids|As-PL
C000433,CHEMICAL,3-chloroperbenzoic acid [Supplementary Concept],Chlorobenzoates|meta-chloroperoxybenzoic acid
NEW15373,NUTRITION,water-soluble diacyl arsenosugar phospholipid,extracellular fatty acids
NEW15374,DISEASE,high neuroticism,higher neuroticism
NEW15375,DISEASE,high neuroticism,gaming addiction
NEW15376,CHEMICAL,high neuroticism,β=0.06
NEW15377,CHEMICAL,high neuroticism,p<0.05
NEW15378,NUTRITION,methionine restriction,methionine restriction
NEW15379,DISEASE,higher-fat diet,higher-fat diets
NEW15380,CHEMICAL,higher-fat diet,low HDL-cholesterol concentration
NEW15381,NUTRITION,red onion,Red onion
NEW15382,CHEMICAL,red onion,highest AOA
NEW15383,CHEMICAL,carbon onion,carbon onions
NEW15384,CHEMICAL,carbon onion,isopropanol alcohol
NEW15385,MENTAL_HEALTH,carbon onion,ultrasonic agitation
C047505,CHEMICAL,R 59022 [Supplementary Concept],Pyrimidinones|R59022|Thiazoles
NEW15386,DISEASE,carbon onion,cancer cell death
NEW15387,MENTAL_HEALTH,carbon onion,schizophrenia substance dependence
C095370,CHEMICAL,3-methyl-8-(2-deoxyribofuranosyl)isoxanthopterin [Supplementary Concept],isoxanthopterin|Deoxyguanosine/analogs  and  derivatives|Xanthopterin/analogs  and  derivatives
NEW15388,DISEASE,carbon onion,crustacean eye
NEW15389,CHEMICAL,serotonin reuptake blocker,Serotonin reuptake blockers
NEW15390,DISEASE,serotonin reuptake blocker,paraphilic disturbances
NEW15391,DISEASE,serotonin reuptake blocker,sexual obsessions
NEW15392,DISEASE,serotonin reuptake blocker,compulsions
NEW15393,CHEBI,androgen receptor blockade,androgen receptor blockade
NEW15394,DISEASE,androgen receptor blockade,tic symptoms
D005485,CHEMICAL,Flutamide,|PMS Flutamide|Flutamide|Flutacell|ApoFlutamide|Grisetin|Eulexine|NovoFlutamide|Cytamid|PMS-Flutamide|Fluta-cell|Flutandrona|Flutaplex|Fluken|Fluta GRY|Novo Flutamide|SCH 13521|Niftolide|Drogenil|Flutexin|Flulem|Eulexin|Oncosal|Testotard|Niftolid|Flumid|Fluta-GRY|Chimax|Euflex|Apo-Flutamide|Apo Flutamide|FlutaGRY|Prostogenat|Prostica|SCH13521|Fluta cell|SCH-13521|Flutamin|Fluta 1A Pharma|Prostacur|Fugerel|Novo-Flutamide|flutamide|Apimid
NEW15395,DISEASE,androgen receptor blockade,tic symptom severity
NEW15396,DISEASE,lid nasal gel,LID nasal gel
NEW15397,CHEMICAL,lid nasal gel,HPMC|hydroxypropyl methyl cellulose
D001408,DISEASE,Bacillus anthracis,Bacillus anthracis
D011808,CHEMICAL,Quinone Reductases,"Reductases, Menaquinone|menaquinone|Menaquinone Reductases|Reductases, Quinone"
NEW15398,MENTAL_HEALTH,lid nasal gel,greater craving
NEW15399,CHEMICAL,receptor protein tyrosine phosphatase β/ζ,receptor protein tyrosine phosphatase β/ζ
C514862,DISEASE,"Akt1 protein, mouse [Supplementary Concept]",thymoma viral proto-oncogene|Proto-Oncogene Proteins c-akt
NEW15400,CHEMICAL,synergistic photo-chemotherapy,Synergistic photo-chemotherapy
NEW15401,DISEASE,synergistic photo-chemotherapy,promising cancer treatment
NEW15402,CHEMICAL,dopac level,DOPAC levels
NEW15403,CHEBI,safe antimicrobial peptide,safe antimicrobial peptide
NEW15404,CHEBI,safe antimicrobial peptide,food preservative
NEW15405,CHEMICAL,IMPORTANCE Nisin,IMPORTANCE Nisin
NEW15406,CHEMICAL,IMPORTANCE Nisin,selective serotonin reuptake inhibitor fluoxetine
C489810,CHEMICAL,"type 2A protein serine-threonine phosphatase 55 kDa B, Arabidopsis [Supplementary Concept]",SMAPs|Arabidopsis Proteins|Protein Phosphatase 2|PP2A
NEW15407,DISEASE,IMPORTANCE Nisin,tumor suppression
NEW15408,DISEASE,IMPORTANCE Nisin,hyperactive protein translation
NEW15409,MENTAL_HEALTH,IMPORTANCE Nisin,particular dissociation kinetics
NEW15410,MENTAL_HEALTH,opioid-induced respiratory depression,Opioid-induced respiratory depression
NEW15411,CHEBI,opioid-induced respiratory depression,opioid receptor antagonist naloxone
NEW15412,CHEMICAL,opioid-induced respiratory depression,continuous naloxone infusion
NEW15413,CHEMICAL,opioid-induced respiratory depression,single naloxone dose
NEW15414,CHEMICAL,diazeniumdiolate amidine,diazeniumdiolated amidines
NEW15415,CHEMICAL,diazeniumdiolate amidine,useful NO donor compounds
D000077212,CHEMICAL,Ropivacaine,"AL381|Ropivacaine Monohydrochloride, (S)-isomer|ropivacaine|Ropivacaine Monohydrochloride|1-Propyl-2',6'-pipecoloxylidide|LEA103|1 Propyl 2',6' pipecoloxylidide|Naropin|Naropeine|AL-381|AL 381|LEA 103|LEA-103|Ropivacaine Hydrochloride"
NEW15416,DISEASE,[3h]rauwolscine,peripheral nerve catheters
C084825,CHEMICAL,thioproperazine [Supplementary Concept],thioproperazine|Thioproperazine|Phenothiazines
D006591,CHEMICAL,Hexobarbital,"Hexenal|Evipan|Hexobarbital, Sodium|Sodium Hexobarbital|hexobarbitone|Hexobarbitone"
NEW15417,DISEASE,[3h]rauwolscine,experimental catatonia
NEW15418,DISEASE,alcoholic liver injury,Alcoholic liver injury
NEW15419,CHEMICAL,alcoholic liver injury,long-term excessive alcohol consumption
NEW15420,CHEBI,mitochondrial dysfunction,riboflavin supplementation
NEW15421,CHEMICAL,skf injection,SKF injection
NEW15422,CHEMICAL,significant xanthine oxidase inhibition,significant xanthine oxidase inhibition
C496347,CHEMICAL,"DHC-1, herbal formulation [Supplementary Concept]",herbal formulation|Urinil B|Plant Extracts
D033461,DISEASE,Hyperuricemia,hyperuricemia|Uric Acid (1963-2002)
NEW15423,DISEASE,significant xanthine oxidase inhibition,visceral hypersensitivity
NEW15424,DISEASE,significant xanthine oxidase inhibition,visceral pain perception
NEW15425,DISEASE,significant xanthine oxidase inhibition,recurrent wheezing
NEW15426,CHEMICAL,5-ht network,5-HT network
NEW15427,MENTAL_HEALTH,5-ht network,interferon (IFN)-induced depression
NEW15428,CHEMICAL,increase serum triglyceride level,Increased serum triglyceride levels
NEW15429,DISEASE,er-positive breast cancer cell,ER-positive breast cancer cells
NEW15430,CHEMICAL,nmda glutamatergic neurotransmission,NMDA glutamatergic neurotransmission
NEW15431,CHEBI,uncompetitive nmda receptor antagonist,uncompetitive NMDA receptor antagonist
NEW15432,CHEMICAL,drug-induced parkinsonism,DIP|Drug-induced parkinsonism
NEW15433,DISEASE,drug-induced parkinsonism,akinetic rigid syndrome
NEW15434,DISEASE,drug-induced parkinsonism,psychiatric patients drugs
NEW15435,CHEBI,drug-induced parkinsonism,causative drug
NEW15436,DISEASE,drug-induced parkinsonism,persistent parkinsonism
NEW15437,CHEMICAL,irreversible dip,Irreversible DIP
NEW15438,DISEASE,irreversible dip,presymptomatic parkinsonian deficit
D014190,MENTAL_HEALTH,Transvestism,"Fetishism, Transvestic|Transvestic Fetishism|Transvestic Fetishisms|Fetishisms, Transvestic|Transvestisms|transvestism"
NEW15439,DISEASE,bona endometrial precancer,bona endometrial precancers
NEW15440,CHEBI,bona endometrial precancer,endogenous hormones
NEW15441,MENTAL_HEALTH,bona endometrial precancer,specimen fragmentation
NEW15442,DISEASE,hair loss prevention,hair loss prevention
NEW15443,CHEMICAL,VitD. current study,VitD. Current studies
NEW15444,DISEASE,escherichia coli mastitis,Escherichia coli mastitis
NEW15445,NUTRITION,escherichia coli mastitis,dairy cattle
C089242,CHEMICAL,"S100A7 protein, human [Supplementary Concept]",Psoriasin|S100 Calcium Binding Protein A7
NEW15446,MENTAL_HEALTH,escherichia coli mastitis,local host defense mechanism
NEW15447,DISEASE,genital staphylococcal infection,genital staphylococcal infections
NEW15448,CHEBI,gaseous antigen,gaseous antigen
NEW15449,CHEMICAL,gaseous antigen,oxygen contact
NEW15450,DISEASE,hyper-sensitivity,hyper-sensitivity
C095252,CHEMICAL,A'-neogammacer-22(29)-en-3-ol [Supplementary Concept],DYRK1A|A|Triterpenes
NEW15451,DISEASE,hyper-sensitivity,human nervous system diseases
NEW15452,CHEMICAL,elevated homocysteine concentration,elevated homocysteine concentrations
D062966,CHEMICAL,Ozone Depletion,"Layer Depletion, Ozone|Holes, Ozone|Hole, Ozone|Depletion, Ozone Layer|Ozone Holes|Ozone Layer Depletion|ozone|Depletion, Ozone|Ozone Hole"
NEW15453,MENTAL_HEALTH,alcohol abuser,anticipatory stable conditioned response
NEW15454,MENTAL_HEALTH,alcohol abuser,aversive conditioned response
NEW15455,DISEASE,alcohol abuser,rare autoimmune disease
NEW15456,DISEASE,alcohol abuser,bodyweight loss
NEW15457,CHEMICAL,alcohol abuser,glucose level
NEW15458,DISEASE,alcohol abuser,disorder level rise
NEW15459,MENTAL_HEALTH,alcohol abuser,cycle mechanism
NEW15460,DISEASE,alcohol abuser,micronutrient deficiency
NEW15461,CHEMICAL,moderate alcohol consumption,moderate alcohol consumption
NEW15462,DISEASE,moderate alcohol consumption,metabolic alterations
NEW15463,DISEASE,moderate alcohol consumption,aggravating parkinsonism
NEW15464,MENTAL_HEALTH,moderate alcohol consumption,agonist-induced psychosis
http://purl.obolibrary.org/obo/CHEBI_38218,CHEMICAL,isophthalonitrile,"1,3-Benzenedicarbonitrile|Isophthalodinitrile|benzene-1,3-dicarbonitrile|m-Dicyanobenzene|3-Cyanobenzonitrile|IPN|1,3-Dicyanobenzene|yl- 4-yl)methyl]imidazole|(E)-N-[17-(cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6beta-yl]-3-(furan-3-yl)-N-methylprop-2-enamide monohydrochloride|losartan"
http://purl.obolibrary.org/obo/CHEBI_20725,CHEMICAL,6-hydroxydopa,"3,4,6-topa|2,5-dihydroxytyrosine|2-amino-3-(2,4,5-trihydroxyphenyl)propanoic acid|3,4,6-trihydroxyphenylalanine|6-hydroxy-dopamine (6-OHDA)-induced|6-OHdopa|6-hydroxydopamine (6-OHDA)-treated|2,4,5-trihydroxyphenylalanine"
NEW15465,MENTAL_HEALTH,3 week,dyskinesia rats|3 weeks
NEW15466,DISEASE,l-dopa-induced excessive dopamine release,L-DOPA-induced excessive dopamine release
D000069058,CHEMICAL,Vardenafil Dihydrochloride,"Trihydrate, Vardenafil Hydrochloride|Dihydrochloride, Vardenafil|vardenafil|1-(((3-(3,4-dihydro-5-methyl)-4-oxo-7-propylimidazo(5,1-f)-as-triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethylpiperazine|Hydrochloride Trihydrate, Vardenafil|Hydrochloride, Vardenafil|Vardenafil|Levitra|Vardenafil Hydrochloride Trihydrate|Vardenafil Hydrochloride|Vardenafil Hydrochloride Anhydrous|Vardenafil hydrochloride|Anhydrous, Vardenafil Hydrochloride|Hydrochloride Anhydrous, Vardenafil"
NEW15467,NUTRITION,distal tracheobronchial tree,distal tracheobronchial tree
NEW15468,DISEASE,distal tracheobronchial tree,severe pulmonary complications
NEW15469,CHEBI,female reproductive hormone cycle event,female reproductive hormone cycle events
D000067562,MENTAL_HEALTH,Late Onset Disorders,"Late-Onset Disorder|Disease, Late Onset|Disorders, Late-Onset|Late Onset Disease|Disorders, Late Onset|Onset Disorder, Late|Late Onset Diseases|disorder onset|Onset Disorders, Later|Disorders, Later Onset|Diseases, Late Onset|Disorder, Later Onset|Later Onset Disorder|Later Onset Disorders|Late-Onset Disorders|Onset Diseases, Late|Onset Disorders, Late|Disorder, Late-Onset|Onset Disease, Late|Late Onset Disorder|Disorder, Late Onset|Onset Disorder, Later"
NEW15470,MENTAL_HEALTH,incident depression,Incident depression
NEW15471,CHEBI,non-selective beta-blocker related,non-selective beta-blockers related
NEW15472,DISEASE,non-selective beta-blocker related,hyperandrogenemia
NEW15473,CHEBI,non-selective beta-blocker related,reproductive endocrine abnormalities
NEW15474,CHEMICAL,non-selective beta-blocker related,nicotine abstinence-alleviating effects
NEW15475,CHEBI,pleiotrope alpha-melanophore stimulating hormone,pleiotrope alpha-melanophore stimulating hormone
NEW15476,CHEMICAL,cy-3-g,Cy-3-g
C580075,DISEASE,Familial Acute Myeloid Leukemia with Mutated Cebpa [Supplementary Concept],"acute myeloid leukaemia|Leukemia, Myeloid, Acute"
NEW15477,DISEASE,2-year-old asthmatic boy,2-year-old asthmatic boy
NEW15478,CHEMICAL,2-year-old asthmatic boy,(AV)-reentry tachycardia
D008133,DISEASE,Long QT Syndrome,|long QT syndrome|prolonged QT interval|Electrocardiogram QT Prolonged|Long QT syndrome|LQTS
http://purl.obolibrary.org/obo/UPHENO_0001001,DISEASE,phenotype,LQT3 phenotype
NEW15479,DISEASE,abort cardiac arrest,aborted cardiac arrest
NEW15480,CHEBI,thyroid hormone alpha,thyroid hormone alpha
NEW15481,DISEASE,thyroid hormone alpha,tissue-specific hypothyroidism
NEW15482,DISEASE,different sarcoma cell line,different sarcoma cell lines
NEW15483,CHEBI,specific ppardelta agonist,specific PPARdelta agonist
NEW15484,MENTAL_HEALTH,specific ppardelta agonist,subsequent DNA fragmentation
NEW15485,DISEASE,specific ppardelta agonist,transient focal cerebral ischemia
NEW15486,CHEMICAL,ppardelta-mediated mir-15a inhibition,PPARdelta-mediated miR-15a inhibition
NEW15487,DISEASE,ppardelta-mediated mir-15a inhibition,stroke-related vascular dysfunction
NEW15488,CHEBI,estrogen mimic,estrogen mimics
NEW15489,CHEMICAL,dopamine receptor activation,dopamine receptor activation
C536503,DISEASE,Thakker Donnai syndrome [Supplementary Concept],"Facies|Muscular Atrophy|Abnormalities, Multiple|structural anomalies"
NEW15490,DISEASE,dopamine receptor activation,behavioral disabilities
NEW15491,CHEMICAL,dopamine receptor activation,tGnRH-A
NEW15492,CHEMICAL,dopamine receptor activation,excess unlabeled tGnRH
NEW15493,CHEBI,antiviral factor,antiviral factors
NEW15494,CHEBI,antiviral factor,non-competitive N-methyl-D-aspartate receptor antagonist
NEW15495,CHEMICAL,subanesthetic dose,Subanesthetic dose
NEW15496,CHEMICAL,dose intravenous ketamine,dose intravenous ketamine
D005228,NUTRITION,"Fatty Acids, Essential","essential fatty acids|Acids, Essential Fatty|Essential Fatty Acids"
NEW15497,DISEASE,alcohol-induced tissue damage,alcohol-induced tissue damage
NEW15498,NUTRITION,alcohol-induced tissue damage,impaired fatty acid
NEW15499,DISEASE,pellagra erythaema,pellagra erythaema
NEW15500,CHEBI,pellagra erythaema,niacin supplementation
NEW15501,DISEASE,pellagra erythaema,treatability
NEW15502,DISEASE,pellagra erythaema,non-specific erythaema
NEW15503,MENTAL_HEALTH,hazard regression,hazards regression
NEW15504,CHEMICAL,excessive alcohol user,Excessive alcohol users
NEW15505,DISEASE,excessive alcohol user,frequent lung infections
NEW15506,CHEBI,excessive alcohol user,poor antibiotic response
D007711,DISEASE,Klebsiella pneumoniae,Bacterium pneumoniae crouposae|Bacillus pneumoniae|Klebsiella pneumoniae aerogenes|Hyalococcus pneumoniae|Klebsiella pneumoniae|Klebsiella rhinoscleromatis
NEW15507,CHEMICAL,excessive alcohol user,cAMP levels
NEW15508,DISEASE,e. amylovora,E. amylovora
D013307,CHEMICAL,Streptomycin,Strepto Fatol||Streptomycin Sulfate|Strepto Hefa|Estreptomicina Clariana|Streptomycin Sulphate|Streptomycin Grünenthal|Streptomycine Panpharma|streptomycin|Estreptomicina Normon|Strepto-Fatol|Strepto-Hefa|Estreptomicina CEPA|Streptomycin Sulfate (2:3) Salt
NEW15509,CHEMICAL,e. amylovora,streptomycin resistance
C525624,CHEMICAL,"D-tagatose 3-epimerase, Pseudomonas cichorii [Supplementary Concept]",d-tagatose|Carbohydrate Epimerases
NEW15510,MENTAL_HEALTH,e. amylovora,apprehension
NEW15511,CHEMICAL,increase brain kyna level,increased brain KYNA levels
NEW15512,DISEASE,antilipolysacchride factor,ALF|antilipolysacchride factor
NEW15513,CHEMICAL,brain kyna level,Brain KYNA levels
NEW15514,DISEASE,brain kyna level,TAA-induced ALF
http://purl.obolibrary.org/obo/SYMP_0000296,DISEASE,hepatic dysfunction,hepatic dysfunction|Hepatic disfunction
NEW15515,CHEMICAL,imipramine administration,Imipramine administration
NEW15516,DISEASE,imipramine administration,liver necrosis
NEW15517,CHEMICAL,ccl4 ml,CCl4 ml
D054407,CHEMICAL,Chemokine CCL4,"Inflammatory Protein-1beta2, Macrophage|CCL4 Chemokine|CCL4L2 Chemokine|CCL4, Chemokine|CCL4L1 Chemokine|MIP-1beta|Chemokine CCL4L1|Macrophage Inflammatory Protein 1-beta|Macrophage Inflammatory Protein 1 beta|Chemokine, CCL4L1|Macrophage Inflammatory Protein 1beta2|CCl4|Macrophage Inflammatory Protein-1beta2|Chemokine, CCL4|CCL4L1, Chemokine|Chemokine CCL4L2|MIP 1beta|CCL4L2, Chemokine|Chemokine, CCL4L2"
NEW15518,DISEASE,ccl4 ml,CCl4-induced liver necrosis
NEW15519,CHEMICAL,long-term ethanol treatment,Long-term ethanol treatment
NEW15520,DISEASE,long-term ethanol treatment,dMMR adenomas
NEW15521,CHEMICAL,hair calcium,hair calcium
NEW15522,MENTAL_HEALTH,psychotic disorder secondary,psychotic disorder secondary
NEW15523,MENTAL_HEALTH,behavioral agitation,behavioral agitation
NEW15524,CHEMICAL,behavioral agitation,risperidone mg
NEW15525,DISEASE,psychotic thinking,psychotic thinking
NEW15526,DISEASE,psychotic thinking,adolescent's cardiac illnesses
NEW15527,DISEASE,psychotic thinking,psychotic disorders due
NEW15528,CHEMICAL,"mg/kg l-365,031 l-365,260","mg/kg L-365,031 L-365,260"
NEW15529,CHEBI,non-peptide cck antagonist,non-peptide CCK antagonists
C053649,CHEMICAL,L 365031 [Supplementary Concept],"L-365,031|Benzodiazepinones"
NEW15530,CHEMICAL,non-peptide cck antagonist,MK-329 greater
NEW15531,CHEMICAL,zidovudine monotherapy,zidovudine monotherapy
NEW15532,DISEASE,hiv disease,HIV disease
NEW15533,CHEBI,hiv disease,multiple prolonged drug regimens
NEW15534,CHEMICAL,mek inhibitor pd184352,MEK inhibitor PD184352
NEW15535,DISEASE,mek inhibitor pd184352,human tumor xenograft models
NEW15536,CHEMICAL,multiple inhaler type,multiple inhaler types
NEW15537,CHEBI,primary drug treatment,primary drug treatment
NEW15538,CHEMICAL,nonselective sri clomipramine,nonselective SRI clomipramine
NEW15539,CHEMICAL,nonselective sri clomipramine,selective norepinephrine reuptake inhibitor desipramine
NEW15540,DISEASE,nonselective sri clomipramine,hyperandrogenemia elevated blood pressure
NEW15541,CHEMICAL,nonselective sri clomipramine,first maternal cousin
NEW15542,DISEASE,related dyslipidemia,related dyslipidemia
D050612,NUTRITION,Fatty Acid Transport Proteins,fatty acid transport proteins|Fatty Acid Transport Protein|Fatty Acid-Transport Protein
C408462,CHEMICAL,"ACBP protein, Trypanosoma brucei [Supplementary Concept]",Protozoan Proteins|ACBP|Intracellular Signaling Peptides and Proteins
NEW15543,CHEMICAL,omega-oxidation cytochrome p450 cyp4a gene expression,omega-oxidation cytochrome P450 CYP4A gene expression
NEW15544,NUTRITION,cyp4a fatty acid omega-hydroxylase p450s,CYP4A fatty acid omega-hydroxylase P450s
http://purl.obolibrary.org/obo/CHEBI_59554,NUTRITION,medium-chain fatty acid,medium-chain fatty acids|medium-chain fatty acid MCFA CYP4A LCFA CYP4Fomega-hydroxylase genes|MCFAs|MCFA
NEW15545,DISEASE,nutritional alteration,nutritional alterations
NEW15546,CHEMICAL,nutritional alteration,SS-high group
NEW15547,CHEMICAL,natural actomyosin,NAM|natural actomyosin
NEW15548,DISEASE,natural actomyosin,associated tissue loss
NEW15549,DISEASE,jellyfish stinging cell,jellyfish stinging cells
NEW15550,CHEBI,jellyfish stinging cell,contact complex venoms
D003064,CHEBI,Cnidarian Venoms,"Jellyfish Venoms|Sea Anemone Venoms|Venom, Cnidarian|Sea Anemone Venom|Venom, Chironex|Jellyfish venoms|Cnidarian Venom|Jellyfish Venom|Venom, Sea Anemone|Portuguese Man-of-War Venom|Venom, Portuguese Man-of-War|Venoms, Nematocyst|Venom, Jellyfish|Venoms, Chironex|Venoms, Cnidarian|Venoms, Sea Anemone|Nematocyst Venoms|Chironex Venoms|Venoms, Jellyfish|Chironex Venom|Portuguese Man of War Venom"
NEW15551,CHEMICAL,jellyfish stinging cell,potent proteinaceous porins
NEW15552,DISEASE,jellyfish stinging cell,neurotoxic peptides
NEW15553,CHEBI,venom component,venom components
NEW15554,DISEASE,venom component,innate hypersensitivity reactions
NEW15555,CHEBI,venom component,retinol concentration
D052201,DISEASE,Lactobacillus rhamnosus,Lactobacillus|Culturelle|Lactobacillus GG
NEW15556,DISEASE,venom component,morphological impairment
http://purl.obolibrary.org/obo/CHEBI_166993,NUTRITION,callicarpenal,"2-[(1S,2R,4aR,8aR)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]acetaldehyde|diamondback moth"
C554435,CHEMICAL,4'-amino-4'-avermectin B1 benzoate [Supplementary Concept],emamectin benzoate|Ivermectin/analogs  and  derivatives
NEW15557,DISEASE,p. xylostella,P. xylostella
C415329,CHEMICAL,spinosad [Supplementary Concept],Macrolides|spinosad|Drug Combinations
NEW15558,CHEMICAL,superoxide level,superoxide level
NEW15559,DISEASE,superoxide level,malnutrition group
D001275,CHEMICAL,ATP Citrate (pro-S)-Lyase,"Synthase, ATP Citrate|Citrate Lyase, ATP|Lyase, ATP Citrate|ATP Citrate Lyase|Citrate Synthase, ATP|citrate synthase|Cleavage Enzyme, Citrate|Citrate Cleavage Enzyme|Citrate Lyase, ATP-Dependent|ATP Citrate (pro-3S)-Lyase|ATP Dependent Citrate Lyase|ATP Citrate Synthase|Lyase, ATP-Dependent Citrate|ATP-Dependent Citrate Lyase"
NEW15560,CHEBI,dopamine agonist therapy dysregulation,dopamine agonist therapy dysregulation
NEW15561,CHEBI,hiv drug regiment,HIV drug regiment
NEW15562,DISEASE,hiv drug regiment,syndrome therapy
NEW15563,CHEBI,hiv drug regiment,new antiviral agents
NEW15564,CHEBI,mutation-induced drug resistance problem,mutation-induced drug resistance problems
C121001,DISEASE,NR2B NMDA receptor [Supplementary Concept],"GluN2B|Receptors, N-Methyl-D-Aspartate"
NEW15565,CHEMICAL,extrasynaptic nmda receptor,extrasynaptic NMDA receptors
NEW15566,CHEBI,ad drug development,AD drug development
NEW15567,CHEBI,antimicrobial use,antimicrobial use
NEW15568,CHEBI,antimicrobial use,good antimicrobial stewardship practices
NEW15569,MENTAL_HEALTH,resistance phenotype,resistance phenotypes
NEW15570,CHEMICAL,resistance phenotype,faecium E. hirae
NEW15571,MENTAL_HEALTH,craving response,craving response
NEW15572,CHEMICAL,craving response,HGH release
NEW15573,CHEMICAL,craving response,dopamine receptor sensitivity
NEW15574,DISEASE,craving response,PSP patients
NEW15575,DISEASE,craving response,ocular disturbances
NEW15576,CHEMICAL,gamma aminobutyric acid agonist specific,gamma aminobutyric acid agonist specific
NEW15577,CHEMICAL,α-1 receptor subtype,α-1 receptor subtype
NEW15578,DISEASE,α-1 receptor subtype,compulsive gnawing
NEW15579,CHEMICAL,infusion muscimol,Infusion muscimol
NEW15580,CHEMICAL,infusion muscimol,apomorphine effects
NEW15581,DISEASE,infusion muscimol,head-to-tail ipsiversive circling
D003336,CHEMICAL,Tectum Mesencephali,"Inferior Colliculus Commissure|Commissure of Superior Colliculus|Superior Colliculus Commissure|Superior Colliculus Commissures|Mesencephalus, Tectum|Tectum Mesencephalus|Quadrigeminal Plate|MRF-DLSC|Lamina Quadrigemina|Plate, Quadrigeminal|Commissure of Inferior Colliculus|Quadrigemina, Lamina|Quadrigemina, Corpora|Colliculus Commissure, Superior|Quadrigeminal Plates|Colliculus Commissures, Superior|Inferior Colliculus Commissures|superior colliculus|Corpora Quadrigemina|Colliculus Commissures, Inferior|Plates, Quadrigeminal|Colliculus Commissure, Inferior"
NEW15582,CHEMICAL,various eet product,Various EET products
NEW15583,DISEASE,various eet product,cancer tumor growth
NEW15584,CHEBI,various eet product,date first-line oral glucose-lowering drug
NEW15585,DISEASE,persistent hyperglycaemia,Persistent hyperglycaemia
NEW15586,CHEBI,ppar-gamma agonist,PPAR-gamma agonists
NEW15587,DISEASE,ppar-gamma agonist,hand myocardial infarct size
NEW15588,CHEBI,ppar-gamma agonist rosiglitazone,PPAR-gamma agonist rosiglitazone
NEW15589,CHEMICAL,ppar-gamma agonist rosiglitazone,PTEN(+/)(-)murine model
NEW15590,DISEASE,ppar-gamma agonist rosiglitazone,hyperplastic endometrial lesions
NEW15591,CHEMICAL,"24(r),25-dihydroxyergocalciferol","24(R),25-Dihydroxyergocalciferol"
NEW15592,CHEMICAL,gstm1 gene,GSTM1 gene
NEW15593,CHEMICAL,mumol/l,mumol/L
NEW15594,CHEMICAL,42-hour mtx concentration,42-hour MTX concentration
NEW15595,CHEMICAL,average mtx clearance,average MTX clearance
NEW15596,CHEMICAL,altered mtx pharmacokinetic,altered MTX pharmacokinetics
NEW15597,DISEASE,altered mtx pharmacokinetic,MTX-induced toxicity
NEW15598,CHEBI,indirectly-acting sympathomimetic amine,indirectly-acting sympathomimetic amines
NEW15599,CHEMICAL,indirectly-acting sympathomimetic amine,minimal tyramine potentiation
NEW15600,CHEMICAL,exogenous surfactant,exogenous surfactants
NEW15601,NUTRITION,blue rockfish,blue rockfish
NEW15602,NUTRITION,copper rockfish,copper rockfish
NEW15603,CHEMICAL,copper rockfish,alcohol-aversive agent
NEW15604,DISEASE,copper rockfish,disulfiram-ethanol reaction
NEW15605,MENTAL_HEALTH,copper rockfish,changes hyperactivity
C464966,CHEMICAL,VX-745 [Supplementary Concept],Pyridazines|Pyrimidines|VX-745
NEW15606,CHEMICAL,acute vx-745 application,acute VX-745 application
NEW15607,MENTAL_HEALTH,acute vx-745 application,resistance arteries
NEW15608,DISEASE,common chronic liver disease,common chronic liver disease
NEW15609,DISEASE,common chronic liver disease,hepatic steatosis due
NEW15610,DISEASE,androgen deprivation therapy,castration-resistant prostate cancer
C000607739,CHEMICAL,darolutamide [Supplementary Concept],Darolutamide|Pyrazoles
NEW15611,CHEBI,androgen deprivation therapy,unique androgen-receptor antagonist
C043425,CHEMICAL,vanoxerine [Supplementary Concept],Piperazines|Vanoxerine|GBR-12909
NEW15612,CHEMICAL,pb(ac)2 exposure,Pb(Ac)2 exposure
NEW15613,CHEMICAL,pb(ac)2 exposure,interleukin (IL)-1β
NEW15614,CHEMICAL,ape administration,APE administration
C565157,DISEASE,"Corneal Degeneration, Ribbonlike, with Deafness [Supplementary Concept]","Corneal Dystrophies, Hereditary|Deafness/congenital|keratopathy"
D015352,DISEASE,Dry Eye Syndromes,"Evaporative Dry Eyes|dry eye|Dry Eye Disease|Evaporative Dry Eye|Dry Eye Diseases|Dry Eye Syndrome|Evaporative Dry Eye Disease|Dry Eye|Evaporative Dry Eye Syndrome|Dry Eyes|Dry Eye, Evaporative"
D000075363,DISEASE,Immunoglobulin Light-chain Amyloidosis,"Systemic Amyloidoses, Primary|Immunoglobulin Light-chain Amyloidoses|Amyloidoses, Primary|Amyloidosis, Primary|Primary Systemic Amyloidosis|Amyloidoses, Primary Systemic|AL Amyloidoses|systemic amyloidoses|AL Amyloidosis|Amyloidosis, Primary Systemic|Primary Systemic Amyloidoses|Primary Amyloidosis|Amyloidosis, Immunoglobulin Light-chain|Immunoglobulin Light chain Amyloidosis|Primary Amyloidoses|Systemic Amyloidosis, Primary|Amyloidosis, Immunoglobulin Light chain"
NEW15615,DISEASE,ape administration,human disorders
NEW15616,CHEMICAL,specie glycoursodeoxycholic acid,species glycoursodeoxycholic acid|GUDCA
C031655,CHEMICAL,ursodoxicoltaurine [Supplementary Concept],Taurochenodeoxycholic Acid|TUDCA|tauroursodeoxycholic acid
NEW15617,CHEMICAL,specie glycoursodeoxycholic acid,TNF-α production
NEW15618,DISEASE,specie glycoursodeoxycholic acid,tumour necrosis factor (TNF)-α production
NEW15619,CHEMICAL,specie glycoursodeoxycholic acid,glutathione production
C000600266,CHEMICAL,aducanumab [Supplementary Concept],"Antibodies, Monoclonal, Humanized|Aducanumab"
NEW15620,CHEMICAL,bivalent cation,bivalent cations
NEW15621,MENTAL_HEALTH,bivalent cation,BPM resistance
NEW15622,NUTRITION,lanthane,lanthane
NEW15623,CHEMICAL,lanthane,calcium conductivity
NEW15624,NUTRITION,long chain polyunsaturated fatty acid level,Long chain polyunsaturated fatty acid levels
D013390,CHEMICAL,Succinylcholine,"|Quelicin|Bromide, Suxamethonium|Succinate, Dicholine|Lysthenon|Succinylcholine Dichloride|Myorelaxin|Succinyldicholine|Suxamethonium Chloride|Suxamethonium Bromide|Dicholine Succinate|Succinylcholine Diperchlorate|Succinylcholine Chloride|Succinylcholine Iodide|Succicuran|Diiodide, Succinylcholine|Dichloride, Succinylcholine|Anectine|Dibromide, Succinylcholine|Succinylcholine Dichloride, Di H2O|Succinylcholine Dichloride, Di-H2O|Succinylcholine Dibromide|Diperchlorate, Succinylcholine|Celocurine|Succinylcholine Diiodide|Listenon|succinylcholine|Ditilin|Suxamethonium"
NEW15625,CHEMICAL,long chain polyunsaturated fatty acid level,magnesium sulphate infusion
NEW15626,DISEASE,long chain polyunsaturated fatty acid level,congenital long QT syndrome
NEW15627,CHEMICAL,high-frequency tens,high-frequency TENS
NEW15628,CHEMICAL,functional single nucleotide polymorphism present,functional single nucleotide polymorphism present
NEW15629,DISEASE,functional single nucleotide polymorphism present,violent behavior
NEW15630,CHEMICAL,val allele,Val allele
NEW15631,DISEASE,val allele,homicidal behavior
NEW15632,DISEASE,sex steroid,birth defects other
NEW15633,CHEMICAL,periconceptional use,periconceptional use
NEW15634,CHEBI,folic acid fortification,folic acid fortification
NEW15635,DISEASE,folic acid fortification,specific birth defects
NEW15636,DISEASE,folic acid fortification,atypical HLH transcriptional regulators
NEW15637,DISEASE,folic acid fortification,diabetic populations
NEW15638,CHEMICAL,adhd symptom,ATR|anterior thalamic radiation
NEW15639,CHEBI,adhd symptom,beta modulation
NEW15640,DISEASE,due respiratory viral infection,due respiratory viral infections
NEW15641,CHEMICAL,iron supplementation,Iron supplementation
NEW15642,DISEASE,iron supplementation,anemia cases
NEW15643,CHEMICAL,iron supplementation,serotonin synthesizing apparatus
NEW15644,CHEMICAL,iron supplementation,transsulfuration pathway abnormalities
NEW15645,MENTAL_HEALTH,iron supplementation,complex syndromes
NEW15646,CHEMICAL,phase-high performance chromatography method,phase-high performance chromatography method
C503840,CHEMICAL,dieckol [Supplementary Concept],Benzofurans|dieckol
NEW15647,DISEASE,phase-high performance chromatography method,Eisenia bicyclis
NEW15648,NUTRITION,phase-high performance chromatography method,major phlorotannins
C064093,CHEMICAL,phlorofucofuroeckol A [Supplementary Concept],phlorofucofuroeckol-A|Benzofurans|Dioxins
http://purl.obolibrary.org/obo/SYMP_0000309,CHEMICAL,loss of appetite,appetite loss|lack of appetite|inappetence
NEW15649,CHEMICAL,l-dopa reuptake inhibitor,l-DOPA reuptake inhibitors
D008468,CHEMICAL,Meclizine,"Meclizine Dihydrochloride|D Vert|Meclozine|Ru Vert M|Monohydrochloride, Meclizine|Agyrax|Meclizine Hydrochloride|DVert|Meclizine Monohydrochloride|Dihydrochloride, Meclizine|Histametizyn|Ru-Vert-M|Hydrochloride, Meclizine|Bonamine|D-Vert|Antivert|Chiclida|Parachloramine|meclizine|Bonine"
NEW15650,CHEBI,pxr agonist,PXR agonist
NEW15651,CHEMICAL,rifampicin-treate alcl3-rat,Rifampicin-treated AlCl3-rats
NEW15652,CHEMICAL,rifampicin-treate alcl3-rat,nitrite level
NEW15653,DISEASE,lysinibacillus sp. btku3 strain,Lysinibacillus sp. BTKU3 strain
C115058,CHEMICAL,difenoconazole [Supplementary Concept],difenoconazole|Triazoles|Difenoconazole|Dioxolanes|DFZ
NEW15654,DISEASE,postnatal gut dysbiosis,Postnatal gut dysbiosis
NEW15655,DISEASE,extensive gut dysbiosis,extensive gut dysbiosis
NEW15656,CHEBI,extensive gut dysbiosis,neurotoxin levels
NEW15657,DISEASE,extensive gut dysbiosis,neurodevelopmental damage
NEW15658,CHEMICAL,neuroprotectant kynurenic acid,neuroprotectant kynurenic acid
NEW15659,CHEMICAL,dose mg/kg,dose mg/kg
NEW15660,DISEASE,dose mg/kg,typical motor syndrome
NEW15661,CHEMICAL,catecholamine level,catecholamine levels
D020240,MENTAL_HEALTH,"Apraxia, Ideomotor","apraxia|Apraxias, Ideokinetic|Kinetic Apraxias, Limb|Apraxia, Limb Kinetic|Apraxias, Classic|Transcortical Apraxias|Dyspraxias, Ideomotor|Classic Apraxias|Apraxia, Ideokinetic|Apraxias, Transcortical|Limb Kinetic Apraxias|Apraxias, Ideomotor|Ideomotor Dyspraxia|Apraxia, Classic|Transcortical Apraxia|Classic Apraxia|Ideokinetic Apraxia|Ideomotor Apraxias|Apraxias, Limb Kinetic|Kinetic Apraxia, Limb|Ideomotor Dyspraxias|Ideomotor Apraxia|Ideokinetic Apraxias|Apraxia, Transcortical|Limb Kinetic Apraxia|Dyspraxia, Ideomotor"
NEW15662,CHEMICAL,low melatonin secretion,flumazenil group
D006862,CHEMICAL,Hydrogen Sulfide,"Hydrogen Sulfide (H2S2)|Sulfide, Hydrogen|Hydrogen Sulfide (H2(Sx))|Hydrogen sulfide|Hydrogen Sulfide (H2S3)|hydrogen sulfide|H2S"
NEW15663,CHEBI,low melatonin secretion,main toxic substance
NEW15664,DISEASE,s. platensis,S. platensis
NEW15665,CHEMICAL,s. platensis,NO bioavailability
NEW15666,CHEMICAL,s. platensis,cavernous total antioxidant capacity|TAC
C055492,CHEMICAL,4-hydroxy-N-desmethyltamoxifen [Supplementary Concept],Z-endoxifen|endoxifen|Tamoxifen/analogs  and  derivatives|Endoxifen
NEW15667,DISEASE,capsaicin-mediated bradycardia,capsaicin-mediated bradycardia
NEW15668,CHEMICAL,capsaicin-mediated bradycardia,± bpm
D050598,CHEMICAL,Vesicular Glutamate Transport Protein 1,GLT-1|Vesicular Glutamate Transporter 1|glutamate transporter-1|VGLUT1 Protein|VGLUT1|Brain Specific Na Dependent Inorganic Phosphate Cotransporter|vesicular glutamate transporter 1|Brain-Specific Na-Dependent Inorganic Phosphate Cotransporter|BNPI Protein
http://purl.obolibrary.org/obo/CHEBI_25029,CHEMICAL,leukotriene,leukotriene|leucotriene|leucotrienes|Leukotrien|leukotrienes|Leukotriene
NEW15669,CHEMICAL,Fomosan,Fomosan
NEW15670,DISEASE,death due,death due
NEW15671,DISEASE,death due,alcohol-related traffic accident
NEW15672,DISEASE,alcohol liver disease,Alcohol liver disease
NEW15673,CHEMICAL,alcohol liver disease,daily alcohol consumption
NEW15674,CHEMICAL,conyza bonariensis,Conyza bonariensis
D011815,MENTAL_HEALTH,R Factors,"Factors, Resistance|Resistance Factor|Resistance Factors|Plasmid, R|Factor, R|Factor, Resistance|Resistance factors|R Factor|Plasmids, R|R Plasmids|R Plasmid|Factors, R"
C050296,CHEMICAL,metsulfuron methyl [Supplementary Concept],Arylsulfonates|tribenuron-methyl
C037991,CHEMICAL,"2,4-D amine [Supplementary Concept]","2,4-D|2,4-Dichlorophenoxyacetic Acid|Dimethylamines"
C010974,CHEMICAL,glyphosate [Supplementary Concept],glyphosate|Glycine/analogs  and  derivatives
NEW15675,MENTAL_HEALTH,resistance mechanism,resistance mechanism
NEW15676,MENTAL_HEALTH,high-level resistance,high-level resistance
NEW15677,CHEMICAL,high-level resistance,RT deoxynucleoside-triphosphate
NEW15678,CHEMICAL,3'-azido-3'-deoxythymidine azt,3'-azido-3'-deoxythymidine AZT
NEW15679,MENTAL_HEALTH,3'-azido-3'-deoxythymidine azt,disease psychosis
NEW15680,DISEASE,3'-azido-3'-deoxythymidine azt,Parkinson's disease psychosis
NEW15681,CHEMICAL,3'-azido-3'-deoxythymidine azt,norepinephrine substrates
NEW15682,CHEBI,apoe4 carrier,ApoE4 carriers
NEW15683,MENTAL_HEALTH,apoe4 carrier,Blessed Dementia Scale
NEW15684,CHEMICAL,apoe3 carrier,ApoE3 carriers
NEW15685,CHEMICAL,dha+epa level,DHA+EPA levels
NEW15686,CHEBI,apoe-ε4 allele carrier,APOE-ε4 allele carriers
NEW15687,CHEMICAL,covid-19 survivor,COVID-19 survivors
NEW15688,CHEBI,selective taar1 full agonist,selective TAAR1 full agonist
NEW15689,CHEMICAL,ro5256390,RO5256390
NEW15690,CHEBI,kappa receptor antagonist,kappa receptor antagonists
C480351,CHEMICAL,astodrimer [Supplementary Concept],Polylysine|SPL7013|Dendrimers
NEW15691,CHEBI,allergene,allergene
NEW15692,DISEASE,antidepressant therapy,spontaneous intracerebral hemorrhage
NEW15693,CHEMICAL,high serum uric acid ua level,higher serum uric acid UA levels
NEW15694,DISEASE,high serum uric acid ua level,depressed inpatients
NEW15695,CHEMICAL,high serum uric acid ua level,losartan treatment
NEW15696,DISEASE,frailty score,Frailty score
NEW15697,CHEMICAL,frailty score,serum losartan
C073600,CHEMICAL,"2-butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-carboxaldehyde [Supplementary Concept]",Losartan/analogs  and  derivatives|EXP3179
NEW15698,CHEBI,second-generation factor-related apoptosis-inducing ligand receptor agonist,second-generation factor-related apoptosis-inducing ligand receptor agonist
D053218,DISEASE,"Receptors, Death Domain","Receptors, Death Domain Family|death receptors|Death Receptor|DR Family Receptors|Receptors, DR Family|Death Domain Receptors|Death Receptors|Receptor, Death"
NEW15699,MENTAL_HEALTH,steroid phobia,steroid phobia
D000077216,DISEASE,"Carcinoma, Ovarian Epithelial","Carcinoma, Epithelial Ovarian|Ovarian Epithelial Cancers|Epithelial Ovarian Carcinoma|Carcinomas, Ovarian Epithelial|Ovarian Epithelial Cancer|Epithelial Ovarian Cancer|Cancer, Ovarian Epithelial|Ovarian Epithelial Carcinoma|Epithelial Ovarian Cancers|Epithelial Cancer, Ovarian|Epithelial Ovarian Carcinomas|Epithelial Carcinoma, Ovarian|ovarian carcinoma|Ovarian Epithelial Carcinomas|Epithelial Carcinomas, Ovarian|Cancer, Epithelial Ovarian|Epithelial Cancers, Ovarian|Ovarian Carcinoma, Epithelial|Ovarian Cancer, Epithelial|Cancers, Epithelial Ovarian|Carcinomas, Epithelial Ovarian|Cancers, Ovarian Epithelial|Ovarian Carcinomas, Epithelial|Ovarian Cancers, Epithelial"
NEW15700,CHEMICAL,steroid phobia,immunosuppressed CD163high CD206high tumor-associated macrophages
D059016,DISEASE,Tumor Microenvironment,"Microenvironments, Tumor|Cancer Microenvironment|Tumor Microenvironments|Cancer Microenvironments|tumor microenvironment|Microenvironment, Cancer|Microenvironment, Tumor|Microenvironments, Cancer"
C000712172,CHEBI,thiamine hydrochloride [Supplementary Concept],Thiamine/analogs  and  derivatives|thiamine hydrochloride
NEW15701,CHEMICAL,acid analysis,acids analysis
NEW15702,MENTAL_HEALTH,acid analysis,irritability mental retardation
NEW15703,CHEMICAL,circulate serotonin,circulating serotonin
NEW15704,MENTAL_HEALTH,newborn olfactory projection neuron,newborn olfactory projection neurons
NEW15705,CHEMICAL,uro-s,URO-S
NEW15706,DISEASE,uro-s,autosomal recessive disorder
D017092,DISEASE,"Porphyria, Erythropoietic","Gunthers Disease|Porphyrias, Erythropoietic|Gunther Disease|Congenital Erythropoietic Porphyria|congenital erythropoietic porphyria|UROS Deficiency|Erythropoietic Porphyrias, Congenital|Congenital Erythropoietic Porphyrias|Erythropoietic Porphyria|Porphyria, Erythropoietic, Congenital|Deficiency of Uroporphyrinogen III Synthase|Uroporphyrinogen III Synthase, Deficiency of|Erythropoietic Porphyria, Congenital|Erythropoietic Porphyrias|Porphyrias, Congenital Erythropoietic|Gunther's Disease|Porphyria, Congenital Erythropoietic"
NEW15707,CHEMICAL,lipopolysaccharide lps level,Lipopolysaccharide LPS levels
NEW15708,CHEMICAL,trna3lys,tRNA3Lys
NEW15709,NUTRITION,trna3lys,RT tryptophan fluorescence
NEW15710,CHEBI,vitamin k status,vitamin K status
D003876,DISEASE,"Dermatitis, Atopic","Atopic dermatitis|Neurodermatitis, Disseminated|Atopic Eczema|Dermatitides, Atopic|Infantile Eczema|Neurodermatitides, Disseminated|Disseminated Neurodermatitides|Eczema, Atopic|Atopic Neurodermatitis|Atopic Neurodermatitides|Eczema, Infantile|Atopic Dermatitides|Neurodermatitis, Atopic|Neurodermatitides, Atopic|Disseminated Neurodermatitis|Atopic Dermatitis"
NEW15711,CHEMICAL,plasma adrenaline,Plasma adrenaline
NEW15712,DISEASE,plasma adrenaline,phobic patients
NEW15713,CHEMICAL,plasma adrenaline,diazapam mg/kg body weight
D016854,MENTAL_HEALTH,Dental Anxiety,"dental phobia|Fear, Dental|Anxieties, Dental|Phobia, Dental|Fears, Dental|Dental Phobias|Anxiety, Dental|Dental Phobia|Odontophobia|Odontophobias|Dental Fear|Dental Anxieties|Dental Fears|Phobias, Dental"
NEW15714,CHEMICAL,plasma adrenaline,prolonged NMDA receptor activation
NEW15715,CHEMICAL,increase plasma homocysteine,Increased plasma homocysteine
NEW15716,DISEASE,increase plasma homocysteine,pathological disorders
D000026,DISEASE,"Abortion, Habitual","Recurrent Abortion|recurrent miscarriages|recurrent abortions|Abortion, Recurrent|Recurrent Early Pregnancy Loss|Habitual Abortions|Habitual Abortion|Miscarriage, Recurrent|Recurrent Miscarriages|Recurrent Abortions|Recurrent Miscarriage"
D008244,CHEMICAL,Lysophosphatidylcholines,Lysophosphatidylcholine|LPC|Lysolecithin|lysophosphatidylcholines|Lysolecithins
NEW15717,CHEMICAL,copper ammunition,Copper ammunitions
NEW15718,MENTAL_HEALTH,copper ammunition,minimal fragmentation
NEW15719,CHEMICAL,thymidine derivative,thymidine derivative
http://purl.obolibrary.org/obo/CHEBI_33838,CHEMICAL,nucleoside,"nucleosides|2',3'-dideoxynucleoside|a nucleoside|Nucleoside"
NEW15720,CHEMICAL,Tau amyloid-β generation,Tau Amyloid-β generation
C007768,CHEMICAL,formononetin [Supplementary Concept],Isoflavones|Formononetin
NEW15721,CHEMICAL,a. indica,A. indica|MeOH-AI
NEW15722,DISEASE,a. indica,oil-induced diarrhea severity
NEW15723,CHEMICAL,alcohol amblyopia,alcohol amblyopia
NEW15724,MENTAL_HEALTH,alcohol amblyopia,tobacco abuse
NEW15725,CHEMICAL,berberis aristata dc,Berberis aristata DC
NEW15726,DISEASE,berberis aristata dc,testicular toxicity
NEW15727,CHEMICAL,aristata extract,aristata extract
NEW15728,DISEASE,aristata extract,testicular damage
D011718,CHEMICAL,Pyrazinamide,|Tisamid|pyrazinamide
NEW15729,DISEASE,aristata extract,TB|first-line anti-tuberculosis
NEW15730,DISEASE,aristata extract,tuberculosis treatment
NEW15731,DISEASE,vertebral mineralization,vertebral mineralization
NEW15732,CHEBI,bmp antagonist,BMP antagonists
NEW15733,DISEASE,bmp antagonist,numerous human connective tissue disorders
NEW15734,DISEASE,folie à double forme,folie à double forme
NEW15735,DISEASE,folie à double forme,folie circulaire
NEW15736,MENTAL_HEALTH,folie à double forme,higher resistance
NEW15737,CHEMICAL,serotonin abnormality,serotonin abnormalities
D016736,DISEASE,Antiphospholipid Syndrome,"Syndrome, Anti-Phospholipid|Syndrome, Anti-Phospholipid Antibody|Anti Phospholipid Antibody Syndrome|Syndrome, Antiphospholipid|antiphospholipid antibody syndrome|APS|Antiphospholipid Antibody Syndrome|Anti-Phospholipid Antibody Syndrome|anti-phospholipid antibody|Syndrome, Hughes|Anti-Phospholipid Syndrome|anti-phospholipid syndrome|Syndrome, Antiphospholipid Antibody|Antibody Syndrome, Antiphospholipid|Antibody Syndrome, Anti-Phospholipid|Anti Phospholipid Syndrome|Hughes Syndrome|Antiphospholipid Antibody Syndromes"
NEW15738,CHEBI,serotonin abnormality,antibody carriers
NEW15739,DISEASE,serotonin abnormality,syndrome patients
NEW15740,MENTAL_HEALTH,least-square regression model,least-squares regression model
NEW15741,NUTRITION,least-square regression model,shikimic acid concentrations
NEW15742,MENTAL_HEALTH,least-square regression model,SPSS regression analysis
NEW15743,CHEMICAL,homozygous sip1 mouse,homozygous Sip1 mice|Sip1fI/fI
NEW15744,CHEBI,homozygous sip1 mouse,respective receptor agonists
NEW15745,DISEASE,significant multi-morbidity,significant multi-morbidity
NEW15746,CHEBI,vital endocrine organ,vital endocrine organ
NEW15747,CHEBI,vital endocrine organ,endocrine pathways
NEW15748,DISEASE,prenatal alcohol exposure,detrimental alcohol-induced defects
NEW15749,DISEASE,prenatal alcohol exposure,neurobehavioral deficits
NEW15750,CHEMICAL,prenatal alcohol exposure,oxidized phosphatidylcholines
NEW15751,NUTRITION,prenatal alcohol exposure,oxidized phospholipids
NEW15752,CHEMICAL,gut microbiota dysbiosis,serum 25(OH)D3 levels
NEW15753,CHEBI,gut microbiota dysbiosis,vitamin D treatment
NEW15754,MENTAL_HEALTH,gut microbiota dysbiosis,moderate ADHD
NEW15755,DISEASE,bipolar adolescent,bipolar adolescents
NEW15756,MENTAL_HEALTH,bipolar adolescent,co-occurring alcohol dependence
NEW15757,CHEMICAL,selenium status,selenium status
D064702,MENTAL_HEALTH,"International Classification of Functioning, Disability and Health",Disability Evaluation (2002-2013)|disability
NEW15758,CHEMICAL,selenium status,5HT2C receptor gene mutation
NEW15759,CHEBI,correspond endocrine syndrome,corresponding endocrine syndromes
C493962,CHEMICAL,"Cdkn1b protein, rat [Supplementary Concept]",p27(kip1|Cyclin-Dependent Kinase Inhibitor p27
NEW15760,CHEBI,correspond endocrine syndrome,multiple endocrine neoplasias
NEW15761,DISEASE,correspond endocrine syndrome,susceptibility to multiple endocrine neoplasias|MEN
NEW15762,CHEMICAL,other non-short-stature indication,Other non-short-stature indications
D005126,DISEASE,Eye Burns,"Eye Burn|Burn, Eye|burns|Burns, Eye"
NEW15763,CHEMICAL,other non-short-stature indication,cerebral Trp availability
NEW15764,MENTAL_HEALTH,postoperative delirium,postoperative delirium
NEW15765,DISEASE,levodopa-treated parkinson patient,levodopa-treated Parkinson patients
NEW15766,DISEASE,levodopa-treated parkinson patient,psychotic mania symptoms
http://purl.obolibrary.org/obo/CHEBI_35478,NUTRITION,lithium salt,Lithiumsalz|lithium salts|Lithium salts|Lithiumsalze
NEW15767,CHEBI,"parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","Parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"
NEW15768,CHEMICAL,clopyralid sensitivity,clopyralid sensitivity
C011767,CHEMICAL,clopyralid [Supplementary Concept],clopyralid|Picolinic Acids
http://purl.obolibrary.org/obo/CHEBI_85012,CHEBI,thrombopoietin receptor agonist,thrombopoietin TPO receptor agonist lusutrombopag|thrombopoietin receptor agonists|Thrombopoietin receptor agonists|TPO receptor agonist|TPO receptor agonists
NEW15769,DISEASE,non-ischemic heart failure,non-ischemic heart failure
NEW15770,DISEASE,non-ischemic heart failure,sustained tachyarrhythmias
NEW15771,DISEASE,heart failure entity,heart failure entities
NEW15772,DISEASE,heart failure entity,impaired coronary blood flow
D000069287,CHEMICAL,Capecitabine,capecitabine|N(4)-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine|Capecitabine|XELOX|Xeloda
NEW15773,CHEMICAL,5-methyltetrahydrofolate specie,5-methyltetrahydrofolate species
NEW15774,CHEBI,contraceptive microbicide,Contraceptive microbicides
D058458,CHEMICAL,Nitrogen Cycle,"N-9|nitrogen|Cycle, Nitrogen|Ammonification|N-24|Nitrogen Cycles"
NEW15775,CHEMICAL,sco mg/kg,Sco mg/kg
NEW15776,CHEMICAL,g-protein-activated inwardly rectifying potassium girk channel,G-protein-activated inwardly rectifying potassium GIRK channels
NEW15777,DISEASE,g-protein-activated inwardly rectifying potassium girk channel,cold pain
NEW15778,CHEMICAL,g-protein-activated inwardly rectifying potassium girk channel,milk-cereal drink|Horlicks
NEW15779,CHEMICAL,g-protein-activated inwardly rectifying potassium girk channel,ribonucleic acid levels
NEW15780,DISEASE,g-protein-activated inwardly rectifying potassium girk channel,histamine-induced catalepsy
NEW15781,CHEMICAL,histamine h1-receptor blocker,Histamine H1-receptor blockers
NEW15782,CHEMICAL,imipramine- drug,imipramine- drugs
NEW15783,DISEASE,histamine-induced catalepsy,Histamine-induced catalepsy
NEW15784,CHEMICAL,α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid ampa receptor glua1 subunit-deficient glua1-/- mouse,α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA receptor GluA1 subunit-deficient GluA1-/- mice
NEW15785,MENTAL_HEALTH,α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid ampa receptor glua1 subunit-deficient glua1-/- mouse,novelty-induced hyperactivity
NEW15786,DISEASE,α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid ampa receptor glua1 subunit-deficient glua1-/- mouse,cognitive defects
NEW15787,DISEASE,cognition loss,cognition loss
D003983,CHEMICAL,Dibenzylchlorethamine,"Dibenamine|dibenamine|Dibenzyl Chlorethylamine|Chlorethylamine, Dibenzyl"
NEW15788,DISEASE,cognition loss,resultant hypotension
NEW15789,CHEBI,combined nutraceutical supplement,combined nutraceutical supplement
NEW15790,DISEASE,combined nutraceutical supplement,early metabolic alterations
D004714,DISEASE,Endometrial Hyperplasia,"Hyperplasia, Simple Endometrial|Complex Endometrial Hyperplasias|Hyperplasia, Complex Endometrial|Simple Endometrial Hyperplasia|endometrial hyperplasia|Hyperplasias, Simple Endometrial|Simple Endometrial Hyperplasias|Hyperplasia, Atypical Endometrial|Atypical Endometrial Hyperplasia|Endometrial Hyperplasias, Atypical|Endometrial Hyperplasias|Hyperplasias, Atypical Endometrial|Hyperplasias, Endometrial|Complex Endometrial Hyperplasia|Endometrial Hyperplasia, Simple|Endometrial Hyperplasia, Complex|Hyperplasia, Endometrial|Atypical Endometrial Hyperplasias|Endometrial Hyperplasias, Simple|Endometrial Hyperplasias, Complex|Endometrial Hyperplasia, Atypical|Hyperplasias, Complex Endometrial"
NEW15791,DISEASE,breast cancer risk,influenza encephalopathy
D000743,DISEASE,"Anemia, Hemolytic","|Haemolytic Anaemias|Microangiopathic Hemolytic Anemias|Hemolytic Anemia|hemolytic anemia|Anemia, Microangiopathic Hemolytic|Anemia, Acquired Hemolytic|Haemolytic Anaemia|Anemia, Microangiopathic|Hemolytic Anemia, Microangiopathic|Microangiopathic Anemia|Anemia, Hemolytic, Acquired|Microangiopathic Hemolytic Anemia|Hemolytic Anemia, Acquired|Acquired Hemolytic Anemia|Anaemia, Haemolytic"
NEW15792,CHEBI,base antacid,based antacid
NEW15793,CHEMICAL,significant quick-eze use,significant Quick-Eze use
NEW15794,DISEASE,significant quick-eze use,functional hepatic urea cycle
NEW15795,CHEMICAL,first drug,tuberculostatic iproniazid
NEW15796,CHEMICAL,hypomethylating agent azacitidine,hypomethylating agent azacitidine|AZA
NEW15797,MENTAL_HEALTH,hypomethylating agent azacitidine,higher risk myelodysplastic syndromes
NEW15798,CHEMICAL,hypomethylating agent azacitidine,hypomethylating agent azacitidine
NEW15799,CHEMICAL,hypomethylating agent azacitidine,low-dose chemotherapy
NEW15800,CHEMICAL,aza-7,AZA-7
NEW15801,DISEASE,aza-7,leukemia transformation
NEW15802,DISEASE,aza-7,excess blasts|RAEB
NEW15803,CHEMICAL,gamma-aminobutyric acid gaba metabolism,Gamma-aminobutyric acid GABA metabolism
NEW15804,CHEMICAL,gaba alteration,GABA alterations
NEW15805,MENTAL_HEALTH,gaba alteration,hyperarousal symptoms
NEW15806,CHEMICAL,gaba signal,GABA signal
NEW15807,CHEMICAL,rsno,RSNO
NEW15808,MENTAL_HEALTH,rsno,solvent displacement method
D026403,CHEMICAL,S-Nitrosothiols,S-Nitrosothiol|Nitrosothiols
NEW15809,CHEBI,nitric oxide releasing polymer hexagon,nitric oxide releasing polymer hexagons
NEW15810,CHEBI,novel antibacterial agent,novel antibacterial agent
NEW15811,MENTAL_HEALTH,novel antibacterial agent,rapid displacement
NEW15812,DISEASE,elderly hypertensive male patient,elderly hypertensive male patient
NEW15813,CHEMICAL,elderly hypertensive male patient,[3H]N-methyl scopolamine-binding activity
NEW15814,CHEMICAL,serotonin synthesis production,serotonin synthesis production
NEW15815,DISEASE,serotonin synthesis production,neuropsychiatric disorders similar
NEW15816,DISEASE,aqueous nymphaea lotus extract,ANL|aqueous Nymphaea lotus extract
NEW15817,CHEMICAL,aqueous nymphaea lotus extract,picrotoxin- seizures
NEW15818,DISEASE,aqueous nymphaea lotus extract,spontaneous recurrent seizures
D030721,CHEMICAL,Nymphaea,"Nymphaea lotus|Lily, Water|Waterlily|Water Lily"
NEW15819,DISEASE,aqueous nymphaea lotus extract,neurotoxins-induced seizures
NEW15820,DISEASE,aqueous nymphaea lotus extract,penile dysfunction
NEW15821,CHEMICAL,l-name chronic intake,L-NAME chronic intake
NEW15822,DISEASE,l-name chronic intake,male sexual behaviour
NEW15823,CHEMICAL,nymphea lotus,Nymphea lotus
NEW15824,DISEASE,nymphea lotus,hypertensive male rats
D017334,CHEMICAL,Teicoplanin,Teichomycin|Teicoplanin|Teichomycin A2|Targocid
C449179,CHEMICAL,N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide [Supplementary Concept],YM598|Pyrimidines|Sulfonamides
D000077868,CHEMICAL,Atrasentan,"A 147627|A-127722.5|Xinlay|A147627|(11C)ABT-627|A-127722|atrasentan|A-147627|A 127722.5|A 127722|A127722.5|Atrasentan Hydrochloride|2-(4-Methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(((dibutylamino)carbonyl)methyl)pyrrolidine-3-carboxylic acid|ABT-627|A127722|ABT627|ABT 627"
NEW15825,DISEASE,human melanoma cell line skmel-,human melanoma cell line SKMel-
NEW15826,CHEBI,novel endothelin-a eta receptor antagonist,novel endothelin-A ETA receptor antagonist
C001801,CHEMICAL,mitragynine [Supplementary Concept],Secologanin Tryptamine Alkaloids|mitragynine
http://purl.obolibrary.org/obo/DOID_11130,DISEASE,secondary hypertension,secondary hypertension
NEW15827,CHEBI,selective nk1 receptor antagonist,selective NK1 receptor antagonists
D000116,CHEMICAL,Acetylgalactosamine,2 Acetamido 2 D galactopyranose|2-Acetamido-2-D-galactopyranose|2-Acetamido-2-Deoxygalactose|2-Acetamido-2-Deoxy-D-Galactose|2 Acetamido 2 Deoxy D Galactose|N-Acetyl-D-Galactosamine|2 Acetamido 2 Deoxygalactose|N Acetyl D Galactosamine|d-galactosamine
NEW15828,CHEMICAL,acetaminophen toxicity,acetaminophen toxicity
D054596,CHEMICAL,"Protein Tyrosine Phosphatase, Non-Receptor Type 22","Lymphoid Phosphatase|PTPase, Lyp1|Tyrosine Protein Phosphatase, Non-Receptor Type 22|Tyrosine Protein Phosphatase, Non Receptor Type 22|PTPN 22 Protein|Lyp2 PTPase|Protein Tyrosine Phosphatase Lyp|PTPase Lyp|Lyp1 PTPase|Protein-Tyrosine Phosphatase Lyp|PTPN-22 Protein|Protein Tyrosine Phosphatase, Non Receptor Type 22|PTPase, Lyp2|protein-tyrosine phosphatase"
C073972,NUTRITION,dimethyl mercury [Supplementary Concept],Methylmercury Compounds|dimethyl mercury
D014222,CHEMICAL,Triamcinolone Acetonide,"triamcinolone|Acetonide, Triamcinolone|Kenacort A|Cinonide|Tricort 40|Kenalog 40|Azmacort|Kenalog|Tricort-40|Triamcinolone acetonide|Tricort40"
NEW15829,CHEBI,aid liver drug metabolism,AID liver drug metabolism
NEW15830,CHEMICAL,such pns sow,Such PNS sows
NEW15831,DISEASE,such pns sow,abnormal maternal behaviour
NEW15832,DISEASE,self-reported delusion,alcohol disorder
NEW15833,DISEASE,sympathomimetic toxidrome,sympathomimetic toxidrome
NEW15834,MENTAL_HEALTH,excited delirium syndrome,Excited delirium syndrome
NEW15835,CHEBI,excited delirium syndrome,sympathomimetic surge
NEW15836,MENTAL_HEALTH,excited delirium syndrome,marked agitation
NEW15837,DISEASE,excited delirium syndrome,Excited delirium syndrome|ExDS
NEW15838,CHEMICAL,prehospital ketamine,Prehospital ketamine
NEW15839,MENTAL_HEALTH,prehospital ketamine,excited delirium
NEW15840,CHEBI,adrenocorticotrophic hormone rat model,Adrenocorticotrophic hormone rat model
NEW15841,DISEASE,adrenocorticotrophic hormone rat model,cognitive senescence
NEW15842,CHEBI,hpg axis hormone,HPG axis hormones
C472067,CHEMICAL,levocetirizine [Supplementary Concept],Levocetirizine|levocetirizine|Cetirizine
NEW15843,CHEMICAL,simple well histamine receptor,simpler better histamine receptor
NEW15844,CHEBI,lithium mood stabilizer,lithium mood stabilizers
NEW15845,CHEMICAL,lithium mood stabilizer,GD symptoms
NEW15846,CHEMICAL,lithium mood stabilizer,different DAA receptors
NEW15847,CHEBI,selective da-1 agonist,Selective DA-1 agonists
NEW15848,MENTAL_HEALTH,selective da-1 agonist,renal vascular resistance
C504483,DISEASE,"IQSEC1 protein, human [Supplementary Concept]",Guanine Nucleotide Exchange Factors|human ARF
NEW15849,CHEBI,peripheral thyroid hormone action compatible,peripheral thyroid hormone action compatible
NEW15850,CHEBI,peripheral thyroid hormone action compatible,approved biased agonist oliceridine
NEW15851,CHEBI,peripheral thyroid hormone action compatible,biased MOR agonists
NEW15852,MENTAL_HEALTH,respiration depression,respiration depression
NEW15853,DISEASE,respiration depression,single hepatotoxic dose
NEW15854,CHEMICAL,dibenzazepine mg/kg,dibenzazepine mg/kg
C004822,CHEMICAL,"10,11-dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide [Supplementary Concept]",Carbamazepine/analogs  and  derivatives|dibenzazepine
NEW15855,MENTAL_HEALTH,dibenzazepine mg/kg,greater repression
D013287,CHEBI,Illicit Drugs,"Street Drug|Drugs, Street|Illegal Drug|Drug, Club|club drug|Drug, Street|Drugs, Illicit|Illicit Drug|Drug, Illegal|Drugs, Illegal|Street Drugs|Illegal Drugs|Drug, Illicit|Recreational Drug|Recreational Drugs|Drug, Recreational|Club Drug|Drugs, Club|Club Drugs|Drugs, Recreational"
D043586,CHEMICAL,Methylmalonyl-CoA Decarboxylase,"Carboxylase, Propionyl-Coenzyme A|Propionyl CoA Carboxylase|Propionyl-Coenzyme A Carboxylase|Decarboxylase, Methylmalonyl-CoA|propionyl coenzyme A|Propionyl Coenzyme A Carboxylase|Propionyl-CoA Carboxylase|Methylmalonyl CoA Decarboxylase"
NEW15856,CHEMICAL,dibenzazepine mg/kg,acetyl CoA. disorder
NEW15857,CHEMICAL,dibenzazepine mg/kg,carboxylases pyruvate
http://purl.obolibrary.org/obo/DOID_857,DISEASE,multiple carboxylase deficiency,Multiple carboxylases deficiency
NEW15858,CHEMICAL,trinitrate ointment,trinitrate ointment
NEW15859,DISEASE,trinitrate ointment,chronic anal fissure
NEW15860,CHEMICAL,myrtus communis,Myrtus communis|Mc-80ME
NEW15861,CHEBI,antibiotic resistant,Antibiotic resistant
NEW15862,DISEASE,antibiotic resistant,early stage colon cancer
NEW15863,MENTAL_HEALTH,5-fu resistance,5-FU resistance
NEW15864,CHEBI,5-fu resistance,drug transport
NEW15865,MENTAL_HEALTH,certain resistance mechanism,Certain resistance mechanisms
D054067,CHEMICAL,Dihydropyrimidine Dehydrogenase Deficiency,"Dihydropyrimidine Dehydrogenase Deficiencies|Familial Pyrimidinemia|Familial Pyrimidemia|Thymine-Uracilurias, Hereditary|Dihydropyrimidinuria|Pyrimidemias, Familial|Pyrimidemia, Familial|Familial Pyrimidemias|Deficiency, DPD|dihydropyrimidine dehydrogenase|Thymine-Uraciluria, Hereditary|Dehydrogenase Deficiencies, Dihydropyrimidine|Dihydropyrimidinurias|Hereditary Thymine-Uracilurias|Deficiencies, Dihydropyrimidine Dehydrogenase|Pyrimidinemia, Familial|Deficiencies, DPD|Thymine Uraciluria, Hereditary|Hereditary Thymine-Uraciluria|Dehydrogenase Deficiency, Dihydropyrimidine|Deficiency, Dihydropyrimidine Dehydrogenase|Familial Pyrimidinemias|Pyrimidinemias, Familial|DPD Deficiencies|DPD Deficiency|Hereditary Thymine Uraciluria"
NEW15866,MENTAL_HEALTH,severe alcohol withdrawal syndrome,severe alcohol withdrawal syndromes
NEW15867,CHEMICAL,thyrotoxic periodic paralysis,Thyrotoxic periodic paralysis|TPP
D018943,CHEMICAL,Anthracyclines,Anthracycline|Anthracyclines|anthracyclines
D004317,CHEMICAL,Doxorubicin,"|Adriblastin|Onkodox|Doxorubicine Baxter|Adriamycin|DOXO-cell|Adriblastina|Doxorubicina Funk|Adriblastine|Doxorubicin NC|Doxorubicina Ferrer Farm|Urokit Doxo-cell|Urokit Doxo cell|doxorubicin|Doxorubicina Tedec|Hydrochloride, Doxorubicin|doxorubicin-|Doxolem|Adrimedac|Doxorubicin Hydrochloride|Ribodoxo|Rubex|Adriablastine|DOXO cell|Myocet|Doxorubicin Hexal|adriamycin|Doxotec|Adriablastin|Farmiblastina"
NEW15868,DISEASE,thyrotoxic periodic paralysis,dose-dependent cardiotoxicity
D064730,CHEMICAL,Dexrazoxane,"Razoxane, (S)-Isomer|NSC-169780|ICRF-187|dexrazoxane|Cardioxane|ADR529|Razoxane, (S)-Isomer, Hydrochloride|NSC 169780|ICRF187|Hydrochloride, Dexrazoxane|Zinecard|ADR 529|Dexrazoxane Hydrochloride|NSC169780|Cardioxan|ICRF 187|ADR-529"
NEW15869,DISEASE,thyrotoxic periodic paralysis,anthracycline-induced cardiotoxicity
NEW15870,CHEMICAL,class statin,classes statins
NEW15871,DISEASE,class statin,neurotransmitter abnormalities
NEW15872,DISEASE,severe mood episode,severe mood episodes
NEW15873,DISEASE,severe mood episode,naloxone-precipitated withdrawal syndrome
NEW15874,CHEMICAL,nicotinic acetylcholine receptor subtype inhibitor,Nicotinic acetylcholine receptor subtype inhibitors
NEW15875,DISEASE,nicotinic acetylcholine receptor subtype inhibitor,acute dependence
NEW15876,DISEASE,nicotinic acetylcholine receptor subtype inhibitor,schizophrenic women
NEW15877,DISEASE,nicotinic acetylcholine receptor subtype inhibitor,toxic multinodular goiter
NEW15878,DISEASE,nicotinic acetylcholine receptor subtype inhibitor,toxic adenoma
NEW15879,DISEASE,overt hyperthyroidism,Overt hyperthyroidism
NEW15880,CHEMICAL,overt hyperthyroidism,thyroxine values
NEW15881,DISEASE,subclinical hyperthyroidism,subclinical hyperthyroidism
NEW15882,CHEMICAL,subclinical hyperthyroidism,radioactive iodine ablation
NEW15883,DISEASE,ensue inflammation,ensuing inflammation
NEW15884,MENTAL_HEALTH,ensue inflammation,mental confusion
NEW15885,CHEBI,ensue inflammation,vitamin B3 deficiency
NEW15886,CHEBI,ensue inflammation,vitamin B3 fortification programs
NEW15887,CHEMICAL,nad+ metabolism,NAD+ metabolism
NEW15888,CHEMICAL,nad+ metabolism,NAD+ biosynthetic pathway
NEW15889,CHEMICAL,host 's nad+ salvage pathway,host's NAD+ salvage pathway
NEW15890,CHEMICAL,host 's nad+ salvage pathway,COVID-19 severity
D041221,DISEASE,Candida glabrata,Candida|Torulopsis glabrata
D003883,DISEASE,Arthrodermataceae,"Ctenomyces|Nannizzias|Cutaneous Fungus|Nannizzia|Arthroderma|Arthrodermas|dermatophytes|Ctenomyce|Dermatomyces|Dermatophytes|Fungi, Cutaneous|Dermatomyce|Keratinomyce|Cutaneous Fungi|Fungus, Cutaneous|Keratinomyces|Dermatophyte"
D001236,DISEASE,Aspergillus oryzae,Aspergillus|Eurotium oryzae
NEW15891,NUTRITION,simple oxygenated xanthone,simple oxygenated xanthones
NEW15892,DISEASE,simple oxygenated xanthone,moderate-to-severe cognitive impairment related
NEW15893,DISEASE,simple oxygenated xanthone,themselves
D009145,DISEASE,Mushroom Poisoning,"Poisoning, Mushroom|Poisonings, Mushroom|Mushroom Poisonings|mushroom poisoning"
NEW15894,CHEBI,toxin responsible,toxin responsible
NEW15895,MENTAL_HEALTH,erythropoietin resistance index,erythropoietin resistance index
NEW15896,CHEBI,erythropoietin resistance index,agent responsiveness
NEW15897,CHEMICAL,cerebral regional oxygen saturation,cerebral regional oxygen saturation
D013960,CHEBI,Thyroid Function Tests,"Thyrotroph Thyroid Hormone Sensitivity Index|Thyroid Function Test|Sum Activity of Peripheral Deiodinases|Jostel TSH Index|TSH Index, Jostel's|Thyrotropin Index, Jostel's|Thyroid Gland Function Tests|SPINA-GT|Test, Thyroid Function|Jostels Thyrotropin Index|Jostel Thyrotropin Index|Secretory Capacity of the Thyroid Gland|Test, Protein-Bound Iodine|Jostel's TSH Indices|Protein-Bound Iodine Test|Protein Bound Iodine Test|Protein-Bound Iodine Tests|SPINA-GD|Jostel's Thyrotropin Index|hormone sensitivity|Function Test, Thyroid|Iodine Test, Protein-Bound|Jostels TSH Index|Jostel's TSH Index"
NEW15898,DISEASE,hormone therapy,to autism spectrum disorders|ASDs
NEW15899,MENTAL_HEALTH,hormone therapy,Autism Genetic Resource Exchange
NEW15900,CHEBI,adjuvant vitamin d supplementation therapy,adjuvant vitamin D supplementation therapy
NEW15901,CHEBI,low vitamin d,beta activity
NEW15902,MENTAL_HEALTH,low vitamin d,insomnia management
D050901,CHEMICAL,Nitrate Reductase,"Nitrate Reductase, Respiratory|nitrate reductase|Reductase, Nitrate|Reductase, Respiratory Nitrate|Quinol-Nitrate Oxidoreductase|Respiratory Nitrate Reductase|Oxidoreductase, Quinol-Nitrate|Quinol Nitrate Oxidoreductase"
NEW15903,CHEMICAL,low vitamin d,glutamate molecule
D050790,CHEMICAL,Glutamate Synthase (NADH),"NADH Glutamate Synthase|glutamate synthase|NADH Dependent Glutamate Synthase|Glutamate Synthase, NADH-Dependent|NADH-GOGAT|L-Glutamate Synthetase|Synthase, NADH-Dependent Glutamate|L Glutamate Synthetase|NADH-Glutamate Synthase|NADH GOGAT|Synthetase, L-Glutamate|NADH-Dependent Glutamate Synthase"
NEW15904,CHEMICAL,Montmorency tart cherry juice,Montmorency tart cherry juice
NEW15905,MENTAL_HEALTH,Montmorency tart cherry juice,visual distractibility threshold
NEW15906,CHEMICAL,adjunctive tiagabine,adjunctive tiagabine
NEW15907,DISEASE,adjunctive tiagabine,aggressive outbursts
NEW15908,DISEASE,adjunctive tiagabine,disinhibited behaviors
NEW15909,DISEASE,diet-induced obesity,pre-existing obesity
NEW15910,DISEASE,diet-induced obese,Diet-induced obese
NEW15911,DISEASE,cardiovascular autonomic neuropathy,cardiovascular autonomic neuropathy|CAN
NEW15912,CHEMICAL,±6.42 %,±6.42 %
NEW15913,CHEBI,selective leukotriene receptor antagonist,selective leukotriene receptor antagonist
NEW15914,DISEASE,pancreatic cell damage,pancreatic cell damage
NEW15915,DISEASE,high-fat diet-induced obesity,high-fat diet-induced obesity
NEW15916,MENTAL_HEALTH,nonaddictive analgesia,nonaddictive analgesia
NEW15917,DISEASE,nutritional impairment,nutritional impairments
NEW15918,CHEMICAL,atypical vesicular glutamate transporter type 3,atypical vesicular glutamate transporter type 3|VGLUT3
NEW15919,DISEASE,atypical vesicular glutamate transporter type 3,l-DOPA-induced phosphorylation
C431939,CHEBI,carotenoid cleavage dioxygenase 1 [Supplementary Concept],carotenoid|Dioxygenases
NEW15920,MENTAL_HEALTH,atypical vesicular glutamate transporter type 3,Depression Inventory-II
NEW15921,CHEMICAL,dietary flavonoid,dietary flavonoids
NEW15922,CHEBI,specific carotenoid,specific carotenoids
http://purl.obolibrary.org/obo/CHEBI_38077,CHEMICAL,polypyrrole,PPys|polypyrroles|poly(pyrrole)s|Polyaniline nanoparticles
C038678,CHEMICAL,N-methylpyrrolidone [Supplementary Concept],Pyrrolidinones|NMP|N-methylpyrrolidone
NEW15923,DISEASE,ampa-type glutamate receptor,alprazolam-induced spatial deficits
D045730,CHEMICAL,Soy Foods,"Miso|Soy-PL|Soy Food|Soy Protein, Texturized|Tempeh|Vegetable Protein, Texturized|Soy Bean Curds|Soy Cheeses|Soy Proteins, Texturized|Soy Sauce|Curds, Soy Bean|Bean Curd, Soy|Food, Soy|Texturized Soy Protein|Vegetable Proteins, Texturized|Sauce, Soy|Texturized Vegetable Protein|soy|Natto|Protein, Texturized Soy|Bean Curds, Soy|Curd, Soy Bean|Tofu|Soy Cheese|Soy Bean Curd|Cheeses, Soy|Proteins, Texturized Soy|Cheese, Soy|Foods, Soy|Texturized Soy Proteins|Protein, Texturized Vegetable"
D058867,CHEMICAL,Lipoprotein Lipase Activators,"Lipoprotein Lipase Activating Agents|lipase|Activators, Lipoprotein Lipase|Lipase Activators, Lipoprotein"
NEW15924,CHEMICAL,endogenous acetylcholine,endogenous acetylcholine
NEW15925,CHEBI,endogenous acetylcholine,novel cholinomimetic agents
NEW15926,CHEMICAL,endogenous ach,endogenous ACh
NEW15927,MENTAL_HEALTH,endogenous ach,regression equation
NEW15928,CHEMICAL,glutamate receptor dysfunction,Glutamate receptor dysfunction
NEW15929,DISEASE,treatment-resistant depressive,treatment-resistant depressives
NEW15930,CHEBI,nmdar antagonist administration,NMDAR antagonist administration
NEW15931,DISEASE,nmdar antagonist administration,models anxiety- behaviors
NEW15932,DISEASE,depressive phenotype,depressive phenotype
NEW15933,MENTAL_HEALTH,rapid movement sleep behavior disorder,rapid movement sleep behavior disorder
NEW15934,MENTAL_HEALTH,profound insomnia,profound insomnia
NEW15935,DISEASE,central neurogenic hypoventilation,central neurogenic hypoventilation
D010845,DISEASE,Obesity Hypoventilation Syndrome,"Obesity-Hypoventilation Syndromes|Pickwickian Syndrome|hypoventilation|Obesity-Hypoventilation Syndrome|Hypoventilation Syndrome, Obesity"
NEW15936,CHEMICAL,central neurogenic hypoventilation,anti-N-methyl-d-aspartate receptor antibody encephalitis
D012135,DISEASE,Respiratory Sounds,"Wheezing|Rales|Rhonchi|Respiratory Sound|Rale|Breathing Sounds|Stridor|Rub, Pleural|Sound, Breathing|Breathing Sound|stridor|Lung Sounds|Sounds, Lung|Stridors|Sound, Lung|Rhonchus|Pleural Rub|Pleural Rubs|Crackle|Sounds, Breathing|Lung Sound|Wheezings|Crackles|Sound, Respiratory"
NEW15937,CHEMICAL,combined serotonin,combined serotonin
NEW15938,DISEASE,combined serotonin,extrapyramidal motor symptoms
NEW15939,CHEMICAL,h(1)-histamine receptor blocker,H(1)-histamine receptor blockers
C014742,CHEMICAL,quifenadine [Supplementary Concept],Benzhydryl Compounds|Quifenadine
NEW15940,DISEASE,h(1)-histamine receptor blocker,supraventricular PB
NEW15941,CHEMICAL,Quifanidine,Quifanidine
NEW15942,DISEASE,Quifanidine,sinus node depression
NEW15943,NUTRITION,low cholesterol,low cholesterol
NEW15944,CHEMICAL,low cholesterol,cholesterolemia
http://purl.obolibrary.org/obo/CHEBI_84071,NUTRITION,c22-c26 saturated fatty acid,saturated fatty acid diet|elevated saturated fatty acids|saturated fatty acid levels|long-chain saturated fatty acid tetracosanoic acid|Elevated saturated fatty acids|C22-C26 saturated fatty acids
NEW15945,DISEASE,hematopathologic finding,hematopathologic findings
NEW15946,CHEMICAL,hematopathologic finding,unexplained cytopenia(s
NEW15947,CHEMICAL,valproic acid vpa injection,Valproic acid VPA injection
NEW15948,CHEMICAL,vpa rat,VPA rats
D066255,CHEMICAL,EGF Family of Proteins,"proteins|Epidermal Growth Factors|Proteins EGF Family|EGF Receptor Ligands|Epidermal Growth Factor-Like Proteins|Ligands, EGF Receptor|Receptor Ligands, EGF|DEPs|Epidermal Growth Factor Like Proteins"
NEW15949,CHEMICAL,prazosin addition,prazosin addition
NEW15950,CHEMICAL,prazosin addition,number ISRCTN61562706
NEW15951,CHEMICAL,clinical trial prazosin,clinical trial Prazosin
NEW15952,CHEBI,acridinecarboxamide topoisomerase poison,acridinecarboxamide topoisomerase poisons
NEW15953,MENTAL_HEALTH,acridinecarboxamide topoisomerase poison,molecular rationalization
NEW15954,CHEBI,appropriate antimicrobial medication,appropriate antimicrobial medications
D017282,DISEASE,Tick-Borne Diseases,"Tick-Borne Infection|Diseases, Tick-Borne|Tick Borne Infection|Tick Borne Diseases|Infections, Tick Borne|tick-borne diseases|Diseases, Tick Borne|Disease, Tick Borne|Tick Borne Infections|Borne Diseases, Tick|Borne Disease, Tick|tick-borne infections|Tick-Borne Infections|Infection, Tick-Borne|Tick Borne Disease|Tick-Borne Disease|Disease, Tick-Borne|Infections, Tick-Borne"
NEW15955,CHEMICAL,odorata Cav,odorata Cav
NEW15956,CHEMICAL,nmdar-dependent bursting activity,NMDAR-dependent bursting activity
NEW15957,CHEMICAL,nmdar-dependent bursting activity,rapid antidepressant actions
NEW15958,MENTAL_HEALTH,nmdar-dependent bursting activity,depression pathogenesis
NEW15959,DISEASE,functional fragile x mental retardation protein,functional Fragile X mental retardation protein
NEW15960,CHEMICAL,functional fragile x mental retardation protein,synaptic metabotropic glutamate receptors
NEW15961,CHEMICAL,pi3 k signaling,PI3 K signaling
D002697,CHEMICAL,Chloral Hydrate,"Chloral hydrate|Hydrate, Chloral|Noctec"
NEW15962,CHEMICAL,pi3 k signaling,hydrate chloral
NEW15963,NUTRITION,pi3 k signaling,omega-3 polyunsaturated fatty acids
NEW15964,CHEBI,pi3 k signaling,first dual orexin receptor antagonist
NEW15965,CHEMICAL,pi3 k signaling,increased plasma norepinephrine
NEW15966,CHEMICAL,high baclofen dose,higher baclofen doses
C534342,CHEMICAL,drospirenone and ethinyl estradiol combination [Supplementary Concept],Ethinyl Estradiol|Androstenes|drospirenone|DRSP
NEW15967,CHEBI,to oseltamivir carboxylate,ruined carriers
NEW15968,DISEASE,androgenetic alopecia aga management,Androgenetic alopecia AGA management
NEW15969,CHEMICAL,androgenetic alopecia aga management,gender-diverse|TGD
NEW15970,CHEMICAL,androgenetic alopecia aga management,gas extraction
NEW15971,CHEMICAL,androgenetic alopecia aga management,silicone fiber-based membrane-dialyzer assembly
NEW15972,MENTAL_HEALTH,androgenetic alopecia aga management,direct purging
NEW15973,CHEMICAL,gas sensor,gas sensors
D014946,DISEASE,Wound Infection,"Wound Infections|wound infection|Infection, Wound|Infections, Wound"
NEW15974,DISEASE,gas sensor,tumor behaviors
NEW15975,CHEBI,transient receptor potential vanilloid type1 agonist,transient receptor potential vanilloid type1 agonist
NEW15976,DISEASE,transient receptor potential vanilloid type1 agonist,anaplastic thyroid cancer cells
NEW15977,CHEMICAL,mitochondrial calcium homeostasis,mitochondrial calcium homeostasis
NEW15978,CHEMICAL,low-dose dietary capsaicin,low-dose dietary capsaicin
D006334,DISEASE,Heart Function Tests,"Heart Function Test|Cardiac Function Tests|Test, Heart Function|Function Test, Cardiac|Function Tests, Cardiac|Function Tests, Heart|Tests, Cardiac Function|heart function|Function Test, Heart|Tests, Heart Function|Test, Cardiac Function|Cardiac Function Test"
NEW15979,MENTAL_HEALTH,erectile dysfunction present,erectile dysfunction present
NEW15980,CHEMICAL,erectile dysfunction present,protaglandins
NEW15981,CHEMICAL,frog wsc,frog WSC
NEW15982,DISEASE,frog wsc,passive-protective behavior
NEW15983,DISEASE,catalepsy homologue,catalepsy homologue
NEW15984,CHEMICAL,catalepsy homologue,high dopamine content
NEW15985,CHEBI,catalepsy homologue,μ-opioid receptor agonist DAMGO
NEW15986,MENTAL_HEALTH,negative schizophrenia,negative schizophrenia
NEW15987,CHEMICAL,negative schizophrenia,gamma-aminobutyric acid GABAA receptor subunits
D036841,DISEASE,Ciguatera Poisoning,"Ciguatera Poisonings|Ciguatera Fish Poisoning|Poisonings, Ciguatera Fish|Poisonings, Ciguatera|Ciguatera Fish Poisonings|Ciguatera|Poisoning, Ciguatera Fish|Poisoning, Ciguatera|Ciguatera poisoning"
NEW15988,DISEASE,negative schizophrenia,common food-borne illness related
NEW15989,DISEASE,toxinological syndrome,toxinological syndrome
NEW15990,CHEMICAL,hallucinogen persist perception disorder,hallucinogen persisting perception disorder
C004704,CHEMICAL,cyclobenzaprine [Supplementary Concept],Amitriptyline/analogs  and  derivatives|Cyclobenzaprine
http://purl.obolibrary.org/obo/CHEBI_51371,CHEMICAL,muscle relaxant,dimethylpropanamine skeletal muscle relaxant|muscle relaxants
NEW15991,DISEASE,partial onset seizure,partial onset seizures
NEW15992,CHEMICAL,podophyllin reaction,podophyllin reaction
D001913,DISEASE,Bowen's Disease,"Bowens Disease|Disease, Bowen's|Disease, Bowen|Bowen Disease|Bowen's disease"
NEW15993,DISEASE,organic skin disease,organic skin disease
NEW15994,CHEMICAL,organic skin disease,(ER)-mediated pathway activation
NEW15995,DISEASE,non-malignant catatonia,non-malignant catatonia
NEW15996,CHEMICAL,weak n-methyl-d-aspartate nmda receptor-antagonist,weak N-Methyl-D-Aspartate NMDA receptor-antagonists
NEW15997,CHEMICAL,blood aba level,Blood ABA levels
NEW15998,DISEASE,activity-based anorexia,advanced COPD stages
NEW15999,DISEASE,activity-based anorexia,COPD stages
NEW16000,DISEASE,activity-based anorexia,COPD pathogenesis
NEW16001,CHEBI,serum thyroid hormone concentration,serum thyroid hormone concentrations
NEW16002,CHEBI,serum thyroid hormone concentration,hormone function
NEW16003,MENTAL_HEALTH,somatic anxiety,somatic anxiety
NEW16004,DISEASE,somatic anxiety,Postoperative pain scores
http://purl.obolibrary.org/obo/CHEBI_6121,CHEMICAL,ketamine,Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|ketamine|NMDA|KETAMINE|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|dl-ketamine|2-(2-chlorophenyl)-2-(methylamino)cyclohexanone|special K|ketaminum|ketamina|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|DL-ketamine|(+-)-ketamine|small-dose ketamine
NEW16005,DISEASE,depressed mood,Depressed mood
http://purl.obolibrary.org/obo/CHEBI_8411,CHEMICAL,primidolol,beta-adrenoblocker|Primidolol
D006998,MENTAL_HEALTH,Hypochondriasis,"Hypochondriacal Neuroses|Neurosis, Hypochondriacal|hypochondriasis|Hypochondriacal Neurosis"
NEW16006,DISEASE,psychosocial dysadaptation,psychosocial dysadaptation
NEW16007,CHEMICAL,transepithelial electrical resistance,potassium ions
D065348,DISEASE,Macular Pigment,"Macular pigment|Pigment, Macular|MP"
NEW16008,CHEMICAL,membrane-impermeant no scavenger cptio,membrane-impermeant NO scavenger cPTIO
NEW16009,CHEMICAL,nos inhibitor l-name,NOS inhibitor L-NAME
C096240,CHEMICAL,"cyclosporin A, MeAla(3)-Phe(7)-Ser(8)- [Supplementary Concept]",Cyclosporins|cyclosporin A
NEW16010,CHEMICAL,transmitter release,transmitter release
NEW16011,CHEMICAL,transmitter release,NO signalling pathway
NEW16012,MENTAL_HEALTH,long-lasting depression,long-lasting depression
NEW16013,CHEBI,gabaa agonist midazolam,GABAA agonist midazolam
NEW16014,DISEASE,gabaa agonist midazolam,devastating cerebral injuries
NEW16015,CHEMICAL,gabaa agonist midazolam,current second-line combination treatment
NEW16016,CHEBI,nmdar antagonist s-ketamine,NMDAR antagonist s-ketamine
NEW16017,CHEBI,nmdar antagonist s-ketamine,cytokinin receptor family
NEW16018,NUTRITION,primary root growth promotion,primary root growth promotion
NEW16019,DISEASE,primary root growth promotion,arterial thromboembolism
NEW16020,CHEMICAL,primary root growth promotion,R-warfarin
NEW16021,CHEBI,ppar-γ agonist pioglitazone,PPAR-γ agonist pioglitazone
NEW16022,DISEASE,ppar-γ agonist pioglitazone,Klebsiella pneumonia
NEW16023,CHEMICAL,14n nuclear quadrupole coupling hyperfine structure,14N nuclear quadrupole coupling hyperfine structure
NEW16024,DISEASE,14n nuclear quadrupole coupling hyperfine structure,DS pneumonias
NEW16025,DISEASE,14n nuclear quadrupole coupling hyperfine structure,non-COVID-19 pneumonias
NEW16026,DISEASE,14n nuclear quadrupole coupling hyperfine structure,delayed onset catatonia
NEW16027,MENTAL_HEALTH,14n nuclear quadrupole coupling hyperfine structure,COVID-induced brief psychotic disorder
NEW16028,DISEASE,14n nuclear quadrupole coupling hyperfine structure,AKI kidney injury
C523273,CHEMICAL,"NrdR protein, E coli [Supplementary Concept]",Escherichia coli Proteins|NrdR
NEW16029,CHEMICAL,14n nuclear quadrupole coupling hyperfine structure,elevated dNTPs
NEW16030,CHEBI,glycoprotein iib/iiia receptor antagonist,Glycoprotein IIb/IIIa receptor antagonists
C046817,CHEMICAL,cefteram pivoxil [Supplementary Concept],Cefmenoxime/analogs  and  derivatives|Tomiron
NEW16031,CHEBI,glycoprotein iib/iiia receptor antagonist,useful oral antimicrobial agent
NEW16032,DISEASE,schizophrenia abnormal gene,schizophrenia abnormal gene
NEW16033,DISEASE,schizophrenia abnormal gene,trauma memory
D002692,DISEASE,Chlamydia trachomatis,Chlamydia trachomatis|Chlamydia (1966-1975)
NEW16034,NUTRITION,serum folate level,serum folate levels
NEW16035,NUTRITION,serum folate level,Serum folate levels
NEW16036,MENTAL_HEALTH,previous suicide attempt,previous suicide attempt
NEW16037,MENTAL_HEALTH,logistic regression model,logistic regression models
NEW16038,CHEBI,reduce serum folate level,Reduced serum folate levels
NEW16039,DISEASE,physician-confirmed food allergy,physician-confirmed food allergies
D007064,CHEMICAL,L-Iditol 2-Dehydrogenase,"Dehydrogenase, Iditol|Iditol Dehydrogenase|2-Dehydrogenase, L-Iditol|L Iditol 2 Dehydrogenase|Dehydrogenase, Polyol|Polyol Dehydrogenase|Dehydrogenase, Sorbitol|polyol|Sorbitol Dehydrogenase"
D009004,CHEMICAL,Monosaccharide Transport Proteins,"Hexose Transporter|Glucose Transport-Inducing Protein|Transport-Inducing Protein, Glucose|monosaccharide|Preactin, Band 4.5|Transport Proteins, Hexose|4.5 Preactin, Band|Glucose Transport Inducing Protein|Hexose Transport Proteins|Proteins, Monosaccharide Transport|Transport Proteins, Monosaccharide|Erythrocyte Band 4.5 Protein|Band 4.5 Preactin"
NEW16040,DISEASE,gut microbiota alteration,gut microbiota alterations
NEW16041,CHEBI,lxr agonist treatment,LXR agonist treatment
NEW16042,DISEASE,intrauterine growth retardation iugr neonatus,intrauterine growth retardation IUGR neonatus
NEW16043,NUTRITION,intrauterine growth retardation iugr neonatus,lower cholesterol concentrations
NEW16044,CHEMICAL,intrauterine growth retardation iugr neonatus,newer benzodiazepine
NEW16045,NUTRITION,intrauterine growth retardation iugr neonatus,snow crab fishing industry
NEW16046,MENTAL_HEALTH,resistance test,resistance test
NEW16047,CHEBI,ssri initiation,SSRI initiation
NEW16048,CHEBI,flexible 32-channel polymer microelectrode array,flexible 32-channel polymer microelectrode arrays
NEW16049,MENTAL_HEALTH,flexible 32-channel polymer microelectrode array,schizophrenia model
http://purl.obolibrary.org/obo/DOID_2228,DISEASE,thrombocytosis,Thrombocythaemia|hyperviscosity
NEW16050,CHEBI,polymer formation,polymer formation
D053718,DISEASE,Scleromyxedema,"papular mucinosis|Mucinosis, Papular|Myxedematosus, Lichen|Papular Mucinosis|Lichen Myxedematosus"
D007166,CHEMICAL,Immunosuppressive Agents,"Immunosuppressant|Agents, Immunosuppressive|Agent, Immunosuppressive|immunosuppressants|Immunosuppressive Agent|Immunosuppressants"
NEW16051,CHEMICAL,testosterone supplementation,Testosterone supplementation
NEW16052,MENTAL_HEALTH,testosterone supplementation,distressful low desire disorder
NEW16053,CHEMICAL,srs-4,SRS-4
NEW16054,CHEMICAL,serum homocysteine,Serum homocysteine
NEW16055,CHEMICAL,serum homocysteine,plasma Abeta levels
D065708,DISEASE,Porencephaly,"Col4a1 Related Brain Small Vessel Disease|small vessel disease|Porencephalies, Posttraumatic|Brain Small Vessel Disease With Axenfeld Rieger Anomaly|Posttraumatic Porencephalies|Post traumatic Porencephaly|Porencephaly, Post-traumatic|Congenital Porencephaly|Type 1 Porencephaly|Retinal Arteriolar Tortuosity, Infantile Hemiparesis, and Leukoencephalopathy, Autosomal Dominant|Leukoencephalopathy with Axenfeld-Rieger Anomaly|Porencephaly, Type 1, Autosomal Dominant|Post-traumatic Porencephaly|Brain Small Vessel Disease with Hemorrhage|Porencephaly, Familial|Porencephaly Type 1|Porencephaly, Developmental|Porencephaly, Posttraumatic|Posttraumatic Porencephaly|Developmental Porencephaly|Porencephalies, Post-traumatic|Autosomal Dominant Porencephaly Type 1|Post-traumatic Porencephalies|Col4a1-Related Brain Small-Vessel Disease|Brain Small-Vessel Disease with Hemorrhage|Porencephaly, Congenital|Porencephalies|Brain Small Vessel Disease With Axenfeld-Rieger Anomaly|Encephaloclastic Porencephaly|Familial Porencephaly|Familial Porencephalic White Matter Disease|Infantile Hemiplegia with Porencephaly|Porencephaly, Type 1|Leukoencephalopathy with Axenfeld Rieger Anomaly|Porencephaly, Encephaloclastic"
NEW16056,CHEBI,vitamin intervention,Vitamin Intervention
NEW16057,DISEASE,vitamin intervention,Stroke Prevention
NEW16058,CHEMICAL,fxrα,fxrα
D061985,DISEASE,Madin Darby Canine Kidney Cells,"kidney|MDCK Cells|MDCK Cell|Cells, MDCK|Cell, MDCK"
NEW16059,CHEMICAL,high-carbohydrate diet,High-carbohydrate diet
NEW16060,CHEMICAL,high-carbohydrate diet,triglyceride concentrations
NEW16061,CHEMICAL,high carbohydrate level,High carbohydrate levels
NEW16062,NUTRITION,high carbohydrate level,cholesterol synthesis
NEW16063,CHEBI,characterize virulence factor,characterized virulence factor
NEW16064,CHEBI,characterize virulence factor,AB-type toxin
C508358,DISEASE,"PLEKHF1 protein, human [Supplementary Concept]",Apoptosis Regulatory Proteins|Apoptosis-Inducing Protein
C000625557,CHEMICAL,roluperidone [Supplementary Concept],Roluperidone|Indoles
NEW16065,DISEASE,mda-mb-231 breast cancer cell,MDA-MB-231 breast cancer cells
NEW16066,NUTRITION,mda-mb-231 breast cancer cell,phosphatidylserine disruption
NEW16067,DISEASE,germ cell tumor risk,Germ cell tumor risk
NEW16068,CHEBI,germ cell tumor risk,androgene action
NEW16069,DISEASE,germ cell tumor risk,5α-reductase deficiency
NEW16070,DISEASE,germ cell tumor risk,hemochromatosis gene|HFE
NEW16071,DISEASE,germ cell tumor risk,male breast cancer risk
NEW16072,CHEMICAL,germ cell tumor risk,first-line antidepressants
NEW16073,CHEBI,estrogen molecule,estrogen molecules
NEW16074,CHEMICAL,estrogen molecule,hepatic glucose production
C052407,CHEMICAL,"HGP-30 peptide, Human immunodeficiency virus-1 [Supplementary Concept]","HGP|HIV Antigens|Peptides|gag Gene Products, Human Immunodeficiency Virus"
NEW16075,CHEMICAL,response to thyrotropin-releasing hormone,tetrodotoxin solution
NEW16076,CHEMICAL,4-(4-hydroxyphenyl)-2-butanone,4-(4-hydroxyphenyl)-2-butanone
NEW16077,DISEASE,4-(4-hydroxyphenyl)-2-butanone,weight loss supplement
http://purl.obolibrary.org/obo/CHEBI_39093,CHEMICAL,organophosphorus pesticide,OPPs|organophosphorus pesticides|Organophosphorus pesticides
NEW16078,DISEASE,severe hypersensitivity reaction,severe hypersensitivity reactions
NEW16079,DISEASE,oral hypoaesthesia,oral hypoaesthesia
NEW16080,NUTRITION,phospholipid vesicle,Phospholipid vesicles
NEW16081,DISEASE,phospholipid vesicle,intravascular clotting
NEW16082,DISEASE,phospholipid vesicle,hyperkinetic movement disorders
D006529,DISEASE,Hepatomegaly,"|Liver, Enlarged|Enlarged Liver|enlargement of the liver|hepatomegaly"
NEW16083,CHEMICAL,antibiotic-resistant iturin c,Antibiotic-resistant Iturin C
NEW16084,MENTAL_HEALTH,antibiotic-resistant iturin c,resistance potential
NEW16085,CHEMICAL,first rrr pattern,first RRR pattern
NEW16086,DISEASE,first rrr pattern,residual schizophrenic symptoms
C583443,CHEMICAL,technetium 99m diethylenetriaminepentaacetic acid neolactosyl human serum albumin [Supplementary Concept],Organotechnetium Compounds|[99mTc]DTPA|Serum Albumin
NEW16087,DISEASE,various brain tumor,Various brain tumors
NEW16088,CHEMICAL,various brain tumor,[18F]FDG PET
NEW16089,DISEASE,recurrent tumor,recurrent tumors
NEW16090,DISEASE,radiation necrosis,radiation necrosis
NEW16091,CHEMICAL,[11c]methylmethionine,[11C]methylmethionine
http://purl.obolibrary.org/obo/CHEBI_50949,CHEBI,serotonin uptake inhibitor,selective serotonin uptake inhibitor|serotonin reuptake inhibitor|SSRI
NEW16092,MENTAL_HEALTH,depression rating scale,depression rating scale
NEW16093,CHEMICAL,tacrolimus treatment,tacrolimus treatment
D000405,MENTAL_HEALTH,Akinetic Mutism,"Coma Vigilans|Akinetic Mutisms|Coma Vigil|Mutism, Akinetic|Vigils, Coma|Vigil, Coma|Akinetic Autism|Autism, Akinetic|akinetic mutism"
D022061,CHEMICAL,Tacrolimus Binding Protein 1A,FKBP 12|Macrophilin-12|Macrophilin 12|Tacrolimus|FK506-Binding Protein 1|FKBP12|FK506 Binding Protein 1A|FK506 Binding Protein 1|FK506-Binding Protein 1A|FKBP-12
NEW16094,DISEASE,tacrolimus treatment,tacrolimus-induced neuropsychiatric symptoms
NEW16095,DISEASE,tacrolimus treatment,coronavirus pandemic
NEW16096,CHEMICAL,betel nut abuse,betel nut abuse
NEW16097,CHEMICAL,asai-mutant,asaI-mutant
NEW16098,DISEASE,asai-mutant,maturing biofilm
NEW16099,CHEMICAL,exogenous c4-hsl,exogenous C4-HSL
NEW16100,CHEMICAL,asai/c4-hsl,AsaI/C4-HSL
NEW16101,DISEASE,deficit patient,deficit patients
NEW16102,CHEMICAL,deficit patient,"16,061"
NEW16103,CHEBI,antiviral drug toxicity,antiviral drug toxicity
NEW16104,DISEASE,antiviral drug toxicity,noninfectious organ diseases
NEW16105,DISEASE,goal-oriented behavior,goal-oriented behavior
D000077733,DISEASE,Immunoglobulin G4-Related Disease,"IgG4 Related Sclerosing Disease|IgG4-Related Sclerosing Diseases|Sclerosing Disease, IgG4-Related|Immunoglobulin G4 Related Kidney Disease|systemic disease|IgG4-Related Sclerosing Disease|IgG4 Related Systemic Disease|Immunoglobulin G4 Related Disease|IgG4 Related Disease|IgG4-Associated Autoimmune Diseases|IgG4-RD|Autoimmune Disease, IgG4-Associated|IgG4 Related Kidney Disease|IgG4-Related Kidney Disease|Kidney Disease, IgG4-Related|Immunoglobulin G4-Related Sclerosing Disease|IgG4 Associated Autoimmune Disease|Immunoglobulin G4-Related Diseases|IgG4-Associated Autoimmune Disease|IgG4-Related Disease|IgG4-Related Kidney Diseases|Immunoglobulin G4 Related Sclerosing Disease|IgG4-Related Diseases|Immunoglobulin G4-Related Kidney Disease"
NEW16106,DISEASE,minimal facial acne,minimal facial acne
NEW16107,MENTAL_HEALTH,dysmorphophobia related,dysmorphophobia related
NEW16108,DISEASE,primary dysthymic patient,primary dysthymic patients
NEW16109,DISEASE,p. pedunculata,P. pedunculata
NEW16110,DISEASE,serious extrapyramidal side effect,SC impairment
D000069476,CHEMICAL,Linagliptin,"BI-1356|1H-purine-2,6-dione, 8-((3r)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-|linagliptin|BI1356|BI 1356|Tradjenta|1356, BI|Trajenta|(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione"
NEW16111,CHEMICAL,rat rotenone model muscle coordination,rat rotenone model muscle coordination
NEW16112,CHEMICAL,dopamine da replacement,dopamine DA replacement
NEW16113,CHEMICAL,retinoic acid/estradiol model,retinoic acid/estradiol model
NEW16114,CHEBI,prenatal folic acid supplementation,prenatal folic acid supplementation
NEW16115,MENTAL_HEALTH,prenatal folic acid supplementation,US autism diagnoses
NEW16116,MENTAL_HEALTH,autism symptomatology,autism symptomatology
NEW16117,CHEMICAL,pufa treatment,PUFA treatments
NEW16118,CHEBI,ghrelin receptor inverse agonist,ghrelin receptor inverse agonist
D057927,DISEASE,Hydrophobic and Hydrophilic Interactions,"Interaction, Hydrophilic|Hydrophobic Interactions|Hydrophilic Interactions|Interactions, Hydrophobic|Interactions, Hydrophilic|Hydrophobicity|Hydrophobic Interaction|Hydrophilic and Hydrophobic Interactions|Interaction, Hydrophobic|hydrophobicity|Hydrophilicities|Hydrophilicity|Hydrophilic Interaction|hydrophobic|Hydrophobicities"
NEW16119,CHEMICAL,KbFwLL-NH2,KbFwLL-NH2
NEW16120,DISEASE,vulvovaginal atrophy,Vulvovaginal atrophy
NEW16121,MENTAL_HEALTH,dissociation energy,dissociation energies
NEW16122,CHEMICAL,dissociation energy,"benzoic acid-2,2,2-trideutero-1-trideuteromethyl-ethyl ester"
NEW16123,CHEMICAL,dissociation energy,benzoic acid-1-methyl-ethyl ester
NEW16124,CHEMICAL,dissociation energy,nicotinic acid-1-deutero-1-methyl-ethyl ester
NEW16125,CHEMICAL,dissociation energy,"nicotinic acid-2,2,2-trideutero-1-trideuteromethyl-ethyl ester"
NEW16126,CHEMICAL,dissociation energy,benzoic acid-1-deutero-1-methyl-ethyl ester
NEW16127,NUTRITION,largemouth bass ranavirus,Largemouth bass ranavirus
NEW16128,NUTRITION,largemouth bass ranavirus,cultured largemouth bass
NEW16129,DISEASE,largemouth bass ranavirus,infectious skin ulcerative syndrome
NEW16130,MENTAL_HEALTH,largemouth bass ranavirus,Marijuana Craving Questionnaire
NEW16131,CHEMICAL,gaba pathway,GABA pathway
NEW16132,DISEASE,gaba pathway,RTT neuropathology
NEW16133,MENTAL_HEALTH,second compound,lateral displacement
NEW16134,DISEASE,second compound,obstructive sleep apnea-hypopnea syndrome
NEW16135,DISEASE,severe hypoxia group,severe hypoxia group
NEW16136,CHEMICAL,severe hypoxia group,higher serum FT3 level
NEW16137,CHEMICAL,serum ft3 level ng/l,serum FT3 level ng/L
NEW16138,CHEMICAL,serum ft3,serum FT3
NEW16139,DISEASE,osahs patient,OSAHS patients
NEW16140,CHEBI,ft3 level,thyroid hormone replacement therapy
NEW16141,CHEBI,ft3 level,thyroid stimulating hormone concentration
NEW16142,DISEASE,osahs child,OSAHS children
NEW16143,MENTAL_HEALTH,population fragmentation,population fragmentation
NEW16144,CHEMICAL,population fragmentation,Wisconsin glaciation
NEW16145,DISEASE,population fragmentation,age-associated cardiovascular dysfunction
NEW16146,CHEMICAL,glucose response,Glucose response
NEW16147,CHEMICAL,glucose response,H4CBD treatment
NEW16148,CHEMICAL,glucose response,glucose tolerance independent
NEW16149,DISEASE,glucose response,TG synthesis
NEW16150,NUTRITION,intestinal yeast cyclic dipeptide,intestinal yeast cyclic dipeptides
NEW16151,CHEMICAL,glutamate receptor activation,glutamate receptor activation
NEW16152,CHEMICAL,ampa receptor activation,AMPA receptor activation
NEW16153,DISEASE,cerebellar overactivity,cerebellar overactivity
NEW16154,CHEMICAL,cerebellar overactivity,abnormal glutamate signaling
http://purl.obolibrary.org/obo/DOID_1837,DISEASE,diabetic ketoacidosis,"ketosis-prone diabetes mellitus|DIABETES MELLITUS, KETOSIS-PRONE|severe diabetic ketoacidosis"
NEW16155,CHEMICAL,po2 necessary,PO2 necessary
NEW16156,NUTRITION,inorganic potassium phosphate,inorganic potassium phosphates
NEW16157,MENTAL_HEALTH,oxyhemoglobin dissociation curve,oxyhemoglobin dissociation curve
NEW16158,CHEMICAL,oxyhemoglobin dissociation curve,CO2 content
NEW16159,CHEMICAL,oxyhemoglobin dissociation curve,DPG|non diphosphoglycerate
D010710,CHEMICAL,Phosphates,"inorganic phosphates|Phosphate|Phosphates, Inorganic|Inorganic Phosphate|Phosphate, Inorganic|Inorganic Phosphates|Orthophosphate"
NEW16160,CHEMICAL,oxyhemoglobin dissociation curve,Pi-0.09 Na+
NEW16161,CHEMICAL,dpg level,DPG level
NEW16162,DISEASE,dpg level,chronic neurocognitive deficits
NEW16163,DISEASE,dpg level,alcohol optic neuropathy
NEW16164,DISEASE,dpg level,TAON deficits
NEW16165,CHEBI,folate substituion,folate substituion
NEW16166,CHEMICAL,mri-voxel-based specific regional analysis system,MRI-voxel-based specific regional analysis system
NEW16167,DISEASE,low urinary tract symptom,lower urinary tracts symptoms|LUTS
NEW16168,CHEBI,low urinary tract symptom,agents alpha-adrenergic antagonists
NEW16169,DISEASE,low urinary tract symptom,LUTS secondary
NEW16170,DISEASE,low urinary tract symptom,benign prostate hyperplasia
NEW16171,CHEMICAL,Background risperidone,Background Risperidone
NEW16172,CHEMICAL,chronic ethanol consumption,Chronic ethanol consumption
NEW16173,DISEASE,chronic ethanol consumption,gender-dependent neuronal damage
NEW16174,DISEASE,ethanol consumption,ARN structure
NEW16175,MENTAL_HEALTH,ethanol consumption,heroin-induced ventilatory depression
NEW16176,DISEASE,overdose death,overdose deaths
NEW16177,CHEMICAL,naloxone possible explanation,naloxone possible explanation
NEW16178,MENTAL_HEALTH,bio-based disease resistance inducer able,bio-based disease resistance inducers able
NEW16179,CHEBI,bio-based disease resistance inducer able,synthetic fungicides
NEW16180,CHEMICAL,superoxide dismutase glutathione s-transferase,superoxide dismutase glutathione S-transferase
NEW16181,MENTAL_HEALTH,superoxide dismutase glutathione s-transferase,defense mechanism
NEW16182,DISEASE,necrotic mechanism,necrotic mechanisms
http://purl.obolibrary.org/obo/CHEBI_170865,CHEMICAL,"13,14-dihydro pgf2a","resolvins RvD1|(E)-7-[3,5-dihydroxy-2-(3-hydroxyoctyl)cyclopentyl]hept-5-enoic acid"
NEW16183,CHEMICAL,numerous antidepressant,Numerous antidepressants
NEW16184,DISEASE,numerous antidepressant,genetic derangements
NEW16185,DISEASE,numerous antidepressant,appetitive visual learning
D009655,CHEMICAL,Octopamine,para-Octopamine|4-Octopamine|Norsynephrine|alpha-(Aminoethyl)-4-hydroxybenzenemethanol|p-Octopamine|octopamine|Norsympatol
NEW16186,DISEASE,numerous antidepressant,cell-mediated angioedema
NEW16187,DISEASE,urogenital infection,urogenital infections
NEW16188,CHEMICAL,urogenital infection,GEU
NEW16189,DISEASE,urogenital infection,possible infection
NEW16190,DISEASE,severe hepatic disorder,severe hepatic disorders
D005460,CHEMICAL,"Fluorides, Topical","Varnishes, Fluoride|topical fluorides|Topical Fluorides|Fluoride Varnishes"
http://purl.obolibrary.org/obo/DOID_2497,DISEASE,enamel erosion,enamel erosion
NEW16191,CHEBI,gastric acid-neutralizing antacid rinse,gastric acid-neutralizing antacid rinses
NEW16192,CHEMICAL,gastric acid-neutralizing antacid rinse,calcium overload
NEW16193,CHEMICAL,gastric acid-neutralizing antacid rinse,acute ATP loss
NEW16194,CHEMICAL,polydatin treatment,polydatin treatment
NEW16195,DISEASE,polydatin treatment,infarction volume
D057765,DISEASE,Eosinophilic Esophagitis,"Eosinophilic Chronic Esophagitides|Esophagitis, Eosinophilic Chronic|Eosinophilic Esophagitides|EoE|Esophagitis, Eosinophilic|Eosinophilic Chronic Esophagitis|Esophagitides, Eosinophilic Chronic|Chronic Esophagitis, Eosinophilic|Esophagitides, Eosinophilic|Eosinophilic esophagitis|Chronic Esophagitides, Eosinophilic"
NEW16196,DISEASE,polydatin treatment,immune-mediated disorder
NEW16197,DISEASE,adult coeliac disease,adult coeliac disease
NEW16198,DISEASE,adult coeliac disease,concomitant depressive symptoms
NEW16199,DISEASE,adult coeliac disease,adult celiac disease
NEW16200,CHEBI,San Filippo Neri Hospital,San Filippo Neri Hospital
NEW16201,CHEBI,non-competitive n-methyl-d-aspartate receptor antagonist,non-competitive N-methyl-d-aspartate receptor antagonist
NEW16202,CHEMICAL,organophosphorus anticholinesterase,organophosphorus anticholinesterases
NEW16203,CHEMICAL,organophosphorus anticholinesterase,DFP treatment groups
NEW16204,DISEASE,abnormal sexual behavior,abnormal sexual behavior
NEW16205,DISEASE,abnormal sexual behavior,necrophilia
NEW16206,MENTAL_HEALTH,abnormal sexual behavior,bestiality
D014843,MENTAL_HEALTH,Voyeurism,voyeurism|Voyeurisms
NEW16207,DISEASE,abnormal sexual behavior,harassment sexual assault
C537345,DISEASE,Sitosterolemia [Supplementary Concept],"Lipid Metabolism, Inborn Errors|Hypercholesterolemia|sitosterolemia|Intestinal Diseases|Phytosterols/adverse effects"
NEW16208,DISEASE,abnormal sexual behavior,atherosclerotic cardiovascular disease
D029842,NUTRITION,Phyllanthus emblica,"Phyllanthus emblicas|officinali, Emblica|emblica, Phyllanthus|Mirobalanus embilicas|embilicas, Mirobalanus|Emblica officinali|Emblica officinalis|Amlas|Mirobalanus embilica|Amla|Phyllanthus emblica"
NEW16209,DISEASE,abnormal sexual behavior,GI disorder
NEW16210,CHEMICAL,intravenous iron therapy,Intravenous iron therapy
NEW16211,CHEMICAL,intravenous iron use,Intravenous iron use
NEW16212,CHEBI,intravenous iron use,mGLu2/3 agonist
NEW16213,CHEMICAL,intravenous iron use,glutamate system modulators
NEW16214,CHEMICAL,permethrin susceptibility screening,permethrin susceptibility screening
NEW16215,CHEMICAL,permethrin susceptibility screening,dose % permethrin
D026023,CHEMICAL,Permethrin,"cis-permethrin|Permethrin, (cis)-Isomer|Permethrin, (trans)-Isomer|Cyclopropanecarboxylic Acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-, (3-phenoxyphenyl)methyl ester|Permethrin, (1R-trans)-Isomer|cis permethrin|Elimite|NRDC 147|NIA-33297|S 3151|NRDC-143|NRDC147|Permethrin, (cis-(+-))-Isomer|FMC33297|cis-(1RS)-permethrin|Nittifor|NIA 33297|3-Phenoxybenzyl-(+-)-cis,trans-2,2-dichlorovinyl-2,2-dimethyl-cyclopropylcarboxylic acid, ester|Permethrin, (trans-(+-))-Isomer|PP-557|(m-Phenoxybenzyl)-cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate|trans permethrin|S3151|NRDC-147|FMC-33297|Permethrin, (1R-cis)-Isomer|NRDC 143|Permethrin, (1S-cis)-Isomer|PP 557|S-3151|3-Phenoxybenzyl-cis,trans-(1RS)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate|NIA33297|trans-permethrin|FMC 33297|permethrin|Permethrin, trans-(1RS)-Isomer|Permethrin, (1S-trans)-Isomer|permethrin, cis-(1RS)-isomer|NRDC143|PP557|trans-(1RS)-Permethrin|Ambush"
NEW16216,MENTAL_HEALTH,permethrin susceptibility screening,common fatigue
NEW16217,DISEASE,permethrin susceptibility screening,suicide-related behaviors
NEW16218,MENTAL_HEALTH,permethrin susceptibility screening,cocaine-induced paranoia
NEW16219,MENTAL_HEALTH,multimodal analgesia,multimodal analgesia
D017024,CHEBI,"Chemotherapy, Adjuvant","Adjuvant Chemotherapy|adjuvant drug|Drug Therapy, Adjuvant|Adjuvant Drug Therapy"
NEW16220,CHEBI,Federal Drug Administration,Federal Drug Administration
NEW16221,CHEMICAL,dopamine level,Dopamine levels
NEW16222,CHEMICAL,inhibitor tolcapone,inhibitor tolcapone
NEW16223,CHEMICAL,inhibitor tolcapone,prefrontal dopamine levels
C491010,CHEMICAL,ZJ-17 compound [Supplementary Concept],Urea/analogs  and  derivatives|ZJ-17
NEW16224,MENTAL_HEALTH,inhibitor tolcapone,agitation behaviour
C491011,CHEMICAL,ZJ-11 compound [Supplementary Concept],Urea/analogs  and  derivatives|ZJ-11
NEW16225,CHEMICAL,extracellular naag,extracellular NAAG
NEW16226,DISEASE,extracellular naag,neuropathic models
C486420,CHEMICAL,UR-3216 [Supplementary Concept],UR-3216|Piperidines|Nitro Compounds
NEW16227,CHEBI,extracellular naag,novel GPIIb/IIIa antagonist
NEW16228,CHEMICAL,class antagonist xv459,Class antagonist XV459
NEW16229,CHEBI,class antagonist xv459,Class antagonist YZ211
C120234,CHEMICAL,orbofiban [Supplementary Concept],Alanine|Pyrrolidines|orbofiban
C100917,CHEMICAL,sibrafiban [Supplementary Concept],Piperidines|Oximes|sibrafiban
NEW16230,CHEBI,class antagonist xv459,Class antagonist
NEW16231,CHEMICAL,class antagonist xv459,IC(50)=30 nM
C118235,CHEMICAL,roxifiban [Supplementary Concept],Amidines|roxifiban|Isoxazoles
NEW16232,CHEMICAL,class antagonist xv459,catecholamine synthesis
NEW16233,CHEMICAL,class antagonist xv459,gamma-linolenic acids
NEW16234,CHEMICAL,class antagonist xv459,n-6 PUFAs
NEW16235,CHEMICAL,class antagonist xv459,n-6/n-3 PUFAs
NEW16236,CHEMICAL,class antagonist xv459,monounsaturated nervonic acid
NEW16237,CHEMICAL,class antagonist xv459,acid ratio
NEW16238,NUTRITION,class antagonist xv459,altered fatty acid FA metabolism
NEW16239,CHEMICAL,auranofin af,Auranofin AF
NEW16240,DISEASE,auranofin af,pain narcotic usage
NEW16241,CHEMICAL,oral indomethacin,oral indomethacin
NEW16242,DISEASE,combined dama action,combined DAMA actions
NEW16243,CHEMICAL,combined dama action,L-DOPA effect
NEW16244,DISEASE,antidyskinetic effect,Antidyskinetic effects
D055413,CHEMICAL,Growth Differentiation Factor 10,GDF-10|10|BMP-3b|Bone Morphogenetic Protein 3B
NEW16245,CHEMICAL,antidyskinetic effect,ADL5510
NEW16246,MENTAL_HEALTH,establish l-dopa-induced dyskinesia,established L-dopa-induced dyskinesia
NEW16247,DISEASE,parkinsonian monkey,Parkinsonian monkeys
NEW16248,DISEASE,winter depressive patient,winter depressive patients
NEW16249,CHEMICAL,winter depressive patient,excessive circulating melatonin
NEW16250,DISEASE,hypersomnia common,hypersomnia common
NEW16251,MENTAL_HEALTH,fluoxetine-induced mania,Fluoxetine-induced mania
NEW16252,CHEMICAL,kynurenine metabolism,kynurenine metabolism
D013496,CHEMICAL,Suprofen,|TN-762|R 25061|R-25061|TN762|R25061|suprofen|TN 762
NEW16253,MENTAL_HEALTH,kynurenine metabolism,uterine hyperactivity
NEW16254,NUTRITION,erythrocyte ghost phospholipid datum,Erythrocyte ghost phospholipid data
NEW16255,CHEMICAL,"2r,4r-apdc","2R,4R-APDC"
NEW16256,MENTAL_HEALTH,"2r,4r-apdc",similar equilibrium dissociation constants
NEW16257,CHEMICAL,"2r,4r-apdc",synaptic noradrenaline
NEW16258,CHEMICAL,beta-2 adrenergic agonist salbutamol,beta-2 adrenergic agonist salbutamol
NEW16259,CHEMICAL,depression score,oral salbutamol treatment
C078452,CHEMICAL,ziconotide [Supplementary Concept],omega-Conotoxins|Ziconotide|ziconotide
NEW16260,CHEBI,depression score,conopeptide intrathecal IT analgesic
NEW16261,CHEBI,Pocock scorpion venom,Pocock scorpion venom
NEW16262,CHEMICAL,Pocock scorpion venom,Centro de Biotecnología
NEW16263,DISEASE,venom poisoning,venom poisoning
NEW16264,CHEBI,venom poisoning,subcutaneous venom injection
D031881,CHEMICAL,Nigella sativa,"Nigella sativa|Cumin, Black|Black Cumins|Nigella sativas|Kalonjus|Kalonji|Cumins, Black|Black Cumin|sativa, Nigella"
D063246,CHEMICAL,"Organogenesis, Plant","Plant Organ Formation|Developments, Plant Organ|Formations, Plant Organ|Organ Formation, Plant|Plant Organ Formations|Organ Development, Plant|Plant Organogeneses|Plant Organ Development|plant|Formation, Plant Organ|Organ Formations, Plant|Development, Plant Organ|Plant Organogenesis|Organogeneses, Plant|Plant Organ Developments|Organ Developments, Plant"
NEW16265,CHEMICAL,ethanol aqueous extract,Ethanol aqueous extract
NEW16266,MENTAL_HEALTH,displacement average,displacement averages
D011455,CHEMICAL,"Prostaglandins A, Synthetic","Prostaglandin A Analogues|Analogs, Prostaglandin A|Synthetic, PGA|Synthetic Prostaglandins A|PGA Synthetic|Analogues, Prostaglandin A|Prostaglandin A Analogs|PGA"
NEW16267,CHEBI,displacement average,free pteroylglutamic acid
NEW16268,MENTAL_HEALTH,complete dissociation,Complete dissociation
NEW16269,CHEMICAL,complete dissociation,pteroyltriglutamate
NEW16270,NUTRITION,complete dissociation,biological folate activity
D007780,DISEASE,Lactobacillus casei,casei|Lactobacillus (1966-1971)
NEW16271,MENTAL_HEALTH,antidepressant fluoxetine,reverse depletion-induced anergia
NEW16272,DISEASE,depressed individual,Depressed individuals
NEW16273,MENTAL_HEALTH,depressed individual,anergia
NEW16274,DISEASE,depressed individual,effort-related motivational symptoms
NEW16275,CHEMICAL,atypical dopamine da transport blocker,Atypical dopamine DA transport blockers
NEW16276,CHEMICAL,agent tetrabenazine,agent tetrabenazine
NEW16277,DISEASE,agent tetrabenazine,motivational deficits
D017094,DISEASE,"Porphyrias, Hepatic","Hepatic Porphyrias|Porphyria, Hepatic|porphyrias|hepatic porphyrias|Hepatic Porphyria"
NEW16278,DISEASE,agent tetrabenazine,rare hereditary metabolic disorders
NEW16279,CHEMICAL,endogenous acetylcholine degradation,endogenous acetylcholine degradation
D005997,NUTRITION,Glycerylphosphorylcholine,"Choline Alphoscerate|3-Phosphocholine, Glycerol|Alfoscerate, Choline|choline alphoscerate|Alphoscerate, Choline|Glycerol 3 Phosphocholine|L-alpha-Glycerylphosphorylcholine|Choline Alfoscerate|Choline Glycerophosphate|Glycerophosphate, Choline|Glycerophosphorylcholine|L alpha Glycerylphosphorylcholine|Glycerol 3-Phosphocholine"
NEW16280,DISEASE,endogenous acetylcholine degradation,VaD patients
NEW16281,CHEMICAL,endogenous acetylcholine degradation,blood glucose levels
NEW16282,CHEMICAL,aspartame intake,aspartame intake
NEW16283,DISEASE,aspartame intake,impaired blood glucose tolerance
NEW16284,DISEASE,basic furnace sludge,basic furnace sludge
D019812,CHEMICAL,Heparan Sulfate Proteoglycans,"Proteoheparan Sulfate|Heparan Sulfate Proteoglycan|Proteoglycans, Heparan Sulfate|sulfate|HSPG|Proteoglycan, Heparan Sulfate|Sulfate Proteoglycans, Heparan"
NEW16285,DISEASE,basic oxygen furnace sludge,basic oxygen furnace sludge|BOFS
D004688,MENTAL_HEALTH,Encopresis,encopresis
NEW16286,DISEASE,basic oxygen furnace sludge,severe fecal retention unresponsive
C483757,CHEMICAL,"2-amino-3-(3,4-dichlorobenzyloxy)-6-fluorobicyclo(3.1.0)hexane-2,6-dicarboxylic acid [Supplementary Concept]",Bridged Bicyclo Compounds|Dicarboxylic Acids|MGS0039
NEW16287,CHEBI,group mglu receptor antagonist,group mGlu receptor antagonist
C114624,CHEMICAL,LY 341495 [Supplementary Concept],LY341495|Amino Acids|Xanthenes
NEW16288,DISEASE,group mglu receptor antagonist,epithelial ovarian cancer cells
NEW16289,DISEASE,fearful memory,fearful memories
NEW16290,CHEMICAL,fearful memory,SKF83959 pharmacotherapy training
NEW16291,CHEMICAL,impaired da transmission,impaired DA transmission
NEW16292,DISEASE,impaired da transmission,effortful food-seeking behaviors
NEW16293,DISEASE,muscarinic agonist pilocarpine,effort-related choice behavior similar
NEW16294,DISEASE,da receptor,effort-related choice behavior
NEW16295,CHEBI,soft polymer nanoparticle,Soft polymer nanoparticles
NEW16296,CHEMICAL,soft polymer nanoparticle,slow-release nanostars
NEW16297,CHEBI,controlled release analgesic system,Controlled release analgesic systems
NEW16298,CHEBI,controlled release analgesic system,repeated drug dosing
NEW16299,CHEBI,controlled release analgesic system,dosing drug dependency
NEW16300,CHEMICAL,bupivacaine/meloxicam pr,bupivacaine/meloxicam PR
NEW16301,DISEASE,bupivacaine/meloxicam pr,pain consumption relative
NEW16302,CHEBI,novel polymer technology,novel polymer technology
D000077239,CHEMICAL,Meloxicam,meloxicam|Masflex|Parocin|Movicox|Reumoxicam|Uticox|Mobic|Mobec|Mobicox|Miloxicam|Movalis
C565390,CHEMICAL,Methylmalonic Aciduria due to Methylmalonyl-CoA Mutase Deficiency [Supplementary Concept],"MMA|Methylmalonyl-CoA Mutase/deficiency|Amino Acid Metabolism, Inborn Errors|methylmalonic aciduria"
NEW16303,MENTAL_HEALTH,novel polymer technology,analgesia regimen
NEW16304,NUTRITION,spanish cohort,Spanish cohort
NEW16305,MENTAL_HEALTH,spanish cohort,Autism Sequencing Consortium
NEW16306,MENTAL_HEALTH,autism trio,autism trios
NEW16307,CHEMICAL,polygenic risk score,polygenic risk scores|PRS
NEW16308,DISEASE,polygenic risk score,Psychiatric Consortium PGC repository
NEW16309,NUTRITION,polygenic risk score,Spanish trios's
NEW16310,CHEMICAL,s-predixcan,S-Predixcan
NEW16311,DISEASE,maternal pre-pregnancy obesity,maternal pre-pregnancy obesity
NEW16312,NUTRITION,maternal pre-pregnancy obesity,Spanish children
NEW16313,MENTAL_HEALTH,multivariate linear regression model,multivariate linear regression models
NEW16314,NUTRITION,multivariate linear regression model,umbilical cord blood mercury
NEW16315,NUTRITION,multivariate linear regression model,long-chain polyunsaturated fatty acid concentrations
NEW16316,CHEBI,multivariate linear regression model,effective analgesic
NEW16317,DISEASE,cch-induced neuronal degeneration,CCH-induced neuronal degeneration
NEW16318,DISEASE,ischemic neuronal damage,ischemic neuronal damage
C000645105,DISEASE,Lactobacillus collinoides [Supplementary Concept],Lactobacillus collinoides|Lactobacillus
NEW16319,CHEMICAL,common phenolic acid,common phenolic acids
D052196,DISEASE,Lactobacillus brevis,Lactobacillus (1967-2005)|Lactobacillus brevis
D048191,DISEASE,Lactobacillus plantarum,Lactobacillus (1965-2004)|Lactobacillus plantarum
NEW16320,CHEMICAL,alkyl catechol,alkyl catechols
NEW16321,DISEASE,alkyl catechol,multiple chronic diseases
NEW16322,DISEASE,artificial fever,artificial fever
C078893,CHEMICAL,indium In 113m sulfur colloid [Supplementary Concept],Sulfur|sulphur|Indium
D010273,DISEASE,"Parasitic Diseases, Animal","Parasitic Infections, Animal|Parasitic Disease, Animal|Animal Parasitic Diseases|Disease, Animal Parasitic|Animal Parasitic Infections|Infection, Animal Parasitic|parasitic disease|Parasitic Infection, Animal|Diseases, Animal Parasitic|Animal Parasitic Infection|Infections, Animal Parasitic|Animal Parasitic Disease"
NEW16323,DISEASE,artificial fever,different gastrointestinal symptoms
NEW16324,MENTAL_HEALTH,artificial fever,Alzheimer 's disease|presenile dementia
NEW16325,CHEMICAL,adaboost+dt,Adaboost+DT
NEW16326,CHEMICAL,metabolite 3-methoxy-4-hydroxyphenyglycol,metabolites 3-methoxy-4-hydroxyphenyglycol
NEW16327,CHEMICAL,5-hiaa psychopathological variable,5-HIAA psychopathological variables
NEW16328,CHEMICAL,glutathione function,glutathione function
NEW16329,CHEMICAL,single-nucleotide polymorphism snp diagnostic marker,Single-nucleotide polymorphism SNP diagnostic markers
NEW16330,NUTRITION,single-nucleotide polymorphism snp diagnostic marker,bread wheat lines
NEW16331,CHEMICAL,single-nucleotide polymorphism snp diagnostic marker,FarmCPU algorithm
NEW16332,CHEMICAL,Q.Yr.bisa-2D,Q.Yr.bisa-2D
NEW16333,MENTAL_HEALTH,Q.Yr.bisa-2D,Pst resistance
NEW16334,CHEMICAL,dopamine neurotransmission,Dopamine neurotransmission
NEW16335,CHEBI,dopamine neurotransmission,pharmaceutical agents
D000647,DISEASE,Amnesia,"|amnesias|Dissociative Amnesias|Amnesias, Dissociative|Amnesias, Global|Amnesias, Tactile|amnesia|Temporary Amnesias|Amnestic States|Amnesias, Hysterical|Amnesia Memory Loss|Amnesia-Memory Losses|Amnesia, Dissociative|Tactile Amnesia|Amnesia-Memory Loss|State, Amnestic|Amnestic State|Global Amnesia|Amnesias|Hysterical Amnesia|Amnesias, Temporary|Amnesia, Hysterical|Temporary Amnesia|Dissociative Amnesia|Global Amnesias|Tactile Amnesias|States, Amnestic|Amnesia, Global|Amnesia, Tactile|Amnesia, Temporary|Hysterical Amnesias"
NEW16336,DISEASE,p. elegan,P. elegans
NEW16337,CHEBI,p. elegan,carotenoid supplementation
NEW16338,CHEMICAL,stress-induced corticosterone,Stress-induced corticosterone
NEW16339,DISEASE,stress-induced corticosterone,pigmentary patches
NEW16340,DISEASE,stress-induced corticosterone,painful chemotherapy-induced peripheral neuropathy
NEW16341,CHEMICAL,naltrexone mg/kg,Naltrexone mg/kg
NEW16342,DISEASE,naltrexone mg/kg,self-biting behavior
NEW16343,DISEASE,naltrexone mg/kg,pemoline-induced self-biting behavior
NEW16344,CHEMICAL,elevated plasma homocysteine,Elevated plasma homocysteine
NEW16345,CHEBI,fracture prevention,vitamine D.
NEW16346,DISEASE,fracture prevention,Makino|P. alkekengi
C472867,DISEASE,"RXFP2 protein, human [Supplementary Concept]","testis descent|Receptors, G-Protein-Coupled"
NEW16347,CHEMICAL,phthalate mixture risk assessment,phthalate mixture risk assessments
NEW16348,DISEASE,phthalate mixture risk assessment,male developmental toxicity
C563551,DISEASE,"Myeloproliferative Syndrome, Transient [Supplementary Concept]",Down Syndrome|Leukemoid Reaction|transient abnormal myelopoiesis
http://purl.obolibrary.org/obo/DOID_0050879,DISEASE,fragile x-associated tremor/ataxia syndrome,Fragile X-associated tremor/ataxia syndrome|FXTAS syndrome
NEW16349,DISEASE,late-onset neurological disorder,late-onset neurological disorder
http://purl.obolibrary.org/obo/DOID_5425,DISEASE,ovarian hyperstimulation syndrome,OHSS|secondary Meig's syndrome|severe ovarian hyperstimulation syndrome
NEW16350,CHEBI,antagonist protocol,antagonist protocol
NEW16351,CHEMICAL,gonadotrophin-releasing-hormone agonist,gonadotrophin-releasing-hormone agonist
NEW16352,CHEMICAL,alternate-day therapy,alternate-day therapy
NEW16353,DISEASE,cs-induced neuropsychiatric disorder,CIPD|CS-induced neuropsychiatric disorders
http://purl.obolibrary.org/obo/DOID_594,MENTAL_HEALTH,panic disorder,panic anxiety syndrome|comorbid panic disorder
NEW16354,CHEMICAL,comt snp rs4818 allele,COMT SNP rs4818 allele
NEW16355,CHEMICAL,gene-gene interaction effect,Gene-gene interaction effect
NEW16356,CHEMICAL,[³h]-domperidone,[³H]-domperidone
NEW16357,CHEMICAL,[³h]-domperidone,hypothalamic Nhlh2
NEW16358,CHEMICAL,bifidobacterium longum strain,Bifidobacterium longum strains
NEW16359,CHEBI,bifidobacterium longum strain,folic acid derivatives
NEW16360,CHEBI,high-dose intravenous vitamin c,High-dose intravenous vitamin C
NEW16361,CHEMICAL,high-dose intravenous vitamin c,harmful reactive oxygen species
NEW16362,CHEBI,supplementary vitamin c,supplementary vitamin C
NEW16363,DISEASE,supplementary vitamin c,post-cardiac arrest patients
NEW16364,CHEBI,supplementary vitamin c,agonist dose-response curves
D012710,CHEMICAL,"Serum Albumin, Bovine","Bovine Serum Albumin|Serum, Fetal Calf|Albumin, Bovine Serum|Albumin, Bovine|Albumin Bovine|Fetal Calf Serum|Fetal Bovine Serum|Bovine Serum, Fetal|FCS|Serum, Fetal Bovine|Bovine Albumin|Bovine, Albumin|Calf Serum, Fetal|fetal calf serum"
NEW16365,DISEASE,supplementary vitamin c,morula development
NEW16366,CHEMICAL,psychiatric symptom,trihexyphenidyl anti-cholinergic agent
NEW16367,CHEMICAL,traditional prescription kyung-ok-ko,traditional prescription Kyung-Ok-Ko
D000070660,CHEMICAL,Wolfiporia,"Fu-Ling|Tuckahoe Fungus|Fungus, Tuckahoe|Fuling|Wolfiporia cocos|Poria cocos|Wolfiporia extensa|Fu Ling"
D032305,NUTRITION,Lycium,"Berry Plant, Goji|Goji Berries|Berry, Goji|Goji Berry|Plants, Goji Berry|Berry Plants, Goji|Lycium barbarum|Wolfberry|Goji Berry Plant|Berries, Goji|Lycium chinense|Plant, Goji Berry|Goji Berry Plants|Wolfberries"
NEW16368,DISEASE,traditional prescription kyung-ok-ko,age-associated disorders
NEW16369,CHEMICAL,traditional prescription kyung-ok-ko,dehydroepiandrosterone s.c.)-induced PCOS rat model
NEW16370,DISEASE,pcos induction,PCOS induction
D005497,DISEASE,Follicular Cyst,"Cysts, Follicular|follicular cysts|Cyst, Follicular|Follicular Cysts"
NEW16371,CHEMICAL,pre-administration,DHEA injection
NEW16372,CHEMICAL,pre-administration,serum glucose
NEW16373,NUTRITION,chinense Miller,chinense Miller
NEW16374,NUTRITION,Lycium chinense Miller,Lycium chinense Miller
NEW16375,CHEMICAL,low-dose clozapine treatment,low-dose clozapine treatment
NEW16376,DISEASE,behavioural disturbance,behavioural disturbances
NEW16377,DISEASE,behavioural disturbance,antibiotic-related encephalopathy
NEW16378,DISEASE,behavioural disturbance,excluded organic encephalopathy
NEW16379,CHEBI,behavioural disturbance,high dose vitamin
NEW16380,CHEBI,behavioural disturbance,monoaminergic agonist properties
NEW16381,DISEASE,various cancer cell,various cancer cells
http://purl.obolibrary.org/obo/CHEBI_182917,CHEMICAL,tryptophan conjugated cholic acid,"3-(1H-indol-3-yl)-2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propanoic acid|N-methyltaurine conjugated cholic acid"
NEW16382,DISEASE,regal,regal|Pygoplites diacanthus
NEW16383,NUTRITION,angelfish regal,angelfish regal
NEW16384,NUTRITION,regal angelfish,regal angelfish
NEW16385,DISEASE,major biliary bile acid,major biliary bile acids
NEW16386,CHEMICAL,novel n-acyl amidated bile acid,novel N-acyl amidated bile acids
NEW16387,NUTRITION,angelfish,angelfish
NEW16388,CHEMICAL,angelfish,N-methyltaurine conjugation
NEW16389,DISEASE,biliary bile acid,biliary bile acids
D003840,CHEMICAL,Deoxycholic Acid,"12beta-Isomer Deoxycholic Acid|Deoxycholate|deoxycholic acid|Dihydroxycholanoic Acid|Deoxycholic Acid, 3beta-Isomer|Sodium Deoxycholate|Desoxycholic Acid|Deoxycholic Acid, Disodium Salt|Deoxycholic Acid, 5alpha Isomer|Deoxycholic Acid, 5alpha-Isomer|Lagodeoxycholic Acid|Kybella|Deoxycholate, Sodium|Deoxycholic Acid, 12beta-Isomer|Deoxycholic Acid, Sodium Salt, 12beta-Isomer|5alpha-Isomer Deoxycholic Acid|Deoxycholic Acid, Monosodium Salt|Deoxycholic Acid, 12beta Isomer|Choleic Acid|Deoxycholic Acid, 3beta Isomer|3beta-Isomer Deoxycholic Acid|Deoxycholic Acid, Monopotassium Salt|Deoxycholic Acid, Monoammonium Salt|Deoxycholic Acid, Magnesium (2:1) Salt"
NEW16390,DISEASE,biliary bile acid,Proliferative Kidney Disease
NEW16391,CHEMICAL,hydropinic therapy,hydropinic therapy
NEW16392,DISEASE,hydropinic therapy,dispeptic patients
D066150,DISEASE,Organisation for Economic Co-Operation and Development,OECD|Organization for Economic Cooperation and Development|development
C536735,DISEASE,Winter Shortland Temple syndrome [Supplementary Concept],Syndactyly|Skin Abnormalities|Intestines/abnormalities|craniofacial malformations|Craniofacial Abnormalities
NEW16393,CHEMICAL,alcohol exposure,Alcohol exposure
C536730,DISEASE,Zuska's Disease [Supplementary Concept],Abscess|squamous metaplasia|Breast Diseases|Fistula
NEW16394,CHEMICAL,suvorexant treatment,suvorexant treatment
NEW16395,MENTAL_HEALTH,suvorexant treatment,trauma-related insomnia
NEW16396,CHEMICAL,l. paracasei hm1,L. paracasei HM1
NEW16397,MENTAL_HEALTH,l. paracasei hm1,agitation speed
NEW16398,CHEMICAL,hiv protease inhibitor saquinavir,HIV protease inhibitor saquinavir|Saq-NO
NEW16399,CHEBI,hiv protease inhibitor saquinavir,p53-deficient hormone resistant prostate cancer PC-3 cells
NEW16400,DISEASE,hiv protease inhibitor saquinavir,prostate cancer cell growth
NEW16401,CHEMICAL,hiv protease inhibitor saquinavir,saquinavir TRAIL sensitivity
NEW16402,DISEASE,depressive symptomatology,Depressive symptomatology
NEW16403,CHEMICAL,low serum testosterone level,low serum testosterone levels
NEW16404,CHEBI,specific antigen fixation,specific antigen fixation
NEW16405,CHEBI,specific antigen fixation,mentioned parasympatholytics
NEW16406,CHEMICAL,specific antigen fixation,M-cholinereceptors
C569455,CHEMICAL,theabrownin [Supplementary Concept],theabrownin|Catechin/analogs  and  derivatives
D001442,CHEMICAL,Bacteroides Infections,"Bacteroides|Infections, Bacteroides|Infection, Bacteroides|Bacteroides Infection"
C000641481,CHEMICAL,Intestinimonas butyriciproducens [Supplementary Concept],Clostridiales|Intestinimonas
D057790,DISEASE,Staphylococcus saprophyticus,Staphylococcus|Staphylococcus (1976-2010)
C036658,CHEMICAL,acrylic acid [Supplementary Concept],Acrylates|acrylic acid
NEW16407,DISEASE,specific antigen fixation,BA saprophyticus subsp
D019826,CHEMICAL,Cholic Acid,cholic acid|Cholbam
C090905,CHEMICAL,homoserine hydroxamic acid [Supplementary Concept],Homoserine/analogs  and  derivatives|l-homoserine
NEW16408,CHEMICAL,theophylline administration,theophylline administration
NEW16409,DISEASE,theophylline administration,glucocorticoid-induced hyperglycemia
NEW16410,CHEMICAL,theophylline administration,GR activity
NEW16411,CHEMICAL,faah level,FAAH levels
NEW16412,CHEBI,sr agonist,SR agonists
NEW16413,DISEASE,sr agonist,opioid withdrawal behaviors
NEW16414,CHEMICAL,increase intracellular cyclic adenosine monophosphate camp level,increased intracellular cyclic adenosine monophosphate cAMP level
NEW16415,CHEMICAL,increase intracellular cyclic adenosine monophosphate camp level,10mg/kg day
NEW16416,CHEMICAL,chronic morphine injection,Chronic morphine injection
NEW16417,DISEASE,precipitate opioid withdrawal syndrome,precipitated opioid withdrawal syndrome
NEW16418,CHEMICAL,precipitate opioid withdrawal syndrome,morphine dependent mice
NEW16419,CHEMICAL,acute inorganic arsenic,iAs|Acute inorganic arsenic
NEW16420,DISEASE,acute inorganic arsenic,exacerbating infections
NEW16421,CHEBI,acute inorganic arsenic,low due toxins
NEW16422,CHEMICAL,acute inorganic arsenic,cardiotonic steroid binding pocket
NEW16423,CHEMICAL,gl-iv-03,GL-IV-03
NEW16424,MENTAL_HEALTH,gl-iv-03,agonists agitation response
NEW16425,CHEMICAL,gl-iv-03,nonsedative drug candidates
NEW16426,DISEASE,gaba agonist muscimol,severe oculomotor impairment
NEW16427,DISEASE,gaba agonist muscimol,abnormal mood
NEW16428,DISEASE,gaba agonist muscimol,cataleptic responses
C523483,CHEMICAL,linaclotide [Supplementary Concept],linaclotide|Peptides
NEW16429,DISEASE,gaba agonist muscimol,comorbid chronic pelvic pain syndromes
NEW16430,DISEASE,gaba agonist muscimol,chronic endometriosis-associated pain
C402769,CHEMICAL,tipifarnib [Supplementary Concept],OPC-21268|Quinolones|1H)- quinolinone
NEW16431,CHEBI,gaba agonist muscimol,selective V1 receptor antagonist radioligand
NEW16432,CHEMICAL,gaba agonist muscimol,mol/L kidney
NEW16433,CHEMICAL,gaba agonist muscimol,vasopressin V1 receptors
NEW16434,CHEMICAL,gaba agonist muscimol,sarcosine7]AVP
NEW16435,MENTAL_HEALTH,gaba agonist muscimol,concentration-dependent displacement
NEW16436,CHEBI,gaba agonist muscimol,effective V1 antagonist
NEW16437,CHEBI,gaba agonist muscimol,narcotic analgesic-induced emesis
NEW16438,CHEMICAL,immunosuppressant tacrolimus,immunosuppressant tacrolimus
NEW16439,DISEASE,immunosuppressant tacrolimus,human cancer models
C040946,DISEASE,uterine-derived cell growth factor [Supplementary Concept],tumor cell growth|Pregnancy Proteins
C000588757,CHEMICAL,BAL27862 [Supplementary Concept],Oxadiazoles|BAL27862|Benzimidazoles
NEW16440,CHEMICAL,immunosuppressant tacrolimus,tubulin dissociation constant
D004565,DISEASE,Electroconvulsive Therapy,"electric shock|Shock Therapy, Electric|Electric Shock Therapy|Electroconvulsive Therapies|Convulsive Therapy, Electric|Therapies, Electric Convulsive|Electroshock Therapy|Therapy, Electroshock|Electroshock Therapies|Therapies, Electric Shock|Therapies, Electroshock|Shock Therapies, Electric|ECT (Psychotherapy)|Electric Shock Therapies|Therapy, Electric Convulsive|Electric Convulsive Therapy|Convulsive Therapies, Electric|Therapies, Electroconvulsive|Electric Convulsive Therapies|Therapy, Electroconvulsive|Therapy, Electric Shock"
C104753,CHEMICAL,eglumetad [Supplementary Concept],Bridged Bicyclo Compounds|LY354740
NEW16441,CHEBI,immunosuppressant tacrolimus,group agonist
NEW16442,CHEMICAL,immunosuppressant tacrolimus,metabotropic glutamate receptor group
NEW16443,CHEBI,immunosuppressant tacrolimus,narcotic analgesics number
NEW16444,MENTAL_HEALTH,oxygen repression,oxygen repression
NEW16445,CHEMICAL,oxygen repression,DppsR/OprrA
NEW16446,CHEBI,oxygen repression,efficient lycopene production
NEW16447,CHEBI,native carotenoid pigment decaprenoxanthin,native carotenoid pigment decaprenoxanthin
NEW16448,CHEMICAL,carotenogenesis repressor gene,carotenogenesis repressor gene
NEW16449,CHEMICAL,carotenogenesis repressor gene,decaprenoxanthin production
NEW16450,CHEBI,carotenoid biosynthesis,Carotenoid biosynthesis
NEW16451,DISEASE,carotenoid biosynthesis,potent neurotoxic metal
NEW16452,CHEMICAL,al exposure,Al exposure
C562587,CHEMICAL,Purine Nucleoside Phosphorylase Deficiency [Supplementary Concept],"Primary Immunodeficiency Diseases|Purine nucleoside phosphorylase deficiency|Purine-Nucleoside Phosphorylase/deficiency|Purine-Pyrimidine Metabolism, Inborn Errors"
NEW16453,DISEASE,al exposure,rare autosomal recessive immunodeficiency disease
C501277,CHEMICAL,Mangifera indica extract [Supplementary Concept],Mangifera indica|Mangifera|Plant Extracts
NEW16454,CHEMICAL,thymus kotschyanus extract,Thymus kotschyanus extract
NEW16455,CHEBI,bisphosphonate drug,bisphosphonate drug
NEW16456,CHEMICAL,dppc vehicle,DPPC vehicle
D055371,DISEASE,Acute Lung Injury,"Acute Lung Injuries|Lung Injuries, Acute|acute lung injury|Lung Injury, Acute"
NEW16457,CHEMICAL,dry powder inhalation,NPDPIs|dry powder inhalation
NEW16458,DISEASE,dry powder inhalation,promising dry powder inhaler
NEW16459,CHEMICAL,smoke exposure,smoke exposure
NEW16460,DISEASE,smoke exposure,columnar cells
NEW16461,CHEMICAL,smoke exposure,eg glutathione
NEW16462,CHEMICAL,smoke exposure,sulphur-containing groups
NEW16463,MENTAL_HEALTH,smoke exposure,due displacement
NEW16464,NUTRITION,chronic lithium ingestion,Chronic lithium ingestion
NEW16465,MENTAL_HEALTH,chronic lithium ingestion,fatigue substance
NEW16466,DISEASE,chronic lithium ingestion,respiratory disturbance index
D011530,CHEMICAL,Protriptyline,"Protriptyline Hydrochloride|Hydrochloride, Protriptyline|protriptyline|Vivactil"
NEW16467,CHEMICAL,selective norepinephrine reuptake inhibitor atomoxetine,selective norepinephrine reuptake inhibitor atomoxetine
NEW16468,CHEBI,menopausal hormone therapy,menopausal hormone therapy
NEW16469,CHEMICAL,moderate alcohol use,moderate alcohol use
NEW16470,CHEMICAL,diacylglycerol kinase (dgkη)-knockout mouse,diacylglycerol kinase (DGKη)-knockout mice
NEW16471,MENTAL_HEALTH,diacylglycerol kinase (dgkη)-knockout mouse,disorder remedy-sensitive mania-like behaviors
NEW16472,CHEMICAL,acid (pufa)-containe phosphatidic acid pa molecular specie,acid (PUFA)-containing phosphatidic acid PA molecular species
NEW16473,DISEASE,acid (pufa)-containe phosphatidic acid pa molecular specie,DGKη deficiency
C558154,CHEMICAL,xanthohumol D [Supplementary Concept],Flavonoids|xanthohumol|XN|Xanthohumol
NEW16474,DISEASE,acid (pufa)-containe phosphatidic acid pa molecular specie,oxaliplatin-induced neuropathic pain
NEW16475,DISEASE,significant allodynia,Significant allodynia
D000096,CHEMICAL,Acetone,acetone|Solvents
NEW16476,CHEMICAL,n-(2-chloroethyl)-n-ethyl-2-bromobenzylamine dsp-4,N-(2-Chloroethyl)-N-ethyl-2-bromobenzylamine DSP-4
NEW16477,CHEMICAL,noradrenaline depletion,Noradrenaline depletion
http://purl.obolibrary.org/obo/CHEBI_134825,CHEMICAL,guanacline,cyclazenine|guanacline sulfate|para-chlorophenylalanine PCPA|p-chlorophenylalanine PCPA
NEW16478,CHEMICAL,idazoxan 5-ht₃ receptor antagonist bemesetron,idazoxan 5-HT₃ receptor antagonist bemesetron
C042253,CHEMICAL,bemesetron [Supplementary Concept],"MDL 72222|3-tropanyl-3,5-dichlorobenzoate|MDL-72222|Tropanes"
NEW16479,MENTAL_HEALTH,idazoxan 5-ht₃ receptor antagonist bemesetron,VLX-induced analgesia
NEW16480,CHEMICAL,maternal catecholamine,maternal catecholamines
D058496,DISEASE,Smith-Magenis Syndrome,"Smith-Magenis syndrome|Chromosome 17p11.2 Deletion Syndrome|Syndrome, Smith-Magenis|Smith Magenis Syndrome|17p11.2 Monosomy"
D057094,CHEMICAL,"Nuclear Receptor Subfamily 1, Group F, Member 1","Retinoid-Related Orphan Receptor-alpha3|Retinoid Related Orphan Receptor alpha4|Retinoid-Related Orphan Receptor-alpha4|Retinoid Related Orphan Receptor alpha|Retinoid Related Orphan Receptor alpha1|Retinoid-Related Orphan Receptor-alpha|Nuclear Receptor RZR-alpha|Nuclear Receptor ROR alpha|hENT1|Retinoid Related Orphan Receptor alpha3|Nuclear Receptor NR1F1|1|RAR Related Orphan Receptor A|Retinoid-Related Orphan Receptor-alpha2|Retinoid Related Orphan Receptor alpha2|Retinoid-Related Orphan Receptor-alpha1|RZR-alpha, Nuclear Receptor|Receptor NR1F1, Nuclear|Nuclear Receptor ROR-alpha|RAR-Related Orphan Receptor A|NR1F1, Nuclear Receptor|Nuclear Receptor RZR alpha"
D033705,CHEMICAL,Equilibrative Nucleoside Transport Proteins,Equilibrative Nucleoside Transport Protein|nucleoside transport
NEW16481,CHEMICAL,7-deazapurine nucleoside antibiotic tubercidin,7-deazapurine nucleoside antibiotic tubercidin
D001595,CHEMICAL,Benzylamine Oxidase,"Oxidase, Clorgyline-Resistant Amine|benzylamine|Oxidase, Benzylamine|Amine Oxidase, Clorgyline-Resistant|Clorgyline-Resistant Amine Oxidase|Clorgyline Resistant Amine Oxidase"
NEW16482,MENTAL_HEALTH,7-deazapurine nucleoside antibiotic tubercidin,SN Ar displacement
NEW16483,CHEMICAL,7-deazapurine nucleoside antibiotic tubercidin,fluoro-diazotization
NEW16484,CHEMICAL,"2',3',5'-o-acetyladenosine","2',3',5'-O-acetyladenosine"
NEW16485,CHEMICAL,"2',3',5'-o-acetyladenosine",aryl isocyanates
NEW16486,MENTAL_HEALTH,nucleophillic displacement,Nucleophillic displacement
NEW16487,CHEMICAL,nucleophillic displacement,tetra-n-butylammonium fluoride
http://purl.obolibrary.org/obo/CHEBI_52473,CHEMICAL,triflate ester,trifluoromethanesulfonate ester|triflate ester moiety|trifluoromethanesulfonate esters|trifluoromethanesulphonate esters|triflate esters|trifluoromethanesulphonate ester
NEW16488,CHEMICAL,toyocamycin analogue,toyocamycin analogues
NEW16489,DISEASE,toyocamycin analogue,human CMV
NEW16490,CHEMICAL,pseudomonas(p. aeruginosa,Pseudomonas(P. aeruginosa
NEW16491,CHEMICAL,leucine catabolite beta-hydroxy-beta-methylbutyrate,HMB|leucine catabolite beta-hydroxy-beta-methylbutyrate
C018091,CHEMICAL,maduramicin [Supplementary Concept],Lactones|Maduramicin|maduramicin
NEW16492,CHEBI,leucine catabolite beta-hydroxy-beta-methylbutyrate,coccidiostat
NEW16493,CHEMICAL,maduramicin residue,maduramicin residues
D003410,DISEASE,Cri-du-Chat Syndrome,"chat syndrome|Deletion of Short Arm of Chromosome 5 Syndrome|Syndrome, Crying Cat|5p Deletion Syndromes|Cat Cry Syndrome|Minus Syndromes, 5p|du chat syndrome|Syndromes, Crying Cat|Deletion Syndromes, 5p|Syndromes, 5p Deletion|Deletion Syndrome, 5p|Syndromes, Cat Cry|CdCS|5p Deletion Syndrome|Cat Cry Syndromes|5p Minus Syndrome|Crying Cat Syndrome|5p Minus Syndromes|Syndrome, Cat Cry|Syndrome, Chromosome 5p-|Syndrome, 5p Deletion|Syndrome, 5p-|5p- Syndromes|Cri-du-Chat Syndromes|Chromosome 5p- Syndromes|5p Syndrome|Cri du Chat Syndrome|Syndrome, 5p Minus|Crying Cat Syndromes|5p- Syndromes, Chromosome|Syndromes, 5p Minus|Minus Syndrome, 5p|5p- Syndrome|Chromosome 5p Deletion Syndrome|Syndrome, Cri-du-Chat|Syndromes, Chromosome 5p-|Chromosome 5 Short Arm Deletion Syndrome|Syndromes, Cri-du-Chat|5p- Syndrome, Chromosome|Chromosome 5p- Syndrome"
NEW16494,MENTAL_HEALTH,maduramicin residue,childhood apraxia
NEW16495,CHEMICAL,maduramicin residue,topographically-parallel corticostriatal
NEW16496,DISEASE,ejaculatory behaviour,ejaculatory behaviour
C579167,CHEMICAL,"Chrna7 protein, human [Supplementary Concept]",CHRFAM7A|alpha7 Nicotinic Acetylcholine Receptor
D063268,CHEMICAL,Sialic Acid Binding Ig-like Lectin 3,"Sialic Acid Binding Ig like Lectin 3|Antigen, CD33|Glycoprotein gp67|gp67, Glycoprotein|CD33 Antigens|sialic acid|Siglec-3|CD33 Antigen|Antigens, CD33"
D060327,CHEMICAL,Solid-Phase Synthesis Techniques,"Solid Phase Synthesis Techniques|Syntheses, Solid-Phase Nucleotide|Solid-Phase Nucleotide Synthesis|Peptide Synthesis, Solid Phase|Solid-Phase Synthesis Methods|Solid Phase Synthesis|Synthesis Technique, Solid-Phase|Synthesis Techniques, Solid-Phase|Method, Solid-Phase Synthesis|Solid-Phase Syntheses|Synthesis Method, Solid-Phase|Solid Phase Synthesis Methods|Solid Phase Nucleotide Synthesis Techniques|Techniques, Solid-Phase Synthesis|Syntheses, Solid-Phase|Technique, Solid-Phase Synthesis|Peptide Syntheses, Solid-Phase|Nucleotide Synthesis, Solid-Phase|Solid-Phase Peptide Synthesis Techniques|Synthesis Methods, Solid-Phase|Syntheses, Solid-Phase Peptide|Solid-Phase Synthesis Method|nucleotide synthesis|Methods, Solid-Phase Synthesis|Synthesis, Solid Phase|Solid Phase Peptide Synthesis|Solid-Phase Nucleotide Synthesis Techniques|Synthesis, Solid-Phase|Solid Phase Peptide Synthesis Techniques|Solid-Phase Nucleotide Syntheses|Solid-Phase Peptide Synthesis|Peptide Synthesis, Solid-Phase|Synthesis, Solid-Phase Peptide|Solid Phase Nucleotide Synthesis|Nucleotide Syntheses, Solid-Phase|Synthesis, Solid-Phase Nucleotide|Solid-Phase Peptide Syntheses|Solid-Phase Synthesis Technique|Solid-Phase Synthesis"
NEW16497,MENTAL_HEALTH,retinal projection growth,retinal projection growth
NEW16498,MENTAL_HEALTH,stress-induced motivational anhedonia,stress-induced motivational anhedonia
NEW16499,CHEBI,stress-induced motivational anhedonia,fenofibrate agonist
NEW16500,DISEASE,improve luts,improved LUTS
NEW16501,DISEASE,improve luts,pelvic atherosclerosis
NEW16502,CHEMICAL,improve luts,nitric oxide levels
NEW16503,CHEBI,potential adverse drug event,Potential adverse drug events
NEW16504,CHEMICAL,pde-5 inhibitor tadalafil,PDE-5 inhibitor tadalafil
NEW16505,MENTAL_HEALTH,pde-5 inhibitor tadalafil,concomitant erectile dysfunction
http://purl.obolibrary.org/obo/CHEBI_3176,CHEMICAL,brinzolamide,"(4R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide|Azopt|Brinzolamide|timolol-pilocarpine"
NEW16506,CHEBI,β-adrenergic antagonist toxicity,β-Adrenergic antagonist toxicity
NEW16507,DISEASE,β-adrenergic antagonist toxicity,cardiovascular collapse refractory
NEW16508,CHEMICAL,high-dose insulin,High-dose insulin
NEW16509,CHEBI,high-dose insulin,β-adrenergic antagonist cardiotoxicity
NEW16510,MENTAL_HEALTH,suicide group,suicide group
NEW16511,CHEMICAL,suicide group,3H-imipramine
NEW16512,CHEMICAL,suicide group,presynaptic serotonin marker
NEW16513,CHEMICAL,propranolol overdose,propranolol overdose
NEW16514,DISEASE,persistent hypotension,persistent hypotension
NEW16515,CHEBI,persistent hypotension,beta adrenergic blockade
NEW16516,CHEMICAL,serum propranolol level,serum propranolol level
NEW16517,DISEASE,serum propranolol level,ASD-like behavior
NEW16518,CHEBI,chronic drug exposure,chronic drug exposure
NEW16519,MENTAL_HEALTH,glutamate system,conditioned response
NEW16520,CHEMICAL,dopamine da system,dopamine DA system
NEW16521,DISEASE,da defect,DA defects
C046785,CHEMICAL,bryostatin 1 [Supplementary Concept],Bryostatins|Bryostatin-1
NEW16522,CHEBI,da defect,orphan drug status
NEW16523,CHEBI,anesthetic drug agent,Anesthetic drug agents
NEW16524,DISEASE,anesthetic drug agent,upper airway collapsibility
NEW16525,MENTAL_HEALTH,repetitive sleep fragmentation,repetitive sleep fragmentation
NEW16526,CHEBI,repetitive sleep fragmentation,opioid analgesic potency
NEW16527,DISEASE,intermittent hypoxemia,intermittent hypoxemia
NEW16528,MENTAL_HEALTH,long-term alcohol abuse,long-term alcohol abuse
NEW16529,CHEMICAL,serum histamine,serum histamine
NEW16530,CHEBI,antihistamine release,antihistamine release
NEW16531,CHEMICAL,cysteinyl leukotriene,Cysteinyl leukotrienes
NEW16532,DISEASE,cysteinyl leukotriene,postinfectious cough
NEW16533,MENTAL_HEALTH,left-right orientation,left-right orientation
NEW16534,CHEMICAL,left-right orientation,ASP traits
D005862,MENTAL_HEALTH,Gerstmann Syndrome,"Finger-Agnosia-Left-Right-Confusion-Acalculia-Agraphias|Finger-Agnosia-Left-Right-Confusion-Acalculia-Agraphia||Gerstmann Syndrome, Acquired|Syndrome, Developmental Gerstmann|Acquired Gerstmann's Syndrome|de Gerstmann, Syndrome|Gerstmann syndrome|Syndrome, Gerstmann-Badal|Syndrome, Gerstmann|Developmental Gerstmann Syndrome|Gerstmann, Syndrome de|Gerstmann's Syndrome|Gerstmann Badal Syndrome|Syndrome, Acquired Gerstmann's|Acquired Gerstmann Syndrome|Developmental Gerstmann's Syndrome|Gerstmann's Syndrome, Developmental|Syndrome de Gerstmann|Gerstmann Syndrome, Developmental|Developmental Gerstmanns Syndrome|Gerstmann's Syndrome, Acquired|Syndrome, Acquired Gerstmann|finger agnosia|Gerstmann-Badal Syndrome|Gerstmann Syndrome 2"
NEW16535,DISEASE,left-right orientation,ASD-like behavioral symptoms
NEW16536,CHEBI,antibiotic treatment,antibiotics treatment
NEW16537,NUTRITION,phospholipid profile,phospholipid profile
NEW16538,CHEMICAL,maternal ethanol consumption,maternal ethanol consumption
D054811,CHEMICAL,Phytochelatins,Phytochelatin|Phytochelatins
NEW16539,DISEASE,maternal ethanol consumption,metal toxicity
NEW16540,DISEASE,pbc patient,PBC patients
NEW16541,CHEMICAL,pbc patient,AMA|anti-mitochondrial antibodies
NEW16542,DISEASE,pbc-aih overlap syndrome,PBC-AIH overlap syndrome
D019819,CHEMICAL,Budesonide,"Horacort|Pulmicort|Budesonide, (R)-Isomer|Rhinocort|budesonide|Budesonide, (S)-Isomer"
D002792,CHEMICAL,Cholestyramine Resin,"Colestyramines|MK135|Questrans|Cholestyramine|Questran|Cholestyramines|MK-135|Cuemids|Resin, Cholestyramine|Colestyramin|Colestyramine|Resins, Cholestyramine|MK 135|Cuemid|Quantalan|Cholestyramine Resins|Colestyramins|cholestyramine|Quantalans"
NEW16543,CHEMICAL,n-methyl d-aspartate receptor nmdar antagonist gas nitrous oxide,N-methyl d-aspartate receptor NMDAR antagonist gas nitrous oxide
NEW16544,CHEBI,same common drug therapy,same common drug therapy
NEW16545,DISEASE,same common drug therapy,behavioral hypersensitivity
NEW16546,CHEBI,same common drug therapy,glutamate transporter activator riluzole
D027341,CHEMICAL,Excitatory Amino Acid Transporter 1,"GLAST-1 Glutamate Aspartate Transporter|GLAST|GLAST 1 Glutamate Aspartate Transporter|Glutamate Aspartate Transporter 1|SLC1A3 Transporter|EAAT 1 Excitatory Amino Acid Transporter|EAAT-1 Excitatory Amino Acid Transporter|Transporter, SLC1A3|glutamate-aspartate transporter"
NEW16547,CHEMICAL,same common drug therapy,selective GLT-1 blocker dihydrokainic acid
NEW16548,CHEMICAL,six-herb medicine formula,six-herb medicine formula
NEW16549,CHEMICAL,six-herb medicine formula,BBTD AD
NEW16550,CHEMICAL,six-herb medicine formula,Baizhu Tianma decoction
NEW16551,CHEMICAL,six-herb medicine formula,aglycone metabolite
D004932,DISEASE,Esophageal and Gastric Varices,"Varix, Gastric|Gastric Varix|Esophageal Varices|Varices, Esophageal|Gastric Varices|Esophageal Varix|Varices, Gastric|Varix, Esophageal|esophageal varices"
NEW16552,DISEASE,six-herb medicine formula,gastrointestinal bleeding
NEW16553,DISEASE,six-herb medicine formula,infantile hemangiomas
NEW16554,DISEASE,prolonged qtc interval,prolonged QTc interval|LQT
NEW16555,CHEMICAL,channel blocker phenytoin,channel blocker phenytoin
NEW16556,DISEASE,channel blocker phenytoin,acute liver cytolysis
NEW16557,CHEMICAL,drowsiness/lethargy,Drowsiness/lethargy
NEW16558,MENTAL_HEALTH,major depressive disorder pathogenesis,Major Depressive Disorder pathogenesis
NEW16559,DISEASE,major depressive disorder pathogenesis,gut-brain axis GBA dysfunction
NEW16560,DISEASE,major depressive disorder pathogenesis,microcytic anaemias
NEW16561,CHEMICAL,cytoplasmic luminal mutation,cytoplasmic luminal mutations
C030720,CHEMICAL,triacetic acid lactone [Supplementary Concept],triacetic acid lactone|Pyrones
NEW16562,MENTAL_HEALTH,cytoplasmic luminal mutation,derailment product
NEW16563,CHEMICAL,stnfr60 level,sTNFR60 levels
NEW16564,MENTAL_HEALTH,stnfr60 level,depression mania
NEW16565,MENTAL_HEALTH,pregnancy neonatal abstinence syndrome,pregnancy neonatal abstinence syndrome
NEW16566,CHEMICAL,uplc-qtofms-based metabolomic method,UPLC-QTOFMS-based metabolomic method
NEW16567,DISEASE,uplc-qtofms-based metabolomic method,VaD. Experimental VaD model
NEW16568,CHEMICAL,uplc-qtofms-based metabolomic method,YGS|Traditional Chinese medicine Yi-Gan San
NEW16569,DISEASE,vad rat,VaD rats
NEW16570,CHEMICAL,vad rat,hematoxylin-eosin staining
NEW16571,DISEASE,2-vo-induced VaD,2-VO-induced VaD
NEW16572,CHEMICAL,2-vo-induced VaD,arachidonic acid metabolism
NEW16573,DISEASE,2-vo-induced VaD,protein fibrillation
NEW16574,CHEBI,several hepatotoxic agent,Several hepatotoxic agents
NEW16575,CHEMICAL,toxicity acetaminophen,toxicity acetaminophen
NEW16576,CHEMICAL,toxicity acetaminophen,membrane calcium pumps
NEW16577,DISEASE,toxicity acetaminophen,severe hepatotoxicity
NEW16578,CHEBI,anticonvulsant drug valproic acid,anticonvulsant drug valproic acid
NEW16579,CHEMICAL,particular 4-en-valproate,particular 4-en-valproate
http://purl.obolibrary.org/obo/CHEBI_63794,CHEBI,retinoid x receptor agonist,retinoid X receptor agonist|retinoid X receptor agonists
D016410,DISEASE,"Lymphoma, T-Cell, Cutaneous","Lymphomas, Cutaneous T-Cell|Cutaneous T-Cell Lymphoma|Cutaneous T-Cell Lymphomas|Lymphoma, Cutaneous T-Cell|T-Cell Lymphomas, Cutaneous|Lymphoma, T Cell, Cutaneous|Granulomatous Slack Skin|Cutaneous T Cell Lymphoma|T Cell Lymphoma, Cutaneous|Slack Skin, Granulomatous|T-Cell Lymphoma, Cutaneous|cutaneous T-cell lymphoma"
NEW16580,CHEBI,U.S. Food drug,U.S. Food drug
D011952,CHEMICAL,"Receptors, Concanavalin A","Receptor, Concanavalin A|concanavalin A|Concanavalin A Binding Sites|Concanavalin A Receptor|Concanavalin A Receptors"
C027774,CHEMICAL,concanavalin A-binding glycoproteins [Supplementary Concept],"Receptors, Concanavalin A|Con A"
NEW16581,CHEMICAL,il-2 % reduction,IL-2 % reduction
NEW16582,CHEMICAL,antitcr,antiTCR
NEW16583,DISEASE,splenic t cell proliferation,splenic T cell proliferation
NEW16584,CHEMICAL,tnf-alpha production,TNF-alpha production
NEW16585,CHEBI,partial agonist property,partial agonist properties
NEW16586,CHEMICAL,% ±,% ±
NEW16587,CHEMICAL,% ±     iron acquisition,% ±    iron acquisition
NEW16588,CHEMICAL,ton/tol transport,ton/tol transport
NEW16589,MENTAL_HEALTH,post-schizophrenic depression,post-schizophrenic depression
NEW16590,CHEMICAL,δ-tocotrienol,δ-tocotrienols
NEW16591,DISEASE,δ-tocotrienol,diet-induced metabolic syndrome
D000820,DISEASE,Animal Diseases,"animal diseases|Diseases, Animal"
NEW16592,CHEBI,antimicrobial protein,Antimicrobial proteins
NEW16593,CHEBI,antimicrobial protein,T-2/HT-2 toxins
NEW16594,MENTAL_HEALTH,antimicrobial protein,coronary vascular resistance
D008600,DISEASE,Menstruation-Inducing Agents,Menstruation|Emmenagogues|Menstruation Inducing Agents
NEW16595,CHEBI,antimicrobial protein,systemic endocrine events
NEW16596,DISEASE,ischaemic priapism,ischaemic priapism
NEW16597,CHEBI,ischaemic priapism,cavernosal sympathomimetic injections
NEW16598,MENTAL_HEALTH,exacerbated postparturient insulin resistance,Exacerbated postparturient insulin resistance
NEW16599,CHEBI,vitamin e supplementation,Vitamin E supplementation
NEW16600,NUTRITION,dl-alpha-tocopheryl acetate,dl-alpha-tocopheryl acetate
NEW16601,CHEMICAL,dl-alpha-tocopheryl acetate,conjugated diene formation
NEW16602,MENTAL_HEALTH,dl-alpha-tocopheryl acetate,lipoprotein resistance
NEW16603,CHEMICAL,dl-alpha-tocopheryl acetate,000+/-7129
NEW16604,DISEASE,dl-alpha-tocopheryl acetate,atherosclerotic vascular disease
C495008,CHEMICAL,N-(3-oxo-hexahydrocyclopenta(b)furan-3a-yl)acylamide [Supplementary Concept],FAA|Amides|Furans|Cyclopentanes
NEW16605,CHEMICAL,five-factor borderline inventory-short form,FFBI-SF|Five-Factor Borderline Inventory-Short Form
NEW16606,DISEASE,polycystic ovary pco phenotype model,polycystic ovary PCO phenotype model
NEW16607,DISEASE,ne-induced polycystic condition,NE-induced polycystic condition
NEW16608,DISEASE,ne-induced polycystic condition,PCO phenotype
NEW16609,DISEASE,ss patient,SS patients
NEW16610,NUTRITION,ss patient,Asian water buffalo
NEW16611,DISEASE,ss patient,Bubalus bubalis|two Asian water buffalo
NEW16612,CHEMICAL,ss patient,postnatal Copper
NEW16613,CHEMICAL,ss patient,Copper-to-Zinc ratio
C098825,CHEBI,"HIV-1 immunogen, incomplete Freund's adjuvant [Supplementary Concept]",immunogen|AIDS Vaccines
NEW16614,CHEMICAL,ss patient,inhibitory adenosine receptors
NEW16615,CHEMICAL,ss patient,extracellular adenosine
NEW16616,MENTAL_HEALTH,ss patient,slower subsequent hypoxic depression
NEW16617,MENTAL_HEALTH,hypoxic depression,hypoxic depression
D052066,CHEMICAL,N-Ethylmaleimide-Sensitive Proteins,"ATPase, NSF|N-Ethylmaleimide-Sensitive ATPase|ATPase, N-Ethylmaleimide-Sensitive|N Ethylmaleimide Sensitive Proteins|N Ethylmaleimide Sensitive Protein|N Ethylmaleimide Sensitive Fusion Protein|N-Ethylmaleimide-Sensitive Fusion Protein|N-Ethylmaleimide-Sensitive Protein|N Ethylmaleimide Sensitive Factors|NSF ATPase|N-Ethylmaleimide-Sensitive Factor|N-Ethylmaleimide-Sensitive Factors|NEM-Sensitive Fusion Proteins|N-ethylmaleimide|N Ethylmaleimide Sensitive Factor|NEM Sensitive Fusion Proteins|N Ethylmaleimide Sensitive ATPase"
D017696,CHEMICAL,"Myopathies, Nemaline","Rod Myopathies|Adult Onset Nemaline Myopathy|Autosomal Recessive Nemaline Myopathy|Myopathy, Nemaline|Nemaline Myopathy, Autosomal Dominant|Nemaline Myopathy, Adult Onset|Nemaline Myopathy|Nemaline Rod Disease|Rod-Body Myopathies|Late Onset Nemaline Myopathy|Rod-Body Myopathy|Nemaline Myopathy, Late Onset|Myopathy, Rod|Myopathies, Rod-Body|Rod Myopathy|Myopathies, Rod|Childhood Onset Nemaline Myopathy|Autosomal Dominant Nemaline Myopathy|Myopathy, Rod-Body|Rod Body Myopathy|NEM|Nemaline Myopathy, Autosomal Recessive|Nemaline Myopathy, Childhood Onset|Nemaline Body Disease|Rod Body Disease|Nemaline myopathy|Nemaline Myopathies|Myopathy, Rod Body"
NEW16618,CHEMICAL,hypoxic depression,CB1 cannabinoid receptor antagonist AM251
NEW16619,CHEBI,hypoxic depression,GI mGluR antagonist AIDA
NEW16620,NUTRITION,elevated plasma very-long-chain fatty acid,elevated plasma very-long-chain fatty acids
NEW16621,DISEASE,elevated psychiatric morbidity,elevated psychiatric morbidity
NEW16622,CHEMICAL,gut tryptamine increase,Gut tryptamine increase
NEW16623,DISEASE,gut tryptamine increase,necrotizing ability
NEW16624,CHEMICAL,gut tryptamine increase,tryptamine cytotoxicity
NEW16625,DISEASE,viral infection-induced dysbiosis,viral infection-induced dysbiosis
NEW16626,CHEBI,viral infection-induced dysbiosis,major virulence factor
NEW16627,CHEMICAL,ns structural arrangement,NSs structural arrangements
NEW16628,MENTAL_HEALTH,ns structural arrangement,strong detergent resistance
NEW16629,CHEMICAL,ns structural arrangement,nm-width fibrils
NEW16630,DISEASE,catatonic sign,catatonic signs
NEW16631,CHEMICAL,multiple-voxel h-mrs,Multiple-voxel H-MRS
NEW16632,DISEASE,multiple-voxel h-mrs,atypical schizophrenic patients
NEW16633,MENTAL_HEALTH,behavioral depression,behavioral depression
C038193,CHEMICAL,4-hydroxybenzoic acid [Supplementary Concept],PHBA|Para-hydroxybenzoic acid|Parabens
NEW16634,CHEBI,antiviral medication,antiviral medications
D017245,CHEMICAL,Foscarnet,Foscarnet Magnesium (2:3) Salt|Foscarnet Trisodium Salt|Foscarnet Sodium|Foscarnet Trilithium Salt|Phosphonoformate|Trisodium Phosphonoformate|Foscavir|Foscarnet Manganese (2+) (2:3) Salt|Foscarnet Calcium (2:3) Salt|Foscarnet Disodium Salt|foscarnet|Foscarnet Sodium Hexahydrate|Foscarnet Barium (2:3) Salt|Foscarnet Tripotassium Salt|Phosphonoformic Acid
NEW16635,CHEBI,antiviral medication,oral estrogen antagonist
NEW16636,CHEBI,high luteinizing hormone concentration,high luteinizing hormone concentrations
NEW16637,DISEASE,high luteinizing hormone concentration,concomitant hyperinsulinemia
NEW16638,MENTAL_HEALTH,evoke agitation,evoked agitation
NEW16639,CHEMICAL,cyclic metaphosphate structure,cyclic metaphosphate structure
NEW16640,MENTAL_HEALTH,cyclic metaphosphate structure,final fragmentation product
C031866,NUTRITION,de-epoxy rosamicin [Supplementary Concept],potassium dihydrogen phosphate|Leucomycins
NEW16641,DISEASE,cyclic metaphosphate structure,atherothrombotic cardiovascular disease
D021921,DISEASE,"Aortic Stenosis, Supravalvular","Stenosis, Aortic Supravalvular|aortic stenosis|Aortic Supravalvular Stenosis|Stenoses, Aortic Supravalvular|Stenosis, Supravalvular Aortic|Supravalvular Aortic Stenosis|Supravalvular Stenosis, Aortic|Supravalvar Aortic Stenosis|Aortic Supravalvular Stenoses|Supravalvular Stenoses, Aortic"
NEW16642,CHEMICAL,p-glycoprotein inhibitor,P-glycoprotein inhibitors
NEW16643,CHEMICAL,α1-adrenergic antagonist prazosin,α1-adrenergic antagonist prazosin
NEW16644,DISEASE,α1-adrenergic antagonist prazosin,posttraumatic stress disorder-related nightmares
NEW16645,DISEASE,patient allergic,patient allergic
NEW16646,CHEMICAL,patient allergic,GRPs|recombinant gibberellin-regulated proteins
NEW16647,CHEMICAL,bell/chili pepper cedar pollen,bell/chili pepper cedar pollen
NEW16648,CHEMICAL,pufa supplement,PUFA supplements
NEW16649,CHEMICAL,pufa treatment,PUFA treatment
NEW16650,CHEMICAL,serine/threonine kinase glycogen synthase kinase-3,GSK-3|serine/threonine kinase glycogen synthase kinase-3
http://purl.org/sig/ont/fma/fma24890,CHEMICAL,arm,PAPD5/7 arm|Brachial region|Proximal segment of free upper limb
C050807,CHEMICAL,"presurface protein 2, hepatitis B surface antigen [Supplementary Concept]",Protein Precursors|HBsAg|Hepatitis B Surface Antigens
NEW16651,DISEASE,down patient,Down patients
NEW16652,DISEASE,alzheimer degenerative deficiency,Alzheimer degenerative deficiency
NEW16653,CHEMICAL,omega-3 pufas arachidonic acid,omega-3 PUFAs arachidonic acid|ARA
D000079404,DISEASE,Regulated Cell Death,"Cell Death, Regulated|regulated cell death"
C420120,CHEBI,gamma-aminobutyryl-2-methyltryptophyl-2-methyltryptophyl-2-methyltryptophyl-lysinamide [Supplementary Concept],Oligopeptides|growth hormone releasing peptide
NEW16654,MENTAL_HEALTH,arsenic resistance operon,arsenic resistance operon
NEW16655,CHEMICAL,arsenic resistance operon,hydroxyarsinothricin butanoate
NEW16656,MENTAL_HEALTH,importance antimicrobial resistance,IMPORTANCE Antimicrobial resistance
NEW16657,CHEBI,importance antimicrobial resistance,novel potent antibiotics
D029821,CHEMICAL,"Enterovirus A, Human","Human Enterovirus 71|Human Enterovirus A|A71|EV-A71|Enterovirus 71, Human"
NEW16658,DISEASE,importance antimicrobial resistance,MODY families
NEW16659,DISEASE,bone metastasis,bone metastases
D000077294,CHEBI,"Receptor, Transforming Growth Factor-beta Type II","TGF beta Type II Receptors|Transforming Growth Factor-beta Type II Receptors|transforming growth factor beta|TGFBR2|TbetaR II Kinase|Kinase, TbetaR-II|Transforming Growth Factor beta Type II Receptors|Type II TGF beta Receptor|Receptor, Transforming Growth Factor beta Type II|Transforming Growth Factor-beta Type II Receptor|Type II TGF-beta Receptors|TbetaR-II Kinase|Transforming Growth Factor beta Type II Receptor|TGF beta Type II Receptor|Type II TGF-beta Receptor|TGF-beta Type II Receptors|TGF-beta Type II Receptor|Type II TGF beta Receptors"
NEW16660,DISEASE,bone metastasis,impaired coronary microvascular function
NEW16661,DISEASE,acid-induced adipocyte inflammation,acid-induced adipocyte inflammation
NEW16662,CHEMICAL,saturated free,Saturated free
D002083,CHEMICAL,Butylated Hydroxyanisole,"|AMIF 72|butylated hydroxyanisole|Methoxyphenol, Butyl|Butylhydroxyanisole|(1,1-Dimethylethyl)-4-methoxyphenol|AMIF-72|Nipantiox 1 F|AMIF72|Embanox|Butyl Methoxyphenol|Nipantiox 1F|Nipantiox 1-F|Tenox BHA|BHA|Hydroxyanisole, Butylated"
NEW16663,DISEASE,levodopa-induced lao aim,levodopa-induced LAO AIMs
NEW16664,DISEASE,lid model,LID model
NEW16665,DISEASE,parkinsonian sign,parkinsonian signs
NEW16666,CHEMICAL,striatal n-methyl-d-aspartate receptor function,striatal N-methyl-D-aspartate receptor function
NEW16667,MENTAL_HEALTH,define schizophrenia,defined schizophrenia
NEW16668,CHEMICAL,oxidize β-cyclodextrin,oxidized β-cyclodextrin
NEW16669,CHEMICAL,oxidize β-cyclodextrin,tyramine functionalities
NEW16670,DISEASE,organization pain relief,Organization pain relief
NEW16671,DISEASE,rapid pain relief,Rapid pain relief
NEW16672,CHEBI,rapid pain relief,opioid analgesic use
NEW16673,MENTAL_HEALTH,psychological resistance,psychological resistance
NEW16674,DISEASE,psychological resistance,pain amelioration
NEW16675,CHEMICAL,p97/vcp valosin,p97/VCP Valosin
NEW16676,DISEASE,p97/vcp valosin,hyperactive alleles
NEW16677,DISEASE,human disease mutation,human disease mutations
NEW16678,CHEBI,human disease mutation,analgesic use
NEW16679,CHEMICAL,recombinant pegylated human ifn alpha,recombinant pegylated human IFN alpha
NEW16680,CHEMICAL,recombinant pegylated human ifn alpha,inositol levels
NEW16681,CHEMICAL,soya isoflavone,soya isoflavones
NEW16682,CHEBI,soya isoflavone,oestrogen receptors
NEW16683,CHEBI,vitamin d skeleton,vitamin D skeleton
NEW16684,CHEBI,vitamin d skeleton,vitamin D receptor VDR binding affinity
NEW16685,DISEASE,vitamin d skeleton,glomerular inflammation
NEW16686,DISEASE,vitamin d skeleton,glomerulomegaly
NEW16687,DISEASE,tubulointerstitial fibrosis,tubulointerstitial fibrosis
NEW16688,MENTAL_HEALTH,addition insulin resistance,addition insulin resistance
D003928,DISEASE,Diabetic Nephropathies,"Diabetic Nephropathy|Diabetic Kidney Disease|Diabetic Kidney Diseases|Glomerulosclerosis, Nodular||Glomerulosclerosis, Diabetic|Kimmelstiel Wilson Disease|Nephropathy, Diabetic|Nephropathies, Diabetic|Kidney Diseases, Diabetic|Kimmelstiel-Wilson Syndrome|Diabetic Glomerulosclerosis|Kimmelstiel-Wilson Disease|Kimmelstiel Wilson Syndrome|diabetic nephropathy|Nodular Glomerulosclerosis|Kidney Disease, Diabetic|Syndrome, Kimmelstiel-Wilson|Intracapillary Glomerulosclerosis"
NEW16689,CHEMICAL,nicotine abstinence,nicotine abstinence
NEW16690,CHEMICAL,nicotine abstinence,smoking individuals
NEW16691,CHEMICAL,nicotine abstinent patient,nicotine abstinent patients
NEW16692,DISEASE,abstinence-induced pain sensitivity,abstinence-induced pain sensitivity
NEW16693,CHEMICAL,nicotine abstinence duration,nicotine abstinence duration
http://purl.obolibrary.org/obo/CHEBI_28313,CHEMICAL,nornicotine,S-(-)-nornicotine|l-nor-nicotine|nicotine dependence/abstinence|Nornicotine|1'-demethyl nicotine|(S)-1'-demethylnicotine|(-)-nornicotine|3-[(2S)-pyrrolidin-2-yl]pyridine
NEW16694,CHEBI,unopposed estrogen use,Unopposed estrogen use
D065311,DISEASE,Adenocarcinoma in Situ,"in Situ, Adenocarcinoma|Adenocarcinoma, Intraepithelial|Adenocarcinomas, Intraepithelial|Adenocarcinomas, Preinvasive|Intraepithelial Adenocarcinomas|adenocarcinoma|Situ, Adenocarcinoma in|Adenocarcinoma in Situs|Preinvasive Adenocarcinoma|Adenocarcinoma, Preinvasive|Preinvasive Adenocarcinomas|Intraepithelial Adenocarcinoma"
NEW16695,MENTAL_HEALTH,unopposed estrogen use,childhood enuresis
http://purl.obolibrary.org/obo/CHEBI_50811,CHEMICAL,carbon nanohorn,Carbon nanohorns|CNH
NEW16696,CHEMICAL,oxcnh-cap-ibn composite nanoparticle,OxCNH-CaP-IBN composite nanoparticles
NEW16697,DISEASE,oxcnh-cap-ibn composite nanoparticle,metastatic bone destruction
NEW16698,CHEMICAL,dissolve phosphate ion,dissolved phosphate ions
D002130,NUTRITION,Calcium Phosphates,"calcium phosphates|Phosphates, Calcium"
NEW16699,CHEMICAL,composite,composites
NEW16700,MENTAL_HEALTH,composite,engineering fixation applications
NEW16701,MENTAL_HEALTH,2-adrenergic receptor agonist,agoraphobia panic attacks
NEW16702,CHEBI,2-adrenergic receptor agonist,growth hormone levels
NEW16703,MENTAL_HEALTH,2-adrenergic receptor agonist,self-rated drowsiness
NEW16704,CHEBI,2-adrenergic receptor agonist,2-adrenergic receptor antagonist yohimbine
NEW16705,CHEMICAL,2-adrenergic receptor agonist,plasma MHPG levels
NEW16706,CHEMICAL,active alpha-2 adrenergic receptor agonist clonidine,active alpha-2 adrenergic receptor agonist clonidine
NEW16707,DISEASE,active alpha-2 adrenergic receptor agonist clonidine,problematic spasticity
NEW16708,DISEASE,active alpha-2 adrenergic receptor agonist clonidine,spinal cord injury patients
D002128,CHEMICAL,Calcium Metabolism Disorders,"calcium metabolism|Disorder, Calcium Metabolism|Calcium Metabolism Disorder|Disorders, Calcium Metabolism"
NEW16709,DISEASE,active alpha-2 adrenergic receptor agonist clonidine,primary diabetic ulcer DFU cells
NEW16710,CHEMICAL,active alpha-2 adrenergic receptor agonist clonidine,DFU therapy
NEW16711,DISEASE,APEC isolate,APEC isolates
NEW16712,DISEASE,APEC strain,APEC strains
NEW16713,CHEBI,APEC strain,tested antimicrobials
NEW16714,DISEASE,pneumonia onset,pneumonia onset
NEW16715,DISEASE,pneumonia onset,nosocomial CRGNB pneumonia
D010926,CHEBI,Placental Hormones,"Hormones, Placental|placental hormones"
NEW16716,CHEMICAL,pneumonia onset,decreased bicarbonate buffer
NEW16717,MENTAL_HEALTH,pneumonia onset,schizophrenia RCTs
NEW16718,CHEMICAL,addon administration,addon administration
NEW16719,MENTAL_HEALTH,addon administration,acute agitation
NEW16720,CHEMICAL,serotonin-dopamine activity modulator,serotonin-dopamine activity modulator
NEW16721,CHEBI,serotonin-dopamine activity modulator,second D2 partial agonist
NEW16722,CHEBI,second partial agonist,second partial agonist
NEW16723,CHEMICAL,second partial agonist,α1B receptors
NEW16724,DISEASE,second partial agonist,extrapyramidal dysfunction
NEW16725,CHEMICAL,brexpiprazole target dosing,Brexpiprazole target dosing
NEW16726,MENTAL_HEALTH,brexpiprazole target dosing,depression augmentation
NEW16727,CHEMICAL,57co-cyanocobalamin,57Co-cyanocobalamin
NEW16728,CHEMICAL,57co-cyanocobalamin,phytohemagglutinin lymphocytes
C021557,CHEMICAL,"5,10-methenyltetrahydrofolate synthetase [Supplementary Concept]",5-formyltetrahydrofolate|Carbon-Nitrogen Ligases
NEW16729,NUTRITION,uninterrupted folate cycle,uninterrupted folate cycle
NEW16730,CHEMICAL,uninterrupted folate cycle,Me-Cbl synthesis
NEW16731,CHEBI,uninterrupted folate cycle,available KOR agonist
NEW16732,CHEMICAL,depression antidepressant,depression antidepressants
NEW16733,MENTAL_HEALTH,depression antidepressant,perimenopausal depression
NEW16734,CHEMICAL,depression antidepressant,front-line treatments
NEW16735,CHEMICAL,chronic ven treatment,Chronic VEN treatment
NEW16736,CHEMICAL,chronic ven treatment,acH3K9 level
NEW16737,CHEMICAL,chronic ven treatment,CUS rats
NEW16738,CHEMICAL,chronic ven treatment,TH protein expression
NEW16739,CHEBI,synaptic serotonin availability,SSRI efficacy
NEW16740,CHEMICAL,serotonin hypersensitivity,serotonin hypersensitivity
NEW16741,CHEMICAL,female pd patient,hypersensitive serotonin receptors
D051703,DISEASE,Sp Transcription Factors,"Sephacryl Phosphocellulose Transcription Factors|SP|Specificity Protein Transcription Factors|Transcription Factors, Sp"
NEW16742,CHEBI,freshwater fish,vitamin K. Menaquinone-7
NEW16743,MENTAL_HEALTH,severe dementia,severe dementia
D019959,MENTAL_HEALTH,Feeding and Eating Disorders of Childhood,eating disorders|Childhood Eating and Feeding Disorders
NEW16744,CHEMICAL,da metabolism,DA metabolism
NEW16745,CHEMICAL,dopamine innervation,dopamine innervation
NEW16746,DISEASE,dopamine innervation,CKD-associated adverse cardiovascular events
NEW16747,DISEASE,young autistic child biological fluid,young autistic children biological fluids
NEW16748,CHEMICAL,p-cresol circulating concentration,p-cresol circulating concentrations
NEW16749,DISEASE,p-cresol circulating concentration,postictal hypoxia
D009553,CHEMICAL,Nimodipine,"|e 9736, Bay|Calnit|Nimodipin ISIS|Modus|Nimodipin Hexal|Nymalize|Remontal|nimodipine|Hexal, Nimodipin|Kenesil|Admon|Nimotop|Brainal|Bayvit, Nimodipino|Bay e 9736|Nimodipin-ISIS|Nimodipino Bayvit"
NEW16750,DISEASE,p-cresol circulating concentration,postictal cerebral hypoperfusion
NEW16751,CHEMICAL,p-cresol circulating concentration,Ca2 redox imbalance
C060285,CHEMICAL,lacidipine [Supplementary Concept],Dihydropyridines|lacidipine|Lacidipine
NEW16752,MENTAL_HEALTH,p-cresol circulating concentration,AD-type dementia
D010899,DISEASE,Pituitary Apoplexy,"Apoplexy, Pituitary|pituitary apoplexy"
http://purl.obolibrary.org/obo/CHEBI_4110,CHEMICAL,cathinone,cathinone|amphetamine (AMPH)-type|catinona|cathinonum|Norephedrone|Cathinone|(2S)-2-amino-1-phenylpropan-1-one|D-Cathinone
NEW16753,DISEASE,pkc-mediated mitochondrial dysfunction,PKC-mediated mitochondrial dysfunction
NEW16754,DISEASE,pkc-mediated mitochondrial dysfunction,psychiatric disturbance
NEW16755,DISEASE,pkc-mediated mitochondrial dysfunction,moderate manic episodes
NEW16756,NUTRITION,pkc-mediated mitochondrial dysfunction,lithium valproate
NEW16757,CHEMICAL,pkc-mediated mitochondrial dysfunction,firstpsychotropic drugs
NEW16758,MENTAL_HEALTH,ms-ms fragmentation pattern,MS-MS fragmentation pattern
NEW16759,DISEASE,ms-ms fragmentation pattern,programmed cell death signal transduction pathways
NEW16760,CHEMICAL,low dose intravenous ketamine,low dose intravenous ketamine
NEW16761,NUTRITION,phosphorus metabolite level,phosphorus metabolite levels
NEW16762,DISEASE,leave temporal lobe,left temporal lobe
NEW16763,MENTAL_HEALTH,leave temporal lobe,schizophrenia spectrum disorders
NEW16764,NUTRITION,membrane phospholipid abnormality,Membrane phospholipid abnormalities
NEW16765,CHEMICAL,membrane phospholipid abnormality,amyloid β25 peptide
NEW16766,MENTAL_HEALTH,topographical disorientation,topographical disorientation
http://purl.obolibrary.org/obo/CHEBI_80298,CHEBI,gonadotropin-releasing hormone ii,GnRH-II|gonadotropin-releasing hormone (GnRH)-agonists|Gonadoliberin-II
D008994,CHEMICAL,Monoacylglycerol Lipases,"monoacylglycerol lipase|Monoester Hydrolase, Glycerol|Lipase, Monoacylglycerol|Lipases, Monoglyceride|Monoglyceride Lipases|Monoglyceride Esterases|Glycerol Monoester Hydrolases|Monoglyceride Lipase|Monoacylglycerol Lipase|Hydrolases, Glycerol Monoester|Glycerol Monoester Hydrolase|Lipase, Monoglyceride|Monoglyceride Esterase|Hydrolase, Glycerol Monoester|Esterases, Monoglyceride|Monoglyceride Hydrolase|Monoester Hydrolases, Glycerol|Esterase, Monoglyceride|Hydrolase, Monoglyceride|Lipases, Monoacylglycerol"
NEW16767,NUTRITION,primary endocannabinoid enzyme fatty acid amide hydrolase,primary endocannabinoid enzymes fatty acid amide hydrolase
NEW16768,CHEMICAL,high bpa level,higher BPA levels
C000624641,CHEMICAL,"2,3-dihydro-3beta-methoxy withaferin-A [Supplementary Concept]",Withaferin A|Withanolides|WFA
NEW16769,MENTAL_HEALTH,high bpa level,experiment significant depression
NEW16770,CHEMICAL,lactate accumulation,lactate accumulation
NEW16771,DISEASE,lactate accumulation,gram-negative bacterium Vibrio campbellii
NEW16772,CHEMICAL,oxygen uptake,oxygen uptake
NEW16773,DISEASE,oxygen uptake,cocaine-induced myocardial ischemia
NEW16774,DISEASE,oxygen uptake,lethal arrhythmias
NEW16775,DISEASE,oxygen uptake,early afterdepolarizations
NEW16776,CHEMICAL,oxygen uptake,potassium current
NEW16777,DISEASE,dengue infection,dengue infection
NEW16778,DISEASE,aids pandemic,AIDS pandemic
NEW16779,CHEBI,aids pandemic,available antiviral therapies
NEW16780,CHEMICAL,vif-a3f,Vif-A3F
NEW16781,CHEBI,vif-a3f,antiviral drug development
NEW16782,NUTRITION,vif-a3f,impaired intracellular cholesterol trafficking
NEW16783,CHEMICAL,tisafp8,TisAFP8
NEW16784,CHEMICAL,tisafp8,isoform TisAFP6
NEW16785,MENTAL_HEALTH,great depression,greatest depression
NEW16786,CHEBI,"5-ht2 agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane","5-HT2 agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane"
D018690,CHEBI,Excitatory Amino Acid Agonists,"EAA agonists|Amino Acid Agonist, Excitatory|Glutamate Agonist|Agonist, Glutamate|Agonists, Glutamate|Amino Acid Agonists, Excitatory|Glutamate Agonists|Amino Acids, Excitatory, Agonists|Agonists, EAA|EAA Agonists|Agonists, Excitatory Amino Acid|Excitatory Amino Acid Agonist|Agonist, EAA|EAA Agonist"
NEW16787,DISEASE,"5-ht2 agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane",dose-dependent behavioural syndrome similar
NEW16788,DISEASE,behavioral syndrome,behavioral syndrome
NEW16789,CHEMICAL,behavioral syndrome,gamma-D-glutamyl-amino-methylsulfonic acid
NEW16790,CHEMICAL,behavioral syndrome,DL-2-amino-5 phosphonovalerate
NEW16791,DISEASE,pain-like behavioral syndrome,pain-like behavioral syndrome
NEW16792,CHEMICAL,isomer-specific fragment,Isomer-specific fragments
NEW16793,CHEMICAL,deregulate acrolein metabolism,deregulated acrolein metabolism
NEW16794,CHEMICAL,dietary soy isoflavone intervention,dietary soy isoflavone intervention
NEW16795,DISEASE,dietary soy isoflavone intervention,metabolic syndrome markers
NEW16796,DISEASE,dietary soy isoflavone intervention,RA homeostasis
NEW16797,DISEASE,dietary soy isoflavone intervention,local RA degradation
NEW16798,CHEBI,dietary soy isoflavone intervention,tetracycline antibiotic
NEW16799,CHEBI,rar antagonist,RAR antagonist
NEW16800,DISEASE,rar antagonist,MCMV infection
NEW16801,CHEBI,indolic antimicrobial metabolite,indolic antimicrobial metabolite
NEW16802,CHEBI,indolic antimicrobial metabolite,major phytoalexin
C494598,CHEMICAL,glucosyl jasmonate [Supplementary Concept],Cyclopentanes|Oxylipins|jasmonate|Glucosides
NEW16803,DISEASE,indolic antimicrobial metabolite,pathogen infection
NEW16804,CHEMICAL,indolic antimicrobial metabolite,camalexin biosynthesis
NEW16805,CHEMICAL,indolic antimicrobial metabolite,occurring excitotoxin
NEW16806,CHEMICAL,indolic antimicrobial metabolite,used particulate steroid
NEW16807,CHEMICAL,conclusion dexamethasone,Conclusion Dexamethasone
NEW16808,DISEASE,conclusion dexamethasone,moderate CTS cases
C001520,CHEMICAL,lanthionine [Supplementary Concept],Sulfides|lanthionine|Alanine/analogs  and  derivatives
NEW16809,MENTAL_HEALTH,conclusion dexamethasone,proteolytic resistance
NEW16810,CHEMICAL,fty720 administration,FTY720 administration
NEW16811,CHEMICAL,fty720 administration,sunitinib treatment
NEW16812,DISEASE,fty720 administration,tumor growth inhibition effect
NEW16813,DISEASE,mesocorticolimbic dopamine system,severe medical disorder
NEW16814,CHEMICAL,catechu l. treatment,catechu L. treatment
NEW16815,MENTAL_HEALTH,locomotion hyperactivity phenotype,locomotion hyperactivity phenotypes
NEW16816,CHEBI,locomotion hyperactivity phenotype,mAChR antagonists
NEW16817,DISEASE,chronic intermittent hypoxia,hypoxia-induced hypertension
NEW16818,CHEBI,adipose-produce hormone leptin,adipose-produce hormone leptin
NEW16819,DISEASE,adipose-produce hormone leptin,upper airway obstruction
NEW16820,CHEBI,adipose-produce hormone leptin,broad-spectrum antiepileptic drug
NEW16821,CHEBI,adipose-produce hormone leptin,selective non-competitive α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid AMPA receptor antagonist licensed
NEW16822,DISEASE,chronic epilepsy model,chronic epilepsy model
NEW16823,CHEBI,bile sequestrant,bile sequestrants
NEW16824,CHEMICAL,bile sequestrant,bile salt reabsorption
NEW16825,CHEBI,bile sequestrant,sequestrant
NEW16826,MENTAL_HEALTH,chromosome autistic psychotic rett syndrome child,Chromosomes autistic psychotic Rett syndrome children
NEW16827,CHEMICAL,chromosome autistic psychotic rett syndrome child,folic-acid-depleted medium
NEW16828,DISEASE,psychotic child,psychotic children
NEW16829,CHEMICAL,5-hydroxy-indoleacetic acid,5-hydroxy-indoleacetic acid
NEW16830,CHEMICAL,5-hydroxy-indoleacetic acid,standard urinary amino acid detection testing methods
NEW16831,CHEMICAL,5-hydroxy-indoleacetic acid,low-phenylalanine diets
NEW16832,MENTAL_HEALTH,5-hydroxy-indoleacetic acid,more perseveration
NEW16833,CHEMICAL,glucolipid metabolism disorder,glucolipid metabolism disorders
NEW16834,DISEASE,glucolipid metabolism disorder,metabolic liver disease
NEW16835,NUTRITION,glucolipid metabolism disorder,largemouth bass
NEW16836,DISEASE,fish pasteurellosis,Fish pasteurellosis
D000086966,DISEASE,Bacterial Zoonoses,"Bacterial Disease, Zoonotic|Zoonosis, Bacterial|Zoonotic Spillovers, Bacterial|Diseases, Bacterial Zoonotic|Bacterial Zoonotic Diseases|Zoonotic Diseases, Bacterial|Bacterial Zoonotic Infections|Zoonotic Spillover, Bacterial|Zoonotic Bacterial Infection|Zoonotic Bacterial Infections|Infections, Zoonotic Bacterial|Zoonose, Bacterial|Infections, Bacterial Zoonotic|Zoonotic Bacterial Diseases|Bacterial Diseases, Zoonotic|bacterial disease|Bacterial Zoonotic Disease|Diseases, Zoonotic Bacterial|Bacterial Infections, Zoonotic|Infection, Zoonotic Bacterial|Disease, Bacterial Zoonotic|Disease, Zoonotic Bacterial|Zoonoses, Bacterial|Bacterial Zoonotic Spillover|Bacterial Zoonotic Infection|Zoonotic Disease, Bacterial|Zoonotic Bacterial Disease|Bacterial Infection, Zoonotic|Bacterial Zoonotic Spillovers|Zoonotic Infections, Bacterial|Zoonotic Infection, Bacterial|Infection, Bacterial Zoonotic|Bacterial Zoonosis|Bacterial Zoonose"
NEW16837,CHEBI,range phytotoxin,range phytotoxin
NEW16838,DISEASE,range phytotoxin,B. glumae
http://purl.obolibrary.org/obo/DOID_6088,MENTAL_HEALTH,acute stress disorder,Acute stress disorder symptoms|acute stress disorder symptoms|traumatic stress disorder
NEW16839,CHEMICAL,cortisol awakening response,cortisol awakening responses
NEW16840,CHEMICAL,cortisol awakening response,cortisol awakening response
NEW16841,CHEBI,Drug Commission,Drug Commission
NEW16842,CHEBI,Drug Commission,new antihistamines
NEW16843,CHEMICAL,Drug Commission,CNS-stimulation
NEW16844,DISEASE,blood cell formation,blood cell formation
NEW16845,CHEMICAL,cadmium treatment,Cadmium treatments
NEW16846,NUTRITION,cadmium treatment,wheat cultivars
NEW16847,DISEASE,cadmium treatment,necrotic patches
NEW16848,CHEMICAL,cd toxicity symptom,Cd toxicity symptoms
D014908,NUTRITION,Triticum,"Wheat Triticum|durum wheat|Triticum durum|Wheat|Triticum turgidum|Durum Wheats|Triticum aestivum|Triticum turgidum subsp. durum|Triticum vulgare|Wheat, Durum|Triticum spelta|Durum Wheat"
NEW16849,CHEMICAL,prophylactic pregabalin,prophylactic pregabalin
NEW16850,MENTAL_HEALTH,clinical syndrome,Clinical syndromes
NEW16851,DISEASE,clinical syndrome,HIT platelet count
NEW16852,DISEASE,clinical syndrome,associated disseminated intravascular coagulation
NEW16853,DISEASE,clinical syndrome,fondaparinux-associated HIT
NEW16854,DISEASE,clinical syndrome,heparin's flush'-induced HIT
NEW16855,CHEMICAL,nascent pf4-ahit-igg complex,nascent PF4-aHIT-IgG complexes
NEW16856,DISEASE,nascent pf4-ahit-igg complex,additional heparin-dependent HIT antibodies
NEW16857,CHEMICAL,"new p(1),p(4)-di(adenosine-5 tetraphosphate ap4a derivative","new P(1),P(4)-di(adenosine-5 tetraphosphate Ap4A derivatives"
NEW16858,CHEMICAL,"new p(1),p(4)-di(adenosine-5 tetraphosphate ap4a derivative",platelet P2Y1
NEW16859,CHEMICAL,(ml)-based decision algorithm,(ML)-based decision algorithms
NEW16860,CHEMICAL,acid content,acids contents
NEW16861,MENTAL_HEALTH,acid content,analyzer DNA fragmentation
NEW16862,CHEMICAL,acid content,amino acid analyzer
NEW16863,DISEASE,ralstonia spp,Ralstonia spp
NEW16864,MENTAL_HEALTH,ralstonia spp,treatment-refractory schizophrenia
NEW16865,CHEBI,vitamin pyridoxine deficiency,vitamin pyridoxine deficiency
NEW16866,CHEMICAL,plasma homocysteine level,Plasma homocysteine levels
NEW16867,CHEMICAL,plasma homocysteine level,polymorphism SNP MTHFR C677 T
NEW16868,CHEMICAL,plasma homocysteine concentration,plasma homocysteine concentration
NEW16869,NUTRITION,spot seal pup,spotted seal pups
NEW16870,DISEASE,spot seal pup,mild hemolytic disorder due
NEW16871,DISEASE,circadian disruption-induced metabolic syndrome,Circadian disruption-induced metabolic syndrome
D003692,CHEMICAL,Delayed-Action Preparations,"Timed-Release Preparations|Formulations, Controlled Release|Release Formulations, Controlled|Delayed-Action Preparation|Controlled Release Preparations|Depot Preparation|Controlled-Release Formulation|Controlled-Release Formulations|Extended Release Formulation|Sustained Release Preparation|Sustained-Release Preparations|Release Formulation, Controlled|Delayed Action Preparation|Sustained Release Formulations|Sustained-Release Preparation|Prolonged Action Preparation|Extended Release Preparations|Controlled-Release Preparation|Extended Release Preparation|Depot Preparations|extended-release formulation|Sustained Release Formulation|Prolonged-Action Preparation|Prolonged-Action Preparations|Slow Release Formulation|Delayed Action Preparations|Extended Release Formulations|Formulation, Controlled Release|Controlled-Release Preparations|Timed Release Preparations|Timed Release Preparation|Controlled Release Preparation|Controlled Release Formulation|Controlled Release Formulations|Timed-Release Preparation"
C449521,CHEMICAL,SLI381 [Supplementary Concept],Amphetamines|Adderall
NEW16872,CHEMICAL,circadian disruption-induced metabolic syndrome,alpha-tocopherol-enriched chow
NEW16873,NUTRITION,fatty acid peroxide,fatty acid peroxides
D016893,DISEASE,Carotid Stenosis,"Common Carotid Artery Stenosis|Carotid Artery Stenoses|Artery Narrowings, Carotid|Artery Stenosis, Carotid|Artery Stenoses, Carotid|Stenoses, Carotid|Carotid Artery Plaque|Carotid Stenoses|Plaques, Carotid Artery|Stenosis, External Carotid Artery|Carotid Artery Plaques|carotid artery stenosis|Artery Plaque, Carotid|Narrowing, Carotid Artery|Carotid Artery Narrowing|Stenosis, Carotid|Plaque, Carotid Artery|Carotid Artery Narrowings|Carotid Artery Stenosis|Carotid Ulcers|Stenosis, Carotid Artery|Internal Carotid Artery Stenosis|Ulcer, Carotid|Ulcers, Carotid|Carotid Ulcer|Carotid Artery Ulcerating Plaque|Artery Narrowing, Carotid|External Carotid Artery Stenosis|Plaque, Ulcerating, Carotid Artery|Narrowings, Carotid Artery|Stenoses, Carotid Artery|Ulcerating Plaque, Carotid Artery|Artery Plaques, Carotid|Stenosis, Common Carotid Artery"
NEW16874,CHEMICAL,serum thiobarbituric acid reactive substance,Serum thiobarbituric acid reactive substances
NEW16875,DISEASE,serum thiobarbituric acid reactive substance,collagen-induced platelet aggregation responses
NEW16876,DISEASE,strain p. diazotrophicus,strain P. diazotrophicus
NEW16877,NUTRITION,prenylflavonoid xanthohumol,prenylflavonoids xanthohumol
NEW16878,CHEMICAL,prenylflavonoid xanthohumol,[3H]EBOB binding
NEW16879,MENTAL_HEALTH,prenylflavonoid xanthohumol,GABA-induced displacement
NEW16880,CHEBI,subclinical vitamin deficiency other,subclinical vitamin deficiencies other
NEW16881,DISEASE,subclinical vitamin deficiency other,cerebral impairment
NEW16882,DISEASE,subclinical vitamin deficiency other,vasomotor sympathetic activity
NEW16883,DISEASE,subclinical vitamin deficiency other,inflexibility
NEW16884,DISEASE,subclinical vitamin deficiency other,compulsivity
NEW16885,CHEMICAL,coumestrol binding,coumestrol binding
NEW16886,DISEASE,coumestrol binding,microglia-mediated inflammation
D003375,CHEMICAL,Coumestrol,coumestrol|Coumarins (1972-1974)|Benzofurans (1972-1974)
D016660,CHEMICAL,NAD(P)H Dehydrogenase (Quinone),"Quinone Reductase|Phylloquinone Reductase|Reductase, Phylloquinone|Vitamin K Reductase|Reductase, Menadione|DT Diaphorase|quinone reductase|Reductase, Quinone|Menadione Reductase|Reductase, Vitamin K|Diaphorase, DT"
C108134,CHEMICAL,"TPS10 protein, Arabidopsis [Supplementary Concept]",Intramolecular Lyases|(E)-β-ocimene|Arabidopsis Proteins
NEW16887,CHEMICAL,coumestrol binding,lunatus (E)-β-ocimene synthase
NEW16888,NUTRITION,coumestrol binding,crayfish consumption
NEW16889,DISEASE,coumestrol binding,related Haff disease
NEW16890,DISEASE,coumestrol binding,mental sluggishness
NEW16891,NUTRITION,crayfish muscle,crayfish muscle
NEW16892,DISEASE,crayfish muscle,rhabdomyolysis disease animal model
NEW16893,CHEBI,crayfish muscle,potential toxin tool
NEW16894,CHEMICAL,molecule vegfr1/2/3 inhibitor,molecule VEGFR1/2/3 inhibitors
D000077210,CHEMICAL,Sunitinib,"SU 011248|Sunitinib|SU-11248|sunitinib|Sutent|SU 11248|SU11248|Sunitinib Malate|SU011248|SU-011248|5-(5-Fluoro-2-oxo-1,2-dihydroindolylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide"
C516667,CHEMICAL,pazopanib [Supplementary Concept],pazopanib|Indazoles|Pyrimidines|Sulfonamides
NEW16895,CHEMICAL,nivolumab immune checkpoint inhibitor,nivolumab immune checkpoint inhibitor
D014403,CHEMICAL,Tubocurarine,|Tubocurarine Chloride|d-tubocurarine|d-Tubocurare|d-Tubocurarine|Tubocurare
NEW16896,CHEBI,nivolumab immune checkpoint inhibitor,P2-purinoceptor antagonist
D013498,CHEMICAL,Suramin,"Naphuride|Moranil|suramin|Salt Suramin, Monosodium|Sodium, Suramin|Monosodium Salt Suramin|Germanin|Hexasodium Salt Suramin|Naganol|Suramin, Hexasodium Salt|Suramin Sodium|Suramin, Monosodium Salt|Salt Suramin, Hexasodium|Naganin"
NEW16897,MENTAL_HEALTH,nivolumab immune checkpoint inhibitor,field-induced cathodal orientation
NEW16898,CHEBI,promising drug molecule,promising drug molecules
NEW16899,CHEBI,promising drug molecule,drug molecules
NEW16900,MENTAL_HEALTH,promising drug molecule,protein orientation
NEW16901,DISEASE,morbid vasospasm,morbid vasospasm
NEW16902,DISEASE,morbid vasospasm,stomachache
NEW16903,DISEASE,morbid vasospasm,nervousness/restlessness
NEW16904,MENTAL_HEALTH,morbid vasospasm,mucosal immune depression
D000072230,DISEASE,Sustained Virologic Response,"Virologic Response, Sustained|Response, Sustained Virologic|Sustained Viral Suppressions|Sustained Viral Suppression|Sustained Virologic Responses|Suppression, Sustained Viral|viral suppression"
NEW16905,CHEBI,cholecalciferol deficiency,Cholecalciferol deficiency
NEW16906,MENTAL_HEALTH,multiple regression analysis,Multiple regression analysis
NEW16907,CHEMICAL,foh-monofaes,FOH-monoFAEs
NEW16908,CHEBI,carotenoid standard,carotenoid standards
NEW16909,CHEMICAL,carotenoid standard,isoFOH
C483031,CHEMICAL,fucoxanthinol [Supplementary Concept],FOH|beta Carotene/analogs  and  derivatives|fucoxanthinol
NEW16910,CHEMICAL,carotenoid standard,MX|mactraxanthin
NEW16911,MENTAL_HEALTH,multiple linear regression,multiple linear regression
C536911,DISEASE,Familial medullary thyroid carcinoma [Supplementary Concept],"Carcinoma, Medullary/congenital|Multiple Endocrine Neoplasia Type 2a|Thyroid Neoplasms|Medullary thyroid cancer"
D018814,CHEBI,Multiple Endocrine Neoplasia Type 2b,"MEN 2b|MEN 3|MEN2b|Wagenmann-Froboese Syndrome|Multiple Endocrine Neoplasia, Type IIb|Syndrome, Wagenmann-Froboese|Multiple Endocrine Neoplasia, Type 2b|Neuroma Syndrome, Mucosal|Neuromata, Mucosal, With Endocrine Tumors|multiple endocrine neoplasia|Mucosal Neuroma Syndrome|MEN IIb|Neoplasms, Multiple Endocrine Type 2b|MEA IIb|MEN III|Multiple Endocrine Neoplasms Type 2b|Neoplasia, Multiple Endocrine Type 2b|Wagenmann Froboese Syndrome|Mucosal Neuroma Syndromes|MEA 2b"
NEW16912,DISEASE,multiple linear regression,multiple endocrine neoplasia 2|MEN2
NEW16913,CHEBI,multiple linear regression,rare endocrine tumor
NEW16914,CHEMICAL,metastatic mtc,metastatic MTC
NEW16915,DISEASE,metastatic mtc,unilateral testis involvement
NEW16916,CHEMICAL,sodium nitrite intoxication,sodium nitrite intoxication
NEW16917,CHEMICAL,sodium nitrite intoxication,saponated cresol solution
NEW16918,CHEMICAL,Chilto powder,Chilto powder
NEW16919,DISEASE,Chilto powder,glucose adsorption
NEW16920,CHEMICAL,Chilto powder,glucose diffusion rate
NEW16921,DISEASE,human aggression,human aggression
NEW16922,CHEMICAL,human aggression,isotope cisternography
http://purl.obolibrary.org/obo/CHEBI_24712,CHEMICAL,hydroxymethyl group,hydroxymethyl|beta-hydroxyl group|serine side-chain|-CH2-OH|alpha-hydroxyl group
NEW16923,CHEMICAL,progesterone nucleus,progesterone nucleus
D058646,CHEMICAL,Adrenergic alpha-1 Receptor Agonists,"alpha1-Agonists, Adrenergic|Adrenergic alpha 1 Receptor Agonists|Adrenergic alpha1-Agonists|Adrenergic alpha 1 Agonists|Adrenergic alpha-1 Agonists|Adrenergic alpha1 Agonists|Agonists, Adrenergic alpha-1|Adrenergic alpha-1 Receptor Agonist|Adrenergic alpha 1 Receptor Agonist|α1-agonists"
NEW16924,DISEASE,deficit hypersensitivity disorder,deficit hypersensitivity disorder
NEW16925,DISEASE,nasal decongestion,nasal decongestion
NEW16926,CHEBI,systemic antifungal drug,systemic antifungal drugs
NEW16927,DISEASE,systemic antifungal drug,Cryptococcus neoformans meningitis
NEW16928,CHEMICAL,h2s metabolism,H2S metabolism
NEW16929,CHEMICAL,cerebral h2s metabolism,cerebral H2S metabolism
NEW16930,CHEMICAL,syndrome fas group,syndrome FAS group
NEW16931,CHEMICAL,tyrosine analog,tyrosine analog
NEW16932,DISEASE,tyrosine analog,bone marrow B cells
NEW16933,MENTAL_HEALTH,drug-induced delirium,Drug-induced delirium
NEW16934,CHEBI,drug-induced delirium,opioid drug groups
NEW16935,CHEMICAL,anabolic androgen steroid user,Anabolic androgen steroid users
NEW16936,DISEASE,anabolic androgen steroid user,more anger issues
NEW16937,CHEMICAL,vinyl phosphonate,vinyl phosphonates
NEW16938,CHEMICAL,vinyl phosphonate,vinylated nucleosides
NEW16939,CHEMICAL,n-9 user,N-9 users
NEW16940,CHEMICAL,acute cocaine intoxication,acute cocaine intoxication
D002305,DISEASE,Cardiac Tamponade,"|cardiac tamponade|Tamponade, Cardiac|Pericardial Tamponade|Cardiac Tamponades|Pericardial Tamponades|Tamponades, Cardiac|Tamponades, Pericardial|Tamponade, Pericardial"
D006342,DISEASE,"Heart Rupture, Post-Infarction","Post-Infarction Heart Rupture|Post-Infarction Heart Ruptures|Post Infarction Heart Rupture|Ruptures, Post-Infarction Heart|Rupture, Post-Infarction Heart|Heart Rupture, Post Infarction|Cardiac Rupture, Post-Infarction|Heart Ruptures, Post-Infarction|Cardiac Rupture, Post Infarction|Post-Infarction Cardiac Ruptures|Cardiac Ruptures, Post-Infarction|Rupture, Post-Infarction Cardiac|Ruptures, Post-Infarction Cardiac|heart rupture|Post-Infarction Cardiac Rupture"
NEW16941,DISEASE,acute cocaine intoxication,massive myocardial infarction
NEW16942,DISEASE,acute cocaine intoxication,myocardial damage
NEW16943,DISEASE,similar death,similar deaths
NEW16944,CHEMICAL,similar death,cocaine abuser
D020921,DISEASE,Sleep Arousal Disorders,"Arousal Disorders, Sleep|Arousal, Confusional|arousal disorders|Confusional Arousal|Arousal Disorder, Sleep|Arousals, Confusional|Confusional Arousals|Sleep Arousal Disorder"
NEW16945,MENTAL_HEALTH,similar death,sexsomnia eating disorder
NEW16946,CHEBI,similar death,drug consumption
NEW16947,MENTAL_HEALTH,similar death,lower insulin resistance
C522181,CHEMICAL,apixaban [Supplementary Concept],apixaban|Pyrazoles|Pyridones
NEW16948,CHEMICAL,acid exposure,acid exposure
http://purl.obolibrary.org/obo/CHEBI_6413,CHEMICAL,letrozole,"Letrozol|letrozole|4,4'-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile|aromatase-inhibitor letrozole|Femara|Letrozole"
NEW16949,CHEMICAL,letrozole stimulation,letrozole stimulation
NEW16950,CHEMICAL,letrozole stimulation,calcium metabolism parameters
NEW16951,CHEMICAL,biscationic quaternary phosphonium compound,Biscationic quaternary phosphonium compounds
NEW16952,DISEASE,structural rigidity,structural rigidity
NEW16953,DISEASE,neurometabolic factor,Neurometabolic factors
D018823,CHEMICAL,gamma-Endorphin,"Endorphin, gamma|endorphin|gamma Endorphin|beta-Endorphin (1-17)"
D050538,CHEMICAL,Malate Dehydrogenase (NADP+),"malate|Dehydrogenase, NADP-Malate|NADP Malate Dehydrogenase|NADP-Malate Dehydrogenase|Malate Dehydrogenase (NADP)"
NEW16954,DISEASE,neurometabolic factor,spikelet degeneration phenotype
NEW16955,CHEMICAL,impaired striatal phasic dopamine release,impaired striatal phasic dopamine release
NEW16956,DISEASE,hippocampal-dependent behavior,hippocampal-dependent behavior
NEW16957,CHEMICAL,hippocampal-dependent behavior,PGC-1α+/+ mice
NEW16958,CHEBI,hippocampal-dependent behavior,uppermost carotenoid tertile
NEW16959,CHEBI,mixed-effects regression model,E individual carotenoids
NEW16960,DISEASE,mixed-effects regression model,previtellogenic|PRV
NEW16961,CHEMICAL,oestradiol level,oestradiol levels
NEW16962,CHEMICAL,final oocyte maturation,FOM|final oocyte maturation
NEW16963,DISEASE,final oocyte maturation,normal premature ovarian failure|POF
NEW16964,CHEBI,estrogen therapy,Estrogen therapy
NEW16965,DISEASE,estrogen therapy,coronary heart disease oral
NEW16966,MENTAL_HEALTH,estrogen therapy,suicide vulnerability
NEW16967,NUTRITION,estrogen therapy,hemicellulose hydrolysates
NEW16968,CHEMICAL,estrogen therapy,phenolic compounds
NEW16969,DISEASE,estrogen therapy,hypertension dyslipdaemia
http://purl.obolibrary.org/obo/CHEBI_92458,CHEMICAL,"4-fluorobenzoic acid 4-[[5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester",Phthalic acid ester
NEW16970,CHEMICAL,phthalate metabolite level,phthalate metabolite levels
NEW16971,CHEMICAL,phthalate metabolite concentration,phthalate metabolite concentrations
NEW16972,MENTAL_HEALTH,phthalate metabolite concentration,ADHD symptom traits
D000090702,DISEASE,Constitutive Androstane Receptor,"Receptor, CAR Nuclear|Androstane Receptor, Constitutive|constitutive androstane receptor|Active Receptor, Constitutive|Constitutive Active Receptor|CAR Orphan Nuclear Receptor|CAR Nuclear Receptor|Constitutive Androstane Receptor beta|Receptor, Constitutive Active|Nuclear Receptor, CAR|CAR"
NEW16973,CHEBI,xenobiotic agonist,Xenobiotic agonists
NEW16974,CHEBI,xenobiotic agonist,hepatic drug metabolizing enzymes
NEW16975,DISEASE,brain tumour stem cell,Brain tumour stem cells
NEW16976,CHEBI,functional drug metabolism,functional drug metabolism
NEW16977,MENTAL_HEALTH,medium-sized projection neuron,medium-sized projection neurons
NEW16978,CHEMICAL,medium-sized projection neuron,striatum tonic GABA currents
NEW16979,DISEASE,medium-sized projection neuron,peripheral infection
D024221,DISEASE,Antineoplastic Protocols,"Cancer Treatment Protocol|Antineoplastic Protocol|Treatment Protocol, Cancer|Cancer Treatment Protocols|Protocol, Cancer Treatment|Treatment Protocols, Cancer|Protocols, Cancer Treatment|cancer treatment|Protocol, Antineoplastic|Protocols, Antineoplastic"
NEW16980,CHEBI,third phytoalexin,third phytoalexin
NEW16981,CHEMICAL,third phytoalexin,rare coumarin
NEW16982,CHEBI,class cxcr4 antagonist,class CXCR4 antagonist
C536697,DISEASE,WHIM syndrome [Supplementary Concept],Warts|Primary Immunodeficiency Diseases|WHIM syndrome
NEW16983,CHEBI,class cxcr4 antagonist,partial mu-opiate agonist
NEW16984,CHEBI,female androgen insufficiency syndrome,female androgen insufficiency syndrome
D019529,DISEASE,Sexuality,Sex Behavior (1974-1996)|sexuality
NEW16985,DISEASE,female androgen insufficiency syndrome,psychiatric regimens
NEW16986,CHEBI,female androgen insufficiency syndrome,serotonin 5HT1B receptor agonist
NEW16987,DISEASE,female androgen insufficiency syndrome,lethal hemorrhagic infection
NEW16988,DISEASE,female androgen insufficiency syndrome,human herpes viruses
NEW16989,CHEBI,female androgen insufficiency syndrome,potent antiviral agent
NEW16990,DISEASE,female androgen insufficiency syndrome,various viral infections
NEW16991,CHEBI,female androgen insufficiency syndrome,drug metabolites
NEW16992,MENTAL_HEALTH,fragmentation scheme,Fragmentation schemes
NEW16993,DISEASE,tourette patient,Tourette patients
NEW16994,CHEMICAL,tourette patient,urinary beta-phenylethylamine level
NEW16995,CHEMICAL,urinary beta-phenylethylamine level,urinary beta-phenylethylamine levels
NEW16996,MENTAL_HEALTH,urinary beta-phenylethylamine level,Tourette Syndrome Global Scale
NEW16997,CHEMICAL,b-n-methylamino-l-alanine,B-N-methylamino-L-alanine
NEW16998,DISEASE,b-n-methylamino-l-alanine,neurotoxic amino acid
D014418,NUTRITION,Tupaiidae,"Shrew, Tree|Treeshrews|Treeshrew|tree shrews|Shrews, Tree|Ptilocercus|Tree Shrew|Tree Shrews|Tupaiinae"
NEW16999,CHEMICAL,dietary gaba,dietary GABA
NEW17000,MENTAL_HEALTH,regression equation,regression equations
NEW17001,CHEMICAL,regression equation,tailor-made pectins
NEW17002,CHEMICAL,regression equation,lower testosterone
NEW17003,CHEMICAL,regression equation,decreased plasma testosterone
C000610981,CHEMICAL,"MTNR1A protein, human [Supplementary Concept]","Receptor, Melatonin, MT1|MTNR1A"
C425931,CHEMICAL,GW 501516 [Supplementary Concept],GW501516|Thiazoles
NEW17004,DISEASE,regression equation,pioglitazone more weight loss
NEW17005,MENTAL_HEALTH,tnfα-induced insulin resistance,TNFα-induced insulin resistance
NEW17006,CHEMICAL,cytoplasmic human uterine progesterone receptor,cytoplasmic human uterine progesterone receptor
NEW17007,MENTAL_HEALTH,cytoplasmic human uterine progesterone receptor,monophasic first order dissociation curve
NEW17008,CHEMICAL,3h-dihydrospirorenone,3H-dihydrospirorenone
NEW17009,CHEMICAL,label steroid,labeled steroid
NEW17010,CHEMICAL,label steroid,dextran-coated charcoal treatment
NEW17011,CHEMICAL,80-gene molecular subtyping profile,80-Gene Molecular Subtyping Profile
NEW17012,DISEASE,80-gene molecular subtyping profile,cancer patient
NEW17013,DISEASE,pericardial edema,Pericardial edema
C451427,CHEMICAL,zoxamide [Supplementary Concept],Amides|zoxamide
NEW17014,CHEMICAL,mesolimbic dopamine da system,DA antagonism
NEW17015,DISEASE,mesolimbic dopamine da system,related hypersomnia
NEW17016,DISEASE,mesolimbic dopamine da system,hypersomniac episodes
D000668,CHEMICAL,Ampicillin Resistance,"Resistance, Ampicillin|Ampicillin Resistances|ampicillin|Resistances, Ampicillin"
D041121,DISEASE,Klebsiella oxytoca,Bacillus oxytocus perniciosus|Klebsiella
NEW17017,DISEASE,strain e13 t (= dsm t,strain E13 T (= DSM T
NEW17018,CHEBI,strain e13 t (= dsm t,acquired antibiotic resistance genes
NEW17019,CHEMICAL,strain e13 t (= dsm t,tet(D tetracycline resistance genes
C406452,CHEMICAL,"(7-methoxycoumarin-4-yl)methyl-caged 8-bromoadenosine cyclic 3',5'-monophosphate [Supplementary Concept]",Coumarins|8-Br-cAMP|Cyclic AMP/analogs  and  derivatives
D013999,CHEMICAL,Timolol,"|Timolol Hemihydrate|Timoptic|Blocadren|Timacar|Timolol Maleate, (1:1) Salt|MK 950|Timolol Maleate|Timoptol|Optimol|MK950|timolol|MK-950|L 714,465|L-714,465|2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (S)-|(S)-1-((1,1-Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadazol-3-yl)oxy)-2-propanol|L714,465"
C057416,CHEMICAL,KT 5720 [Supplementary Concept],Pyrroles|KT5720|Carbazoles
NEW17020,CHEMICAL,strain e13 t (= dsm t,8-HO-DPAT
C085974,CHEMICAL,forskolin receptor [Supplementary Concept],"forskolin|Receptors, Cell Surface"
http://purl.obolibrary.org/obo/CHEBI_38634,CHEMICAL,voltage-gated sodium channel blocker,Nav channel blocker|Nav channel blockers|voltage-dependent sodium channel blockers|Voltage-gated KCNQ/Kv7 potassium channels
NEW17021,MENTAL_HEALTH,memory disorder due,memory disorders due
NEW17022,CHEMICAL,pufa related,PUFA related
NEW17023,DISEASE,categorical depressive disorder,categorical depressive disorders
NEW17024,MENTAL_HEALTH,dha intake,current depressive disorder
NEW17025,CHEMICAL,conotoxin family,conotoxin family
D020916,CHEMICAL,Conotoxins,mu Conotoxin|alpha-Conotoxin|alpha Conotoxin|α-conotoxins|mu Conotoxins|alpha-Conotoxins|mu-Conotoxin|mu-Conotoxins|Conotoxin|alpha Conotoxins
NEW17026,CHEMICAL,α5/5 conotoxin isomer,α5/5 conotoxin isomers
NEW17027,CHEBI,α5/5 conotoxin isomer,venom gland
NEW17028,DISEASE,gaba signaling,myoclonic seizure susceptibility
NEW17029,DISEASE,erythroleukemia cell line,erythroleukemia cell lines
NEW17030,CHEBI,erythroleukemia cell line,mM vitamin E
NEW17031,CHEMICAL,alcohol withdrawal syndrome,Alcohol withdrawal syndrome
NEW17032,DISEASE,alcohol withdrawal syndrome,complex neurologic disorder
NEW17033,NUTRITION,cherax destructor hemocyanin,Cherax destructor hemocyanin
NEW17034,MENTAL_HEALTH,cherax destructor hemocyanin,alkaline dissociation product
D064286,CHEMICAL,ATP Binding Cassette Transporter 1,"Cholesterol-Efflux Regulatory Protein|dATP|ATP-Binding Cassette Sub-Family A Member 1|ATP Binding Cassette Transporter, Subfamily A, Member 1|CERP Protein|ATP|ABCA1 Protein|ATP Binding Cassette Sub Family A Member 1|Cholesterol Efflux Regulatory Protein"
D019916,CHEMICAL,Choline-Phosphate Cytidylyltransferase,"Phosphocholine Cytidyltransferase|CTP Phosphocholine Cytidylyl Transferase|Cytidylyl-Transferase, CTP Phosphocholine|CDP-Choline Synthetase|Cytidylyltransferase, Choline-Phosphate|Cytidyltransferase, CTP Phosphorylcholine|CTP Phosphorylcholine Cytidyltransferase|Choline Phosphate Cytidylyltransferase|Phosphorylcholine Cytidyltransferase, CTP|CTP Phosphocholine Cytidylyl-Transferase|Cytidyltransferase, Phosphocholine|Synthetase, CDP-Choline|Phosphocholine Cytidylyltransferase, CTP|Transferase, Phosphorylcholine Cytidyl|CTP Phosphocholine Cytidylyltransferase|Phosphorylcholine Cytidyl Transferase|Cytidyl Transferase, Phosphorylcholine|Phosphocholine Cytidylyl-Transferase, CTP|CTP|CDP Choline Synthetase|Cytidylyltransferase, CTP Phosphocholine"
D005957,CHEMICAL,UTP-Glucose-1-Phosphate Uridylyltransferase,"UDPG Pyrophosphorylase|Pyrophosphorylase, UDPG|UTP|UDP Glucose Pyrophosphorylase|Uridylyltransferase, UTP-Glucose-1-Phosphate|UTP Glucose 1 Phosphate Uridylyltransferase|Pyrophosphorylase, UDP Glucose|Glucosephosphate Uridylyltransferase|Uridylyltransferase, Glucosephosphate"
NEW17035,DISEASE,peripheral blood carbonyl stress marker,peripheral blood carbonyl stress markers
NEW17036,CHEMICAL,advanced product age pentosidine,advanced product AGE pentosidine
D017127,DISEASE,"Glycation End Products, Advanced","Products, Maillard|Endproducts, Advanced Glycosylation|Product, Maillard Reaction|Advanced Glycation End Product|Advanced Glycosylation End Product|Maillard Reaction End Product|Maillard Reaction Product|Advanced Maillard Reaction End Products|Maillard Reaction Products|Advanced Glycation End Products|Reaction Products, Maillard|Maillard Reaction End Products|Endproducts, Advanced Glycation|Endproduct, Advanced Glycation|glycation end product|Advanced Glycation Endproducts|Glycation Endproduct, Advanced|Product, Maillard|Glycosylation End Products, Advanced|Maillard Product|Advanced Glycation Endproduct|Glycosylation Endproducts, Advanced|Maillard Products|Reaction Product, Maillard|Advanced Maillard Reaction End Product|Glycation Endproducts, Advanced|Advanced Glycosylation End Products|Products, Maillard Reaction|Advanced Glycosylation Endproducts"
NEW17037,CHEMICAL,reactive carbonyl-detoxifying b6 vitamin pyridoxal,reactive carbonyl-detoxifying B6 vitamin pyridoxal
NEW17038,CHEMICAL,glyceraldehyde-derived ages,Glyceraldehyde-derived AGEs
NEW17039,DISEASE,glyceraldehyde-derived ages,strong neurotoxicity
http://cbmi.med.harvard.edu/asdphenotype#Class_148,CHEMICAL,exposures,Overexposure|Over-exposure
D019551,CHEBI,Dental Disinfectants,"disinfectants|Disinfectants, Dental"
NEW17040,CHEBI,peroxiproliferator-activated receptor alpha agonist,peroxiproliferator-activated receptor alpha agonists
NEW17041,DISEASE,peroxiproliferator-activated receptor alpha agonist,ocular ischemia
http://purl.obolibrary.org/obo/DOID_807,DISEASE,carotid artery occlusion,unilateral common carotid artery occlusion|Occlusion and stenosis of carotid artery
NEW17042,DISEASE,uccao-induced retinal dysfunction,UCCAO-induced retinal dysfunction
NEW17043,DISEASE,mixed dyslipidemia,mixed dyslipidemia
NEW17044,CHEMICAL,third-generation fibric acid derivative,third-generation fibric acid derivative
NEW17045,DISEASE,third-generation fibric acid derivative,cardiomyocyte hypertrophy
NEW17046,DISEASE,third-generation fibric acid derivative,experimental ischemia/reperfusion injury
NEW17047,CHEMICAL,fenofibrate therapy,fenofibrate therapy
NEW17048,MENTAL_HEALTH,fenofibrate therapy,myocardial insulin resistance
NEW17049,MENTAL_HEALTH,fenofibrate therapy,intrahepatic resistance
D011170,DISEASE,"Portasystemic Shunt, Surgical","Shunt, Surgical Portasystemic|Portasystemic Shunt|Portosystemic Shunts, Surgical|Surgical Portosystemic Shunt|Surgical Portosystemic Shunts|Shunt, Surgical Portosystemic|Surgical Portasystemic Shunt|Shunt, Portosystemic|Shunts, Portasystemic|Shunts, Portosystemic|Portosystemic Shunts|Surgical Portasystemic Shunts|Portasystemic Shunts, Surgical|Shunts, Surgical Portosystemic|Portasystemic Shunts|Portosystemic Shunt, Surgical|Shunts, Surgical Portasystemic|Portosystemic Shunt|Shunt, Portasystemic|portosystemic shunts"
NEW17050,DISEASE,fenofibrate therapy,extensive HPC damage
C092427,DISEASE,CM 178-78 [Supplementary Concept],Diamines|CM
NEW17051,MENTAL_HEALTH,fenofibrate therapy,scopolamine-induced amnesia
NEW17052,CHEMICAL,ingredient osthole,ingredient osthole
NEW17053,CHEMICAL,pectin receptor,pectin receptors
NEW17054,CHEMICAL,pectin receptor,substrate-bound chemicals
NEW17055,MENTAL_HEALTH,somatotopic projection,somatotopic projection
NEW17056,MENTAL_HEALTH,somatotopic projection,chemosensory orientation
NEW17057,CHEMICAL,somatotopic projection,p-T305-CaMKII
NEW17058,CHEBI,rt inhibitor,RT inhibitors
D058008,CHEMICAL,Xenotropic murine leukemia virus-related virus,"Xenotropic MuLV-related virus|Virus, XMRV|MuLV-related virus, Xenotropic|XMRV|Xenotropic murine leukemia virus related virus|Viruses, XMRV|Xenotropic MuLV related virus|XMRV Virus|MuLV-related viruses, Xenotropic|xenotropic murine leukemia virus-related virus|Xenotropic MuLV-related viruses|XMRV Viruses"
NEW17059,CHEMICAL,rt inhibitor,NE children
NEW17060,NUTRITION,pacific mackerel Trachurus symmetricus,Pacific mackerel Trachurus symmetricus
NEW17061,DISEASE,crypt cell,Crypt cells
NEW17062,MENTAL_HEALTH,mild-to-moderate erectile dysfunction,mild-to-moderate erectile dysfunction
D048271,CHEMICAL,Chitosan,Chitosan|chitosan|Poliglusam
NEW17063,CHEMICAL,increase salicylic acid,Increased salicylic acid
D000040,CHEMICAL,Abscisic Acid,"Abscisic Acid, (E,E)-(+-)-Isomer|Abscissic Acid|Abscisic Acid, (E,Z)-(+,-)-Isomer|Abscisic Acid, (R)-Isomer|Abscisic Acid, (+,-)-Isomer|abscisic acid|Abscisic Acid Monoammonium Salt, (R)-Isomer|2,4-Pentadienoic acid, 5-(1-hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-, (S-(Z,E))-|Abscisic Acid, (Z,E)-Isomer|Abscissins"
C032285,CHEMICAL,sodium iodate [Supplementary Concept],Iodates|NaIO3
NEW17064,CHEBI,oxidative toxic agent,oxidative toxic agent
C534740,CHEMICAL,betulinic acid methyl ester [Supplementary Concept],betulinic acid|Triterpenes
NEW17065,DISEASE,ndma-induced toxicity,NDMA-induced toxicity
NEW17066,CHEMICAL,long-term liquorice ingestion,Long-term liquorice ingestion
NEW17067,DISEASE,long-term liquorice ingestion,hypokalaemic periodic paralysis
D000077489,CHEMICAL,Piperazine,"piperazine|Piperazine Hexahydrate|Piperazine Hydrobromide|1,4-Piperazine|NAN-190|Piperazinium Oleate|Piperazine Hydrate|Piperazine Phosphate|Piperazine Phosphate (1:1)|Piperazine Diacetate|Piperazine Hydrochloride|Piperazine Tartrate|1,4-Diazacyclohexane|Pripsen|Piperazine Tartrate, (R-(R*,R*))-isomer|Piperazine Phosphate Anhydrous|Piperazine Tartrate (1:1), (R-(R*,R*))-isomer|1,4 Diazacyclohexane|1,4 Piperazine|Piperazine Monohydrochloride|Piperazine Dihydrochloride|Piperazine Salt|Piperazine Sulfate"
NEW17068,DISEASE,long-term liquorice ingestion,ROT-induced cell death
NEW17069,CHEMICAL,serotonin 5-ht1a receptor antagonist butyl piperazine,serotonin 5-HT1A receptor antagonist butyl piperazine
NEW17070,DISEASE,nicotine administration,factor CRF systems
NEW17071,DISEASE,brain crf system,brain CRF systems
NEW17072,DISEASE,olb,OLB
C090047,CHEMICAL,skin peptide tyrosine-tyrosine [Supplementary Concept],Pancreatic Polypeptide|peptide tyrosine tyrosine
D050418,CHEMICAL,Pancreatic Polypeptide-Secreting Cells,"Cells, Pancreatic Polypeptide-Secreting|Pancreatic PP Cells|pancreatic polypeptide|PP Cells, Pancreatic|Pancreatic Polypeptide Cell|Pancreatic Polypeptide-Secreting Cell|Cell, Pancreatic Polypeptide-Secreting|Pancreatic PP Cell|Pancreatic Polypeptide Cells|Pancreatic Polypeptide Secreting Cells|PP Cell, Pancreatic|PP"
NEW17073,CHEMICAL,ee/ln ee/drsp coc treatment,EE/LN EE/DRSP COC treatment
NEW17074,DISEASE,ee/ln ee/drsp coc treatment,pancreatic β-cell dysfunction
NEW17075,DISEASE,ee/ln ee/drsp coc treatment,atherothrombosis
NEW17076,DISEASE,ee/ln ee/drsp coc treatment,cellular metabolic derangements
NEW17077,MENTAL_HEALTH,ee/ln ee/drsp coc treatment,Beck Depression
NEW17078,DISEASE,consecutive hypertensive patient,consecutive hypertensive patients
NEW17079,CHEMICAL,consecutive hypertensive patient,Irbesartan Treatment
NEW17080,DISEASE,gastrointestinal bacterial community,gastrointestinal bacterial communities
NEW17081,CHEMICAL,gastrointestinal bacterial community,bacterial-derived metabolites
NEW17082,CHEMICAL,gastrointestinal bacterial community,PM-exposure
NEW17083,DISEASE,anti-gamma aminobutyric acid b receptor encephalitis,Anti-gamma aminobutyric acid B receptor encephalitis
NEW17084,DISEASE,anti-gamma aminobutyric acid b receptor encephalitis,lung cancer patients
NEW17085,CHEMICAL,metoclopramide poisoning,metoclopramide poisoning
NEW17086,CHEBI,poison gland mucus,Poison gland mucus
NEW17087,DISEASE,poison gland mucus,similar oral movements
NEW17088,CHEBI,crf1 receptor antagonist,CRF1 receptor antagonists
C548518,CHEMICAL,"CEA X protein, human [Supplementary Concept]",CeA.|Carcinoembryonic Antigen
NEW17089,CHEBI,basal thyroid-stimulating hormone,Basal thyroid-stimulating hormone
NEW17090,CHEMICAL,combined estrogen-progestin regiman,combined estrogen-progestin regimen
NEW17091,CHEBI,potent estrogen,potent estrogens
NEW17092,DISEASE,potent estrogen,psychic disorders related
NEW17093,DISEASE,endocrine therapy,advanced breast cancer
NEW17094,CHEMICAL,anti-progestin capable,anti-progestins capable
NEW17095,DISEASE,steroid-induced growth factor,steroid-induced growth factors
NEW17096,DISEASE,early breast cancer,early breast cancer
NEW17097,CHEMICAL,early breast cancer,non-hormonal modalities
NEW17098,CHEBI,new endocrine agent,newer endocrine agents
NEW17099,CHEMICAL,nbm ch neuron,NBM Ch neurons
NEW17100,MENTAL_HEALTH,nbm ch neuron,indirect inhibitory projection
NEW17101,CHEBI,nbm ch neuron,specific N-methyl-D-aspartate NMDA receptor antagonist 3-((+/-)-2-(carboxypiperazine-4-yl))-propyl-1-phosphonic acid
NEW17102,MENTAL_HEALTH,glutamatergic corticostriatal projection,glutamatergic corticostriatal projection
NEW17103,CHEMICAL,glutamatergic corticostriatal projection,KA neurotoxicity
D002541,DISEASE,Cerebral Decortication,"Decortication, Cerebral|Cortex Decortication, Cerebral|Cortex Decortications, Cerebral|Decortications, Cerebral|cerebral decortication|Cerebral Cortex Decortications|Decortication, Cerebral Cortex|Cerebral Cortex Decortication|Cerebral Decortications|Decortications, Cerebral Cortex"
D009812,DISEASE,Odorants,Odor|Scents|Fragrance|aromas|Scent|Odors|Odorant|Aromas|Fragrances|Aroma
NEW17104,DISEASE,hepatocellular hypertrophy,hepatocellular hypertrophy
D057093,CHEMICAL,Orphan Nuclear Receptors,"nuclear receptors|Receptor, Orphan Nuclear|Orphan Nuclear Receptor|Nuclear Receptor, Orphan|Receptors, Orphan Nuclear|Nuclear Receptors, Orphan|NRs"
NEW17105,CHEMICAL,pronamide administration,pronamide administration
NEW17106,MENTAL_HEALTH,pronamide administration,suicide inhibition
C023666,CHEMICAL,pyridine [Supplementary Concept],pyridine|Pyridines
NEW17107,DISEASE,purine metabolism,Rett patients
NEW17108,DISEASE,purine metabolism,Rett children
NEW17109,CHEBI,decrease plasma nicotinamide concentration,Decreased plasma nicotinamide concentrations
NEW17110,CHEMICAL,photoadduct,photoadducts
NEW17111,CHEMICAL,photoadduct,peroxynitrite-modified biomolecules
D010282,DISEASE,Parathyroid Neoplasms,"Parathyroid Neoplasm|Adenomas, Parathyroid|Neoplasms, Parathyroid|Carcinoma, Parathyroid|Parathyroid Carcinomas|Cancer, Parathyroid|Cancers, Parathyroid|Cancer of Parathyroid|Parathyroid Cancers|parathyroid adenoma|Parathyroid Adenoma|Parathyroid Cancer|Adenoma, Parathyroid|Neoplasm, Parathyroid|Cancer of the Parathyroid|Carcinomas, Parathyroid|Parathyroid Carcinoma|Parathyroid Adenomas"
http://purl.obolibrary.org/obo/CHEBI_166646,CHEMICAL,dihydrorotenone,"(1R,6S,13R)-16,17-dimethoxy-6-propan-2-yl-2,7,20-trioxapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-3(11),4(8),9,14,16,18-hexaen-12-one|[(3)H]tamsulosin"
NEW17112,CHEMICAL,[(3)h]prazosin,[(3)H]prazosin
NEW17113,CHEBI,certain β-adrenoceptor antagonists/inverse agonist,certain β-adrenoceptor antagonists/inverse agonists
NEW17114,CHEBI,peroxiproliferator activate receptor γ agonist pioglitazone AK Scientific,peroxiproliferator activated receptor γ agonist pioglitazone AK Scientific
D000071070,DISEASE,Familial Multiple Lipomatosis,"Multiple Lipomas, Familial|Familial Multiple Lipomatoses|Lipoma Dolorosa|Lipomatosis, Familial Multiple|Familial Multiple Lipomas|Dercum's Disease Type III|Lipomatoses, Familial Multiple|Familial Multiple Lipoma|Multiple Lipoma, Familial|Adiposis Dolorosa Type III|multiple lipomas"
NEW17115,CHEMICAL,peroxiproliferator activate receptor γ agonist pioglitazone AK Scientific,rosiglitazone gamma agonist
D008067,DISEASE,Lipoma,"Lipomas|Fatty Tumor|Fatty Tumors|Lipomatosis, Multiple|Lipomatoses, Multiple|Multiple Lipomatosis|Hibernoma|Tumors, Fatty|Atypical Lipomas|lipomas|Pleomorphic Lipomas|Lipomatas|Tumor, Fatty|Pleomorphic Lipoma|Lipoma, Atypical|Atypical Lipoma|Multiple Lipomatoses|Hibernomas|Lipomas, Atypical|Lipoma, Pleomorphic|Lipomata|Lipomas, Pleomorphic"
D018902,CHEMICAL,"Chondrodysplasia Punctata, Rhizomelic","Punctata, Rhizomelic Chondrodysplasia|Chondrodysplasia Punctata, Rhizomelic Form|Rhizomelic Chondrodysplasia Punctata|Rhizomelic Chondrodysplasia Punctatas|Chondrodysplasia punctata|CDP|Punctatas, Rhizomelic Chondrodysplasia|Chondrodysplasia Punctatas, Rhizomelic|chondrodysplasia punctata"
NEW17116,CHEMICAL,peroxiproliferator activate receptor γ agonist pioglitazone AK Scientific,punctate calcium deposits
NEW17117,CHEMICAL,peroxiproliferator activate receptor γ agonist pioglitazone AK Scientific,mucopolysacharidosis type
NEW17118,CHEMICAL,peroxiproliferator activate receptor γ agonist pioglitazone AK Scientific,type GM1 gangliosidosis
D002869,DISEASE,Chromosome Aberrations,"Abnormalities, Autosome|Chromosomal Abnormality|Chromosome Aberration|Cytogenetic Aberrations|Chromosome Abnormalities|Aberrations, Chromosomal|Chromosomal Abnormalities|Aberrations, Chromosome|Chromosome Abnormality|Abnormality, Chromosomal|Aberration, Chromosome|Cytogenetic Aberration|Abnormality, Cytogenetic|Aberration, Chromosomal|chromosomal abnormalities|Abnormalities, Chromosome|Abnormalities, Cytogenetic|Autosome Abnormality|Abnormalities, Chromosomal|Cytogenetic Abnormalities|Cytogenetic Abnormality|Abnormality, Chromosome|Chromosomal Aberration|Aberrations, Cytogenetic|Chromosomal Aberrations|Autosome Abnormalities|Aberration, Cytogenetic|Abnormality, Autosome"
NEW17119,CHEMICAL,peroxiproliferator activate receptor γ agonist pioglitazone AK Scientific,maternal alcohol intoxication
NEW17120,DISEASE,maternal hepatic lesion,maternal hepatic lesions
NEW17121,CHEBI,maternal hepatic lesion,estrogen receptor signaling
NEW17122,CHEBI,prevalent xenoestrogen,prevalent xenoestrogen
NEW17123,DISEASE,bpa exposure,migraine symptoms
NEW17124,CHEMICAL,bpa treatment,BPA treatment
NEW17125,DISEASE,bpa treatment,migraine-like behaviors
NEW17126,CHEBI,bpa treatment,estrogen genes
NEW17127,CHEBI,pervasive xenoestrogen,pervasive xenoestrogen
NEW17128,DISEASE,pervasive xenoestrogen,migraine-like behavior
C105101,CHEMICAL,"FPR2 protein, human [Supplementary Concept]","FPR|Receptors, Lipoxin|formyl peptide receptor|Receptors, Formyl Peptide"
NEW17129,MENTAL_HEALTH,pervasive xenoestrogen,pseudopod projection
NEW17130,MENTAL_HEALTH,cholinergic projection,cholinergic projection
NEW17131,MENTAL_HEALTH,cholinergic projection,anxiety associated cardiovascular reactivity
NEW17132,CHEBI,cholinergic projection,BZR agonists
NEW17133,CHEBI,recent vitamin d intervention study,recent vitamin D intervention studies
NEW17134,CHEBI,iodine-rich drug,iodine-rich drug
NEW17135,DISEASE,iodine-rich drug,maternal tachyarrhythmias
NEW17136,DISEASE,iodine-rich drug,maternal/fetal tachyarrhythmias
NEW17137,DISEASE,iodine-rich drug,term toxemia
NEW17138,MENTAL_HEALTH,sevoflurane-induced pica,sevoflurane-induced pica
D058927,CHEMICAL,5-Lipoxygenase-Activating Proteins,Arachidonate 5 Lipoxygenase Activating Proteins|5 Lipoxygenase Activating Proteins|Arachidonate 5 Lipoxygenase Activating Protein|5-Lipoxygenase-Activating Protein|zileuton|5-LO-Activating Protein|5 LO Activating Protein|Arachidonate 5-Lipoxygenase Activating Protein|5-lipoxygenase|Arachidonate 5-Lipoxygenase Activating Proteins|5 Lipoxygenase Activating Protein
D052246,CHEMICAL,Cyclooxygenase 2 Inhibitors,"Cyclooxygenase-2 Inhibitors|COX2 Inhibitors||COX-2 Inhibitor|Coxib|Inhibitor, COX-2|COX-2 inhibitors|COX-2 Inhibitors|Coxibs|Inhibitors, Cyclooxygenase 2|flurbiprofen|Inhibitor, Cyclooxygenase 2|COX 2 Inhibitors|Cyclooxygenase-2 Inhibitor|Inhibitor, COX2|Inhibitors, COX2|Inhibitors, Cyclooxygenase-2|cyclooxygenase|COX 2 Inhibitor|COX2 Inhibitor|Cyclooxygenase 2 Inhibitor|2 Inhibitor, Cyclooxygenase|Inhibitor, Cyclooxygenase-2|Inhibitors, COX-2"
NEW17139,CHEMICAL,leukotriene pathway,leukotriene pathway
NEW17140,DISEASE,leukotriene pathway,abnormal involuntary movements
NEW17141,CHEMICAL,cynanchi atrati,Cynanchi atrati
NEW17142,DISEASE,cynanchi atrati,acute urinary infection
NEW17143,DISEASE,skin inflammation process,skin inflammation process
C024989,CHEMICAL,coenzyme Q10 [Supplementary Concept],CoQ10|coenzyme Q10|Ubiquinone/analogs  and  derivatives
NEW17144,DISEASE,rtt patient,RTT erythrocytes
NEW17145,CHEBI,vitamin e-derivative trolox,vitamin E-derivative Trolox
NEW17146,DISEASE,vitamin e-derivative trolox,hypoxia tolerance
NEW17147,CHEMICAL,in trolox treatment,in Trolox treatment
NEW17148,DISEASE,in trolox treatment,complex Rett phenotype
NEW17149,CHEBI,in trolox treatment,vitamin E-derivative based pharmacotherapy
NEW17150,DISEASE,in trolox treatment,hypoxia susceptibility
NEW17151,DISEASE,in trolox treatment,seizure-like discharges
NEW17152,MENTAL_HEALTH,augmented mglur-induced long-term depression,Augmented mGluR-induced long-term depression
NEW17153,CHEBI,augmented mglur-induced long-term depression,mGluR1 antagonists
http://purl.obolibrary.org/obo/CHEBI_33709,CHEMICAL,amino acid,various amino acids
NEW17154,DISEASE,young-onset mouse,young-onset mice
NEW17155,MENTAL_HEALTH,young-onset mouse,sleep-wake fragmentation
NEW17156,CHEMICAL,dta-induced orexin neurodegeneration,DTA-induced orexin neurodegeneration
C553414,CHEMICAL,avanafil [Supplementary Concept],Avanafil|Pyrimidines
C579978,DISEASE,Catsper1-Related Nonsyndromic Male Infertility [Supplementary Concept],"Infertility, Male|male infertility"
NEW17157,NUTRITION,dta-induced orexin neurodegeneration,steroid hormone biosynthesis metabolism
D057845,CHEMICAL,Pyrimidine Phosphorylases,"Phosphorylases, Pyrimidine|pyrimidine|Nucleoside Phosphorylase, Pyrimidine|Pyrimidine Nucleoside Phosphorylase|Phosphorylase, Pyrimidine Nucleoside"
NEW17158,CHEMICAL,dta-induced orexin neurodegeneration,purine metabolisms
NEW17159,CHEMICAL,dta-induced orexin neurodegeneration,carnitine acylation
NEW17160,NUTRITION,dta-induced orexin neurodegeneration,disturbed phospholipid metabolism
NEW17161,CHEBI,pharmaceutical manipulation,pharmaceutical manipulation
NEW17162,CHEMICAL,α7 nachr,α7 nAChRs
NEW17163,CHEMICAL,diacylglycerol kinase dgk δ,Diacylglycerol kinase DGK δ
NEW17164,NUTRITION,diacylglycerol kinase dgk δ,acid (SFA)-
NEW17165,NUTRITION,diacylglycerol kinase dgk δ,monounsaturated fatty acid (MUFA)-containing phosphatidic acids
NEW17166,DISEASE,mood impairment,mood impairments
NEW17167,CHEBI,anticholinergic drug category,anticholinergic drug categories
NEW17168,DISEASE,bacillus sp. b87,Bacillus sp. B87
NEW17169,DISEASE,bacillus sp. b87,three-component non-hemolytic enterotoxin
NEW17170,NUTRITION,soybean gall midge,Soybean gall midge
D030262,NUTRITION,Soybean Proteins,"Dietary Soybean Protein|Protein, Soybean|soybean|Soy Proteins|Protein, Soy Bean|Proteins, Soy|Soybean Protein|Soy Bean Protein|Soybean Protein, Dietary|Bean Protein, Soy|Protein, Dietary Soybean|Soy Bean Proteins|Proteins, Dietary Soybean|Soy Protein|Soybean Proteins, Dietary|Protein, Soy|Dietary Soybean Proteins"
NEW17171,CHEBI,immunogenic neoantigen,immunogenic neoantigens
NEW17172,MENTAL_HEALTH,immunogenic neoantigen,regularized regression model
http://purl.obolibrary.org/obo/CHEBI_35479,CHEMICAL,alkali metal salt,metal salts
NEW17173,DISEASE,differential ion mobility spectrometry,Differential ion mobility spectrometry|DIMS
NEW17174,DISEASE,differential ion mobility spectrometry,optic nerve dysmorphogenesis
NEW17175,CHEBI,selective serotonin uptake inhibitor citalopram,selective serotonin uptake inhibitor citalopram
NEW17176,MENTAL_HEALTH,Montgomery-Asberg depression rating scale,Montgomery-Asberg Depression Rating Scale
NEW17177,CHEMICAL,serotonin-norepinephrine uptake inhibitor desipramine,serotonin-norepinephrine uptake inhibitor desipramine
NEW17178,MENTAL_HEALTH,nonlinear regression analysis,nonlinear regression analysis
NEW17179,CHEMICAL,Background Bromodihydrochlorophenylbenzodiazepine,Background Bromodihydrochlorophenylbenzodiazepine
NEW17180,DISEASE,trauma anxiety disorder,trauma anxiety disorders
NEW17181,CHEMICAL,trauma anxiety disorder,bromdihydrochlorphenylbenzodiazepine
NEW17182,DISEASE,trauma anxiety disorder,PTHS.SIGNIFICANCE STATEMENT Pitt-Hopkins syndrome
NEW17183,CHEMICAL,serotonin metabolism,serotonin metabolism
NEW17184,MENTAL_HEALTH,serotonin metabolism,primary endogenous depression
NEW17185,CHEMICAL,opium cure,opium cure
NEW17186,CHEMICAL,strong antidepressant effect,strong antidepressant effect
NEW17187,CHEMICAL,opiate partial agonist buprenorphine,opiate partial agonist buprenorphine
D015473,DISEASE,"Leukemia, Promyelocytic, Acute","Leukemia, Acute Promyelocytic|Leukemia, Progranulocytic|Myeloid Leukemia, Acute, M3|Acute Promyelocytic Leukemia|Leukemia, Myeloid, Acute, M3|acute promyelocytic leukemia|Progranulocytic Leukemia|Acute Promyelocytic Leukemias|ANLL, M3|AML M3|Promyelocytic Leukemia, Acute|M3 ANLL"
NEW17188,CHEMICAL,opiate partial agonist buprenorphine,increased ATRA metabolism
NEW17189,DISEASE,opiate partial agonist buprenorphine,hematological abnormalities
NEW17190,DISEASE,catatonic episode,catatonic episode
NEW17191,DISEASE,usher syndrome type ib,Usher syndrome type IB
D000081412,CHEMICAL,Myosin VIIa,"VIIa, Unconventional Myosin|Myosin VIIa, Unconventional|protein, MYO7A|myosin VIIA|MYO7A protein|Myosin-VIIa|VIIa, Myosin|Unconventional Myosin VIIa"
NEW17192,DISEASE,combined blindness,combined blindness
NEW17193,DISEASE,combined blindness,AHDS patients
NEW17194,CHEMICAL,combined blindness,serum malonyl dialdehyde
NEW17195,DISEASE,ovarian section,Ovarian sections
http://purl.obolibrary.org/obo/CHEBI_27705,CHEMICAL,delta-carotene,"lycopenes|epsilon,psi-carotene|delta-carotene"
NEW17196,DISEASE,atherosclerotic burden,atherosclerotic burden
NEW17197,DISEASE,rts group,RTS groups
NEW17198,CHEBI,plasma lycopene isomer,plasma lycopene isomers
C000645456,CHEMICAL,Lachnoclostridium edouardi [Supplementary Concept],Clostridiales|Lachnoclostridium
NEW17199,CHEMICAL,energetic kyn,energetic Kyn
NEW17200,NUTRITION,tryptophan intervention,tryptophan interventions
NEW17201,DISEASE,tryptophan intervention,reactive aggression
NEW17202,NUTRITION,tryptophan modulation,tryptophan modulation
NEW17203,CHEMICAL,central anandamide level,central anandamide levels
NEW17204,CHEMICAL,selective kappa-opioid receptor agonist spiradoline mesylate,selective kappa-opioid receptor agonist spiradoline mesylate
C051272,CHEMICAL,spiradoline [Supplementary Concept],Spiradoline|spiradoline|Pyrrolidines
NEW17205,CHEMICAL,estradiol replacement therapy,Estradiol replacement therapy
NEW17206,CHEMICAL,tryptophan-kynurenine metabolic pathway,tryptophan-kynurenine metabolic pathway
NEW17207,DISEASE,neurotoxic pathway,neurotoxic pathway
C514283,CHEMICAL,oligonol [Supplementary Concept],Phenols|Oligonol|Catechin/analogs  and  derivatives
NEW17208,DISEASE,neurotoxic pathway,fewer cognitive deficits
NEW17209,CHEMICAL,tg-ad mouse,Tg-AD mice
NEW17210,CHEMICAL,continuous oligonol treatment,continuous Oligonol treatment
D000074924,DISEASE,Nut and Peanut Hypersensitivity,Peanut and Nut Allergies|Peanut and Tree Nut Allergies|Nut and Peanut Allergy|Peanut and Tree Nut Hypersensitivity|Tree Nut and Peanut Allergy|Peanut and Tree Nut Allergy|peanut allergy|Nut and Peanut Allergies|Peanut and Nut Allergy
NEW17211,NUTRITION,continuous oligonol treatment,tree nuts
D055728,DISEASE,Primary Myelofibrosis,"myelofibrosis|Fibroses, Bone Marrow|Myelofibrosis With Myeloid Metaplasia|Metaplasias, Myeloid|Myelosclerosis|Chronic Idiopathic Myelofibrosis|Metaplasia, Agnogenic Myeloid|Nonleukemic Myeloses|Agnogenic Myeloid Metaplasias|Myeloid Metaplasia, Agnogenic|Myeloses, Nonleukemic|Myeloid Metaplasias, Agnogenic|Myelofibroses, Primary|Fibrosis, Bone Marrow|Nonleukemic Myelosis|Idiopathic Myelofibrosis|Myelofibrosis|Myeloid Metaplasia|Metaplasias, Agnogenic Myeloid|Bone Marrow Fibrosis|Myeloscleroses|Myelofibroses|Myelosis, Nonleukemic|Agnogenic Myeloid Metaplasia|Myelofibrosis, Primary|Metaplasia, Myeloid|Bone Marrow Fibroses|Primary Myelofibroses|Myeloid Metaplasias"
NEW17212,CHEBI,continuous oligonol treatment,potent telomerase inhibitor
NEW17213,CHEMICAL,continuous oligonol treatment,rapid-acting antidepressant
NEW17214,NUTRITION,low serum cholesterol level,low serum cholesterol level
NEW17215,CHEMICAL,5-ht vomiting network,5-HT vomiting network
NEW17216,DISEASE,5-ht vomiting network,DAS-induced acute vomiting
C467566,CHEMICAL,pomalidomide [Supplementary Concept],Pomalidomide|Thalidomide/analogs  and  derivatives|pomalidomide
NEW17217,DISEASE,5-ht vomiting network,relapsed multiple myeloma
NEW17218,DISEASE,p450c17 deficiency,P450c17 deficiencies
NEW17219,CHEMICAL,p450c17 deficiency,steroid biosynthesis
NEW17220,CHEBI,cry1a toxin,Cry1A toxins
NEW17221,CHEMICAL,cry1a toxin,Mg2 signaling pathway
NEW17222,DISEASE,cry1a toxin,6-OHDA-induced neurotoxicity
NEW17223,CHEMICAL,NEKY,NEKY
NEW17224,CHEMICAL,3-hydroxykyn,3HKYN|3-hydroxyKYN
NEW17225,CHEMICAL,excitatory NEKY,excitatory NEKY
NEW17226,CHEMICAL,opposite neuroactivitie,opposite neuroactivities
NEW17227,CHEMICAL,opposite neuroactivitie,standard anxiogens
NEW17228,CHEMICAL,opposite neuroactivitie,anxiogenic NEKY
NEW17229,DISEASE,opposite neuroactivitie,DON|6-diazo-5-oxo-norleucine
NEW17230,DISEASE,don contamination level,DON contamination levels
NEW17231,DISEASE,don contamination level,harvested grain
NEW17232,CHEMICAL,Columbia Take-Home Naloxone thn program,Columbia Take-Home Naloxone THN program
NEW17233,MENTAL_HEALTH,bayesian logistic regression,Bayesian logistic regression
NEW17234,CHEMICAL,bayesian logistic regression,×    NTX treatment
NEW17235,CHEMICAL,bayesian logistic regression,NTX treatment
NEW17236,DISEASE,allergic response,allergic response
D053662,CHEMICAL,Interleukin-4 Receptor alpha Subunit,"Interleukin-4 Receptors alpha|Interleukin-4 Receptor alpha Chain|alpha-subunit, Receptor, Interleukin-4|Interleukin 4 Receptors alpha|Interleukin 4 Receptor alpha Subunit|interleukin-4|Interleukin 4 Receptor alpha Chain|CD124 Antigens|IL-4|Receptors alpha, Interleukin-4|Receptor, Interleukin-4, alpha Subunit|Antigens, CD124|CD124 Antigen|Antigen, CD124"
D053779,CHEMICAL,Latent TGF-beta Binding Proteins,TGF-β|Latent TGF beta Binding Proteins|Latent TGF-beta Binding Protein 4|Latent TGF beta Binding Protein 4|Latent TGF-beta Binding Protein|Latent TGF-beta Binding Protein 1|Latent TGF beta Binding Protein|Latent TGF beta Binding Protein 2|Latent TGF-beta Binding Protein 3|Latent TGF-beta Binding Protein 2|Latent TGF beta Binding Protein 1|Latent TGF beta Binding Protein 3
NEW17237,NUTRITION,soybean protoplast,soybean protoplasts
NEW17238,MENTAL_HEALTH,soybean protoplast,transcriptional repression activities
NEW17239,DISEASE,soybean protoplast,memory defects
NEW17240,CHEMICAL,soybean protoplast,high 7-dehydrocholesterol
NEW17241,DISEASE,vitamin e supplementation,SLOS patients
D002819,DISEASE,Chorea,"Syndromes, Chorea||Movements, Choreiform|Disorders, Choreatic|choreoathetosis|Rheumatic Choreas|Dyskinesias, Paroxysmal|Paroxysmal Dyskinesia|Benign Hereditary Choreas|Choreatic Disorder|Chronic Progressive Chorea|Disorder, Chorea|Choreiform Movements|Syndrome, Chorea|Benign Hereditary Chorea|Choreas, Hereditary|Choreatic Disorders|Sydenham's Chorea|Chorea, Sydenham|Sydenhams Chorea|Senile Chorea|Rheumatic Chorea|Choreas, Sydenham|Choreas, Benign Hereditary|Chronic Progressive Choreas|Movement, Choreic|St. Vituss Dance|Chorea, Senile|Syndrome, Choreatic|Disorders, Chorea|Chorea, Benign Hereditary|Hereditary Chorea|Hereditary Chorea, Benign|Disorder, Choreatic|Choreiform Movement|Chorea, Sydenham's|Movements, Choreic|Senile Choreas|St. Vitus's Dance|St. Vitus's Dances|Dyskinesia, Paroxysmal|St. Vitus Dance|Choreatic Syndromes|Hereditary Progressive Chorea Without Dementia|Sydenham Choreas|Syndromes, Choreatic|Choreas, Chronic Progressive|Chorea Syndromes|Choreas, Senile|Choreatic Syndrome|Chorea Disorders|Chorea Disorder|Paroxysmal Dyskinesias|Chorea, Rheumatic|Sydenham Chorea|Choreas|Chorea Syndrome|Chorea, Hereditary|Movement, Choreiform|Choreic Movement|choreiform movements|Chorea, Chronic Progressive|Hereditary Choreas, Benign|Progressive Choreas, Chronic|Choreas, Rheumatic|Choreic Movements|Progressive Chorea, Chronic|Hereditary Choreas"
NEW17242,CHEMICAL,leucine incorporation,leucine incorporation
NEW17243,CHEMICAL,leucine incorporation,leucine/min/microgram
http://purl.obolibrary.org/obo/CHEBI_3216,CHEMICAL,buprenorphine,"2-[3-cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|(-)-buprenorphine|(5alpha,6beta,14beta,18R)-17-(cyclopropylmethyl)-18-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol|buprenorphine|Buprenorphine|ED-initiated buprenorphine|buprenorphinum|21-cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine|2-(N-cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|buprenorphine/naloxone|buprenorfina|17-cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol"
NEW17244,DISEASE,atherosclerotic cerebral infarction,atherosclerotic cerebral infarction
NEW17245,CHEMICAL,zinc deficiency,Zinc deficiencies
NEW17246,DISEASE,zinc deficiency,thyroid function disorders
NEW17247,CHEMICAL,glutamic acid decarboxylase isoform,glutamic acid decarboxylase isoform
NEW17248,DISEASE,glutamic acid decarboxylase isoform,chronic psychotic disorders
NEW17249,CHEBI,glutamic acid decarboxylase isoform,used neuroleptic drug
NEW17250,CHEMICAL,thiobarbituric acid reactive product,thiobarbituric acid reactive products
D008063,CHEMICAL,Thioctic Acid,"Alpha-Lipogamma|PleomixAlpha|alpha-Vibolex|espa-lipon|Alpha-Lippon AL|Alphaflam|MTW-Alphaliponsaure|alpha-Liponaure Heumann|MTWAlphaliponsaure|alphaLiponaure Heumann|Alpha-Liponsaure Sofotec|biomo lipon|MTW Alphaliponsaure|espalipon|Alpha-Lipon Stada|alphaLiponsaure von ct|Alpha Lipogamma|Neurium|Tromlipon|biomo-lipon|Injekt, Thiogamma|alpha Liponaure Heumann|Juthiac|Pleomix Alpha|Verla Lipon|Thioctacide T|lipoic acid|Thiogamma Injekt|alpha Liponsaure von ct|Fenint|Verla-Lipon|AlphaLippon AL|Pleomix Alpha N|alphaVibolex|Azulipont|Thioctacid|alpha Lipoic Acid|duralipon|AlphaLiponsaure Sofotec|alpha-Lipoic Acid|Alpha Liponsaure Sofotec|espa lipon|PleomixAlpha N|Lipoic Acid|Alpha Lipon Stada|Alpha Lippon AL|Liponsaureratiopharm|alpha Vibolex|VerlaLipon|Acid, alpha-Lipoic|Liponsaure ratiopharm|Thiogamma oral|AlphaLipogamma|Pleomix-Alpha N|AlphaLipon Stada|Pleomix-Alpha|Liponsaure-ratiopharm|biomolipon|alpha-Liponsaure von ct"
NEW17251,CHEMICAL,ala supplementation,ALA supplementation
NEW17252,DISEASE,ala supplementation,mg/kg catalepsy dose
NEW17253,DISEASE,ala supplementation,HAL-induced TD
NEW17254,CHEMICAL,metabolite dihydro lipoic acid,metabolite dihydro lipoic acid
D016576,CHEMICAL,Fleroxacin,FLRX|AM-833|Quinodis|Ro 23-6240|Ro 236240|AM833|AM 833|Ro 23 6240|Fleroxacin
NEW17255,DISEASE,metabolite dihydro lipoic acid,obstetrical infections
NEW17256,CHEMICAL,sex-hormone signaling,sex-hormone signaling
NEW17257,DISEASE,myotoxic complication,myotoxic complication
C509671,DISEASE,"voltage-sensor-containing phosphatase, Ciona intestinalis [Supplementary Concept]",Phosphoric Monoester Hydrolases|C. intestinalis
NEW17258,CHEBI,novel toxin,novel toxins
NEW17259,CHEBI,unique venom proteome,unique venom proteome
NEW17260,DISEASE,bite envenoming,bite envenoming
NEW17261,MENTAL_HEALTH,bite envenoming,appropriate analgesia
NEW17262,DISEASE,bite envenoming,moderate pain
NEW17263,CHEMICAL,serum creatine kinase level,serum creatine kinase level
D000081030,DISEASE,Myotoxicity,"Toxic Myopathies|myotoxicity|Drug Induced Myopathy|Myopathies, Drug Related|Drug Associated Myopathy|Drug Related Myopathies|Drug Associated Myopathies|Myopathy, Drug Related|Related Myopathy, Drug|Myopathy, Drug Induced|Related Myopathies, Drug|Induced Myopathy, Drug|Drug Related Myopathy|Myotoxicities|Toxic Myopathy|Myopathy, Toxic|Drug Induced Myopathies|Myalgia-Arthralgia Syndromes|Myopathy, Drug Associated|Myalgia-Arthralgia Syndrome|Myalgia Arthralgia Syndrome"
NEW17264,DISEASE,x-linked disorder,X-linked disorder
C096915,MENTAL_HEALTH,"FXR2 protein, human [Supplementary Concept]",fragile X mental retardation gene|RNA-Binding Proteins
NEW17265,DISEASE,schisandrae lignan,Schisandrae lignans
NEW17266,CHEBI,schisandrae lignan,sympathomimetic vasoconstriction
NEW17267,CHEMICAL,schisandrae lignan,endocannabinoids system
NEW17268,DISEASE,hepatotoxic metabolite,hepatotoxic metabolites
NEW17269,NUTRITION,hepatotoxic metabolite,omega-3 fatty acid family
NEW17270,DISEASE,hepatotoxic metabolite,central deficits
NEW17271,CHEMICAL,docosahexaenoic acid dha,docosahexaenoic acid DHA
NEW17272,DISEASE,gray matter volume reduction,gray matter volume reductions
NEW17273,CHEMICAL,pufa composition,PUFA composition
NEW17274,NUTRITION,pufa composition,monounsaturated fatty acid composition
NEW17275,DISEASE,age-related reduction,age-related reduction
C000618185,CHEMICAL,"SMXL2 protein, Arabidopsis [Supplementary Concept]",smxl2|Arabidopsis Proteins|Intracellular Signaling Peptides and Proteins
NEW17276,MENTAL_HEALTH,age-related reduction,petiole orientation
D000956,CHEBI,"Antigens, Viral","viral antigen|Viral Antigen|Antigen, Viral|Viral Antigens"
NEW17277,DISEASE,age-related reduction,human encephalitis
http://purl.obolibrary.org/obo/CHEBI_80008,CHEMICAL,bila 2185bs,acupuncture/acupressure
NEW17278,CHEMICAL,de adnp mutation,de ADNP mutations
NEW17279,DISEASE,de adnp mutation,intractable autism/intellectual disability syndrome
NEW17280,DISEASE,de adnp mutation,exogenous hypercalcemia
NEW17281,CHEMICAL,calcium sulfate bead,Calcium sulfate beads
NEW17282,DISEASE,calcium sulfate bead,postoperative hardware infections
D059245,DISEASE,Transient Tachypnea of the Newborn,PPHN|newborn|Newborn Transient Tachypnea|Transient Tachypnea of Newborn|Newborn Transient Tachypneas
NEW17283,CHEMICAL,calcium sulfate bead,recombinant human superoxide dismutase
NEW17284,CHEMICAL,calcium sulfate bead,L-citrulline
NEW17285,DISEASE,calcium sulfate bead,Parkinsonism syndrome
NEW17286,DISEASE,lung mitochondrial dysfunction present,lung mitochondrial dysfunction present
NEW17287,CHEBI,lung mitochondrial dysfunction present,high dietary vitamin E.
NEW17288,MENTAL_HEALTH,histamine neuron,insomnia dual orexin receptor antagonists
NEW17289,CHEMICAL,proline content,proline contents
C512397,CHEMICAL,thienorphine [Supplementary Concept],thienorphine|Buprenorphine/analogs  and  derivatives
NEW17290,DISEASE,proline content,stimulus shock termination
NEW17291,DISEASE,proline content,postprandial triglyceride-rich lipoproteins|TRLs
NEW17292,NUTRITION,proline content,small dense low-density lipoprotein LDL particles
D006946,DISEASE,Hyperinsulinism,"Hyperinsulinemia||Hyperinsulinemia, Compensatory|compensatory hyperinsulinemia|Exogenous Hyperinsulinism|Compensatory Hyperinsulinemia|Endogenous Hyperinsulinism|Hyperinsulinism, Exogenous|hyperinsulinemia|Hyperinsulinism, Endogenous"
NEW17293,NUTRITION,proline content,low-density lipoprotein particles
NEW17294,CHEMICAL,ester-rich fasting,ester-rich fasting
NEW17295,DISEASE,cucumber vascular wilt disease,cucumber vascular wilt disease
NEW17296,CHEMICAL,serum ua concentration,serum UA concentrations
NEW17297,DISEASE,serum ua concentration,first-episode manic patients
NEW17298,DISEASE,first-episode bpd,first-episode BPD
NEW17299,CHEMICAL,first-episode bpd,serum UA
NEW17300,CHEMICAL,first-episode bpd,GSK3β phosphorylation
NEW17301,MENTAL_HEALTH,first-episode bpd,Akt repression
NEW17302,CHEMICAL,double-blind controlled trial progabide,double-blind controlled trial progabide
NEW17303,CHEMICAL,progabide treatment,progabide treatment
NEW17304,CHEMICAL,% grje dietary supplementation,% GRJE dietary supplementation
NEW17305,NUTRITION,% grje dietary supplementation,juvenile black rockfish
NEW17306,CHEMICAL,SsCCL25,SsCCL25
NEW17307,NUTRITION,SsCCL25,black rockfish
NEW17308,CHEMICAL,endothelium-dependent challenge,endothelium-dependent challenge
NEW17309,CHEMICAL,elagolix exposure,Elagolix exposures
NEW17310,DISEASE,elagolix exposure,moderate/severe renal impairment
NEW17311,DISEASE,elagolix exposure,mild hepatic impairment
NEW17312,CHEMICAL,elagolix dose,elagolix dose
NEW17313,CHEBI,elagolix dose,nonpeptide oral gonadotropin-releasing hormone antagonist
C401888,CHEMICAL,pyrithiobac sodium [Supplementary Concept],pyrithiobac|Benzoates
NEW17314,CHEMICAL,elagolix dose,A205
NEW17315,CHEBI,high vitamin e intake,Higher vitamin E intake
NEW17316,CHEMICAL,report acyclovir,report acyclovir
C536897,DISEASE,Tang Hsi Ryu syndrome [Supplementary Concept],Pigmentation Disorders|Hepatomegaly|Nervous System Diseases|Splenomegaly|oedema
NEW17317,CHEBI,bite venom,bite venom
NEW17318,CHEMICAL,pure compound 2-phenylchromone,pure compound 2-phenylchromone
NEW17319,CHEBI,agonist medication,agonist medications
NEW17320,CHEMICAL,sanocrysin,sanocrysin
NEW17321,DISEASE,sanocrysin,tuberculosis animals
NEW17322,CHEMICAL,sanocrysin,myochrysine gold salts
NEW17323,CHEMICAL,sanocrysin therapy,Sanocrysin therapy
NEW17324,CHEBI,h. current analgesic regime,h. Current analgesic regimes
NEW17325,CHEBI,beta adrenoreceptor agonist,beta adrenoreceptor agonists
NEW17326,CHEBI,beta adrenoreceptor agonist,efficacious analgesic adjunct
NEW17327,CHEBI,act μ-opioid receptor antagonist,acting μ-opioid receptor antagonist
NEW17328,MENTAL_HEALTH,resistance mdr1a/b knockout mouse,resistance mdr1a/b knockout mice
NEW17329,DISEASE,constipation-induced reduction,constipation-induced reduction
NEW17330,CHEBI,constipation-induced reduction,peripheral mu-opioid receptor antagonist
NEW17331,DISEASE,pantoea ananatis brt175,Pantoea ananatis BRT175
NEW17332,CHEBI,pantoea ananatis brt175,antibiotic activity
NEW17333,CHEMICAL,pantoea ananatis brt175,arginine ABC transporter permease subunit gene
NEW17334,CHEMICAL,importance formylaminooxyvinylglycine,IMPORTANCE formylaminooxyvinylglycine
NEW17335,DISEASE,importance formylaminooxyvinylglycine,pathogen Erwinia amylovora
C088137,CHEMICAL,aminoethoxyvinylglycine [Supplementary Concept],Glycine/analogs  and  derivatives|AVG|aminoethoxyvinylglycine
NEW17336,CHEMICAL,l-arginine transporter,l-arginine transporter
NEW17337,CHEMICAL,l-asparagine transporter,l-asparagine transporter
NEW17338,CHEMICAL,dietary proanthocyanidin,PAC|dietary proanthocyanidins
D000069349,CHEMICAL,Linezolid,"Linezolide|N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide|Linezolid|100766, U|Zyvox|PNU 100766|PNU100766|U 100766|PNU-100766|U-100766|U100766|linezolid"
NEW17339,DISEASE,dietary proanthocyanidin,meticillin-resistant Staphylococcus aureus
D000077299,DISEASE,Healthcare-Associated Pneumonia,"Pneumonia, Healthcare-Associated|Healthcare-Associated Pneumonias|Hospital Acquired Pneumonia|Pneumonia, Nosocomial|Healthcare Associated Pneumonia|Pneumonia, Hospital Acquired|nosocomial pneumonia|Nosocomial Pneumonias|Nosocomial Pneumonia|Hospital Acquired Pneumonias"
NEW17340,CHEMICAL,linezolid therapy,linezolid therapy
NEW17341,DISEASE,linezolid therapy,difficile-related diarrhoea
D020314,DISEASE,Central Nervous System Fungal Infections,"CNS Fungal Infection|Fungal Infection, CNS|Fungal Infections, CNS|CNS Fungal Infections|fungal infections|Central Nervous System Mycoses|Infections, CNS Fungal|Mycoses, Central Nervous System|Infection, CNS Fungal|Infections, Fungal, Central Nervous System|Fungal Infections, Central Nervous System"
NEW17342,DISEASE,linezolid therapy,serotonin-like syndrome
D001066,DISEASE,Appetite,"Appetite Alterations|Alterations, Appetite|Alteration, Appetite|alterations|Appetite Alteration|Appetites"
NEW17343,DISEASE,linezolid therapy,multidrug-resistant infections
NEW17344,CHEMICAL,melatonin mt(1 receptor,melatonin MT(1 receptors
NEW17345,DISEASE,melatonin mt(1 receptor,particular RBD
http://purl.obolibrary.org/obo/IAO_0000409,CHEMICAL,denotator type,type    HSV-I
NEW17346,DISEASE,primary herpes,primary herpes
NEW17347,DISEASE,orolabial,orolabial
C048621,DISEASE,"glycoprotein E, herpes simplex-virus type 2 [Supplementary Concept]",herpes simplex virus type|Viral Envelope Proteins
NEW17348,DISEASE,recurrent hsv-i infection hsv-i,recurrent HSV-I infection HSV-I
D017789,DISEASE,"Granuloma, Pyogenic","Angiogranulomas|Granuloma Telangiecticum|Capillary Hemangioma, Lobular|Hemangioma, Lobular Capillary|Pyogenic Granuloma|pyogenic granuloma|Lobular Capillary Hemangioma|Granuloma Pyogenicum|Angiogranuloma"
NEW17349,DISEASE,recurrent hsv-i infection hsv-i,chronic HSV-I infection
NEW17350,DISEASE,recurrent hsv-i infection hsv-i,HSV-related folliculitis
D065310,DISEASE,Squamous Intraepithelial Lesions of the Cervix,Epithelial Cells (1996-2014)|lesions
C477373,DISEASE,"MON1B protein, human [Supplementary Concept]",HSV-I|Intracellular Signaling Peptides and Proteins
NEW17351,CHEBI,antagonist muscle,antagonist muscles
NEW17352,DISEASE,antagonist muscle,primary ataxic syndromes
D064830,DISEASE,Temperance Movement,"Movements, Temperance|Movement, Temperance|Temperance Movements|movement|Women's Christian Temperance Union"
NEW17353,DISEASE,antagonist muscle,akinetic syndromes
D020232,CHEMICAL,Kluver-Bucy Syndrome,"Kluver Bucy Syndrome|Klüver-Bucy syndrome|Temporal Lobectomy Behavior Syndrome|Syndrome, Kluver-Bucy"
NEW17354,CHEMICAL,neuro-transmitter serotonin,neuro-transmitter serotonin
NEW17355,DISEASE,neuro-transmitter serotonin,eating behaviour
NEW17356,CHEBI,nervosa serotonin agonist,Nervosa serotonin agonists
C100640,CHEMICAL,8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthine [Supplementary Concept],FSCPX|Xanthines
D058907,CHEBI,Adenosine A1 Receptor Agonists,"Receptor, Adenosine A1/agonists (2004-2010)|A1 receptor agonists"
NEW17357,MENTAL_HEALTH,nervosa serotonin agonist,pure dextral displacement
NEW17358,DISEASE,nervosa serotonin agonist,endotoxin-induced acute lung injury
http://purl.obolibrary.org/obo/CHEBI_73311,CHEBI,adenosine receptor agonist,adenosine receptor agonist|CGS21680C|selective A(2a adenosine receptor agonist|Adenosine A(2A receptors|receptor agonist 2-[4-(2-p-carboxy ethyl)phenylamino]-5'-N-ethylcarboxamido adenosine
NEW17359,CHEMICAL,cv ccpa,CV CCPA
http://purl.obolibrary.org/obo/CHEBI_3095,CHEBI,biguanide,"biguanide|Hbig|Biguanide|imidodicarbonimidic diamide|H2N-C(=NH)-NH-C(=NH)-NH2|1,2,3-triimidodicarbonic diamide|Thiazolidinediones TZDs"
NEW17360,CHEBI,glitazone class,glitazones class
NEW17361,CHEMICAL,fly gd model,fly GD model
D017637,DISEASE,Clonal Deletion,"Deletions, Clonal|Abortion, Clonal|Deletion, Clonal|Abortions, Clonal|Clonal Deletions|Clonal Abortions|deletions|Clonal Abortion"
NEW17362,DISEASE,fly gd model,obstructive sleep apnea/hypopnea syndrome
NEW17363,MENTAL_HEALTH,dissociation constant,Dissociation constants
C012526,CHEMICAL,quercitrin [Supplementary Concept],quercetin-3-O-rhamnoside|Quercetin/analogs  and  derivatives
NEW17364,DISEASE,dissociation constant,metabolic stroke
NEW17365,DISEASE,cobalamin-responsive patient,cobalamin-responsive patients
NEW17366,CHEMICAL,exist antidepressant drug,existing antidepressant drugs
NEW17367,CHEMICAL,glucose catabolism,glucose catabolism
D015323,CHEMICAL,"Pyruvate Metabolism, Inborn Errors","pyruvate metabolism|Pyruvates (1966-1988)|Carbohydrate Metabolism, Inborn Errors (1966-1988)"
NEW17368,CHEMICAL,metabolism pentose phosphate pathway,metabolism pentose phosphate pathways
NEW17369,CHEMICAL,lipopolysaccharide injection,Lipopolysaccharide injection
NEW17370,CHEMICAL,high-carbohydrate level,High-carbohydrate levels
NEW17371,CHEMICAL,high-carbohydrate level,p-adenosine monophosphate (AMP)-activated protein kinase
NEW17372,DISEASE,high-carbohydrate level,weight gain rate
http://purl.obolibrary.org/obo/CHEBI_8764,CHEMICAL,mycophenolate mofetil,"Cellcept|2-(morpholin-4-yl)ethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate|Tacrolimus (FK506)/mycophenolate mofetil|MMF|2-morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate|mycophenolic acid morpholinoethyl ester|RS 61443"
NEW17373,DISEASE,steroid-resistant chronic graft-versus-host disease,steroid-resistant chronic graft-versus-host disease
NEW17374,CHEMICAL,tn crt2,Tn CRT2
NEW17375,DISEASE,tn crt2,hemolytic assay
NEW17376,DISEASE,average daily weight gain,average daily weight gain
NEW17377,NUTRITION,finisher herd,Finisher herds
NEW17378,DISEASE,testosterone level,male VaD patients
NEW17379,DISEASE,estradiol level,female VaD patients
NEW17380,DISEASE,migraine patient,Migraine patients
NEW17381,DISEASE,meningeal inflammation,meningeal inflammation
NEW17382,MENTAL_HEALTH,meningeal inflammation,trinitrate-induced delayed headache
NEW17383,CHEBI,conventional μ-opioid receptor agonist,conventional μ-opioid receptor agonists
NEW17384,DISEASE,conventional μ-opioid receptor agonist,IC/PBS pain
NEW17385,DISEASE,conventional μ-opioid receptor agonist,pain hypersensitivity
NEW17386,CHEBI,selective μ-opioid receptor antagonist ctap,selective μ-opioid receptor antagonist CTAP
NEW17387,CHEMICAL,microglial inhibitor minocycline,microglial inhibitor minocycline
NEW17388,CHEMICAL,low frequency electroacupuncture,low frequency electroacupuncture
NEW17389,MENTAL_HEALTH,ethanol-induced analgesia,ethanol-induced analgesia
NEW17390,DISEASE,plp deficiency,PLP deficiency
C097250,NUTRITION,betaine reductase [Supplementary Concept],trimethylglycine|Amino Acid Oxidoreductases
NEW17391,DISEASE,plp deficiency,hyperhomocysteinemia MTHFR gene mutation
D015456,DISEASE,"Leukemia, Biphenotypic, Acute","Biphenotypic Leukemias, Acute|Acute Leukemias, Hybrid|Leukemia, Mixed, B and T Cell|Lymphocytic Leukemia, Acute, B and T Cell|Leukemia, Lymphocytic, Acute, Mixed Cell|Biphenotypic Acute Leukemias|Biphenotypic Acute Leukemia|Leukemia, Mixed Cell|Mixed-Cell Leukemias|Acute Leukemia, Biphenotypic|Lymphocytic Leukemia, Acute, B- and T-Cell|Acute Leukemia, Mixed-Lineage|Hybrid Acute Leukemia|B- and T-Cell Acute Lymphoblastic Leukemia|Biphenotypic Leukemia, Acute|Leukemia, Mixed, B- and T-Cell|Leukemia, Lymphocytic, Acute, Mixed-Cell|Mixed Lineage Acute Leukemias|Leukemias, Biphenotypic Acute|Leukemia, Biphenotypic Acute|Leukemias, Mixed-Cell|Acute Biphenotypic Leukemias|Acute Leukemias, Biphenotypic|Leukemia, Hybrid Acute|Leukemia, Acute Biphenotypic|Acute Leukemias, Mixed-Lineage|Leukemias, Mixed-Lineage Acute|Acute Leukemia, Hybrid|Leukemias, Hybrid Acute|B and T Cell Acute Lymphoblastic Leukemia|Acute Biphenotypic Leukemia|B- and T-Cell Leukemia, Acute|Mixed-Cell Leukemia|Hybrid Acute Leukemias|B and T Cell Leukemia, Acute|Mixed-Lineage Acute Leukemia|Leukemia, Mixed-Lineage Acute|Leukemias, Acute Biphenotypic|Leukemia, Mixed-Cell|Mixed-Lineage Acute Leukemias|T cell acute lymphoblastic leukemia"
NEW17392,CHEBI,plp deficiency,antigen (HLA)-haploidentical mother
NEW17393,DISEASE,gsh concentration,neuroblastoma cell lines
NEW17394,CHEMICAL,faah gene,FAAH gene
NEW17395,NUTRITION,faah gene,Spanish population sample
NEW17396,MENTAL_HEALTH,gene cannabis dependence,gene cannabis dependence
NEW17397,CHEBI,selective a2a receptor antagonist,selective A2A receptor antagonist
NEW17398,DISEASE,selective a2a receptor antagonist,akathisia-like behavior
http://purl.obolibrary.org/obo/CHEBI_51052,CHEMICAL,lucanthone,1-((2-(diethylamino)ethyl)amino)-4-methylthioxanthen-9-one|lucanthone|1-{[2-(diethylamino)ethyl]amino}-4-methyl-9H-thioxanthen-9-one|Lucanthone|1-diethylaminoethylethylamino-4-methyl-thioxanthenone|indenoisoquinolines|1-{[2-(diethylamino)ethyl]amino}-4-methylthioxanthen-9-one|lucanthonum|lucantona
NEW17399,CHEBI,non-camptothecinic base topoisomerase poison,non-camptothecinic based topoisomerase poisons
NEW17400,CHEMICAL,intravenous apomorphine,intravenous apomorphine
NEW17401,CHEMICAL,one parenteral dopamine agonist,sphingomyelin SM profiles
D051147,CHEMICAL,Ganglioside Galactosyltransferase,"UDPGal GM2 Beta1 3 Galactosyltransferase|Galactosyltransferase, UDP Galactose-GM2|UDPGalactose-N-Acetylgalactosaminyl-(N-Acetylneuraminyl)-Galactosyl-Glucosyl-Ceramide Galactosyltransferase|Ganglioside GM1 Synthase|UDP Galactose GM2 Ganglioside Beta 1 3 Galactosyltransferase|Beta-1-3-Galactosyltransferase, UDP-Galactose-GM2 Ganglioside|Synthase, Ganglioside GM1|GM1 Synthase, Ganglioside|UDP Galactose Ceramide Galactosyltransferase|UDP-Galactose-GM2 Ganglioside Beta-1-3-Galactosyltransferase|Ganglioside Beta-1-3-Galactosyltransferase, UDP-Galactose-GM2|UDP Galactose GM2 Galactosyltransferase|UDP Galactose-GM2 Galactosyltransferase|ceramide|Galactose-GM2 Galactosyltransferase, UDP|Cer|Galactosyltransferase, Ganglioside|Galactose-Ceramide Galactosyltransferase, UDP|Beta1-3-Galactosyltransferase, UDPGal-GM2|Galactosyltransferase, UDP Galactose-Ceramide|UDPGal-GM2 Beta1-3-Galactosyltransferase|UDP Galactose-Ceramide Galactosyltransferase"
NEW17402,DISEASE,one parenteral dopamine agonist,streptozotocin-induced hyperglycemia
NEW17403,CHEMICAL,avp action,AVP action
NEW17404,DISEASE,avp action,volume overload conditions
NEW17405,DISEASE,avp action,hyponatremic states
NEW17406,DISEASE,avp action,failure HF syndrome
C104999,CHEMICAL,acetyl-E VEALEKK VAALESK VQALEKK VEALEHG-amide [Supplementary Concept],V₁(a|Recombinant Proteins
NEW17407,MENTAL_HEALTH,avp action,severe major depression
NEW17408,NUTRITION,avp action,HIV-inhibiting MIP-1 alpha
C515429,NUTRITION,"CCL3 protein, human [Supplementary Concept]",Chemokine CCL3|MIP-1 alpha
NEW17409,CHEMICAL,depressed individual,current antidepressant treatments
NEW17410,DISEASE,depressed participant,Depressed participants
NEW17411,CHEMICAL,depressed participant,higher cortisol levels
NEW17412,DISEASE,depressed participant,negative psychotic symptoms
NEW17413,CHEMICAL,depressed participant,adjunctive raloxifene
NEW17414,MENTAL_HEALTH,alogia SANSS,Alogia SANSS
NEW17415,CHEMICAL,mixed μ/κ opioid,mixed μ/κ opioid
NEW17416,CHEBI,mixed micro-/kappa-opioid analgesic,mixed micro-/kappa-opioid analgesic
NEW17417,DISEASE,mixed micro-/kappa-opioid analgesic,OCD 2012
NEW17418,CHEMICAL,epinephrine dose-response curve,epinephrine dose-response curve
NEW17419,DISEASE,ser-the aggression,SER-the aggression
NEW17420,MENTAL_HEALTH,ser-the aggression,locomotor hyperactivity
C050232,CHEMICAL,"1,3-ditolylguanidine [Supplementary Concept]","1,3-Di-o-tolylguanidine|Guanidines|DTG"
NEW17421,MENTAL_HEALTH,l-dopa hyperactivity,L-DOPA hyperactivity
NEW17422,CHEMICAL,cocaine locomotor hyperactivity,cocaine locomotor hyperactivity
NEW17423,DISEASE,importance gut bacterial infection,IMPORTANCE Gut bacterial infections
D003969,DISEASE,Vipoma,"WDHA Syndrome|WDHA Syndromes|Pancreatic Cholera|Syndrome, Vipoma|Cholera, Pancreatic|Tumors, VIP-Secreting (VIPoma)|Syndrome, Verner-Morrison|VIPomas, Pancreatic|Vasoactive Intestinal Peptide-Producing Tumor|VIPoma, Pancreatic|Vasoactive Intestinal Peptide (VIP) Tumor|Watery Diarrhea Syndrome|VIP Secreting Tumor (VIPoma)|Vipomas|Pancreatic VIPoma|Diarrheogenic Islet Cell Tumor|Tumor, VIP-Secreting (VIPoma)|VIP-Secreting Tumor (VIPoma)|watery diarrhea|Watery Diarrhea, Hypokalemia, and Achlorhydria Syndrome|Pancreatic VIPomas|Watery Diarrhea with Hypokalemic Alkalosis|Vasoactive Intestinal Peptide Producing Tumor|Verner Morrison Syndrome|VIP-Secreting Tumors (VIPoma)|WDHH|Vipoma Syndrome|Verner-Morrison Syndrome|Tumors, Diarrheogenic|Diarrheogenic Tumor|Diarrheogenic Tumors|Tumor, Diarrheogenic|WDHA"
NEW17424,CHEMICAL,low-dose ttx,low-dose TTX
NEW17425,DISEASE,low-dose ttx,severe treatment-resistant cancer pain
NEW17426,CHEMICAL,Aviophobia,Aviophobia
D002024,NUTRITION,Bufo marinus,"Toad, Giant|toad|Rhinella marina|Marine Toad|Toad, Marine|Marine Toads|Toads, Marine|Toads, Giant|Giant Toad|Giant Toads"
NEW17427,MENTAL_HEALTH,Aviophobia,orientation responses
NEW17428,CHEMICAL,Aviophobia,stress-induced cortisol elevation
NEW17429,CHEMICAL,Aviophobia,antidepressant discontinuation
NEW17430,CHEMICAL,Aviophobia,AAM|antidepressant-associated mania
NEW17431,MENTAL_HEALTH,treatment-emergent mania,treatment-emergent mania
NEW17432,DISEASE,treatment-emergent mania,treatment-emergent manic episodes
D014994,CHEMICAL,Xylose,D-Xylose|xylose|D Xylose
D013013,CHEMICAL,Sorbose,D-Sorbose|D Sorbose|L Sorbose|sorbose|L-Sorbose
NEW17433,CHEMICAL,treatment-emergent mania,alpha-lactose
NEW17434,CHEMICAL,treatment-emergent mania,beta-lactose
NEW17435,CHEMICAL,treatment-emergent mania,% w/v glucose
NEW17436,DISEASE,treatment-emergent mania,hypoxia exposure
NEW17437,CHEMICAL,ua dilator muscle,UA dilator muscles
NEW17438,MENTAL_HEALTH,fatigue resistance,fatigue resistance
NEW17439,CHEMICAL,ERα level,ERα level
NEW17440,CHEMICAL,resveratrol dimer,Resveratrol dimer
D046930,DISEASE,Thymus Plant,"Plant, Thymus|Thymus vulgari|vulgaris, Thymus|Plants, Thymus|Thymus vulgaris|Thymus Plants|Thyme|Thymes"
NEW17441,NUTRITION,resveratrol dimer,dietary food additive
D017365,CHEMICAL,Spices,Spice|spice
NEW17442,MENTAL_HEALTH,resveratrol dimer,nausea delirium
D004078,CHEMICAL,Dihydralazine,"dihydralazine|Dihydralazine Sulfate|Sulfate, Dihydralazine|Dihydrazinophthalazin|Dihydrallazine|Depressan|Dihydralazine"
NEW17443,CHEMICAL,day minoxidil,day minoxidil
D006983,DISEASE,Hypertrichosis,hypertrichosis|Hypertrichoses
NEW17444,DISEASE,day minoxidil,mild OSAS
NEW17445,CHEMICAL,nasal steroid,Nasal steroids
NEW17446,DISEASE,nasal steroid,diabetic hyperglycemia
NEW17447,CHEMICAL,nasal steroid,fasting plasma glucose levels
NEW17448,CHEBI,nasal steroid,glucagon receptor antagonist administration
NEW17449,DISEASE,fatty liver disease secondary,fatty liver disease secondary
NEW17450,CHEMICAL,fatty liver disease secondary,impaired amino acid turnover
NEW17451,CHEMICAL,fatty liver disease secondary,certain glucagonotropic amino acids
NEW17452,CHEMICAL,fatty liver disease secondary,amino acid turnover
NEW17453,DISEASE,hepatic sensitivity,hepatic sensitivity
NEW17454,CHEMICAL,fernblock ® ifc,Fernblock ® IFC
NEW17455,DISEASE,fernblock ® ifc,pigmentary disorders
NEW17456,DISEASE,Melasma quality,Melasma Quality
NEW17457,DISEASE,Melasma quality,Melasma Area
NEW17458,CHEMICAL,Melasma quality,melanin indexes
NEW17459,CHEMICAL,oral PLE aqueous extract product,oral PLE aqueous extract product
NEW17460,CHEMICAL,oral PLE aqueous extract product,topical hydroquinone
D008548,DISEASE,Melanosis,Freckle|melasma|Freckles|Melasma|Melanism|Chloasmas|Chloasma|Melasmas|Melanoses
NEW17461,CHEMICAL,doxylamine/dicyclomine/pyridoxine combination,doxylamine/dicyclomine/pyridoxine combination
NEW17462,MENTAL_HEALTH,non-puerperal depression,non-puerperal depression
NEW17463,CHEMICAL,dha 22:6n-3,DHA 22:6n-3
NEW17464,MENTAL_HEALTH,syndrome ds trisomy cell,syndrome DS trisomy cells
NEW17465,CHEBI,syndrome ds trisomy cell,glycogen synthase kinase-3 beta (GSK3β)-transcription factor EB
NEW17466,CHEMICAL,syndrome ds trisomy cell,EB signaling
NEW17467,DISEASE,syndrome ds trisomy cell,dAGEs-induced neurotoxicity
NEW17468,CHEMICAL,cholesterol-lowering agent,cholesterol-lowering agents
C537301,DISEASE,Griscelli syndrome type 1 [Supplementary Concept],"neurologic impairment|Piebaldism|Pigmentation Disorders|Hearing Loss, Sensorineural"
NEW17469,CHEMICAL,kynurenine pathway metabolite,kynurenine pathway metabolite
D031941,DISEASE,"Hemorrhagic Septicemia, Viral","Viral Haemorrhagic Septicaemia|septicemia|Haemorrhagic Septicaemia, Viral|Septicaemia, Viral Haemorrhagic|Viral Hemorrhagic Septicemia|Septicemia, Viral Hemorrhagic"
NEW17470,DISEASE,kynurenine pathway metabolite,inflammatory neurologic diseases independent
NEW17471,CHEMICAL,neuroactive kynurenine pathway metabolite,neuroactive kynurenine pathway metabolites
NEW17472,DISEASE,neuroactive kynurenine pathway metabolite,inflammatory neurologic diseases
NEW17473,DISEASE,neuroactive kynurenine pathway metabolite,brain infection
NEW17474,CHEMICAL,kynurenine pathway metabolism,kynurenine pathway metabolism
NEW17475,CHEMICAL,nimodipine pre-treatment,nimodipine pre-treatment
NEW17476,CHEMICAL,nimodipine pre-treatment,NA content
NEW17477,NUTRITION,various alpha 2-adrenoceptor,Various alpha 2-adrenoceptor
NEW17478,CHEMICAL,alpha 2-adrenoceptor,alleviating alcohol abstinence syndrome
C534368,CHEMICAL,fipronil sulfone [Supplementary Concept],Pyrazoles|fipronil
NEW17479,DISEASE,alpha 2-adrenoceptor,cognitive deficiencies
NEW17480,CHEMICAL,alpha 2-adrenoceptor,dim light melatonin onset
NEW17481,MENTAL_HEALTH,efficacious analgesia,efficacious analgesia
NEW17482,CHEMICAL,acetylcholinesterase inhibitor soman,acetylcholinesterase inhibitor soman
NEW17483,CHEMICAL,acetylcholinesterase inhibitor soman,combined oral contraceptive pills
D005867,CHEMICAL,Gestrinone,"R2323|18,19-Dinorpregna-4,9,11-trien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-|gestrinone|Dimetriose|R 2323|R-2323|Nemestran"
D003613,CHEMICAL,Danazol,Norciden|Danazol Ratiopharm||Cyclomen|Panacrine|Danazol-Ratiopharm|Azol|danazol|Ladogal|Danazant|Danatrol|Danoval|Danol|Danocrine
NEW17484,CHEMICAL,[3h]mtx,[3H]MTX
D005493,CHEMICAL,Folic Acid Antagonists,"Acid Antagonist, Folic|Dihydrofolate Reductase Inhibitors|Antagonists, Folic Acid|Reductase Inhibitors, Dihydrofolate|Antifolates|antifolate|Dihydrofolate Reductase Inhibitor|Folic Acid Antagonist|Folic Acid Metabolism Inhibitors|Antagonist, Folic Acid|Reductase Inhibitor, Dihydrofolate|Antifolate|Acid Antagonists, Folic|Inhibitor, Dihydrofolate Reductase|Inhibitors, Dihydrofolate Reductase"
NEW17485,DISEASE,[3h]mtx,sarcoma line
NEW17486,CHEMICAL,[3h]mtx,long-chain gamma-glutamyl derivatives
NEW17487,CHEMICAL,[3h]mtx,metachlorophenylpiperazine agonist
D044282,CHEMICAL,"Receptor, Serotonin, 5-HT1A","Receptor, Serotonin 1A|5-Hydroxytryptamine 1A Receptors|5-HT1A Serotonin Receptor|5-HT(1A|Receptor, 5-HT1A|Receptor Serotonin, 5-HT1a|5-HT1a Receptor Serotonin|Serotonin, 5-HT1a Receptor|5-HT(1A) Receptor|Serotonin 1A Receptor|5 Hydroxytryptamine 1A Receptors|5 Hydroxytryptamine 1A Receptor|Receptor, 5-HT1A Serotonin|Serotonin Receptor, 5 HT1A|5-Hydroxytryptamine 1A Receptor|1A Receptor, 5-Hydroxytryptamine|Serotonin Receptor, 5-HT1A|5-HT1A Receptor|1A Receptors, 5-Hydroxytryptamine|5 HT1A Receptor|Receptors, 5-Hydroxytryptamine 1A|Serotonin, 5 HT1a Receptor|Receptor, 5 Hydroxytryptamine 1A|Receptor, 5-Hydroxytryptamine 1A"
NEW17488,MENTAL_HEALTH,[3h]mtx,dysthymia patients
NEW17489,DISEASE,cortisol response,tenseness scores
NEW17490,CHEMICAL,nicotine replacement therapy,Nicotine replacement therapies
NEW17491,MENTAL_HEALTH,nicotine replacement therapy,tobacco craving
NEW17492,MENTAL_HEALTH,nicotine replacement therapy,atypical withdrawal syndromes
NEW17493,DISEASE,differentiated thyroid cancer,Differentiated thyroid cancer
NEW17494,CHEBI,differentiated thyroid cancer,VEGF receptor inhibitors
NEW17495,CHEMICAL,vegf receptor inhibitor pazopanib,VEGF receptor inhibitor pazopanib
NEW17496,DISEASE,vegf receptor inhibitor pazopanib,advanced solid tumors
NEW17497,CHEMICAL,mek inhibitor trametinib,MEK inhibitor trametinib
NEW17498,CHEMICAL,mek inhibitor trametinib,Alz-heimer's disease
C003915,CHEMICAL,diminazene aceturate [Supplementary Concept],DIZE|Diminazene aceturate|Diminazene/analogs  and  derivatives
NEW17499,CHEMICAL,mek inhibitor trametinib,lipopolysaccharide (LPS)/D-galactosamine (D-Gal)-induced fulminant hepatitis
NEW17500,DISEASE,lethal inflammatory disorder,lethal inflammatory disorder
NEW17501,DISEASE,lethal inflammatory disorder,inflammation-based lethal inflammatory liver disorders
NEW17502,CHEMICAL,high plasma homocysteine,High plasma homocysteine
NEW17503,DISEASE,high plasma homocysteine,stroke survivors
NEW17504,MENTAL_HEALTH,high plasma homocysteine,poststroke depression
D018651,NUTRITION,Chicory,Cichorium intybus|chicory
NEW17505,CHEMICAL,flc-like,FLC-like|CiMFL
NEW17506,MENTAL_HEALTH,flc-like,flowering repression
NEW17507,DISEASE,formalin-induced inflammatory pain,formalin-induced inflammatory pain
NEW17508,CHEMICAL,formalin-induced inflammatory pain,P2X3 receptor antagonist A-317491
NEW17509,CHEBI,novel benzodiazepine receptor partial inverse agonist,novel benzodiazepine receptor partial inverse agonist
NEW17510,CHEBI,novel benzodiazepine receptor partial inverse agonist,drug candidate
NEW17511,CHEMICAL,alpha-adrenergic agonist midodrine,alpha-adrenergic agonist midodrine
NEW17512,CHEMICAL,5-hydroxytryptamine agonist/antagonist dihydroergotamine,5-hydroxytryptamine agonist/antagonist dihydroergotamine
NEW17513,CHEBI,5-ht antagonist cyproheptadine,5-HT antagonist cyproheptadine
NEW17514,DISEASE,precede viral infection,preceding viral infection
NEW17515,MENTAL_HEALTH,precede viral infection,new depression episode
NEW17516,CHEBI,chronic opioid analgesic use,chronic opioid analgesic use
NEW17517,MENTAL_HEALTH,postoperative analgesia,Postoperative analgesia
NEW17518,CHEBI,postoperative analgesia,analgesic acetaminophen/ibuprofen medication use
D014736,DISEASE,Vibrio parahaemolyticus,Pasteurella parahaemolytica|Beneckea parahaemolytica|Vibrio parahaemolyticus|Oceanomonas parahaemolytica
http://purl.obolibrary.org/obo/NCBITaxon_6687,NUTRITION,penaeus monodon,shrimp Litopenaeus
NEW17519,MENTAL_HEALTH,migraine dialysis headache subgroup,migraine dialysis headache subgroups
NEW17520,CHEMICAL,boron substitution,boron substitution
NEW17521,CHEMICAL,exocyclic b-o-n linkage,exocyclic B-O-N linkage
NEW17522,MENTAL_HEALTH,exocyclic b-o-n linkage,surprising hydrolytic resistance
NEW17523,DISEASE,exocyclic b-o-n linkage,addiction behaviors
NEW17524,CHEMICAL,plasma oxytocin level,plasma oxytocin level
NEW17525,MENTAL_HEALTH,plasma oxytocin level,heroin craving
NEW17526,CHEMICAL,ttx level,TTX levels
NEW17527,CHEMICAL,ttx level,TTX ELISA
NEW17528,CHEBI,nicotine agonist,Nicotine agonists
D003093,DISEASE,"Colitis, Ulcerative","Inflammatory Bowel Disease, Ulcerative Colitis Type|ulcerative colitis|Colitis Gravis|Ulcerative Colitis|Idiopathic Proctocolitis"
NEW17529,CHEMICAL,nmda receptor agonist quinolinic acid,NMDA receptor agonist quinolinic acid
NEW17530,CHEMICAL,nmda receptor agonist quinolinic acid,kynurenine metabolite levels
D018869,DISEASE,Heat-Shock Response,"Heat-Shock Reaction|Heat Stress Reaction|Heat-Stress Reactions|Stress, Heat|Heat Shock Stress|Heat Stresses|Heat shock response|Heat Stress|Shock, Heat|Heat-Stress Responses|Stress, Heat Shock|Heat Shock Stresses|Heat-Stress Reaction|Heat Shock Reaction|Heat Stress Response|Heat Shocks|Heat-Shock Reactions|Heat Shock Response|Heat-Stress Response|Heat-Shock Responses|Heat Shock"
C529323,CHEMICAL,"Naxe protein, mouse [Supplementary Concept]",Phosphoproteins|Racemases and Epimerases|NAXE|APOA1BP
NEW17531,DISEASE,nmda receptor agonist quinolinic acid,infantile neurometabolic disease
NEW17532,DISEASE,nmda receptor agonist quinolinic acid,fluctuating disease course
NEW17533,CHEMICAL,glutamatergic n-methyl-d-aspartate receptor antagonist ketamine,glutamatergic N-methyl-D-aspartate receptor antagonist ketamine
NEW17534,DISEASE,moderate accidental trauma,moderate accidental trauma
D015651,DISEASE,Mycotoxicosis,"Poisonings, Fungus|Poisoning, Fungus|Mycotoxicoses|Fungus Poisoning|mycotoxicosis|Fungus Poisonings"
NEW17535,CHEMICAL,moderate accidental trauma,equine practice
NEW17536,DISEASE,moderate accidental trauma,colic cases
D000071438,DISEASE,Fatty Acid-Binding Protein 7,"Mammary Derived Growth Inhibitor Related Protein|Fatty Acid Binding Protein, Brain|Fatty Acid Binding Protein 7|Lipid-Binding Protein, Brain|Brain Lipid-Binding Protein|fatty acid binding protein|fatty acid-binding protein|Brain Lipid Binding Protein|Fatty Acid-Binding Protein, Brain|Mammary-Derived Growth Inhibitor Related Protein"
NEW17537,DISEASE,moderate accidental trauma,SNpc impairments
NEW17538,DISEASE,moderate accidental trauma,αSyn neurotoxicity
NEW17539,CHEBI,intracellular fatty acid carrier protein,intracellular fatty acid carrier protein
NEW17540,CHEMICAL,electroacupuncture treatment,electroacupuncture treatment
NEW17541,CHEBI,electroacupuncture treatment,positive analgesic effects
NEW17542,CHEMICAL,maternal tobacco smoking,Maternal tobacco smoking
NEW17543,CHEMICAL,maternal tobacco smoking,developmental nicotine exposure
NEW17544,CHEMICAL,alpha-5 nicotinic acetylcholine receptor subunit,alpha-5 nicotinic acetylcholine receptor subunit
NEW17545,DISEASE,alpha-5 nicotinic acetylcholine receptor subunit,DNE|developmental nicotine exposure
http://purl.obolibrary.org/obo/CHEBI_15857,CHEMICAL,5-l-glutamyl amino acid,L-gamma-glutamyl amino acid|N(alpha)-(L-gamma-glutamyl) amino acid|5-L-Glutamyl amino acid|L-gamma-Glutamyl amino acid|amino acid position
D057055,CHEMICAL,Aspartic Acid Proteases,"Aspartyl Proteinases|Aspartic Proteinases|Aspartic Proteinase|Acid Proteinase, Aspartic|Proteinase, Aspartic|Aspartic Acid Proteinases|Proteinases, Aspartic|Protease, Aspartyl|Aspartyl Protease|Acid Protease, Aspartic|Aspartyl Proteases|Proteases, Aspartyl|Proteases, Aspartic Acid|Aspartyl Proteinase|Aspartic Acid Proteinase|Aspartic Acid Protease|Acid Proteases, Aspartic|Proteinases, Aspartic Acid|Proteinases, Aspartyl|aspartic acid|Proteinase, Aspartic Acid|Proteinase, Aspartyl|Protease, Aspartic Acid"
NEW17546,CHEMICAL,asparagine substitution,asparagine substitution
NEW17547,CHEMICAL,chrna5 single nucleotide polymorphism snp rs16969968,CHRNA5 single nucleotide polymorphism SNP rs16969968
NEW17548,DISEASE,female central precocious puberty patient,female central precocious puberty patients
D008719,CHEMICAL,Methiothepin,"Methiothepin Maleate|Methiothepine|Metitepine|Maleate, Methiothepin|methiothepin"
NEW17549,CHEMICAL,dom nm. dissociation constant,DOM nM. dissociation constant
C045918,CHEMICAL,2-methyl-5-HT [Supplementary Concept],Serotonin/analogs  and  derivatives|2-methyl-5-HT
NEW17550,CHEMICAL,nm dopamine,nM dopamine
NEW17551,CHEMICAL,[3h]spiperone,[3H]spiperone
C011639,CHEMICAL,ADTN [Supplementary Concept],Tetrahydronaphthalenes|ADTN
NEW17552,CHEBI,act μ-opiate antagonist,acting μ-opiate antagonists
NEW17553,CHEMICAL,rapid antidepressant effect,Rapid antidepressant effects
NEW17554,CHEMICAL,n-methyl-d-aspartate glutamate-receptor antagonist,N-methyl-D-aspartate glutamate-receptor antagonists
NEW17555,MENTAL_HEALTH,n-methyl-d-aspartate glutamate-receptor antagonist,bipolar disorder depression
NEW17556,CHEMICAL,glx glutamate,Glx glutamate
NEW17557,CHEMICAL,glx glutamate,ketamine dose
NEW17558,CHEBI,other endocrine abnormality,Other endocrine abnormalities
NEW17559,CHEBI,other endocrine abnormality,due growth hormone deficiency
NEW17560,DISEASE,hypothalamic-pituitary abnormality,hypothalamic-pituitary abnormalities
NEW17561,DISEASE,hypothalamic-pituitary abnormality,severe neutropenia
NEW17562,DISEASE,hypothalamic-pituitary abnormality,delayed diarrhea cholinergic syndrome
NEW17563,DISEASE,peritoneal metastasis,peritoneal metastasis
NEW17564,CHEMICAL,peritoneal metastasis,levofolinate calcium|FOLFIRI
D000068818,CHEMICAL,Cetuximab,IMC C225|C225|MAb C225|Erbitux|cetuximab|IMC-C225
NEW17565,DISEASE,peritoneal metastasis,irinotecan-induced cholinergic syndrome
D006986,CHEMICAL,Hypervitaminosis A,hypervitaminosis A|Vitamin A (1966-1986)
NEW17566,DISEASE,peritoneal metastasis,blurred vision
NEW17567,CHEMICAL,corrected calcium,corrected calcium
NEW17568,DISEASE,corrected calcium,ARF due rhabdomyolysis
NEW17569,MENTAL_HEALTH,myocardial resistance,myocardial resistance
D054059,DISEASE,Coronary Occlusion,"Coronary Occlusions|Occlusion, Coronary|Occlusions, Coronary|coronary occlusion"
NEW17570,MENTAL_HEALTH,heart resistance,heart resistance
NEW17571,DISEASE,accelerate liver fibrosis,Accelerated liver fibrosis
NEW17572,DISEASE,accelerate liver fibrosis,chronic hepatitis C patients
NEW17573,DISEASE,frequent hepatic decompensation event,frequent hepatic decompensation events
NEW17574,DISEASE,Protocadherin female limited epilepsy,Protocadherin female limited epilepsy
NEW17575,DISEASE,Protocadherin female limited epilepsy,onset epilepsy syndrome
NEW17576,CHEMICAL,PCDH19-FE mim300088,PCDH19-FE MIM300088
http://purl.obolibrary.org/obo/CHEBI_35482,CHEBI,opioid analgesic,narcotic analgesics|opioid analgesics|opioid analgesic drugs|narcotics|narcotic analgesic|narcotic
NEW17577,DISEASE,(hypo)manic,(hypo)manic
D000090983,CHEMICAL,2019-nCoV Vaccine mRNA-1273,"mRNA-1273.211|TAK 919|COVID-19 Vaccine Moderna|Moderna COVID 19 Vaccine|M-1273|COVID 19 Vaccine Moderna|M1273|2019 nCoV Vaccine mRNA 1273|Moderna COVID-19 Vaccine|COVID-19 Vaccine, Moderna|Moderna COVID 19 Vaccine RNA|Elasomeran|M 1273|mRNA-1273|TAK919|mRNA-1273, 2019-nCoV Vaccine|Vaccine, Moderna COVID-19|mRNA 1273.211|Moderna, COVID-19 Vaccine|Moderna COVID-19 Vaccine RNA|mRNA 1273|TAK-919"
NEW17578,DISEASE,moderate-to-severe psoriatic patient,moderate-to-severe psoriatic patients
D001905,CHEBI,Botulinum Toxins,"Clostridium botulinum Toxins|Botulin|Toxin, Botulinum|Botulinum Neurotoxin|Botulinum Toxin|Toxins, Clostridium botulinum|Neurotoxin, Botulinum|Botulinum Neurotoxins|Botulinum neurotoxins|Neurotoxins, Botulinum|Toxins, Botulinum"
D048568,DISEASE,Clostridium botulinum type G,Clostridium botulinum|Clostridium botulinum G
NEW17579,CHEMICAL,hypocapnic csa,hypocapnic CSA
NEW17580,DISEASE,chronic sci patient,chronic SCI patients
NEW17581,CHEMICAL,co2 reserve,CO2 reserve
NEW17582,DISEASE,hypocapnic central apnea,hypocapnic central apnea
NEW17583,DISEASE,mild metabolic acidosis,mild metabolic acidosis
D054020,CHEMICAL,"Lasers, Gas","Lasers, Helium|Vapor Lasers, Gold|Xenon Ion Laser|HeNe Laser|Gold Vapor Lasers|Argon Ion Lasers|Laser, CO2|HeNe Lasers|Lasers, HeNe|Laser, Metal Vapor|Nitrogen Laser|Xenon Ion Lasers|Lasers, CO2|Lasers, Nitrogen|Ion Laser, Argon|Helium Laser|Laser, Helium|Lasers, Helium Neon Gas|Vapor Laser, Metal|Lasers, Metal Vapor|Helium Neon Gas Lasers|Gold Vapor Laser|Laser, Gold Vapor|Vapor Laser, Gold|Lasers, Gold Vapor|Laser, Copper Vapor|Nitrogen Lasers|Ion Laser, Xenon|Helium Lasers|Vapor Lasers, Metal|Laser, HeNe|Laser, Nitrogen|Gas Laser|Vapor Lasers, Copper|Laser, Gas|Gas Lasers|Laser, Carbon Dioxide|Lasers, Copper Vapor|Ion Lasers, Xenon|Lasers, Argon Ion|Copper Vapor Lasers|Metal Vapor Laser|Lasers, Carbon Dioxide|Dioxide Laser, Carbon|Laser, Argon Ion|Dioxide Lasers, Carbon|CO2|Copper Vapor Laser|Carbon Dioxide Lasers|Laser, Xenon Ion|Vapor Laser, Copper|Metal Vapor Lasers|Ion Lasers, Argon|CO2 Laser|Carbon Dioxide Laser|Lasers, Xenon Ion|Argon Ion Laser|CO2 Lasers"
NEW17584,DISEASE,spontaneous central apnea,spontaneous central apnea
NEW17585,DISEASE,plant gain,plant gain
NEW17586,DISEASE,hypocapnic central apnea due,hypocapnic central apnea due
NEW17587,CHEMICAL,nocturnal oxygen saturation,nocturnal oxygen saturation
NEW17588,CHEMICAL,high-dose acetazolamide,high-dose acetazolamide
NEW17589,DISEASE,high-dose acetazolamide,cervical spinal cord injury
NEW17590,DISEASE,high-dose acetazolamide,central SDB
NEW17591,CHEBI,endocrine factor,Endocrine factors
NEW17592,CHEMICAL,eulophia macrobulbon,Eulophia macrobulbon
C050767,CHEMICAL,hydroxypropyl distarch phosphate [Supplementary Concept],HDP|Hydroxyethyl Starch Derivatives/analogs  and  derivatives|hydroxypropyl distarch phosphate
NEW17593,CHEMICAL,oral myo-inositol,Oral myo-inositol
D000426,CHEMICAL,Alcohol Dehydrogenase,"Alcohol Dehydrogenase, Yeast|Alcohol Dehydrogenase (NAD+)|Yeast Alcohol Dehydrogenase|Oxidoreductase, Alcohol-NAD+|Dehydrogenase, Yeast Alcohol|Alcohol Dehydrogenase II|alcohol dehydrogenase|Dehydrogenase, Alcohol|Alcohol NAD+ Oxidoreductase|Alcohol Dehydrogenase I|Alcohol-NAD+ Oxidoreductase"
NEW17594,NUTRITION,chronic alcohol abuse,fatty acid ethyl esters
NEW17595,CHEMICAL,chronic alcohol abuse,FAEEs|ethanol to fatty acid ethyl esters
NEW17596,DISEASE,chronic alcohol abuse,ethanol-induced pancreatic injury
NEW17597,CHEMICAL,repetitive ethanol intoxication,repetitive ethanol intoxication
NEW17598,DISEASE,repetitive ethanol intoxication,non-apoptotic neurodegenerative processes
NEW17599,DISEASE,repetitive ethanol intoxication,selective neurodegeneration
NEW17600,DISEASE,repetitive ethanol intoxication,trauma-like brain edema
C537889,CHEMICAL,Pfeiffer Palm Teller syndrome [Supplementary Concept],"Abnormalities, Multiple|Teller|Dental Enamel Hypoplasia|Joint Diseases|Facies|Growth Disorders"
NEW17601,CHEMICAL,repetitive ethanol intoxication,N-terminal truncated soluble 3kD
NEW17602,MENTAL_HEALTH,repetitive ethanol intoxication,Down Syndrome brain
NEW17603,DISEASE,idiopathic short stature,idiopathic short stature
NEW17604,CHEMICAL,injectable recombinant human (rh)igf-i,Injectable recombinant human (rh)IGF-I|mecasermin
C566531,MENTAL_HEALTH,Pseudoacromegaly with Severe Insulin Resistance [Supplementary Concept],Acromegaly|Insulin Resistance|severe insulin resistance
NEW17605,DISEASE,cognitive abnormality,cognitive abnormalities
NEW17606,DISEASE,hypersomnia due drug,hypersomnia due drug
http://purl.obolibrary.org/obo/DOID_9207,DISEASE,periodic limb movement disorder,nocturnal myoclonus|periodic leg movement disorders
NEW17607,CHEMICAL,exogenous atp,exogenous ATP
NEW17608,CHEMICAL,exogenous atp,elevated intracellular calcium responses
NEW17609,CHEMICAL,exogenous atp,intracellular calcium elevations
NEW17610,DISEASE,exogenous atp,diverse cancers
NEW17611,DISEASE,exogenous atp,metastasis tumor growth
NEW17612,CHEBI,gonadotropin-releasing hormone analogue,Gonadotropin-releasing hormone analogues
NEW17613,DISEASE,gonadotropin-releasing hormone analogue,premature luteinizing hormone
NEW17614,CHEBI,conventional gnrh antagonist protocol,Conventional GnRH antagonist protocols
NEW17615,DISEASE,conventional gnrh antagonist protocol,controlled ovarian hyperstimulation
NEW17616,DISEASE,p. plecoglossicida,P. plecoglossicida
NEW17617,NUTRITION,p. plecoglossicida,large yellow croaker|Larimichthys crocea
D036441,NUTRITION,Osmeriformes,Smelt|ayu|Galaxiidae|Galaxiid|Ayu|Plecoglossus altiveli|Galaxias maculatus|Plecoglossidae|Osmeridae|Smelts|Plecoglossinae|Galaxiids|Plecoglossus altivelis
NEW17618,DISEASE,spleen granuloma,spleen granulomas
D005218,DISEASE,Fat Necrosis,"fat necrosis|Necrosis, Fat|Steatonecroses|Fat Necroses|Steatonecrosis"
NEW17619,DISEASE,spleen granuloma,days infection b liver steatosis
NEW17620,MENTAL_HEALTH,spleen granuloma,binary logistic regression analysis
D015675,CHEMICAL,Osteocalcin,"4-Carboxyglutamic Protein, Bone|Calcium Binding Protein, Vitamin K Dependent|Vitamin K Dependent Bone Protein|4 Carboxyglutamic Protein, Bone|Protein, Bone Gla|Protein, Bone 4-Carboxyglutamic|Bone Gla Protein|Calcium-Binding Protein, Vitamin K-Dependent|Vitamin K-Dependent Bone Protein|ucOC|Bone gamma-Carboxyglutamic Acid Protein|Bone 4-Carboxyglutamic Protein|Bone gamma Carboxyglutamic Acid Protein|Gla Protein, Bone|osteocalcin"
NEW17621,MENTAL_HEALTH,spleen granuloma,impaired orientation
NEW17622,CHEBI,spleen granuloma,vitamin K evaluation
C482445,DISEASE,"Npc1l1 protein, mouse [Supplementary Concept]",C1-like|Membrane Transport Proteins
NEW17623,NUTRITION,spleen granuloma,biliary cholesterol
NEW17624,CHEBI,hormone hypothalamic-pituitary-adrenal axis hormone,hormones hypothalamic-pituitary-adrenal axis hormones
NEW17625,DISEASE,hormone hypothalamic-pituitary-adrenal axis hormone,poorer cognitive functioning
NEW17626,MENTAL_HEALTH,multiple regression analysis,Multiple regression analyses
NEW17627,MENTAL_HEALTH,multiple regression analysis,ADHD severity
NEW17628,CHEMICAL,cortisol diurnal slope,cortisol diurnal slope
NEW17629,CHEBI,hpa axis hormone level,HPA axis hormone levels
NEW17630,CHEBI,estrogen metabolite,estrogen metabolites
NEW17631,CHEMICAL,estrogen metabolite,OHE1|4-hydroxylation estrone
D004970,CHEMICAL,Estrone,"Unigen|Folliculin (Hormone)|Estrone, (+-)-Isomer|Estrone, (9 beta)-Isomer|Estrovarin|Wehgen|Kestrone|estrone|Estrone, (8 alpha)-Isomer"
NEW17632,CHEBI,estrogen hydroxylation pathway,estrogen hydroxylation pathway
NEW17633,MENTAL_HEALTH,estrogen hydroxylation pathway,nociceptor hyperactivity
NEW17634,CHEBI,endocrine hormone,axis hormones
NEW17635,DISEASE,ra derivative,RA derivatives
NEW17636,DISEASE,ra derivative,RA dimer
NEW17637,CHEMICAL,cystine importer-overexpressing strain,cystine importer-overexpressing strain
NEW17638,DISEASE,s. platensis extract,S. platensis extract
C053099,NUTRITION,"allantoin, heparin, onion extract drug combination [Supplementary Concept]",Heparin|Allantoin|onion|Plant Extracts|Drug Combinations
NEW17639,DISEASE,endophyte nitrogen-fixing p. stutzeri,endophyte nitrogen-fixing P. stutzeri
NEW17640,CHEMICAL,asmsrb-rnai hairy root,AsMsrB-RNAi hairy roots
NEW17641,DISEASE,asmsrb-rnai hairy root,infection threads
NEW17642,CHEMICAL,asmsrb,AsMsrB
NEW17643,DISEASE,premature adrenarche,premature adrenarche
NEW17644,CHEBI,premature adrenarche,exaggerated androgen synthesis
C536845,CHEBI,Familial hypersecretion of adrenal androgens [Supplementary Concept],Adrenocortical Hyperfunction|adrenal androgens
NEW17645,CHEMICAL,premature adrenarche,dopamine precursor levodopa
NEW17646,CHEMICAL,striatal dopamine d5 receptor,striatal dopamine D5 receptor
NEW17647,CHEBI,partial d5 receptor agonist,partial D5 receptor agonist
NEW17648,DISEASE,partial d5 receptor agonist,significant dyskinetic movements
NEW17649,DISEASE,partial d5 receptor agonist,dyskinetic behavior
C080703,CHEMICAL,SK and F 83959 [Supplementary Concept],"2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/analogs  and  derivatives|SKF-83959"
NEW17650,CHEMICAL,metoclopramide side effect related,Metoclopramide side effects related
NEW17651,MENTAL_HEALTH,resistance exercise,Resistance exercise
NEW17652,DISEASE,resistance exercise,glutamate-induced memory impairment
NEW17653,CHEBI,flavour enhancer,flavour enhancer
NEW17654,CHEMICAL,excessive food additive monosodium glutamate,MSG|Excessive food additives Monosodium glutamate
NEW17655,DISEASE,excessive food additive monosodium glutamate,interspecific hybrid sterility
NEW17656,NUTRITION,excessive food additive monosodium glutamate,rice genotypes
C484246,CHEMICAL,"DTC1 protein, Oryza sativa [Supplementary Concept]",Plant Proteins|O. sativa|Isomerases
NEW17657,MENTAL_HEALTH,resistance quantitative trait locus,resistance quantitative trait locus
NEW17658,CHEMICAL,gabrg2 gaba a receptor subunit gamma2 polymorphism,GABRG2 GABA A receptor subunit gamma2 polymorphism
NEW17659,CHEMICAL,rs7713917 a g snp,rs7713917 A G SNP
NEW17660,CHEMICAL,rs7713917 a g snp,1000-fold excess estradiol-17 beta
NEW17661,CHEMICAL,high-dose trimethoprim-sulfamethoxazole,high-dose trimethoprim-sulfamethoxazole
NEW17662,MENTAL_HEALTH,high-dose trimethoprim-sulfamethoxazole,hypothyroid-induced central nervous system depression
NEW17663,CHEMICAL,analog n-oleoylalanine,OlAla|analog N-Oleoylalanine
NEW17664,CHEMICAL,endogenous amide n-oleoylglycine,OlGly|endogenous amide N-Oleoylglycine
NEW17665,CHEBI,endogenous amide n-oleoylglycine,antimicrobials active
http://purl.obolibrary.org/obo/DOID_0090070,DISEASE,hypogonadotropic hypogonadism,congenital idiopathic hypogonadotropic hypogonadism|isolated hypogonadotropic hypogonadism|hypogonadotropism|isolated congenital gonadotropin deficiency
NEW17666,DISEASE,anorexic patient,anorexic patients
D008303,DISEASE,Malignant Carcinoid Syndrome,"Carcinoid Syndromes, Malignant|Malignant Carcinoid Syndromes|Syndromes, Malignant Carcinoid|carcinoid syndrome|Carcinoid Syndrome, Malignant|Syndrome, Malignant Carcinoid"
NEW17667,CHEMICAL,excessive dietary leucine intake,excessive dietary leucine intake
C565923,DISEASE,"Aural Atresia, Multiple Congenital Anomalies, and Mental Retardation [Supplementary Concept]","multiple congenital anomalies|Abnormalities, Multiple|Intellectual Disability|Ear Canal/abnormalities"
NEW17668,CHEMICAL,excessive dietary leucine intake,progestogen/estrogen compound
NEW17669,CHEBI,dose thyroid hormone,dosing thyroid hormone
NEW17670,MENTAL_HEALTH,dose thyroid hormone,polyneuropathy syndromes
D008324,DISEASE,"Mammary Tumor Virus, Mouse","mammary cancer|Mammary Cancer Virus|Mammary Tumor Viruses, Mouse|Mouse mammary tumor virus|Bittner Virus"
D017313,CHEMICAL,Fenretinide,"4-HPR|N-(4-Hydroxyphenyl)-trans-Retinamide|Fenretinide, 13 cis Isomer|13-cis-Isomer Fenretinide|N-(4-Hydroxyphenyl)retinamide|MCN-R-1967|MCNR1967|Fenretinide, 13-cis-Isomer|4 Hydroxyphenylretinamide|4-Hydroxyphenylretinamide|Fenretinimide|MCN R 1967"
NEW17671,DISEASE,dose thyroid hormone,esophageal tumors
NEW17672,DISEASE,dose thyroid hormone,esophageal lesions
NEW17673,DISEASE,dose thyroid hormone,spontaneous thymic lymphomas
NEW17674,DISEASE,forestomach carcinoma,forestomach carcinomas
NEW17675,CHEMICAL,c3h-a(vy mouse,C3H-A(vy mice
NEW17676,DISEASE,c3h-a(vy mouse,amnesic effect
NEW17677,DISEASE,c3h-a(vy mouse,amnesic effects
http://purl.obolibrary.org/obo/CHEBI_135598,CHEMICAL,tetrofosmin,99m-technetium methoxyisobutylisonitrile
NEW17678,DISEASE,localized tumor,localized tumor
http://purl.obolibrary.org/obo/CHEBI_48525,CHEMICAL,calcimimetic,calcimimetics
C085911,CHEMICAL,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one [Supplementary Concept],LY294002|Chromones|Morpholines
NEW17679,DISEASE,phosphatidylinositol 3‑kinase/v‑akt murine thymoma viral oncogene homologue,phosphatidylinositol 3‑kinase/v‑akt murine thymoma viral oncogene homologue
NEW17680,DISEASE,contralateral limb,contralateral limbs
NEW17681,CHEMICAL,n-6/3 pufa ratio,n-6/3 PUFA ratio
NEW17682,CHEMICAL,pufa ratio,PUFA ratio
NEW17683,CHEMICAL,pufa ratio,erythrocyte sphingomyelin
NEW17684,NUTRITION,pufa ratio,erythrocyte phospholipid species
NEW17685,NUTRITION,pufa ratio,phosphatidylethanolamine concentrations
NEW17686,CHEMICAL,tension-frequency relationship,tension-frequency relationship
NEW17687,CHEMICAL,cel treatment,CEL treatment
NEW17688,CHEMICAL,cel treatment,intracellular reactive oxygen species levels
NEW17689,MENTAL_HEALTH,cannabis use,vivid hallucinations
NEW17690,DISEASE,cdk4/6 inhibitor,oestrogen receptor-positive ER+ HER2-negative breast cancer
NEW17691,MENTAL_HEALTH,disease dependence,disease dependence
NEW17692,CHEMICAL,cannabis product,Cannabis products
NEW17693,CHEMICAL,s-oxazepam,S-oxazepam
NEW17694,MENTAL_HEALTH,low peripheral resistance,low peripheral resistance
NEW17695,NUTRITION,low peripheral resistance,large bore capillaries
NEW17696,CHEMICAL,hypoglycemic activity,Hypoglycemic activity
NEW17697,DISEASE,hypoglycemic activity,diabetic rat model
NEW17698,MENTAL_HEALTH,hypoglycemic activity,complete resistance
NEW17699,CHEBI,addition estrogen deficiency,addition estrogen deficiency
NEW17700,DISEASE,addition estrogen deficiency,frequency infection
NEW17701,DISEASE,addition estrogen deficiency,vaginal atrophy
NEW17702,DISEASE,androgen deficiency,diminished sexual desire
NEW17703,DISEASE,diabetic sponge cake,diabetic sponge cakes
NEW17704,DISEASE,brain matter myelin abnormality,Brain matter myelin abnormalities
NEW17705,NUTRITION,cell membrane fatty acid abnormality,cell membrane fatty acid abnormalities
NEW17706,CHEBI,certain b vitamin,certain B vitamins
NEW17707,CHEBI,il-4 agonist administration,IL-4 agonist administration
NEW17708,DISEASE,il-4 agonist administration,relevant mouse stroke model
NEW17709,DISEASE,il-4 agonist administration,ischemic stroke treatment
NEW17710,NUTRITION,circulate lecithin,circulating lecithin
NEW17711,DISEASE,circulate lecithin,SDAT patients
D041603,CHEMICAL,Pinus taeda,"loblolly pine|Pine, Loblolly|taeda, Pinus|Loblolly Pine|Pines, Loblolly|Loblolly Pines|Pinus taedas"
NEW17712,DISEASE,circulate lecithin,late-stage LP female gametophytes
NEW17713,CHEMICAL,• anionic molecule inhibitory,• anionic molecule inhibitory
NEW17714,CHEMICAL,• exact mass,• Exact mass
C068271,CHEMICAL,inositol hexakisphosphate receptor [Supplementary Concept],"Receptors, Cytoplasmic and Nuclear|inositol hexakisphosphate"
NEW17715,MENTAL_HEALTH,mass spectrometry ms-ms fragmentation,mass spectrometry MS-MS fragmentation
NEW17716,CHEBI,potent act nachr antagonist,potent acting nAChR antagonist
NEW17717,DISEASE,fibrosis rat,fibrosis rats
NEW17718,CHEMICAL,advanced pulmonary fibrosis stage,advanced pulmonary fibrosis stage|M21-M28
C511383,CHEMICAL,"2,6-dihydroxy-3,4-dimethylbenzoic acid methyl ester [Supplementary Concept]","Hydroxybenzoates|3,4-dimethylbenzoic acid"
C001317,CHEMICAL,gamma-guanidinobutyric acid [Supplementary Concept],4-guanidinobutyric acid|Guanidines
NEW17719,DISEASE,Shuangshen Pingfei Formula,SSPF|Shuangshen Pingfei Formula
NEW17720,CHEMICAL,serine acid,Serine acids
NEW17721,NUTRITION,serine acid,familial lecithin cholesterol acyltransferase deficiency
NEW17722,DISEASE,serine acid,rare lipid disorder
NEW17723,DISEASE,abnormal lipoprotein,abnormal lipoprotein
NEW17724,CHEMICAL,aluminum exposure,aluminum exposure
NEW17725,CHEMICAL,dopaminergic d2 antagonist haloperidol,dopaminergic D2 antagonist haloperidol
NEW17726,DISEASE,dopaminergic d2 antagonist haloperidol,disease bradykinesia
http://purl.obolibrary.org/obo/PR_Q9XZT6,CHEMICAL,deoxynucleoside kinase (fruit fly),fly-tk2|dnk|multispecific deoxynucleoside kinase (fruit fly)|deoxynucleosides|deoxyribonucleoside kinase (fruit fly)|cg5452|dm-dnk
NEW17727,NUTRITION,corresponding triphosphate,corresponding triphosphates
NEW17728,CHEMICAL,adrenal steroid synthesis pathway protein,adrenal steroid synthesis pathway proteins
NEW17729,NUTRITION,methionine positron emission tomography,Methionine positron emission tomography
NEW17730,DISEASE,methionine positron emission tomography,tumor invasion
NEW17731,CHEMICAL,methionine positron emission tomography,unconjugated phenylethylamine
NEW17732,DISEASE,methionine positron emission tomography,mood behaviour
NEW17733,NUTRITION,tryptophan level,tryptophan levels
NEW17734,NUTRITION,kg-1 trehalose,kg-1 trehalose
NEW17735,NUTRITION,kg-1 trehalose,trehalose transporter isoform X4
NEW17736,NUTRITION,kg-1 trehalose,trehalose transporter homolog isoform X2
NEW17737,NUTRITION,kg-1 trehalose,juvenile red claw crayfish
NEW17738,CHEMICAL,cqkpi,CqKPI
NEW17739,DISEASE,cqkpi,hwajinpoensis C. albicans
NEW17740,NUTRITION,typha angustifolia,Typha angustifolia
NEW17741,MENTAL_HEALTH,typha angustifolia,multi-linear regression model
D020260,CHEMICAL,"Heavy Metal Poisoning, Nervous System","heavy metals|Poisoning, Heavy Metals, Nervous System"
NEW17742,NUTRITION,typha angustifolia L.,Typha angustifolia L.
NEW17743,DISEASE,typha angustifolia L.,stranguria
NEW17744,DISEASE,typha angustifolia L.,postmenopausal estrogen-receptor positive breast cancer
NEW17745,CHEBI,typha angustifolia L.,only endocrine agent
NEW17746,CHEBI,selective estrogen receptor er modulator,selective estrogen receptor ER modulator
NEW17747,DISEASE,selective estrogen receptor er modulator,positive solid tumors
NEW17748,DISEASE,selective estrogen receptor er modulator,endocrine-refractory metastatic breast cancer
D001441,DISEASE,Bacteroides fragilis,Bacteroides fragilis|Bacteroides (1966-1975)
NEW17749,DISEASE,selective estrogen receptor er modulator,MDD microbiome
NEW17750,CHEMICAL,cerebral serotonin,cerebral serotonin
NEW17751,CHEMICAL,heartland bandavirus,Heartland bandavirus
NEW17752,CHEMICAL,IMPORTANCE Heartland bandavirus,HRTV|IMPORTANCE Heartland bandavirus
NEW17753,CHEMICAL,IMPORTANCE Heartland bandavirus,Dabie bandavirus
D000085142,DISEASE,Severe Fever with Thrombocytopenia Syndrome,"severe fever|SFTS Virus Infection|Severe Fever with Thrombocytopenia Syndrome Bunyavirus Infection|Virus Infection, SFTS|thrombocytopenia syndrome|SFTS Virus Infections|Infection, SFTS Virus"
NEW17754,DISEASE,IMPORTANCE Heartland bandavirus,gastrointestinal discomfort
C053539,CHEMICAL,penciclovir [Supplementary Concept],Guanine|penciclovir
NEW17755,CHEMICAL,Acyclovir 's main metabolite 9-carboxymethoxymethylguanine,Acyclovir's main metabolite 9-carboxymethoxymethylguanine
NEW17756,DISEASE,Acyclovir 's main metabolite 9-carboxymethoxymethylguanine,neurotoxic symptoms
NEW17757,DISEASE,Acyclovir 's main metabolite 9-carboxymethoxymethylguanine,impaired renal function
NEW17758,CHEBI,Acyclovir 's main metabolite 9-carboxymethoxymethylguanine,presumptive neurotoxin
D006606,DISEASE,Hiccup,|Hiccoughs|Hiccough|Hiccups|hiccups
NEW17759,CHEMICAL,schizophrenia pathophysiology,glutamate NMDA receptors
NEW17760,DISEASE,schizophrenia pathophysiology,hypersensitivity reactions
D064427,CHEBI,Nutritive Sweeteners,"Artificial Sweeteners, Nutritive|sweeteners|Sweeteners, Nutritive"
NEW17761,DISEASE,atopic child,allergenic adverse reactions
NEW17762,DISEASE,spleen t cell function,Spleen T cell function
NEW17763,CHEMICAL,spleen t cell function,ethanol-exposed 6-day pups
NEW17764,CHEMICAL,long-acting beta2-agonist,long-acting beta2-agonists
NEW17765,CHEMICAL,long-acting beta2-agonist,serum potassium concentration
NEW17766,DISEASE,long-acting beta2-agonist,paradoxical bronchospasm
NEW17767,CHEMICAL,lysine methylation,lysine methylation
NEW17768,DISEASE,lysine methylation,multiple neurodevelopmental disorders
NEW17769,CHEMICAL,lysine methylation,delta-opioid receptor-preferring agonist D-Ala2-D-Leu2-enkephalin|DADLE
C504157,CHEMICAL,Met-enkephalin-glycyl-tyrosine [Supplementary Concept],"Met-enkephalin|Enkephalin, Methionine/analogs  and  derivatives"
NEW17770,DISEASE,lysine methylation,tumor incidence
NEW17771,CHEMICAL,memory-enhancing acute potential,Memory-enhancing acute potentials
NEW17772,CHEBI,mixture b. monnieri,mixture B. monnieri
NEW17773,DISEASE,mixture b. monnieri,heart failure mortality
NEW17774,CHEBI,dopamine agonist agent,dopamine agonist agent
NEW17775,DISEASE,nutritional dermatosis,Nutritional dermatoses
NEW17776,MENTAL_HEALTH,nutritional dermatosis,population displacement
D000079685,CHEMICAL,Famine,famine|Hunger|Starvation
NEW17777,DISEASE,nutritional dermatosis,5-FU-induced injury
NEW17778,CHEMICAL,nutritional dermatosis,aspartate aminotransferase AST content
C030069,CHEMICAL,"spore-specific proteins, Bacillus [Supplementary Concept]",Bacterial Proteins|CSK22
NEW17779,MENTAL_HEALTH,nutritional dermatosis,dissociation pathways
NEW17780,DISEASE,baseline neuroticism,baseline neuroticism
NEW17781,DISEASE,baseline neuroticism,aggression aggression scores
NEW17782,DISEASE,questionnaire neuroticism,questionnaire neuroticism
NEW17783,DISEASE,questionnaire neuroticism,OAS-M aggression scores
NEW17784,DISEASE,questionnaire neuroticism,catatonic youngsters
NEW17785,MENTAL_HEALTH,questionnaire neuroticism,baseline anxiety scores
NEW17786,MENTAL_HEALTH,questionnaire neuroticism,VAMS anxiety subscale
NEW17787,CHEBI,questionnaire neuroticism,adrenal ascorbic acid
NEW17788,CHEMICAL,gal-3 gene deletion,Gal-3 gene deletion
NEW17789,CHEMICAL,gal-3 gene deletion,hippocampal GABA-AR2S
NEW17790,CHEMICAL,gal-3 deficiency,Gal-3 deficiency
NEW17791,CHEMICAL,n-ethyl-2-(1-ethyl-2-hydroxy-2-nitrosohydrazino)-ethanamine,NOC12|N-ethyl-2-(1-ethyl-2-hydroxy-2-nitrosohydrazino)-ethanamine
NEW17792,DISEASE,n-ethyl-2-(1-ethyl-2-hydroxy-2-nitrosohydrazino)-ethanamine,human neuroblastoma SH-SY5Y cell cultures
D030421,CHEMICAL,Peroxynitrous Acid,"Peroxynitrite|peroxynitrite|Peroxynitrites|Acid, Peroxynitrous|Peroxonitrite|Peroxynitrous Acids|Peroxonitrites|Peroxynitrous Acid, Potassium Salt|Acids, Peroxynitrous"
C002385,CHEMICAL,linsidomine [Supplementary Concept],3-morpholinosydnonimine|Molsidomine/analogs  and  derivatives
D020030,CHEMICAL,Nitric Oxide Donors,"Donor, Nitric Oxide|Oxide Donor, Nitric|Donors, Nitric Oxide|nitric oxide donor|Nitric Oxide Donor|Oxide Donors, Nitric"
NEW17793,DISEASE,n-ethyl-2-(1-ethyl-2-hydroxy-2-nitrosohydrazino)-ethanamine,peroxynitrite-induced cell death
NEW17794,NUTRITION,n-ethyl-2-(1-ethyl-2-hydroxy-2-nitrosohydrazino)-ethanamine,phosphatidylserine synthase gene
D014005,DISEASE,Tinea,"Trichophyton mentagrophytes Infection|Trichophyton mentagrophytes Infections|Trichophytosis|Infection, Trichophyton mentagrophytes|Dermatophytoses|Tinea Corporis|Epidermophytoses|Epidermophytosis|Dermatophytosis|dermatophytosis|Tineas|Trichophytoses|Ringworm"
NEW17795,CHEBI,n-ethyl-2-(1-ethyl-2-hydroxy-2-nitrosohydrazino)-ethanamine,new promising systemic antifungal drug
NEW17796,DISEASE,n-ethyl-2-(1-ethyl-2-hydroxy-2-nitrosohydrazino)-ethanamine,deep fungal infections
NEW17797,DISEASE,dietary-induced binge,dietary-induced binge
NEW17798,CHEMICAL,dietary-induced binge,central norepinephrine
NEW17799,CHEMICAL,dietary-induced binge,brain norepinephrine system
NEW17800,DISEASE,parkinson patient,Parkinson patients
NEW17801,CHEMICAL,l-dopa treatment,l-DOPA treatment
NEW17802,MENTAL_HEALTH,striatal projection neuron,striatal projection neurons
NEW17803,DISEASE,tremulous jaw movement,Tremulous jaw movements
NEW17804,CHEMICAL,tremulous jaw movement,acetylcholine agonist tacrine
NEW17805,CHEBI,tremulous jaw movement,dopamine antagonist pimozide
NEW17806,DISEASE,tremulous jaw movement,pimozide-induced TJM activity
C098657,CHEMICAL,"5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine [Supplementary Concept]",Triazoles|SCH58261|Pyrimidines
NEW17807,DISEASE,maladaptive personality symptom,maladaptive personality symptoms
NEW17808,DISEASE,whole plant,maximal electroshock seizure model
NEW17809,CHEMICAL,t20 diet,T20 diet
NEW17810,CHEMICAL,dopamine receptor availability related,dopamine receptor availability related
NEW17811,DISEASE,preventable death,preventable death
NEW17812,CHEMICAL,aluminium dust,aluminium dust
NEW17813,MENTAL_HEALTH,aluminium dust,pre-clinical mild cognitive disorder
NEW17814,DISEASE,aluminium dust,reactive gliosis
NEW17815,CHEMICAL,aluminium dust,Aβ1 42
D017135,CHEMICAL,Desogestrel,"13 Ethyl 11 methylene 18,19 dinor 17 alpha pregn 4 en 20 yn 17 ol|alpha-pregn-4-en-20-yn-17-ol, 13-Ethyl-11-methylene-18,19-dinor-17|Org2969|Cerazette|desogestrel|13-Ethyl-11-methylene-18,19-dinor-17 alpha-pregn-4-en-20-yn-17-ol|18,19-Dinorpregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-, (17alpha)-|Marvelon|Org-2969|Org 2969"
NEW17816,CHEMICAL,aluminium dust,oral contraceptive steroid preparations
NEW17817,CHEBI,aluminium dust,oestrogen ethinyloestradiol
C033273,CHEMICAL,Gestodene [Supplementary Concept],gestodene|Norpregnenes
C421822,CHEMICAL,7-methyl-norethisterone [Supplementary Concept],Norethindrone/analogs  and  derivatives|norethisterone
D016912,CHEMICAL,Levonorgestrel,"Microval|Mirena|levonorgestrel|Norgeston|l Norgestrel|Microlut|Norplant|D-Norgestrel|duofem|Norplant 2|NorLevo|Capronor|Norplant-2|18,19-dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(-)-|D Norgestrel|Norplant2|l-Norgestrel|Plan B|Cerazet|Vikela"
NEW17818,CHEMICAL,different progestogen,acetylenic steroids
NEW17819,CHEMICAL,different progestogen,EE2 2-hydroxylation
NEW17820,DISEASE,different progestogen,multiple sclerosis symptoms
NEW17821,CHEMICAL,nabiximol thc combination,Nabiximols THC combination
C008577,CHEMICAL,myricitrin [Supplementary Concept],Flavonoids|myricitrin
NEW17822,MENTAL_HEALTH,pathological gambling patient,pathological gambling patients
NEW17823,MENTAL_HEALTH,arnd characteristic,ARND characteristics
D009015,CHEMICAL,Morantel,"Morantel Tartrate|morantel|Paratect|Tartrate, Morantel"
NEW17824,CHEMICAL,arnd characteristic,contortus ACR-26/ACR-27 nAChRs
NEW17825,DISEASE,arnd characteristic,Parascaris equorum
NEW17826,CHEMICAL,"8-[3-[1-[(3-fluorophenyl)methyl]-4-piperidinyl]-1-oxopropyl]-1,2,5,6-tetrahydro-4h-pyrrolo[3,2,1-ij]quinolin-4-one","TAK-802|8-[3-[1-[(3-fluorophenyl)methyl]-4-piperidinyl]-1-oxopropyl]-1,2,5,6-tetrahydro-4H-pyrrolo[3,2,1-ij]quinolin-4-one"
NEW17827,CHEMICAL,intraoral sucrose,intraoral sucrose
NEW17828,DISEASE,intraoral sucrose,subsequent weight gain
NEW17829,DISEASE,intraoral sucrose,obesity risk
NEW17830,DISEASE,soilborne oomycete phytophthora cinnamomi-which,soilborne oomycete Phytophthora cinnamomi-which
NEW17831,NUTRITION,chestnut hybrid,chestnut hybrid
NEW17832,MENTAL_HEALTH,chestnut hybrid,inherited partial resistance
NEW17833,CHEMICAL,thyroid-abs,thyroid-Abs
D053379,CHEMICAL,Chromogranin A,"chromogranin|Secretory Protein, Parathyroid|CHGA Protein|Parathyroid Secretory Protein|Secretory Protein I, Parathyroid Gland"
NEW17834,CHEMICAL,acd/logp,ACD/LogP
NEW17835,CHEMICAL,androgen therapy,serum creatinine level
NEW17836,CHEMICAL,copper solution,copper solution
NEW17837,CHEMICAL,copper solution,urea creatinine levels
NEW17838,DISEASE,copper solution,intense gastrointestinal mild hemolysis
NEW17839,CHEMICAL,thiourea group,thiourea group
NEW17840,NUTRITION,thiourea group,thein binding affinity
NEW17841,MENTAL_HEALTH,compounds12a c displacement,compounds12a c displacement
http://purl.obolibrary.org/obo/CHEBI_16526,CHEMICAL,carbon dioxide,CARBON DIOXIDE|dioxidocarbon|R-744|E 290|methanedione|CO2|carbonic anhydride|[CO2]|carbon dioxide inhalation|E290|carbon dioxide|Carbon dioxide|E-290
NEW17842,DISEASE,focal bilateral amygdala damage,focal bilateral amygdala damage
NEW17843,CHEMICAL,isoproterenol infusion,Isoproterenol infusions
NEW17844,CHEBI,several dopaminergic agonist,Several dopaminergic agonists
NEW17845,CHEMICAL,ml417,ML417
NEW17846,DISEASE,ml417,movement scoring method
NEW17847,DISEASE,thymic carcinoid,Thymic carcinoid
NEW17848,DISEASE,thymic carcinoid,rare differentiated neuroendocrine neoplasm
NEW17849,DISEASE,abnormal mental behavior,abnormal mental behavior
NEW17850,CHEMICAL,abnormal mental behavior,elevated blood cortisol levels
NEW17851,DISEASE,dysregulate depressed function,dysregulated depressed function
NEW17852,CHEMICAL,dysregulate depressed function,tyrosine metabolism pathway
NEW17853,DISEASE,dysregulate depressed function,migraine rats
NEW17854,CHEMICAL,3-(4-hydroxyphenyl)pyruvate,3-(4-hydroxyphenyl)pyruvate
C583815,CHEMICAL,"methyl 3, 4-dihydroxyphenylacetate [Supplementary Concept]","3,4-dihydroxyphenylacetate|DOPAC|Phenylacetates"
D007014,DISEASE,Hypophosphatasia,Hypophosphatasias|HPP|Hypophosphatasia
D001712,CHEMICAL,Biperiden,"|Biperiden, 1R-(1 alpha,2 alpha(R*),4 alpha)-Isomer|Biperidene|alpha-Bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|Akineton|biperiden|Biperiden, 1S-(1 alpha,2 alpha(R*),4 alpha)-Isomer|Hydrochloride, Biperiden|Biperiden Hydrochloride"
NEW17855,CHEBI,sympathomimetic decongestant,sympathomimetic decongestants
NEW17856,MENTAL_HEALTH,sympathomimetic decongestant,nasal airway resistance
NEW17857,CHEBI,non-selective alpha-adrenoceptor agonist,non-selective alpha-adrenoceptor agonists
NEW17858,CHEMICAL,standard decongestant,standard decongestants
NEW17859,CHEBI,standard decongestant,nonselective alpha-adrenoceptor agonists
NEW17860,CHEBI,selective alpha(2)-adrenoceptor agonist,selective alpha(2)-adrenoceptor agonist
NEW17861,DISEASE,selective alpha(2)-adrenoceptor agonist,nasal congestion
NEW17862,DISEASE,selective alpha(2)-adrenoceptor agonist,infection-induced death
NEW17863,CHEMICAL,selective alpha(2)-adrenoceptor agonist,baseline binge-eating BE behavior
NEW17864,NUTRITION,fatty acid class,fatty acid classes
NEW17865,DISEASE,fatty acid class,diabetic VED
NEW17866,MENTAL_HEALTH,fatty acid class,lower hyperarousal
NEW17867,CHEBI,fatty acid class,allele carriers
NEW17868,DISEASE,fatty acid class,PTSD better spatial processing
NEW17869,DISEASE,parkinson 's syndrome,Parkinson's syndrome
NEW17870,MENTAL_HEALTH,parkinson 's syndrome,depression susceptibility
NEW17871,MENTAL_HEALTH,parkinson 's syndrome,headache attack
D016123,DISEASE,Campylobacter jejuni,Campylobacter fetus subsp. jejuni|C. jejuni|jejuni|Vibrio jejuni|Vibrio hepaticus
NEW17872,DISEASE,parkinson 's syndrome,congestive failure
NEW17873,CHEMICAL,pimavanserin inverse agonist,Pimavanserin inverse agonist
NEW17874,DISEASE,pimavanserin inverse agonist,maximum weight gain
NEW17875,DISEASE,pimavanserin inverse agonist,PIP syndrome
NEW17876,DISEASE,pimavanserin inverse agonist,premature apoptosis
NEW17877,CHEMICAL,combustion value,combustion values
NEW17878,CHEMICAL,combustion value,DF supplements
NEW17879,NUTRITION,combustion value,cholesterol content
NEW17880,NUTRITION,lr cholesterol,LR cholesterol
NEW17881,DISEASE,lr cholesterol,FXS group
NEW17882,NUTRITION,lr cholesterol,plasma cholesterol
NEW17883,NUTRITION,lrs cholesterol,LRs cholesterol
C039671,CHEMICAL,ciglitazone [Supplementary Concept],Thiazolidinediones|ciglitazone
D059585,DISEASE,G1 Phase Cell Cycle Checkpoints,"G1 Restriction Point|G1 Restriction Points|START Cell Cycle Checkpoint|Checkpoints, G1 Phase|Restriction Points, G1|G1 Cell Cycle Arrest|Cell-cycle arrest|Restriction Point, G1|G1 S Phase Cell Cycle Checkpoint|G1 Phase Checkpoints|G1-S Phase Cell Cycle Checkpoint|cell-cycle arrest|G1 Cell Cycle Checkpoints|G1 Phase Restriction Point|Checkpoint, G1 Phase|G1 Phase Checkpoint"
C078862,DISEASE,melanoma growth stimulating activity receptor [Supplementary Concept],"Receptors, Cytokine|melanoma growth"
NEW17884,CHEMICAL,lrs cholesterol,low ciglitazone concentrations
NEW17885,DISEASE,lrs cholesterol,human melanoma xenograft development
NEW17886,DISEASE,lrs cholesterol,melanoma treatment
NEW17887,CHEMICAL,thiazolidinedione tzd family,thiazolidinedione TZD family
NEW17888,DISEASE,due concomitant tonic pain,due concomitant tonic pain
NEW17889,DISEASE,due concomitant tonic pain,experimental pain model
NEW17890,DISEASE,phasic pain relief,phasic pain relief
NEW17891,CHEMICAL,phasic pain relief,narco-analgesic drug
NEW17892,CHEMICAL,da toxicosis,DA toxicosis
NEW17893,DISEASE,da toxicosis,severe tardive EPS
NEW17894,NUTRITION,Background lithium,Background Lithium
NEW17895,DISEASE,Background lithium,neuropathic pain rat models
NEW17896,DISEASE,Background lithium,painful cluster headaches
NEW17897,DISEASE,Background lithium,neuropathic mice
NEW17898,MENTAL_HEALTH,Background lithium,long-lasting analgesia
NEW17899,DISEASE,inflammation level,Inflammation levels
NEW17900,CHEBI,allergen binding,allergen binding
NEW17901,MENTAL_HEALTH,allergen binding,preferred orientation
NEW17902,MENTAL_HEALTH,dolutegravir resistance,dolutegravir resistance
NEW17903,DISEASE,dolutegravir resistance,viral fitness
NEW17904,NUTRITION,lithium administration,lithium administration
NEW17905,MENTAL_HEALTH,lithium administration,morphine-induced amnesia
NEW17906,CHEMICAL,up state,UP states
NEW17907,CHEMICAL,cholinergic-induced increase,cholinergic-induced increase
NEW17908,CHEMICAL,carbachol-induced csd inhibition,carbachol-induced CSD inhibition
NEW17909,CHEMICAL,carbachol-induced csd inhibition,preferential M1 muscarinic antagonist telenzepine
NEW17910,CHEMICAL,preferential m1 muscarinic agonist mcn-a-343,preferential M1 muscarinic agonist McN-A-343
NEW17911,NUTRITION,tree oil ρ-cymene,tree oil ρ-cymene
NEW17912,DISEASE,tree oil ρ-cymene,Gram-negative bacterium
NEW17913,DISEASE,tree oil ρ-cymene,SalmonellaTyphimurium
NEW17914,CHEMICAL,asp goal,ASP goals
NEW17915,CHEBI,severe hyperhomocysteinemia,B vitamin deficiency
NEW17916,CHEBI,recent b vitamin supplementation trial,Recent B vitamin supplementation trials
D020774,DISEASE,Pick Disease of the Brain,"Pick Disease|Atrophy, Lobar (Brain)|Picks Disease of Brain|Circumscribed Lobar Atrophy of the Brain|brain atrophy|Lobar Atrophies (Brain)|Atrophies, Lobar (Brain)|Lobar Atrophy of the Brain|Picks Disease|Lobar Atrophy Of Brain|Dementia with Lobar Atrophy and Neuronal Cytoplasmic Inclusions|Disease, Pick's|Brain Atrophy, Circumscribed Lobar|Pick Disease Of Brain|Lobar Atrophy (Brain)|Pick's Disease|Disease, Pick"
NEW17917,CHEBI,vitamin supplementation,vitamins supplementation
NEW17918,CHEMICAL,vitamin supplementation,plasma Hcy
NEW17919,CHEMICAL,vitamin supplementation,anti-ischemic interventions
NEW17920,MENTAL_HEALTH,drug effect,cycloheximide-induced amnesia
NEW17921,CHEMICAL,uncycle n-methyl scaffold,uncycled N-methyl scaffold
NEW17922,CHEMICAL,side chain procaine,side chain procaine
NEW17923,CHEMICAL,n-methyl scaffold,N-methyl scaffold
NEW17924,DISEASE,n-methyl scaffold,LA structure angioedema
D013134,CHEMICAL,Spiperone,Spiroperone|Spiroperidol|spiperone
NEW17925,MENTAL_HEALTH,n-methyl scaffold,displacement curves
NEW17926,CHEBI,selective serotonergic drug,selective serotonergic drugs
C018855,CHEMICAL,2-tert-butylhydroquinone [Supplementary Concept],Tert-butylhydroquinone|tBHQ|Hydroquinones
NEW17927,MENTAL_HEALTH,selective serotonergic drug,reactive species-mediated dissociation
NEW17928,CHEMICAL,selective serotonergic drug,GSH/ATP levels
NEW17929,CHEBI,novel cholinomimetic,novel cholinomimetics
NEW17930,DISEASE,novel cholinomimetic,cognitive endophenotypes
NEW17931,MENTAL_HEALTH,resistance heritability,Resistance heritability
NEW17932,NUTRITION,resistance heritability,sheepshead minnow
NEW17933,CHEMICAL,resistance heritability,male Mecp2-null mice
NEW17934,MENTAL_HEALTH,neocortical projection neuron,neocortical projection neurons
NEW17935,CHEMICAL,neocortical projection neuron,Mecp2-null heterozygous mice
NEW17936,CHEMICAL,ppar-α agonist fenofibrate,PPAR-α agonist fenofibrate
NEW17937,CHEMICAL,mdma challenge,MDMA challenge
NEW17938,CHEMICAL,mdma challenge,5-hydroxyhyptamine
NEW17939,CHEMICAL,mdma challenge,hypothalamic serotonin
NEW17940,MENTAL_HEALTH,mdma challenge,hyperactivity levels
D065148,DISEASE,Nicolau Syndrome,"Syndrome, Nicolau|Cutis Medicamentosa, Embolia|Nicolau's syndrome|Nicolau Livedoid Syndrome|Nicolau Livedoid Dermatitis|Nicolaus Syndrome|Syndrome, Nicolau's Livedoid|Syndrome, Nicolau's|Embolia Cutis Medicamentosa|Dermatitides, Livedo-like|Livedo-like Dermatitides|Livedoid Syndrome, Nicolau's|Nicolau's Livedoid Syndrome|Livedoid Dermatitis, Nicolau|Dermatitis, Livedo-like|Nicolaus Livedoid Syndrome|Nicolau's Syndrome|Medicamentosa, Embolia Cutis|Livedo like Dermatitis|Dermatitis, Nicolau Livedoid|Livedo-like Dermatitis"
NEW17941,DISEASE,mdma challenge,hemorrhagic patch
D004008,CHEMICAL,Diclofenac,"|Diclofenac Potassium|Diclonate P|GP-45,840|SR 38|Diclofenac Sodium|SR38|Feloran|Orthophen|diclofenac sodium|Ortofen|Novapirina|Voltaren|Dicrofenac|Diclofenac, Sodium|Voltarol|Orthofen|SR-38|GP 45,840|Dichlofenal|GP45,840|Sodium Diclofenac|Diclophenac"
NEW17942,CHEBI,lipophilic drug,lipophilic drug
D004620,DISEASE,"Embolism, Fat","Fat Embolisms|Fat Embolism Syndrome|fat embolism|Embolisms, Fat|Fat Embolism"
NEW17943,CHEBI,carotenoid degradation,carotenoid degradation
NEW17944,MENTAL_HEALTH,carotenoid degradation,one-step regression analysis
NEW17945,CHEMICAL,pah metabolite,PAH metabolites
NEW17946,MENTAL_HEALTH,pah metabolite,multivariate regression models
NEW17947,CHEMICAL,pah metabolite,ITC|isothermal titration calorimetry
NEW17948,DISEASE,induce aggregation/fibrillation,induced aggregation/fibrillation
NEW17949,NUTRITION,croceine croaker,croceine croaker
NEW17950,DISEASE,croceine croaker,anepithymia
NEW17951,CHEMICAL,swim bladder peptide fraction,swim bladder peptide fraction|SBP-III-3
C522605,DISEASE,"Cd99 protein, mouse [Supplementary Concept]",Cancer Research|12E7 Antigen
NEW17952,CHEMICAL,swim bladder peptide fraction,excessive LA
NEW17953,CHEBI,swim bladder peptide fraction,drug actions
NEW17954,DISEASE,swim bladder peptide fraction,current pandemic
http://purl.obolibrary.org/obo/CHEBI_36808,CHEMICAL,duloxetine hydrochloride,N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine hydrochloride|N-methyl-3-(naphthalen-1-yloxy)-3-(2-thienyl)propan-1-amine hydrochloride|Dapoxetine HCl
NEW17955,CHEMICAL,low-level developmental mehg,low-level developmental MeHg
NEW17956,DISEASE,low-level developmental mehg,sensory deficits
NEW17957,CHEMICAL,low-level developmental mehg,developmental MeHg
NEW17958,NUTRITION,mean mercury ingestion,mean mercury ingestion
NEW17959,CHEMICAL,mean mercury ingestion,µg Hg/kg·day
NEW17960,CHEMICAL,mean mercury ingestion,Hg/kg·day
C109476,CHEMICAL,epoxiconazole [Supplementary Concept],Epoxiconazole|Triazoles|Epoxy Compounds
NEW17961,CHEBI,binge episode,worldwide fungicide
D011129,DISEASE,Polyradiculoneuropathy,"Polyradiculoneuritis|Autoimmune Demyelinating Disease, Peripheral|Polyradiculoneuropathies|Peripheral Autoimmune Demyelinating Disease|Demyelinating Disease, Peripheral Autoimmune|demyelinating disease|Polyradiculoneuritides|Demyelinating Autoimmune Disease, Peripheral"
NEW17962,CHEMICAL,serum na level,serum Na level
NEW17963,DISEASE,serum na level,hyponatremic patients
NEW17964,MENTAL_HEALTH,transient mutism,Transient mutism
NEW17965,DISEASE,transient mutism,reversible bilateral symmetric hyperintensity
NEW17966,CHEMICAL,transient mutism,amphotericin B. Fluid-attenuated inversion recovery
NEW17967,CHEBI,transient mutism,antifungal prophylaxis
NEW17968,DISEASE,relative toxicity,relative toxicities
NEW17969,CHEMICAL,relative toxicity,IN-JT333 >
NEW17970,CHEMICAL,relative toxicity,IN-MK638 IN-MF014
NEW17971,DISEASE,visual function loss,visual function loss
NEW17972,CHEMICAL,visual function loss,antiglaucomatous eye
NEW17973,DISEASE,b. aegyptiaca gall,B. aegyptiaca galls
NEW17974,CHEMICAL,b. aegyptiaca gall,moderate xanthine oxidase inhibitory activity
NEW17975,MENTAL_HEALTH,intrathecal analgesia,intrathecal analgesia
NEW17976,CHEMICAL,capsaicin-sensitive adenosine release,capsaicin-sensitive adenosine release
NEW17977,CHEMICAL,extracellular adenosine availability,extracellular adenosine availability
NEW17978,CHEMICAL,extracellular adenosine availability,AK inhibitors
D012460,CHEMICAL,Sulfasalazine,|Sulfasalazin medac|Sulfasalazine FNA|Asulfidine|Colo Pleon|Azulfadine|sulphasalazine|Azulfidine EN|Salicylazosulfapyridine|ratio-Sulfasalazine|Sulfasalazin Heyl|Ucine|Azulfidine|Colo-Pleon|Sulphasalazine|Sulfasalazin-Heyl|Pyralin EN|Ulcol|sulfasalazine|ratio Sulfasalazine|Pleon|Salazosulfapyridine|Salazopyrin
NEW17979,DISEASE,extracellular adenosine availability,pain signalling
NEW17980,CHEMICAL,adenosine analog,Adenosine analogs
NEW17981,DISEASE,adenosine analog,human uterine progesterone receptors
NEW17982,CHEMICAL,tritium label cyproterone acetate,tritium labeled cyproterone acetate
NEW17983,CHEMICAL,tritium label cyproterone acetate,3H-progesterone
C486424,CHEMICAL,"Pgrmc1 protein, rat [Supplementary Concept]","Membrane Proteins|Receptors, Progesterone|progesterone receptor"
NEW17984,CHEMICAL,beta-estradiol oophorectomized animal,beta-estradiol oophorectomized animals
D019749,CHEMICAL,Sulfur-Sulfur Bond Isomerases,"Bond Isomerases, S-S|S44819|Sulfur Sulfur Bond Isomerases|S-S Bond Isomerases|9S|Isomerases, S-S Bond|sulfur|Bond Isomerases, Sulfur-Sulfur|S-8510|Isomerases, Sulfur-Sulfur Bond"
NEW17985,CHEMICAL,beta-estradiol oophorectomized animal,[3H]ORG binding moiety
NEW17986,DISEASE,tumor cytosol,Tumor cytosol
NEW17987,DISEASE,tumor cytosol,human ovarian carcinoma
NEW17988,CHEMICAL,cortical gaba content,cortical GABA content
NEW17989,CHEMICAL,covid-19 outcome,COVID-19 outcome
NEW17990,CHEMICAL,neuroendocrine dopamine release,neuroendocrine dopamine release
NEW17991,MENTAL_HEALTH,transendothelial electrical resistance,transendothelial electrical resistance
NEW17992,CHEMICAL,transendothelial electrical resistance,myosin light chain phosphorylation
NEW17993,DISEASE,human pulmonary artery endothelial cell,human pulmonary artery endothelial cells
C532507,CHEMICAL,"GPER1 protein, mouse [Supplementary Concept]","Receptors, Estrogen|Receptors, G-Protein-Coupled|GPER"
NEW17994,DISEASE,human pulmonary artery endothelial cell,early-onset cognitive impairment
NEW17995,CHEMICAL,selective gper agonist g-1,selective GPER agonist G-1
NEW17996,DISEASE,selective gper agonist g-1,TBI rats
NEW17997,DISEASE,selective gper agonist g-1,hippocampal CA1 neuronal loss
NEW17998,CHEMICAL,selective gper agonist g-1,inhibitor LY294002
NEW17999,MENTAL_HEALTH,selective gper agonist g-1,postoperative amnesia
D004872,CHEBI,Ergocalciferols,"|ergocalciferol|Vitamin D 2|vitamin D2|Vitamin D2|Ergocalciferol|Calciferols|D2, Vitamin"
NEW18000,DISEASE,selective gper agonist g-1,Fas death receptor
NEW18001,MENTAL_HEALTH,vitamin d metabolite,characteristic spectrometric fragmentation patterns
NEW18002,MENTAL_HEALTH,vitamin d metabolite,same time resistance
NEW18003,DISEASE,vitamin d metabolite,HL-60 promyelocytic leukemia cells
NEW18004,CHEBI,vitamin k supplementation,vitamin K supplementation
D016058,MENTAL_HEALTH,"Analgesia, Patient-Controlled","Analgesia, Patient Controlled|patient-controlled analgesia|Patient Controlled Analgesia|Patient-Controlled Analgesia"
NEW18005,CHEMICAL,ampa receptor potentiator,AMPA receptor potentiators
C539313,CHEMICAL,"Cnih2 protein, rat [Supplementary Concept]","CNIH-2|Receptors, AMPA"
NEW18006,CHEMICAL,non-competitive antagonist,[(3)H]-LY450295 potentiator binding
NEW18007,CHEBI,multimodal serotonergic drug,multimodal serotonergic drug
NEW18008,CHEMICAL,nhe rat,NHE rats
NEW18009,DISEASE,nhe rat,immunological abnormality
NEW18010,CHEMICAL,nhe rat,glutamatergic N-methyl-D-aspartate NMDA receptors
NEW18011,NUTRITION,southeast asian tree,Southeast Asian tree
NEW18012,CHEMICAL,southeast asian tree,opium withdrawal
NEW18013,DISEASE,southeast asian tree,solid malignancies
NEW18014,DISEASE,ibs-d patient,IBS-D patients
NEW18015,DISEASE,ibs-d patient,bile acid sequestrants
NEW18016,CHEMICAL,fibro-scan,fibro-scan
NEW18017,DISEASE,fibro-scan,liver stiffness
NEW18018,DISEASE,fibro-scan,liver fibrosis biomarkers
D000080242,CHEMICAL,8-Hydroxy-2'-Deoxyguanosine,"8-Oxo-Deoxyguanosine|8-Oxo-7,8-Dihydro-2'-Deoxyguanosine|8-hydroxy-2'-deoxyguanosine|8-OH-dG|2' Deoxy 8 Oxo 7,8 Dihydroguanosine|8-oxo-dGuo|8 Oxo 7 Hydrodeoxyguanosine|8 Hydroxydeoxyguanosine|2'-Deoxy-8-Oxo-7,8-Dihydroguanosine|8 Oxo Deoxyguanosine|8 Oxo 7,8 Dihydrodeoxyguanosine|2'-Deoxy-7,8-Dihydro-8-Oxoguanosine|8-oxodG|8OHdG|8 Oxo 2' Deoxyguanosine|7 Hydro 8 Oxodeoxyguanosine|8-Hydroxydeoxyguanosine|2'-Deoxy-8-Hydroxyguanosine|8-Oxo-7-Hydrodeoxyguanosine|8-OHdG|7,8 Dihydro 8 Oxo 2' Deoxyguanosine|2' Deoxy 7,8 Dihydro 8 Oxoguanosine|2' Deoxy 8 Hydroxyguanosine|2' Deoxy 8 Oxoguanosine|7-Hydro-8-Oxodeoxyguanosine|8-Oxo-2'-Deoxyguanosine|8 Oxo 7,8 Dihydro 2' Deoxyguanosine|8-oxodGuo|8-oxo-dG|2'-Deoxy-8-Oxoguanosine|7,8-Dihydro-8-Oxo-2'-Deoxyguanosine|8 Hydroxy 2' Deoxyguanosine|8-Oxo-7,8-Dihydrodeoxyguanosine"
NEW18019,DISEASE,fibro-scan,non-alcoholic steatohepatitis secondary
NEW18020,DISEASE,in amyloid-β Aβ fibrillation diagnosis,in amyloid-β Aβ fibrillation diagnosis
NEW18021,CHEMICAL,glutamate dysfunction,Glutamate dysfunction
NEW18022,CHEMICAL,ota level,OTA levels
NEW18023,CHEMICAL,ota level,mean OTA value
NEW18024,DISEASE,ota level,severe cognitive impairments
C477279,CHEMICAL,danggui buxue decoction [Supplementary Concept],"Drugs, Chinese Herbal|Buxue Tang"
NEW18025,CHEMICAL,dialectical behavioral therapy,DBT|Dialectical behavioral therapy
NEW18026,DISEASE,traditional medicine TCM formula,traditional medicine TCM formula
D029382,CHEMICAL,Dicarboxylic Acid Transporters,"dicarboxylate|Dicarboxylate Transporter|Dicarboxylate Transport Protein|Transporters, Dicarboxylic Acid|Dicarboxylic Acid Transport Proteins|Dicarboxylate Binding Protein|Dicarboxylate-Binding Protein|Dicarboxylate Carrier"
NEW18027,CHEMICAL,small-molecule selective gsk3β inhibitor,small-molecule selective GSK3β inhibitor
NEW18028,DISEASE,small-molecule selective gsk3β inhibitor,chemo-resistant PDX glioblastoma models
NEW18029,CHEMICAL,small-molecule selective gsk3β inhibitor,enhanced lomustine antitumor effect
NEW18030,CHEMICAL,small-molecule selective gsk3β inhibitor,wine fining
NEW18031,DISEASE,grape seed proanthocyanidin extract,myocardial reperfusion arrhythmias
NEW18032,CHEBI,act muscarinic agonist,acting muscarinic agonist
NEW18033,MENTAL_HEALTH,motor conversion disorder,motor conversion disorder
D020559,CHEMICAL,Monomeric GTP-Binding Proteins,"G-Protein, Small|Monomeric GTP Binding Proteins|Monomeric G Proteins|G-Proteins, Monomeric|ras-Related GTPases|GTP-Binding Proteins, ras-Related|ras Related GTPases|ras-Related G-Proteins|G-Proteins, Small|ras-Related GTP-Binding Protein|Monomeric G Protein|ras-Related GTP-Binding Proteins|Small G Protein|GTPase, Small|Small GTPase|Protein, ras-Related GTP-Binding|ras Related G Proteins|Small G-Proteins|GTPases, Small|G-proteins|ras Related GTP Binding Proteins|G-Protein, Monomeric|Small G-Protein|Small GTPases|Proteins, ras-Related GTP-Binding|GTP Binding Proteins, Monomeric|ras Related GTPase|Small G Proteins|GTP-Binding Protein, ras-Related|ras-Related GTPase|GTPases, ras-Related|G Proteins, Monomeric|GTP-Binding Proteins, Monomeric|Monomeric G-Proteins|ras Related GTP Binding Protein|G-Proteins, ras-Related|GTPase, ras-Related|Monomeric G-Protein"
NEW18034,MENTAL_HEALTH,motor conversion disorder,medium spiny projection neurons
NEW18035,CHEMICAL,approve antidepressant medication,approved antidepressant medications
NEW18036,CHEMICAL,noncompetitive n-methyl-d-aspartate nmda receptor antagonist ketamine,noncompetitive N-methyl-D-aspartate NMDA receptor antagonist ketamine
NEW18037,CHEMICAL,single subanesthetic dose infusion,single subanesthetic dose infusion
NEW18038,DISEASE,hand due gelatin embolism,hand due gelatin embolism
NEW18039,DISEASE,acute ischemic insult,acute ischemic insult
NEW18040,CHEMICAL,postsynaptic dopamine da receptor supersensitivity,postsynaptic dopamine DA receptor supersensitivity
NEW18041,CHEMICAL,postsynaptic da receptor supersensitivity,Postsynaptic DA receptor supersensitivity
NEW18042,CHEMICAL,postsynaptic da receptor supersensitivity,DA agonist
NEW18043,DISEASE,ginseng total saponin,ginseng total saponin|GTS
NEW18044,CHEMICAL,ginseng total saponin,postsynaptic DA receptor
NEW18045,CHEMICAL,ginseng total saponin,datumetine
NEW18046,CHEBI,ginseng total saponin,precursor stabilizer
NEW18047,CHEMICAL,novel three-zone ionization source,novel three-zones ionization source
NEW18048,CHEMICAL,novel three-zone ionization source,sample gas
NEW18049,CHEMICAL,novel three-zone ionization source,RH gas samples
NEW18050,MENTAL_HEALTH,novel three-zone ionization source,microbubble purging process
NEW18051,CHEBI,novel three-zone ionization source,A1R agonist
D001657,MENTAL_HEALTH,Biliary Dyskinesia,"Biliary Dyskinesias|Dyskinesia, Biliary|Dyskinesias, Gallbladder|Dyskinesias, Biliary|Gallbladder Dyskinesias|Dyskinesia, Gallbladder|biliary dyskinesia|Gallbladder Dyskinesia"
D004899,DISEASE,"Erythroblastosis, Fetal","Erythroblastosis Fetalis|Hemolytic Disease of Newborn|Newborn Hemolytic Disease|Erythroblastosis Fetali|Fetal Erythroblastoses|Fetalis, Erythroblastosis|Fetal Erythroblastosis|Fetali, Erythroblastosis|hemolytic disease|Erythroblastoses, Fetal|Newborn Hemolytic Diseases"
NEW18052,NUTRITION,cholesterol stone,Cholesterol stones
NEW18053,CHEBI,cholesterol stone,vascular endothelial growth factor receptor inhibitor
NEW18054,DISEASE,cholesterol stone,skin toxicity
NEW18055,DISEASE,cholesterol stone,mania/depression
NEW18056,MENTAL_HEALTH,drug-receptor dissociation constant,drug-receptor dissociation constant
NEW18057,CHEMICAL,plasma catecholamine,plasma catecholamines
D010673,DISEASE,Pheochromocytoma,"Extra-Adrenal Pheochromocytoma|Extra-Adrenal Pheochromocytomas|pheochromocytoma|Pheochromocytoma, Extra-Adrenal|Pheochromocytoma, Extra Adrenal|Pheochromocytomas|Pheochromocytomas, Extra-Adrenal"
NEW18058,CHEMICAL,Pseudarcobacter,Pseudarcobacter
D020640,DISEASE,Arcobacter,Arcobacter|Arcobacter butzleri
NEW18059,DISEASE,Pseudarcobacter,Arcobacter parvum comb
NEW18060,CHEMICAL,Aliarcobacter,Aliarcobacter
NEW18061,CHEMICAL,low la content,low LA content
D004083,CHEMICAL,Cholestanol,"Coprostanol|Dihydrocholesterol|beta Cholestanol|5 alpha-Cholestan-3 beta-ol|cholestanol|Cholestanol, (3alpha, 5beta)-Isomer|5 beta-Cholestan-3 alpha-ol|beta-Cholestan-3 beta-ol, 5|Coprosterol|beta-ol, 5 beta-Cholestan-3|5 beta Cholestan 3 beta ol|Cholestan-3-ol|5 beta-Cholestan-3 beta-ol|Cholestan 3 ol|beta-Cholestanol|5 alpha Cholestan 3 alpha ol|5 alpha Cholestan 3 beta ol|5 alpha-Cholestan-3 alpha-ol"
NEW18062,DISEASE,unexpected stroke,unexpected stroke
NEW18063,CHEMICAL,unexpected stroke,normal serum sterol
NEW18064,NUTRITION,unexpected stroke,fatty acid contents
C479581,CHEMICAL,procyanidin B3 [Supplementary Concept],Proanthocyanidins|Biflavonoids|procyanidin B3|Catechin
NEW18065,MENTAL_HEALTH,unexpected stroke,planar orientation
NEW18066,NUTRITION,catechin molecule,catechin molecule
NEW18067,MENTAL_HEALTH,catechin molecule,outlet resistance
NEW18068,CHEBI,systemic oestrogen replacement,systemic oestrogen replacement
C019984,CHEMICAL,cytokinin oxidase [Supplementary Concept],Oxidoreductases|CKX|cytokinin dehydrogenase
NEW18069,CHEMICAL,systemic oestrogen replacement,Zn nutrition
NEW18070,CHEBI,novel antimicrobial agent,novel antimicrobial agents
NEW18071,CHEMICAL,novel antimicrobial agent,effective decolonization
C073340,CHEMICAL,ranitidine bismuth citrate [Supplementary Concept],Bismuth|ranitidine bismuth citrate|Ranitidine/analogs  and  derivatives
NEW18072,DISEASE,novel antimicrobial agent,virus-associated pneumonia
NEW18073,MENTAL_HEALTH,novel antimicrobial agent,irreversible displacement
NEW18074,CHEMICAL,Chrysanthemum × grandiflora,Chrysanthemum × grandiflora
NEW18075,MENTAL_HEALTH,Chrysanthemum × grandiflora,strong salt resistance
NEW18076,DISEASE,c. grandiflora,C. grandiflora
NEW18077,CHEMICAL,c. grandiflora,mM NaCl solution
NEW18078,CHEMICAL,nacl imposition,NaCl imposition
NEW18079,CHEMICAL,mg-3zn substrate,Mg-3Zn substrate
NEW18080,CHEMICAL,mg-3zn substrate,NA pretreatment film
NEW18081,CHEBI,mg-3zn substrate,acid NA solution
NEW18082,NUTRITION,phosphate coating,phosphate coating
NEW18083,DISEASE,heat shock protein gene,heat shock protein gene
NEW18084,NUTRITION,heat shock protein gene,miiuy croaker
NEW18085,CHEMICAL,csltl-2,CsLTL-2
D058642,DISEASE,Planococcus Bacteria,bacteria|Aeromonas hydrophila
D017829,CHEMICAL,Granisetron,"BRL 43694|Granisetron Hydrochloride||Monohydrochloride, Granisetron|BRL-43694|Granisetron Monohydrochloride|granisetron|BRL 43694A|BRL43694A|BRL43694|1-Methyl-N-(endo-9-Methyl-9-Azabicyclo(3.3.1)non-3-yl)-1H-Indazole-3-Carboxamide|BRL-43694A|Hydrochloride, Granisetron|Kytril"
NEW18086,CHEMICAL,nitrogen equilibrium,nitrogen equilibrium
NEW18087,CHEMICAL,nitrogen equilibrium,N/kg/day
NEW18088,CHEBI,selective npr agonist,selective nPR agonists
NEW18089,DISEASE,selective npr agonist,apnea frequency
NEW18090,NUTRITION,sleep loss,low sex steroid hormone concentrations
NEW18091,CHEBI,intact opioid drug product,intact opioid drug products
NEW18092,CHEBI,intact opioid drug product,oral drug addiction
NEW18093,CHEBI,n-methyl-d-aspartate antagonist s-ketamine,N-methyl-D-aspartate antagonist S-ketamine
NEW18094,CHEMICAL,raclopride bp,raclopride BP
NEW18095,DISEASE,raclopride bp,heightened mood
NEW18096,CHEMICAL,glutamatergic nmda receptor,glutamatergic NMDA receptor
NEW18097,DISEASE,glutamatergic nmda receptor,psychotic symptom formation
NEW18098,CHEBI,circulate estrogen,circulating estrogen
NEW18099,DISEASE,circulate estrogen,night sweats
NEW18100,DISEASE,circulate estrogen,genito-urinary syndrome
NEW18101,DISEASE,age-related loss,age-related loss
NEW18102,DISEASE,premature neonate,premature neonate
NEW18103,DISEASE,premature neonate,persistent hyponatremia
NEW18104,DISEASE,premature neonate,asthma allergic rhinitis
NEW18105,CHEBI,neuropsychiatric adverse drug reaction,neuropsychiatric adverse drug reactions
NEW18106,MENTAL_HEALTH,publish soil-to-small mammal bioaccumulation regression model,Published soil-to-small mammal bioaccumulation regression models
NEW18107,CHEMICAL,publish soil-to-small mammal bioaccumulation regression model,arsenic body burdens
C533772,CHEMICAL,thiophene-3-boronic acid [Supplementary Concept],thiophene-3-boronic acid|Boronic Acids|Thiophenes
NEW18108,MENTAL_HEALTH,publish soil-to-small mammal bioaccumulation regression model,site orientation
NEW18109,MENTAL_HEALTH,paratope orientation controller,paratope orientation controller
http://purl.obolibrary.org/obo/CHEBI_26375,CHEMICAL,pterins,Albumin-bound 25OHD
NEW18110,DISEASE,esbl strain,ESBL strains
NEW18111,NUTRITION,esbl strain,Christmas shearwater
NEW18112,CHEBI,double mixture disc,double mixture discs
C053268,CHEMICAL,cefpodoxime [Supplementary Concept],cefpodoxime|Ceftizoxime/analogs  and  derivatives
C013841,CHEMICAL,benzotript [Supplementary Concept],benzotript|Benzamides
NEW18113,CHEMICAL,cyclohexane-cyclohexane pair,cyclohexane-cyclohexane pairs
NEW18114,CHEBI,cyclohexane-cyclohexane pair,polymer segments
NEW18115,MENTAL_HEALTH,cyclohexane-cyclohexane pair,special orientation
NEW18116,CHEMICAL,hyperexcitability,alpha(α)-synucleinopathies
NEW18117,DISEASE,hyperexcitability,vascular cognitive impairment|VCI
NEW18118,DISEASE,amnestic effect,amnestic effect
http://purl.obolibrary.org/obo/CHEBI_35473,CHEBI,tranquilizing drug,tranquillising agent|tranquillizing agents|tranquilising drug|tranquilizing drugs|ataractics|antidepressive drug
NEW18119,DISEASE,postpartum psychosis,postpartum psychoses
NEW18120,CHEMICAL,sodium pump activity,sodium pump activity
NEW18121,DISEASE,sodium pump activity,bipolar manic-depressive group
NEW18122,DISEASE,bipolar group,bipolar group
NEW18123,CHEMICAL,bipolar group,lower sodium pump activity
NEW18124,DISEASE,bipolar group,unipolar depressive group
NEW18125,MENTAL_HEALTH,bipolar group,chronic abuse group
C043958,NUTRITION,2-butanol [Supplementary Concept],Lithium salt|Butanols
NEW18126,CHEMICAL,bipolar group,ICS model
NEW18127,CHEMICAL,bipolar group,(R)-CPP
NEW18128,CHEBI,bipolar group,NR2A antagonist
NEW18129,CHEMICAL,bipolar group,NR2A-NMDA receptor-knockout
NEW18130,CHEMICAL,bipolar group,NR2A-NMDA receptor system
NEW18131,CHEBI,bipolar group,endogenous opioid analgesic tolerance
NEW18132,CHEMICAL,antiopioid n-methyl-d-aspartate receptor system,antiopioid N-methyl-D-aspartate receptor system
NEW18133,CHEBI,antiopioid n-methyl-d-aspartate receptor system,μ-opioid receptor-mediated analgesic mechanisms
NEW18134,MENTAL_HEALTH,antiopioid n-methyl-d-aspartate receptor system,favorable catalytic orientation
NEW18135,MENTAL_HEALTH,lesion orientation,lesion orientation
NEW18136,CHEMICAL,lesion orientation,O4-methylene group
NEW18137,DISEASE,lesion orientation,oxidative hepatic injury
NEW18138,CHEMICAL,glutathione gsh precursor,glutathione GSH precursor
NEW18139,DISEASE,hepatotoxic dose,hepatotoxic dose
http://purl.obolibrary.org/obo/CHEBI_142185,CHEMICAL,5-hydroxytryptamine 2c receptor agonist,5-hydroxytryptamine 2C receptor agonists|5-HT2c agonist|serotonin 2C receptor agonists|5-HT2c agonists|5-hydroxytryptamine receptor 2C agonists|5-HT2C receptor agonists|serotonin receptor 2C agonist|5-hydroxytryptamine receptor 2C agonist|5-HT2C receptor agonist|serotonin receptor 2C agonists
NEW18140,MENTAL_HEALTH,urethral resistance,urethral resistance
NEW18141,MENTAL_HEALTH,comorbid insomnia,comorbid insomnia
NEW18142,MENTAL_HEALTH,insomnia severity,insomnia severity
NEW18143,NUTRITION,insomnia severity,key branched chain amino acid metabolites
NEW18144,CHEMICAL,eb diet,EB diet
NEW18145,DISEASE,eb diet,muscle incoordination
NEW18146,CHEMICAL,intracerebroventricular stz,Intracerebroventricular STZ
NEW18147,CHEBI,established 3d gelatin scaffold model,established 3D gelatin scaffold model
NEW18148,DISEASE,established 3d gelatin scaffold model,neuronal stem cell exposure
http://purl.obolibrary.org/obo/DOID_0110445,DISEASE,dilated cardiomyopathy 1kk,early dilated cardiomyopathy|CMD1KK
http://purl.obolibrary.org/obo/CHEBI_135869,CHEMICAL,iopronic acid,bilimiro|oravue|TRIAC|triiodothyroacetic acid|triac
NEW18149,CHEMICAL,triac therapy,TRIAC therapy
NEW18150,DISEASE,triac therapy,thyrotoxic cardiomyopathy
NEW18151,CHEMICAL,cortisol infusion,cortisol infusion
NEW18152,CHEMICAL,csf 5-hydroxyindoleacetic acid,CSF 5-hydroxyindoleacetic acid
NEW18153,DISEASE,serious ocular complication,serious ocular complications
NEW18154,CHEBI,serious ocular complication,estrogen dosage
NEW18155,CHEBI,serious ocular complication,third-generation progestins
NEW18156,CHEBI,soy phytoestrogen,soy phytoestrogens
NEW18157,CHEMICAL,soy phytoestrogen,metabotropic glutamate receptor signaling
NEW18158,DISEASE,soy phytoestrogen,lower seizure threshold
NEW18159,CHEMICAL,soy-based infant formula,soy-based infant formula
NEW18160,CHEBI,soy-based infant formula,adrenocorticotropic hormone (ACTH)-treated rats
D012439,CHEMICAL,Saccharin,"Saccharin Calcium|Saccharin Sodium|Calcium, Saccharin|saccharin|Saccharin"
NEW18161,DISEASE,soy-based infant formula,human gastrointestinal tract
NEW18162,CHEMICAL,saccharin/sucralose consumption,Saccharin/sucralose consumption
NEW18163,CHEMICAL,saccharin/sucralose consumption,serum lipopolysaccharide
NEW18164,CHEMICAL,metformin supplementation,Metformin supplementation
NEW18165,CHEMICAL,metformin supplementation,NAFLD.IMPORTANCE
NEW18166,DISEASE,metformin supplementation,NAFLD treatment
NEW18167,DISEASE,metformin supplementation,gingival inflammation
D014993,CHEMICAL,Xylitol,Xylitol|Sweetening Agents
NEW18168,DISEASE,metformin supplementation,respiratory tract due
NEW18169,MENTAL_HEALTH,metformin supplementation,body syndromes
D014502,CHEMICAL,Uranyl Nitrate,"Nitrate, Uranyl|Uranium Nitrate|Uranium nitrate|Nitrate, Uranium"
NEW18170,DISEASE,metformin supplementation,nephrotoxic
NEW18171,DISEASE,hyperactive psd,hyperactive PSD
http://purl.obolibrary.org/obo/CHEBI_72730,CHEMICAL,flavanone glycoside,flavanone glycosides|flavonoid glycosides
NEW18172,CHEMICAL,cauliflower waste extract,cauliflower waste extract
D038225,CHEMICAL,tau-Crystallins,"Tau|tau Crystallin|tau-Crystallin|tau Crystallins|Crystallins, tau"
NEW18173,DISEASE,neurological dementia,Neurological dementias
NEW18174,CHEBI,systemic narcotic administration,systemic narcotic administration
NEW18175,DISEASE,anticholinergic poisoning,anticholinergic poisoning
C020193,CHEMICAL,"activated charcoal, colloidal silver, dimethicone, liquorice, silicone dioxide drug combination [Supplementary Concept]",activated charcoal|Salicylates|Silver Compounds|Drug Combinations
D006246,CHEMICAL,Harmaline,"Harmidine|Dihydroharmine|Harmaline|3H-Pyrido(3,4-b)indole, 4,9-dihydro-7-methoxy-1-methyl-"
D056831,DISEASE,Coordination Complexes,"Complexes, Coordination|Metal Complexes|Complexes, Metal|coordination"
NEW18176,CHEMICAL,phyllanthus tenellus Roxb,Phyllanthus tenellus Roxb
NEW18177,DISEASE,phyllanthus tenellus Roxb,intestinal infections
C049096,CHEMICAL,corilagin [Supplementary Concept],Hydrolyzable Tannins|Corilagin|Glucosides
D012431,CHEMICAL,Rutin,"Quercetin 3 Rutinoside|Quercetin, 3-Rhamnosyl-Glucosyl|rutin|Rutoside|3-Rhamnosyl-Glucosyl Quercetin|Quercetin-3-Rutinoside"
NEW18178,DISEASE,phyllanthus tenellus Roxb,P. tenellus extract
NEW18179,CHEBI,% drug loading,% drug loading
D059038,CHEMICAL,Black Sea,SEA
NEW18180,DISEASE,% drug loading,chronic physical disorders
D010148,DISEASE,"Pain, Intractable","intractable pain|Intractable Pains|Pains, Intractable|Intractable Pain|Pain, Refractory|Refractory Pains|Pains, Refractory|Refractory Pain"
NEW18181,CHEMICAL,serum testosterone level,Serum testosterone levels
NEW18182,DISEASE,serum testosterone level,AO AGHD patients
NEW18183,DISEASE,serum testosterone level,AGHD patients
NEW18184,DISEASE,serum testosterone level,adult growth hormone deficiency|AGHD
NEW18185,CHEMICAL,testosterone level,testosterone level
NEW18186,MENTAL_HEALTH,testosterone level,equatorial projection
NEW18187,NUTRITION,testosterone level,angle alpha
NEW18188,CHEBI,nicotinic acid niacin stimulation,nicotinic acid niacin stimulation
NEW18189,CHEMICAL,well-studied kynurenine pathway upregulation,well-studied kynurenine pathway upregulation
C000589289,CHEMICAL,"6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine [Supplementary Concept]",Indoles|Cebranopadol|Spiro Compounds
NEW18190,CHEMICAL,act acetylcholinesterase inhibitor neostigmine,acting acetylcholinesterase inhibitor neostigmine
NEW18191,MENTAL_HEALTH,scop amnesia,SCOP amnesia
D018738,CHEMICAL,Hexamethonium,"Dibromide, Hexamethonium|Hexamethonium Bitartrate|Hexamethonium Diiodide|Hexamethonium Diperchlorate|Dihydrate, Hexamethonium Dichloride|Monotartrate, Hexamethonium|Dimethylsulfate, Hexamethonium|Hexamethonium Dibromide Dihydrate|Hexamethonium Dihydroxide|hexamethonium|Hexamethonium Bromide|Bitartrate, Hexamethonium|Dihydroxide, Hexamethonium|Chloride, Hexamethonium|Dibromide Dihydrate, Hexamethonium|Hexamethonium Iodide|Hexamethonium Chloride|Dihydrate, Hexamethonium Dibromide|Hexamethonium Dichloride Dihydrate|Hexamethonium Dibromide|Iodide, Hexamethonium|Dichloride Dihydrate, Hexamethonium|Diiodide, Hexamethonium|Depressin|Hexamethonium Dimethylsulfate|Diperchlorate, Hexamethonium|Bromide, Hexamethonium|Hexonium|Hexamethonium Monotartrate"
NEW18192,CHEMICAL,scop amnesia,MECA 1 3
D008595,DISEASE,Menorrhagia,"Heavy Menstrual Bleeding|Menstrual Bleeding, Heavy|Hypermenorrhea|Heavy Periods|menorrhagia|Heavy Period"
NEW18193,DISEASE,scop amnesia,gonorrhea affections
NEW18194,CHEMICAL,% carbohydrate iron,% carbohydrate Iron
NEW18195,CHEMICAL,zeylanicus plant powder,zeylanicus plant powder
C497232,CHEMICAL,balaglitazone [Supplementary Concept],Balaglitazone|Thiazolidinediones|Quinazolines
NEW18196,CHEMICAL,zeylanicus plant powder,new glitazone
NEW18197,CHEBI,zeylanicus plant powder,full PPAR gamma agonists
NEW18198,CHEBI,zeylanicus plant powder,marketed PPAR gamma agonists
NEW18199,DISEASE,zeylanicus plant powder,less heart enlargement
http://purl.obolibrary.org/obo/CHEBI_135535,CHEMICAL,etofibrate,tricerol|MBX-102 acid/JNJ39659100|etofibrate HCl|etofibrate hydrochloride|ethofibrate
NEW18200,CHEBI,novel ppar-gamma agonist,novel PPAR-gamma agonist
NEW18201,CHEBI,free drug level,free drug levels
NEW18202,MENTAL_HEALTH,free drug level,PPAR-gamma corepressor displacement
NEW18203,DISEASE,diabetic ob/ob mouse,diabetic ob/ob mouse
D006218,CHEMICAL,Halofenate,MK-185|MK 185|halofenate|MK185
NEW18204,MENTAL_HEALTH,diabetic ob/ob mouse,addition hyperactivity response
NEW18205,CHEMICAL,clone α-like bioctr,cloned α-like BiOctR
NEW18206,DISEASE,glaucoma surgery,glaucoma surgery
NEW18207,DISEASE,glaucoma surgery,severe glaucoma
D014130,CHEMICAL,Trabeculectomy,Trabeculotomies|Goniotomies|Goniotomy|Trabeculoplasty|Trabeculotomy|Trabeculoplasties|Trabeculectomies|trabeculectomy
NEW18208,CHEBI,gelatin stent,gelatin stents
NEW18209,DISEASE,gelatin stent,gestational stage
NEW18210,CHEMICAL,gelatin stent,MAOI tranylcypromine
NEW18211,NUTRITION,adjunctive folate,adjunctive folate
NEW18212,CHEMICAL,chronic cort exposure,chronic CORT exposure
NEW18213,DISEASE,chronic cort exposure,anhedonia-like behaviors
NEW18214,DISEASE,chronic cort exposure,devastating neurodegenerative disease
NEW18215,DISEASE,chronic cort exposure,congenital neuronal ceroid-lipofuscinosis
NEW18216,CHEMICAL,ors structure,ORS structure
D012725,MENTAL_HEALTH,Sexual Behavior,"Sexual Activity|Behavior, Sexual|sexual orientation|Activities, Sexual|Behavior, Premarital Sex|Premarital Sex Behavior|Sexual Activities|Sex, Oral|Behavior, Sex|Sex Behavior|Anal Sex|Sex, Anal|Sexual Orientation|Oral Sex|Orientation, Sexual|Sex Orientation|Activity, Sexual"
D018753,CHEMICAL,"Diet, Protein-Restricted","protein-restricted diet|Protein-Restricted Diet|Diet, Protein Free|Diets, Protein-Restricted|Low Protein Diet|Low-Protein Diet|Low-Protein Diets|Diet, Protein Restricted|Protein-Restricted Diets|Protein-Free Diets|Diet, Low-Protein|Protein Restricted Diet|Diets, Low-Protein|Diets, Protein-Free|Diet, Low Protein|Protein-Free Diet|Diet, Protein-Free"
D020176,DISEASE,Tyrosinemias,"Tyrosinemia Type 1s|Tyrosinemia Type 1|Deficiency, Tat|Deficiency Disease, 4-Hydroxyphenol Pyruvic Acid Oxidase|Deficiency Diseases, Fumarylacetoacetase|Type I Hypertyrosinemia|Tyrosinoses, Oculocutaneous Type|Fumarylacetoacetase Deficiency Disease|Diseases, Fumarylacetoacetase Deficiency|Tyrosinemia, Hepatorenal|Tyrosinemia, Type III|Hereditary Tyrosinemia, Type II|Richner-Hanhart Syndrome|Syndromes, Richner-Hanhart|Type Tyrosinosis, Oculocutaneous|4-Hydroxyphenylpyruvate Dioxygenase Deficiency|Deficiencies, Tat|Richner Hanhart Syndrome|Tyrosine Transaminase Deficiency|Deficiency Disease, Tyrosine Transaminase|Tyrosinemias, Hepatorenal|Tyrosinemias, Type 2|Type II Tyrosinemia|Type I Tyrosinemias|Deficiency, Fumarylacetoacetase|Deficiencies, Fumarylacetoacetase|Type III Tyrosinemia|Oculocutaneous Type Tyrosinoses|4 Hydroxyphenol Pyruvic Acid Oxidase Deficiency Disease|Oregon Type Tyrosinemia|Type I Hypertyrosinemias|Dioxygenase Deficiency, 4-Hydroxyphenylpyruvate|4-Hydroxyphenol Pyruvic Acid Oxidase Deficiency Disease|Tyrosine Aminotransferase Deficiency|Tyrosinemias, Type II|Richner-Hanhart Syndromes|Fumarylacetoacetase Deficiency Diseases|Tyrosinemia, Hereditary|Deficiencies, 4-Hydroxyphenylpyruvate Dioxygenase|Tyrosinemia, Type 2|Tyrosinemias, Hereditary|Tyrosinemia|Tyrosinosis, Oculocutaneous Type|Hereditary Tyrosinemia, Type III|Tyrosinemias, Type III|Tyrosinemias, Type I|Deficiency Disease, Fumarylacetoacetase|Deficiency, 4-Hydroxyphenylpyruvate Dioxygenase|Dioxygenase Deficiencies, 4-Hydroxyphenylpyruvate|Tat Deficiencies|Oculocutaneous Type Tyrosinosis|Syndrome, Richner-Hanhart|Tyrosinemia, Type II|Type 2 Tyrosinemias|hypertyrosinemia|Type I Tyrosinemia|Disease, Fumarylacetoacetase Deficiency|Hereditary Tyrosinemia, Type I|Fumarylacetoacetase Deficiencies|Hepatorenal Tyrosinemias|Tyrosine Transaminase Deficiency Disease|Tyrosinemia, Type I|Deficiency Disease, 4 Hydroxyphenol Pyruvic Acid Oxidase|Fumarylacetoacetase Deficiency|2 Tyrosinemias, Type|4 Hydroxyphenylpyruvate Dioxygenase Deficiency Disease|Hereditary Tyrosinemias|Tat Deficiency|Hepatorenal Tyrosinemia|Hypertyrosinemias, Type I|Hypertyrosinemia|Type III Tyrosinemias|Type 2 Tyrosinemia|Keratosis Palmoplantaris with Corneal Dystrophy|Richner-Hanhart Syndrome, Tyrosinosis, Oculocutaneous Type|Hereditary Tyrosinemia|Type II Tyrosinemias|Hypertyrosinemia, Type I|Type Tyrosinoses, Oculocutaneous|4-Hydroxyphenylpyruvic Acid Oxidase Deficiency"
NEW18217,CHEBI,ors structure,contrast drug response
NEW18218,DISEASE,ors structure,impaired working memory
NEW18219,DISEASE,ors structure,pentylenetetrazol-induced convulsion
http://purl.obolibrary.org/obo/CHEBI_150866,CHEMICAL,gs-441524 monophosphate,"GS-441524 monophosphate|remdesivir monophosphate|[4,3-b]pyridine monophosphate|RDV-MP|[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen phosphate"
http://purl.obolibrary.org/obo/CHEBI_45327,CHEMICAL,adenine arabinoside,"Vidarabine|9H-adenin-9-yl beta-D-arabinofuranoside|9-(beta-D-arabinofuranosyl)-9H-adenine|2-(6-AMINO-PURIN-9-YL)-5-HYDROXYMETHYL-TETRAHYDRO-FURAN-3,4-DIOL|9-beta-D-Arabinofuranosyladenine|Spongoadenosine|adenine arabinoside (ara-A)/kg|9-beta-D-arabinofuranosyl-9H-purin-6-amine"
NEW18220,CHEMICAL,gabapentin toxicity,gabapentin toxicity
NEW18221,CHEMICAL,tyrosine hydroxylase rate-limiting enzyme,tyrosine hydroxylase rate-limiting enzyme
NEW18222,CHEMICAL,norepinephrine biosynthesis,norepinephrine biosynthesis
NEW18223,DISEASE,norepinephrine biosynthesis,trigeminal neuropathic pain
NEW18224,CHEMICAL,capsaicin administration,Capsaicin administration
NEW18225,DISEASE,capsaicin administration,infraorbital nerve
NEW18226,CHEMICAL,capsaicin administration,beta-adrenergics
NEW18227,DISEASE,serotonin hypothesis,depression-associated memory loss
D044302,CHEMICAL,"Receptor, Serotonin, 5-HT1B","5-HT(1Dbeta) Receptor|1B Receptor, 5-Hydroxytryptamine|Receptors, 5-Hydroxytryptamine 1B|Serotonin 1Dbeta Receptor|Receptor, Serotonin 1B|5-HT1B Receptor|1B Receptors, 5-Hydroxytryptamine|Receptor, 5 Hydroxytryptamine 1B|5-HT-1B receptor|Receptor, 5-HT1Dbeta|Receptor, Serotonin 1Dbeta|Receptor, 5-HT1B|Receptor, Serotonin Type 1Dbeta|5-Hydroxytryptamine 1B Receptor|5-HT1Dbeta Receptor|5 HT1B Receptor|Receptors, Serotonin 1Dbeta|5-HT(1B) Receptor|Receptor, 5-Hydroxytryptamine 1B|5 HT1Dbeta Receptor|Serotonin 1B Receptor|Serotonin 1Dbeta Receptors|5 Hydroxytryptamine 1B Receptor|5-Hydroxytryptamine 1B Receptors|Serotonin 1D Beta Receptor|5 Hydroxytryptamine 1B Receptors"
NEW18228,CHEMICAL,5-ht-1b receptor,5-HT-1B receptors
C089750,CHEMICAL,zolmitriptan [Supplementary Concept],Zolmitriptan||Oxazolidinones|Tryptamines
NEW18229,DISEASE,associate memory loss,associated memory loss
NEW18230,DISEASE,lactobacillus family,Lactobacillus family
C040968,CHEMICAL,seglitide [Supplementary Concept],"MK-678|Peptides, Cyclic|seglitide"
NEW18231,MENTAL_HEALTH,lactobacillus family,subiculo-accumbens projection system
NEW18232,CHEBI,major carotenoid,major carotenoids
NEW18233,DISEASE,alzheimer 's multi-infarct dementia patient,Alzheimer's multi-infarct dementia patients
NEW18234,CHEMICAL,gsh/gssg ratio,GSH/GSSG ratio
NEW18235,DISEASE,recent zika fever epidemic,recent Zika fever epidemic
C418604,DISEASE,"TRIM8 protein, human [Supplementary Concept]",Carrier Proteins|Nerve Tissue Proteins|human glioblastoma
NEW18236,CHEMICAL,ozone therapy,ozone therapy
D045473,DISEASE,SARS Virus,"Severe Acute Respiratory Syndrome Virus|SARS-CoV|SARS Related Coronavirus|SARS Associated Coronavirus|Urbani SARS Associated Coronavirus|Urbani SARS-Associated Coronavirus|SARS Coronavirus|Severe acute respiratory syndrome-related coronavirus|SARS-Associated Coronavirus|Coronavirus, SARS-Related|Coronavirus, SARS|SARS|Severe acute respiratory syndrome related coronavirus|SARS-Related Coronavirus|Coronavirus, Urbani SARS-Associated|SARS-Associated Coronavirus, Urbani|Coronavirus, SARS-Associated"
NEW18237,CHEBI,unaffected obligatory carrier,unaffected obligatory carriers
D005481,DISEASE,Flurothyl,Fluorothyl||Flurotyl|Indoklon|flurothyl|hexafluorodiethyl ether
NEW18238,CHEMICAL,biperiden abuser,biperiden abusers
NEW18239,DISEASE,biperiden abuser,polytoxicomania
NEW18240,CHEMICAL,intra-articular ia hyaluronic acid injection,Intra-articular IA hyaluronic acid injections
NEW18241,DISEASE,intra-articular ia hyaluronic acid injection,TMJ osteoarthritis
NEW18242,DISEASE,intra-articular ia hyaluronic acid injection,mandibular mobility
NEW18243,MENTAL_HEALTH,cholinergic projection system,Cholinergic projection systems
NEW18244,CHEMICAL,cholinergic projection system,dopamine nonresponsive features
NEW18245,CHEBI,cholinergic projection system,targeted cholinergic drug treatment
NEW18246,CHEMICAL,cholinergic projection system,"benzene-1,4-diboronic acid|BA"
C070804,CHEMICAL,alizarin complexone [Supplementary Concept],Anthraquinones|alizarin complexone|ALC
NEW18247,CHEMICAL,cholinergic projection system,boronate ester
NEW18248,MENTAL_HEALTH,cholinergic projection system,competitive binding dissociation
NEW18249,CHEMICAL,gemfibrozil preincubation,gemfibrozil preincubation
NEW18250,DISEASE,gemfibrozil preincubation,P450 human liver microsomes
NEW18251,DISEASE,gemfibrozil preincubation,metabolic alkalosis
NEW18252,NUTRITION,gemfibrozil preincubation,low serum phosphorus concentrations
NEW18253,DISEASE,gemfibrozil preincubation,intestinal atony
D013392,CHEMICAL,Sucralfate,"Ulsanic|Ulcogant||sucralfate|Sulfate, Aluminum Sucrose|Ulcerban|Antepsin|Carafate|Basic Aluminum Sucrose Sulfate|Sucralfate|Aluminum Sucrose Sulfate"
NEW18254,CHEMICAL,mglu1 pam,mGlu1 PAM
NEW18255,DISEASE,mglu1 pam,concomitant cognitive deficits
NEW18256,MENTAL_HEALTH,mglu1 pam,cortical hyperactivity
NEW18257,DISEASE,whose 's depressive symptom,whose's depressive symptoms
NEW18258,MENTAL_HEALTH,whose 's depressive symptom,Epidemiologic Studies Depression Scale
NEW18259,CHEMICAL,whose 's depressive symptom,plasma F2-isoprostanes
NEW18260,CHEBI,whose 's depressive symptom,serum carotenoids
NEW18261,CHEMICAL,whose 's depressive symptom,subsequent F2-isoprostane
NEW18262,MENTAL_HEALTH,whose 's depressive symptom,subsequent depression
NEW18263,CHEMICAL,whose 's depressive symptom,increased F2-isoprostanes
NEW18264,CHEBI,low carotenoid,lower carotenoids
NEW18265,DISEASE,low carotenoid,Rabbit Syndrome
NEW18266,CHEBI,sigma agonist fluvoxamine,sigma agonist fluvoxamine
NEW18267,DISEASE,sigma agonist fluvoxamine,numerous movement disorders
NEW18268,CHEMICAL,sigma agonist fluvoxamine,intracellular magnesium
NEW18269,CHEMICAL,standard antidepressant,sucrose intake
NEW18270,CHEMICAL,"unlabelled 1,25(oh)2d3","unlabelled 1,25(OH)2D3"
D002112,CHEMICAL,Calcifediol,"Calcifediol Anhydrous|25 Hydroxycholecalciferol|Hidroferol|Calcidiol|Monohydrate, 25-Hydroxycholecalciferol|25 Hydroxyvitamin D3|Dedrogyl|25-hydroxycholecalciferol|25-Hydroxyvitamin D3|25-Hydroxyvitamin D 3|25 Hydroxyvitamin D 3|Calcifediol, (3 alpha,5Z,7E)-Isomer|Calcifediol, (3 beta,5E,7E)-Isomer|Anhydrous, Calcifediol|25 Hydroxycholecalciferol Monohydrate|Calderol|25-Hydroxycholecalciferol|25-Hydroxycholecalciferol Monohydrate"
C031424,CHEMICAL,"24,25-dihydroxycholecalciferol receptor [Supplementary Concept]","Receptors, Calcitriol|24,25-dihydroxycholecalciferol"
http://purl.obolibrary.org/obo/CHEBI_35209,CHEMICAL,label,"label|labelled 1,25(OH)2D3"
NEW18271,DISEASE,postpartum depressive symptom,postpartum depressive symptoms
NEW18272,CHEBI,postpartum depressive symptom,mixture modeling
C579116,CHEMICAL,"2-(2,6-diisopropylphenyl)-5-amino-1H-isoindole-1,3-dione [Supplementary Concept]",Phthalimides|TC11
NEW18273,DISEASE,postpartum depressive symptom,subcutaneous tumors
C566375,DISEASE,Expansile Bone Lesions [Supplementary Concept],Bone and Bones/abnormalities|bone lesions|Bone Diseases
NEW18274,DISEASE,postpartum depressive symptom,high-risk MM patients
NEW18275,CHEMICAL,postpartum depressive symptom,riminophenazine compound
NEW18276,CHEMICAL,5-ht neurotransmission,TRP liberation
NEW18277,CHEMICAL,cytosolic tag accumulation,cytosolic TAG accumulation
NEW18278,CHEBI,cognitive development,classical nuclear androgen receptor
NEW18279,CHEBI,circulate androgen,excess androgen production
NEW18280,CHEMICAL,high-dose chemotherapy,high-dose chemotherapy
D006689,DISEASE,Hodgkin Disease,"Nodular Sclerosing Hodgkin's Lymphoma|Granuloma, Malignant|Lymphocyte Rich Classical Hodgkin's Lymphoma|Hodgkin Lymphoma, Adult|Hodgkins Lymphoma|Disease, Hodgkins|Malignant Lymphogranulomas|Hodgkin's disease|Granuloma, Hodgkin's|Mixed Cellularity Hodgkin's Lymphoma|Lymphocyte-Rich Classical Hodgkin's Lymphoma|Adult Hodgkin Lymphoma|Malignant Granulomas|Lymphogranulomas, Malignant|Granuloma, Hodgkin|Lymphocyte Depletion Hodgkin's Lymphoma|Hodgkins Granuloma|Disease, Hodgkin|Nodular Lymphocyte-Predominant Hodgkin's Lymphoma|Disease, Hodgkin's|Nodular Lymphocyte Predominant Hodgkin's Lymphoma|Hodgkin's Granuloma|Malignant Lymphogranuloma|Hodgkin Granuloma|Lymphogranuloma, Malignant|Hodgkin's Lymphoma|Hodgkins Disease|Lymphoma, Hodgkin|Hodgkin Lymphoma|Hodgkin's Disease|Granuloma, Hodgkins|Lymphoma, Hodgkin's|Malignant Granuloma"
NEW18281,CHEMICAL,bicyclam molecule,bicyclam molecule
NEW18282,CHEMICAL,topical nifedipine,topical nifedipine
NEW18283,DISEASE,avian mycoplasma,Avian mycoplasmas
NEW18284,DISEASE,mycoplasma gallisepticum infection,Mycoplasma gallisepticum infection
NEW18285,DISEASE,mycoplasma gallisepticum infection,chronic respiratory disease
NEW18286,DISEASE,mycoplasma gallisepticum infection,infectious sinusitis
NEW18287,CHEBI,melatonin-receptor agonist,melatonin-receptor agonists
NEW18288,DISEASE,melatonin-receptor agonist,chronobiotic effet
NEW18289,CHEMICAL,melatonin-receptor agonist,melatonin agonist action
NEW18290,CHEMICAL,melatonin-receptor agonist,5HT2c antagonist
NEW18291,DISEASE,frequent CAE,frequent CAE
NEW18292,CHEMICAL,frequent CAE,TBA|tributyl aconitate
NEW18293,DISEASE,polyposis registry clinician,Polyposis registry clinicians
NEW18294,NUTRITION,polyposis registry clinician,high amylose maize starch
C551966,NUTRITION,octenyl succinic anhydride-modified starch [Supplementary Concept],Starch/analogs  and  derivatives|potato starch
NEW18295,DISEASE,increase polyp number,increased polyp number
D012811,DISEASE,Sigmoid Neoplasms,"Cancer of Sigmoid|Cancer of the Sigmoid|Neoplasms, Sigmoid|Colon Neoplasms, Sigmoid|Neoplasm, Sigmoid Colon|Cancer, Sigmoid Colon|Sigmoid Cancer|Neoplasm, Sigmoid|Sigmoid Colon Neoplasm|Sigmoid Colon Cancer|colon neoplasms|sigmoid colon|Neoplasms, Sigmoid Colon|Cancer, Sigmoid|Sigmoidal Cancer|Colon Cancer, Sigmoid|Sigmoid Neoplasm|Sigmoid Colon Neoplasms"
NEW18296,CHEMICAL,aspirin group,aspirin groups
NEW18297,CHEMICAL,aspirin group,aspirin group
NEW18298,DISEASE,aspirin group,significant gastrointestinal bleeds
NEW18299,CHEMICAL,metabolise phytanic acid,metabolised phytanic acid
NEW18300,DISEASE,metabolise phytanic acid,peripheral dissociative polyneuropathy
D012174,DISEASE,Retinitis Pigmentosa,"Pigmentary Retinopathy|Pigmentary Retinopathies|Tapetoretinal Degeneration|Retinopathy, Pigmentary|Retinopathies, Pigmentary|retinitis pigmentosa|Tapetoretinal Degenerations"
C002844,CHEMICAL,pristanic acid [Supplementary Concept],Fatty Acids|pristanic acid
D018980,DISEASE,Williams Syndrome,"Stenoses, Hypercalcemia-Supravalvar Aortic|Syndrome, Williams|Supravalvar Aortic Stenosis Syndrome|Hypercalcemia Supravalvar Aortic Stenosis|Aortic Stenoses, Hypercalcemia-Supravalvar|Aortic Stenosis, Hypercalcemia-Supravalvar|Chromosome 7q11.23 Deletion Syndrome|Stenosis, Hypercalcemia-Supravalvar Aortic|Syndrome, Williams-Beuren|Williams-Beuren Syndrome|contiguous gene syndrome|Beuren Syndrome|Hypercalcemia-Supravalvar Aortic Stenoses|Hypercalcemia-Supravalvar Aortic Stenosis|Williams Beuren Syndrome|Williams Contiguous Gene Syndrome|Syndrome, Beuren|Contiguous Gene Syndrome, Williams"
NEW18301,DISEASE,tumor tissue,tumor tissue
NEW18302,DISEASE,breast cancer tissue,breast cancer tissue
NEW18303,CHEBI,breast cancer tissue,neoantigen production due
NEW18304,CHEMICAL,natural coumarin,Natural coumarins
NEW18305,DISEASE,natural coumarin,Alzheimer's disease inhibition
NEW18306,CHEMICAL,natural coumarin,DA neurons
NEW18307,DISEASE,natural coumarin,dopamine-induced neurodegeneration
C569370,DISEASE,"PRRT2 protein, human [Supplementary Concept]",PRRT2|Nerve Tissue Proteins|Membrane Proteins
C537180,MENTAL_HEALTH,Familial paroxysmal dystonia [Supplementary Concept],Dystonia|paroxysmal kinesigenic dyskinesia
NEW18308,DISEASE,increase prostate index,increased prostate index
NEW18309,CHEBI,increase prostate index,cell antigen PCNA index
NEW18310,DISEASE,increase prostate index,increased erection latency
NEW18311,NUTRITION,seahorse extract,Seahorse extracts
NEW18312,CHEBI,seahorse extract,candidate marine drug
NEW18313,CHEMICAL,Suicidegene therapy,Suicidegene therapy
D019574,DISEASE,Optic Nerve Neoplasms,"Optic Nerve Sheath Tumors, Malignant|Tumor, Benign, Optic Nerve|Optic Nerve Sheath Tumors|Benign Optic Nerve Sheath Tumors|Optic Nerve Sheath Neoplasms, Malignant|Malignant Optic Nerve Neoplasm|Optic Nerve Sheath Tumors, Benign|benign tumor|Benign Optic Nerve Sheath Neoplasms|Tumor, Malignant, Optic Nerve|Malignant Optic Nerve Tumor|Neoplasm, Benign, Optic Nerve|Tumor, Optic Nerve, Malignant|Malignant Optic Nerve Sheath Tumors|Neoplasm, Optic Nerve|Neoplasm, Optic Nerve, Benign|Malignant Optic Nerve Sheath Neoplasms|Optic Nerve Neoplasm, Benign|Benign Optic Nerve Neoplasm|Optic Nerve Sheath Neoplasm|Neoplasms, Optic Nerve|Tumor, Optic Nerve, Benign|Optic Nerve Tumor, Malignant|Optic Nerve Neoplasm|Benign Optic Nerve Tumor"
NEW18314,DISEASE,Suicidegene therapy,uterine leiomyoma
D015774,CHEMICAL,Ganciclovir,"ganciclovir|Cytovene|Gancyclovir|RS-21592|BW-759|BIOLF-62|Ganciclovir Sodium|GCV|Ganciclovir, Monosodium Salt"
NEW18315,MENTAL_HEALTH,Suicidegene therapy,suicide gene therapy
NEW18316,CHEBI,cationic peptide carrier,cationic peptide carriers
NEW18317,CHEBI,cationic peptide carrier,modular non-viral carriers
NEW18318,CHEMICAL,cubic spline,cubic splines
NEW18319,NUTRITION,cubic spline,lithium concentration
NEW18320,DISEASE,cubic spline,any mood episodes
NEW18321,CHEMICAL,xylose consumer,xylose consumer
NEW18322,DISEASE,sp. strain jdr-2,sp. strain JDR-2
NEW18323,CHEMICAL,sp. strain jdr-2,"beta-1,4-xylotriose"
NEW18324,CHEMICAL,sp. strain jdr-2,MeGAX(3
D013318,DISEASE,Stroke Volume,"Ventricular End-Diastolic Volumes|Volumes, Ventricular End-Systolic|Ventricular Ejection Fractions|End-Diastolic Volume, Ventricular|Ventricular End-Systolic Volumes|Ejection Fraction, Ventricular|Ventricular End Diastolic Volume|End-Systolic Volumes, Ventricular|Ventricular End-Diastolic Volume|Volume, Ventricular End-Diastolic|End-Systolic Volume, Ventricular|End-Diastolic Volumes, Ventricular|Fractions, Ventricular Ejection|Ejection Fractions, Ventricular|Ventricular End Systolic Volume|Volume, Stroke|Ventricular End-Systolic Volume|Volumes, Stroke|Stroke Volumes|Volumes, Ventricular End-Diastolic|Volume, Ventricular End-Systolic|Ventricular Ejection Fraction|Fraction, Ventricular Ejection|stroke volume"
NEW18325,CHEMICAL,sp. strain jdr-2,uric acid levels
NEW18326,CHEBI,sp. strain jdr-2,high serum parathyroid hormone
NEW18327,DISEASE,sp. strain jdr-2,behavioral dysexecutive disorders
NEW18328,CHEMICAL,low serum glucose level,low serum glucose levels
NEW18329,MENTAL_HEALTH,low serum glucose level,steroid psychosis
C009105,CHEMICAL,psilocin [Supplementary Concept],psilocin|Psilocybin/analogs  and  derivatives
NEW18330,CHEMICAL,active hallucinogen,active hallucinogen
NEW18331,CHEMICAL,active hallucinogen,antidepressant actions
NEW18332,CHEMICAL,prefrontal oxygen consumption rate,Prefrontal oxygen consumption rate
NEW18333,DISEASE,malignant pain,malignant pain
NEW18334,NUTRITION,captive adult snow leopard,captive adult snow leopard
NEW18335,MENTAL_HEALTH,captive adult snow leopard,anxiety presence
NEW18336,CHEMICAL,oral fluoxetine,oral fluoxetine
NEW18337,MENTAL_HEALTH,oral fluoxetine,pharmacological dissociation
NEW18338,DISEASE,e. ictaluri,E. ictaluri
NEW18339,NUTRITION,e. ictaluri,yellow catfish
NEW18340,DISEASE,pathophysiology septicemia,pathophysiology septicemia
NEW18341,CHEMICAL,atypical antipsychotic ziprasidone,atypical antipsychotic ziprasidone
NEW18342,DISEASE,atypical antipsychotic ziprasidone,adverse motor events
NEW18343,CHEMICAL,selegiline treatment,selegiline treatment
D000071956,DISEASE,Myocardial Contusions,"Cardiac Contusion|Cardiac Injury, Blunt|cardiac injuries|Heart Contusions|Injury, Blunt Cardiac|Blunt Cardiac Injury|Contusions, Myocardial|Myocardial Contusion|Contusions, Heart|Contusion, Myocardial|Heart Contusion|Contusion, Cardiac|Contusions, Cardiac|Contusion, Heart|Injuries, Blunt Cardiac|Cardiac Injuries, Blunt|Blunt Cardiac Injuries|Cordis, Contusio|Cardiac Contusions|Contusio Cordis"
NEW18344,CHEMICAL,camp signaling pathway,cAMP signaling pathway
NEW18345,CHEMICAL,camp signaling pathway,ethanol sensitivity
NEW18346,CHEBI,camp signaling pathway,postdischarge narcotic refills
NEW18347,CHEBI,camp signaling pathway,narcotic refills
NEW18348,CHEMICAL,ketamine anaesthesia,ketamine anaesthesia
NEW18349,CHEBI,antiviral pf74,Antiviral PF74
NEW18350,MENTAL_HEALTH,antiviral pf74,stress fatigue
NEW18351,DISEASE,nitrous oxide abuse,myeloneuropathy
NEW18352,DISEASE,g. sabinae,G. sabinae
NEW18353,CHEMICAL,g. sabinae,CUP-067943 aecia roestelioid
NEW18354,CHEMICAL,g. sabinae,periderium balanoid
NEW18355,DISEASE,g. sabinae,P. calleryana
NEW18356,MENTAL_HEALTH,fatigue resistance,Fatigue resistance
NEW18357,CHEMICAL,fatigue resistance,FO independent
NEW18358,CHEMICAL,cd tolerance,Cd tolerance
NEW18359,DISEASE,a. auriculiformis,A. auriculiformis
NEW18360,CHEMICAL,a. auriculiformis,coordinated gas exchange
NEW18361,CHEMICAL,aggregated cd toxicity,aggregated Cd toxicity
NEW18362,CHEMICAL,aggregated cd toxicity,GA20ox
D054732,CHEMICAL,Calcium-Calmodulin-Dependent Protein Kinase Type 2,CaM-Kinase IIalpha|CaM KII|Calmodulin Dependent Protein Kinase II|CaCMKII|Calcium-Calmodulin-Dependent Protein Kinase Type 2 gamma Subunit|Calcium-Calmodulin Protein Kinase II|Calcium Calmodulin Dependent Protein Kinase Type 2|Calcium Calmodulin Dependent Protein Kinase II beta|Calcium Calmodulin Dependent Protein Kinase II gamma|Calcium Calmodulin Dependent Protein Kinase Type 2 beta Subunit|CaM KIIbeta|Calcium Calmodulin Dependent PK Type II|Ca(2+)-Calmodulin Dependent Protein Kinase Type II|Calcium Calmodulin Protein Kinase II|Calcium Calmodulin Dependent Protein Kinase Type 2 alpha Subunit|CaM Kinase IIalpha|CaM Kinase II delta|CaMKII|Calcium Dependent CaM Kinase II|CaMKIIgamma|Calcium-Calmodulin Dependent Protein Kinase II delta|Calcium Calmodulin Dependent Protein Kinase Type 2 gamma Subunit|Calcium Calmodulin Dependent Protein Kinase II delta|Calmodulin-Dependent Protein Kinase II|Calcium-Calmodulin-Dependent Protein Kinase Type 2 beta Subunit|CaM KIIdelta|CaM Kinase II alpha|Calcium Calmodulin Dependent Protein Kinase Type 2 delta Subunit|CaM PK II|Calcium-Calmodulin-Dependent Protein Kinase Type 2 alpha Subunit|CaM Kinase II gamma|Calcium-Calmodulin Dependent Protein Kinase II gamma|CaM|Calcium-Dependent CaM Kinase II|Calcium-Calmodulin-Dependent PK Type II|CaM Kinase II|CaM-Kinase II|CaM KIIalpha|Calmodulin Kinase IIalpha|CaM Kinase II beta|Calcium-Calmodulin Dependent Protein Kinase II beta|Calcium-Calmodulin-Dependent Protein Kinase Type 2 delta Subunit
http://purl.obolibrary.org/obo/MFOMD_0000189,MENTAL_HEALTH,premenstrual dysphoric disorder,Premenstrual dysphoric disorder symptoms
NEW18363,DISEASE,functional bowel disease,functional bowel disease
NEW18364,DISEASE,central neuropathic pain,central neuropathic pain
NEW18365,CHEMICAL,pulsatile levodopa administration,Pulsatile levodopa administration
NEW18366,CHEMICAL,plasma agrp elevation,plasma AGRP elevation
NEW18367,DISEASE,plasma agrp elevation,homeostasis disturbance
NEW18368,MENTAL_HEALTH,plasma agrp elevation,anorexia nervosa patients
NEW18369,DISEASE,activity-based anorexia,anxiety- attack-like behaviours
NEW18370,CHEMICAL,mg741,MG741
NEW18371,DISEASE,mg741,hepatic steatosis score
NEW18372,DISEASE,mg741,HFD-induced deterioration
C000712990,CHEMICAL,(E)-5-hydroxy-7-methoxy-3-(2'-hydroxybenzyl)-4-chromanone [Supplementary Concept],Flavonoids|(E)-5-hydroxy-7-methoxy-3-(2-hydroxybenzyl)-4-chromanone
NEW18373,CHEBI,thyroid hormone signaling regulation,thyroid hormone signaling regulation
NEW18374,DISEASE,thyroid hormone signaling regulation,stroke outcome
NEW18375,CHEMICAL,potent serotonin reuptake inhibiting property,potent serotonin reuptake inhibiting properties
NEW18376,CHEMICAL,potent serotonin reuptake inhibition,potent serotonin reuptake inhibition
NEW18377,DISEASE,potent serotonin reuptake inhibition,premenstrual complaints
NEW18378,CHEBI,brain vitamin k,brain vitamin K
NEW18379,CHEMICAL,high brain mk4 concentration,Higher brain MK4 concentrations
NEW18380,DISEASE,high brain mk4 concentration,good seizure control attributable
NEW18381,CHEMICAL,high brain mk4 concentration,toxic intermediates α-aminoadipic semialdehyde|AASA
D050698,CHEMICAL,Glutamate-5-Semialdehyde Dehydrogenase,"Reductase, Beta-Glutamylphosphate|Glutamate Semialdehyde Dehydrogenase|Gamma Glutamylphosphate Reductase|Glutamate-Semialdehyde Dehydrogenase|Glutamate 5 Semialdehyde Dehydrogenase|semialdehyde|Beta-Glutamylphosphate Reductase|Gamma-Glutamylphosphate Reductase|Beta Glutamylphosphate Reductase|Glutamate 5-Semialdehyde Dehydrogenase|Dehydrogenase, Glutamate 5-Semialdehyde|Reductase, Gamma-Glutamylphosphate|Dehydrogenase, Glutamate-5-Semialdehyde|5-Semialdehyde Dehydrogenase, Glutamate|Dehydrogenase, Glutamate-Semialdehyde"
NEW18382,CHEBI,high brain mk4 concentration,pyridoxine responsive individuals
NEW18383,DISEASE,high brain mk4 concentration,good seizure control
NEW18384,CHEBI,folate transporter deficiency,folate transporter deficiency
NEW18385,DISEASE,folate transporter deficiency,non-epileptic manifestations
NEW18386,DISEASE,folate transporter deficiency,bipolar manic
D008746,CHEMICAL,Methylazoxymethanol Acetate,"Acetate, Methylazoxymethanol|(Methyl-ONN-azoxy)methanol Acetate|methylazoxymethanol"
NEW18387,CHEBI,pharmaceutical campaign,pharmaceutical campaign
NEW18388,MENTAL_HEALTH,pharmaceutical campaign,ADHD medication
NEW18389,MENTAL_HEALTH,pharmaceutical campaign,ADHD awareness
NEW18390,MENTAL_HEALTH,d1 agonist,oro-facial dyskinesia
NEW18391,DISEASE,ovarian cancer 3d culture,ovarian cancer 3D cultures
NEW18392,MENTAL_HEALTH,ovarian cancer 3d culture,mitotic spindle disorientation
NEW18393,CHEBI,estrogen pathway activation,estrogen pathway activation
NEW18394,DISEASE,estrogen pathway activation,incessant ovulation
NEW18395,DISEASE,estrogen pathway activation,ovarian carcinogenesis
NEW18396,DISEASE,estrogen pathway activation,white matter abnormality
NEW18397,CHEMICAL,free triiodothyronine,LT4 monotherapy
NEW18398,DISEASE,free triiodothyronine,athyreotic patients
NEW18399,DISEASE,free thyroxine,summary cognitive deficits
NEW18400,CHEBI,peroxiproliferation-activated receptor gamma agonist medication,peroxiproliferation-activated receptor gamma agonist medications
NEW18401,CHEMICAL,antidiabetic glitazone GTZ drug,antidiabetic glitazone GTZ drugs
NEW18402,CHEMICAL,total cholesterol,7-transmembrane receptor family
D017498,CHEMICAL,Adenovirus E1 Proteins,"Proteins, Adenovirus E1|E1|E1 Proteins, Adenovirus"
C528574,CHEMICAL,astressin-2B [Supplementary Concept],"Peptide Fragments|astressin|Peptides, Cyclic"
NEW18403,DISEASE,total cholesterol,possible toxicity
NEW18404,DISEASE,total cholesterol,ischemic cerebral infarction
NEW18405,CHEMICAL,finite-temperature k spectrum,finite-temperature K spectra
NEW18406,CHEMICAL,finite-temperature k spectrum,PES|potential energy surfaces
NEW18407,DISEASE,finite-temperature k spectrum,behavior food consumption
NEW18408,CHEMICAL,catecholaminergic amp system,Catecholaminergic AMP systems
NEW18409,DISEASE,catecholaminergic amp system,obesity-related metabolic syndrome
NEW18410,DISEASE,catecholaminergic amp system,hepatic inflammation
NEW18411,DISEASE,catecholaminergic amp system,chronic liver metabolic diseases
D029774,CHEMICAL,Gynostemma,"Gynostemmas|Gynostemma pentaphyllum|Gynostemma pentaphyllums|pentaphyllum, Gynostemma"
NEW18412,CHEBI,bee venom therapy,Bee venom therapy
NEW18413,CHEMICAL,2=0.52,2=0.52
NEW18414,CHEMICAL,2=0.52,LF+ST
NEW18415,DISEASE,2=0.52,direct acute lung injury
NEW18416,DISEASE,2=0.52,direct ARDS
NEW18417,DISEASE,2=0.52,indirect ARDS
NEW18418,DISEASE,2=0.52,experimental acute lung injury lung injury
NEW18419,MENTAL_HEALTH,schizophrenia b stimulation,schizophrenia b stimulation
NEW18420,CHEBI,d2/d3 partial agonist,D2/D3 partial agonists
D020823,CHEMICAL,ADP-Ribosylation Factor 1,"ARF 1 Protein|ADP ribosylation factor|Protein, ARF1|ADP Ribosylation Factor 1|ARF1 Protein|ARF1p"
NEW18421,DISEASE,smooth muscle contraction,smooth muscle contraction
D011429,DISEASE,Propolis,"Bee Bread|Bee Glue|propolis|Glue, Bee|Bread, Bee"
NEW18422,MENTAL_HEALTH,parallel rightward displacement,parallel rightward displacement
NEW18423,DISEASE,panic attack-like defensive behaviour,panic attack-like defensive behaviours
D003453,DISEASE,Cryptococcosis,"Cryptococcus neoformans Infections|Infection, C neoformans|C neoformans Infections|Infection, C. neoformans|C. gattii Infections|C. gattii Infection|Cryptococcus neoformans Infection|Torulosis|Infection, Cryptococcus gattii|C. neoformans Infections|Cryptococcus Infections|Toruloses|Infections, C gattii|C gattii Infection|Cryptococcus gattii Infections|Cryptococcus Infection|Infection, C. gattii|Infection, C gattii|Cryptococcus gattii Infection|cryptococcus infection|Infection, Cryptococcus|Infection, Cryptococcus neoformans|Cryptococcoses|C gattii Infections|C neoformans Infection|Infections, C. neoformans|C. neoformans Infection"
NEW18424,DISEASE,sarcoidosis patient,sarcoidosis patients
NEW18425,DISEASE,suppression subtractive hybridization,VPAHPND infection
NEW18426,NUTRITION,suppression subtractive hybridization,white shrimp Litopenaeus
NEW18427,CHEBI,suppression subtractive hybridization,anti-viral agent
NEW18428,CHEMICAL,oseltamivir resistance,oseltamivir resistance
NEW18429,DISEASE,oseltamivir resistance,H1N1 subtype neuraminidases
NEW18430,MENTAL_HEALTH,oseltamivir resistance,p11 consequent repression
C570114,CHEMICAL,CCL 34 [Supplementary Concept],Glycolipids|CCl|Serine/analogs  and  derivatives
NEW18431,DISEASE,oseltamivir resistance,insulin-dependent metabolic disorder
NEW18432,CHEMICAL,ccl exposure,CCl exposures
NEW18433,CHEMICAL,ccl exposure,glucagon levels
NEW18434,DISEASE,ccl exposure,liver cell damage
NEW18435,CHEMICAL,acute ccl exposure,acute CCl exposure
NEW18436,CHEMICAL,acute ccl exposure,chronic -exposed liver cells
NEW18437,CHEMICAL,anit feeding,ANIT feeding
NEW18438,CHEMICAL,anit feeding,hydrophobic BAs
NEW18439,DISEASE,anit feeding,significant cholestasis
NEW18440,CHEMICAL,serum alanine aminotransferase,serum alanine aminotransferase
NEW18441,DISEASE,minimal bile duct damage,minimal bile duct damage
NEW18442,CHEMICAL,direct bilirubin,direct bilirubin
D020381,CHEMICAL,Interleukin-17,"CTLA-8|IL-17F|Interleukin-17B|Interleukin-17A|Interleukin 17E|Interleukin-25|Interleukin-17C|Cytotoxic T lymphocyte-Associated Antigen 8|Interleukin-17F|IL-17C|CTLA8|Cytokine CX2|Cytokine ML 1|Interleukin 25|Interleukin 17C|IL-17|Interleukin-17E|Interleukin 17F|IL-17A|Interleukin 17|IL-17B|IL-17E|Interleukin 17A|Cytokine ML-1|Cytotoxic T lymphocyte Associated Antigen 8|Interleukin 17B|IL 17E|CX2, Cytokine"
NEW18443,DISEASE,puccinia striiformis f. sp. tritici,Puccinia striiformis f. sp. tritici
NEW18444,NUTRITION,transgenic wheat,Transgenic wheat
NEW18445,CHEMICAL,pst27791,Pst27791
NEW18446,DISEASE,pst27791,fibrosarcoma (Raf)-like kinase
NEW18447,DISEASE,TaRaf46,TaRaf46
NEW18448,MENTAL_HEALTH,TaRaf46,wheat resistance
NEW18449,CHEMICAL,serotonin neuronal system,Serotonin neuronal systems
NEW18450,CHEMICAL,5-ht(3 receptor antagonist ondansetron,5-HT(3 receptor antagonist ondansetron
NEW18451,DISEASE,5-ht(3 receptor antagonist ondansetron,treatment-resistant OCD patients
NEW18452,CHEMICAL,5-ht(3 receptor antagonist ondansetron,cortico-mesolimbic dopamine release
NEW18453,CHEMICAL,low-dose ondansetron,low-dose ondansetron
NEW18454,MENTAL_HEALTH,low-dose ondansetron,control disorder
NEW18455,CHEMICAL,low-dose ondansetron,midodrine therapy
NEW18456,DISEASE,vasoplegic profile,vasoplegic profile
NEW18457,CHEMICAL,melissa officinalis L.,memory-enhancing herb
NEW18458,CHEMICAL,melissa officinalis L.,inhibitor rivastigmine
NEW18459,CHEMICAL,low dose clonazepam,low dose clonazepam
NEW18460,CHEBI,dopamine agonist due,dopamine agonists due
NEW18461,CHEBI,abnormal thyroid hormone system function,Abnormal thyroid hormone system function
NEW18462,DISEASE,abnormal thyroid hormone system function,brain defects
NEW18463,CHEBI,abnormal thyroid hormone system function,thyroid hormone system function
NEW18464,CHEMICAL,abnormal thyroid hormone system function,fetal alcohol exposure
NEW18465,CHEBI,circulate thyroid hormone,circulating thyroid hormones
NEW18466,CHEMICAL,fas child,FAS children
NEW18467,CHEMICAL,progesterone treatment,progesterone treatment
NEW18468,CHEMICAL,serotonin 5-hydroxytryptamine type receptor,serotonin 5-hydroxytryptamine type receptor
NEW18469,DISEASE,serotonin 5-hydroxytryptamine type receptor,digestive dysfunction
NEW18470,CHEBI,otsuka Pharmaceutical Co. Ltd.,Otsuka Pharmaceutical Co. Ltd.
NEW18471,CHEMICAL,otsuka Pharmaceutical Co. Ltd.,Abilify ®
NEW18472,CHEBI,otsuka Pharmaceutical Co. Ltd.,first dopamine D2 receptor partial agonist antipsychotic aripiprazole
NEW18473,CHEMICAL,otsuka Pharmaceutical Co. Ltd.,mg ramelteon
NEW18474,CHEMICAL,inhibitor flurbiprofen,inhibitor flurbiprofen
NEW18475,DISEASE,interstitial thickening,Interstitial thickening
NEW18476,CHEBI,human pxr agonist,human PXR agonists
NEW18477,DISEASE,human pxr agonist,conclusion postprandial hyperglycemia
http://purl.obolibrary.org/obo/NCBITaxon_6843,DISEASE,chelicerata,Reynoldsia sandwicensis
NEW18478,CHEMICAL,-52‰,-52‰
D053829,DISEASE,Amyloid Precursor Protein Secretases,"APP|Secretase, APP|Amyloid Precursor Protein Secretase|gamma-Secretase|beta-Secretase|amyloid precursor protein|beta Secretase|alpha-Secretase|alpha Secretase|Secretases|Secretase|gamma Secretase|APP Secretase"
NEW18479,CHEBI,agonist dicarboxylic acid,agonist dicarboxylic acid
C036361,CHEMICAL,"1-amino-1,3-dicarboxycyclopentane [Supplementary Concept]","Cycloleucine/analogs  and  derivatives|(1S,3R)-ACPD"
C005356,CHEMICAL,sphingosine phosphorylcholine [Supplementary Concept],Sphingosine/analogs  and  derivatives|Phosphorylcholine/analogs  and  derivatives|lysosphingomyelin
NEW18480,CHEBI,group metabotropic glutamate receptor mglur agonist,Group metabotropic glutamate receptor mGluR agonist
NEW18481,DISEASE,group metabotropic glutamate receptor mglur agonist,major loss
NEW18482,DISEASE,synchronized 1a9 ovarian carcinoma cell,Synchronized 1A9 ovarian carcinoma cells
NEW18483,CHEMICAL,synchronized 1a9 ovarian carcinoma cell,peloruside A. Co-immunoprecipitation
D050257,CHEMICAL,Tubulin Modulators,"Inhibitor, Tubulin|Promoter, Tubulin Polymerization|Inhibitors, Tubulin|Modulators, Tubulin|Tubulin Modulator|Promoters, Tubulin Polymerization|Tubulin Polymerization Promoter|Promoters, Tubulin|Microtubule Modulator|Polymerization Inhibitors, Tubulin|Tubulin Promoter|Tubulin Inhibitor|Modulator, Tubulin|Inhibitor, Tubulin Polymerization|Modulator, Microtubule|Modulators, Microtubule|Polymerization Promoter, Tubulin|Promoter, Tubulin|Tubulin Inhibitors|Microtubule Modulators|Tubulin Promoters|Tubulin Polymerization Promoters|tubulin|Inhibitors, Tubulin Polymerization|Polymerization Inhibitor, Tubulin|Tubulin Polymerization Inhibitors|Tubulin Polymerization Inhibitor|Polymerization Promoters, Tubulin"
NEW18484,CHEMICAL,tubulin heterodimer,tubulin heterodimers
NEW18485,DISEASE,microtubule stabilize agent,internal transformation
NEW18486,DISEASE,stress-induced ibs,stress-induced IBS
NEW18487,CHEBI,stress-induced ibs,AV/GC mixture
NEW18488,CHEMICAL,r-isovaline,R-isovaline
NEW18489,CHEMICAL,r-isovaline,non-proteinogenic amino acid
NEW18490,DISEASE,brain degeneration,brain degeneration
NEW18491,CHEBI,beta gamma secretase,beta gamma secretase
NEW18492,CHEMICAL,beta gamma secretase,amyloid precursor protein(APP
D017405,CHEMICAL,Herpes Simplex Virus Protein Vmw65,"Protein VP-16, HSV-1|Herpes Simplex Virus Protein VP16|Inducing Factor, alpha-Trans|alpha Trans Inducing Factor, Herpes Simplex Virus 1|Herpes Simplex Virus Trans Activator Vmw65|VP16 Protein|Herpes Simplex Virus Trans-Activator Vmw65|HSV-1 Protein VP16|Vmw65 Protein|HSV-1 Protein VP-16|alpha-Trans Inducing Factor|Protein, Vmw65|Herpes Simplex Virus Type 2 Protein VP16|HSV-1|Herpes Simplex Virus Protein VP 16|HSV 1 Protein VP16|HSV 1 Protein VP 16|HSV-1, alpha-TIF|Factor, alpha-Trans Inducing|alpha Trans Inducing Factor|alpha-TIF HSV-1|Protein, VP16|alpha TIF HSV 1|VP16, HSV-1 Protein|Protein VP16, HSV-1|Herpes Simplex Virus Transcriptional Activator Vmw65|alpha-Trans-Inducing Factor, Herpes Simplex Virus 1|VP-16, HSV-1 Protein"
NEW18493,CHEMICAL,retinoic acid signaling defect,retinoic acid signaling defects
NEW18494,DISEASE,retinoic acid signaling defect,cyclical nausea
NEW18495,CHEMICAL,pee group,PEE group
NEW18496,MENTAL_HEALTH,pee group,unpredictable chronic stress
NEW18497,DISEASE,pee group,higher HCC
NEW18498,DISEASE,hypertension higher,hypertension higher
NEW18499,CHEMICAL,hypertension higher,anti-diarrheals
NEW18500,DISEASE,hypertension higher,tumor anti-proliferative agents
NEW18501,DISEASE,disorder pathology,Disorder pathology
C471991,DISEASE,"HPG-1 protein, human [Supplementary Concept]",human prostate|Cell Adhesion Molecules
NEW18502,NUTRITION,disorder pathology,alpha IA-subtype
NEW18503,CHEMICAL,doxazosin therapy,doxazosin therapy
NEW18504,CHEMICAL,norepinephrine system,norepinephrine system
NEW18505,CHEMICAL,nb atom,Nb atoms
D017979,CHEMICAL,Gold Colloid,"gold|Gold, Colloidal|Au|Colloid, Gold|Colloidal Gold"
NEW18506,CHEBI,nb atom,ovarian hormone levels
NEW18507,MENTAL_HEALTH,premenstrual depression,Premenstrual depression
NEW18508,DISEASE,premenstrual depression,primary sleep disorders
NEW18509,CHEMICAL,premenstrual depression,increased GLU
NEW18510,DISEASE,premenstrual depression,skeletal deformities
NEW18511,DISEASE,mtf ts,MtF TS
NEW18512,CHEBI,mtf ts,oestrogens antiandrogens application
NEW18513,DISEASE,endocrinopathy occurence,endocrinopathy occurence
NEW18514,DISEASE,endocrinopathy occurence,autoimmune thyreoiditis
D007713,DISEASE,Klinefelter Syndrome,"XXY Trisomy|Xxyy Syndromes|Trisomy, XXY|Syndrome, Klinefelter's|XXXY Males|Syndromes, XXY|Klinefelter Syndromes|XXY Syndrome|Syndromes, Xxyy|Klinefelters Syndrome|Klinefelter's Syndrome|XXXY Male|Klinefelter syndrome|Syndrome, XXY|Syndrome, Klinefelter|Syndrome, Variants Klinefelter|Klinefelter Syndromes, Variants|Trisomies, XXY|Syndrome, Xxyy|Syndromes, Klinefelter|Syndromes, Variants Klinefelter|XXY Trisomies|49,XXXXY Syndrome|48,XXYY Syndrome|Klinefelter Syndrome, Variants|Xxyy Syndrome|XXY Syndromes"
NEW18515,DISEASE,endocrinopathy occurence,nonfunctional pituitary adenoma
NEW18516,CHEMICAL,endocrinopathy occurence,DM type
NEW18517,CHEMICAL,progesterone increase,progesterone increase
NEW18518,MENTAL_HEALTH,progesterone increase,CL regression
D007660,CHEMICAL,Ketoprofen,"|Orudis|ketoprofen|Benzoylhydratropic Acid|RP, 19,583|Alrheumum|RP 19583|RP19583|Profenid|2-(3-Benzoylphenyl)propionic Acid|RP-19583|Alrheumat|19,583 RP"
NEW18519,DISEASE,progesterone increase,cerebellar degeneracy
NEW18520,MENTAL_HEALTH,progesterone increase,alcoholic dementia
NEW18521,CHEMICAL,progesterone increase,alcohol treatment
NEW18522,DISEASE,rage-dependent neuronal death,RAGE-dependent neuronal death
NEW18523,CHEMICAL,rage-dependent neuronal death,AGE-albumin
NEW18524,DISEASE,adipose inflammation,Adipose inflammation
C496221,CHEMICAL,"Adgre1 protein, rat [Supplementary Concept]","Adgre1|Receptors, Cell Surface"
NEW18525,DISEASE,adipose inflammation,CSD mice
NEW18526,DISEASE,hypoleptinemia,hypoleptinemia
NEW18527,CHEMICAL,impaired glucose homeostasis,impaired glucose homeostasis
NEW18528,CHEMICAL,serotonergic antidepressant exposure,serotonergic antidepressant exposure
NEW18529,CHEMICAL,large-scale dm/q trial,large-scale DM/Q trials
NEW18530,CHEMICAL,large-scale dm/q trial,PBA rating scale
NEW18531,CHEMICAL,dm/q 30/30,DM/Q 30/30
NEW18532,CHEMICAL,subanesthetic dose,subanesthetic dose
NEW18533,CHEMICAL,dissociative anesthetic ketamine,dissociative anesthetic ketamine
NEW18534,CHEBI,nonselective opioid antagonist naltrexone,nonselective opioid antagonist naltrexone
NEW18535,CHEMICAL,nonselective opioid antagonist naltrexone,rapid antidepressant effect
NEW18536,DISEASE,cci-tbi,CCI-TBI
NEW18537,CHEMICAL,cci-tbi,cocaine place
NEW18538,CHEMICAL,dexamethasone treatment,dexamethasone treatment
NEW18539,CHEMICAL,lysine+dextroamphetamine formulation,lysine+dextroamphetamine formulation
NEW18540,DISEASE,cannabinoid hyperemesis syndrome patient,cannabinoid hyperemesis syndrome patients
NEW18541,CHEMICAL,cannabinoid hyperemesis syndrome patient,topical capsaicin
NEW18542,DISEASE,cannabinoid hyperemesis syndrome patient,antipsychotic-induced akathisia
NEW18543,CHEMICAL,cannabinoid hyperemesis syndrome patient,mg/12 h.
NEW18544,CHEMICAL,cannabinoid hyperemesis syndrome patient,B6 mg/12 h
NEW18545,CHEMICAL,cannabinoid hyperemesis syndrome patient,mg/12 h
D015026,CHEMICAL,Zeatin,Amino Alcohols (1973-1974)|zeatin|Purines (1973-1974)
http://purl.obolibrary.org/obo/CHEBI_8228,CHEMICAL,pioglitazone,"Actos|Pioglitazone|pioglitazonum|5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione|pioglitazone|(+-)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|TZD pioglitazone|pioglitazona"
NEW18546,CHEMICAL,sub-cus week exposure,sub-CUS week exposure
NEW18547,CHEMICAL,cus 6-week exposure,CUS 6-week exposure
NEW18548,CHEMICAL,sub-cus,sub-CUS
NEW18549,MENTAL_HEALTH,cus exposure,fEPSP depression
C558329,DISEASE,"6-chloro-N-(3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)imidazo(2,1-b)thiazole-5-sulfonamide [Supplementary Concept]",CDI|Indoles|Thiazoles|Sulfonamides
NEW18550,MENTAL_HEALTH,widespread antibiotic resistance,Widespread antibiotic resistance
NEW18551,DISEASE,widespread antibiotic resistance,fighting infections
NEW18552,CHEMICAL,chronic pbz exposure,chronic PBZ exposure
NEW18553,CHEMICAL,chronic pbz exposure,glyceride metabolism
NEW18554,NUTRITION,lithium-treate excellent lithium responder,lithium-treated excellent lithium responders
NEW18555,NUTRITION,lithium-treate excellent lithium responder,excellent lithium responders
NEW18556,NUTRITION,lithium monotherapy,lithium monotherapy
NEW18557,DISEASE,hyperthymic temperament,hyperthymic temperament
NEW18558,DISEASE,cognitive disorganization,cognitive disorganization
NEW18559,NUTRITION,Lithium Genetics,Lithium Genetics
D000077267,CHEMICAL,Fulvestrant,"Fulvestrant|ZM 182780|fulvestrant|ICI-182780|7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol|Faslodex|ICI 182,780|ZM182780|ICI 182780|ICI182780|ZM-182780"
NEW18560,CHEBI,Lithium Genetics,novel endocrine therapy
NEW18561,DISEASE,Lithium Genetics,hormone positive breast cancer
NEW18562,CHEBI,Lithium Genetics,oestrogen receptor (ER)-positive breast tumours
D000077384,CHEMICAL,Anastrozole,"2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)|anastrozole|Anastrazole|Zeneca ZD 1033|ICI D1033|ZD1033|Arimidex|ZD 1033|ZD-1033"
NEW18563,CHEMICAL,Lithium Genetics,tamoxifen-resistant tumours
NEW18564,CHEBI,stable mood stabilizer,stable mood stabilizer
NEW18565,DISEASE,stable mood stabilizer,self-reported depressive symptoms
NEW18566,CHEBI,selective beta-adrenoceptor agonist,Selective beta-adrenoceptor agonists
NEW18567,DISEASE,selective beta-adrenoceptor agonist,bronchial obstruction
NEW18568,CHEMICAL,red rice extract,red rice extract
C518017,DISEASE,"BRCC3 protein, human [Supplementary Concept]",cancer cell|Deubiquitinating Enzymes
C420323,CHEMICAL,"UL37 protein, Human herpesvirus 5 [Supplementary Concept]",vMIA|Immediate-Early Proteins
NEW18569,CHEBI,red rice extract,antiviral signalling
NEW18570,MENTAL_HEALTH,insulin-resistant syndrome,insulin-resistant syndromes
NEW18571,DISEASE,control pain,control pain
NEW18572,CHEMICAL,iron retention,iron retention
NEW18573,NUTRITION,low folate status,low folate status
NEW18574,NUTRITION,low folate intake,low folate intake
NEW18575,CHEMICAL,interferon-based regimen,Interferon-based regimens
NEW18576,CHEMICAL,cyclase inhibitor tripropylamine,TPA|cyclase inhibitor tripropylamine
NEW18577,NUTRITION,cyclase inhibitor tripropylamine,4-hydroxybenzoate choline
NEW18578,CHEMICAL,cyclase inhibitor tripropylamine,1-palmitoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine
NEW18579,CHEBI,cyclase inhibitor tripropylamine,lycopene accumulation
NEW18580,DISEASE,cyclase inhibitor tripropylamine,TRMA syndrome
NEW18581,CHEBI,combined vitamin preparation,Combined vitamin preparations
NEW18582,CHEMICAL,stress-induced cortisol secretion,stress-induced cortisol secretion
NEW18583,CHEMICAL,stress-induced cortisol secretion,brain 5-HT activity
NEW18584,CHEBI,stress-induced cortisol secretion,5-HT-mediated growth hormone
D000074361,CHEMICAL,Sleep Latency,"Latency, Sleep Onset|Sleep Onset Latencies|Sleep Latencies|Onset Latencies, Sleep|sleep onset|Sleep Latency, REM|Latency, REM Sleep|Sleep Onset Latency|REM Sleep Latency|REM Sleep Latencies|Latency, Sleep|preSO"
NEW18585,CHEBI,depressed patient,drug free
NEW18586,CHEMICAL,hydrophobic property,hydrophobic property
NEW18587,CHEBI,hydrophobic property,weak polar mycotoxins
NEW18588,CHEBI,hydrophobic property,multifunctional mycotoxin adsorbents
NEW18589,MENTAL_HEALTH,hydrophobic property,new orientation
NEW18590,CHEMICAL,nmda treatment,NMDA treatment
NEW18591,DISEASE,viral nervous necrosis,viral nervous necrosis|VNN
NEW18592,CHEBI,viral nervous necrosis,NNV-infected carriers
C572289,CHEMICAL,eicosenoic acid [Supplementary Concept],"Fatty Acids, Monounsaturated|cis-11-eicosenoic acid"
NEW18593,CHEBI,hormone regulation,hormone regulation
NEW18594,DISEASE,hormone regulation,EHP infection
NEW18595,MENTAL_HEALTH,cue-induced craving,Cue-induced craving
NEW18596,CHEBI,cue-induced craving,drug relapse
D056743,CHEMICAL,Cyclin D3,cyclin D3
NEW18597,CHEMICAL,cue-induced craving,naloxone treatment
NEW18598,MENTAL_HEALTH,chronic morphine treatment,withdrawal-induced hyperactivity
D011699,CHEMICAL,Putamen,"Putamens|putamen|Put|Nucleus Putamens|Putamens, Nucleus|Nucleus Putamen|Putamen, Nucleus"
NEW18599,CHEMICAL,gaba agonist 3-aminopropane sulphonic acid,3-APS|GABA agonist 3-aminopropane sulphonic acid
NEW18600,MENTAL_HEALTH,gaba agonist 3-aminopropane sulphonic acid,dopamine-accumbens hyperactivity model
NEW18601,CHEMICAL,gaba uptake system,GABA uptake systems
NEW18602,MENTAL_HEALTH,gaba uptake system,dopamine-dependent hyperactivity
NEW18603,MENTAL_HEALTH,gaba uptake system,dose-related depression
NEW18604,CHEMICAL,gaba uptake blockade,GABA uptake blockade
NEW18605,MENTAL_HEALTH,gaba uptake blockade,GABA-mediated depression
NEW18606,MENTAL_HEALTH,hyperactivity model,hyperactivity model
NEW18607,CHEMICAL,hyperactivity model,GABA uptake blocking compounds
NEW18608,CHEBI,drd1 antagonist,DRD1 antagonist
NEW18609,DISEASE,drd1 antagonist,anorexia weight loss
NEW18610,CHEBI,drd1 antagonist,antibacterial drug consumption
NEW18611,DISEASE,drd1 antagonist,common infections
D000071071,DISEASE,Microaneurysm,"Microaneurysms|Aneurysms, Miliary|Microaneurysms, Retinal|Miliary Aneurysms|Charcot Bouchard Aneurysms|Aneurysm, Charcot-Bouchard|Charcot-Bouchard Aneurysm|Aneurysm, Miliary|Aneurysms, Charcot-Bouchard|Microaneurysm, Retinal|Charcot-Bouchard Aneurysms|Miliary Aneurysm|Retinal Microaneurysms|microaneurysms|Charcot Bouchard Aneurysm|Retinal Microaneurysm"
NEW18612,CHEMICAL,drd1 antagonist,fluorescein leakage
NEW18613,DISEASE,early retinopathy,early retinopathy
NEW18614,CHEMICAL,adjuvant coq10,adjuvant CoQ10
NEW18615,MENTAL_HEALTH,syn orientation,syn orientation
NEW18616,CHEMICAL,syn orientation,3-indole acetic acid
NEW18617,CHEBI,syn orientation,antibiotic resistance marker
NEW18618,CHEMICAL,syn orientation,chloramphenicol resistance gene
NEW18619,CHEMICAL,syn orientation,fenretinide acetate
NEW18620,DISEASE,syn orientation,induced enteritis
C539275,CHEMICAL,"CHRNG protein, human [Supplementary Concept]","AchR|Receptors, Nicotinic"
NEW18621,CHEBI,syn orientation,enteritis drug
NEW18622,DISEASE,induce enteritis model,induced enteritis model
NEW18623,DISEASE,induce enteritis model,brain microsomes
NEW18624,DISEASE,non-aromatized androgene dihydrotestosterone,erection disorders
NEW18625,CHEMICAL,estradiole,estradiole
NEW18626,CHEMICAL,pyruvate dehydrogenase pdh deficiency,Pyruvate dehydrogenase PDH deficiency
NEW18627,DISEASE,pyruvate dehydrogenase pdh deficiency,congenital lactic acidosis
NEW18628,CHEMICAL,sialic-acid dosage,sialic-acid dosage
D015160,DISEASE,Hydrops Fetalis,"Hydrops Fetalis, Immune|Fetal Edema|Hydrops Fetali, Idiopathic|Nonimmunes, Hydrops Fetalis|Nonimmune Hydrops Fetali|hydrops fetalis|Hydrops Fetali, Nonimmune|Nonimmune Hydrops Fetalis|Familial Non-Immune Hydrops Fetalis|Hydrops Fetalis, Nonimmune|Fetalis, Idiopathic Hydrops|Immune Hydrops Fetalis|Non-Immune Hydrops Fetalis|Hydrops Fetalis Nonimmune|Idiopathic Hydrops Fetali|Hydrops Fetalis Nonimmunes|Fetalis Nonimmunes, Hydrops|Nonimmune, Hydrops Fetalis|Fetalis Nonimmune, Hydrops|Edema, Fetal|Hydrops, Fetal|Fetal Hydrops|Fetali, Idiopathic Hydrops|Idiopathic Hydrops Fetalis|Hydrops Fetalis, Non-Immune|Familial Non Immune Hydrops Fetalis|Hydrops Fetalis, Idiopathic"
NEW18629,DISEASE,sialic-acid dosage,central pain transmission
NEW18630,CHEBI,antagonist [11C]raclopride,antagonist [11C]raclopride
C536254,DISEASE,Pyridoxine-dependent epilepsy [Supplementary Concept],Epilepsy|pyridoxine-dependent epilepsy|Pyridoxine-dependent epilepsy
NEW18631,DISEASE,antagonist [11C]raclopride,neurometabolic disorder
NEW18632,CHEMICAL,antagonist [11C]raclopride,lysine metabolism
NEW18633,CHEMICAL,antagonist [11C]raclopride,α-aminoadipic semialdehyde dehydrogenase
NEW18634,DISEASE,antagonist [11C]raclopride,autosomal recessive neurometabolic disorder due
NEW18635,DISEASE,antagonist [11C]raclopride,dopaminergic neuronal death
NEW18636,CHEMICAL,mao b ko mouse,MAO B KO mice
D004660,DISEASE,Encephalitis,"|Rasmussen's Syndrome|brain inflammation|Brain Inflammations|encephalitis|Rasmussen Encephalitis|Encephalitis, Rasmussen|Rasmussen Syndrome|Brain Inflammation|Inflammation, Brain"
NEW18637,DISEASE,altered brain injury gene,Altered brain injury genes
NEW18638,DISEASE,altered brain injury gene,various disorders deficit hyperactive disorder
NEW18639,CHEMICAL,mao b knockout mouse,MAO B knockout mice
NEW18640,NUTRITION,tree algorithm,tree algorithms
NEW18641,DISEASE,tree algorithm,bipolar spectrum disorders|BPSD
NEW18642,DISEASE,srg suppression,SRG suppression
NEW18643,DISEASE,srg suppression,death cues
D055113,DISEASE,Chronic Periodontitis,"Periodontitides, Adult|Adult Periodontitis|Periodontitides, Chronic|Periodontitis, Chronic|periodontitis|Chronic Periodontitides|Adult Periodontitides|Periodontitis, Adult"
NEW18644,DISEASE,srg suppression,thyroid follicular cell hyperplasia
NEW18645,CHEBI,srg suppression,GI drug use
NEW18646,DISEASE,ruminal lactic acidosis,ruminal lactic acidosis
NEW18647,NUTRITION,ruminal lactic acidosis,lower volatile fatty acid concentrations
NEW18648,CHEBI,ruminal lactic acidosis,normal serum vitamin B12
NEW18649,DISEASE,hallucinogen persist perception disorder,Hallucinogen persisting perception disorder
NEW18650,DISEASE,veris L.,veris L.
D004229,CHEMICAL,Dithiothreitol,"Reagent, Cleland's|Cleland Reagent|DTT|Sputolysin|Reagent, Cleland|Cleland's Reagent|Clelands Reagent|Dithiothreitol"
D007611,CHEMICAL,Aprotinin,"Kallikrein-Trypsin Inactivator|Bovine Kunitz Pancreatic Trypsin Inhibitor|Contrical|Trasylol|Basic Pancreatic Trypsin Inhibitor|Kontrikal|Pulmin|BPTI, Basic Pancreatic Trypsin Inhibitor|Trypsin Inhibitor, Kunitz, Pancreatic|Contrykal|Kontrykal|Kallikrein Trypsin Inactivator|Inactivator, Kallikrein-Trypsin|Traskolan|Dilmintal|Antilysin|Zymofren|aprotinin|Trypsin Inhibitor, Basic, Pancreatic|Iniprol|Kunitz Pancreatic Trypsin Inhibitor|Bovine Pancreatic Trypsin Inhibitor"
NEW18651,CHEMICAL,veris L.,oral diethylstilboestrol
D020360,CHEMICAL,Neoadjuvant Therapy,"Treatment, Neoadjuvant|Chemotherapy Treatment, Neoadjuvant|Neoadjuvant Radiation Treatment|Neoadjuvant Chemoradiation|neoadjuvant therapy|Neoadjuvant Chemoradiation Treatments|Neoadjuvant Systemic Treatments|Neoadjuvant Systemic Therapies|Neoadjuvant Therapies|Neoadjuvant Chemotherapy Treatment|Neoadjuvant Chemoradiation Treatment|Radiotherapy, Neoadjuvant|Neoadjuvant Chemoradiation Therapy|Neoadjuvant Treatment|Systemic Therapy, Neoadjuvant|Neoadjuvant Radiation Treatments|Neoadjuvant Chemoradiation Therapies|Neoadjuvant Chemotherapy|Neoadjuvant Radiation Therapies|Neoadjuvant Chemotherapies|Treatment, Neoadjuvant Chemotherapy|Treatment, Neoadjuvant Chemoradiation|Therapy, Neoadjuvant|Neoadjuvant Radiations|Radiation Treatment, Neoadjuvant|Treatment, Neoadjuvant Systemic|Radiation, Neoadjuvant|Neoadjuvant Radiotherapy|Therapy, Neoadjuvant Chemoradiation|Neoadjuvant Chemotherapy Treatments|Systemic Treatment, Neoadjuvant|Neoadjuvant Radiation Therapy|Chemotherapy, Neoadjuvant|Chemoradiation Therapy, Neoadjuvant|Chemoradiation, Neoadjuvant|Neoadjuvant Radiotherapies|Therapy, Neoadjuvant Systemic|Neoadjuvant Systemic Treatment|Treatment, Neoadjuvant Radiation|Neoadjuvant Chemoradiotherapies|Therapy, Neoadjuvant Radiation|Chemoradiotherapy, Neoadjuvant|Chemoradiation Treatment, Neoadjuvant|Neoadjuvant Radiation|Neoadjuvant Treatments|Neoadjuvant Chemoradiotherapy|Neoadjuvant Systemic Therapy|Radiation Therapy, Neoadjuvant|Neoadjuvant Chemoradiations"
D000726,CHEBI,Androgen Antagonists,"Anti-Androgen Effects|Antagonists, Androgen|Effect, Antiandrogen|Anti Androgen Effects|Effects, Anti-Androgen|Antiandrogen Effect|Anti Androgen Effect|Antiandrogen Effects|antiandrogen|Effect, Anti-Androgen|Anti-Androgen Effect|Androgen Antagonist|Antiandrogen|Effects, Antiandrogen|Antiandrogens|Antagonist, Androgen"
NEW18652,DISEASE,veris L.,downstaging prostate tumours
NEW18653,DISEASE,veris L.,erythema nodosum leprosum
C031423,CHEBI,osmotic shock released antigen [Supplementary Concept],Blood Proteins|released antigen
D003168,MENTAL_HEALTH,Complement Fixation Tests,"Conglutination Reactions|Complement Fixation Test|Fixation Test, Complement|Reaction, Conglutination|Conglutinating Complement Absorption Test|Conglutination Reaction|Tests, Complement Fixation|Test, Complement Fixation|Complement Absorption Test, Conglutinating|Fixation Tests, Complement|Reactions, Conglutination|complement fixation"
NEW18654,DISEASE,daa therapy,HCV-associated disease burden
NEW18655,MENTAL_HEALTH,astrovirus projection domain,astrovirus projection domain
NEW18656,CHEMICAL,astrovirus projection domain,amino acid compositions
NEW18657,CHEMICAL,dopamine da depletion,Dopamine DA depletion
NEW18658,DISEASE,dopamine da depletion,abnormal spontaneous motor behavior
NEW18659,DISEASE,dopamine da depletion,daily myoclonic jerks
NEW18660,DISEASE,dopamine da depletion,severe dystonias
D005133,DISEASE,Eye Movements,"Movements, Eye|Movement, Eye|eye movements|Eye Movement"
NEW18661,MENTAL_HEALTH,exercise fatigue,Exercise fatigue
NEW18662,DISEASE,exercise fatigue,fatigue-related decrements
NEW18663,CHEMICAL,norepinephrine-dopamine reuptake inhibition,Norepinephrine-dopamine reuptake inhibition
NEW18664,CHEMICAL,norepinephrine-dopamine reuptake inhibition,norepinephrine-dopamine reuptake inhibition
NEW18665,MENTAL_HEALTH,brain infarct area,exercise fatigue
NEW18666,MENTAL_HEALTH,norepinephrine-dopamine reuptake inhibition,conditional logistic regression model
NEW18667,CHEMICAL,coal combustion emission,Coal combustion emissions|CCE
NEW18668,CHEMICAL,coal combustion emission,CCE relevant
C119064,DISEASE,"DLEC1 protein, human [Supplementary Concept]",Tumor Suppressor Proteins|lung cancer
NEW18669,CHEMICAL,bismuth-containing quadruple therapy,Bismuth-containing quadruple therapy
NEW18670,DISEASE,bismuth-containing quadruple therapy,Helicobacter pylori infection
NEW18671,CHEBI,ip3 receptor antagonist heparin,IP3 receptor antagonist heparin
NEW18672,CHEMICAL,ip3 receptor antagonist heparin,acetylcholine current
NEW18673,CHEMICAL,ryanodine-dependent ca2 mobilization inhibitor dantrolene,ryanodine-dependent Ca2 mobilization inhibitor dantrolene
NEW18674,CHEBI,ip3 receptor agonist inositol triphosphate,IP3 receptor agonist inositol triphosphate
NEW18675,CHEMICAL,"1,4,5-inositol trisphosphate-linked subtype","1,4,5-inositol trisphosphate-linked subtypes"
NEW18676,CHEMICAL,"1,4,5-inositol trisphosphate-linked subtype",postsynaptic calcium concentration
NEW18677,CHEMICAL,serotonergic anxiolytic buspirone,serotonergic anxiolytic buspirone
D000378,DISEASE,Agonistic Behavior,"Agonistic Behaviors|agonistic behaviors|Behavior, Agonistic|Behaviors, Agonistic"
NEW18678,DISEASE,migraine remission,migraine remissions
NEW18679,CHEBI,migraine remission,stable oestrogen levels
NEW18680,CHEMICAL,herbicide paraquat,herbicide paraquat|PQ
NEW18681,CHEMICAL,herbicide paraquat,nigrostriatal dopamine system
NEW18682,DISEASE,herbicide paraquat,permanent toxicity
NEW18683,CHEMICAL,pq       mb exposure,PQ      MB exposure
NEW18684,MENTAL_HEALTH,multiple regression analysis,multiple regression analyses
NEW18685,CHEMICAL,desensitization propertiesat,desensitization propertiesat
NEW18686,CHEBI,a supplementation,A supplementation
D051142,CHEBI,Retinol O-Fatty-Acyltransferase,"Synthetase, Retinol Ester|Fatty-Acyltransferase, Retinol|Ester Synthetase, Retinol|Retinol Fatty-Acyltransferase|Stearate Synthetase, Retinol|Retinol Fatty Acyltransferase|Acyl CoA Retinol Acyltransferase|Retinol-Palmitate Synthetase|Retinol Stearate Synthetase|Retinol Palmitate Synthetase|Fatty Acyl Coenzyme A Retinol Acyltransferase|Fatty Acyl Coenzyme A-Retinol Acyltransferase|Synthetase, Retinol-Palmitate|O-Fatty-Acyltransferase, Retinol|Retinol O Fatty Acyltransferase|Acyltransferase, Acyl CoA-Retinol|Synthetase, Retinol Stearate|CoA-Retinol Acyltransferase, Acyl|retinol palmitate|Acyl CoA-Retinol Acyltransferase|Retinol Ester Synthetase"
NEW18687,CHEMICAL,glutathione metabolic process,glutathione metabolic process
NEW18688,CHEMICAL,serotonin-uptake blocker fluvoxamine maleate,serotonin-uptake blocker fluvoxamine maleate
NEW18689,DISEASE,episodic memory failure,episodic memory failure
NEW18690,CHEMICAL,episodic memory failure,micrograms/kg/day
http://purl.obolibrary.org/obo/CHEBI_35716,CHEMICAL,c-nitro compound,"specifically-acting compounds|compound 5'-chloro-2,2'-dihydroxychalcone"
NEW18691,CHEMICAL,op poisoning,OP poisoning
D005207,DISEASE,Fasciculation,"|Fasciculations, Benign|Fasciculation, Muscular|Fasciculation, Benign|Muscular Fasciculations|Benign Fasciculations|Tongue Fasciculations|Muscle Fasciculations, Skeletal|Muscle Fasciculation, Skeletal|Fasciculations, Tongue|Skeletal Muscle Fasciculation|Muscle fasciculation|fasciculations|Fasciculation, Skeletal Muscle|Muscular Fasciculation|Benign Fasciculation|Fasciculation, Tongue|Fasciculations, Muscular|Fasciculations, Skeletal Muscle|Fasciculations|Skeletal Muscle Fasciculations|Tongue Fasciculation"
NEW18692,DISEASE,miosis op poisoning,Miosis OP poisoning
NEW18693,CHEMICAL,swainsonine concentration,swainsonine concentrations
NEW18694,CHEBI,swainsonine concentration,fungicide treatment
NEW18695,CHEBI,vitamin k-dependent protein osteocalcin,vitamin K-dependent protein osteocalcin
NEW18696,CHEBI,low vitamin k intake,Low vitamin K intake
NEW18697,MENTAL_HEALTH,Schizophrenia spectrum Disorders,Schizophrenia Spectrum Disorders
NEW18698,MENTAL_HEALTH,Schizophrenia spectrum Disorders,early-onset schizophrenia
D008972,CHEMICAL,Molindone,"|Moban|molindone|Hydrochloride, Molindone|Monohydrochloride, Molindone|Molindone Hydrochloride|Molindone Monohydrochloride"
NEW18699,CHEBI,old generation dopamine antagonist medication,older generation dopamine antagonist medications
NEW18700,MENTAL_HEALTH,old generation dopamine antagonist medication,stuttering symptoms
NEW18701,CHEBI,old generation dopamine antagonist medication,adrenergic agonist abuse
NEW18702,DISEASE,old generation dopamine antagonist medication,Psychiatric Clinic
NEW18703,CHEBI,old generation dopamine antagonist medication,pharmaceutical opioid
D002272,CHEBI,Carcinoembryonic Antigen,"Antigen, CD66e|CD66e Antigen|CD66e Antigens|Antigen, Carcinoembryonic|carcinoembryonic antigen|Antigens, CD66e"
NEW18704,NUTRITION,impaired cholesterol,impaired cholesterol
NEW18705,CHEMICAL,sphingolipid catabolism,sphingolipid catabolism
NEW18706,DISEASE,subclinical atherosclerosis,subclinical atherosclerosis
NEW18707,CHEMICAL,subclinical atherosclerosis,medical metformin
NEW18708,DISEASE,gremlin-1-silenced mesothelioma cell,gremlin-1-silenced mesothelioma cells
NEW18709,MENTAL_HEALTH,gremlin-1-silenced mesothelioma cell,adolescent ethanol abuse
NEW18710,MENTAL_HEALTH,gremlin-1-silenced mesothelioma cell,poor resistance profile
NEW18711,NUTRITION,arctic charr,Arctic charr
NEW18712,MENTAL_HEALTH,arctic charr,resistance profiles
NEW18713,CHEMICAL,most steroid metabolite,most steroid metabolites
NEW18714,MENTAL_HEALTH,most steroid metabolite,syndrome Asperger syndrome
D000738,CHEMICAL,Androsterone,androsterone|3 alpha Hydroxy 5 alpha Androstan 17 One|5 alpha-Androstan-3 alpha-ol-17-one|3-alpha-Hydroxy-5-alpha-Androstan-17-One|Epiandrosterone|5 alpha Androstan 3 alpha ol 17 one
NEW18715,CHEMICAL,oral montelukast,Oral montelukast
C018562,CHEMICAL,guggulu extract [Supplementary Concept],Commiphora|guggulipid|Guggulipid|Plant Extracts|Plant Gums
NEW18716,CHEMICAL,oral montelukast,guggulipid group
D005638,CHEMICAL,Fruit,"Capsules, Plant|Fruits|Aril, Plant|Berries|Legume Pods|Pods, Legume|Plant Capsule|Capsule, Plant|Plant Capsules|Plant Aril|Legume Pod|Pod, Legume|Plant Arils|Berry|fruit-|Arils, Plant"
NEW18717,NUTRITION,oral montelukast,% cholesterol/high lipoprotein HDL cholesterol ratio
NEW18718,DISEASE,inflammatory t helper cell,inflammatory T helper cells
NEW18719,DISEASE,inflammatory t helper cell,psychiatric signs
NEW18720,DISEASE,inflammatory t helper cell,psychiatric outcomes
NEW18721,CHEMICAL,cxcl12/cxcr4-cxcr7 receptor,CXCL12/CXCR4-CXCR7 receptors
NEW18722,CHEBI,gabab agonist baclofen,GABAB agonist baclofen
NEW18723,MENTAL_HEALTH,microbial resistance,microbial resistance
NEW18724,CHEBI,microbial resistance,novel antimicrobials
NEW18725,CHEBI,classical antimicrobial agent,classical antimicrobial agents
NEW18726,CHEBI,classical antimicrobial agent,androgen activity
NEW18727,DISEASE,classical antimicrobial agent,antisocial criminal behaviour
NEW18728,CHEMICAL,da symptom,DA symptoms
NEW18729,DISEASE,da symptom,non-betrayal trauma
NEW18730,MENTAL_HEALTH,da symptom,depression levels
NEW18731,DISEASE,da symptom,betrayal trauma
D009388,CHEMICAL,Neostigmine,"|Prozerin|Prostigmin|Proserine|Neostigmine Methylsulfate|Polstigmine|neostigmine|Neostigmine Bromide|Methylsulfate, Neostigmine|Prostigmine|Bromide, Neostigmine|Syntostigmine|Synstigmin"
NEW18732,DISEASE,da symptom,morphine-induced memory recall
NEW18733,CHEBI,peripheral nicotinic antagonist,peripheral nicotinic antagonist
NEW18734,CHEMICAL,low nicotine concentration,lower nicotine concentration
NEW18735,CHEBI,low nicotine concentration,effective anti-viral drug
NEW18736,DISEASE,ndv infected cell,NDV infected cells
NEW18737,DISEASE,anxiety-like behavior,Anxiety-like behavior
NEW18738,DISEASE,anxiety-like behavior,PWD-induced anxiety-like behavior
NEW18739,CHEMICAL,brainstem-acting drug cloperastine,CPS|brainstem-acting drug cloperastine
NEW18740,CHEMICAL,brainstem-acting drug cloperastine,Mecp2-null mice
NEW18741,DISEASE,brainstem-acting drug cloperastine,breathing dysfunction
NEW18742,DISEASE,sarcoma cell,sarcoma cells
NEW18743,CHEMICAL,sarcoma cell,chloroctyl amino-phenildioxan derivatives
NEW18744,CHEBI,liver-specific thyromimetic,Liver-specific thyromimetics
NEW18745,DISEASE,liver-specific thyromimetic,G6pc-/--deficient|GSD Ia
NEW18746,DISEASE,liver-specific thyromimetic,PRRSV infection
NEW18747,NUTRITION,tea catechin,tea catechins
NEW18748,CHEMICAL,cpt1a1 sirna knockdown,CPT1A1 siRNA knockdown
NEW18749,CHEMICAL,cpt1a1 sirna knockdown,treated HBMECs
NEW18750,CHEMICAL,transcript variant 4,ATF3-T4|transcript variants 4
NEW18751,DISEASE,transcript variant 4,TL-induced brain microvascular inflammation
NEW18752,DISEASE,transcript variant 4,lipotoxic
NEW18753,DISEASE,brain microvascular inflammation,brain microvascular inflammation
NEW18754,DISEASE,program cell death signalling pathway,programmed cell death signalling pathways
NEW18755,DISEASE,program cell death signalling pathway,small-fibre peripheral neuropathies
NEW18756,CHEMICAL,gel sample,GEL samples
NEW18757,MENTAL_HEALTH,gel sample,corrosion resistance
NEW18758,DISEASE,antitumor immunity,antitumor immunity
C000711728,CHEMICAL,spartalizumab [Supplementary Concept],"Antibodies, Monoclonal, Humanized|anti-PD1"
NEW18759,DISEASE,antitumor immunity,tumor PDL1
NEW18760,DISEASE,antitumor immunity,immunogenic tumor STING signals
NEW18761,DISEASE,antitumor immunity,due acute diverticulitis
NEW18762,CHEMICAL,high alcohol intake,high alcohol intake
D045724,DISEASE,"Diverticulosis, Stomach","Gastric Diverticulosis|Stomach Diverticulosis|diverticulosis|Diverticulosis, Gastric"
NEW18763,CHEBI,high alcohol intake,prototypic μ-opioid agonist remifentanil
NEW18764,DISEASE,high alcohol intake,infectious viral disease
NEW18765,CHEBI,high alcohol intake,rare endocrine disorder
NEW18766,CHEMICAL,smoking rate,Smoking rates
NEW18767,DISEASE,smoking rate,abdominal adiposity
NEW18768,CHEMICAL,bergamot polyphenolic formulation,Bergamot polyphenolic formulation|BPF99
NEW18769,CHEBI,vitamin d deficiency serum,Vitamin D deficiency serum
NEW18770,DISEASE,vitamin d deficiency serum,disease treatment guidelines
NEW18771,CHEBI,25-oh vitamin d level,25-OH vitamin D levels
NEW18772,CHEBI,extended-release calcifediol,Extended-release calcifediol
NEW18773,DISEASE,extended-release calcifediol,chronic kidney disease stages
NEW18774,CHEMICAL,nmdar antagonist apv,NMDAR antagonist APV
NEW18775,DISEASE,nmdar antagonist apv,gp120-induced mechanical allodynia
NEW18776,DISEASE,nmdar antagonist apv,gp120-induced pain
NEW18777,MENTAL_HEALTH,nmdar antagonist apv,disorder children
NEW18778,CHEMICAL,Trp98Stop,Trp98Stop
NEW18779,DISEASE,Trp98Stop,dysphoric state
NEW18780,CHEMICAL,nicotine seek,Nicotine seeking
NEW18781,DISEASE,nicotine seek,intermittent footshock stress
NEW18782,CHEMICAL,rapid-acting antidepressant property,rapid-acting antidepressant properties
D006331,DISEASE,Heart Diseases,|Heart Disorders|Cardiac Disorder|Cardiac Diseases|Heart Disease|Cardiac Disease|Heart Disorder|Cardiac Disorders|impaired heart function|heart disorders
NEW18783,DISEASE,rapid-acting antidepressant property,HCV-induced hepatic steatosis
NEW18784,DISEASE,comorbid condition,Comorbid conditions
D015428,DISEASE,Myocardial Reperfusion Injury,"Reperfusion Injury, Myocardial|Injury, Myocardial Reperfusion|myocardial injury|Myocardial Reperfusion Injuries|Reperfusion Injuries, Myocardial|Myocardial Ischemic Reperfusion Injury|Injuries, Myocardial Reperfusion"
NEW18785,CHEMICAL,cb(1 antagonist rimonabant,CB(1 antagonist rimonabant
NEW18786,CHEMICAL,cb(1 antagonist rimonabant,CCK(2
NEW18787,DISEASE,beta-hemolytic spirochete,beta-hemolytic spirochetes
C000648218,DISEASE,Brachyspira pilosicoli [Supplementary Concept],Brachyspira|Serpulina pilosicoli
NEW18788,CHEBI,beta-hemolytic spirochete,pharmaceutical intervention
NEW18789,CHEBI,beta-hemolytic spirochete,used chemotherapeutic drug
NEW18790,DISEASE,beta-hemolytic spirochete,psychiatric unit
NEW18791,NUTRITION,plant-derived phenylpropanoid,plant-derived phenylpropanoid
NEW18792,CHEMICAL,levodopa l-dopa therapy,Levodopa L-dopa therapy
NEW18793,MENTAL_HEALTH,levodopa l-dopa therapy,L-dopa-induced dyskinesia
NEW18794,CHEMICAL,camp signaling cascade,cAMP signaling cascade
NEW18795,MENTAL_HEALTH,camp signaling cascade,-dopa-induced dyskinesia
NEW18796,CHEMICAL,dopamine precursor l-3,dopamine precursor L-3
NEW18797,CHEMICAL,"l-3,4-dihydroxyphenylalanine therapy","L-3,4-dihydroxyphenylalanine therapy"
C517782,CHEMICAL,pasireotide [Supplementary Concept],Somatostatin/analogs  and  derivatives|Pasireotide
NEW18798,CHEBI,intramuscular botulinum toxin,intramuscular botulinum toxin
C000627118,DISEASE,"MMAB protein, human [Supplementary Concept]",cobalamin deficiency|Alkyl and Aryl Transferases
NEW18799,CHEMICAL,± sd serum level,± SD serum levels
NEW18800,DISEASE,± sd serum level,delirium non-delirium patients
NEW18801,CHEMICAL,chocolate consumption,chocolate consumption
NEW18802,CHEMICAL,facl4 gene mutation,FACL4 gene mutations
NEW18803,MENTAL_HEALTH,facl4 gene mutation,non-specific mental retardation
D058892,CHEMICAL,Adenosine Deaminase Inhibitors,"adenosine deaminase|Inhibitors, Adenosine Deaminase|ADA Inhibitors|Deaminase Inhibitors, Adenosine|Inhibitors, ADA"
NEW18804,CHEMICAL,available antidepressant agent,available antidepressant agents
NEW18805,CHEBI,glucagon-like peptide receptor agonist,Glucagon-like peptides receptor agonists
NEW18806,MENTAL_HEALTH,hair cortisol,multiple regression analysis r(2 = =
NEW18807,CHEBI,selective adrenergic blocker,selective adrenergic blocker
NEW18808,DISEASE,selective adrenergic blocker,hypertension standing diastolic blood pressure
NEW18809,CHEMICAL,oral labetalol,oral labetalol
NEW18810,MENTAL_HEALTH,oral labetalol,significant fatigue
D019806,CHEMICAL,Cromakalim,"|BRL38227|Cromakalim, (trans)-Isomer|Cromakalim, (3S-cis)-Isomer|Cromakalim, (3S-trans)-Isomer|cromakalim|BRL-38227|Levcromakalim|Cromakalim, (3R-cis)-Isomer|Lemakalim|BRL 38226|BRL38226|BRL-38226|BRL-34915|Cromakalim, (3R-trans)-Isomer|BRL 38227"
NEW18811,CHEMICAL,blocker doxazosin,blocker doxazosin
D053448,DISEASE,Prostatism,prostatism|Prostate (1950-1951)|Prostatic Hyperplasia (1951-2006)
NEW18812,CHEMICAL,adenosine reuptake,adenosine reuptake
NEW18813,CHEMICAL,serotonergic interaction,serotonergic interactions
NEW18814,CHEMICAL,3-hydroxy-3-methylglutaryl coenzyme a hmg-coa reductase inhibitor,3-hydroxy-3-methylglutaryl coenzyme A HMG-CoA reductase inhibitors
D000068558,CHEMICAL,"Amlodipine Besylate, Olmesartan Medoxomil Drug Combination","olmesartan|Amlodipine Besylate Olmesartan Medoxomil Drug Combination|Medoxomil, Amlodipine Besylate-Olmesartan|Amlodipine Besylate-Olmesartan Medoxomil|Amlodipine Besylate, Olmesartan Medoxomil|Besylate-Olmesartan Medoxomil, Amlodipine|Amlodipine Besylate Olmesartan Medoxomil|Amlodipine Besylate-Olmesartan Medoxomil Drug Combination|Azor"
NEW18815,DISEASE,3-hydroxy-3-methylglutaryl coenzyme a hmg-coa reductase inhibitor,arrhythmogenesis
D017035,CHEMICAL,Pravastatin,"|Pravasin|Lin-Pravastatin|Lipostat|RMS431|Mevalotin|Nu Pravastatin|pravastatin|SQ 31000|Liplat|SQ 31,000|Selektine|Lipemol|Elisor|Apo-Pravastatin|Apo Pravastatin|Lin Pravastatin|Pravastatin Sodium Salt|CS 514|Pravastatin tert-Octylamine Salt|CS-514|Sodium Salt, Pravastatin|SQ-31000|Bristacol|Nu-Pravastatin|CS514|Pravastatin Monosodium Salt, (6 beta)-Isomer|Prareduct|Vasten|Pravastatin Sodium|SQ31,000|RMS 431|Pravastatin tert Octylamine Salt|RMS-431|Pravachol|Eptastatin|Pravacol|Pravastatin, (6 beta)-Isomer|SQ-31,000|SQ31000"
NEW18816,CHEMICAL,pravastatin administration,Pravastatin administration
NEW18817,DISEASE,pravastatin administration,favorable ventricular remodeling
NEW18818,CHEMICAL,pravastatin administration,endothelin-1 pathway
C582420,CHEMICAL,methyl-2-ethoxy-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-benzimidazole-7-carboxylate [Supplementary Concept],Tetrazoles|Benzimidazoles|candesartan
NEW18819,CHEBI,pravastatin administration,antagonist pretreatment
NEW18820,CHEBI,dissociation rate,insurmountable antagonists
D004409,MENTAL_HEALTH,"Dyskinesia, Drug-Induced","Medication Induced Dyskinesia||Medication-Induced Dyskinesias|Medication-Induced Dyskinesia|hyper- or dyskinetic|Dyskinesia, Medication-Induced|Dyskinesia, Medication Induced|Dyskinesias, Drug-Induced|induced dyskinesia|Drug-Induced Dyskinesias|Dyskinesia, Drug Induced|Dyskinesias, Medication-Induced|Drug-Induced Dyskinesia"
NEW18821,DISEASE,tumor patient,Tumor patients
NEW18822,MENTAL_HEALTH,ischemia-induced retrograde amnesia,Ischemia-induced retrograde amnesia
NEW18823,CHEMICAL,ischemia-induced retrograde amnesia,FO administration
NEW18824,DISEASE,ischemia-induced retrograde amnesia,transient global cerebral ischemia|TGCI
D015669,CHEMICAL,Acupuncture Points,"Point, Acupuncture|Acupoints|acupuncture points|Points, Acupuncture|Acupuncture Point|Acupoint"
NEW18825,DISEASE,toxic aggregation,toxic aggregation
NEW18826,NUTRITION,southern flounder,southern flounder
NEW18827,MENTAL_HEALTH,southern flounder,metabolic fatigue
NEW18828,MENTAL_HEALTH,southern flounder,major syndromes
NEW18829,NUTRITION,spanish first-grade,Spanish first-grade
NEW18830,CHEBI,spanish first-grade,muscarinic receptor antagonist
NEW18831,CHEBI,calculate antagonist dissociation constant,calculated antagonist dissociation constants
NEW18832,NUTRITION,calculate antagonist dissociation constant,alpha 2-adrenoceptors
D014642,CHEMICAL,Vanilmandelic Acid,"4-Hydroxy-3-Methoxymandelic Acid|Vanillylmandelic Acid|Acid, Vanilmandelic|Acid, 4-Hydroxy-3-Methoxymandelic|Methoxyhydroxymandelic Acid|Acid, Methoxyhydroxymandelic|4 Hydroxy 3 Methoxymandelic Acid|vanillylmandelic acid|Acid, Vanillylmandelic"
NEW18833,CHEMICAL,calculate antagonist dissociation constant,urinary NE
NEW18834,CHEMICAL,mibg scintigraphy,MIBG scintigraphy
NEW18835,DISEASE,mibg scintigraphy,catecholamine-producing tumor
NEW18836,CHEBI,low ascorbic acid level,low ascorbic acid levels
NEW18837,MENTAL_HEALTH,low ascorbic acid level,senile dementia patients
NEW18838,DISEASE,low ascorbic acid level,self-injurious responses
NEW18839,DISEASE,salmonella typhimurium cecal colonization,Salmonella typhimurium cecal colonization
NEW18840,NUTRITION,salmonella typhimurium cecal colonization,quail chicks
NEW18841,DISEASE,cecal microflora,cecal microflora
NEW18842,CHEMICAL,dietary lactose,dietary lactose
NEW18843,DISEASE,bobwhite quail,mynah pox virus
C419502,CHEMICAL,alvimopan [Supplementary Concept],Alvimopan|Piperidines|alvimopan
NEW18844,DISEASE,bobwhite quail,post-operative ileus
NEW18845,MENTAL_HEALTH,bobwhite quail,slower dissociation rate
NEW18846,CHEMICAL,bobwhite quail,t(1/2)=44 min
NEW18847,CHEMICAL,bobwhite quail,long acting partial agonist buprenorphine
NEW18848,MENTAL_HEALTH,bobwhite quail,slow dissociation rate
NEW18849,MENTAL_HEALTH,bobwhite quail,dissociation symptoms
NEW18850,CHEMICAL,one extra carbon,one extra carbon|α-PHP
NEW18851,DISEASE,one extra carbon,memory impairments-effects
NEW18852,DISEASE,one extra carbon,psychiatric events
NEW18853,CHEMICAL,o2 stimulus,O2 stimuli
NEW18854,DISEASE,o2 stimulus,respiratory instability
NEW18855,CHEMICAL,testosterone supplementation,testosterone supplementation
NEW18856,CHEMICAL,acute testosterone supplementation,acute testosterone supplementation
NEW18857,CHEMICAL,testosterone administration,testosterone administration
NEW18858,CHEMICAL,hyperglycaemia,C(60)HyFn
C530950,CHEBI,CD80-CAP [Supplementary Concept],Oligopeptides|competitive antagonist
NEW18859,CHEMICAL,camp production,cAMP production
NEW18860,MENTAL_HEALTH,camp production,ligand dissociation
NEW18861,CHEMICAL,camp production,W124EL1
NEW18862,CHEMICAL,camp production,benzamide motif
NEW18863,CHEMICAL,camp production,immediate-release IR opioids
NEW18864,CHEBI,camp production,μ-opioid-receptor agonists
NEW18865,MENTAL_HEALTH,camp production,slow dissociation profile
NEW18866,DISEASE,second encouraging psychiatric use,second encouraging psychiatric use
NEW18867,NUTRITION,mood disorder patient,lithium use
C071475,CHEMICAL,methyl bensulfuron [Supplementary Concept],Sulfonylurea Compounds|bensulfuron-methyl
NEW18868,MENTAL_HEALTH,mood disorder patient,resistance index
NEW18869,CHEMICAL,mood disorder patient,BCAAs genotypes
NEW18870,CHEMICAL,mood disorder patient,bensulfuron-methyl inhibition
NEW18871,CHEMICAL,subpopulation bc1,subpopulation BC1
NEW18872,CHEMICAL,subpopulation bc1,ALS-inhibiting herbicides
NEW18873,DISEASE,subpopulation bc1,ALS enzyme
NEW18874,CHEMICAL,bc1 population,BC1 population
C549011,CHEMICAL,bispyribac [Supplementary Concept],Benzoates|bispyribac-sodium|Pyrimidines
NEW18875,MENTAL_HEALTH,bc1 population,resistance ratios
NEW18876,MENTAL_HEALTH,bc1 population,non-target-site resistance
C065631,CHEMICAL,phosducin [Supplementary Concept],Eye Proteins|Phosphoproteins|GTP-Binding Protein Regulators|pDC|ivD-pDC
NEW18877,DISEASE,bc1 population,minimal ALL disease
NEW18878,DISEASE,bc1 population,severe HPP types
NEW18879,CHEBI,bc1 population,vitamin B6 metabolism
NEW18880,CHEMICAL,bc1 population,transmethylases
C062485,CHEMICAL,bredinin 5'-monophosphate [Supplementary Concept],Ribonucleotides|Bredinin
D014178,DISEASE,"Translocation, Genetic","Chromosomal Translocation|Translocations, Chromosomal|translocations|Translocations, Genetic|Genetic Translocations|Translocation, Chromosomal|Genetic Translocation|Chromosomal Translocations"
NEW18881,DISEASE,bc1 population,marked chromosomal aberrations
NEW18882,CHEMICAL,bc1 population,gonadotropin-induced cAMP generation
NEW18883,DISEASE,crf action,CRF action
NEW18884,CHEMICAL,crf action,pertussis toxin-insensitive guanyl nucleotide regulatory unit
D007984,DISEASE,Leydig Cell Tumor,"Leydig cell|Tumor, Leydig Cell|Interstitial Cell Tumor|Tumors, Interstitial Cell|Tumor, Interstitial Cell|Interstitial Cell Tumors"
NEW18885,CHEMICAL,crf action,5HT2 receptors
NEW18886,CHEBI,crf action,toxin insensitive G-protein
NEW18887,DISEASE,crf action,CRF secretion
NEW18888,CHEMICAL,high ps level,higher PS level
NEW18889,MENTAL_HEALTH,high ps level,rate dissociation rate
NEW18890,DISEASE,endocrine change,breast cancer cell migration
NEW18891,CHEMICAL,norepinephrine ne transporter,norepinephrine NE transporters
NEW18892,MENTAL_HEALTH,norepinephrine ne transporter,depression research
C000617044,CHEMICAL,Roentgenium [Supplementary Concept],roentgenium|Rg1|Transactinide Series Elements
C035054,CHEMICAL,ginsenoside Rg1 [Supplementary Concept],Ginsenoside Rg1|Ginsenosides
NEW18893,MENTAL_HEALTH,norepinephrine ne transporter,resistance due
NEW18894,CHEMICAL,strong mptpp effect,strongest MPTPp effect
NEW18895,DISEASE,CPu dopamine level,CPu dopamine levels
NEW18896,DISEASE,astrocytic hypertrophy,astrocytic hypertrophy
NEW18897,MENTAL_HEALTH,astrocytic hypertrophy,adult personality disorder
D019955,MENTAL_HEALTH,Conduct Disorder,Callous-Unemotional Traits|Callous Unemotional Traits|Conduct Disorders|Callous-Unemotional Trait|conduct disorder
NEW18898,MENTAL_HEALTH,astrocytic hypertrophy,late-onset ADHD
NEW18899,MENTAL_HEALTH,astrocytic hypertrophy,less insomnia
NEW18900,CHEBI,other drug option,Other drug options
NEW18901,CHEMICAL,iron supplement,iron supplements
NEW18902,DISEASE,iron supplement,involuntary erection
NEW18903,DISEASE,iron supplement,interpersonal hypersensitivity
NEW18904,DISEASE,iron supplement,metabolic syndrome related
D009770,MENTAL_HEALTH,Obsessive Behavior,"Obsessive Behaviors|Obsession|Behavior, Obsessive|Obsessions|Behaviors, Obsessive"
D000077542,CHEMICAL,Eptifibatide,"Eptifibatide|7H-Pyrrolo(2,1-g)(1,2,5,8,11,14,17,20)dithiahexaazacyclotricosine-17-acetic acid, 3-(aminocarbonyl)-11-(4-((aminoiminomethyl)amino)butyl)docosahydro-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxo-, (3R,11S,17S,20S,25aS)-|Integrilin|Epifibatide|Integrelin|eptifibatide|Epifibratide"
NEW18905,CHEBI,iron supplement,glycoprotein IIb/IIIa receptor antagonist
NEW18906,DISEASE,patient 's thrombocytopenia,patient's thrombocytopenia
NEW18907,DISEASE,profound thrombocytopenia,Profound thrombocytopenia
NEW18908,CHEMICAL,intravenous eptifibatide,intravenous eptifibatide
NEW18909,MENTAL_HEALTH,intravenous eptifibatide,elevation acute coronary syndromes
NEW18910,DISEASE,intravenous eptifibatide,NSTE|non-ST-segment elevation
D000789,DISEASE,"Angina, Unstable","Preinfarction Syndrome, Myocardial|Unstable Angina Pectori|Syndromes, Myocardial Preinfarction|Angina at Rest|Anginas, Unstable|Syndrome, Myocardial Preinfarction|Preinfarction Angina|Unstable Angina|Angina Pectori, Unstable|Myocardial Preinfarction Syndrome|Angina Pectoris, Unstable|Anginas, Preinfarction|Angina, Preinfarction|Unstable Anginas|Unstable Angina Pectoris|Myocardial Preinfarction Syndromes|Preinfarction Anginas|Unstable angina|Preinfarction Syndromes, Myocardial"
NEW18911,MENTAL_HEALTH,induce psychosis,paranoid type schizophrenia
NEW18912,MENTAL_HEALTH,acute untreated schizophrenia,acute untreated schizophrenia
NEW18913,NUTRITION,acute untreated schizophrenia,prominent alpha activity
NEW18914,MENTAL_HEALTH,disorganized type schizophrenia,disorganized type schizophrenia
NEW18915,NUTRITION,disorganized type schizophrenia,alpha activity
NEW18916,CHEMICAL,central serotonin 5ht system,central serotonin 5HT system
NEW18917,CHEMICAL,central serotonin 5ht system,meta-chlorphenylpiprazine
NEW18918,CHEBI,central serotonin 5ht system,central serotonin receptor agonist
NEW18919,DISEASE,primary bilateral macronodular adrenal hyperplasia,Primary bilateral macronodular adrenal hyperplasia
NEW18920,CHEMICAL,primary bilateral macronodular adrenal hyperplasia,subclinical cortisol production
NEW18921,DISEASE,primary bilateral macronodular adrenal hyperplasia,bilateral adrenal incidentalomas
C095283,DISEASE,"VP3 protein, Epizootic hemorrhagic disease virus 2 [Supplementary Concept]",Epizootic hemorrhagic disease|Viral Proteins
NEW18922,DISEASE,primary bilateral macronodular adrenal hyperplasia,vector-borne viral diseases
C054597,CHEMICAL,garcinol [Supplementary Concept],garcinol|Terpenes|Garcinol
NEW18923,DISEASE,primary bilateral macronodular adrenal hyperplasia,Garcinia sp.
NEW18924,CHEMICAL,primary bilateral macronodular adrenal hyperplasia,MPTP mouse model
NEW18925,DISEASE,whose 's toxicity,whose's toxicity
NEW18926,CHEBI,whose 's toxicity,adrenergic agonist drugs
NEW18927,CHEBI,appropriate adrenergic agent,appropriate adrenergic agent
NEW18928,DISEASE,appropriate adrenergic agent,massive hepatocellular necrosis
NEW18929,DISEASE,whose be hepatotoxicity,whose's hepatotoxicity
NEW18930,CHEBI,whose be hepatotoxicity,adrenergic antagonist drugs
NEW18931,CHEBI,whose be hepatotoxicity,hepatotoxicant
NEW18932,CHEMICAL,whose be hepatotoxicity,endogenous catecholamine levels
NEW18933,DISEASE,hepatotoxic dose,hepatotoxic doses
C043067,CHEMICAL,"bromobenzene 3,4-oxide [Supplementary Concept]",bromobenzene|Bromobenzenes
NEW18934,CHEMICAL,elevated catecholamine,elevated catecholamines
NEW18935,DISEASE,elevated catecholamine,hepatotoxic effects
NEW18936,CHEBI,ethanol extract,good analgesic activity
NEW18937,CHEMICAL,equianalgesic dose,equianalgesic doses
NEW18938,CHEMICAL,pethidine-tilidine combination,pethidine-tilidine combinations
NEW18939,MENTAL_HEALTH,primary depression,acute schizophrenia
NEW18940,DISEASE,lithium therapy,multiple neuropsychiatric disorders
NEW18941,DISEASE,lithium therapy,neurobehavioural impairments
NEW18942,CHEBI,lithium therapy,critical hormones
NEW18943,MENTAL_HEALTH,lithium therapy,terminal projection areas
NEW18944,CHEMICAL,lithium therapy,cocaine-evoked DA overflow
NEW18945,CHEMICAL,adenosine A2AR,adenosine A2AR
NEW18946,DISEASE,adenosine A2AR,serious neuropathological damage
NEW18947,MENTAL_HEALTH,e3 adhd subunit,E3 AdhD subunit
NEW18948,CHEMICAL,e3 adhd subunit,E2 AdhC.
NEW18949,CHEMICAL,e3 adhd subunit,most 2-oxoacid dehydrogenases
NEW18950,CHEMICAL,e3 adhd subunit,glucose medium
D008733,CHEMICAL,Methoxyflurane,|Pentrane|Methoxyflurane|Anecotan|Penthrane|Methofluranum|methoxyflurane
NEW18951,CHEMICAL,7-ni,7-NI
NEW18952,CHEMICAL,renin-angiotensin-aldosterone blockade,Renin-angiotensin-aldosterone blockade
NEW18953,DISEASE,renin-angiotensin-aldosterone blockade,short-term loss
NEW18954,DISEASE,an-induced cognitive deficit,AN-induced cognitive deficits
NEW18955,CHEMICAL,an-induced cognitive deficit,Astaxanthin pretreatment
NEW18956,CHEMICAL,an-induced cognitive deficit,intracellular glutathione
NEW18957,DISEASE,an-induced cognitive deficit,vascular EC dysfunction
NEW18958,CHEMICAL,free levothyroxine,free levothyroxine
NEW18959,MENTAL_HEALTH,quantile regression,Quantile regression
NEW18960,CHEMICAL,cabergoline therapy,cabergoline therapy
NEW18961,DISEASE,hyperprolactinemic serum,hyperprolactinemic sera
C014225,CHEMICAL,tocophersolan [Supplementary Concept],poly-ethylene-glycol|PEG|Vitamin E
NEW18962,CHEBI,hyperprolactinemic serum,antifungals
NEW18963,CHEBI,specific egfr inhibitor osimertinib mesylate,specific EGFR inhibitor osimertinib mesylate
NEW18964,MENTAL_HEALTH,specific egfr inhibitor osimertinib mesylate,azole resistance
NEW18965,MENTAL_HEALTH,specific egfr inhibitor osimertinib mesylate,fluconazole resistance
NEW18966,MENTAL_HEALTH,specific egfr inhibitor osimertinib mesylate,probable bruxism
NEW18967,MENTAL_HEALTH,bruxism episode,bruxism episodes
NEW18968,CHEMICAL,bruxism episode,pramipexole episodes
NEW18969,CHEMICAL,bruxism episode,pramipexole conditions
NEW18970,MENTAL_HEALTH,post-partum mental illness,post-partum mental illness
NEW18971,CHEMICAL,post-partum mental illness,PlantVis
C057863,CHEMICAL,8-methoxypsoralen-DNA [Supplementary Concept],8-methoxypsoralen|DNA Adducts|Methoxsalen
D011564,CHEMICAL,Furocoumarins,Furocoumarin|Furanocoumarin|furanocoumarin|Furanocoumarins|Psoralens|Angelicins
NEW18972,CHEMICAL,uva light,UVA light
D000971,CHEBI,Antineoplastic Combined Chemotherapy Protocols,"Combined Antineoplastic Agents|Agent, Combined Antineoplastic|Chemotherapy Protocols, Cancer|Protocol, Antineoplastic Chemotherapy|Antineoplastic Chemotherapy Protocol|Protocol, Cancer Chemotherapy|Protocols, Antineoplastic Chemotherapy|Antineoplastic Agent, Combined|Agents, Combined Antineoplastic|Chemotherapy Protocol, Antineoplastic|Combined Antineoplastic Agent|Cancer Chemotherapy Protocols|Combinations, Antineoplastic Drug|Cancer Chemotherapy Protocol|Antineoplastic Drug Combination|Drug Combination, Antineoplastic|anticancer drug|Antineoplastic Agents, Combined|Drug Combinations, Antineoplastic|Chemotherapy Protocol, Cancer|Drug Combinations, Anticancer|Antineoplastic Drug Combinations|Protocols, Cancer Chemotherapy|Anticancer Drug Combination|Antineoplastic Chemotherapy Protocols|Chemotherapy Protocols, Antineoplastic|Anticancer Drug Combinations|Antineoplastic Combined Chemotherapy Regimens|Drug Combination, Anticancer"
NEW18973,CHEMICAL,Psoralea corylifolia L. seed,Psoralea corylifolia L. seed
NEW18974,DISEASE,Psoralea corylifolia L. seed,kidney yang deficiency
NEW18975,MENTAL_HEALTH,long-term mental disorder,long-term mental disorders
NEW18976,CHEBI,prenatal vitamin d,Prenatal vitamin D
NEW18977,DISEASE,prenatal vitamin d,PNM|postnatal months
NEW18978,CHEMICAL,prenatal dexamethasone,Prenatal dexamethasone
C113300,CHEMICAL,TPH hybrid [Supplementary Concept],Composite Resins|TPH
NEW18979,MENTAL_HEALTH,prenatal dexamethasone,depression attention
NEW18980,CHEBI,serum vitamin d level,serum vitamin D level
D004964,CHEMICAL,Estriol,"16alpha,17beta-Estriol|Ovestin|16-alpha-Hydroxy-Estradiol|16beta Hydroxy Estradiol|estriol|(16beta,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol|16alpha,17beta Estriol|(16alpha,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol|16beta-Hydroxy-Estradiol|16 alpha Hydroxy Estradiol|Epiestriol|Estra-1,3,5(10)-Triene-3,16beta,17beta-Triol"
NEW18981,NUTRITION,concurrent lithium therapy,concurrent lithium therapy
NEW18982,MENTAL_HEALTH,refractory early onset schizophrenia,refractory early onset schizophrenia
NEW18983,CHEMICAL,refractory early onset schizophrenia,clozapine regimen
C500350,CHEMICAL,"N,N'-dibenzoylcystine [Supplementary Concept]",Cystine/analogs  and  derivatives|DBC
NEW18984,DISEASE,refractory early onset schizophrenia,sleep-related breathing difficulties
D000293,CHEMICAL,Adolescent,"Youths|Adolescent, Male|Adolescents, Male|Adolescents|Teenagers|Male Adolescents|Adolescence|Youth|Female Adolescent|Male Adolescent|Teens|ESS-CHAD|Adolescents, Female|Female Adolescents|Teenager|Teen|Adolescent, Female"
NEW18985,DISEASE,contrast antipsychotic-induced eps,contrast antipsychotic-induced EPS
http://purl.obolibrary.org/obo/CHEBI_7494,CHEMICAL,nefazodone,"nefazodone|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|mirtazapine α2|nefazodonum|2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-5-ethyl-4-(2-phenoxyethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one|Nefazodone|nefazodona"
NEW18986,DISEASE,eps induction,EPS induction
NEW18987,DISEASE,antipsychotic-induced eps,antipsychotic-induced EPS
NEW18988,CHEMICAL,multiple 5-ht receptor,multiple 5-HT receptors
NEW18989,CHEMICAL,multiple 5-ht receptor,ChEIs reuptake inhibitors
NEW18990,CHEBI,dopamine receptor antagonist haloperidol,dopamine receptor antagonist haloperidol
NEW18991,DISEASE,dopamine receptor antagonist haloperidol,catalepsy sensitization
NEW18992,CHEMICAL,dopamine receptor antagonist haloperidol,glutamatergic AMPA/Kainate-
NEW18993,CHEBI,dopamine receptor antagonist haloperidol,NMDA-receptor antagonists
NEW18994,CHEBI,new selective norepinephrine reuptake inhibitor,new selective norepinephrine reuptake inhibitor
NEW18995,MENTAL_HEALTH,new selective norepinephrine reuptake inhibitor,ADHD tic disorder
NEW18996,CHEMICAL,selective norepinephrine reuptake inhibitor,medication atomoxetine
D004733,CHEMICAL,Enema,Enematas|Enemas|Enemata
D061270,DISEASE,Nasal Septal Perforation,"Septum Perforation, Nasal|perforation|Septum Perforations, Nasal|Septal Perforations, Nasal|Perforation, Nasal Septal|Nasal Septum Perforations|Perforation, Nasal Septum|Perforations, Nasal Septum|Nasal Septal Perforations|Perforations, Nasal Septal|Nasal Septum Perforation|Septal Perforation, Nasal"
NEW18997,DISEASE,selective norepinephrine reuptake inhibitor,metabolic derangement
NEW18998,CHEMICAL,selective norepinephrine reuptake inhibitor,hydroxy-carboxylic acid receptor
D000069462,CHEMICAL,Dimethyl Fumarate,"BG-12 compound|Tecfidera|201, FAG|FAG201|compound, BG 12|BG 00012|BG00012|BG-00012|BG12 compound|FAG 201|Dimethyl fumarate|Dimethylfumarate|2-butenedioic acid, (2E)-, dimethyl ester|Fumarate, Dimethyl|Fumaderm|compound, BG12|12 compound, BG|FAG-201|BG 12 compound|00012, BG"
D009846,DISEASE,Oliguria,|Oligurias|oliguria
NEW18999,DISEASE,selective norepinephrine reuptake inhibitor,central impairment
NEW19000,NUTRITION,aegerita lectin,aegerita lectin
NEW19001,NUTRITION,aegerita lectin,fungi Agrocybe aegerita
NEW19002,CHEMICAL,aegerita lectin,purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase
D006467,DISEASE,Hemophilia A,"Classic Hemophilia|As, Autosomal Hemophilia|congenital deficiency|Hemophilia As, Autosomal|Autosomal Hemophilia A|Factor 8 Deficiency, Congenital|Deficiency, Factor VIII|Hemophilia|Hemophilias, Classic|Hemophilia As|Autosomal Hemophilia As|Hemophilia A, Autosomal|Classic Hemophilias|Hemophilia, Classic|Haemophilia|Factor VIII Deficiency|Hemophilia A, Congenital|Congenital Hemophilia As|Factor VIII Deficiency, Congenital|Congenital Hemophilia A|Hemophilia As, Congenital"
NEW19003,NUTRITION,synthetic calcium phosphate,synthetic calcium phosphates
NEW19004,MENTAL_HEALTH,synthetic calcium phosphate,projection reconstruction technique
NEW19005,CHEMICAL,multinuclear three-dimensional solid-state mri,Multinuclear three-dimensional solid-state MRI
NEW19006,MENTAL_HEALTH,three-dimensional projection reconstruction mri,Three-dimensional projection reconstruction MRI
NEW19007,DISEASE,minimal thyroid abnormality,Minimal thyroid abnormalities
NEW19008,DISEASE,minimal thyroid abnormality,central thyroid disorders
NEW19009,CHEMICAL,minimal thyroid abnormality,exhausted TRH hypothalamic biodisponibility
NEW19010,CHEMICAL,norepinephrine level,norepinephrine level
NEW19011,CHEBI,norepinephrine level,increased hormones biodisponibility
NEW19012,CHEMICAL,serotonin synthesis,5HIA catabolite
NEW19013,DISEASE,serotonin synthesis,acne treatment regimen
NEW19014,MENTAL_HEALTH,antibiotic phobia,antibiotic phobia
NEW19015,CHEBI,antibiotic intervention mouse,antibiotic intervention mice
C116177,DISEASE,capsular polysaccharide 19F [Supplementary Concept],S. pneumoniae|Bacterial Capsules
NEW19016,MENTAL_HEALTH,antibiotic intervention mouse,peripartum depression
NEW19017,DISEASE,bovine mycotoxicosis,Bovine mycotoxicosis
D001906,DISEASE,Botulism,"Infant Botulism|Infantile Botulism|Botulism, Foodborne|Botulism, Toxico Infectious|Foodborne Botulism|Botulism|Toxico-Infectious Botulism|Toxico Infectious Botulism|Foodborne Botulisms|Infection, Clostridium botulinum|Botulism, Infantile|Botulism, Wound|Wound Botulisms|Clostridium botulinum Infection|Botulism, Toxico-Infectious|Infant Botulisms|Clostridium botulinum Infections|Botulism, Infant|Wound Botulism"
NEW19018,DISEASE,bovine mycotoxicosis,Clostridium botulinum bacteria
NEW19019,DISEASE,persistent dizziness,persistent dizziness
D008575,CHEMICAL,Meniere Disease,"Ménière's Vertigo|Vertigo, Aural|Ménière's Diseases|Vertigo, Otogenic|Ménière Disease|Menieres Disease|Vertigo, Auditory|Disease, Meniere|Diseases, Ménière|Ménière's Vertigos|Aural Vertigo|Otogenic Vertigos|Meniere's Disease|Ménière Diseases|Ménière Vertigo|Meniere Syndrome|Otogenic Vertigo|Syndrome, Meniere's|Disease, Ménière|Auditory Vertigo|Ménières Disease|Ménières Vertigo|Ménière's Disease|Ménière's disease|Menieres Syndrome|Meniere's Syndrome|Vertigo, Ménière's|Vertigos, Ménière's|Disease, Ménière's|Disease, Meniere's|Diseases, Ménière's|Auditory Vertigos|Vertigos, Otogenic|Vertigos, Auditory"
NEW19020,NUTRITION,cholesterol determination,Cholesterol determination
D002537,DISEASE,Intracranial Arteriosclerosis,"Intracranial Atheroscleroses|arteriosclerosis|Intracranial Arterioscleroses|Arteriosclerosis, Cerebral|Intracranial Atherosclerosis|Cerebral Atherosclerosis|Atheroscleroses, Intracranial|Arteriosclerosis, Intracranial|Arterioscleroses, Intracranial|Cerebral Atheroscleroses|Atherosclerosis, Intracranial|Cerebral Arteriosclerosis|Cerebral Arterioscleroses|Arterioscleroses, Cerebral|Atheroscleroses, Cerebral|Atherosclerosis, Cerebral"
D041781,DISEASE,"Jaundice, Obstructive","Mechanical Jaundice||Obstructive Jaundice|Jaundice, Mechanical|Cholestatic Jaundice|Cholestatic jaundice|obstructive jaundice|Jaundice, Cholestatic"
NEW19021,NUTRITION,standard cholesterol,standard cholesterol
NEW19022,MENTAL_HEALTH,standard cholesterol,regression coefficient
NEW19023,NUTRITION,prepare cholesterol biosensor,prepared cholesterol biosensor
NEW19024,CHEMICAL,csa array,CSA array
NEW19025,DISEASE,csa array,chronic bacterial sinusitis
D016984,CHEMICAL,Enterococcus faecium,Streptococcus faecium|Enterococcus faecium
NEW19026,CHEMICAL,iron deprivation,iron deprivation
NEW19027,DISEASE,iron deprivation,HPV-positive cancer cells
NEW19028,CHEBI,iron deprivation,antiviral effects
NEW19029,CHEMICAL,5-fluorocytosine therapy,5-Fluorocytosine therapy
NEW19030,CHEMICAL,guanine biosynthesis,guanine biosynthesis
NEW19031,CHEMICAL,inosine monophosphate dehydrogenase inhibitor,inosine monophosphate dehydrogenase inhibitor
C402104,CHEMICAL,5-formyl-2'-deoxycytidine [Supplementary Concept],Deoxycytidine/analogs  and  derivatives|5-FC
D001232,DISEASE,Aspergillus fumigatus,Aspergillus fumigatus|Sartorya fumigata|Neosartorya fumigata|Aspergillus fumigates
NEW19032,CHEMICAL,inosine monophosphate dehydrogenase inhibitor,Amphotericin B susceptibility
NEW19033,DISEASE,compulsive behaviour present,Compulsive behaviour present
NEW19034,DISEASE,different psychiatric disorder,behavior mood symptoms
NEW19035,CHEMICAL,mineral bone disorder,MBD|mineral bone disorders
NEW19036,DISEASE,aki mouse,AKI mice
NEW19037,DISEASE,aki mouse,cardiac hypertrophy phenotype
NEW19038,DISEASE,contractile dysfunction,contractile dysfunction
NEW19039,CHEMICAL,ca2 transient,Ca2 transients
C004180,NUTRITION,dexamethasone 21-phosphate [Supplementary Concept],Dexamethasone/analogs  and  derivatives|dexamethasone sodium phosphate
NEW19040,DISEASE,tumor necrosis factor (tnf)-α,tumor necrosis factor (TNF)-α
NEW19041,CHEMICAL,tumor necrosis factor (tnf)-α,glucagon synthase kinase
C104723,CHEMICAL,"glutamate receptor ionotropic, AMPA 3 [Supplementary Concept]","Receptors, AMPA|glutamate receptor subunit"
http://purl.obolibrary.org/obo/CHEBI_53576,CHEMICAL,pyrimidine-2-thiol,TPEN ED50|2-Pyrimidinethiol|pyrimidine-2-thiol|2-Thiopyrimidine|2-Mercaptopyrimidine|MPY|CaNa2 EDTA
NEW19042,CHEMICAL,modafinil/armodafinil cns stimulant,modafinil/armodafinil CNS stimulants
NEW19043,MENTAL_HEALTH,narcolepsy type,narcolepsy type
NEW19044,CHEBI,sympathomimetic stimulant,sympathomimetic stimulants
NEW19045,MENTAL_HEALTH,sympathomimetic stimulant,excessive sleepiness symptoms
NEW19046,DISEASE,xp-associated neoplasia,XP-associated neoplasia
NEW19047,CHEMICAL,xp-associated neoplasia,topical mitomycin C|MMC
NEW19048,DISEASE,ocular surface,ocular surface
NEW19049,MENTAL_HEALTH,transient mental depression,Transient mental depression
NEW19050,CHEMICAL,transient mental depression,PEG-IFN-alpha-2b|pegylated interferon alpha 2b
D005894,CHEMICAL,Panax,"Ninjin|Korean Red Ginseng|Renshen|Jen Shen|Shinseng|Jen Shens|Korean Ginseng|Schinsengs|Korean red ginseng|Ninjins|Schinseng|Shinsengs|Renshens|Shen, Jen|KRG|Ginseng, Korean Red|Korean Red Ginsengs|Ginseng|Ginseng, Korean|Korean Ginsengs|Red Ginseng, Korean|Panax ginseng|Ginsengs"
NEW19051,CHEMICAL,Viola odorata l,Viola odorata L
NEW19052,DISEASE,renal inflammation,renal inflammation
NEW19053,CHEMICAL,peroxiproliferator-activated receptor gamma agonist ciglitazone,peroxiproliferator-activated receptor gamma agonist ciglitazone
NEW19054,MENTAL_HEALTH,peroxiproliferator-activated receptor gamma agonist ciglitazone,PPARgamma-independent transcriptional repression
NEW19055,NUTRITION,brain omega-3 fatty acid concentration,brain omega-3 fatty acid concentrations
NEW19056,CHEMICAL,brain omega-3 fatty acid concentration,eicospentaenoic acid
NEW19057,CHEMICAL,brain omega-3 fatty acid concentration,SRI treatment
NEW19058,DISEASE,ocd dominant patient,OCD dominant patients
D000073602,CHEBI,Antimicrobial Stewardship,"Stewardship, Antimicrobial|Stewardship, Antibiotic|antimicrobial stewardship|Antibiotic Stewardship"
NEW19059,DISEASE,ocd dominant patient,permanent cognitive disability
NEW19060,CHEMICAL,4-ethylphenylsulfate,4-ethylphenylsulfate
D012980,CHEMICAL,Sodium Salicylate,"|Salicylate, Sodium|sodium salicylate|salicylate"
NEW19061,CHEMICAL,4-ethylphenylsulfate,4-ethylphenylsulfate oxindole
NEW19062,CHEMICAL,4-ethylphenylsulfate,indolepropionate
NEW19063,NUTRITION,4-ethylphenylsulfate,catechol sulfate
NEW19064,DISEASE,crf group,CRF group
NEW19065,CHEMICAL,crf group,0:0/20:4
C093004,CHEMICAL,N-(5-dimethylaminonaphthalenesulfonyl)-1-palmitoyl-sn-glycero-3-phosphoethanolamine [Supplementary Concept],Phosphatidylethanolamines|Dansyl Compounds|LysoPE
C090324,CHEMICAL,docosahexaenoyl lysophosphatidylcholine [Supplementary Concept],Lysophosphatidylcholines|Docosahexaenoic Acids|LysoPC
C098569,CHEMICAL,ProSol PDX [Supplementary Concept],22:4|Sodium Dodecyl Sulfate|Polysorbates|Edetic Acid|Sodium Bicarbonate|Drug Combinations
D008243,CHEMICAL,1-Acylglycerophosphocholine O-Acyltransferase,"Lysolecithin Acyltransferase|Acyl-CoA-1-Acylglycero-3-Phosphocholine-O-Acyltransferase|1-Acylglycerophosphocholine Acyltransferase|1 Acylglycerophosphocholine Acyltransferase|lysophosphatidylcholine|O-Acyltransferase, 1-Acylglycerophosphocholine|CoA Acyltransferase, Lysophosphatidylcholine-Palmitoyl|Acyl CoA Lysolecithin Acyltransferase|Lysophosphatidylcholine-Palmitoyl CoA Acyltransferase|Lysophospholipid Acyltransferase|Acyl CoA 1 Acylglycero 3 Phosphocholine O Acyltransferase|Lysophosphatidylcholine Palmitoyl CoA Acyltransferase|Lysophosphatidylcholine Acyltransferase|1 Acylglycerophosphocholine O Acyltransferase|Acyltransferase, Lysophosphatidylcholine|Acyltransferase, Lysolecithin|Acyltransferase, 1-Acylglycerophosphocholine|Acyltransferase, Lysophosphatidylcholine-Palmitoyl CoA|Acyltransferase, Lysophospholipid"
NEW19066,CHEMICAL,crf group,N-docosahexaenoyl γ-aminobutyric acid
C576492,CHEMICAL,"20-(4-carboxyphenyl)-2,13-dimethyl-3,12-diethyl-(22pi)pentaphyrin [Supplementary Concept]",Porphyrins|20:4
NEW19067,CHEMICAL,crf group,PE 18:0/0:0
D013831,CHEBI,Thiamine,"|Thiamine Mononitrate|vitamin B-1|Aneurin|Vitamin B-1|thiamine|Vitamin B1|Vitamin B 1|Mononitrate, Thiamine|Thiamin"
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Toxicomania,MENTAL_HEALTH,toxicomania,alcoholism tremens
NEW19068,MENTAL_HEALTH,delirium group,delirium group
NEW19069,DISEASE,longstanding malnutrition,longstanding malnutrition
NEW19070,CHEMICAL,glycerol backbone,glycerol backbone
D043263,CHEMICAL,Myosin-Light-Chain Phosphatase,"Smooth Muscle Myosin bound Phosphatase|Calponin Phosphatase|Smooth Muscle Phosphatase-II|Phosphatase, Myosin-Light-Chain|Phosphatase-II, Smooth Muscle|Myosin Phosphatase|Smooth Muscle Phosphatase II|Smooth Muscle Myosin-bound Phosphatase|myosin|Smooth Muscle Phosphatase I|Muscle Phosphatase-II, Smooth|Phosphatase, Calponin|Phosphatase, Myosin|Smooth Muscle MBP|Smooth Muscle Phosphatase-I|Myosin Light Chain Phosphatase"
NEW19071,MENTAL_HEALTH,antiviral treatment,dementia development
NEW19072,DISEASE,antiseizure medication,antiseizure medication
NEW19073,DISEASE,vitamin b6 supplementation,levetiracetam-associated irritability
C496334,DISEASE,"PCGF1 protein, human [Supplementary Concept]",Polycomb Repressive Complex 1|human nervous system
http://purl.obolibrary.org/obo/CHEBI_9937,CHEMICAL,vasopressin,AVP|ADH|Vasopressini injectio|argipressin|arginine vasopressin|d(CH2)5Tyr(Me)arginine vasopressin|VP|beta-Hypophamine|Inyectable de vasopresina|Antidiuretic hormone|Vasopressin|Solute injectable de vasopressine
NEW19074,CHEBI,arginine vasopressin antagonist,arginine vasopressin antagonist
NEW19075,CHEMICAL,nmda receptor antagonist amino phosphono valeric acid,NMDA receptor antagonist amino phosphono valeric acid
NEW19076,CHEMICAL,nmda receptor antagonist amino phosphono valeric acid,NMDA receptor ligands
NEW19077,CHEBI,drug group,drug groups
D012294,CHEMICAL,Rifamycins,rifamycins|Rifomycin|Rifomycins|Rifamycin
D003283,CHEMICAL,"Contraceptives, Postcoital, Synthetic","Postcoital Contraceptive Agents, Synthetic|Synthetic Postcoital Contraceptives|contraceptives|Contraceptives, Synthetic Postcoital|Postcoital Contraceptives, Synthetic|Contraceptive Agents, Postcoital, Synthetic|Synthetic Postcoital Contraceptive Agents"
NEW19078,DISEASE,drug group,sclerosis mice
C029130,CHEMICAL,nitrogenase reductase [Supplementary Concept],Oxidoreductases|nitrogenase Fe protein
NEW19079,MENTAL_HEALTH,drug group,biological nitrogen fixation
NEW19080,NUTRITION,plasma methionine level,plasma methionine levels
NEW19081,CHEMICAL,plasma homocysteine,plasma homocysteine
NEW19082,CHEMICAL,high intensity ultrasound,high intensity ultrasound|HIU
NEW19083,CHEMICAL,high intensity ultrasound,lower NaCl concentration
NEW19084,MENTAL_HEALTH,high intensity ultrasound,unfolding dissociation
NEW19085,CHEBI,high intensity ultrasound,major narcotics
NEW19086,CHEBI,hormone use status,Hormone use status
NEW19087,CHEBI,hormone use status,hormone misuse
NEW19088,CHEMICAL,free amino acid level,Free amino acid levels
NEW19089,MENTAL_HEALTH,free amino acid level,dementia subgroups
NEW19090,CHEMICAL,free amino acid level,amino acid levels
NEW19091,CHEMICAL,high alanine tyrosine level,higher alanine tyrosine levels
NEW19092,CHEMICAL,high glycine level,higher glycine levels
NEW19093,MENTAL_HEALTH,high glycine level,dementia subgroup
NEW19094,CHEMICAL,high glycine level,higher phenylalanine levels
NEW19095,CHEMICAL,high glycine level,subgroup higher alanine
http://purl.obolibrary.org/obo/CHEBI_5118,CHEMICAL,fluoxetine,"SSRIs fluoxetine|Prozac|(+-)-N-methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|rac-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine|fluoxetine|fluoxetina|(+-)-N-methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine|fluoxetinum"
NEW19096,CHEMICAL,imipramine antidepressant,Imipramine antidepressants
NEW19097,DISEASE,oseltamivir-susceptible b/brisbane/60/2008,oseltamivir-susceptible B/Brisbane/60/2008
NEW19098,CHEMICAL,oseltamivir-susceptible b/brisbane/60/2008,common amino acid substitutions
NEW19099,CHEBI,new antimicrobial peptide,new antimicrobial peptide
NEW19100,DISEASE,new antimicrobial peptide,biofilm cells
NEW19101,CHEMICAL,etoh concomitant,EtOH concomitant
NEW19102,CHEMICAL,etoh concomitant,serum estradiol
NEW19103,DISEASE,etoh concomitant,female puberty
NEW19104,CHEMICAL,high dopamine degradation,higher dopamine degradation
NEW19105,CHEBI,psychotic symptom,pyridoxine acid treatment
NEW19106,CHEMICAL,psychotic symptom,high-dose naloxone
NEW19107,DISEASE,psychotic symptom,P. savastanoi pv
D020156,CHEMICAL,Salicylic Acid,"Acid, ortho-Hydroxybenzoic|o Hydroxybenzoic Acid|Acid, Salicylic|2 Hydroxybenzoic Acid|Acid, o-Hydroxybenzoic|ortho-Hydroxybenzoic Acid|2-Hydroxybenzoic Acid|o-Hydroxybenzoic Acid|Acid, 2-Hydroxybenzoic|salicylic acid|ortho Hydroxybenzoic Acid"
NEW19108,CHEMICAL,lactic acid release,lactic acid release
NEW19109,CHEMICAL,metabolic acid lactic,metabolic acid lactic
NEW19110,MENTAL_HEALTH,metabolic acid lactic,pH depression
NEW19111,DISEASE,sleep dysfunction,sleep dysfunction
NEW19112,CHEMICAL,sleep dysfunction,Ri gamma-aminobutyric acid (GABA)-B-receptor
NEW19113,CHEMICAL,sleep dysfunction,N-methyl-D-aspartate (NMDA)-receptor Ma2 dipeptidyl-peptidase-like protein-6
NEW19114,CHEMICAL,sleep dysfunction,methyl-3-O-methyl gallate|M3OMG
http://purl.obolibrary.org/obo/CHEBI_69284,CHEMICAL,suvanine,"(E)-{(8alpha,13E,14alpha)-14-[2-(3-Furyl)ethyl]-8-methylpodocarpan-13-ylidene}methyl hydrogen sulfate - 1,1-dimethylguanidine (1:1)|synthetic antidepressants-"
NEW19115,DISEASE,depressed mood-may,depressed mood-may
NEW19116,CHEBI,depressed mood-may,first antagonists
NEW19117,MENTAL_HEALTH,depressed mood-may,excessive daytime somnolence
NEW19118,MENTAL_HEALTH,depressed mood-may,nocturnal hyperarousal
NEW19119,CHEBI,telomerase inhibitor,telomerase inhibitors
NEW19120,DISEASE,telomerase inhibitor,esophageal adenocarcinoma
NEW19121,CHEMICAL,acetylcholinesterase inhibitor pyridostigmine,acetylcholinesterase inhibitor pyridostigmine
NEW19122,DISEASE,acetylcholinesterase inhibitor pyridostigmine,(LPS)-induced ARDS
NEW19123,CHEMICAL,cholinergic agent pyridostigmine,cholinergic agent pyridostigmine
NEW19124,DISEASE,cholinergic agent pyridostigmine,endotoxin-induced ARDS
C516458,CHEMICAL,isorhamnetin 3-O-rhamnopyranosyl-1-6-glucopyranoside [Supplementary Concept],Disaccharides|Flavones|Iso|Isorhamnetin
NEW19125,CHEMICAL,cholinergic agent pyridostigmine,IL-12p70
NEW19126,CHEMICAL,cholinergic agent pyridostigmine,lipopolysaccharide BMDCs
NEW19127,CHEMICAL,cholinergic agent pyridostigmine,serotonin-dopamine activity
NEW19128,DISEASE,cholinergic agent pyridostigmine,adult bipolar patients
http://purl.obolibrary.org/obo/CHEBI_67461,NUTRITION,clerodin,"3-Deoxycaryoptinol|{(1R,4aR,5S,6R,8S,8aR)-8-(acetyloxy)-5,6-dimethyl-5-[(2S,3aS,6aS)-2,3,3a,6a-tetrahydrofuro[2,3-b]furan-2-yl]octahydro-8aH-spiro[naphthalene-1,2'-oxiran]-8a-yl}methyl acetate|eckol-type phlorotannins"
NEW19129,CHEBI,nutraceutical use,nutraceutical uses
NEW19130,NUTRITION,brown seaweed phlorotannin,brown seaweed phlorotannin
NEW19131,MENTAL_HEALTH,hyperactive delirium,Hyperactive delirium
NEW19132,CHEMICAL,serum glucose level,serum glucose levels
NEW19133,DISEASE,serum glucose level,candidal vulvovaginitis
D014848,DISEASE,Vulvovaginitis,Vulvovaginitides|vulvovaginitis
D003022,CHEMICAL,Clotrimazole,Mycelex|Klotrimazole|Lotrimin|Canesten|Kanesten|Bay b 5097|clotrimazole|FB b 5097
NEW19134,CHEMICAL,au year,Au years
NEW19135,CHEMICAL,au year,membrane sialic acid content
NEW19136,CHEMICAL,16:1n7 t,16:1n7 t
NEW19137,MENTAL_HEALTH,16:1n7 t,clinical regression
NEW19138,MENTAL_HEALTH,16:1n7 t,early onset autism
NEW19139,NUTRITION,abnormal fatty acid metabolism,abnormal fatty acid metabolism
NEW19140,DISEASE,abnormal fatty acid metabolism,fatty fish
NEW19141,CHEMICAL,abnormal fatty acid metabolism,omega-3 oils
D011223,CHEMICAL,Praziquantel,"Praziquantel, (S)-Isomer|Cisticid|Praziquantel|Prasiquantel|Pyquiton|Praziquantel, (+-)-Isomer|Praziquantel, (R)-Isomer|Biltricide|Traziquantel|EMBAY 8440|Drontsit|Cesol|Cysticide|Droncit"
NEW19142,CHEBI,abnormal fatty acid metabolism,undisputed drug
NEW19143,MENTAL_HEALTH,current apprehension,current apprehension
NEW19144,CHEMICAL,fecal spermidine level,fecal spermidine levels
NEW19145,DISEASE,fecal spermidine level,NASH phenotypes
NEW19146,CHEMICAL,daily spermidine intake,daily spermidine intake
NEW19147,CHEMICAL,spermidine supplementation,Spermidine supplementation
NEW19148,DISEASE,spermidine supplementation,NASH mice
C501477,DISEASE,"Thrsp protein, mouse [Supplementary Concept]",Transcription Factors|thyroid hormone-responsive protein
NEW19149,DISEASE,spermidine supplementation,hepatic bile acids
C490486,DISEASE,"NcpI-S protein, T. gondii [Supplementary Concept]",Recombinant Proteins|T. gondii
NEW19150,CHEMICAL,spermidine supplementation,pets/cats
NEW19151,DISEASE,Most infection,Most infections
C449302,CHEMICAL,GW 6471 [Supplementary Concept],Oxazoles|GW6471|Tyrosine/analogs  and  derivatives
NEW19152,NUTRITION,Most infection,hypoxia inducible factor subunit alpha
NEW19153,CHEMICAL,l-carnitine supplementation,L-carnitine supplementation
C106641,CHEMICAL,"DEFB4A protein, human [Supplementary Concept]",β-defensin|beta-Defensins
NEW19154,MENTAL_HEALTH,l-carnitine supplementation,first-line host defense mechanism
NEW19155,CHEMICAL,l-carnitine supplementation,important AMP
NEW19156,CHEMICAL,l-carnitine supplementation,intravenous magnesium
NEW19157,DISEASE,l-carnitine supplementation,human osteosarcoma cell line
NEW19158,CHEMICAL,-3347,-3347
NEW19159,MENTAL_HEALTH,-3347,cell-specific repression
NEW19160,MENTAL_HEALTH,such differential repression,Such differential repression
NEW19161,NUTRITION,such differential repression,ChAT component
NEW19162,NUTRITION,such differential repression,Arctic char
NEW19163,CHEMICAL,such differential repression,iron status
NEW19164,CHEMICAL,progestin-only contraceptive,progestin-only contraceptive
NEW19165,CHEMICAL,dha consumption,DHA consumption
NEW19166,DISEASE,dha consumption,known coronary heart disease
NEW19167,CHEMICAL,hif1-α,HIF1-α
NEW19168,MENTAL_HEALTH,hif1-α,DFO-induced NRP2 repression
NEW19169,DISEASE,hif1-α,mammary gland tissue
NEW19170,MENTAL_HEALTH,plasma agitation,plasma agitation
NEW19171,DISEASE,plasma agitation,hypercholesterolemia treatment
NEW19172,CHEBI,plasma agitation,used drug due
NEW19173,DISEASE,plasma agitation,neuro-inflammation glucose dysmetabolism
NEW19174,MENTAL_HEALTH,competitive displacement assay,Competitive displacement assay
NEW19175,CHEMICAL,competitive displacement assay,oral anhydrous aluminum chloride
NEW19176,DISEASE,alzheimer 's disease-like symptom,Alzheimer's disease-like symptoms
NEW19177,CHEBI,alzheimer 's disease-like symptom,well-established neurotoxin
NEW19178,CHEMICAL,alzheimer 's disease-like symptom,skin-resident memory CD4
D030283,DISEASE,Epsilonretrovirus,"WEHV-1|Epidermal Hyperplasia Virus 2, Walleye|Walleye dermal sarcoma virus|Walleye epidermal hyperplasia virus 2|epidermal hyperplasia|Sarcoma Virus, Walleye Dermal|WDSV|Epsilonretroviruses|WEHV-2|Epidermal Hyperplasia Virus 1, Walleye|Walleye epidermal hyperplasia virus 1"
NEW19179,MENTAL_HEALTH,alzheimer 's disease-like symptom,pituicyte input resistance
NEW19180,CHEBI,antimicrobial activity,antimicrobial activities
NEW19181,DISEASE,antimicrobial activity,Rhizopus oligosporus
NEW19182,DISEASE,antimicrobial activity,Staphylococcus aureus ATCC 6538and fungi
NEW19183,DISEASE,antimicrobial activity,Asperillus niger
D001409,DISEASE,Bacillus cereus,Bacillus cereus
http://purl.org/sig/ont/fma/fma72655,CHEMICAL,right middle frontal gyrus,right middle frontal gyrus|MFG
NEW19184,DISEASE,ptsd development,PTSD development
NEW19185,DISEASE,significant cognitive dysfunction,significant cognitive dysfunctions
NEW19186,CHEMICAL,fenofibrate treatment,Fenofibrate treatment
D000072198,CHEMICAL,ADAM17 Protein,"ADAM-17 Protein|CD156b Antigen|Tumor Necrosis Factor-alpha Convertase|ADAM-17|TNF-alpha Convertase|Disintegrin and Metalloproteinase Domain-Containing Protein 17|TNF alpha Convertase|Tumor Necrosis Factor alpha Converting Enzyme|TNF alpha Converting Enzyme|Disintegrin and Metalloproteinase Domain Containing Protein 17|ADAM 17 Protein|TACA (Enzyme)|Tumor Necrosis Factor Alpha Convertase|Antigen, CD156b|TACE (Enzyme)|Tumor Necrosis Factor-alpha Converting Enzyme|TNF-alpha Converting Enzyme|Convertase, TNF-alpha|TNF- α"
D007150,CHEMICAL,Immunohistochemistry,"Immunolabeling Technique|Immunogold Silver Technics|TH|Technic, Immunogold-Silver|Techniques, Immunogold-Silver|Technic, Immunolabeling|Techniques, Immunogold|Immunolabeling Techniques|Technique, Immunogold-Silver|Immunogold-Silver Technic|Technics, Immunogold|immunohistochemistry|Technique, Immunolabeling|Immunogold Silver Techniques|Immunogold Techniques|Immunogold Technique|Immunogold-Silver Technique|Technic, Immunogold|Immunocytochemistry|Technics, Immunolabeling|Immunolabeling Technics|Immunogold Technics|Technique, Immunogold|Immunogold Technic|Immunolabeling Technic|Immunogold-Silver Technics|Technics, Immunogold-Silver|Immunohistocytochemistry|Techniques, Immunolabeling|Immunogold-Silver Techniques"
NEW19187,MENTAL_HEALTH,fenofibrate treatment,fragmentation studies
NEW19188,DISEASE,fenofibrate treatment,PD-induced cognitive impairment
NEW19189,CHEMICAL,long-term steroid use,long-term steroid use
NEW19190,CHEMICAL,long-term steroid use,steroid dependence
http://purl.obolibrary.org/obo/SYMP_0000682,DISEASE,altered mental status,AMS|Altered mental status
NEW19191,CHEBI,combined androgen blockade,Combined androgen blockade
NEW19192,MENTAL_HEALTH,combined androgen blockade,libido dysfunction
NEW19193,CHEMICAL,dopamine type receptor,Dopamine type receptors
NEW19194,DISEASE,dopamine type receptor,common congenital myopathy
NEW19195,DISEASE,dopamine type receptor,stress-induced premature senescence
NEW19196,DISEASE,dopamine type receptor,different cancer types
NEW19197,DISEASE,aml cell line,AML cell lines
http://purl.obolibrary.org/obo/CHEBI_50864,CHEBI,insulin-sensitizing drug,glitazones|PPAR-gamma agonists|insulin-sensitizing agent|peroxisome proliferator-activated receptor gamma agonist|insulin sensitisers|peroxisome proliferator-activated receptor gamma agonists|proliferator activated receptor gamma agonist|PPARgamma agonist|insulin-sensitising drug|thiazolidinediones|well-known insulin-sensitizing drug|glitazonas|tiazolidinedionas|insulin sensitizers|proliferator activated receptor gamma agonists|PPAR-gamma agonist|glitazone drug|PPARgamma agonists
NEW19198,CHEMICAL,plasma triglyceride,plasma triglyceride
http://purl.obolibrary.org/obo/DOID_809,CHEMICAL,cocaine abuse,METH abuse
NEW19199,CHEMICAL,isotretionin treatment,isotretionin treatment
NEW19200,MENTAL_HEALTH,psychotic mania symptom,Psychotic mania symptoms
NEW19201,DISEASE,psychotic mania symptom,diabetic state
NEW19202,DISEASE,diabetic tissue,diabetic tissues
NEW19203,MENTAL_HEALTH,displacement curve,Displacement curves
NEW19204,CHEMICAL,post-burst afterhyperpolarization,post-burst afterhyperpolarization|AHP
NEW19205,DISEASE,post-burst afterhyperpolarization,age-associated learning deficits
NEW19206,MENTAL_HEALTH,Stroke Aphasia Quality,Stroke Aphasia Quality
NEW19207,CHEMICAL,Life-39 scale,Life-39 scale
NEW19208,CHEMICAL,maintenance antidepressant,Maintenance antidepressant
NEW19209,DISEASE,maintenance antidepressant,recurrent depressive episodes
NEW19210,CHEMICAL,maintenance antidepressant,lithium-intolerant
NEW19211,DISEASE,maintenance antidepressant,lithium-refractory patients
NEW19212,DISEASE,standard candida albicans strain,Standard Candida albicans strains
NEW19213,DISEASE,standard candida albicans strain,psychiatric medicine
NEW19214,CHEBI,partial μ-opioid receptor agonist buprenorphine,partial μ-opioid receptor agonist buprenorphine
NEW19215,DISEASE,partial μ-opioid receptor agonist buprenorphine,difficult-to-treat groups
NEW19216,DISEASE,partial μ-opioid receptor agonist buprenorphine,DSM-III major depressives
NEW19217,DISEASE,gastric motility,gastric motility
NEW19218,DISEASE,gastric motility,reward-seeking behaviour
NEW19219,CHEMICAL,dynamic cysteine s-acylation,dynamic cysteine S-acylation
NEW19220,CHEMICAL,dynamic cysteine s-acylation,intercellular LCFA transport
NEW19221,MENTAL_HEALTH,source dissociation,source dissociation
NEW19222,CHEMICAL,source dissociation,brain phosphatidylcholine
D013108,CHEMICAL,Sphingomyelin Phosphodiesterase,Sphingomyelinase C|Sphingomyelin Cholinephosphohydrolase|Sphingomyelin Cleaving Enzyme|sphingomyelin|Sphingomyelinase
NEW19223,NUTRITION,unsaturated phosphatidyl choline,unsaturated phosphatidyl cholines
NEW19224,DISEASE,unsaturated phosphatidyl choline,acute lung injury ALI oxidation
C006065,CHEMICAL,We 201 [Supplementary Concept],1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine|lysoPC|Lysophosphatidylcholines
NEW19225,DISEASE,unsaturated phosphatidyl choline,ALI associated vascular leak
C000706771,CHEMICAL,levonadifloxacin [Supplementary Concept],Quinolizines|Levonadifloxacin|Quinolones
NEW19226,DISEASE,unsaturated phosphatidyl choline,methicillin-resistant Staphyloccocus aureus
NEW19227,CHEMICAL,unsaturated phosphatidyl choline,novel broad spectrum benzoquinolizine FQ active
http://purl.obolibrary.org/obo/NCBITaxon_1502,DISEASE,clostridium perfringens,Clostridium butyricum MIYAIRI
NEW19228,DISEASE,glp-1 receptor agonist,disability scores
NEW19229,CHEMICAL,pkr inhibitor c16,PKR inhibitor C16
NEW19230,DISEASE,nmdar antagonist memantine,hippocampal damage
D000069501,CHEMICAL,Abiraterone Acetate,"CB7630|abiraterone|17-(3-pyridyl)-5,16-androstadien-3beta-acetate|Zytiga|CB 7630|CB-7630"
NEW19231,CHEBI,nmdar antagonist memantine,androgen biosynthesis
NEW19232,CHEMICAL,downstream plasma dhea-sulfate level,downstream plasma DHEA-sulfate levels
NEW19233,DISEASE,graves 's disease,overt hyperfunction
NEW19234,MENTAL_HEALTH,acute global amnesia,Acute global amnesia
NEW19235,DISEASE,acute global amnesia,cerebral tumours
D020236,MENTAL_HEALTH,"Amnesia, Transient Global","Transient Global Amnesia|TGA (Transient Global Amnesia)|TGAs (Transient Global Amnesia)|Global Amnesia, Transient|transient global amnesia"
NEW19236,DISEASE,acute global amnesia,drug-related confusional state
NEW19237,DISEASE,acute global amnesia,infective diseases
NEW19238,DISEASE,acute global amnesia,minor depressed
NEW19239,DISEASE,acute global amnesia,diurnal hypertension
NEW19240,DISEASE,chronic intermittent hypoxia,sustained hypertension
NEW19241,CHEMICAL,5-mthf formulation,5-MTHF formulation
NEW19242,NUTRITION,5-mthf formulation,normal folate levels
NEW19243,MENTAL_HEALTH,5-mthf formulation,dementia folate deficiency
NEW19244,CHEBI,adjunctive folinic acid,Adjunctive folinic acid
NEW19245,DISEASE,no production,P. leucopus
NEW19246,DISEASE,no production,diabetic wound healing
NEW19247,NUTRITION,mercury accumulation,Mercury accumulation
NEW19248,NUTRITION,wild boar liver,wild boar liver
NEW19249,NUTRITION,boar closest,boar closest
NEW19250,CHEMICAL,se concentration,Se concentrations
D020031,DISEASE,Epstein-Barr Virus Infections,"EBV Infections|Epstein Barr Virus Infections|Human Herpesvirus 4 Infections|Epstein-Barr Virus Infection|Human Herpes Virus 4 Infections|Infection, EBV|Virus Infections, Epstein-Barr|Infection, Epstein-Barr Virus|Virus infections|Infections, Epstein-Barr Virus|Virus Infection, Epstein-Barr|Infections, EBV|Epstein Barr Virus Infection|Herpesvirus 4 Infections, Human|EBV Infection"
NEW19251,CHEBI,se concentration,potent anti-viral agent useful
NEW19252,CHEMICAL,se concentration,elevated Allo levels
NEW19253,CHEMICAL,l. plantarum 8p-a3-clr-amx strain,L. plantarum 8p-a3-Clr-Amx strain
D019980,CHEMICAL,Amoxicillin-Potassium Clavulanate Combination,"|Augmentin|Amox-clav|Synulox|Clavulanate Potentiated Amoxycillin|Potassium Clavulanate-Amoxicillin Combination|Amoxycillin Clavulanic Acid|Coamoxiclav|Amoxi-Clavulanate|Amoxi Clavulanate|BRL-25000|Clavulin|Spektramox|amoxicillin-clavulanic acid|Amoxicillin Potassium Clavulanate Combination|Amoxicillin-Clavulanic Acid|BRL 25000|BRL25000|Amoxicillin Clavulanic Acid|Potassium Clavulanate Amoxicillin Combination|Amoxycillin-Clavulanic Acid|combination of amoxicillin and clavulanic acid|Amox clav|Amoxycillin, Clavulanate Potentiated|Co-amoxiclav|Co amoxiclav"
NEW19254,CHEMICAL,l. plantarum,L. plantarum
NEW19255,CHEBI,l. plantarum,antimicrobial drugs
NEW19256,CHEBI,correspond antimicrobial drug,corresponding antimicrobial drugs
D050536,CHEMICAL,Glycerol-3-Phosphate Dehydrogenase (NAD+),alphaGPDH|glycerol|Glycerol 3-Phosphate Dehydrogenase (NAD+)|alpha Glycerol-3-Phosphate Dehydrogenase (NAD+)|G3P Dehydrogenase (NAD+)
NEW19257,MENTAL_HEALTH,correspond antimicrobial drug,solvent displacement strategy
NEW19258,DISEASE,ovarian membrane,Ovarian membranes
NEW19259,CHEMICAL,ovarian membrane,specific 20beta-S binding
NEW19260,CHEMICAL,borate treatment,borate treatment
NEW19261,MENTAL_HEALTH,borate treatment,extensive tissue dissociation
NEW19262,DISEASE,antibiotic treatment,HFD-induced weight gain
NEW19263,DISEASE,antibiotic treatment,self-care reduction
NEW19264,DISEASE,antibiotic treatment,HFD-induced anhedonia-like behavior
NEW19265,NUTRITION,antibiotic treatment,alpha GLRA1 gene
NEW19266,CHEMICAL,antibiotic treatment,inhibitory glycine receptor subunit alpha
NEW19267,CHEMICAL,nmda antagonist-induced model,NMDA antagonist-induced model
NEW19268,DISEASE,so-called parkinson-plus syndrome,so-called Parkinson-plus syndromes
NEW19269,DISEASE,so-called parkinson-plus syndrome,vascular parkinsonism
NEW19270,DISEASE,so-called parkinson-plus syndrome,multiple systems atrophy
NEW19271,DISEASE,P. maximus,P. maximus
NEW19272,CHEMICAL,P. maximus,iGluR|GluF
NEW19273,DISEASE,lipid metabolic abnormality,lipid metabolic abnormality
NEW19274,DISEASE,lipid metabolic abnormality,human cataracts
NEW19275,CHEMICAL,plasma octanoate,plasma octanoate
NEW19276,CHEMICAL,plasma octanoate,highest trioctanoin infusion rate
NEW19277,CHEMICAL,plasma octanoate,mmol/liter
NEW19278,CHEMICAL,plasma octanoate,highest trioctanoin rates
NEW19279,CHEMICAL,α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation,α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activations
NEW19280,MENTAL_HEALTH,α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation,fast mitochondrial fragmentation
NEW19281,CHEMICAL,tissue damage,N-methyl-d-aspartate-type glutamate receptors
NEW19282,CHEMICAL,radical scavenger melatonin,radical scavenger melatonin
NEW19283,CHEMICAL,melatonin/memantine combination,melatonin/memantine combination
NEW19284,DISEASE,melatonin/memantine combination,traumatic injury
NEW19285,CHEMICAL,pcp treatment,NR2A polypeptides
NEW19286,DISEASE,pcp treatment,Alzheimer's disease research
NEW19287,CHEMICAL,pcp treatment,scopolamine administration
NEW19288,CHEMICAL,i-extract,i-Extract
C030693,CHEMICAL,Ashwagandha [Supplementary Concept],Plant Extracts|Ashwagandha|Withania somnifera
NEW19289,NUTRITION,proanthocyanidin b2,Proanthocyanidin B2
NEW19290,CHEMICAL,proanthocyanidin b2,TASD-41 transgenic mice
D060387,CHEMICAL,Ascorbate Peroxidases,"ascorbate|L-Ascorbic Acid Peroxidase|Ascorbate Peroxidase|L Ascorbic Acid Peroxidase|Peroxidases, Ascorbate|Peroxidase, Ascorbate|Peroxidase, L-Ascorbic Acid|Acid Peroxidase, L-Ascorbic"
D029903,NUTRITION,Melilotus,"Clovers, Sweet|Field Melilot|Sweet Clover, Yellow|Melilot, Field|Common Melilot|Sweet Clovers, Yellow|Melilots, Common|Melilot, Common|Sweetclover, Yellow|Yellow Sweetclovers|Common Melilots|Yellow Sweet Clovers|Clover, Yellow Sweet|Clovers, Yellow Sweet|Yellow Sweetclover|Melilotus officinalis|Sweet Clover|Yellow Sweet Clover|Melilots, Field|Sweetclovers, Yellow|Field Melilots|Sweet Clovers|Clover, Sweet"
NEW19291,CHEMICAL,functional mthfr snp rs1801133,functional MTHFR SNP rs1801133
NEW19292,CHEBI,intelligent premutation carrier,intelligent premutation carriers
NEW19293,MENTAL_HEALTH,intelligent premutation carrier,disorders DSM-III-R criteria
NEW19294,DISEASE,intelligent premutation carrier,remedy cough
NEW19295,CHEMICAL,intelligent premutation carrier,granulysin levels
C075005,CHEMICAL,"GNLY protein, human [Supplementary Concept]","Antigens, Differentiation, T-Lymphocyte|granulysin"
NEW19296,DISEASE,serious rot disease,serious rot disease
NEW19297,CHEMICAL,serious rot disease,gas chromatographic analysis
D000068556,CHEMICAL,Interferon beta-1a,"interferon beta-1a|Interferon beta 1a|Avonex Pen|beta-1a, Interferon|Rebif|beta 1a, Interferon|Avonex"
NEW19298,DISEASE,drug regiman,pseudoparkinsonism
NEW19299,DISEASE,cognition decline,cognition decline
NEW19300,CHEMICAL,acei,ACEI
NEW19301,MENTAL_HEALTH,acei,dementia prevention
C405562,DISEASE,"TOMM7 protein, human [Supplementary Concept]",Mitochondrial Precursor Protein Import Complex Proteins|human AD
D000077204,CHEMICAL,Temozolomide,"Temozolomide|TMZ Bioshuttle|NSC 362856|8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one|TMZ-Bioshuttle|NSC-362856|Methazolastone|M and B 39831|CCRG81045|M and B-39831|Temozolomide Hexyl Ester|CCRG-81045|NSC362856|M and B39831|Temodal|CCRG 81045|TMZA-HE|Temodar"
NEW19302,DISEASE,acei,non-responder aggressive pituitary adenoma management
NEW19303,DISEASE,acei,human leukemia Molt 4B cells
NEW19304,CHEMICAL,dopamine type agonist,Dopamine type agonists
NEW19305,NUTRITION,generalize insect herbivore,generalized insect herbivores
NEW19306,CHEMICAL,generalize insect herbivore,furanocoumarin content
NEW19307,NUTRITION,wild parsnip plant,Wild parsnip plants
C039410,CHEMICAL,sphondin [Supplementary Concept],Methoxsalen/analogs  and  derivatives|sphondin
NEW19308,CHEMICAL,wild parsnip plant,furanocoumarin characteristics-resistance amount
NEW19309,CHEMICAL,monoamine serotonin,monoamines serotonin
NEW19310,CHEMICAL,epidermal growth factor receptor egfr tyrosine kinase inhibitor osimertinib,epidermal growth factor receptor EGFR tyrosine kinase inhibitor osimertinib
NEW19311,DISEASE,epidermal growth factor receptor egfr tyrosine kinase inhibitor osimertinib,EGFR-mutant lung cancer
NEW19312,DISEASE,brain metastasis,brain metastasis
NEW19313,DISEASE,ra receptor,RA receptors
NEW19314,MENTAL_HEALTH,genetic repression,genetic repression
NEW19315,DISEASE,genetic repression,human embryonal carcinoma cell line NTERA-2 clone D1
NEW19316,CHEBI,niacin sensitivity,niacin sensitivity
NEW19317,CHEMICAL,m1r/m4r agonist xanomeline,M1R/M4R agonist xanomeline
D016488,NUTRITION,"Medicine, African Traditional","African Medicine, Traditional|witch|Traditional Medicine, African|African Medicine|Traditional African Medicine|Doctors, African Witch|African Witch Doctors|African Traditional Medicine|Medicine, Traditional African|African Witch Doctor|Medicine, African|Doctor, African Witch|Witch Doctor, African|Witch Doctors, African"
NEW19318,DISEASE,m1r/m4r agonist xanomeline,headaches treatment
NEW19319,DISEASE,mc38 tumor,MC38 tumor
D009355,CHEMICAL,Neomycin,Fradiomycin Sulfate|neomycin|Neomycin Sulfate|Neomycin Palmitate
D000077728,CHEMICAL,"Cilastatin, Imipenem Drug Combination","Imipenem - Cilastatin Sodium|Imipenem Cilastatin|Cilastatin, Imipenem|Primaxin|MK 0787-MK 0791 mixture|Imipenem-Cilastatin, Sodium Salt|MK 787-MK 791 mixture|Imipenem Cilastatin Sodium|Imipenem Cilastatin, Sodium Salt|MK 0787 MK 0791 mixture|Zienam|Imipenem-Cilastatin Sodium|MK 787 MK 791 mixture|imipenem-cilastatin|Imipenem-Cilastatin|Thienam|Tienam 500|Imipenem - Cilastatin"
NEW19320,DISEASE,private psychiatric patient,private psychiatric patients
NEW19321,CHEMICAL,high serum homocysteine,Higher serum homocysteine
NEW19322,DISEASE,serotonergic overstimulation,serotonergic overstimulation
NEW19323,DISEASE,serotonergic overstimulation,diabetic peripheral neuropathic pain
NEW19324,CHEMICAL,sb exposure,Sb exposure
NEW19325,CHEBI,sb exposure,breakthrough drug
NEW19326,CHEBI,rat poison,rat poison
NEW19327,DISEASE,rat poison,resistant tuberculosis treatment
NEW19328,CHEBI,unexpected drug finding,unexpected drug findings
D019297,CHEMICAL,"2,4-Dinitrophenol","2,4-dinitrophenol|2,4-DNP|DNP|2,4 Dinitrophenol"
NEW19329,CHEMICAL,[3h]batrachotoxin,[3H]batrachotoxin
NEW19330,CHEMICAL,[3h]batrachotoxin,mumol/l (+/-)-kavain
NEW19331,CHEBI,folic acid trial,folic acid trials
NEW19332,CHEMICAL,folic acid trial,folic acid-neuropathy
NEW19333,DISEASE,increase cognitive impairment,increased cognitive impairment
NEW19334,NUTRITION,increase cognitive impairment,high folate intake
NEW19335,DISEASE,v. cholerae o395,V. cholerae O395
NEW19336,MENTAL_HEALTH,v. cholerae o395,micromolar dissociation constants
C513735,CHEMICAL,dicyanocobinamide [Supplementary Concept],Organometallic Compounds|Nitriles|dicyanocobinamide
NEW19337,CHEMICAL,defensin gene cluster,defensin gene cluster
NEW19338,DISEASE,defensin gene cluster,ATH|adeno-tonsillar hypertrophy
NEW19339,DISEASE,defensin gene cluster,PCP intoxication
NEW19340,CHEMICAL,chronic intrathecal baclofen therapy,Chronic intrathecal baclofen therapy
NEW19341,CHEMICAL,sterilized pei microparticle,Sterilized PEI microparticles
NEW19342,MENTAL_HEALTH,sterilized pei microparticle,gentle agitation
NEW19343,DISEASE,thyrotoxicosis case,thyrotoxicosis cases
NEW19344,CHEMICAL,thalidomide gavage,Thalidomide gavage
C525734,CHEMICAL,meta-phenylene ethynylene [Supplementary Concept],Alkynes|Phenethylamines|MPE
NEW19345,DISEASE,thalidomide gavage,neuropathic pain rats
D000077269,CHEMICAL,Lenalidomide,"CC 5013|lenalidomide|CC5013|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|IMiD3 Cpd|Revimid|2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H- isoindol-2-yl)-|CC-5013|Revlimid"
NEW19346,DISEASE,thalidomide gavage,peripheral injury-induced proinflammatory cytokines
NEW19347,MENTAL_HEALTH,thalidomide gavage,natural orientation
NEW19348,CHEMICAL,carrot Daucus carota L.,carrots Daucus carota L.
NEW19349,CHEMICAL,tagetes patula L.,Tagetes patula L.
NEW19350,CHEMICAL,ceramide metabolism,ceramide metabolism
NEW19351,DISEASE,ceramide metabolism,different synucleinopathies
NEW19352,CHEMICAL,unsolved amyloid fibril,unsolved amyloid fibril
NEW19353,DISEASE,unsolved amyloid fibril,distinct human neurodegenerative diseases
NEW19354,MENTAL_HEALTH,high resistance level,highest resistance levels
D002981,CHEMICAL,Clindamycin,"Monohydrate Clindamycin Monohydrochloride|Cleocin|Monohydrochloride, Clindamycin|Clindamycin Monohydrochloride|7 Chloro 7 deoxylincomycin|Chlolincocin|clindamycin|Chlorlincocin|Dalacin C|7-Chloro-7-deoxylincomycin|Clindamycin Monohydrochloride, Monohydrate|Monohydrochloride, Monohydrate Clindamycin|Hydrochloride, Clindamycin|Clindamycin Hydrochloride"
D017103,DISEASE,Bacillus Phages,"Bacteriophage, Bacillus|Bacteriophages, Bacillus|Bacteriophage phi 105|Bacillus Bacteriophages|Bacillus|Bacteriophage phi 29|Phage phi 105|Bacillus Bacteriophage|Bacillus Phage|Phage phi 29"
D000077422,CHEMICAL,Enrofloxacin,Bay Vp 2674|Bay-Vp-2674|Endrofloxicin|Baytril|enrofloxacin
NEW19355,CHEBI,important antimicrobial,important antimicrobials
NEW19356,MENTAL_HEALTH,important antimicrobial,antimuscarinic psychosis
NEW19357,CHEMICAL,amphetamine-induced li disruption,Amphetamine-induced LI disruption
NEW19358,DISEASE,scopolamine-induced li disruption,Scopolamine-induced LI disruption
NEW19359,DISEASE,cholinergic-related positive symptom,cholinergic-related positive symptoms
NEW19360,CHEMICAL,antidepressant medication,antidepressants medication
NEW19361,MENTAL_HEALTH,antidepressant medication,morphine-and-bupivacaine-induced analgesia
NEW19362,DISEASE,n-diethyl-benzamide,% L5178Y-R tumor-bearing Balb/c mice death
NEW19363,DISEASE,n-diethyl-benzamide,severe nonmalignant pain
NEW19364,CHEMICAL,oxygen molecule,oxygen transport parameter|oxygen molecules
NEW19365,CHEMICAL,oxygen molecule,fluid phase DMPC membrane
NEW19366,CHEMICAL,all-trans isomer,all-trans isomer
NEW19367,CHEMICAL,all-trans isomer,polar terminal hydroxyl groups located
NEW19368,NUTRITION,zeaxanthin similar,zeaxanthin similar
NEW19369,MENTAL_HEALTH,zeaxanthin similar,transmembrane orientation
NEW19370,CHEMICAL,zeaxanthin-dppc monolayer,zeaxanthin-DPPC monolayers
D024341,CHEBI,Xanthophylls,"Carotenoids, Xanthophyll|xanthophylls|Xanthophyll Carotenoids"
NEW19371,MENTAL_HEALTH,zeaxanthin-dppc monolayer,different orientation
NEW19372,CHEMICAL,repeat corticosterone injection,repeated corticosterone injections
NEW19373,DISEASE,repeat corticosterone injection,depressive behavioral
NEW19374,CHEBI,lactogenic hormone,lactogenic hormones
NEW19375,CHEBI,lactogenic hormone,counterregulatory hormones
NEW19376,MENTAL_HEALTH,peripheral insulin resistance,peripheral insulin resistance
NEW19377,CHEMICAL,peripheral insulin resistance,steroid spectra
NEW19378,CHEBI,transdermal estrogen,Transdermal estrogens
NEW19379,NUTRITION,transdermal estrogen,cholesterol cholesterol levels
NEW19380,DISEASE,transdermal estrogen,hormone-related decrease
NEW19381,CHEBI,b vitamin requirement,B vitamin requirements
NEW19382,MENTAL_HEALTH,b vitamin requirement,carbon fixation pathways
NEW19383,CHEMICAL,b vitamin requirement,acetogenesis
NEW19384,CHEMICAL,b vitamin requirement,sulfate reduction
NEW19385,CHEMICAL,b vitamin requirement,sulfur disproportionation
NEW19386,CHEMICAL,selenium only group,selenium only group
NEW19387,DISEASE,selenium only group,leprosy control
NEW19388,CHEMICAL,selenium only group,testosterone replacement therapy
NEW19389,CHEBI,selenium only group,combination estrogen
NEW19390,CHEMICAL,selenium only group,progesterone replacement
http://purl.obolibrary.org/obo/DOID_679,DISEASE,basal ganglia disease,Biotin-thiamine-responsive basal ganglia disease|BTRBGD
C536317,DISEASE,PEHO syndrome [Supplementary Concept],"Brain Edema|Optic Atrophy|Neurodegenerative Diseases|progressive encephalopathy|Spasms, Infantile"
NEW19391,DISEASE,febrile illness,febrile illness
NEW19392,DISEASE,lung adenocarcinoma patient,lung adenocarcinoma patients
D009888,CHEMICAL,Opipramol,"Opipramol|Hydrochloride, Opipramol|Opipramol Hydrochloride|Insidon"
NEW19393,CHEMICAL,saccharin exposure,saccharin exposure
NEW19394,DISEASE,saccharin exposure,model motor impulsivity
NEW19395,CHEMICAL,stimulant drug methylphenidate,stimulant drug methylphenidate
NEW19396,DISEASE,stimulant drug methylphenidate,significant behavioral impairment
NEW19397,CHEBI,sweetener intake,sweetener intake
NEW19398,DISEASE,cortical eeg hyperarousal,cortical EEG hyperarousal
NEW19399,CHEBI,common endocrine pathology,common endocrine pathology
NEW19400,DISEASE,cardiotoxic agent due,cardiotoxic agents due
D000077237,CHEMICAL,Arsenic Trioxide,Tetraarsenic Oxide|Tetra-Arsenic Oxide|Arsenous Anhydride|Arsenic Oxide (As4O6)|Arsenic(III) Oxide|Arsenic Oxide (As2O3)|arsenic trioxide|Arsenolite|Tetraarsenic Hexaoxide|Tetra-Arsenic Hexaoxide|Diarsenic Trioxide|As2O3|Trisenox|Tetra Arsenic Oxide|As4O6|Naonobin|Trixenox|Tetra Arsenic Hexaoxide
NEW19401,CHEMICAL,cardiotoxic agent due,lidocain
NEW19402,CHEMICAL,cardiotoxic agent due,humans anthracyclines
D008942,CHEMICAL,Mitoxantrone,"|Novantrone|mitoxantrone|Hydrochloride, Mitoxantrone|CL 232325|NSC 301739|Novantron|Acetate, Mitoxantrone|NSC 279836|Mitroxone|NSC 299195|NSC-301739D|Ralenova|NSC 287836|NSC-299195|Mitoxantrone Acetate|Mitoxantrone Hydrochloride|NSC-279836|NSC299195|NSC-287836|NSC-301739|DHAQ|CL-232325|Pralifan|NSC279836|Onkotrone|NSC301739D|Mitozantrone|NSC 301739D|NSC287836|NSC301739|CL232325"
D057889,CHEMICAL,Iridoid Glycosides,"Glycosides, Iridoid|Secoiridoid Glycosides|glycosides|Glycosides, Secoiridoid|Iridoidglycosides"
C005566,CHEMICAL,pivalic acid [Supplementary Concept],pivalic acid|Pentanoic Acids
C031626,CHEMICAL,ribose-5-phosphate [Supplementary Concept],Ribosemonophosphates|D-ribose
NEW19403,DISEASE,cardiotoxic agent due,mitochondrial cardiotoxic effects
D042963,CHEMICAL,Electron Transport Complex II,"Reductase, Succinate Dehydrogenase-CoQ|Succinate Dehydrogenase (Ubiquinone)|Succinate Q Oxidoreductase|Oxidoreductase, Succinate-Ubiquinone|Dehydrogenase-CoQ Reductase, Succinate|Succinate-Ubiquinone Oxidoreductase|Succinate Ubiquinone Oxidoreductase|Succinate-Q Oxidoreductase|Succinate Dehydrogenase-Coenzyme Q Reductase|Succinate Dehydrogenase-CoQ Reductase|Succinate Ubiquinone Reductase|Succinate Coenzyme Q Reductase|coenzyme-Q|Succinate-Coenzyme Q Reductase|Succinate Quinone Oxidoreductase|Succinate-Quinone Oxidoreductase|Succinate Dehydrogenase CoQ Reductase|Oxidoreductase, Succinate-Q|Succinate-Ubiquinone Reductase|Succinate Dehydrogenase Coenzyme Q Reductase|Oxidoreductase, Succinate-Quinone"
NEW19404,DISEASE,cardiotoxic agent due,involuntary movement disorders
D020195,DISEASE,"Epilepsy, Reflex","Epilepsies, Reading|Musicogenic Reflex Epilepsy|Photosensitive Epilepsy|Reflex Epilepsy, Tactile|Reflex Epilepsy, Reading|Epilepsies, Tactile Reflex|Epilepsies, Eating-Induced|Epilepsies, Photosensitive Reflex|Cursive Epilepsy|Epilepsy, Eating-Induced|reflex epilepsy|Epilepsies, Reflex|Cursive Reflex Epilepsy (Running)|Reflex Epilepsies, Eating-Induced|Epilepsy, Writing-Induced Reflex|Epilepsy, Audiogenic Reflex|Epilepsy, Cursive|Reflex Epilepsies|Epilepsy, Reading Reflex|Reflex Epilepsy, Eating-Induced|Photosensitive Epilepsies|Epilepsies, Musicogenic Reflex|Reflex Epilepsies, Photosensitive|Visual Pattern Reflex Epilepsy|Musicogenic Epilepsies|Reading Epilepsy|Audiogenic Reflex Epilepsies|Eating-Induced Epilepsies|Epilepsy, Musicogenic Reflex|Reflex Epilepsy|Eating Induced Epilepsy|Epilepsy, Photosensitive|Epilepsy, Musicogenic|Reflex Epilepsies, Cursive (Running)|Epilepsy, Photogenic|Epilepsy, Reading|Reflex Epilepsy, Photosensitive|Musicogenic Reflex Epilepsies|Reflex Epilepsies, Tactile|Reflex Epilepsy, Eating Induced|Writing-Induced Reflex Epilepsy|Writing-Induced Reflex Epilepsies|Epilepsies, Immersion Related|Tactile Reflex Epilepsy|Epilepsy, Tactile Reflex|Audiogenic Reflex Epilepsy|Reflex Epilepsies, Musicogenic|Epilepsy, Eating-Induced Reflex|Audiogenic Epilepsy|Reflex Epilepsies, Writing-Induced|Epilepsies, Photosensitive|Musicogenic Epilepsy|Epilepsies, Reading Reflex|Reflex Epilepsies, Reading|Reading Epilepsies|Reflex Epilepsy, Audiogenic|Reflex Epilepsy, Visual Pattern|Reflex Epilepsy, Musicogenic|Photosensitive Reflex Epilepsies|Audiogenic Epilepsies|Reflex Epilepsies, Audiogenic|Epilepsies, Audiogenic Reflex|Immersion Related Epilepsy|Eating-Induced Epilepsy|Epilepsies, Musicogenic|Epilepsy, Immersion Related|Tactile Reflex Epilepsies|Epilepsies, Writing-Induced Reflex|Reading Reflex Epilepsies|Eating-Induced Reflex Epilepsy|Reflex Epilepsy, Cursive (Running)|Epilepsies, Cursive|Epilepsy, Photosensitive Reflex|Photosensitive Reflex Epilepsy|Epilepsy, Cursive Reflex (Running)|Cursive Reflex Epilepsies (Running)|Epilepsy, Audiogenic|Writing Induced Reflex Epilepsy|Reflex Epilepsy, Writing-Induced|Decision Making Reflex Epilepsy|Reading Reflex Epilepsy|Epilepsies, Eating-Induced Reflex|Eating-Induced Reflex Epilepsies|Immersion Related Epilepsies"
NEW19405,MENTAL_HEALTH,da function,diabetic impotence
D009170,DISEASE,Nontuberculous Mycobacteria,"Nontuberculous Mycobacterium|Mycobacterium gordonae|Mycolicibacterium flavescens|Mycobacterium flavescens|Mycobacterium terrae|Atypical Mycobacteria|Mycolicibacterium duvalii|Mycobacterium duvalii|Tuberculoid Bacillus|Atypical Mycobacterium|Mycolicibacterium obuense|Non-Tuberculous Mycobacteria|Mycolicibacter terrae|Mycobacterium szulgai|Mycobacterium obuense|Mycobacterium gilvum|Nontuberculous mycobacteria|Mycolicibacterium gilvum|non-tuberculous mycobacteria|Mycobacteria, Atypical|Mycobacterium, Atypical"
NEW19406,DISEASE,da function,impaired lung function
NEW19407,DISEASE,epetraborole,EPT|epetraborole
NEW19408,CHEMICAL,epetraborole,LeuRSMabs
NEW19409,CHEMICAL,epetraborole,LeuRSMtb
C045571,CHEMICAL,cyclosporin G [Supplementary Concept],Cyclosporine|norvaline
NEW19410,DISEASE,epetraborole,EPT mutants
NEW19411,DISEASE,epetraborole,M. abscessus infection
NEW19412,CHEMICAL,asparate-314,asparate-314
NEW19413,CHEMICAL,cleavage-resistant d314e mutant,cleavage-resistant D314E mutant
NEW19414,DISEASE,cleavage-resistant d314e mutant,hippocampal neurodegeneration
NEW19415,DISEASE,focal neuronal lipofuscinosis,Focal neuronal lipofuscinosis
NEW19416,DISEASE,focal neuronal lipofuscinosis,uncommon epileptic disorder related
NEW19417,CHEMICAL,focal neuronal lipofuscinosis,FNL tissue
NEW19418,DISEASE,focal neuronal lipofuscinosis,interictal-like activity
NEW19419,CHEMICAL,first paclitaxel injection,first paclitaxel injection
NEW19420,DISEASE,first paclitaxel injection,day mechanical allodynia
C558337,CHEMICAL,p-O-geranyl-7''-acetoxy coumaric acid [Supplementary Concept],Coumaric Acids|p.o
NEW19421,DISEASE,first paclitaxel injection,non organic major depressive episodes
D000069604,CHEMICAL,Dabigatran,"Dabigatran Etexilate Mesylate|dabigatran|N-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-beta-alanine|Etexilate Mesylate, Dabigatran|Mesylate, Dabigatran Etexilate|BIBR 1048|Dabigatran Etexilate|Pradaxa|Etexilate, Dabigatran"
NEW19422,DISEASE,first paclitaxel injection,non-valvular atrial fibrillation
NEW19423,DISEASE,dabigatran-induced anticoagulation,dabigatran-induced anticoagulation
NEW19424,DISEASE,dabigatran-induced anticoagulation,bleeding surgery
C000594745,CHEMICAL,idarucizumab [Supplementary Concept],"idarucizumab|Antibodies, Monoclonal, Humanized"
NEW19425,CHEMICAL,unlabeled conantokin-g,unlabeled conantokin-G
NEW19426,CHEMICAL,unlabeled conantokin-g,N-methyl-D-aspartate receptor-associated polyamine site
NEW19427,CHEBI,n-methyl-d-aspartate receptor agonist binding site,N-methyl-D-aspartate receptor agonist binding site
NEW19428,CHEMICAL,n-methyl-d-aspartate receptor agonist binding site,polyamine modulatory site
NEW19429,MENTAL_HEALTH,n-methyl-d-aspartate receptor agonist binding site,chromatin fragmentation
NEW19430,DISEASE,n-methyl-d-aspartate receptor agonist binding site,seizure exacerbation
NEW19431,CHEMICAL,oxygen generation datum,oxygen generation data
NEW19432,MENTAL_HEALTH,compulsion zone,compulsion zone
NEW19433,CHEMICAL,compulsion zone,indirect dopamine receptor agonists
D019957,MENTAL_HEALTH,Motor Skills Disorders,"Motor Skills Disorder|Developmental Coordination Disorder|dyspraxia|developmental coordination disorder|Coordination Disorder, Developmental|Developmental Coordination Disorders"
NEW19434,NUTRITION,compulsion zone,fatty acid supplementation
NEW19435,MENTAL_HEALTH,dyslexia disorder,dyslexia disorder
NEW19436,NUTRITION,membrane phospholipid metabolism,membrane phospholipid metabolism
NEW19437,NUTRITION,membrane phospholipid metabolism,phospholipid spectrum
NEW19438,CHEMICAL,membrane phospholipid metabolism,Annexin V Apoptosis Detection Kit
NEW19439,CHEMICAL,membrane phospholipid metabolism,dichloro-dihydro-fluorescein diacetate
NEW19440,CHEMICAL,membrane phospholipid metabolism,kit-8|CCK-8
NEW19441,CHEMICAL,gamma-aminobutyric acid gaba antagonist,gamma-aminobutyric acid GABA antagonists
NEW19442,CHEMICAL,2-deoxyglucose metabolic mapping technique,2-deoxyglucose metabolic mapping technique
NEW19443,MENTAL_HEALTH,2-deoxyglucose metabolic mapping technique,active dyskinesia
NEW19444,CHEMICAL,escitalopram treatment,escitalopram treatment
NEW19445,DISEASE,escitalopram treatment,HIV-1-mediated synaptodendritic damage
NEW19446,CHEBI,escitalopram treatment,antagonist SDA type
C065533,CHEMICAL,perospirone [Supplementary Concept],Isoindoles|Thiazoles|perospirone
NEW19447,DISEASE,treatment-refractory symptom,treatment-refractory symptoms
NEW19448,MENTAL_HEALTH,medication-refractory schizophrenia,medication-refractory schizophrenia
NEW19449,DISEASE,neurological complication,Neurological complications
NEW19450,CHEBI,neurological complication,encephalopathy vitamin B1 deficiency
NEW19451,DISEASE,Chen Tea,Chen Tea
NEW19452,CHEMICAL,chinese green tea,Chinese green tea
NEW19453,CHEBI,chinese green tea,N-methyl-d-aspartate NMDA receptor antagonist
NEW19454,CHEBI,natural delta-tocotrienol,natural delta-tocotrienol
NEW19455,DISEASE,natural delta-tocotrienol,radiation-induced damage
NEW19456,CHEMICAL,natural delta-tocotrienol,total-body irradiated
NEW19457,DISEASE,natural delta-tocotrienol,human acquired immunodeficiency syndrome
C005023,CHEMICAL,fulvic acid [Supplementary Concept],fulvic acid|Fulvic acid|Benzopyrans
NEW19458,CHEBI,nutraceutical property,nutraceutical properties
NEW19459,DISEASE,grand mal seizure,grand mal seizures
D029503,DISEASE,"Anemia, Diamond-Blackfan","Imperfectas, Erythrogenesis|Congenital Anemias, Hypoplastic|Anemia, Blackfan Diamond|Hypoplastic Congenital Anemias|Blackfan Diamond Anemia|Diamond Blackfan Anemia|Erythrogenesis Imperfecta|hypoplastic anemia|Diamond Anemia, Blackfan|Anemias, Hypoplastic Congenital|Diamond-Blackfan Type Anemia|Blackfan Diamond Disease|Diamond-Blackfan Anemia|Congenital Anemia, Hypoplastic|Erythroblastopenias, Inherited|Anemia, Hypoplastic Congenital|Anemia, Diamond-Blackfan Type|Congenital Erythroid Hypoplastic Anemia|Anemia, Congenital Hypoplastic, Of Blackfan And Diamond|Inherited Erythroblastopenias|Anemia, Diamond Blackfan Type|Chronic Congenital Agenerative Anemia|Congenital Hypoplastic Anemia of Blackfan and Diamond|Hypoplastic Congenital Anemia|Blackfan-Diamond Syndrome|Blackfan-Diamond Disease|Disease, Blackfan-Diamond|Erythroblastopenia, Inherited|Inherited Erythroblastopenia|Anemia, Diamond Blackfan|Red Cell Aplasia, Pure, Hereditary|Pure Hereditary Red Cell Aplasia|Blackfan Diamond Syndrome|Erythrogenesis Imperfectas|Congenital Pure Red Cell Anemia|Imperfecta, Erythrogenesis|Congenital Pure Red Cell Aplasia"
http://purl.obolibrary.org/obo/DOID_3576,DISEASE,sagittal sinus thrombosis,Thrombosis of superior sagittal sinus|Thrombosis of superior longitudinal sinus|superior sagittal sinus thrombosis
NEW19460,CHEMICAL,imipramine treatment,imipramine treatment
NEW19461,DISEASE,imipramine treatment,chronic coronary syndromes
D015427,DISEASE,Reperfusion Injury,"|Reperfusion Damages|Injury, Ischemia Reperfusion|Damage, Reperfusion|reperfusion injury|Injury, Ischemia-Reperfusion|Ischemia Reperfusion Injury|Reperfusion Injuries|Ischemia-Reperfusion Injuries|ischemia-reperfusion injury|Ischemia-Reperfusion Injury|Reperfusion Damage|Injury, Reperfusion"
D014292,CHEMICAL,Trimetazidine,"Vastarel|Idaptan|Centrophène|Trimetazidine|Trimetazidine Dihydrochloride|TMZ|Vasartel|Dihydrochloride, Trimetazidine|Trimétazidine Irex"
C039984,CHEMICAL,Bretschneider cardioplegic solution [Supplementary Concept],Mannitol|Potassium Chloride|Glucose|Histidine-tryptophan-ketoglutarate|Procaine
NEW19462,CHEMICAL,imipramine treatment,metformin cotreatment
NEW19463,DISEASE,imipramine treatment,HFD-induced disorders
NEW19464,CHEMICAL,popular phytochemical-rich beverage,popular phytochemical-rich beverage
NEW19465,CHEMICAL,popular phytochemical-rich beverage,glucolipid metabolism
NEW19466,MENTAL_HEALTH,popular phytochemical-rich beverage,AD dementia
NEW19467,DISEASE,popular phytochemical-rich beverage,chronic liver diseases
NEW19468,DISEASE,5-fu-sensitive ht29 colorectal cancer cell,5-FU-sensitive HT29 colorectal cancer cells
D000072516,CHEMICAL,Retinoic Acid 4-Hydroxylase,"CYP26B1, Cytochrome P-450|Cytochrome P 450 CYP26B1|Enzyme, CYP26A1|CYP26A1 Enzyme|RA-4-Hydroxylase|Cytochrome P-450 CYP26B1|P450RAI|Cytochrome P450 4 Hydroxylase|Retinoic Acid 4 Hydroxylase|Cytochrome P-450 26B1|CYP450 4-Hydroxylase|RA 4 Hydroxylase|CYP26A1|Retinoic Acid-Metabolizing Enzyme, CYP26B1|Retinoic Acid Metabolizing Enzyme, CYP26B1|Cytochrome P450 4-Hydroxylase|Cytochrome P450 26A1 Enzyme|CYP26B1"
D018079,CHEMICAL,"Receptors, GABA","gamma Aminobutyric Acid Receptor|acid receptors|Receptors, gamma Aminobutyric Acid|Receptors, gamma-Aminobutyric Acid|gamma-Aminobutyric Acid Receptors|gamma-Aminobutyric Acid Receptor|Receptor, gamma-Aminobutyric Acid|Receptor, GABA|GABA Receptor|GABA Receptors|gamma Aminobutyric Acid Receptors"
NEW19469,DISEASE,5-fu-sensitive ht29 colorectal cancer cell,RA Response Elements
NEW19470,CHEMICAL,yap/rar-rxr cross-talk,YAP/RAR-RXR cross-talk
NEW19471,CHEBI,yap/rar-rxr cross-talk,vitamin A metabolism
NEW19472,DISEASE,colorectal cancer cell,colorectal cancer cells
NEW19473,DISEASE,colorectal cancer cell,colon cancer cell growth
NEW19474,DISEASE,colorectal cancer cell,alpha-synuclein aggregation
NEW19475,DISEASE,various human disease,various human diseases
NEW19476,MENTAL_HEALTH,syndrome ds risk,syndrome DS risk
NEW19477,NUTRITION,syndrome ds risk,choline metabolism
NEW19478,CHEMICAL,folate-homocysteine metabolic pathway gene polymorphism,folate-homocysteine metabolic pathway gene polymorphism
NEW19479,NUTRITION,maternal choline supplementation,Maternal choline supplementation
C480398,CHEMICAL,atraric acid [Supplementary Concept],Hydroxybenzoates|Atraric acid
NEW19480,CHEBI,maternal choline supplementation,wild-type androgen receptor
NEW19481,CHEMICAL,ERα state,ERα states
NEW19482,DISEASE,opportunistic pathogen,opportunistic pathogens
NEW19483,CHEMICAL,importance nontuberculous mycobacterium,NTM|IMPORTANCE Nontuberculous mycobacteria
NEW19484,CHEMICAL,dopamine loss,Dopamine loss
NEW19485,CHEMICAL,dopamine loss,DA replacement
NEW19486,CHEMICAL,dopamine loss,altered DA responses
NEW19487,CHEMICAL,da input,DA inputs
NEW19488,MENTAL_HEALTH,da input,basal hyperactivity
NEW19489,CHEMICAL,new-generation antidepressant,New-generation antidepressants
NEW19490,CHEMICAL,adjunctive n-acetylcysteine,adjunctive N-acetylcysteine
NEW19491,DISEASE,cdg treatment,CDG treatment
NEW19492,CHEMICAL,cdg treatment,lipopolysaccharide (LPS)-stimulated
NEW19493,CHEMICAL,cdg treatment,mouse Kupffer cells|ImKCs
NEW19494,CHEMICAL,polyphenol dhc,polyphenol DHC
D004718,NUTRITION,Saccharomycetales,"budding yeast|Budding Yeast|Endomycopsis|Yeasts, Budding|Endomycetale|Endomycetales|Yeast, Budding|Saccharomycetale|Endomycopses|Budding Yeasts"
NEW19495,CHEBI,polyphenol dhc,D3-preferring D3/D2 receptor partial agonist
NEW19496,CHEMICAL,dxa/piximus,Dxa/Piximus
NEW19497,CHEMICAL,dxa/piximus,female TREM2R47H/+ animals
C074636,CHEMICAL,amyloid beta-protein (25-35) [Supplementary Concept],Peptide Fragments|Aβ25|Amyloid beta-Peptides
NEW19498,CHEMICAL,dxa/piximus,Aβ25 challenge
NEW19499,CHEMICAL,dxa/piximus,ERα pathway
NEW19500,DISEASE,dxa/piximus,35-induced brain injury
NEW19501,CHEMICAL,dxa/piximus,inducible nitric oxide NO synthase
NEW19502,CHEMICAL,dopamine replacement approach,dopamine replacement approach
NEW19503,DISEASE,dui substitution,DUI substitution
NEW19504,DISEASE,hypoxia group,hypoxia group
NEW19505,CHEBI,hypoxia group,non-xenon mixture
NEW19506,CHEMICAL,xenon treatment,xenon treatment
NEW19507,DISEASE,xenon treatment,hypoxia-induced seizures
NEW19508,CHEMICAL,memantine µm.,memantine µM.
NEW19509,CHEMICAL,memantine treatment model,memantine treatment models
NEW19510,DISEASE,memantine treatment model,moderate AD patients
NEW19511,DISEASE,memantine treatment model,preventable birth disorders
NEW19512,MENTAL_HEALTH,facile dissociation,facile dissociation
D050858,CHEMICAL,Betalains,Betalain|Betalains|Betalain Pigments
NEW19513,CHEBI,kappa opiate agonist,kappa opiate agonists
NEW19514,CHEMICAL,kappa opiate agonist,dysphoria psychotomimetic effects
NEW19515,CHEMICAL,sibulelo,Sibulelo
NEW19516,DISEASE,sibulelo,grandparents trauma
NEW19517,MENTAL_HEALTH,mixed mania,mixed mania
NEW19518,CHEMICAL,mixed mania,valproate semisodium
C536858,DISEASE,"Spastic paraplegia 20, autosomal recessive [Supplementary Concept]","muscle wasting|Spastic Paraplegia, Hereditary"
C103016,CHEMICAL,antalarmin [Supplementary Concept],Pyrroles|Pyrimidines|antalarmin
NEW19519,CHEBI,act crf antagonist,acting CRF antagonist
NEW19520,DISEASE,act crf antagonist,bradycardia p<0.001
NEW19521,CHEMICAL,levodopa treatment,Levodopa treatment
NEW19522,DISEASE,levodopa treatment,L-DOPA-induced gene regulation
C000629164,CHEMICAL,"Htr1a protein, mouse [Supplementary Concept]","serotonin receptor 1A|Receptor, Serotonin, 5-HT1A"
NEW19523,CHEBI,azole antifungal,Azole antifungals
D001393,CHEMICAL,Azoles,|azoles|Azole|azole
D053713,DISEASE,Azoospermia,"Infertility, Male (1965-1976)|azoospermia|Oligospermia (1977-2006)"
D009845,DISEASE,Oligospermia,"Low Sperm Counts|Oligoasthenoteratozoospermia|Sperm Count, Low|Hypospermatogeneses|Oligozoospermia|Hypospermatogenesis|Low Sperm Count|Oligoasthenoteratozoospermias|Sperm Counts, Low|oligospermia"
NEW19524,DISEASE,azole antifungal,libido adrenal insufficiency
D000077277,DISEASE,Esophageal Squamous Cell Carcinoma,squamous cell carcinoma|Oesophageal Squamous Cell Carcinoma
NEW19525,DISEASE,azole antifungal,phototoxic reactions
D010522,DISEASE,Periostitis,periostitis|Periostitides
NEW19526,CHEBI,folate supplement,Folate supplements
C046311,CHEMICAL,periodate-lysine-paraformaldehyde [Supplementary Concept],% paraformaldehyde|Periodic Acid|Formaldehyde|Lysine
NEW19527,CHEMICAL,folate supplement,Mn intoxication
NEW19528,CHEMICAL,mets component,MetS components
NEW19529,MENTAL_HEALTH,multivariable regression model,Multivariable regression model
NEW19530,CHEMICAL,SNP rs3776362,SNP rs3776362
NEW19531,MENTAL_HEALTH,SNP rs3776362,Clinical Dementia Rating Sum
NEW19532,CHEBI,moderate depression,vitamin B6 intake
D061217,DISEASE,Weight Reduction Programs,"Weight Loss Program|Program, Weight Loss|Reduction Programs, Weight|Loss Program, Weight|Loss Programs, Weight|Programs, Weight Loss|Program, Weight Reduction|Weight Reduction Program|Reduction Program, Weight|Weight Loss Programs|Weight reduction|Programs, Weight Reduction"
D020261,CHEMICAL,Arsenic Poisoning,"Poisoning, Arsenic|Arsenic Poisoning, Nervous System|Nervous System, Organic Arsenic Poisoning|Encephalopathies, Arsenic|Polyneuropathy, Arsenic Induced|Arsenic Poisoning, Inorganic|Poisonings, Organic Arsenic|Polyneuropathy, Arsenic-Induced|Arsenic-Induced Polyneuropathies|Arsenic-Induced Polyneuropathy|Arsenic Induced Polyneuropathy|Poisonings, Arsenic|Poisoning, Inorganic Arsenic|Poisoning, Arsenic, Nervous System|arsenic|Poisonings, Inorganic Arsenic|Arsenic Poisonings, Organic|Arsenic Encephalopathies|Syndromes, Arsenical Neurotoxicity|Arsenic Encephalopathy|Organic Arsenic Poisoning|Neurotoxicity Syndrome, Arsenical|Nervous System Poisoning, Arsenic|Poisoning, Organic Arsenic|Organic Arsenic Poisoning, Nervous System|Neurotoxicity Syndromes, Arsenical|Inorganic Arsenic Poisoning|Arsenic Poisonings, Inorganic|Arsenic Poisoning, Organic|Encephalopathy, Arsenic|Arsenical Neurotoxicity Syndromes|Arsenic Poisonings|Inorganic Arsenic Poisonings|Organic Arsenic Poisonings|Arsenical Neurotoxicity Syndrome|Syndrome, Arsenical Neurotoxicity"
NEW19533,DISEASE,marmoset wasting syndrome,Marmoset wasting syndrome|MWS
NEW19534,CHEMICAL,marmoset wasting syndrome,dietary magnesium
NEW19535,DISEASE,dyt1 early-onset primary dystonia,DYT1 early-onset primary dystonia
NEW19536,CHEMICAL,dyt1 early-onset primary dystonia,glutamic acid residue
NEW19537,CHEMICAL,small molecule 4-phenylbutyrate,4-PBA|small molecule 4-phenylbutyrate
NEW19538,DISEASE,small molecule 4-phenylbutyrate,dystonia treatment
http://purl.obolibrary.org/obo/DOID_0070340,DISEASE,classic citrullinemia,Classical homocystinuria
D016881,DISEASE,Microsporidiosis,"Microsporidia Infection|Microspora Infections|microsporidiosis|Microspora Infection|Infections, Microsporidia|Microsporidioses|Infections, Microspora|Microsporidia Infections|Infection, Microsporidia|Infection, Microspora"
NEW19539,CHEMICAL,albendazole administration,albendazole administration
D015766,CHEMICAL,Albendazole,"Mediamix V Disthelm|Metiazol|Digezanol|Zentel|Lurdex|Disthelm|Bilutac|Gascop|SKF-62979|Albendoral|albendazole|Albendazole Monohydrochloride|Endoplus|Bendapar|SKF 62979|Valbazen|Monohydrochloride, Albendazole|SK and F-62979|SK and F62979|Albenza|Eskazole|SK and F 62979|Andazol|SKF62979"
NEW19540,DISEASE,rapid deterioration,rapid deterioration
D020192,DISEASE,Lafora Disease,"Progressive Myoclonic Epilepsy, Lafora Type|Progressive Myoclonic Epilepsy Type 2|Lafora Progressive Myoclonus Epilepsy|Progressive Myoclonus Epilepsy, Lafora Type|Lafora-Body Disease, Late Onset|Lafora Myoclonic Epilepsy|Epilepsy, Progressive Myoclonic, Lafora|Epilepsy Progressive Myoclonic 2|Lafora Body Disease, Late Onset|Myoclonic Epilepsy of Lafora|Lafora Progressive Myoclonic Epilepsy|Late Onset Lafora Body Disease|Lafora disease|Lafora Body Disorder|Progressive Myoclonic Epilepsy, Lafora|Epilepsy, Progressive Myoclonic 2A|Lafora Body Disease|Lafora Type Progressive Myoclonic Epilepsy"
NEW19541,CHEMICAL,omega fatty acid,PGs|polyglucosan inclusions
NEW19542,DISEASE,omega fatty acid,generalized epileptic seizures
NEW19543,CHEMICAL,omega fatty acid,selective serotonin reuptake inhibitors Administration-indicated
NEW19544,DISEASE,omega fatty acid,somatoform symptoms
NEW19545,MENTAL_HEALTH,omega fatty acid,functional body syndromes
NEW19546,CHEBI,major analgesic effect,major analgesic effect
NEW19547,DISEASE,mild hypercortisolism,Mild hypercortisolism
NEW19548,CHEMICAL,mild hypercortisolism,excessive cortisol secretion
NEW19549,CHEMICAL,late-night salivary cortisol,late-night salivary cortisol
NEW19550,CHEBI,late-night salivary cortisol,basal morning plasma adrenocorticotroph hormone
NEW19551,CHEMICAL,24-h urinary free cortisol,24-h urinary free cortisol
NEW19552,CHEBI,24-h urinary free cortisol,competitive glucocorticoid receptor antagonist
NEW19553,DISEASE,24-h urinary free cortisol,person-to-person fast transmission global problem
NEW19554,DISEASE,24-h urinary free cortisol,pre-existing neurological disorders
NEW19555,DISEASE,neurotoxic side-effect,Neurotoxic side-effects
NEW19556,DISEASE,tuberculosis chemotherapy,tuberculosis chemotherapy
NEW19557,DISEASE,postinfective IBS,Postinfective IBS
NEW19558,CHEBI,postinfective IBS,addictive psychostimulant drug
C000628501,CHEMICAL,"HTR2B protein, human [Supplementary Concept]","serotonin receptor 2B|Receptor, Serotonin, 5-HT2B"
NEW19559,DISEASE,postinfective IBS,irritable bowl syndrome
NEW19560,DISEASE,postinfective IBS,MDMA abuse
NEW19561,CHEMICAL,tph2 gene,TPH2 gene
NEW19562,DISEASE,tph2 gene,5-HT dysfunction
NEW19563,DISEASE,tph2 gene,various neuropsychiatric disorders related
NEW19564,NUTRITION,strawberry packaging,strawberry packaging
NEW19565,DISEASE,strawberry packaging,mechanical damage
NEW19566,CHEMICAL,combined estrogen/progestogen therapy,Combined estrogen/progestogen therapy
NEW19567,DISEASE,moderate-to-severe dysmenorrhea,moderate-to-severe dysmenorrhea
NEW19568,DISEASE,moderate-to-severe dysmenorrhea,low-to-moderate pain symptoms
NEW19569,CHEMICAL,n-6:n-3 ratio,n-6:n-3 ratio
NEW19570,DISEASE,n-6:n-3 ratio,endometriosis group
NEW19571,NUTRITION,n-6:n-3 ratio,Spanish sample
NEW19572,MENTAL_HEALTH,general anxiety,general anxiety
D010653,CHEMICAL,Phenylbutazone,|Butapyrazole|Phenylbutazone|Diphenylbutazone|Fenilbutazon|Butadion|phenylbutazone|Butacote|Butazolidin|Butapirazol|Butadione
NEW19573,DISEASE,general anxiety,painful musculoskeletal disorders
NEW19574,CHEMICAL,first modern antidepressant,first modern antidepressant
NEW19575,CHEMICAL,first modern antidepressant,drug MAO-inhibition
NEW19576,DISEASE,first modern antidepressant,reserpine-induced sedation
NEW19577,CHEMICAL,first modern antidepressant,MTX GVHD prophylaxis
NEW19578,DISEASE,dukes c colon carcinoma,Dukes C colon carcinoma
NEW19579,CHEMICAL,dukes c colon carcinoma,adjuvant FOLFOX4
NEW19580,CHEBI,potent psychotomimetic drug,potent psychotomimetic drug
NEW19581,CHEMICAL,circulate gonadal steroid,circulating gonadal steroids
NEW19582,DISEASE,circulate gonadal steroid,bone mass
NEW19583,NUTRITION,reduce gonadal steroid hormone concentration,reduced gonadal steroid hormone concentrations
NEW19584,DISEASE,reduce gonadal steroid hormone concentration,athletic amenorrhea
NEW19585,DISEASE,atypical partial lipodystrophy,atypical partial lipodystrophy
C415771,CHEMICAL,metreleptin [Supplementary Concept],Leptin/analogs  and  derivatives|metreleptin
NEW19586,CHEMICAL,low dose morphine,low dose morphine
NEW19587,DISEASE,low dose morphine,sustained hyperalgesia
D006969,DISEASE,"Hypersensitivity, Immediate","IgE-Mediated Hypersensitivity|Hypersensitivities, Atopic|Immediate Hypersensitivity|Type I Hypersensitivities|IgE-Mediated Hypersensitivities|Type I Hypersensitivity|immediate hypersensitivity|Hypersensitivities, Type I|IgE Mediated Hypersensitivity|Hypersensitivity, Type I|Hypersensitivities, Immediate|Atopic Hypersensitivities|Hypersensitivities, IgE-Mediated|Hypersensitivity, IgE-Mediated|Atopic Hypersensitivity|Immediate Hypersensitivities|Hypersensitivity, Atopic"
NEW19588,MENTAL_HEALTH,headache pain,headache pain
NEW19589,CHEMICAL,headache pain,G14F peptide
NEW19590,CHEMICAL,g14f mutant peptide,G14F mutant peptide
NEW19591,CHEMICAL,g14f mutant peptide,Stavudine 2'-3'-didehydro-2'-3'-dideoxythymidine ® model
NEW19592,DISEASE,g14f mutant peptide,AIDS therapy-induced peripheral neuropathy
D006955,DISEASE,Hypernatremia,hypernatremia|Hypernatremias
NEW19593,CHEMICAL,g14f mutant peptide,hyperosmolar sodium
NEW19594,DISEASE,g14f mutant peptide,neurotoxic mechanism
NEW19595,CHEMICAL,extracellular neuroactive amino acid,extracellular neuroactive amino acids
C538113,DISEASE,Herrmann syndrome [Supplementary Concept],Cerebellar Ataxia|Deafness|cerebral dysfunction|Myoclonus|Diabetes Mellitus|Diabetic Neuropathies|Kidney Diseases
NEW19596,DISEASE,few opioid-related adverse event,ORAEs|fewer opioid-related adverse events
NEW19597,CHEMICAL,conventional opioid morphine,conventional opioid morphine
D000071560,CHEMICAL,beta-Arrestin 2,"Arrestin, beta 2|Arrestin-3|β-arrestin|ARRB2 Protein|beta 2 Arrestin|beta Arrestin 2|Arrestin 3"
C080598,CHEMICAL,dapoxetine [Supplementary Concept],Dapoxetine|Benzylamines|Naphthalenes|Dapoxetine hydrochloride
C043482,CHEMICAL,moxonidine [Supplementary Concept],Moxonidine|Imidazoles
NEW19598,CHEBI,act sympatholytic drug,acting sympatholytic drug
NEW19599,CHEBI,classical sympatholytic drug,classical sympatholytic drug
NEW19600,MENTAL_HEALTH,pregnancy-induced analgesia,Pregnancy-induced analgesia
NEW19601,CHEMICAL,high estradiol high progesterone state indicative,high estradiol high progesterone state indicative
NEW19602,DISEASE,high estradiol high progesterone state indicative,pain experience
NEW19603,CHEMICAL,high progesterone level,high progesterone levels
C580335,DISEASE,Nonsyndromic Holoprosencephaly [Supplementary Concept],non-syndromic|Holoprosencephaly
NEW19604,NUTRITION,high progesterone level,yeast colonies
NEW19605,CHEBI,high progesterone level,dextrose agar selection
NEW19606,CHEMICAL,previous oc,Previous OC
NEW19607,DISEASE,previous oc,Candida spp
NEW19608,DISEASE,pandemic due sars-cov-2 infection,pandemic due SARS-CoV-2 infection
NEW19609,DISEASE,single mood episode effective,single mood episodes effective
NEW19610,DISEASE,traumatic memory formation,traumatic memory formation
http://purl.obolibrary.org/obo/DOID_0111860,CHEMICAL,amme complex,AMME syndrome|Ca(2+)-catecholate complexes|chromosome Xq22.3 telomeric deletion syndrome|LSK complex|Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome|ATS-MR
NEW19611,CHEMICAL,phenolic hydroxyls,phenolic hydroxyls
http://purl.obolibrary.org/obo/CHEBI_60272,CHEMICAL,aluminium ion,aluminum ion|aluminum ions
NEW19612,DISEASE,fish death,fish deaths
NEW19613,CHEMICAL,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor,Alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors
NEW19614,CHEMICAL,chronic social defeat stress,subunit GluA2
NEW19615,CHEMICAL,intra-nac injection,intra-NAc injection
NEW19616,DISEASE,complex disorder,complex disorders
NEW19617,DISEASE,painful hiv-related neuropathy,painful HIV-related neuropathy
NEW19618,CHEMICAL,mg ha-1,Mg ha-1
NEW19619,DISEASE,mg ha-1,ha-1 poultry manure
NEW19620,CHEMICAL,npk fertilizer biochar manure,NPK fertilizer biochar manure
NEW19621,CHEMICAL,npk fertilizer biochar manure,N concentrations
NEW19622,CHEMICAL,npk fertilizer biochar manure,exchangeable K
NEW19623,CHEMICAL,npk fertilizer,NPK fertilizer
NEW19624,CHEMICAL,biochar manure,biochar manure
NEW19625,NUTRITION,biochar manure,fresh carrot root yield
D000082462,MENTAL_HEALTH,Plant Defense Against Herbivory,"Anti Herbivore Defenses|Plant Anti Xenosis|Host-Plant Resistance|Anti Herbivore Defense|Plant Antixenosis|Anti-Herbivore Defenses|Tolerance, Host-Plant|Resistance, Host-Plant|Antibiosis, Plant|Plant Anti-Xenosis|Anti-Xenosis, Plant|Host Plant Tolerance|Anti-Herbivore Defense|Plant Antibiosis|Antixenosis, Plant|Host Plant Resistance|plant resistance|Plant Resistance to Herbivory|Host-Plant Tolerance"
NEW19626,CHEMICAL,biochar manure,platinum chemotherapeutic agent
NEW19627,DISEASE,oxaliplatin-induced mechanical allodynia,oxaliplatin-induced mechanical allodynia
NEW19628,CHEBI,oxaliplatin-induced mechanical allodynia,TCS-OX2 orexin type-2 receptor antagonist
C542397,CHEBI,SB 408124 [Supplementary Concept],Phenylurea Compounds|orexin type-1 receptor antagonist|SB-408124
NEW19629,CHEBI,orexin type-1 receptor agonist,Orexin type-1 receptor agonists
NEW19630,DISEASE,orexin type-1 receptor agonist,CIPN pain
NEW19631,CHEMICAL,morphine-dependent mouse,3mg/kg subcutaneous
NEW19632,CHEMICAL,morphine-dependent mouse,SB269970
NEW19633,MENTAL_HEALTH,morphine-dependent mouse,morphine withdrawal syndromes
NEW19634,DISEASE,percent weight loss,percent weight loss
NEW19635,CHEBI,current gaba agonist therapy,current GABA agonist therapies
NEW19636,DISEASE,other metabolic disturbance,Other metabolic disturbances
D046150,MENTAL_HEALTH,Laron Syndrome,"Severe GH Insensitivity|Dwarfism II, Pituitary|growth hormone resistance|Dwarfism IIs, Pituitary|GH Resistance, Primary|Syndrome, Laron|Dwarfism, Laron|Growth Hormone Receptor Deficiency|Laron Dwarfism|Pituitary Dwarfism II|Primary Growth Hormone Resistance|Growth Hormone Insensitivity Syndrome|Primary GH Resistance|Laron Type Dwarfism I|Pituitary Dwarfism IIs|Growth Hormone Receptor Defect"
NEW19637,CHEBI,low affinity nmda receptor antagonist,low affinity NMDA receptor antagonists
NEW19638,NUTRITION,long chain omega-3 fatty acid,long chain omega-3 fatty acids
NEW19639,CHEMICAL,w-3 pufa intake,w-3 PUFA intake
NEW19640,CHEMICAL,Cil/Val,Cil/Val
NEW19641,DISEASE,Cil/Val,hypertension hyperactivity
NEW19642,CHEBI,sympatholytic action,sympatholytic actions
NEW19643,MENTAL_HEALTH,sympatholytic action,nor-adrenergic hyperactivity
NEW19644,CHEBI,female sex hormone cycle,female sex hormone cycle
NEW19645,CHEMICAL,hormone-based contraceptive,Hormone-based contraceptives
NEW19646,CHEMICAL,progestin-only contraceptive,progestin-only contraceptives
D010002,DISEASE,Osteitis Fibrosa Cystica,"Osteitis|Recklinghausens Disease, Bone|Recklinghausen Disease of Bone|Recklinghausen Disease, Bone|Recklinghausen's Disease of Bone"
NEW19647,CHEBI,pyridoxine nutritional status,Pyridoxine nutritional status
NEW19648,CHEBI,high-dose pyridoxine,high-dose pyridoxine
NEW19649,DISEASE,high-dose pyridoxine,certain dysphoric mental states
NEW19650,CHEMICAL,vaginal progesterone,vaginal progesterone
NEW19651,CHEMICAL,vaginal progesterone,low progesterone concentrations
NEW19652,CHEMICAL,vaginal progesterone,[3H]strychnine binding
NEW19653,CHEMICAL,bacterial endotoxin lipopolysaccharide,bacterial endotoxin lipopolysaccharide
NEW19654,DISEASE,bacterial endotoxin lipopolysaccharide,chemical-induced tissue injury
C006018,CHEMICAL,RC-12 [Supplementary Concept],"RC-12|1,2-dimethoxy-4-(bis-diethylaminoethyl)-amino-5-bromobenzene|Ethylenediamines"
D016789,DISEASE,Plasmodium cynomolgi,"cynomolgus, Plasmodium|Plasmodium cynomolgi|Plasmodium cynomolgus"
NEW19655,DISEASE,acute ethanol exposure,birth defects similar
NEW19656,CHEMICAL,embryonic ethanol exposure,embryonic ethanol exposure
NEW19657,DISEASE,embryonic ethanol exposure,later-life neurobehavioral impairments
NEW19658,CHEMICAL,sag treatment,SAG treatment
NEW19659,DISEASE,sag treatment,anxiety risk-taking behavior
NEW19660,DISEASE,sag treatment,long-term neurodevelopmental impairments related
NEW19661,CHEMICAL,combined ethanol exposure,combined ethanol exposure
NEW19662,MENTAL_HEALTH,combined ethanol exposure,human fetal alcohol spectrum disorder
NEW19663,DISEASE,h3 receptor antagonist,PAE-induced deficits
NEW19664,CHEMICAL,target folic acid-conjugated oxidize mesoporous carbon nanosphere,targeted folic acid-conjugated oxidized mesoporous carbon nanospheres
NEW19665,DISEASE,target folic acid-conjugated oxidize mesoporous carbon nanosphere,targeted breast cancer therapy
NEW19666,CHEMICAL,target folic acid-conjugated oxidize mesoporous carbon nanosphere,antitumoral doxorubicin delivery
NEW19667,CHEMICAL,chronic glu output,chronic GLU output
D066328,CHEMICAL,Ventral Striatum,"Striatum, Ventral|striatum|STR"
NEW19668,CHEMICAL,potentiate cortical/limbic cstc subcircuit afferent,potentiated cortical/limbic CSTC subcircuit afferents
NEW19669,CHEMICAL,mouse 's chronic glu-excited str,mice's chronic GLU-excited STR
NEW19670,CHEMICAL,mouse 's chronic glu-excited str,Striatal GABA
NEW19671,DISEASE,mouse 's chronic glu-excited str,hyperactive striatal CSTC output
NEW19672,CHEMICAL,mouse 's chronic glu-excited str,d-serine inputs
NEW19673,DISEASE,ocd-like mouse,OCD-like mice
NEW19674,DISEASE,ocd-like mouse,juvenile-onset tics
NEW19675,DISEASE,ocd-like mouse,comorbid TS-like behaviors
NEW19676,CHEMICAL,cortical-limbic Neuron neuronal circuit model,Cortical-limbic Neuron neuronal circuit model
NEW19677,CHEMICAL,cortical-limbic Neuron neuronal circuit model,abnormal cortical-limbic processing
NEW19678,DISEASE,cortical-limbic Neuron neuronal circuit model,adequate pain relief
NEW19679,DISEASE,cortical-limbic Neuron neuronal circuit model,comorbid AD
NEW19680,MENTAL_HEALTH,cortical-limbic Neuron neuronal circuit model,complex regional pain disorder
NEW19681,DISEASE,cortical-limbic Neuron neuronal circuit model,main psychiatric drugs
NEW19682,CHEMICAL,antidepressant psychoactive drug,antidepressant psychoactive drugs
NEW19683,MENTAL_HEALTH,antidepressant psychoactive drug,life-threatening neuropsychiatric syndromes
NEW19684,DISEASE,combined disorder,combined disorder
NEW19685,CHEMICAL,casein kinase i epsilon,casein kinase I epsilon|CKIepsilon
NEW19686,DISEASE,casein kinase i epsilon,human circadian rhythm sleep disorders
NEW19687,DISEASE,casein kinase i epsilon,non-24-h sleep-wake syndrome
NEW19688,CHEBI,casein kinase i epsilon,new selective serotonin uptake inhibitor
D015031,CHEMICAL,Zimeldine,"Zimelidine|H-102-09|Hydrochloride, Zimelidine|Zimelidin|Zimelidine Hydrochloride|Zimeldine Hydrochloride|Zelmid|H10209|Hydrochloride, Zimeldine|H 102 09"
NEW19689,DISEASE,casein kinase i epsilon,ligand TRAIL death receptors
NEW19690,DISEASE,adenomatous polyposis coli apc gene,adenomatous polyposis coli APC gene
NEW19691,DISEASE,adenomatous polyposis coli apc gene,human colon polyps
NEW19692,DISEASE,adenomatous polyposis coli apc gene,colorectal cancer chemoprevention
NEW19693,MENTAL_HEALTH,adenomatous polyposis coli apc gene,fast dissociation
NEW19694,CHEBI,adenomatous polyposis coli apc gene,passive antagonist
NEW19695,MENTAL_HEALTH,fast dissociation,Fast dissociation
NEW19696,CHEBI,fast dissociation,passive antagonists
NEW19697,MENTAL_HEALTH,fast dissociation,dissociation overall increasing complex affinity
C000721448,DISEASE,Loss of reflex tearing [Supplementary Concept],"Dry Eye Syndromes|tearing|Reflex, Abnormal"
NEW19698,DISEASE,fast dissociation,nasal irritation
NEW19699,DISEASE,fast dissociation,mild toxicity
NEW19700,DISEASE,prenatal ethanol exposure,abnormal cell death
NEW19701,CHEMICAL,nmdar memantine-as,NMDARs memantine-as
NEW19702,CHEMICAL,nmdar memantine-as,NMDA glutamate receptors
NEW19703,NUTRITION,red wheat bran,red wheat bran
NEW19704,CHEMICAL,red wheat bran,normal glucose homeostasis
NEW19705,NUTRITION,red wheat bran,white wheat variety
NEW19706,DISEASE,red wheat bran,variety Danby TaPHS1
NEW19707,MENTAL_HEALTH,phs resistance,PHS resistance
NEW19708,NUTRITION,phs resistance,white wheat
C417722,CHEMICAL,"SNP protein, lizard [Supplementary Concept]",SNP-222|Nuclear Proteins|SNP|Reptilian Proteins
NEW19709,MENTAL_HEALTH,phs resistance,ADHD participants
NEW19710,MENTAL_HEALTH,phs resistance,emotional dysfunction
NEW19711,CHEMICAL,entacapone addition,entacapone addition
NEW19712,MENTAL_HEALTH,entacapone addition,residual schizophrenia
NEW19713,CHEBI,plant-based food flavoring agent,plant-based food flavoring agents
NEW19714,DISEASE,plant-based food flavoring agent,neurological dysfunctions
NEW19715,CHEBI,opioid receptor mor selective antagonist,opioid receptor MOR selective antagonists
NEW19716,CHEMICAL,reboxetine dose,Reboxetine doses
NEW19717,DISEASE,reboxetine dose,narcoleptic episodes
NEW19718,CHEMICAL,reboxetine dose,NADH-TR staining
NEW19719,CHEMICAL,reboxetine dose,thiazolidinedione group
NEW19720,CHEMICAL,reboxetine dose,rosiglitazone use
NEW19721,CHEMICAL,reboxetine dose,lactate levels
NEW19722,CHEMICAL,glutamate modulation,glutamate modulation
NEW19723,CHEMICAL,glutamate modulation,riluzole augmentation
NEW19724,DISEASE,functional impairment,Functional impairments
C116819,CHEMICAL,NGB 2849 [Supplementary Concept],Piperazines|NGB
NEW19725,MENTAL_HEALTH,functional impairment,paired-pulse depression
NEW19726,CHEMICAL,congenital nicotinamide adenine dinucleotide nad deficiency disorder,Congenital nicotinamide adenine dinucleotide NAD deficiency disorders
C000594150,CHEMICAL,3-hydroxy-17-aza-D-homo-5-androsten-17-one [Supplementary Concept],HAAO|Azasteroids|Androstenols
http://purl.obolibrary.org/obo/CHEBI_8552,CHEMICAL,"protein n6,n6-dimethyl-l-lysine","NMDAR-associated proteins|Protein N6,N6-dimethyl-L-lysine|± protein    ±"
NEW19727,CHEMICAL,±        pg/mg protein,±       pg/mg protein
NEW19728,CHEMICAL,±        ng/mg protein,±       ng/mg protein
NEW19729,CHEMICAL,improve ach level,Improved ACh levels
C565579,DISEASE,Facial Dysmorphism with Multiple Malformations [Supplementary Concept],"multiple malformations|Muscular Atrophy|Craniofacial Abnormalities|Abnormalities, Multiple"
NEW19730,CHEMICAL,decrease nad+ production,decreased NAD+ production
NEW19731,DISEASE,decrease nad+ production,similar malformations
NEW19732,CHEBI,decrease nad+ production,first-line drug treatment
NEW19733,MENTAL_HEALTH,decrease nad+ production,major recurrent depression
NEW19734,CHEBI,pharmaceutical dosage,pharmaceutical dosage
C018523,CHEMICAL,4-dimethylaminocinnamaldehyde [Supplementary Concept],Cinnamates|cinnamaldehyde
NEW19735,DISEASE,pharmaceutical dosage,diarrhea incidence
NEW19736,DISEASE,pharmaceutical dosage,endometriosis-associated pain
NEW19737,DISEASE,pharmaceutical dosage,nonmenstrual pelvic pain components
NEW19738,CHEMICAL,pharmaceutical dosage,DMPA-SC|subcutaneous depot medroxyprogesterone acetate
NEW19739,CHEMICAL,elagolix group,elagolix groups
NEW19740,CHEMICAL,elagolix treatment,elagolix treatment
NEW19741,NUTRITION,elagolix treatment,domesticated dromedary camel
D014991,CHEMICAL,Xylazine,BAY-Va 1470|Xylazine Phosphate (1:1)|BAY Va 1470|Xylazine|Xylazine Monohydrochloride|Xylaxine|Xylazine Hydrochloride|Xylazin|xylazine|BAYVa 1470|Rompun
NEW19742,CHEMICAL,mp135,MP135
NEW19743,DISEASE,mp135,reward behavior
NEW19744,DISEASE,opiate use disorder,opiate use disorder
NEW19745,DISEASE,mouse ecohiv infection,mouse EcoHIV infection
NEW19746,CHEMICAL,buprenorphine treatment prior,buprenorphine treatment prior
http://purl.obolibrary.org/obo/NCBITaxon_3655,CHEMICAL,cucumis,Kathetostoma giganteum|Gymnosporia senegalensis
D002119,CHEMICAL,Calcium Carbonate,"|Chalk|Milk of Calcium|Marble|Aragonite|Calcite|Limestone|Calcium carbonate|Carbonate, Calcium|Calcium Milk|Vaterite|calcium carbonate"
http://purl.obolibrary.org/obo/NCBITaxon_137207,NUTRITION,oligoryzomys longicaudatus,Hoplostethus atlanticus
NEW19747,DISEASE,Methicillin-resistant s. aureus isolate,Methicillin-resistant S. aureus isolates
D002440,CHEMICAL,Cefoxitin,"MK 306|Méfoxin|Sodium, Cefoxitin|Mefoxin|MK-306|MK306|Cefoxitin Sodium|Mefoxitin|cefoxitin"
NEW19748,DISEASE,Methicillin-resistant s. aureus isolate,mecA gene
D016106,MENTAL_HEALTH,Methicillin Resistance,"Methicillin-Resistant|Methicillin Resistant|Resistance, Methicillin|methicillin resistance"
http://purl.obolibrary.org/obo/PR_000022301,DISEASE,cytidylate kinase,ycaf|cmk|cmp kinase|p25|mssa|protein mssa|ycag|cytidine monophosphate kinase|MSSA|ck
NEW19749,DISEASE,17β-oestradiol,ERS injury
NEW19750,CHEMICAL,cysteine uptake,cysteine uptake
NEW19751,CHEMICAL,cysteine uptake,hippocampal GSH synthesis
C493400,CHEMICAL,"SLC1A1 protein, human [Supplementary Concept]",EAAC1|Excitatory Amino Acid Transporter 3|excitatory amino acid carrier 1
NEW19752,DISEASE,cysteine uptake,ischemia-induced neuronal death
C000598618,CHEMICAL,mirogabalin [Supplementary Concept],Bridged Bicyclo Compounds|Mirogabalin
NEW19753,CHEMICAL,summarywhat,summaryWhat
NEW19754,DISEASE,summarywhat,rare serious autoimmune disorder
C515728,CHEMICAL,thrombopoietin mimetic peptide [Supplementary Concept],Peptides|● thrombopoietin mimetic peptide
NEW19755,CHEBI,Shandong Quangang Pharmaceutical Co. Ltd.,Shandong Quangang Pharmaceutical Co. Ltd.
NEW19756,CHEMICAL,da reuptake,DA reuptake
C028208,CHEMICAL,metkephamid [Supplementary Concept],"Enkephalin, Methionine/analogs  and  derivatives|metkephamid"
NEW19757,DISEASE,male prepubescent lamb,male prepubescent lambs
C033453,NUTRITION,"enkephalin-Met, Arg(6)-Gly(7)-Leu(8)- [Supplementary Concept]","methionine enkephalin|Enkephalin, Methionine/analogs  and  derivatives"
NEW19758,DISEASE,second degree burn,second degree burns
NEW19759,CHEBI,second degree burn,local antibacterial agents
NEW19760,DISEASE,grubii fungemia,grubii fungemia
NEW19761,CHEMICAL,no synthesis,NO synthesis
NEW19762,MENTAL_HEALTH,purging-type bulimia,purging-type bulimia
D018129,CHEMICAL,Phosphatidylinositol Phosphates,"Phosphatidyl Inositol Phosphates|phosphates|Phosphates, Phosphatidylinositol|Phosphates, Phosphatidyl Inositol|Inositol Phosphates, Phosphatidyl|Polyphosphoinositides|Polyphosphoinositide"
D001639,CHEMICAL,Bicarbonates,"Ions, Carbonic Acid|Carbonates, Hydrogen|Bicarbonate|Hydrogen Carbonates|Ion, Bicarbonate|Carbonic Acid Ions|Bicarbonate Ions|Hydrogen Carbonate|Ions, Bicarbonate|Carbonate, Hydrogen|bicarbonates|Bicarbonate Ion"
NEW19763,CHEBI,selective inhibitor ssri monotherapy,selective inhibitor SSRI monotherapy
NEW19764,CHEMICAL,venlafaxine-extended release,venlafaxine-extended release
NEW19765,CHEMICAL,bupropion-sustained release,bupropion-sustained release
NEW19766,CHEMICAL,antidepressant medication combination,antidepressant medication combinations
NEW19767,DISEASE,great baseline depressive severity,greater baseline depressive severity
NEW19768,DISEASE,great baseline depressive severity,hypocondriasis
NEW19769,CHEMICAL,altered gamma-aminobutyric acid signaling,Altered gamma-aminobutyric acid signaling
C584722,CHEMICAL,meso-zeaxanthin [Supplementary Concept],meso-zeaxanthin|MZ|Zeaxanthins
NEW19770,CHEBI,t2dm patient,carotenoids lutein
NEW19771,CHEBI,drug Latrodectus,drug Latrodectus
NEW19772,CHEMICAL,drug Latrodectus,amino acid exchange
D046788,DISEASE,Patellofemoral Pain Syndrome,"Anterior Knee Pain Syndrome|Patellofemoral Syndrome|Pain Syndrome, Patellofemoral|pain syndrome|Patellofemoral Pain|Pain, Patellofemoral|Patellofemoral Pains"
C049985,CHEMICAL,staurosporine aglycone [Supplementary Concept],Indole Alkaloids|K252a|Carbazoles
NEW19773,CHEMICAL,drug Latrodectus,acute VNS treatment
NEW19774,DISEASE,drug Latrodectus,AD-like effect
NEW19775,CHEMICAL,drug Latrodectus,chronic VNS treatment
NEW19776,CHEBI,anti-inflammatory drug celecoxib,anti-inflammatory drug celecoxib
NEW19777,CHEBI,trpa1 endogenous agonist,TRPA1 endogenous agonists
NEW19778,DISEASE,trpa1 endogenous agonist,trigeminal nociceptors
NEW19779,DISEASE,non-psychotic non-remitting depression,non-psychotic non-remitting depression
NEW19780,DISEASE,impaired sociability,impaired sociability
NEW19781,DISEASE,aeromonas molluscorum av27,Aeromonas molluscorum Av27
C011559,CHEMICAL,tributyltin [Supplementary Concept],tributyltin|Trialkyltin Compounds
NEW19782,CHEMICAL,aeromonas molluscorum av27,TBT|resistant to tributyltin
NEW19783,CHEBI,few virulence factor,Few virulence factors
NEW19784,DISEASE,few virulence factor,strain Av27
NEW19785,DISEASE,few virulence factor,end-stage hepatic disease
NEW19786,DISEASE,few virulence factor,stomach pain
NEW19787,DISEASE,few virulence factor,increased Cardiovascular diseases
NEW19788,CHEMICAL,rat msg exposure,rats MSG exposure
NEW19789,DISEASE,rat msg exposure,typical adult life MetS
NEW19790,CHEMICAL,rat msg exposure,MSG metabolic
NEW19791,MENTAL_HEALTH,bipolar manic episode,bipolar manic episode
NEW19792,MENTAL_HEALTH,religious delusion,religious delusions
NEW19793,DISEASE,ovarian tumor otu deubiquitinase,ovarian tumor OTU deubiquitinase
NEW19794,CHEMICAL,otud7a/cezanne2,OTUD7A/CEZANNE2
NEW19795,CHEMICAL,otud7a/cezanne2,calcium-induced calcium release
NEW19796,CHEMICAL,high activity val158 h allele,high activity Val158 H allele
NEW19797,DISEASE,colon rupture,colon rupture
D017609,CHEMICAL,Barium Compounds,"Ba|Compounds, Barium|barium"
D017971,CHEMICAL,Tin Compounds,"Compounds, Tin|tin"
NEW19798,NUTRITION,lithium level,lithium levels
NEW19799,CHEMICAL,vanadium concentration,vanadium concentrations
NEW19800,CHEMICAL,plasma chromium,plasma chromium
NEW19801,CHEMICAL,% fishmeal cp,% fishmeal CP
C092978,CHEMICAL,immunotoxin LMB-7 [Supplementary Concept],"LMB|Antibodies, Monoclonal|Exotoxins"
NEW19802,NUTRITION,dietary methionine,dietary methionine
NEW19803,DISEASE,dietary methionine,black skin syndrome
NEW19804,CHEMICAL,taurine content,taurine content
NEW19805,DISEASE,juvenile lmb,juvenile LMB
NEW19806,CHEMICAL,juvenile lmb,DM basis|30 % fishmeal CP
NEW19807,DISEASE,rhinosinusitis,rhinosinusitis
NEW19808,CHEBI,rhinosinusitis,antibiotic prescriptions
NEW19809,DISEASE,rhinosinusitis,estrogenic syndrome
NEW19810,DISEASE,rhinosinusitis,strong toxicity
NEW19811,CHEMICAL,rhinosinusitis,GAM medium
NEW19812,CHEMICAL,suitable carbon source,suitable carbon source
NEW19813,DISEASE,suitable carbon source,ZEN degradation
NEW19814,NUTRITION,wheat ingestion,Wheat ingestion
NEW19815,CHEMICAL,wheat ingestion,± times/2 h
NEW19816,DISEASE,wheat ingestion,frequent TLESR
NEW19817,DISEASE,postprandial regurgitation,Postprandial regurgitation
NEW19818,NUTRITION,wheat noodle,Wheat noodle
NEW19819,DISEASE,wheat noodle,higher GERD
NEW19820,DISEASE,wheat noodle,SAHS patients
NEW19821,CHEMICAL,[2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine mesdopetam,[2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine mesdopetam
NEW19822,DISEASE,[2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine mesdopetam,psychiatric disabilities
NEW19823,DISEASE,motor disability,motor disabilities
http://purl.obolibrary.org/obo/SYMP_0000090,CHEMICAL,encephalitis,Covid-19-related encephalitis
NEW19824,DISEASE,retroculus,Retroculus
NEW19825,CHEMICAL,retroculus,crenicichlines
NEW19826,CHEMICAL,retroculus,chaetobranchines
NEW19827,CHEMICAL,retroculus,cichlasomines
NEW19828,MENTAL_HEALTH,retroculus,autism spectrum conditions
NEW19829,CHEBI,prenatal androgen level,Prenatal androgen levels
NEW19830,CHEMICAL,androgen-related condition,androgen-related conditions
NEW19831,CHEMICAL,anti-histamine drug,Anti-histamine drugs
NEW19832,MENTAL_HEALTH,anti-histamine drug,adult bipolar depression
NEW19833,CHEMICAL,stimulant-like medication,stimulant-like medications
NEW19834,MENTAL_HEALTH,stimulant-like medication,odor-induced analgesia
NEW19835,DISEASE,idiopathic premature ovarian failure,idiopathic premature ovarian failure
NEW19836,CHEBI,idiopathic premature ovarian failure,hormone agonist
NEW19837,MENTAL_HEALTH,daytime eat disorder,daytime eating disorders
NEW19838,CHEMICAL,daytime eat disorder,triazolam abuse
NEW19839,MENTAL_HEALTH,sleep-related eat disorder distinct,Sleep-related eating disorders distinct
NEW19840,DISEASE,sleep-related eating,sleep-related eating
NEW19841,CHEMICAL,sleep-related eating,opiate/cocaine abuse
NEW19842,NUTRITION,particular brain phospholipid,particular brain phospholipids
NEW19843,CHEBI,hybrid factor mixture model,hybrid factor mixture models
NEW19844,CHEMICAL,hybrid factor mixture model,recent cannabis users
NEW19845,DISEASE,hybrid factor mixture model,related neurodegenerative diseases
NEW19846,CHEMICAL,protein kinase dyrk1a,protein kinase DYRK1A
NEW19847,CHEMICAL,leucettine,Leucettines
NEW19848,CHEMICAL,leucettine,Threonine-212-Tau phosphorylation
NEW19849,DISEASE,leucettine,glutamate-induced cell death
NEW19850,CHEMICAL,tag concentration,TAG concentrations
NEW19851,DISEASE,cancer Cell line encyclopedia ccle datum,Cancer Cell Line Encyclopedia CCLE data
NEW19852,DISEASE,ongoing coronavirus disease pandemic,ongoing coronavirus disease pandemic
NEW19853,CHEMICAL,ongoing coronavirus disease pandemic,bat coronavirus strain RaTG13
NEW19854,DISEASE,ongoing coronavirus disease pandemic,pangolin coronavirus
NEW19855,CHEMICAL,novel 3-cyanopyridine derivative,novel 3-cyanopyridine derivatives
NEW19856,DISEASE,novel 3-cyanopyridine derivative,human cancer cell lines
NEW19857,CHEBI,potent survivin modulator,potent survivin modulators
C520809,CHEMICAL,eltrombopag [Supplementary Concept],Benzoates|Pyrazoles|Eltrombopag|Hydrazines
NEW19858,CHEBI,potent survivin modulator,bioavailable thrombopoietin receptor agonist
D006327,DISEASE,Heart Block,"|Heart Blocks|Auriculo Ventricular Dissociation|Dissociations, Auriculo-Ventricular|Atrioventricular Dissociation|A-V Dissociations|A V Dissociation|Auriculo-Ventricular Dissociation|Atrioventricular Dissociations|Block, Heart|Dissociations, Atrioventricular|heart block|Dissociation, A-V|Dissociation, Auriculo-Ventricular|A-V Dissociation|Dissociation, Atrioventricular|Auriculo-Ventricular Dissociations|intra-Hisian block|Dissociations, A-V|Blocks, Heart"
NEW19859,DISEASE,potent survivin modulator,symptomatic orthostasis
NEW19860,CHEBI,neurotoxic n-methyl-d-aspartate nmda glutamate agonist quinolinic acid,neurotoxic N-methyl-d-aspartate NMDA glutamate agonist quinolinic acid
NEW19861,CHEMICAL,plasma acylcarnitine profile,plasma acylcarnitine profiles
NEW19862,MENTAL_HEALTH,plasma acylcarnitine profile,MDD core depression
NEW19863,MENTAL_HEALTH,plasma acylcarnitine profile,anxious depression
NEW19864,CHEMICAL,mood stabilizer,MSs|mood stabilizers
NEW19865,MENTAL_HEALTH,mood stabilizer,bipolar disorder BD patients
NEW19866,CHEMICAL,mood stabilizer,serum LDL-cholesterol levels
NEW19867,CHEMICAL,statin use,statin use
C566544,DISEASE,"Short Stature, Auditory Canal Atresia, Mandibular Hypoplasia, Skeletal Abnormalities [Supplementary Concept]","statin-associated muscle symptoms|Bone Diseases, Developmental|SAMS|Mandible/abnormalities|Ear Canal/abnormalities"
NEW19868,DISEASE,statin use,fatal cardiovascular events
http://purl.obolibrary.org/obo/CHEBI_172843,CHEMICAL,casomorphin,endomorphins|2-[[1-[2-[[2-[[2-[[1-[2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoic acid
NEW19869,DISEASE,tumor cell death,tumor cell death
NEW19870,CHEBI,gts patient,Met carriers
NEW19871,MENTAL_HEALTH,gts patient,exacerbated schizophrenia
NEW19872,CHEMICAL,cytochrome c oxidase 2,SCO2|cytochrome c oxidase 2
D000071857,DISEASE,Tumor Suppressor p53-Binding Protein 1,"Tumor Protein p53-Binding Protein, 1|p202 Protein|Tumor Suppressor p53 Binding Protein 1|53BP1 Protein|TP53BP1 Protein|Tumor Protein p53 Binding Protein, 1|tumor suppressor p53"
NEW19873,DISEASE,cytochrome c oxidase 2,HCT116 colorectal cancer cells
NEW19874,CHEMICAL,dfz exposure,DFZ exposure
NEW19875,DISEASE,dfz exposure,hepatic oxidative stress
NEW19876,DISEASE,dfz exposure,glycolipid metabolism disorder
NEW19877,MENTAL_HEALTH,developmental phonagnosia,developmental phonagnosia
D020238,MENTAL_HEALTH,Prosopagnosia,"Facial Recognition Agnosias|developmental prosopagnosia|Agnosia for Face|Developmental Prosopagnosia|Acquired Prosopagnosias|Recognition Agnosias, Facial|Agnosia for Faces|Acquired Prosopagnosia|Recognition Agnosia, Facial|Agnosias, Facial Recognition|Agnosia, Facial Recognition|Prosopagnosia, Acquired|Prosopagnosias|Developmental Prosopagnosias|Prosopagnosias, Developmental|Prosopagnosia, Developmental|Prosopagnosias, Acquired|Facial Recognition Agnosia"
NEW19878,DISEASE,developmental phonagnosia,inherent toxicity
NEW19879,DISEASE,equine neuroaxonal dystrophy/equine degenerative myeloencephalopathy,Equine neuroaxonal dystrophy/equine degenerative myeloencephalopathy
NEW19880,DISEASE,spot surubim Pseudoplatystoma corruscan,spotted surubim Pseudoplatystoma corruscans
NEW19881,NUTRITION,spot surubim Pseudoplatystoma corruscan,large migratory catfish native
NEW19882,CHEBI,purify skin toxin,purified skin toxin
NEW19883,CHEBI,skin toxin,skin toxin
D010525,DISEASE,Peripheral Nerves,"Nerves, Peripheral|Endoneuriums|Perineuriums|Nerve, Peripheral|Perineurium|Epineurium|peripheral nerves|Endoneurium|Epineuriums|Peripheral Nerve"
NEW19884,DISEASE,skin toxin,autoimmune damage
NEW19885,CHEMICAL,skin toxin,classical antidepressants
NEW19886,CHEBI,bee toxin,bee toxin
NEW19887,MENTAL_HEALTH,bee toxin,robust myofiber fragmentation
NEW19888,CHEBI,surface-exposed antigen,surface-exposed antigens
D007922,DISEASE,Leptospirosis,"Fever, Rice-Field|Fever, Mud|Leptospira Infection|Rice-Field Fever|Stuttgart Disease|leptospirosis|Infections, Leptospira|Mud Fever|Cane-Cutter Fever|Leptospira Canicola Infection|Leptospira Canicola Infections|Fever, Canicola|Canicola Fever|Infection, Leptospira|Infection, Leptospira Canicola|Infections, Leptospira Canicola|Leptospirosis Canicola|Cane Cutter Fever|Swineherd's Diseases|Leptospiroses|Leptospira Infections|Fevers, Cane-Cutter|Swineherd's Disease|Leptospirosis Canicolas|Rice Field Fever"
NEW19889,CHEMICAL,nc001,NC001
NEW19890,DISEASE,chronic unpredictable mild stress,anhedonic-like behaviors
NEW19891,CHEBI,increase androgen signaling,Increased androgen signaling
NEW19892,DISEASE,antique pandemic,antique pandemic
D014435,DISEASE,Typhoid Fever,"Infections, Salmonella typhi|Typhoid|typhoid fever|Infection, Salmonella typhi|Enteric Fever|Typhoid Fevers|Fever, Enteric|Salmonella typhi Infection|Abdominal Typhus|Fever, Typhoid|Salmonella typhi Infections|Fevers, Typhoid|Typhoids|Typhus, Abdominal|Fevers, Enteric|Enteric Fevers"
NEW19893,CHEMICAL,kir6.2 mutant mouse,Kir6.2 mutant mice
NEW19894,DISEASE,kir6.2 mutant mouse,severe memory deficits
NEW19895,CHEMICAL,kir6.2 mutant mouse,Kir6.2 activity
NEW19896,MENTAL_HEALTH,therapeutic impotence,Therapeutic impotence
NEW19897,CHEBI,therapeutic impotence,familiar drug
NEW19898,CHEMICAL,therapeutic impotence,pharmacologic therapy stimulants
NEW19899,MENTAL_HEALTH,uncomfortable treat adhd,uncomfortable treating ADHD
NEW19900,CHEMICAL,tobacco smoke toxin,tobacco smoke toxins
NEW19901,DISEASE,tobacco smoke toxin,alcohol-related brain disease
NEW19902,CHEBI,tobacco smoke toxin,estrogen dominance
NEW19903,NUTRITION,tobacco smoke toxin,endogenous precursor steroid hormone
NEW19904,CHEMICAL,intravaginal dehydroepiandrosterone,Intravaginal dehydroepiandrosterone
NEW19905,MENTAL_HEALTH,intravaginal dehydroepiandrosterone,dyspareunia secondary
NEW19906,CHEMICAL,bergenin derivative,bergenin derivatives
NEW19907,CHEMICAL,bergenin derivative,NO generation
D000075244,CHEMICAL,Apelin Receptors,"Angiotensin Receptor Like 1 Protein|Receptors, Apelin|Receptor, Apelin|Apelin Receptor|Apelin|APLNR|Angiotensin Receptor-Like 1 Protein"
NEW19908,DISEASE,hyperketonemia,Hyperketonemia
NEW19909,CHEMICAL,hyperketonemia,serum BHB concentrations
http://purl.obolibrary.org/obo/CHEBI_31538,CHEMICAL,enprostil,Enprostil|gardrin|fundyl|RS84135|gardrine|RS-84135|camleed|sucralphate
NEW19910,DISEASE,upper gastrointestinal bleeding,upper gastrointestinal bleeding
NEW19911,DISEASE,bleed prevention,bleeding prevention
D003543,CHEMICAL,Cysteamine,"Cysteamine Hydrobromide|2 Aminoethanethiol|Cysteamine|Cysteamine, 35S-Labeled|Cysteamine Maleate (1:1)|Cysteamine Tosylate|beta Mercaptoethylamine|Cysteinamine|Becaptan|Cysteamine, 35S Labeled|2-Aminoethanethiol|beta-Mercaptoethylamine|Tartrate, Cysteamine|Cysteamine Hydrochloride|Cysteamine Dihydrochloride|Mercaptoethylamine|Cysteamine Tartrate (1:1)|Bitartrate, Cysteamine|Tosylate, Cysteamine|Cystagon|Hydrochloride, Cysteamine|Mercamine|Hydrobromide, Cysteamine|Mercaptamine|Dihydrochloride, Cysteamine|Cysteamine Bitartrate|Cysteamine Tartrate|35S-Labeled Cysteamine"
D006209,DISEASE,Halitosis,Halitoses|Halitosis|halitosis
NEW19912,CHEMICAL,cysteamine metabolism pathway,cysteamine metabolism pathway
C504810,CHEMICAL,scarlet lightning extract [Supplementary Concept],L. extract|Plant Extracts|Silene
NEW19913,CHEMICAL,symptomatic propylthiouracil hepatic injury,symptomatic propylthiouracil hepatic injury
NEW19914,CHEBI,symptomatic propylthiouracil hepatic injury,adrenal androgen hyperresponsiveness
NEW19915,DISEASE,symptomatic propylthiouracil hepatic injury,syndrome adrenal enzyme dysfunction
NEW19916,MENTAL_HEALTH,symptomatic propylthiouracil hepatic injury,multivariable linear regression
NEW19917,DISEASE,overnight hypoxemia,overnight hypoxemia
NEW19918,CHEMICAL,platelet mao activity,Platelet MAO activity
NEW19919,DISEASE,platelet mao activity,free depressed patients
NEW19920,CHEBI,oestrogen serum level,oestrogen serum levels
NEW19921,CHEMICAL,progesterone serum level,progesterone serum levels
NEW19922,DISEASE,metastatic kidney cancer,metastatic kidney cancer
NEW19923,DISEASE,tumor neovascularization,Tumor neovascularization
NEW19924,DISEASE,hormone therapy ht trial,Hormone therapy HT trials
NEW19925,CHEMICAL,vitagene,Vitagenes
NEW19926,CHEBI,available kappa opioid receptor antagonist,available kappa opioid receptor antagonist
D007317,CHEMICAL,"Insemination, Artificial, Homologous","Artificial Insemination, Husband|Insemination, Homologous|Artificial insemination|Homologous Insemination|Husband Artificial Insemination|AIH|Insemination, Husband Artificial|Insemination, Artificial, Husband|AI"
NEW19927,CHEMICAL,intra-uterine insemination,intra-uterine insemination
NEW19928,DISEASE,intra-uterine insemination,unexplained infertility
NEW19929,NUTRITION,modify high amylopectin cornstarch,modified high amylopectin cornstarch
NEW19930,CHEMICAL,modify high amylopectin cornstarch,glucose transporter deficiency syndrome
NEW19931,CHEMICAL,modify high amylopectin cornstarch,steady-state glucose transport
NEW19932,DISEASE,average path velocity,VAP|average path velocity
NEW19933,MENTAL_HEALTH,displacement hypothesis,displacement hypothesis
NEW19934,CHEBI,displacement hypothesis,estrogen sulfates
NEW19935,CHEBI,cxc chemokine receptor cxcr4 antagonist,CXC chemokine receptor CXCR4 antagonists
NEW19936,DISEASE,cxc chemokine receptor cxcr4 antagonist,mucosal damage
http://purl.obolibrary.org/obo/DOID_0060180,DISEASE,colitis,DSS-induced colitis
D011024,DISEASE,"Pneumonia, Viral","Viral Pneumonias|Pneumonias, Viral|viral pneumonia|Viral Pneumonia"
NEW19937,DISEASE,clostridium acetobutylicum cell,Clostridium acetobutylicum cells
NEW19938,CHEMICAL,clostridium acetobutylicum cell,accumulated butanol
NEW19939,CHEMICAL,clostridium acetobutylicum cell,butanol stress
NEW19940,DISEASE,clostridium acetobutylicum cell,C. acetobutylicum metabolic response
NEW19941,DISEASE,clostridium acetobutylicum cell,C. acetobutylicum
NEW19942,CHEMICAL,clostridium acetobutylicum cell,addition butanol tolerance
NEW19943,DISEASE,contrast locomotor hyperactivity,contrast locomotor hyperactivity
NEW19944,CHEBI,crustacean hyperglycemia hormone,crustacean hyperglycemia hormones
NEW19945,NUTRITION,crustacean hyperglycemia hormone,American lobster Homarus americanus
NEW19946,CHEMICAL,crustacean hyperglycemia hormone,PGE2 activation
NEW19947,CHEMICAL,mef2-reporter mouse,MEF2-reporter mice
NEW19948,DISEASE,mef2-reporter mouse,ideators
NEW19949,DISEASE,mef2-reporter mouse,non-ideators
NEW19950,DISEASE,herpes simplex virus thymidine kinase,Herpes simplex virus thymidine kinase
NEW19951,CHEBI,herpes simplex virus thymidine kinase,agent ganciclovir
NEW19952,CHEBI,agent aciclovir,agent aciclovir
NEW19953,MENTAL_HEALTH,agent aciclovir,mutant suicide gene system
NEW19954,CHEMICAL,agent aciclovir,potent acetylcholine analogue
NEW19955,CHEMICAL,agent aciclovir,carbamylcholine chloride
NEW19956,NUTRITION,agent aciclovir,Spanish case
NEW19957,MENTAL_HEALTH,mixed-effects regression model,mixed-effects regression models
NEW19958,NUTRITION,mixed-effects regression model,free sugar
NEW19959,CHEMICAL,past-year nutrition,Past-year nutrition
NEW19960,DISEASE,past-year nutrition,trans-diagnostic impulsivity
NEW19961,CHEMICAL,glucocorticoid-induced tumor necrosis factor receptor gitr agonistic antibody,glucocorticoid-induced tumor necrosis factor receptor GITR agonistic antibody
NEW19962,CHEMICAL,agonistic antibody,agonistic antibody|DTA-1
C000712933,CHEBI,TLR4 agonist GSK1795091 [Supplementary Concept],Glycolipids|TLR4 agonist
NEW19963,MENTAL_HEALTH,central insulin resistance,Central insulin resistance
NEW19964,CHEMICAL,icv-stz administration,ICV-STZ administration
NEW19965,MENTAL_HEALTH,central insulin resistance,central insulin resistance
NEW19966,CHEMICAL,norepinephrine dosage,norepinephrine dosage
NEW19967,CHEBI,norepinephrine dosage,nonselective irreversible alpha-adrenergic receptor antagonist
NEW19968,NUTRITION,soybean root,soybean roots
NEW19969,DISEASE,soybean root,altered infection thread
C540014,CHEMICAL,GA3 compound [Supplementary Concept],GA3|Xanthones
NEW19970,DISEASE,soybean root,aberrant rhizobia infection
C052949,CHEMICAL,alkylglycerophosphoethanolamine phosphodiesterase [Supplementary Concept],Phosphoric Diester Hydrolases|ATX|Autotaxin
D049368,CHEMICAL,"Receptors, Lysophosphatidic Acid","Receptor, LPA2|vzg 1 Receptor|Receptor, Edg-4|Edg4 Protein|edg 2 Receptor|vzg-1 Receptor|Lysophosphatidic Acid Receptors|Acid Receptor, Lysophosphatidic|LPA 1 Receptor|Acid Receptors, Lysophosphatidic|Receptors, LPA|edg-2 Receptor|lysophosphatidic acid|LPA Receptors|Edg 7 Receptor|Edg2 Protein|LPA3 Receptor|Receptor, Edg-7|Receptor, LPA1|EDG7 Protein|LPA Receptor|Receptor, LPA|LPA2 Receptor|Receptor, Lysophosphatidic Acid|Lysophosphatidic Acid Receptor|Edg-7 Receptor|Receptor, vzg-1|LPA-1 Receptor|Edg-4 Receptor|LPA1 Receptor|Receptor, edg-2|Receptor, LPA3|Edg 4 Receptor"
NEW19971,NUTRITION,soybean root,phospholipid growth factor
NEW19972,CHEMICAL,atx expression,ATX expression
NEW19973,DISEASE,atx expression,obesity-associated metabolic diseases
NEW19974,CHEBI,sp. venom fraction,sp. venom fraction
NEW19975,MENTAL_HEALTH,stepwise regression analysis,Stepwise regression analysis
NEW19976,CHEMICAL,stepwise regression analysis,grain Zn
C559490,CHEMICAL,"vasopressin, Phe(2)-Ile(3)-Hgn(4)-Orn(iPr)(8)- [Supplementary Concept]",IPR|Vasopressins
NEW19977,DISEASE,stepwise regression analysis,ZBR
NEW19978,CHEMICAL,rna m6a regulator,RNA m6A regulators
NEW19979,CHEMICAL,increase aspartate release,increased aspartate release
NEW19980,CHEMICAL,mgso4,MgSO4
NEW19981,DISEASE,ulcer patient,ulcer patients
NEW19982,CHEMICAL,cold sdf-1alpha,cold SDF-1alpha
NEW19983,MENTAL_HEALTH,cold sdf-1alpha,bimodal ligand displacement curve
NEW19984,CHEMICAL,cold sdf-1alpha,IC(50)=7.4 nM
NEW19985,CHEMICAL,bicyclam amd3100,bicyclam AMD3100
D015498,DISEASE,HIV-2,"HTLV-IV|Immunodeficiency Virus Type 2, Human|SBL-6669|Human T-Lymphotropic Virus Type IV|HIV-2|Human Immunodeficiency Virus Type 2|HIV-II|Human T Lymphotropic Virus Type IV|LAV-2|Human immunodeficiency virus 2"
NEW19986,CHEBI,bicyclam amd3100,strong antiviral activity
NEW19987,CHEBI,bicyclam amd3100,potent CXCR4 antagonist
NEW19988,CHEMICAL,cxcr4-specific antibody,CXCR4-specific antibody
NEW19989,CHEMICAL,cxcr4-specific antibody,Asp(171
NEW19990,DISEASE,cxcr4-specific antibody,childhood neuropsychiatric disorders
NEW19991,MENTAL_HEALTH,cxcr4-specific antibody,childhood epileptic syndromes
NEW19992,DISEASE,plasmolysis process,plasmolysis process
NEW19993,CHEMICAL,plasmolysis process,representative micro-anisotropy experimental analysis
NEW19994,NUTRITION,label-free living onion cell membrane,Label-free living onion cell membranes
NEW19995,CHEMICAL,pi3 k inhibitor,PI3 K inhibitors
NEW19996,DISEASE,thirty-five lbw infant,Thirty-five LBW infants
NEW19997,CHEMICAL,thirty-five lbw infant,daily LDX
NEW19998,DISEASE,thirty-five lbw infant,urinary bladder discomfort
NEW19999,DISEASE,cancer patient,pain administration
NEW20000,CHEMICAL,central sympathetic blocker clonidine hydrochloride,central sympathetic blocker clonidine hydrochloride
NEW20001,DISEASE,central sympathetic blocker clonidine hydrochloride,experimental subarachnoid haemorrhage
D000074042,DISEASE,Cerebral Intraventricular Hemorrhage,"Cerebral Intraventricular Haemorrhage|Intraventricular Haemorrhage, Cerebral|Cerebral Intraventricular Haemorrhages|Cerebral Intraventricular Hemorrhages|Intraventricular Haemorrhages, Cerebral|Hemorrhage, Cerebral Intraventricular|haemorrhage|Intraventricular Hemorrhage, Cerebral|Haemorrhage, Cerebral Intraventricular"
NEW20002,CHEMICAL,central sympathetic blocker clonidine hydrochloride,comparison dopamine beta-hydroxylase=1.214+/-0.313
http://purl.obolibrary.org/obo/CHEBI_31918,CHEMICAL,norfenefrine hydrochloride,alpha(2)-blocker clonidine hydrochloride|Norfenefrine hydrochloride
NEW20003,CHEMICAL,cerebral dopamine beta-hydroxylase,cerebral dopamine beta-hydroxylase
NEW20004,CHEMICAL,intact pth level,intact PTH levels
NEW20005,CHEBI,intact pth level,G carriers
NEW20006,CHEMICAL,cinacalcet treatment,cinacalcet treatment
NEW20007,CHEMICAL,cinacalcet response,cinacalcet response
NEW20008,CHEBI,target gpcr antagonist,targeted GPCR antagonists
NEW20009,DISEASE,target gpcr antagonist,superior pain relief
NEW20010,CHEBI,biased agonist,Biased agonists
NEW20011,CHEMICAL,µ-opioid receptor,µ-opioid receptors
NEW20012,DISEASE,µ-opioid receptor,trauma memory formation
NEW20013,DISEASE,urinary homovanillic acid,urinary homovanillic acid
NEW20014,DISEASE,urinary homovanillic acid,rare metabolic disorders
NEW20015,CHEMICAL,urinary homovanillic acid,glutamate Glu receptors
D010649,CHEMICAL,Phenylalanine,"L-Phenylalanine|Phenylalanine, L-Isomer|Phenylalanine, L Isomer|Endorphenyl|L-Isomer Phenylalanine|L-phenylalanine"
C026979,CHEMICAL,6-O-monoacetylmorphine [Supplementary Concept],6-acetylmorphine|Morphine Derivatives
NEW20016,CHEMICAL,histamine production,histamine production
NEW20017,DISEASE,histamine production,histaminergic dysfunction
NEW20018,CHEMICAL,histamine decarboxylase hdc gene,histamine decarboxylase HDC gene
NEW20019,DISEASE,histamine decarboxylase hdc gene,fetus disabilities
NEW20020,DISEASE,histamine decarboxylase hdc gene,congenital neurological disease
D011540,CHEMICAL,Prussian Blue Reaction,"Blue Reactions, Prussian|Blue Reaction, Prussian|Ferrocyanide Reaction|Reaction, Ferrocyanide|Reactions, Prussian Blue|Ferrocyanide Reactions|Prussian Blue Reactions|Reactions, Ferrocyanide|Prussian blue|Reaction, Prussian Blue"
NEW20021,CHEMICAL,histamine decarboxylase hdc gene,chitosan sponge
C028033,NUTRITION,potassium ferricyanide [Supplementary Concept],potassium hexacyanoferrate|Ferricyanides
C466420,CHEMICAL,"5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinato iron(III) chloride [Supplementary Concept]",Metalloporphyrins|iron(III chloride
NEW20022,CHEMICAL,brain 5-ht,Brain 5-HT
NEW20023,DISEASE,brain 5-ht,aberrant social behaviors
NEW20024,CHEBI,[3h]5 alpha-androstane-3 beta,[3H]5 alpha-androstane-3 beta
NEW20025,NUTRITION,[3h]5 alpha-androstane-3 beta,crayfish aquaculture industry
NEW20026,NUTRITION,native crayfish population,native crayfish populations
NEW20027,CHEMICAL,native crayfish population,higher tobacco smoking rates
NEW20028,CHEBI,antihistamine chlorpheniramine,antihistamines chlorpheniramine
NEW20029,DISEASE,induce hypocortisolism,induced hypocortisolism
NEW20030,DISEASE,induce hypocortisolism,IWP-induced pain
D004121,CHEMICAL,Dimethyl Sulfoxide,"Dimethylsulfoxide|Dimethylsulphoxide|Sulfoxide, Dimethyl|Sulphoxide, Dimethyl|Rimso-50|Rimso|DMSO|Sulfinylbis(methane)|Dimexide|Dimethyl Sulphoxide|dimethyl sulfoxide|Rimso 50|Rimso 100|Rheumabene|Rimso50|Sclerosol|Dimethylsulphinyl"
NEW20031,CHEMICAL,n-methyl-d-aspartate glutamate receptor subunit,N-methyl-D-aspartate glutamate receptor subunits
NEW20032,CHEBI,gut neurotoxin p-cresol,gut neurotoxin p-cresol
NEW20033,DISEASE,gut neurotoxin p-cresol,seizure reactions
NEW20034,CHEMICAL,gut neurotoxin p-cresol,adenosine regulation
NEW20035,DISEASE,gut neurotoxin p-cresol,human corpus cavernosum|HCC
NEW20036,CHEBI,selective agonist 2-[4-(2-p-carboxy ethyl)phenylamino]-5'-n-ethylcarboxamido adenosine,selective agonist 2-[4-(2-p-carboxy ethyl)phenylamino]-5'-N-ethylcarboxamido adenosine
NEW20037,DISEASE,HCC strip,HCC strips
NEW20038,CHEMICAL,HCC strip,CGS21680C-sensitive receptors
D043704,CHEMICAL,"Receptor, Adenosine A2B","A2B Receptor, Adenosine|A2B Receptors, Adenosine|Receptors, Adenosine A2B|A(2B|Adenosine A2B Receptor|Adenosine A2B Receptors|Adenosine A(2B) Receptor"
NEW20039,DISEASE,HCC strip,HCC smooth muscle tone
NEW20040,DISEASE,p. staminea,P. staminea
NEW20041,NUTRITION,germinate brown rice,germinated brown rice
NEW20042,CHEMICAL,dopaminergic da cell death,dopaminergic DA cell death
D022123,DISEASE,Lyme Disease Vaccines,"Disease Vaccine, Lyme|Vaccines, Lyme Disease|Vaccine, Lyme Disease|Lyme disease|Lyme Disease Vaccine"
NEW20043,CHEBI,dopaminergic da cell death,antibacterial drugs
NEW20044,NUTRITION,ubiquitous trimethylxanthine,ubiquitous trimethylxanthine
NEW20045,DISEASE,ubiquitous trimethylxanthine,ductus arteriousus
NEW20046,DISEASE,ubiquitous trimethylxanthine,post-operative apnea
NEW20047,CHEMICAL,Illumina Cotton SNP k,Illumina Cotton SNP K
NEW20048,CHEMICAL,Illumina Cotton SNP k,polymorphism SNP data
NEW20049,CHEMICAL,valine (val)66-to-methionine met variant located,valine (Val)66-to-methionine Met variant located
NEW20050,CHEMICAL,valine (val)66-to-methionine met variant located,PI3K/Akt nitric oxide signaling pathways
NEW20051,CHEBI,drug exposure,drug exposures
NEW20052,DISEASE,drug exposure,secondary disabilities
NEW20053,MENTAL_HEALTH,diurnal somnolence,Diurnal somnolence
D016066,DISEASE,"Pleural Effusion, Malignant","Malignant Pleural Effusions|Pleural effusions|Malignant Pleural Effusion|Effusions, Malignant Pleural|Effusion, Malignant Pleural|Pleural Effusions, Malignant"
NEW20054,MENTAL_HEALTH,somnolence report,Somnolence reports
NEW20055,CHEMICAL,population benzodiazepine,populations benzodiazepines
NEW20056,CHEBI,population benzodiazepine,wellknown hepatotoxin
http://purl.obolibrary.org/obo/DOID_9740,DISEASE,postcholecystectomy syndrome,Post-cholecystectomy Mirizzi syndrome
D057792,DISEASE,Mirizzi Syndrome,"Mirizzi syndrome|Mirizzi's Syndrome|Syndrome, Mirizzi|Syndrome, Mirizzi's|Mirizzis Syndrome"
NEW20057,DISEASE,patient 's extrahepatic biliary tree,patient's extrahepatic biliary tree
D042882,DISEASE,Gallstones,"|gallstones|Biliary Calculi|Gall Stones, Common Bile Duct|Common Bile Duct Gall Stones|Common Bile Duct Calculi|Common Bile Duct Gallstone|Gallstone|gallstone|Gall Stones|Calculi, Biliary|Common Bile Duct Gall Stone|Gallstones, Common Bile Duct|Biliary Calculi, Common Bile Duct|Common Bile Duct Gallstones|Gall Stone"
C403304,CHEMICAL,zerumbone [Supplementary Concept],Zerumbone|ZER|zerumbone|Sesquiterpenes
NEW20058,DISEASE,associate fibrogenesis,associated fibrogenesis
NEW20059,CHEMICAL,associate fibrogenesis,ZER treatment
NEW20060,DISEASE,associate fibrogenesis,primary hepatic stellate cells
NEW20061,MENTAL_HEALTH,d supplementation,pediatrics resistance development
NEW20062,DISEASE,d supplementation,N. parkeri
D016644,CHEBI,Canthaxanthin,Carophyll Red|Canthaxanthine|canthaxanthin|Food Orange 8|Orobronze|Roxanthin Red 10|C.I. 40850
http://purl.obolibrary.org/obo/UBERON_0002048,DISEASE,lung,AFP-producing lung HAC
NEW20063,CHEMICAL,increase homocysteine,increased homocysteine
NEW20064,NUTRITION,serum folate,Serum folate
NEW20065,NUTRITION,serum folate value,Serum folate values
NEW20066,NUTRITION,tryptophan (trp)-kynurenine pathway,tryptophan (TRP)-kynurenine pathway
NEW20067,MENTAL_HEALTH,tryptophan (trp)-kynurenine pathway,episodic pain disorder
NEW20068,DISEASE,migraine-associated ca2,migraine-associated Ca2
C093204,CHEMICAL,"unc-2 protein, C elegans [Supplementary Concept]",Membrane Proteins|Caenorhabditis elegans Proteins|UNC-2
NEW20069,CHEBI,migraine-associated ca2,circulating vitamin D. Primary hypoparathyroidism
NEW20070,CHEMICAL,circulate parathormone,circulating parathormone
NEW20071,CHEMICAL,in-tcpp surface-coordinated mof thin film,In-TCPP surface-coordinated MOF thin films
NEW20072,CHEMICAL,in-tcpp surface-coordinated mof thin film,In(NO3)3
C503831,CHEMICAL,"5,10,15,20-tetrakis(4-carboxyphenyl)porphyrin cobalt [Supplementary Concept]",Metalloporphyrins|TCPP
NEW20073,CHEMICAL,porphyrinic mof thin film,porphyrinic MOF thin film
D009528,CHEMICAL,Nicarbazin,Nicarbazine|Nicarbazin
NEW20074,DISEASE,porphyrinic mof thin film,infertility agent
NEW20075,CHEMICAL,antidepressant pharmacotherapy,DiScenna
NEW20076,MENTAL_HEALTH,antidepressant pharmacotherapy,cholinergic projection neurons
NEW20077,DISEASE,antidepressant pharmacotherapy,toxicity effects
NEW20078,CHEMICAL,antidepressant pharmacotherapy,acetic acid mice model
NEW20079,CHEMICAL,rbp1-/- mouse,Rbp1-/- mice
NEW20080,CHEBI,synthetic rxr agonist,synthetic RXR agonist
NEW20081,DISEASE,synthetic rxr agonist,despair behaviors
NEW20082,CHEMICAL,"9-cis-13,14-dihydroretinol","9-cis-13,14-dihydroretinol"
NEW20083,CHEMICAL,dapsone hypersensitivity syndrome,Dapsone hypersensitivity syndrome
C521531,CHEMICAL,API 1252 [Supplementary Concept],AFN-1252|Benzofurans|Pyrones
NEW20084,CHEMICAL,dapsone hypersensitivity syndrome,ABSSSI due
NEW20085,MENTAL_HEALTH,camv 35s-driven rnai repression,CaMV 35S-driven RNAi repression
NEW20086,CHEBI,camv 35s-driven rnai repression,carotenoid biosynthesis
NEW20087,DISEASE,Opioid dependency,Opioid dependency
NEW20088,MENTAL_HEALTH,Opioid dependency,social dysfunction
NEW20089,DISEASE,deposition-induced loss,deposition-induced loss
NEW20090,CHEBI,deposition-induced loss,potent microtubule-stabilizing agent
NEW20091,CHEBI,prototypical beta blocker propranolol,prototypical beta blocker propranolol
NEW20092,MENTAL_HEALTH,prototypical beta blocker propranolol,sympathetic hyperactivity
NEW20093,DISEASE,prototypical beta blocker propranolol,aggravated mitochondrial dysfunction
NEW20094,DISEASE,prototypical beta blocker propranolol,cognitive skills
NEW20095,DISEASE,depressive,primary recurrent familial mood disorders
NEW20096,CHEMICAL,depressive,cloned dopamine D1
NEW20097,DISEASE,large bipolar pedigree,large bipolar pedigrees
NEW20098,DISEASE,mild small vessel disease phenotype,mild small vessel disease phenotypes
NEW20099,CHEBI,mild small vessel disease phenotype,NOTCH3 variant carriers
NEW20100,CHEMICAL,narcolepsy patient,muscarinic agonist carbachol
NEW20101,CHEMICAL,nitric oxide no donor sodium nitroprusside,nitric oxide NO donor Sodium Nitroprusside
NEW20102,MENTAL_HEALTH,nitric oxide no donor sodium nitroprusside,solvent displacement
NEW20103,DISEASE,nitric oxide no donor sodium nitroprusside,addiction-related behaviors
NEW20104,CHEMICAL,nitric oxide no donor sodium nitroprusside,postsynaptic dopamine receptor supersensitivity
NEW20105,MENTAL_HEALTH,smoke cannabis,uremic syndromes
NEW20106,CHEBI,smoke cannabis,intravenous thiamine administrations
NEW20107,DISEASE,smoke cannabis,disturbance T2 MRI lesions
NEW20108,DISEASE,smoke cannabis,childhood acute lymphoblastic leukemia
NEW20109,MENTAL_HEALTH,smoke cannabis,acute neurotoxicity syndromes
NEW20110,CHEMICAL,subacute mtx neurotoxicity,Subacute MTX neurotoxicity
NEW20111,DISEASE,subacute mtx neurotoxicity,hemisensory deficits
NEW20112,DISEASE,transient neurological dysfunction,transient neurological dysfunction
NEW20113,DISEASE,transient neurological dysfunction,possible ischemic infarct
NEW20114,DISEASE,transient neurological dysfunction,transient dysfunction
NEW20115,DISEASE,psychiatric disturbance,psychiatric disturbances
D014749,CHEMICAL,Vincamine,vincamine|Cerebroxine|Pervincamine|Vincimax|Vincapront|Devincan
NEW20116,DISEASE,transduce tumor cell,transduced tumor cells
NEW20117,CHEMICAL,transduce tumor cell,ganciclovir treatment
NEW20118,DISEASE,transduce tumor cell,orthotopic glioblastoma xenograft model
NEW20119,CHEBI,transduce tumor cell,retinol cell surface receptor
NEW20120,CHEMICAL,transduce tumor cell,AI animals
D057947,DISEASE,Parenteral Nutrition Solutions,"Nutrition|Solutions, Intravenous Feeding|NIN|Intravenous Feeding Solutions|Feeding Solutions, Intravenous"
NEW20121,CHEMICAL,transduce tumor cell,Vit-A|national vitamin A
NEW20122,CHEBI,transduce tumor cell,A prophylaxis program
NEW20123,CHEMICAL,elevated local e2 level,elevated local E2 levels
NEW20124,CHEMICAL,elevated local e2 level,S162C
NEW20125,CHEMICAL,elevated local e2 level,L116C
NEW20126,CHEBI,nucleoside analogue reverse transcriptase inhibitor,Nucleoside analogue reverse transcriptase inhibitors
NEW20127,CHEMICAL,folfox chemotherapy,FOLFOX chemotherapy
D015179,DISEASE,Colorectal Neoplasms,"Neoplasm, Colorectal|Colorectal Cancers|Cancers, Colorectal|Cancer, Colorectal|Colorectal Carcinoma|colorectal carcinoma|Carcinoma, Colorectal|Colorectal Carcinomas|Colorectal Cancer|Colorectal Tumor|Tumors, Colorectal|Tumor, Colorectal|Colorectal Tumors|Colorectal Neoplasm|Carcinomas, Colorectal|Neoplasms, Colorectal"
NEW20128,MENTAL_HEALTH,neuroleptic-induced oral dyskinesia,neuroleptic-induced oral dyskinesia
http://purl.obolibrary.org/obo/CHEBI_60649,CHEBI,glucagon receptor antagonist,glucagon receptor antagonists
NEW20129,CHEMICAL,twincretin,twincretins
NEW20130,CHEBI,triple glp-1 agonist,triple GLP-1 agonists
NEW20131,NUTRITION,tryptophan depletion,Tryptophan depletion
NEW20132,NUTRITION,tryptophan degrade enzyme,tryptophan degrading enzyme
D000078862,CHEMICAL,Levomilnacipran,Levomilnacipran|Fetzima|Levomilnacipran Hydrochloride
NEW20133,DISEASE,tryptophan degrade enzyme,persistent penile erection
NEW20134,MENTAL_HEALTH,tryptophan degrade enzyme,transient apical dyskinesia
NEW20135,DISEASE,severe cm,severe CM
NEW20136,CHEMICAL,creatinine clearance,creatinine clearance
D017597,DISEASE,"Renal Blood Flow, Effective","Blood Flow, Renal, Effective|Effective Renal Blood Flow|ERBF|renal blood flow"
NEW20137,CHEMICAL,noradrenaline contraction,noradrenaline contraction
NEW20138,CHEMICAL,% .Q(sys,% .Q(sys
NEW20139,DISEASE,spontaneous non-convulsive seizure,spontaneous non-convulsive seizures
NEW20140,DISEASE,ad-relate abnormal neuronal hyperactivity,AD-related abnormal neuronal hyperactivity
C057682,CHEMICAL,panaxytriol [Supplementary Concept],Fatty Alcohols|Enediynes|panaxytriol
NEW20141,CHEMICAL,Zingiber zerumbet L. Smith,Zingiber zerumbet L. Smith
NEW20142,MENTAL_HEALTH,zerumbone-induced analgesia,zerumbone-induced analgesia
NEW20143,CHEMICAL,atp-sensitive k+ channel,ATP-sensitive K+ channel
NEW20144,CHEBI,sur1-katp channel subtype agonist,SUR1-KATP channel subtype agonists
NEW20145,CHEMICAL,intraperitoneal ellagic acid,Intraperitoneal ellagic acid
NEW20146,DISEASE,intraperitoneal ellagic acid,phasic pain models
NEW20147,DISEASE,p. fluorescens subgroup,P. fluorescens subgroup
NEW20148,CHEMICAL,p. fluorescens subgroup,polyketide antibiotic mupirocin
NEW20149,MENTAL_HEALTH,simple linear regression analysis,Simple linear regression analysis
NEW20150,CHEMICAL,simple linear regression analysis,Cd concentration
NEW20151,MENTAL_HEALTH,low trait anxiety,low trait anxiety
C105109,NUTRITION,TSA-Direct BlueFISH [Supplementary Concept],Bluefish|Tyrosine/analogs  and  derivatives
C014024,CHEMICAL,"2,4,5,2',4',5'-hexachlorobiphenyl [Supplementary Concept]",CB-153|Polychlorinated Biphenyls
NEW20152,MENTAL_HEALTH,low trait anxiety,different regression slopes
NEW20153,CHEBI,growth hormone releasing hormone antagonist,Growth hormone releasing hormone antagonists
NEW20154,DISEASE,growth hormone releasing hormone antagonist,LPS-induced lung endothelial hyperpermeability
NEW20155,DISEASE,severe human disease,severe human disease
http://purl.obolibrary.org/obo/CHEBI_138015,CHEBI,endocrine disruptor,endocrine disrupting compound|hormonally active agents|endocrine disrupting compounds|endocrine disruptors|endocrine disrupting chemicals|endocrine disrupting chemical|endocrine-disrupting chemical|Many endocrine disruptors|endocrine-disrupting chemicals|hormonally active agent
NEW20156,CHEMICAL,μm. ziram,μM. Ziram
NEW20157,DISEASE,μm. ziram,asthenozoospermia spermatozoa
D058492,CHEBI,Drug Repositioning,"Rescue, Drug|Drug Repurposing|Repositioning, Drug|Repurposing, Drug|Drug Rescue"
NEW20158,DISEASE,μm. ziram,Effective Alzheimer Medicines
NEW20159,CHEMICAL,dopamine da concentration,dopamine DA concentration
NEW20160,CHEMICAL,bacillus siamensis strain b44v,Bacillus siamensis strain B44v
NEW20161,NUTRITION,bacillus siamensis strain b44v,catfish culture
NEW20162,DISEASE,bacillus siamensis strain b44v,hydrophila FW52
NEW20163,CHEMICAL,bacillus siamensis strain b44v,mucin binding
NEW20164,CHEMICAL,serotonin turnover,serotonin turnover
NEW20165,CHEMICAL,serum gln concentration,serum Gln concentrations
NEW20166,DISEASE,rtt hippocampus,RTT hippocampus
NEW20167,CHEMICAL,rtt hippocampus,repetitive glutamate transients
NEW20168,MENTAL_HEALTH,hyperarousal symptom,Hyperarousal symptoms
NEW20169,DISEASE,hyperarousal symptom,trauma memories
NEW20170,CHEBI,hyperarousal symptom,future high-risk drug use
NEW20171,MENTAL_HEALTH,fragmentation mechanism,fragmentation mechanism
D053978,CHEMICAL,Pentacyclic Triterpenes,"Triterpenes, Pentacyclic|Hopanes|Derivatives, Adianane|Derivatives, Gammacerane|Adianane Derivatives|Gammaceranes|Hopenoid Derivatives|Fernane Derivatives|Lupanes|Gammacerane Derivatives|Adiananes|Derivatives, Hopane|Derivatives, Lupane|Fernanes|Triterpenes, Baccharane|Lupane Derivatives|Hopane Derivatives|Derivatives, Fernane|pentacyclic triterpenes|Baccharane Triterpenes|Derivatives, Hopenoid"
http://purl.obolibrary.org/obo/CHEBI_176307,CHEMICAL,pelargonidin 3-sophoroside 5-glucoside,"2-[4,5-dihydroxy-2-[7-hydroxy-2-(4-hydroxyphenyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromenylium-3-yl]oxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol|flavonol aglycone"
NEW20172,DISEASE,human hepatocellular carcinoma cell,human hepatocellular carcinoma cells
D044948,CHEMICAL,Flavonols,2 Phenyl 3 Hydroxy Benzopyran 4 Ones|3-hydroxy-4-keto-Flavonoids|3 hydroxy 4 keto Flavonoids|flavonols|2-Phenyl-3-Hydroxy-Benzopyran-4-Ones
NEW20173,DISEASE,different psychiatric diagnosis,different psychiatric diagnosis
NEW20174,MENTAL_HEALTH,parkinson 's Fatigue scale,Parkinson's Fatigue Scale
NEW20175,DISEASE,Disease Rate,Disease Rate
NEW20176,DISEASE,parkinson 's Disease Sleep scale,Parkinson's Disease Sleep Scale
NEW20177,DISEASE,39-item Parkinson 's Disease questionnaire,39-item Parkinson's Disease Questionnaire
NEW20178,DISEASE,wearing-off,wearing-off
NEW20179,CHEMICAL,locomotor-enhancing effect,locomotor-enhancing effects
NEW20180,CHEBI,locomotor-enhancing effect,selective mu-opioid receptor antagonist
C034643,CHEMICAL,naloxonazine [Supplementary Concept],Naloxone/analogs  and  derivatives|naloxonazine
NEW20181,CHEMICAL,locomotor-enhancing effect,naloxone challenge
NEW20182,DISEASE,morphine-dependent diabetic mouse,morphine-dependent diabetic mice
NEW20183,CHEBI,serotonergic antagonist mirtazapine,serotonergic antagonist mirtazapine
NEW20184,DISEASE,serotonergic antagonist mirtazapine,CUD participants
NEW20185,CHEMICAL,serotonergic antagonist mirtazapine,product ions
NEW20186,MENTAL_HEALTH,serotonergic antagonist mirtazapine,collision-induced dissociation mass
NEW20187,CHEMICAL,paa therapy,PAA therapy
D059326,CHEMICAL,Serotonergic Neurons,"Serotoninergic Neuron|Neuron, Serotonergic|Neurons, Serotoninergic|Serotonergic Neuron|serotonergic neurons|Neurons, Serotonergic|Neuron, Serotoninergic|Serotoninergic Neurons"
NEW20188,DISEASE,depressed pregnant woman,depressed pregnant women
NEW20189,CHEBI,depressed pregnant woman,stress hormone levels
NEW20190,MENTAL_HEALTH,depressed pregnant woman,Major Depression N=54 groups
NEW20191,DISEASE,dysthymic group,Dysthymic group
NEW20192,CHEMICAL,dysthymic group,higher prenatal cortisol levels
NEW20193,CHEMICAL,post-lumpectomy,post-lumpectomy
NEW20194,CHEMICAL,multifunctional silica bead,multifunctional silica beads
NEW20195,CHEMICAL,multifunctional silica bead,small molecular aflatoxin B1
NEW20196,MENTAL_HEALTH,novel invertase enzymatic hydrolysate-triggered displacement reaction strategy,novel invertase enzymatic hydrolysate-triggered displacement reaction strategy
NEW20197,MENTAL_HEALTH,competitive-type displacement reaction,competitive-type displacement reaction
D000069295,CHEMICAL,Mammary Analogue Secretory Carcinoma,Carcinoma (2010-2015)|dextran|analogue
NEW20198,CHEMICAL,competitive-type displacement reaction,A A binding sites
NEW20199,CHEMICAL,competitive-type displacement reaction,H2O2-thionine system
NEW20200,CHEMICAL,ige sensitization,IgE sensitization
NEW20201,MENTAL_HEALTH,ige sensitization,pollen-food syndromes
NEW20202,MENTAL_HEALTH,ige sensitization,celery-mugwort-spice syndromes
NEW20203,CHEMICAL,ige sensitization,goosefoot-melon associations
NEW20204,CHEBI,cross-reactive allergen component,cross-reactive allergen components
NEW20205,DISEASE,cross-reactive allergen component,allergy practice
NEW20206,CHEMICAL,inhale allergen,inhaled allergens
D057912,CHEMICAL,Angiotensin II Type 2 Receptor Blockers,angiotensin receptor blockers|Angiotensin II Type 2 Receptor Antagonists|Type 2 Angiotensin Receptor Antagonists|Angiotensin 2 Receptor Antagonists|Type 2 Angiotensin Receptor Blockers
NEW20207,MENTAL_HEALTH,inhale allergen,disorder admissions
C539977,CHEMICAL,perphenazine GABA ester [Supplementary Concept],Perphenazine/analogs  and  derivatives|gamma-Aminobutyric Acid/analogs  and  derivatives|BL-1020
NEW20208,DISEASE,dopamine release,migraine triggers
D005520,CHEBI,Food Preservatives,"Preservatives, Food|food preservatives"
NEW20209,DISEASE,most candida albican,most Candida albicans
NEW20210,CHEBI,most candida albican,azole antifungals
NEW20211,DISEASE,acute alcohol hallucinosis,acute alcohol hallucinosis
NEW20212,CHEMICAL,acute alcohol hallucinosis,inhibitory amino acid neurotransmitter
NEW20213,CHEBI,acute alcohol hallucinosis,current drug
NEW20214,DISEASE,S. nigriventris,S. nigriventris
D014337,NUTRITION,Trout,Chars|trout|Salvelinus|Char
NEW20215,CHEMICAL,S. nigriventris,diurnal Chiloglanis-like benthic ancestor
NEW20216,NUTRITION,cholesterol guideline,Cholesterol guidelines
NEW20217,NUTRITION,erythrocyte lithium influx,Erythrocyte lithium influx
NEW20218,MENTAL_HEALTH,icu delirium,ICU delirium
NEW20219,CHEMICAL,nefazodone weak,nefazodone weak
NEW20220,MENTAL_HEALTH,dysthymia symptom,dysthymia symptoms
NEW20221,MENTAL_HEALTH,syndrome related,syndromes related
NEW20222,CHEBI,selective serotonin-2 antagonist,selective serotonin-2 antagonist
NEW20223,DISEASE,non-epithelial neuroendocrine neoplasm,non-epithelial neuroendocrine neoplasms
D002864,CHEMICAL,Chromogranins,Granins|chromogranins|Granin|Secretogranin|Chromogranin|Secretogranins
D016708,CHEMICAL,Synaptophysin,"p38 Membrane Protein, Synaptic Vesicle|synaptophysin"
NEW20224,CHEMICAL,non-epithelial neuroendocrine neoplasm,keratins tyrosine hydroxylase
NEW20225,DISEASE,non-epithelial neuroendocrine neoplasm,equina neuroendocrine tumor
NEW20226,DISEASE,inflammatory rheumatic disease,inflammatory rheumatic diseases
NEW20227,DISEASE,low extremity arterial disease,lower extremity arterial disease
NEW20228,DISEASE,jaundice syndrome,Jaundice Syndrome
NEW20229,CHEMICAL,jaundice syndrome,sea-pen-farmed Chinook Salmon
NEW20230,CHEMICAL,male daily cannabis smoker,male daily cannabis smokers
NEW20231,CHEMICAL,male daily cannabis smoker,frequent 20-mg oral Δ⁹-tetrahydrocannabinol
NEW20232,CHEMICAL,male daily cannabis smoker,Δ⁹-tetrahydrocannabinol dosages
NEW20233,DISEASE,vibrio cholerae neuraminidase,Vibrio cholerae neuraminidase
NEW20234,CHEMICAL,vibrio cholerae neuraminidase,unmasked GM1
NEW20235,CHEMICAL,vibrio cholerae neuraminidase,sialic acid residues
NEW20236,DISEASE,fetal alcohol exposure,atrial defects
NEW20237,NUTRITION,american bullfrog,American bullfrog
NEW20238,NUTRITION,american bullfrog,yellowfin tuna|Thunnus albacares
NEW20239,NUTRITION,american bullfrog,Carcharhinus plumbeus|sandbar shark
NEW20240,CHEMICAL,american bullfrog,elevated extracellular potassium
NEW20241,CHEBI,alpha7 nicotinic agonist,alpha7 nicotinic agonist
NEW20242,NUTRITION,haliotis tuberculata mortality,Haliotis tuberculata mortality
NEW20243,DISEASE,haliotis tuberculata mortality,pathogenic Vibrio harveyi
NEW20244,CHEMICAL,haliotis tuberculata mortality,aged ≥
NEW20245,CHEBI,haliotis tuberculata mortality,selective noncompetitive AMPA receptor antagonist
NEW20246,CHEMICAL,pentafluorobenzyl ester,Pentafluorobenzyl esters
NEW20247,DISEASE,isolate ovarian follicular cell dna,isolated ovarian follicular cell DNA
NEW20248,NUTRITION,isolate ovarian follicular cell dna,BKME-exposed white sucker
C000659190,DISEASE,Magnusiomyces clavatus [Supplementary Concept],Saccharomycetales|Magnusiomyces clavatus
NEW20249,CHEBI,isolate ovarian follicular cell dna,used antifungal agents
NEW20250,MENTAL_HEALTH,isolate ovarian follicular cell dna,intrinsic resistance
NEW20251,CHEBI,isolate ovarian follicular cell dna,drug binding site
NEW20252,NUTRITION,cortical choline acetyl transferase activity,cortical choline acetyl transferase activity
D000073216,MENTAL_HEALTH,Mental Status and Dementia Tests,"Neurobehavioral Cognitive Status Examination|Mini Mental State Examination|Dementia Rating Scale|Dementia Rating|General Practitioner Assessment of Cognition|Mental Status Test|Unified Parkinson's Disease Rating Scale|Clinical Dementia Rating Scale|Folstein Mini-Mental State Examination|UPDRS Panel|MMSE, Mini Mental State Examination|Mental Status and Dementia Test|Neurocognitive Tests|MicroCog|Mental Status Tests|Cognitive Assessment Screening Instrument|Mini Mental Status Examination|GPCOG|Clinical Dementia Rating|Mini-Cog|Montreal Cognitive Assessment|Neurocognitive Test|COGNISTAT"
NEW20253,CHEBI,important antibacterial drug,important antibacterial drugs
http://purl.obolibrary.org/obo/CHEBI_182239,CHEBI,antibiotic ab3217a,"β-lactam antibiotics|(1R,3S,4S,7R,8R,11R,12R,13R)-8-(4-methoxyphenyl)-2,9,14-trioxa-6-azatricyclo[9.2.1.03,7]tetradecane-4,12,13-triol"
D015624,DISEASE,Lambert-Eaton Myasthenic Syndrome,"Myopathic Myasthenic Syndrome of Eaton Lambert|Syndrome, Lambert-Eaton Myasthenic|Myasthenic Myopathic Syndrome of Eaton Lambert|Myopathic-Myasthenic Syndrome of Eaton-Lambert|Eaton-Lambert Myasthenic-Myopathic Syndrome|Myasthenic-Myopathic Syndrome of Eaton-Lambert|Myopathic-Myasthenic Syndrome of Lambert-Eaton|Eaton-Lambert Myopathic-Myasthenic Syndromes|Lambert-Eaton Syndrome|Myasthenic Syndrome, Eaton-Lambert|Lambert-Eaton myasthenic syndrome|Lambert Eaton Myasthenic Syndrome|Syndrome, Lambert-Eaton|Eaton-Lambert Myasthenic Syndrome|Eaton Lambert Myasthenic Syndrome|Lambert-Eaton Myopathic-Myasthenic Syndromes|Lambert Eaton Syndrome|Lambert-Eaton Myasthenic-Myopathic Syndrome|Myasthenic Syndrome, Lambert-Eaton|Lambert-Eaton Myopathic-Myasthenic Syndrome|Eaton Lambert Syndrome|Myasthenic-Myopathic Syndrome of Lambert-Eaton|Syndrome, Eaton-Lambert|Eaton-Lambert Myopathic-Myasthenic Syndrome|Myasthenic Syndrome, Lambert Eaton|Eaton-Lambert Syndrome|Lambert-Eaton Myasthenic-Myopathic Syndromes|Syndrome, Eaton-Lambert Myasthenic|Myasthenic Myopathic Syndrome of Lambert Eaton"
NEW20254,DISEASE,junctional disorder,junctional disorder
NEW20255,CHEBI,junctional disorder,cholinergic drugs useful
NEW20256,CHEBI,specific ar antagonist,specific AR antagonist
NEW20257,DISEASE,specific ar antagonist,CFA-induced mechanical hypersensitivity
NEW20258,CHEBI,specific ar antagonist,specific MOR agonist
NEW20259,CHEBI,preserve vitamin e levels?vitamin e,preserved vitamin E levels?Vitamin E
http://purl.obolibrary.org/obo/CHEBI_33234,CHEBI,vitamin e,vitamin-E|vitamin E vitamer|rancherosSome vitamin E|vitamin E vitamers|vitamins E|vitamin E
NEW20260,CHEMICAL,cannabis medicine,cannabis medicines
NEW20261,CHEMICAL,typical cannabis side effect,typical cannabis side effects
NEW20262,CHEMICAL,th deficit,TH deficit
NEW20263,DISEASE,functional deficiency,functional deficiencies
NEW20264,DISEASE,grow pituitary adenoma,growing pituitary adenoma
NEW20265,DISEASE,follow-up acromegaly,follow-up acromegaly
NEW20266,CHEMICAL,n-3 pufa dha,n-3 PUFA DHA
NEW20267,DISEASE,positive symptom,positive symptoms
NEW20268,CHEMICAL,heavy cannabis user,heavy cannabis users
NEW20269,CHEMICAL,bdnf snp,BDNF SNP
NEW20270,DISEASE,rtt individual,RTT individuals
NEW20271,DISEASE,rtt pathophysiology,RTT pathophysiology
NEW20272,CHEMICAL,self-control dimension,self-control dimensions
NEW20273,MENTAL_HEALTH,low alexithymia group,low alexithymia group
NEW20274,CHEBI,liver-type mitochondrial aspartate-glutamate carrier,liver-type mitochondrial aspartate-glutamate carrier
NEW20275,DISEASE,niccd patient,NICCD patients
NEW20276,CHEMICAL,multiple aminoacidemia,multiple aminoacidemia
NEW20277,DISEASE,many ctln2 patient,Many CTLN2 patients
NEW20278,DISEASE,hyperammonemic coma,hyperammonemic coma
NEW20279,DISEASE,trd patient,TRD patients
NEW20280,NUTRITION,daily food intake,daily food intake
NEW20281,CHEMICAL,levothyroxine therapy,Levothyroxine therapy
http://purl.obolibrary.org/obo/CHEBI_32940,CHEMICAL,hexacosane,n-hexacosane|phenolic compounds|CH3-[CH2]24-CH3|alkylresorcinol 5-methylresorcinol|Alkylresorcinol|hydroxybenzenes|hexacosane
NEW20282,DISEASE,a. flavus,A. flavus
NEW20283,DISEASE,a. flavus infection/aflatoxin production,A. flavus infection/aflatoxin production
NEW20284,DISEASE,average pain score,average pain score
NEW20285,CHEMICAL,tramadol group,tramadol group
NEW20286,CHEMICAL,mglu5 receptor,mGlu5 receptors
NEW20287,DISEASE,dht-induced tec-secreted apoptotic factor,DHT-induced TEC-secreted apoptotic factors
NEW20288,MENTAL_HEALTH,thymocyte dna fragmentation,thymocyte DNA fragmentation
NEW20289,CHEMICAL,dht priming,DHT priming
NEW20290,DISEASE,dht-induced tec-secreted factor,DHT-induced TEC-secreted factor
NEW20291,CHEMICAL,propylthiouracil preconception,propylthiouracil preconception
NEW20292,CHEMICAL,original kut herb,original KUT herbs
NEW20293,DISEASE,chronic painful peripheral neuropathy,chronic painful peripheral neuropathy
NEW20294,DISEASE,undifferentiated small cell lung cancer,Undifferentiated small cell lung cancer
NEW20295,DISEASE,primary lung cancer,primary lung cancer
NEW20296,DISEASE,vbd treatment,VBD treatment
NEW20297,CHEBI,rapid drug release,rapid drug release
NEW20298,CHEMICAL,% w/w hpc,% w/w HPC
NEW20299,CHEMICAL,w/w LHC,w/w LHC
NEW20300,CHEMICAL,low blood omega-3 lc-pufa,Low blood Omega-3 LC-PUFA
NEW20301,MENTAL_HEALTH,attention-deficit/hyperactivity disorder,Attention-deficit/hyperactivity disorder|ADHD
NEW20302,CHEMICAL,pufa metabolism,PUFA metabolism
NEW20303,CHEMICAL,omega-6 long-chain pufa,LC-PUFA|omega-6 long-chain PUFA
NEW20304,DISEASE,behavioral difficulty,behavioral difficulties
NEW20305,DISEASE,less smoking-related symptomatology,less smoking-related symptomatology|SRS
NEW20306,CHEMICAL,spermine deficiency,spermine deficiency
NEW20307,CHEMICAL,spermidine toxicity,spermidine toxicity
NEW20308,MENTAL_HEALTH,narcolepsy mouse,narcolepsy mice
NEW20309,DISEASE,effective pain management,effective pain management
NEW20310,CHEBI,analgesic tolerance,analgesic tolerance
NEW20311,DISEASE,μg/day transdermal testosterone patch,TTP|μg/day transdermal testosterone patch
NEW20312,CHEBI,concomitant oestrogen,concomitant oestrogen
NEW20313,DISEASE,healthy oophorectomised woman,healthy oophorectomised women
NEW20314,DISEASE,severe psychiatric side effect,Severe psychiatric side effects
NEW20315,MENTAL_HEALTH,dissociative psychosis,dissociative psychosis
NEW20316,CHEMICAL,mefloquine intoxication,mefloquine intoxication
NEW20317,CHEBI,high-affinity trkb receptor agonist,high-affinity TrkB receptor agonist
NEW20318,CHEMICAL,anti-ischemic compound,anti-ischemic compounds
NEW20319,DISEASE,regional myocardial oxygen consumption,regional myocardial oxygen consumption
NEW20320,DISEASE,Cattle encephalon glycoside,Cattle encephalon glycoside
NEW20321,DISEASE,appswe/ps1de9 transgenic ad mouse,APPswe/PS1dE9 transgenic AD mice
NEW20322,MENTAL_HEALTH,cluster headache patient,cluster headache patients
NEW20323,CHEMICAL,more arachidonic acid,more arachidonic acid
NEW20324,CHEMICAL,l-(u-14c)serine,L-(U-14C)serine
NEW20325,CHEBI,intravaginal oestrogen,intravaginal oestrogen
NEW20326,DISEASE,posttraumatic disorder,posttraumatic disorder
NEW20327,CHEMICAL,endogenous cannabinoid anandamide,endogenous cannabinoid anandamide
NEW20328,DISEASE,persistent depressive symptom,persistent depressive symptoms
NEW20329,CHEBI,folate status indicator,folate status indicators
NEW20330,DISEASE,incipient diabetic nephropathy,incipient diabetic nephropathy
NEW20331,DISEASE,hypertensive noninsulin-dependent patient,hypertensive noninsulin-dependent patients
NEW20332,MENTAL_HEALTH,innate disease resistance,Innate disease resistance
NEW20333,NUTRITION,hatchery-reared rainbow trout,hatchery-reared rainbow trout
NEW20334,CHEMICAL,nano‑selenium,Nano‑selenium
NEW20335,CHEMICAL,nano-se supplementation,nano-Se supplementation
NEW20336,CHEMICAL,galactose metabolism,galactose metabolism
NEW20337,CHEMICAL,glutamate-glutamine metabolic pathway,glutamate-glutamine metabolic pathway
NEW20338,CHEMICAL,nano‑selenium,Nano‑selenium|Nano-Se
NEW20339,DISEASE,stress damage,stress damage
NEW20340,DISEASE,cea crf neuron,CeA CRF neurons
NEW20341,CHEMICAL,gamma-aminobutyric acid release,gamma-aminobutyric acid release
http://purl.obolibrary.org/obo/CHEBI_65255,CHEBI,food preservative,food preservative|food preservatives
NEW20342,CHEMICAL,high nitrite level,high nitrite levels
NEW20343,DISEASE,Cannabis Use Disorder,Cannabis Use Disorder
NEW20344,CHEMICAL,unilateral 6-hydroxydopamine lesion,unilateral 6-hydroxydopamine lesions
NEW20345,CHEMICAL,cheonwangbosim-dan,Cheonwangbosim-dan
NEW20346,DISEASE,arterial flutter,arterial flutter
NEW20347,CHEBI,potent serotonin uptake inhibitor clomipramine hydrochloride,potent serotonin uptake inhibitor clomipramine hydrochloride
NEW20348,CHEMICAL,zinc level,zinc level
NEW20349,CHEMICAL,reduce vesicular glutamate,reduced vesicular glutamate
NEW20350,CHEMICAL,acamprosate administration,acamprosate administration
NEW20351,DISEASE,dendritic loss,dendritic loss
NEW20352,CHEMICAL,normal histamine,normal histamine
NEW20353,DISEASE,pws patient,PWS patients
NEW20354,CHEMICAL,histone h3 lysine n-methyltransferase,histone H3 lysine N-methyltransferase
NEW20355,MENTAL_HEALTH,imprint disorder prader-willi syndrome,imprinting disorder Prader-Willi syndrome
NEW20356,CHEMICAL,in morin,In morin
NEW20357,CHEMICAL,fast blood glucose level,fasting blood glucose level
NEW20358,NUTRITION,important tree specie,important tree species
NEW20359,CHEMICAL,hrtcp20 transcription factor,HrTCP20 transcription factor
NEW20360,NUTRITION,aaa tryptophan,AAAs tryptophan
http://purl.obolibrary.org/obo/CHEBI_31293,NUTRITION,bismuth subnitrate,Bismuth subsalicylate preparations|Bismuth hydroxide nitrate oxide|Bismuth subnitrate
NEW20361,CHEMICAL,receptor a(htr1 a,receptor A(HTR1 A
NEW20362,MENTAL_HEALTH,in-source fragmentation,In-source fragmentation
NEW20363,NUTRITION,unconjugated phenol,unconjugated phenols
NEW20364,DISEASE,positive tpo antibody,Positive TPO antibodies
NEW20365,DISEASE,overt hypothyroidism,overt hypothyroidism
NEW20366,CHEBI,pro-opiomelanocortin alpha-melanocyte-stimulating hormone,pro-opiomelanocortin alpha-melanocyte-stimulating hormone
NEW20367,DISEASE,euthymic lithium-treated bipolar patient,euthymic lithium-treated bipolar patients
NEW20368,NUTRITION,wild turkey population,wild turkey population
NEW20369,DISEASE,tnt myopathy,TnT myopathies
NEW20370,CHEMICAL,ja biosynthesis,JA biosynthesis
NEW20371,CHEMICAL,nicotine biosynthetic gene,nicotine biosynthetic genes
NEW20372,DISEASE,arf transcription factor,ARF transcription factor
NEW20373,CHEBI,different hormone signaling pathway,different hormone signaling pathways
NEW20374,MENTAL_HEALTH,tumour repression,tumour repression
NEW20375,CHEMICAL,testosterone support,testosterone support
NEW20376,DISEASE,body mass gain,body mass gain
NEW20377,CHEBI,mutation carrier,mutation carriers
NEW20378,DISEASE,c9orf72 disease spectrum,C9orf72 disease spectrum
NEW20379,CHEBI,human loss-of-function allele carrier,human loss-of-function allele carriers
NEW20380,DISEASE,extensive small vessel disease severity,extensive small vessel disease severity
NEW20381,CHEMICAL,ap-5 50μm,AP-5 50μM
NEW20382,CHEMICAL,n-methyl-d-aspartic acid nmda receptor inhibitor dl-2-amino-5-phosphonopentanoic acid,N-methyl-d-aspartic acid NMDA receptor inhibitor DL-2-amino-5-phosphonopentanoic acid
NEW20383,CHEBI,fat soluble vitamin deficiency,fat soluble vitamin deficiencies|vitamin D
NEW20384,DISEASE,psychrophilum molecular serotype,psychrophilum molecular serotypes
NEW20385,CHEBI,psychrophilum antimicrobial susceptibility,psychrophilum antimicrobial susceptibility
NEW20386,CHEMICAL,utero ethanol exposure,utero ethanol exposure
NEW20387,MENTAL_HEALTH,cns insulin resistance,CNS insulin resistance
NEW20388,DISEASE,chronic loss,chronic loss
NEW20389,DISEASE,generalize disorder-like behavior,generalized disorder-like behaviors
NEW20390,CHEMICAL,gaba inhibition,GABA inhibition
NEW20391,DISEASE,generalize anxiety-like behavior,generalized anxiety-like behavior
NEW20392,CHEBI,antidiuretic hormone level,Antidiuretic hormone levels
NEW20393,CHEMICAL,serum sodium level,serum sodium level
NEW20394,CHEMICAL,urinary sodium concentration,urinary sodium concentration
NEW20395,CHEMICAL,natremia,natremia
NEW20396,CHEBI,cortisone hormone,cortisone hormones
NEW20397,DISEASE,hypoglycemic condition,hypoglycemic condition
NEW20398,CHEMICAL,(32)pi uptake,(32)Pi uptake
NEW20399,CHEMICAL,low self-control,low self-control
NEW20400,CHEBI,decrease serum vitamin b12 level,Decreased serum vitamin B12 levels
NEW20401,DISEASE,haematologic dysfunction,haematologic dysfunction
NEW20402,CHEMICAL,FU(OX,FU(OX
NEW20403,DISEASE,treatment volume reduction,treatment volume reduction
NEW20404,DISEASE,mptp-induced massive oxidative damage,MPTP-induced massive oxidative damage
NEW20405,CHEMICAL,serum glutathione,serum glutathione|GSH
NEW20406,CHEMICAL,mda assay,MDA assay
NEW20407,CHEMICAL,RTI-118,RTI-118
NEW20408,CHEBI,novel nps receptor antagonist,novel NPS receptor antagonist
NEW20409,CHEMICAL,cocaine effect,cocaine effects
NEW20410,CHEMICAL,"u69,593 dose","U69,593 dose"
NEW20411,NUTRITION,trout larvae,trout larvae
NEW20412,DISEASE,pericardial edema,pericardial edemas
NEW20413,DISEASE,pediatric/young adult,pediatric/young adult
NEW20414,NUTRITION,mandarin fish fry cell,mandarin fish fry cells
NEW20415,CHEMICAL,serum chromium,Serum chromium
NEW20416,DISEASE,pcos patient,PCOS patients
NEW20417,DISEASE,congenital long qt syndrome experience,congenital long QT syndrome experience
NEW20418,CHEMICAL,cardiac potassium channel,cardiac potassium channels
NEW20419,DISEASE,congenital long qt syndrome,congenital long QT syndrome|LQTS
NEW20420,CHEBI,amphipathic toxin candidalysin,amphipathic toxin candidalysin
NEW20421,DISEASE,necrotic host cell damage,necrotic host cell damage
NEW20422,CHEMICAL,jef-279,JEF-279
NEW20423,CHEMICAL,monochamus alternatus,Monochamus alternatus|Japanese pine sawyer
NEW20424,CHEBI,neurotoxin entry,neurotoxin entry
NEW20425,DISEASE,transient gut dysbiosis,transient gut dysbiosis
NEW20426,CHEBI,neurotoxin blood level,neurotoxin blood levels
NEW20427,CHEMICAL,partial opiate agonist buprenorphine,partial opiate agonist buprenorphine
NEW20428,DISEASE,neuroleptic-free schizophrenic patient,neuroleptic-free schizophrenic patients
NEW20429,CHEMICAL,hydroxyl moiety,hydroxyl moiety
NEW20430,NUTRITION,seaweed extract,seaweed extract
NEW20431,CHEMICAL,abnormal dopamine neurotransmission,Abnormal dopamine neurotransmission
NEW20432,DISEASE,genetic dystonic disorder,genetic dystonic disorders
NEW20433,CHEMICAL,d1- d2-like dopamine receptor antagonist,D1- D2-like dopamine receptor antagonists
NEW20434,CHEMICAL,dopamine signalling,dopamine signalling
NEW20435,CHEMICAL,d2-dopamine receptor,D2-dopamine receptors
NEW20436,DISEASE,drd mouse,DRD mice
NEW20437,MENTAL_HEALTH,adhd adult,ADHD adults
NEW20438,NUTRITION,auditory discrimination,Auditory Discrimination|TOAD
NEW20439,CHEMICAL,Glabralactone,Glabralactone
NEW20440,DISEASE,paw edema volume,paw edema volume
NEW20441,CHEMICAL,wilfordii genus preparation,wilfordii genus preparations
NEW20442,CHEMICAL,catecholamine synthesis inhibitor,catecholamine synthesis inhibitors
NEW20443,DISEASE,anovular sterility,anovular sterility
http://purl.obolibrary.org/obo/CHEBI_59132,CHEBI,antigen,antigens|antigen (TIA)-1|antigen Aw32
NEW20444,MENTAL_HEALTH,splicing repression,splicing repression
NEW20445,DISEASE,asd-like,ASD-like
NEW20446,NUTRITION,finite ovarian follicle pool,finite ovarian follicle pool
NEW20447,DISEASE,ovarian effect,ovarian effects
NEW20448,DISEASE,left-sided frontal alpha,left-sided frontal alpha
NEW20449,MENTAL_HEALTH,high depression score,higher depression scores
NEW20450,CHEMICAL,exogenous taurine,exogenous taurine
NEW20451,DISEASE,fish physiological disorder,fish physiological disorder
NEW20452,CHEMICAL,high ammonia level,high ammonia level
NEW20453,CHEBI,certain drug withdrawal symptom,certain drug withdrawal symptoms
NEW20454,MENTAL_HEALTH,enkephalin-positive projection neuron,Enkephalin-positive projection neurons
NEW20455,CHEMICAL,distinct nmda receptor subunit phenotype,distinct NMDA receptor subunit phenotypes
NEW20456,CHEMICAL,nmda receptor expression,NMDA receptor expression
NEW20457,CHEMICAL,un-competitive nmda antagonist,un-competitive NMDA antagonists
NEW20458,NUTRITION,germ-tube positive yeast,Germ-tube positive yeast
NEW20459,CHEBI,sheep blood agar,sheep blood agar
NEW20460,CHEBI,agar plate indicative,agar plates indicative
NEW20461,CHEMICAL,g. (+)-alpha-pinene,g. (+)-alpha-pinene
NEW20462,NUTRITION,walnut tree,walnut tree
NEW20463,CHEMICAL,seed oil rich,seed oil rich
NEW20464,NUTRITION,soybean transphosphatidylated phosphatidylserine,Soybean transphosphatidylated phosphatidylserine
NEW20465,NUTRITION,soybean phosphatidylcholine,soybean phosphatidylcholine
NEW20466,CHEMICAL,soybean lecithin transphosphatidylated phosphatidylserine,SB-tPS|Soybean lecithin transphosphatidylated phosphatidylserine
NEW20467,NUTRITION,acid composition,acids composition
NEW20468,NUTRITION,bovine brain cortex-derived phosphatidylserine,bovine brain cortex-derived phosphatidylserine
NEW20469,NUTRITION,fatty acid significant activity,fatty acid significant activities
NEW20470,CHEMICAL,brain glucose concentration,brain glucose concentrations
NEW20471,NUTRITION,high-affinity choline uptake process,high-affinity choline uptake process
NEW20472,CHEBI,high-affinity choline carrier,high-affinity choline carriers
NEW20473,CHEMICAL,(3h)hemicholinium-3,(3H)Hemicholinium-3
NEW20474,NUTRITION,cranberry phytochemical,cranberry phytochemicals
NEW20475,CHEMICAL,atypical antipsychotic agent aripiprazole,atypical antipsychotic agent aripiprazole
NEW20476,DISEASE,treatment-resistant BDD,treatment-resistant BDD
NEW20477,DISEASE,dermatological disorder,dermatological disorders
NEW20478,MENTAL_HEALTH,social phobia secondary,social phobia secondary
NEW20479,MENTAL_HEALTH,major psychiatric syndrome,major psychiatric syndromes
NEW20480,DISEASE,low cardiotoxicity,lower cardiotoxicity
NEW20481,DISEASE,t. latifolia,T. latifolia
NEW20482,CHEMICAL,aerial photograph,aerial photographs|≤13 years
NEW20483,DISEASE,idiopathic heritable related,idiopathic heritable related
NEW20484,DISEASE,regular pulmonary arterial hypertension follow-up schedule,regular pulmonary arterial hypertension follow-up schedule
NEW20485,CHEBI,antagonist sch58261 mg/kg,antagonist SCH58261 mg/kg
NEW20486,CHEMICAL,caffeine administration,caffeine administration
NEW20487,DISEASE,beta-amyloid-induced cognitive impairment,beta-amyloid-induced cognitive impairment
NEW20488,CHEBI,caffeine receptor antagonist,caffeine receptor antagonists
NEW20489,DISEASE,alcohol liver disease,alcohol liver diseases
NEW20490,DISEASE,cellular damage,cellular damage
NEW20491,CHEMICAL,generate cu+ ion,generated Cu+ ions
NEW20492,DISEASE,acidic tumor microenvironment,acidic tumor microenvironment
NEW20493,CHEMICAL,laser-assisted uvulopalatoplasty,Laser-assisted uvulopalatoplasty|LAUP
NEW20494,DISEASE,severe throat pain,severe throat pain
NEW20495,CHEBI,gestagen supplementation,Gestagen supplementation
NEW20496,DISEASE,pms patient,PMS patients
NEW20497,CHEMICAL,benzodiazepine injection,benzodiazepine injections
NEW20498,DISEASE,autistic-like behavior,autistic-like behaviors
http://purl.obolibrary.org/obo/DOID_12257,DISEASE,medulloadrenal hyperfunction,NMDAR hypofunction
NEW20499,CHEBI,nmdar antagonist model,NMDAR antagonist models
NEW20500,CHEMICAL,sildenafil potent phosphodiesterase-5 inhibitor,sildenafil potent phosphodiesterase-5 inhibitor
NEW20501,CHEMICAL,saturated anacardic acid,saturated anacardic acid
NEW20502,CHEBI,selective 5-ht(2a receptor antagonist eplivanserin,selective 5-HT(2A receptor antagonist eplivanserin
NEW20503,DISEASE,light slow-wave sleep,light slow-wave sleep|SWS
NEW20504,CHEMICAL,nonselective serotonin 5-ht(2a/2c receptor antagonist,nonselective serotonin 5-HT(2A/2C receptor antagonists
NEW20505,CHEMICAL,macrophage-activation stimulus,Macrophage-activation stimuli
NEW20506,NUTRITION,bad cholesterol,bad cholesterol
NEW20507,CHEBI,cb2 agonist,CB2 agonist
NEW20508,MENTAL_HEALTH,opioid-induced respiratory depression,opioid-induced respiratory depression
NEW20509,CHEMICAL,chemical chaperone 4-phenylbutyrate,chemical chaperones 4-phenylbutyrate
NEW20510,DISEASE,varied encephalopathy,varied encephalopathies
NEW20511,DISEASE,peripheral hyperinsulinemia,peripheral hyperinsulinemia
NEW20512,CHEMICAL,inhibitor BRAFi,inhibitors BRAFi
NEW20513,DISEASE,metastatic melanoma,metastatic melanoma
NEW20514,CHEBI,ahr antagonist,AhR antagonists
NEW20515,CHEMICAL,n-methyl-d-aspartate nmda receptor antagonist ketamine,N-methyl-D-aspartate NMDA receptor antagonist ketamine
NEW20516,MENTAL_HEALTH,resistant unipolar depression,resistant unipolar depression
NEW20517,CHEMICAL,transient antidepressant effect,transient antidepressant effects
NEW20518,CHEMICAL,monoamine reuptake inhibitor,Monoamine reuptake inhibitors
NEW20519,CHEMICAL,endothelin (et)-1,endothelin (ET)-1
NEW20520,DISEASE,debilitating neurocognitive deficit,Debilitating neurocognitive deficits
NEW20521,NUTRITION,giant freshwater prawn,giant freshwater prawn
NEW20522,CHEMICAL,specific l-(3h glutamate binding,specific L-(3H glutamate binding
http://purl.obolibrary.org/obo/CHEBI_26908,CHEMICAL,tetrahydrofolyl glutamate,L-(3H glutamate
NEW20523,MENTAL_HEALTH,dissociation equilibrium,dissociation equilibrium
NEW20524,DISEASE,rat forebrain,rat forebrain
NEW20525,DISEASE,chronic inflammatory disease,chronic inflammatory diseases
NEW20526,CHEMICAL,% serotonin-norepinephrine reuptake inhibitor,% serotonin-norepinephrine reuptake inhibitor
NEW20527,CHEBI,nmda receptor glycine site agonist d-cycloserine,NMDA receptor glycine site agonist d-cycloserine
NEW20528,CHEMICAL,Amaryllidaceae alkaloid galanthamine,Amaryllidaceae alkaloid galanthamine
NEW20529,NUTRITION,secondary metabolite,secondary metabolite
NEW20530,CHEMICAL,Lycoris longituba,Lycoris longituba
NEW20531,DISEASE,compulsive buying disorder,Compulsive buying disorder
NEW20532,CHEMICAL,pg proband,PG probands
NEW20533,DISEASE,compulsive buying disorder,compulsive buying disorder
NEW20534,CHEMICAL,familial pg spectrum,familial PG spectrum
NEW20535,CHEMICAL,pg patient,PG patients
NEW20536,CHEMICAL,increase gamble-related cue reactivity,increased gamble-related cue reactivity
NEW20537,NUTRITION,cholesterol fraction,cholesterol fractions
NEW20538,CHEBI,ppar alpha agonist,PPAR alpha agonists
NEW20539,CHEMICAL,serum triglyceride concentration,serum triglyceride concentration
NEW20540,DISEASE,gout patient,gout patients
NEW20541,CHEBI,ppar alpha agonist,PPAR alpha agonist
NEW20542,CHEMICAL,spontaneous calcium elevation,spontaneous calcium elevations
NEW20543,DISEASE,insulin-induced hypoglycemia,Insulin-induced hypoglycemia
NEW20544,MENTAL_HEALTH,progressive neurological depression,progressive neurological depression
NEW20545,CHEMICAL,altered regional cerebral acetylcholine metabolism,altered regional cerebral acetylcholine metabolism
NEW20546,DISEASE,mm moderate hypoglycemia,mM moderate hypoglycemia
NEW20547,CHEMICAL,glucose concentration,glucose concentrations
NEW20548,DISEASE,moderate hypoglycemia,Moderate hypoglycemia
NEW20549,CHEMICAL,2h2 2h2]choline incorporation,2H2 2H2]choline incorporation
NEW20550,CHEMICAL,acetylcholine concentration,acetylcholine concentrations
NEW20551,CHEMICAL,impaired acetylcholine metabolism,impaired acetylcholine metabolism
NEW20552,MENTAL_HEALTH,insulin stupor,insulin stupor
NEW20553,NUTRITION,reverse cholesterol transport,reverse cholesterol transport
NEW20554,CHEBI,synthetic lxr agonist,synthetic LXR agonists
NEW20555,DISEASE,marked hypertriglyceridemia,marked hypertriglyceridemia
NEW20556,CHEMICAL,galloylated oligo- pac,Galloylated oligo- PACs
NEW20557,DISEASE,Sorrel herb,Sorrel herb
NEW20558,CHEMICAL,alcohol fetal exposure,alcohol fetal exposure
NEW20559,NUTRITION,acid dietary supplementation,acids dietary supplementation
NEW20560,NUTRITION,short chain fatty acid profile,short chain fatty acid profiles
NEW20561,DISEASE,familial bipolar diathesis,familial bipolar diathesis
NEW20562,DISEASE,persistent crps,persistent CRPS
NEW20563,CHEBI,licensed antagonist,licensed antagonists
NEW20564,DISEASE,invasive pulmonary aspergillosis due,Invasive pulmonary aspergillosis due
NEW20565,DISEASE,serious fungal infection,serious fungal infection
NEW20566,CHEBI,peptidic agonist,Peptidic agonists
NEW20567,DISEASE,prostate tumour,prostate tumours
http://purl.obolibrary.org/obo/DOID_12323,DISEASE,cough variant asthma,Cough variant asthma
NEW20568,CHEBI,responsive leukotriene antagonist,responsive leukotriene antagonists
NEW20569,CHEMICAL,antidepressant prescribing pattern,Antidepressant prescribing patterns
NEW20570,MENTAL_HEALTH,depression Endpoints Research,Depression Endpoints Research
NEW20571,CHEMICAL,initial antidepressant choice,initial antidepressant choice
NEW20572,CHEBI,gamma-aminobutyric acid a receptor gabaar agonist,Gamma-aminobutyric acid A receptor GABAAR agonists
NEW20573,CHEMICAL,non-nmo-related indication,non-NMO-related indications
NEW20574,CHEMICAL,adjunctive aripiprazole,adjunctive aripiprazole
NEW20575,DISEASE,arboviral disease,Arboviral diseases
http://purl.obolibrary.org/obo/DOID_0050175,DISEASE,tick-borne encephalitis,Siberian tick-borne encephalitis|west-Siberian encephalitis|Western European tick-borne encephalitis|Far Eastern TBE|tick-borne louping encephalitis|Taiga encephalitis|Central European encephalitis|Russian spring-summer encephalitis
NEW20576,DISEASE,sandfly-borne,sandfly-borne
NEW20577,DISEASE,aino disease,Aino disease
NEW20578,DISEASE,midge-borne,midge-borne
NEW20579,DISEASE,thogoto fever,Thogoto fever
NEW20580,CHEMICAL,tembusu disease/duck egg-drop syndrome,Tembusu disease/duck egg-drop syndrome
http://purl.obolibrary.org/obo/SYMP_0000613,DISEASE,fever,Soldado fever|pyrexia|Tyuleniy fever|Bhanja fever
NEW20581,DISEASE,cocal disease,Cocal disease
NEW20582,DISEASE,kotonkan disease,Kotonkan disease
NEW20583,DISEASE,main drain disease,Main Drain disease
NEW20584,DISEASE,West Nile encephalitis,West Nile encephalitis
NEW20585,DISEASE,akabane disease,Akabane disease
http://purl.obolibrary.org/obo/DOID_0050171,DISEASE,obsolete snowshoe hare encephalitis,Snowshoe hare encephalitis
NEW20586,CHEBI,excessive estrogen influence,Excessive estrogen influence
NEW20587,CHEMICAL,excessive progesterone influence,Excessive progesterone influence
NEW20588,CHEMICAL,significant ketamine prescribing experience,significant ketamine prescribing experience
NEW20589,CHEMICAL,non-parenteral ketamine,non-parenteral ketamine
NEW20590,MENTAL_HEALTH,disorder specialist,disorder specialists
NEW20591,CHEMICAL,cpe strain,CPE strains
NEW20592,CHEBI,antimicrobial susceptibility,antimicrobial susceptibilities
NEW20593,MENTAL_HEALTH,resistance determinant,resistance determinants
NEW20594,MENTAL_HEALTH,subjective ictal anxiety,subjective ictal anxiety
NEW20595,CHEMICAL,enoxaparin therapy,Enoxaparin therapy
NEW20596,DISEASE,thrombotic event,thrombotic events
NEW20597,CHEMICAL,inflammation myeloperoxidase activity-mpo,inflammation myeloperoxidase activity-MPO
NEW20598,CHEMICAL,glutathione level antioxidant enzyme,glutathione levels antioxidant enzymes
NEW20599,CHEBI,e level,E levels
NEW20600,CHEMICAL,il-1β thiobarbituric acid reactive substances-tbars,IL-1β thiobarbituric acid reactive substances-TBARS
http://purl.obolibrary.org/obo/CHEBI_4667,CHEMICAL,valproate semisodium,valproato semisodico|sodium 2-propylpentanoate--2-propylpentanoic acid (1:1)|valproate semisodium|sodium divalproate|divalproex sodium|sodium hydrogen bis(2-propylpentanoate)|sodium hydrogen divalproate|sodium hydrogen bis(2-propylvalerate)|semisodium valproate|valproatum seminatricum|valproate semisodique
NEW20601,CHEMICAL,bmi β=0.148,BMI β=0.148
NEW20602,MENTAL_HEALTH,increase binge eating symptom,increased binge eating symptoms
NEW20603,CHEMICAL,r(2)=0.086,R(2)=0.086
NEW20604,CHEMICAL,β=0.130,β=0.130
NEW20605,MENTAL_HEALTH,multidrug resistance mechanism,multidrug resistance mechanisms
NEW20606,CHEMICAL,vulvar intraepithelial neoplasia,VIN|vulvar intraepithelial neoplasia
NEW20607,MENTAL_HEALTH,pdt resistance,PDT resistance
NEW20608,CHEMICAL,(+)-9'-allyl-ABA,(+)-9'-allyl-ABA
NEW20609,DISEASE,well-defined nephrotoxic effect,well-defined nephrotoxic effects
NEW20610,CHEMICAL,uvb dose,UVB dose
NEW20611,DISEASE,significant thermal hypersensitivity,significant thermal hypersensitivity
NEW20612,CHEMICAL,third epidural steroid injection,third epidural steroid injection
NEW20613,MENTAL_HEALTH,patient 's psychosis,patient's psychosis
NEW20614,CHEMICAL,epidural steroid,epidural steroids
NEW20615,DISEASE,inflammatory pain model,inflammatory pain models
NEW20616,CHEBI,receptor-alpha agonist,receptor-alpha agonists
NEW20617,NUTRITION,fatty acid amide hydrolase inhibitor,Fatty acid amide hydrolase inhibitors
NEW20618,CHEMICAL,monoacylglycerol lipase inhibitor,monoacylglycerol lipase inhibitors
NEW20619,CHEMICAL,cb(2 receptor,CB(2 receptors
NEW20620,DISEASE,painful neuroma,painful neuromas
NEW20621,CHEMICAL,cb receptor agonist,CB receptor agonists
NEW20622,CHEMICAL,real-time lamp,Real-time LAMP
NEW20623,DISEASE,tap-harboring p. fluorescens,TAP-harboring P. fluorescens
NEW20624,DISEASE,associate wet-dog shake,associated wet-dog shakes
NEW20625,DISEASE,epileptoid eeg,epileptoid EEG
NEW20626,MENTAL_HEALTH,behavioral stupor,behavioral stupor
NEW20627,CHEMICAL,4-ethyloxalacetate,4-ethyloxalacetate
NEW20628,CHEMICAL,pyruvate kinase activity,pyruvate kinase activity
NEW20629,CHEMICAL,brucine base,Brucine base
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Central_Nervous_System_Disorders,MENTAL_HEALTH,central nervous system disorders,central nervous system depression
NEW20630,DISEASE,systemic toxicity,systemic toxicity
NEW20631,DISEASE,chronic abuse,chronic abuse
NEW20632,CHEMICAL,Phetholamine,Phetholamine
NEW20633,CHEMICAL,alloxan administration,alloxan administration
NEW20634,NUTRITION,therapeutic range lithium treatment,therapeutic range lithium treatment
http://purl.obolibrary.org/obo/HP_0003674,DISEASE,onset,NCSE onset
NEW20635,CHEMICAL,∆9-tetrahydrocannabinol,∆9-tetrahydrocannabinol|THC
NEW20636,CHEMICAL,alpha t3 cell,alpha T3 cells
NEW20637,DISEASE,primary pituitary gonadotrope,primary pituitary gonadotropes
NEW20638,CHEBI,receptor-bound antagonist,receptor-bound antagonist
NEW20639,CHEBI,agonist ligand,agonist ligand
NEW20640,CHEMICAL,doxepin mouthwash,doxepin mouthwash
NEW20641,DISEASE,oral mucositis-related pain,oral mucositis-related pain
NEW20642,CHEBI,antacid consumption,antacid consumption
NEW20643,CHEMICAL,low trimipramine group,lower trimipramine group
NEW20644,MENTAL_HEALTH,insomnia symptomatology,insomnia symptomatology
NEW20645,NUTRITION,spanish general population,Spanish general population
NEW20646,CHEMICAL,dopamine neurotransmitter system,dopamine neurotransmitter system
NEW20647,CHEBI,selective α2a-adrenoceptor agonist,selective α2A-adrenoceptor agonist
NEW20648,DISEASE,less wmh volume progression,less WMH volume progression
NEW20649,MENTAL_HEALTH,regression modeling,regression modeling
NEW20650,DISEASE,wmh progression,WMH progression
NEW20651,NUTRITION,sea bass fpies,sea bass FPIES
NEW20652,NUTRITION,tolerate trout,tolerated trout
NEW20653,NUTRITION,tolerate sea bass,tolerated sea bass
NEW20654,MENTAL_HEALTH,generic dsm-iv-tr substance dependence criterion,generic DSM-IV-TR substance dependence criteria
NEW20655,DISEASE,mandibular condyle bone scintigraphy,mandibular condyle bone scintigraphy
NEW20656,NUTRITION,technetium-99m-labeled diphosphate,technetium-99m-labeled diphosphates
NEW20657,DISEASE,acute trauma,acute trauma
NEW20658,CHEMICAL,body-first subtype,body-first subtype
NEW20659,CHEMICAL,striatal gln,striatal Gln
NEW20660,CHEBI,carotenoid pigment,carotenoid pigments
NEW20661,CHEMICAL,c. sativus L.,C. sativus L.
NEW20662,MENTAL_HEALTH,endorphinergic hyperactivity,endorphinergic hyperactivity
NEW20663,DISEASE,tomato mottle mosaic virus,Tomato mottle mosaic virus
NEW20664,CHEMICAL,Li et 2013,Li et 2013
NEW20665,DISEASE,iron-overload mouse,iron-overload mice
NEW20666,CHEMICAL,urea nitrogen suggestive,urea nitrogen suggestive
NEW20667,CHEMICAL,high-affinity anti-cocaine monoclonal antibody,high-affinity anti-cocaine monoclonal antibody
NEW20668,MENTAL_HEALTH,cocaine abuse therapy,cocaine abuse therapy
NEW20669,DISEASE,male ftm transsexual,male FTM transsexuals
NEW20670,CHEBI,masculinize hormone therapy,masculinizing hormone therapy
NEW20671,CHEMICAL,am80 administration,Am80 administration
NEW20672,CHEMICAL,hippocampal adam10-notch-hes5 proliferative pathway,hippocampal ADAM10-Notch-Hes5 proliferative pathway
NEW20673,CHEMICAL,genus Sceletium,genus Sceletium
NEW20674,MENTAL_HEALTH,combat fatigue,combat fatigue
NEW20675,MENTAL_HEALTH,multiple linear regression,Multiple linear regression
NEW20676,NUTRITION,fatty acid intake,fatty acid intakes
NEW20677,CHEMICAL,dietary pufa consumption,dietary PUFA consumption
NEW20678,DISEASE,gonadal neoplasm,gonadal neoplasms
NEW20679,NUTRITION,Whiting Bay,Whiting Bay
NEW20680,CHEMICAL,nitrotyrosine protein modification,nitrotyrosine protein modifications
NEW20681,CHEMICAL,no pathway,NO pathway
NEW20682,MENTAL_HEALTH,appropriate fragmentation pattern,appropriate fragmentation patterns
NEW20683,DISEASE,p. peruviana juice supplementation,P. peruviana juice supplementation
NEW20684,CHEMICAL,testicular glutathione,testicular glutathione
NEW20685,CHEMICAL,peroxidation oxide production,peroxidation oxide production
NEW20686,CHEMICAL,hepatotoxicant carbon tetrachloride,CCl4|hepatotoxicant carbon tetrachloride
NEW20687,DISEASE,p. peruviana,P. peruviana
NEW20688,CHEMICAL,dietary nucleotide,dietary nucleotides
NEW20689,DISEASE,liver cell death,liver cell death
NEW20690,DISEASE,many bipolar patient,Many bipolar patients
NEW20691,CHEMICAL,"methyl 5,5-diphenyl-1-(thiazol-2-yl)pyrrolidine-2-carboxylate derivative","methyl 5,5-diphenyl-1-(thiazol-2-yl)pyrrolidine-2-carboxylate derivatives"
NEW20692,MENTAL_HEALTH,acid dissociation constant,acid dissociation constants
NEW20693,CHEBI,antimicrobial screening,antimicrobial screening
NEW20694,DISEASE,m. tuberculosis h37rv strain,M. tuberculosis H37Rv strain
NEW20695,DISEASE,diet (hfd)-induced mets,diet (HFD)-induced MetS
NEW20696,DISEASE,prostate gland alteration,prostate gland alterations
NEW20697,CHEMICAL,hfd-related mets feature,HFD-related MetS features
NEW20698,DISEASE,bladder derangement,bladder derangements
NEW20699,DISEASE,cerebral ischemia/reperfusion injury,cerebral ischemia/reperfusion injury
NEW20700,CHEMICAL,autophagic inhibitor 3-methyladenine,Autophagic inhibitor 3-methyladenine
NEW20701,CHEMICAL,lc3-ii level,LC3-II levels
http://purl.obolibrary.org/obo/OGMS_0000102,CHEMICAL,injury,OGD/R injury
NEW20702,CHEMICAL,Byur dMar Nyer lNga Ril Bu,Byur dMar Nyer lNga Ril Bu
NEW20703,DISEASE,white vein disease,white vein disease
NEW20704,CHEMICAL,naltrindole hydrochloride,naltrindole hydrochloride|NTI
NEW20705,MENTAL_HEALTH,dpdpe-induced analgesia,DPDPE-induced analgesia
NEW20706,CHEMICAL,nti microgram,NTI micrograms
NEW20707,MENTAL_HEALTH,multiple linear regression analysis,Multiple linear regression analysis
NEW20708,CHEMICAL,squalene content,squalene content
NEW20709,CHEMICAL,half dose hormone replacement therapy,half dose hormone replacement therapy|HRT
NEW20710,MENTAL_HEALTH,cancerophobia effect,cancerophobia effects
NEW20711,DISEASE,climacteric complaint,climacteric complaints
http://purl.obolibrary.org/obo/CHEBI_35474,CHEBI,anxiolytic drug,anti-anxiety agents|minor tranquilisers|anxiolytics|minor tranquilizers|anxiolytic agents|anxiolytic drug|anti-anxiety drugs|minor tranquilizing agents
NEW20712,CHEMICAL,single snp association,single SNP association
NEW20713,MENTAL_HEALTH,binary logistic regression,binary logistic regression
NEW20714,CHEBI,α7nachr agonist pnu,α7nAChR agonist PNU
NEW20715,DISEASE,stress resemble diabete,stress resembling diabetes
NEW20716,CHEMICAL,biotin-dependent mitochondrial enzyme,biotin-dependent mitochondrial enzyme
NEW20717,NUTRITION,alpha pcc,alpha PCC
NEW20718,CHEMICAL,excessive da dose,excessive DA dose
NEW20719,CHEMICAL,release guanfacine,release Guanfacine
NEW20720,DISEASE,delay onset cardiogenic pulmonary edema,delayed onset cardiogenic pulmonary edema
NEW20721,DISEASE,cardiogenic pulmonary edema,cardiogenic pulmonary edema
NEW20722,CHEMICAL,release guanfacine ingestion,release Guanfacine ingestion
NEW20723,MENTAL_HEALTH,inadequate analgesia,inadequate analgesia
NEW20724,CHEMICAL,suicidogen,suicidogen
NEW20725,DISEASE,antineutrophil (anca)-associated vasculitis,antineutrophil (ANCA)-associated vasculitis
NEW20726,DISEASE,systemic vasculitis syndrome,systemic vasculitis syndrome
NEW20727,CHEMICAL,miniature excitatory postsynaptic current,miniature excitatory postsynaptic currents|EPSCs
NEW20728,MENTAL_HEALTH,nts projection,NTS projection
NEW20729,CHEMICAL,no scavenger,NO scavenger
NEW20730,CHEBI,estrogen level,estrogens levels
NEW20731,DISEASE,vaginal atrophy itching,vaginal atrophy itching
NEW20732,CHEBI,short-acting beta-adrenergic agonist,Short-acting beta-adrenergic agonists
NEW20733,DISEASE,various lung disease,various lung diseases
NEW20734,DISEASE,cognitive peculiarity idea,cognitive peculiarities ideas
NEW20735,CHEMICAL,hcy reduction,Hcy reduction
NEW20736,CHEBI,vitamin b complex supplement,vitamin B complex supplements
NEW20737,DISEASE,diet-induced hhcy,Diet-induced HHcy
NEW20738,CHEBI,vitamin b intake,vitamin B intake
NEW20739,DISEASE,stress-induced cognitive decline,stress-induced cognitive decline
NEW20740,DISEASE,diet-induced hhcy,diet-induced HHcy
NEW20741,NUTRITION,disorder fatty acid metabolism,disordered fatty acid metabolism
NEW20742,DISEASE,multi-episode patient,multi-episode patients
NEW20743,DISEASE,sp. nov.,sp. nov.
http://purl.obolibrary.org/obo/CHEBI_132144,CHEMICAL,bacteriohopanetetrol cyclitol ether,bacteriohopanetetrol cyclitol ether|Tetrahydroxybacteriohopane cyclitol ether
NEW20744,CHEMICAL,plasma leu-enk,Plasma Leu-enk
NEW20745,DISEASE,ra activity,RA activity
NEW20746,CHEMICAL,mg/l phe similar,mg/L PHE similar
NEW20747,CHEBI,carrier medium,carrier medium
NEW20748,CHEMICAL,α2δ calcium-channel ligand,α2δ calcium-channel ligand
NEW20749,DISEASE,restless leg syndrome/willis-ekbom disease,RLS/WED|restless legs syndrome/Willis-Ekbom disease
NEW20750,MENTAL_HEALTH,membrane orientation active-layer [al]-face fs,membrane orientation active-layer [AL]-facing FS
NEW20751,CHEMICAL,reverse salt flux,reverse salt flux
NEW20752,CHEBI,clinical antimalarial,clinical antimalarials
NEW20753,CHEBI,specific antimalarial,specific antimalarials
NEW20754,CHEMICAL,oral mq regiman,oral MQ regimen
NEW20755,DISEASE,bioluminescent model brain tumor growth,bioluminescent model brain tumor growth
NEW20756,CHEBI,high-efficacy cannabinoid cb1 receptor agonist,high-efficacy cannabinoid CB1 receptor agonist
NEW20757,DISEASE,paw tremor,paw tremor
NEW20758,CHEMICAL,septal spur,septal spur|SS
NEW20759,CHEBI,serotonergic drug use,serotonergic drug use
NEW20760,CHEMICAL,increase serotonin activity,increased serotonin activity
NEW20761,DISEASE,collateral injury,collaterals injury
NEW20762,DISEASE,blood stasis,blood stasis
NEW20763,DISEASE,renew dislocation,renewed dislocation
NEW20764,DISEASE,delirious state,delirious state
NEW20765,CHEMICAL,anti-brain lysate,anti-brain lysate
NEW20766,CHEMICAL,plasma calcium,plasma calcium
NEW20767,CHEMICAL,adequate calcium intake,adequate calcium intake
NEW20768,CHEMICAL,fix k,fixed K
NEW20769,CHEMICAL,radiocesium fixation,radiocesium fixation
NEW20770,CHEMICAL,k supply,K supply
NEW20771,CHEMICAL,radiocesium transfer,radiocesium transfer
NEW20772,MENTAL_HEALTH,machine regression analysis,machine regression analysis
NEW20773,CHEMICAL,amino acid nitrogen,amino acid nitrogen
NEW20774,DISEASE,global obesity,Global obesity
NEW20775,CHEMICAL,pandemic status,pandemic status
NEW20776,CHEMICAL,lpa signaling,LPA signaling
NEW20777,DISEASE,inflammatory neuropathy,inflammatory neuropathies
NEW20778,NUTRITION,drug/drug contaminant fatty acid cosmetic msi approach,drug/drug contaminant fatty acid cosmetics MSI approach
NEW20779,CHEMICAL,ros scavenger,ROS scavengers
NEW20780,DISEASE,neuronal mild mitochondrial dysfunction,neuronal mild mitochondrial dysfunction
NEW20781,CHEMICAL,scavenger resveratrol,scavengers resveratrol
NEW20782,DISEASE,autoimmune-associated avb,Autoimmune-associated AVB
NEW20783,CHEMICAL,positive anti-ro/ssa,positive anti-Ro/SSA
NEW20784,DISEASE,hyper-inflammatory reaction,Hyper-inflammatory reaction
NEW20785,DISEASE,significant lymphoid atrophy,significant lymphoid atrophy
NEW20786,CHEMICAL,tcdd exposure,TCDD exposure
NEW20787,DISEASE,leishmanial disease,leishmanial disease
NEW20788,MENTAL_HEALTH,nrf2-keap antioxidative defense mechanism,Nrf2-Keap antioxidative defense mechanism
NEW20789,CHEMICAL,short-term iodide excess,short-term iodide excess
NEW20790,MENTAL_HEALTH,whose 's panic disorder,whose's panic disorder
NEW20791,CHEMICAL,long-term dopamine replacement therapy,long-term dopamine replacement therapy
NEW20792,CHEMICAL,glutamate dysregulation,Glutamate dysregulation
NEW20793,CHEMICAL,ly354740     mg/kg,LY354740    mg/kg
NEW20794,MENTAL_HEALTH,postreceptor resistance,postreceptor resistance
NEW20795,CHEBI,endocrine influence,endocrine influences
NEW20796,CHEBI,antifungal chemotherapy,antifungal chemotherapy
NEW20797,DISEASE,fungal keratitis curable,fungal keratitis curable
NEW20798,DISEASE,voluntary tic suppression,voluntary tic suppression
NEW20799,CHEBI,beta frequency range,beta frequency range
NEW20800,CHEMICAL,rhodiola rosea L.,Rhodiola rosea L.
NEW20801,DISEASE,family Crassulaceae,family Crassulaceae
http://purl.obolibrary.org/obo/CHEBI_169010,CHEMICAL,isorientin 4'-o-glucoside 2''-o-p-hydroxybenzoagte,"[(2S,4S,5S)-2-[5,7-dihydroxy-2-[3-hydroxy-4-[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-4-oxochromen-6-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 4-hydroxybenzoate|rosavins"
NEW20802,CHEMICAL,arsenic toxicity,arsenic toxicity
NEW20803,DISEASE,hagsto1-overexpressing FHM cell,HaGSTO1-overexpressing FHM cells
NEW20804,CHEMICAL,hagsto1,HaGSTO1
NEW20805,CHEMICAL,cation ca2,cation Ca2
NEW20806,NUTRITION,croaker zip9 protein,Croaker ZIP9 protein
NEW20807,NUTRITION,croaker granulosa cell,croaker granulosa cells
NEW20808,DISEASE,human breast cancer skbr-3 cell,human breast cancer SKBR-3 cells
NEW20809,NUTRITION,recombinant croaker zip9,Recombinant croaker ZIP9
NEW20810,NUTRITION,wheat powdery mildew,Wheat powdery mildew
NEW20811,MENTAL_HEALTH,cultivar resistance,cultivar resistance
NEW20812,CHEBI,foliar fungicide,foliar fungicides
NEW20813,DISEASE,b. graminis f. sp. tritici isolate,B. graminis f. sp. tritici isolates
http://purl.obolibrary.org/obo/CHEBI_17750,NUTRITION,glycine betaine,"N,N,N-Trimethylglycine|(trimethylammoniumyl)acetate|acidol|Trimethylammonioacetate|(trimethylammonio)acetate|1-carboxy-N,N,N-trimethylmethanaminium inner salt|Trimethylaminoacetate|glycine betaine|N,N,N-trimethylammonioacetate|trimethylglycine|Betaine|Bet|trimethylglycocoll|abromine|choline glycine betaine|Glycine betaine|2-N,N,N-trimethylammonio acetate"
NEW20814,MENTAL_HEALTH,displacement reaction,displacement reactions
NEW20815,DISEASE,chemogenetic suppression,Chemogenetic suppression
NEW20816,CHEMICAL,cocaine cpp,cocaine CPP
NEW20817,DISEASE,food-borne pathogen,food-borne pathogens
NEW20818,CHEMICAL,amyloid hypothesis,amyloid hypothesis
NEW20819,DISEASE,sporadic ad,SAD|sporadic AD
NEW20820,DISEASE,familial ad,familial AD
NEW20821,DISEASE,leishmania cell,Leishmania cells
NEW20822,CHEMICAL,proprietary dihydropyrimidone dhpm derivative,proprietary dihydropyrimidone DHPM derivatives
NEW20823,CHEMICAL,dhfr specificity,DHFR specificity
NEW20824,CHEMICAL,dietary pufa docosahexaenoic acid,dietary PUFA docosahexaenoic acid
NEW20825,CHEBI,exist ad drug research target,Existing AD drug research targets
NEW20826,CHEMICAL,amyloid metabolism/catabolism,amyloid metabolism/catabolism
NEW20827,CHEBI,v1b receptor antagonist ts-121,V1B receptor antagonists TS-121
NEW20828,CHEBI,v1b receptor antagonist,V1B receptor antagonists
NEW20829,DISEASE,allergic response,allergic responses
NEW20830,CHEMICAL,ige antibody,IgE antibodies
NEW20831,CHEMICAL,fentanyl intake,fentanyl intake
NEW20832,CHEMICAL,high circulate corticosterone level,high circulating corticosterone levels
NEW20833,CHEMICAL,glucocorticoid dexamethasone,glucocorticoid dexamethasone
NEW20834,CHEMICAL,glucose deprivation,glucose deprivation
NEW20835,CHEMICAL,dopamine depletion,dopamine depletions
NEW20836,MENTAL_HEALTH,symptom akinesia related,symptoms akinesia related
NEW20837,CHEMICAL,phenylalanine exposure,phenylalanine exposure
NEW20838,DISEASE,myelination lesion,myelination lesions
http://purl.org/sig/ont/fma/fma67251,CHEMICAL,acetylcholine receptor,acetylcholine receptor desensitization
NEW20839,DISEASE,aplysia medial pleural neuron,Aplysia medial pleural neurons
NEW20840,NUTRITION,bismuth drug,bismuth drugs
NEW20841,CHEMICAL,key viral cysteine enzymes/protease,key viral cysteine enzymes/proteases
NEW20842,CHEMICAL,glucagon biology,glucagon biology
NEW20843,MENTAL_HEALTH,hepatic glucagon resistance,hepatic glucagon resistance
NEW20844,CHEMICAL,bup-hcl,Bup-HCl
NEW20845,CHEBI,beta-2 adrenergic agonist,beta-2 adrenergic agonist
NEW20846,DISEASE,physiological hypertrophy,physiological hypertrophy
http://purl.obolibrary.org/obo/CHEBI_32570,CHEMICAL,mycosamine,"3-Amino-3-desoxy-D-rhamnose|3-amino-3,6-dideoxy-D-mannose|N-butylphenol moiety|Mycosamin"
NEW20847,CHEMICAL,benzylic hydroxyl group,benzylic hydroxyl group
NEW20848,CHEMICAL,sodium metabolism,sodium metabolism
NEW20849,CHEMICAL,bacl2 superfusion,BaCl2 superfusion
NEW20850,CHEMICAL,stimulation-induced pr,stimulation-induced PRs
NEW20851,CHEMICAL,prolonged response,prolonged responses|PRs
NEW20852,MENTAL_HEALTH,increase input resistance,increased input resistance
NEW20853,DISEASE,depressive disturbance,depressive disturbances
NEW20854,DISEASE,homozygote sickle-cell disease,homozygote sickle-cell disease
NEW20855,CHEBI,recombinant gelatin,recombinant gelatin
NEW20856,DISEASE,p. pastoris km71,P. pastoris KM71
NEW20857,CHEMICAL,methanol induction,methanol induction
NEW20858,CHEMICAL,(1)h spectrum,(1)H spectra
NEW20859,MENTAL_HEALTH,corresponding displacement peak,corresponding displacement peaks
NEW20860,DISEASE,hormone-receptor-positive early-stage breast cancer,hormone-receptor-positive early-stage breast cancer
NEW20861,CHEMICAL,censusADHD study,censusADHD Study
NEW20862,CHEMICAL,glutamate treatment,glutamate treatment
NEW20863,MENTAL_HEALTH,swell fragmentation,swelling fragmentation
NEW20864,NUTRITION,tumour necrosis factor alpha,tumour necrosis factor alpha
http://purl.obolibrary.org/obo/CHEBI_28697,CHEMICAL,21-deoxycortisol,"dehydroepiandrosterone-sulphate|21-deoxycortisol|4-pregnene-11beta,17alpha-diol-3,20-dione|11beta,17-dihydroxypregn-4-ene-3,20-dione|pregn-4-ene-11beta,17alpha-diol-3,20-dione|11beta,17alpha-dihydroxypregn-4-ene-3,20-dione|(1R,3aS,3bS,9aR,9bS,10S,11aS)-1-acetyl-1,10-dihydroxy-9a,11a-dimethyl-1,2,3,3a,3b,4,5,8,9,9a,9b,10,11,11a-tetradecahydro-7H-cyclopenta[a]phenanthren-7-one|11beta,17-dihydroxyprogesterone|11beta,17alpha-dihydroxyprogesterone|11-beta,17-alpha-dihydroxypregn-4-ene-3,20-dione"
NEW20865,DISEASE,chronic low grade inflammation,chronic low grade inflammation
NEW20866,CHEMICAL,omega-6 pufa,omega-6 PUFA
NEW20867,CHEMICAL,kainic acid i.t,kainic acid i.t
NEW20868,CHEMICAL,[d-arg]-sp,[D-Arg]-SP
NEW20869,CHEMICAL,da signaling,DA signaling
NEW20870,CHEMICAL,excessive no production,excessive NO production
http://purl.obolibrary.org/obo/CHEBI_71201,CHEMICAL,xanthurenate,"guanidinosuccinate|xanthurenate|4,8-dihydroxyquinoline-2-carboxylate"
NEW20871,CHEMICAL,systemic no synthesis,systemic NO synthesis
http://purl.obolibrary.org/obo/UBERON_0001871,DISEASE,temporal lobe,temporal lobe pathology
NEW20872,MENTAL_HEALTH,dementia syndrome,dementia syndromes
NEW20873,DISEASE,rhizoctonia solani viability,Rhizoctonia solani viability
NEW20874,CHEMICAL,carnobacterium maltaromaticum sm-2,Carnobacterium maltaromaticum sm-2
NEW20875,MENTAL_HEALTH,multiple resistance gene,multiple resistance genes
NEW20876,CHEMICAL,tbt exposure,TBT exposure
NEW20877,DISEASE,toxic injury mechanism,toxic injury mechanism
NEW20878,CHEMICAL,tyrosine kinase domain,tyrosine kinase domain
NEW20879,DISEASE,thrombus formation,thrombus formation
http://purl.obolibrary.org/obo/CHEBI_81884,CHEMICAL,zinc phosphide,to zinc phosphide|Zn3P2
NEW20880,DISEASE,mild acute liver cell damage,mild acute liver cell damage
NEW20881,CHEMICAL,topical ketamine,topical ketamine
NEW20882,DISEASE,hs pain,HS pain
NEW20883,CHEMICAL,topical amitriptyline increase,topical amitriptyline increase
NEW20884,CHEBI,compound mixture,compound mixture
NEW20885,DISEASE,topical pain control,topical pain control
NEW20886,CHEBI,dopamine antagonist medication,dopamine antagonist medications
NEW20887,NUTRITION,phlorotannin supplement,phlorotannin supplement
NEW20888,DISEASE,self-reported sleep disturbance,self-reported sleep disturbances
NEW20889,NUTRITION,phlorotannin group,phlorotannin group
NEW20890,CHEBI,general opioid antagonist,general opioid antagonist
NEW20891,CHEMICAL,serum pth level,serum PTH levels
NEW20892,MENTAL_HEALTH,peripheral pth resistance,peripheral PTH resistance
NEW20893,CHEMICAL,catechin-in-cyclodextrin-in-phospholipid liposome,CCPL|catechin-in-cyclodextrin-in-phospholipid liposome
NEW20894,DISEASE,young biofilm,young biofilm
NEW20895,CHEMICAL,encapsulate amphotericin b Constantinides,encapsulated amphotericin B Constantinides
NEW20896,DISEASE,p. falciparum 3d7 strain,P. falciparum 3D7 strain
NEW20897,CHEMICAL,encapsulate amb drug,encapsulated AmB drugs
NEW20898,DISEASE,malaria treatment,malaria treatment
NEW20899,CHEMICAL,nanoencapsulation amb,nanoencapsulation AmB
NEW20900,CHEMICAL,excessive sucrose consumption,Excessive sucrose consumption
NEW20901,MENTAL_HEALTH,addiction-like craving,addiction-like craving
NEW20902,CHEMICAL,gliquidone micrograms/mouse,gliquidone micrograms/mouse
NEW20903,CHEMICAL,clonidine dose-response line,clonidine dose-response line
NEW20904,CHEMICAL,k+ katp channel blocker,K+ KATP channel blocker
NEW20905,MENTAL_HEALTH,dose-dependent displacement,dose-dependent displacement
NEW20906,CHEMICAL,baclofen dose-response line,baclofen dose-response line
NEW20907,CHEMICAL,baclofen antinociception,baclofen antinociception
NEW20908,CHEBI,combined hormone therapy,combined hormone therapy
NEW20909,CHEBI,progestin component,progestin component
NEW20910,CHEMICAL,high atp level,high ATP levels
NEW20911,CHEMICAL,camp hydrolysis,cAMP hydrolysis
NEW20912,DISEASE,chronic respiratory disease,chronic respiratory diseases
NEW20913,DISEASE,toxic fmr1 mrna,toxic FMR1 mRNA
NEW20914,CHEBI,environmental poison,environmental poisons
http://purl.obolibrary.org/obo/SYMP_0000619,DISEASE,tetany,Carotenemia
NEW20915,CHEMICAL,skin blood carotene level,skin blood carotene levels
NEW20916,CHEMICAL,serotonin gene-linked polymorphic region,serotonin gene-linked polymorphic region
NEW20917,MENTAL_HEALTH,anxiety harm avoidance,anxiety harm avoidance
NEW20918,DISEASE,type alcoholism,Type alcoholism
NEW20919,MENTAL_HEALTH,depression pathology,depression pathology
NEW20920,DISEASE,meningitis/encephaliti,meningitis/encephalitis
NEW20921,CHEBI,antiviral treatment,antiviral treatments
NEW20922,DISEASE,glun2b expression,GluN2B expression
NEW20923,DISEASE,chronic ih-induced anxiety-like behavior,chronic IH-induced anxiety-like behavior
NEW20924,CHEMICAL,interface-oriented grain boundary,interface-oriented grain boundary
NEW20925,DISEASE,solid draw shd technology,solid drawing SHD technology
NEW20926,CHEBI,certain vitamin,certain vitamins
NEW20927,CHEBI,popular recreational drug,popular recreational drug
NEW20928,CHEBI,serotonin 5-ht2a/2c antagonist mianserin,serotonin 5-HT2A/2C antagonist mianserin
NEW20929,DISEASE,oral tremor,oral tremor
NEW20930,CHEMICAL,da neurotransmission,DA neurotransmission
NEW20931,CHEBI,ssri administration,SSRI administration
NEW20932,CHEMICAL,da depletion,DA depletions
NEW20933,CHEBI,water-soluble vitamin,Water-soluble vitamins
NEW20934,DISEASE,low-intensity inflammation,low-intensity inflammation
NEW20935,DISEASE,cirrhotic patient,Cirrhotic patients
NEW20936,CHEMICAL,various fat-soluble water-soluble vitamin,various fat-soluble water-soluble vitamins
NEW20937,DISEASE,metabolic syndrome concurrent,metabolic syndrome concurrent
NEW20938,CHEMICAL,anti-pd-1 therapy,anti-PD-1 therapy
NEW20939,DISEASE,murine meer hnscc model,murine MEER HNSCC model
NEW20940,DISEASE,low tumor hypoxia,Lower tumor hypoxia
NEW20941,MENTAL_HEALTH,main nutritional syndrome,main nutritional syndromes
NEW20942,DISEASE,neuromyelopathie,neuromyelopathies
NEW20943,DISEASE,malnutrition marasmus nutritional neuropathy,malnutrition marasmus nutritional neuropathies
NEW20944,CHEMICAL,neurotransmitter acetylcholine,neurotransmitter acetylcholine
NEW20945,DISEASE,memory function,memory functions
http://purl.obolibrary.org/obo/DOID_11949,DISEASE,creutzfeldt-jakob disease,Creutzfeldt-Jacob disease|Subacute spongiform encephalopathy|Creutzfeldt Jakob disease|Transmissible virus dementia|Jakob-Creutzfeldt disease|sporadic Creutzfeldt-Jakob disease|Creutzfeldt Jacob syndrome|CJD
http://purl.obolibrary.org/obo/CHEBI_165545,NUTRITION,n-oleoyl methionine,methionine (M)/valine|(2S)-4-methylsulanyl-2-[[(Z)-octadec-9-enoyl]amino]butanoic acid
NEW20946,CHEBI,antagonist effect,antagonists effects
NEW20947,CHEMICAL,amphetamine mechanism,amphetamine mechanisms
NEW20948,DISEASE,locomotor behavior,locomotor behavior
NEW20949,DISEASE,intraocular inflammation,intraocular inflammation
NEW20950,DISEASE,recurrent multiple brao,recurrent multiple BRAO
NEW20951,CHEMICAL,poly(hamam-b-hepoman,poly(HAMAm-b-HEPOMAn
NEW20952,MENTAL_HEALTH,reversible addition fragmentation chain transfer,reversible addition fragmentation chain transfer
NEW20953,CHEMICAL,tryptophan/nicotinic acid pathway,tryptophan/nicotinic acid pathway
NEW20954,CHEMICAL,pfos co-exposure,PFOS co-exposures
NEW20955,CHEMICAL,gamma-aminobutyric acid gaba antagonist,gamma-Aminobutyric acid GABA antagonists
NEW20956,MENTAL_HEALTH,benzodiazepine-induced amnesia,benzodiazepine-induced amnesia
NEW20957,DISEASE,severe odontogenic infection,severe odontogenic infection
http://purl.obolibrary.org/obo/DOID_0060520,CHEMICAL,penicillin allergy,|penicillin allergy
NEW20958,NUTRITION,tree seedling,tree seedlings
NEW20959,MENTAL_HEALTH,conclusion root trait syndrome,conclusion root trait syndromes
NEW20960,DISEASE,bile acid diarrhoea,bile acid diarrhoea
NEW20961,DISEASE,impaired rate-dependent depression,RDD|Impaired rate-dependent depression
NEW20962,CHEBI,gabab receptor agonist baclofen,GABAB receptor agonist baclofen
NEW20963,CHEMICAL,carbonic anhydrase inhibitor acetazolamide,carbonic anhydrase inhibitor acetazolamide
NEW20964,CHEMICAL,presynaptic p/n type calcium channel,presynaptic P/N type calcium channels
NEW20965,CHEMICAL,ppm ab113 concentration,ppm AB113 concentration
NEW20966,CHEBI,analgesic prescription,analgesic prescription
NEW20967,DISEASE,hepatotoxic dosage,hepatotoxic dosages
NEW20968,DISEASE,increase toxicity,increased toxicity
NEW20969,CHEMICAL,domoic acid poisoning,domoic acid poisoning
NEW20970,DISEASE,multiple poisoning event,multiple poisoning events
NEW20971,CHEMICAL,domoic acid toxicity,Domoic acid toxicity
NEW20972,DISEASE,intermediate toxicity,intermediate toxicity
NEW20973,DISEASE,differential toxicity,differential toxicity
NEW20974,CHEMICAL,domoic acid molecule,domoic acid molecule
NEW20975,MENTAL_HEALTH,dyskinesia performance,Dyskinesia performance
NEW20976,CHEBI,chronic drug treatment,chronic drug treatment
NEW20977,CHEMICAL,(3-ethyl-2-methyl-quinolin-6-yl)-(4-methoxy-cyclohexyl)-methanone methane sulfonate,EMQMCM|(3-ethyl-2-methyl-quinolin-6-yl)-(4-methoxy-cyclohexyl)-methanone methane sulfonate
NEW20978,DISEASE,l-dopa-induced phospho-erk1/2,L-DOPA-induced phospho-ERK1/2
NEW20979,DISEASE,l-dopa-induced improvement,L-DOPA-induced improvement
NEW20980,CHEMICAL,"1r,4r,5s,6r-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate","1R,4R,5S,6R-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate|LY379268"
NEW20981,DISEASE,delusional theme,Delusional themes
NEW20982,DISEASE,somatic damage,somatic damage
NEW20983,CHEMICAL,economy/business,economy/business
NEW20984,CHEMICAL,6f-tricin,6F-tricin
NEW20985,CHEMICAL,lectin griffithsin,lectin griffithsin|GRFT
NEW20986,CHEBI,potent antiviral agent capable,potent antiviral agent capable
NEW20987,CHEBI,broad antiviral activity,broad antiviral activity
NEW20988,DISEASE,little toxicity,little toxicity
NEW20989,CHEBI,antiviral activity,antiviral activity
NEW20990,CHEMICAL,Cinnamon polyphenol extract,CPE|Cinnamon polyphenol extract
NEW20991,CHEBI,antibiotic e. coli,antibiotic E. coli
http://purl.obolibrary.org/obo/CHEBI_48219,CHEBI,disinfectant,Desinfektionsmittel|desinfectant|disinfectants|disinfecting agent|QAC-containing disinfectants
NEW20992,CHEBI,dopamine agonist treatment,Dopamine agonist treatment
NEW20993,CHEBI,plant nephrotoxin,plant nephrotoxin
NEW20994,CHEMICAL,aristolochic acid nephropathy,aristolochic acid nephropathy
NEW20995,DISEASE,associate urothelial malignancy,associated urothelial malignancy
NEW20996,DISEASE,tumor development,tumor development
NEW20997,CHEMICAL,prostaglandin h synthase cyclooxygenase,Prostaglandin H synthase cyclooxygenase
NEW20998,DISEASE,human renal microsome,human renal microsomes
NEW20999,CHEMICAL,amphetamine derivative,amphetamine derivatives
NEW21000,CHEMICAL,guanfacine xr,Guanfacine XR
NEW21001,CHEBI,gamma-aminobutyric acid type b gabab receptor agonist,gamma-aminobutyric acid type B GABAB receptor agonist
NEW21002,DISEASE,fibromyalgia fm patient,fibromyalgia FM patients
NEW21003,DISEASE,pain sleep,pain sleep
NEW21004,CHEMICAL,gabab receptor positive modulator approach,GABAB receptor positive modulator approach
NEW21005,CHEMICAL,cell-membrane fluidity,Cell-membrane fluidity
NEW21006,MENTAL_HEALTH,cold resistance,cold resistance
NEW21007,CHEMICAL,mycobacterium difficult nontuberculous mycobacterium,Mycobacterium difficult nontuberculous Mycobacterium
NEW21008,CHEBI,antibiotic usage,antibiotics usage
NEW21009,MENTAL_HEALTH,antibiotic resistance,antibiotics resistance
NEW21010,DISEASE,communal infection,communal infections
NEW21011,CHEBI,dual co-receptor antagonist,dual co-receptor antagonists
NEW21012,DISEASE,aids prophylaxis drug,AIDS prophylaxis drugs
NEW21013,CHEMICAL,chemotherapeutic agent gemcitabine,chemotherapeutic agent gemcitabine
NEW21014,DISEASE,purge t-cell immunity,purging T-cell immunity
NEW21015,DISEASE,breast tumor growth,breast tumor growth
NEW21016,CHEMICAL,aldh1a1 inhibitor disulfiram,ALDH1A1 inhibitor disulfiram
NEW21017,CHEMICAL,psychic experience,CAPE|Psychic Experiences
NEW21018,CHEMICAL,deuterium isotope effect,deuterium isotope effects
NEW21019,CHEMICAL,theoretical 2h-distribution,theoretical 2H-distribution
NEW21020,CHEMICAL,plasma oxalic acid,plasma oxalic acid
NEW21021,CHEBI,erythrocyte vitamin b6,erythrocyte vitamin B6
NEW21022,DISEASE,aip patient,AIP patients
NEW21023,DISEASE,J. regia,J. regia
NEW21024,DISEASE,vertical oozing canker,vertical oozing canker
NEW21025,NUTRITION,adjuvant thiamine,adjuvant thiamine
NEW21026,DISEASE,mdd adjuvant thiamine,MDD adjuvant thiamine
NEW21027,CHEMICAL,eaa receptor antagonist d-2-amino-5-phosphonovalerate,D-APV|EAA receptor antagonist D-2-amino-5-phosphonovalerate
NEW21028,CHEMICAL,oocyte nmda receptor,oocyte NMDA receptor
NEW21029,CHEMICAL,"1 mm. 6-nitro-7-cyano-quinoxaline-2,3-dione","CNQX|1 mM. 6-Nitro-7-cyano-quinoxaline-2,3-dione"
NEW21030,NUTRITION,ecto-5'-nucleotidase inhibitor alpha,ecto-5'-nucleotidase inhibitor alpha
NEW21031,MENTAL_HEALTH,atp-induced dna fragmentation,ATP-induced DNA fragmentation
NEW21032,CHEMICAL,beta-methylene-ADP,beta-methylene-ADP
NEW21033,DISEASE,gastric dysmotility,gastric dysmotility
NEW21034,MENTAL_HEALTH,specific fragmentation reaction,specific fragmentation reaction
NEW21035,MENTAL_HEALTH,fragmentation route,fragmentation routes
http://purl.obolibrary.org/obo/CHEBI_53756,CHEBI,hiv-1 reverse transcriptase inhibitor,HIV-1 reverse transcriptase inhibitors|HIV reverse transcriptase inhibitors|reverse transcriptase inhibitor|reverse transcriptase inhibitors
NEW21036,DISEASE,impaired cardiovascular reflex,impaired cardiovascular reflexes
NEW21037,DISEASE,purulent meningitis,purulent meningitis
NEW21038,DISEASE,campylobacter ureolyticus,Campylobacter ureolyticus
NEW21039,MENTAL_HEALTH,dna fragmentation assay,DNA fragmentation assay
NEW21040,DISEASE,cytokine-induced death,cytokine-induced death
NEW21041,DISEASE,inflammatory stimulation-induced corneal epithelial cell death,Inflammatory stimulation-induced corneal epithelial cell death
NEW21042,NUTRITION,peroxiproliferator-activated receptor alpha,peroxiproliferator-activated receptor alpha
NEW21043,DISEASE,heart reperfusion,heart reperfusion
NEW21044,DISEASE,short- aas abuse,short- AAS abuse
NEW21045,CHEMICAL,aas dependence,AAS dependence
NEW21046,CHEMICAL,aas user,AAS users
NEW21047,DISEASE,acute injury,acute injuries
NEW21048,MENTAL_HEALTH,neural hyperactivity,neural hyperactivity
NEW21049,CHEMICAL,90 min,90 min|dextran
NEW21050,CHEBI,gene sting agonist capable,genes STING agonists capable
NEW21051,DISEASE,tumor immunotherapy,tumor immunotherapy
NEW21052,MENTAL_HEALTH,dissociation constant value,dissociation constant values
NEW21053,CHEMICAL,± nmol l-1,± nmol L-1
NEW21054,CHEMICAL,central serotonin activity,central serotonin activity
NEW21055,DISEASE,sleep-related disorder,sleep-related disorders
NEW21056,DISEASE,acute manic,acute manic
NEW21057,DISEASE,bipolar adult,bipolar adults
NEW21058,DISEASE,spt-modulated program cell death,SPT-modulated programmed cell death
NEW21059,NUTRITION,male gametophyte development,male gametophyte development
NEW21060,CHEBI,melanocortin receptor agonist,melanocortin receptor agonists
NEW21061,DISEASE,iah-induced brain injury,IAH-induced brain injury
NEW21062,DISEASE,renal nephropathy,renal nephropathy
NEW21063,DISEASE,neuroendocrine cancer,Neuroendocrine cancer
NEW21064,DISEASE,rare malignant tumor,rare malignant tumor
NEW21065,DISEASE,persistent pain condition,persistent pain conditions
NEW21066,CHEMICAL,plant-derived biocide,plant-derived biocide
NEW21067,CHEMICAL,toxicity/cost ratio,toxicity/cost ratio
http://purl.obolibrary.org/obo/NCBITaxon_3977,CHEMICAL,euphorbiaceae,Gaultheria procumbens
NEW21068,CHEMICAL,fdopa PET,FDOPA PET
NEW21069,CHEMICAL,glutamate synthesis,glutamate synthesis
NEW21070,MENTAL_HEALTH,anaplerotic carboxylase fixation,anaplerotic carboxylase fixation
NEW21071,CHEMICAL,copper nanoparticle,copper nanoparticles|CuNPs
NEW21072,MENTAL_HEALTH,olfactory fatigue,olfactory fatigue
http://purl.obolibrary.org/obo/CHEBI_52522,CHEMICAL,bimetallic nanoparticle,Intermetallic nanoparticles
NEW21073,DISEASE,disorder alloy counterpart,disordered alloy counterparts
NEW21074,CHEMICAL,chronic etoh exposure,Chronic EtOH exposure
NEW21075,DISEASE,most necrosis,most necrosis
NEW21076,CHEMICAL,nalmefene group,nalmefene group
http://purl.obolibrary.org/obo/DOID_4481,DISEASE,allergic rhinitis,perennial allergic rhinitis|hay fever|pollenosis|Non-seasonal allergic rhinitis|Perenial allergic rhinitis|atopic rhinitis|seasonal allergic rhinitis
NEW21077,DISEASE,juvenile stage,juvenile stage
NEW21078,MENTAL_HEALTH,growth depression,growth depression
NEW21079,CHEMICAL,gamma-aminobutyric acidergic gabaergic interneuron,gamma-aminobutyric acidergic GABAergic interneurons
NEW21080,CHEMICAL,serotonin synthesis inhibitor,serotonin synthesis inhibitor
http://purl.obolibrary.org/obo/CHEBI_64946,CHEMICAL,anti-hiv agent,benzodiazepine-GABAergic agent|anti-AIDS agents|anti-HIV agents|anti-AIDS agent|diazepam
NEW21081,CHEMICAL,bzt analog,BZT analogs
http://purl.obolibrary.org/obo/CHEBI_63431,CHEMICAL,2-deoxyhexitol derivative,BZT derivative|2-deoxyhexitol derivatives
NEW21082,CHEMICAL,amph abuse,Amph abuse
NEW21083,CHEMICAL,upregulate metabotropic glutamate receptor,upregulated metabotropic glutamate receptor
NEW21084,DISEASE,osteoporosis androgen suppression,Osteoporosis androgen suppression
NEW21085,CHEBI,regioisomeric mixture,regioisomeric mixture
NEW21086,DISEASE,carrageenan-induced inflammatory pain,carrageenan-induced inflammatory pain
NEW21087,CHEMICAL,long-acting dihydropyridine dosage,long-acting dihydropyridine dosage
NEW21088,DISEASE,refractory vasopressor-resistant shock,refractory vasopressor-resistant shock
NEW21089,CHEMICAL,ccb toxicity,CCB toxicity
NEW21090,NUTRITION,marine omega-3 fatty acid supplement,Marine omega-3 fatty acid supplements
NEW21091,DISEASE,substantial aids population,substantial AIDS population
NEW21092,DISEASE,cranial mri abnormality,cranial MRI abnormalities
NEW21093,DISEASE,multiple cortical/subcortical infarct-like lesion,multiple cortical/subcortical infarct-like lesions
NEW21094,DISEASE,central nerve demyelination,central nerve demyelination
NEW21095,CHEMICAL,% ）,% ）
NEW21096,DISEASE,white matter hyperintensitie,white matter hyperintensities
NEW21097,NUTRITION,insufficient folate activity,Insufficient folate activity
NEW21098,DISEASE,congenital tube defect,congenital tube defects
NEW21099,CHEBI,folic acid artificial chemical analogue,folic acid artificial chemical analogue
NEW21100,CHEMICAL,homocysteine metabolism,homocysteine metabolism
NEW21101,CHEMICAL,altered testosterone level,Altered testosterone level
NEW21102,DISEASE,post-weaning multisystemic wasting syndrome,Post-weaning multisystemic wasting syndrome
NEW21103,NUTRITION,weaner pig,weaner pig
NEW21104,DISEASE,daily weight gain,daily weight gain
NEW21105,DISEASE,pmws,PMWS
NEW21106,DISEASE,sporadic cjd case,sporadic CJD cases
NEW21107,DISEASE,amyloid deposition,amyloid deposition
NEW21108,DISEASE,human prion disease,human prion disease
NEW21109,NUTRITION,shipworm symbiotic bacterium,shipworm symbiotic bacterium
NEW21110,DISEASE,t7901,T7901
NEW21111,CHEBI,non-selective serotonin agonist,non-selective serotonin agonist
NEW21112,DISEASE,developmental hyperserotonemia,developmental hyperserotonemia
NEW21113,DISEASE,mediate neuroinflammation,mediated neuroinflammation
NEW21114,DISEASE,johnson grass,Johnson grass
NEW21115,CHEMICAL,phytotoxic sesterterpenoid,phytotoxic sesterterpenoids
NEW21116,CHEMICAL,cysteine proteinase b,Cysteine proteinase B
NEW21117,CHEBI,significant virulence factor,significant virulence factor
NEW21118,DISEASE,retrieve thrombi,retrieved thrombi
NEW21119,NUTRITION,cholesterol cleft,cholesterol clefts
NEW21120,DISEASE,atheromatous component,atheromatous components
NEW21121,DISEASE,necrotic core,necrotic core
NEW21122,DISEASE,stroke onset,stroke onset
NEW21123,CHEMICAL,natural sepiolite,natural sepiolite
NEW21124,CHEMICAL,hcl extractable cd concentration,HCl extractable Cd concentrations
NEW21125,CHEMICAL,Pgr_tv4,Pgr_tv4
NEW21126,MENTAL_HEALTH,dominant-negative repression,dominant-negative repression
NEW21127,DISEASE,primary ovarian explant,primary ovarian explants
NEW21128,CHEMICAL,pgr_tv3,pgr_tv3
NEW21129,CHEMICAL,pgr_tv4,pgr_tv4
NEW21130,CHEBI,recombinant piscine follicle-stimulating hormone,recombinant piscine follicle-stimulating hormone
NEW21131,CHEMICAL,dissociative-hypnotic compound ketamine,dissociative-hypnotic compound ketamine
NEW21132,MENTAL_HEALTH,adjunctive analgesia,adjunctive analgesia
NEW21133,DISEASE,mdd comorbidity,MDD comorbidity
NEW21134,CHEMICAL,[(3)h]-clonidine binding,[(3)H]-clonidine binding
NEW21135,CHEMICAL,noradrenergic-mask,noradrenergic-mask
NEW21136,CHEMICAL,melatonin release,Melatonin release
NEW21137,CHEMICAL,phosphate release,Phosphate release
NEW21138,NUTRITION,biological phosphorus removal,biological phosphorus removal
NEW21139,MENTAL_HEALTH,phosphate fixation,phosphate fixation
NEW21140,NUTRITION,biological phosphorus removal plant,biological phosphorus removal plants
NEW21141,CHEBI,narcotic Commission,Narcotics Commission
NEW21142,DISEASE,qat abuse,qat abuse
NEW21143,CHEMICAL,methanol extract,Methanol extracts
NEW21144,DISEASE,stz-diabetic group,STZ-diabetic groups
NEW21145,CHEMICAL,cinnamon aqueous extract,cinnamon aqueous extract
NEW21146,DISEASE,human prion disease,Human prion diseases
NEW21147,DISEASE,iatrogenic creutzfeldt-jakob secondary,iatrogenic Creutzfeldt-Jakob secondary
NEW21148,CHEBI,human extractive growth hormone,human extractive growth hormone
NEW21149,CHEMICAL,extensive tramadol intake,Extensive tramadol intake
NEW21150,CHEMICAL,Pleuropterus multiflorus,Pleuropterus multiflorus
NEW21151,CHEMICAL,isnomia,isnomia
NEW21152,CHEMICAL,similar gabapentin dose,similar gabapentin doses
NEW21153,CHEMICAL,excess alcohol intake,excess alcohol intake
NEW21154,DISEASE,macrovesicular,macrovesicular
NEW21155,CHEMICAL,selective hedgehog antagonist pf-04449913,selective Hedgehog antagonist PF-04449913
NEW21156,DISEASE,myeloid malignancy,myeloid malignancies
NEW21157,NUTRITION,Starch s,Starch S
NEW21158,DISEASE,melt-blending moulding,melt-blending moulding
NEW21159,DISEASE,gdm dam,GDM dams
NEW21160,CHEMICAL,glucose recovered group,glucose recovered group
NEW21161,CHEMICAL,group glucose recover group,groups glucose recovered group
NEW21162,CHEMICAL,kyn/trp ratio,Kyn/Trp ratio
NEW21163,NUTRITION,tryptophan trp metabolism,tryptophan Trp metabolism
http://purl.obolibrary.org/obo/NCBITaxon_1485,DISEASE,clostridium,Clostridium XlVa
NEW21164,CHEMICAL,5-ht level,5-HT level
NEW21165,CHEBI,lecithin therapy,lecithin therapy
http://purl.obolibrary.org/obo/DOID_0060894,DISEASE,early-onset parkinson's disease,early-onset Parkinson disease|early-onset Alzheimer's disease
NEW21166,CHEMICAL,cocaine sensitization,Cocaine sensitization
NEW21167,MENTAL_HEALTH,pyramidal projection neuron,pyramidal projection neurons
NEW21168,DISEASE,homocystinuria nonresponsive,homocystinuria nonresponsive
NEW21169,CHEMICAL,unfractionate commercial heparin,unfractionated commercial heparin
NEW21170,DISEASE,induce obesity,induced obesity
NEW21171,CHEMICAL,Urtica dioica L.,Urtica dioica L.
NEW21172,CHEMICAL,glucose homeostasis definitive study,glucose homeostasis definitive studies
http://purl.obolibrary.org/obo/PR_000001452,CHEMICAL,free fatty acid receptor,FFAs|fam:ffa_r
NEW21173,MENTAL_HEALTH,pp2a hyperactivity,PP2A hyperactivity
NEW21174,CHEBI,drug concentration,drug concentration
NEW21175,CHEMICAL,bilirubin displacement,bilirubin displacement
NEW21176,DISEASE,deformity lordosis,deformities lordosis
http://purl.obolibrary.org/obo/CHEBI_38656,CHEMICAL,organochlorine pesticide,organochloride pesticides|Chlororganische Pestizide|organochlorine pesticides|Organochlorpestizid|organochlorine pesticide Kepone|organochloride pesticide
http://purl.obolibrary.org/obo/SYMP_0000133,DISEASE,severe necrosis,severe necrosis
NEW21177,CHEMICAL,levamisole-adulterated cocaine use,levamisole-adulterated cocaine use
NEW21178,DISEASE,peripheral vasculitis/vasculopathy,Peripheral vasculitis/vasculopathy
NEW21179,CHEMICAL,sr)-i-bu hcl crystal structure,SR)-i-Bu HCl crystal structure
NEW21180,MENTAL_HEALTH,synclinal orientation,synclinal orientation
NEW21181,CHEMICAL,human ether go-go herg potassium channel,human ether go-go HERG potassium channels
NEW21182,DISEASE,fatal ventricular tachyarrhythmia,fatal ventricular tachyarrhythmia
NEW21183,CHEMICAL,aromatic chalcone,aromatic chalcones
NEW21184,CHEMICAL,"lead compound 5'-chloro-2,2'-dihydroxychalcone","Cl-DHC|lead compound 5'-chloro-2,2'-dihydroxychalcone"
http://purl.obolibrary.org/obo/DOID_162,DISEASE,cancer,malignant neoplasm|cancer DU145|primary cancer|malignant tumor
NEW21185,CHEBI,α2 -adrenoceptor agonist,α2 -adrenoceptor agonists
NEW21186,DISEASE,sympathetic overactivity,sympathetic overactivity
NEW21187,DISEASE,multi-organ dysfunction,multi-organ dysfunction
NEW21188,CHEBI,adrenoceptor agonist,adrenoceptor agonist
NEW21189,DISEASE,septic patient,septic patients
NEW21190,CHEBI,progestin agonist,progestin agonist
NEW21191,DISEASE,pr-rich t47d human breast cancer cell line,PR-rich T47D human breast cancer cell line
NEW21192,CHEBI,m. surinamensis venom,M. surinamensis venom
NEW21193,DISEASE,conclusion potent cardiotoxic activity,conclusion potent cardiotoxic activity
NEW21194,MENTAL_HEALTH,additional depression,additional depression
NEW21195,DISEASE,delusional symptomatology,delusional symptomatology
NEW21196,CHEMICAL,elevated cr,Elevated Cr
NEW21197,CHEMICAL,abnormal local cell-energy demand,abnormal local cell-energy demand
NEW21198,CHEMICAL,elevated cho,elevated Cho
NEW21199,MENTAL_HEALTH,early age-of-onset schizophrenia,early age-of-onset schizophrenia
NEW21200,NUTRITION,phospholipid membrane disturbance,phospholipid membrane disturbances
NEW21201,DISEASE,alcohol-related brain damage,Alcohol-related brain damage
NEW21202,NUTRITION,particular thiamine deficiency,particular thiamine deficiency
NEW21203,CHEMICAL,heavy alcohol use,heavy alcohol use
NEW21204,CHEMICAL,other pioglitazone,others pioglitazone
NEW21205,DISEASE,concomitant osteoporosis,concomitant osteoporosis
NEW21206,DISEASE,high fracture risk,high fracture risk
NEW21207,CHEMICAL,kynurenine pathway,kynurenine pathways
NEW21208,CHEMICAL,kynurenine pathway,Kynurenine pathway
NEW21209,CHEBI,selective s2 serotonergic antagonist,selective S2 serotonergic antagonist
NEW21210,DISEASE,chronic peripheral burn pain,chronic peripheral burning pain
http://purl.obolibrary.org/obo/CHEBI_68557,CHEBI,bradykinin receptor antagonist,Histamine receptor antagonists|bradykinin receptor antagonists
http://purl.obolibrary.org/obo/DOID_1205,DISEASE,allergic disease,allergic diseases|hypersensitivity reaction type I disease|hypersensitivity|allergic hypersensitivity disease
http://purl.obolibrary.org/obo/CHEBI_23116,CHEMICAL,chlorine atom,chlorine atoms|chlorine|cloro|chlore|Chlor|chlorum|17Cl|Cl
NEW21211,CHEMICAL,stacking-interaction energy,stacking-interaction energy
NEW21212,MENTAL_HEALTH,mutual displacement,mutual displacement
NEW21213,DISEASE,psychotic behavior,psychotic behaviors
NEW21214,CHEBI,folate profile,Folate profile
NEW21215,MENTAL_HEALTH,psychosis due,psychosis due
NEW21216,MENTAL_HEALTH,adjust regression model,adjusted regression model
NEW21217,CHEMICAL,≥ parturition,≥ parturitions
NEW21218,CHEBI,high-dose cholecalciferol,high-dose cholecalciferol
NEW21219,DISEASE,tuberculosis patient,tuberculosis patients
NEW21220,DISEASE,Scombroid poisoning,Scombroid poisoning
NEW21221,DISEASE,poison presence,poisoning presence
NEW21222,CHEMICAL,Conclusions- α2δ-1,Conclusions- α2δ-1
NEW21223,DISEASE,ischemia-induced neuronal nmdar hyperactivity,ischemia-induced neuronal NMDAR hyperactivity
NEW21224,CHEMICAL,high testosterone level,higher testosterone levels
NEW21225,CHEMICAL,acetaldehyde accumulation,acetaldehyde accumulation
NEW21226,CHEMICAL,trolox pretreatment,Trolox pretreatment
NEW21227,MENTAL_HEALTH,mrna defense mechanism,mRNA defense mechanism
NEW21228,MENTAL_HEALTH,traditional syndrome,traditional syndromes
NEW21229,DISEASE,advanced chronic kidney disease,advanced chronic kidney disease
NEW21230,CHEMICAL,cyp6dc1,CYP6DC1
NEW21231,MENTAL_HEALTH,lambda-cyhalothrin resistance,lambda-cyhalothrin resistance
NEW21232,DISEASE,PTSD+ individual,PTSD+ individuals
NEW21233,DISEASE,ptsd- individual,PTSD- individuals
NEW21234,DISEASE,great pain severity,greater pain severity
NEW21235,DISEASE,psychiatric use consequence,psychiatric use consequences
NEW21236,DISEASE,sensory impairment,sensory impairments
NEW21237,CHEBI,deletion carrier,deletion carriers
NEW21238,MENTAL_HEALTH,alcohol craving,Alcohol craving
NEW21239,CHEMICAL,serotonin concentration,serotonin concentrations
NEW21240,DISEASE,ocd symptom severity,OCD symptom severity
NEW21241,CHEMICAL,act+ssri condition,ACT+SSRI conditions
NEW21242,CHEMICAL,first-line treatment,first-line treatments
NEW21243,DISEASE,OCD ssri,OCD SSRI
NEW21244,DISEASE,pyramidal tract damage,pyramidal tract damage
NEW21245,MENTAL_HEALTH,pueperal psychosis,pueperal psychosis
NEW21246,MENTAL_HEALTH,numerous dementia,numerous dementia
NEW21247,CHEMICAL,long-term l-dopa treatment,long-term l-DOPA treatment
NEW21248,CHEMICAL,excessive dopamine receptor transmission,excessive dopamine receptor transmission
NEW21249,CHEMICAL,d1- function,D1- function
NEW21250,NUTRITION,low-dose lithium carbonate,low-dose lithium carbonate
NEW21251,DISEASE,carbamazepine-induced hyponatremia,carbamazepine-induced hyponatremia
NEW21252,NUTRITION,black abalone,black abalone
NEW21253,NUTRITION,black white abalone,black white abalone
http://purl.obolibrary.org/obo/SYMP_0000504,MENTAL_HEALTH,headache,Hypnic headache patients|cephalalgia
NEW21254,CHEMICAL,nightly caffeine,nightly caffeine
NEW21255,DISEASE,acute cerebrovascular disease,acute cerebrovascular disease
NEW21256,CHEMICAL,antiparkinsonian drug amantadine hcl,antiparkinsonian drug amantadine HCl
NEW21257,CHEBI,preoperative serum vitamin d,preoperative serum vitamin D
NEW21258,MENTAL_HEALTH,postoperative cognitive disorder,postoperative cognitive disorder
NEW21259,MENTAL_HEALTH,multiple regression analysis,multiple regression analysis
NEW21260,NUTRITION,mercury level,mercury level
NEW21261,CHEMICAL,rapa L.,rapa L.
NEW21262,MENTAL_HEALTH,alleviate fatigue,alleviating fatigue
NEW21263,DISEASE,ischemic deficit,ischemic deficits
NEW21264,CHEMICAL,four-liter fermentor,four-liter fermentor
NEW21265,DISEASE,Flavobacterium sp.,Flavobacterium sp.
NEW21266,CHEBI,zeaxanthin production,zeaxanthin production
NEW21267,CHEMICAL,human recombinant interleukin-2,human recombinant interleukin-2|IL-2
NEW21268,MENTAL_HEALTH,scopolamine-induced hyperactivity,scopolamine-induced hyperactivity
http://purl.org/sig/ont/fma/fma85272,CHEMICAL,capsule,zuranolone capsules
NEW21269,DISEASE,pd diagnosis,PD diagnosis
NEW21270,CHEBI,fxs agonist,FXS agonist
NEW21271,DISEASE,rna toxicity,RNA toxicity
NEW21272,MENTAL_HEALTH,schizophrenia scale,schizophrenia scale
NEW21273,NUTRITION,internal consistency coefficient alpha =,internal consistency coefficient alpha =
NEW21274,DISEASE,gastric cancer pathogenesis,Gastric cancer pathogenesis
NEW21275,CHEBI,microbial virulence factor,microbial virulence factors
NEW21276,CHEMICAL,standard madopar,standard Madopar
NEW21277,CHEMICAL,madopar hbs,Madopar HBS
NEW21278,CHEMICAL,high sucrose/fructose consumption,high sucrose/fructose consumption
NEW21279,DISEASE,fructose-induced de hepatic lipogenesis,fructose-induced de hepatic lipogenesis
NEW21280,DISEASE,consequent hyperglycemia,consequent hyperglycemia
NEW21281,CHEMICAL,iron increase,iron increase
NEW21282,CHEMICAL,hla-20 series,HLA-20 series
NEW21283,CHEBI,mixture modeling,Mixture modeling
NEW21284,DISEASE,depersonalization/derealization dissociative symptom,depersonalization/derealization dissociative symptoms
NEW21285,CHEMICAL,high corticosterone level,high corticosterone levels
NEW21286,CHEMICAL,related to 5-hydroxytriptamine,5-HT|related to 5-hydroxytriptamine
NEW21287,DISEASE,depressed animal,depressed animals
NEW21288,DISEASE,wt parkinsonian mouse,WT parkinsonian mice
http://cbmi.med.harvard.edu/asdphenotype#Class_168,DISEASE,involuntary behaviors,dyskinetic-like behavior
NEW21289,CHEBI,neurotoxin injection,neurotoxin injection
NEW21290,CHEMICAL,injection l-dopa,injection L-DOPA
NEW21291,DISEASE,eyelid opening,eyelid opening
NEW21292,CHEMICAL,atypical ps,atypical PS
NEW21293,NUTRITION,anthocyanin extraction,anthocyanin extraction
NEW21294,MENTAL_HEALTH,dominate fragmentation channel,dominating fragmentation channels
http://purl.obolibrary.org/obo/CHEBI_27007,NUTRITION,tin atom,tin|Sn|estano|tin atom|stannum|etain|Zinn|50Sn
NEW21295,MENTAL_HEALTH,dna fragmentation analysis,DNA fragmentation analysis
NEW21296,CHEMICAL,odoratissimus Linn,odoratissimus Linn
NEW21297,DISEASE,cold/flu,cold/flu
http://purl.obolibrary.org/obo/SYMP_0000056,DISEASE,hyperpigmentation,leucoderma
NEW21298,CHEBI,topical vaginal estrogen therapy,Topical vaginal estrogen therapy
NEW21299,MENTAL_HEALTH,menopause-associated dyspareunia,menopause-associated dyspareunia
NEW21300,MENTAL_HEALTH,heart-rate conditioned response,heart-rate conditioned response
NEW21301,CHEMICAL,apple cider vinegar,apple cider vinegar|ACV
NEW21302,CHEMICAL,synthetic flavonoid,Chrysin|synthetic flavonoid
NEW21303,CHEMICAL,anti-alzheimer 's drug,Rivastigmine|anti-Alzheimer 's drug
NEW21304,DISEASE,depressed patient,depressed patient
NEW21305,CHEMICAL,conventional antidepressant treatment,conventional antidepressant treatment
NEW21306,CHEMICAL,methyl donor betaine,methyl donor betaine
NEW21307,DISEASE,model neurobehavioral deficit,models neurobehavioral deficits
NEW21308,DISEASE,prosthetic joint infection,prosthetic joint infection|PJI
http://purl.obolibrary.org/obo/CHEBI_22918,NUTRITION,branched-chain amino acid,Branched-chain amino acid BCAA metabolism|branched chain amino acids
NEW21309,DISEASE,rare inborn error,rare inborn errors
NEW21310,CHEMICAL,nonsusceptible isolate,nonsusceptible isolates
NEW21311,DISEASE,st69,ST69
http://purl.org/sig/ont/fma/fma295652,DISEASE,sclerotome,ST10
NEW21312,DISEASE,st131,ST131
NEW21313,CHEMICAL,colecystokinin receptor b,colecystokinin receptor B
NEW21314,DISEASE,ischemic cardiovascular disease,ischemic cardiovascular disease
NEW21315,MENTAL_HEALTH,adhd co-morbid condition,ADHD co-morbid conditions
NEW21316,CHEBI,cxcr3 antagonist,CXCR3 antagonists
NEW21317,CHEMICAL,excessive glutamate neurotransmission,Excessive glutamate neurotransmission
http://purl.obolibrary.org/obo/CHEBI_80256,CHEMICAL,neuropeptide w-30,NAAG|neuropeptide N-acetylaspartylglutamate
NEW21318,CHEMICAL,cellular glutamate,cellular glutamate
NEW21319,CHEMICAL,metabolite aminomethylphosphonic acid,metabolite aminomethylphosphonic acid
NEW21320,CHEMICAL,5-f quinazolinone,5-F quinazolinone
NEW21321,CHEBI,egfr inhibitor,EGFR inhibitors
NEW21322,DISEASE,cancer selection criterion,cancer selection criteria
NEW21323,CHEMICAL,5-iodo-3-[2(s)-2-azetidinylmethoxy]pyridine,5-I-A-85380|5-Iodo-3-[2(S)-2-azetidinylmethoxy]pyridine
NEW21324,DISEASE,primary degenerative dementia,primary degenerative dementia
NEW21325,CHEBI,pharmaceutical treatment,pharmaceutical treatment
NEW21326,CHEBI,dopamine agonist levodopa,dopamine agonist levodopa
NEW21327,DISEASE,childhood amblyopia,childhood amblyopia
NEW21328,DISEASE,overall psychotic,overall psychotic
NEW21329,CHEMICAL,e. faecium isolate,E. faecium isolates
NEW21330,CHEMICAL,high-concentration streptomycin,high-concentration streptomycin
NEW21331,CHEMICAL,intramuscular nbqx,intramuscular NBQX
NEW21332,MENTAL_HEALTH,akinesia skill,akinesia skills
NEW21333,DISEASE,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism apparent improvement","1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism apparent improvement"
NEW21334,CHEMICAL,dissolve oxygen,dissolved oxygen
NEW21335,MENTAL_HEALTH,schizophrenia patient,Schizophrenia patients
NEW21336,CHEMICAL,high cho/cre,higher Cho/Cre
NEW21337,CHEMICAL,low naa/cho ratio,lower NAA/Cho ratios
NEW21338,CHEMICAL,morphine compound,morphine compounds
NEW21339,CHEMICAL,bu group,BU group
NEW21340,MENTAL_HEALTH,h postpartum great analgesia,h postpartum greater analgesia
NEW21341,DISEASE,severe pruritus,severe pruritus
NEW21342,DISEASE,epidural nalbuphine,NB|epidural nalbuphine
NEW21343,CHEMICAL,epidural butorphanol,BU|epidural butorphanol
NEW21344,MENTAL_HEALTH,well analgesia,better analgesia
NEW21345,CHEMICAL,epidural morphine,Epidural morphine
NEW21346,MENTAL_HEALTH,specific syndrome,Specific syndromes
NEW21347,NUTRITION,cranberry juice,cranberry juice
NEW21348,DISEASE,obvious depressive-like behavior,obvious depressive-like behaviors
NEW21349,DISEASE,ethanol-associated fetotoxicity,ethanol-associated fetotoxicity
NEW21350,CHEMICAL,maternal hair zinc content,maternal hair zinc content
NEW21351,CHEMICAL,ethanol-exposed infant monkey,ethanol-exposed infant monkeys
NEW21352,DISEASE,craniofacial dysmorphology,craniofacial dysmorphology
NEW21353,CHEMICAL,ongoing antidepressant therapy,ongoing antidepressant therapy
NEW21354,CHEMICAL,nac supplementation,NAC supplementation
NEW21355,CHEMICAL,standard antidepressant treatment,standard antidepressant treatment
NEW21356,CHEMICAL,high-dose nr,high-dose NR
NEW21357,DISEASE,wat dysfunction,WAT dysfunction
NEW21358,CHEMICAL,na regulatory circuit,NA regulatory circuit
NEW21359,MENTAL_HEALTH,additional repression loop,additional repression loop
http://purl.obolibrary.org/obo/CHEBI_35748,NUTRITION,fatty acid ester,a fatty acid ester|fatty acid esters|Saturated fatty acid esters|FAEE
NEW21360,CHEBI,circulate hormone,circulating hormones
NEW21361,DISEASE,murine hair follicle,HF|murine Hair Follicles
NEW21362,DISEASE,aae force,AAE forces
NEW21363,CHEMICAL,pathway ppp rate,Pathway PPP rate
http://purl.obolibrary.org/obo/CHEBI_183852,CHEMICAL,"13,14-dihydro-15-keto-tetranor prostaglandin f1beta","Prostaglandins F2α|3-[(1R,2R,3R,5R)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]propanoic acid"
NEW21364,CHEMICAL,pufa catabolite,PUFA catabolites
NEW21365,MENTAL_HEALTH,lsd flashback syndrome,LSD flashback syndrome
NEW21366,CHEBI,selective serotonin reuptake inhibitor agent,selective serotonin reuptake inhibitor agents
NEW21367,DISEASE,lsd abuse,LSD abuse
NEW21368,DISEASE,early-life inflammation,Early-life inflammation
NEW21369,CHEMICAL,neurochemical/neuropeptide receptor expression,neurochemical/neuropeptide receptor expression
NEW21370,DISEASE,bulimic patient,bulimic patients
NEW21371,NUTRITION,elevated serum phosphorus concentration,elevated serum phosphorus concentration
NEW21372,CHEMICAL,betae2,betaE2
NEW21373,MENTAL_HEALTH,ouabain-induced amnesia,ouabain-induced amnesia
NEW21374,MENTAL_HEALTH,regression log,regression log
NEW21375,CHEMICAL,(V)-0.10 log d,(V)-0.10 log D
NEW21376,CHEMICAL,e(2)(7,E(2)(7
NEW21377,MENTAL_HEALTH,mean maximum lateral displacement,mean maximum lateral displacement
NEW21378,NUTRITION,mackerel Scomber japonicus,mackerel Scomber japonicus
NEW21379,CHEMICAL,ge-ti-π textile,Ge-Ti-π textile
NEW21380,DISEASE,pain score,pain score
NEW21381,MENTAL_HEALTH,resistance development,resistance development
NEW21382,CHEMICAL,blood cd level,blood Cd levels
NEW21383,DISEASE,fibroid tumor size,fibroid tumor size
NEW21384,DISEASE,fibroid cell,fibroid cells
NEW21385,CHEMICAL,µm cdcl2,µM CdCl2
NEW21386,CHEBI,selective serotonin reuptake inhibitor ssri treatment,selective serotonin reuptake inhibitor SSRI treatment
NEW21387,CHEMICAL,elevated monoamine,elevated monoamines
NEW21388,CHEMICAL,atfdh1 mutant,Atfdh1 mutants
NEW21389,MENTAL_HEALTH,gene-for-gene resistance,gene-for-gene resistance
NEW21390,MENTAL_HEALTH,nonhost resistance,nonhost resistance
NEW21391,MENTAL_HEALTH,basal resistance,basal resistance
NEW21392,CHEMICAL,hypothalamic-pituitary-adrenal (hpa)-axis activity,hypothalamic-pituitary-adrenal (HPA)-axis activity
NEW21393,MENTAL_HEALTH,frequent resistance mechanism,frequent resistance mechanism
NEW21394,CHEBI,extended-spectrum beta lactamase,extended-spectrum beta lactamases
NEW21395,MENTAL_HEALTH,unadjusted regression analysis,Unadjusted regression analyses
NEW21396,CHEBI,plasma lutein,plasma lutein
NEW21397,CHEBI,gut microbial uremic toxin,gut microbial uremic toxins
NEW21398,DISEASE,thromboembolic event,thromboembolic events
NEW21399,DISEASE,anoxic depolarization,Anoxic depolarization
NEW21400,CHEMICAL,potent sulfonylurea agent glibenclamide,potent sulfonylurea agent glibenclamide
NEW21401,DISEASE,staphylococcus aureus fads,Staphylococcus aureus FADS
NEW21402,CHEMICAL,atp kinase activity,ATP kinase activity
NEW21403,CHEMICAL,prediabete baseline fasting glucose aged,prediabetes baseline fasting glucose aged
NEW21404,CHEMICAL,lifestyle modification,lifestyle modification|GA group
NEW21405,DISEASE,Saudis,Saudis
NEW21406,CHEMICAL,p2x3 atp receptor,P2X3 ATP receptor
NEW21407,DISEASE,spontaneously hypertension rat,spontaneously hypertension rats
NEW21408,DISEASE,increase chemoreflex hypersensitivity,increased chemoreflex hypersensitivity
NEW21409,CHEBI,idiosyncratic drug hepatotoxicity,Idiosyncratic drug hepatotoxicity
NEW21410,DISEASE,idiosyncratic hepatotoxicity signature,idiosyncratic hepatotoxicity signatures
NEW21411,DISEASE,hepatotoxicity subset,hepatotoxicity subset
NEW21412,DISEASE,postapproval drug failure,postapproval drug failure
NEW21413,CHEMICAL,biospheric molecular oxygen,biospheric molecular oxygen
NEW21414,CHEMICAL,last amino acid,last amino acids
NEW21415,MENTAL_HEALTH,selective fixation,selective fixation
NEW21416,CHEMICAL,liquid chromatography/high tandem mass spectrometry,Liquid chromatography/high tandem mass spectrometry
NEW21417,CHEMICAL,wine waste mixture,wine waste mixture
NEW21418,CHEMICAL,crispr-directed mutagenesis,CRISPR-directed mutagenesis
NEW21419,DISEASE,potent tumour suppressor,potent tumour suppressor
NEW21420,CHEMICAL,bind [14c]inosine,bound [14C]inosine
NEW21421,CHEMICAL,bind inosine,bound inosine
NEW21422,CHEMICAL,gas hydrate,gas hydrates
NEW21423,CHEMICAL,co2 gas,CO2 gas
NEW21424,CHEMICAL,amino acid kinetic promoter,amino acid kinetic promoters
NEW21425,DISEASE,opportunistic pulmonary infection,opportunistic pulmonary infections
NEW21426,DISEASE,structural lung disorder,structural lung disorders
NEW21427,CHEMICAL,polynucleotide kinase 3'-phosphatase pnkp gene,polynucleotide kinase 3'-phosphatase PNKP gene
NEW21428,MENTAL_HEALTH,oculomotor apraxia type,oculomotor apraxia type
NEW21429,CHEMICAL,gtn ointment,GTN ointment
NEW21430,CHEMICAL,diltiazem ointment,Diltiazem ointment
NEW21431,DISEASE,chronic anal fissure comparable,chronic anal fissure comparable
NEW21432,CHEMICAL,dietary gmp,dietary GMP
NEW21433,NUTRITION,juvenile red sea bream,juvenile red sea bream
NEW21434,CHEMICAL,dietary amp supplementation,dietary AMP supplementation
NEW21435,NUTRITION,red sea bream,red sea bream
NEW21436,CHEMICAL,mapk pi-3 k inhibitor,MAPK PI-3 K inhibitors
NEW21437,CHEMICAL,phosphorylate cyclic amp response element binding protein,phosphorylated cyclic AMP response element binding protein
NEW21438,DISEASE,curcumin-induced increase,curcumin-induced increase
NEW21439,CHEBI,estrogen blockade,estrogen blockade
NEW21440,DISEASE,patient 's manic symptom,patient's manic symptoms
NEW21441,CHEMICAL,varenicline treatment,varenicline treatment
NEW21442,DISEASE,serious psychiatric disorder,serious psychiatric disorders
NEW21443,CHEMICAL,representative polyphenol,representative polyphenol
NEW21444,MENTAL_HEALTH,ethanol-mediated dissociation,ethanol-mediated dissociation
NEW21445,DISEASE,veteran ptsd group,Veteran PTSD group
NEW21446,CHEMICAL,mets domain,MetS domains
NEW21447,CHEBI,estrogen receptor alpha gene rs2234693,estrogen receptor alpha gene rs2234693
NEW21448,CHEMICAL,glucose profile,glucose profiles
NEW21449,CHEBI,c allele carrier,C allele carriers
NEW21450,DISEASE,female ptsd group,female PTSD group
NEW21451,DISEASE,combat-related ptsd,combat-related PTSD
NEW21452,DISEASE,combat-related ptsd comorbid,combat-related PTSD comorbid
http://purl.obolibrary.org/obo/CHEBI_66567,CHEMICAL,lespeflorin g5,"X. sorbifolium|(6aR,11aR)-8-methyl-4,10-bis(3-methylbut-2-en-1-yl)-6a,11a-dihydro-6H-[1]benzofuro[3,2-c]chromene-3,9-diol"
NEW21453,DISEASE,cc-nbs-lrr,CNL|CC-NBS-LRR
NEW21454,DISEASE,appetite disturbance,appetite disturbance
NEW21455,CHEMICAL,rs86,RS86
NEW21456,CHEBI,drug tamoxifen,drug tamoxifen
NEW21457,DISEASE,estrogen receptor positive breast cancer,estrogen receptor positive breast cancer
NEW21458,CHEMICAL,nonsteroidal antiestrogen drug,nonsteroidal antiestrogen drug
NEW21459,CHEBI,endocrine treatment,endocrine treatment
NEW21460,DISEASE,diabetic rodent,diabetic rodents
NEW21461,CHEBI,lxr agonist,LXR agonist
NEW21462,CHEMICAL,iron chelation,Iron chelation
NEW21463,DISEASE,malaria parasite,malaria parasites
NEW21464,CHEMICAL,n-3 incorporation,n-3 incorporation
NEW21465,DISEASE,acquire osmotolerance,Acquired osmotolerance
NEW21466,CHEMICAL,nucleotide binding leucine-rich repeat nlr gene,nucleotide binding leucine-rich repeat NLR gene
NEW21467,CHEMICAL,jasmonate pathway,jasmonate pathway
NEW21468,DISEASE,p. arrhenomane infection,P. arrhenomanes infection
NEW21469,CHEMICAL,catalepsy-like immobility,catalepsy-like immobility
NEW21470,CHEMICAL,bar test,BT|bar test
NEW21471,DISEASE,parkinsonian animal,parkinsonian animals
NEW21472,DISEASE,nanocrystalline cellulose,NCC|nanocrystalline cellulose
NEW21473,CHEMICAL,lignoresidue,lignoresidues
NEW21474,CHEMICAL,steroid aldosterone,steroids aldosterone
NEW21475,CHEMICAL,sigma-1 receptor agonist igmesine,sigma-1 receptor agonist igmesine
NEW21476,NUTRITION,mercury intoxication,Mercury intoxication
NEW21477,DISEASE,fatigue disturbance,fatigue disturbances
NEW21478,NUTRITION,mercury level,mercury levels
NEW21479,CHEMICAL,ala treatment,ALA treatment
NEW21480,CHEMICAL,hepatic reduce glutathione content,hepatic reduced glutathione content
NEW21481,DISEASE,ichthyosis premature syndrome,ichthyosis premature syndrome
NEW21482,CHEBI,sub-optimal vitamin d level,Sub-optimal vitamin D levels
NEW21483,CHEBI,anti-mullerian hormone accumulation,anti-mullerian hormone accumulation
NEW21484,DISEASE,pro-inflammatory advanced glycation end Products,pro-inflammatory Advanced Glycation End Products
NEW21485,DISEASE,abnormal folliculogenesis,abnormal folliculogenesis
NEW21486,DISEASE,hepatitis c infection,hepatitis C infection
NEW21487,CHEMICAL,avp analgesia,AVP analgesia
NEW21488,CHEBI,sr vasopressin-1a v1a receptor antagonist,SR vasopressin-1A V1A receptor antagonist
NEW21489,CHEMICAL,dopamine ratio,dopamine ratio
NEW21490,CHEMICAL,high dopamine turnover ratio,higher dopamine turnover ratio
NEW21491,CHEMICAL,phosphorus calcium Survey,Phosphorus Calcium Survey
NEW21492,DISEASE,mineral metabolism disorder,mineral metabolism disorder|CKD-MBD
NEW21493,CHEBI,nonselective muscarinic agonist xanomeline,nonselective muscarinic agonist xanomeline
NEW21494,DISEASE,edema phenotype due,edema phenotypes due
NEW21495,CHEMICAL,steroid responsiveness,steroid responsiveness
http://purl.obolibrary.org/obo/DOID_2590,DISEASE,familial nephrotic syndrome,SSNS|Congenital nephrotic syndrome|familial steroid-sensitive nephrotic syndrome
NEW21496,DISEASE,quetiapine-induced elevation,quetiapine-induced elevations
NEW21497,CHEMICAL,antiretroviral arv drug,antiretrovirals ARVs drugs
NEW21498,MENTAL_HEALTH,stepwise multiple regression analysis,stepwise multiple regression analysis
NEW21499,DISEASE,seizure score,seizure score
http://purl.obolibrary.org/obo/NCBITaxon_1783257,CHEMICAL,pvc group,PTZ group
NEW21500,CHEMICAL,des placement,DES placement
NEW21501,DISEASE,inflow stenosis,inflow stenosis
NEW21502,DISEASE,type cardiorenal syndrome,type cardiorenal syndrome
NEW21503,DISEASE,renal venous congestion,renal venous congestion
NEW21504,CHEMICAL,ace-i/arb withdrawal,ACE-I/ARB withdrawal
NEW21505,CHEBI,progestin action,progestin actions
NEW21506,MENTAL_HEALTH,sperm hyperactivity,sperm hyperactivity
NEW21507,DISEASE,mw2 swap variant,MW2 swap variants
NEW21508,CHEMICAL,nahco3,NaHCO3
NEW21509,CHEMICAL,atg18-retromer,Atg18-retromer
NEW21510,MENTAL_HEALTH,"ptdins(3,5)p2-dependent vacuolar fragmentation","PtdIns(3,5)P2-dependent vacuolar fragmentation"
NEW21511,CHEMICAL,creatine deficiency disorder,Creatine deficiency disorders
NEW21512,CHEMICAL,creatine metabolism,creatine metabolism
NEW21513,CHEMICAL,guanidinoacetic acid gaa toxicity,guanidinoacetic acid GAA toxicity
NEW21514,CHEMICAL,low creatine level,low creatine levels
NEW21515,CHEBI,adjunctive drug treatment,adjunctive drug treatment
NEW21516,MENTAL_HEALTH,motor restlessness,motor restlessness
NEW21517,CHEBI,male c-allele carrier,male C-allele carriers
NEW21518,DISEASE,age attention deficit score,age attention deficit scores
NEW21519,MENTAL_HEALTH,stress-associated suicide risk,stress-associated suicide risk
NEW21520,CHEMICAL,gabra6 rs3219151 t allele,GABRA6 rs3219151 T allele
NEW21521,DISEASE,t-allele carrier,T-allele carriers
NEW21522,MENTAL_HEALTH,adhd score,ADHD scores
NEW21523,CHEMICAL,day/night serum tac,day/night serum TAC
NEW21524,MENTAL_HEALTH,schizophrenia evolution,schizophrenia evolution
NEW21525,DISEASE,cardiovascular mortality,cardiovascular mortality
NEW21526,CHEBI,synthetic pyridoxine,synthetic pyridoxine
NEW21527,CHEMICAL,alpha-2-delta ligand,alpha-2-delta ligands
NEW21528,MENTAL_HEALTH,augmentation control disorder,augmentation control disorders
NEW21529,DISEASE,epilepsy drug,Epilepsy drugs
NEW21530,CHEBI,reproductive endocrine disorder,reproductive endocrine disorders
NEW21531,CHEMICAL,cpd trimester,CPD trimester
NEW21532,CHEMICAL,rapid nicotine metabolism,rapid nicotine metabolism
NEW21533,MENTAL_HEALTH,suicide thought,suicide thoughts
NEW21534,DISEASE,psychiatric association,psychiatric association
NEW21535,CHEMICAL,long-chain poly unsaturated Fatty Acids,long-chain Poly Unsaturated Fatty Acids
NEW21536,CHEMICAL,gaba transmission,GABA transmission
NEW21537,CHEMICAL,gvg,GVG
NEW21538,CHEMICAL,vigabatrin gamma vinyl gaba,Vigabatrin gamma vinyl GABA
NEW21539,MENTAL_HEALTH,suicide inhibitor,suicide inhibitor
http://purl.obolibrary.org/obo/CHEBI_73641,CHEMICAL,rac-methyl lactate,"methyl DL-lactate|(+-)-methyl 2-hydroxypropionate|lactate clearance(LC|rac-methyl 2-hydroxypropanoate|methyl RS-lactate|(+-)-methyl 2-hydroxypropanoate|2-hydroxypropanoic acid methyl ester|methyl 2-hydroxypropionate|methyl alpha-hydroxypropionate|(+-)-methyl lactate|lactic acid, methyl ester|RS-methyl lactate|DL-methyl lactate"
NEW21540,CHEMICAL,epa effect,EPA effects
NEW21541,DISEASE,cums-induced microglial activation,CUMS-induced microglial activation
NEW21542,CHEMICAL,EPA supplement,EPA supplement
NEW21543,MENTAL_HEALTH,nuclear displacement,nuclear displacement
NEW21544,CHEMICAL,t3 g. fraction,T3 g. fraction
NEW21545,DISEASE,early-stage ad patient,early-stage AD patients
NEW21546,NUTRITION,' onion, onion
NEW21547,CHEMICAL,simulated gastric hcl,simulated gastric HCl
NEW21548,DISEASE,fracture toughness,fracture toughness
NEW21549,CHEBI,modify sodium bentonite geosynthetic clay liner,modified sodium bentonite geosynthetic clay liner
NEW21550,CHEMICAL,residue leachate,residue leachate
NEW21551,DISEASE,modify fluid loss test,modified fluid loss test
NEW21552,CHEMICAL,sodium bentonite geosynthetic clay liner,sodium bentonite geosynthetic clay liner|GCL
NEW21553,CHEBI,4-aminoquinoline-based antimalarial,4-aminoquinoline-based antimalarials
NEW21554,DISEASE,amyloid-beta-peptide abeta neurotoxicity,amyloid-beta-peptide Abeta neurotoxicity
NEW21555,CHEMICAL,abnormal glucose metabolism,abnormal glucose metabolism
NEW21556,DISEASE,hyperglycaemia,Hyperglycaemia
NEW21557,DISEASE,hyperinsulinaemia,hyperinsulinaemia
NEW21558,NUTRITION,low hdl cholesterol,low HDL cholesterol
NEW21559,CHEMICAL,antidepressant user,antidepressant users
NEW21560,MENTAL_HEALTH,severe paraphilia,severe paraphilias
NEW21561,CHEBI,antiandrogen treatment,Antiandrogen treatments
NEW21562,DISEASE,severe paraphilic subject,severe paraphilic subjects
NEW21563,CHEMICAL,ammonium cerium nitrate,ammonium cerium nitrate
NEW21564,DISEASE,copd pharmacotherapy guideline,COPD pharmacotherapy guidelines
NEW21565,CHEMICAL,long-acting antimuscarinic agent,long-acting antimuscarinic agents|LAMA
NEW21566,CHEMICAL,1:1-indacaterol,1:1-indacaterol
NEW21567,MENTAL_HEALTH,fatigue level,fatigue levels
NEW21568,CHEMICAL,indacaterol group,indacaterol group
http://purl.obolibrary.org/obo/PR_Q9LVZ7,DISEASE,phosphatidylcholine:diacylglycerol cholinephosphotransferase 1 (arabidopsis thaliana),msj11.22|rod1|protein reduced oleate desaturation 1 (arabidopsis thaliana)|atpdct1|desaturation|at-rod1|at3g15820
NEW21569,DISEASE,multiple neuropathologie,multiple neuropathologies
NEW21570,DISEASE,neurodegeneration dementia,neurodegeneration dementia
NEW21571,DISEASE,carcinosin-tumor-derived breast cancer tissue,Carcinosin-tumor-derived breast cancer tissue
NEW21572,DISEASE,nanoparticle tumor exocancer vaccine,nanoparticle tumor exocancer vaccine
NEW21573,DISEASE,vaccine research,vaccine research
http://purl.obolibrary.org/obo/CHEBI_50804,CHEMICAL,nanoshell,nonhomeopathic nanoparticle
NEW21574,DISEASE,rcc risk,RCC risk
NEW21575,CHEMICAL,pangenotypic direct-acting antiviral agent,Pangenotypic direct-acting antiviral agents
NEW21576,DISEASE,genotype infection,genotype infections
NEW21577,CHEMICAL,sof/vel combination ± ribavirin,SOF/VEL combination ± ribavirin
NEW21578,DISEASE,decompensated cirrhosis,decompensated cirrhosis
NEW21579,DISEASE,hcv patient,HCV patients
NEW21580,CHEMICAL,daa treatment,DAA treatment
NEW21581,DISEASE,disorder muscle strength,disorders muscle strength
NEW21582,CHEMICAL,Ashitaba powder,Ashitaba powder
NEW21583,CHEMICAL,enzyme glutathione synthase,enzyme glutathione synthase
NEW21584,CHEMICAL,be mouse,BE mice
NEW21585,NUTRITION,phospholipid liposome,phospholipid liposomes
NEW21586,MENTAL_HEALTH,mild anxiety,mild anxiety
http://purl.org/sig/ont/fma/fma84050,CHEMICAL,cytokine,Th17/Treg-related cytokine
NEW21587,DISEASE,osa management,OSA management
NEW21588,DISEASE,osa pathogenesis,OSA pathogenesis
NEW21589,DISEASE,itp care,ITP care
NEW21590,CHEBI,anticonvulsant mood stabilizer,anticonvulsant mood stabilizers
NEW21591,CHEMICAL,insp6 non-treated group,InsP6 non-treated group
NEW21592,DISEASE,calcinosis treatment,calcinosis treatment
NEW21593,CHEMICAL,calcium content,calcium content
NEW21594,CHEMICAL,insp6 non-treated rat,InsP6 non-treated rats
NEW21595,CHEMICAL,iron starvation,Iron starvation
NEW21596,MENTAL_HEALTH,morphine-conditioned hyperactivity,morphine-conditioned hyperactivity
NEW21597,CHEBI,agonist levorphanol,agonist levorphanol
NEW21598,CHEMICAL,agonist dissociation constant,agonist dissociation constants|KA
NEW21599,CHEMICAL,"irreversible alpha-2 adrenoceptor antagonist n-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline","irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline|EEDQ"
NEW21600,CHEMICAL,"drug 3,4-methylenedioxymethamphetamine","drug 3,4-methylenedioxymethamphetamine"
NEW21601,CHEMICAL,serotonin system integrity,serotonin system integrity
NEW21602,DISEASE,long-lasting deficit,long-lasting deficits
NEW21603,CHEMICAL,zn uptake,Zn uptake
NEW21604,DISEASE,tg soil,TG soil
NEW21605,CHEMICAL,salicylic acid content,salicylic acid contents
NEW21606,MENTAL_HEALTH,clubroot resistance,clubroot resistance
NEW21607,CHEMICAL,jasmonate acid,jasmonate acid
http://purl.obolibrary.org/obo/CHEBI_84194,CHEMICAL,hydroxytryptophan,hydroxytryptophans|5-hydroxytryptophan 5-HTP
NEW21608,CHEMICAL,glutamate neurotoxicity,glutamate neurotoxicity
NEW21609,MENTAL_HEALTH,late-life depression,late-life depression
NEW21610,MENTAL_HEALTH,initial fixation product,initial fixation product
http://purl.obolibrary.org/obo/CHEBI_17050,CHEMICAL,3-phosphoglyceric acid,3-Phosphoglycerate|Glyceric acid 3-phosphate|3-(dihydrogen phosphate)Glyceric acid|Glycerate 3-phosphate|3-phosphoglyceric acid|glycerate 3-phosphates|DL-Glycerate 3-phosphate|3-(dihydrogen phosphate)Glycerate|2-hydroxy-3-(phosphonooxy)propanoic acid
NEW21611,CHEBI,reaction mixture,reaction mixture
NEW21612,MENTAL_HEALTH,dark (14)co(2 fixation period,dark (14)CO(2 fixation periods
NEW21613,MENTAL_HEALTH,(14)co(2 fixation product,(14)CO(2 fixation products
NEW21614,CHEMICAL,preillumination,preillumination
NEW21615,CHEMICAL,fix carbon atom,fixed carbon atom
NEW21616,MENTAL_HEALTH,dark co(2 fixation,dark CO(2 fixation
NEW21617,NUTRITION,short-chain fatty acid production pathway,short-chain fatty acid production pathways
NEW21618,CHEBI,supraphysiologic hormone supplementation,supraphysiologic hormone supplementation
NEW21619,CHEMICAL,ped user,PED users
NEW21620,DISEASE,increase muscle mass,increased muscle mass
NEW21621,CHEBI,ascorbic acid content,Ascorbic acid content
http://purl.obolibrary.org/obo/CHEBI_135145,CHEBI,neridronic acid,± ascorbic acid|neridronate
NEW21622,CHEMICAL,i.pl,i.pl
NEW21623,DISEASE,chronic constriction injury model,chronic constriction injury model
NEW21624,CHEMICAL,paf receptor antagonist,PAF receptor antagonists
NEW21625,NUTRITION,thrombocytic phospholipid,thrombocytic phospholipids
NEW21626,MENTAL_HEALTH,alcoholic abstinence syndrome,alcoholic abstinence syndrome
NEW21627,CHEMICAL,prostanoid synthesis,prostanoid synthesis
NEW21628,CHEMICAL,salbutamol treatment,Salbutamol treatment
NEW21629,DISEASE,dok7 myasthenic mouse,DOK7 myasthenic mice
NEW21630,DISEASE,myasthenic patient,myasthenic patients
NEW21631,CHEMICAL,β2-adrenergic agonist salbutamol,β2-adrenergic agonist salbutamol
NEW21632,CHEMICAL,medication pyridostigmine,medication pyridostigmine
NEW21633,MENTAL_HEALTH,amnesia induction,amnesia induction
NEW21634,CHEBI,hypophysis-thyroid hormone,hypophysis-thyroid hormones
NEW21635,CHEBI,hormone sth,hormones STH
NEW21636,MENTAL_HEALTH,tumor neurosis factor homolog april,tumor neurosis factor homolog APRIL
NEW21637,DISEASE,primary b,primary B
NEW21638,DISEASE,Albright 's hereditary osteodystrophy,Albright's hereditary osteodystrophy
http://purl.obolibrary.org/obo/DOID_13359,DISEASE,ehlers-danlos syndrome,TRPS1 tricho-rhino-phalangeal syndrome|Cutis hyperelastica|elastic skin
NEW21639,CHEMICAL,objectivevon hippel-lindau disease,OBJECTIVEVon Hippel-Lindau disease
http://purl.obolibrary.org/obo/DOID_4467,DISEASE,clear cell renal cell carcinoma,renal clear cell carcinoma|clear cell kidney carcinoma|conventional renal cell carcinoma|Clear cell carcinoma of kidney|clear cell renal cell carcinomas|Clear-cell metastatic renal cell carcinoma|conventional (Clear cell) renal cell carcinoma
NEW21640,DISEASE,cns hemangioblastoma,CNS hemangioblastomas
NEW21641,CHEMICAL,0.0004).conclusionspropranolol,0.0004).CONCLUSIONSPropranolol
NEW21642,DISEASE,vhl-hb rcc viability,VHL-HB RCC viability
NEW21643,CHEBI,paf antagonist,PAF antagonist
NEW21644,DISEASE,tha microm,THA microM
NEW21645,CHEMICAL,mda production,MDA production
NEW21646,CHEMICAL,elevated ros,elevated ROS
NEW21647,CHEMICAL,paf 1-o-alkyl-2-acetyl-sn-glycero-3-phosphocholine,PAF 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine
NEW21648,DISEASE,human virus-1-associated dementia,human virus-1-associated dementia
NEW21649,CHEMICAL,prenatal acetaminophen exposure due,prenatal acetaminophen exposure due
NEW21650,MENTAL_HEALTH,adhd outcome,ADHD outcomes
NEW21651,DISEASE,localized provoke vulvodynia,Localized provoked vulvodynia
NEW21652,MENTAL_HEALTH,chronic dyspareunia,chronic dyspareunia
NEW21653,DISEASE,acute concomitant poisoning,acute concomitant poisoning
NEW21654,CHEBI,narcotic substance,narcotic substances
NEW21655,DISEASE,acute poisoning,Acute poisoning
NEW21656,DISEASE,mixed decompensated respiratory lactic acidosis,mixed decompensated respiratory lactic acidosis
NEW21657,DISEASE,nosocomial focal low lobe pneumonia,nosocomial focal lower lobe pneumonia
NEW21658,CHEMICAL,lactate mmol l,lactate mmol l
NEW21659,CHEMICAL,phenyl-2- -1-pentanone,phenyl-2- -1-pentanone
NEW21660,DISEASE,convulsive syndrome,convulsive syndrome
NEW21661,CHEBI,poor vitamin k status,Poor vitamin K status
NEW21662,DISEASE,bone complication,bone complications
http://purl.obolibrary.org/obo/DOID_11476,DISEASE,osteoporosis,CKD-associated osteoporosis
NEW21663,NUTRITION,american bison,American bison
NEW21664,DISEASE,natural a. marginale infection,natural A. marginale infection
NEW21665,CHEMICAL,inhale budesonide,inhaled budesonide
NEW21666,DISEASE,respiratory viral infection,respiratory viral infections
NEW21667,CHEMICAL,intranasal corticosteroid,INSs|intranasal corticosteroids
NEW21668,CHEBI,cysteinyl leukotriene receptor antagonist,cysteinyl leukotriene receptor antagonist
NEW21669,CHEMICAL,muscarinic cholinergic antagonist atropine,muscarinic cholinergic antagonist atropine
NEW21670,DISEASE,myopia development,myopia development
NEW21671,DISEASE,p. capensis,P. capensis
NEW21672,CHEMICAL,ml co2 h(-1,ml CO2 h(-1
NEW21673,CHEMICAL,carbon dioxide release,carbon dioxide release
NEW21674,CHEMICAL,h2o h(-1,H2O h(-1
NEW21675,CHEMICAL,high glutamate,higher glutamate
NEW21676,DISEASE,severe functional impairment,severe functional impairment
NEW21677,DISEASE,radicular pain,radicular pain
NEW21678,CHEBI,insufficient analgesic effect,insufficient analgesic effects
NEW21679,CHEMICAL,δ8-thc effect,Δ8-THC effects
NEW21680,CHEBI,drug effect,Drug effect
NEW21681,CHEMICAL,ethinyl estradiol ee concentration,ethinyl estradiol EE concentrations
NEW21682,DISEASE,swollen breast,swollen breasts
NEW21683,CHEMICAL,microg ee,microg EE
http://purl.obolibrary.org/obo/CHEBI_49325,CHEMICAL,oral contraceptive,oral contraceptives|oral contraceptive use
NEW21684,DISEASE,pre-existing mastodynia,pre-existing mastodynia
NEW21685,DISEASE,fibrocystic breast manifestation,fibrocystic breast manifestations
NEW21686,CHEMICAL,alkalien phosphatase activity,enzymorrhea|alkalien phosphatase activity
NEW21687,MENTAL_HEALTH,colon dyskinesia,colon dyskinesia
NEW21688,DISEASE,glutamic antibody-associated encephalitis,Glutamic antibody-associated encephalitis
NEW21689,CHEMICAL,new adp antagonist,new ADP antagonists
http://purl.obolibrary.org/obo/CHEBI_28304,CHEMICAL,heparin,heparin heparins|heparin|Fluxum|Enoxaparin|heparine|heparinum|Parnaparin|Heparinic acid|heparina|Heparin|Bemiparin|Cy 222|Certoparin|Reviparin|Sandoparin
NEW21690,DISEASE,potent platelet aggregation inhibitor,potent platelet aggregation inhibitors
NEW21691,CHEBI,increase dopaminergic agent,Increased dopaminergic agents
NEW21692,DISEASE,painful dystonia,painful dystonia
NEW21693,CHEMICAL,mean ±,mean ±
NEW21694,CHEMICAL,antidepressant therapy,Antidepressant therapy
NEW21695,DISEASE,cms-induced bone loss,CMS-induced bone loss
NEW21696,CHEMICAL,synthetic sulfone,synthetic sulfone
NEW21697,DISEASE,leprosy herpetiformis,leprosy herpetiformis
NEW21698,DISEASE,advanced rheumatoid arthritis,advanced rheumatoid arthritis
NEW21699,CHEBI,botulinus toxin,botulinus toxin
NEW21700,CHEMICAL,acetylcholine molecule,acetylcholine molecules
NEW21701,CHEMICAL,inositol monophosphatase impa1 gene,inositol monophosphatase IMPA1 gene
http://purl.obolibrary.org/obo/DOID_1059,MENTAL_HEALTH,intellectual disability,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15|severe intellectual disability|mental retardation"
NEW21702,CHEMICAL,growth-hormone response,growth-hormone response
NEW21703,CHEMICAL,testosterone increase,testosterone increase
NEW21704,DISEASE,male-based childhood-onset neuropsychiatric disorder,male-based childhood-onset neuropsychiatric disorders
NEW21705,DISEASE,low-flow veno-occlusive priapism,Low-flow veno-occlusive priapism
NEW21706,MENTAL_HEALTH,irreversible erectile dysfunction,irreversible erectile dysfunction
NEW21707,DISEASE,diabetic animal,Diabetic animals
NEW21708,CHEMICAL,gsh level,GSH levels
NEW21709,MENTAL_HEALTH,p linear regression model,p linear regression models
NEW21710,CHEMICAL,ala-d activity,ALA-D activity
NEW21711,CHEMICAL,low-dose ketamine infusion,Low-dose ketamine infusion
NEW21712,CHEBI,adjunct analgesic agent,adjunct analgesic agent
NEW21713,CHEBI,alpha-tocopherol antioxidant,alpha-Tocopherol antioxidant
NEW21714,DISEASE,adrenolytic heart defect,AHD|Adrenolytic heart defect
NEW21715,DISEASE,twitch response,twitch responses
NEW21716,CHEBI,cb agonist,CB agonists
NEW21717,CHEBI,inhaled β2-adrenergic agonist,Inhaled β2-adrenergic agonists
NEW21718,DISEASE,toxicity assessment,toxicity assessment
NEW21719,CHEBI,agar diffusion,agar diffusion
NEW21720,DISEASE,linteus fruiting body hot water extract,PLE|linteus fruiting body hot water extract
NEW21721,MENTAL_HEALTH,dna fragmentation level,DNA fragmentation levels
NEW21722,CHEMICAL,ba5,BA5
NEW21723,DISEASE,leishmania amazonensis-infected macrophage,Leishmania amazonensis-infected macrophages
NEW21724,DISEASE,sepsis-induced hyperlactatemia,sepsis-induced hyperlactatemia
NEW21725,CHEMICAL,lactate clearance,lactate clearance
NEW21726,CHEMICAL,selective mao-a-inhibitor moclobemide,selective MAO-A-inhibitor moclobemide
NEW21727,CHEMICAL,clonidine hormone release,clonidine hormone release
NEW21728,NUTRITION,alpha responsivity,alpha responsivity
NEW21729,CHEBI,norepinephrine reuptake inhibitor maprotiline,norepinephrine reuptake inhibitor maprotiline
NEW21730,CHEMICAL,elevated cortisol level,elevated cortisol level
NEW21731,CHEMICAL,chronic oea treatment,chronic OEA treatment
NEW21732,MENTAL_HEALTH,dementia marker,dementia markers
NEW21733,DISEASE,loss impairment,loss impairments
NEW21734,CHEMICAL,isoflavone daidzein,isoflavones daidzein
NEW21735,DISEASE,frequent headache,frequent headaches
NEW21736,DISEASE,sunflower wrky transcription factor,sunflower WRKY transcription factor
NEW21737,DISEASE,dehydration tolerance,dehydration tolerance
NEW21738,CHEMICAL,hawrky76,HaWRKY76
NEW21739,NUTRITION,elevated erythrocyte choline,elevated erythrocyte choline
NEW21740,CHEMICAL,anti-dementia medication,anti-dementia medications
NEW21741,CHEBI,antibiotic sequence therapy,antibiotic sequence therapy
NEW21742,DISEASE,malignant disease,malignant diseases
NEW21743,NUTRITION,chat level,CHAT levels
NEW21744,CHEBI,administer steroid/gel mixture,administered steroid/gel mixture
NEW21745,DISEASE,benign esophageal stricture,benign esophageal stricture
NEW21746,MENTAL_HEALTH,link intellectual disability,linked intellectual disability
NEW21747,DISEASE,monogenetic cause,monogenetic cause
NEW21748,MENTAL_HEALTH,hepatic antioxidant defense mechanism,hepatic antioxidant defense mechanism
NEW21749,CHEMICAL,chitosan nanoparticle due,chitosan nanoparticles due
NEW21750,DISEASE,nitrosodiethylamine-induced carcinoma change,Nitrosodiethylamine-induced carcinoma changes
NEW21751,CHEMICAL,hydrophilic ascorbic acid,hydrophilic ascorbic acids
NEW21752,DISEASE,human nonmelanoma skin carcinoma,human nonmelanoma skin carcinomas
NEW21753,CHEMICAL,intravenous same,intravenous SAMe
NEW21754,DISEASE,cholestasis serum total,cholestasis serum total
NEW21755,CHEMICAL,nicotinic antagonist hexamethonium,nicotinic antagonist hexamethonium
NEW21756,CHEMICAL,synthetic gestagen levonorgestrel,synthetic gestagen levonorgestrel|LNG
NEW21757,DISEASE,thyroid hormone-dependent metamorphosis,thyroid hormone-dependent metamorphosis
NEW21758,DISEASE,pituitary expression,pituitary expression
NEW21759,MENTAL_HEALTH,strong repression,strong repression
NEW21760,DISEASE,npsle patient,NPSLE patients
NEW21761,CHEMICAL,fxs,Fmr1 KO2 mice|FXS
http://purl.obolibrary.org/obo/PR_P41912,DISEASE,ras modification protein erf4 (yeast),shr5|yshr5|yol110w|hyperactive ras suppressor protein 5 (yeast)|hyperactive|hrc237|erf4
NEW21762,CHEMICAL,extrasynaptic gaba receptor,extrasynaptic GABA receptors
NEW21763,DISEASE,fxs model,FXS model
NEW21764,DISEASE,numerous behavioral deficit,numerous behavioral deficits
NEW21765,CHEMICAL,[cl-]i level,[Cl-]i levels
NEW21766,MENTAL_HEALTH,syndrome autism spectrum Disorders,Syndrome Autism Spectrum Disorders
NEW21767,CHEMICAL,crh concentration,CRH concentrations
NEW21768,DISEASE,csf psychiatric patient,CSF psychiatric patients
NEW21769,CHEMICAL,mild antidepressant response,mild antidepressant response
NEW21770,NUTRITION,sea urchin lesion syndrome,Sea urchin lesion syndrome
NEW21771,DISEASE,necrotic epidermal tissue,necrotic epidermal tissue
NEW21772,NUTRITION,sea urchin disease,sea urchin disease
NEW21773,DISEASE,persistent hyperosmolality,Persistent hyperosmolality
NEW21774,CHEMICAL,meq sodium intake,mEq sodium intake
NEW21775,CHEMICAL,oestrogen-stimulated neurophysin,oestrogen-stimulated neurophysin
NEW21776,DISEASE,orthostasis procedure,orthostasis procedures
NEW21777,CHEBI,oestrogen stimulation,oestrogen stimulation
NEW21778,DISEASE,AVH Group,AVH Group
http://purl.obolibrary.org/obo/CHEBI_16987,CHEMICAL,1-piperideine-6-carboxylate,"1-piperideine-6-carboxylate|delta-1-Piperideine-6-carboxylate|2,3,4,5-tetrahydropyridine-2-carboxylate|ACC-recorded Glu"
http://purl.obolibrary.org/obo/CHEBI_38757,CHEMICAL,isoflavones,isoflavones|an isoflavone|soy-derived phytoestrogen
NEW21779,CHEMICAL,genistein treatment,genistein treatment
NEW21780,CHEMICAL,promoter SbaP,promoter SbaP
NEW21781,DISEASE,white spot syndrome virus immediate early gene,white spot syndrome virus immediate early gene
NEW21782,CHEMICAL,beta-actin promoter,TbaP|beta-actin promoter
NEW21783,CHEBI,vitamin a toxicity,vitamin A toxicity
NEW21784,DISEASE,large carnivorous fish liver,large carnivorous fish liver
NEW21785,CHEBI,vitamin supplement,vitamin supplements
NEW21786,NUTRITION,folate receptor alpha autoantibody,folate receptor alpha autoantibodies
NEW21787,DISEASE,asd study,ASD studies
NEW21788,CHEMICAL,l-leucovorin,l-leucovorin
NEW21789,CHEBI,folate pathway abnormality,folate pathway abnormalities
NEW21790,DISEASE,major metabolic disturbance,major metabolic disturbance
NEW21791,MENTAL_HEALTH,curve % dna fragmentation,curve % DNA fragmentation
NEW21792,MENTAL_HEALTH,fungal hyphae fragmentation assay,fungal hyphae fragmentation assay
NEW21793,CHEBI,potential antifungal activity,Potential antifungal activity
NEW21794,MENTAL_HEALTH,hyphae fragmentation,hyphae fragmentation
NEW21795,CHEMICAL,exenatide therapy,Exenatide therapy
NEW21796,MENTAL_HEALTH,lps-induced autism model,LPS-induced autism model
NEW21797,CHEMICAL,serum gamma-glutamyl transpeptidase,Serum gamma-glutamyl transpeptidase
NEW21798,DISEASE,different liver disease,different liver diseases
NEW21799,DISEASE,postnecrotic cirrhosis,postnecrotic cirrhosis
http://purl.obolibrary.org/obo/DOID_12351,DISEASE,alcoholic hepatitis,|chronic alcholic hepatitis|alcoholic hepatitis|Alcoholic Hepatitis|Alcoholic hepatitis|acute alcoholic liver disease|acute Alcoholic Hepatitis|acute alcoholic hepatitis
NEW21800,CHEBI,novel peroxiproliferator-activated receptor ppar modulator,novel peroxiproliferator-activated receptor PPAR modulator
NEW21801,DISEASE,obesity-related metabolic disorder,obesity-related metabolic disorders
NEW21802,CHEMICAL,epidural morphine,epidural morphine
NEW21803,MENTAL_HEALTH,neonatal neurobehavioral depression,neonatal neurobehavioral depression
NEW21804,CHEMICAL,catecholamine receptor activity,catecholamine receptor activity
NEW21805,DISEASE,distal twitch glycolytic fog muscle,distal twitch glycolytic FOG muscle
NEW21806,DISEASE,contracture tension,Contracture tension
NEW21807,DISEASE,twitch tension,twitch tension
http://purl.obolibrary.org/obo/SYMP_0000213,DISEASE,agraphia,inability to write|impersistence
NEW21808,CHEMICAL,carbon balance,carbon balance
NEW21809,DISEASE,nhcap patient,NHCAP patients
NEW21810,DISEASE,cap patient,CAP patients
NEW21811,CHEMICAL,auricular electroacupuncture,auricular electroacupuncture
NEW21812,CHEMICAL,Metalaxyl-M. Maxim ® xl exposure,Metalaxyl-M. Maxim ® XL exposure
NEW21813,DISEASE,marked edema,marked edema
NEW21814,MENTAL_HEALTH,cellular dissociation,cellular dissociation
NEW21815,CHEMICAL,intrathecal fentanyl injection,intrathecal fentanyl injection
NEW21816,CHEMICAL,drug prazosin,drugs prazosin
NEW21817,CHEMICAL,[3h]norepinephrine,[3H]norepinephrine
NEW21818,DISEASE,experimental seizure model,experimental seizure models
NEW21819,CHEMICAL,gamma-aminobutyric acid gaba transmission,gamma-aminobutyric acid GABA transmission
NEW21820,MENTAL_HEALTH,predictive regression relationship,predictive regression relationship
NEW21821,MENTAL_HEALTH,similar different regression,similar different regression
NEW21822,CHEMICAL,Neu_LR,Neu_LR
NEW21823,MENTAL_HEALTH,regression algorithm,regression algorithm
NEW21824,CHEBI,… drug trafficking,… Drug trafficking
NEW21825,CHEBI,drug market,drug market
NEW21826,CHEMICAL,scopolamine patch,scopolamine patches
NEW21827,MENTAL_HEALTH,toxic psychosis,toxic psychosis
NEW21828,CHEMICAL,da d2 receptor antagonism,DA D2 receptor antagonism
NEW21829,CHEMICAL,nonergot dopamine agonist,Nonergot dopamine agonists
NEW21830,CHEBI,sedative-hypnotic drug,sedative-hypnotic drug
NEW21831,MENTAL_HEALTH,suicide case,suicide cases
http://purl.obolibrary.org/obo/CHEBI_60027,CHEBI,polymer,Polymer|(SNAP)-doped polymer|Kunststoff
NEW21832,CHEMICAL,selenium (se)-polymer,selenium (Se)-polymer
NEW21833,DISEASE,fmr1-knockout mouse,Fmr1-knockout mice
http://purl.obolibrary.org/obo/CHEBI_26915,CHEMICAL,tetrahydronicotinamide adenine dinucleotide phosphate,tetrahydronicotinamide adenine dinucleotide phosphates|nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase activation
NEW21834,CHEMICAL,fmr1-knockout mouse,FMR1-knockout mice
NEW21835,CHEMICAL,congenic fvb129 wild-type control,congenic FVB129 wild-type controls
NEW21836,CHEMICAL,carnosine-stimulated/mediated neuronal histamine system,carnosine-stimulated/mediated neuronal histamine system
NEW21837,CHEBI,cyanocobalamin supplementation,cyanocobalamin supplementation
NEW21838,DISEASE,rvo patient,RVO patients
NEW21839,CHEMICAL,superoxide anion,superoxide anions
NEW21840,DISEASE,visceral leishmaniasis patient,visceral leishmaniasis patients
NEW21841,CHEMICAL,significant erythrocyte mda,significant erythrocyte MDA
NEW21842,CHEMICAL,patient 's creatine kinase level,patient's creatine kinase levels
NEW21843,DISEASE,constant severe pain,constant severe pain
NEW21844,DISEASE,head shake,Head shakes
NEW21845,CHEBI,testosterone extra-gonadal estrogen,testosterone extra-gonadal estrogens
NEW21846,CHEMICAL,letrozole treatment,letrozole treatment
NEW21847,CHEMICAL,shikimate pathway,shikimate pathway
NEW21848,DISEASE,p. damselae subsp,P. damselae subsp
NEW21849,CHEMICAL,his-tagged recombinant microbacterium esterase,his-tagged recombinant Microbacterium esterase
NEW21850,MENTAL_HEALTH,affinity fixation,affinity fixation
NEW21851,CHEMICAL,magnetic chitosan microsphere,magnetic chitosan microspheres|MCS-NTA-Ni
NEW21852,CHEMICAL,single-site cuii,single-site CuII
NEW21853,CHEMICAL,tumor-overexpressed glutathione,tumor-overexpressed glutathione
NEW21854,NUTRITION,officinarum Hance,officinarum Hance
http://purl.obolibrary.org/obo/SYMP_0019145,DISEASE,vomiting,stomachache|emesis
NEW21855,CHEMICAL,FTG,FTG
NEW21856,CHEMICAL,new disulfide bridge,new disulfide bridge
NEW21857,CHEBI,drug selection,drug selection
NEW21858,DISEASE,epileptic patient,epileptic patient
NEW21859,CHEMICAL,cd distribution,Cd distribution
NEW21860,NUTRITION,blueberry anthocyanin,blueberry anthocyanin
NEW21861,CHEMICAL,cd reduction,Cd reductions
NEW21862,DISEASE,rice leave,rice leaves
NEW21863,NUTRITION,blueberry anthocyanin,Blueberry anthocyanin
NEW21864,CHEMICAL,h2o2 accumulation,H2O2 accumulation
NEW21865,CHEMICAL,mg/kg cd stress,mg/kg Cd stress
NEW21866,CHEMICAL,cd oxidative damage,Cd oxidative damage
NEW21867,NUTRITION,g/l blueberry anthocyanin,g/L blueberry anthocyanin
NEW21868,MENTAL_HEALTH,foliar resistance control agent,foliar resistance control agent
NEW21869,CHEMICAL,cd accumulation,Cd accumulation
NEW21870,CHEMICAL,cd toxicity,Cd toxicity
http://cbmi.med.harvard.edu/asdphenotype#Class_297,DISEASE,compulsive behavior,impulsive-compulsive behaviours
NEW21871,DISEASE,severe psychiatric disorder,severe psychiatric disorder
NEW21872,CHEMICAL,congener norfluoxetine,congener norfluoxetine
NEW21873,CHEMICAL,gaba mimetic drug,GABA mimetic drugs
NEW21874,CHEMICAL,allo biosynthesis,ALLO biosynthesis
NEW21875,DISEASE,severe graft-versus-host disease,severe graft-versus-host disease
NEW21876,MENTAL_HEALTH,kinase hsv-tk suicide gene,kinase HSV-tk suicide gene
NEW21877,CHEMICAL,herpes simplex virus thymidine kinase,herpes simplex virus thymidine kinase
NEW21878,CHEBI,drug amitriptyline,drug amitriptyline
NEW21879,DISEASE,trail‑resistant a549 lung cancer cell,TRAIL‑resistant A549 lung cancer cells
NEW21880,CHEMICAL,ketamine self-administration,ketamine self-administration
NEW21881,DISEASE,subsequent alcohol-drinking behavior,subsequent alcohol-drinking behaviors
NEW21882,DISEASE,subclinical hyperthyroidism,Subclinical hyperthyroidism
NEW21883,DISEASE,abnormal low tsh level,abnormal low TSH level
NEW21884,CHEBI,effective 5-ht(1b/1d agonist,effective 5-HT(1B/1D agonists
NEW21885,DISEASE,neurogenic dural vasodilation,neurogenic dural vasodilation
NEW21886,MENTAL_HEALTH,PLS regression,PLS regression
NEW21887,CHEMICAL,l pigment,L pigments
NEW21888,NUTRITION,colored anthocyanin,colored anthocyanins
NEW21889,CHEMICAL,gl wine treatment,GL wine treatments
NEW21890,CHEMICAL,gold-fleshed kiwifruit,gold-fleshed kiwifruit
NEW21891,CHEMICAL,glycine/valine,glycine/valine
NEW21892,DISEASE,chronic severe malnutrition,chronic severe malnutrition
NEW21893,CHEBI,progestogen activity,progestogen activity
NEW21894,DISEASE,hypertension disease,hypertension disease
NEW21895,CHEMICAL,low dose thyroxine,low dose thyroxine
NEW21896,DISEASE,respiratory defect,respiratory defects
NEW21897,CHEMICAL,sv-chd,SV-CHD
NEW21898,CHEMICAL,self-administered ici,self-administered ICI
NEW21899,MENTAL_HEALTH,recurrent priapism,recurrent priapism|stuttering
NEW21900,DISEASE,sickle-cell priapism,sickle-cell priapism
NEW21901,CHEMICAL,adenylic nucleotide atp,adenylic nucleotides ATP
NEW21902,MENTAL_HEALTH,experimental stress anxiety derivative,experimental stress anxiety derivatives
NEW21903,CHEMICAL,injectable contraceptive medroxyprogesterone acetate,injectable contraceptive medroxyprogesterone acetate|MPA
NEW21904,CHEMICAL,injectable contraceptive norethisterone enanthate,injectable contraceptive norethisterone enanthate|NET-EN
NEW21905,DISEASE,autistic-like behaviour,autistic-like behaviour
NEW21906,DISEASE,variable behavioural impairment,variable behavioural impairments
NEW21907,DISEASE,subcortical neural mechanism,subcortical neural mechanisms
NEW21908,CHEMICAL,levamisole level,levamisole levels
NEW21909,DISEASE,cocaine-induced leukoencephalopathy,cocaine-induced leukoencephalopathy
NEW21910,CHEMICAL,use dexmedetomidine,use dexmedetomidine
NEW21911,DISEASE,neuroanesthesia,neuroanesthesia
NEW21912,CHEMICAL,ndn-mutated mouse,Ndn-mutated mice
NEW21913,DISEASE,neuronal abnormality,neuronal abnormalities
http://purl.obolibrary.org/obo/CHEBI_178059,CHEMICAL,myristic acid-13c3,"(1,2,3-13C3)tetradecanoic acid|L-acetylcarnitine|LAC"
NEW21914,CHEMICAL,lac preferential effect,LAC preferential effect
NEW21915,DISEASE,hyperactive behaviour,hyperactive behaviour
NEW21916,CHEMICAL,long-acting mph,long-acting MPH
NEW21917,CHEBI,acute sympathomimetic toxicity,acute sympathomimetic toxicity
NEW21918,DISEASE,huge overdose,huge overdose
NEW21919,NUTRITION,xp-endo finisher instrument,XP-Endo Finisher instruments
NEW21920,MENTAL_HEALTH,high cyclic fatigue resistance,higher cyclic fatigue resistance
http://purl.obolibrary.org/obo/HP_0100035,DISEASE,phonic tics,coprolalia
NEW21921,DISEASE,motor phonic tic,motor phonic tics
NEW21922,DISEASE,significant structural disorder,significant structural disorder
NEW21923,CHEMICAL,carbon skeleton,carbon skeleton
NEW21924,CHEBI,selective d4 agonist,selective D4 agonists
http://purl.obolibrary.org/obo/CHEBI_50370,CHEMICAL,parasympatholytic,erectogenic|parasympatholytics
NEW21925,CHEMICAL,intravenous tramadol,intravenous tramadol
NEW21926,DISEASE,migraine pain,migraine pain
NEW21927,MENTAL_HEALTH,specific resistance,specific resistance
NEW21928,CHEMICAL,solid content,solids content
NEW21929,NUTRITION,water reduction,water reduction
NEW21930,CHEMICAL,fluoroethylnormemtantine,FENM|fluoroethylnormemtantine
NEW21931,DISEASE,eating-disordered patient,eating-disordered patients
NEW21932,MENTAL_HEALTH,increase analgesia,Increased analgesia
NEW21933,MENTAL_HEALTH,electroacupuncture-induced analgesia,electroacupuncture-induced analgesia
NEW21934,CHEBI,electroacupuncture ampa/ka receptor antagonist,electroacupuncture AMPA/KA receptor antagonists
NEW21935,CHEMICAL,low-dose testosterone,Low-dose testosterone
NEW21936,CHEMICAL,adjunctive low-dose transdermal testosterone,adjunctive low-dose transdermal testosterone
NEW21937,MENTAL_HEALTH,antidepressant-resistant major depression,antidepressant-resistant major depression
NEW21938,CHEMICAL,lpa receptor-null mouse,LPA receptor-null mice
http://purl.obolibrary.org/obo/SYMP_0000051,DISEASE,hydrocephalus,Posthemorrhagic hydrocephalus|PHH
NEW21939,DISEASE,officinalis tr,officinalis TR
NEW21940,CHEMICAL,co-substrate,co-substrate
NEW21941,NUTRITION,Bear suppression,Bear Suppression
NEW21942,DISEASE,obsessional thinking,obsessional thinking
NEW21943,DISEASE,prolonged hyperammonemia,prolonged hyperammonemia
NEW21944,CHEMICAL,ammonia ion,ammonia ion
http://purl.obolibrary.org/obo/CHEBI_65259,CHEMICAL,gaba antagonist,GABA antagonists|gamma-aminobutyric acid receptor antagonists|radiolabeled GABA receptor antagonist|gamma-aminobutyric acid receptor antagonist
http://purl.obolibrary.org/obo/CHEBI_67450,CHEMICAL,ananolignan m,"(5R,6S,7R,8R)-8-(isobutyryloxy)-1,2,3,13-tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-5-yl (2Z)-2-methylbut-2-enoate|M SCN-|TCV-309 M"
NEW21945,CHEMICAL,tris-citrate buffer,Tris-citrate buffer
NEW21946,CHEMICAL,Qisheng Wan formula,Qisheng Wan formula|QWF
NEW21947,CHEMICAL,Bajitianwan,BJTW|Bajitianwan
NEW21948,CHEMICAL,f.c.how,F.C.How
NEW21949,DISEASE,type dystonia,Type dystonia
NEW21950,DISEASE,atp1a3 gene,ATP1A3 gene
NEW21951,NUTRITION,acid supplementation,acids supplementation
NEW21952,CHEMICAL,low hodes level,lower HODEs levels
NEW21953,CHEMICAL,wild-type nlg-1,wild-type NLG-1
NEW21954,MENTAL_HEALTH,organic impotence,organic impotence
NEW21955,CHEMICAL,mg./ml,mg./ml
NEW21956,DISEASE,drug-induced erection,drug-induced erections
NEW21957,CHEMICAL,halobenzoquinone,Halobenzoquinones
NEW21958,CHEMICAL,δg efficiency,ΔG efficiency
NEW21959,CHEBI,beta ra,beta RA
NEW21960,DISEASE,systolic dysfunction,systolic dysfunction
NEW21961,CHEMICAL,absent alphara,absent alphaRA
NEW21962,CHEBI,sympatholytic antihypertensive,Sympatholytic antihypertensives
NEW21963,DISEASE,importence,importence
NEW21964,CHEMICAL,continuous glucose monitoring,continuous glucose monitoring
NEW21965,DISEASE,nocturnal hypoglycemia,nocturnal hypoglycemia
NEW21966,DISEASE,cholinergic mesopontine neuron,cholinergic mesopontine neurons
NEW21967,DISEASE,secondary gain,secondary gain
NEW21968,DISEASE,psychogenic illness,psychogenic illness
NEW21969,CHEBI,endothelin-a eta receptor antagonist,endothelin-A ETA receptor antagonists
NEW21970,CHEMICAL,to serotonin reuptake inhibitor,to serotonin reuptake inhibitors|SRIs
NEW21971,DISEASE,resistant ocd,resistant OCD
NEW21972,CHEMICAL,duloxetine group,duloxetine group
NEW21973,CHEMICAL,doxazosin group,doxazosin group
NEW21974,MENTAL_HEALTH,headache severity,headache severity
NEW21975,DISEASE,septal deviation,SD|septal deviation
NEW21976,CHEBI,use disinfectant,used disinfectants
NEW21977,MENTAL_HEALTH,unusual resistance,unusual resistance
NEW21978,CHEMICAL,da d2 receptor antagonist raclopride,DA D2 receptor antagonist raclopride
NEW21979,MENTAL_HEALTH,81297-induced acute oral dyskinesia,81297-induced acute oral dyskinesia
NEW21980,CHEMICAL,skf 81297-induced grooming,SKF 81297-induced grooming
NEW21981,DISEASE,ventral gland,ventral glands
NEW21982,CHEMICAL,ca2 current,Ca2 current
NEW21983,CHEMICAL,strong cd2 inhibition,strong Cd2 inhibition
http://purl.obolibrary.org/obo/CHEBI_27432,CHEMICAL,alpha-linolenic acid,"all-cis-9,12,15-octadecatrienoic acid|9,12,15-Octadecatrienoic acid|(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid|(Z,Z,Z)-9,12,15-octadecatrienoic acid|ALPHA-LINOLENIC ACID|alpha-Linolenic acid|alpha-linolenic acid|linolenic acid|cis,cis,cis-9,12,15-octadecatrienoic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|(9,12,15)-linolenic acid|cis-Delta(9,12,15)-octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|ALA|Alpha-linoleic acid"
NEW21984,CHEMICAL,gaba level,GABA level
NEW21985,DISEASE,ptsd group,PTSD group
NEW21986,CHEMICAL,naloxone stigma,naloxone stigma
NEW21987,CHEMICAL,naloxone distribution program,naloxone distribution programs
NEW21988,DISEASE,oud stigma,OUD stigma
NEW21989,CHEMICAL,systemic modafinil treatment,Systemic modafinil treatment
NEW21990,DISEASE,morphine-induced attention dysfunction,morphine-induced attention dysfunction
NEW21991,CHEMICAL,second-line augmentation,second-line augmentation
NEW21992,CHEMICAL,active tens,Active TENS
NEW21993,DISEASE,movement-evoked pain,movement-evoked pain
NEW21994,CHEMICAL,Navafenterol,Navafenterol
NEW21995,DISEASE,obstructive airway disease,obstructive airways diseases
NEW21996,CHEBI,inhale long-acting dual-pharmacology muscarinic antagonist/β2-adrenoceptor agonist,inhaled long-acting dual-pharmacology muscarinic antagonist/β2-adrenoceptor agonist
NEW21997,DISEASE,osas patient-derived mdsc,OSAS patient-derived MDSC
NEW21998,CHEMICAL,(53.7±3.2)%,(53.7±3.2)%
NEW21999,CHEMICAL,(23.2±1.1)%,(23.2±1.1)%
NEW22000,CHEMICAL,276±4,276±4
NEW22001,CHEMICAL,healthy people-derived mdsc,healthy people-derived MDSC
NEW22002,CHEMICAL,(75.6±7.9)%,(75.6±7.9)%
NEW22003,CHEMICAL,taurine glutamine level,Taurine glutamine levels
NEW22004,CHEMICAL,mirtazapine treatment,mirtazapine treatment
NEW22005,DISEASE,injury due pellet,injuries due pellets
NEW22006,NUTRITION,smooth bore weapon,smooth bore weapon
http://purl.obolibrary.org/obo/CHEBI_36043,CHEBI,antimicrobial drug,antimicrobial drugs
NEW22007,MENTAL_HEALTH,resistance rate,resistance rate
NEW22008,MENTAL_HEALTH,bacterial drug resistance,bacterial drug resistance
NEW22009,DISEASE,secondary pulmonary bacterial infection,Secondary pulmonary bacterial infection
NEW22010,CHEMICAL,covid-19 complication,COVID-19 complication
NEW22011,MENTAL_HEALTH,dissociation enthalpy,dissociation enthalpies
NEW22012,CHEMICAL,technical lignin,technical lignins
NEW22013,CHEMICAL,characteristic lignin subunit,characteristic lignin subunits
NEW22014,CHEMICAL,imidazolium functionalized bipyridine ligand,imidazolium functionalized bipyridine ligands
NEW22015,CHEMICAL,rhenium carbonyl complex,rhenium carbonyl complexes
http://purl.obolibrary.org/obo/CHEBI_16322,CHEMICAL,"myo-inositol 1,3,4,5,6-pentakisphosphate","1D-myo-Inositol 1,3,4,5,6-pentakisphosphate|myo-inositol 1,3,4,5,6-pentakis(dihydrogen phosphate)|inositols myo-inositol|Inositol 1,3,4,5,6-pentakisphosphate|D-myo-Inositol 1,3,4,5,6-pentakisphosphate"
NEW22016,DISEASE,pcos insulin resistance,PCOS insulin resistance
NEW22017,CHEBI,prophylactic vitamin c administration,prophylactic vitamin C administration
NEW22018,CHEBI,vitamin c administration,vitamin C administration
NEW22019,CHEMICAL,sustained antidepressant effect,sustained antidepressant effect
NEW22020,DISEASE,strict lifelong gfd,strict lifelong GFD
NEW22021,DISEASE,micronutrient deficiency,micronutrient deficiencies
NEW22022,DISEASE,paraphiliac disorder,paraphiliac disorders
NEW22023,DISEASE,obsessive compulsive spectrum,obsessive compulsive spectrum
NEW22024,DISEASE,poststroke statin,poststroke statin
NEW22025,DISEASE,depressive change,depressive change
NEW22026,CHEMICAL,several nq,Several NQs
NEW22027,DISEASE,human african trypanosomiasis,human African trypanosomiasis
NEW22028,CHEMICAL,intravenous corticoid,intravenous corticoids
NEW22029,DISEASE,underlie autoimmune encephalopathy,underlying autoimmune encephalopathy
NEW22030,DISEASE,newborn withdrawal syndrome,newborn withdrawal syndrome
http://purl.obolibrary.org/obo/CHEBI_61697,NUTRITION,fatty acid derivative,FA derivatives|FA derivative|fatty acid derivatives|new fatty acid derivatives
NEW22031,NUTRITION,low cholesterol,lower cholesterol
NEW22032,DISEASE,high impulsivity,higher impulsivity
NEW22033,CHEMICAL,indole g,indole g
NEW22034,CHEBI,fxr agonist potency,FXR agonist potency
NEW22035,MENTAL_HEALTH,optimal orientation,optimal orientation
NEW22036,CHEBI,antiandrogenic progestogen,antiandrogenic progestogens
NEW22037,MENTAL_HEALTH,vigilance mood disorder,vigilance mood disorders
NEW22038,CHEMICAL,serotonin neural pathway,serotonin neural pathways
NEW22039,DISEASE,obesity treatment,Obesity treatment
NEW22040,CHEMICAL,novel RSC11 k locus gene,novel RSC11 K locus genes
NEW22041,MENTAL_HEALTH,smv resistance germplasm,SMV resistance germplasm
NEW22042,CHEMICAL,l-dopa/benserazide,L-DOPA/benserazide
NEW22043,MENTAL_HEALTH,reserpine-induced akinesia,reserpine-induced akinesia
NEW22044,CHEMICAL,nsd1015,NSD1015
NEW22045,CHEBI,narcotic dissolution,narcotic dissolution
NEW22046,CHEMICAL,brain dopamine function,brain dopamine function
NEW22047,CHEMICAL,4-methyl histamine,4-methyl histamine
NEW22048,CHEMICAL,2-methyl histamine,2-methyl histamine
NEW22049,CHEMICAL,ranitidine less,ranitidine less
NEW22050,DISEASE,ams domain scale score,AMS domain scale scores
NEW22051,CHEMICAL,ayurvedic syrup shankhapushpi,Ayurvedic syrup shankhapushpi
NEW22052,DISEASE,hypertension xaio chai hu tang,hypertension xaio chai hu tang
NEW22053,MENTAL_HEALTH,pyrabactin resistance,pyrabactin resistance
NEW22054,CHEMICAL,3'-alkyl aba,3'-alkyl ABAs
NEW22055,CHEMICAL,soy isoflavone,Soy isoflavones
NEW22056,DISEASE,postmenopausal syndrome,postmenopausal syndrome
NEW22057,CHEMICAL,soy isoflavone extract,soy isoflavone extract
NEW22058,DISEASE,uvb-induced damage,UVB-induced damage
NEW22059,NUTRITION,soybean cake,soybean cake
NEW22060,DISEASE,primary structural brain disease,primary structural brain disease
NEW22061,DISEASE,global cerebral dysfunction,global cerebral dysfunction
NEW22062,DISEASE,high ptsd prevalence,higher PTSD prevalence
NEW22063,DISEASE,ptsd prevalence,PTSD prevalence
NEW22064,CHEBI,female c allele carrier,female C allele carriers
NEW22065,CHEMICAL,cc homozygote,CC homozygotes
NEW22066,CHEBI,female t allele carrier,female T allele carriers
NEW22067,CHEMICAL,female cc homozygote,female CC homozygotes
NEW22068,DISEASE,high tg,higher TG
NEW22069,NUTRITION,insect cuticle,Insect cuticle
NEW22070,MENTAL_HEALTH,adaptability resistance,adaptability resistance
NEW22071,CHEMICAL,bt product,Bt products
NEW22072,DISEASE,polyuria dysfunction,polyuria dysfunction
NEW22073,MENTAL_HEALTH,pediatric enuresis,pediatric enuresis
NEW22074,DISEASE,physical disturbance,physical disturbance
NEW22075,DISEASE,Rosaceae allergy,Rosaceae allergy
NEW22076,DISEASE,syndrome allergy,syndrome allergies
NEW22077,DISEASE,histamine intolerance,Histamine Intolerance|HIT
NEW22078,MENTAL_HEALTH,misdirect bacterial host defense mechanism,misdirected bacterial host defense mechanism
NEW22079,DISEASE,induce thrombocytopenia,induced thrombocytopenia
NEW22080,DISEASE,tooth trait,tooth traits
NEW22081,MENTAL_HEALTH,dissociative identity disorder patient,dissociative identity disorder patients
NEW22082,MENTAL_HEALTH,suicide behavior,suicide behavior
NEW22083,CHEBI,fetal hormone system,fetal hormone systems
NEW22084,DISEASE,acute poisoning,acute poisonings
NEW22085,CHEBI,pharmaceutical market,pharmaceutical market
http://purl.obolibrary.org/obo/CHEBI_4460,CHEMICAL,devazepide,"devazepidum|N-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide|sulpride|devazepide|MK-329|L 364718|devazepida|(S)-N-(2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)indole-2-carboxamide|3(S)-(-)-1,3-Dihydro-3-(2-indolecarbonylamino)-1-methyl-5-phenyl-2H-(1,4)benzodiazepin-2-one"
NEW22086,CHEMICAL,tolterodine ir,tolterodine IR
NEW22087,DISEASE,allergy symptom,allergy symptoms
NEW22088,NUTRITION,tree pollen,tree pollen
NEW22089,CHEBI,water-soluble vitamin intake,water-soluble vitamin intake
NEW22090,DISEASE,life failure,life failure
NEW22091,DISEASE,apoptotic neuronal death,apoptotic neuronal death
NEW22092,CHEMICAL,glutamate exposure,glutamate exposure
NEW22093,CHEBI,apolipoprotein-e ε4 allele carrier,Apolipoprotein-E ε4 allele carriers
NEW22094,DISEASE,example atherosclerosis,example atherosclerosis
NEW22095,DISEASE,sylvian fissure,Sylvian fissure
NEW22096,CHEMICAL,ica bifurcation,ICA bifurcation
NEW22097,MENTAL_HEALTH,depression group,depression groups
NEW22098,CHEBI,hla antigen association,HLA antigen associations
NEW22099,MENTAL_HEALTH,geriatric depression,geriatric depression
NEW22100,DISEASE,certain depressive subtype,certain depressive subtypes
NEW22101,CHEMICAL,various antidepressant agent,various antidepressant agents
NEW22102,NUTRITION,wheat variety,wheat variety
NEW22103,MENTAL_HEALTH,leaf rust resistance,leaf rust resistance
NEW22104,MENTAL_HEALTH,leaf rust resistance gene,leaf rust resistance gene
NEW22105,NUTRITION,durum wheat genotype,durum wheat genotype
NEW22106,MENTAL_HEALTH,durable resistance cultivar,durable resistance cultivars
NEW22107,NUTRITION,wheat breeding,wheat breeding
NEW22108,CHEMICAL,conserve lysine,conserved lysine
http://purl.obolibrary.org/obo/MFOMD_0000129,MENTAL_HEALTH,fixation,CoR. Fixation
NEW22109,DISEASE,b. subtilis strain,B. subtilis strain
NEW22110,CHEMICAL,iolg,IolG
NEW22111,CHEBI,mixture analysis,Mixture analysis
NEW22112,MENTAL_HEALTH,Health Anxiety Group,Health Anxiety Group
NEW22113,DISEASE,infection Obsessions Group,Infection Obsessions Group
NEW22114,CHEMICAL,csf 5-hydroxyindoleacetic acid 5-hiaa measurement,CSF 5-hydroxyindoleacetic acid 5-HIAA measurements
NEW22115,DISEASE,habitually violent antisocial male alcoholic offender,habitually violent antisocial male alcoholic offenders
NEW22116,DISEASE,peripheral vascular impairment,peripheral vascular impairment
NEW22117,CHEMICAL,sideropaenia,sideropaenia
NEW22118,DISEASE,arthritic deformity,arthritic deformities
NEW22119,DISEASE,distal joint,distal joints
NEW22120,CHEMICAL,altered dopamine concentration,altered dopamine concentrations
NEW22121,CHEMICAL,solid lipid nanoparticle,solid lipid nanoparticles|SLN
NEW22122,CHEBI,promising carrier,promising carrier
NEW22123,CHEMICAL,serotonin noradrenaline reuptake inhibitor,serotonin noradrenaline reuptake inhibitor
NEW22124,DISEASE,mdd relief,MDD relief
NEW22125,CHEMICAL,antidepressant venlafaxine,antidepressant venlafaxine
NEW22126,CHEMICAL,neurotransmitter glutamate,neurotransmitter glutamate
NEW22127,MENTAL_HEALTH,opioid resistance due,opioid resistance due
NEW22128,CHEMICAL,kp modulation,KP modulation
NEW22129,CHEMICAL,overactive presynaptic dopamine system,overactive presynaptic dopamine systems
NEW22130,DISEASE,similar age-dependent injury,similar age-dependent injury
NEW22131,CHEBI,know nephrotoxin,known nephrotoxin
http://purl.obolibrary.org/obo/CHEBI_10554,CHEMICAL,epinine,Epinine|Deoxyepinephrine|catecholamine norepinephrine
NEW22132,MENTAL_HEALTH,disorder syndrome related,disorder syndrome related
NEW22133,CHEMICAL,fenugreek Trigonella foenum-graecum seed,fenugreek Trigonella foenum-graecum seeds
NEW22134,CHEBI,in antimicrobial activity,in antimicrobial activities
NEW22135,DISEASE,a. hydrophila,A. hydrophila
http://cbmi.med.harvard.edu/asdphenotype#Class_163,DISEASE,primary diagnosis,primary DSM-III-R diagnosis
NEW22136,CHEMICAL,serotonin uptake inhibitor fluoxetine,serotonin uptake inhibitor fluoxetine
NEW22137,CHEMICAL,formicamycin biosynthetic gene cluster,formicamycin biosynthetic gene cluster
NEW22138,CHEMICAL,biosynthetic precursor fasamycin,biosynthetic precursors fasamycins
NEW22139,CHEMICAL,formicamycin,formicamycins
NEW22140,CHEBI,type polyketide antibiotic,type polyketide antibiotics
NEW22141,MENTAL_HEALTH,deficiency-induced female depression,deficiency-induced female depression
NEW22142,CHEMICAL,5-hydroxytriptamine deficiency,5-hydroxytriptamine deficiency
NEW22143,DISEASE,concomitant memory impairment,concomitant memory impairment
NEW22144,DISEASE,spine loss,spine loss
NEW22145,DISEASE,inflammation-related brain disorder,inflammation-related brain disorders
NEW22146,CHEMICAL,chimeric antigen receptor car t cell therapy,Chimeric antigen receptor CAR T cell therapy
NEW22147,DISEASE,relapsed hematologic malignancy,relapsed hematologic malignancies
NEW22148,CHEMICAL,adenosine adenosine uptake blocker,Adenosine adenosine uptake blockers
NEW22149,DISEASE,amygdala-kindled seizure,amygdala-kindled seizures
NEW22150,CHEMICAL,chronic ptz treatment,Chronic PTZ treatment
NEW22151,DISEASE,anxio-depressive symptom,anxio-depressive symptoms
NEW22152,CHEBI,nutraceutical supplementation,Nutraceutical supplementation
NEW22153,DISEASE,depressive clinical manifestation,depressive clinical manifestations
NEW22154,CHEMICAL,long-term mph treatment,long-term MPH treatment
NEW22155,NUTRITION,anticipatory alpha oscillation,anticipatory alpha oscillations
NEW22156,CHEBI,inadequate estrogen stimulation,inadequate estrogen stimulation
NEW22157,CHEMICAL,bazibushen formula,BaZiBuShen formula
NEW22158,MENTAL_HEALTH,impotence infertility,impotence infertility
NEW22159,CHEBI,kidney-tonifying drug,kidney-tonifying drug
NEW22160,CHEMICAL,serum malondialdehyde level,serum malondialdehyde levels
NEW22161,DISEASE,diabetic model group,diabetic model group
NEW22162,CHEMICAL,extracellular adenosine signaling,extracellular adenosine signaling
NEW22163,CHEMICAL,equilibrative nucleoside transporter,equilibrative nucleoside transporters
NEW22164,CHEMICAL,pharmacologic ent inhibitor dipyridamole,pharmacologic ENT inhibitor dipyridamole
NEW22165,DISEASE,liver ischemia,liver ischemia
NEW22166,CHEMICAL,hepatic adenosine level,hepatic adenosine levels
NEW22167,CHEMICAL,high acid epa supplement,high acid EPA supplements
NEW22168,NUTRITION,onion stalk,Onion Stalk
NEW22169,DISEASE,febrile disease,febrile disease
NEW22170,DISEASE,consumptive disease,consumptive disease
NEW22171,DISEASE,thoracic obstruction,thoracic obstruction
NEW22172,DISEASE,bellyache due spleen qi deficiency,bellyache due spleen Qi deficiency
NEW22173,CHEBI,yin-yang toxin syndrome,Yin-Yang toxin syndrome
NEW22174,CHEMICAL,altered glutamate neurotransmission,altered glutamate neurotransmission
NEW22175,DISEASE,monoamine deficiency hypothesis,monoamine deficiency hypothesis
NEW22176,NUTRITION,plasma omega-6:omega-3 fatty acid ratio,plasma omega-6:omega-3 fatty acid ratio
NEW22177,CHEMICAL,antidepressant non-responder,antidepressant non-responders
NEW22178,CHEMICAL,serotonin level,serotonin level
NEW22179,CHEMICAL,acaricide resistance,Acaricide resistance
NEW22180,CHEBI,antibiotic residue,antibiotic residues
NEW22181,CHEMICAL,excessive caffeine consumption,Excessive caffeine consumption
NEW22182,CHEBI,selective pparδ agonist,selective PPARδ agonist
NEW22183,DISEASE,aortic inflammation,aortic inflammation
NEW22184,CHEBI,peroxisome-proliferator activate receptor agonist,Peroxisome-proliferator activated receptor agonists
NEW22185,DISEASE,ethanol-induced steatohepatitis,ethanol-induced steatohepatitis
NEW22186,CHEMICAL,objectively-measured plasma tfa concentration,objectively-measured plasma TFA concentrations
NEW22187,NUTRITION,mature bombyx mori silkworm,mature Bombyx mori silkworm
NEW22188,MENTAL_HEALTH,scopolamine (sco)-induced amnesia,scopolamine (Sco)-induced amnesia
http://purl.obolibrary.org/obo/BFO_0000034,CHEMICAL,function,PtrMYB120 function
NEW22189,NUTRITION,anthocyanin biosynthetic gene,anthocyanin biosynthetic genes
NEW22190,CHEMICAL,anthocyanin lignin content,anthocyanin lignin content
NEW22191,CHEMICAL,ppwrky46,PpWRKY46
NEW22192,CHEBI,antimalarial medication,antimalarial medications
NEW22193,MENTAL_HEALTH,local infiltration analgesia,local infiltration analgesia
NEW22194,DISEASE,associate hyperpyrexia,associated hyperpyrexia
NEW22195,CHEMICAL,individual naa,individual NAA
NEW22196,CHEMICAL,acid brain uptake,acids brain uptake
NEW22197,CHEMICAL,serum glutathione level,serum glutathione levels
NEW22198,CHEMICAL,hg level,Hg levels
NEW22199,CHEMICAL,gd phenotype,GD phenotype
NEW22200,DISEASE,dlb abnormality,DLB abnormalities
NEW22201,DISEASE,marked olfactory loss,marked olfactory loss
NEW22202,MENTAL_HEALTH,resistance level,resistance level
NEW22203,CHEMICAL,enr concentration,ENR concentration
NEW22204,CHEBI,antimicrobial residue,antimicrobial residues
NEW22205,DISEASE,bone marrow depression,bone marrow depression
http://purl.obolibrary.org/obo/DOID_1556,DISEASE,arthus reaction,Arthus reaction|hypersensitivity reaction|Arthus phenomenon|Arthus Phenomenon|Arthus type urticaria
NEW22206,DISEASE,thyroid hemorrhage,thyroid hemorrhage
NEW22207,CHEMICAL,co-trimoxazole toxicity,co-trimoxazole toxicity
NEW22208,CHEMICAL,nsaid ketoprofen,NSAID ketoprofen|KETO
NEW22209,MENTAL_HEALTH,hand depression,hand depression
NEW22210,CHEMICAL,pge2 synthesis,PGE2 synthesis
NEW22211,DISEASE,noxious electrical shock,Noxious electrical shock
NEW22212,CHEMICAL,30.1+/-5.4,30.1+/-5.4
NEW22213,DISEASE,addition migraine,addition migraine
NEW22214,MENTAL_HEALTH,ultra-treatment resistant schizophrenia,ultra-treatment resistant schizophrenia
NEW22215,CHEMICAL,dopamine receptor supersensitivity,dopamine receptor supersensitivity
NEW22216,CHEBI,endogenous estrogen,endogenous estrogens
NEW22217,CHEMICAL,amphetamine sensitization,amphetamine sensitization
NEW22218,DISEASE,manic- behavior,manic- behaviors
NEW22219,NUTRITION,vitamin folate,vitamins folate
NEW22220,CHEMICAL,s1p inhibitor,S1P inhibitor
http://purl.org/sig/ont/fma/fma50583,DISEASE,posterior cerebral artery,posterior cerebral artery injury
NEW22221,NUTRITION,rosmarinus officinalis L.,Rosmarinus officinalis L.
NEW22222,DISEASE,cardiovascular disease due,cardiovascular disease due
NEW22223,DISEASE,successful intraoperative ovarian venous sampling,Successful intraoperative ovarian venous sampling
NEW22224,CHEMICAL,elevated testosterone level,elevated testosterone levels
http://purl.org/sig/ont/fma/fma14342,DISEASE,right ovarian vein,right ovarian vein
NEW22225,CHEMICAL,strychnine seizure,strychnine seizures
NEW22226,CHEMICAL,hexobarbitone sleep time,hexobarbitone sleep time
NEW22227,MENTAL_HEALTH,cns depression,CNS depression
NEW22228,CHEMICAL,secretory luminal membrane,secretory luminal membrane
NEW22229,MENTAL_HEALTH,open circuit potential difference,open circuit potential difference|OCPD
NEW22230,CHEMICAL,erinaceus polysaccharide,erinaceus polysaccharides
NEW22231,DISEASE,anti-gastric ulcer,anti-gastric ulcer
NEW22232,DISEASE,anti-hyperlipidemia,anti-hyperlipidemia
http://purl.obolibrary.org/obo/CHEBI_73336,DISEASE,vulnerary,anti-hyperglycemia|wound-healing agents|wound-healing drugs|wound-healing agent|vulneraries|wound-healing drug
NEW22233,CHEBI,serotonin 1a 5-ht1a receptor agonist,serotonin 1A 5-HT1A receptor agonists
NEW22234,DISEASE,nmda receptor agonist dcs,NMDA receptor agonist DCS
NEW22235,CHEBI,5-ht1a receptor agonist,5-HT1A receptor agonist
NEW22236,CHEBI,a2ar antagonist istradefylline,A2AR antagonist istradefylline
NEW22237,MENTAL_HEALTH,bipolar type bp major depressive episode,bipolar type BP major depressive episode
NEW22238,DISEASE,manic switch rate,manic switch rate
NEW22239,CHEMICAL,dopamine synapse activity,dopamine synapse activity
http://purl.obolibrary.org/obo/CHEBI_78206,NUTRITION,fatty acid ethyl ester,Fatty acid ethyl esters|a fatty acid ethyl ester
NEW22240,DISEASE,organ damage,organ damage
NEW22241,CHEMICAL,nonoxidative ethanol metabolite present,nonoxidative ethanol metabolites present
NEW22242,CHEBI,Food Drug Administration,Food Drug Administration
NEW22243,CHEMICAL,monoclonal antibody mab cetuximab,monoclonal antibody mAb cetuximab
NEW22244,DISEASE,multiple cancer cell,multiple cancer cells
NEW22245,DISEASE,Salicornia herbacea,Salicornia herbacea
NEW22246,CHEMICAL,400mm,400mM
NEW22247,CHEMICAL,increase chronic cortisol exposure,increased chronic cortisol exposure
NEW22248,CHEMICAL,pure cortisol exposure,pure cortisol exposure
NEW22249,CHEBI,anabolic growth hormone,anabolic growth hormone
NEW22250,DISEASE,neuromuscular nature,neuromuscular nature
NEW22251,MENTAL_HEALTH,final multivariate logistic regression analysis,final multivariate logistic regression analysis
http://purl.obolibrary.org/obo/CHEBI_35820,CHEBI,antiprotozoal drug,antiprotozoal agents|antiprotozoal agent|antiprotozoal drugs
NEW22252,DISEASE,liver injury degree,liver injury degree
NEW22253,CHEMICAL,cadmium stress,cadmium stress
NEW22254,NUTRITION,hybrid yellow catfish,hybrid yellow catfish
NEW22255,CHEMICAL,benzamide metoclopramide,benzamides metoclopramide
NEW22256,DISEASE,brachiocephalic trunk injury,brachiocephalic trunk injury
NEW22257,DISEASE,blunt trunk injury,blunt trunk injury
NEW22258,CHEMICAL,xylene oxide component,xylene oxide components
NEW22259,NUTRITION,cholesterol serum concentration,cholesterol serum concentrations
NEW22260,DISEASE,depressed subject,Depressed subjects
NEW22261,CHEMICAL,low esterify cholesterol ratio,lower esterified cholesterol ratio
NEW22262,MENTAL_HEALTH,increase peak pulmonary vascular resistance,increased peak pulmonary vascular resistance
NEW22263,CHEBI,thromboxane-receptor antagonist,thromboxane-receptor antagonist
NEW22264,CHEBI,platelet-activating factor-receptor antagonist,platelet-activating factor-receptor antagonist
NEW22265,CHEMICAL,serotonin/norepinephrine reuptake inhibitor,serotonin/norepinephrine reuptake inhibitors
NEW22266,CHEBI,prenatal androgen,prenatal androgens
NEW22267,MENTAL_HEALTH,anhedonia detailed deconstruction,anhedonia detailed deconstruction
NEW22268,CHEBI,stabilizer antipsychotic treatment,stabilizer antipsychotic treatment
NEW22269,CHEMICAL,nmda function,NMDA function
NEW22270,CHEMICAL,adenosine analog cordycepin,adenosine analog cordycepin
NEW22271,CHEMICAL,high-maltose synthetic medium,high-maltose synthetic medium
NEW22272,MENTAL_HEALTH,enhance resistance,enhanced resistance
NEW22273,CHEMICAL,% v/v ethanol lager beer,% v/v ethanol lager beer
NEW22274,CHEMICAL,ethanol content,ethanol content
NEW22275,CHEMICAL,alcoholic beer,alcoholic beer
NEW22276,MENTAL_HEALTH,low thermal resistance,lower thermal resistance
NEW22277,DISEASE,small intestinal bacterial overgrowth,small intestinal bacterial overgrowth|SIBO
NEW22278,CHEMICAL,lactulose hydrogen breath test,lactulose hydrogen breath test
NEW22279,MENTAL_HEALTH,dramatic tumor regression,dramatic tumor regression
NEW22280,DISEASE,late thrombotic event,late thrombotic events
NEW22281,CHEMICAL,amygdala GM volume,amygdala GM volume
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Speech_Anxiety,MENTAL_HEALTH,speech anxiety,speech anxiety
NEW22282,NUTRITION,invertase activity,invertase activity
NEW22283,NUTRITION,chicory intybus 1-feh iia,chicory intybus 1-FEH IIa
NEW22284,MENTAL_HEALTH,severe drug dependence,severe drug dependence
http://purl.obolibrary.org/obo/DOID_9975,CHEMICAL,cocaine dependence,methamphetamine dependence|METH dependence
NEW22285,MENTAL_HEALTH,cortical dementia syndrome,cortical dementia syndromes
NEW22286,DISEASE,delay qt prolongation,Delayed QT prolongation
NEW22287,CHEMICAL,potassium concentration,potassium concentration
NEW22288,CHEMICAL,fingerprint-efficacy relationship,fingerprint-efficacy relationship
NEW22289,CHEMICAL,antidepressant response,Antidepressant response
NEW22290,NUTRITION,blood mercury,blood mercury
NEW22291,MENTAL_HEALTH,depression risk,depression risk
NEW22292,DISEASE,neurological memory impairment,neurological memory impairment
NEW22293,CHEMICAL,time-based PM task,time-based PM tasks|TBPM
NEW22294,CHEBI,adjuvant sympatholytic,Adjuvant sympatholytics
NEW22295,DISEASE,hyperadrenergic symptom,hyperadrenergic symptoms
NEW22296,DISEASE,leishmania donovani promastigote,Leishmania donovani promastigotes
NEW22297,CHEBI,antileishmanial drug target,antileishmanial drug target
http://purl.obolibrary.org/obo/CHEBI_29515,CHEMICAL,ansamitocin p3,"ansamitocin P3|(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1(10,14).0(3,5)]hexacosa-10(26),11,13,16,18-pentaen-6-yl 2-methylpropanoate|2'-De(acetylmethylamino)-2'-methylmaytansine|C15003P3|Maytansinol isobutyrate|ansamitocin P-3|Antibiotic C15003P3"
NEW22298,CHEMICAL,steroid profile,Steroid profile
NEW22299,CHEMICAL,5'-terminal guanine,5'-terminal guanine
NEW22300,MENTAL_HEALTH,orientation similar,orientation similar
NEW22301,CHEMICAL,2'-terminal pyrimidine,2'-terminal pyrimidines
NEW22302,CHEMICAL,2'-terminal purine,2'-terminal purines
NEW22303,DISEASE,skv therapy,SKV therapy
http://purl.obolibrary.org/obo/CHEBI_83192,CHEMICAL,glycerophosphoinositol trisphosphate,inositol trisphosphate receptor
NEW22304,DISEASE,age-onset cognitive deficit,age-onset cognitive deficits
NEW22305,CHEMICAL,dietary n-3 pufa deficiency,dietary n-3 PUFA deficiency
NEW22306,CHEMICAL,altered membrane pufa content,altered membrane PUFA content
NEW22307,CHEBI,d2r antagonist,D2r antagonist
NEW22308,CHEMICAL,cannabinoid nabilone,cannabinoid nabilone
NEW22309,DISEASE,chemotherapy-induced emesis,chemotherapy-induced emesis
NEW22310,DISEASE,musculoskeletal disorder,musculoskeletal disorder
NEW22311,DISEASE,pain reliever,pain relievers
NEW22312,DISEASE,chronic intermittent hypoxia cih exposure,chronic intermittent hypoxia CIH exposure
NEW22313,DISEASE,hypoxia protocol,hypoxia protocol
NEW22314,DISEASE,hypomanic symptom,hypomanic symptoms
NEW22315,CHEMICAL,native loricariid common pleco,native loricariid common pleco|Hypostomus punctatus
NEW22316,DISEASE,p. maculicauda,P. maculicauda
NEW22317,CHEMICAL,α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor,α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor
NEW22318,CHEMICAL,rapamycin signaling,rapamycin signaling
NEW22319,CHEMICAL,fractional co2 laser,fractional CO2 laser
NEW22320,CHEMICAL,% terbinafine cream,% terbinafine cream
NEW22321,CHEMICAL,itraconazole pulse therapy,itraconazole pulse therapy
NEW22322,CHEMICAL,conclusion fractional co2 laser,Conclusion Fractional CO2 laser
NEW22323,CHEMICAL,levosimendan key pathology,levosimendan key pathology
NEW22324,DISEASE,acute heart failure,acute heart failure|AHF
NEW22325,CHEMICAL,α2δ-1-bound n-methyl-d-aspartate receptor,α2δ-1-bound N-methyl-D-aspartate receptors
NEW22326,MENTAL_HEALTH,presynaptic n-methyl-d-aspartate receptor hyperactivity,presynaptic N-methyl-D-aspartate receptor hyperactivity
NEW22327,CHEMICAL,oral antiplatelet,oral antiplatelets
NEW22328,CHEMICAL,serum sphingosine,serum sphingosine
NEW22329,CHEMICAL,serum selenium,serum selenium
NEW22330,DISEASE,alcohol/substance dependence,alcohol/substance dependence
NEW22331,DISEASE,ghb-deficiency-related dysphoric syndrome,GHB-deficiency-related dysphoric syndrome
NEW22332,CHEBI,fast beta power,fast beta power
NEW22333,MENTAL_HEALTH,subsequent regression analysis,subsequent regression analyses
NEW22334,DISEASE,chronic obesity,chronic obesity
NEW22335,CHEMICAL,circulate glycerolipid,circulating glycerolipids
NEW22336,CHEMICAL,thrombopoietin receptor agonist eltrombopag,thrombopoietin receptor agonist eltrombopag
NEW22337,CHEMICAL,varenicline/ethanol co-treatment,Varenicline/ethanol co-treatment
NEW22338,CHEBI,c. bolteae ps immunogen,C. bolteae PS immunogen
NEW22339,CHEMICAL,gpc+pc,GPC+PC
NEW22340,MENTAL_HEALTH,rapid cycling bipolar disorder,rapid cycling bipolar disorder
NEW22341,NUTRITION,altered membrane phospholipid metabolism,altered membrane phospholipid metabolism
NEW22342,CHEMICAL,intravenous m-cpp,intravenous m-CPP
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Panic_Attack,DISEASE,panic attack,anxiety panic attacks
NEW22343,CHEMICAL,oral prednisolone,oral prednisolone
NEW22344,DISEASE,ethanol-induced toxicity,ethanol-induced toxicity
NEW22345,CHEMICAL,purine metabolism transcript,purine metabolism transcripts
NEW22346,DISEASE,hypoxia condition,hypoxia conditions
NEW22347,CHEMICAL,serum uric acid level,serum uric acid level
NEW22348,CHEMICAL,purine metabolic disorder,purine metabolic disorder
NEW22349,MENTAL_HEALTH,disorder narcolepsy,disorder narcolepsy
NEW22350,CHEMICAL,hypocretin ligand-hypocretin receptor pathway,hypocretin ligand-hypocretin receptor pathway
NEW22351,CHEMICAL,∆9-tetrahydrocannabinol,∆9-tetrahydrocannabinol
NEW22352,CHEBI,antigen pertussis toxin,antigens pertussis toxin
NEW22353,DISEASE,suspect humoral immunodeficiency,suspected humoral immunodeficiencies
NEW22354,DISEASE,bacterial nematode,bacterial nematodes
http://purl.obolibrary.org/obo/CHEBI_132281,DISEASE,4-methyltridecane,resistance/tolerance|4-methyltridecane
NEW22355,DISEASE,old depressed patient,older depressed patients
NEW22356,CHEMICAL,serotonin transporter,Serotonin transporters
NEW22357,CHEMICAL,prostacyclin analogue drug,Prostacyclin analogue drugs
NEW22358,DISEASE,vascular remodelling,vascular remodelling
NEW22359,CHEMICAL,endogenous prostacyclin inhibition,endogenous prostacyclin inhibition
NEW22360,CHEBI,opioid receptor mor agonist,opioid receptor MOR agonists
NEW22361,MENTAL_HEALTH,maximal hyperactivity,Maximal hyperactivity
NEW22362,CHEMICAL,gtpɣs binding,GTPɣS binding
NEW22363,MENTAL_HEALTH,opioid-induced hyperactivity,opioid-induced hyperactivity
NEW22364,CHEBI,mor agonist effect,MOR agonist effects
NEW22365,MENTAL_HEALTH,agonist-induced hyperactivity,agonist-induced hyperactivity
NEW22366,CHEBI,mor agonist efficacy,MOR agonist efficacy
NEW22367,CHEMICAL,mosapride citrate tablet,mosapride citrate tablets
NEW22368,CHEBI,high drug safety,high drug safety
NEW22369,CHEMICAL,% conﬁdence interval,% conﬁdence intervals
NEW22370,CHEMICAL,drug halothane,drugs halothane
NEW22371,CHEMICAL,5-mg group,5-mg group
NEW22372,DISEASE,more dizziness,more dizziness
NEW22373,CHEMICAL,40-mg group,40-mg group
NEW22374,DISEASE,more nausea,more nausea
NEW22375,DISEASE,concomitant low grade fever suggestive,concomitant low grade fever suggestive
NEW22376,CHEMICAL,cefazolin g,cefazolin g
NEW22377,CHEMICAL,g q12h,g q12h
NEW22378,CHEMICAL,atypical dopamine-uptake inhibitor,Atypical dopamine-uptake inhibitors
NEW22379,DISEASE,cancer type,cancer types
NEW22380,CHEMICAL,sprinkle,sprinkle
NEW22381,DISEASE,gastrointestinal reflux disease,gastrointestinal reflux disease
NEW22382,CHEMICAL,acetoanaerobium sticklandii dsm,Acetoanaerobium sticklandii DSM
NEW22383,DISEASE,hyperammonia-producing anaerobe,hyperammonia-producing anaerobe
NEW22384,CHEMICAL,novel flat-panel photobioreactor,FPP|novel flat-panel photobioreactor
NEW22385,CHEMICAL,Jonkheer van Tets,Jonkheer van Tets
NEW22386,DISEASE,cold damage,cold damage
NEW22387,NUTRITION,red currant tomato,red currant tomato
NEW22388,MENTAL_HEALTH,dual resistance specificity,dual resistance specificity
NEW22389,CHEBI,adenosine a2b agonist adenosine a1 agonist,adenosine A2B agonist adenosine A1 agonist
NEW22390,DISEASE,colonic hyperpermeability,colonic hyperpermeability
NEW22391,CHEBI,specific antagonist,specific antagonist
NEW22392,DISEASE,intestinal hyperpermeability,intestinal hyperpermeability
NEW22393,CHEBI,selective antagonist,selective antagonists
NEW22394,DISEASE,stz-induced memory impairment,STZ-induced memory impairment
NEW22395,CHEMICAL,low-dose daily niacin supplementation,low-dose daily niacin supplementation
NEW22396,CHEBI,low-dose niacin,low-dose niacin
NEW22397,CHEMICAL,oral fucose,oral fucose
NEW22398,DISEASE,chronic skin infection,chronic skin infections
NEW22399,CHEMICAL,acidergic neurosteroid,acidergic neurosteroid
NEW22400,CHEMICAL,cerebral oxygen metabolism,cerebral oxygen metabolism
NEW22401,CHEMICAL,l fenfluramine,l fenfluramine|FEN
NEW22402,DISEASE,active metabolic transformation,active metabolic transformation
NEW22403,CHEMICAL,blood Sec,blood Sec
NEW22404,CHEMICAL,active se form,active Se forms
NEW22405,CHEMICAL,se metabolite,Se metabolites
NEW22406,DISEASE,liver semet ratio,liver SeMet ratios
NEW22407,CHEMICAL,modern antidepressant,modern antidepressants
NEW22408,CHEMICAL,scale id-pain,scales ID-pain
NEW22409,MENTAL_HEALTH,cox regression analysis,Cox regression analysis
NEW22410,CHEMICAL,HR=0.201,HR=0.201
NEW22411,CHEBI,drug driving,drug driving
NEW22412,CHEBI,yolk lecithin,yolk lecithin
NEW22413,DISEASE,biliary excretion disorder,biliary excretion disorders
NEW22414,MENTAL_HEALTH,subsequent insomnia symptom,subsequent insomnia symptoms
NEW22415,CHEBI,bacterial toxin cnf1,bacterial toxin CNF1
NEW22416,DISEASE,rtt mouse model,RTT mouse model
NEW22417,DISEASE,protein toxin cytotoxic necrotizing factor 1,protein toxin cytotoxic necrotizing factor 1|CNF1
NEW22418,CHEMICAL,cortex mitochondrial atp content,cortex mitochondrial ATP content
NEW22419,DISEASE,seizure phenotype,seizure phenotype
http://purl.obolibrary.org/obo/CHEBI_22901,CHEMICAL,bisphenol,bisphenols
NEW22420,DISEASE,adult diabete,adult diabetes
NEW22421,CHEMICAL,new generation antidepressant,newer generation antidepressants
NEW22422,CHEMICAL,well-recognized antidepressant drug,well-recognized antidepressant drugs
NEW22423,CHEBI,act μ-opioid receptor antagonist,acting μ-opioid receptor antagonists
NEW22424,MENTAL_HEALTH,central analgesia,central analgesia
NEW22425,CHEMICAL,catecholamine depletion,catecholamine depletion
NEW22426,CHEBI,drug category,drug category
NEW22427,DISEASE,ethanol-induced hepatic inflammation,ethanol-induced hepatic inflammation
NEW22428,CHEMICAL,gaba mimetic,GABA mimetics
NEW22429,DISEASE,iatrogenic dyskinesia,iatrogenic dyskinesias
NEW22430,DISEASE,established tumor,established tumors
NEW22431,DISEASE,increase tumor t cell infiltrate,increased tumor T cell infiltrates
NEW22432,CHEBI,vegf receptor inhibitor SUGEN,VEGF receptor inhibitor SUGEN
NEW22433,CHEMICAL,galantamine treatment,Galantamine treatment
NEW22434,CHEMICAL,brimonidine 0.2 % fixed combination,brimonidine 0.2 % fixed combination|BBFC
NEW22435,DISEASE,ocular allergic reaction,ocular allergic reactions
NEW22436,DISEASE,glaucoma patient,glaucoma patients
NEW22437,DISEASE,midline destructive lesion,midline destructive lesions
NEW22438,CHEBI,active antibiotic,active antibiotic
NEW22439,MENTAL_HEALTH,nitrogen fixation process,nitrogen fixation processes
NEW22440,CHEMICAL,enantiomer esketamine,enantiomer esketamine
NEW22441,CHEMICAL,depolarize dopamine response,depolarizing dopamine response
NEW22442,DISEASE,vertebrate neuronal somatic cell hybrid tcx11,vertebrate neuronal somatic cell hybrid TCX11
NEW22443,CHEBI,h3r antagonist pitolisant,H3R antagonist pitolisant
NEW22444,MENTAL_HEALTH,narcolepsy excessive daytime sleepiness,narcolepsy excessive daytime sleepiness
NEW22445,NUTRITION,choline present,choline present
NEW22446,DISEASE,ischemia-induced cell death,ischemia-induced cell death
NEW22447,CHEBI,different toxic substance,different toxic substances
NEW22448,DISEASE,acute health effect,acute health effects
NEW22449,DISEASE,perinatal hypothyroidism,perinatal hypothyroidism
NEW22450,DISEASE,spontaneous locomotor behavior,spontaneous locomotor behaviors
NEW22451,DISEASE,nutritional dermatosis,nutritional dermatoses
NEW22452,DISEASE,active vitamin a metabolite retinoic acid,RA|active vitamin A metabolite retinoic acid
NEW22453,MENTAL_HEALTH,ans displacement assay,ANS displacement assay
NEW22454,CHEBI,cough mixture use,cough mixture use
NEW22455,MENTAL_HEALTH,major depressive episode unresponsive,major depressive episode unresponsive
NEW22456,CHEBI,neuropituitary hormone,neuropituitary hormones
NEW22457,NUTRITION,polar xanthophyll,polar xanthophylls
NEW22458,CHEMICAL,wild type α-synuclein,wild type α-synuclein|α-syn-140
NEW22459,CHEMICAL,α-syn-112,α-Syn-112
NEW22460,DISEASE,parkinsonian brain,parkinsonian brains
NEW22461,MENTAL_HEALTH,antibiotic resistance enzyme,antibiotic resistance enzyme
NEW22462,CHEMICAL,atp hydrolysis,ATP hydrolysis
NEW22463,CHEMICAL,ne inhibitor sivelestat,NE inhibitor Sivelestat
NEW22464,DISEASE,abnormal gut microbiota,abnormal gut microbiota
NEW22465,CHEMICAL,angelica gigas extract,Angelica gigas extract
NEW22466,DISEASE,cognitive impaired mouse,cognitive impaired mice
NEW22467,NUTRITION,angelica gigas,Angelica gigas
NEW22468,DISEASE,mild traumatic brain injury model,mild traumatic brain injury model
NEW22469,DISEASE,mild cognitive impairment model mouse,mild cognitive impairment model mice
NEW22470,DISEASE,inescapable foot shock,inescapable foot shock
NEW22471,CHEMICAL,low sucrose consumption,lower sucrose consumption
NEW22472,DISEASE,only foot shock,only foot shock
NEW22473,CHEMICAL,dibenzoyl-atp,Bz-ATP|dibenzoyl-ATP
NEW22474,DISEASE,pain model,pain models
NEW22475,CHEBI,iv high dose vitamin c,iv high dose vitamin C
NEW22476,CHEMICAL,e2 ubiquitin ligase,E2 ubiquitin ligases
NEW22477,CHEMICAL,fine-tuning flavonoid synthesis,fine-tuning flavonoids synthesis
NEW22478,NUTRITION,ammonia b2:0.4 g potassium dihydrogen phosphate,ammonia B2:0.4 g potassium dihydrogen phosphate
NEW22479,CHEMICAL,g potassium chloride,g potassium chloride
NEW22480,NUTRITION,g urea b3:0.4 g potassium dihydrogen phosphate,g urea B3:0.4 g potassium dihydrogen phosphate
NEW22481,CHEMICAL,cumulative ammonia volatilization,cumulative ammonia volatilization
NEW22482,CHEMICAL,m-ym ym jg,M-YM YM JG
C540010,DISEASE,biochar [Supplementary Concept],biochar|Charcoal
NEW22483,MENTAL_HEALTH,fixation rate,fixation rate
NEW22484,CHEMICAL,m-ym ym jg jz,M-YM YM JG JZ
C051042,CHEMICAL,dansyl undecanoic acid [Supplementary Concept],Fatty Acids|Dansyl Compounds|undecanoic acid
NEW22485,CHEBI,antifungal treatment,antifungal treatments
NEW22486,MENTAL_HEALTH,profound dementia,profound dementia
NEW22487,CHEBI,cck2 selective antagonist,CCK2 selective antagonist
NEW22488,CHEBI,partial opiate agonist tramadol,partial opiate agonist tramadol
http://purl.obolibrary.org/obo/CHEBI_134728,CHEMICAL,mebanazine,mebanazine oxalate|mebanazine monooxalate|ICI-31397|desimipramine|mebanazine hydrochloride|mebanazine monosulfate|mebanazine monohydrochloride|mebanazine sulfate|actomol
NEW22489,CHEMICAL,ftdp-17 model,FTDP-17 model
NEW22490,DISEASE,spontaneous epileptic activity,spontaneous epileptic activity
NEW22491,CHEMICAL,ftdp-17 human mutant tau over-expression,FTDP-17 human mutant tau over-expression
NEW22492,DISEASE,receptor-mediated hyperexcitability,receptor-mediated hyperexcitability
NEW22493,CHEMICAL,defective histamine metabolism,defective histamine metabolism
NEW22494,DISEASE,multifaceted pseudoallergic disorder due,multifaceted pseudoallergic disorder due
NEW22495,MENTAL_HEALTH,suicide inactivation,suicide inactivation
NEW22496,CHEBI,novel antibacterial agent,novel antibacterial agents
NEW22497,CHEBI,obvious endocrine disturbance,obvious endocrine disturbances
NEW22498,CHEMICAL,midnight serum cortisol concentration,midnight serum cortisol concentrations
NEW22499,CHEMICAL,potassium intake,potassium intake
C536148,DISEASE,Meier Blumberg Imahorn syndrome [Supplementary Concept],idiopathic hypercalciuria|Oculocerebrorenal Syndrome|Calcium Metabolism Disorders
NEW22500,NUTRITION,raspberry juice,Raspberry juice
C431914,DISEASE,"SstT protein, Porphyromonas gingivalis [Supplementary Concept]","Bacterial Proteins|P. gingivalis|Amino Acid Transport Systems, Neutral"
NEW22501,CHEMICAL,increase central nervous system norepinephrine outflow,Increased central nervous system norepinephrine outflow
NEW22502,CHEBI,brain-accessible alpha1-adrenergic antagonist prazosin,brain-accessible alpha1-adrenergic antagonist Prazosin
NEW22503,DISEASE,chronic combat-related nightmare,chronic combat-related nightmares
NEW22504,CHEMICAL,elevated serum testosterone,Elevated serum testosterone
NEW22505,DISEASE,hypercholesterolemia disease,hypercholesterolemia disease
C422364,DISEASE,inhibin B [Supplementary Concept],Inhibins|inhibin B
NEW22506,MENTAL_HEALTH,mixed regression model,mixed regression model
C546535,CHEMICAL,Palovarotene [Supplementary Concept],Stilbenes|Palovarotene|palovarotene|Pyrazoles
D009999,DISEASE,"Ossification, Heterotopic","Ossification, Ectopic|Heterotopic Ossification|Pathologic Ossification|Ossification, Pathologic|heterotopic ossification|Ossification, Pathological|Pathological Ossification|Ectopic Ossification"
NEW22507,CHEMICAL,nuclear retinoic acid receptor,nuclear retinoic acid receptor
NEW22508,CHEMICAL,RARγ agonist-loaded poly-lactic acid nanoparticle,RARγ agonist-loaded poly-lactic acid nanoparticles
NEW22509,CHEBI,RARγ agonist treatment,RARγ agonist treatment
NEW22510,DISEASE,low-grade chondrosarcoma,low-grade chondrosarcomas
D004338,CHEBI,Drug Combinations,"Combinations, Drug|Drug combinations|Combination, Drug|Drug Combination"
NEW22511,CHEMICAL,poultry feces-may,poultry feces-may
NEW22512,DISEASE,environmental enteric disorder,environmental enteric disorder
NEW22513,DISEASE,avian coccidiosis,avian coccidiosis
NEW22514,DISEASE,epithelial injury,epithelial injuries
D065906,DISEASE,Hyperlactatemia,Hyperlactatemias|hyperlactatemia
NEW22515,DISEASE,primary trimethylaminuria,primary trimethylaminuria
NEW22516,CHEMICAL,human flavin,human flavin
NEW22517,CHEMICAL,acetaminophen metabolite,acetaminophen metabolite
NEW22518,CHEMICAL,acetaminophen metabolite am,acetaminophen metabolite AM
NEW22519,MENTAL_HEALTH,cannabinoid-mediated analgesia,cannabinoid-mediated analgesia
NEW22520,NUTRITION,fatty acid amide hydrolase faah inhibitor cyclohexylcarbamic acid ester,fatty acid amide hydrolase FAAH inhibitor Cyclohexylcarbamic acid ester
NEW22521,NUTRITION,common buckwheat,Common buckwheat
NEW22522,DISEASE,severe anaphylactic reaction,severe anaphylactic reactions
NEW22523,CHEMICAL,analog ketamine,analog ketamine
NEW22524,CHEMICAL,glutamate hypofunction,glutamate hypofunction
NEW22525,MENTAL_HEALTH,schizophrenia pathogenesis,schizophrenia pathogenesis
http://purl.obolibrary.org/obo/PR_Q9R1M7,CHEMICAL,"glutamate receptor ionotropic, nmda 3a (rat)",nmdar3a (rat)|grin3a|nr3a (rat)|n-methyl-d-aspartate receptor subtype 3a (rat)|glutamate receptor chi-1 (rat)|rgrin3a|NMDARs|nmdar-l1 (rat)|glun3a (rat)|nmdar-l (rat)|n-methyl-d-aspartate receptor (rat)
NEW22526,DISEASE,paediatric psychiatric patient,paediatric psychiatric patients
NEW22527,NUTRITION,sweet cherry fruit,Sweet cherry fruit
NEW22528,DISEASE,complex physiological disorder,complex physiological disorder
NEW22529,CHEMICAL,mev. loss,meV. loss
NEW22530,CHEMICAL,gamma-aminobutyric acid gaba analogue anticonvulsant,gamma-aminobutyric acid GABA analogue anticonvulsant
NEW22531,CHEBI,effective analgesic agent,effective analgesic agent
NEW22532,MENTAL_HEALTH,disorder diagnosis,disorder diagnoses
NEW22533,CHEMICAL,cb₁ receptor,CB₁ receptors|CB₁Rs
NEW22534,MENTAL_HEALTH,cannabinoid-induced anxiety,cannabinoid-induced anxiety
NEW22535,CHEMICAL,kinin b(1)r,kinin B(1)R
NEW22536,CHEMICAL,midbrain da system,midbrain DA system
NEW22537,CHEBI,frequent use antifungal,frequent use antifungals
NEW22538,CHEMICAL,non-echinocandin,non-echinocandins
NEW22539,DISEASE,disorder mouse model,disorder mouse model
D054970,DISEASE,Pure Autonomic Failure,"Syndrome, Bradbury-Eggleston|Bradbury Eggleston Syndrome|Bradbury-Eggleston Syndrome|autonomic failure|Autonomic Failure, Pure"
http://purl.obolibrary.org/obo/DOID_0080855,DISEASE,parkinsonism,levodopa-unresponsive parkinsonism
NEW22540,DISEASE,neurodegeneration formation,neurodegeneration formation
NEW22541,CHEMICAL,to inorganic sodium (meta)arsenite,NaAsO2|to inorganic sodium (meta)arsenite
NEW22542,CHEMICAL,organic dimethylarsinic acid,DMA|organic dimethylarsinic acid
NEW22543,DISEASE,specific learning disability,specific learning disabilities
NEW22544,CHEBI,mixture per,mixture Pers
NEW22545,NUTRITION,hericium erinaceus administration,Hericium erinaceus administration
NEW22546,DISEASE,hippocampal neuronal degeneration,hippocampal neuronal degeneration
D007022,DISEASE,hyper- or hypotension,|hyper- or hypotension
D012601,CHEMICAL,scopolamine,|scopolamine
D008094,CHEMICAL,lithium,|lithium
D006973,DISEASE,hyper- or hypotension,|hyper- or hypotension
D005672,CHEMICAL,fusidic acid,|fusidic acid
D009325,DISEASE,nausea,|nausea
D009203,DISEASE,myocardial infarction,|myocardial infarction
D002037,DISEASE,bundle branch block,|bundle branch block
D004421,DISEASE,tardive dystonia,|tardive dystonia
D003676,CHEMICAL,desferrioxamine,desferrioxamine|
D012164,DISEASE,pigmentary retinal deposits,|pigmentary retinal deposits
D014786,DISEASE,audiovisual toxicity,|audiovisual toxicity
D006319,DISEASE,neurosensorial hearing loss,|neurosensorial hearing loss
D008274,CHEMICAL,magnesium,magnesium|
D009157,DISEASE,Myasthenia gravis,|Myasthenia gravis
C004656,CHEMICAL,Chloroacetaldehyde,|Chloroacetaldehyde
D003556,DISEASE,HC,|HC
D006470,DISEASE,HC,|HC
C084599,CHEMICAL,Clotiazepam,|Clotiazepam
D014148,CHEMICAL,tranexamic acid,|tranexamic acid
D016534,DISEASE,increase in heart rate and cardiac output,|increase in heart rate and cardiac output
D010615,CHEMICAL,phenacetin,|phenacetin
D007681,DISEASE,renal papillary necrosis,|renal papillary necrosis
D007680,DISEASE,renal cancer,|renal cancer
D014229,CHEMICAL,Triazolam,|Triazolam
D005355,DISEASE,fibrous myopathy,|fibrous myopathy
D009135,DISEASE,fibrous myopathy,|fibrous myopathy
D020425,DISEASE,neuropathy of the radial nerve,neuropathy of the radial nerve|
D009408,DISEASE,compression neuropathy,|compression neuropathy
D010490,DISEASE,haemopericardium,|haemopericardium
D009468,DISEASE,neuromuscular disease,|neuromuscular disease
D010996,DISEASE,pleural effusions,|pleural effusions
D001201,DISEASE,ascites,|ascites
D011660,DISEASE,cor pulmonale,|cor pulmonale
D012256,CHEMICAL,riboflavin,|riboflavin
D014987,DISEASE,dry mouth,|dry mouth
D005200,CHEMICAL,N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide,N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide|
D004054,CHEMICAL,diethylstilbestrol,|diethylstilbestrol
D010911,DISEASE,adenohypophyseal tumors,|adenohypophyseal tumors
D014223,CHEMICAL,Triamterene,|Triamterene
D003638,DISEASE,deafness,|deafness
D012293,CHEMICAL,rifampin,|rifampin
D005921,DISEASE,glomerulosclerosis,|glomerulosclerosis
D011692,CHEMICAL,puromycin aminonucleoside,|puromycin aminonucleoside
D007674,DISEASE,nephropathy,|nephropathy
D000799,DISEASE,Angioedema,Angioedema|
D009538,CHEMICAL,AN,|AN
D001176,DISEASE,arthrogryposis,arthrogryposis|
C007112,CHEMICAL,coniine,coniine|
D002543,DISEASE,cranial hemorrhage,|cranial hemorrhage
D014294,CHEMICAL,trimethaphan,|trimethaphan
D000527,CHEMICAL,prostaglandin E1,prostaglandin E1|
D013927,DISEASE,HITT,HITT|
D013921,DISEASE,HITT,HITT|
C030852,CHEMICAL,vinorelbine,|vinorelbine
D009503,DISEASE,neutropenia,|neutropenia
D061205,DISEASE,artery calcification,|artery calcification
D001745,DISEASE,bladder damage,|bladder damage
D009202,DISEASE,myocardial injury,|myocardial injury
D019259,CHEMICAL,lamivudine,|lamivudine
C065046,CHEMICAL,CP 93129,|CP 93129
D013988,CHEMICAL,Ticlopidine,|Ticlopidine
D007565,DISEASE,jaundice,|jaundice
D002779,DISEASE,cholestasis,|cholestasis
D020326,DISEASE,migraineurs (without aura),migraineurs (without aura)|
D009569,CHEMICAL,NO,|NO
D003323,DISEASE,Coronary aneurysm,|Coronary aneurysm
D010409,DISEASE,penile erection,|penile erection
D055154,DISEASE,dysphonia,|dysphonia
C102006,CHEMICAL,citrate,|citrate
D005221,DISEASE,tiredness,tiredness|
D001259,DISEASE,ataxia,|ataxia
D014826,DISEASE,vocal fold palsy,|vocal fold palsy
D006493,CHEMICAL,heparin,heparin|
D012170,DISEASE,retinal vein occlusion,|retinal vein occlusion
D009759,DISEASE,nystagmus,nystagmus|
D006471,DISEASE,gastric hemorrhagic,|gastric hemorrhagic
D002784,CHEMICAL,cholesterol,|cholesterol
D014456,DISEASE,ulcers,ulcers|
C031942,CHEMICAL,argatroban,|argatroban
D016063,DISEASE,intraoperative bleeding,|intraoperative bleeding
D019106,DISEASE,postoperative bleeding,|postoperative bleeding
D002493,DISEASE,Central nervous system complications,|Central nervous system complications
C110904,CHEMICAL,capecitabine,|capecitabine
D013280,DISEASE,stomatitis,|stomatitis
D014839,DISEASE,vomiting,|vomiting
D003967,DISEASE,diarrhea,diarrhea|
D009638,CHEMICAL,norepinephrine,|norepinephrine
D001241,CHEMICAL,aspirin,|aspirin
D007548,CHEMICAL,isosorbide dinitrate,|isosorbide dinitrate
D013345,DISEASE,subarachnoid hemorrhage,|subarachnoid hemorrhage
D005905,CHEMICAL,Glyburide,|Glyburide
D013035,DISEASE,spasm,|spasm
D007530,CHEMICAL,isoflurane,|isoflurane
D012848,DISEASE,sinoatrial block,|sinoatrial block
D003025,DISEASE,talipes equinovarus,|talipes equinovarus
D001017,DISEASE,coarctation of the aorta,|coarctation of the aorta
D006345,DISEASE,ventricular septal defect,|ventricular septal defect
D007690,DISEASE,Potter-type IIa polycystic kidney,|Potter-type IIa polycystic kidney
D003606,CHEMICAL,dacarbazine,|dacarbazine
D006504,DISEASE,Veno-occlusive liver disease,|Veno-occlusive liver disease
D002066,CHEMICAL,Busulfan,|Busulfan
D006221,CHEMICAL,halothane,|halothane
D001855,DISEASE,myelosuppression,|myelosuppression
D003128,DISEASE,coma,|coma
C036006,CHEMICAL,oxcarbazepine,oxcarbazepine|
D000667,CHEMICAL,ampicillin,|ampicillin
D004892,DISEASE,Erythema multiforme,|Erythema multiforme
D004342,DISEASE,allergic reactions,allergic reactions|
D000658,CHEMICAL,amoxicillin,|amoxicillin
D000707,DISEASE,anaphylaxis,|anaphylaxis
D001279,CHEMICAL,atracurium,|atracurium
D010243,DISEASE,paralysis,|paralysis
D014673,CHEMICAL,vecuronium bromide,|vecuronium bromide
C085788,CHEMICAL,MFL,|MFL
D008619,CHEMICAL,mepivacaine,|mepivacaine
D016559,CHEMICAL,tacrolimus,|tacrolimus
C098725,CHEMICAL,S-(-)-ET-126,|S-(-)-ET-126
D001049,DISEASE,desaturation,desaturation|
D014549,DISEASE,incontinence,incontinence|
C047426,CHEMICAL,venlafaxine,|venlafaxine
C010637,CHEMICAL,terodiline,|terodiline
D014750,CHEMICAL,vincristin,vincristin|
D009410,DISEASE,neuronal death,|neuronal death
D010396,CHEMICAL,D-penicillamine,|D-penicillamine
D003907,CHEMICAL,RD,|RD
D004997,CHEMICAL,ethinyl estradiol,|ethinyl estradiol
D000740,DISEASE,anemia,|anemia
D002311,DISEASE,dilated cardiomyopathy,dilated cardiomyopathy|
D007531,CHEMICAL,diisopropylfluorophosphate,|diisopropylfluorophosphate
C032302,CHEMICAL,rilmenidine,|rilmenidine
D001660,DISEASE,biliary pseudolithiasis,|biliary pseudolithiasis
C030262,CHEMICAL,triamcinolone diacetate,|triamcinolone diacetate
D011128,DISEASE,Cauda equina syndrome,|Cauda equina syndrome
D013739,CHEMICAL,Testosterone,|Testosterone
D009336,DISEASE,necrosis,|necrosis
D012906,CHEMICAL,smoking,|smoking
D034381,DISEASE,hearing loss,|hearing loss
C026098,CHEMICAL,levetiracetam,|levetiracetam
D013923,DISEASE,thromboembolic,|thromboembolic
C417083,CHEMICAL,pegylated interferon,|pegylated interferon
D001763,DISEASE,ptosis on the right upper lid,|ptosis on the right upper lid
D015835,DISEASE,restricted right eye movement,restricted right eye movement|
C094645,CHEMICAL,aripiprazole,|aripiprazole
C076029,CHEMICAL,olanzapine,|olanzapine
D000661,CHEMICAL,amphetamine,|amphetamine
D002303,DISEASE,decreased cardiac output,|decreased cardiac output
D002534,DISEASE,reduces frontal lobe oxygenation,|reduces frontal lobe oxygenation
D060845,DISEASE,hoarding,|hoarding
D012817,DISEASE,gastrointestinal symptoms,|gastrointestinal symptoms
D001068,DISEASE,decreased appetite,|decreased appetite
D006940,DISEASE,venous congestion,|venous congestion
D000787,DISEASE,Angina,|Angina
D015760,CHEMICAL,alfentanil,|alfentanil
D006316,DISEASE,"abnormal audiograms with deficits mostly in the high frequency range of 4,000 to 8,000 Hz","abnormal audiograms with deficits mostly in the high frequency range of 4,000 to 8,000 Hz|"
D005480,CHEMICAL,Flurbiprofen,|Flurbiprofen
D006261,DISEASE,headache,|headache
C005238,CHEMICAL,mipafox,|mipafox
D013118,DISEASE,cord damage,|cord damage
D004437,DISEASE,Ebstein's anomaly,|Ebstein's anomaly
D002330,CHEMICAL,BCNU,|BCNU
D031300,DISEASE,retinal vasculitis,|retinal vasculitis
D003704,DISEASE,dementia,dementia|
D014625,DISEASE,adenocarcinoma of the vagina,|adenocarcinoma of the vagina
D018262,DISEASE,clear cell adenocarcinoma,|clear cell adenocarcinoma
D002251,CHEMICAL,carbon tetrachloride,|carbon tetrachloride
D003919,DISEASE,diabetes insipidus,diabetes insipidus|
D004775,DISEASE,enuresis,|enuresis
D041881,DISEASE,acute cholecystitis,|acute cholecystitis
D007511,DISEASE,ischemia,|ischemia
D013611,DISEASE,atrioventricular reentrant tachycardia,|atrioventricular reentrant tachycardia
C072959,CHEMICAL,"1-chloro-1,2,2,2-tetrafluoroethane","|1-chloro-1,2,2,2-tetrafluoroethane"
C067411,CHEMICAL,"1,1-dichloro-2,2,2-trifluoroethane","|1,1-dichloro-2,2,2-trifluoroethane"
D011318,CHEMICAL,prilocaine,|prilocaine
D012678,DISEASE,loss of pinprick sensation,|loss of pinprick sensation
D006976,DISEASE,primary pulmonary hypertension,|primary pulmonary hypertension
D013610,DISEASE,tachy- or bradycardia,|tachy- or bradycardia
D057049,DISEASE,thrombotic microangiopathy,|thrombotic microangiopathy
D001002,DISEASE,anuria,|anuria
D008171,DISEASE,lung toxicity,|lung toxicity
D005128,DISEASE,visual field defects,|visual field defects
D006406,DISEASE,hematoma,|hematoma
D005839,CHEMICAL,gentamicin,|gentamicin
D020293,DISEASE,cerebral vasculitis,|cerebral vasculitis
D008775,CHEMICAL,methylprednisolone,|methylprednisolone
C044834,CHEMICAL,iodixanol,iodixanol|
D003287,CHEMICAL,contrast medium,|contrast medium
D007479,CHEMICAL,iopamidol,iopamidol|
D006514,CHEMICAL,HBsAg,|HBsAg
D006509,DISEASE,hepatitis B virus (HBV) infected,|hepatitis B virus (HBV) infected
D009422,DISEASE,neuropathy,|neuropathy
D015632,CHEMICAL,MPTP,|MPTP
D020968,DISEASE,brachial neuritis,|brachial neuritis
D001022,DISEASE,aortic regurgitation,|aortic regurgitation
D008944,DISEASE,mitral regurgitation,mitral regurgitation|
D000160,DISEASE,adverse effect on the proximal eighth nerve,|adverse effect on the proximal eighth nerve
D006949,DISEASE,hyperlipidemia,|hyperlipidemia
D009401,DISEASE,nephrosis,|nephrosis
C558899,CHEMICAL,lopinavir/ritonavir,|lopinavir/ritonavir
D008113,DISEASE,liver tumors,|liver tumors
D006394,DISEASE,Angiosarcoma,|Angiosarcoma
C492458,CHEMICAL,Simvastatin-ezetimibe,Simvastatin-ezetimibe|
D003731,DISEASE,caries,|caries
D005334,DISEASE,hyperthermia,|hyperthermia
D000860,DISEASE,hypoxia,|hypoxia
D005483,DISEASE,flushing of the face,|flushing of the face
D003484,CHEMICAL,hydrogen cyanamide,|hydrogen cyanamide
D004417,DISEASE,dyspnea,dyspnea|
D007035,DISEASE,hypothermia,|hypothermia
D014299,CHEMICAL,trimipramine,|trimipramine
D001556,CHEMICAL,lindane,lindane|
C068820,CHEMICAL,8-[(4-amino-l-methylbutyl)amino]- 5-(l-hexyloxy)-6-methoxy-4-methylquinoline,|8-[(4-amino-l-methylbutyl)amino]- 5-(l-hexyloxy)-6-methoxy-4-methylquinoline
D006456,DISEASE,hemoglobinuria,|hemoglobinuria
D009212,DISEASE,Myoglobinuria,|Myoglobinuria
D005665,CHEMICAL,furosemide,|furosemide
D007612,CHEMICAL,kanamycin,|kanamycin
C067311,CHEMICAL,docetaxel,|docetaxel
D017180,DISEASE,ventricular tachycardia,|ventricular tachycardia
D011693,DISEASE,petechiae,|petechiae
D003161,DISEASE,compartment syndrome,|compartment syndrome
D001650,DISEASE,Bile duct hamartoma,|Bile duct hamartoma
D006222,DISEASE,hamartoma,|hamartoma
D006099,DISEASE,granulomas,|granulomas
D017542,DISEASE,ruptured aneurysms,ruptured aneurysms|
D004832,DISEASE,absence seizures,|absence seizures
D011342,CHEMICAL,Procainamide,|Procainamide
D015073,CHEMICAL,2-acetylaminofluorene,2-acetylaminofluorene|
D011230,DISEASE,initiation induced by carcinogens,initiation induced by carcinogens|
D001564,CHEMICAL,benzo[a]-pyrene,|benzo[a]-pyrene
D001374,CHEMICAL,5-azacytidine,|5-azacytidine
D019813,CHEMICAL,"1,2-dimethylhydrazine","|1,2-dimethylhydrazine"
D008770,CHEMICAL,N-methyl-N-nitrosourea,|N-methyl-N-nitrosourea
D010291,DISEASE,transient hemiparesis,|transient hemiparesis
D052016,DISEASE,mucositis,|mucositis
D003873,DISEASE,erythroderma,|erythroderma
D007955,DISEASE,leukemoid reaction,|leukemoid reaction
D017093,DISEASE,hepatic failure,|hepatic failure
C413408,CHEMICAL,atazanavir,|atazanavir
C016986,CHEMICAL,aponidine hydrochloride,aponidine hydrochloride|
D015814,DISEASE,ocular hypotensive,|ocular hypotensive
D004774,DISEASE,entropion,|entropion
D003316,DISEASE,corneal abrasion,|corneal abrasion
D003229,DISEASE,Conjunctival blanching,|Conjunctival blanching
C017367,CHEMICAL,Carmofur,|Carmofur
D008801,CHEMICAL,mexiletine,|mexiletine
D020748,CHEMICAL,Ro 40-5967,|Ro 40-5967
D006513,CHEMICAL,hepatitis B virus e antigen,|hepatitis B virus e antigen
D014031,CHEMICAL,tobramycin,|tobramycin
C476217,CHEMICAL,cinacalcet HCl,|cinacalcet HCl
D010248,CHEMICAL,paramethasone,|paramethasone
D014581,DISEASE,urticaria,|urticaria
D003231,DISEASE,conjunctivitis,|conjunctivitis
D010195,DISEASE,pancreatitis,|pancreatitis
D018879,DISEASE,premature ventricular contractions,|premature ventricular contractions
D004487,DISEASE,swelling,|swelling
D009896,DISEASE,optic atrophy,|optic atrophy
D013395,CHEMICAL,sucrose,|sucrose
D001018,DISEASE,angiopathy,angiopathy|
D003630,CHEMICAL,daunorubicin,daunorubicin|
D013449,CHEMICAL,Sulfonamides,|Sulfonamides
D006548,DISEASE,diaphragmatic hernia,|diaphragmatic hernia
D018636,DISEASE,hypoplastic left heart syndrome,|hypoplastic left heart syndrome
D017880,DISEASE,transverse limb deficiency,|transverse limb deficiency
D006344,DISEASE,atrial septal defects,|atrial septal defects
D002972,DISEASE,cleft palate,cleft palate|
D000853,DISEASE,anophthalmia,|anophthalmia
D000014,DISEASE,birth defects,|birth defects
D002754,DISEASE,choanal atresia,|choanal atresia
D008850,DISEASE,microphthalmos,|microphthalmos
D000757,DISEASE,anencephaly,|anencephaly
D000477,CHEMICAL,alkylating agents,|alkylating agents
D002277,DISEASE,carcinoma,|carcinoma
D000855,DISEASE,anorexia,|anorexia
D010689,DISEASE,phlebitis,|phlebitis
C034818,CHEMICAL,"methyl 6,7-dimethoxy-4-ethyl-B-carboline-3-carboxylate","|methyl 6,7-dimethoxy-4-ethyl-B-carboline-3-carboxylate"
D013331,CHEMICAL,strychnine,|strychnine
D015097,CHEMICAL,3-mercaptopropionic acid,3-mercaptopropionic acid|
D010211,DISEASE,papilledema,|papilledema
D012163,DISEASE,retinal detachment,|retinal detachment
D058447,DISEASE,ocular pain,|ocular pain
D009916,DISEASE,orbital toxicity,|orbital toxicity
C042315,CHEMICAL,CI-921,|CI-921
D007239,DISEASE,infection,|infection
C426686,CHEMICAL,Ximelagatran,|Ximelagatran
D006932,DISEASE,hyperbilirubinemia,hyperbilirubinemia|
C021341,CHEMICAL,cefazedone,cefazedone|
D015790,CHEMICAL,cefonicid,|cefonicid
D002653,DISEASE,behavioral disorder,|behavioral disorder
C121249,CHEMICAL,NRA0160,|NRA0160
D014217,CHEMICAL,troleandomycin,|troleandomycin
D004802,DISEASE,eosinophilia,|eosinophilia
D015248,CHEMICAL,gemfibrozil,|gemfibrozil
D008180,DISEASE,lupus erythematosus,|lupus erythematosus
D020447,DISEASE,parasomnias,|parasomnias
D009567,CHEMICAL,nitrazepam,nitrazepam|
D011405,CHEMICAL,propafenone,|propafenone
D003490,DISEASE,cyanosis,|cyanosis
D006311,DISEASE,audiovisual toxicity,|audiovisual toxicity
D020428,DISEASE,femoral nerve palsy,|femoral nerve palsy
D007683,DISEASE,acute tubular necrosis,acute tubular necrosis|
D002512,CHEMICAL,cephalothin,|cephalothin
D003401,CHEMICAL,creatine,|creatine
D010894,CHEMICAL,piroxicam,|piroxicam
D005317,DISEASE,intrauterine growth retardation,|intrauterine growth retardation
D009139,DISEASE,increase of external and skeletal variations,|increase of external and skeletal variations
C106876,CHEMICAL,DFU,|DFU
C007789,CHEMICAL,fucoidan,|fucoidan
D020141,DISEASE,impaired blood clotting,|impaired blood clotting
D004827,DISEASE,epileptic,|epileptic
C106791,CHEMICAL,telithromycin,|telithromycin
D054138,DISEASE,Sinus arrest,|Sinus arrest
C004616,CHEMICAL,2-chloroprocaine-CE,|2-chloroprocaine-CE
D013467,CHEMICAL,sulindac,|sulindac
D012312,CHEMICAL,ritodrine,|ritodrine
D004967,CHEMICAL,estrogen,|estrogen
D009133,DISEASE,muscle wastage,muscle wastage|
D012140,DISEASE,respiratory upset,|respiratory upset
C009265,CHEMICAL,levodopa/carbidopa,|levodopa/carbidopa
C005618,CHEMICAL,benzoylecgonine,|benzoylecgonine
D017673,CHEMICAL,dietary sodium chloride,|dietary sodium chloride
D019438,CHEMICAL,ritonavir,|ritonavir
D017682,DISEASE,myocardial stunning,|myocardial stunning
C021650,CHEMICAL,Hydrocortisone acetate,|Hydrocortisone acetate
D002794,CHEMICAL,choline,choline|
D006528,DISEASE,hepatocellular carcinomas,|hepatocellular carcinomas
D008755,CHEMICAL,methylergonovine,methylergonovine|
D000628,CHEMICAL,aminophylline,|aminophylline
D012798,DISEASE,hypersalivation,hypersalivation|
C093622,CHEMICAL,rizatriptan,|rizatriptan
D001761,CHEMICAL,bleomycin,|bleomycin
D011697,DISEASE,thrombotic thrombocytopenic purpura,|thrombotic thrombocytopenic purpura
D014748,CHEMICAL,vinca alkaloid,|vinca alkaloid
C104457,CHEMICAL,nelarabine,|nelarabine
D006402,DISEASE,hematotoxicity,hematotoxicity|
D008206,DISEASE,lymphadenopathy,|lymphadenopathy
D018805,DISEASE,sepsis,|sepsis
D009393,DISEASE,nephritis,|nephritis
D003872,DISEASE,dermatitis,|dermatitis
D007208,CHEMICAL,indocyanine green,|indocyanine green
D012769,DISEASE,shock,|shock
D016049,CHEMICAL,didanosine,|didanosine
C471405,CHEMICAL,sorafenib,|sorafenib
C473478,CHEMICAL,sunitinib,|sunitinib
D004025,CHEMICAL,dicyclomine,|dicyclomine
D006417,DISEASE,hematuria,|hematuria
C010882,CHEMICAL,chlorhexidine-digluconate,|chlorhexidine-digluconate
D011206,CHEMICAL,povidone-iodine,|povidone-iodine
C006820,CHEMICAL,bromperidol,|bromperidol
D010493,DISEASE,pericarditis,|pericarditis
C036150,CHEMICAL,beta-carboline,|beta-carboline
D009568,CHEMICAL,nitrendipine,|nitrendipine
D009400,DISEASE,nephrosclerosis,|nephrosclerosis
D014717,DISEASE,vertigo,|vertigo
C023470,CHEMICAL,Perhexiline maleate,|Perhexiline maleate
D009943,CHEMICAL,organophosphorus (OP) poisons,organophosphorus (OP) poisons|
D006170,CHEMICAL,gum Arabic,|gum Arabic
C022189,CHEMICAL,zonisamide,|zonisamide
D003513,CHEMICAL,cycloheximide,|cycloheximide
D000641,CHEMICAL,ammonia,|ammonia
D006965,DISEASE,hyperplasia,|hyperplasia
D004491,CHEMICAL,edrophonium,|edrophonium
D015119,CHEMICAL,epsilon-aminocaproic acid,|epsilon-aminocaproic acid
D020225,DISEASE,sagittal sinus thrombosis,|sagittal sinus thrombosis
D020518,DISEASE,focal nodular hyperplasia,|focal nodular hyperplasia
D000236,DISEASE,adenoma,|adenoma
D001157,DISEASE,arterial occlusion,|arterial occlusion
D010400,CHEMICAL,benzylpenicillin,|benzylpenicillin
C047781,CHEMICAL,lamotrigine,|lamotrigine
D000305,CHEMICAL,corticosteroids,|corticosteroids
D008794,CHEMICAL,metrizoate,|metrizoate
D020246,DISEASE,venous thrombosis,|venous thrombosis
D014652,DISEASE,renovascular disease,|renovascular disease
C107135,CHEMICAL,everolimus,|everolimus
D001498,CHEMICAL,BAY k-8644,BAY k-8644|
D011374,CHEMICAL,progesterone,progesterone|
D005705,DISEASE,gallbladder disease,|gallbladder disease
D008353,CHEMICAL,mannitol,|mannitol
D019586,DISEASE,elevated ICP,|elevated ICP
D005414,DISEASE,flatulence,|flatulence
C045645,CHEMICAL,cilostazol,|cilostazol
C048081,CHEMICAL,beraprost,|beraprost
C422649,CHEMICAL,etoricoxib,|etoricoxib
C025541,CHEMICAL,Tri-ortho-tolyl phosphate,|Tri-ortho-tolyl phosphate
D001308,DISEASE,impairment in auditory location discrimination,|impairment in auditory location discrimination
D004656,CHEMICAL,enalapril,|enalapril
D004232,CHEMICAL,diuretic,|diuretic
D001264,DISEASE,choreoathetosis,choreoathetosis|
D015080,CHEMICAL,mesna,|mesna
C038192,CHEMICAL,iopromide,|iopromide
D007472,CHEMICAL,iohexol,|iohexol
D004977,CHEMICAL,ethambutol,|ethambutol
D009901,DISEASE,optic neuropathy,|optic neuropathy
D004041,CHEMICAL,fat,|fat
D009765,DISEASE,obese,|obese
D012804,DISEASE,sinus bradycardia,|sinus bradycardia
D011681,DISEASE,pupillary oscillation,pupillary oscillation|
D004876,CHEMICAL,ergot,|ergot
D007505,CHEMICAL,iron dextran,iron dextran|
D018366,DISEASE,LV Cutaneous lesions,LV Cutaneous lesions|
D020336,DISEASE,spastic paraparesis,|spastic paraparesis
D009220,DISEASE,inflammatory myopathy,|inflammatory myopathy
D002701,CHEMICAL,chloramphenicol,|chloramphenicol
D004917,CHEMICAL,erythromycins,|erythromycins
D008232,DISEASE,post-transplant lmphoproliferate disease,|post-transplant lmphoproliferate disease
D009428,CHEMICAL,netilmicin,|netilmicin
C044946,CHEMICAL,benazapril,|benazapril
D007410,DISEASE,intestinal,|intestinal
D008054,CHEMICAL,lipid hydroperoxides,|lipid hydroperoxides
C012052,CHEMICAL,amisulpride,|amisulpride
D063325,CHEMICAL,tiapride,|tiapride
D001539,CHEMICAL,bendrofluazide,|bendrofluazide
D006073,DISEASE,gout,|gout
C059262,CHEMICAL,cidofovir,cidofovir|
D014640,CHEMICAL,vancomycin,vancomycin|
C418563,CHEMICAL,tenofovir disoproxil fumarate,|tenofovir disoproxil fumarate
D007372,CHEMICAL,interferon,|interferon
C019248,CHEMICAL,pamidronate,|pamidronate
D008550,CHEMICAL,melatonin,|melatonin
D012701,CHEMICAL,serotonin,|serotonin
D004298,CHEMICAL,dopamine,|dopamine
C020976,CHEMICAL,azelastine,|azelastine
D013651,DISEASE,altered taste perception,|altered taste perception
D017693,CHEMICAL,Sodium bicarbonate,|Sodium bicarbonate
D003473,CHEMICAL,nondepolarizing neuromuscular blocking agents,|nondepolarizing neuromuscular blocking agents
D015232,CHEMICAL,Prostaglandin E2,|Prostaglandin E2
D002752,CHEMICAL,chlorthalidone,|chlorthalidone
D015230,CHEMICAL,Prostaglandin D2,|Prostaglandin D2
D013617,DISEASE,supraventricular tachyarrhythmias,|supraventricular tachyarrhythmias
D011183,DISEASE,postoperative delirium,|postoperative delirium
D009643,CHEMICAL,norfloxacin,|norfloxacin
D018818,CHEMICAL,fenoldopam,|fenoldopam
D001167,DISEASE,arteritis,|arteritis
D006495,CHEMICAL,Low-molecular-weight heparin,|Low-molecular-weight heparin
C052342,CHEMICAL,topiramate,|topiramate
D007608,CHEMICAL,kainic acid,|kainic acid
D005492,CHEMICAL,folate,|folate
D005759,DISEASE,gastroenteritis,|gastroenteritis
D013746,DISEASE,tetanic,|tetanic
D014657,DISEASE,vasculitis,|vasculitis
D013256,CHEMICAL,steroid,|steroid
D018658,DISEASE,ventricular septal defect,|ventricular septal defect
D004077,CHEMICAL,digoxin,|digoxin
D014042,CHEMICAL,tolazamide,|tolazamide
C014282,CHEMICAL,cirazoline,|cirazoline
C056299,CHEMICAL,Abbott-53693,|Abbott-53693
D012851,DISEASE,Cerebral sinus thrombosis,|Cerebral sinus thrombosis
D013575,DISEASE,syncope,|syncope
D001766,DISEASE,blindness,|blindness
C476513,CHEMICAL,levobupivacaine,levobupivacaine|
C037663,CHEMICAL,ropivacaine,|ropivacaine
C051883,CHEMICAL,22-oxacalcitriol,|22-oxacalcitriol
D011115,DISEASE,polyneuropathy,|polyneuropathy
D017285,DISEASE,polymyositis,|polymyositis
D013881,CHEMICAL,Mellaril,|Mellaril
D009661,CHEMICAL,Aventyl,|Aventyl
D007662,DISEASE,ketosis,|ketosis
D000140,DISEASE,lactic acidosis,|lactic acidosis
C117268,CHEMICAL,pimecrolimus,|pimecrolimus
D003875,DISEASE,eruptions,|eruptions
D013684,DISEASE,telangiectasis,|telangiectasis
D000157,CHEMICAL,aconitine,|aconitine
D012607,DISEASE,scotomata,|scotomata
C076946,CHEMICAL,E-2020,|E-2020
C049860,CHEMICAL,NIK-247,|NIK-247
D006046,CHEMICAL,gold,gold|
C004504,CHEMICAL,2-bromoethylamine,|2-bromoethylamine
C001335,CHEMICAL,hexachloro-1:3-butadiene,|hexachloro-1:3-butadiene
D020879,DISEASE,neuromuscular blockade,|neuromuscular blockade
D002761,DISEASE,cholangitis,|cholangitis
C012655,CHEMICAL,nimesulide,|nimesulide
D000894,CHEMICAL,NSAID,|NSAID
D000748,DISEASE,macrocytic anemia,|macrocytic anemia
C027278,CHEMICAL,Renografin 76%,Renografin 76%|
D006130,DISEASE,growth impairment,|growth impairment
C099041,CHEMICAL,tolterodine,|tolterodine
D007854,CHEMICAL,lead,|lead
C537296,DISEASE,Granulosa cell tumor of the ovary,|Granulosa cell tumor of the ovary
D011471,DISEASE,prostate cancer,prostate cancer|
D016685,CHEMICAL,Mitomycin C,|Mitomycin C
C015173,CHEMICAL,dipivalyl epinephrine,|dipivalyl epinephrine
D001205,CHEMICAL,Vitamin C,|Vitamin C
D001416,DISEASE,Leg and back pain,|Leg and back pain
D002747,CHEMICAL,Chlorpropamide,|Chlorpropamide
D015313,CHEMICAL,Cefotetan,|Cefotetan
C005177,CHEMICAL,L-DOPA/benserazide,|L-DOPA/benserazide
D008130,CHEMICAL,CCNU,|CCNU
C059896,CHEMICAL,N-butyl-deoxynojirimycin,|N-butyl-deoxynojirimycin
C031662,CHEMICAL,"N10-propargyl-5,8-dideazafolic acid","|N10-propargyl-5,8-dideazafolic acid"
C017610,CHEMICAL,fluphenazine enanthate,|fluphenazine enanthate
D014221,CHEMICAL,triamcinolone,|triamcinolone
C045894,CHEMICAL,lometrexol,|lometrexol
C090450,CHEMICAL,anastrozole,|anastrozole
D001778,DISEASE,blood coagulation,|blood coagulation
D013924,DISEASE,thrombophlebitis,|thrombophlebitis
D007177,DISEASE,inappropriate antidiuretic hormone secretion,|inappropriate antidiuretic hormone secretion
D014667,CHEMICAL,vasopressin,|vasopressin
D020105,CHEMICAL,milrinone,|milrinone
D004737,CHEMICAL,enflurane,|enflurane
D005315,DISEASE,fetal anomalies,|fetal anomalies
D003561,CHEMICAL,cytosine arabinoside,|cytosine arabinoside
D002351,CHEMICAL,carrageenan,carrageenan|
D001791,DISEASE,platelet aggregation,|platelet aggregation
D004052,CHEMICAL,diethylnitrosamine,|diethylnitrosamine
D003920,DISEASE,Diabetes mellitus,|Diabetes mellitus
D003389,DISEASE,cranial neuropathy,|cranial neuropathy
C033457,CHEMICAL,Quinidine phenylethylbarbiturate,|Quinidine phenylethylbarbiturate
D021501,DISEASE,flank pain,|flank pain
D011702,DISEASE,pyeloureteritis cystica,|pyeloureteritis cystica
C400082,CHEMICAL,bortezomib,|bortezomib
C084178,CHEMICAL,telmisartan,|telmisartan
D010068,CHEMICAL,oxacillin,|oxacillin
D000171,CHEMICAL,acrolein,|acrolein
D005476,CHEMICAL,fluphenazine,|fluphenazine
D004893,DISEASE,erythema nodosum,|erythema nodosum
C081489,CHEMICAL,Valsartan,|Valsartan
C061282,CHEMICAL,CGS 21680,|CGS 21680
D008729,CHEMICAL,methoxamine,|methoxamine
D009627,CHEMICAL,nomifensine,nomifensine|
D009230,DISEASE,myxedemic,|myxedemic
D065630,DISEASE,diaphragmatic hernia,|diaphragmatic hernia
D003645,DISEASE,sudden death,|sudden death
D008625,CHEMICAL,Tiopronin,|Tiopronin
D015237,CHEMICAL,prostaglandin F2 alpha,|prostaglandin F2 alpha
D015837,DISEASE,vestibulotoxicity,|vestibulotoxicity
D019559,DISEASE,capillary leak syndrome,|capillary leak syndrome
D013866,CHEMICAL,6-thioguanine,|6-thioguanine
D043343,CHEMICAL,testosterone propionate,|testosterone propionate
D009074,CHEMICAL,MSH,|MSH
C044650,CHEMICAL,imipenem/cilastatin,|imipenem/cilastatin
D010121,CHEMICAL,oxytocin,|oxytocin
D005446,CHEMICAL,fluocinolone acetonide,|fluocinolone acetonide
D010468,DISEASE,visual disturbances,|visual disturbances
D010419,CHEMICAL,pentamidine,|pentamidine
D004456,CHEMICAL,echothiophate iodide,|echothiophate iodide
D000728,CHEMICAL,androgen,|androgen
C033706,CHEMICAL,tiazofurin,|tiazofurin
D014869,DISEASE,Water intoxication,|Water intoxication
D012595,DISEASE,systemic sclerosis,|systemic sclerosis
C055162,CHEMICAL,clopidogrel,|clopidogrel
C006780,CHEMICAL,Bisphenol A,|Bisphenol A
C467567,CHEMICAL,RD,|RD
D000686,DISEASE,AL,|AL
C098010,CHEMICAL,Linezolid,|Linezolid
C531767,DISEASE,optic disc edema,|optic disc edema
D003976,CHEMICAL,diazinon,|diazinon
C051890,CHEMICAL,irinotecan,|irinotecan
C086816,CHEMICAL,desvenlafaxine,|desvenlafaxine
D007249,DISEASE,inflammation,inflammation|
C065180,CHEMICAL,fluvastatin,fluvastatin|
D015251,CHEMICAL,epirubicine,|epirubicine
D010758,CHEMICAL,phosphorus,|phosphorus
D006505,DISEASE,acute hepatitis,|acute hepatitis
C069541,CHEMICAL,quetiapine,|quetiapine
C042288,CHEMICAL,Pilsicainide,|Pilsicainide
D019115,DISEASE,Necrotising fasciitis,|Necrotising fasciitis
D018487,DISEASE,left ventricular systolic and diastolic dysfunction,|left ventricular systolic and diastolic dysfunction
D005901,DISEASE,glaucomatous,|glaucomatous
C106487,CHEMICAL,S-53482,|S-53482
C083440,CHEMICAL,S-23121,|S-23121
D064793,DISEASE,teratogenicity,|teratogenicity
D020964,DISEASE,embryolethality,|embryolethality
D011041,DISEASE,poisoning,|poisoning
C041359,CHEMICAL,terbinafine,|terbinafine
C067431,CHEMICAL,letrozole,|letrozole
C486464,CHEMICAL,telaprevir,|telaprevir
D002386,DISEASE,cataracts,|cataracts
D004408,DISEASE,Dysguesia,|Dysguesia
C049430,CHEMICAL,mivacurium,|mivacurium
C537417,DISEASE,Butyrylcholinesterase deficiency,|Butyrylcholinesterase deficiency
C039726,CHEMICAL,artesunate,|artesunate
C030272,CHEMICAL,maleate,|maleate
D008175,DISEASE,lung cancer,|lung cancer
D052638,CHEMICAL,particulate matter,|particulate matter
D010126,CHEMICAL,ozone,|ozone
C031763,CHEMICAL,"1,3-Butadiene","1,3-Butadiene|"
D010677,DISEASE,Philadelphia chromosome,|Philadelphia chromosome
C051786,CHEMICAL,metolachlor,metolachlor|
D008224,DISEASE,follicular cell lymphoma,|follicular cell lymphoma
D001152,CHEMICAL,inorganic arsenic,inorganic arsenic|
D009369,DISEASE,tumor,|tumor
C024986,CHEMICAL,BaCl2,|BaCl2
D008696,CHEMICAL,Dianabol,|Dianabol
D009136,DISEASE,muscular dystrophy,|muscular dystrophy
D014810,CHEMICAL,vitamin E,|vitamin E
D002806,DISEASE,stippled epiphyses,|stippled epiphyses
D017275,CHEMICAL,Isradipine,|Isradipine
D003035,CHEMICAL,cobalt,|cobalt
C020731,CHEMICAL,carbetocin,|carbetocin
D018457,DISEASE,retained placenta,|retained placenta
D006473,DISEASE,blood loss,|blood loss
D016578,CHEMICAL,crack cocaine,|crack cocaine
D003320,DISEASE,Corneal ulcers,|Corneal ulcers
D003932,CHEMICAL,heroine,|heroine
D020520,DISEASE,globus pallidus infarctions,|globus pallidus infarctions
D009278,CHEMICAL,naphazoline,|naphazoline
C009695,CHEMICAL,xylometazoline,|xylometazoline
D012010,DISEASE,Pure red cell aplasia,|Pure red cell aplasia
D053099,DISEASE,Azotemia,|Azotemia
D002228,CHEMICAL,carbenicillin,|carbenicillin
D020767,DISEASE,intracranial vascular thrombosis,|intracranial vascular thrombosis
D005280,CHEMICAL,fenoterol-hydrobromide,|fenoterol-hydrobromide
C000873,CHEMICAL,methylprednisolone acetate,|methylprednisolone acetate
D015356,DISEASE,retinal artery and choriocapillaris occlusion,|retinal artery and choriocapillaris occlusion
D013752,CHEMICAL,tetracycline,|tetracycline
D007049,DISEASE,sensory and motor dysfunction,|sensory and motor dysfunction
D004976,CHEMICAL,Ethacrynic acid,|Ethacrynic acid
D020758,DISEASE,Thoracic hematomyelia,|Thoracic hematomyelia
D010382,DISEASE,peliosis,|peliosis
D008413,DISEASE,mastitis,|mastitis
D004049,CHEMICAL,diethylcarbamazine,|diethylcarbamazine
D016595,CHEMICAL,misoprostol,|misoprostol
D013852,CHEMICAL,thiotepa,|thiotepa
D020110,CHEMICAL,pinacidil,|pinacidil
D008528,CHEMICAL,mefenamic acid,mefenamic acid|
D009120,DISEASE,muscle cramps,|muscle cramps
C048279,CHEMICAL,chlorhexidine diphosphanilate,|chlorhexidine diphosphanilate
D019793,CHEMICAL,fluorescein,|fluorescein
D013327,CHEMICAL,strophanthidin,strophanthidin|
D010567,CHEMICAL,pertussis vaccine,|pertussis vaccine
D003318,DISEASE,corneal opacities,|corneal opacities
D011559,DISEASE,pseudotumor cerebri,pseudotumor cerebri|
D014985,DISEASE,dry eyes,|dry eyes
D010787,DISEASE,photodermatitis,|photodermatitis
D013827,CHEMICAL,thiabendazole,|thiabendazole
D006994,DISEASE,hypoaldosteronism,|hypoaldosteronism
D001507,CHEMICAL,beclomethasone dipropionate,|beclomethasone dipropionate
D002180,DISEASE,oral candidiasis,|oral candidiasis
D006685,DISEASE,hoarseness,|hoarseness
D005479,CHEMICAL,flurazepam,|flurazepam
D003900,CHEMICAL,deoxycorticosterone,|deoxycorticosterone
D003328,DISEASE,coronary thrombosis,|coronary thrombosis
D001146,DISEASE,Alternating sinus rhythm,|Alternating sinus rhythm
D006876,DISEASE,hydrothorax,|hydrothorax
C034868,CHEMICAL,CPDD,|CPDD
D000784,DISEASE,dissecting aneurysm,|dissecting aneurysm
D000141,DISEASE,renal tubular acidosis,|renal tubular acidosis
C006753,CHEMICAL,Endografine,|Endografine
C025504,CHEMICAL,Dimer-X,|Dimer-X
D015845,DISEASE,tonic pupillary,|tonic pupillary
D014295,CHEMICAL,trimethoprim,|trimethoprim
D002506,CHEMICAL,cephalexin,|cephalexin
D001534,CHEMICAL,bemegride,|bemegride
D001127,CHEMICAL,arginine vasopressin,|arginine vasopressin
D007964,DISEASE,Leukocytosis,|Leukocytosis
D002118,CHEMICAL,Calcium,|Calcium
D000471,DISEASE,metabolic alkalosis,|metabolic alkalosis
D013015,CHEMICAL,"d,l-sotalol","|d,l-sotalol"
D004053,CHEMICAL,diethylpropion,|diethylpropion
D012871,DISEASE,skin eruptions,|skin eruptions
D014514,DISEASE,ureteric calculi,ureteric calculi|
D017091,DISEASE,Ischemic colitis,|Ischemic colitis
D000109,CHEMICAL,acetylcholine,|acetylcholine
C040442,CHEMICAL,helodermin,helodermin|
D005885,DISEASE,gingival hyperplasia,|gingival hyperplasia
D014474,DISEASE,loss of consciousness,|loss of consciousness
C065757,CHEMICAL,Meloxicam,|Meloxicam
D001554,CHEMICAL,benzene,|benzene
D013411,CHEMICAL,sulfadiazine,|sulfadiazine
D004310,DISEASE,Taussig-Bing malformation,|Taussig-Bing malformation
D065817,DISEASE,anotia,|anotia
C027429,CHEMICAL,veralipride,|veralipride
D019888,CHEMICAL,Viracept,|Viracept
D019226,DISEASE,oral ulcers,|oral ulcers
D003560,DISEASE,cysts,cysts|
D007235,DISEASE,preterm infants,|preterm infants
C057837,CHEMICAL,DMPX,|DMPX
D008415,DISEASE,mastocytosis,|mastocytosis
D018856,DISEASE,interstitial cystitis,|interstitial cystitis
D012393,DISEASE,rosacea,rosacea|
C451780,CHEMICAL,niacin extended-release/lovastatin,|niacin extended-release/lovastatin
C105934,CHEMICAL,celecoxib,|celecoxib
D001943,DISEASE,breast cancer,|breast cancer
C035133,CHEMICAL,mirtazapine,|mirtazapine
D011188,CHEMICAL,potassium,|potassium
D010488,DISEASE,polyarteritis nodosa,polyarteritis nodosa|
D004365,CHEMICAL,Chinese herbal,|Chinese herbal
C116926,CHEMICAL,rofecoxib,|rofecoxib
D017512,DISEASE,lichenoid dermatitis,|lichenoid dermatitis
D010100,CHEMICAL,oxygen,|oxygen
C042705,CHEMICAL,PEG-asparaginase,|PEG-asparaginase
D004113,CHEMICAL,Succimer,|Succimer
C085143,CHEMICAL,Piperacillin/tazobactam,|Piperacillin/tazobactam
D054220,DISEASE,cortical dysplasia,cortical dysplasia|
D018119,CHEMICAL,d4T,|d4T
D055370,DISEASE,pulmonary mass,|pulmonary mass
D015433,DISEASE,membranoproliferative glomerulopathy,|membranoproliferative glomerulopathy
D006486,DISEASE,hemosiderosis,|hemosiderosis
D019772,CHEMICAL,Topotecan,|Topotecan
D006961,DISEASE,hyperparathyroidism,|hyperparathyroidism
C071741,CHEMICAL,Remifentanil,|Remifentanil
D010309,DISEASE,parotiditis,|parotiditis
D056648,DISEASE,ANCA positive vasculitis,|ANCA positive vasculitis
D001168,DISEASE,arthritis,|arthritis
D005424,CHEMICAL,flecainide,|flecainide
D006679,DISEASE,HIV seroconversion,HIV seroconversion|
D012770,DISEASE,cardiogenic shock,|cardiogenic shock
C542870,CHEMICAL,botox,|botox
C401859,CHEMICAL,temsirolimus,|temsirolimus
D017257,CHEMICAL,ramipril,|ramipril
D009254,CHEMICAL,nafcillin,|nafcillin
D005947,CHEMICAL,glucose,|glucose
D005690,CHEMICAL,galactose,|galactose
http://purl.obolibrary.org/obo/DOID_0040102,DISEASE,"N,N'-diethylthiourea allergic contact dermatitis","|N,N'-diethylthiourea allergic contact dermatitis"
http://purl.obolibrary.org/obo/CHEBI_82448,NUTRITION,"N,N'-diethylthiourea","|N,N'-diethylthiourea"
http://purl.obolibrary.org/obo/DOID_251,DISEASE,alcohol-induced mental disorder,|alcohol-induced mental disorder
http://purl.obolibrary.org/obo/CHEBI_30879,NUTRITION,alcohol,|alcohol
http://purl.obolibrary.org/obo/DOID_252,DISEASE,alcoholic psychosis,|alcoholic psychosis
http://purl.obolibrary.org/obo/DOID_0040010,DISEASE,mepivacaine allergy,mepivacaine allergy|
http://purl.obolibrary.org/obo/CHEBI_6759,NUTRITION,mepivacaine,|mepivacaine
http://purl.obolibrary.org/obo/DOID_0040103,DISEASE,cefotiam allergy,|cefotiam allergy
http://purl.obolibrary.org/obo/CHEBI_355510,NUTRITION,cefotiam,|cefotiam
http://purl.obolibrary.org/obo/DOID_0040079,DISEASE,"2,4-dinitrophenyl allergic contact dermatitis","|2,4-dinitrophenyl allergic contact dermatitis"
http://purl.obolibrary.org/obo/CHEBI_53018,NUTRITION,"2,4-dinitrophenyl group","|2,4-dinitrophenyl group"
http://purl.obolibrary.org/obo/DOID_0090047,DISEASE,paroxysmal nonkinesigenic dyskinesia 2,|paroxysmal nonkinesigenic dyskinesia 2
http://purl.obolibrary.org/obo/DOID_0060505,DISEASE,apricot allergy,|apricot allergy
http://purl.obolibrary.org/obo/FOODON_00001615,NUTRITION,apricot food product,|apricot food product
http://purl.obolibrary.org/obo/DOID_0040020,DISEASE,cefotaxime allergy,cefotaxime allergy|
http://purl.obolibrary.org/obo/CHEBI_204928,NUTRITION,cefotaxime,|cefotaxime
http://purl.obolibrary.org/obo/DOID_0040011,DISEASE,phenobarbital allergy,|phenobarbital allergy
http://purl.obolibrary.org/obo/CHEBI_8069,NUTRITION,phenobarbital,|phenobarbital
http://purl.obolibrary.org/obo/DOID_8680,DISEASE,alcoholic gastritis,|alcoholic gastritis
http://purl.obolibrary.org/obo/DOID_4377,DISEASE,egg allergy,|egg allergy
http://purl.obolibrary.org/obo/FOODON_00001274,NUTRITION,egg food product,|egg food product
http://purl.obolibrary.org/obo/DOID_0040001,DISEASE,shrimp allergy,|shrimp allergy
http://purl.obolibrary.org/obo/FOODON_00002239,NUTRITION,shrimp food product,|shrimp food product
http://purl.obolibrary.org/obo/DOID_0040002,DISEASE,aspirin allergy,|aspirin allergy
http://purl.obolibrary.org/obo/CHEBI_15365,NUTRITION,acetylsalicylic acid,acetylsalicylic acid|
http://purl.obolibrary.org/obo/DOID_0060495,DISEASE,shellfish allergy,|shellfish allergy
http://purl.obolibrary.org/obo/FOODON_00001293,NUTRITION,shellfish food product,|shellfish food product
http://purl.obolibrary.org/obo/DOID_0060506,DISEASE,cherry allergy,|cherry allergy
http://purl.obolibrary.org/obo/FOODON_00001717,NUTRITION,cherry food product,|cherry food product
http://purl.obolibrary.org/obo/DOID_0060523,DISEASE,mollusc allergy,|mollusc allergy
http://purl.obolibrary.org/obo/FOODON_00002044,NUTRITION,mollusc food product,mollusc food product|
http://purl.obolibrary.org/obo/DOID_0040033,DISEASE,piperacillin allergy,|piperacillin allergy
http://purl.obolibrary.org/obo/CHEBI_8232,NUTRITION,piperacillin,piperacillin|
http://purl.obolibrary.org/obo/DOID_0040016,DISEASE,sulfamethoxazole allergy,|sulfamethoxazole allergy
http://purl.obolibrary.org/obo/CHEBI_9332,NUTRITION,sulfamethoxazole,|sulfamethoxazole
http://purl.obolibrary.org/obo/DOID_0060510,DISEASE,peach allergy,|peach allergy
http://purl.obolibrary.org/obo/FOODON_00002095,NUTRITION,peach food product,|peach food product
http://purl.obolibrary.org/obo/DOID_0040006,DISEASE,carbamazepine allergy,|carbamazepine allergy
http://purl.obolibrary.org/obo/CHEBI_3387,NUTRITION,carbamazepine,|carbamazepine
http://purl.obolibrary.org/obo/DOID_0080949,DISEASE,alcoholic ketoacidosis,|alcoholic ketoacidosis
http://purl.obolibrary.org/obo/DOID_0040024,DISEASE,ceftazidime allergy,|ceftazidime allergy
http://purl.obolibrary.org/obo/CHEBI_3508,NUTRITION,ceftazidime,|ceftazidime
http://purl.obolibrary.org/obo/DOID_0040043,DISEASE,toluene meta-diisocyanate allergic asthma,|toluene meta-diisocyanate allergic asthma
http://purl.obolibrary.org/obo/CHEBI_53555,NUTRITION,toluene meta-diisocyanate,|toluene meta-diisocyanate
http://purl.obolibrary.org/obo/DOID_0040026,DISEASE,chlorhexidine allergy,|chlorhexidine allergy
http://purl.obolibrary.org/obo/CHEBI_3614,NUTRITION,chlorhexidine,|chlorhexidine
http://purl.obolibrary.org/obo/DOID_0040034,DISEASE,rocuronium allergy,|rocuronium allergy
http://purl.obolibrary.org/obo/CHEBI_8884,NUTRITION,rocuronium,|rocuronium
http://purl.obolibrary.org/obo/DOID_0040051,DISEASE,hexahydrophthalic anhydride allergic asthma,|hexahydrophthalic anhydride allergic asthma
http://purl.obolibrary.org/obo/CHEBI_103210,NUTRITION,hexahydrophthalic anhydride,|hexahydrophthalic anhydride
http://purl.obolibrary.org/obo/DOID_0040042,DISEASE,"diphenylmethane-4,4'-diisocyanate allergic asthma","|diphenylmethane-4,4'-diisocyanate allergic asthma"
http://purl.obolibrary.org/obo/CHEBI_53218,NUTRITION,"diphenylmethane-4,4'-diisocyanate","|diphenylmethane-4,4'-diisocyanate"
http://purl.obolibrary.org/obo/DOID_0040025,DISEASE,cefuroxime allergy,cefuroxime allergy|
http://purl.obolibrary.org/obo/CHEBI_3515,NUTRITION,cefuroxime,|cefuroxime
http://purl.obolibrary.org/obo/DOID_0060524,DISEASE,crustacean allergy,|crustacean allergy
http://purl.obolibrary.org/obo/FOODON_00001792,NUTRITION,crustacean food product,|crustacean food product
http://purl.obolibrary.org/obo/DOID_0040007,DISEASE,abacavir allergy,|abacavir allergy
http://purl.obolibrary.org/obo/CHEBI_421707,NUTRITION,abacavir,|abacavir
http://purl.obolibrary.org/obo/DOID_0060515,DISEASE,Atlantic salmon allergy,|Atlantic salmon allergy
http://purl.obolibrary.org/obo/FOODON_00001623,NUTRITION,atlantic salmon food product,|atlantic salmon food product
http://purl.obolibrary.org/obo/DOID_0040015,DISEASE,sulfonamide allergy,|sulfonamide allergy
http://purl.obolibrary.org/obo/CHEBI_35358,NUTRITION,sulfonamide,|sulfonamide
http://purl.obolibrary.org/obo/DOID_12935,DISEASE,alcoholic cardiomyopathy,|alcoholic cardiomyopathy
http://purl.obolibrary.org/obo/DOID_0040052,DISEASE,"diphenylmethane-4,4'-diisocyanate allergic contact dermatitis","|diphenylmethane-4,4'-diisocyanate allergic contact dermatitis"
http://purl.obolibrary.org/obo/DOID_0040035,DISEASE,sulfasalazine allergy,|sulfasalazine allergy
http://purl.obolibrary.org/obo/CHEBI_9334,NUTRITION,sulfasalazine,|sulfasalazine
http://purl.obolibrary.org/obo/DOID_0060519,DISEASE,beta-lactam allergy,|beta-lactam allergy
http://purl.obolibrary.org/obo/CHEBI_35627,NUTRITION,beta-lactam,beta-lactam|
http://purl.obolibrary.org/obo/DOID_0040047,DISEASE,trimellitic anhydride allergic asthma,|trimellitic anhydride allergic asthma
http://purl.obolibrary.org/obo/CHEBI_53050,NUTRITION,trimellitic anhydride,|trimellitic anhydride
http://purl.obolibrary.org/obo/DOID_0060516,DISEASE,carp allergy,|carp allergy
http://purl.obolibrary.org/obo/FOODON_00001684,NUTRITION,carp food product,|carp food product
http://purl.obolibrary.org/obo/DOID_0040070,DISEASE,co-trimoxazole allergy,|co-trimoxazole allergy
http://purl.obolibrary.org/obo/CHEBI_3770,NUTRITION,co-trimoxazole,co-trimoxazole|
http://purl.obolibrary.org/obo/DOID_0040053,DISEASE,cobalt allergic contact dermatitis,|cobalt allergic contact dermatitis
http://purl.obolibrary.org/obo/CHEBI_27638,NUTRITION,cobalt atom,|cobalt atom
http://purl.obolibrary.org/obo/DOID_0040057,DISEASE,benzoic acid allergic contact dermatitis,benzoic acid allergic contact dermatitis|
http://purl.obolibrary.org/obo/CHEBI_30746,NUTRITION,benzoic acid,|benzoic acid
http://purl.obolibrary.org/obo/DOID_0070334,DISEASE,vegetable allergy,|vegetable allergy
http://purl.obolibrary.org/obo/FOODON_00001261,NUTRITION,vegetable food product,|vegetable food product
http://purl.obolibrary.org/obo/DOID_0040080,DISEASE,patent blue V allergy,|patent blue V allergy
http://purl.obolibrary.org/obo/CHEBI_59601,NUTRITION,patent blue V,|patent blue V
http://purl.obolibrary.org/obo/DOID_0040048,DISEASE,phthalic anhydride allergic asthma,|phthalic anhydride allergic asthma
http://purl.obolibrary.org/obo/CHEBI_36605,NUTRITION,phthalic anhydride,|phthalic anhydride
http://purl.obolibrary.org/obo/DOID_4988,DISEASE,alcoholic pancreatitis,alcoholic pancreatitis|
http://purl.obolibrary.org/obo/DOID_0040038,DISEASE,meropenem allergy,|meropenem allergy
http://purl.obolibrary.org/obo/CHEBI_43968,NUTRITION,meropenem,meropenem|
http://purl.obolibrary.org/obo/DOID_0040071,DISEASE,sodium aurothiomalate allergy,|sodium aurothiomalate allergy
http://purl.obolibrary.org/obo/CHEBI_5516,NUTRITION,sodium aurothiomalate,|sodium aurothiomalate
http://purl.obolibrary.org/obo/DOID_0040029,DISEASE,trimethoprim allergy,trimethoprim allergy|
http://purl.obolibrary.org/obo/CHEBI_45924,NUTRITION,trimethoprim,|trimethoprim
http://purl.obolibrary.org/obo/DOID_0040044,DISEASE,methyl isocyanate allergic asthma,|methyl isocyanate allergic asthma
http://purl.obolibrary.org/obo/DOID_0040061,DISEASE,remazole black respiratory allergy,|remazole black respiratory allergy
http://purl.obolibrary.org/obo/CHEBI_53731,NUTRITION,remazole black-GR,|remazole black-GR
http://purl.obolibrary.org/obo/DOID_0040049,DISEASE,maleic anhydride allergic asthma,|maleic anhydride allergic asthma
http://purl.obolibrary.org/obo/CHEBI_474859,NUTRITION,maleic anhydride,|maleic anhydride
http://purl.obolibrary.org/obo/DOID_0040062,DISEASE,chloramine T respiratory allergy,|chloramine T respiratory allergy
http://purl.obolibrary.org/obo/CHEBI_53767,NUTRITION,chloramine T,|chloramine T
http://purl.obolibrary.org/obo/DOID_0040076,DISEASE,phthalyl group allergy,|phthalyl group allergy
http://purl.obolibrary.org/obo/CHEBI_26096,NUTRITION,phthalyl group,|phthalyl group
http://purl.obolibrary.org/obo/DOID_0040066,DISEASE,melphalan allergy,|melphalan allergy
http://purl.obolibrary.org/obo/CHEBI_28876,NUTRITION,melphalan,|melphalan
http://purl.obolibrary.org/obo/DOID_0050667,DISEASE,alcohol-related neurodevelopmental disorder,|alcohol-related neurodevelopmental disorder
http://purl.obolibrary.org/obo/DOID_0060001,DISEASE,withdrawal disorder,|withdrawal disorder
http://purl.obolibrary.org/obo/DOID_0050668,DISEASE,alcohol-related birth defect,|alcohol-related birth defect
http://purl.obolibrary.org/obo/DOID_0070335,DISEASE,celery allergy,|celery allergy
http://purl.obolibrary.org/obo/FOODON_00001705,NUTRITION,celery vegetable food product,|celery vegetable food product
http://purl.obolibrary.org/obo/DOID_0040058,DISEASE,"1,4-phenylenediamine allergic contact dermatitis","|1,4-phenylenediamine allergic contact dermatitis"
http://purl.obolibrary.org/obo/CHEBI_51403,NUTRITION,"1,4-phenylenediamine","1,4-phenylenediamine|"
http://purl.obolibrary.org/obo/DOID_0040075,DISEASE,benzo[d]isothiazol-3-one allergic contact dermatitis,|benzo[d]isothiazol-3-one allergic contact dermatitis
http://purl.obolibrary.org/obo/CHEBI_167099,NUTRITION,benzo[d]isothiazol-3-one,|benzo[d]isothiazol-3-one
http://purl.obolibrary.org/obo/DOID_14018,DISEASE,alcoholic liver cirrhosis,|alcoholic liver cirrhosis
http://purl.obolibrary.org/obo/DOID_0040003,DISEASE,benzylpenicillin allergy,|benzylpenicillin allergy
http://purl.obolibrary.org/obo/CHEBI_18208,NUTRITION,benzylpenicillin,|benzylpenicillin
http://purl.obolibrary.org/obo/DOID_0040030,DISEASE,cefixime allergy,|cefixime allergy
http://purl.obolibrary.org/obo/CHEBI_472657,NUTRITION,cefixime,|cefixime
http://purl.obolibrary.org/obo/DOID_0040013,DISEASE,ranitidine allergy,|ranitidine allergy
http://purl.obolibrary.org/obo/CHEBI_8776,NUTRITION,ranitidine,|ranitidine
http://purl.obolibrary.org/obo/DOID_0050696,DISEASE,fetal alcohol spectrum disorder,|fetal alcohol spectrum disorder
http://purl.obolibrary.org/obo/DOID_0060504,DISEASE,apple allergy,apple allergy|
http://purl.obolibrary.org/obo/FOODON_00001611,NUTRITION,apple food product,|apple food product
http://purl.obolibrary.org/obo/DOID_0040004,DISEASE,amoxicillin allergy,|amoxicillin allergy
http://purl.obolibrary.org/obo/CHEBI_2676,NUTRITION,amoxicillin,|amoxicillin
http://purl.obolibrary.org/obo/DOID_0040021,DISEASE,cephalosporin allergy,|cephalosporin allergy
http://purl.obolibrary.org/obo/CHEBI_23066,NUTRITION,cephalosporin,cephalosporin|
http://purl.obolibrary.org/obo/DOID_0040012,DISEASE,phenytoin allergy,|phenytoin allergy
http://purl.obolibrary.org/obo/CHEBI_8107,NUTRITION,phenytoin,|phenytoin
http://purl.obolibrary.org/obo/DOID_0040104,DISEASE,"toluene 2,4-diisocyanate allergic asthma","|toluene 2,4-diisocyanate allergic asthma"
http://purl.obolibrary.org/obo/CHEBI_53556,NUTRITION,"toluene 2,4-diisocyanate","|toluene 2,4-diisocyanate"
http://purl.obolibrary.org/obo/DOID_0060511,DISEASE,plum allergy,|plum allergy
http://purl.obolibrary.org/obo/FOODON_00002161,NUTRITION,plum fruit food product,|plum fruit food product
http://purl.obolibrary.org/obo/DOID_0090044,DISEASE,dystonia 9,|dystonia 9
http://purl.obolibrary.org/obo/DOID_0040022,DISEASE,amodiaquine allergy,amodiaquine allergy|
http://purl.obolibrary.org/obo/CHEBI_2674,NUTRITION,amodiaquine,amodiaquine|
http://purl.obolibrary.org/obo/DOID_0040005,DISEASE,ceftriaxone allergy,|ceftriaxone allergy
http://purl.obolibrary.org/obo/CHEBI_29007,NUTRITION,ceftriaxone,|ceftriaxone
http://purl.obolibrary.org/obo/DOID_0060512,DISEASE,tomato allergy,|tomato allergy
http://purl.obolibrary.org/obo/FOODON_00001164,NUTRITION,tomato food product,|tomato food product
http://purl.obolibrary.org/obo/DOID_0060530,DISEASE,snail allergy,|snail allergy
http://purl.obolibrary.org/obo/FOODON_00002244,NUTRITION,snail food product,|snail food product
http://purl.obolibrary.org/obo/DOID_0060513,DISEASE,fish allergy,|fish allergy
http://purl.obolibrary.org/obo/FOODON_00001248,NUTRITION,fish food product,|fish food product
http://purl.obolibrary.org/obo/DOID_14183,DISEASE,alcoholic neuropathy,|alcoholic neuropathy
http://purl.obolibrary.org/obo/DOID_0040017,DISEASE,suprofen allergy,|suprofen allergy
http://purl.obolibrary.org/obo/CHEBI_9362,NUTRITION,suprofen,|suprofen
http://purl.obolibrary.org/obo/DOID_0060503,DISEASE,fruit allergy,|fruit allergy
http://purl.obolibrary.org/obo/FOODON_00001057,NUTRITION,plant fruit food product,|plant fruit food product
http://purl.obolibrary.org/obo/CHEBI_17334,NUTRITION,penicillin,|penicillin
http://purl.obolibrary.org/obo/DOID_0060492,DISEASE,chicken egg allergy,chicken egg allergy|
http://purl.obolibrary.org/obo/FOODON_00001275,NUTRITION,hen egg food product,|hen egg food product
http://purl.obolibrary.org/obo/DOID_0090049,DISEASE,paroxysmal nonkinesigenic dyskinesia 1,|paroxysmal nonkinesigenic dyskinesia 1
http://purl.obolibrary.org/obo/DOID_0040023,DISEASE,cefaclor allergy,|cefaclor allergy
http://purl.obolibrary.org/obo/CHEBI_3478,NUTRITION,cefaclor,|cefaclor
http://purl.obolibrary.org/obo/DOID_0040040,DISEASE,hexamethylene diisocyanate allergic asthma,|hexamethylene diisocyanate allergic asthma
http://purl.obolibrary.org/obo/CHEBI_53578,NUTRITION,hexamethylene diisocyanate,|hexamethylene diisocyanate
http://purl.obolibrary.org/obo/DOID_4376,DISEASE,milk allergy,|milk allergy
http://purl.obolibrary.org/obo/FOODON_00001257,NUTRITION,milk or milk based food product,|milk or milk based food product
http://purl.obolibrary.org/obo/DOID_0040027,DISEASE,cyclophosphamide allergy,|cyclophosphamide allergy
http://purl.obolibrary.org/obo/CHEBI_4027,NUTRITION,cyclophosphamide,|cyclophosphamide
http://purl.obolibrary.org/obo/DOID_0040018,DISEASE,thiopental allergy,|thiopental allergy
http://purl.obolibrary.org/obo/CHEBI_102166,NUTRITION,thiopental,|thiopental
http://purl.obolibrary.org/obo/DOID_0040050,DISEASE,tetrachlorophthalic anhydride allergic asthma,|tetrachlorophthalic anhydride allergic asthma
http://purl.obolibrary.org/obo/CHEBI_59097,NUTRITION,tetrachlorophthalic anhydride,|tetrachlorophthalic anhydride
http://purl.obolibrary.org/obo/DOID_0040041,DISEASE,isocyanates allergic asthma,|isocyanates allergic asthma
http://purl.obolibrary.org/obo/CHEBI_53212,NUTRITION,isocyanates,|isocyanates
http://purl.obolibrary.org/obo/DOID_0040008,DISEASE,isoniazide allergy,|isoniazide allergy
http://purl.obolibrary.org/obo/CHEBI_6030,NUTRITION,isoniazide,|isoniazide
http://purl.obolibrary.org/obo/DOID_0060508,DISEASE,orange allergy,|orange allergy
http://purl.obolibrary.org/obo/FOODON_00002071,NUTRITION,orange food product,|orange food product
http://purl.obolibrary.org/obo/DOID_0040014,DISEASE,corticosteroid allergy,|corticosteroid allergy
http://purl.obolibrary.org/obo/CHEBI_50858,NUTRITION,corticosteroid,|corticosteroid
http://purl.obolibrary.org/obo/DOID_0040031,DISEASE,diclofenac allergy,diclofenac allergy|
http://purl.obolibrary.org/obo/CHEBI_47381,NUTRITION,diclofenac,|diclofenac
http://purl.obolibrary.org/obo/DOID_0040032,DISEASE,carbapenem allergy,|carbapenem allergy
http://purl.obolibrary.org/obo/CHEBI_46633,NUTRITION,carbapenems,|carbapenems
http://purl.obolibrary.org/obo/DOID_0060518,DISEASE,rainbow trout allergy,|rainbow trout allergy
http://purl.obolibrary.org/obo/FOODON_00002185,NUTRITION,rainbow trout food product,|rainbow trout food product
http://purl.obolibrary.org/obo/DOID_0040019,DISEASE,D-mannitol allergy,D-mannitol allergy|
http://purl.obolibrary.org/obo/CHEBI_16899,NUTRITION,D-mannitol,|D-mannitol
http://purl.obolibrary.org/obo/DOID_0060509,DISEASE,melon allergy,|melon allergy
http://purl.obolibrary.org/obo/FOODON_00002029,NUTRITION,melon food product,melon food product|
http://purl.obolibrary.org/obo/DOID_0040009,DISEASE,lidocaine allergy,|lidocaine allergy
http://purl.obolibrary.org/obo/CHEBI_6456,NUTRITION,lidocaine,|lidocaine
http://purl.obolibrary.org/obo/DOID_0040063,DISEASE,4-vinylcyclohexene dioxide respiratory allergy,|4-vinylcyclohexene dioxide respiratory allergy
http://purl.obolibrary.org/obo/CHEBI_59001,NUTRITION,4-vinylcyclohexene dioxide,4-vinylcyclohexene dioxide|
http://purl.obolibrary.org/obo/DOID_0040046,DISEASE,nickel allergic contact dermatitis,nickel allergic contact dermatitis|
http://purl.obolibrary.org/obo/CHEBI_28112,NUTRITION,nickel atom,|nickel atom
http://purl.obolibrary.org/obo/DOID_0040036,DISEASE,tubocurarine allergy,|tubocurarine allergy
http://purl.obolibrary.org/obo/CHEBI_9774,NUTRITION,tubocurarine,|tubocurarine
http://purl.obolibrary.org/obo/DOID_0040054,DISEASE,cobalt allergic asthma,|cobalt allergic asthma
http://purl.obolibrary.org/obo/DOID_0040073,DISEASE,disodium cromoglycate allergy,|disodium cromoglycate allergy
http://purl.obolibrary.org/obo/CHEBI_128458,NUTRITION,disodium cromoglycate,|disodium cromoglycate
http://purl.obolibrary.org/obo/DOID_0040056,DISEASE,chromium allergic contact dermatitis,|chromium allergic contact dermatitis
http://purl.obolibrary.org/obo/CHEBI_28073,NUTRITION,chromium atom,|chromium atom
http://purl.obolibrary.org/obo/DOID_0060904,DISEASE,legume allergy,|legume allergy
http://purl.obolibrary.org/obo/FOODON_00001264,NUTRITION,legume food product,|legume food product
http://purl.obolibrary.org/obo/DOID_0040081,DISEASE,acid anhydride respiratory allergy,acid anhydride respiratory allergy|
http://purl.obolibrary.org/obo/CHEBI_36606,NUTRITION,acid anhydride,|acid anhydride
http://purl.obolibrary.org/obo/DOID_0040064,DISEASE,carvone allergic contact dermatitis,|carvone allergic contact dermatitis
http://purl.obolibrary.org/obo/CHEBI_15400,NUTRITION,(-)-carvone,|(-)-carvone
http://purl.obolibrary.org/obo/DOID_0040055,DISEASE,palladium allergic contact dermatitis,|palladium allergic contact dermatitis
http://purl.obolibrary.org/obo/CHEBI_33363,NUTRITION,palladium,|palladium
http://purl.obolibrary.org/obo/DOID_0040072,DISEASE,parthenolide allergic contact dermatitis,|parthenolide allergic contact dermatitis
http://purl.obolibrary.org/obo/CHEBI_7939,NUTRITION,parthenolide,|parthenolide
http://purl.obolibrary.org/obo/DOID_0040037,DISEASE,aztreonam allergy,|aztreonam allergy
http://purl.obolibrary.org/obo/CHEBI_161680,NUTRITION,aztreonam,|aztreonam
http://purl.obolibrary.org/obo/DOID_0040045,DISEASE,nickel allergic asthma,|nickel allergic asthma
http://purl.obolibrary.org/obo/DOID_0040028,DISEASE,succinylcholine allergy,|succinylcholine allergy
http://purl.obolibrary.org/obo/CHEBI_45652,NUTRITION,succinylcholine,succinylcholine|
http://purl.obolibrary.org/obo/DOID_0040065,DISEASE,quinidine allergy,|quinidine allergy
http://purl.obolibrary.org/obo/CHEBI_28593,NUTRITION,quinidine,quinidine|
http://purl.obolibrary.org/obo/DOID_0040082,DISEASE,oxirane allergy,|oxirane allergy
http://purl.obolibrary.org/obo/CHEBI_27561,NUTRITION,oxirane,|oxirane
http://purl.obolibrary.org/obo/DOID_0050665,DISEASE,fetal alcohol syndrome,|fetal alcohol syndrome
http://purl.obolibrary.org/obo/DOID_0040069,DISEASE,"1-chloro-2,4-dinitrobenzene allergic contact dermatitis","1-chloro-2,4-dinitrobenzene allergic contact dermatitis|"
http://purl.obolibrary.org/obo/CHEBI_34718,NUTRITION,"1-chloro-2,4-dinitrobenzene","|1-chloro-2,4-dinitrobenzene"
http://purl.obolibrary.org/obo/DOID_0040077,DISEASE,alcuronium bromide allergy,|alcuronium bromide allergy
http://purl.obolibrary.org/obo/CHEBI_488385,NUTRITION,alcuronium bromide,|alcuronium bromide
http://purl.obolibrary.org/obo/DOID_14081,DISEASE,toxic labyrinthitis,|toxic labyrinthitis
http://purl.obolibrary.org/obo/DOID_0050666,DISEASE,partial fetal alcohol syndrome,|partial fetal alcohol syndrome
http://purl.obolibrary.org/obo/DOID_0040101,DISEASE,"N,N'-diphenylthiourea allergic contact dermatitis","|N,N'-diphenylthiourea allergic contact dermatitis"
http://purl.obolibrary.org/obo/CHEBI_138412,NUTRITION,"N,N'-diphenylthiourea","|N,N'-diphenylthiourea"
http://purl.obolibrary.org/obo/DOID_0040078,DISEASE,gallamine allergy,|gallamine allergy
http://purl.obolibrary.org/obo/CHEBI_503442,NUTRITION,gallamine,|gallamine
http://purl.obolibrary.org/obo/DOID_0040068,DISEASE,4-tert-butylphenol allergic contact dermatitis,|4-tert-butylphenol allergic contact dermatitis
http://purl.obolibrary.org/obo/DOID_0040059,DISEASE,potassium dichromate allergic contact dermatitis,potassium dichromate allergic contact dermatitis|
http://purl.obolibrary.org/obo/CHEBI_53444,NUTRITION,potassium dichromate,|potassium dichromate
http://purl.obolibrary.org/obo/DOID_0040074,DISEASE,formaldehyde allergic contact dermatitis,|formaldehyde allergic contact dermatitis
http://purl.obolibrary.org/obo/CHEBI_16842,NUTRITION,formaldehyde,|formaldehyde
